Sleep	O
disordered	O
breathing	O
during	O
pregnancy	O
was	O
assessed	O
by	O
asking	O
women	O
about	O
the	O
frequency	O
of	O
snoring	O
during	O
the	O
index	O
pregnancy	O
.	O

Based	O
on	O
the	O
lung	O
function	O
and	O
outcome	O
of	O
the	O
analysis	O
inTable	O
1	O
,	O
we	O
had	O
then	O
used	O
those	O
relatively	O
significant	O
variables	O
(	O
p	O
≤	O
0	O
.	O
1	O
)	O
to	O
determine	O
independent	O
predictors	O
with	O
multivariate	O
linear	O
or	O
logistical	O
regression	O
.	O

Iron	O
-	O
deficiency	O
is	O
the	O
most	O
common	O
nutritional	O
deficiency	O
globally	O
.	O

2	O
.	O
2	O
.	O
3	O
.	O

Reducing	O
risks	O
before	O
,	O
during	O
,	O
and	O
between	O
pregnancies	O
through	O
preconception	O
and	O
antenatal	O
care	O
packages	O
may	O
help	O
preterm	O
birth	O
prevention	O
[	O
4	O
,	O
5	O
].	O

In	O
Norway	O
,	O
a	O
study	O
comprising	O
119	O
MS	O
cases	O
and	O
251	O
controls	O
living	O
above	O
the	O
Arctic	O
Circle	O
,	O
where	O
fatty	O
fish	O
is	O
a	O
major	O
contributor	O
to	O
vitamin	O
D	O
intake	O
,	O
reported	O
a	O
lower	O
risk	O
of	O
MS	O
for	O
individuals	O
who	O
ate	O
fish	O
three	O
or	O
more	O
times	O
per	O
week	O
at	O
16	O
–	O
20	O
years	O
of	O
age	O
compared	O
with	O
those	O
with	O
a	O
lower	O
consumption	O
(	O
odds	O
ratio	O
=	O
0	O
.	O
57	O
[	O
95	O
%	O
CI	O
0	O
.	O
33	O
-	O
0	O
.	O
93	O
];	O
P	O
=	O
0	O
.	O
024	O
).	O
19Supplementation	O
with	O
codliver	O
oil	O
was	O
also	O
associated	O
with	O
lower	O
risk	O
of	O
MS	O
,	O
but	O
only	O
among	O
individuals	O
with	O
low	O
summer	O
outdoor	O
activity	O
.	O

The	O
mitochondria	O
of	O
BAT	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
uncoupling	O
protein	O
-	O
1	O
(	O
UCP1	O
)	O
in	O
the	O
inner	O
mitochondrial	O
membrane	O
.	O

Poor	O
nutrition	O
(	O
reduced	O
folate	O
),	O
detoxification	O
of	O
arsenic	O
and	O
consumption	O
of	O
glutathione	O
during	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
can	O
all	O
lead	O
to	O
reduced	O
levels	O
of	O
the	O
DNMT	O
co	O
-	O
substrate	O
S	O
-	O
adenosylmethionine	O
(	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

PubMed	O
Central	O
:	O

Cross	O
-	O
validation	O
was	O
used	O
to	O
determine	O
the	O
penalization	O
parameter	O
.	O

The	O
steers	O
of	O
the	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
were	O
raised	O
under	O
the	O
same	O
conditions	O
as	O
the	O
normally	O
weaned	O
animals	O
,	O
but	O
they	O
were	O
supplemented	O
with	O
grain	O
for	O
55	O
d	O
on	O
pasture	O
(	O
study	O
1	O
,	O
177	O
to	O
231	O
d	O
of	O
age	O
;	O
study	O
2	O
,	O
158	O
to	O
213	O
d	O
of	O
age	O
).	O

The	O
animal	O
studies	O
performed	O
by	O
Roullet	O
have	O
been	O
used	O
as	B
a	O
model	O
to	O
ameliorate	O
and	O
improve	O
upon	O
studies	O
that	O
focus	O
on	O
the	O
association	O
between	O
the	O
risk	O
of	O
autism	O
and	O
the	O
maternal	O
need	O
for	O
anticonvulsants	O
[	O
5	O
].	O

(	O
11	O
)	O
(	O
15	O
to	O
18	O
nmol	O
/	O
L	O
)	O
than	O
our	O
cohort	O
(	O
9	O
to	O
10	O
nmol	O
/	O
L	O
),	O
but	O
this	O
could	O
reflect	O
the	O
higher	O
cholecalciferol	O
doses	O
used	O
in	O
those	O
studies	O
and	O
/	O
or	O
alterations	O
in	O
vitamin	O
D	O
metabolism	O
and	O
volume	O
of	O
distribution	O
in	O
pregnancy	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
was	O
significantly	O
higher	O
for	O
less	O
educated	O
women	O
and	O
women	O
who	O
reported	O
not	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

This	O
was	O
not	O
statistically	O
significant	O
in	O
the	O
MLR	O
models	O
.	O

Among	O
them	O
,	O
70	O
women	O
(	O
45	O
.	O
8	O
%)	O
scored	O
<	O
9	O
and	O
83	O
women	O
(	O
54	O
.	O
2	O
%)	O
scored	O
9	O
–	O
13	O
.	O

We	O
also	O
assumed	B
one	O
fecal	O
contact	O
event	O
to	O
be	O
detected	O
per	O
3	O
-	O
hour	O
structured	O
observation	O
.	O

However	O
,	O
it	O
should	O
also	O
be	O
considered	O
that	O
the	O
high	O
incidence	O
of	O
cardiovascular	O
disorders	O
could	O
be	O
due	B
to	I
alterations	O
in	O
autonomic	O
control	O
.	O

Yet	O
she	O
was	O
surprised	O
by	O
the	O
high	O
prevalence	O
of	O
delayed	O
lactogenesis	O
—	O
meaning	O
no	O
signs	O
of	O
copious	O
milk	O
production	O
within	O
the	O
first	O
72	O
hours	O
of	O
giving	O
birth	O
—	O
in	O
mothers	O
who	O
were	O
striving	O
to	O
breastfeed	O
exclusively	O
.	O
31	O
“	O
I	O
kept	O
thinking	O
,	O
how	O
did	O
our	O
species	O
survive	O
?”	O
she	O
says	O
.	O

For	O
boys	O
,	O
the	O
same	O
change	O
was	O
only	O
correlated	O
with	O
the	O
height	O
of	O
the	O
father	O
,	O
p	O
=	O
0	O
.	O
047	O
.	O

Thus	B
,	O
with	O
differing	O
results	O
it	O
is	O
evident	B
that	O
more	O
specific	O
studies	O
need	O
to	O
be	O
conducted	O
on	O
infertility	O
treatments	O
keeping	O
in	O
mind	O
specific	O
subtypes	O
and	O
their	O
effect	O
on	O
autism	O
in	O
children	O
.	O

The	O
cohort	O
of	O
the	O
mother	O
-	O
child	O
dyads	O
will	O
be	O
followed	O
up	O
from	O
recruitment	O
until	O
42	O
days	O
after	O
birth	O
.	O

The	O
child	O
was	O
treated	O
with	O
nebulized	O
adrenaline	O
followed	O
by	O
salbutamol	O
.	O

Within	O
this	O
window	O
the	O
peak	O
for	O
immune	O
system	O
priming	O
or	O
susceptibility	O
is	O
believed	O
to	O
vary	O
differentially	O
in	O
response	O
to	O
presenting	O
antigens	O
[	O
53	O
,	O
54	O
].	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

Methods	O
We	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
on	O
a	O
sample	O
of	O
400	O
pregnant	O
women	O
admitted	O
to	O
the	O
Cuza	O
-	O
Vodă	O
Obstetrics	O
and	O
Gynaecology	O
Clinical	O
Hospital	O
in	O
Iaşi	O
,	O
Romania	O
,	O
during	O
August	O
-	O
September	O
2010	O
.	O

Interestingly	O
,	O
the	O
ECS	O
is	O
implicated	O
in	O
the	O
intake	O
of	O
palatable	O
food	O
(	O
DiPatrizio	O
and	O
Simansky	O
,	O
2008	O
)	O
and	O
the	O
perception	O
of	O
sweet	O
taste	O
(	O
Niki	O
et	O
al	O
.,	O
2015	O
).	O

All	O
identified	O
observational	O
cohort	O
studies	O
in	O
the	O
current	O
review	O
used	O
food	O
frequency	O
questionnaires	O
(	O
FFQs	O
)	O
to	O
assess	O
fish	O
intake	O
.	O

Physical	O
activity	O
and	O
emotional	O
well	O
-	O
being	O
scores	O
were	O
similar	O
between	O
extended	O
winter	O
and	O
extended	O
summer	O
groups	O
.	O

2010	O
;	O
Poage	O
et	O
al	O
.	O

End	O
Note	O
Research	O
for	O
this	O
article	O
was	O
supported	O
by	O
Hertha	O
Firnberg	O
stipend	O
T283	O
-	O
B13	O
and	O
SFB	O
F1808	O
-	O
B13	O
from	O
the	O
Austrian	O
Science	O
Fund	O
(	O
FWF	O
).	O

Since	O
2013	O
,	O
the	O
database	O
of	O
the	O
US	O
National	O
Library	O
of	O
Medicine	O
National	O
Institutes	O
of	O
Health	O
(	O
PubMed	O
)	O
has	O
gained	O
2050	O
new	O
publications	O
about	O
vitamin	O
D	O
and	O
contains	O
62	O
,	O
427	O
articles	O
regarding	O
this	O
subject	O
.	O

The	O
Swedish	O
Data	O
Inspection	O
Board	O
and	O
the	O
regional	O
Ethical	O
Committee	O
approved	O
the	O
study	O
.	O

In	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
,	O
the	O
urine	O
urea	O
(−	O
70	O
%,	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
creatinine	O
(−	O
58	O
%,	O
P	O
<	O
0	O
.	O
001	O
)	O
values	O
were	O
decreased	O
in	O
comparison	O
with	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
class	O
methylation	O
.	O

Cell	O
Culture	O
BeWo	O
and	O
JEG	O
-	O
3	O
cell	O
lines	O
were	O
maintained	O
at	O
standard	O
culture	O
conditions	O
of	O
5	O
%	O
CO2in	O
air	O
at	O
37	O
°	O
C	O
.	O

PubMed	O
Central	O
:	O

Conclusion	O
Although	O
a	O
high	O
correlation	O
was	O
found	O
between	O
maternal	O
and	O
cord	O
vitamin	O
D	O
levels	O
,	O
the	O
effect	O
on	O
respiratory	O
outcome	O
was	O
different	O
.	O

Through	O
involvement	O
in	O
NAD	O
+	O
synthesis	O
needed	O
for	O
SIRT	O
activity	O
,	O
visfatin	O
has	O
a	O
major	O
role	O
in	O
the	O
regulation	O
of	O
SIRT1	O
-	O
dependent	O
transcription	O
,	O
and	O
this	O
leads	O
to	O
the	O
metabolism	O
of	O
energy	O
and	O
differentiation	O
of	O
stem	O
cells	O
.	O

Maternal	O
high	O
fat	O
exposure	O
We	O
found	O
that	O
exposure	O
to	O
a	O
high	O
fat	O
diet	O
either	O
throughout	O
the	O
lifetime	O
of	O
the	O
mother	O
or	O
restricted	O
to	O
pregnancy	O
and	O
/	O
or	O
lactation	O
led	O
to	O
early	O
pubertal	O
onset	O
.	O

The	O
majority	B
of	O
the	O
participants	O
lived	O
in	O
Keelung	O
,	O
a	O
rainy	O
city	O
whose	O
inhabitants	O
have	O
a	O
higher	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
than	O
elsewhere	O
due	B
to	I
lack	O
of	O
sun	O
exposure	O
[	O
52	O
].	O

Those	O
who	O
did	O
not	O
complete	O
the	O
interview	O
were	O
recorded	O
as	O
having	O
refused	O
to	O
participate	O
and	O
were	O
taken	O
into	O
account	O
when	O
calculating	O
the	O
refusal	O
rate	O
,	O
but	O
excluded	O
from	O
the	O
final	O
analysis	O
.	O

Two	O
weeks	O
before	O
mating	O
female	O
rats	O
were	O
exposed	O
to	O
20	O
%	O
caloric	O
restriction	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD20	O
).	O

CONCLUSIONS	O
In	O
conclusion	O
,	O
this	O
study	O
showed	O
that	O
serum	O
vitamin	O
D	O
deficiency	O
might	O
be	O
a	O
potential	O
environmental	O
predisposing	O
factor	O
for	O
developing	O
multiple	O
sclerosis	O
in	O
our	O
region	O
,	O
and	O
need	O
to	O
follow	O
factors	O
that	O
cause	O
this	O
problem	O
including	O
dietary	O
,	O
genetic	O
,	O
and	O
other	O
ones	O
.	O

Age	O
-	O
and	O
energy	O
-	O
adjusted	O
models	O
(	O
with	O
age	O
in	O
5	O
-	O
year	O
intervals	O
and	O
total	O
energy	O
intake	O
as	O
a	O
continuous	O
variable	O
)	O
were	O
fitted	O
,	O
as	O
well	O
as	O
models	O
adjusted	O
for	O
additional	O
potential	O
confounders	O
,	O
including	O
categories	O
of	O
BMI	O
(<	O
25	O
,	O
25	O
-	O
29	O
.	O
9	O
,	O
30	O
or	O
more	O
),	O
level	O
of	O
education	O
(	O
0	O
to	O
10	O
years	O
,	O
10	O
-	O
13	O
years	O
,	O
13	O
+	O
years	O
),	O
country	O
of	O
birth	O
(	O
Nordic	O
countries	O
or	O
other	O
countries	O
),	O
smoking	O
(	O
yes	O
,	O
no	O
),	O
and	O
intake	O
of	O
selected	O
food	O
groups	O
and	O
nutrient	O
densities	O
(	O
fish	O
other	O
than	O
the	O
main	O
exposure	O
of	O
interest	O
,	O
meat	O
,	O
dairy	O
products	O
,	O
vegetables	O
,	O
fruits	O
,	O
cereals	O
,	O
refined	O
sugar	O
,	O
alcohol	O
,	O
fatty	O
acids	O
other	O
than	O
the	O
main	O
exposure	O
of	O
interest	O
,	O
retinol	O
,	O
and	O
vitamins	O
A	O
,	O
B6	O
,	O
and	O
B12	O
),	O
categorized	O
into	O
quartiles	O
,	O
as	O
well	O
as	O
rheumatoid	O
arthritis	O
(	O
yes	O
,	O
no	O
),	O
gluten	O
intolerance	O
(	O
yes	O
,	O
no	O
),	O
diabetes	O
(	O
yes	O
,	O
no	O
),	O
intake	O
of	O
multivitamin	O
supplements	O
(	O
never	O
,	O
occasional	O
,	O
regular	O
).	O

Our	O
secondary	O
hypotheses	O
were	O
that	O
supplementation	O
would	O
reduce	O
all	O
pneumonias	O
(	O
radiologically	O
confirmed	O
or	O
clinically	O
defined	O
),	O
repeat	O
episodes	O
of	O
pneumonia	O
,	O
hospital	O
admissions	O
,	O
and	O
all	O
cause	O
mortality	O
.	O

These	O
suboptimal	O
levels	O
were	O
also	O
seen	O
in	O
recent	O
reports	O
by	O
Liao	O
et	O
al	O
[	O
31	O
].	O

The	O
exclusion	O
criteria	O
are	O
:	O
1	O
).	O

The	O
sensitization	O
process	O
involves	O
the	O
production	O
of	O
allergen	O
-	O
specific	O
immunoglobulin	O
E	O
(	O
IgE	O
)	O
antibodies	O
,	O
which	O
are	O
fixed	O
to	O
mast	O
cells	O
via	O
their	O
high	O
-	O
affinity	O
receptor	O
,	O
Fc	O
epsilon	O
receptor	O
I	O
(	O
Fc	O
ε	O
RI	O
).	O

IRB	O
approval	O
was	O
obtained	O
from	O
Vanderbilt	O
and	O
Wake	O
Forest	O
Universities	O
.	O

The	O
current	O
experience	O
is	O
that	O
the	O
short	O
acting	O
insulin	O
analogs	O
lispro	O
and	O
aspart	O
are	O
safe	O
,	O
but	O
there	O
are	O
only	O
limited	O
data	O
to	O
support	O
the	O
use	O
of	O
long	O
acting	O
insulin	O
analogs	O
.	O

In	O
our	O
study	O
,	O
in	O
addition	O
to	O
social	O
desirability	O
or	O
recall	O
bias	O
on	O
key	O
variables	O
like	O
chronic	O
conditions	O
,	O
there	O
may	O
have	O
been	O
residual	O
confounding	O
as	B
we	O
did	O
not	O
collect	O
information	O
on	O
other	O
risk	O
factors	O
known	O
to	O
be	O
associated	O
with	O
adverse	O
neonatal	O
outcomes	O
,	O
such	O
as	O
previous	O
history	O
of	O
adverse	O
birth	O
outcomes	O
,	O
domestic	O
violence	O
,	O
harsh	O
working	O
conditions	O
,	O
or	O
exposure	O
to	O
pollutants	O
or	O
chemicals	O
[	O
45	O
],[	O
46	O
],[	O
47	O
],[	O
48	O
],[	O
49	O
],[	O
50	O
].	O

To	O
determine	O
the	O
most	O
robust	O
set	O
of	O
predictors	O
and	O
correlates	O
of	O
infant	O
outcomes	O
,	O
multiple	O
regression	O
analyses	O
were	O
used	O
.	O

At	O
T1	O
and	O
T3	O
,	O
participants	O
answered	O
questionnaires	O
regarding	O
lifestyle	O
factors	O
and	O
background	O
data	O
.	O

However	O
,	O
GEE	O
models	O
using	O
the	O
KAB	O
factor	O
did	O
not	O
show	O
significant	O
results	O
and	O
have	O
not	O
included	O
those	O
data	O
.	O

Data	O
sources	O
for	O
UK	O
and	O
US	O
historical	O
data	O
:	O
(	O
CDC	O
,	O
2012	O
,	O
Office	O
for	O
National	O
Statistics	O
,	O
2012	O
,	O
NIH	O
,	O
1985	O
,	O
Smith	O
et	O
al	O
.,	O
1983	O
,	O
Jamison	O
et	O
al	O
.,	O
2006	O
,	O
Lissauer	O
and	O
Fanaroff	O
,	O
2006	O
,	O
Baker	O
,	O
2000	O
,	O
Philip	O
,	O
2005	O
,	O
Wegman	O
,	O
2001	O
)	O
[	O
54	O
-	O
62	O
].	O

The	O
effect	O
of	O
breastfeeding	O
on	O
the	O
prevention	O
AM	O
is	O
unresolved	O
.	O

In	O
addition	O
,	O
adjustments	O
for	O
multiple	O
testing	O
were	O
made	O
in	O
this	O
model	O
.	O

These	O
supplements	O
are	O
not	O
necessary	O
in	O
most	O
pregnancies	O
,	O
which	O
raises	O
questions	O
about	O
women	O
’	O
s	O
motivation	O
to	O
use	O
them	O
in	O
the	O
absence	O
of	O
formal	O
recommendations	O
.	O

In	O
a	O
past	O
study	O
,	O
a	O
similar	O
gene	O
-	O
environment	O
interaction	O
was	O
noted	O
between	O
the	O
ER22	O
/	O
23EK	O
polymorphism	O
and	O
the	O
effect	O
of	O
childhood	O
adversity	O
on	O
depression	O
[	O
17	O
].	O

Therefore	B
,	O
screening	O
for	O
GDM	O
usually	O
occurs	O
around	O
24	O
–	O
28	O
weeks	O
into	O
the	O
pregnancy	O
.	O

2007	O
).	O

Data	O
monitoring	O
Electronic	O
data	O
monitoring	O
tool	O
We	O
will	O
develop	O
an	O
online	O
monitoring	O
system	O
,	O
which	O
will	O
provide	O
us	O
real	O
-	O
time	O
information	O
on	O
enrolment	O
status	O
,	O
adherence	O
of	O
the	O
data	O
collectors	O
with	O
the	O
evaluation	O
schedule	O
and	O
quality	O
of	O
data	O
for	O
key	O
variables	O
.	O

Biochemical	O
screening	O
of	O
familial	O
disease	O
consists	O
of	O
serum	O
calcitonin	O
evaluation	O
,	O
and	O
genetic	O
screening	O
of	O
individuals	O
with	O
a	O
RET	O
mutation	O
may	O
also	O
be	O
performed	O
.	O

Overall	O
,	O
for	O
approximately	O
half	O
of	O
the	O
participants	O
(	O
46	O
%)	O
the	O
baby	O
included	O
in	O
the	O
study	O
was	O
their	O
first	O
;	O
however	O
,	O
being	O
a	O
first	O
-	O
time	O
mother	O
was	O
more	O
frequent	O
among	O
those	O
vaccinated	O
than	O
unvaccinated	O
(	O
49	O
%	O
vs	O
.	O
43	O
%,	O
respectively	O
).	O

Then	O
,	O
2	O
weeks	O
before	O
mating	O
(	O
Figure1	O
),	O
animals	O
were	O
weighed	O
(	O
average	O
weight	O
240	O
.	O
7	O
±	O
3	O
.	O
4	O
g	O
)	O
and	O
randomly	O
exposed	O
to	O
an	O
ad	O
libitum	O
access	O
of	O
a	O
standard	O
chow	O
(	O
control	O
group	O
;	O
n	O
=	O
9	O
)	O
or	O
a	O
restricted	O
access	O
of	O
the	O
same	O
standard	O
chow	O
(	O
caloric	O
restriction	O
group	O
;	O
n	O
=	O
15	O
).	O

Bindon	O
[	O
115	O
]	O
suggested	O
that	O
maize	O
produces	O
increased	O
glucose	O
from	O
digestion	O
in	O
the	O
small	O
intestine	O
and	O
that	O
steam	O
flaking	O
increases	O
digestion	O
in	O
both	O
the	O
rumen	O
and	O
small	O
intestine	O
.	O

HELLP	O
syndrome	O
is	O
considered	O
a	O
spectrum	O
of	O
preeclampsia	O
.	O

Other	O
familial	O
associations	O
for	O
BMI	O
The	O
mother	O
'	O
s	O
BMI	O
was	O
highly	O
significantly	O
correlated	O
with	O
that	O
of	O
her	O
own	O
mother	O
p	O
<	O
0	O
.	O
001	O
).	O

Overall	O
,	O
this	O
book	O
will	O
be	O
of	O
benefit	O
to	O
postgraduates	O
in	O
the	O
field	O
of	O
nutrition	O
,	O
nutritionists	O
in	O
hospitals	O
and	O
physicians	O
.	O

According	O
to	O
the	O
present	O
study	O
results	O
,	O
mean	O
serum	O
visfatin	O
levels	O
were	O
higher	O
in	O
the	O
second	O
trimester	O
compared	O
with	O
the	O
first	O
.	O

Recently	O
,	O
however	O
,	O
labor	O
induction	O
was	O
positively	O
correlated	O
with	O
autism	O
in	O
a	O
large	O
population	O
study	O
comparing	O
birth	O
records	O
in	O
North	O
Carolina	O
(	O
1990	O
–	O
1998	O
)	O
and	O
corresponding	O
school	O
records	O
of	O
autistic	O
children	O
(	O
1997	O
–	O
2007	O
).	O

Dietary	O
intake	O
of	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
by	O
the	O
level	O
of	O
fatty	O
acids	O
intake	O
is	O
shown	O
in	O
Table3	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
.	O

Epigenetic	O
regulation	O
of	O
gene	O
expression	O
.	O

While	O
on	O
treatment	O
,	O
child	O
had	O
an	O
episode	O
of	O
multifocal	O
clonic	O
movements	O
involving	O
all	O
four	O
limbs	O
lasting	O
for	O
2	O
minutes	O
.	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	O
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

Thus	B
,	O
it	O
is	O
unclear	O
whether	O
exposure	O
to	O
SGAs	O
may	O
cause	O
fetal	O
-	O
weight	O
gain	O
directly	O
or	O
indirectly	O
by	O
inducing	O
maternal	O
weight	O
gain	O
prior	O
to	O
conception	O
.	O

Treatment	O
with	O
THs	O
induces	O
UCP1	O
expression	O
in	O
brown	O
adipocytes	O
in	O
rats	O
,	O
following	O
their	O
binding	O
to	O
TH	O
-	O
responsive	O
elements	O
in	O
the	O
UCP1	O
promoter	O
(	O
Guerra	O
et	O
al	O
.,	O
1996	O
).	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Nowadays	O
,	O
we	O
know	O
that	O
brain	O
cells	O
such	O
as	O
microglia	O
and	O
astrocytes	O
,	O
can	O
secrete	O
cytokines	O
.	O

Conclusions	O
These	O
observations	O
are	O
suggestive	O
of	O
two	O
distinct	O
developmental	O
pathways	O
leading	O
to	O
the	O
acceleration	O
of	O
pubertal	O
timing	O
but	O
with	O
different	O
consequences	O
for	O
ovarian	O
function	O
.	O

It	B
is	I
said	I
that	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
above	O
75	O
nmol	O
/	O
L	O
(	O
30	O
ng	O
/	O
mL	O
)	O
are	O
“	O
not	O
consistently	O
associated	O
with	O
increased	O
benefit	O
”.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Serum	O
levels	O
of	O
vitamin	O
D	O
in	O
three	O
categories	O
in	O
case	O
and	O
control	O
groups	O
.	O

In	O
addition	O
,	O
a	O
significant	O
effect	O
of	O
sex	O
on	O
the	O
plasma	O
levels	O
of	O
total	O
cholesterol	O
,	O
HDL	O
,	O
ALKP	O
,	O
and	O
AST	O
/	O
ALT	O
ratio	O
was	O
also	O
observed	O
.	O

MRC	O
Keneba	O
offers	O
free	O
primary	O
health	O
care	O
to	O
anyone	O
who	O
consults	O
,	O
in	O
collaboration	O
with	O
the	O
Gambian	O
Government	O
Lower	O
River	O
Divisional	O
Health	O
Team	O
.	O

A	O
systematic	O
review	O
of	O
25	O
original	O
studies	O
concluded	O
that	O
this	O
approach	O
of	O
weekly	O
iron	O
and	O
folic	O
acid	O
supplementation	O
was	O
safe	O
and	O
also	O
effective	O
in	O
improving	O
haemoglobin	O
concentration	O
in	O
women	O
of	O
reproductive	O
age	O
[	O
9	O
].	O

Unfortunately	O
,	O
dental	O
surgery	O
is	O
the	O
most	O
common	O
day	O
surgical	O
procedure	O
at	O
most	B
Canadian	O
pediatric	O
hospitals	O
[	O
4	O
].	O

tablet	O
with	O
Internet	O
enabled	O
SIM	O
card	O
for	O
data	O
collection	O
and	O
transmission	O
of	O
data	O
from	O
the	O
community	O
to	O
central	O
database	O
server	O
.	O

No	O
differences	O
in	O
the	O
caloric	O
intake	O
were	O
found	O
between	O
CC	O
and	O
RC	O
offspring	O
at	O
adolescence	O
(	O
Figure3C	O
).	O

SIRT	O
1	O
(	O
SIRT1	O
)	O
affects	O
chromatin	O
modulation	O
,	O
and	O
therefore	B
suppresses	O
transcription	O
and	O
interacts	O
with	O
transcription	O
factors	O
,	O
and	O
is	O
capable	O
of	O
positive	O
or	O
negative	O
regulation	O
of	O
gene	O
expression	O
(	O
15	O
).	O

However	O
,	O
no	O
significant	O
correlation	O
was	O
noted	O
in	O
the	O
preterm	O
group	O
between	O
fetal	O
weight	O
or	O
maternal	O
stress	O
and	O
the	O
relative	O
expression	O
of	O
GRs	O
and	O
GAS5	O
.	O

Ayurveda	O
has	O
focused	O
on	O
this	O
concept	O
&	O
have	O
explained	O
it	O
very	O
effectively	O
.	O

Middle	O
Childhood	O
Another	O
critical	O
period	O
for	O
the	O
development	O
of	O
obesity	O
is	O
during	O
middle	O
childhood	O
.	O

Introduction	O
Psychiatric	O
disorders	O
are	O
among	O
the	O
most	O
common	O
pathologies	O
affecting	O
women	O
of	O
childbearing	O
age	O
.	O

However	O
,	O
when	O
each	O
pregnancy	O
complication	O
was	O
analysed	O
separately	O
,	O
a	O
53	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
with	O
high	O
vitamin	O
D	O
status	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
status	O
(	O
aRR	O
:	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
).	O

Program	O
cost	O
data	O
for	O
these	O
latter	O
two	O
interventions	O
are	O
almost	O
non	O
-	O
existent	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Baseline	O
sample	O
descriptive	O
statistics	O
(	O
N	O
=	O
943	O
).	O
VariablesParticipantsAge	O
(	O
years	O
),	O
mean	O
(	O
SD	O
)	O
943	O
(	O
26	O
.	O
5	O
)	O
Age	O
range	O
(	O
years	O
),	O
n	O
(%)<	O
2031	O
(	O
3	O
.	O
3	O
)	O
20	O
-	O
34837	O
(	O
88	O
.	O
8	O
)≥	O
3575	O
(	O
7	O
.	O
9	O
)	O
Race	O
,	O
n	O
(%)	O
White656	O
(	O
69	O
.	O
6	O
)	O
Black75	O
(	O
7	O
.	O
9	O
)	O
Asian	O
-	O
Pacific	O
Islander25	O
(	O
2	O
.	O
6	O
)	O
Western	O
Hemisphere	O
Indians2	O
(	O
0	O
.	O
2	O
)	O
Other	O
/	O
unknown185	O
(	O
19	O
.	O
6	O
)	O
Ethnicity	O
,	O
n	O
(%)	O
Filipino206	O
(	O
21	O
.	O
8	O
)	O
Hispanic53	O
(	O
5	O
.	O
6	O
)	O
Other	O
Asian	O
/	O
Pacific	O
Islander19	O
(	O
2	O
.	O
0	O
)	O
Southeast	O
Asian6	O
(	O
0	O
.	O
6	O
)	O
Other	O
/	O
unknown	O
/	O
non	O
-	O
Hispanic659	O
(	O
69	O
.	O
9	O
)	O
Marital	O
status	O
,	O
n	O
(%)	O
Single	O
/	O
never	O
married72	O
(	O
7	O
.	O
6	O
)	O
Married663	O
(	O
70	O
.	O
3	O
)	O
Separated	O
/	O
divorced	O
/	O
widowed7	O
(	O
0	O
.	O
7	O
)	O
Unknown	O
/	O
null201	O
(	O
21	O
.	O
3	O
)	O
Sponsor	O
rank	O
,	O
n	O
(%)	O
Enlisted819	O
(	O
86	O
.	O
8	O
)	O
Commissioned	O
officers107	O
(	O
11	O
.	O
3	O
)	O
Warrant	O
officers13	O
(	O
1	O
.	O
4	O
)	O
Other4	O
(	O
0	O
.	O
4	O
)	O
Parity	O
,	O
n	O
(%)	O
No492	O
(	O
52	O
.	O
2	O
)	O
Yes451	O
(	O
47	O
.	O
8	O
)	O
Prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
mean	O
(	O
SD	O
)	O
327	O
(	O
27	O
.	O
2	O
)	O
BMI	O
category	O
,	O
n	O
(%)	O
Underweight7	O
(	O
0	O
.	O
7	O
)	O
Normal154	O
(	O
16	O
.	O
4	O
)	O
Overweight97	O
(	O
10	O
.	O
3	O
)	O
Obese63	O
(	O
6	O
.	O
7	O
)	O
Ever	O
participated	O
in	O
WIC	O
program	O
,	O
n	O
(%)	O
320	O
(	O
33	O
.	O
9	O
)	O
Currently	O
in	O
school	O
or	O
working	O
outside	O
the	O
home	O
,	O
n	O
(%)	O
595	O
(	O
63	O
.	O
1	O
)	O
Ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
,	O
n	O
(%)	O
711	O
(	O
75	O
.	O
4	O
)	O
Equivalence	O
of	O
means	O
at	O
baseline	O
was	O
tested	O
by	O
comparing	O
the	O
baseline	O
treatment	O
and	O
control	O
condition	O
samples	O
.	O

The	O
random	O
allocation	O
sequence	O
will	O
be	O
generated	O
using	O
Stata	O
12	O
software	O
(	O
StataCorp	O
.	O

All	O
rats	O
were	O
kept	O
in	O
the	O
same	O
room	O
with	O
a	O
constant	O
temperature	O
maintained	O
at	O
25	O
°	O
C	O
and	O
a	O
12	O
-	O
h	O
light	O
,	O
12	O
-	O
h	O
dark	O
cycle	O
.	O

Although	O
there	O
are	O
contradicting	O
epidemiological	O
and	O
experimental	O
results	O
regarding	O
the	O
direct	O
influence	O
of	O
smoking	O
on	O
total	O
and	O
specific	O
IgE	O
production	O
,[	O
97	O
,	O
98	O
]	O
smoking	O
should	O
nevertheless	O
be	O
avoided	O
for	O
obvious	O
reasons	O
,	O
such	O
as	O
carcinogenic	O
smoke	O
constituents	O
and	O
the	O
vasoconstrictive	O
effect	O
of	O
nicotine	O
.	O

(	O
a	O
)	O
SC	O
offspring	O
and	O
(	O
b	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F1	O
generation	O
;	O
(	O
c	O
)	O
SC	O
offspring	O
and	O
(	O
d	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F2	O
generation	O
.	O

However	O
,	O
Burgaz	O
et	O
al	O
.	O

Mice	O
were	O
fed	O
a	O
Folate	O
Deficient	O
(	O
FD	O
)	O
or	O
Folate	O
Sufficient	O
(	O
FS	O
)	O
diet	O
,	O
and	O
were	O
assessed	O
for	O
birth	O
defects	O
.	O

Taken	O
in	O
account	O
the	O
lower	O
impact	O
of	O
the	O
exposure	O
to	O
undernutrition	O
observed	O
in	O
females	O
in	O
particular	O
,	O
and	O
the	O
lower	O
risk	O
of	O
cardiovascular	O
diseases	O
described	O
in	O
females	O
in	O
general	O
(	O
Blenck	O
et	O
al	O
.,	O
2016	O
),	O
we	O
can	O
speculate	O
that	O
the	O
CB2	O
receptor	O
up	O
-	O
regulation	O
may	O
play	O
a	O
protective	O
role	O
in	O
adverse	O
metabolic	O
conditions	O
.	O

This	O
tendency	O
continued	O
to	O
strengthen	O
with	O
age	O
(	O
participants	O
were	O
followed	O
through	O
age	O
33	O
)	O
and	O
could	B
not	I
be	I
explained	I
by	O
other	O
factors	O
in	O
their	O
childhood	O
,	O
adolescence	O
,	O
or	O
adulthood	O
(	O
18	O
).	O

Statistical	O
analysis	O
We	O
assumed	B
that	O
the	O
incidence	O
of	O
the	O
first	O
or	O
the	O
only	O
episode	O
of	O
pneumonia	O
(	O
first	O
episode	O
)	O
in	O
our	O
placebo	O
group	O
would	O
be	O
0	O
·	O
0585	O
per	O
child	O
per	O
year	O
based	O
on	O
the	O
report	O
that	O
the	O
incidence	O
of	O
acute	O
lower	O
respiratory	O
infections	O
in	O
developing	O
countries	O
was	O
greater	O
than	O
0	O
·	O
65	O
per	O
child	O
per	O
year	O
,	O
18that	O
12	O
%	O
of	O
these	O
episodes	O
were	O
pneumonia	O
,	O
and	O
75	O
%	O
were	O
first	O
episodes	O
.	O

However	O
,	O
a	O
weak	O
association	O
does	O
not	O
necessarily	O
imply	O
the	O
absence	O
of	O
causality	O
,	O
nor	O
is	O
a	O
strong	O
association	O
necessary	O
or	O
sufficient	O
for	O
causality	O
[	O
213	O
,	O
214	O
].	O

Without	O
sufficient	O
Vitamin	O
D	O
,	O
bones	O
can	O
become	O
thin	O
and	O
brittle	O
.	O

These	O
proteins	O
are	O
associated	O
with	O
several	O
biological	O
pathways	O
including	O
oxidative	O
phosphorylation	O
,	O
cytoskeleton	O
maintenance	O
,	O
calcium	O
homeostasis	O
,	O
chaperoning	O
,	O
synaptic	O
plasticity	O
and	O
neurotransmission	O
.	O

At	O
6	O
months	O
,	O
no	O
significant	O
effects	O
were	O
seen	O
for	O
GWG	O
on	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
P	O
=	O
.	O
11	O
)	O
or	O
average	O
z	O
-	O
scores	O
(	O
P	O
=	O
.	O
16	O
)	O
at	O
6	O
months	O
.	O

Vitamin	O
D	O
restriction	O
during	O
pregnancy	O
and	O
throughout	O
lactation	O
in	O
rats	O
is	O
associated	O
with	O
an	O
increased	O
number	O
of	O
glomeruli	O
and	O
decreased	O
renal	O
corpuscle	O
size	O
among	O
offspring	O
,	O
although	O
the	O
causes	O
and	O
consequences	O
of	O
this	O
abnormal	O
kidney	O
phenotype	O
remain	O
unknown	O
[	O
13	O
].	O

The	O
odds	O
ratios	O
of	O
MS	O
among	O
individuals	O
who	O
reported	O
spending	O
at	O
least	O
2	O
hours	O
per	O
day	O
in	O
the	O
sun	O
during	O
holidays	O
and	O
at	O
weekends	O
at	O
ages	O
6	O
-	O
10	O
years	O
were	O
0	O
.	O
47	O
(	O
95	O
%	O
CI	O
0	O
.	O
26	O
-	O
0	O
.	O
84	O
)	O
for	O
winter	O
and	O
0	O
.	O
50	O
(	O
0	O
.	O
24	O
-	O
1	O
.	O
02	O
)	O
for	O
exposure	O
;	O
inverse	O
but	O
weaker	O
associations	O
were	O
observed	O
with	O
sun	O
exposure	O
at	O
older	O
ages	O
.	O

As	O
in	O
vaginally	O
delivered	O
infants	O
,	O
maternal	O
fish	O
and	O
seafood	O
intake	O
was	O
positively	O
associated	O
with	O
OTUs	O
in	O
the	O
genus	O
Streptococcus	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5c	O
).	O

As	O
a	O
result	O
,	O
GRs	O
cannot	O
bind	O
to	O
their	O
DNA	O
GRE	O
and	O
subsequently	O
their	O
function	O
is	O
compromised	O
[	O
8	O
].	O

The	O
interaction	O
of	O
race	O
with	O
the	O
association	O
between	O
PNV	O
use	O
and	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
was	O
not	O
significant	O
later	O
in	O
pregnancy	O
(	O
interaction	O
P	O
value	O
=	O
0	O
.	O
3	O
).	O

Even	O
those	O
countries	O
with	O
higher	O
mortality	O
rates	O
that	O
are	O
not	O
yet	O
ready	O
to	O
scale	O
up	O
intensive	O
care	O
could	O
see	O
a	O
50	O
%	O
reduction	O
as	O
shown	O
in	O
the	O
mid	O
-	O
20th	O
century	O
in	O
the	O
United	O
States	O
and	O
the	O
United	O
Kingdom	O
.	O

Despite	O
employing	O
nurture	O
as	O
a	O
primary	O
driver	O
of	O
handwashing	O
behavior	O
and	O
including	O
in	O
the	O
intervention	O
all	O
secondary	O
caregivers	O
,	O
not	O
only	O
the	O
mother	O
,	O
there	O
was	O
limited	O
behavioral	O
impact	O
of	O
the	O
intervention	O
.	O

Patients	O
must	O
be	O
monitored	O
closely	O
for	O
potential	O
adverse	O
effects	O
of	O
corticosteroids	O
,	O
especially	O
gestational	O
diabetes	O
,	O
preeclampsia	O
,	O
and	O
intrauterine	O
growth	O
retardation	O
.	O

The	O
incidence	O
of	O
vitamin	O
D	O
deficiency	O
(˂	O
50	O
nmol	O
/	O
L	O
)	O
is	O
frequent	O
among	O
pregnant	O
women	O
even	O
in	O
areas	O
such	O
as	O
Australia	O
and	O
the	O
North	O
Island	O
of	O
New	O
Zealand	O
where	O
sunlight	O
exposure	O
is	O
high	O
.	O

Regarding	O
the	O
body	O
weight	O
during	O
the	O
post	O
-	O
weaning	O
period	O
(	O
Figure2C	O
),	O
three	O
-	O
way	O
ANOVA	O
detected	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
16	O
,	O
58	O
)=	O
689	O
.	O
326	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
436	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Standard	O
case	O
definitions	O
of	O
the	O
types	O
and	O
causes	O
of	O
preterm	O
birth	O
are	O
being	O
developed	O
[	O
31	O
,	O
32	O
]	O
and	O
will	O
be	O
critical	O
to	O
accelerating	O
discovery	O
and	O
making	O
comparisons	O
across	O
studies	O
from	O
basic	O
science	O
to	O
clinical	O
trials	O
and	O
program	O
evaluation	O
.	O

We	O
did	O
not	O
have	O
data	O
on	O
whether	O
women	O
were	O
taking	O
separate	O
calcium	O
or	O
vitamin	O
D	O
supplements	O
beyond	O
what	O
is	O
contained	O
in	O
PNVs	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
.	O

Statistical	O
analysis	O
The	O
analysis	O
was	O
conducted	O
using	O
intention	O
to	O
treat	O
principles	O
,	O
according	O
to	O
the	O
treatment	O
group	O
the	O
woman	O
was	O
randomised	O
to	O
in	O
pregnancy	O
(	O
Lifestyle	O
Advice	O
or	O
Standard	O
Care	O
).	O

Very	O
early	O
in	O
pregnancy	O
,	O
the	O
increase	O
in	O
oestrogen	O
levels	O
causes	O
an	O
approximate	O
doubling	O
in	O
thyroxine	O
-	O
binding	O
globulin	O
(	O
TBG	O
)	O
that	O
can	O
lead	O
to	O
an	O
increases	O
in	O
total	O
T4	O
concentration	O
and	O
a	O
reduced	O
free	O
fraction	O
(	O
Table	O
I	O
).	O

Exposing	O
fetal	O
rats	O
to	O
high	O
levels	O
of	O
glucocorticoids	O
reduces	O
birth	O
weight	O
and	O
results	O
in	O
adults	O
with	O
high	O
blood	O
levels	O
of	O
insulin	O
and	O
glucose	O
.	O

Statistical	O
theory	O
demonstrates	O
that	O
the	O
estimators	O
have	O
smaller	O
mean	O
squared	O
error	O
than	O
ordinary	O
least	O
squares	O
estimators	O
[	O
51	O
].	O

In	O
another	O
study	O
,	O
15administration	O
of	O
600	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
was	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
serum	O
vitamin	O
D	O
,	O
a	O
significant	O
decrease	O
in	O
serum	O
PTH	O
,	O
and	O
hypercalcemia	O
occurring	O
in	O
4	O
%	O
of	O
the	O
subjects	O
during	O
4	O
and	O
12	O
months	O
of	O
intervention	O
.	O

§	O
N	O
(%)	O
of	O
live	O
births	O
.	O

Soap	O
and	O
water	O
were	O
observed	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
at	O
65	O
%	O
of	O
intervention	O
households	O
and	O
10	O
%	O
of	O
control	O
households	O
at	O
the	O
observation	O
conducted	O
at	O
postnatal	O
days	O
4	O
-	O
5	O
(	O
RR	O
=	O
5	O
.	O
6	O
,	O
95	O
%	O
CI	O
3	O
.	O
12	O
–	O
10	O
.	O
14	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
4	O
).	O

Venipunctures	O
for	O
children	O
with	O
S	O
-	O
ECC	O
were	O
drawn	O
by	O
the	O
attending	O
anesthetist	O
during	O
surgery	O
while	O
blood	O
samples	O
from	O
controls	O
were	O
obtained	O
by	O
a	O
research	O
nurse	O
at	O
the	O
Manitoba	O
Institute	O
of	O
Child	O
Health	O
following	O
the	O
application	O
of	O
a	O
topical	O
anaesthetic	O
(	O
EMLA	O
)	O
to	O
the	O
anticubital	O
fossa	O
.	O

Data	O
will	O
be	O
analysed	O
prospectively	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
different	O
time	O
points	O
(	O
longitudinally	O
)	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

Other	O
studies	O
did	O
not	O
effectively	O
account	O
for	O
dietary	O
intake	O
and	O
are	O
thus	B
at	O
risk	O
of	O
bias	O
.	O

The	O
integral	O
absorbance	O
values	O
were	O
measured	O
.	O

However	O
,	O
the	O
vitamin	O
D	O
content	O
of	O
multivitamins	O
for	O
pregnant	O
women	O
in	O
Belgium	O
is	O
only	O
400	O
IU	O
indicating	O
even	O
this	O
recommendation	O
is	O
not	O
followed	O
as	O
pregnant	O
women	O
only	O
take	O
one	O
multivitamin	O
pill	O
a	O
day	O
.	O

One	O
third	O
of	O
respondents	O
(	O
30	O
.	O
1	O
%)	O
attended	O
a	O
health	O
centre	O
out	O
of	O
their	O
catchment	O
health	O
area	O
with	O
Buea	O
Town	O
health	O
centre	O
receiving	O
the	O
highest	O
proportion	O
of	O
women	O
out	O
of	O
the	O
health	O
area	O
(	O
56	O
.	O
8	O
%	O
of	O
attendees	O
).	O

At	O
30	O
weeks	O
,	O
341	O
(	O
94	O
%;	O
160	O
overweight	O
/	O
obese	O
and	O
181	O
normal	O
weight	O
)	O
attended	O
the	O
assessment	O
visit	O
.	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

GAS5	O
was	O
significantly	O
lower	O
in	O
expression	O
in	O
JEG	O
-	O
3	O
cells	O
when	O
compared	O
to	O
BeWo	O
under	O
basal	O
conditions	O
(	O
Figure	O
3	O
(	O
a	O
)).	O

Unlike	O
most	O
organs	O
,	O
which	O
develop	O
mostly	O
in	O
utero	O
,	O
the	O
mammary	O
gland	O
develops	O
in	O
stages	O
:	O
before	O
birth	O
,	O
at	O
puberty	O
,	O
and	O
in	O
pregnancy	O
.	O

Mean	O
birth	O
weight	O
percentile	O
for	O
neonates	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
⩾	O
25	O
and	O
<	O
50	O
nmol	O
l	O
−	O
1was	O
0	O
.	O
39	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
34	O
,	O
0	O
.	O
45	O
).	O

Peer	O
-	O
reviewed	O
journal	O
articles	O
published	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
.	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Author	O
'	O
s	O
manuscript	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Reviewer	O
comments	O
PubMed	O
Central	O
:	O

Maternal	O
dietary	O
risk	O
factors	O
in	O
childhood	O
acute	O
lymphoblastic	O
leukemia	O
(	O
United	O
States	O
).	O

We	O
studied	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
asthma	O
status	O
phenotypes	O
,	O
and	O
did	O
not	O
observe	O
any	O
association	O
(	O
supplementary	O
table	O
E5	O
).	O

The	O
genetic	O
potential	O
of	O
individual	O
cattle	O
can	O
significantly	O
affect	O
IMF	O
deposition	O
.	O

Its	O
indirect	O
effects	O
are	O
attributed	O
to	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
improvement	O
of	O
muscle	O
activities	O
.	O

At	O
the	O
end	O
of	O
their	O
visit	O
,	O
mothers	O
received	O
training	O
on	O
proper	O
pregnancy	O
nutrition	O
.	O

Examples	O
of	O
such	O
proposed	O
adaptations	O
are	O
provided	O
within	O
the	O
OECD	O
Endocrine	O
Disruptor	O
Conceptual	O
Framework	O
(	O
Supplementary	O
Table	O
5	O
;	O
OECD2012	O
).	O

In	O
a	O
population	O
-	O
based	O
Swedish	O
study	O
of	O
2	O
,	O
668	O
men	O
followed	O
for	O
10	O
-	O
years	O
,	O
investigators	O
reported	O
that	O
the	O
multivariable	O
adjusted	O
relative	O
risk	O
for	O
incident	O
type	O
2	O
diabetes	O
was	O
highest	O
for	O
obese	O
snorers	O
(	O
OR	O
=	O
7	O
.	O
0	O
;	O
95	O
%	O
CI	O
2	O
.	O
9	O
-	O
16	O
.	O
9	O
)	O
than	O
for	O
lean	O
non	O
-	O
snorers	O
[	O
38	O
].	O

We	O
present	O
adjusted	O
odds	O
ratios	O
(	O
aORs	O
),	O
as	O
well	O
as	O
95	O
%	O
confidence	O
intervals	O
and	O
p	O
-	O
values	O
.	O

Yet	O
,	O
contrary	O
to	O
many	O
studies	O
,	O
associations	O
between	O
high	O
25	O
(	O
OH	O
)	O
D	O
and	O
GDM	O
have	O
been	O
reported	O
[	O
27	O
,	O
28	O
].	O

Therefore	B
,	O
a	O
better	O
method	O
to	O
achieve	O
high	O
digestibility	O
of	O
starch	O
in	O
the	O
small	O
intestine	O
is	O
required	O
to	O
provide	O
high	O
post	O
-	O
absorptive	O
glucose	O
to	O
the	O
host	O
animal	O
.	O

The	O
number	O
of	O
patients	O
with	O
vitamin	O
D	O
deficiency	O
,	O
insufficiency	O
and	O
normal	O
range	O
in	O
the	O
case	O
group	O
were	O
15	O
(	O
30	O
%),	O
28	O
(	O
56	O
%)	O
and	O
7	O
(	O
14	O
%),	O
respectively	O
.	O

We	O
plan	O
to	O
explore	O
these	O
issues	O
in	O
future	O
experiments	O
.	O

In	O
brief	O
,	O
800	O
secundigravida	O
women	O
,	O
who	O
had	O
previously	O
delivered	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
were	O
randomised	O
to	O
receive	O
either	O
low	O
glycaemic	O
index	O
dietary	O
advice	O
or	O
usual	O
care	O
(	O
no	O
dietary	O
advice	O
)	O
[	O
34	O
].	O

In	O
the	O
early	O
1960s	O
,	O
Williams	O
,	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Everyone	O
has	O
a	O
role	O
to	O
play	O
:	O
actions	O
for	O
the	O
six	O
key	O
constituency	O
groups	O
involved	O
in	O
Every	O
Women	O
Every	O
ChildGovernments	O
and	O
policy	O
-	O
makers	O
at	O
local	O
,	O
national	O
,	O
regional	O
and	O
global	O
levels	O
:	O
Invest	O
•	O
Set	O
national	O
targets	O
for	O
improved	O
survival	O
of	O
premature	O
babies	O
and	O
increase	O
funding	O
to	O
ensuring	O
equitable	O
access	O
to	O
quality	O
care	O
to	O
meet	O
these	O
targets	O
by	O
2025	O
.	O

Indeed	O
,	O
oral	O
administration	O
of	O
vinclozolin	O
to	O
pregnant	O
females	O
(	O
the	O
likely	B
route	O
of	O
administration	O
for	O
humans	O
given	B
that	O
vinclozolin	O
is	O
a	O
fungicide	O
used	O
in	O
the	O
wine	O
industry	O
)	O
failed	O
to	O
induce	O
any	O
adverse	O
phenotypes	O
in	O
subsequent	O
generations	O
(	O
Schneider	O
et	O
al	O
.	O
2008	O
).	O

In	O
Lenters	O
,	O
this	O
EDC	O
was	O
associated	O
with	O
a	O
-	O
0	O
.	O
15	O
g	O
difference	O
in	O
birth	O
weight	O
,	O
which	O
was	O
attenuated	O
after	O
adjusting	O
for	O
gestational	O
age	O
.	O

Most	O
studies	O
do	O
not	O
have	O
grandparental	O
data	O
from	O
both	O
lineages	O
.	O

multiple	O
linear	O
regression	O
analysis	O
,	O
ANCOVA	O
,	O
logistic	O
regression	O
analysis	O
),	O
adjusting	O
for	O
potential	O
covariates	O
.	O

A	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
and	O
between	O
gender	O
and	O
cathelicidin	O
were	O
noted	O
,	O
with	O
higher	O
concentrations	O
in	O
male	O
children	O
.	O

Infertility	O
of	O
the	O
mutagenized	O
mice	O
was	O
confirmed	O
after	O
treatment	O
and	O
mice	O
were	O
allowed	O
8	O
–	O
12	O
wk	O
to	O
recover	O
fertility	O
and	O
then	O
were	O
bred	O
to	O
129X1	O
females	O
.	O

Several	O
studies	O
have	O
revealed	O
that	O
vitamin	O
D	O
supplementation	O
can	O
raise	O
vitamin	O
D	O
reserves	O
gradually	O
,	O
according	O
to	O
baseline	O
concentration	O
of	O
vitamin	O
D	O
,	O
dose	O
and	O
duration	O
of	O
consumption	O
[	O
16	O
–	O
18	O
].	O

Mitotic	O
roles	O
of	O
PLK	O
,	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
).	O

Weak	O
Infrastructure	O
and	O
Political	O
Commitment	O
The	O
efforts	O
of	O
World	O
Food	O
Programme	O
(	O
WFP	O
)	O
in	O
overcoming	O
micronutrient	O
deficiencies	O
in	O
nutritionally	O
-	O
vulnerable	O
groups	O
and	O
low	O
-	O
income	O
food	O
-	O
deficit	O
countries	O
continue	O
to	O
be	O
thwarted	O
by	O
challenges	O
such	O
as	O
technical	O
and	O
managerial	O
capacity	O
constraints	O
,	O
the	O
need	O
for	O
systematic	O
compliance	O
with	O
procurement	O
specifications	O
and	O
quality	O
control	O
,	O
clearer	O
policies	O
on	O
micronutrient	O
content	O
labeling	O
,	O
and	O
the	O
need	O
for	O
cash	O
resources	O
to	O
support	O
many	O
aspects	O
associated	O
with	O
local	O
processing	O
and	O
fortification	O
activities	O
[	O
57	O
].	O

Glucose	O
is	O
derived	O
from	O
either	O
glucose	O
synthesis	O
via	O
gluconeogenesis	O
from	O
propionate	O
/	O
lactate	O
or	O
glucose	O
absorbed	O
from	O
the	O
small	O
intestinal	O
digestion	O
of	O
the	O
rumen	O
bypass	O
[	O
86	O
].	O

Table	O
3	O
summarizes	O
the	O
results	O
of	O
the	O
4	O
multivariable	O
linear	O
regression	O
models	O
assessing	O
factors	O
associated	O
with	O
the	O
natural	O
logarithm	O
of	O
the	O
cathelicidin	O
concentration	O
.	O

Although	O
risk	O
estimates	O
varied	O
by	O
study	O
center	O
,	O
combined	O
results	O
suggest	O
that	O
maternal	O
supplementation	O
for	O
two	O
trimesters	O
may	O
decrease	O
risk	O
of	O
brain	O
tumor	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
0	O
.	O
7	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
0	O
.	O
5	O
-	O
0	O
.	O
9	O
),	O
with	O
a	O
trend	O
of	O
less	O
risk	O
with	O
longer	O
duration	O
of	O
use	O
(	O
p	O
trend	O
=	O
0	O
.	O
0007	O
).	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
associated	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
[	O
6	O
],	O
but	O
the	O
evidence	O
is	O
inconsistent	O
[	O
7	O
,	O
8	O
].	O

In	O
view	O
of	O
previous	O
data	O
in	O
HeLa	O
cells	O
,	O
where	O
GAS5	O
translocates	O
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
with	O
GR	O
in	O
response	O
to	O
dexamethasone	O
[	O
8	O
],	O
this	O
colocalization	O
is	O
highly	B
suggestive	O
of	O
a	O
potential	O
crosstalk	O
at	O
placental	O
level	O
between	O
GAS5	O
and	O
the	O
GR	O
.	O

Results	O
were	O
not	O
related	O
to	O
feeding	O
type	O
.	O

For	O
these	O
patients	O
,	O
surgery	O
could	O
be	O
safely	O
performed	O
during	O
the	O
mid	O
-	O
trimester	O
or	O
delayed	O
until	O
delivery	O
without	O
worsening	O
prognosis3034	O
.	O

However	O
,	O
the	O
potentials	O
of	O
antenatal	O
service	O
have	O
not	O
been	O
maximally	O
utilized	O
in	O
developing	O
countries	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Relation	O
of	O
microbial	O
community	O
composition	O
in	O
vaginally	O
delivered	O
6	O
-	O
week	O
old	O
infants	O
with	O
maternal	O
dietp	O
value1Dietary	O
factorAll	O
(	O
n	O
=	O
97	O
)	O
2Exclusively	O
breastfed	O
(	O
n	O
=	O
74	O
)	O
3aMED	O
score0	O
.	O
190	O
.	O
26Dairy0	O
.	O
600	O
.	O
91Fruit0	O
.	O
0280	O
.	O
022Vegetables0	O
.	O
560	O
.	O
92Whole	O
grains0	O
.	O
470	O
.	O
25Fish	O
and	O
seafood0	O
.	O
330	O
.	O
21Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
520	O
.	O
71Red	O
and	O
processed	O
meat0	O
.	O
860	O
.	O
69Polyunsaturated	O
fat0	O
.	O
760	O
.	O
84EPA0	O
.	O
290	O
.	O
45DHA0	O
.	O
400	O
.	O
50MUFA	O
:	O
SFA	O
ratio0	O
.	O
660	O
.	O
43	O
1All	O
p	O
values	O
are	O
determined	O
by	O
PERMANOVA	O
2p	O
values	O
are	O
adjusted	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
3p	O
values	O
are	O
adjusted	O
for	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

HIV	O
status	O
was	O
not	O
assessed	O
during	O
this	O
study	O
but	O
national	O
sentinel	O
data	O
from	O
antenatal	O
clinics	O
indicates	O
a	O
HIV	O
prevalence	O
of	O
around	O
1	O
%	O
(	O
Schim	O
van	O
der	O
Loeff	O
et	O
al	O
2003	O
).	O

Whilst	O
the	O
latter	O
studies	O
were	O
not	O
specifically	O
performed	O
in	O
women	O
with	O
GDM	O
,	O
they	O
suggest	O
that	O
the	O
concept	O
of	O
GI	O
is	O
valid	O
in	O
pregnancy	O
,	O
and	O
it	O
would	O
be	O
appropriate	O
to	O
recommend	O
low	O
GI	O
carbohydrate	O
to	O
women	O
with	O
GDM	O
.	O

Methylation	O
levels	O
of	O
long	O
interspersed	O
nuclear	O
element	O
-	O
1	O
(	O
LINE	O
-	O
1	O
)	O
and	O
the	O
Alu	O
element	O
AluYb8	O
were	O
determined	O
in	O
380	O
placental	O
samples	O
from	O
term	O
deliveries	O
using	O
bisulfite	O
pyrosequencing	O
.	O

Height	O
was	O
measured	O
with	O
a	O
tape	O
measure	O
while	O
the	O
subjects	O
were	O
in	O
a	O
standing	O
position	O
.	O

Deficiency	O
in	O
vitamin	O
D	O
during	O
periods	O
of	O
tooth	O
development	O
may	O
also	O
result	O
in	O
developmental	O
defects	O
[	O
17	O
]	O
including	O
enamel	O
hypoplasia	O
,	O
a	O
significant	O
risk	O
factor	O
for	O
S	O
-	O
ECC	O
.	O

The	O
findings	O
from	O
the	O
Bangladesh	O
study	O
did	O
however	O
provide	O
additional	O
support	O
for	O
the	O
use	O
of	O
combinations	O
of	O
micronutrients	O
in	O
preference	O
to	O
iron	O
alone	O
,	O
as	B
the	O
prevalence	O
of	O
other	O
nutrient	O
deficiencies	O
including	O
folic	O
acid	O
,	O
riboflavin	O
and	O
vitamin	O
B12	O
,	O
A	O
and	O
C	O
were	O
also	O
decreased	O
in	O
addition	O
to	O
improved	O
values	O
for	O
haematological	O
parameters	O
(	O
Ahmed	O
et	O
al	O
2005	O
).	O

Specifically	O
,	O
interspersed	O
repeats	O
are	O
composed	O
of	O
retrotransposable	O
elements	O
such	O
as	O
long	O
interspersed	O
nuclear	O
elements	O
(	O
LINEs	O
)	O
and	O
short	O
interspersed	O
nuclear	O
elements	O
(	O
SINEs	O
).	O

Although	O
not	O
significant	O
,	O
a	O
negative	O
trend	O
was	O
seen	O
between	O
the	O
number	O
of	O
infections	O
a	O
child	O
experienced	O
and	O
cathelicidin	O
concentration	O
.	O

The	O
association	O
between	O
the	O
positive	O
and	O
the	O
depressive	O
dimension	O
in	O
CAPE	O
,	O
which	O
we	O
unfortunately	O
could	O
not	O
include	O
for	O
practical	O
reasons	O
,	O
is	O
fairly	O
low	O
when	O
distress	O
associated	O
with	O
positive	O
symptoms	O
is	O
held	O
constant	O
(	O
r	O
=	O
0	O
.	O
25	O
;	O
Stefanis	O
et	O
al	O
.,	O
2002	O
[	O
1	O
]).	O

Lastly	O
,	O
the	O
generalizability	O
of	O
our	O
study	O
may	O
be	O
limited	O
,	O
as	B
our	O
cohort	O
was	O
primarily	O
comprised	O
of	O
Non	O
-	O
Hispanic	O
White	O
and	O
well	O
-	O
educated	O
women	O
.	O

Additionally	O
,	O
children	O
in	O
our	O
study	O
were	O
matched	O
by	O
age	O
and	O
sex	O
,	O
but	O
we	O
were	O
unable	O
to	O
match	O
by	O
household	O
economics	O
and	O
caregiver	O
education	O
levels	O
.	O

Vasopressinase	O
is	O
a	O
cysteine	O
aminopeptidase	O
of	O
molecular	O
weight	O
330	O
kDa	O
,	O
and	O
is	O
produced	O
by	O
the	O
placental	O
trophoblasts	O
during	O
pregnancy	O
as	O
discussed	O
by	O
Gordge	O
et	O
al	O
.	O

However	O
,	O
there	O
was	O
a	O
protective	O
association	O
of	O
having	O
high	O
vitamin	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
and	O
GDM	O
once	O
standardised	O
based	O
on	O
month	O
serum	O
was	O
sampled	O
.	O

Sensitivity	O
analysis	O
As	O
the	O
women	O
were	O
allowed	O
to	O
continue	O
taking	O
vitamin	O
D	O
supplements	O
containing	O
up	O
to	O
400	O
IU	O
/	O
d	O
,	O
in	O
sensitivity	O
analyses	O
,	O
we	O
included	O
only	O
women	O
who	O
were	O
not	O
taking	O
additional	O
vitamin	O
D	O
–	O
containing	O
supplements	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
n	O
=	O
224	O
,	O
67	O
.	O
7	O
%).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Multiple	O
national	O
cohort	O
studies	O
have	O
found	O
associations	O
between	O
maternal	O
obesity	O
and	O
shorter	O
duration	O
of	O
breastfeeding	O
,	O
29although	O
the	O
reasons	B
for	O
this	O
relationship	O
are	O
not	O
clear	O
.	O

The	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
reduced	O
risk	O
of	O
PTB	O
was	O
consistent	O
across	O
race	O
/	O
ethnic	O
groups	O
.	O

Bos	O
taurus	O
cattle	O
generally	O
have	O
higher	O
marbling	O
and	O
better	O
tenderness	O
than	O
do	O
Bos	O
indicus	O
animals	O
[	O
1	O
,	O
37	O
].	O

Our	O
primary	O
outcome	O
was	O
the	O
first	O
or	O
only	O
episode	O
of	O
radiologically	O
confirmed	O
pneumonia	O
.	O

Obviously	O
,	O
at	B
least	I
a	O
part	O
of	O
the	O
innate	O
immune	O
system	O
is	O
impaired	O
when	O
LP	O
offspring	O
is	O
faced	O
with	O
a	O
pre	O
-	O
biotical	O
stress	O
like	O
weaning	O
.	O

The	O
aim	O
was	O
to	O
include	O
22	O
women	O
in	O
each	O
cluster	O
of	O
which	O
11	O
in	O
the	O
first	O
trimester	O
and	O
11	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

PubMed	O
Central	O
:	O

Diet	O
of	O
the	O
Infants	O
As	O
mentioned	O
previously	O
,	O
for	O
breast	O
-	O
feeding	O
,	O
there	O
is	O
insufficient	O
evidence	O
to	O
determine	O
whether	O
it	O
is	O
more	O
protective	O
against	O
allergies	O
and	O
asthma	O
than	O
bottle	O
feeding	O
because	O
in	O
a	O
recent	O
study	O
,	O
prolonged	O
and	O
exclusive	O
breast	O
-	O
feeding	O
could	O
not	O
decrease	O
the	O
rate	O
of	O
allergies	O
or	O
asthma	O
in	O
children	O
[	O
88	O
].	O

For	O
both	O
measurements	O
,	O
the	O
tape	O
was	O
positioned	O
at	O
a	O
level	O
parallel	O
to	O
the	O
floor	O
,	O
and	O
the	O
waist	O
-	O
to	O
-	O
hip	O
ratio	O
was	O
calculated	O
.	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Future	O
studies	O
are	O
warranted	O
for	O
replication	O
and	O
should	O
evaluate	O
if	O
this	O
is	O
a	O
causal	O
relationship	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
a	O
lower	O
ambient	O
temperature	O
decreased	O
growth	O
and	O
feed	O
efficiency	O
in	O
Korean	O
cattle	O
steers	O
[	O
78	O
].	O

The	O
CAIR	O
questionnaire	O
was	O
developed	O
by	O
the	O
School	O
of	O
Paediatrics	O
and	O
Child	O
Health	O
of	O
the	O
University	O
of	O
Western	O
Australia	O
and	O
is	O
designed	O
to	O
assess	O
asthma	O
,	O
rhinitis	O
and	O
eczema	O
in	O
infants	O
.	O

McBride	O
et	O
al	O
.	O

However	O
,	O
hypervitaminosis	O
D	O
has	O
never	B
occurred	I
when	O
physiologic	O
amounts	O
of	O
vitamin	O
D	O
are	O
ingested	O
.	O

Introduction	O
Fish	O
is	O
a	O
source	O
of	O
several	O
nutrients	O
that	O
are	O
important	O
during	O
pregnancy	O
for	O
healthy	O
foetal	O
development	O
including	O
iodine	O
,	O
long	O
chain	O
omega	O
-	O
3	O
polyunsaturated	O
fatty	O
acids	O
(	O
LC	O
n	O
-	O
3PUFAs	O
),	O
and	O
vitamins	O
A	O
,	O
D	O
and	O
B12	O
[	O
1	O
].	O

Data	O
collection	O
tools	O
In	O
this	O
study	O
,	O
we	O
used	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
(	O
EPDS	O
)	O
in	O
order	O
to	O
evaluate	O
depression	O
levels	O
.	O

Abbreviations	O
:	O
GWG	O
,	O
gestational	O
weight	O
gain	O
;	O
GDM	O
,	O
gestational	O
diabetes	O
mellitus	O
;	O
25	O
(	O
OH	O
)	O
D	O
,	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
;	O
suboptimal	O
,	O
UCB	O
,	O
umbilical	O
cord	O
blood	O
;	O
25	O
(	O
OH	O
)	O
D	O
<	O
80	O
nmol	O
/	O
L	O
;	O
optimal	O
25	O
(	O
OH	O
)	O
D	O
≥	O
80	O
nmol	O
/	O
L	O
Discussion	O
The	O
primary	O
focus	O
of	O
this	O
work	O
was	O
to	O
determine	O
whether	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
differs	O
between	O
mothers	O
with	O
and	O
without	O
GDM	O
,	O
and	O
whether	O
vitamin	O
D	O
status	O
affects	O
birth	O
size	O
in	O
normal	O
-	O
birth	O
-	O
weight	O
infants	O
.	O

Methods	O
Search	O
Strategy	O
Articles	O
were	O
identified	O
by	O
systematically	O
searching	O
the	O
Medline	O
/	O
PubMed	O
database	O
from	O
inception	O
to	O
January	O
2010	O
using	O
the	O
key	O
words	O
:	O
brain	O
tumors	O
and	O
season	O
of	O
birth	O
.	O

We	O
randomized	O
126	O
(	O
49	O
.	O
8	O
%)	O
participants	O
to	O
the	O
intervention	O
arm	O
and	O
127	O
(	O
50	O
.	O
2	O
%)	O
to	O
the	O
control	O
arm	O
.	O

While	O
farmers	O
live	O
longer	O
than	O
the	O
population	O
-	O
at	O
-	O
large	O
[	O
41	O
],	O
and	O
die	O
less	O
frequently	O
from	O
cancer	O
in	O
general	O
[	O
42	O
],	O
several	O
epidemiologic	O
studies	O
have	O
found	O
an	O
increased	O
risk	O
for	O
brain	O
cancer	O
in	O
this	O
group	O
[	O
43	O
–	O
50	O
].	O

Changes	O
in	O
hormonal	O
levels	O
dictate	O
breast	O
development	O
at	O
each	O
step	O
.	O
25	O
“	O
We	O
know	O
from	O
animal	O
studies	O
that	O
there	O
are	O
chemicals	O
that	O
can	O
adversely	O
affect	O
breast	O
development	O
and	O
lactation	O
,”	O
says	O
Sue	O
Fenton	O
,	O
leader	O
of	O
the	O
Reproductive	O
Endocrinology	O
Group	O
at	O
the	O
National	O
Toxicology	O
Program	O
,	O
based	O
at	O
the	O
NIEHS	O
.	O

Suzuki	O
et	O
al	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
when	O
compared	O
to	O
the	O
women	O
recruited	O
in	O
Auckland	O
and	O
remained	O
lower	O
after	O
adjusting	O
for	O
covariates	O
including	O
maternal	O
body	O
mass	O
index	O
and	O
socioeconomic	O
index	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Foetal	O
ultrasonography	O
:	O
Gestational	O
age	O
and	O
foetal	O
growth	O
Foetal	O
ultrasonography	O
examination	O
is	O
carried	O
out	O
by	O
an	O
obstetrician	O
at	O
the	O
first	O
data	O
collection	O
time	O
point	O
to	O
confirm	O
gestation	O
.	O

RNA	O
Isolation	O
,	O
cDNA	O
Synthesis	O
,	O
and	O
PCR	O
Total	O
ribonucleic	O
acid	O
was	O
isolated	O
using	O
an	O
RNA	O
extraction	O
kit	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
),	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
.	O

We	O
did	O
not	O
observed	O
any	O
correlation	O
at	O
38	O
–	O
40	O
weeks	O
(	O
r	O
=	O
0	O
.	O
14	O
,	O
p	O
=	O
0	O
.	O
29	O
)	O
or	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
(	O
r	O
=	O
0	O
.	O
1	O
,	O
p	O
=	O
0	O
.	O
43	O
)	O
(	O
r	O
=	O
−	O
0	O
.	O
02	O
,	O
p	O
=	O
0	O
.	O
83	O
)	O
respectively	O
.	O

Outcome	O
measurements	O
Neonatal	O
deaths	O
We	O
will	O
investigate	O
all	O
neonatal	O
deaths	O
reported	O
by	O
the	O
SS	O
to	O
the	O
Field	O
Implementers	O
or	O
by	O
maternal	O
recall	O
at	O
the	O
final	O
follow	O
-	O
up	O
visit	O
at	O
42	O
days	O
postpartum	O
,	O
using	O
standard	O
questionnaires	O
collected	O
by	O
trained	O
staff	O
.	O

Conclusions	O
This	O
implementation	O
project	O
was	O
successful	O
in	O
increasing	O
the	O
proportion	O
of	O
women	O
seen	O
according	O
to	O
best	O
practice	O
.	O

A	O
prospective	O
randomised	O
controlled	O
trial	O
in	O
adults	O
showed	O
that	O
dietary	O
sugar	O
,	O
and	O
especially	O
fructose	O
,	O
increased	O
levels	O
of	O
C	O
-	O
reactive	O
protein	O
[	O
37	O
].	O

Common	O
reasons	O
for	O
ineligibility	O
included	O
identification	O
too	O
late	O
in	O
the	O
pregnancy	O
or	O
a	O
due	O
date	O
too	O
late	O
for	O
complete	O
data	O
collection	O
(	O
24	O
%),	O
previous	O
enrollment	O
of	O
another	O
pregnant	O
woman	O
in	O
the	O
same	O
compound	O
(	O
11	O
%),	O
and	O
enrollment	O
in	O
another	O
study	O
(	O
6	O
%).	O

However	O
,	O
no	O
differences	O
in	O
body	O
weight	O
were	O
found	O
between	O
CC	O
males	O
and	O
CC	O
females	O
(	O
Figure2B	O
).	O

3	O
.	O
5	O
.	O

The	O
feeding	O
system	O
for	O
highly	O
marbled	O
beef	O
from	O
Japanese	O
Black	O
cattle	O
has	O
been	O
described	O
previously	O
in	O
a	O
review	O
by	O
Gotoh	O
et	O
al	O
[	O
95	O
].	O

There	O
was	O
no	O
significant	O
effect	O
of	O
the	O
percent	O
of	O
human	O
milk	O
provided	O
on	O
outcomes	O
including	O
change	O
in	O
BMC	O
(	O
p	O
=	O
0	O
.	O
89	O
)	O
or	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
(	O
p	O
=	O
0	O
.	O
25	O
)	O
so	O
all	O
data	O
were	O
analyzed	O
without	O
amount	O
of	O
human	O
milk	O
included	O
as	O
a	O
covariate	O
.	O

Prophylaxis	O
iron	O
supplement	O
and	O
food	O
fortification	O
with	O
iron	O
have	O
the	O
prospects	O
of	O
improving	O
maternal	O
and	O
child	O
health	O
,	O
except	O
for	O
the	O
identified	O
constraints	O
.	O

Approximately	O
6	O
%	O
of	O
the	O
gestational	O
age	O
estimates	O
came	O
from	O
ultrasounds	O
in	O
the	O
last	O
trimester	O
,	O
which	O
have	O
higher	O
rates	O
of	O
estimate	O
error	O
than	O
estimates	O
calculated	O
in	O
early	O
pregnancy	O
.	O

In	O
unadjusted	O
analysis	O
,	O
T1	O
25OHD	O
was	O
associated	O
with	O
IUFD	O
and	O
women	O
with	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
at	O
T1	O
had	O
more	O
than	O
fourfold	O
higher	O
odds	O
of	O
IUFD	O
(	O
OR	O
=	O
4	O
.	O
52	O
,	O
p	O
=	O
0	O
.	O
034	O
).	O

3	O
).	O

The	O
vitamin	O
D	O
theory	O
of	O
autism	O
does	O
not	O
diminish	O
genetic	O
contributions	O
to	O
autism	O
occurrence	O
.	O

By	O
means	O
of	O
succeeding	O
direct	O
and	O
indirect	O
interactions	O
of	O
downstream	O
target	O
genes	O
,	O
mRNA	O
expression	O
regarding	O
metabolic	O
,	O
behavioural	O
,	O
cardiovascular	O
and	O
immune	O
functions	O
is	O
modulated	O
.	O

For	B
this	I
reason	I
,	O
a	O
large	O
amount	O
of	O
concentrate	O
is	O
fed	O
during	O
the	O
fattening	O
period	O
in	O
Japanese	O
Wagyu	O
and	O
Korean	O
beef	O
cattle	O
[	O
95	O
,	O
96	O
].	O

Neonatal	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
reflect	O
a	O
range	O
of	O
in	O
utero	O
factors	O
,	O
most	O
significant	O
of	O
these	O
being	O
the	O
maternal	O
vitamin	O
D	O
status	O
[	O
6	O
].	O

Third	O
,	O
a	O
large	O
percentage	O
of	O
infants	O
in	O
the	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
were	O
male	O
,	O
although	O
our	O
previous	O
study	O
found	O
no	O
gender	O
difference	O
in	O
the	O
infant	O
lung	O
function	O
test	O
[	O
18	O
].	O

In	O
summary	O
,	O
we	O
found	O
some	O
evidence	O
of	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
by	O
trimester	O
on	O
birth	O
outcomes	O
;	O
however	O
,	O
we	O
encourage	O
further	O
investigation	O
by	O
prioritizing	O
prospective	O
cohort	O
designs	O
over	O
retrospective	O
studies	O
to	O
minimize	O
selection	O
and	O
recall	O
biases	O
.	O

Amortization	O
of	O
training	O
and	O
promotional	O
material	O
production	O
costs	O
was	O
assumed	O
to	O
be	O
over	O
5	O
years	O
.	O

Mendez	O
et	O
al	O
.	O

Inclusion	O
criteria	O
We	O
selected	O
two	O
large	O
public	O
hospitals	O
,	O
Hospital	O
Aleman	O
Nicaragüense	O
and	O
Hospital	O
Bertha	O
Calderon	O
Roque	O
.	O

PubMed	O
Central	O
:	O

The	O
small	O
fold	O
changes	O
found	O
in	O
the	O
study	O
,	O
while	O
statistically	O
significant	O
,	O
were	O
too	O
low	O
to	O
be	O
reliably	O
confirmed	O
via	O
immunoblot	O
[	O
49	O
].	O

This	O
alteration	O
was	O
also	O
more	O
evident	O
in	O
males	O
than	O
in	O
females	O
.	O

The	O
intervention	O
period	O
was	O
only	O
3	O
-	O
months	O
,	O
compared	O
with	O
12	O
-	O
months	O
in	O
the	O
present	O
study	O
,	O
and	O
there	O
was	O
a	O
high	O
dropout	O
rate	O
.	O

2	O
.	O
10	O
.	O

While	O
a	O
particular	O
low	O
-	O
level	O
exposure	O
may	O
have	O
no	O
adverse	O
effects	O
,	O
multiple	O
low	O
-	O
level	O
exposures	O
over	O
multiple	O
stages	O
of	O
life	O
may	O
induce	O
adverse	O
phenotypes	O
.	O

The	O
other	O
two	O
questions	O
concerned	O
the	O
timing	O
of	O
the	O
first	O
visit	O
and	O
the	O
total	O
number	O
of	O
ANC	O
visits	O
.	O

At	O
follow	O
-	O
up	O
,	O
44	O
%	O
(	O
47	O
/	O
106	O
)	O
in	O
the	O
control	O
arm	O
and	O
70	O
%	O
in	O
the	O
intervention	O
arm	O
(	O
77	O
/	O
110	O
)	O
reported	O
doing	O
so	O
.	O

Experimental	O
design	O
Six	O
-	O
week	O
-	O
old	O
,	O
female	O
,	O
virgin	O
Swiss	O
Webster	O
mice	O
(	O
n	O
=	O
20	O
,	O
obtained	O
from	O
Oswaldo	O
Cruz	O
Institute	O
Foundation	O
,	O
Rio	O
de	O
Janeiro	O
,	O
RJ	O
,	O
Brazil	O
)	O
were	O
allocated	O
to	O
one	O
of	O
two	O
groups	O
for	O
six	O
weeks	O
:	O
SC	O
(	O
standard	O
chow	O
,	O
fed	O
a	O
diet	O
made	O
according	O
to	O
the	O
AIN93G	O
protocol	O
,	O
including	O
1	O
,	O
000	O
.	O
0	O
IU	O
/	O
kg	O
of	O
vitamin	O
D3	O
)[	O
14	O
]	O
or	O
VitD	O
-	O
(	O
vitamin	O
D	O
restricted	O
,	O
fed	O
the	O
same	O
AIN93G	O
diet	O
but	O
without	O
vitamin	O
D3	O
).	O

However	O
,	O
higher	O
yearly	O
household	O
incomes	O
were	O
associated	O
with	O
higher	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
and	O
having	O
concentrations	O
≥	O
75	O
nmol	O
/	O
L	O
(	O
p	O
=	O
0	O
.	O
002	O
and	O
p	O
=	O
0	O
.	O
002	O
,	O
respectively	O
).	O

This	O
transcription	O
factor	O
plays	O
a	O
role	O
in	O
the	O
control	O
of	O
a	O
wide	O
range	O
of	O
genes	O
,	O
including	O
small	O
nuclear	O
RNAs	O
,	O
immunoglobulins	O
,	O
histone	O
H2B	O
,	O
and	O
the	O
glucocorticoid	O
receptor	O
,	O
and	O
thus	O
has	O
a	O
central	O
role	O
in	O
controlling	O
various	O
functions	O
,	O
including	O
those	O
of	O
immunomodulation	O
and	O
steroid	O
homeostasis	O
in	O
the	O
placenta	O
(	O
Schonemann	O
et	O
al	O
.	O

Similarly	O
,	O
the	O
first	O
animal	O
study	O
to	O
demonstrate	O
that	O
an	O
in	O
utero	O
exposure	O
could	O
induce	O
adverse	O
phenotypes	O
in	O
subsequent	O
generations	O
administered	O
the	O
environmental	O
chemical	O
vinclozolin	O
via	O
the	O
intraperitoneal	O
route	O
(	O
Anway	O
et	O
al	O
.	O
2005	O
).	O

The	O
exclusion	O
criteria	O
are	O
1	O
)	O
<	O
18	O
and	O
>	O
39	O
years	O
;	O
2	O
)	O
Multiple	O
pregnancy	O
;	O
3	O
)	O
Using	O
illicit	O
drugs	O
(	O
self	O
-	O
confessed	O
);	O
4	O
)	O
Smoking	O
(	O
current	O
and	O
/	O
or	O
in	O
past	O
year	O
);	O
5	O
)	O
Known	O
non	O
-	O
communicable	O
disease	O
(	O
NCD	O
)	O
namely	O
diabetes	O
,	O
renal	O
disease	O
,	O
high	O
cholesterol	O
,	O
and	O
hypertension	O
;	O
6	O
)	O
Known	O
infectious	O
disease	O
namely	O
tuberculosis	O
and	O
hepatitis	O
;	O
7	O
)	O
Known	O
serious	O
illness	O
namely	O
cancer	O
,	O
lupus	O
or	O
psychosis	O
.	O

This	O
study	O
is	O
one	O
of	O
the	O
first	O
to	O
prospectively	O
examine	O
impacts	O
of	O
prenatal	O
diet	O
,	O
physical	O
activity	O
,	O
and	O
psychosocial	O
exposures	O
on	O
offspring	O
weight	O
outcomes	O
in	O
a	O
diverse	O
sample	O
.	O

Our	O
objective	O
,	O
in	O
a	O
randomized	O
controlled	O
trial	O
in	O
rural	O
Bangladesh	O
,	O
was	O
to	O
investigate	O
the	O
impact	O
of	O
this	O
intervention	O
on	O
the	O
handwashing	O
behavior	O
of	O
mothers	O
in	O
the	O
neonatal	O
period	O
.	O

Excessive	O
gestational	O
weight	O
gain	O
is	O
also	O
associated	O
with	O
risk	O
of	O
GDM	O
.	O

This	O
prompted	O
her	O
to	O
begin	O
investigating	O
the	O
role	O
of	O
insulin	O
in	O
stimulating	O
milk	O
production	O
.	O

The	O
de	O
novo	O
FA	O
synthesis	O
pathway	O
of	O
ruminants	O
is	O
summarized	O
inFigure	O
3	O
.	O

However	O
,	O
another	O
study	O
found	O
this	O
effect	O
to	O
be	O
only	O
minor	O
[	O
57	O
].	O

At	O
94	O
dpc	O
of	O
gestation	O
,	O
a	O
subset	O
of	O
eight	O
sows	O
per	O
dietary	O
group	O
was	O
subjected	O
to	O
Caesarean	O
section	O
(	O
EXP1	O
).	O

The	O
"	O
middle	O
level	O
symptoms	O
group	O
"	O
was	O
defined	O
as	O
participants	O
not	O
included	O
in	O
the	O
low	O
level	O
or	O
high	O
level	O
groups	O
.	O

F1	O
-	O
VitD	O
-	O
offspring	O
were	O
weaker	O
than	O
the	O
F1	O
-	O
SC	O
offspring	O
.	O

This	O
view	O
of	O
epigenetically	O
mediated	O
phenotypic	O
plasticity	O
falls	O
into	O
the	O
realms	O
of	O
Lamarckian	O
inheritance	O
,	O
the	O
idea	O
that	O
an	O
organism	O
can	O
pass	O
on	O
acquired	O
characteristics	O
to	O
future	O
offspring	O
.	O

After	O
separating	O
the	O
serum	O
from	O
blood	O
sample	O
,	O
the	O
serum	O
was	O
kept	O
under	O
−	O
20	O
°	O
C	O
temperature	O
until	O
the	O
laboratory	O
test	O
was	O
done	O
.	O

We	O
found	O
that	O
76	O
%	O
(	O
n	O
=	O
101	O
)	O
of	O
women	O
were	O
exposed	O
to	O
SGAs	O
throughout	O
pregnancy	O
and	O
72	O
%	O
of	O
the	O
assessed	O
cohort	O
received	O
psychotropic	O
drugs	O
in	O
polytherapy	O
,	O
which	O
is	O
in	O
agreement	O
with	O
previous	O
reports	O
.	O
16192122Frye	O
et	O
al	O
23stated	O
that	O
the	O
proportion	O
of	O
polytherapy	O
treatment	O
increased	O
from	O
3	O
.	O
3	O
%	O
in	O
1974	O
–	O
1979	O
to	O
44	O
%	O
in	O
1990	O
–	O
1995	O
.	O
24Recent	O
studies	O
indicate	O
that	O
this	O
trend	O
towards	O
polytherapy	O
continues	O
to	O
rise	O
,	O
reaching	O
up	O
to	O
80	O
%.	O
22Interestingly	O
,	O
Centorrino	O
and	O
colleagues	O
maintained	O
that	O
there	O
are	O
no	O
apparent	O
advantages	O
in	O
opting	O
for	O
treatments	O
with	O
multiple	O
antipsychotics	O
.	O

Pregnancy	O
itself	O
may	O
also	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
related	O
diseases	O
.	O

A	O
control	O
group	O
of	O
offspring	O
from	O
dams	O
fed	O
the	O
RV	O
diet	O
was	O
weaned	O
to	O
the	O
RV	O
pup	O
diet	O
for	O
29	O
weeks	O
.	O

Prophylaxis	O
Iron	O
Supplements	O
The	O
overall	O
impact	O
of	O
interventions	O
on	O
iron	O
supplementation	O
under	O
field	O
conditions	O
has	O
been	O
limited	O
and	O
its	O
effectiveness	O
questioned	O
[	O
33	O
].	O

Thus	B
,	O
the	O
effects	O
of	O
the	O
maternal	O
caloric	O
restriction	O
on	O
the	O
energy	O
balance	O
of	O
male	O
and	O
female	O
offspring	O
should	O
be	O
interpreted	O
based	O
on	O
their	O
sex	O
-	O
dependent	O
basal	O
metabolism	O
.	O

Considering	B
the	O
possible	O
losses	O
,	O
the	O
sample	O
size	O
was	O
set	O
at	O
74	O
people	O
in	O
each	O
group	O
finally	O
.	O

At	O
the	O
time	O
of	O
resupply	O
,	O
the	O
SS	O
will	O
collect	O
the	O
empty	O
strips	O
from	O
the	O
previous	O
round	O
.	O

Visfatin	O
had	O
been	O
copiously	O
excreted	O
in	O
mother	O
’	O
s	O
milk	O
,	O
and	O
serum	O
visfatin	O
levels	O
were	O
100	O
times	O
higher	O
in	O
mothers	O
’	O
milk	O
than	O
in	O
their	O
blood	O
.	O

Results	O
Approximately	O
5	O
.	O
3	O
%	O
of	O
the	O
study	O
cohort	O
developed	O
gestational	O
diabetes	O
mellitus	O
(	O
68	O
of	O
1	O
,	O
290	O
).	O

Still	O
,	O
we	O
cannot	O
rule	O
out	O
that	O
there	O
are	O
unknown	O
confounders	O
that	O
we	O
have	O
not	O
been	O
adjusted	O
for	O
,	O
for	O
example	O
drugs	O
influencing	O
levels	O
of	O
serum	O
lipids	O
or	O
family	O
history	O
of	O
psychiatric	O
illness	O
.	O

On	O
average	O
,	O
a	O
10	O
-	O
fold	O
increase	O
in	O
exposure	O
to	O
the	O
PFAS	O
class	O
was	O
associated	O
with	O
an	O
-	O
11	O
g	O
change	O
in	O
birth	O
weight	O
,	O
50	O
%	O
CI	O
(-	O
21	O
,	O
-	O
2	O
).	O

Our	O
results	O
show	O
that	O
dosage	O
was	O
a	O
predictor	O
of	O
lower	O
alcohol	O
consumption	O
response	O
.	O

[	O
19	O
]	O
found	O
that	O
individuals	O
born	O
with	O
very	O
low	O
birth	O
weight	O
have	O
lower	O
sympathetic	O
nerve	O
activity	O
under	O
resting	O
conditions	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
in	O
terms	O
of	O
plasma	O
HA1C	O
,	O
literacy	O
level	O
,	O
type	O
of	O
treatment	O
for	O
GDM	O
,	O
or	O
type	O
of	O
delivery	O
.	O

The	O
supplementation	O
should	O
be	O
continued	O
during	O
the	O
breast	O
feeding	O
period	O
even	O
in	O
larger	O
doses	O
of	O
6000IU	O
daily	O
in	O
order	O
to	O
avoid	O
deficiency	O
in	O
neonates	O
[	O
68	O
].	O

Data	O
Collection	O
2	O
.	O
2	O
.	O
1	O
.	O

Because	O
9	O
.	O
75	O
g	O
of	O
sucrose	O
is	O
added	O
as	O
a	O
carrier	O
in	O
the	O
10	O
g	O
of	O
vitamin	O
mix	O
in	O
the	O
RV	O
diet	O
,	O
we	O
reduced	O
the	O
added	O
sucrose	O
to	O
only	O
10	O
g	O
in	O
the	O
HV	O
diet	O
to	O
adjust	O
for	O
the	O
97	O
.	O
5	O
g	O
of	O
sucrose	O
from	O
the	O
100	O
g	O
of	O
vitamin	O
mix	O
.	O
Figure	O
1adepicts	O
the	O
study	O
design	O
.	O

Depression	O
scores	O
were	O
divided	O
into	O
three	O
categories	O
,	O
<	O
9	O
,	O
9	O
–	O
13	O
,	O
and	O
>	O
13	O
,	O
and	O
using	O
the	O
Fisher	O
’	O
s	O
exact	O
test	O
,	O
the	O
comparisons	O
between	O
the	O
two	O
groups	O
were	O
conducted	O
.	O

However	O
,	O
contact	O
with	O
and	O
exposure	O
to	O
antigens	O
may	O
be	O
necessary	O
in	O
early	O
life	O
to	O
develop	O
tolerance	O
in	O
the	O
immune	O
system	O
[	O
118	O
].	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
linked	O
to	O
pro	O
-	O
inflammatory	O
disease	O
.	O

Overall	O
,	O
however	O
,	O
the	O
current	O
study	O
'	O
s	O
findings	O
suggest	O
that	O
dietary	O
variables	O
may	O
exert	O
more	O
of	O
an	O
effect	O
than	O
maternal	O
psychosocial	O
variables	O
on	O
offspring	O
weight	O
outcomes	O
.	O

[	O
1819	O
]	O
To	O
attain	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
that	O
exceed	O
250	O
nmol	O
/	O
L	O
(	O
100	O
ng	O
/	O
mL	O
),	O
a	O
daily	O
vitamin	O
D	O
intake	O
well	O
in	O
excess	O
of	O
10	O
,	O
000	O
IU	O
/	O
d	O
(	O
250	O
μg	O
/	O
d	O
)	O
for	O
several	O
months	O
would	O
be	O
required	O
.	O

Kidney	O
organogenesis	O
is	O
begun	O
and	O
maintained	O
as	B
a	O
result	O
of	O
a	O
series	O
of	O
regulatory	O
molecules	O
.	O

The	O
nail	O
plate	O
was	O
subsequently	O
reflected	O
back	O
into	O
place	O
.	O

Protein	O
spots	O
that	O
were	O
significantly	O
altered	O
were	O
excised	O
for	O
identification	O
by	O
mass	O
spectrometry	O
.	O

Additionally	O
,	O
breast	O
-	O
feeding	O
may	O
decrease	O
the	O
risk	O
of	O
overweight	O
,	O
particularly	O
in	O
children	O
born	O
to	O
overweight	O
mothers	O
.	O

A	O
systematic	O
review	O
in	O
2005	O
found	O
that	O
up	O
to	O
70	O
%	O
of	O
neonatal	O
deaths	O
,	O
worldwide	O
,	O
could	O
be	O
averted	O
by	O
implementing	O
sixteen	O
evidence	O
-	O
based	O
interventions	O
at	O
near	O
universal	O
coverage	O
(	O
99	O
%)	O
that	O
incorporated	O
preconception	O
,	O
antenatal	O
,	O
intrapartum	O
and	O
postnatal	O
interventions	O
[	O
3	O
].	O

This	O
committee	O
will	O
assist	O
in	O
translating	O
the	O
Shonjibon	O
study	O
findings	O
into	O
policy	O
.	O

However	O
,	O
measuring	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
in	O
early	O
pregnancy	O
is	O
common	O
and	O
potentially	O
clinically	O
useful	O
as	O
this	O
is	O
prior	O
to	O
when	O
many	O
of	O
the	O
pregnancy	O
complications	O
that	O
affect	O
late	O
gestation	O
manifest	O
.	O

Differently	O
from	O
what	O
is	O
observed	O
in	O
other	O
pregnancy	O
-	O
associated	O
cancers	O
,	O
no	O
metastasis	O
of	O
DTC	O
to	O
placenta	O
or	O
foetus	O
has	O
been	O
reported	O
.	O

Some	O
earlier	O
studies	O
have	O
shown	O
that	O
severe	O
maternal	O
vitamin	O
D	O
deficiency	O
associates	O
with	O
smaller	O
head	O
circumference	O
at	O
birth	O
[	O
32	O
,	O
33	O
],	O
yet	O
some	O
have	O
not	O
[	O
34	O
,	O
35	O
].	O

In	O
particular	O
,	O
the	O
cellular	O
energy	O
sensor	O
AMPK	O
is	O
essential	O
for	O
a	O
proper	O
mitochondrial	O
activity	O
and	O
metabolic	O
health	O
citeTowler2007	O
.	O

Kynurenine	O
pathway	O
metabolites	O
(	O
mediates	O
interactions	O
between	O
immunological	O
and	O
neurological	O
function	O
)	O
will	O
be	O
determined	O
using	O
LCMSMS	O
[	O
76	O
].	O

Considering	B
the	O
range	O
of	O
obtained	O
serum	O
calcium	O
and	O
phosphorus	O
in	O
mothers	O
,	O
no	O
incidence	O
of	O
hypercalcemia	O
,	O
hyperphosphatemia	O
,	O
or	O
hypervitaminosis	O
,	O
this	O
dosage	O
and	O
route	O
of	O
supplementation	O
of	O
vitamin	O
D	O
seems	O
to	O
be	O
safe	O
for	O
mothers	O
and	O
their	O
infants	O
.	O

More	O
of	O
the	O
women	O
taking	O
the	O
weekly	O
dose	O
were	O
mildly	O
anemic	O
(	O
with	O
hemoglobin	O
levels	O
shown	O
not	O
to	O
carry	O
any	O
risk	O
for	O
mothers	O
and	O
infants	O
)	O
compared	O
with	O
the	O
women	O
taking	O
the	O
daily	O
dose	O
.	O

2011	O
)	O
and	O
may	O
arise	O
sporadically	O
or	O
as	O
the	O
result	O
of	O
an	O
underlying	O
heritable	O
abnormality	O
in	O
genes	O
that	O
contribute	O
to	O
vertebral	O
development	O
.	O

Results	O
.	O

This	O
population	O
of	O
women	O
was	O
predominantly	O
Caucasian	O
and	O
thus	O
maternal	O
ethnicity	O
was	O
categorised	O
into	O
2	O
main	O
groups	O
;	O
Caucasian	O
and	O
non	O
-	O
Caucasian	O
.	O

Special	O
hypoallergenic	O
formula	O
(	O
extensively	O
hydrolyzed	O
,	O
not	O
soy	O
-	O
based	O
)	O
should	O
be	O
used	O
only	O
if	O
the	O
child	O
is	O
diagnosed	O
with	O
atopy	O
.	O

In	O
a	O
study	O
by	O
Hovsepian	O
et	O
al	O
.,	O
in	O
men	O
and	O
women	O
with	O
average	O
age	O
of	O
41	O
.	O
4	O
years	O
in	O
Isfahan	O
,	O
45	O
%	O
of	O
men	O
and	O
52	O
.	O
4	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
20	O
ng	O
/	O
mL	O
([	O
52	O
]).	O

In	O
total	O
we	O
found	O
12	O
,	O
650	O
probe	O
-	O
sets	O
expressed	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
12	O
,	O
005	O
;	O
28	O
dpn	O
:	O
12	O
,	O
307	O
;	O
188	O
dpn	O
:	O
11	O
,	O
784	O
)	O
according	O
to	O
MAS5	O
analysis	O
.	O

It	O
has	O
been	O
noted36that	O
if	B
the	O-
sexes	O-
are	O-
not	O-
equal	O-
in	O-
phenotypic	O-
variance	O-
,	O-
then	I
regression	O
of	O
daughters	O
on	O
fathers	O
,	O
for	O
example	O
,	O
must	O
be	O
adjusted	O
for	O
the	O
difference	O
in	O
variation	O
.	O

Macrosomia	O
,	O
shoulder	O
dystocia	O
with	O
its	O
attendant	O
risks	O
of	O
brachial	O
plexus	O
injury	O
and	O
clavicle	O
fracture	O
,	O
and	O
neonatal	O
hypoglycemia	O
are	O
the	O
serious	O
complications	O
which	O
most	O
commonly	O
occur	O
.	O
6	O
–	O
11Jaundice	O
,	O
polycythemia	O
,	O
respiratory	O
distress	O
,	O
and	O
hypocalcemia	O
have	O
also	O
been	O
reported	O
.	O

Results	O
showed	O
that	O
in	O
the	O
vitamin	O
D	O
group	O
the	O
number	O
of	O
participants	O
with	O
depression	O
scores	O
of	O
<	O
9	O
were	O
more	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
Table	O
3	O
).	O

Five	O
QG	O
levels	O
are	O
used	O
in	O
the	O
Korean	O
beef	O
QG	O
system	O
[	O
QG1	O
++	O
(	O
highest	O
),	O
QG1	O
+,	O
QG1	O
,	O
QG2	O
,	O
and	O
QG3	O
(	O
lowest	O
)]	O
[	O
59	O
].	O

Regardless	O
of	O
maternal	O
pre	O
-	O
pregnancy	O
overweight	O
status	O
,	O
both	O
short	O
and	O
long	O
sleep	O
durations	O
were	O
associated	O
with	O
higher	O
frequencies	O
of	O
elevated	O
plasma	O
glucose	O
concentrations	O
(	O
Figure2b	O
).	O

While	O
historical	O
evidence	O
suggests	O
that	O
vitamin	O
D	O
supplementation	O
can	O
prevent	O
caries	O
onset	O
and	O
progression	O
,	O
much	O
of	O
this	O
research	O
has	O
been	O
overlooked	O
[	O
18	O
,	O
29	O
,	O
30	O
].	O

(	O
2010	O
)¶/†	O
Under	O
-	O
nutritionMouseOral	O
(	O
diet	O
)	O
(↓	O
folate	O
and	O
choline	O
)	O
Early	O
adulthoodLater	O
adulthoodHepatic	O
abnormalitiesmiRNAsTryndyak	O
et	O
al	O
.	O

Overall	O
,	O
these	O
birth	O
weight	O
studies	O
illustrate	O
that	O
more	O
research	O
with	O
larger	O
populations	O
needs	O
to	O
be	O
conducted	O
to	O
determine	O
whether	O
autism	O
etiology	O
is	O
genetic	O
in	O
relation	O
to	O
birth	O
weight	O
,	O
whether	O
birth	O
weight	O
is	O
a	O
risk	O
factor	O
or	O
a	O
cause	O
of	O
autism	O
,	O
how	O
much	O
mother	O
'	O
s	O
gestational	O
age	O
plays	O
a	O
role	O
,	O
and	O
whether	O
pre	O
-	O
or	O
postpregnancy	O
weight	O
of	O
the	O
mother	O
has	O
a	O
larger	O
effect	O
on	O
prevalence	O
of	O
autism	O
and	O
ASD	O
as	B
research	O
currently	O
supports	O
a	O
variety	O
of	O
findings	O
.	O

In	O
addition	O
,	O
mice	O
that	O
overexpress	O
osteocrin	O
have	O
elongated	O
bones	O
and	O
exhibit	O
a	O
kyphosis	O
phenotype	O
(	O
Moffatt	O
et	O
al	O
.	O

Some	O
of	O
the	O
most	O
robust	O
and	O
consistent	O
findings	O
in	O
the	O
DVD	O
model	O
have	O
emerged	O
in	O
behavioural	O
pharmacological	O
studies	O
.	O

Novel	O
and	O
feasible	B
approaches	O
to	O
motivating	O
handwashing	O
behavior	O
change	O
among	O
mothers	O
and	O
other	O
caregivers	O
to	O
protect	O
newborns	O
should	O
be	O
developed	O
and	O
evaluated	O
and	O
,	O
if	O
effective	O
,	O
their	O
impacts	O
on	O
neonatal	O
health	O
should	O
be	O
investigated	O
.	O

or	O
more	O
.	O

Surgeon	O
General	O
has	O
also	O
participated	O
in	O
media	O
outreach	O
to	O
publicise	O
the	O
Report	O
Cards	O
and	O
their	O
recommended	O
actions	O
.	O

Service	O
limitations	O
impaired	O
the	O
delivery	O
of	O
optimal	O
care	O
.	O

Although	O
qualitative	O
results	O
(	O
i	O
.	O
e	O
.,	O
normal	O
/	O
abnormal	O
blood	O
glucose	O
concentrations	O
)	O
for	O
the	O
diagnostic	O
test	O
were	O
available	O
for	O
all	O
251	O
subjects	O
,	O
specific	O
glucose	O
concentrations	O
for	O
each	O
time	O
point	O
(	O
i	O
.	O
e	O
.,	O
fasting	O
;	O
1	O
-	O
hour	O
;	O
2	O
-	O
hour	O
;	O
and	O
3	O
-	O
hour	O
post	O
glucose	O
load	O
)	O
were	O
unavailable	O
for	O
approximately	O
44	O
%	O
of	O
subjects	O
.	O

In	O
addition	O
,	O
an	O
increasing	O
number	O
of	O
studies	O
suggest	O
that	O
gestational	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
and	O
children	O
[	O
16	O
]–[	O
22	O
].	O

The	O
samples	O
were	O
added	O
to	O
ethylenediaminetetraacetic	O
acid	O
-	O
containing	O
tubes	O
and	O
sent	O
to	O
endocrinology	O
and	O
metabolism	O
laboratories	O
of	O
Shahid	O
Beheshti	O
University	O
of	O
Medical	O
Sciences	O
,	O
Tehran	O
within	O
24	O
hours	O
and	O
kept	O
at	O
2	O
-	O
8	O
°	O
C	O
.	O

Test	O
for	O
normality	O
will	O
be	O
performed	O
by	O
the	O
Shapiro	O
-	O
Wilk	O
test	O
.	O

In	O
addition	O
,	O
vitamin	O
D	O
status	O
among	O
women	O
who	O
terminated	O
the	O
pregnancy	O
was	O
not	O
assessed	O
.	O

Any	O
unintended	O
effects	O
of	O
trial	O
intervention	O
will	O
also	O
be	O
notified	O
to	O
data	O
safety	O
and	O
monitoring	O
board	O
.	O

All	O
whole	O
body	O
DEXA	O
scans	O
were	O
done	O
by	O
the	O
same	O
technologist	O
on	O
a	O
Hologic	O
Discovery	O
A	O
densitometer	O
(	O
Bedford	O
,	O
MA	O
,	O
USA	O
).	O

Discussion	O
The	O
study	O
aimed	O
at	O
exploring	O
the	O
perceptions	O
of	O
pregnant	O
women	O
attending	O
antenatal	O
clinic	O
in	O
the	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
regarding	O
antenatal	O
care	O
in	O
terms	O
of	O
their	O
knowledge	O
and	O
satisfaction	O
with	O
service	O
delivery	O
.	O

Further	O
study	O
is	O
warranted	O
to	O
understand	O
what	O
mechanisms	O
affect	O
the	O
adipogenic	O
potential	O
by	O
nutritional	O
modulation	O
during	O
the	O
fetal	O
period	O
at	O
specific	O
gestation	O
stages	O
,	O
thereafter	O
affecting	O
marbling	O
and	O
IMF	O
deposition	O
at	O
the	O
progeny	O
slaughter	O
stage	O
.	O

Cold	O
-	O
acclimation	O
was	O
also	O
shown	O
to	O
increase	O
diet	O
-	O
induced	O
thermogenesis	O
and	O
postprandial	O
insulin	O
sensitivity	O
,	O
without	O
impacting	O
cold	O
-	O
induced	O
thermogenesis	O
(	O
Lee	O
et	O
al	O
.,	O
2014b	O
).	O

Additionally	O
,	O
fewer	O
caregivers	O
of	O
children	O
with	O
S	O
-	O
ECC	O
indicated	O
that	O
their	O
child	O
’	O
s	O
overall	O
health	O
was	O
very	O
good	O
compared	O
to	O
those	O
whose	O
children	O
were	O
caries	O
-	O
free	O
(	O
58	O
.	O
3	O
%	O
vs	O
.	O
82	O
.	O
8	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

Ursodeoxycholic	O
acid	O
supplementation	O
increased	O
IMF	O
and	O
QG	O
in	O
Wagyu	O
heifers	O
[	O
26	O
],	O
demonstrating	O
that	O
bile	O
acid	O
supplementation	O
improves	O
IMF	O
deposition	O
,	O
probably	B
by	O
increasing	O
intestinal	O
fat	O
digestion	O
and	O
absorption	O
by	O
increasing	O
fat	O
emulsification	O
.	O

Also	O
,	O
blood	O
samples	O
were	O
used	O
to	O
prepare	O
serums	O
,	O
which	O
were	O
kept	O
frozen	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
in	O
Johannesburg	O
only	O
45	O
%	O
of	O
women	O
access	O
ANC	O
before	O
20	O
weeks	O
gestation	O
and	O
only	O
23	O
%	O
in	O
their	O
first	O
trimester	O
(	O
as	O
reported	O
from	O
other	O
urban	O
areas	O
)	O
[	O
30	O
].	O

Canaries	O
in	O
the	O
Uranium	O
Mines	O
The	O
arrival	O
of	O
prospectors	O
signified	O
the	O
Navajo	O
Nation	O
’	O
s	O
entrance	O
into	O
the	O
modern	O
wage	O
economy	O
.	O
7Some	O
welcomed	O
the	O
potential	O
income	O
.	O

To	O
date	O
,	O
a	O
convincing	O
explanation	O
for	O
the	O
occurrence	O
of	O
adult	O
gliomas	O
decades	O
after	O
a	O
seasonal	O
exposure	O
at	O
birth	O
remains	O
elusive	O
.	O

In	O
infants	O
,	O
sensitization	O
to	O
a	O
house	O
dust	O
mite	O
mixture	O
including	O
Dermatophagoides	O
farinae	O
,	O
German	O
cockroach	O
,	O
mould	O
mixture	O
,	O
cat	O
and	O
dog	O
dander	O
,	O
maize	O
pollen	O
,	O
Bermuda	O
grass	O
,	O
chicken	O
egg	O
,	O
cow	O
’	O
s	O
milk	O
,	O
cod	O
fish	O
,	O
peanuts	O
,	O
wheat	O
and	O
soy	O
bean	O
flour	O
and	O
potato	O
are	O
measured	O
.	O

For	O
6	O
women	O
information	O
on	O
the	O
age	O
was	O
missing	O
.	O

At	O
the	O
end	O
of	O
the	O
test	O
,	O
animals	O
were	O
returned	O
to	O
their	O
original	O
cages	O
and	O
standard	O
diet	O
.	O

Vitamin	O
D	O
deficiency	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
<	O
20	O
ng	O
/	O
mL	O
)	O
was	O
observed	O
in	O
134	O
women	O
(	O
87	O
.	O
6	O
%).	O

The	O
recently	O
introduced	O
topical	O
calcineurin	O
inhibitors	O
(	O
pimecrolimus	O
and	O
tacrolimus	O
),	O
although	O
effective	O
in	O
the	O
treatment	O
of	O
atopic	O
eczema	O
,	O
are	O
not	O
recommended	O
for	O
use	O
in	O
pregnant	O
patients	O
because	O
of	O
the	O
lack	O
of	O
safety	O
data	O
.	O

The	O
heart	O
rate	O
was	O
130	O
/	O
min	O
,	O
respiratory	O
rate	O
was	O
36	O
/	O
min	O
and	O
oxygen	O
saturation	O
was	O
98	O
%	O
in	O
room	O
air	O
.	O

However	O
,	O
it	O
has	O
been	O
said	O
that	O
the	O
views	O
of	O
pregnant	O
women	O
concerning	O
their	O
care	O
is	O
generally	B
positive	O
as	O
they	O
tend	O
to	O
be	O
uncritical	O
of	O
healthcare	O
,	O
accepting	O
whatever	O
care	O
they	O
receive	O
as	O
appropriate	O
[	O
29	O
].	O

Targeting	O
specific	O
components	O
of	O
the	O
neuroendocrine	O
regulation	O
of	O
energy	O
intake	O
,	O
such	O
as	O
leptin	O
or	O
hypothalamic	O
neuropeptides	O
,	O
has	O
disappointingly	O
revealed	O
unsuccessful	O
as	O
yet	O
.	O

Utrera	O
and	O
Van	O
Vleck	O
[	O
41	O
]	O
presented	O
estimates	O
of	O
heritability	O
for	O
cattle	O
carcass	O
traits	O
in	O
72	O
studies	O
(	O
1962	O
through	O
2004	O
).	O

Alterations	O
in	O
maternal	O
immunity	O
,	O
particularly	O
a	O
decrease	O
in	O
cell	O
-	O
mediated	O
immunity	O
,	O
may	O
predispose	O
the	O
pregnant	O
asthmatic	O
to	O
infections	O
and	O
thus	B
to	O
acute	O
exacerbations	O
of	O
asthma	O
.	O

Household	O
dust	O
concentrations	O
of	O
azinphosmethyl	O
,	O
chlorpyrifos	O
,	O
parathion	O
,	O
and	O
phosmet	O
have	O
been	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
farmer	O
or	O
farmworker	O
homes	O
than	O
in	O
referent	O
homes	O
[	O
29	O
].	O

With	O
further	O
study	O
,	O
cathelicidin	O
may	O
serve	O
as	O
a	O
biomarker	O
of	O
enhanced	O
immune	O
function	O
over	O
time	O
in	O
children	O
with	O
age	O
-	O
based	O
norms	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

©	O
BSIP	O
/	O
UIG	O
/	O
Getty	O
Images	O
She	O
found	O
that	O
measures	O
of	O
glucose	O
intolerance	O
predicted	O
delayed	O
lactogenesis	O
in	O
a	O
group	O
of	O
primiparous	O
Sacramento	O
-	O
area	O
mothers	O
.	O
10In	O
a	O
small	O
group	O
of	O
Cincinnati	O
mothers	O
,	O
she	O
showed	O
that	O
women	O
with	O
weaker	O
insulin	O
response	O
tended	O
to	O
start	O
lactating	O
later	O
than	O
those	O
with	O
good	O
insulin	O
response	O
,	O
with	O
the	O
onset	O
of	O
lactogenesis	O
ranging	O
from	O
10	O
to	O
121	O
hours	O
postpartum	O
.	O
32When	O
Nommsen	O
-	O
Rivers	O
looked	O
at	O
insulin	O
-	O
sensitive	O
genes	O
in	O
the	O
human	O
mammary	O
gland	O
,	O
she	O
found	O
a	O
potential	O
biomarker	O
linking	O
insulin	O
resistance	O
and	O
difficulty	O
lactating	O
.	O
33	O
She	O
then	O
compared	O
milk	O
production	O
over	O
a	O
24	O
-	O
hour	O
period	O
in	O
mothers	O
with	O
evidence	O
of	O
insulin	O
resistance	O
versus	O
mothers	O
without	O
.	O

When	O
considering	O
temporal	O
aspects	O
to	O
reproductive	O
,	O
developmental	O
and	O
endocrine	O
disrupting	O
effects	O
,	O
the	O
TGs	O
currently	O
in	O
use	O
may	O
not	O
incorporate	O
either	O
the	O
most	O
relevant	O
life	O
stage	O
(	O
s	O
),	O
the	O
most	O
sensitive	O
endpoints	O
for	O
epigenetic	O
perturbation	O
and	O
/	O
or	O
sufficient	O
duration	O
of	O
observation	O
to	O
detect	O
later	O
-	O
onset	O
effects	O
.	O

Direct	O
comparisons	O
however	O
of	O
25	O
(	O
OH	O
)	O
D	O
values	O
between	O
studies	O
conducted	O
in	O
the	O
past	O
and	O
recent	O
studies	O
should	O
be	O
done	O
with	O
caution	O
due	O
to	O
well	B
-	I
documented	I
variations	O
in	O
assay	O
techniques	O
.	O

Led	O
by	O
institute	O
scientists	O
Walter	O
Rogan	O
and	O
Beth	O
Gladen	O
,	O
both	O
now	O
retired	O
,	O
the	O
study	O
aimed	O
to	O
gather	O
data	O
on	O
health	O
effects	O
in	O
infants	O
who	O
were	O
exposed	O
via	O
breast	O
milk	O
to	O
polychlorinated	O
biphenyls	O
(	O
PCBs	O
)	O
and	O
to	O
DDT14	O
—	O
which	O
by	O
then	O
had	O
been	O
banned	O
.	O

In	O
tandem	O
with	O
living	O
on	O
a	O
farm	O
,	O
infants	O
have	O
unique	O
vulnerabilities	O
that	O
may	O
lead	O
to	O
higher	O
levels	O
of	O
exposures	O
in	O
the	O
same	O
environment	O
than	O
adults	O
[	O
9	O
].	O

Changes	O
in	O
BMI	O
with	O
age	O
In	O
an	O
analysis	O
of	O
change	O
from	O
birth	O
to	O
5	O
years	O
,	O
the	O
weight	O
difference	O
of	O
the	O
child	O
was	O
calculated	O
(	O
age	O
5	O
–	O
0	O
)	O
and	O
regressed	O
on	O
the	O
other	O
family	O
members	O
’	O
weight	O
.	O

Along	O
this	O
line	O
,	O
it	O
was	O
recently	O
demonstrated	O
that	O
chronic	O
activation	O
of	O
the	O
β3	O
adrenoreceptor	O
induces	O
coupled	O
increases	O
in	O
lipolysis	O
,	O
de	O
novo	O
lipogenesis	O
and	O
fatty	O
acid	O
beta	O
-	O
oxidation	O
not	O
only	O
in	O
white	O
,	O
but	O
also	O
in	O
BAT	O
(	O
Mottillo	O
et	O
al	O
.,	O
2014	O
).	O

We	O
have	O
demonstrated	O
the	O
effective	O
uptake	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
by	O
70	O
%	O
of	O
woman	O
in	O
Yen	O
Bai	O
province	O
with	O
an	O
annual	O
cost	O
of	O
USD	O
0	O
.	O
76	O
/	O
woman	O
.	O

Weight	O
,	O
length	O
,	O
BMI	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
head	O
circumference	O
measures	O
were	O
converted	O
to	O
z	O
-	O
scores	O
for	O
age	O
and	O
gender	O
,	O
using	O
WHO	O
standards	O
[	O
27	O
,	O
30	O
].	O

There	O
is	O
sufficient	B
evidence	I
that	O
increased	O
PFAS	O
(	O
especially	O
PFOA	O
)	O
exposure	O
is	O
associated	O
with	O
low	O
birth	O
weight	O
[	O
18	O
–	O
20	O
],	O
but	O
mixed	O
results	O
are	O
reported	O
for	O
other	O
EDCs	O
and	O
birth	O
weight	O
[	O
18	O
,	O
21	O
].	O

The	O
Block	O
Food	O
Frequency	O
questionnaire	O
was	O
used	O
to	O
assess	O
daily	O
caloric	O
intake	O
,	O
calories	O
from	O
sugar	O
-	O
sweetened	O
beverages	O
,	O
and	O
percent	O
intake	O
from	O
fat	O
,	O
protein	O
,	O
carbohydrates	O
,	O
and	O
sweets	O
.	O

Laboratory	O
studies	O
of	O
preschool	O
-	O
aged	O
children	O
have	O
also	O
demonstrated	O
that	O
restrictions	O
placed	O
on	O
children	O
'	O
s	O
access	O
to	O
palatable	O
,	O
energy	O
-	O
dense	O
foods	O
can	O
lead	B
to	I
increased	O
food	O
intake	O
when	O
restrictions	O
are	O
lifted	O
and	O
food	O
becomes	O
available	O
(	O
80	O
,	O
81	O
).	O

We	O
will	O
compare	O
neonatal	O
mortality	O
rates	O
&	O
their	O
95	O
%	O
confidence	O
intervals	O
adjusted	O
for	O
clustering	O
between	O
treatment	O
groups	O
in	O
each	O
groundwater	O
iron	O
-	O
level	O
group	O
.	O

There	O
was	O
no	O
relationship	O
between	O
compliance	O
and	O
outcome	O
so	O
this	O
was	O
not	O
further	O
considered	O
in	O
the	O
analysis	O
.	O

2	O
).	O

Similarly	O
,	O
Skm1	O
mice	O
also	O
exhibit	O
these	O
skeletal	O
phenotypes	O
.	O

$	O
5	O
.	O
18	O
per	O
woman	O
of	O
reproductive	O
age	O
,	O
as	O
compared	O
to	O
the	O
cost	O
of	O
supplementation	O
per	O
woman	O
of	O
reproductive	O
age	O
of	O
USD0	O
.	O
76	O
.	O

To	O
confirm	O
the	O
presence	O
of	O
the	O
Bcl	O
I	O
polymorphism	O
,	O
17	O
μ	O
L	O
of	O
the	O
PCR	O
product	O
was	O
digested	O
with	O
2	O
μ	O
L	O
of	O
10x	O
Restriction	O
Endonuclease	O
Buffer	O
and	O
15	O
U	O
of	O
the	O
restriction	O
enzyme	O
Bcl	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
for	O
1	O
.	O
5	O
hr	O
at	O
50	O
°	O
C	O
.	O

Interestingly	O
,	O
recent	O
studies	O
have	O
documented	O
epigenetic	O
modifications	O
or	O
affectation	O
of	O
adrenocortical	O
growth	O
in	O
offspring	O
after	O
maternal	O
dietary	O
restriction	O
around	O
the	O
time	O
of	O
conception	O
(	O
Nicholas	O
et	O
al	O
.,	O
2013	O
;	O
Zhang	O
et	O
al	O
.,	O
2013	O
),	O
pointing	O
out	O
the	O
importance	O
of	O
the	O
periconceptional	O
window	O
in	O
the	O
metabolic	O
programming	O
.	O

Linear	O
regression	O
was	O
used	O
to	O
examine	O
the	O
association	O
between	O
the	O
four	O
SNPs	O
and	O
the	O
outcomes	O
using	O
an	O
additive	O
model	O
with	O
the	O
homozygous	O
low	O
-	O
frequency	O
allele	O
(	O
for	O
this	O
cohort	O
)	O
as	O
the	O
reference	O
group	O
.	O

In	O
adults	O
,	O
Toxoplasma	O
gondii	O
infection	O
has	O
been	O
associated	O
with	O
a	O
greater	O
prevalence	O
of	O
astrocytomas	O
[	O
134	O
],	O
while	O
decreased	O
glioma	O
risk	O
has	O
been	O
associated	O
with	O
a	O
history	O
of	O
infections	O
/	O
colds	O
[	O
88	O
],	O
and	O
chicken	O
pox	O
[	O
135	O
,	O
136	O
].	O

Pubertal	O
data	O
are	O
represented	O
as	O
group	O
means	O
and	O
as	O
percentage	O
of	O
offspring	O
entering	O
puberty	O
as	O
a	O
proportion	O
of	O
total	O
.	O

It	O
is	O
noteworthy	O
that	O
the	O
book	O
covers	O
several	O
aspects	O
of	O
food	O
policies	O
as	O
well	O
including	O
food	O
sustainability	O
,	O
food	O
labelling	O
,	O
food	O
industry	O
and	O
consumer	O
nutrition	O
.	O

More	O
targeted	O
care	O
is	O
necessary	O
for	O
reducing	O
deaths	O
among	O
babies	O
28	O
to	O
<	O
32	O
weeks	O
and	O
this	O
reduction	O
could	O
be	O
accelerated	O
as	O
higher	O
-	O
impact	O
interventions	O
are	O
now	O
known	O
,	O
such	O
as	O
antenatal	O
corticosteroids	O
,	O
surfactant	O
,	O
KMC	O
and	O
other	O
enhanced	O
methods	O
of	O
infant	O
warming	O
and	O
feeding	O
which	O
were	O
not	O
available	O
in	O
the	O
mid	O
-	O
20th	O
century	O
in	O
the	O
United	O
States	O
and	O
United	O
Kingdom	O
.	O

Those	O
authors	O
also	O
suggested	O
that	O
providing	O
dietary	O
glucose	O
sources	O
(	O
e	O
.	O
g	O
.,	O
high	O
-	O
starch	O
diet	O
)	O
at	O
an	O
early	O
age	O
can	O
improve	O
IMF	O
deposition	O
.	O

25	O
(	O
OH	O
)	O
D	O
analyses	O
Maternal	O
pregnancy	O
serum	O
samples	O
for	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
were	O
collected	O
at	O
community	O
prenatal	O
clinics	O
at	O
gestational	O
weeks	O
7	O
to	O
25	O
between	O
June	O
2012	O
and	O
November	O
2013	O
as	O
part	O
of	O
the	O
mothers	O
’	O
normal	O
follow	O
-	O
up	O
[	O
hereafter	O
referred	O
to	O
as	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
].	O

It	O
has	O
been	O
proposed	O
that	O
the	O
ratio	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
might	O
be	O
more	O
important	O
in	O
inhibiting	O
the	O
development	O
of	O
several	O
diseases	O
,	O
including	O
cancer	O
,	O
inflammatory	O
and	O
heart	O
diseases	O
[	O
45	O
,	O
46	O
].	O

Two	O
controls	O
were	O
chosen	O
per	O
case	O
,	O
matched	O
for	O
village	O
of	O
residence	O
,	O
age	O
,	O
sex	O
and	O
language	O
group	O
,	O
Reinterviewing	O
was	O
performed	O
to	O
a	O
limited	O
extent	O
to	O
assess	O
the	O
accuracy	O
of	O
replies	O
to	O
questionnaires	O
.	O

Indeed	O
,	O
Nishihara	O
et	O
al	O
.	O

Moreover	O
,	O
the	O
usual	O
recommendations	O
to	O
avoid	O
sun	O
exposure	O
reduces	O
dermal	O
synthesis	O
of	O
vitamin	O
D3Although	O
vitamin	O
D	O
is	O
undoubtedly	B
important	O
for	O
foetal	O
bone	O
development	O
,	O
we	O
know	O
that	O
it	O
plays	O
a	O
much	O
wider	O
role	O
in	O
health	O
and	O
disease	O
prevention	O
.	O

Introduction	O
Birth	O
weight	O
has	O
been	O
considered	O
an	O
important	O
measure	O
for	O
assessing	O
fetal	O
growth	O
and	O
is	O
an	O
indicator	O
of	O
neonatal	O
morbidity	O
,	O
survival	O
,	O
and	O
development	O
in	O
children	O
[	O
1	O
–	O
3	O
].	O

At	O
this	O
time	O
,	O
however	O
,	O
how	O
the	O
protective	O
factor	O
of	O
breast	O
-	O
feeding	O
interacts	O
with	O
transmitting	O
flavor	O
preference	O
for	O
energy	O
-	O
dense	O
foods	O
in	O
overweight	O
mothers	O
is	O
unclear	O
.	O

Topical	O
steroids	O
should	O
be	O
selected	O
based	O
on	O
potency	O
considerations	O
,	O
given	O
the	O
potential	O
for	O
systemic	O
absorption	O
and	O
increased	O
skin	O
surface	O
area	O
of	O
pregnancy	O
.	O

The	O
association	O
of	O
vitamin	O
D	O
status	O
with	O
BMI	O
has	O
been	O
attributed	O
to	O
an	O
excessive	O
storage	O
of	O
vitamin	O
D	O
in	O
fat	O
tissue	O
decreasing	O
thereby	O
serum	O
concentrations	O
[	O
47	O
].	O

It	O
is	O
possible	O
to	O
implement	O
some	O
evidence	O
-	O
based	O
interventions	O
for	O
the	O
care	O
of	O
premature	O
babies	O
at	O
the	O
community	O
level	O
through	O
behaviour	O
change	O
initiatives	O
and	O
women	O
'	O
s	O
groups	O
[	O
16	O
],	O
as	O
well	O
as	O
home	O
-	O
visit	O
packages	O
with	O
extra	O
care	O
for	O
premature	O
babies	O
,	O
particularly	O
breastfeeding	O
support	O
and	O
awareness	O
of	O
the	O
importance	O
of	O
seeking	O
care	O
when	O
danger	O
signs	O
occur	O
[	O
17	O
].	O

Other	O
exposures	O
of	O
environmental	O
origin	O
that	O
have	O
been	O
extensively	O
investigated	O
in	O
both	O
human	O
cohorts	O
and	O
rodent	O
models	O
include	O
stress	O
,	O
recreational	O
drugs	O
,	O
maternal	O
immune	O
activation	O
/	O
infection	O
and	O
parental	O
age	O
.	O

Serum	O
concentrations	O
of	O
lower	O
than	O
12	O
.	O
5	O
nmol	O
/	O
l	O
was	O
considered	O
severe	O
deficiency	O
,	O
12	O
.	O
5	O
to	O
24	O
.	O
9	O
nmol	O
/	O
l	O
was	O
taken	O
as	O
moderate	O
deficiency	O
,	O
25	O
to	O
34	O
.	O
9	O
nmol	O
/	O
l	O
as	O
mild	O
deficiency	O
,	O
and	O
concentrations	O
higher	O
than	O
35	O
nmol	O
/	O
l	O
was	O
regarded	O
as	O
optimal	O
.	O
12	O
Statistical	O
Analysis	O
The	O
data	O
were	O
analyzed	O
by	O
the	O
SPSS	O
package	O
Version	O
11	O
(	O
SPSS	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

Stimulation	O
of	O
BAT	O
activity	O
and	O
/	O
or	O
recruitment	O
of	O
UCP1	O
-	O
positive	O
cells	O
are	O
therefore	O
relevant	O
targets	O
for	O
the	O
treatment	O
of	O
obesity	O
/	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

The	O
authors	O
suggested	O
that	O
a	O
combination	O
of	O
seasonal	O
changes	O
to	O
an	O
individuals	O
’	O
physical	O
activity	O
,	O
diet	O
,	O
sunlight	O
exposure	O
,	O
weather	O
pattern	O
,	O
psychological	O
variables	O
,	O
and	O
weight	O
changes	O
may	O
be	O
contributing	O
factors	O
[	O
23	O
].	O

Thus	B
,	O
identifying	O
optimal	O
mHealth	O
dosages	O
could	O
have	O
potential	O
major	O
benefits	O
for	O
future	O
programs	O
in	O
terms	O
of	O
cost	O
effectiveness	O
and	O
outcomes	O
.	O

However	O
,	O
no	O
differences	O
were	O
noted	O
in	O
the	O
various	O
parameters	O
of	O
lung	O
function	O
between	O
high	O
and	O
low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
groups	O
(	O
Table	O
2	O
).	O

The	O
size	O
of	O
the	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
at	O
this	O
age	O
was	O
similar	O
to	O
that	O
between	O
the	O
mother	O
and	O
the	O
MGM	O
and	O
the	O
father	O
and	O
the	O
PGM	O
.	O

The	O
lower	O
serum	O
VD	O
level	O
was	O
also	O
related	O
to	O
worse	O
sperm	O
parameters	O
[	O
52	O
].	O

Conclusions	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
were	O
associated	O
with	O
substantial	O
reduction	O
in	O
PTB	O
risk	O
in	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
.	O

The	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
the	O
performance	O
of	O
respiratory	O
function	O
in	O
infancy	O
.	O

(	O
A	O
)	O
female	O
offspring	O
whose	O
dams	O
received	O
50	O
%	O
of	O
normal	O
nutrition	O
and	O
who	O
were	O
fed	O
either	O
a	O
postnatal	O
standard	O
chow	O
diet	O
or	O
(	O
C	O
)	O
a	O
high	O
fat	O
postnatal	O
diet	O
,	O
and	O
(	O
B	O
)	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
who	O
were	O
fed	O
a	O
postnatal	O
standard	O
chow	O
diet	O
or	O
(	O
D	O
)	O
a	O
high	O
fat	O
postnatal	O
diet	O
.	O

It	O
is	O
also	O
indicated	O
in	O
pregnant	O
women	O
whose	O
hemoglobin	O
level	O
is	O
required	O
to	O
be	O
restored	O
rapidly	O
such	O
as	O
those	O
who	O
present	O
too	O
close	O
to	O
term	O
and	O
those	O
who	O
have	O
severe	O
anemia	O
[	O
40	O
].	O

There	O
was	O
a	O
systematic	O
and	O
statistically	O
significant	O
difference	O
in	O
the	O
height	O
of	O
the	O
two	O
groups	O
of	O
fathers	O
—	O
those	O
measured	O
were	O
175	O
.	O
8	O
cm	O
tall	O
on	O
average	O
and	O
those	O
reported	O
were	O
significantly	O
taller	O
at	O
178	O
.	O
7	O
cm	O
.	O

Preventive	O
Measures	O
for	O
Mother	O
and	O
Child	O
Strategies	O
for	O
prevention	O
of	O
atopic	O
diseases	O
may	O
be	O
categorized	O
as	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
.	O

During	O
resistance	O
measurements	O
,	O
which	O
include	O
intra	O
,	O
extrathoracic	O
,	O
and	O
pulmonary	O
resistance	O
,	O
the	O
extrathoracic	O
airway	O
resistance	O
dominates	O
in	O
obligatory	O
nasal	O
breathing	O
infants	O
[	O
42	O
].	O

Studies	O
exposing	O
pregnant	O
rats	O
and	O
mice	O
to	O
valproate	O
demonstrated	O
increased	O
autistic	O
-	O
like	O
behaviors	O
in	O
the	O
offspring	O
.	O

Body	O
fat	O
percentage	O
of	O
each	O
child	O
was	O
determined	O
by	O
DEXA	O
and	O
recorded	O
.	O

The	O
LINE	O
-	O
1	O
subclass	O
is	O
the	O
most	O
common	O
LINE	O
,	O
representing	O
about	O
20	O
%	O
of	O
the	O
total	O
human	O
genome	O
,	O
whereas	O
the	O
most	O
abundant	O
type	O
of	O
SINE	O
is	O
the	O
Alu	O
element	O
,	O
as	O
exemplified	O
by	O
AluYb8	O
;	O
together	O
LINE	O
and	O
Alu	O
sequences	O
make	O
up	O
nearly	O
one	O
-	O
third	O
of	O
the	O
genome	O
(	O
Choi	O
et	O
al	O
.	O

Birth	O
weight	O
percentile	O
was	O
calculated	O
using	O
the	O
Fenton	O
growth	O
chart	O
from	O
gestational	O
age	O
and	O
birth	O
weight	O
in	O
grams	O
(	O
Fenton	O
2003	O
),	O
allowing	O
us	O
to	O
account	O
for	O
gestational	O
age	O
in	O
our	O
birth	O
weight	O
metric	O
and	O
to	O
create	O
a	O
normalized	O
distribution	O
for	O
birth	O
weight	O
through	O
birth	O
weight	O
percentile	O
.	O

In	O
western	O
studies	O
,	O
this	O
questionnaire	O
has	O
had	O
high	O
reliability	O
and	O
validity	O
[	O
40	O
,	O
41	O
].	O

The	O
Projahnmo	O
trial	O
demonstrated	O
improved	O
IFA	O
supplements	O
as	O
84	O
%	O
of	O
pregnant	O
women	O
in	O
the	O
home	O
-	O
care	O
treatment	O
arm	O
reported	O
IFA	O
supplements	O
use	O
in	O
pregnancy	O
[	O
18	O
].	O

During	O
pregnancy	O
,	O
women	O
are	O
worried	O
about	O
risks	O
to	O
their	O
own	O
and	O
the	O
fetus	O
health	O
.	O

Environmentally	O
induced	O
epigenetic	O
changes	O
later	O
in	O
life	O
can	O
,	O
therefore	B
,	O
also	O
influence	O
an	O
individual	O
’	O
s	O
health	O
.	O

The	O
estimated	O
associations	O
given	O
by	O
a	O
multinomial	O
logistic	O
regression	O
are	O
relative	O
risk	O
ratios	O
(	O
RRR	O
).	O

The	O
EPDS	O
is	O
a	O
10	O
-	O
item	O
scale	O
assessing	O
depressive	O
symptoms	O
experienced	O
in	O
the	O
past	O
7	O
days	O
[	O
51	O
],	O
which	O
has	O
been	O
validated	O
for	O
assessing	O
perinatal	O
depression	O
in	O
African	O
settings	O
,	O
including	O
South	O
Africa	O
[	O
52	O
].	O

Sex	O
affects	O
IMF	O
content	O
in	O
the	O
LM	O
.	O

Seventy	O
-	O
six	O
per	O
cent	O
of	O
women	O
reported	O
using	O
an	O
SGA	O
throughout	O
their	O
entire	O
pregnancy	O
(	O
n	O
=	O
101	O
),	O
while	O
the	O
remaining	O
reported	O
exposure	O
in	O
at	O
least	O
one	O
trimester	O
.	O

We	O
used	O
sensitive	O
and	O
specific	O
liquid	O
or	O
gas	O
chromatography	O
mass	O
spectrometry	O
[	O
34	O
]	O
to	O
measure	O
gestational	O
EDC	O
exposure	O
.	O

In	O
contrast	O
,	O
we	O
found	O
that	O
maternal	O
high	O
fat	O
feeding	O
which	O
also	O
induces	O
early	O
maturation	O
in	O
offspring	O
was	O
associated	O
with	O
elevated	O
progesterone	O
concentrations	O
.	O

PubMed	O
Central	O
:	O

In	O
the	O
study	O
,	O
the	O
majority	B
of	O
infants	O
with	O
transient	O
early	O
wheezing	O
had	O
diminished	O
airway	O
function	O
in	O
early	O
life	O
.	O

1	O
.	O

To	O
compare	O
pregnancy	O
outcomes	O
following	O
maternal	O
use	O
of	O
SGA	O
monotherapy	O
and	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

We	O
are	O
not	O
basing	O
our	O
conclusion	O
that	O
the	O
maternal	O
line	O
is	O
stronger	O
solely	O
on	O
the	O
fact	O
that	O
the	O
mother	O
–	O
child	O
correlations	O
at	O
age	O
5	O
are	O
significant	O
.	O

Boys	O
were	O
correlated	O
with	O
mothers	O
but	O
not	O
fathers	O
(	O
table	O
4	O
).	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

(	O
2008	O
):	O
VLDL	O
=	O
TG	O
/	O
5	O
;	O
LDL	O
=	O
[(	O
TChol	O
/	O
1	O
.	O
19	O
)+(	O
TG	O
/	O
1	O
.	O
9	O
)−(	O
HDL	O
/	O
1	O
.	O
1	O
)−	O
38	O
].	O

However	O
,	O
no	O
statistical	O
improvement	O
was	O
indicated	O
for	O
those	O
children	O
who	O
were	O
breastfed	O
for	O
longer	O
than	O
six	O
months	O
[	O
24	O
].	O

The	O
Eating	O
Inventory	O
(	O
EI	O
)	O
[	O
28	O
]	O
was	O
used	O
to	O
assess	O
cognitive	O
restraint	O
and	O
disinhibition	O
.	O

Feeding	O
medium	O
-	O
chain	O
TGs	O
,	O
such	O
as	O
coconut	O
oil	O
increased	O
the	O
lipid	O
content	O
in	O
the	O
liver	O
and	O
carcasses	O
of	O
Holstein	O
calves	O
under	O
cold	O
stress	O
[	O
104	O
].	O

Buffy	O
coats	O
are	O
stored	O
in	O
1	O
:	O
1	O
vol	O
:	O
vol	O
RNA	O
later	O
(	O
Ambion	O
).	O

Improvement	O
must	O
be	O
made	O
to	O
attain	O
a	O
desired	O
change	O
and	O
amelioration	O
in	O
our	O
health	O
care	O
delivery	O
package	O
.	O

Asthma	O
Certain	O
physiological	O
changes	O
occur	O
normally	O
during	O
pregnancy	O
(	O
Table2	O
)	O
[	O
17	O
].	O

Persons	O
being	O
observed	O
by	O
a	O
stranger	O
,	O
such	O
as	O
a	O
study	O
data	O
collector	O
,	O
may	O
alter	O
their	O
behavior	O
compared	O
to	O
usual	O
practice	O
,	O
potentially	O
increasing	O
their	O
handwashing	O
in	O
the	O
presence	O
of	O
the	O
observer	O
[	O
29	O
,	O
30	O
].	O

The	O
largest	O
increase	O
in	O
the	O
OCP	O
class	O
was	O
seen	O
with	O
a	O
10	O
-	O
fold	O
increase	O
in	O
HCH	O
exposure	O
(	O
5	O
g	O
),	O
while	O
the	O
largest	O
birth	O
weight	O
decrease	O
was	O
seen	O
in	O
response	O
to	O
a	O
10	O
-	O
fold	O
increase	O
in	O
Nonachlor	O
exposure	O
(	O
10	O
g	O
).	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	O
it	O
was	O
found	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

Notably	O
,	O
high	O
sympathetic	O
nervous	O
system	O
activity	O
,	O
intermittent	O
hypoxemia	O
,	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
,	O
endothelial	O
dysfunction	O
and	O
alterations	O
in	O
cytokine	O
and	O
adipokine	O
synthesis	O
and	O
release	O
have	O
all	O
been	O
proposed	O
mechanisms	O
for	O
these	O
consistently	B
observed	O
epidemiological	O
observations	O
.	O

The	O
strength	O
in	O
this	O
study	O
includes	O
long	O
followup	O
and	O
low	O
risk	O
of	O
selection	O
bias	O
,	O
but	O
numerous	O
subgroup	O
analyses	O
may	O
lead	O
to	O
risk	O
of	O
chance	O
influencing	O
significant	O
associations	O
.	O

We	O
had	O
no	O
information	O
about	O
socioeconomic	O
status	O
,	O
but	O
the	O
adjustment	O
for	O
education	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
socioeconomic	O
status	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Other	O
possible	O
pregnancy	O
-	O
related	O
symptoms	O
included	O
are	O
constipation	O
,	O
nausea	O
,	O
vomiting	O
,	O
extreme	O
tiredness	O
and	O
heartburn	O
.	O

The	O
final	O
results	O
included	O
both	O
95	O
%	O
and	O
50	O
%	O
equi	O
-	O
tailed	O
posterior	O
credible	O
intervals	O
(	O
95	O
%,	O
50	O
%	O
CI	O
)	O
for	O
parameter	O
estimates	O
.	O

The	O
data	O
was	O
entered	O
into	O
Microsoft	O
Excel	O
and	O
exported	O
toEpi	O
-	O
Info	O
(	O
Version	O
3	O
.	O
5	O
.	O
1	O
)	O
for	O
analysis	O
.	O

Many	O
hundreds	O
of	O
studies	O
have	O
investigated	O
such	O
toxicity	O
,	O
yet	O
relatively	O
few	O
have	O
demonstrated	O
a	O
mechanistic	O
association	O
among	O
specific	O
environmental	O
exposures	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
health	O
outcomes	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
/	O
or	O
rodent	O
models	O
.	O

Both	O
the	O
Diabetes	O
Prevention	O
Program86and	O
the	O
Finnish	O
Diabetes	O
Prevention	O
Study87demonstrated	O
this	O
,	O
with	O
an	O
intensive	O
intervention	O
including	O
lifestyle	O
coaches	O
,	O
strict	O
supervised	O
exercise	O
regimes	O
and	O
caloric	O
restriction	O
.	O

Models	O
adjusted	O
for	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
education	O
level	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

[	O
20	O
]	O
reported	O
that	O
only	O
1	O
.	O
7	O
%	O
of	O
women	O
consumed	O
fish	O
oil	O
supplements	O
not	O
affecting	O
outcomes	O
,	O
however	O
,	O
this	O
study	O
did	O
not	O
consider	O
supplements	O
other	O
than	O
fish	O
oil	O
.	O

All	O
clinical	O
investigation	O
was	O
conducted	O
according	O
to	O
the	O
Declaration	O
of	O
Helsinki	O
.	O

One	O
third	O
of	O
respondents	O
were	O
single	O
(	O
n	O
=	O
113	O
).	O

Aims	O
of	O
the	O
study	O
The	O
aims	O
of	O
the	O
NuPED	O
study	O
are	O
1	O
)	O
to	O
assess	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
urban	O
pregnant	O
women	O
in	O
Johannesburg	O
,	O
South	O
Africa	O
,	O
and	O
2	O
)	O
to	O
determine	O
associations	O
with	O
birth	O
outcomes	O
,	O
measures	O
of	O
maternal	O
health	O
,	O
as	O
well	O
as	O
measures	O
of	O
offspring	O
health	O
and	O
development	O
.	O

PubMed	O
Central	O
:	O

Further	O
filtering	O
based	O
on	O
the	O
variability	O
of	O
expression	O
of	O
probe	O
-	O
sets	O
revealed	O
7	O
,	O
937	O
probe	O
-	O
sets	O
for	O
further	O
analysis	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
9	O
,	O
099	O
;	O
28	O
dpn	O
:	O
8	O
,	O
250	O
;	O
188	O
dpn	O
:	O
8	O
,	O
943	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Recommendations	O
for	O
Treatment	O
of	O
Asthma	O
and	O
Allergies	O
in	O
PregnancyDrugs	O
preferred	B
for	O
use	O
during	O
pregnancy	O
Anti	O
-	O
inflammatory	O
:	O
cromolyn	O
beclomethasone	O
,	O
prednisone	O
Bronchodilator	O
:	O
inhaled	O
β2	O
-	O
adrenergic	O
agonist	O
,	O
theophylline	O
Antihistamine	O
:	O
chlorpheniramine	O
,	O
tripelennamine	O
Decongestant	O
:	O
pseudoephedrine	O
,	O
oxymetazoline	O
Cough	O
:	O
guaifenesin	O
,	O
dextromethorphan	O
Antibiotic	O
:	O
amoxicillinDrugs	O
that	O
generally	B
should	O
be	O
avoided	O
during	O
pregnancy	O
α	O
-	O
Adrenergic	O
compounds	O
(	O
other	O
than	O
pseudoephedrine	O
)	O
Epinephrine	O
(	O
other	O
than	O
for	O
anaphylaxis	O
)	O
Iodides	O
Sulfonamides	O
(	O
in	O
late	O
pregnancy	O
)	O
Tetracyclines	O
Quinolones	O
Adapted	O
from	O
the	O
NAEPP	O
expert	O
group	O
report	O
[	O
21	O
].	O

To	O
verify	O
physical	O
presence	O
of	O
the	O
data	O
collectors	O
at	O
the	O
households	O
we	O
will	O
record	O
a	O
Geographic	O
Information	O
System	O
(	O
GIS	O
)	O
data	O
point	O
.	O

The	O
same	O
authors	O
suggested	O
that	O
total	O
IMF	O
within	O
the	O
LM	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
might	O
be	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
by	O
stimulating	O
intramuscular	O
preadipocyte	O
differentiation	O
.	O

These	O
results	O
indicated	O
that	O
black	O
neonates	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
25	O
nmol	O
l	O
−	O
1had	O
an	O
even	O
greater	O
odds	O
of	O
being	O
SGA	O
(	O
OR	O
3	O
.	O
8	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
4	O
,	O
10	O
.	O
6	O
)	O
compared	O
with	O
those	O
with	O
levels	O
⩾	O
50	O
nmol	O
l	O
−	O
1	O
.	O

However	O
,	O
we	O
plan	O
to	O
re	O
-	O
examine	O
this	O
hypothesis	O
in	O
another	O
birth	O
cohort	O
to	O
see	O
if	O
we	O
can	O
replicate	O
the	O
main	O
findings	O
.	O

The	O
adequate	O
intake	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
lactation	O
is	O
unknown	O
,	O
although	O
it	O
appears	O
to	O
be	O
greater	O
than	O
the	O
current	O
dietary	O
recommendations	O
of	O
400	O
IU	O
/	O
d	O
or	O
10	O
µg	O
/	O
d	O
[	O
58	O
].	O

A	O
total	O
of	O
6	O
participants	O
discontinued	O
text4baby	O
during	O
the	O
follow	O
-	O
up	O
period	O
.	O
Figure	O
2depicts	O
the	O
CONSORT	O
flow	O
diagram	O
for	O
the	O
study	O
.	O

These	O
subjects	O
had	O
a	O
fasting	O
glucose	O
up	O
to	O
7	O
.	O
7	O
mmol	O
/	O
dl	O
and	O
a	O
2	O
hour	O
level	O
between	O
7	O
.	O
8	O
mmol	O
/	O
L	O
and	O
11	O
.	O
1	O
mmol	O
/	O
dl	O
.	O

β	O
represents	O
the	O
effect	O
on	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
per	O
common	O
allele	O
.	O

Alternatively	O
,	O
cyclical	O
hypoxemia	O
with	O
re	O
-	O
oxygenation	O
,	O
similar	O
to	O
repeated	O
ischemia	O
-	O
reperfusion	O
damage	O
,	O
may	O
promote	O
the	O
formation	O
of	O
reactive	O
oxygen	O
species	O
that	O
may	O
then	O
elicit	O
the	O
release	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
including	O
interleukin	O
-	O
6	O
and	O
tumor	O
necrosis	O
factor	O
-	O
α	O
[	O
46	O
,	O
47	O
].	O

Stratified	O
random	O
sampling	O
was	O
performed	O
in	O
this	O
study	O
.	O

At	O
the	O
completion	O
of	O
the	O
amplification	O
protocol	O
,	O
all	O
samples	O
were	O
subjected	O
to	O
melting	O
curve	O
analyses	O
and	O
gel	O
electrophoresis	O
to	O
verify	O
the	O
absence	O
of	O
any	O
non	O
-	O
specific	O
product	O
.	O

Significant	O
changes	O
occurred	O
in	O
maternal	O
serum	O
visfatin	O
levels	O
after	O
childbirth	O
.	O

The	O
relationships	O
with	O
grandfathers	O
were	O
not	O
significant	O
(	O
table	O
4	O
).	O

[	O
30	O
],	O
we	O
used	O
the	O
Zymo	O
DNA	O
extraction	O
kit	O
(	O
Zymo	O
Research	O
)	O
to	O
extract	O
microbial	O
DNA	O
from	O
thawed	O
samples	O
and	O
quantified	O
the	O
DNA	O
using	O
OD260	O
/	O
280	O
nanodrop	O
.	O

Prolonged	O
delivery	O
due	O
to	O
oversedation	O
,	O
inappropriate	O
position	O
of	O
the	O
fetus	O
,	O
and	O
unbalanced	O
fetopelvic	O
size	O
and	O
oversedation	O
,	O
which	O
results	O
in	O
induction	O
,	O
can	O
play	O
a	O
role	O
.	O

PubMed	O
Central	O
:	O

During	O
this	O
period	O
the	O
brain	O
and	O
immune	O
systems	O
are	O
less	O
developed	O
,	O
undergoing	O
greater	O
cell	O
growth	O
and	O
differentiation	O
,	O
and	O
possibly	O
more	O
susceptible	O
to	O
DNA	O
and	O
epigenetic	O
changes	O
underlying	O
cancer	O
development	O
in	O
the	O
near	O
or	O
distant	O
future	O
[	O
5	O
,	O
8	O
–	O
13	O
].	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12986	O
-	O
017	O
-	O
0203	O
-	O
5	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
Stata	O
9	O
.	O
0	O
statistical	O
software	O
(	O
Stata	O
,	O
College	O
Station	O
,	O
TX	O
).	O

The	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
deficiency	O
rate	O
of	O
Summer	O
is	O
zero	O
in	O
both	O
groups	O
,	O
but	O
is	O
high	O
of	O
other	O
three	O
seasons	O
(	O
Fig	O
.	O

For	O
example	O
,	O
children	O
in	O
Piaget	O
'	O
s	O
preoperational	O
stage	O
of	O
cognitive	O
development	O
(	O
ages	O
2	O
-	O
7	O
)	O
are	O
characterized	O
by	O
illogical	O
and	O
egocentric	O
thought	O
,	O
while	O
children	O
in	O
the	O
concrete	O
operational	O
stage	O
(	O
ages	O
7	O
-	O
11	O
)	O
cannot	O
think	O
abstractly	O
,	O
reason	O
logically	O
,	O
or	O
make	O
inferences	O
based	O
on	O
available	O
information	O
(	O
90	O
).	O

We	O
compared	O
a	O
number	O
of	O
characteristics	O
for	O
participants	O
who	O
completed	O
the	O
questionnaire	O
,	O
both	O
in	O
the	O
parent	O
study	O
and	O
the	O
follow	O
-	O
up	O
study	O
,	O
with	O
those	O
who	O
only	O
answered	O
the	O
questionnaire	O
in	O
the	O
parent	O
study	O
.	O

Fatty	O
acid	O
metabolism	O
,	O
Biosynthesis	O
of	O
steroids	O
,	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
,	O
FA	O
elongation	O
in	O
mitochondria	O
,	O
Bile	O
acid	O
synthesis	O
)	O
and	O
cell	O
cycle	O
regulation	O
(	O
e	O
.	O
g	O
.	O

Similar	O
methods	O
and	O
aids	O
are	O
used	O
as	O
described	O
for	O
maternal	O
dietary	O
intake	O
.	O

Variables	O
influencing	O
the	O
formation	O
of	O
previtamin	O
D3	O
in	O
the	O
skin	O
include	O
skin	O
pigmentation	O
and	O
intensity	O
of	O
the	O
solar	O
UV	O
light	O
[	O
52	O
]–[	O
55	O
].	O

Frequent	O
home	O
visits	O
confirmed	O
outcomes	O
of	O
interest	O
.	O

Testosterone	O
,	O
progesterone	O
,	O
oestradiol	O
,	O
and	O
lutenising	O
hormone	O
levels	O
in	O
women	O
have	O
been	O
reported	O
to	O
be	O
higher	O
in	O
spring	O
than	O
in	O
autumn	O
[	O
192	O
–	O
194	O
].	O

We	O
identified	O
households	O
with	O
young	O
children	O
with	O
detailed	O
maps	O
and	O
advice	O
from	O
staff	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
a	O
non	O
-	O
governmental	O
organisation	O
working	O
in	O
the	O
region	O
.	O

Those	O
who	O
were	O
never	O
breastfed	O
and	O
only	O
received	O
formula	O
were	O
considered	O
exclusively	O
formula	O
-	O
fed	O
.	O

However	O
,	O
women	O
attending	O
for	O
their	O
subsequent	O
pregnancies	O
and	O
those	O
at	O
their	O
third	O
or	O
more	O
visits	O
were	O
more	O
tolerant	O
of	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
.	O

Previous	O
studies	O
have	O
shown	O
an	O
increased	O
blood	O
level	O
of	O
serotonin	O
in	O
individuals	O
affected	O
with	O
autism	O
spectrum	O
disorder	O
,	O
warranting	O
the	O
exploration	O
of	O
a	O
possible	O
association	O
[	O
65	O
].	O

To	O
compare	O
the	O
difference	O
in	O
outcomes	O
between	O
low	O
and	O
high	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
maternal	O
/	O
cord	O
serum	O
,	O
groups	O
with	O
low	O
and	O
high	O
level	O
were	O
further	O
categorized	O
according	O
to	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
value	O
.	O

No	O
data	O
are	O
available	O
as	O
yet	O
with	O
regard	O
to	O
the	O
impact	O
of	O
early	O
leptin	O
administration	O
on	O
the	O
subsequent	O
“	O
browning	O
”	O
of	O
WAT	O
and	O
the	O
related	O
regulation	O
of	O
glucose	O
metabolism	O
,	O
as	O
well	O
as	O
the	O
response	O
to	O
hypercaloric	O
diets	O
later	O
in	O
life	O
in	O
the	O
offspring	O
.	O

The	O
infant	O
assessment	O
includes	O
HIV	O
status	O
history	O
and	O
a	O
general	O
,	O
ear	O
,	O
nose	O
and	O
throat	O
,	O
respiratory	O
,	O
cardiovascular	O
,	O
abdominal	O
and	O
neurological	O
examination	O
as	O
well	O
as	O
any	O
current	O
complaints	O
.	O

Voxiva	O
collected	O
data	O
on	O
all	O
text4baby	O
participants	O
through	O
enrollment	O
and	O
follow	O
-	O
up	O
service	O
contacts	O
[	O
36	O
].	O

In	O
the	O
group	O
with	O
VD	O
concentration	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
,	O
success	O
rate	O
was	O
32	O
.	O
7	O
%	O
and	O
in	O
the	O
VD	O
-	O
deficient	O
group	O
,	O
32	O
.	O
3	O
%	O
(	O
p	O
=	O
0	O
.	O
05	O
).	O

In	O
addition	O
,	O
clinically	O
she	O
became	O
more	O
alert	O
.	O

Similarly	O
,	O
the	O
activation	O
of	O
TEs	O
would	O
be	O
deleterious	O
for	O
the	O
embryonic	O
genome	O
and	O
so	O
the	O
continued	O
silencing	O
of	O
such	O
loci	O
through	O
early	O
embryogenesis	O
is	O
essential	O
for	O
genome	O
stability	O
and	O
subsequent	O
normal	O
development	O
.	O

Eligibility	O
Criteria	O
Eligibility	O
criteria	O
included	O
Spanish	O
or	O
English	O
speaking	O
women	O
,	O
≥	O
16	O
years	O
,	O
10	O
–	O
28	O
weeks	O
gestation	O
,	O
receiving	O
prenatal	O
care	O
,	O
planning	O
to	O
stay	O
in	O
the	O
area	O
for	O
the	O
full	O
pregnancy	O
,	O
and	O
willing	O
to	O
authorize	O
release	O
of	O
medical	O
information	O
for	O
the	O
purpose	O
of	O
data	O
abstraction	O
.	O

Statistical	O
analysis	O
Data	O
analysis	O
will	O
be	O
by	O
intention	O
to	O
treat	O
.	O

A	O
study	O
in	O
pregnant	O
women	O
in	O
South	O
India	O
assessed	O
maternal	O
vitamin	O
D	O
status	O
by	O
measuring	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
in	O
stored	O
serum	O
samples	O
.	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

A	O
high	O
index	O
of	O
suspicion	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	O
for	O
a	O
successful	O
outcome	O
.	O

4	O
.	O

Thus	B
,	O
patya	O
advised	O
is	O
madhura	O
,	O
shita	O
,	O
drava	O
(	O
liquid	O
),	O
which	O
will	O
prevent	O
dehydration	O
&	O
supply	O
required	O
nourishment	O
.	O

The	O
business	O
community	O
:	O
Invest	O
•	O
Invest	O
additional	O
resources	O
to	O
develop	O
and	O
adapt	O
devices	O
and	O
commodities	O
to	O
prevent	O
and	O
treat	O
preterm	O
birth	O
in	O
low	O
-	O
income	O
settings	O
using	O
innovative	O
partnerships	O
and	O
business	O
models	O
.	O

Bonferrroni	O
analysis	O
showed	O
that	O
CC	O
males	O
treated	O
with	O
AM251	O
exhibited	O
a	O
lower	O
chocolate	O
intake	O
than	O
vehicle	O
-	O
treated	O
CC	O
males	O
.	O

Accordingly	O
,	O
population	O
studies	O
,	O
which	O
have	O
been	O
conducted	O
by	O
the	O
United	O
States	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
have	O
reported	O
a	O
prevalence	O
of	O
ASDs	O
of	O
1	O
of	O
68	O
children	O
at	O
risk	O
.	O

Mc	O
Grath	O
et	O
al	O
.	O

The	O
users	O
’	O
opinion	O
has	O
been	O
sought	O
here	O
and	O
it	O
is	O
noticed	O
that	O
they	O
recommend	O
ameliorations	O
in	O
the	O
interpersonal	O
interaction	O
with	O
staff	O
in	O
terms	O
of	O
more	O
comprehensive	O
health	O
talks	O
and	O
improvement	O
in	O
nursing	O
skills	O
,	O
better	O
infrastructures	O
(	O
like	O
good	O
toilet	O
facilities	O
and	O
comfortable	O
sitting	O
areas	O
)	O
and	O
tolerable	O
waiting	O
times	O
.	O

However	O
,	O
a	O
small	O
pilot	O
study	O
of	O
maternal	O
vitamin	O
D	O
levels	O
in	O
archived	O
prenatal	O
sera	O
,	O
showed	O
no	O
decrease	O
in	O
prenatal	O
vitamin	O
D	O
in	O
subjects	O
who	O
later	O
developed	O
schizophrenia	O
[	O
33	O
].	O

*	O
P	O
-	O
value	O
<	O
0	O
.	O
05	O
from	O
Student	O
t	O
test	O
for	O
continuous	O
variable	O
or	O
from	O
Chi	O
-	O
Square	O
test	O
for	O
categorical	O
variables	O
.	O

Birth	O
outcome	O
data	O
were	O
defined	B
and	O
calculated	O
as	O
follows	O
:	O
(	O
1	O
)	O
gestational	O
age	O
at	O
delivery	O
was	O
calculated	O
using	O
LMP	O
,	O
if	O
available	O
,	O
or	O
gestational	O
age	O
at	O
any	O
ultrasound	O
obtained	O
from	O
antenatal	O
medical	O
records	O
(	O
seeSupplementary	O
material	O
A1for	O
gestational	O
age	O
calculation	O
algorithm	O
);	O
(	O
2	O
)	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
was	O
calculated	O
from	O
weight	O
and	O
gestational	O
age	O
at	O
delivery	O
according	O
to	O
the	O
International	O
Fetal	O
and	O
Newborn	O
Growth	O
Consortium	O
for	O
the	O
21st	O
Century	O
,	O
or	O
intergrowth	O
-	O
21st	O
standards	O
[	O
36	O
];	O
(	O
3	O
)	O
preterm	O
birth	O
(	O
PTB	O
)	O
was	O
defined	B
as	O
born	O
with	O
<	O
37	O
weeks	O
of	O
gestational	O
age	O
;	O
and	O
(	O
4	O
)	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
was	O
defined	B
as	O
born	O
weighing	O
<	O
2500	O
g	O
.	O
Statistical	O
analysis	O
We	O
compared	O
all	O
variables	O
by	O
vaccination	O
status	O
using	O
chi	O
-	O
square	O
test	O
to	O
compare	O
differences	O
between	O
vaccinated	O
and	O
unvaccinated	O
women	O
regardless	O
of	O
trimester	O
of	O
receipt	O
of	O
influenza	O
vaccination	O
.	O

Energy	O
recommendations	O
were	O
calculated	O
according	O
to	O
the	O
Dietary	O
Reference	O
Intakes	O
.	O

This	O
substudy	O
includes	O
women	O
enrolled	O
from	O
Brigham	O
and	O
Women	O
’	O
s	O
Hospital	O
,	O
a	O
high	O
-	O
risk	O
tertiary	O
perinatal	O
center	O
in	O
Boston	O
,	O
MA	O
who	O
had	O
complete	O
exposure	O
(	O
PNV	O
use	O
)	O
and	O
outcome	O
data	O
(	O
vitamin	O
D	O
status	O
at	O
two	O
time	O
points	O
during	O
pregnancy	O
).	O

We	O
estimated	O
the	O
incidence	O
rate	O
ratio	O
(	O
RR	O
)	O
for	O
the	O
episodes	O
of	O
pneumonia	O
with	O
Cox	O
proportional	O
hazard	O
models	O
.	O

Objectives	O
and	O
hypothesis	O
The	O
trial	O
objectives	O
are	O
to	O
evaluate	O
the	O
effect	O
of	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
,	O
low	O
birthweight	O
and	O
preterm	O
delivery	O
.	O

Our	O
research	O
would	O
be	O
strengthened	O
with	O
the	O
addition	O
of	O
HbA1cdata	O
in	O
pregnancy	O
and	O
additional	O
maternal	O
lifestyle	O
variables	O
to	O
allow	O
the	O
associations	O
to	O
be	O
teased	O
out	O
.	O

We	O
are	O
beginning	O
to	O
learn	O
that	O
it	O
plays	O
a	O
much	O
wider	O
role	O
in	O
health	O
and	O
disease	O
prevention	O
.	O

p	O
<	O
0	O
.	O
05	O
was	O
considered	O
as	O
statistically	O
significant	O
.	O

From	O
21	O
days	O
of	O
age	O
,	O
F1	O
females	O
were	O
fed	O
standard	O
chow	O
.	O

As	B
gestational	O
diabetes	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
,	O
and	O
has	O
long	O
-	O
term	O
implications	O
for	O
both	O
mother	O
and	O
child	O
,	O
it	O
is	O
important	O
that	O
it	O
is	O
recognized	O
and	O
appropriately	O
managed	O
.	O

BAT	O
is	O
a	O
highly	O
vascularized	O
tissue	O
innervated	O
by	O
the	O
sympathetic	O
nervous	O
system	O
.	O

The	O
individual	O
scores	O
for	O
the	O
3	O
patterns	O
show	O
the	O
values	O
estimated	O
for	O
each	O
individual	O
based	O
on	O
their	O
consumption	O
of	O
foods	O
and	O
the	O
factor	O
loadings	O
of	O
the	O
foods	O
.	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

The	O
U	O
.	O
S	O
.	O

It	O
is	O
of	O
interest	O
to	O
note	O
that	O
,	O
in	O
spite	O
of	O
the	O
large	O
proportion	O
of	O
exposed	O
women	O
who	O
exhibited	O
characteristics	O
commonly	B
associated	O
with	O
risk	O
for	O
small	O
for	O
gestational	O
age	O
neonates	O
(	O
eg	O
,	O
smoking	O
,	O
hypertension	O
),	O
an	O
increased	O
rate	O
of	O
LGA	O
neonates	O
was	O
observed	O
.	O

Standardised	O
methods	O
of	O
the	O
International	O
Society	O
for	O
the	O
Advancement	O
of	O
Kinanthropometry	O
[	O
45	O
]	O
are	O
used	O
with	O
a	O
calibrated	O
digital	O
scale	O
for	O
weight	O
,	O
a	O
mobile	O
stadiometer	O
for	O
height	O
;	O
and	O
non	O
-	O
stretchable	O
metal	O
measuring	O
tape	O
for	O
MUAC	O
.	O

SPSS	O
16	O
.	O
0	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

Indeed	O
,	O
a	O
number	O
of	O
polymorphisms	O
have	O
been	O
described	O
in	O
the	O
gene	O
coding	O
for	O
the	O
GR	O
although	O
it	O
is	O
still	O
unclear	O
whether	O
the	O
variability	O
in	O
the	O
glucocorticoid	O
responses	O
observed	O
is	O
due	O
to	O
the	O
polymorphisms	O
or	O
to	O
other	O
factors	O
[	O
10	O
].	O

Subjects	O
'	O
weight	O
was	O
measured	O
using	O
a	O
balanced	O
digital	O
scale	O
to	O
the	O
nearest	O
100	O
g	O
,	O
in	O
light	O
clothing	O
and	O
barefoot	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
inverse	O
association	O
may	O
reflect	O
increased	O
immune	O
surveillance	O
on	O
the	O
part	O
of	O
the	O
atopic	O
individual	O
[	O
91	O
,	O
93	O
].	O

,	O
2004	O
[	O
18	O
]	O
Oken	O
et	O
al	O
.	O

Intranasal	O
cromolyn	O
,	O
intranasal	O
steroids	O
,	O
and	O
montelukast	O
are	O
the	O
preferred	B
drugs	O
for	O
the	O
treatment	O
of	O
rhinitis	O
because	O
of	O
the	O
low	O
risk	O
of	O
systemic	O
effects	O
.	O

Participants	O
133	O
women	O
exposed	O
to	O
SGAs	O
and	O
other	O
psychotropic	O
drugs	O
and	O
133	O
matched	O
healthy	O
controls	O
were	O
assessed	O
and	O
analysed	O
.	O

Testing	O
increased	O
in	O
May	O
2016	O
when	O
the	O
initial	O
25	O
(	O
OH	O
)	O
D	O
test	O
was	O
automated	O
as	O
part	O
of	O
initial	O
prenatal	O
screening	O
.	O

Hence	B
,	O
there	O
will	O
not	O
be	O
a	O
single	O
solution	O
,	O
but	O
rather	O
an	O
array	O
of	O
solutions	O
that	O
address	O
the	O
various	O
biological	O
,	O
clinical	O
,	O
behavioural	O
and	O
social	O
risk	O
factors	O
that	O
result	O
in	O
preterm	O
birth	O
.	O

All	O
data	O
are	O
presented	O
as	O
the	O
mean	O
±	O
SD	O
except	O
as	O
noted	O
.	O

However	O
,	O
thyroid	O
cancer	O
detected	O
during	O
pregnancy	O
may	O
cause	O
anxiety	O
about	O
the	O
optimal	O
timing	O
of	O
recommended	O
treatments	O
and	O
about	O
both	O
maternal	O
and	O
neonatal	O
morbidity	O
,	O
as	O
weel	O
as	O
pregnancy	O
following	O
a	O
diagnosis	O
of	O
thyroid	O
cancer	O
obviously	O
needs	O
both	O
maternal	O
and	O
foetal	O
management	O
.	O

Relevant	O
papers	O
were	O
selected	O
based	O
on	O
the	O
inclusion	O
criteria	O
in	O
Supplementary	O
Table	O
1	O
.	O

However	O
,	O
defining	O
the	O
limits	O
of	O
normal	O
variation	O
for	O
specific	O
epigenetic	O
changes	O
of	O
relevance	O
would	O
be	O
a	O
sensible	O
and	O
pragmatic	O
starting	O
point	O
.	O

Finally	O
,	O
Guinchat	O
et	O
al	O
.	O

For	O
the	O
premature	O
baby	O
care	O
agenda	O
,	O
the	O
greatest	O
emphasis	O
is	O
on	O
development	O
and	O
delivery	O
research	O
,	O
with	O
a	O
shorter	O
timeline	O
to	O
impact	O
at	O
scale	O
.	O

Conclusion	O
These	O
preliminary	O
findings	O
suggest	O
associations	O
of	O
short	O
sleep	O
duration	O
and	O
snoring	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
.	O

In	O
this	O
study	O
,	O
the	O
median	O
concentration	O
of	O
the	O
serum	O
vitamin	O
D	O
in	O
the	O
IG	O
raised	O
from	O
24	O
.	O
25	O
to	O
62	O
.	O
10	O
nmol	O
/	O
l	O
,	O
which	O
is	O
in	O
line	O
with	O
a	O
recent	O
survey	O
carried	O
out	O
by	O
Restorff	O
et	O
al	O
.	O
26on	O
33	O
rheumatoid	O
arthritic	O
patients	O
.	O

2	O
.	O
2	O
.	O

Antenatal	O
care	O
services	O
are	O
offered	O
in	O
all	O
the	O
government	O
and	O
in	O
some	O
of	O
the	O
private	O
Health	O
facilities	O
.	O

Animals	O
may	O
require	O
more	O
energy	O
to	O
meet	O
the	O
increased	O
maintenance	O
energy	O
requirements	O
.	O

Identifying	O
mechanisms	O
of	O
these	O
conditions	O
,	O
and	O
strategies	O
for	O
early	O
detection	O
,	O
prevention	O
,	O
and	O
care	O
,	O
represent	B
an	O
important	O
need	O
for	O
reducing	O
the	O
global	O
burden	O
of	O
preterm	O
birth	O
.	O

Personal	O
and	O
family	O
medical	O
histories	O
were	O
obtained	O
using	O
a	O
questionnaire	O
completed	O
during	O
an	O
interview	O
with	O
the	O
parents	O
.	O

In	O
a	O
study	O
by	O
Hashempoor	O
et	O
al	O
.,	O
in	O
Tehran	O
,	O
67	O
.	O
1	O
%	O
of	O
the	O
men	O
and	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
25	O
ng	O
/	O
mL	O
[	O
55	O
].	O

So	O
patyas	O
prescribed	O
are	O
diuretics	O
.	O

Implement	O
•	O
Adapt	O
integrated	O
packages	O
of	O
care	O
,	O
considering	O
contexts	O
,	O
and	O
tailored	O
to	O
local	O
health	O
service	O
delivery	O
channels	O
.	O

Samples	O
were	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
(	O
approximately	O
500	O
mg	O
),	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

In	O
each	O
region	O
the	O
obstetric	O
clinics	O
were	O
ordered	O
by	O
province	O
and	O
size	O
based	O
on	O
the	O
number	O
of	O
deliveries	O
during	O
the	O
past	O
year	O
and	O
60	O
clusters	O
of	O
4	O
clinics	O
were	O
selected	O
per	O
region	O
using	O
systematic	O
sampling	O
in	O
order	O
to	O
have	O
enough	O
replacement	O
clinics	O
in	O
case	O
some	O
refused	O
to	O
participate	O
.	O

This	O
racial	O
difference	O
may	O
reflect	O
an	O
impact	O
on	O
pet	O
owner	O
behavior	O
resulting	O
in	O
increased	O
outdoor	O
exposure	O
that	O
is	O
limited	O
to	O
lighter	O
skinned	O
individuals	O
.	O

3	O
.	O

[	O
13	O
]	O
Use	O
of	O
sun	O
blocks	O
,	O
increased	O
coverage	O
of	O
clothing	O
and	O
time	O
spent	O
indoors	O
increase	O
the	O
risk	O
of	O
Vitamin	O
D	O
deficiency	O
.	O

Results	O
Demographic	O
and	O
underlying	O
variables	O
from	O
the	O
two	O
groups	O
are	O
presented	O
inTable	O
1	O
.	O

RCT	O
cohorts	O
[	O
12	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
atopy	O
without	O
asthma	O
,	O
nonatopic	O
and	O
atopic	O
asthma	O
#	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
without	O
asthma	O
n	O
=	O
794	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
78	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
01	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
96	O
(	O
0	O
.	O
73	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
12	O
)	O
0	O
.	O
30	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
77	O
(	O
0	O
.	O
60	O
–	O
0	O
.	O
99	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
72	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
19	O
Nonatopic	O
asthma	O
n	O
=	O
301	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
82	O
(	O
0	O
.	O
57	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
46	O
–	O
0	O
.	O
99	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
06	O
)	O
0	O
.	O
34	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
87	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
25	O
)	O
0	O
.	O
73	O
(	O
0	O
.	O
49	O
–	O
1	O
.	O
08	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
18	O
)	O
0	O
.	O
71	O
(	O
0	O
.	O
43	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
14	O
Atopic	O
asthma	O
n	O
=	O
337	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
66	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
41	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
77	O
)	O
2	O
.	O
09	O
(	O
1	O
.	O
39	O
–	O
3	O
.	O
14	O
)	O
1	O
.	O
79	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
90	O
)	O
1	O
.	O
14	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
27	O
)	O
0	O
.	O
01	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
75	O
(	O
1	O
.	O
20	O
–	O
2	O
.	O
56	O
)	O
1	O
.	O
27	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
93	O
)	O
2	O
.	O
18	O
(	O
1	O
.	O
45	O
–	O
3	O
.	O
30	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
004	O
#:	O
no	O
atopy	O
or	O
asthma	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
3796	O
);¶:	O
controlling	O
for	O
energy	O
intake	O
;+:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Interestingly	O
,	O
our	O
results	O
show	O
that	O
increasing	O
maternal	O
BMI	O
had	O
a	O
mild	O
protective	O
effect	O
on	O
risk	O
of	O
SGA	O
.	O

In	O
91	O
patients	O
treated	O
due	O
to	O
PCOS	O
,	O
ovulation	O
was	O
found	O
in	O
57	O
.	O
1	O
%,	O
and	O
pregnancy	O
in	O
26	O
.	O
9	O
%	O
after	O
using	O
50mg	O
of	O
CC	O
.	O

Ethical	O
considerations	O
The	O
study	O
was	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
the	O
“	O
Grigore	O
T	O
.	O
Popa	O
”	O
University	O
of	O
Medicine	O
and	O
Pharmacy	O
in	O
Iaşi	O
and	O
permission	O
to	O
administer	O
the	O
questionnaires	O
was	O
received	O
from	O
the	O
Cuza	O
-	O
Vodă	O
Obstetrics	O
and	O
Gynaecology	O
Clinical	O
Hospital	O
.	O

Perinatal	O
outcomes	O
of	O
exposed	O
and	O
healthy	O
comparison	O
groups	O
Maternal	O
characteristics	O
Exposed	O
and	O
control	O
women	O
did	O
not	O
differ	O
with	O
respect	O
to	O
maternal	O
age	O
at	O
conception	O
.	O

Briefly	O
,	O
at	O
insemination	O
German	O
Landrace	O
primiparous	O
sows	O
(	O
n	O
=	O
42	O
)	O
were	O
randomly	O
assigned	O
to	O
either	O
a	O
low	O
protein	O
diet	O
(	O
LP	O
)	O
with	O
6	O
%	O
(	O
w	O
/	O
w	O
)	O
crude	O
protein	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
)	O
containing	O
12	O
%	O
crude	O
protein	O
.	O

The	O
third	O
member	O
of	O
the	O
DNMT3	O
family	O
,	O
DNMT3L	O
,	O
does	O
not	O
possess	O
any	O
DNMT	O
activity	O
,	O
but	O
can	O
help	O
to	O
recruit	O
,	O
and	O
stimulate	O
the	O
activity	O
of	O
,	O
DNMT3A	O
and	O
3B	O
.	O

The	O
relationships	O
among	O
the	O
present	O
study	O
variables	O
in	O
each	O
group	O
were	O
separately	O
assessed	O
using	O
independent	O
t	O
,	O
Pearson	O
’	O
s	O
,	O
linear	O
regression	O
,	O
and	O
Spearman	O
’	O
s	O
ordinal	O
correlation	O
tests	O
.	O

Therefore	B
,	O
it	O
is	O
crucial	O
for	O
dermatologists	O
to	O
be	O
aware	O
of	O
this	O
condition	O
,	O
as	O
it	O
is	O
rare	O
and	O
likely	B
often	O
misdiagnosed	O
.	O

With	O
PSM	O
,	O
after	O
adjusting	O
for	O
risk	O
factors	O
,	O
we	O
observed	O
protective	O
associations	O
between	O
influenza	O
vaccination	O
in	O
the	O
second	O
and	O
third	O
trimester	O
and	O
preterm	O
birth	O
(	O
aOR	O
:	O
0	O
.	O
87	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
75	O
–	O
0	O
.	O
99	O
and	O
aOR	O
:	O
0	O
.	O
66	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
45	O
–	O
0	O
.	O
96	O
,	O
respectively	O
)	O
and	O
between	O
influenza	O
vaccination	O
in	O
the	O
second	O
trimester	O
and	O
low	O
birth	O
weight	O
(	O
aOR	O
:	O
0	O
.	O
80	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
64	O
–	O
0	O
.	O
97	O
).	O

It	O
can	O
be	O
observed	O
that	O
a	O
slight	O
increase	O
in	O
fT4	O
and	O
a	O
reduction	O
in	O
TSH	O
occur	O
between	O
the	O
9thand	O
12thweeks	O
of	O
gestation	O
;	O
subsequently	O
,	O
HCG	O
levels	O
decrease	O
and	O
TSH	O
reaches	O
normal	O
non	O
-	O
pregnant	O
levels	O
.	O

Thus	B
,	O
the	O
reversibility	O
of	O
environmentally	O
induced	O
changes	O
is	O
also	O
critically	O
important	O
when	O
determining	O
the	O
true	B
potential	O
adversity	O
of	O
an	O
environmental	O
exposure	O
.	O

Therefore	B
,	O
it	O
is	O
crucial	O
to	O
monitor	O
the	O
homocysteine	O
levels	O
in	O
body	O
fluids	O
of	O
autistic	O
children	O
.	O

Thirty	O
months	O
after	O
the	O
initial	O
treatment	O
of	O
the	O
thyroid	O
cancer	O
(	O
radioiodine	O
and	O
levothyroxine	O
),	O
remarkable	O
improvements	O
in	O
glycemia	O
were	O
noted	O
and	O
the	O
anti	O
-	O
diabetic	O
treatment	O
could	O
even	O
be	O
discontinued	O
.	O

Data	O
will	O
be	O
tested	O
for	O
outliers	O
and	O
normality	O
by	O
means	O
of	O
Q	O
-	O
Q	O
plots	O
and	O
histogram	O
visual	O
inspection	O
.	O

The	O
positive	O
predictive	O
value	O
(	O
PPV	O
)	O
and	O
negative	O
predictive	O
value	O
(	O
NPV	O
)	O
of	O
self	O
-	O
reporting	O
vaccination	O
and	O
non	O
-	O
vaccination	O
status	O
were	O
then	O
calculated	O
.	O

Acute	O
Type	O
A	O
Aortic	O
Dissection	O
in	O
a	O
36	O
-	O
Week	O
Pregnant	O
Patient	O
Abstract	O
Aortic	O
dissection	O
is	O
a	O
relatively	O
rare	O
yet	O
often	O
fatal	O
condition	O
.	O

Interestingly	O
,	O
caloric	O
restriction	O
induced	O
a	O
higher	O
reduction	O
in	O
total	O
intake	O
in	O
the	O
female	O
offspring	O
treated	O
with	O
AM251	O
.	O

The	O
χ2tests	O
or	O
Fisher	O
'	O
s	O
exact	O
tests	O
were	O
used	O
to	O
examine	O
relationships	O
between	O
categorical	O
variables	O
.	O

The	O
treatment	O
also	O
enhanced	O
UCP1	O
protein	O
levels	O
in	O
BAT	O
,	O
via	O
stimulation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Change	O
in	O
25OHD	O
was	O
calculated	O
as	O
the	O
difference	O
between	O
T3	O
and	O
T1	O
(	O
T3	O
-	O
T1	O
)	O
and	O
was	O
coded	O
into	O
3	O
groups	O
:	O
decrease	O
in	O
25OHD	O
(≤	O
0	O
nmol	O
/	O
L	O
),	O
small	O
increase	O
(	O
0	O
.	O
1	O
–	O
29	O
.	O
99	O
nmol	O
/	O
L	O
)	O
or	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
).	O

In	O
contrast	O
,	O
our	O
data	O
support	O
investigation	O
into	O
higher	O
doses	O
of	O
vitamin	O
D	O
in	O
subgroups	O
at	O
high	O
risk	O
if	O
benefits	O
are	O
demonstrated	O
by	O
ongoing	O
trials	O
in	O
pregnancy	O
of	O
achieving	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

2005	O
)	O
was	O
used	O
.	O

It	O
is	O
the	O
first	O
study	O
to	O
capture	O
mothers	O
’	O
overall	O
dietary	O
patterns	O
and	O
relate	O
them	O
to	O
child	O
leukemia	O
.	O

In	O
addition	O
,	O
it	O
is	O
believed	O
that	O
genomic	O
location	O
and	O
sequence	O
context	O
play	O
a	O
crucial	O
role	O
in	O
the	O
maintenance	O
or	O
loss	O
of	O
DNA	O
methylation	O
in	O
these	O
regions	O
.	O

The	O
proportion	O
of	O
women	O
in	O
our	O
study	O
group	O
taking	O
folic	O
acid	O
is	O
still	O
low	O
,	O
despite	O
its	O
widely	O
recognised	O
benefits	O
,	O
but	O
could	O
be	O
explained	B
by	O
the	O
lack	O
of	O
reimbursement	O
for	O
the	O
cost	O
of	O
folic	O
acid	O
,	O
which	O
must	O
be	O
bought	O
over	O
the	O
counter	O
at	O
any	O
time	O
it	O
is	O
prescribed	O
,	O
during	O
pregnancy	O
or	O
before	O
conception	O
.	O

Moreover	O
,	O
it	O
was	O
shown	O
that	O
leptin	O
injection	O
in	O
the	O
early	O
stage	O
of	O
life	O
in	O
lambs	O
decreases	O
UCP1	O
expression	O
in	O
BAT	O
,	O
but	O
improves	O
thermoregulation	O
,	O
suggesting	O
a	O
particular	O
role	O
of	O
leptin	O
at	O
such	O
a	O
stage	O
in	O
life	O
in	O
large	O
mammals	O
(	O
Mostyn	O
et	O
al	O
.,	O
2002	O
).	O

Discussion	O
A	O
positive	O
correlation	O
was	O
found	O
between	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
the	O
serum	O
of	O
mother	O
and	O
child	O
in	O
this	O
prospective	O
birth	O
cohort	O
study	O
.	O

Portions	O
(	O
100	O
–	O
300	O
mg	O
)	O
of	O
liver	O
and	O
PAT	O
,	O
and	O
the	O
whole	O
hypothalamus	O
were	O
homogenized	O
in	O
ice	O
and	O
RNA	O
was	O
extracted	O
using	O
the	O
Trizol	O
®	O
method	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
(	O
Gibco	O
BRL	O
).	O

If	O
glucose	O
targets	O
are	O
not	O
adequately	O
met	O
by	O
lifestyle	O
measures	O
,	O
and	O
perhaps	O
a	O
review	O
of	O
dietary	O
intake	O
,	O
then	O
pharmacotherapy	O
should	O
be	O
introduced	O
.	O

Only	O
lower	O
maternal	O
fat	O
intake	O
(−	O
0	O
.	O
22	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
trend	O
for	O
higher	O
carbohydrate	O
intake	O
(	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
06	O
)	O
early	O
in	O
pregnancy	O
were	O
correlated	O
with	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

In	O
vitamin	O
D	O
deficient	O
children	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
cathelicidin	O
concentration	O
among	O
the	O
races	O
/	O
ethnicities	O
or	O
by	O
gender	O
.	O

New	O
strategies	O
for	O
prevention	O
are	O
particularly	O
urgent	O
for	O
use	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
where	O
rates	O
are	O
highest	O
.	O

There	O
were	O
significant	O
effect	O
of	O
both	O
diet	O
and	O
time	O
,	O
but	O
no	O
interaction	O
between	O
them	O
on	O
food	O
intake	O
and	O
weight	O
gain	O
,	O
suggesting	O
that	O
vitamin	O
diets	O
strongly	O
alter	O
the	O
phenotype	O
of	O
mature	O
offspring	O
independent	O
of	O
time	O
.	O

The	O
document	O
linking	O
anonymous	O
IDs	O
to	O
participants	O
will	O
be	O
collected	O
and	O
stored	O
separately	O
.	O

Among	O
women	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
overweight	O
,	O
obesity	O
and	O
smoking	O
were	O
more	O
common	O
,	O
and	O
this	O
group	O
also	O
contained	O
more	O
women	O
who	O
had	O
migrated	O
to	O
Sweden	O
.	O

[	O
21	O
]	O
reported	O
differences	O
in	O
outcomes	O
associated	O
with	O
oily	O
fish	O
intake	O
and	O
total	O
fish	O
intake	O
in	O
early	O
compared	O
to	O
late	O
pregnancy	O
.	O

Previously	O
,	O
ELISA	O
was	O
used	O
to	O
measure	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
.	O

After	O
collection	O
the	O
cotton	O
bud	O
end	O
of	O
the	O
swab	O
with	O
the	O
collected	O
sample	O
is	O
immediately	O
preserved	O
in	O
RNAlater	O
(	O
Ambion	O
)	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
.	O

Avoidance	O
of	O
Other	O
Allergens	O
During	O
Pregnancy	O
Avoidance	O
of	O
other	O
allergens	O
is	O
necessary	O
only	O
if	O
the	O
pregnant	O
patients	O
are	O
already	O
sensitized	O
(	O
eg	O
,	O
to	O
cats	O
,	O
dogs	O
,	O
horses	O
,	O
or	O
house	O
dust	O
).	O

[	O
12	O
]	O
Chailurkit	O
et	O
al	O
.	O

An	O
early	O
rebound	O
may	O
reflect	O
the	O
child	O
'	O
s	O
taking	O
more	O
control	O
of	O
intake	O
,	O
exposure	O
to	O
gestational	O
diabetes	O
,	O
or	O
early	O
maturation	O
(	O
84	O
).	O

1	O
.	O

The	O
risk	O
of	O
GDM	O
was	O
particularly	O
elevated	O
among	O
overweight	O
women	O
who	O
snored	O
.	O

This	O
hypothesis	O
has	O
been	O
confirmed	O
by	O
several	O
experimental	O
animal	O
and	O
epidemiological	O
human	O
studies	O
(	O
reviewed	O
in	O
Renz	O
et	O
al	O
[	O
95	O
]).	O

Total	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
and	O
chocolate	O
preference	O
(	O
calculated	O
as	O
the	O
percentage	O
of	O
chocolate	O
eaten	O
on	O
overall	O
intake	O
)	O
were	O
evaluated	O
at	O
adolescence	O
(	O
postnatal	O
weeks	O
8	O
–	O
9	O
)	O
and	O
reevaluated	O
at	O
adulthood	O
(	O
postnatal	O
weeks	O
12	O
–	O
13	O
)	O
in	O
all	O
experimental	O
groups	O
.	O

An	O
18	O
-	O
fold	O
greater	O
risk	O
of	O
primary	O
adult	O
brain	O
tumors	O
has	O
been	O
found	O
among	O
individuals	O
who	O
consumed	O
large	O
amounts	O
of	O
processed	O
meats	O
(	O
high	O
in	O
N	O
-	O
nitroso	O
content	O
)	O
and	O
drank	O
orange	O
/	O
grapefruit	O
juice	O
once	O
per	O
week	O
or	O
less	O
,	O
than	O
among	O
those	O
who	O
consumed	O
less	O
processed	O
meat	O
and	O
drank	O
orange	O
/	O
grapefruit	O
juice	O
more	O
often	O
[	O
164	O
].	O

Although	O
the	O
pathogenesis	O
of	O
obesity	O
is	O
extremely	O
complex	O
and	O
is	O
far	O
from	O
being	O
unraveled	O
,	O
the	O
key	O
component	O
of	O
the	O
obesity	O
epidemic	O
is	O
long	O
-	O
term	O
dysregulation	O
of	O
energy	O
balance	O
,	O
comprising	O
increased	O
energy	O
intake	O
and	O
/	O
or	O
reduced	O
energy	O
expenditure	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Anthropometric	O
data	O
of	O
the	O
total	O
sample	O
and	O
stratified	O
by	O
the	O
classification	O
of	O
pre	O
-	O
pregnancy	O
Body	O
Mass	O
Index	O
(	O
PPBMI	O
)	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
,	O
Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

Gametogenesis	O
and	O
pre	O
-	O
conception	O
Spermatogenesis	O
occurs	O
continuously	O
in	O
adult	O
males	O
and	O
even	O
though	O
females	O
are	O
born	O
with	O
their	O
full	O
complement	O
of	O
oocytes	O
,	O
oocyte	O
maturation	O
occurs	O
in	O
a	O
continuous	O
cycle	O
throughout	O
the	O
reproductive	O
life	O
of	O
adult	O
females	O
.	O

Obviously	O
,	O
another	O
,	O
and	O
more	O
parsimonious	O
explanation	B
,	O
is	O
that	O
vitamin	O
D	O
is	O
involved	O
in	O
all	O
three	O
.	O

Further	O
studies	O
should	O
be	O
performed	O
to	O
clarify	O
the	O
role	O
of	O
the	O
endocannabinoid	O
system	O
and	O
other	O
homeostatic	O
mechanisms	O
implicated	O
in	O
the	O
process	O
of	O
nutritional	O
programming	O
.	O

They	O
are	O
present	O
in	O
most	O
humans	O
and	O
are	O
found	O
in	O
breast	O
milk	O
.	O
21	O
Grandjean	O
wanted	O
to	O
know	O
how	O
breastfeeding	O
correlated	O
with	O
some	O
of	O
the	O
child	O
health	O
outcomes	O
his	O
group	O
had	O
observed	O
.	O

The	O
detection	O
limit	O
of	O
the	O
human	O
cathelicidin	O
ELISA	O
was	O
0	O
.	O
14	O
ng	O
/	O
mL	O
.	O

Therefore	O
,	O
a	O
cell	O
cycle	O
control	O
system	O
can	O
arrest	O
the	O
cycle	O
at	O
certain	O
checkpoints	O
.	O

These	O
were	O
rs12785878	O
(	O
DHCR7	O
),	O
rs10741657	O
(	O
CYP2R1	O
),	O
rs6013897	O
(	O
CYP24A1	O
),	O
and	O
rs2282679	O
(	O
GC	O
).	O

Adequate	O
intravascular	O
volume	O
repletion	O
and	O
oxygenation	O
are	O
particularly	O
important	O
in	O
the	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
to	O
prevent	O
both	O
maternal	O
and	O
fetal	O
complications	O
.	O

The	O
estimate	O
of	O
compliance	O
did	O
not	O
differ	O
between	O
treatment	O
groups	O
(	O
MMN	O
:	O
0	O
.	O
96	O
±	O
0	O
.	O
18	O
;	O
placebo	O
:	O
0	O
.	O
92	O
±	O
0	O
.	O
19	O
,	O
p	O
=	O
0	O
.	O
15	O
).	O

Intervention	O
We	O
trained	O
female	O
behavior	O
change	O
communicators	O
,	O
who	O
typically	O
have	O
Master	O
'	O
s	O
degrees	O
and	O
experience	O
in	O
data	O
collection	O
,	O
to	O
implement	O
the	O
intervention	O
.	O

The	O
initial	O
intervention	O
usually	O
entails	O
dietary	O
advice	O
,	O
individualized	O
if	O
possible	O
,	O
and	O
given	O
by	O
a	O
dietitian	O
.	O

It	O
is	O
essential	O
for	O
the	O
generation	O
of	O
subsequent	O
germ	O
cells	O
(	O
and	O
thus	O
the	O
successful	O
production	O
of	O
future	O
generations	O
)	O
that	O
parental	O
imprints	O
within	O
PGCs	O
are	O
removed	O
and	O
new	O
imprints	O
are	O
re	O
-	O
established	O
according	O
to	O
the	O
gender	O
of	O
the	O
embryo	O
.	O

The	O
correlation	O
between	O
VD	O
and	O
AMH	O
was	O
confirmed	O
in	O
a	O
multi	O
-	O
center	O
study	O
in	O
patients	O
over	O
their	O
40th	O
years	O
of	O
life	O
.	O

A	O
study	O
of	O
Angus	O
-	O
crossbred	O
steers	O
showed	O
that	O
animals	O
not	O
supplemented	O
with	O
vitamin	O
A	O
had	O
higher	O
MS	O
and	O
QG	O
compared	O
to	O
vitamin	O
A	O
-	O
supplemented	O
animals	O
[	O
132	O
].	O

However	O
,	O
again	O
some	O
misclassification	O
of	O
dietary	O
intake	O
cannot	O
be	O
ruled	O
out	O
,	O
such	O
a	O
misclassification	O
is	O
likely	B
to	O
be	O
non	O
-	O
differential	O
,	O
and	O
attenuating	O
any	O
true	B
association	O
.	O

25	O
-(	O
OH	O
)	O
D	O
is	O
then	O
metabolized	O
in	O
the	O
kidney	O
by	O
the	O
1	O
-	O
α	O
hydroxylase	O
to	O
the	O
active	O
steroid	O
hormone	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
].	O

The	O
study	O
tested	O
2	O
primary	O
hypotheses	O
:	O
(	O
1	O
)	O
text4baby	O
group	O
participants	O
would	O
demonstrate	O
increased	O
health	O
-	O
promoting	O
behaviors	O
and	O
decreased	O
risk	O
behaviors	O
compared	O
to	O
control	O
at	O
postpartum	O
follow	O
-	O
up	O
and	O
(	O
2	O
)	O
text4baby	O
participants	O
would	O
demonstrate	O
a	O
dose	O
-	O
response	O
effect	O
of	O
receiving	O
the	O
text	O
messages	O
in	O
which	O
higher	O
doses	O
of	O
text	O
messages	O
would	O
produce	O
greater	O
behavioral	O
outcomes	O
.	O

During	O
the	O
observation	O
period	O
,	O
a	O
data	O
collector	O
positioned	O
herself	O
in	O
the	O
home	O
/	O
compound	O
in	O
order	O
to	O
assess	O
handwashing	O
behaviors	O
at	O
times	O
of	O
possible	O
pathogen	O
transmission	O
to	O
the	O
neonate	O
.	O

2	O
.	O
3	O
.	O

Comparing	O
mothers	O
of	O
children	O
with	O
versus	O
without	O
pediatrician	O
records	O
at	O
6	O
months	O
,	O
those	O
with	O
pediatrician	O
records	O
were	O
older	O
(	O
29	O
.	O
0	O
±	O
5	O
.	O
1	O
versus	O
27	O
.	O
4	O
±	O
5	O
.	O
5	O
years	O
;	O
P	O
=	O
.	O
008	O
),	O
more	O
likely	O
to	O
be	O
non	O
-	O
Hispanic	O
White	O
(	O
73	O
.	O
8	O
%	O
versus	O
53	O
.	O
0	O
%	O
P	O
=	O
.	O
0001	O
),	O
and	O
more	O
likely	O
to	O
be	O
married	O
(	O
74	O
.	O
6	O
versus	O
55	O
.	O
7	O
%;	O
P	O
=	O
.	O
001	O
);	O
no	O
significant	O
differences	O
were	O
observed	O
in	O
prepregnancy	O
BMI	O
,	O
education	O
,	O
income	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
or	O
maternal	O
GWG	O
.	O

Some	O
tumor	O
viruses	O
must	O
be	O
injected	O
in	O
animals	O
on	O
the	O
first	O
day	O
of	O
life	O
to	O
be	O
effective	O
,	O
although	O
they	O
may	O
not	O
cause	O
cancer	O
until	O
years	O
later	O
[	O
7	O
].	O

However	O
,	O
the	O
risk	O
of	O
repeated	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
was	O
13	O
%	O
(	O
relative	O
risk	O
[	O
RR	O
]	O
0	O
·	O
78	O
,	O
95	O
%	O
CI	O
0	O
·	O
64	O
–	O
0	O
·	O
94	O
;	O
p	O
=	O
0	O
·	O
01	O
)	O
lower	O
in	O
the	O
vitamin	O
D3compared	O
with	O
the	O
placebo	O
group	O
.	O
3Other	O
more	O
recent	O
studies	O
assessing	O
different	O
outcomes	O
in	O
children	O
or	O
adults	O
have	O
conflicting	O
findings	O
on	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
.	O
There	O
is	O
growing	O
evidence	O
of	O
the	O
vitamin	O
D	O
parancrine	O
system	O
enhancing	O
innate	O
immunity	O
:	O
4the	O
activation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
monocytes	O
and	O
macrophages	O
by	O
microbial	O
pathogens	O
results	O
in	O
increased	O
expression	O
of	O
CYP27B1	O
and	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
genes	O
within	O
these	O
cells	O
.	O

In	O
LGA	O
infants	O
,	O
hyperinsulinemia	O
in	O
fetal	O
period	O
leads	O
to	O
fetal	O
macrosomia	O
(	O
14	O
).	O

Thus	B
,	O
the	O
down	O
-	O
expression	O
of	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
in	O
the	O
PAT	O
of	O
RC	O
male	O
offspring	O
is	O
consistent	O
with	O
an	O
obese	O
phenotype	O
,	O
hyperleptinemia	O
,	O
adiposity	O
,	O
and	O
alterations	O
in	O
lipid	O
metabolism	O
in	O
absence	O
of	O
increased	O
food	O
intake	O
,	O
as	B
was	O
previously	O
described	O
in	O
animals	O
with	O
deficiency	O
of	O
FAAH	O
and	O
MAGL	O
(	O
Tourino	O
et	O
al	O
.,	O
2010	O
;	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

Food	O
items	O
similar	O
in	O
nutrient	O
profile	O
were	O
combined	O
into	O
33	O
predefined	O
food	O
groups	O
(	O
Table	O
1	O
).	O

Simultaneous	O
with	O
the	O
above	O
two	O
Acta	O
Paediatrica	O
publications	O
,	O
a	O
paper	O
elsewhere	O
reported	O
that	O
among	O
117	O
adult	O
psychiatric	O
outpatients	O
is	O
Sweden	O
with	O
various	O
diagnoses	O
,	O
the	O
10	O
patients	O
with	O
autism	O
had	O
the	O
lowest	O
vitamin	O
D	O
levels	O
of	O
any	O
of	O
the	O
groups	O
studied	O
,	O
a	O
mean	O
of	O
12	O
ng	O
/	O
mL	O
(	O
31	O
nM	O
),	O
approaching	O
the	O
osteomalacic	O
range	O
for	O
adults	O
and	O
the	O
rachitic	O
range	O
for	O
children	O
(	O
6	O
).	O

However	O
,	O
an	O
accelerated	O
reproductive	O
tempo	O
may	O
not	O
be	O
maintained	O
in	O
the	O
face	O
of	O
later	O
nutritional	O
constraints	O
.	O

(	O
2014	O
)¶/*/†	O
Middleton	O
et	O
al	O
.	O

It	O
is	O
necessary	O
to	O
increase	O
exogenous	O
Vitamin	O
D	O
intake	O
in	O
this	O
population	O
especially	O
in	O
fall	O
and	O
winter	O
,	O
when	O
there	O
is	O
an	O
increase	O
of	O
Vitamin	O
D	O
deficiency	O
in	O
Beijing	O
area	O
.	O

Multivariable	O
logistic	O
regression	O
models	O
were	O
used	O
to	O
evaluate	O
associations	O
between	O
maternal	O
characteristics	O
,	O
vitamin	O
D	O
status	O
and	O
SGA	O
.	O

2007	O
;	O
Choi	O
et	O
al	O
.	O

Plots	O
include	O
only	O
infants	O
delivered	O
vaginally	O
(	O
n	O
=	O
97	O
).	O

Urticaria	O
and	O
Angioedema	O
The	O
pattern	O
and	O
causes	O
of	O
urticaria	O
and	O
angioedema	O
in	O
pregnancy	O
are	O
similar	O
to	O
those	O
in	O
nonpregnant	O
patients	O
.	O

2	O
.	O
11	O
.	O

Physical	O
Activity	O
Level	O
The	O
physical	O
activity	O
level	O
was	O
evaluated	O
by	O
the	O
total	O
score	O
obtained	O
with	O
the	O
Habitual	O
Physical	O
Activity	O
Questionnaire	O
proposed	O
by	O
Baecke	O
et	O
al	O
.	O

The	O
child	O
was	O
treated	O
with	O
600	O
,	O
000	O
IU	O
of	O
oral	O
vitamin	O
D	O
and	O
discharged	O
on	O
maintenance	O
doses	O
of	O
calcium	O
gluconate	O
and	O
800	O
IU	O
of	O
oral	O
vitamin	O
D	O
daily	O
for	O
3	O
months	O
.	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
In	O
line	O
with	O
the	O
journal	O
'	O
s	O
open	O
peer	O
review	O
policy	O
,	O
copies	O
of	O
the	O
reviewer	O
reports	O
are	O
included	O
as	O
additional	O
file	O
1	O
.	O

This	O
is	O
also	O
highly	O
topical	O
currently	O
.	O

For	O
the	O
ER22	O
/	O
EK23	O
polymorphism	O
,	O
we	O
have	O
used	O
the	O
following	O
primers	O
:	O
5	O
′-	O
GATTCGGAGTTAACTAAAAG	O
-	O
3	O
′	O
and	O
5	O
′-	O
CTACCCTTTACTGGACCCTA	O
-	O
3	O
′,	O
followed	O
by	O
restriction	O
digest	O
using	O
MnI	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
at	O
37	O
°	O
C	O
for	O
4	O
hours	O
.	O

Multilinear	O
regression	O
analysis	O
was	O
used	O
to	O
identify	O
significant	O
predictors	O
for	O
pre	O
-	O
pregnancy	O
maternal	O
weight	O
gain	O
.	O

Pooled	O
results	O
from	O
Angus	O
,	O
Shorthorn	O
,	O
Murray	O
Grey	O
,	O
and	O
Hereford	O
showed	O
that	O
the	O
grain	O
-	O
finishing	O
group	O
had	O
a	O
greater	O
IMF	O
%	O
than	O
the	O
grass	O
-	O
finishing	O
group	O
[	O
115	O
].	O

Men	O
consuming	O
the	O
most	O
folate	O
(>	O
75thpercentile	O
)	O
had	O
a	O
lower	O
frequency	O
of	O
disomy	O
21	O
,	O
X	O
,	O
sex	O
nullisomy	O
,	O
and	O
lower	O
overall	O
sperm	O
aneuploidy	O
[	O
11	O
].	O

Voxiva	O
,	O
the	O
information	O
technology	O
firm	O
that	O
delivers	O
the	O
text4baby	O
messages	O
and	O
maintains	O
data	O
provided	O
by	O
participants	O
on	O
enrollment	O
,	O
maintained	O
records	O
to	O
identify	O
participants	O
as	O
members	O
of	O
the	O
Madigan	O
study	O
.	O

Moreover	O
,	O
a	O
more	O
detailed	O
investigation	O
into	O
maternal	O
mental	O
health	O
,	O
which	O
includes	O
measures	O
of	O
the	O
frequency	O
and	O
severity	O
of	O
specific	O
psychiatric	O
symptoms	O
during	O
pregnancy	O
,	O
would	O
allow	O
for	O
a	O
more	O
thorough	O
investigation	O
into	O
these	O
critical	O
confounding	O
variables	O
.	O

The	O
period	O
between	O
an	O
environmental	O
exposure	O
and	O
the	O
appearance	O
of	O
cancer	O
may	O
be	O
lengthy	O
,	O
as	O
illustrated	O
by	O
the	O
development	O
of	O
vaginal	O
cancer	O
in	O
daughters	O
years	O
after	O
their	O
mothers	O
used	O
diethylstilbestrol	O
(	O
DES	O
)	O
during	O
pregnancy	O
[	O
3	O
].	O

Mice	O
reared	O
under	O
conditions	O
favoring	O
the	O
right	O
limb	O
develop	O
a	O
right	O
-	O
limb	O
preference	O
,	O
and	O
vice	O
versa	O
[	O
201	O
],	O
further	O
suggesting	O
that	O
environmental	O
factors	O
influence	O
handedness	O
.	O

The	O
first	O
re	O
-	O
programing	O
event	O
immediately	O
following	O
fertilization	O
de	O
-	O
differentiates	O
the	O
mature	O
parental	O
gametes	O
so	O
that	O
the	O
resulting	O
zygote	O
becomes	O
totipotent	O
,	O
capable	O
of	O
producing	O
all	O
the	O
different	O
cell	O
types	O
required	O
to	O
form	O
a	O
new	O
individual	O
.	O

Insulin	O
,	O
but	O
not	O
HOMA	O
,	O
was	O
significantly	O
reduced	O
in	O
the	O
intervention	O
arm	O
.	O

Abstract	O
:	O
TEASER	O
Associations	O
between	O
SNPs	O
in	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
and	O
25	O
(	O
OH	O
)	O
D	O
were	O
assessed	O
before	O
and	O
after	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

The	O
sample	O
size	O
required	O
was	O
estimated	O
to	O
be	O
2769	O
(	O
1938	O
vaccinated	O
and	O
831	O
unvaccinated	O
pregnant	O
women	O
).	O

As	O
a	O
further	O
preventive	O
measure	O
,	O
the	O
early	O
introduction	O
of	O
solid	O
food	O
(	O
ie	O
,	O
baby	O
food	O
from	O
jars	O
and	O
table	O
food	O
)	O
into	O
the	O
infant	O
'	O
s	O
diet	O
has	O
to	O
be	O
revisited	O
.	O

Significantly	O
more	O
children	O
with	O
S	O
-	O
ECC	O
had	O
a	O
first	O
visit	O
to	O
the	O
dentist	O
for	O
a	O
dental	O
problem	O
(	O
e	O
.	O
g	O
.	O

Cellular	O
Distribution	O
of	O
GR	O
α	O
and	O
GAS5	O
in	O
Human	O
Placentas	O
Immunofluorescence	O
analysis	O
of	O
the	O
GR	O
α	O
protein	O
was	O
performed	O
in	O
human	O
placenta	O
tissue	O
sections	O
.	O

Results	O
Among	O
the	O
1311	O
pregnant	O
women	O
participating	O
in	O
the	O
survey	O
,	O
there	O
were	O
271	O
from	O
Brussels	O
,	O
597	O
from	O
Flanders	O
and	O
437	O
from	O
Wallonia	O
(	O
Figure	O
1	O
;	O
Table	O
1	O
).	O

Thus	O
,	O
it	O
will	O
be	O
important	O
to	O
investigate	O
whether	O
maternal	O
dairy	O
consumption	O
fosters	O
the	O
growth	O
of	O
potentially	O
pathogenic	O
microbes	O
in	O
the	O
infant	O
gut	O
,	O
particularly	O
for	O
infants	O
delivered	O
operatively	O
.	O

Women	O
who	O
don	O
’	O
t	O
take	O
vitamins	O
will	O
serve	O
as	O
the	O
control	O
group	O
.	O

Another	O
study	O
in	O
Angus	O
and	O
Wagyu	O
cross	O
heifers	O
raised	O
under	O
early	O
weaning	O
(	O
142	O
days	O
old	O
)	O
and	O
accelerated	O
finishing	O
programs	O
on	O
a	O
high	O
concentrate	O
diet	O
showed	O
increased	O
IMF	O
and	O
greater	O
weight	O
gain	O
compared	O
with	O
heifers	O
weaned	O
at	O
180	O
d	O
of	O
age	O
and	O
grown	O
on	O
pasture	O
for	O
16	O
months	O
before	O
entering	O
the	O
feedlot	O
[	O
53	O
].	O

The	O
challenge	O
of	O
intervening	O
in	O
the	O
obesity	O
epidemic	O
becomes	O
even	O
more	O
daunting	O
with	O
the	O
realization	O
that	O
,	O
in	O
children	O
and	O
adolescents	O
,	O
these	O
influences	O
must	O
be	O
considered	O
separately	O
at	O
each	O
stage	O
of	O
development	O
.	O

PubMed	O
Central	O
:	O

This	O
is	O
similar	O
to	O
that	O
which	O
has	O
previously	O
been	O
shown	O
in	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
at	O
≤	O
26	O
weeks	O
’	O
gestation	O
and	O
placental	O
pathology	O
in	O
pregnancy	O
[	O
51	O
]	O
suggesting	O
that	O
male	O
and	O
female	O
fetuses	O
respond	O
differently	O
to	O
maternal	O
vitamin	O
D	O
status	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Significantly	O
regulated	O
transcripts	O
of	O
metabolic	O
pathways	O
in	O
liver	O
tissue	O
between	O
two	O
ontogenetic	O
stages	O
within	O
one	O
dietary	O
group	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
)	O
Ontogenetic	O
comparisonDietRegulated	O
pathwayDirection	O
of	O
regulation	O
P	O
valueNo	O
.	O

This	O
usually	O
means	O
the	O
commencement	O
of	O
insulin	O
.	O

Background	O
Recent	O
estimates	O
indicate	O
that	O
250	O
million	O
children	O
in	O
low	O
-	O
and	O
middle	O
income	O
countries	O
are	O
at	O
risk	O
of	O
not	O
reaching	O
their	O
developmental	O
potential	O
[	O
1	O
].	O

Statistical	O
Analysis	O
The	O
homogeneity	O
of	O
the	O
two	O
groups	O
was	O
confirmed	O
through	O
statistical	O
tests	O
in	O
terms	O
of	O
underlying	O
and	O
demographic	O
variables	O
such	O
as	O
age	O
,	O
education	O
,	O
employment	O
,	O
household	O
size	O
,	O
and	O
neonatal	O
sex	O
,	O
fertility	O
status	O
,	O
income	O
,	O
childbirth	O
method	O
,	O
and	O
family	O
planning	O
,	O
the	O
time	O
presenting	O
for	O
postpartum	O
childcare	O
,	O
feeding	O
method	O
(	O
formula	O
,	O
breast	O
milk	O
,	O
or	O
both	O
),	O
hypothyroidism	O
,	O
neonatal	O
anemia	O
,	O
and	O
referral	O
to	O
physician	O
.	O

In	O
addition	O
,	O
a	O
long	O
fattening	O
period	O
could	O
result	O
in	O
low	O
yield	O
grade	O
(	O
YG	O
)	O
because	O
long	O
-	O
term	O
fattening	O
increases	O
backfat	O
thickness	O
and	O
carcass	O
weight	O
,	O
which	O
negatively	O
affect	O
YG	O
in	O
Korean	O
cattle	O
[	O
59	O
].	O

Free	O
and	O
colleagues	O
[	O
11	O
]	O
systematically	O
reviewed	O
the	O
evidence	O
on	O
mHealth	O
interventions	O
and	O
found	O
that	O
antiretroviral	O
treatment	O
(	O
ART	O
)	O
and	O
smoking	O
cessation	O
interventions	O
had	O
sufficient	B
evidence	I
of	O
effectiveness	O
to	O
be	O
considered	O
for	O
inclusion	O
in	O
health	O
care	O
services	O
.	O

These	O
women	O
are	O
advised	O
to	O
take	O
10	O
micrograms	O
per	O
day	O
in	O
the	O
form	O
of	O
a	O
multivitamin	O
supplement	O
.	O

If	O
the	O
PTB	O
was	O
indicated	O
,	O
the	O
reason	O
was	O
also	O
collected	O
.	O

[	O
24	O
]	O
adjusted	O
for	O
both	O
maternal	O
and	O
child	O
diets	O
.	O

Our	O
study	O
sample	O
was	O
drawn	O
from	O
Northern	O
New	O
England	O
,	O
which	O
has	O
a	O
relatively	O
homogenous	O
population	O
;	O
this	O
could	O
limit	O
the	O
generalizability	O
of	O
the	O
study	O
.	O

The	O
diluted	O
cDNA	O
were	O
used	O
in	O
each	O
real	O
-	O
time	O
PCR	O
assay	O
.	O

In	O
view	O
of	O
the	O
foregoing	O
,	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
was	O
conducted	O
;	O
furthermore	O
,	O
constraints	O
were	O
highlighted	O
and	O
suggestions	O
for	O
improvement	O
were	O
provided	O
.	O

Several	O
large	O
observational	O
studies	O
and	O
meta	O
-	O
analyses	O
have	O
described	O
the	O
association	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
with	O
pregnancy	O
complications	O
such	O
as	O
pre	O
-	O
eclampsia	O
,	O
gestational	O
diabetes	O
and	O
premature	O
birth	O
.	O
10	O
,	O
11	O
,	O
12	O
,	O
13Racial	O
disparities	O
in	O
maternal	O
and	O
neonatal	O
vitamin	O
D	O
deficiency	O
have	O
been	O
described	O
.	O
1	O
,	O
14	O
,	O
15Vitamin	O
D	O
deficiency	O
is	O
more	B
common	I
and	O
more	O
severe	O
in	O
black	O
mothers	O
.	O
10	O
,	O
15	O
,	O
16	O
,	O
17	O
,	O
18	O
,	O
19Racial	O
disparities	O
are	O
also	O
seen	O
with	O
pregnancy	O
complications	O
such	O
as	O
preterm	O
birth	O
,	O
pre	O
-	O
eclampsia	O
and	O
gestational	O
diabetes	O
,	O
as	O
well	O
as	O
adverse	O
neonatal	O
outcomes	O
including	O
low	O
birth	O
weight	O
and	O
small	O
-	O
for	O
-	O
gestational	O
-	O
age	O
(	O
SGA	O
)	O
status	O
.	O
15	O
,	O
17	O
,	O
20	O
,	O
21However	O
,	O
the	O
majority	B
of	O
studies	O
examined	O
maternal	O
vitamin	O
D	O
levels	O
during	O
the	O
first	O
and	O
second	O
trimesters	O
of	O
pregnancy7	O
,	O
8	O
,	O
22	O
,	O
23and	O
correlated	O
these	O
levels	O
to	O
neonatal	O
outcomes	O
.	O

The	O
relationship	O
between	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
The	O
mean	O
duration	O
of	O
neonatal	O
follow	O
-	O
up	O
was	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

Hurling	O
and	O
colleagues	O
[	O
16	O
]	O
found	O
that	O
an	O
Internet	O
and	O
mHealth	O
intervention	O
among	O
overweight	O
adults	O
that	O
included	O
reminders	O
produced	O
more	O
than	O
2	O
hours	O
more	O
physical	O
activity	O
(	O
PA	O
)	O
per	O
week	O
compared	O
to	O
adults	O
with	O
no	O
access	O
.	O

Following	O
the	O
intervention	O
period	O
mean	O
haemoglobin	O
concentration	O
was	O
higher	O
in	O
women	O
receiving	O
micronutrients	O
(	O
MMN	O
:	O
12	O
.	O
3	O
±	O
1	O
.	O
1g	O
/	O
dL	O
,	O
placebo	O
:	O
11	O
.	O
5	O
±	O
1	O
.	O
4g	O
/	O
dL	O
)	O
with	O
a	O
mean	O
change	O
in	O
haemoglobin	O
concentration	O
of	O
+	O
0	O
.	O
6	O
±	O
1	O
.	O
4g	O
/	O
dL	O
(	O
MMN	O
)	O
and	O
−	O
0	O
.	O
2	O
±	O
1	O
.	O
2g	O
/	O
dL	O
(	O
placebo	O
)	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

We	O
hypothesize	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
moderate	O
calorie	O
-	O
restricted	O
diet	O
could	O
alter	O
the	O
energy	O
homeostasis	O
regulated	O
by	O
the	O
ECS	O
and	O
could	O
re	O
-	O
program	O
fatty	O
-	O
acid	O
metabolism	O
later	O
in	O
life	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
.	O

Thus	O
,	O
the	O
amount	O
of	O
UCP1	O
increases	O
during	O
fetal	O
development	O
,	O
peaks	O
at	O
birth	O
,	O
before	O
declining	O
over	O
the	O
first	O
9	O
months	O
(	O
Lean	O
et	O
al	O
.,	O
1986	O
;	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

Furthermore	O
,	O
IMF	O
has	O
a	O
higher	O
expression	O
of	O
glucose	O
transporter	O
4	O
,	O
which	O
is	O
responsible	O
for	O
uptake	O
of	O
glucose	O
in	O
adipose	O
tissues	O
,	O
compared	O
to	O
subcutaneous	O
fat	O
(	O
reviewed	O
in	O
[	O
90	O
]).	O

Therefore	B
,	O
childhood	O
nutrition	O
and	O
obesity	O
should	O
be	O
examined	O
from	O
a	O
developmental	O
perspective	O
.	O

We	O
suggest	O
that	O
an	O
international	O
multidisciplinary	O
working	O
group	O
to	O
be	O
set	O
up	O
to	O
oversee	O
the	O
design	O
of	O
future	O
prevention	O
or	O
supplementation	O
studies	O
.	O

Life	O
style	O
and	O
environmental	O
factors	O
are	O
the	O
major	O
factors	O
that	O
determine	O
vitamin	O
D	O
status	O
in	O
Thai	O
people	O
.	O

Conclusion	O
In	O
summary	O
,	O
several	O
attributes	O
of	O
the	O
perinatal	O
and	O
labor	O
experiences	O
may	O
be	O
associated	O
with	O
the	O
development	O
of	O
autism	O
.	O

We	O
used	O
logistic	O
regression	O
to	O
analyse	O
the	O
associations	O
between	O
these	O
factors	O
.	O

After	O
delivery	O
,	O
the	O
maternal	O
and	O
fetal	O
surfaces	O
of	O
the	O
placenta	O
were	O
dissected	O
,	O
and	O
fetal	O
membranes	O
were	O
peeled	O
away	O
from	O
the	O
placenta	O
.	O

A	O
total	O
of	O
nine	O
phthalates	O
,	O
BPA	O
,	O
5	O
PFAS	O
,	O
23	O
PCBs	O
,	O
9	O
PBDEs	O
,	O
6	O
OCPs	O
,	O
2	O
OPPs	O
and	O
2	O
heavy	O
metals	O
were	O
measured	O
(	O
Table2	O
).	O

Mobile	O
phones	O
are	O
poised	B
to	O
be	O
powerful	O
tools	O
to	O
promote	O
health	O
in	O
a	O
number	O
of	O
domains	O
and	O
settings	O
worldwide	O
[	O
4	O
].	O

Even	O
fewer	O
(	O
18	O
of	O
the	O
47	O
to	O
-	O
date	O
)	O
further	O
established	O
causality	O
,	O
all	O
of	O
which	O
were	O
studies	O
in	O
rodent	O
models	O
.	O

Conclusions	O
This	O
review	O
assessed	O
the	O
hypothesis	O
that	O
fish	O
intake	O
during	O
pregnancy	O
improves	O
offspring	O
neurodevelopmental	O
outcomes	O
.	O

¶	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

Innovate	O
•	O
Generate	O
and	O
disseminate	O
evidence	O
on	O
preterm	O
birth	O
and	O
provide	O
a	O
platform	O
for	O
sharing	O
best	O
practices	O
,	O
and	O
use	O
the	O
UN	O
Commodities	O
Commission	O
to	O
address	O
gaps	O
for	O
essential	O
equipment	O
and	O
medicines	O
(	O
e	O
.	O
g	O
.,	O
antenatal	O
corticosteroids	O
).	O

In	O
particular	O
,	O
a	O
proteomic	O
study	O
based	O
on	O
two	O
cortical	O
regions	O
of	O
DVD	O
-	O
deficient	O
rats	O
(	O
frontal	O
cortex	O
and	O
hippocampus	O
),	O
identified	O
36	O
dysregulated	O
proteins	O
.	O

showed	O
a	O
statistically	O
significant	O
increase	O
in	O
autism	O
and	O
other	O
mental	O
health	O
disorders	O
following	O
ovulation	O
induction	O
[	O
41	O
].	O

The	O
extent	O
of	O
decay	O
that	O
they	O
experience	O
generally	B
warrants	O
rehabilitative	O
dental	O
surgery	O
under	O
general	O
anesthesia	O
(	O
GA	O
).	O

A	O
limitation	O
of	O
the	O
study	O
is	O
that	O
women	O
who	O
fit	O
the	O
inclusion	O
criteria	O
are	O
invited	O
to	O
join	O
the	O
study	O
by	O
visiting	O
the	O
data	O
collection	O
site	O
at	O
an	O
agreed	O
date	O
.	O

Moreover	O
,	O
the	O
beta	O
actin	O
bands	O
are	O
shown	O
in	O
western	O
blotting	O
figures	O
below	O
each	O
protein	O
analyzed	O
.	O

The	O
persistence	O
of	O
the	O
relationship	O
between	O
postpartum	O
maternal	O
serum	O
visfatin	O
levels	O
and	O
anthropometric	O
indicators	O
can	O
be	O
attributed	O
to	O
excretion	O
of	O
visfatin	O
in	O
mother	O
’	O
s	O
milk	O
,	O
which	O
was	O
confirmed	O
by	O
Bienertová	O
-	O
Vašků	O
et	O
al	O
.(	O
25	O
).	O

Inform	O
•	O
Promote	O
transparent	O
tracking	O
of	O
commitments	O
and	O
accountability	O
and	O
of	O
long	O
-	O
term	O
improvements	O
in	O
national	O
health	O
management	O
and	O
information	O
systems	O
.	O

Serum	O
VD	O
level	O
correlated	O
well	O
with	O
its	O
follicular	O
concentration	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
was	O
inversely	O
proportional	O
to	O
BMI	O
of	O
the	O
patients	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
[	O
54	O
].	O

Neonatal	O
and	O
gestational	O
data	O
were	O
obtained	O
from	O
antenatal	O
and	O
obstetrics	O
medical	O
records	O
.	O

Participants	O
took	O
a	O
survey	O
about	O
their	O
Vitamin	O
D	O
supplement	O
intake	O
history	O
,	O
including	O
brand	O
,	O
gestational	O
week	O
when	O
starting	O
the	O
intake	O
,	O
frequency	O
and	O
dose	O
,	O
and	O
calculation	O
of	O
non	O
-	O
dietary	O
Vitamin	O
D	O
daily	O
intake	O
.	O

During	O
pregnancy	O
and	O
lactation	O
outstanding	O
changes	O
occur	O
in	O
mother	O
’	O
s	O
vitamin	O
D	O
metabolism	O
.	O

Fear	O
of	O
labor	O
pain	O
is	O
another	O
concern	O
of	O
the	O
modern	O
-	O
day	O
mothers	O
[	O
78	O
].	O

There	O
are	O
different	O
forms	O
of	O
preventive	O
treatment	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

Materials	O
and	O
Methods	O
Subjects	O
The	O
offspring	O
of	O
mothers	O
who	O
had	O
participated	O
in	O
an	O
NICHD	O
,	O
IRB	O
-	O
approved	O
vitamin	O
D	O
supplementation	O
study	O
during	O
pregnancy	O
(	O
HR	O
#	O
10727	O
;	O
CTRC	O
protocol	O
#	O
670	O
;	O
n	O
=	O
350	O
)	O
were	O
invited	O
back	O
for	O
yearly	O
follow	O
-	O
up	O
beginning	O
at	O
2	O
years	O
of	O
age	O
.	O

Lineage	O
-	O
tracing	O
studies	O
showed	O
that	O
brown	O
adipocytes	O
in	O
classic	O
BAT	O
areas	O
derive	O
from	O
myogenic	O
factor	O
5	O
(	O
Myf	O
5	O
+)-	O
positive	O
progenitor	O
cells	O
,	O
similarly	O
to	O
skeletal	O
myocytes	O
(	O
Timmons	O
et	O
al	O
.,	O
2007	O
).	O

It	O
is	O
also	O
important	O
to	O
consider	O
,	O
however	O
,	O
early	O
ex	O
utero	O
exposures	O
.	O

It	O
was	O
interesting	O
to	O
investigate	O
trend	O
of	O
vitamin	O
D	O
effectiveness	O
in	O
the	O
two	O
primiparous	O
and	O
multiparous	O
subgroups	O
.	O

There	O
were	O
fewer	O
deaths	O
than	O
we	O
predicted	O
in	O
both	O
groups	O
,	O
possibly	O
due	O
to	O
the	O
intense	O
health	O
surveillance	O
possible	O
during	O
our	O
study	O
.	O

Finally	O
,	O
several	O
hypothalamic	O
nuclei	O
were	O
shown	O
to	O
express	O
BMP	O
-	O
7	O
,	O
suggesting	O
that	O
it	O
may	O
regulate	O
BAT	O
function	O
via	O
a	O
central	O
mechanism	O
,	O
also	O
responsible	O
for	O
decreased	O
food	O
intake	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
).	O

Analysis	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
The	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
were	O
determined	O
by	O
an	O
automated	O
electrochemiluminescence	O
immunoassay	O
(	O
Roche	O
Diagnostics	O
,	O
Mannheim	O
,	O
Germany	O
)	O
in	O
the	O
core	O
lab	O
at	O
Chang	O
Gung	O
Memorial	O
Hospital	O
,	O
which	O
is	O
accredited	O
by	O
the	O
College	O
of	O
American	O
Pathologists	O
.	O

Conversely	O
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

Since	O
,	O
the	O
outcome	O
status	O
(	O
namely	O
psychotic	O
symptoms	O
)	O
among	O
participants	O
was	O
unknown	O
at	O
study	O
entry	O
we	O
cannot	O
draw	O
any	O
conclusions	O
about	O
causality	O
,	O
only	O
about	O
the	O
existence	O
of	O
associations	O
(	O
negative	O
or	O
positive	O
).	O

Women	O
with	O
darker	O
skin	O
Fitzpatrick	O
Class	O
6	O
are	O
more	O
prone	B
to	O
Vitamin	O
D	O
deficiency	O
as	B
they	O
need	O
four	O
to	O
ten	O
times	O
sunlight	O
than	O
Fitzpatrick	O
Class	O
1	O
-	O
4	O
skinned	O
people	O
for	O
adequate	O
Vitamin	O
D	O
synthesis	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
.	O

In	O
Romania	O
it	O
is	O
not	O
clear	O
whether	O
there	O
is	O
a	O
relationship	O
between	O
socio	O
-	O
demographic	O
factors	O
or	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
iron	O
,	O
folic	O
acid	O
and	O
multivitamins	O
in	O
pregnancy	O
.	O

A	O
questionnaire	O
gathered	O
sociodemographic	O
,	O
clinical	O
,	O
anthropometric	O
and	O
lifestyle	O
data	O
,	O
and	O
also	O
a	O
Food	O
Frequency	O
Questionnaire	O
was	O
calculated	O
in	O
order	O
to	O
measure	O
food	O
and	O
energy	O
intake	O
.	O

We	O
collected	O
samples	O
over	O
one	O
winter	O
season	O
to	O
mitigate	O
the	O
effect	O
of	O
varying	O
sun	O
exposure	O
.	O

The	O
risk	O
was	O
also	O
lower	O
for	O
women	O
with	O
a	O
high	O
intake	O
of	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
compared	O
to	O
women	O
with	O
a	O
lower	O
intake	O
of	O
these	O
fatty	O
acids	O
.	O

Thus	B
,	O
environmental	O
exposures	O
to	O
those	O
oocytes	O
and	O
spermatozoa	O
that	O
go	O
onto	O
produce	O
an	O
embryo	O
(	O
pre	O
-	O
conception	O
exposures	O
)	O
are	O
also	O
an	O
important	O
consideration	O
.	O

Cathelicidin	O
concentrations	O
were	O
not	O
significantly	O
different	O
among	O
(	O
or	O
between	O
)	O
the	O
three	O
racial	O
/	O
ethnic	O
groups	O
(	O
p	O
=	O
0	O
.	O
999	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Bivariate	O
Analysis	O
between	O
Cathelicidin	O
and	O
Categorical	O
Variables	O
.	O

The	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
is	O
high	O
even	O
in	O
sunny	O
climates	O
,	O
such	O
as	O
Brazil	O
'	O
s	O
,	O
principally	O
in	O
adolescents	O
[	O
4	O
].	O

Additionally	O
,	O
both	O
CC	O
and	O
RC	O
males	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
compared	O
to	O
the	O
respective	O
CC	O
(	O
postnatal	O
week	O
7	O
on	O
)	O
and	O
RC	O
(	O
postnatal	O
week	O
6	O
on	O
)	O
females	O
in	O
a	O
time	O
period	O
that	O
comprise	O
most	O
weeks	O
of	O
the	O
adolescence	O
and	O
adulthood	O
(	O
Figure2C	O
).	O

However	O
,	O
new	O
evidence	O
suggests	O
that	O
vitamin	O
D	O
could	O
be	O
vital	O
to	O
normal	O
fetal	O
development	O
and	O
that	O
vitamin	O
D	O
restriction	O
in	O
this	O
period	O
may	O
affect	O
chronic	O
disease	O
susceptibility	O
post	O
-	O
natal	O
life	O
[	O
8	O
].	O

All	O
methods	O
were	O
carried	O
out	O
in	O
accordance	O
with	O
the	O
guidelines	O
.	O

Visfatin	O
is	O
expressed	O
in	O
bovine	O
mammary	O
epithelial	O
cells	O
,	O
lactating	O
mammary	O
gland	O
,	O
and	O
milk	O
,	O
which	O
is	O
regulated	O
by	O
the	O
cAMP	O
pathway	O
(	O
24	O
).	O

Evidence	O
shows	O
that	O
women	O
’	O
s	O
actual	O
weight	O
gain	O
during	O
pregnancy	O
is	O
strongly	O
influenced	O
by	O
personal	O
beliefs	O
and	O
healthcare	O
providers	O
’	O
advice	O
[	O
6	O
,	O
7	O
].	O

In	O
a	O
similar	O
study	O
done	O
by	O
Simpson	O
et	O
al	O
.	O

When	O
we	O
stratified	O
by	O
race	O
/	O
ethnicity	O
status	O
,	O
we	O
found	O
that	O
for	O
black	O
women	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
not	O
associated	O
with	O
significantly	O
higher	O
seasonally	O
-	O
adjusted	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
early	O
in	O
pregnancy	O
(	O
OR	O
1	O
.	O
0	O
(	O
0	O
.	O
4	O
,	O
2	O
.	O
3	O
)	O
(	O
Table	O
3	O
).	O

The	O
approach	O
parents	O
take	O
to	O
feeding	O
their	O
children	O
reflects	B
their	O
goals	O
for	O
their	O
children	O
'	O
s	O
eating	O
and	O
health	O
,	O
and	O
these	O
goals	O
are	O
influenced	O
by	O
culture	O
and	O
socioeconomic	O
status	O
(	O
82	O
).	O

Both	O
pregnancy	O
serum	O
and	O
UCB	O
plasma	O
25	O
(	O
OH	O
)	O
D	O
were	O
analysed	O
simultaneously	O
using	O
the	O
IDS	O
-	O
iSYS	O
fully	O
automated	O
immunoassay	O
system	O
with	O
chemiluminescence	O
detection	O
(	O
Immunodiagnostic	O
Systems	O
Ltd	O
.,	O
Bolton	O
,	O
UK	O
).	O

Strengths	O
and	O
limitations	O
Strengths	O
of	O
the	O
ALSPAC	O
birth	O
cohort	O
include	O
its	O
size	O
and	O
population	O
-	O
based	O
prospective	O
design	O
,	O
rich	O
information	O
on	O
numerous	O
potential	O
lifestyle	O
and	O
dietary	O
confounders	O
(	O
including	O
information	O
on	O
childhood	O
free	O
sugar	O
intake	O
and	O
parental	O
sugar	O
intake	O
outside	O
of	O
pregnancy	O
),	O
and	O
detailed	O
phenotypic	O
outcome	O
measurements	O
.	O

The	O
object	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
women	O
who	O
reported	O
taking	O
a	O
prenatal	O
vitamin	O
had	O
lower	O
risk	O
of	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
(	O
kg	O
/	O
m2	O
)	O
was	O
categorised	O
into	O
underweight	O
(<	O
18	O
.	O
5	O
),	O
normal	O
weight	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
),	O
overweight	O
(	O
25	O
.	O
0	O
–	O
29	O
.	O
9	O
)	O
and	O
obese	O
(>	O
30	O
.	O
0	O
).	O

1	O
).	O

Model	O
adjusted	O
for	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
age	O
,	O
race	O
,	O
calcium	O
,	O
iron	O
,	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
education	O
level	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
and	O
sex	O
of	O
the	O
baby	O
.	O

Handwashing	O
behavior	O
may	O
have	O
been	O
different	O
earlier	O
in	O
the	O
newborn	O
period	O
,	O
when	O
threat	O
perceptions	O
may	O
have	O
been	O
higher	O
but	O
household	O
routines	O
may	O
have	O
been	O
disrupted	O
by	O
the	O
arrival	O
of	O
the	O
new	O
baby	O
.	O

There	O
is	O
emerging	O
evidence	O
,	O
both	O
from	O
animal	O
and	O
human	O
studies	O
,	O
of	O
an	O
association	O
between	O
maternal	O
obesity	O
and	O
significantly	O
higher	O
risks	O
of	O
impaired	O
offspring	O
cognitive	O
,	O
motor	O
and	O
behavioural	O
aspects	O
of	O
neurodevelopment	O
[	O
44	O
–	O
46	O
].	O

Ongoing	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
should	O
consider	O
effect	O
modification	O
by	O
race	O
/	O
ethnicity	O
.	O

Term	O
birth	O
is	O
≥	O
37	O
weeks	O
of	O
gestation	O
,	O
late	O
preterm	O
birth	O
is	O
34	O
to	O
<	O
37	O
weeks	O
,	O
moderately	O
preterm	O
is	O
32	O
to	O
<	O
34	O
weeks	O
,	O
and	O
very	O
preterm	O
is	O
<	O
32	O
weeks	O
.	O

After	O
the	O
woman	O
gave	O
birth	O
and	O
began	O
to	O
breastfeed	O
,	O
Biskind	O
noted	O
that	O
her	O
symptoms	O
,	O
which	O
included	O
vomiting	O
,	O
abdominal	O
pain	O
,	O
hyper	O
-	O
irritability	O
,	O
and	O
muscle	O
weakness	O
,	O
began	O
to	O
dissipate	O
.	O

folate	O
,	O
vitamin	O
B6	O
and	O
B12	O
)	O
is	O
closely	O
linked	O
.	O
36	O
A	O
significant	O
weakness	O
of	O
the	O
study	O
arises	O
from	O
the	O
lack	O
of	O
measurement	O
of	O
gene	O
expression	O
at	O
different	O
stages	O
of	O
maturity	O
.	O

of	O
education	O
or	O
less	O
and	O
23	O
(	O
30	O
.	O
3	O
%)	O
had	O
11	O
yrs	O
.	O

Generalized	O
estimating	O
equation	O
models	O
were	O
used	O
to	O
evaluate	O
outcomes	O
.	O

The	O
number	O
of	O
prenatal	O
visits	O
,	O
registration	O
with	O
a	O
physician	O
early	O
in	O
pregnancy	O
and	O
the	O
level	O
of	O
nutritional	O
knowledge	O
were	O
independently	O
associated	O
with	O
the	O
use	O
of	O
folic	O
acid	O
,	O
after	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
,	O
suggesting	O
that	O
educational	O
interventions	O
could	O
play	O
an	O
important	O
role	O
in	O
promoting	O
the	O
use	O
of	O
folic	O
acid	O
supplements	O
.	O

This	O
involves	O
global	O
DNA	O
demethylation	O
and	O
changes	O
in	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNA	O
expression	O
to	O
effectively	O
‘	O
reset	O
’	O
the	O
zygote	O
epigenome	O
and	O
thus	O
genome	O
.	O

Then	O
,	O
we	O
observed	O
the	O
series	O
of	O
slices	O
apart	O
from	O
this	O
mean	O
size	O
to	O
avoid	O
overestimation	O
caused	O
by	O
counting	O
the	O
same	O
glomerulus	O
twice	O
.	O

Issued	O
by	O
the	O
March	O
of	O
Dimes	O
every	O
year	O
since	O
2008	O
,	O
the	O
Report	O
Cards	O
assign	O
a	O
letter	O
grade	O
to	O
the	O
United	O
States	O
and	O
to	O
each	O
of	O
50	O
state	O
governments	O
.	O

analyzed	O
the	O
large	O
Vaccine	O
Safety	O
Datalink	O
dataset	O
(	O
n	O
=	O
57	O
,	O
554	O
pregnant	O
women	O
in	O
the	O
United	O
States	O
)	O
to	O
assess	O
these	O
associations	O
and	O
after	O
using	O
propensity	O
score	O
to	O
minimize	O
bias	O
introduced	O
by	O
the	O
probability	O
of	O
being	O
vaccinated	O
found	O
no	B
association	O
between	O
influenza	O
vaccination	O
during	O
pregnancy	O
and	O
risk	O
of	O
SGA	O
or	O
PTB	O
[	O
26	O
].	O

A	O
deeper	O
shave	O
removal	O
was	O
performed	O
with	O
aggressive	O
electrodessication	O
of	O
the	O
base	O
to	O
minimize	O
risk	O
of	O
recurrence	O
.	O

This	O
finding	O
was	O
not	O
explained	O
solely	O
by	O
social	O
ties	O
between	O
people	O
who	O
were	O
already	O
obese	O
.	O

DISCUSSION	O
To	B
our	I
knowledge	I
this	O
is	O
the	O
first	O
African	O
trial	O
to	O
evaluate	O
the	O
effect	O
of	O
multiple	O
micronutrient	O
supplementation	O
on	O
red	O
cell	O
parameters	O
and	O
iron	O
status	O
among	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
.	O

A	O
study	O
was	O
performed	O
to	O
understand	O
the	O
mechanism	O
re	O
sponsible	O
for	O
improved	O
MS	O
after	O
early	O
weaning	O
and	O
high	O
-	O
concentrate	O
feeding	O
in	O
Angus	O
and	O
Angus	O
×	O
Simmental	O
steers	O
[	O
55	O
].	O

Although	O
earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	O
studies	O
regarding	O
the	O
association	O
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

The	O
left	O
side	O
of	O
the	O
remaining	O
brain	O
was	O
used	O
for	O
folate	O
concentration	O
measurement	O
.	O

A	O
low	O
protein	O
diet	O
during	O
pregnancy	O
provokes	O
a	O
lasting	O
shift	O
of	O
hepatic	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
throughout	O
ontogenesis	O
in	O
a	O
porcine	O
model	O
Abstract	O
Background	O
In	O
rodent	O
models	O
and	O
in	O
humans	O
the	O
impact	O
of	O
gestational	O
diets	O
on	O
the	O
offspring	O
'	O
s	O
phenotype	O
was	O
shown	O
experimentally	O
and	O
epidemiologically	O
.	O

Gene	O
specific	O
DNA	O
methylation	O
will	O
be	O
assessed	O
using	O
the	O
Qiagen	O
EpiTech	O
system	O
.	O

The	O
effect	O
is	O
characterised	O
by	O
a	O
programming	O
of	O
the	O
genome	O
that	O
leads	O
to	O
different	O
responsiveness	O
and	O
adaptability	O
of	O
the	O
gene	O
expression	O
machinery	O
to	O
chronic	O
and	O
acute	O
environmental	O
stimuli	O
,	O
i	O
.	O
e	O
.	O

35	O
±	O
26	O
.	O
13	O
nmol	O
/	O
L	O
and	O
60	O
.	O
45	O
±	O
23	O
.	O
63	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
intervention	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

It	O
was	O
a	O
review	O
that	O
covered	O
the	O
evidence	O
supporting	O
the	O
idea	O
that	O
prenatal	O
infection	O
on	O
the	O
central	O
nervous	O
system	O
may	O
increase	O
the	O
incidence	O
of	O
autism	O
spectrum	O
disorders	O
[	O
63	O
].	O

These	O
associations	O
persisted	O
after	O
adjustment	O
for	O
potential	O
confounding	O
factors	O
(	O
maternal	O
age	O
,	O
physical	O
activity	O
,	O
and	O
smoking	O
status	O
at	O
14	O
weeks	O
of	O
gestation	O
;	O
educational	O
attainment	O
;	O
season	O
of	O
blood	O
measurement	O
;	O
compliance	O
with	O
study	O
medication	O
;	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
;	O
and	O
pregnancy	O
weight	O
gain	O
).	O

Sample	O
preparation	O
and	O
two	O
dimensional	O
gel	O
electrophoresis	O
(	O
2DE	O
)	O
methodology	O
was	O
performed	O
according	O
to	O
Alexander	O
-	O
Kaufman	O
et	O
al	O
[	O
23	O
].	O

The	O
contribution	O
of	O
dietary	O
intakes	O
of	O
PUFAs	O
to	O
total	O
dietary	O
fat	O
is	O
comparable	O
to	O
other	O
Western	O
cohorts	O
[	O
55	O
].	O

For	O
example	O
,	O
the	O
effects	O
of	O
a	O
30	O
%	O
nutrient	O
restriction	O
in	O
cows	O
at	O
early	O
to	O
mid	O
-	O
gestation	O
on	O
offspring	O
(	O
steers	O
and	O
heifers	O
)	O
growth	O
and	O
adiposity	O
were	O
tested	O
in	O
Angus	O
×	O
Gelbvieh	O
[	O
153	O
].	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
an	O
increased	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypothalamus	O
,	O
and	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
the	O
eCBs	O
-	O
metabolizing	O
enzymes	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
.	O

Phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
ten	O
(	O
PTEN	O
),	O
a	O
well	O
-	O
known	O
tumor	O
suppressor	O
is	O
a	O
phosphatase	O
that	O
specifically	O
catalyzes	O
the	O
dephosphorylation	O
of	O
phosphatidylinositol	O
-	O
3	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
PIP3	O
),	O
in	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
diphosphate	O
PIP2	O
(	O
Cantley	O
and	O
Neel	O
,	O
1999	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Associations	O
between	O
infant	O
growth	O
and	O
repetitive	O
element	O
methylation	O
.	O
Covariate	O
(	O
n	O
=	O
380	O
)	O
Linear	O
regression	O
effect	O
estimate	O
(	O
95	O
%	O
CI	O
)	O
p	O
-	O
ValueMean	O
LINE	O
-	O
1	O
(	O
per	O
10	O
%)	O
9	O
.	O
7	O
(	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
)	O
0	O
.	O
01Infant	O
sex12	O
.	O
81	O
(	O
6	O
.	O
54	O
,	O
19	O
.	O
09	O
)<	O
0	O
.	O
0001White	O
maternal	O
ethnicity7	O
.	O
06	O
(	O
0	O
.	O
59	O
,	O
13	O
.	O
53	O
)	O
0	O
.	O
03Mean	O
AluYb8	O
(	O
per	O
10	O
%)	O
14	O
.	O
5	O
(	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)<	O
0	O
.	O
0001Infant	O
sex12	O
.	O
05	O
(	O
5	O
.	O
76	O
,	O
18	O
.	O
33	O
)<	O
0	O
.	O
0001White	O
maternal	O
ethnicity6	O
.	O
91	O
(	O
0	O
.	O
46	O
,	O
13	O
.	O
36	O
)	O
0	O
.	O
04All	O
models	O
were	O
also	O
adjusted	O
for	O
maternal	O
age	O
,	O
BMI	O
before	O
pregnancy	O
,	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
.	O

OVERVIEW	O
OF	O
MUSCLE	O
AND	O
FAT	O
CELL	O
GROWTH	O
IN	O
RUMINANTS	O
Skeletal	O
muscle	O
including	O
the	O
LM	O
mainly	O
consists	O
of	O
skeletal	O
muscle	O
fibres	O
(	O
myofibres	O
),	O
but	O
it	O
also	O
contains	O
fat	O
cells	O
,	O
connective	O
tissue	O
or	O
extracellular	O
matrix	O
,	O
and	O
various	O
other	O
cell	O
types	O
including	O
satellite	O
cells	O
,	O
immune	O
cells	O
and	O
blood	O
vessels	O
.	O

If	O
breastfeeding	O
is	O
not	O
possible	O
,	O
hydrolyzed	O
formulas	O
seem	O
to	O
confer	O
a	O
greater	O
protective	O
effect	O
than	O
traditional	O
formulas	O
.	O

Knowledge	O
of	O
child	O
feeding	O
has	O
largely	O
evolved	B
from	I
laboratory	O
studies	O
that	O
address	O
cause	O
and	O
effect	O
but	O
provide	O
limited	O
insight	O
on	O
the	O
usual	O
environments	O
and	O
social	O
interactions	O
surrounding	O
children	O
'	O
s	O
behavior	O
.	O

The	O
25	O
%	O
prevalence	O
rate	O
of	O
NICU	O
admissions	O
found	O
in	O
the	O
exposed	O
group	O
of	O
the	O
present	O
study	O
is	O
the	O
same	O
as	O
that	O
reported	O
in	O
a	O
recent	O
retrospective	O
chart	O
review	O
,	O
although	O
only	O
16	O
women	O
were	O
assessed	O
.	O
43	O
Our	O
results	O
also	O
suggest	O
that	O
polytherapy	O
in	O
pregnancy	O
may	O
be	O
associated	O
with	O
shorter	O
gestation	O
and	O
increased	O
rates	O
of	O
LGA	O
neonates	O
,	O
instrumental	O
deliveries	O
,	O
fetal	O
distress	O
during	O
delivery	O
,	O
NICU	O
admissions	O
and	O
neonates	O
presenting	O
with	O
PNA	O
symptoms	O
.	O

Conclusion	O
The	O
study	O
shows	O
that	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
regular	O
de	O
-	O
worming	O
is	O
a	O
low	O
-	O
cost	O
and	O
cost	O
-	O
effective	O
intervention	O
and	O
would	O
be	O
appropriate	O
for	O
population	O
-	O
based	O
introduction	O
in	O
settings	O
with	O
a	O
high	O
prevalence	O
of	O
anaemia	O
and	O
iron	O
deficiency	O
and	O
low	O
malaria	O
infection	O
rates	O
.	O

Authors	O
’	O
contributions	O
All	O
authors	O
listed	O
have	O
contributed	O
sufficiently	O
to	O
the	O
project	O
to	O
be	O
included	O
as	O
authors	O
,	O
and	O
all	O
those	O
who	O
are	O
qualified	O
to	O
be	O
authors	O
are	O
listed	O
in	O
the	O
author	O
byline	O
.	O

In	O
2007	O
,	O
44	O
%	O
of	O
mothers	O
in	O
the	O
study	O
area	O
reported	O
not	O
receiving	O
any	O
antenatal	O
care	O
in	O
the	O
third	O
trimester	O
and	O
72	O
%	O
of	O
births	O
were	O
attended	O
by	O
traditional	O
birth	O
attendants	O
[	O
14	O
].	O

In	O
2009	O
,	O
functional	O
human	O
BAT	O
was	O
identified	O
in	O
adults	O
by	O
a	O
combination	O
of	O
CT	O
scans	O
and	O
fluorodeoxyglucose	O
positron	O
emission	O
tomography	O
(	O
FDG	O
-	O
PET	O
)	O
(	O
Cypess	O
et	O
al	O
.,	O
2009	O
;	O
van	O
Marken	O
Lichtenbelt	O
et	O
al	O
.,	O
2009	O
;	O
Virtanen	O
et	O
al	O
.,	O
2009	O
).	O

In	O
May	O
2014	O
,	O
Nicaragua	O
expanded	O
influenza	O
vaccination	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
country	O
.	O

One	O
ecological	O
study	O
reported	O
a	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
but	O
could	O
not	O
specifically	O
address	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
.	O

The	O
mean	O
BMI	O
at	O
delivery	O
was	O
32	O
.	O
3	O
kg	O
m	O
−	O
2	O
.	O

Bile	O
acid	O
supplementation	O
may	O
enhance	O
fat	O
digestion	O
.	O

This	O
outcome	O
represented	B
a	O
simple	O
,	O
clinically	O
relevant	O
measure	O
of	O
composite	O
micronutrient	O
status	O
,	O
achievable	O
within	O
the	O
time	O
and	O
resource	O
constraints	O
under	O
which	O
the	O
nested	O
study	O
was	O
carried	O
out	O
.	O

Another	O
study	O
investigating	O
the	O
effect	O
of	O
a	O
paternal	O
folate	O
-	O
deficient	O
diet	O
in	O
mice	O
found	O
a	O
relationship	O
with	O
decreased	O
placental	O
weight	O
,	O
placental	O
folate	O
and	O
an	O
increased	O
expression	O
of	O
the	O
folate	O
transporter	O
folate	O
receptor	O
[	O
7	O
].	O

This	O
study	O
surprisingly	O
found	O
that	O
the	O
effect	O
of	O
intermediate	O
doses	O
of	O
EPA	O
increased	O
the	O
levels	O
of	O
AA	O
(	O
an	O
omega	O
-	O
6	O
PUFA	O
)	O
in	O
the	O
membrane	O
of	O
red	O
cells	O
,	O
whereas	O
higher	O
doses	O
of	O
EPA	O
did	O
not	O
,	O
and	O
the	O
EPA	O
-	O
induced	O
rise	O
in	O
AA	O
was	O
associated	O
with	O
a	O
clinical	O
improvement	O
.	O

Data	O
was	O
expressed	O
as	O
mean	O
±	O
SEM	O
.	O

Moreover	O
,	O
when	O
we	O
performed	O
RNA	O
FISH	O
,	O
the	O
GAS5	O
transcript	O
was	O
localized	O
almost	O
exclusively	O
in	O
the	O
syncytiotrophoblast	O
layer	O
of	O
the	O
human	O
placenta	O
and	O
colocalizes	O
GR	O
α	O
.	O

Data	O
are	O
available	O
on	O
maternal	O
vitamin	O
use	O
during	O
pregnancy	O
for	O
1051	O
cases	O
and	O
1919	O
controls	O
from	O
eight	O
geographic	O
areas	O
in	O
North	O
America	O
,	O
Europe	O
,	O
and	O
Israel	O
.	O

DNA	O
methylation	O
patterns	O
are	O
essential	O
for	O
the	O
growth	O
and	O
maintenance	O
of	O
tissue	O
-	O
specific	O
expression	O
profiles	O
in	O
different	O
cell	O
types	O
during	O
development	O
,	O
and	O
these	O
patterns	O
become	O
set	O
during	O
in	O
utero	O
development	O
(	O
Hajkova	O
et	O
al	O
.	O

One	O
of	O
the	O
highest	O
p	O
values	O
for	O
the	O
girls	O
(	O
ie	O
,	O
the	O
least	O
significant	O
correlation	O
)	O
was	O
with	O
the	O
PGF	O
,	O
and	O
the	O
highest	O
p	O
values	O
for	O
the	O
boys	O
(	O
ie	O
,	O
the	O
least	O
significant	O
correlation	O
)	O
was	O
with	O
the	O
PGM	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
prospective	O
observational	O
studies	O
,	O
reported	O
reductions	O
in	O
perinatal	O
mortality	O
(	O
stillbirth	O
and	O
early	O
neonatal	O
mortality	O
)	O
with	O
each	O
1	O
g	O
/	O
dl	O
increase	O
in	O
the	O
population	O
mean	O
haemoglobin	O
(	O
RR	O
0	O
.	O
72	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
65	O
–	O
0	O
.	O
81	O
)	O
[	O
9	O
].	O

Of	O
these	O
,	O
38	O
(	O
78	O
%)	O
returned	O
at	O
three	O
months	O
for	O
the	O
final	O
study	O
visit	O
.	O

In	O
all	O
dietary	O
patterns	O
,	O
the	O
most	O
of	O
energy	O
and	O
nutrients	O
intake	O
were	O
different	O
in	O
all	O
levels	O
of	O
dietary	O
patterns	O
adherence	O
.	O

All	O
participants	O
sat	O
still	O
for	O
at	O
least	O
5	O
minutes	O
to	O
assess	O
blood	O
pressure	O
and	O
heart	O
rate	O
at	O
rest	O
.	O

Participants	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
at	O
their	O
first	O
antenatal	O
visit	O
were	O
likely	B
to	O
have	O
increased	O
fasting	O
glucose	O
at	O
28	O
weeks	O
’	O
gestation	O
,	O
regardless	O
of	O
season	O
.	O

DNA	O
is	O
methylated	O
by	O
a	O
family	O
of	O
DNA	O
methyltransferases	O
(	O
DNMTs	O
)	O
(	O
Bestor	O
&	O
Ingram1983	O
;	O
Li	O
et	O
al	O
.	O
1992	O
,	O
1996	O
;	O
Okano	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Aapola	O
et	O
al	O
.	O
2000	O
;	O
Gowher	O
et	O
al	O
.	O
2005	O
).	O

Future	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
offspring	O
weight	O
and	O
,	O
potentially	O
,	O
analysis	O
of	O
growth	O
velocities	O
[	O
51	O
]	O
might	O
better	O
inform	O
how	O
and	O
when	O
nutrient	O
exposures	O
in	O
pregnancy	O
impact	O
growth	O
.	O

There	O
are	O
also	O
data	O
to	O
support	O
low	O
carbohydrate	O
diets	O
in	O
pregnancy	O
,	O
and	O
for	O
the	O
carbohydrate	O
to	O
be	O
of	O
low	O
glycemic	O
index	O
.	O

When	O
mercury	O
confounder	O
was	O
adjusted	O
for	O
,	O
this	O
association	O
became	O
significant	O
:	O
4	O
.	O
0	O
(	O
1	O
.	O
3	O
to	O
6	O
.	O
7	O
).	O
Mothers	O
consuming	O
greater	O
than	O
2	O
fish	O
serves	O
per	O
week	O
had	O
infants	O
with	O
the	O
greatest	O
VRM	O
scores	O
.	O
Seafood	O
intake	O
during	O
pregnancy	O
was	O
associated	O
with	O
a	O
significant	O
reduction	O
in	O
percentage	O
of	O
children	O
with	O
suboptimal	O
IQ	O
and	O
behaviour	O
test	O
scores	O
in	O
9	O
of	O
23	O
outcomes	O
.	O
Non	O
-	O
seafood	O
consumers	O
during	O
pregnancy	O
had	O
children	O
who	O
scored	O
lower	O
on	O
tests	O
of	O
verbal	O
IQ	O
at	O
8	O
years	O
:	O
OR	O
(	O
CI	O
)	O
for	O
no	O
seafood	O
=	O
1	O
.	O
48	O
(	O
1	O
.	O
16	O
–	O
1	O
.	O
90	O
);	O
some	O
seafood	O
1	O
.	O
09	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
20	O
)	O
compared	O
with	O
>	O
340	O
g	O
per	O
week	O
[	O
overall	O
trend	O
:	O
p	O
=	O
0	O
.	O
004	O
].	O
Oily	O
fish	O
consumption	O
more	O
than	O
once	O
per	O
week	O
versus	O
no	O
oily	O
fish	O
reduced	O
the	O
risk	O
of	O
hyperactivity	O
.	O
No	O
association	O
with	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
and	O
full	O
scale	O
IQ	O
,	O
however	O
,	O
total	O
fish	O
intake	O
in	O
late	O
pregnancy	O
of	O
1	O
to	O
2	O
serves	O
per	O
week	O
was	O
associated	O
with	O
having	O
a	O
child	O
with	O
higher	O
IQ	O
at	O
age	O
9	O
years	O
.	O
Higher	O
intakes	O
(	O
3	O
or	O
more	O
serves	O
per	O
week	O
)	O
did	O
not	O
show	O
a	O
statistically	O
significant	O
improvement	O
.	O
Regression	O
coefficients	O
(	O
95	O
%	O
CI	O
)	O
for	O
fish	O
consumption	O
and	O
full	O
scale	O
IQ	O
:	O
less	O
than	O
once	O
per	O
week	O
vs	O
.	O
no	O
fish	O
=	O
7	O
.	O
76	O
(	O
0	O
.	O
38	O
to	O
15	O
.	O
1	O
),	O
once	O
or	O
twice	O
per	O
week	O
vs	O
.	O
no	O
fish	O
=	O
6	O
.	O
91	O
(	O
0	O
.	O
19	O
to	O
13	O
.	O
6	O
).	O
Verbal	O
IQ	O
&	O
fish	O
consumption	O
:	O
Increase	O
of	O
7	O
.	O
32	O
(	O
0	O
.	O
26	O
to	O
14	O
.	O
4	O
)	O
with	O
fish	O
consumption	O
once	O
or	O
twice	O
per	O
week	O
.	O

Primary	O
outcomes	O
were	O
uptake	O
of	O
the	O
new	O
dietetic	O
schedule	O
(	O
process	O
)	O
and	O
requirement	O
for	O
pharmacotherapy	O
(	O
clinical	O
).	O

A	O
lack	O
of	O
vitamins	O
and	O
minerals	O
can	O
adversely	O
influence	O
the	O
newborn	O
’	O
s	O
weight	O
,	O
even	O
if	O
the	O
dietary	O
intake	O
of	O
proteins	O
and	O
energy	O
is	O
adequate	O
[	O
5	O
,	O
6	O
].	O

Some	O
of	O
the	O
best	O
mHealth	O
evidence	O
comes	O
from	O
smoking	O
cessation	O
studies	O
[	O
9	O
,	O
10	O
].	O

Alternatively	O
,	O
fructose	O
might	O
influence	O
atopic	O
immune	O
responses	O
by	O
conditioning	O
the	O
gut	O
microbiome	O
[	O
40	O
,	O
41	O
].	O

These	O
include	O
not	O
only	O
mutations	O
that	O
alter	O
the	O
function	O
of	O
gene	O
products	O
but	O
also	O
those	O
that	O
lead	O
to	O
changes	O
in	O
DNA	O
methylation	O
or	O
miRNA	O
binding	O
sites	O
.	O

Whilst	O
short	O
-	O
term	O
data	O
have	O
not	O
demonstrated	O
adverse	O
effects	O
of	O
glyburide	O
and	O
metformin	O
on	O
the	O
fetus	O
,	O
and	O
they	O
are	O
increasingly	O
being	O
used	O
in	O
pregnancy	O
,	O
there	O
remain	O
long	O
-	O
term	O
concerns	O
regarding	O
their	O
potential	O
for	O
harm	O
.	O

Immature	O
glomeruli	O
normally	B
begin	O
to	O
disappear	O
at	O
this	O
age	O
,	O
but	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
150	O
%	O
more	O
immature	O
glomeruli	O
and	O
25	O
%	O
more	O
mature	O
glomeruli	O
than	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

The	O
vitamin	O
D	O
and	O
control	O
groups	O
were	O
similar	O
regarding	O
to	O
general	O
characteristics	O
except	O
for	O
two	O
variables	O
:	O
unplanned	O
pregnancy	O
and	O
using	O
other	O
supplements	O
out	O
of	O
the	O
study	O
’	O
s	O
protocol	O
.	O

Subjects	O
were	O
enrolled	O
whose	O
mother	O
was	O
healthy	O
(	O
non	O
insulin	O
-	O
dependent	O
diabetic	O
,	O
no	O
other	O
major	O
pregnancy	O
complications	O
),	O
who	O
were	O
expected	O
to	O
have	O
a	O
singleton	O
,	O
non	O
-	O
small	O
for	O
dates	O
infant	O
,	O
and	O
had	O
been	O
admitted	O
to	O
the	O
labor	O
and	O
delivery	O
unit	O
due	O
to	O
the	O
onset	O
of	O
labor	O
or	O
were	O
admitted	O
for	O
a	O
planned	O
induction	O
or	O
c	O
-	O
section	O
delivery	O
at	O
37	O
to	O
41	O
weeks	O
gestation	O
.	O

When	O
evidence	O
for	O
associations	O
persisted	O
,	O
we	O
considered	O
other	O
factors	O
which	O
can	O
be	O
considered	O
either	O
as	O
potential	O
confounders	O
or	O
potential	O
mediators	O
of	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
outcomes	O
,	O
i	O
.	O
e	O
.	O

Priority	O
questions	O
:	O
What	O
are	O
the	O
detailed	O
mechanism	O
(	O
s	O
)	O
that	O
link	O
a	O
particular	O
exposure	O
to	O
a	O
specific	O
adverse	O
effect	O
?	O

However	O
,	O
due	O
to	O
heavy	O
clinical	O
demand	O
,	O
only	O
31	O
.	O
5	O
%	O
of	O
the	O
162	O
women	O
seen	O
after	O
the	O
change	O
in	O
practice	O
received	O
best	O
-	O
practice	O
individual	O
dietitian	O
review	O
at	O
their	O
first	O
visit	O
.	O

In	O
the	O
case	O
of	O
preterm	O
delivery	O
,	O
vitamin	O
D	O
status	O
measured	O
closer	O
to	O
the	O
delivery	O
date	O
was	O
more	O
significantly	O
associated	O
with	O
preterm	O
delivery	O
than	O
earlier	O
measures	O
[	O
26	O
].	O

However	O
,	O
in	O
the	O
present	O
study	O
,	O
renin	O
expression	O
was	O
significantly	O
higher	O
at	O
six	O
months	O
of	O
age	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
,	O
and	O
AT1r	O
expression	O
was	O
higher	O
in	O
F1	O
-	O
VitD	O
-	O
offspring	O
than	O
in	O
F1	O
-	O
SC	O
offspring	O
.	O

When	O
the	O
fetal	O
abdominal	O
circumference	O
was	O
<	O
70th	O
percentile	O
,	O
a	O
higher	O
glucose	O
threshold	O
for	O
initiating	O
insulin	O
therapy	O
did	O
not	O
result	O
in	O
an	O
increase	O
in	O
fetal	O
morbidity	O
or	O
macrosomia	O
.	O
26This	O
protocol	O
allowed	O
more	O
women	O
to	O
avoid	O
insulin	O
therapy	O
.	O

Female	O
military	O
health	O
care	O
beneficiaries	O
aged	O
18	O
-	O
45	O
years	O
who	O
first	O
presented	O
for	O
prenatal	O
care	O
at	O
Madigan	O
prior	O
to	O
14	O
weeks	O
gestation	O
were	O
eligible	O
for	O
the	O
study	O
.	O

The	O
participants	O
,	O
individuals	O
providing	O
antenatal	O
and	O
intrapartum	O
care	O
,	O
and	O
all	O
field	O
researchers	O
involved	O
in	O
data	O
collection	O
and	O
sample	O
analysis	O
were	O
blinded	O
to	O
the	O
assignment	O
to	O
the	O
intervention	O
.	O

To	O
evaluate	O
miRNA	O
expression	O
,	O
U6	O
small	O
nuclear	O
RNA	O
(	O
U6	O
snRNA	O
)	O
was	O
used	O
as	O
a	O
reference	O
gene	O
to	O
normalize	O
the	O
expression	O
of	O
miRNAs	O
.	O

Our	O
results	O
could	O
also	O
indicate	O
that	O
it	O
takes	O
time	O
for	O
changes	O
in	O
vitamin	O
D	O
metabolism	O
to	O
manifest	O
as	O
changes	O
in	O
circulating	O
25OHD	O
.	O

The	O
other	O
theory	O
is	O
that	O
undifferentiated	O
mesenchymal	O
cells	O
undergo	O
metaplastic	O
differentiation	O
in	O
the	O
setting	O
of	O
inflammation	O
or	O
hypoxia	O
.	O

In	O
rats	O
,	O
it	O
has	O
been	O
observed	O
that	O
maternal	O
vitamin	O
D	O
deficiency	O
leads	O
to	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
glomeruli	O
,	O
which	O
is	O
a	O
unique	O
and	O
important	O
effect	O
of	O
vitamin	O
D	O
restriction	O
during	O
fetal	O
development	O
[	O
13	O
].	O

Most	O
subject	O
characteristics	O
and	O
maternal	O
dietary	O
factors	O
were	O
not	O
different	O
between	O
delivery	O
mode	O
groups	O
(	O
Table	O
1	O
).	O

Among	O
the	O
proteins	O
,	O
beef	O
and	O
beans	O
—	O
both	O
sources	O
of	O
the	O
antioxidant	O
glutathione	O
—	O
showed	O
the	O
highest	O
inverse	O
effect	O
.	O

Finally	O
,	O
for	O
thyroid	O
cancer	O
patients	O
,	O
hypothyroidism	O
can	O
rise	O
the	O
maternal	O
risk	O
of	O
recurrence	O
.	O

Between	O
31	O
March	O
2011	O
when	O
the	O
first	O
potential	O
subject	O
with	O
the	O
opportunity	O
to	O
collect	O
a	O
6	O
-	O
week	O
infant	O
stool	O
sample	O
from	O
was	O
screened	O
for	O
eligibility	O
and	O
30	O
June	O
2015	O
when	O
the	O
data	O
were	O
frozen	O
for	O
this	O
analysis	O
,	O
6569	O
women	O
were	O
screened	O
for	O
eligibility	O
and	O
1334	O
were	O
eligible	O
.	O

[	O
18	O
],	O
the	O
phthalate	O
MEOHP	O
.	O

The	O
program	O
is	O
branded	O
as	O
a	O
“	O
trusted	O
friend	O
and	O
advisor	O
”	O
and	O
promotes	O
a	O
broad	O
range	O
of	O
maternal	O
and	O
child	O
health	O
behaviors	O
[	O
30	O
].	O

DEP	O
,	O
one	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
16	O
g	O
birth	O
weight	O
increase	O
using	O
LASSO	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
)	O
and	O
DMP	O
,	O
the	O
other	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
48	O
g	O
decrease	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
).	O

Sequence	O
analysis	O
Exons	O
of	O
candidate	O
genes	O
were	O
sequenced	O
for	O
wild	O
-	O
type	O
and	O
mutant	O
mice	O
,	O
as	O
well	O
as	O
parental	O
controls	O
,	O
at	O
the	O
McGill	O
University	O
and	O
Génome	O
Québec	O
Innovation	O
Centre	O
.	O

Information	O
from	O
a	O
questionnaire	O
at	O
recruitment	O
and	O
from	O
the	O
obstetric	O
records	O
was	O
used	O
to	O
classify	O
women	O
into	O
four	O
mutually	O
exclusive	O
categories	O
:	O
no	O
evidence	O
of	O
glycosuria	O
or	O
diabetes	O
,	O
existing	O
diabetes	O
mellitus	O
before	O
the	O
pregnancy	O
,	O
gestational	O
diabetes	O
and	O
persistent	O
glycosuria	O
during	O
pregnancy	O
.	O

No	O
prior	O
studies	O
have	O
specifically	O
examined	O
impacts	O
of	O
maternal	O
intake	O
of	O
sweets	O
or	O
soft	O
drinks	O
in	O
pregnancy	O
on	O
offspring	O
weight	O
parameters	O
.	O

Caption	O
(	O
FIG	O
)	O
Maternal	O
obesity	O
has	O
been	O
associated	O
with	O
shorter	O
duration	O
of	O
breastfeeding	O
.	O

A	O
study	O
in	O
human	O
subjects	O
involved	O
the	O
administration	O
of	O
100	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
day	O
(	O
2	O
.	O
5	O
mg	O
/	O
day	O
)	O
throughout	O
pregnancy	O
to	O
hypoparathyroid	O
women	O
to	O
maintain	O
serum	O
calcium	O
with	O
no	O
fatal	O
outcome	O
.	O

These	O
functional	O
and	O
behavioral	O
changes	O
may	O
contribute	O
to	O
the	O
signs	O
and	O
symptoms	O
of	O
autism	O
[	O
27	O
].	O

Furthermore	O
,	O
the	O
dietary	O
modifications	O
led	O
to	O
regulation	O
of	O
the	O
'	O
Wnt	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
involved	O
in	O
various	O
aspects	O
of	O
embryogenesis	O
,	O
including	O
cell	O
differentiation	O
and	O
cell	O
proliferation	O
[	O
38	O
].	O

Another	O
limitation	O
is	O
that	O
data	O
on	O
physical	O
activity	O
during	O
pregnancy	O
was	O
only	O
available	O
for	O
a	O
subset	O
of	O
the	O
women	O
and	O
was	O
therefore	B
not	O
used	O
.	O

After	O
birth	O
,	O
offspring	O
were	O
further	O
challenged	O
by	O
a	O
diet	O
that	O
was	O
either	O
standard	O
rat	O
chow	O
or	O
high	O
in	O
fat	O
.	O

The	O
DOHaD	O
hypothesis	O
evolved	O
from	O
Barker	O
’	O
s	O
“	O
thrifty	O
phenotype	O
”	O
hypothesis	O
originally	O
proposed	O
over	O
25	O
years	O
ago	O
(	O
reviewed	O
in	O
Barker2007	O
),	O
and	O
was	O
formed	O
“	O
to	O
recognise	B
….	O
the	O
concept	O
that	O
the	O
early	O
life	O
environment	O
has	O
widespread	O
consequences	O
for	O
later	O
health	O
”	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

Overall	O
,	O
the	O
Ministry	O
of	O
Women	O
and	O
Child	O
Development	O
has	O
been	O
given	O
the	O
responsibility	O
to	O
coordinate	O
monitoring	O
at	O
different	O
levels	O
(	O
5	O
).	O

Therefore	O
,	O
we	O
analyzed	O
data	O
from	O
125	O
women	O
in	O
each	O
arm	O
.	O

Maternal	O
and	O
newborn	O
data	O
Maternal	O
data	O
were	O
obtained	O
from	O
a	O
self	O
-	O
administered	O
baseline	O
questionnaire	O
,	O
filled	O
in	O
after	O
delivery	O
,	O
and	O
from	O
medical	O
records	O
.	O

Gestational	O
age	O
at	O
delivery	O
and	O
data	O
collection	O
was	O
determined	O
by	O
routine	O
ultrasound	O
in	O
the	O
second	O
trimester	O
,	O
but	O
gestational	O
age	O
at	O
inclusion	O
was	O
based	O
on	O
the	O
date	O
of	O
the	O
last	O
menstrual	O
period	O
.	O

The	O
pathophysiological	O
mechanisms	O
underlying	O
these	O
consistently	B
observed	O
associations	O
of	O
short	O
sleep	O
duration	O
,	O
sleep	O
-	O
related	O
breathing	O
disorders	O
,	O
including	O
snoring	O
,	O
with	O
altered	O
glucose	O
metabolism	O
and	O
diabetes	O
are	O
likely	B
to	O
be	O
multifactorial	O
[	O
2	O
,	O
43	O
,	O
44	O
].	O

Handwashing	O
with	O
soap	O
was	O
significantly	O
higher	O
before	O
breastfeeding	O
and	O
after	O
fecal	O
contact	O
among	O
intervention	O
mothers	O
than	O
among	O
controls	O
;	O
however	O
,	O
washing	O
with	O
soap	O
after	O
fecal	O
contact	O
was	O
less	O
common	O
than	O
the	O
prevalence	O
of	O
this	O
behavior	O
observed	O
among	O
mothers	O
of	O
young	O
children	O
in	O
Bangladesh	O
and	O
elsewhere	O
,	O
underscoring	O
the	O
substantial	O
barriers	O
to	O
handwashing	O
faced	O
by	O
mothers	O
of	O
neonates	O
[	O
21	O
].	O

Older	O
,	O
white	O
,	O
lean	O
and	O
better	O
educated	O
women	O
were	O
more	O
likely	B
to	O
report	O
PNV	O
use	O
(	O
Table	O
1	O
).	O

In	O
mothers	O
,	O
sensitisation	O
to	O
a	O
house	O
dust	O
mite	O
mixture	O
including	O
Dermatophagoides	O
farinae	O
,	O
as	O
well	O
as	O
German	O
cockroach	O
,	O
mould	O
mixture	O
,	O
cat	O
and	O
dog	O
dander	O
,	O
maize	O
pollen	O
,	O
Bermuda	O
grass	O
and	O
Quercus	O
robur	O
(	O
English	O
oak	O
),	O
Eucalyptus	O
,	O
Cypressus	O
arizonica	O
(	O
Arizona	O
cypress	O
),	O
Platanus	O
hybrida	O
(	O
London	O
plane	O
)	O
and	O
Acacia	O
trees	O
are	O
measured	O
.	O

For	O
girls	O
,	O
change	O
in	O
height	O
at	O
age	O
5	O
–	O
0	O
was	O
correlated	O
with	O
the	O
height	O
of	O
the	O
mother	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
and	O
father	O
,	O
p	O
=	O
0	O
.	O
0003	O
.	O

Fetal	O
Vitamin	O
D	O
concentrations	O
are	O
mainly	B
dependent	O
on	O
maternal	O
concentration	O
,	O
and	O
maternal	O
deficiency	O
may	O
lead	O
to	O
adverse	O
outcomes	O
in	O
offspring	O
.	O

AT1r	O
expression	O
was	O
significantly	O
higher	O
at	O
6	O
months	O
of	O
age	O
than	O
at	O
weaning	O
only	O
in	O
F1	O
-	O
VitD	O
-	O
offspring	O
(	O
P	O
=	O
0	O
.	O
0007	O
,	O
Fig	O
.	O

A	O
second	O
aim	O
was	O
to	O
determine	O
if	O
the	O
concentration	O
of	O
cathelicidin	O
and	O
vitamin	O
D	O
correlate	O
with	O
the	O
number	O
of	O
infections	O
a	O
child	O
experiences	O
during	O
childhood	O
and	O
as	O
a	O
function	O
of	O
age	O
.	O

They	O
drink	O
more	O
water	O
and	O
eat	O
more	O
foods	O
per	O
unit	O
of	O
body	O
weight	O
than	O
adults	O
and	O
will	O
therefore	O
ingest	O
more	O
toxins	O
from	O
well	O
water	O
and	O
agriculturally	O
treated	O
foods	O
[	O
33	O
,	O
34	O
].	O

Dose	O
-	O
Response	O
Effects	O
of	O
the	O
Text4baby	O
Mobile	O
Health	O
Program	O
:	O
Randomized	O
Controlled	O
Trial	O
Abstract	O
Background	O
Mobile	O
health	O
(	O
mHealth	O
)	O
is	O
growing	O
rapidly	O
,	O
but	O
more	O
studies	O
are	O
needed	O
on	O
how	O
to	O
optimize	O
programs	O
,	O
including	O
optimal	O
timing	O
of	O
messaging	O
,	O
dose	O
of	O
exposure	O
,	O
and	O
value	O
of	O
interactive	O
features	O
.	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

Household	O
pets	O
were	O
assessed	O
during	O
pregnancy	O
and	O
serum	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
)	O
in	O
cord	O
blood	O
was	O
used	O
as	O
the	O
measure	O
of	O
vitamin	O
D	O
and	O
a	O
marker	O
of	O
maternal	O
level	O
.	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Author	O
'	O
s	O
manuscript	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Reviewer	O
comments	O
PubMed	O
Central	O
:	O

These	O
metabolites	O
were	O
analyzed	O
using	O
commercial	O
kits	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
a	O
Hitachi	O
737	O
Automatic	O
Analyzer	O
(	O
Hitachi	O
Ltd	O
,	O
Tokyo	O
,	O
Japan	O
).	O

also	O
did	O
not	O
find	O
an	O
association	O
when	O
analyzing	O
retrospective	O
data	O
by	O
trimester	O
of	O
vaccination	O
and	O
applying	O
propensity	O
score	O
to	O
account	B
for	I
the	O
probability	O
of	O
vaccination	O
;	O
however	O
,	O
this	O
study	O
was	O
performed	O
during	O
the	O
2009	O
pandemic	O
so	B
may	O
not	O
be	O
directly	O
comparable	O
[	O
29	O
].	O

We	O
encouraged	O
families	O
to	O
bring	O
their	O
children	O
to	O
the	O
study	O
hospital	O
for	O
any	O
illness	O
for	O
which	O
quality	O
treatment	O
was	O
offered	O
free	O
of	O
charge	O
.	O

Mining	O
in	O
the	O
area	O
had	O
mostly	O
ceased	O
by	O
the	O
mid	O
-	O
1960s	O
.	O

Logistic	O
regression	O
was	O
used	O
to	O
estimate	O
odds	O
ratios	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
for	O
the	O
association	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
the	O
risk	O
of	O
PTB	O
.	O

Other	O
Allergens	O
Avoidance	O
of	O
allergens	O
(	O
pets	O
,	O
house	O
dust	O
,	O
contact	O
allergens	O
,	O
drugs	O
)	O
is	O
not	O
recommended	O
except	O
when	O
sensitization	O
has	O
already	O
been	O
diagnosed	O
.	O

At	O
birth	O
(	O
Figures	O
4and5	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g004	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Number	O
of	O
developing	O
immature	O
and	O
mature	O
glomeruli	O
at	O
birth	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

VD	O
serum	O
levels	O
are	O
inversely	O
proportional	O
to	O
blood	O
pressure	O
,	O
lipid	O
levels	O
,	O
insulin	O
resistance	O
and	O
metabolic	O
syndrome	O
symptoms	O
in	O
PCOS	O
patients	O
[	O
27	O
,	O
28	O
,	O
29	O
,	O
30	O
].	O
Figure	O
2shows	O
how	O
VD	O
deficiency	O
,	O
together	O
with	O
obesity	O
,	O
may	O
increase	O
insulin	O
resistance	O
and	O
deplete	O
glucose	O
transport	O
through	O
cellular	O
walls	O
—	O
VD	O
stimulates	O
insulin	O
receptor	O
expression	O
and	O
insulin	O
secretion	O
[	O
31	O
].	O

The	O
same	O
was	O
seen	O
for	O
the	O
father	O
and	O
his	O
mother	O
(	O
p	O
=	O
0	O
.	O
008	O
).	O

DNMT1	O
,	O
the	O
maintenance	O
DNMT	O
,	O
preferentially	O
methylates	O
hemimethylated	O
DNA	O
and	O
thus	O
maintains	O
DNA	O
methylation	O
following	O
DNA	O
replication	O
.	O

Vitamin	O
D	O
regulates	O
calcium	O
levels	O
and	O
plays	O
a	O
key	O
role	O
in	O
craniofacial	O
development	O
and	O
the	O
maintenance	O
of	O
good	O
oral	O
health	O
.	O

In	O
many	O
high	O
-	O
income	O
countries	O
and	O
those	O
with	O
emerging	O
economies	O
,	O
there	O
is	O
evidence	O
of	O
an	O
increase	O
in	O
late	O
preterm	O
deliveries	O
due	O
to	O
elective	O
inductions	O
and	O
caesareans	O
without	O
clear	O
medical	O
indication	O
[	O
38	O
].	O

Raw	O
data	O
are	O
captured	O
and	O
saved	O
in	O
password	O
protected	O
Microsoft	O
Access	O
documents	O
with	O
passwords	O
known	O
only	O
to	O
the	O
operator	O
responsible	O
for	O
data	O
imputing	O
and	O
the	O
principal	O
investigators	O
.	O

Thus	B
,	O
'	O
mTOR	O
signaling	O
'	O
is	O
involved	O
in	O
regulating	O
individual	O
cell	O
growth	O
,	O
growth	O
performance	O
,	O
and	O
developmental	O
processes	O
[	O
33	O
,	O
34	O
].	O

Conclusion	O
Our	O
findings	O
raise	O
a	O
possibility	O
that	O
adult	O
women	O
with	O
a	O
high	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
or	O
omega	O
-	O
6	O
PUFA	O
and	O
vitamin	O
D	O
have	O
a	O
lower	O
rate	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

In	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
elderly	O
Danish	O
men	O
and	O
women	O
,	O
investigators	O
noted	O
that	O
self	O
-	O
reported	O
snoring	O
was	O
associated	O
with	O
abnormal	O
glucose	O
tolerance	O
test	O
results	O
after	O
control	O
for	O
confounding	O
factors	O
[	O
36	O
].	O

They	O
included	O
the	O
core	O
research	O
villages	O
of	O
the	O
Keneba	O
,	O
Kanton	O
Kunda	O
and	O
Manduar	O
and	O
9	O
of	O
the	O
villages	O
to	O
the	O
east	O
and	O
west	O
of	O
Keneba	O
.	O

Significantly	O
lower	O
serum	O
testosterone	O
concentration	O
is	O
associated	O
with	O
lower	O
BMD	O
measured	O
densitometrically	O
in	O
the	O
lumbar	O
spine	O
and	O
iliac	O
bone	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

If	O
1	O
parent	O
is	O
allergic	O
,	O
the	O
risk	O
increases	O
to	O
30	O
%,	O
and	O
if	O
both	O
are	O
allergic	O
,	O
the	O
risk	O
is	O
greater	O
than	O
60	O
%,	O
especially	O
for	O
developing	O
the	O
same	O
organ	O
-	O
specific	O
symptoms	O
[	O
54	O
].	O

Similarly	O
,	O
exposure	O
to	O
asbestos	O
70	O
years	O
prior	O
to	O
the	O
development	O
of	O
mesothelioma	O
[	O
4	O
],	O
suggests	O
a	O
“	O
one	O
insult	O
,	O
co	O
-	O
carcinogenic	O
model	O
”	O
of	O
cancer	O
development	O
[	O
5	O
].	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
global	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
phenotype	O
(	O
s	O
);	O
(	O
2	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
size	O
and	O
nature	O
of	O
cohort	O
,	O
type	O
of	O
sample	O
analyzed	O
,	O
use	O
of	O
case	O
controls	O
,	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
,	O
validation	O
in	O
independent	O
cohorts	O
);	O
or	O
(	O
3	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

At	O
present	O
a	O
supplementation	O
program	O
is	O
the	O
most	B
feasible	B
method	O
for	O
addressing	O
iron	O
and	O
folate	O
deficiencies	O
in	O
Viet	O
Nam	O
.	O

We	O
found	O
that	O
among	O
the	O
subgroup	O
of	O
high	O
-	O
exposure	O
participants	O
,	O
text4baby	O
had	O
a	O
positive	O
effect	O
on	O
reducing	O
alcohol	O
use	O
behavior	O
of	O
pregnant	O
and	O
postpartum	O
women	O
.	O

The	O
associations	O
of	O
other	O
maternal	O
dietary	O
factors	O
with	O
specific	O
infant	O
gut	O
microbes	O
were	O
also	O
somewhat	O
unexpected	O
,	O
namely	O
for	O
red	O
and	O
processed	O
meat	O
and	O
for	O
fruit	O
consumption	O
.	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

Smith	O
and	O
Johnson	O
[	O
57	O
]	O
suggested	O
that	O
the	O
glucose	O
contribution	O
to	O
fat	O
synthesis	O
decreases	O
as	O
cattle	O
become	O
fatter	O
,	O
whereas	O
acetate	O
use	O
increases	O
,	O
especially	O
in	O
the	O
IMF	O
area	O
.	O

Serum	O
from	O
mother	O
—	O
cord	O
pairs	O
was	O
collected	O
and	O
frozen	O
for	O
later	O
measurement	O
of	O
25	O
(	O
OH	O
)	O
D	O
.	O
Examinations	O
of	O
infant	O
lung	O
function	O
were	O
performed	O
at	O
6	O
months	O
of	O
age	O
.	O

In	O
addition	O
to	O
associations	O
with	O
25	O
(	O
OH	O
)	O
D	O
,	O
rs2282679	O
in	O
GC	O
has	O
also	O
been	O
associated	O
with	O
serum	O
VDP	O
concentrations	O
,	O
with	O
carriers	O
of	O
the	O
low	O
-	O
frequency	O
C	O
allele	O
having	O
reduced	O
concentrations	O
of	O
VDP	O
and	O
25	O
(	O
OH	O
)	O
D	O
(	O
8	O
).	O

For	B
this	I
reason	I
,	O
preventive	O
interventions	O
may	O
be	O
most	B
effective	O
during	O
pregnancy	O
and	O
postpartum	O
,	O
when	O
women	O
are	O
highly	O
motivated	O
to	O
change	O
for	O
the	O
benefit	O
of	O
their	O
children	O
.	O

This	O
study	O
is	O
novel	O
due	O
to	O
the	O
comprehensive	O
set	O
of	O
nutrition	O
related	O
data	O
and	O
indicators	O
of	O
maternal	O
and	O
infant	O
health	O
being	O
obtained	O
in	O
a	O
South	O
African	O
setting	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Maternal	O
characteristics	O
in	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

We	O
selected	O
infants	O
considered	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
;	O
<	O
10th	O
percentile	O
of	O
birth	O
weight	O
)	O
and	O
matched	O
non	O
-	O
SGA	O
infants	O
to	O
these	O
for	O
infant	O
sex	O
,	O
maternal	O
age	O
(±	O
3	O
years	O
),	O
and	O
gestational	O
age	O
(±	O
2	O
days	O
).	O

The	O
latter	O
exposure	O
was	O
not	O
associated	O
with	O
any	O
outcome	O
(	O
data	O
not	O
shown	O
).	O

Among	O
all	O
the	O
predicted	O
miRNAs	O
,	O
4	O
miRNAs	O
targeting	O
GR	O
were	O
quantitated	O
by	O
real	O
-	O
time	O
PCR	O
and	O
miRNA	O
-	O
124a	O
,	O
which	O
has	O
been	O
identified	O
to	O
target	O
GR	O
3	O
′	O
UTR	O
[	O
2	O
],[	O
3	O
],	O
was	O
more	O
highly	O
expressed	O
in	O
betaine	O
-	O
exposed	O
neonatal	O
livers	O
.	O

nausea	O
&	O
vomiting	O
in	O
intervention	O
clusters	O
and	O
will	O
be	O
cost	O
-	O
effective	O
in	O
reducing	O
neonatal	O
mortality	O
in	O
intervention	O
clusters	O
.	O

In	O
this	O
study	O
,	O
infants	O
with	O
low	O
25	O
(	O
OH	O
)	O
D	O
had	O
higher	O
Rrs	O
but	O
similar	O
VmaxFRC	O
,	O
which	O
implies	B
that	O
low	O
perinatal	O
vitamin	O
D	O
levels	O
might	O
be	O
associated	O
with	O
a	O
higher	O
resistance	O
of	O
the	O
extrathoracic	O
airway	O
.	O

For	O
example	O
,	O
it	O
is	O
surprising	O
that	O
higher	O
maternal	O
fruit	O
intake	O
is	O
associated	O
with	O
an	O
increased	O
probability	B
of	O
an	O
infant	O
delivered	O
vaginally	O
belonging	O
to	O
cluster	O
2	O
,	O
in	O
which	O
the	O
genera	O
Bifidobacterium	O
and	O
Bacteroides	O
are	O
underrepresented	O
and	O
the	O
family	O
Clostridiaceae	O
is	O
overrepresented	O
compared	O
to	O
the	O
other	O
two	O
clusters	O
.	O

Methods	O
The	O
methods	O
and	O
primary	O
clinical	O
findings	O
of	O
the	O
LIMIT	O
randomised	O
trial	O
have	O
been	O
published	O
[	O
21	O
–	O
23	O
],	O
with	O
the	O
trial	O
registered	O
on	O
the	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

Therefore	O
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
is	O
not	O
infrequent	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
the	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

For	O
every	O
5	O
-	O
unit	O
increase	O
in	O
maternal	O
BMI	O
,	O
infants	O
had	O
a	O
1	O
.	O
2	O
greater	O
odds	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
1	O
,	O
1	O
.	O
4	O
)	O
of	O
vitamin	O
D	O
deficiency	O
(	O
Table	O
2	O
).	O

Just	O
as	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
people	O
with	O
HIV	O
/	O
AIDS	O
to	O
remain	O
untreated	O
because	O
they	O
live	O
in	O
poor	O
countries	O
,	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
women	O
to	O
die	O
while	O
giving	O
birth	O
.	O

However	O
,	O
the	O
literature	O
remains	O
inconclusive	O
on	O
the	O
role	O
of	O
dietary	O
factors	O
in	O
the	O
development	O
of	O
this	O
disease	O
.	O

The	O
contents	O
were	O
resuspended	O
in	O
100	O
µL	O
of	O
mobile	O
phase	O
(	O
80	O
%	O
methanol	O
and	O
20	O
%	O
water	O
)	O
and	O
transferred	O
into	O
high	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
injector	O
vials	O
.	O

For	O
busy	O
new	O
mothers	O
to	O
comply	O
with	O
handwashing	O
at	O
all	O
the	O
recommended	O
times	O
may	O
have	O
been	O
extremely	O
difficult	O
.	O

Introduction	O
In	O
2013	O
,	O
an	O
estimated	O
2	O
.	O
8	O
million	O
deaths	O
occurred	O
in	O
the	O
neonatal	O
period	O
globally	O
[	O
1	O
].	O

Demographic	O
information	O
was	O
collected	O
via	O
standardized	O
questions	O
administered	O
by	O
trained	O
research	O
assistants	O
as	O
described	O
in	O
more	O
detail	O
elsewhere	O
[	O
34	O
]	O
(	O
Table1	O
).	O

All	O
supplement	O
use	O
,	O
as	O
well	O
as	O
food	O
cravings	O
and	O
aversions	O
,	O
are	O
additionally	O
recorded	O
daily	O
by	O
participants	O
on	O
a	O
calendar	O
.	O

Rodents	O
for	O
instance	O
have	O
short	O
reproductive	O
cycles	O
closely	O
linked	O
with	O
circadian	O
rhythms	O
,	O
and	O
do	O
not	O
experience	O
menses	O
or	O
true	O
“	O
menopause	O
”	O
as	B
a	O
result	O
of	O
follicular	O
depletion	O
as	O
typically	O
observed	O
in	O
humans	O
,	O
although	O
follicular	O
depletion	O
does	O
occur	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
any	O
of	O
the	O
baseline	O
characteristics	O
between	O
the	O
groups	O
(	O
table	O
1	O
),	O
including	O
reported	O
sun	O
exposure	O
.	O

For	O
a	O
description	O
of	O
placental	O
tissue	O
use	O
,	O
DNA	O
extraction	O
,	O
and	O
DNA	O
purification	O
procedures	O
,	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
).	O

BMI	O
was	O
calculated	O
as	O
weight	O
(	O
kg	O
)/	O
height2	O
(	O
m2	O
).	O

Higher	O
endocannabinoid	O
levels	O
as	B
a	O
result	O
of	O
a	O
lower	O
expression	O
of	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
FAAH	O
and	O
MAGL	O
in	O
liver	O
can	O
be	O
associated	O
with	O
alterations	O
in	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Dinh	O
et	O
al	O
.,	O
2002	O
;	O
Osei	O
-	O
Hyiaman	O
et	O
al	O
.,	O
2005	O
;	O
Di	O
Marzo	O
and	O
MacCarrone	O
,	O
2008	O
),	O
due	O
to	O
the	O
fact	O
that	O
both	O
eCBs	O
anandamide	O
(	O
AEA	O
)	O
and	O
2	O
-	O
AG	O
can	O
inhibit	O
the	O
gene	O
expression	O
of	O
apolipoprotein	O
A1	O
,	O
the	O
primary	O
protein	O
component	O
of	O
HDL	O
,	O
through	O
the	O
activation	O
of	O
CB1	O
receptors	O
in	O
hepatocytes	O
(	O
Haas	O
et	O
al	O
.,	O
2012	O
).	O

Objective	O
The	O
study	O
aims	O
were	O
to	O
evaluate	O
(	O
1	O
)	O
treatment	O
effects	O
and	O
(	O
2	O
)	O
dose	O
-	O
response	O
effects	O
of	O
text4baby	O
on	O
behavioral	O
outcomes	O
compared	O
to	O
control	O
(	O
no	O
text4baby	O
)	O
condition	O
.	O

Methods	O
We	O
conducted	O
a	O
follow	O
up	O
study	O
of	O
infants	O
born	O
to	O
women	O
who	O
participated	O
in	O
the	O
LIMIT	O
trial	O
during	O
pregnancy	O
.	O

Anaemia	O
was	O
less	O
frequent	O
in	O
the	O
MMN	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
more	O
frequent	O
in	O
older	O
women	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
there	O
was	O
no	O
significant	O
interaction	O
between	O
age	O
and	O
intervention	O
group	O
.	O

The	O
calendar	O
and	O
symptoms	O
are	O
explained	O
to	O
the	O
mother	O
at	O
birth	O
and	O
each	O
postnatal	O
visit	O
up	O
to	O
phase	O
7	O
,	O
whereby	O
each	O
new	O
section	O
of	O
the	O
calendar	O
is	O
handed	O
to	O
the	O
mother	O
for	O
return	O
at	O
the	O
next	O
visit	O
.	O

Review	O
of	O
published	O
literature	O
regarding	O
this	O
relationship	O
revealed	O
several	O
relevant	O
studies	O
to	O
ours	O
.	O

Maternal	O
undernutrition	O
Fetal	O
growth	O
restriction	O
as	B
a	O
consequence	B
of	O
impaired	O
intrauterine	O
conditions	O
can	O
be	O
interpreted	B
as	I
part	O
of	O
a	O
life	O
history	O
strategy	B
in	O
which	O
the	O
organism	O
anticipates	O
a	O
shorter	O
life	O
because	B
of	O
a	O
higher	O
risk	O
of	O
extrinsic	O
mortality	O
,	O
and	O
therefore	B
invests	O
less	O
into	O
growth	O
but	O
accelerates	O
maturation	O
to	O
ensure	O
reproductive	O
fitness	O
[	O
10	O
],[	O
36	O
],[	O
39	O
]–[	O
41	O
].	O

The	O
ratio	O
Tpef	O
/	O
Te	O
,	O
the	O
resistance	O
of	O
the	O
respiratory	O
system	O
and	O
the	O
flow	O
of	O
tidal	O
forced	O
expiration	O
are	O
related	O
to	O
respiratory	O
function	O
in	O
infants	O
with	O
recurrent	O
wheezing	O
,	O
asthma	O
,	O
and	O
bronchiolitis	O
.	O

Further	O
study	O
is	O
warranted	O
to	O
clarify	O
how	O
stress	O
intensity	O
affects	O
animal	O
performance	O
and	O
fat	O
deposition	O
.	O

We	O
therefore	B
adjusted	O
additionally	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
(	O
self	O
-	O
reported	O
),	O
gestational	O
age	O
at	O
delivery	O
,	O
birthweight	O
,	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
(	O
all	O
abstracted	O
from	O
obstetric	O
records	O
)	O
and	O
child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
(	O
based	O
on	O
measured	O
height	O
and	O
weight	O
at	O
clinic	O
)	O
(	O
see	O
supplementary	O
figure	O
E1	O
showing	O
a	O
directed	O
acyclic	O
graph	O
).	O

As	B
a	O
result	O
of	O
these	O
findings	O
,	O
it	O
may	O
be	O
advantageous	O
for	O
primary	O
care	O
providers	O
(	O
including	O
dentists	O
and	O
physicians	O
)	O
to	O
consider	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
when	O
assessing	O
the	O
child	O
’	O
s	O
overall	O
health	O
.	O

In	O
fact	O
,	O
adaptations	O
of	O
the	O
fetus	O
to	O
the	O
inadequate	O
intrauterine	O
environment	O
promote	O
alterations	O
in	O
tissue	O
development	O
and	O
function	O
and	O
can	O
result	O
in	O
increased	O
susceptibility	O
to	O
chronic	O
diseases	O
in	O
adulthood	O
[	O
4	O
,	O
5	O
].	O

These	O
can	O
cause	O
vitamin	O
D	O
deficiency	O
in	O
mothers	O
’	O
milk	O
as	O
the	O
only	O
source	O
of	O
vitamin	O
D	O
for	O
babies	O
.	O
6	O
There	O
are	O
evidences	O
showing	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
keeping	O
normal	O
glucose	O
homeostasis	O
.	O
7	O
-	O
10Resistance	O
to	O
insulin	O
and	O
destruction	O
of	O
insulin	O
secretion	O
in	O
human	O
and	O
animal	O
models	O
has	O
considerably	O
been	O
related	O
to	O
vitamin	O
D	O
deficiency	O
.	O

It	O
is	O
a	O
global	O
trend	O
that	O
is	O
observed	O
in	O
all	O
age	O
groups	O
.	O

The	O
weights	O
of	O
the	O
individual	O
fat	O
depots	O
were	O
used	O
to	O
determine	O
total	O
body	O
fat	O
mass	O
.	O

We	O
aimed	O
to	O
determine	O
if	O
exposure	O
to	O
winter	O
and	O
low	O
maternal	O
25	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
)	O
in	O
early	O
pregnancy	O
were	O
associated	O
with	O
maternal	O
glucose	O
metabolism	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
was	O
calculated	O
using	O
the	O
area	O
under	O
the	O
curve	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
values	O
from	O
pregnancy	O
visits	O
3	O
–	O
7	O
.	O

Level	O
of	O
nutritional	O
knowledge	O
was	O
associated	O
with	O
the	O
use	O
of	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
age	O
,	O
area	O
of	O
residence	O
and	O
level	O
of	O
education	O
,	O
which	O
could	O
suggest	O
that	O
the	O
decision	O
to	O
use	O
them	O
depends	O
on	O
other	O
factors	O
,	O
such	O
as	O
attitudes	O
towards	O
pregnancy	O
or	O
beliefs	O
about	O
the	O
importance	O
of	O
vitamins	O
during	O
pregnancy	O
,	O
areas	O
that	O
warrant	O
further	O
study	O
.	O

Birth	O
Weight0	O
.	O
0070	O
.	O
003	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
013	O
)	O
0	O
.	O
013	O
Confounding	O
factors	O
(	O
prematurity	O
,	O
birth	O
weight	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
)	O
were	O
included	O
in	O
the	O
same	O
regression	O
model	O
.	O

However	O
,	O
the	O
situation	O
is	O
often	B
not	O
as	O
straightforward	O
as	O
this	O
.	O

Current	O
evidence	O
for	O
putative	B
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
rodent	O
models	O
.	O

This	O
is	O
a	O
surprisingly	O
high	O
proportion	O
,	O
especially	O
when	O
there	O
is	O
no	O
strong	O
recommendation	O
for	O
the	O
use	O
of	O
multivitamins	O
in	O
Romania	O
or	O
internationally	O
.	O

(	O
2013	O
)*/†	O
Yan	O
et	O
al	O
.	O

Cardiac	O
glycosides	O
in	O
the	O
venom	O
are	O
thought	O
to	O
inhibit	O
proteins	O
that	O
promote	O
cancer	O
cell	O
growth	O
,	O
thereby	O
causing	O
cancer	O
cell	O
death	O
.	O

However	O
,	O
more	O
GDM	O
mothers	O
were	O
vitamin	O
D	O
deficient	O
at	O
the	O
delivery	O
compared	O
with	O
non	O
-	O
GDM	O
mothers	O
[	O
7	O
.	O
4	O
%	O
(	O
6	O
/	O
81	O
)	O
vs	O
2	O
.	O
8	O
%	O
(	O
18	O
/	O
642	O
)	O
(	O
P	O
=	O
0	O
.	O
042	O
)].	O

For	O
the	B
time	I
being	I
,	O
we	O
know	O
that	O
vitamin	O
D	O
exists	O
in	O
two	O
forms	O
:	O
vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
D3	O
(	O
cholecalciferol	O
).	O

Bodnar	O
et	O
al	O
.	O
8conducted	O
a	O
case	O
–	O
control	O
study	O
to	O
examine	O
the	O
association	O
between	O
vitamin	O
D	O
levels	O
,	O
race	O
and	O
SGA	O
.	O

Social	O
and	O
racial	O
disparities	O
in	O
preterm	O
birth	O
rates	O
are	O
a	O
major	O
issue	O
,	O
yet	O
remain	O
poorly	O
understood	O
.	O

The	O
only	O
exclusion	O
criterion	O
was	O
pregnancy	O
exceeding	O
16	O
gestational	O
weeks	O
at	O
inclusion	O
.	O

The	O
adjusted	O
regression	O
is	O
the	O
correlation	O
between	O
the	O
phenotypes	O
.	O

To	O
this	O
date	O
there	O
has	O
been	O
some	O
contradicting	O
evidence	O
as	O
to	O
the	O
role	O
of	O
these	O
polymorphisms	O
in	O
fetal	O
outcomes	O
[	O
17	O
–	O
19	O
].	O

Weaning	O
age	O
Weaning	O
age	O
is	O
known	O
to	O
affect	O
IMF	O
deposition	O
and	O
MS	O
in	O
beef	O
.	O

As	B
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
are	O
related	O
to	O
preeclampsia	O
;	O
these	O
results	O
are	O
consistent	O
with	O
the	O
current	O
findings	O
.	O

Details	O
of	O
study	O
participation	O
are	O
shown	O
inFigure	O
1	O
.	O

PubMed	O
Central	O
:	O

The	O
speculative	O
negative	O
role	O
of	O
fluctuations	O
is	O
vitamin	O
D	O
needs	O
to	O
be	O
considered	O
with	O
caution	O
until	O
further	O
evidence	O
is	O
available	O
.	O

Materials	O
and	O
methods	O
Cross	O
-	O
sectional	O
study	O
of	O
76	O
pregnant	O
women	O
with	O
GDM	O
referred	O
to	O
a	O
multidisciplinary	O
clinic	O
for	O
high	O
risk	O
pregnancies	O
in	O
a	O
tertiary	O
hospital	O
in	O
southern	O
Brazil	O
.	O

At	O
adulthood	O
(	O
Figure3B	O
),	O
we	O
found	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
462	O
.	O
90	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
13	O
.	O
99	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
on	O
chocolate	O
preference	O
.	O

Parenteral	O
iron	O
sucrose	O
complex	O
is	O
known	O
to	O
have	O
several	O
advantages	O
because	O
of	O
its	O
low	O
-	O
allergenic	O
properties	O
and	O
consequently	B
,	O
an	O
extremely	O
low	O
incidence	O
of	O
severe	O
side	O
effects	O
such	O
as	O
anaphylactic	O
reactions	O
[	O
47	O
,	O
48	O
];	O
however	O
,	O
its	O
use	O
requires	O
caution	O
as	B
it	O
may	O
not	O
be	O
completely	O
devoid	O
of	O
side	O
effect	O
.	O

Low	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
during	O
pregnancy	O
is	O
reported	O
to	O
increase	O
the	O
risk	O
for	O
a	O
low	O
IQ	O
and	O
suboptimal	O
neuro	O
-	O
developmental	O
outcomes	O
in	O
childhood	O
[	O
10	O
],	O
factors	O
that	O
in	O
turn	O
are	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
adult	O
mental	O
disorders	O
like	O
schizophrenia	O
[	O
11	O
].	O

2	O
.	O
7	O
.	O

These	O
findings	O
indicate	O
that	O
leptin	O
action	O
and	O
,	O
therefore	B
,	O
the	O
normal	O
function	O
of	O
leptin	O
receptors	O
reduces	O
the	O
endocannabinoid	O
tone	O
and	O
CB1	O
receptor	O
activity	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
).	O

Our	O
novel	O
findings	O
imply	B
that	O
seasonal	O
variation	O
in	O
insulin	O
resistance	O
may	O
not	O
be	O
fully	O
explained	B
by	O
differences	O
in	O
vitamin	O
D	O
status	O
.	O

But	O
the	O
implementation	O
of	O
this	O
recommendation	O
is	O
inadequate	O
.	O

One	O
way	O
to	O
model	O
multi	O
-	O
exposure	O
mixtures	O
is	O
to	O
collapse	O
the	O
exposures	O
into	O
a	O
summary	O
term	O
that	O
is	O
included	O
in	O
regression	O
models	O
for	O
the	O
outcome	O
[	O
28	O
]	O
or	O
use	O
proxy	O
variables	O
[	O
29	O
].	O

Personal	O
Gestational	O
Weight	O
Gain	O
Target	O
When	O
asked	O
how	O
much	O
weight	O
they	O
thought	O
they	O
should	O
gain	O
during	O
their	O
pregnancy	O
,	O
25	O
%	O
of	O
participants	O
had	O
personal	O
weight	O
gain	O
targets	O
below	O
the	O
IOM	O
target	O
range	O
49	O
%	O
had	O
targets	O
within	O
the	O
recommended	O
range	O
15	O
%	O
had	O
weight	O
gain	O
targets	O
above	O
the	O
recommended	O
range	O
and	O
11	O
%	O
did	O
not	O
know	O
how	O
much	O
weight	O
to	O
gain	O
.	O

Therefore	B
after	O
the	O
pregnancy	O
,	O
healthy	O
lifestyle	O
measures	O
should	O
be	O
encouraged	O
to	O
minimize	O
the	O
likelihood	B
of	O
developing	O
diabetes	O
,	O
and	O
regular	O
screening	O
for	O
diabetes	O
should	O
be	O
undertaken	O
.	O

Animal	O
studies	O
have	O
found	O
that	O
vitamin	O
D	O
deficiency	O
can	O
cause	O
deficits	O
in	O
lung	O
function	O
,	O
which	O
can	O
be	O
explained	B
by	O
a	O
change	O
in	O
lung	O
development	O
[	O
32	O
].	O

Non	O
-	O
pregnant	O
women	O
were	O
given	O
supervised	O
doses	O
of	O
albendazole	O
(	O
400	O
mg	O
)	O
every	O
four	O
months	O
in	O
the	O
first	O
year	O
of	O
the	O
program	O
and	O
every	O
six	O
months	O
thereafter	O
.	O

The	O
estimates	O
are	O
greater	O
than	O
those	O
for	O
BMI	O
throughout	O
.	O

However	O
,	O
in	O
9	O
of	O
the	O
12	O
variables	O
studied	O
,	O
age	O
-	O
standardised	O
correlations	O
were	O
of	O
a	O
higher	O
magnitude	O
between	O
mother	O
and	O
offspring	O
,	O
significantly	O
so	O
for	O
height	O
,	O
systolic	O
blood	O
pressure	O
,	O
total	O
cholesterol	O
and	O
high	O
-	O
density	O
lipoprotein	O
cholesterol	O
.	O

Indeed	O
,	O
not	O
all	O
environmentally	O
induced	O
epigenetic	O
changes	O
have	O
proved	B
detrimental	O
.	O

These	O
mutants	O
provide	B
important	O
tools	O
for	O
the	O
study	O
of	O
skeletal	O
malformation	O
disorders	O
that	O
result	O
from	O
the	O
loss	O
of	O
a	O
functional	O
Npr3	O
or	O
Flnb	O
gene	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
recent	O
reports	O
of	O
increased	O
polytherapy	O
involving	O
antipsychotics	O
and	O
antidepressants	O
in	O
the	O
USA	O
,	O
20as	O
well	O
as	O
in	O
other	O
cohorts	O
of	O
pregnant	O
women	O
.	O
14161921	O
We	O
found	O
that	O
women	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
differed	O
significantly	O
with	O
respect	O
to	O
a	O
number	O
of	O
characteristics	O
and	O
behaviours	O
that	O
are	O
known	O
to	O
be	O
associated	O
with	O
increased	O
risks	O
for	O
adverse	O
pregnancy	O
outcomes	O
.	O

Several	O
studies	O
implicated	O
IL	O
-	O
6	O
as	O
a	O
co	O
-	O
inducer	O
of	O
the	O
development	O
of	O
obesity	O
-	O
associated	O
insulin	O
resistance	O
preceding	O
the	O
onset	O
of	O
type	O
2	O
diabetes	O
(	O
Pal	O
et	O
al	O
.,	O
2014	O
).	O

Finding	O
a	O
molecule	O
with	O
as	O
much	O
efficiency	O
as	O
the	O
β3	O
agonist	O
in	O
rodents	O
,	O
would	O
be	O
of	O
considerable	O
therapeutic	O
relevance	O
for	O
the	O
treatment	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

We	O
documented	O
2	O
(	O
2	O
%)	O
stillbirths	O
and	O
4	O
(	O
3	O
%)	O
neonatal	O
deaths	O
in	O
the	O
intervention	O
arm	O
and	O
6	O
(	O
5	O
%)	O
stillbirths	O
and	O
2	O
(	O
6	O
%)	O
neonatal	O
deaths	O
in	O
the	O
control	O
arm	O
.	O

However	O
,	O
a	O
prospective	O
study	O
of	O
42	O
couples	O
,	O
who	O
had	O
paternal	O
methotrxate	O
exposure	O
at	O
the	O
time	O
of	O
conception	O
,	O
did	O
not	O
identify	O
any	O
congenital	O
abnormalities	O
[	O
9	O
].	O

On	O
-	O
going	O
participant	O
follow	O
-	O
up	O
is	O
required	O
to	O
assess	O
the	O
further	O
impact	O
of	O
these	O
findings	O
on	O
childhood	O
outcomes	O
.	O

25	O
(	O
OH	O
)	O
D	O
was	O
similar	O
at	O
baseline	O
between	O
the	O
two	O
groups	O
but	O
significantly	O
higher	O
in	O
the	O
women	O
randomized	O
to	O
cholecalciferol	O
at	O
34	O
weeks	O
of	O
gestation	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
67	O
.	O
3	O
(	O
20	O
.	O
8	O
)	O
nmol	O
/	O
L	O
]	O
compared	O
with	O
placebo	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
43	O
.	O
0	O
(	O
22	O
.	O
2	O
)	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Results	O
Study	O
population	O
Characteristics	O
of	O
the	O
study	O
population	O
are	O
summarized	O
in	O
Table	O
1	O
(	O
n	O
=	O
145	O
).	O

General	O
characteristics	O
of	O
the	O
children	O
are	O
listed	O
inTable	O
1	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
General	O
Characteristics	O
and	O
Linear	O
Index	O
Values	O
of	O
Heart	O
Rate	O
Variability	O
(	O
Time	O
and	O
Frequency	O
Domain	O
)	O
in	O
the	O
Study	O
Population	O
(	O
n	O
=	O
100	O
).	O
General	O
CharacteristicsBirth	O
Weight	O
(	O
g	O
)	O
3008	O
±	O
605Birth	O
Length	O
(	O
cm	O
)	O
47	O
.	O
3	O
±	O
3	O
.	O
29Prematurity	O
(%)	O
Yes10No90Age	O
(	O
Years	O
)	O
8	O
.	O
85	O
±	O
1	O
.	O
82Gender	O
(%)	O
Female37Male63Weight	O
(	O
kg	O
)	O
34	O
.	O
83	O
±	O
13	O
.	O
52Height	O
(	O
cm	O
)	O
135	O
.	O
83	O
±	O
11	O
.	O
93BMI	O
(	O
kg	O
/	O
m2	O
)	O
18	O
.	O
59	O
±	O
4	O
.	O
60WC	O
(	O
cm	O
)	O
60	O
.	O
55	O
±	O
9	O
.	O
55HC	O
(	O
cm	O
)	O
71	O
.	O
99	O
±	O
12	O
.	O
43BF	O
(%)	O
25	O
.	O
78	O
±	O
6	O
.	O
77Nutritional	O
Status	O
(%)	O
Normal67Overweight17Obesity16Physical	O
Activity	O
Index8	O
.	O
18	O
±	O
1	O
.	O
14SBP	O
(	O
mmHg	O
)	O
100	O
±	O
7	O
.	O
50DBP	O
(	O
mmHg	O
)	O
66	O
±	O
4	O
.	O
20	O
Time	O
Domain	O
HR	O
(	O
bpm	O
)	O
83	O
.	O
89	O
±	O
8	O
.	O
12MNN	O
(	O
ms	O
)	O
708	O
.	O
65	O
±	O
85	O
.	O
60SDNN	O
(	O
ms	O
)	O
48	O
.	O
98	O
±	O
20	O
.	O
00RMSSD	O
(	O
ms	O
)	O
51	O
.	O
45	O
±	O
20	O
.	O
64PNN50	O
(%)	O
39	O
.	O
88	O
±	O
12	O
.	O
95	O
Frequency	O
Domain	O
LF	O
(	O
n	O
.	O
u	O
.	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

Background	O
Vitamin	O
D	O
status	O
and	O
season	O
are	O
intrinsically	O
linked	O
;	O
upon	O
exposure	O
to	O
natural	O
ultraviolet	O
solar	O
radiation	O
,	O
endogenous	O
skin	O
production	O
of	O
vitamin	O
D	O
occurs	O
.	O

Being	O
raised	O
on	O
a	O
farm	O
[	O
102	O
–	O
114	O
]	O
or	O
in	O
a	O
rural	O
area	O
[	O
115	O
]	O
has	O
been	O
shown	O
in	O
some	O
studies	O
to	O
protect	O
against	O
asthma	O
,	O
hay	O
fever	O
,	O
and	O
atopic	O
sensitization	O
.	O

Finally	O
,	O
as	O
a	O
retrospective	O
study	O
,	O
we	O
were	O
limited	O
by	O
available	O
data	O
and	O
the	O
amount	O
of	O
cord	O
blood	O
available	O
for	O
further	O
testing	O
.	O

Conclusion	O
Gestational	O
exposure	O
to	O
phthalates	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
or	O
OPPs	O
had	O
null	O
or	O
small	O
associations	O
with	O
birth	O
weight	O
.	O

Streptococcus	O
agalactiae	O
is	O
known	O
to	O
infect	O
farmed	O
fish	O
populations	O
[	O
10	O
],	O
and	O
fishmongers	O
have	O
presented	O
with	O
infections	O
of	O
Streptococcus	O
iniae	O
related	O
to	O
fish	O
handling	O
[	O
11	O
].	O

The	O
mutation	O
underlying	O
the	O
Skm1	O
phenotype	O
occurred	O
at	O
a	O
residue	O
that	O
is	O
highly	O
conserved	O
across	O
species	O
(	O
Figure	O
3B	O
,	O
upper	O
panel	O
)	O
and	O
mouse	O
strains	O
(	O
data	O
not	O
shown	O
).	O

"	O
Cured	O
"	O
patients	O
Pregnant	O
patients	O
with	O
a	O
history	O
of	O
previously	O
treated	O
DTC	O
with	O
no	O
evidence	O
of	O
recurrent	O
or	O
persistent	O
disease	O
by	O
imaging	O
and	O
by	O
thyroglobulin	O
measurement	O
.	O

Women	O
were	O
diagnosed	O
with	O
GDM	O
if	O
two	O
or	O
more	O
of	O
the	O
100	O
gram	O
OGTT	O
glucose	O
levels	O
exceeded	O
the	O
ADA	O
criteria	O
[	O
28	O
]	O
as	O
follows	O
:	O
fasting	O
≥	O
95	O
mg	O
/	O
dl	O
;	O
1	O
-	O
hour	O
≥	O
180	O
mg	O
/	O
dl	O
;	O
2	O
-	O
hour	O
≥	O
155	O
mg	O
/	O
dl	O
;	O
3	O
-	O
hour	O
≥	O
140	O
mg	O
/	O
dl	O
.	O

These	O
expression	O
patterns	O
suggest	O
a	O
dietary	O
effect	O
on	O
cellular	O
turn	O
-	O
over	O
,	O
which	O
might	O
be	O
increased	O
at	O
early	O
stages	O
but	O
decreased	O
at	O
adult	O
stage	O
in	O
LP	O
offspring	O
.	O

We	O
also	O
reported	O
results	O
after	O
stratification	O
so	O
that	O
we	O
(	O
and	O
readers	O
)	O
could	O
assess	O
associations	O
(	O
even	O
with	O
a	O
fair	O
amount	O
of	O
statistical	O
imprecision	O
)	O
without	O
an	O
over	O
-	O
reliance	O
on	O
model	O
-	O
based	O
assumptions	O
.	O

For	O
example	O
,	O
after	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
middle	O
respective	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
for	O
intake	O
of	O
vitamin	O
D	O
were	O
respectively	O
18	O
%	O
and	O
37	O
%	O
lower	O
in	O
the	O
highest	O
quartile	O
compared	O
to	O
the	O
lowest	O
quartile	O
of	O
intake	O
.	O

The	O
costs	O
of	O
the	O
intervention	O
will	O
include	O
cost	O
and	O
distribution	O
of	O
the	O
supplements	O
,	O
training	O
of	O
SS	O
workers	O
,	O
organisational	O
costs	O
associated	O
with	O
the	O
administration	O
of	O
the	O
programme	O
and	O
the	O
cost	O
of	O
incentives	O
.	O

There	O
should	O
be	O
greater	O
emphasis	O
on	O
the	O
universal	O
provision	O
of	O
antenatal	O
corticosteroids	O
,	O
building	O
on	O
the	O
work	O
of	O
the	O
UN	O
Commission	O
on	O
Life	O
-	O
Saving	O
Commodities	O
for	O
Women	O
and	O
Children	O
as	O
an	O
opportunity	O
to	O
accelerate	O
progress	O
.	O

Images	O
PubMed	O
Central	O
:	O

Perceptions	O
of	O
pregnant	O
women	O
The	O
respondent	O
'	O
s	O
knowledge	O
about	O
ANC	O
was	O
evaluated	O
using	O
three	O
questions	O
.	O

2008	O
).	O

##:	O
adjusted	O
OR	O
for	O
total	O
number	O
of	O
prenatal	O
checks	O
,	O
age	O
,	O
schooling	O
,	O
residence	O
area	O
.	O

Skm1	O
mice	O
also	O
exhibited	O
arachnodactyly	O
characterized	O
by	O
elongated	O
phalanges	O
(	O
Figure	O
5	O
,	O
B	O
and	O
D	O
),	O
compared	O
to	O
wild	O
-	O
type	O
littermates	O
(	O
Figure	O
5	O
,	O
A	O
and	O
C	O
),	O
and	O
kinked	O
tail	O
(	O
Figure	O
5B	O
),	O
attributable	B
to	O
either	O
the	O
presence	O
of	O
hemivertebrae	O
or	O
fused	O
vertebrae	O
in	O
the	O
tail	O
region	O
(	O
Figure	O
5E	O
).	O

Thus	B
,	O
managing	O
maternal	O
nutrition	O
is	O
a	O
potentially	O
effective	O
way	O
to	O
promote	O
adipogenesis	O
in	O
fetal	O
muscle	O
[	O
16	O
].	O

Source	O
:	O
Countdown	O
to	O
2015	O
(	O
Requejo	O
et	O
al	O
.,	O
2013	O
)	O
[	O
29	O
].	O

However	O
,	O
maternal	O
hypoxia	O
or	O
hypotension	O
associated	O
with	O
anaphylaxis	O
may	O
be	O
catastrophic	O
not	O
only	O
to	O
the	O
mother	O
but	O
also	O
to	O
her	O
fetus	O
.	O

Conclusions	O
When	O
treating	O
thyroid	O
cancer	O
in	O
pregnancy	O
,	O
3	O
factors	O
should	O
be	O
considered	O
:	O
The	O
effect	O
of	O
cancer	O
on	O
pregnancy	O
:	O
No	O
metastasis	O
to	O
placenta	O
or	O
foetus	O
–	O
no	O
IUGR	O
.	O

Accuracy	O
of	O
women	O
’	O
s	O
weight	O
gain	O
target	O
did	O
not	O
vary	O
by	O
acculturation	O
(	O
language	O
preference	O
,	O
years	O
in	O
the	O
US	O
).	O

By	O
this	O
I	O
mean	O
days	O
when	O
you	O
felt	O
you	O
didn	O
’	O
t	O
have	O
enough	O
to	O
eat	O
.”–	O
that	O
was	O
previously	O
used	O
to	O
determine	O
food	O
insufficiency	O
in	O
pregnant	O
women	O
in	O
South	O
Africa	O
[	O
36	O
].	O

All	O
sows	O
were	O
fed	O
three	O
times	O
per	O
day	O
at	O
05	O
:	O
00	O
,	O
10	O
:	O
00	O
and	O
17	O
:	O
00	O
h	O
,	O
respectively	O
,	O
with	O
free	O
access	O
to	O
water	O
.	O

Interestingly	O
,	O
the	O
“	O
browning	O
”	O
of	O
WAT	O
(	O
i	O
.	O
e	O
.,	O
increased	O
proportion	O
of	O
brown	O
adipocytes	O
)	O
may	O
also	O
involve	O
transdifferentiation	O
of	O
white	O
-	O
to	O
-	O
brown	O
adipose	O
cells	O
(	O
Smorlesi	O
et	O
al	O
.,	O
2012	O
;	O
Frontini	O
et	O
al	O
.,	O
2013	O
),	O
although	O
this	O
issue	O
is	O
still	O
a	O
matter	O
of	O
debate	O
(	O
Wu	O
et	O
al	O
.,	O
2012	O
).	O

The	O
effect	O
of	O
pregnancy	O
on	O
cancer	O
:	O
In	O
vitro	O
accelerated	O
cell	O
growth	O
,	O
no	O
effect	O
seen	O
in	O
vivo	O
.	O

Limited	O
previous	O
research	O
is	O
generally	B
consistent	O
with	O
our	O
findings	O
.	O

the	O
same	O
epigenetic	O
change	O
(	O
s	O
)	O
reported	O
in	O
multiple	O
independent	B
studies	O
or	O
multiple	O
epigenetic	O
changes	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
,	O
therefore	O
,	O
are	O
included	O
in	O
Supplementary	O
Table	O
3	O
.	O

Likewise	O
,	O
pharmaceutical	O
drug	O
-	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
has	O
also	O
been	O
reported	O
.	O

Introduction	O
Across	O
the	O
globe	O
,	O
>	O
1	O
.	O
46	O
billion	O
adults	O
[	O
1	O
],	O
and	O
170	O
million	O
children	O
[	O
2	O
],	O
are	O
overweight	O
or	O
obese	O
.	O

Average	O
maternal	O
intake	O
of	O
vitamin	O
D	O
from	O
foods	O
and	O
prenatal	O
supplements	O
was	O
439	O
±	O
94	O
IU	O
/	O
day	O
.	O

Notably	O
,	O
investigators	O
have	O
reported	O
that	O
short	O
sleep	O
duration	O
and	O
other	O
parameters	O
of	O
sleep	O
disturbance	O
during	O
mid	O
and	O
late	O
pregnancy	O
are	O
associated	O
with	O
increased	O
systematic	O
inflammation	O
and	O
higher	O
stimulated	O
levels	O
of	O
IL	O
-	O
6	O
[	O
49	O
,	O
50	O
];	O
and	O
we	O
have	O
previously	O
reported	O
that	O
early	O
pregnancy	O
CRP	O
concentrations	O
are	O
predictive	O
of	O
incident	O
GDM	O
[	O
51	O
].	O

Male	O
mice	O
of	O
the	O
same	O
age	O
(	O
n	O
=	O
20	O
)	O
were	O
separated	O
and	O
fed	O
only	O
the	O
SC	O
diet	O
.	O

In	O
Korean	O
cattle	O
,	O
Park	O
et	O
al	O
[	O
39	O
]	O
compared	O
marbling	O
degree	O
by	O
sex	O
(	O
bulls	O
,	O
steers	O
,	O
and	O
cows	O
),	O
and	O
steers	O
had	O
the	O
best	O
MS	O
,	O
followed	O
by	O
cows	O
.	O

The	O
GD	O
varied	O
from	O
102	O
.	O
5	O
±	O
1	O
.	O
9	O
µm	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
93	O
.	O
3	O
±	O
1	O
.	O
4	O
µm	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
less	O
9	O
%	O
difference	O
;	O
P	O
=	O
0	O
.	O
03	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
103	O
.	O
0	O
±	O
1	O
.	O
6	O
µm	O
for	O
the	O
F2	O
-	O
SC	O
to	O
98	O
.	O
0	O
±	O
2	O
.	O
2	O
µm	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

For	O
example	O
,	O
antenatal	O
corticosteroids	O
administered	O
to	O
a	O
pregnant	O
woman	O
in	O
preterm	O
labour	O
can	O
prevent	O
respiratory	O
distress	O
syndrome	O
in	O
premature	O
babies	O
reducing	O
newborn	O
mortality	O
and	O
morbidity	O
[	O
5	O
].	O

We	O
recommended	O
handwashing	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
after	O
fecal	O
contact	O
,	O
and	O
before	O
food	O
preparation	O
.	O

Immunofluorescent	O
Analysis	O
Following	O
a	O
series	O
of	O
deparaffinisation	O
and	O
dehydration	O
,	O
placental	O
tissue	O
sections	O
were	O
incubated	O
with	O
10	O
%	O
bovine	O
serum	O
albumin	O
(	O
BSA	O
)	O
for	O
1	O
hr	O
.	O

She	O
clarified	O
the	O
study	O
’	O
s	O
goals	O
and	O
if	O
the	O
mothers	O
were	O
willing	O
to	O
participation	O
a	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
them	O
.	O

Such	O
differences	O
are	O
of	O
critical	O
importance	O
when	O
considering	O
mechanistic	O
relevance	O
to	O
humans	O
.	O

Assessing	O
self	O
-	O
reported	O
influenza	O
vaccination	O
We	O
assessed	O
the	O
validity	O
of	O
self	O
-	O
reporting	O
influenza	O
vaccination	O
or	O
non	O
-	O
vaccination	O
through	O
random	O
sampling	O
of	O
the	O
self	O
-	O
reported	O
vaccinated	O
and	O
unvaccinated	O
group	O
.	O

A	O
Community	O
Health	O
Research	O
Worker	O
confirms	O
a	O
pregnancy	O
in	O
all	O
women	O
of	O
child	O
bearing	O
age	O
who	O
have	O
missed	O
a	O
menstrual	O
cycle	O
with	O
a	O
urine	O
test	O
during	O
the	O
bimonthly	O
visit	O
.	O

Comparing	O
to	O
the	O
control	O
group	O
,	O
depression	O
level	O
decreased	O
in	O
both	O
intervention	O
groups	O
[	O
67	O
].	O

The	O
current	O
vitamin	O
D	O
recommendations	O
for	O
pregnant	O
women	O
are	O
clearly	O
insufficient	O
to	O
prevent	O
and	O
even	O
more	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2431	O
/	O
12	O
/	O
6	O
/	O
prepub	O
PubMed	O
Central	O
:	O

[	O
18	O
]	O
Year2011201120122009201320122013Number	O
of	O
subjects26414469335619901203119Mean	O
age	O
±	O
SD	O
(	O
year	O
)	O
40	O
.	O
3	O
±	O
0	O
.	O
3a	O
(	O
range	O
15	O
–	O
98	O
)	O
67	O
.	O
5	O
±	O
6	O
.	O
0	O
(	O
range	O
60	O
–	O
97	O
)	O
75	O
.	O
2	O
±	O
6	O
.	O
0	O
(	O
range	O
61	O
–	O
97	O
)	O
35	O
.	O
2	O
±	O
0	O
.	O
5a	O
(	O
range	O
20	O
–	O
50	O
)	O
40	O
.	O
1	O
±	O
0	O
.	O
2a	O
(	O
range	O
25	O
–	O
54	O
)	O
29	O
.	O
3	O
±	O
5	O
.	O
7	O
(	O
range	O
18	O
–	O
40	O
)	O
N	O
/	O
A	O
(	O
range	O
3	O
–	O
12	O
.	O
9	O
)	O
SexM	O
50	O
%	O
F	O
50	O
%	O
F	O
100	O
%	O
F	O
100	O
%	O
F	O
100	O
%	O
M	O
72	O
.	O
8	O
%	O
F	O
27	O
.	O
2	O
%	O
F	O
100	O
%	O
N	O
/	O
AMean	O
25	O
(	O
OH	O
)	O
D	O
±	O
SD	O
,	O
ng	O
/	O
mL	O
(	O
nmol	O
/	O
L	O
)	O
31	O
.	O
8	O
±	O
0	O
.	O
3a	O
(	O
79	O
.	O
3	O
±	O
0	O
.	O
8a	O
)	O
27	O
.	O
1	O
±	O
6	O
.	O
3	O
(	O
67	O
.	O
6	O
±	O
15	O
.	O
7	O
)	O
25	O
.	O
8	O
±	O
6	O
.	O
0	O
(	O
64	O
.	O
3	O
±	O
14	O
.	O
9	O
)	O
29	O
.	O
1	O
±	O
0	O
.	O
4	O
(	O
72	O
.	O
6	O
±	O
1	O
.	O
1	O
)	O
M	O
26	O
.	O
0	O
±	O
0	O
.	O
2a	O
(	O
M	O
65	O
.	O
0	O
±	O
0	O
.	O
5a	O
)	O
F	O
21	O
.	O
4	O
±	O
0	O
.	O
2a	O
(	O
F	O
53	O
.	O
5	O
±	O
0	O
.	O
5a	O
)	O
Trimester	O
of	O
pregnancy1st	O
25	O
.	O
7	O
±	O
6	O
.	O
7	O
(	O
1st	O
61	O
.	O
4	O
±	O
16	O
.	O
6	O
)	O
2nd	O
33	O
.	O
8	O
±	O
8	O
.	O
2	O
(	O
2nd	O
84	O
.	O
4	O
±	O
20	O
.	O
4	O
)	O
3rd	O
36	O
.	O
1	O
±	O
8	O
.	O
9	O
(	O
3rd	O
90	O
.	O
0	O
±	O
22	O
.	O
3	O
)	O
N	O
/	O
APercent	O
of	O
subjects	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
mL	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
45	O
.	O
2	O
%	O
54	O
.	O
0	O
%	O
77	O
.	O
4	O
%	O
77	O
.	O
8	O
%	O
N	O
/	O
ATrimester	O
of	O
pregnancy1st	O
83	O
.	O
3	O
%	O
2nd	O
30	O
.	O
9	O
%	O
3rd	O
27	O
.	O
4	O
%	O
Age	O
3	O
–	O
5	O
.	O
9	O
yearsb	O
Urban	O
31	O
.	O
3	O
%	O
Rural	O
24	O
.	O
5	O
%	O
Age	O
6	O
–	O
12	O
.	O
9	O
yearsb	O
Urban	O
52	O
.	O
2	O
%	O
Rural	O
29	O
.	O
2	O
%	O
Totalb	O
Urban	O
45	O
.	O
6	O
%	O
Rural	O
27	O
.	O
7	O
%	O
Percent	O
of	O
subjects	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
5	O
.	O
7	O
%	O
31	O
.	O
8	O
%	O
21	O
.	O
5	O
%	O
N	O
/	O
AM	O
13	O
.	O
9	O
%	O
F	O
43	O
.	O
1	O
%	O
Trimester	O
of	O
pregnancy1st	O
26	O
.	O
7	O
%	O
2nd	O
1	O
.	O
8	O
%	O
3rd	O
2	O
.	O
3	O
%	O
M	O
,	O
male	O
;	O
F	O
,	O
female	O
;	O
N	O
/	O
A	O
,	O
not	O
available	O
.	O

Handwashing	O
with	O
food	O
preparation	O
was	O
added	O
in	O
order	O
to	O
stay	O
consistent	O
with	O
typical	O
handwashing	O
promotion	O
efforts	O
in	O
Bangladesh	O
and	O
to	O
facilitate	O
the	O
development	O
of	O
maternal	O
handwashing	O
behavior	O
relevant	O
to	O
postneonatal	O
morbidity	O
.	O

In	O
the	O
preterm	O
group	O
,	O
the	O
dynamics	O
of	O
GR	O
splicing	O
were	O
altered	O
,	O
since	B
GR	O
α	O
correlated	O
with	O
GR	O
-	O
P	O
(	O
r	O
=	O
0	O
.	O
710	O
,	O
P	O
=	O
0	O
.	O
021	O
)	O
and	O
GR	O
β	O
correlated	O
with	O
GAS5	O
(	O
r	O
=	O
0	O
.	O
792	O
,	O
P	O
=	O
0	O
.	O
011	O
).	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

However	O
,	O
an	O
Australian	O
study	O
showed	O
that	O
both	O
women	O
and	O
providers	O
thought	O
the	O
time	O
for	O
antenatal	O
classes	O
was	O
too	O
small	O
to	O
incorporate	O
all	O
they	O
had	O
to	O
learn	O
with	O
some	O
women	O
complaining	O
of	O
having	O
received	O
too	O
much	O
information	O
[	O
29	O
].	O

Results	O
Both	O
phases	O
only	O
ran	O
for	O
7	O
months	O
;	O
integration	O
required	O
4	O
months	O
.	O

Pubertal	O
onset	O
in	O
nutritionally	O
challenged	O
offspring	O
Irrespective	O
of	O
postnatal	O
diet	O
,	O
changes	O
in	O
early	O
life	O
nutrition	O
resulted	O
in	O
the	O
early	O
onset	O
of	O
puberty	O
.	O

Interestingly	O
,	O
increased	O
FDG	O
uptake	O
was	O
also	O
noted	O
in	O
the	O
subcutaneous	O
fat	O
,	O
in	O
particular	O
in	O
the	O
pelvic	O
area	O
and	O
over	O
the	O
lower	O
extremities	O
.	O

The	O
10	O
µl	O
reactions	O
were	O
incubated	O
at	O
70	O
°	O
C	O
for	O
5	O
min	O
(	O
RT1	O
).	O

29Moreover	O
,	O
in	O
agreement	O
with	O
a	O
recent	O
population	O
-	O
based	O
cohort	O
study	O
that	O
reported	O
an	O
increased	O
incidence	O
of	O
gestational	O
diabetes	O
in	O
mothers	O
taking	O
SGAs	O
during	O
pregnancy	O
,	O
28the	O
exposed	O
women	O
in	O
our	O
cohort	O
experienced	O
more	O
associated	O
comorbidities	O
,	O
including	O
hypertension	O
,	O
gestational	O
diabetes	O
and	O
hypothyroidism	O
.	O

Meanwhile	O
,	O
the	O
least	O
attended	O
were	O
Bonakanda	O
and	O
Bova	O
health	O
centres	O
(	O
0	O
.	O
5	O
%	O
and	O
0	O
.	O
3	O
%	O
respectively	O
).	O

The	O
final	O
adjusted	O
model	O
was	O
:	O
Y	O
=	O
β0	O
+	O
βx1X1	O
....	O
βxpXp	O
+	O
βc1C1	O
+....+	O
βckCk	O
+	O
spline	O
(	O
GA	O
)+	O
error	O
,	O
where	O
Y	O
is	O
the	O
outcome	O
birth	O
weight	O
,	O
β0is	O
the	O
y	O
-	O
intercept	O
,	O
βx1	O
...	O
βxpare	O
the	O
exposure	O
variable	O
regression	O
coefficients	O
,	O
X1	O
...	O
Xpare	O
the	O
exposure	O
variables	O
,	O
spline	O
(	O
GA	O
)	O
is	O
the	O
non	O
-	O
parametric	O
spline	O
for	O
GA	O
,	O
and	O
C1	O
…	O
Ckare	O
the	O
9	O
covariates	O
.	O

Afterwards	O
,	O
participating	O
mothers	O
were	O
matched	O
and	O
divided	O
into	O
groups	O
A	O
and	O
B	O
based	O
on	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
as	O
follows	O
:	O
normal	O
(	O
18	O
.	O
5	O
-	O
25	O
kg	O
/	O
m2	O
)	O
(	O
n	O
=	O
16	O
)	O
and	O
overweight	O
and	O
obese	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
(	O
n	O
=	O
25	O
).	O

Previous	O
research	O
has	O
documented	O
a	O
negative	O
correlation	O
between	O
the	O
number	O
of	O
glomeruli	O
and	O
BP	O
levels	O
in	O
humans	O
[	O
31	O
]	O
and	O
in	O
rodents	O
[	O
27	O
],[	O
32	O
].	O

Bonferroni	O
analysis	O
indicated	O
that	O
while	O
RC	O
female	O
offspring	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
(	O
Figure6A	O
),	O
RC	O
males	O
only	O
presented	O
a	O
significant	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Pparg	O
in	O
PAT	O
(	O
Figure6B	O
),	O
compared	O
to	O
CC	O
ones	O
.	O

To	O
assess	O
the	O
feeding	O
behavior	O
,	O
rats	O
were	O
exposed	O
to	O
a	O
free	O
choice	O
between	O
a	O
mixture	O
of	O
chocolates	O
and	O
a	O
standard	O
chow	O
for	O
limited	O
and	O
unlimited	O
time	O
.	O

The	O
arms	O
were	O
similar	O
with	O
respect	O
to	O
roof	O
and	O
wall	O
materials	O
.	O

In	O
our	O
study	O
,	O
nearly	O
70	O
%	O
of	O
the	O
mothers	O
had	O
vitamin	O
D	O
deficiency	O
.	O

This	O
study	O
was	O
reviewed	O
and	O
approved	O
by	O
the	O
Research	O
and	O
Ethical	O
Review	O
Committees	O
at	O
icddr	O
,	O
b	O
:	O
International	O
Centre	O
for	O
Diarrhoeal	O
Diseases	O
Research	O
,	O
Bangladesh	O
(	O
PR	O
-	O
10036	O
).	O

The	O
effect	O
appeared	O
to	O
be	O
transmitted	O
through	O
the	O
male	O
germ	O
line	O
,	O
with	O
altered	O
DNA	O
methylation	O
patterns	O
detected	O
in	O
the	O
testes	O
of	O
the	O
F1generation	O
and	O
the	O
sperm	O
of	O
the	O
F2and	O
F3generations	O
.	O

While	O
lncRNAs	O
do	O
this	O
in	O
a	O
variety	O
of	O
ways	O
,	O
including	O
chromosome	O
remodeling	O
,	O
and	O
transcriptional	O
or	O
post	O
-	O
transcriptional	O
regulation	O
(	O
Galupa	O
&	O
Heard2015	O
;	O
Kanduri2016	O
;	O
Taylor	O
et	O
al	O
.	O
2015	O
),	O
sncRNAs	O
predominantly	O
mediate	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
).	O

2011	O
;	O
Wilhelm	O
et	O
al	O
.	O

Three	O
medically	O
important	O
cases	O
involved	O
pharmaceutical	O
doses	O
of	O
folic	O
acid	O
(	O
5	O
mg	O
),	O
one	O
of	O
which	O
was	O
a	O
pediatric	O
case	O
involving	O
a	O
multi	O
ingredient	O
intravenous	O
total	O
parental	O
nutrition	O
product	O
(	O
Multi	O
-	O
12	O
/	O
K1	O
pediatric	O
)	O
containing	O
folic	O
acid	O
.	O

This	O
finding	O
is	O
partly	O
consistent	O
with	O
previous	O
studies	O
where	O
25OHD	O
concentrations	O
of	O
25	O
–	O
30	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
higher	O
probability	O
of	O
SGA	O
[	O
5	O
–	O
7	O
].	O

Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
,	O
as	O
well	O
as	O
maternal	O
age	O
,	O
socioeconomic	O
status	O
and	O
maternal	O
smoking	O
.	O

These	O
models	O
were	O
adjusted	O
for	O
BMI	O
,	O
season	O
of	O
conception	O
,	O
education	O
level	O
,	O
origin	O
and	O
gestational	O
age	O
at	O
registration	O
to	O
antenatal	O
care	O
(	O
based	O
on	O
last	O
menstrual	O
period	O
).	O

Upon	O
further	O
exploration	O
through	O
GSEA	O
,	O
we	O
observed	O
an	O
overrepresentation	O
of	O
several	O
TFBSs	O
for	O
transcription	O
factors	O
critical	O
in	O
development	O
,	O
cellular	O
processes	O
,	O
immune	O
modulation	O
,	O
lipid	O
or	O
sterol	O
homeostasis	O
,	O
and	O
gene	O
expression	O
near	O
loci	O
associated	O
with	O
AluYb8	O
,	O
as	O
well	O
as	O
a	O
few	O
developmental	O
and	O
cellular	O
proliferation	O
pathways	O
for	O
LINE	O
-	O
1	O
.	O

Similarly	O
,	O
the	O
study	O
of	O
childhood	O
brain	O
tumors	O
and	O
season	O
of	O
birth	O
have	O
yielded	O
equivocal	O
results	O
[	O
22	O
–	O
26	O
].	O

2011	O
).	O

Trajectory	O
of	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
in	O
relation	O
to	O
neonatal	O
birth	O
size	O
and	O
fetal	O
survival	O
:	O
a	O
prospective	O
cohort	O
study	O
Abstract	O
Background	O
We	O
investigated	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
and	O
late	O
pregnancy	O
with	O
neonatal	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
),	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
and	O
preterm	O
delivery	O
.	O

The	O
sample	O
size	O
in	O
each	O
group	O
was	O
123	O
and	O
128	O
for	O
the	O
vaccinated	O
and	O
unvaccinated	O
groups	O
,	O
respectively	O
.	O

For	O
those	O
overrepresented	O
among	O
loci	O
associated	O
with	O
AluYb8	O
methylation	O
,	O
there	O
were	O
a	O
number	O
of	O
developmentally	O
related	O
TFBS	O
genes	O
(	O
CUX1	O
,	O
CHX10	O
,	O
PAX4	O
,	O
PPARG	O
,	O
TAL1	O
/	O
ITF2	O
heterodimer	O
,	O
HAND1	O
,	O
MYOD	O
,	O
OCT	O
),	O
as	O
well	O
as	O
those	O
involved	O
in	O
cell	O
processes	O
(	O
ACTR3B	O
,	O
S8	O
),	O
gene	O
expression	O
(	O
NFE2L	O
),	O
lipid	O
/	O
sterol	O
homeostasis	O
(	O
NR3C1	O
),	O
and	O
immune	O
modulation	O
(	O
GATA1	O
).	O

The	O
gene	O
underlying	O
the	O
mutation	O
in	O
Skm2	O
mice	O
,	O
Flnb	O
,	O
encodes	O
filamin	O
B	O
,	O
a	O
member	O
of	O
a	O
family	O
of	O
cytoplasmic	O
proteins	O
including	O
filamin	O
A	O
and	O
filamin	O
C	O
.	O
These	O
proteins	O
provide	O
a	O
scaffold	O
for	O
the	O
cytoskeletal	O
network	O
by	O
crosslinking	O
actin	O
to	O
the	O
cytoskeleton	O
,	O
thereby	O
regulating	O
intracellular	O
signaling	O
and	O
protein	O
trafficking	O
(	O
Stossel	O
et	O
al	O
.	O

We	O
also	O
detected	O
interaction	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
13	O
.	O
55	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

The	O
number	O
of	O
children	O
lost	O
to	O
follow	O
-	O
up	O
was	O
low	O
and	O
many	O
children	O
lost	O
at	O
one	O
time	O
because	O
of	O
travel	O
rejoined	O
the	O
study	O
later	O
with	O
rates	O
being	O
similar	O
between	O
the	O
two	O
groups	O
(	O
figure	O
1	O
).	O

The	O
specimens	O
were	O
centrifuged	O
for	O
20	O
minutes	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Anthropometric	O
indicators	O
(	O
birth	O
height	O
,	O
weight	O
,	O
and	O
head	O
circumference	O
)	O
were	O
measured	O
.	O

Besides	O
,	O
activated	O
lymphocytes	O
can	O
cross	O
the	O
blood	O
–	O
brain	O
barrier	O
and	O
secrete	O
cytokines	O
in	O
the	O
brain	O
[	O
72	O
].	O

Because	B
the	O
negative	O
consequences	O
of	O
the	O
HV	O
gestational	O
diet	O
on	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
glucose	O
control	O
were	O
prevented	O
by	O
feeding	O
either	O
the	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
these	O
observations	O
support	O
the	O
PAR	O
hypothesis	O
that	O
offspring	O
fed	O
diets	O
similar	O
to	O
their	O
mothers	O
lead	O
to	O
a	O
more	O
appropriate	O
adaptation	O
to	O
their	O
postnatal	O
environment	O
compared	O
to	O
those	O
fed	O
an	O
unmatched	O
diet	O
.	O

In	O
the	O
studies	O
conducted	O
to	O
date	O
,	O
risk	O
estimates	O
and	O
p	O
-	O
values	O
for	O
the	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
have	O
been	O
nominal	O
to	O
borderline	O
in	O
strength	O
.	O

One	O
option	O
would	O
be	O
a	O
national	O
or	O
multinational	O
study	O
based	O
on	O
randomization	O
of	O
school	O
districts	O
or	O
other	O
suitable	O
units	O
in	O
regions	O
of	O
low	O
sunlight	O
intensity	O
,	O
perhaps	O
including	O
multiple	O
outcomes	O
that	O
might	O
be	O
affected	O
by	O
vitamin	O
D	O
,	O
such	O
as	O
diabetes	O
,	O
obesity	O
,	O
respiratory	O
infections	O
,	O
and	O
asthma	O
.	O
4546Alternatively	O
,	O
high	O
-	O
risk	O
first	O
-	O
degree	O
relatives	O
of	O
individu	O
-	O
als	O
with	O
MS	O
could	O
be	O
targeted	O
in	O
a	O
smaller	O
trial	O
,	O
47although	O
randomization	O
and	O
compliance	O
could	O
be	O
more	O
challenging	O
.	O

Handwashing	O
station	O
placement	O
was	O
guided	O
by	O
the	O
mother	O
and	O
other	O
relatives	O
such	O
that	O
the	O
mother	O
would	O
have	O
access	O
to	O
soap	O
and	O
water	O
in	O
the	O
key	O
locations	O
where	O
she	O
expected	O
to	O
spend	O
time	O
with	O
the	O
neonate	O
.	O

During	O
rapid	O
assessments	O
conducted	O
on	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
the	O
proportion	O
of	O
households	O
observed	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
was	O
77	O
%	O
in	O
the	O
intervention	O
arm	O
and	O
27	O
%	O
in	O
the	O
control	O
arm	O
(	O
RR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
2	O
.	O
11	O
–	O
4	O
.	O
15	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
3	O
).	O

Conclusion	O
Most	O
of	O
the	O
patients	O
took	O
Vitamin	O
D	O
supplements	O
which	O
may	O
help	O
to	O
maintain	O
the	O
nutritional	O
balance	O
of	O
Vitamin	O
D	O
.	O
Background	O
Vitamin	O
D	O
promotes	O
calcium	O
absorption	O
in	O
the	O
gut	O
and	O
maintains	O
adequate	O
serum	O
calcium	O
and	O
phosphate	O
concentrations	O
to	O
ensure	O
normal	O
mineralization	O
of	O
the	O
bone	O
.	O

Assignment	O
of	O
treatments	O
An	O
investigator	O
remote	O
from	O
the	O
field	O
area	O
will	O
assign	O
the	O
interventions	O
to	O
eligible	O
clusters	O
using	O
a	O
fixed	O
randomisation	O
scheme	O
with	O
a	O
uniform	O
allocation	O
ratio	O
of	O
treatments	O
,	O
stratified	O
by	O
subdistrict	O
or	O
Upazila	O
.	O

For	O
the	O
girls	O
,	O
there	O
was	O
a	O
weak	O
correlation	O
with	O
the	O
MGM	O
but	O
a	O
stronger	O
correlation	O
with	O
the	O
PGM	O
at	O
ages	O
0	O
and	O
5	O
.	O

PubMed	O
Central	O
:	O

This	O
is	O
also	O
consistent	O
with	O
another	O
study	O
that	O
observed	O
an	O
increased	O
risk	O
of	O
GDM	O
with	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
(	O
aOR	O
:	O
3	O
.	O
40	O
;	O
95	O
%	O
CI	O
:	O
2	O
.	O
03	O
–	O
4	O
.	O
98	O
[	O
17	O
])	O
and	O
offers	O
potential	O
physiological	O
connections	O
between	O
vitamin	O
D	O
status	O
and	O
the	O
progression	O
of	O
insulin	O
resistance	O
in	O
pregnant	O
women	O
.	O

Fetal	O
demands	O
for	O
iron	O
are	O
maximal	O
during	O
the	O
third	O
trimester	O
and	O
these	O
are	O
estimated	O
at	O
about	O
270	O
mg	O
in	O
a	O
3	O
kg	O
fetus	O
[	O
16	O
].	O

Joo	O
and	O
colleagues	O
[	O
17	O
]	O
found	O
that	O
weekly	O
text	O
messages	O
about	O
diet	O
and	O
PA	O
behavior	O
promoted	O
weight	O
loss	O
.	O

Moreover	O
,	O
serum	O
vitamin	O
D	O
was	O
measured	O
by	O
ELISA	O
kit	O
,	O
which	O
is	O
of	O
lower	O
accuracy	O
compared	O
with	O
HPLC	O
and	O
RIA	O
methods	O
.	O

Thyroid	O
hormones	O
(	O
thyroid	O
stimulating	O
hormone	O
,	O
thyroglobulin	O
,	O
total	O
thyroxine	O
)	O
will	O
be	O
determined	O
in	O
whole	O
blood	O
spots	O
by	O
using	O
electrochemiluminescence	O
immunoassays	O
.	O

UNIMMAP	O
is	O
a	O
balanced	O
preparation	O
of	O
15	O
vitamins	O
and	O
minerals	O
formulated	O
by	O
an	O
Expert	O
Committee	O
of	O
the	O
United	O
Nations	O
Children	O
'	O
s	O
Fund	O
,	O
World	O
Health	O
Organization	O
and	O
the	O
United	O
Nations	O
University	O
,	O
primarily	O
for	O
use	O
by	O
pregnant	O
and	O
lactating	O
women	O
.	O

Similar	O
discussions	O
on	O
the	O
incorporation	O
of	O
epigenetic	O
toxicity	O
into	O
the	O
regulatory	O
framework	O
are	O
also	O
a	O
current	O
focus	O
of	O
industry	O
supported	O
workshops	O
(	O
van	O
Ravenzwaay	O
et	O
al	O
.	O
2014	O
;	O
ECETOC2016	O
;	O
Miousse	O
et	O
al	O
.	O
2015	O
).	O

Children	O
were	O
asked	O
to	O
avoid	O
physical	O
activity	O
and	O
to	O
consume	O
liquids	O
2	O
hours	O
before	O
evaluation	O
to	O
prevent	O
errors	O
in	O
measurement	O
due	O
to	O
fluid	O
imbalances	O
.	O

Values	O
for	O
binary	O
outcomes	O
(*)	O
are	O
number	O
and	O
percentage	O
and	O
treatment	O
effects	O
are	O
relative	O
risks	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
evaluate	O
the	O
effect	O
of	O
postpartum	O
supplementation	O
of	O
vitamin	O
D	O
on	O
antirachitic	O
factor	O
of	O
the	O
mother	O
’	O
s	O
milk	O
,	O
and	O
infant	O
’	O
s	O
health	O
indexes	O
.	O

Genetic	O
influences	O
on	O
EAH	O
(	O
49	O
,	O
65	O
)	O
and	O
other	O
eating	O
behaviors	O
such	O
as	O
emotional	O
eating	O
(	O
66	O
)	O
are	O
supported	O
by	O
findings	O
that	O
the	O
behavior	O
is	O
more	B
common	I
when	O
1	O
or	O
both	O
parents	O
are	O
overweight	O
,	O
even	O
after	O
certain	O
environmental	O
factors	O
(	O
eg	O
,	O
parental	O
eating	O
habits	O
)	O
have	O
been	O
controlled	O
for	O
.	O

Based	O
on	O
an	O
extensive	O
review	O
of	O
the	O
literature	O
,	O
we	O
considered	O
this	O
hypothesis	O
for	O
the	O
3	O
nutritional	O
progressions	O
from	O
fetal	O
life	O
through	O
infancy	O
:	O
prenatal	O
nutrition	O
,	O
breastfeeding	O
and	O
introduction	O
of	O
solid	O
foods	O
.	O

Provider	O
Advice	O
on	O
Gestational	O
Weight	O
Gain	O
and	O
Weight	O
Gain	O
Target	O
Women	O
were	O
asked	O
(	O
1	O
)	O
“	O
Has	O
your	O
health	O
professional	O
told	O
you	O
how	O
many	O
pounds	O
(	O
kilos	O
)	O
you	O
should	O
gain	O
during	O
this	O
pregnancy	O
?”	O
(	O
2	O
)	O
“	O
How	O
many	O
pounds	O
(	O
kilos	O
)	O
did	O
your	O
health	O
professional	O
say	O
you	O
should	O
gain	O
from	O
the	O
beginning	O
to	O
the	O
end	O
of	O
this	O
pregnancy	O
?”	O
and	O
(	O
3	O
)	O
“	O
How	O
many	O
pounds	O
(	O
kilos	O
)	O
do	O
you	O
think	O
you	O
should	O
gain	O
from	O
the	O
beginning	O
to	O
the	O
end	O
of	O
this	O
pregnancy	O
?”	O
Responses	O
were	O
compared	O
to	O
the	O
2009	O
IOM	O
recommendations	O
.	O

The	O
neonatal	O
mortality	O
rate	O
in	O
this	O
area	O
was	O
estimated	O
at	O
29	O
.	O
9	O
deaths	O
per	O
1000	O
live	O
births	O
[	O
14	O
].	O

The	O
most	O
appropriate	O
treatment	O
for	O
clinical	O
N0	O
tumours	O
is	O
still	O
a	O
matter	O
of	O
debate	O
,	O
but	O
most	O
surgeons	O
prefer	O
prophylactic	O
node	O
dissection	O
because	B
MTC	O
metastasize	O
in	O
regional	O
lymph	O
nodes	O
at	O
a	O
very	O
early	O
stage	O
.	O

Circannual	O
rhythms	O
and	O
glucose	O
homeostasis	O
Circannual	O
rhythms	O
have	O
been	O
researched	O
in	O
animals	O
with	O
regards	O
to	O
reproduction	O
,	O
migration	O
and	O
hibernation	O
,	O
and	O
are	O
biological	O
survival	O
mechanisms	O
to	O
allow	O
certain	O
events	O
to	O
occur	O
at	O
the	O
most	O
favourable	O
time	O
in	O
the	O
year	O
[	O
38	O
].	O

It	O
has	O
been	O
shown	O
that	O
mice	O
fed	O
post	O
-	O
weaning	O
a	O
high	O
fat	O
diet	O
(	O
60	O
%	O
calories	O
from	O
fat	O
)	O
had	O
lower	O
expression	O
of	O
the	O
μ	O
-	O
opioid	O
receptor	O
gene	O
which	O
influences	O
reward	O
circuitry	O
in	O
the	O
ventral	O
tegmental	O
area	O
,	O
nucleus	O
accumbens	O
and	O
prefrontal	O
cortex	O
.	O
37	O
In	O
conclusion	O
,	O
the	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
may	O
be	O
a	O
consequence	B
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
but	O
can	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
pup	O
diets	O
.	O

DNA	O
methylation	O
analysis	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

Nutritional	O
programming	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
has	O
been	O
suggested	O
as	O
a	O
promising	B
method	O
to	O
manipulate	O
IMF	O
deposition	O
.	O

For	O
example	O
,	O
glioma	O
risk	O
is	O
greater	O
for	O
males	O
than	O
females	O
[	O
2	O
],	O
yet	O
the	O
pattern	O
of	O
seasonal	O
influence	O
upon	O
handedness	O
does	O
not	O
vary	O
significantly	O
between	O
females	O
and	O
males	O
[	O
177	O
].	O

ESR	O
was	O
measured	O
in	O
this	O
study	O
.	O

Logistic	O
regression	O
for	O
caries	O
status	O
was	O
also	O
performed	O
,	O
revealing	O
that	O
lower	O
household	O
income	O
,	O
poorer	O
ratings	O
of	O
children	O
’	O
s	O
general	O
health	O
,	O
and	O
lower	O
vitamin	O
D	O
levels	O
were	O
significantly	O
associated	O
with	O
S	O
-	O
ECC	O
(	O
Table	O
4	O
).	O

Physiological	O
changes	O
of	O
pregnancy	O
,	O
such	O
as	O
increased	O
heart	O
rate	O
and	O
blood	O
volume	O
,	O
may	O
complicate	O
general	O
anaesthesia	O
,	O
and	O
hypotension	O
caused	O
by	O
vena	O
cava	O
compression	O
of	O
the	O
uterus	O
during	O
a	O
long	O
period	O
in	O
the	O
supine	O
position	O
may	O
cause	O
foetal	O
hypoperfusion1	O
.	O

The	O
incidence	O
rate	O
of	O
repeat	O
episodes	O
of	O
all	O
type	O
pneumonia	O
was	O
significantly	O
higher	O
in	O
the	O
vitamin	O
D	O
group	O
(	O
table	O
3	O
).	O

The	O
second	O
statistical	O
comparison	O
was	O
between	O
those	O
receiving	O
SGA	O
monotherapy	O
and	O
those	O
receiving	O
SGAs	O
along	O
with	O
other	O
psychotropic	O
medications	O
(	O
defined	O
by	O
us	O
as	O
being	O
exposed	O
to	O
polytherapy	O
).	O

So	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
and	O
neonatal	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
.	O

More	O
than	O
60	O
%	O
of	O
all	O
premature	O
babies	O
are	O
born	O
in	O
South	O
Asia	O
and	O
sub	O
-	O
Saharan	O
Africa	O
which	O
have	O
the	O
highest	O
preterm	O
birth	O
rates	O
[	O
15	O
]	O
and	O
half	O
of	O
births	O
are	O
currently	O
in	O
facilities	O
.	O

Moreover	O
,	O
the	O
role	O
of	O
BAT	O
activation	O
appears	O
to	O
be	O
broader	O
than	O
solely	O
the	O
promotion	O
of	O
negative	O
energy	O
balance	O
(	O
for	O
rev	O
.,	O
see	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

Like	O
females	O
,	O
male	O
low	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
high	O
(>	O
125	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
serum	O
concentrations	O
decrease	O
not	O
only	O
spermatozoa	O
count	O
but	O
also	O
their	O
progressive	O
movement	O
as	O
well	O
as	O
increasing	O
morphology	O
abnormalities	O
.	O

This	O
may	O
account	O
for	O
improper	O
protein	O
synthesis	O
[	O
35	O
]	O
in	O
LP	O
offspring	O
.	O

b	O
Predicted	O
probability	O
plot	O
of	O
infant	O
stool	O
cluster	O
membership	O
by	O
maternal	O
dairy	O
intake	O
during	O
pregnancy	O
from	O
multinomial	O
logistic	O
regression	O
models	O
adjusted	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

Blood	O
lead	O
concentration	O
was	O
associated	O
with	O
a	O
45	O
g	O
decrease	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
110	O
,	O
22	O
),	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
)),	O
while	O
mercury	O
exposure	O
was	O
associated	O
with	O
a	O
5	O
g	O
,	O
95	O
%	O
CI	O
(-	O
56	O
,	O
66	O
)	O
increase	O
in	O
birth	O
weight	O
.	O

Humans	O
get	O
vitamin	O
D	O
(	O
cholecalciferol	O
)	O
from	O
exposure	O
to	O
sunlight	O
,	O
diet	O
and	O
dietary	O
supplements	O
.	O

Other	O
proteins	O
associated	O
with	O
DVD	O
deficiency	O
related	O
to	O
mitochondrial	O
function	O
,	O
and	O
the	O
dynamin	O
-	O
like	O
proteins	O
.	O

Until	O
the	O
adequate	O
treatment	O
of	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
is	O
established	O
,	O
a	O
safe	O
approach	O
may	O
be	O
to	O
correct	O
vitamin	O
D	O
deficiency	O
by	O
targeting	O
pregnant	O
women	O
at	O
high	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
.	O

In	O
addition	O
,	O
current	O
OECD	O
human	O
health	O
-	O
related	O
TGs	O
have	O
the	O
potential	O
for	O
adaptation	O
to	O
incorporate	O
adverse	O
epigenetic	O
endpoints	O
(	O
Greally	O
&	O
Jacobs2013	O
).	O

Also	O
,	O
we	O
included	O
50	O
healthy	O
populations	O
randomly	O
from	O
Alzahra	O
hospital	O
’	O
s	O
staff	O
that	O
were	O
matched	O
on	O
sex	O
,	O
age	O
and	O
living	O
style	O
situation	O
to	O
case	O
group	O
as	O
control	O
one	O
.	O

If	O
vitamin	O
D	O
deficiency	O
is	O
regarded	O
as	O
25	O
-	O
OH	O
vitamin	O
D3	O
lower	O
than	O
35	O
nmol	O
/	O
l	O
,	O
1279	O
.	O
2	O
%	O
of	O
patients	O
from	O
IG	O
and	O
81	O
.	O
9	O
%	O
from	O
CG	O
suffered	O
to	O
some	O
degrees	O
from	O
vitamin	O
D	O
deficiency	O
prior	O
to	O
the	O
intervention	O
.	O

Other	O
small	O
-	O
scale	O
studies	O
in	O
Belgium	O
showed	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
among	O
Belgian	O
postmenopausal	O
osteoporotic	O
women	O
[	O
33	O
]	O
and	O
elderly	O
[	O
34	O
].	O

Upon	O
reviewing	O
the	O
CT	O
,	O
we	O
immediately	O
notified	O
the	O
obstetric	O
and	O
vascular	O
teams	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
an	O
emergent	O
cesarean	O
section	O
and	O
repair	O
of	O
her	O
aortic	O
dissection	O
.	O

In	O
general	O
,	O
the	O
term	O
obesity	O
applies	O
to	O
both	O
the	O
obese	O
and	O
the	O
overweight	O
subjects	O
.	O

SEI	O
was	O
calculated	O
using	O
the	O
New	O
Zealand	O
SEI	O
of	O
occupational	O
status	O
,	O
deriving	O
a	O
number	O
between	O
10	O
and	O
90	O
based	O
on	O
the	O
woman	O
’	O
s	O
occupation	O
;	O
a	O
higher	O
number	O
indicates	O
higher	O
socioeconomic	O
status	O
[	O
30	O
].	O

Considering	B
that	O
ANS	O
is	O
stable	O
from	O
intrauterine	O
life	O
through	O
the	O
postnatal	O
period	O
[	O
42	O
–	O
44	O
],	O
an	O
inadequate	O
fetal	O
environment	O
can	O
lead	O
to	O
negative	O
changes	O
in	O
ANS	O
development	O
and	O
functionality	O
,	O
thus	B
promoting	O
long	O
-	O
lasting	O
consequences	O
later	O
in	O
life	O
.	O

Specimens	O
were	O
sent	O
to	O
our	O
microbiology	O
lab	O
for	O
standard	O
bacterial	O
cultures	O
within	O
2	O
hours	O
of	O
collection	O
.	O

Guidelines	O
could	O
be	O
developed	O
for	O
improved	O
molecular	O
(	O
in	O
vivo	O
,	O
in	O
vitro	O
and	O
epidemiological	O
)	O
and	O
bioinformatic	O
study	O
designs	O
that	O
incorporate	O
suitable	O
new	O
technologies	O
(	O
such	O
as	O
omics	O
platforms	O
)	O
and	O
appropriate	O
inhibitors	O
/	O
treatments	O
/	O
cessations	O
(	O
for	O
exposure	O
/	O
change	O
/	O
effect	O
validation	O
)	O
to	O
definitively	B
identify	O
detailed	O
epigenetic	O
mechanisms	O
that	O
link	O
,	O
or	O
act	O
as	B
markers	O
of	O
,	O
environmental	O
exposures	O
and	O
adverse	O
health	O
outcomes	O
.	O

We	O
also	O
examined	O
the	O
maternal	O
attitude	O
versus	O
gene	O
interaction	O
in	O
relation	O
to	O
fetal	O
birth	O
weight	O
.	O

We	O
did	O
not	O
see	O
a	O
U	O
-	O
shaped	O
association	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
SGA	O
,	O
as	O
previously	O
indicated	O
[	O
9	O
].	O

Eligible	O
participants	O
were	O
10	O
–	O
18	O
weeks	O
’	O
gestation	O
,	O
with	O
a	O
singleton	O
pregnancy	O
,	O
over	O
18	O
years	O
of	O
age	O
,	O
not	O
taking	O
any	O
medication	O
,	O
and	O
without	O
previous	O
or	O
current	O
gestational	O
diabetes	O
.	O

Some	O
studies	O
describe	O
a	O
positive	O
association	O
between	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
and	O
certain	O
socio	O
-	O
demographic	O
characteristics	O
,	O
such	O
as	O
age	O
[	O
15	O
,	O
16	O
,	O
18	O
,	O
20	O
],	O
education	O
[	O
15	O
,	O
17	O
,	O
18	O
,	O
36	O
,	O
39	O
]	O
and	O
marital	O
status	O
[	O
17	O
];	O
but	O
others	O
have	O
reported	O
an	O
inverse	O
relation	O
between	O
education	O
and	O
the	O
use	O
of	O
multivitamins	O
[	O
27	O
].	O

It	O
was	O
demonstrated	O
that	O
when	O
the	O
serotonin	O
levels	O
were	O
altered	O
by	O
SSRIs	O
during	O
early	O
development	O
of	O
brain	O
structure	O
,	O
the	O
functions	O
were	O
altered	O
.	O

Discussion	O
The	O
present	O
study	O
extends	O
previous	O
findings	O
and	O
provides	B
evidence	O
for	O
the	O
first	O
time	O
how	O
maternal	O
stress	O
and	O
GR	O
polymorphisms	O
can	O
potentially	O
affect	O
fetal	O
outcome	O
together	O
.	O

The	O
amount	O
of	O
energy	O
consumed	O
in	O
the	O
absence	O
of	O
hunger	O
is	O
variable	O
and	O
related	O
to	O
child	O
weight	O
.	O

Models	O
adjusted	O
for	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
parturitions	O
,	O
education	O
level	O
,	O
age	O
,	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
race	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
influenza	O
circulation	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
and	O
,	O
number	O
of	O
antenatal	O
visits	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
race	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

A	O
Review	O
of	O
Effectiveness	O
of	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
3	O
.	O
1	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#/##/###	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
.	O

Thus	O
,	O
correlation	O
estimates	O
obtained	O
are	O
comparable	O
across	O
cohorts	O
and	O
age	O
groups	O
.	O

In	O
this	O
study	O
,	O
215	O
women	O
with	O
GDM	O
were	O
seen	O
at	O
sites	O
randomized	O
to	O
deliver	O
either	O
MNT	O
or	O
standard	O
care	O
.	O
27Fewer	O
subjects	O
in	O
the	O
MNT	O
group	O
required	O
insulin	O
(	O
24	O
.	O
6	O
%	O
vs	O
31	O
.	O
7	O
%,	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
there	O
was	O
a	O
trend	O
to	O
fewer	O
women	O
having	O
a	O
glycated	O
hemoglobin	O
(	O
HbA1c	O
)	O
>	O
6	O
%	O
(	O
8	O
.	O
1	O
%	O
vs	O
13	O
.	O
6	O
%,	O
p	O
=	O
0	O
.	O
25	O
).	O

For	O
these	O
reasons	B
,	O
differentiated	O
thyroid	O
cancer	O
(	O
DTC	O
)	O
is	O
one	O
of	O
the	O
most	O
common	O
cancers	O
in	O
women	O
in	O
the	O
reproductive	O
age	O
.	O

(	O
9	O
)	O
did	O
not	O
identify	O
these	O
associations	O
.	O

Any	O
agent	O
that	O
can	O
cause	O
anaphylaxis	O
in	O
the	O
nonpregnant	O
state	O
could	O
also	O
cause	O
anaphylaxis	O
in	O
the	O
susceptible	O
or	O
sensitized	O
pregnant	O
patient	O
.	O

The	O
association	O
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risks	O
(	O
RR	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
and	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
.	O

If	O
a	O
mother	O
weaned	O
her	O
child	O
to	O
an	O
exclusively	O
formula	O
-	O
fed	O
diet	O
,	O
she	O
was	O
instructed	O
to	O
discontinue	O
the	O
supplements	O
but	O
to	O
return	O
for	O
the	O
final	O
study	O
visit	O
regardless	O
.	O

Recent	O
research	O
has	O
confirmed	O
that	O
ALL	O
can	O
originate	O
in	O
utero	O
.	O

The	O
impact	O
of	O
the	O
program	O
on	O
women	O
'	O
s	O
iron	O
and	O
helminth	O
infection	O
status	O
in	O
the	O
first	O
12	O
months	O
was	O
assessed	O
using	O
structured	O
questionnaires	O
,	O
stool	O
examination	O
and	O
haemoglobin	O
assessment	O
at	O
the	O
field	O
site	O
,	O
and	O
blood	O
sample	O
analysis	O
for	O
ferritin	O
,	O
soluble	O
Transferrin	O
Receptor	O
and	O
C	O
-	O
Reactive	O
Protein	O
(	O
to	O
identify	O
the	O
presence	O
of	O
acute	O
infection	O
).	O

Studies	O
have	O
consistently	B
found	O
that	O
higher	O
maternal	O
weight	O
entering	O
and	O
during	O
pregnancy	O
increases	O
risk	O
for	O
obesity	O
among	O
offspring	O
in	O
childhood	O
,	O
adolescence	O
,	O
and	O
adulthood	O
[	O
1	O
,	O
2	O
].	O

A	O
mound	O
of	O
uranium	O
-	O
laden	O
waste	O
the	O
size	O
of	O
several	O
football	O
fields	O
,	O
covered	O
with	O
a	O
thin	O
veneer	O
of	O
gravel	O
,	O
dominates	O
the	O
view	O
from	O
her	O
front	O
door	O
.	O

Women	O
who	O
reported	O
no	O
PNV	O
use	O
(	O
versus	O
any	O
reported	O
PNV	O
use	O
)	O
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
at	O
the	O
time	O
of	O
the	O
first	O
sample	O
(	O
OR	O
3	O
.	O
9	O
,	O
95	O
%	O
CI	O
2	O
.	O
9	O
,	O
5	O
.	O
2	O
)	O
and	O
second	O
sample	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
6	O
,	O
2	O
.	O
9	O
)	O
(	O
Table	O
3	O
)	O
in	O
models	O
adjusting	O
for	O
season	O
.	O

Lives	O
saved	O
modelling	O
for	O
preterm	O
mortality	O
reduction	O
A	O
Lives	O
Saved	O
Tool	O
(	O
LiST	O
)	O
analysis	O
examining	O
projected	O
lives	O
saved	O
with	O
interventions	O
for	O
preterm	O
birth	O
was	O
conducted	O
for	O
75	O
Countdown	O
to	O
2015	O
priority	O
countries	O
(	O
These	O
countries	O
are	O
:	O
Afghanistan	O
,	O
Angola	O
,	O
Azerbaijan	O
,	O
Bangladesh	O
,	O
Benin	O
,	O
Bolivia	O
,	O
Botswana	O
,	O
Brazil	O
,	O
Burkina	O
Faso	O
,	O
Burundi	O
,	O
Cambodia	O
,	O
Cameroon	O
,	O
Central	O
African	O
Republic	O
,	O
Chad	O
,	O
China	O
,	O
Comoros	O
,	O
Congo	O
,	O
Democratic	O
Republic	O
of	O
the	O
Congo	O
,	O
Côte	O
d	O
'	O
Ivoire	O
,	O
Djibouti	O
,	O
Egypt	O
,	O
Equatorial	O
Guinea	O
,	O
Eritrea	O
,	O
Ethiopia	O
,	O
Gabon	O
,	O
The	O
Gambia	O
,	O
Ghana	O
,	O
Guatemala	O
,	O
Guinea	O
,	O
Guinea	O
-	O
Bissau	O
,	O
Haiti	O
,	O
India	O
,	O
Indonesia	O
,	O
Iraq	O
,	O
Kenya	O
,	O
Democratic	O
Republic	O
of	O
Korea	O
,	O
Kyrgyz	O
Republic	O
,	O
Lao	O
People	O
'	O
s	O
Democratic	O
Republic	O
,	O
Lesotho	O
,	O
Liberia	O
,	O
Madagascar	O
,	O
Malawi	O
,	O
Mali	O
,	O
Mauritania	O
,	O
Mexico	O
,	O
Morocco	O
,	O
Mozambique	O
,	O
Myanmar	O
,	O
Nepal	O
,	O
Niger	O
,	O
Nigeria	O
,	O
Pakistan	O
,	O
Papua	O
New	O
Guinea	O
,	O
Peru	O
,	O
Philippines	O
,	O
Rwanda	O
,	O
Sao	O
Tome	O
and	O
Principe	O
,	O
Senegal	O
,	O
Sierra	O
Leone	O
,	O
Solomon	O
Islands	O
,	O
Somalia	O
,	O
South	O
Africa	O
,	O
South	O
Sudan	O
,	O
Sudan	O
,	O
Swaziland	O
,	O
Tajikistan	O
,	O
United	O
Republic	O
of	O
Tanzania	O
,	O
Togo	O
,	O
Turkmenistan	O
,	O
Uganda	O
,	O
Uzbekistan	O
,	O
Vietnam	O
,	O
Yemen	O
,	O
Zambia	O
,	O
and	O
Zimbabwe	O
.).	O

In	O
addition	O
,	O
10	O
%	O
of	O
the	O
questionnaires	O
were	O
doubled	O
-	O
checked	O
by	O
a	O
co	O
-	O
investigator	O
,	O
different	O
from	O
the	O
original	O
data	O
entry	O
person	O
.	O

Each	O
data	O
collector	O
will	O
use	O
Samsung	O
Galaxy	O
7	O
in	O
.	O

Factor	O
scores	O
of	O
dietary	O
patterns	O
were	O
calculated	O
by	O
summing	O
intakes	O
of	O
foods	O
weighed	O
by	O
their	O
factor	O
loading	O
for	O
each	O
participant	O
.	O

The	O
plasma	O
of	O
CC	O
and	O
RC	O
females	O
presented	O
a	O
higher	O
AST	O
/	O
ALT	O
ratio	O
than	O
the	O
plasma	O
of	O
CC	O
and	O
RC	O
males	O
,	O
respectively	O
(	O
Table1	O
).	O

Positions	O
of	O
the	O
markers	O
(	O
Mb	O
)	O
are	O
relative	O
to	O
the	O
centromere	O
.	O

Thus	B
,	O
preeclampsia	O
does	O
not	O
seem	O
to	O
mediate	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
trajectory	O
and	O
neonatal	O
birth	O
size	O
or	O
preterm	O
birth	O
.	O

The	O
health	O
district	O
has	O
a	O
total	O
of	O
25	O
health	O
facilities	O
which	O
are	O
inequitably	O
distributed	O
in	O
terms	O
of	O
population	O
coverage	O
over	O
the	O
7	O
health	O
areas	O
.	O

After	O
confirmation	O
of	O
mating	O
,	O
rats	O
were	O
housed	O
individually	O
in	O
standard	O
rat	O
cages	O
with	O
free	O
access	O
to	O
water	O
.	O

Finally	O
,	O
OCP	O
exposure	O
was	O
associated	O
with	O
a	O
μβof	O
7	O
g	O
,	O
95	O
%	O
CI	O
(-	O
25	O
,	O
99	O
)	O
with	O
an	O
estimated	O
σβof	O
18	O
g	O
.	O
We	O
examined	O
associations	O
between	O
individual	O
EDCs	O
and	O
birth	O
weight	O
to	O
understand	O
which	O
individual	O
EDCs	O
within	O
a	O
class	O
drive	O
the	O
value	O
of	O
μβ	O
,	O
given	O
by	O
the	O
posterior	O
distribution	O
of	O
the	O
BHLM	O
regression	O
coefficients	O
βx1	O
...	O
βxp	O
(	O
see	O
Figs	O
.	O
1and2	O
).	O

Information	O
of	O
the	O
single	O
datasets	O
are	O
stored	O
using	O
anonymous	O
IDs	O
.	O

Therefore	B
,	O
this	O
explorative	O
project	O
will	O
contribute	O
to	O
identifying	O
factors	O
that	O
may	O
be	O
targeted	O
in	O
future	O
pre	O
-	O
and	O
/	O
or	O
post	O
-	O
conception	O
maternal	O
interventions	O
for	O
optimal	O
offspring	O
development	O
and	O
possibly	O
reduction	O
in	O
adult	O
NCD	O
risk	O
.	O

2	O
.	O

Therefore	B
,	O
at	O
placental	O
level	O
,	O
the	O
contractile	O
status	O
does	O
not	O
really	O
affect	O
GR	O
transcription	O
.	O

This	O
correlation	O
remained	O
significant	O
even	O
after	O
controlling	O
for	O
multiple	O
confounders	O
.	O

Quartiles	O
were	O
not	O
used	O
because	O
the	O
distribution	O
of	O
25OHD	O
was	O
different	O
at	O
T1	O
and	O
T3	O
.	O

However	O
,	O
the	O
exact	O
window	O
of	O
exposure	O
when	O
the	O
underlying	O
risk	O
factor	O
(	O
s	O
)	O
most	O
occur	O
to	O
cause	O
disease	O
is	O
unknown	O
.	O

Part	O
of	O
the	O
explanation	B
seems	O
to	O
be	O
decreased	O
global	O
methylation	O
in	O
these	O
offspring	O
[	O
40	O
].	O

Voluntary	O
participation	O
of	O
the	O
study	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Two	O
clinical	O
trials	O
support	O
a	O
potential	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
preeclampsia	O
,	O
although	O
neither	O
of	O
these	O
treated	O
with	O
vitamin	O
D	O
supplements	O
alone	O
.	O

Serum	O
concentrations	O
can	O
be	O
detected	O
as	O
early	O
as	O
the	O
7th	O
week	O
of	O
gestation	O
,	O
reaching	O
the	O
maximum	O
around	O
the	O
40th	O
week	O
,	O
and	O
are	O
usually	O
undetectable	O
around	O
the	O
6th	O
week	O
postpartum	O
as	O
described	O
by	O
Davison	O
et	O
al	O
.	O

Greenland	O
and	O
colleagues	O
found	O
maternal	O
handwashing	O
in	O
the	O
neonatal	O
period	O
in	O
Indonesia	O
to	O
be	O
infrequent	O
,	O
with	O
handwashing	O
occurring	O
typically	O
because	O
of	O
discomfort	O
(	O
e	O
.	O
g	O
.,	O
due	O
to	O
sticky	O
substances	O
)	O
or	O
disgust	O
-	O
related	O
motivators	O
(	O
such	O
as	O
apparent	O
smell	O
)	O
[	O
10	O
].	O

South	O
African	O
statistics	O
show	O
that	O
only	O
52	O
%	O
of	O
women	O
attend	O
antenatal	O
care	O
before	O
20	O
weeks	O
’	O
gestation	O
[	O
30	O
],	O
thus	B
access	O
to	O
women	O
early	O
in	O
pregnancy	O
is	O
restricted	O
and	O
limits	O
enrolment	O
into	O
the	O
study	O
.	O

Results	O
The	O
present	O
study	O
was	O
conducted	O
on	O
100	O
children	O
(	O
63	O
boys	O
and	O
37	O
girls	O
)	O
with	O
a	O
mean	O
age	O
of	O
8	O
.	O
85	O
years	O
(	O
Range	O
:	O
6	O
–	O
14	O
;	O
SD	O
=	O
1	O
.	O
82	O
years	O
).	O

It	O
is	O
the	O
single	O
proportion	O
formula	O
(	O
n	O
=	O
[	O
Z	O
α	O
/	O
2	O
]	O
2	O
P	O
(	O
1	O
-	O
p	O
]	O
/	O
d2	O
)	O
at	O
95	O
%	O
confidence	O
interval	O
,	O
where	O
Z	O
α	O
/	O
2	O
=	O
1	O
.	O
96	O
,	O
P	O
=	O
prevalence	O
of	O
50	O
%,	O
and	O
d	O
=	O
5	O
%	O
of	O
marginal	O
error	O
[	O
22	O
].	O

Not	O
only	O
is	O
it	O
unlikely	B
that	O
a	O
human	O
would	O
receive	O
this	O
,	O
or	O
any	O
,	O
environmental	O
exposure	O
via	O
the	O
same	O
route	O
of	O
administration	O
,	O
but	O
also	O
the	O
way	O
in	O
which	O
an	O
exposure	O
is	O
administered	O
determines	O
its	O
overall	O
effect	O
.	O

A	O
significantly	O
larger	O
proportion	O
of	O
exposed	O
neonates	O
were	O
considered	O
LGA	O
(>	O
90th	O
centile	O
;	O
p	O
=	O
0	O
.	O
022	O
).	O

Abbreviations	O
CI	O
:	O
Confidence	O
intervals	O
;	O
dmft	O
:	O
decayed	O
,	O
missing	O
,	O
filled	O
teeth	O
;	O
ECC	O
:	O
Early	O
childhood	O
caries	O
;	O
GA	O
:	O
General	O
anesthesia	O
;	O
HSC	O
:	O
Health	O
sciences	O
centre	O
;	O
IOM	O
:	O
Institute	O
of	O
medicine	O
;	O
MHC	O
:	O
Misericordia	O
health	O
centre	O
;	O
OR	O
:	O
Odds	O
ratio	O
;	O
PTH	O
:	O
Parathyroid	O
hormone	O
;	O
SD	O
:	O
Standard	O
deviation	O
;	O
S	O
-	O
ECC	O
:	O
Severe	O
early	O
childhood	O
caries	O
.	O

This	O
suggestion	O
has	O
earlier	O
been	O
supported	O
by	O
ecological	O
studies	O
showing	O
that	O
variations	O
in	O
schizophrenia	O
outcome	O
between	O
countries	O
may	O
be	O
due	O
to	O
differences	O
in	O
the	O
diet	O
[	O
6	O
,	O
14	O
].	O

Authors	O
suggest	O
that	O
VD	O
may	O
increase	O
fertility	O
through	O
the	O
modulation	O
of	O
androgen	O
activity	O
[	O
44	O
].	O

Fifty	O
-	O
four	O
per	O
cent	O
of	O
women	O
exposed	O
to	O
polytherapy	O
in	O
our	O
study	O
were	O
treated	O
with	O
both	O
an	O
SGA	O
and	O
an	O
antidepressant	O
.	O

This	O
is	O
of	O
concern	O
because	O
excessive	O
weight	O
gain	O
is	O
associated	O
with	O
postpartum	O
weight	O
retention	O
and	O
persistent	O
maternal	O
obesity	O
[	O
4	O
].	O

[	O
6	O
]	O
sampled	O
women	O
in	O
gestational	O
week	O
26	O
–	O
28	O
,	O
and	O
found	O
a	O
higher	O
OR	O
for	O
SGA	O
than	O
the	O
two	O
studies	O
that	O
sampled	O
women	O
in	O
T1	O
.	O

(	O
2015	O
)*/†	O
CaffeineMouseInjection	O
(	O
ip	O
)	O
(	O
20	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
Early	O
adulthood	O
F1offspringCardiac	O
abnormalitiesDNA	O
methylationBuscariollo	O
et	O
al	O
.	O

The	O
fieldworkers	O
obtained	O
written	O
informed	O
consent	O
from	O
the	O
mother	O
,	O
father	O
,	O
or	O
another	O
senior	O
family	O
member	O
before	O
recruitment	O
;	O
allocated	O
the	O
unique	O
identification	O
number	O
(	O
sequentially	O
);	O
and	O
gave	O
the	O
first	O
dose	O
of	O
vitamin	O
D3or	O
placebo	O
.	O

The	O
offspring	O
of	O
women	O
with	O
a	O
serum	O
-	O
free	O
thyroxine	O
(	O
fT4	O
)	O
concentration	O
in	O
the	O
lowest	O
decile	O
of	O
the	O
reference	O
range	O
at	O
12	O
weeks	O
of	O
gestation	O
may	O
have	O
significant	O
delays	O
in	O
neurodevelopment	O
.	O

Women	O
from	O
Algeria	O
,	O
Egypt	O
,	O
Libya	O
,	O
Morocco	O
,	O
Sudan	O
,	O
Tunisia	O
,	O
and	O
Western	O
Sahara	O
were	O
considered	O
of	O
North	O
African	O
descent	O
.	O

In	O
this	O
software	O
,	O
the	O
artifacts	O
were	O
corrected	O
with	O
a	O
moderated	O
filter	O
,	O
and	O
the	O
time	O
-	O
domain	O
components	O
were	O
calculated	O
.	O

It	O
does	O
not	O
include	O
substantial	O
participant	O
investment	O
of	O
time	O
and	O
effort	O
,	O
or	O
interactivity	O
.	O

In	O
addition	O
,	O
quality	O
gaps	O
are	O
a	O
missed	O
opportunity	O
for	O
reaching	O
families	O
;	O
for	O
example	O
,	O
when	O
a	O
midwife	O
is	O
present	O
at	O
birth	O
but	O
is	O
not	O
equipped	O
to	O
prevent	O
post	O
partum	O
haemorrhage	O
or	O
to	O
resuscitate	O
a	O
baby	O
who	O
does	O
not	O
breathe	O
[	O
5	O
,	O
6	O
].	O

The	O
placenta	O
expresses	O
all	O
the	O
necessary	O
components	O
to	O
convert	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
and	O
thus	O
utilise	O
active	O
vitamin	O
D	O
either	O
locally	O
or	O
in	O
a	O
paracrine	O
manner	O
[	O
45	O
,	O
47	O
].	O

Thumbprint	O
or	O
signature	O
consent	O
was	O
obtained	O
from	O
the	O
child	O
'	O
s	O
parents	O
(	O
mother	O
and	O
father	O
if	O
in	O
Kabul	O
or	O
another	O
family	O
member	O
responsible	O
for	O
the	O
child	O
)	O
at	O
home	O
if	O
the	O
child	O
met	O
our	O
study	O
criteria	O
and	O
after	O
either	O
the	O
parent	O
read	O
the	O
Dari	O
consent	O
form	O
or	O
it	O
was	O
explained	O
to	O
him	O
or	O
her	O
by	O
the	O
fieldworker	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Primary	O
Prevention	O
of	O
Asthma	O
and	O
Allergies	O
in	O
Early	O
LifePreventive	O
Measures	O
Smoking	O
and	O
exposure	O
to	O
environmental	O
tobacco	O
smoke	O
should	O
be	O
avoided	O
,	O
especially	O
during	O
pregnancy	O
and	O
early	O
childhood	O
Alcohol	O
consumption	O
should	O
be	O
avoided	O
by	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
Damp	O
housing	O
conditions	O
should	O
be	O
avoided	O
and	O
indoor	O
air	O
pollutants	O
reduced	O
,	O
especially	O
for	O
high	O
-	O
risk	O
children	O
(	O
history	O
of	O
atopy	O
or	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
)	O
Breast	O
-	O
feeding	O
should	O
be	O
performed	O
exclusively	O
until	O
6	O
months	O
with	O
no	O
special	O
diet	O
for	O
the	O
lactating	O
mother	O
(	O
except	O
when	O
the	O
mother	O
is	O
already	O
diagnosed	O
with	O
food	O
allergy	O
)	O
Nonprescription	O
drugs	O
should	O
be	O
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	O
recommended	O
by	O
a	O
physician	O
Smoking	O
and	O
Alcohol	O
Smoking	O
and	O
passive	O
exposure	O
to	O
cigarette	O
smoke	O
as	O
well	O
as	O
alcohol	O
consumption	O
should	O
be	O
strictly	O
avoided	O
.	O

Vitamin	O
D2	O
(	O
ergocalciferol	O
),	O
from	O
dietary	O
sources	O
or	O
supplements	O
,	O
and	O
vitamin	O
D3are	O
metabolized	O
in	O
the	O
liver	O
to	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
),	O
which	O
is	O
the	O
major	O
circulating	O
form	O
of	O
vitamin	O
D	O
and	O
is	O
used	O
to	O
determine	O
an	O
individual	O
'	O
s	O
vitamin	O
D	O
status	O
[	O
1	O
].	O

Defective	O
Spermatogenesis	O
:	O
Martin	O
et	O
al	O
.	O

Vasomotor	O
rhinitis	O
of	O
pregnancy	O
is	O
a	O
syndrome	O
of	O
nasal	O
congestion	O
and	O
vasomotor	O
instability	O
limited	O
to	O
the	O
gestational	O
period	O
.	O

[	O
40	O
]	O
More	O
than	O
60	O
%	O
of	O
the	O
women	O
of	O
the	O
women	O
had	O
low	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
at	O
30	O
-	O
week	O
gestation	O
.	O

The	O
Animal	O
Use	O
Protocol	O
was	O
approved	O
by	O
the	O
McGill	O
University	O
Animal	O
Care	O
Committee	O
.	O

Epigenetic	O
modifications	O
have	O
been	O
suggested	O
to	O
occur	O
during	O
development	O
(	O
fetal	O
programming	O
),	O
growth	O
,	O
and	O
fat	O
deposition	O
in	O
cattle	O
[	O
13	O
,	O
18	O
,	O
159	O
].	O

The	O
exposed	O
neonates	O
were	O
more	O
likely	B
to	O
be	O
born	O
premature	O
,	O
were	O
admitted	O
more	O
often	O
to	O
the	O
neonatal	O
intensive	O
care	O
unit	O
,	O
presented	O
with	O
poor	O
neonatal	O
adaptation	O
signs	O
and	O
had	O
higher	O
rates	O
of	O
congenital	O
malformations	O
.	O

Among	O
these	O
were	O
defects	O
thought	O
to	O
be	O
connected	O
to	O
radiation	O
exposure	O
(	O
e	O
.	O
g	O
.,	O
chromosomal	O
disorders	O
,	O
single	O
gene	O
mutations	O
)	O
as	O
well	O
as	O
distinctly	O
nonrelated	O
defects	O
(	O
e	O
.	O
g	O
.,	O
deaths	O
due	O
to	O
obstetrical	O
complications	O
).	O

This	O
observation	O
is	O
similar	O
to	O
studies	O
carried	O
out	O
in	O
Kenya	O
[	O
13	O
]	O
and	O
South	O
Africa	O
[	O
14	O
]	O
where	O
women	O
started	O
clinic	O
late	O
because	O
of	O
perceived	O
lack	O
of	O
benefit	O
,	O
limited	O
facility	O
access	O
,	O
uncertainty	O
about	O
pregnancy	O
and	O
“	O
laziness	O
”	O
to	O
go	O
for	O
many	O
visits	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
newborn	O
birth	O
size	O
The	O
effect	O
of	O
maternal	O
factors	O
on	O
birth	O
size	O
in	O
fully	O
adjusted	O
models	O
is	O
presented	O
in	O
Table	O
2and	O
Fig	O
.	O

Cells	O
were	O
then	O
washed	O
with	O
PBS	O
prior	O
to	O
an	O
incubation	O
with	O
a	O
TRITC	O
-	O
conjugated	O
secondary	O
antibody	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
USA	O
)	O
for	O
1	O
hr	O
.	O

Considerable	O
controversy	O
still	O
exists	O
over	O
the	O
optimal	O
extent	O
of	O
primary	O
surgical	O
resection	O
.	O

Laboratory	O
analysis	O
Serum	O
25OHD	O
concentrations	O
were	O
determined	O
using	O
the	O
Elecsys	O
Vitamin	O
D	O
Total	O
(	O
Roche	O
Diagnostics	O
GmbH	O
,	O
Mannheim	O
,	O
Germany	O
)	O
automated	O
competitive	O
binding	O
protein	O
assay	O
[	O
3	O
].	O

As	B
a	O
result	O
,	O
higher	O
egg	O
consumption	O
among	O
participants	O
in	O
this	O
study	O
may	O
explain	B
the	O
higher	O
detection	O
rate	O
of	O
Vitamin	O
D2	O
.	O

PubMed	O
Central	O
:	O

In	O
a	O
population	O
-	O
based	O
prospective	O
study	O
,	O
it	O
has	O
been	O
shown	O
that	O
women	O
in	O
the	O
“	O
wheat	O
products	O
”	O
pattern	O
had	O
higher	O
odds	O
of	O
having	O
infants	O
with	O
the	O
low	O
birth	O
weight	O
and	O
head	O
circumference	O
compared	O
with	O
women	O
in	O
the	O
“	O
rice	O
,	O
fish	O
,	O
and	O
vegetables	O
”	O
pattern	O
[	O
24	O
].	O

After	O
electrophoresis	O
,	O
the	O
proteins	O
were	O
electroblotted	O
on	O
to	O
PVDF	O
transfer	O
membranes	O
(	O
Hybond	O
-	O
P	O
;	O
Amersham	O
Biosciences	O
).	O

A	O
linear	O
increase	O
in	O
IMF	O
content	O
was	O
observed	O
in	O
British	O
and	O
Japanese	O
Black	O
×	O
Holstein	O
-	O
type	O
cattle	O
during	O
a	O
long	O
fattening	O
period	O
in	O
a	O
feedlot	O
,	O
as	O
carcass	O
weight	O
increased	O
from	O
200	O
to	O
400	O
kg	O
(	O
reviewed	O
in	O
Pethick	O
et	O
al	O
[	O
69	O
]).	O

Quartiles	O
,	O
based	O
on	O
the	O
distribution	O
amongst	O
the	O
population	O
of	O
women	O
studied	O
,	O
in	O
the	O
standardised	O
concentrations	O
were	O
then	O
used	O
to	O
create	O
cut	O
-	O
points	O
and	O
designated	O
‘	O
low	O
’	O
(<	O
44	O
nmol	O
/	O
L	O
),	O
‘	O
low	O
-	O
moderate	O
’	O
(	O
44	O
–	O
63	O
nmol	O
/	O
L	O
),	O
‘	O
moderate	O
-	O
high	O
’	O
(	O
63	O
–	O
81	O
nmol	O
/	O
L	O
)	O
and	O
‘	O
high	O
’	O
(>	O
81	O
nmol	O
/	O
L	O
)	O
categories	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
.	O
Generalised	O
linear	O
models	O
(	O
Poisson	O
with	O
log	O
link	O
and	O
robust	O
variance	O
estimates	O
)	O
were	O
used	O
to	O
calculate	O
the	O
risk	O
ratios	O
for	O
pregnancy	O
complications	O
by	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
calculated	O
among	O
the	O
women	O
who	O
had	O
an	O
uncomplicated	O
pregnancy	O
.	O

Groundwater	O
iron	O
levels	O
will	O
be	O
measured	O
in	O
all	O
study	O
households	O
using	O
a	O
validated	O
test	O
kit	O
.	O

A	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

The	O
course	O
is	O
variable	O
[	O
43	O
].	O

Therefore	B
,	O
a	O
diet	O
-	O
dependent	O
tissue	O
remodelling	O
might	O
take	O
place	O
in	O
LP	O
offspring	O
as	O
observed	O
previously	O
[	O
30	O
].	O

Medical	O
history	O
of	O
kidney	O
dysfunction	O
.	O

The	O
two	O
factors	O
each	O
had	O
an	O
independent	O
effect	O
,	O
and	O
were	O
more	O
marked	O
for	O
oesophageal	O
cancer	O
than	O
for	O
the	O
other	O
tumours	O
.	O

By	O
eschewing	O
insulin	O
,	O
doctors	O
may	O
actually	O
be	O
treating	O
their	O
own	O
perceived	O
fear	O
of	O
injections	O
,	O
rather	O
than	O
providing	O
the	O
best	O
therapy	O
to	O
the	O
patient	O
.	O

Monitoring	O
involved	O
printing	O
forms	O
,	O
distributing	O
them	O
to	O
the	O
relevant	O
level	O
(	O
village	O
level	O
for	O
iron	O
supplements	O
:	O
commune	O
level	O
for	O
de	O
-	O
worming	O
),	O
and	O
then	O
returning	O
them	O
to	O
Yen	O
Bai	O
and	O
monthly	O
mailing	O
back	O
to	O
NIMPE	O
.	O

At	O
6	O
months	O
,	O
higher	O
percentage	O
of	O
calories	O
from	O
fat	O
early	O
in	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
lower	O
WFA	O
z	O
-	O
scores	O
(	O
Table	O
4	O
;	O
beta	O
=	O
−	O
0	O
.	O
35	O
;	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
reduced	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
OR	O
=	O
0	O
.	O
81	O
(	O
0	O
.	O
70	O
,	O
0	O
.	O
94	O
);	O
P	O
=	O
.	O
007	O
).	O

However	O
,	O
such	O
a	O
relation	O
has	O
not	O
yet	O
been	O
confirmed	O
.	O

Benefit	O
-	O
Cost	O
Analysis	O
Effectiveness	O
data	O
were	O
obtained	O
from	O
the	O
two	O
pilot	O
districts	O
,	O
which	O
were	O
surveyed	O
at	O
baseline	O
and	O
at	O
3	O
,	O
12	O
and	O
30	O
months	O
post	O
-	O
implementation	O
for	O
the	O
impact	O
on	O
anaemia	O
and	O
helminth	O
infection	O
status	O
,	O
and	O
independent	O
compliance	O
monitoring	O
at	O
10	O
weeks	O
,	O
18	O
and	O
36	O
months	O
post	O
-	O
implementation	O
.	O

2	O
-	O
D	O
gel	O
electrophoresis	O
-	O
based	O
proteomics	O
and	O
mass	O
spectroscopy	O
were	O
used	O
to	O
investigate	O
differential	O
protein	O
expression	O
.	O

Levels	O
of	O
vitamin	O
D	O
are	O
known	O
to	O
fluctuate	O
depending	O
on	O
sunlight	O
exposure	O
,	O
which	O
is	O
highest	O
in	O
the	O
summer	O
for	O
the	O
northern	O
hemisphere	O
and	O
tends	O
to	O
increase	O
for	O
latitudes	O
nearer	O
the	O
equator	O
[	O
145	O
,	O
148	O
–	O
150	O
].	O

Children	O
were	O
classified	O
as	O
overweight	O
(+	O
1	O
SDS	O
)	O
or	O
obese	O
(+	O
2	O
SDS	O
)	O
according	B
to	I
BMI	O
-	O
for	O
-	O
age	O
following	O
the	O
cut	O
-	O
off	O
parameters	O
of	O
the	O
WHO	O
growth	O
standards	O
[	O
23	O
].	O

The	O
second	O
section	O
covers	O
the	O
role	O
of	O
nutrition	O
in	O
pregnancy	O
and	O
lactation	O
,	O
exocrine	O
and	O
sports	O
as	O
also	O
food	O
allergy	O
.	O

Fetal	O
nutritional	O
programming	O
Fetal	O
programming	O
or	O
prenatal	O
programing	O
is	O
the	O
concept	O
that	O
mammalian	O
embryonic	O
and	O
fetal	O
development	O
are	O
linked	O
to	O
environmental	O
changes	O
,	O
thus	B
affecting	O
the	O
entire	O
life	O
[	O
152	O
].	O

Further	O
study	O
is	O
necessary	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
C	O
on	O
MS	O
and	O
QG	O
in	O
other	O
breeds	O
of	O
beef	O
cattle	O
.	O

Hence	B
,	O
iron	O
supplementation	O
in	O
pregnancy	O
has	O
become	O
a	O
standard	O
and	O
routine	O
practice	O
as	B
a	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

Further	O
research	O
is	O
required	O
to	O
determine	O
the	O
physiological	O
pathways	O
and	O
clinical	O
significance	O
of	O
our	O
observations	O
.	O

For	O
instance	O
,	O
environmental	O
pollutants	O
such	O
as	O
polychlorinated	O
biphenyls	O
(	O
PCB	O
)	O
and	O
dioxins	O
are	O
known	O
to	O
accumulate	O
in	O
fatty	O
fish	O
[	O
38	O
].	O

Although	O
potentially	O
toxic	O
at	O
high	O
doses	O
,	O
these	O
glycosides	O
are	O
used	O
to	O
treat	O
congestive	O
heart	O
failure	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
risk	O
ratio	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
of	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
according	O
to	O
self	O
-	O
reported	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
.	O
Gestational	O
Diabetes	O
Mellitus	O
*	O
All	O
*	O
Lean	O
*	O
Overweight	O
No	O
N	O
=	O
1222	O
(	O
n	O
)	O
Yes	O
N	O
=	O
68	O
(	O
n	O
)	O
1Adjusted	O
RR	O
(	O
95	O
%	O
CI	O
)	O
1Adjusted	O
RR	O
(	O
95	O
%	O
CI	O
)	O
1Adjusted	O
RR	O
(	O
95	O
%	O
CI	O
)	O
Sleep	O
duration	O
during	O
pregnancy	O
≤	O
4	O
hours1835	O
.	O
56	O
(	O
1	O
.	O
31	O
-	O
23	O
.	O
69	O
)	O
3	O
.	O
23	O
(	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
9	O
.	O
83	O
(	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
5	O
-	O
8	O
hours818521	O
.	O
99	O
(	O
0	O
.	O
89	O
-	O
4	O
.	O
47	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
47	O
-	O
3	O
.	O
43	O
)	O
3	O
.	O
47	O
(	O
0	O
.	O
79	O
-	O
15	O
.	O
22	O
)	O
9	O
hours25071	O
.	O
00	O
--	O
Reference	O
1	O
.	O
00	O
--	O
Reference1	O
.	O
00	O
--	O
Reference	O
≥	O
10	O
hours12961	O
.	O
82	O
(	O
0	O
.	O
60	O
-	O
5	O
.	O
57	O
)	O
1	O
.	O
39	O
(	O
0	O
.	O
32	O
-	O
5	O
.	O
98	O
)	O
2	O
.	O
56	O
(	O
0	O
.	O
40	O
-	O
16	O
.	O
43	O
)	O
Missing70Snore	O
during	O
pregnancy	O
No1112571	O
.	O
00	O
--	O
Reference	O
1	O
.	O
00	O
--	O
Reference1	O
.	O
00	O
--	O
Reference	O
Yes8091	O
.	O
86	O
(	O
0	O
.	O
88	O
-	O
3	O
.	O
94	O
)	O
Insufficient	O
data2	O
.	O
54	O
(	O
0	O
.	O
95	O
-	O
5	O
.	O
73	O
)	O
Missing302	O
*	O
All	O
refers	O
to	O
analysis	O
completed	O
on	O
the	O
entire	O
cohort	O
,	O
and	O
after	O
restriction	O
to	O
lean	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
and	O
overweight	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
women	O
,	O
respectively	O
.	O

Results	O
:	O
A	O
total	O
of	O
3268	O
women	O
were	O
included	O
in	O
the	O
final	O
analysis	O
.	O

This	O
sample	O
would	O
allow	O
detection	O
of	O
a	O
22	O
%	O
relative	O
difference	O
between	O
treatment	O
groups	O
with	O
80	O
%	O
power	O
.	O

Another	O
finding	O
of	O
this	O
study	O
was	O
that	O
vitamin	O
D3supplementation	O
was	O
effective	O
in	O
decreasing	O
depression	O
level	O
in	O
both	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

In	O
contrast	O
,	O
height	O
of	O
the	O
child	O
was	O
strongly	O
associated	O
with	O
those	O
of	O
all	O
family	O
members	O
at	O
age	O
5	O
,	O
but	O
at	O
birth	O
and	O
at	O
age	O
9	O
only	O
there	O
was	O
an	O
association	O
with	O
those	O
of	O
the	O
parents	O
and	O
the	O
paternal	O
grandfather	O
.	O

An	O
increased	O
daily	O
dose	O
of	O
120	O
mg	O
of	O
iron	O
is	O
further	O
suggested	O
if	O
the	O
duration	O
of	O
supplementation	O
in	O
pregnant	O
nonanaemic	O
women	O
is	O
shorter	O
or	O
where	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
in	O
women	O
is	O
high	O
or	O
in	O
settings	O
where	O
pregnant	O
women	O
are	O
generally	O
anaemic	O
[	O
27	O
].	O

Free	O
sugar	O
does	O
not	O
include	O
lactose	O
when	O
naturally	O
present	O
in	O
milk	O
and	O
milk	O
products	O
or	O
the	O
sugars	O
contained	O
within	O
the	O
cellular	O
structure	O
of	O
fruits	O
and	O
vegetables	O
.	O

Steers	O
in	O
the	O
high	O
-	O
energy	O
group	O
had	O
greater	O
LM	O
IMF	O
content	O
than	O
those	O
in	O
the	O
low	O
-	O
energy	O
group	O
,	O
whereas	O
dietary	O
protein	O
levels	O
did	O
not	O
affect	O
IMF	O
content	O
.	O

Age	O
had	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
18	O
and	O
39	O
,	O
respectively	O
.	O

The	O
data	O
were	O
analyzed	O
using	O
the	O
SPSS	O
statistical	O
software	O
(	O
v	O
.	O
16	O
).	O

Conclusions	O
Antenatal	O
dietary	O
and	O
lifestyle	O
advice	O
did	O
not	O
alter	O
infant	O
growth	O
and	O
adiposity	O
at	O
6	O
-	O
months	O
of	O
age	O
.	O

Indeed	O
,	O
for	O
the	O
risk	O
of	O
GDM	O
an	O
opposite	O
effect	O
of	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
observed	O
depending	O
on	O
fetal	O
sex	O
.	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	O
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	O
to	O
be	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

Our	O
observation	O
of	O
increased	O
colonization	O
with	O
the	O
species	O
Acinetobacter	O
rhizosphaerae	O
,	O
a	O
microbe	O
that	O
colonizes	O
and	O
promotes	O
growth	O
in	O
plants	O
[	O
19	O
],	O
with	O
maternal	O
dairy	O
in	O
the	O
Cesarean	O
group	O
is	O
interesting	O
in	O
conjunction	O
with	O
the	O
positive	O
associations	O
found	O
between	O
maternal	O
dairy	O
and	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
Staphylococcus	O
genus	O
in	O
vaginally	O
delivered	O
infants	O
.	O

Many	O
farm	O
chemicals	O
are	O
classified	O
as	O
probable	B
or	O
likely	B
human	O
carcinogens	O
by	O
the	O
US	O
Environmental	O
Protection	O
Agency	O
(	O
EPA	O
),	O
most	O
notably	O
acephate	O
,	O
dichlorvos	O
,	O
dimethoate	O
,	O
lindane	O
,	O
parathion	O
,	O
phosmet	O
,	O
and	O
tetrachlorvinphos	O
[	O
28	O
].	O

However	O
,	O
the	O
perspective	O
is	O
changing	O
from	O
one	O
of	O
not	O
just	O
needing	O
any	O
service	O
to	O
one	O
in	O
which	O
quality	O
is	O
a	O
key	O
component	O
in	O
health	O
care	O
provision	O
[	O
6	O
,	O
7	O
].	O

Model	O
system	O
Stage	O
of	O
development	O
Environmental	O
exposureSpeciesRoute	O
of	O
administrationExposureEffectAdverse	O
phenotype	O
(	O
s	O
)	O
Epigenetic	O
change	O
(	O
s	O
)	O
ReferenceChemicals	O
Bisphenol	O
A	O
(	O
BPA	O
)	O
Mouse	O
RatOral	O
(	O
diet	O
)	O
(	O
50	O
µg	O
-	O
50	O
mg	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
40	O
–	O
200	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Injection	O
(	O
not	O
specified	O
)	O
(	O
20	O
or	O
40	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Combinations	O
of	O
:	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
In	O
utero	O
Lactation	O
Neonatal	O
Childhood	O
Adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adulthood	O
F0	O
-	O
F2generationsReproductive	O
,	O
neurological	O
,	O
behavioral	O
,	O
metabolic	O
and	O
cardiac	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryChao	O
et	O
al	O
.	O

Important	O
changes	O
occur	O
in	O
the	O
maternal	O
concentration	O
of	O
vitamin	O
D	O
and	O
in	O
calcium	O
metabolism	O
to	O
provide	O
the	O
calcium	O
needed	O
for	O
fetal	O
bone	O
mineral	O
accretion	O
during	O
pregnancy	O
.	O

Interventions	O
with	O
the	O
highest	O
impact	O
on	O
the	O
prevention	O
of	O
preterm	O
birth	O
and	O
care	O
of	O
the	O
premature	O
baby	O
in	O
high	O
-	O
mortality	O
and	O
lower	O
-	O
resource	O
settings	O
can	O
be	O
integrated	O
into	O
these	O
health	O
service	O
delivery	O
packages	O
,	O
which	O
exist	O
in	O
most	O
health	O
systems	O
and	O
involve	O
links	O
with	O
maternal	O
and	O
child	O
health	O
services	O
,	O
as	O
well	O
as	O
immunisation	O
,	O
malaria	O
,	O
HIV	O
/	O
AIDS	O
,	O
nutrition	O
,	O
family	O
planning	O
,	O
and	O
other	O
related	O
programs	O
[	O
22	O
].	O

Real	O
-	O
time	O
qPCR	O
was	O
performed	O
using	O
a	O
CFX96	O
Touch	O
™	O
Real	O
-	O
Time	O
PCR	O
Detection	O
System	O
(	O
Bio	O
-	O
Rad	O
).	O

We	O
did	O
not	O
record	O
any	O
immediate	O
or	O
other	O
adverse	O
events	O
associated	O
with	O
vitamin	O
D3supplementation	O
.	O

While	O
DEP	O
was	O
associated	O
with	O
a	O
14	O
g	O
increase	O
in	O
birth	O
weight	O
in	O
the	O
combined	O
analysis	O
,	O
it	O
was	O
associated	O
with	O
a	O
51	O
g	O
increase	O
in	O
males	O
and	O
a	O
9	O
g	O
decrease	O
in	O
females	O
in	O
the	O
sex	O
stratified	O
analysis	O
.	O

Re	O
-	O
establishment	O
of	O
new	O
epigenetic	O
marks	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

We	O
selected	O
infants	O
from	O
inner	O
-	O
city	O
Kabul	O
because	O
we	O
knew	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency12and	O
incidence	O
of	O
pneumonia3	O
,	O
15were	O
high	O
.	O

In	O
contrast	O
,	O
“	O
brite	O
”	O
adipocytes	O
have	O
been	O
shown	O
to	O
originate	O
from	O
Myf	O
-	O
negative	O
(	O
Myf	O
5	O
−)	O
progenitor	O
cells	O
,	O
much	O
like	O
white	O
adipocytes	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
;	O
Long	O
et	O
al	O
.,	O
2014	O
).	O

Women	O
will	O
not	O
receive	O
any	O
additional	O
information	O
or	O
counselling	O
other	O
than	O
usual	O
standard	O
care	O
provided	O
by	O
the	O
existing	O
BRAC	O
structure	O
.	O

Although	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
had	O
similar	O
effects	O
on	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
blood	O
glucose	O
response	O
by	O
preventing	O
the	O
negative	O
consequences	O
of	O
the	O
HV	O
gestational	O
diet	O
,	O
they	O
differed	O
in	O
their	O
impact	O
on	O
expression	O
in	O
food	O
intake	O
regulatory	O
genes	O
in	O
the	O
hypothalamus	O
.	O

After	O
this	O
procedure	O
,	O
children	O
were	O
asked	O
to	O
lay	O
silently	O
in	O
a	O
supine	O
position	O
on	O
a	O
bed	O
with	O
minimal	O
body	O
movement	O
and	O
to	O
maintain	O
spontaneous	O
breathing	O
for	O
10	O
minutes	O
to	O
record	O
both	O
resting	O
heart	O
rate	O
and	O
short	O
-	O
term	O
HRV	O
using	O
a	O
Polar	O
S810i	O
monitor	O
(	O
Polar	O
Electro	O
OY	O
,	O
Finland	O
;	O
sampling	O
rate	O
=	O
100Hz	O
)	O
[	O
27	O
,	O
28	O
].	O

While	O
it	O
has	O
been	O
suggested	O
that	O
body	O
fat	O
and	O
therefore	B
childhood	O
nutrition	O
per	O
se	O
play	O
a	O
direct	O
role	O
in	O
determining	O
the	O
age	O
of	O
pubertal	O
onset	O
[	O
36	O
],[	O
37	O
],	O
the	O
effects	O
of	O
an	O
intrauterine	O
obesogenic	O
environment	O
have	O
not	O
been	O
considered	O
.	O

Recruitment	O
and	O
consent	O
procedures	O
Consecutive	O
sampling	O
is	O
applied	O
,	O
thus	O
,	O
all	O
accessible	O
pregnant	O
women	O
at	O
the	O
recruitment	O
sites	O
may	O
form	O
part	O
of	O
the	O
sample	O
,	O
if	O
they	O
meet	O
the	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
arrive	O
at	O
study	O
site	O
on	O
their	O
booked	O
date	O
and	O
sign	O
informed	O
consent	O
.	O

Standard	O
methods	O
for	O
estimating	O
uncertainty	O
and	O
a	O
cost	O
-	O
effectiveness	O
acceptability	O
curve	O
will	O
be	O
generated	O
to	O
provide	O
information	O
on	O
the	O
probability	O
that	O
the	O
intervention	O
is	O
cost	O
-	O
effective	O
,	O
at	O
different	O
willingness	O
to	O
pay	O
thresholds	O
.	O

The	O
strength	O
of	O
this	O
study	O
lies	O
in	O
its	O
comprehensive	O
sample	O
and	O
size	O
but	O
did	O
not	O
measure	O
some	O
other	O
maternal	O
factors	O
such	O
as	O
substance	O
abuse	O
and	O
nutritional	O
influence	O
[	O
47	O
].	O

We	O
suggest	O
further	O
clinical	O
trial	O
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

We	O
also	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
weight	O
outcomes	O
(	O
Table	O
4	O
).	O

The	O
omnibus	O
tests	O
of	O
model	O
coefficients	O
predicting	O
macrosomia	O
and	O
WFA	O
>	O
90th	O
percentile	O
at	O
birth	O
were	O
insignificant	O
and	O
few	O
cases	O
of	O
each	O
were	O
observed	O
.	O

Between	O
-	O
group	O
and	O
within	O
-	O
group	O
comparison	O
did	O
not	O
reveal	O
any	O
significant	O
difference	O
for	O
serum	O
levels	O
of	O
phosphorus	O
,	O
BMI	O
or	O
HBA1C	O
(	O
table	O
2	O
).	O

At	O
birth	O
,	O
no	O
differences	O
were	O
observed	O
in	O
either	O
BM	O
or	O
NAL	O
between	O
offspring	O
.	O

First	O
,	O
prenatal	O
and	O
early	O
life	O
experiences	O
influence	O
the	O
trajectory	O
of	O
weight	O
into	O
adulthood	O
(	O
1	O
).	O

DNA	O
methylation	O
and	O
infant	O
growth	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpc	O
vs	O
.	O
1	O
dpn	O
AP	O
AMPK	O
signalingup6	O
.	O
96	O
*	O
E	O
-	O
38AKT2	O
,	O
INSR	O
,	O
PIK3C2A	O
,	O
PIK3R1	O
,	O
PPM1B	O
,	O
PRKAA1	O
,	O
PRKACB	O
,	O
RAC1	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown3	O
.	O
25	O
*	O
E	O
-	O
47CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
KIF11	O
,	O
PLK4	O
,	O
PTTG1	O
AP	O
Pyrimidine	O
metabolismdown2	O
.	O
52	O
*	O
E	O
-	O
310CAD	O
,	O
DCTD	O
,	O
DKC1	O
,	O
POLQ	O
,	O
POLR3E	O
,	O
POLR3K	O
,	O
RFC5	O
,	O
RRM1	O
,	O
TYMS	O
,	O
UCK2	O
AP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown2	O
.	O
04	O
*	O
E	O
-	O
46CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
UBC	O
,	O
YWHAE	O
LP	O
Purine	O
metabolismup9	O
.	O
20	O
*	O
E	O
-	O
312DDX39	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
RUVBL1	O
,	O
RUVBL2	O
LP	O
Pyrimidine	O
metabolismup6	O
.	O
15	O
*	O
E	O
-	O
714CTPS	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
PUS1	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
TXNRD1	O
,	O
TYMS	O
,	O
UCK2	O
LP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinaseup7	O
.	O
55	O
*	O
E	O
-	O
57ANAPC4	O
,	O
CDC27	O
,	O
CDK1	O
,	O
ESPL1	O
,	O
FZR1	O
,	O
PPP2R1B	O
,	O
PTTG1	O
LP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationup3	O
.	O
09	O
*	O
E	O
-	O
23CDK1	O
,	O
CHEK1	O
,	O
YWHAZ	O
LP	O
Wnt	O
signalingdown4	O
.	O
02	O
*	O
E	O
-	O
29AKT3	O
,	O
FZD5	O
,	O
MMP7	O
,	O
NLK	O
,	O
SOX4	O
,	O
TCF3	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5A1	O
dpn	O
vs	O
.	O
28	O
dpn	O
AP	O
AMPK	O
signalingup4	O
.	O
26	O
*	O
E	O
-	O
38AK1	O
,	O
CPT1A	O
,	O
EIF4EBP1	O
,	O
HMGCR	O
,	O
MAPK14	O
,	O
NOS3	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
mTOR	O
signalingup1	O
.	O
89	O
*	O
E	O
-	O
27EIF3F	O
,	O
EIF3G	O
,	O
EIF4EBP1	O
,	O
FNBP1	O
,	O
GNB1L	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationdown6	O
.	O
40	O
*	O
E	O
-	O
36ACAD8	O
,	O
ACADL	O
,	O
ACADSB	O
,	O
BCAT1	O
,	O
DBT	O
,	O
MCCC2	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup7	O
.	O
12	O
*	O
E	O
-	O
811ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
GCDH	O
,	O
HMGCL	O
,	O
HMGCS1	O
,	O
MCCC2	O
,	O
MCEE	O
LP	O
Fatty	O
acid	O
metabolismup3	O
.	O
23	O
*	O
E	O
-	O
38ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
CYP51A1	O
,	O
GCDH	O
,	O
PECI	O
LP	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
76	O
*	O
E	O
-	O
65ACAT1	O
,	O
ACAT2	O
,	O
BDH2	O
,	O
HMGCL	O
,	O
HMGCS1	O
LP	O
Biosynthesis	O
of	O
steroidsup3	O
.	O
27	O
*	O
E	O
-	O
45CYP24A1	O
,	O
FDPS	O
,	O
HMGCR	O
,	O
IDI1	O
,	O
SC5DL	O
LP	O
Glucocorticoid	O
receptor	O
signalingup3	O
.	O
57	O
*	O
E	O
-	O
312CDKN1C	O
,	O
CXCL3	O
,	O
IL10	O
,	O
MAP3K1	O
,	O
NCOA2	O
,	O
NFKBIB	O
,	O
NR3C1	O
,	O
POLR2B	O
,	O
PRKACB	O
,	O
RRAS2	O
,	O
SLPI	O
,	O
SMARCA4	O
LP	O
G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
22	O
*	O
E	O
-	O
24CCNE1	O
,	O
CDC25A	O
,	O
CDKN1A	O
,	O
E2F328	O
dpn	O
vs	O
.	O
188	O
dpn	O
AP	O
AMPK	O
signalingup1	O
.	O
50	O
*	O
E	O
-	O
310INSR	O
,	O
MAPK12	O
,	O
PPAT	O
,	O
PPM1A	O
,	O
PPP2CA	O
,	O
PPP2R3A	O
,	O
PRKAA2	O
,	O
SMARCA2	O
,	O
SRC	O
,	O
STK11	O
AP	O
Fatty	O
acid	O
metabolismup1	O
.	O
28	O
*	O
E	O
-	O
28ACADSB	O
,	O
ALDH1A1	O
,	O
CYP1B1	O
,	O
CYP2D6	O
,	O
CYP3A4	O
,	O
CYP4A11	O
,	O
CYP4B1	O
,	O
PECI	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown8	O
.	O
33	O
*	O
E	O
-	O
37ANAPC5	O
,	O
CDK1	O
,	O
PLK1	O
,	O
PLK2	O
,	O
PPP2R1B	O
,	O
SLK	O
,	O
WEE1	O
AP	O
VEGF	O
signalingdown7	O
.	O
3	O
*	O
E	O
-	O
39AKT3	O
,	O
BCL2	O
,	O
KDR	O
,	O
NOS3	O
,	O
PRKCB	O
,	O
RAC2	O
,	O
RRAS	O
,	O
VCL	O
,	O
VEGFC	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup1	O
.	O
07	O
*	O
E	O
-	O
27ACAA1	O
,	O
ACAT1	O
,	O
ALDH1B1	O
,	O
AUH	O
,	O
ECH1	O
,	O
IVD	O
,	O
IWS1	O
LP	O
Fatty	O
acid	O
elongation	O
in	O
mitochondriaup2	O
.	O
05	O
*	O
E	O
-	O
23ACAA1	O
,	O
AUH	O
,	O
ECH1	O
LP	O
mTOR	O
signalingup2	O
.	O
65	O
*	O
E	O
-	O
210AKT3	O
,	O
DDIT4	O
,	O
EIF4B	O
,	O
EIF4G3	O
,	O
PPP2R1B	O
,	O
PRKAB2	O
,	O
PRKAG1	O
,	O
PRKAG2	O
,	O
TSC1	O
,	O
VEGFA	O
LP	O
Actin	O
cytoskeleton	O
signalingdown7	O
.	O
99	O
*	O
E	O
-	O
524ACTB	O
,	O
ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CD14	O
,	O
CFL1	O
,	O
F2R	O
,	O
FGD1	O
,	O
LBP	O
,	O
MAP2K1	O
,	O
MYH9	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
TMSB4X	O
,	O
TMSL3	O
,	O
WASF1	O
LP	O
RhoA	O
signalingdow5	O
.	O
05	O
*	O
E	O
-	O
3n12ACTB	O
,	O
ACTR2	O
,	O
ARHGAP1	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
WASF1	O
LP	O
Rac	O
signalingdown4	O
.	O
34	O
*	O
E	O
-	O
312ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
MAP2K1	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
WASF1	O
LP	O
Complement	O
systemdown2	O
.	O
17	O
*	O
E	O
-	O
25C2	O
,	O
C7	O
,	O
C9	O
,	O
CFB	O
,	O
MBL2	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

BHLM	O
assumes	O
that	O
βxiare	O
Gaussian	O
random	O
effects	O
with	O
group	O
specific	O
mean	O
μβand	O
standard	O
deviation	O
σβ	O
.	O

Concerning	O
to	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
during	O
the	O
post	O
-	O
weaning	O
period	O
(	O
Figure2D	O
),	O
we	O
found	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1712	O
.	O
38	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
30	O
.	O
20	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Length	O
was	O
similar	O
between	O
Hispanic	O
and	O
Caucasians	O
,	O
50	O
.	O
3	O
±	O
2	O
.	O
1	O
cm	O
versus	O
50	O
.	O
5	O
±	O
2	O
.	O
0	O
cm	O
respectively	O
,	O
p	O
=	O
0	O
.	O
72	O
.	O

Children	O
that	O
remained	O
in	O
our	O
study	O
had	O
equally	O
balanced	O
characteristics	O
.	O

The	O
median	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
was	O
21	O
.	O
2	O
ng	O
/	O
mL	O
.	O

There	O
was	O
no	O
significant	O
difference	O
of	O
using	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
in	O
relation	O
to	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
for	O
women	O
with	O
higher	O
education	O
level	O
(	O
Table	O
3	O
).	O

In	O
the	O
present	O
study	O
,	O
the	O
relationship	O
between	O
prenatal	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
in	O
the	O
two	O
years	O
following	O
childbirth	O
was	O
assessed	O
.	O

)—	O
High	O
Frequency	O
in	O
Normalized	O
Units	O
.	O

Overall	O
,	O
this	O
study	O
demonstrated	O
a	O
positive	O
significant	O
association	O
between	O
high	O
adherences	O
to	O
western	O
dietary	O
pattern	O
and	O
chance	O
of	O
having	O
low	O
birth	O
weight	O
infant	O
.	O

Using	O
a	O
job	O
exposure	O
matrix	O
,	O
which	O
can	O
differ	O
from	O
exposure	O
measurement	O
,	O
Birks	O
et	O
al	O
.	O

In	O
addition	O
,	O
results	O
were	O
compared	O
to	O
those	O
of	O
analyses	O
using	O
unimputed	O
data	O
,	O
and	O
(	O
for	O
the	O
primary	O
outcome	O
)	O
to	O
the	O
results	O
of	O
sensitivity	O
analyses	O
using	O
data	O
imputed	O
under	O
various	O
MNAR	O
assumptions	O
.	O

Two	O
independent	O
professional	O
translators	O
did	O
the	O
back	O
-	O
translation	O
,	O
and	O
the	O
consensus	O
version	O
was	O
tested	O
in	O
a	O
pilot	O
study	O
with	O
50	O
subjects	O
.	O

Our	O
study	O
supports	O
these	O
findings	O
,	O
as	B
caries	O
-	O
free	O
children	O
were	O
twice	O
as	O
likely	B
to	O
have	O
optimal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(≥	O
75	O
nmol	O
/	O
L	O
)	O
and	O
those	O
with	O
S	O
-	O
ECC	O
were	O
at	O
nearly	O
three	O
times	O
the	O
odds	B
of	O
having	O
deficient	O
levels	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

Covariates	O
in	O
the	O
birth	O
weight	O
BHLM	O
included	O
:	O
maternal	O
race	O
(	O
white	O
vs	O
.	O
black	O
/	O
other	O
),	O
age	O
at	O
delivery	O
,	O
infant	O
sex	O
,	O
maternal	O
education	O
(<	O
high	O
school	O
vs	O
.	O
≥	O
high	O
school	O
),	O
tobacco	O
exposure	O
(<	O
3ng	O
/	O
ml	O
vs	O
.	O
≥	O
3ng	O
/	O
ml	O
serum	O
cotinine	O
concentrations	O
),	O
household	O
annual	O
income	O
(<$	O
25	O
,	O
000	O
per	O
annum	O
vs	O
.	O
>$	O
25	O
,	O
000	O
per	O
annum	O
),	O
employment	O
,	O
maternal	O
insurance	O
status	O
(	O
public	O
/	O
none	O
vs	O
.	O
private	O
),	O
marital	O
status	O
(	O
single	O
vs	O
.	O
living	O
with	O
a	O
spouse	O
or	O
partner	O
),	O
pre	O
-	O
natal	O
vitamin	O
use	O
(	O
yes	O
vs	O
.	O
no	O
),	O
and	O
maternal	O
BMI	O
(	O
underweight	O
,	O
normal	O
,	O
overweight	O
,	O
obese	O
).	O

For	O
sensitivity	O
,	O
we	O
repeated	O
analyses	O
(	O
1	O
)	O
excluding	O
infants	O
with	O
possible	O
antibiotic	O
exposure	O
(	O
nvaginal	O
=	O
3	O
,	O
nCesarean	O
=	O
2	O
)	O
and	O
those	O
with	O
missing	O
antibiotic	O
exposure	O
information	O
(	O
nvaginal	O
=	O
3	O
,	O
nCesarean	O
=	O
2	O
)	O
and	O
(	O
2	O
)	O
excluding	O
all	O
infants	O
delivered	O
before	O
37	O
weeks	O
gestation	O
(	O
n	O
=	O
8	O
),	O
reported	O
in	O
the	O
supplemental	O
information	O
.	O

The	O
SC	O
diet	O
contained	O
400	O
,	O
000	O
IU	O
of	O
vitamin	O
D3	O
/	O
g	O
or	O
0	O
.	O
250	O
g	O
of	O
vitamin	O
D3	O
/	O
kg	O
of	O
the	O
feed	O
mix	O
,	O
which	O
supplied	O
the	O
recommended	O
levels	O
of	O
vitamin	O
D	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Composition	O
of	O
the	O
diets	O
.	O
Nutrient	O
(	O
g	O
/	O
kg	O
)	O
DietsSCVitD	O
−	O
Corn	O
starch397	O
.	O
50397	O
.	O
50Casein200	O
.	O
00200	O
.	O
00Starch	O
dextrinated132	O
.	O
00132	O
.	O
00Sucrose100	O
.	O
00100	O
.	O
00Soya	O
bean	O
oil70	O
.	O
0070	O
.	O
00Fiber50	O
.	O
0050	O
.	O
00L	O
-	O
cystine3	O
.	O
003	O
.	O
00Choline2	O
.	O
502	O
.	O
50Mineral	O
mix35	O
.	O
0035	O
.	O
00Calcium	O
carbonate357	O
.	O
00357	O
.	O
00Vitamin	O
mix10	O
.	O
0010	O
.	O
00Vitamin	O
D30	O
.	O
250	O
.	O
00	O
All	O
the	O
nutrients	O
corresponded	O
to	O
the	O
recommendations	O
of	O
AIN93G	O
for	O
rodents	O
.	O

Castration	O
of	O
bulls	O
profoundly	O
increased	O
MS	O
,	O
QG	O
,	O
and	O
IMF	O
contents	O
in	O
Korean	O
cattle	O
[	O
9	O
,	O
39	O
].	O

Our	O
findings	O
indicated	O
a	O
protective	O
effect	O
of	O
vitamin	O
D	O
for	O
the	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Unfortunately	O
,	O
we	O
do	O
not	O
have	O
information	O
about	O
specific	O
vitamin	O
D	O
supplementation	O
.	O

There	O
was	O
also	O
interclass	O
variation	O
in	O
the	O
frequency	O
of	O
CpGs	O
association	O
with	O
PcG	O
target	O
genes	O
,	O
with	O
classes	O
7	O
and	O
9	O
in	O
particular	O
having	O
a	O
much	O
higher	O
proportion	O
than	O
the	O
others	O
(	O
Figure	O
2F	O
).	O

Information	O
obtained	O
included	O
the	O
infant	O
’	O
s	O
length	O
,	O
weight	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
anthropometric	O
measurements	O
(	O
arm	O
,	O
thigh	O
,	O
waist	O
and	O
hip	O
circumferences	O
;	O
biceps	O
,	O
triceps	O
,	O
sub	O
-	O
scapular	O
,	O
abdominal	O
,	O
supra	O
-	O
iliac	O
and	O
thigh	O
skin	O
-	O
fold	O
thickness	O
).	O

(	O
2014a	O
)*/†	O
Pandey	O
et	O
al	O
.	O

Because	B
of	O
substantial	O
antibody	O
levels	O
from	O
transplacental	O
transmission	O
,	O
infants	O
are	O
less	O
likely	B
to	O
get	O
respiratory	O
infection	O
before	O
6	O
months	O
of	O
age	O
.	O

Materials	O
and	O
methods	O
Ethics	O
statement	O
Experimental	O
procedures	O
with	O
animals	O
were	O
carried	O
out	O
following	O
with	O
the	O
recommendations	O
of	O
the	O
European	O
Communities	O
directive	O
2010	O
/	O
63	O
/	O
EU	O
and	O
Spanish	O
legislation	O
(	O
Real	O
Decreto	O
53	O
/	O
2013	O
,	O
BOE	O
34	O
/	O
11370	O
-	O
11421	O
,	O
2013	O
)	O
regulating	O
the	O
care	O
and	O
use	O
of	O
laboratory	O
animals	O
.	O

In	O
this	O
pilot	O
study	O
,	O
we	O
assessed	O
associations	O
of	O
maternal	O
self	O
-	O
reported	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
with	O
glucose	O
intolerance	O
and	O
a	O
diagnosis	O
of	O
GDM	O
later	O
in	O
pregnancy	O
.	O

Two	O
Dimensional	O
Gel	O
Electrophoresis	O
Protein	O
concentration	O
was	O
determined	O
by	O
the	O
Bradford	O
method	O
[	O
24	O
].	O

Differences	O
between	O
male	O
and	O
female	O
offspring	O
(	O
CC	O
)	O
were	O
also	O
observed	O
.	O

Optimal	O
management	O
of	O
these	O
disorders	O
during	O
pregnancy	O
is	O
vital	O
to	O
ensure	O
the	O
welfare	O
of	O
the	O
mother	O
and	O
the	O
baby	O
.	O

Antiepileptic	O
Drugs	O
Although	O
it	O
has	O
been	O
shown	O
that	O
autism	O
is	O
unlikely	B
to	O
be	O
caused	O
by	O
a	O
single	O
factor	O
,	O
there	O
have	O
been	O
many	O
studies	O
conducted	O
studying	O
the	O
relationship	O
between	O
the	O
use	O
of	O
certain	O
medications	O
during	O
pregnancy	O
and	O
the	O
associated	O
risk	O
of	O
autism	O
.	O

In	O
7	O
/	O
10	O
infants	O
with	O
data	O
available	O
,	O
treated	O
with	O
LCF	O
for	O
median	O
95	O
days	O
(	O
range	O
25	O
-	O
310	O
),	O
median	O
PTH	O
rose	O
to	O
17	O
.	O
1pmol	O
/	O
L	O
([	O
8	O
.	O
2	O
-	O
49	O
.	O
3	O
],	O
P	O
=	O
0	O
.	O
02	O
)	O
with	O
a	O
trend	O
to	O
lower	O
25OHVit	O
D	O
(	O
median	O
23nmol	O
/	O
L	O
[<	O
10	O
-	O
108	O
],	O
P	O
=	O
0	O
.	O
09	O
)	O
despite	O
continued	O
high	O
-	O
normal	O
calcium	O
levels	O
(	O
median	O
2	O
.	O
66mmol	O
/	O
L	O
[	O
2	O
.	O
11	O
-	O
2	O
.	O
75	O
]).	O

Conclusions	O
Maternal	O
vitamin	O
D	O
concentration	O
was	O
similar	O
in	O
mothers	O
with	O
and	O
without	O
GDM	O
in	O
a	O
mostly	B
vitamin	O
D	O
sufficient	O
population	O
.	O

Eventually	O
,	O
as	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
increases	O
to	O
toxic	O
concentrations	O
,	O
the	O
classic	O
situation	O
of	O
hypercalciuria	O
,	O
hypercalcemia	O
,	O
and	O
,	O
finally	O
,	O
extraskeletal	O
calcification	O
becomes	O
evident	B
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
at	O
14	O
and	O
34	O
weeks	O
of	O
gestation	O
were	O
normally	O
distributed	O
.	O

In	O
relation	O
to	O
sun	O
exposure	O
and	O
related	O
measures	O
,	O
one	O
of	O
these	O
studies	O
,	O
which	O
comprised	O
136	O
individuals	O
with	O
MS	O
and	O
272	O
age	O
and	O
sex	O
-	O
matched	O
controls	O
in	O
Tasmania	O
,	O
16collected	O
information	O
on	O
sun	O
exposure	O
at	O
different	O
ages	O
.	O

She	O
denied	O
contractions	O
,	O
vaginal	O
bleeding	O
,	O
or	O
leakage	O
of	O
fluid	O
.	O

As	B
I	O
discussed	O
in	O
my	O
original	O
paper	O
,	O
this	O
has	O
been	O
known	O
since	O
the	O
early	O
1980s	O
but	O
was	O
dismissed	O
as	B
being	O
because	B
of	O
ascertainment	O
bias	O
.	O

Based	B
on	I
the	O
PAR	O
hypothesis	O
,	O
the	O
high	O
multivitamin	O
gestational	O
diet	O
would	O
lead	O
to	O
developmental	O
adaptation	O
in	O
the	O
offspring	O
consistent	O
with	O
a	O
high	O
vitamin	O
post	O
-	O
weaning	O
environment	O
.	O

Whilst	O
18	O
-	O
month	O
follow	O
-	O
up	O
data	O
on	O
126	O
offspring	O
of	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
treated	O
with	O
metformin	O
during	O
pregnancy	O
have	O
not	O
revealed	O
any	O
deficiencies	O
in	O
growth	O
or	O
motor	O
-	O
social	O
development	O
,	O
this	O
may	O
be	O
too	O
short	O
a	O
time	O
frame	O
for	O
potential	O
programming	O
effects	O
of	O
metformin	O
to	O
become	O
evident	O
.	O
80	O
In	O
view	O
of	O
the	O
above	O
concerns	O
regarding	O
the	O
potential	O
of	O
glyburide	O
and	O
metformin	O
to	O
have	O
long	O
-	O
term	O
effects	O
on	O
the	O
mother	O
and	O
child	O
,	O
I	O
would	O
recommend	O
caution	O
with	O
their	O
use	O
in	O
the	O
treatment	O
of	O
GDM	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cpt1a	O
,	O
Cpt1b	O
,	O
and	O
Acox1	O
in	O
liver	O
and	O
PAT	O
,	O
Acaca	O
,	O
Fasn	O
,	O
Insig1	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Chrebp	O
,	O
Scd1	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
(	O
see	O
TableS3for	O
statistical	O
values	O
).	O

PATCH	O
is	O
an	O
unselected	O
,	O
population	O
-	O
based	O
birth	O
cohort	O
study	O
investigating	O
the	O
risk	O
factors	O
for	O
immune	O
-	O
related	O
and	O
allergic	O
diseases	O
in	O
children	O
in	O
Keelung	O
,	O
a	O
city	O
in	O
northern	O
Taiwan	O
.	O

PubMed	O
Central	O
:	O

After	O
adjusting	O
each	O
model	O
for	O
the	O
treatment	O
effect	O
,	O
no	O
predictors	O
were	O
significantly	O
associated	O
with	O
the	O
outcome	O
.	O

However	O
,	O
there	O
is	O
again	O
a	O
limitation	O
with	O
interpreting	O
medical	O
records	O
,	O
such	O
as	O
prescribed	O
versus	O
actual	O
use	O
of	O
SSRIs	O
.	O

For	O
77	O
.	O
6	O
%	O
of	O
the	O
women	O
their	O
pregnancy	O
was	O
planned	O
(	O
unknown	O
for	O
3	O
.	O
3	O
%	O
of	O
the	O
women	O
).	O

The	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
was	O
registered	O
prospectively	O
(	O
ISRCTN	O
:	O
82927713	O
;	O
EUDRACT	O
:	O
2007	O
-	O
001716	O
-	O
23	O
);	O
full	O
approval	O
from	O
UK	O
Medicines	O
and	O
Healthcare	O
Products	O
Regulatory	O
Agency	O
was	O
granted	O
,	O
and	O
written	O
,	O
informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

Thus	B
,	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
risk	O
of	O
miscarriage	O
needs	O
further	O
investigation	O
.	O

There	O
is	O
no	O
dietary	O
recommended	O
intake	O
(	O
DRI	O
)	O
for	O
vitamin	O
D	O
.	O
What	O
is	O
known	O
today	O
is	O
that	O
for	O
a	O
pregnant	O
woman	O
,	O
the	O
adequate	O
intake	O
for	O
vitamin	O
D	O
is	O
200	O
IU	O
per	O
day	O
.	O

After	O
birth	O
,	O
pups	O
were	O
weighed	O
and	O
litter	O
size	O
adjusted	O
to	O
eight	O
pups	O
per	O
litter	O
(	O
4	O
male	O
and	O
4	O
female	O
)	O
to	O
ensure	O
standardised	O
nutrition	O
until	O
weaning	O
at	O
day	O
22	O
.	O

Results	O
Correlation	O
of	O
offspring	O
'	O
s	O
BMI	O
with	O
that	O
of	O
the	O
mother	O
increased	O
with	O
age	O
(	O
correlation	O
coefficient	O
0	O
.	O
15	O
increasing	O
to	O
0	O
.	O
28	O
,	O
p	O
value	O
<	O
0	O
.	O
001	O
in	O
all	O
cases	O
)	O
while	O
no	O
consistent	O
pattern	O
was	O
seen	O
with	O
offspring	O
and	O
fathers	O
.	O

Black	O
line	O
represents	O
fitted	O
LOESS	O
curve	O
,	O
dark	O
gray	O
area	O
represents	O
1	O
standard	O
deviation	O
,	O
and	O
light	O
gray	O
area	O
represents	O
2	O
standard	O
deviations	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Association	O
of	O
mother	O
’	O
s	O
personal	O
gestational	O
weight	O
gain	O
targets	O
and	O
their	O
provider	O
giving	O
advice	O
on	O
appropriate	O
weight	O
gainProfessional	O
advice	O
on	O
weight	O
gain	O
receivedNoYesTotalAccuracy	O
of	O
mother	O
’	O
s	O
weight	O
gain	O
targetUnder	O
IOM	O
rec28	O
(	O
34	O
.	O
1	O
%)	O
3	O
(	O
11	O
.	O
1	O
%)	O
31	O
(	O
28	O
.	O
4	O
%)	O
Within	O
IOM	O
rec40	O
(	O
48	O
.	O
8	O
%)	O
21	O
(	O
77	O
.	O
8	O
%)	O
61	O
(	O
56	O
.	O
0	O
%)	O
Above	O
IOM	O
rec15	O
(	O
18	O
.	O
1	O
%)	O
3	O
(	O
11	O
.	O
1	O
%)	O
17	O
(	O
15	O
.	O
6	O
%)	O
83	O
(	O
100	O
%)	O
27	O
(	O
100	O
%)	O
110	O
(	O
100	O
%)	O
χ2	O
(	O
2	O
)	O
=	O
7	O
.	O
519	O
,	O
p	O
=	O
0	O
.	O
023	O
Discussion	O
Despite	O
the	O
attention	O
garnered	O
by	O
the	O
2009	O
revision	O
of	O
the	O
IOM	O
’	O
s	O
guidelines	O
for	O
weight	O
gain	O
during	O
pregnancy	O
,	O
many	O
of	O
the	O
low	O
-	O
income	O
,	O
minority	O
women	O
in	O
this	O
sample	O
did	O
not	O
receive	O
information	O
about	O
appropriate	O
GWG	O
.	O

In	O
the	O
homozygous	O
group	O
for	O
Tth111	O
I	O
polymorphism	O
,	O
mothers	O
with	O
negative	O
attitudes	O
towards	O
the	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
with	O
significantly	O
lower	O
birth	O
weights	O
compared	O
to	O
women	O
with	O
positive	O
/	O
neutral	O
attitudes	O
.	O

The	O
high	O
compliance	O
,	O
regular	O
follow	O
-	O
up	O
and	O
long	O
duration	O
of	O
our	O
study	O
further	O
increases	O
confidence	O
in	O
the	O
findings	O
.	O

Despite	O
the	O
similar	O
latitudes	O
of	O
Adelaide	O
and	O
Auckland	O
(	O
Adelaide	O
:	O
34	O
.	O
93	O
°	O
S	O
and	O
Auckland	O
36	O
.	O
85	O
°	O
S	O
),	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
.	O

(	O
2012	O
)	O
*	O
Lifestyle	O
factors	O
Smoking	O
:	O
Cigarette	O
smokeAdulthood	O
LifetimeAdulthoodCOPD	O
Breast	O
and	O
lung	O
cancer	O
↓	O
lung	O
cancer	O
overall	O
survivalDNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsLin	O
et	O
al	O
.	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	B
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	B
light	I
of	I
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	B
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

We	O
used	O
array	O
control	O
probes	O
to	O
assess	O
the	O
quality	O
of	O
our	O
samples	O
and	O
evaluate	O
potential	O
problems	O
such	O
as	O
poor	O
bisulfite	O
conversion	O
or	O
color	O
-	O
specific	O
issues	O
for	O
each	O
array	O
.	O

Do	O
these	O
mechanism	O
(	O
s	O
)	O
function	O
in	O
humans	O
?	O

Skm2	O
mice	O
,	O
carrying	O
a	O
mutation	O
in	O
Flnb	O
,	O
present	O
with	O
scoliosis	O
and	O
lordosis	O
.	O

Ørskov	O
[	O
110	O
]	O
reported	O
that	O
up	O
to	O
42	O
%	O
of	O
dietary	O
starch	O
may	O
escape	O
ruminal	O
fermentation	O
and	O
reach	O
the	O
small	O
intestine	O
.	O

However	O
,	O
our	O
main	O
exposure	O
(	O
fish	O
/	O
fatty	O
acids	O
)	O
did	O
not	O
differ	O
between	O
those	O
who	O
participated	O
and	O
those	O
who	O
did	O
not	O
participate	O
in	O
the	O
study	O
.	O

Secondly	O
,	O
there	O
are	O
multiple	O
interrelated	O
factors	O
which	O
impact	O
on	O
neurodevelopment	O
,	O
and	O
not	O
all	O
confounders	O
were	O
accounted	O
for	O
in	O
all	O
analyses	O
.	O

Arsenic	O
is	O
chemically	O
very	O
similar	O
to	O
zinc	O
and	O
can	O
replace	O
zinc	O
in	O
proteins	O
that	O
are	O
important	O
in	O
DNA	O
repair	O
.	O
41	O
“	O
Arsenic	O
goes	O
in	O
and	O
kicks	O
zinc	O
out	O
,	O
but	O
the	O
arsenic	O
doesn	O
’	O
t	O
replace	O
the	O
function	O
of	O
zinc	O
.	O

The	O
results	O
showed	O
that	O
in	O
both	O
subgroups	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
statistically	O
significant	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
at	O
childbirth	O
and	O
lower	O
depression	O
score	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
than	O
the	O
control	O
group	O
(	O
Table	O
4	O
).	O

Rojroongwasonkul	O
et	O
al	O
.	O

On	O
the	O
other	O
hand	O
,	O
Wilkerson	O
et	O
al	O
.	O

All	O
authors	O
have	O
read	O
and	O
approved	O
the	O
submitted	O
manuscript	O
.	O

Conclusion	O
:	O
MMN	O
supplementation	O
should	O
be	O
considered	O
as	O
a	O
strategy	O
for	O
improving	O
the	O
micronutrient	O
and	O
haematological	O
status	O
of	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
.	O

Results	O
In	O
total	O
,	O
682	O
women	O
were	O
included	O
in	O
the	O
analysis	O
(	O
Fig	O
.	O

Such	O
changes	O
in	O
early	O
life	O
are	O
likely	B
to	O
lead	O
to	O
metabolic	O
syndrome	O
in	O
adult	O
animals	O
(	O
15	O
).	O

These	O
findings	O
support	O
the	O
inverse	O
association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
found	O
in	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Within	O
the	O
14	O
h	O
after	O
birth	O
,	O
pups	O
were	O
weighed	O
,	O
sexed	O
,	O
and	O
culled	O
to	O
comprise	O
up	O
to	O
8	O
pups	O
per	O
mother	O
(	O
4	O
males	O
and	O
4	O
females	O
where	O
possible	O
).	O

Conclusion	O
As	O
conclusion	O
,	O
our	O
results	O
demonstrated	O
that	O
the	O
exposure	O
to	O
a	O
moderate	O
maternal	O
restricted	O
diet	O
from	O
the	O
preconceptional	O
period	O
predisposed	O
for	O
the	O
development	O
of	O
features	O
related	O
to	O
the	O
metabolic	O
syndrome	O
,	O
affected	O
subtly	O
the	O
feeding	O
behavior	O
and	O
altered	O
the	O
gene	O
expression	O
of	O
relevant	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
,	O
including	O
the	O
endocannabinoid	O
signaling	O
system	O
,	O
in	O
metabolically	O
-	O
relevant	O
tissues	O
(	O
hypothalamus	O
,	O
liver	O
and	O
PAT	O
)	O
of	O
adult	O
offspring	O
in	O
a	O
sex	O
specific	O
-	O
manner	O
.	O

The	O
patient	O
was	O
anxious	O
but	O
cooperative	O
with	O
no	O
focal	O
neurologic	O
deficits	O
.	O

of	O
Infections	O
in	O
the	O
last	O
year	O
[	O
median	O
(	O
range	O
)]	O
1	O
.	O
0	O
(	O
0	O
.	O
0	O
–	O
5	O
.	O
0	O
)	O
Child	O
’	O
s	O
daily	O
vitamin	O
D	O
intake	O
at	O
time	O
of	O
visit	O
(	O
IU	O
/	O
day	O
)	O
1205	O
.	O
3	O
±	O
109	O
.	O
8	O
(	O
17	O
.	O
1	O
–	O
512	O
.	O
5	O
)	O
Child	O
'	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
time	O
of	O
visit	O
(	O
ng	O
/	O
mL	O
)	O
127	O
.	O
2	O
±	O
9	O
.	O
4	O
(	O
8	O
.	O
3	O
–	O
61	O
.	O
5	O
)	O
Child	O
'	O
s	O
vitamin	O
D	O
status	O
at	O
time	O
of	O
visit	O
Sufficient	O
(≥	O
20	O
ng	O
/	O
mL	O
)	O
[	O
n	O
(%)]	O
106	O
(	O
79	O
.	O
7	O
)	O
Deficient	O
(<	O
20	O
ng	O
/	O
mL	O
)	O
[	O
n	O
(%)]	O
27	O
(	O
20	O
.	O
3	O
)	O
Total	O
Circulating	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
mL	O
)	O
at	O
birth122	O
.	O
8	O
±	O
9	O
.	O
8	O
(	O
3	O
.	O
6	O
–	O
47	O
.	O
8	O
)	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
mL	O
)	O
within	O
1	O
month	O
prior	O
to	O
delivery139	O
.	O
2	O
±	O
15	O
.	O
0	O
(	O
10	O
.	O
0	O
–	O
78	O
.	O
6	O
)	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
area	O
under	O
curve	O
,	O
pregnancy	O
visits	O
3	O
–	O
71153	O
.	O
1	O
±	O
44	O
.	O
6	O
(	O
50	O
.	O
1	O
–	O
251	O
.	O
4	O
)	O
1mean	O
±	O
STD	O
(	O
range	O
)	O
Study	O
Outcomes	O
The	O
median	O
cathelicidin	O
concentration	O
for	O
the	O
entire	O
cohort	O
was	O
28	O
.	O
1	O
ng	O
/	O
mL	O
,	O
ranging	O
from	O
5	O
.	O
6	O
to	O
3368	O
.	O
6	O
ng	O
/	O
mL	O
.	O

Background	O
Information	O
At	O
study	O
entry	O
,	O
participants	O
reported	O
via	O
questionnaire	O
information	O
on	O
maternal	O
race	O
/	O
ethnicity	O
,	O
age	O
,	O
education	O
,	O
parity	O
,	O
employment	O
,	O
marital	O
status	O
,	O
and	O
household	O
income	O
.	O

Recent	O
animal	O
studies	O
proved	B
that	O
sperm	O
count	O
,	O
motility	O
,	O
histological	O
structure	O
of	O
testis	O
,	O
and	O
spermatogenesis	O
are	O
more	O
dependent	O
on	O
proper	O
serum	O
calcium	O
and	O
phosphorus	O
levels	O
rather	O
than	O
VD	O
status	O
[	O
47	O
].	O

While	O
,	O
the	O
circulating	O
half	O
-	O
life	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
is	O
around	O
4	O
h	O
.	O
Its	O
blood	O
concentration	O
is	O
1000	O
times	O
less	O
than	O
25	O
-	O
hydroxyvitamin	O
D	O
.	O
Serum	O
levels	O
of	O
PTH	O
,	O
calcium	O
,	O
and	O
phosphate	O
have	O
influence	O
on	O
regulatory	O
and	O
production	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

have	O
significantly	O
rendered	O
the	O
sun	O
redundant	O
.	O

Fasting	O
blood	O
glucose	O
was	O
measured	O
at	O
both	O
time	O
points	O
,	O
and	O
a	O
glucose	O
challenge	O
test	O
(	O
1	O
-	O
h	O
post	O
a	O
50	O
-	O
g	O
glucose	O
load	O
)	O
was	O
performed	O
at	O
28	O
weeks	O
’	O
gestation	O
.	O

Based	O
on	O
the	O
behavioural	O
findings	O
in	O
DVD	O
-	O
deficient	O
rats	O
,	O
there	O
is	O
a	O
case	O
to	O
explore	O
proteomic	O
dysregulation	O
in	O
rats	O
after	O
exposure	O
to	O
drugs	O
known	O
to	O
disrupt	O
dopaminergic	O
and	O
glutaminergic	O
pathways	O
.	O

The	O
remaining	O
piglets	O
were	O
cross	O
-	O
fostered	O
to	O
non	O
-	O
experimental	O
sows	O
of	O
2ndto	O
4thparities	O
,	O
which	O
were	O
on	O
the	O
AP	O
diet	O
during	O
gestation	O
.	O

Out	O
of	O
which	O
,	O
184	O
qualified	O
mothers	O
were	O
selected	O
who	O
completed	O
the	O
baseline	O
depression	O
questionnaire	O
.	O

Since	O
our	O
previous	O
review	O
[	O
2	O
],	O
two	O
new	O
original	O
papers	O
have	O
been	O
published	O
,	O
explaining	B
the	O
significance	O
of	O
vitamin	O
D	O
in	O
PCOS	O
pathogenesis	O
.	O

PBDEs	O
are	O
flame	O
retardants	O
[	O
13	O
]	O
and	O
OCPs	O
are	O
agricultural	O
pesticides	O
[	O
5	O
,	O
14	O
].	O

During	O
exposure	O
to	O
sunlight	O
,	O
ultraviolet	O
B	O
(	O
UVB	O
)	O
(	O
wavelength	O
290	O
–	O
305	O
nm	O
)	O
penetrates	O
the	O
skin	O
and	O
converts	O
7	O
-	O
dehydrocholesterol	O
to	O
previtamin	O
D3	O
.	O

Dietary	O
patterns	O
have	O
shifted	O
from	O
a	O
prudent	O
diet	O
(	O
high	O
fruit	O
and	O
vegetable	O
-,	O
and	O
omega	O
-	O
3	O
fatty	O
acid	O
intake	O
;	O
low	O
omega	O
-	O
6	O
fatty	O
acid	O
intake	O
)	O
to	O
a	O
western	O
-	O
style	O
diet	O
(	O
higher	O
levels	O
omega	O
-	O
6	O
fats	O
,	O
lower	O
amounts	O
of	O
fresh	O
fruits	O
and	O
vegetables	O
,	O
and	O
omega	O
-	O
3	O
fats	O
).	O

[	O
25	O
]	O
As	O
expected	O
,	O
low	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
is	O
a	O
risk	O
factor	O
for	O
insulin	O
resistance	O
,	O
glucose	O
intolerance	O
,	O
and	O
features	O
of	O
metabolic	O
syndrome	O
in	O
normoglycemic	O
subjects	O
.	O

In	B
our	I
experience	I
,	O
the	O
best	O
follow	O
-	O
up	O
method	O
to	O
detect	O
loco	O
-	O
regional	O
recurrences	O
is	O
,	O
without	B
question	I
,	O
neck	O
sonography	O
,	O
followed	O
by	O
a	O
meticulous	O
physical	O
examination	O
by	O
experienced	O
personnel	O
and	O
,	O
when	O
indicated	O
,	O
ultrasound	O
-	O
guided	O
FNA	O
to	O
confirm	O
clinical	O
suspicion	O
of	O
neck	O
recurrence41	O
-	O
45	O
.	O

Similar	O
data	O
are	O
not	O
readily	O
available	O
in	O
pediatric	O
populations	O
.	O

The	O
only	O
study	O
satisfying	O
this	O
condition	O
used	O
a	O
nested	O
case	O
-	O
control	O
design	O
to	O
sample	O
an	O
underlying	O
prospective	O
cohort	O
comprising	O
over	O
7	O
million	O
individuals	O
who	O
served	O
in	O
the	O
US	O
military	O
and	O
had	O
at	O
least	O
two	O
serum	O
samples	O
stored	O
in	O
the	O
US	O
Department	O
of	O
Defense	O
Serum	O
Repository	O
.	O
18The	O
study	O
concluded	O
that	O
serum	O
concentration	O
of	O
25	O
hydroxyvitamin	O
D	O
in	O
healthy	O
young	O
white	O
adults	O
is	O
an	O
important	O
predictor	O
of	O
their	O
risk	O
of	O
developing	O
MS	O
,	O
independently	O
from	O
their	O
place	O
of	O
birth	O
and	O
latitude	O
of	O
residence	O
during	O
childhood	O
.	O
18In	O
a	O
prospective	O
investigation	O
comprising	O
approximately	O
200	O
,	O
000	O
women	O
in	O
the	O
USA	O
,	O
vitamin	O
D	O
intake	O
was	O
measured	O
every	O
4	O
years	O
by	O
a	O
comprehensive	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
.	O
37The	O
incidence	O
of	O
MS	O
during	O
the	O
30	O
-	O
year	O
follow	O
-	O
up	O
decreased	O
with	O
increasing	O
vitamin	O
D	O
intake	O
(	O
P	O
=	O
0	O
.	O
03	O
for	O
trend	O
)	O
and	O
was	O
33	O
%	O
lower	O
among	O
women	O
in	O
the	O
highest	O
quintile	O
of	O
vitamin	O
D	O
intake	O
versus	O
those	O
in	O
the	O
lowest	O
quintile	O
.	O
17Furthermore	O
,	O
MS	O
incidence	O
was	O
41	O
%	O
lower	O
among	O
women	O
taking	O
400	O
IU	O
per	O
day	O
or	O
more	O
from	O
supplements	O
compared	O
with	O
non	O
-	O
users	O
.	O
17Attempts	O
to	O
relate	O
vitamin	O
D	O
intake	O
to	O
MS	O
risk	O
have	O
also	O
been	O
made	O
in	O
casecontrol	O
studies	O
.	O

Western	O
blotting	O
analyses	O
The	O
results	O
of	O
protein	O
expression	O
analysis	O
of	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
groups	O
are	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
result	O
of	O
the	O
F1	O
and	O
F2	O
SC	O
counterparts	O
.	O

Women	O
with	O
PPBMI	O
<	O
25	O
kg	O
/	O
m2or	O
≥	O
25	O
kg	O
/	O
m2experienced	O
greater	O
weight	O
gain	O
than	O
the	O
obese	O
group	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
(	O
Table1	O
).	O

Goodenday	O
,	O
et	O
al	O
.	O

This	O
should	O
be	O
vigorously	O
pursued	O
.	O

Furthermore	O
,	O
treatment	O
of	O
brown	O
adipocytes	O
and	O
human	O
skeletal	O
myocytes	O
with	O
bile	O
acids	O
(	O
BA	O
)	O
were	O
shown	O
to	O
increase	O
D2	O
activity	O
and	O
oxygen	O
consumption	O
via	O
the	O
activation	O
of	O
UCP1	O
(	O
Watanabe	O
et	O
al	O
.,	O
2006	O
).	O

Nonpharmacological	O
Management	O
of	O
Allergic	O
Diseases	O
During	O
Pregnancy	O
Mothers	O
with	O
diagnosed	O
allergy	O
should	O
avoid	O
exposure	O
to	O
and	O
contact	O
with	O
specific	O
allergens	O
(	O
including	O
food	O
allergens	O
)	O
and	O
should	O
especially	O
avoid	O
the	O
inhalation	O
of	O
potent	O
triggers	O
for	O
asthma	O
,	O
such	O
as	O
animal	O
dander	O
,	O
house	O
dust	O
,	O
tobacco	O
smoke	O
,	O
and	O
irritating	O
pollutants	O
[	O
22	O
].	O

Vitamin	O
D	O
status	O
(	O
measured	O
as	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
))	O
of	O
pregnant	O
women	O
has	O
been	O
inversely	O
associated	O
with	O
adverse	O
gestational	O
outcomes	O
and	O
associated	O
with	O
uteroplacental	O
dysfunction	O
[	O
2	O
].	O

vitamins	O
C	O
,	O
D	O
and	O
E	O
)	O
protect	O
against	O
AM	O
.	O

However	O
,	O
the	O
fetal	O
programming	O
did	O
not	O
significantly	O
affect	O
beef	O
quality	O
characteristics	O
at	O
30	O
mo	O
of	O
age	O
.	O

Confidentiality	O
of	O
the	O
respondents	O
was	O
observed	O
by	O
coding	O
questionnaires	O
and	O
the	O
database	O
was	O
password	O
-	O
protected	O
.	O

For	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
,	O
there	O
was	O
a	O
58	O
%	O
lower	O
risk	O
of	O
spontaneous	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
42	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
89	O
,	O
p	O
=	O
0	O
.	O
02	O
;	O
AAR	O
=	O
4	O
.	O
8	O
%;	O
NNT	O
=	O
21	O
)	O
and	O
a	O
61	O
%	O
lower	O
risk	O
of	O
indicated	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
39	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
76	O
,	O
p	O
=	O
0	O
.	O
006	O
;	O
AAR	O
=	O
6	O
.	O
5	O
%;	O
NNT	O
=	O
15	O
)	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
risk	O
of	O
preterm	O
birth	O
by	O
preterm	O
birth	O
subtype	O
.	O
Spontaneous	O
Preterm	O
Birth	O
RatesSpontaneous	O
Preterm	O
Birth	O
:	O
ORIndicated	O
Preterm	O
Birth	O
RatesIndicated	O
Preterm	O
Birth	O
:	O
OR	O
(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
248	O
)	O
21	O
(	O
8	O
%)	O
1	O
.	O
028	O
(	O
11	O
%)	O
1	O
.	O
0N	O
preterm	O
(%)	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
267	O
)	O
17	O
(	O
6	O
%)	O
0	O
.	O
7416	O
(	O
6	O
%)	O
0	O
.	O
50	O
N	O
preterm	O
(%)(	O
0	O
.	O
38	O
,	O
1	O
.	O
43	O
)	O
(	O
0	O
.	O
26	O
,	O
0	O
.	O
95	O
)	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
255	O
)	O
16	O
(	O
6	O
%)	O
0	O
.	O
7216	O
(	O
6	O
%)	O
0	O
.	O
53	O
N	O
preterm	O
(%)(	O
0	O
.	O
37	O
,	O
1	O
.	O
42	O
)	O
(	O
0	O
.	O
28	O
,	O
0	O
.	O
99	O
)	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
294	O
)	O
11	O
(	O
4	O
%)	O
0	O
.	O
42	O
14	O
(	O
5	O
%)	O
0	O
.	O
39	O
N	O
preterm	O
(%)	O
(	O
0	O
.	O
20	O
,	O
0	O
.	O
89	O
)(	O
0	O
.	O
20	O
,	O
0	O
.	O
76	O
)	O
Bold	O
values	O
signify	O
significance	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

These	O
women	O
received	O
a	O
standard	O
antenatal	O
preparation	O
of	O
60mg	O
elemental	O
iron	O
and	O
250μg	O
of	O
folic	O
acid	O
daily	O
.	O

In	O
-	O
house	O
precision	O
testing	O
yielded	O
intra	O
-	O
assay	O
coefficients	O
of	O
variation	O
(	O
CVs	O
)	O
of	O
3	O
.	O
7	O
%	O
and	O
3	O
.	O
4	O
%	O
at	O
15	O
and	O
32	O
ng	O
/	O
mL	O
,	O
respectively	O
,	O
and	O
inter	O
-	O
assay	O
CVs	O
of	O
7	O
.	O
9	O
%	O
and	O
5	O
.	O
4	O
%	O
at	O
17	O
and	O
33	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

The	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
was	O
significantly	O
lower	O
among	O
third	O
than	O
first	O
trimester	O
pregnant	O
women	O
(	O
Table	O
5	O
).	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

We	O
combined	O
EPA	O
,	O
DHA	O
and	O
DPA	O
to	O
estimate	O
the	O
total	O
intake	O
of	O
marine	O
fatty	O
acids	O
.	O

The	O
overall	O
characteristics	O
of	O
the	O
study	O
population	O
across	O
different	O
categories	O
of	O
dietary	O
patterns	O
are	O
presented	O
inTable	O
6	O
.	O

These	O
approaches	O
,	O
however	O
,	O
assign	O
equal	O
weight	O
and	O
importance	O
to	O
all	O
chemicals	O
,	O
irrespective	O
of	O
their	O
predictive	O
value	O
.	O

•	O
Improve	O
methods	O
for	O
diagnosing	O
and	O
treating	O
prematurity	O
-	O
related	O
impairment	O
in	O
childhood	O
.	O

We	O
analysed	O
associations	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
in	O
pregnancy	O
(	O
estimated	O
by	O
a	O
food	O
frequency	O
questionnaire	O
),	O
and	O
current	O
doctor	O
-	O
diagnosed	O
asthma	O
,	O
wheezing	O
,	O
hay	O
fever	O
,	O
eczema	O
,	O
atopy	O
,	O
serum	O
total	O
IgE	O
and	O
lung	O
function	O
in	O
children	O
aged	O
7	O
–	O
9	O
years	O
(	O
n	O
=	O
8956	O
with	O
information	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
and	O
at	O
least	O
one	O
outcome	O
of	O
interest	O
).	O

Immunotherapy	O
may	O
be	O
continued	O
as	O
maintenance	O
treatment	O
but	O
should	O
not	O
be	O
initiated	O
during	O
pregnancy	O
.	O

Some	O
of	O
our	O
findings	O
are	O
comparable	O
with	O
those	O
of	O
studies	O
conducted	O
in	O
other	O
countries	O
.	O

The	O
total	O
annual	O
cost	O
of	O
the	O
program	O
was	O
USD	O
133	O
,	O
900	O
of	O
which	O
programmatic	O
costs	O
made	O
up	O
69	O
%	O
of	O
the	O
total	O
,	O
the	O
major	O
component	O
being	O
the	O
supply	O
and	O
transport	O
of	O
supplements	O
(	O
47	O
%	O
of	O
the	O
total	O
).	O

In	O
the	O
clinical	O
setting	O
,	O
pregnant	O
women	O
should	O
receive	O
advice	O
about	O
vitamin	O
D	O
,	O
especially	O
during	O
winter	O
.	O

Factors	O
that	O
modify	O
intake	O
regulation	O
include	O
the	O
types	O
and	O
amounts	O
of	O
food	O
to	O
which	O
children	O
are	O
exposed	O
,	O
social	O
modeling	O
of	O
eating	O
behaviors	O
,	O
and	O
child	O
feeding	O
styles	O
and	O
practices	O
(	O
73	O
).	O

The	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
Iran	O
was	O
showed	O
in	O
numerous	O
studies	O
.	O

Early	O
diagnosis	O
of	O
autism	O
and	O
any	O
subsequent	O
related	O
intervention	O
(	O
s	O
)	O
may	O
serve	O
to	O
alleviate	O
the	O
challenges	O
that	O
are	O
faced	O
by	O
those	O
individuals	O
,	O
who	O
must	O
manage	O
the	O
effects	O
of	O
autism	O
on	O
an	O
ongoing	O
basis	O
,	O
including	O
patients	O
,	O
their	O
guardians	O
and	O
/	O
or	O
families	O
,	O
and	O
related	O
healthcare	O
professionals	O
.	O

Various	O
symptoms	O
are	O
faced	O
by	O
woman	O
like	O
in	O
first	O
trimester	O
,	O
nausea	O
,	O
vomiting	O
is	O
seen	O
very	O
comman	O
.	O

Consolidated	O
Standards	O
of	O
Reporting	O
Trials	O
diagram	O
.	O

A	O
longitudinal	O
study	O
over	O
a	O
period	O
of	O
27	O
years	O
discovered	O
that	O
aortic	O
dissection	O
was	O
the	O
initial	O
clinical	O
diagnosis	O
in	O
only	O
15	O
%	O
of	O
patients	O
presenting	O
with	O
an	O
aortic	O
dissection	O
[	O
1	O
].	O

Studies	O
have	O
shown	O
that	O
at	B
least	I
three	O
polymorphisms	O
are	O
associated	O
with	O
altered	O
glucocorticoid	O
sensitivity	O
and	O
also	O
with	O
changes	O
in	O
body	O
composition	O
and	O
metabolic	O
parameters	O
[	O
10	O
,	O
11	O
],	O
which	O
could	O
affect	O
fetal	O
development	O
as	O
well	O
.	O

If	O
these	O
two	O
interventions	O
were	O
added	O
to	O
existing	O
health	O
system	O
packages	O
,	O
especially	O
noting	O
the	O
recent	O
shifts	O
to	O
more	O
facility	O
births	O
in	O
Africa	O
and	O
Asia	O
,	O
then	O
a	O
high	O
impact	O
is	O
possible	O
even	O
in	O
a	O
relatively	O
short	O
time	O
frame	O
.	O

New	O
drugs	O
with	O
anti	O
-	O
angiogenetic	O
,	O
anti	O
-	O
tyrosine	O
kinase	O
and	O
anti	O
-	O
VEGF	O
effects	O
are	O
currently	O
under	O
observation	O
.	O

Non	O
-	O
melanoma	O
skin	O
cancer	O
and	O
,	O
less	O
strongly	O
,	O
melanoma	O
are	O
more	B
common	I
in	O
individuals	O
with	O
high	O
levels	O
of	O
sun	O
exposure	O
.	O

The	O
sampling	O
flow	O
chart	O
was	O
presented	O
in	O
Fig	O
.	O

These	O
findings	O
suggest	O
that	O
improvements	O
in	O
vitamin	O
D	O
status	O
may	O
decrease	O
the	O
disparity	O
in	O
PTB	O
rates	O
between	O
race	O
/	O
ethnic	O
groups	O
.	O

Methods	O
Study	O
Design	O
and	O
Participants	O
Between	O
2007	O
and	O
2009	O
,	O
2246	O
pregnant	O
women	O
enrolled	O
in	O
a	O
three	O
site	O
,	O
observational	O
cohort	O
study	O
of	O
the	O
prevention	O
of	O
preeclampsia	O
in	O
Boston	O
and	O
Philadelphia	O
.	O
20Women	O
provided	O
written	O
,	O
informed	O
consent	O
to	O
participate	O
and	O
the	O
Institutional	O
Review	O
Board	O
of	O
participating	O
institutions	O
approved	O
the	O
study	O
.	O

The	O
uncertainty	O
concerning	O
the	O
optimal	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
is	O
even	O
higher	O
.	O

Our	O
research	O
also	O
showed	O
that	O
IMF	O
had	O
the	O
lowest	O
transcriptional	O
activity	O
for	O
many	O
adipose	O
development	O
and	O
lipid	O
metabolism	O
genes	O
,	O
including	O
adipogenesis	O
,	O
FA	O
transport	O
,	O
lipogenesis	O
,	O
lipolysis	O
,	O
and	O
FA	O
oxidation	O
among	O
several	O
fat	O
depots	O
(	O
abdominal	O
,	O
perirenal	O
,	O
subcutaneous	O
,	O
and	O
intramuscular	O
)	O
of	O
Korean	O
cattle	O
[	O
7	O
].	O

Epidemiological	O
studies	O
have	O
shown	O
that	O
VD	O
deficiency	O
increases	O
not	O
only	O
infertility	O
rate	O
but	O
also	O
the	O
risk	O
of	O
serious	O
pregnancy	O
complications	O
,	O
such	O
as	O
preeclampsia	O
and	O
preterm	O
birth	O
[	O
64	O
].	O

We	O
measured	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
and	O
compared	O
them	O
between	O
the	O
two	O
groups	O
.	O

According	O
to	O
the	O
recent	O
studies	O
[	O
47	O
],	O
we	O
can	O
suggest	O
that	O
it	O
was	O
not	O
a	O
result	O
of	O
direct	O
VD	O
action	O
,	O
but	B
its	O
role	O
in	O
ion	O
homeostasis	O
[	O
51	O
].	O

Secondary	O
analyses	O
of	O
this	O
trial	O
found	O
a	O
71	O
%	O
reduction	O
in	O
neonatal	O
mortality	O
in	O
women	O
who	O
started	O
IFA	O
supplements	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
(	O
HR	O
0	O
.	O
29	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
09	O
–	O
0	O
.	O
88	O
)	O
[	O
8	O
].	O

We	O
collected	O
:	O
•	O
Demographic	O
data	O
:	O
age	O
,	O
area	O
of	O
residence	O
(	O
urban	O
or	O
rural	O
),	O
family	O
status	O
(	O
married	O
or	O
single	O
,	O
wanted	O
or	O
unwanted	O
pregnancy	O
,	O
parity	O
),	O
and	O
duration	O
of	O
formal	O
education	O
;	O
•	O
Engagement	O
with	O
prenatal	O
care	O
:	O
gestational	O
age	O
at	O
the	O
beginning	O
of	O
care	O
,	O
provider	O
of	O
care	O
(	O
general	O
practitioner	O
or	O
obstetrician	O
),	O
and	O
total	O
number	O
of	O
visits	O
.	O

Examination	O
of	O
the	O
skeletal	O
abnormalities	O
To	O
further	O
characterize	O
the	O
skeletal	O
abnormalities	O
,	O
we	O
performed	O
radiography	O
on	O
wild	O
-	O
type	O
and	O
mutant	O
mice	O
aged	O
6	O
wk	O
.	O

Expression	O
of	O
anorexigenic	O
POMC	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
BDNF	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
was	O
higher	O
,	O
and	O
DopaR1	O
was	O
lower	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
in	O
pups	O
fed	O
the	O
HV	O
diet	O
.	O

Vaginal	O
smears	O
were	O
initially	O
evaluated	O
under	O
wet	O
conditions	O
where	O
the	O
sample	O
was	O
placed	O
on	O
a	O
glass	O
microscope	O
slide	O
and	O
examined	O
under	O
a	O
light	O
microscope	O
at	O
20	O
–	O
40	O
×	O
magnification	O
.	O

Girls	O
were	O
correlated	O
with	O
fathers	O
but	O
not	O
mothers	O
and	O
were	O
also	O
correlated	O
with	O
the	O
MGM	O
and	O
PGM	O
.	O

The	O
FA	O
de	O
novo	O
synthesis	O
occurs	O
mainly	O
in	O
adipose	O
tissue	O
in	O
ruminants	O
[	O
84	O
],	O
whereas	O
it	O
occurs	O
in	O
the	O
liver	O
in	O
humans	O
and	O
rodents	O
.	O

Marbling	O
is	O
positively	O
correlated	O
with	O
juiciness	O
,	O
tenderness	O
,	O
and	O
palatability	O
of	O
beef	O
[	O
1	O
].	O

Limited	O
information	O
is	O
available	O
on	O
the	O
effects	O
of	O
the	O
dietary	O
energy	O
-	O
to	O
-	O
protein	O
ratio	O
on	O
IMF	O
content	O
in	O
cattle	O
.	O

[	O
20	O
]	O
measured	O
supplement	O
usage	O
during	O
pregnancy	O
.	O

Furthermore	O
,	O
multivitamin	O
supplements	O
available	O
during	O
the	O
study	O
period	O
contained	O
very	O
little	O
(	O
maximum	O
50	O
IU	O
),	O
if	O
any	O
,	O
vitamin	O
D	O
and	O
thus	B
are	O
an	O
unlikely	B
source	O
of	O
variation	O
within	O
the	O
population	O
.	O

This	O
time	O
,	O
a	O
significant	O
difference	O
in	O
VD	O
levels	O
was	O
found	O
between	O
Caucasian	O
and	O
Asian	O
women	O
(	O
p	O
=	O
0	O
.	O
001	O
).	O

In	O
contrast	O
,	O
the	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
show	O
changes	O
in	O
body	O
weight	O
and	O
adiposity	O
,	O
but	O
exhibited	O
higher	O
levels	O
of	O
LDL	O
and	O
glucose	O
in	O
plasma	O
,	O
and	O
a	O
reduction	O
in	O
chocolate	O
preference	O
at	O
adolescence	O
and	O
total	O
caloric	O
intake	O
at	O
adulthood	O
.	O

These	O
stages	O
are	O
opportunities	O
for	O
interventions	O
to	O
prevent	O
obesity	O
by	O
controlling	O
caloric	O
intake	O
and	O
increasing	O
energy	O
expenditure	O
.	O

It	O
was	O
validated	O
for	O
the	O
population	O
in	O
the	O
Transition	O
and	O
Health	O
during	O
Urbanisation	O
of	O
South	O
Africans	O
(	O
THUSA	O
)	O
study	O
[	O
39	O
]	O
and	O
its	O
reproducibility	O
was	O
proven	O
[	O
40	O
,	O
41	O
].	O

The	O
biochemistry	O
of	O
our	O
patients	O
with	O
IIH	O
raises	O
variations	O
in	O
Vitamin	O
D	O
metabolism	O
or	O
calcium	O
set	O
-	O
point	O
as	B
potential	O
associated	O
factors	O
.	O

Recent	O
studies	O
of	O
the	O
text4baby	O
program	O
have	O
found	O
that	O
it	O
changes	O
attitudes	O
and	O
beliefs	O
,	O
but	O
effects	O
on	O
behavior	O
have	O
not	O
previously	O
been	O
established	O
[	O
23	O
,	O
26	O
].	O

indicates	O
the	O
existence	O
of	O
conflicting	O
data	O
in	O
the	O
literature	O
with	O
regard	O
to	O
the	O
impact	O
of	O
the	O
factor	O
on	O
UCP1	O
activity	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
involvement	O
of	O
maternal	O
vitamin	O
D	O
during	O
pregnancy	O
in	O
autism	O
requires	O
proper	O
investigation	O
.	O

Our	O
aim	O
was	O
to	O
assess	O
whether	O
oral	O
supplementation	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
will	O
reduce	O
the	O
incidence	O
and	O
severity	O
of	O
pneumonia	O
in	O
a	O
high	O
-	O
risk	O
infant	O
population	O
.	O

Statistical	O
Analyses	O
The	O
statistical	O
analyses	O
were	O
carried	O
out	O
using	O
STATA	O
10	O
.	O
1	O
(	O
StataCorp	O
,	O
Texas	O
,	O
USA	O
).	O

PubMed	O
Central	O
:	O

Within	O
the	O
significantly	O
different	O
spots	O
,	O
three	O
calcium	O
binding	O
proteins	O
(	O
calbindin1	O
,	O
calbindin2	O
and	O
hippocalcin	O
)	O
were	O
altered	O
.	O

The	O
median	O
age	O
at	O
diagnosis	O
is	O
low	O
,	O
below	O
40	O
years	O
in	O
most	O
populations	O
.	O

The	O
authors	O
suggested	O
that	O
feeding	O
concentrate	O
plus	O
roughage	O
or	O
starch	O
after	O
early	O
weaning	O
at	O
a	O
young	O
age	O
could	O
alter	O
adipogenic	O
and	O
lipogenic	O
potential	O
in	O
loin	O
meat	O
.	O

[	O
3	O
].	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
the	O
Institute	O
of	O
Medicine	O
guidelines	O
.	O

We	O
have	O
identified	O
a	O
specific	O
group	O
of	O
mothers	O
(	O
Tht	O
III	O
I	O
polymorphism	O
,	O
CC	O
group	O
)	O
in	O
whom	O
maternal	O
attitudes	O
predicted	O
fetal	O
weight	O
.	O

Only	O
38	O
%	O
of	O
herb	O
users	O
discussed	O
it	O
with	O
their	O
provider	O
and	O
82	O
%	O
were	O
satisfied	O
with	O
the	O
conversation	O
.	O

After	O
12	O
months	O
the	O
cost	O
of	O
delivery	O
to	O
the	O
province	O
was	O
included	O
in	O
the	O
contract	O
with	O
the	O
manufacturer	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
in	O
hypothalamus	O
and	O
liver	O
,	O
Cnr2	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
liver	O
and	O
PAT	O
,	O
and	O
Dagl	O
α	O
in	O
PAT	O
(	O
see	O
TableS2for	O
statistical	O
values	O
).	O

Non	O
-	O
fasting	O
venous	O
blood	O
samples	O
were	O
drawn	O
in	O
gel	O
serum	O
separating	O
tubes	O
and	O
centrifuged	O
for	O
10	O
min	O
within	O
2	O
h	O
of	O
sampling	O
.	O

The	O
study	O
was	O
conducted	O
per	O
the	O
guidelines	O
laid	O
down	O
in	O
the	O
Declaration	O
of	O
Helsinki	O
with	O
institutional	O
ethical	O
approval	O
and	O
written	O
maternal	O
consent	O
.	O

These	O
values	O
were	O
changed	O
by	O
intervention	O
to	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%,	O
respectively	O
.	O

In	O
Utero	O
Cigarette	O
Smoke	O
Exposure	O
and	O
Age	O
at	O
Menopause	O
It	O
is	O
well	O
documented	O
that	O
women	O
who	O
smoke	O
cigarettes	O
begin	O
menopause	O
earlier	O
than	O
nonsmokers	O
.	O

Review	O
of	O
Literature	O
Several	O
recent	O
studies	O
have	O
explored	O
season	O
of	O
birth	O
as	O
a	O
risk	O
factor	O
for	O
adult	O
glioma	O
,	O
but	O
results	O
have	O
been	O
mixed	O
(	O
Table	O
1	O
).	O

Current	O
Body	O
Mass	O
Index	O
(	O
BMI	O
)	O
was	O
classified	O
by	O
gestational	O
week	O
,	O
according	O
to	O
Atalah	O
.	O

In	O
their	O
study	O
,	O
genotype	O
differences	O
were	O
generally	B
observed	O
in	O
IMF	O
contents	O
of	O
4	O
muscles	O
(	O
biceps	O
femoris	O
,	O
supraspinatus	O
,	O
semitendinosus	O
,	O
longissimus	O
lumborum	O
,	O
and	O
infraspinatus	O
),	O
although	O
semitendinosus	O
muscle	O
IMF	O
did	O
not	O
differ	O
among	O
genotypes	O
.	O

Those	O
patients	O
who	O
failed	O
this	O
screening	O
test	O
(	O
glucose	O
≥	O
140	O
mg	O
/	O
dl	O
)	O
were	O
then	O
followed	O
-	O
up	O
within	O
1	O
-	O
2	O
weeks	O
with	O
a	O
100	O
gram	O
,	O
3	O
-	O
hour	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
).	O

This	O
is	O
especially	O
important	O
for	O
pregnant	O
asthmatic	O
patients	O
,	O
in	O
whom	O
smoking	O
-	O
related	O
morbidity	O
is	O
independent	O
of	O
--	O
and	O
adds	O
to	O
--	O
the	O
morbidity	O
resulting	O
from	O
asthma	O
[	O
96	O
].	O

Statistical	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
(	O
two	O
-	O
sided	O
)	O
with	O
no	O
adjustment	O
for	O
multiple	O
comparisons	O
,	O
and	O
all	O
analyses	O
followed	O
a	O
pre	O
-	O
specified	O
plan	O
.	O

Micelle	O
formation	O
profoundly	O
increases	O
the	O
fraction	O
of	O
lipid	O
molecules	O
accessible	O
to	O
the	O
action	O
of	O
intestinal	O
lipase	O
,	O
aiding	O
fat	O
digestion	O
in	O
the	O
intestine	O
.	O

Fewer	O
neonates	O
in	O
the	O
treatment	O
group	O
were	O
large	O
for	O
gestational	O
age	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
incidence	O
of	O
small	O
for	O
gestational	O
age	O
infants	O
.	O

The	O
mobile	O
phase	O
flow	O
rate	O
was	O
600	O
µL	O
/	O
min	O
through	O
a	O
Luna	O
3	O
µ	O
C18	O
(	O
2	O
)	O
100A	O
250	O
×	O
4	O
.	O
6	O
mm	O
column	O
held	O
at	O
40	O
°	O
C	O
(	O
Phenomenex	O
,	O
Auckland	O
,	O
New	O
Zealand	O
).	O

A	O
diet	O
higher	O
in	O
n	O
-	O
6	O
PUFAs	O
--	O
as	O
present	O
,	O
for	O
example	O
,	O
in	O
margarine	O
and	O
vegetable	O
oils	O
--	O
seems	O
to	O
be	O
more	O
likely	B
to	O
induce	O
eczema	O
than	O
n	O
-	O
3	O
PUFAs	O
,	O
which	O
are	O
for	O
instance	O
found	O
in	O
fish	O
[	O
79	O
].	O

However	O
,	O
we	O
confirmed	O
our	O
second	O
hypothesis	O
that	O
there	O
was	O
a	O
dose	O
-	O
response	O
effect	O
of	O
text4baby	O
,	O
with	O
higher	O
levels	O
of	O
text	O
message	O
exposure	O
predicting	O
lower	O
self	O
-	O
reported	O
alcohol	O
consumption	O
.	O

As	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
is	O
not	O
normally	O
distributed	O
,	O
non	O
-	O
parametric	O
methods	O
were	O
used	O
.	O

Sociodemographics	O
The	O
demographic	O
variables	O
used	O
in	O
this	O
study	O
included	O
maternal	O
age	O
,	O
country	O
of	O
origin	O
,	O
ethnicity	O
,	O
education	O
,	O
language	O
preference	O
,	O
years	O
spent	O
in	O
the	O
US	O
,	O
parity	O
,	O
use	O
of	O
tobacco	O
,	O
alcohol	O
and	O
prenatal	O
vitamins	O
during	O
pregnancy	O
,	O
employment	O
,	O
and	O
participation	O
in	O
the	O
Special	O
Supplemental	O
Nutrition	O
Program	O
for	O
Women	O
,	O
Infants	O
and	O
Children	O
(	O
WIC	O
).	O

In	O
the	O
case	O
of	O
cockroach	O
sensitivity	O
,	O
over	O
60	O
%	O
of	O
inner	O
-	O
city	O
residents	O
with	O
asthma	O
test	O
positive	O
for	O
cockroach	O
allergen	O
[	O
79	O
],	O
with	O
black	O
children	O
and	O
those	O
receiving	O
public	O
assistance	O
most	O
likely	O
to	O
be	O
sensitized	O
[	O
70	O
].	O

They	O
were	O
more	O
likely	B
to	O
have	O
experienced	O
fetal	O
distress	O
,	O
been	O
delivered	O
by	O
an	O
elective	O
or	O
emergency	O
cesarean	O
section	O
,	O
and	O
had	O
an	O
Apgar	O
score	O
of	O
less	O
than	O
6	O
at	O
one	O
minute	O
.	O

Liver	O
samples	O
were	O
collected	O
immediately	O
,	O
snap	O
-	O
frozen	O
in	O
liquid	O
nitrogen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

After	O
birth	O
,	O
the	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
re	O
main	O
on	O
some	O
parts	O
of	O
the	O
stromal	O
vascular	O
cells	O
in	O
adipose	O
tissue	O
,	O
later	O
serving	O
as	O
precursors	O
to	O
preadipocytes	O
and	O
adipocytes	O
[	O
16	O
,	O
22	O
].	O

Red	O
circles	O
indicate	O
increased	O
spots	O
,	O
blue	O
circles	O
indicate	O
spots	O
reduced	O
in	O
the	O
average	O
gel	O
in	O
DVD	O
animals	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
differentially	O
expressed	O
protein	O
spots	O
in	O
nucleus	O
accumbens	O
tissue	O
from	O
adult	O
DVD	O
-	O
deficient	O
and	O
control	O
ratsFold	O
changep	O
valueProteinUniprot	O
Accession	O
NumberMowse	O
scoreMolecular	O
weightpH	O
Calcium	O
Binding	O
Proteins	O
1	O
.	O
140	O
.	O
031Calreticulin	O
CALRP18418114479664	O
.	O
33	O
-	O
1	O
.	O
250	O
.	O
050Calbindin	O
(	O
calretinin	O
)	O
CALB2P47728156313844	O
.	O
94	O
-	O
1	O
.	O
180	O
.	O
045Calbindin	O
CALB1P0717169299754	O
.	O
711	O
.	O
170	O
.	O
032Hippocalcin	O
HPCAP8407679224134	O
.	O
87	O
General	O
cellular	O
metabolism	O
proteins	O
1	O
.	O
470	O
.	O
026L	O
-	O
lactate	O
dehydrogenase	O
B	O
chain	O
LDHBP42123119365895	O
.	O
701	O
.	O
230	O
.	O
004Aldose	O
reductase	O
ALDRP07943154357746	O
.	O
26	O
-	O
1	O
.	O
110	O
.	O
014crystallin	O
,	O
mu	O
CRYMQ9QYU496335335	O
.	O
34	O
-	O
1	O
.	O
090	O
.	O
030Malate	O
dehydrogenase	O
,	O
cytoplasmic	O
MDHCO8898969364606	O
.	O
16	O
-	O
1	O
.	O
350	O
.	O
030Glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
[	O
NAD	O
+],	O
cytoplasmic	O
GPDAO35077141374286	O
.	O
16	O
-	O
1	O
.	O
170	O
.	O
043Glutathione	O
S	O
-	O
transferase	O
P	O
GSTP1P0490678234246	O
.	O
89	O
Mitochondria	O
Proteins	O
-	O
1	O
.	O
540	O
.	O
041Hexokinase	O
1	O
HXK1P05708761023426	O
.	O
29	O
-	O
1	O
.	O
350	O
.	O
048Dynamin	O
1	O
-	O
like	O
protein	O
DNM1LO35303106838566	O
.	O
64	O
-	O
1	O
.	O
120	O
.	O
046Ubiquinol	O
-	O
cytochrome	O
-	O
c	O
reductase	O
complex	O
core	O
protein	O
1	O
,	O
UQCR1Q68FY0145528155	O
.	O
57	O
-	O
1	O
.	O
140	O
.	O
033Isocitrate	O
dehydrogenase	O
(	O
NAD	O
)	O
subunit	O
alpha	O
,	O
mitochondrial	O
IDH3AQ99NA5113395886	O
.	O
471	O
.	O
160	O
.	O
037IDH3AQ99NA5117	O
..-	O
1	O
.	O
370	O
.	O
011NADH	O
dehydrogenase	O
1	O
alpha	O
subcomplex	O
subunit	O
10	O
,	O
NDUAAQ561S0219404687	O
.	O
64	O
-	O
1	O
.	O
100	O
.	O
039Pyruvate	O
dehydrogenase	O
E1	O
component	O
subunit	O
beta	O
,	O
ODPBP4943295389576	O
.	O
20	O
-	O
1	O
.	O
180	O
.	O
033Voltage	O
-	O
dependent	O
anion	O
-	O
selective	O
channel	O
protein	O
2	O
VDAC2P8115559317267	O
.	O
44	O
Signal	O
transduction	O
and	O
MAP	O
-	O
related	O
proteins	O
-	O
1	O
.	O
280	O
.	O
007Mitogen	O
-	O
activated	O
protein	O
kinase	O
1	O
(	O
ERK	O
-	O
2	O
;	O
MAPK	O
2	O
)	O
MK01P6308657412496	O
.	O
50	O
-	O
1	O
.	O
240	O
.	O
009Serine	O
/	O
threonine	O
-	O
protein	O
phosphatase	O
2A	O
catalytic	O
subunit	O
beta	O
isoform	O
PP2ABP62716107355525	O
.	O
211	O
.	O
230	O
.	O
036Guanine	O
nucleotide	O
-	O
binding	O
protein	O
G	O
(	O
I	O
)/	O
G	O
(	O
S	O
)/	O
G	O
(	O
T	O
)	O
subunit	O
beta	O
1	O
GBB1P5431164373535	O
.	O
60	O
-	O
1	O
.	O
150	O
.	O
031Guanine	O
nucleotide	O
-	O
binding	O
protein	O
G	O
(	O
I	O
)/	O
G	O
(	O
S	O
)/	O
G	O
(	O
T	O
)	O
subunit	O
beta	O
2	O
GBB2P5431374373075	O
.	O
60	O
-	O
1	O
.	O
240	O
.	O
029Dynamin	O
1	O
DYN1P21575152958676	O
.	O
32	O
-	O
1	O
.	O
670	O
.	O
047Thimet	O
oligopeptidase	O
MEPDP24155112782645	O
.	O
54	O
-	O
1	O
.	O
220	O
.	O
006Dihydropyrimidinase	O
-	O
related	O
protein	O
2	O
(	O
DRP	O
-	O
2	O
;	O
CRMP	O
-	O
2	O
)	O
DPYL2P47942101622395	O
.	O
951	O
.	O
170	O
.	O
038DPYL2P4794253	O
..	O
1	O
.	O
240	O
.	O
007DPYL2P4794285	O
..-	O
1	O
.	O
210	O
.	O
024Syntaxin	O
-	O
binding	O
protein	O
1	O
STXB1P6176591675266	O
.	O
49	O
-	O
1	O
.	O
250	O
.	O
036Adenosylhomocysteinase	O
SAHHP1076093475076	O
.	O
071	O
.	O
310	O
.	O
013Ras	O
-	O
related	O
protein	O
Rab	O
-	O
3C	O
RAB3CP6282464258565	O
.	O
101	O
.	O
140	O
.	O
003Beta	O
-	O
synuclein	O
SYUBQ6375456144954	O
.	O
481	O
.	O
170	O
.	O
013Myosin	O
light	O
polypeptide	O
6	O
MYL6Q6411954169644	O
.	O
46	O
Proteins	O
not	O
otherwise	O
classified	O
1	O
.	O
480	O
.	O
011Eukaryotic	O
initiation	O
factor	O
4A	O
-	O
II	O
IF4A2Q5RKI190463735	O
.	O
331	O
.	O
190	O
.	O
001Glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
G3PP0479778358058	O
.	O
14	O
-	O
1	O
.	O
150	O
.	O
047ADP	O
-	O
ribosylation	O
factor	O
1	O
ARF1P84079128206846	O
.	O
32	O
Ingenuity	O
Pathway	O
Analysis	O
identified	O
two	O
major	O
networks	O
;	O
(	O
a	O
)	O
Cellular	O
Movement	O
,	O
cellular	O
assembly	O
and	O
organization	O
,	O
cell	O
signaling	O
;	O
and	O
(	O
b	O
)	O
Protein	O
synthsis	O
,	O
RNA	O
Post	O
-	O
transcriptional	O
Modification	O
,	O
Cancer	O
.	O

Background	O
Adequate	O
nutrition	O
during	O
pregnancy	O
is	O
associated	O
with	O
optimal	O
foetal	O
growth	O
[	O
1	O
,	O
2	O
],	O
normal	O
pregnancy	O
duration	O
[	O
3	O
]	O
and	O
a	O
decrease	O
in	O
the	O
risk	O
of	O
congenital	O
abnormalities	O
[	O
4	O
].	O

This	O
indicates	O
that	O
there	O
may	O
be	O
a	O
window	O
of	O
opportunity	O
during	O
fetal	O
development	O
in	O
which	O
allergic	O
manifestation	O
risk	O
may	O
be	O
altered	O
.	O

A	O
targeted	O
screening	O
strategy	O
to	O
detect	O
and	O
treat	O
women	O
at	O
high	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
is	O
needed	O
in	O
Belgium	O
and	O
in	O
Europe	O
.	O

PubMed	O
Central	O
:	O

Of	O
the	O
recruited	O
eligible	O
families	O
,	O
29	O
%	O
(	O
987	O
/	O
3408	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
VIDI	O
study	O
.	O

Not	O
only	O
do	O
such	O
advertisements	O
promote	O
eating	O
,	O
but	O
eating	O
while	O
watching	O
television	O
also	O
often	B
leads	B
to	O
overeating	O
because	B
children	O
do	O
not	O
notice	O
how	O
much	O
they	O
are	O
eating	O
(	O
88	O
).	O

A	O
review	O
of	O
the	O
literature	O
revealed	O
a	O
paucity	O
of	O
published	O
cases	O
describing	O
the	O
successful	O
,	O
emergent	O
repair	O
of	O
acute	O
type	O
A	O
aortic	O
dissections	O
in	O
third	O
-	O
trimester	O
gravid	O
patients	O
.	O

This	O
insufficiency	O
is	O
likely	B
related	O
to	O
diet	O
[	O
3	O
]	O
and	O
is	O
gaining	O
recognition	O
as	O
a	O
public	O
health	O
problem	O
.	O

Thyroid	O
hormone	O
deficiency	O
may	O
cause	O
severe	O
neurologic	O
disorders	O
,	O
resulting	O
from	O
defects	O
in	O
neuronal	O
cell	O
differentiation	O
and	O
migration	O
,	O
axonal	O
and	O
dendritic	O
outgrowth	O
,	O
myelin	O
formation	O
and	O
synaptogenesis7913	O
.	O

25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
maternal	O
and	O
cord	O
serum	O
were	O
highly	O
correlated	O
(	O
r2	O
=	O
0	O
.	O
457	O
,	O
p	O
<	O
0	O
.	O
0001	O
).	O

After	O
adjusting	O
for	O
Medicaid	O
status	O
,	O
BMI	O
at	O
delivery	O
and	O
prenatal	O
vitamin	O
use	O
,	O
black	O
infants	O
had	O
a	O
3	O
.	O
6	O
greater	O
odds	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
2	O
.	O
4	O
,	O
5	O
.	O
6	O
)	O
of	O
having	O
vitamin	O
D	O
deficiency	O
compared	O
with	O
white	O
infants	O
(	O
Table	O
2	O
).	O

In	O
our	O
cohort	O
,	O
dietary	O
energy	O
,	O
protein	O
and	O
fat	O
were	O
significantly	O
higher	O
during	O
extended	O
summer	O
,	O
while	O
carbohydrates	O
,	O
glycaemic	O
index	O
,	O
glycaemic	O
load	O
,	O
physical	O
activity	O
and	O
well	O
-	O
being	O
were	O
no	O
different	O
across	O
seasons	O
.	O

Predictors	O
included	O
both	O
baseline	O
and	O
pregnancy	O
changes	O
over	O
time	O
(	O
between	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
).	O

Given	B
this	O
scenario	O
and	O
taking	O
into	O
account	O
changing	O
numbers	O
of	O
births	O
,	O
the	O
global	O
total	O
of	O
preterm	O
deaths	O
will	O
not	O
reduce	O
significantly	O
by	O
2025	O
,	O
with	O
around	O
900	O
,	O
000	O
premature	O
babies	O
continuing	O
to	O
die	O
every	O
year	O
.	O

Both	O
the	O
tails	O
and	O
globular	O
domains	O
of	O
histones	O
can	O
undergo	O
multiple	O
posttranslational	O
modifications	O
,	O
including	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ADP	O
ribosylation	O
,	O
ubiquitination	O
and	O
sumoylation	O
,	O
giving	O
rise	O
to	O
the	O
so	O
-	O
called	O
histone	O
code	O
(	O
Strahl	O
&	O
Allis2000	O
;	O
Turner2000	O
;	O
Jenuwein	O
&	O
Allis2001	O
;	O
Bhaumik	O
et	O
al	O
.	O
2007	O
;	O
Kouzarides2007	O
;	O
Suganuma	O
&	O
Workman2011	O
).	O

Differences	O
were	O
considered	O
significant	O
at	O
P	O
≤	O
0	O
.	O
05	O
.	O

This	O
includes	O
changes	O
in	O
raphe	O
and	O
callosal	O
connections	O
,	O
sensory	O
processing	O
,	O
myelin	O
sheath	O
formation	O
,	O
neophobia	O
,	O
and	O
disrupted	O
juvenile	O
play	O
behavior	O
.	O

Infants	O
who	O
were	O
exclusively	O
breastfed	O
or	O
had	O
high	O
levels	O
of	O
skin	O
pigmentation	O
,	O
inadequate	O
sunlight	O
exposure	O
,	O
or	O
inadequate	O
vitamin	O
supplement	O
are	O
at	O
risk	O
of	O
a	O
vitamin	O
D	O
deficiency	O
[	O
26	O
].	O

Anaphylaxis	O
The	O
exact	O
prevalence	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
unknown	O
,	O
but	O
it	O
is	O
extremely	O
uncommon	O
[	O
30	O
].	O

At	O
weaning	O
,	O
however	O
,	O
the	O
F2	O
-	O
VitD	O
offspring	O
had	O
higher	O
BMs	O
(+	O
26	O
%)	O
than	O
the	O
F2	O
-	O
SC	O
offspring	O
(	O
P	O
=	O
0	O
.	O
03	O
).	O

Phthalates	O
and	O
BPA	O
were	O
less	O
strongly	O
correlated	O
with	O
other	O
chemicals	O
and	O
,	O
with	O
the	O
exception	O
of	O
the	O
di	O
-	O
2	O
-	O
ethylhexylphthalate	O
metabolites	O
,	O
weakly	O
correlated	O
with	O
each	O
other	O
.	O

For	O
various	O
reasons	O
,	O
blood	O
samples	O
were	O
only	O
collected	O
for	O
97	O
.	O
9	O
%	O
(	O
n	O
=	O
141	O
)	O
of	O
children	O
with	O
S	O
-	O
ECC	O
and	O
99	O
.	O
2	O
%	O
(	O
n	O
=	O
121	O
)	O
of	O
controls	O
.	O

Thus	B
,	O
Model	O
1	O
indicates	O
that	O
every	O
1	O
-	O
year	O
increase	O
in	O
a	O
child	O
’	O
s	O
age	O
is	O
associated	O
with	O
a	O
0	O
.	O
145	O
unit	O
increase	O
in	O
their	O
log	O
cathelicidin	O
concentration	O
,	O
equivalent	O
to	O
a	O
e0	O
.	O
145	O
=	O
1	O
.	O
2	O
-	O
fold	O
increase	O
from	O
1	O
year	O
to	O
the	O
next	O
.	O

In	O
Matlab	O
,	O
Bangladesh	O
,	O
we	O
randomly	O
allocated	O
pregnant	O
women	O
at	O
28	O
–	O
32	O
weeks	O
'	O
gestation	O
to	O
intensive	O
handwashing	O
promotion	O
or	O
control	O
.	O

In	O
spite	O
of	O
the	O
theoretical	O
proliferative	O
stimulation	O
caused	O
by	O
HCG	O
and	O
placental	O
growth	O
factors	O
,	O
published	O
data	O
indicate	O
that	O
there	O
is	O
no	O
evidence	O
that	O
thyroid	O
cancer	O
can	O
be	O
influenced	O
by	O
pregnancy	O
.	O

This	O
mutation	O
occurs	O
within	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
receptor	O
,	O
which	O
is	O
important	O
for	O
ligand	O
binding	O
(	O
Figure	O
3C	O
,	O
upper	O
panel	O
).	O

Infant	O
'	O
s	O
Diet	O
Regarding	O
the	O
nutrition	O
of	O
the	O
baby	O
,	O
reduced	O
breast	O
-	O
feeding	O
and	O
early	O
introduction	O
of	O
solid	O
food	O
have	O
been	O
discussed	O
as	O
confounders	O
to	O
allergy	O
development	O
.	O

They	O
showed	O
that	O
supplementation	O
with	O
an	O
oral	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
and	O
500	O
-	O
1000	O
mg	O
daily	O
of	O
calcium	O
led	O
to	O
an	O
increase	O
in	O
the	O
concentration	O
of	O
serum	O
vitamin	O
D	O
from	O
15	O
to	O
81	O
.	O
4	O
nmol	O
/	O
l	O
.	O

From	O
October	O
2009	O
to	O
August	O
2011	O
,	O
otherwise	O
-	O
healthy	O
children	O
with	O
S	O
-	O
ECC	O
were	O
recruited	O
from	O
the	O
MHC	O
in	O
Winnipeg	O
,	O
Canada	O
(	O
49	O
°	O
53	O
′	O
North	O
)	O
on	O
the	O
day	O
of	O
their	O
dental	O
surgery	O
.	O

2009	O
),	O
during	O
intrauterine	O
development	O
affect	O
these	O
epigenetic	O
markers	O
in	O
a	O
more	O
quantitative	O
way	O
.	O

If	O
there	O
were	O
two	O
types	O
of	O
infection	O
during	O
a	O
single	O
visit	O
to	O
the	O
physician	O
or	O
hospital	O
,	O
that	O
event	O
was	O
counted	O
as	O
a	O
single	O
event	O
.	O

2	O
.	O

Follow	O
-	O
up	O
assessments	O
of	O
mothers	O
include	O
anthropometric	O
measures	O
,	O
diet	O
history	O
,	O
nutrient	O
status	O
,	O
blood	O
pressure	O
,	O
breast	O
milk	O
composition	O
,	O
and	O
measures	O
of	O
postnatal	O
depression	O
and	O
fatigue	O
.	O

These	O
actions	O
would	O
reduce	O
disability	O
and	O
chronic	O
disease	O
,	O
improve	O
reproductive	O
and	O
maternal	O
health	O
,	O
and	O
build	O
sustainable	O
health	O
systems	O
.	O

The	O
use	O
of	O
supplements	O
during	O
pregnancy	O
varies	O
widely	O
between	O
countries	O
.	O

This	O
increase	O
was	O
not	O
statistically	O
significant	O
at	O
the	O
0	O
.	O
05	O
level	O
based	O
on	O
a	O
frequentist	O
hypothesis	O
test	O
using	O
the	O
posterior	O
credible	O
interval	O
.	O

However	O
,	O
smaller	O
bowls	O
and	O
different	O
sizes	O
of	O
small	O
spoons	O
are	O
used	O
for	O
infant	O
dietary	O
intake	O
to	O
ease	O
realistic	O
reporting	O
for	O
the	O
mother	O
.	O

A	O
recent	O
study17found	O
that	O
female	O
grandchildren	O
have	O
an	O
increased	O
risk	O
of	O
cardiovascular	O
mortality	O
if	O
their	O
PGM	O
experienced	O
a	O
drastic	O
change	O
in	O
food	O
availability	O
in	O
their	O
childhood	O
.	O

She	O
had	O
no	O
palpable	O
pedal	O
pulses	O
and	O
bilateral	O
1	O
+	O
edema	O
of	O
her	O
lower	O
extremities	O
.	O

Furthermore	O
,	O
the	O
placenta	O
responses	O
to	O
maternal	O
diet	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
(	O
Tarrade	O
et	O
al	O
.,	O
2015	O
),	O
suggesting	O
that	O
the	O
sexual	O
dimorphism	O
in	O
adiposity	O
-	O
relevant	O
parameters	O
could	O
be	O
present	O
at	O
very	O
early	O
stages	O
.	O

Mitotic	O
cyclins	O
interact	O
with	O
Polo	O
-	O
like	O
kinases	O
(	O
PLK	O
),	O
an	O
evolutionary	O
conserved	O
family	O
of	O
essential	O
cell	O
cycle	O
regulators	O
,	O
which	O
are	O
required	O
at	O
several	O
key	O
points	O
within	O
mitosis	O
,	O
including	O
entry	O
into	O
and	O
exit	O
from	O
mitosis	O
[	O
23	O
,	O
24	O
].	O

The	O
lowest	O
OCP	O
GM	O
was	O
DDT	O
(	O
1	O
.	O
1	O
ng	O
/	O
ml	O
),	O
and	O
DDE	O
had	O
the	O
highest	O
GM	O
(	O
74	O
ng	O
/	O
ml	O
).	O

Groundwater	O
iron	O
We	O
will	O
measure	O
the	O
level	O
of	O
groundwater	O
iron	O
in	O
all	O
the	O
households	O
of	O
our	O
study	O
using	O
a	O
validated	O
test	O
kit	O
tool	O
[±	O
0	O
.	O
1	O
mg	O
/	O
L	O
,	O
FerroVer	O
method	O
,	O
HACH	O
Iron	O
Test	O
kit	O
,	O
Model	O
IR	O
-	O
18B	O
].	O

For	O
searches	O
performed	O
using	O
MASCOT	O
,	O
E	O
-	O
value	O
and	O
Score	O
,	O
as	O
well	O
as	O
matching	O
peptides	O
and	O
sequence	O
coverage	O
,	O
were	O
used	O
to	O
determine	O
matches	O
.	O

There	O
are	O
a	O
number	O
of	O
case	O
reports	O
and	O
small	O
case	O
series	O
of	O
glargine	O
being	O
utilized	O
without	O
the	O
development	O
of	O
pregnancy	O
complications	O
.	O

When	O
body	O
weight	O
at	O
three	O
months	O
was	O
included	O
as	O
a	O
covariate	O
in	O
this	O
analysis	O
,	O
changes	O
in	O
BMC	O
remained	B
significant	O
,	O
p	O
=	O
0	O
.	O
03	O
,	O
but	O
changes	O
in	O
BMD	O
were	O
not	O
(	O
p	O
=	O
0	O
.	O
06	O
).	O

Routine	O
use	O
of	O
iron	O
supplements	O
is	O
common	O
,	O
as	B
it	O
is	O
difficult	O
to	O
ensure	O
adequate	O
intake	O
from	O
food	O
sources	O
,	O
even	O
from	O
those	O
with	O
relatively	O
high	O
iron	O
bioavailability	O
[	O
29	O
,	O
30	O
].	O

Investigators	O
have	O
shown	O
that	O
self	O
-	O
reported	O
snoring	O
correlates	O
well	O
with	O
objective	O
findings	O
from	O
nocturnal	O
polysomnography	O
,	O
especially	O
in	O
frequent	O
snorers	O
[	O
40	O
].	O

It	O
was	O
therefore	O
necessary	O
to	O
distinguish	O
frequent	O
snorers	O
from	O
infrequent	O
snorers	O
in	O
our	O
study	O
.	O

Exposure	O
to	O
Tobacco	O
Smoke	O
One	O
of	O
the	O
most	O
frequently	O
discussed	O
risk	O
factors	O
for	O
induction	O
of	O
sensitization	O
in	O
all	O
populations	O
and	O
age	O
groups	O
is	O
tobacco	O
smoke	O
(	O
active	O
smoking	O
or	O
the	O
passive	O
environmental	O
exposure	O
).	O

Since	B
,	O
fetus	O
and	O
baby	O
are	O
both	O
dependent	O
upon	O
mother	O
for	O
blood	O
and	O
milk	O
respectively	O
,	O
mother	O
’	O
s	O
vitamin	O
D	O
supplementation	O
is	O
highly	O
vital	O
.	O

They	O
include	O
epigenetic	O
regulation	O
(	O
Nijland	O
et	O
al	O
.,	O
2010	O
;	O
Martinez	O
et	O
al	O
.,	O
2014	O
),	O
leptin	O
signaling	O
(	O
Yura	O
et	O
al	O
.,	O
2005	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
),	O
hypothalamic	O
development	O
(	O
Sebert	O
et	O
al	O
.,	O
2009	O
;	O
García	O
et	O
al	O
.,	O
2010	O
),	O
and	O
dopaminergic	O
and	O
serotonergic	O
signaling	O
systems	O
(	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
).	O

Specifically	O
they	O
were	O
asked	O
"	O
Since	O
becoming	O
pregnant	O
,	O
when	O
you	O
are	O
asleep	O
,	O
to	O
the	O
best	O
of	O
your	O
knowledge	O
,	O
have	O
you	O
snored	O
?"	O

SIRTs	O
have	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	O
for	O
memory	O
formation	O
.	O

(	O
2012	O
)*	O
Yoshioka	O
et	O
al	O
.	O

We	O
computed	O
6	O
-	O
month	O
WFA	O
and	O
sex	O
-	O
specific	O
z	O
scores	O
with	O
2000	O
CDC	O
reference	O
data	O
[	O
22	O
]	O
and	O
defined	O
risk	O
of	O
obesity	O
as	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
.	O

Due	O
to	O
the	O
high	O
mutagenic	O
potential	O
of	O
5mC	O
to	O
spontaneously	O
deaminate	O
to	O
thymine	O
,	O
the	O
mammalian	O
genome	O
is	O
largely	O
depleted	O
of	O
CpGs	O
(	O
Bird1980	O
;	O
Bird	O
&	O
Taggart1980	O
),	O
with	O
the	O
exception	O
of	O
distinct	O
regions	O
known	O
as	O
CpG	O
islands	O
(	O
CGIs	O
)	O
(	O
Bird	O
et	O
al	O
.	O
1985	O
).	O

At	O
the	O
opposite	O
,	O
systemic	O
administration	O
of	O
FGF21	O
in	O
obese	O
mice	O
resulted	O
in	O
reduced	O
adiposity	O
,	O
improved	O
glycemic	O
control	O
,	O
as	O
well	O
as	O
increased	O
energy	O
expenditure	O
,	O
as	O
mentioned	O
by	O
the	O
authors	O
(	O
Coskun	O
et	O
al	O
.,	O
2008	O
).	O

While	O
the	O
use	O
of	O
a	O
more	O
sensitive	O
test	O
would	O
provide	O
more	O
detailed	O
and	O
accurate	O
estimates	O
of	O
early	O
neurodevelopmental	O
achievement	O
,	O
the	O
ASQ	O
has	O
been	O
validated	O
against	O
robust	O
assessment	O
tools	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

Each	O
individual	O
has	O
a	O
family	O
id	O
and	O
within	O
a	O
family	O
individuals	O
are	O
also	O
numbered	O
according	O
to	O
the	O
group	O
to	O
which	O
they	O
belong	O
:	O
child	O
=	O
1	O
,	O
mother	O
=	O
2	O
,	O
father	O
=	O
3	O
,	O
MGM	O
=	O
4	O
,	O
maternal	O
grandfather	O
(	O
MGF	O
)=	O
5	O
,	O
PGM	O
=	O
6	O
and	O
PGF	O
=	O
7	O
.	O

The	O
2002	O
Feeding	O
Infants	O
and	O
Toddlers	O
Study	O
,	O
designed	O
to	O
update	O
knowledge	O
on	O
the	O
feeding	O
patterns	O
of	O
the	O
youngest	O
Americans	O
,	O
found	O
that	O
even	O
before	O
their	O
second	O
birthday	O
,	O
many	O
American	O
toddlers	O
develop	O
the	O
unhealthy	O
eating	O
habits	O
of	O
adults	O
(	O
35	O
).	O

By	O
1978	O
environmental	O
chemicals	O
were	O
known	B
to	O
be	O
widespread	O
contaminants	O
in	O
human	O
milk	O
.	O

Excess	O
energy	O
supplied	O
to	O
mature	O
animals	O
during	O
the	O
late	O
fattening	O
period	O
may	O
significantly	O
decrease	O
feed	O
efficiency	O
.	O

Post	O
-	O
partum	O
management	O
of	O
gestational	O
diabetes	O
The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
should	O
not	O
conclude	O
with	O
the	O
delivery	O
of	O
the	O
fetus	O
.	O

Relative	O
changes	O
in	O
mRNA	O
levels	O
were	O
determined	O
using	O
a	O
mixed	O
model	O
analysis	O
,	O
including	O
effects	O
of	O
dietary	O
treatment	O
,	O
sex	O
,	O
mother	O
,	O
birth	O
weight	O
and	O
interaction	O
between	O
diet	O
and	O
sex	O
(	O
vijkl	O
=	O
dieti	O
+	O
sexj	O
+	O
motherk	O
(	O
dieti	O
)	O
+	O
weightl	O
+	O
(	O
dietxsex	O
)	O
ij	O
+	O
errorijkl	O
).	O

Additionally	O
,	O
there	O
is	O
growing	O
evidence	O
that	O
mHealth	O
programs	O
are	O
effective	O
in	O
promoting	O
diabetes	O
self	O
-	O
management	O
[	O
20	O
],	O
as	O
treatment	O
adherence	O
tools	O
,	O
and	O
as	O
reminder	O
systems	O
for	O
health	O
behavior	O
and	O
treatment	O
[	O
11	O
].	O

Participants	O
provided	O
consent	O
,	O
completed	O
a	O
baseline	O
questionnaire	O
,	O
and	O
then	O
were	O
randomized	O
to	O
enroll	O
in	O
text4baby	O
or	O
not	O
.	O

Studies	O
in	O
adults	O
have	O
found	O
a	O
greater	O
increase	O
in	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
subjects	O
who	O
started	O
at	O
a	O
lower	O
level	O
before	O
supplementation	O
[	O
17	O
].	O

We	O
repeated	O
the	O
random	O
sample	O
selection	O
a	O
thousand	O
times	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
95	O
%	O
confidence	O
intervals	O
represent	O
50th	O
,	O
2	O
.	O
5th	O
and	O
97	O
.	O
5th	O
percentiles	O
,	O
respectively	O
[	O
40	O
].	O

Thyroid	O
hormones	O
are	O
major	O
factors	O
for	O
the	O
normal	O
development	O
of	O
foetal	O
brain	O
,	O
and	O
until	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
when	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
thyroid	O
axis	O
becomes	O
functional	O
,	O
the	O
foetal	O
brain	O
is	O
strictly	O
dependent	O
on	O
local	O
deiodination	O
of	O
maternal	O
thyroxine7	O
-	O
12	O
.	O

New	O
Evidence	O
Emerges	O
For	O
nearly	O
30	O
years	O
Philippe	O
Grandjean	O
has	O
led	O
studies	O
on	O
the	O
effects	O
of	O
marine	O
contaminants	O
on	O
the	O
health	O
of	O
adults	O
and	O
children	O
in	O
the	O
Faroe	O
Islands	O
,	O
19an	O
archipelago	O
in	O
the	O
North	O
Atlantic	O
about	O
halfway	O
between	O
Scotland	O
and	O
Iceland	O
.	O

GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	B
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
,	O
with	O
GAS5	O
being	O
primarily	B
localized	O
in	O
the	O
syncytiotrophoblasts	O
.	O

Given	B
the	O
suggestion	O
of	O
a	O
U	O
-	O
shaped	O
relation	O
between	O
sleep	O
duration	O
and	O
GDM	O
risk	O
(	O
with	O
elevated	O
risks	O
for	O
both	O
short	O
and	O
long	O
sleep	O
duration	O
),	O
and	O
given	B
suggestion	O
of	O
a	O
linear	O
trend	O
in	O
risk	O
of	O
GDM	O
for	O
sleep	O
duration	O
ranging	O
from	O
≤	O
4	O
to	O
5	O
-	O
8	O
hours	O
,	O
we	O
modeled	O
the	O
risk	O
of	O
GDM	O
in	O
relation	O
to	O
maternal	O
sleep	O
duration	O
as	O
a	O
continuous	O
variable	O
,	O
restricting	O
the	O
study	O
population	O
to	O
women	O
who	O
reported	O
sleeping	O
<	O
10	O
hours	O
.	O

Vitamin	O
D	O
status	O
trajectory	O
from	O
early	O
to	O
late	O
pregnancy	O
was	O
inversely	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
with	O
the	O
lowest	O
odds	O
among	O
women	O
with	O
the	O
highest	O
increment	O
in	O
25OHD	O
.	O

We	O
concluded	O
that	O
the	O
significant	O
association	O
between	O
prenatal	O
diethylstilbestrol	O
exposure	O
and	O
all	O
three	O
end	O
points	O
considered	O
conferred	O
weight	B
to	O
the	O
hypothesis	O
of	O
a	O
common	O
etiology	O
for	O
these	O
disorders	O
,	O
and	O
therefore	O
to	O
the	O
existence	O
of	O
a	O
testicular	O
dysgenesis	O
syndrome	O
(	O
Martin	O
et	O
al	O
.	O

Discussion	O
Clinically	O
,	O
AAOC	O
appears	O
as	O
a	O
friable	O
erythematous	O
exophytic	O
papule	O
on	O
digits	O
,	O
palms	O
,	O
or	O
soles	O
and	O
can	O
develop	O
at	O
any	O
age	O
with	O
slight	O
female	O
predominance	O
.	O

In	O
the	O
same	O
period	O
881	O
probe	O
-	O
sets	O
exhibited	O
ontogenetic	O
regulation	O
that	O
was	O
specific	O
to	O
LP	O
offspring	O
.	O

Obesity	O
is	O
a	O
growing	O
epidemic	O
.	O

Randomised	O
clinical	O
trials	O
have	O
been	O
conducted	O
using	O
fish	O
oil	O
supplementation	O
in	O
pregnancy	O
,	O
but	O
not	O
with	O
fish	O
considered	O
as	O
a	O
whole	O
food	O
.	O

The	O
focus	O
was	O
on	O
those	O
canonical	O
pathways	O
which	O
came	O
up	O
at	O
least	O
once	O
within	O
the	O
top	O
ten	O
regulated	O
pathways	O
within	O
one	O
single	O
analysis	O
.	O

This	O
case	O
report	O
highlights	O
the	O
importance	O
of	O
measuring	O
serum	O
calcium	O
levels	O
in	O
infants	O
with	O
acute	O
stridor	O
and	O
or	O
wheeze	O
.	O

Another	O
point	O
that	O
needs	O
to	O
be	O
considered	O
is	O
the	O
measurements	O
error	O
in	O
nutritional	O
assessment	O
;	O
this	O
may	O
increase	O
the	O
likelihood	O
of	O
misclassification	O
,	O
contributing	O
to	O
the	O
discrepancy	O
among	O
our	O
results	O
.	O

Mice	O
with	O
visible	O
abnormalities	O
in	O
the	O
third	O
generation	O
(	O
G3	O
)	O
were	O
kept	O
for	O
further	O
analysis	O
.	O

Kidney	O
stereology	O
We	O
studied	O
the	O
F1	O
and	O
F2	O
generations	O
of	O
both	O
diet	O
groups	O
.	O

However	O
,	O
inconsistencies	O
between	O
studies	O
reflect	O
uncertainty	O
about	O
the	O
true	O
effect	O
of	O
vitamin	O
D	O
deficiency	O
on	O
pregnancy	O
outcome	O
[	O
5	O
,	O
6	O
].	O

However	O
,	O
the	O
models	O
were	O
adjusted	O
for	O
gestational	O
age	O
at	O
registration	O
for	O
antenatal	O
care	O
.	O

MAW	O
conceived	O
,	O
designed	O
and	O
obtained	O
funding	O
for	O
the	O
study	O
.	O

Similarly	O
,	O
infants	O
of	O
black	O
mothers	O
with	O
history	O
of	O
PIH	O
were	O
associated	O
with	O
2	O
.	O
3	O
greater	O
odds	O
of	O
SGA	O
after	O
adjustment	O
for	O
confounding	O
variables	O
.	O

Height	O
—	O
child	O
age	O
9	O
As	O
at	O
age	O
5	O
,	O
the	O
child	O
’	O
s	O
height	O
at	O
age	O
9	O
was	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
mother	O
and	O
father	O
and	O
PGF	O
.	O

Evidence	O
-	O
based	O
preventive	O
treatment	O
options	O
for	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
include	O
prophylaxis	O
iron	O
supplements	O
and	O
food	O
fortification	O
with	O
iron	O
.	O

Differentiated	O
thyroid	O
cancer	O
(	O
DTC	O
)	O
in	O
young	O
people	O
generally	B
has	O
an	O
excellent	O
prognosis	O
,	O
and	O
disease	O
-	O
free	O
survival	O
among	O
women	O
with	O
DTC	O
diagnosed	O
during	O
pregnancy	O
may	O
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

Participants	O
were	O
asked	O
whether	O
they	O
considered	O
the	O
household	O
'	O
s	O
economic	O
situation	O
in	O
the	O
preceding	O
year	O
to	O
have	O
been	O
always	O
in	O
deficit	O
,	O
occasionally	O
deficit	O
,	O
balanced	O
or	O
surplus	O
.	O

At	O
150	O
days	O
of	O
postnatal	O
age	O
animals	O
were	O
DEXA	O
scanned	O
for	O
body	O
composition	O
,	O
then	O
fasted	O
overnight	O
and	O
killed	O
by	O
injection	O
of	O
pentobarbitone	O
(	O
60	O
mg	O
/	O
kg	O
,	O
s	O
.	O
c	O
.)	O
anaesthesia	O
followed	O
by	O
decapitation	O
.	O

The	O
initial	O
reduction	O
has	O
been	O
explained	B
to	O
result	O
from	O
increased	O
red	O
cell	O
mass	O
and	O
demands	O
of	O
the	O
fetus	O
which	O
exceeds	O
iron	O
intake	O
with	O
consequent	O
reduction	O
in	O
iron	O
stores	O
of	O
the	O
woman	O
'	O
s	O
body	O
[	O
2	O
].	O

A	O
larger	O
sample	O
size	O
also	O
enabled	O
subgroup	O
analysis	O
by	O
PTB	O
subtype	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
among	O
women	O
with	O
a	O
previous	O
PTB	O
.	O

(	O
2010	O
)¶/*/†	O
Lifestyle	O
factors	O
Alcohol	O
(	O
ethanol	O
)	O
Mouse	O
RatOral	O
(	O
water	O
)	O
(	O
10	O
g	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
5	O
.	O
25	O
g	O
/	O
kg	O
/	O
d	O
or	O
56	O
%	O
(	O
v	O
/	O
v	O
)/	O
d	O
)	O
Injection	O
(	O
ip	O
)	O
(	O
2	O
.	O
9	O
g	O
/	O
kg	O
+	O
1	O
.	O
45	O
g	O
/	O
kg	O
2	O
h	O
later	O
In	O
utero	O
Neonatal	O
Adolescence	O
/	O
early	O
adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adolescence	O
Adulthood	O
F0	O
-	O
F1generationsNeurological	O
,	O
behavioral	O
,	O
cardiac	O
and	O
mesenchymal	O
stem	O
cell	O
abnormalitiesHistone	O
modification	O
miRNAsIgnacio	O
et	O
al	O
.	O

These	O
agents	O
include	O
terbutaline	O
,	O
which	O
is	O
commonly	O
used	O
as	O
a	O
tocolytic	O
and	O
a	O
bronchodilator	O
in	O
obstetrics	O
.	O

The	O
identification	O
of	O
external	O
factors	O
particularly	O
perinatal	O
risk	O
factors	O
forms	O
the	O
initial	O
critical	O
step	O
in	O
preventing	O
and	O
alleviating	O
risks	O
.	O

Energy	O
and	O
nutrients	O
intake	O
of	O
the	O
study	O
participants	O
across	O
different	O
categories	O
of	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
dietary	O
patterns	O
were	O
reported	O
in	O
Tables3	O
,	O
4	O
,	O
and5	O
,	O
respectively	O
.	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

Additional	O
assessments	O
during	O
pregnancy	O
include	O
anthropometric	O
and	O
blood	O
pressure	O
measurements	O
,	O
obstetric	O
ultrasound	O
screens	O
,	O
and	O
assessments	O
of	O
food	O
security	O
,	O
maternal	O
fatigue	O
,	O
prenatal	O
depression	O
,	O
allergy	O
,	O
immune	O
function	O
,	O
morbidity	O
and	O
gestational	O
diabetes	O
.	O

All	O
of	O
the	O
partners	O
,	O
donors	O
and	O
contributors	O
involved	O
in	O
the	O
Born	O
Too	O
Soon	O
movement	O
see	O
the	O
report	O
and	O
this	O
supplement	O
as	O
important	O
next	O
steps	O
towards	O
a	O
world	O
where	O
every	O
woman	O
,	O
every	O
newborn	O
and	O
every	O
child	O
is	O
given	O
the	O
best	O
chance	O
to	O
survive	O
and	O
thrive	O
.	O

A	O
successful	O
supplementation	O
program	O
must	O
include	O
training	O
of	O
health	O
care	O
system	O
workers	O
,	O
provision	O
of	O
accessible	O
educational	O
materials	O
for	O
the	O
target	O
group	O
and	O
the	O
broader	O
community	O
and	O
a	O
reliable	O
distribution	O
system	O
.	O

Fourteen	O
cases	O
were	O
female	O
(	O
93	O
%).	O

Experiences	O
on	O
parenteral	O
iron	O
use	O
are	O
predominantly	O
,	O
but	O
not	O
exclusively	O
,	O
from	O
the	O
developed	O
world	O
as	B
reports	O
of	O
its	O
prophylactic	O
use	O
in	O
pregnancy	O
are	O
scant	O
;	O
this	O
may	O
be	O
related	O
to	O
concerns	O
about	O
adverse	O
reactions	O
associated	O
with	O
its	O
use	O
in	O
parenteral	O
form	O
.	O

The	O
incidence	O
of	O
PTB	O
across	O
25	O
(	O
OH	O
)	O
D	O
groups	O
was	O
tested	O
for	O
trend	O
.	O

Trial	O
Registration	O
ClincalTrials	O
.	O
govNCT00697294	O
Background	O
Vitamin	O
D	O
has	O
been	O
given	O
to	O
infants	O
to	O
prevent	O
and	O
treat	O
rickets	O
for	O
almost	O
100	O
years	O
.	O

While	O
some	O
evidence	O
suggests	O
that	O
meconium	O
aspiration	O
syndrome	O
may	O
have	O
a	O
link	O
as	O
a	O
contributing	O
factor	O
,	O
more	O
studies	O
are	O
needed	O
.	O

This	O
suggests	O
that	O
our	O
microarray	O
data	O
are	O
reliable	O
.	O

Furthermore	O
,	O
follow	O
-	O
up	O
of	O
280	O
infants	O
(	O
35	O
%	O
of	O
the	O
randomised	O
cohort	O
)	O
at	O
6	O
-	O
months	O
of	O
age	O
demonstrated	O
no	O
evidence	O
of	O
an	O
effect	O
of	O
the	O
intervention	O
on	O
early	O
infant	O
measures	O
of	O
growth	O
or	O
adiposity	O
[	O
19	O
].	O

The	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
cohort	O
(	O
overall	O
and	O
by	O
GDM	O
status	O
),	O
are	O
presented	O
in	O
Table1	O
.	O

Infant	O
immune	O
response	O
The	O
infant	O
’	O
s	O
IgG	O
response	O
to	O
measles	O
immunisation	O
is	O
assessed	O
at	O
phase	O
7	O
,	O
which	O
is	O
6	O
weeks	O
after	O
measles	O
immunisation	O
was	O
administered	O
at	O
the	O
study	O
site	O
.	O

(	O
2009	O
)	O
reported	O
that	O
calorie	O
restriction	O
during	O
adolescence	O
and	O
young	O
adulthood	O
as	B
a	O
result	O
of	O
the	O
Dutch	O
Hunger	O
Winter	O
was	O
associated	O
with	O
altered	O
DNA	O
methylation	O
and	O
reduced	O
risk	O
of	O
colorectal	O
cancer	O
in	O
later	O
life	O
.	O

A	O
p	O
value	O
≤	O
0	O
.	O
05	O
was	O
significant	O
.	O

The	O
EPDS	O
was	O
originally	O
utilized	O
in	O
the	O
postpartum	O
period	O
only	O
.	O

So	O
far	O
,	O
no	O
human	O
studies	O
have	O
been	O
published	O
concerning	O
this	O
compound	O
,	O
and	O
ulipristal	O
acetate	O
remains	O
our	O
main	O
weapon	O
against	O
UM	O
.	O

Bailey	O
et	O
al	O
had	O
discovered	O
that	O
,	O
after	O
transplacental	O
circulation	O
,	O
the	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
was	O
significant	O
higher	O
in	O
infants	O
than	O
mother	O
[	O
44	O
].	O

Transcriptional	O
excursions	O
regarding	O
stress	O
and	O
immune	O
response	O
The	O
biological	O
effect	O
of	O
glucocorticoids	O
is	O
modulated	O
by	O
glucocorticoid	O
receptors	O
.	O

Adverse	O
Reactions	O
to	O
Food	O
No	O
studies	O
have	O
focused	O
explicitly	O
on	O
the	O
prevalence	O
of	O
food	O
allergy	O
in	O
pregnant	O
women	O
primarily	O
because	O
often	O
the	O
immune	O
response	O
in	O
the	O
offspring	O
is	O
the	O
main	O
focus	O
of	O
research	O
.	O

The	O
foods	O
that	O
women	O
eat	O
when	O
they	O
are	O
pregnant	O
and	O
nursing	O
are	O
precisely	O
the	O
ones	O
that	O
their	O
infants	O
should	O
prefer	O
because	B
the	O
mothers	O
'	O
eating	O
them	O
teaches	O
the	O
child	O
that	O
these	O
foods	O
are	O
available	O
,	O
safe	O
,	O
and	O
nutritious	O
.	O

There	O
is	O
a	O
growing	O
concern	O
about	O
the	O
health	O
consequences	O
of	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
worldwide	O
among	O
the	O
general	O
population	O
,	O
including	O
pregnant	O
women	O
.	O

There	O
is	O
limited	O
but	O
still	O
important	O
placental	O
transfer	O
of	O
maternal	O
T4	O
to	O
the	O
foetus18	O
,	O
while	O
placental	O
type	O
III	O
deiodinase	O
catalyzes	O
the	O
conversion	O
of	O
T4	O
to	O
the	O
more	O
active	O
form	O
reverse	O
-	O
T3	O
,	O
which	O
crosses	O
the	O
placental	O
barrier	O
,	O
and	O
to	O
the	O
less	O
active	O
3	O
,	O
3	O
'-	O
diiodothyronine	O
(	O
T2	O
),	O
representing	B
a	O
homeostatic	O
mechanism	O
for	O
maintaining	O
T3production	O
in	O
the	O
placenta	O
when	O
maternal	O
serum	O
T4concentrations	O
are	O
modified18	O
.	O

A	O
large	O
Norwegian	O
study31has	O
recently	O
reported	O
largely	O
similar	O
father	O
–	O
offspring	O
and	O
mother	O
–	O
offspring	O
associations	O
in	O
adults	O
across	O
cardiovascular	O
risk	O
factors	O
.	O

Upon	O
arrival	O
at	O
RMMCH	O
on	O
the	O
booked	O
date	O
,	O
the	O
trained	O
fieldworkers	O
explain	O
the	O
informed	O
consent	O
form	O
in	O
local	O
languages	O
and	O
all	O
are	O
given	O
the	O
opportunity	O
to	O
ask	O
questions	O
.	O

In	O
agreement	O
with	O
our	O
findings	O
,	O
others	O
have	O
discovered	O
that	O
mothers	O
with	O
higher	O
vitamin	O
D	O
concentration	O
have	O
infants	O
with	O
smaller	O
head	O
circumference	O
at	O
birth	O
[	O
36	O
,	O
37	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Selected	O
baseline	O
characteristics	O
by	O
categories	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
of	O
33	O
623	O
participants	O
with	O
questionnaire	O
data	O
in	O
the	O
women	O
'	O
s	O
lifestyle	O
and	O
health	O
studyPositive	O
psychotic	O
-	O
like	O
symptomsaLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
groupN	O
=	O
18	O
411N	O
=	O
14	O
395N	O
=	O
817Characteristics	O
(	O
55	O
%)(	O
43	O
%)(	O
2	O
.	O
4	O
%)	O
Ageb	O
,	O
years	O
,	O
mean	O
(	O
SD	O
)	O
52	O
(	O
6	O
)	O
51	O
(	O
6	O
)	O
50	O
(	O
6	O
)	O
BMI	O
,	O
kg	O
/	O
m2	O
,	O
mean	O
(	O
SD	O
)	O
23	O
(	O
3	O
.	O
4	O
)	O
23	O
(	O
3	O
.	O
8	O
)	O
24	O
(	O
4	O
.	O
0	O
)	O
BMI	O
,	O
kg	O
/	O
m2	O
,	O
No	O
.	O

Finally	O
,	O
regression	O
analysis	O
revealed	O
that	O
birth	O
weight	O
was	O
the	O
only	O
significant	O
predictor	O
of	O
HF	O
,	O
and	O
explained	O
16	O
%	O
of	O
the	O
variance	O
in	O
HF	O
(	O
R2	O
=	O
0	O
.	O
16	O
)	O
(	O
Table	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
systolic	O
(	O
A	O
)	O
and	O
diastolic	O
(	O
B	O
)	O
blood	O
pressure	O
levels	O
.	O

The	O
characteristics	O
of	O
subjects	O
used	O
in	O
these	O
analyses	O
(	O
n	O
=	O
380	O
)	O
are	O
shown	O
in	O
Supplemental	O
Material	O
,	O
Table	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
).	O

However	O
,	O
none	O
of	O
these	O
covariates	O
change	O
the	O
estimates	O
substantially	O
,	O
and	O
was	O
therefore	B
not	O
included	O
in	O
the	O
final	O
multivariate	O
model	O
cSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
and	O
docosapentaenoic	O
acid	O
dAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
fat	O
other	O
than	O
eicosapentaenoic	O
acid	O
,	O
docosahexaenoic	O
acid	O
and	O
docosapentaenoic	O
acid	O
eSum	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
fAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
other	O
than	O
omega	O
-	O
6	O
fatty	O
acids	O
gSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
),	O
docosapentaenoic	O
acid	O
and	O
α	O
-	O
linolenic	O
acid	O
hAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
other	O
than	O
omega	O
-	O
3	O
fatty	O
acids	O
The	O
intake	O
of	O
vitamin	O
D	O
was	O
significantly	O
associated	O
with	O
a	O
decreased	O
relative	O
risk	O
of	O
both	O
the	O
middle	O
and	O
high	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Table4	O
).	O

Also	O
,	O
approximately	O
40	O
%	O
of	O
normal	O
weight	O
women	O
gain	O
more	O
than	O
recommended	O
[	O
6	O
],	O
increasing	O
the	O
risk	O
of	O
obesity	O
in	O
their	O
offspring	O
.	O

Researchers	O
at	O
the	O
University	O
of	O
Texas	O
M	O
.	O
D	O
.	O

The	O
SS	O
will	O
then	O
make	O
regular	O
fortnightly	O
visits	O
to	O
the	O
woman	O
until	O
delivery	O
to	O
ensure	O
resupply	O
of	O
supplements	O
,	O
and	O
provide	O
counselling	O
in	O
support	O
of	O
early	O
uptake	O
,	O
continued	O
use	O
,	O
and	O
compliance	O
with	O
the	O
supplementation	O
regime	O
until	O
delivery	O
.	O

In	O
various	O
human	O
and	O
animal	O
studies	O
a	O
gestational	O
low	O
protein	O
intake	O
during	O
pregnancy	O
was	O
accompanied	O
by	O
low	O
birth	O
weight	O
offspring	O
,	O
which	O
was	O
subsequently	O
predisposed	O
for	O
metabolic	O
disorders	O
and	O
alterations	O
in	O
body	O
composition	O
[	O
6	O
,	O
8	O
-	O
10	O
].	O

Cord	O
blood	O
and	O
infant	O
blood	O
at	O
three	O
months	O
of	O
age	O
were	O
analyzed	O
for	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
by	O
DiaSorin	O
radioimmunoassay	O
(	O
DiaSorin	O
Inc	O
.,	O
Stillwater	O
MN	O
)	O
at	O
Yale	O
University	O
.	O

Vitamin	O
D	O
is	O
present	O
in	O
a	O
small	O
number	O
of	O
foods	O
,	O
although	O
,	O
for	O
an	O
average	O
person	O
food	O
will	O
only	O
supply	O
about	O
10	O
%	O
of	O
the	O
amount	O
needed	O
.	O

Furthermore	O
,	O
it	O
is	O
also	O
important	O
to	O
consider	O
the	O
broader	O
repercussions	O
of	O
regulatory	O
toxicology	O
.	O

The	O
results	O
showed	O
inverse	O
correlation	O
between	O
the	O
HRV	O
parameters	O
with	O
BMI	O
(	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
047	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
021	O
;	O
HF	O
:	O
P	O
=	O
0	O
.	O
041	O
),	O
systolic	O
(	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
023	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
032	O
)	O
and	O
diastolic	O
(	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
030	O
)	O
blood	O
pressure	O
levels	O
.	O

Likely	B
,	O
the	O
analysis	O
with	O
PSM	O
corrected	O
for	O
biases	O
related	O
to	O
the	O
probability	O
of	O
influenza	O
vaccination	O
by	O
controlling	O
for	O
differences	O
between	O
vaccinated	O
and	O
unvaccinated	O
women	O
that	O
we	O
were	O
not	O
able	O
to	O
control	O
for	O
in	O
MLR	O
[	O
43	O
].	O

In	O
the	O
Angus	O
study	O
,	O
early	O
weaning	O
at	O
105	O
d	O
of	O
age	O
and	O
high	O
concentrate	O
feeding	O
for	O
148	O
d	O
followed	O
by	O
grazing	O
and	O
feedlot	O
entry	O
increased	O
both	O
the	O
MS	O
and	O
hot	O
carcass	O
weight	O
(	O
HCW	O
)	O
compared	O
with	O
normal	O
weaning	O
at	O
253	O
d	O
of	O
age	O
(	O
normally	O
weaned	O
calves	O
stayed	O
with	O
their	O
dams	O
to	O
graze	O
on	O
pasture	O
),	O
although	O
feedlot	O
performance	O
remained	O
unchanged	O
[	O
54	O
].	O

However	O
,	O
literature	O
has	O
presented	O
different	O
views	O
on	O
iron	O
requirements	O
during	O
pregnancy	O
ranging	O
from	O
450	O
to	O
1	O
,	O
150	O
mg	O
with	O
a	O
median	O
of	O
790	O
mg	O
[	O
14	O
,	O
19	O
–	O
21	O
].	O

Birth	O
weight	O
percentiles	O
for	O
neonates	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
25	O
mol	O
l	O
−	O
1were	O
significantly	O
lower	O
compared	O
with	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
⩾	O
50	O
nmol	O
l	O
−	O
1	O
(	O
adjusted	O
mean	O
weight	O
percentile	O
0	O
.	O
35	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
27	O
,	O
0	O
.	O
43	O
)	O
vs	O
0	O
.	O
46	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
39	O
,	O
0	O
.	O
53	O
),	O
P	O
=	O
0	O
.	O
02	O
).	O

Our	O
study	O
is	O
also	O
limited	O
by	O
lack	O
of	O
detailed	O
data	O
about	O
PNV	O
use	O
.	O

The	O
medical	O
doctor	O
diagnoses	O
and	O
determines	O
the	O
duration	O
of	O
each	O
morbidity	O
event	O
using	O
the	O
structured	O
questionnaire	O
with	O
reference	O
to	O
the	O
morbidity	O
calendar	O
.	O

Early	O
recognition	O
and	O
treatment	O
are	O
crucial	O
for	O
survival	O
.	O

Methods	O
HOME	O
Study	O
The	O
HOME	O
Study	O
is	O
a	O
prospective	O
birth	O
cohort	O
study	O
in	O
the	O
Cincinnati	O
,	O
Ohio	O
area	O
.	O

Prenatal	O
folic	O
acid	O
supplements	O
have	O
been	O
shown	O
to	O
reduce	O
the	O
risk	O
of	O
neural	O
tube	O
defects	O
in	O
children	O
and	O
are	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
autistic	O
disorder	O
[	O
32	O
].	O

Breast	O
-	O
feeding	O
reduced	O
the	O
likelihood	B
of	O
early	O
adolescent	O
overweight	O
in	O
children	O
whose	O
mothers	O
'	O
prepregnancy	O
BMI	O
was	O
25	O
or	O
higher	O
,	O
although	O
the	O
effect	O
of	O
breast	O
-	O
feeding	O
was	O
not	O
significant	O
in	O
children	O
of	O
healthy	O
-	O
weight	O
mothers	O
(	O
21	O
,	O
22	O
).	O

In	O
an	O
analysis	O
of	O
change	O
between	O
the	O
different	O
ages	O
,	O
differences	O
in	O
BMI	O
for	O
different	O
age	O
groups	O
are	O
calculated	O
and	O
regressed	O
on	O
the	O
BMI	O
of	O
each	O
of	O
the	O
other	O
family	O
members	O
in	O
turn	O
.	O

Nutrition	O
during	O
pregnancy	O
and	O
early	O
development	O
(	O
NuPED	O
)	O
in	O
urban	O
South	O
Africa	O
:	O
a	O
study	O
protocol	O
for	O
a	O
prospective	O
cohort	O
Abstract	O
Background	O
Adequate	O
nutrition	O
during	O
pregnancy	O
is	O
important	O
to	O
ensure	O
optimal	O
birth	O
outcomes	O
,	O
maternal	O
health	O
and	O
offspring	O
development	O
.	O

The	O
Hosmer	O
-	O
Lemeshow	O
test	O
was	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
models	O
created	O
.	O

Among	O
women	O
with	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
adjusted	O
OR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
8	O
),	O
but	O
not	O
at	O
the	O
later	O
time	O
point	O
(	O
OR	O
1	O
.	O
4	O
,	O
95	O
%	O
CI	O
0	O
.	O
9	O
,	O
2	O
.	O
3	O
).	O

Consistent	O
with	O
the	O
Flnb	O
knockout	O
mice	O
,	O
the	O
Skm2	O
phenotype	O
resembles	O
that	O
seen	O
in	O
human	O
vertebral	O
malformation	O
syndromes	O
involving	O
this	O
gene	O
.	O

This	O
process	O
was	O
carried	O
out	O
in	O
the	O
2	O
following	O
hours	O
after	O
the	O
beginning	O
of	O
the	O
dark	O
phase	O
in	O
a	O
separate	O
room	O
from	O
the	O
other	O
experimental	O
animals	O
.	O

Antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
(	O
KMC	O
)	O
are	O
evidence	O
-	O
based	O
interventions	O
that	O
are	O
feasible	B
to	O
scale	O
up	O
in	O
low	O
-	O
resource	O
settings	O
and	O
may	O
serve	O
as	O
entry	O
points	O
for	O
strengthening	O
health	O
systems	O
[	O
20	O
,	O
21	O
].	O

IPG	O
strips	O
were	O
reduced	O
,	O
alkylated	O
and	O
detergent	O
exchanged	O
using	O
SDS	O
equilibration	O
buffer	O
(	O
Proteome	O
Systems	O
,	O
20	O
min	O
)	O
and	O
loaded	O
onto	O
pre	O
-	O
cast	O
SDS	O
-	O
PAGE	O
gels	O
(	O
GelChip	O
™	O
2D	O
,	O
6	O
–	O
15	O
%,	O
10	O
×	O
15	O
cm	O
;	O
Proteome	O
Systems	O
)	O
for	O
second	O
dimension	O
molecular	O
mass	O
separation	O
using	O
the	O
ElectrophoreticIQ3	O
system	O
(	O
50mA	O
/	O
gel	O
,	O
15	O
°	O
C	O
for	O
90	O
min	O
).	O

As	O
both	O
juxtamedullary	O
and	O
superficial	O
glomeruli	O
should	O
be	O
counted	O
and	O
the	O
diameter	O
of	O
juxtamedullary	O
glomeruli	O
is	O
greater	O
than	O
that	O
of	O
superficial	O
glomeruli	O
,	O
the	O
right	O
solution	O
is	O
to	O
estimate	O
the	O
size	O
of	O
the	O
glomeruli	O
in	O
a	O
random	O
way	O
and	O
determine	O
their	O
mean	O
size	O
.	O

Vasopressinase	O
is	O
metabolized	O
in	O
the	O
liver	O
,	O
which	O
may	O
explain	O
higher	O
concentrations	O
of	O
the	O
enzyme	O
in	O
patients	O
with	O
fatty	O
liver	O
,	O
hepatitis	O
and	O
preeclampsia	O
as	O
discussed	O
by	O
Barbey	O
et	O
al	O
.	O

In	O
the	O
present	O
study	O
,	O
offspring	O
of	O
nutritionally	O
challenged	O
dams	O
develop	O
obesity	O
;	O
thus	B
a	O
perpetuation	O
and	O
possibly	O
a	O
compounding	O
of	O
accelerated	O
pubertal	O
onset	O
may	O
ensue	O
in	O
the	O
next	O
generation	O
as	B
these	O
offspring	O
will	O
themselves	O
be	O
fatter	O
at	O
an	O
earlier	O
reproductive	O
age	O
.	O

The	O
satisfaction	O
of	O
respondents	O
with	O
some	O
of	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
(	O
reception	O
,	O
sitting	O
area	O
comfort	O
,	O
waiting	O
time	O
,	O
staff	O
rapport	O
,	O
competence	O
of	O
personnel	O
and	O
comprehensiveness	O
of	O
health	O
talks	O
)	O
was	O
compared	O
with	O
the	O
respondents	O
’	O
socio	O
-	O
demographic	O
characteristics	O
to	O
elucidate	O
the	O
degree	O
to	O
which	O
the	O
latter	O
affected	O
satisfaction	O
.	O

Dietary	O
data	O
are	O
captured	O
in	O
Microsoft	O
Excel	O
(	O
Microsoft	O
Corporation	O
,	O
Washington	O
,	O
USA	O
)	O
and	O
all	O
electronic	O
entries	O
are	O
double	O
checked	O
by	O
a	O
registered	O
dietitian	O
for	O
the	O
correct	O
food	O
code	O
and	O
a	O
reasonable	O
amount	O
reported	O
.	O

The	O
total	O
number	O
of	O
glomeruli	O
per	O
kidney	O
,	O
adjusted	O
to	O
the	O
entire	O
organ	O
,	O
was	O
estimated	O
from	O
the	O
analyzed	O
fraction	O
of	O
the	O
kidney	O
[	O
17	O
],[	O
18	O
].	O

Male	O
piglets	O
were	O
castrated	O
at	O
d	O
4	O
of	O
age	O
.	O

We	O
also	O
aimed	O
to	O
examine	O
the	O
relationship	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
and	O
the	O
risk	O
of	O
an	O
adverse	O
pregnancy	O
outcome	O
and	O
included	O
determining	O
the	O
effect	O
modification	O
of	O
fetal	O
sex	O
on	O
the	O
association	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
.	O

Meanwhile	O
,	O
Jones	O
et	O
al	O
.	O

In	O
addition	O
,	O
high	O
IMF	O
deposition	O
may	O
negatively	O
affect	O
YG	O
(	O
or	O
retail	O
beef	O
yield	O
).	O

Therefore	B
,	O
consumption	O
of	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
is	O
associated	O
with	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
pregnant	O
women	O
.	O

Little	O
is	O
known	O
about	O
specific	O
determinants	O
of	O
asthma	O
and	O
atopy	O
in	O
the	O
farm	O
setting	O
.	O

Most	O
women	O
(	O
96	O
.	O
0	O
%)	O
registered	O
their	O
pregnancy	O
with	O
their	O
general	O
practitioner	O
and	O
had	O
the	O
first	O
prenatal	O
visit	O
in	O
the	O
second	O
(	O
61	O
.	O
0	O
%)	O
or	O
the	O
third	O
(	O
19	O
.	O
0	O
%)	O
month	O
;	O
only	O
9	O
.	O
0	O
%	O
of	O
women	O
had	O
the	O
first	O
visit	O
in	O
the	O
fifth	O
month	O
.	O

Surveys	O
were	O
conducted	O
to	O
assess	O
program	O
impact	O
,	O
compliance	O
and	O
cost	O
[	O
13	O
],[	O
14	O
].	O

Currently	O
,	O
essential	O
care	O
reaches	O
only	O
half	O
of	O
the	O
people	O
in	O
need	O
(	O
Figure3	O
),	O
and	O
there	O
is	O
a	O
wide	O
variation	O
in	O
coverage	O
levels	O
among	O
countries	O
,	O
with	O
some	O
countries	O
achieving	O
nearly	O
universal	O
coverage	O
and	O
others	O
reaching	O
less	O
than	O
a	O
quarter	O
of	O
the	O
population	O
.	O

Introduction	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
,	O
and	O
it	O
is	O
related	O
to	O
excess	O
vasopressinase	O
activity	O
.	O

Genotyping	O
/	O
mapping	O
DNA	O
was	O
isolated	O
from	O
tail	O
biopsy	O
specimens	O
using	O
overnight	O
digestion	O
in	O
a	O
lysis	O
buffer	O
containing	O
proteinase	O
K	O
(	O
10	O
nM	O
Tris	O
,	O
2	O
mM	O
EDTA	O
,	O
0	O
.	O
5	O
%	O
SDS	O
,	O
0	O
.	O
4	O
M	O
NaCl	O
,	O
and	O
0	O
.	O
2	O
mg	O
/	O
ml	O
proteinase	O
K	O
),	O
followed	O
by	O
a	O
phenol	O
/	O
chloroform	O
extraction	O
.	O

A	O
significant	O
percent	O
of	O
infants	O
with	O
a	O
history	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
bronchiolitis	O
infection	O
,	O
which	O
peaks	O
during	O
the	O
winter	O
season	O
,	O
develop	O
asthma	O
[	O
64	O
].	O

Similar	O
studies	O
were	O
conducted	O
illustrating	O
that	O
relative	O
microcephaly	O
was	O
more	O
frequent	O
in	O
children	O
with	O
ASD	O
.	O

Farming	O
Farming	O
,	O
by	O
virtue	O
of	O
its	O
seasonal	O
nature	O
,	O
conveys	O
increased	O
risk	O
at	O
certain	O
times	O
of	O
the	O
year	O
of	O
exposure	O
to	O
pesticides	O
and	O
other	O
agricultural	O
chemicals	O
.	O

Both	O
during	O
suppressive	O
or	O
substitutive	O
therapy	O
,	O
L	O
-	O
T4	O
requirement	O
increases	O
very	O
early	O
during	O
pregnancy	O
,	O
reaching	O
a	O
plateau	O
after	O
16thto	O
20thweeks	O
of	O
gestation	O
,	O
with	O
a	O
required	O
L	O
-	O
T4	O
dosage	O
approximately	O
30	O
to	O
50	O
%	O
higher	O
than	O
that	O
administered	O
before	O
pregnancy	O
.	O

During	O
this	O
time	O
,	O
a	O
protocol	O
was	O
instituted	O
which	O
included	O
routine	O
25	O
(	O
OH	O
)	O
D	O
testing	O
at	O
each	O
patient	O
’	O
s	O
first	O
prenatal	O
visit	O
.	O

Unadjusted	O
odds	O
ratios	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
were	O
also	O
calculated	O
.	O

Alcohol	O
Consumption	O
Alcohol	O
consumption	O
by	O
the	O
mother	O
during	O
pregnancy	O
is	O
associated	O
with	O
higher	O
total	O
IgE	O
levels	O
in	O
cord	O
blood	O
[	O
76	O
].	O

The	O
most	O
discussed	O
health	O
topic	O
was	O
hygiene	O
and	O
nutrition	O
in	O
pregnancy	O
like	O
in	O
other	O
studies	O
[	O
4	O
,	O
22	O
].	O

Thus	B
,	O
the	O
strength	O
and	O
duration	O
of	O
sunlight	O
exposure	O
become	O
the	O
main	O
factors	O
affecting	O
the	O
Vitamin	O
D	O
level	O
in	O
their	O
bodies	O
.	O

At	O
6	O
months	O
,	O
no	O
significant	O
differences	O
in	O
WFA	O
z	O
-	O
scores	O
were	O
observed	O
between	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

In	O
contrast	O
,	O
the	O
LDL	O
was	O
two	O
-	O
fold	O
increased	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
artherosclerosis	O
within	O
the	O
artery	O
wall	O
and	O
poses	O
a	O
risk	O
for	O
cardiovascular	O
disease	O
.	O

Drugs	O
All	O
nonprescription	O
drugs	O
(	O
eg	O
,	O
antiacids	O
)	O
should	O
be	O
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	O
recommended	O
by	O
a	O
physician	O
;	O
patients	O
should	O
avoid	O
intake	O
of	O
any	O
medication	O
including	O
over	O
-	O
the	O
-	O
counter	O
substances	O
without	O
consulting	O
their	O
physicians	O
.	O

Using	O
50	O
%	O
CIs	O
gives	O
higher	O
power	O
to	O
detect	O
small	O
effects	O
in	O
the	O
data	O
and	O
they	O
can	O
serve	O
as	O
a	O
screening	O
tool	O
for	O
identifying	O
weak	O
effects	O
that	O
may	O
warrant	O
further	O
study	O
[	O
33	O
].	O

Each	O
point	O
represents	O
an	O
individual	O
,	O
and	O
lines	O
indicate	O
the	O
distance	O
from	O
tertile	O
centroid	O
.	O

Inform	O
•	O
Educate	O
,	O
engage	O
and	O
mobilise	O
communities	O
to	O
improve	O
health	O
education	O
and	O
care	O
,	O
beginning	O
in	O
adolescence	O
;	O
promote	O
cost	O
-	O
effective	O
solutions	O
;	O
track	O
progress	O
and	O
hold	O
all	O
stakeholders	O
at	O
global	O
,	O
regional	O
,	O
national	O
and	O
local	O
levels	O
accountable	O
for	O
their	O
commitments	O
;	O
promote	O
accountability	O
through	O
the	O
issuance	O
of	O
annual	O
Countdown	O
to	O
2015	O
country	O
data	O
profiles	O
and	O
global	O
and	O
national	O
reports	O
that	O
document	O
preterm	O
birth	O
rates	O
and	O
associated	O
mortality	O
and	O
coverage	O
of	O
evidence	O
-	O
based	O
interventions	O
.	O

Weight	O
at	O
puberty	O
Offspring	O
that	O
were	O
exposed	O
to	O
altered	O
maternal	O
nutrition	O
(	O
either	O
maternal	O
undernutrition	O
or	O
high	O
fat	O
diet	O
)	O
all	O
showed	O
significantly	O
lower	O
body	O
weights	O
at	O
pubertal	O
onset	O
compared	O
to	O
Cont	O
offspring	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Table	O
1	O
).	O

We	O
obtained	O
similar	O
results	O
with	O
PSM	O
(	O
Table	O
2	O
).	O

Numerous	O
publications	O
proclaim	O
this	O
particle	O
a	O
panacea	O
for	O
various	O
mental	O
and	O
somatic	O
chronic	O
diseases	O
,	O
while	O
other	O
advise	O
caution	O
in	O
prescribing	O
it	O
to	O
some	O
groups	O
of	O
patients	O
.	O

They	O
were	O
followed	O
up	O
at	O
3	O
time	O
points	O
thereafter	O
through	O
delivery	O
of	O
their	O
baby	O
.	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	O
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

Indeed	O
,	O
BAT	O
is	O
now	O
known	O
to	O
exert	O
anti	O
-	O
type	O
2	O
diabetic	O
effects	O
associated	O
with	O
improvments	O
of	O
dyslipidemia	O
and	O
insulin	O
secretion	O
as	O
well	O
as	O
decrease	O
insulin	O
resistance	O
in	O
type	O
2	O
diabetes	O
(	O
de	O
Souza	O
et	O
al	O
.,	O
1997	O
;	O
Liu	O
et	O
al	O
.,	O
1998	O
;	O
Frontini	O
et	O
al	O
.,	O
2013	O
;	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

The	O
text4baby	O
program	O
is	O
an	O
example	O
of	O
scaled	O
mHealth	O
for	O
behavior	O
change	O
[	O
24	O
](	O
seeFigure	O
1	O
).	O

We	O
then	O
evaluated	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
by	O
MLR	O
models	O
,	O
including	O
variables	O
measured	O
after	O
-	O
vaccination	O
:	O
delivery	O
hospital	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
influenza	O
circulation	O
.	O

RPMM	O
classes	O
were	O
labeled	O
using	O
a	O
series	O
of	O
numbers	O
,	O
ranging	O
from	O
1	O
to	O
16	O
(	O
with	O
class	O
1	O
having	O
the	O
lowest	O
methylation	O
level	O
and	O
class	O
16	O
having	O
the	O
highest	O
methylation	O
level	O
).	O

The	O
cycle	O
conditions	O
were	O
50	O
°	O
C	O
for	O
2	O
minutes	O
,	O
95	O
°	O
C	O
for	O
10	O
minutes	O
,	O
40	O
cycles	O
for	O
95	O
°	O
C	O
for	O
15	O
seconds	O
,	O
and	O
60	O
°	O
C	O
for	O
1	O
minute	O
.	O

Results	O
were	O
considered	O
statistically	O
significant	O
if	O
P	O
<	O
0	O
.	O
05	O
.	O

Further	O
,	O
a	O
possible	O
association	O
exists	O
with	O
ventilation	O
of	O
neonates	O
[	O
16	O
].	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
,	O
aFisher	O
’	O
s	O
Exact	O
Test	O
.	O

Of	O
note	O
is	O
that	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
a	O
southern	O
United	O
States	O
climate	O
are	O
low	O
despite	O
sunshine	O
exposure	O
year	O
round	O
at	O
the	O
latitude	O
in	O
Houston	O
.	O

Hence	B
,	O
its	O
contribution	O
to	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
cannot	O
be	O
underscored	O
.	O

There	O
have	O
been	O
over	O
1200	O
publications	O
using	O
data	O
from	O
ALSPAC	O
(	O
ALSPAC	O
2016	O
),	O
many	O
of	O
which	O
have	O
linked	O
pre	O
-	O
conception	O
and	O
in	O
utero	O
environmental	O
factors	O
(	O
including	O
chemicals	O
,	O
pharmaceuticals	O
,	O
nutrition	O
,	O
smoking	O
,	O
anxiety	O
and	O
depression	O
)	O
with	O
adverse	O
outcomes	O
(	O
such	O
as	O
asthma	O
and	O
other	O
respiratory	O
disorders	O
,	O
increased	O
weight	O
/	O
BMI	O
-	O
related	O
issues	O
and	O
behavioral	O
problems	O
)	O
(	O
Golding2010	O
;	O
Boyd	O
et	O
al	O
.	O
2013	O
).	O

Animal	O
models	O
have	O
confirmed	O
that	O
DVD	O
deficiency	O
is	O
associated	O
with	O
a	O
range	O
of	O
altered	O
genomic	O
,	O
proteomic	O
,	O
structural	O
and	O
behavioural	O
outcomes	O
in	O
the	O
rat	O
.	O

Probe	O
-	O
sets	O
with	O
a	O
low	O
standard	O
deviation	O
(	O
s	O
≤	O
0	O
.	O
25	O
)	O
were	O
discarded	O
,	O
because	O
such	O
transcripts	O
are	O
not	O
likely	B
to	O
be	O
regulated	O
.	O

JL	O
:	O
Acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

Different	O
approaches	O
were	O
used	O
to	O
delineate	O
the	O
impact	O
of	O
UCP1	O
on	O
insulin	O
sensitivity	O
.	O

This	O
stage	O
appeared	O
as	O
a	O
phase	O
of	O
recovery	O
of	O
the	O
activity	O
of	O
genes	O
.	O

Analyses	O
included	O
descriptive	O
and	O
bivariate	O
statistics	O
as	O
well	O
as	O
multiple	O
and	O
logistic	O
regression	O
.	O

Consequently	B
,	O
the	O
exposure	O
to	O
a	O
moderate	O
or	O
severe	O
restricted	O
diet	O
during	O
pregnancy	O
has	O
been	O
associated	O
to	O
features	O
of	O
metabolic	O
syndrome	O
in	O
adult	O
offspring	O
such	O
as	O
higher	O
adiposity	O
(	O
Yura	O
et	O
al	O
.,	O
2005	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
),	O
alterations	O
in	O
glucose	O
metabolism	O
(	O
Jimenez	O
-	O
Chillaron	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Theys	O
et	O
al	O
.,	O
2011	O
),	O
or	O
alterations	O
in	O
the	O
lipid	O
plasmatic	O
profile	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
,	O
2012	O
).	O

Eligibility	O
criteria	O
included	O
nonsmoking	O
,	O
adults	O
(	O
age	O
>	O
18	O
years	O
),	O
fluency	O
in	O
English	O
,	O
access	O
to	O
telephone	O
,	O
gestational	O
age	O
between	O
10	O
and	O
16	O
weeks	O
,	O
singleton	O
pregnancy	O
,	O
no	O
current	O
or	O
history	O
of	O
eating	O
disorders	O
,	O
and	O
without	O
major	O
psychiatric	O
illness	O
(	O
i	O
.	O
e	O
.,	O
schizophrenia	O
,	O
bipolar	O
disorder	O
,	O
and	O
panic	O
/	O
anxiety	O
disorder	O
)	O
or	O
major	O
medical	O
problems	O
,	O
including	O
diabetes	O
,	O
stroke	O
,	O
and	O
cancer	O
.	O

As	B
such	I
,	O
these	O
studies	O
are	O
of	O
greater	O
mechanistic	O
relevance	O
,	O
and	O
provide	O
more	B
comprehensive	I
evidence	O
for	O
putative	B
causal	O
relationships	O
.	O

Data	O
were	O
imputed	O
separately	O
by	O
treatment	O
group	O
using	O
the	O
fully	O
conditional	O
specification	O
(	O
chained	O
equations	O
)	O
method	O
to	O
create	O
100	O
complete	O
datasets	O
for	O
analysis	O
under	O
the	O
assumption	O
that	O
the	O
data	O
were	O
missing	O
at	O
random	O
(	O
i	O
.	O
e	O
.,	O
that	O
“	O
missingness	O
”	O
was	O
independent	O
of	O
the	O
values	O
of	O
the	O
missing	O
observations	O
,	O
conditional	O
on	O
observed	O
data	O
).	O

Therefore	B
,	O
fetal	O
nutritional	O
programming	O
via	O
nutrition	O
of	O
dams	O
during	O
gestation	O
may	O
be	O
one	O
way	O
to	O
increase	O
marbling	O
in	O
offspring	O
later	O
in	O
life	O
.	O

Finally	O
,	O
while	O
the	O
use	O
of	O
rodent	O
models	O
for	O
reproductive	O
investigation	O
is	O
generally	B
well	O
accepted	O
,	O
a	O
number	O
of	O
differences	O
must	O
be	O
recognized	B
.	O

MS	O
heritability	O
is	O
relatively	O
high	O
in	O
Korean	O
cattle	O
(	O
0	O
.	O
57	O
in	O
Yoon	O
et	O
al	O
[	O
42	O
];	O
0	O
:	O
64	O
in	O
Park	O
et	O
al	O
[	O
43	O
]).	O

Although	O
their	O
safety	O
has	O
not	O
been	O
proven	O
,	O
it	O
is	O
often	O
rationalized	B
that	O
a	O
change	O
in	O
the	O
basal	O
insulin	O
will	O
result	O
in	O
deterioration	O
in	O
glycemic	O
control	O
,	O
and	O
therefore	B
the	O
risk	O
of	O
continuing	O
glargine	O
is	O
less	O
than	O
the	O
risk	O
from	O
changing	O
insulins	O
.	O

The	O
distinguishing	O
feature	O
of	O
AAOC	O
is	O
that	O
the	O
capillary	O
formation	O
is	O
not	O
lobular	O
as	O
seen	O
in	O
PG	O
but	O
rather	O
a	O
diffuse	O
pattern	O
.	O

[	O
2	O
].	O

All	O
parents	O
and	O
children	O
signed	O
written	O
informed	O
consent	O
/	O
assent	O
forms	O
.	O

In	O
this	O
context	O
,	O
it	O
is	O
plausible	O
in	O
our	O
experimental	O
model	O
that	O
RC	O
offspring	O
did	O
not	O
showed	O
underweight	O
and	O
,	O
therefore	B
,	O
hyperphagia	O
in	O
any	O
stage	O
.	O

Further	O
,	O
prenatal	O
vitamin	O
D3	O
depletion	O
has	O
been	O
associated	O
with	O
altered	O
brain	O
development	O
in	O
rodent	O
studies	O
[	O
151	O
].	O

The	O
expression	O
and	O
activity	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
CYP27B1	O
)	O
was	O
evaluated	O
in	O
in	O
vitro	O
experiments	O
on	O
decidua	O
cell	O
cultures	O
collected	O
in	O
the	O
1st	O
and	O
3rd	O
trimesters	O
[	O
15	O
].	O

The	O
pressure	O
to	O
thinness	O
in	O
western	O
societies	O
associated	O
to	O
a	O
higher	O
prevalence	O
of	O
women	O
with	O
a	O
past	O
of	O
eating	O
disorders	O
or	O
a	O
worry	O
in	O
excess	O
about	O
body	O
changing	O
during	O
pregnancy	O
and	O
postpartum	O
have	O
raised	O
the	O
risk	O
for	O
giving	O
birth	O
underweight	O
babies	O
(	O
Easter	O
et	O
al	O
.,	O
2013	O
;	O
Linna	O
et	O
al	O
.,	O
2014	O
).	O

We	O
conducted	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
and	O
highlighted	O
their	O
constraints	O
as	O
well	O
as	O
interventions	O
required	O
to	O
strengthen	O
the	O
health	O
services	O
.	O

Throughout	O
in	O
utero	O
development	O
,	O
the	O
placenta	O
,	O
through	O
the	O
production	O
of	O
various	O
enzymes	O
and	O
hormones	O
,	O
plays	O
an	O
important	O
role	O
in	O
controlling	O
growth	O
and	O
development	O
through	O
the	O
transfer	O
of	O
nutrients	O
and	O
waste	O
and	O
in	O
protecting	O
the	O
fetus	O
from	O
many	O
xenobiotic	O
insults	O
(	O
Robins	O
et	O
al	O
.	O

Infants	O
of	O
overweight	O
/	O
obese	O
mothers	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
than	O
nonexposed	O
counterparts	O
,	O
but	O
the	O
postnatal	O
weight	O
trajectories	O
were	O
different	O
.	O

More	O
recently	O
,	O
the	O
effects	O
of	O
relative	O
‘	O
overnutrition	O
’	O
have	O
come	O
into	O
question	O
.	O

Environments	O
Studies	O
have	O
demonstrated	O
that	O
environmental	O
conditions	O
,	O
such	O
as	O
temperature	O
stress	O
,	O
can	O
negatively	O
affect	O
animal	O
growth	O
and	O
beef	O
quality	O
in	O
cattle	O
[	O
74	O
].	O

Conclusion	O
The	O
importance	O
of	O
nutritional	O
counseling	O
before	O
conception	O
and	O
during	O
pregnancy	O
should	O
be	O
emphasized	O
in	O
order	O
to	O
encourage	O
proper	O
PPBMI	O
and	O
avoidance	O
of	O
excessive	O
gestational	O
weight	O
gain	O
,	O
since	O
both	O
are	O
related	O
to	O
risk	O
for	O
GDM	O
.	O

Epidemiological	O
data	O
were	O
obtained	O
from	O
children	O
with	O
autism	O
,	O
including	O
residential	O
history	O
of	O
the	O
mother	O
,	O
which	O
was	O
compared	O
to	O
the	O
traffic	O
-	O
related	O
air	O
pollution	O
assigned	O
to	O
each	O
location	O
using	O
measures	O
from	O
the	O
Environmental	O
Protection	O
Agency	O
'	O
s	O
Air	O
Quality	O
System	O
data	O
.	O

The	O
autumn	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
the	O
intervention	O
group	O
is	O
significantly	O
higher	O
than	O
that	O
of	O
control	O
group	O
.	O

Other	O
research	O
has	O
found	O
that	O
a	O
reduction	O
in	O
physical	O
activity	O
by	O
bed	O
rest	O
was	O
associated	O
with	O
an	O
increase	O
in	O
infant	O
birth	O
weight	O
[	O
44	O
].	O

Education	O
and	O
current	O
income	O
were	O
not	O
significantly	O
associated	O
with	O
adolescent	O
overweight	O
,	O
and	O
lifetime	O
income	O
was	O
only	O
marginally	O
significant	O
(	O
21	O
).	O

Conclusions	B
regarding	O
other	O
FGAs	O
are	O
limited	O
due	O
to	O
either	O
poor	O
methodology	O
or	O
incomplete	O
reporting	O
.	O
9Although	O
the	O
reproductive	O
safety	O
of	O
FGAs	O
is	O
as	O
yet	O
unconfirmed	O
,	O
the	O
adverse	O
side	O
effect	O
profile	O
necessitated	O
the	O
development	O
of	O
newer	O
medications	O
in	O
recent	O
years	O
.	O

Laboratory	O
analysis	O
Haematological	O
analysis	O
included	O
haemoglobin	O
concentration	O
,	O
white	O
blood	O
cell	O
count	O
,	O
mean	O
cell	O
volume	O
(	O
MCV	O
),	O
mean	O
cell	O
haemoglobin	O
(	O
MCH	O
),	O
reticulocyte	O
count	O
(	O
Cel	O
-	O
Dyn	O
3700	O
Analyser	O
,	O
Abbott	O
Diagnostics	O
,	O
USA	O
and	O
Medonic	O
CA530	O
,	O
Clinical	O
Diagnostic	O
Solutions	O
,	O
Inc	O
.,	O
USA	O
),	O
and	O
zinc	O
protoporphyrin	O
concentration	O
(	O
ZnPP	O
)	O
(	O
AVIV	O
ZP	O
Hematofluorometer	O
Model	O
206	O
,	O
Analis	O
Scientific	O
Instruments	O
,	O
Belgium	O
).	O

Effect	O
on	O
the	O
incidence	O
of	O
pneumonia	O
of	O
vitamin	O
D	O
supplementation	O
by	O
quarterly	O
bolus	O
dose	O
to	O
infants	O
in	O
Kabul	O
:	O
a	O
randomised	O
controlled	O
superiority	O
trial	O
AbstractSummary	O
Background	O
Vitamin	O
D	O
has	O
a	O
role	O
in	O
regulating	O
immune	O
function	O
,	O
and	O
its	O
deficiency	O
is	O
a	O
suggested	O
risk	O
factor	O
for	O
childhood	O
pneumonia	O
.	O

The	O
special	O
nuclear	O
receptors	O
for	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
and	O
also	O
essential	O
enzymes	O
for	O
hydroxylation	O
of	O
vitamin	O
D	O
are	O
found	O
in	O
the	O
central	O
nervous	O
system	O
.	O

A	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
association	O
between	O
autism	O
and	O
developmental	O
abnormalities	O
in	O
children	O
with	O
perinatal	O
cocaine	O
exposure	O
.	O

The	O
pathogenesis	O
of	O
this	O
condition	O
is	O
unknown	O
,	O
although	O
there	O
is	O
speculation	O
that	O
it	O
may	O
be	O
caused	O
by	O
allergic	O
sensitization	O
to	O
endogenous	O
hormones	O
[	O
46	O
,	O
47	O
].	O

Other	O
putative	O
candidates	O
include	O
harmonic	O
variation	O
in	O
population	O
mixing	O
,	O
diet	O
,	O
temperature	O
,	O
humidity	O
,	O
sunlight	O
/	O
photoperiod	O
,	O
levels	O
of	O
vitamin	O
D3	O
,	O
and	O
endogenous	O
hormones	O
[	O
6	O
,	O
7	O
].	O

P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

Additional	O
separate	O
adjustment	O
for	O
maternal	O
intake	O
of	O
vitamin	O
E	O
,	O
zinc	O
,	O
selenium	O
,	O
n	O
-	O
3	O
PUFAs	O
,	O
n	O
-	O
6	O
PUFAs	O
,	O
and	O
total	O
fruits	O
and	O
vegetables	O
in	O
pregnancy	O
did	O
not	O
substantially	O
alter	O
the	O
main	O
findings	O
(	O
data	O
not	O
shown	O
),	O
nor	O
did	O
additional	O
separate	O
adjustment	O
for	O
child	O
'	O
s	O
free	O
sugar	O
intake	O
at	O
age	O
3	O
years	O
(	O
supplementary	O
table	O
E3	O
).	O

CC	O
females	O
showed	O
an	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
but	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
(	O
Figures4B	O
,	O
C	O
).	O

or	O
medians	O
with	O
interquartile	O
ranges	O
,	O
if	O
nonnormally	O
distributed	O
.	O

Statistical	O
Analyses	O
Treatment	O
effects	O
on	O
weight	O
gain	O
and	O
72	O
h	O
food	O
intake	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
model	O
procedure	O
in	O
SAS	O
(	O
Version	O
9	O
.	O
2	O
,	O
SAS	O
Institute	O
Inc	O
.,	O
Carey	O
,	O
NC	O
,	O
USA	O
)	O
with	O
gestational	O
diets	O
,	O
pup	O
diets	O
and	O
time	O
as	O
the	O
main	O
factors	O
.	O

Postponing	O
surgery	O
to	O
at	B
least	I
6	O
-	O
7	O
months	O
after	O
diagnosis	O
of	O
DTC	O
in	O
the	O
first	O
trimester	O
does	O
not	O
adversely	O
affect	O
prognosis	O
;	O
on	O
the	O
other	O
hand	O
,	O
thyroidectomy	O
can	O
be	O
safely	O
performed	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
or	O
after	O
delivery15	O
.	O

These	O
disorders	O
represent	O
the	O
most	O
common	O
group	O
of	O
medical	O
conditions	O
that	O
complicate	O
pregnancy	O
.	O

A	O
positive	O
score	O
on	O
any	O
of	O
these	O
three	O
symptoms	O
indicates	O
an	O
allergic	O
phenotype	O
.	O

Most	B
preterm	O
births	O
occur	O
over	O
32	O
weeks	O
of	O
gestation	O
(	O
84	O
%),	O
and	O
deaths	O
in	O
these	O
babies	O
can	O
almost	B
all	I
be	O
prevented	O
and	O
in	O
most	B
cases	O
,	O
intensive	O
care	O
is	O
not	O
needed	O
[	O
6	O
]	O
(	O
Figure1	O
).	O

All	O
reports	O
will	O
be	O
auto	O
-	O
generated	O
from	O
the	O
system	O
and	O
will	O
be	O
available	O
anytime	O
for	O
the	O
investigators	O
’	O
assessment	O
.	O

Oesophageal	O
cancer	O
studies	O
in	O
the	O
Caspian	O
Littoral	O
of	O
Iran	O
:	O
results	O
of	O
a	O
case	O
-	O
control	O
study	O
.	O

[	O
31	O
]	O
The	O
American	O
Academy	O
of	O
Pediatrics	O
recommendations	O
focus	O
on	O
supplementing	O
the	O
infant	O
and	O
make	O
no	O
specific	O
recommendations	O
about	O
universally	O
supplementing	O
breastfeeding	O
mothers	O
.	O

In	O
women	O
belonging	O
to	O
the	O
high	O
level	O
symptoms	O
group	O
,	O
the	O
RRs	O
with	O
increasing	O
quartiles	O
of	O
omega	O
-	O
6	O
intake	O
were	O
:	O
0	O
.	O
67	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
55	O
-	O
0	O
.	O
82	O
),	O
0	O
.	O
66	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
54	O
-	O
0	O
.	O
81	O
),	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

These	O
responses	O
were	O
compared	O
to	O
the	O
socio	O
-	O
demographic	O
characteristics	O
;	O
marital	O
status	O
,	O
age	O
groups	O
,	O
number	O
of	O
pregnancy	O
(	O
primigravidavs	O
?	O
2	O
pregnancies	O
),	O
number	O
of	O
visits	O
and	O
educational	O
level	O
(	O
Table	O
2	O
).	O

Disappointingly	O
,	O
we	O
found	O
no	O
overlap	O
with	O
the	O
proteins	O
identified	O
in	O
the	O
current	O
study	O
versus	O
those	O
in	O
the	O
previous	O
publication	O
[	O
18	O
].	O

As	O
shown	O
inTable	O
2	O
,	O
among	O
the	O
4	O
miRNAs	O
targeting	O
GR	O
,	O
miR	O
-	O
124a	O
,	O
which	O
has	O
been	O
identified	O
to	O
target	O
GR	O
3	O
′	O
UTR	O
[	O
2	O
],[	O
3	O
],	O
was	O
significantly	O
higher	O
expression	O
in	O
the	O
liver	O
of	O
betaine	O
-	O
exposed	O
piglets	O
,	O
compared	O
to	O
that	O
of	O
control	O
group	O
.	O

A	O
significant	O
correlation	O
was	O
observed	O
between	O
the	O
first	O
and	O
second	O
trimesters	O
visfatin	O
level	O
with	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
,	O
such	O
that	O
this	O
relationship	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

For	O
example	O
,	O
the	O
Coordinated	O
School	O
Health	O
Program	O
model	O
from	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
proposes	O
a	O
multilevel	O
approach	O
in	O
which	O
8	O
different	O
school	O
components	O
(	O
eg	O
,	O
health	O
education	O
,	O
nutrition	O
services	O
,	O
healthy	O
school	O
environment	O
,	O
family	O
and	O
community	O
involvement	O
)	O
interact	O
to	O
influence	O
student	O
health	O
(	O
91	O
).	O

The	O
incidence	O
of	O
GDM	O
is	O
increasing	O
,	O
in	O
parallel	O
to	O
the	O
increase	O
in	O
type	O
2	O
diabetes	O
.	O

Each	O
adult	O
egg	O
-	O
laying	O
hen	O
consumes	O
100	O
–	O
115	O
g	O
/	O
day	O
feeds	O
fortified	O
with	O
1600	O
IU	O
/	O
kg	O
Vitamin	O
D	O
(	O
both	O
Vitamin	O
D2	O
and	O
Vitamin	O
D3	O
),	O
as	O
indicated	O
by	O
Chinese	O
nutrition	O
standards	O
for	O
feeding	O
egg	O
-	O
laying	O
hens	O
.	O

We	O
sequentially	O
excluded	O
12	O
women	O
with	O
early	O
pregnancy	O
losses	O
,	O
52	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
,	O
and	O
23	O
who	O
did	O
not	O
complete	O
the	O
interview	O
.	O

However	O
,	O
this	O
difference	O
was	O
not	O
observed	O
in	O
Alentejana	O
bulls	O
,	O
indicating	O
a	O
breed	O
difference	O
in	O
IMF	O
content	O
in	O
response	O
to	O
the	O
roughage	O
-	O
to	O
-	O
concentrate	O
ratio	O
.	O

Weight	O
was	O
also	O
not	O
significantly	O
different	O
between	O
groups	O
at	O
this	O
time	O
,	O
3	O
.	O
68	O
±	O
0	O
.	O
4	O
kg	O
versus	O
3	O
.	O
47	O
±	O
0	O
.	O
4	O
kg	O
for	O
Hispanic	O
and	O
Caucasians	O
respectively	O
,	O
p	O
=	O
0	O
.	O
08	O
.	O

As	O
a	O
secondary	O
investigation	O
,	O
we	O
assessed	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
by	O
trimester	O
in	O
which	O
women	O
received	O
influenza	O
vaccination	O
;	O
the	O
unvaccinated	O
group	O
was	O
used	O
as	O
a	O
control	O
for	O
all	O
models	O
.	O

However	O
,	O
there	O
is	O
insufficient	O
evidence	O
to	O
implicate	O
any	O
one	O
perinatal	O
or	O
neonatal	O
factor	O
in	O
autism	O
etiology	O
,	O
although	O
there	O
is	O
some	O
evidence	O
to	O
suggest	O
that	O
exposure	O
to	O
a	O
broad	O
class	O
of	O
conditions	O
reflecting	O
general	O
compromises	O
to	O
perinatal	O
and	O
neonatal	O
health	O
may	O
increase	O
the	O
risk	O
.	O

A	O
similar	O
process	O
was	O
used	O
to	O
identify	O
papers	O
on	O
risk	O
factors	O
related	O
to	O
season	O
of	O
birth	O
.	O

In	O
those	O
studies	O
,	O
25OHD	O
was	O
used	O
as	O
a	O
categorical	O
variable	O
.	O

[	O
24	O
]	O
found	O
that	O
seafood	O
consumption	O
that	O
excluded	O
fish	O
intake	O
had	O
a	O
detrimental	O
effect	O
on	O
neurodevelopment	O
,	O
while	O
fish	O
intake	O
alone	O
led	O
to	O
improved	O
outcomes	O
.	O

Overall	O
,	O
participants	O
included	O
in	O
this	O
analysis	O
tended	O
to	O
be	O
Caucasian	O
,	O
well	O
-	O
educated	O
,	O
and	O
married	O
.	O

Discussion	O
Using	O
a	O
large	O
-	O
scale	O
ENU	O
mutagenesis	O
screen	O
,	O
we	O
have	O
identified	O
two	O
novel	O
mutations	O
,	O
Skm1	O
and	O
Skm2	O
,	O
that	O
result	O
in	O
congenital	O
spinal	O
deformities	O
in	O
mice	O
.	O

[	O
21	O
]	O
reported	O
that	O
increased	O
exposure	O
to	O
PCBs	O
was	O
associated	O
with	O
decreased	O
birth	O
weight	O
.	O

The	O
"	O
low	O
level	O
symptoms	O
group	O
"	O
included	O
women	O
with	O
no	O
or	O
few	O
experiences	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(≤	O
3	O
"	O
sometimes	O
"	O
and	O
no	O
"	O
almost	O
always	O
"	O
and	O
"	O
often	O
"	O
answers	O
to	O
any	O
of	O
the	O
questions	O
).	O

The	O
subjects	O
provided	O
written	O
consent	O
for	O
participation	O
in	O
the	O
study	O
.	O

It	O
also	O
sought	O
to	O
establish	O
reasons	O
that	O
determined	O
these	O
women	O
'	O
s	O
choice	O
of	O
ANC	O
site	O
as	O
well	O
as	O
explore	O
the	O
geographic	O
distribution	O
of	O
the	O
women	O
with	O
respect	O
to	O
their	O
residence	O
and	O
their	O
attending	O
health	O
centre	O
.	O

Subjects	O
in	O
this	O
study	O
reside	O
in	O
an	O
areas	O
from	O
39	O
″	O
26	O
’	O
N	O
to	O
41	O
″	O
03	O
’	O
N	O
.	O

Participants	O
were	O
selected	O
in	O
a	O
convenience	O
manner	O
.	O

Conversely	O
,	O
vitamin	O
D	O
deficiency	O
results	O
in	O
proximal	O
muscle	O
weakness	O
and	O
decreased	O
lower	O
extremity	O
muscle	O
function	O
perhaps	O
contributing	O
to	O
the	O
risk	O
for	O
cesarean	O
section	O
.	O

Similar	O
,	O
but	O
in	O
the	O
inverse	O
direction	O
,	O
results	O
were	O
observed	O
in	O
models	O
where	O
percentage	O
of	O
calories	O
from	O
carbohydrates	O
(	O
instead	O
of	O
fat	O
)	O
was	O
included	O
(	O
B	O
=	O
0	O
.	O
04	O
(	O
0	O
.	O
01	O
,	O
0	O
.	O
06	O
);	O
beta	O
=	O
0	O
.	O
27	O
;	O
P	O
=.	O
006	O
for	O
WFA	O
z	O
and	O
OR	O
=	O
1	O
.	O
1	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
005	O
for	O
WFA	O
>	O
90th	O
percentile	O
).	O

Labor	O
Induction	O
and	O
Augmentation	O
Since	O
the	O
early	O
1990s	O
,	O
a	O
number	O
of	O
studies	O
have	O
suggested	O
the	O
link	O
between	O
ASD	O
and	O
labor	O
induction	O
,	O
such	O
as	O
the	O
use	O
of	O
oxytocin	O
[	O
67	O
].	O

The	O
purpose	O
of	O
this	O
paper	O
is	O
to	O
examine	O
the	O
prevalence	O
and	O
accuracy	O
of	O
provider	O
advice	O
on	O
maternal	O
weight	O
gain	O
and	O
its	O
association	O
with	O
personal	O
beliefs	O
about	O
necessary	O
maternal	O
weight	O
gain	O
within	O
a	O
sample	O
of	O
predominantly	O
Latina	O
pregnant	O
women	O
who	O
received	O
prenatal	O
care	O
in	O
their	O
dominant	O
language	O
.	O

It	O
cannot	O
,	O
however	O
,	O
correct	O
for	O
potential	O
bias	O
and	O
confounding	O
of	O
the	O
studies	O
included	O
;	O
we	O
addressed	O
this	O
issue	O
in	O
our	O
review	O
(	O
Martin	O
et	O
al	O
.	O

For	O
example	O
,	O
the	O
fact	O
that	O
prenatal	O
folate	O
supplementation	O
substantially	O
reduces	O
the	O
risk	O
of	O
neural	O
tube	O
defect	O
only	O
if	O
it	O
is	O
taken	O
preconceptually	O
is	O
well	O
known	O
but	O
improving	O
vitamin	O
A	O
status	O
before	O
pregnancy	O
has	O
also	O
been	O
shown	O
to	O
have	O
a	O
dramatic	O
and	O
as	O
yet	O
unexplained	O
effect	O
on	O
maternal	O
morbidity	O
and	O
mortality	O
(	O
West	O
et	O
al	O
1999	O
).	O

01117961	O
)	O
[	O
16	O
].	O

Those	O
presently	O
taking	O
vitamin	O
D	O
drops	O
also	O
had	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
92	O
.	O
2	O
±	O
34	O
.	O
6	O
nmol	O
/	O
L	O
vs	O
.	O
72	O
.	O
2	O
±	O
28	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Results	O
were	O
similar	O
when	O
analyses	O
were	O
repeated	O
using	O
maternal	O
nightly	O
sleep	O
duration	O
prior	O
to	O
pregnancy	O
(	O
data	O
not	O
shown	O
).	O

Methods	O
Participants	O
The	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
is	O
a	O
population	O
-	O
based	O
birth	O
cohort	O
that	O
recruited	O
14	O
541	O
predominantly	O
white	O
pregnant	O
women	O
resident	O
in	O
Avon	O
,	O
UK	O
with	O
expected	O
dates	O
of	O
delivery	O
from	O
April	O
1	O
,	O
1991	O
to	O
December	O
31	O
,	O
1992	O
.	O

The	O
physiologically	O
elevated	O
position	O
of	O
the	O
diaphragm	O
and	O
hyperventilation	O
in	O
pregnancy	O
further	O
increase	O
the	O
risk	O
of	O
hypoxia	O
.	O

Methods	O
Recruitment	O
and	O
study	O
participants	O
At	O
Kätilöopisto	O
Maternity	O
Hospital	O
,	O
Helsinki	O
,	O
Finland	O
,	O
987	O
families	O
were	O
recruited	O
into	O
the	O
VIDI	O
study	O
between	O
January	O
2013	O
and	O
June	O
2014	O
,	O
after	O
delivery	O
during	O
the	O
mother	O
’	O
s	O
hospital	O
stay	O
.	O

As	O
Fernell	O
et	O
al	O
.	O

If	O
adequate	O
amounts	O
of	O
vitamin	O
D	O
prevent	O
autism	O
,	O
one	O
would	O
expect	O
children	O
with	O
rickets	O
to	O
have	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

Additionally	O
,	O
CC	O
and	O
RC	O
adolescent	O
females	O
showed	O
an	O
increase	O
in	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adolescent	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3A	O
).	O

Although	O
the	O
FFQ	O
that	O
we	O
used	O
had	O
not	O
been	O
formally	O
calibrated	O
against	O
other	O
instruments	O
such	O
as	O
diet	O
diaries	O
,	O
it	O
was	O
based	O
on	O
the	O
one	O
used	O
by	O
Yarnell	O
et	O
al	O
.	O

The	O
long	O
-	O
term	O
impact	O
of	O
the	O
Yen	O
Bai	O
program	O
is	O
shown	O
inTable	O
3	O
.	O

rs10741657	O
is	O
located	O
within	O
the	O
promoter	O
region	O
of	O
the	O
CYP2R1	O
gene	O
,	O
and	O
our	O
findings	O
would	O
suggest	O
that	O
presence	O
of	O
the	O
A	O
allele	O
increases	O
enzyme	O
production	O
.	O

Nephrin	O
does	O
not	O
affect	O
podocyte	O
apoptosis	O
and	O
gene	O
expression	O
patterns	O
[	O
36	O
].	O

Curiously	O
,	O
it	O
has	O
recently	O
been	O
shown	O
that	O
dynamin	O
1	O
-	O
like	O
protein	O
is	O
also	O
important	O
for	O
mitochondrial	O
fission	O
and	O
general	O
morphology	O
[	O
33	O
].	O

Forty	O
participants	O
in	O
this	O
study	O
had	O
plasma	O
samples	O
collected	O
at	O
two	O
subsequent	O
yearly	O
visits	O
,	O
spaced	O
roughly	O
twelve	O
months	O
apart	O
.	O

51	O
.	O
9	O
±	O
27	O
.	O
7	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
p	O
=	O
0	O
.	O
010	O
)	O
and	O
the	O
risk	O
(	O
OR	O
)	O
of	O
myomas	O
in	O
the	O
VD	O
deficiency	O
group	O
is	O
2	O
.	O
4	O
(	O
95	O
%;	O
RR	O
1	O
.	O
2	O
–	O
4	O
.	O
9	O
),	O
(	O
p	O
=	O
0	O
.	O
16	O
)	O
[	O
33	O
].	O

These	O
include	O
both	O
direct	O
and	O
indirect	O
processes	O
that	O
ultimately	O
lead	O
to	O
alterations	O
in	O
DNA	O
methylation	O
,	O
histone	O
modification	O
and	O
/	O
or	O
ncRNA	O
expression	O
.	O

This	O
holds	O
true	B
for	O
the	O
existing	O
inequalities	O
in	O
care	O
within	O
and	O
across	O
high	O
-	O
income	O
as	O
well	O
as	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
.	O

Including	O
all	O
piglets	O
derived	O
from	O
the	O
complete	O
experiment	O
,	O
LP	O
offspring	O
was	O
growth	O
-	O
restricted	O
compared	O
to	O
AP	O
offspring	O
,	O
but	O
litter	O
size	O
did	O
not	O
differ	O
[	O
15	O
].	O

Additionally	O
,	O
we	O
investigated	O
whether	O
a	O
lifetime	O
of	O
high	O
fat	O
consumption	O
by	O
the	O
dam	O
has	O
differing	O
effects	O
compared	O
to	O
high	O
fat	O
consumption	O
that	O
is	O
restricted	O
to	O
pregnancy	O
and	O
lactation	O
.	O

The	O
degree	O
to	O
which	O
taste	O
and	O
smell	O
are	O
agreeable	O
is	O
determined	O
by	O
innate	O
factors	O
(	O
25	O
),	O
learning	O
and	O
experience	O
,	O
and	O
the	O
interactions	O
among	O
these	O
.	O

Global	O
Methylation	O
Status	O
Neither	O
the	O
gestational	O
nor	O
post	O
-	O
weaning	O
diet	O
had	O
any	O
effect	O
on	O
the	O
global	O
methylation	O
status	O
in	O
the	O
offspring	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
6c	O
).	O

Some	O
members	O
of	O
the	O
BMP	O
family	O
were	O
shown	O
to	O
play	O
a	O
role	O
in	O
energy	O
homeostasis	O
and	O
the	O
early	O
steps	O
of	O
adipogenesis	O
,	O
in	O
particular	O
.	O

Whether	O
women	O
treated	O
for	O
thyroid	O
cancer	O
should	O
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	O
,	O
but	O
current	O
evidence	O
suggests	O
that	O
DTC	O
should	O
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	O
to	O
postpone	O
it	O
to	O
at	B
least	I
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

Vitamin	O
C	O
or	O
L	O
-	O
ascorbic	O
acid	O
has	O
several	O
roles	O
including	O
in	O
oxidation	O
–	O
reduction	O
reactions	O
and	O
collagen	O
synthesis	O
[	O
147	O
].	O

There	O
were	O
no	O
cases	O
of	O
vitamin	O
D	O
toxicity	O
based	O
on	O
elevated	O
serum	O
calcium	O
levels	O
(≥	O
11	O
mg	O
/	O
dL	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
g004	O
Caption	O
(	O
FIG	O
):	O
FIG	O
4	O
Preterm	O
birth	O
rates	O
among	O
women	O
with	O
low	O
initial	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
40	O
ng	O
/	O
mL	O
at	O
≤	O
20	O
weeks	O
),	O
comparing	O
those	O
with	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
those	O
with	O
concentrations	O
<	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
.	O

2	O
.	O

Activation	O
of	O
the	O
RAS	O
may	O
play	O
a	O
significant	O
role	O
in	O
the	O
development	O
of	O
mechanisms	O
that	O
lead	O
to	O
kidney	O
damage	O
[	O
33	O
].	O

Conversely	O
,	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
female	O
fetus	O
was	O
not	O
associated	O
with	O
changing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

The	O
rationale	O
for	O
this	O
combination	O
is	O
to	O
meet	O
increased	O
folic	O
acid	O
requirements	O
in	O
pregnancy	O
brought	O
about	O
by	O
the	O
rapidly	O
dividing	O
cells	O
in	O
the	O
fetus	O
and	O
elevated	O
urinary	O
losses	O
[	O
7	O
].	O

For	B
this	I
reason	I
,	O
in	O
2007	O
,	O
the	O
Canadian	O
Paediatric	O
Society	O
cautioned	O
pregnant	O
women	O
they	O
may	O
require	O
not	O
400	O
IU	O
/	O
day	O
but	O
2000	O
IU	O
/	O
day	O
,	O
or	O
more	O
,	O
to	O
prevent	O
gestational	O
vitamin	O
D	O
deficiency	O
(	O
9	O
).	O

Thus	B
,	O
occurrence	O
of	O
gastrointestinal	O
symptoms	O
is	O
usually	O
considered	O
as	B
a	O
critical	O
adverse	O
effect	O
on	O
which	O
a	O
tolerable	O
upper	O
intake	O
level	O
for	O
iron	O
is	O
based	O
for	O
an	O
individual	O
.	O

Differences	O
in	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
among	O
both	O
regions	O
were	O
not	O
significant	O
.	O

Surgery	O
is	O
the	O
only	O
treatment	O
which	O
is	O
considered	O
potentially	O
curative	O
for	O
metastatic	O
or	O
recurrent	O
medullary	O
carcinoma	O
.	O

Similarly	O
Holmes	O
et	O
al	O
reported	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
among	O
pregnant	O
women	O
taking	O
PNV	O
in	O
a	O
longitudinal	O
study	O
,	O
but	O
only	O
included	O
Caucasian	O
women	O
.	O
23	O
Our	O
study	O
has	O
several	O
strengths	O
including	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
at	O
two	O
separate	O
time	O
points	O
,	O
self	O
-	O
reported	O
race	O
/	O
ethnicity	O
,	O
and	O
measured	O
height	O
and	O
weight	O
during	O
the	O
first	O
trimester	O
and	O
weight	O
at	O
subsequent	O
visits	O
.	O

Long	O
-	O
Term	O
Effects	O
of	O
Prenatal	O
Exposure	O
to	O
Undernutrition	O
on	O
Cannabinoid	O
Receptor	O
-	O
Related	O
Behaviors	O
:	O
Sex	O
and	O
Tissue	O
-	O
Specific	O
Alterations	O
in	O
the	O
mRNA	O
Expression	O
of	O
Cannabinoid	O
Receptors	O
and	O
Lipid	O
Metabolic	O
Regulators	O
Abstract	O
Maternal	O
malnutrition	O
causes	O
long	O
-	O
lasting	O
alterations	O
in	O
feeding	O
behavior	O
and	O
energy	O
homeostasis	O
in	O
offspring	O
.	O

We	O
carried	O
out	O
sensitivity	O
analysis	O
using	O
different	O
thresholds	O
for	O
25OHD	O
in	O
the	O
multiple	O
regression	O
models	O
.	O

Innovate	O
•	O
Support	O
high	O
-	O
priority	O
research	O
efforts	O
to	O
address	O
solution	O
gaps	O
and	O
implementation	O
research	O
to	O
inform	O
the	O
scale	O
up	O
of	O
evidence	O
-	O
based	O
interventions	O
to	O
reduce	O
preterm	O
deaths	O
.	O

Groups	O
denoted	O
by	O
different	O
letters	O
are	O
significantly	O
different	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
among	O
Belgian	O
pregnant	O
women	O
and	O
to	O
assess	O
the	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Some	O
of	O
this	O
damage	O
done	O
by	O
maternal	O
Vitamin	O
D	O
deficiency	O
gets	O
evident	B
after	O
many	O
years	O
.	O

Analyses	O
were	O
conducted	O
separately	O
for	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
women	O
,	O
given	O
the	O
observed	O
difference	O
in	O
impact	O
of	O
the	O
lifestyle	O
treatment	O
on	O
GWG	O
[	O
16	O
]	O
and	O
effects	O
of	O
maternal	O
prepregnancy	O
weight	O
on	O
offspring	O
weight	O
outcomes	O
[	O
31	O
].	O

4	O
.	O

The	O
field	O
team	O
leader	O
consulted	O
the	O
assignment	O
table	O
in	O
order	O
to	O
determine	O
the	O
arm	O
to	O
which	O
the	O
participant	O
was	O
allocated	O
.	O

A	O
study	O
of	O
Bangladeshi	O
adolescents	O
receiving	O
a	O
micronutrient	O
fortified	O
beverage	O
6d	O
/	O
week	O
reported	O
haematological	O
effects	O
which	O
were	O
of	O
a	O
similar	O
magnitude	O
to	O
those	O
in	O
the	O
current	O
study	O
(	O
Hyder	O
et	O
al	O
2007	O
).	O

This	O
is	O
important	O
since	B
children	O
with	O
low	O
birth	O
weight	O
with	O
higher	O
plasma	O
ACE	O
activity	O
would	O
presumably	B
have	O
high	O
angiotensin	O
II	O
levels	O
and	O
lower	O
associated	O
levels	O
of	O
cardiac	O
vagal	O
activity	O
.	O

This	O
was	O
based	O
on	O
the	O
independent	O
monitoring	O
survey	O
one	O
year	O
after	O
the	O
province	O
-	O
wide	O
expansion	O
of	O
the	O
program	O
,	O
at	O
which	O
time	O
81	O
%	O
of	O
surveyed	O
women	O
were	O
receiving	O
the	O
supplements	O
regularly	O
and	O
87	O
%	O
of	O
those	O
were	O
taking	O
75	O
%	O
or	O
more	O
of	O
the	O
supplied	O
supplements	O
[	O
13	O
].	O

AMH	O
level	O
reduction	O
and	O
an	O
increase	O
of	O
circulating	O
sRAGE	O
after	O
VD3exerted	O
an	O
anti	O
-	O
inflammatory	O
action	O
,	O
which	O
may	O
lead	O
to	O
improved	O
folliculogenesis	O
in	O
PCOS	O
patients	O
.	O

Varying	O
observations	O
,	O
however	O
,	O
have	O
been	O
made	O
when	O
determining	O
whether	O
a	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
concentrations	O
exists	O
.	O

Thus	O
,	O
throughout	O
development	O
,	O
epigenetic	O
processes	O
regulate	O
the	O
expression	O
and	O
silencing	O
of	O
specific	O
genes	O
to	O
drive	O
the	O
mammalian	O
life	O
cycle	O
.	O

We	O
initially	O
tested	O
all	O
covariates	O
,	O
and	O
those	O
included	O
in	O
the	O
final	O
models	O
were	O
considered	O
to	O
be	O
important	O
confounding	O
factors	O
for	O
the	O
relation	O
between	O
the	O
main	O
exposure	O
and	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Stage	O
-	O
specific	O
feeding	O
systems	O
A	O
significant	O
proportion	O
of	O
consumers	O
in	O
Korea	O
,	O
Japan	O
,	O
and	O
the	O
USA	O
prefer	O
highly	O
marbled	O
beef	O
to	O
minimally	O
marbled	O
beef	O
.	O

Pregnancy	O
loss	O
models	O
are	O
also	O
adjusted	O
for	O
gestational	O
age	O
at	O
registration	O
for	O
antenatal	O
care	O
fNo	O
case	O
of	O
pregnancy	O
loss	O
in	O
category	O
gAdjusted	O
for	O
education	O
,	O
origin	O
,	O
season	O
of	O
conception	O
,	O
BMI	O
at	O
T1	O
and	O
25OHD	O
at	O
T1	O
Vitamin	O
D	O
status	O
trajectory	O
between	O
T1	O
and	O
T3	O
was	O
inversely	O
related	O
to	O
SGA	O
,	O
preterm	O
and	O
LBW	O
(	O
Table3	O
).	O

2009	O
;	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

Results	O
Forty	O
five	O
patients	O
including	O
24	O
with	O
the	O
age	O
of	O
30	O
.	O
7	O
±	O
6	O
.	O
2	O
years	O
in	O
the	O
IG	O
and	O
21	O
with	O
the	O
age	O
of	O
29	O
.	O
5	O
±	O
4	O
.	O
0	O
years	O
in	O
the	O
CG	O
completed	O
the	O
study	O
.	O

Lack	O
of	O
statistically	O
significant	O
associations	O
with	O
other	O
pregnancy	O
complications	O
may	O
reflect	O
the	O
fact	O
that	O
this	O
was	O
a	O
largely	O
vitamin	O
D	O
-	O
replete	O
population	O
(>	O
72	O
%	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
>	O
50	O
nmol	O
/	O
L	O
)	O
likely	B
due	O
to	O
their	O
residence	O
latitude	O
as	O
low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
found	O
in	O
the	O
SCOPE	O
Ireland	O
cohort	O
[	O
52	O
].	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

In	O
cases	O
where	O
the	O
serum	O
albumin	O
levels	O
were	O
below	O
the	O
appropriate	O
thresholds	O
for	O
a	O
child	O
’	O
s	O
age	O
,	O
the	O
corrected	O
calcium	O
level	O
was	O
used	O
in	O
place	O
of	O
the	O
standard	O
calcium	O
values	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Countries	O
that	O
have	O
halved	O
their	O
deaths	O
due	O
to	O
preterm	O
birth	O
in	O
just	O
one	O
decade	O
.	O

Further	O
research	O
is	O
necessary	O
to	O
differentiate	O
between	O
the	O
underlying	O
obstetric	O
complications	O
that	O
lead	O
to	O
the	O
eventual	O
use	O
of	O
induction	O
and	O
their	O
respective	O
potential	O
association	O
with	O
autism	O
[	O
52	O
].	O

In	O
data	O
derived	O
from	O
adoption	O
studies	O
[	O
17	O
],[	O
18	O
],	O
young	O
girls	O
who	O
migrated	O
from	O
underprivileged	O
countries	O
to	O
developed	O
countries	O
entered	O
puberty	O
significantly	O
earlier	O
than	O
girls	O
who	O
remained	O
in	O
their	O
country	O
of	O
origin	O
[	O
19	O
],[	O
20	O
],	O
and	O
in	O
unrelated	O
studies	O
such	O
children	O
have	O
shown	O
persistent	O
differences	O
in	O
ovarian	O
function	O
later	O
in	O
life	O
[	O
11	O
].	O

(	O
2012	O
)*/†	O
MethylmercuryMouseOral	O
(	O
water	O
)	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
+	O
neonatalAdulthoodBehavioral	O
abnormalitiesHistone	O
modification	O
DNA	O
methylationOnishchenko	O
et	O
al	O
.	O

Several	O
small	O
studies	O
comparing	O
metformin	O
to	O
insulin	O
for	O
the	O
treatment	O
of	O
GDM	O
have	O
also	O
been	O
performed	O
(	O
Table	O
5	O
).	O

The	O
importance	O
of	O
an	O
exacerbation	O
of	O
eczema	O
and	O
dermatitis	O
during	O
pregnancy	O
should	O
not	O
be	O
underestimated	O
as	O
readout	O
of	O
the	O
atopic	O
state	O
,	O
being	O
of	O
interest	O
for	O
the	O
genetic	O
predisposition	O
of	O
the	O
newborn	O
[	O
42	O
].	O

Urine	O
samples	O
are	O
transferred	O
into	O
labelled	O
microtubes	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
within	O
4	O
h	O
.	O
Breast	O
milk	O
samples	O
(	O
fore	O
-	O
milk	O
)	O
are	O
collected	O
from	O
lactating	O
mothers	O
at	O
phases	O
5	O
and	O
6	O
as	O
described	O
previously	O
[	O
68	O
].	O

Fat	O
addition	O
can	O
affect	O
IMF	O
deposition	O
.	O

The	O
program	O
applies	O
and	O
adapts	O
Social	O
Cognitive	O
Theory	O
,	O
the	O
Health	O
Belief	O
Model	O
,	O
and	O
Diffusion	O
of	O
Innovation	O
theory	O
[	O
27	O
-	O
29	O
].	O

In	O
conclusion	O
,	O
this	O
study	O
is	O
the	O
first	O
to	O
examine	O
cathelicidin	O
concentrations	O
in	O
healthy	O
children	O
over	O
time	O
.	O

Significantly	O
more	O
children	O
in	O
the	O
S	O
-	O
ECC	O
group	O
were	O
bottle	O
-	O
fed	O
compared	O
to	O
controls	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
bottle	O
-	O
fed	O
to	O
a	O
later	O
age	O
(	O
19	O
.	O
7	O
±	O
8	O
.	O
7	O
months	O
vs	O
.	O
16	O
.	O
4	O
±	O
7	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

Women	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
had	O
moved	O
and	O
their	O
medical	O
records	O
could	O
not	O
be	O
retrieved	O
.	O

Therefore	B
,	O
women	O
who	O
have	O
already	O
breastfed	O
or	O
those	O
who	O
breastfeed	O
longer	O
could	O
have	O
lower	O
levels	O
of	O
chemicals	O
in	O
their	O
bodies	O
simply	O
because	B
they	O
have	O
already	O
excreted	O
some	O
of	O
their	O
body	O
burden	O
,	O
not	O
because	B
lower	O
exposures	O
allowed	O
them	O
to	O
lactate	O
normally	O
.	O

Measures	O
of	O
cardiorespiratory	O
fitness	O
however	O
,	O
improved	O
.	O

Variables	O
which	O
did	O
not	O
require	O
adjustment	O
for	O
baseline	O
values	O
were	O
compared	O
using	O
an	O
independent	O
t	O
-	O
test	O
for	O
continuous	O
variables	O
,	O
Wilcoxon	O
ranksum	O
for	O
non	O
normally	O
distributed	O
variables	O
(	O
CRP	O
)	O
and	O
a	O
chi	O
-	O
squared	O
test	O
of	O
proportions	O
for	O
categorical	O
variables	O
.	O

Human	O
variability	O
It	O
is	O
known	O
that	O
different	O
strains	O
of	O
laboratory	O
animals	O
can	O
respond	O
very	O
differently	O
to	O
the	O
same	O
environmental	O
exposure	O
.	O

In	O
addition	O
there	O
are	O
possible	O
effects	O
on	O
reduced	O
anaemia	O
in	O
children	O
and	O
men	O
associated	O
with	O
de	O
-	O
worming	O
women	O
of	O
reproductive	O
age	O
and	O
a	O
consequent	O
reduction	O
in	O
helminth	O
transmission	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0023723	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Effectiveness	O
of	O
the	O
Yen	O
Bai	O
iron	O
supplementation	O
and	O
de	O
-	O
worming	O
program	O
.	O
SurveySample	O
sizeHaemoglobin	O
(	O
g	O
/	O
L	O
)	O
Prevalence	O
of	O
anaemiaBaseline34912238	O
%	O
3	O
month57412627	O
%	O
12	O
month57213120	O
%	O
30	O
month30313019	O
%	O
Data	O
sourced	O
from	O
Casey	O
et	O
al	O
[	O
13	O
].	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

The	O
study	O
provided	O
the	O
first	O
scientific	O
evidence	O
that	O
even	O
low	O
-	O
level	O
exposures	O
to	O
environmental	O
chemicals	O
could	O
contaminate	O
human	O
milk	O
.	O

A	O
synopsis	O
from	O
this	O
review	O
is	O
also	O
submitted	O
for	O
publication	O
on	O
the	O
WAO	O
homepage	O
(	O
http	O
://	O
www	O
.	O
worldallergy	O
.	O
org	O
/	O
adrc	O
/).	O

Experiments	O
with	O
animals	O
models	O
have	O
succeeded	O
in	O
simulate	O
metabolic	O
alterations	O
of	O
undernutrition	O
during	O
gestational	O
periods	O
in	O
humans	O
,	O
particularly	O
by	O
the	O
implementation	O
of	O
a	O
moderate	O
or	O
severe	O
calorie	O
restricted	O
diets	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
García	O
et	O
al	O
.,	O
2010	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

In	O
fact	O
,	O
children	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
below	O
this	O
threshold	B
were	O
twice	O
as	O
likely	B
to	O
have	O
S	O
-	O
ECC	O
.	O

There	O
are	O
numerous	O
studies	O
which	O
have	O
shown	O
that	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
(	O
Most	O
recent	O
:	O
[	O
14	O
–	O
17	O
]),	O
particularly	O
in	O
populations	O
that	O
reside	O
at	O
higher	O
latitudes	O
.	O

Therefore	B
,	O
podocin	O
expression	O
was	O
significantly	O
different	O
between	O
the	O
F1	O
and	O
F2	O
generations	O
among	O
VitD	O
-	O
offspring	O
at	O
weaning	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
=	O
0	O
.	O
004	O
).	O

[	O
34	O
]	O
It	O
is	O
now	O
recognized	B
that	O
everyone	O
is	O
at	O
risk	O
for	O
vitamin	O
D	O
deficiency	O
.	O

Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
females	O
presented	O
a	O
significant	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
,	O
Fasn	O
,	O
Cpt1a	O
,	O
Acox1	O
,	O
Insig1	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
in	O
PAT	O
compared	O
to	O
that	O
of	O
CC	O
ones	O
(	O
Figures5A	O
–	O
C	O
).	O

As	O
a	O
part	O
of	O
the	O
capacity	O
building	O
efforts	O
,	O
the	O
Ministry	O
of	O
Women	O
&	O
Child	O
Development	O
has	O
recommended	O
policy	O
related	O
and	O
institutional	O
transformations	O
.	O

Fasting	O
serum	O
blood	O
samples	O
were	O
collected	O
at	O
the	O
first	O
antenatal	O
visit	O
(	O
early	O
pregnancy	O
)	O
and	O
at	O
the	O
28	O
-	O
week	O
gestation	O
visit	O
(	O
late	O
pregnancy	O
)	O
for	O
the	O
measurement	O
of	O
insulin	O
and	O
25OHD	O
.	O

Yen	O
Bai	O
is	O
a	O
mountainous	O
,	O
predominantly	O
rural	O
province	O
located	O
approximately	O
180	O
km	O
from	O
Hanoi	O
.	O

A	O
report	O
of	O
the	O
Young	O
Finns	O
Study	O
followed	O
offspring	O
in	O
relation	O
to	O
parental	O
BMI	O
from	O
3	O
to	O
18	O
years	O
and	O
later	O
again	O
when	O
children	O
were	O
24	O
–	O
39	O
years	O
old	O
.	O

Maternal	O
mortality	O
ratio	O
(	O
MMR	O
)	O
has	O
dropped	O
by	O
47	O
%	O
worldwide	O
during	O
the	O
past	O
20years	O
.	O

The	O
present	O
knowledge	O
on	O
the	O
impact	O
of	O
the	O
main	O
batokines	O
,	O
as	O
well	O
as	O
of	O
the	O
principal	O
other	O
UCP1	O
modulators	O
on	O
peripheral	O
metabolism	O
is	O
schematized	O
by	O
Figure1	O
.	O

These	O
changes	O
occur	O
according	O
to	O
the	O
needs	O
for	O
the	O
mineralization	O
of	O
the	O
fetus	O
bones	O
as	O
well	O
as	O
adequate	O
secretion	O
of	O
vitamin	O
D	O
in	O
mother	O
’	O
s	O
milk	O
.	O
1	O
Due	B
to	I
rapid	O
fetal	O
development	O
,	O
particularly	O
bone	O
calcification	O
at	O
the	O
terminal	O
stages	O
of	O
pregnancy	O
,	O
there	O
is	O
a	O
possibility	O
of	O
vitamin	O
D	O
deficiency	O
to	O
occur	O
in	O
mothers	O
.	O

Differentiated	O
Thyroid	O
Cancer	O
(	O
DTC	O
)	O
–	O
cancer	O
arising	O
from	O
follicular	O
thyroid	O
cells	O
Mostly	B
diagnosed	O
in	O
young	O
people	O
,	O
DTC	O
usually	O
has	O
a	O
good	O
prognosis	O
with	O
an	O
overall	O
90	O
-	O
95	O
%	O
long	O
-	O
term	O
disease	O
-	O
free	O
survival	O
for	O
early	O
stage	O
or	O
low	O
risk	O
tumours	O
,	O
which	O
represent	B
the	O
vast	O
majority	B
of	O
tumours	O
diagnosed	O
below	O
40	O
-	O
45	O
years	O
of	O
age	O
.	O

Second	O
-	O
generation	O
antipsychotics	O
(	O
SGAs	O
),	O
also	O
known	O
as	O
atypical	O
antipsychotics	O
,	O
are	O
a	O
group	O
of	O
medications	O
primarily	O
used	O
in	O
the	O
treatment	O
of	O
schizophrenia	O
and	O
bipolar	O
disorder	O
.	O

Dryness	O
,	O
rashes	O
,	O
and	O
related	O
skin	O
conditions	O
,	O
to	O
which	O
infants	O
may	O
be	O
particularly	O
susceptible	O
,	O
serve	O
to	O
disrupt	O
the	O
protective	O
barrier	O
of	O
the	O
skin	O
[	O
36	O
,	O
38	O
].	O

Specifically	O
,	O
recommending	O
vitamin	O
D	O
supplementation	O
for	O
children	O
at	O
risk	O
of	O
dental	O
caries	O
may	O
result	O
in	O
a	O
decrease	O
in	O
the	O
overall	O
prevalence	O
of	O
S	O
-	O
ECC	O
and	O
,	O
ultimately	O
,	O
reduce	O
the	O
burden	O
on	O
pediatric	O
day	O
surgery	O
centres	O
.	O

South	O
Africa	O
has	O
large	O
economic	O
disparities	O
and	O
20	O
%	O
of	O
the	O
population	O
are	O
living	O
in	O
extreme	O
poverty	O
,	O
indicating	O
they	O
cannot	O
afford	O
the	O
minimum	O
required	O
food	O
intake	O
[	O
17	O
].	O

Both	O
of	O
these	O
findings	O
,	O
as	O
with	O
the	O
PFAS	O
findings	O
,	O
should	O
be	O
interpreted	B
cautiously	O
because	O
alpha	O
=	O
0	O
.	O
5	O
.	O

The	O
iron	O
status	O
indices	O
,	O
ferritin	O
and	O
transferrin	O
receptor	O
,	O
as	O
well	O
as	O
the	O
vitamin	O
A	O
status	O
indicator	O
retinol	O
binding	O
protein	O
will	O
be	O
determined	O
using	O
the	O
Q	O
-	O
Plex	O
™	O
Human	O
Micronutrient	O
Array	O
(	O
7	O
-	O
plex	O
,	O
Quansys	O
Bioscience	O
,	O
Logan	O
,	O
UT	O
,	O
USA	O
)	O
[	O
69	O
].	O

The	O
size	O
of	O
this	O
study	O
’	O
s	O
cohort	O
provided	O
us	O
with	O
80	O
%	O
power	O
to	O
detect	O
correlations	O
as	O
small	O
as	O
0	O
.	O
24	O
.	O

On	O
the	O
other	O
hand	O
,	O
evidence	O
-	O
based	O
research	O
did	O
not	O
prove	O
a	O
significant	O
difference	O
so	O
far	O
in	O
ovulation	O
stimulation	O
or	O
embryo	O
development	O
depending	O
on	O
vitamin	O
D	O
level	O
.	O

Demographic	O
and	O
clinical	O
data	O
were	O
collected	O
using	O
structured	O
questionnaires	O
.	O

Conclusions	O
Traditional	O
interventions	O
for	O
child	O
and	O
adolescent	O
obesity	O
often	B
focus	B
on	O
the	O
individual	O
child	O
,	O
with	O
or	O
without	O
family	O
involvement	O
,	O
and	O
include	O
education	O
,	O
modification	O
of	O
diet	O
,	O
and	O
increases	O
in	O
physical	O
activity	O
.	O

Based	B
on	I
our	O
interpretation	O
of	O
the	O
data	O
and	O
of	O
the	O
earlier	O
literature	O
,	O
these	O
3	O
factors	O
were	O
labeled	O
as	O
the	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
patterns	O
.	O

Furthermore	O
,	O
studies	O
have	O
shown	O
that	O
vitamin	O
D	O
supports	O
early	O
placental	O
development	O
[	O
44	O
,	O
45	O
]	O
in	O
which	O
,	O
abnormal	O
placentation	O
can	O
be	O
a	O
characteristic	O
of	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
GDM	O
,	O
PE	O
,	O
sPTB	O
and	O
SGA	O
[	O
46	O
].	O

The	O
means	O
for	O
serum	O
25	O
(	O
OH	O
)	O
D	O
by	O
month	O
of	O
sampling	O
were	O
also	O
separated	O
for	O
women	O
recruited	O
in	O
Adelaide	O
and	O
women	O
recruited	O
in	O
Auckland	O
(	O
Fig	O
.	O
1b	O
).	O

There	O
were	O
post	O
-	O
natal	O
lectures	O
on	O
the	O
immediate	O
care	O
of	O
the	O
newborn	O
and	O
breastfeeding	O
.	O

Maternal	O
age	O
was	O
determined	O
at	O
delivery	O
.	O

However	O
,	O
there	O
is	O
also	O
limited	O
evidence	O
for	O
a	O
U	O
-	O
shaped	O
association	O
where	O
high	O
25OHD	O
concentrations	O
(>	O
80	O
nmol	O
/	O
L	O
)	O
may	O
be	O
related	O
to	O
higher	O
risk	O
of	O
SGA	O
[	O
9	O
].	O

None	O
of	O
the	O
GR	O
splice	O
variants	O
were	O
associated	O
with	O
maternal	O
stress	O
.	O

It	O
will	O
also	O
provide	O
valuable	O
evidence	O
about	O
the	O
role	O
of	O
groundwater	O
iron	O
level	O
in	O
modifying	O
the	O
responses	O
of	O
antenatal	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
since	O
there	O
is	O
already	O
some	O
evidence	O
which	O
suggests	O
a	O
positive	O
,	O
dose	O
-	O
response	O
association	O
between	O
natural	O
iron	O
in	O
groundwater	O
and	O
the	O
iron	O
status	O
of	O
women	O
[	O
6	O
].	O

PFAS	O
were	O
expressed	O
in	O
units	O
of	O
μg	O
/	O
L	O
serum	O
.	O

Similarly	O
,	O
a	O
growth	O
stage	O
-	O
specific	O
feeding	O
system	O
has	O
generally	B
been	O
applied	O
to	O
Korean	O
cattle	O
to	O
produce	O
highly	O
marbled	O
beef	O
.	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

Intervention	O
From	O
the	O
formative	O
study	O
,	O
we	O
identified	O
culturally	O
appropriate	O
and	O
feasible	O
ways	O
of	O
implementing	O
the	O
intervention	O
[	O
14	O
].	O

Much	O
of	O
the	O
controversy	O
is	O
concerned	O
with	O
multigenerational	O
versus	O
transgenerational	O
epigenetic	O
toxicity	O
(	O
or	O
epigenetic	O
effect	O
(	O
s	O
)	O
versus	O
epigenetic	O
inheritance	O
)	O
(	O
Figure	O
3	O
).	O

Finally	O
,	O
136	O
participants	O
completed	O
the	O
EPDS	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Furthermore	O
,	O
there	O
is	O
a	O
seasonal	O
dependence	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
although	O
we	O
did	O
not	O
have	O
enough	O
subjects	O
to	O
identify	O
the	O
degree	O
to	O
which	O
this	O
seasonal	O
dependence	O
was	O
affected	O
by	O
ethnicity	O
.	O

No	O
other	O
significant	O
associations	O
between	O
birth	O
outcomes	O
and	O
vaccination	O
by	O
trimester	O
were	O
noted	O
.	O

The	O
human	O
placenta	O
is	O
exposed	O
to	O
increased	O
levels	O
of	O
cortisol	O
as	O
pregnancy	O
progresses	O
[	O
20	O
]	O
and	O
its	O
effects	O
are	O
mediated	O
via	O
binding	O
and	O
activating	O
the	O
GR	O
.	O

However	O
,	O
no	O
differences	O
were	O
found	O
in	O
the	O
incidence	O
of	O
wheeze	O
and	O
eczema	O
or	O
the	O
rate	O
of	O
nasopharyngeal	O
bacterial	O
colonization	O
between	O
the	O
groups	O
with	O
high	O
and	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
of	O
mother	O
—	O
cord	O
serum	O
pairs	O
.	O

It	O
is	O
recommended	O
that	O
future	O
studies	O
be	O
conducted	O
with	O
larger	O
sample	O
sizes	O
and	O
longer	O
follow	O
-	O
up	O
periods	O
.	O

Discussion	O
Current	O
study	O
on	O
812	O
subjects	O
is	O
one	O
of	O
the	O
largest	O
studies	O
evaluating	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
of	O
pregnancy	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

As	O
such	O
,	O
this	O
study	O
should	O
be	O
repeated	O
with	O
a	O
larger	O
sample	O
size	O
to	O
replicate	O
its	O
findings	O
.	O

Regardless	O
,	O
serum	O
calcium	O
in	O
the	O
cord	O
blood	O
and	O
in	O
the	O
first	O
days	O
of	O
life	O
is	O
likely	B
controlled	O
by	O
a	O
variety	O
of	O
factors	O
,	O
of	O
which	O
vitamin	O
D	O
is	O
only	O
one	O
factor	O
.	O

While	O
in	O
children	O
a	O
high	O
consumption	O
of	O
sugar	O
-	O
sweetened	O
beverages	O
[	O
5	O
–	O
7	O
]	O
and	O
fruit	O
juice	O
[	O
7	O
,	O
8	O
]	O
has	O
been	O
linked	O
to	O
asthma	O
,	O
and	O
particularly	O
atopic	O
asthma	O
[	O
7	O
],	O
the	O
relation	O
between	O
total	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
and	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
has	O
not	O
been	O
studied	O
.	O

Pregnancy	O
-	O
associated	O
hormones	O
have	O
direct	O
and	O
indirect	O
effects	O
on	O
nasal	O
blood	O
flow	O
and	O
mucous	O
glands	O
.	O

Studies	O
examining	O
the	O
impact	O
of	O
environmental	O
exposures	O
on	O
DNA	O
methylation	O
have	O
often	O
focused	O
on	O
the	O
global	O
extent	O
of	O
5	O
-	O
methylcytosine	O
,	O
using	O
various	O
approaches	O
(	O
Einstein	O
et	O
al	O
.	O

Data	O
analysis	O
Variable	O
definitions	O
Age	O
was	O
categorized	O
into	O
three	O
groups	O
:	O
<	O
18	O
,	O
18	O
–	O
34	O
and	O
≥	O
35	O
years	O
old	O
.	O

Glucose	O
can	O
also	O
be	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
de	O
novo	O
synthesis	O
in	O
ruminants	O
.	O

Further	O
studies	O
controlling	O
for	O
known	O
predictors	O
of	O
LGA	O
are	O
necessary	O
to	O
confirm	O
the	O
findings	O
,	O
and	O
an	O
exploration	O
of	O
the	O
potential	O
biological	O
mechanisms	O
underpinning	O
this	O
phenomenon	O
is	O
warranted	O
.	O

In	O
preliminary	O
analyses	O
of	O
all	O
infants	O
,	O
delivery	O
mode	O
,	O
feeding	O
method	O
,	O
as	O
previously	O
shown	O
in	O
our	O
cohort	O
[	O
24	O
],	O
and	O
parity	O
were	O
significantly	O
related	O
to	O
infant	O
stool	O
microbial	O
community	O
composition	O
at	O
6	O
weeks	O
of	O
age	O
.	O

The	O
day	O
of	O
birth	O
was	O
defined	O
as	O
postnatal	O
day	O
0	O
(	O
PND	O
0	O
).	O

In	O
the	O
same	O
region	O
,	O
Mullany	O
and	O
colleagues	O
found	O
that	O
reported	O
caregiver	O
handwashing	O
was	O
associated	O
with	O
a	O
24	O
%	O
lower	O
risk	O
of	O
umbilical	O
cord	O
infection	O
[	O
3	O
].	O

Although	O
the	O
mature	O
animals	O
did	O
not	O
show	O
significant	O
proteinuria	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
altered	O
podocin	O
expression	O
in	O
the	O
F1	O
generation	O
from	O
weaning	O
until	O
six	O
months	O
of	O
age	O
,	O
but	O
not	O
in	O
the	O
F2	O
generation	O
.	O

A	O
study	O
in	O
rats	O
exposed	O
to	O
uranium	O
found	O
the	O
offspring	O
had	O
a	O
higher	O
body	O
burden	O
of	O
uranium	O
than	O
the	O
dams	O
.	O

In	O
a	O
study	O
by	O
Mozaffari	O
-	O
Khosravi	O
et	O
al	O
.,	O
high	O
doses	O
of	O
vitamin	O
D	O
have	O
been	O
effective	O
in	O
men	O
and	O
women	O
who	O
were	O
depressed	O
[	O
30	O
].	O

In	O
another	O
study	O
in	O
US	O
,	O
in	O
498	O
pregnant	O
mothers	O
with	O
the	O
mean	O
gestational	O
age	O
of	O
15	O
weeks	O
,	O
generally	B
there	O
was	O
an	O
inverse	O
relationship	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
depression	O
level	O
.	O

We	O
inquired	O
about	O
the	O
consumption	O
of	O
each	O
food	O
item	O
,	O
based	O
on	O
commonly	O
used	O
units	O
or	O
portion	O
sizes	O
,	O
over	O
the	O
preceding	O
12	O
months	O
on	O
a	O
daily	O
,	O
weekly	O
,	O
or	O
monthly	O
basis	O
.	O

However	O
,	O
in	O
developing	O
countries	O
,	O
it	O
is	O
still	O
a	O
common	O
problem	O
in	O
the	O
pediatric	O
population	O
[	O
4	O
,	O
5	O
].	O

The	O
endocannabinoid	O
system	O
(	O
ECS	O
)	O
is	O
also	O
implicated	O
in	O
metabolic	O
and	O
behavioral	O
mechanisms	O
involved	O
in	O
fetal	O
programming	O
such	O
as	O
leptin	O
signaling	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
)	O
or	O
dopaminergic	O
system	O
(	O
Melis	O
et	O
al	O
.,	O
2004	O
).	O

In	O
another	O
study	O
,	O
the	O
cold	O
-	O
induced	O
increase	O
in	O
thermogenesis	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
body	O
weight	O
,	O
mainly	B
affecting	O
the	O
fat	O
mass	O
compartment	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

There	O
has	O
been	O
considerable	O
research	O
interest	O
in	O
the	O
provision	O
of	O
antenatal	O
dietary	O
interventions	O
during	O
pregnancy	O
to	O
limit	O
weight	O
gain	O
and	O
improve	O
pregnancy	O
and	O
birth	O
outcomes	O
for	O
women	O
and	O
their	O
infants	O
.	O

Ayas	O
et	O
al	O
,	O
in	O
their	O
study	O
of	O
70	O
,	O
026	O
US	O
nurses	O
,	O
followed	O
for	O
10	O
years	O
,	O
reported	O
that	O
individuals	O
who	O
slept	O
≤	O
5	O
hours	O
per	O
night	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
symptomatic	O
incident	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
34	O
;	O
95	O
%	O
CI	O
1	O
.	O
04	O
-	O
1	O
.	O
72	O
)	O
[	O
4	O
].	O

Data	O
Collection	O
Procedures	O
Investigators	O
held	O
an	O
introductory	O
meeting	O
and	O
training	O
session	O
on	O
the	O
study	O
protocol	O
with	O
clinical	O
staff	O
at	O
Madigan	O
in	O
November	O
2011	O
.	O

A	O
Review	O
of	O
the	O
Perinatal	O
and	O
Labor	O
Risk	O
Factors	O
and	O
Autism	O
Abstract	O
Autism	O
is	O
a	O
neurodevelopmental	O
disorder	O
marked	O
by	O
severe	O
deficits	O
in	O
social	O
communication	O
and	O
interactions	O
.	O

Clinically	O
-	O
relevant	O
trends	O
were	O
seen	O
in	O
changes	O
in	O
medication	O
requirements	O
;	O
the	O
percentage	O
of	O
women	O
requiring	O
pharmacologic	O
treatment	O
decreased	O
from	O
31	O
.	O
1	O
%	O
to	O
26	O
.	O
9	O
%.	O

In	O
the	O
term	O
group	O
,	O
the	O
only	O
significant	O
correlation	O
was	O
between	O
GAS5	O
and	O
maternal	O
stress	O
(	O
r	O
=	O
−	O
0	O
.	O
711	O
,	O
P	O
=	O
0	O
.	O
021	O
).	O

Furthermore	O
,	O
evaluating	O
the	O
social	O
characteristics	O
of	O
the	O
assessed	O
cohort	O
would	O
enable	O
us	O
to	O
identify	O
potential	O
confounding	O
variables	O
that	O
may	O
affect	O
pregnancy	O
outcomes	O
,	O
such	O
as	O
socioeconomic	O
status	O
and	O
lifestyle	O
differences	O
.	O

Classification	O
and	O
Mechanism	O
Hypersensitivity	O
against	O
allergens	O
can	O
be	O
mediated	O
by	O
either	O
antibodies	O
or	O
T	O
lymphocytes	O
.	O

Pyrosequencing	O
of	O
these	O
repeat	O
elements	O
was	O
successful	O
in	O
380	O
samples	O
;	O
we	O
noted	O
no	O
significant	O
differences	O
in	O
the	O
demographics	O
or	O
clinical	O
characteristics	O
of	O
these	O
samples	O
compared	O
with	O
the	O
larger	O
population	O
.	O

However	O
,	O
cortisol	O
treatments	O
did	O
not	O
exert	O
any	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
GR	O
α	O
(	O
Figure	O
4	O
(	O
b	O
)),	O
GR	O
β	O
(	O
Figure	O
4	O
(	O
c	O
)),	O
GR	O
γ	O
(	O
Figure	O
4	O
(	O
d	O
)),	O
and	O
GR	O
-	O
P	O
in	O
either	O
of	O
the	O
cell	O
lines	O
(	O
Figure	O
4	O
(	O
e	O
)).	O

We	O
did	O
not	O
have	O
measures	O
of	O
total	O
texts	O
or	O
potentially	O
competing	O
messages	O
received	O
by	O
participants	O
in	O
this	O
study	O
,	O
and	O
those	O
are	O
important	O
topics	O
for	O
future	O
research	O
.	O

We	O
recorded	O
GWG	O
at	O
first	O
measurement	O
,	O
at	O
approximately	O
the	O
12th	O
,	O
20th	O
and	O
30th	O
gestational	O
weeks	O
,	O
and	O
at	O
last	O
measurement	O
.	O

Assessment	O
of	O
GDM	O
The	O
diagnosis	O
of	O
GDM	O
was	O
based	O
on	O
a	O
two	O
-	O
hour	O
75	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
).	O

Intravenous	O
magnesium	O
sulfate	O
may	O
be	O
beneficial	O
in	O
acute	O
severe	O
asthma	O
as	O
an	O
adjunct	O
to	O
inhaled	O
β2agonists	O
and	O
corticosteroids	O
.	O

Study	O
has	O
shown	O
that	O
exposing	O
edible	O
mushroom	O
to	O
ultraviolet	O
B	O
light	O
could	O
increase	O
its	O
Vitamin	O
D2	O
content	O
and	O
raise	O
serum	O
25	O
-	O
OH	O
VitD2	O
in	O
healthy	O
adults	O
[	O
2	O
,	O
3	O
].	O

A	O
comprehensive	O
systematic	O
review	O
by	O
Thangaratinam	O
and	O
colleagues	O
[	O
14	O
]	O
has	O
identified	O
numerous	O
studies	O
assessing	O
dietary	O
and	O
lifestyle	O
interventions	O
in	O
pregnancy	O
,	O
albeit	O
mostly	O
small	O
in	O
scope	O
.	O

The	O
most	O
common	O
allergens	O
worldwide	O
include	O
pollen	O
,	O
dust	O
mites	O
,	O
molds	O
,	O
animal	O
dander	O
,	O
cockroach	O
,	O
insect	O
venom	O
,	O
and	O
certain	O
foods	O
.	O

Subjects	O
who	O
could	O
not	O
be	O
traced	O
by	O
the	O
field	O
teams	O
or	O
who	O
did	O
not	O
attend	O
after	O
direct	O
invitation	O
were	O
not	O
recruited	O
(	O
n	O
=	O
128	O
).	O

Both	O
the	O
maternal	O
and	O
paternal	O
grandparental	O
couples	O
had	O
significant	O
BMI	O
associations	O
(	O
p	O
=	O
0	O
.	O
033	O
and	O
p	O
=	O
0	O
.	O
013	O
,	O
respectively	O
).	O

Furthermore	O
,	O
women	O
with	O
highest	O
quartile	O
of	O
traditional	O
dietary	O
pattern	O
had	O
significantly	O
higher	O
social	O
-	O
economic	O
level	O
,	O
education	O
,	O
and	O
husband	O
'	O
s	O
education	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
.	O

GWG	O
was	O
adjusted	O
for	O
consecutive	O
gestational	O
week	O
.	O

[	O
44	O
]	O
and	O
Lenters	O
et	O
al	O
.	O

Missing	O
values	O
of	O
other	O
variables	O
were	O
not	O
imputed	O
.	O

The	O
pathophysiology	O
is	O
not	O
well	O
understood	O
but	O
has	O
been	O
hypothesized	O
to	O
result	O
from	O
excessive	O
stimulation	O
of	O
V1	O
receptors	O
by	O
vasopressinase	O
-	O
altered	O
AVP	O
leading	O
to	O
platelet	O
aggregation	O
,	O
vasospasm	O
,	O
endothelial	O
constriction	O
,	O
and	O
brain	O
stimulation	O
as	O
discussed	O
by	O
Krege	O
and	O
Katz	O
[	O
6	O
].	O

Setting	O
Motherisk	O
Program	O
,	O
The	O
Hospital	O
for	O
Sick	O
Children	O
,	O
Toronto	O
,	O
Canada	O
.	O

However	O
,	O
controversy	O
surrounds	O
the	O
exact	O
mechanisms	O
by	O
which	O
these	O
responses	O
are	O
regulated	O
.	O

Our	O
recruitment	O
data	O
to	O
date	O
indicate	O
that	O
of	O
those	O
invited	O
to	O
take	O
part	O
in	O
the	O
study	O
;	O
only	O
approximately	O
50	O
%	O
arrive	O
at	O
the	O
data	O
collection	O
site	O
on	O
the	O
booked	O
date	O
.	O

Food	O
intake	O
over	O
72	O
hours	O
was	O
measured	O
every	O
2	O
weeks	O
from	O
0	O
–	O
29	O
weeks	O
post	O
-	O
weaning	O
.	O

All	O
births	O
were	O
notified	O
either	O
by	O
the	O
respondent	O
/	O
family	O
or	O
upon	O
telephone	O
call	O
by	O
study	O
staff	O
following	O
the	O
estimated	O
date	O
of	O
delivery	O
.	O

Such	O
a	O
change	O
results	O
in	O
the	O
inhibition	O
of	O
PTH	O
secretion	O
from	O
parathyroid	O
cells	O
.	O
27	O
The	O
increase	O
of	O
serum	O
calcium	O
in	O
the	O
IG	O
in	O
the	O
present	O
study	O
is	O
similar	O
to	O
that	O
reported	O
in	O
the	O
other	O
studies	O
.	O
15	O
,	O
17	O
-	O
20	O
,	O
22	O
-	O
25	O
,	O
27	O
,	O
28The	O
mechanism	O
of	O
increasing	O
serum	O
calcium	O
by	O
vitamin	O
D	O
is	O
that	O
vitamin	O
D	O
attaches	O
optionally	O
to	O
receptors	O
X	O
of	O
retinoic	O
acid	O
(	O
RXR	O
),	O
and	O
composes	O
a	O
heteromeric	O
complex	O
with	O
a	O
certain	O
sequence	O
on	O
the	O
DNA	O
,	O
known	O
as	O
reacting	O
elements	O
to	O
vitamin	O
D	O
.	O
This	O
leads	O
to	O
the	O
transcription	O
of	O
a	O
special	O
mRNA	O
,	O
which	O
results	O
in	O
the	O
translation	O
of	O
several	O
proteins	O
such	O
as	O
epithelial	O
calcium	O
channels	O
and	O
the	O
proteins	O
attached	O
to	O
calcium	O
.	O

Role	O
of	O
vitamin	O
D	O
in	O
pregnant	O
women	O
Adequate	O
vitamin	O
D	O
intake	O
is	O
essential	O
for	O
maternal	O
and	O
fetal	O
health	O
during	O
pregnancy	O
,	O
and	O
prevention	O
of	O
adverse	O
outcomes	O
.	O

Though	O
,	O
the	O
interpretation	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
may	O
be	O
complicated	O
by	O
the	O
presence	O
of	O
C3	O
-	O
epimer	O
of	O
25	O
(	O
OH	O
)	O
D	O
[	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
],	O
a	O
vitamin	O
metabolite	O
that	O
may	O
be	O
erroneously	O
included	O
as	O
25	O
(	O
OH	O
)	O
D	O
by	O
LC	O
-	O
MS	O
and	O
immunoassay	O
methods	O
[	O
43	O
].	O

Additionally	O
,	O
it	O
has	O
been	O
revealed	O
that	O
some	O
ECS	O
components	O
are	O
sensible	O
to	O
dietary	O
conditions	O
.	O

In	O
Belgium	O
,	O
pregnant	O
women	O
who	O
reported	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
had	O
a	O
lower	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
women	O
who	O
reported	O
using	O
sunscreen	O
lotion	O
had	O
a	O
lower	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
.	O

Finally	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
and	O
ncRNAs	O
are	O
not	O
separate	O
processes	O
;	O
they	O
are	O
closely	O
linked	O
throughout	O
mammalian	O
development	O
.	O

In	O
general	O
,	O
histone	O
acetylation	O
and	O
demethylation	O
are	O
associated	O
with	O
active	O
chromatin	O
(	O
euchromatin	O
),	O
while	O
histone	O
deacteylation	O
and	O
methylation	O
are	O
associated	O
with	O
repressive	O
chromatin	O
(	O
heterochromatin	O
).	O

One	O
such	O
study	O
,	O
led	O
by	O
Maria	O
Limson	O
-	O
Zamora	O
,	O
head	O
of	O
Health	O
Canada	O
’	O
s	O
Bioassay	O
Section	O
,	O
compared	O
biomarkers	O
of	O
kidney	O
function	O
in	O
the	O
urine	O
of	O
Canadians	O
chronically	O
exposed	O
to	O
high	O
(	O
2	O
–	O
780	O
µg	O
/	O
L	O
)	O
or	O
low	O
(	O
0	O
.	O
02	O
µg	O
/	O
L	O
)	O
levels	O
of	O
uranium	O
in	O
their	O
drinking	O
water	O
.	O

Setting	O
Community	O
-	O
based	O
study	O
with	O
linkage	O
to	O
health	O
records	O
in	O
the	O
Republic	O
of	O
Ireland	O
.	O

We	O
also	O
report	O
the	O
proportion	O
of	O
mothers	O
who	O
maintained	O
soap	O
and	O
water	O
at	O
at	O
least	O
one	O
handwashing	O
station	O
in	O
the	O
home	O
and	O
at	O
a	O
handwashing	O
station	O
in	O
the	O
room	O
where	O
the	O
neonate	O
was	O
cared	O
for	O
and	O
compare	O
the	O
intervention	O
and	O
control	O
groups	O
at	O
each	O
time	O
point	O
that	O
this	O
outcome	O
was	O
observed	O
.	O

Thereafter	O
,	O
the	O
tissue	O
sections	O
were	O
rehydrated	O
by	O
placing	O
the	O
slides	O
in	O
ethanol	O
solution	O
of	O
different	O
concentrations	O
(	O
100	O
%,	O
90	O
%,	O
80	O
%,	O
70	O
%,	O
50	O
%,	O
and	O
30	O
%)	O
for	O
3	O
minutes	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
providers	O
are	O
as	O
comfortable	O
discussing	O
weight	O
gain	O
restrictions	O
with	O
overweight	O
and	O
obese	O
women	O
as	O
they	O
are	O
with	O
normal	O
weight	O
women	O
,	O
but	O
that	O
overweight	O
and	O
obese	O
women	O
still	O
have	O
weight	O
gain	O
targets	O
in	O
excess	O
of	O
clinical	O
guidelines	O
.	O

There	O
was	O
a	O
similar	O
lower	O
risk	O
(	O
59	O
%)	O
after	O
adjusting	O
for	O
SES	O
variables	O
(	O
insurance	O
status	O
and	O
education	O
)	O
(	O
OR	O
=	O
0	O
.	O
41	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
24	O
–	O
0	O
.	O
72	O
,	O
p	O
=	O
0	O
.	O
002	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
risk	O
of	O
preterm	O
birth	O
(	O
N	O
=	O
1064	O
).	O
Preterm	O
Birth	O
(<	O
37	O
Weeks	O
)	O
Term	O
Birth	O
(≥	O
37	O
Weeks	O
)	O
p	O
-	O
value	O
(	O
test	O
for	O
trend	O
)	O
ORSES	O
Adjusted	O
†	O
OR	O
(	O
95	O
%	O
CI	O
)(	O
95	O
%	O
CI	O
)<	O
20	O
ng	O
/	O
mL49	O
(	O
20	O
%)	O
199	O
(	O
80	O
%)	O
0	O
.	O
0003	O
1	O
.	O
01	O
.	O
0N	O
(%)	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL33	O
(	O
12	O
%)	O
234	O
(	O
88	O
%)	O
0	O
.	O
57	O
0	O
.	O
63	O
(	O
0	O
.	O
37	O
,	O
1	O
.	O
04	O
)	O
N	O
(%)	O
(	O
0	O
.	O
35	O
,	O
0	O
.	O
93	O
)	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL32	O
(	O
13	O
%)	O
223	O
(	O
87	O
%)	O
0	O
.	O
580	O
.	O
53	O
(	O
0	O
.	O
31	O
,	O
0	O
.	O
91	O
)	O
N	O
(%)	O
(	O
0	O
.	O
36	O
,	O
0	O
.	O
95	O
)	O
≥	O
40	O
ng	O
/	O
mL25	O
(	O
9	O
%)	O
269	O
(	O
91	O
%)	O
0	O
.	O
380	O
.	O
41	O
(	O
0	O
.	O
24	O
,	O
0	O
.	O
72	O
)	O
N	O
(%)	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
63	O
)	O
Bold	O
values	O
signify	O
significance	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Infant	O
dietary	O
intake	O
and	O
feeding	O
practices	O
Data	O
on	O
infant	O
feeding	O
practices	O
are	O
collected	O
at	O
each	O
postnatal	O
phase	O
(	O
5	O
to	O
8	O
).	O

Leukotriene	O
modifiers	O
may	O
be	O
used	O
as	O
alternative	O
add	O
-	O
on	O
treatment	O
;	O
montelukast	O
and	O
zafirlukast	O
are	O
the	O
preferred	B
antileukotriene	O
drugs	O
(	O
but	O
zileuton	O
is	O
not	O
).	O

The	O
contaminated	O
water	O
looked	O
and	O
tasted	O
perfectly	O
clean	O
.	O

Of	O
the	O
available	O
medications	O
for	O
allergic	O
rhinitis	O
(	O
AR	O
),	O
chlorpheniramine	O
is	O
recommended	O
as	O
the	O
first	O
-	O
generation	O
antihistamine	O
of	O
choice	O
for	O
use	O
during	O
pregnancy	O
[	O
11	O
].	O

These	O
confounders	O
included	O
women	O
'	O
s	O
age	O
and	O
BMI	O
and	O
were	O
not	B
explained	I
by	O
gestational	O
age	O
.	O

Furthermore	O
,	O
adult	O
fracture	O
-	O
outcome	O
supplementation	O
studies21show	O
no	O
benefit	O
from	O
adding	O
calcium	O
.	O

Artificial	O
Insemination	O
and	O
Fertility	O
Medications	O
There	O
is	O
an	O
increase	O
in	O
prevalence	O
in	O
the	O
number	O
of	O
women	O
utilizing	O
fertility	O
measures	O
,	O
thus	B
calling	O
for	O
studies	O
to	O
determine	O
the	O
association	O
between	O
assisted	O
reproductive	O
therapy	O
and	O
neurodevelopmental	O
complications	O
,	O
and	O
more	O
specifically	O
autism	O
.	O

BAT	O
,	O
the	O
principal	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
i	O
.	O
e	O
.,	O
heat	O
production	O
that	O
does	O
not	O
involve	O
skeletal	O
muscle	O
contraction	O
),	O
is	O
present	O
in	O
most	O
mammals	O
and	O
its	O
maturation	O
in	O
the	O
perinatal	O
period	O
varies	O
between	O
species	O
,	O
according	O
to	O
their	O
developmental	O
status	O
at	O
birth	O
(	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
distributions	O
of	O
the	O
demographic	O
characteristics	O
of	O
this	O
subsample	O
and	O
the	O
larger	O
population	O
examined	O
for	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
extent	O
(	O
data	O
not	O
shown	O
).	O

All	O
data	O
were	O
tested	O
for	O
normality	O
prior	O
to	O
analyses	O
.	O

No	O
differences	O
in	O
adiposity	O
were	O
observed	O
between	O
CC	O
and	O
RC	O
females	O
(	O
Table2	O
).	O

However	O
,	O
fat	O
weights	O
in	O
the	O
subcutaneous	O
,	O
mesenteric	O
,	O
and	O
intermuscular	O
regions	O
were	O
not	O
different	O
between	O
the	O
groups	O
.	O

A	O
similar	O
explanation	B
is	O
plausible	O
in	O
this	O
study	O
for	O
BMI	O
.	O

While	O
the	O
rodent	O
and	O
human	O
life	O
cycles	O
share	O
many	O
commonalities	O
they	O
do	O
exhibit	O
subtle	O
differences	O
,	O
both	O
with	O
each	O
other	O
and	O
other	O
mammalian	O
species	O
(	O
Kristensen	O
et	O
al	O
.	O
2013	O
;	O
Laird2013	O
;	O
Leitch	O
et	O
al	O
.	O
2013	O
;	O
Surani2015	O
).	O

Several	O
hypothetical	O
arguments	O
have	O
been	O
offered	O
in	O
explanation	O
of	O
a	O
season	O
of	O
birth	O
effect	O
for	O
adult	O
gliomas	O
,	O
if	O
such	O
an	O
association	O
exists	O
.	O

However	O
,	O
if	O
an	O
epigenetic	O
change	O
becomes	O
permanently	O
established	O
in	O
the	O
germ	O
line	O
,	O
it	O
will	O
be	O
transmitted	O
across	O
future	O
generations	O
,	O
even	O
in	O
the	O
absence	O
of	O
the	O
original	O
stimulus	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
CC	O
females	O
;$$	O
P	O
<	O
0	O
.	O
01	O
vs	O
.	O
RC	O
males	O
.	O

Self	O
-	O
reported	O
psychotic	O
experiences	O
in	O
the	O
general	O
population	O
may	O
represent	O
the	O
developmental	O
expression	O
of	O
population	O
genetic	O
risk	O
for	O
psychosis	O
[	O
9	O
].	O

Competing	O
interets	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
conflict	O
of	O
interest	O
Authors	O
'	O
contribution	O
The	O
chapter	O
was	O
coordinated	O
by	O
JEL	O
with	O
MVK	O
;	O
drafted	O
by	O
JEL	O
,	O
MVK	O
,	O
CPH	O
,	O
EL	O
and	O
all	O
other	O
authors	O
reviewed	O
and	O
contributed	O
.	O

Although	O
the	O
95	O
%	O
CI	O
for	O
μβfor	O
PFAS	O
did	O
cover	O
zero	O
,	O
the	O
estimate	O
was	O
significantly	O
lower	O
than	O
zero	O
based	O
on	O
the	O
upper	O
limit	O
of	O
the	O
50	O
%	O
CI	O
(-	O
21	O
,	O
-	O
2	O
).	O

PubMed	O
Central	O
:	O

χ2test	O
or	O
Fisher	O
’	O
s	O
Exact	O
test	O
after	O
adjusting	O
for	O
cluster	O
effect	O
will	O
be	O
used	O
when	O
appropriate	O
.	O

Since	O
these	O
requirements	O
are	O
difficult	O
to	O
meet	O
through	O
an	O
ordinary	O
diet	O
,	O
especially	O
in	O
developing	O
countries	O
where	O
most	O
diets	O
do	O
not	O
contain	O
adequate	O
bioavailable	O
iron	O
,	O
routine	O
iron	O
supplementation	O
in	O
pregnancy	O
has	O
been	O
found	O
to	O
be	O
of	O
immense	O
benefit	O
[	O
14	O
,	O
19	O
–	O
21	O
].	O

Another	O
significant	O
factor	O
for	O
sample	O
loss	O
was	O
that	O
a	O
number	O
of	O
the	O
women	O
did	O
not	O
return	O
to	O
the	O
specified	O
hospital	O
for	O
childbirth	O
.	O

The	O
mean	O
gestational	O
age	O
of	O
enrolled	O
infants	O
was	O
38	O
.	O
5	O
±	O
1	O
.	O
3	O
weeks	O
,	O
and	O
63	O
.	O
4	O
%	O
of	O
the	O
infants	O
were	O
delivered	O
naturally	O
.	O

Any	O
drug	O
may	O
carry	O
a	O
small	O
risk	O
that	O
must	O
be	O
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

In	O
order	O
to	O
investigate	O
potential	O
unmeasured	O
confounding	O
by	O
genetic	O
or	O
shared	O
environmental	O
or	O
lifestyle	O
factors	O
,	O
we	O
used	O
a	O
parental	O
comparison	O
approach	O
,	O
whereby	O
effect	O
estimates	O
for	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
were	O
compared	O
with	O
effect	O
estimates	O
for	O
maternal	O
and	O
paternal	O
sugar	O
intake	O
after	O
pregnancy	O
.	O

Thus	B
,	O
levels	O
of	O
neonates	O
at	O
birth	O
depend	O
entirely	O
on	O
that	O
of	O
the	O
mother	O
and	O
,	O
accordingly	O
,	O
several	O
studies	O
have	O
consistently	B
correlated	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
to	O
those	O
of	O
their	O
mothers	O
.	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6In	O
addition	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
has	O
been	O
linked	O
to	O
decreased	O
fetal	O
growth	O
and	O
birth	O
size	O
in	O
observational	O
studies	O
.	O
7	O
,	O
8	O
,	O
9	O
Maternal	O
vitamin	O
D	O
deficiency	O
is	O
prevalent	O
,	O
the	O
extent	O
of	O
which	O
can	O
be	O
influenced	O
by	O
many	O
variables	O
including	O
skin	O
pigmentation	O
,	O
sun	O
exposure	O
,	O
season	O
,	O
age	O
,	O
vitamin	O
supplementation	O
and	O
obesity	O
.	O

In	O
a	O
group	O
of	O
1245	O
adult	O
patients	O
with	O
documented	O
asthma	O
,	O
24	O
%	O
had	O
seasonal	O
AR	O
only	O
,	O
6	O
%	O
had	O
perennial	O
AR	O
only	O
,	O
and	O
22	O
%	O
were	O
considered	O
to	O
have	O
both	O
[	O
26	O
].	O

In	O
addition	O
,	O
it	O
is	O
found	O
very	O
useful	O
in	O
developing	O
countries	O
where	O
the	O
rate	O
of	O
compliance	O
with	O
preventive	O
treatment	O
of	O
iron	O
is	O
poor	O
[	O
4	O
].	O

While	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
greater	O
reduction	O
in	O
depression	O
scores	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

However	O
,	O
one	O
large	O
retrospective	O
cohort	O
study	O
of	O
116	O
,	O
303	O
pregnancies	O
,	O
merits	O
discussion	O
.	O

The	O
outcomes	O
assessed	O
were	O
25	O
(	O
OH	O
)	O
D	O
at	O
14	O
weeks	O
of	O
gestation	O
in	O
all	O
study	O
participants	O
and	O
the	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
in	O
the	O
participants	O
randomized	O
to	O
cholecalciferol	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
difference	O
between	O
the	O
two	O
groups	O
was	O
meaningful	B
concerning	O
over	O
-	O
time	O
reduction	O
of	O
depression	O
.	O

Results	O
Sample	O
Demographics	O
The	O
mean	O
age	O
of	O
respondents	O
(	O
N	O
=	O
123	O
)	O
was	O
26	O
.	O
3	O
years	O
(	O
SD	O
5	O
.	O
9	O
).	O

Maternal	O
obesity	O
significantly	O
predicts	O
child	O
and	O
adult	O
obesity	O
in	O
her	O
offspring	O
[	O
4	O
,	O
5	O
],	O
and	O
associated	O
cardio	O
-	O
metabolic	O
risk	O
factors	O
,	O
including	O
hypertension	O
,	O
hyperlipidaemia	O
,	O
diabetes	O
,	O
and	O
cardiovascular	O
disease	O
[	O
6	O
–	O
8	O
].	O

Results	O
Identification	O
of	O
the	O
Skm	O
mutants	O
During	O
our	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
,	O
we	O
identified	O
two	O
mutations	O
that	O
contribute	O
to	O
skeletal	O
malformations	O
in	O
mice	O
.	O

When	O
the	O
item	O
was	O
unique	O
in	O
the	O
nutrient	O
profile	O
,	O
it	O
was	O
not	O
combined	O
(	O
e	O
.	O
g	O
.,	O
salt	O
).	O

At	O
baseline	O
,	O
no	O
correlation	O
was	O
observed	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
depression	O
score	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

Vitamin	O
D	O
is	O
also	O
a	O
potential	O
immunosuppressant	O
,	O
which	O
down	O
-	O
regulates	O
the	O
expression	O
of	O
pro	O
-	O
inflammation	O
markers	O
,	O
such	O
as	O
TNF	O
-	O
α	O
and	O
IL	O
-	O
2	O
,	O
among	O
pregnant	O
women	O
with	O
GDM	O
[	O
8	O
].	O

The	O
RNA	O
samples	O
were	O
visualised	O
on	O
1	O
%	O
agarose	O
gels	O
containing	O
ethidium	O
bromide	O
to	O
check	O
RNA	O
integrity	O
.	O

Both	O
hypotheses	O
would	O
suggest	O
a	O
higher	O
thyroid	O
neoplasm	O
proliferation	O
in	O
stimulated	O
thyroid	O
tissue	O
during	O
pregnancy	O
or	O
adolescence	O
,	O
though	O
even	O
in	O
growing	O
tissues	O
these	O
cancers	O
show	O
a	O
very	O
good	O
prognosis	O
.	O

Vitamin	O
D	O
stimulates	O
anti	O
-	O
Müllerian	O
hormone	O
(	O
AMH	O
)	O
production	O
as	O
well	O
,	O
which	O
is	O
highly	O
correlated	O
with	O
ovarian	O
reserve	O
preservation	O
.	O

The	O
US	O
military	O
has	O
made	O
major	O
investments	O
in	O
mHealth	O
programs	O
to	O
promote	O
health	O
and	O
improve	O
treatment	O
among	O
enlisted	O
personnel	O
and	O
their	O
families	O
[	O
32	O
].	O

In	O
our	O
case	O
,	O
the	O
infant	O
was	O
hypernatremic	O
with	O
high	O
serum	O
osmolality	O
and	O
a	O
relatively	O
low	O
ADH	O
level	O
(<	O
0	O
.	O
5	O
pg	O
/	O
mL	O
).	O

Detailed	O
information	O
about	O
food	O
preparation	O
and	O
brands	O
is	O
also	O
lacking	O
in	O
this	O
instrument	O
.	O

An	O
effective	O
continuum	O
of	O
care	O
addresses	O
the	O
health	O
needs	O
of	O
the	O
adolescent	O
,	O
woman	O
,	O
mother	O
,	O
newborn	O
and	O
child	O
throughout	O
the	O
life	O
cycle	O
,	O
wherever	O
care	O
is	O
provided	O
,	O
whether	O
it	O
be	O
at	O
the	O
home	O
,	O
primary	O
care	O
level	O
or	O
district	O
and	O
regional	O
hospitals	O
.	O

Women	O
were	O
not	O
enrolled	O
in	O
any	O
other	O
study	O
;	O
in	O
some	O
of	O
the	O
villages	O
,	O
a	O
study	O
on	O
antenatal	O
nutrition	O
that	O
enrolled	O
women	O
early	O
in	O
pregnancy	O
was	O
being	O
implemented	O
concurrently	O
.	O
Eligible	O
women	O
were	O
requested	O
to	O
provide	O
signed	O
informed	O
consent	O
.	O

Also	O
,	O
excessive	O
GWG	O
was	O
classified	O
based	O
on	O
the	O
1990	O
IOM	O
GWG	O
guidelines	O
;	O
our	O
data	O
were	O
collected	O
before	O
the	O
newly	O
revised	O
2009	O
IOM	O
GWG	O
guidelines	O
were	O
released	O
.	O

Again	O
,	O
the	O
resources	O
and	O
intensive	O
psychology	O
training	O
required	O
to	O
administer	O
,	O
for	O
example	O
,	O
the	O
more	O
complex	O
Bayley	O
Scale	O
,	O
while	O
generating	O
more	O
detailed	O
information	O
,	O
was	O
not	O
considered	O
feasible	O
in	O
our	O
study	O
population	O
.	O

All	O
Western	O
blotting	O
data	O
were	O
corrected	O
and	O
normalized	O
to	O
beta	O
actin	O
.	O

Measurement	O
data	O
were	O
presented	O
as	O
mean	O
±	O
for	O
standard	O
deviation	O
.	O

Avoidance	O
of	O
food	O
because	O
of	O
severe	O
dental	O
problems	O
may	O
,	O
in	O
turn	O
,	O
contribute	O
to	O
the	O
nutritional	O
deficiencies	O
identified	O
in	O
this	O
sample	O
[	O
12	O
].	O

High	O
birth	O
weight	O
is	O
an	O
important	O
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	O
been	O
linked	O
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

An	O
association	O
between	O
thyroid	O
cancer	O
and	O
parity	O
or	O
full	O
-	O
term	O
pregnancy	O
has	O
been	O
assessed	O
in	O
many	O
studies	O
without	O
significant	O
or	O
conclusive	O
results6	O
.	O

This	O
may	O
be	O
because	B
reported	O
data	O
were	O
exaggerated	O
by	O
the	O
partner	O
or	O
because	B
,	O
for	O
some	O
reason	O
,	O
reported	O
is	O
a	O
healthier	O
group	O
than	O
measured	O
height	O
.	O

In	O
a	O
number	O
of	O
studies	O
,	O
season	O
of	O
birth	O
has	O
been	O
associated	O
with	O
the	O
development	O
of	O
allergic	O
conditions	O
later	O
in	O
life	O
,	O
such	O
as	O
asthma	O
[	O
61	O
–	O
65	O
],	O
atopic	O
dermatitis	O
[	O
66	O
],	O
house	O
dust	O
mite	O
allergy	O
[	O
60	O
,	O
61	O
,	O
65	O
,	O
67	O
–	O
69	O
],	O
cockroach	O
allergy	O
[	O
70	O
,	O
71	O
],	O
grass	O
/	O
birch	O
/	O
hay	O
and	O
other	O
pollen	O
allergy	O
[	O
51	O
,	O
60	O
,	O
63	O
,	O
67	O
,	O
68	O
,	O
72	O
–	O
76	O
],	O
animal	O
dander	O
allergy	O
[	O
51	O
,	O
67	O
],	O
mold	O
allergy	O
[	O
74	O
],	O
food	O
allergy	O
[	O
51	O
,	O
55	O
,	O
67	O
],	O
allergic	O
rhinitis	O
[	O
62	O
,	O
77	O
],	O
and	O
otherwise	O
unspecified	O
atopy	O
(	O
NOS	O
)	O
[	O
55	O
,	O
78	O
].	O

In	O
this	O
case	O
also	O
,	O
the	O
mutation	O
occurred	O
at	O
a	O
residue	O
highly	O
conserved	O
across	O
species	O
(	O
Figure	O
3B	O
,	O
bottom	O
panel	O
)	O
and	O
mouse	O
strains	O
(	O
data	O
not	O
shown	O
).	O

Studies	O
found	O
that	O
about	O
70	O
%	O
of	O
pregnant	O
women	O
are	O
affected	O
by	O
these	O
symptoms	O
during	O
their	O
last	O
trimenon	O
,[	O
85	O
]	O
and	O
50	O
%	O
of	O
them	O
are	O
likely	B
to	O
take	O
acid	O
-	O
suppressing	O
medication	O
.	O

However	O
,	O
the	O
relationship	O
between	O
vitamin	O
D	O
levels	O
and	O
respiratory	O
function	O
during	O
infancy	O
has	O
not	O
yet	O
been	O
clarified	O
.	O

However	O
,	O
as	O
misclassification	O
of	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
is	O
likely	B
to	O
have	O
been	O
random	O
with	O
respect	O
to	O
childhood	O
outcomes	O
,	O
the	O
strength	O
of	O
associations	O
may	O
have	O
been	O
underestimated	O
.	O

We	O
also	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
3	O
.	O
64	O
;	O
P	O
<	O
0	O
.	O
05	O
],	O
and	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
2	O
.	O
954	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

Circadian	O
rhythms	O
follow	O
the	O
daily	O
,	O
24	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
[	O
14	O
],	O
while	O
seasonal	O
fluctuations	O
influence	O
circannual	O
rhythms	O
[	O
15	O
].	O

The	O
classification	O
of	O
women	O
into	O
three	O
groups	O
with	O
different	O
levels	O
of	O
symptoms	O
(	O
low	O
,	O
middle	O
and	O
high	O
)	O
was	O
based	O
on	O
predefined	O
,	O
but	O
arbitrary	O
cut	O
-	O
offs	O
from	O
the	O
self	O
-	O
reported	O
answers	O
to	O
the	O
CAPE	O
questionnaire	O
.	O

Curvilinear	O
relations	O
were	O
observed	O
across	O
nocturnal	O
sleep	O
duration	O
categories	O
.	O

In	O
vivo	O
and	O
in	O
vitro	O
models	O
have	O
shown	O
that	O
such	O
transfer	O
may	O
lead	O
to	O
reduced	O
neonatal	O
immunity	O
.	O

of	O
filtered	O
probe	O
-	O
setsNo	O
.	O

Other	O
studies	O
found	O
a	O
significant	O
correlation	O
between	O
low	O
birth	O
weight	O
and	O
increased	O
sympathetic	O
activity	O
in	O
adolescent	O
twin	O
pairs	O
and	O
young	O
adults	O
;	O
however	O
,	O
this	O
result	O
did	O
not	O
observed	O
gender	O
differences	O
[	O
37	O
,	O
38	O
].	O

However	O
,	O
in	O
secondary	O
analyses	O
stratifying	O
influenza	O
vaccination	O
by	O
trimester	O
we	O
observed	O
a	O
protective	O
effect	O
of	O
vaccination	O
on	O
PTB	O
in	O
the	O
second	O
and	O
third	O
trimester	O
and	O
on	O
LBW	O
in	O
the	O
second	O
trimester	O
.	O

Throughout	O
the	O
manuscript	O
,	O
we	O
have	O
provided	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
as	O
ng	O
/	O
mL	O
,	O
these	O
may	O
be	O
multiplied	O
by	O
2	O
.	O
5	O
to	O
obtain	O
results	O
in	O
nmol	O
/	O
L	O
.	O

We	O
used	O
targeted	O
sequencing	O
of	O
the	O
16S	O
rRNA	O
V4	O
-	O
V5	O
hypervariable	O
region	O
to	O
characterize	O
infant	O
gut	O
microbiota	O
.	O

Other	O
studies	O
from	O
low	O
-	O
income	O
countries	O
have	O
reported	O
that	O
preterm	O
delivery	O
is	O
one	O
of	O
the	O
main	O
contributors	O
to	O
neonatal	O
deaths	O
[	O
12	O
,	O
13	O
].	O

Mechanisms	O
regulating	O
pubertal	O
onset	O
are	O
no	O
doubt	O
multifactorial	O
.	O

In	O
our	O
study	O
,	O
no	O
hypocalcaemia	O
was	O
observed	O
indicating	O
the	O
safety	O
and	O
efficiency	O
of	O
this	O
supplementation	O
method	O
.	O

It	O
is	O
when	O
these	O
environmentally	O
induced	O
perturbations	O
exceed	O
the	O
capacity	O
of	O
the	O
cell	O
to	O
maintain	O
homeostasis	O
that	O
epigenetic	O
toxicity	O
occurs	O
,	O
potentially	O
leading	O
to	O
altered	O
phenotypes	O
and	O
adversely	O
impacting	O
public	O
health	O
.	O

The	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
CV	O
were	O
5	O
%.	O

As	B
such	I
a	O
dose	O
is	O
far	O
higher	O
than	O
the	O
daily	O
dietary	O
allowance	O
recommended	O
for	O
lactating	O
mothers	O
its	O
safety	O
over	O
prolonged	O
periods	O
is	O
not	O
known	O
and	O
should	O
be	O
examined	O
.	O

The	O
pleasant	O
feeling	O
of	O
motherhood	O
can	O
probably	B
play	O
a	O
role	O
in	O
decreasing	O
depression	O
specially	O
in	O
primiparous	O
mothers	O
[	O
77	O
].	O

It	O
has	O
been	O
hypothesised	O
that	O
vitamin	O
D	O
insufficiency	O
could	O
account	O
for	O
some	O
of	O
the	O
increased	O
risk	O
of	O
schizophrenia	O
observed	O
among	O
dark	O
-	O
skinned	O
immigrants	O
moving	O
to	O
countries	O
with	O
less	O
sun	O
exposure	O
[	O
12	O
].	O

Pearson	O
’	O
s	O
correlation	O
and	O
multiple	O
linear	O
regression	O
analyses	O
were	O
performed	O
to	O
verify	O
the	O
relationship	O
between	O
HRV	O
parameters	O
and	O
independent	O
factors	O
.	O

PubMed	O
Central	O
:	O

Gender	O
-	O
specific	O
effects	O
were	O
also	O
observed	O
in	O
a	O
number	O
of	O
the	O
famine	O
cohorts	O
,	O
with	O
an	O
increased	O
risk	O
of	O
obesity	O
occurring	O
in	O
female	O
descendants	O
only	O
(	O
Lumey	O
et	O
al	O
.	O
2011	O
;	O
Pembrey	O
et	O
al	O
.	O
2014	O
).	O

Findings	O
from	O
epidemiological	O
and	O
animal	O
experimental	O
studies	O
indicate	O
that	O
chronic	O
partial	O
sleep	O
loss	O
is	O
associated	O
with	O
increased	O
risks	O
of	O
obesity	O
and	O
a	O
myriad	O
of	O
obesity	O
-	O
related	O
disorders	O
including	O
impaired	O
glucose	O
tolerance	O
,	O
hypertension	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	O
,	O
coronary	O
heart	O
disease	O
,	O
stroke	O
and	O
premature	O
mortality	O
[	O
1	O
-	O
8	O
].	O

Inclusion	O
criteria	O
for	O
the	O
HOME	O
Study	O
included	O
women	O
who	O
were	O
>	O
18	O
years	O
old	O
,	O
<	O
19	O
weeks	O
gestation	O
at	O
the	O
time	O
of	O
enrollment	O
,	O
and	O
living	O
in	O
a	O
residence	O
built	O
before	O
1987	O
.	O

Food	O
Fortification	O
with	O
Iron	O
Food	O
fortification	O
with	O
iron	O
has	O
also	O
been	O
shown	O
to	O
be	O
an	O
equally	O
effective	O
strategy	O
of	O
boosting	O
haemoglobin	O
level	O
in	O
the	O
population	O
,	O
including	O
pregnant	O
women	O
.	O

The	O
corresponding	O
author	O
had	O
full	O
access	O
to	O
all	O
the	O
data	O
in	O
the	O
study	O
and	O
had	O
final	O
responsibility	O
for	O
the	O
decision	O
to	O
submit	O
for	O
publication	O
.	O

Several	O
factors	O
,	O
including	O
MS	O
or	O
QG	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
need	O
to	O
be	O
considered	O
to	O
determine	O
the	O
optimum	O
slaughter	O
weight	O
for	O
the	O
maximum	O
profit	O
.	O

Associations	O
have	O
also	O
been	O
shown	O
between	O
vitamin	O
D	O
insufficiency	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
increased	O
risk	O
of	O
infant	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
and	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
[	O
4	O
].	O

Furthermore	O
,	O
increased	O
BMI	O
is	O
known	O
to	O
be	O
associated	O
with	O
reduced	O
serum	O
25	O
(	O
OH	O
)	O
D	O
[	O
38	O
–	O
40	O
]	O
as	O
adipose	O
tissue	O
is	O
thought	O
to	O
sequester	O
25	O
(	O
OH	O
)	O
D	O
[	O
41	O
].	O

The	O
absorption	O
of	O
dietary	O
vitamin	O
D	O
is	O
generally	B
high	O
at	O
all	O
stages	O
of	O
life	O
[	O
34	O
],	O
but	O
serum	O
levels	O
also	O
depend	O
on	O
the	O
endogenous	O
production	O
of	O
vitamin	O
D	O
due	O
to	O
sun	O
exposure	O
which	O
is	O
subject	O
to	O
seasonal	O
variations	O
.	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
measured	O
by	O
ELISA	O
and	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

Regarding	O
the	O
absence	O
of	O
hyperphagia	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
the	O
food	O
intake	O
has	O
been	O
associated	O
with	O
the	O
cannabinoid	O
activation	O
in	O
specific	O
hypothalamic	O
areas	O
(	O
Soria	O
-	O
Gomez	O
et	O
al	O
.,	O
2014	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
A	O
research	O
pipeline	O
advancing	O
knowledge	O
to	O
address	O
preterm	O
birth	O
.	O
DescriptionDiscoveryDevelopmentDeliveryCharacterise	O
the	O
problemUnderstand	O
the	O
problemCreate	O
and	O
develop	O
new	O
interventionsAdvance	O
equitable	O
access	O
to	O
interventionsResearch	O
aimDescriptive	O
epidemiology	O
to	O
understand	O
determinants	O
,	O
advance	O
definitionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDelivery	O
of	O
interventions	O
at	O
scale	O
through	O
innovative	O
approachesPreterm	O
prevention	O
research	O
themes	O
•	O
Improve	O
collection	O
,	O
analysis	O
,	O
interpretation	O
,	O
application	O
of	O
epidemiological	O
data	O
for	O
:•	O
Refining	O
,	O
disseminating	O
standard	O
definitions	O
of	O
exposures	O
,	O
outcomes	O
and	O
phenotypes	O
•	O
Further	O
understanding	O
of	O
risk	O
factors	O
for	O
preterm	O
birth	O
•	O
Monitoring	O
and	O
evaluating	O
impact	O
of	O
interventions	O
•	O
Improving	O
the	O
estimates	O
and	O
data	O
collection	O
systems	O
•	O
Increase	O
knowledge	O
of	O
the	O
biology	O
of	O
normal	O
and	O
abnormal	O
pregnancy	O
•	O
Better	O
understand	O
modifiable	O
mechanisms	O
contributing	O
to	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
preconceptual	O
or	O
antenatal	O
nutrition	O
,	O
infection	O
and	O
immune	O
response	O
)•	O
Advance	O
understanding	O
of	O
underlying	O
pathophysiology	O
of	O
preterm	O
newborns	O
and	O
impact	O
of	O
co	O
-	O
morbidities	O
on	O
outcomes	O
in	O
different	O
country	O
settings	O
•	O
Create	O
,	O
develop	O
new	O
interventions	O
(	O
e	O
.	O
g	O
.,	O
novel	O
approaches	O
to	O
preventing	O
preterm	O
birth	O
)•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
or	O
expand	O
utilisation	O
and	O
access	O
•	O
Evaluate	O
impact	O
,	O
cost	O
and	O
process	O
of	O
known	O
interventions	O
to	O
reduce	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
family	O
planning	O
,	O
STI	O
management	O
,	O
malaria	O
prevention	O
)•	O
Social	O
behaviour	O
change	O
research	O
to	O
address	O
lifestyle	O
factors	O
and	O
other	O
risks	O
for	O
preterm	O
birth	O
•	O
Effective	O
approaches	O
to	O
increase	O
use	O
of	O
antenatal	O
steroids	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settingsPremature	O
baby	O
care	O
research	O
themes	O
•	O
Create	O
new	O
devices	O
and	O
drugs	O
for	O
preterm	O
babies	O
that	O
are	O
feasible	O
to	O
use	O
in	O
low	O
-	O
income	O
settings	O
•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
and	O
/	O
or	O
improve	O
deliverability	O
in	O
challenging	O
settings	O
or	O
at	O
community	O
level	O
(	O
e	O
.	O
g	O
.,	O
robust	O
,	O
simpler	O
technologies	O
)•	O
Implementation	O
research	O
to	O
adapt	O
and	O
scale	O
up	O
context	O
-	O
specific	O
packages	O
of	O
care	O
for	O
preterm	O
babies	O
(	O
e	O
.	O
g	O
.,	O
examining	O
task	O
shifting	O
,	O
innovative	O
commodities	O
,	O
etc	O
.	O

Therefore	B
,	O
thyroxine	O
therapy	O
aims	O
at	O
suppressing	O
pituitary	O
secretion	O
of	O
TSH	O
,	O
as	B
indicated	O
by	O
serum	O
TSH	O
levels	O
below	O
0	O
.	O
05	O
mIU	O
/	O
L	O
.	O

Major	O
Maternal	O
Dietary	O
Patterns	O
during	O
Early	O
Pregnancy	O
and	O
Their	O
Association	O
with	O
Neonatal	O
Anthropometric	O
Measurement	O
Abstract	O
Background	O
Anthropometric	O
measurements	O
of	O
newborn	O
infant	O
are	O
widely	O
assessed	O
as	O
determinants	O
of	O
maternal	O
nutrition	O
.	O

Calcium	O
is	O
transported	O
from	O
the	O
mother	O
to	O
the	O
fetus	O
through	O
the	O
placenta	O
.	O

The	O
ability	O
to	O
find	O
associations	O
between	O
specific	O
seasonal	O
risk	O
factors	O
occurring	O
around	O
the	O
time	O
of	O
birth	O
and	O
adult	O
glioma	O
incidence	O
is	O
limited	O
by	O
the	O
rarity	O
of	O
this	O
cancer	O
in	O
the	O
population	O
and	O
the	O
vast	O
time	O
period	O
from	O
exposure	O
to	O
disease	O
.	O

Credit	O
:	O
Boston	O
Consulting	O
Group	O
with	O
the	O
Global	O
Preterm	O
Birth	O
Mortality	O
Reduction	O
Analysis	O
Group	O
.	O

Absolute	O
risk	O
reduction	O
(	O
ARR	O
)	O
and	O
number	O
needed	O
to	O
treat	O
(	O
NNT	O
)	O
were	O
also	O
calculated	O
.	O

A	O
wide	O
range	O
of	O
services	O
encompassing	O
supplementary	O
nutrition	O
;	O
immunization	O
services	O
;	O
health	O
check	O
-	O
ups	O
for	O
children	O
less	O
than	O
six	O
years	O
of	O
age	O
;	O
antenatal	O
care	O
of	O
expectant	O
mothers	O
and	O
postnatal	O
care	O
of	O
nursing	O
mothers	O
;	O
referral	O
services	O
to	O
the	O
beneficiaries	O
who	O
are	O
in	O
the	O
need	O
of	O
prompt	O
medical	O
attention	O
;	O
non	O
-	O
formal	O
pre	O
-	O
school	O
education	O
for	O
children	O
in	O
the	O
3	O
-	O
6	O
years	O
age	O
group	O
;	O
and	O
nutrition	O
&	O
health	O
education	O
especially	O
for	O
the	O
women	O
in	O
the	O
15	O
-	O
45	O
years	O
age	O
group	O
are	O
provided	O
to	O
the	O
beneficiaries	O
(	O
4	O
,	O
5	O
).	O

(	O
2012a	O
)*	O
PeanutMouseOral	O
(	O
gavage	O
)	O
(	O
5	O
or	O
10	O
mg	O
peanut	O
+	O
10	O
or	O
20	O
µg	O
CT	O
/	O
mouse	O
/	O
d	O
+	O
200	O
mg	O
/	O
mouse	O
challenge	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
±	O
childhoodChildhood	O
to	O
adolescence	O
F1offspring	O
↑	O
peanut	O
-	O
specific	O
allergy	O
and	O
anaphylaxisDNA	O
methylationSong	O
et	O
al	O
.	O

Study	O
Protocol	O
Health	O
History	O
Information	O
During	O
the	O
yearly	O
visits	O
,	O
5	O
-	O
mL	O
of	O
whole	O
blood	O
were	O
obtained	O
by	O
venous	O
puncture	O
,	O
and	O
the	O
child	O
’	O
s	O
health	O
status	O
,	O
medication	O
usage	O
,	O
and	O
hospitalization	O
history	O
were	O
assessed	O
by	O
both	O
standardized	O
questionnaires	O
completed	O
by	O
a	O
parent	O
of	O
each	O
child	O
and	O
the	O
child	O
’	O
s	O
medical	O
records	O
.	O

Characterization	O
of	O
Two	O
ENU	O
-	O
Induced	O
Mutations	O
Affecting	O
Mouse	O
Skeletal	O
Morphology	O
Abstract	O
Using	O
the	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
mutagenesis	O
screen	O
,	O
we	O
have	O
identified	O
two	O
skeletal	O
morphology	O
mutants	O
,	O
Skm1	O
and	O
Skm2	O
.	O

Therefore	B
,	O
it	O
seems	O
reasonable	B
to	O
recommend	O
that	O
when	O
there	O
is	O
no	O
medical	O
or	O
obstetric	O
contraindication	O
,	O
women	O
with	O
GDM	O
should	O
maintain	O
a	O
sensible	O
level	O
of	O
light	O
and	O
moderate	O
intensity	O
physical	O
activity	O
until	O
the	O
latter	O
stages	O
of	O
the	O
pregnancy	O
.	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Box	O
1	O
.	O

We	O
conducted	O
a	O
pilot	O
study	O
in	O
four	O
BRAC	O
village	O
fieldworker	O
areas	O
,	O
two	O
with	O
intervention	O
and	O
two	O
comparison	O
areas	O
,	O
to	O
test	O
the	O
feasibility	O
of	O
our	O
intervention	O
.	O

Exposure	O
to	O
certain	O
medications	O
such	O
as	O
perinatal	O
medications	O
,	O
antiepileptic	O
drugs	O
,	O
supplements	O
,	O
and	O
SSRIs	O
has	O
been	O
studied	O
as	O
well	O
as	O
drug	O
exposure	O
to	O
cocaine	O
and	O
smoking	O
.	O

Since	O
its	O
launch	O
the	O
scheme	O
has	O
been	O
reformed	O
on	O
the	O
basis	O
of	O
different	O
outcome	O
indicators	O
and	O
evaluation	O
reports	O
(	O
3	O
,	O
4	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Plasma	O
levels	O
of	O
leptin	O
,	O
metabolites	O
,	O
alkaline	O
phosphatase	O
,	O
and	O
hepatic	O
transaminases	O
in	O
adult	O
rat	O
offspring	O
at	O
postnatal	O
weeks	O
21	O
–	O
23	O
†	O
.	O
MaleFemaleTwo	O
-	O
way	O
ANOVACC	O
(	O
n	O
=	O
6	O
)	O
RC	O
(	O
n	O
=	O
7	O
)	O
CC	O
(	O
n	O
=	O
5	O
)	O
RC	O
(	O
n	O
=	O
7	O
)	O
InteractionPrenatal	O
dietSex	O
Leptin	O
(	O
ng	O
/	O
mL	O
)	O
5	O
.	O
82	O
±	O
0	O
.	O
8812	O
.	O
06	O
±	O
2	O
.	O
13	O
*	O
6	O
.	O
07	O
±	O
2	O
.	O
175	O
.	O
97	O
±	O
1	O
.	O
36	O
$$	O
nsnsnsGlucose	O
(	O
mg	O
/	O
dL	O
)	O
187	O
.	O
33	O
±	O
12	O
.	O
11207	O
.	O
71	O
±	O
19	O
.	O
27169	O
.	O
60	O
±	O
15	O
.	O
65216	O
.	O
00	O
±	O
10	O
.	O
86	O
#	O
ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
5	O
.	O
339	O
,	O
P	O
=	O
0	O
.	O
031nsTriglycerides	O
(	O
mg	O
/	O
dL	O
)	O
79	O
.	O
50	O
±	O
3	O
.	O
12114	O
.	O
13	O
±	O
9	O
.	O
66	O
*	O
82	O
.	O
60	O
±	O
15	O
.	O
9696	O
.	O
50	O
±	O
11	O
.	O
64ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
5	O
.	O
462	O
,	O
P	O
=	O
0	O
.	O
029nsCholesterol	O
(	O
mg	O
/	O
dL	O
)	O
39	O
.	O
00	O
±	O
5	O
.	O
4944	O
.	O
86	O
±	O
2	O
.	O
1337	O
.	O
20	O
±	O
2	O
.	O
5331	O
.	O
13	O
±	O
2	O
.	O
56	O
$$$	O
nsNs	O
F	O
(	O
1	O
,	O
22	O
)=	O
6	O
.	O
112	O
,	O
P	O
=	O
0	O
.	O
022HDL	O
(	O
mg	O
/	O
dL	O
)	O
26	O
.	O
67	O
±	O
3	O
.	O
044	O
.	O
43	O
±	O
0	O
.	O
81	O
***	O
21	O
.	O
60	O
±	O
2	O
.	O
912	O
.	O
12	O
±	O
0	O
.	O
55	O
###	O
ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
147	O
.	O
457	O
,	O
P	O
<	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
22	O
)=	O
4	O
.	O
603	O
,	O
P	O
=	O
0	O
.	O
043LDL	O
(	O
mg	O
/	O
dL	O
)	O
12	O
.	O
37	O
±	O
2	O
.	O
7955	O
.	O
67	O
±	O
3	O
.	O
5	O
***	O
17	O
.	O
09	O
±	O
8	O
.	O
3737	O
.	O
01	O
±	O
7	O
.	O
55	O
#,$	O
ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
29	O
.	O
887	O
,	O
P	O
<	O
0	O
.	O
001NsVLDL	O
(	O
mg	O
/	O
dL	O
)	O
15	O
.	O
90	O
±	O
0	O
.	O
6222	O
.	O
863	O
±	O
1	O
.	O
93	O
*	O
16	O
.	O
52	O
±	O
3	O
.	O
1919	O
.	O
30	O
±	O
2	O
.	O
33ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
5	O
.	O
462	O
,	O
P	O
=	O
0	O
.	O
029NsUrea	O
(	O
mg	O
/	O
dL	O
)	O
27	O
.	O
50	O
±	O
2	O
.	O
8931	O
.	O
25	O
±	O
1	O
.	O
6630	O
.	O
40	O
±	O
2	O
.	O
0234	O
.	O
75	O
±	O
2	O
.	O
07ns	O
F	O
(	O
1	O
,	O
22	O
)=	O
4	O
.	O
876	O
,	O
P	O
=	O
0	O
.	O
038nsBilirubin	O
(	O
mg	O
/	O
dL	O
)	O
0	O
.	O
13	O
±	O
0	O
.	O
020	O
.	O
30	O
±	O
0	O
.	O
07	O
*	O
0	O
.	O
20	O
±	O
0	O
.	O
050	O
.	O
16	O
±	O
0	O
.	O
02	O
$	O
F	O
(	O
1	O
,	O
22	O
)=	O
5	O
.	O
733	O
,	O
P	O
=	O
0	O
.	O
026nsnsALKP	O
(	O
UI	O
)	O
73	O
.	O
13	O
±	O
3	O
.	O
3972	O
.	O
14	O
±	O
3	O
.	O
4863	O
.	O
20	O
±	O
7	O
.	O
7965	O
.	O
43	O
±	O
2	O
.	O
30nsns	O
F	O
(	O
1	O
,	O
23	O
)=	O
4	O
.	O
608	O
,	O
P	O
=	O
0	O
.	O
043γGT	O
(	O
UI	O
)	O
10	O
.	O
50	O
±	O
1	O
.	O
0110	O
.	O
86	O
±	O
0	O
.	O
3412	O
.	O
20	O
±	O
0	O
.	O
9611	O
.	O
50	O
±	O
0	O
.	O
93nsnsNsAST	O
(	O
UI	O
)	O
162	O
.	O
50	O
±	O
33	O
.	O
02138	O
.	O
14	O
±	O
18	O
.	O
33145	O
.	O
00	O
±	O
20	O
.	O
39133	O
.	O
14	O
±	O
1	O
.	O
21nsnsNsALT	O
(	O
UI	O
)	O
55	O
.	O
00	O
±	O
3	O
.	O
9669	O
.	O
86	O
±	O
6	O
.	O
8270	O
.	O
40	O
±	O
8	O
.	O
3756	O
.	O
63	O
±	O
7	O
.	O
27	O
F	O
(	O
1	O
,	O
22	O
)=	O
4	O
.	O
697	O
,	O
P	O
=	O
0	O
.	O
041nsNsAST	O
/	O
ALT0	O
.	O
39	O
±	O
0	O
.	O
060	O
.	O
52	O
±	O
0	O
.	O
034	O
.	O
05	O
±	O
0	O
.	O
24	O
***	O
4	O
.	O
84	O
±	O
0	O
.	O
25	O
$$$	O
nsns	O
F	O
(	O
1	O
,	O
23	O
)=	O
452	O
.	O
066	O
,	O
P	O
<	O
0	O
.	O
001	O
CC	O
,	O
offspring	O
from	O
control	O
-	O
fed	O
dams	O
;	O
RC	O
,	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
.	O

However	O
,	O
the	O
clinical	O
relevance	O
,	O
if	O
any	O
,	O
of	O
the	O
inverse	O
relationship	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
head	O
circumference	O
at	O
birth	O
remains	O
unexplained	O
.	O

A	O
multi	O
-	O
disciplinary	O
approach	O
is	O
needed	O
to	O
identify	O
women	O
at	O
risk	O
and	O
discover	O
new	O
strategies	O
for	O
prevention	O
including	O
potential	O
biomarkers	O
,	O
such	O
as	O
genomic	O
,	O
microbial	O
,	O
immunologic	O
,	O
and	O
hormonal	O
factors	O
.	O

Nevertheless	O
due	O
to	O
small	O
number	O
of	O
deficient	O
mothers	O
we	O
could	O
not	O
investigate	O
this	O
reliably	O
.	O

Previously	O
collected	O
cord	O
blood	O
samples	O
from	O
all	O
singleton	O
births	O
from	O
November	O
2010	O
to	O
April	O
2011	O
(	O
one	O
winter	O
season	O
)	O
served	O
as	O
the	O
study	O
population	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
adiposity	O
in	O
adult	O
offspring	O
We	O
detected	O
a	O
prenatal	O
diet	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perirenal	O
and	O
abdominal	O
fat	O
relative	O
to	O
body	O
weight	O
(	O
Table2	O
).	O

Data	O
were	O
accepted	O
with	O
a	O
coefficient	O
of	O
variance	O
(	O
CV	O
)	O
of	O
<	O
10	O
%.	O

Although	O
a	O
circulating	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
less	O
than	O
20	O
ng	O
/	O
mL	O
is	O
defined	B
as	B
vitamin	O
D	O
deficiency	O
[	O
27	O
,	O
28	O
],	O
the	O
mean	O
levels	O
may	O
vary	O
among	O
different	O
populations	O
[	O
29	O
].	O

In	O
contrast	O
,	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
gain	O
after	O
lactation	O
,	O
despite	O
of	O
the	O
lack	O
of	O
effect	O
on	O
caloric	O
intake	O
during	O
this	O
period	O
.	O

We	O
were	O
also	O
able	O
to	O
perform	O
sensitivity	O
analysis	O
for	O
self	O
-	O
reported	O
vaccination	O
.	O

All	O
mothers	O
reported	O
taking	O
a	O
prenatal	O
vitamin	O
supplement	O
throughout	O
the	O
pregnancy	O
.	O

Subsequent	O
identification	O
of	O
human	O
relevant	O
mechanisms	O
of	O
epigenetic	O
toxicity	O
can	O
then	O
be	O
further	O
validated	O
as	O
appropriate	O
in	O
smaller	O
more	O
focused	O
studies	O
.	O

Nevertheless	O
,	O
such	O
work	O
provides	O
valuable	O
data	O
.	O

Introduction	O
Although	O
,	O
overnutrition	O
is	O
an	O
important	O
life	O
style	O
factor	O
for	O
the	O
development	O
of	O
metabolic	O
syndrome	O
,	O
obesity	O
,	O
cardiovascular	O
disease	O
and	O
diabetes	O
mellitus	O
(	O
Alberti	O
et	O
al	O
.,	O
2009	O
),	O
maternal	O
undernutrition	O
resulting	O
in	O
early	O
life	O
nutritional	O
unbalance	O
can	O
be	O
also	O
related	O
to	O
the	O
onset	O
of	O
long	O
-	O
term	O
metabolic	O
alterations	O
observed	O
later	O
in	O
life	O
.	O

The	O
signals	O
that	O
mediate	O
the	O
effects	O
of	O
maternal	O
metabolic	O
disorders	O
in	O
overfed	O
offspring	O
have	O
not	O
been	O
fully	O
identified	O
.	O

At	O
10	O
days	O
of	O
age	O
,	O
generation	O
contributed	O
significantly	O
to	O
KM	O
(	O
P	O
<	O
0	O
.	O
0001	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

In	O
particular	O
the	O
Denver	O
test	O
,	O
utilised	O
in	O
the	O
ALSPAC	O
study	O
[	O
18	O
]	O
has	O
been	O
criticised	O
for	O
its	O
low	O
specificity	O
and	O
potentially	O
outdated	O
‘	O
norm	O
’	O
as	O
it	O
was	O
standardised	O
in	O
1980	O
[	O
30	O
].	O

Assessing	O
cognitive	O
development	O
differences	O
in	O
infancy	O
and	O
childhood	O
is	O
fraught	O
with	O
difficulties	O
due	O
to	O
the	O
nature	O
of	O
childhood	O
development	O
and	O
the	O
accurate	O
measurement	O
of	O
such	O
.	O

To	O
date	O
,	O
four	O
splice	O
variants	O
of	O
the	O
GR	O
gene	O
have	O
been	O
reported	O
,	O
formed	O
by	O
alternative	O
splicing	O
,	O
termed	O
GR	O
α	O
,	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
and	O
GR	O
-	O
P	O
[	O
2	O
].	O

Preterm	O
birth	O
as	O
a	O
marker	O
for	O
women	O
'	O
s	O
and	O
children	O
'	O
s	O
health	O
The	O
Born	O
Too	O
Soon	O
report	O
,	O
published	O
in	O
2012	O
,	O
drew	O
global	O
attention	O
to	O
the	O
issue	O
of	O
preterm	O
birth	O
and	O
reported	O
that	O
more	O
than	O
1	O
in	O
10	O
of	O
the	O
world	O
'	O
s	O
babies	O
are	O
born	O
too	O
soon	O
each	O
year	O
,	O
15	O
million	O
each	O
year	O
[	O
1	O
].	O

This	O
represents	O
an	O
adulthood	O
exposure	O
to	O
the	O
parent	O
,	O
but	O
a	O
very	O
early	O
life	O
exposure	O
to	O
the	O
offspring	O
.	O

A	O
report	O
from	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
found	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
of	O
one	O
to	O
three	O
servings	O
per	O
week	O
was	O
shown	O
to	O
provide	O
a	O
modest	O
but	O
significant	O
improvement	O
in	O
developmental	O
scores	O
of	O
the	O
offspring	O
for	O
language	O
and	O
social	O
activity	O
at	O
fifteen	O
to	O
eighteen	O
months	O
of	O
age	O
[	O
18	O
].	O

These	O
results	O
did	O
not	O
change	O
after	O
adjusting	O
for	O
mode	O
of	O
delivery	O
(	O
vaginal	O
,	O
vacuum	O
assisted	O
or	O
caesarean	O
section	O
).	O

None	O
of	O
these	O
events	O
were	O
adjudged	O
by	O
the	O
data	O
and	O
safety	O
monitoring	O
committee	O
to	O
be	O
treatment	O
related	O
and	O
there	O
were	O
no	O
serious	O
adverse	O
events	O
associated	O
with	O
the	O
use	O
of	O
metformin	O
.	O

Trial	O
registration	O
Iranian	O
Registry	O
of	O
Clinical	O
Trials	O
IRCT2015020310327N11	O
.	O

In	O
a	O
subset	O
of	O
40	O
children	O
with	O
two	O
consecutive	O
visits	O
roughly	O
twelve	O
months	O
apart	O
,	O
the	O
median	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
the	O
first	O
visit	O
to	O
the	O
second	O
visit	O
was	O
24	O
.	O
0	O
ng	O
/	O
mL	O
(	O
ranging	O
from	O
-	O
1	O
.	O
9	O
ng	O
/	O
mL	O
to	O
+	O
223	O
.	O
4ng	O
/	O
mL	O
,	O
p	O
≤	O
0	O
.	O
0001	O
);	O
ρ	O
value	O
represents	O
Spearman	O
correlation	O
.	O

We	O
hypothesized	O
that	O
offspring	O
exposed	O
to	O
maternal	O
obesity	O
,	O
excessive	O
GWG	O
,	O
poor	O
prenatal	O
eating	O
habits	O
,	O
less	O
exercise	O
in	O
pregnancy	O
,	O
and	O
greater	O
maternal	O
psychosocial	O
distress	O
during	O
gestation	O
would	O
have	O
higher	O
weight	O
for	O
age	O
(	O
WFA	O
)	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
than	O
nonexposed	O
counterparts	O
.	O

At	O
adulthood	O
(	O
Figure3D	O
),	O
we	O
observed	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
367	O
.	O
04	O
,	O
P	O
<	O
0	O
.	O
001	O
],	O
diet	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
6	O
.	O
49	O
,	O
P	O
<	O
0	O
.	O
05	O
],	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
124	O
.	O
57	O
,	O
P	O
<	O
0	O
.	O
01	O
].	O

A	O
linear	O
mixed	O
-	O
model	O
analysis	O
is	O
adopted	O
.	O

Grace	O
and	O
colleagues	O
have	O
suggested	O
that	O
dopamine	O
may	O
modulate	O
a	O
range	O
of	O
limbic	O
and	O
cortical	O
functions	O
relevant	O
to	O
the	O
pathophysiology	O
of	O
schizophrenia	O
via	O
the	O
nucleus	O
accumbens	O
[	O
17	O
].	O

Even	O
during	O
pregnancy	O
,	O
US	O
guided	O
fine	O
-	O
needle	O
aspiration	O
biopsy	O
(	O
FNA	O
)	O
is	O
the	O
investigation	O
of	O
choice	O
,	O
thanks	O
to	O
its	O
reliability	O
and	O
safety1926	O
.	O

The	O
potential	O
for	O
contamination	O
by	O
heavy	O
metals	O
,	O
as	O
well	O
as	O
risk	O
of	O
listeriosis	O
requires	O
careful	O
consideration	O
of	O
the	O
shaping	O
of	O
dietary	O
messages	O
related	O
to	O
fish	O
intake	O
during	O
pregnancy	O
.	O

We	O
have	O
no	O
baseline	O
measure	O
of	O
symptom	O
levels	O
to	O
further	O
elucidate	O
causality	O
between	O
different	O
levels	O
of	O
intake	O
of	O
fatty	O
fish	O
or	O
shellfish	O
and	O
the	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Of	O
all	O
women	O
included	O
,	O
76	O
.	O
2	O
%	O
reported	O
taking	O
at	O
least	O
1	O
multivitamin	O
during	O
pregnancy	O
.	O

1	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

Recently	O
,	O
a	O
meta	O
-	O
analysis	O
reported	O
that	O
vitamin	O
D	O
supplementation	O
in	O
childhood	O
can	O
help	O
prevent	O
caries	O
[	O
30	O
],	O
and	O
it	O
has	O
also	O
been	O
suggested	O
that	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
between	O
75	O
–	O
100	O
nmol	O
/	O
L	O
may	O
reduce	O
the	O
risk	O
for	O
caries	O
[	O
22	O
].	O

Risk	O
for	O
glioma	O
also	O
is	O
nearly	O
equal	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
individuals	O
but	O
higher	O
for	O
right	O
-	O
handers	O
.	O

Although	O
transplacental	O
transport	O
has	O
not	O
been	O
studied	O
in	O
humans	O
,	O
vitamin	O
D	O
passage	O
from	O
the	O
mother	O
to	O
the	O
fetus	O
would	O
be	O
facilitated	O
by	O
serum	O
concentrations	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
being	O
higher	O
in	O
the	O
maternal	O
compared	O
to	O
the	O
fetal	O
circulations	O
.	O

The	O
decrease	O
in	O
male	O
birth	O
weight	O
associated	O
with	O
Pb	O
exposure	O
was	O
roughly	B
double	O
the	O
associated	O
birth	O
weight	O
decrease	O
in	O
the	O
combined	O
analysis	O
(	O
94	O
g	O
decrease	O
compared	O
with	O
45	O
g	O
decrease	O
).	O

“	O
Now	O
it	O
’	O
s	O
just	O
a	O
huge	O
wound	O
.”	O
For	O
the	O
Bells	O
and	O
other	O
Diné	O
(	O
the	O
term	O
by	O
which	O
many	O
Navajo	O
people	O
refer	O
to	O
themselves	O
),	O
the	O
Church	O
Rock	O
spill	O
was	O
a	O
turning	O
point	O
.	O

Staff	O
are	O
currently	O
being	O
surveyed	O
regarding	O
their	O
guideline	O
knowledge	O
and	O
acceptance	O
.	O

The	O
resources	O
to	O
assist	O
with	O
this	O
include	O
the	O
Condensed	O
Food	O
Composition	O
Tables	O
for	O
South	O
Africa	O
[	O
43	O
]	O
and	O
the	O
South	O
African	O
Medical	O
Research	O
Council	O
(	O
SAMRC	O
)	O
Food	O
Quantities	O
Manual	O
[	O
44	O
].	O

Another	O
study	O
describes	O
what	O
we	O
have	O
already	O
learned	O
from	O
the	O
paragraph	O
on	O
endometriosis	O
.	O

Effective	O
interventions	O
directed	O
specifically	O
at	O
preventing	O
neonatal	O
deaths	O
are	O
required	O
to	O
improve	O
overall	O
child	O
survival	O
.	O

Except	O
for	O
saccharin	O
,	O
which	O
can	O
cross	O
the	O
placenta	O
and	O
is	O
therefore	B
not	O
recommended	O
,	O
other	O
noncaloric	O
sweeteners	O
may	O
be	O
used	O
in	O
moderation	O
.	O

After	O
cross	O
analysis	O
including	O
the	O
number	O
and	O
quality	O
of	O
transferred	O
embryos	O
,	O
it	O
was	O
shown	O
that	O
the	O
patients	O
with	O
proper	O
VD	O
levels	O
have	O
a	O
four	O
time	O
higher	O
chance	B
for	O
a	O
successful	O
procedure	O
.	O

Therefore	B
,	O
there	O
is	O
an	O
urgent	O
need	O
of	O
randomised	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
to	O
investigate	O
the	O
maternal	O
and	O
neonatal	O
health	O
benefits	O
of	O
correcting	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
[	O
24	O
].	O

[	O
29	O
]	O
Vitamin	O
D	O
appears	O
to	O
have	O
a	O
protective	O
effect	O
against	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

However	O
,	O
cord	O
serum	O
levels	O
ranged	O
widely	B
from	O
10	O
.	O
95	O
to	O
34	O
.	O
4	O
ng	O
/	O
mL	O
[	O
7	O
,	O
11	O
–	O
13	O
,	O
30	O
].	O

[	O
38	O
],	O
animal	O
models	O
were	O
used	O
to	O
study	O
the	O
importance	O
of	O
serotonin	O
homeostasis	O
for	O
the	O
development	O
of	O
rat	O
pups	O
'	O
brains	O
.	O

Studies	O
of	O
EAH	O
among	O
girls	O
have	O
shown	O
positive	O
associations	O
with	O
mothers	O
'	O
but	O
not	O
fathers	O
'	O
disinhibited	O
eating	O
(	O
52	O
,	O
65	O
).	O

Modern	O
techniques	O
for	O
genetic	O
analysis	O
create	O
opportunities	O
for	O
understanding	O
the	O
heritability	O
of	O
complex	O
traits	O
and	O
risk	O
for	O
chronic	O
diseases	O
.	O
2732Height	O
is	O
one	O
of	O
the	O
more	O
complex	O
genetically	O
inherited	O
traits	O
because	B
as	O
many	O
as	O
20	O
genes	O
—	O
if	O
not	O
more	O
—	O
interact	O
to	O
determine	O
a	O
child	O
’	O
s	O
height	O
.	O

We	O
found	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
to	O
be	O
positively	O
related	O
to	O
OTUs	O
in	O
the	O
genus	O
Streptococcus	O
in	O
the	O
infant	O
gut	O
,	O
which	O
included	O
the	O
species	O
Streptococcus	O
agalactiae	O
,	O
or	O
Group	O
B	O
Streptococcus	O
.	O

The	O
relative	O
risk	O
of	O
mortality	O
associated	O
with	O
a	O
10	O
g	O
/	O
L	O
increase	O
in	O
hemoglobin	O
is	O
estimated	O
as	O
0	O
.	O
75	O
for	O
maternal	O
mortality	O
,	O
and	O
0	O
.	O
72	O
for	O
perinatal	O
mortality	O
[	O
21	O
].	O

Physical	O
Examination	O
Physical	O
examination	O
revealed	O
an	O
overweight	O
female	O
appearing	O
her	O
stated	O
age	O
of	O
41	O
years	O
in	O
moderate	O
distress	O
secondary	O
to	O
chest	O
pain	O
and	O
nausea	O
.	O

This	O
study	O
suggested	O
that	O
changes	O
in	O
MS	O
with	O
slaughter	O
age	O
vary	O
among	O
farms	O
.	O

Following	O
supplementation	O
these	O
were	O
36	O
%	O
and	O
62	O
%	O
respectively	O
,	O
generating	O
RR	O
=	O
0	O
.	O
59	O
(	O
0	O
.	O
46	O
,	O
0	O
.	O
76	O
)	O
for	O
anaemia	O
in	O
the	O
MMN	O
group	O
.	O

There	O
is	O
some	O
controversy	O
surrounding	O
the	O
exact	O
function	O
of	O
GR	O
β	O
,	O
but	O
it	O
appears	O
to	O
exert	O
a	O
dominant	O
-	O
negative	O
effect	O
on	O
GR	O
α	O
-	O
induced	O
transcriptional	O
activity	O
[	O
8	O
].	O

Furthermore	O
,	O
the	O
transcriptional	O
adaptations	O
may	O
have	O
consequences	O
for	O
the	O
offspring	O
'	O
s	O
phenotype	O
,	O
including	O
alterations	O
of	O
plasma	O
parameters	O
[	O
44	O
-	O
46	O
,	O
50	O
],	O
hepatic	O
histology	O
[	O
46	O
]	O
and	O
body	O
composition	O
[	O
47	O
].	O

The	O
red	O
dashed	O
lines	O
represent	O
the	O
null	O
limits	O
for	O
the	O
permutation	O
distribution	O
of	O
regression	O
coefficient	O
t	O
-	O
statistics	O
(	O
t	O
-	O
stat	O
),	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Podolian	O
bulls	O
fed	O
grazing	O
pasture	O
and	O
fed	O
a	O
high	O
protein	O
(	O
15	O
%	O
CP	O
,	O
DM	O
basis	O
)	O
supplement	O
had	O
higher	O
IMF	O
content	O
in	O
the	O
LM	O
than	O
did	O
animals	O
grazing	O
pasture	O
and	O
fed	O
a	O
low	O
protein	O
(	O
12	O
%	O
CP	O
)	O
supplement	O
[	O
126	O
].	O

String	O
beans	O
and	O
peas	O
also	O
correlated	O
inversely	O
with	O
ALL	O
risk	O
.	O

However	O
,	O
because	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
have	O
a	O
moderate	O
correlation	O
,	O
it	O
is	O
possible	O
that	O
these	O
two	O
repetitive	O
element	O
methylation	O
markers	O
may	O
explain	O
both	O
similar	O
and	O
different	O
sources	O
of	O
variation	O
in	O
infant	O
growth	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
10	O
The	O
United	O
Nations	O
-	O
Life	O
-	O
saving	O
Commodities	O
for	O
Women	O
and	O
Children	O
--	O
potential	O
for	O
action	O
to	O
reduce	O
preterm	O
deaths	O
.	O

The	O
elimination	O
of	O
the	O
problem	O
at	O
this	O
short	O
period	O
is	O
valuable	O
in	O
the	O
health	O
of	O
mothers	O
’	O
and	O
their	O
breast	O
–	O
fed	O
children	O
.	O

The	O
aim	O
is	O
to	O
achieve	O
normoglycemia	O
whilst	O
providing	O
the	O
required	O
nutrients	O
for	O
normal	O
fetal	O
growth	O
and	O
maternal	O
health	O
.	O

Introduction	O
Autism	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
method	O
of	O
prevention	O
;	O
thus	B
there	O
is	O
a	O
need	O
for	O
research	O
to	O
identify	O
its	O
possible	O
causative	O
factors	O
.	O

1	O
Maternal	O
vitamin	O
D	O
status	O
and	O
gestational	O
diabetes	O
mellitus	O
.	O

A	O
strong	O
relationship	O
was	O
found	O
between	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
anthropometric	O
indicators	O
in	O
groups	O
A	O
and	O
B	O
,	O
with	O
a	O
possible	O
mechanism	O
of	O
maternal	O
visfatin	O
entering	O
the	O
fetal	O
blood	O
circulation	O
through	O
the	O
placenta	O
as	B
a	O
result	O
of	O
endocrine	O
changes	O
.	O

We	O
similarly	O
found	O
that	O
the	O
C	O
allele	O
was	O
associated	O
with	O
lower	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
following	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

MS	O
increased	O
with	O
increasing	O
slaughter	O
age	O
from	O
16	O
.	O
2	O
months	O
(	O
485	O
d	O
)	O
to	O
20	O
.	O
3	O
months	O
(	O
610	O
d	O
)	O
in	O
Holstein	O
-	O
Friesian	O
and	O
Norwegian	O
dairy	O
breeds	O
[	O
67	O
].	O

Risk	O
factors	O
that	O
may	O
exhibit	O
seasonal	O
epidemicity	O
include	O
exposure	O
to	O
infectious	O
agents	O
,	O
allergens	O
,	O
pesticides	O
,	O
indoor	O
environmental	O
tobacco	O
smoke	O
,	O
and	O
other	O
sources	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
e	O
.	O
g	O
.,	O
soot	O
from	O
fires	O
for	O
home	O
heating	O
),	O
and	O
use	O
of	O
antihistamines	O
.	O

The	O
fact	O
that	O
anaemia	O
frequently	O
does	O
occur	O
in	O
pregnancy	O
among	O
women	O
in	O
developing	O
countries	O
is	O
an	O
indication	O
that	O
preexisting	O
iron	O
stores	O
are	O
often	B
inadequate	O
and	O
physiological	O
adaptations	O
to	O
pregnancy	O
are	O
insufficient	O
to	O
meet	O
the	O
increased	O
requirements	O
[	O
4	O
].	O

Macrosomia	O
was	O
defined	O
as	O
weight	O
>	O
4000	O
grams	O
[	O
21	O
].	O

Bell	O
-	O
Jefferson	O
and	O
her	O
brother	O
Peterson	O
Bell	O
played	O
in	O
and	O
around	O
the	O
mines	O
,	O
splashing	O
and	O
swimming	O
in	O
pools	O
of	O
radioactive	O
water	O
that	O
had	O
been	O
pumped	O
out	O
of	O
the	O
mines	O
and	O
then	O
collected	O
on	O
their	O
property	O
.	O

All	O
participants	O
received	O
standard	O
antenatal	O
care	O
and	O
could	O
continue	O
self	O
-	O
administration	O
of	O
dietary	O
supplements	O
containing	O
up	O
to	O
400	O
IU	O
/	O
d	O
vitamin	O
D	O
.	O
Maternal	O
assessments	O
during	O
pregnancy	O
Prior	O
to	O
commencing	O
the	O
study	O
medication	O
and	O
again	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
the	O
women	O
attended	O
the	O
research	O
center	O
for	O
a	O
detailed	O
assessment	O
of	O
diet	O
(	O
including	O
supplement	O
use	O
),	O
lifestyle	O
(	O
smoking	O
,	O
physical	O
activity	O
participation	O
,	O
employment	O
),	O
and	O
health	O
(	O
medical	O
history	O
,	O
current	O
medication	O
use	O
)	O
using	O
interviewer	O
-	O
led	O
questionnaires	O
.	O

2	O
.	O
2	O
.	O
3	O
.	O

Thus	B
,	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
neonatal	O
birth	O
size	O
is	O
not	O
clear	O
and	O
warrants	O
further	O
investigation	O
.	O

The	O
corresponding	O
RR	O
for	O
lean	O
women	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
was	O
3	O
.	O
23	O
(	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
and	O
9	O
.	O
83	O
(	O
95	O
%	O
CI	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
for	O
overweight	O
women	O
(≥	O
25	O
kg	O
/	O
m2	O
).	O

There	O
were	O
no	O
other	O
effects	O
on	O
infant	O
growth	O
,	O
adiposity	O
,	O
or	O
neurodevelopment	O
.	O

To	B
our	I
knowledge	I
,	O
this	O
is	O
the	O
first	O
examination	O
of	O
the	O
relation	O
between	O
plasma	O
glucose	O
concentrations	O
,	O
GDM	O
risk	O
and	O
sleep	O
parameters	O
(	O
i	O
.	O
e	O
.,	O
snoring	O
and	O
habitual	O
sleep	O
duration	O
)	O
during	O
pregnancy	O
.	O

The	O
authors	O
mentioned	O
that	O
slight	O
heat	O
stress	O
might	O
induce	O
IMF	O
deposition	O
.	O

Sampling	O
during	O
pregnancy	O
and	O
delivery	O
showed	O
that	O
the	O
women	O
had	O
unusually	O
high	O
serum	O
levels	O
of	O
PFOA	O
—	O
twice	O
the	O
U	O
.	O
S	O
.	O
average	O
—	O
possibly	O
due	B
to	I
the	O
presence	O
of	O
a	O
chemical	O
plant	O
nearby	O
.	O

For	O
example	O
,	O
epigenetic	O
mechanisms	O
and	O
markers	O
identified	O
within	O
the	O
47	O
studies	O
highlighted	O
in	O
this	O
review	O
could	O
be	O
further	O
examined	O
and	O
potentially	O
validated	O
in	O
existing	O
regulatory	O
studies	O
.	O

A	O
total	O
of	O
70	O
.	O
3	O
%	O
(	O
663	O
/	O
943	O
)	O
of	O
the	O
participants	O
reported	O
being	O
married	O
.	O

At	O
weaning	O
,	O
10	O
male	O
offspring	O
(	O
one	O
per	O
dam	O
)	O
per	O
gestational	O
diet	O
group	O
were	O
terminated	O
.	O

Thus	B
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
needs	O
both	O
maternal	O
and	O
foetal	O
control	O
.	O

Monitoring	O
and	O
supervision	O
is	O
an	O
integral	O
component	O
of	O
ICDS	O
scheme	O
and	O
is	O
thus	O
done	O
at	O
four	O
levels	O
starting	O
from	O
the	O
central	O
,	O
state	O
,	O
block	O
and	O
finally	O
the	O
village	O
level	O
.	O

School	O
programs	O
intended	O
to	O
alleviate	O
the	O
obesity	O
crisis	O
need	O
funding	O
,	O
partnerships	O
,	O
and	O
evaluation	O
.	O

The	O
responses	O
in	O
the	O
questionnaires	O
were	O
transcribed	O
into	O
EPIInfo	O
version	O
3	O
.	O
5	O
.	O
1	O
database	O
(	O
CDC	O
/	O
WHO	O
,	O
Atlanta	O
,	O
USA	O
).	O

Reports	O
by	O
Mischoulon	O
et	O
al	O
.	O

Its	O
chemical	O
structure	O
resembles	O
steroid	O
hormones	O
and	O
it	O
acts	O
likewise	O
via	O
nuclear	O
receptor	O
(	O
VDR	O
,	O
vitamin	O
D	O
receptor	O
).	O

(	O
2013	O
)*/†	O
Izzotti	O
et	O
al	O
.	O

Genetic	O
,	O
management	O
,	O
and	O
nutritional	O
factors	O
affecting	O
intramuscular	O
fat	O
deposition	O
in	O
beef	O
cattle	O
—	O
A	O
review	O
Abstract	O
Intramuscular	O
fat	O
(	O
IMF	O
)	O
content	O
in	O
skeletal	O
muscle	O
including	O
the	O
longissimus	O
dorsi	O
muscle	O
(	O
LM	O
),	O
also	O
known	O
as	O
marbling	O
fat	O
,	O
is	O
one	O
of	O
the	O
most	O
important	O
factors	O
determining	O
beef	O
quality	O
in	O
several	O
countries	O
including	O
Korea	O
,	O
Japan	O
,	O
Australia	O
,	O
and	O
the	O
United	O
States	O
.	O

Broad	O
,	O
low	O
-	O
touch	O
interventions	O
can	O
be	O
effective	O
and	O
given	B
low	O
participant	O
burden	O
should	O
be	O
considered	O
as	O
scalable	O
program	O
options	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
reports	O
of	O
significant	O
weight	O
gain	O
induced	O
by	O
SGAs	O
.	O
25	O
–	O
28There	O
were	O
no	O
differences	O
in	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
,	O
and	O
as	O
such	O
,	O
more	O
consideration	O
should	O
be	O
given	O
to	O
the	O
management	O
of	O
preconceptional	O
weight	O
.	O

Adjusted	O
R2	O
=	O
8	O
.	O
37	O
%.	O

Vitamin	O
D	O
testing	O
and	O
supplementation	O
of	O
pregnant	O
women	O
is	O
a	O
safe	O
,	O
affordable	O
prevention	O
tool	O
that	O
could	O
substantially	B
reduce	O
the	O
occurrence	O
of	O
PTB	O
and	O
the	O
heavy	O
burden	O
of	O
associated	O
morbidity	O
,	O
mortality	O
and	O
economic	O
costs	O
.	O

Adjusting	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
,	O
maternal	O
fruit	O
consumption	O
was	O
associated	O
with	O
infant	O
stool	O
microbiome	O
composition	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
028	O
;	O
Table	O
2	O
;	O
Fig	O
.	O

“	O
We	O
didn	O
’	O
t	O
know	O
what	O
it	O
is	O
.	O

Red	O
cell	O
parameters	O
and	O
free	O
erythrocyte	O
protoporphyrin	O
concentration	O
were	O
measured	O
at	O
baseline	O
and	O
after	O
12	O
-	O
months	O
in	O
those	O
women	O
who	O
did	O
not	O
conceive	O
.	O

Therefore	B
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	O
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

However	O
,	O
other	O
contributing	O
factors	O
could	O
not	O
be	O
excluded	O
.	O

Epigenetic	O
mechanisms	O
Histones	O
are	O
a	O
family	O
of	O
highly	O
conserved	O
,	O
small	O
,	O
basic	O
(	O
positively	O
charged	O
)	O
proteins	O
around	O
which	O
(	O
negatively	O
charged	O
)	O
DNA	O
winds	O
to	O
form	O
nucleosomes	O
,	O
the	O
main	O
structural	O
units	O
of	O
chromatin	O
(	O
the	O
protein	O
-	O
DNA	O
complex	O
)	O
that	O
enable	O
DNA	O
to	O
be	O
packaged	O
into	O
the	O
nucleus	O
(	O
Kornberg	O
&	O
Lorch1999	O
).	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
was	O
determined	O
on	O
average	O
at	O
11	O
weeks	O
of	O
gestation	O
in	O
pregnancy	O
and	O
in	O
umbilical	O
cord	O
blood	O
(	O
UCB	O
)	O
at	O
birth	O
.	O

Viruses	O
Environmental	O
exposures	O
to	O
viruses	O
,	O
microbes	O
and	O
other	O
pathogens	O
generally	B
tend	O
to	O
occur	O
more	O
often	O
in	O
particular	O
seasons	O
[	O
25	O
,	O
126	O
,	O
127	O
].	O

Furthermore	O
,	O
while	O
the	O
incidence	O
and	O
the	O
prevalence	O
of	O
autism	O
also	O
tend	O
to	O
raise	O
on	O
an	O
ever	O
-	O
increasing	O
basis	O
,	O
public	O
health	O
concerns	O
over	O
the	O
disorder	O
have	O
also	O
been	O
coupled	O
with	O
concerns	O
over	O
its	O
etiology	O
,	O
which	O
is	O
still	O
in	O
the	O
investigative	O
stage	O
of	O
clinical	O
research	O
[	O
2	O
].	O

With	O
respect	O
to	O
GDM	O
,	O
there	O
have	O
been	O
several	O
small	O
randomized	O
studies	O
comparing	O
the	O
use	O
of	O
rapid	O
acting	O
insulin	O
analogues	O
with	O
regular	O
insulin	O
.	O

Children	O
with	O
vomiting	O
were	O
excluded	O
temporarily	O
and	O
enrolled	O
2	O
weeks	O
later	O
after	O
recovery	O
.	O

(	O
2012	O
)	O
demonstrated	O
a	O
beneficial	O
heritable	O
histone	O
modification	O
-	O
mediated	O
reprograming	O
of	O
hepatic	O
wound	O
healing	O
in	O
male	O
rats	O
that	O
reduced	O
fibrotic	O
scarring	O
in	O
the	O
subsequent	O
offspring	O
of	O
rats	O
treated	O
with	O
the	O
hepatotoxin	O
carbon	O
tetrachloride	O
.	O

Our	O
objective	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
in	O
overweight	O
or	O
obese	O
women	O
on	O
infant	O
outcomes	O
6	O
months	O
after	O
birth	O
.	O

3	O
.	O
4	O
.	O
4	O
.	O

Within	O
the	O
entire	O
cohort	O
,	O
age	O
of	O
the	O
child	O
and	O
cathelicidin	O
concentration	O
demonstrated	O
a	O
positive	O
correlation	O
(	O
ρ	O
=	O
0	O
.	O
236	O
,	O
p	O
=	O
0	O
.	O
005	O
).	O

Subjects	O
used	O
in	O
an	O
Australian	O
study	O
were	O
diagnosed	O
with	O
autism	O
spectrum	O
disorder	O
and	O
compared	O
to	O
control	O
subjects	O
.	O

Cost	O
-	O
effectiveness	O
analysis	O
The	O
economic	O
evaluation	O
will	O
take	O
a	O
societal	O
perspective	O
.	O

The	O
production	O
of	O
highly	O
marbled	O
beef	O
in	O
Korea	O
is	O
essential	O
to	O
compete	O
with	O
cheap	O
imported	O
beef	O
that	O
has	O
a	O
relatively	O
low	O
marbling	O
score	O
(	O
MS	O
).	O

PubMed	O
Central	O
:	O

and	O
Peet	O
&	O
Horrobin	O
suggest	O
that	O
there	O
might	O
be	O
such	O
a	O
therapeutic	O
window	O
for	O
DHA	O
and	O
EPA	O
regarding	O
their	O
protective	O
role	O
for	O
schizophrenia	O
or	O
depression	O
[	O
39	O
-	O
41	O
].	O

[	O
22	O
],	O
Mendez	O
et	O
al	O
.	O

In	O
clinical	O
studies	O
,	O
researchers	O
from	O
Kaiser	O
Permanente	O
Northern	O
California	O
Hospitals	O
examined	O
291	O
children	O
born	O
from	O
1995	O
to	O
1999	O
,	O
compared	O
to	O
284	O
controls	O
.	O

2	O
.	O
6	O
.	O

The	O
mean	O
levels	O
of	O
vitamin	O
D	O
in	O
the	O
two	O
groups	O
are	O
shown	O
inFigure	O
1	O
.	O

Artificial	O
insemination	O
and	O
fertility	O
medications	O
were	O
largely	O
found	O
to	O
have	O
to	O
link	O
,	O
yet	O
reports	O
are	O
conflicted	O
.	O

They	O
have	O
stated	O
that	O
,	O
these	O
unexpected	O
results	O
could	O
be	O
due	O
to	O
genetic	O
differences	O
which	O
lead	O
to	O
a	O
disturbance	O
in	O
conversion	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
into	O
its	O
active	O
form	O
,	O
calcitriol	O
[	O
35	O
].	O

Furthermore	O
,	O
there	O
may	O
be	O
possible	O
fetal	O
sex	O
specific	O
differences	O
in	O
vitamin	O
D	O
status	O
worth	O
considering	O
in	O
future	O
studies	O
.	O

In	O
addition	O
,	O
regarding	O
the	O
distribution	O
of	O
the	O
women	O
across	O
categories	O
of	O
western	O
dietary	O
pattern	O
,	O
it	O
was	O
found	O
that	O
those	O
with	O
the	O
highest	O
adherence	O
had	O
significantly	O
higher	O
social	O
-	O
economic	O
level	O
,	O
employed	O
husband	O
,	O
history	O
of	O
cesarean	O
,	O
and	O
less	O
IUGR	O
and	O
stillbirth	O
history	O
.	O

In	O
pregnancy	O
,	O
acute	O
type	O
A	O
aortic	O
dissection	O
has	O
an	O
overall	O
incidence	O
of	O
0	O
.	O
4	O
cases	O
per	O
100	O
,	O
000	O
person	O
years	O
[	O
2	O
].	O

The	O
reproductive	O
safety	O
of	O
antipsychotic	O
medications	O
should	O
be	O
studied	O
in	O
the	O
reality	O
of	O
polytherapy	O
,	O
associated	O
comorbidities	O
and	O
environmental	O
and	O
genetic	O
confounders	O
.	O

However	O
,	O
allergen	O
avoidance	O
may	O
not	O
be	O
preventive	O
or	O
practical	O
in	O
all	O
cohorts	O
[	O
113	O
].	O

Results	O
from	O
the	O
Northern	O
Finland	O
1966	O
Birth	O
Cohort	O
showed	O
that	O
vitamin	O
D	O
supplementation	O
during	O
the	O
first	O
year	O
of	O
life	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
schizophrenia	O
in	O
males	O
,	O
but	O
not	O
in	O
women	O
[	O
32	O
].	O

Our	O
results	O
suggested	O
that	O
impaired	O
cardiac	O
autonomic	O
modulation	O
characterized	O
by	O
a	O
reduction	O
in	O
the	O
parasympathetic	O
activity	O
occurs	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

The	O
statistical	O
calculation	O
involved	O
is	O
the	O
linear	O
multiple	O
regression	O
:	O
fixed	O
model	O
,	O
single	O
regression	O
coefficient	O
.	O

Wistar	O
rats	O
(	O
age	O
100	O
±	O
5	O
days	O
)	O
were	O
time	O
mated	O
using	O
a	O
rat	O
estrous	O
cycle	O
monitor	O
to	O
assess	O
the	O
stage	O
of	O
estrous	O
before	O
introducing	O
the	O
male	O
.	O

Only	O
Mendez	O
et	O
al	O
.	O

Women	O
who	O
have	O
intestinal	O
malabsorption	O
diseases	O
like	O
celiac	O
disease	O
and	O
Crohn	O
'	O
s	O
disease	O
or	O
partial	O
removal	O
or	O
bypass	O
of	O
the	O
stomach	O
or	O
intestines	O
absorb	O
less	O
of	O
both	O
dietary	O
and	O
supplemental	O
vitamin	O
D	O
are	O
at	O
increased	O
risk	O
of	O
deficiency	O
.	O

If	O
this	O
is	O
the	O
case	O
,	O
adult	O
health	O
outcomes	O
may	O
reflect	O
season	O
of	O
birth	O
if	O
food	O
intake	O
is	O
seasonal	O
,	O
and	O
if	O
exposure	O
occurs	O
at	O
a	O
critical	O
stage	O
of	O
fetal	O
development	O
.	O

With	O
1	O
ng	O
/	O
mL	O
reduction	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
,	O
the	O
anxiety	O
and	O
depression	O
levels	O
increased	O
0	O
.	O
043	O
and	O
0	O
.	O
040	O
,	O
respectively	O
[	O
64	O
].	O

Evaluation	O
Data	O
collection	O
team	O
A	O
separate	O
team	O
of	O
trained	O
data	O
collectors	O
not	O
involved	O
in	O
the	O
implementation	O
of	O
the	O
intervention	O
will	O
collect	O
data	O
for	O
evaluation	O
.	O

At	O
the	O
postpartum	O
follow	O
-	O
up	O
,	O
the	O
overall	O
rate	O
declined	O
to	O
55	O
.	O
4	O
%	O
(	O
128	O
/	O
231	O
).	O

One	B
explanation	I
is	O
that	O
PFAS	O
interact	O
with	O
estrogen	O
receptors	O
and	O
disrupt	O
hormonal	O
balances	O
[	O
20	O
].	O

Results	O
Most	O
women	O
reported	O
multivitamin	O
763	O
/	O
1019	O
(	O
74	O
.	O
9	O
%)	O
use	O
before	O
and	O
/	O
or	O
early	O
in	O
pregnancy	O
.	O

To	O
assess	O
whether	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
increased	O
among	O
pregnant	O
patients	O
at	O
MUSC	O
during	O
this	O
time	O
period	O
,	O
first	O
test	O
results	O
and	O
test	O
results	O
closest	O
to	O
delivery	O
were	O
compared	O
using	O
a	O
paired	O
t	O
-	O
test	O
for	O
those	O
with	O
≥	O
2	O
tests	O
.	O

Studies	O
have	O
shown	O
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
is	O
associated	O
with	O
psychological	O
symptoms	O
like	O
anxiety	O
,	O
depression	O
and	O
reduced	O
cognitive	O
function	O
[	O
26	O
,	O
27	O
].	O

Although	O
the	O
precise	O
mechanism	O
is	O
unclear	O
,	O
it	O
is	O
thought	O
that	O
epigenetic	O
modifications	O
(	O
study	O
of	O
heritable	O
changes	O
in	O
gene	O
activity	O
that	O
are	O
not	O
caused	O
by	O
changes	O
in	O
the	O
DNA	O
sequence	O
)	O
play	O
a	O
role	O
in	O
both	O
neural	O
tube	O
defects	O
and	O
decreased	O
fertility	O
of	O
men	O
with	O
a	O
folate	O
deficiency	O
[	O
8	O
].	O

Our	O
study	O
did	O
not	O
find	O
a	O
difference	O
in	O
self	O
-	O
reported	O
physical	O
activity	O
across	O
the	O
seasons	O
.	O

Phase	O
3	O
data	O
are	O
collected	O
at	O
36	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
).	O

These	O
studies	O
do	O
not	O
necessarily	O
rule	O
out	O
an	O
epigenetic	O
mechanism	O
of	O
toxicity	O
per	O
se	O
,	O
but	O
they	O
do	O
exclude	B
a	O
link	O
between	O
the	O
specific	O
epigenetic	O
,	O
exposure	O
and	O
/	O
or	O
adverse	O
endpoints	O
/	O
markers	O
investigated	O
.	O

Due	O
to	O
the	O
low	O
PPV	O
and	O
high	O
NPV	O
,	O
we	O
excluded	O
from	O
further	O
analyses	O
women	O
who	O
self	O
-	O
reported	O
vaccination	O
status	O
but	O
did	O
not	O
present	O
evidence	O
of	O
vaccination	O
,	O
and	O
we	O
included	O
all	O
participants	O
who	O
self	O
-	O
reported	O
non	O
-	O
vaccination	O
status	O
.	O

A	O
total	O
of	O
100	O
children	O
were	O
identified	O
during	O
the	O
study	O
period	O
.	O

Primarily	O
utilized	O
by	O
monocytes	O
,	O
macrophages	O
,	O
mucosal	O
epithelial	O
cells	O
,	O
and	O
keratinocytes	O
as	O
part	O
of	O
the	O
innate	O
immune	O
system	O
,	O
these	O
cells	O
release	O
cathelicidin	O
along	O
with	O
other	O
cytokines	O
and	O
signal	O
molecules	O
as	O
a	O
first	O
line	O
of	O
defense	O
[	O
5	O
].	O

Implications	O
for	O
regulatory	O
toxicology	O
and	O
intervention	O
All	O
the	O
previous	O
considerations	O
are	O
vital	O
for	O
effective	O
regulatory	O
toxicology	O
and	O
potential	O
intervention	O
.	O

Interestingly	O
,	O
mice	O
carrying	O
additional	O
copies	O
of	O
Pten	O
(	O
Ptentgmice	O
)	O
are	O
not	O
only	O
protected	O
from	O
cancer	O
and	O
exhibit	O
extended	O
longevity	O
,	O
but	O
,	O
according	O
to	O
the	O
authors	O
,	O
they	O
also	O
present	O
enhanced	O
energy	O
expenditure	O
that	O
participates	O
in	O
counteracting	O
the	O
development	O
of	O
obesity	O
.	O

The	O
observed	O
difference	O
in	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
between	O
the	O
homozygous	O
gene	O
variants	O
was	O
higher	O
in	O
the	O
studies	O
by	O
Sollid	O
et	O
al	O
.	O

In	O
terms	O
of	O
the	O
polymorphisms	O
analyses	O
,	O
only	O
the	O
maternal	O
Tth111	O
I	O
polymorphism	O
was	O
suggestive	O
of	O
a	O
gene	O
-	O
environment	O
interaction	O
since	B
,	O
only	O
in	O
Tth111	O
I	O
(	O
CC	O
),	O
negative	O
versus	O
positive	O
/	O
neutral	O
maternal	O
attitudes	O
towards	O
the	O
pregnancy	O
predicted	O
fetal	O
weight	O
reduction	O
,	O
but	O
not	O
in	O
the	O
Tth111	O
I	O
(	O
GC	O
)	O
group	O
,	O
independent	O
of	O
important	O
confounders	O
.	O

To	O
this	O
end	O
,	O
a	O
variety	O
of	O
food	O
items	O
such	O
as	O
cereal	O
flour	O
(	O
maize	O
or	O
wheat	O
),	O
salt	O
,	O
beverage	O
,	O
milk	O
,	O
sugar	O
,	O
noodles	O
,	O
rice	O
,	O
and	O
fish	O
sauce	O
had	O
been	O
fortified	O
with	O
iron	O
and	O
used	O
successfully	O
as	B
dietary	O
supplements	O
to	O
boost	O
iron	O
stores	O
,	O
and	O
hence	B
improve	O
haemoglobin	O
levels	O
in	O
the	O
population	O
[	O
28	O
–	O
31	O
].	O

To	O
study	O
the	O
Vitamin	O
D	O
nutritional	O
status	O
of	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
and	O
analyze	O
the	O
different	O
sources	O
of	O
Vitamin	O
D	O
intake	O
.	O

We	O
highlight	O
evidence	O
-	O
based	O
interventions	O
along	O
the	O
continuum	O
of	O
care	O
,	O
noting	O
gaps	O
in	O
coverage	O
,	O
quality	O
,	O
equity	O
and	O
implications	O
for	O
integration	O
and	O
scale	O
up	O
.	O

Chi	O
-	O
square	O
test	O
was	O
used	O
to	O
examine	O
significant	O
differences	O
in	O
the	O
distribution	O
of	O
study	O
participants	O
in	O
terms	O
of	O
categorical	O
variables	O
across	O
different	O
quintile	O
categories	O
of	O
dietary	O
pattern	O
scores	O
.	O

Bell	O
and	O
Greenwood	O
[	O
158	O
]	O
also	O
suggest	O
that	O
effects	O
of	O
fetal	O
programming	O
during	O
early	O
-	O
mid	O
-	O
gestation	O
on	O
postnatal	O
growth	O
or	O
composition	O
are	O
generally	B
minor	O
.	O

Inconsistencies	O
in	O
the	O
literature	O
may	O
also	O
reflect	O
other	O
causative	O
factors	O
in	O
which	O
vitamin	O
D	O
is	O
a	O
mediator	O
.	O

Hence	B
,	O
we	O
aimed	O
this	O
study	O
to	O
assess	O
the	O
effectiveness	O
of	O
vitamin	O
D3supplementation	O
on	O
antenatal	O
and	O
postnatal	O
depression	O
levels	O
.	O

Receiving	O
advice	O
did	O
not	O
vary	O
by	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
χ	O
(	O
2	O
)	O
2	O
=	O
0	O
.	O
421	O
,	O
p	O
=	O
0	O
.	O
810	O
].	O

The	O
complex	O
interaction	O
of	O
nature	O
and	O
nurture	O
in	O
the	O
regulation	O
of	O
appetite	O
(	O
45	O
)	O
is	O
exemplified	O
by	O
a	O
behavior	O
known	O
as	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
(	O
EAH	O
),	O
a	O
behavioral	O
marker	O
of	O
impaired	O
satiety	O
(	O
46	O
-	O
49	O
).	O

Comparable	O
results	O
were	O
documented	O
with	O
dietary	O
supplements	O
containing	O
iron	O
and	O
ironfortified	O
milk	O
[	O
30	O
,	O
31	O
].	O

Firstly	O
,	O
children	O
develop	O
in	O
‘	O
spurts	O
’	O
rather	O
than	O
in	O
a	O
continuous	O
fashion	O
,	O
which	O
means	O
they	O
may	O
slip	O
in	O
and	O
out	O
of	O
the	O
‘	O
normal	O
’	O
reference	O
ranges	O
,	O
particularly	O
in	O
the	O
earlier	O
years	O
[	O
27	O
,	O
28	O
].	O

Priority	O
questions	O
:	O
What	O
is	O
the	O
‘	O
normal	O
’	O
epigenome	O
?	O

All	O
data	O
were	O
anonymised	O
to	O
maintain	O
participant	O
confidentiality	O
.	O

[	O
23	O
]	O
Preeclampsia	O
is	O
associated	O
with	O
low	O
circulating	O
levels	O
of	O
IGF	O
-	O
I	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
,	O
in	O
vitro	O
,	O
IGF	O
-	O
1	O
increases	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
production	O
by	O
primary	O
human	O
syncytiotrophoblasts	O
from	O
placentas	O
from	O
normal	O
pregnancies	O
but	O
not	O
from	O
preeclamptic	O
pregnancies	O
.	O

The	O
patients	O
were	O
asked	O
to	O
refer	O
to	O
Yazd	O
Diabetes	O
Research	O
Center	O
3	O
-	O
10	O
days	O
after	O
delivery	O
,	O
so	O
that	O
some	O
variables	O
are	O
recorded	O
,	O
and	O
their	O
anthropometric	O
parameters	O
such	O
as	O
heights	O
and	O
weights	O
are	O
measured	O
.	O

Steers	O
were	O
fed	O
the	O
same	O
total	O
digestible	O
nutrient	O
(	O
TDN	O
)	O
but	O
different	O
dietary	O
roughage	O
/	O
concentrate	O
ratios	O
(	O
low	O
-	O
concentrate	O
group	O
:	O
35	O
%	O
roughage	O
and	O
65	O
%	O
concentrate	O
;	O
high	O
-	O
concentrate	O
group	O
:	O
10	O
%	O
roughage	O
and	O
90	O
%	O
concentrate	O
).	O

Effects	O
of	O
nutritional	O
restriction	O
from	O
early	O
gestation	O
to	O
parturition	O
and	O
/	O
or	O
throughout	O
lactation	O
on	O
offspring	O
growth	O
and	O
production	O
characteristics	O
to	O
30	O
mo	O
of	O
age	O
and	O
health	O
and	O
reproductive	O
performance	O
of	O
cows	O
were	O
studied	O
in	O
large	O
maternal	O
grazing	O
systems	O
with	O
offspring	O
of	O
Hereford	O
cows	O
mated	O
to	O
Piedmontese	O
or	O
Wagyu	O
sires	O
[	O
33	O
].	O

After	O
adjusting	O
for	O
body	O
length	O
and	O
comparing	O
with	O
a	O
local	O
reference	O
,	O
the	O
high	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
still	O
had	O
significantly	O
lower	O
Rrs	O
than	O
did	O
the	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
(	O
Table	O
1	O
).	O

Discussion	O
3	O
.	O
1	O
.	O

Finally	O
,	O
the	O
cumulative	O
effects	O
of	O
multiple	O
factors	O
contribute	O
to	O
eating	O
behavior	O
and	O
obesity	O
(	O
3	O
).	O

In	O
addition	O
,	O
antibodies	O
can	O
be	O
transferred	O
to	O
the	O
child	O
via	O
placenta	O
(	O
IgG	O
,	O
IgA	O
)	O
or	O
breast	O
milk	O
(	O
IgA	O
,	O
IgG	O
,	O
IgM	O
,	O
IgE	O
),[	O
61	O
,	O
62	O
]	O
and	O
even	O
a	O
transamniotic	O
transfer	O
of	O
intact	O
maternal	O
IgE	O
into	O
the	O
amniotic	O
fluid	O
can	O
occur	O
[	O
63	O
].	O

Methods	O
We	O
conducted	O
a	O
review	O
of	O
literature	O
on	O
evidence	O
-	O
based	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
with	O
particular	O
reference	O
to	O
developing	O
countries	O
.	O

As	O
adults	O
these	O
animals	O
had	O
larger	O
lateral	O
ventricles	O
and	O
reduced	O
NGF	O
expression	O
compared	O
to	O
controls	O
[	O
8	O
].	O

As	O
a	O
result	O
,	O
26	O
items	O
were	O
included	O
in	O
the	O
final	O
analysis	O
.	O

First	O
,	O
Pearson	O
’	O
s	O
correlation	O
was	O
used	O
to	O
evaluate	O
the	O
relationship	O
between	O
dependent	O
variables	O
and	O
each	O
of	O
the	O
independent	O
variables	O
(	O
Tables1and2	O
).	O

In	O
order	O
to	O
compare	O
the	O
frequency	O
of	O
handwashing	O
during	O
the	O
observation	O
period	O
between	O
treatment	O
arms	O
,	O
we	O
used	O
mixed	O
linear	O
regression	O
to	O
calculate	O
the	O
difference	O
in	O
the	O
mean	O
number	O
of	O
observed	O
handwashing	O
events	O
between	O
arms	O
,	O
separately	O
among	O
and	O
other	O
household	O
members	O
,	O
in	O
an	O
intent	O
-	O
to	O
-	O
treat	O
analysis	O
.	O

The	O
YG	O
was	O
lowest	O
in	O
winter	O
and	O
highest	O
in	O
spring	O
and	O
summer	O
.	O

Staff	O
regularly	O
contacted	O
women	O
during	O
the	O
two	O
weeks	O
preceding	O
their	O
estimated	O
due	O
date	O
to	O
identify	O
births	O
as	O
soon	O
as	O
possible	O
after	O
delivery	O
;	O
women	O
and	O
their	O
families	O
were	O
also	O
encouraged	O
to	O
contact	O
study	O
staff	O
for	O
birth	O
notification	O
.	O

She	O
assessed	O
the	O
presence	O
of	O
fully	O
stocked	O
handwashing	O
stations	O
anywhere	O
in	O
the	O
home	O
and	O
specifically	O
in	O
the	O
room	O
where	O
the	O
newborn	O
spent	O
most	O
of	O
his	O
/	O
her	O
time	O
.	O

For	O
white	O
mothers	O
,	O
measurement	O
of	O
maternal	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
<	O
22	O
weeks	O
'	O
gestation	O
showed	O
a	O
U	O
-	O
shaped	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
risk	O
of	O
SGA	O
,	O
where	O
the	O
highest	O
risk	O
for	O
SGA	O
was	O
seen	O
with	O
both	O
low	O
and	O
high	O
vitamin	O
D	O
levels	O
.	O

Similarly	O
,	O
a	O
greater	O
proportion	O
of	O
offspring	O
from	O
overweight	O
/	O
obese	O
mothers	O
were	O
classified	O
as	O
macrosomic	O
(>	O
4000	O
grams	O
;	O
17	O
.	O
2	O
%	O
versus	O
4	O
.	O
8	O
%,	O
resp	O
.	O

Lastly	O
,	O
total	O
circulating	O
cathelicidin	O
was	O
measured	O
rather	O
than	O
cell	O
-	O
specific	O
mRNA	O
expression	O
of	O
cathelicidin	O
or	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3concentration	O
[	O
17	O
],	O
which	O
may	O
be	O
more	O
closely	O
linked	O
with	O
vitamin	O
D	O
status	O
during	O
fetal	O
and	O
childhood	O
development	O
.	O

Of	O
these	O
,	O
94	O
.	O
7	O
%	O
(	O
943	O
/	O
996	O
)	O
completed	O
a	O
baseline	O
survey	O
.	O

While	O
low	O
maternal	O
education	O
has	O
been	O
associated	O
with	O
higher	O
rates	O
of	O
excessive	O
weight	O
gain	O
[	O
2	O
],	O
our	O
study	O
did	O
not	O
find	O
any	O
significant	O
effect	O
of	O
maternal	O
education	O
on	O
weight	O
gain	O
target	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
the	O
MLR	O
approach	O
also	O
trended	O
in	O
the	O
same	O
direction	O
.	O

This	O
reduction	O
is	O
achievable	O
with	O
improved	O
essential	O
care	O
of	O
premature	O
babies	O
and	O
better	O
case	O
management	O
of	O
infections	O
and	O
respiratory	O
distress	O
syndrome	O
,	O
especially	O
since	B
the	O
deaths	O
of	O
moderately	O
-	O
preterm	O
babies	O
are	O
the	O
most	O
common	O
and	O
preventable	O
ones	O
.	O

Finally	O
,	O
the	O
candidates	O
were	O
referred	O
to	O
the	O
lab	O
in	O
order	O
to	O
provide	O
blood	O
samples	O
for	O
determining	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Many	O
Research	O
Gaps	O
to	O
Fill	O
Many	O
experts	B
point	O
out	O
that	O
the	O
health	O
benefits	O
of	O
breastfeeding	O
almost	B
always	I
outweigh	O
the	O
costs	O
of	O
exposure	O
to	O
environmental	O
chemicals	O
through	O
breast	O
milk	O
.	O
35Worldwide	O
,	O
breastfeeding	O
has	O
been	O
shown	O
to	O
lower	O
the	O
rate	O
of	O
infant	O
infection	O
,	O
and	O
in	O
developing	O
countries	O
it	O
is	O
strongly	B
protective	O
against	O
death	O
from	O
infection	O
in	O
the	O
first	O
few	O
years	O
of	O
life	O
.	O
36Breastfed	O
babies	O
also	O
are	O
less	O
likely	B
to	O
die	O
of	O
sudden	O
infant	O
death	O
syndrome	O
.	O
37Mothers	O
who	O
breastfeed	O
have	O
a	O
lower	O
risk	O
of	O
breast	O
cancer	O
later	O
in	O
life	O
.	O
38	O
In	O
the	O
developed	O
world	O
,	O
the	O
most	B
important	O
health	O
gains	O
associated	O
with	O
breastfeeding	O
may	O
be	O
cognitive	O
,	O
says	O
Kramer	O
.	O

Although	O
women	O
from	O
both	O
the	O
monotherapy	O
and	O
polytherapy	O
subgroups	O
did	O
not	O
differ	O
in	O
their	O
age	O
at	O
conception	O
,	O
pre	O
-	O
pregnancy	O
weight	O
,	O
pregnancy	O
weight	O
gain	O
and	O
neonatal	O
birth	O
weight	O
,	O
the	O
women	O
exposed	O
to	O
polytherapy	O
took	O
fewer	O
vitamins	O
,	O
smoked	O
more	O
cigarettes	O
,	O
experienced	O
a	O
significantly	O
shorter	O
gestation	O
,	O
tended	O
to	O
breastfeed	O
less	O
and	O
delivered	O
twice	O
as	O
many	O
LGA	O
neonates	O
.	O

Introduction	O
The	O
belief	O
that	O
the	O
sequence	O
of	O
our	O
DNA	O
(	O
our	O
genome	O
)	O
is	O
the	O
sole	O
determinant	O
of	O
our	O
life	O
-	O
long	O
development	O
and	O
health	O
has	O
long	O
been	O
regarded	O
as	B
too	O
simplistic	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
a	O
widespread	O
global	O
problem	O
,	O
which	O
even	O
can	O
observe	O
in	O
the	O
countries	O
which	O
get	O
enough	O
sunlight	O
[	O
49	O
,	O
51	O
].	O

This	O
multiplex	O
immune	O
-	O
assay	O
also	O
includes	O
the	O
acute	O
phase	O
proteins	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
and	O
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
),	O
as	O
well	O
as	O
the	O
malaria	O
marker	O
HRP2	O
and	O
thyroglobulin	O
,	O
which	O
is	O
a	O
marker	O
of	O
iodine	O
status	O
.	O

Increased	O
intestinal	O
calcium	O
absorption	O
seems	O
to	O
be	O
the	O
primary	O
mechanism	O
for	O
obtaining	O
extra	O
calcium	O
in	O
physiological	O
pregnancy	O
,	O
but	O
frequent	O
nausea	O
and	O
vomiting	O
or	O
sometimes	O
diarrhea	O
reduce	O
the	O
amount	O
of	O
calcium	O
absorbed	O
by	O
the	O
mother23	O
.	O

However	O
,	O
as	O
stated	O
above	O
,	O
all	O
10	O
of	O
the	O
studies	O
shown	O
inTable	O
1further	O
confirmed	O
identified	O
associations	O
between	O
environmental	O
exposures	O
,	O
specific	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
;	O
and	O
seven	O
of	O
the	O
10	O
studies	O
either	O
directly	O
sampled	O
the	O
target	O
tissue	O
or	O
validated	O
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	O
.	O

Serum	O
25	O
-	O
OHD	O
was	O
measured	O
by	O
radioimmunoassay	O
kit	O
methodology	O
(	O
DiaSorin	O
,	O
Stillwater	O
,	O
MN	O
).	O

Therefore	O
,	O
the	O
Nutrition	O
during	O
Pregnancy	O
and	O
Early	O
Development	O
(	O
NuPED	O
)	O
cohort	O
study	O
was	O
initiated	O
to	O
assess	O
early	O
nutrition	O
-	O
related	O
exposures	O
predictive	O
of	O
early	O
childhood	O
development	O
in	O
urban	O
South	O
Africa	O
.	O

For	O
3	O
women	O
information	O
on	O
the	O
trimester	O
was	O
missing	O
.	O

These	O
speculations	O
relate	O
two	O
studies	O
in	O
which	O
supplementation	O
of	O
a	O
single	O
large	O
dose	O
(	O
300	O
00033or	O
500	O
00023IU	O
)	O
of	O
vitamin	O
D	O
for	O
reducing	O
fractures	O
in	O
elderly	O
women	O
led	O
to	O
an	O
increase	O
in	O
fractures	O
,	O
plus	O
similar	O
discrepancies	O
in	O
prostate	O
cancer	O
research	O
with	O
vitamin	O
D	O
.	O
22Our	O
findings	O
and	O
particularly	O
the	O
slightly	O
higher	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
vitamin	O
D	O
group	O
could	O
be	O
due	O
to	O
such	O
fluctuations	O
if	O
the	O
hypothesis	O
is	O
true	B
.	O

Results	O
:	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
found	O
to	O
be	O
significantly	O
positively	O
associated	O
with	O
birth	O
weight	O
percentile	O
(	O
p	O
=	O
0	O
.	O
01	O
and	O
p	O
<	O
0	O
.	O
0001	O
,	O
respectively	O
)	O
and	O
were	O
found	O
to	O
differ	O
significantly	O
among	O
infants	O
exposed	O
to	O
tobacco	O
smoke	O
and	O
alcohol	O
.	O

In	O
the	O
same	O
study	O
,	O
patients	O
with	O
the	O
highest	O
concentrations	O
of	O
VD2had	O
the	O
lowest	O
glucose	O
concentration	O
in	O
follicular	O
fluid	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
[	O
61	O
].	O

These	O
findings	O
were	O
subsequently	O
corroborated	O
and	O
extended	O
by	O
others	O
,	O
including	O
,	O
Al	O
-	O
Delaimy	O
et	O
al	O
[	O
32	O
]	O
who	O
reported	O
that	O
self	O
-	O
reported	O
regular	O
snoring	O
was	O
independently	O
associated	O
with	O
a	O
2	O
-	O
fold	O
increased	O
risk	O
(	O
RR	O
=	O
2	O
.	O
03	O
;	O
95	O
%	O
CI	O
1	O
.	O
71	O
-	O
2	O
.	O
40	O
)	O
of	O
developing	O
type	O
2	O
diabetes	O
over	O
a	O
10	O
-	O
year	O
follow	O
-	O
up	O
period	O
.	O

Finally	O
,	O
PFAS	O
affect	O
adipose	O
tissue	O
development	O
and	O
the	O
regulatory	O
systems	O
involved	O
in	O
body	O
weight	O
homeostasis	O
,	O
which	O
may	O
impact	O
fetal	O
growth	O
outcomes	O
[	O
20	O
],	O
including	O
those	O
that	O
occur	O
after	O
birth	O
such	O
as	O
infant	O
mortality	O
or	O
cardiovascular	O
disease	O
which	O
are	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
[	O
16	O
,	O
17	O
].	O

Infants	O
with	O
lower	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(<	O
13	O
.	O
7	O
ng	O
/	O
ml	O
)	O
had	O
higher	O
resistance	O
of	O
respiratory	O
system	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
a	O
higher	O
risk	O
of	O
a	O
respiratory	O
tract	O
infection	O
before	O
the	O
age	O
of	O
6	O
months	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

The	O
threshold	O
of	O
≥	O
10	O
was	O
used	O
based	O
on	O
the	O
EPDS	O
[	O
62	O
].	O

They	O
opined	O
that	O
sufficient	O
attention	O
should	O
be	O
paid	O
to	O
adolescent	O
girls	O
and	O
women	O
of	O
reproductive	O
age	O
long	O
before	O
pregnancy	O
and	O
suggested	O
intermittent	O
low	O
-	O
dose	O
iron	O
supplements	O
and	O
in	O
some	O
cases	O
,	O
combined	O
with	O
necessary	O
micronutrients	O
[	O
36	O
,	O
37	O
].	O

Examining	O
large	O
groups	O
of	O
VD	O
-	O
deficient	O
patients	O
should	O
not	O
be	O
a	O
problem	O
—	O
most	O
societies	O
are	O
VD	O
-	O
deficient	O
either	O
way	O
.	O

Furthermore	O
,	O
the	O
study	O
field	O
-	O
supervisors	O
mapped	O
the	O
region	O
independently	O
to	O
verify	O
the	O
accuracy	O
of	O
the	O
maps	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
and	O
during	O
recruitment	O
they	O
visited	O
every	O
house	O
in	O
the	O
mapped	O
region	O
to	O
identify	O
families	O
with	O
young	O
children	O
.	O

Outcomes	O
SGA	O
was	O
defined	O
as	O
either	O
weight	O
or	O
length	O
at	O
birth	O
below	O
2	O
SD	O
of	O
the	O
gender	O
-	O
specific	O
population	O
mean	O
[	O
14	O
].	O

Litter	O
size	O
during	O
suckling	O
was	O
standardised	O
to	O
11	O
piglets	O
per	O
sow	O
.	O

In	O
both	O
models	O
,	O
we	O
observed	O
a	O
trend	O
whereby	O
the	O
later	O
in	O
pregnancy	O
a	O
women	O
received	O
vaccination	O
the	O
lower	O
her	O
adjusted	O
odds	O
of	O
PTB	O
.	O

Whether	O
the	O
greater	O
bioavailability	O
of	O
calcium	O
from	O
human	O
milk	O
compared	O
to	O
formula	O
affects	O
the	O
needed	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
by	O
infants	O
is	O
unknown	O
.	O

Results	O
Cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
significantly	O
lower	O
in	O
Hispanic	O
than	O
non	O
-	O
Hispanic	O
Caucasian	O
infants	O
(	O
16	O
.	O
4	O
±	O
6	O
.	O
5	O
ng	O
/	O
mL	O
,	O
n	O
=	O
27	O
,	O
vs	O
22	O
.	O
3	O
±	O
9	O
.	O
4	O
n	O
=	O
22	O
,	O
p	O
=	O
0	O
.	O
013	O
).	O

Percentage	O
differences	O
in	O
metabolic	O
markers	O
were	O
calculated	O
using	O
the	O
equation	O
:	O
([	O
eB	O
-	O
1	O
]*	O
100	O
).	O

Similarly	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
with	O
regards	O
to	O
the	O
individual	O
components	O
of	O
the	O
Ages	O
and	O
Stages	O
score	O
(	O
Table	O
3	O
).	O

BAT	O
activity	O
is	O
well	O
known	O
to	O
mostly	O
rely	O
on	O
lipid	O
metabolism	O
,	O
UCP1	O
being	O
directly	O
activated	O
by	O
fatty	O
acids	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

Rates	O
of	O
hypocalcaemia	O
(<	O
2	O
.	O
25mmol	O
/	O
L	O
)	O
fell	O
steadily	O
(	O
42	O
.	O
4	O
%	O
vs	O
32	O
.	O
3	O
%	O
vs	O
24	O
.	O
8	O
%	O
%,	O
χ2P	O
<	O
0	O
.	O
001	O
).	O

2009	O
).	O

There	O
are	O
two	O
known	O
factors	O
which	O
contribute	O
to	O
development	O
of	O
iron	O
deficiency	O
anaemia	O
(	O
IDA	O
)	O
in	O
pregnancy	O
;	O
the	O
first	O
is	O
the	O
woman	O
'	O
s	O
iron	O
stores	O
at	O
the	O
time	O
of	O
conception	O
and	O
the	O
second	O
is	O
the	O
amount	O
of	O
iron	O
absorbed	O
during	O
gestation	O
.	O

No	O
reliably	O
effective	O
chemotherapeutic	O
regimen	O
has	O
been	O
identified	O
.	O

Little	O
is	O
known	O
about	O
the	O
dietary	O
behaviour	O
and	O
nutritional	O
status	O
of	O
pregnant	O
women	O
living	O
in	O
South	O
Africa	O
.	O

The	O
different	O
dietary	O
exposure	O
of	O
the	O
offspring	O
during	O
prenatal	O
development	O
can	O
be	O
expected	O
to	O
cause	O
slight	O
shifts	O
of	O
the	O
developmental	O
age	O
of	O
the	O
offspring	O
that	O
may	O
be	O
reflected	O
by	O
subtle	O
changes	O
of	O
the	O
transcriptome	O
and	O
could	O
hamper	O
the	O
identification	O
of	O
direct	O
effects	O
of	O
the	O
gestational	O
diets	O
on	O
the	O
hepatic	O
expression	O
.	O

Characteristics	O
of	O
the	O
women	O
and	O
the	O
live	O
born	O
infants	O
are	O
shown	O
in	O
Table	O
1	O
.	O

A	O
non	O
parametric	O
test	O
(	O
Mann	O
Whitney	O
U	O
test	O
)	O
was	O
used	O
whenever	O
the	O
continuous	O
measures	O
were	O
not	O
normally	O
distributed	O
.	O

Maternal	O
vitamin	O
D	O
deficiency	O
may	O
also	O
have	O
contributed	O
to	O
an	O
increased	O
number	O
of	O
glomeruli	O
,	O
thus	B
producing	O
smaller	O
glomeruli	O
than	O
in	O
animals	O
fed	O
SC	O
.	O

Ayurvedic	O
diet	O
in	O
pregnancy	O
Abstract	O
Purpose	O
:	O
The	O
fast	O
changing	O
life	O
style	O
of	O
the	O
modern	O
era	O
has	O
caused	O
increase	O
in	O
the	O
pregnancy	O
complications	O
,	O
anamolies	O
etc	O
.	O

Gernand	O
et	O
al	O
.	O
22also	O
examined	O
second	O
-	O
trimester	O
vitamin	O
D	O
levels	O
and	O
risk	O
of	O
SGA	O
in	O
a	O
population	O
at	O
risk	O
of	O
pre	O
-	O
eclampsia	O
.	O

This	O
questionnaire	O
has	O
been	O
well	O
validated	O
[	O
23	O
]	O
and	O
validated	O
in	O
pregnancy	O
[	O
24	O
].	O

Therefore	B
,	O
the	O
down	O
-	O
regulation	O
of	O
cell	O
cycle	O
regulating	O
pathways	O
might	O
lead	O
to	O
a	O
lengthened	O
cell	O
cycle	O
in	O
LP	O
fetuses	O
and	O
offspring	O
[	O
27	O
]	O
and	O
cumulate	O
in	O
growth	O
retardation	O
in	O
LP	O
fetuses	O
.	O

For	O
example	O
,	O
researchers	O
have	O
reported	O
a	O
common	O
occurrence	O
of	O
unbooked	O
pregnancies	O
[	O
49	O
,	O
50	O
]	O
and	O
a	O
wide	O
range	O
(	O
60	O
%	O
to	O
90	O
%)	O
of	O
antenatal	O
care	O
utilization	O
rates	O
(	O
i	O
.	O
e	O
.,	O
antenatal	O
care	O
clinic	O
attendance	O
of	O
at	O
least	O
once	O
during	O
most	O
recent	O
pregnancy	O
)	O
[	O
51	O
–	O
53	O
].	O

Two	O
previous	O
studies	O
have	O
investigated	O
but	O
not	O
found	O
any	O
association	O
between	O
25OHD	O
and	O
miscarriage	O
[	O
5	O
,	O
13	O
].	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

Within	O
24	O
hours	O
of	O
delivery	O
,	O
each	O
litter	O
was	O
culled	O
to	O
10	O
pups	O
to	O
minimize	O
the	O
difference	O
in	O
milk	O
availability	O
.	O

The	O
odds	O
of	O
belonging	O
to	O
the	O
cluster	O
2	O
were	O
2	O
.	O
36	O
times	O
greater	O
for	O
each	O
additional	O
maternal	O
serving	O
of	O
dairy	O
per	O
day	O
(	O
95	O
%	O
CI	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
;	O
Fig	O
.	O

The	O
ECS	O
keeps	O
a	O
homeostatic	O
role	O
in	O
regulating	O
energy	O
balance	O
and	O
food	O
intake	O
(	O
Cristino	O
et	O
al	O
.,	O
2014	O
),	O
and	O
its	O
overactivation	O
,	O
mainly	O
via	O
CB1	O
receptors	O
,	O
favors	O
the	O
energy	O
accumulation	O
,	O
increases	O
the	O
appetite	O
for	O
highly	O
palatable	O
foods	O
,	O
decreases	O
the	O
satiety	O
and	O
reduces	O
the	O
energy	O
expenditure	O
.	O

Although	O
an	O
assessment	O
was	O
conducted	O
at	O
6	O
months	O
post	O
-	O
partum	O
involving	O
66	O
%	O
of	O
participants	O
[	O
18	O
],	O
there	O
have	O
been	O
no	O
early	O
infant	O
outcomes	O
reported	O
to	O
date	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Numerous	O
individual	O
nutrients	O
consumed	O
by	O
the	O
mother	O
during	O
pregnancy	O
have	O
been	O
suggested	O
as	O
being	O
preventive	O
for	O
development	O
of	O
atopic	O
diseases	O
in	O
the	O
child	O
;	O
these	O
include	O
apples	O
or	O
fish	O
,[	O
80	O
]	O
vitamin	O
D	O
,[	O
107	O
]	O
vitamin	O
E	O
,[	O
108	O
]	O
and	O
various	O
probiotics	O
,	O
the	O
latter	O
having	O
been	O
shown	O
to	O
be	O
effective	O
in	O
mouse	O
models	O
[	O
109	O
]	O
and	O
human	O
studies	O
[	O
110	O
].	O

Then	O
,	O
the	O
hypothalamus	O
was	O
dissected	O
out	O
from	O
the	O
base	O
of	O
the	O
brain	O
according	O
the	O
rat	O
brain	O
atlas	O
of	O
Paxinos	O
and	O
Watson	O
(	O
2007	O
).	O

Smears	O
were	O
then	O
visualised	O
under	O
a	O
light	O
microscope	O
and	O
digital	O
images	O
captured	O
,	O
which	O
were	O
re	O
-	O
assessed	O
for	O
the	O
proportion	O
of	O
three	O
cell	O
types	O
:	O
epithelial	O
cells	O
,	O
cornified	O
cells	O
,	O
and	O
leukocytes	O
.	O

More	O
frequent	O
intake	O
of	O
foods	O
containing	O
or	O
fortified	O
with	O
vitamin	O
D	O
(	O
e	O
.	O
g	O
.	O

Variations	O
in	O
visfatin	O
level	O
during	O
pregnancy	O
Mean	O
non	O
-	O
fasting	O
serum	O
visfatin	O
level	O
of	O
participating	O
mothers	O
(	O
n	O
=	O
41	O
)	O
was	O
59	O
.	O
4	O
±	O
68	O
.	O
01	O
ng	O
/	O
mL	O
(	O
range	O
,	O
4	O
.	O
9	O
-	O
234	O
ng	O
/	O
mL	O
)	O
in	O
the	O
first	O
trimester	O
,	O
and	O
76	O
.	O
98	O
±	O
75	O
.	O
55	O
ng	O
/	O
mL	O
(	O
range	O
,	O
4	O
.	O
6	O
-	O
248	O
ng	O
/	O
mL	O
)	O
in	O
the	O
second	O
trimester	O
,	O
and	O
variations	O
in	O
visfatin	O
level	O
were	O
reported	O
as	O
17	O
.	O
58	O
±	O
26	O
.	O
46	O
ng	O
/	O
mL	O
.	O

An	O
increase	O
in	O
maternal	O
blood	O
glucose	O
leads	O
to	O
a	O
rise	O
in	O
fetal	O
blood	O
glucose	O
,	O
which	O
in	O
turn	O
stimulates	O
fetal	O
pancreatic	O
islet	O
cells	O
,	O
resulting	O
in	O
hyperinsulinemia	O
.	O

Mothers	O
also	O
took	O
individual	O
micronutrient	O
supplements	O
(	O
e	O
.	O
g	O
.,	O
vitamin	O
C	O
tablets	O
),	O
but	O
most	O
mothers	O
who	O
took	O
these	O
also	O
took	O
multivitamins	O
,	O
making	O
it	O
impossible	O
to	O
determine	O
potential	O
independent	O
effects	O
of	O
these	O
micronutrients	O
.	O

As	O
was	O
recently	O
pointed	O
out	O
in	O
a	O
Cochrane	O
review	O
,	O
the	O
topic	O
of	O
maternal	O
vitamin	O
D	O
requirements	O
during	O
pregnancy	O
has	O
been	O
poorly	O
studied	O
.	O

In	O
infants	O
with	O
risk	O
of	O
allergy	O
,	O
introduction	O
of	O
solid	O
foods	O
in	O
general	O
should	O
be	O
postponed	O
until	O
6	O
months	O
of	O
age	O
,	O
milk	O
products	O
until	O
12	O
months	O
,	O
hen	O
'	O
s	O
egg	O
until	O
24	O
months	O
,	O
and	O
peanut	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
until	O
at	O
least	O
36	O
months	O
.	O

129S1	O
male	O
G0	O
mutagenized	O
mice	O
were	O
crossed	O
to	O
129X1	O
females	O
and	O
the	O
resulting	O
G1	O
males	O
were	O
outcrossed	O
to	O
DBA	O
/	O
2J	O
females	O
to	O
generate	O
G2	O
progeny	O
.	O

For	O
example	O
,	O
the	O
Antenatal	O
Care	O
package	O
may	O
start	O
as	O
the	O
WHO	O
focused	O
four	O
visit	O
package	O
and	O
then	O
later	O
add	O
on	O
diabetes	O
screening	O
and	O
routine	O
ultra	O
-	O
sound	O
as	O
the	O
system	O
capacity	O
and	O
funding	O
increases	O
[	O
26	O
].	O

PubMed	O
Central	O
:	O

Nutrition	O
during	O
pregnancy	O
is	O
an	O
important	O
factor	O
associated	O
with	O
both	O
maternal	O
and	O
infant	O
health	O
outcomes	O
[	O
80	O
].	O

The	O
Skm1	O
mutation	O
lies	O
within	O
the	O
Npr3	O
gene	O
coding	O
for	O
natriuretic	O
peptide	O
receptor	O
C	O
(	O
NPR	O
-	O
C	O
).	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
was	O
measured	O
with	O
the	O
Chemiluminescence	O
immunoassay	O
(	O
CLIA	O
)	O
method	O
[	O
45	O
].	O

For	O
adding	O
a	O
poly	O
-	O
A	O
tail	O
to	O
the	O
end	O
of	O
each	O
RNA	O
transcript	O
,	O
the	O
total	O
RNA	O
was	O
treated	O
with	O
the	O
Poly	O
(	O
A	O
)	O
Tailing	O
Kit	O
(	O
Ambion	O
,	O
AM1350	O
).	O

The	O
development	O
of	O
adipose	O
tissue	O
coincides	O
with	O
myogenesis	O
during	O
a	O
particular	O
time	O
in	O
fetal	O
development	O
[	O
18	O
].	O

Nulliparous	O
and	O
multiparous	O
pregnant	O
women	O
were	O
entered	O
into	O
this	O
study	O
.	O

Misclassification	O
of	O
fish	O
and	O
PUFA	O
or	O
vitamin	O
D	O
intake	O
due	O
to	O
measurement	O
error	O
associated	O
with	O
the	O
food	O
frequency	O
questionnaire	O
is	O
unavoidable	O
,	O
but	O
given	B
the	O
study	O
design	O
likely	B
non	O
-	O
differential	O
,	O
and	O
thus	B
attenuating	O
any	O
true	B
association	O
.	O

In	O
the	O
treatment	O
group	O
,	O
the	O
aim	O
was	O
to	O
maintain	O
a	O
fasting	O
glucose	O
level	O
of	O
<	O
5	O
.	O
5	O
mmol	O
/	O
L	O
,	O
and	O
2	O
hour	O
post	O
-	O
prandial	O
reading	O
<	O
7	O
.	O
0	O
mmol	O
/	O
L	O
.	O

Based	O
on	O
these	O
assumptions	O
,	O
80	O
%	O
power	O
,	O
and	O
a	O
.	O
05	O
significance	O
level	O
,	O
we	O
estimated	O
that	O
we	O
would	O
need	O
to	O
conduct	O
3	O
-	O
hour	O
structured	O
observations	O
among	O
80	O
respondents	O
in	O
each	O
study	O
arm	O
.	O

PubMed	O
Central	O
:	O

Low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
low	O
household	O
income	O
,	O
and	O
poorer	O
ratings	O
of	O
the	O
child	O
’	O
s	O
general	O
health	O
were	O
significantly	O
associated	O
with	O
S	O
-	O
ECC	O
on	O
logistic	O
regression	O
.	O

The	O
cost	O
of	O
coverage	O
with	O
weekly	O
iron	O
-	O
folic	O
acid	O
is	O
comparable	O
to	O
program	O
estimates	O
for	O
distribution	O
of	O
other	O
nutritional	O
supplements	O
such	O
as	O
twice	O
-	O
yearly	O
vitamin	O
A	O
,	O
and	O
zinc	O
.	O

There	O
were	O
420	O
fathers	O
with	O
height	O
and	O
weight	O
recorded	O
when	O
the	O
child	O
was	O
aged	O
5	O
,	O
but	O
most	O
of	O
these	O
were	O
based	O
on	O
partners	O
’	O
self	O
-	O
report	O
and	O
only	O
77	O
were	O
measured	O
.	O

Case	O
Report	O
A	O
previously	O
healthy	O
47	O
-	O
year	O
-	O
old	O
woman	O
in	O
her	O
33rd	O
week	O
of	O
twin	O
gestation	O
presented	O
with	O
progressive	O
lethargy	O
,	O
confusion	O
,	O
polydipsia	O
,	O
and	O
polyuria	O
for	O
approximately	O
one	O
month	O
.	O

),	O
regression	O
coefficient	O
(	O
standard	O
error	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t004	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Multivariate	O
logistic	O
regression	O
analysis	O
for	O
clinical	O
outcome	O
(	O
ever	O
RTI	O
till	O
6	O
months	O
of	O
age	O
).	O
OR95	O
%	O
CIp	O
valueLow	O
cord	O
25	O
(	O
OH	O
)	O
D7	O
.	O
6131	O
.	O
71	O
–	O
33	O
.	O
89	O
0	O
.	O
008	O
Z	O
score	O
of	O
VmaxFRC1	O
.	O
7290	O
.	O
846	O
–	O
3	O
.	O
5330	O
.	O
133Ever	O
eczema	O
at	O
6	O
months0	O
.	O
3220	O
.	O
034	O
–	O
3	O
.	O
0330	O
.	O
322Postnatal	O
smoke	O
exposure1	O
.	O
5760	O
.	O
402	O
–	O
6	O
.	O
1720	O
.	O
514Male0	O
.	O
4540	O
.	O
105	O
–	O
1	O
.	O
9660	O
.	O
454	O
OR	O
,	O
odd	O
ratio	O
;	O
CI	O
,	O
confidence	O
interval	O
.	O

Infant	O
lung	O
function	O
testing	O
Measurements	O
were	O
taken	O
of	O
healthy	O
infants	O
who	O
had	O
had	O
no	O
respiratory	O
tract	O
infection	O
for	O
at	O
least	O
3	O
weeks	O
.	O

Impact	O
of	O
perinatal	O
nutritional	O
changes	O
Epidemiological	O
evidence	O
in	O
humans	O
strongly	O
suggests	O
that	O
the	O
intrauterine	O
and	O
early	O
postnatal	O
environments	O
have	O
a	O
significant	O
long	O
-	O
term	O
influence	O
on	O
body	O
weight	O
and	O
energy	O
homeostasis	O
in	O
offspring	O
(	O
for	O
rev	O
.,	O
see	O
Breton	O
,	O
2013	O
).	O

PubMed	O
Central	O
:	O

Specifically	O
,	O
each	O
of	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
are	O
simultaneously	O
evaluated	O
for	O
their	O
association	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
extent	O
and	O
the	O
genomic	O
locations	O
or	O
TFBS	O
that	O
are	O
overrepresented	O
within	O
1	O
kb	O
of	O
the	O
loci	O
[	O
for	O
the	O
GSEA	O
results	O
,	O
see	O
Supplemental	O
Material	O
,	O
Figure	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

A	O
similar	O
analysis	O
of	O
change	O
is	O
conducted	O
for	O
height	O
.	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
and	O
a	O
higher	O
restriction	O
in	O
total	O
caloric	O
intake	O
after	O
the	O
administration	O
of	O
AM251	O
,	O
a	O
CB1	O
receptor	O
inverse	O
agonist	O
with	O
anorexigenic	O
and	O
anti	O
-	O
obesity	O
properties	O
.	O

Therefore	B
,	O
this	O
group	O
received	O
two	O
1000	O
unit	O
vitamin	O
D3pills	O
(	O
Totally	O
2000	O
IU	O
)	O
daily	O
from	O
the	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
until	O
childbirth	O
.	O

Overall	O
,	O
handedness	O
appears	O
to	O
be	O
a	O
surrogate	O
marker	O
for	O
an	O
underlying	O
but	O
unidentified	O
risk	O
factor	O
that	O
interacts	O
with	O
seasonality	O
and	O
other	O
factors	O
to	O
possibly	O
explain	O
glioma	O
risk	O
.	O

Methods	O
Participants	O
Between	O
Nov	O
4	O
and	O
Dec	O
4	O
,	O
2008	O
,	O
we	O
did	O
a	O
community	O
based	O
randomised	O
placebo	O
-	O
controlled	O
superiority	O
trial	O
in	O
Kabul	O
,	O
Afghanistan	O
,	O
within	O
the	O
catchment	O
area	O
of	O
the	O
Maiwand	O
Teaching	O
Hospital	O
,	O
which	O
serves	O
an	O
inner	O
-	O
city	O
population	O
.	O

The	O
independent	O
and	O
paired	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
quantitative	O
variables	O
,	O
the	O
chi	O
-	O
square	O
test	O
was	O
used	O
for	O
qualitative	O
variables	O
,	O
and	O
the	O
Mann	O
-	O
Whitney	O
U	O
and	O
Wilcoxon	O
Signed	O
-	O
Rank	O
tests	O
were	O
used	O
for	O
non	O
-	O
normally	O
distributed	O
variables	O
.	O

While	O
there	O
is	O
still	O
room	O
for	O
much	O
further	O
research	O
,	O
current	O
understanding	O
suggests	O
that	O
length	O
of	O
labor	O
is	O
possibly	O
associated	O
with	O
autism	O
.	O

The	O
HFol	O
pup	O
diet	O
reduced	O
SeroR2A	O
expression	O
in	O
mature	O
offspring	O
of	O
the	O
dams	O
fed	O
the	O
HV	O
diet	O
,	O
but	O
not	O
by	O
the	O
HV	O
pup	O
diet	O
(	O
Figure	O
5b	O
).	O

Medical	O
history	O
of	O
bone	O
mineral	O
metabolic	O
disease	O
;	O
2	O
).	O

The	O
mean	O
age	O
of	O
the	O
respondents	O
was	O
25	O
.	O
2	O
years	O
(	O
SD	O
5	O
.	O
1	O
).	O

A	O
study	O
examined	O
the	O
incidence	O
of	O
autism	O
in	O
the	O
neonatal	O
intensive	O
care	O
unit	O
and	O
risk	O
factors	O
connected	O
with	O
autistic	O
development	O
.	O

Women	O
who	O
delivered	O
a	O
live	O
-	O
born	O
infant	O
but	O
who	O
were	O
not	O
included	O
in	O
this	O
analysis	O
due	O
to	O
missing	O
25	O
(	O
OH	O
)	O
D	O
or	O
genetic	O
analysis	O
were	O
of	O
similar	O
age	O
,	O
smoking	O
status	O
,	O
and	O
BMI	O
to	O
those	O
included	O
in	O
the	O
analysis	O
(	O
P	O
>	O
0	O
.	O
05	O
for	O
all	O
).	O

However	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
in	O
Japan	O
,	O
higher	O
dietary	O
vitamin	O
D	O
intake	O
was	O
independently	O
associated	O
with	O
a	O
lower	O
prevalence	O
of	O
depressive	O
symptoms	O
during	O
pregnancy	O
[	O
66	O
].	O

More	O
studies	O
that	O
incorporate	O
some	O
form	O
of	O
inhibition	O
/	O
treatment	O
/	O
cessation	O
into	O
the	O
experimental	O
design	O
are	O
vital	O
for	O
establishing	O
whether	O
or	O
not	O
an	O
exposure	O
truly	O
represents	O
an	O
epigenetic	O
toxicant	O
.	O

(	O
A	O
)	O
Genome	O
-	O
wide	O
linkage	O
analysis	O
of	O
the	O
visible	O
mutants	O
(	O
Skm1	O
,	O
left	O
panel	O
;	O
Skm2	O
,	O
right	O
panel	O
)	O
was	O
conducted	O
with	O
12	O
animals	O
(	O
6	O
mutant	O
and	O
6	O
normal	O
)	O
using	O
polymorphic	O
markers	O
informative	O
for	O
the	O
129S1	O
and	O
DBA	O
/	O
2J	O
parents	O
.	O

Before	O
the	O
tests	O
,	O
body	O
weight	O
was	O
measured	O
and	O
crown	O
—	O
heel	O
length	O
was	O
obtained	O
on	O
a	O
measuring	O
board	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
age	O
,	O
gestational	O
week	O
or	O
pre	O
-	O
pregnancy	O
BMI	O
between	O
participants	O
in	O
intervention	O
group	O
and	O
control	O
group	O
.	O

In	O
the	O
second	O
trimester	O
,	O
blood	O
volume	O
increases	O
by	O
45	O
%	O
with	O
an	O
increase	O
in	O
plasma	O
volume	O
of	O
50	O
%;	O
red	O
cell	O
mass	O
is	O
raised	O
by	O
35	O
%	O
which	O
amounts	O
to	O
about	O
450	O
mg	O
of	O
iron	O
in	O
a	O
55	O
kg	O
woman	O
[	O
4	O
].	O

We	O
monitored	O
the	O
control	O
group	O
to	O
ensure	O
that	O
none	O
of	O
these	O
participants	O
separately	O
enrolled	O
for	O
text4baby	O
(	O
none	O
did	O
).	O

(	O
C	O
)	O
Skm2	O
mice	O
exhibit	O
severe	O
scoliosis	O
and	O
lordosis	O
.	O

However	O
,	O
at	O
childbirth	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
in	O
comparison	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Daily	O
use	O
of	O
iron	O
supplements	O
is	O
effective	O
when	O
administered	O
under	O
supervision	O
in	O
clinical	O
interventional	O
trials	O
,	O
but	O
is	O
less	O
so	O
in	O
public	O
health	O
programmes	O
because	O
of	O
difficulty	O
engaging	O
with	O
the	O
target	O
population	O
.	O

Nevertheless	O
there	O
is	O
a	O
consensus	B
to	O
consider	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
ml	O
as	O
inadequately	O
low	O
[	O
25	O
],	O
and	O
some	O
evidence	O
suggests	O
that	O
values	O
higher	O
than	O
30	O
ng	O
/	O
ml	O
may	O
be	O
associated	O
with	O
better	O
health	O
outcomes	O
in	O
the	O
adult	O
population	O
.[	O
26	O
],[	O
27	O
].	O

Trafficking	O
of	O
cells	O
could	O
therefore	B
be	O
responsible	O
for	O
the	O
passing	O
of	O
allergy	O
risk	O
from	O
mother	O
to	O
fetus	O
.	O

The	O
George	O
Washington	O
University	O
approved	O
this	O
study	O
under	O
an	O
institutional	O
agreement	O
with	O
the	O
Department	O
of	O
Defense	O
(	O
DOD	O
)	O
Human	O
Research	O
Protection	O
Program	O
on	O
August	O
1	O
,	O
2011	O
.	O

All	O
nutrient	O
values	O
were	O
energy	O
-	O
adjusted	O
using	O
the	O
residuals	O
method	O
.	O

2011	O
),	O
and	O
the	O
use	O
of	O
forward	O
genetics	O
screens	O
has	O
been	O
shown	O
to	O
be	O
a	O
valuable	O
tool	O
for	O
the	O
discovery	O
of	O
mutations	O
that	O
are	O
important	O
during	O
skeletogenesis	O
in	O
the	O
mouse	O
(	O
Mohan	O
et	O
al	O
.	O

household	O
income	O
,	O
parental	O
education	O
,	O
etc	O
.).	O

According	O
to	B
our	I
knowledge	I
,	O
there	O
was	O
no	O
clinical	O
trial	O
that	O
has	O
evaluated	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
perinatal	O
depression	O
.	O

CQ	O
analyzed	O
the	O
data	O
.	O

Data	O
are	O
collected	O
on	O
dual	O
core	O
electronic	O
archives	O
with	O
automatic	O
backup	O
.	O

Research	O
indicates	O
that	O
adequate	O
vitamin	O
D	O
intake	O
in	O
pregnancy	O
is	O
optimal	O
for	O
maternal	O
,	O
fetal	O
and	O
child	O
health	O
.	O

Women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
received	O
a	O
comprehensive	O
intervention	O
over	O
the	O
course	O
of	O
their	O
pregnancy	O
that	O
included	O
a	O
combination	O
of	O
dietary	O
,	O
exercise	O
and	O
behavioural	O
strategies	O
,	O
delivered	O
by	O
a	O
research	O
dietician	O
and	O
trained	O
research	O
assistants	O
[	O
22	O
].	O

Nonetheless	O
,	O
such	O
supplements	O
are	O
not	O
universally	O
consumed	O
by	O
the	O
population	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
.	O

According	O
to	O
the	O
national	O
guidelines	B
,	O
GDM	O
was	O
diagnosed	O
if	O
the	O
OGTT	O
results	O
exceeded	O
cut	O
-	O
offs	O
for	O
one	O
or	O
more	O
values	O
:	O
fasting	O
plasma	O
glucose	O
≥	O
5	O
.	O
3	O
mmol	O
/	O
l	O
,	O
1	O
-	O
h	O
≥	O
10	O
.	O
0	O
mmol	O
/	O
l	O
and	O
2	O
-	O
h	O
≥	O
8	O
.	O
6	O
mmol	O
/	O
l	O
[	O
19	O
].	O

It	O
is	O
also	O
possible	O
that	O
associations	O
between	O
maternal	O
exposures	O
and	O
infant	O
microbiota	O
at	O
6	O
weeks	O
of	O
life	O
are	O
influenced	O
by	O
factors	O
not	O
investigated	O
in	O
this	O
study	O
.	O

Far	O
fewer	O
studies	O
have	O
examined	O
the	O
relationship	O
between	O
cord	O
blood	O
vitamin	O
D	O
levels	O
,	O
which	O
may	O
more	O
accurately	B
reflect	O
fetal	O
levels	O
of	O
vitamin	O
D	O
,	O
and	O
neonatal	O
outcomes	O
.	O
14	O
,	O
24Given	B
the	O
racial	O
disparities	O
seen	O
in	O
both	O
vitamin	O
D	O
deficiency	O
and	O
perinatal	O
outcomes	O
,	O
vitamin	O
D	O
has	O
been	O
proposed	O
as	O
part	O
of	O
the	O
explanation	B
for	O
this	O
disparity	O
,	O
particularly	O
with	O
regard	O
to	O
fetal	O
growth	O
and	O
SGA	O
.	O
8	O
Increased	O
awareness	O
of	O
the	O
growing	O
prevalence	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
has	O
led	O
to	O
an	O
urgent	O
need	O
for	O
consideration	O
of	O
supplementation	O
during	O
pregnancy	O
.	O

We	O
did	O
not	O
have	O
PTH	O
values	O
on	O
the	O
cord	O
blood	O
but	O
PTH	O
values	O
at	O
three	O
months	O
of	O
age	O
were	O
not	O
correlated	O
significantly	O
with	O
25	O
(	O
OH	O
)	O
D	O
values	O
at	O
birth	O
or	O
three	O
months	O
or	O
with	O
bone	O
mineral	O
outcomes	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
measured	O
in	O
4	O
,	O
236	O
pregnant	O
mothers	O
around	O
their	O
13	O
weeks	O
of	O
gestation	O
and	O
their	O
depression	O
scores	O
were	O
measured	O
at	O
16	O
weeks	O
.	O

Parents	O
,	O
advocates	O
and	O
civil	O
society	O
have	O
captured	O
the	O
attention	O
of	O
governments	O
and	O
monitored	O
progress	O
in	O
the	O
United	O
States	O
through	O
support	O
of	O
an	O
annual	O
Premature	O
Birth	O
Report	O
Card	O
.	O

Venous	O
blood	O
from	O
the	O
infant	O
(	O
3	O
ml	O
)	O
is	O
drawn	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
.	O

The	O
incidence	O
of	O
left	O
-	O
handedness	O
is	O
disproportionately	O
higher	O
among	O
males	O
[	O
202	O
],	O
a	O
finding	O
which	O
is	O
consistently	B
observed	O
across	O
species	O
[	O
201	O
,	O
209	O
–	O
212	O
].	O

Although	O
iron	O
deficiency	O
is	O
the	O
commonest	O
cause	O
of	O
nutritional	O
morbidity	O
worldwide	O
(	O
Stoltzfus	O
2003	O
),	O
in	O
women	O
of	O
reproductive	O
age	O
concurrent	O
deficiencies	O
of	O
vitamins	O
A	O
,	O
C	O
,	O
B	O
and	O
folate	O
also	O
frequently	O
occur	O
and	O
all	O
contribute	O
to	O
an	O
increased	O
anaemia	O
risk	O
(	O
Huffman	O
SL	O
et	O
al	O
1998	O
).	O

Venous	O
blood	O
was	O
placed	O
in	O
EDTA	O
,	O
sedivette	O
and	O
serum	O
tubes	O
(	O
Sarstedt	O
Monovette	O
,	O
UK	O
).	O

Conversely	O
,	O
results	O
from	O
a	O
US	O
cohort	O
study	O
demonstrated	O
a	O
significant	O
improvement	O
in	O
IQ	O
with	O
consumption	O
of	O
more	O
than	O
two	O
maternal	O
servings	O
of	O
fish	O
intake	O
per	O
week	O
as	O
assessed	O
via	O
‘	O
milestone	O
’	O
achievement	O
in	O
children	O
aged	O
six	O
months	O
and	O
eighteen	O
months	O
[	O
23	O
].	O

Because	O
these	O
studies	O
have	O
pointed	O
to	O
all	O
of	O
these	O
various	O
factors	O
which	O
in	O
and	O
of	O
themselves	O
can	O
all	O
occur	O
within	O
a	O
delivery	O
room	O
atmosphere	O
,	O
they	O
warrant	O
a	O
further	O
look	O
into	O
even	O
more	O
specific	O
delivery	O
room	O
attributes	O
to	O
see	O
if	O
there	O
is	O
a	O
more	O
direct	O
association	O
between	O
them	O
and	O
autism	O
.	O

These	O
include	O
a	O
restriction	O
in	O
fat	O
and	O
simple	O
carbohydrate	O
intake	O
,	O
regular	O
distribution	O
of	O
meals	O
,	O
carbohydrate	O
foods	O
favoring	O
those	O
with	O
low	O
glycemic	O
index	O
,	O
and	O
caloric	O
restriction	O
for	O
those	O
who	O
are	O
obese	O
.	O

Serum	O
visfatin	O
levels	O
fluctuate	O
as	O
pregnancy	O
advances	O
(	O
10	O
).	O

Current	O
evidence	O
for	O
putative	B
environmentally	O
induced	O
epigenetic	O
toxicity	O
Human	O
cohorts	O
For	O
many	O
decades	O
,	O
there	O
have	O
been	O
epidemiological	O
studies	O
linking	O
the	O
risks	O
of	O
adverse	O
phenotypes	O
to	O
a	O
wide	O
range	O
of	O
environmental	O
factors	O
.	O

Future	O
studies	O
examining	O
the	O
relationship	O
between	O
maternal	O
diet	O
and	O
components	O
of	O
breast	O
milk	O
including	O
microbial	O
and	O
nutritional	O
profiles	O
,	O
as	O
well	O
as	O
the	O
potential	O
influence	O
of	O
maternal	O
diet	O
on	O
the	O
fetal	O
microbiome	O
,	O
may	O
offer	O
insight	O
into	O
the	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
influences	O
the	O
infant	O
gut	O
microbiome	O
.	O

In	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
,	O
we	O
identified	O
three	O
clusters	O
that	O
differed	O
slightly	O
from	O
vaginally	O
delivered	O
infants	O
,	O
which	O
were	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
Bifidobacterium	O
,	O
high	O
Clostridium	O
and	O
low	O
Streptococcus	O
and	O
Ruminococcus	O
genera	O
,	O
and	O
high	O
abundance	O
of	O
the	O
family	O
Enterobacteriaceae	O
.	O

In	O
addition	O
,	O
a	O
recent	O
meta	O
-	O
analysis	O
found	O
a	O
strong	O
association	O
between	O
receipt	O
of	O
influenza	O
vaccination	O
and	O
reduced	O
likelihood	B
of	O
PTB	O
and	O
LBW	O
,	O
and	O
the	O
magnitude	O
of	O
the	O
association	O
that	O
Nunes	O
et	O
al	O
.	O

Smith	O
et	O
al	O
[	O
145	O
]	O
suggested	O
a	O
possible	O
connection	O
between	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3and	O
calcium	O
homeostasis	O
in	O
the	O
regulation	O
of	O
marbling	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
humans	O
has	O
been	O
associated	O
with	O
cardiovascular	O
disease	O
,	O
diabetes	O
and	O
obesity	O
in	O
offspring	O
[	O
23	O
],	O
which	O
could	O
be	O
linked	O
to	O
the	O
potential	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
regulation	O
of	O
adiposity	O
[	O
24	O
],[	O
25	O
].	O

Bayesian	O
hierarchical	O
linear	O
models	O
(	O
BHLMs	O
)	O
are	O
one	O
possible	O
solution	O
to	O
analyzing	O
the	O
effect	O
of	O
multiple	O
correlated	O
exposures	O
[	O
32	O
].	O

Earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
[	O
13	O
]	O
and	O
few	O
data	O
are	O
available	O
linking	O
habitual	O
diet	O
to	O
neonatal	O
anthropometric	O
measurements	O
.	O

Methods	O
:	O
A	O
case	O
-	O
control	O
study	O
was	O
conducted	O
from	O
July	O
1	O
,	O
2008	O
to	O
July	O
31	O
,	O
2009	O
.	O

Civil	O
society	O
:	O
Invest	O
•	O
Advocate	O
for	O
increased	O
attention	O
to	O
the	O
health	O
of	O
women	O
,	O
newborns	O
and	O
children	O
through	O
strengthening	O
parent	O
groups	O
and	O
conducting	O
national	O
campaigns	O
focusing	O
on	O
preterm	O
birth	O
.	O

Similarly	O
,	O
Josefson	O
et	O
al	O
.	O

These	O
data	O
were	O
processed	O
in	O
a	O
specific	O
previous	O
routine	O
designed	O
in	O
MatLab	O
(	O
Math	O
Works	O
,	O
6	O
.	O
0	O
version	O
,	O
USA	O
)	O
for	O
the	O
automatic	O
selection	O
of	O
5	O
minutes	O
RR	O
with	O
the	O
smallest	O
variance	O
[	O
29	O
].	O

The	O
inclusion	O
and	O
exclusion	O
criteria	O
for	O
participants	O
were	O
designed	O
as	O
such	O
to	O
obtain	O
a	O
sample	O
of	O
generally	O
healthy	O
women	O
,	O
who	O
are	O
able	O
to	O
speak	O
the	O
local	O
language	O
and	O
who	O
could	O
be	O
followed	O
-	O
up	O
from	O
early	O
pregnancy	O
until	O
the	O
infants	O
are	O
12	O
months	O
old	O
.	O

A	O
breakdown	O
of	O
unit	O
costs	O
is	O
shown	O
inTable	O
2	O
.	O

If	O
she	O
finds	O
any	O
unused	O
capsules	O
,	O
she	O
will	O
inquire	O
about	O
the	O
missing	O
doses	O
and	O
further	O
counsel	O
the	O
women	O
about	O
the	O
importance	O
of	O
regular	O
consumption	O
of	O
IFA	O
supplements	O
.	O

In	O
this	O
study	O
,	O
although	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
was	O
not	O
associated	O
with	O
higher	O
risk	O
of	O
wheeze	O
at	O
6	O
months	O
,	O
it	O
is	O
related	O
with	O
increased	O
respiratory	O
resistance	O
.	O

Methods	O
We	O
did	O
a	O
randomised	O
placebo	O
-	O
controlled	O
trial	O
to	O
compare	O
oral	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3with	O
placebo	O
given	O
to	O
children	O
aged	O
1	O
–	O
11	O
months	O
in	O
Kabul	O
,	O
Afghanistan	O
.	O

Patients	O
with	O
active	O
DTC	O
can	O
be	O
reassured	B
that	O
,	O
as	O
mentioned	O
above	O
,	O
pregnancy	O
itself	O
does	O
not	O
appear	O
to	O
increase	O
disease	O
progression	O
,	O
and	O
therefore	B
a	O
gap	O
in	O
treatment	O
during	O
pregnancy	O
is	O
not	O
contraindicated	O
.	O

Results	O
Those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
had	O
lower	O
25OHD	O
compared	O
to	O
extended	O
summer	O
(	O
32	O
.	O
9	O
nmol	O
/	O
L	O
vs	O
.	O
44	O
.	O
1	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Providing	O
equitable	O
care	O
means	O
ensuring	O
care	O
for	O
all	O
according	O
to	O
need	O
,	O
rather	O
than	O
income	O
,	O
gender	O
or	O
other	O
social	O
grouping	O
.	O

Women	O
enrolled	O
at	O
a	O
median	O
(	O
interquartile	O
range	O
)	O
gestational	O
age	O
of	O
9	O
.	O
6	O
weeks	O
(	O
8	O
.	O
4	O
–	O
11	O
.	O
4	O
).	O

Access	O
to	O
a	O
deep	O
tubewell	O
was	O
also	O
somewhat	O
different	O
between	O
the	O
two	O
groups	O
(	O
59	O
%	O
controls	O
,	O
68	O
%	O
intervention	O
).	O

Other	O
adverse	O
outcomes	O
have	O
also	O
been	O
attributed	O
to	O
oral	O
corticosteroids	O
,	O
including	O
an	O
increased	O
risk	O
of	O
preeclampsia	O
,[	O
13	O
,	O
14	O
]	O
preterm	O
birth	O
,[	O
12	O
,	O
15	O
]	O
and	O
lower	O
birth	O
weight	O
[	O
16	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Screenshot	O
of	O
You	O
Have	O
text4baby	O
.	O

We	O
used	O
calculations	O
from	O
Horton	O
and	O
Ross	O
(	O
2003	O
)[	O
6	O
]	O
to	O
estimate	O
a	O
benefit	O
:	O
cost	O
ratio	O
based	O
on	O
improved	O
labour	O
market	O
productivity	O
for	O
women	O
of	O
reproductive	O
age	O
.	O

Many	O
series	O
have	O
reported	O
reduced	O
rates	O
of	O
tumour	O
recurrence	O
both	O
in	O
PTC	O
and	O
in	O
FTC	O
.	O

WAT	O
is	O
an	O
energy	O
-	O
storing	O
tissue	O
that	O
has	O
evolutionary	O
enabled	O
humans	O
to	O
survive	O
for	O
longer	O
periods	O
between	O
meals	O
,	O
storing	O
energy	O
mainly	O
as	O
triglycerides	O
and	O
releasing	O
fatty	O
acids	O
during	O
fasting	O
periods	O
.	O

The	O
large	O
number	O
of	O
23	O
PCBs	O
examined	O
in	O
this	O
study	O
meant	B
that	O
the	O
BHLM	O
performed	O
more	O
aggressive	O
shrinkage	O
on	O
the	O
model	O
regression	O
coefficients	O
for	O
this	O
class	O
.	O

The	O
effectiveness	O
of	O
calcium	O
supplementation	O
on	O
prevention	O
of	O
perinatal	O
depression	O
has	O
been	O
shown	O
in	O
a	O
previous	O
study	O
[	O
65	O
].	O

In	O
a	O
recent	O
study	O
by	O
Kino	O
and	O
colleagues	O
it	O
was	O
demonstrated	O
that	O
GAS5	O
ncRNA	O
may	O
be	O
a	O
repressor	O
for	O
the	O
GR	O
by	O
acting	O
as	O
a	O
decoy	O
“	O
glucocorticoid	O
response	O
element	O
(	O
GRE	O
),”	O
thus	B
,	O
competing	O
with	O
DNA	O
GREs	O
for	O
binding	O
to	O
the	O
GR	O
.	O

Author	O
contributions	O
FR	O
,	O
JS	O
,	O
and	O
RG	O
conceived	O
the	O
study	O
and	O
got	O
financial	O
support	O
.	O

If	O
universal	O
coverage	O
of	O
selected	O
interventions	O
were	O
to	O
be	O
achieved	O
,	O
then	O
84	O
%	O
or	O
more	O
than	O
921	O
,	O
000	O
preterm	O
neonatal	O
deaths	O
could	O
be	O
prevented	O
annually	O
,	O
with	O
antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
having	O
the	O
highest	O
impact	O
.	O

The	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
was	O
increased	O
in	O
RC	O
male	O
hypothalamus	O
,	O
but	O
a	O
down	O
-	O
expression	O
of	O
most	O
eCBs	O
-	O
metabolizing	O
enzymes	O
(	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
and	O
several	O
key	O
regulators	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1b	O
,	O
Acox1	O
),	O
mitochondrial	O
respiration	O
(	O
Cox4i1	O
),	O
and	O
lipid	O
flux	O
(	O
Ppar	O
γ	O
)	O
was	O
found	O
in	O
their	O
PAT	O
.	O

Assays	O
for	O
25	O
(	O
OH	O
)	O
D	O
,	O
the	O
main	O
circulating	O
form	O
of	O
vitamin	O
D	O
,	O
were	O
conducted	O
by	O
the	O
Hospitals	O
in	O
Common	O
Laboratory	O
(	O
HICL	O
)	O
at	O
Mount	O
Sinai	O
Hospital	O
in	O
Toronto	O
,	O
Canada	O
using	O
Chemiluminescence	O
Immunoassay	O
.	O

In	O
Romania	O
,	O
a	O
study	O
conducted	O
by	O
the	O
Alfred	O
Rusescu	O
Institute	O
of	O
Mother	O
’	O
s	O
and	O
Child	O
’	O
s	O
Care	O
(	O
IOMC	O
),	O
found	O
that	O
the	O
use	O
of	O
iron	O
supplements	O
during	O
pregnancy	O
in	O
Romania	O
only	O
reduced	O
the	O
incidence	O
of	O
anaemia	O
at	O
birth	O
by	O
5	O
%	O
even	O
when	O
iron	O
supplements	O
were	O
provided	O
free	O
of	O
charge	O
under	O
reimbursement	O
arrangements	O
from	O
16	O
weeks	O
of	O
gestation	O
,	O
and	O
treatment	O
was	O
supervised	O
by	O
primary	O
care	O
physicians	O
[	O
14	O
].	O

There	O
is	O
a	O
similar	O
gap	O
in	O
the	O
knowledge	O
base	O
for	O
optimal	O
dosing	O
,	O
as	B
there	O
is	O
little	O
empirical	O
robust	O
evidence	O
to	O
support	O
600	O
IU	O
/	O
day	O
.	O

Untraced	O
women	O
were	O
more	O
likely	B
to	O
be	O
nulliparous	O
,	O
to	O
have	O
lower	O
mean	O
anthropometric	O
indices	O
and	O
were	O
more	O
likely	B
to	O
have	O
received	O
formal	O
schooling	O
.	O

EAH	O
has	O
also	O
been	O
associated	O
with	O
restrictive	O
feeding	O
practices	O
,	O
although	O
not	O
consistently	O
.	O

Neonatal	O
data	O
collected	O
at	O
birth	O
from	O
the	O
medical	O
file	O
include	O
date	O
and	O
time	O
of	O
birth	O
,	O
gender	O
,	O
Apgar	O
score	O
(	O
at	O
1	O
and	O
5	O
min	O
)	O
[	O
56	O
],	O
vital	O
signs	O
,	O
medical	O
interventions	O
required	O
,	O
foetal	O
distress	O
and	O
presence	O
of	O
meconium	O
stained	O
liquor	O
.	O

Review	O
by	O
a	O
third	O
physician	O
will	O
resolve	O
any	O
discrepancy	O
between	O
the	O
two	O
diagnoses	O
.	O

The	O
risk	O
of	O
GDM	O
was	O
particularly	O
elevated	O
among	O
overweight	O
women	O
who	O
also	O
reported	O
snoring	O
during	O
pregnancy	O
.	O

Thus	O
,	O
correlations	O
between	O
the	O
phenotypes	O
reported	O
here	O
can	O
be	O
taken	O
to	O
approximate	O
half	O
the	O
heritability	O
.	O

Quantitatively	O
,	O
it	O
was	O
estimated	O
that	O
50	O
g	O
of	O
BAT	O
can	O
burn	O
as	O
much	O
as	O
20	O
%	O
of	O
daily	O
energy	O
intake	O
(	O
Rothwell	O
and	O
Stock	O
,	O
1983	O
).	O

Pregnant	O
patients	O
with	O
severe	O
or	O
uncontrolled	O
asthma	O
should	O
be	O
considered	O
high	O
-	O
risk	O
and	O
be	O
treated	O
promptly	O
and	O
optimally	O
to	O
ensure	O
a	O
favorable	O
outcome	O
for	O
mother	O
and	O
baby	O
.	O

Overall	O
,	O
we	O
did	O
not	O
observe	O
statistically	O
significant	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
after	O
adjusting	O
for	O
risk	O
factors	O
,	O
with	O
either	O
MLR	O
or	O
PSM	O
.	O

Radioimmunoassay	O
and	O
ELISA	O
were	O
performed	O
to	O
analyze	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
,	O
respectively	O
.	O

At	O
least	O
one	O
chronic	O
condition	O
of	O
the	O
following	O
:	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
.	O

Consequently	B
,	O
these	O
studies	O
are	O
rarely	O
considered	O
acceptable	O
to	O
many	O
regulatory	O
authorities	O
and	O
are	O
not	O
specifically	O
requested	O
for	O
ethical	O
reasons	O
,	O
the	O
numbers	O
of	O
animals	O
needed	O
to	O
ensure	O
appropriate	O
statistical	O
power	O
would	O
be	O
both	O
unworkable	O
,	O
and	O
unethical	O
.	O

In	O
addition	O
,	O
the	O
mutant	O
mice	O
showed	O
an	O
abnormal	O
thoracic	O
cage	O
with	O
less	O
ribs	O
,	O
a	O
malformed	O
sternum	O
,	O
and	O
fusion	O
of	O
several	O
vertebrae	O
.	O

A	O
confirmatory	O
factor	O
analysis	O
of	O
related	O
knowledge	O
,	O
attitudes	O
,	O
and	O
beliefs	O
(	O
KABs	O
)	O
was	O
also	O
conducted	O
to	O
examine	O
correlation	O
in	O
agreement	O
and	O
changes	O
in	O
agreement	O
of	O
beliefs	O
.	O

95	O
%	O
CI	O
=	O
95	O
%	O
Confidence	O
Intervals	O
.	O

Multiple	O
regression	O
analysis	O
was	O
performed	O
for	O
mean	O
25	O
(	O
OH	O
)	O
D	O
including	O
independent	O
variables	O
significantly	O
associated	O
with	O
vitamin	O
D	O
levels	O
on	O
bivariate	O
analysis	O
or	O
known	O
to	O
influence	O
vitamin	O
D	O
status	O
.	O

This	O
may	O
be	O
an	O
early	O
indicator	O
of	O
placental	O
insufficiency	O
.	O

The	O
minimum	O
sample	O
size	O
for	O
each	O
analysis	O
was	O
five	O
animals	O
per	O
group	O
.	O

This	O
review	O
will	O
deal	O
only	O
with	O
dietary	O
and	O
environmental	O
control	O
measures	O
(	O
see	O
later	O
)	O
for	O
the	O
prevention	O
(	O
primary	O
and	O
secondary	O
)	O
of	O
atopic	O
diseases	O
.	O

Furthermore	O
,	O
genes	O
involved	O
in	O
'	O
actin	O
cytoskeleton	O
signaling	O
',	O
'	O
RhoA	O
signaling	O
',	O
'	O
Rac	O
signaling	O
'	O
and	O
'	O
complement	O
system	O
'	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
.	O

We	O
found	O
no	O
significant	O
association	O
either	O
between	O
maternal	O
western	O
dietary	O
pattern	O
and	O
head	O
circumference	O
of	O
infant	O
or	O
between	O
healthy	O
or	O
traditional	O
dietary	O
pattern	O
and	O
mentioned	O
measure	O
.	O

masanumasik	O
patya	O
which	O
will	O
lead	O
to	O
healthly	O
&	O
safe	O
motherhood	O
along	O
with	O
its	O
outcome	O
.	O

The	O
influence	O
of	O
paternal	O
diet	O
on	O
congenital	O
abnormalities	O
and	O
fertility	O
is	O
still	O
being	O
elucidated	O
.	O

Mothers	O
'	O
eating	O
behaviors	O
during	O
pregnancy	O
,	O
especially	O
intake	O
of	O
sweets	O
in	O
OW	O
/	O
OB	O
mothers	O
,	O
may	O
have	O
a	O
lasting	O
effect	O
on	O
child	O
weight	O
.	O

In	O
normal	O
weight	O
mothers	O
,	O
higher	O
intake	O
of	O
soft	O
drinks	O
was	O
the	O
strongest	O
predictor	O
of	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
but	O
was	O
not	O
a	O
significant	O
predictor	O
of	O
weight	O
at	O
6	O
months	O
.	O

2011	O
.	O

In	O
Cameroon	O
,	O
there	O
are	O
few	O
reported	O
studies	O
on	O
the	O
quality	O
of	O
ANC	O
services	O
rendered	O
;	O
meanwhile	O
the	O
study	O
of	O
consumer	O
perceptions	O
in	O
relation	O
to	O
behavioral	O
outcomes	O
has	O
been	O
on	O
the	O
rise	O
in	O
other	O
countries	O
[	O
8	O
].	O

However	O
,	O
there	O
was	O
no	O
direct	O
evidence	O
that	O
CRP	O
concentration	O
was	O
affected	O
by	O
micronutrient	O
supplementation	O
.	O

randomized	O
controlled	O
trials	O
which	O
found	O
that	O
among	O
women	O
with	O
low	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(≤	O
20	O
ng	O
/	O
mL	O
),	O
there	O
was	O
a	O
lower	O
risk	O
of	O
PTB	O
(	O
78	O
%)	O
for	O
those	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
who	O
did	O
not	O
(	O
RR	O
=	O
0	O
.	O
22	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
05	O
–	O
0	O
.	O
92	O
)	O
[	O
12	O
].	O

Although	O
both	O
cell	O
lines	O
(	O
JEG	O
-	O
3	O
and	O
BeWo	O
)	O
could	O
represent	B
a	O
cytotrophoblastic	O
milieu	O
in	O
vitro	O
,	O
they	O
have	O
differences	O
in	O
their	O
fusogenic	O
capacities	O
.	O

Therefore	B
,	O
the	O
brain	O
can	O
regionally	O
activate	O
vitamin	O
D	O
,	O
which	O
implicates	B
vitamin	O
D	O
’	O
s	O
role	O
in	O
brain	O
function	O
more	O
prominent	O
[	O
22	O
–	O
25	O
].	O

Education	O
level	O
was	O
graded	O
from	O
one	O
(=	O
comprehensive	O
school	O
/	O
lower	O
secondary	O
education	O
)	O
to	O
six	O
(	O
university	O
degree	O
/	O
first	O
or	O
second	O
stage	O
of	O
tertiary	O
education	O
).	O

Cognitive	O
development	O
during	O
adolescence	O
should	O
also	O
be	O
considered	O
.	O

Several	O
modifications	O
of	O
vitamin	O
D	O
metabolism	O
occur	O
during	O
pregnancy	O
.	O

The	O
LM	O
of	O
Wagyu	O
contains	O
the	O
highest	O
fat	O
content	O
(	O
36	O
.	O
5	O
%:	O
average	O
value	O
from	O
two	O
publications	O
[	O
25	O
,	O
26	O
]),	O
and	O
the	O
LM	O
from	O
Korean	O
cattle	O
contains	O
the	O
second	O
highest	O
fat	O
content	O
worldwide	O
(	O
13	O
.	O
7	O
%:	O
average	O
value	O
from	O
four	O
publications	O
[	O
10	O
,	O
27	O
–	O
29	O
]),	O
followed	O
by	O
Angus	O
(	O
9	O
.	O
3	O
%:	O
average	O
value	O
from	O
three	O
publications	O
[	O
30	O
–	O
32	O
]),	O
Hereford	O
crossbred	O
or	O
Hereford	O
(	O
7	O
.	O
6	O
%:	O
average	O
value	O
from	O
two	O
publications	O
[	O
30	O
,	O
33	O
]),	O
and	O
Brahman	O
(	O
2	O
.	O
8	O
%:	O
average	O
value	O
from	O
four	O
publications	O
[	O
32	O
,	O
34	O
–	O
36	O
])	O
(	O
Table	O
1	O
).	O

There	O
is	O
a	O
"	O
know	O
-	O
do	O
gap	O
",	O
or	O
a	O
gap	O
between	O
what	O
is	O
known	O
to	O
work	O
and	O
what	O
is	O
done	O
in	O
practice	O
.	O

Building	O
on	O
a	O
previous	O
analysis	O
of	O
the	O
HOME	O
Study	O
data	O
[	O
14	O
],	O
we	O
examined	O
OPPs	O
as	O
the	O
molar	O
sum	O
of	O
diethylphosphate	O
(	O
DEP	O
)	O
and	O
dimethylphosphate	O
(	O
DMP	O
)	O
metabolite	O
concentrations	O
.	O

A	O
factor	O
loading	O
criteria	O
of	O
0	O
.	O
4	O
was	O
used	O
to	O
determine	O
whether	O
to	O
retain	O
individual	O
items	O
in	O
a	O
single	O
principal	O
factor	O
.	O

Several	O
maternal	O
demographic	O
characteristics	O
predicted	O
birth	O
weight	O
,	O
including	O
age	O
,	O
race	O
,	O
marital	O
status	O
,	O
annual	O
household	O
income	O
,	O
public	O
or	O
no	O
insurance	O
and	O
other	O
SES	O
variables	O
.	O

It	B
is	I
clear	I
that	O
the	O
processes	O
arising	O
during	O
fetal	O
development	O
can	O
influence	O
health	O
later	O
in	O
life	O
.	O

To	O
more	O
precisely	O
identify	O
which	O
microbial	O
taxa	O
contribute	O
to	O
the	O
observed	O
differences	O
in	O
infant	O
stool	O
microbial	O
community	O
composition	O
by	O
maternal	O
dietary	O
factors	O
,	O
we	O
used	O
a	O
series	O
of	O
linear	O
models	O
to	O
test	O
the	O
relationships	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
each	O
OTU	O
.	O

With	O
evidence	O
of	O
the	O
program	O
'	O
s	O
positive	O
impact	O
on	O
women	O
'	O
s	O
iron	O
status	O
the	O
weekly	O
supplement	O
program	O
with	O
twice	O
-	O
yearly	O
de	O
-	O
worming	O
was	O
scaled	O
up	O
to	O
province	O
level	O
(	O
with	O
an	O
estimated	O
target	O
group	O
of	O
250	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
)	O
commencing	O
March	O
2008	O
.	O

Identifying	O
modifiable	O
,	O
prenatal	O
causes	O
of	O
childhood	O
obesity	O
will	O
inform	O
future	O
interventions	O
targeting	O
pregnancy	O
as	O
a	O
“	O
teachable	O
moment	O
”	O
for	O
primary	O
and	O
secondary	O
obesity	O
prevention	O
.	O

Herb	O
users	O
were	O
more	O
likely	O
to	O
be	O
high	O
school	O
graduates	O
,	O
identify	O
as	O
black	O
,	O
and	O
have	O
an	O
obstetrical	O
condition	O
.	O

2a	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S3	O
).	O

In	O
the	O
late	O
1990s	O
/	O
early	O
2000s	O
,	O
these	O
studies	O
began	O
to	O
associate	O
adverse	O
phenotypes	O
resulting	O
from	O
environmental	O
exposures	O
with	O
epigenetic	O
mechanisms	O
(	O
Issa	O
et	O
al	O
.	O
1996	O
;	O
Tao	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Choi	O
et	O
al	O
.	O
1999	O
;	O
Bielawski	O
et	O
al	O
.	O
2002	O
;	O
Govindarajan	O
et	O
al	O
.	O
2002	O
;	O
Chen	O
et	O
al	O
.	O
2004	O
;	O
Marwick	O
et	O
al	O
.	O
2004	O
;	O
Pulling	O
et	O
al	O
.	O
2004	O
;	O
Vuillemenot	O
et	O
al	O
.	O
2004	O
;	O
Wu	O
et	O
al	O
.	O
2004	O
).	O

The	O
BPA	O
,	O
TCDD	O
,	O
alcohol	O
and	O
smoking	O
-	O
related	O
evidence	O
is	O
particularly	O
compelling	O
as	B
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	B
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

Studies	O
falling	O
into	O
categories	O
3	O
and	O
/	O
or	O
4	O
provide	O
more	B
comprehensive	I
mechanistic	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
and	O
are	O
shown	O
inTable	O
2	O
.	O

(%)	O
0	O
-	O
10	O
years4	O
853	O
(	O
26	O
)	O
3	O
829	O
(	O
27	O
)	O
235	O
(	O
29	O
)	O
11	O
-	O
13	O
years6	O
899	O
(	O
37	O
)	O
5	O
845	O
(	O
41	O
)	O
336	O
(	O
41	O
)	O
over	O
13	O
years6	O
342	O
(	O
34	O
)	O
4	O
463	O
(	O
31	O
)	O
227	O
(	O
28	O
)	O
missing317	O
(	O
2	O
)	O
258	O
(	O
2	O
)	O
19	O
(	O
2	O
)	O
Country	O
of	O
birth	O
,	O
No	O
.	O

Furthermore	O
,	O
respondents	O
had	O
some	O
reservations	O
with	O
respect	O
to	O
the	O
sitting	O
comfort	O
in	O
some	O
health	O
centres	O
,	O
complaining	O
that	O
the	O
benches	O
were	O
too	O
hard	O
and	O
lacked	O
back	O
-	O
rests	O
.	O

By	O
pooling	O
our	O
efforts	O
with	O
each	O
organisation	O
playing	O
to	O
its	O
strengths	O
,	O
our	O
shared	O
goal	O
,	O
as	O
epitomised	O
in	O
Every	O
Woman	O
Every	O
Child	O
,	O
can	O
be	O
realised	O
--	O
a	O
day	O
when	O
pregnancies	O
are	O
wanted	O
and	O
safe	O
,	O
women	O
survive	O
,	O
babies	O
everywhere	O
get	O
a	O
healthy	O
start	O
in	O
life	O
,	O
and	O
children	O
thrive	O
.	O

1	O
Flow	O
chart	O
of	O
the	O
study	O
inclusion	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
and	O
their	O
infants	O
at	O
birthMeanSDBirth	O
weight	O
(	O
grams	O
)	O
a3542537	O
.	O
7Birth	O
length	O
(	O
cm	O
)	O
a502	O
.	O
3Gestational	O
age	O
at	O
delivery	O
(	O
days	O
)	O
28012	O
.	O
4Gestational	O
age	O
T1	O
(	O
days	O
)	O
7613	O
.	O
8Gestational	O
age	O
T3	O
(	O
days	O
)	O
23412	O
.	O
9Maternal	O
s	O
-	O
25OHD	O
T1	O
(	O
nmol	O
/	O
L	O
)	O
6424	O
.	O
4Maternal	O
s	O
-	O
25OHD	O
T3	O
(	O
nmol	O
/	O
L	O
)	O
7534	O
.	O
4N	O
(%)	O
Male	O
gender	O
of	O
infanta976	O
(	O
49	O
.	O
8	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
weight	O
or	O
length	O
)	O
93	O
(	O
4	O
.	O
5	O
)	O
Low	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
58	O
(	O
2	O
.	O
8	O
)	O
Preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
78	O
(	O
3	O
.	O
8	O
)	O
Spontaneous	O
preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
55	O
(	O
2	O
.	O
7	O
)	O
Pregnancy	O
loss97	O
(	O
4	O
.	O
7	O
)	O
Intrauterine	O
fetal	O
death	O
(≥	O
22	O
weeks	O
)	O
9	O
(	O
0	O
.	O
5	O
)	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
aLive	O
born	O
infants	O
only	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
The	O
pregnant	O
women	O
’	O
s	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
(	O
T1	O
)	O
and	O
third	O
(	O
T3	O
)	O
trimester	O
of	O
pregnancy	O
,	O
and	O
their	O
characteristics	O
(	O
mean	O
or	O
percent	O
)	O
grouped	O
by	O
25OHD	O
concentration	O
in	O
(	O
T1	O
)	O
T1	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N198291788565125	O
%	O
10	O
.	O
114	O
.	O
840	O
.	O
128	O
.	O
76	O
.	O
4BMI	O
T1	O
(	O
kg	O
/	O
m2	O
)	O
25	O
.	O
124	O
.	O
924	O
.	O
423	O
.	O
924	O
.	O
4Age	O
T1	O
(	O
years	O
)	O
29	O
.	O
430	O
.	O
931	O
.	O
632	O
.	O
032	O
.	O
4Born	O
in	O
Sweden	O
(%)	O
14	O
.	O
154	O
.	O
683	O
.	O
387	O
.	O
893	O
.	O
5Tobacco	O
use	O
T1	O
(%)	O
6	O
.	O
84	O
.	O
64	O
.	O
04	O
.	O
61	O
.	O
6Nulliparous	O
T1	O
(%)	O
34	O
.	O
842	O
.	O
042	O
.	O
643	O
.	O
142	O
.	O
7Vitamin	O
D	O
supplement	O
use	O
T1	O
(%)	O
10	O
.	O
628	O
.	O
245	O
.	O
256	O
.	O
662	O
.	O
9University	O
level	O
education	O
(%)	O
32	O
.	O
354	O
.	O
961	O
.	O
367	O
.	O
366	O
.	O
1Small	O
for	O
gestational	O
age	O
(%)	O
5	O
.	O
74	O
.	O
25	O
.	O
34	O
.	O
14	O
.	O
0Preterm	O
delivery	O
(%)	O
4	O
.	O
15	O
.	O
23	O
.	O
83	O
.	O
91	O
.	O
6Low	O
birth	O
weight	O
(%)	O
3	O
.	O
04	O
.	O
53	O
.	O
12	O
.	O
11	O
.	O
6Pregnancy	O
loss	O
(%)	O
6	O
.	O
35	O
.	O
64	O
.	O
55	O
.	O
10T3	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N163330473409443	O
%	O
9	O
.	O
018	O
.	O
226	O
.	O
022	O
.	O
524	O
.	O
4Small	O
for	O
gestational	O
age	O
(%)	O
7	O
.	O
55	O
.	O
54	O
.	O
74	O
.	O
62	O
.	O
3Preterm	O
delivery	O
(%)	O
4	O
.	O
31	O
.	O
23	O
.	O
62	O
.	O
21	O
.	O
6Low	O
birth	O
weight	O
(%)	O
4	O
.	O
30	O
.	O
32	O
.	O
71	O
.	O
21	O
.	O
4	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
Birth	O
size	O
and	O
preterm	O
delivery	O
In	O
total	O
,	O
93	O
(	O
4	O
.	O
5	O
%)	O
infants	O
were	O
born	O
SGA	O
.	O

Rats	O
exposed	O
to	O
low	O
prenatal	O
vitamin	O
D	O
have	O
a	O
broad	O
range	O
of	O
neurobiological	O
outcomes	O
that	O
are	O
informative	O
for	O
schizophrenia	O
research	O
.	O

Furthermore	O
,	O
during	O
pregnancy	O
,	O
nasal	O
congestion	O
can	O
worsen	O
,	O
although	O
the	O
exact	O
mechanism	O
for	O
this	O
is	O
not	O
defined	O
.	O

However	O
,	O
women	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
less	O
satisfied	O
with	O
the	O
reception	O
as	O
compared	O
to	O
those	O
with	O
a	O
low	O
educational	O
level	O
.	O

In	O
addition	O
,	O
studies	O
within	O
categories	O
1	O
and	O
2	O
may	O
also	O
enable	O
the	O
identification	O
of	O
markers	O
and	O
/	O
or	O
mechanisms	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
through	O
a	O
weight	O
of	O
evidence	O
approach	O
(	O
e	O
.	O
g	O
.	O

Exposure	O
to	O
advertisements	O
would	O
decrease	O
by	O
restricting	O
food	O
advertisements	O
that	O
target	O
children	O
,	O
especially	O
during	O
times	O
,	O
such	O
as	O
Saturday	O
mornings	O
,	O
when	O
many	O
children	O
are	O
watching	O
television	O
(	O
87	O
).	O

Therefore	B
,	O
the	O
high	O
risk	O
of	O
cardiometabolic	O
diseases	O
among	O
these	O
children	O
could	O
be	O
attributed	O
,	O
at	B
least	I
in	I
part	I
,	O
to	O
a	O
reduction	O
in	O
the	O
protective	O
actions	O
of	O
the	O
cardiac	O
vagal	O
tone	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
mean	O
AluYb8	O
levels	O
differed	O
significantly	O
by	O
maternal	O
tobacco	O
use	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
whereas	O
mean	O
LINE	O
-	O
1	O
levels	O
significantly	O
differed	O
only	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
02	O
;	O
Table	O
2	O
).	O

Also	O
,	O
the	O
dietary	O
intake	O
of	O
PUFA	O
was	O
negatively	O
correlated	O
with	O
the	O
severity	O
of	O
psychotic	O
symptoms	O
in	O
patients	O
with	O
schizophrenia	O
[	O
15	O
].	O

In	O
an	O
adjusted	O
analysis	O
,	O
maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
infant	O
stool	O
microbiome	O
composition	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
034	O
;	O
Fig	O
.	O

However	O
,	O
routine	O
vitamin	O
D	O
supplementation	O
did	O
not	O
occur	O
during	O
the	O
time	O
period	O
the	O
women	O
in	O
the	O
current	O
study	O
were	O
recruited	O
.	O

Schizophrenia	O
in	O
adulthood	O
is	O
often	B
preceded	O
by	O
milder	O
symptoms	O
and	O
delusions	O
during	O
adolescence	O
.	O

To	O
address	O
this	O
gap	O
in	O
the	O
literature	O
,	O
the	O
aim	O
of	O
this	O
follow	O
-	O
up	O
study	O
was	O
to	O
determine	O
if	O
maternal	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
and	O
/	O
or	O
a	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
affect	O
the	O
circulating	O
concentration	O
of	O
cathelicidin	O
in	O
healthy	O
children	O
years	O
after	O
delivery	O
.	O

Introduction	O
Mobile	O
health	O
(	O
mHealth	O
),	O
the	O
use	O
of	O
mobile	O
phones	O
as	O
a	O
tool	O
for	O
health	O
care	O
treatment	O
and	O
public	O
health	O
behavior	O
change	O
,	O
is	O
a	O
rapidly	O
expanding	O
field	O
that	O
has	O
significant	O
promise	O
to	O
improve	O
public	O
health	O
and	O
increase	O
the	O
effectiveness	O
of	O
disease	O
prevention	O
and	O
health	O
promotion	O
programs	O
[	O
1	O
-	O
3	O
].	O

The	O
authors	O
suggested	O
that	O
the	O
prepartum	O
maternal	O
dietary	O
energy	O
source	O
during	O
late	O
gestation	O
can	O
alter	O
the	O
development	O
of	O
fetal	O
adipose	O
tissue	O
,	O
affecting	O
IMF	O
deposition	O
in	O
progeny	O
.	O

The	O
mean	O
BW	O
was	O
3008	O
g	O
(	O
Range	O
:	O
1400	O
to	O
4590	O
;	O
SD	O
=	O
605	O
g	O
)	O
with	O
birth	O
length	O
47	O
.	O
1	O
cm	O
(	O
Range	O
:	O
39	O
.	O
0	O
–	O
53	O
.	O
0	O
;	O
SD	O
=	O
3	O
.	O
28	O
cm	O
).	O

Declaration	O
This	O
article	O
is	O
part	O
of	O
a	O
supplement	O
jointly	O
funded	O
by	O
Save	O
the	O
Children	O
'	O
s	O
Saving	O
Newborn	O
Lives	O
programme	O
through	O
a	O
grant	O
from	O
The	O
Bill	O
&	O
Melinda	O
Gates	O
Foundation	O
and	O
March	O
of	O
Dimes	O
Foundation	O
and	O
published	O
in	O
collaboration	O
with	O
the	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
and	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
).	O

Using	O
data	O
from	O
the	O
general	O
Australian	O
population	O
,	O
we	O
anticipated	O
a	O
minimum	O
incidence	O
in	O
the	O
standard	O
care	O
group	O
of	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
of	O
approximately	O
25	O
%	O
[	O
35	O
].	O

Statistical	O
analysis	O
Statistical	O
analysis	O
was	O
performed	O
using	O
SPSS11	O
.	O
5	O
software	O
.	O

An	O
adequate	O
pre	O
-	O
pregnancy	O
nutritional	O
status	O
was	O
associated	O
with	O
gestational	O
weight	O
gain	O
above	O
recommendations	O
.	O

Seasonal	O
variation	O
in	O
vitamin	O
D	O
levels	O
also	O
has	O
been	O
suggested	O
as	O
a	O
factor	O
differentially	O
affecting	O
newborn	O
growth	O
plate	O
width	O
,	O
and	O
this	O
may	O
explain	O
why	O
babies	O
born	O
in	O
Australia	O
around	O
October	O
(	O
spring	O
)	O
are	O
relatively	O
heavier	O
than	O
those	O
born	O
at	O
other	O
times	O
[	O
156	O
].	O

Maternal	O
age	O
,	O
BMI	O
,	O
SEI	O
,	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
never	O
/	O
former	O
vs	O
.	O
current	O
),	O
recreational	O
walking	O
(	O
1	O
–	O
3	O
times	O
/	O
week	O
and	O
≥	O
4	O
times	O
/	O
week	O
vs	O
.	O
never	O
),	O
ethnicity	O
(	O
Caucasian	O
vs	O
.	O
non	O
-	O
Caucasian	O
)	O
and	O
recruitment	O
site	O
(	O
Adelaide	O
vs	O
.	O
Auckland	O
)	O
were	O
significantly	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
along	O
with	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
never	O
/	O
former	O
vs	O
.	O
current	O
)	O
included	O
as	O
main	O
effects	O
within	O
the	O
generalised	O
linear	O
models	O
.	O

These	O
DNA	O
repetitive	O
elements	O
are	O
made	O
up	O
of	O
interspersed	O
and	O
tandem	O
repeats	O
and	O
comprise	O
at	O
least	O
half	O
of	O
the	O
human	O
genome	O
(	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

These	O
neuroendocrine	O
cells	O
are	O
believed	O
to	O
be	O
of	O
neural	O
crest	O
origin	O
,	O
thus	B
having	O
a	O
separate	O
lineage	O
from	O
the	O
endoderm	O
-	O
derived	O
follicular	O
thyroid	O
cells	O
.	O

This	O
procedure	O
guaranteed	O
that	O
offspring	O
received	O
the	O
experimental	O
diet	O
only	O
during	O
organogenesis	O
.	O

As	B
children	O
become	O
more	O
independent	O
during	O
middle	O
childhood	O
and	O
adolescence	O
,	O
school	O
nutrition	O
,	O
food	O
marketing	O
,	O
and	O
social	O
networks	O
become	O
focal	O
points	O
for	O
obesity	O
prevention	O
or	O
intervention	O
.	O

The	O
LOESS	O
curve	O
showed	O
gestational	O
age	O
rising	O
with	O
increasing	O
25	O
(	O
OH	O
)	O
D	O
.	O
Women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

Decreases	O
in	O
urine	O
output	O
and	O
podocin	O
expression	O
and	O
increases	O
in	O
urea	O
and	O
creatinine	O
in	O
the	O
urine	O
were	O
observed	O
in	O
F1	O
offspring	O
.	O

Hemodynamic	O
Variables	O
and	O
Heart	O
Rate	O
Variability	O
(	O
HRV	O
)	O
Blood	O
pressure	O
(	O
BP	O
)	O
levels	O
were	O
measured	O
twice	O
in	O
the	O
right	O
arm	O
with	O
the	O
child	O
in	O
a	O
seated	O
position	O
using	O
an	O
automated	O
oscillometric	O
device	O
(	O
Omron	O
HEM907XL	O
;	O
Omron	O
Healthcare	O
;	O
USA	O
)	O
with	O
an	O
appropriate	O
cuff	O
size	O
.	O

This	O
subtle	O
difference	O
may	O
indicate	O
some	O
alterations	O
in	O
the	O
central	O
rewarding	O
functions	O
of	O
the	O
ECS	O
,	O
as	B
was	O
previously	O
described	O
in	O
animals	O
with	O
reduced	O
preference	O
for	O
highly	O
palatable	O
foods	O
(	O
Brand	O
et	O
al	O
.,	O
2012	O
).	O

Moreover	O
,	O
additional	O
clinical	O
trial	O
studies	O
will	O
have	O
to	O
be	O
conducted	O
to	O
determine	O
the	O
effect	O
of	O
mega	O
doses	O
of	O
vitamin	O
D	O
on	O
other	O
health	O
-	O
related	O
parameters	O
such	O
as	O
the	O
factors	O
related	O
to	O
metabolic	O
syndrome	O
as	O
well	O
as	O
inflammatory	O
markers	O
.	O

This	O
finding	O
is	O
in	O
agreement	O
with	O
previous	O
studies	O
in	O
humans	O
,	O
which	O
demonstrated	O
that	O
offspring	O
exposed	O
to	O
famine	O
or	O
hyperemesis	O
gravidarum	O
in	O
the	O
first	O
part	O
of	O
pregnancy	O
did	O
not	O
show	O
lower	O
birth	O
weight	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
;	O
Grooten	O
et	O
al	O
.,	O
2015	O
).	O

Screening	O
for	O
diabetes	O
,	O
at	O
regular	O
intervals	O
,	O
is	O
recommended	O
by	O
a	O
number	O
of	O
diabetes	O
societies	O
.	O
4	O
,	O
85This	O
is	O
important	O
for	O
the	O
early	O
diagnosis	O
of	O
diabetes	O
,	O
to	O
facilitate	O
the	O
prevention	O
of	O
complications	O
.	O

However	O
,	O
at	O
least	O
two	O
old	O
papers	O
have	O
addressed	O
it	O
(	O
10	O
,	O
11	O
),	O
both	O
published	O
before	O
Kanner	O
described	O
autism	O
in	O
1943	O
.	O

Thirty	O
-	O
eight	O
per	O
cent	O
of	O
mothers	O
taking	O
SGAs	O
did	O
not	O
breastfeed	O
,	O
which	O
is	O
approximately	O
eight	O
times	O
greater	O
than	O
in	O
controls	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

A	O
recent	O
study	O
further	O
revealed	O
that	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
inversely	O
correlated	O
with	O
the	O
risk	O
of	O
transient	O
early	O
wheezing	O
[	O
11	O
].	O

We	O
used	O
the	O
Akaike	O
Information	O
criterion	O
(	O
AIC	O
)	O
to	O
identify	O
the	O
most	O
parsimonious	O
model	O
.	O

This	O
recommendation	O
has	O
recently	O
been	O
reaffirmed	B
as	O
being	O
appropriate	O
by	O
both	O
the	O
Institute	O
of	O
Medicine	O
[	O
2	O
]	O
and	O
the	O
American	O
Academy	O
of	O
Pediatrics	O
[	O
3	O
]	O
whereas	O
the	O
Endocrine	O
Society	O
considers	B
the	O
400	O
IU	O
to	O
be	O
a	O
minimum	O
appropriate	O
dose	O
[	O
4	O
].	O

found	O
that	O
5000	O
IU	O
vitamin	O
D	O
per	O
day	O
for	O
6	O
weeks	O
had	O
no	O
effect	O
on	O
men	O
and	O
women	O
’	O
s	O
cognitive	O
and	O
emotional	O
function	O
[	O
69	O
].	O

Intrauterine	O
transmission	O
must	O
be	O
considered	O
important	O
as	B
the	O
maternal	O
relationship	O
is	O
consistent	O
at	O
all	O
time	O
points	O
and	O
between	O
each	O
mother	O
–	O
child	O
pair	O
,	O
for	O
example	O
,	O
the	O
mother	O
and	O
her	O
children	O
,	O
the	O
mother	O
and	O
her	O
own	O
mother	O
and	O
the	O
father	O
and	O
his	O
mother	O
.	O

2011	O
;	O
Lester	O
and	O
Padbury	O
2009	O
).	O

Of	O
the	O
SGA	O
deliveries	O
,	O
37	O
were	O
SGA	O
by	O
weight	O
and	O
56	O
by	O
length	O
.	O

p	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Compared	O
with	O
whites	O
,	O
blacks	O
had	O
a	O
lower	O
mean	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
higher	O
incidence	O
of	O
SGA	O
(	O
P	O
⩽	O
0	O
.	O
01	O
).	O

Two	O
spectrophotometric	O
readings	O
of	O
the	O
DNA	O
samples	O
were	O
averaged	O
to	O
determine	O
the	O
concentration	O
,	O
which	O
had	O
a	O
ratio	O
of	O
A260to	O
A280between	O
1	O
.	O
8	O
and	O
2	O
.	O
0	O
and	O
was	O
free	O
of	O
RNA	O
and	O
protein	O
contamination	O
.	O

The	O
husband	O
has	O
been	O
shown	O
to	O
play	O
a	O
significant	O
role	O
in	O
determining	O
the	O
choice	O
of	O
ANC	O
site	O
by	O
the	O
woman	O
in	O
a	O
Nigerian	O
[	O
19	O
]	O
and	O
Ugandan	O
study	O
[	O
20	O
]	O
where	O
they	O
accounted	O
for	O
43	O
%	O
and	O
32	O
%	O
of	O
all	O
recommendations	O
respectively	O
.	O

Administration	O
of	O
vitamin	O
D	O
is	O
recommended	O
in	O
the	O
case	O
of	O
considerable	O
deficiency	O
,	O
particularly	O
in	O
obese	O
,	O
insulin	O
resistant	O
women	O
with	O
low	O
AMH	O
levels	O
,	O
as	O
well	O
as	O
in	O
men	O
with	O
oligo	O
-	O
and	O
asthenozoospermia	O
.	O

Offspring	O
'	O
s	O
BMI	O
was	O
correlated	O
to	O
a	O
lesser	O
extent	O
with	O
that	O
of	O
the	O
maternal	O
grandmother	O
while	O
for	O
girls	O
only	O
there	O
was	O
an	O
association	O
with	O
that	O
of	O
the	O
paternal	O
grandmother	O
at	O
ages	O
0	O
and	O
5	O
(	O
correlation	O
coefficients	O
0	O
.	O
25	O
,	O
0	O
.	O
28	O
,	O
p	O
values	O
0	O
.	O
02	O
,	O
0	O
.	O
01	O
,	O
respectively	O
).	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
metabolic	O
enzymes	O
regulating	O
de	O
novo	O
lipogenesis	O
(	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
)	O
and	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
,	O
Cpt1b	O
,	O
Acox1	O
),	O
and	O
key	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Chrebp	O
,	O
Srebp1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
)	O
and	O
mitochondrial	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure5	O
).	O

The	O
down	O
-	O
expression	O
of	O
all	O
these	O
elements	O
in	O
PAT	O
indicates	O
lower	O
energy	O
expenditure	O
in	O
RC	O
males	O
,	O
which	O
agrees	O
with	O
the	O
increased	O
perirenal	O
adiposity	O
and	O
the	O
higher	O
levels	O
of	O
triglycerides	O
in	O
plasma	O
.	O

The	O
IG	O
received	O
an	O
IM	O
injection	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
whereas	O
CG	O
did	O
not	O
.	O

Supplements	O
were	O
also	O
included	O
to	O
assess	O
total	O
nutrient	O
intake	O
.	O

Gestational	O
diabetes	O
in	O
humans	O
is	O
a	O
situation	O
of	O
increased	O
nutrient	O
supply	O
that	O
,	O
together	O
with	O
the	O
high	O
maternal	O
body	O
mass	O
index	O
,	O
can	O
be	O
accompanied	O
by	O
enhanced	O
birth	O
-	O
weight	O
and	O
adverse	O
long	O
-	O
term	O
metabolic	O
consequences	O
,	O
as	O
described	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
2003	O
),	O
as	O
well	O
as	O
in	O
several	O
publications	O
(	O
Larsson	O
et	O
al	O
.,	O
1986	O
;	O
Dabelea	O
et	O
al	O
.,	O
2000	O
;	O
Singh	O
et	O
al	O
.,	O
2006	O
).	O

This	O
association	O
indicates	O
that	O
overweight	O
mothers	O
are	O
more	O
likely	B
to	O
have	O
overweight	O
children	O
,	O
and	O
these	O
odds	O
increase	O
with	O
the	O
age	O
of	O
the	O
child	O
.	O

Reported	O
sleep	O
duration	O
before	O
pregnancy	O
was	O
highly	O
correlated	O
with	O
sleep	O
duration	O
during	O
pregnancy	O
(	O
ρ	O
=	O
0	O
.	O
92	O
,	O
p	O
<	O
0	O
.	O
002	O
).	O

Hypothalamic	O
gene	O
expression	O
of	O
feeding	O
-	O
related	O
neuropeptides	O
including	O
neuropeptide	O
Y	O
,	O
pro	O
-	O
opiomelanocortin	O
(	O
POMC	O
),	O
insulin	O
receptor	O
,	O
leptin	O
receptor	O
,	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
),	O
receptors	O
for	O
dopamine	O
(	O
DopaR1	O
/	O
2	O
/	O
5	O
)	O
and	O
serotonin	O
(	O
SeroR1A	O
/	O
2A	O
/	O
2C	O
),	O
as	O
well	O
as	O
global	O
DNA	O
methylation	O
and	O
brain	O
and	O
plasma	O
folate	O
concentrations	O
were	O
measured	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
primary	O
outcome	O
between	O
the	O
two	O
groups	O
(	O
metformin	O
116	O
[	O
32	O
%]	O
events	O
,	O
insulin	O
119	O
events	O
[	O
32	O
.	O
2	O
%],	O
RR	O
1	O
.	O
0	O
[	O
0	O
.	O
9	O
–	O
1	O
.	O
1	O
],	O
p	O
=	O
0	O
.	O
95	O
).	O

Potential	O
confounders	O
for	O
the	O
associations	O
studied	O
were	O
identified	O
using	O
directed	O
acyclic	O
graphs	O
(	O
www	O
.	O
dagitty	O
.	O
net	O
)	O
[	O
17	O
].	O

In	O
these	O
studies	O
,	O
the	O
normally	O
weaned	O
steers	O
remained	O
on	O
pasture	O
during	O
nursing	O
and	O
weaning	O
at	O
231	O
d	O
(	O
study	O
1	O
)	O
and	O
213	O
d	O
of	O
age	O
(	O
study	O
2	O
),	O
respectively	O
,	O
and	O
they	O
were	O
then	O
placed	O
on	O
a	O
finishing	O
diet	O
.	O

Melatonin	O
inhibits	O
the	O
release	O
of	O
insulin	O
from	O
pancreatic	O
beta	O
cells	O
[	O
40	O
,	O
41	O
],	O
although	O
conflicting	O
research	O
exists	O
with	O
the	O
Nurses	O
’	O
Health	O
Study	O
finding	O
low	O
melatonin	O
associated	O
with	O
increased	O
risk	O
of	O
type	O
2	O
diabetes	O
,	O
potentially	O
medicated	O
through	O
increased	O
insulin	O
resistance	O
[	O
42	O
].	O

Our	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
significantly	O
relationship	O
with	O
poorer	O
lung	O
function	O
performance	O
and	O
higher	O
likelihood	B
of	O
a	O
respiratory	O
tract	O
infection	O
before	O
6	O
months	O
of	O
age	O
.	O

Infertile	O
males	O
with	O
oligo	O
-,	O
astheno	O
-,	O
terato	O
-	O
and	O
normospermia	O
present	O
a	O
higher	O
risk	O
of	O
osteoporosis	O
and	O
have	O
lower	O
bone	O
mineral	O
density	O
(	O
BMD	O
)	O
proportionally	O
to	O
testosterone	O
and	O
VD	O
concentration	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
comparison	O
with	O
healthy	O
controls	O
at	O
the	O
same	O
age	O
.	O

Valproate	O
is	O
used	O
for	O
the	O
treatment	O
of	O
epilepsy	O
and	O
other	O
neuropsychological	O
disorders	O
and	O
is	O
considered	O
one	O
of	O
the	O
only	O
available	O
treatment	O
options	O
for	O
women	O
of	O
childbearing	O
potential	O
[	O
6	O
].	O

Introduction	O
Cathelicidin	O
(	O
Human	O
LL	O
-	O
37	O
),	O
activated	O
by	O
n	O
-	O
terminal	O
cleavage	O
of	O
the	O
propeptide	O
hCAP18	O
,	O
serves	O
as	O
a	O
cytokine	O
in	O
the	O
immune	O
system	O
as	O
well	O
as	O
an	O
antimicrobial	O
peptide	O
with	O
its	O
ability	O
to	O
form	O
an	O
α	O
-	O
helix	O
in	O
aqueous	O
solution	O
that	O
disrupts	O
the	O
lipid	O
membranes	O
of	O
invading	O
organisms	O
and	O
results	O
in	O
their	O
destruction	O
[	O
1	O
–	O
4	O
].	O

It	O
is	O
important	O
to	O
continue	O
supplementing	O
non	O
-	O
human	O
models	O
with	O
human	O
-	O
derived	O
data	O
,	O
incorporating	O
new	O
technologies	O
to	O
maximize	O
data	O
collection	O
,	O
and	O
updating	O
and	O
re	O
-	O
evaluating	O
current	O
conclusions	B
as	O
novel	O
information	O
becomes	O
available	O
.	O

The	O
present	O
study	O
involved	O
a	O
substantially	O
larger	O
sample	O
,	O
and	O
reinforces	O
the	O
observed	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
levels	O
and	O
S	O
-	O
ECC	O
.	O

As	O
the	O
trajectories	O
of	O
physical	O
and	O
mental	O
health	O
later	O
in	O
life	O
are	O
determined	O
fundamentally	O
during	O
the	O
first	O
1000	O
days	O
of	O
life	O
,	O
both	O
the	O
World	O
Health	O
Assembly	O
Nutrition	O
Targets	O
and	O
the	O
Sustainable	O
Developmental	O
Goals	O
call	O
for	O
action	O
to	O
,	O
among	O
others	O
,	O
improve	O
maternal	O
,	O
infant	O
and	O
young	O
child	O
nutrition	O
in	O
an	O
effort	O
to	O
ensure	O
sustainable	O
social	O
and	O
economic	O
progress	O
.	O

The	O
epidemiological	O
data	O
from	O
the	O
Dutch	O
Famine	O
have	O
showed	O
that	O
people	O
whose	O
mothers	O
were	O
exposed	O
to	O
undernutrition	O
in	O
early	O
gestation	O
developed	O
more	O
metabolic	O
abnormalities	O
than	O
people	O
exposed	O
in	O
other	O
pregnancy	O
stages	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
).	O

Because	O
BDNF	O
may	O
be	O
differentially	O
expressed	O
in	O
specific	O
regions	O
of	O
the	O
hypothalamus	O
,	O
where	O
high	O
levels	O
are	O
present	O
in	O
the	O
ventromedial	O
hypothalamus	O
,	O
32the	O
relationship	O
between	O
BDNF	O
and	O
SeroR	O
is	O
unknown	O
from	O
whole	O
hypothalamus	O
in	O
our	O
study	O
.	O

2011	O
).	O

The	O
critical	O
review	O
of	O
the	O
available	O
literature	O
does	O
not	O
provide	O
a	O
consistent	O
answer	O
to	O
this	O
question	O
.	O

2	O
.	O
2	O
.	O

We	O
hypothesized	O
that	O
there	O
is	O
a	O
maternal	O
stress	O
-	O
GR	O
interaction	O
that	O
can	O
influence	O
fetal	O
birth	O
weight	O
.	O

Attendance	O
at	O
the	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
,	O
compared	O
to	O
summer	O
,	O
was	O
associated	O
with	O
significantly	O
higher	O
HOMA	O
-	O
IR	O
(	O
32	O
.	O
8	O
%)	O
and	O
insulin	O
(	O
32	O
.	O
4	O
%)	O
in	O
early	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
.	O

Therefore	O
,	O
we	O
recommended	O
the	O
following	O
times	O
of	O
possible	O
pathogen	O
transmission	O
to	O
the	O
neonate	O
for	O
handwashing	O
with	O
soap	O
:	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
and	O
after	O
fecal	O
contact	O
.	O

Infant	O
lung	O
function	O
testing	O
was	O
performed	O
with	O
the	O
Jaeger	O
Masterscreen	O
BabyBody	O
Paediatrics	O
System	O
(	O
CareFusion	O
,	O
Höchberg	O
,	O
Germany	O
),	O
which	O
conforms	O
with	O
the	O
American	O
Thoracic	O
Society	O
and	O
European	O
Respiratory	O
Society	O
recommendations	B
[	O
22	O
–	O
25	O
].	O

Larger	O
observational	O
studies	O
are	O
required	O
to	O
establish	O
a	O
true	B
link	O
between	O
the	O
use	O
of	O
SSRIs	O
and	O
autism	O
.	O

The	O
spill	O
dumped	O
94	O
million	O
gallons	O
of	O
mill	O
process	O
effluent	O
and	O
1	O
,	O
100	O
tons	O
of	O
tailings	O
—	O
an	O
acidic	O
,	O
radioactive	O
sludge	O
—	O
into	O
a	O
large	O
arroyo	O
that	O
emptied	O
into	O
the	O
Puerco	O
River	O
.	O
4	O
The	O
Church	O
Rock	O
spill	O
occurred	O
less	O
than	O
four	O
months	O
after	O
the	O
partial	O
meltdown	O
of	O
the	O
Three	O
Mile	O
Island	O
nuclear	O
reactor	O
,	O
and	O
it	O
released	O
three	O
times	O
as	O
much	O
radiation	O
,	O
making	O
it	O
the	O
biggest	O
nuclear	O
spill	O
in	O
U	O
.	O
S	O
.	O
history	O
,	O
yet	O
it	O
received	O
only	O
a	O
tiny	O
fraction	O
of	O
the	O
news	O
coverage	O
.	O
5Declared	O
a	O
Superfund	O
site	O
in	O
1983	O
,	O
the	O
heaps	O
of	O
waste	O
around	O
the	O
mill	O
still	O
cause	O
radiation	O
survey	O
instruments	O
to	O
squeal	O
from	O
the	O
invisible	O
uranium	O
atoms	O
that	O
remain	O
active	O
30	O
years	O
later	O
.	O
6	O
“	O
This	O
area	O
used	O
to	O
be	O
my	O
playground	O
,”	O
Bell	O
-	O
Jefferson	O
says	O
.	O

2	O
.	O
1	O
.	O
β	O
2	O
Adrenergic	O
Receptor	O
Agonists	O
Beyond	O
the	O
cases	O
conducted	O
to	O
study	O
the	O
relationship	O
between	O
pregnancy	O
complications	O
and	O
augmented	O
childbirth	O
to	O
autism	O
,	O
several	O
studies	O
have	O
been	O
done	O
to	O
investigate	O
the	O
association	O
between	O
prenatal	O
exposures	O
to	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
to	O
autism	O
spectrum	O
disorders	O
.	O

For	O
fatty	O
fish	O
(	O
herring	O
/	O
mackerel	O
,	O
salmon	O
-	O
type	O
fish	O
),	O
the	O
strongest	O
inverse	O
association	O
was	O
found	O
for	O
an	O
intermediate	O
intake	O
(	O
RR	O
:	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
66	O
-	O
0	O
.	O
98	O
),	O
whereas	O
a	O
high	O
intake	O
of	O
fatty	O
fish	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
RR	O
:	O
1	O
.	O
90	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
34	O
-	O
2	O
.	O
70	O
).	O

A	O
morbidity	O
calendar	O
,	O
kept	O
daily	O
by	O
the	O
mother	O
/	O
caregiver	O
,	O
is	O
used	O
as	O
reference	O
.	O

This	O
study	O
suggests	O
a	O
clear	B
relationship	O
between	O
vitamin	O
D	O
levels	O
and	O
the	O
caries	O
status	O
of	O
preschool	O
children	O
.	O

Partial	O
Implementation	O
of	O
Preventive	O
Treatments	O
The	O
success	O
of	O
routine	O
iron	O
and	O
folate	O
supplementation	O
,	O
especially	O
in	O
areas	O
with	O
a	O
high	O
prevalence	O
of	O
anemia	O
,	O
recommended	O
as	O
a	O
component	O
of	O
antenatal	O
care	O
package	O
for	O
all	O
pregnant	O
women	O
by	O
the	O
World	O
Health	O
Organization	O
is	O
threatened	O
by	O
the	O
practice	O
of	O
partial	O
implementation	O
of	O
preventive	O
treatments	O
of	O
health	O
workers	O
.	O

In	O
Australia	O
and	O
New	O
Zealand	O
,	O
the	O
deficiency	O
cut	O
-	O
offs	O
are	O
based	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
bone	O
health	O
where	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
at	O
the	O
end	O
of	O
winter	O
is	O
required	O
for	O
optimal	O
musculoskeletal	O
health	O
[	O
1	O
].	O

Over	O
half	O
(	O
27	O
of	O
49	O
)	O
of	O
the	O
significantly	O
dysregulated	O
spots	O
that	O
were	O
identified	O
as	O
a	O
known	O
protein	O
had	O
a	O
fold	O
change	O
of	O
less	O
than	O
1	O
.	O
3	O
.	O

While	O
the	O
majority	O
of	O
patients	O
who	O
present	O
with	O
aortic	O
dissection	O
are	O
older	O
than	O
50	O
years	O
of	O
age	O
and	O
have	O
a	O
history	O
of	O
hypertension	O
,	O
younger	O
patients	O
with	O
connective	O
tissue	O
disease	O
,	O
bicuspid	O
aortic	O
valves	O
,	O
and	O
a	O
family	O
history	O
of	O
aortic	O
dissection	O
are	O
also	O
at	O
an	O
increased	O
risk	O
for	O
developing	O
this	O
condition	O
.	O

Many	O
factors	O
can	O
alter	O
cutaneous	O
vitamin	O
D	O
production	O
such	O
as	O
aging	O
,	O
skin	O
pigmentation	O
,	O
sunscreen	O
usage	O
,	O
time	O
of	O
the	O
day	O
,	O
season	O
and	O
latitude5	O
,	O
7	O
.	O

In	O
some	O
cases	O
,	O
an	O
additional	O
morning	O
injection	O
of	O
basal	O
insulin	O
may	O
further	O
improve	O
glycemic	O
control	O
.	O

Additionally	O
,	O
Pb	O
was	O
associated	O
with	O
a	O
58	O
g	O
decrease	O
in	O
birth	O
weight	O
in	O
the	O
LASSO	O
analysis	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
)	O
and	O
a	O
53	O
g	O
decrease	O
in	O
the	O
Elastic	O
Net	O
analysis	O
(	O
Additional	O
file1	O
:	O
Figure	O
S4	O
).	O

We	O
abstracted	O
laboratory	O
results	O
from	O
participants	O
'	O
50	O
gram	O
1	O
-	O
hour	O
glucose	O
challenge	O
test	O
and	O
from	O
the	O
diagnostic	O
100	O
gram	O
3	O
-	O
hour	O
OGTT	O
.	O

Vertebral	O
malformations	O
that	O
cause	O
kyphosis	O
or	O
scoliosis	O
are	O
an	O
important	O
health	O
problem	O
that	O
can	O
result	O
in	O
disability	O
and	O
suffering	O
attributable	B
to	O
both	O
physical	O
pain	O
and	O
psychological	O
distress	O
from	O
the	O
disfigurement	O
.	O

The	O
continuum	O
of	O
care	O
is	O
a	O
core	O
organising	O
principle	O
for	O
health	O
systems	O
emphasising	O
linkages	O
between	O
healthcare	O
packages	O
across	O
time	O
and	O
through	O
various	O
service	O
delivery	O
strategies	O
[	O
2	O
].	O

Sensitivity	O
analysis	O
There	O
were	O
no	O
significant	O
changes	O
in	O
the	O
multiple	O
regression	O
models	O
using	O
different	O
25OHD	O
variables	O
as	O
independent	O
variables	O
associated	O
with	O
markers	O
of	O
glucose	O
metabolism	O
;	O
early	O
pregnancy	O
25OHD	O
(	O
continuous	O
);	O
greater	O
or	O
less	O
than	O
50	O
nmol	O
/	O
L	O
(	O
insufficiency	O
),	O
greater	O
or	O
less	O
than	O
39	O
.	O
2	O
nmol	O
/	O
L	O
(	O
median	O
)	O
(	O
data	O
not	O
shown	O
).	O

Although	O
poor	O
lung	O
function	O
performance	O
and	O
an	O
increased	O
risk	O
of	O
respiratory	O
tract	O
infection	O
were	O
related	O
to	O
relatively	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
,	O
further	O
extrapolating	O
the	O
effects	O
of	O
vitamin	O
D	O
on	O
the	O
respiratory	O
function	O
of	O
the	O
general	O
infant	O
population	O
might	O
still	O
be	O
difficult	O
.	O

The	O
p	O
value	O
of	O
each	O
correlation	O
(	O
or	O
equivalently	O
the	O
SE	O
of	O
the	O
correlation	O
)	O
is	O
adjusted	O
for	O
the	O
estimation	O
of	O
the	O
other	O
correlation	O
coefficients	O
and	O
the	O
fixed	O
effects	O
.	O

High	O
educational	O
level	O
and	O
primiparity	O
are	O
negatively	O
associated	O
with	O
pregnant	O
women	O
'	O
s	O
satisfaction	O
of	O
care	O
received	O
at	O
ANC	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
it	O
is	O
clinically	O
relevant	O
to	O
report	O
that	O
approximately	O
twice	O
as	O
many	O
neonates	O
exposed	O
to	O
polytherapy	O
were	O
LGA	O
(	O
13	O
.	O
6	O
%	O
vs	O
6	O
.	O
5	O
%).	O

Analysis	O
included	O
descriptive	O
statistics	O
(	O
frequencies	O
,	O
means	O
±	O
Standard	O
Deviations	O
(	O
SD	O
)),	O
Chi	O
-	O
square	O
analysis	O
,	O
and	O
t	O
-	O
tests	O
.	O

Consequently	B
,	O
a	O
range	O
of	O
mechanisms	O
for	O
the	O
demethylation	O
of	O
DNA	O
have	O
been	O
proposed	O
(	O
described	O
in	O
relation	O
to	O
mammalian	O
development	O
in	O
Dean2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
,	O
2016	O
).	O

Proteins	O
symbols	O
in	O
red	O
were	O
up	O
-	O
regulated	O
,	O
while	O
green	O
were	O
down	O
-	O
regulated	O
.	O

NcDNA	O
is	O
transcribed	O
into	O
ncRNAs	O
,	O
which	O
play	O
major	O
roles	O
in	O
regulating	O
gene	O
expression	O
.	O

Maternal	O
“	O
diabetes	O
”	O
was	O
not	O
associated	O
with	O
any	O
respiratory	O
or	O
atopic	O
outcome	O
,	O
but	O
was	O
associated	O
with	O
higher	O
birthweight	O
.	O

Yet	O
another	O
recent	O
paper	O
reported	O
that	O
the	O
prevalence	O
of	O
autism	O
in	O
three	O
U	O
.	O
S	O
.	O
states	O
was	O
higher	O
in	O
areas	O
of	O
higher	O
precipitation	O
and	O
clouds	O
(	O
16	O
).	O

After	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
,	O
more	O
than	O
four	O
prenatal	O
visits	O
and	O
level	O
of	O
nutritional	O
knowledge	O
remained	O
associated	O
with	O
iron	O
supplementation	O
.	O

In	O
second	O
trimester	O
,	O
development	O
of	O
muscles	O
,	O
organs	O
occurs	O
,	O
so	O
the	O
diet	O
rich	O
in	O
proteins	O
is	O
advised	O
.	O

Ponderal	O
index	O
is	O
the	O
clinical	O
measure	O
normally	B
used	O
at	O
birth	O
.	O

The	O
results	O
of	O
this	O
observational	O
study	O
were	O
based	O
on	O
questionnaires	O
filled	O
out	O
by	O
the	O
mothers	O
after	O
childbirth	O
.	O

(	O
2006	O
)],	O
presence	O
within	O
1	O
kb	O
of	O
at	O
least	O
one	O
of	O
258	O
computationally	O
predicted	O
transcription	O
factor	O
binding	O
site	O
(	O
TFBS	O
)	O
sequences	O
obtained	O
from	O
the	O
tfbsConsSites	O
track	O
of	O
the	O
University	O
of	O
California	O
–	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genomes	O
Browser	O
site	O
(	O
TFBS	O
z	O
-	O
score	O
>	O
2	O
)	O
(	O
Kent	O
et	O
al	O
.	O

Dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
cohort	O
of	O
33	O
000	O
women	O
from	O
the	O
general	O
population	O
Abstract	O
Background	O
Low	O
intake	O
of	O
fish	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
)	O
and	O
vitamin	O
D	O
deficiency	O
has	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

Yet	O
similar	O
to	O
other	O
reports	O
in	O
predominantly	O
white	O
women	O
[	O
6	O
],	O
we	O
found	O
that	O
pre	O
-	O
pregnancy	O
BMI	O
is	O
strongly	O
associated	O
with	O
Latina	O
women	O
’	O
s	O
target	O
weight	O
gain	O
.	O

Recruitment	O
and	O
consent	O
of	O
women	O
In	O
the	O
intervention	O
clusters	O
,	O
SSs	O
will	O
make	O
systematic	O
door	O
-	O
to	O
-	O
door	O
visits	O
to	O
identify	O
new	O
pregnancies	O
through	O
menstrual	O
cycle	O
tracking	O
of	O
all	O
women	O
of	O
reproductive	O
age	O
.	O

Our	O
analysis	O
was	O
by	O
intention	O
to	O
treat	O
.	O

First	O
,	O
each	O
EDC	O
class	O
contains	O
between	O
4	O
to	O
23	O
chemicals	O
with	O
varying	O
associations	O
between	O
any	O
given	O
chemical	O
and	O
birth	O
weight	O
.	O

C	O
–	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Levels	O
of	O
adiposity	O
in	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
of	O
rat	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
21	O
–	O
23	O
†	O
.	O
MaleFemaleTwo	O
-	O
way	O
ANOVACC	O
(	O
n	O
=	O
12	O
)	O
RC	O
(	O
n	O
=	O
15	O
)	O
CC	O
(	O
n	O
=	O
11	O
)	O
RC	O
(	O
n	O
=	O
17	O
)	O
InteractionPrenatal	O
dietSex	O
Perirenal	O
fat	O
(	O
g	O
)	O
8	O
.	O
90	O
±	O
0	O
.	O
4112	O
.	O
30	O
±	O
0	O
.	O
64	O
***	O
4	O
.	O
82	O
±	O
0	O
.	O
36	O
***	O
5	O
.	O
73	O
±	O
0	O
.	O
69	O
$$$	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
214	O
,	O
P	O
=	O
0	O
.	O
045	O
F	O
(	O
1	O
,	O
51	O
)=	O
12	O
.	O
542	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
76	O
.	O
281	O
,	O
P	O
<	O
0	O
.	O
001Perirenal	O
fat	O
/	O
BW	O
(%)	O
1	O
.	O
97	O
±	O
0	O
.	O
082	O
.	O
47	O
±	O
0	O
.	O
12	O
*	O
1	O
.	O
80	O
±	O
0	O
.	O
122	O
.	O
06	O
±	O
0	O
.	O
19	O
$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
106	O
,	O
P	O
=	O
0	O
.	O
017nsPerigonadal	O
fat	O
(	O
g	O
)	O
9	O
.	O
32	O
±	O
0	O
.	O
6111	O
.	O
32	O
±	O
0	O
.	O
70	O
*	O
6	O
.	O
14	O
±	O
0	O
.	O
67	O
**	O
7	O
.	O
2	O
±	O
0	O
.	O
49	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
059	O
,	O
P	O
=	O
0	O
.	O
049	O
F	O
(	O
1	O
,	O
51	O
)=	O
34	O
.	O
261	O
,	O
P	O
<	O
0	O
.	O
001Perigonadal	O
fat	O
/	O
BW	O
(%)	O
2	O
.	O
06	O
±	O
0	O
.	O
122	O
.	O
27	O
±	O
0	O
.	O
132	O
.	O
29	O
±	O
0	O
.	O
212	O
.	O
66	O
±	O
0	O
.	O
14nsNs	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
111	O
,	O
P	O
=	O
0	O
.	O
048Abdominal	O
fat	O
(	O
g	O
)	O
18	O
.	O
22	O
±	O
0	O
.	O
9423	O
.	O
63	O
±	O
1	O
.	O
14	O
**	O
10	O
.	O
96	O
±	O
0	O
.	O
96	O
***	O
12	O
.	O
95	O
±	O
1	O
.	O
11	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
11	O
.	O
302	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
66	O
.	O
545	O
,	O
P	O
<	O
0	O
.	O
001Abdominal	O
fat	O
/	O
BW	O
(%)	O
4	O
.	O
03	O
±	O
0	O
.	O
184	O
.	O
74	O
±	O
0	O
.	O
204	O
.	O
15	O
±	O
0	O
.	O
284	O
.	O
72	O
±	O
0	O
.	O
30ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
163	O
,	O
P	O
=	O
0	O
.	O
016ns	O
CC	O
,	O
offspring	O
from	O
control	O
-	O
fed	O
dams	O
;	O
RC	O
,	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
.	O

Thus	B
,	O
although	O
comparison	O
and	O
integration	O
of	O
these	O
different	O
human	O
cohort	O
,	O
animal	O
,	O
and	O
in	O
vitro	O
studies	O
is	O
complicated	O
by	O
the	O
different	O
doses	O
,	O
routes	O
of	O
administration	O
,	O
timings	O
and	O
lengths	O
of	O
exposures	O
,	O
the	O
various	O
strains	O
,	O
species	O
,	O
cell	O
types	O
or	O
statistical	O
methods	O
used	O
,	O
and	O
/	O
or	O
the	O
specific	O
adverse	O
outcome	O
(	O
s	O
)	O
or	O
marker	O
(	O
s	O
)	O
selected	O
,	O
the	O
current	O
evidence	O
demonstrates	O
a	O
mechanistic	O
association	O
between	O
specific	O
environmental	O
exposures	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
health	O
outcomes	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
model	O
systems	O
.	O

The	O
median	O
was	O
nine	O
and	O
the	O
mode	O
was	O
13	O
.	O

Circulating	O
concentrations	O
of	O
25OHD	O
below	O
25	O
or	O
30	O
nmol	O
/	O
L	O
have	O
been	O
associated	O
with	O
50	O
–	O
300	O
%	O
increased	O
odds	O
of	O
SGA	O
,	O
compared	O
to	O
higher	O
concentrations	O
[	O
5	O
–	O
7	O
].	O

These	O
visits	O
will	O
be	O
made	O
between	O
12	O
and	O
14	O
weeks	O
,	O
20	O
–	O
24	O
weeks	O
,	O
28	O
–	O
32	O
weeks	O
,	O
within	O
24	O
h	O
of	O
delivery	O
,	O
7	O
–	O
10	O
days	O
after	O
delivery	O
,	O
38	O
–	O
42	O
days	O
after	O
delivery	O
(	O
Fig	O
.	O

In	O
addition	O
,	O
individuals	O
with	O
the	O
risk	O
factors	O
that	O
we	O
have	O
identified	O
may	O
benefit	O
even	O
more	O
from	O
supplementation	O
or	O
higher	O
dose	O
supplementation	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
with	O
an	O
online	O
miRNA	O
prediction	O
tool	O
[	O
4	O
].	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

A	O
trained	O
interviewer	O
administered	O
a	O
questionnaire	O
to	O
gather	O
sociodemographic	O
,	O
clinical	O
,	O
anthropometric	O
and	O
lifestyle	O
habits	O
data	O
.	O

Immediate	O
-	O
phase	O
type	O
I	O
allergic	O
symptoms	O
usually	O
occur	O
within	O
several	O
minutes	O
after	O
allergen	O
contact	O
.	O

Similarly	O
in	O
UCB	O
,	O
the	O
adjusted	O
analysis	O
showed	O
no	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
in	O
infants	O
born	O
to	O
women	O
with	O
and	O
without	O
GDM	O
(	O
79	O
.	O
1	O
±	O
2	O
.	O
3	O
vs	O
80	O
.	O
1	O
±	O
0	O
.	O
8	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
69	O
)	O
(	O
Fig	O
.	O
1	O
).	O

Vitamin	O
D	O
is	O
to	O
a	O
large	O
extent	O
metabolized	O
in	O
the	O
body	O
through	O
sun	O
exposure	O
,	O
and	O
people	O
with	O
dark	O
skin	O
need	O
more	O
sun	O
exposure	O
to	O
maintain	O
adequate	O
blood	O
levels	O
.	O

In	O
obese	O
mothers	O
,	O
we	O
found	O
that	O
higher	O
intake	O
of	O
sweets	O
early	O
in	O
pregnancy	O
was	O
related	O
to	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
and	O
6	O
months	O
.	O

Castration	O
also	O
increased	O
MS	O
in	O
Canadian	O
beef	O
carcasses	O
[	O
60	O
].	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

The	O
main	O
mediators	O
of	O
such	O
beneficial	O
effects	O
seem	O
to	O
include	O
fibroblast	O
growth	O
factor	O
21	O
(	O
FGF21	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
bone	O
morphogenic	O
proteins	O
(	O
BMPs	O
)	O
and	O
prostaglandin	O
D2	O
synthase	O
.	O

Haematological	O
effects	O
of	O
multimicronutrient	O
supplementation	O
in	O
non	O
-	O
pregnant	O
Gambian	O
women	O
Abstract	O
Background	O
/	O
Objectives	O
:	O
The	O
use	O
of	O
multimicronutrient	O
(	O
MMN	O
)	O
supplementation	O
to	O
reduce	O
the	O
burden	O
of	O
anaemia	O
in	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
has	O
been	O
little	O
studied	O
,	O
particularly	O
in	O
Africa	O
.	O

Abbreviations	O
25	O
(	O
OH	O
)	O
D	O
:	O
25	O
-	O
hydroxyvitamin	O
D	O
;	O
BMC	O
:	O
Bone	O
Mineral	O
Content	O
;	O
BMD	O
:	O
Bone	O
Mineral	O
Density	O
;	O
DXA	O
:	O
dual	O
-	O
energy	O
x	O
-	O
ray	O
absorptiometry	O
.	O

Estimated	O
delivery	O
dates	O
and	O
contact	O
information	O
for	O
each	O
pregnant	O
woman	O
identified	O
in	O
the	O
surveillance	O
area	O
are	O
maintained	O
by	O
icddr	O
,	O
b	O
Matlab	O
field	O
site	O
staff	O
.	O

Shown	O
as	O
mean	O
and	O
95	O
%	O
CI	O
for	O
each	O
group	O
.	O

As	O
described	O
previously	O
[	O
27	O
,	O
28	O
],	O
eligible	O
participants	O
for	O
the	O
NHBCS	O
are	O
pregnant	O
women	O
obtaining	O
prenatal	O
care	O
in	O
New	O
Hampshire	O
,	O
US	O
clinics	O
,	O
who	O
reported	O
relying	O
on	O
a	O
private	O
,	O
unregulated	O
well	O
as	O
their	O
home	O
water	O
source	O
.	O

1	O
Simplistic	O
conceptual	O
framework	O
of	O
exposure	O
and	O
outcome	O
variables	O
in	O
the	O
NuPED	O
study	O
.	O

This	O
group	O
often	B
uses	O
dietary	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
They	O
also	O
have	O
a	O
Vitamin	O
D2	O
detection	O
rate	O
of	O
19	O
.	O
4	O
%,	O
which	O
can	O
be	O
explained	B
by	O
consuming	O
edible	O
fungi	O
or	O
supplements	O
containing	O
Vitamin	O
D2	O
.	O

Detailed	O
procedures	O
and	O
data	O
collection	O
of	O
tidal	O
breathing	O
analysis	O
,	O
respiratory	O
mechanics	O
,	O
and	O
forced	O
tidal	O
expiration	O
were	O
stated	O
in	O
our	O
previous	O
study	O
[	O
18	O
].	O

Both	O
methods	O
are	O
interviewer	O
administered	O
by	O
using	O
standardised	O
probing	O
questions	O
[	O
37	O
].	O

No	O
umbilical	O
cord	O
care	O
events	O
were	O
observed	O
,	O
given	B
that	O
observations	O
were	O
conducted	O
after	O
the	O
typical	O
time	O
of	O
cord	O
separation	O
.	O

For	O
the	O
Bcl	O
I	O
,	O
the	O
following	O
primers	O
were	O
used	O
:	O
5	O
′-	O
AAGCTTAACAATGGCCAT	O
-	O
3	O
′	O
and	O
5	O
′-	O
TGCTGCCTTATTTGTAAATTCGT	O
-	O
3	O
′.	O

It	O
was	O
determined	O
that	O
both	O
maternal	O
race	O
and	O
marital	O
status	O
(	O
both	O
missing	O
for	O
215	O
/	O
943	O
,	O
22	O
.	O
7	O
%	O
of	O
baseline	O
participants	O
)	O
were	O
potentially	O
variables	O
that	O
were	O
differentially	O
missing	O
for	O
women	O
of	O
certain	O
racial	O
and	O
marital	O
statuses	O
.	O

This	O
problem	O
can	O
have	O
negative	O
effects	O
on	O
infant	O
development	O
and	O
can	O
cause	O
behavioral	O
,	O
cognitive	O
,	O
social	O
and	O
emotional	O
problems	O
in	O
infant	O
which	O
could	O
continue	O
throughout	O
childhood	O
[	O
3	O
–	O
5	O
].	O

The	O
cohort	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
influence	O
of	O
maternal	O
diet	O
,	O
physical	O
activity	O
and	O
the	O
other	O
life	O
style	O
factors	O
on	O
the	O
occurrence	O
of	O
preeclampsia	O
,	O
gestational	O
diabetes	O
mellitus	O
and	O
other	O
adverse	O
pregnancy	O
outcomes	O
.	O

Birth	O
weight	O
percentile	O
was	O
stratified	O
into	O
three	O
clinically	O
meaningful	O
categories	O
to	O
create	O
birth	O
weight	O
status	O
:	O
SGA	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
below	O
the	O
10th	O
percentile	O
for	O
that	O
gestational	O
age	O
;	O
appropriate	O
for	O
gestational	O
age	O
(	O
AGA	O
)	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
above	O
the	O
10th	O
percentile	O
for	O
that	O
gestational	O
age	O
and	O
below	O
the	O
90th	O
percentile	O
for	O
that	O
gestational	O
age	O
;	O
and	O
large	O
for	O
gestational	O
age	O
(	O
LGA	O
)	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
above	O
the	O
90th	O
percentile	O
for	O
that	O
gestational	O
age	O
.	O

Furthermore	O
,	O
alterations	O
of	O
the	O
maternal	O
diet	O
,	O
that	O
is	O
,	O
avoidance	O
of	O
milk	O
and	O
egg	O
consumption	O
during	O
pregnancy	O
did	O
not	O
seem	O
to	O
lower	O
the	O
risk	O
of	O
sensitization	O
in	O
the	O
child	O
[	O
83	O
,	O
84	O
].	O

Role	O
of	O
epigenetics	O
in	O
the	O
mammalian	O
life	O
cycle	O
Normal	O
mammalian	O
development	O
is	O
a	O
cyclical	O
series	O
of	O
events	O
that	O
enable	O
the	O
continued	O
production	O
of	O
multiple	O
generations	O
(	O
described	O
in	O
Gilbert2014	O
).	O

Infant	O
Anthropometrics	O
Trained	O
research	O
staff	O
abstracted	O
infant	O
and	O
child	O
weight	O
and	O
length	O
from	O
obstetric	O
and	O
pediatric	O
records	O
.	O

Solid	O
foods	O
should	O
be	O
introduced	O
at	O
age	O
4	O
-	O
6	O
months	O
.	O

Inclusion	O
of	O
older	O
children	O
and	O
young	O
adults	O
would	O
allow	O
cathelicidin	O
to	O
be	O
followed	O
throughout	O
a	O
longer	O
period	O
of	O
childhood	O
development	O
and	O
further	O
describe	O
how	O
cathelicidin	O
and	O
innate	O
immune	O
function	O
develop	O
over	O
time	O
.	O

Nevertheless	O
,	O
three	O
of	O
four	O
recent	O
U	O
.	O
S	O
.	O
studies	O
found	O
a	O
higher	O
incidence	O
of	O
autism	O
in	O
black	O
children	O
,	O
sometimes	O
appreciably	O
higher	O
(	O
1	O
,	O
2	O
).	O

The	O
red	O
dashed	O
lines	O
represent	O
the	O
null	O
limits	O
for	O
the	O
permutation	O
distribution	O
of	O
regression	O
coefficient	O
t	O
-	O
statistics	O
(	O
t	O
-	O
stat	O
),	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Neuropeptides	O
such	O
as	O
neurotensin	O
can	O
indirectly	O
influence	O
dopaminergic	O
transmission	O
in	O
the	O
nucleus	O
accumbens	O
via	O
glutamate	O
and	O
GABA	O
-	O
ergic	O
mediated	O
processes	O
[	O
38	O
].	O

It	O
has	O
frequently	O
been	O
suggested	O
that	O
adolescents	O
should	O
be	O
the	O
focus	O
of	O
targeted	O
intervention	O
strategies	O
which	O
aim	O
to	O
improve	O
reproductive	O
health	O
particularly	O
before	O
first	O
pregnancies	O
(	O
Leenstra	O
et	O
al	O
2007	O
).	O

However	O
,	O
the	O
depression	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
217	O
).	O

Clinical	O
outcomes	O
are	O
currently	O
being	O
examined	O
.	O

Nommsen	O
-	O
Rivers	O
,	O
the	O
perinatal	O
nutrition	O
expert	O
from	O
the	O
University	O
of	O
Cincinnati	O
,	O
initiated	O
breastfeeding	O
studies	O
in	O
both	O
California	O
and	O
Ohio	O
,	O
which	O
were	O
part	O
of	O
the	O
World	O
Health	O
Organization	O
Multicentre	O
Growth	O
Reference	O
Study	O
.	O
30	O
“	O
Our	O
goal	O
was	O
to	O
enable	O
as	O
many	O
women	O
as	O
possible	O
to	O
follow	O
breastfeeding	O
guidelines	O
by	O
providing	O
lactation	O
support	O
,”	O
she	O
says	O
.	O

It	O
has	O
also	O
been	O
recognized	B
that	O
the	O
pace	O
of	O
such	O
change	O
is	O
sometimes	O
too	O
rapid	O
to	O
be	O
accounted	O
for	O
by	O
natural	O
selection	O
.	O

Inform	O
•	O
Improve	O
data	O
collection	O
to	O
track	O
preterm	O
births	O
and	O
measurements	O
,	O
such	O
as	O
consistent	O
assessment	O
of	O
gestational	O
age	O
,	O
birthweight	O
,	O
cause	O
of	O
death	O
,	O
data	O
on	O
impairment	O
and	O
retinopathy	O
of	O
prematurity	O
.	O

We	O
used	O
multivariable	O
logistic	O
regression	O
to	O
analyze	O
associations	O
of	O
PNV	O
use	O
and	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
defined	B
as	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
.	O

Most	O
women	O
with	O
atopic	O
dermatitis	O
have	O
lived	O
with	O
their	O
condition	O
long	O
before	O
becoming	O
pregnant	O
.	O

P	O
is	O
for	O
trend	O
by	O
linear	O
regression	O
with	O
adjustment	O
for	O
confounders	O
.	O

Children	O
of	O
overweight	O
/	O
obese	O
mothers	O
who	O
were	O
exposed	O
to	O
excessive	O
GWG	O
(	O
n	O
=	O
84	O
)	O
had	O
an	O
approximate	O
4	O
.	O
0	O
-	O
fold	O
increase	O
in	O
odds	O
(	O
CI	O
(	O
1	O
.	O
0	O
,	O
15	O
.	O
1	O
);	O
P	O
=	O
0	O
.	O
04	O
)	O
of	O
being	O
macrosomic	O
and	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
(	O
0	O
.	O
62	O
±	O
0	O
.	O
84	O
versus	O
0	O
.	O
05	O
±	O
0	O
.	O
95	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
GWG	O
.	O

Nutritional	O
intervention	O
is	O
important	O
for	O
the	O
control	O
of	O
GDM	O
,	O
as	O
it	O
provides	O
benefits	O
to	O
mother	O
and	O
fetal	O
health	O
.	O

(	O
2015	O
)*	O
Zhou	O
et	O
al	O
.	O

Exposure	O
to	O
ionizing	O
radiation	O
is	O
the	O
only	O
well	O
established	O
environmental	O
risk	O
factor	O
,	O
and	O
this	O
factor	O
explains	O
only	O
a	O
small	O
percentage	O
of	O
cases	O
.	O

The	O
Ethics	O
Committee	O
of	O
the	O
Federal	O
University	O
of	O
São	O
Paulo	O
approved	O
the	O
study	O
protocol	O
(	O
Number	O
:	O
214	O
.	O
956	O
).	O

Log	O
transformation	O
was	O
used	O
for	O
non	O
-	O
normal	O
distributions	O
.	O

While	O
high	O
fructose	O
consumption	O
has	O
been	O
proposed	O
as	O
a	O
risk	O
factor	O
for	O
obesity	O
[	O
45	O
],	O
we	O
found	O
no	O
evidence	O
to	O
suggest	O
that	O
the	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
were	O
mediated	O
by	O
maternal	O
BMI	O
,	O
gestational	O
weight	O
gain	O
or	O
child	O
'	O
s	O
BMI	O
,	O
nor	O
by	O
prematurity	O
or	O
low	O
birthweight	O
,	O
assuming	O
key	O
assumptions	O
necessary	O
for	O
mediation	O
analyses	O
were	O
met	O
[	O
46	O
,	O
47	O
].	O

Our	O
hypothesis	O
was	O
that	O
lack	O
of	O
prenatal	O
vitamin	O
(	O
PNV	O
)	O
use	O
would	O
be	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
defined	B
as	O
<	O
50	O
nmol	O
/).	O

Poor	O
maternal	O
vitamin	O
D	O
status	O
has	O
been	O
related	O
to	O
fetal	O
growth	O
restriction	O
[	O
15	O
]	O
but	O
it	O
is	O
unknown	O
whether	O
maternal	O
vitamin	O
D	O
status	O
associates	O
with	O
birth	O
size	O
in	O
infants	O
with	O
normal	O
birth	O
weight	O
.	O

The	O
cross	O
-	O
sectional	O
design	O
did	O
not	O
allow	O
us	O
to	O
distinguish	O
between	O
cause	O
and	O
effect	O
.	O

Do	O
low	O
-	O
level	O
exposures	O
induce	O
epigenetic	O
toxicity	O
?	O

The	O
median	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
was	O
significantly	O
higher	O
in	O
the	O
first	O
trimester	O
than	O
in	O
the	O
third	O
trimester	O
:	O
20	O
.	O
4	O
ng	O
/	O
mL	O
and	O
22	O
.	O
7	O
ng	O
/	O
mL	O
respectively	O
.	O

We	O
identified	O
76	O
human	O
cohort	O
studies	O
within	O
PubMed	O
that	O
associated	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
birth	O
outcomes	O
,	O
organ	O
-	O
specific	O
abnormalities	O
/	O
disorders	O
,	O
cancer	O
or	O
mortality	O
)	O
with	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
mainly	O
DNA	O
methylation	O
to	O
-	O
date	O
,	O
but	O
also	O
histone	O
modification	O
,	O
epigenetic	O
machinery	O
and	O
miRNAs	O
)	O
and	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
air	O
pollution	O
,	O
chemicals	O
,	O
fibers	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
childhood	O
,	O
adolescence	O
,	O
adulthood	O
and	O
lifetime	O
).	O

Stridor	O
was	O
present	O
while	O
crying	O
and	O
the	O
infant	O
had	O
a	O
barking	O
cough	O
and	O
occasional	O
wheeze	O
.	O

Previous	O
studies	O
in	O
Mexico	O
and	O
Bangladesh	O
have	O
shown	O
no	O
additional	O
benefit	O
on	O
haematological	O
parameters	O
when	O
women	O
of	O
reproductive	O
age	O
and	O
adolescents	O
were	O
given	O
MMN	O
compared	O
to	O
iron	O
-	O
folate	O
supplements	O
(	O
Ahmed	O
et	O
al	O
2005	O
,	O
Moriarty	O
-	O
Craige	O
et	O
al	O
2004	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

2	O
.	O

3	O
.	O

Among	O
these	O
subjects	O
,	O
their	O
initial	O
mean	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
34	O
.	O
8	O
ng	O
/	O
mL	O
(	O
SD	O
13	O
.	O
0	O
ng	O
/	O
mL	O
)	O
and	O
approximately	O
12	O
months	O
later	O
the	O
mean	O
concentration	O
was	O
28	O
.	O
9	O
ng	O
/	O
mL	O
(	O
SD	O
9	O
.	O
2	O
ng	O
/	O
mL	O
),	O
which	O
was	O
not	O
a	O
clinically	O
significant	O
or	O
statistically	O
significant	O
difference	O
.	O

The	O
cost	O
per	O
anaemia	O
case	O
prevented	O
was	O
calculated	O
as	O
the	O
total	O
cost	O
of	O
the	O
program	O
(	O
both	O
set	O
up	O
and	O
maintenance	O
costs	O
)	O
divided	O
by	O
the	O
difference	O
between	O
the	O
total	O
number	O
of	O
anaemia	O
cases	O
at	O
baseline	O
and	O
the	O
number	O
of	O
anaemia	O
cases	O
after	O
12	O
months	O
of	O
implementation	O
.	O

Additional	O
epigenetic	O
mechanisms	O
are	O
likely	B
to	O
be	O
elucidated	O
as	O
research	O
continues	O
.	O

Although	O
67	O
.	O
3	O
%	O
of	O
the	O
blood	O
samples	O
were	O
taken	O
in	O
the	O
winter	O
,	O
81	O
%	O
of	O
the	O
participants	O
were	O
exposed	O
to	O
sunlight	O
or	O
had	O
outdoor	O
activities	O
for	O
at	O
least	O
15	O
min	O
per	O
day	O
.	O

With	O
regards	O
to	O
waiting	O
time	O
at	O
the	O
clinic	O
,	O
the	O
women	O
recognized	O
that	O
most	O
of	O
the	O
time	O
wasting	O
was	O
due	O
to	O
late	O
coming	O
of	O
their	O
fellow	O
pregnant	O
women	O
.	O

Snoring	O
that	O
is	O
infrequent	O
or	O
non	O
-	O
habitual	O
has	O
not	O
been	O
shown	O
to	O
be	O
a	O
useful	O
screen	O
for	O
sleep	O
disordered	O
breathing	O
in	O
large	O
epidemiologic	O
studies	O
[	O
41	O
,	O
42	O
].	O

Data	O
management	O
Data	O
are	O
managed	O
by	O
two	O
dedicated	O
data	O
managers	O
.	O

A	O
total	O
of	O
2136	O
infants	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
and	O
included	O
in	O
the	O
analysis	O
(	O
96	O
.	O
6	O
%	O
of	O
the	O
randomised	O
sample	O
).	O

Dysfunction	O
of	O
DA	O
signalling	O
has	O
been	O
strongly	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
schizophrenia	O
[	O
13	O
].	O

Of	O
the	O
49	O
study	O
subjects	O
,	O
22	O
were	O
Caucasian	O
and	O
27	O
Hispanic	O
.	O

A	O
recent	O
international	O
expert	B
consultation	O
organized	O
by	O
WHO	O
went	O
further	O
and	O
recommended	O
weekly	O
supplementation	O
with	O
iron	O
and	O
folic	O
acid	O
for	O
all	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
in	O
areas	O
where	O
anaemia	O
prevalence	O
is	O
greater	O
than	O
20	O
%[	O
8	O
].	O

This	O
was	O
the	O
first	O
study	O
to	O
show	O
phenotypic	O
and	O
epigenetic	O
changes	O
in	O
generations	O
not	O
directly	O
exposed	O
to	O
the	O
original	O
stimulus	O
.	O

This	O
included	O
evaluating	O
possible	O
effect	O
measure	O
modifications	O
according	O
to	O
fetal	O
sex	O
.	O

Pregnancy	O
loss	O
before	O
gestational	O
week	O
22	O
was	O
based	O
on	O
self	O
-	O
report	O
data	O
and	O
medical	O
records	O
to	O
verify	O
miscarriage	O
were	O
not	O
available	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

Only	O
4	O
%	O
of	O
women	O
treated	O
with	O
glyburide	O
achieved	O
inadequate	O
control	O
and	O
required	O
a	O
switch	O
to	O
insulin	O
.	O

The	O
height	O
of	O
the	O
child	O
was	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
mother	O
and	O
father	O
,	O
being	O
similar	O
for	O
boys	O
and	O
girls	O
.	O

In	O
the	O
last	O
3	O
years	O
,	O
an	O
increasing	O
amount	O
of	O
research	O
suggests	O
that	O
some	O
of	O
the	O
damage	O
done	O
by	O
Vitamin	O
D	O
deficiency	O
is	O
done	O
in	O
-	O
utero	O
,	O
while	O
the	O
fetus	O
is	O
developing	O
.	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
.	O

Both	O
diet	O
and	O
generation	O
account	B
for	I
the	O
total	O
variation	O
in	O
the	O
number	O
of	O
glomeruli	O
.	O

In	O
retrospect	O
,	O
this	O
should	O
have	O
been	O
explicitly	O
stated	O
in	O
our	O
article	O
(	O
Martin	O
et	O
al	O
.	O

Thus	O
the	O
experimental	O
data	O
will	O
complement	O
previous	O
findings	O
from	O
rodent	O
models	O
and	O
epidemiological	O
human	O
data	O
.	O

High	O
dose	O
of	O
oral	O
iron	O
supplements	O
is	O
commonly	O
associated	O
with	O
gastrointestinal	O
effects	O
such	O
as	O
constipation	O
,	O
nausea	O
,	O
vomiting	O
,	O
and	O
diarrhea	O
;	O
the	O
frequency	O
and	O
severity	O
of	O
which	O
vary	O
according	O
to	O
the	O
amount	O
of	O
elemental	O
iron	O
released	O
into	O
the	O
stomach	O
.	O

In	O
our	O
study	O
,	O
both	O
maternal	O
high	O
fat	O
nutrition	O
and	O
diminished	O
maternal	O
calorie	O
intake	O
impacted	O
on	O
female	O
offspring	O
reproductive	O
maturation	O
resulting	O
in	O
early	O
pubertal	O
onset	O
,	O
most	B
likely	I
through	O
two	O
different	O
,	O
potentially	O
adaptive	O
,	O
pathways	O
.	O

Applying	O
a	O
single	O
factor	O
(	O
e	O
.	O
g	O
.,	O
nutritional	O
or	O
genetic	O
)	O
may	O
not	O
be	O
adequate	O
to	O
increase	O
IMF	O
deposition	O
.	O

Among	O
children	O
with	O
available	O
information	O
,	O
12	O
.	O
2	O
%	O
had	O
current	O
doctor	O
-	O
diagnosed	O
asthma	O
,	O
10	O
.	O
7	O
%	O
had	O
current	O
wheezing	O
with	O
whistling	O
,	O
8	O
.	O
8	O
%	O
had	O
current	O
hay	O
fever	O
,	O
16	O
.	O
2	O
%	O
had	O
current	O
eczema	O
,	O
21	O
.	O
5	O
%	O
had	O
atopy	O
and	O
61	O
.	O
8	O
%	O
did	O
not	O
have	O
any	O
of	O
these	O
five	O
outcomes	O
.	O

Exposure	O
assessment	O
Data	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
were	O
collected	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
at	O
32	O
weeks	O
gestation	O
,	O
covering	O
all	O
the	O
main	O
foods	O
consumed	O
in	O
Britain	O
[	O
13	O
].	O

The	O
Guidelines	O
for	O
maternity	O
care	O
in	O
South	O
Africa	O
[	O
26	O
]	O
therefore	O
recommend	O
routine	O
nutritional	O
assessment	O
–	O
such	O
as	O
measuring	O
mid	O
-	O
upper	O
arm	O
circumference	O
and	O
haemoglobin	O
levels	O
–	O
and	O
daily	O
supplementation	O
of	O
200	O
mg	O
ferrous	O
sulphate	O
,	O
1000	O
mg	O
calcium	O
and	O
5	O
mg	O
folic	O
acid	O
.	O

They	O
could	O
potentially	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
predispose	O
to	O
hypoxia	O
.	O

The	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
was	O
shown	O
to	O
be	O
doubled	O
with	O
maternal	O
use	O
of	O
SSRIs	O
in	O
a	O
recent	O
case	O
controlled	O
study	O
of	O
298	O
children	O
,	O
with	O
prenatal	O
exposure	O
reported	O
for	O
20	O
of	O
those	O
children	O
[	O
36	O
].	O

The	O
genome	O
scan	O
was	O
conducted	O
using	O
an	O
Illumina	O
Mouse	O
Medium	O
density	O
SNP	O
panel	O
(	O
Genetic	O
Analysis	O
Facility	O
,	O
Centre	O
for	O
Applied	O
Genomics	O
,	O
Hospital	O
for	O
Sick	O
Children	O
,	O
Toronto	O
,	O
ON	O
).	O

Methods	O
A	O
total	O
of	O
ninety	O
-	O
eight	O
pregnant	O
women	O
with	O
GDM	O
were	O
enrolled	O
voluntarily	O
in	O
this	O
study	O
.	O

As	O
expected	O
,	O
this	O
study	O
generated	O
some	O
controversy	O
,	O
particularly	O
when	O
subsequent	O
groups	O
failed	O
to	O
reproduce	O
the	O
same	O
results	O
(	O
Gray	O
&	O
Furr2008	O
;	O
Schneider	O
et	O
al	O
.	O
2008	O
;	O
Inawaka	O
et	O
al	O
.	O
2009	O
;	O
Schneider	O
et	O
al	O
.	O
2013	O
).	O

Discussion	O
In	O
this	O
population	O
-	O
based	O
birth	O
cohort	O
study	O
,	O
we	O
found	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
,	O
independently	O
of	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

Prompt	O
resolution	O
of	O
symptoms	O
on	O
correction	O
of	O
hypocalcemia	O
as	O
had	O
happened	O
in	O
our	O
case	O
has	O
also	O
been	O
reported	O
in	O
literature	O
.	O

This	O
work	O
showed	O
that	O
women	O
with	O
signs	O
of	O
insulin	O
resistance	O
produced	O
about	O
half	O
as	O
much	O
milk	O
as	O
those	O
without	O
.	O
34It	O
is	O
important	O
to	O
note	O
,	O
she	O
says	O
,	O
that	O
all	O
the	O
women	O
in	O
this	O
study	O
had	O
concerns	O
about	O
their	O
milk	O
production	O
and	O
were	O
already	O
supplementing	O
with	O
formula	O
.	O

On	O
an	O
isoenergetic	O
basis	O
,	O
pregnant	O
sows	O
were	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
)	O
to	O
investigate	O
the	O
effects	O
on	O
hepatic	O
gene	O
expression	O
in	O
their	O
fetuses	O
and	O
offspring	O
.	O

Hand	O
cleansing	O
technology	O
that	O
does	O
not	O
necessitate	O
as	O
frequent	O
replenishment	O
may	O
be	O
needed	O
to	O
further	O
improve	O
hand	O
hygiene	O
in	O
the	O
newborn	O
period	O
.	O

After	O
weaning	O
,	O
all	O
offspring	O
was	O
fed	O
standard	O
diets	O
ad	O
libitum	O
.	O

Conclusion	O
We	O
observed	O
a	O
high	O
prevalence	O
of	O
risk	O
factors	O
for	O
GDM	O
in	O
this	O
sample	O
.	O

They	O
represent	O
the	O
most	O
common	O
malignant	O
brain	O
tumors	O
[	O
1	O
].	O

Introduction	O
Infection	O
with	O
influenza	O
during	O
pregnancy	O
and	O
its	O
association	O
with	O
adverse	O
birth	O
outcomes	O
has	O
been	O
documented	O
since	O
the	O
early	O
1900s	O
[	O
1	O
],[	O
2	O
].	O

Such	O
findings	O
may	O
have	O
important	O
clinical	O
relevance	O
,	O
as	B
the	O
rates	O
of	O
many	O
adverse	O
delivery	O
/	O
neonatal	O
outcomes	O
were	O
at	O
least	O
twice	O
as	O
high	O
in	O
the	O
polytherapy	O
group	O
.	O

A	O
previous	O
study	O
in	O
Viet	O
Nam	O
followed	O
women	O
of	O
reproductive	O
age	O
receiving	O
weekly	O
supplements	O
,	O
some	O
of	O
whom	O
became	O
pregnant	O
at	O
various	O
points	O
during	O
the	O
12	O
months	O
of	O
follow	O
-	O
up	O
.	O

This	O
was	O
covered	O
under	O
a	O
data	O
use	O
agreement	O
(	O
DUA	O
)	O
between	O
the	O
Department	O
of	O
Defense	O
,	O
National	O
Healthy	O
Mothers	O
,	O
Healthy	O
Babies	O
(	O
HMHB	O
)	O
Coalition	O
,	O
Voxiva	O
,	O
and	O
The	O
George	O
Washington	O
University	O
.	O

Some	O
researchers	O
,	O
on	O
the	O
other	O
hand	O
,	O
believe	O
that	O
both	O
daily	O
and	O
weekly	O
iron	O
supplementation	O
are	O
relatively	O
unsuccessful	O
in	O
the	O
reduction	O
of	O
prevalence	O
of	O
anemia	O
in	O
pregnancy	O
.	O

Pregnant	O
women	O
were	O
recruited	O
from	O
gestational	O
week	O
4	O
during	O
fall	O
2013	O
and	O
spring	O
2014	O
,	O
when	O
registering	O
at	O
one	O
of	O
the	O
participating	O
antenatal	O
care	O
units	O
.	O

Maternal	O
blood	O
samples	O
were	O
obtained	O
at	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
(	O
at	O
baseline	O
)	O
and	O
once	O
more	O
,	O
at	O
childbirth	O
(	O
during	O
first	O
24	O
h	O
after	O
birth	O
in	O
postpartum	O
ward	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Maternal	O
mean	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
glucose	O
challenge	O
.	O

If	O
this	O
theory	O
is	O
true	B
,	O
the	O
path	O
towards	O
effective	O
prevention	O
–	O
and	O
perhaps	O
a	O
treatment	O
effect	O
if	O
adequate	O
physiological	O
doses	O
of	O
vitamin	O
D	O
are	O
given	O
–	O
is	O
so	O
simple	O
,	O
so	O
safe	O
,	O
so	O
inexpensive	O
,	O
so	O
readily	O
available	O
and	O
so	O
easy	O
,	O
that	O
it	O
defies	O
imagination	O
.	O

Consenting	O
non	O
-	O
pregnant	O
women	O
who	O
were	O
menstruating	O
,	O
not	O
breastfeeding	O
an	O
infant	O
,	O
not	O
using	O
contraception	O
or	O
not	O
severely	O
anaemic	O
(	O
haemoglobin	O
concentration	O
<	O
7g	O
/	O
dL	O
)	O
were	O
included	O
in	O
the	O
trial	O
.	O

There	O
were	O
no	O
differences	O
in	O
haematological	O
parameters	O
.	O

These	O
lambs	O
were	O
fatter	O
but	O
had	O
higher	O
hypothalamic	O
POMC	O
expression	O
at	O
postnatal	O
day	O
30	O
and	O
relative	O
milk	O
intake	O
of	O
these	O
lambs	O
was	O
not	O
different	O
from	O
those	O
born	O
to	O
control	O
-	O
fed	O
mothers	O
after	O
the	O
third	O
postnatal	O
week	O
.	O
23In	O
contrast	O
,	O
the	O
data	O
from	O
the	O
present	O
study	O
show	O
that	O
higher	O
food	O
intake	O
in	O
adulthood	O
of	O
offspring	O
born	O
to	O
the	O
HV	O
dams	O
and	O
fed	O
the	O
RV	O
diet	O
is	O
consistent	O
with	O
their	O
lower	O
expression	O
of	O
anorexigenic	O
neuropeptides	O
in	O
the	O
hypothalamus	O
.	O

ADP	O
,	O
ON	O
,	O
LM	O
,	O
and	O
MG	O
contributed	O
to	O
the	O
study	O
conceptualization	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
of	O
article	O
.	O

Thus	O
,	O
a	O
total	O
of	O
33	O
623	O
women	O
were	O
included	O
in	O
the	O
analysis	O
.	O

(	O
13	O
),	O
anthropometric	O
indicators	O
,	O
including	O
weight	O
and	O
height	O
,	O
were	O
measured	O
and	O
plasma	O
lipids	O
,	O
insulin	O
,	O
and	O
adiponectin	O
and	O
visfatin	O
concentrations	O
in	O
the	O
umbilical	O
cord	O
blood	O
of	O
50	O
large	O
-	O
for	O
-	O
gestational	O
age	O
(	O
LGA	O
)	O
and	O
50	O
appropriate	O
-	O
for	O
-	O
gestational	O
age	O
(	O
AGA	O
)	O
infants	O
born	O
following	O
complication	O
-	O
free	O
pregnancies	O
were	O
assessed	O
.	O

For	O
both	O
first	O
and	O
third	O
trimester	O
women	O
there	O
was	O
a	O
clear	O
seasonal	O
trend	O
in	O
the	O
mean	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentrations	O
with	O
lowest	O
concentrations	O
in	O
winter	O
and	O
highest	O
during	O
spring	O
and	O
summer	O
,	O
while	O
decreasing	O
again	O
in	O
autumn	O
.	O

In	O
the	O
present	O
study	O
,	O
no	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
WT1	O
in	O
the	O
kidneys	O
at	O
birth	O
was	O
observed	O
in	O
either	O
the	O
F1	O
or	O
F2	O
generation	O
.	O

A	O
unique	O
form	O
of	O
urticaria	O
associated	O
with	O
pregnancy	O
,	O
which	O
tends	O
to	O
recur	O
in	O
subsequent	O
pregnancies	O
(	O
pregnancy	O
urticaria	O
),	O
has	O
been	O
reported	O
[	O
45	O
].	O

Adequate	O
Vitamin	O
D	O
status	O
(>	O
30	O
nmol	O
/	O
L	O
)	O
significantly	O
promotes	O
calcium	O
absorption	O
and	O
reduces	O
rickets	O
risks	O
,	O
which	O
was	O
deemed	B
as	O
good	O
Vitamin	O
D	O
nutritional	O
status	O
.	O

Therefore	B
,	O
the	O
protective	O
role	O
of	O
high	O
25	O
(	O
OH	O
)	O
D	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
against	O
GDM	O
,	O
as	O
seen	O
with	O
a	O
decreased	O
risk	O
of	O
GDM	O
in	O
women	O
within	O
the	O
‘	O
high	O
’	O
quartile	O
of	O
standardised	O
vitamin	O
D	O
compared	O
to	O
moderate	O
-	O
high	O
,	O
is	O
consistent	O
with	O
knowledge	O
about	O
vitamin	O
D	O
and	O
diabetes	O
.	O

However	O
,	O
our	O
study	O
is	O
limited	O
for	O
not	O
measuring	O
urine	O
calcium	O
and	O
creatinin	O
,	O
since	O
these	O
variables	O
could	O
confirm	O
the	O
presence	O
of	O
hypervitaminosis	O
more	O
exactly	O
and	O
more	O
confidently	O
.	O

The	O
fact	O
that	O
we	O
did	O
not	O
observe	O
differences	O
in	O
other	O
subtypes	O
of	O
SeroR	O
may	O
indicate	O
that	O
SeroR2A	O
is	O
more	O
sensitive	O
to	O
BDNF	O
-	O
induced	O
changes	O
by	O
the	O
vitamin	O
diets	O
.	O

Caption	O
(	O
FIG	O
)	O
The	O
western	O
sandpiper	O
,	O
one	O
of	O
the	O
Arctic	O
species	O
studied	O
UK	O
Organic	O
Certifier	O
Says	O
No	O
to	O
Nanomaterials	O
The	O
Soil	O
Association	O
,	O
a	O
nonprofit	O
UK	O
organization	O
that	O
certifies	O
the	O
majority	O
of	O
that	O
nation	O
’	O
s	O
organic	O
products	O
,	O
announced	O
in	O
January	O
2008	O
it	O
will	O
no	O
longer	O
allow	O
man	O
-	O
made	O
nanomaterials	O
(	O
materials	O
with	O
a	O
mean	O
size	O
of	O
less	O
than	O
200	O
nm	O
)	O
to	O
be	O
used	O
in	O
goods	O
carrying	O
its	O
certification	O
label	O
.	O

In	O
early	O
pregnancy	O
,	O
attending	O
the	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
was	O
associated	O
with	O
significantly	O
lower	O
25OHD	O
concentrations	O
than	O
extended	O
summer	O
(	O
32	O
.	O
9	O
nmol	O
/	O
L	O
[	O
22	O
.	O
6	O
nmol	O
/	O
L	O
]	O
vs	O
.	O
44	O
.	O
1	O
nmol	O
/	O
L	O
[	O
27	O
.	O
6	O
nmol	O
/	O
L	O
],	O
P	O
<	O
0	O
.	O
001	O
).	O

Thus	B
,	O
the	O
dietary	O
energy	O
source	O
may	O
differentially	O
influence	O
marbling	O
and	O
IMF	O
deposition	O
,	O
depending	O
on	O
the	O
feeding	O
period	O
.	O

Understanding	O
the	O
factors	O
affecting	O
IMF	O
deposition	O
and	O
the	O
mechanisms	O
responsible	O
for	O
its	O
deposition	O
is	O
important	O
when	O
manipulating	O
IMF	O
deposition	O
.	O

The	O
homogenates	O
were	O
centrifuged	O
at	O
7380	O
rpm	O
/	O
5000	O
g	O
for	O
20	O
min	O
at	O
4	O
°	O
C	O
,	O
and	O
the	O
supernatants	O
were	O
collected	O
.	O

Methods	O
Study	O
design	O
and	O
setting	O
This	O
is	O
a	O
secondary	O
data	O
analysis	O
of	O
334	O
pregnant	O
women	O
enrolled	O
in	O
the	O
ROLO	O
(	O
Randomised	O
cOntrol	O
trial	O
of	O
a	O
LOw	O
glycaemic	O
index	O
diet	O
in	O
pregnancy	O
to	O
prevent	O
macrosomia	O
)	O
study	O
between	O
2007	O
and	O
2011	O
at	O
The	O
National	O
Maternity	O
Hospital	O
,	O
Dublin	O
,	O
Ireland	O
.	O

Spots	O
were	O
dried	O
in	O
a	O
Vacuum	O
Concentrator	O
(	O
Eppendorf	O
,	O
Hamburg	O
Germany	O
)	O
for	O
25	O
min	O
and	O
rehydrated	O
at	O
4	O
°	O
C	O
in	O
tryptic	O
digest	O
solution	O
(	O
10	O
ng	O
/	O
µl	O
porcine	O
sequencing	O
grade	O
trypsin	O
(	O
Promega	O
)	O
in	O
50	O
mM	O
NH4HCO3	O
)	O
for	O
1	O
h	O
.	O
Remaining	O
tryptic	O
digest	O
solution	O
was	O
removed	O
and	O
gel	O
pieces	O
suspended	O
overnight	O
at	O
37	O
°	O
C	O
in	O
50	O
mM	O
NH4HCO3	O
.	O

Live	O
-	O
born	O
infants	O
at	O
6	O
-	O
months	O
of	O
age	O
,	O
and	O
whose	O
mother	O
provided	O
consent	O
to	O
ongoing	O
follow	O
-	O
up	O
were	O
eligible	O
.	O

Although	O
infectious	O
and	O
inflammatory	O
processes	O
contribute	O
to	O
a	O
high	O
proportion	O
of	O
early	O
spontaneous	O
preterm	O
births	O
[	O
35	O
],	O
antibiotic	O
treatment	O
of	O
reproductive	O
tract	O
infections	O
,	O
especially	O
bacterial	O
vaginosis	O
and	O
other	O
remote	O
site	O
infections	O
,	O
has	O
generally	B
failed	O
to	O
reduce	O
preterm	O
risk	O
[	O
36	O
].	O

Waist	O
circumference	O
(	O
WC	O
)	O
was	O
recorded	O
at	O
a	O
level	O
midway	O
between	O
the	O
lower	O
rib	O
margin	O
and	O
the	O
iliac	O
crest	O
at	O
the	O
end	O
of	O
normal	O
expiration	O
.	O

On	O
the	O
other	O
hand	O
,	O
resting	O
HR	O
values	O
were	O
positive	O
correlated	O
with	O
BMI	O
(	O
r	O
=	O
0	O
.	O
300	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
blood	O
pressure	O
levels	O
(	O
SBP	O
:	O
r	O
=	O
0	O
.	O
382	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
DBP	O
:	O
r	O
=	O
0	O
.	O
317	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

Vitamin	O
D	O
can	O
affect	O
brain	O
function	O
in	O
several	O
ways	O
.	O

Compared	O
to	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
summer	O
,	O
extended	O
winter	O
was	O
associated	O
with	O
increased	O
early	O
-	O
pregnancy	O
HOMA	O
-	O
IR	O
(	O
46	O
.	O
7	O
%)	O
and	O
insulin	O
(	O
47	O
.	O
6	O
%),	O
independent	O
of	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
confounders	O
.	O

CEA	O
,	O
calcitonin	O
,	O
katacalcin	O
,	O
chromogranin	O
-	O
A	O
according	O
to	O
tumour	O
staining	O
),	O
and	O
scanning	O
with	O
specific	O
ligands	O
such	O
as	O
octreotide	O
.	O

We	O
informed	O
all	O
patients	O
about	O
details	O
and	O
goals	O
of	O
this	O
study	O
before	O
the	O
start	O
.	O

Three	O
text	O
messages	O
were	O
delivered	O
per	O
week	O
at	O
random	O
times	O
during	O
waking	O
hours	O
on	O
weekdays	O
.	O

(	O
B	O
–	O
D	O
)	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
for	O
CC	O
vs	O
.	O
RC	O
males	O
;#	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
.	O

A	O
negative	O
correlation	O
was	O
observed	O
between	O
serum	O
retinol	O
concentrations	O
and	O
carcass	O
MS	O
values	O
in	O
Japanese	O
Black	O
cattle	O
[	O
130	O
,	O
131	O
].	O

The	O
placenta	O
and	O
brain	O
,	O
in	O
particular	O
,	O
express	O
many	O
of	O
the	O
imprinted	O
genes	O
,	O
in	O
keeping	O
with	O
experimentally	O
identified	O
roles	O
for	O
imprinted	O
genes	O
in	O
prenatal	O
nutrient	O
acquisition	O
and	O
growth	O
regulation	O
,	O
neurodevelopment	O
,	O
and	O
postnatal	O
energy	O
homeostasis	O
and	O
behavior	O
.	O

However	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
requires	O
an	O
additional	O
hydroxylation	O
in	O
the	O
kidneys	O
to	O
form	O
the	O
biologically	O
active	O
form	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

The	O
classical	O
and	O
non	O
-	O
classical	O
pathways	O
of	O
this	O
hormone	O
affect	O
calcium	O
metabolism	O
,	O
the	O
immune	O
system	O
,	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
infection	O
,	O
and	O
cancer	O
.	O

Previous	O
findings	O
from	O
the	O
GraviD	O
study	O
show	O
lower	O
odds	O
of	O
preeclampsia	O
among	O
women	O
with	O
a	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
in	O
25OHD	O
[	O
3	O
].	O

The	O
authors	O
will	O
organise	O
dissemination	O
seminars	O
to	O
share	O
the	O
findings	O
with	O
all	O
relevant	O
stakeholders	O
.	O

Pathways	O
between	O
the	O
LP	O
stages	O
indicate	O
processes	O
and	O
metabolic	O
regulation	O
,	O
which	O
occur	O
in	O
the	O
LP	O
offspring	O
but	O
not	O
in	O
the	O
AP	O
offspring	O
in	O
the	O
corresponding	O
developmental	O
period	O
.	O

Disordered	O
regulation	O
of	O
feeding	O
pathways	O
can	O
affect	O
growth	O
and	O
metabolism	O
,	O
consequently	B
driving	O
the	O
appearance	O
of	O
metabolic	O
syndrome	O
later	O
in	O
life	O
.	O
7	O
,	O
8	O
An	O
extension	O
of	O
the	O
concept	O
that	O
early	O
life	O
factors	O
contribute	O
to	O
chronic	O
diseases	O
is	O
described	O
by	O
the	O
predictive	O
adaptive	O
response	O
(	O
PAR	O
)	O
hypothesis	O
,	O
which	O
suggests	O
that	O
a	O
mismatch	O
between	O
in	O
utero	O
and	O
postnatal	O
environment	O
increases	O
the	O
risk	O
of	O
developing	O
disease	O
in	O
adulthood	O
.	O
9	O
,	O
10It	O
has	O
been	O
proposed	O
that	O
the	O
offspring	O
modify	O
their	O
phenotype	O
based	O
on	O
their	O
in	O
utero	O
environment	O
in	O
order	O
to	O
adapt	O
to	O
the	O
predicted	O
postnatal	O
setting	O
.	O

A	O
single	O
24	O
-	O
HR	O
,	O
which	O
obtains	O
details	O
about	O
nutritional	O
supplement	O
use	O
as	O
well	O
,	O
is	O
administered	O
at	O
phases	O
1	O
,	O
2	O
and	O
3	O
in	O
pregnancy	O
,	O
as	O
well	O
as	O
at	O
6	O
months	O
postnatally	O
(	O
phase	O
6	O
).	O

Introduction	O
The	O
fifth	O
Millennium	O
Development	O
Goal	O
(	O
MDG	O
),	O
“	O
Improvement	O
of	O
Maternal	O
Health	O
”	O
[	O
1	O
]	O
has	O
Antenatal	O
Care	O
(	O
ANC	O
)	O
coverage	O
or	O
attendance	O
as	O
a	O
progress	O
indicator	O
.	O

Elemental	O
iron	O
powders	O
are	O
the	O
most	O
widely	O
used	O
iron	O
compound	O
in	O
fortification	O
programmes	O
since	O
about	O
50	O
years	O
[	O
32	O
].	O

Wet	O
stool	O
samples	O
were	O
prepared	O
for	O
examination	O
by	O
light	O
microscopy	O
for	O
the	O
presence	O
of	O
helminths	O
.	O

All	O
statistical	O
tests	O
were	O
two	O
-	O
sided	O
,	O
and	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
as	O
statistically	O
significant	O
.	O

30	O
µL	O
aliquots	O
were	O
injected	O
into	O
an	O
HPLC	O
mass	O
spectrometer	O
system	O
consisting	O
of	O
a	O
Waters	O
Alliance	O
2690	O
Separations	O
Module	O
(	O
Waters	O
Corporation	O
,	O
Milford	O
,	O
MA	O
,	O
USA	O
),	O
followed	O
by	O
an	O
Ion	O
Max	O
APCI	O
source	O
on	O
a	O
Finnigan	O
TSQ	O
Quantum	O
Ultra	O
AM	O
triple	O
quadrapole	O
mass	O
spectrometer	O
,	O
all	O
controlled	O
by	O
Finnigan	O
Xcalibur	O
software	O
(	O
Thermo	O
Electron	O
Corporation	O
,	O
San	O
Jose	O
,	O
CA	O
,	O
USA	O
).	O

Modern	O
day	O
cosmetology	O
and	O
our	O
urbanization	O
has	O
eclipsed	O
the	O
sunlight	O
and	O
it	O
is	O
impossible	O
is	O
to	O
fulfill	O
daily	O
intake	O
via	O
diet	O
as	B
a	O
large	O
amount	O
of	O
vitamin	O
D	O
needs	O
to	O
be	O
consumed	O
.	O

A	O
pooled	O
analysis	O
of	O
data	O
from	O
Indonesian	O
Demographic	O
and	O
Health	O
Surveys	O
,	O
which	O
included	O
40	O
,	O
576	O
singleton	O
live	O
-	O
born	O
infants	O
,	O
found	O
mothers	O
using	O
any	O
IFA	O
supplements	O
during	O
pregnancy	O
significantly	O
reduced	O
the	O
risk	O
of	O
early	O
neonatal	O
death	O
of	O
their	O
newborns	O
after	O
adjustment	O
for	O
potential	O
confounders	O
[	O
10	O
].	O

Brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
)	O
as	O
a	O
potential	O
marker	O
of	O
neuronal	O
growth	O
and	O
differentiation	O
will	O
be	O
determined	O
using	O
ELISA	O
[	O
77	O
].	O

The	O
items	O
that	O
were	O
too	O
difficult	O
,	O
too	O
easy	O
,	O
or	O
that	O
were	O
found	O
to	O
have	O
near	O
-	O
zero	O
or	O
negative	O
discrimination	O
were	O
eliminated	O
.	O

We	O
found	O
that	O
cord	O
25	O
(	O
OH	O
)	O
D	O
(	O
dependent	O
variable	O
)	O
was	O
not	O
significantly	O
related	O
to	O
BMC	O
and	O
BMD	O
as	O
shown	O
before	O
,	O
and	O
was	O
not	O
closely	O
related	O
to	O
BMC	O
at	O
three	O
months	O
(	O
p	O
=	O
0	O
.	O
10	O
).	O

From	O
weaning	O
(	O
28	O
dpn	O
)	O
to	O
slaughter	O
(	O
188	O
dpn	O
),	O
all	O
piglets	O
were	O
individually	O
reared	O
.	O

in	O
2006	O
reported	O
that	O
53	O
%	O
and	O
44	O
%	O
of	O
pregnant	O
women	O
received	O
iron	O
and	O
folate	O
supplementation	O
,	O
respectively	O
,	O
during	O
last	O
pregnancy	O
[	O
54	O
].	O

Continuous	O
dietary	O
vitamin	O
A	O
restriction	O
during	O
the	O
late	O
fattening	O
phase	O
is	O
not	O
recommended	O
because	O
prolonged	O
vitamin	O
A	O
restriction	O
may	O
lead	O
to	O
health	O
problems	O
and	O
retard	O
growth	O
rate	O
[	O
130	O
].	O

MTCs	O
,	O
like	O
other	O
neuroendocrine	O
tumours	O
,	O
can	O
express	O
somatostatin	O
receptors	O
.	O

History	O
lessons	O
from	O
neonatal	O
mortality	O
reduction	O
in	O
high	O
income	O
countries	O
The	O
historical	O
data	O
from	O
the	O
United	O
States	O
and	O
United	O
Kingdom	O
(	O
Figure4	O
)	O
shows	O
that	O
a	O
moderate	O
increase	O
in	O
coverage	O
of	O
selected	O
interventions	O
results	O
in	O
a	O
mortality	O
reduction	O
,	O
even	O
in	O
the	O
absence	O
of	O
neonatal	O
intensive	O
care	O
.	O

Discussion	O
This	O
study	O
assessed	O
the	O
relationships	O
between	O
common	O
genetic	O
variants	O
and	O
the	O
response	O
to	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
;	O
rs12785878	O
in	O
DHCR7	O
was	O
associated	O
with	O
25	O
(	O
OH	O
)	O
D	O
status	O
in	O
early	O
pregnancy	O
prior	O
to	O
vitamin	O
D	O
supplementation	O
,	O
whereas	O
rs10741657	O
in	O
CYP2R1	O
and	O
rs2282679	O
in	O
GC	O
were	O
associated	O
with	O
both	O
the	O
achieved	O
and	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
following	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
.	O

Low	O
cord	O
-	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
levels	O
are	O
associated	O
with	O
poor	O
lung	O
function	O
performance	O
and	O
increased	O
respiratory	O
infection	O
in	O
infancy	O
Abstract	O
Background	O
Perinatal	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
wheezing	O
in	O
childhood	O
.	O

Statistical	O
Analysis	O
Chi	O
-	O
squared	O
tests	O
were	O
used	O
to	O
compare	O
frequency	O
distributions	O
.	O

Objective	O
To	O
determine	O
if	O
the	O
effects	O
of	O
HV	O
gestational	O
diets	O
on	O
obesogenic	O
phenotypes	O
in	O
the	O
offspring	O
arise	O
as	B
a	O
consequence	B
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
and	O
if	O
their	O
increased	O
food	O
intake	O
could	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
high	O
folate	O
(	O
10	O
-	O
fold	O
folate	O
,	O
HFol	O
)	O
diets	O
.	O

Afterwards	O
,	O
these	O
time	O
series	O
lasting	O
5	O
minutes	O
were	O
analyzed	O
in	O
Kubios	O
software	O
(	O
Biosignal	O
Analysis	O
and	O
Medical	O
Image	O
Group	O
,	O
University	O
of	O
Kuopio	O
,	O
Finland	O
).	O

Methods	O
Setting	O
and	O
participants	O
This	O
randomized	O
clinical	O
trial	O
was	O
done	O
in	O
pregnant	O
women	O
who	O
were	O
under	O
prenatal	O
care	O
in	O
Hafez	O
hospital	O
which	O
is	O
a	O
tertiary	O
hospital	O
in	O
Shiraz	O
,	O
Iran	O
,	O
affiliated	O
to	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
.	O

There	O
is	O
strong	O
evidence	O
that	O
maternal	O
iron	O
deficiency	O
anaemia	O
increases	O
the	O
risk	O
of	O
adverse	O
perinatal	O
outcomes	O
.	O

However	O
,	O
lack	O
of	O
reported	O
PNV	O
use	O
was	O
not	O
associated	O
with	O
increased	O
odds	O
of	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
later	O
in	O
pregnancy	O
(	O
OR	O
1	O
.	O
1	O
,	O
95	O
%	O
CI	O
0	O
.	O
7	O
,	O
1	O
.	O
6	O
).	O

MTRL	O
,	O
MV	O
,	O
RNB	O
,	O
and	O
FA	O
did	O
the	O
animal	O
experiments	O
and	O
sampling	O
.	O

Trial	O
outcomes	O
The	O
primary	O
trial	O
outcome	O
will	O
be	O
the	O
difference	O
in	O
the	O
neonatal	O
mortality	O
rate	O
between	O
the	O
intervention	O
and	O
control	O
areas	O
.	O

This	O
study	O
demonstrated	O
that	O
as	O
children	O
age	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
increases	O
.	O

Pregnancy	O
status	O
requires	O
much	O
more	O
accuracy	O
in	O
assessing	O
levothyroxine	O
dosage	O
to	O
protect	O
the	O
foetus	O
from	O
maternal	O
hypothyroidism	O
because	O
,	O
as	O
mentioned	O
above	O
,	O
the	O
mother	O
is	O
the	O
only	O
source	O
of	O
thyroid	O
hormones	O
for	O
the	O
embryo	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

Phylogenetic	O
trees	O
were	O
constructed	O
using	O
the	O
FastTree	O
method	O
[	O
41	O
].	O

Eating	O
in	O
the	O
absence	O
of	O
hunger	O
Infants	O
(	O
40	O
,	O
41	O
)	O
and	O
young	O
children	O
(	O
42	O
,	O
43	O
)	O
can	O
adjust	O
their	O
food	O
intake	O
in	O
response	O
to	O
changes	O
in	O
the	O
caloric	O
content	O
of	O
their	O
diet	O
,	O
and	O
biological	O
sensations	O
involving	O
appetite	O
probably	B
underlie	O
this	O
ability	O
.	O

Any	O
drug	O
may	O
carry	O
a	O
small	O
risk	O
that	O
must	O
be	O
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

Similarly	O
,	O
in	O
Sweden	O
,	O
Katsarou	O
et	O
al	O
.	O

It	O
also	O
supports	O
the	O
premise	O
that	O
cathelicidin	O
increases	O
with	O
increasing	O
age	O
,	O
particularly	O
in	O
males	O
.	O

Western	O
dietary	O
pattern	O
as	O
an	O
unhealthy	O
food	O
choice	O
is	O
unable	O
to	O
fulfill	O
the	O
increased	O
key	O
micronutrients	O
requirements	O
for	O
normal	O
fetal	O
growth	O
during	O
pregnancy	O
and	O
results	O
in	O
such	O
adverse	O
effects	O
on	O
the	O
fetus	O
[	O
23	O
].	O

Results	O
from	O
screening	O
and	O
diagnostic	O
testing	O
for	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
were	O
abstracted	O
from	O
medical	O
records	O
.	O

Western	O
blotting	O
analysis	O
After	O
euthanasia	O
,	O
the	O
right	O
kidneys	O
were	O
taken	O
at	O
birth	O
,	O
weaning	O
and	O
6	O
months	O
in	O
both	O
generations	O
to	O
determine	O
total	O
proteins	O
.	O

Introduction	O
By	O
releasing	O
adipokines	O
,	O
adipose	O
tissue	O
has	O
a	O
major	O
role	O
in	O
fertility	O
,	O
and	O
physical	O
and	O
sexual	O
maturation	O
(	O
1	O
).	O

[	O
7	O
]	O
Vitamin	O
D	O
itself	O
is	O
devoid	O
of	O
any	O
biological	O
activity	O
,	O
but	O
enzymatic	O
conversion	O
to	O
1α	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
]	O
generates	O
the	O
hormonal	O
form	O
with	O
diverse	O
biological	O
activities	O
.	O

Mothers	O
are	O
asked	O
how	O
soon	O
after	O
birth	O
the	O
infant	O
was	O
breastfed	O
,	O
if	O
the	O
infant	O
is	O
currently	O
being	O
breastfed	O
and	O
if	O
not	O
,	O
the	O
duration	O
of	O
breastfeeding	O
.	O

Prior	O
to	O
randomization	O
,	O
we	O
recorded	O
baseline	O
knowledge	O
of	O
hygiene	O
and	O
beliefs	O
pertaining	O
to	O
childcare	O
and	O
neonatal	O
illness	O
,	O
perceptions	O
of	O
risk	O
and	O
severity	O
of	O
neonatal	O
illness	O
,	O
antenatal	O
care	O
,	O
and	O
demographic	O
information	O
,	O
using	O
questionnaires	O
and	O
observations	O
.	O

In	O
addition	O
,	O
the	O
type	O
and	O
amounts	O
of	O
fish	O
consumed	O
differed	O
across	O
study	O
locations	O
.	O

The	O
associations	O
differed	O
at	O
the	O
two	O
time	O
points	O
.	O

(	O
B	O
)	O
Haplotype	O
analysis	O
of	O
the	O
proximal	O
region	O
of	O
chromosome	O
15	O
for	O
Skm1	O
(	O
left	O
panel	O
)	O
and	O
of	O
chromosome	O
14	O
for	O
Skm2	O
(	O
right	O
panel	O
).	O

Her	O
serum	O
antidiuretic	O
hormone	O
level	O
,	O
at	O
the	O
time	O
of	O
birth	O
,	O
was	O
<	O
0	O
.	O
5	O
pg	O
/	O
mL	O
(	O
Normal	O
0	O
.	O
0	O
–	O
4	O
.	O
7	O
pg	O
/	O
mL	O
).	O

For	O
the	O
models	O
for	O
the	O
25	O
(	O
OH	O
)	O
D	O
achieved	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
compliance	O
with	O
study	O
medication	O
,	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
,	O
and	O
pregnancy	O
weight	O
gain	O
(	O
instead	O
of	O
BMI	O
)	O
were	O
also	O
included	O
as	B
we	O
have	O
previously	O
demonstrated	O
in	O
this	O
cohort	O
of	O
women	O
that	O
these	O
factors	O
are	O
associated	O
with	O
the	O
response	O
to	O
cholecalciferol	O
supplementation	O
(	O
13	O
).	O

This	O
review	O
discusses	O
vitamin	O
D	O
metabolism	O
,	O
dietary	O
requirements	O
and	O
recommendations	O
and	O
implications	O
of	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
and	O
lactation	O
.	O

[	O
36	O
]	O
also	O
observed	O
a	O
negative	O
correlation	O
between	O
birth	O
weight	O
and	O
heart	O
rate	O
in	O
response	O
to	O
psychological	O
stress	O
in	O
women	O
.	O

This	O
information	O
,	O
filtered	O
according	O
to	O
the	O
geographical	O
area	O
,	O
comes	O
from	O
the	O
registration	O
data	O
collected	O
by	O
the	O
Field	O
Implementers	O
.	O

A	O
community	O
-	O
based	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
rural	O
Bangladesh	O
to	O
evaluate	O
the	O
impact	O
of	O
the	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
early	O
in	O
pregnancy	O
on	O
the	O
risk	O
of	O
neonatal	O
mortality	O
:	O
the	O
Shonjibon	O
trial	O
Abstract	O
Background	O
Iron	O
-	O
deficiency	O
is	O
the	O
most	O
common	O
nutritional	O
deficiency	O
globally	O
.	O

At	O
six	O
months	O
,	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
groups	O
were	O
heavier	O
than	O
their	O
SC	O
counterparts	O
(+	O
17	O
%	O
in	O
F1	O
,	O
+	O
15	O
%	O
in	O
F2	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Model	O
adjusted	O
for	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
age	O
,	O
albendazol	O
and	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
and	O
sex	O
of	O
the	O
baby	O
.	O

Additionally	O
,	O
among	O
women	O
with	O
low	O
initial	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
40	O
ng	O
/	O
mL	O
),	O
PTB	O
rates	O
were	O
significantly	O
lower	O
(	O
60	O
%)	O
for	O
those	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
vs	O
.	O
those	O
who	O
did	O
not	O
,	O
especially	O
for	O
non	O
-	O
white	O
women	O
(	O
78	O
%).	O

The	O
level	O
of	O
this	O
evidence	O
is	O
Grade	O
C	O
as	O
per	O
the	O
ratings	O
outlined	O
inTable	O
3	O
,	O
adapted	O
from	O
Williams	O
et	O
al	O
.	O

reported	O
that	O
as	O
hypoparathyroid	O
patients	O
have	O
completed	O
many	O
pregnancies	O
while	O
receiving	O
ergocalciferol	O
,[	O
21	O
]	O
it	O
is	O
unlikely	B
that	O
material	O
vitamin	O
D	O
,	O
25	O
(	O
OH	O
)	O
D	O
,	O
or	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
per	O
se	O
are	O
teratogens	O
.	O

In	O
assisted	O
reproduction	O
,	O
it	O
is	O
widely	B
used	I
as	O
a	O
parameter	O
of	O
ovarian	O
reserve	O
[	O
43	O
].	O

Full	O
lines	O
indicate	O
stimulatory	O
effects	O
,	O
whereas	O
dotted	O
lines	O
represent	O
inhibitory	O
ones	O
.	O

Case	O
-	O
control	O
studies	O
often	B
focus	O
on	O
high	O
-	O
risk	O
groups	O
,	O
for	O
example	O
women	O
who	O
are	O
overweight	O
and	O
sedentary	O
,	O
which	O
are	O
independent	O
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
as	O
well	O
(	O
for	O
example	O
[	O
16	O
]).	O

These	O
findings	O
preserved	O
even	O
after	O
adjusting	O
for	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

Data	O
collection	O
Figure	O
2summarises	O
the	O
measurements	O
and	O
time	O
points	O
of	O
data	O
collection	O
throughout	O
the	O
project	O
.	O

A	O
barrier	O
to	O
maternal	O
handwashing	O
in	O
rural	O
Bangladesh	O
was	O
the	O
lack	O
of	O
self	O
-	O
efficacy	O
on	O
the	O
part	O
of	O
the	O
mother	O
to	O
prioritize	O
and	O
carry	O
out	O
the	O
behavior	O
because	O
of	O
conflicting	O
opinions	O
from	O
her	O
in	O
-	O
laws	O
,	O
who	O
may	O
drive	O
decision	O
-	O
making	O
regarding	O
childcare	O
and	O
household	O
expenditures	O
.	O

Mean	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
also	O
found	O
to	O
be	O
weakly	O
to	O
moderately	O
correlated	O
,	O
with	O
a	O
Pearson	O
correlation	O
of	O
0	O
.	O
29	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
20	O
,	O
0	O
.	O
38	O
].	O

The	O
primary	O
outcome	O
of	O
interest	O
was	O
maternal	O
handwashing	O
with	O
soap	O
at	O
times	O
of	O
possible	O
pathogen	O
transmission	O
to	O
the	O
neonate	O
.	O

Conclusion	O
Policy	O
makers	O
should	O
implement	O
changes	O
in	O
the	O
health	O
care	O
delivery	O
system	O
taking	O
into	O
account	O
the	O
users	O
’	O
preferences	O
,	O
more	O
so	O
in	O
the	O
light	O
of	O
increasing	O
female	O
education	O
in	O
Cameroon	O
.	O

MH	O
prepared	O
the	O
manuscript	O
in	O
collaboration	O
with	O
ML	O
.	O

A	O
p	O
value	O
≤	O
0	O
.	O
05	O
was	O
significant	O
.	O

All	O
sows	O
were	O
fed	O
AP	O
lactation	O
diets	O
.	O

It	B
is	I
attractive	I
therefore	B
to	O
hypothesise	O
that	O
the	O
change	O
in	O
the	O
ratio	O
of	O
the	O
splicing	O
isoforms	O
alters	O
the	O
responsiveness	O
of	O
placental	O
GRs	O
to	O
cortisol	O
and	O
that	O
this	O
may	O
affect	O
gestational	O
age	O
.	O

Specifically	O
,	O
POU2F1	O
binding	O
sites	O
were	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
.	O

In	O
our	O
experiment	O
the	O
porcine	O
offspring	O
,	O
which	O
was	O
exposed	O
to	O
an	O
undersupply	O
of	O
protein	O
during	O
fetal	O
development	O
but	O
had	O
appropriate	O
postnatal	O
dietary	O
conditions	O
,	O
was	O
able	O
to	O
broadly	O
adapt	O
in	O
terms	O
of	O
their	O
body	O
weight	O
.	O

Additional	O
details	O
about	O
study	O
eligibility	O
,	O
recruitment	O
,	O
and	O
follow	O
-	O
up	O
are	O
described	O
elsewhere	O
[	O
34	O
].	O

The	O
expression	O
level	O
of	O
NCAPG	O
(	O
non	O
-	O
structural	O
maintenance	O
of	O
chromosomes	O
(	O
SMC	O
)	O
condensin	O
I	O
complex	O
subunit	O
G	O
)	O
was	O
highlighted	O
as	O
strongly	O
associated	O
with	O
fetal	O
growth	O
retardation	O
[	O
28	O
,	O
29	O
].	O

In	O
2010	O
,	O
15	O
million	O
babies	O
--	O
more	O
than	O
1	O
in	O
10	O
births	O
--	O
were	O
born	O
too	O
soon	O
,	O
an	O
emotional	O
and	O
economic	O
toll	O
on	O
families	O
,	O
communities	O
and	O
countries	O
.	O

Neonatal	O
medical	O
records	O
were	O
reviewed	O
for	O
the	O
following	O
information	O
:	O
gestational	O
age	O
,	O
gender	O
,	O
birth	O
weight	O
,	O
birth	O
length	O
,	O
birth	O
head	O
circumference	O
and	O
SGA	O
status	O
.	O

The	O
relationship	O
between	O
visfatin	O
level	O
and	O
neonatal	O
anthropometric	O
indicators	O
at	O
birth	O
In	O
group	O
A	O
,	O
a	O
strong	O
positive	O
relationship	O
was	O
observed	O
between	O
birth	O
head	O
circumference	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
05	O
,	O
r1	O
=	O
0	O
.	O
580	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
051	O
,	O
r2	O
=	O
0	O
.	O
530	O
).	O

In	O
general	O
,	O
patients	O
with	O
severe	O
asthma	O
are	O
more	O
likely	B
to	O
experience	O
worsening	O
of	O
their	O
disease	O
during	O
pregnancy	O
.	O

Saki	O
et	O
al	O
.,	O
showed	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
southern	O
Iranian	O
children	O
,	O
more	O
than	O
80	O
%	O
were	O
deficient	O
[	O
53	O
].	O

Health	O
and	O
dietary	O
information	O
were	O
obtained	O
from	O
parental	O
report	O
and	O
confirmed	O
by	O
medical	O
records	O
from	O
the	O
primary	O
care	O
physician	O
or	O
the	O
hospital	O
.	O

A	O
higher	O
incidence	O
of	O
sinistrality	O
has	O
been	O
observed	O
for	O
individuals	O
born	O
in	O
winter	O
and	O
autumn	O
than	O
for	O
those	O
born	O
summer	O
and	O
spring	O
[	O
191	O
].	O

Cyclin	O
levels	O
undergo	O
an	O
oscillation	O
of	O
synthesis	O
and	O
degradation	O
in	O
each	O
cell	O
cycle	O
and	O
fall	O
at	O
a	O
proper	O
developmental	O
time	O
point	O
to	O
exit	O
the	O
cell	O
cycle	O
[	O
21	O
,	O
22	O
].	O

Thus	B
,	O
Korean	O
and	O
Japanese	O
beef	O
production	O
systems	O
have	O
focused	O
on	O
production	O
of	O
highly	O
marbled	O
beef	O
to	O
satisfy	O
their	O
customers	O
and	O
to	O
protect	O
their	O
beef	O
industry	O
against	O
imported	O
beef	O
that	O
has	O
relatively	O
low	O
MS	O
.	O
As	O
described	O
above	O
,	O
several	O
nutritional	O
factors	O
affect	O
IMF	O
deposition	O
,	O
and	O
these	O
factors	O
must	O
be	O
considered	O
to	O
prepare	O
a	O
proper	O
diet	O
to	O
improve	O
marbling	O
at	O
the	O
proper	O
time	O
in	O
the	O
life	O
cycle	O
.	O

A	O
review	O
of	O
the	O
available	O
evidence	O
indicates	O
that	O
intake	O
of	O
fish	O
during	O
pregnancy	O
is	O
associated	O
with	O
positive	O
foetal	O
neurodevelopmental	O
outcomes	O
,	O
as	O
supported	O
by	O
seven	O
of	O
eight	O
articles	O
reviewed	O
,	O
which	O
showed	O
a	O
beneficial	O
impact	O
on	O
foetal	O
neurodevelopment	O
with	O
one	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
compared	O
with	O
no	O
fish	O
intake	O
.	O

Although	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
black	O
mothers	O
and	O
neonates	O
is	O
well	O
known	O
,	O
debate	O
exists	O
as	O
to	O
the	O
relationship	O
between	O
race	O
,	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O
12	O
,	O
14	O
,	O
15	O
,	O
17	O
,	O
18We	O
examined	O
this	O
relationship	O
in	O
conjunction	O
with	O
additional	O
maternal	O
characteristics	O
in	O
order	O
to	O
identify	O
groups	O
of	O
pregnant	O
women	O
who	O
could	O
benefit	O
most	B
from	O
vitamin	O
D	O
supplementation	O
.	O

Visfatin	O
by	O
effect	O
on	O
the	O
production	O
of	O
SIRT1	O
,	O
consequently	O
,	O
interference	O
in	O
the	O
development	O
of	O
the	O
brain	O
and	O
energy	O
balance	O
regulation	O
may	O
be	O
associated	O
with	O
head	O
circumferences	O
and	O
weights	O
of	O
fetus	O
and	O
child	O
.	O

Although	O
we	O
did	O
not	O
collect	O
data	O
on	O
daily	O
temperature	O
,	O
the	O
temperatures	O
in	O
Ireland	O
are	O
relatively	O
stable	O
across	O
the	O
year	O
,	O
with	O
mean	O
temperature	O
of	O
5	O
.	O
3	O
°	O
C	O
in	O
January	O
and	O
15	O
.	O
6	O
°	O
C	O
in	O
July	O
[	O
47	O
],	O
reducing	B
the	I
likelihood	I
that	O
temperature	O
is	O
responsible	B
.	O

Natriuretic	O
peptides	O
(	O
NP	O
),	O
which	O
are	O
important	O
in	O
cardiovascular	O
homeostasis	O
through	O
the	O
maintenance	O
of	O
blood	O
pressure	O
and	O
extracellular	O
fluid	O
volume	O
,	O
comprise	O
three	O
structurally	O
related	O
molecules	O
:	O
atrial	O
NP	O
,	O
brain	O
NP	O
,	O
and	O
C	O
-	O
type	O
NP	O
(	O
Potter	O
2011	O
).	O

The	O
rate	O
of	O
cockroach	O
sensitization	O
at	O
the	O
age	O
of	O
5	O
years	O
was	O
higher	O
for	O
winter	O
births	O
(	O
72	O
%),	O
than	O
for	O
spring	O
(	O
48	O
%),	O
summer	O
(	O
42	O
%)	O
and	O
fall	O
(	O
43	O
%)	O
births	O
[	O
70	O
].	O

Samples	O
were	O
precipitated	O
using	O
5	O
volumes	O
of	O
room	O
temperature	O
acetone	O
for	O
10	O
min	O
and	O
centrifuged	O
at	O
3	O
,	O
500	O
×	O
g	O
for	O
15	O
min	O
at	O
15	O
°	O
C	O
.	O

Although	O
previous	O
cross	O
-	O
sectional	O
studies	O
have	O
reported	O
a	O
positive	O
association	O
between	O
childhood	O
consumption	O
of	O
sugar	O
-	O
containing	O
drinks	O
,	O
including	O
fruit	O
juice	O
,	O
and	O
asthma	O
[	O
5	O
–	O
8	O
],	O
intake	O
of	O
free	O
sugar	O
in	O
early	O
childhood	O
in	O
our	O
study	O
was	O
not	O
associated	O
with	O
any	O
respiratory	O
or	O
atopic	O
outcome	O
.	O

Both	O
questionnaires	O
are	O
interviewer	O
administered	O
.	O

Mass	O
fortification	O
programme	O
of	O
common	O
local	O
staple	O
foods	O
with	O
iron	O
and	O
folic	O
acid	O
is	O
a	O
long	O
-	O
term	O
goal	O
,	O
which	O
national	O
governments	O
in	O
developing	O
countries	O
should	O
consider	O
as	B
a	O
strategy	O
aimed	O
at	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
general	O
population	O
.	O

The	O
ALSPAC	O
study	O
reports	O
by	O
Daniels	O
et	O
al	O
.	O

All	O
53	O
exposure	O
variables	O
from	O
5	O
chemical	O
classes	O
were	O
included	O
in	O
the	O
final	O
BHLM	O
model	O
for	O
analysis	O
.	O

Methods	O
:	O
This	O
is	O
a	O
randomized	O
clinical	O
trial	O
with	O
the	O
follow	O
-	O
up	O
period	O
of	O
3	O
months	O
.	O

In	O
those	O
studies	O
,	O
vitamin	O
D	O
supplementations	O
started	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
or	O
at	O
the	O
beginning	O
of	O
the	O
second	O
trimester	O
and	O
their	O
participants	O
had	O
higher	O
initial	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
compared	O
to	O
the	O
participants	O
in	O
our	O
study	O
.	O

There	O
were	O
five	O
deaths	O
to	O
6	O
months	O
of	O
age	O
(	O
4	O
neonatal	O
deaths	O
as	O
reported	O
previously	O
[	O
22	O
],	O
and	O
the	O
death	O
of	O
one	O
infant	O
prior	O
to	O
6	O
months	O
of	O
age	O
attributable	O
to	O
sudden	O
infant	O
death	O
syndrome	O
).	O

Generalized	O
estimating	O
equations	O
(	O
GEE	O
)	O
logistic	O
regression	O
was	O
used	O
to	O
construct	O
separate	O
models	O
for	O
each	O
of	O
the	O
attitudes	O
,	O
beliefs	O
,	O
and	O
behavioral	O
outcomes	O
over	O
the	O
3	O
follow	O
-	O
up	O
periods	O
,	O
estimating	O
population	O
-	O
attributable	O
effects	O
for	O
treatment	O
vs	O
control	O
groups	O
,	O
and	O
high	O
(	O
more	O
than	O
the	O
median	O
message	O
exposure	O
of	O
224	O
days	O
)	O
vs	O
lower	O
intervention	O
exposure	O
.	O

[	O
4	O
]	O
Vitamin	O
D	O
by	O
itself	O
has	O
been	O
shown	O
to	O
have	O
beneficial	O
effects	O
in	O
children	O
who	O
wheeze	O
by	O
up	O
regulating	O
antimicrobial	O
proteins	O
or	O
through	O
multiple	O
immune	O
effects	O
.	O

Feeding	O
cereal	O
grains	O
is	O
one	O
way	O
to	O
raise	O
net	O
energy	O
supply	O
because	O
energy	O
dense	O
grains	O
can	O
be	O
utilized	O
in	O
the	O
rumen	O
and	O
the	O
small	O
intestine	O
to	O
produce	O
volatile	O
fatty	O
acids	O
and	O
glucose	O
for	O
energy	O
production	O
.	O

The	O
results	O
demonstrated	O
that	O
terbutaline	O
increased	O
microglial	O
activation	O
in	O
the	O
subjects	O
'	O
cerebral	O
cortex	O
,	O
cerebellar	O
,	O
and	O
cerebrocortical	O
white	O
matter	O
[	O
23	O
].	O

Vitamin	O
D	O
-	O
deficiency	O
in	O
mothers	O
have	O
significantly	O
increased	O
risk	O
of	O
infantile	O
rickets	O
due	B
to	I
inadequate	O
maternal	O
–	O
fetal	O
transfer	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
.[	O
32	O
]	O
Recent	O
retrospective	O
studies	O
found	O
a	O
significant	O
and	O
previously	O
undetected	O
association	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
with	O
rickets	O
-	O
associated	O
infant	O
heart	O
failure	O
and	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
,[	O
33	O
]	O
a	O
serious	O
complication	O
often	B
associated	O
with	O
sepsis	O
without	O
clinical	O
signs	O
of	O
rickets	O
.	O

A	O
twofold	O
increase	O
in	O
the	O
GR	O
α	O
/	O
GAS5	O
ratio	O
was	O
also	O
noted	O
in	O
the	O
preterm	O
group	O
compared	O
with	O
the	O
term	O
group	O
of	O
women	O
.	O

In	O
populations	O
with	O
similar	O
characteristics	O
,	O
quarterly	O
population	O
level	O
supplementation	O
of	O
vitamin	O
D	O
to	O
infants	O
and	O
young	O
children	O
is	O
not	O
a	O
policy	O
option	O
for	O
reducing	O
the	O
burden	O
of	O
pneumonia	O
in	O
children	O
.	O

Any	O
misclassification	O
of	O
other	O
causes	O
of	O
raised	O
respiratory	O
rate	O
as	O
pneumonia	O
,	O
under	O
-	O
reporting	O
,	O
or	O
over	O
-	O
reporting	O
would	O
be	O
distributed	O
equally	O
between	O
the	O
two	O
groups	O
since	O
the	O
families	O
,	O
doctors	O
,	O
radiographers	O
,	O
radiologists	O
,	O
and	O
data	O
entry	O
staff	O
were	O
masked	O
to	O
the	O
randomisation	O
groupings	O
and	O
the	O
randomisation	O
was	O
successful	O
since	O
the	O
characteristics	O
were	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

furthered	O
our	O
understanding	O
of	O
the	O
effects	O
of	O
paternal	O
folate	O
deficiency	O
[	O
6	O
].	O

Similar	O
patterns	O
were	O
seen	O
across	O
the	O
generations	O
for	O
BMI	O
and	O
height	O
.	O

The	O
current	O
lack	O
of	O
evidence	O
of	O
benefit	O
for	O
women	O
at	O
lower	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
points	O
to	O
the	O
need	O
for	O
further	O
research	O
into	O
vitamin	O
D	O
supplementation	O
in	O
pregnant	O
women	O
with	O
clinical	O
neonatal	O
and	O
infant	O
end	O
-	O
points	O
under	O
scrutiny	O
.	O

The	O
tendency	O
to	O
lower	O
chocolate	O
preference	O
suggests	O
an	O
increased	O
threshold	O
of	O
the	O
palatability	O
.	O

In	O
resource	O
-	O
poor	O
countries	O
,	O
rates	O
of	O
maternal	O
anaemia	O
remain	O
high	O
.	O

What	O
Might	O
Delay	O
Lactogenesis	O
?	O

A	O
recent	O
movement	O
suggests	O
minimizing	O
screen	O
time	O
for	O
youth	O
because	B
television	O
,	O
computers	O
,	O
and	O
video	O
games	O
contribute	O
to	O
sedentary	O
behavior	O
.	O

Outliers	O
(	O
n	O
=	O
18	O
)	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
identified	O
with	O
Normal	O
probability	O
plot	O
of	O
residuals	O
,	O
Leverage	O
and	O
Cook	O
’	O
s	O
Distance	O
diagnostic	O
tests	O
,	O
and	O
omitted	O
from	O
the	O
analyses	O
.	O

Conclusions	O
Current	O
research	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
fertility	O
impairments	O
,	O
such	O
as	O
polycystic	O
ovary	O
syndrome	O
,	O
uterine	O
fibroids	O
,	O
improper	O
semen	O
parameters	O
and	O
in	O
the	O
case	O
of	O
in	O
vitro	O
treatments	O
and	O
pregnancy	O
failure	O
,	O
suggests	O
it	O
plays	O
an	O
important	O
role	O
in	O
human	O
reproduction	O
processes	O
.	O

Immediately	O
following	O
fertilization	O
the	O
quiescent	O
embryo	O
genome	O
requires	O
protection	O
,	O
hence	O
higher	O
expression	O
of	O
piRNAs	O
and	O
esiRNAs	O
,	O
both	O
of	O
which	O
are	O
involved	O
in	O
maintaining	O
genome	O
stability	O
(	O
Watanabe	O
et	O
al	O
.	O
2006	O
,	O
2008	O
).	O

Mechanisms	O
and	O
model	O
systems	O
The	O
nature	O
of	O
the	O
research	O
means	O
that	O
studies	O
in	O
humans	O
are	O
mainly	B
restricted	O
to	O
epidemiological	O
cohorts	O
.	O

Researchers	O
from	O
multiple	O
disciplines	O
,	O
including	O
population	O
health	O
,	O
social	O
sciences	O
,	O
computing	O
,	O
and	O
engineering	O
sciences	O
are	O
engaged	O
in	O
mHealth	O
[	O
1	O
],	O
and	O
major	O
government	O
research	O
sponsors	O
including	O
the	O
National	O
Institutes	O
of	O
Health	O
and	O
major	O
private	O
sponsors	O
such	O
as	O
the	O
Bill	O
and	O
Melinda	O
Gates	O
Foundation	O
have	O
initiatives	O
in	O
these	O
areas	O
[	O
7	O
-	O
8	O
].	O

However	O
,	O
getting	O
25	O
(	O
OH	O
)	O
D	O
levels	O
consistently	O
above	O
75	O
nmol	O
/	O
L	O
(	O
30	O
ng	O
/	O
mL	O
)	O
may	O
require	O
at	B
least	I
1500	O
-	O
2000	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
.	O
If	O
a	O
mother	O
is	O
vitamin	O
D	O
deficient	O
,	O
breast	O
milk	O
is	O
not	O
a	O
good	O
source	O
of	O
vitamin	O
D	O
,	O
so	O
infants	O
need	O
to	O
be	O
given	O
vitamin	O
D	O
supplementation	O
until	O
they	O
are	O
weaned	O
.	O

Discovery	O
research	O
Discovery	O
research	O
focuses	O
on	O
better	O
understanding	O
the	O
causes	O
and	O
mechanisms	O
of	O
preterm	O
birth	O
and	O
elucidating	O
factors	O
that	O
regulate	O
uterine	O
quiescence	O
,	O
initiation	O
of	O
labour	O
,	O
and	O
the	O
multiple	O
host	O
,	O
agent	O
,	O
and	O
environmental	O
factors	O
that	O
cause	O
aberrations	O
in	O
these	O
normal	O
processes	O
of	O
pregnancy	O
.	O

The	O
characteristics	O
of	O
the	O
study	O
participants	O
are	O
summarized	O
in	O
(	O
Table	O
1	O
).	O

Introduction	O
In	O
2009	O
,	O
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
)	O
revised	O
its	O
guidelines	O
for	O
appropriate	O
weight	O
gain	O
during	O
pregnancy	O
,	O
taking	O
into	O
account	O
the	O
growing	O
prevalence	O
of	O
obesity	O
in	O
women	O
of	O
childbearing	O
age	O
[	O
1	O
].	O

Quality	O
of	O
life	O
is	O
reduced	O
among	O
those	O
suffering	O
from	O
S	O
-	O
ECC	O
[	O
3	O
,	O
5	O
,	O
6	O
].	O

However	O
an	O
analysis	O
of	O
the	O
effects	O
of	O
supplementation	O
on	O
broader	O
micronutrient	O
status	O
in	O
this	O
population	O
would	O
have	O
been	O
of	O
interest	O
and	O
is	O
a	O
specified	O
outcome	O
in	O
the	O
main	O
trial	O
,	O
which	O
will	O
be	O
reported	O
elsewhere	O
.	O

In	O
this	O
review	O
,	O
the	O
authors	O
underline	B
that	O
regular	O
adjustment	O
of	O
levo	O
-	O
thyroxine	O
and	O
calcium	O
therapy	O
is	O
of	O
outmost	O
importance	O
for	O
both	O
maternal	O
and	O
foetal	O
well	O
-	O
being	O
and	O
offer	O
some	O
insight	O
,	O
very	O
interesting	O
from	O
a	O
practical	O
point	O
of	O
view	O
,	O
to	O
provide	O
a	O
clear	O
and	O
simple	O
pathway	O
for	O
the	O
management	O
of	O
pregnancy	O
-	O
associated	O
thyroid	O
cancer	O
.	O

The	O
neonates	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
did	O
not	O
differ	O
in	O
birth	O
weight	O
or	O
in	O
the	O
proportion	O
of	O
those	O
who	O
were	O
small	O
for	O
gestational	O
age	O
(<	O
10th	O
centile	O
).	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

First	O
,	O
text4baby	O
is	O
a	O
broad	O
,	O
relatively	O
“	O
low	O
-	O
touch	O
”	O
intervention	O
.	O

Introduction	O
Vitamin	O
D	O
is	O
crucial	O
not	O
only	O
for	O
calcium	O
metabolism	O
and	O
skeletal	O
health	O
but	O
also	O
in	O
the	O
homeostasis	O
of	O
many	O
other	O
systems	O
.	O

The	O
GD	O
also	O
decreased	O
approximately	O
5	O
%	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
82	O
.	O
8	O
±	O
0	O
.	O
7	O
µm	O
)	O
in	O
comparison	O
with	O
the	O
F2	O
-	O
SC	O
mice	O
(	O
87	O
.	O
3	O
±	O
1	O
.	O
3	O
µm	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Sampling	O
was	O
evenly	O
distributed	O
across	O
the	O
seasons	O
and	O
time	O
of	O
year	O
cannot	O
explain	O
the	O
high	O
proportion	O
with	O
high	O
25OHD	O
concentrations	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Number	O
of	O
regulated	O
probe	O
-	O
sets	O
in	O
liver	O
tissue	O
.	O

Followup	O
at	O
five	O
weeks	O
revealed	O
a	O
healthy	O
mother	O
and	O
infant	O
.	O

There	O
was	O
no	O
difference	O
between	O
the	O
serum	O
concentration	O
of	O
PTH	O
of	O
the	O
IG	O
and	O
CG	O
prior	O
to	O
intervention	O
,	O
however	O
,	O
serum	O
concentration	O
of	O
PTH	O
after	O
the	O
intervention	O
was	O
significantly	O
lower	O
in	O
the	O
IG	O
than	O
that	O
of	O
CG	O
.	O

Data	O
inTable	O
7represent	O
the	O
crude	O
and	O
adjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
for	O
ORs	O
from	O
the	O
multivariate	O
analysis	O
,	O
where	O
neonatal	O
anthropometric	O
measurements	O
are	O
the	O
dependent	O
variables	O
and	O
major	O
maternal	O
dietary	O
patterns	O
the	O
independent	O
variables	O
.	O

Cold	O
stress	O
causes	O
white	O
fat	O
depot	O
lipolysis	O
in	O
rats	O
[	O
102	O
].	O

Prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
were	O
tested	O
with	O
Fisher	O
’	O
s	O
Exact	O
test	O
.	O

Signals	O
were	O
visualized	O
by	O
chemiluminescence	O
,	O
and	O
the	O
digital	O
images	O
were	O
quantitatively	O
analyzed	O
(	O
Image	O
-	O
Pro	O
Plus	O
version	O
7	O
.	O
01	O
,	O
Media	O
Cybernetics	O
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
).	O

This	O
co	O
-	O
publication	O
makes	O
the	O
article	O
available	O
to	O
the	O
community	O
in	O
a	O
full	O
-	O
text	O
format	O
.	O

Total	O
GWG	O
was	O
positively	O
predictive	O
of	O
higher	O
child	O
WFA	O
z	O
score	O
at	O
birth	O
(	O
beta	O
=.	O
41	O
;	O
t	O
=	O
4	O
.	O
9	O
;	O
P	O
=	O
.	O
0001	O
)	O
and	O
macrosomia	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
001	O
).	O

We	O
will	O
conduct	O
analyses	O
at	O
the	O
infant	O
level	O
adjusted	O
for	O
the	O
cluster	O
randomisation	O
.	O

Serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
recognized	B
as	B
the	O
best	O
indicator	O
of	O
Vitamin	O
D	O
status	O
.	O

)—	O
Low	O
Frequency	O
in	O
Normalized	O
Units	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

There	O
is	O
limited	O
data	O
about	O
the	O
beliefs	O
of	O
Latinas	O
on	O
GWG	O
even	O
though	O
the	O
problem	O
of	O
excessive	O
weight	O
gain	O
during	O
pregnancy	O
is	O
particularly	O
important	O
for	O
this	O
group	O
which	O
now	O
comprises	O
20	O
%	O
of	O
new	O
mothers	O
in	O
the	O
US	O
[	O
1	O
].	O

All	O
other	O
offspring	O
from	O
dams	O
fed	O
the	O
HV	O
diet	O
were	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
.	O

PubMed	O
Central	O
:	O

Our	O
results	O
of	O
a	O
protective	O
effect	O
of	O
vitamin	O
D	O
intake	O
must	O
be	O
considered	O
as	B
rough	O
,	O
since	O
we	O
only	O
measure	O
the	O
dietary	O
intake	O
of	O
vitamin	O
D	O
.	O
A	O
more	O
complete	O
picture	O
of	O
the	O
vitamin	O
D	O
status	O
could	O
have	O
been	O
supplied	O
through	O
vitamin	O
D	O
levels	O
in	O
blood	O
;	O
however	O
,	O
no	O
biological	O
samples	O
are	O
available	O
.	O

The	O
difference	O
was	O
not	O
statistically	O
significant	O
,	O
although	O
our	O
study	O
was	O
not	O
powered	O
to	O
detect	O
differences	O
in	O
death	O
rate	O
.	O

Methods	O
Study	O
Design	O
and	O
Participants	O
We	O
examined	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
randomized	O
controlled	O
trial	O
,	O
Madre	O
Sana	O
,	O
Bebé	O
Sano	O
(	O
Healthy	O
Mother	O
,	O
Healthy	O
Baby	O
),	O
designed	O
to	O
prevent	O
excessive	O
GWG	O
.	O

Then	O
in	O
2005	O
,	O
Anway	O
et	O
al	O
.	O

Additionally	O
,	O
while	O
one	O
study	O
examined	O
the	O
levels	O
of	O
maternal	O
and	O
neonatal	O
vitamin	O
D	O
and	O
cathelicidin	O
concentrations	O
in	O
healthy	O
children	O
at	O
delivery	O
,	O
there	O
is	O
a	O
lack	O
of	O
research	O
to	O
determine	O
correlations	O
between	O
vitamin	O
D	O
status	O
and	O
cathelicidin	O
among	O
healthy	O
children	O
over	O
time	O
[	O
20	O
],	O
as	O
well	O
as	O
which	O
factors	O
such	O
as	O
age	O
of	O
the	O
child	O
,	O
gender	O
,	O
and	O
body	O
composition	O
may	O
independently	O
impact	O
cathelicidin	O
concentrations	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

While	O
a	O
similar	O
robust	O
,	O
dose	O
-	O
dependent	O
relationship	O
is	O
also	O
crucial	O
to	O
facilitate	O
the	O
development	O
of	O
testing	O
methods	O
for	O
hazard	O
assessment	O
,	O
relevant	O
environmental	O
regulation	O
and	O
/	O
or	O
appropriate	O
medical	O
intervention	O
,	O
establishing	O
causality	O
is	O
not	O
necessarily	O
essential	O
.	O

Associations	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
Among	O
all	O
682	O
women	O
,	O
the	O
common	O
allele	O
(	O
T	O
)	O
of	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
greater	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
Table	O
2	O
).	O

The	O
handwashing	O
intervention	O
tested	O
in	O
Pakistan	O
consisted	O
of	O
provision	O
of	O
a	O
bar	O
of	O
soap	O
and	O
“	O
encouragement	O
”	O
by	O
birth	O
attendants	O
for	O
mothers	O
and	O
other	O
family	O
members	O
to	O
wash	O
hands	O
“	O
before	O
handling	O
the	O
newborn	O
infant	O
.”	O
There	O
was	O
no	O
assessment	O
of	O
handwashing	O
behavior	O
measures	O
and	O
thus	O
,	O
it	O
is	O
not	O
clear	O
whether	O
the	O
intervention	O
did	O
not	O
affect	O
handwashing	O
behavior	O
or	O
whether	O
improved	O
handwashing	O
behavior	O
did	O
not	O
reduce	O
neonatal	O
mortality	O
.	O

A	O
)	O
Birthweight	O
in	O
offspring	O
of	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
;	O
B	O
)	O
Birthweight	O
in	O
offspring	O
of	O
dams	O
that	O
were	O
fed	O
a	O
high	O
fat	O
diet	O
;	O
C	O
)	O
Neonatal	O
growth	O
curves	O
in	O
offspring	O
of	O
undernourished	O
dams	O
;	O
D	O
)	O
Neonatal	O
growth	O
curves	O
in	O
offspring	O
of	O
high	O
fat	O
fed	O
dams	O
.	O

In	O
hypothyroid	O
or	O
thyroidectomized	O
pregnant	O
women	O
,	O
such	O
physiological	O
changes	O
obviously	O
cannot	O
occur	O
.	O

The	O
respondents	O
also	O
wished	O
that	O
the	O
health	O
talks	O
(	O
16	O
.	O
3	O
%)	O
should	O
be	O
more	O
regular	O
and	O
that	O
primigravida	O
should	O
be	O
encouraged	O
to	O
come	O
regularly	O
.	O

Oral	O
Supplements	O
Prenatal	O
supplements	O
are	O
an	O
important	O
component	O
of	O
a	O
healthy	O
pregnancy	O
.	O

At	O
present	O
,	O
the	O
largest	O
study	O
to	O
investigate	O
pregnancy	O
outcomes	O
following	O
the	O
maternal	O
use	O
of	O
SGA	O
in	O
monotherapy	O
and	O
in	O
polytherapy	O
,	O
identifying	O
risk	O
behaviours	O
and	O
factors	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
.	O

Multiple	O
linear	O
regression	O
models	O
,	O
adjusted	O
for	O
confounders	O
,	O
were	O
used	O
for	O
analysis	O
.	O

Cesarean	O
sections	O
are	O
also	O
more	O
common	O
,	O
and	O
GDM	O
is	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
pre	O
-	O
eclampsia	O
.	O
9	O
–	O
11	O
Exposure	O
of	O
the	O
fetus	O
to	O
hyperglycemia	O
may	O
also	O
predispose	O
the	O
child	O
to	O
a	O
diabetes	O
phenotype	O
in	O
later	O
life	O
.	O

Data	O
represent	O
at	O
least	O
six	O
litters	O
per	O
maternal	O
dietary	O
group	O
.	O

The	O
COPSAC2000study	O
have	O
failed	O
to	O
show	O
an	O
association	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
lung	O
function	O
at	O
7	O
years	O
of	O
age	O
[	O
33	O
].	O

Vitamin	O
D	O
is	O
primarily	O
synthesized	O
in	O
the	O
skin	O
and	O
is	O
partly	O
derived	O
from	O
dietary	O
sources	O
[	O
4	O
].	O

In	O
a	O
study	O
of	O
neonatal	O
rats	O
,	O
Zerrate	O
et	O
al	O
.	O

It	B
is	I
clear	I
,	O
however	O
,	O
that	O
vitamin	O
D	O
requirements	O
are	O
increased	O
in	O
mothers	O
during	O
pregnancy	O
and	O
lactation	O
.	O

During	O
pregnancy	O
,	O
an	O
increase	O
in	O
insulin	O
resistance	O
occurs	O
.	O

These	O
included	O
maternal	O
age	O
at	O
delivery	O
,	O
sex	O
of	O
child	O
,	O
multiple	O
pregnancy	O
,	O
season	O
of	O
birth	O
,	O
maternal	O
history	O
of	O
atopic	O
diseases	O
(	O
hay	O
fever	O
,	O
asthma	O
,	O
eczema	O
,	O
allergies	O
,	O
or	O
attacks	O
of	O
wheezing	O
with	O
whistling	O
on	O
the	O
chest	O
or	O
attacks	O
of	O
breathlessness	O
in	O
the	O
past	O
2	O
years	O
),	O
parity	O
,	O
highest	O
educational	O
qualification	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
breastfeeding	O
duration	O
and	O
maternal	O
factors	O
during	O
pregnancy	O
(	O
smoking	O
status	O
,	O
anxiety	O
score	O
(	O
Crown	O
–	O
Crisp	O
Experiential	O
Index	O
),	O
paracetamol	O
use	O
,	O
antibiotic	O
use	O
,	O
infections	O
(	O
urinary	O
infection	O
,	O
influenza	O
,	O
rubella	O
,	O
thrush	O
,	O
genital	O
herpes	O
,	O
other	O
),	O
supplement	O
use	O
and	O
total	O
energy	O
intake	O
(	O
kJ	O
·	O
day	O
−	O
1	O
)).	O

In	O
a	O
randomized	O
control	O
trial	O
,	O
a	O
vitamin	O
D	O
supplement	O
can	O
even	O
decrease	O
the	O
risk	O
of	O
seasonal	O
flu	O
in	O
children	O
[	O
50	O
].	O

The	O
dissected	O
hypothalamic	O
blocks	O
contained	O
preoptic	O
,	O
supraoptic	O
,	O
paraventricular	O
,	O
anterior	O
,	O
suprachiasmatic	O
,	O
dorsomedial	O
,	O
ventromedial	O
,	O
arcuate	O
,	O
mammillary	O
,	O
posterior	O
and	O
lateral	O
complex	O
nuclei	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

We	O
restricted	O
our	O
study	O
to	O
primiparous	O
mothers	O
,	O
since	O
they	O
might	O
have	O
been	O
more	O
susceptible	O
to	O
behavior	O
change	O
given	B
their	O
relatively	O
larger	O
change	O
in	O
self	O
-	O
definition	O
,	O
compared	O
to	O
multiparous	O
mothers	O
.	O

ncRNAs	O
can	O
then	O
inhibit	O
the	O
production	O
of	O
protein	O
from	O
mRNAs	O
either	O
via	O
mRNA	O
degradation	O
and	O
/	O
or	O
reduced	O
translation	O
,	O
and	O
/	O
or	O
protect	O
genome	O
stability	O
via	O
the	O
degradation	O
of	O
transposable	O
elements	O
(	O
retrotransposons	O
).	O

Stridor	O
occurring	O
as	O
a	O
consequence	O
of	O
nutritional	O
rickets	O
is	O
reported	O
in	O
literature	O
.	O

2	O
Within	O
groups	O
comparison	O
related	O
to	O
depression	O
scores	O
:	O
The	O
results	O
showed	O
,	O
between	O
the	O
two	O
groups	O
,	O
the	O
difference	O
regards	O
to	O
over	O
-	O
time	O
reduction	O
of	O
depression	O
scores	O
was	O
significant	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
The	O
vitamin	O
D	O
group	O
also	O
had	O
gone	O
through	O
changes	O
with	O
regards	O
to	O
their	O
depression	O
scores	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Fig	O
.	O

This	O
observation	O
is	O
similar	O
to	O
that	O
seen	O
in	O
Uganda	O
[	O
17	O
]	O
and	O
Zimbabwe	O
[	O
18	O
]	O
where	O
it	O
was	O
also	O
shown	O
that	O
the	O
quality	O
of	O
care	O
provided	O
was	O
contributory	O
.	O

We	O
selected	O
a	O
95	O
%	O
confidence	O
level	O
and	O
an	O
assumed	B
prevalence	O
of	O
supplement	O
use	O
of	O
50	O
%,	O
informed	O
by	O
other	O
studies	O
[	O
15	O
-	O
19	O
,	O
22	O
],	O
due	O
to	O
the	O
lack	O
of	O
prior	O
data	O
in	O
our	O
region	O
.	O

A	O
recent	O
Danish	O
birth	O
cohort	O
study	O
investigated	O
the	O
relation	O
between	O
soft	O
drink	O
consumption	O
,	O
but	O
not	O
total	O
free	O
sugar	O
intake	O
,	O
during	O
pregnancy	O
and	O
childhood	O
asthma	O
and	O
allergic	O
rhinitis	O
[	O
10	O
].	O

Methods	O
A	O
cohort	O
of	O
1	O
,	O
290	O
women	O
was	O
interviewed	O
during	O
early	O
pregnancy	O
.	O

In	O
linear	O
regression	O
analysis	O
serum	O
,	O
vitamin	O
D	O
level	O
positively	O
correlated	O
with	O
total	O
testosterone	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
free	O
androgen	O
index	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
functionality	O
of	O
health	O
systems	O
,	O
such	O
as	O
human	O
resource	O
capacity	O
,	O
health	O
facility	O
infrastructure	O
,	O
supply	O
and	O
demand	O
systems	O
,	O
financial	O
resources	O
,	O
government	O
stewardship	O
,	O
district	O
-	O
level	O
management	O
and	O
use	O
of	O
data	O
,	O
will	O
also	O
determine	O
the	O
coverage	O
,	O
quality	O
and	O
rate	O
of	O
change	O
within	O
the	O
continuum	O
of	O
care	O
[	O
28	O
].	O

Weekly	O
Iron	O
-	O
Folic	O
Acid	O
Supplementation	O
with	O
Regular	O
Deworming	O
Is	O
Cost	O
-	O
Effective	O
in	O
Preventing	O
Anaemia	O
in	O
Women	O
of	O
Reproductive	O
Age	O
in	O
Vietnam	O
Abstract	O
Background	O
To	O
estimate	O
the	O
cost	O
and	O
cost	O
-	O
effectiveness	O
of	O
a	O
project	O
administering	O
de	O
-	O
worming	O
and	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
to	O
control	O
anaemia	O
in	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
province	O
,	O
Vietnam	O
.	O

Seasonal	O
variations	O
in	O
carcass	O
characteristics	O
have	O
been	O
observed	O
in	O
Korean	O
cattle	O
steers	O
by	O
our	O
group	O
[	O
2	O
].	O

Our	O
data	O
support	O
an	O
increasing	O
trend	O
in	O
the	O
use	O
of	O
SGAs	O
to	O
treat	O
a	O
variety	O
of	O
psychiatric	O
disorders	O
,	O
with	O
bipolar	O
disorder	O
and	O
depression	O
being	O
reported	O
as	O
the	O
two	O
leading	O
indications	O
and	O
quetiapine	O
being	O
the	O
one	O
most	O
commonly	O
used	O
.	O

Values	O
for	O
BMC	O
at	O
one	O
week	O
,	O
Non	O
-	O
Hispanic	O
Caucasians	O
,	O
(	O
n	O
=	O
22	O
),	O
69	O
.	O
5	O
+	O
8	O
.	O
8	O
(	O
g	O
)	O
and	O
Hispanic	O
,	O
(	O
n	O
=	O
27	O
),	O
72	O
.	O
4	O
±	O
9	O
.	O
2	O
(	O
g	O
),	O
p	O
=	O
0	O
.	O
27	O
.	O

Similarly	O
,	O
we	O
detected	O
a	O
main	O
effect	O
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
12	O
.	O
458	O
,	O
P	O
<	O
0	O
.	O
01	O
]	O
and	O
an	O
almost	O
significant	O
effect	O
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
853	O
,	O
P	O
=	O
0	O
.	O
059	O
]	O
on	O
total	O
caloric	O
intake	O
(	O
Figure3H	O
).	O

Of	O
the	O
total	O
ninety	O
-	O
eight	O
patient	O
,,	O
there	O
were	O
twenty	O
patients	O
whose	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
was	O
lower	O
than	O
50	O
nmol	O
/	O
L	O
which	O
made	O
them	O
meet	O
the	O
criteria	O
for	O
the	O
diagnosis	O
of	O
Vitamin	O
De	O
deficiency	O
,	O
five	O
of	O
them	O
were	O
from	O
control	O
group	O
,	O
and	O
fifteen	O
were	O
from	O
intervention	O
group	O
.	O

SNPs	O
in	O
GC	O
have	O
also	O
been	O
associated	O
with	O
the	O
binding	O
affinities	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
VDP	O
(	O
24	O
),	O
although	O
the	O
effect	O
of	O
rs2282679	O
on	O
binding	O
affinity	O
has	O
not	O
been	O
established	O
.	O

We	O
found	O
some	O
evidence	O
that	O
PFAS	O
,	O
DMP	O
and	O
Pb	O
were	O
associated	O
with	O
small	O
reductions	O
in	O
birth	O
weight	O
.	O

Listed	O
pathways	O
between	O
AP	O
stages	O
(	O
white	O
boxes	O
)	O
indicate	O
the	O
appropriate	O
ontogenetic	O
development	O
,	O
which	O
does	O
not	O
take	O
place	O
in	O
the	O
LP	O
offspring	O
(	O
black	O
boxes	O
)	O
at	O
the	O
corresponding	O
developmental	O
period	O
.	O

The	O
health	O
of	O
the	O
adult	O
South	O
African	O
population	O
is	O
a	O
concern	O
.	O

Part	O
1	O
:	O
Specific	O
Allergic	O
Diseases	O
in	O
Pregnancy	O
Epidemiology	O
:	O
Prevalence	O
of	O
Asthma	O
and	O
Allergy	O
in	O
Pregnant	O
Women	O
Allergic	O
sensitization	O
to	O
common	O
allergens	O
can	O
be	O
detected	O
in	O
approximately	O
25	O
%	O
to	O
35	O
%	O
of	O
the	O
general	O
population	O
in	O
industrialized	O
countries	O
[	O
7	O
].	O

The	O
increase	O
in	O
body	O
weight	O
of	O
RC	O
male	O
offspring	O
is	O
directly	O
associated	O
with	O
an	O
increase	O
in	O
abdominal	O
fat	O
and	O
,	O
particularly	O
,	O
a	O
higher	O
percentage	O
of	O
perirenal	O
adiposity	O
relative	O
to	O
body	O
weight	O
.	O

At	O
all	O
five	O
assessments	O
made	O
during	O
the	O
neonatal	O
period	O
,	O
households	O
in	O
the	O
intervention	O
arm	O
were	O
3	O
or	O
more	O
times	O
as	O
likely	B
as	O
households	O
in	O
the	O
control	O
arm	O
to	O
have	O
at	O
least	O
one	O
handwashing	O
station	O
observed	O
to	O
have	O
soap	O
and	O
water	O
present	O
.	O

Expanding	O
training	O
,	O
research	O
opportunities	O
and	O
mentorship	O
for	O
researchers	O
in	O
low	O
-	O
income	O
settings	O
hold	O
great	O
promise	O
in	O
developing	O
a	O
pipeline	O
of	O
expertise	O
to	O
advance	O
the	O
science	O
with	O
the	O
skills	O
to	O
use	O
this	O
science	O
effectively	O
to	O
promote	O
change	O
[	O
30	O
].	O

Asthma	O
and	O
Allergic	O
Diseases	O
in	O
Pregnancy	O
:	O
A	O
Review	O
Abstract	O
Asthma	O
and	O
allergic	O
disorders	O
can	O
affect	O
the	O
course	O
and	O
outcome	O
of	O
pregnancy	O
.	O

PubMed	O
Central	O
:	O

Birth	O
size	O
,	O
including	O
birth	O
weight	O
(	O
kg	O
),	O
length	O
(	O
cm	O
),	O
and	O
head	O
circumference	O
(	O
cm	O
),	O
was	O
measured	O
by	O
midwives	O
according	O
to	O
standard	O
procedure	O
.	O

At	O
the	O
time	O
of	O
enrolment	O
,	O
we	O
will	O
assign	O
each	O
mother	O
a	O
box	O
consisting	O
of	O
8	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

Primiparous	O
women	O
were	O
more	O
likely	B
to	O
use	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
(	O
aOR	O
,	O
2	O
.	O
0	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
3	O
.	O
7	O
).	O

Questionnaire	O
data	O
were	O
systematically	O
checked	O
for	O
errors	O
during	O
data	O
entry	O
by	O
using	O
legal	O
values	O
and	O
specified	O
ranges	O
in	O
Epi	O
-	O
info	O
.	O

As	O
a	O
result	O
,	O
the	O
genetic	O
etiology	O
of	O
many	O
congenital	O
vertebral	O
malformation	O
syndromes	O
remains	O
unknown	O
.	O

Adipocyte	O
diameter	O
in	O
subcutaneous	O
,	O
mesenteric	O
,	O
and	O
omental	O
fat	O
was	O
larger	O
in	O
offspring	O
of	O
dams	O
nutritionally	O
restricted	O
than	O
in	O
animals	O
from	O
dams	O
with	O
normal	O
dietary	O
intake	O
(	O
100	O
%	O
of	O
NRC	O
recommendations	O
),	O
but	O
marbling	O
data	O
were	O
not	O
reported	O
.	O

Finally	O
,	O
it	O
is	O
easily	O
inducible	O
,	O
such	O
as	O
during	O
mild	O
cold	O
exposure	O
with	O
resulting	O
beneficial	O
effects	O
.	O

By	O
use	O
of	O
the	O
randomisation	O
list	O
,	O
a	O
pharmacist	O
in	O
the	O
Department	O
of	O
Pharmacy	O
,	O
Aga	O
Khan	O
University	O
Hospital	O
,	O
Karachi	O
prepared	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
in	O
olive	O
oil	O
(	O
Sinochem	O
Ningbo	O
Laboratory	O
,	O
China	O
)	O
or	O
placebo	O
(	O
olive	O
oil	O
)	O
in	O
sealed	O
2	O
mL	O
plastic	O
syringes	O
labelled	O
with	O
the	O
unique	O
identification	O
numbers	O
.	O

Significantly	O
more	O
women	O
in	O
the	O
exposed	O
group	O
smoked	O
cigarettes	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
failed	O
to	O
use	O
prenatal	O
vitamins	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
compared	O
with	O
controls	O
.	O

Taking	O
into	O
consideration	O
that	O
participants	O
may	O
opt	O
out	O
of	O
the	O
project	O
(	O
at	O
25	O
%	O
rate	O
),	O
it	O
is	O
calculated	O
that	O
a	O
minimum	O
of	O
245	O
participants	O
should	O
be	O
recruited	O
.	O

More	O
than	O
the	O
total	O
body	O
weight	O
,	O
the	O
distribution	O
of	O
the	O
stored	O
fat	O
is	O
of	O
importance	O
for	O
the	O
development	O
of	O
obesity	O
and	O
its	O
comorbidities	O
.	O

The	O
women	O
were	O
selected	O
via	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
sampling	O
design	O
.	O

More	O
information	O
is	O
available	O
athttp	O
://	O
www	O
.	O
marchofdimes	O
.	O
com	O
/	O
mission	O
/	O
prematurity	O
-	O
reportcard	O
.	O
aspx	O
Inform	O
Improve	O
the	O
data	O
for	O
preterm	O
birth	O
rates	O
,	O
mortality	O
,	O
impairment	O
and	O
their	O
causes	O
,	O
with	O
regular	O
tracking	O
of	O
coverage	O
,	O
quality	O
and	O
equity	O
gaps	O
,	O
as	O
is	O
done	O
through	O
Countdown	O
to	O
2015	O
and	O
linked	O
to	O
the	O
work	O
of	O
the	O
Commission	O
for	O
Information	O
and	O
Accountability	O
using	O
the	O
data	O
for	O
action	O
and	O
accountability	O
,	O
including	O
the	O
establishment	O
of	O
national	O
birth	O
registrations	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Sample	O
demographics	O
(	O
N	O
=	O
123	O
)	O
N	O
(%)	O
Maternal	O
age	O
(	O
years	O
)<	O
184	O
(	O
2	O
.	O
8	O
)	O
18	O
–	O
2460	O
(	O
41	O
.	O
7	O
)	O
25	O
–	O
3042	O
(	O
29	O
.	O
2	O
)>	O
3038	O
(	O
26	O
.	O
4	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
Under0	O
(	O
0	O
)	O
Normal48	O
(	O
39	O
.	O
0	O
)	O
Overweight41	O
(	O
33	O
.	O
3	O
)	O
Obese34	O
(	O
27	O
.	O
6	O
)	O
Country	O
of	O
origin	O
United	O
States30	O
(	O
24	O
.	O
4	O
)	O
Mexico59	O
(	O
48	O
.	O
0	O
)	O
Honduras13	O
(	O
10	O
.	O
6	O
)	O
Other	O
Latin	O
Am	O
.	O

From	O
an	O
evolutionary	O
perspective	O
,	O
these	O
senses	O
,	O
which	O
are	O
well	O
developed	O
at	O
birth	O
,	O
function	O
as	O
gatekeepers	O
throughout	O
life	O
(	O
26	O
).	O

[	O
18	O
],	O
Hibbeln	O
et	O
al	O
.	O

However	O
,	O
some	O
sources	O
did	O
cite	O
other	O
factors	O
that	O
could	O
potentially	O
be	O
associated	O
with	O
the	O
delivery	O
room	O
itself	O
.	O

ADP	O
,	O
GEB	O
and	O
LIG	O
contributed	O
to	O
study	O
conceptualization	O
and	O
design	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
the	O
article	O
.	O

This	O
case	O
–	O
control	O
study	O
has	O
some	O
limitations	O
.	O

These	O
extremely	O
low	O
values	O
are	O
not	O
commonly	O
reported	O
in	O
the	O
United	O
States	O
,	O
although	O
we	O
speculate	O
that	O
an	O
increasing	O
number	O
of	O
cases	O
may	O
be	O
reported	O
in	O
the	O
future	O
due	B
to	I
increased	O
awareness	O
of	O
vitamin	O
D	O
deficiency	O
.	O

The	O
direct	O
effect	O
of	O
vitamin	O
D	O
on	O
AMH	O
level	O
and	O
follicle	O
development	O
was	O
also	O
confirmed	O
in	O
a	O
recently	O
published	O
in	O
vitro	O
experiment	O
[	O
45	O
].	O

For	O
many	O
years	O
,	O
fast	O
-	O
acting	O
(	O
regular	O
)	O
insulin	O
,	O
and	O
intermediate	O
-	O
acting	O
(	O
isophane	O
)	O
insulin	O
have	O
been	O
the	O
preferred	B
insulins	O
for	O
the	O
treatment	O
of	O
GDM	O
.	O

Hence	B
,	O
the	O
effects	O
of	O
maternal	O
attitudes	O
on	O
fetal	O
weight	O
depend	O
on	O
the	O
mother	O
'	O
s	O
polymorphism	O
of	O
GR	O
gene	O
.	O

The	O
pregnancies	O
ranged	O
from	O
1	O
to	O
7	O
,	O
with	O
women	O
with	O
the	O
first	O
pregnancy	O
constituting	O
the	O
highest	O
population	O
.	O

©	O
Phanie	O
/	O
Alamy	O
Stock	O
Photo	O
Caption	O
(	O
FIG	O
)	O
Education	O
and	O
counseling	O
have	O
been	O
important	O
tools	O
in	O
boosting	O
breastfeeding	O
rates	O
,	O
after	O
decades	O
of	O
marketing	O
messages	O
that	O
insinuated	O
breast	O
milk	O
was	O
insufficient	O
to	O
nourish	O
young	O
babies	O
.	O

Results	O
Of	O
the	O
13	O
972	O
singleton	O
or	O
twin	O
children	O
alive	O
at	O
1	O
year	O
of	O
age	O
,	O
information	O
on	O
maternal	O
diet	O
was	O
available	O
for	O
12	O
078	O
,	O
of	O
whom	O
there	O
was	O
information	O
on	O
at	O
least	O
one	O
of	O
the	O
outcomes	O
of	O
interest	O
for	O
8956	O
(	O
supplementary	O
figure	O
E2	O
).	O

The	O
oxygen	O
saturation	O
and	O
heart	O
rate	O
of	O
participants	O
were	O
monitored	O
with	O
pulse	O
oximeter	O
during	O
the	O
procedure	O
and	O
until	O
they	O
became	O
fully	O
awake	O
.	O

WAT	O
has	O
endocrine	O
activity	O
,	O
secreting	O
several	O
factors	O
and	O
hormones	O
,	O
such	O
as	O
leptin	O
and	O
adiponectin	O
.	O

Methods	O
Serum	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
was	O
measured	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
in	O
2800	O
women	O
from	O
Adelaide	O
and	O
Auckland	O
who	O
participated	O
in	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
SCreening	O
fOr	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
.	O

When	O
he	O
analyzed	O
her	O
milk	O
,	O
he	O
found	O
it	O
contained	O
exorbitant	O
levels	O
of	O
DDT	O
.	O
12	O
Two	O
years	O
later	O
,	O
researchers	O
examined	O
milk	O
samples	O
from	O
32	O
black	O
women	O
at	O
a	O
Washington	O
,	O
DC	O
,	O
hospital	O
.	O
13None	O
of	O
the	O
women	O
worked	O
with	O
pesticides	O
or	O
reported	O
an	O
acute	O
exposure	O
to	O
DDT	O
,	O
yet	O
their	O
milk	O
contained	O
trace	O
amounts	O
of	O
the	O
chemical	O
.	O

Expression	O
of	O
psychotic	O
symptoms	O
in	O
populations	O
is	O
continuous	O
and	O
characterized	O
by	O
differing	O
levels	O
of	O
severity	O
and	O
persistence	O
[	O
7	O
].	O

As	O
individuals	O
aged	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
increased	O
.	O

To	O
account	O
for	O
clustering	O
of	O
behavior	O
at	O
the	O
individual	O
level	O
(	O
i	O
.	O
e	O
.,	O
an	O
individual	O
is	O
more	O
likely	O
to	O
behave	O
like	O
herself	O
than	O
she	O
is	O
to	O
behave	O
like	O
others	O
),	O
we	O
introduced	O
a	O
design	O
effect	O
of	O
2	O
,	O
increasing	O
the	O
sample	O
size	O
up	O
to	O
160	O
in	O
each	O
arm	O
.	O

Mean	O
change	O
in	O
haemoglobin	O
concentration	O
was	O
+	O
0	O
.	O
6	O
±	O
1	O
.	O
4g	O
/	O
dL	O
in	O
the	O
intervention	O
arm	O
and	O
−	O
0	O
.	O
2	O
±	O
1	O
.	O
2g	O
/	O
dL	O
in	O
the	O
placebo	O
arm	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Gestational	O
Diabetes	O
Insipidus	O
Associated	O
with	O
HELLP	O
Syndrome	O
:	O
A	O
Case	O
Report	O
Abstract	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
,	O
but	O
well	O
recognized	O
,	O
complication	O
of	O
pregnancy	O
.	O

Although	O
the	O
seasonal	O
variation	O
observed	O
in	O
insulin	O
resistance	O
may	O
be	O
caused	O
by	O
unknown	O
seasonal	O
behaviours	O
or	O
residual	O
confounding	O
factors	O
that	O
we	O
have	O
not	O
included	O
in	O
this	O
analysis	O
,	O
it	O
is	O
possible	O
that	O
there	O
is	O
an	O
unequivocal	O
seasonal	O
cause	O
or	O
circannual	O
rhythm	O
associated	O
with	O
increased	O
insulin	O
resistance	O
in	O
early	O
pregnancy	O
during	O
winter	O
months	O
.	O

Additionally	O
,	O
RC	O
males	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
than	O
RC	O
females	O
in	O
several	O
days	O
of	O
the	O
lactation	O
period	O
(	O
PND	O
1	O
and	O
PND	O
2	O
–	O
5	O
,	O
16	O
,	O
17	O
,	O
and	O
2	O
).	O

The	O
association	O
between	O
polytherapy	O
exposure	O
and	O
higher	O
rates	O
of	O
malformations	O
should	O
be	O
considered	O
in	O
the	O
context	O
of	O
the	O
small	O
sample	O
size	O
,	O
severity	O
of	O
the	O
baseline	O
disorder	O
that	O
required	O
polytherapy	O
,	O
associated	O
comorbidities	O
,	O
as	O
well	O
as	O
any	O
other	O
unknown	O
environmental	O
factors	O
that	O
were	O
not	O
assessed	O
in	O
this	O
study	O
.	O

The	O
SDQ	O
was	O
used	O
to	O
measure	O
maladaptive	O
behaviour	O
.	O
Intervention	O
/	O
comparatorFish	O
intake	O
:	O
rarely	O
/	O
never	O
,	O
once	O
a	O
fortnight	O
,	O
1	O
–	O
3	O
times	O
per	O
week	O
,	O
4	O
or	O
more	O
times	O
per	O
week	O
.	O
Assumed	O
each	O
fish	O
serve	O
was	O
4	O
.	O
5	O
ounces	O
(~	O
0	O
g	O
,	O
64	O
g	O
,	O
255	O
g	O
and	O
510	O
g	O
per	O
week	O
).	O
Second	O
trimester	O
fish	O
servings	O
:	O
more	O
than	O
2	O
weekly	O
fish	O
servings	O
compared	O
to	O
2	O
or	O
less	O
.	O
Did	O
not	O
convert	O
servings	O
to	O
grams	O
.	O
Comparing	O
no	O
seafood	O
intake	O
and	O
1	O
–	O
340	O
g	O
per	O
week	O
with	O
more	O
than	O
340	O
g	O
per	O
week	O
(	O
3	O
servings	O
is	O
estimated	O
as	O
340	O
g	O
).	O
Fish	O
servings	O
per	O
week	O
in	O
early	O
and	O
late	O
pregnancy	O
:	O
never	O
,	O
less	O
than	O
1	O
,	O
1	O
–	O
2	O
times	O
,	O
3	O
or	O
more	O
times	O
.	O
Oily	O
fish	O
servings	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
:	O
never	O
,	O
less	O
than	O
1	O
,	O
1	O
or	O
more	O
.	O
Amount	O
not	O
specified	O
in	O
gramsOutcomeFish	O
consumption	O
during	O
pregnancy	O
resulted	O
in	O
modest	O
but	O
significant	O
improvement	O
in	O
developmental	O
scores	O
for	O
language	O
&	O
social	O
activity	O
at	O
15	O
–	O
18	O
months	O
age	O
.	O
Odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
for	O
high	O
test	O
score	O
for	O
MCDI	O
:	O
Vocabulary	O
comprehension	O
=	O
1	O
.	O
5	O
(	O
1	O
.	O
1	O
–	O
2	O
.	O
0	O
)	O
for	O
one	O
or	O
more	O
serves	O
compared	O
to	O
no	O
serves	O
.	O
Social	O
activity	O
=	O
1	O
.	O
6	O
(	O
1	O
.	O
2	O
–	O
2	O
.	O
2	O
)	O
for	O
1	O
/	O
fortnight	O
,	O
1	O
.	O
7	O
(	O
1	O
.	O
3	O
–	O
2	O
.	O
2	O
)	O
for	O
1	O
–	O
3	O
/	O
week	O
and	O
1	O
.	O
8	O
(	O
1	O
.	O
4	O
–	O
2	O
.	O
4	O
)	O
for	O
4	O
+	O
serves	O
/	O
week	O
compared	O
to	O
no	O
serves	O
.	O
Non	O
-	O
significant	O
increase	O
in	O
VRM	O
of	O
2	O
.	O
8	O
points	O
for	O
each	O
additional	O
weekly	O
fish	O
serving	O
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
2	O
to	O
5	O
.	O
4	O
).	O

They	O
consume	O
more	O
eggs	O
,	O
dairy	O
,	O
fish	O
and	O
animal	O
liver	O
products	O
and	O
have	O
a	O
more	O
balanced	O
diet	O
,	O
based	O
on	O
dietary	O
records	O
.	O

Perceptions	O
of	O
antenatal	O
care	O
services	O
by	O
pregnant	O
women	O
attending	O
government	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
Cameroon	O
:	O
a	O
cross	O
sectional	O
study	O
Abstract	O
Introduction	O
User	O
'	O
sperception	O
of	O
quality	O
of	O
ANC	O
services	O
crucially	O
impacts	O
continuity	O
of	O
use	O
of	O
these	O
services	O
and	O
hence	B
pregnancy	O
outcome	O
.	O

Earlier	O
studies	O
have	O
also	O
shown	O
that	O
high	O
-	O
quality	O
diet	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
is	O
positively	O
associated	O
with	O
birth	O
size	O
including	O
birth	O
weight	O
and	O
birth	O
length	O
[	O
15	O
].	O

The	O
seasonal	O
differences	O
outlined	O
in	O
the	O
studies	O
above	O
could	O
be	O
attributed	O
to	O
seasonal	O
25OHD	O
,	O
or	O
evolutionary	O
circannual	O
rhythms	O
to	O
protect	O
mother	O
and	O
fetus	O
.	O

An	O
explanation	B
that	O
emerges	O
from	O
these	O
studies	O
is	O
that	O
the	O
putative	B
fetal	O
underweight	O
caused	O
by	O
maternal	O
undernutrition	O
may	O
be	O
recovered	O
in	O
few	O
days	O
of	O
normal	O
nutrition	O
,	O
as	B
was	O
previously	O
suggested	O
(	O
Cleal	O
et	O
al	O
.,	O
2007	O
;	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

Maternal	O
age	O
ranged	O
from	O
22	O
to	O
44	O
years	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
9	O
years	O
.	O

of	O
commonly	O
regulated	O
probe	O
-	O
sets	O
of	O
LP	O
and	O
AP	O
offspring	O
(	O
intersection	O
)	O
94	O
dpc	O
12	O
,	O
6507	O
,	O
9371	O
,	O
001	O
(	O
541	O
up	O
,	O
460	O
down	O
)	O
1	O
dpn	O
12	O
,	O
0059	O
,	O
0991	O
(	O
0	O
up	O
,	O
1	O
down	O
)	O
28	O
dpn	O
12	O
,	O
3078	O
,	O
250483	O
(	O
214	O
up	O
,	O
269	O
down	O
)	O
188	O
dpn	O
11	O
,	O
7848	O
,	O
9432	O
,	O
084	O
(	O
952	O
up	O
,	O
1	O
,	O
132	O
down	O
)	O
developmental	O
period	O
1	O
13	O
,	O
35710	O
,	O
2938	O
,	O
166	O
(	O
3	O
,	O
731	O
up	O
,	O
4	O
,	O
435	O
down	O
)	O
1	O
,	O
042	O
(	O
384	O
up	O
,	O
658	O
down	O
)	O
1	O
,	O
034	O
(	O
503	O
up	O
,	O
531	O
down	O
)	O
6	O
,	O
090	O
(	O
2	O
,	O
844	O
up	O
,	O
3	O
,	O
246	O
down	O
)	O
developmental	O
period	O
2	O
13	O
,	O
35910	O
,	O
3178	O
,	O
329	O
(	O
4	O
,	O
118	O
up	O
,	O
4	O
,	O
211	O
down	O
)	O
881	O
(	O
423	O
up	O
,	O
458	O
down	O
)	O
991	O
(	O
448	O
up	O
,	O
543	O
down	O
)	O
6	O
,	O
457	O
(	O
3	O
,	O
247	O
up	O
,	O
3	O
,	O
210	O
down	O
)	O
developmental	O
period	O
3	O
12	O
,	O
6378	O
,	O
8926	O
,	O
612	O
(	O
2	O
,	O
810	O
up	O
,	O
3	O
,	O
803	O
down	O
)	O
1	O
,	O
959	O
(	O
834	O
up	O
,	O
1	O
,	O
125	O
down	O
)	O
1	O
,	O
549	O
(	O
697	O
up	O
,	O
852	O
down	O
)	O
3	O
,	O
104	O
(	O
1	O
,	O
279	O
up	O
,	O
1	O
,	O
825	O
down	O
)	O
Developmental	O
period	O
1	O
indicates	O
the	O
comparisons	O
between	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
;	O
Developmental	O
period	O
2	O
indicates	O
the	O
comparisons	O
between	O
stages	O
1	O
dpc	O
and	O
28	O
dpn	O
;	O
Developmental	O
period	O
3	O
indicates	O
the	O
comparisons	O
between	O
stages	O
28	O
dpc	O
and	O
188	O
dpn	O
;	O
'	O
Up	O
'	O
indicates	O
higher	O
expression	O
values	O
of	O
later	O
stages	O
,	O
'	O
down	O
'	O
indicates	O
lower	O
expression	O
values	O
at	O
later	O
stages	O
.	O

The	O
litter	O
was	O
reduced	O
at	O
birth	O
to	O
six	O
pups	O
per	O
dam	O
(	O
1	O
∶	O
1	O
male	O
to	O
female	O
ratio	O
)	O
to	O
ensure	O
adequate	O
and	O
standardized	O
nutrition	O
until	O
weaning	O
.	O

Measured	O
the	O
odds	O
of	O
improved	O
development	O
scores	O
due	O
to	O
fish	O
intake	O
.	O

Understanding	O
the	O
extent	O
to	O
which	O
hand	O
hygiene	O
behavior	O
of	O
mothers	O
and	O
other	O
caregivers	O
needs	O
to	O
improve	O
at	O
other	O
times	O
of	O
potential	O
pathogen	O
transmission	O
would	O
support	O
the	O
development	O
of	O
feasible	B
guidance	O
on	O
handwashing	O
to	O
reduce	O
neonatal	O
infections	O
.	O

Bodnar	O
et	O
al	O
.	O

The	O
expression	O
of	O
214	O
probe	O
-	O
sets	O
was	O
increased	O
in	O
the	O
LP	O
offspring	O
compared	O
with	O
AP	O
offspring	O
.	O

Earlier	O
studies	O
have	O
also	O
shown	O
that	O
high	O
-	O
quality	O
diet	O
assessed	O
by	O
using	O
the	O
Alternate	O
Healthy	O
Eating	O
Index	O
(	O
AHEI	O
)	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
is	O
positively	O
associated	O
with	O
birth	O
size	O
including	O
birth	O
weight	O
and	O
birth	O
length	O
[	O
15	O
].	O

Supplementary	O
materialERJ	O
-	O
00073	O
-	O
2017_Supplement	O
Disclosures10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp2	O
A	O
.	O
BédardERJ	O
-	O
00073	O
-	O
2017_Bedard	O
A	O
.	O
J	O
.	O

The	O
questionnaire	O
asked	O
about	O
76	O
food	O
items	O
,	O
plus	O
use	O
of	O
vitamins	O
,	O
certain	O
reduced	O
-	O
fat	O
foods	O
,	O
and	O
cooking	O
fat	O
.	O

It	O
would	O
have	O
been	O
worthwhile	O
to	O
include	O
some	O
more	O
topics	O
such	O
as	O
management	O
of	O
severely	O
acute	O
malnutrition	O
,	O
examples	O
of	O
high	O
,	O
low	O
and	O
moderate	O
glycaemic	O
index	O
foods	O
,	O
how	O
to	O
read	O
food	O
labels	O
(	O
with	O
examples	O
),	O
etc	O
and	O
also	O
additional	O
references	O
for	O
further	O
reading	O
would	O
have	O
been	O
beneficial	O
as	O
the	O
chapters	O
are	O
a	O
quick	O
guide	O
to	O
appraise	O
the	O
topic	O
.	O

DNA	O
methylation	O
is	O
a	O
key	O
mode	O
of	O
epigenetic	O
regulation	O
,	O
which	O
can	O
lead	O
to	O
silencing	O
of	O
genomic	O
regions	O
.	O

However	O
in	O
our	O
community	O
,	O
ANC	O
user	O
'	O
s	O
perceptions	O
of	O
quality	O
are	O
not	O
known	O
.	O

There	O
may	O
be	O
some	O
self	O
-	O
selection	O
bias	O
in	O
relation	O
to	O
participating	O
grandparents	O
,	O
as	B
clearly	O
grandparents	O
who	O
were	O
deceased	O
could	O
not	O
participate	O
.	O
26In	O
previous	O
analyses	O
,	O
we	O
have	O
shown	O
that	O
the	O
original	O
index	O
mothers	O
were	O
representative	O
of	O
the	O
general	O
population	O
,	O
22and	O
our	O
findings	O
were	O
consistent	O
across	O
the	O
three	O
sweeps	O
,	O
so	O
we	O
do	O
not	O
think	O
self	O
-	O
selection	O
can	O
be	O
the	O
main	O
explanatory	B
factor	O
for	O
our	O
findings	O
.	O

Meta	O
-	O
analysis	O
[	O
8	O
]	O
and	O
prospective	O
follow	O
-	O
up	O
studies	O
indicates	O
that	O
up	O
to	O
75	O
-	O
90	O
%	O
of	O
developmental	O
psychotic	O
experiences	O
are	O
transitory	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
SAS	O
9	O
.	O
3	O
.	O

As	O
federal	O
and	O
state	O
governments	O
devote	O
attention	O
and	O
resources	O
to	O
the	O
problem	O
,	O
the	O
Report	O
Cards	O
will	O
continue	O
to	O
mobilise	O
stakeholders	O
and	O
mark	O
progress	O
.	O

Until	O
2014	O
,	O
it	O
remained	O
unknown	O
which	O
element	O
—	O
endometrial	O
or	O
egg	O
quality	O
—	O
is	O
more	O
affected	O
by	O
VD	O
deficiency	O
.	O

4	O
.	O

Overall	O
,	O
13	O
%	O
(	O
415	O
)	O
were	O
younger	O
than	O
18	O
years	O
(	O
range	O
:	O
12	O
–	O
17	O
),	O
80	O
%	O
(	O
2620	O
)	O
were	O
between	O
18	O
and	O
34	O
years	O
,	O
and	O
7	O
%	O
(	O
233	O
)	O
were	O
35	O
years	O
and	O
older	O
(	O
range	O
:	O
35	O
–	O
45	O
;	O
Table	O
1	O
).	O

Baseline	O
predictors	O
of	O
anaemia	O
,	O
after	O
adjustment	O
(	O
Table	O
4	O
),	O
included	O
older	O
age	O
OR	O
=	O
2	O
.	O
01	O
(	O
1	O
.	O
16	O
,	O
3	O
.	O
48	O
)	O
and	O
economic	O
deficit	O
OR	O
=	O
1	O
.	O
98	O
(	O
1	O
.	O
21	O
,	O
3	O
.	O
25	O
).	O

Consent	O
was	O
obtained	O
prior	O
to	O
delivery	O
.	O

The	O
diets	O
were	O
produced	O
by	O
PragSolucoes	O
(	O
Jau	O
,	O
SP	O
,	O
Brazil	O
).	O

Few	O
studies	O
of	O
school	O
eating	O
patterns	O
have	O
focused	O
on	O
kindergarten	O
and	O
early	O
elementary	O
years	O
,	O
but	O
in	O
third	O
grade	O
,	O
school	O
lunch	O
choices	O
begin	O
to	O
influence	O
children	O
'	O
s	O
overall	O
diets	O
(	O
92	O
).	O

Final	O
live	O
-	O
birth	O
rates	O
were	O
31	O
%	O
among	O
vitamin	O
D	O
-	O
deficient	O
recipients	O
,	O
compared	O
with	O
59	O
%	O
among	O
vitamin	O
D	O
-	O
replete	O
recipients	O
.	O

Recruitment	O
of	O
study	O
participants	O
takes	O
place	O
in	O
two	O
of	O
the	O
seven	O
municipal	O
regions	O
of	O
the	O
city	O
from	O
which	O
four	O
primary	O
health	O
care	O
clinics	O
were	O
identified	O
.	O

A	O
curvilinear	O
relation	O
was	O
seen	O
across	O
levels	O
of	O
maternal	O
habitual	O
nightly	O
sleep	O
duration	O
in	O
early	O
pregnancy	O
for	O
maternal	O
mean	O
-	O
1	O
hour	O
plasma	O
glucose	O
concentration	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
during	O
weeks	O
24	O
-	O
28	O
gestation	O
(	O
Figure1	O
).	O

Adipogenesis	O
in	O
beef	O
cattle	O
is	O
first	O
initiated	O
in	O
abdominal	O
(	O
visceral	O
)	O
adipocytes	O
around	O
mid	O
-	O
gestation	O
[	O
16	O
].	O

However	O
psychotic	O
-	O
like	O
experiences	O
in	O
the	O
general	O
population	O
might	O
be	O
more	O
equally	O
distributed	O
among	O
women	O
and	O
men	O
[	O
60	O
].	O

Several	O
studies	O
have	O
shown	O
that	O
restricting	O
vitamin	O
A	O
in	O
the	O
diet	O
,	O
or	O
low	O
beta	O
-	O
carotene	O
(	O
a	O
precursor	O
of	O
vitamin	O
A	O
)	O
intake	O
,	O
increases	O
body	O
fat	O
,	O
including	O
IMF	O
,	O
deposition	O
.	O

Other	O
lifestyle	O
and	O
dress	O
habits	O
were	O
not	O
evaluated	O
,	O
and	O
all	O
participants	O
were	O
observed	O
by	O
the	O
study	O
staff	O
for	O
typical	O
Western	O
-	O
style	O
US	O
clothing	O
(	O
sleeveless	O
or	O
short	O
-	O
sleeved	O
shirts	O
in	O
the	O
summer	O
,	O
jackets	O
or	O
coats	O
in	O
the	O
winter	O
).	O

Attendance	O
at	O
the	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
was	O
associated	O
with	O
reduced	O
intake	O
of	O
energy	O
(	O
kcal	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
1795	O
.	O
2	O
±	O
412	O
.	O
0	O
vs	O
.	O
1904	O
.	O
7	O
±	O
418	O
.	O
2	O
,	O
P	O
=	O
0	O
.	O
031	O
),	O
protein	O
(	O
g	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
74	O
.	O
4	O
±	O
17	O
.	O
4	O
vs	O
79	O
.	O
7	O
±	O
20	O
.	O
7	O
,	O
P	O
=	O
0	O
.	O
023	O
)	O
and	O
fat	O
(	O
g	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
69	O
.	O
9	O
±	O
19	O
.	O
7	O
vs	O
77	O
.	O
2	O
±	O
22	O
.	O
8	O
,	O
P	O
=	O
0	O
.	O
005	O
).	O

The	O
risk	O
differences	O
and	O
risk	O
ratios	O
were	O
not	O
substantively	O
altered	O
in	O
multivariate	O
analyses	O
accounting	O
for	O
baseline	O
differences	O
between	O
the	O
groups	O
with	O
respect	O
to	O
mother	O
'	O
s	O
education	O
and	O
water	O
source	O
.	O

The	O
activity	O
of	O
ATP	O
citrate	O
lyase	O
is	O
known	O
to	O
be	O
low	O
in	O
ruminants	O
[	O
87	O
];	O
thus	B
,	O
glucose	O
is	O
used	O
as	O
a	O
lipogenic	O
substrate	O
less	O
in	O
ruminants	O
than	O
in	O
monogastric	O
animals	O
[	O
87	O
].	O

But	O
,	O
adjustment	O
for	O
multivitamin	O
supplement	O
intake	O
,	O
containing	O
vitamin	O
D	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Labor	O
induction	O
and	O
augmentation	O
appear	O
to	O
be	O
an	O
area	O
of	O
association	O
.	O

The	O
strengths	O
of	O
our	O
study	O
include	O
its	O
thorough	O
diet	O
data	O
design	O
and	O
large	O
sample	O
size	O
.	O

Female	O
rats	O
were	O
not	O
used	O
in	O
these	O
experiments	O
,	O
because	O
the	O
estrous	O
cycle	O
can	O
introduce	O
variability	O
in	O
protein	O
expression	O
in	O
the	O
region	O
of	O
interest	O
[	O
20	O
],[	O
21	O
].	O

Evaluation	O
of	O
context	O
-	O
specific	O
neonatal	O
care	O
packages	O
regarding	O
outcome	O
,	O
cost	O
and	O
economic	O
results	O
is	O
important	O
,	O
including	O
adaptations	O
such	O
as	O
task	O
shifting	O
to	O
various	O
cadres	O
and	O
use	O
of	O
innovative	O
technologies	O
[	O
41	O
].	O

Studies	O
suggest	O
that	O
the	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
may	O
be	O
better	O
observed	O
during	O
high	O
influenza	O
circulation	O
period	O
,	O
and	O
there	O
was	O
a	O
substantial	O
influenza	O
circulation	O
in	O
Nicaragua	O
in	O
2014	O
[	O
20	O
],[	O
21	O
],[	O
55	O
].	O

In	O
another	O
study	O
,	O
Graugnard	O
et	O
al	O
[	O
56	O
]	O
reported	O
that	O
a	O
high	O
-	O
starch	O
diet	O
induced	O
precocious	O
upregulation	O
of	O
the	O
adipogenic	O
gene	O
network	O
in	O
the	O
longissimus	O
lumborum	O
of	O
early	O
-	O
weaned	O
(	O
average	O
155	O
d	O
)	O
Angus	O
cattle	O
.	O

In	O
addition	O
to	O
using	O
lipids	O
,	O
BAT	O
also	O
displays	O
a	O
very	O
high	O
rate	O
of	O
glucose	O
uptake	O
,	O
particularly	O
under	O
sympathetic	O
activation	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

For	O
these	O
analyses	O
,	O
we	O
classified	O
women	O
by	O
the	O
joint	O
distribution	O
of	O
pre	O
-	O
pregnancy	O
lean	O
or	O
overweight	O
status	O
(<	O
25	O
vs	O
.	O
≥	O
25	O
kg	O
/	O
m2	O
)	O
and	O
snoring	O
during	O
early	O
pregnancy	O
(	O
no	O
vs	O
.	O
yes	O
)	O
thus	O
resulting	O
in	O
the	O
following	O
categories	O
:	O
lean	O
and	O
non	O
-	O
snorer	O
(	O
the	O
reference	O
group	O
);	O
lean	O
and	O
snorer	O
;	O
overweight	O
and	O
non	O
-	O
snorer	O
;	O
and	O
overweight	O
and	O
snorer	O
.	O

This	O
complicated	O
relationship	O
is	O
well	O
described	O
in	O
some	O
recent	O
review	O
publications	O
[	O
40	O
].	O

Cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
analyzed	O
using	O
the	O
LIAISON	O
25	O
OH	O
Vitamin	O
D	O
assay	O
(	O
DiaSorin	O
Inc	O
.,	O
Stillwater	O
,	O
MN	O
,	O
USA	O
).	O

2007	O
).	O

Nevertheless	O
,	O
they	O
do	O
set	O
a	O
precedent	O
for	O
the	O
existence	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
,	O
and	O
provide	O
tools	O
for	O
linking	O
environmental	O
exposures	O
to	O
adverse	O
health	O
outcomes	O
.	O

(	O
2010	O
)*/‡	O
Only	O
studies	O
assessing	O
both	O
adverse	O
phenotypes	O
and	O
associated	O
epigenetic	O
changes	O
in	O
response	O
to	O
an	O
environmental	O
exposure	O
were	O
reviewed	O
.	O

Intervention	O
in	O
the	O
control	O
group	O
:	O
the	O
control	O
group	O
received	O
two	O
placebo	O
pills	O
composed	O
of	O
starch	O
daily	O
from	O
26	O
to	O
28	O
weeks	O
.	O

Prior	O
to	O
cortisol	O
treatment	O
,	O
both	O
cell	O
lines	O
were	O
maintained	O
for	O
3	O
hours	O
in	O
phenol	O
red	O
-	O
free	O
media	O
containing	O
charcoal	O
stripped	O
FBS	O
.	O

The	O
first	O
national	O
micronutrients	O
status	O
survey	O
,	O
published	O
in	O
early	O
2013	O
,	O
reported	O
that	O
iron	O
deficiency	O
among	O
non	O
-	O
pregnant	O
non	O
-	O
lactating	O
women	O
was	O
7	O
.	O
1	O
%.	O

In	O
that	O
reaction	O
,	O
the	O
cutaneous	O
precursor	O
of	O
Vitamin	O
D	O
,	O
7	O
-	O
dehydrocholesterol	O
undergoes	O
photochemical	O
cleavage	O
of	O
the	O
carbon	O
bond	O
between	O
carbons	O
9	O
and	O
10	O
of	O
the	O
steroid	O
ring	O
to	O
become	O
active	O
Vitamin	O
D3	O
.	O

Linoleic	O
acid	O
is	O
the	O
parent	O
fatty	O
acid	O
of	O
the	O
omega	O
-	O
6	O
family	O
,	O
and	O
the	O
main	O
source	O
in	O
a	O
typical	O
Swedish	O
diet	O
is	O
vegetable	O
oil	O
(	O
such	O
as	O
corn	O
oil	O
,	O
sunflower	O
oil	O
,	O
soy	O
oil	O
,	O
rapeseed	O
oil	O
and	O
margarine	O
).	O

Regression	O
analysis	O
After	O
adjusting	O
for	O
risk	O
factors	O
,	O
we	O
did	O
not	O
find	O
an	O
association	O
between	O
receiving	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
with	O
either	O
of	O
the	O
two	O
different	O
analytical	O
approaches	O
.	O

To	O
date	O
,	O
small	O
short	O
-	O
term	O
studies	O
focusing	O
on	O
dietary	O
counseling	O
alone	O
,	O
or	O
a	O
combination	O
of	O
behavioral	O
strategies	O
with	O
weekly	O
exercise	O
classes	O
,	O
have	O
not	O
demonstrated	O
an	O
improvement	O
in	O
glucose	O
tolerance	O
.	O
88	O
,	O
89In	O
part	O
,	O
this	O
is	O
probably	B
due	O
to	O
the	O
real	O
life	O
challenges	O
of	O
maintaining	O
motivation	O
for	O
healthy	O
lifestyle	O
change	O
amongst	O
young	O
women	O
at	O
a	O
time	O
that	O
they	O
are	O
having	O
to	O
deal	O
with	O
young	O
children	O
,	O
return	O
to	O
work	O
,	O
and	O
further	O
education	O
.	O

Thus	O
,	O
recommendations	O
for	O
vitamin	O
D	O
supplementation	O
to	O
improve	O
glucose	O
homeostasis	O
in	O
pregnancy	O
cannot	O
be	O
made	O
based	B
on	I
our	O
results	O
.	O

Risk	O
Factors	O
Related	O
To	O
Season	O
of	O
Birth	O
The	O
underlying	O
rationale	O
for	O
the	O
occurrence	O
of	O
a	O
glioma	O
decades	O
after	O
a	O
seasonal	O
exposure	O
remains	O
elusive	O
.	O

In	O
mice	O
with	O
VD	O
1	O
-	O
α	O
-	O
hydroxylase	O
[	O
1α	O
(	O
OH	O
)	O
ase	O
(−/−)]	O
deletion	O
,	O
serious	O
fertility	O
abnormalities	O
were	O
reversed	O
with	O
diet	O
modification	O
without	O
VD	O
supplementation	O
.	O

If	O
these	O
findings	O
are	O
replicated	O
we	O
would	O
design	O
an	O
appropriate	O
intervention	O
study	O
in	O
pregnancy	O
to	O
establish	O
or	O
refute	O
causality	O
.	O

A	O
previous	O
study	O
has	O
shown	O
that	O
a	O
poor	O
distribution	O
system	O
and	O
irregular	O
availability	O
were	O
the	O
most	O
significant	O
environmental	O
risk	O
factors	O
for	O
taking	O
iron	O
supplementation	O
continuously	O
[	O
19	O
].	O

Written	O
informed	O
consent	O
was	O
obtained	O
for	O
participation	O
from	O
all	O
subjects	O
for	O
themselves	O
and	O
their	O
children	O
.	O

We	O
calculated	O
the	O
average	O
daily	O
intake	O
of	O
vitamin	O
D	O
from	O
supplementation	O
during	O
the	O
last	O
two	O
months	O
of	O
pregnancy	O
.	O

Only	O
the	O
HFol	O
pup	O
diet	O
lowered	O
SeroR2A	O
expression	O
compared	O
to	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
RV	O
pup	O
diet	O
(	O
P	O
=	O
0	O
.	O
008	O
)	O
(	O
Figure	O
5b	O
).	O

Due	O
to	O
heterogeneity	O
in	O
methodology	O
and	O
measured	O
outcomes	O
,	O
a	O
qualitative	O
comparison	O
of	O
study	O
findings	O
was	O
conducted	O
.	O

recently	O
reported	O
that	O
2	O
-	O
3	O
weekly	O
servings	O
of	O
fatty	O
fish	O
increased	O
25	O
(	O
OH	O
)	O
D	O
by	O
45	O
%	O
in	O
a	O
population	O
of	O
Swedish	O
women	O
[	O
35	O
].	O

Table	O
4presents	O
results	O
of	O
unadjusted	O
and	O
adjusted	O
versions	O
of	O
the	O
second	O
set	O
of	O
GEE	O
models	O
.	O

Participants	O
were	O
dichotomised	O
into	O
the	O
season	O
during	O
which	O
the	O
first	O
antenatal	O
visit	O
took	O
place	O
;	O
extended	O
summer	O
(	O
May	O
–	O
October	O
)	O
or	O
extended	O
winter	O
(	O
November	O
–	O
April	O
).	O

For	O
instance	O
,	O
it	O
has	O
been	O
proposed	O
that	O
aberration	O
in	O
metabolism	O
of	O
phospholipids	O
could	O
be	O
a	O
biochemical	O
basis	O
for	O
psychiatric	O
disorders	O
[	O
13	O
].	O

Improved	O
metrics	O
are	O
critical	O
for	O
both	O
burden	O
and	O
tracking	O
programmatic	O
change	O
.	O

Pb	O
,	O
while	O
not	O
conventionally	O
considered	O
an	O
EDC	O
,	O
is	O
a	O
widespread	O
reproductive	O
[	O
38	O
]	O
toxin	O
that	O
impacts	O
neurodevelopment	O
[	O
6	O
]	O
and	O
birth	O
weight	O
at	O
very	O
low	O
exposure	O
levels	O
[	O
39	O
]	O
and	O
so	O
is	O
included	O
in	O
this	O
study	O
.	O

However	O
,	O
attitudes	O
are	O
changing	O
towards	O
the	O
“	O
minimum	O
of	O
4	O
visits	O
”	O
recommended	O
by	O
the	O
WHO	O
after	O
the	O
work	O
of	O
Nigenda	O
et	O
al	O
[	O
21	O
]	O
and	O
Langer	O
et	O
al	O
.	O

Design	O
Descriptive	O
cohort	O
study	O
using	O
a	O
prospectively	O
collected	O
database	O
.	O

Average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
from	O
September	O
2005	O
to	O
September	O
2008	O
were	O
obtained	O
from	O
the	O
Australian	O
Government	O
Bureau	O
of	O
Meteorology	O
and	O
compared	O
against	O
serum	O
vitamin	O
D	O
measured	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Fig	O
.	O

The	O
present	O
study	O
achieved	O
a	O
greater	O
improvement	O
in	O
haemoglobin	O
concentration	O
and	O
a	O
greater	O
decline	O
in	O
the	O
prevalence	O
of	O
anaemia	O
compared	O
to	O
these	O
previous	O
reports	O
.	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

randomized	O
clinical	O
trials	O
[	O
12	O
,	O
14	O
,	O
15	O
]	O
as	O
well	O
as	O
epidemiological	O
studies	O
[	O
4	O
–	O
10	O
].	O

Data	O
will	O
be	O
analysed	O
cross	O
-	O
sectionally	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
each	O
time	O
point	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

Antibiotic	O
Resistance	O
Seen	O
in	O
Arctic	O
Wildfowl	O
Swedish	O
researchers	O
reported	O
in	O
the	O
January	O
2008	O
issue	O
of	O
Emerging	O
Infectious	O
Diseases	O
that	O
birds	O
living	O
in	O
three	O
different	O
geographic	O
regions	O
of	O
the	O
Arctic	O
tundra	O
carry	O
E	O
.	O
coli	O
bacteria	O
resistant	O
to	O
multiple	O
types	O
of	O
antibiotics	O
.	O

It	O
is	O
likely	B
that	O
visfatin	O
can	O
be	O
used	O
in	O
the	O
future	O
as	O
a	O
biomarker	O
predicting	O
fetal	O
and	O
neonatal	O
growth	O
.	O

Moreover	O
,	O
long	O
-	O
lasting	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
components	O
of	O
the	O
ECS	O
,	O
which	O
modulates	O
appetite	O
and	O
energy	O
homeostasis	O
,	O
and	O
other	O
key	O
enzymes	O
and	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
,	O
were	O
found	O
in	O
metabolically	O
relevant	O
tissues	O
(	O
liver	O
and	O
PAT	O
)	O
of	O
adult	O
offspring	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

Thus	O
,	O
to	O
formulate	O
the	O
10	O
-	O
fold	O
HFol	O
diet	O
,	O
we	O
added	O
18	O
mg	O
of	O
folate	O
to	O
make	O
a	O
total	O
of	O
20	O
mg	O
/	O
kg	O
.	O

Interpretation	O
of	O
the	O
current	O
study	O
is	O
also	O
limited	O
because	O
of	O
the	O
lack	O
of	O
immunoblot	O
confirmation	O
of	O
the	O
differentially	O
expressed	O
spots	O
.	O

The	O
same	O
infectious	O
agent	O
may	O
present	O
a	O
different	O
pattern	O
of	O
incidence	O
depending	O
on	O
the	O
host	O
location	O
.	O

Among	O
these	O
women	O
,	O
one	O
(	O
10	O
%)	O
had	O
25OHD	O
concentration	O
<	O
30	O
nmol	O
/	O
L	O
in	O
T1	O
.	O

Imprinted	O
genes	O
are	O
generally	O
widely	O
and	O
highly	O
expressed	O
during	O
prenatal	O
development	O
and	O
predominantly	O
down	O
-	O
regulated	O
after	O
birth	O
.	O

Although	O
this	O
association	O
became	O
significant	O
even	O
after	O
taking	O
potential	O
confounders	O
into	O
account	O
in	O
model	O
1	O
[	O
OR	O
0	O
.	O
80	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
34	O
-	O
1	O
.	O
93	O
),	O
P	O
<	O
0	O
.	O
01	O
],	O
such	O
association	O
was	O
not	O
seen	O
in	O
models	O
2	O
and	O
3	O
.	O

In	O
these	O
models	O
,	O
we	O
examined	O
the	O
effects	O
of	O
text4baby	O
participation	O
(	O
treatment	O
condition	O
)	O
on	O
postpartum	O
KAB	O
and	O
behavioral	O
outcomes	O
targeted	O
by	O
the	O
text	O
messages	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
ml	O
),	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Importantly	O
,	O
we	O
also	O
found	O
that	O
less	O
well	O
-	O
educated	O
women	O
who	O
engaged	O
with	O
prenatal	O
care	O
were	O
more	O
likely	B
to	O
take	O
folic	O
acid	O
.	O

In	O
three	O
different	O
moments	O
of	O
post	O
-	O
natal	O
life	O
(	O
birth	O
,	O
10	O
-	O
days	O
and	O
3	O
months	O
of	O
age	O
),	O
BM	O
was	O
not	O
affected	O
by	O
the	O
maternal	O
diet	O
restricted	O
in	O
vitamin	O
D	O
.	O
At	O
weaning	O
and	O
at	O
six	O
months	O
of	O
age	O
,	O
the	O
VitD	O
-	O
offspring	O
were	O
heavier	O
than	O
the	O
SC	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

“	O
Maintaining	O
a	O
high	O
iron	O
environment	O
in	O
the	O
intestine	O
by	O
ingesting	O
significantly	O
more	O
iron	O
than	O
needed	O
every	O
day	O
overwhelms	O
this	O
safety	O
system	O
,”	O
says	O
coauthor	O
Fernando	O
E	O
.	O
Viteri	O
.	O

Proportion	O
(%)	O
of	O
women	O
with	O
1	O
-	O
hour	O
glucose	O
concentrations	O
≥	O
140	O
mg	O
/	O
dl	O
(	O
b	O
).	O

Newborn	O
birth	O
size	O
was	O
investigated	O
in	O
categories	O
of	O
maternal	O
prepregnancy	O
BMI	O
(	O
underweight	O
,	O
normal	O
weight	O
,	O
overweight	O
,	O
obese	O
),	O
GWG	O
(	O
inadequate	O
,	O
adequate	O
,	O
excessive	O
),	O
prepregnancy	O
smoking	O
status	O
(	O
yes	O
,	O
no	O
),	O
maternal	O
education	O
(	O
higher	O
,	O
lower	O
),	O
parity	O
(	O
nullipara	O
,	O
secundipara	O
,	O
multipara	O
),	O
GDM	O
status	O
(	O
yes	O
,	O
no	O
),	O
vitamin	O
D	O
status	O
(	O
suboptimal	O
,	O
optimal	O
)	O
in	O
pregnancy	O
and	O
in	O
UCB	O
,	O
with	O
ANCOVA	O
with	O
Bonferroni	O
correction	O
when	O
applicable	O
,	O
and	O
adjusted	O
for	O
maternal	O
height	O
.	O

Materials	O
and	O
methods	O
The	O
planned	O
implementation	O
consisted	O
of	O
a	O
9	O
-	O
month	O
pre	O
(	O
usual	O
care	O
)/	O
post	O
(	O
new	O
model	O
of	O
care	O
)	O
design	O
with	O
a	O
month	O
for	O
‘	O
integration	O
’	O
across	O
2012	O
-	O
2013	O
.	O

Identified	O
Major	O
Dietary	O
Patterns	O
Three	O
major	O
dietary	O
patterns	O
were	O
identified	O
according	O
to	O
the	O
results	O
obtained	O
from	O
the	O
factor	O
loading	O
matrix	O
(	O
Table	O
2	O
):	O
(	O
i	O
)	O
“	O
western	O
dietary	O
pattern	O
”	O
which	O
was	O
greatly	O
loaded	O
by	O
processed	O
meats	O
,	O
fruit	O
,	O
fruit	O
juice	O
,	O
citrus	O
,	O
nuts	O
,	O
fish	O
,	O
desserts	O
and	O
sweets	O
,	O
sugar	O
,	O
saturated	O
fat	O
,	O
sweat	O
fruit	O
,	O
potato	O
,	O
legumes	O
,	O
coffee	O
,	O
egg	O
,	O
pizza	O
,	O
high	O
fat	O
dairy	O
,	O
whole	O
grain	O
,	O
and	O
soft	O
drink	O
;	O
(	O
ii	O
)	O
“	O
traditional	O
dietary	O
pattern	O
”	O
which	O
was	O
high	O
in	O
refined	O
grains	O
,	O
colored	O
vegetables	O
,	O
olive	O
,	O
sugar	O
,	O
salt	O
,	O
spices	O
,	O
unsaturated	O
fat	O
,	O
garlic	O
,	O
onion	O
,	O
and	O
tea	O
;	O
(	O
iii	O
)	O
“	O
healthy	O
dietary	O
pattern	O
”	O
which	O
was	O
high	O
in	O
green	O
vegetables	O
,	O
leafy	O
vegetable	O
,	O
colored	O
vegetables	O
,	O
fruit	O
,	O
low	O
-	O
fat	O
dairy	O
,	O
poultry	O
,	O
bulky	O
vegetables	O
,	O
red	O
meat	O
,	O
citrus	O
,	O
nuts	O
,	O
fish	O
,	O
evil	O
,	O
marinades	O
,	O
sweat	O
fruit	O
,	O
egg	O
,	O
and	O
unsaturated	O
fat	O
.	O

The	O
study	O
had	O
significant	O
selection	O
and	O
recall	O
biases	O
.	O

Concerns	O
have	O
been	O
expressed	O
about	O
the	O
use	O
of	O
glargine	O
in	O
pregnancy	O
,	O
because	O
of	O
its	O
potential	O
effect	O
on	O
mitogenesis	O
,	O
mediated	O
by	O
its	O
high	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
,	O
which	O
is	O
six	O
times	O
that	O
of	O
natural	O
insulin48	O
,	O
49Whilst	O
insulin	O
detemir	O
has	O
a	O
lower	O
binding	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
than	O
natural	O
insulin	O
,	O
there	O
is	O
even	O
less	O
information	O
regarding	O
its	O
use	O
in	O
pregnancy	O
.	O

Between	O
-	O
group	O
comparisons	O
were	O
made	O
using	O
t	O
or	O
Wilcoxon	O
tests	O
,	O
and	O
within	O
-	O
group	O
comparisons	O
were	O
made	O
using	O
paired	O
t	O
-	O
test	O
or	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
.	O

Based	O
on	O
the	O
hypothesis	O
under	O
study	O
we	O
interpreted	O
the	O
RR	O
<	O
1	O
as	O
a	O
negative	O
association	O
(	O
for	O
simplicity	O
we	O
refer	O
to	O
it	O
from	O
now	O
on	O
"	O
decreased	O
risk	O
")	O
and	O
RR	O
>	O
1	O
as	O
a	O
positive	O
association	O
(	O
for	O
simplicity	O
we	O
refer	O
to	O
it	O
from	O
now	O
on	O
as	O
"	O
increased	O
risk	O
").	O

Between	O
October	O
2010	O
and	O
October	O
2011	O
,	O
data	O
collectors	O
approached	O
primiparous	O
women	O
identified	O
in	O
the	O
study	O
area	O
through	O
the	O
HDSS	O
pregnancy	O
database	O
with	O
a	O
due	O
date	O
between	O
December	O
1	O
,	O
2010	O
,	O
and	O
December	O
1	O
,	O
2011	O
.	O

Our	O
results	O
indicates	O
that	O
25OHD	O
at	O
T3	O
but	O
not	O
at	O
T1	O
is	O
associated	O
with	O
SGA	O
and	O
LBW	O
,	O
despite	O
better	O
statistical	O
power	O
at	O
T1	O
due	O
to	O
more	O
25OHD	O
samples	O
and	O
subsequently	O
more	O
cases	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
birth	O
.	O

It	O
could	O
be	O
hypothesised	O
that	O
increased	O
insulin	O
resistance	O
during	O
winter	O
pregnancies	O
is	O
an	O
evolutionary	O
protective	O
mechanism	O
for	O
the	O
mother	O
and	O
fetus	O
,	O
of	O
laying	O
down	O
additional	O
fat	O
stores	O
to	O
ensure	O
survival	O
through	O
winter	O
.	O

We	O
used	O
linear	O
regression	O
to	O
determine	O
the	O
association	O
between	O
methylation	O
of	O
LINE	O
-	O
1	O
or	O
AluYb8	O
and	O
the	O
aggregate	O
methylation	O
values	O
for	O
each	O
of	O
the	O
16	O
methylation	O
classes	O
determined	O
by	O
RPMM	O
and	O
the	O
41	O
bioinformatic	O
classes	O
.	O

The	O
1949	O
discovery	O
of	O
DDT	O
in	O
breast	O
milk	O
was	O
an	O
early	O
glimpse	O
into	O
the	O
understanding	O
that	O
a	O
mother	O
’	O
s	O
environmental	O
exposures	O
may	O
also	O
affect	O
her	O
baby	O
.	O

Compared	O
to	O
that	O
,	O
the	O
reductions	O
in	O
neonatal	O
deaths	O
have	O
been	O
slower	O
.	O

This	O
fact	O
might	O
be	O
a	O
consequence	B
of	O
the	O
inadequate	O
fetal	O
programming	O
of	O
metabolic	O
systems	O
involved	O
in	O
energy	O
homeostasis	O
(	O
Hales	O
and	O
Barker	O
,	O
2001	O
;	O
Vaag	O
et	O
al	O
.,	O
2012	O
).	O

2001	O
).	O

Secondary	O
analyses	O
will	O
examine	O
each	O
outcome	O
variable	O
using	O
separate	O
mixed	O
models	O
.	O

Children	O
with	O
autism	O
had	O
significantly	O
lower	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
than	O
healthy	O
children	O
.	O

The	O
main	O
objectives	O
in	O
clinical	O
monitoring	O
of	O
pregnant	O
thyroid	O
cancer	O
patients	O
are	O
:	O
1	O
)	O
to	O
reach	O
an	O
adequate	O
balance	O
of	O
maternal	O
calcium	O
and	O
thyroid	O
hormones	O
that	O
is	O
absolutely	O
required	O
by	O
the	O
foetal	O
central	O
nervous	O
system	O
for	O
normal	O
maturation	O
;	O
2	O
)	O
to	O
maintain	O
optimal	O
levels	O
of	O
maternal	O
thyroxin	O
to	O
avoid	O
possible	O
recurrence	O
or	O
spread	O
of	O
disease	O
;	O
and	O
3	O
)	O
to	O
perform	O
safe	O
follow	O
-	O
up	O
visits	O
for	O
the	O
mother	O
and	O
to	O
plan	O
further	O
therapy	O
when	O
needed	O
.	O

The	O
use	O
of	O
folic	O
acid	O
was	O
independently	O
associated	O
with	O
a	O
higher	O
level	O
of	O
formal	O
education	O
(	O
aOR	O
,	O
5	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
1	O
-	O
12	O
.	O
8	O
)	O
and	O
an	O
early	O
start	O
in	O
prenatal	O
care	O
(	O
aOR	O
,	O
3	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
11	O
.	O
1	O
).	O

A	O
study	O
of	O
pregnant	O
women	O
in	O
the	O
rural	O
central	O
highlands	O
in	O
2001	O
identified	O
anaemia	O
prevalence	O
in	O
pregnant	O
women	O
,	O
post	O
-	O
partum	O
women	O
and	O
non	O
-	O
pregnant	O
women	O
of	O
53	O
%,	O
62	O
%	O
and	O
54	O
%	O
respectively	O
[	O
11	O
].	O

Together	O
with	O
the	O
observation	O
that	O
the	O
offspring	O
of	O
both	O
groups	O
did	O
not	O
differ	O
in	O
bodyweight	O
but	O
in	O
body	O
composition	O
and	O
fat	O
content	O
[	O
17	O
],	O
the	O
data	O
indicate	O
that	O
the	O
activity	O
of	O
different	O
genes	O
led	O
to	O
different	O
partitioning	O
of	O
nutrients	O
among	O
peripheral	O
and	O
visceral	O
organs	O
and	O
tissues	O
.	O

OTUs	O
classified	O
to	O
the	O
genus	O
Enterococcus	O
(	O
one	O
q	O
value	O
<	O
0	O
.	O
10	O
)	O
and	O
the	O
Lachnospiraceae	O
family	O
were	O
positively	O
related	O
with	O
and	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
,	O
the	O
species	O
Escherichia	O
coli	O
and	O
the	O
genera	O
Streptococcus	O
and	O
Blautia	O
,	O
were	O
negatively	O
related	O
with	O
the	O
maternal	O
aMED	O
score	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5a	O
).	O

In	O
addition	O
,	O
studies	O
within	O
categories	O
1	O
and	O
2	O
may	O
also	O
enable	O
identification	O
of	O
markers	O
and	O
/	O
or	O
mechanisms	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
through	O
a	O
weight	O
of	O
evidence	O
approach	O
(	O
e	O
.	O
g	O
.	O

One	O
paediatric	O
trial	O
showed	O
16	O
%	O
higher	O
rates	O
of	O
tuberculosis	O
symptom	O
resolution	O
,	O
29an	O
adult	O
trial	O
showed	O
23	O
%	O
greater	O
sputum	O
conversion	O
rate	O
at	O
6	O
months	O
,	O
30another	O
trial	O
showed	O
20	O
%	O
greater	O
restriction	O
of	O
BCG	O
-	O
lux	O
growth	O
in	O
blood	O
,	O
31another	O
trial	O
found	O
accelerated	O
sputum	O
conversion	O
only	O
in	O
a	O
certain	O
genotype	O
of	O
the	O
sample	O
,	O
20whereas	O
yet	O
another	O
found	O
no	O
significant	O
difference	O
in	O
sputum	O
conversion32in	O
the	O
intervention	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Inclusion	O
Criteria	O
Studies	O
were	O
included	O
only	O
if	O
the	O
target	O
population	O
,	O
outcome	O
and	O
exposures	O
of	O
interest	O
were	O
clearly	O
defined	O
and	O
results	O
were	O
based	O
on	O
valid	O
statistical	O
methodology	O
with	O
evaluation	O
of	O
errors	O
and	O
discussion	O
of	O
study	O
bias	O
.	O

AluYb8	O
levels	O
were	O
found	O
to	O
marginally	O
differ	O
by	O
infant	O
sex	O
,	O
which	O
is	O
consistent	O
with	O
the	O
previous	O
literature	O
in	O
that	O
repetitive	O
element	O
methylation	O
markers	O
in	O
blood	O
may	O
vary	O
by	O
sex	O
(	O
Cash	O
et	O
al	O
.	O

In	O
addition	O
to	O
an	O
unadjusted	O
model	O
,	O
which	O
strictly	O
looked	O
at	O
the	O
effect	O
of	O
the	O
intervention	O
on	O
those	O
who	O
completed	O
baseline	O
and	O
at	O
least	O
1	O
follow	O
-	O
up	O
interview	O
(	O
n	O
=	O
459	O
),	O
a	O
second	O
adjusted	O
model	O
included	O
several	O
maternal	O
covariates	O
:	O
age	O
quintile	O
,	O
parity	O
,	O
marital	O
status	O
,	O
and	O
race	O
.	O

We	O
will	O
exclude	O
areas	O
where	O
access	O
is	O
extremely	O
difficult	O
,	O
for	O
example	O
in	O
flood	O
-	O
prone	O
areas	O
.	O

Infancy	O
and	O
Early	O
Childhood	O
Taste	O
acquisition	O
and	O
preference	O
The	O
biological	O
substrate	O
that	O
underlies	O
the	O
taste	O
and	O
rewarding	O
properties	O
of	O
foods	O
is	O
relevant	O
because	B
the	O
best	O
predictor	O
of	O
food	O
preference	O
is	O
whether	O
a	O
child	O
likes	O
the	O
taste	O
(	O
23	O
).	O

A	O
molecular	O
study	O
revealed	O
that	O
early	O
weaning	O
and	O
a	O
high	O
-	O
starch	O
diet	O
activated	O
precocious	O
pre	O
-	O
adipocyte	O
differentiation	O
and	O
fat	O
accumulation	O
by	O
activating	O
adipogenic	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
(	O
PPARG	O
)	O
and	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
α	O
pathways	O
.	O

In	O
Indonesia	O
,	O
the	O
haemoglobin	O
concentration	O
of	O
adolescent	O
girls	O
improved	O
on	O
supplementation	O
with	O
combinations	O
of	O
iron	O
,	O
folic	O
acid	O
,	O
retinol	O
and	O
vitamin	O
C	O
,	O
over	O
placebo	O
but	O
did	O
not	O
respond	O
better	O
to	O
daily	O
rather	O
that	O
weekly	O
supplementation	O
,	O
although	O
serum	O
ferritin	O
increased	O
more	O
in	O
the	O
daily	O
supplemented	O
group	O
(	O
Angeles	O
-	O
Agdeppa	O
et	O
al	O
1997	O
).	O

Both	O
these	O
prospective	O
studies	O
had	O
relatively	O
few	O
cases	O
of	O
pregnancy	O
loss	O
and	O
may	O
therefore	B
have	O
been	O
insufficiently	O
powered	O
to	O
study	O
this	O
association	O
.	O

For	O
the	O
N363S	O
polymorphism	O
,	O
specific	O
PCR	O
primers	O
were	O
used	O
:	O
5	O
′-	O
AGTACCTCTGGAGGACA	O
G	O
AT	O
-	O
3	O
′	O
and	O
5	O
′-	O
GTCCATTCTTAAGAAACAGG	O
-	O
3	O
′	O
under	O
the	O
same	O
PCR	O
conditions	O
.	O

A	O
study	O
of	O
266	O
cases	O
and	O
matched	O
controls	O
among	O
Navajo	O
births	O
over	O
18	O
years	O
suggested	O
that	O
children	O
of	O
women	O
who	O
lived	O
near	O
abandoned	O
uranium	O
sites	O
were	O
1	O
.	O
83	O
times	O
more	O
likely	B
to	O
have	O
1	O
of	O
33	O
selected	O
defects	O
.	O

Written	O
informed	O
consent	O
is	O
again	O
obtained	O
before	O
infant	O
assessments	O
at	O
6	O
weeks	O
postnatally	O
.	O

We	O
controlled	O
for	O
intervention	O
grouping	O
in	O
the	O
multiple	O
linear	O
regression	O
models	O
.	O

Then	O
,	O
41	O
eligible	O
pregnant	O
women	O
in	O
their	O
first	O
trimester	O
were	O
selected	O
through	O
convenience	O
sampling	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
associations	O
of	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
with	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
versus	O
paternal	O
intake	O
after	O
pregnancyFree	O
sugar	O
intakep	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
n	O
=	O
3063	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
04	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
55	O
)	O
1	O
.	O
33	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
82	O
)	O
1	O
.	O
64	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
37	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
004	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
02	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
36	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
53	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
79	O
)	O
1	O
.	O
61	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
33	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
22	O
)	O
0	O
.	O
005	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
12	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
73	O
)	O
1	O
.	O
36	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
86	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
68	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
22	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
10	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
30	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
Atopic	O
asthma	O
n	O
=	O
2830	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
11	O
(	O
1	O
.	O
26	O
–	O
3	O
.	O
52	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
66	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
82	O
(	O
1	O
.	O
60	O
–	O
4	O
.	O
96	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
01	O
–	O
4	O
.	O
00	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
36	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
13	O
(	O
1	O
.	O
27	O
–	O
3	O
.	O
57	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
65	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
80	O
(	O
1	O
.	O
58	O
–	O
4	O
.	O
94	O
)	O
1	O
.	O
96	O
(	O
0	O
.	O
98	O
–	O
3	O
.	O
93	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
35	O
)	O
0	O
.	O
04	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
60	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
26	O
(	O
0	O
.	O
75	O
–	O
2	O
.	O
11	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
87	O
–	O
2	O
.	O
48	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
48	O
–	O
1	O
.	O
77	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
21	O
)	O
0	O
.	O
55	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
96	O
(	O
0	O
.	O
59	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
73	O
–	O
2	O
.	O
06	O
)	O
1	O
.	O
39	O
(	O
0	O
.	O
82	O
–	O
2	O
.	O
35	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
45	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
19	O
)	O
0	O
.	O
72	O
#:	O
controlling	O
only	O
for	O
previously	O
mentioned	O
potential	O
confounders	O
;¶:	O
mutually	O
adjusting	O
for	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
in	O
addition	O
to	O
previously	O
mentioned	O
potential	O
confounders	O
When	O
we	O
analysed	O
the	O
association	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
the	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
,	O
we	O
observed	O
a	O
stronger	O
association	O
for	O
children	O
with	O
two	O
or	O
more	O
positive	O
reactions	O
(	O
table	O
5	O
).	O

Here	O
,	O
the	O
perception	O
of	O
the	O
past	O
users	O
is	O
the	O
only	O
driving	O
tool	O
to	O
refer	O
.	O

Since	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
is	O
determined	O
by	O
preexisting	O
body	O
iron	O
stores	O
,	O
among	O
other	O
factors	O
,	O
we	O
recommend	O
that	O
the	O
mass	O
fortification	O
programme	O
should	O
be	O
located	O
and	O
implemented	O
within	O
the	O
context	O
of	O
reproductive	O
health	O
services	O
.	O

The	O
authors	O
of	O
the	O
study	O
suggest	O
a	O
direct	O
effect	O
of	O
vitamin	O
D	O
on	O
AMH	O
production	O
,	O
and	O
thus	B
longer	O
maintenance	O
of	O
ovarian	O
reserve	O
in	O
the	O
patients	O
with	O
its	O
higher	O
concentration	O
[	O
46	O
].	O

White	O
mothers	O
were	O
found	O
to	O
have	O
a	O
significantly	O
higher	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
45	O
.	O
8	O
ng	O
/	O
mL	O
;	O
114	O
.	O
5	O
nmol	O
/	O
L	O
)	O
than	O
both	O
Black	O
(	O
34	O
.	O
8	O
ng	O
/	O
mL	O
;	O
87	O
.	O
0	O
nmol	O
/	O
L	O
)	O
and	O
Hispanic	O
mothers	O
(	O
38	O
.	O
0	O
ng	O
/	O
mL	O
;	O
95	O
.	O
0	O
nmol	O
/	O
L	O
)	O
throughout	O
pregnancy	O
(	O
p	O
≤	O
0	O
.	O
0001	O
and	O
≤	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

The	O
two	O
groups	O
did	O
not	O
statistically	O
differ	O
with	O
respect	O
to	O
the	O
proportion	O
of	O
deliveries	O
requiring	O
the	O
use	O
of	O
either	O
a	O
vacuum	O
or	O
forceps	O
,	O
or	O
the	O
rate	O
of	O
fetal	O
distress	O
reported	O
during	O
labour	O
.	O

Thirty	O
-	O
eight	O
percent	O
were	O
over	O
35	O
yrs	O
.	O

Furthermore	O
,	O
our	O
findings	O
of	O
a	O
more	O
pronounced	O
protective	O
effect	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
than	O
for	O
omega	O
-	O
3	O
fatty	O
acid	O
are	O
in	O
agreement	O
with	O
the	O
results	O
from	O
an	O
EPA	O
supplementation	O
study	O
in	O
schizophrenia	O
presented	O
by	O
Horrobins	O
et	O
al	O
.	O

Almost	O
all	O
participants	O
were	O
found	O
to	O
have	O
water	O
,	O
but	O
just	O
15	O
(	O
12	O
%)	O
in	O
each	O
arm	O
were	O
observed	O
to	O
have	O
bar	O
soap	O
at	O
the	O
main	O
handwashing	O
station	O
;	O
other	O
types	O
of	O
soap	O
were	O
rarely	O
observed	O
.	O

Pregnancy	O
data	O
are	O
collected	O
at	O
the	O
antenatal	O
care	O
(	O
ANC	O
)	O
clinic	O
of	O
RMMCH	O
in	O
addition	O
to	O
routine	O
care	O
.	O

Building	O
the	O
platform	O
to	O
accelerate	O
research	O
Underlying	O
this	O
entire	O
research	O
agenda	O
is	O
the	O
development	O
and	O
implementation	O
of	O
the	O
capacity	O
to	O
advance	O
the	O
science	O
of	O
prevention	O
of	O
preterm	O
birth	O
,	O
manage	O
preterm	O
labour	O
and	O
improve	O
care	O
of	O
premature	O
babies	O
.	O

Further	O
adjustment	O
for	O
race	O
in	O
lean	O
women	O
attenuated	O
the	O
odds	O
ratio	O
in	O
the	O
first	O
trimester	O
(	O
OR	O
1	O
.	O
8	O
,	O
95	O
%	O
CI	O
1	O
.	O
0	O
,	O
3	O
.	O
0	O
).	O

This	O
is	O
achieved	O
through	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
.	O

Hibbeln	O
et	O
al	O
.	O

The	O
PRISMA	O
statement	O
process	O
was	O
followed	O
[	O
17	O
]	O
as	O
shown	O
inFigure	O
1	O
.	O

Results	O
56	O
%	O
of	O
black	O
and	O
86	O
%	O
of	O
white	O
women	O
reported	O
pre	O
-	O
and	O
/	O
or	O
post	O
-	O
conceptional	O
PNV	O
use	O
.	O

Imputation	O
of	O
missing	O
values	O
for	O
GWG	O
at	O
12	O
gestational	O
weeks	O
was	O
conducted	O
using	O
a	O
mean	O
value	O
of	O
two	O
consecutive	O
measurements	O
(	O
n	O
=	O
12	O
).	O

The	O
GRS	O
score	O
ranged	O
from	O
0	O
to	O
4	O
,	O
with	O
a	O
score	O
of	O
0	O
representing	O
no	O
risk	O
alleles	O
.	O

The	O
outcome	O
in	O
each	O
model	O
was	O
the	O
infant	O
gut	O
microbiome	O
cluster	O
membership	O
;	O
cluster	O
1	O
was	O
used	O
as	O
the	O
reference	O
in	O
all	O
models	O
.	O

Maternal	O
handwashing	O
with	O
soap	O
may	O
prevent	O
neonatal	O
sepsis	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipogenesis	O
(	O
Chrebp	O
,	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
),	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
/	O
b	O
,	O
Acox1	O
),	O
cholesterol	O
metabolism	O
(	O
Srebf1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
),	O
and	O
thermogenesis	O
/	O
mitochondria	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
in	O
the	O
liver	O
(	O
A	O
,	O
B	O
)	O
and	O
/	O
or	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
)	O
(	O
C	O
,	O
D	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

In	O
the	O
multivariable	O
analysis	O
with	O
change	O
in	O
25OHD	O
as	O
the	O
independent	O
variable	O
,	O
T1	O
25OHD	O
was	O
also	O
included	O
as	O
a	O
confounder	O
.	O

Although	O
there	O
is	O
evidence	O
that	O
the	O
embryonic	O
environment	O
,	O
including	O
oxygen	O
tension	O
,	O
exposure	O
to	O
teratogens	O
,	O
and	O
prenatal	O
vitamin	O
deficiencies	O
,	O
can	O
all	O
contribute	O
to	O
congenital	O
defects	O
(	O
Hensinger	O
2009	O
),	O
the	O
genetic	O
contribution	O
to	O
the	O
pathogenesis	O
of	O
vertebral	O
malformation	O
syndromes	O
is	O
less	O
understood	O
.	O

This	O
paper	O
was	O
limited	O
to	O
the	O
six	O
randomised	O
and	O
quasi	O
-	O
randomised	O
trials	O
(	O
listed	O
inTable	O
1	O
)	O
on	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
,	O
which	O
met	O
at	O
least	O
one	O
of	O
the	O
following	O
inclusion	O
criteria	O
:	O
(	O
i	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
ii	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
routine	O
-	O
intermittent	O
(	O
weekly	O
and	O
twice	O
weekly	O
)	O
regimens	O
;	O
(	O
iii	O
)	O
comparison	O
between	O
intermittent	O
oral	O
iron	O
or	O
ironfolic	O
acid	O
supplementation	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
iv	O
)	O
comparison	O
between	O
intravenous	O
route	O
versus	O
oral	O
route	O
of	O
iron	O
supplementation	O
;	O
(	O
v	O
)	O
comparison	O
between	O
food	O
fortification	O
with	O
iron	O
and	O
no	O
fortification	O
/	O
placebo	O
.	O

Supplementation	O
with	O
cholecalciferol	O
increases	O
maternal	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
7	O
),	O
and	O
we	O
have	O
previously	O
demonstrated	O
that	O
the	O
25	O
(	O
OH	O
)	O
D	O
achieved	O
in	O
response	O
to	O
supplementation	O
in	O
pregnancy	O
is	O
associated	O
with	O
pregnancy	O
weight	O
gain	O
,	O
compliance	O
,	O
and	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
(	O
13	O
).	O

1	O
).	O

As	O
yet	O
there	O
is	O
no	O
precedent	O
for	O
epigenetically	O
mediated	O
toxicity	O
in	O
chemical	O
regulation	O
.	O

trials	O
[	O
12	O
]	O
and	O
the	O
Bodnar	O
et	O
al	O
.	O

The	O
MS	O
and	O
IMF	O
content	O
in	O
Angus	O
steers	O
increases	O
in	O
a	O
linear	O
fashion	O
with	O
increasing	O
HCW	O
from	O
208	O
to	O
380	O
kg	O
[	O
72	O
].	O

In	O
these	O
models	O
,	O
we	O
examined	O
the	O
effects	O
of	O
high	O
vs	O
low	O
dosage	O
of	O
text4baby	O
,	O
as	B
measured	O
by	O
a	O
median	O
split	O
variable	O
in	O
which	O
the	O
top	O
50	O
%	O
of	O
the	O
distribution	O
of	O
text	O
message	O
exposure	O
among	O
text4baby	O
intervention	O
participants	O
was	O
compared	O
to	O
the	O
bottom	O
half	O
among	O
that	O
same	O
group	O
.	O

This	O
review	O
focuses	O
on	O
neurodevelopmental	O
outcomes	O
for	O
the	O
foetus	O
as	O
much	O
of	O
the	O
published	O
research	O
into	O
fish	O
consumption	O
during	O
pregnancy	O
has	O
focused	O
on	O
methyl	O
-	O
mercury	O
,	O
LC	O
n	O
-	O
3PUFAs	O
and	O
iodine	O
,	O
all	O
known	O
to	O
impact	O
foetal	O
neurodevelopment	O
[	O
13	O
,	O
14	O
].	O

Maternal	O
BMI	O
and	O
Offspring	O
Weight	O
Parameters	O
At	O
birth	O
,	O
WFA	O
z	O
-	O
scores	O
were	O
significantly	O
higher	O
for	O
offspring	O
of	O
overweight	O
/	O
obese	O
compared	O
with	O
normal	O
weight	O
mothers	O
(	O
0	O
.	O
42	O
±	O
0	O
.	O
92	O
versus	O
0	O
.	O
21	O
±	O
0	O
.	O
76	O
,	O
resp	O
.	O

However	O
,	O
an	O
atopic	O
family	O
history	O
has	O
been	O
recognized	O
to	O
be	O
a	O
simple	O
and	O
inexpensive	O
risk	O
indicator	O
.	O

The	O
prevention	O
of	O
multiple	O
micronutrient	O
deficiencies	O
as	O
a	O
strategy	O
to	O
reduce	O
the	O
risk	O
of	O
prenatal	O
anaemia	O
has	O
been	O
little	O
studied	O
and	O
attention	O
has	O
tended	O
to	O
focus	O
instead	O
on	O
iron	O
supplementation	O
during	O
pregnancy	O
,	O
with	O
conflicting	O
results	O
(	O
Reveiz	O
et	O
al	O
2007	O
)	O
.	O

This	O
calculated	O
variable	O
was	O
used	O
for	O
the	O
GEE	O
dose	O
-	O
response	O
models	O
.	O
Table	O
2displays	O
a	O
summary	O
of	O
the	O
mean	O
messages	O
delivered	O
to	O
participants	O
based	O
on	O
the	O
calculated	O
variable	O
,	O
standard	O
deviation	O
,	O
and	O
range	O
of	O
estimated	O
total	O
text	O
messages	O
delivered	O
.	O

Compliance	O
with	O
study	O
medication	O
was	O
assessed	O
by	O
asking	O
participants	O
to	O
bring	O
any	O
remaining	O
study	O
medication	O
to	O
each	O
assessment	O
.	O

None	O
of	O
the	O
mothers	O
reported	O
taking	O
additional	O
vitamin	O
D	O
supplements	O
separate	O
from	O
their	O
prenatal	O
vitamins	O
.	O

[	O
57	O
].	O

Effects	O
of	O
moderate	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
This	O
differential	O
sex	O
effect	O
on	O
body	O
weight	O
after	O
maternal	O
caloric	O
restriction	O
was	O
in	O
agreement	O
with	O
data	O
from	O
previous	O
studies	O
(	O
Palou	O
et	O
al	O
.,	O
2010	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Sociodemographic	O
and	O
other	O
characteristics	O
of	O
the	O
study	O
subjects	O
,	O
Seattle	O
,	O
Washington	O
,	O
USA	O
2003	O
-	O
2006Gestational	O
Diabetes	O
MellitusEntire	O
Study	O
CohortN	O
=	O
1290NoN	O
=	O
1222YesN	O
=	O
68Characteristicsn	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Maternal	O
age	O
at	O
Interview	O
(	O
years	O
)*	O
33	O
.	O
3	O
±	O
4	O
.	O
433	O
.	O
2	O
±	O
4	O
.	O
335	O
.	O
2	O
±	O
5	O
.	O
0	O
<	O
35	O
years772	O
(	O
59	O
.	O
8	O
)	O
746	O
(	O
61	O
.	O
0	O
)	O
26	O
(	O
38	O
.	O
2	O
)	O
≥	O
35	O
years518	O
(	O
40	O
.	O
2	O
)	O
476	O
(	O
39	O
.	O
0	O
)	O
42	O
(	O
61	O
.	O
8	O
)	O
Maternal	O
race	O
/	O
ethnicity	O
*	O
Non	O
-	O
Hispanic	O
White1133	O
(	O
87	O
.	O
8	O
)	O
1080	O
(	O
88	O
.	O
4	O
)	O
53	O
(	O
77	O
.	O
9	O
)	O
Other157	O
(	O
12	O
.	O
2	O
)	O
141	O
(	O
11	O
.	O
5	O
)	O
15	O
(	O
22	O
.	O
1	O
)	O
Medical	O
bill	O
payment	O
status	O
Insurance1239	O
(	O
96	O
.	O
1	O
)	O
1173	O
(	O
96	O
.	O
0	O
)	O
66	O
(	O
97	O
.	O
1	O
)	O
Medicaid26	O
(	O
2	O
.	O
0	O
)	O
24	O
(	O
2	O
.	O
0	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
unknown25	O
(	O
1	O
.	O
9	O
)	O
25	O
(	O
2	O
.	O
0	O
)	O
0	O
(	O
0	O
)	O
Nulliparous768	O
(	O
59	O
.	O
5	O
)	O
727	O
(	O
59	O
.	O
5	O
)	O
41	O
(	O
60	O
.	O
3	O
)≤	O
High	O
school	O
education37	O
(	O
2	O
.	O
9	O
)	O
33	O
(	O
2	O
.	O
7	O
)	O
4	O
(	O
5	O
.	O
9	O
)	O
Unmarried106	O
(	O
8	O
.	O
2	O
)	O
98	O
(	O
8	O
.	O
0	O
)	O
8	O
(	O
11	O
.	O
8	O
)	O
Smoked	O
during	O
pregnancy67	O
(	O
5	O
.	O
2	O
)	O
65	O
(	O
5	O
.	O
3	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
No	O
prenatal	O
vitamins32	O
(	O
2	O
.	O
5	O
)	O
30	O
(	O
2	O
.	O
5	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
Pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
kg	O
/	O
m2	O
)*	O
23	O
.	O
5	O
±	O
4	O
.	O
523	O
.	O
3	O
±	O
4	O
.	O
426	O
.	O
6	O
±	O
6	O
.	O
3	O
Lean	O
(<	O
18	O
.	O
5	O
)	O
58	O
(	O
4	O
.	O
5	O
)	O
57	O
(	O
4	O
.	O
7	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
Normal	O
(	O
18	O
.	O
5	O
-	O
24	O
.	O
9	O
)	O
908	O
(	O
70	O
.	O
4	O
)	O
876	O
(	O
71	O
.	O
7	O
)	O
32	O
(	O
47	O
.	O
1	O
)	O
Overweight	O
(	O
25	O
-	O
29	O
.	O
9	O
)	O
229	O
(	O
17	O
.	O
7	O
)	O
208	O
(	O
17	O
.	O
0	O
)	O
21	O
(	O
30	O
.	O
9	O
)	O
Obese	O
(≥	O
30	O
)	O
95	O
(	O
7	O
.	O
4	O
)	O
81	O
(	O
6	O
.	O
6	O
)	O
14	O
(	O
20	O
.	O
4	O
)	O
Mean	O
±	O
standard	O
deviation	O
(	O
SD	O
).	O

Pathway	O
analysis	O
Gene	O
lists	O
from	O
microarray	O
results	O
were	O
submitted	O
to	O
the	O
manually	O
curated	O
database	O
'	O
Ingenuity	O
Pathways	O
Analysis	O
'	O
to	O
elucidate	O
putative	O
pathways	O
associated	O
with	O
an	O
altered	O
gene	O
expression	O
in	O
porcine	O
liver	O
.	O

While	O
association	O
between	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
and	O
autism	O
spectrum	O
disorders	O
is	O
not	O
strong	O
,	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
has	O
shown	O
to	O
increase	O
incidence	O
.	O

Background	O
Studies	O
have	O
examined	O
the	O
maternal	O
contribution	O
to	O
infant	O
health	O
,	O
including	O
the	O
effect	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
and	O
lactation	O
.	O

The	O
results	O
for	O
boys	O
and	O
girls	O
were	O
similar	O
(	O
table	O
5	O
).	O

studied	O
the	O
association	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
antenatal	O
depression	O
.	O

If	O
so	O
,	O
then	O
in	O
terms	O
of	O
policy	O
and	O
guidelines	O
,	O
it	O
is	O
hard	O
to	O
know	O
what	O
regimen	O
to	O
recommend	O
for	O
future	O
trials	O
,	O
given	O
that	O
clinical	O
practice	O
and	O
evidence	O
suggests	O
that	O
daily	O
or	O
weekly	O
supplementations	O
though	O
ideal	O
are	O
not	O
complied	O
with13	O
,	O
14and	O
are	O
impractical	O
for	O
families	O
,	O
especially	O
in	O
developing	O
countries	O
,	O
and	O
food	O
fortification	O
at	O
the	O
population	O
level	O
will	O
not	O
be	O
an	O
option	O
during	O
exclusive	O
breastfeeding	O
periods	O
(	O
aged	O
<	O
6	O
months	O
),	O
nor	O
is	O
it	O
likely	B
to	O
be	O
adequate	O
in	O
highly	O
deficient	O
populations	O
.	O

All	O
eight	O
studies	O
included	O
in	O
the	O
final	O
review	O
were	O
observational	O
in	O
design	O
.	O

Red	O
and	O
processed	O
meat	O
intake	O
is	O
considered	O
less	O
healthful	O
,	O
and	O
consumption	O
below	O
the	O
median	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

It	O
has	O
been	O
suggested	O
that	O
foods	O
containing	O
allergy	O
-	O
provoking	O
proteins	O
such	O
as	O
milk	O
,	O
egg	O
,	O
peanuts	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
should	O
not	O
be	O
introduced	O
into	O
the	O
diet	O
of	O
the	O
child	O
before	O
the	O
age	O
of	O
6	O
months	O
to	O
3	O
years	O
[	O
117	O
].	O

It	O
was	O
recently	O
shown	O
that	O
a	O
maternal	O
supplementation	O
of	O
2100	O
IU	O
vitamin	O
D	O
/	O
day	O
was	O
needed	O
,	O
when	O
administered	O
during	O
the	O
period	O
of	O
lactation	O
,	O
in	O
order	O
to	O
observe	O
an	O
increase	O
in	O
serum	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
breast	O
-	O
fed	O
infants	O
comparable	O
to	O
that	O
observed	O
in	O
children	O
given	O
400	O
IU	O
/	O
day	O
.	O

There	O
has	O
been	O
increasing	O
concerns	O
by	O
consumers	O
about	O
the	O
negative	O
impact	O
of	O
extremely	O
highly	O
marbled	O
beef	O
on	O
human	O
health	O
,	O
such	O
as	O
cardiovascular	O
diseases	O
and	O
arteriosclerosis	O
.	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
(	O
RC	O
males	O
)	O
exhibited	O
a	O
differential	O
response	O
to	O
the	O
CB1	O
antagonist	O
AM251	O
in	O
a	O
chocolate	O
preference	O
test	O
as	O
well	O
as	O
increased	O
body	O
weight	O
,	O
perirenal	O
adiposity	O
,	O
and	O
plasma	O
levels	O
of	O
triglycerides	O
,	O
LDL	O
,	O
VLDL	O
,	O
bilirubin	O
,	O
and	O
leptin	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
associations	O
between	O
fetal	O
growth	O
and	O
maternal	O
vitamin	O
D	O
status	O
are	O
due	O
to	O
residual	O
confounding	O
or	O
reverse	O
causation	O
.	O

A	O
major	O
issue	O
in	O
sex	O
differences	O
is	O
the	O
need	O
for	O
control	O
the	O
estrous	O
phase	O
on	O
which	O
the	O
evaluations	O
were	O
performed	O
in	O
order	O
to	O
clarify	O
the	O
impact	O
of	O
sex	O
hormones	O
variations	O
in	O
the	O
female	O
.	O

First	O
,	O
from	O
2007	O
–	O
2013	O
,	O
the	O
Government	O
of	O
Nicaragua	O
provided	O
influenza	O
vaccination	O
only	O
for	O
pregnant	O
women	O
with	O
chronic	O
conditions	O
[	O
34	O
].	O

The	O
different	O
epigenetic	O
pathways	O
converge	O
and	O
interact	O
to	O
regulate	O
gene	O
expression	O
at	O
multiple	O
levels	O
(	O
Figure	O
2	O
).	O

In	O
previous	O
studies	O
,	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
generally	B
higher	O
than	O
20	O
ng	O
/	O
ml	O
in	O
maternal	O
serum	O
[	O
6	O
,	O
8	O
,	O
9	O
].	O

Skm1	O
mice	O
in	O
the	O
lateral	O
position	O
showing	O
kyphosis	O
(	O
C	O
)	O
and	O
in	O
the	O
supine	O
position	O
showing	O
elongated	O
body	O
(	O
D	O
).	O

Main	O
Outcome	O
Measure	O
:	O
25	O
(	O
OH	O
)	O
D	O
at	O
randomization	O
and	O
34	O
weeks	O
of	O
gestation	O
were	O
measured	O
in	O
a	O
single	O
batch	O
(	O
Liaison	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

Pregnancy	O
is	O
a	O
physiologically	O
unique	O
period	O
,	O
involving	O
hemodilution	O
and	O
hormonal	O
and	O
metabolic	O
changes	O
.	O

Assessment	O
of	O
25	O
(	O
OH	O
)	O
D	O
On	O
the	O
day	O
that	O
the	O
study	O
medication	O
was	O
dispensed	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
a	O
nonfasted	O
venous	O
blood	O
sample	O
was	O
obtained	O
and	O
serum	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Data	O
were	O
assessed	O
for	O
normality	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
and	O
visual	O
inspection	O
of	O
histograms	O
.	O

Results	O
:	O
Black	O
race	O
,	O
Medicaid	O
status	O
,	O
mean	O
body	O
mass	O
index	O
at	O
delivery	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
were	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
.	O

This	O
leads	O
to	O
the	O
hypothesis	O
that	O
the	O
offspring	O
'	O
s	O
transcriptome	O
exhibits	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
changes	O
,	O
depending	O
on	O
the	O
maternal	O
diet	O
.	O

CT	O
:	O
cholera	O
toxin	O
;	O
ih	O
:	O
intrahippocampal	O
;	O
im	O
:	O
intramuscular	O
;	O
ip	O
:	O
intraperitoneal	O
;	O
sc	O
:	O
subcutaneous	O
.	O

122	O
caries	O
-	O
free	O
controls	O
were	O
recruited	O
from	O
the	O
community	O
.	O

Also	O
,	O
our	O
study	O
showed	O
significant	O
discrepancy	O
between	O
the	O
two	O
groups	O
according	O
to	O
the	O
rate	O
of	O
deficiency	O
,	O
insufficiency	O
and	O
normal	O
range	O
of	O
vitamin	O
D	O
categories	O
(	O
P	O
=	O
0	O
.	O
021	O
).	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

Missing	O
data	O
were	O
imputed	O
for	O
all	O
randomised	O
participants	O
except	O
those	O
who	O
had	O
no	O
live	O
birth	O
,	O
who	O
had	O
an	O
infant	O
death	O
,	O
or	O
who	O
withdrew	O
from	O
the	O
study	O
and	O
also	O
withdrew	O
permission	O
to	O
use	O
data	O
.	O

The	O
composition	O
of	O
the	O
various	O
multivitamin	O
compounds	O
taken	O
also	O
varied	O
:	O
the	O
daily	O
dose	O
of	O
vitamin	O
C	O
ranged	O
from	O
0	O
to	O
600	O
mg	O
,	O
vitamin	O
E	O
ranged	O
from	O
0	O
to	O
70	O
mg	O
,	O
vitamin	O
A	O
ranged	O
from	O
0	O
to	O
30	O
,	O
000	O
IU	O
,	O
and	O
folate	O
ranged	O
from	O
0	O
to	O
2000	O
micrograms	O
.	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
12	O
.	O

Further	O
,	O
analyses	O
were	O
based	O
on	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
follow	O
-	O
up	O
(	O
96	O
.	O
6	O
%	O
of	O
those	O
randomised	O
)	O
by	O
using	O
multiple	O
imputation	O
to	O
address	O
missing	O
data	O
for	O
infants	O
who	O
were	O
not	O
assessed	O
at	O
6	O
months	O
.	O

Consistently	B
,	O
in	O
porcine	O
offspring	O
a	O
diet	O
-	O
dependent	O
regulation	O
of	O
'	O
glucocorticoid	O
receptor	O
signaling	O
'	O
was	O
also	O
found	O
.	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

Synthesis	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2Din	O
the	O
kidney	O
increases	O
during	O
pregnancy	O
.	O

The	O
total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
was	O
grouped	O
into	O
six	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
).	O

As	O
in	O
our	O
studies	O
,	O
these	O
inconsistent	O
findings	O
point	O
to	O
the	O
existence	O
of	O
complicated	O
pathways	O
for	O
the	O
function	O
of	O
vitamin	O
D	O
in	O
disease	O
processes	O
,	O
or	O
simply	O
that	O
the	O
correct	O
effective	O
dose	O
of	O
vitamin	O
D	O
supplementation	O
needs	O
to	O
be	O
better	O
defined	O
.	O

Children	O
of	O
normal	O
weight	O
mothers	O
who	O
were	O
exposed	O
to	O
excessive	O
GWG	O
(	O
n	O
=	O
71	O
)	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
(	O
0	O
.	O
42	O
±	O
0	O
.	O
75	O
versus	O
0	O
.	O
03	O
±	O
0	O
.	O
73	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
GWG	O
,	O
but	O
no	O
significant	O
effects	O
were	O
seen	O
on	O
odds	O
of	O
macrosomia	O
or	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
.	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

Homes	O
with	O
high	O
pet	O
activities	O
have	O
been	O
shown	O
to	O
have	O
greater	O
levels	O
of	O
pesticide	O
residues	O
in	O
sampled	O
carpet	O
dust	O
than	O
homes	O
with	O
low	O
pet	O
activities	O
[	O
31	O
,	O
32	O
].	O

A	O
single	O
24	O
-	O
HR	O
for	O
the	O
infant	O
is	O
administered	O
at	O
phase	O
6	O
for	O
quantitative	O
assessment	O
(	O
macro	O
-	O
and	O
micronutrient	O
intakes	O
)	O
of	O
intakes	O
at	O
6	O
months	O
postnatally	O
.	O

Metformin	O
alters	O
gene	O
expression	O
in	O
mice	O
livers	O
and	O
has	O
been	O
demonstrated	O
to	O
have	O
an	O
antiproliferative	O
effect	O
through	O
reductions	O
in	O
cyclin	O
D1	O
and	O
activation	O
of	O
AMP	O
kinase	O
.	O
79The	O
programming	O
and	O
developmental	O
effects	O
of	O
these	O
on	O
a	O
fetus	O
are	O
unknown	O
.	O

Although	O
,	O
laboratories	O
at	O
the	O
health	O
facilities	O
in	O
developing	O
countries	O
usually	O
lack	O
the	O
capacity	O
to	O
conduct	O
quality	O
blood	O
test	O
,	O
they	O
could	O
be	O
strengthened	O
to	O
provide	O
reliable	O
estimations	O
of	O
red	O
blood	O
cell	O
indices	O
such	O
as	O
haemoglobin	O
,	O
haematocrit	O
,	O
mean	O
cell	O
volume	O
,	O
mean	O
cell	O
haemoglobin	O
,	O
and	O
mean	O
cell	O
haemoglobin	O
concentration	O
.	O

Health	O
outcomes	O
must	O
be	O
included	O
in	O
the	O
educational	O
agenda	O
and	O
become	O
part	O
of	O
school	O
accountability	O
to	O
obtain	O
support	O
and	O
funding	O
for	O
health	O
-	O
based	O
policies	O
and	O
interventions	O
,	O
such	O
as	O
physical	O
education	O
,	O
comprehensive	O
health	O
education	O
,	O
or	O
BMI	O
monitoring	O
.	O

Methods	O
The	O
data	O
form	O
part	O
of	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
,	O
established	O
in	O
2001	O
and	O
followed	O
up	O
through	O
to	O
2013	O
.	O

Interventions	O
that	O
have	O
been	O
identified	O
through	O
global	O
reviews	O
of	O
the	O
evidence	O
are	O
summarised	O
elsewhere	O
[	O
4	O
-	O
6	O
]	O
and	O
shown	O
in	O
Figure1	O
.	O

Blood	O
was	O
collected	O
into	O
heparinised	O
Vacutainer	O
tubes	O
and	O
stored	O
on	O
ice	O
until	O
centrifugation	O
and	O
removal	O
of	O
plasma	O
for	O
analysis	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Description	O
of	O
early	O
life	O
nutrition	O
and	O
offspring	O
groups	O
.	O
Pre	O
-	O
pregnancyPregnancyLactationOffspring	O
Postnatal	O
DietGroup	O
(	O
sample	O
size	O
)	O
100	O
%	O
Control	O
DietControlCont	O
(	O
18	O
)	O
High	O
FatCont	O
+	O
HF	O
(	O
16	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
Diet100	O
%	O
Control	O
DietControlUNP	O
(	O
14	O
)	O
High	O
FatUNP	O
+	O
HF	O
(	O
14	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
DietControlUNL	O
(	O
12	O
)	O
High	O
FatUNL	O
+	O
HF	O
(	O
12	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
DietControlUNPL	O
(	O
12	O
)	O
High	O
FatUNPL	O
+	O
HF	O
(	O
12	O
)	O
100	O
%	O
Control	O
Diet100	O
%	O
High	O
Fat	O
DietControlPLHF	O
(	O
16	O
)	O
High	O
FatPLHF	O
+	O
HF	O
(	O
16	O
)	O
100	O
%	O
High	O
Fat	O
DietControlMHF	O
(	O
16	O
)	O
High	O
FatMHF	O
+	O
HF	O
(	O
16	O
)	O
Estrous	O
Staging	O
in	O
Adult	O
Offspring	O
In	O
order	O
to	O
assess	O
stage	O
of	O
estrous	O
cycle	O
in	O
adult	O
offspring	O
,	O
vaginal	O
smears	O
were	O
collected	O
at	O
the	O
time	O
of	O
post	O
mortem	O
after	O
pentobarbitone	O
injection	O
prior	O
to	O
decapitation	O
.	O

The	O
maternal	O
and	O
paternal	O
grandparents	O
had	O
separate	O
fixed	O
effects	O
,	O
that	O
is	O
,	O
a	O
different	O
effect	O
for	O
the	O
MGM	O
than	O
the	O
PGM	O
and	O
a	O
different	O
effect	O
for	O
the	O
MGF	O
than	O
the	O
PGF	O
as	O
the	O
populations	O
were	O
not	O
balanced	O
.	O

Body	O
mass	O
(	O
BM	O
)	O
and	O
naso	O
-	O
anal	O
length	O
(	O
NAL	O
)	O
were	O
evaluated	O
at	O
birth	O
,	O
10	O
days	O
,	O
weaning	O
,	O
3	O
months	O
and	O
6	O
months	O
of	O
age	O
.	O

In	O
intervention	O
clusters	O
trained	O
BRAC	O
village	O
volunteers	O
will	O
identify	O
pregnant	O
women	O
&	O
provide	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
in	O
offspring	O
exposed	O
to	O
a	O
prenatal	O
HF	O
diet	O
had	O
no	O
further	O
effect	O
(	O
Figure	O
3B	O
,	O
C	O
;	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Percentage	O
of	O
offspring	O
entering	O
puberty	O
over	O
time	O
in	O
animals	O
whose	O
dams	O
received	O
a	O
high	O
fat	O
diet	O
.	O

25	O
-	O
OH	O
Vitamin	O
D2	O
is	O
also	O
detected	O
in	O
the	O
serum	O
of	O
these	O
four	O
participants	O
.	O

Over	O
half	O
the	O
children	O
aged	O
6	O
–	O
12	O
.	O
9	O
years	O
residing	O
in	O
urban	O
areas	O
had	O
serum	O
25	O
(	O
OH	O
)	O
D	O
less	O
then	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
).	O

A	O
comment	O
to	O
the	O
authors	O
(	O
20	O
)	O
detailed	O
the	O
evidence	O
that	O
antiepileptic	O
drugs	O
are	O
one	O
of	O
the	O
few	O
classes	O
of	O
drugs	O
that	O
consistently	B
and	O
significantly	O
interfere	O
with	O
vitamin	O
D	O
metabolism	O
,	O
lowering	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

),	O
and	O
World	O
Food	O
Program	O
(	O
viz	O
.	O

ENU	O
mutagenesis	O
Male	O
129S1	O
mice	O
received	O
one	O
intraperitoneal	O
injection	O
of	O
ENU	O
at	O
a	O
dose	O
of	O
150	O
mg	O
/	O
kg	O
at	O
age	O
8	O
–	O
12	O
wk	O
.	O

The	O
Block	O
Children	O
’	O
s	O
Food	O
Frequency	O
questionnaire	O
was	O
administered	O
at	O
each	O
yearly	O
visit	O
[	O
24	O
].	O

Our	O
study	O
can	O
be	O
the	O
basis	O
for	O
further	O
and	O
more	O
precise	O
studies	O
.	O

Serum	O
calcium	O
concentrations	O
were	O
monitored	O
as	O
clinically	O
indicated	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
fetal	O
nutritional	O
programming	O
affects	O
growth	O
and	O
/	O
or	O
beef	O
quality	O
,	O
including	O
marbling	O
.	O

In	O
particular	O
,	O
mHealth	O
programs	O
have	O
proven	B
effective	O
in	O
drug	O
adherence	O
,	O
as	O
patient	O
reminder	O
systems	O
,	O
and	O
in	O
some	O
areas	O
of	O
areas	O
of	O
chronic	O
disease	O
management	O
,	O
prevention	O
,	O
and	O
control	O
[	O
5	O
,	O
6	O
].	O

For	O
an	O
excellent	O
discussion	O
of	O
the	O
obstetric	O
management	O
of	O
GDM	O
,	O
I	O
will	O
refer	O
the	O
reader	O
to	O
the	O
review	O
by	O
Conway	O
.	O
24	O
Diabetes	O
education	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
therapy	O
,	O
and	O
exercise	O
Self	O
-	O
care	O
is	O
an	O
important	O
component	O
of	O
the	O
management	O
of	O
GDM	O
.	O

Birth	O
data	O
are	O
collected	O
in	O
the	O
relevant	O
wards	O
at	O
RMMCH	O
.	O

The	O
DiNEH	O
(	O
Diné	O
Network	O
for	O
Environmental	O
Health	O
)	O
Project	O
was	O
originally	O
started	O
to	O
address	O
community	O
concerns	O
about	O
the	O
high	O
rate	O
of	O
kidney	O
disease	O
in	O
this	O
population	O
,	O
which	O
some	O
community	O
leaders	O
and	O
health	O
professionals	O
suspected	B
was	O
related	O
to	O
drinking	O
contaminated	O
water	O
.	O

The	O
main	O
finding	O
was	O
a	O
significant	O
effect	O
of	O
high	O
exposure	O
to	O
text4baby	O
on	O
self	O
-	O
reported	O
alcohol	O
consumption	O
postpartum	O
(	O
OR	O
0	O
.	O
212	O
,	O
95	O
%	O
CI	O
0	O
.	O
046	O
-	O
0	O
.	O
973	O
,	O
P	O
=.	O
046	O
),	O
as	B
measured	O
by	O
the	O
question	O
“	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?”	O
The	O
text4baby	O
participants	O
also	O
reported	O
lower	O
quantities	O
of	O
alcohol	O
consumed	O
postpartum	O
.	O

Of	O
all	O
pregnancies	O
,	O
1	O
–	O
14	O
%	O
are	O
affected	O
by	O
GDM	O
[	O
9	O
],	O
and	O
globally	O
GDM	O
prevalence	O
has	O
been	O
increasing	O
in	O
line	O
with	O
increasing	O
obesity	O
[	O
10	O
].	O

Finally	O
,	O
to	O
make	O
our	O
search	O
inclusive	O
of	O
those	O
studies	O
in	O
which	O
season	O
of	O
birth	O
was	O
a	O
secondary	O
factor	O
we	O
checked	O
the	O
tables	O
of	O
every	O
article	O
known	O
to	O
us	O
that	O
examined	O
risk	O
factors	O
for	O
brain	O
tumors	O
.	O

Formula	O
-	O
fed	O
infants	O
typically	O
consume	O
300	O
-	O
500	O
IU	O
/	O
day	O
from	O
their	O
formula	O
and	O
therefore	B
generally	B
meet	O
the	O
current	O
recommendations	O
without	O
an	O
additional	O
oral	O
supplement	O
of	O
vitamin	O
D	O
drops	O
especially	O
after	O
the	O
first	O
6	O
to	O
8	O
weeks	O
of	O
life	O
.	O

Due	O
to	O
developmental	O
plasticity	O
,	O
environmental	O
factors	O
induce	O
altered	O
expression	O
of	O
the	O
genome	O
and	O
ultimately	O
modify	O
the	O
offspring	O
'	O
s	O
phenotype	O
[	O
7	O
].	O

Participants	O
:	O
In	O
total	O
,	O
682	O
women	O
of	O
white	O
ethnicity	O
(	O
351	O
placebo	O
,	O
331	O
cholecalciferol	O
)	O
were	O
included	O
.	O

Indeed	O
,	O
discrepancies	O
were	O
also	O
found	O
in	O
the	O
literature	O
.	O

For	O
example	O
,	O
high	O
intake	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
partly	O
replaces	O
omega	O
-	O
6	O
fatty	O
acids	O
incorporation	O
into	O
membrane	O
phospholipids	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
have	O
a	O
higher	O
affinity	O
than	O
omega	O
-	O
6	O
fatty	O
acids	O
for	O
several	O
enzymes	O
[	O
44	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Summary	O
of	O
the	O
main	O
findings	O
for	O
the	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
childhood	O
outcomes	O
:	O
a	O
)	O
atopy	O
(	O
n	O
=	O
6117	O
)	O
and	O
b	O
)	O
atopic	O
asthma	O
(	O
n	O
=	O
5228	O
).	O

Neither	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
nor	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
related	O
to	O
birth	O
length	O
or	O
ponderal	O
index	O
.	O

There	O
were	O
35	O
spots	O
that	O
were	O
significantly	O
altered	O
between	O
the	O
two	O
groups	O
,	O
22	O
were	O
down	O
-	O
regulated	O
and	O
13	O
up	O
-	O
regulated	O
(	O
Table	O
1	O
).	O

Animal	O
studies	O
,	O
studies	O
not	O
reported	O
in	O
English	O
,	O
and	O
studies	O
of	O
populations	O
exposed	O
to	O
contaminants	O
were	O
excluded	O
.	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
the	O
71	O
infants	O
who	O
successfully	O
underwent	O
later	O
infant	O
lung	O
function	O
testing	O
was	O
13	O
.	O
8	O
±	O
6	O
.	O
3	O
ng	O
/	O
ml	O
,	O
and	O
that	O
of	O
their	O
mothers	O
was	O
15	O
.	O
0	O
±	O
6	O
.	O
1	O
ng	O
/	O
ml	O
,	O
which	O
were	O
also	O
significantly	O
correlated	O
(	O
r2	O
=	O
0	O
.	O
468	O
,	O
p	O
<	O
0	O
.	O
0001	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Correlation	O
between	O
maternal	O
and	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

To	O
determine	O
if	O
IIH	O
is	O
occurring	O
more	O
commonly	O
,	O
de	O
-	O
identified	O
,	O
first	O
-	O
measured	O
serum	O
calcium	O
from	O
all	O
infants	O
<	O
6	O
months	O
(	O
n	O
=	O
5796	O
)	O
measured	O
in	O
our	O
laboratory	O
,	O
were	O
grouped	O
by	O
years	O
2005	O
-	O
2007	O
(	O
n	O
=	O
1516	O
),	O
2008	O
-	O
2010	O
(	O
n	O
=	O
1945	O
)	O
and	O
2011	O
-	O
2013	O
(	O
n	O
=	O
2335	O
).	O

In	O
a	O
larger	O
study	O
,	O
Burris	O
et	O
al	O
.	O
14examined	O
the	O
relationship	O
between	O
second	O
-	O
trimester	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
and	O
SGA	O
in	O
blacks	O
and	O
whites	O
and	O
found	O
a	O
higher	O
risk	O
of	O
SGA	O
in	O
both	O
vitamin	O
D	O
-	O
deficient	O
black	O
and	O
white	O
infants	O
.	O

Furthermore	O
,	O
only	O
women	O
who	O
attended	O
the	O
2	O
-	O
year	O
follow	O
-	O
up	O
appointment	O
had	O
pregnancy	O
serum	O
25OHD	O
measured	O
,	O
and	O
some	O
differences	O
were	O
observed	O
in	O
the	O
baseline	O
characteristics	O
of	O
those	O
included	O
and	O
excluded	O
from	O
this	O
analysis	O
[	O
48	O
].	O

(	O
2015	O
)*/†	O
Lin	O
et	O
al	O
.	O

Despite	O
few	O
cases	O
of	O
IUFD	O
in	O
the	O
GraviD	O
cohort	O
,	O
our	O
results	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
may	O
be	O
linked	O
to	O
IUFD	O
.	O

Regarding	O
to	O
the	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
lung	O
function	O
in	O
adults	O
,	O
the	O
HUNT	O
study	O
revealed	O
that	O
low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
was	O
not	O
associated	O
with	O
airway	O
obstruction	O
in	O
most	B
asthma	O
adults	O
with	O
the	O
exception	O
of	O
males	O
with	O
asthma	O
but	O
without	O
allergic	O
rhinitis	O
[	O
36	O
].	O

It	O
can	O
be	O
argued	O
that	O
a	O
steady	O
-	O
state	O
adequate	O
vitamin	O
D	O
concentration	O
was	O
not	O
reached	O
in	O
some	O
children	O
because	O
of	O
fluctuations	O
in	O
serum	O
concentrations	O
due	O
to	O
our	O
study	O
regimen	O
.	O

Maternal	O
characteristics	O
are	O
shown	O
in	O
Table	O
1	O
.	O

The	O
prenatal	O
data	O
from	O
the	O
mother	O
’	O
s	O
recall	O
was	O
confirmed	O
with	O
medical	O
records	O
.	O

Taking	O
together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
ECS	O
could	O
play	O
a	O
putative	B
role	O
in	O
nutritional	O
programming	O
and	O
hence	B
in	O
the	O
early	O
origin	O
of	O
metabolic	O
diseases	O
.	O

Ovarian	O
function	O
Maternal	O
exposure	O
to	O
either	O
caloric	O
restriction	O
or	O
to	O
high	O
fat	O
nutrition	O
was	O
associated	O
with	O
accelerated	O
puberty	O
in	O
female	O
offspring	O
,	O
but	O
there	O
were	O
distinct	O
differences	O
in	O
mature	O
ovarian	O
function	O
as	O
measured	O
by	O
progesterone	O
concentrations	O
in	O
the	O
proestrous	O
phase	O
.	O

Moreover	O
,	O
accumulating	O
evidence	O
link	O
habitual	O
snoring	O
and	O
sleep	O
apnea	O
,	O
both	O
part	O
of	O
a	O
spectrum	O
of	O
sleep	O
-	O
related	O
breathing	O
disorders	O
,	O
with	O
cardiometabolic	O
abnormalities	O
that	O
include	O
hypertension	O
,	O
dyslipidemia	O
,	O
obesity	O
,	O
hyperglycemia	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
[	O
2	O
,	O
7	O
,	O
12	O
-	O
15	O
].	O

Since	B
PTB	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
and	O
multiple	O
short	O
and	O
long	O
term	O
health	O
problems	O
[	O
3	O
],	O
it	O
is	O
critical	O
to	O
identify	O
modifiable	O
maternal	O
risk	O
factors	O
that	O
could	O
significantly	O
reduce	O
PTB	O
risk	O
at	O
the	O
population	O
level	O
.	O

(	O
B	O
)	O
Alignment	O
of	O
the	O
amino	O
acid	O
sequence	O
for	O
NPR3	O
(	O
top	O
)	O
and	O
FLNB	O
(	O
bottom	O
)	O
orthologs	O
.	O

Obesity	O
is	O
linked	O
to	O
in	O
utero	O
exposure	O
to	O
glucocorticoids	O
,	O
protein	O
restrictions	O
,	O
and	O
maternal	O
diet	O
and	O
obesity	O
.	O

It	O
seems	O
that	O
in	O
addition	O
to	O
calcium	O
homeostasis	O
and	O
bone	O
health	O
,	O
vitamin	O
D	O
is	O
also	O
essential	O
for	O
brain	O
development	O
and	O
function	O
[	O
20	O
,	O
21	O
].	O

Ancient	O
rules	O
of	O
aurea	O
mediocritas	O
are	O
applicable	O
once	O
again	O
.	O

The	O
cost	O
per	O
woman	O
is	O
around	O
four	O
to	O
five	O
times	O
higher	O
than	O
that	O
of	O
fortification	O
programs	O
.	O

The	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
,	O
OPPs	O
,	O
Pb	O
and	O
Hg	O
were	O
examined	O
using	O
BLHM	O
(	O
Table3	O
).	O

They	O
also	O
have	O
a	O
higher	O
risk	O
of	O
a	O
respiratory	O
tract	O
infection	O
before	O
this	O
age	O
.	O

Control	O
We	O
used	O
usual	O
iron	O
supplementation	O
program	O
as	O
the	O
comparator	O
.	O

Second	O
-	O
generation	O
antihistamines	O
such	O
as	O
loratadine	O
or	O
cetirizine	O
[	O
21	O
,	O
29	O
]	O
can	O
also	O
be	O
used	O
(	O
after	O
the	O
first	O
trimester	O
--	O
as	O
a	O
general	O
precaution	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Comparison	O
of	O
demographic	O
data	O
in	O
the	O
intervention	O
and	O
control	O
groupVariablesVitamin	O
DControl	O
p	O
-	O
valueAge	O
(	O
year	O
)	O
Mean	O
±	O
sd26	O
.	O
40	O
±	O
4	O
.	O
8826	O
.	O
22	O
±	O
4	O
.	O
330	O
.	O
80Job	O
N	O
(%)	O
0	O
.	O
96	O
Housewife72	O
(	O
96	O
)	O
75	O
(	O
96	O
.	O
2	O
)	O
Employed3	O
(	O
4	O
)	O
3	O
(	O
3	O
.	O
8	O
)	O
Education	O
N	O
(%)	O
0	O
.	O
55	O
High	O
school26	O
(	O
34	O
.	O
7	O
)	O
21	O
(	O
26	O
.	O
9	O
)	O
High	O
school	O
diploma34	O
(	O
45	O
.	O
3	O
)	O
38	O
(	O
48	O
.	O
7	O
)	O
University15	O
(	O
20	O
.	O
0	O
)	O
19	O
(	O
24	O
.	O
4	O
)	O
Parity0	O
.	O
17	O
Nullipara41	O
(	O
54	O
.	O
7	O
)	O
51	O
(	O
65	O
.	O
4	O
)	O
Multipara34	O
(	O
45	O
.	O
3	O
)	O
27	O
(	O
34	O
.	O
6	O
)	O
Using	O
others	O
supplements0	O
.	O
017	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Planned	O
pregnancy0	O
.	O
01	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Seasonal	O
distribution	O
in	O
onset	O
N	O
(%)	O
0	O
.	O
32	O
Autumn9	O
(	O
12	O
)	O
6	O
(	O
7	O
.	O
7	O
)	O
Winter11	O
(	O
14	O
.	O
7	O
)	O
7	O
(	O
9	O
)	O
Spring55	O
(	O
73	O
.	O
3	O
)	O
65	O
(	O
83	O
.	O
3	O
)	O
Sun	O
exposure	O
(	O
minutes	O
)	O
0	O
.	O
55	O
<	O
1514	O
(	O
21	O
.	O
9	O
)	O
12	O
(	O
16	O
.	O
7	O
)	O
15	O
–	O
3028	O
(	O
43	O
.	O
8	O
)	O
33	O
(	O
45	O
.	O
8	O
)	O
30	O
–	O
6010	O
(	O
15	O
.	O
6	O
)	O
17	O
(	O
23	O
.	O
6	O
)	O
>	O
6012	O
(	O
18	O
.	O
8	O
)	O
10	O
(	O
13	O
.	O
9	O
)	O
At	O
baseline	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
12	O
.	O
35	O
±	O
7	O
.	O
17	O
ng	O
/	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
4	O
and	O
49	O
.	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

Such	O
benefits	O
are	O
not	O
just	O
limited	O
to	O
nutrition	O
;	O
advantageous	O
chemically	O
induced	O
epigenetic	O
changes	O
have	O
also	O
been	O
reported	O
.	O

Information	O
on	O
medical	O
and	O
reproductive	O
histories	O
and	O
sociodemographic	O
and	O
lifestyle	O
characteristics	O
including	O
average	O
number	O
of	O
hours	O
of	O
sleep	O
before	O
and	O
during	O
early	O
pregnancy	O
was	O
collected	O
.	O

found	O
that	O
vitamin	O
D	O
insufficiency	O
is	O
common	O
in	O
the	O
sunny	O
climate	O
in	O
Saudi	O
Arabia	O
[	O
3	O
].	O

It	O
is	O
well	O
known	O
that	O
male	O
heights	O
tend	O
to	O
be	O
greater	O
in	O
reported	O
than	O
measured	O
data	O
.	O
37Our	O
analysis	O
suggests	O
that	O
it	O
is	O
unlikely	B
that	O
correlations	O
were	O
affected	O
by	O
this	O
feature	O
.	O

-	O
not	O
regulated	O
Discussion	O
We	O
applied	O
whole	O
-	O
genome	O
microarrays	O
to	O
evaluate	O
hepatic	O
gene	O
expression	O
profiles	O
of	O
offspring	O
from	O
sows	O
fed	O
either	O
an	O
isocaloric	O
maternal	O
low	O
protein	O
or	O
adequate	O
protein	O
diet	O
throughout	O
their	O
pregnancy	O
.	O

Conclusions	O
Ongoing	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
should	O
consider	O
potential	O
effect	O
modification	O
by	O
race	O
/	O
ethnicity	O
.	O

Laboratory	O
analysis	O
Maternal	O
blood	O
was	O
obtained	O
at	O
the	O
initial	O
visit	O
(	O
median	O
gestational	O
age	O
9	O
.	O
6	O
weeks	O
,	O
IQR	O
8	O
.	O
4	O
–	O
11	O
.	O
4	O
)	O
and	O
again	O
in	O
the	O
late	O
second	O
/	O
early	O
third	O
trimester	O
(	O
mean	O
26	O
.	O
0	O
weeks	O
’	O
gestation	O
,	O
IQR	O
25	O
.	O
0	O
–	O
26	O
.	O
9	O
).	O

A	O
smaller	O
sample	O
size	O
of	O
570	O
women	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
28	O
clusters	O
is	O
needed	O
to	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
LBW	O
with	O
the	O
same	O
assumptions	O
.	O

Authors	O
reported	O
that	O
fish	O
consumption	O
two	O
to	O
three	O
times	O
per	O
week	O
during	O
pregnancy	O
was	O
beneficial	O
for	O
children	O
who	O
were	O
breastfed	O
for	O
less	O
than	O
six	O
months	O
.	O

Traditionally	O
,	O
and	O
in	O
may	O
regions	O
of	O
the	O
world	O
today	O
,	O
seasonal	O
availability	O
of	O
food	O
determines	O
dietary	O
intakes	O
.	O

The	O
concordance	O
of	O
providers	O
’	O
weight	O
gain	O
advice	O
with	O
IOM	O
recommendations	O
did	O
not	O
vary	O
by	O
mothers	O
’	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
χ	O
(	O
2	O
)	O
2	O
=	O
2	O
.	O
382	O
,	O
p	O
=	O
0	O
.	O
304	O
].	O

For	O
regulatory	O
purposes	O
,	O
there	O
are	O
major	O
limitations	O
to	O
simply	O
extending	O
lifetime	O
rodent	O
studies	O
beyond	O
the	O
standard	O
2	O
years	O
to	O
examine	O
later	O
-	O
onset	O
epigenetic	O
adverse	O
outcomes	O
,	O
including	O
financial	O
,	O
ethical	O
and	O
scientific	O
considerations	O
.	O

Results	O
GDM	O
was	O
observed	O
in	O
81	O
of	O
the	O
723	O
women	O
(	O
11	O
%).	O

Recently	O
,	O
Moses	O
et	O
al	O
.	O

Rates	O
of	O
hypercalcaemia	O
(>	O
2	O
.	O
75mmol	O
/	O
L	O
)	O
increased	O
from	O
2011	O
(	O
1	O
.	O
1	O
%	O
vs	O
1	O
.	O
3	O
%	O
vs	O
8	O
.	O
7	O
%,	O
χ2P	O
<	O
0	O
.	O
001	O
).	O

reported	O
was	O
comparable	O
to	O
our	O
findings	O
[	O
44	O
].	O

Novel	O
approaches	O
to	O
motivating	O
handwashing	O
behavior	O
to	O
protect	O
newborns	O
should	O
be	O
developed	O
and	O
evaluated	O
.	O

[	O
9	O
]	O
The	O
actions	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
are	O
mediated	O
through	O
specific	O
,	O
high	O
affinity	O
binding	O
to	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
),	O
which	O
is	O
present	O
in	O
multiple	O
tissues	O
.	O

He	O
also	O
suggests	O
that	O
if	O
a	O
lactating	O
mother	O
were	O
informed	O
of	O
the	O
contaminant	O
levels	O
in	O
her	O
milk	O
,	O
she	O
may	O
be	O
scared	O
to	O
continue	O
breastfeeding	O
or	O
even	O
discouraged	O
from	O
doing	O
so	O
by	O
her	O
healthcare	O
provider	O
.	O

They	O
sought	O
to	O
have	O
the	O
mother	O
and	O
family	O
members	O
identify	O
perceived	O
barriers	O
to	O
their	O
own	O
handwashing	O
,	O
to	O
address	O
those	O
barriers	O
through	O
behavioral	O
solutions	O
,	O
and	O
to	O
enhance	O
maternal	O
self	O
-	O
efficacy	O
for	O
handwashing	O
in	O
the	O
neonatal	O
period	O
.	O

Furthermore	O
,	O
associations	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
obstetric	O
complications	O
(	O
4	O
)	O
and	O
offspring	O
musculoskeletal	O
development	O
(	O
5	O
–	O
7	O
)	O
have	O
been	O
reported	O
.	O

In	O
addition	O
,	O
treating	O
the	O
infant	O
with	O
DDAVP	O
besides	O
intravenous	O
fluids	O
may	O
also	O
be	O
beneficial	O
.	O

Although	O
,	O
only	O
hypothesis	O
generating	O
,	O
two	O
ecological	O
studies	O
support	O
the	O
hypothesis	O
by	O
reporting	O
the	O
ratio	O
of	O
saturated	O
fat	O
to	O
PUFA	O
in	O
the	O
diet	O
is	O
a	O
strong	O
predictor	O
of	O
schizophrenia	O
outcome	O
,	O
measured	O
as	B
according	O
to	O
either	O
clinical	O
or	O
to	O
social	O
variables	O
[	O
6	O
,	O
14	O
].	O

We	O
used	O
a	O
zero	O
replacement	O
procedure	O
and	O
log	O
-	O
ratio	O
transformation	O
to	O
account	O
for	O
the	O
zero	O
-	O
inflated	O
and	O
compositional	O
nature	O
of	O
the	O
data	O
[	O
48	O
]	O
before	O
running	O
linear	O
models	O
.	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

There	O
was	O
also	O
a	O
larger	O
,	O
statistically	O
significant	O
percentage	O
who	O
reported	O
consuming	O
3	O
or	O
more	O
vegetables	O
per	O
day	O
in	O
the	O
control	O
vs	O
treatment	O
group	O
:	O
37	O
.	O
8	O
%	O
(	O
95	O
%	O
CI	O
33	O
.	O
44	O
-	O
42	O
.	O
19	O
)	O
in	O
control	O
vs	O
30	O
.	O
0	O
%	O
(	O
95	O
%	O
CI	O
25	O
.	O
81	O
-	O
34	O
.	O
15	O
,	O
P	O
=.	O
046	O
)	O
in	O
the	O
treatment	O
group	O
,	O
respectively	O
.	O

Compulsive	O
feeding	O
test	O
This	O
test	O
was	O
an	O
adaptation	O
of	O
the	O
Compulsive	O
Feeding	O
Test	O
described	O
by	O
Heyne	O
et	O
al	O
.	O

In	O
these	O
models	O
,	O
we	O
found	O
a	O
significant	O
effect	O
of	O
text4baby	O
on	O
self	O
-	O
reported	O
alcohol	O
consumption	O
postpartum	O
(	O
OR	O
0	O
.	O
212	O
,	O
95	O
%	O
CI	O
0	O
.	O
046	O
-	O
0	O
.	O
973	O
,	O
P	O
=.	O
046	O
),	O
as	B
measured	O
by	O
the	O
question	O
“	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?”	O
The	O
lower	O
OR	O
indicates	O
lower	O
odds	O
of	O
consuming	O
alcoholic	O
beverages	O
at	O
postpartum	O
follow	O
-	O
up	O
.	O

Furthermore	O
,	O
lower	O
risk	O
of	O
low	O
birth	O
head	O
circumference	O
was	O
nonsignificantly	O
associated	O
with	O
a	O
traditional	O
dietary	O
pattern	O
[	O
OR	O
0	O
.	O
58	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
13	O
-	O
2	O
.	O
51	O
),	O
P	O
=	O
0	O
.	O
41	O
].	O

In	O
1995	O
former	O
uranium	O
miner	O
George	O
Tutt	O
recollected	O
,	O
“	O
We	O
were	O
blessed	O
,	O
we	O
thought	O
.	O

NPR3	O
contains	O
an	O
extracellular	O
domain	O
(	O
ECD	O
),	O
transmembrane	O
(	O
TM	O
)	O
domain	O
,	O
and	O
cytoplasmic	O
domain	O
(	O
CD	O
).	O

Such	O
an	O
approach	O
would	O
have	O
to	O
encompass	O
emerging	O
knowledge	O
about	O
how	O
obesity	O
is	O
the	O
consequence	B
of	O
complex	O
factors	O
acting	O
at	O
many	O
stages	O
throughout	O
a	O
person	O
'	O
s	O
lifetime	O
.	O

These	O
modifications	O
alter	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
(	O
such	O
as	O
transcription	O
factors	O
and	O
RNA	O
polymerases	O
)	O
so	O
that	O
it	O
is	O
the	O
overall	O
combined	O
effect	O
of	O
the	O
histone	O
code	O
that	O
determines	O
an	O
active	O
or	O
repressive	O
chromatin	O
structure	O
and	O
thus	O
regulates	O
gene	O
expression	O
.	O

Of	O
PNV	O
users	O
,	O
477	O
(	O
62	O
.	O
5	O
%)	O
reported	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
,	O
238	O
(	O
31	O
.	O
2	O
%)	O
reported	O
use	O
only	O
after	O
pregnancy	O
was	O
diagnosed	O
,	O
and	O
just	O
48	O
(	O
6	O
.	O
3	O
%)	O
of	O
women	O
reported	O
using	O
PNVs	O
prior	O
to	O
pregnancy	O
but	O
discontinuing	O
PNV	O
use	O
after	O
diagnosis	O
of	O
pregnancy	O
.	O

No	O
difference	O
in	O
serum	O
25OHD	O
was	O
noted	O
between	O
groups	O
.	O

This	O
ability	O
has	O
been	O
documented	O
at	O
meals	O
(	O
42	O
,	O
43	O
)	O
and	O
during	O
the	O
course	O
of	O
a	O
day	O
(	O
44	O
).	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
upon	O
enrollment	O
,	O
and	O
depression	O
score	O
of	O
0	O
to	O
13	O
.	O

To	O
date	O
,	O
there	O
has	O
been	O
limited	O
investigation	O
of	O
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
developing	O
infant	O
gut	O
microbiome	O
.	O

Overall	O
satisfaction	O
Most	O
of	O
the	O
women	O
were	O
satisfied	O
with	O
the	O
care	O
rendered	O
them	O
at	O
the	O
different	O
health	O
centres	O
with	O
96	O
.	O
9	O
%	O
being	O
“	O
very	O
satisfied	O
”.	O

Schools	O
can	O
intervene	O
by	O
offering	O
healthy	O
food	O
choices	O
in	O
their	O
breakfast	O
and	O
lunch	O
programs	O
and	O
vending	O
machines	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s12940	O
-	O
017	O
-	O
0332	O
-	O
3	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

The	O
exclusion	O
criteria	O
included	O
changing	O
the	O
routine	O
treatment	O
as	O
well	O
as	O
taking	O
vitamin	O
D	O
,	O
Ca	O
,	O
and	O
multivitamin	O
supplements	O
.	O

Innovate	O
•	O
Develop	O
and	O
test	O
innovative	O
approaches	O
to	O
deliver	O
essential	O
services	O
for	O
prevention	O
and	O
care	O
,	O
particularly	O
ones	O
aimed	O
at	O
the	O
most	O
vulnerable	O
and	O
marginalised	O
people	O
.	O

We	O
know	O
a	O
lot	O
about	O
the	O
benefits	O
of	O
breastfeeding	O
for	O
mothers	O
and	O
babies	O
,	O
says	O
Alison	O
Stuebe	O
,	O
an	O
obstetrician	O
/	O
gynecologist	O
at	O
the	O
University	O
of	O
North	O
Carolina	O
School	O
of	O
Medicine	O
,	O
but	O
“	O
we	O
know	O
far	O
less	O
than	O
we	O
should	O
about	O
how	O
the	O
breast	O
functions	O
in	O
lactation	O
and	O
what	O
specific	O
factors	O
might	O
be	O
making	O
it	O
harder	O
than	O
evolution	O
had	O
intended	O
.”	O
“	O
Very	O
few	O
studies	O
have	O
looked	O
at	O
the	O
factors	O
that	O
may	O
interfere	O
with	O
lactation	O
,”	O
agrees	O
Philippe	O
Grandjean	O
,	O
an	O
epidemiologist	O
at	O
the	O
Harvard	O
School	O
of	O
Public	O
Health	O
and	O
the	O
University	O
of	O
Southern	O
Denmark	O
.	O

PubMed	O
Central	O
:	O

We	O
had	O
previously	O
shown	O
a	O
seasonal	O
dependence	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
prepubertal	O
girls	O
in	O
Houston	O
[	O
18	O
]	O
with	O
no	O
differences	O
in	O
calcium	O
absorption	O
or	O
kinetics	O
between	O
Hispanic	O
and	O
Caucasian	O
prepubertal	O
girls	O
.	O

Here	O
the	O
focus	O
is	O
on	O
the	O
hepatic	O
transcriptomic	O
response	O
.	O

The	O
study	O
combined	O
two	O
cohorts	O
,	O
and	O
serum	O
samples	O
were	O
collected	O
late	O
in	O
pregnancy	O
or	O
approximately	O
2	O
weeks	O
after	O
birth	O
.	O

In	O
severe	O
cases	O
,	O
both	O
maternal	O
and	O
fetal	O
survival	O
can	O
be	O
threatened	O
at	O
or	O
near	O
birth	O
.	O

Compared	O
with	O
women	O
who	O
did	O
not	O
snore	O
during	O
pregnancy	O
,	O
the	O
adjusted	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
were	O
noted	O
to	O
be	O
6	O
.	O
4	O
mg	O
/	O
dl	O
higher	O
among	O
those	O
women	O
who	O
snored	O
during	O
pregnancy	O
(	O
β	O
=	O
6	O
.	O
4	O
mg	O
/	O
dl	O
,	O
95	O
%	O
CI	O
0	O
.	O
32	O
-	O
12	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
04	O
).	O

The	O
US	O
Preventive	O
Services	O
Task	O
Force	O
does	O
not	O
comment	O
for	O
or	O
against	O
routine	O
screening	O
for	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
.	O

Approximately	O
25	O
-	O
30	O
g	O
of	O
calcium	O
are	O
transferred	O
to	O
the	O
fetal	O
skeleton	O
by	O
the	O
end	O
of	O
pregnancy	O
,	O
most	O
of	O
which	O
is	O
transferred	O
during	O
the	O
last	O
trimester	O
.	O

In	O
previous	O
work	O
and	O
a	O
scoping	O
study	O
,	O
we	O
found	O
that	O
most	O
of	O
the	O
research	O
carried	O
out	O
in	O
relation	O
to	O
impaired	O
spermatogenesis	O
had	O
investigated	O
time	O
trends	O
rather	O
than	O
association	O
with	O
specific	O
risk	O
factors	O
(	O
Martin	O
et	O
al	O
.	O

Only	O
4	O
studies	O
tested	O
at	O
multiple	O
time	O
points	O
[	O
18	O
,	O
21	O
,	O
22	O
,	O
24	O
],	O
four	O
beyond	O
two	O
years	O
[	O
20	O
,	O
21	O
,	O
23	O
,	O
24	O
],	O
and	O
only	O
two	O
looked	O
at	O
children	O
of	O
school	O
age	O
[	O
20	O
,	O
21	O
].	O

This	O
is	O
carried	O
out	O
at	O
each	O
age	O
point	O
of	O
the	O
index	O
child	O
—	O
at	O
birth	O
and	O
at	O
ages	O
5	O
and	O
9	O
.	O

The	O
fractionator	O
method	O
was	O
used	O
to	O
estimate	O
the	O
number	O
of	O
glomeruli	O
in	O
a	O
slice	O
(	O
starting	O
with	O
a	O
random	O
number	O
for	O
each	O
10th	O
section	O
).	O

Overall	O
,	O
nutritional	O
manipulation	O
during	O
the	O
early	O
,	O
mid	O
-,	O
or	O
late	O
gestation	O
period	O
may	O
affects	O
adiposity	O
or	O
marbling	O
of	O
beef	O
,	O
but	O
these	O
effects	O
are	O
generally	B
small	O
and	O
often	O
masked	O
by	O
postnatal	O
nutritional	O
status	O
,	O
as	O
mentioned	O
by	O
Bell	O
and	O
Greenwood	O
[	O
158	O
].	O

None	O
of	O
the	O
OCP	O
class	O
95	O
%	O
CIs	O
excluded	O
zero	O
.	O

Discussion	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
that	O
occurs	O
in	O
4	O
out	O
of	O
100	O
,	O
000	O
pregnancies	O
as	O
discussed	O
by	O
Durr	O
[	O
1	O
].	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
significantly	O
more	O
likely	B
to	O
have	O
vitamin	O
D	O
levels	O
below	O
recognized	B
thresholds	B
for	O
optimal	O
and	O
adequate	O
status	O
(	O
i	O
.	O
e	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Repeat	O
element	O
methylation	O
markers	O
grouped	O
by	O
in	O
utero	O
exposures	O
.	O
Group	O
mean	O
±	O
SDExposure	O
n	O
LINE	O
-	O
1AluYb8Array	O
-	O
based	O
methylationSexMale19051	O
.	O
7	O
±	O
4	O
.	O
465	O
.	O
3	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012Female19051	O
.	O
7	O
±	O
4	O
.	O
964	O
.	O
6	O
±	O
3	O
.	O
30	O
.	O
237	O
±	O
0	O
.	O
013	O
p	O
-	O
Value0	O
.	O
900	O
.	O
040	O
.	O
28Maternal	O
ethnicityCaucasian21751	O
.	O
4	O
±	O
4	O
.	O
564	O
.	O
9	O
±	O
3	O
.	O
30	O
.	O
239	O
±	O
0	O
.	O
013Non	O
-	O
Caucasian16352	O
.	O
0	O
±	O
4	O
.	O
865	O
.	O
1	O
±	O
3	O
.	O
30	O
.	O
236	O
±	O
0	O
.	O
011	O
p	O
-	O
Value0	O
.	O
210	O
.	O
470	O
.	O
17Maternal	O
tobacco	O
use	O
during	O
pregnancyYes3652	O
.	O
9	O
±	O
4	O
.	O
766	O
.	O
2	O
±	O
2	O
.	O
30	O
.	O
240	O
±	O
0	O
.	O
011No34351	O
.	O
6	O
±	O
4	O
.	O
664	O
.	O
8	O
±	O
3	O
.	O
40	O
.	O
237	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
10	O
<	O
0	O
.	O
010	O
.	O
31Maternal	O
alcohol	O
use	O
during	O
pregnancyYes355	O
.	O
0	O
±	O
1	O
.	O
066	O
.	O
0	O
±	O
3	O
.	O
40	O
.	O
230	O
±	O
0	O
.	O
001No37751	O
.	O
7	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
020	O
.	O
660	O
.	O
51Maternal	O
prenatal	O
vitamin	O
use	O
during	O
pregnancyYes31451	O
.	O
8	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012No6651	O
.	O
3	O
±	O
4	O
.	O
764	O
.	O
6	O
±	O
3	O
.	O
40	O
.	O
238	O
±	O
0	O
.	O
014	O
p	O
-	O
Value0	O
.	O
500	O
.	O
290	O
.	O
80	O
p	O
-	O
Values	O
obtained	O
from	O
Kruskal	O
–	O
Wallis	O
tests	O
.	O

Of	O
note	O
is	O
that	O
few	O
subjects	O
had	O
a	O
cord	O
25	O
(	O
OH	O
)	O
D	O
<	O
6	O
ng	O
/	O
mL	O
,	O
a	O
value	O
found	O
in	O
studies	O
in	O
pregnant	O
women	O
and	O
newborns	O
in	O
the	O
Middle	O
East	O
[	O
9	O
,	O
10	O
].	O

Discussion	O
Our	O
data	O
suggest	O
that	O
while	O
prenatal	O
PNV	O
use	O
is	O
associated	O
with	O
lower	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
,	O
the	O
association	O
is	O
not	O
uniform	O
.	O

Intervention	O
in	O
the	O
supplement	O
consumer	O
(	O
vitamin	O
D	O
)	O
group	O
:	O
In	O
2007	O
and	O
2010	O
,	O
the	O
Canadian	O
Pediatric	O
Association	O
recommended	O
a	O
daily	O
amount	O
of	O
2000	O
IU	O
of	O
vitamin	O
D	O
for	O
pregnant	O
and	O
breast	O
-	O
feeding	O
women	O
[	O
47	O
,	O
46	O
].	O

A	O
multi	O
-	O
centered	O
study	O
of	O
four	O
Midwest	O
states	O
examining	O
rural	O
and	O
farm	O
exposures	O
observed	O
a	O
statistically	O
significant	O
increased	O
risk	O
of	O
adult	O
gliomas	O
for	O
springtime	O
births	O
,	O
but	O
only	O
among	O
those	O
born	O
“	O
off	O
”	O
a	O
farm	O
[	O
21	O
].	O

Among	O
these	O
,	O
39	O
%	O
of	O
intervention	O
households	O
and	O
3	O
%	O
of	O
control	O
households	O
were	O
observed	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
station	O
at	O
all	O
of	O
the	O
visits	O
.	O

We	O
would	O
like	O
to	O
propose	O
a	O
potential	O
model	O
where	O
,	O
during	O
preterm	O
birth	O
,	O
GR	O
α	O
is	O
the	O
predominant	B
receptor	O
since	B
there	O
is	O
a	O
decrease	O
in	O
negative	O
regulators	O
such	O
as	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
and	O
the	O
“	O
pseudo	O
-	O
GRE	O
”	O
GAS5	O
.	O

The	O
relationships	O
were	O
similar	O
to	O
those	O
in	O
the	O
whole	O
cohort	O
.	O

Moreover	O
,	O
40	O
subjects	O
with	O
samples	O
from	O
two	O
subsequent	O
years	O
showed	O
a	O
highly	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
visit	O
one	O
to	O
visit	O
two	O
.	O

We	O
analyzed	O
various	O
housekeeping	O
genes	O
and	O
selected	O
the	O
most	O
suitable	O
according	O
to	O
their	O
homogeneity	O
.	O

Therefore	B
,	O
increased	O
glucose	O
availability	O
is	O
important	O
for	O
providing	O
glycerol	O
for	O
IMF	O
deposition	O
in	O
ruminants	O
[	O
69	O
],	O
similar	O
to	O
monogastric	O
animals	O
such	O
as	O
pigs	O
.	O

Therefore	O
,	O
a	O
multiple	O
imputation	O
model	O
was	O
constructed	O
to	O
account	O
for	O
missing	O
race	O
and	O
marital	O
status	O
through	O
use	O
of	O
a	O
logit	O
function	O
with	O
parity	O
,	O
age	O
,	O
and	O
treatment	O
status	O
as	B
predictors	O
of	O
both	O
race	O
and	O
marital	O
status	O
.	O

There	O
have	O
been	O
experiments	O
with	O
fortification	O
of	O
fish	O
sauce	O
however	O
this	O
is	O
not	O
yet	O
on	O
a	O
commercial	O
scale	O
.	O

However	O
,	O
it	O
will	O
be	O
increasingly	O
important	O
to	O
examine	O
,	O
in	O
larger	O
studies	O
,	O
how	O
additional	O
specific	O
exposures	O
,	O
such	O
as	O
lead	O
as	O
has	O
been	O
done	O
by	O
previous	O
researchers	O
(	O
Pilsner	O
et	O
al	O
.	O

Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

Discussion	O
In	O
our	O
study	O
,	O
less	O
than	O
half	O
the	O
participants	O
used	O
folic	O
acid	O
or	O
iron	O
during	O
their	O
pregnancy	O
,	O
while	O
approximately	O
two	O
thirds	O
took	O
multivitamin	O
supplements	O
.	O

The	O
25	O
(	O
OH	O
)	O
D	O
distribution	O
based	O
on	O
caries	O
-	O
status	O
appears	O
in	O
Table	O
2	O
.	O

values94	O
dpc	O
CCND20	O
.	O
022	O
-	O
1	O
.	O
25down0	O
.	O
0001	O
-	O
1	O
.	O
83down0	O
.	O
47	O
*	O
NCAPG0	O
.	O
019	O
-	O
1	O
.	O
73down0	O
.	O
003	O
-	O
1	O
.	O
58down0	O
.	O
47	O
*	O
MGMT0	O
.	O
031	O
+	O
1	O
.	O
12up0	O
.	O
011	O
+	O
1	O
.	O
32up0	O
.	O
53	O
**	O
GADD45B0	O
.	O
669	O
-	O
1	O
.	O
08n	O
.	O
r	O
.	O
0	O
.	O
522	O
+	O
1	O
.	O
17n	O
.	O
r0	O
.	O
68	O
***	O
1	O
dpn	O
SDHB0	O
.	O
0006	O
-	O
1	O
.	O
19down0	O
.	O
028	O
-	O
1	O
.	O
30down0	O
.	O
71	O
***	O
CCND20	O
.	O
711	O
-	O
1	O
.	O
06n	O
.	O
r	O
.	O
0	O
.	O
651	O
-	O
1	O
.	O
09n	O
.	O
r	O
.	O
0	O
.	O
46	O
*	O
PPARGC1A0	O
.	O
745	O
-	O
1	O
.	O
03n	O
.	O
r	O
.	O
0	O
.	O
761	O
-	O
1	O
.	O
04n	O
.	O
r	O
.	O
0	O
.	O
67	O
***	O
188	O
dpn	O
PRKAA10	O
.	O
0004	O
-	O
1	O
.	O
68down0	O
.	O
027	O
-	O
1	O
.	O
40down0	O
.	O
77	O
***	O
PRKAA20	O
.	O
009	O
-	O
1	O
.	O
36down0	O
.	O
095	O
-	O
1	O
.	O
25down0	O
.	O
10PPARGC1A0	O
.	O
126	O
-	O
1	O
.	O
35n	O
.	O
r	O
.	O
0	O
.	O
105	O
-	O
1	O
.	O
36n	O
.	O
r	O
.	O
0	O
.	O
86	O
***	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
*	O
calculated	O
by	O
factorial	O
normalisation	O
on	O
RPL10	O
expression	O
values	O
;	O
**	O
p	O
-	O
value	O
of	O
pamn	O
'	O
rho	O
;	O
n	O
.	O
r	O
.	O

One	O
case	O
of	O
anaphylaxis	O
and	O
3	O
cases	O
of	O
serious	O
allergic	O
reaction	O
involved	O
women	O
taking	O
prenatal	O
supplements	O
,	O
two	O
of	O
which	O
reported	O
spontaneous	O
abortion	O
.	O

Therefore	B
,	O
expression	O
profiles	O
at	O
weaning	O
and	O
adult	O
stages	O
point	O
to	O
an	O
alarm	O
alert	O
(	O
activated	O
defence	O
)	O
in	O
LP	O
offspring	O
.	O

Analysis	O
of	O
SNPs	O
Genotyping	O
was	O
undertaken	O
by	O
LGC	O
Genomics	O
(	O
Hoddeston	O
,	O
UK	O
)	O
using	O
KASP	O
competitive	O
allele	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
.	O

Indeed	O
,	O
it	O
negatively	O
regulates	O
the	O
energy	O
balance	O
by	O
increasing	O
energy	O
expenditure	O
.	O

Results	O
Subjects	O
and	O
demographic	O
data	O
From	O
the	O
original	O
201	O
neonates	O
enrolled	O
in	O
the	O
study	O
,	O
122	O
pairs	O
of	O
maternal	O
-	O
cord	O
serum	O
were	O
collected	O
(	O
Fig	O
1	O
).	O

Preexisting	O
asthma	O
symptoms	O
may	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
.	O

The	O
existence	O
of	O
receptors	O
for	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
)	O
in	O
the	O
brain	O
induces	O
a	O
direct	O
effect	O
.	O

Further	O
,	O
the	O
various	O
chapters	O
in	O
the	O
book	O
explain	O
the	O
basic	O
principles	O
in	O
nutrition	O
coupled	O
with	O
applications	O
in	O
different	O
clinical	O
conditions	O
.	O

A	O
community	O
-	O
based	O
cluster	O
randomised	O
trial	O
from	O
China	O
reported	O
a	O
54	O
%	O
reduction	O
of	O
early	O
neonatal	O
mortality	O
in	O
newborns	O
of	O
women	O
who	O
received	O
IFA	O
supplements	O
compared	O
to	O
those	O
receiving	O
folic	O
acid	O
alone	O
(	O
HR	O
0	O
.	O
46	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
21	O
–	O
0	O
.	O
98	O
)	O
[	O
7	O
].	O

BMC	O
=	O
bone	O
mineral	O
content	O
BMD	O
=	O
bone	O
mineral	O
density	O
PTH	O
=	O
serum	O
parathyroid	O
hormone	O
25	O
(	O
OH	O
)	O
D	O
=	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
(	O
conversion	O
to	O
nmol	O
/	O
L	O
is	O
by	O
multiplying	O
values	O
shown	O
by	O
2	O
.	O
5	O
)	O
For	O
entire	O
49	O
subjects	O
enrolled	O
:	O
Values	O
for	O
cord	O
25	O
(	O
OH	O
)	O
D	O
,	O
Non	O
-	O
Hispanic	O
Caucasian	O
(	O
n	O
=	O
22	O
),	O
22	O
.	O
3	O
±	O
9	O
.	O
4	O
ng	O
/	O
mL	O
and	O
Hispanic	O
(	O
n	O
=	O
27	O
),	O
16	O
.	O
4	O
±	O
6	O
.	O
5	O
ng	O
/	O
mL	O
,	O
p	O
=	O
0	O
.	O
01	O
.	O

#	O
Beta	O
(	O
s	O
.	O
e	O
.	O

In	O
addition	O
,	O
immature	O
and	O
mature	O
glomeruli	O
were	O
estimated	O
at	O
birth	O
and	O
on	O
day	O
10	O
,	O
when	O
glomerular	O
development	O
is	O
completed	O
.	O

There	O
is	O
now	O
increasing	O
evidence	O
that	O
the	O
newer	O
rapid	O
acting	O
insulin	O
analogs	O
lispro	O
and	O
aspart	O
are	O
also	O
safe	O
in	O
pregnancy	O
,	O
and	O
indeed	O
,	O
they	O
are	O
commonly	O
used	O
.	O

However	O
,	O
our	O
data	O
remain	O
relevant	O
because	B
PNV	O
use	O
is	O
likely	B
to	O
be	O
more	O
modifiable	O
than	O
latitude	O
of	O
residence	O
,	O
skin	O
pigmentation	O
,	O
sun	O
exposure	O
which	O
should	O
be	O
limited	O
due	B
to	I
skin	O
cancer	O
risk	O
,	O
or	O
even	O
dietary	O
patterns	O
which	O
can	O
be	O
difficult	O
to	O
change	O
.	O

Results	O
Of	O
the	O
160	O
women	O
surveyed	O
,	O
39	O
%	O
reported	O
using	O
herbs	O
and	O
61	O
%	O
did	O
not	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
systematically	O
investigated	O
confounders	O
between	O
groups	O
,	O
and	O
adjusted	O
for	O
those	O
when	O
applicable	O
.	O

For	O
all	O
regression	O
analyses	O
,	O
two	O
stages	O
of	O
adjustment	O
were	O
used	O
.	O

Therefore	B
,	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
dose	O
employed	O
in	O
this	O
study	O
is	O
of	O
higher	O
effectiveness	O
compared	O
with	O
an	O
oral	O
dose	O
,	O
especially	O
in	O
people	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
vitamin	O
D	O
can	O
directly	O
stimulate	O
several	O
immune	O
cells	O
and	O
can	O
promote	O
the	O
production	O
of	O
antimicrobial	O
peptides	O
[	O
45	O
–	O
47	O
].	O

3	O
.	O
3	O
.	O

2	O
Number	O
of	O
surveyed	O
women	O
at	O
delivery	O
,	O
number	O
of	O
pregnant	O
women	O
vaccinated	O
for	O
month	O
stratified	O
by	O
trimester	O
of	O
vaccination	O
,	O
and	O
proportion	O
of	O
influenza	O
positive	O
samples	O
from	O
routine	O
surveillance	O
*,	O
Nicaragua	O
2014	O
*	O
Proportions	O
of	O
influenza	O
positive	O
samples	O
from	O
routine	O
surveillance	O
correspond	O
to	O
year	O
2014	O
.	O

These	O
probe	O
-	O
sets	O
represent	O
5	O
,	O
887	O
genes	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
6	O
,	O
965	O
;	O
28	O
dpn	O
:	O
6	O
,	O
387	O
;	O
188	O
dpn	O
:	O
6	O
,	O
958	O
),	O
according	O
to	O
the	O
recent	O
annotation	O
[	O
18	O
].	O

In	O
order	O
to	O
explore	O
the	O
biological	O
plausibility	O
of	O
this	O
candidate	O
,	O
we	O
have	O
a	O
rat	O
model	O
that	O
we	O
call	O
the	O
Developmental	O
Vitamin	O
D	O
(	O
DVD	O
)	O
model	O
.	O

Criteria	O
for	O
admission	O
and	O
hospital	O
management	O
of	O
the	O
pregnant	O
woman	O
with	O
acute	O
asthma	O
should	O
be	O
more	O
lenient	O
than	O
for	O
nonpregnant	O
patients	O
.	O

Debate	O
also	O
exists	O
in	O
relation	O
to	O
seasonality	O
of	O
physical	O
activity	O
levels	O
[	O
30	O
,	O
44	O
].	O

There	O
were	O
no	O
significant	O
associations	O
found	O
with	O
in	O
vitro	O
fertilization	O
/	O
intracytoplasmic	O
sperm	O
injection	O
(	O
ICSI	O
)	O
or	O
with	O
cryopreserved	O
embryos	O
or	O
gametes	O
,	O
types	O
of	O
hormones	O
,	O
or	O
cause	O
of	O
infertility	O
.	O

However	O
,	O
in	O
Viet	O
Nam	O
fortification	O
of	O
cereals	O
is	O
not	O
easily	O
available	O
for	O
rural	O
areas	O
(	O
rice	O
,	O
the	O
main	O
staple	O
,	O
is	O
more	O
costly	O
to	O
fortify	O
,	O
and	O
less	O
feasible	O
to	O
fortify	O
given	B
the	O
lack	O
of	O
central	O
processing	O
).	O

Authors	O
'	O
contributions	O
Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
KW	O
CCM	O
SP	O
.	O

Cont	O
–	O
control	O
pregnancies	O
;	O
UN	O
P	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
only	O
;	O
UN	O
L	O
–	O
dams	O
undernourished	O
during	O
lactation	O
only	O
;	O
UN	O
PL	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
and	O
lactation	O
;	O
MHF	O
–	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
pre	O
-	O
conceptionally	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
;	O
PLHF	O
–	O
dams	O
fed	O
a	O
chow	O
diet	O
pre	O
-	O
conceptionally	O
and	O
a	O
high	O
fat	O
diet	O
throughout	O
pregnancy	O
and	O
lactation	O
only	O
.	O

To	O
reduce	O
exposure	O
misclassification	O
,	O
we	O
pooled	O
the	O
exposures	O
at	O
16	O
and	O
26	O
weeks	O
[	O
40	O
].	O

Stage	O
of	O
development	O
Environmental	O
exposureExposureEffectAdverse	O
phenotype	O
(	O
s	O
)	O
Epigenetic	O
change	O
(	O
s	O
)	O
Reference	O
(	O
s	O
)	O
Air	O
pollution	O
ECATChildhoodChildhoodAsthmaEpigenetic	O
machinerySomineni	O
et	O
al	O
.	O

The	O
immunoreactive	O
bands	O
were	O
analyzed	O
using	O
Image	O
J	O
1	O
.	O
34s	O
image	O
-	O
analysis	O
software	O
(	O
National	O
Institute	O
of	O
Health	O
,	O
USA	O
).	O

report	O
,	O
the	O
Somali	O
immigrants	O
in	O
Sweden	O
call	O
autism	O
the	O
‘	O
Swedish	O
disease	O
’	O
and	O
Somali	O
immigrants	O
in	O
Minnesota	O
call	O
it	O
the	O
‘	O
American	O
disease	O
,’	O
but	O
in	O
equatorial	O
Somalia	O
,	O
autism	O
has	O
no	O
name	O
.	O

The	O
drop	O
-	O
outs	O
had	O
a	O
slightly	O
higher	O
BMI	O
,	O
lower	O
education	O
and	O
were	O
more	O
often	B
smokers	O
and	O
born	O
outside	O
of	O
the	O
Nordic	O
countries	O
.	O

Eligibility	O
criteria	O
for	O
infants	O
included	O
viable	O
infants	O
of	O
term	O
births	O
(	O
born	O
>	O
37	O
weeks	O
of	O
gestation	O
)	O
with	O
no	O
known	O
genetic	O
disorders	O
or	O
life	O
-	O
threatening	O
illnesses	O
.	O

Scenario	O
2	O
:	O
Countries	O
take	O
action	O
to	O
catch	O
up	O
with	O
top	O
performers	O
within	O
their	O
region	O
Preterm	O
mortality	O
could	O
be	O
halved	O
by	O
2025	O
if	O
governments	O
took	O
action	O
now	O
to	O
match	O
the	O
top	O
performers	O
within	O
their	O
regions	O
or	O
to	O
match	O
the	O
historical	O
reductions	O
in	O
the	O
United	O
States	O
and	O
the	O
United	O
Kingdom	O
from	O
basic	O
interventions	O
before	O
widespread	O
use	O
of	O
intensive	O
care	O
(	O
Figure4	O
).	O

Pre	O
-	O
eclampsia	O
is	O
a	O
known	O
independent	O
risk	O
factor	O
for	O
SGA	O
.	O

The	O
study	O
investigates	O
the	O
indicated	O
variables	O
from	O
early	O
pregnancy	O
to	O
infants	O
up	O
to	O
12	O
months	O
.	O

Furthermore	O
,	O
we	O
did	O
not	O
record	O
when	O
during	O
the	O
pregnancy	O
the	O
supplements	O
were	O
taken	O
,	O
which	O
is	O
of	O
particular	O
importance	O
for	O
folic	O
acid	O
.	O

Twelve	O
months	O
of	O
daily	O
MMN	O
supplementation	O
significantly	O
improved	O
haemoglobin	O
concentration	O
in	O
this	O
group	O
of	O
women	O
.	O

It	O
has	O
policy	O
significance	O
given	B
the	O
recommendation	O
to	O
expand	O
coverage	O
of	O
supplementation	O
with	O
weekly	O
iron	O
and	O
folic	O
acid	O
supplements	O
to	O
women	O
of	O
reproductive	O
age	O
,	O
as	O
well	O
as	O
for	O
other	O
similar	O
supplementation	O
programs	O
,	O
such	O
as	O
multiple	O
micronutrient	O
powders	O
and	O
zinc	O
for	O
children	O
.	O

Penetration	O
of	O
adverse	O
effect	O
(	O
s	O
)	O
to	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
(	O
the	O
F3generation	O
following	O
in	O
utero	O
exposure	O
,	O
or	O
the	O
F2generation	O
following	O
ex	O
utero	O
exposure	O
)	O
represents	B
true	B
epigenetic	O
inheritance	O
and	O
thus	B
transgenerational	O
toxicity	O
.	O

Surprisingly	O
,	O
physical	O
activity	O
and	O
television	O
viewing	O
were	O
not	O
significantly	O
related	O
to	O
offspring	O
weight	O
outcomes	O
in	O
normal	O
weight	O
or	O
overweight	O
/	O
obese	O
mothers	O
.	O

All	O
the	O
AWCs	O
are	O
manned	O
by	O
members	O
from	O
the	O
ICDS	O
team	O
-	O
consisting	O
of	O
Anganwadi	O
helpers	O
,	O
Anganwadi	O
workers	O
,	O
Supervisors	O
,	O
Child	O
Development	O
Project	O
Officers	O
(	O
CDPOs	O
)	O
and	O
District	O
Program	O
Officers	O
(	O
1	O
,	O
4	O
).	O

More	O
information	O
on	O
Voxiva	O
and	O
text4baby	O
has	O
been	O
published	O
elsewhere	O
[	O
24	O
].	O

The	O
differences	O
in	O
gene	O
regulation	O
dependent	O
on	O
diet	O
and	O
ontogenetic	O
stage	O
indicate	O
fetal	O
programming	O
in	O
terms	O
of	O
developmental	O
and	O
metabolic	O
disorders	O
(	O
arrows	O
between	O
boxes	O
show	O
direction	O
of	O
the	O
comparison	O
;	O
small	O
arrows	O
indicate	O
up	O
and	O
down	O
regulation	O
,	O
respectively	O
;	O
PLK	O
,	O
Polo	O
-	O
like	O
kinase	O
;	O
VEGF	O
,	O
Vascular	O
endothelial	O
growth	O
factor	O
,	O
mTOR	O
,	O
mammalian	O
target	O
of	O
rapamycin	O
;	O
AMPK	O
,	O
AMP	O
-	O
activated	O
protein	O
kinase	O
;	O
RhoA	O
,	O
Ras	O
homolog	O
gene	O
family	O
,	O
member	O
A	O
;	O
Rac	O
,	O
Ras	O
-	O
related	O
C3	O
botulinum	O
toxin	O
substrate	O
;	O
FA	O
,	O
Fatty	O
acid	O
)	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
microarray	O
data	O
and	O
qRT	O
-	O
PCR	O
of	O
selected	O
transcriptsGene	O
nameMicroarrayqRT	O
-	O
PCR	O
#	O
Correlation	O
##	O
p	O
-	O
valueFCRegulationp	O
-	O
valueFCRegulationExpr	O
.	O

Cut	O
-	O
off	O
points	O
with	O
values	O
more	O
than	O
9	O
,	O
12	O
,	O
13	O
,	O
and	O
14	O
were	O
used	O
in	O
different	O
studies	O
to	O
determine	O
perinatal	O
depression	O
[	O
37	O
,	O
43	O
,	O
44	O
].	O

During	O
the	O
first	O
visit	O
,	O
the	O
data	O
collector	O
will	O
download	O
the	O
details	O
of	O
the	O
newly	O
registered	O
pregnant	O
women	O
for	O
her	O
assigned	O
cluster	O
from	O
the	O
central	O
server	O
.	O

Other	O
investigators	O
have	O
reported	O
similar	O
small	O
or	O
statistically	O
non	O
-	O
significant	O
associations	O
between	O
birth	O
weight	O
and	O
phthalates	O
[	O
37	O
],	O
PCBs	O
[	O
15	O
],	O
PBDEs	O
[	O
13	O
],	O
and	O
OCPs	O
[	O
25	O
].	O

Even	O
more	O
intriguing	O
,	O
both	O
papers	O
report	O
that	O
the	O
mental	O
condition	O
in	O
rickets	O
improved	O
with	O
vitamin	O
D	O
.	O
Another	O
of	O
the	O
mysteries	O
of	O
autism	O
is	O
the	O
apparent	O
increased	O
incidence	O
of	O
autism	O
in	O
the	O
children	O
of	O
richer	O
college	O
-	O
educated	O
parents	O
,	O
especially	O
women	O
,	O
a	O
finding	O
announced	O
a	O
few	O
months	O
ago	O
(	O
12	O
).	O

Cathelicidin	O
(	O
ng	O
/	O
mL	O
)	O
CharacteristicMedian	O
(	O
IQR	O
)	O
1p	O
-	O
valueRace	O
/	O
Ethnicity0	O
.	O
999	O
Black26	O
.	O
8	O
(	O
23	O
.	O
3	O
,	O
41	O
.	O
6	O
)	O
White27	O
.	O
7	O
(	O
18	O
.	O
0	O
,	O
51	O
.	O
9	O
)	O
Hispanic30	O
.	O
2	O
(	O
20	O
.	O
2	O
,	O
39	O
.	O
0	O
)	O
Vitamin	O
D	O
status	O
at	O
Follow	O
-	O
up	O
Visit0	O
.	O
78	O
Deficient	O
(<	O
20	O
ng	O
/	O
mL	O
)	O
27	O
.	O
4	O
(	O
19	O
.	O
8	O
,	O
35	O
.	O
9	O
)	O
Sufficient	O
(≥	O
20	O
ng	O
/	O
mL	O
)	O
29	O
.	O
6	O
(	O
20	O
.	O
2	O
,	O
43	O
.	O
2	O
)	O
1IQR	O
represents	O
25th	O
and	O
75th	O
percentile	O
No	O
significant	O
overall	O
correlation	O
existed	O
between	O
the	O
children	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
,	O
nor	O
did	O
one	O
exist	O
when	O
the	O
cohort	O
was	O
stratified	O
by	O
race	O
/	O
ethnicity	O
.	O

The	O
Skm2	O
mutants	O
generated	O
a	O
significant	O
linkage	O
(	O
LOD	O
score	O
=	O
3	O
.	O
612	O
)	O
at	O
chromosome	O
14	O
at	O
marker	O
rs3687889	O
(	O
19	O
.	O
69	O
Mb	O
)	O
(	O
Figure	O
2A	O
,	O
bottom	O
panel	O
).	O

Ionization	O
was	O
in	O
positive	O
mode	O
and	O
Q2	O
had	O
1	O
.	O
2	O
mTorr	O
of	O
argon	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
CpG	O
class	O
methylation	O
,	O
as	O
indicated	O
by	O
the	O
key	O
.	O

Other	O
work	O
has	O
shown	O
that	O
generational	O
acculturation	O
was	O
positively	O
associated	O
with	O
excessive	O
GWG	O
[	O
10	O
].	O

Such	O
differences	O
are	O
largely	O
driven	O
by	O
diverse	O
genetic	O
backgrounds	O
.	O

2010	O
,	O
2011	O
;	O
Wolff	O
et	O
al	O
.	O

Excessive	O
weight	O
gain	O
during	O
pregnancy	O
is	O
associated	O
with	O
complications	O
in	O
delivery	O
[	O
3	O
],	O
increased	O
postpartum	O
weight	O
retention	O
[	O
4	O
],	O
persistent	O
obesity	O
[	O
4	O
],	O
increased	O
BMI	O
in	O
offspring	O
in	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
[	O
5	O
],	O
and	O
longer	O
maternal	O
hospital	O
stay	O
after	O
labor	O
and	O
delivery	O
[	O
5	O
].	O

Pubertal	O
onset	O
and	O
adult	O
ovarian	O
function	O
is	O
dependent	O
on	O
maternal	O
nutritional	O
background	O
Pubertal	O
onset	O
in	O
control	O
offspring	O
Pubertal	O
age	O
of	O
offspring	O
born	O
to	O
control	O
dams	O
was	O
similar	O
to	O
that	O
reported	O
previously	O
[	O
38	O
].	O

These	O
birds	O
,	O
which	O
lived	O
in	O
northeastern	O
Siberia	O
,	O
northern	O
Alaska	O
,	O
and	O
northern	O
Greenland	O
,	O
are	O
believed	O
to	O
have	O
had	O
no	O
contact	O
with	O
humans	O
.	O

Change	O
in	O
25OHD	O
during	O
pregnancy	O
was	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
,	O
with	O
the	O
lowest	O
odds	O
for	O
women	O
with	O
an	O
increment	O
in	O
25OHD	O
≥	O
30	O
nmol	O
/	O
L	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
:	O
Flowchart	O
of	O
design	O
and	O
protocol	O
of	O
the	O
study	O
.	O

We	O
also	O
found	O
that	O
33	O
%	O
of	O
children	O
have	O
excess	O
weight	O
and	O
16	O
%	O
of	O
them	O
were	O
already	O
obese	O
.	O

Abroms	O
and	O
colleagues	O
designed	O
and	O
evaluated	O
the	O
text2quit	O
intervention	O
,	O
which	O
delivers	O
text	O
messages	O
using	O
a	O
tailored	O
feedback	O
approach	O
to	O
promote	O
smoking	O
cessation	O
,	O
and	O
found	O
that	O
11	O
.	O
1	O
%	O
of	O
former	O
smokers	O
who	O
participated	O
in	O
the	O
intervention	O
remained	O
abstinent	O
after	O
6	O
months	O
compared	O
to	O
5	O
.	O
0	O
%	O
among	O
the	O
comparison	O
group	O
[	O
12	O
].	O

Data	O
analysis	O
was	O
done	O
using	O
EPI	O
info	O
version	O
3	O
.	O
5	O
.	O
1	O
.	O

While	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
has	O
previously	O
been	O
associated	O
with	O
reduced	O
risk	O
of	O
wheezing	O
and	O
type	O
1	O
diabetes	O
.	O

Thus	B
,	O
both	O
maternal	O
underfeeding	O
or	O
overfeeding	O
were	O
reported	O
to	O
exert	O
a	O
predisposing	O
effect	O
for	O
the	O
development	O
of	O
later	O
obesity	O
(	O
Breton	O
,	O
2013	O
).	O

Thirteen	O
of	O
14	O
cases	O
had	O
no	O
documented	O
recurrence	O
.	O

For	O
example	O
,	O
the	O
increased	O
prevalence	O
of	O
the	O
use	O
of	O
anticonvulsant	O
medications	O
during	O
pregnancy	O
is	O
correlated	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

Two	O
of	O
these	O
studies	O
used	O
similar	O
methods	O
to	O
our	O
study	O
.	O

More	O
than	O
70	O
%	O
of	O
mothers	O
in	O
the	O
population	O
had	O
at	O
least	O
a	O
college	O
degree	O
,	O
more	O
than	O
90	O
%	O
were	O
married	O
,	O
and	O
most	O
were	O
first	O
-	O
time	O
mothers	O
.	O

In	O
2006	O
Albendazole	O
sourced	O
from	O
UNICEF	O
was	O
quoted	O
at	O
USD1	O
.	O
617	O
/	O
100	O
tabs	O
.	O

[	O
34	O
]	O
Interestingly	O
,	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
also	O
associated	O
with	O
risks	O
of	O
health	O
problems	O
later	O
in	O
childhood	O
,	O
including	O
improper	O
bone	O
development	O
at	O
9	O
yrs	O
of	O
age	O
,	O
asthma	O
,[	O
36	O
]	O
dental	O
cavities	O
,	O
schizophrenia	O
,	O
and	O
type	O
I	O
diabetes	O
.	O

These	O
factors	O
can	O
contribute	O
to	O
poor	O
judgment	O
when	O
it	O
comes	O
to	O
food	O
selection	O
and	O
other	O
health	O
-	O
related	O
behaviors	O
.	O

We	O
observed	O
no	O
association	O
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
and	O
fasting	O
plasma	O
glucose	O
(	O
B	O
-	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
;	O
P	O
=	O
0	O
.	O
54	O
),	O
1	O
-	O
h	O
glucose	O
(	O
B	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
01	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
53	O
)	O
or	O
2	O
-	O
h	O
glucose	O
(	O
B	O
-	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
01	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
54	O
).	O

In	O
the	O
strata	O
,	O
each	O
eligible	O
pregnant	O
woman	O
was	O
assigned	O
in	O
the	O
control	O
or	O
the	O
vitamin	O
D	O
groups	O
using	O
block	O
randomization	O
strategy	O
.	O

Furthermore	O
,	O
genes	O
associated	O
with	O
the	O
complement	O
system	O
were	O
found	O
to	O
be	O
regulated	O
in	O
a	O
diet	O
-	O
dependent	O
manner	O
at	O
stage	O
28	O
dpn	O
.	O

A	O
recent	O
study	O
,	O
21has	O
indicated	O
that	O
administrating	O
a	O
high	O
dose	O
of	O
vitamin	O
D	O
every	O
two	O
months	O
was	O
an	O
easy	O
and	O
comfortable	O
treatment	O
.	O

Maternal	O
medical	O
assessment	O
and	O
history	O
Medical	O
history	O
is	O
obtained	O
at	O
each	O
prenatal	O
visit	O
(	O
phases	O
1	O
to	O
3	O
)	O
by	O
means	O
of	O
participant	O
responses	O
and	O
inspection	O
of	O
medical	O
files	O
.	O

Living	O
in	O
urban	O
areas	O
such	O
as	O
in	O
Bangkok	O
,	O
increases	O
the	O
risk	O
of	O
vitamin	O
D	O
insufficiency	O
due	O
to	O
increased	O
pollution	O
,	O
which	O
decreases	O
the	O
amount	O
of	O
UVB	O
available	O
for	O
cutaneous	O
vitamin	O
D	O
synthesis	O
.	O

Analysis	O
conducted	O
using	O
data	O
from	O
Liu	O
et	O
al	O
.,	O
2012	O
[	O
50	O
].	O

Therefore	B
,	O
at	O
baseline	O
we	O
excluded	O
those	O
mothers	O
with	O
the	O
EPDS	O
scores	O
of	O
>	O
13	O
and	O
they	O
were	O
referred	O
to	O
a	O
psychologist	O
for	O
further	O
evaluation	O
and	O
management	O
.	O

Of	O
the	O
9	O
PBDEs	O
,	O
a	O
10	O
-	O
fold	O
increase	O
in	O
PBDE	O
17	O
was	O
associated	O
with	O
the	O
greatest	O
birth	O
weight	O
increase	O
(	O
12	O
g	O
)	O
while	O
PBDE	O
153	O
was	O
associated	O
with	O
the	O
greatest	O
decrease	O
(	O
23	O
g	O
).	O

Identification	O
of	O
environmental	O
factors	O
is	O
the	O
first	O
step	O
in	O
preventing	O
and	O
mitigating	O
risks	O
by	O
primary	O
prevention	O
[	O
1	O
].	O

The	O
new	O
study	O
appears	O
in	O
the	O
July	O
2006	O
issue	O
of	O
Archives	O
of	O
Medical	O
Research	O
.	O

Result	O
:	O
As	O
mentioned	O
above	O
,	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
month	O
is	O
proved	B
to	O
se	O
helpful	O
for	O
mother	O
&	O
fetus	O
.	O

†	O
Adjusted	O
for	O
insurance	O
status	O
and	O
years	O
of	O
education	O
(	O
social	O
economic	O
status	O
proxy	O
variables	O
).	O

However	O
,	O
of	O
these	O
six	O
deficient	O
GDM	O
-	O
mothers	O
five	O
(	O
83	O
%)	O
were	O
smokers	O
,	O
and	O
correspondingly	O
in	O
non	O
-	O
GDM	O
mothers	O
four	O
out	O
of	O
eighteen	O
were	O
smokers	O
(	O
24	O
%)	O
(	O
P	O
=	O
0	O
.	O
018	O
).	O

Despite	O
these	O
limitations	O
,	O
the	O
large	O
sample	O
size	O
provided	B
sufficient	O
statistical	O
power	O
,	O
allowing	O
greater	O
confidence	O
in	O
our	O
findings	O
.	O

For	O
the	O
QFFQ	O
data	O
,	O
portion	O
sizes	O
are	O
converted	O
to	O
grams	O
per	O
week	O
per	O
food	O
item	O
,	O
by	O
two	O
registered	O
dietitians	O
/	O
nutritionists	O
.	O

It	O
found	O
an	O
increase	O
in	O
stillbirth	O
and	O
perinatal	O
mortality	O
,	O
as	O
well	O
as	O
pre	O
-	O
eclampsia	O
amongst	O
those	O
treated	O
with	O
metformin	O
,	O
compared	O
to	O
women	O
treated	O
with	O
insulin	O
or	O
sulphonylureas	O
.	O

An	O
overview	O
of	O
the	O
relevant	O
TGs	O
that	O
could	O
be	O
explored	O
for	O
adaptation	O
(	O
updated	O
from	O
Greally	O
&	O
Jacobs2013	O
),	O
is	O
provided	O
inTable	O
3	O
.	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
,	O
since	B
there	O
were	O
no	O
adverse	O
effects	O
reported	O
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
day	O
,	O
but	O
to	O
proclaim	O
it	O
the	O
Golden	O
Fleece	O
,	O
more	O
evidence	O
is	O
needed	O
.	O

Statistical	O
Analyses	O
We	O
used	O
descriptive	O
analyses	O
to	O
examine	O
the	O
distribution	O
of	O
EDC	O
variables	O
,	O
birth	O
weight	O
,	O
and	O
participant	O
characteristics	O
.	O

It	O
should	O
also	O
be	O
noted	O
that	O
,	O
despite	O
ongoing	O
research	O
efforts	O
,	O
relatively	O
little	O
has	O
yet	O
been	O
divulged	O
regarding	O
delivery	O
-	O
room	O
attributes	O
that	O
may	O
be	O
directly	O
or	O
indirectly	O
associated	O
with	O
the	O
incidence	O
of	O
autism	O
.	O

However	O
,	O
no	O
differences	O
were	O
found	O
between	O
the	O
groups	O
in	O
the	O
F2	O
generation	O
:	O
8	O
.	O
7	O
±	O
0	O
.	O
4	O
mg	O
(	O
F2	O
-	O
SC	O
)	O
vs	O
.	O
9	O
.	O
0	O
±	O
0	O
.	O
9	O
mg	O
(	O
F2	O
-	O
VitD	O
-)	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Program	O
cost	O
assessment	O
Costs	O
of	O
the	O
intervention	O
included	O
both	O
programmatic	O
costs	O
and	O
health	O
system	O
costs	O
.	O

Birth	O
weight	O
,	O
gestational	O
age	O
,	O
and	O
preterm	O
birth	O
may	O
correlate	O
with	O
autism	O
and	O
intellectual	O
disabilities	O
.	O

To	O
some	O
real	O
but	O
unknown	O
extent	O
,	O
autism	O
is	O
an	O
iatrogenic	O
disease	O
,	O
caused	O
by	O
governments	O
,	O
organizations	O
,	O
committees	O
,	O
newspapers	O
and	O
physicians	O
who	O
promulgated	O
the	O
current	O
warnings	O
about	O
sun	O
-	O
exposure	O
for	O
pregnant	O
women	O
and	O
young	O
children	O
without	O
any	O
understanding	O
of	O
the	O
tragedy	O
they	O
engendered	O
.	O

To	O
some	O
extent	O
,	O
the	O
effect	O
of	O
child	O
feeding	O
practices	O
on	O
children	O
'	O
s	O
health	O
requires	O
careful	O
consideration	O
of	O
context	O
.	O

Height	O
and	O
weight	O
were	O
collected	O
in	O
participants	O
either	O
through	O
self	O
-	O
report	O
or	O
measurement	O
at	O
various	O
sweeps	O
(	O
seetable	O
1	O
).	O

For	O
instance	O
,	O
at	O
a	O
mean	O
maternal	O
BMI	O
of	O
32	O
.	O
3	O
kg	O
m	O
−	O
2	O
,	O
an	O
infant	O
who	O
is	O
black	O
,	O
on	O
Medicaid	O
and	O
no	O
prenatal	O
vitamin	O
use	O
has	O
an	O
86	O
%	O
(	O
95	O
%	O
CI	O
:	O
82	O
,	O
97	O
)	O
probability	B
of	O
vitamin	O
D	O
deficiency	O
,	O
whereas	O
a	O
black	O
infant	O
who	O
is	O
not	O
on	O
Medicaid	O
and	O
with	O
prenatal	O
vitamin	O
use	O
has	O
a	O
66	O
%	O
(	O
95	O
%	O
CI	O
:	O
44	O
,	O
67	O
)	O
probability	B
of	O
vitamin	O
D	O
deficiency	O
.	O

Though	O
the	O
causes	O
are	O
not	O
known	O
,	O
socioenvironmental	O
influences	O
contribute	O
to	O
developmental	O
shifts	O
in	O
intake	O
regulation	O
by	O
overriding	O
biologically	O
based	O
cues	O
of	O
hunger	O
and	O
satiety	O
.	O

Trial	O
Registration	O
Number	O
:	O
IRCT138902113840N1	O
Introduction	O
Vitamin	O
D	O
is	O
a	O
secosteroid	O
,	O
which	O
is	O
metabolized	O
in	O
liver	O
and	O
kidney	O
.	O

Two	O
hospital	O
-	O
based	O
case	O
-	O
control	O
studies	O
in	O
Ethiopia1and	O
India2suggest	O
that	O
vitamin	O
D	O
deficiency	O
might	O
substantially	O
increase	O
the	O
risk	O
of	O
severe	O
pneumonia	O
in	O
children	O
.	O

However	O
,	O
of	O
the	O
128	O
respondents	O
who	O
indicated	O
zero	O
drinks	O
per	O
day	O
,	O
only	O
51	O
(	O
40	O
%)	O
of	O
them	O
were	O
in	O
the	O
control	O
group	O
and	O
77	O
(	O
60	O
%)	O
in	O
text4baby	O
.	O

Intriguingly	O
,	O
our	O
data	O
indicated	O
that	O
either	O
male	O
or	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
display	O
higher	O
caloric	O
intake	O
after	O
weaning	O
,	O
despite	O
of	O
the	O
fact	O
that	O
the	O
males	O
exhibited	O
greater	O
body	O
weight	O
at	O
adulthood	O
.	O

Using	O
an	O
in	O
vitro	O
system	O
of	O
adipose	O
tissue	O
from	O
Angus	O
and	O
Wagyu	O
steers	O
,	O
Rhoades	O
et	O
al	O
[	O
91	O
]	O
reported	O
that	O
the	O
rate	O
of	O
glucose	O
incorporation	O
into	O
FA	O
was	O
over	O
two	O
times	O
higher	O
than	O
the	O
rate	O
of	O
acetate	O
incorporation	O
into	O
IMF	O
,	O
although	O
they	O
were	O
similar	O
in	O
subcutaneous	O
fat	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
List	O
and	O
proportion	O
of	O
psychotropic	O
medications	O
used	O
together	O
with	O
an	O
SGANPer	O
centSelective	O
serotonin	O
reuptake	O
inhibitor4634	O
.	O
6Benzodiazepine2115	O
.	O
8Anticonvulsant1914	O
.	O
3Serotonin	O
-	O
norepinephrine	O
reuptake	O
inhibitor1612	O
.	O
0Atypical	O
antidepressant129	O
.	O
0Non	O
-	O
benzo	O
hypnotic86	O
.	O
0Typical	O
antipsychotic53	O
.	O
8Serotonin	O
antagonist	O
and	O
reuptake	O
inhibitor43	O
.	O
0Tetracyclic	O
antidepressant43	O
.	O
0Tricyclic	O
antidepressant32	O
.	O
3Norepinephrine	O
reuptake	O
inhibitor21	O
.	O
5Synthetic	O
cannaboid21	O
.	O
5Psychostimulant10	O
.	O
8GABA	O
analogue10	O
.	O
8Other	O
dopamine	O
antagonist10	O
.	O
8	O
Women	O
taking	O
more	O
than	O
two	O
psychotropic	O
medications	O
may	O
be	O
included	O
in	O
more	O
than	O
one	O
category	O
.	O

Management	O
and	O
training	O
Overall	O
around	O
3920	O
SS	O
and	O
100	O
FI	O
will	O
deliver	O
the	O
intervention	O
,	O
under	O
the	O
supervision	O
of	O
central	O
field	O
supervisory	O
team	O
.	O

Kawachi	O
[	O
137	O
]	O
described	O
that	O
the	O
number	O
of	O
adipocytes	O
increases	O
in	O
muscle	O
between	O
13	O
and	O
19	O
months	O
of	O
age	O
,	O
so	O
feeding	O
a	O
vitamin	O
A	O
-	O
deficient	O
diet	O
during	O
this	O
stage	O
may	O
stimulate	O
marbling	O
.	O

This	O
program	O
has	O
several	O
limitations	O
:	O
the	O
high	O
proportion	O
of	O
concentrate	O
in	O
the	O
diet	O
and	O
long	O
fattening	O
period	O
(>	O
30	O
months	O
,	O
especially	O
in	O
Korean	O
cattle	O
and	O
Japanese	O
Black	O
cattle	O
)	O
may	O
increase	O
feed	O
costs	O
.	O

Statistics	O
Both	O
R	O
(	O
version	O
2	O
.	O
11	O
.	O
1	O
)	O
and	O
SPSS	O
(	O
PASW	O
version	O
18	O
.	O
0	O
.	O
1	O
)	O
statistical	O
packages	O
were	O
used	O
.	O

A	O
team	O
including	O
nutritionist	O
and	O
epidemiologist	O
Esther	O
Casanueva	O
of	O
the	O
National	O
Institute	O
of	O
Perinatology	O
Isidro	O
Espinosa	O
de	O
los	O
Reyes	O
(	O
INPerIER	O
)	O
in	O
Mexico	O
City	O
and	O
colleagues	O
elsewhere	O
in	O
Mexico	O
City	O
and	O
California	O
studied	O
116	O
women	O
receiving	O
prenatal	O
care	O
at	O
INPerIER	O
.	O

Thus	B
,	O
this	O
suggests	O
that	O
BMI	O
is	O
not	O
transmitted	O
via	O
mitochondrial	O
DNA	O
or	O
,	O
if	O
so	O
,	O
only	O
weakly	O
.	O

In	O
the	O
United	O
States	O
staple	O
foods	O
like	O
milk	O
,	O
breakfast	O
cereals	O
and	O
margarines	O
are	O
artificially	O
fortified	O
with	O
vitamin	O
D	O
.[	O
14	O
]	O
At	O
present	O
,	O
the	O
number	O
and	O
variety	O
of	O
vitamin	O
D	O
fortified	O
foods	O
available	O
on	O
the	O
market	O
differs	O
significantly	O
between	O
countries	O
and	O
is	O
attributed	O
to	O
the	O
country	O
-	O
specific	O
policies	O
on	O
food	O
fortification	O
which	O
are	O
not	O
yet	O
unified	O
.	O

Gale	O
et	O
al	O
.	O

Evidence	O
of	O
an	O
association	O
between	O
adult	O
-	O
onset	O
glioma	O
and	O
date	O
of	O
birth	O
suggests	O
an	O
etiologic	O
role	O
for	O
a	O
seasonally	O
variable	O
environmental	O
exposure	O
occurring	O
prenatally	O
around	O
the	O
time	O
of	O
birth	O
.	O

Findings	O
suggest	O
the	O
need	O
for	O
prenatal	O
providers	O
of	O
low	O
-	O
income	O
,	O
minority	O
women	O
to	O
engage	O
patients	O
in	O
shaping	O
healthy	O
weight	O
gain	O
targets	O
as	B
a	O
precursor	O
to	O
preventing	O
excessive	O
GWG	O
and	O
its	O
complications	O
.	O

Thus	B
it	O
is	O
possible	O
that	O
the	O
study	O
of	O
Suzuki	O
et	O
al	O
.	O

Prevention	O
strategies	O
for	O
iron	O
deficiency	O
and	O
maternal	O
anaemia	O
include	O
nutritional	O
education	O
,	O
promoting	O
the	O
intake	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
,	O
and	O
food	O
fortification	O
[	O
13	O
].	O

We	O
will	O
train	O
the	O
evaluation	O
team	O
over	O
a	O
four	O
-	O
week	O
period	O
,	O
and	O
standardize	O
measurement	O
methods	O
and	O
retrain	O
as	O
needed	O
every	O
six	O
months	O
.	O

Antenatal	O
corticosteroid	O
injections	O
given	O
to	O
women	O
in	O
preterm	O
labour	O
are	O
highly	O
effective	O
at	O
preventing	O
respiratory	O
distress	O
syndrome	O
in	O
premature	O
babies	O
and	O
associated	O
mortality	O
and	O
long	O
-	O
term	O
impairment	O
,	O
but	O
remain	O
under	O
-	O
used	O
in	O
many	O
low	O
-	O
and	O
some	O
middle	O
-	O
income	O
countries	O
.	O

Most	O
of	O
the	O
women	O
were	O
attending	O
their	O
second	O
consultation	O
and	O
two	O
women	O
were	O
at	O
their	O
ninth	O
visit	O
.	O

While	O
many	O
hundreds	O
of	O
studies	O
have	O
investigated	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
,	O
relatively	O
few	O
(	O
47	O
to	O
-	O
date	O
)	O
have	O
demonstrated	O
a	O
mechanistic	O
association	O
among	O
specific	O
environmental	O
exposures	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

The	O
HDL	O
was	O
10	O
-	O
fold	O
reduced	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
indicates	O
a	O
significant	O
reduction	O
of	O
the	O
outlet	O
rate	O
of	O
fat	O
molecules	O
(	O
cholesterol	O
,	O
phospholipids	O
and	O
triglycerides	O
)	O
from	O
cells	O
.	O

There	O
are	O
few	O
trials	O
examining	O
the	O
efficacy	O
of	O
dietary	O
therapy	O
for	O
GDM	O
,	O
However	O
,	O
a	O
cluster	O
randomized	O
controlled	O
study	O
has	O
provided	O
support	O
for	O
Medical	O
Nutrition	O
Therapy	O
(	O
MNT	O
)	O
for	O
GDM	O
,	O
as	B
recommended	O
by	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
(	O
2004	O
).	O

Phthalates	O
are	O
used	O
as	O
plasticizers	O
[	O
1	O
,	O
4	O
,	O
5	O
,	O
8	O
]	O
and	O
also	O
found	O
in	O
personal	O
care	O
and	O
consumer	O
products	O
[	O
1	O
,	O
3	O
,	O
7	O
].	O

Conclusion	O
-	O
Together	O
rapid	O
change	O
is	O
possible	O
Over	O
the	O
last	O
decade	O
,	O
the	O
world	O
has	O
changed	O
.	O

Zinc	O
concentrations	O
are	O
determined	O
in	O
serum	O
using	O
atomic	O
absorption	O
spectrometry	O
[	O
74	O
].	O

Informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

Frequent	O
review	O
and	O
titration	O
of	O
the	O
insulin	O
dosage	O
is	O
recommended	O
.	O

We	O
are	O
aware	O
that	O
some	O
arachidonic	O
acid	O
(	O
AA	O
)	O
could	O
be	O
found	O
in	O
fish	O
[	O
27	O
],	O
however	O
,	O
we	O
choose	O
to	O
include	O
those	O
fatty	O
acids	O
that	O
are	O
dominating	O
in	O
fatty	O
fish	O
into	O
the	O
variable	O
"	O
marine	O
fatty	O
acids	O
".	O

Limitations	O
This	O
study	O
is	O
based	O
on	O
retrospectively	O
self	O
-	O
reported	O
data	O
,	O
which	O
could	O
have	O
led	O
to	O
an	O
underestimation	O
of	O
the	O
use	O
of	O
supplements	O
,	O
especially	O
folic	O
acid	O
[	O
27	O
].	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
since	O
there	O
were	O
no	O
adverse	O
effects	O
reported	O
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
d	O
[	O
66	O
],	O
but	O
to	O
proclaim	O
it	O
the	O
Golden	O
Fleece	O
,	O
more	O
evidence	O
is	O
still	O
required	O
.	O

MATERIALS	O
AND	O
METHODS	O
Animals	O
and	O
Diets	O
First	O
-	O
time	O
pregnant	O
Wistar	O
rats	O
(	O
day	O
2	O
–	O
3	O
of	O
pregnancy	O
)	O
was	O
purchased	O
from	O
Charles	O
River	O
(	O
Montreal	O
,	O
QC	O
,	O
Canada	O
).	O

Thus	B
,	O
clinical	O
skills	O
of	O
local	O
health	O
staff	O
could	O
be	O
improved	O
through	O
targeted	O
trainings	O
such	O
as	O
the	O
WHO	O
training	O
on	O
Life	O
Saving	O
Skills	O
[	O
61	O
]	O
for	O
health	O
workers	O
.	O

Studies	O
on	O
children	O
are	O
likely	B
to	O
be	O
over	O
-	O
representative	O
of	O
individuals	O
from	O
more	O
recent	O
birth	O
years	O
,	O
but	O
the	O
separation	O
of	O
birth	O
cohort	O
and	O
age	O
effects	O
on	O
BMI	O
correlation	O
was	O
possible	O
in	O
this	O
study	O
by	O
including	O
age	O
-	O
fixed	O
and	O
generation	O
-	O
fixed	O
effects	O
in	O
the	O
model	O
.	O

For	O
now	O
,	O
though	O
,	O
600	O
IU	O
in	O
prenatal	O
vitamins	O
remains	O
the	O
recommended	O
daily	O
intake	O
for	O
pregnant	O
women	O
.	O

The	O
annual	O
average	O
sunlight	O
exposure	O
time	O
in	O
this	O
area	O
is	O
2000	O
–	O
2500	O
h	O
:	O
160	O
–	O
200	O
h	O
/	O
m	O
in	O
winter	O
and	O
200	O
–	O
240	O
h	O
/	O
m	O
in	O
spring	O
and	O
fall	O
,	O
the	O
sunshine	O
intensity	O
and	O
temperature	O
are	O
appropriate	O
for	O
outdoor	O
activities	O
;	O
up	O
to	O
240	O
–	O
280	O
h	O
/	O
m	O
in	O
summer	O
with	O
the	O
strongest	O
sunshine	O
intensity	O
(	O
data	O
from	O
data	O
.	O
cma	O
.	O
cn	O
).	O

However	O
,	O
there	O
were	O
elements	O
of	O
dissatisfaction	O
with	O
health	O
centre	O
services	O
,	O
poor	O
sitting	O
facilities	O
,	O
amenities	O
,	O
few	O
health	O
education	O
talks	O
and	O
poor	O
nursing	O
skills	O
.	O

In	O
this	O
review	O
,	O
we	O
first	O
provide	O
an	O
overview	O
of	O
muscle	O
and	O
fat	O
cell	O
growth	O
in	O
ruminants	O
.	O

The	O
search	O
strategy	O
did	O
not	O
yield	O
any	O
randomised	O
controlled	O
trials	O
of	O
fish	O
intake	O
in	O
pregnant	O
women	O
and	O
associated	O
foetal	O
neurodevelopmental	O
outcomes	O
.	O

Conclusions	O
The	O
level	O
of	O
nutritional	O
knowledge	O
was	O
significantly	O
and	O
independently	O
associated	O
with	O
iron	O
,	O
folic	O
acid	O
and	O
multivitamin	O
supplements	O
use	O
during	O
pregnancy	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
up	O
-	O
regulation	O
of	O
'	O
VEGF	O
signaling	O
'	O
reflects	O
the	O
effort	O
on	O
cell	O
maintenance	O
and	O
angiogenic	O
growth	O
in	O
LP	O
offspring	O
at	O
stage	O
188	O
dpn	O
.	O

The	O
median	O
concentration	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D3	O
in	O
the	O
IG	O
was	O
to	O
62	O
.	O
10	O
nmol	O
/	O
l	O
after	O
the	O
intervention	O
,	O
showing	O
an	O
increase	O
of	O
around	O
158	O
%,	O
compared	O
to	O
before	O
intervention	O
(	O
24	O
.	O
25	O
nmol	O
/	O
l	O
)	O
whereas	O
the	O
CG	O
showed	O
a	O
decrease	O
of	O
around	O
4	O
.	O
5	O
%.	O

Skin	O
prick	O
tests	O
to	O
determine	O
sensitisation	O
to	O
common	O
allergens	O
are	O
common	O
medical	O
practice	O
in	O
infants	O
older	O
than	O
4	O
months	O
[	O
59	O
,	O
60	O
].	O

Data	O
collection	O
started	O
in	O
December	O
2011	O
and	O
follow	O
-	O
up	O
ended	O
in	O
January	O
2013	O
.	O

AAOC	O
can	O
also	O
mimic	O
other	O
benign	O
growths	O
.	O

Recent	O
data	O
has	O
extended	O
this	O
list	O
to	O
include	O
specific	O
regions	O
not	O
associated	O
with	O
TEs	O
that	O
are	O
preferentially	O
located	O
within	O
CGIs	O
,	O
enhancers	O
,	O
promoters	O
and	O
gene	O
bodies	O
(	O
Seisenberger	O
et	O
al	O
.	O
2012	O
;	O
Hackett	O
et	O
al	O
.	O
2013	O
;	O
Tang	O
et	O
al	O
.	O
2015	O
).	O

According	O
to	O
the	O
Lambda	O
test	O
,	O
this	O
correlation	O
was	O
significantly	O
greater	O
in	O
group	O
A	O
than	O
in	O
group	O
B	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

but	O
sometimes	O
thyroidectomised	O
women	O
need	O
more	O
.	O

In	O
order	O
to	O
further	O
explore	O
the	O
impact	O
of	O
DVD	O
on	O
brain	O
function	O
,	O
we	O
undertook	O
a	O
proteomic	O
study	O
of	O
the	O
nucleus	O
accumbens	O
.	O

The	O
variables	O
fall	O
mainly	O
in	O
the	O
modifiable	O
risk	O
factors	O
category	O
with	O
the	O
core	O
interest	O
being	O
nutritional	O
status	O
.	O

The	O
goals	O
and	O
principles	O
of	O
management	O
for	O
acute	O
and	O
chronic	O
asthma	O
,	O
rhinitis	O
,	O
and	O
dermatologic	O
disorders	O
are	O
the	O
same	O
during	O
pregnancy	O
as	O
those	O
for	O
asthma	O
in	O
the	O
general	O
population	O
.	O

(	O
2014	O
)	O
Nickel	O
(	O
Ni	O
)	O
LifetimeAdulthood	O
↓	O
NSCLC	O
overall	O
and	O
relapse	O
free	O
survivalmiRNAsChiou	O
et	O
al	O
.	O

Food	O
Fortification	O
with	O
Iron	O
Iron	O
fortification	O
involves	O
the	O
addition	O
of	O
iron	O
,	O
usually	O
with	O
folic	O
acid	O
,	O
to	O
an	O
appropriate	O
food	O
vehicle	O
that	O
is	O
made	O
available	O
to	O
the	O
population	O
at	O
large	O
.	O

Having	O
this	O
option	O
of	O
attending	O
may	O
contribute	O
to	O
self	O
-	O
selection	O
bias	O
.	O

Blacks	O
had	O
a	O
significantly	O
greater	O
proportion	O
of	O
SGA	O
when	O
compared	O
with	O
whites	O
(	O
P	O
=	O
0	O
.	O
01	O
;	O
Table	O
1	O
).	O

However	O
,	O
these	O
changes	O
with	O
slaugther	O
age	O
were	O
not	O
observed	O
in	O
double	O
-	O
muscled	O
Belgian	O
Blue	O
bulls	O
[	O
24	O
].	O

Conclusions	O
These	O
preliminary	O
findings	O
suggest	O
associations	O
of	O
short	O
sleep	O
duration	O
and	O
snoring	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
.	O

The	O
examples	O
of	O
Sri	O
Lanka	O
and	O
Turkey	O
(	O
see	O
Figure5	O
)	O
present	O
examples	O
of	O
significant	O
reduction	O
in	O
mortality	O
,	O
halving	O
deaths	O
in	O
10	O
years	O
linked	O
to	O
scale	O
up	O
of	O
intensive	O
care	O
.	O

In	O
our	O
study	O
,	O
after	O
adjusting	O
for	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
the	O
only	O
socio	O
-	O
demographic	O
factors	O
that	O
persisted	O
on	O
being	O
associated	O
with	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
were	O
:	O
area	O
of	O
residence	O
;	O
level	O
of	O
education	O
;	O
parity	O
and	O
receipt	O
of	O
advice	O
about	O
diet	O
and	O
breastfeeding	O
.	O

PTB	O
was	O
defined	B
as	B
delivery	O
of	O
a	O
liveborn	O
infant	O
at	O
<	O
37	O
weeks	O
gestation	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
similar	O
between	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
.	O

However	O
,	O
when	O
LMP	O
was	O
determined	O
to	O
be	O
unreliable	O
,	O
we	O
calculated	O
gestational	O
age	O
at	O
delivery	O
using	O
data	O
from	O
an	O
ultrasound	O
.	O

The	O
ferritin	O
level	O
was	O
significantly	O
higher	O
in	O
areas	O
where	O
groundwater	O
iron	O
concentration	O
was	O
high	O
.	O

This	O
association	O
between	O
the	O
GRS	O
and	O
25	O
(	O
OH	O
)	O
D	O
was	O
not	O
present	O
presupplementation	O
in	O
early	O
pregnancy	O
(	O
Fig	O
.	O

These	O
experiences	O
,	O
combined	O
with	O
repeated	O
exposure	O
to	O
nutritious	O
foods	O
and	O
flavor	O
variety	O
(	O
31	O
-	O
34	O
),	O
should	O
make	O
children	O
more	O
likely	B
to	O
choose	O
a	O
healthy	O
diet	O
.	O

On	O
the	O
contrary	O
,	O
the	O
diet	O
should	O
be	O
well	O
balanced	O
and	O
consist	O
of	O
as	O
many	O
different	O
nutrients	O
as	O
possible	O
,	O
as	O
the	O
current	O
literature	O
suggests	O
that	O
antigens	O
obtained	O
via	O
the	O
oral	O
route	O
during	O
pregnancy	O
and	O
lactation	O
are	O
needed	O
to	O
develop	O
allergen	O
tolerance	O
in	O
the	O
child	O
[	O
105	O
].	O

The	O
US	O
educational	O
system	O
has	O
typically	B
fallen	O
short	O
in	O
considering	O
health	O
a	O
priority	O
for	O
academic	O
emphasis	O
or	O
outcomes	O
.	O

Median	O
CRP	O
was	O
0	O
mg	O
/	O
L	O
for	O
both	O
groups	O
and	O
there	O
were	O
no	O
differences	O
in	O
proportion	O
of	O
women	O
with	O
a	O
raised	O
CRP	O
(>	O
10g	O
/	O
L	O
)	O
in	O
either	O
group	O
.	O

Given	O
the	O
significant	O
number	O
of	O
characteristic	O
and	O
lifestyle	O
differences	O
between	O
the	O
two	O
populations	O
,	O
this	O
is	O
not	O
overly	O
surprising	O
.	O

It	O
is	O
important	O
to	O
consider	O
how	O
S	O
-	O
ECC	O
and	O
poor	O
nutritional	O
status	O
are	O
connected	O
.	O

Thus	B
,	O
the	O
evidence	O
in	O
these	O
cohort	O
studies	O
supports	O
the	O
current	O
recommendations	O
for	O
fish	O
consumption	O
during	O
pregnancy	O
[	O
2	O
,	O
3	O
,	O
4	O
].	O

(	O
Pesticides	O
also	O
are	O
used	O
outside	O
the	O
farm	O
in	O
urban	O
schools	O
,	O
homes	O
,	O
and	O
day	O
-	O
care	O
centers	O
for	O
control	O
of	O
roaches	O
,	O
rats	O
,	O
and	O
other	O
vermin	O
,	O
and	O
conceivably	O
their	O
peak	O
period	O
of	O
application	O
may	O
differ	O
seasonally	O
from	O
that	O
on	O
farms	O
[	O
33	O
,	O
40	O
].)	O

Furthermore	O
,	O
some	O
of	O
these	O
factors	O
are	O
related	O
to	O
or	O
co	O
-	O
exist	O
with	O
poor	O
vitamin	O
D	O
status	O
[	O
24	O
,	O
25	O
],	O
which	O
further	O
increases	O
the	O
challenge	O
when	O
dissecting	O
independent	O
effect	O
.	O

Calcium	O
binding	O
proteins	O
have	O
been	O
of	O
interest	O
to	O
schizophrenia	O
research	O
for	O
some	O
time	O
[	O
27	O
],	O
in	O
particular	O
with	O
respect	O
to	O
the	O
expression	O
in	O
cortical	O
GABAergic	O
interneurons	O
[	O
28	O
].	O

Standard	O
measuring	O
equipment	O
,	O
common	O
size	O
containers	O
(	O
e	O
.	O
g	O
.	O

In	O
previous	O
studies	O
,	O
the	O
prevalence	O
of	O
antenatal	O
depression	O
had	O
been	O
studied	O
,	O
using	O
various	O
tools	O
and	O
cut	O
-	O
off	O
points	O
.	O

Rats	O
had	O
ad	O
libitum	O
access	O
to	O
the	O
standard	O
chow	O
and	O
water	O
,	O
and	O
had	O
limited	O
access	O
to	O
the	O
chocolate	O
for	O
1	O
h	O
during	O
the	O
light	O
phase	O
.	O

Briefly	O
,	O
we	O
conducted	O
a	O
multicentre	O
randomised	O
trial	O
involving	O
women	O
with	O
a	O
singleton	O
pregnancy	O
,	O
between	O
10	O
+	O
0and	O
20	O
+	O
0weeks	O
’	O
gestation	O
,	O
and	O
body	O
mass	O
index	O
≥	O
25	O
.	O
0	O
kg	O
/	O
m2	O
,	O
who	O
were	O
randomised	O
to	O
either	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
(	O
Lifestyle	O
Advice	O
Group	O
)	O
or	O
standard	O
antenatal	O
care	O
(	O
Standard	O
Care	O
Group	O
)	O
[	O
22	O
].	O

(	O
2015	O
)	O
described	O
a	O
protective	O
effect	O
of	O
early	O
(	O
in	O
utero	O
through	O
lactation	O
)	O
exposure	O
to	O
dietary	O
omega	O
-	O
3	O
fatty	O
acids	O
on	O
neuroplasticity	O
in	O
rats	O
that	O
involved	O
specific	O
changes	O
in	O
DNA	O
methylation	O
.	O

Management	O
and	O
follow	O
-	O
up	O
of	O
thyroid	O
cancer	O
in	O
pregnant	O
women	O
AbstractSUMMARY	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
female	O
patients	O
.	O

Ad	O
libitum	O
access	O
to	O
food	O
and	O
water	O
was	O
provided	O
throughout	O
the	O
study	O
period	O
.	O

We	O
identified	O
additive	O
and	O
modifiable	O
maternal	O
risk	O
factors	O
that	O
would	O
benefit	O
most	B
from	O
risk	O
reduction	O
and	O
targeted	O
vitamin	O
D	O
supplementation	O
.	O

In	O
male	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
no	O
differences	O
were	O
found	O
after	O
the	O
24	O
h	O
observation	O
of	O
water	O
intake	O
.	O

Since	O
Cesarean	O
delivery	O
results	O
in	O
differential	O
microbial	O
community	O
structure	O
of	O
the	O
infant	O
gut	O
[	O
24	O
],	O
and	O
the	O
gut	O
microbiome	O
is	O
a	O
complex	O
system	O
,	O
such	O
differences	O
are	O
plausible	O
;	O
experimental	O
studies	O
will	O
be	O
required	O
to	O
confirm	O
this	O
observation	O
.	O

Studies	O
conducted	O
on	O
pregnant	O
women	O
in	O
Zimbabwe	O
,	O
China	O
,	O
India	O
,	O
and	O
Mexico	O
from	O
1996	O
to	O
2008	O
indicated	O
that	O
between	O
43	O
%	O
and	O
73	O
%	O
of	O
the	O
women	O
were	O
iron	O
deficient	O
(	O
usually	O
diagnosed	O
as	O
a	O
low	O
-	O
ferritin	O
concentration	O
);	O
out	O
of	O
these	O
,	O
7	O
%	O
to	O
33	O
%	O
had	O
IDA	O
[	O
4	O
].	O

Methods	O
Pregnant	O
Wistar	O
rats	O
were	O
fed	O
either	O
a	O
calorie	O
-	O
restricted	O
diet	O
,	O
a	O
high	O
fat	O
diet	O
,	O
or	O
a	O
control	O
diet	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

However	O
,	O
previous	O
studies	O
suggested	O
that	O
specific	O
CB1	O
receptor	O
deletion	O
in	O
the	O
hypothalamus	O
was	O
able	O
to	O
decrease	O
body	O
weight	O
and	O
increase	O
energy	O
expenditure	O
,	O
but	O
was	O
not	O
accompanied	O
with	O
changes	O
in	O
food	O
intake	O
(	O
Cardinal	O
et	O
al	O
.,	O
2012	O
).	O

Therefore	O
,	O
pregnancy	O
in	O
thyroid	O
cancer	O
patients	O
is	O
not	O
unusual	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

All	O
tests	O
were	O
two	O
-	O
tailed	O
.	O

Between	O
December	O
2003	O
and	O
July	O
2006	O
,	O
1	O
,	O
393	O
(	O
82	O
%)	O
of	O
1	O
,	O
685	O
approached	O
women	O
consented	O
to	O
participate	O
.	O

On	O
the	O
other	O
hand	O
,	O
numerous	O
other	O
studies	O
report	O
a	O
lack	O
of	O
association	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
[	O
23	O
],[	O
24	O
],[	O
25	O
],[	O
26	O
],[	O
27	O
],[	O
28	O
],[	O
29	O
],[	O
30	O
].	O

During	O
a	O
national	O
survey	O
in	O
2012	O
,	O
approximately	O
40	O
%	O
of	O
the	O
population	O
were	O
reported	O
to	O
have	O
a	O
monotonous	O
diet	O
based	O
mainly	O
on	O
starches	O
[	O
18	O
].	O

However	O
,	O
such	O
associations	O
were	O
not	O
seen	O
in	O
women	O
taking	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
.	O

Behavioral	O
and	O
Psychosocial	O
Factors	O
during	O
Pregnancy	O
Self	O
-	O
reported	O
measures	O
of	O
dietary	O
intake	O
and	O
exercise	O
expenditure	O
were	O
obtained	O
by	O
trained	O
assessors	O
at	O
study	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
.	O

Although	O
age	O
and	O
economic	O
deficit	O
were	O
predictors	O
of	O
anaemia	O
at	O
baseline	O
,	O
in	O
a	O
sub	O
analysis	O
these	O
groups	O
did	O
not	O
respond	O
differently	O
to	O
supplementation	O
.	O
Table	O
3includes	O
the	O
haematological	O
findings	O
at	O
follow	O
up	O
.	O

Some	O
cross	O
-	O
sectional	O
studies	O
show	O
the	O
same	O
positive	O
results	O
for	O
the	O
use	O
of	O
multivitamins	O
[	O
10	O
],	O
but	O
there	O
is	O
still	O
debate	O
as	O
to	O
whether	O
these	O
are	O
superior	O
to	O
iron	O
and	O
folic	O
acid	O
[	O
11	O
].	O

Furthermore	O
,	O
epigenetic	O
changes	O
may	O
themselves	O
have	O
no	O
consequences	O
on	O
gene	O
expression	O
(	O
as	B
demonstrated	O
in	O
a	O
recent	O
in	O
vitro	O
study	O
by	O
Ramos	O
et	O
al	O
.	O

However	O
,	O
a	O
woman	O
with	O
GDM	O
is	O
a	O
woman	O
at	O
high	O
risk	O
of	O
future	O
diabetes	O
.	O

Discussion	O
Developmental	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
a	O
subtle	O
alteration	O
in	O
the	O
expression	O
of	O
protein	O
involved	O
in	O
functions	O
related	O
to	O
calcium	O
binding	O
proteins	O
,	O
and	O
mitochondrial	O
functioning	O
.	O

Collaboration	O
between	O
scientists	O
from	O
academia	O
,	O
industry	O
,	O
and	O
governmental	O
and	O
regulatory	O
bodies	O
will	O
promote	O
further	O
research	O
within	O
a	O
regulatory	O
context	O
,	O
and	O
drive	O
the	O
development	O
and	O
implementation	O
of	O
epigenetically	O
relevant	O
integrated	O
testing	O
strategies	O
or	O
policies	O
for	O
the	O
continued	O
protection	O
of	O
public	O
health	O
.	O

Thus	B
doses	O
of	O
D	O
vitamin	O
and	O
calcium	O
supplementation	O
,	O
which	O
may	O
differ	O
from	O
those	O
recommended	O
in	O
normal	O
pregnancy	O
,	O
need	O
to	O
be	O
carefully	O
tailored	O
in	O
thyroidectomised	O
patients	O
.	O

Determination	O
of	O
Dietary	O
Patterns	O
We	O
applied	O
principal	O
component	O
analysis	O
in	O
order	O
to	O
find	O
major	O
dietary	O
patterns	O
.	O

For	O
example	O
,	O
researchers	O
could	O
not	O
ethically	O
randomize	O
people	O
such	O
that	O
some	O
were	O
not	O
allowed	O
to	O
breastfeed	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
(	O
n	O
=	O
3268	O
)	O
with	O
multiple	O
logistic	O
regression	O
(	O
MLR	O
)	O
method	O
,	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonVaccinated	O
in	O
first	O
trimester	O
(	O
n	O
=	O
140	O
)	O
Vaccinated	O
in	O
second	O
trimester	O
(	O
n	O
=	O
1142	O
)	O
Vaccinated	O
in	O
third	O
trimester	O
(	O
n	O
=	O
581	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
p	O
-	O
valueaOR	O
(	O
95	O
%	O
CI	O
)	O
p	O
-	O
valueaOR	O
(	O
95	O
%	O
CI	O
)	O
p	O
-	O
valueSmall	O
for	O
gestational	O
age	O
*(	O
SGAi	O
)	O
1	O
.	O
13	O
(	O
0	O
.	O
66	O
;	O
1	O
.	O
94	O
)	O
0	O
.	O
661	O
.	O
03	O
(	O
0	O
.	O
79	O
;	O
1	O
.	O
34	O
)	O
0	O
.	O
820	O
.	O
92	O
(	O
0	O
.	O
65	O
;	O
1	O
.	O
30	O
)	O
0	O
.	O
64Preterm	O
birth	O
**(	O
PTB	O
)	O
1	O
.	O
43	O
(	O
0	O
.	O
86	O
;	O
2	O
.	O
39	O
)	O
0	O
.	O
170	O
.	O
91	O
(	O
0	O
.	O
70	O
;	O
1	O
.	O
17	O
)	O
0	O
.	O
450	O
.	O
86	O
(	O
0	O
.	O
62	O
;	O
1	O
.	O
18	O
)	O
0	O
.	O
35Low	O
birth	O
weight	O
(	O
LBW	O
)***	O
1	O
.	O
56	O
(	O
0	O
.	O
81	O
;	O
3	O
.	O
02	O
)	O
0	O
.	O
190	O
.	O
88	O
(	O
0	O
.	O
61	O
;	O
1	O
.	O
26	O
)	O
0	O
.	O
480	O
.	O
85	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
32	O
)	O
0	O
.	O
47	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

Data	O
were	O
processed	O
and	O
analysed	O
using	O
SPSS	O
for	O
Windows	O
v15	O
.	O

There	O
were	O
no	O
differences	O
between	O
these	O
two	O
groups	O
with	O
respect	O
to	O
maternal	O
age	O
at	O
conception	O
,	O
pre	O
-	O
pregnancy	O
weight	O
,	O
prenatal	O
vitamin	O
use	O
,	O
alcohol	O
use	O
,	O
smoking	O
,	O
maternal	O
weight	O
gain	O
in	O
pregnancy	O
and	O
duration	O
of	O
fetal	O
exposure	O
to	O
SGA	O
.	O

Vitamin	O
D	O
also	O
has	O
an	O
immunological	O
role	O
as	B
it	O
can	O
induce	O
the	O
production	O
of	O
antimicrobial	O
peptides	O
such	O
as	O
cathelicidin	O
and	O
certain	O
defensins	O
,	O
which	O
protect	O
us	O
from	O
oral	O
pathogens	O
[	O
22	O
,	O
24	O
].	O

PubMed	O
Central	O
:	O

The	O
main	O
positive	O
findings	O
of	O
our	O
study	O
are	O
summarised	O
infigure	O
1	O
.	O

In	O
the	O
meta	O
-	O
analysis	O
of	O
Veisani	O
et	O
al	O
.,	O
postnatal	O
depression	O
was	O
reported	O
at	O
25	O
.	O
3	O
%	O
[	O
9	O
],	O
and	O
in	O
two	O
recent	O
studies	O
in	O
eastern	O
and	O
central	O
part	O
of	O
Iran	O
,	O
the	O
prevalence	O
has	O
been	O
reported	O
at	O
28	O
.	O
9	O
–	O
34	O
.	O
8	O
%	O
[	O
10	O
,	O
11	O
].	O

To	O
account	O
for	O
differences	O
in	O
baseline	O
and	O
trajectories	O
of	O
infant	O
gut	O
microbial	O
profiles	O
,	O
we	O
stratified	O
analyses	O
by	O
delivery	O
mode	O
.	O

The	O
location	O
of	O
the	O
mutation	O
is	O
indicated	O
by	O
the	O
arrowhead	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Coverage	O
along	O
the	O
continuum	O
of	O
care	O
for	O
75	O
Countdown	O
to	O
2015	O
priority	O
countries	O
.	O

It	O
is	O
also	O
possible	O
that	O
children	O
who	O
become	O
autistic	O
may	O
also	O
be	O
slow	O
to	O
deliver	O
that	O
the	O
prolonged	O
delivery	O
is	O
a	O
symptom	O
of	O
,	O
rather	O
than	O
a	O
cause	O
of	O
,	O
autism	O
.	O

The	O
next	O
follow	O
-	O
up	O
of	O
infants	O
was	O
performed	O
between	O
six	O
months	O
and	O
one	O
year	O
after	O
childbirth	O
(	O
both	O
cesarean	O
and	O
vaginal	O
)	O
through	O
telephone	O
contact	O
with	O
the	O
mothers	O
,	O
during	O
which	O
they	O
were	O
asked	O
to	O
attend	O
their	O
local	O
health	O
centers	O
for	O
the	O
assessment	O
of	O
anthropometric	O
indicators	O
(	O
growth	O
monitoring	O
curve	O
,	O
height	O
,	O
weight	O
,	O
and	O
head	O
circumference	O
)	O
and	O
also	O
neonatal	O
diseases	O
.	O

However	O
these	O
socio	O
-	O
demographic	O
factors	O
were	O
not	O
independent	O
determinants	O
of	O
the	O
use	O
of	O
iron	O
supplements	O
.	O

Therefore	B
,	O
it	O
has	O
not	O
been	O
possible	O
to	O
ascertain	O
whether	O
the	O
associations	O
at	O
implantation	O
in	O
early	O
pregnancy	O
differ	O
from	O
those	O
during	O
the	O
fetal	O
growth	O
spurt	O
in	O
late	O
pregnancy	O
.	O

Analysis	O
of	O
baseline	O
(	O
phase	O
1	O
)	O
data	O
will	O
be	O
conducted	O
to	O
describe	O
the	O
nutritional	O
status	O
and	O
basic	O
socio	O
-	O
economic	O
characteristics	O
of	O
the	O
pregnant	O
women	O
.	O

We	O
collected	O
information	O
about	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
.	O

In	O
order	O
not	O
to	O
deprive	O
the	O
participants	O
from	O
antenatal	O
supplements	O
all	O
participating	O
mothers	O
were	O
allowed	O
to	O
use	O
prescribed	O
supplementation	O
outside	O
this	O
study	O
’	O
s	O
protocol	O
.	O

All	O
biomarker	O
samples	O
were	O
log10transformed	O
and	O
treated	O
as	O
continuous	O
variables	O
.	O

Glioma	O
patients	O
are	O
known	O
to	O
suffer	O
from	O
an	O
impaired	O
immune	O
system	O
[	O
99	O
],	O
and	O
the	O
reduced	O
association	O
with	O
allergies	O
alternatively	O
could	O
be	O
due	O
to	O
immunosuppression	O
induced	O
by	O
the	O
tumor	O
(	O
i	O
.	O
e	O
.,	O
reverse	O
causality	O
)	O
[	O
84	O
].	O

A	O
greater	O
understanding	O
of	O
the	O
variables	O
that	O
influence	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
can	O
have	O
an	O
immense	O
public	O
health	O
impact	O
in	O
the	O
reduction	O
of	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

Comparisons	O
between	O
LP	O
and	O
AP	O
within	O
stages	O
Expression	O
of	O
mRNA	O
was	O
compared	O
in	O
LP	O
and	O
AP	O
offspring	O
within	O
each	O
ontogenetic	O
stage	O
(	O
Figure1	O
).	O

Multigenerational	O
versus	O
transgenerational	O
epigenetic	O
toxicity	O
following	O
in	O
utero	O
or	O
ex	O
utero	O
environmental	O
exposure	O
.	O

However	O
,	O
vitamin	O
D	O
insufficiency	O
is	O
still	O
under	O
-	O
recognized	O
and	O
under	O
-	O
treated	O
,	O
despite	O
its	O
prevalence	O
.	O

This	O
was	O
largely	O
driven	O
by	O
a	O
55	O
%	O
decreased	O
risk	O
of	O
GDM	O
in	O
women	O
with	O
a	O
male	O
fetus	O
with	O
high	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
when	O
compared	O
to	O
those	O
carrying	O
a	O
male	O
fetus	O
with	O
moderate	O
-	O
high	O
serum	O
25	O
(	O
OH	O
)	O
D	O
(	O
aRR	O
:	O
0	O
.	O
45	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
).	O

Families	O
used	O
it	O
for	O
cooking	O
,	O
drinking	O
,	O
and	O
cleaning	O
.	O

Our	O
study	O
was	O
approved	O
by	O
the	O
ethics	O
and	O
review	O
board	O
of	O
the	O
Ministry	O
of	O
Public	O
Health	O
of	O
Afghanistan	O
(	O
reference	O
422328	O
;	O
issued	O
May	O
12	O
,	O
2007	O
)	O
and	O
the	O
ethics	O
committee	O
of	O
the	O
London	O
School	O
of	O
Hygiene	O
and	O
Tropical	O
Medicine	O
(	O
application	O
number	O
5117	O
;	O
issued	O
May	O
29	O
,	O
2008	O
).	O

Equal	O
quantities	O
of	O
total	O
protein	O
were	O
resuspended	O
in	O
sample	O
buffer	O
containing	O
SDS	O
,	O
heated	O
for	O
5	O
min	O
at	O
100	O
°	O
C	O
and	O
separated	O
by	O
SDS	O
/	O
PAGE	O
.	O

Urine	O
parameters	O
(	O
Table	O
2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Urine	O
parameters	O
.	O
ParametersF1	O
-	O
SCF1	O
-	O
VitD	O
-	O
F2	O
-	O
SCF2	O
-	O
VitD	O
-	O
WI	O
,	O
g	O
/	O
100	O
g	O
BM	O
/	O
day	O
16	O
.	O
3	O
±	O
1	O
.	O
014	O
.	O
4	O
±	O
1	O
.	O
615	O
.	O
2	O
±	O
1	O
.	O
113	O
.	O
3	O
±	O
1	O
.	O
3	O
Urine	O
output	O
0	O
.	O
05	O
±	O
0	O
.	O
0020	O
.	O
02	O
±	O
0	O
.	O
004	O
†	O
0	O
.	O
04	O
±	O
0	O
.	O
0060	O
.	O
04	O
±	O
0	O
.	O
004	O
Urea	O
,	O
mg	O
/	O
dL	O
36	O
.	O
5	O
±	O
3	O
.	O
8194	O
.	O
7	O
±	O
23	O
.	O
2	O
†	O
45	O
.	O
5	O
±	O
8	O
.	O
158	O
.	O
2	O
±	O
8	O
.	O
5	O
‡	O
Creatinine	O
,	O
mg	O
/	O
dL	O
1	O
.	O
2	O
±	O
0	O
.	O
13	O
.	O
3	O
±	O
0	O
.	O
2	O
†	O
1	O
.	O
0	O
±	O
0	O
.	O
11	O
.	O
4	O
±	O
0	O
.	O
1	O
‡	O
Uric	O
acid	O
,	O
mg	O
/	O
dL	O
0	O
.	O
6	O
±	O
0	O
.	O
21	O
.	O
2	O
±	O
0	O
.	O
60	O
.	O
5	O
±	O
0	O
.	O
10	O
.	O
9	O
±	O
0	O
.	O
3	O
Proteinuria	O
,	O
g	O
/	O
L	O
0	O
.	O
43	O
±	O
0	O
.	O
10	O
.	O
55	O
±	O
0	O
.	O
10	O
.	O
40	O
±	O
0	O
.	O
10	O
.	O
44	O
±	O
0	O
.	O
1	O
Data	O
were	O
kept	O
for	O
six	O
-	O
month	O
-	O
old	O
male	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

The	O
between	O
groups	O
comparisons	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
presented	O
in	O
Table	O
3	O
.	O

Immediately	O
after	O
delivery	O
the	O
weight	O
of	O
the	O
newborn	O
was	O
recorded	O
.	O

The	O
difference	O
may	O
be	O
due	O
to	O
genetic	O
factors	O
,	O
management	O
,	O
or	O
feed	O
.	O

Rarely	O
,	O
systemic	O
corticoids	O
may	O
be	O
used	O
for	O
severe	O
recalcitrant	O
urticaria	O
and	O
angioedema	O
during	O
pregnancy	O
.	O

[	O
16	O
]	O
Charatcharoen	O
-	O
witthaya	O
et	O
al	O
.	O

There	O
is	O
also	O
a	O
need	O
to	O
understand	O
how	O
to	O
screen	O
more	O
effectively	O
for	O
and	O
treat	O
possible	O
prematurity	O
-	O
related	O
cognitive	O
,	O
motor	O
and	O
behavioural	O
disabilities	O
,	O
including	O
in	O
older	O
children	O
.	O

We	O
evaluated	O
growth	O
,	O
timing	O
of	O
reproductive	O
maturation	O
and	O
adult	O
ovarian	O
function	O
.	O

Minority	O
women	O
are	O
at	O
increased	O
risk	O
for	O
excessive	O
GWG	O
,	O
yet	O
are	O
underrepresented	O
in	O
published	O
weight	O
control	O
interventions	O
.	O

Our	O
objective	O
was	O
to	O
compare	O
maternal	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
concentrations	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
between	O
mothers	O
with	O
and	O
without	O
GDM	O
,	O
and	O
to	O
investigate	O
if	O
an	O
association	O
existed	O
between	O
maternal	O
vitamin	O
D	O
concentration	O
and	O
infant	O
birth	O
size	O
.	O

This	O
was	O
the	O
first	O
use	O
of	O
a	O
newly	O
developed	O
questionnaire	O
,	O
which	O
we	O
administered	O
2	O
–	O
3	O
days	O
after	O
delivery	O
,	O
to	O
include	O
women	O
who	O
may	O
not	O
have	O
engaged	O
with	O
prenatal	O
care	O
.	O

Absolute	O
values	O
from	O
each	O
sample	O
were	O
normalized	O
with	O
regard	O
to	O
the	O
housekeeping	O
gene	O
Actb	O
.	O

The	O
costs	O
of	O
providing	O
weekly	O
iron	O
-	O
folic	O
acid	O
in	O
a	O
program	O
setting	O
may	O
also	O
be	O
useful	O
for	O
estimating	O
costs	O
of	O
providing	O
micronutrient	O
powders	O
for	O
home	O
fortification	O
for	O
children	O
6	O
–	O
36	O
months	O
,	O
and	O
for	O
therapeutic	O
zinc	O
for	O
children	O
under	O
five	O
.	O

Boys	O
were	O
also	O
strongly	O
correlated	O
with	O
the	O
PGF	O
at	O
the	O
age	O
of	O
9	O
only	O
.	O

The	O
Skm2	O
mutation	O
lies	O
within	O
a	O
highly	O
conserved	O
hydrophobic	O
region	O
in	O
the	O
actin	O
-	O
binding	O
site	O
2	O
(	O
ABS2	O
),	O
which	O
corresponds	O
to	O
the	O
last	O
α	O
-	O
helix	O
of	O
the	O
calponin	O
homology	O
domain	O
1	O
,	O
and	O
is	O
critical	O
for	O
the	O
binding	O
of	O
F	O
-	O
actin	O
(	O
van	O
der	O
Flier	O
and	O
Sonnenberg	O
2001	O
).	O

FA	O
for	O
TG	O
synthesis	O
is	O
derived	O
from	O
de	O
novo	O
synthesis	O
or	O
diet	O
-	O
originating	O
FAs	O
.	O

As	O
described	O
previously	O
[	O
24	O
],	O
16S	O
rDNA	O
V4	O
-	O
V5	O
amplicons	O
were	O
generated	O
from	O
purified	O
genomic	O
DNA	O
samples	O
using	O
fusion	O
primers	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

ATP	O
citrate	O
and	O
NADP	O
malate	O
dehydrogenase	O
are	O
two	O
key	O
enzymes	O
utilizing	O
glucose	O
in	O
the	O
FA	O
de	O
novo	O
synthesis	O
pathway	O
.	O

Fortunately	O
,	O
we	O
controlled	O
for	O
household	O
income	O
in	O
the	O
regression	O
models	O
.	O

Age	O
,	O
depression	O
score	O
,	O
amount	O
of	O
sun	O
exposure	O
and	O
seasons	O
were	O
compared	O
between	O
women	O
with	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
and	O
who	O
had	O
concentrations	O
of	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
Table	O
2	O
).	O

Issues	O
specific	O
to	O
pre	O
-	O
existing	O
diabetes	O
in	O
pregnancy	O
include	O
tight	O
glycemic	O
control	O
and	O
adequate	O
folate	O
supplementation	O
.	O
53	O
,	O
54Additionally	O
,	O
post	O
partum	O
evaluation	O
and	O
management	O
of	O
reversible	O
cardiovascular	O
risk	O
factors	O
such	O
as	O
smoking	O
,	O
obesity	O
,	O
hypertension	O
,	O
and	O
hyperlipidemia	O
should	O
be	O
undertaken	O
.	O

Since	O
the	O
mid	O
-	O
1990s	O
,	O
the	O
use	O
of	O
SGAs	O
has	O
increased	O
drastically	O
and	O
expanded	O
rapidly	O
to	O
the	O
treatment	O
of	O
depressive	O
and	O
anxiety	O
disorders	O
.	O
10	O
–	O
13Furthermore	O
,	O
deinstitutionalisation	O
,	O
the	O
destigmatisation	O
of	O
mental	O
illness	O
and	O
the	O
improved	O
side	O
effect	O
profile	O
of	O
SGAs	O
,	O
particularly	O
the	O
reduced	O
incidence	O
of	O
hyperprolactinaemia	O
in	O
most	O
SGAs	O
,	O
have	O
all	O
contributed	O
to	O
increased	O
fertility	O
rates	O
among	O
treated	O
women	O
.	O
9The	O
rise	O
in	O
birth	O
rate	O
in	O
women	O
with	O
psychiatric	O
disorders	O
,	O
combined	O
with	O
the	O
increase	O
in	O
off	O
-	O
label	O
usage	O
of	O
these	O
medications	O
,	O
has	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
fetuses	O
exposed	O
to	O
this	O
newer	O
class	O
of	O
antipsychotics	O
.	O

The	O
epidemiologic	O
association	O
of	O
obesity	O
,	O
particularly	O
of	O
the	O
visceral	O
type	O
,	O
with	O
type	O
2	O
diabetes	O
has	O
been	O
recognized	O
for	O
decades	O
.	O

First	O
Lamarck	O
,	O
and	O
then	O
Waddington	O
,	O
suggested	O
that	O
alternative	O
mechanisms	O
,	O
now	O
termed	O
epigenetics	O
,	O
must	O
also	O
contribute	O
to	O
phenotypic	O
outcomes	O
(	O
Noble2006	O
).	O

*	O
Studies	O
demonstrating	O
environmentally	O
-	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
.	O

Increasing	O
digestion	O
of	O
rumen	O
-	O
bypassed	O
starch	O
in	O
the	O
small	O
intestine	O
helps	O
increase	O
the	O
glucose	O
supply	O
.	O

(	O
C	O
)	O
Schematic	O
representation	O
of	O
NPR3	O
(	O
top	O
)	O
and	O
FLNB	O
(	O
bottom	O
).	O
The	O
arrows	O
indicate	O
location	O
of	O
Skm	O
mutations	O
(	O
black	O
)	O
and	O
other	O
reported	O
mutations	O
(	O
gray	O
).	O

Student	O
’	O
s	O
t	O
test	O
was	O
used	O
to	O
compare	O
the	O
difference	O
in	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
between	O
the	O
two	O
groups	O
.	O

Environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
an	O
issue	O
that	O
has	O
been	O
highlighted	O
as	O
a	O
current	O
research	O
focus	O
within	O
Public	O
Health	O
England	O
’	O
s	O
(	O
PHE	O
'	O
s	O
)	O
Center	O
for	O
Radiation	O
,	O
Chemical	O
and	O
Environmental	O
Hazards	O
(	O
CRCE	O
),	O
the	O
wider	O
PHE	O
organization	O
as	O
part	O
of	O
the	O
early	O
life	O
priority	O
‘	O
ensuring	O
every	O
child	O
has	O
the	O
best	O
start	O
in	O
life	O
’,	O
and	O
the	O
international	O
research	O
and	O
governmental	O
communities	O
.	O

The	O
elevated	O
fat	O
mass	O
and	O
body	O
weight	O
justify	O
the	O
higher	O
levels	O
of	O
triglycerides	O
,	O
LDL	O
,	O
VLDL	O
,	O
bilirubin	O
,	O
and	O
the	O
adipocytes	O
-	O
specific	O
satiety	O
hormone	O
leptin	O
in	O
plasma	O
.	O

A	O
recent	O
study	O
illustrates	O
that	O
the	O
neuropathology	O
of	O
some	O
individuals	O
who	O
are	O
diagnosed	O
as	O
having	O
ASD	O
may	O
actually	O
also	O
have	O
focal	O
cortical	O
dysplasias	O
,	O
which	O
could	O
explain	B
the	O
high	O
incidence	O
of	O
sensory	O
irregularities	O
and	O
seizures	O
in	O
ASD	O
diagnosed	O
patients	O
[	O
59	O
].	O

An	O
initial	O
diagnosis	O
of	O
autism	O
occurs	O
as	O
an	O
individual	O
is	O
noticeably	O
unable	O
to	O
achieve	O
certain	O
early	O
childhood	O
milestones	O
in	O
terms	O
of	O
communication	O
and	O
socialization	O
.	O

We	O
had	O
no	O
information	O
as	O
to	O
the	O
duration	O
of	O
use	O
or	O
the	O
vitamin	O
D	O
dose	O
in	O
the	O
PNV	O
which	O
typically	O
is	O
400	O
–	O
600	O
IU	O
per	O
tablet	O
,	O
but	O
can	O
vary	O
.	O

None	O
of	O
the	O
individual	O
phthalate	O
metabolites	O
or	O
BPA	O
were	O
statistically	O
significant	O
at	O
the	O
0	O
.	O
05	O
or	O
0	O
.	O
5	O
level	O
,	O
which	O
may	O
explain	B
why	O
the	O
class	O
as	O
a	O
whole	O
was	O
not	O
significantly	O
different	O
from	O
zero	O
.	O

Body	O
fat	O
(%	O
BF	O
)	O
was	O
calculated	O
from	O
BIA	O
data	O
with	O
prediction	O
equations	O
[	O
25	O
].	O

The	O
plasma	O
was	O
removed	O
,	O
frozen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
for	O
biochemical	O
and	O
hormonal	O
analysis	O
.	O

Serum	O
concentration	O
of	O
Ca	O
in	O
the	O
CG	O
after	O
the	O
intervention	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
prior	O
treatment	O
,	O
whereas	O
there	O
was	O
no	O
significant	O
difference	O
between	O
serum	O
concentration	O
of	O
Ca	O
before	O
and	O
after	O
the	O
intervention	O
in	O
the	O
CG	O
.	O

T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
(	O
equal	O
to	O
40	O
ng	O
/	O
ml	O
)	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
(	O
OR	O
0	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
and	O
LBW	O
(	O
OR	O
0	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
046	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
or	O
12	O
ng	O
/	O
ml	O
).	O

As	B
a	O
result	O
,	O
the	O
study	O
may	O
be	O
underpowered	O
.	O

The	O
ROLO	O
trial	O
evaluated	O
the	O
effect	O
of	O
a	O
low	O
glycaemic	O
index	O
diet	O
among	O
women	O
who	O
had	O
previously	O
given	O
birth	O
to	O
an	O
infant	O
with	O
weight	O
above	O
4	O
kg	O
[	O
16	O
].	O

2015	O
.	O

The	O
questions	O
were	O
translated	O
from	O
English	O
into	O
Swedish	O
and	O
back	O
-	O
translated	O
to	O
increase	O
fidelity	O
to	O
the	O
original	O
scale	O
.	O

Health	O
staff	O
interviews	O
and	O
participating	O
women	O
surveys	O
were	O
conducted	O
in	O
2006	O
and	O
2009	O
.	O

We	O
therefore	O
limited	O
our	O
study	O
population	O
to	O
only	O
women	O
of	O
white	O
ethnicity	O
(	O
95	O
.	O
8	O
%	O
of	O
eligible	O
women	O
).	O

The	O
intake	O
of	O
fatty	O
acids	O
and	O
vitamin	O
D	O
was	O
categorized	O
into	O
quartiles	O
,	O
with	O
the	O
lowest	O
quartile	O
as	O
the	O
reference	O
category	O
for	O
comparison	O
.	O

Activation	O
of	O
AKT	O
is	O
known	O
to	O
trigger	O
a	O
complex	O
cascade	O
of	O
events	O
that	O
include	O
the	O
inhibition	O
of	O
FOXO	O
transcription	O
factors	O
(	O
Ortega	O
-	O
Molina	O
et	O
al	O
.,	O
2012	O
).	O

In	O
1	O
study	O
,	O
at	B
least	I
half	O
of	O
food	O
advertisements	O
during	O
children	O
'	O
s	O
television	O
programming	O
were	O
for	O
energy	O
-	O
dense	O
,	O
low	O
-	O
nutrient	O
foods	O
such	O
as	O
cereal	O
,	O
candy	O
,	O
snacks	O
,	O
soda	O
,	O
and	O
fast	O
food	O
(	O
87	O
).	O

Of	O
note	O
is	O
that	O
in	O
that	O
study	O
,	O
about	O
10	O
%	O
of	O
infants	O
with	O
these	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
had	O
evidence	O
of	O
hypocalcemia	O
although	O
none	O
had	O
physical	O
symptoms	O
and	O
it	O
is	O
not	O
clear	O
if	O
there	O
was	O
a	O
true	O
cause	O
and	O
effect	O
in	O
this	O
group	O
.	O

None	O
of	O
the	O
women	O
were	O
anemic	O
at	O
that	O
point	O
,	O
but	O
66	O
%	O
had	O
low	O
levels	O
of	O
ferritin	O
(	O
the	O
principal	O
form	O
of	O
stored	O
iron	O
),	O
suggesting	O
low	O
iron	O
nutritional	O
status	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
and	O
by	O
ANOVA	O
.	O

(	O
2016	O
),	O
could	O
impair	O
the	O
sympathetic	O
neurotransmission	O
and	O
hormones	O
involved	O
in	O
energy	O
metabolism	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
;	O
Keimpema	O
et	O
al	O
.,	O
2013	O
,	O
2014	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

For	O
example	O
,	O
phthalates	O
metabolites	O
and	O
BPA	O
have	O
short	O
half	O
-	O
lives	O
and	O
this	O
may	O
have	O
attenuated	O
regression	O
estimates	O
and	O
reduced	O
statistical	O
power	O
[	O
48	O
].	O

Vitamin	O
D	O
posters	O
and	O
brochures	O
were	O
available	O
for	O
all	O
patients	O
at	O
MUSC	O
clinics	O
and	O
educational	O
materials	O
were	O
included	O
in	O
the	O
prenatal	O
packet	O
received	O
by	O
all	O
first	O
time	O
OB	O
patients	O
.	O

2	O
.	O
2	O
.	O

Maternal	O
health	O
and	O
nutrition	O
gained	O
heightened	O
attention	O
three	O
decades	O
ago	O
with	O
the	O
publication	O
of	O
the	O
developmental	O
origins	O
of	O
health	O
and	O
disease	O
(	O
DOHaD	O
)	O
hypothesis	O
.	O

Logistic	O
regression	O
analysis	O
was	O
performed	O
in	O
order	O
to	O
identify	O
the	O
significant	O
predictors	O
for	O
the	O
LGA	O
outcome	O
.	O

Placental	O
samples	O
were	O
washed	O
in	O
PBS	O
and	O
immediately	O
stored	O
in	O
RNAlater	O
(	O
Applied	O
Biosystems	O
,	O
UK	O
)	O
at	O
−	O
80	O
°	O
C	O
.	O

At	O
diagnosis	O
,	O
median	O
age	O
was	O
13	O
days	O
(	O
range	O
4	O
-	O
50	O
),	O
77	O
%	O
were	O
breast	O
-	O
fed	O
,	O
54	O
%	O
were	O
symptomatic	O
and	O
25	O
%	O
had	O
nephrocalcinosis	O
.	O

For	O
our	O
per	O
-	O
protocol	O
analysis	O
we	O
included	O
children	O
who	O
in	O
both	O
groups	O
received	O
all	O
doses	O
with	O
an	O
interval	O
between	O
the	O
doses	O
of	O
60	O
and	O
120	O
days	O
and	O
had	O
not	O
violated	O
the	O
randomisation	O
codes	O
.	O

‡	O
Studies	O
demonstrating	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
animal	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

Overall	O
,	O
the	O
prevalence	O
of	O
handwashing	O
with	O
soap	O
at	O
both	O
these	O
times	O
was	O
low	O
,	O
even	O
in	O
the	O
intervention	O
group	O
(	O
8	O
%	O
before	O
breastfeeding	O
and	O
14	O
%	O
after	O
fecal	O
contact	O
).	O

BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

A	O
design	O
effect	O
of	O
1	O
.	O
5	O
was	O
considered	O
to	O
account	O
for	O
any	O
potential	O
biases	O
.	O

We	O
also	O
consider	O
research	O
gaps	O
since	B
advancing	O
the	O
research	O
agenda	O
is	O
a	O
critical	O
need	O
to	O
reduce	O
the	O
global	O
burden	O
of	O
preterm	O
birth	O
,	O
requiring	O
innovations	O
for	O
both	O
prevention	O
and	O
care	O
.	O

In	O
an	O
analysis	O
of	O
questionnaire	O
data	O
from	O
8	O
,	O
765	O
children	O
aged	O
5	O
to	O
7	O
years	O
,	O
smoking	O
after	O
pregnancy	O
was	O
not	O
associated	O
with	O
childhood	O
obesity	O
but	O
intrauterine	O
exposure	O
was	O
(	O
20	O
).	O

Renin	O
expression	O
(	O
Figure	O
8	O
)	O
and	O
AT1r	O
expression	O
(	O
Figure	O
9	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g008	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
8	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
weaning	O
and	O
6	O
months	O
of	O
age	O
for	O
renin	O
expression	O
.	O

Do	O
we	O
know	O
how	O
VD	O
levels	O
impact	O
the	O
oocyte	O
quality	O
?	O

¶	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

Given	O
the	O
a	O
priori	O
nature	O
of	O
the	O
hypothesis	O
being	O
tested	O
,	O
and	O
the	O
fact	O
that	O
some	O
outcomes	O
of	O
interest	O
are	O
highly	O
correlated	O
,	O
it	O
did	O
not	O
seem	O
appropriate	O
to	O
correct	O
for	O
multiple	O
testing	O
.	O

This	O
family	O
,	O
which	O
can	O
oxidize	O
5mC	O
to	O
5	O
-	O
hydroxymethylcytosine	O
(	O
5hmC	O
)	O
and	O
further	O
to	O
5	O
-	O
formylcytosine	O
(	O
5fC	O
)	O
and	O
5	O
-	O
carboxycytosine	O
(	O
5caC	O
)	O
(	O
Tahiliani	O
et	O
al	O
.	O
2009	O
;	O
Ito	O
et	O
al	O
.	O
2011	O
),	O
has	O
fueled	O
research	O
into	O
indirect	O
active	O
DNA	O
demethylation	O
pathways	O
.	O

In	O
the	O
1980s	O
,	O
with	O
routine	O
treatment	O
for	O
women	O
with	O
mild	O
GDM	O
,	O
their	O
outcomes	O
were	O
not	O
different	O
to	O
women	O
with	O
normal	O
glucose	O
tolerance	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Results	O
from	O
38	O
subjects	O
who	O
completed	O
3	O
month	O
supplementation	O
studyNon	O
-	O
Hispanic	O
Caucasian	O
(	O
n	O
=	O
19	O
)	O
Hispanic	O
(	O
n	O
=	O
19	O
)	O
p	O
-	O
valueCord	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
mL	O
)	O
23	O
.	O
0	O
±	O
9	O
.	O
416	O
.	O
9	O
±	O
7	O
.	O
20	O
.	O
03BMC	O
at	O
one	O
week	O
(	O
g	O
)	O
69	O
.	O
4	O
±	O
9	O
.	O
172	O
.	O
8	O
±	O
9	O
.	O
20	O
.	O
27BMD	O
at	O
one	O
week	O
(	O
g	O
/	O
cm2	O
)	O
0	O
.	O
196	O
±	O
0	O
.	O
0100	O
.	O
199	O
±	O
0	O
.	O
0110	O
.	O
293	O
month	O
BMC	O
(	O
g	O
)	O
110	O
.	O
6	O
±	O
13	O
.	O
9123	O
.	O
8	O
±	O
13	O
.	O
40	O
.	O
0053	O
month	O
PTH	O
(	O
ng	O
/	O
L	O
)	O
14	O
.	O
4	O
±	O
16	O
.	O
4	O
(	O
n	O
=	O
19	O
)	O
17	O
.	O
6	O
±	O
10	O
.	O
5	O
(	O
n	O
=	O
18	O
)	O
0	O
.	O
483	O
month	O
total	O
serum	O
Ca	O
(	O
mg	O
/	O
dL	O
)	O
10	O
.	O
6	O
±	O
0	O
.	O
4	O
(	O
n	O
=	O
19	O
)	O
10	O
.	O
6	O
±	O
0	O
.	O
4	O
(	O
n	O
=	O
17	O
)	O
0	O
.	O
703	O
month	O
BMD	O
(	O
g	O
/	O
cm2	O
)	O
0	O
.	O
205	O
±	O
0	O
.	O
0130	O
.	O
219	O
±	O
0	O
.	O
0120	O
.	O
0023	O
month	O
weight	O
(	O
kg	O
)	O
6	O
.	O
0	O
±	O
5	O
.	O
86	O
.	O
4	O
±	O
6	O
.	O
10	O
.	O
103	O
month	O
length	O
(	O
cm	O
)	O
60	O
.	O
6	O
±	O
2	O
.	O
261	O
.	O
2	O
±	O
2	O
.	O
70	O
.	O
413	O
month	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
mL	O
)	O
37	O
.	O
7	O
±	O
7	O
.	O
631	O
.	O
2	O
±	O
8	O
.	O
10	O
.	O
014	O
Data	O
are	O
Mean	O
±	O
SD	O
.	O

Study	O
eligibility	O
criteria	O
for	O
mothers	O
included	O
healthy	O
mothers	O
ranging	O
from	O
18	O
to	O
40	O
years	O
of	O
age	O
,	O
with	O
no	O
history	O
of	O
gestational	O
diabetes	O
,	O
psychological	O
disorders	O
,	O
or	O
genetic	O
disorders	O
.	O

However	O
,	O
the	O
associations	O
with	O
dietary	O
components	O
and	O
health	O
are	O
often	B
non	O
-	O
linear	O
with	O
advantageous	O
effects	O
of	O
a	O
balanced	O
nutrition	O
[	O
47	O
-	O
50	O
].	O

Age	O
-	O
matched	O
caries	O
-	O
free	O
controls	O
were	O
recruited	O
from	O
the	O
community	O
by	O
advertisement	O
and	O
underwent	O
a	O
dental	O
screening	O
by	O
a	O
study	O
team	O
member	O
(	O
RJS	O
).	O

The	O
mean	O
serum	O
calcifediol	O
concentration	O
was	O
consistently	B
and	O
significantly	O
higher	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
in	O
the	O
placebo	O
group	O
at	O
1	O
week	O
,	O
4	O
weeks	O
,	O
and	O
3	O
months	O
after	O
administration	O
of	O
the	O
first	O
dose	O
of	O
vitamin	O
D	O
during	O
the	O
winter	O
and	O
at	O
2	O
weeks	O
'	O
post	O
administration	O
of	O
dose	O
3	O
(	O
spring	O
;	O
figure	O
3	O
).	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
244X	O
/	O
10	O
/	O
38	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Appendix	O
1	O
.	O

The	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
was	O
acceptable	O
for	O
all	O
sections	O
(	O
general	O
recommendations	O
,	O
0	O
.	O
66	O
;	O
sources	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
;	O
the	O
role	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
),	O
except	O
for	O
breastfeeding	O
(	O
0	O
.	O
60	O
),	O
which	O
was	O
therefore	O
eliminated	O
.	O

Tissue	O
Collection	O
Whole	O
rat	O
brains	O
were	O
removed	O
rapidly	O
after	O
decapitation	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
and	O
immediately	O
frozen	O
on	O
dry	O
ice	O
,	O
and	O
then	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Moreover	O
,	O
previously	O
noted	O
associations	O
between	O
current	O
smoking	O
and	O
age	O
at	O
menopause	O
were	O
not	O
observed	O
among	O
these	O
women	O
.	O

Descriptive	O
statistics	O
including	O
means	O
,	O
percentages	O
,	O
and	O
standard	O
deviations	O
were	O
calculated	O
for	O
all	O
outcomes	O
and	O
demographic	O
variables	O
.	O

PubMed	O
Central	O
:	O

We	O
believe	O
that	O
this	O
study	O
provides	B
a	O
clearer	B
understanding	I
of	O
the	O
effect	O
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
respiratory	O
function	O
and	O
respiratory	O
outcome	O
in	O
infancy	O
.	O

However	O
,	O
recent	O
studies	O
have	O
proposed	O
the	O
presence	O
of	O
a	O
relationship	O
between	O
maternal	O
serum	O
visfatin	O
level	O
and	O
fetal	O
growth	O
.	O

It	O
is	O
established	O
that	O
diet	O
is	O
an	O
important	O
driver	O
of	O
the	O
gut	O
microbiome	O
.	O

Developmental	O
Perspectives	O
on	O
Nutrition	O
and	O
Obesity	O
From	O
Gestation	O
to	O
Adolescence	O
Abstract	O
:	O
KEY	O
-	O
POINTS	O
Obesity	O
results	O
from	O
a	O
complex	O
combination	O
of	O
factors	O
that	O
act	O
at	O
many	O
stages	O
throughout	O
a	O
person	O
'	O
s	O
life	O
.	O

If	O
a	O
child	O
was	O
not	O
seen	O
for	O
more	O
than	O
45	O
days	O
,	O
at	O
the	O
two	O
weekly	O
visits	O
,	O
or	O
at	O
the	O
hospital	O
,	O
they	O
were	O
censored	O
for	O
that	O
period	O
of	O
our	O
study	O
.	O

The	O
execution	O
of	O
the	O
study	O
is	O
coordinated	O
by	O
the	O
Centre	O
of	O
Excellence	O
for	O
Nutrition	O
of	O
the	O
North	O
-	O
West	O
University	O
.	O

Anaemic	O
subjects	O
at	O
baseline	O
showed	O
an	O
increase	O
in	O
mean	O
haemoglobin	O
from	O
10	O
.	O
6g	O
/	O
dL	O
to	O
11	O
.	O
8g	O
/	O
L	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
after	O
MMN	O
supplementation	O
.	O

•	O
Implementation	O
research	O
to	O
develop	O
and	O
deliver	O
innovations	O
to	O
reach	O
the	O
poorest	O
.	O

Results	O
Seventy	O
-	O
six	O
women	O
were	O
evaluated	O
,	O
53	O
(	O
69	O
.	O
7	O
%)	O
had	O
10	O
yrs	O
.	O

The	O
study	O
was	O
approved	O
as	O
minimal	O
risk	O
research	O
by	O
the	O
Madigan	O
Institutional	O
Review	O
Board	O
(	O
IRB	O
)	O
on	O
July	O
26	O
,	O
2011	O
.	O

Miners	O
then	O
transported	O
the	O
ore	O
to	O
a	O
mill	O
,	O
where	O
it	O
was	O
crushed	O
and	O
soaked	O
in	O
sulfuric	O
acid	O
to	O
extract	O
the	O
uranium	O
.	O
20More	O
chemicals	O
were	O
added	O
to	O
precipitate	O
out	O
the	O
uranium	O
,	O
leaving	O
behind	O
a	O
radioactive	O
slurry	O
.	O

The	O
average	O
age	O
was	O
29	O
.	O
6	O
±	O
4	O
years	O
,	O
the	O
mean	O
pregnancy	O
days	O
were	O
240	O
±	O
42	O
,	O
and	O
mean	O
fetal	O
weight	O
was	O
2805	O
±	O
95	O
gr	O
.	O

Ethics	O
Approval	O
was	O
granted	O
by	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Local	O
Health	O
Network	O
Human	O
Research	O
and	O
Ethics	O
Committee	O
at	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Hospital	O
,	O
the	O
Central	O
Northern	O
Adelaide	O
Health	O
Service	O
Ethics	O
of	O
Human	O
Research	O
Committee	O
(	O
Lyell	O
McEwin	O
Hospital	O
)	O
and	O
the	O
Flinders	O
Clinical	O
Research	O
Ethics	O
Committee	O
(	O
Flinders	O
Medical	O
Centre	O
).	O

Although	O
the	O
exact	O
mechanisms	O
underlying	O
these	O
associations	O
have	O
yet	O
to	O
be	O
fully	O
elucidated	O
,	O
evidence	O
from	O
experimental	O
studies	O
suggest	O
that	O
insufficient	O
sleep	O
and	O
sleep	O
fragmentation	O
result	O
in	O
metabolic	O
and	O
neuroendocrine	O
alterations	O
,	O
particularly	O
alterations	O
in	O
the	O
hypothalamic	O
-	O
pituitary	O
adrenal	O
(	O
HPA	O
)	O
axis	O
,	O
that	O
may	O
contribute	O
to	O
the	O
development	O
of	O
impaired	O
glucose	O
tolerance	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
mellitus	O
[	O
16	O
-	O
20	O
].	O

The	O
coordination	O
of	O
several	O
factors	O
affects	O
IMF	O
deposition	O
.	O

The	O
median	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
-(	O
OH	O
)	O
D	O
]	O
concentration	O
was	O
significantly	O
lower	O
in	O
the	O
first	O
trimester	O
(	O
20	O
.	O
4	O
ng	O
/	O
ml	O
)	O
than	O
in	O
third	O
trimester	O
(	O
22	O
.	O
7	O
ng	O
/	O
ml	O
).	O

Normal	O
development	O
of	O
the	O
kidney	O
is	O
a	O
highly	O
complex	O
process	O
that	O
requires	O
precise	O
cellular	O
proliferation	O
,	O
differentiation	O
and	O
apoptosis	O
[	O
11	O
].	O

[	O
17	O
]	O
Rojroongwasonkul	O
et	O
al	O
.	O

Burgdorf	O
and	O
Nasemann6proposed	O
2	O
theories	O
of	O
cutaneous	O
ossification	O
.	O

Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
the	O
search	O
terms	O
:	O
pregnant	O
,	O
neurodevelopment	O
,	O
cognition	O
,	O
fish	O
and	O
seafood	O
.	O

PTB	O
rates	O
were	O
20	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
248	O
),	O
12	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
267	O
),	O
13	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
255	O
)	O
and	O
9	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
294	O
)	O
(	O
Table	O
2	O
).	O

One	O
possibility	O
that	O
emerges	O
from	O
our	O
data	O
is	O
that	O
male	O
offspring	O
can	O
increase	O
their	O
body	O
weight	O
by	O
either	O
a	O
reduction	O
of	O
energy	O
expenditure	O
or	O
higher	O
metabolism	O
efficiency	O
.	O

In	O
two	O
community	O
clinics	O
,	O
we	O
conducted	O
an	O
hour	O
-	O
long	O
observation	O
to	O
understand	O
the	O
implementation	O
of	O
the	O
national	O
IFA	O
programme	O
.	O

However	O
,	O
it	O
may	O
not	O
be	O
the	O
absolute	O
content	O
but	O
the	O
ratio	O
of	O
n	O
-	O
6	O
to	O
n	O
-	O
3	O
PUFAs	O
that	O
may	O
influence	O
the	O
development	O
of	O
either	O
tolerance	O
or	O
sensitization	O
to	O
food	O
,	O
as	O
a	O
high	O
ratio	O
of	O
9	O
of	O
n	O
-	O
6	O
/	O
n	O
-	O
3	O
in	O
the	O
diet	O
of	O
the	O
mother	O
prevented	O
the	O
induction	O
of	O
oral	O
tolerance	O
to	O
ovalbumin	O
in	O
the	O
offspring	O
in	O
a	O
rat	O
study	O
[	O
81	O
].	O

Vitamin	O
D	O
deficiency	O
was	O
found	O
in	O
at	O
least	O
one	O
fourth	O
of	O
children	O
living	O
in	O
rural	O
areas	O
.	O

An	O
increase	O
in	O
this	O
hormone	O
can	O
lead	O
to	O
brain	O
dysfunctions	O
[	O
70	O
,	O
71	O
].	O

Manipulating	O
dietary	O
fat	O
digestion	O
and	O
absorption	O
in	O
the	O
small	O
intestine	O
may	O
enhance	O
MS	O
.	O
Emulsifying	O
fat	O
may	O
affect	O
the	O
digestion	O
and	O
absorption	O
of	O
fat	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Schematic	O
representation	O
of	O
the	O
main	O
factors	O
described	O
in	O
the	O
review	O
,	O
which	O
modulate	O
UCP1	O
activity	O
.	O

The	O
higher	O
prevalence	O
of	O
PNA	O
signs	O
found	O
in	O
the	O
exposed	O
group	O
,	O
compared	O
with	O
the	O
controls	O
,	O
may	B
be	I
driven	O
by	O
concurrent	O
SSRI	O
exposure	O
,	O
as	B
12	O
of	O
the	O
15	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
also	O
exposed	O
to	O
an	O
SSRI	O
.	O

In	O
addition	O
,	O
Skm2	O
mutants	O
were	O
dehydrated	O
and	O
presented	O
with	O
tachypnea	O
,	O
likely	B
as	O
a	O
consequence	B
of	O
thoracic	O
deformities	O
.	O

This	O
was	O
then	O
carried	O
out	O
separately	O
for	O
boys	O
and	O
girls	O
.	O

To	O
correct	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
bias	O
,	O
we	O
used	O
inverse	O
probability	O
weighting	O
and	O
assigned	O
to	O
each	O
woman	O
a	O
weight	O
that	O
was	O
the	O
inverse	O
of	O
the	O
probability	O
of	O
her	O
selection	O
for	O
given	O
values	O
of	O
covariates	O
(	O
see	O
further	O
details	O
in	O
the	O
supplementary	O
material	O
)	O
[	O
35	O
].	O

The	O
spread	O
and	O
importance	O
of	O
postpartum	O
depression	O
have	O
led	O
researchers	O
to	O
create	O
preventative	O
methods	O
such	O
as	O
educational	O
programs	O
,	O
modified	O
care	O
,	O
dietary	O
supplements	O
,	O
antidepressant	O
medication	O
and	O
social	O
support	O
[	O
12	O
–	O
14	O
].	O

It	O
is	O
well	O
known	O
that	O
lower	O
HRV	O
parameters	O
are	O
associated	O
with	O
increased	O
mortality	O
due	O
to	O
heart	O
failure	O
,	O
coronary	O
heart	O
disease	O
and	O
ischemic	O
cardiomyopathy	O
during	O
adulthood	O
[	O
40	O
].	O

Indeed	O
,	O
vaccine	O
uptake	O
remained	O
somewhat	O
higher	O
among	O
pregnant	O
women	O
with	O
pre	O
-	O
existing	O
chronic	O
medical	O
conditions	O
in	O
our	O
study	O
year	O
suggesting	O
that	O
the	O
recommendation	O
may	O
have	O
been	O
slow	O
to	O
take	O
effect	O
.	O

Comparatively	O
,	O
maternal	O
high	O
fat	O
nutrition	O
led	O
to	O
a	O
small	O
but	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
birth	O
weight	O
compared	O
to	O
Cont	O
(	O
Figure	O
1B	O
).	O

We	O
subsequently	O
stratified	O
by	O
race	O
/	O
ethnicity	O
and	O
obesity	O
status	O
to	O
examine	O
whether	O
PNV	O
was	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
in	O
high	O
risk	O
groups	O
.	O

Maternal	O
average	O
nightly	O
sleep	O
duration	O
during	O
pregnancy	O
was	O
ascertained	O
by	O
asking	O
women	O
the	O
following	O
question	O
:	O
"	O
Since	O
becoming	O
pregnant	O
,	O
how	O
many	O
hours	O
per	O
night	O
do	O
you	O
sleep	O
?"	O

The	O
informed	O
consent	O
form	O
is	O
given	O
to	O
the	O
participant	O
to	O
read	O
,	O
consider	O
and	O
discuss	O
with	O
her	O
partner	O
and	O
/	O
or	O
family	O
.	O

In	O
addition	O
to	O
the	O
most	O
common	O
factors	O
the	O
sedentary	O
lifestyle	O
may	O
also	O
be	O
a	O
risk	O
factor	O
for	O
GDM	O
.	O

Black	O
and	O
Hispanic	O
mothers	O
were	O
found	O
to	O
have	O
a	O
statistically	O
significant	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
throughout	O
pregnancy	O
as	O
well	O
(	O
p	O
≤	O
0	O
.	O
0001	O
).	O

It	O
will	O
also	O
serve	O
as	O
a	O
reminder	O
for	O
regular	O
consumption	O
and	O
safely	O
store	O
the	O
medicines	O
away	O
from	O
child	O
access	O
.	O

The	O
etiology	O
of	O
this	O
disease	O
is	O
largely	O
unknown	O
.	O

There	O
are	O
some	O
significant	O
intrapartum	O
interventions	O
that	O
reduce	O
the	O
impact	O
of	O
preterm	O
birth	O
.	O

Potential	O
predictors	O
associated	O
with	O
each	O
outcome	O
at	O
P	O
<	O
0	O
.	O
2	O
in	O
bivariate	O
analyses	O
were	O
entered	O
into	O
multiple	O
regression	O
models	O
and	O
evaluated	O
using	O
backward	O
elimination	O
.	O

To	O
prevent	O
neural	O
tube	O
defects	O
,	O
400	O
μg	O
of	O
folic	O
acid	O
should	O
be	O
taken	O
daily	O
,	O
starting	O
one	O
month	O
before	O
conception	O
and	O
throughout	O
the	O
first	O
trimester	O
.	O

Discussion	O
The	O
text4baby	O
program	O
is	O
significant	O
in	O
that	O
it	O
represents	O
one	O
of	O
the	O
largest	O
worldwide	O
mHealth	O
programs	O
to	O
date	O
,	O
with	O
more	O
than	O
800	O
,	O
000	O
enrollees	O
from	O
inception	O
in	O
February	O
2010	O
through	O
November	O
2014	O
[	O
40	O
].	O

Transplacental	O
transfer	O
occurs	O
,	O
67	O
,	O
81and	O
until	O
studies	O
demonstrating	O
safety	O
are	O
performed	O
,	O
they	O
should	O
be	O
avoided	O
in	O
pregnancy	O
.	O

Moreover	O
,	O
similar	O
to	O
that	O
find	O
by	O
Restroff	O
et	O
al	O
.	O
26serum	O
PTH	O
of	O
the	O
IG	O
decreased	O
significantly	O
by	O
22	O
%	O
in	O
our	O
study	O
.	O

Meanwhile	O
,	O
in	O
the	O
United	O
States	O
,	O
another	O
team	O
of	O
researchers	O
pursued	O
a	O
similar	O
line	O
of	O
investigation	O
.	O

[	O
5	O
]	O
The	O
increasing	O
prevalence	O
of	O
disorders	O
linked	O
to	O
vitamin	O
D	O
deficiency	O
is	O
reflected	O
in	O
the	O
several	O
hundred	O
children	O
with	O
rickets	O
treated	O
each	O
year	O
.	O

Regarding	O
the	O
LP	O
model	O
used	O
in	O
rodents	O
,	O
it	O
has	O
been	O
suggested	O
that	O
the	O
maternal	O
LP	O
diet	O
had	O
an	O
impact	O
on	O
'	O
insulin	O
signaling	O
'	O
as	O
well	O
as	O
on	O
'	O
IGF1	O
signaling	O
'	O
and	O
its	O
binding	O
proteins	O
[	O
30	O
,	O
39	O
-	O
43	O
].	O

The	O
means	O
of	O
normal	O
distribution	O
data	O
were	O
analyzed	O
using	O
parametric	O
tests	O
such	O
as	O
Student	O
’	O
s	O
t	O
-	O
test	O
or	O
paired	O
t	O
-	O
test	O
.	O

From	O
the	O
infants	O
,	O
a	O
2	O
–	O
5	O
ml	O
urine	O
sample	O
is	O
collected	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
using	O
adhesive	O
paediatric	O
urine	O
collection	O
bags	O
.	O

The	O
two	O
OPPs	O
and	O
two	O
heavy	O
metals	O
were	O
examined	O
individually	O
as	O
covariates	O
with	O
no	O
hierarchical	O
priors	O
.	O

However	O
,	O
according	O
to	O
national	O
figures	O
from	O
the	O
National	O
Food	O
Administration	O
,	O
a	O
low	O
number	O
of	O
Swedish	O
women	O
took	O
fish	O
oil	O
supplements	O
(	O
1	O
%)	O
at	O
the	O
time	O
of	O
the	O
study	O
.	O

Although	O
there	O
was	O
a	O
trend	O
in	O
that	O
study	O
towards	O
a	O
relative	O
increase	O
in	O
25	O
(	O
OH	O
)	O
D	O
in	O
infants	O
with	O
lower	O
baseline	O
values	O
who	O
received	O
supplementation	O
,	O
this	O
was	O
not	O
clearly	O
demonstrated	O
.	O

The	O
odds	O
of	O
belonging	O
to	O
cluster	O
2	O
are	O
2	O
.	O
73	O
times	O
greater	O
for	O
each	O
additional	O
maternal	O
serving	O
of	O
fruit	O
per	O
day	O
(	O
95	O
%	O
CI	O
1	O
.	O
36	O
,	O
5	O
.	O
46	O
;	O
Table	O
3	O
,	O
Fig	O
.	O

Pregnancy	O
does	O
not	O
exacerbate	O
hypocalcaemia	O
and	O
secondary	O
hyperparathyroidism	O
in	O
people	O
with	O
pre	O
-	O
existing	O
vitamin	O
D	O
deficiency	O
.	O

Health	O
system	O
costs	O
included	O
institutional	O
administrative	O
costs	O
and	O
health	O
worker	O
income	O
.	O

A	O
recent	O
systematic	O
review	O
concluded	O
that	O
antenatal	O
vitamin	O
D	O
supplementation	O
is	O
effective	O
in	O
improving	O
the	O
vitamin	O
D	O
status	O
of	O
Asian	O
and	O
white	O
women	O
,	O
improves	O
growth	O
in	O
the	O
first	O
year	O
of	O
life	O
in	O
South	O
Asian	O
babies	O
and	O
therefore	B
may	O
contribute	O
to	O
reducing	O
the	O
incidence	O
of	O
rickets	O
in	O
this	O
latter	O
group	O
,	O
without	O
evidence	O
of	O
harm	O
.	O

It	O
is	O
important	O
,	O
however	O
,	O
to	O
assess	O
the	O
intrinsic	O
iatrogenic	O
risk	O
of	O
birth	O
defects	O
or	O
perinatal	O
complications	O
and	O
the	O
general	O
safety	O
for	O
the	O
expectant	O
mother	O
before	O
discontinuing	O
anticonvulsants	O
[	O
31	O
].	O

Podocin	O
expression	O
(	O
Figure	O
10	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g010	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
10	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
weaning	O
and	O
6	O
months	O
of	O
age	O
for	O
podocin	O
expression	O
.	O

Diet	O
affected	O
the	O
GD	O
in	O
10	O
-	O
day	O
-	O
old	O
offspring	O
(	O
P	O
<	O
0	O
.	O
0001	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

2008	O
;	O
Lu	O
et	O
al	O
.	O

Of	O
those	O
who	O
delivered	O
preterm	O
,	O
10	O
delivered	O
before	O
gestational	O
week	O
31	O
and	O
thus	O
before	O
the	O
T3	O
blood	O
sample	O
could	O
be	O
drawn	O
.	O

Based	O
on	O
our	O
data	O
-	O
driven	O
RPMM	O
approach	O
,	O
we	O
observed	O
that	O
AluYb8	O
methylation	O
was	O
significantly	O
and	O
positively	O
correlated	O
with	O
methylation	O
at	O
CpG	O
loci	O
in	O
an	O
intermediately	O
methylated	O
class	O
containing	O
loci	O
that	O
were	O
located	O
predominantly	O
within	O
CGIs	O
and	O
associated	O
with	O
PcG	O
target	O
genes	O
.	O

Measuring	O
dietary	O
intake	O
in	O
cohort	O
studies	O
is	O
problematic	O
due	O
to	O
the	O
difficulty	O
in	O
obtaining	O
detailed	O
information	O
without	O
causing	O
significant	O
subject	O
burden	O
.	O

Early	O
pregnancy	O
registration	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
(	O
aOR	O
,	O
3	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
11	O
.	O
9	O
).	O

The	O
MS	O
generally	B
increases	O
with	O
slaughter	O
age	O
in	O
Korean	O
cattle	O
.	O

Additionally	O
,	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
0	O
and	O
24	O
,	O
median	O
9	O
.	O
50	O
,	O
and	O
mode	O
13	O
were	O
observed	O
.	O

The	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
has	O
been	O
reported	O
to	O
range	O
from	O
15	O
%	O
to	O
80	O
%.	O

Before	O
doing	O
so	O
,	O
the	O
expression	O
of	O
GAS5	O
and	O
GRs	O
was	O
examined	O
in	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
without	O
administering	O
cortisol	O
.	O

(	O
p	O
=	O
0	O
.	O
002	O
)	O
[	O
5	O
].	O

Urinalysis	O
was	O
significant	O
for	O
a	O
specific	O
gravity	O
of	O
1	O
.	O
008	O
,	O
red	O
blood	O
cells	O
8	O
–	O
10	O
/	O
high	O
-	O
power	O
field	O
,	O
and	O
30	O
mg	O
/	O
dL	O
of	O
protein	O
.	O

Folate	O
Concentration	O
Analysis	O
Plasma	O
and	O
brain	O
folate	O
concentrations	O
were	O
determined	O
by	O
the	O
microbiological	O
microtiter	O
plate	O
assay	O
using	O
Lactobacillus	O
casei	O
.	O
16	O
,	O
17	O
Hypothalamic	O
Global	O
DNA	O
Methylation	O
Analysis	O
DNA	O
was	O
isolated	O
using	O
the	O
protocol	O
outlined	O
by	O
the	O
DNeasy	O
Blood	O
and	O
Tissue	O
Kit	O
(	O
Qiagen	O
Tech	O
.,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
).	O

Fibroblast	O
growth	O
factor	O
21	O
is	O
a	O
member	O
of	O
the	O
fibroblast	O
growth	O
factor	O
(	O
FGF	O
)	O
family	O
that	O
acts	O
as	O
a	O
hormone	O
and	O
that	O
,	O
in	O
contrast	O
to	O
other	O
endocrine	O
FGFs	O
,	O
is	O
devoid	O
of	O
proliferative	O
activity	O
(	O
Itoh	O
,	O
2014	O
).	O

Note	O
:	O
interventions	O
for	O
preterm	O
birth	O
are	O
bold	O
.	O

A	O
possible	O
increase	O
in	O
the	O
rate	O
of	O
miscarriages	O
has	O
been	O
reported	O
to	O
occur	O
in	O
the	O
early	O
period	O
after	O
therapy	O
,	O
but	O
it	O
remains	O
uncertain	O
whether	O
abortion	O
can	O
be	O
caused	O
either	O
by	O
I	O
-	O
131	O
itself	O
,	O
by	O
the	O
thyroid	O
autoimmunity	O
often	B
associated	O
with	O
disease	O
or	O
by	O
the	O
hypothyroid	O
-	O
hyperprolactinaemic	O
status	O
accompanying	O
I	O
-	O
131	O
therapy	O
.	O

Two	O
hypotheses	O
are	O
currently	O
proposed	O
to	O
explain	B
the	O
progression	O
of	O
chronic	O
renal	O
disease	O
.	O

Lastly	O
,	O
the	O
environmental	O
impact	O
of	O
perinatal	O
air	O
pollutants	O
has	O
also	O
been	O
observed	O
[	O
20	O
,	O
21	O
].	O

If	O
an	O
association	O
exists	O
the	O
effect	O
probably	B
represents	O
the	O
interplay	O
between	O
various	O
environmental	O
,	O
genetic	O
,	O
lifestyle	O
,	O
and	O
socioeconomic	O
factors	O
,	O
operating	O
on	O
mother	O
and	O
child	O
within	O
a	O
precise	O
window	O
of	O
vulnerability	O
.	O

Acute	O
aortic	O
dissection	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
has	O
been	O
attributed	O
to	O
hemodynamic	O
alterations	O
that	O
occur	O
in	O
late	O
pregnancy	O
.	O

in	O
their	O
study	O
used	O
a	O
dosage	O
of	O
14	O
,	O
000	O
IU	O
vitamin	O
D	O
supplement	O
per	O
week	O
,	O
equal	O
to	O
2000	O
IU	O
per	O
day	O
,	O
started	O
at	O
27	O
–	O
30	O
weeks	O
of	O
gestation	O
.	O

Since	O
iron	O
tablets	O
induce	O
a	O
high	O
concentration	O
of	O
free	O
radicals	O
in	O
the	O
intestinal	O
milieu	O
,	O
which	O
may	O
damage	O
the	O
intestinal	O
epithelium	O
,	O
the	O
minimal	O
essential	O
iron	O
dose	O
is	O
to	O
be	O
recommended	O
[	O
59	O
].	O

Additional	O
dietary	O
measures	O
are	O
usually	O
based	O
upon	O
the	O
general	O
recommendations	O
for	O
diabetes	O
mellitus	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
number	O
of	O
positive	O
skin	O
prick	O
tests	O
(	O
SPTs	O
)#	O
Free	O
sugar1	O
positive	O
SPT	O
¶≥	O
2	O
positive	O
SPTs	O
+	O
Adjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendAdjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendQuintile	O
1	O
1	O
.	O
001	O
.	O
00	O
Quintile	O
2	O
0	O
.	O
87	O
(	O
0	O
.	O
68	O
–	O
1	O
.	O
12	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
57	O
)	O
Quintile	O
3	O
1	O
.	O
07	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
37	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
56	O
)	O
Quintile	O
4	O
1	O
.	O
09	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
43	O
)	O
1	O
.	O
37	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
90	O
)	O
Quintile	O
5	O
1	O
.	O
19	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
18	O
–	O
2	O
.	O
52	O
)	O
Per	O
quintile	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
121	O
.	O
13	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
006	O
#:	O
no	O
positive	O
SPT	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
4797	O
);¶:	O
n	O
=	O
783	O
;+:	O
n	O
=	O
531	O
;§:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

A	O
dose	O
of	O
600	O
,	O
000	O
IU	O
vitamin	O
D	O
resulted	O
in	O
hypercalcemia	O
,	O
therefore	B
,	O
it	O
can	O
not	O
be	O
regarded	B
a	O
safe	O
dose	O
.	O
17There	O
is	O
no	O
study	O
to	O
evaluate	O
vitamin	O
D	O
status	O
in	O
mothers	O
with	O
previous	O
GDM	O
,	O
and	O
present	O
oral	O
vitamin	O
D	O
products	O
are	O
not	O
fully	O
effective	O
,	O
16therefore	B
,	O
this	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
effect	O
of	O
intramuscular	O
injection	O
of	O
300	O
,	O
000	O
IU	O
during	O
a	O
three	O
-	O
month	O
period	O
.	O

Actions	O
taken	O
during	O
labour	O
and	O
birth	O
,	O
and	O
particularly	O
improved	O
care	O
of	O
the	O
neonate	O
have	O
been	O
shown	O
to	O
have	O
major	O
impact	O
[	O
5	O
,	O
6	O
].	O

The	O
inverse	O
probability	O
weighting	O
analysis	O
also	O
produced	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

Moreover	O
,	O
the	O
expression	O
of	O
the	O
catalytic	O
subunits	O
of	O
AMPK	O
,	O
PRKAA1	O
and	O
PRKAA2	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
compared	O
to	O
AP	O
offspring	O
at	O
stage	O
188	O
dpn	O
,	O
which	O
may	O
contribute	O
to	O
an	O
imbalanced	O
cellular	O
metabolism	O
.	O

In	O
a	O
recent	O
study	O
,	O
serum	O
levels	O
of	O
vitamin	O
D	O
,	O
steroid	O
hormones	O
,	O
SHBG	O
and	O
ovarian	O
reserve	O
markers	O
were	O
determined	O
in	O
73	O
non	O
-	O
obese	O
,	O
healthy	O
,	O
parous	O
women	O
.	O

Using	O
a	O
data	O
-	O
driven	O
recursively	O
partitioned	O
mixture	O
model	O
(	O
RPMM	O
),	O
these	O
CpG	O
loci	O
were	O
clustered	O
into	O
16	O
methylation	O
classes	O
based	O
on	O
like	O
methylation	O
pattern	O
obtained	O
from	O
the	O
array	O
results	O
,	O
pruning	O
the	O
model	O
after	O
four	O
splits	O
to	O
maintain	O
power	O
(	O
Houseman	O
et	O
al	O
.	O

Strong	O
relationships	O
have	O
recently	O
been	O
reported	O
between	O
serum	O
visfatin	O
levels	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
and	O
insulin	O
secretion	O
in	O
the	O
fetus	O
and	O
final	O
birth	O
weight	O
,	O
which	O
shows	O
the	O
role	O
of	O
visfatin	O
secretion	O
in	O
early	O
pregnancy	O
in	O
the	O
later	O
metabolic	O
modeling	O
of	O
the	O
fetus	O
(	O
11	O
).	O

At	O
birth	O
,	O
maternal	O
and	O
neonatal	O
health	O
is	O
assessed	O
and	O
an	O
umbilical	O
cord	O
blood	O
sample	O
collected	O
.	O

To	O
consistently	O
raise	O
the	O
blood	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
above	O
75	O
nmol	O
/	O
L	O
at	O
least	O
1500	O
–	O
2000	O
IU	O
/	O
day	O
VD	O
is	O
required	O
[	O
69	O
].	O

due	O
to	O
the	O
change	O
in	O
the	O
diet	O
of	O
pregnant	O
women	O
.	O

Also	O
,	O
Omani	O
et	O
al	O
.	O

Given	O
that	O
the	O
month	O
in	O
which	O
the	O
serum	O
was	O
sampled	O
heavily	O
influences	O
vitamin	O
D	O
status	O
,	O
“	O
standardised	O
”	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
calculated	O
as	O
previously	O
described	O
[	O
34	O
]	O
in	O
order	O
to	O
normalise	O
against	O
seasonal	O
variation	O
.	O

While	O
there	O
is	O
little	O
conclusive	O
evidence	O
to	O
support	O
that	O
a	O
prudent	O
diet	O
is	O
protective	O
against	O
AM	O
especially	O
after	O
birth	O
,	O
modest	O
evidence	O
suggests	O
that	O
a	O
prenatal	O
maternal	O
nutrition	O
high	O
in	O
n	O
-	O
3	O
and	O
micronutrients	O
(	O
e	O
.	O
g	O
.	O

The	O
authors	O
suggested	O
that	O
future	O
studies	O
with	O
larger	O
sample	O
sizes	O
would	O
be	O
helpful	O
to	O
endorse	O
or	O
challenge	O
their	O
findings	O
.	O

There	O
was	O
no	O
evidence	O
of	O
rickets	O
both	O
clinically	O
and	O
radiologically	O
.	O

In	O
the	O
United	O
States	O
,	O
about	O
18	O
%	O
to	O
30	O
%	O
of	O
women	O
in	O
the	O
childbearing	O
age	O
have	O
allergic	O
diseases	O
,	O
especially	O
rhinitis	O
[	O
8	O
]	O
and	O
asthma	O
[	O
9	O
].	O

Analysis	O
was	O
performed	O
using	O
SPSS	O
18	O
.	O
0	O
for	O
Macintosh	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
).	O

The	O
LASSO	O
regression	O
coefficients	O
tended	O
to	O
be	O
larger	O
in	O
magnitude	O
than	O
BHLM	O
with	O
wider	O
and	O
less	O
precise	O
95	O
%	O
intervals	O
,	O
which	O
we	O
expected	O
because	O
LASSO	O
does	O
not	O
use	O
shrinkage	O
that	O
borrows	O
information	O
between	O
chemicals	O
within	O
a	O
particular	O
class	O
.	O

For	O
example	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

From	O
the	O
responses	O
to	O
the	O
questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
,	O
a	O
variable	O
was	O
created	O
by	O
categorizing	O
women	O
into	O
three	O
groups	O
(	O
Additional	O
file1	O
).	O

These	O
surveys	O
were	O
conducted	O
at	O
3	O
and	O
12	O
months	O
post	O
-	O
implementation	O
[	O
15	O
].	O

It	O
was	O
assessed	O
that	O
maternal	O
smoking	O
was	O
related	O
to	O
a	O
modest	O
increase	O
in	O
the	O
risk	O
of	O
Pervasive	O
Developmental	O
Disorders	O
,	O
however	O
,	O
there	O
was	O
no	O
known	O
association	O
between	O
maternal	O
smoking	O
and	O
childhood	O
autism	O
[	O
34	O
].	O

We	O
included	O
primiparous	O
mothers	O
for	O
the	O
handwashing	O
study	O
because	O
we	O
anticipated	O
that	O
they	O
would	O
be	O
at	O
a	O
uniquely	O
teachable	O
moment	O
[	O
15	O
,	O
16	O
].	O

Fifth	O
,	O
we	O
adjusted	O
for	O
gestational	O
age	O
non	O
-	O
parametrically	O
.	O

In	O
this	O
regard	O
,	O
developmental	O
plasticity	O
would	O
confer	O
a	O
phenotype	O
that	O
is	O
better	O
suited	O
for	O
the	O
environment	O
and	O
thereby	O
increase	O
the	O
organism	O
'	O
s	O
chances	O
of	O
reproducing	O
successfully	O
.	O

At	O
10	O
days	O
of	O
age	O
(	O
Figures	O
6and7	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g006	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Number	O
of	O
developing	O
immature	O
and	O
mature	O
glomeruli	O
at	O
10	O
days	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

Vitamin	O
D2	O
cannot	O
be	O
synthesized	O
endogenously	O
,	O
i	O
.	O
e	O
.,	O
it	O
is	O
an	O
exogenous	O
only	O
Vitamin	O
D	O
,	O
which	O
comes	O
from	O
artificially	O
synthesized	O
compounds	O
or	O
some	O
plant	O
foods	O
such	O
as	O
edible	O
mushroom	O
grown	O
in	O
natural	O
environment	O
.	O

Optimal	O
management	O
of	O
these	O
disorders	O
during	O
pregnancy	O
is	O
vital	O
to	O
ensure	O
the	O
welfare	O
of	O
the	O
mother	O
and	O
the	O
baby	O
.	O

In	O
utero	O
adaptation	O
may	O
lead	O
to	O
lifelong	O
changes	O
in	O
the	O
body	O
’	O
s	O
metabolism	O
,	O
hormone	O
regulation	O
,	O
and	O
the	O
number	O
of	O
cells	O
present	O
in	O
key	O
organs	O
[	O
14	O
,	O
157	O
,	O
158	O
].	O

Presently	O
,	O
over	O
40	O
million	O
pregnant	O
women	O
suffer	O
from	O
iron	O
deficiency	O
(	O
ID	O
)	O
and	O
its	O
consequences	O
in	O
developing	O
countries	O
[	O
8	O
].	O

The	O
peptide	O
mixture	O
was	O
then	O
bound	O
and	O
aspirated	O
5	O
times	O
through	O
the	O
column	O
and	O
bound	O
peptides	O
washed	O
with	O
5	O
×	O
10	O
µl	O
of	O
1	O
%	O
formic	O
acid	O
.	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

Pregnancy	O
itself	O
may	O
also	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
other	O
diseases	O
[	O
10	O
].	O

While	O
the	O
intervention	O
increased	O
the	O
frequency	O
of	O
handwashing	O
,	O
mothers	O
and	O
others	O
washed	O
hands	O
with	O
soap	O
at	O
less	O
than	O
10	O
%	O
of	O
the	O
times	O
we	O
recommended	O
for	O
handwashing	O
.	O

After	O
log	O
-	O
transforming	O
total	O
IgE	O
,	O
linear	O
regression	O
was	O
used	O
to	O
estimate	O
geometric	O
mean	O
ratios	O
for	O
IgE	O
;	O
confidence	O
limits	O
were	O
calculated	O
using	O
Huber	O
variances	O
.	O

Almost	O
half	O
of	O
the	O
intervention	O
group	O
achieved	O
concentrations	O
of	O
30	O
ng	O
/	O
mL	O
[	O
59	O
].	O

By	O
contrast	O
,	O
subjects	O
were	O
generally	O
older	O
,	O
better	O
nourished	O
,	O
multiparous	O
and	O
poorly	O
educated	O
.	O

In	O
previous	O
publications	O
,	O
we	O
have	O
reported	O
on	O
the	O
representativeness	O
of	O
the	O
participating	O
mothers	O
and	O
children	O
and	O
find	O
,	O
as	B
with	I
many	O
cohorts	O
,	O
that	O
less	O
affluent	O
and	O
younger	O
mothers	O
were	O
less	O
likely	B
to	O
continue	O
to	O
participate	O
,	O
but	O
the	O
baseline	O
maternal	O
BMI	O
does	O
not	O
differ	O
between	O
responders	O
and	O
non	O
-	O
responders	O
.	O
22Also	O
,	O
we	O
only	O
report	O
statistically	O
significant	O
findings	O
which	O
by	O
definition	O
are	O
sufficiently	O
powered	O
when	O
the	O
child	O
is	O
aged	O
9	O
.	O

Caregivers	O
completed	O
a	O
questionnaire	O
administered	O
by	O
staff	O
which	O
collected	O
information	O
about	O
the	O
child	O
and	O
caregiver	O
,	O
dietary	O
intakes	O
,	O
use	O
of	O
supplements	O
,	O
sun	O
exposure	O
and	O
skin	O
pigmentation	O
,	O
oral	O
hygiene	O
behaviours	O
,	O
and	O
socioeconomic	O
factors	O
including	O
household	O
income	O
,	O
parental	O
education	O
level	O
,	O
and	O
receipt	O
of	O
government	O
assistance	O
[	O
12	O
].	O

Gestational	O
EDC	O
exposures	O
may	O
be	O
associated	O
with	O
changes	O
in	O
fetal	O
growth	O
that	O
elevates	O
the	O
risk	O
for	O
poor	O
health	O
later	O
in	O
life	O
,	O
but	O
few	O
studies	O
have	O
examined	O
the	O
health	O
effects	O
of	O
simultaneous	O
exposure	O
to	O
multiple	O
chemicals	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Body	O
weight	O
(	O
g	O
)	O
and	O
caloric	O
intake	O
(	O
kcal	O
/	O
kg	O
)	O
in	O
dams	O
(	O
A	O
)	O
and	O
their	O
offspring	O
(	O
B	O
–	O
D	O
)	O
in	O
gestation	O
,	O
lactation	O
and	O
/	O
or	O
postweaning	O
periods	O
.	O

Because	O
subjects	O
were	O
selected	O
based	O
on	O
SGA	O
status	O
and	O
matched	O
to	O
non	O
-	O
SGA	O
infants	O
on	O
sex	O
,	O
gestational	O
age	O
,	O
and	O
maternal	O
age	O
,	O
we	O
observed	O
no	O
significant	O
differences	O
in	O
those	O
characteristics	O
among	O
birth	O
weight	O
groups	O
(	O
SGA	O
,	O
AGA	O
,	O
LGA	O
).	O

Study	O
location	O
and	O
population	O
Kiang	O
West	O
is	O
a	O
semi	O
-	O
arid	O
area	O
of	O
savannah	O
-	O
scrubland	O
with	O
a	O
rural	O
population	O
of	O
14	O
000	O
people	O
,	O
predominantly	O
of	O
the	O
Mandinka	O
tribe	O
.	O

A	O
brief	O
wash	O
in	O
1x	O
PBS	O
solution	O
was	O
performed	O
after	O
this	O
.	O

1	O
Seasonal	O
variation	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
.	O
a	O
.	O

Samples	O
with	O
concentrations	O
above	O
the	O
standard	O
curve	O
upper	O
limit	O
were	O
diluted	O
further	O
due	O
to	O
their	O
higher	O
cathelicidin	O
concentration	O
.	O

Other	O
grouping	O
schemes	O
,	O
however	O
,	O
may	O
be	O
more	O
informative	O
.	O

The	O
newly	O
synthesized	O
cytokines	O
and	O
chemokines	O
lead	O
to	O
the	O
late	O
-	O
phase	O
reaction	O
associated	O
with	O
tissue	O
edema	O
by	O
recruitment	O
and	O
activation	O
of	O
additional	O
inflammatory	O
cells	O
,	O
including	O
basophils	O
,	O
eosinophils	O
,	O
and	O
T	O
helper	O
type	O
2	O
(	O
Th2	O
)	O
lymphocytes	O
[	O
6	O
].	O

“	O
It	O
’	O
s	O
not	O
supposed	B
to	I
be	O
this	O
hard	O
.”	O
Nommsen	O
-	O
Rivers	O
also	O
observed	O
a	O
cluster	O
of	O
variables	O
,	O
all	O
linked	O
with	O
glucose	O
intolerance	O
,	O
that	O
were	O
significantly	O
associated	O
with	O
delayed	O
lactogenesis	O
.	O

The	O
methodology	O
has	O
been	O
described	O
elsewhere	O
and	O
a	O
number	O
of	O
reports	O
with	O
this	O
data	O
set	O
have	O
been	O
published	O
previously	O
.	O
212226Briefly	O
,	O
mothers	O
were	O
recruited	O
at	O
the	O
antenatal	O
booking	O
visit	O
initially	O
and	O
,	O
in	O
addition	O
to	O
their	O
infant	O
,	O
were	O
asked	O
to	O
recruit	O
if	O
possible	O
their	O
partner	O
and	O
at	O
least	O
one	O
living	O
grandparent	O
.	O

Maternal	O
allergy	O
assessment	O
The	O
International	O
Study	O
for	O
Asthma	O
and	O
Allergies	O
in	O
Childhood	O
(	O
ISAAC	O
)	O
questionnaire	O
[	O
48	O
]	O
is	O
used	O
to	O
assess	O
allergy	O
symptoms	O
in	O
maternal	O
participants	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
,	O
and	O
7	O
postnatally	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Body	O
mass	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
at	O
3	O
and	O
6	O
months	O
of	O
age	O
.	O

Therefore	O
,	O
the	O
current	O
study	O
includes	O
133	O
women	O
who	O
received	O
SGA	O
medications	O
during	O
pregnancy	O
and	O
133	O
matched	O
healthy	O
women	O
(	O
N	O
=	O
266	O
).	O

In	O
Iran	O
,	O
iron	O
and	O
folic	O
acid	O
supplements	O
are	O
routinely	O
given	O
to	O
all	O
pregnant	O
mothers	O
and	O
some	O
mothers	O
based	O
on	O
doctors	O
’	O
order	O
may	O
consume	O
multivitamins	O
or	O
calcium	O
.	O

Future	O
studies	O
will	O
elucidate	O
the	O
long	O
term	O
effects	O
of	O
maternal	O
nutrition	O
on	O
offspring	O
reproductive	O
capability	O
and	O
to	O
determine	O
the	O
molecular	O
mechanisms	O
underlying	O
early	O
pubertal	O
onset	O
.	O

Although	O
the	O
evidence	O
for	O
use	O
of	O
mobile	O
phones	O
beyond	O
these	O
areas	O
is	O
still	O
emerging	O
,	O
the	O
overall	O
trend	O
is	O
that	O
they	O
can	O
be	O
effective	O
tools	O
for	O
health	O
promotion	O
,	O
disease	O
prevention	O
,	O
and	O
as	O
adjunct	O
treatment	O
tools	O
.	O

Discussion	O
The	O
importance	O
of	O
perinatal	O
nutrition	O
and	O
its	O
role	O
in	O
offspring	O
health	O
,	O
is	O
recognised	O
[	O
79	O
].	O

However	O
,	O
recent	O
animal	O
and	O
human	O
studies	O
indicate	O
that	O
acid	O
suppression	O
and	O
the	O
resulting	O
elevated	O
pH	O
in	O
the	O
stomach	O
may	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
sensitization	O
to	O
food	O
[	O
86	O
,	O
87	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
number	O
of	O
prenatal	O
visits	O
,	O
among	O
categories	O
of	O
formal	O
educationFormal	O
education	O
(	O
years	O
)	O
Number	O
of	O
prenatal	O
visitsp	O
<	O
44	O
-	O
10	O
>	O
10	O
Folic	O
acid	O
use	O
(%)≤	O
8	O
2	O
.	O
114	O
.	O
630	O
.	O
8	O
.	O
007	O
9	O
-	O
12	O
4	O
.	O
344	O
.	O
372	O
.	O
5	O
<.	O
001	O
>	O
12	O
069	O
.	O
474	O
.	O
7	O
.	O
21	O
Iron	O
use	O
(%)≤	O
8	O
16	O
.	O
756	O
.	O
176	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
21	O
.	O
751	O
.	O
466	O
.	O
7	O
<.	O
001	O
>	O
12	O
10077	O
.	O
862	O
.	O
6	O
.	O
19	O
Multivitamins	O
use	O
(%)≤	O
8	O
22	O
.	O
953	O
.	O
776	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
26	O
.	O
17079	O
.	O
7	O
<.	O
001	O
>	O
12	O
10088	O
.	O
987	O
.	O
5	O
.	O
88	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
the	O
interaction	O
between	O
the	O
number	O
of	O
prenatal	O
visits	O
and	O
formal	O
education	O
level	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
Education	O
*	O
Prenatal	O
care	O
interaction	O
PC1	O
*	O
E1110	O
.	O
63	O
(	O
14	O
.	O
94	O
-	O
818	O
.	O
97	O
)	O
63	O
.	O
86	O
(	O
8	O
.	O
47	O
-	O
481	O
.	O
41	O
)	O
10	O
.	O
35	O
(	O
4	O
.	O
60	O
-	O
23	O
.	O
27	O
)	O
7	O
.	O
95	O
(	O
3	O
.	O
36	O
-	O
18	O
.	O
83	O
)	O
18	O
.	O
20	O
(	O
8	O
.	O
46	O
-	O
39	O
.	O
16	O
)	O
11	O
.	O
25	O
(	O
4	O
.	O
96	O
-	O
25	O
.	O
49	O
)	O
PC1	O
*	O
E251	O
.	O
78	O
(	O
6	O
.	O
83	O
-	O
392	O
.	O
29	O
)	O
32	O
.	O
281	O
(	O
4	O
.	O
97	O
-	O
294	O
.	O
63	O
)	O
7	O
.	O
45	O
(	O
2	O
.	O
66	O
-	O
20	O
.	O
88	O
)	O
6	O
.	O
20	O
(	O
2	O
.	O
17	O
-	O
17	O
.	O
73	O
)	O
15	O
.	O
33	O
(	O
5	O
.	O
64	O
-	O
41	O
.	O
68	O
)	O
11	O
.	O
71	O
(	O
4	O
.	O
17	O
-	O
32	O
.	O
87	O
)	O
PC2	O
*	O
E113	O
.	O
73	O
(	O
5	O
.	O
50	O
-	O
34	O
.	O
22	O
)	O
10	O
.	O
941	O
(	O
4	O
.	O
30	O
-	O
27	O
.	O
78	O
)	O
1	O
.	O
62	O
(	O
0	O
.	O
82	O
-	O
3	O
.	O
19	O
)	O
1	O
.	O
38	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
79	O
)	O
4	O
.	O
67	O
(	O
2	O
.	O
28	O
-	O
9	O
.	O
55	O
)	O
3	O
.	O
65	O
(	O
1	O
.	O
72	O
-	O
7	O
.	O
71	O
)	O
PC2	O
*	O
E22	O
.	O
96	O
(	O
1	O
.	O
70	O
-	O
5	O
.	O
15	O
)	O
2	O
.	O
51	O
(	O
1	O
.	O
41	O
-	O
4	O
.	O
49	O
)	O
1	O
.	O
95	O
(	O
1	O
.	O
13	O
-	O
3	O
.	O
38	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
10	O
-	O
3	O
.	O
03	O
)	O
2	O
.	O
31	O
(	O
1	O
.	O
23	O
-	O
4	O
.	O
34	O
)	O
2	O
.	O
03	O
(	O
1	O
.	O
05	O
-	O
3	O
.	O
91	O
)	O
Nutritional	O
knowledge	O
score	O
Low111111	O
Medium6	O
.	O
67	O
(	O
2	O
.	O
62	O
-	O
17	O
.	O
01	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
74	O
-	O
2	O
.	O
89	O
)	O
1	O
.	O
80	O
(	O
0	O
.	O
99	O
-	O
3	O
.	O
27	O
)	O
1	O
.	O
65	O
(	O
0	O
.	O
86	O
-	O
3	O
.	O
15	O
)	O
3	O
.	O
58	O
(	O
1	O
.	O
88	O
-	O
6	O
.	O
80	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
52	O
-	O
2	O
.	O
50	O
)	O
High8	O
.	O
30	O
(	O
2	O
.	O
99	O
-	O
23	O
.	O
4	O
)	O
7	O
.	O
13	O
(	O
2	O
.	O
33	O
-	O
21	O
.	O
80	O
)	O
2	O
.	O
41	O
(	O
1	O
.	O
14	O
-	O
5	O
.	O
14	O
)	O
2	O
.	O
37	O
(	O
1	O
.	O
50	O
-	O
5	O
.	O
65	O
)	O
3	O
.	O
48	O
(	O
1	O
.	O
50	O
-	O
8	O
.	O
10	O
)	O
3	O
.	O
62	O
(	O
1	O
.	O
38	O
-	O
9	O
.	O
51	O
)	O
PC1	O
–	O
prenatal	O
care	O
:≥	O
10	O
visits	O
;	O
PC2	O
-	O
prenatal	O
care	O
:	O
4	O
–	O
9	O
visits	O
;	O
reference	O
category	O
-	O
<	O
4	O
visits	O
.	O

Both	O
bioinformatically	O
informed	O
CpG	O
classes	O
that	O
were	O
significantly	O
associated	O
with	O
AluYb8	O
methylation	O
contained	O
loci	O
that	O
are	O
proximal	O
to	O
TFBSs	O
.	O

The	O
women	O
who	O
contacted	O
Motherisk	O
tended	O
to	O
be	O
middle	O
to	O
upper	O
-	O
middle	O
class	O
,	O
which	O
represents	O
the	O
majority	O
of	O
the	O
population	O
,	O
and	O
may	O
be	O
higher	O
functioning	O
than	O
those	O
who	O
did	O
not	O
,	O
as	B
they	O
independently	O
sought	O
access	O
to	O
counselling	O
in	O
order	O
to	O
help	O
educate	O
themselves	O
on	O
the	O
potential	O
teratogenic	O
risks	O
associated	O
with	O
their	O
medications	O
.	O
16A	O
smaller	O
proportion	O
of	O
callers	O
came	O
from	O
the	O
lower	O
socioeconomic	O
and	O
/	O
or	O
immigrant	O
population	O
;	O
however	O
,	O
this	O
may	O
not	O
affect	O
the	O
generalisability	O
of	O
the	O
results	O
,	O
as	B
their	O
outcomes	O
may	O
be	O
confounded	O
by	O
other	O
factors	O
unrelated	O
to	O
the	O
drug	O
effect	O
.	O

In	O
animals	O
,	O
D3is	O
synthesized	O
in	O
the	O
skin	O
from	O
its	O
derivate	O
(	O
7	O
-	O
dehydrocholesterol	O
)	O
in	O
the	O
presence	O
of	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
),	O
while	O
D2is	O
made	O
in	O
fungi	O
and	O
yeast	O
.	O

The	O
findings	O
from	O
this	O
analysis	O
support	O
the	O
previously	O
identified	O
association	O
between	O
higher	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
reduced	O
risk	O
of	O
PTB	O
and	O
shows	O
that	O
the	O
benefits	O
identified	O
in	O
the	O
RCTs	O
by	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

However	O
,	O
in	O
contrary	O
to	O
these	O
reports	O
,	O
a	O
survey	O
in	O
Canadian	O
children	O
showed	O
that	O
both	O
low	O
and	O
high	O
vitamin	O
D	O
levels	O
were	O
related	O
to	O
increased	O
risk	O
of	O
wheeze	O
and	O
reduced	O
performance	O
of	O
lung	O
function	O
[	O
35	O
].	O

In	O
addition	O
,	O
multiplex	O
PCR	O
was	O
performed	O
for	O
detecting	O
Streptococcus	O
pneumoniae	O
,	O
Haemophilus	O
influenzae	O
,	O
Moraxella	O
catarrhalis	O
,	O
Streptococcus	O
pyogens	O
,	O
and	O
Staphylococcus	O
aureus	O
[	O
20	O
].	O

Conclusions	O
Despite	O
the	O
fact	O
that	O
the	O
seminal	O
work	O
on	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
was	O
published	O
over	O
a	O
decade	O
ago	O
,	O
this	O
area	O
of	O
research	O
largely	O
remains	O
in	O
its	O
infancy	O
,	O
striving	O
to	O
elucidate	O
putative	B
mechanisms	O
of	O
epigenetic	O
toxicity	O
and	O
identify	O
mechanistic	O
associations	O
in	O
human	O
cohorts	O
.	O

These	O
studies	O
were	O
largely	O
retrospective	O
,	O
unrandomized	O
,	O
or	O
lacked	O
power	O
to	O
detect	O
differences	O
in	O
serious	O
adverse	O
perinatal	O
outcomes	O
and	O
will	O
not	O
be	O
listed	O
here	O
.	O

Eligible	O
studies	O
included	O
those	O
of	O
healthy	O
pregnant	O
women	O
who	O
had	O
experienced	O
full	O
term	O
births	O
and	O
those	O
that	O
had	O
measured	O
fish	O
or	O
seafood	O
intake	O
and	O
assessed	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
.	O

Maternal	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
measured	O
at	O
baseline	O
and	O
childbirth	O
.	O

Interestingly	O
,	O
our	O
findings	O
that	O
male	O
gender	O
correlates	O
with	O
cathelicidin	O
peeks	O
further	O
interest	O
in	O
understanding	O
gender	O
differences	O
in	O
regards	O
to	O
the	O
immune	O
system	O
.	O

First	O
,	O
we	O
know	O
that	O
it	O
would	O
be	O
better	O
to	O
evaluate	O
levels	O
of	O
cord	O
plasma	O
and	O
breast	O
milk	O
concentrations	O
of	O
visfatin	O
and	O
assess	O
their	O
correlation	O
with	O
the	O
children	O
’	O
s	O
anthropometric	O
in	O
order	O
to	O
support	O
our	O
results	O
.	O

When	O
the	O
data	O
were	O
stratified	O
by	O
gender	O
in	O
post	O
-	O
hoc	O
analyses	O
,	O
only	O
the	O
male	O
population	O
continued	O
to	O
demonstrate	O
this	O
correlation	O
(	O
ρ	O
=	O
0	O
.	O
292	O
,	O
p	O
=	O
0	O
.	O
014	O
),	O
while	O
females	O
did	O
not	O
(	O
ρ	O
=	O
0	O
.	O
103	O
,	O
p	O
=	O
0	O
.	O
425	O
).	O

A	O
targeted	O
screening	O
strategy	O
to	O
detect	O
and	O
treat	O
women	O
at	O
high	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
is	O
clearly	O
needed	O
in	O
Belgium	O
and	O
in	O
other	O
European	O
countries	O
.	O

The	O
same	O
study	O
stressed	O
that	O
the	O
level	O
of	O
knowledge	O
about	O
food	O
sources	O
and	O
the	O
role	O
of	O
folic	O
acid	O
during	O
pregnancy	O
was	O
influenced	O
by	O
socio	O
-	O
demographic	O
factors	O
,	O
especially	O
the	O
level	O
of	O
education	O
[	O
38	O
].	O

The	O
castration	O
rate	O
of	O
bulls	O
has	O
been	O
increasing	O
in	O
Korea	O
in	O
the	O
21st	O
century	O
,	O
and	O
it	O
was	O
about	O
95	O
%	O
in	O
2013	O
[	O
59	O
].	O

However	O
,	O
it	O
appears	O
that	O
,	O
at	B
least	I
in	O
a	O
southern	O
US	O
setting	O
,	O
400	O
IU	O
/	O
day	O
is	O
adequate	O
for	O
infants	O
regardless	O
of	O
vitamin	O
D	O
status	O
at	O
birth	O
.	O

No	O
specific	O
etiologic	O
agent	O
to	O
date	O
has	O
been	O
identified	O
to	O
support	O
such	O
a	O
long	O
induction	O
period	O
for	O
this	O
cancer	O
.	O

Both	O
Cell	O
-	O
dyn	O
and	O
Medonic	O
CA530	O
analysers	O
were	O
used	O
for	O
processing	O
of	O
haematological	O
samples	O
due	O
to	O
a	O
technical	O
fault	O
with	O
the	O
Cell	O
-	O
dyn	O
machine	O
.	O

Each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
also	O
was	O
compared	O
to	O
the	O
frequency	O
of	O
infections	O
each	O
child	O
had	O
diagnosed	O
within	O
the	O
last	O
year	O
,	O
and	O
to	O
the	O
age	O
of	O
the	O
child	O
.	O

Trial	O
registration	O
ISRCTN	O
registry	O
,	O
ISRCTN54392969	O
,	O
date	O
of	O
registration	O
:	O
22	O
/	O
04	O
/	O
2009	O
,	O
retrospectively	O
registered	O
.	O

Her	O
physical	O
examination	O
was	O
significant	O
for	O
confusion	O
,	O
dry	O
oral	O
mucosa	O
,	O
and	O
gravid	O
abdomen	O
.	O

Materials	O
and	O
Methods	O
Animal	O
protocols	O
were	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
State	O
University	O
of	O
Rio	O
de	O
Janeiro	O
(	O
Protocol	O
Number	O
CEA	O
/	O
242	O
/	O
2008	O
),	O
and	O
the	O
procedures	O
were	O
conducted	O
in	O
accordance	O
with	O
the	O
guidelines	O
for	O
experimentation	O
with	O
animals	O
(	O
NIH	O
Publication	O
N	O
°.	O

Preterm	O
birth	O
is	O
a	O
problem	O
that	O
we	O
all	O
share	O
;	O
therefore	O
,	O
the	O
solutions	O
must	O
also	O
be	O
shared	O
,	O
and	O
won	O
through	O
cooperation	O
,	O
collaboration	O
and	O
coordination	O
of	O
the	O
many	O
constituencies	O
and	O
stakeholders	O
.	O

20	O
pairs	O
of	O
female	O
fieldworkers	O
visited	O
every	O
home	O
starting	O
from	O
streets	O
closest	O
to	O
the	O
hospital	O
and	O
radiating	O
out	O
until	O
we	O
reached	O
our	O
required	O
sample	O
size	O
.	O

For	O
entire	O
cohort	O
,	O
we	O
found	O
a	O
positive	O
correlation	O
between	O
BW	O
and	O
birth	O
length	O
(	O
r	O
=	O
0	O
.	O
603	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
results	O
are	O
given	O
in	O
Additional	O
file1	O
:	O
Figure	O
S4	O
.	O

The	O
quality	O
of	O
clinical	O
assessment	O
in	O
the	O
clinics	O
and	O
during	O
home	O
visits	O
was	O
monitored	O
weekly	O
by	O
study	O
supervisors	O
.	O

Recommendations	O
are	O
individualized	O
after	O
a	O
dietary	O
assessment	O
of	O
each	O
patient	O
.	O

Unlike	O
the	O
situation	O
for	O
women	O
with	O
pre	O
-	O
existing	O
type	O
1	O
diabetes	O
however	O
,	O
significant	O
hypoglycemia	O
is	O
uncommon	O
in	O
women	O
with	O
insulin	O
-	O
treated	O
GDM	O
.	O

Exposure	O
was	O
measured	O
by	O
an	O
estimated	O
count	O
of	O
total	O
messages	O
delivered	O
to	O
participants	O
based	O
on	O
service	O
enrollment	O
and	O
end	O
dates	O
validated	O
by	O
the	O
Voxiva	O
text4baby	O
service	O
database	O
,	O
which	O
were	O
linked	O
to	O
individuals	O
and	O
provided	O
to	O
the	O
investigators	O
under	O
the	O
DUA	O
.	O

(	O
E	O
)	O
Radiograph	O
of	O
the	O
tail	O
of	O
Skm1	O
.	O

3	O
.	O
3	O
.	O

However	O
,	O
the	O
latter	O
explanation	B
is	O
less	O
likely	B
since	B
the	O
two	O
groups	O
do	O
not	O
differ	O
in	O
weight	O
or	O
heights	O
and	O
weights	O
of	O
their	O
partners	O
—	O
that	O
is	O
,	O
the	O
mother	O
,	O
or	O
heights	O
and	O
lengths	O
of	O
child	O
at	O
age	O
0	O
.	O

Maternal	O
medical	O
records	O
were	O
reviewed	O
for	O
the	O
following	O
information	O
:	O
race	O
,	O
prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
and	O
BMI	O
at	O
delivery	O
,	O
insurance	O
status	O
,	O
prenatal	O
vitamin	O
use	O
and	O
maternal	O
complications	O
including	O
smoking	O
,	O
hypertension	O
,	O
diabetes	O
,	O
chorioamnionitis	O
,	O
preterm	O
labor	O
and	O
premature	O
rupture	O
of	O
membranes	O
.	O

Overall	O
,	O
differences	O
in	O
study	O
design	O
,	O
populations	O
,	O
influenza	O
virus	O
and	O
circulation	O
variability	O
make	O
it	O
a	O
challenge	O
to	O
compare	O
results	O
[	O
31	O
].	O

These	O
pathways	O
had	O
scores	O
of	O
32	O
and	O
29	O
respectively	O
(	O
both	O
highly	O
significant	O
).	O
Figure	O
2shows	O
the	O
first	O
pathway	O
,	O
annotated	O
for	O
functions	O
related	O
to	O
calcium	O
buffering	O
.	O

White	O
perirenal	O
and	O
perigonadal	O
fat	O
were	O
completely	O
dissected	O
out	O
,	O
weighed	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
until	O
RT	O
-	O
qPCR	O
analyses	O
.	O

Thus	B
,	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
conduct	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
children	O
stratified	O
by	O
birth	O
weight	O
quartiles	O
to	O
identify	O
alterations	O
in	O
autonomic	O
function	O
through	O
the	O
analysis	O
of	O
heart	O
rate	O
variability	O
(	O
HRV	O
).	O

The	O
latter	O
is	O
possibly	O
due	O
to	O
the	O
fact	O
that	O
women	O
using	O
sunscreen	O
lotion	O
are	O
more	O
often	O
exposed	O
to	O
the	O
sun	O
.	O

The	O
work	O
,	O
which	O
is	O
being	O
overseen	O
by	O
the	O
State	O
Environmental	O
Protection	O
Administration	O
and	O
the	O
Ministry	O
of	O
Agriculture	O
,	O
will	O
also	O
compile	O
information	O
on	O
methods	O
of	O
environmental	O
remediation	O
currently	O
available	O
in	O
the	O
country	O
.	O

Skm1	O
mice	O
were	O
visibly	O
leaner	O
than	O
their	O
littermate	O
controls	O
and	O
presented	O
with	O
either	O
an	O
elongated	O
body	O
or	O
a	O
thoracolumbar	O
kyphosis	O
and	O
a	O
kinked	O
tail	O
(	O
Figure	O
1B	O
).	O

The	O
PCM	O
-	O
I	O
consists	O
of	O
items	O
derived	O
from	O
:	O
1	O
)	O
the	O
Kilifi	O
Developmental	O
Inventory	O
(	O
KDI	O
)	O
[	O
63	O
],	O
previously	O
used	O
by	O
the	O
investigators	O
to	O
determine	O
psychomotor	O
development	O
in	O
an	O
infant	O
population	O
in	O
South	O
Africa	O
[	O
64	O
],	O
2	O
)	O
the	O
Developmental	O
Milestone	O
Checklist	O
(	O
DMC	O
-	O
II	O
)	O
[	O
65	O
,	O
66	O
],	O
and	O
3	O
)	O
the	O
Profile	O
of	O
Social	O
-	O
Emotional	O
Development	O
(	O
PSED	O
),	O
which	O
is	O
based	O
in	O
part	O
on	O
the	O
Brief	O
Infant	O
/	O
Toddler	O
Social	O
Emotional	O
Assessment	O
[	O
67	O
].	O

Furthermore	O
,	O
screening	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
is	O
likely	B
to	O
identify	O
a	O
large	O
proportion	O
of	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
or	O
insufficient	O
,	O
and	O
who	O
might	O
benefit	O
from	O
vitamin	O
D	O
supplementation	O
for	O
prevention	O
of	O
osteoporosis	O
and	O
other	O
complications	O
,	O
especially	O
multiple	O
sclerosis	O
.	O

Methods	O
Employing	O
a	O
novel	O
mixed	O
-	O
method	O
approach	O
which	O
adjusts	O
for	O
age	O
and	O
familial	O
group	O
,	O
BMI	O
correlations	O
were	O
estimated	O
at	O
three	O
ages	O
of	O
the	O
index	O
child	O
,	O
that	O
is	O
,	O
at	O
birth	O
and	O
at	O
ages	O
5	O
and	O
9	O
.	O

Appropriate	O
sized	O
cuffs	O
are	O
used	O
for	O
obese	O
participants	O
.	O

Offspring	O
then	O
were	O
fed	O
either	O
a	O
control	O
or	O
a	O
high	O
fat	O
diet	O
from	O
the	O
time	O
of	O
weaning	O
to	O
adulthood	O
.	O

Total	O
GWG	O
was	O
computed	O
based	O
on	O
pregravid	O
weight	O
and	O
weight	O
at	O
the	O
last	O
clinic	O
visit	O
prior	O
to	O
delivery	O
.	O

Such	O
results	O
may	O
be	O
considered	O
in	O
context	O
with	O
exposure	O
to	O
psychotropic	O
drugs	O
.	O

Women	O
exposed	O
in	O
utero	O
to	O
the	O
estrogen	O
-	O
like	O
compound	O
DES	O
show	O
a	O
higher	O
prevalence	O
for	O
left	O
handedness	O
[	O
195	O
,	O
196	O
].	O

Finally	O
,	O
we	O
were	O
not	O
able	O
to	O
obtain	O
information	O
on	O
previous	O
pregnancy	O
outcomes	O
;	O
previous	O
history	O
of	O
PTB	O
or	O
abortion	O
in	O
the	O
second	O
trimester	O
has	O
been	O
associated	O
with	O
an	O
increased	O
frequency	O
of	O
PTB	O
[	O
54	O
].	O

Univariate	O
associations	O
of	O
exposures	O
and	O
demographics	O
with	O
birth	O
weight	O
percentile	O
status	O
or	O
with	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
were	O
examined	O
using	O
Kruskal	O
–	O
Wallis	O
tests	O
for	O
continuous	O
covariates	O
and	O
chi	O
-	O
square	O
tests	O
for	O
categorical	O
covariates	O
.	O

PTB	O
rates	O
by	O
serum	O
25	O
(	O
OH	O
)	O
D	O
group	O
and	O
PTB	O
subtype	O
are	O
shown	O
inTable	O
3	O
.	O

suggested	O
that	O
more	O
accurate	O
clinical	O
trials	O
are	O
required	O
to	O
reach	O
a	O
conclusion	O
about	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
depression	O
[	O
31	O
].	O

…	O
But	O
for	O
mining	O
,	O
one	O
can	O
just	O
walk	O
to	O
it	O
in	O
the	O
canyon	O
.	O

It	O
is	O
interesting	O
that	O
in	O
the	O
Caucasian	O
population	O
,	O
the	O
chance	B
of	O
achieving	O
clinical	O
pregnancy	O
(	O
defined	O
as	O
fetal	O
heartbeat	O
visible	O
in	O
ultrasound	O
at	O
7	O
–	O
8	O
weeks	O
of	O
gestation	O
)	O
increased	O
with	O
VD	O
serum	O
levels	O
,	O
while	O
in	O
Asians	O
the	O
reverse	O
relationship	O
was	O
demonstrated	O
[	O
55	O
].	O

In	O
attention	O
to	O
exclusion	O
criteria	O
(	O
not	O
to	O
give	O
blood	O
sample	O
or	O
usage	O
of	O
vitamin	O
D	O
supplement	O
during	O
the	O
study	O
period	O
)	O
none	O
of	O
the	O
case	O
and	O
control	O
populations	O
were	O
not	O
excluded	O
from	O
our	O
research	O
.	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
sleep	O
disturbances	O
may	O
augment	O
pro	O
-	O
inflammatory	O
responses	O
that	O
may	O
then	O
contribute	O
to	O
altered	O
glucose	O
metabolism	O
.	O

It	O
has	O
been	O
suggested	O
that	O
all	O
Hispanics	O
and	O
all	O
pregnant	O
and	O
lactating	O
women	O
have	O
their	O
25	O
(	O
OH	O
)	O
D	O
levels	O
monitored	O
[	O
4	O
].	O

We	O
also	O
stratified	O
based	O
on	O
fetal	O
sex	O
to	O
evaluate	O
possible	O
effect	O
measure	O
modifications	O
according	O
to	O
whether	O
the	O
mother	O
was	O
carry	O
a	O
male	O
or	O
female	O
fetus	O
.	O

Our	O
main	O
analyses	O
focused	O
on	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
).	O

Results	O
A	O
total	O
of	O
266	O
children	O
(	O
51	O
.	O
1	O
%	O
male	O
)	O
participated	O
;	O
144	O
children	O
with	O
S	O
-	O
ECC	O
and	O
122	O
caries	O
-	O
free	O
.	O

Many	O
investigators	O
have	O
explored	O
the	O
relationship	O
between	O
EDC	O
exposures	O
and	O
birth	O
weight	O
[	O
18	O
].	O

Only	O
6	O
%	O
of	O
women	O
started	O
visits	O
in	O
the	O
first	O
trimester	O
while	O
14	O
.	O
5	O
%	O
began	O
in	O
the	O
third	O
trimester	O
.	O

In	O
order	O
to	O
address	O
difficulties	O
with	O
heritability	O
interpretation	O
,	O
we	O
have	O
employed	O
a	O
mixed	O
-	O
model	O
analysis	O
that	O
uses	O
fixed	O
and	O
random	O
effects	O
.	O
27The	O
family	O
component	O
of	O
variance	O
is	O
partitioned	O
into	O
variances	O
of	O
and	O
correlations	O
between	O
family	O
members	O
.	O

Vitamin	O
D	O
may	O
affect	O
fetal	O
growth	O
through	O
its	O
effect	O
on	O
calcium	O
metabolism	O
,	O
bone	O
growth	O
and	O
placental	O
development	O
.	O
32Although	O
initial	O
studies	O
showed	O
conflicting	O
results	O
,	O
more	O
recent	O
studies	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
may	O
adversely	O
affect	O
growth	O
and	O
lead	O
to	O
low	O
birth	O
weight	O
or	O
SGA	O
infants	O
.	O
7	O
,	O
9	O
,	O
11	O
,	O
12	O
,	O
18	O
,	O
22	O
,	O
23	O
,	O
33Because	B
of	O
a	O
known	O
relationship	O
between	O
race	O
and	O
vitamin	O
D	O
status	O
,	O
attention	O
then	O
turned	O
to	O
investigation	O
of	O
the	O
relationship	O
between	O
race	O
,	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O

Furthermore	O
,	O
we	O
found	O
an	O
inverse	O
association	O
between	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
and	O
infant	O
head	O
circumference	O
.	O

The	O
location	O
of	O
the	O
mutation	O
is	O
indicated	O
by	O
shading	O
.	O

We	O
further	O
hypothesised	O
that	O
household	O
wealth	O
and	O
maternal	O
education	O
would	O
modify	O
the	O
neonatal	O
mortality	O
responses	O
with	O
a	O
greater	O
reduction	O
for	O
women	O
from	O
the	O
poorest	O
households	O
,	O
and	O
women	O
with	O
no	O
education	O
.	O

In	O
this	O
study	O
,	O
they	O
selected	O
mothers	O
who	O
needed	O
antidepressant	O
drugs	O
after	O
childbirth	O
as	O
the	O
case	O
group	O
.	O

RESULTS	O
This	O
case	O
-	O
control	O
study	O
evaluated	O
50	O
MS	O
patients	O
as	O
case	O
group	O
and	O
50	O
healthy	O
people	O
as	O
control	O
.	O

These	O
regulations	O
may	O
indicate	O
an	O
impaired	O
fetal	O
growth	O
performance	O
due	O
to	O
the	O
gestational	O
low	O
protein	O
diet	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
captures	O
the	O
effect	O
of	O
multiple	O
vitamin	O
D	O
input	O
sources	O
(	O
supplement	O
,	O
sun	O
,	O
and	O
food	O
)	O
and	O
makes	O
provision	O
for	O
inter	O
-	O
individual	O
variability	O
in	O
dose	O
response	O
[	O
11	O
].	O

Results	O
Geographical	O
accessibility	O
and	O
perceived	O
quality	O
of	O
care	O
were	O
the	O
predominant	O
reasons	O
for	O
choosing	O
or	O
changing	O
a	O
site	O
for	O
ANC	O
.	O

The	O
monotherapy	O
and	O
polytherapy	O
groups	O
did	O
not	O
differ	O
with	O
respect	O
to	O
the	O
rate	O
of	O
preterm	O
deliveries	O
,	O
birth	O
weight	O
or	O
proportion	O
of	O
small	O
for	O
gestational	O
age	O
neonates	O
.	O

Those	O
two	O
publications	O
only	O
seemingly	O
contradict	O
each	O
other	O
.	O

Consent	O
was	O
obtained	O
to	O
request	O
a	O
report	O
from	O
the	O
child	O
'	O
s	O
physician	O
,	O
which	O
included	O
hospital	O
birth	O
records	O
,	O
postnatal	O
assessments	O
and	O
information	O
on	O
congenital	O
malformations	O
and	O
the	O
child	O
'	O
s	O
health	O
.	O

A	O
minimum	O
sample	O
of	O
120	O
children	O
in	O
each	O
group	O
was	O
expected	O
to	O
provide	O
80	O
%	O
power	O
to	O
detect	O
a	O
one	O
-	O
tailed	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
levels	O
between	O
the	O
groups	O
at	O
α	O
=	O
0	O
.	O
05	O
.	O

Their	O
perinatal	O
mortality	O
rate	O
was	O
2	O
.	O
3	O
times	O
that	O
of	O
women	O
with	O
normal	O
glucose	O
tolerance	O
.	O

To	O
convert	O
serum	O
vitamin	O
D	O
levels	O
from	O
ng	O
/	O
mL	O
to	O
nmol	O
/	O
L	O
,	O
multiply	O
by	O
2	O
.	O
5	O
.	O

Discussion	O
This	O
highly	O
novel	O
cohort	O
study	O
is	O
one	O
of	O
very	O
few	O
human	O
studies	O
in	O
the	O
literature	O
with	O
examination	O
data	O
across	O
three	O
generations	O
and	O
both	O
lineages	O
which	O
can	O
be	O
linked	O
to	O
children	O
’	O
s	O
growth	O
patterns	O
at	O
three	O
different	O
time	O
points	O
.	O
22To	B
the	I
best	I
of	I
our	I
knowledge	I
,	O
there	O
are	O
no	O
other	O
reported	O
human	O
cross	O
-	O
generational	O
data	O
sets	O
in	O
the	O
literature	O
with	O
four	O
grandparental	O
lines	O
and	O
three	O
time	O
points	O
of	O
measured	O
BMI	O
,	O
so	O
this	O
is	O
an	O
original	O
contribution	O
to	O
the	O
scientific	O
literature	O
.	O

This	O
susceptibility	O
is	O
mainly	B
because	B
decision	O
making	O
,	O
critical	O
thinking	O
,	O
and	O
abstract	O
thinking	O
are	O
underdeveloped	O
in	O
childhood	O
.	O

The	O
CAPE	O
tool	O
has	O
proven	O
to	O
be	O
a	O
stable	O
,	O
valid	O
and	O
reliable	O
self	O
-	O
report	O
instrument	O
for	O
the	O
measurement	O
of	O
psychotic	O
-	O
like	O
experiences	O
in	O
the	O
general	O
population	O
based	O
on	O
cross	O
-	O
validation	O
with	O
interview	O
-	O
based	O
data	O
[	O
24	O
,	O
25	O
].	O

Fetal	O
programming	O
of	O
nutritional	O
restriction	O
with	O
pasture	O
-	O
based	O
systems	O
retarded	O
offspring	O
growth	O
performance	O
(	O
body	O
weight	O
,	O
feed	O
intake	O
,	O
carcass	O
weight	O
)	O
and	O
production	O
parameters	O
including	O
muscle	O
weight	O
,	O
meat	O
yield	O
,	O
and	O
fat	O
and	O
bone	O
weight	O
at	O
any	O
given	O
age	O
.	O

PubMed	O
Central	O
:	O

The	O
maternal	O
baseline	O
depression	O
levels	O
were	O
evaluated	O
.	O

It	O
is	O
crucial	O
to	O
ensure	O
that	O
at	O
-	O
risk	O
women	O
are	O
aware	O
of	O
this	O
need	O
.	O

We	O
will	O
exclude	O
five	O
Upazilas	O
from	O
Kishoreganj	O
,	O
six	O
Upazilas	O
from	O
Netrokona	O
and	O
two	O
Upazilas	O
from	O
Sherpur	O
because	O
of	O
insufficient	O
BRAC	O
Program	O
Officer	O
(	O
PO	O
)	O
coverage	O
.	O

Dependence	O
of	O
male	O
fertility	O
on	O
VD	O
is	O
depicted	O
inFigure	O
3	O
.	O

[	O
21	O
]	O
was	O
the	O
only	O
study	O
to	O
report	O
a	O
neutral	O
effect	O
of	O
seafood	O
intake	O
on	O
all	O
neurodevelopmental	O
outcomes	O
.	O

The	O
remaining	O
analyses	O
were	O
conducted	O
on	O
live	O
births	O
(	O
N	O
=	O
229	O
).	O

Data	O
and	O
sample	O
collection	O
Individual	O
informed	O
consent	O
was	O
obtained	O
in	O
the	O
local	O
language	O
by	O
Gambian	O
MRC	O
fieldworkers	O
.	O

One	O
likely	B
reason	B
for	O
the	O
difference	O
is	O
convenience	O
.	O

This	O
study	O
aimed	O
to	O
examine	O
the	O
association	O
of	O
gestational	O
exposure	O
to	O
five	O
chemical	O
classes	O
of	O
potential	O
EDCs	O
:	O
phthalates	O
and	O
bisphenol	O
A	O
,	O
perfluoroalkyl	O
substances	O
(	O
PFAS	O
),	O
polychlorinated	O
biphenyls	O
(	O
PCBs	O
),	O
polybrominated	O
diphenyl	O
ethers	O
(	O
PBDEs	O
),	O
and	O
organochlorine	O
pesticides	O
(	O
OCPs	O
)	O
with	O
infant	O
birth	O
weight	O
.	O

If	O
there	O
is	O
a	O
causal	O
intrauterine	O
effect	O
,	O
one	O
would	O
expect	O
a	O
stronger	O
association	O
with	O
maternal	O
intake	O
in	O
pregnancy	O
than	O
with	O
maternal	O
post	O
-	O
natal	O
intake	O
or	O
paternal	O
intake	O
(	O
the	O
latter	O
two	O
exposures	O
cannot	O
have	O
a	O
direct	O
biological	O
effect	O
on	O
offspring	O
asthma	O
risk	O
)	O
(	O
see	O
further	O
details	O
in	O
the	O
supplementary	O
material	O
)	O
[	O
32	O
,	O
33	O
].	O

Of	O
the	O
vegetables	O
and	O
fruits	O
,	O
carrots	O
and	O
cantaloupe	O
showed	O
the	O
highest	O
inverse	O
effect	O
,	O
perhaps	O
because	B
of	O
these	O
foods	O
’	O
high	O
carotenoid	O
content	O
.	O

Conclusions	O
Women	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	B
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
pregnancy	O
,	O
which	O
had	O
a	O
lasting	O
association	O
to	O
28	O
weeks	O
,	O
and	O
was	O
independent	O
of	O
25OHD	O
.	O

In	O
the	O
third	O
trimester	O
,	O
surgery	O
may	O
induce	O
premature	O
labour	O
.	O

The	O
first	O
section	O
comprises	O
10	O
chapters	O
on	O
various	O
aspects	O
of	O
nutrition	O
such	O
as	O
nutrition	O
adequacy	O
to	O
dietary	O
supplements	O
.	O

The	O
BRAC	O
PO	O
will	O
provide	O
technical	O
support	O
to	O
the	O
SK	O
and	O
SS	O
,	O
and	O
will	O
help	O
them	O
resolve	O
any	O
problems	O
through	O
regular	O
meetings	O
in	O
the	O
field	O
.	O

The	O
F2	O
offspring	O
were	O
separated	O
and	O
analyzed	O
in	O
the	O
same	O
way	O
as	O
the	O
F1	O
offspring	O
.	O

In	O
children	O
,	O
high	O
birth	O
weight	O
has	O
been	O
associated	O
with	O
increased	O
risk	O
for	O
astrocytoma	O
and	O
medulloblastoma	O
/	O
primitive	O
neuroectodermal	O
tumors	O
(	O
PNET	O
)	O
[	O
173	O
].	O

The	O
rate	O
of	O
neonatal	O
hypoglycemia	O
(	O
5	O
.	O
3	O
%)	O
was	O
similar	O
to	O
insulin	O
(	O
3	O
.	O
7	O
%),	O
but	O
lower	O
than	O
glyburide	O
(	O
33	O
%)	O
(	O
p	O
=	O
0	O
.	O
006	O
).	O

The	O
child	O
'	O
s	O
BMI	O
was	O
also	O
correlated	O
with	O
the	O
MGM	O
.	O

“	O
Unfortunately	O
,	O
we	O
don	O
’	O
t	O
have	O
a	O
good	O
understanding	O
of	O
what	O
could	O
be	O
going	O
on	O
‘	O
under	O
the	O
hood	O
’—	O
what	O
biological	O
mechanisms	O
could	O
be	O
driving	O
these	O
associations	O
,”	O
she	O
says	O
.	O

The	O
IG	O
was	O
given	O
intramuscular	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
while	O
the	O
CG	O
was	O
not	O
.	O

We	O
found	O
support	O
for	O
a	O
protective	O
effect	O
regarding	O
the	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
with	O
high	O
dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
,	O
as	O
well	O
as	O
of	O
vitamin	O
D	O
.	O
The	O
associations	O
were	O
J	O
-	O
shaped	O
with	O
the	O
strongest	O
reduced	O
risk	O
for	O
an	O
intermediate	O
intake	O
of	O
fish	O
or	O
PUFA	O
.	O

Associations	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
birth	O
size	O
were	O
inconsistent	O
.	O

Total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
mL	O
)	O
was	O
measured	O
using	O
standardized	O
methodology	O
for	O
LC	O
/	O
MS	O
analysis	O
in	O
a	O
MUSC	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
(	O
CLIA	O
)-	O
certified	O
clinical	O
laboratory	O
.	O

We	O
observed	O
that	O
increasing	O
AluYb8	O
methylation	O
was	O
associated	O
with	O
greater	O
extents	O
of	O
methylation	O
at	O
CpG	O
loci	O
located	O
in	O
a	O
PcG	O
target	O
,	O
and	O
thus	O
a	O
change	O
in	O
the	O
extent	O
of	O
methylation	O
of	O
AluYb8	O
may	O
represent	O
an	O
alteration	O
in	O
the	O
methylation	O
of	O
these	O
key	O
loci	O
important	O
in	O
tissue	O
development	O
and	O
differentiation	O
.	O

Materials	O
and	O
methods	O
For	O
this	O
study	O
,	O
following	O
IRB	O
approval	O
(	O
HR	O
#	O
Pro00020570	O
),	O
de	O
-	O
identified	O
medical	O
record	O
data	O
were	O
obtained	O
for	O
all	O
pregnant	O
women	O
aged	O
18	O
–	O
45	O
years	O
who	O
received	O
a	O
25	O
(	O
OH	O
)	O
D	O
test	O
and	O
delivered	O
at	O
MUSC	O
between	O
September	O
2015	O
and	O
December	O
2016	O
.	O

Researchers	O
were	O
blinded	O
to	O
subject	O
allocation	O
scheme	O
and	O
subjects	O
and	O
field	O
staff	O
knew	O
only	O
the	O
colour	O
-	O
coded	O
allocation	O
groups	O
.	O

No	O
current	O
medical	O
illness	O
;	O
4	O
).	O

We	O
will	O
use	O
different	O
colour	O
coding	O
to	O
highlight	O
visits	O
that	O
are	O
pending	O
or	O
imminent	O
.	O

However	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
in	O
the	O
female	O
rat	O
,	O
sex	O
steroids	O
regulate	O
both	O
the	O
expression	O
and	O
function	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
,	O
so	O
a	O
potential	O
explanation	B
will	O
also	O
involve	O
the	O
impact	O
of	O
malnutrition	O
on	O
this	O
important	O
modulatory	O
system	O
,	O
as	B
it	O
was	O
described	O
previously	O
(	O
Bonnin	O
et	O
al	O
.,	O
1993	O
;	O
Rodríguez	O
de	O
Fonseca	O
et	O
al	O
.,	O
1994	O
).	O

25	O
(	O
OH	O
)	O
D	O
levels	O
of	O
maternal	O
-	O
cord	O
pairs	O
Among	O
the	O
122	O
specimens	O
collected	O
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
the	O
maternal	O
and	O
cord	O
serum	O
were	O
14	O
.	O
4	O
±	O
6	O
.	O
5	O
and	O
14	O
.	O
0	O
±	O
6	O
.	O
6	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

Decades	O
of	O
uranium	O
mining	O
have	O
dotted	O
the	O
landscape	O
across	O
the	O
Navajo	O
Nation	O
with	O
piles	O
of	O
contaminated	O
mine	O
waste	O
.	O

Infant	O
lung	O
function	O
testing	O
has	O
been	O
widely	B
used	I
in	O
research	O
and	O
clinical	O
practices	O
.	O

In	O
addition	O
,	O
microarray	O
analyses	O
demonstrated	O
that	O
many	O
transcripts	O
were	O
differentially	O
expressed	O
between	O
JEG	O
-	O
3	O
and	O
BeWo	O
cells	O
[	O
25	O
].	O

PubMed	O
Central	O
:	O

Post	O
hoc	O
analysis	O
showed	O
a	O
positive	O
association	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
and	O
atopic	O
asthma	O
(	O
OR	O
2	O
.	O
01	O
,	O
95	O
%	O
CI	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
004	O
)	O
(	O
table	O
3	O
).	O

An	O
analysis	O
of	O
10	O
developing	O
countries	O
reported	O
$	O
0	O
.	O
32	O
per	O
head	O
or	O
0	O
.	O
57	O
%	O
of	O
gross	O
domestic	O
product	O
as	O
a	O
median	O
value	O
of	O
physical	O
productivity	O
loss	O
per	O
year	O
resulting	O
from	O
iron	O
deficiency	O
[	O
13	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

PubMed	O
Central	O
:	O

For	O
vitamin	O
D	O
,	O
there	O
are	O
still	O
underlying	O
questions	O
:	O
How	O
much	O
is	O
the	O
daily	O
requirement	O
and	O
How	O
much	O
is	O
too	O
much	O
?	O

This	O
compares	O
to	O
estimates	O
by	O
the	O
National	O
Institute	O
of	O
Nutrition	O
that	O
only	O
20	O
%	O
of	O
pregnant	O
women	O
are	O
covered	O
by	O
the	O
national	O
antenatal	O
program	O
of	O
daily	O
iron	O
supplementation	O
for	O
which	O
there	O
is	O
no	O
costing	O
.[	O
18	O
].	O

In	O
the	O
light	O
of	O
provided	O
evidence	O
,	O
VD	O
supplementation	O
was	O
incorporated	O
in	O
the	O
schemes	O
of	O
PCOS	O
treatment	O
.	O

It	O
should	O
be	O
mentioned	O
that	O
refined	O
grains	O
are	O
major	O
source	O
of	O
carbohydrate	O
intake	O
in	O
Iranian	O
diet	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
higher	O
risk	O
of	O
some	O
chronic	O
disorders	O
.	O

We	O
also	O
undertook	O
sensitivity	O
analysis	O
in	O
which	O
women	O
who	O
reported	O
having	O
taken	O
any	O
additional	O
vitamin	O
D	O
–	O
containing	O
supplements	O
within	O
90	O
days	O
of	O
the	O
late	O
-	O
pregnancy	O
blood	O
sampling	O
were	O
excluded	O
.	O

All	O
measurements	O
were	O
made	O
by	O
the	O
same	O
trained	O
researcher	O
who	O
was	O
blinded	O
to	O
the	O
clinical	O
data	O
.	O

Under	O
this	O
condition	O
,	O
FGF21	O
expression	O
was	O
indeed	O
decreased	O
in	O
the	O
liver	O
,	O
but	O
enhanced	O
in	O
BAT	O
,	O
as	O
well	O
as	O
in	O
WAT	O
,	O
where	O
it	O
acted	O
to	O
markedly	O
increase	O
UCP1	O
expression	O
and	O
the	O
“	O
browning	O
”	O
of	O
subcutaneous	O
tissue	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

In	O
the	O
previous	O
study	O
,	O
in	O
contrast	O
to	O
data	O
from	O
nonpregnant	O
adults	O
,	O
baseline	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
measures	O
of	O
adiposity	O
,	O
and	O
maternal	O
age	O
were	O
not	O
associated	O
with	O
response	O
to	O
cholecalciferol	O
supplementation	O
in	O
pregnancy	O
(	O
13	O
).	O

Furthermore	O
terbutaline	O
has	O
been	O
shown	O
to	O
increase	O
microglial	O
activation	O
associated	O
with	O
behavioral	O
abnormalities	O
akin	O
to	O
autism	O
.	O

p	O
value	O
is	O
in	O
bold	O
when	O
statistically	O
significant	O
aAdjusted	O
for	O
maternal	O
height	O
and	O
other	O
listed	O
maternal	O
factors	O
as	O
changing	O
covariates	O
bTwo	O
values	O
are	O
missing	O
from	O
analyses	O
cAdjusted	O
for	O
gestational	O
age	O
Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Neither	O
trial	O
utilised	O
a	O
placebo	O
-	O
controlled	O
design	O
,	O
limiting	O
the	O
interpretation	O
of	O
the	O
study	O
results	O
.	O

Participants	O
were	O
randomized	O
to	O
either	O
cholecalciferol	O
1000	O
IU	O
/	O
d	O
or	O
matched	O
placebo	O
[	O
Merck	O
KGaA	O
,	O
Darmstadt	O
,	O
Germany	O
/	O
Sharp	O
Clinical	O
Services	O
,	O
Crickhowell	O
,	O
United	O
Kingdom	O
(	O
previously	O
DHP	O
-	O
Bilcare	O
)],	O
which	O
was	O
commenced	O
before	O
17	O
weeks	O
of	O
gestation	O
.	O

We	O
collected	O
self	O
-	O
reported	O
data	O
regarding	O
socio	O
-	O
demographic	O
characteristics	O
,	O
number	O
of	O
prenatal	O
check	O
-	O
ups	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
.	O

Therefore	B
,	O
'	O
mTOR	O
signaling	O
'	O
might	O
be	O
involved	O
in	O
compensatory	O
growth	O
processes	O
at	O
adult	O
stage	O
in	O
LP	O
offspring	O
.	O

The	O
treatment	O
cost	O
per	O
woman	O
was	O
calculated	O
based	O
on	O
total	O
cost	O
divided	O
by	O
the	O
number	O
of	O
women	O
taking	O
75	O
%	O
or	O
more	O
of	O
the	O
supplements	O
.	O

Increased	O
rates	O
of	O
infantile	O
hypercalcaemia	O
following	O
guidelines	O
for	O
antenatal	O
vitamin	O
D3	O
supplementation	O
Consultations	O
for	O
infantile	O
hypercalcaemia	O
(	O
IIH	O
)	O
have	O
increased	O
at	O
Sydney	O
Children	O
’	O
s	O
Hospital	O
since	O
guidelines	O
for	O
vitamin	O
D3supplementation	O
during	O
pregnancy	O
were	O
introduced	O
in	O
2006	O
.	O

Results	O
All	O
15	O
cases	O
of	O
anaphylaxis	O
involved	O
multi	O
ingredient	O
products	O
with	O
NHP	O
doses	O
(	O
up	O
to	O
and	O
including	O
1	O
mg	O
).	O

We	O
investigated	O
the	O
offspring	O
'	O
s	O
hepatic	O
gene	O
expression	O
at	O
94	O
dpc	O
,	O
1	O
dpn	O
,	O
28	O
dpn	O
and	O
188	O
dpn	O
by	O
24	O
k	O
-	O
microarray	O
analysis	O
.	O

Discussion	O
At	O
present	O
,	O
this	O
is	O
one	O
of	O
the	O
largest	O
studies	O
to	O
investigate	O
pregnancy	O
outcomes	O
following	O
maternal	O
use	O
of	O
SGA	O
monotherapy	O
and	O
polytherapy	O
with	O
other	O
psychotropic	O
medications	O
.	O

Higher	O
prenatal	O
vitamin	O
D	O
levels	O
are	O
shown	O
to	O
have	O
a	O
protective	O
role	O
against	O
wheezing	O
in	O
young	O
children	O
in	O
epidemiological	O
studies	O
.	O

The	O
same	O
results	O
were	O
obtained	O
after	O
adjusting	O
for	O
potential	O
confounding	O
variables	O
in	O
model	O
1	O
[	O
OR	O
2	O
.	O
05	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
1	O
.	O
01	O
-	O
4	O
.	O
15	O
),	O
P	O
=	O
0	O
.	O
05	O
]	O
and	O
model	O
2	O
[	O
OR	O
2	O
.	O
04	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
97	O
-	O
4	O
.	O
32	O
),	O
P	O
=	O
0	O
.	O
06	O
].	O

Models	O
will	O
include	O
treatment	O
group	O
as	O
a	O
fixed	O
effect	O
,	O
community	O
-	O
cluster	O
as	O
a	O
random	O
effect	O
to	O
account	O
for	O
the	O
cluster	O
effect	O
.	O

For	O
all	O
analyses	O
a	O
p	O
value	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
;	O
all	O
were	O
undertaken	O
using	O
the	O
Statistical	O
Package	O
for	O
Social	O
Science	O
(	O
SPSS	O
)	O
program	O
for	O
Windows	O
Version	O
13	O
.	O
0	O
(	O
SPSS	O
13	O
.	O
0	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

As	B
a	O
result	O
of	O
this	O
improvement	O
,	O
physical	O
activity	O
increases	O
and	O
this	O
have	O
positive	O
effects	O
on	O
health	O
.	O

Vitamin	O
D	O
and	O
calcium	O
deficiency	O
can	O
lead	O
to	O
maternal	O
anorexia	O
with	O
poor	O
weight	O
gain	O
,	O
and	O
impaired	O
bone	O
ossification	O
or	O
osteopenia	O
among	O
newborn	O
infant	O
..	O
Neonatal	O
hypocalcemia	O
with	O
seizures	O
is	O
not	O
uncommon	O
in	O
D	O
-	O
vitamin	O
deficient	O
mothers	O
.	O

More	O
detailed	O
studies	O
of	O
inflammatory	O
markers	O
and	O
MMN	O
supplementation	O
are	O
required	O
in	O
order	O
to	O
understand	O
their	O
roles	O
in	O
the	O
aetiology	O
of	O
anaemia	O
in	O
this	O
population	O
of	O
women	O
,	O
particularly	O
in	O
areas	O
of	O
high	O
malarial	O
endemicity	O
.	O

Thus	B
,	O
these	O
neuropeptides	O
are	O
of	O
interest	O
as	O
potential	O
targets	O
for	O
novel	O
antipsychotic	O
agents	O
[	O
39	O
],[	O
40	O
].	O

proposed	O
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	O
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

Probably	B
the	O
most	O
familiar	O
technique	O
in	O
estimating	O
heritability	O
is	O
parent	O
–	O
offspring	O
regression	O
in	O
which	O
,	O
for	O
example	O
,	O
a	O
trait	O
'	O
s	O
heritability	O
can	O
be	O
estimated	O
as	O
the	O
slope	O
of	O
the	O
regression	O
of	O
offspring	O
phenotype	O
on	O
mid	O
-	O
parent	O
phenotype	O
.	O

Also	O
note	O
that	O
,	O
as	O
in	O
that	O
analysis	O
,	O
5we	O
found	O
no	O
difference	O
in	O
BMI	O
heritability	O
estimates	O
between	O
men	O
and	O
women	O
.	O

It	O
covers	O
various	O
infertility	O
issues	O
,	O
such	O
as	O
polycystic	O
ovary	O
syndrome	O
,	O
endometriosis	O
,	O
myoma	O
-	O
induced	O
infertility	O
,	O
male	O
infertility	O
,	O
premature	O
ovary	O
failure	O
and	O
in	O
vitro	O
fertilization	O
techniques	O
.	O

Full	O
coverage	O
of	O
antenatal	O
corticosteroids	O
alone	O
resulted	O
in	O
high	O
mortality	O
reductions	O
,	O
a	O
41	O
%	O
decrease	O
from	O
2010	O
[	O
20	O
].	O

The	O
above	O
studies	O
confirm	O
the	O
present	O
study	O
results	O
.	O

No	O
lamellar	O
bone	O
or	O
cartilage	O
is	O
seen	O
.	O

Therefore	B
,	O
it	O
is	O
possible	O
that	O
the	O
RAS	O
hyperactivity	O
could	O
,	O
at	B
least	I
in	I
part	I
,	O
mediate	O
the	O
impairment	O
of	O
cardiac	O
vagal	O
tone	O
observed	O
in	O
low	O
birth	O
weight	O
children	O
.	O

As	O
four	O
SNPs	O
were	O
assessed	O
,	O
a	O
Bonferroni	O
correction	O
was	O
used	O
to	O
account	O
for	O
multiple	O
testing	O
.	O

Twenty	O
-	O
four	O
of	O
the	O
participants	O
started	O
to	O
take	O
Vitamin	O
D	O
supplement	O
before	O
pregnancy	O
,	O
and	O
the	O
range	O
of	O
the	O
Vitamin	O
D	O
supplement	O
intake	O
duration	O
was	O
2	O
to	O
131	O
weeks	O
.	O

The	O
lowest	O
odds	O
of	O
SGA	O
and	O
LBW	O
are	O
found	O
among	O
women	O
with	O
the	O
largest	O
increments	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
).	O

Leptin	O
is	O
a	O
permissive	O
neuro	O
-	O
regulatory	O
factor	O
for	O
the	O
onset	O
of	O
puberty	O
[	O
43	O
],[	O
44	O
].	O

However	O
,	O
little	O
seasonal	O
variation	O
exists	O
in	O
the	O
light	O
/	O
dark	O
cycle	O
in	O
the	O
area	O
where	O
the	O
majority	O
of	O
study	O
participants	O
were	O
born	O
[	O
208	O
].	O

Of	O
those	O
,	O
8	O
%	O
(	O
137	O
)	O
were	O
vaccinated	O
in	O
their	O
first	O
trimester	O
,	O
61	O
%	O
(	O
1093	O
)	O
in	O
their	O
second	O
trimester	O
,	O
and	O
31	O
%	O
(	O
559	O
)	O
in	O
their	O
third	O
trimester	O
.	O

This	O
sensitization	O
of	O
the	O
mother	O
was	O
shown	O
to	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
food	O
allergy	O
in	O
the	O
newborn	O
in	O
a	O
BALB	O
/	O
c	O
mouse	O
model	O
[	O
39	O
].	O

Excluding	O
infants	O
who	O
may	O
have	O
received	O
antibiotics	O
,	O
or	O
those	O
delivered	O
prematurely	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S10	O
,	O
Figure	O
S7a	O
),	O
did	O
not	O
qualitatively	O
change	O
the	O
results	O
.	O

Children	O
with	O
severe	O
decay	O
can	O
also	O
have	O
altered	O
eating	O
habits	O
and	O
preferences	O
[	O
5	O
,	O
9	O
].	O

Accordingly	O
,	O
we	O
adjusted	O
for	O
feeding	O
method	O
(	O
exclusively	O
breastfed	O
,	O
combination	O
fed	O
,	O
exclusively	O
formula	O
fed	O
),	O
maternal	O
BMI	O
(	O
continuous	O
),	O
parity	O
(	O
continuous	O
),	O
and	O
batch	O
and	O
performed	O
a	O
sensitivity	O
analysis	O
in	O
exclusively	O
breastfed	O
infants	O
.	O

Participants	O
could	O
respond	O
“	O
yes	O
”/“	O
no	O
”/“	O
don	O
’	O
t	O
know	O
”	O
to	O
each	O
question	O
.	O

The	O
groups	O
were	O
well	O
matched	O
for	O
age	O
and	O
sex	O
as	O
there	O
were	O
no	O
significant	O
differences	O
(	O
p	O
=	O
0	O
.	O
14	O
and	O
p	O
=	O
0	O
.	O
37	O
,	O
respectively	O
).	O

Female	O
rat	O
pups	O
born	O
to	O
and	O
suckled	O
by	O
fat	O
-	O
fed	O
mothers	O
have	O
high	O
blood	O
pressure	O
,	O
even	O
after	O
being	O
placed	O
on	O
a	O
balanced	O
diet	O
after	O
weaning	O
.	O

Here	O
,	O
no	O
confounders	O
were	O
included	O
due	O
to	O
the	O
small	O
number	O
of	O
cases	O
(	O
N	O
=	O
9	O
).	O

MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

This	O
behavior	O
is	O
analogous	O
to	O
external	O
(	O
53	O
)	O
or	O
disinhibited	O
(	O
54	O
)	O
eating	O
behavior	O
in	O
adults	O
.	O

Data	O
analysis	O
Data	O
were	O
tested	O
for	O
normal	O
distribution	O
and	O
homogeneity	O
of	O
variance	O
,	O
and	O
the	O
differences	O
between	O
the	O
groups	O
were	O
analyzed	O
by	O
a	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
and	O
post	O
-	O
hoc	O
test	O
of	O
Tukey	O
,	O
two	O
-	O
way	O
ANOVA	O
(	O
generation	O
vs	O
.	O
diet	O
)	O
and	O
unpaired	O
t	O
-	O
tests	O
(	O
GraphPad	O
Prism	O
5	O
.	O
03	O
,	O
GraphPad	O
Software	O
,	O
La	O
Jolla	O
,	O
CA	O
,	O
USA	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Mean	O
BMI	O
and	O
height	O
(	O
m	O
)	O
at	O
all	O
ages	O
for	O
children	O
and	O
for	O
lineage	O
groups	O
with	O
SD	O
and	O
rangeChild	O
age	O
0N	O
=	O
924Child	O
age	O
5N	O
=	O
568Child	O
age	O
9N	O
=	O
298MotherN	O
=	O
556FatherN	O
=	O
450MGMN	O
=	O
375MGFN	O
=	O
228PGMN	O
=	O
226PGFN	O
=	O
142Mean13	O
.	O
6016	O
.	O
6218	O
.	O
1026	O
.	O
2826	O
.	O
8928	O
.	O
7728	O
.	O
2829	O
.	O
2928	O
.	O
66BMI	O
(	O
SD	O
)(	O
1	O
.	O
78	O
)(	O
1	O
.	O
73	O
)(	O
3	O
.	O
23	O
)(	O
5	O
.	O
11	O
)(	O
3	O
.	O
68	O
)(	O
6	O
.	O
07	O
)(	O
4	O
.	O
14	O
)(	O
5	O
.	O
42	O
)(	O
4	O
.	O
47	O
)	O
Range7	O
.	O
08	O
–	O
31	O
.	O
8012	O
.	O
54	O
–	O
24	O
.	O
3311	O
.	O
88	O
–	O
38	O
.	O
4216	O
.	O
87	O
–	O
51	O
.	O
5317	O
.	O
55	O
–	O
39	O
.	O
2815	O
.	O
39	O
–	O
64	O
.	O
9119	O
.	O
19	O
–	O
41	O
.	O
5919	O
.	O
24	O
–	O
60	O
.	O
0116	O
.	O
31	O
–	O
50	O
.	O
12Mean0	O
.	O
511	O
.	O
121	O
.	O
391	O
.	O
631	O
.	O
781	O
.	O
581	O
.	O
721	O
.	O
581	O
.	O
71Height	O
(	O
SD	O
)(	O
0	O
.	O
03	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
08	O
)(	O
0	O
.	O
06	O
)(	O
0	O
.	O
07	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
06	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
06	O
)	O
Range0	O
.	O
36	O
–	O
0	O
.	O
620	O
.	O
97	O
–	O
1	O
.	O
271	O
.	O
19	O
–	O
1	O
.	O
581	O
.	O
45	O
–	O
1	O
.	O
851	O
.	O
52	O
–	O
2	O
.	O
081	O
.	O
39	O
–	O
1	O
.	O
761	O
.	O
55	O
–	O
1	O
.	O
881	O
.	O
44	O
–	O
1	O
.	O
731	O
.	O
56	O
–	O
1	O
.	O
94	O
BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

Out	O
of	O
all	O
participants	O
randomly	O
selected	O
for	O
this	O
assessment	O
who	O
self	O
-	O
reported	O
receiving	O
influenza	O
vaccination	O
(	O
n	O
=	O
123	O
),	O
61	O
%	O
(	O
75	O
)	O
had	O
evidence	O
of	O
vaccination	O
.	O

Proper	O
nutritional	O
levels	O
and	O
proper	O
selection	O
of	O
the	O
types	O
of	O
energy	O
sources	O
for	O
dams	O
during	O
each	O
period	O
of	O
gestation	O
stages	O
may	O
improve	O
future	O
production	O
efficiency	O
of	O
progeny	O
.	O

Epigenetics	O
encompasses	O
the	O
mechanisms	O
that	O
regulate	O
gene	O
expression	O
without	O
altering	O
the	O
underlying	O
DNA	O
sequence	O
,	O
and	O
the	O
complete	O
epigenetic	O
status	O
of	O
a	O
cell	O
at	O
any	O
given	O
time	O
is	O
termed	O
the	O
epigenome	O
.	O

This	O
is	O
why	O
even	O
during	O
the	O
most	O
physiological	O
pregnancy	O
vitamin	O
D	O
supplementation	O
in	O
the	O
amount	O
of	O
800	O
–	O
1000	O
IU	O
daily	O
is	O
highly	O
recommended	O
[	O
65	O
].	O

INTRODUCTION	O
Many	O
women	O
in	O
low	O
-	O
income	O
countries	O
suffer	O
from	O
sub	O
-	O
optimal	O
micronutrition	O
as	B
a	O
consequence	B
of	O
eating	O
diets	O
which	O
are	O
often	B
low	O
in	O
animal	O
-	O
source	O
foods	O
and	O
which	O
do	O
not	O
meet	O
dynamic	O
micronutrient	O
requirements	O
throughout	O
the	O
reproductive	O
lifecycle	O
(	O
Bartley	O
et	O
al	O
2005	O
).	O

Children	O
'	O
s	O
patterns	O
of	O
weight	O
gain	O
vary	O
by	O
sex	O
and	O
age	O
(	O
85	O
),	O
and	O
during	O
stages	O
of	O
rapid	O
growth	O
,	O
caloric	O
requirements	O
increase	O
.	O

We	O
aimed	O
to	O
compare	O
vitamin	O
D	O
status	O
in	O
two	O
distinct	O
populations	O
of	O
pregnant	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
and	O
to	O
investigate	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
.	O

The	O
remaining	O
seven	O
deaths	O
were	O
due	O
to	O
accidental	O
or	O
congenital	O
causes	O
.	O

In	O
unadjusted	O
bivariate	O
analyses	O
,	O
black	O
women	O
,	O
overweight	O
/	O
obese	O
women	O
,	O
less	O
educated	O
women	O
,	O
and	O
younger	O
women	O
were	O
more	O
likely	B
to	O
have	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
Table	O
2	O
).	O

The	O
seven	O
studies	O
,	O
which	O
demonstrated	O
a	O
benefit	O
in	O
neurodevelopment	O
,	O
had	O
a	O
follow	O
up	O
time	O
ranging	O
from	O
six	O
months	O
to	O
nine	O
years	O
.	O

The	O
dams	O
were	O
limited	O
in	O
their	O
feed	O
to	O
maintain	O
similar	O
energy	O
intake	O
among	O
the	O
groups	O
.	O

The	O
first	O
emotional	O
attachment	O
to	O
flavors	O
should	O
be	O
exploited	O
to	O
try	O
to	O
reduce	O
the	O
prevalence	O
of	O
obesity	O
in	O
future	O
generations	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
not	O
all	O
environmentally	O
induced	O
adverse	O
phenotypes	O
have	O
been	O
associated	O
with	O
epigenetic	O
changes	O
.	O

The	O
appropriate	O
concentration	O
range	O
for	O
restriction	O
of	O
vita	O
min	O
A	O
has	O
been	O
suggested	O
as	O
an	O
important	O
factor	O
for	O
enhancing	O
MS	O
and	O
preventing	O
health	O
-	O
related	O
problems	O
,	O
including	O
the	O
incidence	O
of	O
blindness	O
and	O
muscular	O
edema	O
.	O

Witham	O
et	O
al	O
.	O
24showed	O
that	O
single	O
doses	O
of	O
100	O
,	O
000	O
and	O
200	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
in	O
diabetic	O
type	O
II	O
patients	O
increased	O
serum	O
vitamin	O
D	O
from	O
41	O
to	O
63	O
and	O
from	O
48	O
to79	O
nmol	O
./	O
l	O
respectively	O
.	O

In	O
addition	O
,	O
we	O
have	O
identified	O
particular	O
regions	O
of	O
the	O
genome	O
susceptible	O
to	O
alterations	O
by	O
the	O
intrauterine	O
environment	O
.	O

which	O
found	O
an	O
improvement	O
in	O
neurodevelopmental	O
scores	O
at	O
six	O
months	O
in	O
only	O
the	O
highest	O
quintile	O
of	O
fish	O
intake	O
while	O
this	O
improvement	O
was	O
evident	O
in	O
the	O
highest	O
three	O
quintiles	O
at	O
eighteen	O
months	O
[	O
22	O
].	O

Approval	O
was	O
obtained	O
from	O
the	O
Institutional	O
Review	O
Board	O
of	O
Baylor	O
College	O
of	O
Medicine	O
and	O
Affiliated	O
Hospitals	O
.	O

This	O
is	O
therefore	B
a	O
novel	O
analysis	O
and	O
a	O
considerable	O
expansion	O
on	O
the	O
previous	O
one	O
.	O

in	O
Oslo	O
,	O
prevalence	O
of	O
depression	O
at	O
28	O
weeks	O
was	O
13	O
%	O
in	O
all	O
of	O
samples	O
.	O

This	O
was	O
seen	O
by	O
evaluating	O
medical	O
records	O
,	O
considering	O
both	O
the	O
SSRI	O
exposure	O
and	O
the	O
mental	O
health	O
history	O
of	O
the	O
mother	O
,	O
and	O
pointing	O
to	O
a	O
high	O
association	O
with	O
SSRI	O
treatment	O
and	O
autism	O
during	O
the	O
first	O
trimester	O
.	O

Syntaxin	O
-	O
binding	O
protein	O
1	O
was	O
also	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
DVD	O
-	O
deficient	O
rats	O
.	O

Half	O
took	O
60	O
mg	O
of	O
iron	O
as	O
ferrous	O
sulfate	O
with	O
200	O
μg	O
of	O
folic	O
acid	O
and	O
1	O
μg	O
of	O
vitamin	O
B12once	O
a	O
day	O
;	O
the	O
others	O
took	O
double	O
this	O
dose	O
once	O
a	O
week	O
.	O

Indeed	O
,	O
numerous	O
adult	O
onset	O
diseases	O
have	O
been	O
associated	O
with	O
abnormal	O
epigenetic	O
changes	O
,	O
including	O
cancer	O
,	O
diabetes	O
,	O
and	O
neurological	O
,	O
renal	O
,	O
cardiac	O
and	O
respiratory	O
conditions	O
(	O
Hamm	O
&	O
Costa2015	O
);	O
and	O
epigenetic	O
processes	O
play	O
a	O
key	O
role	O
in	O
initiating	O
the	O
onset	O
of	O
puberty	O
,	O
changes	O
to	O
which	O
can	O
also	O
increase	O
the	O
risk	O
of	O
some	O
of	O
these	O
adult	O
onset	O
diseases	O
(	O
Rzeczkowska	O
et	O
al	O
.	O
2014	O
).	O

This	O
also	O
illustrates	O
the	O
difficulty	O
of	O
selecting	O
a	O
suitable	O
marker	O
of	O
impaired	O
spermatotogenesis	O
.	O

However	O
,	O
dissatisfaction	O
abounded	O
with	O
respect	O
to	O
this	O
aspect	O
,	O
especially	O
for	O
women	O
of	O
higher	O
educational	O
levels	O
.	O

We	O
found	O
a	O
high	O
prevalence	O
of	O
pre	O
-	O
pregnancy	O
overweight	O
/	O
obesity	O
(	O
n	O
=	O
55	O
;	O
72	O
.	O
3	O
%)	O
and	O
excessive	O
gestational	O
weight	O
gain	O
(	O
Table1	O
).	O

Even	O
though	O
women	O
with	O
infectious	O
disease	O
are	O
excluded	O
,	O
women	O
who	O
are	O
HIV	O
positive	O
are	O
still	O
included	O
.	O

Offspring	O
of	O
mothers	O
enrolled	O
in	O
an	O
NICHD	O
pregnancy	O
vitamin	O
D	O
supplementation	O
trial	O
(	O
results	O
of	O
which	O
were	O
previously	O
published	O
[	O
21	O
,	O
22	O
])	O
were	O
seen	O
in	O
follow	O
-	O
up	O
from	O
ages	O
2	O
–	O
7	O
years	O
during	O
a	O
three	O
-	O
year	O
study	O
period	O
.	O

It	O
is	O
,	O
therefore	O
,	O
vital	O
for	O
normal	O
embryo	O
development	O
that	O
these	O
imprints	O
are	O
maintained	O
during	O
the	O
first	O
global	O
epigenetic	O
re	O
-	O
programing	O
event	O
.	O

However	O
,	O
1	O
study	O
showed	O
that	O
adolescents	O
who	O
had	O
been	O
born	O
prematurely	O
had	O
a	O
substantially	O
decreased	O
expiratory	O
volume	O
and	O
increased	O
bronchial	O
hyperresponsiveness	O
,	O
making	O
them	O
potential	O
candidates	O
for	O
developing	O
asthma	O
[	O
91	O
].	O

This	O
effect	O
did	O
not	O
vary	O
by	O
histology	O
and	O
was	O
seen	O
for	O
supplementation	O
during	O
pregnancy	O
rather	O
than	O
during	O
the	O
month	O
before	O
pregnancy	O
or	O
while	O
breast	O
feeding	O
.	O

The	O
last	O
weakness	O
of	O
this	O
study	O
was	O
that	O
it	O
had	O
the	O
statistical	O
authority	O
to	O
identify	O
differences	O
in	O
depressive	O
symptoms	O
,	O
but	O
not	O
in	O
the	O
diagnoses	O
of	O
major	O
depressive	O
disorder	O
.	O

The	O
expression	O
of	O
adipogenic	O
factors	O
(	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
beta	O
,	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
alpha	O
,	O
and	O
PPARG	O
)	O
in	O
the	O
subcutaneous	O
fat	O
and	O
IMF	O
was	O
higher	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
,	O
indicating	O
that	O
the	O
dietary	O
roughage	O
/	O
concentrate	O
ratio	O
affects	O
adipogenic	O
gene	O
expression	O
in	O
fat	O
tissues	O
.	O

There	O
are	O
very	O
few	O
data	O
on	O
25	O
(	O
OH	O
)	O
D	O
in	O
cord	O
blood	O
in	O
the	O
Hispanic	O
population	O
and	O
no	O
data	O
looking	O
specifically	O
at	O
the	O
relative	O
increase	O
over	O
time	O
based	O
on	O
cord	O
25	O
(	O
OH	O
)	O
D	O
[	O
11	O
].	O

Mass	O
calibration	O
was	O
performed	O
using	O
trypsin	O
autolysis	O
peaks	O
,	O
2211	O
.	O
11	O
Da	O
and	O
842	O
.	O
51	O
Da	O
as	O
internal	O
standards	O
.	O

Baseline	O
characteristics	O
between	O
the	O
low	O
and	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
compared	O
using	O
a	O
two	O
-	O
sided	O
t	O
-	O
test	O
for	O
equal	O
means	O
for	O
continuous	O
,	O
normally	O
distributed	O
variables	O
and	O
and	O
χ2	O
-	O
test	O
for	O
categorical	O
variables	O
.	O

All	O
parents	O
provided	O
written	O
informed	O
consent	O
at	O
recruitment	O
,	O
and	O
a	O
small	O
honorarium	O
was	O
provided	O
.	O

Lastly	O
,	O
we	O
did	O
not	O
perform	O
a	O
formal	O
process	O
evaluation	O
,	O
a	O
process	O
that	O
can	O
elucidate	O
whether	O
the	O
intervention	O
was	O
not	O
implemented	O
as	O
designed	O
or	O
whether	O
the	O
implementation	O
proceeded	O
as	O
planned	O
but	O
the	O
intervention	O
was	O
not	O
efficacious	O
in	O
changing	O
behavior	O
as	O
intended	O
.	O

Hamilton	O
Monte	O
Carlo	O
sampling	O
was	O
used	O
to	O
obtain	O
2	O
chains	O
of	O
20	O
,	O
000	O
iterations	O
with	O
500	O
warm	O
-	O
up	O
iterations	O
.	O

Ethics	O
approval	O
was	O
obtained	O
from	O
the	O
ALSPAC	O
Ethics	O
and	O
Law	O
Committee	O
(	O
IRB	O
00003312	O
)	O
and	O
the	O
Local	O
National	O
Health	O
Service	O
Research	O
Ethics	O
Committees	O
.	O

*	O
Studies	O
directly	O
sampling	O
the	O
target	O
tissue	O
or	O
validating	O
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	O
.	O

The	O
plasma	O
samples	O
were	O
analyzed	O
for	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
using	O
chemiluminescence	O
,	O
an	O
automated	O
radioimmunoassay21in	O
the	O
Weiss	O
laboratory	O
at	O
the	O
Channing	O
Laboratory	O
,	O
Boston	O
,	O
MA	O
.	O

Adipogenesis	O
normally	O
begins	O
around	O
mid	O
-	O
gestation	O
in	O
ruminant	O
animals	O
[	O
20	O
].	O

We	O
evaluated	O
confounding	O
due	O
to	O
several	O
maternal	O
characteristics	O
.	O

Our	O
study	O
also	O
reports	O
that	O
those	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
calcium	O
and	O
elevated	O
PTH	O
levels	O
,	O
as	O
observed	O
in	O
our	O
pilot	O
study	O
[	O
14	O
].	O

Diagnostic	O
Tests	O
and	O
Clinical	O
Course	O
EKG	O
showed	O
a	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
75	O
and	O
no	O
signs	O
of	O
ischemic	O
changes	O
.	O

2	O
.	O
4	O
.	O

Maternal	O
and	O
Infant	O
GR	O
Polymorphisms	O
,	O
Maternal	O
Attitudes	O
,	O
and	O
Fetal	O
Birth	O
Weight	O
Four	O
GR	O
polymorphisms	O
were	O
investigated	O
:	O
Bcl	O
I	O
,	O
N363S	O
,	O
Tth111	O
I	O
,	O
and	O
ER22	O
/	O
23EK	O
(	O
Table	O
3	O
).	O

However	O
,	O
comparing	O
to	O
our	O
study	O
,	O
the	O
median	O
level	O
of	O
cord	O
25	O
(	O
OH	O
)	O
D	O
of	O
COPSAC2000was	O
relatively	O
high	O
(	O
19	O
ng	O
/	O
ml	O
).	O

Of	O
those	O
who	O
reported	O
receiving	O
advice	O
on	O
GWG	O
,	O
59	O
%	O
(	O
17	O
/	O
29	O
)	O
reported	O
receiving	O
advice	O
that	O
fell	O
within	O
and	O
31	O
%	O
(	O
9	O
/	O
29	O
)	O
that	O
was	O
above	O
the	O
IOM	O
recommendations	O
,	O
and	O
10	O
%	O
(	O
3	O
/	O
29	O
)	O
could	O
not	O
remember	O
the	O
advice	O
.	O

The	O
exact	O
cause	O
of	O
maternal	O
stress	O
was	O
not	O
identified	O
.	O

Reference	O
obstetric	O
hospital	O
in	O
Nicaragua	O
:	O
Hospital	O
Bertha	O
Calderon	O
Roque	O
.	O

Although	O
toddlers	O
were	O
more	O
likely	B
to	O
eat	O
fruits	O
than	O
vegetables	O
,	O
1	O
in	O
4	O
did	O
not	O
eat	O
any	O
vegetables	O
on	O
a	O
given	O
day	O
.	O

Implement	O
•	O
Strengthen	O
community	O
and	O
local	O
capabilities	O
to	O
scale	O
up	O
implementation	O
of	O
interventions	O
for	O
preterm	O
birth	O
and	O
support	O
families	O
who	O
have	O
lost	O
babies	O
or	O
require	O
long	O
-	O
term	O
support	O
for	O
disability	O
.	O

To	B
my	I
knowledge	I
,	O
the	O
neuropsychiatric	O
symptoms	O
of	O
rickets	O
have	O
not	O
been	O
studied	O
in	O
the	O
modern	O
era	O
.	O

In	O
The	O
Gambia	O
,	O
as	O
in	O
other	O
parts	O
of	O
sub	O
-	O
Saharan	O
Africa	O
,	O
seasonal	O
multiple	O
micronutrient	O
deficiencies	O
are	O
common	O
(	O
Bates	O
et	O
al	O
1984	O
,	O
Powers	O
and	O
Bates	O
1987	O
),	O
and	O
maternal	O
anaemia	O
and	O
its	O
sequelae	O
remain	O
frequent	O
problems	O
,	O
particularly	O
in	O
rural	O
areas	O
(	O
Powers	O
and	O
Bates	O
1987	O
,	O
Topley	O
1968	O
).	O

Therefore	O
,	O
the	O
transcriptional	O
control	O
of	O
cyclins	O
provides	O
an	O
additional	O
level	O
of	O
growth	O
regulation	O
.	O

Concerning	O
the	O
potential	O
explanations	B
of	O
the	O
differential	O
phenotypic	O
features	O
between	O
males	O
and	O
females	O
,	O
the	O
leptin	O
sensibility	O
can	O
play	O
an	O
important	O
role	O
.	O

In	O
particular	O
,	O
a	O
7	O
.	O
5	O
-	O
fold	O
OR	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
3	O
–	O
44	O
.	O
9	O
)	O
for	O
low	O
grade	O
astrocytoma	O
has	O
been	O
observed	O
for	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

Statistical	O
analyses	O
were	O
performed	O
using	O
the	O
R	O
software	O
(	O
www	O
.	O
r	O
-	O
project	O
.	O
org	O
).	O

The	O
vast	O
majority	O
of	O
the	O
mammalian	O
genome	O
is	O
composed	O
of	O
so	O
-	O
called	O
non	O
-	O
coding	O
DNA	O
(	O
ncDNA	O
),	O
with	O
only	O
1	O
–	O
5	O
%	O
coding	O
for	O
proteins	O
.	O

For	O
boys	O
,	O
the	O
correlation	O
with	O
the	O
MGM	O
was	O
significant	O
.	O

Nutritional	O
fetal	O
programming	O
becomes	O
apparent	O
as	O
an	O
altered	O
hepatic	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
and	O
cell	O
maintenance	O
,	O
and	O
lipid	O
,	O
ketone	O
body	O
,	O
and	O
amino	O
acid	O
metabolism	O
,	O
indicating	O
different	O
functional	O
demands	O
and	O
replies	O
of	O
the	O
liver	O
in	O
both	O
experimental	O
groups	O
under	O
identical	O
nutritional	O
conditions	O
post	O
natum	O
.	O

Maternal	O
Vitamin	O
D	O
Deficiency	O
Delays	O
Glomerular	O
Maturity	O
in	O
F1	O
and	O
F2	O
Offspring	O
Abstract	O
Background	O
There	O
is	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
in	O
women	O
of	O
reproductive	O
age	O
.	O

Smoking	O
during	O
pregnancy	O
was	O
rare	O
at	O
4	O
.	O
8	O
%,	O
and	O
the	O
population	O
was	O
slightly	O
overweight	O
with	O
an	O
average	O
pre	O
-	O
pregnancy	O
BMI	O
of	O
25	O
.	O
6	O
.	O

Rather	O
than	O
occurring	O
randomly	O
throughout	O
social	O
networks	O
,	O
people	O
with	O
BMI	O
≥	O
30	O
kg	O
/	O
m2were	O
clustered	O
in	O
the	O
32	O
-	O
year	O
data	O
set	O
.	O

Mutations	O
in	O
human	O
FLNB	O
have	O
been	O
found	O
in	O
various	O
skeletal	O
disorders	O
with	O
vertebral	O
abnormalities	O
,	O
including	O
spondylocarpotarsal	O
synostosis	O
,	O
boomerang	O
dysplasia	O
,	O
Larsen	O
syndrome	O
,	O
and	O
atelosteogenesis	O
III	O
.	O

The	O
timing	O
of	O
supplementation	O
may	O
likewise	O
be	O
a	O
crucial	O
factor	O
(	O
Owens	O
and	O
Fall	O
2008	O
).	O

In	O
each	O
clinic	O
all	O
gynaecologist	O
-	O
obstetricians	O
were	O
invited	O
to	O
participate	O
in	O
order	O
to	O
level	O
out	O
a	O
possible	O
gynaecologist	O
effect	O
.	O

Previous	O
clinical	O
trials	O
,	O
in	O
which	O
vitamin	O
D	O
supplementations	O
were	O
consumed	O
during	O
pregnancy	O
[	O
18	O
,	O
58	O
],	O
have	O
not	O
evaluated	O
the	O
antenatal	O
and	O
postnatal	O
depression	O
disorders	O
.	O

BMP8B	O
,	O
another	O
member	O
of	O
the	O
BMP	O
family	O
,	O
was	O
found	O
to	O
be	O
expressed	O
in	O
BAT	O
,	O
as	O
well	O
as	O
in	O
the	O
hypothalamus	O
(	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

In	O
addition	O
,	O
we	O
performed	O
propensity	O
score	O
matching	O
(	O
PSM	O
)	O
to	O
control	O
for	O
the	O
individual	O
differences	O
in	O
probability	O
of	O
being	O
vaccinated	O
.	O

Conclusions	O
In	O
conclusion	O
,	O
we	O
identified	O
three	O
clusters	O
of	O
infant	O
gut	O
microbial	O
communities	O
and	O
observed	O
effects	O
of	O
multiple	O
maternal	O
prenatal	O
dietary	O
factors	O
on	O
the	O
infant	O
gut	O
microbiome	O
that	O
often	O
varied	O
by	O
delivery	O
mode	O
.	O

Both	O
the	O
lack	O
of	O
receipt	O
of	O
clinical	O
guidance	O
and	O
the	O
recollection	O
of	O
inaccurate	O
information	O
observed	O
in	O
this	O
study	O
are	O
of	O
concern	O
because	O
receipt	O
of	O
provider	O
advice	O
has	O
been	O
shown	O
in	O
prior	O
work	O
to	O
be	O
the	O
most	B
important	O
predictor	O
of	O
a	O
woman	O
’	O
s	O
weight	O
gain	O
target	O
[	O
6	O
].	O

To	B
the	I
best	I
of	I
our	I
knowledge	I
,	O
this	O
is	O
the	O
first	O
study	O
to	O
have	O
examined	O
the	O
factors	O
that	O
influence	O
use	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
during	O
pregnancy	O
in	O
Eastern	O
Europe	O
.	O

Life	O
history	O
theory	O
links	O
earlier	O
ages	O
of	O
maturation	O
to	O
ecological	O
circumstances	O
including	O
energy	O
availability	O
,	O
risks	O
of	O
predation	O
and	O
other	O
causes	O
of	O
extrinsic	O
mortality	O
[	O
25	O
].	O

For	O
plasma	O
separation	O
,	O
samples	O
were	O
centrifuged	O
at	O
3000	O
rpm	O
and	O
4	O
°	O
C	O
for	O
10	O
minutes	O
.	O

BMI	O
tends	O
to	O
decrease	O
during	O
early	O
childhood	O
and	O
then	O
,	O
typically	B
between	O
the	O
ages	O
of	O
6	O
and	O
8	O
,	O
begins	O
to	O
rise	O
again	O
(	O
adiposity	O
rebound	O
).	O

Thus	B
,	O
even	O
though	O
there	O
is	O
no	O
consensus	O
on	O
recommending	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
,	O
they	O
are	O
used	O
more	O
often	O
by	O
those	O
women	O
with	O
a	O
better	O
socio	O
-	O
economic	O
status	O
,	O
with	O
a	O
higher	O
level	O
of	O
education	O
and	O
who	O
attended	O
more	O
prenatal	O
consultations	O
.	O

Similar	O
analyses	O
were	O
conducted	O
using	O
logistic	O
regression	O
to	O
examine	O
impact	O
on	O
odds	O
of	O
macrosomia	O
.	O

Current	O
U	O
.	O
S	O
.	O
guidelines	B
call	O
for	O
pregnant	O
women	O
to	O
get	O
400	O
-	O
600	O
IU	O
.	O

Methods	O
An	O
observational	O
analytic	O
cross	O
-	O
sectional	O
study	O
was	O
carried	O
out	O
amongst	O
pregnant	O
women	O
attending	O
selected	O
government	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

The	O
assay	O
has	O
shown	O
good	O
correlation	O
with	O
standard	O
reference	O
results	O
from	O
liquid	O
-	O
chromatography	O
tandem	O
mass	O
spectrometry	O
[	O
19	O
].	O

Pre	O
-	O
pregnancy	O
weekly	O
supplements	O
that	O
contain	O
folic	O
acid	O
may	O
also	O
decrease	O
the	O
risk	O
of	O
neural	O
tube	O
defects	O
.	O

Because	B
POMC	O
was	O
not	O
brought	O
to	O
control	O
levels	O
,	O
vitamins	O
other	O
than	O
folate	O
may	O
play	O
a	O
role	O
in	O
correcting	O
POMC	O
.	O

Therefore	B
,	O
drawing	O
conclusions	B
about	O
the	O
effects	O
of	O
perinatal	O
and	O
postnatal	O
vitamin	O
D	O
status	O
from	O
these	O
results	O
can	O
be	O
difficult	O
.	O

They	O
suggested	O
that	O
serum	O
vitamin	O
A	O
level	O
affects	O
the	O
LM	O
MS	O
during	O
the	O
early	O
fattening	O
stage	O
and	O
that	O
restricting	O
vitamin	O
A	O
during	O
the	O
later	O
stages	O
of	O
growth	O
affects	O
growth	O
rate	O
.	O

In	B
light	I
of	I
the	O
inflammatory	O
nature	O
of	O
depression	O
and	O
the	O
strong	O
role	O
of	O
vitamin	O
D	O
as	B
an	O
anti	O
-	O
inflammatory	O
and	O
immunomodulator	O
,	O
inflammation	O
may	O
mediate	O
the	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
depression	O
during	O
pregnancy	O
[	O
73	O
,	O
74	O
].	O

The	O
putative	B
connection	O
between	O
handedness	O
,	O
season	O
of	O
birth	O
,	O
and	O
glioma	O
risk	O
remains	O
difficult	O
to	O
interpret	O
.	O

Exposure	O
to	O
an	O
adverse	O
intrauterine	O
environment	O
during	O
sensitive	O
periods	O
of	O
fetal	O
development	O
produces	O
long	O
-	O
term	O
alterations	O
in	O
the	O
autonomic	O
nervous	O
system	O
(	O
ANS	O
)	O
[	O
15	O
,	O
16	O
,	O
17	O
].	O

Research	O
on	O
the	O
reliability	O
of	O
parental	O
reports	O
on	O
child	O
development	O
is	O
conflicting	O
[	O
31	O
],	O
Daniels	O
et	O
al	O
.	O

We	O
computed	O
the	O
alternative	O
Mediterranean	O
diet	O
(	O
aMED	O
)	O
score	O
based	O
on	O
FFQ	O
-	O
derived	O
measures	O
of	O
daily	O
food	O
intake	O
,	O
following	O
the	O
method	O
of	O
Tobias	O
et	O
al	O
.	O

When	O
RMSSD	O
was	O
tested	O
as	O
the	O
dependent	O
variable	O
,	O
we	O
found	O
that	O
only	O
birth	O
weight	O
emerged	O
as	O
independent	O
determinant	O
for	O
this	O
HRV	O
parameter	O
(	O
Table	O
2	O
).	O

The	O
inter	O
-	O
assay	O
coefficient	O
of	O
variation	O
is	O
6	O
%	O
at	O
40	O
nmol	O
/	O
L	O
for	O
both	O
25OHD3and	O
25OHD2	O
.	O

Women	O
in	O
the	O
highest	O
compared	O
with	O
the	O
lowest	O
quartile	O
of	O
vitamin	O
D	O
consumption	O
experienced	O
a	O
37	O
%	O
(	O
95	O
%	O
CI	O
,	O
22	O
-	O
50	O
%)	O
lower	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

The	O
μβposterior	O
mean	O
for	O
the	O
phthalates	O
and	O
BPA	O
was	O
1	O
g	O
with	O
95	O
%	O
CI	O
(-	O
20	O
,	O
23	O
),	O
meaning	O
the	O
average	O
association	O
between	O
the	O
9	O
phthalates	O
and	O
BPA	O
and	O
birth	O
weight	O
was	O
1	O
g	O
.	O
Another	O
way	O
to	O
interpret	O
this	O
is	O
that	O
for	O
every	O
10	O
-	O
fold	O
increase	O
in	O
exposure	O
to	O
phthalates	O
and	O
BPA	O
as	O
a	O
whole	O
,	O
there	O
was	O
a	O
1	O
g	O
increase	O
in	O
birth	O
weight	O
.	O

Women	O
who	O
reported	O
a	O
preference	O
for	O
shadow	O
had	O
a	O
higher	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
in	O
our	O
study	O
.	O

An	O
intake	O
of	O
fish	O
may	O
reflect	O
a	O
health	O
conscious	O
diet	O
and	O
thus	B
the	O
positive	O
effects	O
may	O
not	O
be	O
directly	O
attributed	O
to	O
the	O
fish	O
but	O
rather	O
to	O
the	O
diet	O
as	O
a	O
whole	O
.	O

Analyses	O
were	O
performed	O
to	O
test	O
for	O
effect	O
modification	O
by	O
maternal	O
BMI	O
category	O
.	O

Our	O
data	O
are	O
consistent	O
with	O
other	O
similar	O
cohort	O
data	O
.	O

Authors	O
state	O
that	O
the	O
proliferation	O
of	O
spermatogenic	O
cells	O
was	O
decreased	O
with	O
calcium	O
-	O
dependent	O
down	O
regulation	O
of	O
cyclin	O
E	O
and	O
CDK2	O
,	O
and	O
up	O
regulation	O
of	O
p53	O
and	O
p21	O
expression	O
,	O
which	O
is	O
not	O
a	O
direct	O
effect	O
of	O
active	O
vitamin	O
D	O
deficiency	O
.	O

We	O
therefore	B
propose	O
that	O
one	B
explanation	I
for	O
our	O
main	O
findings	O
is	O
that	O
high	O
fetal	O
exposure	O
to	O
fructose	O
may	O
cause	O
persistence	O
of	O
Th2	O
immune	O
responses	O
post	O
-	O
natally	O
and	O
allergic	O
inflammation	O
in	O
the	O
developing	O
lung	O
.	O

Persistence	O
and	O
clinical	O
relevant	O
impairment	O
may	O
be	O
related	O
to	O
a	O
family	O
history	O
of	O
schizophrenia	O
and	O
environmental	O
risk	O
factors	O
that	O
might	O
interact	O
with	O
the	O
genetic	O
risk	O
.	O

Inclusion	O
criteria	O
were	O
as	O
follows	O
:	O
age	O
older	O
than	O
18	O
years	O
,	O
singleton	O
pregnancy	O
,	O
and	O
gestation	O
less	O
than	O
17	O
weeks	O
based	O
on	O
last	O
menstrual	O
period	O
and	O
ultrasound	O
measurements	O
.	O

In	O
Angus	O
,	O
Hereford	O
,	O
and	O
Wagyu	O
×	O
Angus	O
,	O
the	O
IMF	O
contents	O
in	O
the	O
5	O
muscles	O
(	O
biceps	O
femoris	O
,	O
supraspinatus	O
,	O
semitendinosus	O
,	O
longissimus	O
lumborum	O
,	O
and	O
infraspinatus	O
)	O
and	O
MSA	O
MS	O
increased	O
with	O
the	O
increasing	O
slaughter	O
stages	O
(	O
0	O
,	O
168	O
,	O
326	O
,	O
431	O
and	O
585	O
d	O
after	O
weaning	O
)	O
[	O
30	O
].	O

We	O
will	O
publish	O
the	O
analysis	O
of	O
the	O
outcomes	O
in	O
the	O
form	O
of	O
internal	O
documents	O
,	O
working	O
papers	O
,	O
and	O
in	O
international	O
peer	O
-	O
reviewed	O
journals	O
.	O

Risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
,	O
in	O
addition	O
to	O
geographic	O
and	O
seasonal	O
variation	O
,	O
are	O
well	B
established	I
.	O

DNA	O
methylation	O
and	O
in	O
utero	O
exposures	O
.	O

(	O
A	O
)	O
Genomic	O
DNA	O
sequence	O
chromatograms	O
from	O
normal	O
(	O
upper	O
)	O
and	O
mutant	O
(	O
lower	O
)	O
Skm1	O
and	O
Skm2	O
mice	O
(	O
left	O
panel	O
and	O
right	O
panel	O
,	O
respectively	O
).	O

Significantly	O
more	O
neonates	O
exposed	O
to	O
SGAs	O
were	O
admitted	O
to	O
an	O
NICU	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
and	O
presented	O
with	O
poor	O
neonatal	O
adaptation	O
(	O
PNA	O
)	O
signs	O
,	O
such	O
as	O
central	O
nervous	O
system	O
,	O
respiratory	O
and	O
gastrointestinal	O
problems	O
,	O
(	O
p	O
=	O
0	O
.	O
007	O
),	O
compared	O
with	O
controls	O
.	O

Kawachi	O
[	O
137	O
]	O
described	O
that	O
the	O
plasma	O
retinol	O
level	O
in	O
Japanese	O
fattening	O
cattle	O
is	O
about	O
300	O
μg	O
/	O
L	O
(	O
100	O
IU	O
/	O
dL	O
)	O
and	O
that	O
a	O
vitamin	O
A	O
-	O
deficient	O
diet	O
decreases	O
the	O
plasma	O
concentration	O
to	O
<	O
90	O
μg	O
/	O
L	O
(	O
30	O
IU	O
/	O
dL	O
).	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

Further	O
investigation	O
of	O
potential	O
confounding	O
/	O
mediation	O
of	O
main	O
findings	O
and	O
sensitivity	O
analyses	O
Additional	O
separate	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
,	O
gestational	O
age	O
at	O
delivery	O
,	O
birthweight	O
,	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
and	O
child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
did	O
not	O
substantially	O
alter	O
the	O
main	O
findings	O
and	O
therefore	B
no	O
further	O
formal	O
mediation	O
analysis	O
was	O
conducted	O
(	O
supplementary	O
table	O
E3	O
).	O

It	O
is	O
important	O
to	O
identify	O
the	O
mechanisms	O
responsible	O
for	O
initial	O
muscle	O
and	O
fat	O
cell	O
growth	O
during	O
the	O
developmental	O
stage	O
of	O
cattle	O
to	O
better	O
understand	O
IMF	O
deposition	O
in	O
later	O
life	O
.	O

Complete	O
blood	O
count	O
showed	O
hemoglobin	O
of	O
13	O
.	O
7	O
g	O
/	O
dL	O
,	O
hematocrit	O
42	O
.	O
6	O
%,	O
white	O
blood	O
cell	O
count	O
15	O
,	O
200	O
/	O
mm3	O
,	O
and	O
platelet	O
count	O
of	O
76	O
,	O
000	O
/	O
mm3	O
.	O

Very	O
recently	O
,	O
chronic	O
cold	O
acclimation	O
in	O
human	O
subjects	O
was	O
reported	O
to	O
increase	O
the	O
volume	O
of	O
metabolically	O
active	O
BAT	O
,	O
increasing	O
its	O
oxidative	O
capacity	O
,	O
therefore	O
its	O
contribution	O
to	O
cold	O
-	O
induced	O
thermogenesis	O
(	O
Blondin	O
et	O
al	O
.,	O
2014	O
).	O

These	O
children	O
could	O
re	O
-	O
enter	O
the	O
study	O
when	O
next	O
seen	O
.	O

Preterm	O
delivery	O
occurred	O
in	O
ten	O
pregnancies	O
.	O

Romanian	O
recommendations	O
stipulate	O
that	O
women	O
with	O
a	O
haemoglobin	O
higher	O
than	O
11	O
g	O
/	O
dl	O
should	O
take	O
60	O
mg	O
of	O
iron	O
and	O
350	O
μg	O
of	O
folic	O
acid	O
from	O
the	O
16thweek	O
of	O
pregnancy	O
to	O
prevent	O
anaemia	O
,	O
but	O
only	O
iron	O
products	O
are	O
reimbursed	O
by	O
the	O
health	O
insurance	O
system	O
.	O

These	O
include	O
the	O
type	O
of	O
birth	O
,	O
such	O
as	O
whether	O
it	O
was	O
breech	O
,	O
a	O
prolonged	O
birth	O
,	O
or	O
an	O
induced	O
birth	O
,	O
along	O
with	O
various	O
forms	O
of	O
fetal	O
measures	O
such	O
as	O
birth	O
cry	O
,	O
fetal	O
distress	O
,	O
low	O
heart	O
rate	O
,	O
or	O
high	O
fetal	O
blood	O
pressure	O
[	O
2	O
,	O
3	O
,	O
13	O
–	O
15	O
,	O
60	O
].	O

Data	O
relating	O
to	O
pre	O
-	O
pregnancy	O
lifestyle	O
behaviours	O
were	O
not	O
collected	O
.	O

Whilst	O
this	O
study	O
is	O
inadequately	O
powered	O
to	O
demonstrate	O
safety	O
of	O
acarbose	O
,	O
it	O
is	O
not	O
absorbed	O
from	O
the	O
gut	O
,	O
and	O
therefore	B
would	O
be	O
unlikely	B
to	O
affect	O
the	O
fetus	O
.	O

These	O
results	O
are	O
in	O
keeping	O
with	O
data	O
showing	O
a	O
physiological	O
role	O
of	O
BAT	O
in	O
whole	O
-	O
body	O
energy	O
expenditure	O
,	O
glucose	O
homeostasis	O
,	O
and	O
insulin	O
sensitivity	O
in	O
humans	O
during	O
prolonged	O
cold	O
exposure	O
(	O
Chondronikola	O
et	O
al	O
.,	O
2014	O
).	O

The	O
relatively	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
may	O
have	O
important	O
health	O
implications	O
for	O
Thai	O
people	O
as	O
the	O
science	O
of	O
vitamin	O
D	O
continues	O
to	O
be	O
unraveled	O
.	O

Sleep	O
was	O
assessed	O
using	O
the	O
General	O
Sleep	O
Disturbance	O
questionnaire	O
[	O
30	O
].	O

A	O
recent	O
study	O
of	O
pregnant	O
women	O
in	O
Europe	O
reported	O
that	O
only	O
12	O
%	O
had	O
an	O
optimal	O
level	O
of	O
vitamin	O
D	O
[	O
20	O
].	O

Two	O
ml	O
blood	O
sample	O
was	O
taken	O
from	O
all	O
participants	O
and	O
then	O
,	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
was	O
measured	O
using	O
proper	O
kit	O
(	O
Immunodiagnostic	O
systems	O
–	O
ids	O
–	O
made	O
by	O
UK	O
).	O

A	O
stool	O
sample	O
was	O
requested	O
and	O
sterile	O
universal	O
containers	O
provided	O
at	O
the	O
study	O
visit	O
following	O
the	O
trial	O
.	O

Between	O
fetal	O
and	O
perinatal	O
stages	O
(	O
period	O
I	O
),	O
there	O
were	O
1	O
,	O
034	O
(	O
503	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
probe	O
-	O
sets	O
showing	O
levels	O
and	O
directions	O
of	O
regulation	O
in	O
the	O
AP	O
group	O
that	O
were	O
different	O
from	O
the	O
LP	O
group	O
.	O

Once	O
transcription	O
within	O
the	O
embryo	O
genome	O
is	O
activated	O
,	O
however	O
,	O
there	O
is	O
rapid	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
processes	O
for	O
which	O
miRNA	O
-	O
mediated	O
regulation	O
is	O
essential	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
hence	O
increased	O
expression	O
of	O
miRNAs	O
.	O

Some	O
children	O
develop	O
a	O
rampant	O
subtype	O
of	O
ECC	O
termed	O
Severe	O
Early	O
Childhood	O
Caries	O
(	O
S	O
-	O
ECC	O
),	O
a	O
condition	O
known	O
to	O
affect	O
health	O
and	O
well	O
-	O
being	O
[	O
3	O
].	O

The	O
FFQ	O
lacked	O
quantitative	O
information	O
on	O
soft	O
drink	O
consumption	O
and	O
this	O
will	O
have	O
led	O
to	O
underestimation	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
.	O

Tips	O
were	O
activated	O
with	O
acetonitrile	O
and	O
washed	O
with	O
5	O
×	O
10	O
µl	O
of	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
formic	O
acid	O
.	O

Despite	O
these	O
,	O
our	O
study	O
was	O
able	O
to	O
replicate	O
findings	O
reported	O
in	O
individuals	O
from	O
developed	O
countries	O
.	O

Prepregnancy	O
BMI	O
was	O
also	O
examined	O
as	O
a	O
categorical	O
predictor	O
(	O
median	O
split	O
within	O
weight	O
groups	O
),	O
but	O
the	O
same	O
results	O
were	O
observed	O
.	O

In	O
an	O
observational	O
study	O
of	O
23	O
,	O
662	O
infants	O
in	O
Nepal	O
,	O
Rhee	O
and	O
colleagues	O
found	O
that	O
neonates	O
of	O
mothers	O
who	O
reported	O
washing	O
their	O
hands	O
were	O
at	O
44	O
%	O
lower	O
risk	O
of	O
mortality	O
than	O
neonates	O
of	O
mothers	O
who	O
did	O
not	O
report	O
handwashing	O
[	O
2	O
].	O

GR	O
Polymorphisms	O
For	O
the	O
Bcl	O
I	O
,	O
N363S	O
,	O
Tth111	O
I	O
,	O
and	O
ER22	O
/	O
23EK	O
GR	O
polymorphisms	O
DNA	O
was	O
extracted	O
using	O
the	O
Phusion	O
Blood	O
Direct	O
PCR	O
Kit	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
),	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Naturally	O
,	O
some	O
factors	O
are	O
difficult	O
to	O
control	O
for	O
as	B
they	O
are	O
critical	O
to	O
explaining	B
why	O
children	O
are	O
at	O
risk	O
for	O
caries	O
(	O
e	O
.	O
g	O
.	O

This	O
passes	O
through	O
the	O
anterior	O
commissure	O
,	O
which	O
was	O
used	O
as	O
a	O
horizontal	O
limit	O
.	O

There	O
was	O
a	O
low	O
prevalence	O
of	O
malaria	O
parasitaemia	O
in	O
the	O
current	O
study	O
,	O
which	O
is	O
likely	B
to	O
have	O
been	O
a	O
consequence	B
of	O
cross	O
-	O
sectional	O
sampling	O
of	O
partially	O
immune	O
adults	O
early	O
in	O
the	O
wet	O
season	O
,	O
in	O
an	O
area	O
of	O
highly	O
seasonal	O
endemicity	O
.	O

Importantly	O
,	O
the	O
improved	O
metabolic	O
profile	O
was	O
lost	O
when	O
BAT	O
used	O
for	O
transplantation	O
came	O
from	O
IL	O
-	O
6	O
knockout	O
mice	O
,	O
clearly	B
demonstrating	I
that	O
BAT	O
-	O
derived	O
IL	O
-	O
6	O
is	O
required	O
for	O
the	O
profound	O
effects	O
of	O
BAT	O
transplantation	O
on	O
glucose	O
homeostasis	O
and	O
insulin	O
sensitivity	O
(	O
Stanford	O
et	O
al	O
.,	O
2013	O
).	O

Respondents	O
of	O
low	O
educational	O
level	O
tend	O
to	O
be	O
very	O
satisfied	O
with	O
the	O
personnel	O
'	O
s	O
competence	O
and	O
they	O
also	O
rated	O
the	O
health	O
talks	O
as	O
very	O
satisfactory	O
,	O
in	O
marked	O
contrast	O
to	O
those	O
of	O
a	O
higher	O
educational	O
level	O
who	O
were	O
much	O
more	O
likely	B
not	O
to	O
be	O
satisfied	O
with	O
the	O
health	O
talks	O
.	O

Statistical	O
analysis	O
All	O
data	O
are	O
expressed	O
as	O
mean	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

What	O
are	O
the	O
potential	O
human	O
disease	O
outcome	O
(	O
s	O
)?	O

Research	O
suggests	O
that	O
vitamin	O
D	O
is	O
important	O
for	O
differentiation	O
and	O
maturation	O
during	O
cell	O
proliferation	O
[	O
9	O
]	O
and	O
that	O
it	O
down	O
-	O
regulates	O
renin	O
gene	O
expression	O
in	O
the	O
kidneys	O
[	O
13	O
].	O

There	O
are	O
a	O
number	O
of	O
limitations	O
to	O
our	O
findings	O
.	O

Adjuvant	O
therapies	O
Thyroid	O
hormones	O
–	O
Endocrine	O
therapy	O
:	O
post	O
-	O
operative	O
oral	O
administration	O
of	O
supraphysiologic	O
oral	O
doses	O
of	O
levothyroxine	O
are	O
used	O
assuming	O
that	O
the	O
suppression	O
of	O
endogenous	O
production	O
of	O
TSH	O
deprives	O
TSH	O
-	O
dependent	O
DTC	O
cells	O
of	O
an	O
important	O
growth	O
-	O
promoting	O
influence	O
and	O
the	O
goal	O
for	O
basal	O
serum	O
TSH	O
should	O
be	O
in	O
the	O
0	O
.	O
1	O
to	O
0	O
.	O
4	O
mIU	O
/	O
L	O
range	O
.	O

Results	O
Of	O
1078	O
women	O
who	O
presented	O
for	O
care	O
during	O
the	O
study	O
period	O
,	O
996	O
met	O
criteria	O
and	O
were	O
asked	O
to	O
participate	O
(	O
92	O
.	O
39	O
%).	O

No	O
other	O
clothing	O
or	O
lifestyle	O
habits	O
affecting	O
sunlight	O
exposure	O
were	O
observed	O
by	O
the	O
study	O
staff	O
as	O
related	O
to	O
ethnicity	O
.	O

Emulsifier	O
supplementation	O
increased	O
digestion	O
and	O
absorption	O
of	O
a	O
high	O
energy	O
/	O
fat	O
diet	O
in	O
ruminants	O
[	O
106	O
,	O
107	O
].	O

Data	O
are	O
expressed	O
as	O
group	O
means	O
±	O
SEM	O
.	O

Education	O
was	O
re	O
-	O
categorised	O
into	O
‘	O
lower	O
’	O
and	O
‘	O
higher	O
’	O
education	O
(	O
lower	O
=	O
lower	O
or	O
upper	O
secondary	O
or	O
post	O
-	O
secondary	O
non	O
-	O
tertiary	O
education	O
,	O
higher	O
=	O
first	O
or	O
second	O
stage	O
of	O
tertiary	O
education	O
),	O
due	O
to	O
a	O
low	O
number	O
of	O
subjects	O
in	O
other	O
education	O
categories	O
.	O

Everyone	O
has	O
a	O
role	O
to	O
play	O
in	O
reaching	O
this	O
target	O
including	O
government	O
leaders	O
,	O
professionals	O
,	O
private	O
sector	O
,	O
and	O
of	O
course	O
families	O
who	O
are	O
affected	O
the	O
most	O
and	O
whose	O
voices	O
have	O
been	O
critical	O
for	O
change	O
in	O
many	O
of	O
the	O
countries	O
with	O
the	O
most	O
progress	O
.	O

Additionally	O
,	O
obstetrical	O
health	O
care	O
providers	O
received	O
education	O
regarding	O
the	O
potential	O
health	O
impact	O
of	O
low	O
vitamin	O
D	O
status	O
via	O
continuing	O
medical	O
education	O
(	O
CME	O
)	O
and	O
nurses	O
provided	O
vitamin	O
D	O
education	O
and	O
standard	O
recommendations	O
for	O
improving	O
vitamin	O
D	O
status	O
using	O
supplements	O
to	O
obstetrical	O
(	O
OB	O
)	O
patients	O
at	O
the	O
initial	O
visit	O
.	O

To	O
investigate	O
the	O
role	O
of	O
visfatin	O
in	O
the	O
growth	O
of	O
the	O
fetus	O
and	O
up	O
to	O
a	O
year	O
after	O
birth	O
,	O
we	O
measured	O
serum	O
visfatin	O
levels	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
in	O
an	O
Iranian	O
population	O
.	O

Integrated	O
service	O
delivery	O
packages	O
of	O
evidence	O
-	O
based	O
interventions	O
within	O
the	O
continuum	O
of	O
care	O
have	O
many	O
advantages	O
:	O
cost	O
-	O
effectiveness	O
is	O
enhanced	O
;	O
available	O
human	O
resources	O
are	O
maximised	O
;	O
and	O
services	O
are	O
more	O
family	O
-	O
friendly	O
,	O
reducing	O
the	O
need	O
for	O
multiple	O
visits	O
[	O
24	O
].	O

Although	O
the	O
evidence	O
from	O
mobile	O
phone	O
studies	O
is	O
less	O
conclusive	O
in	O
these	O
areas	O
,	O
preliminary	O
research	O
has	O
shown	O
promise	O
in	O
delivering	O
healthy	O
eating	O
and	O
active	O
living	O
(	O
HEAL	O
)	O
interventions	O
.	O

Women	O
in	O
the	O
highest	O
quintile	O
of	O
total	O
sugar	O
intake	O
during	O
pregnancy	O
had	O
a	O
lower	O
pre	O
-	O
pregnancy	O
BMI	O
,	O
higher	O
total	O
energy	O
intake	O
and	O
gained	O
more	O
weight	O
during	O
pregnancy	O
than	O
women	O
in	O
the	O
lowest	O
quintile	O
.	O

Pre	O
-	O
cast	O
immobilised	O
pH	O
gradient	O
strips	O
(	O
IPG	O
,	O
11	O
cm	O
,	O
pH	O
3	O
–	O
10	O
,	O
Proteome	O
Systems	O
,	O
North	O
Ryde	O
,	O
Australia	O
)	O
were	O
passively	O
rehydrated	O
in	O
200	O
µg	O
sample	O
protein	O
extract	O
for	O
6	O
hr	O
at	O
room	O
temperature	O
.	O

Introduction	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
patients	O
and	O
is	O
more	O
frequently	O
diagnosed	O
in	O
women	O
.	O

In	O
obese	O
mothers	O
,	O
lower	O
protein	O
intake	O
early	O
in	O
pregnancy	O
and	O
increased	O
protein	O
intakes	O
over	O
the	O
course	O
of	O
the	O
pregnancy	O
were	O
independently	O
related	O
to	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

These	O
effects	O
are	O
partly	O
interrelated	O
,	O
but	O
can	O
also	O
be	O
dissociated	O
and	O
exerted	O
by	O
different	O
UCP1	O
-	O
expressing	O
types	O
of	O
adipocytes	O
(	O
i	O
.	O
e	O
.,	O
brown	O
and	O
“	O
brite	O
”	O
adipocytes	O
).	O

The	O
changes	O
in	O
gene	O
expression	O
were	O
not	O
persistent	O
in	O
terms	O
of	O
consistent	O
differential	O
expression	O
of	O
genes	O
at	O
all	O
stages	O
.	O

Muscle	O
and	O
fat	O
cell	O
growth	O
typically	O
occur	O
as	O
mass	O
increases	O
due	O
to	O
both	O
hyperplasia	O
(	O
increase	O
in	O
cell	O
number	O
)	O
and	O
hypertrophy	O
(	O
increase	O
in	O
cell	O
size	O
)	O
[	O
14	O
,	O
15	O
].	O

Previous	O
studies	O
identify	O
edible	O
fungi	O
as	B
the	O
primary	O
plant	O
-	O
based	O
dietary	O
source	O
of	O
Vitamin	O
D	O
.	O
However	O
,	O
edible	O
fungi	O
were	O
hardly	O
seen	O
in	O
the	O
dietary	O
records	O
among	O
participants	O
in	O
this	O
study	O
.	O

Data	O
will	O
then	O
be	O
screened	O
by	O
means	O
of	O
range	O
checks	O
and	O
for	O
outliers	O
in	O
total	O
energy	O
,	O
protein	O
,	O
fat	O
,	O
vitamin	O
A	O
and	O
vitamin	O
C	O
intake	O
.	O

Similarly	O
,	O
38	O
%	O
of	O
exposed	O
women	O
in	O
this	O
earlier	O
study	O
,	O
in	O
contrast	O
to	O
18	O
%	O
in	O
the	O
current	O
study	O
,	O
reported	O
smoking	O
during	O
pregnancy	O
—	O
a	O
risk	O
factor	O
that	O
has	O
also	O
been	O
associated	O
with	O
elevated	O
risks	O
of	O
small	O
for	O
gestational	O
age39	O
–	O
41and	O
intrauterine	O
growth	O
-	O
restricted42neonates	O
.	O

Pearson	O
'	O
s	O
product	O
moment	O
correlations	O
were	O
conducted	O
to	O
examine	O
unadjusted	O
associations	O
between	O
WFA	O
z	O
-	O
scores	O
and	O
maternal	O
variables	O
.	O

2007	O
).	O

Consequently	B
,	O
there	O
is	O
worldwide	O
recognition	O
of	O
this	O
phenomenon	O
,	O
and	O
discussion	O
on	O
how	O
to	O
both	O
guide	O
further	O
scientific	O
research	O
towards	O
a	O
greater	O
mechanistic	O
understanding	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
humans	O
,	O
and	O
translate	O
relevant	O
research	O
outcomes	O
into	O
appropriate	O
regulatory	O
policies	O
for	O
effective	O
public	O
health	O
protection	O
.	O

One	O
possible	O
interpretation	B
for	O
these	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	O
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Furthermore	O
,	O
most	O
participants	O
who	O
reported	O
receiving	O
advice	O
on	O
GWG	O
got	O
recommendations	O
within	O
the	O
current	O
IOM	O
standards	O
.	O

Increased	O
placental	O
AluYb8	O
methylation	O
was	O
positively	O
associated	O
with	O
average	O
methylation	O
among	O
CpG	O
loci	O
found	O
in	O
polycomb	O
group	O
target	O
genes	O
;	O
developmentally	O
related	O
transcription	O
factor	O
binding	O
sites	O
were	O
overrepresented	O
for	O
differentially	O
methylated	O
loci	O
associated	O
with	O
both	O
elements	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
14	O
Civil	O
society	O
-	O
Chinese	O
parents	O
mobilising	O
for	O
their	O
preterm	O
babies	O
.	O

As	O
with	O
any	O
rapidly	O
developing	O
field	O
,	O
there	O
is	O
a	O
continuous	O
generation	O
of	O
new	O
information	O
that	O
must	O
be	O
incorporated	O
as	O
appropriate	O
,	O
such	O
as	O
novel	O
histone	O
or	O
DNA	O
modifications	O
and	O
ncRNAs	O
families	O
implicated	O
in	O
the	O
epigenetic	O
regulation	O
of	O
the	O
mammalian	O
life	O
cycle	O
(	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Sun	O
et	O
al	O
.	O
2014	O
;	O
Garcia	O
-	O
Lopez	O
et	O
al	O
.	O
2015	O
;	O
Sharma	O
et	O
al	O
.	O
2016	O
);	O
and	O
new	O
functions	O
for	O
existing	O
epigenetic	O
mechanisms	O
within	O
mammalian	O
development	O
(	O
Gou	O
et	O
al	O
.	O
2014	O
;	O
Kuramochi	O
-	O
Miyagawa	O
et	O
al	O
.	O
2008	O
;	O
Watanabe	O
et	O
al	O
.	O
2008	O
,	O
2011	O
;	O
Li	O
et	O
al	O
.	O
2015	O
,	O
Pantano	O
et	O
al	O
.	O
2015	O
;	O
Williams	O
et	O
al	O
.	O
2015	O
;	O
Zhang	O
et	O
al	O
.	O
2015	O
).	O

Black	O
infants	O
had	O
3	O
.	O
6	O
greater	O
adjusted	O
odds	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
2	O
.	O
4	O
,	O
5	O
.	O
6	O
)	O
of	O
vitamin	O
D	O
deficiency	O
when	O
compared	O
with	O
white	O
infants	O
.	O

Further	O
evidence	O
is	O
suggested	O
by	O
other	O
studies	O
.	O

However	O
,	O
randomised	O
controlled	O
trials	O
are	O
required	O
in	O
specific	O
risk	O
groups	O
of	O
vitamin	O
D	O
deficiency	O
to	O
clarify	O
if	O
vitamin	O
D	O
supplementation	O
affects	O
the	O
risk	O
of	O
GDM	O
.	O

Specifically	O
,	O
it	O
is	O
the	O
prescriptions	O
taken	O
during	O
pregnancy	O
,	O
the	O
length	O
of	O
labor	O
,	O
viral	O
infection	O
,	O
abnormal	O
presentation	O
at	O
delivery	O
,	O
and	O
finally	O
low	O
birth	O
weight	O
that	O
were	O
associated	O
with	O
autism	O
.	O

(	O
2013	O
)*	O
Phthalates	O
:	O
Dibutylphthalate	O
(	O
DBP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
500	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1male	O
offspring	O
↓	O
testicular	O
testosterone	O
and	O
Leydig	O
stem	O
cellsHistone	O
modificationKilcoyne	O
et	O
al	O
.	O

These	O
analyses	O
were	O
also	O
repeated	O
but	O
using	O
the	O
current	O
definitions	O
of	O
vitamin	O
D	O
deficiency	O
:	O
<	O
25	O
,	O
25	O
–	O
50	O
,	O
50	O
–	O
75	O
and	O
>	O
75	O
nmol	O
/	O
L	O
in	O
the	O
non	O
-	O
standardised	O
data	O
[	O
7	O
].	O

Additionally	O
,	O
these	O
women	O
may	O
choose	O
to	O
eat	O
traditional	O
foods	O
[	O
82	O
]	O
that	O
do	O
not	O
form	O
part	O
of	O
the	O
South	O
African	O
Food	O
Database	O
for	O
nutritional	O
analysis	O
;	O
and	O
may	O
not	O
be	O
able	O
to	O
speak	O
a	O
local	O
language	O
[	O
83	O
]	O
hampering	O
detailed	O
reporting	O
during	O
dietary	O
assessments	O
.	O

The	O
decreased	O
flake	O
thickness	O
of	O
steam	O
-	O
flaked	O
sorghum	O
increased	O
starch	O
digestion	O
and	O
liver	O
gluconeogenesis	O
[	O
114	O
].	O

Examining	O
GWG	O
as	O
a	O
potential	O
mediator	O
,	O
the	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
were	O
generally	O
attenuated	O
(	O
Table	O
4	O
).	O

Setting	O
:	O
Hospital	O
antenatal	O
clinics	O
.	O

There	O
is	O
now	O
a	O
small	O
but	O
growing	O
body	O
of	O
data	O
supporting	O
the	O
efficacy	O
of	O
prenatal	O
multi	O
-	O
micronutrients	O
in	O
improving	O
selected	O
perinatal	O
outcomes	O
of	O
women	O
and	O
babies	O
in	O
resource	O
-	O
poor	O
settings	O
.	O

Part	O
2	O
:	O
Prevention	O
of	O
Asthma	O
and	O
Allergies	O
in	O
Early	O
Life	O
Infants	O
With	O
High	O
-	O
Risk	O
of	O
Allergy	O
The	O
potential	O
risk	O
for	O
the	O
development	O
of	O
atopy	O
among	O
newborns	O
is	O
high	O
.	O

Two	O
-	O
thirds	O
of	O
untraced	O
women	O
were	O
nulliparous	O
compared	O
with	O
one	O
third	O
of	O
the	O
traced	O
women	O
,	O
characterising	O
a	O
group	O
of	O
younger	O
,	O
more	O
mobile	O
but	O
less	O
reproductively	O
-	O
active	O
women	O
,	O
akin	O
to	O
that	O
in	O
the	O
Bangladeshi	O
study	O
(	O
Hyder	O
et	O
al	O
2007	O
).	O

Maternal	O
vitamin	O
D	O
status	O
,	O
gestational	O
diabetes	O
and	O
infant	O
birth	O
size	O
Abstract	O
Background	O
Maternal	O
vitamin	O
D	O
status	O
has	O
been	O
associated	O
with	O
both	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
and	O
fetal	O
growth	O
restriction	O
,	O
however	O
,	O
the	O
evidence	O
is	O
inconsistent	O
.	O

There	O
is	O
also	O
evidence	O
of	O
a	O
relationship	O
between	O
engagement	O
with	O
prenatal	O
care	O
and	O
use	O
of	O
multivitamin	O
supplements	O
,	O
the	O
adequacy	O
of	O
prenatal	O
care	O
being	O
assessed	O
according	O
to	O
Adequacy	O
of	O
Prenatal	O
Care	O
Utilisation	O
Index	O
,	O
which	O
takes	O
into	O
account	O
the	O
month	O
of	O
initiation	O
of	O
care	O
and	O
the	O
proportion	O
of	O
recommended	O
visits	O
adjusted	O
for	O
the	O
gestational	O
age	O
at	O
initiation	O
of	O
care	O
and	O
gestational	O
age	O
at	O
delivery	O
[	O
27	O
].	O

When	O
women	O
were	O
categorised	O
based	O
on	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
deficiency	O
and	O
serum	O
25	O
(	O
OH	O
)	O
D	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
used	O
as	O
the	O
reference	O
,	O
no	O
significant	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
adverse	O
pregnancy	O
outcome	O
was	O
found	O
(	O
Table2	O
).	O

Maternal	O
diet	O
effect	O
p	O
<	O
0	O
.	O
001	O
,	O
postnatal	O
diet	O
effect	O
p	O
<	O
0	O
.	O
001	O
in	O
control	O
offspring	O
-	O
in	O
maternal	O
high	O
fat	O
offspring	O
postnatal	O
diet	O
had	O
no	O
effect	O
.	O

The	O
future	O
of	O
mHealth	O
will	O
include	O
going	O
beyond	O
small	O
-	O
scale	O
pilots	O
and	O
trials	O
and	O
reaching	O
population	O
-	O
level	O
effects	O
through	O
large	O
-	O
scale	O
implementation	O
.	O

2	O
.	O

It	O
is	O
also	O
possible	O
that	O
as	B
a	O
result	O
of	O
vascular	O
changes	O
in	O
pregnancy	O
the	O
maternal	O
cerebral	O
environment	O
is	O
more	O
vulnerable	O
to	O
inflammation	O
perhaps	O
,	O
explaining	B
in	O
part	O
the	O
link	O
between	O
vitamin	O
D	O
and	O
depression	O
in	O
pregnancy	O
.	O

We	O
were	O
able	O
to	O
adjust	O
for	O
smoking	O
,	O
BMI	O
,	O
migration	O
,	O
education	O
and	O
alcohol	O
that	O
could	O
confound	O
our	O
associations	O
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Our	O
population	O
had	O
more	O
male	O
infants	O
than	O
female	O
infants	O
(	O
57	O
.	O
2	O
%	O
males	O
),	O
and	O
an	O
average	O
birth	O
weight	O
and	O
gestational	O
age	O
of	O
3427	O
g	O
and	O
39	O
.	O
3	O
weeks	O
,	O
respectively	O
.	O

Mean	O
±	O
SD	O
SEI	O
of	O
the	O
Auckland	O
women	O
was	O
also	O
higher	O
compared	O
to	O
that	O
in	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Auckland	O
:	O
48	O
.	O
0	O
±	O
14	O
.	O
8	O
vs	O
.	O
Adelaide	O
:	O
27	O
.	O
7	O
±	O
10	O
.	O
5	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

In	O
the	O
group	O
of	O
children	O
with	O
a	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
≥	O
20	O
ng	O
/	O
mL	O
,	O
cathelicidin	O
concentration	O
was	O
significantly	O
positively	O
associated	O
with	O
age	O
(	O
ρ	O
=	O
0	O
.	O
373	O
,	O
p	O
=	O
0	O
.	O
0002	O
).	O

Thus	O
a	O
study	O
with	O
80	O
%	O
power	O
and	O
95	O
%	O
significance	O
needed	O
22	O
079	O
child	O
-	O
months	O
per	O
group	O
(	O
total	O
of	O
2454	O
children	O
for	O
18	O
months	O
follow	O
-	O
up	O
).	O

While	O
the	O
microbiome	O
-	O
wide	O
significance	O
of	O
maternal	O
dietary	O
factors	O
after	O
adjusting	O
p	O
values	O
using	O
the	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
method	O
was	O
not	O
observed	O
,	O
OTUs	O
with	O
the	O
same	O
taxonomic	O
assignment	O
tended	O
to	O
appear	O
together	O
in	O
the	O
most	O
significant	O
results	O
,	O
supporting	O
a	O
true	O
association	O
of	O
maternal	O
dietary	O
factors	O
and	O
infant	O
gut	O
microbiota	O
.	O

We	O
decided	O
to	O
incorporate	O
GAS5	O
in	O
the	O
current	O
study	O
as	B
it	O
can	O
act	O
as	O
a	O
GR	O
DNA	O
binding	O
decoy	O
and	O
as	O
a	O
result	O
compromise	O
its	O
activity	O
[	O
8	O
].	O

Although	O
,	O
the	O
point	O
estimates	O
indicated	O
a	O
marginal	O
increased	O
risk	O
for	O
developing	O
any	O
pregnancy	O
complication	O
with	O
severe	O
(<	O
25	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
those	O
who	O
had	O
levels	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
(	O
aRR	O
:	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
).	O

Given	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
and	O
probably	B
in	O
many	O
European	O
countries	O
,	O
a	O
vitamin	O
D	O
nutrition	O
policy	O
is	O
needed	O
at	O
the	O
country	O
and	O
European	O
level	O
.	O

Genotyping	O
of	O
120	O
mice	O
,	O
including	O
10	O
mice	O
with	O
a	O
deviant	O
phenotype	O
,	O
confined	B
the	O
mutation	O
to	O
a	O
region	O
of	O
24	O
.	O
6	O
Mb	O
on	O
chromosome	O
14	O
(	O
Figure	O
2B	O
,	O
right	O
panel	O
),	O
containing	O
394	O
known	B
/	O
predicted	O
genes	O
and	O
3	O
genes	O
with	O
the	O
associated	O
mouse	O
phenotype	O
of	O
kyphosis	O
[	O
Ataxin	O
7	O
,	O
Topoisomerase	O
(	O
DNA	O
)	O
II	O
beta	O
,	O
and	O
Filamin	O
b	O
].	O

Similarly	O
,	O
little	O
is	O
known	O
about	O
the	O
role	O
of	O
GR	O
-	O
P	O
,	O
a	O
truncated	O
isoform	O
that	O
lacks	O
a	O
large	O
part	O
of	O
the	O
ligand	O
-	O
binding	O
domain	O
,	O
including	O
the	O
domains	O
for	O
silencing	O
of	O
GR	O
in	O
the	O
absence	O
of	O
hormone	O
and	O
transcriptional	O
activation	O
[	O
24	O
].	O

As	B
this	O
is	O
an	O
observational	O
study	O
,	O
we	O
cannot	O
conclude	O
that	O
the	O
information	O
about	O
the	O
roles	O
or	O
sources	O
of	O
nutrients	O
or	O
general	O
recommendations	O
about	O
diet	O
during	O
pregnancy	O
directly	O
influence	O
the	O
frequency	O
with	O
which	O
supplements	O
are	O
used	O
,	O
despite	O
the	O
fact	O
that	O
nutritional	O
knowledge	O
appears	O
to	O
be	O
an	O
important	O
determinant	O
.	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

The	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
,	O
Vitamin	O
D	O
supplement	O
intake	O
and	O
control	O
group	O
.	O

Trial	O
Registration	O
:	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

The	O
investigators	O
found	O
signs	O
of	O
kidney	O
damage	O
that	O
increased	O
with	O
higher	O
daily	O
intake	O
of	O
uranium	O
in	O
the	O
drinking	O
water	O
.	O
27	O
Uranium	O
appears	O
to	O
exert	O
its	O
chemical	O
effects	O
on	O
the	O
kidney	O
’	O
s	O
proximal	O
tubules	O
.	O
28Arsenic	O
and	O
cadmium	O
—	O
which	O
,	O
along	O
with	O
other	O
potentially	O
hazardous	O
metals	O
,	O
are	O
sometimes	O
found	O
in	O
uranium	O
tailings29	O
—	O
create	O
similar	O
signatures	O
of	O
metal	O
damage	O
in	O
the	O
kidneys	O
.	O
30	O
Lewis	O
’	O
s	O
early	O
data	O
from	O
the	O
DiNEH	O
Project	O
suggest	O
that	O
self	O
-	O
reported	O
kidney	O
disease	O
,	O
hypertension	O
,	O
and	O
autoimmune	O
diseases	O
were	O
more	O
prevalent	O
among	O
people	O
who	O
lived	O
closer	O
to	O
mine	O
waste	O
sites	O
.	O
31Her	O
colleague	O
at	O
the	O
University	O
of	O
New	O
Mexico	O
,	O
immunologist	O
Ester	O
Erdei	O
,	O
believes	O
the	O
increase	O
in	O
hypertension	O
and	O
autoimmune	O
diseases	O
might	O
be	O
connected	O
to	O
consumption	O
of	O
contaminated	O
water	O
.	O

Nonetheless	O
,	O
analyses	O
using	O
the	O
2009	O
criteria	O
confirmed	O
the	O
current	O
study	O
'	O
s	O
findings	O
(	O
data	O
not	O
shown	O
).	O

The	O
main	O
aim	O
was	O
to	O
study	O
factors	O
identified	O
in	O
a	O
previous	O
study	O
as	O
potentially	O
causally	O
related	O
to	O
cancer	O
of	O
the	O
oesophagus	O
.	O

Additionally	O
,	O
if	O
participants	O
answered	O
yes	O
to	O
having	O
consumed	O
alcoholic	O
beverages	O
,	O
we	O
asked	O
them	O
“	O
How	O
many	O
drinks	O
do	O
you	O
normally	O
drink	O
per	O
day	O
.”	O
At	O
baseline	O
,	O
97	O
.	O
3	O
%	O
(	O
918	O
/	O
943	O
)	O
of	O
all	O
participants	O
reported	O
zero	O
drinks	O
per	O
day	O
and	O
this	O
rate	O
remained	O
fairly	O
constant	O
at	O
97	O
.	O
6	O
%	O
(	O
448	O
/	O
459	O
)	O
at	O
the	O
first	O
follow	O
-	O
up	O
,	O
with	O
no	O
differences	O
between	O
study	O
conditions	O
.	O

2007	O
).	O

Whether	O
a	O
food	O
tastes	O
good	O
or	O
bad	O
and	O
the	O
pleasure	O
of	O
eating	O
is	O
a	O
complex	O
process	O
mediated	O
by	O
chemical	O
senses	O
in	O
the	O
periphery	O
and	O
multiple	O
brain	O
substrates	O
,	O
which	O
are	O
remarkably	O
well	O
conserved	O
phylogenetically	O
(	O
24	O
).	O

Studies	O
have	O
found	O
a	O
significant	O
association	O
between	O
maternal	O
prepregnancy	O
overweight	O
or	O
obesity	O
and	O
overweight	O
in	O
children	O
.	O

VITAMIND	O
METABOLISM	O
Vitamin	O
D	O
is	O
a	O
misnomer	O
.	O

A	O
putative	B
decrease	O
in	O
hypothalamic	O
sensitivity	O
to	O
leptin	O
may	O
result	O
in	O
an	O
inability	O
to	O
detect	O
satiety	O
despite	O
the	O
fat	O
stores	O
,	O
which	O
finally	O
develop	O
to	O
obesity	O
(	O
Sasaki	O
,	O
2015	O
).	O

Cocaine	O
has	O
been	O
associated	O
with	O
an	O
increase	O
in	O
the	O
onset	O
of	O
neurodevelopmental	O
abnormalities	O
,	O
but	O
the	O
direct	O
influence	O
on	O
autism	O
development	O
is	O
still	O
lacking	O
.	O

This	O
group	O
also	O
received	O
routine	O
prenatal	O
care	O
.	O

In	O
line	O
with	O
this	O
,	O
there	O
was	O
no	O
association	O
between	O
maternal	O
intake	O
of	O
foods	O
during	O
pregnancy	O
and	O
the	O
occurrence	O
of	O
asthma	O
,	O
respiratory	O
disease	O
,	O
or	O
allergy	O
in	O
5	O
-	O
year	O
-	O
old	O
children	O
[	O
80	O
].	O

Interestingly	O
,	O
pregnancy	O
vitamin	O
D	O
status	O
associated	O
positively	O
with	O
birth	O
weight	O
,	O
but	O
an	O
inverse	O
association	O
was	O
observed	O
between	O
newborn	O
vitamin	O
D	O
status	O
and	O
head	O
circumference	O
at	O
birth	O
.	O

Patient	O
eligibility	O
Participants	O
were	O
recruited	O
at	O
the	O
first	O
antenatal	O
hospital	O
visit	O
.	O

RNA	O
Fluorescent	O
In	O
Situ	O
Hybridization	O
(	O
FISH	O
)	O
The	O
slides	O
of	O
the	O
paraffin	O
embedded	O
placental	O
tissue	O
samples	O
were	O
placed	O
in	O
a	O
coplin	O
jar	O
and	O
deparaffinised	O
for	O
30	O
minutes	O
at	O
37	O
°	O
C	O
using	O
Histo	O
-	O
Clear	O
(	O
Fisher	O
Scientific	O
,	O
UK	O
).	O

Discussion	O
It	O
is	O
known	O
that	O
the	O
ANS	O
development	O
begins	O
in	O
fetal	O
life	O
and	O
persists	O
after	O
birth	O
[	O
30	O
,	O
31	O
].	O

There	O
is	O
an	O
urgent	O
need	O
for	O
action	O
on	O
a	O
dual	O
track	O
:	O
(	O
1	O
)	O
through	O
strategic	O
research	O
to	O
advance	O
the	O
prevention	O
of	O
preterm	O
birth	O
and	O
(	O
2	O
)	O
improved	O
implementation	O
and	O
innovation	O
for	O
care	O
of	O
the	O
premature	O
neonate	O
.	O

Body	O
Composition	O
Body	O
composition	O
was	O
evaluated	O
using	O
bioelectrical	O
impedance	O
(	O
BIA	O
)	O
with	O
a	O
single	O
-	O
frequency	O
hand	O
-	O
to	O
-	O
foot	O
(	O
ImpediMed	O
DF50	O
monitor	O
,	O
Impedimed	O
,	O
Australia	O
)	O
[	O
24	O
].	O

Concentrate	O
diets	O
are	O
generally	B
a	O
major	O
glucose	O
source	O
through	O
either	O
production	O
of	O
rumen	O
propionate	O
or	O
glucose	O
absorption	O
from	O
the	O
small	O
intestine	O
from	O
a	O
rumen	O
-	O
bypassed	O
concentrate	O
,	O
as	O
described	O
above	O
,	O
whereas	O
roughage	O
is	O
a	O
major	O
acetate	O
source	O
that	O
results	O
from	O
the	O
rumen	O
fermentation	O
process	O
.	O

(	O
2014	O
)	O
concluded	O
that	O
modest	O
evidence	O
exist	O
for	O
a	O
positive	O
relation	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
birth	O
weight	O
[	O
31	O
].	O

Ethical	O
clearance	O
was	O
obtained	O
from	O
the	O
Faculty	O
of	O
Health	O
Sciences	O
’	O
Institutional	O
Review	O
Board	O
(	O
IRB	O
)	O
of	O
the	O
University	O
of	O
Buea	O
,	O
administrative	O
Clearance	O
from	O
the	O
Regional	O
Delegation	O
of	O
Public	O
Health	O
of	O
the	O
South	O
West	O
Region	O
in	O
Buea	O
and	O
from	O
the	O
heads	O
of	O
the	O
different	O
health	O
centres	O
involved	O
in	O
the	O
study	O
.	O

“	O
There	O
are	O
inherent	O
difficulties	O
with	O
studying	O
breastfeeding	O
prospectively	O
in	O
a	O
rigorous	O
manner	O
,”	O
explains	O
Tonse	O
Raju	O
,	O
chief	O
of	O
the	O
Pregnancy	O
and	O
Perinatology	O
Branch	O
at	O
the	O
Eunice	O
Kennedy	O
Shriver	O
National	O
Institute	O
of	O
Child	O
Health	O
and	O
Human	O
Development	O
.	O

For	O
the	O
purposes	O
of	O
analysis	O
we	O
combined	O
the	O
last	O
three	O
categories	O
to	O
create	O
a	O
binary	O
maternal	O
“	O
diabetes	O
”	O
variable	O
(	O
see	O
supplementary	O
material	O
for	O
further	O
details	O
).	O

The	O
effect	O
of	O
high	O
/	O
low	O
25	O
(	O
OH	O
)	O
D	O
was	O
corrected	O
for	O
the	O
effects	O
of	O
other	O
independent	O
risk	O
factors	O
of	O
dependent	O
variables	O
.	O

We	O
analysed	O
free	O
sugar	O
intake	O
in	O
quintiles	O
:	O
1	O
)	O
as	O
a	O
categorical	O
variable	O
using	O
the	O
lowest	O
quintile	O
as	O
reference	O
to	O
allow	O
for	O
a	O
nonlinear	O
pattern	O
of	O
association	O
and	O
2	O
)	O
as	O
a	O
continuous	O
variable	O
to	O
test	O
for	O
linear	O
trend	O
(	O
i	O
.	O
e	O
.	O

PubMed	O
Central	O
:	O

This	O
is	O
related	O
to	O
lower	O
BAT	O
levels	O
of	O
phosphorylated	O
AKT	O
and	O
FOXO1	O
,	O
higher	O
BAT	O
and	O
WAT	O
expression	O
of	O
UCP1	O
,	O
as	O
well	O
as	O
of	O
its	O
transcriptional	O
regulator	O
,	O
PGC1	O
-	O
α	O
(	O
Ortega	O
-	O
Molina	O
et	O
al	O
.,	O
2012	O
).	O

The	O
VD	O
levels	O
in	O
patients	O
with	O
clinical	O
pregnancy	O
(	O
30	O
.	O
95	O
%)	O
were	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
compared	O
to	O
those	O
with	O
early	O
spontaneous	O
abortion	O
.	O

Interestingly	O
,	O
some	O
of	O
these	O
molecules	O
,	O
called	O
batokines	O
,	O
can	O
be	O
secreted	O
by	O
BAT	O
itself	O
,	O
indicating	O
the	O
occurrence	O
of	O
autocrine	O
effects	O
.	O

Statistical	O
analysis	O
Concentrations	O
of	O
25OHD	O
at	O
T1	O
and	O
T3	O
were	O
used	O
as	O
categorical	O
variables	O
,	O
grouped	O
into	O
25OHD	O
<	O
30	O
(	O
used	O
as	O
reference	O
category	O
),	O
30	O
–	O
49	O
.	O
9	O
,	O
50	O
–	O
74	O
.	O
9	O
,	O
75	O
–	O
99	O
.	O
9	O
and	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

In	O
the	O
analysis	O
of	O
change	O
from	O
age	O
5	O
to	O
9	O
(	O
age	O
9	O
–	O
5	O
),	O
BMI	O
change	O
in	O
girls	O
was	O
associated	O
with	O
the	O
BMI	O
of	O
the	O
mother	O
,	O
p	O
=	O
0	O
.	O
008	O
.	O

Hence	O
,	O
not	O
surprisingly	O
,	O
31	O
%	O
and	O
13	O
%	O
of	O
South	O
African	O
women	O
of	O
reproductive	O
age	O
are	O
anaemic	O
[	O
22	O
]	O
and	O
vitamin	O
A	O
deficient	O
[	O
18	O
],	O
respectively	O
,	O
while	O
68	O
%	O
of	O
women	O
are	O
overweight	O
or	O
obese	O
,	O
and	O
46	O
%	O
hypertensive	O
[	O
22	O
].	O

The	O
mother	O
is	O
given	O
medical	O
advice	O
and	O
referred	O
if	O
necessary	O
.	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

We	O
used	O
vsearch	O
[	O
34	O
]	O
to	O
remove	O
chimeras	O
both	O
de	O
novo	O
and	O
in	O
comparison	O
to	O
the	O
RDP	O
classifier	O
training	O
reference	O
.	O

Averaging	O
parameters	O
were	O
set	O
at	O
70	O
%,	O
therefore	O
for	O
a	O
protein	O
spot	O
to	O
appear	O
in	O
the	O
averaged	O
gel	O
it	O
must	O
be	O
present	O
in	O
70	O
%	O
of	O
all	O
gels	O
within	O
a	O
group	O
.	O

In	O
this	O
study	O
,	O
VD	O
levels	O
were	O
estimated	O
in	O
donor	O
’	O
s	O
serum	O
before	O
the	O
embryo	O
transfer	O
.	O

Oral	O
consent	O
for	O
participation	O
was	O
provided	O
by	O
all	O
women	O
over	O
the	O
phone	O
.	O

Reflux	O
Treatment	O
Pregnancy	O
-	O
associated	O
reflux	O
should	O
be	O
treated	O
by	O
nonpharmacological	O
measures	O
first	O
.	O

However	O
,	O
recently	O
it	O
has	O
become	B
clear	I
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
has	O
potent	O
anti	O
-	O
proliferative	O
and	O
immunomodulatory	O
actions	O
that	O
are	O
not	O
immediately	O
linked	O
to	O
its	O
role	O
as	O
a	O
skeletal	O
regulator	O
.	O

After	O
degranulation	O
,	O
mast	O
cells	O
lose	O
membrane	O
area	O
,	O
become	O
activated	O
,	O
and	O
start	O
a	O
de	O
novo	O
synthesis	O
of	O
prostaglandins	O
and	O
leukotrienes	O
from	O
membrane	O
arachidonic	O
acid	O
[	O
4	O
,	O
5	O
].	O

Our	O
primary	O
objective	O
was	O
to	O
compare	O
the	O
effects	O
of	O
RV	O
,	O
HV	O
and	O
HFol	O
pup	O
diets	O
on	O
food	O
intake	O
,	O
body	O
weight	O
,	O
glucose	O
control	O
and	O
hypothalamic	O
gene	O
expression	O
of	O
feeding	O
neuropeptides	O
in	O
offspring	O
born	O
to	O
HV	O
dams	O
with	O
offspring	O
born	O
to	O
RV	O
dams	O
and	O
weaned	O
to	O
RV	O
diet	O
.	O

1	O
pregnant	O
woman	O
from	O
2ndtrimester	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Approaches	O
to	O
prevent	O
preterm	O
birth	O
and	O
reduce	O
deaths	O
among	O
premature	O
babies	O
.	O

All	O
authors	O
have	O
interpreted	O
the	O
results	O
,	O
reviewed	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Thus	B
,	O
both	O
prenatal	O
and	O
maternal	O
variables	O
can	O
increase	O
the	O
risk	O
of	O
obesity	O
in	O
even	O
the	O
youngest	O
children	O
,	O
long	O
before	O
social	O
factors	O
have	O
an	O
influence	O
.	O

Surprisingly	O
,	O
high	O
maternal	O
seafood	O
consumption	O
,	O
of	O
the	O
type	O
known	B
to	O
be	O
contaminated	O
with	O
mercury	O
,	O
has	O
been	O
associated	O
with	O
fewer	O
–	O
not	O
more	O
–	O
autistic	O
markers	O
in	O
the	O
offspring	O
(	O
17	O
).	O

These	O
independent	O
variables	O
explained	O
23	O
%	O
of	O
the	O
variability	O
in	O
PNN50	O
index	O
(	O
R2	O
=	O
0	O
.	O
23	O
)	O
(	O
Table	O
2	O
).	O

Note	O
that	O
a	O
similar	O
pattern	O
was	O
not	O
seen	O
for	O
offspring	O
and	O
fathers	O
.	O

Multiple	O
regression	O
analyses	O
were	O
then	O
conducted	O
to	O
determine	O
the	O
most	O
robust	O
set	O
of	O
predictors	O
of	O
offspring	O
weight	O
parameters	O
after	O
adjustment	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

So	O
,	O
hyperphagia	O
could	O
be	O
a	O
compensatory	O
effect	O
after	O
prolonged	O
underweight	O
.	O

ESR	O
was	O
also	O
noted	O
to	O
be	O
lower	O
in	O
the	O
MMN	O
group	O
than	O
in	O
the	O
placebo	O
group	O
(	O
22	O
±	O
13	O
.	O
5mm	O
/	O
hr	O
versus	O
26	O
±	O
15	O
.	O
5mm	O
/	O
hr	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

The	O
effects	O
are	O
also	O
seen	O
in	O
children	O
,	O
with	O
27	O
%	O
of	O
under	O
-	O
fives	O
being	O
stunted	O
[	O
22	O
].	O

The	O
fieldworkers	O
followed	O
up	O
the	O
children	O
every	O
2	O
weeks	O
until	O
June	O
,	O
2009	O
,	O
to	O
obtain	O
background	O
information	O
,	O
assess	O
illness	O
(	O
symptom	O
history	O
and	O
examination	O
of	O
chest	O
in	O
-	O
drawing	O
,	O
body	O
temperature	O
[	O
Thermoval	O
Classic	O
Hartmann	O
digital	O
thermometer	O
],	O
signs	O
of	O
dehydration	O
by	O
skin	O
pinching	O
,	O
respiratory	O
rate	O
count	O
over	O
1	O
min	O
with	O
a	O
stopwatch	O
),	O
and	O
to	O
refer	O
to	O
the	O
study	O
hospital	O
if	O
needed	O
.	O

Implementation	O
research	O
is	O
needed	O
to	O
understand	O
the	O
most	O
efficient	O
means	O
of	O
scaling	O
up	O
evidenced	O
based	O
solutions	O
.	O

These	O
findings	O
are	O
in	O
keeping	O
with	O
another	O
study	O
that	O
found	O
the	O
highest	O
incidence	O
of	O
gestational	O
diabetes	O
in	O
pregnancies	O
with	O
winter	O
conception	O
[	O
26	O
].	O

Methods	O
This	O
work	O
studied	O
the	O
first	O
two	O
generations	O
of	O
offspring	O
(	O
F1	O
and	O
F2	O
)	O
of	O
Swiss	O
mice	O
from	O
mothers	O
fed	O
one	O
of	O
two	O
diets	O
:	O
SC	O
(	O
standard	O
chow	O
)	O
or	O
VitD	O
-	O
(	O
vitamin	O
D	O
-	O
deficient	O
).	O

Of	O
all	O
women	O
included	O
,	O
62	O
.	O
0	O
%	O
reported	O
taking	O
vitamin	O
D	O
-	O
containing	O
multivitamins	O
,	O
of	O
which	O
only	O
24	O
.	O
2	O
%	O
started	O
taking	O
those	O
before	O
pregnancy	O
.	O

Materials	O
and	O
Methods	O
2	O
.	O
1	O
.	O

Women	O
were	O
encouraged	O
to	O
set	O
achievable	O
goals	O
for	O
change	O
,	O
supported	O
to	O
make	O
these	O
lifestyle	O
changes	O
,	O
to	O
identify	O
potential	O
barriers	O
and	O
enablers	O
to	O
their	O
implementation	O
,	O
and	O
to	O
self	O
-	O
monitor	O
their	O
progress	O
[	O
21	O
,	O
22	O
].	O

From	O
a	O
public	O
health	O
perspective	O
,	O
this	O
is	O
crucially	O
important	O
,	O
and	O
should	O
motivate	O
more	O
effective	O
implementation	O
of	O
nutritional	O
educational	O
programmes	O
for	O
women	O
of	O
childbearing	O
age	O
.	O

study	O
which	O
showed	O
that	O
“	O
health	O
conscious	O
”	O
dietary	O
patterns	O
were	O
negatively	O
associated	O
with	O
decreasing	O
educational	O
level	O
,	O
age	O
,	O
and	O
socioeconomic	O
status	O
[	O
21	O
].	O

Among	O
the	O
regulators	O
that	O
may	O
link	O
the	O
maternal	O
diet	O
during	O
gestation	O
with	O
the	O
metabolic	O
outcome	O
of	O
the	O
offspring	O
,	O
leptin	O
is	O
one	O
of	O
the	O
main	O
candidates	O
.	O

Structured	O
questionnaires	O
for	O
health	O
workers	O
at	O
district	O
,	O
commune	O
and	O
village	O
level	O
were	O
used	O
to	O
collect	O
ongoing	O
distribution	O
and	O
monitoring	O
costs	O
,	O
and	O
for	O
participants	O
to	O
collect	O
transport	O
and	O
loss	O
of	O
earnings	O
costs	O
.	O

After	O
PSM	O
,	O
we	O
evaluated	O
these	O
variables	O
for	O
significant	O
differences	O
between	O
the	O
vaccination	O
status	O
groups	O
in	O
order	O
to	O
know	O
how	O
well	O
matching	O
occurred	O
.	O

PFHXS	O
exhibited	O
the	O
largest	O
association	O
in	O
the	O
BHLM	O
with	O
a	O
10	O
-	O
fold	O
exposure	O
increase	O
associated	O
with	O
a	O
17	O
g	O
birth	O
weight	O
decrease	O
,	O
whereas	O
PFNA	O
was	O
the	O
weakest	O
predictor	O
of	O
birth	O
weight	O
.	O

The	O
participants	O
were	O
divided	O
in	O
to	O
two	O
subgroups	O
,	O
the	O
nulliparous	O
and	O
multiparous	O
subgroups	O
and	O
data	O
was	O
analyzed	O
once	O
more	O
.	O

Under	O
certain	O
conditions	O
,	O
another	O
type	O
of	O
adipocytes	O
,	O
named	O
brite	O
or	O
beige	O
cells	O
,	O
can	O
be	O
found	O
dispersed	O
within	O
some	O
of	O
the	O
WAT	O
depots	O
.	O

A	O
Comparative	O
Study	O
of	O
25	O
(	O
OH	O
)	O
Vitamin	O
D	O
Serum	O
Levels	O
in	O
Patients	O
with	O
Multiple	O
Sclerosis	O
and	O
Control	O
Group	O
in	O
Isfahan	O
,	O
Iran	O
Abstract	O
Objectives	O
:	O
There	O
is	O
no	O
study	O
about	O
correlation	O
between	O
vitamin	O
D	O
serum	O
level	O
and	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
in	O
Iran	O
.	O

These	O
animals	O
were	O
from	O
four	O
separate	O
litters	O
per	O
experimental	O
group	O
.	O

1	O
Posterior	O
95	O
%	O
CIs	O
of	O
BHLM	O
regression	O
coefficients	O
,	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
n	O
=	O
272	O
,	O
Cincinnati	O
,	O
OH	O
Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

There	O
is	O
evidence	O
that	O
angiotensin	O
II	O
inhibits	O
parasympathetic	O
modulation	O
[	O
51	O
].	O

High	O
fat	O
perinatal	O
nutrition	O
advanced	O
the	O
age	O
at	O
puberty	O
to	O
the	O
same	O
degree	O
as	O
did	O
post	O
-	O
weaning	O
high	O
fat	O
nutrition	O
in	O
control	O
offspring	O
,	O
and	O
intriguingly	O
the	O
addition	O
of	O
a	O
high	O
fat	O
postnatal	O
diet	O
following	O
high	O
fat	O
prenatal	O
nutrition	O
had	O
no	O
further	O
effect	O
on	O
pubertal	O
age	O
.	O

That	O
is	O
,	O
analyses	O
were	O
conducted	O
assuming	O
that	O
missing	O
values	O
had	O
,	O
firstly	O
,	O
a	O
substantially	O
greater	O
incidence	O
,	O
and	O
secondly	O
,	O
a	O
substantially	O
reduced	O
incidence	O
of	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
as	O
compared	O
with	O
the	O
observed	O
data	O
.	O

Proliferative	O
potential	O
is	O
lower	O
in	O
intramuscular	O
preadipocytes	O
than	O
in	O
subcutaneous	O
preadipocytes	O
[	O
97	O
].	O

Clients	O
with	O
a	O
high	O
educational	O
level	O
,	O
were	O
less	O
satisfied	O
with	O
the	O
health	O
talks	O
.	O

Birth	O
size	O
measures	O
were	O
transformed	O
into	O
SDS	O
by	O
using	O
Finnish	O
sex	O
-	O
specific	O
normative	O
data	O
for	O
fetal	O
growth	O
[	O
20	O
].	O

It	O
is	O
the	O
complex	O
interaction	O
among	O
our	O
genome	O
,	O
epigenome	O
and	O
environment	O
that	O
shapes	O
our	O
development	O
into	O
unique	O
individuals	O
,	O
and	O
thus	B
influences	O
our	O
health	O
and	O
potentially	O
the	O
health	O
of	O
our	O
future	O
offspring	O
.	O

Ten	O
thousand	O
permutations	O
were	O
used	O
,	O
and	O
a	O
hypothesized	O
association	O
was	O
considered	O
significant	O
at	O
the	O
p	O
≤	O
0	O
.	O
05	O
level	O
.	O

Identifications	O
were	O
based	O
on	O
the	O
observed	O
pI	O
and	O
Mr	O
(	O
kDa	O
)	O
of	O
the	O
matched	O
protein	O
,	O
the	O
number	O
of	O
matching	O
peptide	O
masses	O
and	O
the	O
total	O
percentage	O
of	O
the	O
amino	O
acid	O
sequence	O
that	O
those	O
peptides	O
covered	O
,	O
in	O
comparison	O
to	O
other	O
database	O
entries	O
.	O

Several	O
tests	O
,	O
including	O
the	O
analysis	O
of	O
tidal	O
breathing	O
,	O
mechanics	O
of	O
respiratory	O
system	O
,	O
flow	O
-	O
volume	O
curves	O
of	O
forced	O
expiration	O
,	O
and	O
measurement	O
of	O
lung	O
volume	O
,	O
were	O
used	O
to	O
evaluate	O
respiratory	O
function	O
.	O

Ninety	O
-	O
seven	O
percent	O
(	O
3172	O
)	O
reported	O
having	O
at	O
least	O
one	O
antenatal	O
visit	O
during	O
pregnancy	O
,	O
78	O
%	O
(	O
2549	O
)	O
reported	O
four	O
or	O
more	O
antenatal	O
visits	O
,	O
and	O
91	O
%	O
(	O
2984	O
)	O
reported	O
having	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine	O
;	O
all	O
of	O
these	O
antenatal	O
care	O
indicators	O
were	O
significantly	O
more	B
common	I
among	O
vaccinated	O
compared	O
to	O
unvaccinated	O
women	O
.	O

Methods	O
Using	O
data	O
from	O
the	O
Health	O
Outcomes	O
and	O
Measures	O
of	O
Environment	O
(	O
HOME	O
)	O
Study	O
,	O
we	O
examined	O
272	O
pregnant	O
women	O
enrolled	O
between	O
2003	O
-	O
2006	O
.	O

Humans	O
also	O
evolved	O
to	O
adapt	O
to	O
environmental	O
daily	O
and	O
seasonal	O
changes	O
,	O
with	O
a	O
central	O
biological	O
clock	O
located	O
in	O
the	O
suprachiasmatic	O
nucleus	O
of	O
the	O
hypothalamus	O
,	O
responsible	O
for	O
timing	O
of	O
metabolism	O
,	O
physiology	O
and	O
behaviours	O
[	O
17	O
].	O

All	O
of	O
them	O
were	O
residents	O
of	O
Isfahan	O
with	O
the	O
age	O
of	O
15	O
to	O
55	O
years	O
.	O

The	O
intake	O
of	O
individual	O
seafood	O
items	O
was	O
grouped	O
into	O
four	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
1	O
time	O
per	O
week	O
and	O
2	O
times	O
per	O
week	O
or	O
more	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

The	O
study	O
inclusion	O
criteria	O
were	O
age	O
18	O
-	O
40	O
years	O
,	O
singleton	O
pregnancy	O
,	O
no	O
systemic	O
diseases	O
such	O
as	O
lupus	O
and	O
diabetes	O
mellitus	O
,	O
and	O
Iranian	O
nationality	O
.	O

BAT	O
transplantation	O
also	O
increased	O
insulin	O
-	O
stimulated	O
glucose	O
uptake	O
in	O
BAT	O
,	O
WAT	O
,	O
and	O
heart	O
,	O
but	O
not	O
in	O
skeletal	O
muscle	O
(	O
Stanford	O
et	O
al	O
.,	O
2013	O
).	O

First	O
,	O
our	O
determination	O
of	O
maternal	O
sleep	O
duration	O
and	O
snoring	O
was	O
based	O
on	O
reports	O
made	O
early	O
during	O
pregnancy	O
,	O
so	O
reporting	O
was	O
not	O
conditional	O
on	O
pregnancy	O
outcomes	O
or	O
on	O
signs	O
and	O
symptoms	O
of	O
GDM	O
.	O

These	O
works	O
of	O
literature	O
were	O
obtained	O
from	O
the	O
commonly	O
used	O
medical	O
databases	O
such	O
as	O
PubMed	O
(	O
Medline	O
),	O
AJOL	O
,	O
and	O
Google	O
Scholar	O
;	O
in	O
addition	O
,	O
Cochrane	O
Library	O
was	O
used	O
as	O
source	O
for	O
systematic	O
reviews	O
on	O
the	O
subject	O
matter	O
.	O

It	O
is	O
entirely	O
plausible	O
that	O
this	O
is	O
biologically	O
mediated	O
,	O
and	O
not	O
purely	O
environmental	O
,	O
as	B
we	O
posit	B
,	O
and	O
was	O
also	O
reported	O
in	O
the	O
Overkalix	O
study	O
.	O
1718	O
In	O
a	O
meta	O
-	O
analysis	O
of	O
26	O
family	O
studies	O
,	O
5BMI	O
heritability	O
estimates	O
ranging	O
from	O
0	O
.	O
24	O
to	O
0	O
.	O
81	O
were	O
reported	O
.	O

The	O
vast	O
majority	O
of	O
participants	O
were	O
enlisted	O
service	O
members	O
or	O
a	O
dependent	O
family	O
member	O
of	O
an	O
enlisted	O
service	O
member	O
(	O
86	O
.	O
8	O
%,	O
819	O
/	O
943	O
)	O
and	O
all	O
but	O
4	O
of	O
the	O
remainder	O
were	O
commissioned	O
or	O
warrant	O
officers	O
(	O
14	O
.	O
2	O
%,	O
120	O
/	O
943	O
).	O

The	O
search	O
generated	O
27	O
related	O
articles	O
in	O
the	O
following	O
categories	O
:	O
prevalence	O
—	O
2	O
,	O
treatments	O
—	O
8	O
,	O
reviews	O
—	O
6	O
,	O
interventions	O
/	O
trials	O
—	O
6	O
,	O
dosage	O
—	O
1	O
,	O
and	O
technical	O
reports	O
—	O
4	O
.	O

Early	O
life	O
nutrition	O
,	O
the	O
developing	O
immune	O
system	O
and	O
subsequent	O
allergic	O
manifestations	O
Over	O
the	O
last	O
half	O
-	O
century	O
,	O
chronic	O
disease	O
incidence	O
,	O
including	O
allergic	O
manifestations	O
(	O
AM	O
),	O
has	O
increased	O
exponentially	O
in	O
developed	O
nations	O
and	O
amongst	O
the	O
wealthy	O
in	O
developing	O
nations	O
.	O

The	O
cRNA	O
was	O
fragmented	O
(≈	O
100	O
bp	O
)	O
and	O
hybridised	O
on	O
Affymetrix	O
GeneChip	O
®	O
porcine	O
Genome	O
Array	O
.	O

Due	O
to	O
the	O
risks	O
associated	O
with	O
consuming	O
fish	O
and	O
seafood	O
during	O
pregnancy	O
related	O
to	O
food	O
safety	O
and	O
heavy	O
metal	O
contamination	O
,	O
pregnant	O
women	O
may	O
question	O
the	O
necessity	O
of	O
including	O
these	O
foods	O
in	O
their	O
diets	O
,	O
when	O
nutrition	O
supplements	O
are	O
readily	O
accessible	O
in	O
Western	O
countries	O
[	O
32	O
].	O

This	O
highlights	O
the	O
importance	O
of	O
prenatal	O
care	O
,	O
both	O
in	O
terms	O
of	O
frequency	O
and	O
content	O
,	O
in	O
improving	O
adherence	O
to	O
programs	O
to	O
prevent	O
anaemia	O
.	O

Using	O
a	O
nail	O
splitter	O
,	O
the	O
nail	O
plate	O
was	O
vertically	O
cut	O
and	O
reflected	O
proximally	O
to	O
completely	O
visualize	O
the	O
lesion	O
.	O

Discussion	O
In	O
this	O
study	O
we	O
examined	O
the	O
relationship	O
between	O
gestational	O
exposure	O
to	O
53	O
different	O
EDCs	O
and	O
birth	O
weight	O
in	O
a	O
prospective	O
birth	O
cohort	O
of	O
mother	O
-	O
infant	O
pairs	O
.	O

Thus	O
,	O
genes	O
and	O
pathways	O
identified	O
as	O
regulated	O
in	O
one	O
offspring	O
group	O
were	O
either	O
unregulated	O
or	O
showed	O
an	O
opposite	O
direction	O
of	O
regulation	O
in	O
the	O
corresponding	O
ontogenetic	O
period	O
within	O
the	O
other	O
dietary	O
group	O
.	O

The	O
potential	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
to	O
influence	O
inception	O
of	O
offspring	O
allergic	O
airways	O
disease	O
through	O
this	O
mechanism	O
was	O
recently	O
confirmed	O
in	O
a	O
mouse	O
model	O
[	O
42	O
].	O

Research	O
assistants	O
used	O
Harpenden	O
skin	O
-	O
fold	O
callipers	O
to	O
obtain	O
skinfold	O
thickness	O
measurements	O
,	O
and	O
received	O
ongoing	O
standardised	O
training	O
[	O
29	O
].	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Briefly	O
,	O
0	O
.	O
04	O
g	O
–	O
0	O
.	O
07	O
g	O
of	O
crude	O
fresh	O
frozen	O
NAc	O
tissue	O
was	O
placed	O
in	O
Buffer	O
1	O
(	O
7M	O
Urea	O
,	O
2M	O
Thiourea	O
,	O
1	O
%	O
C7bZO	O
,	O
40	O
mM	O
Tris	O
).	O

However	O
,	O
it	O
is	O
unclear	O
if	O
less	O
intensive	O
interventions	O
can	O
be	O
effective	O
in	O
this	O
population	O
.	O

In	O
Utero	O
Exposures	O
,	O
Infant	O
Growth	O
,	O
and	O
DNA	O
Methylation	O
of	O
Repetitive	O
Elements	O
and	O
Developmentally	O
Related	O
Genes	O
in	O
Human	O
Placenta	O
Abstract	O
Background	O
:	O
Fetal	O
programming	O
describes	O
the	O
theory	O
linking	O
environmental	O
conditions	O
during	O
embryonic	O
and	O
fetal	O
development	O
with	O
risk	O
of	O
diseases	O
later	O
in	O
life	O
.	O

Interpretation	O
of	O
the	O
findings	O
with	O
respect	O
to	O
mechanistic	O
connections	O
between	O
environmental	O
factors	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
effects	O
in	O
the	O
target	O
organ	O
/	O
tissue	O
can	O
therefore	B
be	O
challenging	O
.	O

Identifying	O
caries	O
-	O
free	O
controls	O
living	O
in	O
these	O
same	O
communities	O
proved	B
challenging	O
.	O

In	O
bulls	O
of	O
two	O
Portuguese	O
breeds	O
(	O
Alentejana	O
and	O
Barrosã	O
),	O
the	O
effects	O
of	O
high	O
(	O
70	O
%	O
concentrate	O
30	O
%	O
maize	O
silage	O
)	O
and	O
low	O
isoenergetic	O
and	O
isonitrogenous	O
concentrates	O
(	O
30	O
%	O
concentrate	O
70	O
%	O
maize	O
silage	O
)	O
on	O
IMF	O
contents	O
were	O
examined	O
in	O
the	O
longissimus	O
lumborum	O
and	O
the	O
semitendinosus	O
muscles	O
[	O
119	O
].	O

Methods	O
Survey	O
Sample	O
size	O
calculation	O
Sample	O
size	O
planning	O
was	O
informed	O
by	O
calculating	O
sample	O
needs	O
in	O
order	O
to	O
detect	O
a	O
40	O
%	O
reduction	O
of	O
low	O
birth	O
weight	O
among	O
newborns	O
of	O
vaccinated	O
(	O
regardless	O
of	O
vaccination	O
trimester	O
)	O
compared	O
to	O
unvaccinated	O
mothers	O
[	O
20	O
],[	O
21	O
],	O
assuming	O
a	O
two	O
-	O
sided	O
95	O
%	O
confidence	O
level	O
,	O
80	O
%	O
power	O
,	O
and	O
a	O
ratio	O
of	O
unvaccinated	O
to	O
vaccinated	O
of	O
2	O
:	O
5	O
[	O
33	O
].	O

Mice	O
were	O
housed	O
at	O
the	O
McGill	O
University	O
Life	O
Sciences	O
Centre	O
Animal	O
Facility	O
in	O
accordance	O
with	O
the	O
guidelines	O
specified	O
by	O
the	O
Canadian	O
Council	O
on	O
Animal	O
Care	O
.	O

Two	O
infants	O
with	O
a	O
congenital	O
disease	O
(	O
Down	O
syndrome	O
and	O
Rieger	O
syndrome	O
)	O
were	O
excluded	O
.	O

At	O
6	O
months	O
of	O
age	O
,	O
F1	O
-	O
VitD	O
-	O
mice	O
exhibited	O
more	O
glomeruli	O
,	O
while	O
F2	O
-	O
VitD	O
-	O
mice	O
exhibited	O
the	O
same	O
number	O
of	O
glomeruli	O
as	O
F2	O
-	O
SC	O
mice	O
,	O
but	O
fewer	O
glomeruli	O
compared	O
to	O
the	O
F1	O
-	O
VitD	O
group	O
.	O

Postnatal	O
assessments	O
focus	O
mainly	O
on	O
offspring	O
health	O
and	O
development	O
at	O
6	O
weeks	O
,	O
6	O
months	O
,	O
7	O
.	O
5	O
months	O
(	O
6	O
months	O
+	O
6	O
weeks	O
)	O
and	O
12	O
months	O
’	O
postnatal	O
age	O
.	O

,	O
2005	O
[	O
19	O
]	O
Hibbeln	O
et	O
al	O
.	O

However	O
,	O
the	O
exposed	O
group	O
did	O
have	O
a	O
significantly	O
increased	O
rate	O
of	O
LGA	O
neonates	O
.	O

Besides	O
,	O
P	O
-	O
values	O
<	O
0	O
.	O
05	O
were	O
considered	O
as	O
statistically	O
significant	O
.	O

NPR	O
-	O
C	O
acts	O
as	O
a	O
clearance	O
receptor	O
for	O
these	O
peptides	O
through	O
an	O
endocytic	O
mechanism	O
that	O
involves	O
recycling	O
of	O
the	O
receptor	O
at	O
the	O
cellular	O
membrane	O
(	O
Rubattu	O
et	O
al	O
.	O

Results	O
The	O
two	O
groups	O
were	O
similar	O
in	O
relation	O
to	O
baseline	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Although	O
hyperglycemia	O
usually	O
resolves	O
with	O
the	O
conclusion	O
of	O
the	O
pregnancy	O
,	O
women	O
who	O
have	O
had	O
GDM	O
are	O
at	O
high	O
risk	O
of	O
developing	O
diabetes	O
later	O
in	O
life	O
.	O

We	O
therefore	B
undertook	O
this	O
study	O
to	O
determine	O
whether	O
SNPs	O
within	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
known	O
to	O
modify	O
vitamin	O
D	O
status	O
are	O
also	O
associated	O
with	O
the	O
response	O
to	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

From	O
third	O
day	O
of	O
pregnancy	O
to	O
term	O
,	O
dams	O
(	O
n	O
=	O
10	O
per	O
gestational	O
diet	O
group	O
)	O
were	O
fed	O
the	O
AIN	O
-	O
93G	O
diet13containing	O
either	O
the	O
RV	O
or	O
HV	O
amount	O
of	O
the	O
multivitamin	O
mix	O
.	O

In	O
conclusion	O
,	O
vitamin	O
D	O
deficiency	O
is	O
highly	O
prevalent	O
among	O
pregnant	O
women	O
in	O
Belgium	O
and	O
this	O
raises	O
concerns	O
about	O
the	O
health	O
consequences	O
for	O
the	O
mother	O
and	O
the	O
offspring	O
.	O

While	O
neither	O
PCBs	O
nor	O
DDE	O
were	O
associated	O
with	O
a	O
discernible	O
difference	O
in	O
how	O
much	O
weight	O
the	O
infant	O
gained	O
or	O
the	O
number	O
of	O
doctor	O
visits	O
for	O
illnesses	O
in	O
the	O
first	O
year	O
of	O
life	O
,	O
the	O
researchers	O
did	O
note	O
one	O
surprising	O
result	O
:	O
The	O
median	O
duration	O
of	O
breastfeeding	O
was	O
shorter	O
in	O
mothers	O
with	O
higher	O
estimated	O
levels	O
of	O
DDE	O
in	O
their	O
milk	O
compared	O
with	O
mothers	O
who	O
had	O
lower	O
levels	O
,	O
an	O
association	O
that	O
was	O
not	O
seen	O
with	O
PCBs	O
.	O

In	O
2007	O
,	O
the	O
Registered	O
Nurses	O
'	O
Association	O
of	O
Ontario	O
set	O
forth	O
school	O
policies	O
that	O
would	O
prevent	O
childhood	O
obesity	O
;	O
these	O
policies	O
included	O
promoting	O
physical	O
education	O
classes	O
for	O
all	O
students	O
,	O
requiring	O
physical	O
education	O
specialists	O
to	O
be	O
involved	O
in	O
physical	O
education	O
classes	O
,	O
selling	O
healthy	O
foods	O
in	O
cafeterias	O
and	O
vending	O
machines	O
,	O
and	O
promoting	O
walking	O
or	O
biking	O
to	O
and	O
from	O
school	O
(	O
95	O
).	O

There	O
is	O
a	O
need	O
to	O
understand	O
optimal	O
levels	O
of	O
dosage	O
and	O
other	O
factors	O
that	O
affect	O
mHealth	O
intervention	O
outcomes	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
hypothesized	O
that	O
prenatal	O
vitamin	O
D	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
schizophrenia	O
,	O
supported	O
by	O
the	O
role	O
of	O
this	O
vitamin	O
in	O
cell	O
growth	O
and	O
differentiation	O
,	O
the	O
excess	O
of	O
winter	O
births	O
in	O
schizophrenia	O
(	O
a	O
period	O
when	O
vitamin	O
D	O
levels	O
are	O
low	O
),	O
and	O
increased	O
births	O
of	O
pre	O
-	O
schizophrenic	O
subjects	O
in	O
urban	O
areas	O
,	O
where	O
vitamin	O
D	O
deficiency	O
is	O
higher	O
[	O
12	O
,	O
18	O
].	O

Black	O
and	O
Hispanic	O
children	O
also	O
had	O
significantly	O
different	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
(	O
p	O
=	O
0	O
.	O
023	O
).	O

An	O
information	O
sheet	O
in	O
English	O
was	O
provided	O
for	O
women	O
to	O
take	O
away	O
.	O

Maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
and	O
childhood	O
respiratory	O
and	O
atopic	O
outcomes	O
Abstract	O
The	O
possible	O
role	O
of	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
in	O
the	O
inception	O
of	O
respiratory	O
and	O
atopic	O
diseases	O
has	O
not	O
been	O
studied	O
.	O

The	O
appropriate	O
age	O
for	O
,	O
and	O
duration	O
of	O
,	O
vitamin	O
A	O
deple	O
tion	O
or	O
supplementation	O
have	O
been	O
suggested	O
as	O
important	O
factors	O
that	O
affect	O
MS	O
.	O
Oka	O
et	O
al	O
[	O
134	O
]	O
reported	O
that	O
restricting	O
vitamin	O
A	O
in	O
15	O
-	O
month	O
-	O
old	O
cattle	O
until	O
the	O
final	O
finishing	O
phase	O
(	O
29	O
months	O
of	O
age	O
)	O
increased	O
MS	O
,	O
but	O
not	O
in	O
23	O
-	O
month	O
-	O
old	O
cattle	O
prior	O
to	O
finishing	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
using	O
the	O
PITA	O
algorithm	O
.	O

,	O
2007	O
[	O
20	O
]	O
Gale	O
et	O
al	O
.	O

When	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
models	O
,	O
no	O
significant	O
relationship	O
between	O
any	O
of	O
the	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
and	O
cathelicidin	O
was	O
found	O
.	O

In	O
contrast	O
,	O
male	O
offspring	O
from	O
the	O
HV	O
dams	O
weaned	O
to	O
either	O
the	O
HFol	O
or	O
HV	O
pup	O
diet	O
did	O
not	O
differ	O
in	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
glucose	O
response	O
compared	O
to	O
those	O
from	O
the	O
RV	O
dams	O
(	O
Figure	O
2	O
,	O
3	O
,	O
4	O
).	O

Simple	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
univariate	O
associations	O
between	O
metabolic	O
markers	O
,	O
25OHD	O
,	O
and	O
early	O
-	O
pregnancy	O
season	O
.	O

Together	O
with	O
the	O
observation	O
that	O
the	O
offspring	O
of	O
both	O
groups	O
did	O
not	O
differ	O
in	O
body	O
weight	O
but	O
in	O
body	O
composition	O
and	O
fat	O
content	O
,	O
the	O
data	O
indicate	O
that	O
the	O
activity	O
of	O
various	O
genes	O
led	O
to	O
diverse	O
partitioning	O
of	O
nutrients	O
among	O
peripheral	O
and	O
visceral	O
organs	O
and	O
tissues	O
.	O

Studies	O
have	O
indicated	O
that	O
during	O
pregnancy	O
vitamin	O
D	O
deficiency	O
varies	O
from	O
18	O
%	O
to	O
84	O
%,	O
which	O
varies	O
with	O
the	O
region	O
under	O
the	O
study	O
and	O
type	O
of	O
clothing	O
.	O
2	O
,	O
3Vitamin	O
D	O
deficiency	O
among	O
breast	O
-	O
fed	O
children	O
in	O
the	O
regions	O
with	O
heavy	O
sunshine	O
such	O
as	O
the	O
Middle	O
East	O
is	O
high	O
.	O
3	O
-	O
5This	O
hypovitaminosis	O
which	O
is	O
due	B
to	I
limited	O
exposure	O
to	O
sun	O
of	O
mothers	O
’	O
and	O
their	O
babies	O
as	O
well	O
as	O
low	O
vitamin	O
D	O
intake	O
by	O
mothers	O
.	O

In	O
this	O
regard	O
,	O
intrauterine	O
growth	O
should	O
be	O
identified	O
on	O
the	O
basis	O
of	O
measures	O
of	O
fetal	O
growth	O
patterns	O
,	O
rather	O
than	O
birth	O
weight	O
[	O
30	O
].	O

have	O
shown	O
that	O
placental	O
GR	O
-	O
P	O
mRNA	O
levels	O
were	O
reduced	O
significantly	O
after	O
spontaneous	O
labor	O
[	O
20	O
].	O

Therefore	B
,	O
fat	O
degradation	O
by	O
lipolysis	O
should	O
be	O
minimized	O
to	O
prevent	O
loss	O
of	O
IMF	O
,	O
and	O
management	O
and	O
transport	O
systems	O
that	O
minimize	O
stress	O
are	O
needed	O
.	O

Reported	O
sleep	O
duration	O
is	O
known	O
to	O
be	O
only	O
moderately	O
correlated	O
with	O
wrist	O
actigraph	O
-	O
measured	O
sleep	O
duration	O
(	O
ρ	O
=	O
0	O
.	O
47	O
),	O
and	O
reports	O
are	O
generally	B
longer	O
by	O
approximately	O
34	O
minutes	O
for	O
each	O
hour	O
of	O
objectively	O
measured	O
sleep	O
[	O
39	O
].	O

Accelerating	O
evidence	O
-	O
based	O
action	O
for	O
prevention	O
and	O
care	O
Addressing	O
the	O
burden	O
of	O
preterm	O
birth	O
has	O
a	O
dual	O
track	O
--	O
prevention	O
and	O
care	O
(	O
Figure1	O
).	O

The	O
results	O
from	O
infant	O
gut	O
microbiome	O
cluster	O
analyses	O
are	O
consistent	O
with	O
this	O
observation	O
.	O

The	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
was	O
used	O
to	O
evaluate	O
depression	O
scores	O
.	O

reported	O
an	O
inverse	O
correlation	O
between	O
prenatal	O
vitamin	O
D	O
intake	O
and	O
recurrent	O
wheezing	O
of	O
offspring	O
[	O
5	O
].	O

We	O
,	O
therefore	B
,	O
wanted	O
to	O
examine	O
both	O
the	O
potential	O
public	O
health	O
concerns	O
and	O
the	O
resulting	O
regulatory	O
implications	O
of	O
such	O
toxicity	O
.	O

in	O
taxonomy	O
labels	O
indicate	O
that	O
the	O
level	O
of	O
taxonomy	O
is	O
family	O
,	O
genus	O
,	O
or	O
species	O
Discussion	O
We	O
observed	O
differences	O
in	O
both	O
overall	O
infant	O
gut	O
microbial	O
community	O
structure	O
and	O
specific	O
microbes	O
in	O
relation	O
to	O
maternal	O
dietary	O
factors	O
,	O
often	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
pattern	O
.	O

A	O
number	O
of	O
reporter	O
mouse	O
models	O
,	O
including	O
the	O
Agouti	O
Avy	O
,	O
CabpIAP	O
and	O
AuxinFu	O
,	O
have	O
also	O
been	O
used	O
to	O
investigate	O
environmentally	O
induced	O
epigenetic	O
changes	O
in	O
in	O
vivo	O
exploratory	O
research	O
(	O
Dolinoy	O
et	O
al	O
.	O
2007	O
;	O
Waterland	O
et	O
al	O
.	O
2006	O
;	O
Rosenfeld2010	O
).	O

The	O
spicules	O
of	O
bone	O
contained	O
osteocytes	O
and	O
were	O
lined	O
by	O
benign	O
-	O
appearing	O
osteoblasts	O
(	O
Fig	O
3	O
).	O

The	O
mortality	O
rate	O
in	O
our	O
study	O
cohort	O
was	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
95	O
%	O
CI	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
):	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
;	O
ten	O
cases	O
)	O
in	O
our	O
vitamin	O
D	O
group	O
and	O
3	O
·	O
4	O
per	O
1000	O
child	O
years	O
(	O
1	O
·	O
3	O
–	O
7	O
·	O
1	O
;	O
seven	O
cases	O
)	O
in	O
our	O
placebo	O
group	O
.	O

Although	O
peripheral	O
ossifying	O
fibroma	O
exhibits	O
features	O
of	O
vascular	O
proliferation	O
and	O
ossification	O
,	O
it	O
mostly	O
contains	O
fibroblasts	O
and	O
stroma	O
.	O

Restricted	O
fetal	O
growth	O
is	O
one	B
of	I
the	I
most	I
important	O
global	O
public	O
health	O
problems	O
which	O
provides	O
a	O
foundation	O
for	O
developing	O
chronic	O
diseases	O
throughout	O
their	O
life	O
[	O
2	O
].	O

Based	O
on	O
aggregated	O
evidence	O
from	O
animal	O
and	O
human	O
studies	O
,	O
Witter	O
et	O
al	O
.	O

Maternal	O
serum	O
T1	O
and	O
T3	O
samples	O
were	O
analysed	O
in	O
sequence	O
.	O

Characteristics	O
of	O
the	O
women	O
in	O
the	O
two	O
treatment	O
arms	O
were	O
compared	O
using	O
the	O
t	O
test	O
,	O
Mann	O
-	O
Whitney	O
U	O
test	O
,	O
and	O
χ2test	O
for	O
normally	O
distributed	O
,	O
nonnormally	O
distributed	O
,	O
and	O
categorical	O
variables	O
,	O
respectively	O
.	O

Primiparous	O
and	O
secundiparous	O
women	O
were	O
predominant	O
(	O
49	O
.	O
5	O
%	O
and	O
32	O
.	O
3	O
%,	O
respectively	O
);	O
10	O
.	O
0	O
%	O
of	O
women	O
declared	O
that	O
the	O
pregnancy	O
was	O
unwanted	O
(	O
Table	O
1	O
).	O

The	O
Cincinnati	O
Children	O
’	O
s	O
Hospital	O
Medical	O
Center	O
(	O
CCHMC	O
)	O
and	O
participating	O
delivery	O
hospitals	O
’	O
Institutional	O
Review	O
Boards	O
(	O
IRB	O
)	O
approved	O
the	O
HOME	O
Study	O
.	O

Presented	O
as	O
percentage	O
of	O
children	O
in	O
the	O
lowest	O
quartile	O
for	O
WISC	O
-	O
III	O
and	O
ALSPAC	O
development	O
test	O
subscales	O
or	O
in	O
the	O
suboptimum	O
range	O
of	O
behavioural	O
scores	O
for	O
the	O
SDQ	O
.	O

For	O
example	O
,	O
certain	O
metals	O
and	O
environmental	O
chemicals	O
can	O
directly	O
bind	O
and	O
alter	O
the	O
activity	O
of	O
DNMTs	O
,	O
TETs	O
and	O
histone	O
modifiers	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Wang	O
&	O
Wang2013	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

This	O
experiment	O
was	O
conducted	O
over	O
8	O
replicates	O
and	O
offspring	O
of	O
a	O
subset	O
of	O
4	O
sows	O
(	O
2	O
per	O
diet	O
per	O
replicate	O
)	O
with	O
a	O
minimum	O
of	O
11	O
live	O
born	O
piglets	O
(	O
median	O
litter	O
size	O
=	O
13	O
)	O
were	O
used	O
.	O

PubMed	O
Central	O
:	O

The	O
observed	O
transcriptional	O
postnatal	O
regulations	O
were	O
delayed	O
long	O
-	O
term	O
effects	O
of	O
the	O
prenatal	O
nutritional	O
supply	O
.	O

The	O
mean	O
serum	O
cord	O
25	O
(	O
OH	O
)	O
D	O
values	O
for	O
each	O
group	O
were	O
22	O
.	O
3	O
±	O
9	O
.	O
4	O
ng	O
/	O
mL	O
for	O
Caucasian	O
and	O
16	O
.	O
4	O
±	O
6	O
.	O
5	O
ng	O
/	O
mL	O
for	O
Hispanic	O
infants	O
(	O
p	O
=	O
0	O
.	O
013	O
for	O
difference	O
).	O

Epidemiologic	O
evidence	O
in	O
support	O
of	O
a	O
viral	O
or	O
pathogenic	O
etiology	O
for	O
adult	O
brain	O
tumors	O
remains	O
controversial	O
and	O
the	O
windows	O
of	O
interest	O
of	O
these	O
studies	O
have	O
been	O
outside	O
the	O
perinatal	O
period	O
.	O

While	O
maternal	O
age	O
is	O
also	O
a	O
known	O
risk	O
factor	O
,	O
it	O
was	O
not	O
associated	O
with	O
PTB	O
in	O
univariate	O
analysis	O
within	O
this	O
cohort	O
(	O
p	O
=	O
0	O
.	O
87	O
).	O

Plasma	O
concentrations	O
of	O
insulin	O
were	O
determined	O
by	O
the	O
Human	O
Endocrine	O
Panel	O
.	O

A	O
new	O
generation	O
begins	O
with	O
the	O
fusion	O
of	O
the	O
male	O
(	O
spermatozoa	O
)	O
and	O
female	O
(	O
oocyte	O
)	O
gametes	O
(	O
fertilization	O
)	O
to	O
produce	O
a	O
single	O
cell	O
(	O
zygote	O
)	O
containing	O
one	O
haploid	O
female	O
pronucleus	O
and	O
one	O
haploid	O
male	O
pronucleus	O
.	O

CT	O
revealed	O
a	O
Stanford	O
type	O
A	O
aortic	O
dissection	O
involving	O
the	O
ascending	O
and	O
descending	O
aorta	O
.	O

Serum	O
vitamin	O
D3	O
level	O
was	O
found	O
to	O
be	O
low	O
(	O
4	O
.	O
7	O
ng	O
/	O
ml	O
).	O

Height	O
was	O
measured	O
by	O
trained	O
research	O
staff	O
using	O
a	O
stadiometer	O
at	O
study	O
entry	O
and	O
was	O
used	O
with	O
pregravid	O
weight	O
to	O
calculate	O
BMI	O
.	O

Neonatal	O
deaths	O
accounted	O
for	O
46	O
%	O
of	O
all	O
under	O
-	O
five	O
deaths	O
in	O
2016	O
compared	O
with	O
37	O
·	O
4	O
%	O
in	O
1990	O
[	O
1	O
,	O
2	O
].	O

Measurement	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
Non	O
-	O
fasting	O
whole	O
peripheral	O
blood	O
samples	O
were	O
collected	O
into	O
non	O
-	O
heparinised	O
tubes	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
.	O

Increasing	O
evidence	O
regarding	O
the	O
role	O
of	O
healthy	O
intestinal	O
,	O
skin	O
,	O
and	O
mucosal	O
microbiota	O
affirms	B
that	O
most	O
organisms	O
transmitted	O
from	O
mothers	O
to	O
neonates	O
are	O
not	O
pathogenic	O
.	O

We	O
tested	O
the	O
contribution	O
of	O
maternal	O
dietary	O
measures	O
(	O
as	O
continuous	O
variables	O
)	O
to	O
the	O
infant	O
microbiome	O
at	O
6	O
weeks	O
using	O
the	O
adonis	O
function	O
in	O
the	O
R	O
package	O
vegan	O
[	O
45	O
]	O
with	O
10	O
,	O
000	O
permutations	O
.	O

Patients	O
should	O
have	O
easy	O
access	O
to	O
their	O
physicians	O
during	O
times	O
of	O
increased	O
symptoms	O
.	O

They	O
were	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
based	O
on	O
new	O
perspective	O
towards	O
normal	O
serum	O
vitamin	O
D	O
concentration	O
[	O
46	O
].	O

Tissue	O
sampling	O
included	O
offspring	O
of	O
these	O
sows	O
at	O
one	O
prenatal	O
(	O
94	O
dpc	O
)	O
and	O
three	O
postnatal	O
(	O
1	O
,	O
28	O
,	O
188	O
dpn	O
)	O
time	O
points	O
(	O
Figure3	O
).	O

Regarding	O
female	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
a	O
main	O
effect	O
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
7	O
.	O
517	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
and	O
an	O
almost	O
significant	O
effect	O
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
928	O
,	O
P	O
=	O
0	O
.	O
056	O
]	O
on	O
chocolate	O
intake	O
(	O
Figure3G	O
).	O

Body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
calculated	O
from	O
measurements	O
obtained	O
during	O
the	O
first	O
trimester	O
visit	O
(	O
kg	O
/	O
m2	O
).	O

A	O
recent	O
study	O
published	O
in	O
The	O
Lancet	O
examined	O
preterm	O
birth	O
prevention	O
potential	O
in	O
39	O
high	O
-	O
income	O
countries	O
and	O
estimated	O
that	O
if	O
five	O
interventions	O
reached	O
high	O
coverage	O
there	O
would	O
only	O
be	O
a	O
5	O
%	O
relative	O
reduction	O
of	O
preterm	O
birth	O
rate	O
from	O
9	O
·	O
59	O
%	O
to	O
9	O
·	O
07	O
%	O
of	O
livebirths	O
by	O
2015	O
,	O
averting	O
an	O
estimated	O
58	O
,	O
000	O
preterm	O
births	O
and	O
saving	O
US	O
$	O
3	O
billion	O
annually	O
[	O
11	O
].	O

UNICEF	O
has	O
reported	O
deaths	O
of	O
an	O
estimated	O
50	O
,	O
000	O
young	O
women	O
per	O
year	O
globally	O
in	O
pregnancy	O
and	O
childbirth	O
due	O
to	O
severe	O
iron	O
deficiency	O
anemia	O
[	O
12	O
].	O

Methods	O
and	O
Findings	O
Cost	O
effectiveness	O
was	O
evaluated	O
using	O
data	O
on	O
programmatic	O
costs	O
based	B
on	I
two	O
surveys	O
in	O
2006	O
and	O
2009	O
and	O
impact	O
on	O
anaemia	O
and	O
iron	O
status	O
collected	O
in	O
2006	O
,	O
2007	O
,	O
and	O
2008	O
.	O

Examining	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
combines	O
social	O
context	O
and	O
biological	O
influences	O
with	O
individual	O
behavior	O
(	O
4	O
,	O
5	O
).	O

The	O
higher	O
gene	O
expression	O
of	O
Cnr1	O
in	O
the	O
hypothalamus	O
,	O
which	O
was	O
subtly	O
more	O
evident	O
in	O
male	O
than	O
female	O
offspring	O
from	O
caloric	O
-	O
restricted	O
dams	O
,	O
was	O
not	O
so	O
clear	O
in	O
previous	O
studies	O
(	O
Matias	O
et	O
al	O
.,	O
2003	O
).	O

Insecticides	O
and	O
herbicides	O
constitute	O
the	O
bulk	O
of	O
farm	O
chemical	O
exposures	O
:	O
two	O
key	O
routes	O
of	O
exposure	O
are	O
dermal	O
and	O
respiratory	O
[	O
27	O
],	O
bypassing	O
detoxification	O
in	O
the	O
liver	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
7	O
Targets	O
for	O
action	O
by	O
2025	O
.	O

A	O
longer	O
follow	O
up	O
of	O
the	O
ALSPAC	O
cohort	O
demonstrated	O
a	O
reduction	O
in	O
the	O
percentage	O
of	O
children	O
with	O
suboptimal	O
IQ	O
at	O
eight	O
years	O
of	O
age	O
amongst	O
mothers	O
with	O
a	O
high	O
seafood	O
intake	O
(	O
greater	O
than	O
340	O
g	O
)	O
during	O
pregnancy	O
[	O
20	O
].	O

Various	O
B	O
vitamins	O
such	O
as	O
B6	O
(	O
pyridoxine	O
),	O
B12	O
(	O
cobalamin	O
),	O
and	O
B9	O
(	O
folic	O
acid	O
)	O
are	O
required	O
as	O
cofactors	O
by	O
the	O
enzymes	O
involved	O
in	O
homocysteine	O
metabolism	O
.	O

The	O
National	O
Beef	O
Quality	O
Audit	O
of	O
the	O
USA	O
(	O
beef	O
of	O
steers	O
and	O
heifers	O
in	O
28	O
packing	O
plants	O
during	O
October	O
–	O
December	O
1991	O
)	O
found	O
that	O
MS	O
increased	O
with	O
increasing	O
slaugher	O
weight	O
from	O
173	O
to	O
over	O
543	O
kg	O
[	O
71	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Bayesian	O
estimates	O
of	O
the	O
average	O
of	O
the	O
beta	O
coefficients	O
,	O
denoted	O
μβ	O
,	O
within	O
each	O
EDC	O
class	O
in	O
relation	O
to	O
birth	O
weight	O
(	O
g	O
)	O
in	O
the	O
HOME	O
study	O
,	O
2003	O
-	O
2006	O
,	O
n	O
=	O
272	O
,	O
Cincinnati	O
,	O
OHDifference	O
in	O
birthweight	O
(	O
grams	O
)	O
Primary	O
analysis	O
(	O
GA	O
Included	O
)	O
Secondary	O
analysis	O
(	O
GA	O
Excluded	O
)	O
Independent	O
variablePosterior	O
mean	O
(	O
SD	O
)	O
95	O
%	O
CI50	O
%	O
CIPosterior	O
mean	O
(	O
SD	O
)	O
95	O
%	O
CI50	O
%	O
CIPhthalate	O
Class	O
and	O
BPA1	O
.	O
18	O
(	O
10	O
.	O
3	O
)(-	O
19	O
.	O
8	O
,	O
23	O
.	O
4	O
)(-	O
4	O
.	O
28	O
,	O
6	O
.	O
34	O
)	O
2	O
.	O
66	O
(	O
10	O
.	O
4	O
)(-	O
18	O
.	O
4	O
,	O
22	O
.	O
4	O
)(-	O
3	O
.	O
32	O
,	O
8	O
.	O
85	O
)	O
PFAS	O
Class	O
-	O
10	O
.	O
6	O
(	O
23	O
.	O
8	O
)(-	O
51	O
.	O
5	O
,	O
34	O
.	O
0	O
)(	O
-	O
20	O
.	O
9	O
,	O
-	O
2	O
.	O
26	O
)-	O
18	O
.	O
7	O
(	O
28	O
.	O
0	O
)(-	O
72	O
.	O
6	O
,	O
36	O
.	O
2	O
)(	O
-	O
30	O
.	O
5	O
,	O
-	O
6	O
.	O
99	O
)	O
PCB	O
Class0	O
.	O
22	O
(	O
4	O
.	O
70	O
)(-	O
9	O
.	O
31	O
,	O
10	O
.	O
1	O
)(-	O
2	O
.	O
48	O
,	O
2	O
.	O
91	O
)	O
0	O
.	O
47	O
(	O
6	O
.	O
21	O
)(-	O
11	O
.	O
3	O
,	O
13	O
.	O
6	O
)(-	O
3	O
.	O
04	O
,	O
3	O
.	O
37	O
)	O
PDBE	O
Class	O
-	O
3	O
.	O
93	O
(	O
12	O
.	O
5	O
)(-	O
30	O
.	O
8	O
,	O
22	O
.	O
2	O
)(-	O
9	O
.	O
94	O
,	O
2	O
.	O
27	O
)-	O
9	O
.	O
07	O
(	O
15	O
.	O
1	O
)(-	O
37	O
.	O
4	O
,	O
22	O
.	O
6	O
)(	O
-	O
16	O
.	O
6	O
,	O
-	O
2	O
.	O
29	O
)	O
OC	O
Pesticide	O
Class7	O
.	O
26	O
(	O
17	O
.	O
9	O
)(-	O
25	O
.	O
4	O
,	O
39	O
.	O
9	O
)(-	O
2	O
.	O
63	O
,	O
16	O
.	O
1	O
)	O
13	O
.	O
3	O
(	O
22	O
.	O
1	O
)(-	O
28	O
.	O
5	O
,	O
56	O
.	O
5	O
)(	O
1	O
.	O
61	O
,	O
25	O
.	O
1	O
)	O
DEP14	O
.	O
1	O
(	O
33	O
.	O
2	O
)(-	O
51	O
.	O
4	O
,	O
79	O
.	O
3	O
)(-	O
8	O
.	O
02	O
,	O
35	O
.	O
9	O
)-	O
18	O
.	O
6	O
(	O
43	O
.	O
4	O
)(-	O
103	O
,	O
64	O
.	O
6	O
)(-	O
48	O
.	O
1	O
,	O
11	O
.	O
5	O
)	O
DMP	O
-	O
56	O
.	O
8	O
(	O
33	O
.	O
8	O
)(-	O
123	O
,	O
10	O
.	O
2	O
)(	O
-	O
79	O
.	O
3	O
,	O
-	O
34	O
.	O
0	O
)-	O
69	O
.	O
4	O
(	O
45	O
.	O
2	O
)(-	O
156	O
,	O
20	O
.	O
8	O
)(	O
-	O
101	O
,	O
-	O
38	O
.	O
8	O
)	O
Lead	O
-	O
44	O
.	O
8	O
(	O
33	O
.	O
5	O
)(-	O
110	O
,	O
21	O
.	O
7	O
)(	O
-	O
67	O
.	O
6	O
,	O
-	O
22	O
.	O
2	O
)	O
1	O
.	O
51	O
(	O
44	O
.	O
4	O
)(-	O
83	O
.	O
9	O
,	O
88	O
.	O
2	O
)(-	O
27	O
.	O
9	O
,	O
31	O
.	O
4	O
)	O
Mercury5	O
.	O
44	O
(	O
31	O
.	O
2	O
)(-	O
55	O
.	O
9	O
,	O
66	O
.	O
4	O
)(-	O
15	O
.	O
7	O
,	O
26	O
.	O
6	O
)-	O
13	O
.	O
9	O
(	O
39	O
.	O
7	O
)(-	O
92	O
.	O
6	O
,	O
63	O
.	O
7	O
)(-	O
40	O
.	O
8	O
,	O
12	O
.	O
7	O
)	O
Race	O
(	O
Black	O
/	O
Other	O
)-	O
98	O
.	O
2	O
(	O
90	O
.	O
6	O
)(-	O
277	O
,	O
82	O
.	O
7	O
)	O
(-	O
158	O
,	O
-	O
38	O
.	O
6	O
)-	O
274	O
(	O
119	O
)(	O
-	O
508	O
,	O
-	O
37	O
.	O
6	O
)(	O
-	O
354	O
,	O
-	O
193	O
)	O
Age	O
at	O
Delivery6	O
.	O
04	O
(	O
7	O
.	O
71	O
)(-	O
8	O
.	O
95	O
,	O
21	O
.	O
1	O
)(	O
0	O
.	O
83	O
,	O
11	O
.	O
3	O
)	O
1	O
.	O
48	O
(	O
9	O
.	O
97	O
)(-	O
18	O
.	O
2	O
,	O
20	O
.	O
8	O
)(-	O
5	O
.	O
24	O
,	O
8	O
.	O
31	O
)	O
Infant	O
Sex	O
(	O
female	O
)-	O
201	O
(	O
58	O
.	O
0	O
)(	O
-	O
315	O
,	O
-	O
87	O
.	O
8	O
)(	O
-	O
240	O
,	O
-	O
162	O
)-	O
163	O
(	O
72	O
.	O
9	O
)(	O
-	O
307	O
,	O
-	O
21	O
.	O
1	O
)(	O
-	O
212	O
,	O
-	O
114	O
)	O
Did	O
not	O
finish	O
high	O
school	O
-	O
124	O
(	O
80	O
.	O
1	O
)(-	O
282	O
,	O
34	O
.	O
2	O
)(	O
-	O
177	O
,	O
-	O
70	O
.	O
4	O
)-	O
98	O
.	O
2	O
(	O
104	O
)(-	O
302	O
,	O
104	O
)(-	O
168	O
,	O
-	O
28	O
.	O
1	O
)	O
Cotinine	O
(	O
ng	O
/	O
ml	O
>	O
3	O
)-	O
76	O
.	O
7	O
(	O
38	O
.	O
2	O
)(-	O
151	O
,	O
0	O
.	O
53	O
)(	O
-	O
103	O
,	O
-	O
51	O
.	O
3	O
)-	O
98	O
.	O
8	O
(	O
49	O
.	O
5	O
)(-	O
195	O
,	O
-	O
2	O
.	O
45	O
)(	O
-	O
133	O
,	O
-	O
65	O
.	O
8	O
)	O
Low	O
income	O
(<$	O
25	O
,	O
000	O
/	O
yr	O
)-	O
35	O
.	O
7	O
(	O
102	O
)(-	O
237	O
,	O
163	O
)(-	O
104	O
,	O
34	O
.	O
8	O
)	O
86	O
.	O
3	O
(	O
131	O
)(-	O
173	O
,	O
344	O
)(-	O
1	O
.	O
91	O
,	O
173	O
)	O
Unemployment	O
-	O
83	O
.	O
6	O
(	O
76	O
.	O
7	O
)(-	O
233	O
,	O
65	O
.	O
9	O
)(	O
-	O
135	O
,	O
-	O
31	O
.	O
0	O
)-	O
5	O
.	O
46	O
(	O
101	O
)(-	O
205	O
,	O
189	O
)(-	O
73	O
.	O
2	O
,	O
64	O
.	O
0	O
)	O
Public	O
/	O
No	O
Insurance91	O
.	O
4	O
(	O
106	O
)(-	O
117	O
,	O
301	O
)(	O
19	O
.	O
1	O
,	O
162	O
)	O
15	O
.	O
0	O
(	O
141	O
)(-	O
251	O
,	O
291	O
)(-	O
80	O
.	O
1	O
,	O
109	O
)	O
Marital	O
Status	O
(	O
Unmarried	O
)-	O
67	O
.	O
2	O
(	O
99	O
.	O
8	O
)(-	O
263	O
,	O
132	O
)(	O
-	O
134	O
,	O
-	O
1	O
.	O
78	O
)-	O
68	O
.	O
4	O
(	O
143	O
)(-	O
364	O
,	O
208	O
)(-	O
161	O
,	O
27	O
.	O
2	O
)	O
Pre	O
-	O
natal	O
vitamins	O
(	O
Yes	O
)	O
139	O
(	O
68	O
.	O
2	O
)(	O
273	O
,	O
6	O
.	O
99	O
)(	O
185	O
,	O
92	O
.	O
2	O
)	O
92	O
.	O
9	O
(	O
88	O
.	O
1	O
)(	O
266	O
,	O
81	O
.	O
1	O
)(	O
150	O
,	O
33	O
.	O
4	O
)	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
19	O
.	O
6	O
(	O
4	O
.	O
96	O
)(	O
9	O
.	O
84	O
,	O
29	O
.	O
2	O
)(	O
16	O
.	O
2	O
,	O
23	O
.	O
0	O
)	O
23	O
.	O
8	O
(	O
6	O
.	O
28	O
)(	O
11	O
.	O
9	O
,	O
36	O
.	O
3	O
)(	O
19	O
.	O
4	O
,	O
28	O
.	O
0	O
)	O
Abbreviations	O
:	O
SD	O
standard	O
deviation	O
,	O
CI	O
credible	O
interval	O
,	O
SES	O
socioeconomic	O
status	O
,	O
BMI	O
body	O
mass	O
index	O
Significance	O
:	O
Italicized	O
95	O
%	O
CIs	O
and	O
50	O
%	O
CIs	O
do	O
not	O
contain	O
zero	O
and	O
therefore	O
are	O
considered	O
significant	O
at	O
p	O
=	O
0	O
.	O
05	O
or	O
p	O
=	O
0	O
.	O
5	O
respectively	O
Results	O
Of	O
389	O
singleton	O
live	O
births	O
,	O
272	O
(	O
69	O
.	O
9	O
%)	O
had	O
all	O
covariates	O
and	O
were	O
included	O
in	O
analysis	O
.	O

This	O
finding	O
was	O
possibly	O
confounded	O
by	O
smoking	O
,	O
which	O
was	O
more	O
prevalent	O
in	O
the	O
deficient	O
GDM	O
mothers	O
compared	O
with	O
deficient	O
non	O
-	O
GDM	O
mothers	O
.	O

PubMed	O
Central	O
:	O

The	O
women	O
benefitted	O
from	O
knowledge	O
about	O
their	O
care	O
and	O
positive	O
notions	O
about	O
ANC	O
after	O
their	O
interview	O
.	O

The	O
average	O
daily	O
Vitamin	O
D	O
intake	O
dose	O
in	O
the	O
rest	O
eighty	O
-	O
four	O
participants	O
was	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

The	O
standard	O
chow	O
(	O
Standard	O
Chow	O
SAFE	O
A04	O
,	O
Panlab	O
,	O
Barcelona	O
,	O
Spain	O
)	O
contained	O
16	O
.	O
1	O
%	O
of	O
protein	O
,	O
60	O
%	O
carbohydrate	O
,	O
3	O
.	O
1	O
%	O
fat	O
,	O
4	O
%	O
fiber	O
,	O
and	O
0	O
.	O
0025	O
%	O
sodium	O
,	O
resulting	O
in	O
a	O
2	O
.	O
9	O
kcal	O
/	O
g	O
as	O
energy	O
.	O

Nonetheless	O
,	O
the	O
effects	O
we	O
observe	O
may	O
be	O
due	O
in	O
part	O
to	O
maternal	O
diet	O
during	O
lactation	O
.	O

For	O
1	O
hospital	O
(	O
n	O
=	O
23	O
women	O
)	O
certain	O
questions	O
(	O
mainly	O
nationality	O
,	O
ethnicity	O
,	O
education	O
level	O
)	O
needed	O
to	O
be	O
omitted	O
from	O
the	O
questionnaire	O
upon	O
decision	O
of	O
the	O
ethical	O
committee	O
of	O
this	O
particular	O
hospital	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Geographical	O
distribution	O
of	O
the	O
55	O
hospitals	O
visited	O
in	O
Belgium	O
and	O
the	O
number	O
of	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
investigated	O
by	O
site	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
Belgium	O
2010	O
–	O
2011	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
pregnant	O
women	O
by	O
region	O
,	O
trimester	O
and	O
age	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O
RegionsBrussels	O
**	O
Flanders	O
**	O
WalloniaAge	O
(	O
years	O
)	O
1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15	O
–	O
20721110211721	O
–	O
2534277751567326	O
–	O
304139108149765831	O
–	O
3534536975494536	O
–	O
4014142319132441	O
–	O
45231332Total132138289307218219	O
6	O
missing	O
data	O
for	O
age	O
.	O

In	O
contrast	O
,	O
CC	O
females	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
and	O
Cox4i1	O
(	O
Figures5C	O
,	O
D	O
).	O

It	O
has	O
long	O
been	O
proposed	O
that	O
the	O
mother	O
should	O
avoid	O
such	O
foods	O
containing	O
potential	O
allergens	O
during	O
pregnancy	O
and	O
lactation	O
to	O
prevent	O
food	O
sensitization	O
in	O
the	O
child	O
.	O

We	O
assessed	O
glucose	O
intolerance	O
by	O
analyzing	O
results	O
of	O
the	O
1	O
-	O
hour	O
oral	O
glucose	O
screening	O
test	O
results	O
.	O

MH	O
processed	O
all	O
food	O
diaries	O
and	O
calculated	O
intake	O
of	O
energy	O
and	O
nutrients	O
,	O
prepared	O
a	O
database	O
with	O
all	O
variables	O
as	O
well	O
as	O
performed	O
the	O
data	O
analyses	O
,	O
in	O
collaboration	O
with	O
MOl	O
who	O
supervised	O
the	O
statistical	O
analyses	O
.	O

The	O
early	O
-	O
pregnancy	O
exposure	O
to	O
extended	O
winter	O
,	O
compared	O
to	O
extended	O
summer	O
,	O
was	O
also	O
associated	O
with	O
increased	O
HOMA	O
-	O
IR	O
(	O
53	O
.	O
7	O
%)	O
and	O
insulin	O
(	O
49	O
.	O
5	O
%)	O
in	O
late	O
pregnancy	O
.	O

However	O
,	O
there	O
was	O
no	O
difference	O
in	O
sperm	O
tail	O
DNA	O
fragmentation	O
,	O
tail	O
length	O
,	O
or	O
motility	O
(	O
p	O
>	O
0	O
.	O
05	O
).	O

2	O
Posterior	O
50	O
%	O
CIs	O
of	O
BHLM	O
regression	O
coefficients	O
,	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
n	O
=	O
272	O
,	O
Cincinnati	O
,	O
OH	O
To	O
examine	O
the	O
impact	O
of	O
shrinkage	O
and	O
the	O
choice	O
of	O
prior	O
distributions	O
on	O
the	O
BHLM	O
results	O
,	O
we	O
applied	O
LASSO	O
and	O
Elastic	O
Net	O
to	O
the	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
.	O

Results	O
:	O
Anaemic	O
women	O
(	O
haemoglobin	O
concentration	O
<	O
12g	O
/	O
dL	O
)	O
were	O
more	O
likely	B
to	O
be	O
older	O
and	O
in	O
economic	O
deficit	O
at	O
baseline	O
.	O

trial	O
cohort	O
.	O

Reminder	O
texts	O
were	O
sent	O
1	O
week	O
before	O
each	O
follow	O
-	O
up	O
survey	O
prompting	O
online	O
or	O
in	O
-	O
clinic	O
survey	O
completion	O
.	O

Our	O
high	O
level	O
symptoms	O
group	O
consisted	O
of	O
840	O
persons	O
or	O
about	O
2	O
.	O
5	O
%	O
of	O
the	O
whole	O
study	O
group	O
.	O

While	O
shared	O
genes	O
account	O
for	O
some	O
of	O
the	O
similarity	O
in	O
maternal	O
and	O
offspring	O
weight	O
,	O
evidence	O
suggests	O
that	O
exposure	O
to	O
the	O
uterine	O
environment	O
of	O
an	O
obese	O
woman	O
itself	O
may	O
directly	O
program	O
offspring	O
obesity	O
[	O
3	O
].	O

3	O
.	O
3	O
.	O

Four	O
multivariable	O
regressions	O
were	O
performed	O
to	O
assess	O
whether	O
any	O
significant	O
associations	O
existed	O
between	O
the	O
natural	O
logarithm	O
of	O
each	O
subject	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
each	O
of	O
the	O
following	O
vitamin	O
D	O
measurements	O
:	O
(	O
1	O
)	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
at	O
time	O
of	O
follow	O
-	O
up	O
,	O
(	O
2	O
)	O
child	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
birth	O
,	O
(	O
3	O
)	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
Visits	O
3	O
to	O
7	O
as	O
area	O
under	O
the	O
curve	O
),	O
and	O
(	O
4	O
)	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
one	O
month	O
before	O
delivery	O
;	O
all	O
analyses	O
controlled	O
for	O
race	O
/	O
ethnicity	O
,	O
age	O
,	O
gender	O
,	O
and	O
percent	O
fat	O
.	O

Changes	O
in	O
the	O
epigenetic	O
regulation	O
of	O
the	O
fetal	O
GR	O
promoter	O
have	O
been	O
associated	O
with	O
exposure	O
to	O
prenatal	O
maternal	O
stress	O
[	O
9	O
]	O
reflecting	B
a	O
possible	O
effect	O
of	O
maternal	O
stress	O
on	O
the	O
expression	O
and	O
function	O
of	O
the	O
GR	O
in	O
the	O
fetus	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
food	O
preference	O
in	O
adolescent	O
and	O
adult	O
offspring	O
Compulsive	O
feeding	O
test	O
(	O
chocolate	O
preference	O
and	O
total	O
caloric	O
intake	O
)	O
was	O
evaluated	O
in	O
adolescent	O
and	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
8	O
–	O
9	O
and	O
12	O
–	O
13	O
,	O
respectively	O
(	O
Figures3A	O
–	O
D	O
).	O

Having	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
at	O
least	O
40	O
ng	O
/	O
mL	O
during	O
pregnancy	O
could	O
reduce	O
PTB	O
risk	O
by	O
>	O
60	O
%	O
and	O
would	O
achieve	O
the	O
optimal	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
[	O
13	O
].	O

It	O
has	O
been	O
suggested	O
that	O
vitamin	O
D	O
might	O
be	O
used	O
in	O
the	O
treatment	O
of	O
opportunistic	O
and	O
antibiotic	O
-	O
resistant	O
infections	O
.	O

The	O
protocol	O
was	O
also	O
reviewed	O
at	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
and	O
was	O
determined	O
to	O
be	O
public	O
health	O
practice	O
-	O
program	O
evaluation	O
.	O

For	O
thyroidectomized	O
high	O
-	O
risk	O
,	O
non	O
-	O
pregnant	O
patients	O
,	O
I	O
-	O
131	O
scan	O
is	O
also	O
indicated	O
,	O
and	O
serum	O
HTG	O
measurements	O
–	O
performed	O
both	O
with	O
thyroxine	O
deprivation	O
or	O
under	O
rTSH	O
(	O
recombinant	O
human	O
TSH	O
)	O
stimulation	O
–	O
is	O
a	O
useful	O
and	O
reliable	O
marker	O
of	O
disease	O
progression	O
or	O
persistence	O
.	O

Once	O
the	O
woman	O
reports	O
a	O
missed	O
period	O
,	O
the	O
SS	O
will	O
immediately	O
notify	O
the	O
Field	O
Implementers	O
by	O
mobile	O
phone	O
.	O

Then	O
,	O
they	O
were	O
provided	O
with	O
two	O
small	O
cans	O
containing	O
both	O
types	O
of	O
food	O
that	O
were	O
previously	O
weighed	O
.	O

Both	O
diet	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
generation	O
(	O
P	O
=	O
0	O
.	O
04	O
)	O
affected	O
the	O
number	O
of	O
glomeruli	O
at	O
6	O
months	O
of	O
age	O
,	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

[	O
30	O
]	O
The	O
Canadian	O
Pediatric	O
Society	O
recommended	O
2000	O
IU	O
of	O
vitamin	O
D3	O
for	O
pregnant	O
and	O
lactating	O
mothers	O
with	O
periodic	O
blood	O
tests	O
to	O
check	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
and	O
calcium	O
.	O

Maternal	O
and	O
offspring	O
health	O
is	O
followed	O
-	O
up	O
at	O
6	O
weeks	O
,	O
as	O
well	O
as	O
at	O
6	O
,	O
≈	O
7	O
.	O
5	O
and	O
12	O
months	O
after	O
birth	O
.	O

Ruth	O
et	O
al	O
.	O

The	O
hypernatremia	O
and	O
the	O
acute	O
kidney	O
injury	O
corrected	O
over	O
a	O
course	O
of	O
several	O
days	O
with	O
continued	O
fluid	O
administration	O
.	O

The	O
results	O
from	O
these	O
and	O
other	O
lactation	O
studies	O
have	O
been	O
mixed	O
.	O

While	O
ensuring	O
a	O
95	O
%	O
coverage	O
rate	O
is	O
ideal	O
and	O
would	O
result	O
in	O
a	O
major	O
mortality	O
reduction	O
,	O
this	O
process	O
will	O
take	O
time	O
.	O

Alternatively	O
,	O
an	O
equally	O
effective	O
,	O
safe	O
,	O
and	O
affordable	O
iron	O
compound	O
with	O
little	O
or	O
no	O
side	O
effect	O
can	O
be	O
developed	O
for	O
use	O
especially	O
in	O
public	O
health	O
antenatal	O
supplementation	O
programmes	O
.	O

After	O
exclusions	O
,	O
a	O
final	O
sample	O
of	O
3268	O
women	O
was	O
included	O
in	O
the	O
analysis	O
(	O
Fig	O
.	O

4	O
.	O
1	O
.	O

Even	O
though	O
our	O
results	O
highlight	O
the	O
importance	O
of	O
nutritional	O
knowledge	O
in	O
the	O
decision	O
to	O
use	O
iron	O
or	O
folic	O
acid	O
,	O
we	O
cannot	O
draw	O
conclusions	O
about	O
overall	O
compliance	O
with	O
supplement	O
regimes	O
,	O
because	O
we	O
did	O
not	O
record	O
the	O
dose	O
or	O
duration	O
of	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
use	O
.	O

The	O
resulting	O
plasma	O
was	O
frozen	O
at	O
a	O
temperature	O
of	O
≤-	O
20	O
°	O
C	O
until	O
required	O
for	O
analysis	O
.	O

All	O
RNA	O
samples	O
were	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
downstream	O
analysis	O
was	O
performed	O
.	O

Imputation	O
of	O
missing	O
values	O
for	O
education	O
(	O
n	O
=	O
12	O
)	O
and	O
parity	O
(	O
n	O
=	O
2	O
)	O
were	O
conducted	O
using	O
the	O
median	O
value	O
in	O
subgroups	O
by	O
GDM	O
status	O
.	O

TL	O
,	O
T	O
lymphocytes	O
;	O
SNS	O
,	O
sympathetic	O
nervous	O
system	O
.	O

Whether	O
“	O
brite	O
”	O
adipocytes	O
descend	O
from	O
unique	O
precursors	O
,	O
or	O
share	O
progenitors	O
with	O
either	O
white	O
or	O
classic	O
brown	O
adipocytes	O
still	O
remains	O
to	O
be	O
established	O
(	O
for	O
rev	O
.,	O
see	O
Chechi	O
et	O
al	O
.,	O
2013	O
).	O

We	O
defined	B
vitamin	O
D	O
deficiency	O
as	O
<	O
50	O
nmol	O
/	O
L	O
,	O
a	O
common	B
cut	O
-	O
point	O
in	O
the	O
literature	O
.	O
5	O
,	O
22	O
,	O
23	O
Statistical	O
analyses	O
First	O
,	O
we	O
analyzed	O
bivariate	O
associations	O
between	O
25	O
(	O
OH	O
)	O
D	O
category	O
and	O
PNV	O
use	O
as	O
well	O
as	O
covariates	O
including	O
maternal	O
age	O
,	O
race	O
/	O
ethnicity	O
,	O
smoking	O
,	O
education	O
and	O
BMI	O
.	O

At	O
birth	O
10	O
piglets	O
in	O
each	O
litter	O
were	O
distributed	O
over	O
three	O
time	O
points	O
(	O
1	O
,	O
28	O
,	O
188	O
dpn	O
).	O

2010	O
).	O

In	O
third	O
trimester	O
retention	O
of	O
water	O
,	O
constipation	O
is	O
seen	O
&	O
finally	O
preparation	O
of	O
genital	O
tract	O
for	O
delivery	O
is	O
needed	O
.	O

The	O
8	O
DVD	O
deficient	O
and	O
8	O
control	O
sample	O
tissues	O
were	O
used	O
to	O
perform	O
duplicate	O
2DE	O
analyses	O
,	O
providing	O
a	O
total	O
of	O
16	O
gels	O
for	O
each	O
group	O
.	O

The	O
Edinburgh	O
Postnatal	O
Depression	O
Scale	O
was	O
used	O
to	O
examine	O
levels	O
of	O
depressive	O
symptoms	O
[	O
27	O
].	O

However	O
,	O
to	B
our	I
knowledge	I
,	O
no	O
study	O
has	O
investigated	O
the	O
association	O
between	O
dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
or	O
vitamin	O
D	O
and	O
the	O
risk	O
of	O
having	O
positive	O
psychotic	O
symptoms	O
in	O
the	O
general	O
adult	O
population	O
.	O

First	O
,	O
we	O
had	O
a	O
low	O
follow	O
-	O
up	O
rate	O
and	O
,	O
thus	O
,	O
used	O
imputation	O
techniques	O
to	O
support	O
the	O
analysis	O
.	O

Meanwhile	O
,	O
fewer	O
children	O
with	O
S	O
-	O
ECC	O
were	O
breastfed	O
compared	O
to	O
the	O
caries	O
-	O
free	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Thus	B
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	O
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

The	O
registration	O
ID	O
isACTRN12612000588897	O
.	O

Both	O
adjusted	O
and	O
unadjusted	O
analyses	O
were	O
performed	O
,	O
with	O
adjustment	O
for	O
variables	O
used	O
to	O
stratify	O
randomisation	O
(	O
maternal	O
early	O
pregnancy	O
BMI	O
category	O
,	O
parity	O
,	O
and	O
centre	O
of	O
birth	O
),	O
in	O
addition	O
to	O
maternal	O
socioeconomic	O
status	O
,	O
age	O
,	O
and	O
smoking	O
status	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Multiple	O
Linear	O
Regression	O
Analyses	O
for	O
the	O
Dependent	O
Variables	O
RMSSD	O
,	O
PNN50	O
and	O
HF	O
index	O
.	O
βSECI	O
(	O
95	O
%)	O
P	O
Value	O
RMSSD	O
(	O
ms	O
)	O
Birth	O
Weight0	O
.	O
0110	O
.	O
004	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
019	O
)	O
0	O
.	O
018	O
PNN50	O
(%)	O
Birth	O
Weight0	O
.	O
0080	O
.	O
003	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
012	O
)	O
0	O
.	O
007Age1	O
.	O
3650	O
.	O
677	O
(	O
0	O
.	O
019	O
to	O
2	O
.	O
710	O
)	O
0	O
.	O
047BMI	O
-	O
0	O
.	O
7530	O
.	O
308	O
(-	O
1	O
.	O
364	O
to	O
-	O
0	O
.	O
142	O
)	O
0	O
.	O
016	O
HF	O
(	O
n	O
.	O
u	O
.)	O

Although	O
the	O
women	O
were	O
recruited	O
prospectively	O
,	O
there	O
are	O
potential	O
limitations	O
in	O
the	O
retrospectivity	O
of	O
a	O
database	O
.	O

Additionally	O
,	O
for	O
women	O
with	O
a	O
prior	O
PTB	O
,	O
the	O
substantial	O
decrease	O
in	O
recurrent	O
PTB	O
risk	O
(	O
80	O
%)	O
for	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
indicates	O
that	O
improving	O
vitamin	O
D	O
status	O
in	O
this	O
high	O
risk	O
subgroup	O
could	O
sizably	O
reduce	O
PTB	O
rates	O
.	O

Direct	O
iron	O
supplementation	O
has	O
been	O
extensively	O
used	O
in	O
most	O
developing	O
countries	O
as	B
an	O
intervention	O
to	O
prevent	O
iron	O
deficiency	O
and	O
consequently	B
anaemia	O
during	O
pregnancy	O
[	O
7	O
].	O

This	O
suggests	O
that	O
the	O
interventions	O
(	O
prenatal	O
visits	O
)	O
are	O
productive	O
,	O
and	O
that	O
the	O
Romanian	O
government	O
should	O
seek	O
ways	O
of	O
encouraging	O
less	O
well	O
-	O
educated	O
women	O
to	O
participate	O
.	O

Test	O
of	O
feeding	O
response	O
to	O
AM251	O
To	O
evaluate	O
the	O
implication	O
of	O
the	O
cannabinoid	O
CB1	O
receptors	O
in	O
the	O
differential	O
response	O
on	O
caloric	O
intake	O
and	O
chocolate	O
preference	O
,	O
adult	O
rats	O
(	O
postnatal	O
weeks	O
13	O
–	O
14	O
)	O
were	O
firstly	O
treated	O
with	O
a	O
dose	O
of	O
the	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
(	O
3	O
mg	O
/	O
kg	O
)	O
and	O
then	O
exposed	O
to	O
a	O
free	O
choice	O
between	O
a	O
mixture	O
of	O
chocolates	O
and	O
a	O
standard	O
chow	O
.	O

BMI	O
between	O
18	O
.	O
5	O
and	O
25	O
kg	O
/	O
m2is	O
considered	O
normal	O
,	O
and	O
≥	O
25	O
kg	O
/	O
m2is	O
abnormal	O
.	O

The	O
role	O
of	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
during	O
pregnancy	O
to	O
increase	O
intestinal	O
calcium	O
absorption	O
is	O
since	O
long	B
acknowledged	I
[	O
24	O
].	O

Primary	O
prevention	O
has	O
been	O
suggested	O
for	O
those	O
newborns	O
who	O
have	O
at	O
least	O
1	O
parent	O
or	O
sibling	O
with	O
proven	O
atopy	O
.	O

Breast	O
-	O
feeding	O
Infants	O
should	O
be	O
breast	O
-	O
fed	O
for	O
at	O
least	O
4	O
months	O
but	O
no	O
longer	O
than	O
9	O
months	O
.	O

In	O
addition	O
,	O
it	O
is	O
possible	O
to	O
have	O
adverse	O
outcomes	O
that	O
are	O
reversible	O
.	O

This	O
is	O
a	O
nonparametric	O
permutational	O
multivariate	O
analysis	O
of	O
variance	O
(	O
PERMANOVA	O
)	O
test	O
that	O
partitions	O
a	O
distance	O
matrix	O
by	O
sources	O
of	O
variation	O
and	O
can	O
accept	O
both	O
categorical	O
and	O
continuous	O
variables	O
.	O

Such	O
results	O
should	O
be	O
further	O
investigated	O
in	O
future	O
research	O
.	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Our	O
results	O
also	O
concur	O
with	O
findings	O
by	O
Morley	O
et	O
al	O
.	O

Besides	O
,	O
depression	O
scores	O
were	O
evaluated	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
and	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Multiple	O
regression	O
analysis	O
revealed	O
that	O
S	O
-	O
ECC	O
,	O
infrequent	O
milk	O
consumption	O
,	O
and	O
winter	O
season	O
were	O
significantly	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

In	O
utero	O
exposure	O
to	O
SGA	O
monotherapy	O
appears	O
to	O
be	O
associated	O
with	O
less	O
risk	O
to	O
the	O
fetus	O
.	O

Once	O
again	O
some	O
of	O
the	O
most	O
active	O
TEs	O
also	O
escape	O
this	O
second	O
phase	O
of	O
epigenetic	O
re	O
-	O
programing	O
,	O
thereby	O
maintaining	O
genome	O
stability	O
.	O

Methods	O
/	O
design	O
The	O
effect	O
of	O
the	O
early	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
neonatal	O
mortality	O
will	O
be	O
examined	O
using	O
a	O
community	O
based	O
,	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
five	O
districts	O
with	O
30	O
,	O
000	O
live	O
births	O
.	O

The	O
region	O
of	O
the	O
mutation	O
was	O
localized	O
to	O
a	O
22	O
.	O
6	O
Mb	O
interval	O
on	O
chromosome	O
15	O
(	O
Figure	O
2B	O
,	O
left	O
panel	O
)	O
containing	O
180	O
known	B
genes	O
.	O

Furthermore	O
,	O
metformin	O
can	O
promote	O
the	O
development	O
of	O
lactic	O
acidosis	O
,	O
which	O
surely	O
must	O
be	O
a	O
concern	O
in	O
situations	O
of	O
fetal	O
distress	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
associated	O
with	O
the	O
non	O
-	O
classical	O
actions	O
of	O
this	O
hormone	O
,	O
being	O
linked	O
with	O
preeclampsia	O
,	O
insulin	O
resistance	O
,	O
gestational	O
diabetes	O
mellitus	O
,[	O
22	O
]	O
bacterial	O
vaginosis	O
,	O
and	O
an	O
increased	O
risk	O
for	O
caesarean	O
section	O
delivery	O
.	O

Finally	O
,	O
lambda	O
stat	O
was	O
used	O
to	O
compare	O
correlation	O
coefficients	O
of	O
variables	O
in	O
the	O
two	O
groups	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

We	O
describe	O
where	O
these	O
contexts	O
interact	O
with	O
biological	O
processes	O
to	O
affect	O
food	O
behavior	O
and	O
obesity	O
.	O

A	O
recent	O
meta	O
-	O
analysis	O
of	O
observational	O
studies	O
reported	O
that	O
vitamin	O
D	O
<	O
50	O
nmol	O
/	O
L	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
(	O
OR	O
=	O
1	O
.	O
53	O
)	O
of	O
developing	O
gestational	O
diabetes	O
[	O
9	O
].	O

Use	O
of	O
vitamin	O
supplements	O
was	O
not	O
significantly	O
linked	O
to	O
leukemia	O
risk	O
.	O

One	O
of	O
the	O
reasons	B
for	O
a	O
visfatin	O
effect	O
on	O
fetal	O
development	O
is	O
its	O
effect	O
on	O
sirtuins	O
(	O
SIRT	O
).	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2431	O
/	O
13	O
/	O
174	O
/	O
prepub	O
PubMed	O
Central	O
:	O

All	O
mothers	O
provided	O
written	O
informed	O
consent	O
,	O
and	O
all	O
procedures	O
were	O
conducted	O
in	O
accordance	O
with	O
ethical	O
standards	O
for	O
human	O
experimentation	O
.	O

Are	O
multiple	O
exposures	O
additive	O
and	O
/	O
or	O
cumulative	O
?	O

Seasonal	O
variation	O
has	O
been	O
reported	O
in	O
HbA1cand	O
glucose	O
concentrations	O
among	O
individuals	O
with	O
type	O
2	O
diabetes	O
,	O
with	O
highest	O
levels	O
observed	O
in	O
winter	O
and	O
lowest	O
in	O
summer	O
[	O
19	O
–	O
23	O
].	O

3	O
.	O
4	O
.	O
2	O
.	O

Moreover	O
,	O
there	O
were	O
additional	O
studies	O
that	O
have	O
investigated	O
environmentally	O
induced	O
epigenetic	O
changes	O
without	O
simultaneously	O
assessing	O
any	O
phenotypic	O
/	O
toxicological	O
endpoints	O
and	O
/	O
or	O
focused	O
on	O
acute	O
exposures	O
(	O
less	O
than	O
24	O
h	O
).	O

The	O
infant	O
reported	O
here	O
was	O
managed	O
as	O
a	O
case	O
of	O
acute	O
laryngotracheobronchitis	O
initially	O
as	O
there	O
was	O
no	O
evidence	O
of	O
rickets	O
and	O
the	O
diagnosis	O
of	O
hypocalcemia	O
was	O
made	O
only	O
after	O
he	O
had	O
convulsions	O
.	O

•	O
Increase	O
reach	O
of	O
existing	O
preventive	O
interventions	O
in	O
the	O
preconception	O
period	O
,	O
especially	O
family	O
planning	O
,	O
and	O
including	O
adolescent	O
-	O
friendly	O
services	O
.	O

Among	O
the	O
SGA	O
cases	O
defined	O
by	O
length	O
only	O
,	O
most	O
were	O
close	O
to	O
also	O
meeting	O
the	O
SGA	O
definition	O
for	O
birth	O
weight	O
.	O

To	O
account	O
for	O
the	O
effect	O
of	O
gestation	O
duration	O
on	O
birth	O
weight	O
,	O
we	O
controlled	O
for	O
gestational	O
age	O
(	O
GA	O
)	O
non	O
-	O
parametrically	O
using	O
the	O
'	O
splines	O
'	O
package	O
in	O
R	O
[	O
40	O
].	O

Maternal	O
height	O
(	O
cm	O
)	O
and	O
weight	O
(	O
kg	O
)	O
before	O
pregnancy	O
and	O
parity	O
were	O
collected	O
primarily	O
from	O
the	O
prenatal	O
maternity	O
card	O
or	O
,	O
if	O
missing	O
,	O
from	O
our	O
baseline	O
questionnaire	O
.	O

A	O
one	O
-	O
week	O
dietary	O
history	O
,	O
menstrual	O
and	O
medical	O
history	O
was	O
completed	O
for	O
each	O
subject	O
.	O

Although	O
the	O
issue	O
of	O
supplementation	O
in	O
younger	O
women	O
is	O
critical	O
,	O
they	O
may	O
be	O
difficult	O
to	O
target	O
over	O
a	O
long	O
period	O
of	O
time	O
and	O
may	O
not	O
begin	O
their	O
reproductive	O
lives	O
proximal	O
to	O
the	O
supplementation	O
period	O
.	O

Previous	O
studies	O
demonstrated	O
short	O
-	O
term	O
effects	O
on	O
KAB	O
among	O
participants	O
,	O
including	O
the	O
initial	O
outcomes	O
of	O
the	O
Madigan	O
study	O
[	O
23	O
,	O
26	O
].	O

Apart	O
from	O
this	O
function	O
,	O
these	O
proteins	O
are	O
essential	O
for	O
the	O
insertion	O
of	O
dopamine	O
receptor	O
2	O
(	O
DRD2	O
)	O
into	O
the	O
nonsynaptic	O
membrane	O
of	O
dopaminergic	O
neurons	O
[	O
32	O
].	O

None	O
of	O
the	O
children	O
with	O
major	O
malformations	O
were	O
exposed	O
to	O
antiepileptic	O
drugs	O
(	O
table	O
3	O
).	O

The	O
result	O
was	O
that	O
196	O
participants	O
will	O
be	O
required	O
.	O

[	O
24	O
]	O
included	O
supplement	O
usage	O
as	O
a	O
confounder	O
.	O

Furthermore	O
,	O
the	O
diet	O
-	O
dependent	O
transcriptional	O
excursions	O
revealed	O
an	O
impact	O
on	O
N	O
-	O
metabolism	O
.	O

We	O
stored	O
the	O
serum	O
samples	O
at	O
−	O
20	O
°	O
C	O
and	O
analysed	O
them	O
at	O
the	O
end	O
of	O
our	O
study	O
with	O
IDS	O
-	O
iSYS	O
Multi	O
-	O
Discipline	O
Automated	O
Chemiluminescent	O
assay	O
(	O
Immunodiagnostic	O
Systems	O
Ltd	O
,	O
Tyne	O
and	O
Wear	O
,	O
UK	O
)	O
at	O
the	O
Manchester	O
Royal	O
Infirmary	O
,	O
Manchester	O
,	O
UK	O
(	O
Supra	O
-	O
Regional	O
Vitamin	O
D	O
Reference	O
Laboratories	O
accredited	O
to	O
ISO9001	O
:	O
2000	O
and	O
ISO13485	O
:	O
2003	O
and	O
participating	O
in	O
the	O
Vitamin	O
D	O
Quality	O
Assurance	O
Scheme	O
).	O

Another	O
study	O
found	O
increased	O
sympathetic	O
activation	O
and	O
reduced	O
parasympathetic	O
activity	O
,	O
demonstrating	O
autonomic	O
imbalance	O
only	O
in	O
women	O
with	O
low	O
birth	O
weight	O
who	O
submitted	O
to	O
a	O
stress	O
test	O
[	O
20	O
].	O

However	O
,	O
the	O
age	O
of	O
the	O
mother	O
needs	O
to	O
be	O
taken	O
into	O
consideration	O
,	O
as	B
artificial	O
insemination	O
among	O
older	O
mothers	O
has	O
been	O
studied	O
to	O
lead	O
to	O
more	O
complications	O
.	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

BAT	O
activation	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
or	O
thyroid	O
hormone	O
treatment	O
was	O
shown	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
(	O
Cawthorne	O
et	O
al	O
.,	O
1984	O
;	O
Forest	O
et	O
al	O
.,	O
1987	O
;	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

This	O
paper	O
reviews	O
the	O
plausibility	O
of	O
evidence	O
focusing	O
on	O
the	O
seasonal	O
interrelation	O
of	O
farming	O
,	O
allergies	O
,	O
viruses	O
,	O
vitamin	O
D	O
,	O
diet	O
,	O
birth	O
weight	O
,	O
and	O
handedness	O
.	O

The	O
prior	O
distribution	O
depends	O
on	O
hyperparameters	O
,	O
including	O
a	O
mean	O
μβand	O
standard	O
deviation	O
σβ	O
,	O
which	O
are	O
informed	O
by	O
the	O
data	O
and	O
can	O
be	O
quantified	O
when	O
fitted	O
to	O
the	O
data	O
.	O

We	O
examined	O
several	O
additional	O
models	O
with	O
various	O
cutpoints	O
for	O
25	O
(	O
OH	O
)	O
D	O
based	O
on	O
clinical	O
guidelines	B
and	O
previous	O
literature	O
,	O
while	O
adjusting	O
for	O
maternal	O
PIH	O
and	O
maternal	O
BMI	O
at	O
delivery	O
.	O

Whenever	O
possible	O
,	O
the	O
operation	O
should	O
be	O
performed	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery37	O
.	O

There	O
were	O
significant	O
differences	O
between	O
primigravida	O
or	O
multigravida	O
and	O
the	O
educational	O
levels	O
on	O
the	O
aspect	O
of	O
the	O
comprehensiveness	O
of	O
health	O
talks	O
.	O

It	O
consists	O
of	O
a	O
library	O
of	O
prenatal	O
and	O
postpartum	O
text	O
messages	O
delivered	O
on	O
a	O
schedule	O
timed	O
to	O
the	O
baby	O
’	O
s	O
due	O
date	O
or	O
birthdate	O
[	O
25	O
].	O

Additionally	O
,	O
the	O
caregiver	O
questionnaire	O
involved	O
retrospective	O
questions	O
on	O
prenatal	O
diet	O
and	O
the	O
child	O
’	O
s	O
first	O
12	O
months	O
of	O
life	O
which	O
may	O
have	O
introduced	O
recall	O
bias	O
.	O

Interestingly	O
,	O
very	O
low	O
birth	O
weight	O
has	O
been	O
associated	O
with	O
left	O
-	O
or	O
mix	O
-	O
handedness	O
[	O
175	O
,	O
176	O
],	O
a	O
factor	O
associated	O
in	O
some	O
studies	O
with	O
season	O
of	O
birth	O
[	O
177	O
]	O
and	O
reduced	O
glioma	O
risk	O
[	O
178	O
].	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
identified	O
between	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
and	O
those	O
in	O
the	O
Standard	O
Care	O
group	O
with	O
regards	O
to	O
the	O
overall	O
Ages	O
and	O
Stages	O
total	O
score	O
(	O
Lifestyle	O
Advice	O
262	O
.	O
47	O
(±	O
34	O
.	O
92	O
)	O
vs	O
.	O
Standard	O
Care	O
258	O
.	O
72	O
(±	O
36	O
.	O
54	O
);	O
aMD	O
3	O
.	O
53	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
33	O
to	O
7	O
.	O
40	O
;	O
p	O
=	O
0	O
.	O
07	O
),	O
or	O
in	O
the	O
proportion	O
of	O
infants	O
identified	O
with	O
>	O
1	O
domain	O
below	O
the	O
cut	O
-	O
off	O
(	O
Lifestyle	O
Advice	O
49	O
(	O
4	O
.	O
58	O
%)	O
vs	O
.	O
Standard	O
Care	O
69	O
(	O
6	O
.	O
51	O
%);	O
aRR	O
0	O
.	O
69	O
;	O
95	O
%	O
CI	O
0	O
.	O
43	O
to	O
1	O
.	O
11	O
;	O
p	O
=	O
0	O
.	O
13	O
)	O
(	O
Table	O
3	O
).	O

These	O
were	O
divided	O
into	O
four	O
categories	O
and	O
concerned	O
knowledge	O
of	O
general	O
dietary	O
recommendations	O
during	O
pregnancy	O
,	O
the	O
sources	O
of	O
nutrients	O
,	O
the	O
roles	O
of	O
nutrients	O
during	O
pregnancy	O
,	O
and	O
the	O
importance	O
of	O
breastfeeding	O
.	O

Models	O
adjusted	O
for	O
delivery	O
hospital	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
influenza	O
circulation	O
.	O

Species	O
of	O
the	O
genus	O
Acinetobacter	O
are	O
increasingly	O
involved	O
in	O
nosocomial	O
infections	O
[	O
20	O
],	O
while	O
the	O
species	O
Clostridium	O
neonatale	O
was	O
initially	O
isolated	O
from	O
infants	O
affected	O
by	O
necrotizing	O
enterocolitis	O
[	O
21	O
],	O
and	O
the	O
pathogenic	O
potential	O
of	O
species	O
in	O
the	O
genus	O
Staphylococcus	O
is	O
well	O
-	O
established	O
[	O
22	O
,	O
23	O
].	O

Fenton	O
and	O
colleagues	O
have	O
shown	O
that	O
gestational	O
exposure	O
to	O
PFOA	O
altered	O
the	O
normal	O
formation	O
of	O
the	O
milk	O
duct	O
system	O
in	O
mice	O
.	O
26In	O
a	O
multigenerational	O
mouse	O
follow	O
-	O
up	O
study	O
,	O
they	O
showed	O
that	O
PFOA	O
exposure	O
not	O
only	O
impaired	O
the	O
mouse	O
mothers	O
’	O
ability	O
to	O
lactate	O
,	O
but	O
also	O
adversely	O
affected	O
prenatal	O
development	O
of	O
the	O
mammary	O
gland	O
in	O
their	O
female	O
offspring	O
.	O

Rats	O
receiving	O
daily	O
doses	O
of	O
arsenic	O
equivalent	O
to	O
the	O
levels	O
in	O
groundwater	O
from	O
heavily	O
arsenic	O
-	O
contaminated	O
areas	O
of	O
the	O
Bengal	O
Basin	O
retained	O
significantly	O
less	O
of	O
the	O
element	O
in	O
blood	O
and	O
liver	O
and	O
excreted	O
significantly	O
more	O
in	O
urine	O
when	O
fed	O
2	O
mg	O
/	O
mL	O
AGE	O
.	O

MHF	O
–	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
pre	O
-	O
conceptionally	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
;	O
PLHF	O
–	O
dams	O
fed	O
a	O
chow	O
diet	O
pre	O
-	O
conceptionally	O
and	O
a	O
high	O
fat	O
diet	O
through	O
pregnancy	O
and	O
lactation	O
only	O
.	O

These	O
soldiers	O
and	O
family	O
members	O
could	O
benefit	O
significantly	O
from	O
mHealth	O
programs	O
such	O
as	O
text4baby	O
because	B
it	O
is	O
a	O
free	O
resource	O
and	O
is	O
highly	O
portable	O
,	O
permitting	O
families	O
to	O
receive	O
these	O
messages	O
anywhere	O
in	O
the	O
world	O
where	O
text	O
messages	O
can	O
be	O
received	O
.	O

A	O
study	O
examining	O
young	O
adults	O
with	O
low	O
birth	O
weight	O
found	O
that	O
these	O
subjects	O
possessed	O
significantly	O
increased	O
parasympathetic	O
parameters	O
of	O
the	O
time	O
domain	O
[	O
19	O
].	O

Sufficient	O
maternal	O
vitamin	O
D	O
status	O
,	O
specified	O
as	B
25	O
(	O
OH	O
)	O
D	O
above	O
50	O
nmol	O
/	O
L	O
,	O
seems	B
a	O
threshold	O
value	O
,	O
above	O
which	O
the	O
physiological	O
requirements	O
of	O
pregnancy	O
are	O
achieved	O
.	O

For	O
this	O
study	O
,	O
we	O
analysed	O
the	O
early	O
-	O
pregnancy	O
food	O
diaries	O
only	O
.	O

Results	O
A	O
total	O
of	O
122	O
mother	O
—	O
infant	O
pairs	O
were	O
enrolled	O
in	O
this	O
study	O
,	O
and	O
71	O
infants	O
underwent	O
lung	O
function	O
testing	O
at	O
6	O
months	O
of	O
age	O
.	O

White	O
adipocytes	O
are	O
composed	O
of	O
a	O
large	O
single	O
,	O
spherical	O
lipid	O
vacuole	O
and	O
a	O
peripherally	O
located	O
nucleus	O
,	O
together	O
with	O
few	O
mitochondria	O
.	O

In	B
general	I
,	O
higher	O
serum	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
are	O
associated	O
with	O
improved	O
oral	O
health	O
outcomes	O
[	O
14	O
,	O
20	O
-	O
22	O
].	O

The	O
primary	O
antisera	O
were	O
used	O
at	O
a	O
1	O
:	O
1000	O
dilution	O
for	O
GR	O
α	O
/	O
β	O
and	O
1	O
:	O
2000	O
for	O
GAPDH	O
,	O
overnight	O
at	O
4	O
°	O
C	O
.	O

Obviously	O
,	O
the	O
increased	O
mRNA	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
regulators	O
within	O
developmental	O
period	O
I	O
in	O
LP	O
offspring	O
accounts	O
for	O
compensatory	O
regulations	O
regarding	O
the	O
lowered	O
fetal	O
weight	O
due	O
to	O
the	O
gestational	O
diet	O
.	O

The	O
P8	O
rump	O
fat	O
depth	O
was	O
generally	O
greater	O
in	O
Hereford	O
than	O
Angus	O
,	O
and	O
Meat	O
Standard	O
Australia	O
(	O
MSA	O
)	O
MS	O
was	O
generally	O
lower	O
in	O
Hereford	O
than	O
in	O
Angus	O
and	O
Wagyu	O
×	O
Angus	O
.	O

The	O
United	O
Nations	O
and	O
other	O
multilateral	O
organistions	O
:	O
Invest	O
•	O
Support	O
countries	O
develop	O
and	O
align	O
their	O
national	O
health	O
plans	O
,	O
including	O
costing	O
and	O
tracking	O
implementation	O
to	O
achieve	O
the	O
health	O
MDGs	O
and	O
preterm	O
birth	O
mortality	O
-	O
reduction	O
targets	O
.	O

For	O
instance	O
,	O
infection	O
with	O
influenza	O
virus	O
during	O
pregnancy	O
may	O
prompt	O
an	O
inflammatory	O
[	O
cascade	O
]	O
response	O
that	O
is	O
associated	O
with	O
preterm	O
birth	O
[	O
3	O
],[	O
4	O
].	O

Multiple	O
linear	O
regression	O
,	O
model	O
-	O
based	O
clustering	O
methods	O
,	O
and	O
gene	O
set	O
enrichment	O
analysis	O
examined	O
the	O
association	O
between	O
birth	O
weight	O
percentile	O
,	O
demographic	O
variables	O
,	O
and	O
repetitive	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
CpG	O
locus	O
methylation	O
.	O

In	O
addition	O
,	O
studies	O
in	O
humans	O
and	O
humanized	O
gnotobiotic	O
mice	O
show	O
that	O
diets	O
with	O
reduced	O
carbohydrates	O
[	O
4	O
],	O
or	O
high	O
in	O
polysaccharides	O
,	O
alter	O
gut	O
microbiome	O
composition	O
[	O
5	O
].	O

High	O
concentration	O
of	O
vitamin	O
D	O
and	O
its	O
metabolites	O
in	O
decidua	O
during	O
the	O
1st	O
trimester	O
suggests	O
its	O
important	O
role	O
in	O
the	O
implantation	O
process	O
and	O
a	O
local	O
immunological	O
embryo	O
-	O
protection	O
.	O

Based	O
on	O
the	O
results	O
from	O
these	O
observational	O
studies	O
the	O
current	O
recommendation	O
of	O
two	O
to	O
three	O
servings	O
per	O
week	O
appears	O
appropriate	O
.	O

Permission	O
for	O
this	O
study	O
was	O
obtained	O
from	O
the	O
London	O
School	O
of	O
Hygiene	O
and	O
Tropical	O
Medicine	O
Ethics	O
Committee	O
and	O
the	O
Gambian	O
Government	O
/	O
MRC	O
Joint	O
Ethics	O
Committee	O
.	O

To	O
be	O
sure	O
that	O
sun	O
exposure	O
didn	O
’	O
t	O
influence	O
our	O
analysis	O
,	O
we	O
decided	O
to	O
take	O
blood	O
sample	O
in	O
winter	O
(	O
from	O
December	O
to	O
February	O
).	O

This	O
also	O
reduces	O
the	O
Type	O
I	O
error	O
(	O
false	O
positive	O
)	O
rate	O
because	O
the	O
shrunken	O
beta	O
coefficients	O
are	O
closer	O
to	O
zero	O
[	O
33	O
].	O

Season	O
was	O
coded	O
as	O
a	O
binary	O
variable	O
,	O
since	O
this	O
explained	B
30	O
%	O
of	O
vitamin	O
D	O
status	O
in	O
a	O
previous	O
study	O
in	O
pregnant	O
women	O
at	O
the	O
same	O
latitude	O
[	O
16	O
].	O

We	O
also	O
found	O
a	O
sex	O
effect	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Faah	O
in	O
liver	O
and	O
PAT	O
,	O
Mgll	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
in	O
liver	O
,	O
and	O
Dagl	O
α	O
and	O
Dagl	O
β	O
in	O
PAT	O
.	O

Mice	O
with	O
a	O
mutation	O
in	O
Npr3	O
,	O
or	O
Npr3	O
knockout	O
mice	O
,	O
all	O
exhibit	O
the	O
same	O
skeletal	O
-	O
overgrowth	O
phenotype	O
,	O
resulting	O
in	O
an	O
elongated	O
body	O
and	O
thoracic	O
kyphosis	O
(	O
Jaubert	O
et	O
al	O
.	O

The	O
results	O
of	O
original	O
publications	O
dated	O
up	O
to	O
2015	O
have	O
been	O
summarized	O
and	O
discussed	O
in	O
a	O
critical	O
manner	O
.	O

This	B
means	I
that	I
Nampt	O
promotes	O
osteocyte	O
differentiation	O
through	O
a	O
pathway	O
mediated	O
by	O
SIRT1	O
(	O
16	O
,	O
17	O
).	O

1	O
The	O
flow	O
chart	O
of	O
sampling	O
The	O
mean	O
age	O
of	O
the	O
participants	O
was	O
26	O
.	O
31	O
±	O
4	O
.	O
59	O
.	O

These	O
data	O
corroborate	O
a	O
previous	O
preliminary	O
study	O
of	O
placental	O
GRs	O
[	O
20	O
].	O

Therefore	B
,	O
determining	O
VD	O
status	O
of	O
those	O
patients	O
is	O
so	O
important	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
the	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
(	O
Table	O
3	O
).	O

The	O
temperature	O
profiles	O
comprised	O
an	O
initial	O
denaturation	O
step	O
at	O
95	O
°	O
C	O
for	O
10	O
min	O
and	O
40	O
cycles	O
consisting	O
of	O
denaturation	O
at	O
95	O
°	O
C	O
for	O
15	O
s	O
,	O
annealing	O
at	O
60	O
°	O
C	O
for	O
10	O
s	O
and	O
extension	O
/	O
fluorescence	O
acquisition	O
at	O
72	O
°	O
C	O
for	O
15	O
s	O
.	O
For	O
all	O
the	O
assays	O
threshold	O
cycles	O
were	O
converted	O
to	O
copy	O
numbers	O
using	O
a	O
standard	O
curve	O
generated	O
by	O
amplifying	O
serial	O
dilutions	O
of	O
an	O
external	O
PCR	O
standard	O
(	O
107	O
-	O
102copies	O
).	O

Increasion	O
of	O
nerve	O
growth	O
factor	O
in	O
PC12	O
cells	O
by	O
Cytoplasmic	O
SIRT1	O
Induced	O
neuritogenesis	O
(	O
18	O
).	O

But	O
neither	O
body	O
weight	O
at	O
weaning	O
nor	O
body	O
weight	O
at	O
188	O
dpn	O
differed	O
significantly	O
among	O
offspring	O
of	O
the	O
LP	O
and	O
the	O
AP	O
group	O
,	O
whereas	O
visceral	O
and	O
subcutaneous	O
fat	O
content	O
remained	O
higher	O
in	O
LP	O
than	O
in	O
AP	O
during	O
postnatal	O
life	O
[	O
15	O
-	O
17	O
].	O

In	O
addition	O
,	O
concurrent	O
in	O
vivo	O
and	O
in	O
vitro	O
studies	O
have	O
improved	O
our	O
knowledge	O
of	O
the	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
,	O
including	O
recent	O
insights	O
into	O
early	O
human	O
development	O
(	O
Laird2013	O
;	O
Slieker	O
et	O
al	O
.	O
2015	O
;	O
Surani2015	O
;	O
Williams	O
et	O
al	O
.	O
2015	O
),	O
and	O
epigenetic	O
inheritance	O
in	O
simpler	O
model	O
systems	O
such	O
as	O
Caenorhabditis	O
elegans	O
,	O
Drosophilamelanogaster	O
and	O
Daniorerio	O
(	O
zebrafish	O
)	O
(	O
Padilla	O
et	O
al	O
.	O
2014	O
;	O
Somer	O
&	O
Thummel2014	O
;	O
Williams	O
et	O
al	O
.	O
2014	O
).	O

95	O
%	O
CI	O
=	O
95	O
%	O
Confidence	O
Intervals	O
.	O

A	O
recent	O
meta	O
-	O
analysis	O
of	O
10	O
studies	O
concluded	O
that	O
25OHD	O
concentrations	O
<	O
50	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
an	O
approximately	O
30	O
%	O
increased	O
risk	O
of	O
preterm	O
delivery	O
[	O
10	O
].	O

Skilled	O
examiners	O
and	O
good	O
quality	O
images	O
with	O
grey	O
-	O
scale	O
and	O
power	O
Doppler	O
US	O
seem	O
more	O
reliable	O
than	O
other	O
techniques	O
in	O
detecting	O
and	O
differentiating	O
malignant	O
and	O
benign	O
solid	O
thyroid	O
nodules	O
,	O
especially	O
for	O
small	O
lesions	O
.	O

These	O
results	O
were	O
consistent	O
when	O
infants	O
delivered	O
prematurely	O
were	O
not	O
included	O
in	O
the	O
analyses	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S9	O
,	O
Figure	O
S6a	O
).	O

Mentioned	O
foods	O
as	O
an	O
unhealthy	O
food	O
might	O
have	O
been	O
given	O
an	O
adverse	O
score	O
in	O
the	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
in	O
the	O
current	O
study	O
.	O

The	O
Born	O
Too	O
Soon	O
series	O
in	O
Reproductive	O
Health	O
was	O
funded	O
by	O
March	O
of	O
Dimes	O
and	O
Save	O
the	O
Children	O
.	O

In	O
conclusion	O
,	O
this	O
novel	O
cohort	O
study	O
shows	O
clear	O
familial	O
associations	O
across	O
three	O
generations	O
for	O
height	O
in	O
both	O
lineages	O
,	O
but	O
the	O
BMI	O
pattern	O
is	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O

It	O
is	O
known	O
that	O
down	O
-	O
regulation	O
of	O
calcium	O
binding	O
proteins	O
shift	O
essential	O
calcium	O
buffering	O
requirements	O
to	O
the	O
mitochondrial	O
compartment	O
,	O
which	O
,	O
in	O
turn	O
,	O
leads	O
to	O
compromised	O
mitochondrial	O
energy	O
production	O
[	O
34	O
].	O

The	O
range	O
between	O
therapeutic	O
and	O
toxic	O
doses	O
is	O
narrow	O
,	O
and	O
vitamin	O
D	O
toxicity	O
,	O
when	O
it	O
occurs	O
,	O
is	O
a	O
serious	O
problem	O
.	O

These	O
findings	O
indicate	O
that	O
serotonin	O
homeostasis	O
is	O
necessary	O
for	O
proper	O
brain	O
maturation	O
and	O
fetal	O
development	O
.	O

Results	O
Cord	O
blood	O
and	O
initial	O
bone	O
mineralization	O
values	O
A	O
total	O
of	O
49	O
singleton	O
infants	O
were	O
enrolled	O
at	O
one	O
week	O
of	O
age	O
for	O
this	O
research	O
project	O
.	O

For	O
example	O
,	O
the	O
maternal	O
aMED	O
score	O
was	O
consistently	B
positively	O
and	O
negatively	O
associated	O
with	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
additionally	O
negatively	O
associated	O
with	O
the	O
species	O
Escherichia	O
coli	O
,	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

Adverse	O
effect	O
(	O
s	O
)	O
that	O
affect	O
multiple	O
generations	O
,	O
all	O
of	O
which	O
were	O
exposed	O
either	O
directly	O
or	O
indirectly	O
to	O
the	O
original	O
factor	O
represent	B
epigenetic	O
effect	O
(	O
s	O
)	O
and	O
thus	B
multigenerational	O
toxicity	O
.	O

Exclusion	O
Criteria	O
were	O
:	O
the	O
participants	O
with	O
the	O
EPDS	O
baseline	O
scores	O
of	O
>	O
13	O
,	O
not	O
providing	O
blood	O
sample	O
at	O
the	O
onset	O
of	O
the	O
study	O
,	O
and	O
less	O
than	O
8	O
weeks	O
consumption	O
of	O
vitamin	O
D3supplementations	O
(	O
for	O
example	O
due	O
to	O
preterm	O
labor	O
or	O
stopping	O
consumption	O
),	O
irregular	O
consumption	O
(	O
for	O
example	O
every	O
two	O
/	O
three	O
days	O
instead	O
of	O
daily	O
consumption	O
).	O

The	O
transfer	O
of	O
maternal	O
cytokines	O
was	O
confirmed	O
in	O
a	O
study	O
of	O
suckling	O
piglets	O
[	O
65	O
].	O

Pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
calculated	O
as	O
weight	O
in	O
kilograms	O
divided	O
by	O
height	O
in	O
meters	O
squared	O
.	O

Funding	O
This	O
work	O
was	O
supported	O
by	O
the	O
Instituto	O
de	O
Salud	O
Carlos	O
III	O
,	O
Ministerio	O
de	O
Economía	O
y	O
Competitividad	O
con	O
-	O
founded	O
by	O
UE	O
-	O
ERDF	O
program	O
(	O
CP12	O
/	O
03109	O
and	O
PI16	O
/	O
01374	O
to	O
JS	O
,	O
PI12	O
/	O
02261	O
to	O
FR	O
,	O
and	O
PSI	O
-	O
2012	O
-	O
35388	O
to	O
RG	O
),	O
Red	O
de	O
Trastornos	O
Adictivos	O
(	O
RD12	O
/	O
0028	O
/	O
0001	O
to	O
FR	O
),	O
CIBERobn	O
,	O
Consejería	O
de	O
Economía	O
,	O
Innovación	O
y	O
Ciencia	O
,	O
Junta	O
de	O
Andalucía	O
,	O
UE	O
/	O
ERDF	O
(	O
PI45403	O
,	O
CTS	O
-	O
8221	O
,	O
CTS	O
-	O
433	O
to	O
FR	O
),	O
Consejería	O
de	O
Salud	O
,	O
Junta	O
de	O
Andalucía	O
,	O
UE	O
/	O
ERDF	O
(	O
SAS111224	O
to	O
JS	O
and	O
FR	O
.	O

2	O
.	O
2	O
.	O
2	O
.	O

Fourteen	O
women	O
withheld	O
consent	O
and	O
declined	O
to	O
participate	O
in	O
the	O
study	O
partly	O
because	O
they	O
did	O
not	O
have	O
time	O
or	O
they	O
did	O
not	O
want	O
to	O
answer	O
any	O
questions	O
.	O

However	O
,	O
most	O
of	O
the	O
evidence	O
is	O
from	O
observational	O
epidemiological	O
studies	O
except	O
for	O
a	O
very	O
few	O
randomised	O
controlled	O
trials	O
.	O

As	O
previously	O
discussed	O
,	O
an	O
allergic	O
status	O
of	O
the	O
mother	O
has	O
the	O
potency	B
to	O
affect	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
by	O
numerous	O
factors	O
transferable	O
via	O
placenta	O
or	O
breast	O
milk	O
and	O
even	O
via	O
the	O
transamniotic	O
route	O
,	O
for	O
instance	O
,	O
intact	O
maternal	O
IgE	O
in	O
amniotic	O
fluid	O
,	O
maternal	O
DNA	O
in	O
cord	O
blood	O
,	O
leukocytes	O
,	O
and	O
chemokines	O
such	O
as	O
IL	O
-	O
8	O
,	O
RANTES	O
,	O
interferon	O
-	O
γ	O
-	O
inducible	O
protein	O
10	O
,	O
or	O
monokine	O
induced	O
by	O
IFN	O
-	O
γ	O
,	O
allergens	O
,	O
as	O
well	O
as	O
antibodies	O
.	O

Such	O
desensitization	O
is	O
likely	B
occurring	O
in	O
situations	O
of	O
chronic	O
elevation	O
in	O
IL	O
-	O
6	O
levels	O
,	O
such	O
as	O
occurs	O
in	O
human	O
obesity	O
.	O

An	O
increasing	O
body	O
of	O
evidence	O
suggests	O
that	O
low	O
birth	O
weight	O
is	O
correlated	O
with	O
alterations	O
in	O
autonomic	O
responses	O
[	O
15	O
–	O
20	O
].	O

Significant	O
differences	O
were	O
noted	O
between	O
groups	O
for	O
maternal	O
ethnicity	O
and	O
maternal	O
tobacco	O
smoking	O
during	O
pregnancy	O
,	O
with	O
a	O
greater	O
proportion	O
of	O
non	O
-	O
Caucasian	O
infants	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
infants	O
with	O
exposure	O
to	O
tobacco	O
smoke	O
in	O
the	O
SGA	O
category	O
(	O
p	O
=	O
0	O
.	O
03	O
).	O

In	O
another	O
study	O
of	O
Massachusetts	O
women	O
,	O
black	O
women	O
reported	O
taking	O
periconceptional	O
multivitamins	O
half	O
as	O
often	O
as	O
white	O
women	O
.	O
19Additionally	O
,	O
our	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
is	O
similar	O
to	O
that	O
reported	O
in	O
NHANES24and	O
in	O
another	O
Boston	O
cohort	O
,	O
Project	O
Viva	O
.	O
13	O
,	O
25Others	O
have	O
analyzed	O
the	O
association	O
between	O
PNV	O
use	O
and	O
vitamin	O
D	O
status	O
.	O

While	O
there	O
is	O
interest	O
in	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
multiple	O
sclerosis	O
,	O
following	O
epidemiological	O
studies	O
demonstrating	O
an	O
association	O
between	O
vitamin	O
D	O
supplementation	O
and	O
reduced	O
prevalence	O
of	O
the	O
disease	O
,	O
future	O
research	O
,	O
including	O
randomized	O
controlled	O
trials	O
in	O
pregnant	O
or	O
nonpregnant	O
individuals	O
,	O
is	O
awaited	O
to	O
confirm	O
or	O
refute	O
such	O
benefit	O
.	O

Currently	O
conducted	O
animal	O
studies	O
provide	O
data	O
on	O
probable	B
therapeutic	O
use	O
of	O
paricalcitol	O
,	O
a	O
VD3analog	O
with	O
lower	O
calcemic	O
activity	O
,	O
in	O
uterine	O
fibroid	O
treatment	O
[	O
36	O
].	O

Higher	O
IMF	O
deposition	O
with	O
higher	O
concentrate	O
feeding	O
may	O
occur	O
if	O
IMF	O
preferentially	O
uses	O
glucose	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
,	O
while	O
subcutaneous	O
fat	O
uses	O
acetate	O
,	O
as	O
described	O
by	O
Smith	O
and	O
Crouse	O
[	O
88	O
].	O

Multi	O
-	O
country	O
studies	O
in	O
middle	O
-	O
and	O
low	O
-	O
income	O
countries	O
tracking	O
pregnant	O
women	O
with	O
improved	O
and	O
accurate	O
gestational	O
dating	O
may	O
help	O
contribute	O
to	O
improved	O
pregnancy	O
monitoring	O
and	O
a	O
better	O
understanding	O
of	O
all	O
pregnancy	O
outcomes	O
for	O
women	O
,	O
stillbirths	O
and	O
newborns	O
.	O

Although	O
SGA	O
status	O
was	O
the	O
main	O
outcome	O
of	O
our	O
study	O
,	O
we	O
also	O
evaluated	O
models	O
of	O
25	O
(	O
OH	O
)	O
D	O
and	O
birth	O
weight	O
percentile	O
after	O
adjusting	O
for	O
maternal	O
PIH	O
and	O
maternal	O
BMI	O
at	O
delivery	O
.	O

Induction	O
of	O
the	O
1α	O
-	O
hydroxylase	O
in	O
early	O
gestation	O
might	O
provide	O
a	O
mechanism	O
by	O
which	O
environmental	O
or	O
dietary	O
vitamin	O
D	O
can	O
influence	O
fetal	O
-	O
placental	O
development	O
.	O

Several	O
studies	O
have	O
reported	O
higher	O
IMF	O
content	O
in	O
high	O
concentrate	O
diets	O
compared	O
with	O
low	O
concentrate	O
diets	O
(	O
reviewed	O
in	O
Wood	O
et	O
al	O
[	O
116	O
]).	O

Decreasing	O
slaughter	O
age	O
may	O
be	O
better	O
for	O
reducing	O
production	O
costs	O
when	O
feed	O
prices	O
are	O
high	O
.	O

Any	O
cases	O
with	O
identified	O
hypercalcemia	O
(≥	O
11	O
mg	O
/	O
dL	O
)	O
were	O
reviewed	O
by	O
a	O
member	O
of	O
the	O
Maternal	O
-	O
Fetal	O
Medicine	O
Division	O
at	O
MUSC	O
.	O

Osteocrin	O
,	O
a	O
bone	O
-	O
secreted	O
protein	O
important	O
in	O
osteoblast	O
regulation	O
,	O
shows	O
homology	O
to	O
the	O
NP	O
family	O
and	O
can	O
also	O
bind	O
to	O
NPR	O
-	O
C	O
(	O
Moffatt	O
et	O
al	O
.	O

Considering	O
the	O
factors	O
affecting	O
vitamin	O
D	O
production	O
such	O
as	O
clothing	O
type	O
,	O
skin	O
color	O
and	O
the	O
time	O
of	O
day	O
being	O
exposed	O
to	O
the	O
sun	O
[	O
48	O
–	O
50	O
],	O
these	O
results	O
are	O
justifiable	B
.	O

Prevention	O
of	O
preterm	O
birth	O
is	O
primarily	B
a	O
knowledge	O
gap	O
Despite	O
the	O
burden	O
of	O
preterm	O
birth	O
,	O
few	O
effective	O
prevention	O
strategies	O
are	O
available	O
for	O
clinicians	O
,	O
policy	O
-	O
makers	O
and	O
program	O
managers	O
.	O

Prevalence	O
of	O
anaemia	O
fell	O
from	O
38	O
%	O
at	O
baseline	O
,	O
to	O
20	O
%	O
after	O
12	O
months	O
.	O

All	O
analyses	O
were	O
performed	O
in	O
R	O
software	O
(	O
R	O
version	O
3	O
.	O
2	O
.	O
2	O
).	O

Average	O
energy	O
intake	O
was	O
above	O
recommendations	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Figure1	O
).	O

Additional	O
studies	O
are	O
required	O
better	O
to	O
understand	O
women	O
’	O
s	O
attitudes	O
towards	O
using	O
supplements	O
and	O
the	O
way	O
nutritional	O
knowledge	O
is	O
delivered	O
and	O
used	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
between	O
overall	O
satisfaction	O
and	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
populationSocio	O
–	O
demographic	O
characteristicsLevel	O
of	O
satisfactionX2	O
;	O
P	O
-	O
valueSatisfied	O
(%)	O
Not	O
satisfied	O
(%)	O
marital	O
statussingle99	O
(	O
87	O
.	O
6	O
)	O
14	O
(	O
12	O
.	O
4	O
)	O
1	O
.	O
99	O
;	O
p	O
=	O
0	O
.	O
159married218	O
(	O
80	O
.	O
1	O
)	O
54	O
(	O
19	O
.	O
9	O
)	O
Age	O
group15	O
–	O
2061	O
(	O
85	O
.	O
9	O
)	O
10	O
(	O
14	O
.	O
1	O
)	O
5	O
.	O
66	O
;	O
p	O
=	O
0	O
.	O
22621	O
–	O
25125	O
(	O
79	O
.	O
6	O
)	O
32	O
(	O
20	O
.	O
4	O
)	O
26	O
–	O
3087	O
(	O
88	O
.	O
8	O
)	O
11	O
(	O
11	O
.	O
2	O
)	O
31	O
–	O
3536	O
(	O
85	O
.	O
7	O
)	O
6	O
(	O
14	O
.	O
3	O
)	O
36	O
–	O
4014	O
(	O
82	O
.	O
4	O
)	O
3	O
(	O
17	O
.	O
6	O
)	O
Pregnancy	O
groupprimigravida138	O
(	O
87	O
.	O
9	O
)	O
19	O
(	O
12	O
.	O
1	O
)	O
4	O
.	O
217	O
;	O
p	O
=	O
0	O
.	O
042	O
–	O
7	O
pregnancies214	O
(	O
93	O
.	O
6	O
)	O
14	O
(	O
6	O
.	O
4	O
)	O
Number	O
of	O
visit2105	O
(	O
82	O
.	O
7	O
)	O
22	O
(	O
17	O
.	O
3	O
)	O
1	O
.	O
249	O
;	O
p	O
=	O
0	O
.	O
333	O
–	O
9222	O
(	O
86	O
)	O
36	O
(	O
14	O
)	O
Educational	O
levelPrimary98	O
(	O
92	O
.	O
5	O
)	O
8	O
(	O
7	O
.	O
5	O
)	O
8	O
.	O
714	O
;	O
p	O
=	O
0	O
.	O
01Secondary190	O
(	O
94	O
.	O
1	O
)	O
12	O
(	O
5	O
.	O
9	O
)	O
Tertiary64	O
(	O
83	O
.	O
1	O
)	O
13	O
(	O
16	O
.	O
9	O
)	O
Recommendations	O
from	O
the	O
study	O
participants	O
Of	O
the	O
385	O
respondents	O
,	O
less	O
than	O
half	O
,	O
42	O
.	O
3	O
%	O
(	O
163	O
)	O
proposed	O
a	O
recommendation	O
to	O
ameliorate	O
or	O
improve	O
service	O
delivery	O
by	O
the	O
health	O
centres	O
.	O

Placental	O
Tissue	O
Placental	O
tissues	O
were	O
obtained	O
from	O
women	O
delivering	O
at	O
term	O
(>	O
37	O
weeks	O
of	O
gestation	O
)	O
and	O
preterm	O
(<	O
37	O
weeks	O
of	O
gestation	O
)	O
(	O
total	O
n	O
=	O
23	O
).	O

“	O
We	O
’	O
re	O
still	O
analyzing	O
data	O
—	O
it	O
generated	O
just	O
an	O
enormous	O
amount	O
of	O
data	O
,”	O
Lewis	O
says	O
.	O

In	O
our	O
clinical	O
samples	O
,	O
GR	O
γ	O
is	O
present	O
at	O
much	O
lower	O
levels	O
than	O
the	O
GR	O
α	O
isoform	O
in	O
the	O
placentas	O
studied	O
.	O

The	O
cattle	O
with	O
a	O
TT	O
genotype	O
(	O
approximately	O
6	O
.	O
15	O
%)	O
that	O
were	O
not	O
supplemented	O
with	O
vitamin	O
A	O
had	O
22	O
.	O
9	O
%	O
greater	O
IMF	O
compared	O
with	O
those	O
with	O
the	O
CC	O
genotype	O
(	O
approximately	O
4	O
.	O
95	O
%).	O

Also	O
the	O
present	O
diet	O
substances	O
causes	O
complication	O
.	O

Overall	O
,	O
a	O
woman	O
requires	O
about	O
2	O
–	O
2	O
.	O
8	O
mg	O
of	O
iron	O
per	O
day	O
during	O
pregnancy	O
[	O
17	O
].	O

All	O
models	O
were	O
adjusted	O
for	O
infant	O
sex	O
and	O
maternal	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
before	O
pregnancy	O
,	O
ethnicity	O
(	O
non	O
-	O
Caucasian	O
/	O
Caucasian	O
),	O
and	O
alcohol	O
,	O
tobacco	O
,	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
(	O
all	O
yes	O
/	O
no	O
).	O

Subgroup	O
analyses	O
revealed	O
some	O
potentially	O
key	O
findings	O
.	O

This	O
kind	O
of	O
damage	O
has	O
been	O
implicated	O
in	O
cancer	O
induction	O
.	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
in	O
offspring	O
exposed	O
to	O
a	O
prenatal	O
HF	O
diet	O
had	O
no	O
further	O
effect	O
(	O
Figure	O
4D	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g004	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Circulating	O
adult	O
female	O
progesterone	O
concentrations	O
at	O
proestrous	O
.	O

There	O
are	O
very	O
few	O
human	O
studies	O
which	O
include	O
three	O
generations	O
of	O
family	O
members	O
and	O
which	O
also	O
collect	O
anthropometric	O
data	O
or	O
study	O
heritability	O
patterns	O
.	O

For	O
laryngeal	O
spasm	O
,	O
intubation	O
and	O
,	O
in	O
rare	O
cases	O
,	O
tracheotomy	O
may	O
be	O
necessary	O
.	O

The	O
authors	O
noted	O
that	O
the	O
ART	O
and	O
smoking	O
cessation	O
studies	O
exhibited	O
no	O
evidence	O
of	O
bias	O
and	O
had	O
significant	O
effects	O
on	O
reduced	O
viral	O
load	O
(	O
ART	O
)	O
and	O
biochemically	O
validated	O
smoking	O
cessation	O
[	O
11	O
].	O

In	O
2014	O
,	O
we	O
conducted	O
an	O
observational	O
study	O
to	O
test	O
this	O
hypothesis	O
using	O
data	O
from	O
two	O
large	O
hospitals	O
in	O
Managua	O
,	O
Nicaragua	O
.	O

WT1	O
is	O
expressed	O
in	O
the	O
metanephric	O
blastema	O
and	O
probably	B
plays	O
a	O
key	O
role	O
in	O
podocyte	O
differentiation	O
[	O
12	O
],[	O
30	O
].	O

When	O
women	O
receive	O
weight	O
gain	O
advice	O
that	O
is	O
inconsistent	O
with	O
IOM	O
recommendations	O
(	O
i	O
.	O
e	O
.,	O
above	O
or	O
below	O
),	O
they	O
are	O
3	O
.	O
6	O
times	O
more	O
likely	B
to	O
gain	O
more	O
or	O
less	O
than	O
IOM	O
recommendations	O
,	O
respectively	O
[	O
7	O
].	O

Furthermore	O
,	O
many	O
healthcare	O
facilities	O
in	O
Johannesburg	O
serve	O
a	O
predominantly	O
migrant	O
population	O
[	O
81	O
]	O
posing	O
a	O
challenge	O
for	O
longitudinal	O
data	O
collection	O
.	O

Of	O
those	O
invited	O
,	O
over	O
half	O
decided	O
to	O
participate	O
.	O

Missing	O
data	O
on	O
prepregnancy	O
smoking	O
as	B
number	O
of	O
cigarettes	O
daily	O
were	O
imputed	O
as	B
a	O
median	O
value	O
(=	O
zero	O
)	O
by	O
GDM	O
status	O
according	O
to	O
smoking	O
status	O
(	O
n	O
=	O
22	O
).	O

The	O
text4baby	O
program	O
also	O
offers	O
an	O
example	O
of	O
using	O
behavioral	O
theory	O
to	O
the	O
design	O
mHealth	O
interventions	O
[	O
1	O
].	O

2008	O
)	O
by	O
rating	O
the	O
quality	O
of	O
individual	O
studies	O
and	O
carrying	O
out	O
a	O
sensitivity	O
analysis	O
by	O
excluding	O
studies	O
for	O
which	O
the	O
quality	O
score	O
was	O
below	O
a	O
chosen	O
value	O
.	O

Obesity	O
is	O
well	O
known	O
to	O
be	O
a	O
risk	O
factor	O
for	O
vitamin	O
D	O
deficiency	O
because	B
of	O
a	O
sequestering	O
of	O
vitamin	O
D	O
in	O
adipose	O
tissue	O
.	O
35Maternal	O
obesity	O
during	O
pregnancy	O
has	O
also	O
been	O
associated	O
with	O
lower	O
vitamin	O
D	O
levels	O
in	O
neonates	O
at	O
delivery	O
.	O
24	O
,	O
36	O
,	O
37	O
,	O
38Our	O
data	O
are	O
consistent	O
and	O
illustrate	O
the	O
inverse	O
relationship	O
between	O
maternal	O
BMI	O
at	O
delivery	O
and	O
vitamin	O
D	O
status	O
after	O
adjusting	O
for	O
confounding	O
variables	O
.	O

Disruptions	O
in	O
pathways	O
related	O
to	O
calcium	O
-	O
binding	O
proteins	O
and	O
mitochondrial	O
function	O
may	O
underlie	O
some	O
of	O
the	O
behavioural	O
features	O
associated	O
with	O
animal	O
models	O
of	O
developmental	O
vitamin	O
D	O
deficiency	O
Introduction	O
Based	O
on	O
clues	O
from	O
epidemiology	O
,	O
we	O
have	O
proposed	O
that	O
low	O
prenatal	O
vitamin	O
D	O
may	O
be	O
a	O
risk	O
factor	O
for	O
later	O
development	O
of	O
schizophrenia	O
[	O
1	O
].	O

Nevertheless	O
,	O
such	O
studies	O
have	O
helped	O
to	O
identify	O
putative	B
markers	O
and	O
assays	O
that	O
may	O
be	O
useful	O
for	O
biomonitoring	O
such	O
exposures	O
and	O
toxicities	O
,	O
and	O
testing	O
the	O
epigenetic	O
toxicity	O
potential	O
of	O
environmental	O
exposures	O
,	O
respectively	O
.	O

It	O
is	O
known	O
that	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D	O
is	O
responsible	B
for	O
increasing	O
intracellular	O
Ca	O
+	O
2concentration	O
and	O
the	O
activity	O
of	O
acrosine	O
,	O
which	O
is	O
accountable	O
for	O
acrosome	O
reactions	O
that	O
are	O
essential	O
for	O
the	O
fertilization	O
process	O
.	O

Strengths	O
and	O
limitations	O
of	O
this	O
study	O
A	O
cohort	O
study	O
using	O
a	O
prospectively	O
collected	O
database	O
,	O
including	O
comparison	O
groups	O
and	O
matching	O
.	O

While	O
,	O
any	O
statistically	O
significant	O
differences	O
were	O
not	O
observed	O
regarding	O
to	O
depression	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
Table	O
4	O
).	O

Having	O
many	O
exposure	O
variables	O
complicates	O
the	O
interpretation	B
of	O
associations	O
between	O
the	O
5	O
EDC	O
classes	O
and	O
birth	O
weight	O
when	O
using	O
traditional	O
multi	O
-	O
variable	O
linear	O
methods	O
.	O

A	O
total	O
of	O
136	O
children	O
(	O
52	O
.	O
1	O
%)	O
had	O
levels	O
<	O
75	O
nmol	O
/	O
L	O
,	O
indicating	O
suboptimal	O
vitamin	O
D	O
while	O
43	O
children	O
(	O
16	O
.	O
5	O
%)	O
had	O
inadequate	O
vitamin	O
D	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

These	O
cells	O
,	O
which	O
will	O
be	O
discussed	O
below	O
,	O
present	O
a	O
phenotype	O
with	O
metabolic	O
properties	O
that	O
are	O
closest	O
to	O
brown	O
than	O
to	O
white	O
adipocytes	O
.	O

per	O
quintile	O
effect	O
).	O

Methods	O
Medical	O
record	O
data	O
were	O
obtained	O
for	O
pregnant	O
patients	O
aged	O
18	O
–	O
45	O
years	O
between	O
September	O
2015	O
and	O
December	O
2016	O
.	O

Mechanisms	O
We	O
speculate	O
that	O
high	O
maternal	O
fructose	O
consumption	O
may	O
underlie	O
the	O
positive	O
associations	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
and	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
.	O

We	O
find	O
no	O
support	O
for	O
this	O
in	O
our	O
results	O
,	O
since	O
,	O
the	O
effect	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
psychotic	O
-	O
like	O
symptoms	O
were	O
almost	O
similar	O
to	O
those	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
.	O

Regulations	O
are	O
frequently	O
a	O
fine	O
balance	O
between	O
maximizing	O
the	O
‘	O
modern	O
life	O
’	O
benefits	O
of	O
an	O
environmental	O
chemical	O
while	O
minimizing	O
any	O
potential	O
adverse	O
effects	O
.	O

Additionally	O
,	O
PFAS	O
alter	O
human	O
[	O
20	O
]	O
and	O
animal	O
[	O
3	O
]	O
serum	O
lipid	O
levels	O
,	O
potentially	O
affecting	O
fetal	O
growth	O
and	O
development	O
.	O

PubMed	O
Central	O
:	O

A	O
large	O
laboratory	O
(	O
Quest	O
Diagnostics	O
)	O
recently	O
reported	O
the	O
possibility	O
of	O
thousands	O
of	O
incorrect	O
vitamin	O
D	O
level	O
results	O
.	O

Castration	O
of	O
bulls	O
increases	O
IMF	O
deposition	O
in	O
most	O
cattle	O
breeds	O
.	O

To	O
validate	O
the	O
nutritional	O
knowledge	O
questionnaire	O
,	O
item	O
analysis	O
was	O
performed	O
to	O
determine	O
item	O
difficulty	O
and	O
item	O
discrimination	O
indices	O
to	O
increase	O
reliability	O
.	O

Similar	O
to	O
other	O
aspects	O
of	O
appetite	O
regulation	O
(	O
70	O
,	O
71	O
),	O
EAH	O
appears	O
to	O
become	O
more	O
problematic	O
throughout	O
childhood	O
(	O
45	O
,	O
72	O
).	O

Neonatal	O
anthropometric	O
measurements	O
were	O
categorized	O
according	O
to	O
WHO	O
standards	O
and	O
as	O
follows	O
:	O
low	O
birth	O
weight	O
(	O
LBW	O
);	O
a	O
birth	O
weight	O
less	O
than	O
2500	O
g	O
,	O
normal	O
birth	O
weight	O
;	O
a	O
birth	O
weight	O
more	O
than	O
2500	O
g	O
and	O
less	O
than	O
3900	O
,	O
low	O
height	O
;	O
a	O
height	O
less	O
than	O
47	O
cm	O
,	O
normal	O
height	O
;	O
a	O
height	O
more	O
than	O
47	O
cm	O
and	O
less	O
than	O
55	O
cm	O
,	O
low	O
head	O
circumference	O
;	O
a	O
head	O
circumference	O
less	O
than	O
33	O
cm	O
,	O
normal	O
head	O
circumference	O
;	O
a	O
head	O
circumference	O
more	O
than	O
33	O
cm	O
and	O
less	O
than	O
37	O
cm	O
[	O
21	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Results	O
:	O
We	O
gathered	O
42	O
females	O
and	O
8	O
males	O
as	O
case	O
group	O
and	O
the	O
same	O
numbers	O
as	O
control	O
group	O
without	O
significant	O
age	O
difference	O
.	O

There	O
were	O
no	O
differences	O
among	O
deeply	O
deficient	O
(	O
VD	O
<	O
50nmol	O
/	O
L	O
)	O
and	O
VD	O
insufficient	O
(	O
VD	O
<	O
75nmol	O
/	O
L	O
)	O
recipients	O
.	O

Innovate	O
•	O
Work	O
in	O
partnership	O
to	O
provide	O
universal	O
access	O
to	O
the	O
essential	O
package	O
of	O
interventions	O
,	O
including	O
both	O
prevention	O
and	O
care	O
,	O
and	O
involving	O
task	O
shifting	O
where	O
appropriate	O
.	O

Confirmation	O
and	O
expansion	O
of	O
these	O
findings	O
in	O
additional	O
populations	O
,	O
with	O
additional	O
environmental	O
data	O
and	O
more	O
comprehensive	O
methylation	O
profiles	O
as	O
well	O
as	O
studies	O
of	O
the	O
mechanism	O
of	O
these	O
alterations	O
,	O
will	O
provide	O
additional	O
valuable	O
insights	O
into	O
the	O
epigenetic	O
mechanisms	O
controlling	O
fetal	O
growth	O
.	O

Conversely	O
,	O
many	O
FGAs	O
(	O
including	O
haloperidol	O
,	O
chlorpromazine	O
,	O
fluphenazine	O
,	O
thioridazine	O
)	O
have	O
been	O
associated	O
with	O
perinatal	O
complications	O
,	O
particularly	O
when	O
exposure	O
is	O
later	O
in	O
pregnancy	O
.	O
9These	O
include	O
but	O
are	O
not	O
limited	O
to	O
withdrawal	O
symptoms	O
,	O
unstable	O
body	O
temperature	O
,	O
extrapyramidal	O
signs	O
,	O
respiratory	O
distress	O
,	O
seizures	O
and	O
transient	O
neurodevelopmental	O
delay	O
.	O

This	O
disparity	O
may	O
reflect	O
tissue	O
-	O
specific	O
differences	O
in	O
these	O
relationships	O
,	O
as	O
well	O
as	O
the	O
larger	O
and	O
therefore	O
more	O
precise	O
nature	O
of	O
our	O
examination	O
.	O

Insulin	O
resistance	O
is	O
present	O
even	O
in	O
simple	O
obesity	O
,	O
without	O
hyperglycemia	O
,	O
indicating	O
a	O
fundamental	O
abnormality	O
of	O
insulin	O
signaling	O
in	O
states	O
of	O
excess	O
adipose	O
tissue	O
mass	O
.	O

Array	O
-	O
based	O
mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
CpG	O
loci	O
was	O
not	O
found	O
to	O
be	O
associated	O
with	O
any	O
of	O
our	O
in	O
utero	O
exposures	O
,	O
contrasting	O
with	O
our	O
repetitive	O
element	O
methylation	O
markers	O
.	O

Yet	O
,	O
specific	O
DNA	O
demethylase	O
enzyme	O
(	O
s	O
)	O
in	O
mammals	O
remained	O
elusive	O
until	O
the	O
discovery	O
of	O
the	O
10	O
–	O
11	O
translocation	O
(	O
TET	O
)	O
enzyme	O
family	O
.	O

A	O
computational	O
analysis	O
of	O
these	O
data	O
revealed	O
that	O
many	O
of	O
the	O
proteins	O
dysregulated	O
in	O
the	O
DVD	O
model	O
have	O
also	O
been	O
shown	O
to	O
be	O
altered	O
in	O
schizophrenia	O
post	O
-	O
mortem	O
brain	O
studies	O
[	O
18	O
].	O

2	O
Data	O
collection	O
per	O
phase	O
during	O
the	O
NuPED	O
study	O
.	O

[	O
1	O
]	O
The	O
question	O
scientists	O
have	O
been	O
working	O
on	O
for	O
almost	O
a	O
decade	O
is	O
why	O
and	O
how	O
vitamin	O
D	O
is	O
affecting	O
conception	O
,	O
pregnancy	O
and	O
the	O
health	O
of	O
the	O
newborn	O
.	O

Trunk	O
blood	O
was	O
collected	O
and	O
centrifuged	O
,	O
and	O
plasma	O
samples	O
were	O
added	O
with	O
0	O
.	O
5	O
%	O
ascorbic	O
acid	O
to	O
prevent	O
folate	O
oxidation	O
.	O

The	O
number	O
of	O
adolescents	O
in	O
the	O
present	O
study	O
was	O
small	O
(	O
n	O
=	O
23	O
)	O
and	O
conclusions	O
cannot	O
readily	O
be	O
drawn	O
concerning	O
the	O
haematological	O
responses	O
of	O
this	O
sub	O
-	O
group	O
.	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

[	O
18	O
]	O
and	O
Hibbeln	O
et	O
al	O
.	O

At	O
some	O
time	O
in	O
their	O
life	O
,	O
these	O
children	O
laid	O
down	O
less	O
cortical	O
bone	O
than	O
normal	O
children	O
,	O
a	O
finding	O
consistent	O
with	O
undetected	O
and	O
untreated	O
childhood	O
or	O
even	O
intrauterine	O
vitamin	O
D	O
deficiency	O
.	O

Early	O
recognition	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	O
for	O
a	O
successful	O
outcome	O
.	O

Statistical	O
significance	O
was	O
declared	O
at	O
α	O
=	O
0	O
.	O
05	O
.	O

Our	O
results	O
suggest	O
that	O
habitual	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
precede	O
the	O
clinical	O
diagnosis	O
of	O
GDM	O
.	O

We	O
aimed	O
to	O
investigate	O
the	O
pregnancy	O
outcomes	O
of	O
women	O
receiving	O
SGAs	O
relative	O
to	O
a	O
comparison	O
group	O
of	O
matched	O
healthy	O
controls	O
and	O
to	O
compare	O
the	O
outcomes	O
of	O
antipsychotic	O
monotherapy	O
with	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

The	O
PCR	O
conditions	O
used	O
were	O
40	O
cycles	O
of	O
98	O
°	O
C	O
for	O
5	O
sec	O
,	O
annealing	O
at	O
50	O
°	O
C	O
for	O
5	O
sec	O
,	O
and	O
elongation	O
at	O
72	O
°	O
C	O
for	O
15	O
sec	O
.	O

Statistical	O
significance	O
was	O
not	O
reached	O
for	O
these	O
outcomes	O
.	O

Estimates	O
of	O
BAT	O
mass	O
and	O
activity	O
from	O
FDG	O
-	O
PET	O
studies	O
suggest	O
that	O
humans	O
have	O
,	O
on	O
average	O
,	O
50	O
–	O
80	O
g	O
of	O
BAT	O
(	O
Peirce	O
et	O
al	O
.,	O
2014	O
).	O

Thus	B
,	O
an	O
overview	O
of	O
non	O
-	O
neoplastic	O
,	O
pre	O
-	O
neoplastic	O
,	O
neoplastic	O
and	O
benign	O
pathologies	O
within	O
each	O
model	O
system	O
is	O
essential	O
for	O
the	O
accurate	O
interpretation	O
of	O
life	O
-	O
long	O
rodent	O
studies	O
.	O

The	O
analysis5reported	O
that	O
heritability	O
estimates	O
rose	O
by	O
0	O
.	O
012	O
/	O
year	O
throughout	O
childhood	O
(	O
age	O
≤	O
18	O
years	O
)	O
but	O
decreased	O
by	O
−	O
0	O
.	O
002	O
/	O
year	O
in	O
adulthood	O
.	O

The	O
women	O
with	O
high	O
level	O
of	O
education	O
and	O
women	O
attending	O
for	O
their	O
first	O
pregnancies	O
were	O
not	O
satisfied	O
with	O
the	O
competence	O
of	O
the	O
staff	O
.	O

A	O
difference	O
in	O
nature	O
of	O
antenatal	O
depression	O
compared	O
to	O
postnatal	O
depression	O
can	O
reflect	O
another	O
possible	O
reason	B
for	O
achieving	O
this	O
result	O
.	O

Prenatal	O
vitamins	O
,	O
which	O
contain	O
zinc	O
,	O
are	O
generally	B
obtained	O
via	O
a	O
prescription	O
through	O
the	O
Indian	O
Health	O
Service	O
.	O

We	O
were	O
unable	O
to	O
adjust	O
for	O
antibiotic	O
usage	O
due	O
to	O
a	O
paucity	O
of	O
exposure	O
and	O
imprecise	O
data	O
on	O
timing	O
of	O
exposure	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
milieu	O
of	O
higher	O
melatonin	O
and	O
insulin	O
resistance	O
during	O
winter	O
in	O
early	O
pregnancy	O
may	O
set	O
the	O
scene	O
for	O
glucose	O
homeostasis	O
throughout	O
the	O
remaining	O
months	O
of	O
pregnancy	O
.	O

2011	O
).	O

Hub	O
proteins	O
not	O
significantly	O
dysregulated	O
in	O
the	O
study	O
are	O
shown	O
as	O
clear	O
.	O

IIH	O
was	O
associated	O
with	O
significant	O
morbidity	O
,	O
including	O
symptomatic	O
hypercalcaemia	O
and	O
nephrocalcinosis	O
.	O

Besides	O
sunlight	O
exposure	O
,	O
Vitamin	O
D	O
supplementation	O
is	O
also	O
an	O
important	O
factor	O
that	O
affects	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
among	O
women	O
with	O
GDM	O
.	O

Physiology	O
of	O
pregnancy	O
Thyroid	O
hormones	O
and	O
foetal	O
development	O
The	O
first	O
endocrine	O
structure	O
to	O
appear	O
during	O
embryonic	O
development	O
is	O
the	O
thyroid	O
gland	O
.	O

However	O
,	O
these	O
children	O
represent	O
a	O
small	O
proportion	O
of	O
the	O
individuals	O
with	O
a	O
suboptimal	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
.	O

Couples	O
with	O
serum	O
concentration	O
exceeding	O
50	O
nmol	O
/	O
L	O
have	O
a	O
higher	O
chance	B
of	O
conception	O
,	O
but	O
this	O
does	O
not	O
regard	O
all	O
patients	O
,	O
where	O
especially	O
males	O
should	O
be	O
supplemented	O
with	O
vitamin	O
D	O
from	O
the	O
beginning	O
of	O
the	O
therapy	O
.	O

The	O
World	O
Health	O
Organization	O
recommends	O
a	O
daily	O
intake	O
of	O
60	O
mg	O
iron	O
and	O
400	O
μg	O
folic	O
acid	O
for	O
six	O
months	O
to	O
prevent	O
anaemia	O
[	O
33	O
].	O

Animal	O
and	O
cell	O
culture	O
studies	O
have	O
suggested	O
a	O
potential	O
solution	O
:	O
zinc	O
supplementation	O
.	O
44Hudson	O
and	O
Lewis	O
want	O
to	O
see	O
if	O
zinc	O
supplementation	O
may	O
prevent	O
arsenic	O
from	O
damaging	O
DNA	O
repair	O
enzymes	O
in	O
women	O
enrolled	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
,	O
and	O
they	O
have	O
identified	O
an	O
easy	O
way	O
to	O
do	O
this	O
.	O

An	O
increase	O
in	O
vitamin	O
D	O
can	O
cause	O
parathyroid	O
hormones	O
to	O
decrease	O
.	O

However	O
,	O
should	O
the	O
researchers	O
be	O
able	O
to	O
obtain	O
additional	O
funding	O
,	O
additional	O
participants	O
may	O
be	O
included	O
.	O

Despite	O
of	O
these	O
alterations	O
,	O
in	O
general	O
,	O
the	O
female	O
phenotype	O
seems	O
less	O
severely	O
affected	O
after	O
the	O
exposure	O
to	O
maternal	O
undernutrition	O
in	O
early	O
development	O
.	O

The	O
researcher	O
took	O
non	O
-	O
fasting	O
venous	O
blood	O
samples	O
from	O
mothers	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
gestational	O
weeks	O
between	O
09	O
:	O
00	O
and	O
11	O
:	O
00	O
am	O
.	O

In	O
reporting	O
the	O
results	O
,	O
we	O
use	O
the	O
lowest	O
level	O
of	O
assigned	O
taxonomy	O
available	O
,	O
which	O
is	O
most	O
commonly	O
the	O
genus	O
,	O
but	O
ranges	O
from	O
the	O
family	O
to	O
the	O
species	O
level	O
.	O

Information	O
on	O
morbidity	O
and	O
menstrual	O
patterns	O
was	O
also	O
recorded	O
at	O
these	O
visits	O
.	O

This	O
manually	O
-	O
curated	O
database	O
builds	O
hypothetical	O
networks	O
based	O
on	O
the	O
candidate	O
proteins	O
and	O
other	O
potentially	O
associated	O
proteins	O
in	O
the	O
database	O
.	O

Skm1	O
homozygous	O
mutant	O
mice	O
were	O
born	O
with	O
expected	O
Mendelian	O
frequency	O
and	O
were	O
easily	O
distinguished	O
from	O
their	O
wild	O
-	O
type	O
littermates	O
at	O
weaning	O
.	O

The	O
association	O
between	O
“	O
standardised	O
”	O
25	O
(	O
OH	O
)	O
D	O
with	O
pregnancy	O
complications	O
is	O
presented	O
in	O
Table	O
2	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
established	O
that	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
is	O
recommended	O
during	O
pregnancy	O
and	O
lactation	O
[	O
7	O
].	O

Structured	O
questionnaires	O
were	O
administered	O
to	O
assess	O
the	O
availability	O
of	O
supplements	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
and	O
women	O
'	O
s	O
attitude	O
about	O
,	O
and	O
their	O
history	O
of	O
,	O
taking	O
the	O
supplements	O
[	O
13	O
].	O

Recommendations	O
The	O
World	O
Health	O
Organization	O
has	O
recommended	O
that	O
weekly	O
iron	O
and	O
folic	O
acid	O
supplementation	O
should	O
be	O
considered	O
as	B
a	O
strategy	O
for	O
prevention	O
of	O
iron	O
deficiency	O
in	O
population	O
groups	O
.	O

The	O
key	O
thresholds	B
used	O
to	O
quantify	O
25	O
(	O
OH	O
)	O
D	O
levels	O
within	O
this	O
study	O
were	O
≥	O
75	O
nmol	O
/	O
L	O
(	O
optimal	O
based	B
on	I
HICL	O
and	O
HSC	O
),	O
≥	O
50	O
nmol	O
/	O
L	O
(	O
adequate	O
based	B
on	I
Institute	O
of	O
Medicine	O
(	O
IOM	O
)),	O
and	O
<	O
35	O
nmol	O
/	O
L	O
(	O
common	B
threshold	B
used	O
to	O
denote	O
deficiency	O
)	O
[	O
14	O
,	O
16	O
,	O
26	O
-	O
28	O
].	O

A	O
specific	O
Alexa	O
488	O
-	O
conjugated	O
GAS5	O
hybridization	O
probe	O
(	O
GTGCTATCCAGAGCCACACTGCATCTGCACCCAGCACCATACCTCACAG	O
)	O
was	O
utilised	O
as	O
previously	O
described	O
[	O
8	O
]	O
and	O
followed	O
by	O
an	O
overnight	O
incubation	O
at	O
37	O
°	O
C	O
in	O
a	O
humidified	O
chamber	O
.	O

Do	O
we	O
run	O
the	O
risk	O
of	O
banning	O
a	O
chemical	O
that	O
does	O
not	O
demonstrate	O
any	O
epigenetic	O
toxicity	O
at	O
the	O
levels	O
found	O
within	O
the	O
environment	O
or	O
human	O
populations	O
only	O
to	O
replace	O
it	O
with	O
an	O
alternative	O
whose	O
characteristics	O
and	O
potential	O
effects	O
we	O
know	O
even	O
less	O
about	O
?	O

However	O
,	O
why	O
would	O
foreign	O
air	O
pollution	O
of	O
today	O
do	O
what	O
American	O
air	O
pollution	O
of	O
the	O
1950s	O
and	O
60s	O
could	O
not	O
?	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
mothers	O
and	O
offspring	O
who	O
had	O
information	O
on	O
at	O
least	O
one	O
of	O
the	O
outcomes	O
of	O
interest	O
(	O
wheeze	O
,	O
asthma	O
,	O
atopy	O
,	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
and	O
lung	O
function	O
)	O
by	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
#	O
Free	O
sugar	O
intake	O
g	O
·	O
day	O
−	O
1p	O
-	O
valueQuintile	O
1	O
(	O
1	O
.	O
6	O
–	O
34	O
.	O
0	O
)	O
Quintile	O
2	O
(	O
34	O
.	O
0	O
–	O
46	O
.	O
6	O
)	O
Quintile	O
3	O
(	O
46	O
.	O
6	O
–	O
60	O
.	O
8	O
)	O
Quintile	O
4	O
(	O
60	O
.	O
8	O
–	O
82	O
.	O
4	O
)	O
Quintile	O
5	O
(	O
82	O
.	O
4	O
–	O
345	O
.	O
1	O
)	O
Mother	O
'	O
s	O
age	O
years	O
29	O
.	O
4	O
±	O
4	O
.	O
729	O
.	O
1	O
±	O
4	O
.	O
529	O
.	O
2	O
±	O
4	O
.	O
628	O
.	O
9	O
±	O
4	O
.	O
527	O
.	O
9	O
±	O
4	O
.	O
7	O
<	O
0	O
.	O
001	O
Parity	O
043	O
.	O
246	O
.	O
148	O
.	O
644	O
.	O
944	O
.	O
00	O
.	O
001	O
135	O
.	O
437	O
.	O
235	O
.	O
136	O
.	O
335	O
.	O
9	O
≥	O
221	O
.	O
416	O
.	O
716	O
.	O
318	O
.	O
820	O
.	O
0	O
Sex	O
of	O
child	O
Male51	O
.	O
252	O
.	O
350	O
.	O
552	O
.	O
349	O
.	O
50	O
.	O
39	O
Female48	O
.	O
847	O
.	O
749	O
.	O
547	O
.	O
750	O
.	O
5	O
Multiple	O
pregnancy	O
Singleton97	O
.	O
396	O
.	O
798	O
.	O
098	O
.	O
397	O
.	O
30	O
.	O
01	O
Twin2	O
.	O
73	O
.	O
32	O
.	O
01	O
.	O
72	O
.	O
7	O
Season	O
of	O
birth	O
Winter15	O
.	O
017	O
.	O
616	O
.	O
615	O
.	O
716	O
.	O
0	O
<	O
0	O
.	O
001	O
Spring23	O
.	O
625	O
.	O
326	O
.	O
829	O
.	O
130	O
.	O
7	O
Summer33	O
.	O
129	O
.	O
331	O
.	O
828	O
.	O
927	O
.	O
1	O
Autumn28	O
.	O
327	O
.	O
824	O
.	O
926	O
.	O
426	O
.	O
2	O
Breastfeeding	O
duration	O
months	O
Never21	O
.	O
318	O
.	O
917	O
.	O
522	O
.	O
127	O
.	O
1	O
<	O
0	O
.	O
001	O
<	O
334	O
.	O
030	O
.	O
030	O
.	O
129	O
.	O
234	O
.	O
2	O
3	O
–	O
613	O
.	O
114	O
.	O
914	O
.	O
613	O
.	O
312	O
.	O
8	O
≥	O
631	O
.	O
536	O
.	O
337	O
.	O
435	O
.	O
425	O
.	O
9	O
Mother	O
'	O
s	O
educational	O
level	O
Certificate	O
of	O
Secondary	O
Education16	O
.	O
712	O
.	O
913	O
.	O
414	O
.	O
520	O
.	O
4	O
<	O
0	O
.	O
001	O
Vocational8	O
.	O
69	O
.	O
28	O
.	O
18	O
.	O
510	O
.	O
8	O
Ordinary	O
level36	O
.	O
235	O
.	O
032	O
.	O
835	O
.	O
138	O
.	O
8	O
Advanced	O
level24	O
.	O
626	O
.	O
626	O
.	O
326	O
.	O
021	O
.	O
2	O
Degree14	O
.	O
016	O
.	O
219	O
.	O
415	O
.	O
98	O
.	O
9	O
Maternal	O
ethnicity	O
White97	O
.	O
897	O
.	O
298	O
.	O
598	O
.	O
498	O
.	O
80	O
.	O
003	O
Non	O
-	O
white2	O
.	O
22	O
.	O
81	O
.	O
51	O
.	O
61	O
.	O
2	O
Housing	O
tenure	O
Owned	O
/	O
mortgaged82	O
.	O
686	O
.	O
586	O
.	O
585	O
.	O
176	O
.	O
8	O
<	O
0	O
.	O
001	O
Council	O
rented9	O
.	O
97	O
.	O
26	O
.	O
68	O
.	O
815	O
.	O
8	O
Non	O
-	O
council	O
rented7	O
.	O
56	O
.	O
37	O
.	O
06	O
.	O
17	O
.	O
5	O
Financial	O
difficulties	O
No82	O
.	O
682	O
.	O
884	O
.	O
385	O
.	O
378	O
.	O
8	O
<	O
0	O
.	O
001	O
Yes17	O
.	O
417	O
.	O
215	O
.	O
714	O
.	O
721	O
.	O
2	O
Maternal	O
history	O
of	O
atopic	O
diseases	O
No32	O
.	O
232	O
.	O
033	O
.	O
731	O
.	O
428	O
.	O
90	O
.	O
05	O
Yes67	O
.	O
868	O
.	O
066	O
.	O
368	O
.	O
671	O
.	O
1	O
Maternal	O
anxiety	O
score	O
during	O
pregnancy	O
0	O
–	O
924	O
.	O
023	O
.	O
423	O
.	O
120	O
.	O
814	O
.	O
3	O
<	O
0	O
.	O
001	O
10	O
–	O
1425	O
.	O
127	O
.	O
525	O
.	O
726	O
.	O
124	O
.	O
3	O
15	O
–	O
2024	O
.	O
425	O
.	O
127	O
.	O
327	O
.	O
125	O
.	O
4	O
≥	O
2026	O
.	O
524	O
.	O
124	O
.	O
026	O
.	O
136	O
.	O
1	O
Maximum	O
maternal	O
tobacco	O
exposure	O
cigarettes	O
·	O
day	O
−	O
1	O
None27	O
.	O
827	O
.	O
628	O
.	O
928	O
.	O
219	O
.	O
2	O
<	O
0	O
.	O
001	O
Passive	O
only45	O
.	O
448	O
.	O
547	O
.	O
346	O
.	O
042	O
.	O
3	O
1	O
–	O
97	O
.	O
67	O
.	O
78	O
.	O
18	O
.	O
08	O
.	O
1	O
10	O
–	O
1912	O
.	O
510	O
.	O
19	O
.	O
410	O
.	O
115	O
.	O
2	O
≥	O
206	O
.	O
76	O
.	O
26	O
.	O
27	O
.	O
715	O
.	O
2	O
Maternal	O
paracetamol	O
use	O
during	O
pregnancy	O
No38	O
.	O
038	O
.	O
037	O
.	O
738	O
.	O
036	O
.	O
40	O
.	O
86	O
Yes62	O
.	O
062	O
.	O
062	O
.	O
362	O
.	O
063	O
.	O
6	O
Maternal	O
antibiotic	O
use	O
during	O
pregnancy	O
No83	O
.	O
785	O
.	O
484	O
.	O
083	O
.	O
782	O
.	O
90	O
.	O
34	O
Yes16	O
.	O
314	O
.	O
616	O
.	O
016	O
.	O
317	O
.	O
1	O
Maternal	O
supplement	O
use	O
during	O
pregnancy	O
No44	O
.	O
543	O
.	O
144	O
.	O
441	O
.	O
941	O
.	O
60	O
.	O
26	O
Yes55	O
.	O
556	O
.	O
955	O
.	O
658	O
.	O
158	O
.	O
4	O
Maternal	O
infections	O
during	O
pregnancy	O
No57	O
.	O
255	O
.	O
155	O
.	O
853	O
.	O
349	O
.	O
3	O
<	O
0	O
.	O
001	O
Yes42	O
.	O
844	O
.	O
944	O
.	O
246	O
.	O
750	O
.	O
7	O
Total	O
energy	O
intake	O
kJ	O
·	O
day	O
−	O
15567	O
±	O
13766499	O
±	O
13267166	O
±	O
13607931	O
±	O
14889317	O
±	O
1994	O
<	O
0	O
.	O
001	O
Maternal	O
pre	O
-	O
pregnancy	O
BMI	O
kg	O
·	O
m	O
−	O
2	O
<	O
18	O
.	O
502	O
.	O
72	O
.	O
84	O
.	O
44	O
.	O
08	O
.	O
1	O
<	O
0	O
.	O
001	O
18	O
.	O
50	O
–	O
24	O
.	O
9970	O
.	O
874	O
.	O
377	O
.	O
776	O
.	O
777	O
.	O
4	O
25	O
.	O
00	O
–	O
29	O
.	O
9917	O
.	O
717	O
.	O
113	O
.	O
514	O
.	O
811	O
.	O
6	O
≥	O
30	O
.	O
008	O
.	O
85	O
.	O
84	O
.	O
44	O
.	O
52	O
.	O
9	O
Birthweight	O
g	O
<	O
25004	O
.	O
24	O
.	O
03	O
.	O
64	O
.	O
35	O
.	O
60	O
.	O
02	O
2500	O
–	O
299914	O
.	O
213	O
.	O
213	O
.	O
912	O
.	O
815	O
.	O
2	O
3000	O
–	O
349934	O
.	O
834	O
.	O
935	O
.	O
136	O
.	O
735	O
.	O
6	O
3500	O
–	O
399932	O
.	O
233	O
.	O
633	O
.	O
533	O
.	O
633	O
.	O
0	O
≥	O
400014	O
.	O
714	O
.	O
413	O
.	O
812	O
.	O
611	O
.	O
0	O
Gestational	O
age	O
weeks	O
39	O
.	O
4	O
±	O
1	O
.	O
839	O
.	O
5	O
±	O
1	O
.	O
739	O
.	O
5	O
±	O
1	O
.	O
739	O
.	O
5	O
±	O
1	O
.	O
839	O
.	O
4	O
±	O
1	O
.	O
90	O
.	O
28	O
Child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
kg	O
·	O
m	O
−	O
2	O
<	O
15	O
.	O
0025	O
.	O
826	O
.	O
330	O
.	O
327	O
.	O
730	O
.	O
7	O
<	O
0	O
.	O
001	O
15	O
.	O
00	O
–	O
17	O
.	O
4951	O
.	O
952	O
.	O
351	O
.	O
254	O
.	O
452	O
.	O
6	O
17	O
.	O
50	O
–	O
20	O
.	O
4917	O
.	O
216	O
.	O
614	O
.	O
214	O
.	O
313	O
.	O
6	O
≥	O
20	O
.	O
505	O
.	O
24	O
.	O
84	O
.	O
33	O
.	O
53	O
.	O
1	O
Maternal	O
weight	O
gain	O
during	O
pregnancy	O
Quartile	O
130	O
.	O
323	O
.	O
724	O
.	O
523	O
.	O
524	O
.	O
5	O
<	O
0	O
.	O
001	O
Quartile	O
224	O
.	O
325	O
.	O
025	O
.	O
124	O
.	O
725	O
.	O
0	O
Quartile	O
324	O
.	O
227	O
.	O
026	O
.	O
326	O
.	O
423	O
.	O
4	O
Quartile	O
421	O
.	O
324	O
.	O
324	O
.	O
125	O
.	O
427	O
.	O
1	O
Data	O
are	O
presented	O
as	O
mean	O
±	O
sdor	O
%,	O
unless	O
otherwise	O
stated	O
.	O

All	O
continuous	O
variables	O
were	O
examined	O
for	O
normality	O
with	O
the	O
Shapiro	O
-	O
Wilk	O
test	O
and	O
expressed	O
as	O
the	O
mean	O
±	O
Standard	O
Deviation	O
(	O
SD	O
).	O

A	O
considerable	O
amount	O
of	O
glucose	O
is	O
absorbed	O
from	O
the	O
small	O
intestine	O
when	O
high	O
-	O
starch	O
diets	O
are	O
fed	O
,	O
especially	O
during	O
the	O
beef	O
cattle	O
fattening	O
period	O
.	O

Even	O
more	O
importantly	O
,	O
the	O
body	O
grew	O
faster	O
than	O
the	O
head	O
for	O
those	O
with	O
ASD	O
by	O
the	O
end	O
of	O
the	O
first	O
year	O
of	O
life	O
,	O
suggesting	O
a	O
closer	O
following	O
of	O
length	O
to	O
circumference	O
during	O
development	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
a	O
slightly	O
negative	O
trend	O
of	O
increased	O
cathelicidin	O
correlated	O
with	O
a	O
decreased	O
frequency	O
of	O
diagnosed	O
infections	O
within	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
147	O
,	O
p	O
=	O
0	O
.	O
092	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Cathelicidin	O
Concentration	O
by	O
Age	O
.	O

Western	O
Immunoblotting	O
Proteins	O
from	O
placental	O
lysates	O
and	O
BeWo	O
cells	O
treated	O
with	O
10	O
–	O
1000	O
nM	O
cortisol	O
were	O
separated	O
on	O
an	O
SDS	O
-	O
12	O
%	O
polyacrylamide	O
gel	O
and	O
transferred	O
to	O
a	O
nitrocellulose	O
membrane	O
.	O

However	O
,	O
we	O
are	O
not	O
seeking	O
to	O
report	O
or	O
measure	O
adiposity	O
in	O
itself	O
in	O
this	O
analysis	O
;	O
for	O
comparator	O
purposes	O
,	O
we	O
report	O
BMI	O
at	O
the	O
three	O
time	O
points	O
in	O
order	O
to	O
compare	O
like	O
with	O
like	O
both	O
(	O
1	O
)	O
in	O
relation	O
to	O
the	O
child	O
over	O
time	O
and	O
(	O
2	O
)	O
in	O
relation	O
to	O
the	O
adults	O
.	O

Further	O
research	O
is	O
required	O
,	O
particularly	O
to	O
establish	O
the	O
dose	O
needed	O
to	O
supplement	O
pregnant	O
women	O
with	O
pre	O
-	O
existing	O
deficiency	O
and	O
the	O
optimal	O
gestation	O
at	O
which	O
vitamin	O
D	O
supplementation	O
should	O
be	O
started	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
No	O
.	O

One	O
earlier	O
study	O
,	O
from	O
Denmark	O
,	O
found	O
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
associated	O
with	O
pregnancy	O
loss	O
in	O
the	O
first	O
trimester	O
[	O
24	O
].	O

Information	O
on	O
BMI	O
at	O
T1	O
and	O
season	O
of	O
conception	O
(	O
December	O
–	O
May	O
or	O
June	O
–	O
November	O
)	O
was	O
obtained	O
from	O
the	O
medical	O
records	O
.	O

We	O
observed	O
a	O
negative	O
association	O
between	O
fruit	O
intake	O
and	O
OTUs	O
of	O
the	O
genus	O
Bifidobacterium	O
and	O
a	O
positive	O
association	O
with	O
OTUs	O
in	O
the	O
Clostridiaceae	O
family	O
in	O
the	O
infant	O
gut	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2d	O
).	O

Because	B
we	O
were	O
concerned	O
that	O
ever	O
-	O
users	O
included	O
a	O
heterogeneous	O
category	O
of	O
PNV	O
users	O
including	O
women	O
who	O
only	O
used	O
before	O
pregnancy	O
or	O
only	O
after	O
pregnancy	O
diagnosis	O
,	O
we	O
compared	O
this	O
estimate	O
to	O
an	O
analogous	O
model	O
comparing	O
women	O
who	O
used	O
both	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
(	O
always	O
users	O
,	O
n	O
=	O
477	O
)	O
to	O
never	O
users	O
(	O
n	O
=	O
256	O
).	O

The	O
resulting	O
digested	O
fragments	O
were	O
separated	O
on	O
a	O
2	O
%	O
agarose	O
gel	O
to	O
determine	O
the	O
genotypes	O
.	O

2	O
.	O
8	O
.	O

A	O
burgeoning	O
body	O
of	O
research	O
—	O
from	O
rodent	O
toxicology	O
to	O
human	O
epidemiology	O
studies	O
—	O
suggests	O
that	O
certain	O
environmental	O
exposures	O
may	O
impair	O
a	O
mother	O
’	O
s	O
ability	O
to	O
nurse	O
her	O
child	O
.	O

PFAS	O
are	O
used	O
as	O
stain	O
and	O
water	O
repellants	O
[	O
11	O
],	O
fire	O
fighting	O
foams	O
[	O
11	O
]	O
and	O
food	O
contact	O
material	O
[	O
3	O
]	O
while	O
PCBs	O
were	O
used	O
as	O
hydraulic	O
oil	O
additives	O
[	O
2	O
],	O
coolant	O
fluids	O
[	O
2	O
,	O
5	O
]	O
and	O
insulators	O
[	O
12	O
].	O

However	O
,	O
its	O
use	O
should	O
be	O
limited	O
to	O
a	O
selected	O
group	O
of	O
patients	O
who	O
are	O
unable	O
to	O
tolerate	O
oral	O
iron	O
and	O
in	O
whom	O
oral	O
iron	O
therapy	O
fails	O
due	O
to	O
noncompliance	O
.	O

We	O
defined	O
severe	O
pneumonia	O
as	O
cough	O
plus	O
chest	O
in	O
-	O
drawing	O
and	O
very	O
severe	O
diseases	O
as	O
cough	O
plus	O
any	O
danger	O
signs	O
.	O

The	O
condition	O
may	O
be	O
defined	O
as	O
a	O
chronic	O
neurodevelopmental	O
disorder	O
that	O
first	O
becomes	O
prevalent	O
in	O
an	O
individual	O
during	O
his	O
/	O
her	O
early	O
childhood	O
.	O

Some	O
sires	O
may	O
have	O
high	O
breeding	O
value	O
for	O
both	O
IMF	O
and	O
YG	O
,	O
and	O
selection	O
of	O
such	O
sires	O
is	O
likely	B
to	O
be	O
beneficial	O
for	O
increasing	O
IMF	O
deposition	O
without	O
decreasing	O
YG	O
.	O

Therefore	B
,	O
no	O
special	O
diet	O
for	O
the	O
mother	O
is	O
required	O
during	O
pregnancy	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Raw	O
BMI	O
correlations	O
between	O
child	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
members	O
,	O
with	O
sample	O
size	O
(	O
N	O
)	O
for	O
each	O
pairGroupChildMotherFatherMGMMGFPGMPGFChild	O
'	O
s	O
age	O
01	O
.	O
0000	O
.	O
1390	O
.	O
0540	O
.	O
1130	O
.	O
0630	O
.	O
0930	O
.	O
054p	O
Value0	O
.	O
002	O
*	O
0	O
.	O
2770	O
.	O
043	O
*	O
0	O
.	O
3760	O
.	O
1970	O
.	O
548N494402321201196125Child	O
'	O
s	O
age	O
5	O
0	O
.	O
1560	O
.	O
1610	O
.	O
1480	O
.	O
1150	O
.	O
0940	O
.	O
020p	O
Value	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
002	O
*	O
0	O
.	O
029	O
*	O
0	O
.	O
1910	O
.	O
2620	O
.	O
849N54037921713214491Child	O
'	O
s	O
age	O
9	O
0	O
.	O
2420	O
.	O
0610	O
.	O
2800	O
.	O
2440	O
.	O
0440	O
.	O
050p	O
Value	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
3690	O
.	O
001	O
*	O
0	O
.	O
024	O
*	O
0	O
.	O
6810	O
.	O
722N242218128858953	O
*	O
Significant	O
associations	O
,	O
mainly	O
in	O
the	O
maternal	O
line	O
.	O

All	O
experiments	O
were	O
carried	O
out	O
in	O
triplicate	O
.	O

Results	O
:	O
The	O
infants	O
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

According	O
to	O
a	O
study	O
on	O
300	O
men	O
,	O
Bloomberg	O
concluded	O
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
D3increased	O
intracellular	O
calcium	O
concentration	O
and	O
sperm	O
motility	O
and	O
induced	O
the	O
acrosome	O
reaction	O
in	O
mature	O
spermatozoa	O
.	O

Questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Community	O
Assessment	O
of	O
Psychic	O
Experiences	O
,	O
CAPE	O
-	O
42	O
,	O
Stefanis	O
et	O
al	O
.,	O
2002	O
[	O
1	O
]),	O
answered	O
by	O
33	O
623	O
women	O
in	O
the	O
follow	O
-	O
up	O
study	O
of	O
Women	O
'	O
s	O
Lifestyle	O
and	O
Health	O
Cohort	O
Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
file	O
PubMed	O
Central	O
:	O

[	O
47	O
],	O
we	O
identified	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
at	O
6	O
weeks	O
of	O
age	O
using	O
the	O
partitioning	O
around	O
medoids	O
(	O
PAM	O
)	O
method	O
of	O
clustering	O
on	O
generalized	O
UniFrac	O
distances	O
.	O

An	O
associated	O
issue	O
is	O
that	O
,	O
after	O
the	O
start	O
of	O
our	O
trial	O
,	O
speculations	O
arose	O
that	O
high	O
fluctuations	O
of	O
natural	O
or	O
supplemented	O
vitamin	O
D	O
intake	O
might	O
be	O
linked	O
to	O
negative	O
outcomes	O
.	O

Sampling	O
The	O
target	O
population	O
of	O
the	O
survey	O
comprised	O
all	O
pregnant	O
women	O
in	O
Belgium	O
during	O
the	O
first	O
and	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
the	O
period	O
from	O
September	O
2010	O
to	O
June	O
2011	O
.	O

†	O
Studies	O
validating	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fatty	O
acidsDietary	O
intake	O
g	O
/	O
day	O
·	O
MJPositive	O
psychotic	O
-	O
like	O
symptomsaMedianInterquintile	O
rangeLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
group	O
Energy	O
adjustedMultivariatebEnergy	O
adjustedMultivariatebMarine	O
fatty	O
acidscNo	O
.	O
No	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CINo	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CI	O
0	O
.	O
016	O
(	O
0	O
.	O
00	O
-	O
0	O
.	O
02	O
)	O
4478Ref	O
.	O
36372370	O
.	O
030	O
(	O
0	O
.	O
02	O
-	O
0	O
.	O
04	O
)	O
460635870	O
.	O
940	O
.	O
89	O
-	O
1	O
.	O
000	O
.	O
97d0	O
.	O
91	O
-	O
1	O
.	O
031770	O
.	O
710	O
.	O
58	O
-	O
0	O
.	O
870	O
.	O
75d0	O
.	O
61	O
-	O
0	O
.	O
920	O
.	O
050	O
(	O
0	O
.	O
04	O
-	O
0	O
.	O
06	O
)	O
473335380	O
.	O
910	O
.	O
86	O
-	O
0	O
.	O
970	O
.	O
96d0	O
.	O
90	O
-	O
1	O
.	O
021760	O
.	O
690	O
.	O
57	O
-	O
0	O
.	O
850	O
.	O
76d0	O
.	O
61	O
-	O
0	O
.	O
930	O
.	O
070	O
(	O
0	O
.	O
06	O
-	O
0	O
.	O
80	O
)	O
459436331	O
.	O
000	O
.	O
94	O
-	O
1	O
.	O
061	O
.	O
05d0	O
.	O
98	O
-	O
1	O
.	O
132270	O
.	O
960	O
.	O
80	O
-	O
1	O
.	O
161	O
.	O
05d0	O
.	O
85	O
-	O
1	O
.	O
29	O
Omega	O
-	O
6	O
fatty	O
acidse	O
0	O
.	O
6	O
(	O
0	O
.	O
1	O
-	O
0	O
.	O
7	O
)	O
4408Ref	O
.	O
37122610	O
.	O
7	O
(	O
0	O
.	O
6	O
-	O
0	O
.	O
8	O
)	O
470935130	O
.	O
880	O
.	O
82	O
-	O
0	O
.	O
930	O
.	O
88f0	O
.	O
83	O
-	O
0	O
.	O
941820	O
.	O
640	O
.	O
53	O
-	O
0	O
.	O
780	O
.	O
67f0	O
.	O
55	O
-	O
0	O
.	O
820	O
.	O
8	O
(	O
0	O
.	O
7	O
-	O
0	O
.	O
8	O
)	O
467035820	O
.	O
900	O
.	O
85	O
-	O
0	O
.	O
960	O
.	O
91f0	O
.	O
86	O
-	O
0	O
.	O
971730	O
.	O
620	O
.	O
51	O
-	O
0	O
.	O
750	O
.	O
66f0	O
.	O
54	O
-	O
0	O
.	O
810	O
.	O
9	O
(	O
0	O
.	O
9	O
-	O
2	O
.	O
1	O
)	O
462435880	O
.	O
920	O
.	O
86	O
-	O
0	O
.	O
980	O
.	O
93f0	O
.	O
86	O
-	O
0	O
.	O
992010	O
.	O
730	O
.	O
60	O
-	O
0	O
.	O
880	O
.	O
78f0	O
.	O
64	O
-	O
0	O
.	O
97	O
Omega	O
-	O
3	O
fatty	O
acidsg	O
0	O
.	O
14	O
(	O
0	O
.	O
02	O
-	O
0	O
.	O
17	O
)	O
4444Ref	O
.	O
36632520	O
.	O
18	O
(	O
0	O
.	O
17	O
-	O
0	O
.	O
20	O
)	O
461336280	O
.	O
950	O
.	O
89	O
-	O
1	O
.	O
010	O
.	O
98b0	O
.	O
92	O
-	O
1	O
.	O
041750	O
.	O
660	O
.	O
54	O
-	O
0	O
.	O
810	O
.	O
73h0	O
.	O
60	O
-	O
0	O
.	O
890	O
.	O
21	O
(	O
0	O
.	O
20	O
-	O
0	O
.	O
22	O
)	O
473635120	O
.	O
900	O
.	O
84	O
-	O
0	O
.	O
960	O
.	O
95b0	O
.	O
89	O
-	O
1	O
.	O
011760	O
.	O
660	O
.	O
53	O
-	O
0	O
.	O
800	O
.	O
76h0	O
.	O
62	O
-	O
0	O
.	O
940	O
.	O
26	O
(	O
0	O
.	O
22	O
-	O
0	O
.	O
93	O
)	O
461835920	O
.	O
960	O
.	O
90	O
-	O
1	O
.	O
021	O
.	O
02b0	O
.	O
95	O
-	O
1	O
.	O
092140	O
.	O
830	O
.	O
69	O
-	O
1	O
.	O
001	O
.	O
00h0	O
.	O
82	O
-	O
1	O
.	O
23	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bIn	O
the	O
multivariate	O
analysis	O
presented	O
,	O
we	O
initially	O
tested	O
the	O
effects	O
of	O
adjusting	O
also	O
for	O
BMI	O
,	O
level	O
of	O
education	O
,	O
country	O
of	O
birth	O
,	O
smoking	O
,	O
dietary	O
intake	O
of	O
meat	O
,	O
dairy	O
products	O
,	O
fruits	O
,	O
cereals	O
and	O
refined	O
sugar	O
,	O
rheumatoid	O
arthritis	O
,	O
gluten	O
intolerance	O
,	O
diabetes	O
and	O
multivitamin	O
supplement	O
.	O

BMI	O
—	O
child	O
age	O
0	O
In	O
the	O
nuclear	O
family	O
,	O
the	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
was	O
highly	O
significant	O
(	O
table	O
4	O
).	O

showing	O
a	O
negative	O
correlation	O
between	O
dietary	O
PUFA	O
intake	O
and	O
the	O
severity	O
of	O
psychotic	O
symptoms	O
[	O
15	O
],	O
as	O
well	O
as	O
studies	O
showing	O
that	O
patients	O
with	O
schizophrenia	O
or	O
depression	O
have	O
lower	O
levels	O
of	O
PUFAs	O
in	O
brain	O
tissue	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblasts	O
and	O
with	O
a	O
low	O
intake	O
of	O
fish	O
and	O
PUFAs	O
[	O
16	O
,	O
29	O
-	O
31	O
].	O

Although	O
we	O
are	O
the	O
first	O
to	O
show	O
that	O
the	O
brain	O
at	O
maturity	O
responds	O
to	O
vitamins	O
,	O
our	O
results	O
are	O
substantiated	O
by	O
a	O
report	O
of	O
hypothalamic	O
changes	O
in	O
the	O
food	O
intake	O
regulatory	O
genes	O
due	B
to	I
the	O
interaction	O
of	O
maternal	O
and	O
post	O
-	O
weaning	O
diets	O
high	O
in	O
saturated	O
fats	O
in	O
male	O
offspring	O
.	O
29	O
Surprisingly	O
,	O
a	O
ten	O
-	O
fold	O
addition	O
of	O
folate	O
alone	O
to	O
the	O
RV	O
diet	O
modified	O
some	O
of	O
the	O
effects	O
of	O
the	O
maternal	O
HV	O
diet	O
on	O
the	O
offspring	O
,	O
suggesting	O
a	O
possible	O
primary	O
role	O
for	O
this	O
methyl	O
group	O
vitamin	O
.	O

Associations	O
between	O
SNPs	O
and	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
following	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
.	O

If	O
there	O
are	O
more	O
than	O
5	O
%	O
errors	O
,	O
respective	O
data	O
are	O
re	O
-	O
captured	O
.	O

The	O
required	O
dosage	O
of	O
insulin	O
usually	O
increases	O
gradually	O
over	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

The	O
LOESS	O
curve	O
for	O
the	O
MUSC	O
cohort	O
closely	O
tracks	O
the	O
LOESS	O
curve	O
for	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Understanding	O
the	O
reasons	B
for	O
racial	O
and	O
ethnic	O
disparities	O
in	O
preterm	O
birth	O
will	O
advance	O
the	O
field	O
of	O
pregnancy	O
health	O
broadly	O
,	O
as	O
well	O
as	O
accelerate	O
solutions	O
for	O
those	O
populations	O
most	O
in	O
need	O
.	O

Engagement	O
with	O
prenatal	O
care	O
appeared	O
to	O
increase	O
the	O
likelihood	B
that	O
less	O
well	O
-	O
educated	O
women	O
would	O
take	O
supplements	O
during	O
pregnancy	O
,	O
suggesting	O
that	O
the	O
prenatal	O
nutritional	O
advice	O
may	O
be	O
a	O
useful	O
intervention	O
.	O

1c	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S2a	O
).	O

Effects	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
in	O
overweight	O
and	O
obese	O
women	O
on	O
6	O
month	O
infant	O
outcomes	O
:	O
follow	O
-	O
up	O
from	O
the	O
LIMIT	O
randomised	O
trial	O
Abstract	O
Background	O
The	O
immediate	O
impact	O
of	O
providing	O
an	O
antenatal	O
dietary	O
intervention	O
during	O
pregnancy	O
has	O
been	O
extensively	O
studied	O
,	O
but	O
little	O
is	O
known	O
of	O
the	O
effects	O
beyond	O
the	O
neonatal	O
period	O
.	O

At	O
weaning	O
,	O
only	O
eight	O
Skm2	O
mutants	O
out	O
of	O
84	O
progeny	O
were	O
identified	O
(	O
9	O
.	O
5	O
%	O
ratio	O
),	O
suggesting	O
embryonic	O
or	O
perinatal	O
mortality	O
.	O

Study	O
Limitations	O
This	O
study	O
provides	O
useful	O
data	O
of	O
the	O
relationship	O
between	O
serum	O
visfatin	O
and	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

According	O
to	O
USDA	O
nutrition	O
data	O
,	O
the	O
main	O
food	O
sources	O
of	O
Vitamin	O
D	O
are	O
cheese	O
(	O
7	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
egg	O
yolk	O
(	O
5	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
canned	O
sardine	O
(	O
4	O
.	O
8	O
μg	O
/	O
100	O
g	O
),	O
butter	O
(	O
1	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
and	O
animal	O
organs	O
and	O
meat	O
products	O
(	O
less	O
than	O
1	O
%)	O
[	O
5	O
].	O

For	O
the	O
24	O
-	O
HR	O
all	O
portion	O
sizes	O
are	O
converted	O
to	O
grams	O
per	O
day	O
per	O
food	O
item	O
.	O

To	O
combat	O
prenatal	O
influences	O
on	O
child	O
obesity	O
,	O
pregnant	O
women	O
should	O
be	O
strongly	O
discouraged	O
from	O
smoking	O
and	O
encouraged	O
to	O
consume	O
a	O
diet	O
low	O
in	O
fat	O
with	O
adequate	O
protein	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Only	O
few	O
of	O
these	O
polymorphisms	O
are	O
functionally	O
relevant	O
and	O
these	O
are	O
the	O
Tth111	O
I	O
,	O
the	O
ER22	O
/	O
23EK	O
,	O
the	O
N363S	O
,	O
the	O
—	O
already	O
mentioned	O
—	O
Bcl	O
I	O
,	O
and	O
the	O
GR	O
-	O
9	O
β	O
.	O

Women	O
were	O
recruited	O
between	O
13	O
and	O
19	O
weeks	O
of	O
pregnancy	O
from	O
prenatal	O
clinics	O
between	O
2003	O
and	O
2006	O
.	O

Parents	O
and	O
other	O
individuals	O
track	O
dust	O
and	O
dirt	O
into	O
the	O
home	O
,	O
on	O
shoes	O
and	O
clothes	O
,	O
after	O
working	O
on	O
the	O
farm	O
.	O

Vitamin	O
D	O
group	O
received	O
2000	O
IU	O
vitamin	O
D3daily	O
from	O
26	O
to	O
28	O
weeks	O
of	O
gestation	O
until	O
childbirth	O
.	O

No	O
genes	O
were	O
found	O
consistently	O
differentially	O
expressed	O
between	O
the	O
groups	O
along	O
all	O
examined	O
stages	O
.	O

Within	O
our	O
sample	O
,	O
provider	O
advice	O
and	O
accuracy	O
did	O
not	O
vary	O
based	O
on	O
women	O
’	O
s	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

ANC	O
coverage	O
in	O
Cameroon	O
in	O
2007	O
stood	O
at	O
82	O
%	O
with	O
60	O
%	O
of	O
pregnant	O
women	O
having	O
four	O
or	O
more	O
visits	O
[	O
2	O
].	O

All	O
outcomes	O
were	O
assessed	O
for	O
normality	O
using	O
visual	O
inspection	O
.	O

[	O
40	O
]	O
shows	O
that	O
assisted	O
reproductive	O
therapy	O
and	O
a	O
history	O
of	O
infertility	O
do	O
not	O
increase	O
the	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
.	O

Fertility	O
cannot	O
be	O
the	O
only	O
concern	O
of	O
a	O
physician	O
consulting	O
male	O
patients	O
.	O

At	O
initial	O
recruitment	O
within	O
the	O
main	O
study	O
baseline	O
stool	O
samples	O
had	O
not	O
been	O
collected	O
.	O

In	O
the	O
present	O
study	O
,	O
vitamin	O
D	O
restriction	O
during	O
nephrogenesis	O
reduced	O
podocin	O
expression	O
in	O
the	O
F1	O
generation	O
from	O
weaning	O
until	O
six	O
months	O
of	O
age	O
but	O
not	O
in	O
the	O
F2	O
generation	O
.	O

Serum	O
was	O
processed	O
within	O
4	O
h	O
of	O
collection	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
until	O
required	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
mean	O
vitamin	O
D	O
concentrations	O
in	O
vitamin	O
D	O
group	O
were	O
significantly	O
higher	O
after	O
taking	O
2000	O
IU	O
of	O
vitamin	O
D	O
supplementation	O
per	O
day	O
for	O
at	B
least	I
8	O
weeks	O
.	O

Conclusion	O
In	O
conclusion	O
,	O
lower	O
early	O
pregnancy	O
25OHD	O
was	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Very	O
few	O
women	O
(	O
6	O
%)	O
enrolled	O
for	O
ANC	O
during	O
their	O
first	O
trimester	O
of	O
pregnancy	O
,	O
the	O
median	O
gestational	O
age	O
was	O
28	O
weeks	O
(	O
range	O
15	O
to	O
41	O
weeks	O
).	O

The	O
authors	O
concluded	O
that	O
higher	O
subjective	O
social	O
standing	O
in	O
school	O
might	O
protect	O
against	O
weight	O
gain	O
in	O
adolescent	O
girls	O
.	O

Means	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

With	O
this	O
,	O
there	O
was	O
a	O
1	O
%	O
incidence	O
of	O
serious	O
perinatal	O
outcomes	O
(	O
death	O
,	O
shoulder	O
dystocia	O
,	O
fracture	O
,	O
and	O
nerve	O
palsy	O
)	O
compared	O
to	O
4	O
%	O
amongst	O
women	O
provided	O
with	O
standard	O
pregnancy	O
care	O
only	O
(	O
adjusted	O
risk	O
reduction	O
0	O
.	O
33	O
,	O
p	O
=	O
0	O
.	O
01	O
).	O

*:	O
p	O
<	O
0	O
.	O
05	O
compared	O
between	O
the	O
two	O
groups	O
Vitamin	O
D	O
supplement	O
intake	O
situation	O
There	O
were	O
fourteen	O
out	O
of	O
total	O
ninety	O
-	O
eight	O
participants	O
(	O
19	O
.	O
5	O
%)	O
who	O
did	O
not	O
take	O
Vitamin	O
D	O
supplement	O
.	O

Fasting	O
glucose	O
and	O
HbA1cwere	O
lowest	O
among	O
Greek	O
patients	O
with	O
type	O
2	O
diabetes	O
during	O
August	O
and	O
September	O
[	O
23	O
].	O

Despite	O
considerable	O
efforts	O
to	O
unravel	O
the	O
etiologic	O
basis	O
for	O
this	O
cancer	O
and	O
attempts	O
to	O
find	O
a	O
cure	O
,	O
gliomas	O
largely	O
remain	O
refractory	O
to	O
treatment	O
.	O

It	O
can	O
provide	O
information	O
on	O
genetic	O
and	O
physiological	O
diseases	O
,	O
improper	O
lifestyle	O
(	O
including	O
dietary	O
habits	O
),	O
and	O
a	O
variety	O
of	O
pathological	O
conditions	O
.	O

In	O
healthy	O
controls	O
,	O
25	O
[	O
OH	O
]	O
D	O
has	O
shown	O
to	O
be	O
positively	O
correlated	O
with	O
AMH	O
status	O
,	O
presenting	O
seasonal	O
variance	O
[	O
25	O
].	O

[	O
18	O
],	O
the	O
predictors	O
selected	O
by	O
LASSO	O
and	O
Elastic	O
Net	O
were	O
incorporated	O
into	O
an	O
omnibus	O
multiple	O
linear	O
regression	O
model	O
to	O
obtain	O
unpenalized	O
,	O
mutually	O
adjusted	O
estimates	O
.	O

Furthermore	O
,	O
in	O
Thailand	O
dairy	O
products	O
are	O
not	O
fortified	O
with	O
vitamin	O
D	O
and	O
very	O
few	O
vitamin	O
D	O
-	O
rich	O
foods	O
are	O
part	O
of	O
the	O
Thai	O
diet	O
.	O

The	O
BP	O
of	O
the	O
F2	O
-	O
VitD	O
-	O
offspring	O
increased	O
more	O
slowly	O
than	O
that	O
of	O
the	O
F1	O
-	O
VitD	O
-	O
offspring	O
,	O
and	O
at	O
6	O
months	O
,	O
the	O
difference	O
between	O
these	O
groups	O
was	O
significant	O
(	O
F2	O
-	O
VitD	O
-	O
mice	O
had	O
10	O
%	O
lower	O
BP	O
than	O
F1	O
-	O
VitD	O
-	O
mice	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

3	O
.	O
4	O
.	O

In	O
a	O
pilot	O
study	O
published	O
in	O
2012	O
,	O
we	O
were	O
the	O
first	O
to	O
specifically	O
report	O
differences	O
in	O
actual	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
between	O
children	O
with	O
and	O
without	O
severe	O
decay	O
[	O
14	O
].	O

Additionally	O
,	O
the	O
diagnosis	O
of	O
GDM	O
indicates	O
that	O
the	O
mother	O
has	O
a	O
predisposition	O
to	O
diabetes	O
.	O

AM251	O
(	O
Tocris	O
,	O
Bioscence	O
,	O
Bristol	O
,	O
UK	O
)	O
was	O
dissolved	O
in	O
a	O
vehicle	O
containing	O
5	O
%	O
Tween	O
80	O
and	O
95	O
%	O
saline	O
.	O

All	O
participants	O
were	O
analyzed	O
in	O
the	O
group	O
to	O
which	O
they	O
were	O
originally	O
randomized	O
.	O

In	O
an	O
epidemiological	O
study	O
conducted	O
in	O
India	O
by	O
Mamidala	O
et	O
al	O
.,	O
maternal	O
hormonal	O
intervention	O
was	O
a	O
significant	O
risk	O
factor	O
for	O
ASD	O
,	O
possibly	O
due	O
to	O
maternal	O
hormone	O
disturbances	O
causing	O
obstetric	O
complications	O
,	O
which	O
in	O
turn	O
are	O
a	O
risk	O
for	O
ASD	O
[	O
42	O
].	O

This	O
review	O
will	O
examine	O
the	O
pharmacological	O
options	O
for	O
the	O
management	O
of	O
gestational	O
diabetes	O
,	O
as	O
well	O
as	O
the	O
evidence	O
for	O
blood	O
glucose	O
monitoring	O
,	O
dietary	O
and	O
exercise	O
therapy	O
.	O

*	O
Family	O
planning	O
scaled	O
to	O
60	O
%	O
coverage	O
or	O
to	O
a	O
level	O
whereby	O
the	O
total	O
fertility	O
rate	O
is	O
2	O
.	O
5	O
.	O

In	O
the	O
fetal	O
stage	O
,	O
the	O
main	O
process	O
is	O
increasing	O
the	O
number	O
of	O
adipocytes	O
(	O
hyperplasia	O
)	O
derived	O
from	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
[	O
21	O
].	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

2005	O
).	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

To	O
understand	O
this	O
result	O
,	O
it	O
should	O
be	O
emphasized	O
that	O
nephrogenesis	O
in	O
rodents	O
,	O
unlike	O
in	O
humans	O
,	O
continues	O
after	O
delivery	O
for	O
the	O
first	O
10	O
days	O
of	O
postnatal	O
life	O
.	O

When	O
the	O
“	O
deficient	O
”	O
threshold	B
(<	O
35	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
,	O
this	O
relationship	O
failed	O
to	O
reach	O
significance	O
(	O
p	O
=	O
0	O
.	O
12	O
(	O
Fisher	O
’	O
s	O
Exact	O
Test	O
),	O
OR	O
=	O
2	O
.	O
7	O
).	O

To	O
investigate	O
confounding	O
by	O
post	O
-	O
natal	O
sugar	O
intake	O
,	O
we	O
adjusted	O
additionally	O
for	O
child	O
'	O
s	O
sugar	O
intake	O
at	O
age	O
3	O
years	O
.	O

The	O
median	O
(	O
IQR	O
)	O
change	O
in	O
25OHD	O
from	O
early	O
pregnancy	O
to	O
late	O
pregnancy	O
among	O
women	O
attending	O
the	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
was	O
0	O
.	O
60	O
nmol	O
/	O
L	O
(	O
22	O
.	O
42	O
)	O
and	O
during	O
extended	O
summer	O
was	O
−	O
11	O
.	O
14	O
nmol	O
/	O
L	O
(	O
22	O
.	O
75	O
).	O

Reporting	O
the	O
50	O
%	O
CIs	O
also	O
decreases	O
the	O
Type	O
II	O
error	O
resulting	O
from	O
BHLM	O
shrinkage	O
.	O

Side	O
Effects	O
of	O
Iron	O
Supplements	O
Gastrointestinal	O
distress	O
is	O
commonly	O
observed	O
in	O
women	O
consuming	O
high	O
levels	O
of	O
supplemental	O
iron	O
on	O
an	O
empty	O
stomach	O
[	O
7	O
].	O

The	O
women	O
in	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
significantly	O
younger	O
,	O
had	O
a	O
higher	O
prevalence	O
of	O
overweight	O
and	O
obesity	O
and	O
were	O
less	O
educated	O
than	O
women	O
with	O
less	O
or	O
no	O
experience	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Regarding	O
chocolate	O
preference	O
in	O
adolescence	O
(	O
Figure3A	O
),	O
three	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
474	O
.	O
01	O
,	O
P	O
<	O
0	O
.	O
001	O
],	O
diet	O
[	O
F	O
(	O
1	O
,	O
67	O
)=	O
7	O
.	O
49	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
67	O
)=	O
37	O
.	O
81	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Radunz	O
et	O
al	O
[	O
156	O
]	O
tested	O
the	O
effects	O
of	O
three	O
maternal	O
late	O
-	O
gestational	O
dietary	O
energy	O
sources	O
(	O
grass	O
hay	O
,	O
corn	O
,	O
and	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
)	O
on	O
progeny	O
postnatal	O
growth	O
and	O
beef	O
MS	O
in	O
an	O
Angus	O
cross	O
-	O
breed	O
.	O

Differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
Hispanic	O
and	O
Caucasian	O
infants	O
may	O
be	O
related	O
to	O
lifestyle	O
including	O
sunshine	O
exposure	O
.	O

The	O
benefits	O
of	O
supplementation	O
for	O
tuberculosis	O
are	O
similarly	O
unclear	O
.	O

Likewise	O
it	O
should	O
be	O
unacceptable	O
for	O
almost	O
3	O
million	O
newborns	O
,	O
to	O
die	O
,	O
including	O
those	O
who	O
are	O
born	O
too	O
soon	O
.	O

In	O
our	O
study	O
,	O
an	O
approximate	O
4	O
-	O
fold	O
change	O
in	O
the	O
GR	O
α	O
/	O
GR	O
-	O
P	O
in	O
preterm	O
labor	O
was	O
detected	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
parameters	O
of	O
the	O
time	O
domain	O
:	O
(	O
A	O
)	O
RMSSD	O
and	O
(	O
B	O
)	O
PNN50	O
.	O

One	O
mouse	O
per	O
metabolic	O
cage	O
was	O
kept	O
in	O
a	O
system	O
containing	O
six	O
different	O
metabolic	O
cages	O
(	O
n	O
=	O
6	O
per	O
group	O
)	O
for	O
48	O
h	O
(	O
to	O
acclimatize	O
)	O
and	O
then	O
left	O
for	O
three	O
days	O
to	O
document	O
water	O
intake	O
and	O
take	O
24	O
h	O
urine	O
samples	O
for	O
a	O
volume	O
determination	O
.	O

In	O
addition	O
,	O
there	O
were	O
no	O
significant	O
correlations	O
found	O
between	O
concentration	O
of	O
cathelicidin	O
and	O
the	O
child	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
birth	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
,	O
or	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
area	O
under	O
the	O
curve	O
from	O
pregnancy	O
visits	O
3	O
–	O
7	O
.	O

2	O
.	O
3	O
.	O

Sequencing	O
of	O
genomic	O
DNA	O
revealed	O
a	O
T	O
-	O
to	O
-	O
A	O
transversion	O
at	O
nucleotide	O
position	O
1151	O
,	O
causing	O
a	O
mutation	O
from	O
an	O
isoleucine	O
residue	O
to	O
an	O
asparagine	O
residue	O
(	O
I384N	O
)	O
(	O
Figure	O
3A	O
,	O
left	O
panel	O
).	O

PubMed	O
Central	O
:	O

in	O
acute	O
and	O
delayed	O
response	O
to	O
the	O
nutritional	O
stimulus	O
.	O

[	O
17	O
]	O
New	O
research	O
suggests	O
that	O
women	O
who	O
take	O
high	O
doses	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
have	O
a	O
greatly	O
reduced	O
risk	O
of	O
complications	O
,	O
including	O
gestational	O
diabetes	O
,	O
preterm	O
birth	O
,	O
and	O
infection	O
.	O

RC	O
male	O
offspring	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
,	O
Acox1	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
(	O
Figures5C	O
,	O
D	O
).	O

A	O
2008	O
review	O
detailed	O
the	O
devastating	O
effect	O
gestational	O
vitamin	O
D	O
deficiency	O
has	O
on	O
developing	O
mammalian	O
brains	O
(	O
7	O
).	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	O
that	O
a	O
prolonged	O
feeding	O
period	O
gives	O
the	O
cattle	O
time	O
to	O
obtain	O
high	O
IMF	O
levels	O
because	O
time	O
is	O
needed	O
for	O
muscle	O
to	O
reach	O
maturity	O
,	O
followed	O
by	O
time	O
for	O
the	O
muscle	O
to	O
fill	O
up	O
with	O
IMF	O
.	O

In	O
several	O
cases	O
,	O
a	O
maternal	O
dietary	O
factor	O
was	O
associated	O
with	O
a	O
microbe	O
in	O
both	O
delivery	O
groups	O
but	O
in	O
opposite	O
directions	O
.	O

Based	O
on	O
these	O
considerations	O
,	O
we	O
aim	O
to	O
focus	O
on	O
the	O
long	O
-	O
term	O
effects	O
on	O
cannabinoid	O
-	O
related	O
behaviors	O
(	O
i	O
.	O
e	O
.,	O
cannabinoid	O
receptor	O
antagonist	O
-	O
induced	O
suppression	O
of	O
feeding	O
),	O
and	O
effects	O
on	O
lipid	O
-	O
related	O
metabolic	O
pathways	O
of	O
a	O
maternal	O
exposure	O
to	O
a	O
moderate	O
caloric	O
restriction	O
during	O
the	O
preconceptional	O
and	O
gestational	O
period	O
.	O

Folate	O
deficiency	O
was	O
associated	O
with	O
an	O
increase	O
in	O
DNA	O
damage	O
in	O
spermatocytes	O
.	O

No	O
individual	O
comparison	O
for	O
each	O
category	O
—	O
pooled	O
estimate	O
only	O
.	O
Fish	O
intake	O
during	O
pregnancy	O
estimated	O
via	O
semi	O
-	O
quantitative	O
FFQ	O
.	O
Peabody	O
Picture	O
Vocabulary	O
Test	O
(	O
PPVT	O
)	O
and	O
Wide	O
Range	O
Assessment	O
of	O
Visual	O
Motor	O
Abilities	O
(	O
WRAVMA	O
)	O
tested	O
at	O
~	O
38	O
months	O
age	O
of	O
child	O
and	O
analysed	O
for	O
association	O
with	O
fish	O
intake	O
.	O
FFQ	O
of	O
typical	O
diet	O
during	O
pregnancy	O
completed	O
3	O
months	O
after	O
delivery	O
and	O
fish	O
and	O
shellfish	O
/	O
squid	O
intake	O
estimated	O
.	O
Neurodevelopment	O
(	O
as	O
well	O
as	O
diet	O
and	O
physical	O
activity	O
)	O
assessed	O
when	O
child	O
was	O
4	O
years	O
of	O
age	O
using	O
the	O
McCarthy	O
Scales	O
of	O
Children	O
’	O
s	O
Abilities	O
(	O
MCSA	O
)	O
tests	O
—	O
global	O
cognitive	O
scale	O
&	O
5	O
subscales	O
(	O
perceptive	O
-	O
performance	O
,	O
memory	O
,	O
verbal	O
,	O
quantitative	O
and	O
motor	O
).	O
Fish	O
intake	O
measured	O
via	O
FFQ	O
4	O
days	O
after	O
birth	O
of	O
child	O
.	O

On	O
the	O
contrary	O
to	O
the	O
above	O
mentioned	O
studies	O
,	O
Neilson	O
et	O
al	O
.,	O
in	O
a	O
case	O
–	O
control	O
study	O
,	O
found	O
that	O
an	O
increase	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
can	O
enhance	O
the	O
possibility	O
of	O
postnatal	O
depression	O
.	O

Inform	O
•	O
Strengthen	O
global	O
networks	O
to	O
disseminate	O
new	O
research	O
findings	O
and	O
best	O
practice	O
related	O
to	O
preterm	O
birth	O
through	O
leveraging	O
the	O
momentum	O
from	O
Born	O
Too	O
Soon	O
and	O
commitments	O
of	O
these	O
institutions	O
.	O

Restricting	O
children	O
'	O
s	O
access	O
to	O
a	O
preferred	O
food	O
has	O
been	O
associated	O
with	O
higher	O
levels	O
of	O
EAH	O
in	O
girls	O
aged	O
3	O
to	O
5	O
years	O
(	O
49	O
,	O
78	O
)	O
and	O
in	O
non	O
-	O
Hispanic	O
white	O
girls	O
aged	O
5	O
to	O
9	O
years	O
(	O
47	O
,	O
72	O
,	O
79	O
).	O

The	O
same	O
report	O
estimated	O
that	O
up	O
to	O
2	O
kg	O
of	O
starch	O
/	O
d	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
of	O
dairy	O
cows	O
;	O
the	O
average	O
starch	O
digestibility	O
in	O
the	O
small	O
intestine	O
was	O
60	O
.	O
6	O
%.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

3	O
.	O
4	O
.	O

2b	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S4	O
).	O

AGE	O
was	O
also	O
seen	O
to	O
significantly	O
reduce	O
intracellular	O
reactive	O
oxygen	O
species	O
in	O
several	O
cell	O
types	O
.	O

Maximum	O
starch	O
utilization	O
can	O
be	O
achieved	O
by	O
optimizing	O
fermentation	O
of	O
starch	O
in	O
the	O
rumen	O
to	O
produce	O
propionate	O
(	O
gluconeogenic	O
precursor	O
)	O
and	O
maximizing	O
starch	O
digestion	O
and	O
absorption	O
in	O
the	O
small	O
intestine	O
.	O

The	O
plasma	O
levels	O
of	O
HDL	O
were	O
significantly	O
decreased	O
in	O
RC	O
males	O
and	O
females	O
.	O

Consequently	B
,	O
autism	O
results	O
in	O
a	O
patient	O
experiencing	O
a	O
life	O
that	O
is	O
marked	O
by	O
the	O
ongoing	O
challenge	O
of	O
its	O
negative	O
effects	O
on	O
communication	O
and	O
interaction	O
with	O
others	O
.	O

2003	O
;	O
Spanò	O
et	O
al	O
.	O

Each	O
membrane	O
was	O
blocked	O
by	O
incubation	O
in	O
6	O
%	O
(	O
w	O
/	O
v	O
)	O
non	O
-	O
fat	O
dry	O
milk	O
in	O
Tris	O
-	O
buffered	O
saline	O
(	O
20	O
mM	O
Tris	O
/	O
HCL	O
[	O
pH	O
7	O
.	O
4	O
]	O
and	O
500	O
mM	O
NaCl	O
)	O
containing	O
0	O
.	O
05	O
%	O
Tween	O
20	O
(	O
TBS	O
-	O
T	O
).	O

Those	O
younger	O
than	O
18	O
years	O
gave	O
their	O
consent	O
in	O
the	O
presence	O
of	O
and	O
with	O
the	O
approval	O
of	O
one	O
of	O
their	O
parents	O
or	O
legal	O
guardians	O
.	O

“	O
Both	O
radon	O
and	O
its	O
daughter	O
products	O
emit	O
alpha	O
particles	O
,	O
and	O
this	O
is	O
a	O
very	O
effective	O
way	O
to	O
cause	O
damage	O
that	O
can	O
lead	O
to	O
cancer	O
.”	O
In	O
just	O
over	O
a	O
decade	O
,	O
Navajo	O
miners	O
were	O
being	O
diagnosed	O
with	O
lung	O
cancer	O
,	O
14a	O
relatively	O
rare	O
disease	O
in	O
this	O
largely	O
nonsmoking	O
population	O
.	O
15Beginning	O
in	O
1950	O
,	O
workers	O
with	O
the	O
U	O
.	O
S	O
.	O
Public	O
Health	O
Service	O
led	O
by	O
Duncan	O
Holaday	O
and	O
Victor	O
Archer	O
began	O
following	O
uranium	O
miners	O
in	O
the	O
Southwest	O
,	O
both	O
Navajo	O
and	O
white	O
,	O
to	O
measure	O
their	O
exposures	O
and	O
assess	O
their	O
specific	O
cancer	O
risks	O
.	O

The	O
presence	O
of	O
somatostatin	O
receptors	O
provides	O
the	O
basis	O
for	O
treatment	O
with	O
longacting	O
analogues	O
of	O
somatostatin	O
or	O
with	O
Y	O
-	O
octreotide	O
(	O
DOTATOC	O
)	O
in	O
some	O
patients	O
.	O

The	O
study	O
had	O
recruited	O
women	O
from	O
2004	O
–	O
2009	O
.	O

The	O
curvilinear	O
relationship	O
remained	O
evident	B
after	O
participants	O
were	O
stratified	O
on	O
the	O
basis	O
of	O
lean	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
and	O
overweight	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
pre	O
-	O
pregnancy	O
status	O
(	O
Figure2a	O
).	O

2010	O
).	O

This	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
then	O
added	O
to	O
the	O
overall	O
population	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
:	O
68	O
.	O
09	O
nmol	O
/	O
L	O
.	O

Results	O
from	O
an	O
international	O
case	O
-	O
control	O
study	O
of	O
childhood	O
brain	O
tumors	O
:	O
the	O
role	O
of	O
prenatal	O
vitamin	O
supplementation	O
.	O

Among	O
women	O
with	O
≥	O
2	O
tests	O
(	O
N	O
=	O
390	O
),	O
there	O
was	O
an	O
increase	O
in	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
from	O
24	O
ng	O
/	O
mL	O
to	O
39	O
ng	O
/	O
mL	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

The	O
behavior	O
change	O
communication	O
strategy	O
was	O
based	B
on	I
a	O
theoretical	O
model	O
constructed	O
a	O
priori	O
that	O
included	O
concepts	O
of	O
the	O
Health	O
Belief	O
Model	O
and	O
the	O
heuristic	B
model	O
for	O
teachable	O
moments	O
,	O
described	O
by	O
McBride	O
and	O
colleagues	O
[	O
13	O
,	O
15	O
,	O
18	O
].	O

Protected	O
dietary	O
fats	O
are	O
bypassed	O
in	O
the	O
rumen	O
without	O
digestion	O
,	O
and	O
they	O
are	O
digested	O
and	O
absorbed	O
in	O
the	O
small	O
intestine	O
.	O

In	O
addition	O
,	O
the	O
economics	O
of	O
preterm	O
birth	O
prevention	O
and	O
care	O
,	O
including	O
the	O
cost	O
-	O
benefit	O
and	O
cost	O
-	O
effectiveness	O
of	O
interventions	O
delivered	O
singly	O
or	O
as	O
a	O
package	O
across	O
the	O
continuum	O
of	O
care	O
and	O
in	O
different	O
settings	O
and	O
populations	O
as	O
well	O
as	O
the	O
costs	O
of	O
doing	O
nothing	O
,	O
need	O
to	O
be	O
better	O
studied	O
[	O
12	O
,	O
42	O
].	O

Finally	O
,	O
a	O
2008	O
paper	O
reported	O
that	O
autism	O
was	O
more	B
common	I
among	O
mothers	O
who	O
took	O
antiepileptic	O
drugs	O
(	O
19	O
).	O

The	O
second	O
dietary	O
assessment	O
method	O
,	O
the	O
QFFQ	O
,	O
is	O
completed	O
at	O
phases	O
1	O
and	O
3	O
.	O

In	O
the	O
neonatal	O
period	O
,	O
we	O
observed	O
soap	O
and	O
water	O
at	O
handwashing	O
places	O
and	O
,	O
at	O
the	O
end	O
of	O
the	O
neonatal	O
period	O
,	O
we	O
estimated	O
impact	O
on	O
maternal	O
handwashing	O
by	O
structured	O
observation	O
.	O

In	O
the	O
1948	O
UK	O
birth	O
cohort	O
,	O
both	O
being	O
born	O
smaller	O
and	O
accelerated	O
weight	O
gain	O
in	O
childhood	O
led	O
to	O
independent	O
and	O
interactive	O
effects	O
on	O
the	O
age	O
of	O
menarche	O
[	O
12	O
],	O
and	O
we	O
have	O
recently	O
confirmed	O
this	O
observation	O
in	O
an	O
Australian	O
cohort	O
[	O
13	O
].	O

In	O
summary	O
,	O
despite	O
a	O
location	O
near	O
the	O
equator	O
where	O
sunlight	O
is	O
available	O
year	O
round	O
,	O
Thai	O
people	O
are	O
at	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
due	O
to	O
environmental	O
,	O
cultural	O
,	O
lifestyle	O
and	O
dietary	O
factors	O
.	O

Homocysteine	O
is	O
an	O
amino	O
acid	O
,	O
which	O
plays	O
several	O
important	O
roles	O
in	O
human	O
physiology	O
.	O

In	O
juvenile	O
LP	O
offspring	O
,	O
mRNA	O
expression	O
profiles	O
were	O
moderately	O
altered	O
compared	O
to	O
AP	O
offspring	O
.	O

The	O
effects	O
of	O
several	O
management	O
factors	O
,	O
including	O
weaning	O
age	O
,	O
castration	O
,	O
slaughter	O
weight	O
and	O
age	O
,	O
and	O
environmental	O
conditions	O
on	O
IMF	O
deposition	O
are	O
also	O
reviewed	O
.	O

UCP1	O
is	O
expressed	O
in	O
classical	O
brown	O
adipocytes	O
,	O
as	O
well	O
as	O
in	O
“	O
beige	O
cells	O
”	O
in	O
white	O
adipose	O
tissue	O
(	O
WAT	O
).	O

After	O
12	O
months	O
of	O
the	O
project	O
mean	O
hemoglobin	O
increased	O
from	O
122	O
g	O
/	O
L	O
to	O
130g	O
/	O
L	O
,	O
the	O
prevalence	O
of	O
anaemia	O
decreased	O
from	O
38	O
%	O
to	O
20	O
%	O
and	O
the	O
prevalence	O
of	O
hookworm	O
infection	O
decreased	O
from	O
76	O
%	O
to	O
22	O
%[	O
13	O
].	O

Transcriptional	O
excursions	O
regarding	O
cell	O
maintenance	O
and	O
proliferation	O
Mammalian	O
cell	O
division	O
is	O
precisely	O
regulated	O
by	O
variate	O
factors	O
and	O
functional	O
networks	O
.	O

Conclusion	O
In	O
the	O
present	O
study	O
,	O
it	O
was	O
observed	O
that	O
2000	O
IU	O
vitamin	O
D3per	O
day	O
for	O
at	B
least	I
8	O
weeks	O
during	O
late	O
pregnancy	O
,	O
can	O
be	O
effective	O
in	O
decreasing	O
perinatal	O
depression	O
levels	O
(	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
).	O

Overall	O
,	O
47	O
%	O
of	O
the	O
infants	O
(	O
18	O
/	O
39	O
)	O
were	O
exclusively	O
breast	O
-	O
fed	O
at	O
3	O
months	O
,	O
28	O
%	O
primarily	O
breast	O
-	O
fed	O
(	O
51	O
-	O
90	O
%	O
human	O
milk	O
)	O
and	O
25	O
%	O
primarily	O
formula	O
-	O
fed	O
.	O

PubMed	O
Central	O
:	O

The	O
strategy	O
is	O
to	O
develop	O
Anganwadi	O
as	O
a	O
“	O
vibrant	O
early	O
childhood	O
development	O
centre	O
”	O
by	O
giving	O
greater	O
focus	O
on	O
under	O
three	O
years	O
children	O
,	O
strengthening	O
early	O
childhood	O
education	O
,	O
and	O
by	O
ensuring	O
care	O
and	O
counseling	O
of	O
mothers	O
and	O
family	O
.	O

The	O
animal	O
experiment	O
was	O
performed	O
as	O
described	O
[	O
15	O
].	O

We	O
assessed	O
nutritional	O
knowledge	O
using	O
a	O
standardized	O
questionnaire	O
divided	O
into	O
three	O
sections	O
:	O
general	O
nutritional	O
recommendations	O
for	O
pregnant	O
women	O
;	O
the	O
roles	O
of	O
nutrients	O
;	O
and	O
sources	O
of	O
nutrients	O
.	O

Returning	O
to	O
our	O
data	O
,	O
weight	O
recovery	O
in	O
offspring	O
may	O
occur	O
as	O
a	O
result	O
of	O
an	O
accelerated	O
catch	O
-	O
up	O
growth	O
before	O
birth	O
caused	O
by	O
an	O
ad	O
libitum	O
maternal	O
feeding	O
.	O

The	O
notion	O
that	O
human	O
BAT	O
is	O
solely	O
apparent	O
during	O
the	O
neonatal	O
stage	O
prevailed	O
for	O
decades	O
(	O
Heaton	O
,	O
1972	O
;	O
Nedergaard	O
et	O
al	O
.,	O
2007	O
).	O

In	O
Belgium	O
,	O
pregnant	O
women	O
of	O
different	O
ethnic	O
origins	O
had	O
substantially	O
lower	O
vitamin	O
D	O
concentrations	O
than	O
Caucasian	O
women	O
and	O
were	O
vitamin	O
D	O
deficient	O
all	O
year	O
long	O
except	O
during	O
summer	O
for	O
third	O
trimester	O
women	O
.	O

In	O
2010	O
,	O
84	O
women	O
were	O
examined	O
during	O
IVF	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
those	O
born	O
with	O
low	O
or	O
high	O
birth	O
weight	O
have	O
impairment	O
of	O
the	O
arterial	O
vascular	O
system	O
with	O
modifications	O
in	O
both	O
functional	O
(	O
e	O
.	O
g	O
.,	O
endothelium	O
dysfunction	O
,	O
reduction	O
in	O
nitric	O
oxide	O
production	O
)	O
and	O
structural	O
/	O
mechanical	O
(	O
e	O
.	O
g	O
.,	O
higher	O
arterial	O
intima	O
-	O
media	O
thickness	O
,	O
elastin	O
synthesis	O
deficiency	O
,	O
increased	O
arterial	O
stiffness	O
)	O
properties	O
[	O
8	O
,	O
9	O
,	O
11	O
–	O
14	O
].	O

Quantitative	O
analysis	O
with	O
RT	O
-	O
PCR	O
showed	O
higher	O
gene	O
expression	O
of	O
CYP27B1	O
in	O
both	O
stromal	O
cells	O
CD10	O
+	O
VEand	O
CD10	O
−	O
VEin	O
the	O
1st	O
trimester	O
of	O
pregnancy	O
.	O

Pups	O
were	O
sexed	O
by	O
measuring	O
the	O
anogenital	O
distance	O
,	O
which	O
is	O
sexually	O
dimorphic	O
in	O
mice	O
(	O
the	O
male	O
'	O
s	O
anogenital	O
distance	O
is	O
approximately	O
twice	O
as	O
long	O
as	O
the	O
female	O
'	O
s	O
)[	O
15	O
].	O

With	O
a	O
larger	O
sample	O
,	O
it	O
would	O
be	O
possible	O
to	O
extend	O
our	O
calculations	O
to	O
estimate	O
the	O
cost	O
per	O
death	O
averted	O
with	O
a	O
reduction	O
of	O
the	O
prevalence	O
of	O
severe	O
anemia	O
in	O
pregnant	O
women	O
.	O

Most	B
experts	B
agree	O
that	O
serum	O
vitamin	O
D	O
levels	O
below	O
50	O
nmol	O
/	O
L	O
(	O
20	O
ng	O
/	O
mL	O
)	O
represent	B
deficiency	O
.	O

Thus	B
,	O
a	O
combination	O
of	O
several	O
strategies	O
may	O
be	O
needed	O
to	O
manipulate	O
IMF	O
deposition	O
,	O
depending	O
on	O
the	O
consumer	O
’	O
s	O
beef	O
preference	O
.	O

Moreover	O
,	O
comparing	O
offspring	O
of	O
the	O
same	O
groups	O
at	O
10	O
days	O
and	O
6	O
months	O
of	O
age	O
,	O
the	O
number	O
of	O
glomeruli	O
was	O
not	O
significantly	O
different	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
test	O
of	O
Tukey	O
).	O

These	O
groups	O
were	O
chosen	O
to	O
study	O
whether	O
vitamin	O
D	O
insufficiency	O
(	O
30	O
–	O
50	O
nmol	O
/	O
L	O
),	O
sufficiency	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
or	O
high	O
status	O
(≥	O
75	O
or	O
≥	O
100	O
nmol	O
/	O
L	O
)	O
was	O
associated	O
with	O
the	O
outcomes	O
studied	O
,	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

No	O
difference	O
in	O
the	O
ratio	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2	O
was	O
found	O
between	O
both	O
groups	O
.	O

Methods	O
The	O
aims	O
of	O
this	O
prospective	O
cohort	O
study	O
are	O
:	O
1	O
)	O
to	O
assess	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
urban	O
pregnant	O
women	O
in	O
Johannesburg	O
,	O
South	O
Africa	O
,	O
and	O
2	O
)	O
to	O
determine	O
associations	O
with	O
birth	O
outcomes	O
,	O
measures	O
of	O
maternal	O
health	O
,	O
as	O
well	O
as	O
measures	O
of	O
offspring	O
health	O
and	O
development	O
.	O

Number	O
of	O
subjects	O
in	O
each	O
analysis	O
is	O
reported	O
in	O
Tables	O
.	O

Excessive	O
rebound	O
and	O
early	O
rebound	O
(	O
before	O
age	O
5	O
)	O
are	O
related	O
to	O
higher	O
BMI	O
in	O
adulthood	O
(	O
83	O
).	O

Subjects	O
were	O
asked	O
to	O
notify	O
fieldworkers	O
of	O
suspected	O
pregnancy	O
and	O
following	O
confirmation	O
of	O
pregnancy	O
by	O
study	O
midwives	O
,	O
women	O
were	O
instructed	O
to	O
stop	O
supplementation	O
and	O
no	O
further	O
supplements	O
were	O
issued	O
.	O

Little	O
,	O
however	O
,	O
is	O
known	O
about	O
the	O
consequences	O
of	O
insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
during	O
pregnancy	O
on	O
glucose	O
tolerance	O
and	O
gestational	O
diabetes	O
.	O

Their	O
studies	O
suggest	O
that	O
the	O
abnormal	O
growth	O
in	O
children	O
with	O
autism	O
spectrum	O
disorders	O
may	O
be	O
related	O
to	O
the	O
causal	O
factors	O
that	O
also	O
increase	O
the	O
risk	O
for	O
ASD	O
,	O
as	B
it	O
was	O
found	O
that	O
children	O
with	O
ASD	O
had	O
proportionally	O
smaller	O
head	O
circumference	O
compared	O
to	O
height	O
during	O
their	O
first	O
year	O
of	O
life	O
,	O
which	O
was	O
absent	O
in	O
premature	O
/	O
low	O
birth	O
weight	O
children	O
with	O
ASD	O
.	O

Unfortunately	O
,	O
the	O
tiny	O
10	O
μg	O
(	O
400	O
IU	O
)	O
dose	O
in	O
prenatal	O
vitamins	O
is	O
virtually	B
irrelevant	O
in	O
preventing	O
the	O
current	O
epidemic	O
of	O
gestational	O
vitamin	O
D	O
deficiency	O
(	O
8	O
).	O

Following	O
weaning	O
,	O
steers	O
were	O
grown	O
with	O
a	O
forage	O
-	O
only	O
system	O
and	O
forage	O
with	O
high	O
-	O
energy	O
supplemented	O
system	O
to	O
test	O
effects	O
of	O
a	O
high	O
-	O
energy	O
grain	O
-	O
based	O
substitution	O
on	O
fat	O
deposition	O
with	O
5	O
times	O
serial	O
slaughter	O
.	O

It	O
is	O
the	O
precursor	O
to	O
form	O
25	O
-	O
hydroxyvitamin	O
D3	O
[	O
25	O
(	O
OH	O
)	O
D3	O
],	O
a	O
prehormone	O
,	O
which	O
is	O
ultimately	O
converted	O
to	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
],	O
one	O
of	O
the	O
most	O
potent	O
steroid	O
hormones	O
known	O
.	O

Differences	O
in	O
age	O
,	O
health	O
and	O
initial	O
vitamin	O
D	O
status	O
between	O
cohorts	O
,	O
as	O
well	O
as	O
study	O
design	O
,	O
may	O
explain	B
the	O
conflicting	O
data	O
.	O

cups	O
,	O
bowls	O
and	O
glasses	O
)	O
as	O
well	O
as	O
two	O
-	O
and	O
three	O
-	O
dimensional	O
food	O
models	O
are	O
being	O
used	O
to	O
assist	O
in	O
quantifying	O
portion	O
sizes	O
.	O

In	O
addition	O
to	O
hypothalamic	O
genes	O
,	O
measurement	O
of	O
genes	O
in	O
regions	O
of	O
the	O
brain	O
involved	O
in	O
reward	O
and	O
motivation	O
may	O
have	O
contributed	O
to	O
a	O
fuller	O
understanding	O
of	O
the	O
overall	O
impact	O
of	O
the	O
diets	O
on	O
regulation	O
of	O
food	O
intake	O
.	O

This	O
indicates	O
that	O
improving	O
the	O
vitamin	O
D	O
status	O
of	O
non	O
-	O
white	O
women	O
,	O
who	O
are	O
known	O
to	O
have	O
particularly	O
low	O
vitamin	O
D	O
concentrations	O
,	O
could	O
dramatically	B
decrease	O
racial	O
disparities	O
in	O
PTB	O
rates	O
.	O

The	O
method	O
also	O
requires	O
that	O
included	O
studies	O
report	O
a	O
measure	O
of	O
association	O
such	O
as	O
a	O
risk	O
ratio	O
or	O
odds	O
ratio	O
.	O

It	O
was	O
translated	O
to	O
Persian	O
and	O
was	O
used	O
in	O
the	O
study	O
by	O
Mazhari	O
and	O
Nakhaee	O
,	O
with	O
a	O
validity	O
and	O
reliability	O
of	O
0	O
.	O
76	O
and	O
0	O
.	O
83	O
,	O
respectively	O
[	O
42	O
].	O

The	O
lack	O
of	O
a	O
relation	O
with	O
maternal	O
diabetes	O
would	O
suggest	O
that	O
higher	O
fetal	O
exposure	O
to	O
glucose	O
is	O
unlikely	B
to	O
explain	O
our	O
main	O
findings	O
.	O

Significantly	O
more	O
children	O
with	O
S	O
-	O
ECC	O
had	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
compared	O
to	O
their	O
caries	O
-	O
free	O
peers	O
(	O
p	O
=	O
0	O
.	O
006	O
)	O
(	O
Table	O
2	O
).	O

Of	O
course	O
,	O
it	O
is	O
vital	O
that	O
any	O
environmental	O
toxicant	O
is	O
carefully	O
regulated	O
or	O
even	O
banned	O
from	O
use	O
.	O

At	O
65	O
.	O
4	O
%,	O
the	O
prevalence	O
for	O
overweight	O
and	O
obesity	O
in	O
Latinas	O
aged	O
20	O
–	O
39	O
years	O
is	O
higher	O
than	O
the	O
national	O
prevalence	O
for	O
all	O
women	O
in	O
that	O
age	O
group	O
[	O
8	O
].	O

Age	O
and	O
overall	O
dietary	O
intake	O
as	O
well	O
as	O
the	O
intake	O
of	O
fish	O
and	O
fatty	O
acids	O
did	O
not	O
differ	O
significantly	O
between	O
those	O
who	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
and	O
those	O
who	O
did	O
not	O
(	O
drop	O
-	O
outs	O
).	O

Causal	O
biological	O
mechanisms	O
for	O
the	O
observed	O
positive	O
,	O
though	O
statistically	O
in	O
-	O
significant	O
association	O
between	O
long	O
sleep	O
duration	O
and	O
GDM	O
are	O
not	O
clear	O
.	O

Methods	O
To	O
investigate	O
potential	O
relationships	O
between	O
household	O
pet	O
exposure	O
and	O
cord	O
blood	O
vitamin	O
D	O
concentrations	O
,	O
we	O
analyzed	O
information	O
from	O
a	O
large	O
,	O
geographically	O
-	O
based	O
,	O
general	O
risk	O
birth	O
cohort	O
.	O

Maternal	O
intelligence	O
,	O
alcohol	O
consumption	O
,	O
smoking	O
and	O
breastfeeding	O
practices	O
were	O
included	O
as	O
covariates	O
in	O
all	O
studies	O
.	O

The	O
key	O
is	O
integrating	O
and	O
interpreting	O
it	O
correctly	O
,	O
in	O
terms	O
of	O
differences	O
/	O
similarities	O
at	O
both	O
the	O
system	O
(	O
in	O
vitro	O
versus	O
in	O
vivo	O
)	O
and	O
species	O
(	O
human	O
versus	O
non	O
-	O
human	O
)	O
levels	O
.	O

Thus	O
,	O
PGCs	O
undergo	O
a	O
second	O
round	O
of	O
global	O
demethylation	O
and	O
changes	O
in	O
histone	O
modification	O
and	O
non	O
-	O
coding	O
RNA	O
expression	O
,	O
this	O
time	O
including	O
removal	O
of	O
the	O
parent	O
-	O
specific	O
imprints	O
.	O

In	O
our	O
study	O
,	O
measures	O
of	O
reliability	O
,	O
including	O
a	O
Cronbach	O
’	O
s	O
alpha	O
and	O
a	O
test	O
-	O
retest	O
correlation	O
were	O
0	O
.	O
86	O
and	O
0	O
.	O
92	O
,	O
respectively	O
.	O

Text	O
messaging	O
interventions	O
can	O
do	O
much	O
more	O
than	O
simply	O
deliver	O
text	O
reminders	O
—	O
they	O
can	O
deliver	O
right	O
into	O
the	O
hands	O
of	O
highly	O
targeted	O
population	O
the	O
public	O
service	O
announcements	O
that	O
in	O
years	O
past	O
would	O
have	O
appeared	O
in	O
mass	O
media	O
[	O
45	O
].	O

Additionally	O
,	O
skin	O
prick	O
tests	O
for	O
common	O
allergens	O
are	O
used	O
at	O
phase	O
7	O
postnatally	O
to	O
assess	O
sensitisation	O
[	O
49	O
].	O

However	O
,	O
due	B
to	I
the	O
higher	O
Type	O
I	O
error	O
rate	O
associated	O
with	O
using	O
alpha	O
level	O
=	O
0	O
.	O
5	O
,	O
this	O
association	O
should	O
be	O
interpreted	O
with	O
caution	O
.	O

Additionally	O
,	O
because	O
Rhode	O
Island	O
is	O
a	O
small	O
state	O
representing	O
a	O
small	O
geographic	O
area	O
,	O
recruiting	O
participants	O
from	O
this	O
state	O
may	O
affect	O
the	O
generalizability	O
of	O
our	O
findings	O
;	O
however	O
,	O
because	O
the	O
Women	O
and	O
Infants	O
Hospital	O
performs	O
>	O
85	O
%	O
of	O
all	O
obstetrical	O
deliveries	O
in	O
Providence	O
County	O
(	O
the	O
largest	O
population	O
center	O
in	O
Rhode	O
Island	O
),	O
we	O
believe	O
this	O
limitation	O
is	O
compensated	O
for	O
to	O
some	O
extent	O
by	O
the	O
lack	O
of	O
ascertainment	O
bias	O
in	O
this	O
population	O
-	O
based	O
study	O
.	O

Non	O
-	O
persistent	O
chemicals	O
exhibit	O
larger	O
degrees	O
of	O
measurement	O
error	O
.	O

Our	O
study	O
did	O
not	O
have	O
a	O
sample	O
group	O
large	O
or	O
accessible	O
enough	O
to	O
allow	O
an	O
assessment	O
of	O
long	O
-	O
term	O
pregnancy	O
outcomes	O
.	O

The	O
areas	O
in	O
which	O
BAT	O
is	O
observed	O
in	O
adult	O
humans	O
include	O
supraclavicular	O
,	O
neck	O
,	O
paravertebral	O
,	O
and	O
suprarenal	O
sites	O
(	O
Nedergaard	O
et	O
al	O
.,	O
2007	O
).	O

There	O
were	O
no	O
maternal	O
deaths	O
.	O

This	O
is	O
in	O
keeping	O
with	O
the	O
observation	O
of	O
increased	O
plasma	O
IL	O
-	O
6	O
levels	O
in	O
obese	O
patients	O
(	O
Cottam	O
et	O
al	O
.,	O
2004	O
).	O

Discussion	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
children	O
with	O
S	O
-	O
ECC	O
have	O
different	O
nutritional	O
profiles	O
than	O
their	O
caries	O
-	O
free	O
peers	O
,	O
specifically	O
vitamin	O
D	O
,	O
calcium	O
and	O
albumin	O
status	O
.	O

The	O
primary	O
hypothesis	O
is	O
that	O
in	O
a	O
community	O
-	O
based	O
,	O
cluster	O
randomized	O
controlled	O
trial	O
of	O
women	O
from	O
rural	O
Bangladesh	O
,	O
daily	O
supplementation	O
with	O
60	O
mg	O
elemental	O
iron	O
and	O
400	O
μg	O
folic	O
acid	O
starting	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
and	O
sustained	O
for	O
at	O
least	O
180	O
days	O
,	O
will	O
reduce	O
neonatal	O
mortality	O
by	O
25	O
%	O
from	O
33	O
/	O
1000	O
to	O
24	O
.	O
8	O
/	O
1000	O
live	O
births	O
compared	O
to	O
usual	O
iron	O
-	O
folic	O
acid	O
supplementation	O
programs	O
.	O

The	O
most	O
complete	O
data	O
were	O
available	O
for	O
the	O
latter	O
at	O
these	O
time	O
points	O
.	O

Fatty	O
fish	O
is	O
a	O
rich	O
dietary	O
source	O
of	O
essential	O
fatty	O
acids	O
and	O
vitamin	O
D	O
,	O
both	O
of	O
which	O
could	O
be	O
implicated	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

Development	O
of	O
new	O
fusion	O
technologies	O
(	O
e	O
.	O
g	O
.,	O
nutrigenomics	O
)	O
with	O
genetic	O
,	O
epigenetic	O
,	O
and	O
nutritional	O
factors	O
may	O
be	O
more	O
efficient	O
to	O
optimize	O
IMF	O
deposition	O
and	O
improve	O
feed	O
efficiency	O
.	O

High	O
levels	O
of	O
IMF	O
deposition	O
requires	O
excess	O
energy	O
con	O
sumption	O
above	O
the	O
maintenance	O
and	O
normal	O
production	O
requirements	O
[	O
69	O
].	O

The	O
children	O
’	O
s	O
mean	O
current	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
the	O
follow	O
-	O
up	O
visit	O
was	O
27	O
.	O
2	O
ng	O
/	O
mL	O
(	O
range	O
8	O
.	O
30	O
–	O
61	O
.	O
5	O
ng	O
/	O
mL	O
;	O
68	O
.	O
3	O
nmol	O
/	O
L	O
).	O

A	O
stepwise	O
approach	O
is	O
suggested	O
for	O
medical	O
treatment	O
,	O
where	O
inhaled	O
salbutamol	O
is	O
the	O
preferred	B
short	O
-	O
acting	O
β	O
agonist	O
with	O
an	O
outstanding	O
safety	O
profile	O
,	O
and	O
inhaled	O
corticosteroids	O
(	O
eg	O
,	O
budesonide	O
)	O
should	O
be	O
used	O
confidently	O
as	O
long	O
-	O
term	O
control	O
medications	O
.	O

Thai	O
women	O
are	O
at	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
likely	B
due	O
to	O
sunscreen	O
usage	O
and	O
sun	O
avoidant	O
behavior	O
due	O
to	O
the	O
desire	O
to	O
maintain	O
a	O
fair	O
complexion	O
.	O

(	O
2015	O
)	O
*	O
Polycyclic	O
aromatic	O
hydrocarbons	O
(	O
PAHs	O
)	O
AdulthoodAdulthoodPBL	O
chromosomal	O
aberrationsDNA	O
methylationYang	O
et	O
al	O
.	O

Dietary	O
energy	O
and	O
protein	O
levels	O
Studies	O
in	O
pigs	O
indicate	O
that	O
a	O
deficiency	O
of	O
essential	O
amino	O
acids	O
such	O
as	O
lysine	O
increases	O
IMF	O
content	O
[	O
123	O
,	O
124	O
],	O
and	O
it	O
has	O
been	O
suggested	O
that	O
an	O
amino	O
acid	O
imbalance	O
relative	O
to	O
energy	O
levels	O
may	O
increase	O
IMF	O
content	O
in	O
cattle	O
(	O
reviewed	O
in	O
Pethick	O
et	O
al	O
[	O
69	O
]).	O

In	O
contradistinction	O
,	O
metformin	O
reduces	O
insulin	O
resistance	O
and	O
hepatic	O
gluconeogenesis	O
,	O
which	O
theoretically	O
would	O
be	O
beneficial	O
for	O
the	O
preservation	O
of	O
β	O
-	O
cell	O
function	O
.	O

Interventions	O
using	O
mobile	O
phones	O
are	O
growing	O
worldwide	O
,	O
and	O
some	O
are	O
achieving	O
significant	O
scale	O
and	O
population	O
-	O
level	O
reach	O
.	O

This	O
study	O
sought	O
to	O
determine	O
if	O
circulating	O
cathelicidin	O
concentrations	O
in	O
healthy	O
children	O
are	O
related	O
to	O
the	O
age	O
of	O
the	O
child	O
,	O
body	O
composition	O
and	O
vitamin	O
D	O
status	O
at	O
birth	O
and	O
at	O
the	O
time	O
of	O
the	O
study	O
visit	O
.	O

If	O
an	O
environmental	O
exposure	O
is	O
truly	B
transgenerational	O
,	O
then	O
:	O
(	O
1	O
)	O
following	O
an	O
in	O
utero	O
exposure	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	B
least	I
the	O
F3generation	O
(	O
great	O
-	O
great	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
mother	O
and	O
F3represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
;	O
or	O
(	O
2	O
)	O
following	O
an	O
ex	O
utero	O
exposure	O
in	O
childhood	O
/	O
adulthood	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	B
least	I
the	O
F2generation	O
(	O
the	O
great	O
-	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
generation	O
and	O
F2represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
.	O

The	O
offspring	O
are	O
hypertensive	O
,	O
show	O
vascular	O
changes	O
,	O
and	O
have	O
high	O
blood	O
insulin	O
levels	O
.	O

A	O
robust	O
,	O
dose	O
-	O
dependent	O
,	O
causal	O
relationship	O
among	O
a	O
specific	O
environmental	O
exposure	O
,	O
an	O
epigenetic	O
change	O
and	O
an	O
adverse	O
public	O
health	O
outcome	O
is	O
required	O
to	O
classify	O
a	O
chemical	O
as	B
an	O
epigenetic	O
toxicant	O
.	O

In	O
animal	O
studies	O
,	O
therapeutic	O
immunity	O
to	O
intracranial	O
tumors	O
has	O
been	O
induced	O
by	O
peripheral	O
immunization	O
with	O
interleukin	O
-	O
4	O
(	O
IL	O
-	O
4	O
)	O
transduced	O
glioma	O
cells	O
[	O
100	O
,	O
101	O
].	O

It	O
has	O
been	O
suggested	O
that	O
these	O
results	O
may	O
reflect	O
a	O
regression	O
to	O
the	O
mean	O
phenomenon	O
or	O
may	O
be	O
related	O
in	O
part	O
to	O
measurement	O
variability	O
(	O
8	O
).	O

Korean	O
farmers	O
often	O
feed	O
a	O
total	O
mixed	O
ration	O
during	O
the	O
growing	O
and	O
early	O
finishing	O
stages	O
instead	O
of	O
feeding	O
concentrate	O
and	O
roughage	O
separately	O
.	O

EDC	O
concentrations	O
were	O
quantified	O
in	O
blood	O
and	O
urine	O
samples	O
collected	O
at	O
16	O
and	O
26	O
weeks	O
gestation	O
.	O

Differences	O
were	O
considered	O
significant	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Body	O
weight	O
and	O
caloric	O
intake	O
of	O
offspring	O
were	O
monitored	O
from	O
birth	O
(	O
PND0	O
)	O
to	O
adulthood	O
(	O
postnatal	O
weeks	O
21	O
–	O
23	O
).	O

Small	O
but	O
relevant	O
differences	O
of	O
0	O
.	O
15	O
–	O
0	O
.	O
16	O
standard	O
deviations	O
in	O
secondary	O
continuous	O
outcomes	O
could	O
also	O
be	O
detected	O
.	O

Follow	O
-	O
up	O
surveys	O
were	O
primarily	O
completed	O
remotely	O
online	O
.	O

reported	O
a	O
single	O
case	O
of	O
accelerated	O
tumour	O
growth	O
during	O
pregnancy	O
,	O
but	O
this	O
would	O
appear	O
to	O
be	O
an	O
exception	O
rather	O
than	O
the	O
rule29	O
.	O

High	O
fat	O
feeding	O
of	O
pregnant	O
or	O
lactating	O
mothers	O
was	O
shown	O
to	O
induce	O
glucose	O
intolerance	O
and	O
the	O
development	O
of	O
obesity	O
in	O
the	O
progeny	O
during	O
adult	O
life	O
(	O
Bayol	O
et	O
al	O
.,	O
2008	O
;	O
Samuelsson	O
et	O
al	O
.,	O
2008	O
).	O

2008	O
).	O

For	O
instance	O
,	O
the	O
gene	O
deletion	O
of	O
the	O
2	O
-	O
AG	O
-	O
degrading	O
enzyme	O
Mgll	O
has	O
been	O
linked	O
to	O
attenuation	O
of	O
diet	O
-	O
induced	O
insulin	O
resistance	O
and	O
improvement	O
of	O
atherosclerosis	O
via	O
CB2	O
activation	O
(	O
Taschler	O
et	O
al	O
.,	O
2011	O
;	O
Vujic	O
et	O
al	O
.,	O
2016	O
).	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

2007	O
;	O
Zhou	O
et	O
al	O
.	O

A	O
potential	O
limitation	O
of	O
our	O
follow	O
-	O
up	O
study	O
is	O
the	O
risk	O
of	O
selection	O
bias	O
,	O
with	O
only	O
82	O
%	O
of	O
the	O
available	O
cohort	O
contributing	O
data	O
at	O
6	O
-	O
month	O
follow	O
-	O
up	O
assessments	O
.	O

Vitamin	O
D	O
uptake	O
in	O
the	O
common	O
diet	O
is	O
of	O
minor	O
significance	O
,	O
although	O
cholecalciferol	O
can	O
be	O
found	O
in	O
sea	O
fish	O
fat	O
and	O
liver	O
oil	O
,	O
while	O
ergocalciferol	O
in	O
green	O
plants	O
and	O
mushrooms	O
.	O

Of	O
the	O
32	O
Navajo	O
men	O
who	O
developed	O
lung	O
cancer	O
,	O
72	O
%	O
had	O
worked	O
as	O
uranium	O
miners	O
,	O
compared	O
with	O
none	O
of	O
the	O
controls	O
.	O

Key	O
constructs	O
addressed	O
in	O
the	O
handwashing	O
intervention	O
included	O
the	O
following	O
:	O
nurture	O
as	O
motivator	O
for	O
handwashing	O
(	O
to	O
have	O
healthy	O
baby	O
who	O
grows	O
well	O
,	O
mother	O
'	O
s	O
desire	O
to	O
take	O
good	O
care	O
of	O
baby	O
)	O
improved	O
convenience	O
(	O
three	O
handwashing	O
stations	O
were	O
provided	O
for	O
continuous	O
stocking	O
with	O
soap	O
and	O
water	O
,	O
including	O
in	O
the	O
room	O
where	O
the	O
baby	O
would	O
likely	O
spend	O
time	O
;	O
soap	O
was	O
replenished	O
by	O
study	O
staff	O
as	O
needed	O
throughout	O
the	O
perinatal	O
period	O
)	O
cues	O
to	O
action	O
(	O
encouraged	O
verbal	O
reminders	O
,	O
provided	O
cue	O
cards	O
with	O
times	O
for	O
handwashing	O
)	O
There	O
is	O
prior	O
observational	O
evidence	O
supporting	O
the	O
beneficial	O
effect	O
of	O
maternal	O
handwashing	O
before	O
contact	O
with	O
the	O
umbilical	O
cord	O
for	O
prevention	O
of	O
neonatal	O
infections	O
[	O
3	O
].	O

Transcriptional	O
excursions	O
regarding	O
lipid	O
-,	O
energy	O
-	O
and	O
N	O
-	O
metabolism	O
During	O
postnatal	O
development	O
a	O
remarkable	O
number	O
of	O
diet	O
-	O
and	O
stage	O
-	O
dependent	O
transcriptionally	O
regulated	O
pathways	O
were	O
related	O
to	O
lipid	O
metabolism	O
,	O
including	O
'	O
fatty	O
acid	O
metabolism	O
',	O
'	O
fatty	O
acid	O
elongation	O
in	O
mitochondria	O
',	O
'	O
synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
',	O
'	O
bile	O
acid	O
synthesis	O
'	O
and	O
'	O
biosynthesis	O
of	O
steroids	O
'.	O

The	O
concentration	O
of	O
vitamin	O
D	O
and	O
Ca	O
+	O
2were	O
not	O
dependent	O
on	O
menstrual	O
cycle	O
phase	O
.	O

Treatment	O
with	O
LCF	O
prevented	O
further	O
symptomatic	O
hypercalcaemia	O
,	O
but	O
resulted	O
in	O
elevated	O
PTH	O
.	O

Restricting	O
the	O
definition	O
of	O
pneumonia	O
confirmed	O
with	O
chest	O
radiography	O
to	O
consolidation	O
only	O
,	O
gave	O
a	O
rate	O
of	O
0	O
·	O
011	O
per	O
child	O
per	O
year	O
(	O
95	O
%	O
CI	O
0	O
·	O
008	O
–	O
0	O
·	O
017	O
)	O
in	O
the	O
vitamin	O
D	O
group	O
and	O
0	O
·	O
008	O
(	O
0	O
·	O
005	O
–	O
0	O
·	O
013	O
)	O
in	O
the	O
placebo	O
group	O
;	O
this	O
difference	O
was	O
not	O
significant	O
RR	O
1	O
·	O
44	O
(	O
0	O
·	O
76	O
–	O
2	O
·	O
72	O
).	O

We	O
used	O
the	O
elbow	O
method	O
to	O
determine	O
the	O
optimal	O
number	O
of	O
clusters	O
,	O
which	O
is	O
based	O
on	O
the	O
within	O
-	O
cluster	O
sum	O
of	O
squares	O
.	O

In	O
a	O
study	O
by	O
Shackle	O
et	O
al	O
.	O

Genotyping	O
,	O
which	O
was	O
not	O
practical	O
in	O
our	O
study	O
setting	O
,	O
might	O
have	O
aided	O
the	O
interpretation	O
of	O
our	O
findings	O
,	O
as	O
shown	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
for	O
tuberculosis	O
.	O
20	O
We	O
accounted	O
for	O
nutritional	O
factors	O
through	O
a	O
diet	O
questionnaire	O
,	O
weight	O
at	O
recruitment	O
,	O
and	O
growth	O
comparison	O
at	O
the	O
end	O
of	O
our	O
study	O
—	O
any	O
nutritional	O
deficiencies	O
would	O
have	O
been	O
equally	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

To	O
get	O
access	O
to	O
the	O
workers	O
,	O
the	O
researchers	O
had	O
to	O
strike	O
a	O
Faustian	O
bargain	O
with	O
the	O
mining	O
companies	O
:	O
They	O
could	O
not	O
inform	O
the	O
miners	O
of	O
the	O
potential	O
health	O
hazards	O
of	O
their	O
work	O
.	O
2Seeing	O
it	O
as	O
the	O
only	O
way	O
to	O
convince	O
government	O
regulators	O
to	O
improve	O
safety	O
in	O
the	O
mines	O
,	O
the	O
researchers	O
accepted	O
.	O
16By	O
1965	O
,	O
the	O
investigators	O
reported	O
an	O
association	O
between	O
cumulative	O
exposure	O
to	O
uranium	O
and	O
lung	O
cancer	O
among	O
white	O
miners	O
and	O
had	O
definitively	O
identified	O
the	O
cause	O
as	B
radiation	O
exposure	O
.	O
17	O
In	O
1984	O
another	O
team	O
published	O
results	O
of	O
a	O
case	O
–	O
control	O
study	O
that	O
further	O
implicated	O
uranium	O
mining	O
as	B
a	O
cause	O
of	O
lung	O
cancer	O
in	O
Navajo	O
men	O
.	O

Method	O
:	O
Masanumasik	O
patya	O
of	O
Ayurveda	O
,	O
as	O
the	O
name	O
suggest	O
,	O
is	O
advised	O
according	O
to	O
the	O
month	O
&	O
by	O
the	O
need	O
of	O
fetal	O
development	O
.	O

Vitamin	O
C	O
increased	O
preadipocyte	O
growth	O
of	O
3T3	O
L1	O
cells	O
[	O
148	O
]	O
and	O
also	O
had	O
a	O
positive	O
effect	O
on	O
differentiation	O
of	O
sheep	O
preadipocytes	O
in	O
primary	O
culture	O
[	O
149	O
].	O

of	O
regulated	O
probe	O
-	O
sets	O
private	O
to	O
LP	O
offspringNo	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Association	O
between	O
caries	O
status	O
and	O
child	O
and	O
caregiver	O
characteristicsVariableOverall	O
valueCaries	O
statusP	O
valueS	O
-	O
ECCCaries	O
-	O
freeN	O
(%)	O
95	O
%	O
CIN	O
(%)	O
95	O
%	O
CIChild	O
Child	O
’	O
s	O
age	O
(	O
Months	O
)†	O
40	O
.	O
8	O
±	O
14	O
.	O
142	O
.	O
0	O
±	O
11	O
.	O
9	O
/	O
39	O
.	O
4	O
±	O
16	O
.	O
3	O
/	O
0	O
.	O
14Sex	O
*	O
Male13670	O
(	O
51	O
.	O
5	O
)	O
43	O
.	O
1	O
,	O
59	O
.	O
966	O
(	O
48	O
.	O
5	O
)	O
40	O
.	O
1	O
,	O
56	O
.	O
90	O
.	O
37Female13074	O
(	O
56	O
.	O
9	O
)	O
48	O
.	O
4	O
,	O
65	O
.	O
456	O
(	O
43	O
.	O
1	O
)	O
34	O
.	O
6	O
,	O
51	O
.	O
6	O
Height	O
(	O
cm	O
)†	O
98	O
.	O
4	O
±	O
9	O
.	O
799	O
.	O
3	O
±	O
8	O
.	O
1	O
/	O
97	O
.	O
3	O
±	O
11	O
.	O
1	O
/	O
0	O
.	O
10Weight	O
(	O
kg	O
)†	O
16	O
.	O
4	O
±	O
3	O
.	O
717	O
.	O
0	O
±	O
3	O
.	O
3	O
/	O
15	O
.	O
8	O
±	O
4	O
.	O
0	O
/	O
0	O
.	O
01Skin	O
colour	O
*	O
Dark	O
/	O
Mid	O
-	O
colour11676	O
(	O
65	O
.	O
6	O
)	O
56	O
.	O
9	O
,	O
74	O
.	O
240	O
(	O
34	O
.	O
5	O
)	O
25	O
.	O
8	O
,	O
43	O
.	O
10	O
.	O
001Light15068	O
(	O
45	O
.	O
3	O
)	O
37	O
.	O
4	O
,	O
53	O
.	O
382	O
(	O
54	O
.	O
7	O
)	O
46	O
.	O
7	O
,	O
62	O
.	O
6	O
Multivitamin	O
Use	O
*	O
Yes14376	O
(	O
53	O
.	O
1	O
)	O
45	O
.	O
0	O
,	O
61	O
.	O
367	O
(	O
46	O
.	O
9	O
)	O
38	O
.	O
7	O
,	O
55	O
.	O
00	O
.	O
73No12368	O
(	O
55	O
.	O
3	O
)	O
46	O
.	O
5	O
,	O
64	O
.	O
155	O
(	O
44	O
.	O
7	O
)	O
35	O
.	O
9	O
,	O
53	O
.	O
5	O
Age	O
started	O
cleaning	O
mouth	O
(	O
Months	O
)†	O
12	O
.	O
9	O
±	O
8	O
.	O
614	O
.	O
5	O
±	O
9	O
.	O
5	O
/	O
10	O
.	O
9	O
±	O
7	O
.	O
1	O
/<	O
0	O
.	O
001Mean	O
age	O
at	O
first	O
dental	O
visit	O
(	O
Months	O
)†	O
26	O
.	O
2	O
±	O
11	O
.	O
827	O
.	O
0	O
±	O
11	O
.	O
9	O
/	O
24	O
.	O
7	O
±	O
11	O
.	O
7	O
/	O
0	O
.	O
17Breast	O
-	O
fed	O
*	O
Yes20493	O
(	O
45	O
.	O
6	O
)	O
38	O
.	O
8	O
,	O
52	O
.	O
4111	O
(	O
54	O
.	O
4	O
)	O
48	O
.	O
0	O
,	O
61	O
.	O
0	O
<	O
0	O
.	O
001No6150	O
(	O
82	O
.	O
0	O
)	O
72	O
.	O
3	O
,	O
91	O
.	O
611	O
(	O
18	O
.	O
0	O
)	O
8	O
.	O
4	O
,	O
27	O
.	O
7	O
Bottle	O
-	O
fed	O
*	O
Yes194114	O
(	O
58	O
.	O
8	O
)	O
51	O
.	O
8	O
,	O
65	O
.	O
780	O
(	O
41	O
.	O
2	O
)	O
34	O
.	O
3	O
,	O
48	O
.	O
20	O
.	O
01No7129	O
(	O
40	O
.	O
8	O
)	O
29	O
.	O
4	O
,	O
52	O
.	O
342	O
(	O
59	O
.	O
2	O
)	O
47	O
.	O
7	O
,	O
70	O
.	O
6	O
Parent	O
/	O
Caregiver	O
Caregiver	O
status	O
Mother247132	O
(	O
53	O
.	O
4	O
)	O
47	O
.	O
2	O
,	O
59	O
.	O
7115	O
(	O
46	O
.	O
6	O
)	O
40	O
.	O
0	O
,	O
53	O
.	O
00	O
.	O
62Father159	O
(	O
60	O
.	O
0	O
)	O
35	O
.	O
2	O
,	O
84	O
.	O
86	O
(	O
40	O
.	O
0	O
)	O
15	O
.	O
2	O
,	O
64	O
.	O
8	O
Other43	O
(	O
75	O
.	O
0	O
)	O
32	O
.	O
6	O
,	O
117	O
.	O
41	O
(	O
25	O
.	O
0	O
)-	O
17	O
.	O
4	O
,	O
67	O
.	O
4	O
Graduated	O
high	O
school	O
*	O
<	O
0	O
.	O
001Grade	O
12	O
or	O
higher19786	O
(	O
43	O
.	O
7	O
)	O
36	O
.	O
7	O
,	O
50	O
.	O
6111	O
(	O
56	O
.	O
3	O
)	O
49	O
.	O
4	O
,	O
63	O
.	O
3	O
<	O
Grade	O
126655	O
(	O
83	O
.	O
3	O
)	O
74	O
.	O
0	O
,	O
92	O
.	O
011	O
(	O
16	O
.	O
7	O
)	O
7	O
.	O
7	O
,	O
25	O
.	O
7	O
Afford	O
dental	O
care	O
*	O
Yes222123	O
(	O
55	O
.	O
4	O
)	O
48	O
.	O
9	O
,	O
61	O
.	O
999	O
(	O
44	O
.	O
6	O
)	O
38	O
.	O
1	O
,	O
51	O
.	O
10	O
.	O
28No4119	O
(	O
46	O
.	O
3	O
)	O
331	O
.	O
1	O
,	O
61	O
.	O
622	O
(	O
53	O
.	O
7	O
)	O
38	O
.	O
0	O
,	O
69	O
.	O
0	O
Receives	O
social	O
assistance	O
*	O
<	O
0	O
.	O
001Yes10381	O
(	O
78	O
.	O
6	O
)	O
70	O
.	O
7	O
,	O
86	O
.	O
622	O
(	O
21	O
.	O
4	O
)	O
13	O
.	O
4	O
,	O
29	O
.	O
3	O
No15861	O
(	O
38	O
.	O
6	O
)	O
31	O
.	O
0	O
,	O
46	O
.	O
297	O
(	O
61	O
.	O
4	O
)	O
53	O
.	O
8	O
,	O
69	O
.	O
0	O
Yearly	O
household	O
income	O
*	O
<	O
0	O
.	O
001	O
<$	O
28	O
00011985	O
(	O
71	O
.	O
4	O
)	O
63	O
.	O
3	O
,	O
79	O
.	O
534	O
(	O
28	O
.	O
6	O
)	O
20	O
.	O
5	O
,	O
36	O
.	O
7	O
>$	O
28	O
00013447	O
(	O
35	O
.	O
1	O
)	O
27	O
.	O
0	O
,	O
43	O
.	O
087	O
(	O
64	O
.	O
9	O
)	O
56	O
.	O
8	O
,	O
73	O
.	O
0	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

Further	O
,	O
our	O
analysis	O
was	O
limited	O
to	O
prenatal	O
exposure	O
to	O
estrogenic	O
agents	O
.	O

In	O
animal	O
models	O
,	O
prenatal	O
exposures	O
to	O
overnutrition	O
,	O
high	O
-	O
fat	O
and	O
high	O
-	O
protein	O
diets	O
,	O
“	O
junk	O
”	O
food	O
,	O
and	O
stress	O
have	O
been	O
linked	O
with	O
greater	O
adiposity	O
in	O
offspring	O
[	O
10	O
–	O
12	O
].	O

Established	O
as	O
the	O
chorioallantoic	O
placenta	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
villous	O
tissues	O
secrete	O
multiple	O
hormones	O
that	O
maintain	O
pregnancy	O
and	O
regulate	O
placental	O
physiology	O
.	O

(	O
Table	O
1	O
)	O
Over	O
40	O
%	O
of	O
pregnant	O
women	O
exceed	O
the	O
IOM	O
recommendations	O
for	O
gestational	O
weight	O
gain	O
(	O
GWG	O
),	O
with	O
overweight	O
and	O
obese	O
women	O
at	O
increased	O
risk	O
[	O
2	O
].	O

The	O
OGTT	O
diagnostic	O
criteria	O
for	O
GDM	O
was	O
as	O
follows	O
:	O
oral	O
intake	O
of	O
83	O
g	O
glucose	O
powder	O
;	O
the	O
normal	O
fasting	O
glucose	O
level	O
was	O
5	O
.	O
1	O
mmol	O
/	O
L	O
;	O
1	O
h	O
post	O
oral	O
glucose	O
intake	O
was	O
10	O
.	O
0	O
mmol	O
/	O
L	O
;	O
2	O
h	O
post	O
oral	O
glucose	O
intake	O
was	O
8	O
.	O
5	O
mmol	O
/	O
L	O
;	O
diagnosis	O
of	O
GDM	O
was	O
reached	O
if	O
the	O
glucose	O
level	O
of	O
more	O
than	O
one	O
time	O
point	O
was	O
high	O
than	O
normal	O
.	O

In	O
terms	O
of	O
generalisability	O
of	O
our	O
results	O
it	O
is	O
relevant	O
to	O
compare	O
the	O
levels	O
of	O
dietary	O
intake	O
of	O
PUFAs	O
and	O
vitamin	O
D	O
in	O
our	O
cohort	O
to	O
other	O
populations	O
.	O

Of	O
these	O
,	O
55	O
%	O
had	O
received	O
influenza	O
vaccination	O
in	O
2014	O
.	O

To	O
explore	O
relationships	O
between	O
race	O
,	O
vitamin	O
D	O
levels	O
and	O
SGA	O
,	O
we	O
first	O
evaluated	O
race	O
as	O
a	O
predictor	O
of	O
vitamin	O
D	O
levels	O
(	O
sufficient	O
or	O
deficient	O
)	O
in	O
cord	O
blood	O
and	O
assessed	O
for	O
potential	O
confounders	O
:	O
Medicaid	O
status	O
,	O
BMI	O
at	O
delivery	O
,	O
hypertension	O
,	O
maternal	O
age	O
and	O
prenatal	O
vitamin	O
use	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
both	O
prior	O
to	O
and	O
during	O
pregnancy	O
and	O
lactation	O
,	O
or	O
only	O
during	O
pregnancy	O
and	O
lactation	O
,	O
significantly	O
advanced	O
the	O
age	O
of	O
puberty	O
in	O
female	O
offspring	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Figure	O
3A	O
;	O
Table	O
1	O
).	O

According	O
to	O
the	O
World	O
Health	O
Organization	O
,	O
347	O
millions	O
of	O
people	O
are	O
diabetic	O
in	O
the	O
world	O
,	O
and	O
it	O
is	O
predicted	O
that	O
in	O
2030	O
,	O
diabetes	O
will	O
be	O
the	O
7th	O
cause	O
of	O
death	O
considering	O
the	O
worldwide	O
population	O
(	O
WHO	O
,	O
2014	O
).	O

Those	O
who	O
consented	O
and	O
signed	O
the	O
content	O
form	O
were	O
enrolled	O
into	O
the	O
study	O
.	O

After	O
gathering	O
information	O
,	O
we	O
divided	O
all	O
subjects	O
into	O
three	O
categories	O
on	O
the	O
base	O
of	O
their	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
serum	O
level	O
as	O
follows	O
:	O
vitamin	O
D	O
deficient	O
patients	O
(	O
serum	O
level	O
below	O
25	O
nmol	O
/	O
L	O
),	O
vitamin	O
D	O
insufficient	O
cases	O
(	O
serum	O
level	O
between	O
25	O
and	O
75	O
nmol	O
/	O
L	O
)	O
and	O
subjects	O
with	O
normal	O
or	O
higher	O
than	O
normal	O
vitamin	O
D	O
level	O
(	O
serum	O
level	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
).	O

Trained	O
examiners	O
conducted	O
Neurodevelopmental	O
testing	O
of	O
child	O
was	O
completed	O
via	O
a	O
Neonatal	O
Behavioural	O
Assessment	O
3	O
days	O
post	O
birth	O
(	O
28	O
behavioural	O
&	O
18	O
reflex	O
items	O
).	O
Comparator	O
and	O
ComparisonFish	O
intake	O
in	O
quintilesWeekly	O
servingsCategories	O
:	O
no	O
fish	O
(	O
0	O
g	O
),	O
1	O
–	O
2	O
servings	O
(	O
1	O
–	O
340	O
g	O
per	O
week	O
),	O
or	O
3	O
or	O
more	O
servings	O
per	O
week	O
(	O
over	O
340	O
g	O
).	O
Fish	O
consumption	O
:	O
No	O
fish	O
serves	O
,	O
less	O
than	O
or	O
equal	O
to	O
2	O
servings	O
per	O
week	O
,	O
greater	O
than	O
2	O
servings	O
per	O
week	O
.	O
Maternal	O
fish	O
intake	O
of	O
more	O
than	O
2	O
–	O
3	O
times	O
per	O
week	O
compared	O
to	O
up	O
to	O
once	O
per	O
week	O
.	O
No	O
mention	O
of	O
intake	O
in	O
grams	O
.	O
Maternal	O
seafood	O
intake	O
in	O
grams	O
(	O
average	O
intake	O
=	O
300	O
–	O
360	O
g	O
per	O
week	O
).	O
OutcomeHighest	O
3	O
quintiles	O
of	O
fish	O
intake	O
resulted	O
in	O
improved	O
motor	O
,	O
social	O
/	O
cognitive	O
and	O
total	O
development	O
scores	O
at	O
18	O
months	O
:	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
1	O
.	O
28	O
(	O
1	O
.	O
20	O
,	O
1	O
.	O
38	O
)	O
for	O
highest	O
versus	O
lowest	O
quintile	O
.	O
This	O
association	O
was	O
less	O
obvious	O
at	O
6	O
months	O
(	O
only	O
the	O
highest	O
quintile	O
showed	O
significant	O
improvement	O
).	O
Offspring	O
of	O
women	O
who	O
ate	O
fish	O
more	O
than	O
twice	O
a	O
week	O
scored	O
significantly	O
higher	O
on	O
WRAVMA	O
drawing	O
and	O
total	O
scores	O
compared	O
with	O
no	O
serves	O
.	O
OR	O
(	O
95	O
%	O
CI	O
)	O
for	O
WRAVMA	O
drawing	O
=	O
6	O
.	O
0	O
(	O
1	O
.	O
8	O
,	O
10	O
.	O
2	O
)	O
for	O
more	O
than	O
two	O
serves	O
per	O
week	O
compared	O
with	O
no	O
serves	O
.	O
WRAVMA	O
total	O
score	O
=	O
5	O
.	O
3	O
(	O
0	O
.	O
9	O
,	O
9	O
.	O
6	O
)	O
for	O
more	O
than	O
two	O
serves	O
per	O
week	O
compared	O
to	O
no	O
serves	O
.	O
Pregnant	O
women	O
fish	O
consumption	O
greater	O
than	O
2	O
–	O
3	O
times	O
per	O
week	O
had	O
children	O
with	O
significantly	O
higher	O
cognition	O
and	O
motor	O
development	O
scores	O
compared	O
to	O
women	O
consuming	O
fish	O
less	O
than	O
once	O
a	O
week	O
.	O

Smoking	O
status	O
was	O
categorised	O
as	O
the	O
maximum	O
exposure	O
during	O
pregnancy	O
(	O
never	O
,	O
passive	O
smoking	O
only	O
,	O
1	O
–	O
9	O
,	O
10	O
–	O
19	O
and	O
≥	O
20	O
cigarettes	O
per	O
day	O
).	O

Women	O
with	O
a	O
higher	O
education	O
(	O
aOR	O
,	O
2	O
.	O
3	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
4	O
.	O
9	O
),	O
more	O
than	O
10	O
prenatal	O
visits	O
(	O
aOR	O
,	O
7	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
4	O
-	O
15	O
.	O
0	O
)	O
and	O
those	O
who	O
received	O
advice	O
on	O
breastfeeding	O
(	O
aOR	O
,	O
2	O
.	O
0	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
3	O
.	O
5	O
)	O
were	O
more	O
likely	B
to	O
use	O
iron	O
during	O
pregnancy	O
.	O

Neonatal	O
rickets	O
and	O
hypocalcemia	O
have	O
been	O
reported	O
in	O
some	O
,	O
but	O
not	O
all	O
infants	O
with	O
cord	O
or	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
values	O
<	O
6	O
-	O
10	O
ng	O
/	O
mL	O
from	O
the	O
Middle	O
East	O
.	O

A	O
fitness	O
advantage	O
would	O
be	O
obtained	O
only	O
if	O
there	O
were	O
sufficient	O
nutrient	O
stores	O
to	O
support	O
earlier	O
reproduction	O
,	O
and	O
an	O
integrated	O
adaptive	O
response	O
would	O
thus	B
require	O
both	O
accelerated	O
puberty	O
and	O
altered	O
metabolism	O
.	O

All	O
statistical	O
analyses	O
were	O
run	O
using	O
SAS	O
version	O
9	O
.	O
3	O
,	O
Cary	O
,	O
NC	O
.	O

Similarly	O
to	O
what	O
was	O
proposed	O
for	O
skeletal	O
muscle	O
(	O
Dulloo	O
et	O
al	O
.,	O
2004	O
),	O
this	O
may	O
contribute	O
to	O
dissipate	O
excess	O
lipids	O
as	O
occurs	O
during	O
prolonged	O
stimulation	O
of	O
lipolysis	O
(	O
e	O
.	O
g	O
.,	O
chronic	O
β3	O
adrenoreceptor	O
treatment	O
).	O

Moreover	O
,	O
experimental	O
studies	O
in	O
humans	O
[	O
21	O
,	O
22	O
]	O
and	O
animals	O
[	O
23	O
,	O
24	O
]	O
have	O
demonstrated	O
that	O
intermittent	O
hypoxia	O
,	O
known	O
to	O
occur	O
in	O
sleep	O
apnea	O
,	O
exerts	O
adverse	O
effects	O
on	O
glucose	O
metabolism	O
.	O

The	O
literature	O
also	O
contains	O
many	O
in	O
vitro	O
studies	O
investigating	O
the	O
role	O
of	O
specific	O
epigenetic	O
mechanisms	O
in	O
adverse	O
outcomes	O
induced	O
by	O
environmental	O
exposures	O
.	O

Newborn	O
and	O
infant	O
children	O
have	O
greater	O
contact	O
with	O
these	O
contaminants	O
since	O
they	O
lie	O
,	O
crawl	O
and	O
play	O
near	O
the	O
ground	O
and	O
frequently	O
place	O
their	O
hands	O
,	O
objects	O
or	O
food	O
in	O
their	O
mouths	O
[	O
29	O
,	O
33	O
,	O
34	O
].	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Conclusions	O
In	O
conclusion	O
,	O
once	O
standardised	O
against	O
month	O
of	O
sampling	O
,	O
we	O
demonstrate	O
a	O
protective	O
effect	O
of	O
high	O
vitamin	O
D	O
with	O
GDM	O
.	O

Prior	O
to	O
proper	O
analysis	O
,	O
the	O
frequencies	O
and	O
ranges	O
of	O
every	O
variable	O
were	O
verified	O
for	O
consistency	O
with	O
the	O
study	O
population	O
.	O

We	O
explore	O
women	O
’	O
s	O
and	O
family	O
members	O
’	O
perceptions	O
of	O
:	O
cultural	O
norms	O
during	O
pregnancy	O
;	O
birth	O
weight	O
;	O
IFA	O
supplementation	O
;	O
and	O
experience	O
using	O
IFA	O
supplements	O
during	O
pregnancy	O
.	O

With	O
the	O
MLR	O
models	O
,	O
the	O
adjusted	O
ORs	O
and	O
their	O
respective	O
95	O
%	O
CIs	O
for	O
SGA	O
,	O
PTB	O
,	O
and	O
LWB	O
were	O
1	O
.	O
03	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
31	O
),	O
0	O
.	O
95	O
(	O
0	O
.	O
75	O
–	O
1	O
.	O
20	O
),	O
and	O
0	O
.	O
89	O
(	O
0	O
.	O
66	O
–	O
1	O
.	O
22	O
).	O

Caution	O
should	O
be	O
used	O
in	O
interpreting	B
any	O
results	O
for	O
changes	O
in	O
25	O
(	O
OH	O
)	O
D	O
based	O
on	O
baseline	O
levels	O
.	O

Nutritional	O
factors	O
,	O
including	O
fat	O
metabolism	O
,	O
digestion	O
and	O
absorption	O
of	O
feed	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
and	O
vitamin	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
are	O
important	O
for	O
IMF	O
deposition	O
.	O

Having	O
done	O
so	O
,	O
however	O
,	O
some	O
of	O
our	O
participants	O
may	O
not	O
have	O
accurately	O
remembered	O
their	O
use	O
of	O
supplements	O
early	O
in	O
pregnancy	O
or	O
before	O
conception	O
.	O

Multiple	O
epidemiologic	O
studies	O
have	O
found	O
an	O
association	O
between	O
higher	O
maternal	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentration	O
,	O
the	O
physiological	O
measure	O
of	O
vitamin	O
D	O
status	O
,	O
and	O
lower	O
PTB	O
risk	O
[	O
4	O
–	O
10	O
].	O

At	O
birth	O
(	O
phase	O
4	O
),	O
umbilical	O
cord	O
blood	O
samples	O
are	O
taken	O
immediately	O
after	O
the	O
separation	O
of	O
the	O
newborn	O
from	O
the	O
umbilical	O
cord	O
and	O
before	O
placental	O
delivery	O
into	O
labelled	O
EDTA	O
-	O
coated	O
,	O
serum	O
and	O
trace	O
element	O
free	O
evacuated	O
tubes	O
.	O

However	O
,	O
no	O
relationship	O
was	O
seen	O
between	O
vitamin	O
D	O
status	O
and	O
SGA	O
among	O
black	O
mothers	O
.	O

Although	O
thyroid	O
cancer	O
during	O
pregnancy	O
may	O
have	O
a	O
faster	O
growth2728since	O
hormonal	O
factors	O
(	O
mainly	B
HCG	O
)	O
may	O
accelerate	O
tumour	O
progression	O
,	O
the	O
real	O
impact	O
of	O
pregnancy	O
seems	O
to	O
be	O
minimal	O
.	O

Children	O
born	O
to	O
women	O
who	O
smoke	O
during	O
pregnancy	O
typically	B
weigh	O
less	O
at	O
birth	O
,	O
and	O
they	O
often	B
have	O
a	O
catch	O
-	O
up	O
period	O
during	O
their	O
first	O
year	O
,	O
although	O
studies	O
have	O
not	O
consistently	O
found	O
a	O
link	O
between	O
catch	O
-	O
up	O
growth	O
and	O
greater	O
childhood	O
body	O
mass	O
index	O
(	O
BMI	O
).	O

The	O
prevalence	O
of	O
postnatal	O
depression	O
in	O
some	O
Asian	O
countries	O
has	O
been	O
reported	O
between	O
22	O
and	O
46	O
.	O
9	O
%	O
[	O
7	O
,	O
8	O
].	O

As	B
a	O
result	O
,	O
breastfeeding	O
studies	O
may	O
not	O
pass	O
muster	O
with	O
funding	O
committees	O
,	O
says	O
Raju	O
.	O

Using	O
the	O
Institute	O
of	O
Medicine	O
’	O
s	O
definition	O
of	O
sufficiency	O
(	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
)	O
[	O
25	O
],	O
the	O
cohort	O
also	O
was	O
divided	O
into	O
two	O
groups	O
based	O
on	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
,	O
with	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
50	O
.	O
0	O
nmol	O
/	O
L	O
)	O
defined	O
as	O
deficient	O
.	O

However	O
,	O
the	O
overall	O
proportion	O
of	O
events	O
accompanied	O
by	O
handwashing	O
was	O
low	O
in	O
the	O
intervention	O
arm	O
compared	O
with	O
the	O
times	O
that	O
we	O
recommended	O
for	O
handwashing	O
.	O

In	O
low	O
birth	O
weight	O
males	O
there	O
was	O
no	O
significant	O
increased	O
risk	O
observed	O
for	O
autism	O
alone	O
.	O

One	O
other	O
important	O
finding	O
of	O
this	O
study	O
was	O
that	O
intensively	O
treated	O
women	O
had	O
better	O
quality	O
of	O
life	O
and	O
lower	O
rates	O
of	O
depression	O
.	O

Opposing	O
influences	O
of	O
prenatal	O
and	O
postnatal	O
growth	O
have	O
previously	O
been	O
described	O
for	O
adrenarche	O
[	O
14	O
],	O
central	O
fat	O
distribution	O
[	O
15	O
]	O
and	O
insulin	O
sensitivity	O
at	O
age	O
8	O
years	O
[	O
16	O
].	O

The	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	O
of	O
GWG	O
,	O
maternal	O
eating	O
and	O
exercise	O
behaviors	O
,	O
and	O
psychosocial	O
factors	O
on	O
offspring	O
weight	O
status	O
.	O

Of	O
these	O
,	O
22	O
were	O
down	O
-	O
regulated	O
and	O
13	O
up	O
-	O
regulated	O
.	O

One	O
of	O
the	O
latest	O
cohort	O
studies	O
on	O
the	O
topic	O
that	O
involved	O
268	O
subjects	O
also	O
suggests	O
positive	O
association	O
between	O
prolonged	O
labor	O
and	O
autism	O
[	O
53	O
].	O

We	O
used	O
block	O
randomization	O
,	O
using	O
blocks	O
of	O
4	O
,	O
to	O
randomize	O
participants	O
to	O
either	O
the	O
intervention	O
or	O
control	O
arm	O
.	O

Among	O
38	O
infants	O
who	O
completed	O
a	O
3	O
month	O
vitamin	O
D	O
supplementation	O
intervention	O
,	O
provision	O
of	O
400	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
increased	O
final	O
25	O
(	O
OH	O
)	O
D	O
to	O
a	O
higher	O
level	O
in	O
non	O
-	O
Hispanic	O
Caucasian	O
compared	O
to	O
Hispanic	O
infants	O
.	O

The	O
phenomenon	O
of	O
circannual	O
rhythms	O
has	O
also	O
been	O
explored	O
in	O
relation	O
to	O
gestational	O
diabetes	O
[	O
24	O
–	O
26	O
,	O
28	O
].	O

Current	O
international	O
dietary	O
guidelines	O
advise	O
people	O
to	O
reduce	O
their	O
consumption	O
of	O
sugar	O
,	O
and	O
more	O
particularly	O
free	O
sugars	O
,	O
which	O
comprise	O
sugars	O
(	O
monosaccharides	O
and	O
disaccharides	O
)	O
added	O
to	O
foods	O
or	O
drinks	O
by	O
the	O
manufacturer	O
,	O
cook	O
or	O
consumer	O
,	O
and	O
sugars	O
naturally	O
present	O
in	O
honey	O
,	O
syrups	O
and	O
unsweetened	O
fruit	O
juices	O
[	O
4	O
].	O

In	O
addition	O
,	O
total	O
and	O
specific	O
IgE	O
levels	O
,[	O
72	O
,	O
73	O
]	O
total	O
eosinophil	O
counts	O
,[	O
74	O
]	O
incidence	O
of	O
airway	O
disease	O
,[	O
74	O
]	O
and	O
positive	O
results	O
on	O
skin	O
prick	O
tests	O
[	O
75	O
]	O
were	O
also	O
increased	O
in	O
children	O
who	O
were	O
exposed	O
to	O
smoke	O
either	O
during	O
pregnancy	O
or	O
in	O
early	O
childhood	O
.	O

EDCs	O
with	O
measurements	O
below	O
the	O
limit	O
of	O
detection	O
(	O
LOD	O
)	O
were	O
assigned	O
LOD	O
/√	O
2	O
[	O
10	O
,	O
35	O
,	O
36	O
].	O

Therefore	B
these	O
costs	O
need	O
to	O
be	O
incorporated	O
into	O
the	O
overall	O
cost	O
of	O
an	O
intervention	O
program	O
.	O

[	O
2	O
]	O
hypothesize	O
that	O
the	O
increased	O
prevalence	O
of	O
autism	O
may	O
be	O
in	O
part	O
due	O
to	O
higher	O
success	O
in	O
obstetric	O
and	O
neonatal	O
care	O
,	O
which	O
resulted	O
in	O
an	O
increased	O
survival	O
rates	O
of	O
hypoxic	O
neonates	O
with	O
brain	O
damage	O
.	O

Previous	O
studies	O
in	O
rodents	O
have	O
shown	O
that	O
the	O
restriction	O
of	O
vitamin	O
D	O
for	O
a	O
period	O
of	O
six	O
weeks	O
prior	O
to	O
mating	O
assures	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
[	O
13	O
],[	O
22	O
].	O

Thus	B
,	O
environmentally	O
induced	O
epigenetic	O
changes	O
may	O
not	O
always	O
be	O
mechanistically	O
involved	O
in	O
adverse	O
effects	O
;	O
instead	O
,	O
they	O
may	O
act	O
as	O
markers	O
of	O
past	O
exposures	O
(	O
Bakulski	O
&	O
Fallin2014	O
),	O
or	O
represent	O
adaptations	O
involved	O
in	O
maintaining	O
cellular	O
homeostasis	O
.	O

To	O
accelerate	O
change	O
,	O
we	O
provide	O
an	O
overview	O
of	O
the	O
comprehensive	B
strategy	O
required	O
,	O
the	O
tools	O
available	O
for	O
context	O
-	O
specific	O
health	O
system	O
implementation	O
now	O
,	O
and	O
the	O
priorities	O
for	O
research	O
and	O
innovation	O
.	O

(%)	O
<	O
25	O
normal	O
weight13	O
381	O
(	O
73	O
)	O
10	O
030	O
(	O
70	O
)	O
506	O
(	O
62	O
)	O
25	O
-	O
29	O
.	O
9	O
overweight3	O
697	O
(	O
20	O
)	O
3005	O
(	O
21	O
)	O
198	O
(	O
24	O
)	O
≥	O
30	O
obese770	O
(	O
4	O
)	O
857	O
(	O
6	O
)	O
71	O
(	O
9	O
)	O
missing563	O
(	O
3	O
)	O
503	O
(	O
3	O
)	O
42	O
(	O
5	O
)	O
Education	O
,	O
No	O
.	O

Glucocorticoids	O
should	O
be	O
administered	O
early	O
to	O
patients	O
with	O
severe	O
anaphylaxis	O
.	O

However	O
,	O
subungual	O
exostosis	O
has	O
a	O
fibrous	O
cap	O
and	O
lacks	O
capillary	O
proliferation	O
.	O

Wilcoxon	O
test	O
.	O

Discussion	O
We	O
found	O
a	O
clear	O
association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
PTB	O
risk	O
in	O
the	O
general	O
obstetrical	O
population	O
at	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
.	O

The	O
hyperparameter	O
μβis	O
the	O
average	O
association	O
between	O
the	O
exposure	O
variables	O
within	O
a	O
chemical	O
class	O
and	O
the	O
outcome	O
,	O
whereas	O
σβgoverns	O
the	O
heterogeneity	O
of	O
effects	O
for	O
the	O
class	O
regression	O
coefficients	O
.	O

Study	O
design	O
We	O
studied	O
1019	O
women	O
enrolled	O
in	O
a	O
prospective	O
study	O
at	O
Brigham	O
and	O
Women	O
’	O
s	O
Hospital	O
in	O
Boston	O
,	O
2007	O
–	O
2009	O
.	O

In	O
addition	O
,	O
Japanese	O
farmers	O
generally	B
restrict	O
vitamin	O
A	O
levels	O
in	O
the	O
diet	O
during	O
the	O
mid	O
-	O
fattening	O
stage	O
to	O
produce	O
highly	O
marbled	O
Japanese	O
Black	O
cattle	O
beef	O
.	O

Participants	O
Women	O
who	O
participated	O
in	O
the	O
LIMIT	O
randomised	O
trial	O
,	O
gave	O
birth	O
to	O
a	O
live	O
infant	O
,	O
and	O
who	O
provided	O
consent	O
to	O
the	O
ongoing	O
follow	O
-	O
up	O
of	O
their	O
child	O
,	O
were	O
eligible	O
for	O
inclusion	O
.	O

The	O
identification	O
of	O
prenatal	O
factors	O
that	O
are	O
linked	O
to	O
autism	O
may	O
serve	O
as	O
a	O
paradigm	O
shift	O
in	O
our	O
current	O
view	O
and	O
management	O
of	O
autism	O
.	O

Supplementary	O
material10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp1	O
Please	O
note	O
:	O
supplementary	O
material	O
is	O
not	O
edited	O
by	O
the	O
Editorial	O
Office	O
,	O
and	O
is	O
uploaded	O
as	O
it	O
has	O
been	O
supplied	O
by	O
the	O
author	O
.	O

Studies	O
are	O
underway	O
to	O
establish	O
the	O
recommended	O
daily	O
doses	O
of	O
vitamin	O
D	O
in	O
pregnant	O
women	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Significantly	O
regulated	O
transcripts	O
of	O
metabolic	O
pathways	O
in	O
liver	O
tissue	O
within	O
different	O
ontogenetic	O
stages	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
).	O
Ontogenetic	O
stageRegulated	O
pathwayDirection	O
of	O
regulation	O
P	O
valueNo	O
.	O

Higher	O
vaccination	O
among	O
pregnant	O
women	O
with	O
high	O
-	O
risk	O
pregnancies	O
could	O
have	O
caused	O
a	O
selection	O
bias	O
as	B
those	O
vaccinated	O
women	O
would	O
have	O
been	O
at	O
higher	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
compared	O
to	O
unvaccinated	O
women	O
.	O

However	O
,	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
alone	O
was	O
the	O
only	O
predicted	O
higher	O
probability	B
of	O
respiratory	O
infection	O
in	O
the	O
first	O
6	O
months	O
of	O
life	O
(	O
Table	O
4	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
linear	O
regression	O
analysis	O
of	O
lung	O
function	O
outcome	O
(	O
Z	O
score	O
of	O
Rrs	O
).	O
Beta	O
(	O
s	O
.	O
e	O
.	O

The	O
mixed	O
ration	O
is	O
made	O
by	O
using	O
agricultural	O
by	O
-	O
products	O
(	O
soybean	O
curd	O
cake	O
and	O
pomace	O
of	O
citrus	O
,	O
apple	O
,	O
and	O
carrot	O
)	O
[	O
96	O
].	O

Visible	O
skeletal	O
malformations	O
in	O
Skm1	O
(	O
B	O
)	O
mice	O
and	O
Skm2	O
(	O
C	O
)	O
mice	O
.	O

Data	O
processing	O
and	O
statistical	O
analysis	O
We	O
identified	O
open	O
reference	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
using	O
QIIME	O
version	O
1	O
.	O
9	O
.	O
1	O
[	O
35	O
]	O
with	O
the	O
UCLUST	O
algorithm	O
and	O
97	O
%	O
similarity	O
[	O
36	O
].	O

The	O
DVD	O
adult	O
rat	O
is	O
also	O
more	O
sensitive	O
to	O
haloperidol	O
,	O
a	O
dopamine	O
(	O
DA	O
)	O
D2	O
receptor	O
antagonist	O
[	O
10	O
],	O
that	O
is	O
a	O
widely	O
used	O
antipsychotic	O
medication	O
used	O
to	O
treat	O
schizophrenia	O
.	O

Thus	O
,	O
central	O
or	O
visceral	O
obesity	O
,	O
in	O
which	O
fat	O
accumulates	O
in	O
the	O
trunk	O
and	O
in	O
the	O
abdominal	O
cavity	O
(	O
in	O
the	O
mesentery	O
and	O
around	O
the	O
viscera	O
),	O
is	O
associated	O
with	O
a	O
much	O
higher	O
risk	O
for	O
several	O
diseases	O
than	O
excess	O
subcutaneous	O
fat	O
accumulation	O
.	O

Cluster	O
1	O
is	O
the	O
reference	O
group	O
.	O

There	O
was	O
no	O
significant	O
relationship	O
between	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
or	O
BMD	O
in	O
the	O
first	O
week	O
of	O
life	O
(	O
n	O
=	O
49	O
)	O
or	O
after	O
3	O
months	O
of	O
vitamin	O
D	O
supplementation	O
.	O

Why	O
is	O
the	O
Endometrium	O
So	O
Susceptible	O
to	O
VD	O
Levels	O
?	O

Important	O
research	O
themes	O
can	O
be	O
summarised	O
across	O
the	O
research	O
pipeline	O
of	O
description	O
,	O
discovery	O
,	O
development	O
and	O
delivery	O
science	O
,	O
showing	O
the	O
dual	O
agenda	O
of	O
preventing	O
preterm	O
birth	O
and	O
addressing	O
the	O
care	O
and	O
survival	O
gap	O
for	O
babies	O
born	O
preterm	O
(	O
Table1	O
)	O
[	O
30	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

Terbutaline	O
can	O
cross	O
the	O
placenta	O
and	O
potentially	O
affect	O
the	O
developing	O
neonatal	O
brain	O
[	O
22	O
].	O

Baseline	O
characteristics	O
of	O
the	O
intervention	O
and	O
placebo	O
groups	O
were	O
not	O
different	O
except	O
for	O
total	O
white	O
cell	O
concentration	O
at	O
baseline	O
(	O
Table	O
3	O
).	O

On	O
examination	O
,	O
the	O
infant	O
was	O
afebrile	O
,	O
alert	O
and	O
interacting	O
with	O
his	O
mother	O
.	O

Our	O
primary	O
endpoint	O
was	O
the	O
first	O
episode	O
of	O
pneumonia	O
from	O
the	O
time	O
of	O
enrolment	O
confirmed	O
by	O
chest	O
radiograph	O
(	O
consolidation	O
or	O
infiltrates	O
).	O

Sample	O
size	O
calculation	O
was	O
undertaken	O
using	O
the	O
single	O
proportion	O
formula	O
[	O
22	O
].	O

The	O
majority	B
of	O
women	O
in	O
the	O
exposed	O
group	O
reported	O
taking	O
quetiapine	O
(	O
69	O
.	O
9	O
%),	O
followed	O
by	O
olanzapine	O
(	O
16	O
.	O
5	O
%),	O
risperidone	O
(	O
10	O
.	O
5	O
%),	O
aripiprazole	O
(	O
1	O
.	O
5	O
%),	O
paliperidone	O
(	O
0	O
.	O
8	O
%)	O
and	O
quetiapine	O
plus	O
olanzapine	O
(	O
0	O
.	O
8	O
%).	O

Duration	O
of	O
gestation	O
We	O
will	O
measure	O
the	O
duration	O
of	O
gestation	O
will	O
be	O
measured	O
using	O
the	O
date	O
of	O
last	O
menstrual	O
period	O
with	O
the	O
pregnancy	O
confirmed	O
by	O
urine	O
test	O
in	O
the	O
field	O
.	O

Congenital	O
spine	O
deformities	O
occur	O
with	O
an	O
approximate	O
frequency	O
of	O
0	O
.	O
5	O
–	O
1	O
per	O
1000	O
live	O
births	O
(	O
Sparrow	O
et	O
al	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

Detailed	O
descriptions	O
of	O
the	O
recruitment	O
and	O
data	O
collection	O
have	O
been	O
reported	O
previously	O
[	O
17	O
,	O
18	O
].	O

We	O
merged	O
the	O
forward	O
and	O
reverse	O
reads	O
based	O
on	O
sequence	O
overlap	O
[	O
33	O
],	O
removed	O
the	O
primer	O
sequences	O
,	O
and	O
discarded	O
the	O
sequences	O
containing	O
any	O
ambiguous	O
nucleotides	O
.	O

CMH	O
was	O
responsible	O
for	O
the	O
questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptom	O
,	O
funding	O
and	O
the	O
initial	O
idea	O
in	O
collaboration	O
with	O
MH	O
.	O

The	O
other	O
seasonal	O
behaviours	O
were	O
not	O
significantly	O
associated	O
with	O
metabolic	O
markers	O
.	O

The	O
ratio	O
of	O
time	O
to	O
reach	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
(	O
Tpef	O
/	O
Te	O
)	O
in	O
the	O
tidal	O
breathing	O
analysis	O
,	O
the	O
resistance	O
and	O
compliance	O
of	O
the	O
respiratory	O
system	O
(	O
Rrs	O
and	O
Crs	O
)	O
in	O
respiratory	O
mechanics	O
,	O
and	O
the	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
(	O
VmaxFRC	O
)	O
in	O
forced	O
tidal	O
expiration	O
were	O
collected	O
for	O
further	O
analysis	O
.	O

Variables	O
that	O
were	O
significant	O
or	O
approached	O
significance	O
(	O
P	O
<	O
0	O
.	O
10	O
)	O
within	O
each	O
category	O
in	O
the	O
stepwise	O
analyses	O
were	O
included	O
together	O
in	O
a	O
comprehensive	O
model	O
.	O

The	O
measurement	O
is	O
taken	O
with	O
the	O
infant	O
lying	O
on	O
his	O
/	O
her	O
back	O
on	O
the	O
infantometer	O
,	O
legs	O
extended	O
with	O
the	O
head	O
and	O
foot	O
board	O
making	O
contact	O
with	O
the	O
infant	O
.	O

Data	O
collection	O
is	O
projected	O
to	O
be	O
complete	O
by	O
mid	O
-	O
2008	O
.	O

Associations	O
between	O
neonatal	O
outcomes	O
and	O
25OHD	O
at	O
T1	O
,	O
T3	O
and	O
change	O
in	O
25OHD	O
(	O
T3	O
-	O
T1	O
)	O
were	O
studied	O
using	O
logistic	O
regression	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
6	O
month	O
infant	O
general	O
health	O
and	O
health	O
utilisation	O
outcomes	O
by	O
treatment	O
groupOutcomeLifestyle	O
Advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
Care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueWell	O
Since	O
Discharge491	O
(	O
83	O
.	O
50	O
)	O
548	O
(	O
87	O
.	O
82	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
91	O
,	O
1	O
.	O
00	O
)	O
0	O
.	O
0330	O
.	O
96	O
(	O
0	O
.	O
92	O
,	O
1	O
.	O
01	O
)	O
0	O
.	O
131Visited	O
Doctor	O
/	O
Hospital	O
Since	O
Discharge251	O
(	O
42	O
.	O
83	O
)	O
267	O
(	O
42	O
.	O
86	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
88	O
,	O
1	O
.	O
14	O
)	O
0	O
.	O
9930	O
.	O
97	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
690Admitted	O
to	O
Hospital36	O
(	O
14	O
.	O
34	O
)	O
33	O
(	O
12	O
.	O
36	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
80	O
)	O
0	O
.	O
5071	O
.	O
08	O
(	O
0	O
.	O
68	O
,	O
1	O
.	O
71	O
)	O
0	O
.	O
740	O
Values	O
are	O
number	O
and	O
percentage	O
,	O
and	O
treatment	O
effects	O
are	O
relative	O
risks	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

Oral	O
antidiabetic	O
agents	O
in	O
gestational	O
diabetes	O
There	O
is	O
controversy	O
regarding	O
the	O
use	O
of	O
oral	O
hypoglycemic	O
agents	O
during	O
pregnancy	O
.	O

The	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
and	O
the	O
milk	O
replacement	O
+	O
concentrate	O
group	O
showed	O
changes	O
in	O
the	O
adipokine	O
signaling	O
pathway	O
compared	O
to	O
control	O
group	O
.	O

Impact	O
of	O
maternal	O
caloric	O
restriction	O
on	O
the	O
expression	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
in	O
organs	O
related	O
to	O
energy	O
expenditure	O
and	O
metabolism	O
The	O
sex	O
-	O
dependent	O
effects	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
and	O
metabolic	O
profile	O
in	O
offspring	O
can	O
be	O
a	O
result	O
of	O
a	O
differential	O
re	O
-	O
programming	O
in	O
energy	O
metabolism	O
.	O

2010	O
;	O
Pavanello	O
et	O
al	O
.	O

In	O
contrast	O
maternal	O
intakes	O
of	O
carbohydrate	O
were	O
negatively	O
associated	O
with	O
infant	O
length	O
and	O
abdominal	O
circumference	O
[	O
26	O
].	O

Growing	O
evidence	O
suggests	O
that	O
prenatal	O
and	O
maternal	O
interactions	O
and	O
influences	O
must	O
be	O
considered	O
along	O
with	O
biological	O
and	O
environmental	O
variables	O
throughout	O
infancy	O
,	O
childhood	O
,	O
and	O
adolescence	O
that	O
may	O
lead	B
to	I
—	O
or	O
prevent	O
—	O
obesity	O
.	O

In	O
2008	O
,	O
Young	O
et	O
al	O
.	O

In	O
total	O
,	O
18	O
of	O
the	O
40	O
studies	O
shown	O
inTable	O
2validated	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
;	O
thereby	O
demonstrating	O
a	O
definitive	O
causal	O
link	O
between	O
exposure	O
(	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
cadmium	O
,	O
methylmercury	O
,	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetra	O
-	O
chloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
),	O
urethane	O
,	O
vinyl	O
carbamate	O
,	O
alcohol	O
,	O
caffeine	O
,	O
overnutrition	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
4	O
-(	O
methyl	O
-	O
nitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
),	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

Thus	O
,	O
the	O
total	O
number	O
of	O
subjects	O
was	O
723	O
.	O

Samples	O
were	O
GC	O
-	O
RMA	O
normalised	O
(	O
Log2	O
).	O

The	O
reasons	B
why	O
vitamin	O
D	O
deficiency	O
is	O
thought	O
to	O
be	O
a	O
risk	O
factor	O
for	O
MS	O
are	O
as	O
follows	O
:	O
First	O
,	O
MS	O
frequency	O
increases	O
with	O
increasing	O
latitude	O
,	O
which	O
is	O
strongly	O
inversely	O
correlated	O
with	O
duration	O
and	O
intensity	O
of	O
UVB	O
from	O
sunlight	O
and	O
vitamin	O
D	O
concentrations	O
.	O
2830	O
–	O
35Second	O
,	O
prevalence	O
of	O
MS	O
is	O
lower	O
than	O
expected	O
at	O
high	O
latitudes	O
in	O
populations	O
with	O
high	O
consumption	O
of	O
vitamin	O
-	O
D	O
-	O
rich	O
fatty	O
fish43536	O
.	O

In	O
2000	O
she	O
received	O
an	O
environmental	O
justice	O
grant	O
from	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
to	O
collect	O
clinical	O
and	O
survey	O
data	O
from	O
people	O
living	O
on	O
the	O
Eastern	O
Navajo	O
Nation	O
.	O

The	O
recommendations	O
for	O
medical	O
treatment	O
have	O
been	O
summarized	O
by	O
a	O
Working	O
Group	O
of	O
the	O
National	O
Asthma	O
Education	O
and	O
Prevention	O
Program	O
in	O
a	O
report	O
on	O
managing	O
asthma	O
during	O
pregnancy	O
[	O
21	O
].	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	O
due	B
to	I
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

The	O
problem	O
of	O
pregnancy	O
-	O
associated	O
thyroid	O
cancer	O
can	O
affect	O
three	O
groups	O
of	O
patients	O
:	O
New	O
diagnosis	O
Patients	O
with	O
no	O
prior	O
history	O
of	O
cancer	O
,	O
in	O
whom	O
a	O
malignant	O
thyroid	O
nodule	O
is	O
suspected	O
or	O
diagnosed	O
during	O
pregnancy	O
.	O

In	O
general	O
,	O
results	O
are	O
given	O
for	O
the	O
comparisons	O
in	O
the	O
direction	O
of	O
LP	O
vs	O
.	O
AP	O
;	O
thus	O
'	O
up	O
-	O
regulation	O
'	O
or	O
'	O
increased	O
expression	O
'	O
indicates	O
higher	O
expression	O
in	O
LP	O
than	O
in	O
AP	O
.	O

Methods	O
Study	O
population	O
and	O
setting	O
This	O
preliminary	O
(	O
pilot	O
)	O
study	O
is	O
based	O
on	O
data	O
collected	O
from	O
a	O
cohort	O
of	O
women	O
attending	O
prenatal	O
care	O
clinics	O
affiliated	O
with	O
Swedish	O
Medical	O
Center	O
in	O
Seattle	O
,	O
Washington	O
.	O

Background	O
Mood	O
disorders	O
in	O
pregnancy	O
and	O
post	O
-	O
partum	O
period	O
are	O
common	O
and	O
considered	O
as	O
a	O
public	O
health	O
issue	O
.	O

In	O
the	O
general	O
population	O
,	O
aortic	O
dissection	O
has	O
an	O
estimated	O
incidence	O
of	O
2	O
.	O
9	O
per	O
100	O
,	O
000	O
person	O
years	O
[	O
1	O
].	O

Vitamin	O
D	O
Vitamin	O
D	O
also	O
inhibits	O
adipogenesis	O
in	O
vitro	O
.	O

Identifying	O
and	O
understanding	O
environmentally	O
induced	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
may	O
lead	O
to	O
adverse	O
outcomes	O
is	O
vital	O
for	O
protecting	O
public	O
health	O
.	O

There	O
is	O
also	O
evidence	O
that	O
prenatal	O
supplementation	O
with	O
zinc	O
has	O
a	O
positive	O
effect	O
on	O
birth	O
weight	O
[	O
47	O
]	O
and	O
fetal	O
HRV	O
measures	O
[	O
48	O
,	O
49	O
].	O

In	O
both	O
models	O
,	O
some	O
variables	O
were	O
excluded	O
when	O
there	O
was	O
evidence	O
of	O
multi	O
-	O
colinearity	O
.	O

Some	O
researchers	O
defined	B
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
lower	O
than	O
50	O
nmol	O
/	O
L	O
as	B
diagnostic	O
criteria	O
for	O
Vitamin	O
D	O
deficiency	O
,	O
50	O
–	O
75	O
nmol	O
/	O
L	O
as	B
inadequate	O
,	O
and	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
as	B
adequate	O
[	O
4	O
,	O
6	O
,	O
7	O
].	O

We	O
analyzed	O
maternal	O
plasma	O
glucose	O
concentrations	O
1	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
as	O
part	O
of	O
routine	O
mid	O
-	O
pregnancy	O
screening	O
for	O
GDM	O
.	O

For	O
example	O
,	O
Michael	O
Kramer	O
,	O
a	O
perinatal	O
epidemiologist	O
at	O
McGill	O
University	O
in	O
Montreal	O
,	O
points	O
out	O
that	O
investigators	O
are	O
more	O
likely	B
to	O
submit	O
,	O
and	O
journal	O
editors	O
to	O
accept	O
,	O
papers	O
reporting	O
significant	O
associations	O
than	O
those	O
showing	O
no	O
such	O
association	O
—	O
a	O
phenomenon	O
known	B
as	O
publication	O
bias	O
,	O
which	O
can	O
affect	O
observational	O
studies	O
in	O
any	O
field	O
.	O

EK	O
:	O
Acquisition	O
of	O
data	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

The	O
process	O
of	O
skeletal	O
muscle	O
and	O
adipose	O
tissue	O
development	O
during	O
the	O
fetal	O
stage	O
in	O
laboratory	O
animals	O
and	O
livestock	O
including	O
ruminants	O
has	O
been	O
well	O
described	O
in	O
reviews	O
by	O
Du	O
et	O
al	O
[	O
16	O
–	O
18	O
].	O

Only	O
expression	O
of	O
GAS5	O
was	O
significantly	O
upregulated	O
by	O
cortisol	O
in	O
all	O
treatments	O
compared	O
with	O
basal	O
levels	O
,	O
but	O
none	O
of	O
the	O
GRs	O
changed	O
expression	O
significantly	O
.	O

Recent	O
work	O
has	O
demonstrated	O
that	O
placental	O
genetic	O
and	O
epigenetic	O
profiles	O
may	O
possibly	O
serve	O
as	O
markers	O
(	O
Filiberto	O
et	O
al	O
.	O

This	O
is	O
largely	O
attributable	B
to	O
the	O
fact	O
that	O
,	O
in	O
humans	O
,	O
vertebral	O
malformation	O
syndromes	O
often	B
represent	B
a	O
sporadic	O
occurrence	O
within	O
a	O
family	O
and	O
traditional	O
linkage	O
analysis	O
to	O
identify	O
the	O
chromosomal	O
regions	O
responsible	O
for	O
these	O
defects	O
is	O
often	O
not	O
possible	O
.	O

Our	O
findings	O
suggest	O
that	O
women	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
have	O
altered	O
glucose	O
metabolism	O
in	O
later	O
gestation	O
,	O
but	O
the	O
evidence	O
is	O
not	O
consistent	O
for	O
insulin	O
resistance	O
.	O

[	O
Mean	O
±	O
SD	O
or	O
Median	O
(	O
interquartile	O
range	O
)	O
or	O
n	O
(%)]	O
PPBMI	O
(	O
kg	O
/	O
m2	O
)	O
p	O
**	O
Total	O
(	O
n	O
=	O
76	O
)	O
<	O
25	O
(	O
n	O
=	O
21	O
)	O
≥	O
25	O
(	O
n	O
=	O
25	O
)	O
≥	O
30	O
(	O
n	O
=	O
30	O
)	O
Feature	O
Weight	O
gain	O
before	O
diagnosis	O
(	O
kg	O
)	O
8	O
,	O
1	O
(	O
2	O
,	O
2	O
–	O
11	O
,	O
1	O
)	O
9	O
.	O
0	O
(	O
7	O
,	O
6	O
-	O
11	O
,	O
1	O
)	O
a9	O
,	O
2	O
(	O
2	O
,	O
5	O
-	O
13	O
,	O
9	O
)	O
a3	O
,	O
4	O
(	O
0	O
,	O
1	O
-	O
9	O
.	O
0	O
)	O
b0	O
.	O
002	O
Below	O
the	O
recommended	O
26	O
(	O
34	O
,	O
2	O
)	O
4	O
(	O
19	O
.	O
0	O
)	O
7	O
(	O
28	O
.	O
0	O
)	O
15	O
(	O
50	O
.	O
0	O
)	O
0	O
,	O
166	O
Adequate	O
4	O
(	O
5	O
,	O
3	O
)	O
2	O
(	O
9	O
,	O
5	O
)	O
1	O
(	O
4	O
.	O
0	O
)	O
1	O
(	O
3	O
,	O
3	O
)	O
Above	O
the	O
recommended	O
46	O
(	O
60	O
,	O
5	O
)	O
15	O
(	O
71	O
,	O
4	O
)	O
17	O
(	O
68	O
.	O
0	O
)	O
14	O
(	O
46	O
,	O
7	O
)	O
BMI	O
at	O
diagnosis	O
(	O
kg	O
/	O
m2	O
)	O
32	O
,	O
2	O
±	O
5	O
,	O
826	O
,	O
1	O
±	O
2	O
.	O
0a30	O
,	O
9	O
±	O
3	O
,	O
1b37	O
,	O
5	O
±	O
4	O
,	O
5c	O
<	O
0	O
.	O
001	O
Low	O
weight	O
1	O
(	O
1	O
,	O
3	O
)	O
1	O
(	O
4	O
,	O
8	O
)	O
0	O
(	O
0	O
)	O
0	O
(	O
0	O
)<	O
0	O
.	O
001	O
Normal	O
weight	O
16	O
(	O
21	O
,	O
1	O
)	O
14	O
(	O
66	O
,	O
7	O
)*	O
2	O
(	O
8	O
.	O
0	O
)	O
0	O
(	O
0	O
)	O
Overweight	O
22	O
(	O
28	O
,	O
9	O
)	O
6	O
(	O
28	O
,	O
6	O
)	O
14	O
(	O
56	O
.	O
0	O
)*	O
2	O
(	O
6	O
,	O
7	O
)	O
Obesity	O
37	O
(	O
48	O
,	O
7	O
)	O
0	O
(	O
0	O
)	O
9	O
(	O
36	O
.	O
0	O
)	O
28	O
(	O
93	O
,	O
3	O
)*	O
a	O
,	O
b	O
,	O
c	O
=	O
mean	O
/	O
median	O
significantly	O
different	O
between	O
groups	O
*=	O
association	O
found	O
p	O
**=	O
comparison	O
between	O
groups	O
BMI	O
=	O
Body	O
Mass	O
Index	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Graphical	O
analysis	O
on	O
Bland	O
-	O
Altman	O
showing	O
agreement	O
between	O
the	O
average	O
of	O
energy	O
intake	O
and	O
recommendation	O
(	O
kcal	O
)	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
gestational	O
diabetes	O
mellitus	O
.	O

Similar	O
results	O
were	O
found	O
when	O
analysing	O
the	O
contributing	O
factors	O
for	O
the	O
use	O
of	O
multivitamins	O
:	O
more	O
than	O
12	O
years	O
of	O
schooling	O
(	O
aOR	O
,	O
3	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
4	O
-	O
7	O
.	O
9	O
)	O
and	O
appropriate	O
prenatal	O
care	O
(	O
aOR	O
,	O
9	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
4	O
.	O
5	O
-	O
19	O
.	O
5	O
).	O

Factors	O
related	O
to	O
the	O
delivery	O
room	O
experience	O
may	O
be	O
associated	O
with	O
meconium	O
aspiration	O
syndrome	O
,	O
birth	O
weight	O
,	O
and	O
labor	O
time	O
.	O

The	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
20	O
ng	O
/	O
ml	O
(	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
following	O
variables	O
as	O
predictors	O
in	O
the	O
model	O
:	O
season	O
,	O
age	O
,	O
trimester	O
of	O
pregnancy	O
,	O
region	O
,	O
BMI	O
,	O
smoking	O
behaviour	O
,	O
alcohol	O
consumption	O
,	O
use	O
of	O
vitamin	O
D	O
-	O
containing	O
food	O
supplements	O
,	O
fish	O
consumption	O
,	O
milk	O
and	O
dairy	O
product	O
consumption	O
,	O
education	O
level	O
,	O
ethnicity	O
,	O
parity	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekdays	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekend	O
days	O
,	O
use	O
of	O
sunscreen	O
lotion	O
,	O
use	O
of	O
solarium	O
,	O
shadow	O
or	O
sun	O
preference	O
and	O
sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
(	O
yes	O
/	O
no	O
question	O
).	O

Vitamin	O
D	O
is	O
known	O
to	O
influence	O
insulin	O
secretion	O
.	O

All	O
participants	O
’	O
records	O
and	O
clinical	O
information	O
were	O
anonymized	O
and	O
deidentified	O
before	O
analysis	O
.	O

In	O
final	O
,	O
multiple	O
regression	O
analyses	O
that	O
included	O
adjustments	O
for	O
confounding	O
variables	O
,	O
the	O
strongest	O
predictor	O
of	O
higher	O
WFA	O
z	O
score	O
at	O
birth	O
was	O
greater	O
consumption	O
of	O
soft	O
drinks	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
04	O
;	O
Table	O
4	O
).	O

We	O
found	O
,	O
despite	O
being	O
at	O
similar	O
latitudes	O
,	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
was	O
different	O
between	O
women	O
recruited	O
in	O
Adelaide	O
compared	O
to	O
women	O
recruited	O
in	O
Auckland	O
.	O

The	O
same	O
authors	O
reported	O
that	O
exclusion	O
of	O
a	O
vitamin	O
A	O
supplement	O
induced	O
hyperplasia	O
in	O
IMF	O
,	O
but	O
not	O
in	O
the	O
subcutaneous	O
fat	O
depot	O
.	O

In	O
one	O
study	O
,	O
aspart	O
was	O
detected	O
in	O
the	O
cord	O
blood	O
for	O
one	O
subject	O
.	O
45However	O
,	O
as	B
it	O
was	O
not	O
detected	O
in	O
other	O
subjects	O
,	O
the	O
authors	O
postulated	O
that	O
this	O
was	O
due	O
to	O
the	O
disruption	O
of	O
the	O
uterine	O
-	O
placental	O
barrier	O
during	O
delivery	O
,	O
when	O
the	O
mother	O
had	O
been	O
receiving	O
an	O
aspart	O
infusion	O
.	O

PCBs	O
ranged	O
from	O
0	O
.	O
06	O
ng	O
/	O
ml	O
(	O
PCB	O
49	O
)	O
to	O
11	O
.	O
4	O
ng	O
/	O
ml	O
(	O
PCB	O
153	O
),	O
PBDEs	O
held	O
a	O
minimum	O
GM	O
0	O
.	O
06	O
ng	O
/	O
ml	O
(	O
PBDE	O
66	O
)	O
and	O
a	O
maximum	O
concentration	O
of	O
19	O
.	O
1	O
ng	O
/	O
ml	O
(	O
PBDE	O
47	O
).	O

We	O
will	O
identify	O
any	O
such	O
program	O
by	O
contacting	O
local	O
officials	O
in	O
the	O
sub	O
-	O
districts	O
in	O
the	O
Dhaka	O
Division	O
.	O

More	O
than	O
three	O
-	O
quarters	O
of	O
the	O
Cincinnati	O
women	O
breastfed	O
exclusively	O
for	O
less	O
than	O
1	O
month	O
.	O

In	O
conclusion	O
,	O
this	O
study	O
is	O
the	O
first	O
to	O
reveal	O
that	O
infants	O
with	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
have	O
poorer	O
lung	O
function	O
at	O
6	O
months	O
of	O
age	O
compared	O
with	O
those	O
with	O
high	O
levels	O
.	O

However	O
,	O
the	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
lower	O
than	O
the	O
baseline	O
depression	O
scores	O
((	O
p	O
=	O
0	O
.	O
048	O
and	O
p	O
=	O
0	O
.	O
014	O
,	O
respectively	O
).	O

As	O
those	O
authors	O
recognize	O
that	O
the	O
evidence	O
to	O
propose	O
such	O
intakes	O
is	O
scarce	O
and	O
as	O
long	O
as	O
the	O
health	O
benefits	O
of	O
having	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
higher	O
than	O
30	O
ng	O
/	O
ml	O
are	O
not	O
clearly	O
established	O
particularly	O
in	O
pregnant	O
women	O
,	O
the	O
Belgian	O
Superior	O
Health	O
council	O
still	O
recommends	O
a	O
vitamin	O
D	O
supplement	O
of	O
20	O
µg	O
/	O
day	O
or	O
800	O
IU	O
during	O
pregnancy	O
[	O
58	O
].	O

BMI	O
change	O
in	O
boys	O
was	O
associated	O
(	O
with	O
borderline	O
significance	O
)	O
with	O
the	O
PGF	O
,	O
p	O
=	O
0	O
.	O
061	O
.	O

Interestingly	O
,	O
the	O
CB2	O
receptor	O
activation	O
was	O
associated	O
with	O
anti	O
-	O
obesity	O
effects	O
(	O
Verty	O
et	O
al	O
.,	O
2015	O
)	O
and	O
a	O
decreased	O
risk	O
for	O
cardiovascular	O
diseases	O
.	O

Twenty	O
-	O
four	O
per	O
cent	O
of	O
women	O
in	O
this	O
earlier	O
study	O
reportedly	O
suffered	O
from	O
schizophrenia	O
,	O
a	O
severe	O
psychiatric	O
disorder	O
that	O
is	O
independently	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
small	O
for	O
gestational	O
age	O
and	O
low	O
birth	O
weight	O
births	O
.	O
17In	O
contrast	O
,	O
only	O
3	O
%	O
of	O
women	O
in	O
the	O
present	O
study	O
reported	O
a	O
diagnosis	O
of	O
schizophrenia	O
.	O

85	O
-	O
23	O
,	O
revised	O
1996	O
).	O

Li	O
et	O
al	O
.	O

Tocolytic	O
medicines	O
rarely	O
stop	O
preterm	O
labour	O
,	O
but	B
may	O
help	O
delay	O
labour	O
for	O
hours	O
or	O
days	O
,	O
allowing	O
the	O
baby	O
additional	O
precious	O
time	O
to	O
develop	O
before	O
birth	O
.	O

Limited	O
data	O
are	O
available	O
regarding	O
the	O
association	O
of	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
in	O
Middle	O
Eastern	O
countries	O
,	O
where	O
mentioned	O
factors	O
are	O
different	O
from	O
western	O
population	O
[	O
19	O
].	O

A	O
recent	O
report	O
shows	O
that	O
combined	O
common	O
single	O
-	O
nucleotide	O
polymorphisms	O
explain	B
a	O
large	O
proportion	O
of	O
the	O
heritability	O
for	O
human	O
height	O
.	O
33What	O
is	O
under	O
-	O
researched	O
to	O
date	O
is	O
the	O
degree	O
to	O
which	O
the	O
X	O
chromosome	O
might	O
be	O
contributing	O
to	O
human	O
obesity	O
.	O
34Unlike	O
other	O
authors	O
,	O
35we	O
did	O
not	O
find	O
heritability	O
for	O
postnatal	O
length	O
to	O
be	O
higher	O
for	O
maternal	O
height	O
than	O
for	O
paternal	O
height	O
.	O

PubMed	O
Central	O
:	O

None	O
of	O
the	O
respiratory	O
secretion	O
contact	O
events	O
in	O
either	O
group	O
were	O
followed	O
by	O
handwashing	O
with	O
soap	O
.	O

Bonferroni	O
analysis	O
showed	O
that	O
RC	O
adolescent	O
females	O
exhibited	O
a	O
decrease	O
in	O
chocolate	O
preference	O
at	O
the	O
second	O
day	O
of	O
the	O
test	O
.	O

Methods	O
This	O
article	O
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
of	O
publications	O
describing	O
the	O
function	O
of	O
cholecalciferol	O
in	O
reproduction	O
and	O
its	O
place	O
in	O
infertility	O
treatment	O
.	O

2	O
.	O
2	O
.	O
4	O
.	O

This	O
intervention	O
is	O
consistent	O
with	O
the	O
Bangladesh	O
Ministry	O
of	O
Health	O
guidelines	O
.	O

Behrman	O
,	O
Alderman	O
and	O
Hoddinott	O
,	O
2004	O
[	O
23	O
],	O
cite	O
estimates	O
for	O
Nepal	O
of	O
$	O
13	O
.	O
14	O
per	O
pregnancy	O
(	O
based	O
on	O
program	O
estimates	O
extrapolated	O
from	O
a	O
research	O
study	O
).	O

Pre	O
-	O
Pregnancy	O
Body	O
Mass	O
Index	O
(	O
BMI	O
)	O
Self	O
-	O
reported	O
pre	O
-	O
pregnancy	O
weight	O
and	O
measured	O
height	O
collected	O
at	O
baseline	O
were	O
used	O
to	O
calculate	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
9	O
].	O

Retinoic	O
acid	O
positively	O
regulates	O
growth	O
hormone	O
gene	O
expression	O
[	O
135	O
]	O
and	O
decreases	O
fat	O
deposition	O
and	O
IMF	O
in	O
steers	O
[	O
136	O
].	O

Nulliparous	O
and	O
multiparous	O
mothers	O
were	O
considered	O
as	O
the	O
strata	O
.	O

We	O
will	O
use	O
this	O
data	O
to	O
calculate	O
estimates	O
of	O
neonatal	O
mortality	O
in	O
both	O
arms	O
from	O
baseline	O
to	O
the	O
end	O
of	O
the	O
intervention	O
period	O
.	O

The	O
incidence	O
of	O
maternal	O
hypoglycemia	O
was	O
lower	O
in	O
the	O
glyburide	O
group	O
(	O
2	O
%	O
vs	O
20	O
%).	O

Vinter	O
and	O
colleagues	O
[	O
18	O
]	O
conducted	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
participants	O
6	O
-	O
months	O
after	O
birth	O
,	O
in	O
which	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
was	O
provided	O
to	O
overweight	O
and	O
obese	O
women	O
[	O
15	O
].	O

LASSO	O
selected	O
7	O
predictor	O
variables	O
(	O
2	O
phthalates	O
,	O
2	O
PCBs	O
,	O
2	O
PBDEs	O
and	O
1	O
OCP	O
)	O
out	O
of	O
a	O
possible	O
53	O
.	O

We	O
are	O
presenting	O
a	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

©	O
David	O
Litman	O
/	O
Shutterstock	O
.	O
com	O
Romano	O
and	O
colleagues	O
reported	O
that	O
women	O
with	O
the	O
highest	O
PFOA	O
levels	O
were	O
77	O
%	O
more	O
likely	B
to	O
stop	O
exclusive	O
breastfeeding	O
by	O
3	O
months	O
and	O
41	O
%	O
more	O
likely	B
to	O
stop	O
by	O
6	O
months	O
than	O
women	O
with	O
the	O
lowest	O
levels	O
.	O

Data	O
collectors	O
were	O
not	O
blinded	O
to	O
the	O
assignment	O
status	O
of	O
participants	O
,	O
since	O
the	O
intervention	O
included	O
various	O
hardware	O
(	O
handwashing	O
stations	O
and	O
visual	O
materials	O
hung	O
in	O
the	O
home	O
),	O
which	O
were	O
expected	O
to	O
be	O
visible	O
during	O
the	O
data	O
collector	O
'	O
s	O
visit	O
to	O
the	O
household	O
.	O

3	O
.	O
3	O
.	O

In	O
addition	O
,	O
recent	O
publications	O
revealed	O
that	O
an	O
effect	O
(	O
positive	O
or	O
negative	O
)	O
of	O
peanut	O
avoidance	O
on	O
sensitization	O
was	O
not	O
detectable	O
(	O
although	O
too	O
few	O
valuable	O
subjects	O
and	O
the	O
observational	O
nature	O
of	O
the	O
reports	O
reduce	O
the	O
ability	O
to	O
make	O
firm	O
conclusions	O
)	O
[	O
101	O
,	O
102	O
].	O

In	O
a	O
study	O
by	O
Gur	O
et	O
al	O
.	O

It	O
was	O
also	O
shown	O
that	O
iron	O
fortification	O
of	O
sugar	O
(	O
with	O
mean	O
intake	O
of	O
4	O
mg	O
/	O
day	O
)	O
in	O
nonpregnant	O
Guatemalan	O
women	O
over	O
three	O
years	O
resulted	O
in	O
a	O
substantial	O
increase	O
in	O
iron	O
stores	O
,	O
with	O
reserves	O
still	O
increasing	O
by	O
about	O
40	O
mg	O
/	O
year	O
after	O
the	O
third	O
year	O
[	O
41	O
].	O

A	O
number	O
of	O
studies	O
have	O
found	O
associations	O
between	O
sperm	O
motility	O
or	O
sperm	O
DNA	O
damage	O
with	O
levels	O
of	O
estrogenic	O
chemicals	O
measured	O
either	O
in	O
urine	O
or	O
serum	O
(	O
Duty	O
et	O
al	O
.	O

OTUs	O
classified	O
to	O
the	O
genus	O
Streptococcus	O
including	O
the	O
species	O
Streptococcus	O
agalactiae	O
were	O
positively	O
associated	O
with	O
maternal	O
fish	O
and	O
seafood	O
intake	O
,	O
while	O
OTUs	O
classified	O
to	O
the	O
species	O
Bacteroides	O
uniformis	O
were	O
negatively	O
associated	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2c	O
).	O

In	O
marked	O
contrast	O
,	O
the	O
Kenyan	O
study	O
by	O
Ouma	O
and	O
collaborators	O
[	O
24	O
]	O
and	O
that	O
in	O
Nigeria	O
by	O
Dairo	O
and	O
Owoyokun	O
[	O
25	O
]	O
found	O
that	O
only	O
10	O
.	O
4	O
%	O
and	O
up	O
to	O
89	O
.	O
6	O
%	O
of	O
pregnant	O
women	O
were	O
informed	O
of	O
pregnancy	O
danger	O
signs	O
respectively	O
.	O

Recent	O
nationwide	O
shortages	O
of	O
low	O
-	O
calcium	O
formula	O
(	O
LCF	O
)	O
suggest	O
this	O
problem	O
may	O
be	O
widespread	O
.	O

Specifically	O
,	O
these	O
studies	O
provide	O
mechanistic	O
associations	O
between	O
bisphenol	O
A	O
(	O
BPA	O
),	O
formaldehyde	O
,	O
arsenic	O
,	O
nickel	O
,	O
or	O
cigarette	O
smoke	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
,	O
and	O
potential	O
mechanisms	O
of	O
epigenetic	O
toxicity	O
in	O
humans	O
.	O

In	O
contrast	O
,	O
in	O
another	O
study	O
40	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
week	O
was	O
used	O
for	O
6	O
months	O
,	O
but	O
vitamin	O
D	O
was	O
not	O
effective	O
in	O
decreasing	O
depression	O
level	O
compared	O
to	O
the	O
control	O
group	O
[	O
68	O
].	O

It	O
was	O
found	O
that	O
maternal	O
prenatal	O
weight	O
gain	O
,	O
but	O
not	O
prepregnancy	O
body	O
mass	O
index	O
,	O
is	O
directly	O
related	O
to	O
an	O
increased	O
risk	O
of	O
ASD	O
.	O

Patients	O
were	O
divided	O
into	O
two	O
groups	O
,	O
Vitamin	O
D	O
supplement	O
intake	O
group	O
(	O
intervention	O
)	O
or	O
control	O
group	O
,	O
based	O
on	O
whether	O
Vitamin	O
D	O
supplement	O
was	O
take	O
or	O
not	O
before	O
blood	O
test	O
.	O

Additionally	O
,	O
classes	O
7	O
,	O
11	O
,	O
and	O
12	O
were	O
marginally	O
positively	O
associated	O
with	O
AluYb8	O
methylation	O
levels	O
,	O
with	O
CpGs	O
exhibiting	O
low	O
to	O
intermediate	O
methylation	O
.	O

In	O
contrast	O
,	O
all	O
5	O
PFAS	O
were	O
associated	O
with	O
reductions	O
in	O
birth	O
weight	O
,	O
although	O
none	O
of	O
the	O
95	O
%	O
CIs	O
excluded	O
zero	O
.	O

Those	O
in	O
the	O
S	O
-	O
ECC	O
group	O
were	O
found	O
to	O
have	O
relatively	O
poor	O
vitamin	O
D	O
status	O
compared	O
to	O
caries	O
-	O
free	O
children	O
.	O

The	O
diagnosis	O
is	O
made	O
with	O
an	O
oral	O
glucose	O
tolerance	O
test	O
,	O
though	O
the	O
criteria	O
vary	O
around	O
the	O
world	O
(	O
Table	O
1	O
).	O

We	O
assessed	O
self	O
-	O
reports	O
of	O
influenza	O
vaccination	O
status	O
by	O
further	O
reviewing	O
medical	O
records	O
of	O
those	O
who	O
self	O
-	O
reported	O
but	O
did	O
not	O
have	O
readily	O
available	O
evidence	O
of	O
vaccination	O
status	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Compulsive	O
feeding	O
(	O
A	O
–	O
D	O
)	O
and	O
feeding	O
response	O
to	O
AM25	O
(	O
E	O
–	O
H	O
)	O
for	O
chocolate	O
preference	O
(%)	O
and	O
caloric	O
intake	O
(	O
kcal	O
/	O
kg	O
)	O
in	O
offspring	O
in	O
adolescence	O
and	O
/	O
or	O
adulthood	O
.	O

These	O
cohorts	O
often	B
have	O
limited	O
availability	O
of	O
appropriate	O
biosample	O
at	O
appropriate	O
collection	O
windows	O
(	O
Bakulski	O
&	O
Fallin2014	O
).	O

Thus	B
,	O
optimal	O
asthma	O
treatment	O
is	O
crucial	O
,	O
as	O
the	O
risk	O
of	O
preeclampsia	O
,	O
premature	O
birth	O
,	O
low	O
birth	O
weight	O
,[	O
19	O
]	O
and	O
maternal	O
and	O
neonatal	O
hypoxia	O
and	O
morbidity	O
[	O
10	O
,	O
20	O
]	O
posed	O
by	O
undertreated	O
asthma	O
may	O
be	O
greater	O
than	O
that	O
from	O
the	O
use	O
of	O
oral	O
steroids	O
for	O
the	O
treatment	O
of	O
asthma	O
.	O

Therefore	B
,	O
a	O
clinician	O
must	O
be	O
careful	O
when	O
prescribing	O
vitamin	O
D	O
preparations	O
,	O
especially	O
in	O
male	O
patients	O
.	O

Diets	O
were	O
formulated	O
to	O
be	O
isocaloric	O
(	O
13	O
.	O
6	O
MJ	O
ME	O
/	O
kg	O
on	O
average	O
)	O
[	O
15	O
].	O

A	O
simple	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
correlation	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
between	O
maternal	O
and	O
cord	O
serum	O
.	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adolescent	O
females	O
displayed	O
higher	O
caloric	O
intake	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adolescent	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
/	O
or	O
4	O
).	O

Neither	O
BMI	O
,	O
nor	O
percent	O
fat	O
were	O
found	O
to	O
correlate	O
with	O
cathelicidin	O
concentration	O
.	O

PubMed	O
Central	O
:	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s40168	O
-	O
018	O
-	O
0490	O
-	O
8	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Consent	O
/	O
Assent	O
Process	O
Eligible	O
women	O
were	O
informed	O
of	O
the	O
study	O
and	O
,	O
if	O
interested	O
,	O
consented	O
in	O
their	O
language	O
of	O
preference	O
(	O
Spanish	O
/	O
English	O
).	O

Gene	O
rs12800438	O
is	O
correlated	O
with	O
higher	O
serum	O
25	O
[	O
OH	O
]	O
D	O
levels	O
,	O
and	O
gene	O
rs6058017	O
-	O
with	O
lighter	O
skin	O
pigmentation	O
[	O
35	O
].	O

Both	O
mother	O
and	O
infant	O
presented	O
with	O
hypernatremia	O
and	O
dehydration	O
.	O

These	O
mice	O
were	O
the	O
F0	O
generation	O
.	O

Results	O
Descriptive	O
statistics	O
are	O
displayed	O
intable	O
2for	O
children	O
at	O
each	O
age	O
point	O
and	O
for	O
each	O
of	O
the	O
adult	O
lineage	O
groups	O
.	O

The	O
higher	O
leptin	O
sensitivity	O
described	O
in	O
females	O
than	O
in	O
males	O
has	O
been	O
associated	O
with	O
gonadal	O
hormones	O
(	O
Clegg	O
et	O
al	O
.,	O
2003	O
,	O
2006	O
)	O
and	O
may	O
explain	B
in	O
part	O
the	O
higher	O
levels	O
of	O
leptin	O
found	O
in	O
the	O
plasma	O
of	O
male	O
offspring	O
.	O

Conclusion	O
After	O
a	O
careful	O
review	O
of	O
previous	O
studies	O
on	O
visfatin	O
and	O
pregnancy	O
,	O
we	O
can	O
claim	O
the	O
present	O
study	O
is	O
the	O
first	O
in	O
Iran	O
to	O
have	O
specifically	O
addressed	O
the	O
relationship	O
between	O
maternal	O
visfatin	O
levels	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

These	O
drugs	O
,	O
such	O
as	O
Fluoxetine	O
,	O
Sertraline	O
,	O
and	O
Citalopram	O
,	O
work	O
by	O
inhibiting	O
the	O
reuptake	O
of	O
the	O
neurotransmitter	O
serotonin	O
,	O
resulting	O
in	O
a	O
greater	O
amount	O
of	O
serotonin	O
at	O
the	O
synapse	O
.	O

Packs	O
of	O
study	O
treatment	O
were	O
randomly	O
assigned	O
in	O
a	O
1	O
:	O
1	O
ratio	O
by	O
Sharp	O
Clinical	O
Services	O
by	O
a	O
computer	O
-	O
generated	O
sequence	O
in	O
randomly	O
permuted	O
blocks	O
of	O
10	O
,	O
starting	O
randomly	O
midway	O
through	O
the	O
block	O
,	O
and	O
sequentially	O
numbered	O
,	O
before	O
delivery	O
to	O
the	O
study	O
sites	O
,	O
and	O
then	O
dispensed	O
in	O
order	O
by	O
each	O
study	O
pharmacist	O
.	O

Although	O
the	O
primary	O
outcome	O
of	O
birth	O
weight	O
did	O
not	O
significantly	O
differ	O
between	O
the	O
intervention	O
and	O
control	O
group	O
,	O
the	O
secondary	O
outcomes	O
of	O
dietary	O
glycaemic	O
index	O
,	O
gestational	O
weight	O
gain	O
and	O
glucose	O
intolerance	O
were	O
significantly	O
reduced	O
in	O
the	O
intervention	O
arm	O
.	O

We	O
studied	O
kidney	O
stereology	O
at	O
birth	O
,	O
10	O
days	O
and	O
6	O
months	O
of	O
age	O
in	O
each	O
generation	O
(	O
n	O
=	O
6	O
for	O
each	O
group	O
).	O

The	O
health	O
care	O
education	O
topics	O
were	O
similar	O
among	O
the	O
studies	O
reviewed	O
though	O
there	O
were	O
some	O
disparities	O
in	O
the	O
frequency	O
.	O

Further	O
research	O
is	O
needed	O
on	O
short	O
and	O
long	O
-	O
term	O
health	O
consequences	O
for	O
mother	O
and	O
baby	O
from	O
efforts	O
to	O
prevent	O
preterm	O
labour	O
[	O
5	O
].	O

Fetuses	O
were	O
killed	O
by	O
i	O
.	O
v	O
.	O

Several	O
countries	O
,	O
including	O
Korea	O
,	O
Japan	O
,	O
Australia	O
and	O
the	O
USA	O
,	O
have	O
considered	O
IMF	O
content	O
as	O
important	O
to	O
beef	O
quality	O
grade	O
(	O
QG	O
),	O
whereas	O
European	O
countries	O
,	O
including	O
France	O
and	O
Germany	O
,	O
prefer	O
leaner	O
meat	O
(	O
less	O
IMF	O
content	O
).	O

Endocrine	O
disrupting	O
chemicals	O
can	O
bind	O
to	O
nuclear	O
receptors	O
,	O
and	O
either	O
directly	O
induce	O
activity	O
altering	O
modifications	O
to	O
the	O
epigenetic	O
machinery	O
(	O
such	O
as	O
histone	O
methyl	O
transferases	O
);	O
or	O
act	O
as	O
transcription	O
factors	O
,	O
binding	O
to	O
hormone	O
-	O
responsive	O
promotor	O
elements	O
and	O
promoting	O
expression	O
of	O
ncRNAs	O
and	O
/	O
or	O
epigenetic	O
machinery	O
(	O
Kabir	O
et	O
al	O
.	O
2015	O
;	O
Trevino	O
et	O
al	O
.	O
2015	O
).	O

At	O
this	O
stage	O
the	O
animals	O
experienced	O
a	O
kind	O
of	O
release	O
from	O
metabolic	O
burden	O
after	O
cross	O
-	O
fostering	O
and	O
suckling	O
.	O

Interestingly	O
,	O
in	O
humans	O
,	O
a	O
mild	O
cold	O
exposure	O
(	O
12	O
h	O
to	O
19	O
°	O
C	O
)	O
was	O
recently	O
shown	O
to	O
increase	O
the	O
diurnal	O
plasma	O
FGF21	O
levels	O
,	O
with	O
a	O
positive	O
correlation	O
with	O
the	O
changes	O
in	O
adipose	O
tissue	O
microdialysate	O
glycerol	O
and	O
total	O
energy	O
expenditure	O
(	O
Lee	O
et	O
al	O
.,	O
2013	O
).	O

Baseline	O
characteristics	O
of	O
the	O
women	O
randomized	O
to	O
placebo	O
and	O
cholecalciferol	O
were	O
similar	O
(	O
Table	O
1	O
).	O

Animals	O
were	O
handled	O
and	O
allowed	O
to	O
acclimate	O
for	O
at	O
least	O
4	O
weeks	O
before	O
the	O
diet	O
assignation	O
.	O

We	O
will	O
also	O
exclude	O
three	O
Upazilas	O
from	O
Gazipur	O
because	O
of	O
the	O
high	O
number	O
of	O
garment	O
industries	O
,	O
which	O
would	O
have	O
high	O
numbers	O
of	O
working	O
women	O
and	O
would	O
be	O
difficult	O
to	O
follow	O
-	O
up	O
and	O
eight	O
Upazilas	O
from	O
Mymensingh	O
because	O
of	O
the	O
high	O
prevalence	O
of	O
malaria	O
and	O
kalazar	O
.	O

Introduction	O
Adolescent	O
and	O
adult	O
women	O
of	O
childbearing	O
age	O
in	O
the	O
United	O
States	O
of	O
America	O
have	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
[	O
1	O
],[	O
2	O
].	O

Data	O
collection	O
related	O
to	O
depression	O
,	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
done	O
by	O
a	O
trained	O
midwife	O
outside	O
the	O
research	O
team	O
.	O

When	O
considering	O
class	O
-	O
specific	O
relationships	O
,	O
a	O
positive	O
association	O
was	O
noted	O
between	O
AluYb8	O
methylation	O
and	O
methylation	O
of	O
CpGs	O
encompassing	O
the	O
low	O
to	O
intermediately	O
methylated	O
class	O
9	O
(	O
Figure	O
1	O
).	O

In	O
many	O
ways	O
,	O
inconsistencies	O
in	O
the	O
literature	O
on	O
EAH	O
parallel	O
those	O
observed	O
in	O
the	O
general	O
literature	O
on	O
child	O
feeding	O
,	O
which	O
may	O
reflect	B
the	O
early	O
stage	O
of	O
the	O
work	O
in	O
the	O
field	O
.	O

For	O
1307	O
women	O
a	O
general	O
questionnaire	O
was	O
available	O
.	O

For	O
example	O
,	O
chemicals	O
can	O
have	O
far	O
-	O
reaching	O
benefits	O
to	O
society	O
,	O
from	O
agriculture	O
to	O
medicine	O
and	O
food	O
/	O
product	O
safety	O
to	O
the	O
development	O
of	O
new	O
technologies	O
.	O

Therefore	B
,	O
the	O
definition	O
used	O
in	O
this	O
study	O
is	O
likely	B
to	O
be	O
relevant	O
.	O

Robinson	O
et	O
al	O
.	O

Association	O
of	O
SNPs	O
With	O
Baseline	O
25	O
(	O
OH	O
)	O
D	O
in	O
Early	O
PregnancySNPReference	O
AlleleCommon	O
AlleleUnivariateAdjustedaCorrected	O
P	O
Valuebnβ	O
(	O
95	O
%	O
CI	O
)	O
P	O
Valuenβ	O
(	O
95	O
%	O
CI	O
)	O
P	O
Value	O
rs12785878	O
(	O
DHCR7	O
)	O
GT6793	O
.	O
7	O
(	O
1	O
.	O
5	O
to	O
5	O
.	O
8	O
)	O
0	O
.	O
0016223	O
.	O
1	O
(	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
)	O
0	O
.	O
0040	O
.	O
012rs10741657	O
(	O
CYP2R1	O
)	O
AG672	O
−	O
1	O
.	O
1	O
(−	O
2	O
.	O
9	O
to	O
0	O
.	O
7	O
)	O
0	O
.	O
24616	O
−	O
1	O
.	O
4	O
(−	O
3	O
.	O
2	O
to	O
0	O
.	O
4	O
)	O
0	O
.	O
120	O
.	O
47rs6013897	O
(	O
CYP24A1	O
)	O
AT6701	O
.	O
2	O
(−	O
1	O
.	O
1	O
to	O
3	O
.	O
4	O
)	O
0	O
.	O
316130	O
.	O
8	O
(−	O
1	O
.	O
4	O
to	O
3	O
.	O
0	O
)	O
0	O
.	O
461	O
.	O
0rs2282679	O
(	O
GC	O
)	O
CA6792	O
.	O
2	O
(	O
0	O
.	O
3	O
to	O
4	O
.	O
1	O
)	O
0	O
.	O
026221	O
.	O
7	O
(−	O
0	O
.	O
2	O
to	O
3	O
.	O
5	O
)	O
0	O
.	O
080	O
.	O
31	O
The	O
homozygous	O
low	O
-	O
frequency	O
gene	O
variant	O
was	O
used	O
as	O
the	O
reference	O
group	O
,	O
and	O
β	O
represents	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
per	O
common	O
allele	O
.	O

As	O
mentioned	O
above	O
,	O
BAT	O
is	O
the	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
both	O
cold	O
and	O
diet	O
-	O
induced	O
)	O
that	O
,	O
by	O
utilizing	O
large	O
quantities	O
of	O
glucose	O
and	O
lipids	O
from	O
the	O
circulation	O
,	O
can	O
promote	O
negative	O
energy	O
balance	O
.	O

Rodent	O
models	O
of	O
leptin	O
deficiency	O
exhibit	O
marked	O
decreases	O
in	O
BAT	O
thermogenic	O
capacity	O
,	O
as	O
well	O
as	O
activity	O
(	O
Ueno	O
et	O
al	O
.,	O
1998	O
).	O

We	O
found	O
that	O
exposure	O
to	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
had	O
null	O
or	O
small	O
associations	O
with	O
birth	O
weight	O
.	O

The	O
fact	O
that	O
several	O
risk	O
factors	O
during	O
the	O
prenatal	O
and	O
labor	O
periods	O
are	O
implicated	O
in	O
autism	O
should	O
prompt	O
the	O
medical	O
community	O
to	O
focus	O
on	O
the	O
pregnancy	O
and	O
labor	O
periods	O
as	O
preventive	O
measures	O
to	O
curb	O
the	O
incidence	O
of	O
autism	O
.	O

Fat	O
synthesis	O
and	O
degradation	O
metabolism	O
IMF	O
deposition	O
results	O
from	O
a	O
balance	O
among	O
uptake	O
,	O
synthesis	O
,	O
and	O
degradation	O
of	O
triglycerides	O
(	O
TGs	O
).	O

From	O
652	O
children	O
during	O
five	O
separate	O
periods	O
of	O
testing	O
serum	O
calcifediol	O
,	O
only	O
one	O
child	O
in	O
each	O
of	O
two	O
testing	O
periods	O
had	O
results	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
in	O
the	O
intervention	O
group	O
—	O
a	O
toxic	O
level	O
.	O

We	O
assessed	O
differences	O
between	O
the	O
study	O
arms	O
,	O
with	O
respect	O
to	O
observed	O
handwashing	O
with	O
soap	O
among	O
other	O
family	O
members	O
interacting	O
with	O
the	O
neonate	O
.	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

Dietary	O
data	O
from	O
food	O
diaries	O
were	O
analysed	O
using	O
NetWISP	O
version	O
3	O
.	O
0	O
(	O
Tinuviel	O
Software	O
,	O
Llanfechell	O
,	O
Anglesey	O
,	O
UK	O
).	O

Homozygous	O
Skm1	O
mice	O
show	O
kyphosis	O
or	O
an	O
elongated	O
torso	O
and	O
homozygous	O
Skm2	O
mice	O
exhibit	O
shortened	O
stature	O
,	O
scoliosis	O
,	O
and	O
lordosis	O
.	O

SIRTs	O
are	O
a	O
class	O
of	O
proteins	O
that	O
have	O
a	O
role	O
in	O
cellular	O
processes	O
associated	O
with	O
body	O
metabolism	O
such	O
as	O
cell	O
differentiation	O
,	O
aging	O
,	O
transcription	O
,	O
apoptosis	O
,	O
inflammation	O
,	O
and	O
stress	O
resistance	O
,	O
as	O
well	O
as	O
energy	O
efficiency	O
and	O
alertness	O
during	O
low	O
-	O
calorie	O
situations	O
.	O

Lung	O
function	O
and	O
outcome	O
vs	O
25	O
(	O
OH	O
)	O
D	O
levels	O
To	O
compare	O
the	O
effect	O
of	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
on	O
lung	O
function	O
at	O
6	O
months	O
of	O
age	O
,	O
we	O
defined	B
those	O
with	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
≥	O
13	O
.	O
8	O
ng	O
/	O
ml	O
as	B
the	O
“	O
high	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
,	O
and	O
the	O
rest	O
as	B
the	O
“	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
.	O

However	O
,	O
at	O
6	O
month	O
of	O
age	O
,	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
,	O
the	O
VitD	O
-	O
mice	O
had	O
significantly	O
higher	O
values	O
of	O
renin	O
expression	O
than	O
the	O
SC	O
mice	O
(	O
P	O
=	O
0	O
.	O
001	O
).	O

Mice	O
that	O
carry	O
a	O
mutation	O
in	O
Npr3	O
exhibit	O
a	O
skeletal	O
overgrowth	O
phenotype	O
,	O
resulting	O
in	O
an	O
elongated	O
body	O
and	O
kyphosis	O
.	O

However	O
,	O
thyroid	O
cancer	O
in	O
young	O
people	O
has	O
generally	B
an	O
excellent	O
prognosis	O
,	O
and	O
survival	O
among	O
women	O
with	O
thyroid	O
cancer	O
diagnosed	O
during	O
pregnancy	O
may	O
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

Weekly	O
supplements	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
program	O
reported	O
here	O
are	O
accessed	O
at	O
village	O
level	O
.	O

Given	B
the	O
exploratory	O
nature	O
of	O
this	O
work	O
,	O
we	O
also	O
planned	O
to	O
conduct	O
post	O
-	O
hoc	O
exploratory	O
analyses	O
where	O
appropriate	O
.	O

It	O
represents	O
one	O
of	O
the	O
largest	O
mHealth	O
text	O
-	O
based	O
programs	O
developed	O
to	O
date	O
.	O

Pregnant	O
sows	O
were	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
).	O

Much	O
of	O
the	O
animal	O
studies	O
to	O
date	O
on	O
environmental	O
chemicals	O
have	O
involved	O
administration	O
of	O
high	O
doses	O
,	O
many	O
orders	O
of	O
magnitude	O
above	O
likely	B
exposures	O
in	O
real	O
human	O
populations	O
.	O

During	O
gestation	O
,	O
risk	O
factors	O
for	O
obesity	O
include	O
maternal	O
diet	O
,	O
overweight	O
,	O
and	O
smoking	O
.	O

Much	O
more	O
work	O
is	O
needed	O
to	O
identify	O
other	O
ways	O
than	O
cold	O
exposure	O
to	O
increase	O
BAT	O
activity	O
in	O
obese	O
subjects	O
.	O

Dietary	O
data	O
was	O
collected	O
using	O
a	O
validated	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

[	O
26	O
]	O
Vitamin	O
D	O
may	O
influence	O
the	O
course	O
of	O
infectious	O
diseases	O
during	O
pregnancy	O
.	O

Thus	B
,	O
it	O
may	O
be	O
that	O
,	O
in	O
some	O
cases	O
,	O
depression	O
itself	O
or	O
other	O
concomitant	O
factors	O
have	O
a	O
combined	O
effect	O
that	O
is	O
not	O
necessarily	O
due	O
to	O
the	O
use	O
of	O
SSRIs	O
.	O

Investigators	O
have	O
shown	O
that	O
both	O
acute	O
total	O
and	O
short	O
-	O
term	O
partial	O
sleep	O
loss	O
results	O
in	O
elevated	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
concentrations	O
[	O
48	O
].	O

Attempts	O
at	O
stimulating	O
BAT	O
function	O
in	O
humans	O
With	O
regard	O
to	O
the	O
relationship	O
between	O
BAT	O
and	O
body	O
weight	O
in	O
humans	O
,	O
an	O
inverse	O
correlation	O
between	O
BMI	O
and	O
the	O
amount	O
of	O
BAT	O
was	O
described	O
,	O
already	O
5	O
years	O
ago	O
(	O
Cypess	O
et	O
al	O
.,	O
2009	O
;	O
van	O
Marken	O
Lichtenbelt	O
et	O
al	O
.,	O
2009	O
).	O

Breastfeeding	O
,	O
child	O
fish	O
consumption	O
,	O
maternal	O
dental	O
&	O
lifestyle	O
questionnaires	O
.	O
Neurodevelopmental	O
testing	O
of	O
child	O
completed	O
by	O
mother	O
using	O
ALSPAC	O
adaption	O
of	O
the	O
MacArthur	O
Communicative	O
Development	O
Inventory	O
(	O
MCDI	O
)	O
at	O
15	O
months	O
and	O
Denver	O
Developmental	O
Screening	O
Test	O
(	O
DDST	O
)	O
at	O
18	O
months	O
of	O
age	O
.	O
Fish	O
and	O
seafood	O
intake	O
measured	O
via	O
a	O
validated	O
FFQ	O
(	O
calibrated	O
for	O
LC	O
n	O
-	O
3PUFAs	O
in	O
blood	O
)	O
at	O
28	O
weeks	O
gestation	O
.	O
Infant	O
cognition	O
measured	O
usingVisual	O
Recognition	O
Memory	O
(	O
VRM	O
)	O
paradigm	O
at	O
6	O
months	O
of	O
age	O
.	O
Seafood	O
consumption	O
assessed	O
at	O
32	O
weeks	O
gestation	O
via	O
FFQ	O
.	O
Postal	O
questionnaires	O
on	O
diet	O
,	O
education	O
,	O
social	O
,	O
behavioural	O
and	O
developmental	O
outcomes	O
at	O
child	O
age	O
:	O
6	O
,	O
18	O
,	O
30	O
,	O
42	O
,	O
and	O
81	O
months	O
.	O
Wechsler	O
Intelligence	O
Scale	O
for	O
Children	O
III	O
used	O
to	O
assess	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
at	O
8	O
years	O
and	O
Strengths	O
and	O
Difficulties	O
Questionnaire	O
(	O
SDQ	O
)	O
conducted	O
.	O

The	O
biological	O
mechanisms	O
underlying	O
the	O
etiology	O
of	O
schizophrenia	O
and	O
psychotic	O
symptoms	O
are	O
largely	O
unknown	O
.	O

However	O
,	O
a	O
limitation	O
due	O
to	O
the	O
high	O
-	O
risk	O
nature	O
of	O
our	O
population	O
is	O
that	O
the	O
generalisability	O
of	O
our	O
findings	O
to	O
populations	O
with	O
low	O
-	O
to	O
-	O
moderate	O
risk	O
of	O
vitamin	O
deficiency	O
is	O
unknown	O
.	O

Case	O
Report	O
A	O
previously	O
healthy	O
41	O
-	O
year	O
-	O
old	O
G1P0	O
female	O
presented	O
to	O
the	O
emergency	O
department	O
during	O
the	O
36th	O
week	O
of	O
pregnancy	O
with	O
a	O
sudden	O
onset	O
of	O
severe	O
midsternal	O
chest	O
pain	O
radiating	O
to	O
her	O
back	O
.	O

Only	O
those	O
who	O
had	O
completed	O
the	O
2	O
-	O
year	O
follow	O
-	O
up	O
appointment	O
had	O
serum	O
25OHD	O
measured	O
in	O
the	O
pregnancy	O
sample	O
,	O
thus	O
334	O
participants	O
were	O
included	O
.	O

Adjustments	O
are	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

These	O
findings	O
suggest	O
that	O
pathways	O
associated	O
to	O
lipid	O
metabolism	O
are	O
part	O
of	O
postnatal	O
adaptive	O
responses	O
to	O
the	O
prenatal	O
nutritional	O
environment	O
in	O
LP	O
offspring	O
.	O

The	O
study	O
by	O
Burris	O
et	O
al	O
.	O

Through	O
technological	O
advances	O
,	O
humans	O
have	O
access	O
to	O
light	O
continuously	O
and	O
are	O
no	O
longer	O
dependant	O
on	O
the	O
rising	O
and	O
setting	O
of	O
the	O
sun	O
to	O
regulate	O
circannual	O
rhythms	O
.	O

In	O
the	O
study	O
on	O
25	O
(	O
OH	O
)	O
D3	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3and	O
Ca2	O
+	O
levels	O
,	O
significantly	O
higher	O
concentrations	O
of	O
VD3were	O
confirmed	O
in	O
87	O
patients	O
with	O
endometriosis	O
(	O
62	O
.	O
15	O
±	O
36	O
.	O
9	O
nmol	O
/	O
L	O
vs	O
.	O

It	O
is	O
associated	O
with	O
inadequate	O
invasion	O
of	O
extravillous	O
trophoblasts	O
and	O
inadequate	O
angiogenesis	O
,	O
with	O
insufficient	O
conversion	O
of	O
arterial	O
spiral	O
arteries	O
in	O
the	O
decidua	O
[	O
1	O
].	O

They	O
speculated	O
that	O
“	O
DDE	O
may	O
be	O
interfering	O
with	O
the	O
mother	O
’	O
s	O
ability	O
to	O
lactate	O
,	O
possibly	O
because	B
of	O
its	O
estrogenic	O
properties	O
.”	O
14	O
Over	O
the	O
next	O
three	O
decades	O
,	O
these	O
and	O
other	O
researchers	O
tried	O
to	O
replicate	O
the	O
findings	O
of	O
the	O
North	O
Carolina	O
study	O
.	O

Conclusion	O
We	O
found	O
that	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
common	O
in	O
newborns	O
in	O
a	O
southern	O
US	O
climate	O
,	O
especially	O
among	O
Hispanic	O
infants	O
.	O

The	O
increase	O
in	O
blood	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3levels	O
in	O
response	O
to	O
decreased	O
calcium	O
intake	O
may	O
downregulate	O
preadipocyte	O
differentiation	O
,	O
thus	B
decreasing	O
beef	O
marbling	O
.	O

The	O
membrane	O
was	O
blocked	O
in	O
TBS	O
containing	O
5	O
%	O
dried	O
milk	O
powder	O
(	O
w	O
/	O
v	O
)	O
and	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
overnight	O
at	O
4	O
°	O
C	O
.	O

The	O
impact	O
of	O
these	O
2	O
factors	O
for	O
sensitization	O
to	O
other	O
allergens	O
,	O
such	O
as	O
aeroallergens	O
,	O
has	O
not	O
been	O
investigated	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
children	O
born	O
to	O
parents	O
with	O
socioeconomic	O
problems	O
have	O
a	O
higher	O
probability	B
of	O
low	O
birth	O
weight	O
and	O
ANS	O
dysfunction	O
[	O
45	O
].	O

Maternal	O
dietary	O
intake	O
Maternal	O
dietary	O
intake	O
data	O
are	O
obtained	O
by	O
means	O
of	O
two	O
dietary	O
assessment	O
methods	O
,	O
namely	O
the	O
24	O
-	O
h	O
recall	O
(	O
24	O
-	O
HR	O
)	O
and	O
a	O
quantified	O
food	O
frequency	O
questionnaire	O
(	O
QFFQ	O
).	O

We	O
will	O
have	O
a	O
total	O
number	O
of	O
112	O
BRAC	O
PO	O
for	O
randomisation	O
.	O

Indeed	O
,	O
there	O
are	O
many	O
examples	O
in	O
the	O
literature	O
of	O
how	O
single	O
polymorphisms	O
(	O
SNPs	O
)	O
can	O
affect	O
the	O
response	O
of	O
individuals	O
and	O
populations	O
to	O
different	O
environmental	O
exposures	O
.	O

Our	O
observations	O
of	O
impaired	O
post	O
-	O
load	O
glucose	O
tolerance	O
and	O
increased	O
risk	O
of	O
GDM	O
among	O
women	O
who	O
snore	O
during	O
pregnancy	O
are	O
also	O
consistent	O
with	O
a	O
growing	O
body	O
of	O
epidemiological	O
evidence	O
that	O
documents	O
markers	O
of	O
the	O
severity	O
of	O
obstructive	O
sleep	O
apnea	O
(	O
OSA	O
)	O
and	O
increased	O
risk	O
of	O
type	O
2	O
diabetes	O
in	O
diverse	O
populations	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
from	O
various	O
geographic	O
regions	O
[	O
32	O
,	O
36	O
-	O
38	O
].	O

Vitamin	O
D3	O
can	O
be	O
synthesized	O
de	O
novo	O
.	O

This	O
study	O
was	O
limited	O
in	O
its	O
assessment	O
of	O
environmental	O
exposures	O
because	O
of	O
the	O
low	O
number	O
of	O
exposed	O
individuals	O
and	O
low	O
power	O
,	O
making	O
this	O
part	O
of	O
our	O
analysis	O
largely	O
exploratory	O
in	O
nature	O
.	O

Future	O
studies	O
are	O
essential	O
to	O
determine	O
the	O
true	O
vitamin	O
D	O
requirement	O
during	O
pregnancy	O
not	O
only	O
for	O
maternal	O
skeletal	O
preservation	O
and	O
fetal	O
skeletal	O
formation	O
,	O
but	O
also	O
for	O
fetal	O
“	O
imprinting	O
"	O
that	O
may	O
affect	O
neurodevelopment	O
,	O
immune	O
function	O
and	O
chronic	O
disease	O
susceptibility	O
soon	O
after	O
birth	O
as	O
well	O
as	O
later	O
in	O
life	O
.	O

GABA	O
,	O
γ	O
-	O
aminobutyric	O
acid	O
;	O
SGA	O
,	O
second	O
generation	O
antipsychotic	O
.	O

Maternal	O
short	O
stature	O
is	O
,	O
in	O
turn	O
,	O
a	O
risk	O
factor	O
for	O
birth	O
complications	O
[	O
24	O
]	O
–	O
illustrating	O
the	O
intergenerational	O
effect	O
of	O
poor	O
nutrition	O
.	O

3	O
.	O
2	O
.	O

This	O
vulnerable	O
population	O
is	O
already	O
at	O
increased	O
risk	O
of	O
excessive	O
GWG	O
and	O
the	O
concomitant	O
adverse	O
effects	O
on	O
mother	O
and	O
child	O
.	O

INTRODUCTION	O
Multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
a	O
chronic	O
probably	B
with	O
autoimmune	O
basis	O
and	O
uncertain	O
etiology	O
characterized	O
by	O
demyelinative	O
and	O
inflammatory	O
physiopathology	O
causing	O
axonal	O
damages	O
.	O
12This	O
disease	O
affects	O
females	O
more	O
than	O
males	O
with	O
ordinary	O
10	O
years	O
relapsing	O
-	O
remitting	O
course	O
and	O
secondary	O
progressive	O
phase	O
.	O
2On	O
histological	O
basis	O
,	O
T	O
helper	O
cells	O
type	O
1	O
(	O
Th1	O
)	O
is	O
the	O
most	B
responsible	B
cause	O
for	O
pathologies	O
seen	O
in	O
MS	O
.	O
1	O
–	O
3There	O
are	O
multiple	O
risk	O
factors	O
for	O
MS	O
in	O
a	O
complex	O
relationship	O
with	O
each	O
other	O
from	O
genetic	O
ones	O
to	O
environmental	O
factors	O
but	O
exact	O
mechanism	O
leading	O
to	O
MS	O
has	O
remained	O
unclear	O
yet	O
.	O
45From	O
guessed	O
environmental	O
risk	O
factors	O
for	O
MS	O
,	O
past	O
infection	O
with	O
EBV	O
,	O
smoking	O
and	O
low	O
serum	O
level	O
of	O
vitamin	O
D	O
are	O
more	O
favorable	O
.	O
67The	O
most	B
important	O
vitamin	O
in	O
calcium	O
and	O
phosphor	O
homeostasis	O
is	O
vitamin	O
D	O
.	O
This	O
vitamin	O
has	O
proposed	O
potential	O
power	O
for	O
modulating	O
immune	O
system	O
.	O
48This	O
is	O
achieved	O
via	O
enhancing	O
the	O
phagocytic	O
function	O
of	O
monocytes9and	O
decreasing	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
12	O
,	O
TNF	O
-	O
α	O
and	O
PGE2	O
by	O
monocytes	O
.	O
10Also	O
,	O
immature	O
or	O
semi	O
mature	O
APC	O
’	O
s	O
cannot	O
mature	O
in	O
presence	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O
8Many	O
studies	O
showed	O
a	O
role	O
of	O
paracrine	O
function	O
and	O
nerve	O
growth	O
factor	O
synthesis	O
of	O
vitamin	O
D	O
in	O
CNS	O
and	O
also	O
,	O
showed	O
that	O
deficiency	O
of	O
this	O
vitamin	O
in	O
pregnancy	O
period	O
can	O
cause	O
neural	O
system	O
disorder	O
in	O
animal	O
cases	O
.	O
811	O
–	O
14Then	O
,	O
vitamin	O
D	O
has	O
a	O
near	O
relation	O
with	O
MS	O
and	O
the	O
results	O
of	O
different	O
studies	O
can	O
be	O
summarized	O
as	O
follows	O
:	O
First	O
,	O
the	O
effect	O
of	O
latitude	O
via	O
exposure	O
to	O
sun	O
light	O
and	O
serum	O
level	O
of	O
vitamin	O
D	O
on	O
MS	O
prevalence	O
,	O
that	O
increases	O
with	O
distance	O
from	O
equator	O
,	O
with	O
only	O
one	O
exception	O
in	O
Norway	O
.	O
23815Second	O
,	O
Vander	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

There	O
was	O
no	O
effect	O
of	O
the	O
gestational	O
or	O
pup	O
diets	O
on	O
hypothalamic	O
expression	O
of	O
other	O
genes	O
.	O

Vitamin	O
D	O
deficiency	O
,	O
defined	O
as	O
serum	O
concentration	O
of	O
25	O
-	O
hydroxycalciferol	O
of	O
less	O
than	O
50	O
nmol	O
/	O
L	O
,	O
is	O
commonly	B
noted	O
more	O
frequently	O
than	O
only	O
in	O
fertility	O
clinic	O
patients	O
.	O

It	O
could	O
be	O
argued	O
that	O
as	B
routine	O
prenatal	O
care	O
in	O
Romania	O
does	O
not	O
usually	O
begin	O
until	O
after	O
the	O
first	O
trimester	O
is	O
almost	O
ended	O
,	O
including	O
advice	O
about	O
folic	O
acid	O
as	O
part	O
of	O
prenatal	O
care	O
is	O
redundant	O
as	O
the	O
neural	O
tube	O
has	O
fully	O
developed	O
within	O
28	O
days	O
of	O
conception	O
[	O
9	O
].	O

Blood	O
samples	O
were	O
obtained	O
during	O
yearly	O
visits	O
from	O
133	O
children	O
,	O
ages	O
2	O
–	O
7	O
,	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
pregnancy	O
vitamin	O
D	O
supplementation	O
RCT	O
.	O

Epigenetic	O
programing	O
is	O
fundamental	O
for	O
normal	O
mammalian	O
development	O
,	O
and	O
provides	O
a	O
more	O
subtle	O
mechanism	O
by	O
which	O
the	O
environment	O
can	O
rapidly	O
alter	O
gene	O
expression	O
within	O
single	O
or	O
multiple	O
generations	O
.	O

Liver	O
tissue	O
was	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
,	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
use	O
for	O
RNA	O
isolation	O
.	O

In	O
a	O
large	O
retrospective	O
study	O
,	O
Dottorini	O
et	O
al	O
.	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

The	O
patients	O
’	O
weights	O
were	O
measured	O
by	O
Seca	O
scale	O
with	O
0	O
.	O
1	O
kg	O
accuracy	O
.	O

Four	O
experienced	O
paediatricians	O
and	O
30	O
female	O
fieldworkers	O
(	O
medical	O
students	O
,	O
nurses	O
,	O
midwives	O
,	O
or	O
community	O
health	O
workers	O
)	O
were	O
rigorously	O
trained	O
in	O
our	O
study	O
protocols	O
,	O
the	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
strategy	O
,	O
and	O
the	O
assessment	O
of	O
signs	O
and	O
symptoms	O
required	O
by	O
our	O
study	O
.	O

At	O
that	O
time	O
no	O
trials	O
had	O
reported	O
the	O
effects	O
of	O
IFA	O
on	O
neonatal	O
mortality	O
,	O
although	O
these	O
supplements	O
were	O
known	O
to	O
benefit	O
both	O
maternal	O
and	O
infant	O
health	O
[	O
3	O
].	O

Thyroid	O
hormones	O
(	O
THs	O
)	O
are	O
well	O
known	O
mediators	O
of	O
overall	O
energy	O
expenditure	O
(	O
Klieverik	O
et	O
al	O
.,	O
2009	O
).	O

Similar	O
results	O
have	O
been	O
reported	O
in	O
human	O
subjects	O
.	O

Background	O
Placental	O
pathology	O
is	O
often	B
found	O
in	O
pregnancies	O
complicated	O
by	O
intrauterine	O
growth	O
restriction	O
,	O
preeclampsia	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Prepregnancy	O
smoking	O
status	O
was	O
assessed	O
as	O
number	O
of	O
cigarettes	O
per	O
day	O
.	O

PubMed	O
Central	O
:	O

Also	O
,	O
gestational	O
age	O
at	O
delivery	O
was	O
estimated	O
by	O
routine	O
ultrasound	O
,	O
which	O
is	O
considered	O
more	O
accurate	O
than	O
dating	O
by	O
last	O
menstrual	O
period	O
[	O
26	O
].	O

Typically	O
,	O
the	O
subject	O
of	O
observation	O
was	O
the	O
mother	O
;	O
other	O
family	O
members	O
interacting	O
with	O
the	O
neonate	O
(	O
including	O
touching	O
,	O
cooing	O
,	O
feeding	O
,	O
and	O
bathing	O
)	O
were	O
observed	O
as	O
well	O
.	O

Table	O
1	O
shows	O
the	O
demographics	O
and	O
clinical	O
characteristics	O
of	O
the	O
133	O
children	O
participants	O
in	O
this	O
study	O
with	O
measurement	O
of	O
circulating	O
cathelicidin	O
.	O

Complementary	O
DNA	O
was	O
synthesized	O
from	O
the	O
tailed	O
RNA	O
using	O
gene	O
-	O
specific	O
primers	O
with	O
oligo	O
-	O
dT	O
(	O
a	O
short	O
sequence	O
of	O
deoxy	O
-	O
thymine	O
nucleotides	O
)	O
adapters	O
.	O

During	O
pregnancy	O
,	O
cellular	O
immunity	O
undergoes	O
changes	O
,	O
as	O
reflected	O
by	O
a	O
decrease	O
in	O
T	O
-	O
cell	O
number	O
.	O

The	O
Skm1	O
mutants	O
generated	O
a	O
significant	O
linkage	O
(	O
LOD	O
score	O
=	O
3	O
.	O
612	O
)	O
at	O
chromosome	O
15	O
at	O
marker	O
rs13482455	O
(	O
16	O
.	O
73	O
Mb	O
)	O
(	O
Figure	O
2A	O
,	O
top	O
panel	O
).	O

There	O
are	O
eight	O
data	O
collection	O
time	O
points	O
(	O
here	O
forth	O
referred	O
to	O
as	O
phases	O
).	O

I	O
agree	O
with	O
Dr	O
Eyles	O
’	O
comment	O
that	O
the	O
vitamin	O
D	O
theory	O
is	O
‘	O
highly	O
parsimonious	O
.’	O
Indeed	O
,	O
it	O
was	O
love	O
of	O
parsimony	O
that	O
led	O
me	O
to	O
first	O
hypothesize	O
that	O
vitamin	O
D	O
is	O
intimately	O
involved	O
in	O
the	O
pathology	O
and	O
epidemiology	O
of	O
both	O
autism	O
and	O
influenza	O
(	O
21	O
).	O

Promotional	O
and	O
training	O
costs	O
are	O
amortized	O
over	O
5	O
years	O
as	O
a	O
realistic	O
assumption	O
of	O
the	O
lifespan	O
of	O
printed	O
materials	O
and	O
accounting	O
for	O
staff	O
turnover	O
in	O
the	O
health	O
care	O
system	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0023723	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Basis	O
for	O
costs	O
and	O
source	O
of	O
data	O
.	O
Project	O
costsIron	O
-	O
folic	O
acidsupplementsPromotionTrainingMonitoring	O
USD4	O
.	O
55	O
/′	O
000	O
tablets	O
:	O
52	O
tablets	O
/	O
year	O
,	O
target	O
population	O
250	O
,	O
000	O
;	O
costs	O
,	O
insurance	O
,	O
freight	O
included	O
.	O

Currently	O
,	O
maternal	O
undernutrition	O
is	O
a	O
problem	O
not	O
exclusive	O
of	O
developing	O
countries	O
.	O

Our	O
results	O
showed	O
several	O
factors	O
to	O
be	O
significant	O
,	O
including	O
BMI	O
at	O
delivery	O
,	O
pre	O
-	O
eclampsia	O
,	O
Medicaid	O
status	O
(	O
as	B
a	O
measure	O
of	O
socioeconomic	O
status	O
)	O
and	O
prenatal	O
vitamin	O
use	O
.	O

Additionally	O
we	O
lacked	O
data	O
on	O
sun	O
exposure	O
,	O
actual	O
skin	O
pigmentation	O
or	O
food	O
intake	O
which	O
contribute	O
to	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
.	O

According	O
to	O
our	O
results	O
,	O
a	O
maternal	O
caloric	O
restriction	O
prior	O
to	O
mating	O
could	O
be	O
critical	O
for	O
the	O
less	O
compulsive	O
feeding	O
observed	O
in	O
female	O
offspring	O
.	O

Transgenic	O
mice	O
that	O
overexpress	O
the	O
brain	O
NP	O
or	O
C	O
-	O
type	O
NP	O
ligand	O
exhibit	O
elongated	O
bones	O
and	O
skeletal	O
overgrowth	O
(	O
Suda	O
et	O
al	O
.	O

Empowering	O
families	O
and	O
schools	O
and	O
giving	O
them	O
resources	O
to	O
engage	O
in	O
obesity	O
prevention	O
efforts	O
and	O
to	O
provide	O
environments	O
that	O
support	O
healthy	O
behaviors	O
are	O
critical	O
issues	O
that	O
governments	O
and	O
social	O
institutions	O
need	O
to	O
address	O
.	O

However	O
,	O
studies	O
during	O
postnatal	O
periods	O
(	O
after	O
weaning	O
or	O
finishing	O
period	O
)	O
show	O
that	O
feeding	O
a	O
high	O
starch	O
diet	O
along	O
with	O
early	O
weaning	O
in	O
steers	O
generally	B
increased	O
marbling	O
,	O
as	O
described	O
above	O
[	O
51	O
,	O
53	O
,	O
157	O
].	O

(%)	O
never8	O
111	O
(	O
44	O
)	O
5	O
702	O
(	O
40	O
)	O
281	O
(	O
35	O
)	O
ever10	O
250	O
(	O
56	O
)	O
8	O
656	O
(	O
60	O
)	O
534	O
(	O
65	O
)	O
missing50	O
(	O
0	O
.	O
3	O
)	O
37	O
(	O
0	O
.	O
3	O
)	O
2	O
(	O
0	O
.	O
2	O
)	O
Alcohol	O
intake	O
,	O
No	O
.	O

Recent	O
research	O
has	O
suggested	O
that	O
effects	O
of	O
methyl	O
-	O
mercury	O
on	O
infant	O
brain	O
development	O
may	O
be	O
mediated	O
by	O
LC	O
n	O
-	O
3PUFA	O
[	O
36	O
].	O

Apart	O
from	O
its	O
effectiveness	O
,	O
it	O
was	O
argued	O
that	O
intermittent	O
supplementation	O
is	O
more	O
physiological	O
by	O
avoiding	O
mucosal	O
absorption	O
block	O
and	O
excessive	O
pooling	O
of	O
intestinal	O
iron	O
with	O
associated	O
oxidative	O
stress	O
;	O
furthermore	O
,	O
it	O
has	O
logistic	O
advantages	O
of	O
distribution	O
particularly	O
in	O
areas	O
of	O
limited	O
supply	O
and	O
many	O
of	O
the	O
gastrointestinal	O
side	O
effects	O
of	O
daily	O
iron	O
are	O
avoided	O
[	O
4	O
].	O

Notably	O
,	O
q	O
-	O
values	O
between	O
ontogenetic	O
stages	O
within	O
diet	O
were	O
remarkable	O
lower	O
(	O
q	O
≤	O
0	O
.	O
05	O
)	O
than	O
between	O
diets	O
within	O
stage	O
(	O
q	O
≤	O
0	O
.	O
25	O
).	O

1998	O
).	O

Abstract	O
Cryptorchidism	O
and	O
retention	O
of	O
Müllerian	O
duct	O
structures	O
occur	O
with	O
high	O
frequency	O
among	O
the	O
male	O
offspring	O
of	O
CD	O
-	O
1	O
mice	O
treated	O
with	O
100	O
micrograms	O
diethylstilbestrol	O
/	O
kg	O
body	O
weight	O
on	O
days	O
9	O
through	O
16	O
of	O
pregnancy	O
.	O

Interestingly	O
,	O
epidemiological	O
studies	O
in	O
women	O
showed	O
that	O
maternal	O
malnutrition	O
during	O
pregnancy	O
can	O
result	O
in	O
fetal	O
growth	O
retardation	O
[	O
11	O
,	O
12	O
].	O

Infant	O
Feeding	O
:	O
(	O
breast	O
,	O
formula	O
,	O
or	O
a	O
combination	O
of	O
the	O
two	O
),	O
as	O
assessed	O
by	O
questionnaire	O
completed	O
by	O
the	O
infant	O
’	O
s	O
primary	O
caregiver	O
.	O

For	O
other	O
abbreviations	O
,	O
see	O
text	O
.	O

The	O
cohort	O
’	O
s	O
median	O
cathelicidin	O
concentration	O
was	O
28	O
.	O
1	O
ng	O
/	O
mL	O
(	O
range	O
:	O
5	O
.	O
6	O
–	O
3368	O
.	O
6	O
)	O
and	O
did	O
not	O
correlate	O
with	O
25	O
(	O
OH	O
)	O
D	O
,	O
but	O
was	O
positively	O
correlated	O
with	O
advancing	O
age	O
(	O
ρ	O
=	O
0	O
.	O
236	O
&	O
p	O
=	O
0	O
.	O
005	O
,	O
respectively	O
).	O

This	O
paper	O
evaluates	O
a	O
theory	O
-	O
informed	O
implementation	O
plan	O
to	O
translate	O
a	O
dietetic	O
model	O
of	O
care	O
based	O
on	O
the	O
American	O
guidelines	O
in	O
an	O
Australian	O
maternity	O
hospital	O
.	O

Feeding	O
behavior	O
(	O
compulsive	O
feeding	O
and	O
feeding	O
response	O
to	O
AM251	O
)	O
was	O
evaluated	O
at	O
adolescence	O
(	O
postnatal	O
weeks	O
8	O
–	O
9	O
)	O
and	O
adulthood	O
(	O
postnatal	O
weeks	O
12	O
–	O
13	O
).	O

Since	O
the	O
discovery	O
that	O
most	B
tissues	O
and	O
cells	O
have	O
vitamin	O
D	O
receptors	O
,	O
there	O
has	O
been	O
great	O
interest	O
in	O
its	O
role	O
in	O
the	O
development	O
of	O
many	O
diseases	O
,	O
such	O
as	O
cancer	O
[	O
1	O
],	O
cardiovascular	O
diseases	O
[	O
2	O
],	O
infectious	O
diseases	O
[	O
3	O
],	O
and	O
autoimmune	O
disease	O
[	O
4	O
].	O

Male	O
offspring	O
from	O
the	O
HV	O
dams	O
weaned	O
to	O
the	O
RV	O
diet	O
had	O
5	O
%	O
higher	O
72	O
h	O
food	O
intake	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
03	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
4	O
),	O
8	O
%	O
higher	O
weight	O
gain	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
0006	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
3	O
)	O
and	O
36	O
%	O
higher	O
glucose	O
response	O
to	O
glucose	O
gavage	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
compared	O
to	O
those	O
from	O
the	O
RV	O
dams	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
2	O
,	O
3	O
,	O
4	O
).	O

Late	O
pregnancy	O
loss	O
was	O
defined	O
as	O
spontaneous	O
abortion	O
at	O
gestational	O
week	O
≥	O
14	O
+	O
0	O
,	O
including	O
IUFD	O
.	O

From	O
these	O
results	O
,	O
the	O
authors	O
have	O
suggested	O
that	O
metformin	O
is	O
a	O
safe	O
and	O
effective	O
treatment	O
for	O
GDM	O
.	O

There	O
are	O
some	O
differences	O
in	O
the	O
management	O
of	O
the	O
two	O
most	O
important	O
histotypes	O
:	O
DTC	O
(	O
differentiated	O
thyroid	O
cancer	O
:	O
follicular	O
and	O
papillary	O
cancer	O
)	O
and	O
MTC	O
(	O
medullary	O
thyroid	O
cancer	O
)	O
just	O
as	O
for	O
non	O
-	O
pregnant	O
patients	O
[	O
Boxes	O
1	O
-	O
2	O
].	O

This	O
overcomes	B
the	O
bias	O
of	O
subject	O
selection	O
and	O
allowed	O
a	O
large	O
sample	O
that	O
was	O
more	O
representative	O
of	O
the	O
larger	O
obstetrical	O
population	O
since	B
it	O
included	O
a	O
diversity	O
of	O
socioeconomic	O
backgrounds	O
,	O
race	O
/	O
ethnic	O
groups	O
,	O
pregnancy	O
-	O
related	O
conditions	O
,	O
and	O
medical	O
histories	O
.	O

This	O
should	O
be	O
solved	O
in	O
the	O
future	O
by	O
the	O
identification	O
of	O
selective	O
human	O
β3	O
agonists	O
(	O
Mund	O
and	O
Frishman	O
,	O
2013	O
;	O
Bordicchia	O
et	O
al	O
.,	O
2014	O
).	O

It	O
has	O
been	O
estimated	O
that	O
exposure	O
to	O
sunlight	O
for	O
usually	O
no	O
more	O
than	O
5	O
-	O
15	O
min	O
/	O
d	O
between	O
10	O
AM	O
and	O
3	O
PM	O
,	O
in	O
the	O
spring	O
,	O
summer	O
,	O
and	O
fall	O
at	O
latitudes	O
above	O
and	O
below	O
35	O
°	O
(	O
and	O
all	O
year	O
near	O
the	O
equator	O
)	O
to	O
exposed	O
parts	O
of	O
the	O
body	O
involving	O
“	O
arms	O
,	O
legs	O
and	O
face	O
“	O
provides	O
the	O
body	O
with	O
its	O
required	O
1000	O
IU	O
of	O
cholecalciferol	O
.	O

Both	O
intervention	O
and	O
control	O
participants	O
received	O
maternal	O
and	O
neonatal	O
health	O
counseling	O
,	O
patterned	B
on	I
information	O
delivered	O
in	O
Projahnmo	O
[	O
17	O
]	O
(	O
see	O
visit	O
schedule	O
inFigure	O
1	O
).	O

These	O
costs	O
were	O
identified	O
through	O
the	O
accounts	O
of	O
the	O
relevant	O
agencies	O
and	O
structured	O
interviews	O
with	O
health	O
staff	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
.	O

Although	O
there	O
was	O
no	O
association	O
between	O
maternal	O
Vitamin	O
D	O
status	O
and	O
offspring	O
birth	O
size	O
.	O

The	O
secondary	O
hypotheses	O
are	O
that	O
the	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
in	O
intervention	O
clusters	O
will	O
reduce	O
preterm	O
delivery	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
),	O
and	O
low	O
birth	O
weight	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
).	O

1	O
.	O

The	O
intestinal	O
mucosa	O
is	O
renewed	O
every	O
5	O
to	O
6	O
days	O
and	O
will	O
absorb	O
as	O
much	O
iron	O
as	O
necessary	O
to	O
maintain	O
iron	O
balance	O
;	O
however	O
,	O
mature	O
cells	O
will	O
stop	O
absorbing	O
iron	O
entirely	O
if	O
they	O
are	O
flooded	O
with	O
it	O
,	O
even	O
if	O
there	O
is	O
an	O
iron	O
deficit	O
.	O

Similar	O
findings	O
concerning	O
PFAS	O
exposure	O
have	O
been	O
reported	O
elsewhere	O
[	O
5	O
,	O
19	O
].	O

Also	O
,	O
at	O
6	O
months	O
,	O
children	O
exposed	O
to	O
excessive	O
GWG	O
had	O
near	O
significant	O
(	O
P	O
=	O
.	O
06	O
)	O
higher	O
odds	O
of	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
weight	O
gain	O
(	O
OR	O
=	O
6	O
.	O
2	O
(	O
0	O
.	O
94	O
,	O
41	O
.	O
1	O
),	O
but	O
no	O
significant	O
association	O
was	O
seen	O
on	O
WFA	O
z	O
-	O
scores	O
(	O
0	O
.	O
45	O
±	O
0	O
.	O
14	O
versus	O
0	O
.	O
08	O
±	O
0	O
.	O
18	O
;	O
P	O
=	O
.	O
11	O
).	O

After	O
30	O
min	O
,	O
animals	O
were	O
placed	O
in	O
an	O
individual	O
cage	O
without	O
bedding	O
material	O
.	O

Assuming	O
that	O
anaemia	O
cases	O
prevented	O
is	O
the	O
measure	O
of	O
effectiveness	O
,	O
the	O
cost	O
-	O
effectiveness	O
of	O
the	O
intervention	O
is	O
USD	O
4	O
.	O
24	O
per	O
anaemia	O
case	O
prevented	O
(	O
USD133900	O
/	O
(	O
175581	O
×	O
18	O
)).	O

RNA	O
isolation	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
analysis	O
We	O
performed	O
real	O
-	O
time	O
qPCR	O
(	O
TaqMan	O
,	O
Life	O
Technologies	O
)	O
as	O
described	O
previously	O
(	O
Decara	O
et	O
al	O
.,	O
2012	O
).	O

In	O
our	O
study	O
,	O
antenatal	O
depression	O
score	O
had	O
no	O
association	O
with	O
the	O
baseline	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
.	O

Additional	O
file	O
Caption	O
(	O
MEDIA	O
):	O
ADDITIONAL	O
FILE	O
1	O
:	O
Contains	O
supplemental	O
tables	O
(	O
Tables	O
S1	O
–	O
S16	O
)	O
and	O
figures	O
(	O
Figures	O
S1	O
–	O
S7	O
).	O

2	O
.	O
10	O
.	O

Targeted	O
genotyping	O
of	O
genes	O
of	O
interest	O
in	O
the	O
context	O
of	O
fatty	O
acid	O
,	O
lipid	O
and	O
micronutrient	O
metabolism	O
will	O
also	O
be	O
investigated	O
following	O
the	O
Ion	O
AmpliSeq	O
Targeted	O
Sequencing	O
approach	O
using	O
the	O
Ion	O
Chef	O
™	O
and	O
Ion	O
S5	O
™	O
Systems	O
(	O
ThermoFisher	O
).	O

Schizophrenia	O
and	O
schizoaffective	O
disorders	O
accounted	O
for	O
3	O
%	O
and	O
1	O
.	O
5	O
%,	O
respectively	O
,	O
of	O
the	O
exposed	O
cohort	O
.	O

These	O
studies	O
are	O
highly	O
therapeutically	O
relevant	O
,	O
as	O
BAT	O
activation	O
in	O
overweight	O
or	O
obese	O
subjects	O
will	O
activate	O
thermogenesis	O
and	O
dissipate	O
heat	O
,	O
while	O
at	O
the	O
same	O
time	O
improving	O
glucose	O
metabolism	O
and	O
insulin	O
resistance	O
.	O

Results	O
72	O
%	O
of	O
exposed	O
women	O
received	O
SGAs	O
in	O
polytherapy	O
,	O
and	O
101	O
women	O
took	O
their	O
medications	O
throughout	O
pregnancy	O
.	O

In	O
brief	O
,	O
community	O
leaders	O
and	O
health	O
staff	O
at	O
all	O
levels	O
were	O
sensitized	O
,	O
promotional	O
materials	O
were	O
developed	O
,	O
and	O
village	O
health	O
workers	O
were	O
trained	O
to	O
distribute	O
supplements	O
each	O
month	O
to	O
non	O
-	O
pregnant	O
women	O
.	O

Supplementation	O
raised	O
the	O
serum	O
concentration	O
of	O
calcifediol	O
in	O
the	O
intervention	O
group	O
at	O
several	O
points	O
in	O
our	O
study	O
.	O

For	O
example	O
,	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
,	O
specifically	O
being	O
overweight	O
or	O
obese	O
,	O
has	O
been	O
shown	O
to	O
be	O
independently	O
associated	O
with	O
an	O
elevated	O
risk	O
for	O
LGA	O
births	O
.	O
35	O
–	O
38Although	O
this	O
study	O
is	O
the	O
first	O
to	O
corroborate	O
Newham	O
et	O
al	O
'	O
s19report	O
of	O
increased	O
risks	O
of	O
LGA	O
deliveries	O
in	O
women	O
exposed	O
to	O
SGAs	O
,	O
the	O
study	O
design	O
was	O
not	O
able	O
to	O
adequately	O
separate	O
the	O
effect	O
of	O
pre	O
-	O
pregnancy	O
weight	O
on	O
this	O
outcome	O
.	O

The	O
right	O
side	O
of	O
the	O
hypothalamus	O
was	O
used	O
for	O
relative	O
gene	O
expression	O
and	O
the	O
left	O
side	O
for	O
DNA	O
methylation	O
status	O
.	O

Despite	O
unclear	O
mechanisms	O
,	O
the	O
positive	O
relationship	O
between	O
later	O
pregnancy	O
hyperglycemia	O
and	O
GDM	O
risk	O
were	O
evident	B
among	O
women	O
who	O
reported	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
in	O
our	O
cohort	O
.	O

No	O
other	O
women	O
living	O
in	O
the	O
same	O
household	O
compound	O
had	O
previously	O
taken	O
part	O
in	O
either	O
arm	O
of	O
the	O
study	O
.	O

This	O
led	O
to	O
the	O
hypothesis	O
that	O
the	O
age	O
of	O
menarche	O
is	O
directly	O
linked	O
to	O
a	O
critical	O
degree	O
of	O
body	O
fat	O
[	O
8	O
];	O
however	O
although	O
prepubertal	O
nutrition	O
and	O
the	O
age	O
of	O
puberty	O
are	O
certainly	O
associated	O
in	O
some	O
way	O
,	O
this	O
concept	O
did	O
not	O
stand	O
up	O
to	O
critical	O
analysis	O
of	O
the	O
data	O
[	O
9	O
].	O

Management	O
consists	O
of	O
correcting	O
hypocalcemia	O
and	O
determining	O
the	O
cause	O
of	O
hypocalcemia	O
and	O
treating	O
it	O
.	O

The	O
seven	O
constituencies	O
,	O
as	O
identified	O
by	O
Every	O
Woman	O
Every	O
Child	O
[	O
7	O
],	O
have	O
four	O
action	O
themes	O
,	O
which	O
link	O
closely	O
to	O
the	O
principles	O
of	O
Act	O
,	O
Monitor	O
and	O
Review	O
recommended	O
by	O
the	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
.	O

Recruitment	O
Recruitment	O
and	O
enrollment	O
took	O
place	O
at	O
various	O
obstetric	O
clinics	O
in	O
an	O
urban	O
area	O
of	O
the	O
South	O
East	O
from	O
January	O
–	O
April	O
2011	O
.	O

In	O
the	O
Elastic	O
Net	O
analysis	O
,	O
DEP	O
was	O
associated	O
with	O
a	O
21	O
g	O
increase	O
and	O
DMP	O
with	O
a	O
54g	O
decrease	O
in	O
birth	O
weight	O
(	O
Additional	O
file1	O
:	O
Figure	O
S4	O
).	O

Diet	O
and	O
lifestyle	O
exposure	O
assessment	O
The	O
self	O
-	O
administered	O
questionnaire	O
in	O
the	O
parent	O
study	O
assessed	O
lifestyle	O
variables	O
(	O
smoking	O
history	O
,	O
alcoholic	O
drinking	O
),	O
anthropometry	O
(	O
height	O
,	O
weight	O
,	O
body	O
mass	O
index	O
,	O
BMI	O
),	O
medical	O
history	O
(	O
previous	O
diagnosis	O
of	O
major	O
diseases	O
)	O
and	O
average	O
intake	O
of	O
foods	O
and	O
beverages	O
[	O
19	O
].	O

In	O
order	O
to	O
advocate	O
evidence	O
-	O
based	O
healthcare	O
policy	O
and	O
practice	O
,	O
the	O
identification	O
of	O
nutrient	O
deficiencies	O
and	O
poor	O
eating	O
patterns	O
of	O
pregnant	O
women	O
in	O
South	O
Africa	O
,	O
which	O
are	O
associated	O
with	O
adverse	O
neonatal	O
outcomes	O
and	O
delayed	O
early	O
offspring	O
development	O
,	O
is	O
imperative	O
.	O

They	O
speculated	O
that	O
this	O
is	O
due	B
primarily	B
to	I
passive	O
absorption	O
of	O
calcium	O
at	O
this	O
age	O
.	O

This	O
supplement	O
identifies	O
risks	O
for	O
preterm	O
birth	O
and	O
the	O
solutions	O
needed	O
to	O
reduce	O
those	O
risks	O
across	O
the	O
RMNCH	O
continuum	O
;	O
yet	O
for	O
many	O
of	O
these	O
risks	O
,	O
we	O
do	O
not	O
have	O
effective	O
solutions	O
.	O

Laboratory	O
Measurements	O
After	O
an	O
overnight	O
fasting	O
,	O
samples	O
of	O
6	O
ml	O
peripheral	O
blood	O
were	O
taken	O
from	O
all	O
of	O
the	O
patients	O
at	O
most	O
10	O
days	O
after	O
the	O
delivery	O
,	O
and	O
were	O
used	O
to	O
determine	O
plasma	O
glycosylated	O
hemoglobin	O
A1C	O
(	O
HBA1C	O
)	O
test	O
by	O
immunoassay	O
method	O
.	O

PubMed	O
Central	O
:	O

(	O
2012b	O
)*	O
Li	O
et	O
al	O
.	O

Somatic	O
versus	O
germ	O
cell	O
change	O
If	O
an	O
epigenetic	O
change	O
occurs	O
in	O
a	O
somatic	O
cell	O
or	O
in	O
a	O
germ	O
cell	O
that	O
is	O
correctly	O
‘	O
reset	O
’	O
during	O
germ	O
line	O
development	O
in	O
the	O
subsequent	O
offspring	O
,	O
then	O
only	O
one	O
generation	O
will	O
be	O
affected	O
.	O

Charatcharoenwitthaya	O
et	O
al	O
.	O

Future	O
interventions	O
can	O
tailor	O
text	O
message	O
and	O
other	O
mHealth	O
message	O
content	O
(	O
eg	O
,	O
through	O
social	O
media	O
or	O
apps	O
)	O
both	O
to	O
a	O
specific	O
target	O
audience	O
and	O
to	O
an	O
optimal	O
time	O
for	O
delivery	O
.	O

Among	O
the	O
71	O
infants	O
who	O
underwent	O
infant	O
lung	O
function	O
testing	O
,	O
bacterial	O
cultures	O
from	O
nasopharyngeal	O
specimens	O
were	O
taken	O
from	O
66	O
infants	O
,	O
with	O
a	O
positive	O
culture	O
rate	O
of	O
68	O
.	O
2	O
%	O
(	O
45	O
/	O
66	O
).	O

Vitamin	O
D	O
deficiency	O
during	O
early	O
pregnancy	O
significantly	O
increases	O
the	O
risk	O
for	O
gestational	O
diabetes	O
in	O
later	O
pregnancy	O
.	O

Fructose	O
also	O
causes	O
generation	O
of	O
uric	O
acid	O
[	O
38	O
],	O
and	O
experimental	O
evidence	O
in	O
mice	O
suggests	O
that	O
uric	O
acid	O
may	O
be	O
an	O
essential	O
initiator	O
and	O
amplifier	O
of	O
T	O
-	O
helper	O
cell	O
type	O
2	O
(	O
Th2	O
)	O
immunity	O
and	O
allergic	O
inflammation	O
,	O
through	O
activation	O
of	O
inflammatory	O
dendritic	O
cells	O
[	O
39	O
].	O

The	O
correlations	O
between	O
the	O
mother	O
and	O
the	O
MGF	O
and	O
the	O
father	O
and	O
his	O
father	O
,	O
the	O
PGF	O
,	O
were	O
not	O
statistically	O
significant	O
.	O

The	O
homozygous	O
low	O
-	O
frequency	O
allele	O
was	O
used	O
as	O
the	O
reference	O
group	O
,	O
with	O
the	O
β	O
representing	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
per	O
common	O
allele	O
(	O
additive	O
model	O
).	O

This	O
resulted	O
in	O
41	O
distinct	O
bioinformatically	O
derived	O
classes	O
,	O
containing	O
at	O
least	O
one	O
CpG	O
,	O
based	O
on	O
bioinformatic	O
attributes	O
[	O
for	O
the	O
distribution	O
of	O
CpG	O
loci	O
by	O
bioinformatically	O
derived	O
class	O
,	O
see	O
Supplemental	O
Material	O
,	O
Table	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

In	O
the	O
literature	O
,	O
recent	O
studies	O
across	O
a	O
wide	O
range	O
of	O
populations	O
have	O
demonstrated	O
a	O
positive	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
[	O
8	O
–	O
11	O
,	O
15	O
,	O
16	O
,	O
18	O
,	O
19	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
.	O

While	O
the	O
findings	O
reveal	O
a	O
relatively	O
modest	O
impact	O
on	O
weight	O
gain	O
[	O
14	O
],	O
very	O
little	O
attention	O
has	O
been	O
directed	O
towards	O
the	O
ongoing	O
follow	O
-	O
up	O
of	O
women	O
and	O
infants	O
beyond	O
the	O
neonatal	O
period	O
to	O
assess	O
longer	O
term	O
outcomes	O
.	O

Both	O
histone	O
modifications	O
and	O
DNA	O
methylation	O
changes	O
can	O
inhibit	O
or	O
promote	O
transcription	O
of	O
mRNAs	O
and	O
ncRNAs	O
.	O

In	O
early	O
pregnancy	O
,	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
were	O
significantly	O
more	O
likely	B
to	O
be	O
at	O
risk	O
of	O
25OHD	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
)	O
and	O
25OHD	O
inadequacy	O
(<	O
50	O
nmol	O
/	O
L	O
),	O
than	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
summer	O
(	O
Table2	O
).	O

Also	O
,	O
the	O
present	O
study	O
has	O
been	O
recorded	O
in	O
the	O
Iranian	O
Registry	O
of	O
Clinical	O
Trials	O
’	O
website	O
with	O
the	O
code	O
number	O
IRCT2015020310327N11	O
.	O

Parity	O
was	O
categorised	O
into	O
nullipara	O
,	O
secundipara	O
and	O
multipara	O
(>	O
two	O
deliveries	O
).	O

Only	O
a	O
small	O
change	O
in	O
glycemic	O
index	O
of	O
women	O
’	O
s	O
diet	O
occurred	O
after	O
seeing	O
a	O
dietitian	O
,	O
pre	O
-	O
to	O
post	O
-	O
implementation	O
(-	O
2	O
.	O
0	O
±	O
4	O
.	O
4	O
vs	O
.	O
-	O
3	O
.	O
0	O
±	O
5	O
.	O
0	O
).	O

The	O
females	O
with	O
caloric	O
restriction	O
were	O
fed	O
with	O
a	O
daily	O
amount	O
of	O
food	O
corresponding	O
to	O
the	O
80	O
%	O
of	O
the	O
calories	O
that	O
the	O
control	O
rats	O
were	O
fed	O
in	O
the	O
previous	O
day	O
of	O
the	O
experiment	O
,	O
according	O
to	O
the	O
body	O
weight	O
(	O
20	O
%	O
of	O
caloric	O
restriction	O
).	O

Similar	O
studies	O
using	O
a	O
Swedish	O
medical	O
birth	O
registry	O
observed	O
different	O
factors	O
that	O
affected	O
autism	O
spectrum	O
disorders	O
.	O

These	O
cells	O
can	O
also	O
produce	O
prostaglandins	O
and	O
other	O
neuroendocrine	O
markers	O
such	O
as	O
chromogranin	O
A	O
,	O
sometimes	O
used	O
together	O
with	O
calcitonin	O
and	O
CEA	O
in	O
MTC	O
patients	O
during	O
follow	O
-	O
up	O
.	O

However	O
,	O
no	O
differences	O
in	O
chocolate	O
preference	O
were	O
found	O
between	O
CC	O
and	O
RC	O
offspring	O
at	O
adulthood	O
(	O
Figure3B	O
).	O

Analyses	O
will	O
be	O
done	O
by	O
the	O
SAMRC	O
by	O
linking	O
data	O
to	O
the	O
most	O
recent	O
food	O
composition	O
database	O
.	O

This	O
evaluation	O
was	O
performed	O
after	O
5	O
minutes	O
of	O
rest	O
in	O
the	O
supine	O
position	O
,	O
and	O
the	O
electrodes	O
were	O
applied	O
to	O
the	O
hand	O
,	O
wrist	O
,	O
ankle	O
and	O
foot	O
of	O
the	O
right	O
-	O
hand	O
side	O
of	O
the	O
body	O
.	O

Materials	O
and	O
Methods	O
:	O
Forty	O
-	O
one	O
eligible	O
pregnant	O
women	O
in	O
their	O
first	O
trimester	O
were	O
divided	O
and	O
matched	O
in	O
terms	O
of	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
before	O
pregnancy	O
into	O
normal	O
and	O
higher	O
than	O
normal	O
BMI	O
groups	O
,	O
A	O
and	O
B	O
.	O
Serum	O
visfatin	O
levels	O
were	O
measured	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
using	O
ELISA	O
.	O

8	O
),	O
and	O
this	O
parameter	O
was	O
higher	O
in	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
than	O
in	O
the	O
corresponding	O
F1	O
and	O
F2	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Factors	O
affecting	O
IMF	O
deposition	O
can	O
be	O
sub	O
-	O
categorized	O
into	O
genetic	O
(	O
breed	O
and	O
sex	O
differences	O
,	O
heritability	O
),	O
management	O
(	O
weaning	O
age	O
,	O
castration	O
,	O
slaughter	O
weight	O
and	O
age	O
,	O
and	O
environment	O
),	O
and	O
nutritional	O
factors	O
(	O
fat	O
metabolism	O
,	O
fat	O
digestion	O
and	O
absorption	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
roughage	O
vs	O
concentrate	O
ratio	O
,	O
dietary	O
energy	O
and	O
protein	O
levels	O
,	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
,	O
fetal	O
and	O
neonatal	O
nutritional	O
programming	O
,	O
and	O
stage	O
-	O
specific	O
feeding	O
systems	O
).	O

Hence	B
,	O
it	O
would	O
be	O
expected	O
,	O
with	O
the	O
inclusion	O
of	O
these	O
and	O
other	O
innovations	O
,	O
that	O
mortality	O
reduction	O
could	O
be	O
more	O
rapid	O
than	O
for	O
the	O
historical	O
examples	O
.	O

Such	O
low	O
consumption	O
rate	O
and	O
amount	O
cannot	O
be	O
the	O
leading	O
cause	O
of	O
high	O
Vitamin	O
D	O
detection	O
rate	O
in	O
these	O
participants	O
.	O

In	O
a	O
study	O
by	O
Mozafari	O
-	O
Khosravi	O
et	O
al	O
.,	O
300	O
,	O
000	O
and	O
150	O
,	O
000	O
IU	O
vitamin	O
D	O
were	O
administered	O
by	O
injection	O
to	O
the	O
two	O
groups	O
who	O
suffered	O
depression	O
and	O
the	O
third	O
group	O
did	O
not	O
receive	O
vitamin	O
D	O
.	O
High	O
doses	O
of	O
vitamin	O
D	O
were	O
effective	O
in	O
decreasing	O
depression	O
levels	O
after	O
3	O
months	O
[	O
30	O
].	O

Articles	O
directed	O
at	O
identifying	O
suitable	O
models	O
to	O
explain	O
the	O
relationship	O
between	O
components	O
in	O
fish	O
or	O
developing	O
tools	O
to	O
analyse	O
the	O
risk	O
-	O
benefit	O
of	O
fish	O
consumption	O
without	O
measuring	O
neurodevelopmental	O
outcomes	O
were	O
not	O
deemed	O
eligible	O
for	O
this	O
review	O
.	O

Maternal	O
characteristics	O
,	O
as	O
described	O
in	O
Table1	O
,	O
did	O
not	O
differ	O
between	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
or	O
summer	O
.	O

PA01	O
.	O
78	O
.	O

Indeed	O
,	O
reported	O
handwashing	O
behavior	O
is	O
susceptible	O
to	O
social	O
desirability	O
bias	O
,	O
with	O
wealthier	O
or	O
more	O
educated	O
respondents	O
;	O
that	O
is	O
,	O
those	O
whose	O
children	O
are	O
already	O
at	O
lower	O
risk	O
of	O
neonatal	O
mortality	O
,	O
potentially	O
more	O
likely	B
to	O
overreport	O
handwashing	O
behavior	O
than	O
less	O
wealthy	O
or	O
less	O
educated	O
counterparts	O
[	O
7	O
,	O
8	O
].	O

Fructose	O
,	O
which	O
is	O
a	O
major	O
component	O
of	O
added	O
sugars	O
,	O
and	O
is	O
present	O
naturally	O
in	O
fruit	O
juice	O
and	O
in	O
sweetened	O
drinks	O
as	O
added	O
sucrose	O
(	O
ratio	O
of	O
fructose	O
/	O
glucose	O
50	O
/	O
50	O
%)	O
or	O
isolated	O
fructose	O
,	O
has	O
been	O
mooted	O
as	O
driving	O
previous	O
cross	O
-	O
sectional	O
findings	O
linking	O
sugar	O
-	O
containing	O
beverage	O
consumption	O
to	O
asthma	O
in	O
children	O
[	O
7	O
,	O
8	O
].	O

Heart	O
rate	O
variability	O
(	O
HRV	O
)	O
was	O
evaluated	O
by	O
heart	O
rate	O
monitoring	O
,	O
including	O
measurements	O
of	O
both	O
the	O
time	O
and	O
frequency	O
domains	O
.	O

Literature	O
from	O
Pubmed	O
(	O
MEDLINE	O
),	O
AJOL	O
,	O
Google	O
Scholar	O
,	O
and	O
Cochrane	O
database	O
was	O
reviewed	O
.	O

The	O
order	O
of	O
introduction	O
seems	O
to	O
have	O
little	O
effect	O
on	O
AM	O
.	O

A	O
recent	O
2011	O
population	O
-	O
based	O
study	O
of	O
acute	O
type	O
A	O
aortic	O
dissection	O
in	O
pregnancy	O
revealed	O
an	O
overall	O
incidence	O
of	O
0	O
.	O
4	O
cases	O
per	O
100	O
,	O
000	O
person	O
-	O
years	O
and	O
a	O
prehospital	O
mortality	O
rate	O
of	O
53	O
%	O
[	O
2	O
].	O

Behavior	O
change	O
communicators	O
used	O
a	O
participatory	O
approach	O
to	O
motivate	O
maternal	O
handwashing	O
with	O
soap	O
and	O
provided	O
soap	O
and	O
handwashing	O
stations	O
.	O

Our	O
Elastic	O
Net	O
analysis	O
identified	O
1	O
EDC	O
in	O
common	O
with	O
Lenters	O
et	O
al	O
.	O

In	O
conclusion	O
,	O
we	O
found	O
that	O
lack	O
of	O
PNV	O
use	O
during	O
pregnancy	O
was	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
early	O
in	O
pregnancy	O
,	O
but	O
not	O
among	O
black	O
women	O
.	O

Current	O
evidence	O
for	O
putative	B
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
.	O

PubMed	O
Central	O
:	O

Published	O
studies	O
have	O
differed	O
substantially	O
from	O
one	O
another	O
in	O
design	O
and	O
in	O
ability	O
to	O
account	B
for	I
variations	O
in	O
circulating	O
influenza	O
viruses	O
,	O
vaccine	O
components	O
,	O
target	O
population	O
,	O
and	O
place	O
of	O
study	O
,	O
making	O
cross	O
-	O
study	O
comparisons	O
difficult	O
[	O
31	O
].	O

A	O
PET	O
/	O
CT	O
study	O
revealed	O
the	O
presence	O
of	O
BAT	O
depots	O
in	O
the	O
lower	O
neck	O
,	O
suprascapular	O
,	O
mediastinal	O
,	O
and	O
thoracic	O
paravertebral	O
regions	O
.	O

(	O
2015	O
)	O
and	O
Leseva	O
et	O
al	O
.	O

To	O
expand	O
on	O
the	O
bioinformatically	O
informed	O
analysis	O
,	O
which	O
suggested	O
that	O
methylation	O
of	O
CpG	O
loci	O
proximal	O
to	O
a	O
TFBS	O
were	O
associated	O
with	O
AluYb8	O
methylation	O
,	O
we	O
performed	O
a	O
GSEA	O
using	O
specific	O
TFBS	O
,	O
obtained	O
from	O
the	O
UCSC	O
Genomes	O
Browser	O
.	O

Another	O
factor	O
possibly	O
associated	O
with	O
pet	O
ownership	O
is	O
increased	O
Vitamin	O
D	O
among	O
family	O
members	O
as	O
pet	O
keeping	O
may	O
be	O
correlated	O
with	O
lifestyles	O
involving	O
increased	O
outdoor	O
exposure	O
,	O
such	O
as	O
dog	O
walking	O
.	O

Briefly	O
,	O
each	O
animal	O
was	O
laid	O
in	O
a	O
supine	O
position	O
and	O
samples	O
were	O
obtained	O
by	O
inserting	O
the	O
tip	O
of	O
a	O
100	O
ul	O
pipette	O
tip	O
approximately	O
2	O
–	O
4	O
mm	O
into	O
the	O
vagina	O
,	O
releasing	O
sterile	O
water	O
(∼	O
50	O
ul	O
)	O
and	O
immediately	O
drawing	O
back	O
to	O
collect	O
the	O
sample	O
.	O

The	O
essential	O
enzymes	O
for	O
vitamin	O
D	O
hydroxylation	O
are	O
found	O
in	O
the	O
brain	O
that	O
can	O
produce	O
calcitriol	O
.	O

The	O
aims	O
of	O
this	O
review	O
are	O
to	O
describe	O
some	O
of	O
the	O
main	O
factors	O
regulating	O
UCP1	O
activity	O
in	O
brown	O
and	O
brite	O
adipocytes	O
,	O
as	O
well	O
as	O
to	O
discuss	O
the	O
potential	O
role	O
of	O
UCP1	O
activation	O
for	O
the	O
treatment	O
of	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
associated	O
with	O
obesity	O
.	O

Measures	O
2	O
.	O
2	O
.	O
1	O
.	O

Thus	O
,	O
miRNAs	O
are	O
involved	O
in	O
fine	O
tuning	O
gene	O
expression	O
,	O
whilst	O
piRNAs	O
and	O
esiRNAs	O
play	O
a	O
primary	O
role	O
in	O
maintaining	O
genome	O
stability	O
.	O

Data	O
on	O
education	O
level	O
(≤	O
primary	O
level	O
,	O
secondary	O
level	O
or	O
university	O
level	O
)	O
and	O
origin	O
(	O
continent	O
of	O
birth	O
:	O
Northern	O
Europe	O
,	O
Continental	O
Europe	O
,	O
America	O
,	O
Asia	O
,	O
Africa	O
)	O
were	O
collected	O
from	O
study	O
questionnaires	O
.	O

Amongst	O
other	O
functions	O
,	O
it	O
is	O
thought	O
that	O
this	O
family	O
of	O
diffuse	O
cytoplasmic	O
proteins	O
provides	O
a	O
‘	O
sink	O
’	O
allowing	O
cells	O
to	O
rapidly	O
buffer	O
intracellular	O
calcium	O
after	O
actions	O
potentials	O
,	O
thus	B
allowing	O
the	O
cell	O
to	O
rapidly	O
repolarise	O
for	O
further	O
firing	O
.	O

Prenatal	O
vitamin	O
supplement	O
composition	O
varied	O
by	O
brand	O
;	O
however	O
,	O
most	O
brands	O
included	O
200	O
IU	O
vitamin	O
D	O
per	O
pill	O
.	O

Response	O
to	O
an	O
immunisation	O
is	O
regarded	O
as	O
a	O
good	O
marker	O
to	O
measure	O
immune	O
function	O
in	O
vivo	O
[	O
61	O
]	O
and	O
the	O
response	O
will	O
be	O
in	O
the	O
log	O
phase	O
6	O
weeks	O
after	O
immunisation	O
,	O
which	O
is	O
the	O
most	O
sensitive	O
stage	O
to	O
measure	O
differences	O
in	O
response	O
among	O
infants	O
.	O

The	O
comparison	O
revealed	O
a	O
larger	O
,	O
statistically	O
significant	O
percent	O
reporting	O
smoking	O
in	O
the	O
last	O
30	O
days	O
:	O
15	O
.	O
3	O
%	O
(	O
95	O
%	O
CI	O
12	O
.	O
08	O
-	O
18	O
.	O
58	O
)	O
in	O
the	O
control	O
vs	O
9	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
6	O
.	O
95	O
-	O
12	O
.	O
32	O
,	O
P	O
=	O
.	O
048	O
)	O
in	O
the	O
treatment	O
group	O
,	O
respectively	O
.	O

are	O
achievable	O
in	O
a	O
general	O
obstetrical	O
population	O
.	O

These	O
four	O
miRNAs	O
are	O
miR	O
-	O
124a	O
,	O
miR	O
-	O
142	O
-	O
3p	O
,	O
miR	O
-	O
30	O
and	O
miR	O
-	O
204	O
,	O
the	O
miRNAs	O
binding	O
sites	O
on	O
the	O
3	O
′	O
UTR	O
of	O
GR	O
were	O
shown	O
inFig	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
global	O
epigenetic	O
change	O
(	O
s	O
);	O
(	O
2	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
);	O
(	O
3	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
;	O
or	O
(	O
4	O
)	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
rodent	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

Secondary	O
outcomes	O
Infant	O
Anthropometric	O
Measurements	O
:	O
We	O
have	O
an	O
established	O
and	O
validated	O
method	O
of	O
conducting	O
anthropometric	O
measurements	O
in	O
infants	O
[	O
28	O
].	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
Complutense	O
University	O
of	O
Madrid	O
.	O

Comparisons	O
of	O
mouse	O
phenotypes	O
with	O
clinical	O
descriptions	O
will	O
facilitate	O
a	O
better	O
understanding	O
of	O
the	O
genetic	O
component	O
of	O
vertebral	O
malformations	O
.	O

Although	O
they	O
did	O
not	O
start	O
early	O
,	O
these	O
figures	O
indicate	O
there	O
is	O
a	O
substantial	O
opportunity	O
to	O
improve	O
IFA	O
supplements	O
distribution	O
in	O
rural	O
Bangladesh	O
.	O

For	O
example	O
,	O
birth	O
weights	O
in	O
agricultural	O
societies	O
are	O
highest	O
at	O
the	O
peak	O
of	O
the	O
dry	O
season	O
,	O
corresponding	O
to	O
the	O
time	O
of	O
harvesting	O
and	O
greatest	O
food	O
availability	O
[	O
174	O
].	O

This	O
study	O
is	O
significant	O
for	O
at	O
least	O
3	O
reasons	O
.	O

Interpretations	O
Quarterly	O
bolus	O
doses	O
of	O
oral	O
vitamin	O
D3supplementation	O
to	O
infants	O
are	O
not	O
an	O
effective	O
intervention	O
to	O
reduce	O
the	O
incidence	O
of	O
pneumonia	O
in	O
infants	O
in	O
this	O
setting	O
.	O

These	O
findings	O
suggest	O
that	O
cellular	O
energics	O
may	O
be	O
altered	O
in	O
this	O
brain	O
region	O
in	O
the	O
DVD	O
-	O
deficient	O
rat	O
.	O

Nutrition	O
for	O
the	O
primary	O
care	O
provider	O
This	O
book	O
focuses	O
on	O
the	O
various	O
nutritional	O
aspects	O
of	O
the	O
current	O
needs	O
of	O
the	O
society	O
at	O
large	O
and	O
for	O
the	O
health	O
practitioners	O
.	O

Biological	O
samples	O
are	O
processed	O
on	O
site	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
for	O
a	O
maximum	O
of	O
14	O
days	O
.	O

Those	O
interested	O
,	O
receive	O
a	O
study	O
information	O
leaflet	O
and	O
are	O
screened	O
for	O
eligibility	O
individually	O
in	O
a	O
private	O
space	O
upon	O
which	O
a	O
booking	O
date	O
is	O
supplied	O
if	O
eligible	O
.	O

Results	O
The	O
mean	O
age	O
of	O
participants	O
was	O
40	O
.	O
8	O
±	O
14	O
.	O
1	O
months	O
.	O

These	O
data	O
suggest	O
that	O
dosage	O
of	O
texts	O
received	O
regarding	O
risks	O
of	O
alcohol	O
use	O
,	O
which	O
included	O
messages	O
regarding	O
risks	O
due	O
to	O
alcohol	O
while	O
breastfeeding	O
,	O
had	O
a	O
cumulative	O
effective	O
.	O

In	O
Afghanistan	O
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
is	O
low10and	O
exposure	O
of	O
women	O
to	O
sunlight	O
is	O
limited	O
by	O
the	O
widespread	O
use	O
of	O
the	O
burqa	O
.	O

Although	O
episodes	O
of	O
wheezing	O
during	O
childhood	O
are	O
mostly	B
caused	O
by	O
a	O
viral	O
respiratory	O
infection	O
,	O
their	O
detailed	O
pathogenesis	O
and	O
relationship	O
with	O
asthma	O
are	O
unclear	O
.	O

X	O
-	O
ray	O
measurement	O
Mice	O
(	O
age	O
approximately	O
7	O
wk	O
)	O
were	O
anesthetized	O
using	O
a	O
combination	O
of	O
100	O
mg	O
/	O
kg	O
ketamine	O
HCl	O
,	O
10	O
mg	O
/	O
kg	O
xyaline	O
HCl	O
,	O
and	O
3	O
mg	O
/	O
kg	O
acepromazine	O
administered	O
by	O
subcutaneous	O
injection	O
and	O
radiographs	O
were	O
performed	O
using	O
a	O
Faxitron	O
(	O
Hewlett	O
Packard	O
,	O
Palo	O
Alto	O
,	O
CA	O
).	O

Of	O
total	O
participants	O
92	O
(	O
60	O
.	O
1	O
%)	O
mothers	O
were	O
nulliparous	O
and	O
61	O
(	O
39	O
.	O
9	O
%)	O
were	O
multiparous	O
women	O
.	O

In	O
retrospect	O
,	O
a	O
comprehensive	B
food	O
frequency	O
assessment	O
would	O
have	O
been	O
a	O
useful	O
addition	O
to	O
the	O
study	O
.	O

Mean	O
cost	O
per	O
person	O
-	O
year	O
of	O
“	O
useful	O
”	O
coverage	O
was	O
estimated	O
as	O
USD8	O
.	O
53	O
(	O
vitamin	O
A	O
)	O
and	O
USD0	O
.	O
74	O
(	O
iodine	O
)	O
but	O
not	O
available	O
for	O
iron	O
or	O
zinc	O
.	O

Introduction	O
Gliomas	O
are	O
a	O
heterogeneous	O
group	O
of	O
neoplasms	O
in	O
terms	O
of	O
cellular	O
origin	O
and	O
location	O
.	O

At	O
baseline	O
,	O
40	O
%	O
of	O
control	O
(	O
50	O
/	O
124	O
)	O
and	O
46	O
%	O
of	O
intervention	O
(	O
57	O
/	O
125	O
)	O
participants	O
said	O
they	O
reminded	O
someone	O
else	O
to	O
wash	O
hands	O
on	O
a	O
typical	O
day	O
.	O

An	O
alternative	O
,	O
attribute	O
-	O
driven	O
clustering	O
scheme	O
for	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
employed	O
by	O
grouping	O
CpGs	O
by	O
epigenetically	O
relevant	O
bioinformatic	O
attributes	O
:	O
CpG	O
island	O
(	O
CGI	O
)	O
status	O
(	O
Takai	O
and	O
Jones	O
2002	O
),	O
polycomb	O
group	O
(	O
PcG	O
)	O
target	O
status	O
of	O
the	O
associated	O
gene	O
[	O
i	O
.	O
e	O
.,	O
gene	O
was	O
described	O
as	O
a	O
PcG	O
target	O
in	O
at	O
least	O
one	O
ofBracken	O
et	O
al	O
.	O

There	O
is	O
also	O
evidence	O
that	O
PFOA	O
can	O
alter	O
the	O
expression	O
of	O
milk	O
protein	O
genes	O
,	O
which	O
are	O
important	O
for	O
the	O
production	O
of	O
milk	O
.	O
26Fenton	O
further	O
notes	O
that	O
PFASs	O
are	O
only	O
one	O
class	O
of	O
environmental	O
chemicals	O
that	O
may	O
cause	O
concern	O
for	O
lactation	O
.	O
28	O
Poor	O
maternal	O
metabolic	O
health	O
may	O
be	O
another	O
factor	O
that	O
hampers	O
lactation	O
.	O

Meaning	O
that	O
over	O
time	O
,	O
depression	O
scores	O
decreased	O
much	O
more	O
in	O
the	O
vitamin	O
D	O
group	O
in	O
comparison	O
to	O
control	O
group	O
and	O
this	O
shows	O
the	O
possible	O
effects	O
of	O
the	O
vitamin	O
D3supplementation	O
.	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

Dietary	O
sources	O
of	O
vitamin	O
D	O
include	O
:	O
Fatty	O
fish	O
species	O
,	O
such	O
as	O
Catfish	O
,	O
Salmon	O
,	O
Mackerel	O
,	O
Tuna	O
etc	O
.,	O
egg	O
,	O
beef	O
and	O
fish	O
liver	O
oils	O
.	O

ASD	O
may	O
involve	O
additional	O
pathologies	O
at	O
the	O
neuroanatomical	O
level	O
.	O

Also	O
,	O
some	O
maternal	O
dietary	O
patterns	O
characterized	O
by	O
high	O
intakes	O
of	O
vegetable	O
,	O
fruit	O
,	O
white	O
rice	O
[	O
25	O
],	O
Vitamin	O
C	O
,	O
milk	O
,	O
and	O
fat	O
[	O
26	O
]	O
are	O
associated	O
with	O
larger	O
birth	O
size	O
of	O
infant	O
.	O

Current	O
methods	O
to	O
increase	O
IMF	O
deposition	O
are	O
generally	B
limited	O
to	O
increasing	O
overall	O
body	O
fat	O
deposition	O
,	O
including	O
inedible	O
fat	O
.	O

In	O
the	O
same	O
report	O
[	O
68	O
],	O
the	O
MS	O
in	O
5	O
,	O
826	O
Korean	O
cattle	O
steers	O
from	O
several	O
farms	O
in	O
Gangwon	O
Province	O
was	O
analyzed	O
in	O
2010	O
to	O
2012	O
;	O
MS	O
increased	O
from	O
4	O
.	O
9	O
to	O
5	O
.	O
7	O
as	O
slaughter	O
age	O
increased	O
from	O
26	O
to	O
35	O
months	O
.	O

Therefore	B
,	O
breastmilk	O
,	O
a	O
normally	O
poor	O
source	O
of	O
vitamin	O
D	O
,	O
11becomes	O
even	O
more	O
deficient	O
.	O

The	O
feeding	O
strategy	B
for	O
highly	O
marbled	O
Korean	O
cattle	O
beef	O
has	O
been	O
also	O
described	O
by	O
Jo	O
et	O
al	O
[	O
96	O
].	O

Thus	B
,	O
metabolism	O
of	O
the	O
parent	O
environmental	O
compound	O
can	O
vary	O
greatly	O
between	O
models	O
,	O
resulting	O
in	O
the	O
production	O
of	O
different	O
types	O
and	O
levels	O
of	O
metabolites	O
.	O

4	O
.	O

For	O
missing	O
data	O
and	O
attrition	O
of	O
participants	O
,	O
a	O
t	O
test	O
was	O
used	O
to	O
compare	O
covariates	O
,	O
including	O
sociodemographic	O
and	O
other	O
variables	O
used	O
in	O
the	O
regressions	O
,	O
between	O
cases	O
with	O
and	O
without	O
missing	O
data	O
to	O
verify	O
whether	O
or	O
not	O
data	O
were	O
missing	O
completely	O
at	O
random	O
.	O

However	O
,	O
the	O
exact	O
association	O
between	O
single	O
cord	O
-	O
serum	O
vitamin	O
D	O
level	O
and	O
postnatal	O
immunity	O
is	O
unclear	O
.	O

Since	O
the	O
exogenous	O
desmopressin	O
is	O
deaminated	O
at	O
the	O
N	O
-	O
terminus	O
,	O
it	O
can	O
escape	O
the	O
degrading	O
effect	O
of	O
the	O
vasopressinase	O
and	O
is	O
considered	O
the	O
treatment	O
of	O
choice	O
in	O
patients	O
with	O
gestational	O
diabetes	O
insipidus	O
as	O
demonstrated	O
by	O
Schrier	O
[	O
4	O
].	O

Conclusions	O
Our	O
data	O
indicate	O
that	O
maternal	O
diet	O
influences	O
the	O
infant	O
gut	O
microbiome	O
and	O
that	O
these	O
effects	O
differ	O
by	O
delivery	O
mode	O
.	O

2	O
.	O
9	O
.	O

PCOS	O
is	O
very	O
heterogonous	O
and	O
it	O
is	O
often	B
impossible	O
to	O
determine	O
the	O
cause	O
-	O
effect	O
relation	O
between	O
clinical	O
symptoms	O
and	O
biochemical	O
disorders	O
[	O
24	O
].	O

In	O
addition	O
,	O
follow	O
-	O
up	O
studies	O
have	O
shown	O
no	O
significant	O
increase	O
in	O
risk	O
.	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

Although	O
most	O
drugs	O
do	O
not	O
harm	O
the	O
fetus	O
,	O
this	O
knowledge	O
is	O
incomplete	O
.	O

Since	B
there	O
were	O
few	O
adverse	O
events	O
being	O
reported	O
,	O
chloral	O
hydrate	O
has	O
been	O
the	O
preferred	B
medication	O
for	O
infant	O
lung	O
function	O
tests	O
for	O
over	O
20	O
years	O
at	O
US	O
and	O
Europe	O
[	O
21	O
].	O

Participants	O
in	O
the	O
two	O
treatment	O
arms	O
had	O
similar	O
baseline	O
measures	O
,	O
including	O
demographics	O
,	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
station	O
,	O
wealth	O
measures	O
,	O
and	O
number	O
of	O
years	O
of	O
education	O
for	O
the	O
mother	O
(	O
Table	O
1	O
).	O

Furthermore	O
,	O
this	O
study	O
was	O
conducted	O
in	O
Hamilton	O
County	O
,	O
Ohio	O
,	O
an	O
area	O
with	O
worse	O
perinatal	O
outcomes	O
than	O
national	O
averages	O
,	O
including	O
higher	O
infant	O
mortality	O
,	O
preterm	O
birth	O
and	O
low	O
birth	O
weight	O
rates	O
,	O
as	O
well	O
as	O
considerable	O
racial	O
disparities	O
in	O
infant	O
mortality	O
and	O
perinatal	O
outcomes	O
.	O
34All	O
of	O
cord	O
blood	O
samples	O
were	O
collected	O
over	O
one	O
winter	O
season	O
,	O
thus	B
negating	O
seasonal	O
variations	O
in	O
vitamin	O
D	O
levels	O
that	O
may	O
have	O
been	O
seen	O
in	O
other	O
studies	O
.	O

Implement	O
•	O
Use	O
evidence	O
-	O
based	O
standards	O
to	O
prevent	O
or	O
treat	O
preterm	O
births	O
;	O
implement	O
training	O
;	O
and	O
update	O
curricula	O
with	O
evidence	O
-	O
based	O
interventions	O
.	O

Functional	O
and	O
developmental	O
kidney	O
measurements	O
were	O
taken	O
.	O

Infant	O
stool	O
samples	O
were	O
collected	O
from	O
145	O
infants	O
,	O
and	O
maternal	O
prenatal	O
diet	O
was	O
assessed	O
using	O
a	O
food	O
frequency	O
questionnaire	O
.	O

In	O
addition	O
,	O
we	O
lacked	O
specific	O
information	O
regarding	O
the	O
timing	O
of	O
antenatal	O
supplements	O
or	O
health	O
complications	O
during	O
pregnancy	O
,	O
and	O
the	O
literature	O
shows	O
that	O
the	O
timing	O
of	O
these	O
events	O
with	O
respect	O
to	O
trimester	O
of	O
gestation	O
could	O
be	O
associated	O
with	O
birth	O
outcomes	O
[	O
51	O
],[	O
52	O
].	O

Inclusion	O
criteria	O
were	O
being	O
a	O
resident	O
of	O
the	O
Department	O
of	O
Managua	O
and	O
having	O
a	O
singleton	O
birth	O
.	O

The	O
meagre	O
body	O
of	O
literature	O
regarding	O
pregnancy	O
outcomes	O
following	O
the	O
maternal	O
use	O
of	O
SGAs	O
has	O
produced	O
conflicting	O
findings	O
,	O
which	O
may	O
be	O
attributed	O
to	O
the	O
different	O
methodologies	O
and	O
inadequate	O
control	O
for	O
confounding	O
variables	O
.	O
15A	O
number	O
of	O
studies	O
have	O
found	O
that	O
exposure	O
to	O
SGAs	O
is	O
associated	O
with	O
a	O
significantly	O
increased	O
risk	O
of	O
low	O
birth	O
weight16	O
–	O
18and	O
small	O
for	O
gestational	O
age	O
infants	O
,	O
in	O
comparison	O
to	O
healthy	O
controls	O
.	O
17Conversely	O
,	O
Lin	O
et	O
al	O
17found	O
that	O
the	O
risk	O
of	O
low	O
birth	O
weight	O
,	O
preterm	O
births	O
and	O
small	O
/	O
large	O
for	O
gestational	O
age	O
(	O
LGA	O
)	O
infants	O
did	O
not	O
differ	O
between	O
women	O
with	O
schizophrenia	O
receiving	O
SGAs	O
and	O
those	O
with	O
the	O
disorder	O
who	O
did	O
not	O
use	O
an	O
antipsychotic	O
drug	O
.	O

2011	O
).	O

[	O
8	O
]	O
The	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
,	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D3	O
)	O
has	O
well	B
-	I
established	I
effects	O
on	O
bone	O
metabolism	O
and	O
mineral	O
homeostasis	O
.	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
early	O
life	O
bone	O
mineral	O
content	O
(	O
BMC	O
)	O
and	O
the	O
effects	O
of	O
three	O
months	O
of	O
vitamin	O
D	O
supplementation	O
in	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
(	O
henceforth	O
,	O
"	O
Caucasian	O
")	O
infants	O
on	O
vitamin	O
D	O
levels	O
.	O

The	O
selection	O
of	O
covariates	O
included	O
in	O
the	O
final	O
multivariate	O
models	O
was	O
based	O
on	O
proportional	O
(≥	O
10	O
%)	O
change	O
in	O
β	O
-	O
coefficients	O
and	O
previous	O
subject	O
matter	O
knowledge	O
.	O

We	O
have	O
shown	O
that	O
a	O
quarterly	O
100	O
000	O
IU	O
supplementation	O
of	O
vitamin	O
D3did	O
not	O
reduce	O
the	O
incidence	O
of	O
pneumonias	O
in	O
children	O
living	O
in	O
regions	O
with	O
high	O
vitamin	O
D	O
deficiency	O
.	O

One	O
powerful	O
early	O
life	O
exposure	O
is	O
maternal	O
obesity	O
during	O
pregnancy	O
.	O

However	O
,	O
due	O
to	O
a	O
wide	O
range	O
of	O
nutrient	O
interactions	O
,	O
maternal	O
dietary	O
patterns	O
should	O
be	O
explored	O
to	O
achieve	O
the	O
association	O
between	O
maternal	O
nutrition	O
and	O
fetal	O
growth	O
.	O

Differences	O
in	O
the	O
definition	O
of	O
atopy	O
,	O
a	O
lack	O
of	O
objective	O
measures	O
of	O
atopy	O
,	O
residual	O
confounding	O
,	O
and	O
bias	O
(	O
e	O
.	O
g	O
.,	O
detection	O
,	O
selection	O
,	O
interview	O
,	O
recall	O
)	O
are	O
important	O
to	O
consider	O
when	O
interpreting	O
the	O
above	O
studies	O
[	O
92	O
,	O
121	O
].	O

,	O
39who	O
found	O
that	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
was	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
in	O
white	O
but	O
not	O
black	O
women	O
.	O

to	O
expand	O
the	O
delivery	O
of	O
services	O
in	O
selected	O
districts	O
of	O
some	O
of	O
the	O
states	O
of	O
the	O
country	O
)	O
(	O
1	O
).	O

The	O
latter	O
were	O
subdivided	O
into	O
three	O
categories	O
according	O
to	O
current	O
recommendations	O
:	O
≤	O
4	O
visits	O
(	O
inadequate	O
),	O
5	O
–	O
9	O
visits	O
(	O
intermediate	O
),	O
≥	O
10	O
visits	O
(	O
adequate	O
)	O
[	O
14	O
];	O
•	O
Components	O
of	O
prenatal	O
care	O
:	O
advice	O
given	O
on	O
breastfeeding	O
and	O
diet	O
(	O
yes	O
/	O
no	O
answers	O
);	O
•	O
Use	O
of	O
oral	O
supplements	O
:	O
including	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamins	O
(	O
yes	O
/	O
no	O
answers	O
to	O
each	O
),	O
and	O
the	O
trade	O
names	O
of	O
supplements	O
used	O
.	O

BMI	O
of	O
boys	O
was	O
correlated	O
with	O
that	O
of	O
the	O
MGM	O
at	O
two	O
points	O
but	O
was	O
not	O
correlated	O
with	O
that	O
of	O
the	O
PGM	O
.	O

Notably	O
,	O
at	O
stage	O
1	O
dpn	O
no	O
regulation	O
of	O
a	O
distinct	O
pathway	O
was	O
found	O
in	O
LP	O
offspring	O
.	O

The	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
higher	O
plasma	O
levels	O
of	O
LDL	O
and	O
glucose	O
as	O
well	O
as	O
a	O
reduction	O
in	O
chocolate	O
and	O
caloric	O
intake	O
at	O
post	O
-	O
weaning	O
periods	O
in	O
the	O
feeding	O
tests	O
.	O

Note	O
that	O
obstetric	O
care	O
would	O
also	O
have	O
an	O
impact	O
,	O
but	O
is	O
not	O
estimated	O
separately	O
Targets	O
for	O
action	O
by	O
2025	O
The	O
Born	O
Too	O
Soon	O
report	O
initiated	O
a	O
process	O
towards	O
achieving	O
goals	O
for	O
preterm	O
birth	O
prevention	O
and	O
presented	O
a	O
new	O
goal	O
for	O
the	O
reduction	O
of	O
deaths	O
due	O
to	O
complications	O
of	O
preterm	O
birth	O
(	O
Figure7	O
)	O
[	O
48	O
].	O

PubMed	O
Central	O
:	O

We	O
only	O
found	O
a	O
difference	O
between	O
RC	O
and	O
CC	O
female	O
offspring	O
at	O
PND	O
20	O
.	O

However	O
,	O
significantly	O
more	O
children	O
receiving	O
vitamin	O
D	O
drops	O
belonged	O
to	O
the	O
caries	O
-	O
free	O
group	O
(	O
14	O
.	O
0	O
%	O
S	O
-	O
ECC	O
(	O
n	O
=	O
6	O
)	O
vs	O
.	O
86	O
.	O
0	O
%	O
caries	O
-	O
free	O
(	O
n	O
=	O
37	O
),	O
p	O
<	O
0	O
.	O
001	O
).	O

Some	O
have	O
proposed	O
that	O
maternal	O
vaccination	O
may	O
also	O
have	O
beneficial	O
effects	O
on	O
birth	O
outcomes	O
.	O

Lastly	O
,	O
we	O
are	O
not	B
suggesting	I
the	O
futility	O
of	O
PNV	O
use	O
in	O
black	O
women	O
.	O

Inform	O
•	O
Support	O
the	O
production	O
,	O
dissemination	O
and	O
use	O
of	O
coverage	O
data	O
for	O
evidence	O
-	O
based	O
interventions	O
through	O
the	O
Countdown	O
to	O
2015	O
and	O
Commission	O
for	O
Information	O
and	O
Accountability	O
through	O
the	O
independent	O
Expert	O
Review	O
Group	O
.	O

Environmental	O
Risk	O
Factors	O
for	O
Atopy	O
The	O
causes	O
of	O
allergy	O
in	O
general	O
and	O
of	O
specific	O
sensitization	O
in	O
newborns	O
in	O
particular	O
have	O
not	O
yet	O
been	O
completely	O
determined	O
.	O

Conclusion	O
:	O
Identification	O
of	O
risk	O
factors	O
(	O
black	O
race	O
,	O
Medicaid	O
status	O
,	O
obesity	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
)	O
can	O
lead	B
to	I
opportunities	O
for	O
targeted	O
prenatal	O
vitamin	O
supplementation	O
to	O
reduce	O
the	O
risk	O
of	O
neonatal	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
status	O
.	O

Other	O
studies	O
show	O
that	O
factors	O
associated	O
with	O
multivitamin	O
supplementation	O
during	O
pregnancy	O
are	O
schooling	O
level	O
[	O
15	O
,	O
40	O
]	O
and	O
age	O
[	O
28	O
].	O

It	O
does	O
appear	O
however	O
that	O
such	O
modification	O
does	O
not	O
reverse	O
the	O
altered	O
tempo	O
of	O
reproductive	O
maturation	O
in	O
programmed	O
offspring	O
.	O

The	O
impact	O
of	O
raising	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
to	O
≥	O
40	O
ng	O
/	O
mL	O
was	O
assessed	O
by	O
comparing	O
PTB	O
rates	O
for	O
women	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
vs	O
.	O
those	O
who	O
did	O
not	O
among	O
women	O
with	O
low	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
40	O
ng	O
/	O
mL	O
)	O
on	O
their	O
first	O
test	O
.	O

For	O
patients	O
with	O
advanced	O
disease	O
,	O
ultrasound	O
control	O
of	O
tissue	O
growth	O
can	O
help	O
in	O
therapeutic	O
decisions	O
,	O
such	O
as	O
timing	O
of	O
surgery	O
.	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

The	O
assertion	O
that	O
autism	O
patients	O
engage	O
in	O
repetitive	O
,	O
behavioral	O
patterns	O
has	O
arguably	O
become	O
stereotyped	O
.	O

A	O
rise	O
in	O
Nampt	O
leads	O
to	O
higher	O
concentrations	O
of	O
NAD	O
+	O
and	O
higher	O
activity	O
of	O
SIRT1	O
.	O

DNA	O
methylation	O
involves	O
the	O
addition	O
of	O
a	O
methyl	O
group	O
,	O
primarily	O
to	O
the	O
C5	O
of	O
cytosine	O
within	O
cytosine	O
–	O
phosphate	O
–	O
guanine	O
dinucelotides	O
(	O
CpGs	O
)	O
to	O
produce	O
5	O
-	O
methylcytosine	O
(	O
5mC	O
).	O

The	O
smoking	O
evidence	O
is	O
particularly	O
compelling	O
as	B
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	O
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

There	O
was	O
no	O
significant	O
effect	O
of	O
birth	O
hospital	O
on	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
when	O
ethnicity	O
was	O
accounted	O
for	O
by	O
covariate	O
analysis	O
(	O
p	O
=	O
0	O
.	O
37	O
).	O

Bodnar	O
et	O
al	O
.	O

In	O
an	O
additional	O
analysis	O
of	O
the	O
association	O
between	O
alcohol	O
intake	O
and	O
psychotic	O
-	O
like	O
symptoms	O
,	O
we	O
categorized	O
women	O
into	O
never	O
drinkers	O
or	O
drinkers	O
,	O
and	O
used	O
drinkers	O
as	O
the	O
reference	O
category	O
.	O

Infant	O
morbidity	O
Infant	O
morbidity	O
assessment	O
is	O
performed	O
at	O
each	O
postnatal	O
visit	O
by	O
a	O
medical	O
doctor	O
with	O
a	O
structured	O
questionnaire	O
.	O

3	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
BMI	O
correlations	O
from	O
a	O
mixed	O
model	O
between	O
the	O
child	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
membersGroupChildMotherFatherMGMMGFPGMPGFChild	O
'	O
s	O
age	O
01	O
.	O
0000	O
.	O
1470	O
.	O
0580	O
.	O
1410	O
.	O
0940	O
.	O
1570	O
.	O
062p	O
Value0	O
.	O
001	O
*	O
0	O
.	O
2460	O
.	O
031	O
*	O
0	O
.	O
2860	O
.	O
0580	O
.	O
360Child	O
'	O
s	O
age	O
5	O
0	O
.	O
1500	O
.	O
1630	O
.	O
1380	O
.	O
1130	O
.	O
1120	O
.	O
015p	O
Value0	O
.	O
0007	O
*	O
0	O
.	O
002	O
*	O
0	O
.	O
024	O
*	O
0	O
.	O
2000	O
.	O
1450	O
.	O
891Child	O
'	O
s	O
age	O
9	O
0	O
.	O
2790	O
.	O
0660	O
.	O
3280	O
.	O
2310	O
.	O
114	O
−	O
0	O
.	O
041p	O
Value	O
<	O
0	O
.	O
0001	O
*	O
0	O
.	O
352	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
033	O
*	O
0	O
.	O
3340	O
.	O
797Mother	O
1	O
.	O
0000	O
.	O
0940	O
.	O
2450	O
.	O
070	O
−	O
0	O
.	O
0100	O
.	O
004p	O
Value0	O
.	O
084	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
4770	O
.	O
8920	O
.	O
967Father	O
1	O
.	O
000	O
−	O
0	O
.	O
094	O
−	O
0	O
.	O
1310	O
.	O
2550	O
.	O
072p	O
Value	O
0	O
.	O
1850	O
.	O
1090	O
.	O
006	O
*	O
0	O
.	O
589MGM	O
1	O
.	O
0000	O
.	O
140	O
−	O
0	O
.	O
009	O
−	O
0	O
.	O
018p	O
Value	O
0	O
.	O
047	O
*	O
0	O
.	O
9170	O
.	O
895MGF	O
1	O
.	O
0000	O
−	O
0	O
.	O
139	O
−	O
0	O
.	O
116p	O
Value	O
0	O
.	O
2370	O
.	O
388PGM	O
1	O
.	O
0000	O
.	O
277p	O
Value	O
0	O
.	O
004	O
*	O
PGF	O
1	O
.	O
000	O
BMI	O
correlations	O
between	O
girls	O
and	O
boys	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
members	O
Girl	O
'	O
s	O
age	O
0	O
–	O
0	O
.	O
1120	O
.	O
0560	O
.	O
0930	O
.	O
0250	O
.	O
2470	O
.	O
034p	O
Value0	O
.	O
0850	O
.	O
4060	O
.	O
1970	O
.	O
8250	O
.	O
016	O
*	O
0	O
.	O
788Boy	O
'	O
s	O
age	O
0	O
–	O
0	O
.	O
1690	O
.	O
0540	O
.	O
3360	O
.	O
1840	O
.	O
0490	O
.	O
087p	O
Value0	O
.	O
005	O
*	O
0	O
.	O
4580	O
.	O
003	O
*	O
0	O
.	O
1270	O
.	O
6730	O
.	O
323Girl	O
'	O
s	O
age	O
5	O
–	O
0	O
.	O
0630	O
.	O
1750	O
.	O
1330	O
.	O
1320	O
.	O
2770	O
.	O
140p	O
Value0	O
.	O
3040	O
.	O
013	O
*	O
0	O
.	O
0640	O
.	O
2700	O
.	O
012	O
*	O
0	O
.	O
254Boy	O
'	O
s	O
age	O
5	O
–	O
0	O
.	O
2300	O
.	O
1240	O
.	O
1720	O
.	O
049	O
−	O
0	O
.	O
041	O
−	O
0	O
.	O
224p	O
Value0	O
.	O
0002	O
*	O
0	O
.	O
1070	O
.	O
1140	O
.	O
7040	O
.	O
6980	O
.	O
265Girl	O
'	O
s	O
age	O
9	O
–	O
0	O
.	O
2480	O
.	O
0190	O
.	O
2620	O
.	O
2280	O
.	O
018	O
−	O
0	O
.	O
089p	O
Value0	O
.	O
012	O
*	O
0	O
.	O
8250	O
.	O
019	O
*	O
0	O
.	O
1340	O
.	O
9140	O
.	O
624Boy	O
'	O
s	O
age	O
9	O
–	O
0	O
.	O
2580	O
.	O
1810	O
.	O
5160	O
.	O
3210	O
.	O
1470	O
.	O
538p	O
Value0	O
.	O
012	O
*	O
0	O
.	O
077	O
<	O
0	O
.	O
0001	O
*	O
0	O
.	O
006	O
*	O
0	O
.	O
3030	O
.	O
0001	O
*	O
*	O
Significant	O
findings	O
.	O

In	O
life	O
history	O
terms	O
,	O
the	O
trade	O
-	O
off	O
for	O
those	O
born	O
to	O
dams	O
undernourished	O
during	O
pregnancy	O
may	O
be	O
an	O
earlier	O
maturation	O
but	O
a	O
faster	O
decline	O
in	O
ovarian	O
function	O
with	O
aging	O
,	O
associated	O
with	O
significantly	O
reduced	O
adult	O
progesterone	O
levels	O
.	O

SGA	O
was	O
defined	B
as	O
weight	O
<	O
10	O
%	O
for	O
gestational	O
age	O
according	O
to	O
the	O
Fenton	O
growth	O
chart25and	O
the	O
WHO	O
growth	O
chart	O
(	O
for	O
infants	O
of	O
⩾	O
37	O
weeks	O
).	O
26All	O
information	O
was	O
deidentified	O
and	O
entered	O
into	O
a	O
REDCap	O
database	O
.	O
27	O
Cord	O
blood	O
sample	O
analysis	O
Cord	O
blood	O
samples	O
were	O
spun	O
and	O
the	O
serum	O
was	O
frozen	O
at	O
−	O
80	O
°	O
C	O
.	O

Conclusions	O
:	O
The	O
single	O
300	O
,	O
000	O
IM	O
dose	O
of	O
vitamin	O
D	O
is	O
regarded	B
as	B
an	O
effective	O
and	O
safe	O
to	O
promptly	O
improve	O
vitamin	O
D	O
status	O
in	O
GDM	O
.	O

Subungual	O
exostosis	O
usually	O
presents	O
as	O
a	O
growth	O
under	O
the	O
nail	O
,	O
causing	O
onycholysis	O
.	O

For	O
SGA	O
,	O
appropriate	O
for	O
gestational	O
age	O
and	O
large	O
for	O
gestational	O
age	O
were	O
combined	O
as	O
reference	O
.	O

We	O
also	O
did	O
not	O
find	O
any	O
significant	O
relationship	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
values	O
and	O
growth	O
outcomes	O
.	O

After	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
women	O
who	O
reported	O
sleeping	O
≤	O
4	O
hours	O
per	O
night	O
during	O
early	O
pregnancy	O
had	O
a	O
5	O
.	O
56	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
as	O
compared	O
with	O
those	O
women	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
(	O
the	O
reference	O
group	O
)	O
(	O
RR	O
=	O
5	O
.	O
56	O
;	O
95	O
%	O
CI	O
1	O
.	O
31	O
-	O
23	O
.	O
69	O
).	O

Murphy	O
et	O
al	O
.	O

There	O
was	O
again	O
a	O
strong	O
correlation	O
of	O
the	O
child	O
with	O
the	O
mother	O
,	O
this	O
time	O
being	O
similar	O
for	O
boys	O
and	O
girls	O
(	O
table	O
4	O
).	O

The	O
software	O
assembled	O
a	O
genetic	O
map	O
from	O
the	O
SNP	O
data	O
using	O
the	O
settings	O
of	O
binary	O
model	O
,	O
expectation	O
-	O
maximum	O
algorithm	O
,	O
and	O
1000	O
permutations	O
.	O

Conclusions	O
:	O
Genetic	O
variation	O
in	O
DHCR7	O
,	O
which	O
encodes	O
7	O
-	O
dehyrocholesterol	O
reductase	O
in	O
the	O
epidermal	O
vitamin	O
D	O
biosynthesis	O
pathway	O
,	O
appears	O
to	O
modify	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
.	O
In	O
contrast	O
,	O
the	O
response	O
to	O
antenatal	O
cholecalciferol	O
supplementation	O
was	O
associated	O
with	O
SNPs	O
in	O
CYP2R1	O
,	O
which	O
may	O
alter	O
25	O
-	O
hydroxylase	O
activity	O
,	O
and	O
GC	O
,	O
which	O
may	O
affect	O
vitamin	O
D	O
binding	O
protein	O
synthesis	O
or	O
metabolite	O
affinity	O
.	O

Funding	O
Wellcome	O
Trust	O
and	O
British	O
Council	O
.	O

We	O
have	O
investigated	O
whether	O
a	O
high	O
intake	O
of	O
free	O
sugar	O
in	O
pregnancy	O
is	O
associated	O
with	O
adverse	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
large	O
population	O
-	O
based	O
UK	O
birth	O
cohort	O
.	O

LOD	O
scores	O
above	O
the	O
threshold	O
line	O
were	O
considered	O
significant	O
.	O

Those	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
those	O
with	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
38	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
23	O
–	O
0	O
.	O
63	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
AAR	O
=	O
11	O
.	O
3	O
%;	O
NNT	O
=	O
9	O
)	O
(	O
Table	O
2	O
).	O

The	O
vast	O
majority	O
of	O
mothers	O
reported	O
prenatal	O
vitamin	O
use	O
;	O
only	O
three	O
subjects	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

In	O
addition	O
,	O
the	O
urine	O
urea	O
(+	O
433	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
creatinine	O
(+	O
175	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
values	O
were	O
significantly	O
higher	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
.	O

We	O
identified	O
147	O
rodent	O
studies	O
within	O
PubMed	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
demonstrating	O
both	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
reduced	O
fertility	O
,	O
reproductive	O
,	O
developmental	O
or	O
other	O
organ	O
-	O
specific	O
abnormalities	O
,	O
or	O
adult	O
onset	O
diseases	O
(	O
cancer	O
,	O
diabetes	O
,	O
obesity	O
or	O
immune	O
disorders	O
))	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
histone	O
modification	O
,	O
DNA	O
methylation	O
,	O
epigenetic	O
machinery	O
or	O
miRNAs	O
)	O
following	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
chemicals	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
,	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
lactation	O
,	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
).	O

Protein	O
expression	O
was	O
detected	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
using	O
an	O
ECL	O
(	O
enhanced	O
chemiluminescence	O
)	O
detection	O
system	O
(	O
Amersham	O
Biosciences	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Frequency	O
of	O
sequence	O
features	O
associated	O
with	O
RPMM	O
class	O
CpG	O
loci	O
:	O
percentage	O
of	O
CpG	O
loci	O
found	O
in	O
LINE	O
-	O
1	O
(	O
A	O
),	O
LINE	O
-	O
2	O
(	O
B	O
),	O
Alu	O
(	O
C	O
),	O
and	O
MIR	O
(	O
D	O
),	O
within	O
a	O
CGI	O
(	O
E	O
),	O
or	O
having	O
the	O
associated	O
gene	O
considered	O
a	O
PcG	O
protein	O
target	O
gene	O
(	O
F	O
).	O

Currently	O
,	O
there	O
are	O
no	O
routine	O
data	O
available	O
for	O
many	O
of	O
the	O
interventions	O
for	O
preterm	O
birth	O
prevention	O
and	O
care	O
.	O

25OHD	O
and	O
glucose	O
homeostasis	O
Within	O
our	O
cohort	O
,	O
early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
was	O
associated	O
with	O
significantly	O
higher	O
fasting	O
glucose	O
at	O
28	O
weeks	O
’	O
gestation	O
,	O
independent	O
of	O
season	O
and	O
potential	O
confounders	O
.	O

(	O
B	O
)	O
Skm1	O
mice	O
show	O
kyphotic	O
spines	O
and	O
kinked	O
tails	O
(	O
left	O
)	O
and	O
elongated	O
bodies	O
(	O
right	O
).	O

At	O
28	O
dpn	O
and	O
188	O
dpn	O
of	O
age	O
,	O
pigs	O
were	O
weighed	O
after	O
an	O
overnight	O
fast	O
and	O
killed	O
by	O
electronarcosis	O
followed	O
by	O
exsanguination	O
in	O
the	O
experimental	O
slaughterhouse	O
of	O
FBN	O
.	O

This	O
sensitivity	O
could	O
be	O
one	O
mechanism	O
linking	O
maternal	O
stress	O
to	O
fetal	O
development	O
.	O

The	O
results	O
for	O
omega	O
-	O
3	O
fatty	O
acid	O
and	O
marine	O
fatty	O
acids	O
(	O
EPA	O
,	O
DHA	O
)	O
had	O
a	O
similar	O
pattern	O
,	O
indicating	O
a	O
reduced	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
among	O
women	O
with	O
intermediate	O
levels	O
of	O
intake	O
.	O

The	O
fact	O
that	O
it	O
may	O
cause	O
epigenetic	O
toxicity	O
in	O
any	O
generation	O
makes	O
it	O
relevant	O
to	O
public	O
health	O
.	O

More	O
information	O
is	O
urgently	O
needed	O
from	O
both	O
providers	O
and	O
patients	O
on	O
the	O
reasons	B
for	O
these	O
shifts	O
in	O
clinical	O
practice	O
and	O
how	O
to	O
promote	O
more	O
conservative	O
obstetric	O
management	O
.	O

In	O
summary	O
,	O
available	O
data	O
support	O
the	O
notion	O
that	O
habitual	O
snoring	O
may	O
be	O
a	O
risk	O
factor	O
for	O
abnormal	O
glucose	O
metabolism	O
.	O

In	O
keeping	O
with	O
prior	O
studies	O
that	O
sought	O
to	O
assess	O
the	O
extent	O
to	O
which	O
adiposity	O
modified	O
associations	O
between	O
sleep	O
disorders	O
and	O
abnormal	O
carbohydrate	O
metabolism	O
[	O
1	O
,	O
2	O
,	O
4	O
,	O
5	O
,	O
18	O
],	O
we	O
also	O
evaluated	O
the	O
joint	O
effect	O
of	O
pre	O
-	O
pregnancy	O
overweight	O
status	O
and	O
snoring	O
on	O
GDM	O
risk	O
.	O

The	O
association	O
of	O
autism	O
prevalence	O
and	O
the	O
mean	O
annual	O
precipitation	O
received	O
by	O
a	O
county	O
between	O
1987	O
and	O
2001	O
was	O
positive	O
and	O
significant	O
(	O
p	O
=	O
0	O
.	O
0034	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
0018	O
–	O
0	O
.	O
0050	O
).	O

Limitations	O
of	O
this	O
study	O
include	O
the	O
cohort	O
size	O
and	O
an	O
unequal	O
distribution	O
of	O
subjects	O
within	O
age	O
groups	O
.	O

nutritional	O
supply	O
.	O

It	O
is	O
important	O
to	O
note	O
the	O
number	O
methodological	O
limitations	O
in	O
research	O
on	O
diet	O
and	O
infant	O
neurodevelopment	O
that	O
are	O
present	O
in	O
these	O
studies	O
.	O

Overall	O
,	O
severe	O
temperature	O
stress	O
may	O
have	O
significant	O
negative	O
effects	O
on	O
animal	O
production	O
,	O
including	O
growth	O
performance	O
and	O
product	O
quality	O
,	O
although	O
mild	O
temperature	O
stress	O
may	O
differentially	O
affect	O
production	O
.	O

Implications	O
for	O
research	O
and	O
practice	O
are	O
also	O
discussed	O
.	O

A	O
significant	O
interaction	O
was	O
detected	O
between	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
genotype	O
and	O
vitamin	O
A	O
supplementation	O
for	O
IMF	O
content	O
in	O
the	O
LM	O
.	O

For	O
children	O
aged	O
24	O
to	O
47	O
months	O
,	O
only	O
maternal	O
prepregnancy	O
obesity	O
had	O
a	O
significant	O
effect	O
;	O
for	O
children	O
aged	O
48	O
to	O
71	O
months	O
,	O
either	O
maternal	O
prepregnancy	O
overweight	O
or	O
obesity	O
increased	O
risk	O
;	O
and	O
in	O
children	O
aged	O
72	O
to	O
95	O
months	O
,	O
maternal	O
overweight	O
or	O
obesity	O
imparted	O
an	O
even	O
higher	O
risk	O
(	O
21	O
,	O
22	O
).	O

Further	O
studies	O
are	O
needed	O
to	O
better	O
elucidate	O
the	O
role	O
of	O
dietary	O
factors	O
and	O
specific	O
nutrients	O
in	O
the	O
risk	O
for	O
this	O
disease	O
.	O

According	O
to	O
this	O
,	O
AM251	O
was	O
specifically	O
able	O
to	O
reduce	O
chocolate	O
intake	O
in	O
CC	O
male	O
offspring	O
,	O
but	O
not	O
in	O
CC	O
females	O
or	O
RC	O
males	O
.	O

The	O
predominant	O
topics	O
discussed	O
during	O
health	O
talks	O
were	O
hygiene	O
and	O
nutrition	O
.	O

The	O
associations	O
of	O
greater	O
magnitude	O
present	O
in	O
male	O
infants	O
correspond	O
with	O
previously	O
published	O
studies	O
[	O
24	O
].	O

Diagnosis	O
of	O
Allergy	O
During	O
Pregnancy	O
The	O
diagnosis	O
of	O
allergy	O
in	O
pregnant	O
women	O
should	O
focus	O
on	O
a	O
detailed	O
medical	O
history	O
and	O
symptom	O
analysis	O
.	O

Histologically	O
in	O
AAOC	O
the	O
diffuse	O
capillary	O
formations	O
have	O
spicules	O
of	O
woven	O
bones	O
dispersed	O
.	O

One	O
approach	O
is	O
to	O
consider	O
serum	O
testing	O
in	O
patients	O
at	O
high	O
risk	O
for	O
vitamin	O
D	O
deficiency	O
but	O
treating	O
without	O
testing	O
those	O
at	O
lower	O
risk	O
.	O

Initially	O
,	O
the	O
Field	O
Implementers	O
will	O
enter	O
all	O
the	O
required	O
registration	O
information	O
of	O
the	O
woman	O
into	O
the	O
system	O
.	O

Hyperplasia	O
of	O
the	O
rete	O
testis	O
and	O
Müllerian	O
duct	O
structures	O
were	O
found	O
in	O
many	O
of	O
the	O
DES	O
-	O
treated	O
male	O
mice	O
,	O
as	O
was	O
a	O
low	O
but	O
significant	O
number	O
of	O
reproductive	O
tract	O
neoplasms	O
.	O

(	O
2014	O
)*	O
Smoking	O
:	O
Cigarette	O
smokeMouse	O
RatInhalation	O
(	O
exposure	O
chamber	O
)	O
(	O
1	O
–	O
2	O
h	O
/	O
d	O
,	O
1	O
h	O
/	O
2	O
d	O
or	O
8	O
–	O
10	O
cigarettes	O
/	O
d	O
)	O
Combinations	O
of	O
:	O
Neonatal	O
Adolescence	O
Early	O
adulthoodAdolescence	O
AdulthoodPulmonary	O
inflammation	O
and	O
abnormalitiesHistone	O
modification	O
miRNAsHalappanavar	O
et	O
al	O
.	O

Discussion	O
Despite	O
the	O
fact	O
that	O
more	O
than	O
60	O
%	O
of	O
the	O
pregnant	O
women	O
reported	O
taking	O
multivitamins	O
containing	O
vitamin	O
D	O
during	O
pregnancy	O
,	O
nearly	O
45	O
%	O
of	O
the	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
).	O

In	O
two	O
separate	O
studies	O
,	O
early	O
-	O
weaned	O
steers	O
(	O
weaned	O
at	O
177	O
d	O
[	O
study	O
1	O
]	O
and	O
158	O
d	O
[	O
study	O
2	O
]	O
of	O
age	O
and	O
placed	O
on	O
a	O
finishing	O
diet	O
)	O
increased	O
MS	O
and	O
body	O
weight	O
gain	O
,	O
improved	O
feed	O
efficiency	O
,	O
and	O
improved	O
QG	O
of	O
the	O
beef	O
compared	O
with	O
normally	O
weaned	O
steers	O
or	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
[	O
51	O
].	O

These	O
clinically	O
relevant	B
cut	O
points	O
(	O
20	O
ng	O
/	O
mL	O
from	O
the	O
Institute	O
of	O
Medicine	O
guidelines	B
[	O
16	O
],	O
30	O
ng	O
/	O
mL	O
from	O
the	O
Endocrine	O
Society	O
Clinical	O
Practice	O
Guideline	B
[	O
17	O
],	O
and	O
40	O
ng	O
/	O
mL	O
from	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
found	O
to	O
achieve	O
maximal	O
production	O
of	O
the	O
active	O
hormone	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
[	O
13	O
])	O
are	O
similar	O
to	O
quartiles	O
based	O
on	O
the	O
distribution	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(	O
21	O
,	O
31	O
and	O
41	O
ng	O
/	O
mL	O
).	O

Furthermore	O
,	O
the	O
high	O
frequency	O
of	O
gastrointestinal	O
side	O
effects	O
experienced	O
by	O
people	O
with	O
type	O
2	O
diabetes	O
suggests	O
that	O
any	O
future	O
role	O
of	O
acarbose	O
,	O
even	O
if	O
subsequent	O
studies	O
confirm	O
safety	O
,	O
will	O
be	O
limited	O
.	O

An	O
increase	O
in	O
C	O
-	O
reactive	O
protein	O
indicates	O
inflammation	O
,	O
which	O
is	O
common	O
in	O
infection	O
.	O

In	B
general	I
,	O
screening	O
for	O
GDM	O
depends	O
on	O
a	O
presence	O
of	O
risk	O
factors	O
according	O
to	O
national	O
recommendations	B
[	O
19	O
]	O
and	O
based	O
on	O
these	O
,	O
OGTT	O
was	O
performed	O
on	O
490	O
(	O
54	O
.	O
5	O
%)	O
of	O
the	O
participating	O
mothers	O
.	O

However	O
,	O
the	O
neonatal	O
mortality	O
analyses	O
were	O
post	O
-	O
hoc	O
analyses	O
,	O
and	O
the	O
sample	O
size	O
was	O
small	O
resulting	O
in	O
poor	O
precision	O
in	O
the	O
effect	O
estimates	O
,	O
and	O
reduced	O
power	O
to	O
explore	O
all	O
the	O
factors	O
modifying	O
the	O
effects	O
on	O
neonatal	O
mortality	O
.	O

3	O
.	O
4	O
.	O
3	O
.	O

A	O
sufficient	O
supply	O
of	O
vitamin	O
D	O
to	O
the	O
breast	O
fed	O
infant	O
is	O
achieved	O
only	O
by	O
increasing	O
the	O
maternal	O
supplementation	O
up	O
to	O
2000	O
IU	O
/	O
day	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
research	O
council	O
(	O
research	O
project	O
number	O
:	O
193053	O
)	O
and	O
ethics	O
committee	O
(	O
research	O
ethics	O
number	O
:	O
IR	O
.	O
MUI	O
.	O
REC193053	O
).	O

The	O
reported	O
adherence	O
rates	O
to	O
folic	O
acid	O
intake	O
in	O
other	O
countries	O
vary	O
depending	O
on	O
concomitant	O
recommendations	O
for	O
cereal	O
fortification	O
and	O
on	O
the	O
period	O
analysed	O
–	O
pre	O
-	O
or	O
peri	O
-	O
conception	O
.	O

Improve	O
adherence	O
and	O
monitor	O
compliance	O
To	O
improve	O
adherence	O
,	O
a	O
local	O
pharmaceutical	O
company	O
(	O
Eskayef	O
Bangladesh	O
Limited	O
)	O
will	O
produce	O
IFA	O
supplements	O
in	O
an	O
attractive	O
capsule	O
shell	O
and	O
special	O
blister	O
package	O
.	O

There	O
are	O
an	O
estimated	O
22	O
.	O
2	O
m	O
women	O
of	O
reproductive	O
age	O
(	O
15	O
–	O
44	O
)	O
in	O
Viet	O
Nam	O
out	O
of	O
a	O
working	O
-	O
age	O
population	O
(	O
15	O
–	O
64	O
)	O
of	O
60	O
.	O
6	O
m	O
(	O
and	O
total	O
population	O
89	O
m	O
)[	O
17	O
].	O

Majority	O
of	O
the	O
positive	O
cultures	O
showed	O
growth	O
for	O
Staphylococcus	O
aureus	O
,	O
except	O
for	O
one	O
was	O
Moraxella	O
catarrhalis	O
.	O

3	O
.	O

Additionally	O
,	O
using	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
is	O
a	O
better	B
indicator	O
of	O
vitamin	O
D	O
status	O
and	O
statistically	O
more	O
powerful	O
than	O
using	O
reported	O
intake	O
because	B
it	O
accounts	O
for	O
all	O
vitamin	O
D	O
input	O
sources	O
(	O
sun	O
exposure	O
,	O
food	O
,	O
and	O
supplements	O
)	O
and	O
makes	O
provision	O
for	O
inter	O
-	O
individual	O
variability	O
in	O
vitamin	O
D	O
dose	O
response	O
.	O

Studies	O
falling	O
into	O
category	O
3	O
provide	O
more	O
comprehensive	O
mechanistic	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
and	O
are	O
shown	O
inTable	O
1	O
.	O

In	O
contrast	O
,	O
Newham	O
et	O
al	O
19found	O
that	O
neonates	O
exposed	O
to	O
SGAs	O
(	O
n	O
=	O
25	O
)	O
were	O
significantly	O
more	O
likely	B
to	O
be	O
LGA	O
compared	O
with	O
healthy	O
controls	O
.	O

BMP	O
-	O
7	O
can	O
also	O
affect	O
energy	O
homeostasis	O
by	O
acting	O
on	O
mature	O
brown	O
adipocytes	O
,	O
resulting	O
in	O
the	O
induction	O
of	O
UCP1	O
,	O
thereby	O
enhancing	O
thermogenesis	O
.	O

Women	O
with	O
T3	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
and	O
30	O
–	O
50	O
nmol	O
/	O
L	O
had	O
lower	O
OR	O
for	O
LBW	O
(	O
OR	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
046	O
and	O
OR	O
=	O
0	O
.	O
07	O
,	O
p	O
=	O
0	O
.	O
017	O
,	O
respectively	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
.	O

None	O
of	O
the	O
term	O
or	O
preterm	O
women	O
were	O
administered	O
any	O
antidepressants	O
or	O
synthetic	O
glucocorticoids	O
during	O
pregnancy	O
.	O

T1	O
25OHD	O
was	O
also	O
investigated	O
as	O
a	O
continuous	O
variable	O
as	O
there	O
were	O
few	O
cases	O
in	O
some	O
categories	O
.	O

Due	O
to	O
this	O
heterogeneity	O
a	O
qualitative	O
rather	O
than	O
quantitative	O
approach	O
was	O
deemed	O
appropriate	O
for	O
comparison	O
and	O
presentation	O
of	O
findings	O
.	O

All	O
had	O
come	O
to	O
INPerIER	O
for	O
prenatal	O
care	O
by	O
gestational	O
week	O
20	O
.	O

Given	O
the	O
rarity	O
of	O
some	O
infections	O
and	O
brain	O
tumors	O
,	O
the	O
interpretability	O
of	O
seasonal	O
patterns	O
,	O
or	O
the	O
lack	O
thereof	O
,	O
may	O
be	O
confounded	O
by	O
time	O
-	O
and	O
/	O
or	O
space	O
-	O
dependent	O
factors	O
[	O
126	O
].	O

Whereas	O
future	O
observational	O
epidemiological	O
studies	O
and	O
genetic	O
and	O
molecular	O
investigations	O
will	O
be	O
useful	O
to	O
strengthen	O
and	O
refine	O
the	O
hypothesis	O
,	O
it	O
might	O
be	O
necessary	O
to	O
do	O
a	O
large	O
randomized	O
trial	O
to	O
establish	O
the	O
safety	O
and	O
efficacy	O
needed	O
to	O
promote	O
large	O
-	O
scale	O
vitamin	O
D	O
supplementation	O
.	O

However	O
,	O
it	O
is	O
now	B
becoming	I
clear	I
that	O
pre	O
-	O
conception	O
and	O
postnatal	O
exposures	O
can	O
also	O
be	O
detrimental	O
to	O
future	O
health	O
across	O
multiple	O
generations	O
.	O

Both	O
MS	O
and	O
IMF	O
contents	O
increased	O
with	O
increasing	O
slaughter	O
age	O
(	O
2	O
,	O
4	O
,	O
6	O
,	O
12	O
,	O
and	O
24	O
months	O
)	O
in	O
bulls	O
of	O
German	O
Angus	O
,	O
Galloway	O
,	O
and	O
Holstein	O
-	O
Friesian	O
breeds	O
[	O
24	O
].	O

Prepregnancy	O
BMI	O
,	O
GWG	O
,	O
and	O
parity	O
had	O
independent	O
effects	O
on	O
birth	O
size	O
(	O
Table2and	O
Fig	O
.	O
2	O
).	O

It	O
is	O
responsible	B
for	O
the	O
stimulation	O
of	O
primary	O
follicles	O
in	O
the	O
ovaries	O
and	O
their	O
susceptibility	O
to	O
FSH	O
.	O

(	O
2016	O
)	O
examined	O
occupational	O
EDC	O
exposures	O
in	O
a	O
meta	O
-	O
analysis	O
of	O
European	O
birth	O
cohorts	O
and	O
found	O
that	O
pregnant	O
women	O
exposed	O
to	O
more	O
than	O
1	O
EDC	O
class	O
were	O
more	O
likely	B
to	O
have	O
a	O
low	O
birth	O
weight	O
infant	O
[	O
15	O
].	O

The	O
variations	O
of	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
with	O
seasons	O
reflect	O
the	O
changes	O
in	O
UVB	O
exposure	O
,	O
one	O
of	O
the	O
main	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
many	O
European	O
countries	O
.	O

A	O
prospective	O
randomized	O
control	O
trial	O
is	O
necessary	O
to	O
adequately	O
determine	O
the	O
role	O
for	O
male	O
prenatal	O
vitamins	O
.	O

Management	O
of	O
Acute	O
Asthma	O
Treatment	O
of	O
acute	O
asthma	O
is	O
similar	O
to	O
that	O
recommended	O
for	O
nonpregnant	O
patients	O
including	O
inhaled	O
β2agonists	O
,	O
oxygen	O
(	O
essential	O
),	O
and	O
corticosteroids	O
(	O
oral	O
or	O
parenteral	O
)	O
[	O
22	O
].	O

We	O
were	O
unable	O
to	O
assess	O
whether	O
associations	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
in	O
pregnancy	O
and	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
persist	O
beyond	O
the	O
age	O
of	O
7	O
years	O
,	O
as	O
no	O
data	O
on	O
atopy	O
(	O
only	O
data	O
on	O
asthma	O
status	O
)	O
have	O
been	O
collected	O
in	O
ALSPAC	O
children	O
after	O
the	O
age	O
of	O
7	O
years	O
.	O

Methods	O
Study	O
population	O
Subjects	O
for	O
the	O
present	O
study	O
were	O
from	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
(	O
NHBCS	O
)	O
who	O
provided	O
infant	O
stool	O
samples	O
at	O
6	O
-	O
week	O
postpartum	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Participant	O
characteristics	O
and	O
comparison	O
of	O
characteristics	O
between	O
women	O
recruited	O
at	O
the	O
Adelaide	O
and	O
Auckland	O
SCOPE	O
centresAll	O
women	O
(	O
n	O
=	O
2800	O
)	O
Adelaide	O
(	O
n	O
=	O
1156	O
)	O
Auckland	O
(	O
n	O
=	O
1644	O
)	O
P	O
value	O
*	O
Age	O
yrs	O
,	O
mean	O
(	O
SD	O
)	O
28	O
(	O
6	O
)	O
23	O
.	O
73	O
(	O
5	O
.	O
11	O
)	O
30	O
.	O
44	O
(	O
4	O
.	O
82	O
)<	O
0	O
.	O
0001BMI	O
kg	O
/	O
m2	O
,	O
mean	O
(	O
SD	O
)	O
25	O
.	O
8	O
(	O
5	O
.	O
44	O
)	O
27	O
.	O
04	O
(	O
6	O
.	O
56	O
)	O
24	O
.	O
88	O
(	O
4	O
.	O
26	O
)<	O
0	O
.	O
0001Ethnicity	O
<	O
0	O
.	O
0001	O
Caucasian2449	O
(	O
87	O
)	O
1060	O
(	O
92	O
)	O
1389	O
(	O
84	O
)	O
Non	O
Caucasian351	O
(	O
13	O
)	O
96	O
(	O
8	O
)	O
255	O
(	O
16	O
)	O
Smoking	O
status	O
,	O
n	O
(%)<	O
0	O
.	O
0001	O
No2152	O
(	O
77	O
)	O
704	O
(	O
61	O
)	O
1448	O
(	O
88	O
)	O
Quit	O
during	O
pregnancy306	O
(	O
11	O
)	O
175	O
(	O
15	O
)	O
131	O
(	O
8	O
)	O
Smoking342	O
(	O
12	O
)	O
277	O
(	O
24	O
)	O
65	O
(	O
4	O
)	O
Alcohol	O
Consumption	O
,	O
n	O
(%)<	O
0	O
.	O
0001	O
No1480	O
(	O
53	O
)	O
708	O
(	O
61	O
)	O
772	O
(	O
47	O
)	O
Stopped	O
during	O
pregnancy1185	O
(	O
42	O
)	O
397	O
(	O
34	O
)	O
788	O
(	O
48	O
)	O
Consuming	O
alcohol135	O
(	O
5	O
)	O
51	O
(	O
4	O
)	O
84	O
(	O
5	O
)	O
Fruit	O
Intake	O
,	O
n	O
(%)<	O
0	O
.	O
0001	O
≥	O
1x	O
per	O
day2032	O
(	O
73	O
)	O
586	O
(	O
51	O
)	O
1446	O
(	O
88	O
)	O
3	O
-	O
6x	O
per	O
week405	O
(	O
14	O
)	O
272	O
(	O
24	O
)	O
133	O
(	O
8	O
)	O
1	O
-	O
2x	O
per	O
week223	O
(	O
8	O
)	O
181	O
(	O
16	O
)	O
42	O
(	O
3	O
)	O
1	O
-	O
3x	O
per	O
month	O
or	O
less140	O
(	O
5	O
)	O
117	O
(	O
10	O
)	O
23	O
(	O
1	O
)	O
Recreational	O
Walking	O
<	O
0	O
.	O
0001	O
Never428	O
(	O
15	O
)	O
265	O
(	O
23	O
)	O
163	O
(	O
10	O
)	O
1	O
-	O
3	O
times	O
/	O
week1773	O
(	O
63	O
)	O
668	O
(	O
58	O
)	O
1105	O
(	O
68	O
)	O
≥	O
4	O
times	O
/	O
week590	O
(	O
22	O
)	O
221	O
(	O
19	O
)	O
369	O
(	O
23	O
)	O
Time	O
watching	O
TV	O
<	O
0	O
.	O
0001	O
<	O
5	O
hours	O
per	O
day2404	O
(	O
86	O
)	O
901	O
(	O
78	O
)	O
1503	O
(	O
92	O
)	O
≥	O
5	O
hours	O
per	O
day387	O
(	O
14	O
)	O
253	O
(	O
22	O
)	O
134	O
(	O
8	O
)	O
Season	O
serum	O
was	O
sampled0	O
.	O
3213	O
Summer636	O
(	O
23	O
)	O
278	O
(	O
24	O
)	O
358	O
(	O
22	O
)	O
Autumn705	O
(	O
25	O
)	O
273	O
(	O
24	O
)	O
432	O
(	O
26	O
)	O
Winter727	O
(	O
26	O
)	O
300	O
(	O
26	O
)	O
427	O
(	O
26	O
)	O
Spring732	O
(	O
26	O
)	O
305	O
(	O
26	O
)	O
427	O
(	O
26	O
)	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
nmol	O
/	O
L	O
,	O
mean	O
(	O
SD	O
)	O
68	O
.	O
09	O
(	O
27	O
.	O
14	O
)	O
60	O
.	O
06	O
(	O
23	O
.	O
68	O
)	O
73	O
.	O
74	O
(	O
27	O
.	O
99	O
)<	O
0	O
.	O
0001Vitamin	O
D	O
Status	O
<	O
0	O
.	O
0001	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
48	O
(	O
4	O
)	O
51	O
(	O
3	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
375	O
(	O
32	O
)	O
298	O
(	O
18	O
)	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
422	O
(	O
37	O
)	O
506	O
(	O
31	O
)	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
311	O
(	O
27	O
)	O
787	O
(	O
48	O
)	O
*	O
P	O
values	O
for	O
continuous	O
variables	O
were	O
determined	O
using	O
a	O
Welch	O
’	O
s	O
t	O
-	O
test	O
and	O
categorical	O
variables	O
a	O
Fisher	O
’	O
s	O
exact	O
test	O
comparing	O
Adelaide	O
and	O
Auckland	O
women	O
Standardising	O
serum	O
25	O
(	O
OH	O
)	O
D	O
based	O
on	O
seasonal	O
variation	O
As	O
expected	O
,	O
there	O
was	O
a	O
seasonal	O
influence	O
on	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
thus	B
,	O
“	O
standardised	O
”	O
vitamin	O
D	O
concentrations	O
were	O
calculated	O
to	O
account	O
for	O
the	O
month	O
of	O
serum	O
collection	O
.	O

Thyroid	O
receptors	O
(	O
TRs	O
)	O
are	O
composed	O
of	O
several	O
isoforms	O
that	O
specifically	O
regulate	O
UCP1	O
expression	O
and	O
thermogenesis	O
.	O

Most	O
women	O
(	O
66	O
–	O
96	O
%)	O
in	O
their	O
middle	O
and	O
late	O
pregnancy	O
in	O
Beijing	O
are	O
Vitamin	O
D	O
deficient	O
if	O
diagnosed	O
with	O
the	O
criteria	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
<	O
50	O
nmol	O
/	O
L	O
(	O
ELISA	O
method	O
),	O
as	B
indicated	O
in	O
two	O
studies	O
from	O
Department	O
of	O
Endocrinology	O
and	O
Department	O
of	O
Laboratory	O
Medicine	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
[	O
6	O
].	O

Early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
exposure	O
to	O
extended	O
winter	O
were	O
independently	O
associated	O
with	O
significantly	O
higher	O
glucose	O
in	O
late	O
pregnancy	O
(	O
B	O
=	O
0	O
.	O
15	O
,	O
and	O
0	O
.	O
13	O
,	O
respectively	O
),	O
controlling	O
for	O
confounders	O
.	O

In	O
his	O
invited	O
commentary	O
,	O
Dr	O
.	O
Eyles	O
asked	O
,	O
‘	O
Does	O
skin	O
colour	O
modify	O
the	O
risk	O
’	O
of	O
autism	O
,	O
noting	B
melanin	O
in	O
the	O
skin	O
is	O
an	O
effective	O
sunblock	O
.	O

Crosstabs	O
of	O
these	O
same	O
variables	O
by	O
study	O
condition	O
and	O
survey	O
time	O
points	O
were	O
also	O
calculated	O
.	O

In	O
the	O
present	O
study	O
,	O
body	O
weight	O
did	O
not	O
predict	O
the	O
age	O
at	O
puberty	O
.	O

The	O
up	O
-	O
to	O
-	O
date	O
annotation	O
of	O
Affymetrix	O
probe	O
-	O
sets	O
to	O
EnsEMBL	O
Sscofa	O
9	O
(	O
20	O
,	O
439	O
of	O
23	O
,	O
935	O
annotated	O
probe	O
-	O
sets	O
)	O
was	O
used	O
[	O
18	O
].	O

8	O
.	O
07	O
(	O
0	O
.	O
28	O
to	O
15	O
.	O
9	O
)	O
with	O
three	O
or	O
more	O
serves	O
per	O
week	O
.	O
QualityNeutralPositiveNeutralPositiveType	O
of	O
studyProspective	O
population	O
-	O
based	O
cohortProspective	O
cohort	O
(	O
Project	O
Viva	O
)	O
Prospective	O
birth	O
cohortBirth	O
cohort	O
studyNHMRC	O
Level	O
of	O
evidence	O
[	O
20	O
]	O
Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3PopulationPregnant	O
women	O
recruited	O
throughout	O
Denmark	O
.	O
Pregnant	O
women	O
recruited	O
in	O
Massachusetts	O
,	O
USA	O
.	O
Pregnant	O
women	O
living	O
in	O
Menorca	O
,	O
Spain	O
.	O
Pregnant	O
women	O
recruited	O
in	O
Japan	O
.	O

Changing	O
levels	O
of	O
progesterone	O
and	O
triggering	O
by	O
nonsteroidal	O
anti	O
-	O
inflammatory	O
drugs	O
were	O
suggested	O
as	O
potential	O
causes	O
[	O
36	O
].	O

Conclusion	O
Providing	O
pregnant	O
women	O
who	O
were	O
overweight	O
or	O
obese	O
with	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
did	O
not	O
alter	O
6	O
-	O
month	O
infant	O
growth	O
and	O
adiposity	O
.	O

All	O
foot	O
and	O
headwear	O
is	O
removed	O
before	O
measurements	O
are	O
taken	O
.	O

Disruption	O
of	O
our	O
circadian	O
clock	O
,	O
for	O
example	O
though	O
shift	O
work	O
that	O
interferes	O
with	O
light	O
-	O
dark	O
environmental	O
phases	O
,	O
can	O
negatively	O
affect	O
cardiometabolic	O
function	O
and	O
increase	O
insulin	O
resistance	O
[	O
16	O
].	O

N	O
—	O
sample	O
size25	O
,	O
446	O
mothers	O
-	O
child	O
pairs	O
.	O
341	O
mother	O
-	O
child	O
pairs	O
.	O
392	O
mother	O
-	O
child	O
pairs498	O
mother	O
-	O
infant	O
pairsMethodValidated	O
FFQ	O
conducted	O
at	O
25	O
weeks	O
gestation	O
to	O
estimate	O
fish	O
intake	O
.	O
Standardised	O
interview	O
with	O
mother	O
used	O
to	O
assess	O
child	O
neurodevelopment	O
at	O
6	O
and	O
18	O
months	O
.	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

Additionally	O
,	O
a	O
number	O
of	O
nonrandomized	O
or	O
retrospective	O
studies	O
examining	O
the	O
treatment	O
of	O
GDM	O
with	O
glyburide	O
have	O
been	O
reported	O
(	O
Table	O
4	O
).	O

Using	O
a	O
similar	O
experimental	O
paradigm	O
,	O
we	O
have	O
previously	O
demonstrated	O
that	O
prenatal	O
undernutrition	O
in	O
a	O
rodent	O
model	O
was	O
associated	O
with	O
a	O
prepubertal	O
increase	O
in	O
food	O
intake	O
[	O
29	O
]	O
and	O
alterations	O
in	O
epigenetic	O
regulation	O
of	O
and	O
mRNA	O
levels	O
of	O
hepatic	O
genes	O
to	O
favour	O
lipogenesis	O
[	O
42	O
].	O

Women	O
(	O
n	O
=	O
32	O
)	O
who	O
developed	O
gestational	O
diabetes	O
(	O
GDM	O
)	O
were	O
excluded	O
from	O
analysis	O
a	O
priori	O
,	O
given	O
potential	O
impact	O
of	O
GDM	O
on	O
both	O
offspring	O
and	O
maternal	O
weight	O
gain	O
[	O
18	O
].	O

The	O
prevalence	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
12	O
%	O
during	O
the	O
first	O
trimester	O
and	O
was	O
slightly	O
higher	O
,	O
13	O
%,	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Serum	O
visfatin	O
levels	O
were	O
measured	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
human	O
visfatin	O
(	O
ZellBio	O
GmbH	O
,	O
Germany	O
;	O
Ulm	O
kit	O
,	O
Cat	O
No	O
:	O
ZB	O
-	O
3408	O
-	O
H9648	O
).	O

Evidence	O
in	O
some	O
studies	O
pointed	O
out	O
that	O
hyperphagia	O
could	O
be	O
a	O
transitory	O
effect	O
that	O
disappears	O
when	O
the	O
underweighted	O
animals	O
after	O
maternal	O
undernutrition	O
were	O
able	O
to	O
reach	O
the	O
weight	O
as	O
controls	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

Farmers	O
represent	O
a	O
diverse	O
group	O
(	O
e	O
.	O
g	O
.,	O
with	O
dairy	O
,	O
field	O
crop	O
,	O
hog	O
,	O
beef	O
cattle	O
,	O
poultry	O
,	O
fish	O
,	O
marijuana	O
,	O
cotton	O
,	O
and	O
organic	O
),	O
and	O
the	O
heterogeneity	O
of	O
brain	O
cancer	O
risk	O
for	O
farmers	O
could	O
reflect	O
differences	O
in	O
activities	O
,	O
as	O
well	O
as	O
in	O
the	O
type	O
,	O
magnitude	O
,	O
and	O
seasonality	O
of	O
exposures	O
.	O

Follow	O
-	O
up	O
Follow	O
-	O
up	O
is	O
planned	O
according	O
to	O
the	O
stage	O
of	O
the	O
disease	O
and	O
to	O
the	O
extent	O
of	O
the	O
surgery	O
performed	O
.	O

Like	O
the	O
early	O
zygote	O
,	O
mature	O
gametes	O
are	O
transcriptionally	O
quiescent	O
.	O

Furthermore	O
,	O
better	O
overall	O
diet	O
quality	O
has	O
been	O
associated	O
with	O
a	O
lower	O
risk	O
for	O
maternal	O
perinatal	O
depression	O
and	O
gestational	O
weight	O
gain	O
,	O
which	O
in	O
turn	O
are	O
risk	O
factors	O
for	O
suboptimal	O
offspring	O
development	O
[	O
14	O
–	O
16	O
].	O

Our	O
findings	O
are	O
consistent	O
with	O
a	O
number	O
of	O
studies	O
that	O
found	O
an	O
association	O
between	O
receiving	O
influenza	O
vaccination	O
and	O
reduced	O
likelihood	B
of	O
delivering	O
a	O
baby	O
PTB	O
or	O
with	O
LBW	O
[	O
16	O
],[	O
17	O
],[	O
18	O
],[	O
19	O
],[	O
20	O
],[	O
21	O
],[	O
22	O
].	O

Although	O
there	O
is	O
a	O
possibility	O
that	O
vaccination	O
can	O
explain	B
these	O
protective	O
effects	O
,	O
observational	O
studies	O
have	O
inherent	O
biases	O
that	O
preclude	O
them	O
from	O
establishing	O
causality	O
[	O
41	O
],[	O
42	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
oral	O
glucose	O
challenge	O
.	O

Data	O
represent	O
at	O
least	O
six	O
litters	O
per	O
maternal	O
dietary	O
group	O
.	O

Because	O
the	O
nucleus	O
accumbens	O
has	O
been	O
implicated	O
in	O
neuropsychiatric	O
disorders	O
,	O
in	O
the	O
current	O
study	O
we	O
examined	O
protein	O
expression	O
in	O
this	O
region	O
in	O
adult	O
rats	O
exposed	O
to	O
DVD	O
deficiency	O
Methods	O
Female	O
Sprague	O
Dawley	O
rats	O
were	O
maintained	O
on	O
a	O
vitamin	O
D	O
deficient	O
diet	O
for	O
6	O
weeks	O
,	O
mated	O
and	O
allowed	O
to	O
give	O
birth	O
,	O
after	O
which	O
a	O
diet	O
containing	O
vitamin	O
D	O
was	O
reintroduced	O
.	O

On	O
the	O
other	O
hand	O
,	O
these	O
outcomes	O
also	O
were	O
twice	O
as	O
common	O
among	O
children	O
whose	O
mothers	O
worked	O
at	O
an	O
electronics	O
assembly	O
plant	O
as	O
in	O
other	O
children	O
.	O
37	O
Animal	O
studies	O
suggest	O
potential	O
reproductive	O
implications	O
of	O
exposure	O
.	O

(	O
2006	O
),	O
Lee	O
et	O
al	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
point	O
estimates	O
for	O
women	O
carrying	O
a	O
male	O
fetus	O
indicated	O
decreased	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
with	O
high	O
serum	O
25	O
(	O
OH	O
)	O
D	O
compared	O
to	O
moderately	O
-	O
high	O
(	O
aRR	O
:	O
0	O
.	O
86	O
;	O
9	O
%%	O
CI	O
:	O
0	O
.	O
71	O
,	O
1	O
.	O
04	O
).	O

Caption	O
(	O
FIG	O
)	O
Introduced	O
in	O
the	O
1940s	O
,	O
DDT	O
was	O
widely	O
used	O
until	O
it	O
was	O
banned	O
for	O
most	O
uses	O
in	O
the	O
1970s	O
.	O

If	O
so	O
,	O
it	O
would	O
be	O
predicted	O
that	O
it	O
is	O
this	O
mismatch	O
between	O
the	O
HV	O
diet	O
fed	O
to	O
the	O
dams	O
and	O
the	O
vitamin	O
content	O
of	O
diets	O
fed	O
to	O
the	O
offspring	O
that	O
leads	O
to	O
an	O
obesogenic	O
phenotype	O
.	O

This	O
might	O
suggest	O
the	O
existence	O
of	O
social	O
inequities	O
and	O
the	O
influence	O
of	O
economic	O
factors	O
in	O
making	O
health	O
-	O
related	O
decisions	O
,	O
as	O
in	O
our	O
country	O
,	O
women	O
in	O
the	O
urban	O
area	O
,	O
more	O
educated	O
and	O
with	O
less	O
children	O
are	O
usually	O
having	O
a	O
better	O
financial	O
status	O
.	O

(	O
PDF	O
3429	O
kb	O
)	O
PubMed	O
Central	O
:	O

However	O
,	O
both	O
MS	O
and	O
QG	O
were	O
best	O
in	O
autumn	O
and	O
worst	O
in	O
spring	O
.	O

Expression	O
of	O
podocin	O
was	O
45	O
%	O
weaker	O
at	O
weaning	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
70	O
%	O
weaker	O
at	O
6	O
months	O
of	O
age	O
in	O
the	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
SC	O
mice	O
(	O
P	O
=	O
0	O
.	O
0004	O
).	O

However	O
,	O
glucose	O
is	O
believed	O
to	O
be	O
preferred	O
to	O
acetate	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
for	O
IMF	O
deposition	O
[	O
88	O
].	O

While	O
we	O
did	O
not	O
adjust	O
the	O
p	O
value	O
for	O
the	O
number	O
of	O
comparisons	O
undertaken	O
,	O
we	O
report	O
the	O
false	O
discovery	O
rate	O
,	O
which	O
provides	O
an	O
estimate	O
of	O
the	O
proportion	O
of	O
significantly	O
different	O
proteins	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
that	O
may	O
be	O
truly	O
null	O
[	O
25	O
],[	O
26	O
].	O

Even	O
though	O
some	O
negative	O
outcomes	O
with	O
U	O
-	O
shaped	O
associations	O
were	O
observed	O
,	O
with	O
risks	O
at	O
both	O
low	O
and	O
high	O
levels	O
[	O
66	O
],	O
the	O
recent	O
meta	O
-	O
analysis	O
did	O
not	O
find	O
any	O
association	O
with	O
high	O
VD	O
levels	O
and	O
negative	O
health	O
outcomes	O
[	O
67	O
].	O

(	O
DOCX	O
15	O
kb	O
)	O
PubMed	O
Central	O
:	O

Cranial	O
ultrasound	O
was	O
done	O
following	O
the	O
seizures	O
and	O
was	O
reported	O
as	O
normal	O
.	O

For	O
each	O
subject	O
,	O
41	O
corresponding	O
aggregate	O
methylation	O
values	O
were	O
obtained	O
by	O
averaging	O
together	O
average	O
β	O
-	O
values	O
from	O
all	O
CpGs	O
within	O
the	O
class	O
.	O

The	O
predicted	O
probabilities	O
of	O
vitamin	O
D	O
deficiency	O
,	O
based	O
on	O
significant	O
predictors	O
in	O
the	O
multivariable	O
regression	O
model	O
,	O
are	O
shown	O
inFigure	O
2	O
.	O

Of	O
course	O
,	O
birth	O
weight	O
is	O
likely	B
a	O
proxy	O
for	O
a	O
complex	O
interplay	O
of	O
underlying	O
etiologic	O
mechanisms	O
and	O
environmental	O
factors	O
that	O
overall	O
contribute	O
to	O
infant	O
health	O
at	O
birth	O
and	O
beyond	O
.	O

Although	O
the	O
role	O
of	O
hypothalamic	O
regulation	O
in	O
determining	O
the	O
phenotype	O
is	O
uncertain	O
,	O
our	O
gene	O
expression	O
data	O
are	O
novel	O
because	B
we	O
show	O
that	O
feeding	O
neurocircuitry	O
undergoes	O
modification	O
both	O
in	O
utero	O
and	O
into	O
maturity	O
.	O

Open	O
-	O
reference	O
OTU	O
picking	O
identified	O
a	O
total	O
of	O
4260	O
OTUs	O
in	O
our	O
population	O
of	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
,	O
with	O
2850	O
OTUs	O
corresponding	O
to	O
Greengenes	O
IDs	O
and	O
1410	O
de	O
novo	O
OTUs	O
.	O

The	O
proportion	O
of	O
children	O
without	O
an	O
episode	O
of	O
pneumonia	O
during	O
our	O
18	O
month	O
study	O
did	O
not	O
differ	O
between	O
the	O
groups	O
(	O
figure	O
2	O
).	O

Investigation	O
of	O
the	O
vitamin	O
D	O
nutritional	O
status	O
in	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
in	O
Beijing	O
Abstract	O
Background	O
Vitamin	O
D	O
deficiency	O
is	O
a	O
common	O
issue	O
,	O
which	O
has	O
relation	O
with	O
GDM	O
,	O
during	O
the	O
pregnant	O
period	O
.	O

Images	O
were	O
captured	O
using	O
a	O
Plan	O
Apo	O
Neofluor	O
63X	O
NA	O
1	O
.	O
25	O
oil	O
objective	O
(	O
Zeiss	O
)	O
on	O
a	O
Zeiss	O
Axiovert	O
200M	O
microscope	O
and	O
viewed	O
using	O
the	O
AxioVision	O
software	O
.	O

Methods	O
Study	O
population	O
Women	O
aged	O
30	O
-	O
49	O
years	O
,	O
residing	O
in	O
the	O
Uppsala	O
Health	O
Care	O
Region	O
in	O
Sweden	O
during	O
1991	O
and	O
1992	O
,	O
form	O
the	O
source	O
population	O
for	O
this	O
study	O
.	O

The	O
serum	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
was	O
measured	O
by	O
ELISA	O
and	O
kit	O
of	O
immunodiagnostic	O
systems	O
Ltd	O
(	O
Nyco	O
card	O
equipment	O
,	O
Nyco	O
corporation	O
,	O
Norway	O
).	O

We	O
do	O
so	O
based	O
on	O
the	O
facts	O
that	O
the	O
overall	O
maternal	O
–	O
child	O
relationships	O
are	O
significant	O
at	O
all	O
three	O
time	O
points	O
,	O
that	O
there	O
are	O
correlations	O
between	O
all	O
three	O
mother	O
–	O
child	O
pairs	O
,	O
for	O
example	O
,	O
mother	O
–	O
child	O
,	O
MGM	O
–	O
mother	O
and	O
PGM	O
–	O
father	O
,	O
and	O
that	O
,	O
in	O
contrast	O
to	O
height	O
,	O
where	O
both	O
lineages	O
show	O
significant	O
associations	O
,	O
the	O
pattern	O
for	O
BMI	O
is	O
primarily	B
the	O
maternal	O
lineage	O
.	O

The	O
increased	O
proportion	O
of	O
preterm	O
deliveries	O
observed	O
in	O
the	O
exposed	O
group	O
may	O
be	O
influenced	O
by	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
,	O
as	B
was	O
reported	O
in	O
a	O
recent	O
paper	O
by	O
Khatibi	O
et	O
al	O
.	O

However	O
it	O
is	O
of	O
low	O
potency	O
and	O
insulin	O
therapy	O
will	O
often	O
need	O
to	O
be	O
introduced	O
.	O

The	O
biological	O
underpinnings	O
of	O
EAH	O
and	O
other	O
appetite	O
-	O
related	O
behaviors	O
are	O
not	O
well	O
understood	O
.	O

Anthropometric	O
Measures	O
Height	O
(	O
cm	O
)	O
was	O
measured	O
with	O
a	O
Harpenden	O
stadiometer	O
(	O
Holtain	O
,	O
Limited	O
,	O
Crosswell	O
,	O
UK	O
)	O
and	O
weight	O
(	O
kg	O
)	O
was	O
measured	O
using	O
the	O
Healthometer	O
ProPlus	O
scale	O
,	O
(	O
Welch	O
Allyn	O
,	O
Inc	O
.,	O
Skaneateles	O
Falls	O
,	O
NY	O
).	O

Also	O
in	O
our	O
study	O
,	O
selection	O
of	O
participants	O
at	O
the	O
beginning	O
was	O
through	O
convenience	O
method	O
.	O

Furthermore	O
,	O
few	O
data	O
have	O
evaluated	O
Hispanic	O
infants	O
who	O
may	O
be	O
at	O
high	O
-	O
risk	O
for	O
low	O
vitamin	O
D	O
status	O
due	B
to	I
poor	O
maternal	O
vitamin	O
D	O
intake	O
[	O
4	O
].	O

The	O
use	O
of	O
forward	O
primers	O
containing	O
one	O
of	O
eight	O
five	O
-	O
nucleotide	O
barcodes	O
between	O
the	O
Illumina	O
-	O
specific	O
bridge	O
and	O
sequencing	O
primer	O
regions	O
and	O
the	O
16S	O
-	O
specific	O
region	O
and	O
a	O
single	O
reverse	O
primer	O
containing	O
1	O
of	O
12	O
Illumina	O
indices	O
enables	O
96	O
samples	O
per	O
lane	O
multiplexing	O
.	O

Therefore	B
,	O
we	O
were	O
unable	O
to	O
fully	O
assess	O
the	O
influence	O
of	O
confounding	O
factors	O
in	O
SGA	O
monotherapy	O
.	O

The	O
data	O
may	O
be	O
useful	O
as	O
comparison	O
with	O
human	O
health	O
care	O
studies	O
of	O
methyl	O
donor	O
supplementation	O
in	O
the	O
mothers	O
’	O
diets	O
.	O

In	O
a	O
structured	O
interview	O
,	O
women	O
are	O
asked	O
questions	O
on	O
food	O
insecurity	O
and	O
child	O
hunger	O
using	O
the	O
Community	O
Childhood	O
Hunger	O
Identification	O
Project	O
(	O
CCHIP	O
)	O
index	O
[	O
34	O
]	O
that	O
was	O
also	O
used	O
to	O
determine	O
the	O
status	O
of	O
food	O
security	O
in	O
previous	O
national	O
surveys	O
in	O
South	O
Africa	O
[	O
35	O
].	O

The	O
same	O
authors	O
suggested	O
that	O
feeding	O
a	O
corn	O
-	O
based	O
diet	O
increased	O
glucose	O
uptake	O
in	O
IMF	O
,	O
whereas	O
feeding	O
a	O
hay	O
-	O
based	O
diet	O
may	O
promote	O
subcutaneous	O
fat	O
deposition	O
via	O
incorporation	O
of	O
acetate	O
into	O
FAs	O
.	O

At	O
baseline	O
,	O
23	O
%	O
of	O
control	O
(	O
29	O
/	O
124	O
)	O
and	O
20	O
%	O
of	O
intervention	O
(	O
25	O
/	O
125	O
)	O
participants	O
said	O
that	O
another	O
person	O
reminded	O
them	O
to	O
wash	O
hands	O
on	O
a	O
typical	O
day	O
.	O

Second	O
,	O
the	O
sample	O
was	O
not	O
randomly	O
selected	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
peopleStudyChailurkit	O
et	O
al	O
.	O

The	O
25	O
µl	O
PCR	O
mixture	O
included	O
2	O
µl	O
RT	O
product	O
,	O
2	O
µl	O
primers	O
,	O
8	O
.	O
5	O
µl	O
sterile	O
3d	O
H2O	O
run	O
on	O
an	O
Mx3000P	O
instrument	O
(	O
Agilent	O
Technologies	O
)	O
and	O
analyzed	O
using	O
Mx3000P	O
System	O
SDS	O
software	O
(	O
Stratagene	O
).	O

The	O
estimates	O
increased	O
rapidly	O
from	O
age	O
0	O
to	O
5	O
and	O
then	O
at	O
a	O
slower	O
rate	O
,	O
reaching	O
maximum	O
values	O
in	O
adulthood	O
.	O

Significance	O
was	O
accepted	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

We	O
calculated	O
basic	O
descriptive	O
statistics	O
for	O
participant	O
variables	O
(	O
Table1	O
),	O
EDC	O
concentration	O
geometric	O
means	O
and	O
percentiles	O
(	O
Table2	O
).	O

The	O
origins	O
of	O
many	O
childhood	O
and	O
adult	O
malignancies	O
are	O
believed	O
to	O
be	O
determined	O
during	O
a	O
finite	O
perinatal	O
window	O
.	O

Maternal	O
and	O
neonatal	O
characteristics	O
of	O
our	O
study	O
population	O
,	O
stratified	O
by	O
race	O
,	O
are	O
shown	O
inTable	O
1	O
.	O

After	O
determination	O
of	O
estrous	O
stage	O
,	O
samples	O
were	O
air	O
dried	O
and	O
stained	O
using	O
an	O
adaptation	O
of	O
the	O
Papanicolaou	O
(	O
PAP	O
)	O
stain	O
used	O
for	O
humans	O
[	O
63	O
].	O

The	O
present	O
study	O
evaluates	O
the	O
final	O
outcomes	O
of	O
text4baby	O
from	O
a	O
randomized	O
trial	O
of	O
pregnant	O
female	O
soldiers	O
and	O
family	O
members	O
[	O
23	O
].	O

Cord	O
and	O
3	O
-	O
month	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
not	O
significantly	O
related	O
to	O
weight	O
,	O
length	O
or	O
head	O
circumference	O
at	O
3	O
months	O
.	O

[	O
32	O
]	O
Role	O
of	O
vitamin	O
D	O
in	O
newborn	O
and	O
infant	O
Adequate	O
maternal	O
vitamin	O
D	O
levels	O
are	O
also	O
important	O
for	O
fetal	O
and	O
child	O
health	O
.	O

All	O
women	O
aged	O
between	O
15	O
to	O
49	O
years	O
,	O
who	O
are	O
pregnant	O
and	O
their	O
gestational	O
age	O
is	O
≤	O
90	O
days	O
,	O
and	O
are	O
permanent	O
residents	O
of	O
the	O
Shonjibon	O
study	O
area	O
will	O
be	O
eligible	O
for	O
the	O
study	O
.	O

The	O
infant	O
’	O
s	O
medical	O
plan	O
is	O
managed	O
accordingly	O
.	O

Second	O
,	O
during	O
certain	O
critical	O
periods	O
,	O
vulnerabilities	O
are	O
intensified	O
to	O
specific	O
maternal	O
and	O
environmental	O
exposures	O
that	O
can	O
lead	B
to	I
obesity	O
(	O
2	O
).	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

While	O
the	O
omega	O
-	O
3	O
and	O
mercury	O
content	O
of	O
fish	O
is	O
well	B
known	I
,	O
less	O
well	O
known	O
is	O
the	O
fact	O
that	O
fish	O
is	O
one	O
of	O
the	O
few	O
foods	O
with	O
significant	O
amounts	O
of	O
vitamin	O
D	O
,	O
which	O
,	O
as	O
referenced	O
earlier	O
,	O
protects	O
the	O
genome	O
from	O
damage	O
by	O
toxins	O
.	O

Abstract	O
Background	O
Pet	O
keeping	O
has	O
been	O
linked	O
with	O
decreased	O
risk	O
of	O
allergic	O
sensitization	O
,	O
which	O
has	O
been	O
associated	O
with	O
the	O
Hygiene	O
Hypothesis	O
;	O
and	O
more	O
recently	O
,	O
by	O
ourselves	O
and	O
others	O
,	O
to	O
particular	O
home	O
microbiome	O
patterns	O
.	O

The	O
basis	B
for	O
these	O
recommendations	O
was	O
made	O
before	O
it	O
was	O
possible	O
to	O
measure	O
the	O
circulating	O
concentration	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
],	O
the	O
indicator	O
of	O
nutritional	O
vitamin	O
D	O
status	O
.	O

Consistent	O
with	O
this	O
,	O
we	O
observed	O
that	O
both	O
prenatal	O
and	O
lactational	O
undernutrition	O
accelerated	O
puberty	O
–	O
although	O
only	O
the	O
former	O
was	O
accompanied	O
by	O
the	O
later	O
development	O
of	O
obesity	O
and	O
other	O
components	O
of	O
metabolic	O
compromise	O
,	O
as	B
previously	O
reported	O
[	O
29	O
].	O

By	O
race	O
/	O
ethnicity	O
,	O
the	O
PTB	O
rate	O
was	O
38	O
%	O
(	O
95	O
%	O
CI	O
=	O
-	O
58	O
-	O
75	O
%,	O
p	O
=	O
0	O
.	O
33	O
)	O
lower	O
among	O
white	O
women	O
(	O
8	O
%	O
and	O
13	O
%	O
respectively	O
,	O
AAR	O
=	O
4	O
.	O
8	O
%,	O
NNT	O
=	O
21	O
)	O
and	O
78	O
%	O
(	O
95	O
%	O
CI	O
=	O
12	O
–	O
95	O
%,	O
p	O
=	O
0	O
.	O
01	O
)	O
lower	O
among	O
non	O
-	O
white	O
women	O
(	O
4	O
%	O
and	O
18	O
%	O
respectively	O
,	O
AAR	O
=	O
13	O
.	O
8	O
%,	O
NNT	O
=	O
7	O
).	O

The	O
majority	O
(	O
84	O
%)	O
of	O
respondents	O
in	O
the	O
intervention	O
arm	O
and	O
44	O
%	O
of	O
respondents	O
in	O
the	O
control	O
arm	O
reported	O
that	O
the	O
primary	O
handwashing	O
station	O
used	O
by	O
the	O
respondent	O
was	O
located	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
,	O
at	O
postnatal	O
days	O
4	O
-	O
5	O
(	O
RR	O
=	O
2	O
.	O
2	O
,	O
95	O
%	O
CI	O
1	O
.	O
72	O
–	O
2	O
.	O
92	O
,	O
p	O
<	O
.	O
0001	O
),	O
decaying	O
to	O
51	O
%	O
of	O
respondents	O
in	O
the	O
intervention	O
arm	O
and	O
9	O
%	O
of	O
respondents	O
in	O
the	O
control	O
arm	O
during	O
the	O
last	O
week	O
of	O
the	O
neonatal	O
period	O
(	O
RR	O
=	O
4	O
.	O
7	O
,	O
95	O
%	O
CI	O
2	O
.	O
53	O
–	O
8	O
.	O
76	O
,	O
p	O
<	O
.	O
0001	O
).	O

The	O
parent	O
-	O
trial	O
was	O
subjected	O
to	O
the	O
scrutiny	O
of	O
an	O
independent	O
Data	O
Safety	O
and	O
Monitoring	O
Board	O
and	O
operated	O
under	O
the	O
auspices	O
of	O
Good	O
Clinical	O
Practice	O
guidelines	O
(	O
MRC	O
1999	O
).	O

Methods	O
This	O
is	O
a	O
secondary	O
data	O
analysis	O
of	O
334	O
pregnant	O
women	O
enrolled	O
in	O
the	O
ROLO	O
study	O
,	O
Dublin	O
.	O

Diet	O
,	O
generation	O
,	O
and	O
the	O
interaction	O
between	O
diet	O
and	O
generation	O
did	O
not	O
affect	O
the	O
KM	O
significantly	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

Models	O
adjusted	O
for	O
delivery	O
hospital	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
influenza	O
circulation	O
.	O

This	O
difference	O
was	O
abolished	O
in	O
RC	O
males	O
(	O
Figure3E	O
).	O

Also	O
,	O
since	O
more	O
than	O
95	O
%	O
of	O
the	O
mothers	O
had	O
lower	O
than	O
30	O
ng	O
/	O
mL	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
,	O
it	O
is	O
not	O
clear	O
if	O
the	O
same	O
results	O
would	O
be	O
observed	O
in	O
mothers	O
with	O
higher	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
.	O
Therefore	B
,	O
we	O
suggest	O
further	O
clinical	O
trials	O
,	O
using	O
2000	O
IU	O
vitamin	O
D	O
on	O
a	O
larger	O
population	O
,	O
mothers	O
with	O
high	O
levels	O
of	O
depression	O
,	O
and	O
high	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Intact	O
PTH	O
was	O
measured	O
by	O
immunochemiluminometric	O
assay	O
(	O
ICNA	O
)	O
with	O
a	O
sensitivity	O
of	O
3	O
pg	O
/	O
mL	O
.	O

Birth	O
weight	O
We	O
will	O
measure	O
birth	O
weight	O
within	O
24	O
h	O
of	O
delivery	O
using	O
standard	O
methods	O
with	O
a	O
portable	O
electronic	O
scale	O
.	O

Lastly	O
,	O
we	O
conducted	O
these	O
analyses	O
under	O
the	O
assumption	O
that	O
structurally	O
similar	O
chemicals	O
would	O
have	O
similar	O
modes	O
of	O
action	O
and	O
therefore	B
should	O
be	O
grouped	O
together	O
.	O

The	O
mean	O
depression	O
scores	O
in	O
the	O
nulliparous	O
and	O
multiparous	O
women	O
were	O
8	O
.	O
58	O
±	O
3	O
.	O
53	O
and	O
8	O
.	O
48	O
±	O
4	O
.	O
29	O
,	O
respectively	O
with	O
no	O
significant	O
difference	O
(	O
p	O
=	O
0	O
.	O
86	O
).	O

Both	O
,	O
the	O
EpiTect	O
Methyl	O
II	O
Signature	O
and	O
EpiTect	O
Methyl	O
II	O
Complete	O
PCR	O
Arrays	O
(	O
Qiagen	O
)	O
will	O
be	O
considered	O
.	O

A	O
basal	O
-	O
bolus	O
regimen	O
of	O
insulin	O
gives	O
the	O
most	O
effective	O
glucose	O
control	O
,	O
and	O
produces	O
better	O
fetal	O
outcomes	O
than	O
a	O
twice	O
daily	O
regime	O
.	O
34Prandial	O
fast	O
-	O
acting	O
insulin	O
is	O
administered	O
to	O
control	O
post	O
-	O
prandial	O
hyperglycemia	O
,	O
and	O
bedtime	O
basal	O
insulin	O
is	O
given	O
if	O
there	O
is	O
fasting	O
hyperglycemia	O
.	O

Only	O
the	O
pregnancy	O
grouping	O
and	O
the	O
educational	O
level	O
of	O
respondents	O
was	O
associated	O
with	O
a	O
statistical	O
significant	O
difference	O
in	O
terms	O
of	O
their	O
overall	O
satisfaction	O
.	O

Retention	O
times	O
(	O
Rt	O
)	O
were	O
:	O
7	O
.	O
0	O
minutes	O
for	O
corticosterone	O
-	O
d8	O
and	O
12	O
.	O
5	O
minutes	O
for	O
progesterone	O
.	O

Future	O
research	O
is	O
needed	O
to	O
determine	O
whether	O
differences	O
in	O
postnatal	O
feeding	O
behaviors	O
might	O
explain	O
differential	O
growth	O
rates	O
in	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

We	O
will	O
financially	O
incentivise	O
the	O
SS	O
for	O
early	O
identification	O
of	O
pregnant	O
women	O
.	O

Multivariable	O
logistic	O
regression	O
analyses	O
of	O
the	O
outcome	O
variables	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
performed	O
with	O
25OHD	O
at	O
T1	O
,	O
T3	O
and	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
as	O
the	O
independent	O
variables	O
.	O

Values	O
are	O
plotted	O
for	O
the	O
entire	O
cohort	O
(	O
black	O
),	O
lean	O
(	O
body	O
mass	O
index	O
<	O
25	O
kg	O
/	O
m2	O
,	O
blue	O
)	O
and	O
overweight	O
(	O
body	O
mass	O
index	O
≥	O
25	O
kg	O
/	O
m2	O
,	O
red	O
)	O
women	O
,	O
respectively	O
.	O

Despite	O
these	O
limitations	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
a	O
gene	O
-	O
maternal	O
environment	O
synergism	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
,	O
using	O
a	O
very	O
brief	O
assessment	O
of	O
maternal	O
attitudes	O
to	O
pregnancy	O
.	O

The	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
]	O
increases	O
intestinal	O
calcium	O
absorption	O
and	O
decreases	O
renal	O
calcium	O
excretion	O
,	O
thus	O
increasing	O
the	O
pool	O
of	O
calcium	O
available	O
both	O
for	O
mother	O
and	O
foetus	O
.	O

The	O
observation	O
that	O
lactational	O
undernutrition	O
can	O
lead	O
to	O
a	O
modification	O
of	O
the	O
adult	O
metabolic	O
phenotype	O
is	O
compatible	O
with	O
work	O
by	O
others	O
showing	O
that	O
postnatal	O
undernutrition	O
can	O
modify	O
metabolic	O
programming	O
[	O
52	O
],[	O
53	O
].	O

For	O
instance	O
,	O
experimental	O
research	O
has	O
demonstrated	O
social	O
modeling	O
influences	O
on	O
both	O
the	O
types	O
(	O
74	O
)	O
and	O
amounts	O
of	O
food	O
eaten	O
by	O
young	O
children	O
(	O
75	O
-	O
77	O
).	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g005	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Photomicrographs	O
of	O
the	O
developing	O
kidneys	O
of	O
offspring	O
at	O
birth	O
.	O

This	O
supplement	O
should	O
include	O
400	O
μ	O
g	O
of	O
folic	O
acid	O
or	O
lower	O
doses	O
,	O
if	O
this	O
amount	O
is	O
not	O
available	O
[	O
7	O
].	O

To	O
further	O
evaluate	O
the	O
association	O
between	O
infant	O
birth	O
weight	O
and	O
repetitive	O
element	O
methylation	O
identified	O
in	O
the	O
univariate	O
analyses	O
,	O
controlled	O
for	O
confounders	O
,	O
we	O
used	O
multiple	O
linear	O
regression	O
.	O

If	O
nodal	O
involvement	O
is	O
confirmed	O
,	O
total	O
thyroidectomy	O
and	O
modified	O
radical	O
neck	O
dissection	O
are	O
indicated	O
.	O

A	O
final	O
advantage	O
of	O
Bayesian	O
modeling	O
is	O
that	O
posterior	O
distributions	O
of	O
the	O
regression	O
coefficients	O
are	O
shrunk	O
towards	O
pooled	O
mean	O
μβ	O
,	O
reducing	O
the	O
Type	O
I	O
error	O
(	O
false	O
positives	O
)	O
rate	O
when	O
the	O
interval	O
estimates	O
are	O
used	O
for	O
frequentist	O
hypothesis	O
testing	O
.	O

Association	O
of	O
influenza	O
vaccination	O
during	O
pregnancy	O
with	O
birth	O
outcomes	O
in	O
Nicaragua	O
Abstract	O
Background	O
:	O
Studies	O
have	O
shown	O
that	O
influenza	O
vaccination	O
during	O
pregnancy	O
reduces	O
the	O
risk	O
of	O
influenza	O
disease	O
in	O
pregnant	O
women	O
and	O
their	O
offspring	O
.	O

Remarkably	O
,	O
few	O
data	O
have	O
looked	O
at	O
modern	O
techniques	O
of	O
assessing	O
bone	O
mineral	O
status	O
and	O
compared	O
it	O
to	O
vitamin	O
D	O
levels	O
and	O
supplementation	O
in	O
this	O
population	O
[	O
5	O
].	O

Both	O
excessive	O
[	O
4	O
]	O
and	O
inadequate	O
[	O
5	O
]	O
weight	O
gain	O
in	O
the	O
mother	O
during	O
gestation	O
have	O
been	O
shown	O
to	O
lead	O
to	O
overly	O
rapid	O
fetal	O
and	O
infant	O
growth	O
rates	O
and	O
the	O
programming	O
of	O
future	O
risk	O
of	O
childhood	O
overweight	O
and	O
metabolic	O
disease	O
.	O

Compliance	O
with	O
supplementation	O
was	O
assessed	O
by	O
pill	O
counts	O
(	O
compliance	O
factor	O
=	O
ratio	O
of	O
the	O
number	O
of	O
tablets	O
apparently	O
consumed	O
/	O
number	O
of	O
days	O
enrolled	O
in	O
study	O
).	O

Here	O
,	O
we	O
also	O
review	O
these	O
factors	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
.	O

Seven	O
of	O
the	O
eight	O
reviewed	O
articles	O
showed	O
a	O
beneficial	O
impact	O
on	O
certain	O
measures	O
of	O
offspring	O
neurodevelopment	O
with	O
fish	O
intake	O
ranging	O
from	O
less	O
than	O
one	O
to	O
three	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
.	O

Several	O
studies	O
have	O
been	O
shown	O
that	O
,	O
with	O
cutoff	O
score	O
of	O
12	O
–	O
13	O
,	O
this	O
scale	O
develops	O
into	O
more	O
indicative	B
in	O
identifying	O
real	O
depression	O
in	O
women	O
[	O
36	O
,	O
37	O
,	O
42	O
].	O

For	O
example	O
,	O
fetuses	O
exposed	O
to	O
flavors	O
,	O
usually	O
detected	O
by	O
the	O
sense	O
of	O
smell	O
,	O
in	O
amniotic	O
fluid	O
and	O
infants	O
exposed	O
to	O
flavors	O
in	O
breast	O
milk	O
(	O
both	O
of	O
which	O
reflect	O
flavors	O
of	O
the	O
mother	O
'	O
s	O
diet	O
)	O
(	O
38	O
)	O
learn	O
to	O
like	O
those	O
flavors	O
as	O
they	O
make	O
the	O
transition	O
to	O
eating	O
adult	O
foods	O
(	O
39	O
).	O

As	O
indicated	O
by	O
the	O
seasonal	O
variation	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
amongst	O
women	O
recruited	O
in	O
Adelaide	O
,	O
vitamin	O
D	O
status	O
declined	O
significantly	O
from	O
February	O
to	O
April	O
whilst	O
in	O
the	O
women	O
recruited	O
in	O
Auckland	O
,	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
March	O
and	O
April	O
remained	O
elevated	O
before	O
declining	O
.	O

As	B
such	I
,	O
epigenetics	O
is	O
high	O
on	O
the	O
agenda	O
of	O
the	O
OECD	O
expert	O
working	O
group	O
on	O
an	O
integrated	O
approach	O
to	O
testing	O
and	O
assessment	O
(	O
IATA	O
)	O
for	O
non	O
-	O
genotoxic	O
carcinogens	O
(	O
NGTxC	O
)	O
and	O
the	O
OECD	O
endocrine	O
disrupters	O
testing	O
and	O
assessment	O
advisory	O
group	O
(	O
EDTA	O
AG	O
)	O
(	O
Greally	O
&	O
Jacobs2013	O
;	O
Jacobs	O
et	O
al	O
.	O
2015	O
).	O

Maternal	O
Diet	O
During	O
Lactation	O
Regarding	O
maternal	O
lactation	O
diets	O
,	O
a	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
[	O
99	O
]	O
found	O
some	O
evidence	O
of	O
reduced	O
atopic	O
dermatitis	O
,	O
but	O
suggested	O
that	O
more	O
studies	O
are	O
needed	O
.	O

Last	O
,	O
the	O
sample	O
size	O
was	O
rather	O
small	O
,	O
and	O
the	O
vitamin	O
D	O
levels	O
of	O
the	O
participants	O
were	O
generally	B
suboptimal	O
in	O
our	O
study	O
.	O

Interestingly	O
,	O
adjustment	O
for	O
GWG	O
attenuated	O
but	O
generally	O
did	O
not	O
completely	O
remove	O
the	O
impact	O
of	O
dietary	O
variables	O
on	O
offspring	O
weight	O
,	O
particularly	O
at	O
6	O
months	O
.	O

To	O
test	O
this	O
,	O
we	O
have	O
performed	O
qPCR	O
for	O
all	O
GRs	O
and	O
GAS5	O
in	O
the	O
same	O
cohort	O
of	O
placentas	O
divided	O
this	O
time	O
to	O
labor	O
(	O
n	O
=	O
18	O
)	O
and	O
nonlabor	O
(	O
n	O
=	O
5	O
).	O

Nodes	O
in	O
the	O
jugular	O
chains	O
should	O
also	O
be	O
carefully	O
examined	O
with	O
US	O
before	O
surgery	O
and	O
,	O
when	O
suspicious	O
,	O
FNAB	O
should	O
be	O
obtained	O
.	O

There	O
will	O
be	O
one	O
FI	O
for	O
each	O
cluster	O
.	O

Methods	O
The	O
study	O
was	O
a	O
randomized	O
trial	O
of	O
text4baby	O
at	O
Madigan	O
Army	O
Medical	O
Center	O
.	O

However	O
,	O
until	O
these	O
results	O
,	O
no	O
behavioral	O
effects	O
had	O
been	O
observed	O
.	O

Our	O
recent	O
study	O
also	O
revealed	O
that	O
growth	O
performance	O
was	O
not	O
affected	O
by	O
mild	O
heat	O
stress	O
in	O
Korean	O
cattle	O
[	O
83	O
].	O

However	O
,	O
they	O
were	O
different	O
regarding	O
to	O
using	O
other	O
supplements	O
outside	O
the	O
study	O
’	O
s	O
protocol	O
and	O
planned	O
pregnancy	O
(	O
Table	O
1	O
).	O

At	O
the	O
end	O
of	O
each	O
interview	O
,	O
the	O
data	O
collector	O
will	O
store	O
the	O
data	O
on	O
the	O
local	O
device	O
and	O
then	O
upload	O
the	O
data	O
to	O
the	O
central	O
server	O
after	O
the	O
end	O
of	O
a	O
day	O
’	O
s	O
work	O
.	O

In	O
addition	O
,	O
we	O
will	O
establish	O
five	O
district	O
advisory	O
committees	O
consisting	O
of	O
local	O
health	O
officers	O
,	O
local	O
government	O
officials	O
,	O
local	O
community	O
groups	O
,	O
other	O
relevant	O
NGOs	O
and	O
project	O
staff	O
to	O
help	O
guide	O
the	O
research	O
team	O
.	O

Most	O
of	O
the	O
respondents	O
were	O
in	O
secondary	O
school	O
(	O
n	O
=	O
141	O
,	O
36	O
.	O
5	O
%).	O

This	O
may	O
be	O
attributed	O
to	O
regular	O
milk	O
intake	O
,	O
which	O
was	O
common	B
in	O
both	O
groups	O
.	O

Overall	O
,	O
the	O
sequence	O
of	O
events	O
in	O
this	O
patient	O
suggests	O
that	O
the	O
metabolic	O
and	O
trophic	O
effects	O
of	O
THs	O
on	O
BAT	O
may	O
play	O
a	O
critical	O
role	O
in	O
non	O
-	O
insulin	O
-	O
mediated	O
glucose	O
utilization	O
,	O
ultimately	O
leading	O
to	O
near	O
-	O
normal	O
glucose	O
levels	O
(	O
Skarulis	O
et	O
al	O
.,	O
2010	O
).	O

BMI	O
—	O
child	O
age	O
9	O
There	O
were	O
298	O
children	O
measured	O
starting	O
at	O
age	O
9	O
,	O
with	O
recruitment	O
conducted	O
over	O
a	O
13	O
-	O
month	O
period	O
(	O
mean	O
age	O
9	O
.	O
85	O
years	O
,	O
SD	O
=	O
0	O
.	O
29	O
,	O
minimum	O
=	O
9	O
.	O
2	O
,	O
maximum	O
=	O
10	O
.	O
89	O
).	O

Fasting	O
blood	O
samples	O
were	O
also	O
obtained	O
on	O
follow	O
ups	O
and	O
were	O
used	O
to	O
prepare	O
serums	O
,	O
which	O
were	O
kept	O
similarly	O
.	O

Scaling	O
up	O
preterm	O
birth	O
interventions	O
within	O
the	O
existing	O
health	O
system	O
There	O
is	O
increasing	O
global	O
consensus	B
around	O
essential	O
reproductive	O
,	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
(	O
RMNCH	O
)	O
interventions	O
[	O
22	O
,	O
23	O
],	O
including	O
those	O
to	O
address	O
preterm	O
birth	O
(	O
Figure2	O
).	O

It	O
was	O
widely	O
believed	O
that	O
these	O
20	O
–	O
30	O
000	O
protein	O
-	O
coding	O
genes	O
were	O
the	O
sole	O
mediators	O
and	O
executors	O
of	O
all	O
cellular	O
functions	O
.	O

PNV	O
use	O
was	O
ascertained	O
by	O
questionnaire	O
that	O
asked	O
women	O
,	O
“	O
Prior	O
to	O
pregnancy	O
,	O
did	O
you	O
take	O
a	O
multivitamin	O
?”	O
and	O
“	O
Since	O
getting	O
pregnant	O
have	O
you	O
taken	O
a	O
multivitamin	O
?”	O
We	O
categorized	O
women	O
as	O
PNV	O
users	O
if	O
they	O
reported	O
any	O
PNV	O
use	O
.	O

We	O
further	O
evaluated	O
the	O
relationship	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
and	O
outcomes	O
using	O
a	O
general	O
linear	O
regression	O
model	O
.	O

Body	O
mass	O
index	O
is	O
associated	O
with	O
the	O
maternal	O
lines	O
but	O
height	O
is	O
heritable	O
across	O
family	O
lines	O
in	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
Abstract	O
Objectives	O
Overweight	O
and	O
obesity	O
is	O
a	O
problem	O
in	O
children	O
in	O
particular	O
and	O
determining	O
pathways	O
of	O
transmission	O
is	O
important	O
in	O
prevention	O
.	O

Diet	O
There	O
should	O
be	O
no	O
special	O
diet	O
for	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
,	O
unless	O
the	O
mother	O
or	O
child	O
has	O
a	O
diagnosed	O
food	O
sensitization	O
.	O

We	O
included	O
them	O
if	O
they	O
had	O
the	O
following	O
criteria	O
:	O
no	O
known	O
diseases	O
related	O
to	O
vitamin	O
D	O
deficiency	O
such	O
as	O
rickets	O
or	O
parathyroid	O
diseases	O
and	O
no	O
intake	O
of	O
drug	O
or	O
supplement	O
containing	O
vitamin	O
D	O
or	O
calcium	O
.	O

Evidence	O
suggests	O
that	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
and	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
[	O
2	O
–	O
4	O
].	O

Discussion	O
The	O
present	O
study	O
did	O
not	O
find	O
an	O
association	O
between	O
maternal	O
influenza	O
vaccination	O
administered	O
at	O
any	O
point	O
in	O
pregnancy	O
and	O
adverse	O
birth	O
outcomes	O
among	O
their	O
babies	O
.	O

Results	O
There	O
were	O
35	O
spots	O
,	O
mapped	O
to	O
33	O
unique	O
proteins	O
,	O
which	O
were	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
.	O

Mean	O
infant	O
birth	O
weight	O
was	O
3542	O
(	O
538	O
)	O
grams	O
and	O
mean	O
gestational	O
age	O
at	O
delivery	O
was	O
280	O
(	O
12	O
.	O
4	O
)	O
days	O
.	O

However	O
,	O
to	O
determine	O
whether	O
,	O
or	O
not	O
,	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
a	O
real	O
concern	O
for	O
public	O
health	O
there	O
are	O
a	O
number	O
of	O
important	O
considerations	O
.	O

PubMed	O
Central	O
:	O

Our	O
case	O
report	O
highlights	O
the	O
early	O
,	O
successful	O
diagnosis	O
and	O
surgical	O
repair	O
of	O
a	O
healthy	O
41	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
with	O
an	O
acute	O
type	O
A	O
aortic	O
dissection	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

Results	O
General	O
characteristics	O
of	O
the	O
study	O
subjects	O
Ninety	O
-	O
eight	O
pregnant	O
women	O
with	O
GDM	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Any	O
needed	O
dosing	O
adjustments	O
were	O
made	O
based	O
on	O
follow	O
-	O
up	O
testing	O
.	O

The	O
cut	O
-	O
off	O
points	O
used	O
to	O
define	O
vitamin	O
D	O
insufficiency	O
and	O
deficiency	O
are	O
not	O
well	O
established	O
and	O
remain	O
controversial	O
.	O

The	O
male	O
pups	O
were	O
weaned	O
on	O
postnatal	O
day	O
21	O
and	O
housed	O
in	O
groups	O
of	O
3	O
–	O
6	O
.	O

Consistent	O
with	O
this	O
finding	O
,	O
expression	O
of	O
genes	O
associated	O
with	O
an	O
impaired	O
immunity	O
were	O
found	O
to	O
be	O
altered	O
in	O
offspring	O
of	O
protein	O
malnourished	O
dams	O
[	O
62	O
,	O
63	O
].	O

However	O
,	O
at	O
94	O
dpc	O
and	O
188	O
dpn	O
179	O
probe	O
-	O
sets	O
were	O
differentially	O
regulated	O
in	O
both	O
stages	O
between	O
LP	O
and	O
AP	O
.	O

There	O
was	O
also	O
a	O
correlation	O
with	O
the	O
MGM	O
for	O
both	O
boys	O
and	O
girls	O
.	O

Free	O
vitamin	O
D	O
supplements	O
were	O
offered	O
and	O
the	O
treatment	O
goal	O
was	O
≥	O
40	O
ng	O
/	O
mL	O
.	O

A	O
comparison	O
group	O
was	O
comprised	O
of	O
women	O
who	O
contacted	O
Motherisk	O
between	O
2005	O
and	O
2009	O
,	O
and	O
reported	O
exposure	O
to	O
non	O
-	O
teratogenic	O
agents	O
(	O
eg	O
,	O
acetaminophen	O
,	O
antihistamines	O
,	O
etc	O
).	O

“	O
The	O
conventional	B
wisdom	I
has	O
been	O
that	O
mothers	O
’	O
worries	O
about	O
milk	O
supply	O
are	O
due	B
either	O-
to	I
their	O
misperception	O
of	O
normal	O
lactation	O
and	O
infant	O
breastfeeding	O
behaviors	O
or	O
to	O
mismanagement	O
of	O
breastfeeding	O
technique	O
,	O
and	O
only	O
on	O
very	O
rare	O
occasions	O
due	B
to	I
an	O
intrinsic	O
inability	O
to	O
make	O
enough	O
milk	O
,”	O
says	O
Laurie	O
Nommsen	O
-	O
Rivers	O
,	O
a	O
perinatal	O
nutrition	O
specialist	O
at	O
the	O
University	O
of	O
Cincinnati	O
College	O
of	O
Allied	O
Health	O
Sciences	O
.	O

Among	O
women	O
with	O
initial	O
25	O
(	O
OH	O
)	O
D	O
<	O
40	O
ng	O
/	O
mL	O
,	O
PTB	O
rates	O
were	O
60	O
%	O
lower	O
for	O
those	O
with	O
≥	O
40	O
vs	O
.	O
<	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
(	O
p	O
=	O
0	O
.	O
006	O
);	O
38	O
%	O
for	O
whites	O
(	O
p	O
=	O
0	O
.	O
33	O
)	O
and	O
78	O
%	O
for	O
non	O
-	O
whites	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

Additional	O
file	O
Caption	O
(	O
MEDIA	O
):	O
ADDITIONAL	O
FILE	O
1	O
:	O
Table	O
S1	O
.	O

Figure2gives	O
a	O
comprehensive	O
overview	O
of	O
the	O
pathways	O
found	O
regulated	O
between	O
stages	O
and	O
diets	O
.	O

As	B
such	I
,	O
confirmation	O
of	O
these	O
findings	O
in	O
severely	O
vitamin	O
D	O
–	O
deficient	O
women	O
is	O
needed	O
as	B
it	O
is	O
possible	O
that	O
women	O
with	O
specific	O
genotypes	O
were	O
selectively	O
excluded	O
by	O
this	O
inclusion	O
criterion	O
.	O

Results	O
of	O
samples	O
analyzed	O
in	O
this	O
assay	O
are	O
consistently	O
found	O
to	O
agree	O
with	O
the	O
mid	O
-	O
range	O
of	O
outcomes	O
of	O
those	O
using	O
this	O
assay	O
and	O
participating	O
in	O
the	O
international	O
DEQUAS	O
standardization	O
system	O
.	O

pain	O
or	O
caries	O
)	O
than	O
controls	O
(	O
40	O
.	O
7	O
%	O
vs	O
.	O
5	O
.	O
4	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

An	O
increase	O
in	O
serum	O
retinol	O
and	O
improved	O
anthropometric	O
status	O
(	O
weight	O
,	O
height	O
,	O
BMI	O
)	O
in	O
supplemented	O
girls	O
was	O
also	O
recorded	O
(	O
Hyder	O
et	O
al	O
2007	O
),	O
indicating	O
the	O
potential	O
benefits	O
of	O
MMN	O
supplementation	O
for	O
a	O
risk	O
group	O
attempting	O
to	O
satisfy	O
increased	O
nutritional	O
requirements	O
for	O
pubertal	O
growth	O
while	O
commonly	O
manifesting	O
a	O
substantial	O
degree	O
of	O
undernutrition	O
.	O

What	O
we	O
can	O
do	O
is	O
modulate	O
children	O
'	O
s	O
flavor	O
preferences	O
by	O
providing	O
early	O
exposure	O
,	O
starting	O
in	O
utero	O
and	O
early	O
infancy	O
,	O
to	O
a	O
variety	O
of	O
healthy	O
flavors	O
.	O

In	O
contrast	O
,	O
and	O
consistent	O
with	O
previous	O
studies	O
,	O
PFAS	O
,	O
Pb	O
,	O
and	O
OPP	O
exposures	O
were	O
more	O
strongly	O
associated	O
with	O
reduced	O
birth	O
weight	O
[	O
19	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

This	O
study	O
investigates	O
the	O
effects	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
on	O
glomerular	O
development	O
in	O
early	O
postnatal	O
life	O
and	O
its	O
effects	O
on	O
renal	O
structure	O
at	O
maturity	O
.	O

In	O
the	O
February	O
2008	O
issue	O
of	O
Food	O
and	O
Chemical	O
Toxicology	O
,	O
researchers	O
from	O
India	O
report	O
that	O
aqueous	O
garlic	O
extract	O
(	O
AGE	O
)	O
fed	O
to	O
at	O
-	O
risk	O
individuals	O
may	O
reduce	O
the	O
toxic	O
effects	O
of	O
arsenic	O
.	O

In	O
addition	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
significantly	O
lower	O
in	O
summer	O
,	O
spring	O
and	O
autumn	O
compared	O
to	O
winter	O
(	O
Table	O
4	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t004	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Risk	O
of	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
in	O
Belgium	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
(	O
n	O
=	O
1100	O
),	O
results	O
of	O
multiple	O
logistic	O
regressions	O
.	O
N	O
of	O
subjectsN	O
of	O
deficient	O
casesOR	O
[	O
95	O
%	O
Conf	O
Interval	O
]	O
p	O
Season	O
Winter4702781	O
.	O
000Spring3841270	O
.	O
2340	O
.	O
1650	O
.	O
332	O
<	O
0	O
.	O
001Summer93120	O
.	O
1000	O
.	O
0490	O
.	O
203	O
<	O
0	O
.	O
001Autumn3511660	O
.	O
5500	O
.	O
3910	O
.	O
7750	O
.	O
001BMI	O
*	O
1	O
.	O
0511	O
.	O
0221	O
.	O
080	O
<	O
0	O
.	O
001	O
Smoking	O
yes2191181	O
.	O
000no10784650	O
.	O
7010	O
.	O
4801	O
.	O
0250	O
.	O
067	O
Use	O
of	O
multivitamins	O
containing	O
vitamin	O
D	O
no4893171	O
.	O
000yes8092660	O
.	O
2240	O
.	O
1680	O
.	O
300	O
<	O
0	O
.	O
001	O
Ethnicity	O
Caucasian	O
,	O
white9553691	O
.	O
000Asiatic33192	O
.	O
8231	O
.	O
2356	O
.	O
4540	O
.	O
014African	O
(	O
black	O
)	O
64341	O
.	O
3090	O
.	O
6942	O
.	O
4680	O
.	O
406North	O
African1741306	O
.	O
0483	O
.	O
8139	O
.	O
595	O
<	O
0	O
.	O
001Hispanic1275	O
.	O
3051	O
.	O
54918	O
.	O
1670	O
.	O
008	O
Education	O
level	O
Secondary	O
education	O
or	O
less7194131	O
.	O
000High	O
school3531080	O
.	O
4880	O
.	O
3490	O
.	O
681	O
<	O
0	O
.	O
001University195520	O
.	O
5090	O
.	O
3310	O
.	O
7830	O
.	O
002	O
Frequency	O
of	O
fish	O
consumption	O
(	O
non	O
-	O
fatty	O
fish	O
)	O
Never2261171	O
.	O
000Less	O
than	O
once	O
a	O
month225900	O
.	O
5640	O
.	O
3540	O
.	O
8970	O
.	O
0161	O
–	O
3	O
days	O
a	O
month5052160	O
.	O
8390	O
.	O
5641	O
.	O
2480	O
.	O
3861	O
day	O
per	O
week2701240	O
.	O
7940	O
.	O
5061	O
.	O
2480	O
.	O
3182	O
–	O
4	O
days	O
a	O
week	O
or	O
more	O
frequent69350	O
.	O
5620	O
.	O
2891	O
.	O
0950	O
.	O
090	O
Sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
Yes8823661	O
.	O
000No4082151	O
.	O
7031	O
.	O
2482	O
.	O
3240	O
.	O
001	O
First	O
trimester	O
BMI	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
.	O

There	O
was	O
no	O
association	O
between	O
the	O
education	O
level	O
of	O
the	O
primary	O
caregiver	O
and	O
the	O
child	O
’	O
s	O
vitamin	O
D	O
status	O
with	O
respect	O
to	O
both	O
the	O
mean	O
levels	O
and	O
the	O
proportion	O
with	O
levels	O
≥	O
75	O
nmol	O
/	O
L	O
(	O
p	O
=	O
0	O
.	O
74	O
and	O
p	O
=	O
0	O
.	O
35	O
,	O
respectively	O
).	O

Smoking	O
increased	O
the	O
risk	O
of	O
both	O
vitamin	O
D	O
deficiency	O
and	O
severe	O
vitamin	O
D	O
deficiency	O
;	O
the	O
mechanism	O
for	O
this	O
appears	O
to	O
be	O
unclear	O
[	O
50	O
].	O

These	O
differences	O
cannot	O
be	O
compared	O
directly	O
due	O
to	O
discrepancies	O
in	O
national	O
guidelines	O
and	O
the	O
financial	O
barriers	O
in	O
some	O
regions	O
[	O
27	O
].	O

Two	O
have	O
concluded	O
that	O
metformin	O
is	O
as	O
effective	O
as	O
insulin	O
for	O
glycemic	O
control	O
in	O
GDM	O
,	O
and	O
that	O
it	O
is	O
safe	O
.	O

A	O
post	O
-	O
hoc	O
analysis	O
was	O
conducted	O
to	O
determine	O
if	O
BMI	O
and	O
percent	O
fat	O
had	O
an	O
effect	O
on	O
cathelicidin	O
concentration	O
.	O

Low	O
Utilization	O
of	O
Maternal	O
Health	O
Service	O
in	O
Developing	O
Countries	O
It	O
is	O
well	B
established	I
that	O
antenatal	O
care	O
provides	O
pregnant	O
women	O
with	O
opportunities	O
to	O
receive	O
cost	O
-	O
effective	O
interventions	O
which	O
are	O
beneficial	O
to	O
mother	O
and	O
child	O
;	O
these	O
interventions	O
include	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anemia	O
.	O

Methods	O
Ethics	O
Statement	O
This	O
study	O
was	O
conducted	O
according	O
to	O
the	O
guidelines	O
laid	O
down	O
in	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
all	O
procedures	O
involving	O
human	O
subjects	O
were	O
approved	O
by	O
the	O
medical	O
ethical	O
committee	O
of	O
the	O
Erasme	O
hospital	O
in	O
Brussels	O
.	O

A	O
transgenerational	O
change	O
thus	B
represents	O
epigenetic	O
inheritance	O
.	O

There	O
are	O
two	O
main	O
sources	O
of	O
obtaining	O
vitamin	O
D	O
:	O
endogenous	O
synthesis	O
and	O
exogenous	O
attainment	O
from	O
diet	O
and	O
supplementation	O
[	O
15	O
,	O
16	O
].	O

It	O
has	O
been	O
shown	O
that	O
mothers	O
with	O
higher	O
depression	O
scores	O
had	O
lower	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
compared	O
to	O
who	O
had	O
lower	O
depression	O
scores	O
[	O
34	O
].	O

Future	O
research	O
should	O
focus	O
on	O
polytherapy	O
in	O
pregnancy	O
in	O
order	O
to	O
define	O
its	O
reproductive	O
safety	O
and	O
to	O
separate	O
the	O
effects	O
of	O
medication	O
exposure	O
,	O
underlying	O
psychopathology	O
and	O
associated	O
comorbidities	O
.	O

In	O
contrast	O
to	O
the	O
above	O
-	O
mentioned	O
studies	O
,	O
our	O
results	O
show	O
that	O
the	O
combination	O
of	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
increased	O
odds	O
of	O
SGA	O
,	O
but	O
this	O
relationship	O
was	O
not	O
preserved	O
for	O
white	O
infants	O
.	O

The	O
quantity	O
μβis	O
the	O
average	O
association	O
between	O
all	O
regression	O
coefficients	O
and	O
the	O
outcome	O
,	O
whereas	O
σβcaptures	O
the	O
heterogeneity	O
of	O
effects	O
.	O

Conclusions	O
:	O
We	O
found	O
the	O
same	O
results	O
as	O
those	O
studies	O
carried	O
out	O
in	O
Europe	O
and	O
North	O
America	O
;	O
i	O
.	O
e	O
.,	O
lower	O
serum	O
vitamin	O
D	O
level	O
in	O
MS	O
patients	O
than	O
that	O
in	O
normal	O
population	O
,	O
in	O
spite	O
of	O
sufficient	O
sun	O
exposure	O
in	O
Isfahan	O
region	O
.	O

However	O
,	O
it	O
is	O
unknown	O
whether	O
changes	O
in	O
nutritional	O
programming	O
by	O
maternal	O
diet	O
restriction	O
during	O
fetal	O
development	O
could	O
modify	O
the	O
expression	O
of	O
ECS	O
components	O
later	O
in	O
life	O
and	O
lead	O
to	O
long	O
-	O
lasting	O
impact	O
on	O
energy	O
metabolism	O
and	O
feeding	O
behavior	O
.	O

The	O
reality	O
is	O
that	O
the	O
actual	O
vitamin	O
D	O
requirement	O
during	O
pregnancy	O
is	O
not	O
known	O
.	O

The	O
estimates	O
are	O
examined	O
for	O
patterns	O
by	O
sex	O
and	O
by	O
generation	O
across	O
families	O
so	O
that	O
possible	O
causes	O
may	O
be	O
inferred	O
.	O

Models	O
adjusted	O
for	O
race	O
,	O
education	O
level	O
,	O
iron	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
iron	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
)	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

Introduction	O
There	O
were	O
15	O
million	O
preterm	O
births	O
(	O
PTB	O
)	O
(<	O
37	O
weeks	O
)	O
worldwide	O
and	O
more	O
than	O
1	O
million	O
infant	O
deaths	O
from	O
PTB	O
complications	O
in	O
2010	O
[	O
1	O
].	O

Iron	O
deficiency	O
anaemia	O
accounts	O
for	O
75	O
–	O
95	O
%	O
of	O
cases	O
of	O
anaemia	O
in	O
pregnancy	O
[	O
9	O
].	O

Finally	O
,	O
adverse	O
birth	O
outcomes	O
were	O
infrequent	O
among	O
the	O
participants	O
and	O
did	O
not	O
differ	O
by	O
vaccination	O
status	O
(	O
p	O
-	O
value	O
>	O
0	O
.	O
05	O
);	O
the	O
percentage	O
with	O
preterm	O
birth	O
was	O
5	O
%,	O
small	O
for	O
gestational	O
age	O
was	O
10	O
%	O
and	O
low	O
birth	O
weight	O
was	O
6	O
%	O
(	O
Table	O
1	O
).	O

Although	O
maternal	O
obesity	O
and	O
excessive	O
GWG	O
are	O
both	O
the	O
result	O
of	O
energy	O
intake	O
exceeding	O
energy	O
expenditure	O
,	O
few	O
studies	O
have	O
examined	O
the	O
specific	O
influences	O
of	O
maternal	O
dietary	O
and	O
exercise	O
behaviors	O
during	O
pregnancy	O
on	O
offspring	O
obesity	O
risk	O
.	O

Nephrin	O
is	O
expressed	O
late	O
in	O
the	O
process	O
of	O
podocyte	O
differentiation	O
and	O
is	O
a	O
locus	O
for	O
the	O
formation	O
of	O
the	O
slit	O
diaphragm	O
,	O
foot	O
process	O
maintenance	O
and	O
physical	O
integrity	O
in	O
vivo	O
,	O
but	O
it	O
is	O
dispensable	O
for	O
cell	O
survival	O
and	O
has	O
little	O
impact	O
on	O
gene	O
regulation	O
during	O
glomerular	O
development	O
.	O

Women	O
in	O
the	O
high	O
level	O
group	O
were	O
more	O
likely	B
to	O
be	O
never	O
drinkers	O
than	O
women	O
in	O
the	O
low	O
level	O
group	O
,	O
the	O
multivariate	O
RR	O
,	O
adjusted	O
for	O
smoking	O
,	O
BMI	O
,	O
education	O
and	O
country	O
of	O
birth	O
,	O
was	O
1	O
.	O
5	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
1	O
.	O
8	O
).	O

Enhanced	O
knowledge	O
of	O
possible	O
metabolic	O
consequences	O
of	O
sleep	O
disturbances	O
in	O
pregnancy	O
will	O
likely	B
have	O
important	O
clinical	O
implications	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
impaired	O
glucose	O
tolerance	O
and	O
GDM	O
among	O
pregnant	O
women	O
.	O

Based	O
on	O
our	O
current	O
information	O
,	O
insulin	O
is	O
still	O
the	O
best	O
option	O
,	O
with	O
the	O
least	O
potential	O
for	O
long	O
-	O
term	O
risk	O
to	O
the	O
mother	O
and	O
child	O
.	O

Interestingly	O
,	O
GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	B
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
.	O

The	O
health	O
centres	O
are	O
run	O
by	O
senior	O
nurses	O
or	O
midwives	O
(	O
Head	O
of	O
centres	O
)	O
with	O
the	O
exception	O
of	O
Muea	O
health	O
centre	O
which	O
is	O
headed	O
by	O
a	O
medical	O
doctor	O
.	O

However	O
,	O
we	O
considered	O
it	O
unethical	O
to	O
withhold	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
deworming	O
from	O
women	O
of	O
reproductive	O
age	O
over	O
a	O
long	O
period	O
of	O
time	O
given	B
the	O
evidence	O
from	O
short	O
-	O
term	O
studies	O
on	O
the	O
efficacy	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
[	O
8	O
].	O

Adapted	O
from	O
(	O
Kerber	O
et	O
al	O
.,	O
2007	O
;	O
Lawn	O
et	O
al	O
.,	O
2012	O
;	O
PMNCH	O
2012	O
)	O
[	O
22	O
,	O
23	O
,	O
51	O
].	O

At	O
baseline	O
,	O
the	O
majority	O
in	O
each	O
arm	O
,	O
67	O
%	O
of	O
controls	O
and	O
60	O
%	O
of	O
intervention	O
participants	O
,	O
indicated	O
that	O
their	O
main	O
handwashing	O
station	O
was	O
near	O
the	O
tubewell	O
.	O

Steam	O
flaking	O
further	O
increases	O
marbling	O
in	O
cases	O
of	O
maize	O
and	O
sorghum	O
,	O
and	O
is	O
more	O
effective	O
for	O
sorghum	O
.	O

Maternal	O
nutrient	O
restriction	O
causes	O
adiposity	O
in	O
offspring	O
[	O
26	O
],	O
and	O
recent	O
data	O
suggest	O
that	O
maternal	O
vitamin	O
D	O
deficiency	O
affects	O
adiposity	O
,	O
although	O
the	O
mechanisms	O
are	O
not	O
yet	O
fully	O
understood	O
[	O
23	O
].	O

Results	O
at	O
3	O
months	O
Overall	O
compliance	O
with	O
the	O
vitamin	O
D	O
drops	O
was	O
excellent	O
with	O
90	O
%	O
of	O
the	O
drops	O
given	O
overall	O
based	O
on	O
measurement	O
of	O
the	O
volume	O
of	O
returned	O
droppers	O
.	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
,	O
Kruskal	O
-	O
Wallis	O
and	O
Bland	O
-	O
Altman	O
tests	O
were	O
employed	O
.	O

However	O
,	O
it	O
is	O
important	O
not	O
to	O
put	O
the	O
mother	O
on	O
a	O
rigid	O
elimination	O
diet	O
because	O
this	O
could	O
negatively	O
influence	O
the	O
nutrition	O
of	O
both	O
the	O
mother	O
and	O
the	O
growing	O
infant	O
[	O
48	O
].	O

But	O
a	O
handful	O
of	O
researchers	O
are	O
exploring	O
whether	O
certain	O
environmental	O
exposures	O
may	O
affect	O
some	O
women	O
’	O
s	O
ability	O
to	O
lactate	O
.	O

Larger	O
studies	O
are	O
needed	O
to	O
determine	O
whether	O
maternal	O
dietary	O
patterns	O
lead	O
to	O
significant	O
modifications	O
in	O
neonatal	O
anthropometric	O
measurements	O
.	O

Exclusions	O
were	O
referred	O
for	O
clinical	O
management	O
as	O
required	O
.	O

Infants	O
reported	O
to	O
have	O
never	O
been	O
introduced	O
to	O
formula	O
and	O
to	O
be	O
breastfed	O
were	O
considered	O
to	O
be	O
exclusively	O
breastfed	O
,	O
while	O
those	O
who	O
were	O
ever	O
breastfed	O
and	O
ever	O
formula	O
-	O
fed	O
were	O
considered	O
to	O
be	O
fed	O
with	O
a	O
combination	O
of	O
breast	O
milk	O
and	O
formula	O
regardless	O
of	O
whether	O
or	O
not	O
the	O
infant	O
was	O
still	O
breastfed	O
at	O
the	O
time	O
of	O
stool	O
collection	O
.	O

Studies	O
specifically	O
utilising	O
UNIMMAP	O
benefit	O
from	O
and	O
contribute	O
to	O
datasets	O
based	O
on	O
a	O
uniform	O
and	O
targeted	O
intervention	O
,	O
facilitating	O
the	O
interpretation	O
and	O
reproducibility	O
of	O
their	O
results	O
.	O

Data	O
obtained	O
from	O
physicians	O
were	O
cross	O
-	O
referenced	O
with	O
information	O
provided	O
by	O
the	O
mothers	O
in	O
order	O
to	O
increase	O
accuracy	O
and	O
minimise	O
recall	O
bias	O
.	O

Castration	O
Castration	O
of	O
bulls	O
generally	B
increases	O
IMF	O
content	O
in	O
several	O
cattle	O
breeds	O
,	O
although	O
it	O
reduces	O
growth	O
rate	O
[	O
40	O
].	O

This	O
information	O
was	O
delivered	O
through	O
two	O
dedicated	O
sessions	O
with	O
the	O
research	O
dietician	O
(	O
at	O
trial	O
entry	O
,	O
and	O
28	O
weeks	O
)	O
and	O
trained	O
research	O
assistants	O
(	O
via	O
telephone	O
call	O
at	O
22	O
,	O
24	O
,	O
and	O
32	O
weeks	O
,	O
and	O
a	O
face	O
–	O
face	O
visit	O
at	O
36	O
weeks	O
)	O
[	O
21	O
,	O
22	O
].	O

As	O
our	O
results	O
suggest	O
,	O
distinct	O
mechanisms	O
and	O
selective	O
pressures	O
are	O
likely	B
responsible	O
for	O
their	O
alteration	O
.	O

Primigravida	O
on	O
the	O
contrary	O
expected	O
vital	O
information	O
from	O
the	O
health	O
talks	O
to	O
help	O
them	O
cope	O
well	O
with	O
their	O
pregnancy	O
and	O
labor	O
[	O
29	O
].	O

Indeed	O
,	O
numerous	O
environmental	O
factors	O
have	O
been	O
shown	O
to	O
induce	O
epigenetic	O
changes	O
via	O
a	O
variety	O
of	O
mechanisms	O
.	O

Furthermore	O
,	O
sex	O
specific	O
differences	O
in	O
pregnancy	O
outcome	O
have	O
also	O
been	O
reported	O
whereby	O
the	O
risk	O
of	O
sPTB	O
,	O
PE	O
and	O
GDM	O
are	O
all	O
higher	O
in	O
pregnancies	O
with	O
a	O
male	O
fetus	O
[	O
48	O
–	O
50	O
].	O

RNA	O
was	O
quantified	O
by	O
spectrometry	O
with	O
a	O
NanoDrop	O
ND	O
-	O
1000	O
spectrophotometer	O
(	O
PEQLAB	O
,	O
Erlangen	O
,	O
Germany	O
).	O

While	O
there	O
are	O
,	O
for	O
example	O
,	O
more	O
mothers	O
than	O
fathers	O
,	O
there	O
are	O
relatively	O
less	O
grandparents	O
,	O
and	O
yet	O
both	O
grandmothers	O
do	O
show	O
statistically	O
significant	O
associations	O
.	O

The	O
decrease	O
in	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
with	O
increased	O
maternal	O
fish	O
and	O
seafood	O
intake	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
is	O
a	O
possibly	O
beneficial	O
change	O
to	O
infant	O
intestinal	O
microbial	O
communities	O
.	O

Examinations	O
of	O
infant	O
lung	O
function	O
were	O
successfully	O
performed	O
for	O
71	O
infants	O
at	O
6	O
months	O
of	O
age	O
.	O

Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sex	O
.	O

Primary	O
MTC	O
lesions	O
become	O
visible	O
at	O
echography	O
as	O
solid	O
masses	O
,	O
often	B
with	O
calcifications	O
.	O

Follow	O
-	O
up	O
of	O
a	O
smaller	O
proportion	O
of	O
child	O
participants	O
at	O
2	O
to	O
3	O
years	O
of	O
age	O
[	O
42	O
,	O
43	O
]	O
demonstrated	O
no	O
significant	O
differences	O
in	O
the	O
metabolic	O
profile	O
of	O
children	O
[	O
42	O
],	O
or	O
on	O
measures	O
of	O
growth	O
and	O
adiposity	O
[	O
43	O
].	O

In	O
nonpregnant	O
humans	O
,	O
intake	O
of	O
soft	O
drinks	O
and	O
junk	O
food	O
[	O
13	O
],	O
higher	O
dietary	O
disinhibition	O
[	O
14	O
],	O
and	O
restrictive	O
dieting	O
practices	O
[	O
15	O
]	O
have	O
been	O
positively	O
correlated	O
with	O
overweight	O
in	O
children	O
.	O

Biochemical	O
analyses	O
Haemoglobin	O
is	O
determined	O
on	O
site	O
in	O
whole	O
blood	O
(	O
20	O
μL	O
)	O
using	O
HemoCue	O
(	O
Hb	O
201	O
+,	O
Ängelholm	O
,	O
Sweden	O
).	O

Thus	O
,	O
1	O
,	O
290	O
women	O
remained	O
for	O
analysis	O
.	O

ESR	O
is	O
a	O
non	O
-	O
specific	O
,	O
indirect	O
measurement	O
of	O
plasma	O
acute	O
-	O
phase	O
protein	O
and	O
systemic	O
inflammatory	O
status	O
that	O
is	O
known	O
to	O
correlate	O
with	O
haemoglobin	O
and	O
plasma	O
fibrinogen	O
concentrations	O
(	O
Kanfer	O
and	O
Nicol	O
1997	O
).	O

Genes	O
associated	O
with	O
the	O
'	O
complement	O
system	O
'	O
showed	O
increased	O
mRNA	O
expression	O
levels	O
,	O
whereas	O
the	O
canonical	O
pathway	O
'	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
'	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
.	O

In	O
order	O
to	O
assess	O
the	O
effectiveness	O
of	O
MMN	O
supplementation	O
in	O
anaemia	O
prevention	O
in	O
rural	O
Gambian	O
women	O
,	O
we	O
analysed	O
a	O
sub	O
-	O
sample	O
of	O
participants	O
enrolled	O
as	O
part	O
of	O
a	O
large	O
MMN	O
,	O
placebo	O
-	O
controlled	O
supplementation	O
trial	O
.	O

Glucose	O
response	O
to	O
a	O
glucose	O
load	O
was	O
measured	O
at	O
18	O
weeks	O
post	O
-	O
weaning	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

In	O
our	O
study	O
setting	O
,	O
according	O
to	O
the	O
recommendations	O
from	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
[	O
25	O
],	O
all	O
pregnant	O
women	O
were	O
screened	O
at	O
24	O
-	O
28	O
weeks	O
gestation	O
using	O
a	O
50	O
gram	O
1	O
-	O
hour	O
oral	O
glucose	O
challenge	O
test	O
.	O

Hence	B
there	O
is	O
a	O
need	O
to	O
mobilize	O
efforts	O
for	O
a	O
better	O
quality	O
assessment	O
in	O
our	O
health	O
care	O
provision	O
with	O
the	O
aim	O
of	O
improving	O
quality	O
in	O
terms	O
of	O
provision	O
of	O
health	O
care	O
services	O
.	O

The	O
intake	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
was	O
significantly	O
less	O
common	O
in	O
women	O
who	O
declared	O
the	O
pregnancy	O
was	O
unwanted	O
.	O

Season	O
of	O
first	O
antenatal	O
visit	O
was	O
categorised	O
as	O
extended	O
winter	O
(	O
November	O
–	O
April	O
)	O
or	O
extended	O
summer	O
(	O
May	O
–	O
October	O
).	O

75	O
%	O
of	O
black	O
and	O
19	O
%	O
of	O
white	O
women	O
were	O
vitamin	O
D	O
deficient	O
in	O
the	O
first	O
trimester	O
.	O

In	O
a	O
recent	O
population	O
-	O
based	O
cohort	O
study	O
in	O
Norway	O
,	O
it	O
was	O
shown	O
that	O
a	O
positive	O
association	O
exists	O
for	O
cesarean	O
delivery	O
and	O
risk	O
of	O
asthma	O
in	O
the	O
child	O
(	O
especially	O
when	O
the	O
cesarean	O
delivery	O
was	O
performed	O
because	O
of	O
an	O
emergency	O
in	O
contrast	O
to	O
a	O
planned	O
section	O
)	O
[	O
92	O
].	O

Several	O
studies	O
have	O
reported	O
that	O
early	O
weaning	O
or	O
early	O
weaning	O
combined	O
with	O
a	O
high	O
-	O
grain	O
diet	O
increases	O
IMF	O
deposition	O
in	O
beef	O
cattle	O
.	O

The	O
EPA	O
has	O
mapped	O
521	O
abandoned	O
uranium	O
mines	O
on	O
the	O
reservation	O
,	O
ranging	O
from	O
small	O
holes	O
dug	O
by	O
a	O
single	O
prospector	O
into	O
the	O
side	O
of	O
a	O
mesa	O
to	O
large	O
commercial	O
mining	O
operations	O
.	O
1The	O
Navajo	O
people	O
did	O
not	O
have	O
a	O
word	O
for	O
“	O
radioactivity	O
”	O
when	O
mining	O
outfits	O
looking	O
for	O
vanadium2and	O
uranium3began	O
moving	O
onto	O
their	O
land	O
in	O
the	O
1940s	O
,	O
and	O
they	O
did	B
not	I
understand	I
that	O
radiation	O
could	O
be	O
dangerous	O
.	O

One	O
fifth	O
of	O
the	O
participants	O
were	O
dissatisfied	O
with	O
the	O
amenities	O
that	O
were	O
provided	O
at	O
some	O
of	O
the	O
health	O
institutions	O
.	O

Inclusion	O
of	O
such	O
endpoints	O
as	B
non	O
-	O
compulsory	O
measurements	O
would	O
(	O
1	O
)	O
encourage	O
better	O
use	O
of	O
existing	O
studies	O
by	O
adding	O
a	O
valuable	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
component	O
that	O
is	O
not	O
currently	O
included	O
,	O
(	O
2	O
)	O
provide	O
an	O
extensive	O
sample	O
resource	O
and	O
(	O
3	O
)	O
initiate	O
the	O
collection	O
of	O
epigenetic	O
data	O
in	O
a	O
regulatory	O
context	O
.	O

These	O
associations	O
were	O
strongest	O
in	O
nonsmokers	O
.	O
16	O
Caption	O
(	O
FIG	O
)	O
Lactation	O
support	O
includes	O
teaching	O
women	O
techniques	O
to	O
breastfeed	O
and	O
build	O
their	O
milk	O
supply	O
,	O
as	O
well	O
as	O
reassuring	O
them	O
of	O
their	O
ability	O
to	O
nourish	O
their	O
infants	O
.	O

At	O
weaning	O
,	O
renin	O
expression	O
did	O
not	O
differ	O
between	O
the	O
VitD	O
-	O
and	O
SC	O
mice	O
in	O
either	O
the	O
F1	O
or	O
F2	O
generations	O
.	O

This	O
could	O
be	O
interpreted	B
as	I
support	O
of	O
our	O
finding	O
that	O
late	O
rather	O
than	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
is	O
the	O
stronger	O
predictor	O
of	O
fetal	O
growth	O
restriction	O
.	O

Instead	O
,	O
like	O
older	O
children	O
,	O
they	O
were	O
more	O
likely	B
to	O
eat	O
fatty	O
foods	O
such	O
as	O
french	O
fries	O
,	O
salty	O
snacks	O
,	O
and	O
sweet	O
beverages	O
and	O
less	O
likely	B
to	O
eat	O
bitter	O
-	O
tasting	O
vegetables	O
(	O
36	O
,	O
37	O
).	O

Statistical	O
analysis	O
Data	O
was	O
blinded	O
until	O
completion	O
of	O
the	O
analysis	O
,	O
which	O
was	O
performed	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

The	O
vitamin	O
D3and	O
the	O
placebo	O
were	O
the	O
same	O
colour	O
(	O
pale	O
yellow	O
),	O
taste	O
,	O
and	O
quantity	O
(	O
0	O
·	O
5	O
mL	O
)	O
and	O
therefore	O
the	O
study	O
staff	O
and	O
the	O
families	O
did	O
not	O
know	O
to	O
which	O
group	O
the	O
children	O
were	O
assigned	O
.	O

The	O
study	O
was	O
restricted	O
to	O
a	O
sub	O
-	O
sample	O
of	O
geographically	O
selected	O
villages	O
but	O
this	O
does	O
not	O
appear	O
to	O
have	O
biased	O
the	O
results	O
of	O
the	O
study	O
,	O
as	B
the	O
placebo	O
and	O
intervention	O
groups	O
were	O
comparable	O
at	O
baseline	O
.	O

Temperature	O
,	O
humidity	O
,	O
precipitation	O
,	O
and	O
indoor	O
air	O
quality	O
are	O
among	O
the	O
mitigating	O
factors	O
that	O
may	O
affect	O
the	O
survival	O
and	O
transmissibility	O
of	O
a	O
pathogen	O
and	O
explain	O
different	O
seasonal	O
peaks	O
for	O
a	O
disease	O
in	O
different	O
studies	O
.	O

The	O
methylation	O
status	O
of	O
these	O
elements	O
may	O
represent	O
a	O
passive	O
dosimeter	O
by	O
being	O
altered	O
by	O
various	O
exposures	O
,	O
although	O
differences	O
in	O
the	O
underlying	O
structure	O
of	O
these	O
elements	O
and	O
the	O
unclear	O
function	O
of	O
methylation	O
of	O
these	O
regions	O
suggest	O
that	O
their	O
alteration	O
and	O
their	O
potential	O
relevance	O
need	O
to	O
be	O
more	O
carefully	O
examined	O
.	O

Methods	O
To	O
obtain	O
vitamin	O
D3depletion	O
,	O
female	O
Sprague	O
-	O
Dawley	O
rats	O
(	O
Herston	O
Animal	O
Facility	O
,	O
Queensland	O
,	O
Australia	O
)	O
were	O
kept	O
on	O
a	O
vitamin	O
D	O
deficient	O
diet	O
(	O
Dyets	O
Inc	O
.,	O
PA	O
,	O
USA	O
).	O

Findings	O
1524	O
children	O
were	O
assigned	O
to	O
receive	O
vitamin	O
D3and	O
1522	O
placebo	O
.	O

The	O
survey	O
instrument	O
included	O
24	O
validated	O
items	O
on	O
participant	O
attitudes	O
,	O
beliefs	O
,	O
and	O
behaviors	O
related	O
to	O
the	O
text	O
messages	O
contained	O
in	O
text4baby	O
,	O
which	O
were	O
repeated	O
in	O
the	O
4	O
surveys	O
in	O
this	O
study	O
as	O
described	O
in	O
detail	O
elsewhere	O
[	O
23	O
].	O

Serum	O
calcium	O
was	O
7	O
.	O
5	O
mg	O
/	O
dl	O
.	O

Expression	O
of	O
cathelicidin	O
,	O
an	O
antimicrobial	O
peptide	O
,	O
can	O
be	O
augmented	O
by	O
lung	O
epithelial	O
cells	O
under	O
the	O
stimulation	O
of	O
vitamin	O
D	O
[	O
48	O
].	O

Since	B
this	O
new	O
standard	O
of	O
care	O
was	O
implemented	O
in	O
September	O
2015	O
,	O
there	O
have	O
been	O
ongoing	O
improvements	O
in	O
automation	O
,	O
provider	O
practice	O
,	O
and	O
integration	O
within	O
the	O
existing	O
MUSC	O
health	O
care	O
system	O
.	O

At	O
this	O
time	O
point	O
the	O
fetuses	O
were	O
subjected	O
to	O
a	O
serious	O
nutritional	O
deficiency	O
that	O
requires	O
an	O
acute	O
transcriptomic	O
response	O
.	O

The	O
expression	O
of	O
1	O
-	O
α	O
hydroxylase	O
is	O
increased	O
in	O
the	O
kidney	O
and	O
placenta	O
and	O
the	O
concentration	O
of	O
serum	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
increases	O
in	O
normal	O
pregnancy	O
from	O
the	O
first	O
to	O
the	O
third	O
trimester	O
.	O

Evidence	O
for	O
genetic	O
influence	O
on	O
intake	O
regulation	O
is	O
also	O
reflected	O
in	O
the	O
relative	O
stability	O
of	O
behaviors	O
like	O
EAH	O
within	O
people	O
during	O
2	O
-	O
to	O
6	O
-	O
year	O
periods	O
in	O
childhood	O
(	O
47	O
,	O
67	O
).	O

The	O
position	O
of	O
chocolate	O
mixture	O
was	O
switched	O
every	O
day	O
.	O

It	O
is	O
still	O
unknown	O
whether	O
both	O
,	O
the	O
endocannabinoid	O
(	O
eCB	O
)	O
machinery	O
and	O
the	O
lipid	O
metabolism	O
are	O
implicated	O
in	O
long	O
-	O
term	O
adaptive	O
responses	O
to	O
fetal	O
reprogramming	O
caused	O
by	O
maternal	O
undernutrition	O
.	O

Its	O
pathophysiology	O
is	O
thought	O
to	O
result	O
from	O
increased	O
degradation	O
of	O
arginine	O
vasopressin	O
(	O
AVP	O
)	O
by	O
a	O
placental	O
enzyme	O
called	O
vasopressinase	O
.	O

Metabolism	O
is	O
another	O
major	O
factor	O
that	O
can	O
determine	O
the	O
overall	O
effect	O
of	O
an	O
environmental	O
exposure	O
.	O

The	O
filter	O
paper	O
cards	O
are	O
allowed	O
to	O
dry	O
at	O
room	O
temperature	O
for	O
24	O
h	O
,	O
placed	O
in	O
ziplock	O
bags	O
with	O
desiccants	O
,	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
until	O
analysis	O
.	O

Briefly	O
,	O
data	O
are	O
collected	O
early	O
pregnancy	O
,	O
mid	O
-	O
pregnancy	O
,	O
late	O
pregnancy	O
and	O
at	O
birth	O
.	O

To	O
examine	O
whether	O
“	O
global	O
methylation	O
”	O
represented	O
as	O
an	O
average	O
of	O
gene	O
-	O
associated	O
methylation	O
identified	O
in	O
a	O
genomewide	O
manner	O
was	O
associated	O
with	O
infant	O
growth	O
,	O
we	O
tested	O
for	O
an	O
association	O
between	O
birth	O
weight	O
percentile	O
and	O
mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
loci	O
measured	O
using	O
the	O
Illumina	O
Infinium	O
array	O
in	O
a	O
subset	O
of	O
184	O
placenta	O
samples	O
.	O

Background	O
Insufficient	O
sleep	O
duration	O
and	O
poor	O
sleep	O
quality	O
are	O
considered	O
to	O
be	O
endemic	O
in	O
modern	O
society	O
.	O

Although	O
not	O
reaching	O
statistical	O
significance	O
,	O
more	O
women	O
receiving	O
monotherapy	O
breastfed	O
compared	O
with	O
those	O
receiving	O
polytherapy	O
,	O
and	O
women	O
in	O
the	O
polytherapy	O
group	O
were	O
approximately	O
twice	O
as	O
likely	B
to	O
suffer	O
from	O
hypertension	O
(	O
12	O
.	O
5	O
%	O
vs	O
5	O
.	O
4	O
%)	O
and	O
gestational	O
diabetes	O
(	O
9	O
.	O
4	O
%	O
vs	O
5	O
.	O
4	O
%).	O

Scoliotic	O
and	O
lordotic	O
curvatures	O
of	O
the	O
vertebral	O
columns	O
are	O
indicated	O
by	O
arrowhead	O
relative	O
to	O
wild	O
-	O
type	O
littermates	O
.	O

Non	O
z	O
-	O
score	O
outcomes	O
were	O
additionally	O
adjusted	O
for	O
actual	O
age	O
at	O
assessment	O
and	O
infant	O
gender	O
.	O

However	O
,	O
at	O
all	O
ages	O
,	O
both	O
F1	O
and	O
F2	O
VitD	O
-	O
mice	O
had	O
shorter	O
glomerular	O
diameters	O
,	O
and	O
diet	O
played	O
a	O
significant	O
role	O
in	O
the	O
total	O
variation	O
.	O

Complex	O
evaluation	O
of	O
vitamin	O
D	O
activity	O
mechanism	O
on	O
fertility	O
requires	O
further	O
studies	O
.	O

Depending	O
of	O
the	O
size	O
of	O
the	O
fold	O
changes	O
,	O
we	O
planned	O
to	O
use	O
western	O
blot	O
and	O
/	O
or	O
bioinformatics	O
as	O
secondary	O
analyses	O
.	O

Other	O
studies	O
,	O
however	O
,	O
found	O
no	O
link	O
between	O
feeding	O
restriction	O
and	O
EAH	O
(	O
54	O
).	O

It	O
may	O
also	O
exert	O
determinant	O
developmental	O
effects	O
,	O
given	O
the	O
observation	O
that	O
the	O
postnatal	O
maturation	O
of	O
BAT	O
appears	O
to	O
relate	O
to	O
the	O
onset	O
of	O
feeding	O
and	O
initiation	O
of	O
hepatic	O
function	O
,	O
as	O
mediated	O
by	O
the	O
release	O
of	O
FGF21	O
(	O
Hondares	O
et	O
al	O
.,	O
2010	O
).	O

Given	O
that	O
vitamin	O
D	O
levels	O
in	O
the	O
population	O
fluctuate	O
across	O
the	O
seasons	O
and	O
decrease	O
across	O
higher	O
latitude	O
[	O
4	O
],	O
low	O
prenatal	O
vitamin	O
D	O
‘	O
fits	O
’	O
these	O
key	O
environmental	O
features	O
and	O
is	O
therefore	B
a	O
plausible	O
candidate	O
risk	O
factor	O
for	O
this	O
disease	O
.	O

3	O
.	O
6	O
.	O

Cancer	O
Causes	O
Control	O
15	O
(	O
6	O
):	O
559	O
–	O
570	O
.	O

of	O
total	O
regulated	O
probe	O
-	O
setsNo	O
.	O

Another	O
study	O
randomized	O
29	O
women	O
with	O
GDM	O
to	O
30	O
minutes	O
of	O
exercise	O
at	O
70	O
%	O
estimated	O
maximal	O
heart	O
rate	O
,	O
3	O
–	O
4	O
times	O
per	O
week	O
,	O
or	O
control	O
.	O
32There	O
was	O
a	O
trend	O
to	O
improved	O
glucose	O
levels	O
in	O
those	O
who	O
exercised	O
,	O
which	O
did	O
not	O
reach	O
significance	O
.	O

Women	O
who	O
have	O
vitamin	O
D	O
deficiency	O
do	O
not	O
usually	O
feel	O
any	O
different	O
but	O
in	O
some	O
may	O
have	O
muscle	O
weakness	O
and	O
weakened	O
bones	O
.	O

Adverse	O
health	O
outcomes	O
during	O
pregnancy	O
are	O
preeclampsia	O
;	O
gestational	O
diabetes	O
mellitus	O
and	O
caesarean	O
section	O
.	O

The	O
participants	O
were	O
selected	O
from	O
one	O
prenatal	O
clinic	O
.	O

Blood	O
samples	O
were	O
briefly	O
collected	O
into	O
tubes	O
containing	O
EDTA	O
(	O
6	O
%)	O
and	O
centrifuged	O
(	O
1500	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
).	O

These	O
are	O
largely	O
consensus	B
-	O
based	O
as	B
the	O
risk	O
of	O
complications	O
is	O
continuous	O
and	O
there	O
are	O
no	O
obvious	O
thresholds	O
above	O
which	O
the	O
risk	O
markedly	O
increases	O
.	O

Much	O
of	O
the	O
early	O
research	O
in	O
this	O
field	O
was	O
conducted	O
by	O
May	O
Mellanby	O
,	O
who	O
identified	O
an	O
association	O
between	O
vitamin	O
D	O
supplementation	O
and	O
reduced	O
caries	O
-	O
risk	O
[	O
18	O
,	O
31	O
].	O

“	O
We	O
started	O
to	O
look	O
at	O
breastfeeding	O
as	B
a	O
confounding	O
factor	O
in	O
our	O
studies	O
primarily	B
because	B
it	O
is	O
known	O
to	O
be	O
beneficial	O
to	O
child	O
health	O
,”	O
he	O
says	O
.	O

College	O
Station	O
,	O
TX	O
:	O
StataCorp	O
LP	O
).	O

Pre	O
-	O
eclampsia	O
,	O
coupled	O
with	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
,	O
resulted	O
in	O
significant	O
increases	O
in	O
the	O
predicted	O
probability	B
of	O
delivering	O
an	O
SGA	O
infant	O
.	O

This	O
association	O
persisted	O
in	O
multivariate	O
analysis	O
adjusting	O
for	O
maternal	O
age	O
,	O
BMI	O
,	O
smoking	O
status	O
,	O
physical	O
activity	O
,	O
educational	O
achievement	O
and	O
season	O
of	O
blood	O
sampling	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
per	O
T	O
allele	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
016	O
].	O

Ironically	O
,	O
both	O
early	O
gestational	O
iron	O
-	O
deficiency	O
anemia	O
and	O
hemoconcentration	O
later	O
in	O
pregnancy	O
increase	O
the	O
risk	O
of	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
assessed	O
by	O
chemiluminescence	O
immunoassay	O
(	O
Liaison	O
automated	O
platform	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

This	O
was	O
done	O
through	O
a	O
cohort	O
study	O
using	O
555	O
,	O
828	O
children	O
in	O
Denmark	O
using	O
information	O
from	O
a	O
birth	O
register	O
and	O
evaluated	O
with	O
statistical	O
analyses	O
.	O

However	O
,	O
in	O
a	O
cross	O
-	O
sectional	O
setting	O
causal	O
relationships	O
cannot	O
be	O
determined	O
.	O

The	O
gestation	O
period	O
is	O
very	O
important	O
because	O
it	O
determines	O
the	O
fate	O
of	O
progenitor	O
cells	O
that	O
will	O
become	O
muscle	O
cells	O
,	O
fibroblasts	O
,	O
or	O
adipocytes	O
[	O
16	O
].	O

[	O
20	O
]	O
included	O
the	O
home	O
environment	O
as	O
a	O
confounder	O
,	O
but	O
not	O
paternal	O
IQ	O
.	O

Despite	O
active	O
research	O
and	O
impressive	O
improvements	O
in	O
the	O
understanding	O
of	O
the	O
regulation	O
of	O
energy	O
balance	O
,	O
there	O
are	O
only	O
a	O
very	O
limited	O
number	O
of	O
drugs	O
that	O
can	O
be	O
used	O
for	O
the	O
efficient	O
treatment	O
of	O
obesity	O
and	O
its	O
comorbidities	O
.	O

The	O
DXA	O
instrument	O
undergoes	O
regularly	O
scheduled	O
quality	O
control	O
testing	O
for	O
phantom	O
reproducibility	O
and	O
signal	O
uniformity	O
.	O

Supplementation	O
of	O
women	O
is	O
more	O
costly	O
per	O
person	O
,	O
but	O
has	O
a	O
stronger	O
effect	O
on	O
anaemia	O
.	O

Statistical	O
methods	O
.	O

After	O
staining	O
and	O
washing	O
steps	O
the	O
arrays	O
were	O
scanned	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

Shown	O
as	O
β	O
and	O
95	O
%	O
CI	O
.	O

They	O
were	O
randomized	O
to	O
receive	O
treatment	O
for	O
GDM	O
,	O
including	O
dietary	O
advice	O
,	O
blood	O
glucose	O
monitoring	O
,	O
and	O
insulin	O
as	O
required	O
,	O
or	O
standard	O
pregnancy	O
care	O
.	O

Hypocalcemia	O
has	O
also	O
been	O
shown	O
to	O
occur	O
in	O
exclusively	O
breast	O
fed	O
babies	O
not	O
exposed	O
to	O
sunlight	O
and	O
in	O
infants	O
whose	O
mothers	O
are	O
deficient	O
in	O
vitamin	O
D	O
.[	O
1	O
]	O
Symptoms	O
of	O
hypocalcemia	O
in	O
children	O
include	O
lethargy	O
,	O
recurrent	O
respiratory	O
tract	O
infections	O
,	O
focal	O
clonic	O
seizures	O
,	O
jitteriness	O
,	O
carpopedal	O
spasm	O
and	O
rarely	O
stridor	O
due	O
to	O
laryngospasm	O
.	O

These	O
findings	O
are	O
supported	O
by	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

High	O
Prevalence	O
of	O
Vitamin	O
D	O
Deficiency	O
in	O
Pregnant	O
Women	O
:	O
A	O
National	O
Cross	O
-	O
Sectional	O
Survey	O
Abstract	O
An	O
increasing	O
number	O
of	O
studies	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
,	O
neonates	O
and	O
children	O
.	O

Carney	O
et	O
al	O
.	O

Vitamin	O
D	O
status	O
is	O
determined	O
by	O
measuring	O
circulating	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D2	O
+	O
3	O
(	O
25	O
(	O
OH	O
)	O
D	O
).	O

As	O
with	O
asthma	O
,	O
preexisting	O
AR	O
can	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
[	O
27	O
].	O

Other	O
factors	O
include	O
poor	O
nutrition	O
,	O
crowding	O
,	O
seasonal	O
travel	O
,	O
hygiene	O
practices	O
,	O
cultural	O
practices	O
in	O
food	O
consumption	O
/	O
preparation	O
,	O
changes	O
in	O
herd	O
immunity	O
,	O
or	O
evolution	O
of	O
the	O
infectious	O
agent	O
over	O
time	O
.	O

Our	O
findings	O
provide	O
further	O
support	O
for	O
the	O
hypothesis	O
that	O
an	O
aberration	O
in	O
lipid	O
metabolism	O
may	O
be	O
involved	O
in	O
the	O
biochemical	O
basis	O
for	O
psychiatric	O
disorders	O
[	O
13	O
].	O

The	O
offspring	O
of	O
overweight	O
mothers	O
were	O
larger	O
at	O
birth	O
but	O
,	O
by	O
6	O
-	O
months	O
,	O
did	O
not	O
significantly	O
differ	O
from	O
those	O
of	O
normal	O
weight	O
mothers	O
.	O

Those	O
children	O
whose	O
mothers	O
were	O
not	O
exposed	O
to	O
folic	O
acid	O
comprised	O
0	O
.	O
21	O
%	O
of	O
the	O
group	O
.	O

However	O
,	O
it	O
is	O
unclear	O
at	O
this	O
time	O
whether	O
or	O
not	O
supplementation	O
of	O
vitamins	O
such	O
as	O
folate	O
can	O
reduce	O
congenital	O
anomalies	O
in	O
men	O
with	O
an	O
otherwise	O
well	O
-	O
balanced	O
diet	O
.	O

Regarding	O
formal	O
education	O
,	O
25	O
.	O
5	O
%	O
had	O
completed	O
less	O
than	O
8	O
years	O
of	O
school	O
,	O
whereas	O
34	O
.	O
0	O
%	O
had	O
a	O
university	O
degree	O
.	O

However	O
,	O
unlike	O
the	O
HAPO	O
trial	O
,	O
we	O
found	O
increased	O
fasting	O
plasma	O
glucose	O
in	O
late	O
pregnancy	O
among	O
those	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

As	O
shown	O
in	O
Figure2	O
,	O
there	O
was	O
a	O
greater	O
increase	O
in	O
25	O
(	O
OH	O
)	O
D	O
in	O
those	O
with	O
starting	O
values	O
<	O
20	O
ng	O
/	O
mL	O
(	O
n	O
=	O
18	O
,	O
increase	O
of	O
20	O
.	O
4	O
±	O
8	O
.	O
2	O
ng	O
/	O
mL	O
)	O
versus	O
an	O
increase	O
of	O
9	O
.	O
2	O
±	O
10	O
.	O
6	O
ng	O
/	O
mL	O
in	O
those	O
20	O
subjects	O
with	O
a	O
starting	O
25	O
(	O
OH	O
)	O
D	O
value	O
>	O
20	O
ng	O
/	O
mL	O
(	O
Figure2	O
).	O

Apart	O
from	O
the	O
structured	O
clinical	O
contacts	O
outlined	O
(	O
during	O
which	O
subjects	O
were	O
given	O
transport	O
and	O
a	O
meal	O
)	O
no	O
additional	O
benefits	O
were	O
provided	O
to	O
trial	O
participants	O
.	O

Women	O
with	O
no	O
or	O
few	O
psychotic	O
-	O
like	O
symptoms	O
smoked	O
less	O
than	O
women	O
in	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
.	O

The	O
considerable	O
inter	O
-	O
and	O
intra	O
-	O
human	O
/	O
mammalian	O
variation	O
combined	O
with	O
the	O
vast	O
number	O
of	O
potential	O
epigenetic	O
changes	O
make	O
this	O
a	O
very	O
challenging	O
task	O
.	O

Factors	O
associated	O
with	O
vitamin	O
and	O
mineral	O
supplementation	O
during	O
pregnancy	O
Age	O
,	O
level	O
of	O
education	O
,	O
being	O
married	O
and	O
low	O
gestational	O
age	O
at	O
the	O
first	O
prenatal	O
check	O
-	O
up	O
and	O
total	O
number	O
of	O
prenatal	O
medical	O
visits	O
were	O
positively	O
associated	O
with	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
.	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Strengths	O
and	O
limitations	O
of	O
this	O
study	O
This	O
is	O
one	O
of	O
the	O
few	O
studies	O
to	O
examine	O
association	O
between	O
grandparents	O
’	O
characteristics	O
and	O
grandchildren	O
'	O
s	O
growth	O
across	O
seven	O
lineages	O
and	O
at	O
three	O
time	O
points	O
.	O

For	O
example	O
,	O
the	O
G	O
allele	O
at	O
rs12785878	O
(	O
DHCR7	O
)	O
is	O
typically	O
more	O
prevalent	O
in	O
nonwhite	O
populations	O
(	O
25	O
–	O
29	O
).	O

All	O
statistical	O
analyses	O
were	O
conducted	O
using	O
the	O
IBM	O
SPSS	O
program	O
for	O
Windows	O
,	O
version	O
22	O
(	O
IBM	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

The	O
glycosylated	O
hemoglobin	O
A1C	O
(	O
HBA1C	O
),	O
serum	O
25	O
-	O
OH	O
-	O
D	O
,	O
parathyroid	O
hormone	O
(	O
PTH	O
),	O
serum	O
calcium	O
and	O
phosphorus	O
were	O
measured	O
.	O

The	O
MS	O
of	O
Korean	O
cattle	O
steers	O
(	O
81	O
animals	O
)	O
raised	O
at	O
the	O
Livestock	O
Improvement	O
Main	O
Center	O
of	O
the	O
National	O
Agricultural	O
Cooperative	O
Federation	O
in	O
Korea	O
increased	O
from	O
6	O
.	O
0	O
to	O
7	O
.	O
06	O
as	O
slaughter	O
age	O
increased	O
from	O
26	O
to	O
31	O
months	O
[	O
68	O
].	O

Vitamin	O
D	O
,	O
which	O
has	O
a	O
unique	O
role	O
in	O
brain	O
homeostasis	O
,	O
embryogenesis	O
and	O
neurodevelopment	O
,	O
neural	O
differentiation	O
,	O
and	O
gene	O
regulation	O
,	O
has	O
recently	O
been	O
proposed	O
as	O
a	O
possible	O
environmental	O
risk	O
factor	O
for	O
autism	O
during	O
early	O
childhood	O
.	O

Although	O
14	O
.	O
3	O
%	O
of	O
exposed	O
mothers	O
were	O
also	O
taking	O
an	O
antiepileptic	O
drug	O
,	O
primarily	O
lamotrigine	O
,	O
the	O
reported	O
malformations	O
were	O
not	O
found	O
among	O
those	O
infants	O
exposed	O
to	O
anticonvulsants	O
.	O

The	O
present	O
trial	O
showed	O
that	O
consuming	O
2000	O
IU	O
vitamin	O
D3per	O
day	O
in	O
late	O
pregnancy	O
was	O
effective	O
in	O
decreasing	O
depression	O
scores	O
in	O
perinatal	O
period	O
.	O

This	O
is	O
consistent	O
with	O
our	O
previous	O
observations	O
that	O
these	O
offspring	O
have	O
altered	O
leptin	O
regulation	O
and	O
are	O
hyperleptinemic	O
as	O
adults	O
[	O
51	O
].	O

This	O
was	O
more	O
pronounced	O
in	O
women	O
who	O
received	O
best	O
-	O
practice	O
care	O
(	O
25	O
.	O
0	O
%	O
(	O
yes	O
)	O
vs	O
.	O
27	O
.	O
2	O
%	O
(	O
no	O
)).	O

Simpler	O
and	O
lower	O
-	O
cost	O
methods	O
for	O
measuring	O
gestational	O
age	O
are	O
particularly	O
needed	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
the	O
burden	O
of	O
preterm	O
birth	O
is	O
highest	O
.	O

Continuous	O
data	O
were	O
compared	O
between	O
groups	O
using	O
independent	O
t	O
tests	O
and	O
Mann	O
-	O
Whitney	O
U	O
tests	O
when	O
data	O
violated	O
assumptions	O
.	O

It	O
may	O
be	O
hypothesised	O
that	O
during	O
winter	O
months	O
,	O
which	O
are	O
characterised	O
by	O
increased	O
darkness	O
,	O
women	O
may	O
be	O
exposed	O
to	O
melatonin	O
close	O
to	O
morning	O
and	O
evening	O
meals	O
,	O
reducing	O
their	O
ability	O
to	O
deal	O
with	O
carbohydrate	O
based	O
foods	O
.	O

On	O
the	O
third	O
day	O
postpartum	O
,	O
the	O
diagnosis	O
of	O
gestational	O
diabetes	O
insipidus	O
was	O
suspected	O
and	O
the	O
patient	O
was	O
started	O
on	O
intranasal	O
DDAVP	O
spray	O
5	O
mcg	O
twice	O
a	O
day	O
,	O
after	O
an	O
initial	O
dose	O
of	O
10	O
mcg	O
.	O

Anthropometric	O
measurements	O
included	O
height	O
,	O
measured	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
using	O
a	O
stadiometer	O
,	O
and	O
weight	O
,	O
assessed	O
to	O
the	O
nearest	O
0	O
.	O
1	O
kg	O
using	O
calibrated	O
electronic	O
scales	O
.	O

[	O
13	O
]	O
and	O
Kruavit	O
et	O
al	O
.	O

A	O
few	O
reports	O
reveal	O
that	O
some	O
may	O
be	O
suffering	O
from	O
a	O
degree	O
of	O
malnutrition	O
,	O
specifically	O
anaemia	O
and	O
low	O
iron	O
concentrations	O
,	O
and	O
have	O
altered	O
growth	O
patterns	O
impacting	O
height	O
and	O
body	O
mass	O
index	O
[	O
10	O
-	O
13	O
].	O

Similar	O
to	O
other	O
studies	O
,	O
we	O
combined	O
overweight	O
and	O
obese	O
(	O
BMI	O
29	O
–	O
40	O
)	O
women	O
in	O
our	O
analysis	O
and	O
,	O
thus	O
,	O
also	O
set	O
an	O
upper	O
weight	O
gain	O
goal	O
of	O
25	O
pounds	O
(	O
11	O
.	O
4	O
kg	O
)	O
for	O
these	O
heaviest	O
women	O
[	O
19	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
.	O

Our	O
findings	O
emphasize	O
the	O
utility	O
of	O
ENU	O
mutagenesis	O
for	O
the	O
identification	O
of	O
genes	O
important	O
in	O
spinal	O
formation	O
.	O

The	O
quality	O
rating	O
of	O
the	O
studies	O
eligible	O
for	O
review	O
was	O
assessed	O
based	O
on	O
the	O
NHMRC	O
guidelines	O
for	O
review	O
of	O
scientific	O
literature	O
[	O
16	O
].	O

The	O
study	O
was	O
evaluated	O
as	B
more	O
economic	O
and	O
effective	O
in	O
terms	O
of	O
patients	O
’	O
compliance	O
.	O

Regarding	O
male	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
that	O
there	O
was	O
not	O
prenatal	O
diet	O
effect	O
on	O
chocolate	O
intake	O
and	O
total	O
caloric	O
intake	O
in	O
a	O
treatment	O
-	O
independent	O
manner	O
.	O

In	O
recent	O
decades	O
researchers	O
have	O
paid	O
great	O
amount	O
of	O
attention	O
to	O
these	O
subjects	O
and	O
showed	O
that	O
mood	O
illness	O
related	O
to	O
childbirth	O
can	O
lead	O
to	O
serious	O
complications	O
for	O
mother	O
,	O
fetus	O
,	O
newborn	O
and	O
family	O
[	O
1	O
,	O
2	O
].	O

Authors	O
'	O
contributions	O
EW	O
was	O
responsible	O
for	O
the	O
recruitment	O
,	O
data	O
collection	O
and	O
funding	O
.	O

Analysis	O
of	O
the	O
pathways	O
involved	O
was	O
carried	O
out	O
using	O
Ingenuity	O
Pathway	O
Analysis	O
[	O
67	O
].	O

Whether	O
vitamin	O
D	O
metabolism	O
is	O
altered	O
in	O
placental	O
dysfunction	O
in	O
unclear	O
and	O
warrants	O
further	O
investigation	O
.	O

The	O
disorder	O
is	O
debilitating	O
for	O
the	O
patient	O
and	O
immensely	O
challenging	O
for	O
his	O
/	O
her	O
family	O
.	O

5	O
.	O

A	O
plot	O
of	O
gestational	O
age	O
at	O
birth	O
as	O
a	O
function	O
of	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
with	O
the	O
fitted	O
LOESS	O
curves	O
for	O
both	O
the	O
MUSC	O
cohort	O
and	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Estimation	O
of	O
foetal	O
crown	O
rump	O
length	O
and	O
/	O
or	O
biparietal	O
diameter	O
or	O
femur	O
length	O
between	O
6	O
and	O
18	O
weeks	O
’	O
gestation	O
indicates	O
an	O
accuracy	O
within	O
5	O
–	O
7	O
days	O
[	O
54	O
].	O

These	O
inconsistencies	O
may	B
be	I
due	I
to	I
a	O
shortage	O
of	O
statistical	O
tools	O
to	O
explore	O
the	O
effects	O
of	O
multiple	O
chemical	O
exposure	O
mixtures	O
on	O
birth	O
weight	O
.	O

The	O
hemivertebrae	O
and	O
fused	O
vertebrae	O
are	O
indicated	O
by	O
arrowheads	O
.	O

We	O
then	O
performed	O
multivariable	O
logistic	O
regression	O
models	O
to	O
estimate	O
adjusted	O
associations	O
of	O
PNV	O
use	O
and	O
vitamin	O
D	O
deficiency	O
.	O

The	O
weight	O
of	O
the	O
supplements	O
bottles	O
at	O
this	O
visit	O
compared	O
to	O
when	O
they	O
were	O
given	O
to	O
the	O
mothers	O
at	O
the	O
first	O
visit	O
was	O
used	O
as	O
a	O
measure	O
of	O
compliance	O
of	O
how	O
often	O
the	O
drops	O
were	O
given	O
to	O
the	O
infant	O
.	O

The	O
mean	O
GD	O
was	O
12	O
%	O
smaller	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
43	O
.	O
3	O
±	O
0	O
.	O
3	O
µm	O
for	O
F1	O
-	O
VitD	O
-	O
mice	O
vs	O
.	O
49	O
.	O
3	O
±	O
0	O
.	O
6	O
µm	O
for	O
F1	O
-	O
SC	O
mice	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
)	O
and	O
8	O
%	O
smaller	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F2	O
-	O
SC	O
(	O
46	O
.	O
0	O
±	O
0	O
.	O
8	O
µm	O
and	O
50	O
.	O
2	O
±	O
1	O
.	O
2	O
µm	O
,	O
respectively	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

This	O
statistical	O
pooling	O
of	O
several	O
studies	O
,	O
taking	O
into	O
account	O
the	O
size	O
of	O
individual	O
studies	O
,	O
confers	O
more	O
power	O
to	O
detect	O
a	O
potential	O
association	O
,	O
and	O
quantitative	O
meta	O
-	O
analyses	O
are	O
often	O
put	O
at	O
the	O
top	O
of	O
evidence	O
hierarchies	O
.	O

We	O
additionally	O
considered	O
each	O
of	O
those	O
dietary	O
components	O
and	O
maternal	O
dairy	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
),	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
intakes	O
separately	O
.	O

These	O
correlations	O
measure	O
the	O
degree	O
of	O
association	O
between	O
the	O
phenotypic	O
values	O
.	O

Reproducibility	O
of	O
DXA	O
Infant	O
Scans	O
;	O
BMC	O
=	O
3	O
.	O
8	O
%	O
and	O
BMD	O
=	O
4	O
.	O
1	O
%.	O

Some	O
evidence	O
suggests	O
that	O
maternal	O
prenatal	O
intake	O
of	O
protein	O
and	O
fat	O
[	O
7	O
–	O
9	O
]	O
may	O
be	O
positively	O
associated	O
with	O
birth	O
weight	O
.	O

Importantly	O
,	O
when	O
performing	O
in	O
vivo	O
testing	O
such	O
as	O
skin	O
tests	O
or	O
provocation	O
test	O
,	O
the	O
exceptional	O
immunologic	O
status	O
accompanying	O
pregnancy	O
should	O
be	O
considered	O
when	O
interpreting	O
test	O
results	O
.	O

We	O
sought	O
to	O
examine	O
these	O
issues	O
among	O
women	O
delivering	O
at	O
Boston	O
Medical	O
Center	O
(	O
BMC	O
),	O
an	O
urban	O
medical	O
center	O
serving	O
many	O
of	O
the	O
low	O
income	O
and	O
underserved	O
populations	O
of	O
Boston	O
,	O
Massachusetts	O
.	O

One	O
male	O
mouse	O
per	O
litter	O
was	O
randomly	O
selected	O
to	O
form	O
the	O
groups	O
(	O
the	O
animals	O
from	O
the	O
same	O
litter	O
were	O
never	O
allocated	O
to	O
the	O
same	O
group	O
).	O

There	O
are	O
several	O
implications	O
of	O
the	O
Madigan	O
study	O
and	O
text4baby	O
for	O
future	O
mHealth	O
interventions	O
and	O
research	O
.	O

Pregnancyassociated	O
immune	O
tolerance	O
,	O
designed	O
for	O
foetal	O
survival	O
,	O
might	O
enhance	O
disease	O
progression	O
.	O

For	O
this	O
reason	O
—	O
although	O
we	O
did	O
mention	O
impaired	O
spermatogenesis	O
as	O
one	O
of	O
the	O
end	O
points	O
encompassed	O
by	O
the	O
testicular	O
dysgenesis	O
syndrome	O
—	O
it	O
was	O
necessary	O
to	O
exclude	O
this	O
end	O
point	O
from	O
our	O
analysis	O
.	O

Both	O
the	O
F1	O
and	O
F2	O
generations	O
of	O
the	O
VitD	O
-	O
group	O
had	O
more	O
immature	O
glomeruli	O
than	O
offspring	O
from	O
the	O
SC	O
group	O
.	O

Since	O
the	O
case	O
definition	O
for	O
S	O
-	O
ECC	O
is	O
age	O
specific	O
,	O
participants	O
needed	O
to	O
be	O
≤	O
71	O
months	O
of	O
age	O
[	O
25	O
].	O

For	O
example	O
,	O
robust	O
epigenetic	O
changes	O
induced	O
by	O
environmental	O
exposures	O
in	O
the	O
absence	O
of	O
a	O
phenotypic	O
consequence	O
essentially	B
become	O
the	O
‘	O
new	O
normal	O
’	O
epigenome	O
,	O
which	O
could	O
have	O
greater	O
susceptibility	O
to	O
disease	O
development	O
and	O
/	O
or	O
future	O
exposures	O
(	O
as	B
demonstrated	O
in	O
two	O
in	O
vivo	O
rat	O
models	O
(	O
Greathouse	O
et	O
al	O
.	O
2012	O
;	O
Wong	O
et	O
al	O
.	O
2015	O
)).	O

2	O
.	O
5	O
.	O

Using	O
this	O
calculation	O
,	O
we	O
identified	O
the	O
number	O
of	O
messages	O
delivered	O
to	O
each	O
participant	O
during	O
the	O
study	O
period	O
.	O

These	O
results	O
were	O
in	O
line	O
with	O
Northstone	O
et	O
al	O
.	O

Serum	O
analysis	O
for	O
calcium	O
,	O
PTH	O
,	O
and	O
albumin	O
was	O
performed	O
by	O
the	O
Department	O
of	O
Biochemistry	O
and	O
Genetics	O
Laboratory	O
at	O
HSC	O
.	O

Analysis	O
of	O
data	O
from	O
the	O
National	O
Longitudinal	O
Survey	O
of	O
Youth	O
Child	O
-	O
Mother	O
File	O
found	O
that	O
having	O
an	O
unmarried	O
mother	O
increased	O
the	O
risk	O
for	O
adolescent	O
overweight	O
.	O

We	O
were	O
unable	O
to	O
assess	O
associations	O
with	O
maternal	O
sugar	O
intake	O
in	O
early	O
pregnancy	O
;	O
however	O
,	O
intakes	O
in	O
early	O
and	O
late	O
pregnancy	O
are	O
likely	B
to	O
be	O
highly	O
correlated	O
.	O

The	O
prominent	O
down	O
-	O
regulation	O
of	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
in	O
the	O
liver	O
of	O
RC	O
females	O
may	O
result	O
in	O
a	O
different	O
endocannabinoid	O
signaling	O
than	O
that	O
of	O
RC	O
males	O
.	O

The	O
mean	O
score	O
was	O
11	O
.	O
0	O
(	O
95	O
%	O
CI	O
,	O
10	O
.	O
5	O
-	O
11	O
.	O
5	O
)	O
and	O
standard	O
deviation	O
was	O
4	O
.	O
8	O
(	O
Table	O
1	O
).	O

Fish	O
consumption	O
is	O
generally	O
recommended	O
as	O
healthful	O
due	O
to	O
its	O
DHA	O
and	O
EPA	O
content	O
despite	O
the	O
exposure	O
to	O
heavy	O
metals	O
and	O
other	O
contaminants	O
that	O
may	O
be	O
detrimental	O
to	O
health	O
[	O
12	O
].	O

Because	B
women	O
are	O
more	O
motivated	O
to	O
change	O
behaviors	O
during	O
pregnancy	O
and	O
immediately	O
postpartum	O
,	O
these	O
intervals	O
can	O
be	O
targeted	O
to	O
shape	O
eating	O
patterns	O
of	O
both	O
mother	O
and	O
child	O
.	O

In	O
order	O
to	O
survey	O
expression	O
of	O
the	O
liver	O
tissue	O
samples	O
,	O
total	O
transcript	O
levels	O
of	O
selected	O
target	O
and	O
reference	O
genes	O
(	O
Table5	O
)	O
were	O
quantified	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
performed	O
on	O
a	O
LightCycler	O
®	O
480	O
system	O
using	O
the	O
LightCycler	O
480	O
SYBR	O
Green	O
I	O
Master	O
(	O
Roche	O
,	O
Mannheim	O
,	O
Germany	O
).	O

Similarly	O
,	O
histone	O
acetylases	O
require	O
the	O
co	O
-	O
substrate	O
acetyl	O
-	O
CoA	O
,	O
and	O
altered	O
glycolytic	O
production	O
of	O
acetyl	O
-	O
CoA	O
can	O
lead	O
to	O
changes	O
in	O
histone	O
acetylation	O
(	O
Wellen	O
et	O
al	O
.	O
2009	O
;	O
Moussaieff	O
et	O
al	O
.	O
2015	O
).	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Vitamin	O
D	O
or	O
placebo	O
was	O
given	O
by	O
fieldworkers	O
once	O
every	O
3	O
months	O
for	O
18	O
months	O
.	O

Laboratory	O
studies	O
revealed	O
a	O
serum	O
sodium	O
of	O
171	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
1	O
mEq	O
/	O
L	O
,	O
chloride	O
138	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
21	O
mEq	O
/	O
L	O
,	O
glucose	O
197	O
mg	O
/	O
dL	O
,	O
BUN	O
49	O
mg	O
/	O
dL	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
calcium	O
7	O
.	O
8	O
mEq	O
/	O
L	O
,	O
total	O
protein	O
5	O
.	O
4	O
gm	O
/	O
dL	O
,	O
albumin	O
1	O
.	O
6	O
gm	O
/	O
dL	O
,	O
alkaline	O
phosphatase	O
576	O
units	O
/	O
L	O
,	O
AST	O
391	O
units	O
/	O
L	O
,	O
and	O
ALT	O
443	O
units	O
/	O
L	O
.	O

TL	O
and	O
BN	O
contributed	O
with	O
specific	O
knowledge	O
in	O
the	O
topic	O
of	O
fatty	O
acids	O
and	O
psychiatric	O
diseases	O
.	O

3	O
.	O

Higher	O
VDR	O
/	O
RXR	O
binding	O
may	O
decrease	O
formation	O
of	O
the	O
PPARG	O
/	O
RXR	O
heterodimer	O
,	O
thus	B
inhibiting	O
adipogenesis	O
(	O
Figure	O
4	O
).	O

This	O
trial	O
was	O
registered	O
athttp	O
://	O
www	O
.	O
clinicaltrials	O
.	O
gov	O
(	O
Identifier	O
:	O
NCT01309321	O
).	O

For	O
instance	O
,	O
interferon	O
-	O
γ	O
(	O
IFN	O
-	O
γ	O
)	O
and	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
were	O
detected	O
in	O
the	O
colostrums	O
of	O
healthy	O
women	O
[	O
64	O
].	O

Maternal	O
BMI	O
was	O
much	O
more	O
strongly	O
associated	O
with	O
offspring	O
BMI	O
than	O
that	O
of	O
father	O
initially	O
,	O
but	O
no	O
differences	O
in	O
parental	O
associations	O
were	O
seen	O
when	O
the	O
offspring	O
became	O
adults	O
.	O
29	O
We	O
approached	O
this	O
analysis	O
looking	O
for	O
consistency	O
and	O
coherence	O
of	O
association	O
as	O
well	O
as	O
magnitude	O
and	O
statistical	O
significance	O
and	O
include	O
also	O
the	O
height	O
analysis	O
,	O
which	O
has	O
the	O
same	O
numbers	O
of	O
respondents	O
,	O
to	O
show	O
that	O
the	O
absence	O
of	O
an	O
association	O
for	O
BMI	O
by	O
comparison	O
is	O
not	O
simply	O
due	O
to	O
a	O
power	O
problem	O
.	O

Maternal	O
insulin	O
resistance	O
was	O
calculated	O
using	O
the	O
Homeostasis	O
Model	O
Assessment	O
(	O
HOMA	O
-	O
IR	O
)	O
equation	O
:	O
[	O
fasting	O
serum	O
insulin	O
(	O
μU	O
/	O
ml	O
)	O
×	O
fasting	O
plasma	O
glucose	O
(	O
mmol	O
/	O
l	O
)/	O
22	O
.	O
5	O
].	O

We	O
also	O
obtained	O
anthropometric	O
data	O
(	O
height	O
and	O
weight	O
),	O
demographic	O
data	O
(	O
occupation	O
and	O
education	O
),	O
and	O
clinical	O
data	O
(	O
delivery	O
status	O
,	O
IUGR	O
and	O
history	O
of	O
preterm	O
birth	O
,	O
abortion	O
,	O
delivery	O
status	O
,	O
and	O
stillbirth	O
)	O
of	O
the	O
pregnant	O
women	O
.	O

Role	O
of	O
the	O
funding	O
source	O
The	O
sponsor	O
of	O
the	O
study	O
had	O
no	O
role	O
in	O
study	O
design	O
,	O
data	O
collection	O
,	O
data	O
analysis	O
,	O
data	O
interpretation	O
,	O
or	O
writing	O
of	O
the	O
report	O
.	O

In	O
most	O
cases	O
,	O
this	O
is	O
type	O
2	O
diabetes	O
.	O

3	O
.	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

Of	O
note	O
,	O
one	O
of	O
these	O
children	O
was	O
obese	O
,	O
one	O
had	O
seasonal	O
allergies	O
treated	O
with	O
a	O
long	O
-	O
term	O
steroid	O
nasal	O
spray	O
,	O
and	O
the	O
third	O
had	O
a	O
history	O
of	O
febrile	O
seizures	O
.	O

All	O
mothers	O
are	O
asked	O
details	O
about	O
any	O
other	O
food	O
or	O
drink	O
(	O
including	O
infant	O
formula	O
,	O
medicine	O
and	O
supplements	O
)	O
given	O
to	O
the	O
infant	O
.	O

Meconium	O
Aspiration	O
Syndrome	O
Meconium	O
aspiration	O
syndrome	O
,	O
which	O
occurs	O
when	O
a	O
fetus	O
who	O
is	O
under	O
stress	O
and	O
not	O
getting	O
enough	O
oxygen	O
inhales	O
waste	O
products	O
inside	O
the	O
womb	O
,	O
was	O
linked	O
to	O
a	O
sevenfold	O
increase	O
in	O
the	O
likelihood	B
that	O
a	O
child	O
would	O
later	O
develop	O
autism	O
.	O

Third	O
,	O
BHLM	O
results	O
are	O
sensitive	O
to	O
the	O
assigned	O
prior	O
distributions	O
of	O
hyperparameters	O
μβand	O
σβ	O
.	O

Height	O
is	O
also	O
examined	O
for	O
comparative	O
purposes	O
.	O

4	O
.	O

During	O
pregnancy	O
.	O

In	O
a	O
European	O
population	O
,	O
64	O
%	O
of	O
infants	O
had	O
a	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
3	O
-	O
6	O
days	O
of	O
age	O
that	O
was	O
below	O
12	O
ng	O
/	O
mL	O
[	O
12	O
].	O

At	O
the	O
beginning	O
of	O
the	O
test	O
,	O
the	O
rats	O
were	O
individually	O
housed	O
and	O
exposed	O
to	O
the	O
two	O
types	O
of	O
food	O
(	O
chocolate	O
and	O
standard	O
chow	O
)	O
for	O
4	O
days	O
.	O

From	O
postnatal	O
day	O
27	O
,	O
offspring	O
were	O
checked	O
daily	O
for	O
markers	O
of	O
reproductive	O
maturity	O
:	O
vaginal	O
opening	O
and	O
canalisation	O
in	O
females	O
and	O
balanopreputial	O
separation	O
in	O
males	O
.	O

The	O
patients	O
had	O
GDM	O
if	O
50	O
g	O
resulted	O
in	O
a	O
glucose	O
serum	O
concentration	O
of	O
7	O
.	O
2	O
mmol	O
/	O
lit	O
,	O
and	O
if	O
100	O
g	O
GTT	O
test	O
was	O
disturbed	O
on	O
the	O
basis	O
of	O
Carpenter	O
and	O
Coustan	O
criteria	O
.	O
25The	O
study	O
inclusion	O
criteria	O
were	O
the	O
absence	O
of	O
thyroid	O
,	O
kidney	O
and	O
liver	O
diseases	O
as	O
well	O
as	O
malabsorption	O
.	O

Following	O
background	O
subtraction	O
and	O
volume	O
normalization	O
of	O
all	O
gels	O
,	O
average	O
gels	O
were	O
created	O
for	O
each	O
group	O
to	O
assist	O
comparison	O
and	O
reduce	O
within	O
group	O
variations	O
.	O

Foetal	O
crown	O
-	O
rump	O
length	O
is	O
used	O
to	O
determine	O
gestational	O
age	O
of	O
participants	O
in	O
their	O
first	O
trimester	O
[	O
55	O
].	O

Ethnicity	O
was	O
reported	O
by	O
the	O
participant	O
and	O
subsequently	O
categorized	O
as	O
white	O
or	O
nonwhite	O
.	O

Despite	O
we	O
found	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
,	O
opposite	O
results	O
after	O
the	O
exposure	O
to	O
undernutrition	O
(	O
Bispham	O
et	O
al	O
.,	O
2005	O
)	O
and	O
similar	O
results	O
after	O
malnutrition	O
during	O
early	O
development	O
have	O
been	O
documented	O
(	O
Ahmad	O
et	O
al	O
.,	O
2013	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
).	O

1	O
,	O
25	O
-	O
Dihydroxyvitamin	O
D3	O
(	O
active	O
form	O
of	O
vitamin	O
D	O
)	O
inhibits	O
preadipocyte	O
differentiation	O
[	O
141	O
]	O
and	O
suppresses	O
adipogenic	O
PPARG	O
gene	O
expression	O
in	O
3T3	O
L1	O
cells	O
[	O
142	O
].	O

[	O
25	O
]	O
may	O
have	O
detected	O
a	O
benefit	O
had	O
fish	O
been	O
considered	O
separately	O
from	O
total	O
seafood	O
.	O

In	O
addition	O
,	O
it	O
may	O
be	O
helpful	O
for	O
countries	O
to	O
assess	O
knowledge	O
,	O
attitudes	O
and	O
practices	O
of	O
influenza	O
vaccination	O
recommendations	O
among	O
health	O
personnel	O
,	O
especially	O
in	O
countries	O
where	O
influenza	O
vaccination	O
recommendations	O
and	O
practices	O
have	O
recently	O
been	O
implemented	O
or	O
expanded	O
.	O

Although	O
a	O
recent	O
pilot	O
randomized	O
trial	O
[	O
39	O
]	O
found	O
no	O
significant	O
impact	O
of	O
a	O
low	O
glycemic	O
index	O
diet	O
on	O
the	O
offspring	O
weight	O
of	O
overweight	O
/	O
obese	O
mothers	O
,	O
future	O
,	O
larger	O
randomized	O
trials	O
and	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
diet	O
in	O
pregnancy	O
are	O
needed	O
to	O
untangle	O
the	O
relationship	O
between	O
weight	O
status	O
,	O
time	O
in	O
pregnancy	O
of	O
nutrient	O
exposures	O
,	O
and	O
offspring	O
weight	O
outcomes	O
.	O

We	O
will	O
use	O
physician	O
-	O
certified	O
verbal	O
autopsy	O
method	O
to	O
identify	O
cases	O
of	O
death	O
related	O
to	O
preterm	O
delivery	O
and	O
birth	O
asphyxia	O
using	O
the	O
hierarchical	O
assignment	O
of	O
causes	O
of	O
death	O
.	O

Subjects	O
returned	O
for	O
a	O
repeat	O
DXA	O
scan	O
and	O
a	O
serum	O
sample	O
was	O
obtained	O
for	O
25	O
(	O
OH	O
)	O
D	O
and	O
parathyroid	O
hormone	O
(	O
PTH	O
)	O
levels	O
.	O

Database	O
searching	O
and	O
secondary	O
analyses	O
Data	O
generated	O
from	O
peptide	O
mass	O
mapping	O
(	O
PMM	O
)	O
of	O
each	O
spot	O
were	O
used	O
to	O
perform	O
searches	O
of	O
the	O
SWISS	O
-	O
PROT	O
,	O
NCBI	O
and	O
TrEMBL	O
databases	O
using	O
the	O
programs	O
Aldente	O
(	O
www	O
.	O
expasy	O
.	O
ch	O
)	O
and	O
MASCOT	O
(	O
www	O
.	O
matrixscience	O
.	O
com	O
).	O

They	O
were	O
not	O
told	O
that	O
the	O
men	O
who	O
worked	O
in	O
the	O
mines	O
were	O
breathing	O
carcinogenic	O
radon	O
gas	O
and	O
showering	O
in	O
radioactive	O
water	O
,	O
nor	O
that	O
the	O
women	O
washing	O
their	O
husbands	O
’	O
work	O
clothes	O
could	O
spread	O
radionuclides	O
to	O
the	O
rest	O
of	O
the	O
family	O
’	O
s	O
laundry	O
.	O

No	O
Australian	O
GDM	O
Nutrition	O
Practice	O
Guidelines	O
exist	O
and	O
systematic	O
delivery	O
of	O
dietetic	O
care	O
to	O
women	O
with	O
GDM	O
does	O
not	O
occur	O
in	O
Australia	O
.	O

In	O
term	O
placentas	O
,	O
there	O
was	O
a	O
significant	O
correlation	O
between	O
GR	O
β	O
and	O
GR	O
γ	O
(	O
r	O
=	O
0	O
.	O
580	O
,	O
P	O
=	O
0	O
.	O
038	O
)	O
and	O
with	O
GR	O
-	O
P	O
(	O
r	O
=	O
0	O
.	O
980	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
BP	O
of	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
F2	O
-	O
SC	O
mice	O
only	O
at	O
6	O
months	O
of	O
age	O
(+	O
8	O
%;	O
P	O
<	O
0	O
.	O
05	O
).	O

There	O
is	O
significant	O
interest	O
in	O
what	O
influences	O
weight	O
gain	O
over	O
the	O
life	O
course	O
and	O
the	O
degree	O
to	O
which	O
risk	O
of	O
overweight	O
or	O
obesity	O
is	O
transmitted	O
across	O
generations	O
of	O
families	O
.	O
1	O
–	O
3From	O
studies	O
that	O
have	O
examined	O
the	O
heritability	O
of	O
BMI	O
,	O
45it	B
is	I
clear	I
that	O
BMI	O
does	O
have	O
a	O
heritable	O
component	O
.	O

Previous	O
evidence	O
on	O
the	O
longer	O
-	O
term	O
effects	O
of	O
antenatal	O
dietary	O
and	O
lifestyle	O
interventions	O
is	O
limited	O
.	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

The	O
mechanism	O
of	O
action	O
may	O
involve	O
epigenetic	O
processes	O
or	O
DNA	O
changes	O
with	O
the	O
capacity	O
to	O
modulate	O
or	O
influence	O
oncogenic	O
outcomes	O
in	O
the	O
distant	O
future	O
.	O

Evidence	O
shows	O
that	O
postnatal	O
depression	O
is	O
an	O
extension	O
of	O
antenatal	O
depression	O
which	O
continues	O
postpartum	O
.	O

3	O
.	O
2	O
.	O

A	O
range	O
of	O
epigenetic	O
processes	O
including	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
),	O
(	O
such	O
as	O
long	O
ncRNAs	O
(	O
lncRNAs	O
),	O
microRNAs	O
(	O
miRNAs	O
),	O
piwi	O
-	O
interacting	O
RNAs	O
(	O
piRNAs	O
)	O
and	O
endogenous	O
short	O
interfering	O
RNAs	O
(	O
esiRNAs	O
))	O
form	O
an	O
efficient	O
and	O
robust	O
complex	O
interactive	O
network	O
that	O
regulates	O
gene	O
expression	O
at	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
levels	O
.	O

Of	O
these	O
,	O
448	O
probe	O
-	O
sets	O
were	O
up	O
-	O
regulated	O
and	O
543	O
probe	O
-	O
sets	O
showed	O
lower	O
expression	O
at	O
a	O
higher	O
age	O
.	O

On	O
the	O
second	O
day	O
,	O
anthropometric	O
measures	O
,	O
blood	O
pressure	O
,	O
and	O
HRV	O
were	O
evaluated	O
.	O

In	O
contrast	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
the	O
2	O
-	O
AG	O
-	O
synthesizing	O
enzymes	O
Dagl	O
α	O
and	O
Dagl	O
β	O
is	O
opposed	O
to	O
what	O
was	O
previously	O
found	O
in	O
the	O
adipose	O
tissue	O
of	O
obese	O
subjects	O
(	O
Engeli	O
et	O
al	O
.,	O
2014	O
).	O

This	O
was	O
the	O
first	O
study	O
to	O
suggest	O
that	O
smoking	O
during	O
pregnancy	O
is	O
linked	O
to	O
adverse	O
changes	O
in	O
the	O
lipoprotein	O
levels	O
of	O
children	O
(	O
19	O
).	O

Client	O
satisfaction	O
remained	O
high	O
over	O
the	O
project	O
,	O
between	O
4	O
.	O
3	O
-	O
4	O
.	O
7	O
/	O
5	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
reproductive	O
system	O
(	O
after	O
:	O
Grzechocinska	O
B	O
,	O
Dabrowski	O
FA	O
,	O
Cyganek	O
A	O
,	O
Wielgos	O
M	O
.	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
impaired	O
fertility	O
treatment	O
[	O
2	O
]).	O

The	O
main	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
association	O
between	O
the	O
dietary	O
intake	O
of	O
different	O
fish	O
species	O
,	O
the	O
dietary	O
intake	O
of	O
PUFAs	O
(	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
)	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
population	O
-	O
based	O
study	O
among	O
Swedish	O
women	O
.	O

In	O
addition	O
,	O
it	O
appears	O
Australian	O
women	O
are	O
falling	O
short	O
of	O
LC	O
n	O
-	O
3PUFA	O
intake	O
recommendations	O
during	O
pregnancy	O
[	O
6	O
,	O
7	O
].	O

We	O
would	O
like	O
to	O
acknowledge	O
Gefried	O
Pali	O
for	O
the	O
photograph	O
arts	O
.	O

Promising	B
evidence	O
came	O
from	O
a	O
trial	O
in	O
China	O
investigating	O
the	O
effects	O
of	O
IFA	O
supplements	O
in	O
pregnancy	O
on	O
neonatal	O
deaths	O
[	O
19	O
].	O

Children	O
born	O
to	O
mothers	O
with	O
antiphospholipid	O
syndrome	O
were	O
observed	O
to	O
have	O
a	O
higher	O
frequency	O
of	O
autism	O
spectrum	O
disorders	O
in	O
comparison	O
to	O
mothers	O
without	O
antiphospholipid	O
syndrome	O
,	O
which	O
further	O
supports	O
findings	O
that	O
perinatal	O
complications	O
increase	O
the	O
risk	O
of	O
autism	O
in	O
children	O
[	O
28	O
].	O

Experts	O
have	O
decried	O
the	O
lack	O
of	O
trustworthy	O
statistics	O
on	O
the	O
sources	O
and	O
extent	O
of	O
pollution	O
and	O
the	O
number	O
of	O
remediation	O
facilities	O
.	O

Although	O
a	O
few	O
other	O
studies	O
have	O
correlated	O
array	O
-	O
based	O
methylation	O
levels	O
with	O
repetitive	O
element	O
methylation	O
markers	O
(	O
Fryer	O
et	O
al	O
.	O

This	O
bioinformatic	O
classification	O
resulted	O
in	O
41	O
distinct	O
bioinformatic	O
classes	O
containing	O
at	O
least	O
one	O
CpG	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
2	O
).	O

[	O
11	O
]	O
Roles	O
of	O
vitamin	O
D	O
are	O
to	O
maintain	O
skeletal	O
calcium	O
balance	O
by	O
promoting	O
calcium	O
absorption	O
in	O
the	O
intestines	O
,	O
promoting	O
bone	O
resobption	O
by	O
increasing	O
osteoclast	O
number	O
,	O
maintaining	O
calcium	O
and	O
phosphate	O
levels	O
for	O
bone	O
formation	O
,	O
and	O
allowing	O
proper	O
functioning	O
of	O
parathyroid	O
hormone	O
to	O
maintain	O
serum	O
calcium	O
levels	O
.	O

The	O
heightened	O
preference	O
for	O
sweet	O
taste	O
,	O
which	O
is	O
evident	O
within	O
hours	O
after	O
birth	O
and	O
persists	O
until	O
adolescence	O
(	O
27	O
,	O
28	O
)	O
most	B
likely	I
evolved	O
because	B
sweet	O
-	O
tasting	O
foods	O
are	O
high	O
in	O
energy	O
.	O

As	B
nodal	O
spread	O
is	O
relatively	O
common	O
,	O
initial	O
surgical	O
exploration	O
should	O
include	O
careful	O
examination	O
of	O
the	O
central	O
compartment	O
nodes	O
(	O
paratracheal	O
and	O
tracheoesophageal	O
)	O
as	O
well	O
as	O
dissection	O
of	O
clinically	O
suspicious	O
nodes	O
for	O
frozen	O
section	O
examination	O
.	O

Data	O
regarding	O
the	O
long	O
-	O
acting	O
insulin	O
analogs	O
are	O
less	O
clear	O
than	O
for	O
rapid	O
-	O
acting	O
analogs	O
.	O

classified	B
childhood	O
wheezing	O
into	O
four	O
distinct	O
phenotypes	O
:	O
no	O
wheezing	O
,	O
transient	O
early	O
wheezing	O
,	O
late	O
-	O
onset	O
wheezing	O
,	O
and	O
persistent	O
wheezing	O
[	O
16	O
].	O

Height	O
—	O
child	O
age	O
0	O
The	O
child	O
’	O
s	O
height	O
/	O
length	O
was	O
correlated	O
with	O
that	O
of	O
its	O
mother	O
and	O
father	O
and	O
not	O
with	O
that	O
of	O
the	O
other	O
family	O
members	O
(	O
table	O
5	O
).	O

Delusions	O
Inventory	O
,	O
[	O
PDI	O
;	O
[	O
22	O
]];	O
which	O
is	O
based	O
on	O
the	O
9thedition	O
of	O
the	O
Present	O
State	O
Examination	O
[	O
23	O
].	O

Socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
group	O
and	O
description	O
of	O
prenatal	O
care	O
The	O
mean	O
age	O
of	O
participants	O
was	O
27	O
.	O
5	O
years	O
:	O
63	O
.	O
8	O
%	O
were	O
aged	O
between	O
19	O
and	O
30	O
years	O
,	O
5	O
.	O
3	O
%	O
were	O
≤	O
18	O
years	O
and	O
8	O
.	O
8	O
%	O
were	O
aged	O
over	O
35	O
years	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
associated	O
with	O
60	O
%	O
lower	O
preterm	O
birth	O
risk	O
among	O
general	O
obstetrical	O
patients	O
at	O
an	O
urban	O
medical	O
center	O
Abstract	O
Background	O
Given	O
the	O
high	O
rate	O
of	O
preterm	O
birth	O
(	O
PTB	O
)	O
nationwide	O
and	O
data	O
from	O
RCTs	O
demonstrating	O
risk	O
reduction	O
with	O
vitamin	O
D	O
supplementation	O
,	O
the	O
Medical	O
University	O
of	O
South	O
Carolina	O
(	O
MUSC	O
)	O
implemented	O
a	O
new	O
standard	O
of	O
care	O
for	O
pregnant	O
women	O
to	O
receive	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
.	O

The	O
comparisons	O
of	O
the	O
relative	O
mRNA	O
abundances	O
depending	O
on	O
dietary	O
group	O
and	O
ontogenetic	O
stages	O
provide	O
an	O
overall	O
view	O
of	O
the	O
developmental	O
plasticity	O
of	O
the	O
liver	O
.	O

Briefly	O
,	O
they	O
proposed	O
that	O
mesenchymal	O
stem	O
cells	O
are	O
first	O
committed	O
to	O
the	O
myogenic	O
and	O
adipogenic	O
–	O
fibrogenic	O
cell	O
lineages	O
during	O
fetal	O
muscle	O
development	O
[	O
16	O
].	O

There	O
is	O
increasing	O
evidence	O
that	O
nutrients	O
[	O
12	O
]	O
and	O
some	O
foods	O
[	O
13	O
,	O
14	O
]	O
play	O
an	O
important	O
role	O
in	O
the	O
fetal	O
growth	O
.	O

Vitamin	O
A	O
Restricting	O
vitamin	O
A	O
intake	O
increases	O
IMF	O
deposition	O
.	O

Even	O
in	O
the	O
last	O
published	O
guidelines	O
the	O
treatment	O
of	O
vitamin	O
D	O
deficient	O
women	O
is	O
not	O
specifically	O
discussed	O
[	O
24	O
].	O

Prenatal	O
diet	O
influences	O
the	O
risk	O
of	O
infant	O
and	O
child	O
allergy	O
.	O

Alcohol	O
consumption	O
in	O
adults	O
is	O
also	O
a	O
risk	O
factor	O
for	O
elevated	O
specific	O
IgE	O
levels	O
against	O
food	O
antigens	O
[	O
77	O
,	O
78	O
].	O

We	O
thus	O
propose	O
a	O
large	O
-	O
scale	O
prospective	O
trial	O
to	O
measure	O
the	O
impact	O
of	O
the	O
early	O
introduction	O
of	O
antenatal	O
iron	O
/	O
folic	O
acid	O
supplementation	O
in	O
pregnancy	O
on	O
neonatal	O
outcomes	O
in	O
rural	O
Bangladesh	O
.	O

We	O
intended	O
to	O
recruit	O
a	O
minimum	O
of	O
250	O
participants	O
.	O

Average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Between	O
1970	O
and	O
2000	O
,	O
there	O
was	O
a	O
25	O
%	O
increase	O
in	O
the	O
per	O
capita	O
consumption	O
of	O
all	O
refined	O
sugars	O
in	O
the	O
USA	O
,	O
matching	O
a	O
worldwide	O
trend	O
[	O
3	O
].	O

[	O
18	O
]	O
did	O
not	O
find	O
an	O
association	O
.	O

Measurement	O
of	O
adiposity	O
Adiposity	O
was	O
estimated	O
by	O
calculating	O
the	O
percentage	O
of	O
abdominal	O
fat	O
weight	O
over	O
total	O
body	O
weight	O
.	O

Children	O
of	O
school	O
age	O
are	O
highly	O
susceptible	O
to	O
environmental	O
stimuli	O
such	O
as	O
marketing	O
and	O
food	O
availability	O
.	O

Forty	O
-	O
four	O
per	O
cent	O
,	O
16	O
.	O
5	O
%	O
and	O
11	O
.	O
3	O
%	O
of	O
women	O
in	O
the	O
exposed	O
group	O
reported	O
the	O
use	O
of	O
two	O
,	O
three	O
and	O
four	O
or	O
more	O
psychotropic	O
medications	O
,	O
respectively	O
.	O

While	O
there	O
was	O
a	O
large	O
sample	O
size	O
,	O
there	O
was	O
an	O
absence	O
of	O
detailed	O
information	O
on	O
dosage	O
and	O
frequency	O
of	O
hormonal	O
intervention	O
.	O

It	O
synchronizes	O
growth	O
and	O
fertility	O
with	O
periods	O
of	O
either	O
adequate	O
or	O
inadequate	O
food	O
availability	O
[	O
45	O
];	O
post	O
-	O
weaning	O
treatment	O
with	O
leptin	O
accelerates	O
puberty	O
in	O
rodents	O
[	O
46	O
],[	O
47	O
],	O
and	O
leptin	O
in	O
the	O
rat	O
neonate	O
affects	O
hypothalamic	O
maturation	O
[	O
48	O
].	O

While	O
,	O
the	O
mean	O
depression	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
one	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
>	O
0	O
.	O
001	O
)	O
(	O
Table	O
3	O
).	O

2	O
.	O
1	O
.	O

The	O
analysis	O
showed	O
that	O
high	O
cord	O
25	O
(	O
OH	O
)	O
D	O
was	O
the	O
strongest	O
predictor	O
of	O
good	O
lung	O
function	O
performance	O
(	O
Table	O
3	O
),	O
and	O
vice	O
versa	O
,	O
low	O
cord	O
level	O
predicted	O
poor	O
lung	O
function	O
outcome	O
.	O

2007	O
;	O
Sinclair	O
et	O
al	O
.	O

Interestingly	O
,	O
the	O
height	O
of	O
the	O
child	O
continued	O
at	O
ages	O
5	O
and	O
9	O
to	O
be	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
PGF	O
,	O
not	O
easily	O
explainable	O
by	O
conventional	O
genetic	O
inheritance	O
,	O
though	O
there	O
may	O
be	O
a	O
Y	O
-	O
related	O
influence	O
at	O
play	O
through	O
the	O
father	O
,	O
who	O
himself	O
is	O
highly	O
correlated	O
with	O
his	O
father	O
.	O

Maternal	O
attitudes	O
were	O
divided	O
into	O
two	O
groups	O
:	O
negative	O
attitudes	O
(	O
48	O
%)	O
and	O
positive	O
(	O
35	O
.	O
7	O
%)/	O
neutral	O
attitudes	O
(	O
16	O
.	O
3	O
%).	O

Her	O
cardiac	O
and	O
pulmonary	O
examination	O
was	O
also	O
normal	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
plasma	O
levels	O
of	O
leptin	O
,	O
metabolites	O
,	O
alkaline	O
phosphatase	O
,	O
and	O
hepatic	O
transaminases	O
in	O
adult	O
offspring	O
Two	O
-	O
way	O
ANOVA	O
showed	O
an	O
effect	O
of	O
prenatal	O
diet	O
on	O
the	O
plasma	O
levels	O
of	O
glucose	O
,	O
the	O
lipid	O
profile	O
(	O
triglycerides	O
,	O
HDL	O
,	O
LDL	O
,	O
and	O
VLDL	O
)	O
and	O
urea	O
(	O
Table1	O
).	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

(	O
2016	O
)	O
concluded	O
in	O
their	O
meta	O
-	O
analysis	O
that	O
maternal	O
vitamin	O
D	O
insufficiency	O
(<	O
50	O
nmol	O
/	O
L	O
or	O
<	O
75	O
nmol	O
/	O
L	O
)	O
was	O
associated	O
with	O
greater	O
risk	O
of	O
GDM	O
[	O
6	O
].	O

The	O
lack	O
of	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
cathelicidin	O
in	O
this	O
study	O
may	O
be	O
due	O
to	O
the	O
narrow	O
range	O
in	O
observed	O
25	O
(	O
OH	O
)	O
D	O
values	O
and	O
warrants	O
additional	O
studies	O
for	O
further	O
observation	O
.	O

Further	O
,	O
several	O
studies	O
examined	O
head	O
circumference	O
and	O
height	O
abnormalities	O
in	O
autism	O
patients	O
.	O

In	O
order	O
to	O
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
,	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

Analysis	O
of	O
Samples	O
Approximately	O
5	O
ml	O
whole	O
blood	O
was	O
collected	O
by	O
venipuncture	O
in	O
a	O
non	O
-	O
heparinized	O
tube	O
.	O

Gestation	O
was	O
determined	O
by	O
first	O
trimester	O
ultrasound	O
examination	O
.	O

While	O
mothers	O
in	O
the	O
intervention	O
arm	O
were	O
significantly	O
more	O
likely	B
to	O
maintain	O
needed	O
handwashing	O
materials	O
in	O
the	O
places	O
where	O
they	O
spent	O
time	O
with	O
their	O
newborns	O
,	O
and	O
more	O
frequently	O
washed	O
their	O
hands	O
,	O
handwashing	O
with	O
soap	O
was	O
observed	O
at	O
a	O
minority	O
of	O
the	O
times	O
we	O
recommended	O
.	O

Patrick	O
and	O
colleagues	O
[	O
14	O
]	O
found	O
that	O
,	O
compared	O
to	O
control	O
,	O
short	O
message	O
service	O
(	O
SMS	O
)	O
text	O
messaging	O
and	O
multimedia	O
message	O
service	O
(	O
MMS	O
)	O
participants	O
achieved	O
1	O
.	O
97	O
kg	O
greater	O
weight	O
loss	O
.	O

Similarly	O
,	O
a	O
pooled	O
analysis	O
from	O
Pakistan	O
on	O
8512	O
live	O
births	O
reported	O
maternal	O
antenatal	O
IFA	O
supplements	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
death	O
on	O
day	O
0	O
by	O
33	O
%	O
and	O
during	O
the	O
neonatal	O
period	O
by	O
29	O
%.	O

Glucose	O
response	O
to	O
glucose	O
gavage	O
(	O
0	O
.	O
375	O
g	O
glucose	O
mL	O
−	O
1	O
,	O
5	O
g	O
of	O
glucose	O
per	O
kg	O
body	O
weight	O
)	O
was	O
measured	O
at	O
18	O
weeks	O
post	O
-	O
weaning	O
.	O

However	O
,	O
some	O
recent	O
insights	O
are	O
presented	O
and	O
discussed	O
in	O
Hatanaka	O
et	O
al	O
.	O

It	O
was	O
described	O
that	O
long	O
-	O
term	O
undernutrition	O
from	O
early	O
stages	O
lead	O
to	O
higher	O
gene	O
expression	O
of	O
Cnr1	O
in	O
several	O
brain	O
regions	O
of	O
the	O
leptin	O
-	O
deficient	O
obese	O
Zucker	O
rats	O
(	O
Thanos	O
et	O
al	O
.,	O
2008	O
).	O

The	O
Beat	O
Savory	O
Relief	O
for	O
Arsenic	O
Poisoning	O
?	O

In	O
contrast	O
,	O
for	O
PFAS	O
exposure	O
,	O
the	O
μβand	O
σβposterior	O
means	O
were	O
larger	O
in	O
magnitude	O
and	O
equal	O
to	O
-	O
11	O
g	O
,	O
95	O
%	O
CI	O
(-	O
52	O
,	O
34	O
)	O
and	O
24	O
g	O
,	O
respectively	O
.	O

One	O
-	O
way	O
Analysis	O
of	O
Variance	O
(	O
ANOVA	O
)	O
statistical	O
tests	O
were	O
used	O
to	O
reveal	O
statistically	O
significant	O
protein	O
expression	O
differences	O
between	O
the	O
two	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Diet	O
significantly	O
affected	O
the	O
GD	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
=	O
0	O
.	O
0008	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

Out	O
of	O
these	O
60	O
clusters	O
,	O
30	O
clusters	O
were	O
randomly	O
selected	O
and	O
within	O
each	O
cluster	O
the	O
first	O
clinic	O
was	O
invited	O
to	O
participate	O
.	O

(	O
2014	O
)*	O
4	O
-(	O
methylnitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
)	O
MouseInjection	O
(	O
ip	O
)	O
(	O
2	O
mg	O
/	O
mouse	O
or	O
doses	O
of	O
100	O
and	O
75	O
mg	O
/	O
kg	O
a	O
wk	O
apart	O
)	O
Late	O
childhood	O
/	O
adolescenceAdolescence	O
AdulthoodPulmonary	O
tumorsDNA	O
methylation	O
Epigenetic	O
machineryJin	O
et	O
al	O
.	O

Participants	O
were	O
categorized	O
by	O
quintiles	O
of	O
dietary	O
pattern	O
scores	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
017	O
-	O
1600	O
-	O
5	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Black	O
mothers	O
on	O
Medicaid	O
who	O
were	O
obese	O
and	O
did	O
not	O
take	O
prenatal	O
vitamins	O
had	O
the	O
highest	O
probability	B
of	O
having	O
an	O
infant	O
with	O
vitamin	O
D	O
deficiency	O
.	O

We	O
will	O
estimate	O
incremental	O
cost	O
-	O
effectiveness	O
ratios	O
as	O
incremental	O
cost	O
per	O
neonate	O
death	O
avoided	O
;	O
per	O
low	O
birth	O
weight	O
infant	O
avoided	O
and	O
per	O
life	O
-	O
year	O
saved	O
.	O

Normally	O
distributed	O
data	O
will	O
be	O
expressed	O
as	O
means	O
±	O
SD	O
;	O
non	O
-	O
normally	O
distributed	O
data	O
will	O
be	O
expressed	O
as	O
medians	O
(	O
25th	O
percentile	O
,	O
75th	O
percentile	O
).	O

Hughes	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Association	O
of	O
LINE	O
-	O
1	O
(	O
A	O
)	O
and	O
AluYb8	O
(	O
B	O
)	O
methylation	O
with	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
.	O

Participants	O
were	O
also	O
required	O
to	O
have	O
a	O
working	O
cell	O
phone	O
,	O
and	O
speak	O
and	O
read	O
English	O
.	O

It	O
is	O
influenced	O
by	O
the	O
size	O
,	O
shape	O
,	O
and	O
number	O
of	O
erythrocytes	O
,	O
as	O
well	O
as	O
by	O
other	O
plasma	O
constituents	O
such	O
as	O
immunoglobulins	O
(	O
Brigden	O
1999	O
,	O
Gabay	O
and	O
Kushner	O
1999	O
).	O

Most	B
prenatal	O
vitamins	O
have	O
around	O
400	O
IU	O
of	O
vitamin	O
D	O
,	O
and	O
most	B
health	O
groups	O
recommend	O
taking	O
no	O
more	O
than	O
2	O
,	O
000	O
IU	O
of	O
the	O
vitamin	O
in	O
supplement	O
form	O
daily	O
.	O

Cord	O
25	O
(	O
OH	O
)	O
D	O
averaged	O
16	O
.	O
3	O
ng	O
/	O
mL	O
and	O
BMC	O
at	O
one	O
week	O
of	O
life	O
averaged	O
72	O
.	O
6	O
g	O
for	O
the	O
8	O
Hispanic	O
infants	O
who	O
did	O
not	O
return	O
at	O
3	O
months	O
.	O

In	O
their	O
study	O
,	O
YG	O
was	O
reduced	O
,	O
and	O
HCW	O
tended	O
to	O
be	O
reduced	O
in	O
offspring	O
of	O
dams	O
nutritionally	O
restricted	O
.	O

A	O
rumen	O
-	O
protected	O
form	O
of	O
vitamin	O
C	O
is	O
preferred	B
as	O
a	O
dietary	O
supplement	O
because	O
vitamin	O
C	O
is	O
most	B
likely	I
degraded	O
in	O
the	O
rumen	O
[	O
146	O
].	O

There	O
are	O
no	O
current	O
studies	O
that	O
can	O
give	O
real	O
good	O
answers	B
to	O
the	O
question	O
if	O
dietary	O
deficiency	O
interacts	O
with	O
genetic	O
vulnerability	O
for	O
schizophrenia	O
.	O

The	O
mothers	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
caudal	O
anesthesia	O
use	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
one	O
hour	O
.	O

This	O
suggests	O
that	O
SSRIs	O
may	O
have	O
similar	O
effects	O
in	O
human	O
neonates	O
[	O
38	O
].	O

Two	O
-	O
week	O
-	O
old	O
Korean	O
cattle	O
calves	O
were	O
fed	O
different	O
diets	O
,	O
i	O
.	O
e	O
.,	O
mother	O
’	O
s	O
milk	O
+	O
roughage	O
(	O
control	O
),	O
milk	O
replacement	O
+	O
concentrate	O
,	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
,	O
and	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
[	O
58	O
].	O

The	O
analysis	O
of	O
the	O
cannabinoid	O
-	O
regulated	O
metabolism	O
,	O
such	O
as	O
the	O
expression	O
of	O
key	O
enzymes	O
,	O
receptors	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
,	O
could	O
provide	O
some	O
clues	O
to	O
what	O
may	O
be	O
happening	O
.	O

The	O
'	O
mTOR	O
signaling	O
'	O
acts	O
as	O
an	O
important	O
nutrient	O
sensing	O
pathway	O
that	O
controls	O
protein	O
synthesis	O
in	O
mammalian	O
cells	O
at	O
the	O
level	O
of	O
translation	O
[	O
31	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonInfluenza	O
vaccine	O
2014	O
seasonMultiple	O
Logistic	O
Regression	O
(	O
MLR	O
)	O
Propensity	O
score	O
Model	O
(	O
PSM	O
)†	O
+	O
MLRǂn	O
=	O
1600	O
×	O
1000	O
simulations	O
¥	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
SGAi	O
)	O
1	O
.	O
03	O
*(	O
0	O
.	O
82	O
;	O
1	O
.	O
31	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
83	O
;	O
1	O
.	O
24	O
)	O
Preterm	O
birth	O
(	O
PTB	O
)	O
0	O
.	O
95	O
**(	O
0	O
.	O
75	O
;	O
1	O
.	O
20	O
)	O
0	O
.	O
88	O
(	O
0	O
.	O
73	O
;	O
1	O
.	O
06	O
)	O
Low	O
birth	O
weight	O
(	O
LBW	O
)	O
0	O
.	O
89	O
***(	O
0	O
.	O
66	O
;	O
1	O
.	O
22	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
62	O
;	O
1	O
.	O
06	O
)	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

Examining	O
predictors	O
of	O
birth	O
weight	O
,	O
the	O
strongest	O
predictor	O
of	O
higher	O
WFA	O
z	O
score	O
was	O
consumption	O
of	O
a	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
19	O
;	O
P	O
=	O
0	O
.	O
004	O
;	O
Table	O
3	O
).	O

Vitamin	O
D	O
freely	O
crosses	O
the	O
placenta	O
during	O
pregnancy	O
.	O

Animals	O
In	O
the	O
present	O
study	O
,	O
we	O
used	O
an	O
established	O
model	O
of	O
developmental	O
programming	O
via	O
maternal	O
nutrient	O
manipulation	O
[	O
29	O
],[	O
62	O
].	O

Prevalence	O
and	O
Burden	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
in	O
Developing	O
Countries	O
Worldwide	O
,	O
anemia	O
affects	O
over	O
two	O
billion	O
people	O
and	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
has	O
estimated	O
that	O
half	O
of	O
these	O
are	O
due	O
to	O
iron	O
deficiency	O
[	O
5	O
,	O
6	O
].	O

RNA	O
isolation	O
,	O
target	O
preparation	O
and	O
hybridisation	O
According	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
total	O
RNA	O
from	O
individual	O
liver	O
samples	O
was	O
isolated	O
using	O
Tri	O
-	O
Reagent	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
Taufkirchen	O
,	O
Germany	O
).	O

This	O
Zinc	O
-	O
finger	O
transcription	O
factor	O
induces	O
differentiation	O
of	O
brown	O
adipocytes	O
(	O
Seale	O
et	O
al	O
.,	O
2011	O
).	O

PubMed	O
Central	O
:	O

CC	O
females	O
exhibited	O
an	O
increased	O
caloric	O
intake	O
than	O
CC	O
males	O
from	O
the	O
13th	O
postnatal	O
week	O
(	O
adulthood	O
)	O
onward	O
,	O
meanwhile	O
RC	O
females	O
showed	O
a	O
higher	O
caloric	O
intake	O
than	O
RC	O
males	O
from	O
the	O
7th	O
postnatal	O
week	O
(	O
adolescence	O
)	O
to	O
adulthood	O
(	O
Figure2D	O
).	O

Characteristics	O
of	O
participants	O
and	O
their	O
parent	O
or	O
caregiver	O
appear	O
in	O
Table	O
1	O
.	O

If	O
the	O
measurements	O
cannot	O
be	O
taken	O
by	O
the	O
study	O
nurses	O
,	O
hospital	O
records	O
are	O
used	O
to	O
obtain	O
anthropometrical	O
data	O
(	O
using	O
the	O
same	O
calibrated	O
infant	O
scale	O
).	O

Women	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
were	O
matched	O
for	O
age	O
at	O
conception	O
(±	O
3	O
years	O
)	O
and	O
pregnancy	O
duration	O
at	O
the	O
initial	O
time	O
of	O
contact	O
(±	O
2	O
weeks	O
).	O

Folate	O
Status	O
Both	O
brain	O
(	O
Figure	O
6a	O
)	O
and	O
plasma	O
(	O
Figure	O
6b	O
)	O
folate	O
levels	O
were	O
unaffected	O
by	O
the	O
diets	O
of	O
the	O
dams	O
but	O
were	O
elevated	O
by	O
the	O
high	O
multivitamin	O
or	O
high	O
folate	O
pup	O
diet	O
.	O

In	B
general	I
,	O
these	O
indicate	O
that	O
glyburide	O
is	O
effective	O
in	O
achieving	O
glycemic	O
control	O
in	O
the	O
majority	O
of	O
patients	O
.	O

In	O
order	O
to	O
investigate	O
transcriptional	O
features	O
of	O
developmental	O
nutritional	O
programming	O
we	O
conducted	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

METHODS	O
Our	O
study	O
was	O
a	O
case	O
-	O
control	O
type	O
.	O

Women	O
interested	O
to	O
partake	O
in	O
the	O
study	O
are	O
screened	O
according	O
to	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
and	O
referred	O
to	O
RMMCH	O
ANC	O
clinic	O
for	O
signing	O
informed	O
consent	O
and	O
data	O
collection	O
if	O
eligible	O
.	O

These	O
proteins	O
are	O
essential	O
for	O
clathrin	O
-	O
mediated	O
endocytosis	O
,	O
a	O
role	O
of	O
particular	O
importance	O
in	O
neurons	O
for	O
neurotransmitter	O
release	O
[	O
31	O
].	O

The	O
study	O
was	O
able	O
to	O
adjust	O
for	O
several	O
important	O
confounds	O
,	O
including	O
length	O
of	O
gestation	O
and	O
infant	O
sex	O
;	O
however	O
,	O
the	O
sample	O
size	O
was	O
moderate	O
,	O
and	O
only	O
69	O
%	O
of	O
the	O
offspring	O
(	O
mostly	O
non	O
-	O
Hispanic	O
White	O
)	O
had	O
data	O
available	O
at	O
6	O
months	O
.	O

The	O
effectiveness	O
of	O
the	O
distribution	O
system	O
and	O
women	O
'	O
s	O
compliance	O
were	O
assessed	O
by	O
an	O
independent	O
Non	O
-	O
Government	O
Organization	O
at	O
10	O
weeks	O
and	O
18	O
and	O
36	O
months	O
post	O
-	O
implementation	O
.	O

Date	O
of	O
registration	O
:	O
March	O
9th	O
2015	O
.	O

The	O
modification	O
of	O
insulin	O
sensitivity	O
occurs	O
via	O
the	O
effect	O
of	O
the	O
PTEN	O
/	O
AKT	O
-	O
mediated	O
regulation	O
of	O
adipose	O
tissue	O
lipolysis	O
.	O

2	O
Associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
in	O
infants	O
delivered	O
vaginally	O
.	O

The	O
early	O
zygote	O
has	O
low	O
levels	O
of	O
miRNAs	O
,	O
but	O
high	O
expression	O
of	O
piRNAs	O
and	O
esiRNAs	O
,	O
with	O
esiRNAs	O
being	O
the	O
predominate	O
species	O
(	O
Garcia	O
-	O
Lopez	O
et	O
al	O
.	O
2015	O
).	O

Implementing	O
KMC	O
alone	O
also	O
suggests	O
that	O
a	O
high	O
reduction	O
of	O
deaths	O
could	O
be	O
achieved	O
[	O
21	O
],	O
averting	O
approximately	O
531	O
,	O
000	O
neonatal	O
deaths	O
in	O
2025	O
.	O

Anderson	O
Cancer	O
Center	O
are	O
currently	O
conducting	O
clinical	O
trials	O
in	O
Shanghai	O
on	O
a	O
cancer	O
therapy	O
that	O
uses	O
the	O
venom	O
of	O
the	O
Asiatic	O
toad	O
(	O
Bufo	O
gargarizans	O
).	O

Also	O
,	O
emphasis	O
is	O
placed	O
on	O
dished	O
food	O
not	O
eaten	O
and	O
the	O
amount	O
left	O
in	O
the	O
bowl	O
to	O
ensure	O
actual	O
intake	O
is	O
reported	O
.	O

Participants	O
were	O
asked	O
to	O
report	O
their	O
dietary	O
intakes	O
of	O
foods	O
based	O
on	O
nine	O
multiple	O
choice	O
frequency	O
response	O
categories	O
varying	O
from	O
“	O
never	O
or	O
less	O
than	O
once	O
a	O
month	O
”	O
to	O
“	O
12	O
or	O
more	O
times	O
per	O
day	O
”.	O

In	O
this	O
model	O
,	O
environmental	O
exposures	O
and	O
lifestyle	O
changes	O
that	O
occur	O
afterwards	O
play	O
a	O
mainly	B
secondary	O
role	O
to	O
the	O
programming	O
or	O
imprinting	O
that	O
occurs	O
during	O
pregnancy	O
and	O
/	O
or	O
early	O
infancy	O
[	O
14	O
,	O
15	O
].	O

Cont	O
–	O
control	O
pregnancies	O
;	O
MHF	O
–	O
dams	O
fed	O
a	O
HF	O
diet	O
pre	O
-	O
conceptionally	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
;	O
PLHF	O
–	O
dams	O
fed	O
a	O
chow	O
diet	O
pre	O
-	O
conceptionally	O
and	O
a	O
HF	O
diet	O
through	O
pregnancy	O
and	O
lactation	O
only	O
.	O

Vitamin	O
D	O
has	O
been	O
shown	O
to	O
facilitate	O
the	O
transport	O
of	O
nutrients	O
across	O
the	O
placenta	O
[	O
20	O
,	O
21	O
],	O
which	O
could	O
contribute	O
to	O
fetal	O
growth	O
[	O
22	O
].	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
found	O
in	O
the	O
liver	O
Ppar	O
α	O
gene	O
expression	O
and	O
the	O
PAT	O
Ppar	O
γ	O
gene	O
expression	O
(	O
TableS4	O
).	O

found	O
that	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
59	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
women	O
with	O
concentrations	O
≤	O
20	O
ng	O
/	O
mL	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
[	O
12	O
].	O

Care	O
of	O
premature	O
babies	O
is	O
primarily	B
an	O
action	O
gap	O
As	B
evidenced	O
by	O
the	O
large	O
survival	O
gap	O
between	O
babies	O
born	O
in	O
high	O
-	O
income	O
countries	O
and	O
those	O
born	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
effective	O
interventions	O
exist	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
,	O
yet	O
this	O
care	O
does	O
not	O
reach	O
the	O
poor	O
and	O
most	O
disadvantaged	O
populations	O
where	O
the	O
burden	O
is	O
highest	O
[	O
6	O
].	O

Important	O
research	O
priorities	O
have	O
been	O
highlighted	O
[	O
4	O
-	O
6	O
].	O

To	B
our	I
knowledge	I
,	O
no	O
previous	O
study	O
has	O
related	O
25OHD	O
concentration	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
to	O
neonatal	O
outcomes	O
related	O
to	O
placental	O
dysfunction	O
.	O

After	O
kidney	O
damage	O
occurs	O
,	O
chronic	O
renal	O
disease	O
progresses	O
through	O
a	O
cycle	O
that	O
passes	O
the	O
damage	O
from	O
lost	O
or	O
damaged	O
nephrons	O
to	O
healthy	O
nephrons	O
.	O

A	O
case	O
-	O
control	O
study	O
by	O
Zhang	O
et	O
al	O
.	O

One	O
southern	O
U	O
.	O
S	O
.	O
state	O
,	O
with	O
the	O
second	O
highest	O
preterm	O
birth	O
rate	O
in	O
the	O
country	O
,	O
has	O
received	O
an	O
"	O
F	O
"	O
on	O
its	O
Report	O
Card	O
every	O
year	O
since	O
2008	O
.	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

The	O
beta	O
estimate	O
indicates	O
how	O
much	O
the	O
log	O
cathelicidin	O
concentration	O
is	O
predicted	O
to	O
increase	O
with	O
a	O
1	O
-	O
unit	O
change	O
in	O
the	O
independent	O
variable	O
,	O
and	O
exponentiating	O
the	O
beta	O
value	O
provides	O
a	O
fold	O
-	O
increase	O
estimate	O
.	O

Within	O
developmental	O
period	O
III	O
,	O
AP	O
offspring	O
showed	O
a	O
decreased	O
expression	O
of	O
genes	O
associated	O
with	O
Polo	O
-	O
like	O
kinases	O
,	O
which	O
is	O
in	O
line	O
with	O
the	O
assumption	O
that	O
LP	O
pigs	O
have	O
not	O
terminated	O
their	O
growth	O
at	O
stage	O
188	O
dpn	O
;	O
in	O
particular	O
their	O
liver	O
has	O
not	O
attained	O
a	O
steady	O
-	O
state	O
and	O
that	O
there	O
is	O
persistent	O
functional	O
demand	O
towards	O
cell	O
proliferation	O
potentially	O
to	O
respond	O
to	O
an	O
elevated	O
metabolic	O
burden	O
,	O
including	O
a	O
higher	O
turn	O
over	O
of	O
lipids	O
and	O
ketone	O
bodies	O
.	O

An	O
increase	O
of	O
'	O
mTOR	O
signaling	O
'	O
within	O
developmental	O
period	O
II	O
was	O
observed	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
the	O
LP	O
group	O
.	O

Matias	O
et	O
al	O
.	O

Considering	B
this	O
and	O
the	O
physiological	O
changes	O
to	O
the	O
vitamin	O
D	O
pathway	O
in	O
pregnancy	O
,	O
it	O
is	O
therefore	B
possible	O
that	O
the	O
genetic	O
variants	O
associated	O
with	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
the	O
response	O
to	O
supplementation	O
also	O
differ	O
between	O
the	O
pregnant	O
and	O
nonpregnant	O
state	O
.	O

For	O
diagnosis	O
,	O
a	O
diary	O
of	O
allergy	O
symptoms	O
and	O
avoidance	O
of	O
specific	O
allergens	O
accompanied	O
by	O
monitoring	O
of	O
changes	O
of	O
allergic	O
symptoms	O
may	O
be	O
helpful	O
.	O

At	O
stage	O
94	O
dpc	O
1	O
,	O
001	O
probe	O
-	O
sets	O
differed	O
significantly	O
between	O
LP	O
and	O
AP	O
fetuses	O
(	O
541	O
LP	O
≻	O
AP	O
).	O

In	O
contrast	O
to	O
BMP7	O
and	O
BMP8B	O
,	O
BMP4	O
was	O
shown	O
to	O
promote	O
the	O
differentiation	O
of	O
mesenchymal	O
stem	O
cells	O
into	O
white	O
adipocytes	O
,	O
inducing	O
fat	O
storage	O
and	O
decreasing	O
energy	O
expenditure	O
in	O
rodents	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Normal	O
Physiological	O
Respiratory	O
Changes	O
During	O
PregnancyIncreasedDecreasedTidal	O
volumeFunctional	O
residual	O
capacityMinute	O
ventilationResidual	O
volumeAlveolar	O
-	O
arterial	O
O2gradientDiffusion	O
capacityOxygen	O
partial	O
pressurePaCO2pH	O
,	O
normal	O
or	O
slightly	O
elevated	O
(	O
respiratory	O
alkalosis	O
)	O
Respiratory	O
rate	O
unchanged	O
Adapted	O
from	O
Weinberger	O
et	O
al	O
[	O
17	O
].	O

Improved	O
human	O
exposure	O
data	O
could	O
be	O
collected	O
and	O
used	O
to	O
facilitate	O
the	O
use	O
of	O
more	O
relevant	O
doses	O
,	O
routes	O
of	O
administration	O
,	O
metabolites	O
and	O
mixtures	O
.	O

Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
measured	O
on	O
average	O
at	O
11	O
weeks	O
of	O
gestation	O
,	O
and	O
GDM	O
was	O
diagnosed	O
on	O
average	O
at	O
26	O
weeks	O
of	O
gestation	O
in	O
both	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

Characterizing	O
normal	O
variation	O
within	O
the	O
epigenome	O
between	O
non	O
-	O
disease	O
states	O
would	O
provide	O
valuable	O
data	O
to	O
begin	O
establishing	O
limits	O
of	O
epignetic	O
change	O
above	O
which	O
cellular	O
homeostasis	O
fails	O
and	O
epigenetic	O
toxicity	O
is	O
induced	O
.	O

The	O
capillaries	O
were	O
not	O
arranged	O
in	O
lobules	O
and	O
rather	O
were	O
dispersed	O
among	O
spicules	O
of	O
mineralized	O
bone	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
prevalent	O
in	O
India	O
,	O
a	O
finding	O
that	O
is	O
unexpected	O
in	O
a	O
tropical	O
country	O
with	O
abundant	O
sunshine	O
.	O

Multiple	O
studies	O
in	O
high	O
-	O
income	O
contexts	O
have	O
attempted	O
to	O
prevent	O
preterm	O
birth	O
,	O
but	O
have	O
not	O
yet	O
identified	O
high	O
-	O
impact	O
interventions	O
in	O
the	O
preconception	O
and	O
antenatal	O
periods	O
.	O

We	O
used	O
priors	O
following	O
recommendations	O
of	O
a	O
recent	O
study	O
of	O
vague	O
priors	O
for	O
random	O
effects	O
models	O
[	O
47	O
].	O

As	O
with	O
any	O
longitudinal	O
study	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
exclusion	O
of	O
mother	O
–	O
child	O
pairs	O
without	O
complete	O
information	O
might	O
have	O
biased	O
our	O
findings	O
.	O

It	O
can	B
be	I
concluded	I
that	O
women	O
with	O
low	O
socioeconomic	O
status	O
need	O
specific	O
dietary	O
intervention	O
programs	O
due	B
to	I
increase	O
in	O
nutritional	O
demands	O
during	O
pregnancy	O
.	O

Methods	O
We	O
interviewed	O
women	O
from	O
the	O
inpatient	O
post	O
-	O
natal	O
unit	O
at	O
BMC	O
about	O
what	O
herbs	O
they	O
used	O
during	O
pregnancy	O
,	O
socioeconomic	O
factors	O
,	O
changes	O
to	O
diet	O
,	O
and	O
use	O
of	O
prenatal	O
vitamins	O
.	O

Another	O
paper	O
published	O
after	O
my	O
original	O
paper	O
found	O
that	O
autistic	O
boys	O
have	O
unexplained	O
reductions	O
in	O
metacarpal	O
bone	O
thickness	O
(	O
15	O
).	O

Women	O
of	O
high	O
educational	O
level	O
were	O
the	O
most	O
interested	O
in	O
the	O
health	O
talk	O
recommendation	O
(	O
76	O
%	O
of	O
all	O
recommendations	O
were	O
made	O
by	O
this	O
class	O
of	O
respondents	O
),	O
arguing	O
that	O
the	O
“	O
lectures	O
”	O
should	O
be	O
more	O
detailed	O
than	O
what	O
they	O
were	O
at	O
the	O
moment	O
.	O

The	O
PGM	O
was	O
significantly	O
correlated	O
with	O
girls	O
,	O
but	O
not	O
boys	O
,	O
at	O
age	O
0	O
.	O

It	O
would	O
be	O
of	O
interest	O
to	O
repeat	O
these	O
experiments	O
in	O
primary	O
cell	O
lines	O
of	O
syncytialised	O
trophoblasts	O
.	O

Knowledge	O
about	O
antenatal	O
care	O
varied	O
and	O
majority	O
of	O
respondents	O
(	O
96	O
.	O
4	O
%)	O
were	O
satisfied	O
with	O
the	O
antenatal	O
services	O
received	O
.	O

In	O
this	O
subgroup	O
analysis	O
,	O
after	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
a	O
1	O
-	O
hour	O
increase	O
in	O
nightly	O
sleep	O
was	O
associated	O
with	O
a	O
15	O
%	O
reduction	O
in	O
GDM	O
risk	O
(	O
RR	O
=	O
0	O
.	O
85	O
;	O
95	O
%	O
CI	O
0	O
.	O
69	O
-	O
1	O
.	O
05	O
);	O
though	O
this	O
association	O
was	O
not	O
statistically	O
significant	O
.	O

By	O
self	O
-	O
selection	O
,	O
those	O
who	O
manifest	O
seasonal	O
allergies	O
may	O
choose	O
a	O
career	O
path	O
other	O
than	O
farming	O
(	O
i	O
.	O
e	O
.,	O
healthy	O
worker	O
effect	O
)	O
[	O
116	O
].	O

But	O
new	O
research	O
suggests	O
that	O
a	O
weekly	O
iron	O
supplement	O
coinciding	O
with	O
the	O
renewal	O
of	O
the	O
small	O
intestine	O
’	O
s	O
mucosal	O
lining	O
cells	O
(	O
where	O
nutrient	O
absorption	O
occurs	O
)	O
works	O
better	O
than	O
a	O
daily	O
supplement	O
and	O
prevents	O
problems	O
resulting	O
from	O
too	O
much	O
iron	O
at	O
the	O
wrong	O
times	O
.	O

As	O
discussed	O
earlier	O
,	O
some	O
life	O
stages	O
may	O
be	O
more	O
susceptible	O
than	O
others	O
to	O
a	O
particular	O
exposure	O
.	O

It	O
has	O
long	O
been	O
suggested	O
that	O
5mC	O
can	O
be	O
removed	O
by	O
both	O
passive	O
(	O
through	O
lack	O
of	O
maintenance	O
during	O
replication	O
)	O
and	O
active	O
(	O
enzymatic	O
)	O
mechanisms	O
.	O

11	O
.	O
8	O
%	O
at	O
18	O
weeks	O
and	O
13	O
.	O
5	O
%	O
at	O
32	O
weeks	O
were	O
depressed	O
with	O
the	O
threshold	O
score	O
of	O
13	O
or	O
higher	O
[	O
60	O
].	O

BeWo	O
cells	O
were	O
cultured	O
in	O
Ham	O
F12	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
)	O
containing	O
10	O
%	O
heat	O
-	O
inactivated	O
fetal	O
bovine	O
serum	O
(	O
FBS	O
)	O
and	O
0	O
.	O
5	O
%	O
penicillin	O
streptomycin	O
,	O
whereas	O
JEG	O
-	O
3	O
cells	O
were	O
maintained	O
in	O
MEME	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
)	O
containing	O
10	O
%	O
heat	O
-	O
inactivated	O
FBS	O
and	O
0	O
.	O
5	O
%	O
penicillin	O
streptomycin	O
,	O
0	O
.	O
5	O
%	O
L	O
-	O
glutamine	O
,	O
0	O
.	O
5	O
%	O
sodium	O
pyruvate	O
,	O
and	O
0	O
.	O
5	O
%	O
MEM	O
nonessential	O
amino	O
acids	O
.	O

No	O
increase	O
in	O
pregnancy	O
complications	O
have	O
been	O
found	O
in	O
observational	O
studies	O
where	O
lispro	O
was	O
used	O
,	O
in	O
either	O
women	O
with	O
GDM38	O
,	O
43or	O
pre	O
-	O
existing	O
diabetes	O
.	O
38	O
–	O
43There	O
are	O
few	O
reports	O
regarding	O
the	O
use	O
of	O
aspart	O
in	O
pregnancy	O
.	O

The	O
limitations	O
of	O
this	O
study	O
include	O
the	O
small	O
sample	O
size	O
based	O
on	O
a	O
cross	O
-	O
sectional	O
analysis	O
,	O
which	O
prevent	O
us	O
from	O
establishing	O
causal	O
relationships	O
.	O

Secondly	O
,	O
we	O
analysed	O
the	O
differences	O
among	O
both	O
experimental	O
groups	O
regarding	O
the	O
more	O
long	O
-	O
term	O
and	O
more	O
pronounced	O
changes	O
of	O
expression	O
patterns	O
between	O
the	O
adjacent	O
stages	O
.	O

Of	O
187	O
infant	O
stool	O
samples	O
with	O
available	O
sequencing	O
data	O
,	O
we	O
dropped	O
18	O
for	O
missing	O
maternal	O
FFQ	O
data	O
,	O
14	O
for	O
missing	O
infant	O
feeding	O
method	O
,	O
and	O
7	O
for	O
missing	O
maternal	O
BMI	O
.	O

All	O
participants	O
provided	O
written	O
or	O
verbal	O
informed	O
consent	O
.	O

2009	O
;	O
Lupski	O
2010	O
;	O
Weisenberger	O
et	O
al	O
.	O

Nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
these	O
supplements	O
,	O
regardless	O
of	O
the	O
frequency	O
of	O
prenatal	O
visits	O
or	O
socio	O
-	O
demographic	O
characteristics	O
.	O

Genes	O
influence	O
many	O
aspects	O
of	O
eating	O
behavior	O
,	O
including	O
taste	O
sensitivity	O
(	O
55	O
),	O
food	O
preference	O
(	O
56	O
),	O
intake	O
of	O
specific	O
foods	O
(	O
57	O
),	O
meal	O
patterns	O
(	O
58	O
),	O
energy	O
density	O
(	O
59	O
),	O
macronutrient	O
intake	O
(	O
60	O
,	O
61	O
),	O
and	O
meal	O
(	O
61	O
-	O
63	O
)	O
and	O
daily	O
energy	O
intake	O
(	O
61	O
).	O

We	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
(	O
Table	O
3	O
).	O

We	O
decided	O
not	O
to	O
include	O
dietary	O
Vitamin	O
D	O
estimates	O
in	O
the	O
final	O
multivariate	O
models	O
as	B
fish	O
is	O
a	O
rich	O
source	O
of	O
vitamin	O
D	O
and	O
could	O
account	O
for	O
some	O
of	O
the	O
effect	O
of	O
fish	O
on	O
our	O
outcome	O
.	O

Examination	O
for	O
concentration	O
of	O
VD2and	O
glucose	O
of	O
follicular	O
fluid	O
in	O
101	O
patients	O
treated	O
with	O
IVF	O
-	O
ICSI	O
method	O
reported	O
poorer	O
quality	O
of	O
embryos	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
a	O
lower	O
rate	O
of	O
clinical	O
pregnancies	O
(	O
14	O
.	O
5	O
%)	O
in	O
patients	O
with	O
VD	O
levels	O
exceeding	O
75	O
nmol	O
/	O
L	O
.	O

The	O
demonstrated	O
KAB	O
and	O
behavioral	O
effects	O
of	O
this	O
broad	O
,	O
low	O
-	O
touch	O
program	O
offers	O
lessons	O
for	O
future	O
scalable	O
mHealth	O
efforts	O
.	O

Women	O
with	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
those	O
with	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
.	O

There	O
were	O
several	O
limitations	O
to	O
the	O
study	O
.	O

A	O
recent	O
survey	O
[	O
25	O
]	O
of	O
the	O
cost	O
of	O
micronutrient	O
supplementation	O
programs	O
(	O
both	O
published	O
and	O
“	O
grey	O
”	O
literature	O
)	O
identified	O
43	O
studies	O
,	O
of	O
which	O
31	O
were	O
for	O
vitamin	O
A	O
,	O
and	O
the	O
rest	O
for	O
iron	O
(	O
7	O
),	O
iodine	O
(	O
4	O
)	O
and	O
zinc	O
(	O
1	O
).	O

Moreover	O
,	O
their	O
offspring	O
displayed	O
normoweight	O
at	O
birth	O
and	O
during	O
lactation	O
in	O
a	O
sex	O
and	O
diet	O
-	O
independent	O
manner	O
.	O

Only	O
a	O
very	O
limited	O
number	O
of	O
human	O
studies	O
on	O
the	O
maternofetal	O
transfer	O
of	O
cytokines	O
and	O
chemokines	O
are	O
available	O
.	O

The	O
predominance	O
of	O
papillary	O
cancer	O
may	O
be	O
an	O
important	O
factor	O
favouring	B
localized	O
disease	O
,	O
as	B
these	O
cancers	O
metastasize	O
slowly	O
,	O
and	O
mostly	B
in	O
the	O
lymphatic	O
system	O
,	O
whereas	O
less	O
common	O
follicular	O
cancers	O
tend	O
to	O
spread	O
via	O
angio	O
-	O
invasion	O
with	O
a	O
higher	O
frequency	O
of	O
distant	O
metastasis	O
.	O

Moreover	O
,	O
the	O
nature	O
of	O
maternal	O
stress	O
was	O
not	O
identified	O
and	O
further	O
analytical	O
approaches	O
are	O
needed	O
to	O
provide	O
conclusive	O
evidence	O
for	O
a	O
gene	O
-	O
environment	O
interaction	O
.	O

We	O
found	O
that	O
48	O
.	O
0	O
%	O
of	O
women	O
took	O
folic	O
acid	O
at	O
some	O
stage	O
during	O
pregnancy	O
,	O
compared	O
with	O
27	O
.	O
0	O
%	O
in	O
the	O
IOMC	O
study	O
.	O

Using	O
both	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
as	O
covariates	O
in	O
the	O
GWG	O
analysis	O
induced	O
a	O
multicollinearity	O
problem	O
based	O
on	O
Cook	O
’	O
s	O
Distance	O
and	O
Levene	O
’	O
s	O
test	O
,	O
but	O
excluding	O
these	O
covariates	O
from	O
the	O
model	O
did	O
not	O
change	O
the	O
results	O
.	O

Conclusions	O
Vitamin	O
D	O
deficiency	O
in	O
late	O
pregnancy	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
SGA	O
and	O
LBW	O
.	O

Design	O
and	O
data	O
collection	O
At	O
first	O
,	O
a	O
research	O
team	O
member	O
who	O
was	O
responsible	O
for	O
data	O
collection	O
visited	O
the	O
prenatal	O
care	O
clinic	O
of	O
the	O
hospital	O
daily	O
and	O
based	O
on	O
the	O
inclusion	O
criteria	O
,	O
invited	O
the	O
mothers	O
to	O
participate	O
in	O
the	O
study	O
.	O

Cattle	O
management	O
factors	O
are	O
also	O
important	O
for	O
IMF	O
deposition	O
.	O

In	O
addition	O
,	O
significantly	O
higher	O
proportions	O
of	O
exposed	O
women	O
smoked	O
more	O
cigarettes	O
during	O
pregnancy	O
and	O
were	O
less	O
likely	B
to	O
breastfeed	O
and	O
take	O
prenatal	O
vitamins	O
.	O

Exposure	O
Maternal	O
blood	O
samples	O
were	O
collected	O
from	O
each	O
participant	O
at	O
two	O
time	O
points	O
;	O
before	O
gestational	O
week	O
16	O
(	O
predominantly	O
week	O
8	O
–	O
12	O
,	O
first	O
trimester	O
,	O
T1	O
)	O
and	O
after	O
gestational	O
week	O
31	O
(	O
predominantly	O
week	O
32	O
–	O
35	O
,	O
third	O
trimester	O
,	O
T3	O
).	O

According	O
to	O
GPPAQ	O
,	O
participants	O
were	O
categorized	O
into	O
4	O
levels	O
of	O
physical	O
activity	O
based	O
on	O
hours	O
/	O
week	O
.	O

Detailed	O
information	O
on	O
25	O
(	O
OH	O
)	O
D	O
analysis	O
has	O
been	O
previously	O
reported	O
[	O
5	O
].	O

Legends	O
:	O
BM	O
,	O
body	O
mass	O
;	O
FI	O
,	O
food	O
intake	O
;	O
WI	O
,	O
water	O
intake	O
.	O

Such	O
method	O
allows	B
nutrition	O
researchers	O
to	O
identify	O
Vitamin	O
D	O
food	O
sources	O
and	O
evaluate	O
dietary	O
pattern	O
.	O

Between	O
birth	O
and	O
postnatal	O
day	O
22	O
,	O
pups	O
born	O
to	O
dams	O
that	O
were	O
calorie	O
restricted	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
remained	O
lighter	O
than	O
controls	O
(	O
Figure	O
1C	O
),	O
and	O
were	O
significantly	O
lighter	O
at	O
weaning	O
(	O
day	O
22	O
)	O
compared	O
to	O
ad	O
-	O
libitum	O
fed	O
controls	O
(	O
Cont	O
59	O
.	O
1	O
±	O
0	O
.	O
7	O
g	O
,	O
UNP	O
54	O
.	O
1	O
±	O
0	O
.	O
8	O
,	O
UNL	O
38	O
.	O
5	O
±	O
0	O
.	O
9	O
g	O
,	O
UNPL	O
33	O
.	O
0	O
±	O
0	O
.	O
7	O
;	O
p	O
<	O
0	O
.	O
05	O
).	O

Background	O
Gestational	O
diabetes	O
(	O
GDM	O
)	O
is	O
defined	O
as	O
“	O
carbohydrate	O
intolerance	O
with	O
onset	O
or	O
first	O
recognition	O
during	O
pregnancy	O
”.	O
1Large	O
studies	O
have	O
found	O
that	O
GDM	O
occurs	O
in	O
2	O
.	O
2	O
%–	O
8	O
.	O
8	O
%	O
of	O
pregnancies	O
,	O
depending	O
on	O
the	O
ethnic	O
mix	O
of	O
the	O
population	O
and	O
the	O
criteria	O
used	O
for	O
diagnosis	O
.	O
2In	O
some	O
specific	O
populations	O
however	O
,	O
the	O
incidence	O
can	O
be	O
considerably	O
higher	O
.	O

The	O
validity	O
of	O
the	O
fat	O
estimates	O
from	O
the	O
FFQ	O
assessed	O
using	O
Pearson	O
correlation	O
coefficients	O
between	O
FFQ	O
data	O
and	O
estimates	O
derived	O
from	O
weighed	O
food	O
records	O
varied	O
between	O
r	O
=	O
0	O
.	O
4	O
and	O
r	O
=	O
0	O
.	O
5	O
.	O

25	O
(	O
OH	O
)	O
D	O
before	O
and	O
after	O
supplementation	O
with	O
cholecalciferol	O
in	O
pregnancy	O
according	O
to	O
GRS	O
for	O
the	O
SNPs	O
rs10741657	O
(	O
CYP2R1	O
)	O
and	O
rs2282679	O
(	O
GC	O
).	O

Even	O
after	O
stratifying	O
by	O
season	O
and	O
only	O
analyzing	O
data	O
collected	O
during	O
the	O
winter	O
(	O
October	O
-	O
April	O
)	O
to	O
control	O
for	O
endogenous	O
production	O
,	O
a	O
statistically	O
significant	O
difference	O
remained	O
(	O
63	O
.	O
5	O
±	O
27	O
.	O
7	O
nmol	O
/	O
L	O
vs	O
.	O
79	O
.	O
4	O
±	O
26	O
.	O
7	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
all	O
fitted	O
models	O
,	O
the	O
low	O
level	O
of	O
each	O
dietary	O
pattern	O
(	O
quartile	O
1	O
)	O
was	O
defined	O
as	O
the	O
reference	O
category	O
.	O

All	O
potential	O
participants	O
were	O
identified	O
from	O
a	O
database	O
of	O
women	O
who	O
directly	O
contacted	O
the	O
Motherisk	O
Program	O
at	O
the	O
Hospital	O
for	O
Sick	O
Children	O
in	O
Toronto	O
,	O
Canada	O
,	O
between	O
2005	O
and	O
2009	O
.	O

In	O
previous	O
case	O
reports	O
,	O
the	O
investigators	O
believed	O
that	O
the	O
vascular	O
proliferation	O
in	O
both	O
AAOC	O
and	O
PG	O
were	O
induced	O
by	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
).	O
2	O
,	O
3	O
,	O
4Endothelial	O
cells	O
produce	O
signals	O
such	O
as	O
bone	O
morphogenic	O
protein	O
(	O
BMP	O
)	O
to	O
induce	O
metaplastic	O
differentiation	O
and	O
ectopic	O
bone	O
formation	O
.	O
9Osteoblasts	O
are	O
also	O
responsible	O
for	O
production	O
of	O
VEGF	O
.	O
10The	O
combination	O
of	O
VEGF	O
and	O
hypoxia	O
induce	O
BMP	O
expression	O
.	O
9Together	O
,	O
VEGF	O
and	O
BMP	O
are	O
the	O
most	B
likely	I
factors	O
that	O
induce	O
vascular	O
proliferation	O
and	O
bone	O
formation	O
in	O
AAOC	O
.	O

However	O
,	O
a	O
large	O
randomized	O
controlled	O
trial	O
comparing	O
aspart	O
with	O
regular	O
human	O
insulin	O
in	O
322	O
pregnant	O
women	O
with	O
type	O
1	O
diabetes	O
has	O
been	O
performed	O
.	O
44Comparable	O
birth	O
outcomes	O
were	O
found	O
between	O
the	O
two	O
arms	O
,	O
suggesting	O
that	O
aspart	O
is	O
as	O
safe	O
and	O
effective	O
as	O
human	O
insulin	O
.	O

The	O
Ct	O
value	O
is	O
defined	O
as	O
the	O
fractional	O
cycle	O
number	O
at	O
which	O
the	O
fluorescence	O
passes	O
the	O
fixed	O
threshold	O
.	O

We	O
note	O
that	O
our	O
study	O
was	O
of	O
limited	O
size	O
however	O
,	O
and	O
that	O
larger	O
studies	O
are	O
needed	O
in	O
diverse	O
global	O
populations	O
.	O

To	O
avoid	O
litter	O
effects	O
,	O
samples	O
from	O
6	O
to	O
15	O
liters	O
per	O
perinatal	O
group	O
were	O
used	O
in	O
all	O
determinations	O
.	O

Heritability	O
Heritability	O
of	O
the	O
marbling	O
trait	O
has	O
been	O
reported	O
in	O
several	O
cattle	O
breeds	O
.	O

The	O
Genetics	O
of	O
Pre	O
-	O
eclampsia	O
(	O
GOPEC	O
)	O
consortium	O
studied	O
patterns	O
of	O
inheritance	O
across	O
three	O
generations	O
in	O
relation	O
to	O
risk	O
of	O
pre	O
-	O
eclampsia	O
.	O
10A	O
US	O
study	O
,	O
employing	O
self	O
-	O
reported	O
grandparental	O
data	O
,	O
looked	O
at	O
familial	O
associations	O
for	O
childhood	O
overweight	O
.	O
11In	O
Hong	O
Kong	O
,	O
an	O
economy	O
in	O
epidemiological	O
transition	O
,	O
grandparental	O
and	O
parental	O
education	O
in	O
relation	O
to	O
childhood	O
weight	O
was	O
studied	O
,	O
the	O
parental	O
influence	O
being	O
stronger	O
.	O
12A	O
small	O
number	O
of	O
studies	O
have	O
been	O
reported	O
which	O
examine	O
grandparental	O
morbidity	O
and	O
mortality	O
data	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
and	O
growth	O
patterns	O
.	O
13	O
–	O
16Most	O
recently	O
,	O
data	O
from	O
the	O
Overkalix	O
study	O
in	O
Sweden	O
,	O
which	O
relates	O
famine	O
experience	O
decades	O
ago	O
with	O
current	O
grandchildren	O
'	O
s	O
cardiovascular	O
disease	O
outcomes	O
,	O
suggest	O
that	O
the	O
paternal	O
grandmother	O
'	O
s	O
(	O
PGM	O
)	O
exposure	O
to	O
famine	O
-	O
like	O
conditions	O
in	O
childhood	O
was	O
associated	O
with	O
an	O
increased	O
likelihood	B
of	O
cardiovascular	O
disease	O
in	O
her	O
adult	O
granddaughter	O
,	O
whereas	O
the	O
mortality	O
association	O
was	O
limited	O
to	O
grandsons	O
for	O
the	O
paternal	O
grandfather	O
(	O
PGF	O
).	O
1718The	O
maternal	O
grandmother	O
(	O
MGM	O
)	O
may	O
be	O
particularly	O
significant	O
,	O
because	B
she	O
supplies	O
the	O
ovum	O
through	O
the	O
mother	O
to	O
her	O
grandchild	O
,	O
as	O
well	O
as	O
her	O
nurturing	O
role	O
to	O
the	O
mother	O
and	O
grandchild	O
.	O
119Both	O
grandmothers	O
provide	O
an	O
intrauterine	O
environment	O
for	O
the	O
respective	O
parents	O
of	O
any	O
index	O
grandchild	O
.	O

trial	O
cohort	O
(	O
N	O
=	O
509	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Zoom	O
of	O
the	O
fitted	O
LOESS	O
curve	O
of	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
gestational	O
age	O
(	O
weeks	O
)	O
at	O
birth	O
with	O
1	O
and	O
2	O
SD	O
windows	O
superimposed	O
.	O

Fetal	O
heart	O
tones	O
were	O
155	O
.	O

In	O
our	O
study	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
was	O
an	O
independent	O
determinant	O
for	O
the	O
use	O
of	O
folic	O
acid	O
during	O
pregnancy	O
.	O

[	O
22	O
]	O
have	O
proposed	O
that	O
the	O
fetus	O
uses	O
nutritional	O
signals	O
(	O
and	O
/	O
or	O
changes	O
in	O
the	O
endocrine	O
environment	O
)	O
to	O
anticipate	O
its	O
future	O
energetic	O
environment	O
,	O
and	O
through	O
developmental	O
plasticity	O
adjusts	O
its	O
phenotype	O
accordingly	O
[	O
23	O
],[	O
24	O
].	O

The	O
mean	O
age	O
was	O
40	O
.	O
8	O
±	O
14	O
.	O
1	O
months	O
.	O

Differences	O
markedly	O
less	O
than	O
are	O
less	O
likely	O
to	O
be	O
biologically	O
relevant	O
and	O
this	O
study	O
was	O
not	O
designed	O
to	O
identify	O
small	O
differences	O
.	O

We	O
acknowledge	O
that	O
our	O
sample	O
included	O
small	O
numbers	O
in	O
certain	O
categories	O
of	O
polymorphic	O
groups	O
.	O

Yet	O
,	O
visfatin	O
’	O
s	O
regulatory	O
and	O
release	O
mechanisms	O
in	O
the	O
fetus	O
and	O
neonate	O
are	O
still	O
unclear	O
(	O
5	O
).	O

In	O
several	O
cases	O
,	O
peptides	O
were	O
concentrated	O
and	O
desalted	O
using	O
C18Perfect	O
Pure	O
Tips	O
(	O
Eppendorf	O
).	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

In	O
this	O
study	O
only	O
183	O
autistic	O
children	O
were	O
considered	O
and	O
medical	O
conditions	O
of	O
the	O
mother	O
based	O
on	O
a	O
maternal	O
self	O
-	O
report	O
[	O
18	O
].	O

Depression	O
scores	O
decreased	O
in	O
the	O
both	O
our	O
groups	O
over	O
time	O
which	O
indicates	O
that	O
depression	O
could	O
be	O
more	O
critical	O
during	O
pregnancy	O
than	O
postpartum	O
period	O
.	O

Although	O
most	O
of	O
the	O
existing	O
data	O
regarding	O
asthma	O
and	O
allergy	O
medications	O
during	O
pregnancy	O
have	O
not	O
demonstrated	O
adverse	O
effects	O
,	O
data	O
regarding	O
the	O
use	O
of	O
oral	O
corticosteroids	O
have	O
not	O
been	O
totally	O
reassuring	O
.	O

Smoking	O
has	O
been	O
found	O
to	O
be	O
an	O
environmental	O
hazard	O
.	O

However	O
,	O
they	O
showed	O
that	O
the	O
decrease	O
of	O
PTH	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

Existing	O
evidence	O
is	O
currently	O
insufficient	O
to	O
inform	O
advice	O
regarding	O
fish	O
intake	O
during	O
pregnancy	O
.	O

Park	O
et	O
al	O
[	O
15	O
]	O
studied	O
Korean	O
infants	O
at	O
2	O
to	O
5	O
months	O
of	O
age	O
and	O
found	O
no	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
BMC	O
assessed	O
by	O
DXA	O
even	O
though	O
many	O
of	O
the	O
infants	O
had	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

A	O
previous	O
study	O
in	O
Romania	O
reported	O
that	O
supplemental	O
iron	O
was	O
taken	O
by	O
53	O
.	O
3	O
%	O
of	O
women	O
during	O
pregancy	O
[	O
14	O
].	O

Disruptions	O
of	O
the	O
process	O
of	O
major	O
neovascularization	O
can	O
lead	B
to	I
serious	O
pregnancy	O
complications	O
,	O
including	O
preeclampsia	O
(	O
PE	O
)	O
in	O
further	O
gestation	O
.	O

The	O
impact	O
of	O
UCP1	O
deletion	O
on	O
insulin	O
sensitivity	O
in	O
these	O
mice	O
was	O
not	O
reported	O
.	O

The	O
mortality	O
rate	O
for	O
untreated	O
proximal	O
aortic	O
dissections	O
increases	O
by	O
1	O
–	O
3	O
%	O
per	O
hour	O
after	O
presentation	O
and	O
is	O
roughly	O
25	O
%	O
during	O
the	O
first	O
24	O
hours	O
and	O
up	O
to	O
70	O
%	O
at	O
1	O
week	O
and	O
80	O
%	O
at	O
2	O
weeks	O
[	O
5	O
].	O

Although	O
the	O
incidence	O
of	O
infant	O
wheeze	O
was	O
similar	O
between	O
the	O
groups	O
,	O
the	O
percentage	O
of	O
respiratory	O
tract	O
infection	O
was	O
significantly	O
higher	O
in	O
infants	O
with	O
a	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
Table	O
1	O
).	O

De	O
novo	O
methylation	O
is	O
established	O
by	O
the	O
de	O
novo	O
DNMTs	O
3A	O
and	O
3B	O
,	O
which	O
preferentially	O
methylate	O
unmethylated	O
DNA	O
.	O

Furthermore	O
,	O
in	O
this	O
study	O
,	O
we	O
performed	O
analysis	O
only	O
of	O
candidate	O
SNPs	O
previously	O
identified	O
to	O
be	O
associated	O
with	O
differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
status	O
.	O

(	O
2014	O
)*	O
Pascual	O
et	O
al	O
.	O

Women	O
received	O
30	O
tablets	O
according	O
to	O
their	O
allocated	O
intervention	O
group	O
and	O
were	O
instructed	O
to	O
take	O
one	O
tablet	O
daily	O
.	O

Data	O
collection	O
schedule	O
The	O
data	O
collectors	O
will	O
visit	O
each	O
woman	O
a	O
total	O
number	O
of	O
six	O
times	O
from	O
the	O
time	O
of	O
enrolment	O
till	O
42	O
days	O
after	O
delivery	O
.	O

Conclusions	O
In	O
a	O
large	O
ethnically	O
diverse	O
cohort	O
of	O
newborns	O
,	O
the	O
presence	O
of	O
a	O
pet	O
in	O
the	O
home	O
during	O
the	O
prenatal	O
time	O
period	O
was	O
associated	O
with	O
higher	O
cord	O
blood	O
vitamin	O
D	O
,	O
but	O
only	O
among	O
Whites	O
.	O

old	O
.	O

Born	O
Too	O
Soon	O
:	O
Accelerating	O
actions	O
for	O
prevention	O
and	O
care	O
of	O
15	O
million	O
newborns	O
born	O
too	O
soon	O
Abstract	O
Preterm	O
birth	O
complication	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
resulting	O
in	O
over	O
one	O
million	O
deaths	O
each	O
year	O
of	O
the	O
15	O
million	O
babies	O
born	O
preterm	O
.	O

Thus	B
,	O
hypothyroidism	O
must	O
be	O
absolutely	O
avoided	O
in	O
all	O
pregnant	O
woman	O
,	O
especially	O
in	O
thyroid	O
cancer	O
patients	O
,	O
and	O
therefore	B
correct	O
supplementation	O
of	O
thyroxine	O
is	O
of	O
extreme	O
importance	O
.	O

JF	O
:	O
Analysis	O
and	O
interpretation	O
of	O
data	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

Pregnant	O
women	O
were	O
advised	O
to	O
use	O
the	O
daily	O
supplements	O
provided	O
through	O
Government	O
antenatal	O
clinics	O
,	O
or	O
if	O
these	O
were	O
not	O
available	O
,	O
to	O
use	O
a	O
double	O
dose	O
of	O
the	O
weekly	O
supplements	O
.	O

However	O
this	O
is	O
not	B
surprising	I
because	B
previous	O
studies	O
have	O
reported	O
that	O
DNA	O
methylation	O
of	O
genes	O
in	O
the	O
absence	O
of	O
a	O
detectable	O
change	O
in	O
global	O
methylation	O
,	O
suggesting	O
that	O
epigenetic	O
changes	O
are	O
site	O
-	O
specific	O
.	O
33In	O
addition	O
,	O
the	O
RV	O
,	O
HV	O
and	O
HFol	O
diets	O
in	O
our	O
study	O
contain	O
high	O
amounts	O
of	O
choline	O
,	O
which	O
is	O
another	O
factor	O
affecting	O
DNA	O
methylation	O
,	O
34	O
,	O
35and	O
it	O
alone	O
may	O
have	O
obscured	O
detection	O
of	O
the	O
effect	O
of	O
folate	O
on	O
methylation	O
.	O

Although	O
most	O
drugs	O
do	O
not	O
harm	O
the	O
fetus	O
,	O
this	O
knowledge	O
is	O
incomplete	O
.	O

Multiple	O
births	O
and	O
major	O
congenital	O
anomalies	O
were	O
excluded	O
.	O

Data	O
collection	O
At	O
the	O
first	O
antenatal	O
consultation	O
,	O
participants	O
were	O
weighed	O
in	O
light	O
clothing	O
using	O
a	O
SECA	O
weighing	O
scales	O
(	O
SECA	O
GmbH	O
&	O
Co	O
.	O
Kg	O
.	O

A	O
simplistic	O
conceptual	O
framework	O
showing	O
the	O
modifiable	O
and	O
non	O
-	O
modifiable	O
exposure	O
variables	O
,	O
as	O
well	O
as	O
the	O
outcome	O
variables	O
that	O
will	O
be	O
determined	O
to	O
achieve	O
the	O
aims	O
,	O
is	O
shown	O
in	O
Fig	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
long	O
-	O
lasting	O
adaptive	O
responses	O
to	O
maternal	O
caloric	O
restriction	O
affected	O
cannabinoid	O
-	O
regulated	O
mechanisms	O
involved	O
in	O
feeding	O
behavior	O
,	O
adipose	O
β	O
-	O
oxidation	O
,	O
and	O
hepatic	O
lipid	O
and	O
cholesterol	O
biosynthesis	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

This	O
relationship	O
was	O
also	O
present	O
when	O
the	O
IOM	O
threshold	B
for	O
adequacy	O
(	O
50	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
(	O
p	O
=	O
0	O
.	O
05	O
,	O
OR	O
=	O
0	O
.	O
5	O
).	O

2	O
Maternal	O
factors	O
and	O
birth	O
size	O
.	O

Moreover	O
,	O
umbilical	O
cord	O
serum	O
visfatin	O
concentrations	O
were	O
found	O
to	O
have	O
a	O
positive	O
relationship	O
with	O
insulin	O
levels	O
(	O
13	O
).	O

A	O
survey	O
of	O
the	O
100	O
largest	O
school	O
districts	O
in	O
2006	O
found	O
that	O
,	O
among	O
the	O
local	O
wellness	O
policies	O
implemented	O
,	O
99	O
%	O
dealt	O
with	O
nutrition	O
standards	O
of	O
school	O
meals	O
,	O
97	O
%	O
required	O
nutrition	O
education	O
for	O
at	O
least	O
some	O
grades	O
,	O
and	O
65	O
%	O
set	O
standards	O
for	O
when	O
teachers	O
can	O
use	O
food	O
to	O
reward	O
children	O
for	O
good	O
behavior	O
or	O
academic	O
accomplishments	O
(	O
94	O
).	O

This	O
experiment	O
would	O
provide	B
a	O
better	O
insight	O
into	O
the	O
regulation	O
of	O
GAS5	O
by	O
cortisol	O
.	O

A	O
study	O
on	O
hormonal	O
factors	O
in	O
147	O
males	O
,	O
selected	O
from	O
170	O
volunteers	O
,	O
homogenous	O
according	O
to	O
age	O
(	O
29	O
±	O
8	O
.	O
5	O
years	O
),	O
BMI	O
(	O
24	O
.	O
3	O
±	O
3	O
.	O
2	O
)	O
and	O
stimulants	O
intake	O
demonstrated	O
an	O
abnormal	O
(	O
both	O
low	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
high	O
(>	O
125	O
nmol	O
/	O
L	O
)	O
concentration	O
of	O
VD	O
which	O
negatively	O
affected	O
the	O
sperm	O
count	O
,	O
motility	O
and	O
morphology	O
[	O
53	O
].	O

A	O
chart	O
review	O
documented	O
diagnosed	O
medical	O
conditions	O
.	O

PubMed	O
Central	O
:	O

Therefore	B
,	O
prevention	O
of	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
essential	O
.	O

Rather	O
than	O
basing	O
the	O
need	O
for	O
insulin	O
on	O
glycemic	O
parameters	O
alone	O
,	O
some	O
have	O
advocated	O
the	O
combined	O
use	O
of	O
ultrasound	O
assessment	O
of	O
fetal	O
abdominal	O
circumference	O
in	O
combination	O
with	O
blood	O
glucose	O
levels	O
.	O

Forty	O
two	O
females	O
and	O
8	O
males	O
were	O
included	O
in	O
each	O
group	O
.	O

Furthermore	O
,	O
a	O
large	O
study	O
utilising	O
data	O
from	O
the	O
Swedish	O
Medical	O
Birth	O
Register	O
reported	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
associated	O
with	O
exposure	O
to	O
either	O
a	O
typical	O
antipsychotic	O
or	O
SGA	O
;	O
however	O
,	O
this	O
finding	O
failed	O
to	O
reach	O
statistical	O
significance	O
after	O
controlling	O
for	O
exposure	O
to	O
anticonvulsants	O
.	O
18	O
Another	O
growing	O
concern	O
is	O
the	O
increased	O
use	O
of	O
multiple	O
psychotropic	O
medications	O
in	O
the	O
treatment	O
of	O
mental	O
illness	O
.	O

Medullary	O
Thyroid	O
Cancer	O
(	O
MTC	O
)	O
–	O
cancer	O
arising	O
from	O
parafollicular	O
thyroid	O
cells	O
Medullary	O
carcinoma	O
of	O
the	O
thyroid	O
(	O
MTC	O
)	O
constitutes	O
approximately	O
5	O
-	O
10	O
%	O
of	O
thyroid	O
cancers	O
,	O
although	O
there	O
are	O
no	O
precise	O
figures	O
for	O
incidence	O
and	O
survival	O
rates	O
because	O
of	O
the	O
large	O
geographic	O
variations	O
,	O
mainly	B
due	O
to	O
its	O
familial	O
pattern	O
.	O

Allergic	O
rhinitis	O
is	O
often	O
preexisting	O
but	O
may	O
occur	O
or	O
be	O
recognized	O
for	O
the	O
first	O
time	O
during	O
pregnancy	O
.	O

The	O
researchers	O
proposed	O
three	O
possible	O
explanations	O
for	O
their	O
findings	O
:	O
the	O
birds	O
could	O
have	O
been	O
exposed	O
to	O
the	O
bacteria	O
through	O
contact	O
with	O
other	O
species	O
of	O
birds	O
migrating	O
from	O
other	O
regions	O
,	O
or	O
resistance	O
could	O
have	O
developed	O
either	O
through	O
spontaneous	O
mutations	O
or	O
through	O
horizontal	O
gene	O
transfer	O
from	O
other	O
microbes	O
.	O

Although	O
this	O
is	O
not	O
a	O
large	O
number	O
of	O
total	O
messages	O
,	O
it	O
is	O
worth	O
noting	O
that	O
they	O
reinforce	O
information	O
women	O
are	O
already	O
receiving	O
from	O
other	O
sources	O
regarding	O
avoiding	O
alcohol	O
use	O
.	O

To	O
assess	O
participants	O
'	O
information	O
regarding	O
age	O
and	O
gender	O
,	O
marital	O
status	O
,	O
and	O
educational	O
level	O
,	O
we	O
used	O
a	O
standard	O
self	O
-	O
reported	O
questionnaire	O
.	O

Birth	O
Weight	O
Birth	O
weight	O
has	O
been	O
reported	O
to	O
vary	O
by	O
season	O
of	O
birth	O
[	O
168	O
–	O
170	O
].	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
relationship	O
between	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
and	O
to	O
assess	O
the	O
influence	O
of	O
socio	O
-	O
demographic	O
factors	O
and	O
prenatal	O
care	O
.	O

Animals	O
were	O
housed	O
on	O
a	O
12	O
-	O
h	O
light	O
/	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
06	O
:	O
00	O
h	O
)	O
using	O
incandescent	O
lighting	O
,	O
to	O
avoid	O
ultraviolet	O
radiation	O
within	O
the	O
vitamin	O
D3action	O
spectrum	O
.	O

In	O
addition	O
,	O
participants	O
with	O
GDM	O
in	O
this	O
study	O
were	O
mostly	B
urban	O
residents	O
with	O
a	O
higher	O
socioeconomic	O
status	O
.	O

As	O
well	O
as	O
being	O
a	O
source	O
of	O
essential	O
nutrients	O
,	O
fish	O
are	O
also	O
a	O
potential	O
source	O
of	O
contaminants	O
including	O
mercury	O
,	O
polychlorinated	O
biphenyls	O
and	O
dioxins	O
[	O
9	O
].	O

In	O
contrast	O
,	O
a	O
reduction	O
or	O
inhibition	O
of	O
Nampt	O
leads	O
to	O
reduced	O
NAD	O
+	O
concentration	O
and	O
SIRT1	O
activity	O
,	O
resulting	O
in	O
inhibition	O
of	O
osteocyte	O
differentiation	O
.	O

Materials	O
and	O
Methods	O
Ethical	O
Considerations	O
The	O
study	O
was	O
explained	O
to	O
all	O
participants	O
,	O
and	O
they	O
could	O
withdraw	O
from	O
the	O
study	O
as	O
they	O
wished	O
.	O

The	O
pills	O
were	O
counted	O
and	O
compliance	O
calculated	O
as	O
the	O
number	O
consumed	O
divided	O
by	O
the	O
expected	O
consumption	O
based	O
on	O
the	O
number	O
of	O
days	O
since	O
the	O
medication	O
was	O
dispensed	O
and	O
expressed	O
as	O
a	O
percentage	O
.	O

Discussion	O
This	O
clinical	O
trial	O
evaluated	O
the	O
effect	O
of	O
2000	O
IU	O
of	O
vitamin	O
D3supplement	O
per	O
day	O
during	O
late	O
pregnancy	O
on	O
perinatal	O
depression	O
.	O

Since	O
the	O
number	O
of	O
animals	O
needed	O
to	O
control	O
the	O
three	O
phases	O
of	O
the	O
estrous	O
cycle	O
,	O
including	O
morning	O
to	O
afternoon	O
time	O
variations	O
,	O
was	O
too	O
high	O
to	O
be	O
affordable	O
,	O
we	O
had	O
to	O
use	O
randomly	O
cycling	O
female	O
animals	O
sacrificed	O
only	O
during	O
the	O
morning	O
time	O
.	O

Few	O
case	O
reports	O
have	O
suggested	O
an	O
interaction	O
between	O
season	O
or	O
latitude	O
and	O
psychological	O
problems	O
[	O
28	O
,	O
29	O
].	O

Eligible	O
women	O
initiated	O
prenatal	O
care	O
before	O
20	O
weeks	O
gestation	O
,	O
were	O
18	O
years	O
of	O
age	O
or	O
older	O
,	O
could	O
speak	O
and	O
read	O
English	O
,	O
and	O
planned	O
to	O
carry	O
the	O
pregnancy	O
to	O
term	O
and	O
to	O
deliver	O
at	O
either	O
hospital	O
.	O

These	O
grades	O
,	O
used	O
as	O
a	O
rallying	O
point	O
,	O
have	O
helped	O
bring	O
visibility	O
and	O
promote	O
change	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
the	O
vast	B
majority	B
of	O
the	O
reported	O
differences	O
between	O
the	O
exposed	O
and	O
comparison	O
groups	O
were	O
found	O
in	O
patients	O
exposed	O
to	O
polytherapy	O
.	O

Therefore	B
,	O
it	O
is	O
suggested	O
that	O
antiacids	O
should	O
be	O
taken	O
only	O
when	O
prescribed	O
by	O
an	O
attending	O
physician	O
to	O
the	O
childbearing	O
mother	O
.	O

The	O
overall	O
satisfaction	O
of	O
the	O
women	O
attending	O
ANC	O
in	O
the	O
study	O
health	O
district	O
was	O
high	O
(	O
91	O
.	O
4	O
%).	O

Adolescence	O
In	O
addition	O
to	O
developmental	O
risks	O
carried	O
from	O
earlier	O
life	O
,	O
by	O
adolescence	O
the	O
cumulative	O
effects	O
of	O
social	O
disadvantage	O
on	O
obesity	O
become	O
apparent	O
.	O

Based	B
on	I
our	O
analysis	O
,	O
a	O
minimum	O
threshold	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
50	O
nmol	O
l	O
−	O
1was	O
protective	O
against	O
SGA	O
status	O
among	O
black	O
infants	O
.	O

Fieldworkers	O
allocated	O
children	O
to	O
randomisation	O
groups	O
during	O
recruitment	O
and	O
gave	O
vitamin	O
D	O
or	O
placebo	O
.	O

Genes	O
associated	O
with	O
'	O
AMPK	O
signaling	O
'	O
were	O
found	O
to	O
be	O
increased	O
at	O
stage	O
1	O
dpn	O
,	O
while	O
expression	O
of	O
genes	O
associated	O
with	O
'	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
',	O
'	O
mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinase	O
'	O
and	O
'	O
pyrimidine	O
metabolism	O
'	O
were	O
decreased	O
(	O
Table3	O
).	O

Additionally	O
,	O
there	O
have	O
been	O
studies	O
that	O
used	O
combinations	O
of	O
mobile	O
phone	O
and	O
other	O
new	O
technologies	O
for	O
weight	O
control	O
and	O
found	O
positive	O
effects	O
[	O
18	O
].	O

Gestational	O
diabetes	O
mellitus	O
was	O
diagnosed	O
by	O
performing	O
oral	O
glucose	O
(	O
50	O
g	O
and	O
100	O
g	O
)	O
tolerance	O
test	O
(	O
GTT	O
)	O
at	O
24	O
-	O
28thweek	O
of	O
gestation	O
.	O

Slides	O
were	O
washed	O
with	O
PBS	O
and	O
mounted	O
in	O
Vectashield	O
Mounting	O
Medium	O
(	O
Vector	O
Labs	O
)	O
containing	O
the	O
dye	O
4	O
,	O
6	O
-	O
diamido	O
-	O
2	O
-	O
phenylindole	O
(	O
DAPI	O
)	O
to	O
counterstain	O
nuclei	O
.	O

Discussion	O
Season	O
of	O
birth	O
in	O
its	O
own	O
right	O
cannot	O
be	O
deemed	O
a	O
cause	O
for	O
glioma	O
.	O

Of	O
note	O
is	O
that	O
the	O
BMC	O
and	O
BMD	O
were	O
greater	O
in	O
Hispanic	O
infants	O
at	O
three	O
months	O
but	O
not	O
at	O
one	O
week	O
of	O
age	O
.	O

Concomitant	O
treatment	O
The	O
research	O
team	O
will	O
advise	O
all	O
Shonjibon	O
study	O
participants	O
in	O
the	O
intervention	O
arm	O
not	O
to	O
consume	O
any	O
additional	O
iron	O
or	O
folic	O
acid	O
supplements	O
from	O
other	O
sources	O
during	O
her	O
pregnancy	O
.	O

Of	O
note	O
,	O
most	O
of	O
the	O
children	O
in	O
this	O
study	O
were	O
not	O
vitamin	O
D	O
deficient	O
and	O
the	O
vitamin	O
D	O
ranges	O
were	O
relatively	O
narrow	O
.	O

Although	O
our	O
study	O
included	O
only	O
women	O
of	O
white	O
ethnicity	O
,	O
the	O
G	O
allele	O
was	O
associated	O
with	O
lower	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
.	O
The	O
greater	O
prevalence	O
of	O
the	O
G	O
allele	O
at	O
rs12785878	O
with	O
a	O
resulting	O
increase	O
in	O
7	O
-	O
DHC	O
reductase	O
activity	O
(	O
either	O
due	O
to	O
a	O
functional	O
modification	O
or	O
increased	O
synthesis	O
)	O
leading	O
to	O
reduced	O
availability	O
of	O
7	O
-	O
DHC	O
for	O
conversion	O
to	O
previtamin	O
D	O
might	O
contribute	O
to	O
lower	O
25	O
(	O
OH	O
)	O
D	O
in	O
individuals	O
with	O
darker	O
skin	O
pigmentation	O
.	O

Each	O
1	O
%	O
increase	O
in	O
percentage	O
of	O
calories	O
consumed	O
from	O
sweets	O
early	O
in	O
pregnancy	O
increased	O
the	O
odds	O
of	O
macrosomia	O
by	O
10	O
%	O
and	O
WFA	O
>	O
90th	O
percentile	O
by	O
20	O
%.	O

In	O
particular	O
,	O
the	O
degradation	O
of	O
essential	O
,	O
branch	O
-	O
chained	O
amino	O
acids	O
like	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
was	O
found	O
to	O
be	O
regulated	O
,	O
which	O
may	O
illustrate	O
the	O
LP	O
offspring	O
'	O
s	O
efforts	O
to	O
mimic	O
prenatal	O
experiences	O
in	O
terms	O
of	O
dietary	O
supply	O
during	O
postnatal	O
development	O
in	O
the	O
face	O
of	O
richer	O
conditions	O
.	O

The	O
baby	O
had	O
been	O
on	O
cow	O
'	O
s	O
milk	O
since	O
birth	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
MelbourneTraining	O
of	O
trainers	O
amortized	O
over	O
5	O
years	O
:	O
USD85	O
.	O
67	O
/	O
year	O
;	O
training	O
of	O
local	O
health	O
staff	O
USD10	O
/	O
person	O
,	O
2000	O
staff	O
,	O
amortized	O
over	O
5	O
years	O
.	O

When	O
considering	O
class	O
-	O
specific	O
relationships	O
,	O
there	O
was	O
a	O
positive	O
association	O
between	O
AluYb8	O
methylation	O
levels	O
and	O
mean	O
methylation	O
across	O
loci	O
allocated	O
within	O
a	O
PcG	O
target	O
gene	O
and	O
LINE	O
-	O
2	O
element	O
and	O
proximal	O
to	O
a	O
TFBS	O
(	O
class	O
PcG	O
/	O
LINE	O
-	O
2	O
/	O
TFBS	O
)	O
and	O
loci	O
located	O
within	O
a	O
CGI	O
and	O
PcG	O
target	O
gene	O
and	O
proximal	O
to	O
a	O
TFBS	O
(	O
class	O
CpG	O
/	O
PcG	O
/	O
TFBS	O
).	O

This	O
process	O
has	O
been	O
called	O
nutritional	O
programming	O
(	O
Lucas	O
,	O
1991	O
;	O
Hales	O
and	O
Barker	O
,	O
2001	O
;	O
Gluckman	O
and	O
Hanson	O
,	O
2004	O
;	O
Barker	O
,	O
2007	O
;	O
Vaag	O
et	O
al	O
.,	O
2012	O
).	O

Furthermore	O
,	O
the	O
gestation	O
at	O
which	O
vitamin	O
D	O
was	O
measured	O
is	O
also	O
important	O
.	O

Further	O
adjustments	O
were	O
made	O
for	O
physical	O
activity	O
and	O
social	O
-	O
economic	O
levels	O
in	O
model	O
2	O
,	O
and	O
additionally	O
adjustment	O
for	O
delivery	O
status	O
,	O
IUGR	O
,	O
preterm	O
delivery	O
,	O
history	O
of	O
abortion	O
,	O
and	O
stillbirth	O
were	O
made	O
in	O
model	O
3	O
.	O

Methods	O
Design	O
and	O
study	O
population	O
We	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
during	O
August	O
and	O
September	O
2010	O
on	O
a	O
sample	O
of	O
400	O
consecutive	O
women	O
who	O
had	O
given	O
birth	O
in	O
a	O
regional	O
specialist	O
obstetric	O
centre	O
,	O
the	O
Cuza	O
-	O
Vodă	O
Clinical	O
Hospital	O
in	O
Iaşi	O
,	O
Romania	O
.	O

We	O
re	O
-	O
analysed	O
a	O
subsample	O
of	O
77	O
samples	O
and	O
verified	O
the	O
correction	O
(	O
adjusted	O
R2	O
=	O
0	O
.	O
922	O
,	O
SEE	O
=	O
9	O
.	O
2	O
nmol	O
/	O
l	O
).	O

Second	O
,	O
our	O
previous	O
report	O
concluded	O
that	O
relatively	O
low	O
vitamin	O
D	O
levels	O
were	O
common	B
in	O
the	O
PATCH	O
population	O
sample	O
of	O
children	O
and	O
young	O
adults	O
with	O
an	O
inverse	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
age	O
being	O
shown	O
here	O
[	O
51	O
].	O

Current	O
coverage	O
levels	O
for	O
eight	O
indicators	O
across	O
the	O
continuum	O
of	O
care	O
,	O
chosen	O
by	O
the	O
United	O
Nations	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
,	O
are	O
tracked	O
for	O
the	O
75	O
priority	O
Countdown	O
to	O
2015	O
countries	O
which	O
collectively	O
account	B
for	I
90	O
%	O
of	O
maternal	O
,	O
newborn	O
and	O
child	O
deaths	O
[	O
29	O
].	O

Age	O
–	O
genotype	O
interactions	O
are	O
also	O
modelled	O
by	O
the	O
latter	O
.	O

[	O
2	O
].	O

The	O
Shapiro	O
-	O
Wilk	O
and	O
Levene	O
tests	O
were	O
used	O
to	O
assess	O
normality	O
and	O
homogeneity	O
of	O
variance	O
of	O
data	O
,	O
respectively	O
.	O

The	O
annual	O
cost	O
of	O
USD0	O
.	O
76	O
per	O
woman	O
treated	O
is	O
consistent	O
with	O
a	O
cost	O
estimate	O
of	O
USD10	O
-	O
13	O
per	O
pregnancy	O
[	O
22	O
],[	O
23	O
],	O
since	B
pregnant	O
women	O
receive	O
more	O
tablets	O
.	O

check	O
-	O
ups	O
<	O
4	O
4	O
-	O
9	O
111111	O
18	O
.	O
9212	O
.	O
065	O
.	O
705	O
.	O
555	O
.	O
344	O
.	O
12	O
≥	O
10	O
(	O
4	O
.	O
41	O
;	O
81	O
.	O
24	O
)*(	O
2	O
.	O
75	O
;	O
52	O
.	O
84	O
)**(	O
2	O
.	O
85	O
;	O
11	O
.	O
38	O
)*(	O
2	O
.	O
70	O
;	O
11	O
.	O
39	O
)**(	O
2	O
.	O
77	O
;	O
10	O
.	O
29	O
)*(	O
2	O
.	O
08	O
;	O
8	O
.	O
15	O
)**	O
83	O
.	O
0335	O
.	O
927	O
.	O
777	O
.	O
1616	O
.	O
449	O
.	O
38	O
(	O
19	O
.	O
5	O
;	O
344	O
.	O
7	O
)*(	O
8	O
.	O
24	O
;	O
156	O
.	O
5	O
)**(	O
4	O
.	O
02	O
;	O
14	O
.	O
67	O
)*(	O
3	O
.	O
42	O
;	O
15	O
.	O
00	O
)**(	O
8	O
.	O
59	O
;	O
31	O
.	O
51	O
)*(	O
4	O
.	O
50	O
;	O
19	O
.	O
48	O
)**	O
Low	O
score	O
111111	O
Medium	O
score	O
6	O
.	O
674	O
.	O
431	O
.	O
801	O
.	O
793	O
.	O
583	O
.	O
08	O
High	O
score	O
(	O
2	O
.	O
62	O
;	O
17	O
.	O
01	O
)(	O
1	O
.	O
70	O
;	O
11	O
.	O
55	O
)(	O
0	O
.	O
99	O
;	O
3	O
.	O
27	O
)(	O
0	O
.	O
95	O
;	O
3	O
.	O
35	O
)(	O
1	O
.	O
88	O
;	O
6	O
.	O
80	O
)(	O
1	O
.	O
58	O
;	O
6	O
.	O
01	O
)	O
8	O
.	O
304	O
.	O
722	O
.	O
412	O
.	O
583	O
.	O
482	O
.	O
81	O
(	O
2	O
.	O
99	O
;	O
23	O
.	O
40	O
)(	O
1	O
.	O
61	O
;	O
13	O
.	O
84	O
)(	O
1	O
.	O
14	O
;	O
5	O
.	O
14	O
)(	O
1	O
.	O
16	O
;	O
5	O
.	O
74	O
)(	O
1	O
.	O
50	O
;	O
8	O
.	O
10	O
)(	O
1	O
.	O
16	O
;	O
6	O
.	O
84	O
)	O
Breastfeeding	O
advice1	O
.	O
851	O
.	O
501	O
.	O
961	O
.	O
971	O
.	O
261	O
.	O
10	O
(	O
0	O
.	O
96	O
;	O
3	O
.	O
55	O
)(	O
0	O
.	O
76	O
;	O
2	O
.	O
95	O
)(	O
1	O
.	O
12	O
;	O
3	O
.	O
46	O
)(	O
1	O
.	O
11	O
;	O
3	O
.	O
50	O
)(	O
0	O
.	O
68	O
;	O
2	O
.	O
32	O
)(	O
0	O
.	O
59	O
;	O
2	O
.	O
06	O
)	O
Diet	O
advice1	O
.	O
531	O
.	O
39	O
1	O
.	O
56	O
1	O
.	O
53	O
1	O
.	O
71	O
1	O
.	O
59	O
(	O
0	O
.	O
96	O
;	O
2	O
.	O
44	O
)(	O
0	O
.	O
85	O
;	O
2	O
.	O
27	O
)	O
(	O
1	O
.	O
01	O
;	O
2	O
.	O
40	O
)	O
(	O
0	O
.	O
98	O
;	O
2	O
.	O
37	O
)	O
(	O
1	O
.	O
03	O
;	O
2	O
.	O
84	O
)	O
(	O
0	O
.	O
95	O
;	O
2	O
.	O
68	O
)	O
*:	O
crude	O
OR	O
;	O
**:	O
OR	O
adjusted	O
for	O
age	O
,	O
schooling	O
,	O
residence	O
area	O
.	O

GR	O
γ	O
is	O
a	O
ligand	O
-	O
dependent	O
transcription	O
factor	O
with	O
reduced	O
transactivating	O
activity	O
and	O
its	O
function	O
is	O
still	O
under	O
investigation	O
.	O

Understanding	O
beliefs	O
about	O
appropriate	O
weight	O
gain	O
during	O
pregnancy	O
is	O
crucial	O
for	O
intervention	O
planning	O
.	O

Supplementation	O
with	O
400	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
to	O
these	O
infants	O
led	O
to	O
a	O
relatively	O
greater	O
increase	O
in	O
those	O
who	O
were	O
born	O
with	O
the	O
lowest	O
vitamin	O
D	O
status	O
and	O
there	O
was	O
no	O
suggestion	O
of	O
any	O
bone	O
mineral	O
outcome	O
deficits	O
at	O
one	O
week	O
or	O
three	O
months	O
of	O
age	O
in	O
infants	O
with	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Vitamin	O
D	O
in	O
pregnancy	O
:	O
A	O
metabolic	O
outlook	O
Abstract	O
Vitamin	O
D	O
deficiency	O
is	O
a	O
preventable	O
health	O
problem	O
.	O

The	O
application	O
will	O
navigate	O
the	O
data	O
collectors	O
through	O
a	O
step	O
-	O
by	O
-	O
step	O
process	O
while	O
interviewing	O
the	O
pregnant	O
women	O
to	O
collect	O
all	O
required	O
information	O
to	O
be	O
collected	O
at	O
each	O
specific	O
visit	O
.	O

However	O
,	O
fortification	O
benefits	O
both	O
men	O
and	O
women	O
while	O
supplementation	O
directly	O
benefits	O
only	O
women	O
and	O
will	O
only	O
have	O
large	O
labour	O
market	O
benefits	O
in	O
countries	O
where	O
women	O
'	O
s	O
participation	O
in	O
the	O
labour	O
market	O
is	O
high	O
.	O

Methods	O
Design	O
and	O
Measures	O
As	O
previously	O
reported	O
[	O
23	O
],	O
the	O
investigators	O
conducted	O
an	O
RCT	O
of	O
text4baby	O
prenatal	O
messages	O
at	O
Madigan	O
Army	O
Medical	O
Center	O
(	O
Madigan	O
),	O
a	O
large	O
tertiary	O
-	O
care	O
Army	O
Medical	O
Center	O
in	O
Tacoma	O
,	O
Washington	O
.	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

The	O
RC	O
females	O
presented	O
an	O
increase	O
in	O
the	O
plasma	O
levels	O
of	O
glucose	O
.	O

Women	O
with	O
PPBMI	O
25	O
.	O
0	O
-	O
29	O
.	O
9	O
kg	O
/	O
m2had	O
higher	O
energy	O
intakes	O
than	O
is	O
recommended	O
(	O
p	O
=	O
0	O
.	O
006	O
)	O
(	O
Figure2	O
).	O

Lower	O
maternal	O
seafood	O
intake	O
during	O
pregnancy	O
was	O
associated	O
with	O
low	O
verbal	O
intelligence	O
quotient	O
,	O
suboptimum	O
outcomes	O
for	O
prosocial	O
behaviour	O
,	O
fine	O
motor	O
,	O
communication	O
and	O
social	O
development	O
scores	O
.	O

After	O
eliminating	O
some	O
of	O
the	O
mothers	O
who	O
scored	O
>	O
13	O
,	O
153	O
women	O
continued	O
their	O
participation	O
in	O
the	O
study	O
.	O

However	O
,	O
a	O
recent	O
longitudinal	O
study	O
using	O
birth	O
data	O
from	O
4800	O
children	O
from	O
the	O
United	O
States	O
showed	O
that	O
children	O
born	O
to	O
over	O
-/	O
underweight	O
mothers	O
during	O
prepregnancy	O
had	O
increased	O
incidences	O
of	O
being	O
born	O
with	O
a	O
low	O
birth	O
weight	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g009	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
9	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
weaning	O
and	O
6	O
months	O
of	O
age	O
for	O
AT1	O
receptor	O
expression	O
.	O

PCBs	O
ranged	O
from	O
an	O
8	O
g	O
birth	O
weight	O
increase	O
associated	O
with	O
a	O
10	O
-	O
fold	O
increase	O
of	O
PCB	O
105	O
to	O
a	O
7	O
g	O
decrease	O
associated	O
with	O
a	O
10	O
-	O
fold	O
increase	O
in	O
PCB	O
199	O
.	O

[	O
34	O
]	O
A	O
few	O
studies	O
have	O
observed	O
that	O
maternal	O
Vitamin	O
D	O
concentrations	O
are	O
related	O
to	O
offspring	O
birth	O
weight	O
and	O
growth	O
during	O
the	O
postnatal	O
years	O
.	O

To	O
estimate	O
the	O
association	O
between	O
exposure	O
to	O
extended	O
winter	O
and	O
the	O
transformed	O
metabolic	O
markers	O
,	O
the	O
reverse	O
transformation	O
of	O
the	O
B	O
values	O
from	O
regression	O
models	O
were	O
computed	O
.	O

Vitamin	O
A	O
-	O
unsupplemented	O
TT	O
steers	O
(	O
approximately	O
6	O
.	O
15	O
%)	O
had	O
24	O
.	O
4	O
%	O
greater	O
IMF	O
content	O
compared	O
with	O
supplemented	O
TT	O
steers	O
(	O
approximately	O
4	O
.	O
9	O
%).	O

Although	O
this	O
is	O
probably	B
true	B
,	O
a	O
sufficient	O
serum	O
concentrations	O
for	O
the	O
immunological	O
effects	O
of	O
vitamin	O
D	O
is	O
unknown	O
and	O
could	O
be	O
higher	O
or	O
lower	O
than	O
that	O
of	O
the	O
skeletal	O
system	O
accepted	O
concentrations	O
.	O
6The	O
need	O
for	O
a	O
steady	O
state	O
is	O
currently	O
highly	O
speculative	O
and	O
relates	O
to	O
vitamin	O
D2supplementation	O
for	O
negative	O
cancer22and	O
bone	O
outcomes	O
.	O
23	O
Our	O
findings	O
are	O
at	O
odds	O
with	O
smaller	O
case	O
-	O
control	O
hospital	O
studies	O
that	O
show	O
an	O
enhanced	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
or	O
rickets	O
in	O
children	O
with	O
pneumonia	O
and	O
the	O
increasing	O
evidence	O
suggesting	O
that	O
calcitriol	O
,	O
the	O
biologically	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
has	O
an	O
important	O
role	O
in	O
the	O
human	O
immune	O
system	O
.	O
4A	O
systematic	O
review	O
of	O
the	O
role	O
of	O
vitamin	O
D	O
supplementation	O
in	O
infectious	O
diseases	O
had	O
mixed	O
findings	O
,	O
concluding	B
that	O
more	O
rigorously	O
designed	O
clinical	O
trials	O
are	O
needed	O
(	O
panel	O
).	O
25No	O
studies	O
report	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
radiologically	O
confirmed	O
pneumonias	O
.	O

Today	O
,	O
we	O
know	O
it	O
is	O
directly	O
associated	O
with	O
rs6058017	O
gene	O
polymorphism	O
[	O
35	O
].	O

OR	O
#-	O
adjusted	O
for	O
the	O
interaction	O
effect	O
(	O
PC	O
*	O
E	O
).	O

We	O
will	O
randomly	O
select	O
100	O
clusters	O
with	O
an	O
equal	O
number	O
of	O
clusters	O
in	O
each	O
arm	O
.	O

We	O
therefore	B
sought	O
to	O
review	O
the	O
existing	O
literature	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
to	O
evaluate	O
the	O
current	O
evidence	O
for	O
such	O
toxicity	O
.	O

Statistical	O
analysis	O
The	O
first	O
statistical	O
comparison	O
was	O
performed	O
between	O
those	O
exposed	O
to	O
SGAs	O
and	O
matched	O
unexposed	O
healthy	O
controls	O
.	O

These	O
findings	O
suggest	O
that	O
proteins	O
involved	O
in	O
SNAP	O
and	O
SNARE	O
mediated	O
vesicle	O
release	O
may	O
be	O
disrupted	O
in	O
the	O
DVD	O
model	O
.	O

Asthma	O
,	O
allergies	O
,	O
and	O
other	O
atopic	O
diseases	O
have	O
been	O
inversely	O
associated	O
with	O
adult	O
glioma	O
risk	O
in	O
several	O
epidemiologic	O
studies	O
and	O
meta	O
-	O
analyses	O
[	O
83	O
–	O
93	O
],	O
although	O
some	O
reports	O
do	O
not	O
support	O
this	O
conclusion	O
[	O
94	O
–	O
98	O
].	O

A	O
significant	O
role	O
for	O
folate	O
in	O
the	O
complete	O
vitamin	O
mixture	O
in	O
determining	O
the	O
effect	O
of	O
the	O
HV	O
diet	O
was	O
supported	O
by	O
the	O
reductions	O
in	O
food	O
intake	O
,	O
body	O
weight	O
and	O
blood	O
glucose	O
.	O

A	O
previous	O
small	O
study	O
in	O
Brussels	O
suggested	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
high	O
among	O
the	O
adult	O
population	O
and	O
that	O
immigrants	O
were	O
at	O
greater	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
32	O
].	O

Table	O
3	O
,	O
Table	O
4present	O
results	O
by	O
trimester	O
of	O
influenza	O
vaccination	O
for	O
the	O
MLR	O
and	O
PSM	O
models	O
,	O
respectively	O
.	O

In	O
addition	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
threefold	O
higher	O
among	O
women	O
of	O
Asiatic	O
descent	O
,	O
six	O
fold	O
higher	O
for	O
North	O
African	O
women	O
and	O
five	O
fold	O
higher	O
for	O
women	O
of	O
Hispanic	O
descent	O
compared	O
to	O
Caucasians	O
.	O

Surprisingly	O
,	O
the	O
change	O
in	O
vitamin	O
D	O
concentration	O
(	O
baseline	O
to	O
childbirth	O
)	O
was	O
not	O
correlated	O
with	O
changes	O
in	O
depression	O
scores	O
from	O
baseline	O
to	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
or	O
to	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

The	O
diagnosis	O
and	O
treatment	O
of	O
drug	O
allergy	O
are	O
the	O
same	O
in	O
pregnant	O
as	O
in	O
nonpregnant	O
patients	O
.	O

Therefore	B
,	O
genetic	O
variations	O
in	O
vitamin	O
-	O
D	O
-	O
related	O
genes	O
might	O
also	O
affect	O
MS	O
risk	O
,	O
either	O
directly	O
or	O
by	O
modifying	O
the	O
effects	O
of	O
vitamin	O
D	O
.	O
40	O
Our	O
implications	O
for	O
future	O
research	O
and	O
MS	O
prevention	O
and	O
according	O
to	O
the	O
basis	O
of	O
the	O
results	O
of	O
the	O
only	O
longitudinal	O
study	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
and	O
MS	O
onset	O
,	O
18and	O
assum	O
-	O
ing	O
that	O
these	O
results	O
are	O
unbiased	O
and	O
vitamin	O
D	O
is	O
truly	B
protective	O
against	O
MS	O
,	O
over	O
70	O
%	O
of	O
MS	O
cases	O
in	O
the	O
USA	O
and	O
Europe	O
could	O
be	O
prevented	O
by	O
increasing	O
the	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
adolescents	O
and	O
young	O
adults	O
to	O
above	O
100	O
nmol	O
/	O
L	O
.	O
4142These	O
concentrations	O
are	O
commonly	O
found	O
only	O
in	O
individuals	O
with	O
outdoor	O
lifestyles	O
in	O
sunny	O
regions	O
,	O
but	O
could	O
be	O
reached	O
in	O
most	B
people	O
by	O
taking	O
1000	O
-	O
4000	O
IU	O
colecalciferol	O
daily	O
.	O
8254344Although	O
these	O
doses	O
are	O
largely	O
considered	O
safe	O
and	O
potentially	O
beneficial	O
for	O
other	O
outcomes	O
,	O
819confirmation	O
of	O
safety	O
and	O
efficacy	O
in	O
a	O
large	O
randomized	O
trial	O
is	O
needed	O
before	O
making	O
general	O
recommendations	O
.	O

Reducing	O
anaemia	O
rates	O
by	O
18	O
.	O
2	O
%	O
for	O
women	O
of	O
reproductive	O
age	O
therefore	O
constitutes	O
a	O
6	O
.	O
7	O
%	O
reduction	O
in	O
anaemia	O
on	O
average	O
in	O
the	O
labour	O
force	O
(	O
using	O
the	O
proportion	O
of	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
overall	O
labour	O
force	O
in	O
Vietnam	O
:	O
women	O
'	O
s	O
labour	O
force	O
participation	O
rate	O
is	O
similar	O
to	O
men	O
'	O
s	O
).	O

These	O
results	O
need	O
confirmation	O
,	O
preferably	B
by	O
adjusted	O
statistical	O
analysis	O
as	B
confounding	O
can	O
be	O
expected	O
,	O
which	O
was	O
not	O
possible	O
in	O
our	O
present	O
study	O
due	O
to	O
few	O
cases	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
:	O
The	O
serum	O
concentrations	O
of	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D3	O
),	O
parathyroid	O
hormone	O
(	O
PTH	O
),	O
calcium	O
and	O
phosphorus	O
,	O
and	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
of	O
subjects	O
in	O
the	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
)	O
VariablesIGCGP	O
value25	O
(	O
OH	O
)	O
D3	O
(	O
nmol	O
/	O
l	O
)	O
Before24	O
.	O
25	O
(	O
13	O
.	O
3	O
-	O
202	O
.	O
4	O
)	O
δ25	O
.	O
30	O
(	O
12	O
.	O
8	O
-	O
137	O
.	O
2	O
)	O
0	O
.	O
44After62	O
.	O
10	O
(	O
31	O
.	O
7	O
-	O
278	O
.	O
9	O
)	O
24	O
.	O
10	O
(	O
18	O
.	O
0	O
-	O
191	O
.	O
7	O
)<	O
0	O
.	O
001P	O
value	O
<	O
0	O
.	O
0010	O
.	O
02PTH	O
Pmol	O
/	O
l	O
)	O
Before3	O
.	O
42	O
±	O
1	O
.	O
083	O
.	O
6	O
±	O
1	O
.	O
050	O
.	O
6After2	O
.	O
88	O
±	O
1	O
.	O
064	O
.	O
78	O
±	O
2	O
.	O
400	O
.	O
003P	O
value0	O
.	O
0010	O
.	O
1Serum	O
Calcium	O
(	O
mg	O
/	O
dl	O
)	O
Before9	O
.	O
01	O
±	O
0	O
.	O
28	O
.	O
9	O
±	O
0	O
.	O
100	O
.	O
1After9	O
.	O
17	O
±	O
0	O
.	O
359	O
.	O
12	O
±	O
0	O
.	O
450	O
.	O
7P	O
value0	O
.	O
070	O
.	O
013Serum	O
Phosphor	O
(	O
mg	O
/	O
dl	O
)	O
Before3	O
.	O
37	O
±	O
0	O
.	O
453	O
.	O
61	O
±	O
0	O
.	O
390	O
.	O
07After3	O
.	O
25	O
±	O
0	O
.	O
33	O
.	O
41	O
±	O
0	O
.	O
360	O
.	O
3P	O
value0	O
.	O
50	O
.	O
5BMI	O
(	O
kg	O
/	O
m2	O
)	O
Before29	O
.	O
15	O
±	O
527	O
.	O
9	O
±	O
3	O
.	O
60	O
.	O
4After29	O
.	O
0	O
±	O
5	O
.	O
627	O
.	O
4	O
±	O
3	O
.	O
70	O
.	O
1P	O
value0	O
.	O
350	O
.	O
25HBA1C	O
(%)	O
Before5	O
.	O
48	O
±	O
0	O
.	O
65	O
.	O
20	O
±	O
0	O
.	O
730	O
.	O
1After5	O
.	O
58	O
±	O
125	O
.	O
21	O
±	O
0	O
.	O
520	O
.	O
2P	O
value0	O
.	O
730	O
.	O
67	O
™:	O
Median	O
(	O
Min	O
-	O
Max	O
)	O
None	O
of	O
the	O
groups	O
had	O
severe	O
vitamin	O
D	O
deficiency	O
before	O
the	O
intervention	O
.	O

Similarly	O
,	O
dietary	O
forage	O
level	O
affected	O
MS	O
.	O
Jersey	O
steers	O
fed	O
a	O
low	O
forage	O
diet	O
(	O
6	O
%	O
Sudan	O
grass	O
,	O
6	O
%	O
alfalfa	O
hay	O
and	O
63	O
.	O
15	O
%	O
steam	O
-	O
flaked	O
corn	O
,	O
dry	O
matter	O
[	O
DM	O
]	O
basis	O
)	O
in	O
a	O
feedlot	O
finishing	O
diet	O
had	O
greater	O
MS	O
in	O
the	O
strip	O
loin	O
than	O
did	O
animals	O
fed	O
a	O
high	O
forage	O
level	O
diet	O
(	O
12	O
%	O
Sudan	O
grass	O
,	O
12	O
%	O
alfalfa	O
hay	O
and	O
51	O
.	O
20	O
%	O
steam	O
-	O
flaked	O
corn	O
)	O
[	O
121	O
].	O

These	O
data	O
and	O
the	O
duration	O
of	O
pregnancy	O
were	O
retrospectively	O
collected	O
from	O
birth	O
records	O
.	O

Muscle	O
and	O
fat	O
cell	O
development	O
are	O
dependent	O
on	O
myogenesis	O
(	O
muscle	O
cell	O
formation	O
)	O
and	O
adipogenesis	O
(	O
fat	O
cell	O
formation	O
),	O
respectively	O
[	O
16	O
].	O

This	O
has	O
been	O
elegantly	O
demonstrated	O
by	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
offspring	O
of	O
Pima	O
Indian	O
mothers	O
.	O
16	O
,	O
17Offspring	O
who	O
were	O
born	O
to	O
mothers	O
who	O
were	O
already	O
diabetic	O
when	O
pregnant	O
had	O
a	O
45	O
%	O
likelihood	B
of	O
type	O
2	O
diabetes	O
by	O
the	O
age	O
of	O
20	O
–	O
24	O
,	O
whereas	O
it	O
was	O
8	O
.	O
6	O
%	O
amongst	O
those	O
with	O
mothers	O
who	O
only	O
developed	O
diabetes	O
after	O
pregnancy	O
(	O
ie	O
,	O
were	O
prediabetic	O
).	O

It	O
has	O
a	O
critical	O
role	O
in	O
enamel	O
,	O
dentin	O
,	O
and	O
oral	O
bone	O
formation	O
as	B
ameloblasts	O
and	O
odontoblasts	O
are	O
target	O
cells	O
for	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
,	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
[	O
17	O
].	O

Pregnant	O
women	O
in	O
the	O
Buea	O
Health	O
District	O
have	O
different	O
knowledge	O
about	O
ANC	O
which	O
varies	O
significantly	O
among	O
the	O
pregnancy	O
groups	O
,	O
number	O
of	O
visits	O
and	O
age	O
.	O

Preterm	O
birth	O
is	O
not	O
a	O
single	O
condition	O
,	O
but	O
a	O
single	O
outcome	O
(	O
birth	O
before	O
37	O
completed	O
weeks	O
)	O
due	O
to	O
multiple	O
causes	O
.	O

)	O
45	O
.	O
02	O
±	O
13	O
.	O
32LF	O
/	O
HF	O
Ratio1	O
.	O
37	O
±	O
0	O
.	O
87	O
Values	O
expressed	O
as	O
percentage	O
or	O
mean	O
±	O
SD	O
.	O

Correlation	O
between	O
continuous	O
T1	O
25OHD	O
and	O
continuous	O
change	O
in	O
25OHD	O
was	O
low	O
(	O
r	O
=	O
−	O
0	O
.	O
22	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
it	O
was	O
therefore	B
considered	O
acceptable	O
to	O
include	O
both	O
variables	O
in	O
the	O
same	O
model	O
.	O

AA	O
exists	O
in	O
limited	O
levels	O
in	O
liver	O
,	O
meat	O
and	O
eggs	O
,	O
but	O
can	O
be	O
metabolized	O
in	O
humans	O
from	O
other	O
fatty	O
acids	O
in	O
the	O
omega	O
-	O
6	O
fatty	O
acid	O
family	O
.	O

A	O
schematic	O
matrix	O
of	O
the	O
basic	O
health	O
packages	O
(	O
Figure2	O
)	O
outlines	O
these	O
packages	O
spanning	O
the	O
continuum	O
of	O
care	O
and	O
through	O
various	O
service	O
delivery	O
modes	O
within	O
the	O
health	O
system	O
,	O
highlighting	O
the	O
interventions	O
included	O
to	O
address	O
preterm	O
birth	O
.	O

The	O
activities	O
carried	O
out	O
in	O
the	O
health	O
centres	O
were	O
similar	O
in	O
the	O
institutions	O
involved	O
in	O
the	O
study	O
.	O

In	B
light	I
of	I
the	O
above	O
case	O
,	O
we	O
recommend	O
maintaining	O
a	O
high	O
index	O
of	O
suspicion	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
patients	O
who	O
present	O
with	O
typical	O
symptoms	O
and	O
signs	O
especially	O
in	O
the	O
presence	O
of	O
other	O
risk	O
factors	O
such	O
as	O
preeclampsia	O
,	O
HELLP	O
syndrome	O
,	O
and	O
twin	O
pregnancies	O
.	O

The	O
infant	O
received	O
2	O
boluses	O
of	O
10	O
%	O
Dextrose	O
for	O
hypoglycemia	O
and	O
was	O
then	O
placed	O
on	O
Dextrose	O
10	O
%	O
in	O
water	O
at	O
6	O
mL	O
/	O
hour	O
with	O
normal	O
saline	O
at	O
1	O
mL	O
/	O
hour	O
via	O
umbilical	O
vein	O
.	O

No	O
differences	O
between	O
the	O
groups	O
were	O
observed	O
in	O
several	O
other	O
characteristics	O
,	O
including	O
GWG	O
,	O
duration	O
of	O
gestation	O
,	O
and	O
supplemental	O
vitamin	O
D	O
intake	O
.	O

The	O
diet	O
of	O
pregnant	O
woman	O
is	O
not	O
only	O
explained	O
according	O
to	O
the	O
need	O
of	O
the	O
mother	O
but	O
also	O
by	O
the	O
fetus	O
,	O
which	O
is	O
advised	O
month	O
wise	O
(	O
masanumasik	O
patya	O
).	O

PubMed	O
Central	O
:	O

•	O
Children	O
with	O
S	O
-	O
ECC	O
are	O
likely	B
malnourished	O
,	O
as	B
they	O
displayed	O
significantly	O
lower	O
levels	O
of	O
calcium	O
and	O
serum	O
albumin	O
as	O
well	O
as	O
higher	O
levels	O
of	O
PTH	O
compared	O
to	O
the	O
control	O
group	O
.	O

Bridging	O
this	O
gap	O
will	O
be	O
critical	O
for	O
saving	O
premature	O
babies	O
globally	O
,	O
and	O
must	O
be	O
linked	O
to	O
implementation	O
research	O
and	O
context	O
specific	O
adaptation	O
and	O
innovation	O
.	O

Since	O
2007	O
,	O
the	O
Nicaraguan	O
Government	O
has	O
provided	O
influenza	O
vaccination	O
to	O
women	O
with	O
high	O
-	O
risk	O
pregnancies	O
in	O
the	O
month	O
of	O
May	O
,	O
following	O
the	O
vaccination	O
schedule	O
for	O
countries	O
with	O
southern	O
hemisphere	O
circulation	O
of	O
influenza	O
viruses	O
[	O
33	O
],[	O
34	O
].	O

In	O
accordance	O
to	O
this	O
,	O
an	O
inverse	O
correlation	O
has	O
been	O
described	O
between	O
birth	O
weight	O
with	O
both	O
angiotensin	O
II	O
and	O
ACE	O
activity	O
[	O
52	O
–	O
54	O
].	O

Innovate	O
•	O
Develop	O
affordable	O
new	O
diagnostics	O
,	O
medicines	O
,	O
technologies	O
and	O
other	O
interventions	O
,	O
including	O
social	O
and	O
behavioural	O
change	O
,	O
for	O
preterm	O
birth	O
and	O
make	O
them	O
available	O
to	O
the	O
most	O
vulnerable	O
and	O
marginalised	O
.	O

However	O
,	O
after	O
adjusting	O
for	O
maternal	O
age	O
,	O
BMI	O
,	O
SEI	O
,	O
smoking	O
status	O
and	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
,	O
ethnicity	O
,	O
recreational	O
walking	O
and	O
season	O
,	O
the	O
women	O
recruited	O
in	O
Adelaide	O
still	O
had	O
significantly	O
lower	O
serum	O
25	O
(	O
OH	O
)	O
D	O
when	O
compared	O
with	O
those	O
in	O
Auckland	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
indicating	O
the	O
influence	O
of	O
other	O
confounders	O
not	O
measured	O
as	O
part	O
of	O
the	O
study	O
on	O
vitamin	O
D	O
status	O
.	O

A	O
self	O
-	O
report	O
,	O
food	O
frequency	O
questionnaire	O
was	O
used	O
,	O
which	O
is	O
useful	O
in	O
ranking	O
nutrient	O
intakes	O
of	O
individual	O
subjects	O
but	O
can	O
be	O
subject	O
to	O
bias	O
,	O
particularly	O
in	O
obese	O
individuals	O
[	O
52	O
].	O

Briefly	O
,	O
100	O
µL	O
of	O
IS	O
(	O
20	O
ng	O
/	O
mL	O
in	O
water	O
)	O
was	O
added	O
to	O
200	O
µL	O
plasma	O
or	O
standard	O
mixture	O
in	O
a	O
glass	O
tube	O
.	O

Sample	O
collection	O
and	O
DNA	O
extraction	O
Infant	O
stool	O
samples	O
were	O
collected	O
at	O
the	O
6	O
-	O
week	O
maternal	O
postpartum	O
follow	O
-	O
up	O
appointment	O
and	O
were	O
aliquoted	O
and	O
frozen	O
at	O
−	O
80	O
°	O
C	O
within	O
24	O
h	O
.	O
Following	O
established	O
methods	O
reviewed	O
by	O
Wu	O
et	O
al	O
.	O

The	O
role	O
of	O
maternal	O
disease	O
cannot	O
be	O
ignored	O
as	B
antiphospholipid	O
syndrome	O
and	O
perinatal	O
inflammation	O
may	O
have	O
important	O
roles	O
in	O
the	O
eventual	O
development	O
of	O
autism	O
.	O

To	O
assess	O
the	O
relationship	O
between	O
maternal	O
dietary	O
factors	O
and	O
infant	O
gut	O
cluster	O
membership	O
,	O
we	O
used	O
multinomial	O
logistic	O
regression	O
with	O
cluster	O
1	O
as	O
the	O
reference	O
group	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
breeding	O
scheme	O
and	O
visible	O
morphology	O
of	O
skeletal	O
morphology	O
mutants	O
(	O
Skm	O
).	O

PubMed	O
Central	O
:	O

Women	O
who	O
did	O
not	O
conceive	O
while	O
enrolled	O
in	O
PMMST	O
,	O
had	O
received	O
at	O
least	O
one	O
year	O
of	O
MMN	O
supplementation	O
or	O
placebo	O
and	O
were	O
still	O
resident	O
in	O
the	O
selected	O
villages	O
in	O
Kiang	O
West	O
,	O
were	O
eligible	O
for	O
inclusion	O
in	O
the	O
current	O
study	O
.	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Arachnodactyly	O
and	O
kinked	O
tail	O
in	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
).	O

However	O
,	O
it	O
is	O
possible	O
that	O
alternate	O
SNPs	O
/	O
genes	O
that	O
are	O
not	O
clinically	O
important	O
to	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
nonpregnant	O
adults	O
would	O
be	O
significant	O
in	O
pregnant	O
women	O
and	O
could	O
be	O
identified	O
by	O
GWAS	O
.	O

5	O
)	O
DVD	O
-	O
deficient	O
rats	O
also	O
have	O
altered	O
attentional	O
processing	O
indicated	O
by	O
impaired	O
latent	O
inhibition	O
[	O
11	O
].	O

In	O
humans	O
,	O
PTEN	O
haploinsufficiency	O
was	O
shown	O
to	O
have	O
divergent	O
effects	O
,	O
as	O
they	O
increase	O
the	O
risk	O
of	O
obesity	O
,	O
while	O
decreasing	O
that	O
of	O
type	O
2	O
diabetes	O
by	O
markedly	O
improving	O
insulin	O
sensitivity	O
(	O
Pal	O
et	O
al	O
.,	O
2012	O
).	O

The	O
estimated	O
dollar	O
value	O
per	O
capita	O
of	O
the	O
productivity	O
gains	O
are	O
calculated	O
as	O
USD1	O
.	O
29	O
,	O
i	O
.	O
e	O
.	O

The	O
interest	O
of	O
OECD	O
member	O
countries	O
in	O
epigenetics	O
within	O
the	O
former	O
expert	O
group	O
is	O
particularly	O
strong	O
,	O
where	O
epigenetic	O
mechanisms	O
are	O
playing	O
a	O
pivotal	O
role	O
in	O
the	O
development	O
of	O
tools	O
for	O
improved	O
chemical	O
safety	O
assessment	O
(	O
Jacobs	O
et	O
al	O
.	O
2015	O
).	O

[	O
16	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
healthy	O
young	O
Thai	O
men	O
and	O
women	O
(	O
age	O
25	O
–	O
54	O
years	O
)	O
and	O
found	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
three	O
-	O
fold	O
higher	O
in	O
females	O
than	O
in	O
males	O
(	O
43	O
.	O
1	O
%	O
in	O
females	O
compared	O
to	O
13	O
.	O
9	O
%	O
in	O
males	O
).	O

In	O
infertility	O
studies	O
,	O
VD	O
level	O
was	O
described	O
as	O
a	O
predictor	O
for	O
ovulation	O
stimulation	O
success	O
with	O
the	O
use	O
of	O
clomiphene	O
citrate	O
(	O
CC	O
).	O

A	O
link	O
has	O
been	O
found	O
between	O
paternal	O
dioxin	O
exposure	O
,	O
a	O
component	O
of	O
the	O
herbicide	O
Agent	O
Orange	O
used	O
in	O
the	O
Vietnam	O
War	O
,	O
and	O
spermatazoidfolate	O
deficiency	O
resulting	O
in	O
an	O
increased	O
rate	O
of	O
spina	O
bifida	O
[	O
8	O
].	O

Separate	O
models	O
were	O
fitted	O
for	O
sleep	O
duration	O
and	O
snoring	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
016	O
-	O
1024	O
-	O
7	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Second	O
,	O
the	O
model	O
also	O
excluded	O
non	O
-	O
linear	O
relationships	O
,	O
including	O
potential	O
threshold	O
effects	O
that	O
could	O
yield	O
important	O
information	O
about	O
the	O
relationships	O
between	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

In	O
addition	O
,	O
there	O
were	O
no	O
apparent	O
changes	O
in	O
protein	O
expression	O
of	O
GR	O
α	O
/	O
β	O
in	O
BeWo	O
cells	O
treated	O
with	O
10	O
–	O
1000	O
nM	O
of	O
cortisol	O
,	O
corroborating	O
the	O
qPCR	O
studies	O
(	O
data	O
not	O
shown	O
).	O

Eligible	O
criteria	O
included	O
singleton	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
without	O
any	O
medical	O
condition	O
,	O
use	O
of	O
medications	O
,	O
and	O
without	O
following	O
a	O
specific	O
diet	O
.	O

However	O
,	O
we	O
observed	O
that	O
vitamin	O
D	O
deficiency	O
at	O
delivery	O
was	O
more	O
prevalent	O
in	O
mothers	O
with	O
GDM	O
compared	O
with	O
non	O
-	O
GDM	O
mothers	O
,	O
but	O
this	O
was	O
not	O
marked	O
during	O
pregnancy	O
.	O

During	O
lactation	O
,	O
a	O
special	O
diet	O
for	O
the	O
mother	O
(	O
or	O
,	O
if	O
not	O
breast	O
-	O
feeding	O
,	O
hypoallergenic	O
formula	O
nutrition	O
for	O
the	O
infant	O
)	O
should	O
be	O
considered	O
only	O
in	O
individuals	O
with	O
an	O
established	O
atopy	O
risk	O
or	O
existing	O
allergy	O
[	O
82	O
,	O
115	O
].	O

Despite	O
this	O
fact	O
,	O
the	O
overall	O
direction	O
of	O
results	O
was	O
consistent	O
with	O
previous	O
text4baby	O
studies	O
and	O
additionally	O
we	O
found	O
a	O
behavioral	O
effect	O
.	O

Vitamin	O
A	O
(	O
also	O
known	O
as	O
retinol	O
)	O
inhibits	O
adipocyte	O
differentiation	O
[	O
128	O
].	O

Several	O
recent	O
studies	O
in	O
poorer	O
countries	O
have	O
already	O
demonstrated	O
improved	O
parameters	O
of	O
fetal	O
growth	O
and	O
gestational	O
length	O
with	O
various	O
prenatal	O
MMN	O
supplementation	O
regimen	O
,	O
although	O
effects	O
have	O
been	O
inconsistent	O
and	O
the	O
mechanisms	O
of	O
action	O
are	O
unclear	O
(	O
Christian	O
et	O
al	O
2003	O
)	O
(	O
Kaestel	O
et	O
al	O
2005	O
)	O
(	O
Fawzi	O
et	O
al	O
2007	O
).	O

Also	O
,	O
maternal	O
25OHD	O
<	O
28	O
nmol	O
/	O
L	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
have	O
been	O
associated	O
with	O
lower	O
infant	O
birth	O
size	O
and	O
shorter	O
gestational	O
length	O
in	O
a	O
smaller	O
longitudinal	O
study	O
[	O
8	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Concentrations	O
(	O
μg	O
/	O
g	O
creatinine	O
phthalates	O
and	O
BPA	O
,	O
ng	O
/	O
g	O
lipids	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
,	O
μg	O
/	O
L	O
serum	O
PFAS	O
,	O
DEP	O
,	O
DMP	O
and	O
Hg	O
,	O
μg	O
/	O
dL	O
Pb	O
)	O
of	O
EDCs	O
collected	O
via	O
urine	O
or	O
blood	O
sample	O
from	O
pregnant	O
women	O
for	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
Cincinnati	O
,	O
OH	O
,	O
n	O
=	O
272PercentilesIncluded	O
in	O
AnalysesMedian	O
NHANES	O
(	O
2003	O
-	O
2004	O
)	O
EDC	O
%>	O
LODMean	O
LODbGM	O
(	O
GSD	O
)	O
25th50th75thMBP1000	O
.	O
6027	O
.	O
2	O
(	O
1	O
.	O
9	O
)	O
17	O
.	O
625	O
.	O
837	O
.	O
8Yes24MIBP990	O
.	O
305	O
.	O
9	O
(	O
1	O
.	O
9	O
)	O
4	O
.	O
06	O
.	O
19	O
.	O
1Yes4	O
.	O
0MEP1000	O
.	O
53152	O
(	O
3	O
.	O
0	O
)	O
77	O
.	O
4143330	O
.	O
7Yes120MBZP980	O
.	O
229	O
.	O
8	O
(	O
2	O
.	O
4	O
)	O
5	O
.	O
610	O
.	O
714	O
.	O
9Yes10MCPP990	O
.	O
202	O
.	O
4	O
(	O
1	O
.	O
9	O
)	O
1	O
.	O
62	O
.	O
33	O
.	O
4Yes2	O
.	O
9MEHP981	O
.	O
205	O
.	O
9	O
(	O
2	O
.	O
8	O
)	O
3	O
.	O
34	O
.	O
710	O
.	O
4Yes2	O
.	O
2MECPP1000	O
.	O
6041	O
.	O
3	O
(	O
2	O
.	O
5	O
)	O
21	O
.	O
534	O
.	O
970Yes31MEHHP1000	O
.	O
7028	O
.	O
7	O
(	O
2	O
.	O
6	O
)	O
14	O
.	O
925	O
.	O
353	O
.	O
2Yes19MEOHP1000	O
.	O
7022	O
.	O
3	O
(	O
2	O
.	O
5	O
)	O
12	O
.	O
31840	O
.	O
3YesaBPA960	O
.	O
42	O
.	O
1	O
(	O
1	O
.	O
9	O
)	O
1	O
.	O
41	O
.	O
92	O
.	O
9Yes2	O
.	O
7PCB	O
-	O
28820	O
.	O
790	O
.	O
7	O
(	O
3	O
.	O
1	O
)	O
0	O
.	O
611	O
.	O
4No5	O
.	O
0PCB	O
-	O
44920	O
.	O
530	O
.	O
07	O
(	O
1	O
.	O
8	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
09YesaPCB	O
-	O
491000	O
.	O
530	O
.	O
06	O
(	O
1	O
.	O
8	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
07YesaPCB	O
-	O
52910	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
1	O
)	O
0	O
.	O
040	O
.	O
070	O
.	O
2YesaPCB	O
-	O
66750	O
.	O
530	O
.	O
4	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
10	O
.	O
61No1	O
.	O
4PCB	O
-	O
74990	O
.	O
632	O
.	O
8	O
(	O
1	O
.	O
8	O
)	O
1	O
.	O
92	O
.	O
74Yes5	O
.	O
4PCB	O
-	O
871000	O
.	O
530	O
.	O
09	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
2YesaPCB	O
-	O
99990	O
.	O
532	O
.	O
7	O
(	O
2	O
.	O
1	O
)	O
1	O
.	O
72	O
.	O
83	O
.	O
9Yes3	O
.	O
9PCB	O
-	O
101320	O
.	O
530	O
.	O
1	O
(	O
2	O
.	O
1	O
)	O
0	O
.	O
050	O
.	O
070	O
.	O
4No1	O
.	O
6PCB	O
-	O
105930	O
.	O
531	O
(	O
2	O
.	O
8	O
)	O
0	O
.	O
61	O
.	O
11	O
.	O
7Yes1	O
.	O
2PCB	O
-	O
110990	O
.	O
530	O
.	O
09	O
(	O
3	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
1YesaPCB	O
-	O
118990	O
.	O
785	O
(	O
1	O
.	O
9	O
)	O
3	O
.	O
14	O
.	O
87Yes5	O
.	O
0PCB	O
-	O
128970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
5	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
146930	O
.	O
531	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
81	O
.	O
11	O
.	O
8Yes2	O
.	O
3PCB	O
-	O
149970	O
.	O
530	O
.	O
08	O
(	O
2	O
.	O
5	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
1YesaPCB	O
-	O
151970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
2	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
1531000	O
.	O
8111	O
.	O
4	O
(	O
1	O
.	O
9	O
)	O
7	O
.	O
510	O
.	O
915	O
.	O
3Yes22PCB	O
-	O
156960	O
.	O
531	O
.	O
6	O
(	O
2	O
.	O
4	O
)	O
11	O
.	O
62	O
.	O
7Yes3	O
.	O
4PCB	O
-	O
157510	O
.	O
530	O
.	O
2	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
6No0	O
.	O
9PCB	O
-	O
167590	O
.	O
530	O
.	O
2	O
(	O
3	O
.	O
9	O
)	O
0	O
.	O
060	O
.	O
30	O
.	O
6No0	O
.	O
9PCB	O
-	O
1701000	O
.	O
612	O
.	O
9	O
(	O
2	O
.	O
2	O
)	O
1	O
.	O
82	O
.	O
84	O
.	O
3Yes6	O
.	O
3PCB	O
-	O
172340	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
4No0	O
.	O
9PCB	O
-	O
177610	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
070	O
.	O
40	O
.	O
7No1	O
.	O
3PCB	O
-	O
178520	O
.	O
530	O
.	O
2	O
(	O
4	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
7No1	O
.	O
2PCB	O
-	O
1801000	O
.	O
786	O
.	O
7	O
(	O
2	O
.	O
1	O
)	O
4	O
.	O
16	O
.	O
39	O
.	O
7YesaPCB	O
-	O
183870	O
.	O
530	O
.	O
7	O
(	O
3	O
.	O
3	O
)	O
0	O
.	O
50	O
.	O
81	O
.	O
4Yes1	O
.	O
7PCB	O
-	O
187980	O
.	O
532	O
(	O
2	O
.	O
4	O
)	O
1	O
.	O
323	O
.	O
2Yes4	O
.	O
6PCB	O
-	O
189970	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
1	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
08YesaPCB	O
-	O
194920	O
.	O
531	O
.	O
3	O
(	O
2	O
.	O
7	O
)	O
0	O
.	O
91	O
.	O
42	O
.	O
2Yes4	O
.	O
0PCB	O
-	O
195390	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
5No0	O
.	O
6PCB	O
-	O
199930	O
.	O
531	O
.	O
2	O
(	O
2	O
.	O
9	O
)	O
0	O
.	O
81	O
.	O
32	O
.	O
2Yes3	O
.	O
7PCB	O
-	O
206810	O
.	O
530	O
.	O
9	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
40	O
.	O
91	O
.	O
3Yes2	O
.	O
3PCB	O
-	O
209350	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
2	O
)	O
0	O
.	O
050	O
.	O
080	O
.	O
4No1	O
.	O
2PCB	O
-	O
38	O
/	O
158990	O
.	O
788	O
(	O
2	O
.	O
1	O
)	O
5	O
.	O
27	O
.	O
811	O
.	O
3No16PCB	O
-	O
196	O
/	O
203960	O
.	O
531	O
.	O
5	O
(	O
2	O
.	O
4	O
)	O
1	O
.	O
11	O
.	O
62	O
.	O
6No3	O
.	O
3PFOA1006	O
.	O
055	O
.	O
6	O
(	O
1	O
.	O
7	O
)	O
3	O
.	O
85	O
.	O
48	O
.	O
1Yes3	O
.	O
6PFOS10014	O
.	O
213	O
.	O
6	O
(	O
1	O
.	O
5	O
)	O
1014	O
.	O
417	O
.	O
9Yes18PFNA1000	O
.	O
961	O
(	O
1	O
.	O
4	O
)	O
0	O
.	O
811	O
.	O
2Yes0	O
.	O
9PFHXS1001	O
.	O
961	O
.	O
6	O
(	O
2	O
)	O
11	O
.	O
62	O
.	O
6Yes1	O
.	O
6PFDEA300	O
.	O
210	O
.	O
2	O
(	O
1	O
.	O
6	O
)	O
0	O
.	O
20	O
.	O
20	O
.	O
3YesaBB	O
-	O
153850	O
.	O
530	O
.	O
9	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
51	O
.	O
12NoaPBDE	O
-	O
17960	O
.	O
530	O
.	O
07	O
(	O
2	O
.	O
2	O
)	O
0	O
.	O
040	O
.	O
060	O
.	O
08YesaPBDE	O
-	O
28810	O
.	O
530	O
.	O
7	O
(	O
4	O
.	O
1	O
)	O
0	O
.	O
30	O
.	O
91	O
.	O
7Yes1	O
.	O
0PBDE	O
-	O
471000	O
.	O
8619	O
.	O
1	O
(	O
2	O
.	O
7	O
)	O
9	O
.	O
61830Yes19PBDE	O
-	O
66920	O
.	O
530	O
.	O
06	O
(	O
2	O
)	O
0	O
.	O
040	O
.	O
050	O
.	O
07YesaPBDE	O
-	O
85490	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
8	O
)	O
0	O
.	O
060	O
.	O
20	O
.	O
7Yes	O
<	O
LODPBDE	O
-	O
991000	O
.	O
654	O
.	O
4	O
(	O
2	O
.	O
9	O
)	O
2	O
.	O
24	O
.	O
27	O
.	O
4Yes	O
<	O
LODPBDE	O
-	O
100990	O
.	O
533	O
.	O
7	O
(	O
3	O
)	O
23	O
.	O
56	O
.	O
4Yes3	O
.	O
2PBDE	O
-	O
153990	O
.	O
535	O
.	O
2	O
(	O
3	O
.	O
3	O
)	O
2	O
.	O
44	O
.	O
29	O
.	O
2Yes4	O
.	O
0PBDE	O
-	O
154420	O
.	O
530	O
.	O
2	O
(	O
4	O
.	O
7	O
)	O
0	O
.	O
050	O
.	O
10	O
.	O
6No0	O
.	O
8PBDE	O
-	O
18380	O
.	O
530	O
.	O
1	O
(	O
3	O
.	O
3	O
)	O
0	O
.	O
040	O
.	O
070	O
.	O
2Yesaβ	O
-	O
HCH272	O
.	O
630	O
.	O
5	O
(	O
3	O
.	O
5	O
)	O
0	O
.	O
220	O
.	O
321	O
.	O
6Yes	O
<	O
LODHCB943	O
.	O
926	O
.	O
6	O
(	O
1	O
.	O
9	O
)	O
5	O
.	O
57	O
.	O
29	O
.	O
1Yes16p	O
'	O
p	O
'-	O
DDT522	O
.	O
631	O
.	O
1	O
(	O
3	O
.	O
7	O
)	O
0	O
.	O
321	O
.	O
93	O
.	O
2Yes	O
<	O
LODp	O
'	O
p	O
'-	O
DDE1002	O
.	O
6374	O
(	O
1	O
.	O
8	O
)	O
5170102Yes206Oxychlordane902	O
.	O
634	O
.	O
4	O
(	O
2	O
.	O
5	O
)	O
3	O
.	O
45	O
.	O
17	O
.	O
5Yes11	O
trans	O
-	O
Nonachlor972	O
.	O
637	O
.	O
5	O
(	O
2	O
.	O
1	O
)	O
5	O
.	O
17	O
.	O
512Yes15DEP80	O
.	O
560	O
.	O
08	O
(	O
5	O
.	O
4	O
)	O
0	O
.	O
020	O
.	O
090	O
.	O
3YesaDMP270	O
.	O
620	O
.	O
4	O
(	O
4	O
.	O
2	O
)	O
0	O
.	O
10	O
.	O
40	O
.	O
9YesaPb960	O
.	O
250	O
.	O
7	O
(	O
1	O
.	O
4	O
)	O
0	O
.	O
50	O
.	O
70	O
.	O
8YesaHg790	O
.	O
20	O
.	O
6	O
(	O
2	O
.	O
3	O
)	O
0	O
.	O
40	O
.	O
61	O
.	O
0Yesa	O
Abbreviations	O
:	O
GM	O
geometric	O
mean	O
,	O
GSD	O
geometric	O
standard	O
deviation	O
,	O
BPA	O
bisphenol	O
A	O
,	O
β	O
-	O
HCH	O
beta	O
-	O
hexachlorocyclohexane	O
,	O
HCB	O
Hexachlorobenzene	O
,	O
DDT	O
dichlorodiphenoltrichloroethane	O
,	O
DDE	O
dichlorodiphenoldichloroethylene	O
aData	O
not	O
available	O
.	O
bLODs	O
varied	O
by	O
sample	O
size	O
;	O
LODs	O
for	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
are	O
lipid	O
-	O
adjusted	O
and	O
measured	O
in	O
pg	O
/	O
g	O
Potential	O
Confounders	O
We	O
drew	O
a	O
directed	O
acyclic	O
graph	O
to	O
select	O
confounders	O
based	B
on	I
the	O
relationships	O
between	O
the	O
HOME	O
Study	O
[	O
10	O
,	O
34	O
]	O
covariates	O
and	O
EDCs	O
and	O
birth	O
weight	O
(	O
Additional	O
file1	O
:	O
Figure	O
S1	O
).	O

P	O
-	O
values	O
refer	O
to	O
differences	O
between	O
the	O
groupsMaternal	O
characteristics	O
n	O
Non	O
-	O
GDM	O
n	O
GDM	O
p	O
valueAge	O
at	O
delivery	O
(	O
y	O
)	O
64231	O
.	O
4	O
±	O
4	O
.	O
38132	O
.	O
7	O
±	O
4	O
.	O
50	O
.	O
018Level	O
of	O
educationa6325	O
.	O
0	O
±	O
1	O
.	O
3794	O
.	O
7	O
±	O
1	O
.	O
40	O
.	O
051Parity6401	O
.	O
5	O
±	O
0	O
.	O
7811	O
.	O
5	O
±	O
0	O
.	O
70	O
.	O
275Prepregnancy	O
smoking	O
,	O
number	O
of	O
cigarettes	O
daily6251	O
.	O
2	O
±	O
3	O
.	O
7762	O
.	O
0	O
±	O
4	O
.	O
60	O
.	O
064Alcohol	O
consumption	O
before	O
pregnancy	O
,	O
portion	O
/	O
wk	O
.	O
6251	O
.	O
9	O
±	O
2	O
.	O
0782	O
.	O
3	O
±	O
3	O
.	O
50	O
.	O
755Prepregnancy	O
height	O
(	O
cm	O
)	O
642166	O
.	O
3	O
±	O
6	O
.	O
081165	O
.	O
9	O
±	O
5	O
.	O
40	O
.	O
398Prepregnancy	O
weight	O
(	O
kg	O
)	O
63163	O
.	O
5	O
±	O
10	O
.	O
28172	O
.	O
1	O
±	O
13	O
.	O
5	O
<	O
0	O
.	O
001Prepregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
63923	O
.	O
0	O
±	O
3	O
.	O
58126	O
.	O
2	O
±	O
4	O
.	O
8	O
<	O
0	O
.	O
001Duration	O
of	O
gestation	O
at	O
OGTT	O
(	O
wk	O
)	O
32326	O
.	O
3	O
±	O
4	O
.	O
38025	O
.	O
9	O
±	O
5	O
.	O
90	O
.	O
774Duration	O
of	O
gestation	O
at	O
pregnancy	O
blood	O
sampling	O
(	O
wk	O
)	O
64211	O
.	O
3	O
±	O
1	O
.	O
98111	O
.	O
2	O
±	O
2	O
.	O
20	O
.	O
089Duration	O
of	O
gestation	O
at	O
delivery	O
(	O
wk	O
)	O
64240	O
.	O
2	O
±	O
1	O
.	O
18140	O
.	O
1	O
±	O
1	O
.	O
10	O
.	O
410Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
64281	O
.	O
9	O
±	O
19	O
.	O
58180	O
.	O
0	O
±	O
21	O
.	O
20	O
.	O
417UCB	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
64280	O
.	O
1	O
±	O
20	O
.	O
08178	O
.	O
4	O
±	O
18	O
.	O
80	O
.	O
448Supplemental	O
vitamin	O
D	O
intake	O
during	O
pregnancy	O
(	O
μ	O
g	O
/	O
d	O
)	O
62115	O
.	O
5	O
±	O
16	O
.	O
67613	O
.	O
5	O
±	O
10	O
.	O
80	O
.	O
162Cumulative	O
gestational	O
weight	O
gain	O
atb	O
(	O
kg	O
)	O
0	O
.	O
093	O
first	O
measurement5801	O
.	O
7	O
±	O
0	O
.	O
5741	O
.	O
6	O
±	O
0	O
.	O
5	O
12th	O
gestational	O
week5803	O
.	O
8	O
±	O
1	O
.	O
0743	O
.	O
6	O
±	O
1	O
.	O
1	O
20th	O
gestational	O
week5806	O
.	O
3	O
±	O
0	O
.	O
8746	O
.	O
2	O
±	O
0	O
.	O
8	O
30th	O
gestational	O
week5809	O
.	O
7	O
±	O
0	O
.	O
5749	O
.	O
7	O
±	O
0	O
.	O
4	O
last	O
measurement58013	O
.	O
8	O
±	O
0	O
.	O
47413	O
.	O
7	O
±	O
0	O
.	O
3	O
GDM	O
gestational	O
diabetes	O
mellitus	O
,	O
25	O
(	O
OH	O
)	O
D	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
,	O
UCB	O
umbilical	O
cord	O
blood	O
Values	O
are	O
means	O
±	O
SD	O
aScale	O
from	O
1	O
=	O
lower	O
secondary	O
education	O
to	O
6	O
=	O
first	O
or	O
second	O
stage	O
of	O
tertiary	O
education	O
bValues	O
are	O
adjusted	O
for	O
duration	O
of	O
gestation	O
Independent	O
sample	O
t	O
-	O
tests	O
,	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
,	O
repeated	O
measures	O
ANOVA	O
or	O
the	O
Pearson	O
Chi	O
-	O
Square	O
test	O
,	O
when	O
appropriate	O
,	O
were	O
applied	O
to	O
compare	O
maternal	O
characteristics	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

One	O
notion	O
is	O
that	O
primitive	O
mesenchymal	O
cells	O
differentiate	O
into	O
normal	O
osteoblasts	O
in	O
the	O
wrong	O
location	O
.	O

On	O
the	O
aetiology	O
of	O
autism	O
I	O
have	O
suggested	O
that	O
the	O
primary	O
environmental	O
trigger	O
for	O
autism	O
is	O
not	O
vaccinations	O
,	O
toxins	O
or	O
infections	O
,	O
but	O
gestational	O
and	O
early	O
childhood	O
vitamin	O
D	O
deficiency	O
(	O
1	O
,	O
2	O
).	O

This	O
fall	O
is	O
usually	O
attributed	O
to	O
improvements	O
in	O
child	O
health	O
and	O
nutrition	O
since	O
the	O
early	O
19thcentury	O
,	O
when	O
the	O
age	O
of	O
menarche	O
was	O
highest	O
.	O

RPMM	O
was	O
selected	O
for	O
this	O
analysis	O
because	O
we	O
have	O
demonstrated	O
that	O
RPMM	O
provides	O
more	O
consistent	O
clustering	O
and	O
more	O
robustness	O
in	O
the	O
selection	O
of	O
the	O
number	O
of	O
classes	O
because	O
of	O
its	O
hierarchical	O
presentation	O
of	O
classes	O
,	O
compared	O
with	O
metric	O
hierarchical	O
clustering	O
,	O
for	O
this	O
data	O
set	O
[	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

These	O
two	O
enzymes	O
are	O
induced	O
in	O
adipose	O
tissues	O
of	O
ruminants	O
by	O
increasing	O
energy	O
intake	O
[	O
89	O
].	O

Among	O
women	O
with	O
initial	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
40	O
ng	O
/	O
mL	O
,	O
the	O
significantly	O
lower	O
PTB	O
rate	O
(	O
60	O
%)	O
for	O
those	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
who	O
did	O
not	O
reach	O
the	O
target	O
concentration	O
on	O
a	O
follow	O
-	O
up	O
test	O
suggests	O
that	O
maternal	O
vitamin	O
D	O
status	O
is	O
a	O
modifiable	O
risk	O
factor	O
that	O
can	O
be	O
addressed	O
during	O
the	O
prenatal	O
period	O
.	O

These	O
findings	O
highlight	O
the	O
differences	O
one	O
may	O
find	O
when	O
examining	O
localized	O
and	O
circulating	O
levels	O
of	O
immune	O
factors	O
.	O

Using	O
a	O
new	O
assessment	O
technique	O
,	O
we	O
investigated	O
Vitamin	O
D	O
nutritional	O
status	O
among	O
outpatients	O
with	O
GDM	O
in	O
our	O
hospital	O
,	O
and	O
analyzed	O
Vitamin	O
D	O
sources	O
and	O
its	O
association	O
with	O
dietary	O
pattern	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
.	O

In	O
a	O
term	O
fetus	O
,	O
amnion	O
and	O
decida	O
have	O
higher	O
levels	O
of	O
mRNA	O
of	O
the	O
visfatin	O
gene	O
(	O
4	O
).	O

When	O
radical	O
thyroidectomy	O
is	O
performed	O
,	O
the	O
second	O
most	O
frequently	O
used	O
post	O
-	O
operative	O
adjuvant	O
therapy	O
for	O
non	O
-	O
pregnant	O
patients	O
with	O
DTC	O
is	O
radioactive	O
iodine	O
(	O
RAI	O
,	O
I	O
-	O
131	O
)	O
administered	O
to	O
eradicate	O
persistent	O
neck	O
disease	O
or	O
distant	O
metastatic	O
lesions	O
.	O

Risk	O
factors	O
for	O
the	O
development	O
of	O
GDM	O
include	O
obesity	O
,	O
older	O
age	O
,	O
family	O
history	O
,	O
previous	O
history	O
of	O
GDM	O
or	O
poor	O
obstetric	O
outcomes	O
,	O
ethnicity	O
,	O
polycystic	O
ovary	O
syndrome	O
and	O
as	O
more	O
recently	O
noted	O
,	O
hypertension	O
.	O
4	O
,	O
5	O
The	O
major	O
significance	O
of	O
GDM	O
is	O
that	O
it	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
.	O

In	O
order	O
to	O
identify	O
molecular	O
pathways	O
affected	O
by	O
the	O
gestational	O
diets	O
we	O
first	O
analysed	O
differential	O
expression	O
between	O
the	O
dietary	O
groups	O
within	O
each	O
stage	O
separately	O
.	O

This	O
study	O
evaluated	O
the	O
effect	O
of	O
vitamin	O
D3supplementation	O
on	O
perinatal	O
depression	O
scores	O
.	O

The	O
Chang	O
Gung	O
Ethics	O
Committee	O
approved	O
the	O
study	O
,	O
and	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
or	O
legal	O
guardians	O
of	O
the	O
neonates	O
.	O

Loss	O
to	O
follow	O
-	O
up	O
is	O
described	O
inFigure	O
2	O
.	O

Pregnant	O
women	O
(<	O
18	O
weeks	O
’	O
gestation	O
)	O
(	O
n	O
=	O
250	O
)	O
are	O
being	O
recruited	O
from	O
primary	O
healthcare	O
clinics	O
in	O
Johannesburg	O
and	O
are	O
followed	O
-	O
up	O
at	O
a	O
provincial	O
hospital	O
.	O

Acute	O
stridor	O
and	O
wheeze	O
as	O
an	O
initial	O
manifestation	O
of	O
hypocalcemia	O
in	O
an	O
infant	O
Sir	O
,	O
A	O
4	O
-	O
month	O
-	O
old	O
male	O
infant	O
who	O
was	O
delivered	O
at	O
term	O
with	O
a	O
normal	O
birth	O
weight	O
and	O
uneventful	O
neonatal	O
period	O
was	O
brought	O
with	O
history	O
of	O
cough	O
and	O
noisy	O
breathing	O
of	O
1	O
-	O
day	O
duration	O
.	O

In	O
that	O
final	O
stage	O
,	O
the	O
milk	O
duct	O
system	O
forms	O
in	O
preparation	O
for	O
lactation	O
and	O
breastfeeding	O
.	O

On	O
a	O
subsequent	O
encounter	O
with	O
the	O
allergen	O
,	O
bridging	O
of	O
2	O
or	O
more	O
IgE	O
antibodies	O
leads	O
to	O
degranulation	O
of	O
the	O
mast	O
cell	O
with	O
release	O
of	O
preformed	O
mediators	O
such	O
as	O
histamine	O
,	O
serotonin	O
,	O
tryptase	O
,	O
chymase	O
,	O
kininogenase	O
,	O
and	O
heparin	O
.	O

(	O
2006	O
),	O
Schlesinger	O
et	O
al	O
.	O

Thus	B
,	O
spermatozoal	O
chromatin	O
may	O
also	O
transmit	O
unique	O
epigenetic	O
information	O
that	O
helps	O
to	O
activate	O
and	O
regulate	O
early	O
embryo	O
development	O
and	O
contribute	O
to	O
epigenetic	O
inheritance	O
across	O
multiple	O
generations	O
.	O

Adipogenesis	O
is	O
a	O
comprehensive	O
term	O
that	O
includes	O
commitment	O
of	O
mesenchymal	O
stem	O
cells	O
to	O
preadipocytes	O
,	O
determination	O
and	O
proliferation	O
of	O
preadipocytes	O
,	O
and	O
differentiation	O
of	O
preadipocytes	O
into	O
mature	O
adipocytes	O
[	O
19	O
].	O

Eligible	O
females	O
were	O
invited	O
to	O
attend	O
a	O
recruitment	O
clinic	O
where	O
informed	O
consent	O
was	O
sought	O
in	O
writing	O
from	O
individuals	O
or	O
guardians	O
,	O
in	O
the	O
cases	O
of	O
girls	O
under	O
18	O
-	O
years	O
old	O
.	O

Of	O
the	O
study	O
population	O
,	O
97	O
%	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
].	O

These	O
include	O
ethnicity	O
,	O
extent	O
of	O
skin	O
covering	O
,	O
liberal	O
use	O
of	O
sun	O
protection	O
,	O
adiposity	O
,	O
and	O
age	O
.	O

It	O
has	O
been	O
suggested	O
but	O
is	O
not	O
proven	O
that	O
early	O
life	O
calcium	O
absorption	O
is	O
primarily	B
non	O
-	O
vitamin	O
D	O
dependent	O
[	O
2	O
].	O

After	O
baseline	O
,	O
participants	O
in	O
both	O
groups	O
were	O
surveyed	O
again	O
after	O
4	O
weeks	O
,	O
at	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
at	O
the	O
time	O
of	O
first	O
postpartum	O
medical	O
appointment	O
.	O

The	O
possible	O
reasons	B
for	O
the	O
higher	O
uptake	O
of	O
the	O
weekly	O
supplements	O
are	O
many	O
.	O

A	O
Cochrane	O
review	O
of	O
a	O
randomized	O
control	O
trial	O
conducted	O
in	O
Pakistan	O
reported	O
that	O
daily	O
iron	O
treatment	O
is	O
better	O
than	O
intermittent	O
iron	O
supplementation	O
in	O
increasing	O
haemoglobin	O
level	O
at	O
delivery	O
among	O
pregnant	O
women	O
in	O
developing	O
countries	O
[	O
2	O
].	O

This	O
is	O
because	O
the	O
male	O
and	O
female	O
pronuclei	O
are	O
differentially	O
imprinted	O
;	O
that	O
is	O
certain	O
genes	O
carry	O
a	O
parent	O
-	O
of	O
-	O
origin	O
epigenetic	O
mark	O
so	O
that	O
they	O
are	O
only	O
expressed	O
from	O
a	O
single	O
parental	O
allele	O
,	O
ensuring	O
the	O
correct	O
dosage	O
of	O
maternally	O
and	O
paternally	O
derived	O
gene	O
products	O
(	O
reviewed	O
in	O
Bartolomei	O
&	O
Ferguson	O
-	O
Smith2011	O
).	O

Responses	O
were	O
recorded	O
as	O
integers	O
.	O

While	O
lack	O
of	O
PNV	O
use	O
among	O
overweight	O
/	O
obese	O
pregnant	O
women	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
this	O
was	O
not	O
the	O
case	O
for	O
black	O
women	O
,	O
who	O
were	O
less	O
likely	B
to	O
take	O
PNV	O
’	O
s	O
compared	O
to	O
white	O
women	O
.	O

However	O
,	O
only	O
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

Clearly	O
,	O
further	O
investigation	O
is	O
required	O
into	O
the	O
effects	O
of	O
vitamin	O
D	O
,	O
of	O
vitamin	O
D	O
supplementation	O
,	O
and	O
of	O
vitamin	O
D	O
analogs	O
for	O
improvement	O
in	O
human	O
health	O
generally	O
and	O
mothers	O
and	O
children	O
specifically	O
.	O

The	O
ascertainment	O
of	O
study	O
outcomes	O
was	O
robust	O
,	O
and	O
done	O
clinically	O
through	O
masked	O
experienced	O
and	O
retrained	O
paediatricians	O
with	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
clinical	O
definitions	O
of	O
pneumonia	O
applied	O
in	O
other	O
trials18and	O
radiologically	O
through	O
the	O
interpretation	O
of	O
chest	O
radiographs	O
by	O
masked	O
,	O
experienced	O
,	O
and	O
external	O
readers	O
by	O
use	O
of	O
WHO	O
standards	O
.	O

Women	O
with	O
a	O
small	O
increase	O
in	O
25OHD	O
(	O
0	O
–	O
30	O
nmol	O
/	O
L	O
)	O
had	O
significantly	O
higher	O
OR	O
of	O
SGA	O
(	O
OR	O
=	O
2	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
019	O
)	O
and	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
047	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
significance	O
for	O
LBW	O
(	O
OR	O
=	O
3	O
.	O
1	O
,	O
p	O
=	O
0	O
.	O
056	O
),	O
compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
.	O

Adjusted	O
analysis	O
(	O
model	O
2	O
)	O
–	O
25OHD	O
,	O
season	O
and	O
markers	O
of	O
glucose	O
metabolism	O
The	O
final	O
adjusted	O
,	O
multiple	O
linear	O
regression	O
model	O
included	O
extended	O
winter	O
at	O
first	O
antenatal	O
visit	O
,	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
and	O
the	O
following	O
confounders	O
:	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
education	O
,	O
being	O
part	O
of	O
the	O
ROLO	O
study	O
intervention	O
group	O
,	O
early	O
-	O
pregnancy	O
energy	O
(	O
kcal	O
),	O
protein	O
(	O
g	O
)	O
and	O
fat	O
(	O
g	O
),	O
physical	O
activity	O
and	O
well	O
-	O
being	O
score	O
(	O
Model	O
2	O
,	O
Table4	O
).	O

These	O
results	O
remained	O
when	O
only	O
those	O
who	O
had	O
undergone	O
OGTT	O
were	O
included	O
:	O
pregnancy	O
and	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
similar	O
in	O
GDM	O
(	O
n	O
=	O
80	O
)	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
n	O
=	O
323	O
)	O
(	O
P	O
=	O
0	O
.	O
94	O
and	O
P	O
=	O
0	O
.	O
43	O
,	O
respectively	O
).	O

More	O
research	O
in	O
this	O
area	O
is	O
required	O
to	O
draw	O
sound	O
conclusions	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fishDietary	O
intakePositive	O
psychotic	O
-	O
like	O
symptomsaLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
groupEnergy	O
adjustedMultivariatebEnergy	O
adjustedMultivariatebNo	O
.	O
No	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CINo	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CI	O
Salmon	O
-	O
type	O
fish	O
and	O
herring	O
/	O
mackerel	O
,	O
frequency	O
never5	O
027Ref	O
.	O
4	O
0902521	O
-	O
3	O
per	O
month5	O
9624	O
5470	O
.	O
930	O
.	O
88	O
-	O
0	O
.	O
980	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052160	O
.	O
720	O
.	O
60	O
-	O
0	O
.	O
860	O
.	O
81c0	O
.	O
66	O
-	O
0	O
.	O
981	O
per	O
week6	O
3814	O
7270	O
.	O
900	O
.	O
85	O
-	O
0	O
.	O
950	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052480	O
.	O
760	O
.	O
64	O
-	O
0	O
.	O
900	O
.	O
92c0	O
.	O
75	O
-	O
1	O
.	O
12	O
≥	O
2	O
per	O
week4945261	O
.	O
271	O
.	O
12	O
-	O
1	O
.	O
431	O
.	O
32c1	O
.	O
15	O
-	O
1	O
.	O
51481	O
.	O
741	O
.	O
26	O
-	O
2	O
.	O
391	O
.	O
90c1	O
.	O
34	O
-	O
2	O
.	O
70	O
Cod	O
/	O
saithe	O
/	O
pike	O
,	O
frequency	O
never1	O
289Ref	O
.	O
1	O
136961	O
-	O
3	O
per	O
month7	O
0095	O
3110	O
.	O
850	O
.	O
78	O
-	O
0	O
.	O
930	O
.	O
89d0	O
.	O
82	O
-	O
0	O
.	O
983220	O
.	O
620	O
.	O
49	O
-	O
0	O
.	O
780	O
.	O
70d0	O
.	O
55	O
-	O
0	O
.	O
891	O
per	O
week8	O
0966	O
1850	O
.	O
840	O
.	O
77	O
-	O
0	O
.	O
920	O
.	O
87d0	O
.	O
80	O
-	O
0	O
.	O
952700	O
.	O
430	O
.	O
34	O
-	O
0	O
.	O
550	O
.	O
46d0	O
.	O
36	O
-	O
0	O
.	O
59	O
≥	O
2	O
per	O
week1	O
4701	O
2580	O
.	O
930	O
.	O
83	O
-	O
1	O
.	O
040	O
.	O
90d0	O
.	O
81	O
-	O
1	O
.	O
01760	O
.	O
690	O
.	O
50	O
-	O
0	O
.	O
930	O
.	O
57d0	O
.	O
41	O
-	O
0	O
.	O
79	O
Shellfish	O
,	O
frequency	O
never4	O
540Ref	O
.	O
3	O
8152431	O
-	O
3	O
per	O
month11	O
0758	O
2190	O
.	O
880	O
.	O
84	O
-	O
0	O
.	O
930	O
.	O
90e0	O
.	O
85	O
-	O
0	O
.	O
954120	O
.	O
700	O
.	O
59	O
-	O
0	O
.	O
820	O
.	O
78e0	O
.	O
66	O
-	O
0	O
.	O
931	O
per	O
week1	O
8931	O
4530	O
.	O
910	O
.	O
84	O
-	O
0	O
.	O
990	O
.	O
92e0	O
.	O
84	O
-	O
1	O
.	O
00780	O
.	O
770	O
.	O
59	O
-	O
1	O
.	O
000	O
.	O
84e0	O
.	O
64	O
-	O
1	O
.	O
11	O
≥	O
2	O
per	O
week3564031	O
.	O
341	O
.	O
15	O
-	O
1	O
.	O
551	O
.	O
28e1	O
.	O
09	O
-	O
1	O
.	O
49311	O
.	O
701	O
.	O
16	O
-	O
2	O
.	O
481	O
.	O
42e0	O
.	O
94	O
-	O
2	O
.	O
14	O
All	O
fish	O
and	O
seafood	O
,	O
frequency	O
never533Ref	O
.	O
476441	O
-	O
3	O
per	O
month1	O
1319960	O
.	O
960	O
.	O
82	O
-	O
1	O
.	O
110	O
.	O
96	O
f0	O
.	O
83	O
-	O
1	O
.	O
12840	O
.	O
870	O
.	O
60	O
-	O
1	O
.	O
270	O
.	O
89	O
f0	O
.	O
61	O
-	O
1	O
.	O
311	O
per	O
week7	O
0255	O
4500	O
.	O
830	O
.	O
73	O
-	O
0	O
.	O
950	O
.	O
86	O
f0	O
.	O
76	O
-	O
0	O
.	O
892900	O
.	O
480	O
.	O
34	O
-	O
0	O
.	O
670	O
.	O
51	O
f0	O
.	O
36	O
-	O
0	O
.	O
712	O
per	O
week7	O
2155	O
2610	O
.	O
770	O
.	O
68	O
-	O
0	O
.	O
880	O
.	O
82	O
f0	O
.	O
71	O
-	O
0	O
.	O
932640	O
.	O
420	O
.	O
30	O
-	O
0	O
.	O
580	O
.	O
45	O
f0	O
.	O
32	O
-	O
0	O
.	O
643	O
-	O
4	O
per	O
week1	O
9871	O
6680	O
.	O
880	O
.	O
77	O
-	O
1	O
.	O
020	O
.	O
93	O
f0	O
.	O
80	O
-	O
1	O
.	O
07800	O
.	O
450	O
.	O
31	O
-	O
0	O
.	O
660	O
.	O
47	O
f0	O
.	O
31	O
-	O
0	O
.	O
70	O
>	O
5	O
per	O
week5205411	O
.	O
090	O
.	O
92	O
-	O
1	O
.	O
301	O
.	O
13	O
f0	O
.	O
94	O
-	O
1	O
.	O
35551	O
.	O
190	O
.	O
78	O
-	O
1	O
.	O
811	O
.	O
12	O
f0	O
.	O
72	O
-	O
1	O
.	O
74	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bIn	O
the	O
multivariate	O
analysis	O
presented	O
,	O
we	O
initially	O
tested	O
the	O
effects	O
of	O
adjusting	O
also	O
for	O
BMI	O
,	O
level	O
of	O
education	O
,	O
country	O
of	O
birth	O
,	O
smoking	O
,	O
dietary	O
intake	O
of	O
meat	O
,	O
dairy	O
products	O
,	O
fruits	O
,	O
cereals	O
and	O
refined	O
sugar	O
,	O
rheumatoid	O
arthritis	O
,	O
gluten	O
intolerance	O
,	O
diabetes	O
and	O
multivitamin	O
supplement	O
.	O

(	O
2009	O
)*	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetrachloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
)	O
Mouse	O
RatInjection	O
(	O
ip	O
)	O
(	O
50	O
µg	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
1	O
µg	O
/	O
kg	O
/	O
d	O
)	O
In	O
utero	O
Early	O
adulthood	O
In	O
utero	O
Neonatal	O
Adolescence	O
/	O
early	O
adulthood	O
Adulthood	O
F0	O
-	O
F1generations	O
↓	O
gonado	O
-	O
tropins	O
and	O
gonadal	O
steroid	O
-	O
genesis	O
Mammary	O
and	O
hepatic	O
abnormalitiesHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPapoutsis	O
et	O
al	O
.	O

Determination	O
of	O
estrous	O
stage	O
was	O
assessed	O
as	O
previously	O
described	O
[	O
63	O
],[	O
64	O
].	O

Background	O
Even	O
though	O
psychoses	O
are	O
relatively	O
rare	O
,	O
between	O
5	O
-	O
15	O
%	O
of	O
the	O
general	O
population	O
has	O
been	O
estimated	O
to	O
report	O
single	O
schizophrenia	O
-	O
like	O
symptoms	O
like	O
delusions	O
,	O
magical	O
thinking	O
,	O
and	O
hearing	O
internal	O
voices	O
at	O
some	O
point	O
in	O
their	O
lifetime	O
[	O
1	O
-	O
3	O
].	O

Compared	O
with	O
lean	O
women	O
non	O
-	O
snorers	O
,	O
those	O
women	O
who	O
were	O
both	O
overweight	O
and	O
who	O
snored	O
had	O
a	O
statistically	O
significant	O
6	O
.	O
91	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
)	O
(	O
Table3	O
).	O

RMP	O
and	O
MG	O
commented	O
on	O
the	O
manuscript	O
.	O

Of	O
these	O
,	O
49	O
.	O
6	O
%	O
recommendations	O
were	O
made	O
by	O
friends	O
and	O
neighbors	O
(	O
12	O
.	O
4	O
%)	O
mother	O
or	O
sister	O
(	O
12	O
.	O
4	O
%)	O
and	O
husband	O
(	O
10	O
%).	O

Fasting	O
and	O
post	O
-	O
prandial	O
glucose	O
testing	O
is	O
necessary	O
for	O
monitoring	O
and	O
guidance	O
of	O
therapy	O
.	O

Lower	O
levels	O
of	O
PUFA	O
have	O
been	O
found	O
in	O
brain	O
content	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblast	O
among	O
patients	O
with	O
schizophrenia	O
,	O
compared	O
with	O
a	O
healthy	O
population	O
[	O
13	O
,	O
16	O
].	O

Weitz	O
et	O
al	O
.	O

Based	O
on	O
a	O
False	O
Discovery	O
Rate	O
of	O
28	O
%,	O
we	O
predict	O
that	O
nine	O
of	O
these	O
spots	O
would	O
be	O
false	O
positives	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Altered	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
DVD	O
-	O
deficient	O
and	O
control	O
male	O
rats	O
.	O

They	O
have	O
all	O
demonstrated	O
that	O
the	O
rapid	O
acting	O
analogues	O
are	O
as	O
effective	O
as	O
regular	O
insulin	O
in	O
the	O
treatment	O
of	O
GDM	O
,	O
with	O
comparable	O
,	O
if	O
not	O
favorable	O
,	O
outcomes	O
(	O
Table	O
3	O
).	O

Ingenuity	O
Pathway	O
Analysis	O
indicates	O
enrichment	O
of	O
molecular	O
routes	O
related	O
to	O
genetic	O
information	O
and	O
nucleic	O
acid	O
processing	O
and	O
cell	O
cycle	O
that	O
were	O
found	O
to	O
be	O
diminished	O
,	O
whereas	O
the	O
'	O
Wnt	O
signaling	O
'	O
was	O
found	O
to	O
be	O
increased	O
in	O
LP	O
offspring	O
(	O
Table2	O
).	O

In	O
addition	O
to	O
FAs	O
,	O
a	O
glycerol	O
“	O
backbone	O
”,	O
mainly	O
supplied	O
by	O
glucose	O
,	O
is	O
needed	O
for	O
TG	O
synthesis	O
.	O

Adipose	O
tissue	O
is	O
also	O
believed	O
to	O
be	O
associated	O
with	O
vitamin	O
D	O
[	O
26	O
–	O
29	O
].	O

Selecting	O
a	O
sire	O
is	O
important	O
for	O
high	O
-	O
quality	O
beef	O
production	O
;	O
animals	O
with	O
high	O
genetic	O
potential	O
will	O
generally	B
exhibit	O
higher	O
MS	O
at	O
slaughter	O
age	O
,	O
whereas	O
animals	O
with	O
low	O
genetic	O
potential	O
will	O
give	O
low	O
MS	O
[	O
50	O
].	O

The	O
economic	O
analysis	O
will	O
estimate	O
the	O
incremental	O
cost	O
per	O
life	O
saved	O
per	O
year	O
of	O
the	O
intervention	O
over	O
standard	O
care	O
.	O

Maternal	O
Behaviors	O
during	O
Pregnancy	O
Impact	O
Offspring	O
Obesity	O
Risk	O
Abstract	O
This	O
study	O
investigated	O
the	O
effects	O
of	O
maternal	O
changes	O
during	O
pregnancy	O
in	O
diet	O
,	O
exercise	O
,	O
and	O
psychosocial	O
factors	O
on	O
offspring	O
weight	O
parameters	O
at	O
birth	O
and	O
6	O
months	O
.	O

As	O
with	O
the	O
trials	O
in	O
the	O
older	O
children	O
,	O
giving	O
higher	O
doses	O
of	O
vitamin	O
D	O
,	O
25	O
,	O
34we	O
too	O
did	O
not	O
record	O
any	O
adverse	O
effects	O
associated	O
with	O
vitamin	O
D	O
supplementation	O
.	O

Women	O
with	O
T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
had	O
a	O
lower	O
OR	O
for	O
SGA	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
compared	O
to	O
those	O
with	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

For	O
example	O
,	O
serum	O
ferritin	O
level	O
,	O
being	O
an	O
acute	O
-	O
phase	O
protein	O
,	O
is	O
raised	O
in	O
associated	O
underlying	O
infections	O
and	O
long	O
-	O
term	O
diseases	O
;	O
it	O
can	O
therefore	B
give	O
a	O
false	O
normal	O
or	O
high	O
level	O
in	O
a	O
state	O
of	O
iron	O
deficiency	O
.	O

The	O
patient	O
denied	O
any	O
significant	O
past	O
medical	O
history	O
other	O
than	O
mild	O
hypertension	O
that	O
developed	O
during	O
the	O
third	O
trimester	O
of	O
her	O
pregnancy	O
.	O

This	O
manuscript	O
reports	O
the	O
effect	O
of	O
the	O
LIMIT	O
antenatal	O
dietary	O
intervention	O
,	O
on	O
6	O
-	O
month	O
infant	O
outcomes	O
.	O

The	O
patient	O
underwent	O
an	O
emergent	O
cesarean	O
section	O
,	O
which	O
was	O
complicated	O
by	O
the	O
demise	O
of	O
one	O
of	O
the	O
twin	O
babies	O
.	O

This	O
study	O
demonstrated	O
a	O
significant	O
association	O
between	O
high	O
adherences	O
to	O
western	O
dietary	O
pattern	O
and	O
chance	O
of	O
having	O
low	O
birth	O
weight	O
infant	O
.	O

However	O
,	O
a	O
functional	O
role	O
for	O
ncDNA	O
was	O
inferred	B
from	O
the	O
strong	O
correlation	O
between	O
increasing	O
ncDNA	O
abundance	O
and	O
increasing	O
organism	O
complexity	O
(	O
Mattick2007	O
).	O

1b	O
).	O

A	O
smaller	O
(	O
n	O
=	O
498	O
)	O
Japanese	O
study	O
did	O
not	O
demonstrate	O
a	O
positive	O
or	O
negative	O
association	O
between	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
and	O
neurodevelopment	O
as	O
measured	O
by	O
the	O
Neonatal	O
Behavioural	O
Assessment	O
tool	O
in	O
infants	O
at	O
three	O
days	O
of	O
age	O
[	O
25	O
].	O

Characteristics	O
of	O
the	O
women	O
and	O
infants	O
for	O
whom	O
data	O
was	O
available	O
and	O
who	O
participated	O
in	O
the	O
6	O
-	O
month	O
follow	O
-	O
up	O
study	O
were	O
similar	O
between	O
the	O
two	O
randomised	O
treatment	O
groups	O
,	O
and	O
similar	O
to	O
the	O
full	O
randomised	O
cohort	O
[	O
22	O
].	O

[	O
14	O
]	O
Soontrapa	O
et	O
al	O
.	O

When	O
the	O
requirement	O
was	O
not	O
met	O
,	O
we	O
randomly	O
sampled	O
from	O
the	O
vaccinated	O
cases	O
to	O
obtain	O
an	O
unvaccinated	O
to	O
vaccinated	O
ratio	O
greater	O
than	O
one	O
.	O

CQ	O
and	O
MAW	O
drafted	O
the	O
manuscript	O
.	O

Discussion	O
Aortic	O
dissection	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
with	O
significant	O
morbidity	O
and	O
mortality	O
for	O
both	O
the	O
mother	O
and	O
infant	O
.	O

Maternal	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
and	O
smoking	O
status	O
at	O
14	O
weeks	O
of	O
gestation	O
,	O
educational	O
attainment	O
,	O
and	O
season	O
of	O
blood	O
measurement	O
were	O
included	O
in	O
the	O
model	O
for	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
as	B
these	O
have	O
been	O
shown	O
to	O
be	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
in	O
pregnancy	O
(	O
17	O
–	O
21	O
).	O

Here	O
we	O
provide	O
accompanying	O
data	O
about	O
the	O
expression	O
of	O
hepatic	O
miRNAs	O
targeting	O
porcine	O
GR	O
3	O
′	O
UTR	O
in	O
the	O
neonatal	O
piglets	O
.	O

For	O
instance	O
,	O
the	O
Mediterranean	O
diet	O
during	O
pregnancy	O
has	O
been	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
both	O
persistent	O
and	O
atopic	O
wheeze	O
and	O
atopy	O
in	O
children	O
at	O
6	O
.	O
5	O
years	O
old	O
[	O
1	O
,	O
2	O
].	O

Pregnancy	O
and	O
birth	O
outcome	O
data	O
were	O
obtained	O
from	O
antenatal	O
and	O
hospital	O
medical	O
records	O
and	O
included	O
date	O
of	O
last	O
menstrual	O
period	O
(	O
LMP	O
),	O
gestational	O
age	O
calculated	O
by	O
ultrasound	O
when	O
LMP	O
was	O
not	O
available	O
from	O
antenatal	O
medical	O
records	O
,	O
delivery	O
date	O
,	O
and	O
birth	O
weight	O
.	O

In	O
our	O
study	O
,	O
women	O
who	O
scored	O
at	O
least	O
“	O
medium	O
”	O
in	O
the	O
nutritional	O
knowledge	O
questionnaire	O
were	O
more	O
likely	B
to	O
use	O
multivitamins	O
.	O

VD	O
analog	O
supplementation	O
proved	B
to	O
be	O
effective	O
not	O
only	O
in	O
fertility	O
treatment	O
but	O
also	O
in	O
the	O
prevention	O
of	O
type	O
1	O
diabetes	O
in	O
non	O
-	O
obese	O
diabetic	O
(	O
NOD	O
)	O
mice	O
and	O
the	O
prolongation	O
of	O
survival	O
of	O
syngeneic	O
islets	O
grafts	O
[	O
58	O
].	O

Statistical	O
analysis	O
was	O
not	O
applied	O
to	O
the	O
relative	O
change	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
values	O
with	O
low	O
baseline	O
versus	O
high	O
baseline	O
data	O
as	O
there	O
is	O
currently	O
no	O
accepted	O
optimal	O
approach	O
for	O
such	O
an	O
evaluation	O
as	O
reviewed	O
recently	O
by	O
Tu	O
and	O
Gilthorpe	O
[	O
8	O
].	O

With	O
respect	O
to	O
schizophrenia	O
,	O
several	O
of	O
proteins	O
identified	O
in	O
this	O
study	O
have	O
also	O
been	O
reported	O
to	O
be	O
disrupted	O
in	O
post	O
-	O
mortem	O
brain	O
tissue	O
from	O
patients	O
with	O
schizophrenia	O
.	O

During	O
days	O
30	O
–	O
32	O
,	O
we	O
completed	O
3	O
-	O
hour	O
structured	O
observations	O
of	O
106	O
(	O
85	O
%)	O
control	O
and	O
112	O
(	O
90	O
%)	O
intervention	O
participants	O
(	O
Table	O
2	O
).	O

The	O
data	O
the	O
team	O
amassed	O
over	O
the	O
last	O
13	O
years	O
suggests	O
that	O
health	O
problems	O
from	O
these	O
mines	O
in	O
fact	O
aren	O
’	O
t	O
limited	O
to	O
the	O
miners	O
who	O
worked	O
in	O
them	O
but	O
also	O
extend	O
to	O
those	O
exposed	O
through	O
drinking	O
water	O
or	O
simply	O
living	O
near	O
a	O
mine	O
.	O

Biologically	O
,	O
the	O
stress	O
hormone	O
cortisol	O
acts	O
by	O
activating	O
glucocorticoid	O
receptors	O
(	O
GRs	O
).	O

In	O
our	O
population	O
,	O
the	O
SNPs	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
differed	O
from	O
those	O
associated	O
with	O
the	O
response	O
to	O
cholecalciferol	O
supplementation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Perinatal	O
outcomes	O
of	O
exposed	O
and	O
healthy	O
comparison	O
groupsVariableExposed	O
groupHealthy	O
comparison	O
groupp	O
ValueMaternal	O
characteristics	O
(	O
N	O
=	O
133	O
)(	O
N	O
=	O
133	O
)	O
MeanSDMeanSD	O
Age	O
at	O
conception	O
(	O
months	O
)*	O
378	O
.	O
3361	O
.	O
79383	O
.	O
6153	O
.	O
920	O
.	O
459	O
Pre	O
-	O
pregnancy	O
weight	O
(	O
kg	O
)†	O
74	O
.	O
2720	O
.	O
8664	O
.	O
5613	O
.	O
01	O
<	O
0	O
.	O
001	O
Maternal	O
pregnancy	O
weight	O
gain	O
(	O
kg	O
)†	O
15	O
.	O
019	O
.	O
3314	O
.	O
685	O
.	O
570	O
.	O
535N	O
%	O
N	O
%	O
Vitamin	O
use	O
‡	O
11387	O
.	O
613199	O
.	O
2	O
<	O
0	O
.	O
001	O
Alcohol	O
use	O
‡	O
86	O
.	O
0129	O
.	O
10	O
.	O
343	O
Smoking	O
‡	O
2418	O
.	O
000	O
.	O
0	O
<	O
0	O
.	O
001	O
Breastfeeding	O
‡,§	O
6962	O
.	O
210095	O
.	O
2	O
<	O
0	O
.	O
001	O
Hypertension	O
‡	O
1410	O
.	O
564	O
.	O
50	O
.	O
063	O
Gestational	O
diabetes	O
‡	O
118	O
.	O
353	O
.	O
80	O
.	O
122	O
Hypothyroidism	O
¶	O
75	O
.	O
321	O
.	O
50	O
.	O
172Pregnancy	O
outcomes	O
for	O
live	O
births	O
(	O
N	O
=	O
113	O
)(	O
N	O
=	O
116	O
)	O
MeanSDMeanSD	O
Gestational	O
age	O
†	O
39	O
.	O
031	O
.	O
8639	O
.	O
471	O
.	O
490	O
.	O
091	O
Birth	O
weight	O
*	O
3405	O
.	O
07583	O
.	O
673365	O
.	O
69511	O
.	O
090	O
.	O
591N	O
%	O
N	O
%	O
Congenital	O
malformations	O
¶	O
76	O
.	O
232	O
.	O
60	O
.	O
211	O
Preterm	O
delivery	O
‡	O
1210	O
.	O
654	O
.	O
30	O
.	O
071	O
Small	O
for	O
gestational	O
age	O
(<	O
10th	O
centile	O
)‡	O
1311	O
.	O
6108	O
.	O
80	O
.	O
495	O
Large	O
for	O
gestational	O
age	O
(>	O
90th	O
centile	O
)‡	O
1311	O
.	O
643	O
.	O
50	O
.	O
022Delivery	O
and	O
neonatal	O
outcomes	O
for	O
live	O
births	O
(	O
N	O
=	O
113	O
)(	O
N	O
=	O
116	O
)	O
N	O
%	O
N	O
%	O
Method	O
of	O
delivery	O
‡	O
0	O
.	O
042	O
Vaginal7869	O
.	O
08976	O
.	O
7	O
C	O
-	O
section	O
repeat54	O
.	O
497	O
.	O
8	O
C	O
-	O
section	O
emergency1715	O
.	O
01512	O
.	O
9	O
C	O
-	O
section	O
schedules1311	O
.	O
532	O
.	O
6	O
Forceps	O
/	O
vacuum	O
used	O
‡	O
108	O
.	O
91614	O
.	O
00	O
.	O
229	O
Fetal	O
distress	O
‡	O
2022	O
.	O
51514	O
.	O
30	O
.	O
140	O
Admitted	O
to	O
the	O
NICU	O
‡	O
2325	O
.	O
3119	O
.	O
50	O
.	O
002	O
PNA	O
signs	O
‡	O
1516	O
.	O
565	O
.	O
20	O
.	O
007	O
*	O
Independent	O
t	O
test	O
.	O

Dopamine	O
projections	O
involve	O
a	O
range	O
of	O
cortical	O
and	O
subcortical	O
regions	O
,	O
however	O
its	O
role	O
in	O
the	O
nucleus	O
accumbens	O
has	O
been	O
of	O
particular	O
interest	O
with	O
respect	O
to	O
neuropsychiatric	O
disorders	O
[	O
14	O
]–[	O
16	O
].	O

78	O
%).	O

This	O
is	O
supported	O
by	O
the	O
recent	O
finding	O
from	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
examining	O
the	O
effects	O
of	O
a	O
single	O
annual	O
megadose	O
of	O
vitamin	O
D3	O
(	O
500	O
,	O
000	O
IU	O
,	O
equivalent	O
to	O
approximately	O
1370	O
IU	O
/	O
d	O
)	O
on	O
fall	O
and	O
fracture	O
outcomes	O
in	O
community	O
-	O
dwelling	O
elderly	O
women	O
with	O
a	O
history	O
of	O
fall	O
or	O
fracture	O
.	O

Average	O
level	O
of	O
influenza	O
activity	O
corresponds	O
to	O
years	O
2011	O
–	O
2013	O
(	O
Nicaragua	O
,	O
national	O
influenza	O
surveillance	O
data	O
,	O
Severe	O
Acute	O
Respiratory	O
Infections	O
network	O
,	O
SARInet	O
,	O
PAHO	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Adjusted	O
risk	O
ratio	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
of	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
according	O
to	O
self	O
-	O
reporting	O
snoring	O
during	O
early	O
and	O
pre	O
-	O
pregnancy	O
overweight	O
status	O
.	O
Gestational	O
Diabetes	O
MellitusNoN	O
=	O
1222	O
(	O
n	O
)	O
YesN	O
=	O
68	O
(	O
n	O
)	O
Unadjusted	O
RR	O
(	O
95	O
%	O
CI	O
)	O
1Adjusted	O
RR	O
(	O
95	O
%	O
CI	O
)	O
Overweight	O
&	O
Snore	O
StatusLean	O
&	O
Non	O
-	O
Snorer862311	O
.	O
00	O
--	O
Reference1	O
.	O
00	O
--	O
ReferenceLean	O
&	O
Snorer5110	O
.	O
55	O
(	O
0	O
.	O
07	O
-	O
4	O
.	O
07	O
)*	O
0	O
.	O
43	O
(	O
0	O
.	O
06	O
-	O
3	O
.	O
28	O
)*	O
Overweight	O
&	O
Non	O
-	O
Snorer250262	O
.	O
89	O
(	O
1	O
.	O
69	O
-	O
4	O
.	O
96	O
)	O
2	O
.	O
85	O
(	O
1	O
.	O
65	O
-	O
4	O
.	O
92	O
)	O
Overweight	O
&	O
Snorer2987	O
.	O
67	O
(	O
3	O
.	O
24	O
-	O
18	O
.	O
1	O
)	O
6	O
.	O
91	O
(	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
)	O
Missing302P	O
-	O
value	O
for	O
interaction0	O
.	O
160	O
.	O
13	O
1RRs	O
and	O
95	O
%	O
CIs	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
*	O
The	O
data	O
are	O
insufficient	O
to	O
adequately	O
interpret	O
relative	O
risk	O
estimates	O
for	O
lean	O
snorers	O
Discussion	O
Using	O
sleep	O
duration	O
and	O
snoring	O
information	O
,	O
provided	O
in	O
early	O
pregnancy	O
,	O
we	O
were	O
able	O
to	O
detect	O
associations	O
between	O
sleep	O
characteristics	O
and	O
maternal	O
plasma	O
1	O
-	O
hour	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
screening	O
test	O
later	O
in	O
pregnancy	O
.	O

(	O
2014	O
)*/†	O
Xie	O
et	O
al	O
.	O

Daily	O
vitamin	O
D	O
intake	O
of	O
400	O
IU	O
during	O
the	O
first	O
months	O
of	O
life	O
appears	O
adequate	O
to	O
increase	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
support	O
BMC	O
increases	O
despite	O
low	O
initial	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
some	O
infants	O
.	O

This	O
hypothesis	O
suggests	O
that	O
structural	O
and	O
functional	O
adaptations	O
are	O
associated	O
with	O
glomerular	O
hypertension	O
,	O
hyperfiltration	O
,	O
and	O
hypertrophy	O
partially	O
compensated	O
for	O
nephron	O
losses	O
[	O
34	O
].	O

Similar	O
to	O
rickets	O
,	O
city	O
life	O
affords	O
less	O
vitamin	O
D	O
,	O
because	B
of	O
tall	O
buildings	O
,	O
indoor	O
occupations	O
and	O
increased	O
urban	O
air	O
pollution	O
,	O
all	O
of	O
which	O
block	O
ultraviolet	O
B	O
light	O
from	O
penetrating	O
the	O
atmosphere	O
.	O

Study	O
population	O
The	O
study	O
population	O
is	O
urban	O
pregnant	O
women	O
attending	O
ANC	O
at	O
either	O
one	O
of	O
four	O
selected	O
primary	O
health	O
care	O
clinics	O
or	O
at	O
the	O
ANC	O
clinic	O
of	O
the	O
hospital	O
.	O

Hypervitaminosis	O
D	O
is	O
thought	O
to	O
be	O
associated	O
with	O
a	O
rare	O
infant	O
disease	O
with	O
supravalvular	O
aortic	O
stenosis	O
,	O
elfin	O
facies	O
and	O
mental	O
retardation	O
.	O

Among	O
these	O
,	O
one	O
-	O
quarter	O
are	O
attributed	O
to	O
infectious	O
causes	O
.	O

It	O
is	O
plausible	O
that	O
those	O
with	O
S	O
-	O
ECC	O
are	O
also	O
deficient	O
in	O
important	O
vitamins	O
and	O
nutrients	O
,	O
including	O
vitamin	O
D	O
[	O
14	O
].	O

Other	O
publication	O
has	O
also	O
reported	O
a	O
protective	O
effect	O
of	O
adherence	O
to	O
Mediterranean	O
diet	O
during	O
pregnancy	O
and	O
risk	O
of	O
delivering	O
a	O
fetal	O
growth	O
–	O
restricted	O
infant	O
for	O
weight	O
in	O
Atlantic	O
area	O
[	O
16	O
].	O

Further	O
evidence	O
for	O
the	O
hypothesis	O
that	O
PUFA	O
is	O
involved	O
in	O
the	O
etiology	O
of	O
psychiatric	O
disease	O
has	O
been	O
put	O
forward	O
through	O
the	O
study	O
by	O
Stokes	O
et	O
al	O
.	O

Previous	O
researches	O
have	O
demonstrated	O
metabolic	O
alterations	O
after	O
undernutrition	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

Blood	O
glucose	O
levels	O
are	O
usually	O
monitored	O
in	O
the	O
fasting	O
state	O
and	O
1	O
–	O
2	O
hours	O
after	O
meals	O
.	O

Results	O
After	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
GDM	O
risk	O
was	O
increased	O
among	O
women	O
sleeping	O
≤	O
4	O
hours	O
compared	O
with	O
those	O
sleeping	O
9	O
hours	O
per	O
night	O
(	O
RR	O
=	O
5	O
.	O
56	O
;	O
95	O
%	O
CI	O
1	O
.	O
31	O
-	O
23	O
.	O
69	O
).	O

MTC	O
arises	O
from	O
C	O
cells	O
secreting	O
calcitonin	O
,	O
a	O
32	O
-	O
amino	O
acid	O
peptide	O
.	O

Second	O
,	O
we	O
did	O
not	O
identify	O
associations	O
between	O
several	O
SNPs	O
and	O
either	O
baseline	O
and	O
/	O
or	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
that	O
had	O
previously	O
been	O
associated	O
with	O
25	O
(	O
OH	O
)	O
D	O
in	O
GWAS	O
(	O
8	O
,	O
22	O
).	O

There	O
are	O
no	O
indications	O
for	O
termination	O
of	O
pregnancy4	O
.	O

[	O
28	O
]	O
A	O
study	O
on	O
rodents	O
showed	O
that	O
hypovitaminosis	O
D	O
trabecular	O
bone	O
loss	O
,	O
and	O
concluded	O
that	O
vitamin	O
D	O
is	O
indispensable	O
for	O
normal	O
bone	O
mineralization	O
during	O
the	O
reproductive	O
period	O
in	O
rats	O
.	O

study	O
[	O
4	O
]	O
assessed	O
the	O
non	O
-	O
linear	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
,	O
both	O
identifying	O
a	O
decreasing	O
risk	O
of	O
PTB	O
as	B
25	O
(	O
OH	O
)	O
D	O
increased	O
to	O
approximately	O
40	O
ng	O
/	O
mL	O
.	O
Fig	O
1shows	O
that	O
the	O
increase	O
in	O
gestational	O
age	O
at	O
birth	O
with	O
rising	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
is	O
similar	O
between	O
the	O
general	O
obstetrical	O
population	O
at	O
MUSC	O
and	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

E1	O
–	O
education	O
:	O
>	O
12	O
years	O
;	O
E2	O
–	O
9	O
–	O
12	O
years	O
;	O
reference	O
category	O
-	O
≤	O
8	O
years	O
.	O

DMP	O
in	O
the	O
combined	O
analysis	O
was	O
associated	O
with	O
a	O
57	O
g	O
decrease	O
in	O
birth	O
weight	O
;	O
looking	O
at	O
the	O
stratified	O
analysis	O
revealed	O
that	O
this	O
decrease	O
is	O
greater	O
in	O
magnitude	O
for	O
male	O
infants	O
(	O
88	O
g	O
decrease	O
),	O
and	O
lesser	O
in	O
female	O
infants	O
(	O
27	O
g	O
decrease	O
).	O

Pregnancy	O
outcomes	O
The	O
gestational	O
age	O
of	O
neonates	O
born	O
to	O
women	O
receiving	O
polytherapy	O
was	O
significantly	O
shorter	O
than	O
those	O
exposed	O
to	O
monotherapy	O
(	O
38	O
.	O
77	O
vs	O
39	O
.	O
70	O
,	O
p	O
=	O
0	O
.	O
005	O
).	O

To	O
determine	O
the	O
effect	O
of	O
birth	O
weight	O
on	O
HRV	O
parameters	O
,	O
we	O
perform	O
multivariate	O
linear	O
regression	O
analysis	O
adjusted	O
for	O
potentially	O
confounding	O
factors	O
(	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
).	O

However	O
,	O
little	O
is	O
known	O
about	O
how	O
well	O
the	O
recommendations	O
were	O
implemented	O
.	O

Randomisation	O
and	O
masking	O
An	O
independent	O
statistician	O
(	O
Shabbar	O
Jaffar	O
,	O
London	O
School	O
of	O
Hygiene	O
and	O
Tropical	O
Medicine	O
,	O
London	O
,	O
UK	O
)	O
randomised	O
unique	O
identification	O
numbers	O
individually	O
in	O
fixed	O
blocks	O
of	O
20	O
to	O
the	O
vitamin	O
D3or	O
placebo	O
group	O
by	O
use	O
of	O
a	O
random	O
number	O
generator	O
with	O
the	O
SAS	O
routine	O
.	O

Certain	O
medications	O
like	O
steroids	O
,	O
anti	O
-	O
epileptic	O
medications	O
,	O
cholesterol	O
-	O
lowering	O
drugs	O
,	O
and	O
some	O
diuretics	O
reduce	O
absorption	O
of	O
vitamin	O
D	O
from	O
the	O
intestines	O
.	O

Nulliparous	O
women	O
carrying	O
a	O
singleton	O
pregnancy	O
were	O
recruited	O
between	O
November	O
2004	O
and	O
September	O
2008	O
in	O
Adelaide	O
(	O
Australia	O
)	O
and	O
Auckland	O
(	O
New	O
Zealand	O
).	O

The	O
classical	O
frequency	O
low	O
frequency	O
(	O
LF	O
=	O
0	O
.	O
041	O
–	O
0	O
.	O
15	O
Hz	O
)	O
and	O
high	O
frequency	O
(	O
HF	O
=	O
0	O
.	O
15	O
–	O
0	O
.	O
40	O
Hz	O
)	O
bands	O
were	O
expressed	O
in	O
normalized	O
units	O
(	O
n	O
.	O
u	O
.).	O

Emotional	O
well	O
-	O
being	O
was	O
examined	O
using	O
the	O
5	O
-	O
item	O
World	O
Health	O
Organization	O
Well	O
-	O
Being	O
Index	O
(	O
WHO	O
-	O
5	O
)	O
[	O
36	O
].	O

The	O
chance	B
of	O
becoming	O
obese	O
during	O
a	O
given	O
period	O
increased	O
with	O
development	O
of	O
obesity	O
in	O
a	O
friend	O
(	O
57	O
%	O
increase	O
),	O
a	O
sibling	O
(	O
40	O
%	O
increase	O
),	O
or	O
a	O
spouse	O
(	O
37	O
%	O
increase	O
).	O

Depression	O
scores	O
were	O
measured	O
three	O
days	O
after	O
childbirth	O
using	O
a	O
questionnaire	O
based	O
on	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
(	O
EPDS	O
)	O
[	O
33	O
].	O

Brown	O
adipose	O
tissue	O
activity	O
as	O
a	O
target	O
for	O
the	O
treatment	O
of	O
obesity	O
/	O
insulin	O
resistance	O
Abstract	O
Presence	O
of	O
brown	O
adipose	O
tissue	O
(	O
BAT	O
),	O
characterized	O
by	O
the	O
expression	O
of	O
the	O
thermogenic	O
uncoupling	O
protein	O
1	O
(	O
UCP1	O
),	O
has	O
recently	O
been	O
described	O
in	O
adult	O
humans	O
.	O

Follow	O
-	O
up	O
assessments	O
of	O
the	O
offspring	O
include	O
feeding	O
practices	O
,	O
nutrient	O
status	O
,	O
measures	O
of	O
growth	O
,	O
psychomotor	O
,	O
socio	O
-	O
emotional	O
and	O
immune	O
development	O
,	O
morbidity	O
,	O
allergy	O
,	O
as	O
well	O
as	O
analysis	O
of	O
the	O
gut	O
microbiome	O
and	O
the	O
epigenome	O
.	O

Furthermore	O
,	O
many	O
studies	O
found	O
no	O
benefit	O
of	O
a	O
restricted	O
diet	O
avoiding	O
the	O
consumption	O
of	O
allergy	O
-	O
inducing	O
food	O
during	O
pregnancy	O
[	O
82	O
].	O

Despite	O
this	O
,	O
exclusive	O
breastfeeding	O
to	O
4	O
-	O
6	O
months	O
should	O
be	O
encouraged	O
as	O
human	O
milk	O
contains	O
numerous	O
immunological	O
properties	O
and	O
is	O
associated	O
with	O
other	O
health	O
benefits	O
.	O

Concerning	O
the	O
analysis	O
of	O
total	O
GWG	O
,	O
absolute	O
values	O
were	O
used	O
,	O
and	O
women	O
who	O
had	O
their	O
final	O
weight	O
recorded	O
more	O
than	O
three	O
weeks	O
before	O
the	O
delivery	O
were	O
omitted	O
(	O
n	O
=	O
7	O
).	O

The	O
present	O
study	O
has	O
certain	O
limitations	O
.	O

Controlling	O
for	O
mediators	O
may	O
attenuate	O
the	O
total	O
effect	O
of	O
EDCs	O
on	O
birth	O
weight	O
.	O

Although	O
insulin	O
resistance	O
is	O
a	O
physiologic	O
hallmark	O
of	O
obesity	O
,	O
she	O
says	O
insulin	O
previously	O
was	O
thought	O
to	O
have	O
little	O
,	O
if	O
any	O
,	O
role	O
in	O
lactation	O
.	O

Eighty	O
-	O
four	O
cases	O
(	O
85	O
.	O
7	O
%)	O
took	O
Vitamin	O
D	O
supplements	O
with	O
duration	O
of	O
2w	O
-	O
31w	O
,	O
and	O
with	O
average	O
daily	O
intake	O
dose	O
of	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

Yet	O
this	O
is	O
also	O
a	O
story	O
of	O
hope	O
in	O
the	O
significant	O
opportunities	O
for	O
change	O
,	O
especially	O
as	O
we	O
approach	O
the	O
final	O
sprint	O
for	O
the	O
MDG	O
4	O
target	O
and	O
aim	O
to	O
maintain	O
momentum	O
beyond	O
2015	O
.	O

We	O
will	O
check	O
the	O
model	O
assumptions	O
and	O
make	O
appropriate	O
adjustments	O
to	O
the	O
analysis	O
where	O
necessary	O
.	O

Infant	O
sex	O
and	O
maternal	O
ethnicity	O
were	O
also	O
significant	O
predictors	O
of	O
birth	O
weight	O
percentile	O
(	O
Table	O
1	O
);	O
all	O
other	O
covariates	O
were	O
not	O
significant	O
.	O

Nonetheless	O
,	O
only	O
9	O
.	O
7	O
%	O
in	O
the	O
vitamin	O
D	O
group	O
achieved	O
serum	O
concentrations	O
higher	O
than	O
30	O
ng	O
/	O
mL	O
.	O

The	O
results	O
of	O
imputed	O
analyses	O
were	O
compared	O
with	O
those	O
from	O
complete	O
-	O
case	O
analyses	O
,	O
and	O
further	O
sensitivity	O
analyses	O
were	O
also	O
conducted	O
for	O
the	O
primary	O
outcome	O
on	O
the	O
assumption	O
that	O
data	O
were	O
Missing	O
Not	O
At	O
Random	O
(	O
MNAR	O
).	O

When	O
corporate	O
and	O
government	O
officials	O
appeared	O
in	O
the	O
spill	O
’	O
s	O
aftermath	O
and	O
began	O
inquiring	O
into	O
exposure	O
to	O
the	O
slurry	O
and	O
potential	O
health	O
problems	O
,	O
the	O
Navajo	O
people	O
finally	O
learned	O
the	O
truth	O
—	O
far	O
from	O
being	O
harmless	O
,	O
these	O
uranium	O
mines	O
were	O
poisoning	O
people	O
,	O
and	O
researchers	O
say	O
they	O
will	O
continue	O
to	O
do	O
so	O
for	O
decades	O
to	O
come	O
.	O

The	O
vitamin	O
D	O
was	O
added	O
separately	O
only	O
to	O
the	O
SC	O
diet	O
,	O
and	O
the	O
vitamin	O
mixture	O
added	O
to	O
both	O
the	O
SC	O
and	O
VitD	O
-	O
diets	O
did	O
not	O
contain	O
vitamin	O
D	O
.	O
Table	O
1shows	O
the	O
nutritional	O
components	O
in	O
each	O
diet	O
,	O
including	O
the	O
dietary	O
composition	O
of	O
vitamin	O
D	O
.	O
The	O
recommended	O
minimum	O
dietary	O
requirement	O
of	O
pregnant	O
mice	O
for	O
vitamin	O
D	O
,	O
according	O
to	O
the	O
AIN93G	O
,	O
is	O
1	O
,	O
000	O
.	O
0	O
IU	O
/	O
kg	O
of	O
diet	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
pedigrees	O
based	O
on	O
their	O
skeletal	O
disfigurement	O
,	O
Skm1	O
and	O
Skm2	O
.	O

However	O
,	O
as	O
these	O
different	O
cells	O
are	O
often	O
mixed	O
,	O
such	O
as	O
occurs	O
for	O
classical	O
and	O
“	O
brite	O
”	O
adipocytes	O
in	O
some	O
human	O
depots	O
(	O
Wu	O
et	O
al	O
.,	O
2012	O
;	O
Cypess	O
et	O
al	O
.,	O
2013	O
;	O
Jespersen	O
et	O
al	O
.,	O
2013	O
),	O
only	O
the	O
use	O
of	O
specific	O
cell	O
surface	O
markers	O
(	O
i	O
.	O
e	O
.,	O
ASC	O
-	O
1	O
,	O
PAT2	O
,	O
and	O
P2RX5	O
for	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
,	O
respectively	O
)	O
will	O
allow	O
for	O
their	O
identification	O
,	O
as	O
well	O
as	O
for	O
the	O
precise	O
understanding	O
of	O
their	O
respective	O
therapeutic	O
properties	O
(	O
Ussar	O
et	O
al	O
.,	O
2014	O
).	O

The	O
PAT	O
of	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
β	O
-	O
oxidation	O
enzymes	O
Cpt1b	O
and	O
Acox1	O
,	O
the	O
mitochondrial	O
respiratory	O
chain	O
subunit	O
Cox4i1	O
and	O
the	O
lipid	O
storage	O
-	O
stimulating	O
transcription	O
factor	O
Ppar	O
γ	O
.	O

The	O
percentage	O
of	O
women	O
with	O
vitamin	O
D	O
insufficiency	O
and	O
deficiency	O
was	O
higher	O
in	O
the	O
first	O
than	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
but	O
the	O
prevalence	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
higher	O
in	O
the	O
third	O
trimester	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
All	O
womenWalloniaFlanders1sttrimester3rdtrimesterN1300453633633665Age28	O
.	O
5	O
±	O
5	O
.	O
127	O
.	O
9	O
±	O
5	O
.	O
528	O
.	O
8	O
±	O
4	O
.	O
728	O
.	O
3	O
±	O
5	O
.	O
128	O
.	O
8	O
±	O
5	O
.	O
1Gestational	O
weeks22	O
.	O
2	O
±	O
12	O
.	O
522	O
.	O
1	O
±	O
12	O
.	O
822	O
.	O
4	O
±	O
12	O
.	O
39	O
.	O
9	O
±	O
2	O
.	O
834	O
.	O
1	O
±	O
3	O
.	O
625	O
-(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
ml	O
)	O
Median21	O
.	O
220	O
.	O
922	O
.	O
320	O
.	O
422	O
.	O
7	O
*	O
IQR13	O
.	O
8	O
–	O
30	O
.	O
013	O
.	O
5	O
–	O
29	O
.	O
114	O
.	O
6	O
–	O
30	O
.	O
613	O
.	O
6	O
–	O
26	O
.	O
714	O
.	O
3	O
–	O
34	O
.	O
195	O
%	O
CI20	O
.	O
5	O
–	O
22	O
.	O
219	O
.	O
8	O
–	O
22	O
.	O
321	O
.	O
2	O
–	O
23	O
.	O
219	O
.	O
3	O
–	O
21	O
.	O
121	O
.	O
6	O
–	O
24	O
.	O
4	O
%	O
<	O
10	O
ng	O
/	O
ml12	O
.	O
112	O
.	O
310	O
.	O
911	O
.	O
612	O
.	O
6	O
%	O
<	O
20	O
ng	O
/	O
ml44	O
.	O
645	O
.	O
742	O
.	O
347	O
.	O
042	O
.	O
3	O
%	O
<	O
30	O
ng	O
/	O
ml74	O
.	O
176	O
.	O
372	O
.	O
582	O
.	O
266	O
.	O
7	O
Different	O
from	O
first	O
trimester	O
pregnant	O
women	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
we	O
summarized	O
the	O
intake	O
of	O
α	O
-	O
linolenic	O
,	O
EPA	O
,	O
DHA	O
and	O
docosapentaenoic	O
acids	O
(	O
DPA	O
).	O

Results	O
:	O
Only	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
<	O
0	O
.	O
004	O
].	O

In	O
Finland	O
,	O
maternal	O
vitamin	O
D	O
status	O
has	O
improved	O
considerably	O
due	B
to	I
national	O
health	O
policies	O
.	O

There	O
is	O
also	O
a	O
need	O
for	O
more	O
studies	O
on	O
what	O
specific	O
features	O
and	O
approaches	O
in	O
mHealth	O
programs	O
are	O
most	O
effective	O
,	O
including	O
studies	O
on	O
the	O
optimal	O
timing	O
of	O
messaging	O
,	O
dose	O
of	O
exposure	O
,	O
and	O
value	O
of	O
interactive	O
feature	O
[	O
23	O
].	O

Detecting	O
a	O
thyroid	O
cancer	O
during	O
pregnancy	O
should	O
not	O
be	O
a	O
reason	O
for	O
termination	O
of	O
pregnancy	O
,	O
and	O
in	O
the	O
large	O
majority	B
of	O
cases	O
it	O
does	O
not	O
require	O
urgent	O
surgery4	O
.	O

1	O
Exclusion	O
criteria	O
and	O
data	O
cleaning	O
algorithm	O
.	O

It	B
is	I
clear	I
that	O
a	O
deficiency	O
of	O
paternal	O
micronutrients	O
could	O
affect	O
the	O
development	O
of	O
offspring	O
through	O
epigenetic	O
regulation	O
.	O

The	O
RR	O
comparing	O
growing	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
for	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
compared	O
with	O
the	O
low	O
level	O
group	O
was	O
1	O
.	O
7	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
5	O
-	O
2	O
.	O
0	O
)	O
and	O
5	O
.	O
6	O
(	O
95	O
%	O
CI	O
,	O
4	O
.	O
0	O
-	O
6	O
.	O
8	O
),	O
respectively	O
.	O

The	O
researchers	O
found	O
that	O
prematurity	O
,	O
low	O
Apgar	O
scores	O
,	O
growth	O
restriction	O
,	O
or	O
macrosomia	O
,	O
and	O
if	O
the	O
mother	O
was	O
from	O
sub	O
-	O
Saharan	O
Africa	O
or	O
East	O
Asia	O
had	O
a	O
positive	O
correlation	O
with	O
autism	O
spectrum	O
disorders	O
[	O
9	O
].	O

However	O
,	O
little	O
research	O
has	O
comprehensively	O
examined	O
the	O
impact	O
of	O
maternal	O
prenatal	O
behaviors	O
and	O
psychosocial	O
variables	O
measured	O
during	O
pregnancy	O
on	O
subsequent	O
offspring	O
weight	O
status	O
at	O
birth	O
and	O
6	O
months	O
.	O

Surely	O
,	O
it	O
is	O
better	O
for	O
both	O
society	O
and	O
public	O
health	O
to	O
fully	O
assess	O
the	O
potential	O
epigenetic	O
effects	O
of	O
environmental	O
exposures	O
and	O
introduce	O
regulations	O
and	O
TGs	O
based	O
on	O
relevant	O
data	O
and	O
proven	O
mechanisms	O
of	O
toxicity	O
.	O

Zeybel	O
et	O
al	O
.	O

Fat	O
digestion	O
and	O
absorption	O
Many	O
of	O
the	O
FAs	O
generated	O
by	O
digestion	O
in	O
the	O
rumen	O
pass	O
into	O
the	O
small	O
intestine	O
,	O
where	O
they	O
are	O
absorbed	O
into	O
circulation	O
via	O
the	O
lymph	O
and	O
blood	O
.	O

Mothers	O
also	O
reported	O
duration	O
of	O
breastfeeding	O
on	O
postpartum	O
questionnaires	O
.	O

In	O
our	O
original	O
publication	O
,	O
we	O
used	O
examination	O
data	O
at	O
one	O
time	O
point	O
only	O
for	O
the	O
children	O
when	O
they	O
were	O
aged	O
5	O
;	O
we	O
now	O
report	O
examination	O
data	O
at	O
three	O
separate	O
time	O
points	O
,	O
including	O
a	O
completely	O
new	O
sweep	O
of	O
data	O
when	O
children	O
were	O
aged	O
9	O
.	O

Children	O
were	O
assessed	O
based	O
on	O
the	O
ministry	O
of	O
health	O
’	O
s	O
questionnaire	O
for	O
children	O
under	O
8	O
years	O
of	O
age	O
.	O

Caulfield	O
et	O
al	O
.	O

Secondary	O
analysis	O
examining	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
healthy	O
lifestyle	O
randomized	O
controlled	O
trial	O
conducted	O
in	O
and	O
urban	O
area	O
of	O
the	O
South	O
East	O
.	O

In	O
total	O
,	O
1810	O
women	O
had	O
samples	O
collected	O
both	O
in	O
T1	O
and	O
T3	O
.	O

Very	O
little	O
is	O
known	O
about	O
the	O
diet	O
and	O
nutritional	O
status	O
of	O
pregnant	O
women	O
in	O
South	O
Africa	O
,	O
specifically	O
residing	O
in	O
urban	O
areas	O
.	O

Investigators	O
will	O
extract	O
and	O
code	O
the	O
symptoms	O
from	O
both	O
the	O
closed	O
-	O
ended	O
questions	O
and	O
open	O
narratives	O
.	O

Because	O
LASSO	O
and	O
Elastic	O
Net	O
do	O
not	O
estimate	O
the	O
μβparameter	O
,	O
this	O
makes	O
Additional	O
file1	O
:	O
Figures	O
S2	O
and	O
S3	O
harder	O
to	O
interpret	O
because	O
they	O
do	O
not	O
estimate	O
the	O
average	O
association	O
between	O
the	O
exposure	O
variables	O
and	O
the	O
outcome	O
within	O
a	O
chemical	O
class	O
.	O

Public	O
health	O
interventions	O
have	O
included	O
reducing	O
maternal	O
disease	O
,	O
prenatal	O
care	O
of	O
mothers	O
,	O
reduction	O
of	O
exposure	O
to	O
teratogens	O
(	O
agent	O
that	O
can	O
disturb	O
the	O
development	O
of	O
an	O
embryo	O
or	O
fetus	O
),	O
and	O
nutritional	O
interventions	O
[	O
2	O
].	O

1a	O
).	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
034	O
for	O
maternal	O
dairy	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
dairy	O
intake	O
tertiles	O
.	O

Behaviourally	O
,	O
adult	O
DVD	O
-	O
deficient	O
rats	O
were	O
more	O
active	O
than	O
controls	O
(	O
i	O
.	O
e	O
.	O

This	O
suggests	O
that	O
dietary	O
exposures	O
may	O
impact	O
offspring	O
weight	O
status	O
above	O
and	O
beyond	O
the	O
potential	O
influence	O
of	O
excessive	O
GWG	O
.	O

Spectral	O
analysis	O
was	O
estimated	O
as	O
recommended	O
using	O
the	O
non	O
-	O
parametric	O
method	O
of	O
fast	O
Fourier	O
Transform	O
Algorithms	O
[	O
28	O
,	O
29	O
].	O

Maternal	O
serum	O
vitamin	O
D	O
levels	O
tend	O
to	O
be	O
closely	O
correlated	O
with	O
infant	O
cord	O
serum	O
levels	O
[	O
146	O
,	O
147	O
].	O

Based	O
on	O
the	O
information	O
available	O
(	O
Table1	O
),	O
loratadine	O
or	O
cetirizine	O
may	O
be	O
considered	O
the	O
second	O
-	O
generation	O
antihistamines	O
of	O
choice	O
.	O

Statistical	O
Analysis	O
As	O
was	O
mentioned	O
,	O
principal	O
component	O
analysis	O
was	O
used	O
to	O
identify	O
major	O
dietary	O
patterns	O
based	O
on	O
the	O
33	O
food	O
groups	O
.	O

Secondary	O
outcomes	O
were	O
change	O
in	O
:	O
staff	O
’	O
s	O
awareness	O
,	O
knowledge	O
,	O
and	O
acceptance	O
of	O
the	O
model	O
,	O
and	O
change	O
in	O
client	O
satisfaction	O
(	O
process	O
),	O
and	O
in	O
dietary	O
indices	O
,	O
physical	O
activity	O
levels	O
,	O
and	O
key	O
maternal	O
and	O
infant	O
outcomes	O
(	O
clinical	O
).	O

LBW	O
was	O
defined	O
as	O
weight	O
at	O
birth	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
before	O
gestational	O
week	O
+	O
days	O
37	O
+	O
0	O
,	O
including	O
both	O
induced	O
and	O
spontaneous	O
preterm	O
delivery	O
.	O

The	O
small	O
sample	O
size	O
of	O
the	O
groups	O
could	O
explain	B
these	O
results	O
.	O

Regarding	O
the	O
time	O
exposure	O
to	O
diet	O
,	O
Palou	O
et	O
al	O
.	O

Two	O
previous	O
studies	O
in	O
nonpregnant	O
adults	O
similarly	O
found	O
that	O
rs2282679	O
(	O
GC	O
)	O
and	O
rs10741567	O
(	O
CYP2R1	O
)	O
are	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
increment	O
in	O
response	O
to	O
supplementation	O
(	O
10	O
,	O
11	O
),	O
whereas	O
Barry	O
et	O
al	O
.	O

In	O
group	O
B	O
,	O
second	O
trimester	O
visfatin	O
levels	O
correlated	O
negatively	O
with	O
birth	O
length	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
and	O
infant	O
’	O
s	O
head	O
circumference	O
(	O
p2	O
=	O
0	O
.	O
050	O
,	O
r2	O
=-	O
0	O
.	O
392	O
).	O

The	O
participants	O
who	O
had	O
depression	O
scores	O
of	O
>	O
13	O
were	O
exited	O
from	O
this	O
clinical	O
trial	O
and	O
referred	O
to	O
psychiatrist	O
for	O
further	O
assessment	O
and	O
treatment	O
,	O
because	O
,	O
the	O
nature	O
of	O
our	O
study	O
was	O
preventative	O
than	O
management	O
.	O

It	O
is	O
also	O
worth	O
noting	O
that	O
some	O
of	O
these	O
RNA	O
-	O
mediated	O
phenotypes	O
have	O
been	O
shown	O
to	O
be	O
dependent	O
upon	O
the	O
remaining	O
member	O
of	O
the	O
DNMT	O
family	O
,	O
DNMT2	O
(	O
Kiani	O
et	O
al	O
.	O
2013	O
).	O

Results	O
The	O
incidence	O
rate	O
of	O
Vitamin	O
D	O
deficiency	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
was	O
20	O
.	O
4	O
%.	O

Children	O
underwent	O
a	O
blood	O
draw	O
for	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
),	O
calcium	O
,	O
parathyroid	O
hormone	O
,	O
and	O
albumin	O
levels	O
.	O

Prenatal	O
data	O
collection	O
time	O
points	O
are	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
phase	O
1	O
);	O
±	O
22	O
weeks	O
’	O
gestation	O
(	O
phase	O
2	O
);	O
±	O
36	O
weeks	O
’	O
gestation	O
(	O
phase	O
3	O
)	O
and	O
at	O
birth	O
(	O
phase	O
4	O
).	O

Usually	O
,	O
patients	O
are	O
recommended	O
to	O
postpone	O
pregnancy	O
to	O
6	O
-	O
12	O
months	O
after	O
radioiodine	O
(	O
I	O
-	O
131	O
)	O
treatment	O
to	O
avoid	O
a	O
potentially	O
higher	O
risk	O
of	O
miscarriage	O
in	O
the	O
first	O
few	O
months	O
after	O
radioiodine	O
therapy	O
and	O
to	O
allow	O
time	O
enough	O
to	O
exclude	O
residual	O
disease	O
requiring	O
further	O
treatment41438	O
.	O

Mothers	O
with	O
GDM	O
were	O
older	O
(	O
P	O
=	O
0	O
.	O
018	O
),	O
heavier	O
and	O
had	O
higher	O
prepregnancy	O
BMI	O
(	O
P	O
for	O
both	O
<	O
0	O
.	O
001	O
),	O
and	O
their	O
educational	O
level	O
was	O
at	O
borderline	O
of	O
significance	O
(	O
P	O
=	O
0	O
.	O
051	O
)	O
lower	O
compared	O
with	O
mothers	O
without	O
GDM	O
.	O

The	O
liver	O
of	O
adult	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
.	O

The	O
first	O
choice	O
in	O
the	O
prophylaxis	O
of	O
iron	O
deficiency	O
anaemia	O
for	O
almost	B
all	I
women	O
is	O
oral	O
iron	O
replacement	O
because	O
of	O
its	O
effectiveness	O
,	O
safety	O
,	O
and	O
low	O
cost	O
[	O
25	O
].	O

To	O
date	O
,	O
there	O
have	O
been	O
very	O
few	O
large	O
-	O
scale	O
mHealth	O
programs	O
shown	O
to	O
be	O
effective	O
.	O

It	O
was	O
a	O
possible	O
reason	B
that	O
we	O
did	O
not	O
observe	O
any	O
relationship	O
between	O
antenatal	O
depression	O
score	O
and	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
.	O

During	O
acute	O
cold	O
exposure	O
,	O
BAT	O
was	O
shown	O
as	O
a	O
significant	O
independent	O
determinant	O
of	O
plasma	O
glucose	O
and	O
HbA1c	O
levels	O
(	O
Matsushita	O
et	O
al	O
.,	O
2014	O
).	O

The	O
article	O
has	O
been	O
reformatted	O
for	O
journal	O
publication	O
and	O
has	O
undergone	O
peer	O
review	O
according	O
to	O
Reproductive	O
Health	O
'	O
s	O
standard	O
process	O
for	O
supplements	O
and	O
may	O
feature	O
some	O
variations	O
in	O
content	O
when	O
compared	O
to	O
the	O
original	O
report	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
.	O

Note	O
that	O
confidence	O
intervals	O
for	O
beta	O
coefficients	O
from	O
LASSO	O
and	O
Elastic	O
Net	O
are	O
not	O
available	O
using	O
standard	O
software	O
,	O
and	O
calculating	O
standard	O
errors	O
for	O
parameter	O
estimates	O
is	O
challenging	O
because	O
the	O
shrinkage	O
estimation	O
produces	O
biased	O
estimates	O
for	O
large	O
coefficients	O
.	O

The	O
objectives	O
of	O
the	O
present	O
study	O
were	O
to	O
compare	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
two	O
consecutive	O
time	O
points	O
between	O
mothers	O
with	O
and	O
without	O
GDM	O
,	O
and	O
to	O
investigate	O
associations	O
between	O
maternal	O
factors	O
and	O
infant	O
’	O
s	O
birth	O
size	O
,	O
and	O
the	O
potential	O
role	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
therein	O
.	O

Those	O
who	O
had	O
a	O
longer	O
period	O
of	O
weekly	O
supplementation	O
prior	O
to	O
pregnancy	O
maintained	O
higher	O
Hb	O
concentration	O
during	O
pregnancy	O
[	O
20	O
].	O

Women	O
with	O
a	O
≥	O
30	O
nmol	O
/	O
L	O
increment	O
in	O
25OHD	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

In	O
the	O
kidneys	O
,	O
25	O
[	O
OH	O
]	O
D	O
is	O
decomposed	O
by	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
by	O
CYP27B1	O
)	O
to	O
an	O
active	O
form	O
of	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
13	O
].	O

There	O
are	O
2	O
important	O
limitations	O
of	O
this	O
study	O
.	O

Academic	O
and	O
research	O
institutions	O
:	O
Invest	O
•	O
Agree	O
upon	O
and	O
promote	O
an	O
innovative	O
research	O
agenda	O
for	O
prevention	O
of	O
preterm	O
birth	O
and	O
improved	O
pregnancy	O
outcomes	O
and	O
implementation	O
research	O
to	O
reduce	O
deaths	O
from	O
preterm	O
birth	O
.	O

Case	O
report	O
A	O
12	O
-	O
week	O
-	O
pregnant	O
35	O
-	O
year	O
-	O
old	O
woman	O
presented	O
with	O
an	O
approximately	O
4	O
-	O
week	O
history	O
of	O
a	O
growing	O
,	O
tender	O
papule	O
under	O
her	O
right	O
great	O
toenail	O
.	O

b	O
Predicted	O
probability	O
plot	O
of	O
infant	O
stool	O
cluster	O
membership	O
by	O
maternal	O
fruit	O
intake	O
during	O
pregnancy	O
from	O
multinomial	O
logistic	O
regression	O
models	O
adjusted	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

Finally	O
,	O
we	O
analyzed	O
cord	O
blood	O
vitamin	O
D	O
levels	O
at	O
the	O
time	O
of	O
delivery	O
,	O
rather	O
than	O
maternal	O
serum	O
vitamin	O
D	O
levels	O
during	O
pregnancy	O
.	O

It	O
has	O
been	O
argued	O
that	O
the	O
effects	O
of	O
intrauterine	O
cues	O
such	O
as	O
prenatal	O
undernutrition	O
on	O
later	O
metabolic	O
function	O
have	O
an	O
adaptive	O
origin	O
[	O
21	O
],	O
in	O
that	O
they	O
are	O
a	O
result	O
of	O
evolved	O
processes	O
designed	O
to	O
maintain	O
reproductive	O
fitness	O
across	O
a	O
range	O
of	O
potential	O
environments	O
.	O

Daily	O
consumption	O
of	O
vegetables	O
,	O
fruits	O
,	O
legumes	O
,	O
soy	O
,	O
and	O
nuts	O
,	O
whole	O
grains	O
,	O
fish	O
and	O
seafood	O
,	O
and	O
monounsaturated	O
to	O
saturated	O
fat	O
ratio	O
(	O
MUFA	O
:	O
SFA	O
)	O
above	O
the	O
median	O
is	O
considered	O
healthful	O
and	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

We	O
assessed	O
violation	O
of	O
the	O
proportionality	O
assumption	O
with	O
Schoenfeld	O
residuals	O
.	O

SNPs	O
at	O
rs12785878	O
(	O
DHCR7	O
),	O
rs10741657	O
(	O
CYP2R1	O
),	O
rs6013897	O
(	O
CYP24A1	O
),	O
and	O
rs2282679	O
(	O
GC	O
)	O
were	O
genotyped	O
.	O

PubMed	O
Central	O
:	O

Moreover	O
,	O
subsequent	O
studies	O
have	O
further	O
demonstrated	O
that	O
early	O
life	O
trauma	O
or	O
parental	O
stress	O
can	O
induce	O
altered	O
miRNA	O
expression	O
in	O
sperm	O
,	O
which	O
in	O
turn	O
can	O
transmit	O
behavioral	O
and	O
metabolic	O
abnormalities	O
through	O
to	O
the	O
next	O
murine	O
generation	O
(	O
Rodgers	O
et	O
al	O
.	O
2013	O
;	O
Gapp	O
et	O
al	O
.	O
2014	O
;	O
Rodgers	O
et	O
al	O
.	O
2015	O
).	O

Prolonged	O
labor	O
may	O
also	O
lead	O
to	O
neurological	O
deficits	O
and	O
thus	B
autism	O
.	O

Amongst	O
sibships	O
discordant	O
for	O
exposure	O
to	O
hyperglycemia	O
,	O
the	O
sibling	O
exposed	O
to	O
hyperglycemia	O
had	O
a	O
considerably	O
higher	O
risk	O
of	O
subsequent	O
diabetes	O
,	O
suggesting	O
that	O
genetic	O
factors	O
were	O
not	O
predominantly	O
responsible	B
for	O
the	O
difference	O
in	O
diabetes	O
incidence	O
.	O

Our	O
observations	O
took	O
place	O
at	O
the	O
end	O
of	O
the	O
neonatal	O
period	O
.	O

A	O
number	O
of	O
410	O
women	O
was	O
invited	O
to	O
participate	O
at	O
the	O
study	O
.	O

In	O
a	O
study	O
of	O
188	O
,	O
075	O
cases	O
,	O
significant	O
variations	O
of	O
semen	O
characteristics	O
have	O
been	O
observed	O
with	O
a	O
clear	O
improvement	O
of	O
sperm	O
morphology	O
in	O
August	O
[	O
62	O
].	O

The	O
cDNA	O
was	O
synthesized	O
using	O
the	O
High	O
Capacity	O
cDNA	O
Archive	O
Kit	O
in	O
the	O
ABI	O
(	O
Applied	O
Biosystems	O
Inc	O
,	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
)	O
Gene	O
Amp	O
PCR	O
System	O
2700	O
.	O

Information	O
about	O
the	O
quantity	O
of	O
vitamin	O
D	O
within	O
supplements	O
was	O
not	O
collected	O
.	O

Interestingly	O
,	O
there	O
were	O
consistent	O
positive	O
correlations	O
between	O
BW	O
with	O
parameters	O
of	O
the	O
time	O
domain	O
(	O
RMSSD	O
:	O
r	O
=	O
0	O
.	O
328	O
,	O
P	O
=	O
0	O
.	O
001	O
;	O
PNN50	O
:	O
r	O
=	O
0	O
.	O
386	O
,	O
P	O
=	O
0	O
.	O
001	O
)	O
(	O
Fig	O
2	O
)	O
and	O
frequency	O
domain	O
(	O
HF	O
:	O
r	O
=	O
0	O
.	O
332	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
(	O
Fig	O
3	O
),	O
suggesting	O
that	O
impaired	O
vagal	O
modulation	O
to	O
the	O
heart	O
in	O
children	O
is	O
influenced	O
by	O
low	O
birth	O
weight	O
.	O

The	O
primary	O
outcome	O
variable	O
was	O
a	O
composite	O
of	O
neonatal	O
hypoglycemia	O
,	O
respiratory	O
distress	O
,	O
need	O
for	O
phototherapy	O
,	O
birth	O
trauma	O
,	O
Apgar	O
score	O
less	O
than	O
7	O
,	O
or	O
prematurity	O
.	O

However	O
,	O
no	O
differences	O
were	O
noted	O
in	O
the	O
Crs	O
and	O
VmaxFRCbetween	O
the	O
two	O
groups	O
(	O
high	O
vs	O
.	O
low	O
:	O
Crs	O
,	O
97	O
.	O
5	O
±	O
28	O
.	O
6	O
vs	O
.	O
98	O
.	O
1	O
±	O
27	O
.	O
8	O
mL	O
/	O
kPa	O
;	O
VmaxFRC	O
,	O
191	O
±	O
90	O
vs	O
.	O
210	O
±	O
92	O
mL	O
/	O
s	O
).	O

Cold	O
stress	O
stimulates	O
lipolysis	O
by	O
increasing	O
the	O
secretion	O
of	O
stress	O
hormones	O
including	O
epinephrine	O
and	O
norepinephrine	O
in	O
humans	O
[	O
101	O
].	O

Prenatal	O
vitamin	O
D	O
inadequacy	O
has	O
been	O
hypothesized	O
as	O
a	O
risk	O
factor	O
for	O
pediatric	O
atopy	O
and	O
asthma	O
.	O

Survival	O
analysis	O
could	O
therefore	B
not	O
be	O
performed	O
,	O
as	B
time	O
to	O
event	O
data	O
were	O
missing	O
.	O

Several	O
studies	O
have	O
examined	O
factors	O
which	O
predict	O
failure	O
of	O
glyburide	O
to	O
achieve	O
adequate	O
glycemic	O
control	O
.	O

GDM	O
was	O
diagnosed	O
in	O
11	O
%	O
of	O
mothers	O
in	O
our	O
cohort	O
.	O

Statistical	O
analysis	O
Women	O
who	O
had	O
a	O
measurement	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
both	O
14	O
and	O
34	O
weeks	O
of	O
gestation	O
,	O
had	O
genetic	O
analysis	O
,	O
and	O
delivered	O
a	O
live	O
-	O
born	O
infant	O
were	O
included	O
in	O
the	O
analysis	O
.	O

All	O
TGs	O
cited	O
are	O
publically	O
available	O
from	O
the	O
OECD	O
website	O
(	O
http	O
://	O
www	O
.	O
oecd	O
-	O
ilibrary	O
.	O
org	O
/	O
environment	O
/	O
oecd	O
-	O
guidelines	O
-	O
for	O
-	O
the	O
-	O
testing	O
-	O
of	O
-	O
chemicals	O
-	O
section	O
-	O
4	O
-	O
health	O
-	O
effects_20745788	O
).	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
first	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

We	O
will	O
maintain	O
a	O
backup	O
copy	O
of	O
the	O
database	O
on	O
a	O
different	O
server	O
.	O

However	O
,	O
until	O
their	O
safety	O
in	O
pregnancy	O
can	O
be	O
clearly	O
established	O
,	O
the	O
initiation	O
of	O
long	O
-	O
acting	O
insulin	O
analog	O
therapy	O
in	O
women	O
with	O
GDM	O
cannot	O
be	O
recommended	O
.	O

Methods	O
Study	O
objects	O
Pregnant	O
women	O
in	O
middle	O
and	O
late	O
pregnancy	O
who	O
were	O
diagnosed	O
with	O
GDM	O
by	O
75	O
-	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
at	O
the	O
outpatient	O
nutrition	O
clinic	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
from	O
October	O
2013	O
to	O
July	O
2015	O
were	O
enrolled	O
in	O
this	O
study	O
.	O

APGAR	O
scores	O
were	O
0	O
,	O
4	O
,	O
and	O
7	O
at	O
one	O
,	O
five	O
,	O
and	O
ten	O
minutes	O
,	O
respectively	O
.	O

Thus	O
,	O
there	O
exists	O
a	O
near	O
-	O
global	O
public	O
health	O
policy	O
of	O
maternal	O
iron	O
supplementation	O
during	O
pregnancy	O
.	O

In	O
Models	O
1	O
and	O
4	O
),	O
higher	O
cathelicidin	O
concentrations	O
were	O
significantly	O
associated	O
with	O
male	O
gender	O
(	O
beta	O
=	O
0	O
.	O
318	O
,	O
p	O
=	O
0	O
.	O
047	O
),	O
indicating	O
that	O
after	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
model	O
,	O
males	O
’	O
cathelicidin	O
levels	O
were	O
1	O
.	O
4	O
times	O
higher	O
than	O
females	O
’.	O

In	O
addition	O
,	O
residual	O
confounding	O
due	O
to	O
genetic	O
backgrounds	O
could	O
not	O
be	O
excluded	O
,	O
although	O
we	O
controlled	O
some	O
important	O
potential	O
confounding	O
factors	O
.	O

Furthermore	O
,	O
while	O
multivitamin	O
intake	O
has	O
been	O
shown	O
to	O
vary	O
by	O
race	O
,	O
19it	O
remains	O
unknown	O
whether	O
multivitamin	O
intake	O
improves	O
vitamin	O
D	O
status	O
among	O
the	O
highest	O
risk	O
groups	O
(	O
African	O
Americans	O
and	O
overweight	O
/	O
obese	O
)	O
during	O
pregnancy	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Manitoba	O
’	O
s	O
Health	O
Research	O
Ethics	O
Board	O
,	O
the	O
Misericordia	O
Health	O
Centre	O
(	O
MHC	O
),	O
and	O
the	O
Health	O
Sciences	O
Centre	O
(	O
HSC	O
),	O
Winnipeg	O
,	O
Canada	O
.	O

Combined	O
with	O
other	O
experimental	O
findings	O
,	O
the	O
current	O
study	O
lends	O
further	O
credibility	O
to	O
the	O
notion	O
that	O
developmental	O
vitamin	O
D	O
deficiency	O
impacts	O
adversely	O
on	O
normal	O
brain	O
development	O
[	O
30	O
].	O

Mellin	O
’	O
s	O
Food	O
Company	O
On	O
the	O
other	O
hand	O
,	O
two	O
other	O
studies	O
found	O
no	O
association	O
between	O
DDE	O
/	O
DDT	O
and	O
shortened	O
lactation	O
time	O
.	O

Slaughter	O
age	O
IMF	O
content	O
increases	O
with	O
increasing	O
age	O
in	O
most	O
cattle	O
breeds	O
.	O

In	O
all	O
cases	O
,	O
multiple	O
comparisons	O
were	O
assessed	O
by	O
Bonferroni	O
post	O
-	O
hoc	O
test	O
.	O

An	O
alternative	O
hypothesis	O
,	O
which	O
has	O
received	O
less	O
attention	O
,	O
is	O
that	O
the	O
epidemic	O
of	O
asthma	O
and	O
atopy	O
in	O
the	O
West	O
could	O
partly	O
be	O
explained	O
by	O
an	O
increasing	O
dietary	O
intake	O
of	O
foods	O
and	O
constituents	O
which	O
may	O
be	O
harmful	O
.	O

PTB	O
rates	O
ranged	O
from	O
5	O
%	O
to	O
18	O
%	O
around	O
the	O
world	O
and	O
the	O
rate	O
in	O
the	O
United	O
States	O
was	O
disproportionately	O
high	O
(	O
12	O
%)	O
compared	O
to	O
other	O
developed	O
counties	O
[	O
1	O
].	O

Vitamin	O
C	O
Vitamin	O
C	O
can	O
be	O
synthesized	O
from	O
glucose	O
in	O
the	O
liver	O
of	O
many	O
mammalian	O
species	O
other	O
than	O
guinea	O
pigs	O
,	O
humans	O
,	O
and	O
other	O
primates	O
[	O
146	O
].	O

PubMed	O
Central	O
:	O

Thus	B
,	O
the	O
majority	B
of	O
whole	O
system	O
studies	O
have	O
been	O
performed	O
in	O
animal	O
models	O
,	O
predominantly	O
rodents	O
.	O

Thus	B
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	O
grow	O
continuously	O
even	O
though	O
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	O
slow	O
or	O
cease	O
.	O

It	O
is	O
noteworthy	O
,	O
however	O
,	O
that	O
complementary	O
researches	O
are	O
necessary	O
to	O
determine	O
the	O
mechanisms	O
involved	O
as	O
well	O
as	O
the	O
potential	O
influence	O
of	O
birth	O
weight	O
on	O
the	O
cardiac	O
autonomic	O
modulation	O
.	O

However	O
,	O
they	O
suggested	O
that	O
this	O
applied	O
only	O
in	O
developed	O
countries	O
and	O
when	O
no	O
adjustments	O
for	O
confounders	O
were	O
made	O
[	O
6	O
].	O

The	O
mean	O
body	O
weight	O
and	O
body	O
length	O
at	O
birth	O
were	O
3	O
.	O
0	O
±	O
0	O
.	O
6	O
kg	O
and	O
48	O
.	O
4	O
±	O
9	O
.	O
9	O
cm	O
respectively	O
.	O

In	O
a	O
recently	O
published	O
meta	O
-	O
analysis	O
,[	O
12	O
]	O
6	O
cohort	O
studies	O
evaluating	O
the	O
relationship	O
between	O
first	O
trimester	O
maternal	O
use	O
of	O
oral	O
corticosteroids	O
and	O
congenital	O
malformations	O
did	O
not	O
show	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
(	O
summary	O
odds	O
ratio	O
,	O
1	O
.	O
45	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
08	O
-	O
2	O
.	O
60	O
).	O

These	O
subjects	O
had	O
cathelicidin	O
values	O
of	O
737	O
.	O
5	O
,	O
2000	O
.	O
4	O
,	O
and	O
3368	O
.	O
6	O
ng	O
/	O
mL	O
,	O
while	O
the	O
next	O
highest	O
value	O
was	O
195	O
.	O
6	O
ng	O
/	O
mL	O
.	O

Statistical	O
Analyses	O
Statistical	O
analyses	O
were	O
carried	O
out	O
using	O
StatView	O
(	O
Version	O
5	O
,	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
)	O
statistical	O
packages	O
.	O

So	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
.	O

There	O
are	O
a	O
number	O
of	O
limitations	O
inherent	O
in	O
the	O
design	O
of	O
the	O
present	O
study	O
that	O
should	O
be	O
acknowledged	O
.	O

Newborn	O
head	O
circumference	O
was	O
larger	O
in	O
those	O
with	O
suboptimal	O
UBC	O
25	O
(	O
OH	O
)	O
D	O
compared	O
with	O
mothers	O
with	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
003	O
).	O

Discussion	O
These	O
data	O
demonstrate	O
that	O
intrauterine	O
,	O
lactational	O
and	O
post	O
-	O
weaning	O
nutritional	O
histories	O
make	O
differential	O
contributions	O
to	O
the	O
age	O
of	O
puberty	O
in	O
the	O
female	O
rat	O
,	O
and	O
lead	O
to	O
persistent	O
effects	O
on	O
ovarian	O
function	O
extending	O
into	O
adulthood	O
.	O

There	O
are	O
also	O
several	O
evidences	O
regarding	O
the	O
association	O
between	O
the	O
impaired	O
growth	O
indices	O
at	O
birth	O
and	O
increased	O
risk	O
of	O
developing	O
some	O
chronic	O
disorders	O
such	O
as	O
obesity	O
,	O
diabetes	O
[	O
5	O
],	O
cardiovascular	O
diseases	O
[	O
5	O
],	O
endothelial	O
dysfunction	O
[	O
6	O
],	O
nonalcoholic	O
fatty	O
liver	O
disease	O
[	O
7	O
],	O
and	O
chronic	O
kidney	O
disease	O
[	O
8	O
].	O

Authors	O
'	O
contributions	O
Each	O
author	O
was	O
involved	O
in	O
all	O
aspects	O
of	O
study	O
design	O
,	O
data	O
interpretation	O
and	O
manuscript	O
preparation	O
.	O

The	O
study	O
is	O
a	O
randomized	O
controlled	O
clinical	O
trial	O
with	O
the	O
follow	O
-	O
up	O
period	O
of	O
three	O
months	O
after	O
delivery	O
in	O
48	O
women	O
with	O
GDM	O
.	O

Mechanisms	O
leading	O
to	O
aortic	O
dissection	O
involve	O
a	O
weakening	O
of	O
the	O
layers	O
of	O
the	O
aorta	O
allowing	O
blood	O
to	O
enter	O
the	O
media	O
and	O
separate	O
the	O
intimal	O
and	O
adventitial	O
layers	O
creating	O
a	O
false	O
lumen	O
.	O

Visfatin	O
as	O
a	O
predictor	O
for	O
growth	O
of	O
fetus	O
and	O
infant	O
Abstract	O
Objective	O
:	O
Visfatin	O
is	O
an	O
adipocytokine	O
that	O
functions	O
as	O
an	O
enzyme	O
and	O
a	O
growth	O
factor	O
to	O
investigate	O
the	O
relationship	O
between	O
serum	O
visfatin	O
and	O
the	O
fetus	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

Contact	O
with	O
allergens	O
during	O
early	O
childhood	O
may	O
enhance	O
the	O
risk	O
of	O
developing	O
allergies	O
later	O
in	O
life	O
,	O
especially	O
in	O
individuals	O
with	O
a	O
predisposition	O
for	O
atopic	O
and	O
allergic	O
conditions	O
[	O
51	O
,	O
55	O
].	O

Although	O
previously	O
suggested	O
that	O
pregnant	O
women	O
with	O
risks	O
avoid	O
peanuts	O
,	O
a	O
subsequent	O
study	O
found	O
no	O
evidence	O
of	O
prenatal	O
sensitization	O
from	O
maternal	O
consumption	O
of	O
peanuts	O
[	O
100	O
].	O

Many	O
women	O
who	O
gestate	O
through	O
a	O
typical	O
winter	O
in	O
the	O
northern	O
hemisphere	O
are	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
4	O
,	O
5	O
].	O

INTRODUCTION	O
Intramuscular	O
fat	O
(	O
IMF	O
)	O
deposition	O
or	O
marbling	O
in	O
muscle	O
including	O
the	O
longissimus	O
thoracis	O
et	O
lumborum	O
,	O
infraspinatus	O
,	O
and	O
biceps	O
femoris	O
,	O
especially	O
in	O
Korean	O
cattle	O
(	O
also	O
called	O
Hanwoo	O
)	O
and	O
Japanese	O
Black	O
cattle	O
,	O
is	O
one	O
of	O
the	O
most	O
important	O
traits	O
influencing	O
beef	O
quality	O
and	O
palatability	O
attributes	O
.	O

Conclusions	O
High	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
was	O
shown	O
to	O
be	O
protective	O
against	O
the	O
development	O
of	O
GDM	O
.	O

A	O
cohort	O
study	O
on	O
the	O
Isle	O
of	O
Wight	O
,	O
United	O
Kingdom	O
,	O
found	O
adverse	O
reactions	O
to	O
food	O
in	O
approximately	O
20	O
%	O
of	O
969	O
pregnant	O
women	O
[	O
38	O
].	O

Materials	O
and	O
methods	O
Cross	O
-	O
sectional	O
study	O
of	O
76	O
pregnant	O
women	O
who	O
were	O
referred	O
to	O
a	O
multidisciplinary	O
clinic	O
for	O
high	O
risk	O
pregnancies	O
,	O
in	O
a	O
tertiary	O
hospital	O
in	O
southern	O
Brazil	O
,	O
at	O
the	O
time	O
of	O
GDM	O
diagnosis	O
.	O

Therefore	B
,	O
strategies	O
that	O
up	O
-	O
regulate	O
both	O
hyperplasia	O
and	O
hypertrophy	O
of	O
fat	O
cells	O
are	O
effective	O
ways	O
to	O
improve	O
IMF	O
deposition	O
.	O

Twelve	O
weeks	O
after	O
the	O
administration	O
of	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
this	O
figure	O
was	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
.	O

On	O
a	O
broader	O
scale	O
the	O
reduced	O
capacity	O
for	O
work	O
and	O
education	O
due	B
to	I
anaemia	O
and	O
iron	O
deficiency	O
can	O
adversely	O
impact	O
a	O
population	O
'	O
s	O
social	O
and	O
economic	O
development	O
[	O
6	O
].	O

Polycystic	O
Ovary	O
Syndrome	O
PCOS	O
is	O
the	O
most	O
often	B
diagnosed	O
endocrinological	O
disorder	O
in	O
women	O
in	O
their	O
reproductive	O
period	O
,	O
affecting	B
15	O
%–	O
20	O
%	O
of	O
population	O
,	O
according	O
to	O
the	O
European	O
Society	O
for	O
Human	O
Reproduction	O
and	O
Embryology	O
standards	O
[	O
21	O
].	O

Urine	O
Measurement	O
Urine	O
samples	O
were	O
taken	O
at	O
6	O
months	O
of	O
age	O
,	O
during	O
the	O
week	O
before	O
euthanasia	O
.	O

found	O
that	O
the	O
length	O
of	O
breastfeeding	O
influenced	O
whether	O
a	O
significant	O
difference	O
was	O
found	O
in	O
offspring	O
neurodevelopment	O
when	O
comparing	O
high	O
and	O
low	O
fish	O
intakes	O
during	O
pregnancy	O
[	O
24	O
].	O

While	O
SGAs	O
readily	O
cross	O
the	O
placenta	O
,	O
14the	O
existing	O
studies	O
that	O
have	O
investigated	O
the	O
reproductive	O
safety	O
of	O
these	O
agents	O
did	O
not	O
reach	O
conclusive	O
results	O
due	O
to	O
the	O
methodological	O
limitations	O
,	O
small	O
sample	O
sizes	O
and	O
failure	O
to	O
assess	O
SGAs	O
in	O
monotherapy	O
.	O

Details	O
of	O
assay	O
performance	O
and	O
quality	O
control	O
through	O
participation	O
in	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
,	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
,	O
and	O
UK	O
National	O
External	O
Quality	O
Assessment	O
Service	O
are	O
given	O
elsewhere	O
(	O
15	O
,	O
16	O
).	O

Maternal	O
fatigue	O
is	O
assessed	O
at	O
the	O
same	O
time	O
points	O
using	O
the	O
Multidimensional	O
Assessment	O
of	O
Fatigue	O
(	O
MAF	O
)	O
scale	O
,	O
which	O
was	O
shown	O
to	O
be	O
a	O
reliable	O
and	O
valid	O
measure	O
of	O
fatigue	O
in	O
pregnant	O
and	O
postpartum	O
women	O
[	O
53	O
].	O

This	O
system	O
will	O
allow	O
the	O
field	O
supervisors	O
to	O
monitor	O
the	O
performance	O
of	O
individual	O
data	O
collectors	O
.	O

Conventional	O
dietary	O
sources	O
of	O
α	O
-	O
linolenic	O
acid	O
are	O
rapeseed	O
oil	O
,	O
soy	O
oil	O
,	O
dark	O
green	O
leafy	O
vegetables	O
,	O
flax	O
seed	O
,	O
walnuts	O
and	O
soy	O
beans	O
.	O

After	O
adjustments	O
(	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
),	O
no	O
significant	O
interactions	O
were	O
observed	O
in	O
normal	O
weight	O
or	O
overweight	O
/	O
obese	O
mothers	O
(	O
data	O
not	O
shown	O
).	O

Introduction	O
Vitamin	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
))	O
is	O
commonly	O
known	O
for	O
its	O
role	O
in	O
calcium	O
metabolism	O
and	O
bone	O
health	O
,	O
but	O
more	O
recently	O
has	O
gained	O
attention	O
for	O
the	O
significant	O
role	O
it	O
plays	O
in	O
pregnancy	O
and	O
perinatal	O
outcomes	O
.	O

Also	O
,	O
mothers	O
felt	O
that	O
the	O
neonatal	O
period	O
is	O
a	O
particularly	O
busy	O
time	O
,	O
with	O
increased	O
childcare	O
responsibilities	O
and	O
sometimes	O
increased	O
housework	O
,	O
which	O
interfere	O
with	O
her	O
ability	O
to	O
wash	O
hands	O
even	O
when	O
she	O
feels	O
she	O
should	O
[	O
13	O
].	O

However	O
,	O
in	O
Cameroon	O
,	O
MMR	O
has	O
risen	O
by	O
8	O
%	O
from	O
680	O
to	O
872	O
deaths	O
per	O
100	O
000	O
in	O
the	O
past	O
9	O
years	O
after	O
the	O
initial	O
decrease	O
[	O
3	O
].	O

However	O
,	O
BHLM	O
examines	O
the	O
average	O
effect	O
of	O
EDC	O
exposure	O
on	O
birth	O
weight	O
at	O
the	O
class	O
level	O
using	O
the	O
parameter	O
μβ	O
,	O
which	O
is	O
less	O
susceptible	O
to	O
random	O
variation	O
[	O
32	O
].	O

Mice	O
were	O
outcrossed	O
to	O
DBA	O
/	O
2J	O
at	O
the	O
first	O
generation	O
(	O
G1	O
)	O
to	O
facilitate	O
mapping	O
using	O
a	O
panel	O
of	O
markers	O
polymorphic	O
between	O
129S1	O
and	O
DBA	O
/	O
2J	O
strains	O
,	O
and	O
second	O
generation	O
(	O
G2	O
)	O
progeny	O
were	O
backcrossed	O
to	O
G1	O
mice	O
to	O
generate	O
homozygosity	O
.	O

We	O
did	O
not	O
observe	O
an	O
overall	O
association	O
between	O
any	O
attribute	O
-	O
defined	O
gene	O
-	O
associated	O
class	O
methylation	O
and	O
LINE	O
-	O
1	O
methylation	O
levels	O
.	O

The	O
genes	O
underlying	O
these	O
new	O
ENU	O
-	O
derived	O
mutants	O
have	O
previously	O
been	O
associated	O
with	O
skeletal	O
abnormalities	O
in	O
both	O
mice	O
and	O
humans	O
,	O
and	O
thus	B
serve	O
as	B
excellent	O
tools	O
for	O
the	O
study	O
of	O
the	O
human	O
skeleton	O
and	O
its	O
development	O
.	O

[	O
44	O
]	O
Although	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
is	O
the	O
active	O
circulating	O
form	O
of	O
vitamin	O
D	O
,	O
measuring	O
this	O
level	O
is	O
not	O
helpful	O
because	O
it	O
is	O
quickly	O
and	O
tightly	O
regulated	O
by	O
the	O
kidney	O
.	O

The	O
primary	O
known	O
action	O
of	O
vasopressinase	O
is	O
in	O
vivo	O
as	O
well	O
as	O
in	O
vitro	O
degradation	O
of	O
vasopressin	O
by	O
removing	O
amino	O
acids	O
from	O
the	O
N	O
-	O
terminus	O
.	O

Height	O
was	O
also	O
examined	O
for	O
comparative	O
purposes	O
.	O

Results	O
Mean	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
all	O
women	O
was	O
68	O
.	O
1	O
±	O
27	O
.	O
1	O
nmol	O
/	O
L	O
and	O
28	O
%	O
(	O
n	O
=	O
772	O
)	O
were	O
considered	O
vitamin	O
D	O
deficient	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

2009	O
).	O

Latitude	O
is	O
an	O
important	O
determinant	O
of	O
vitamin	O
D	O
status	O
since	O
the	O
amount	O
of	O
UVB	O
that	O
penetrates	O
the	O
earth	O
'	O
s	O
surface	O
decreases	O
markedly	O
with	O
increasing	O
latitude	O
[	O
8	O
].	O

The	O
mean	O
levels	O
of	O
vitamin	O
D	O
in	O
the	O
case	O
group	O
for	O
deficient	O
,	O
insufficient	O
and	O
normal	O
categories	O
were	O
13	O
.	O
78	O
,	O
49	O
.	O
14	O
,	O
and	O
116	O
.	O
81	O
,	O
respectively	O
and	O
these	O
numbers	O
for	O
control	O
group	O
were	O
17	O
.	O
44	O
,	O
53	O
.	O
34	O
,	O
and	O
93	O
.	O
97	O
,	O
respectively	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
Relative	O
expression	O
of	O
the	O
genes	O
of	O
interest	O
was	O
assessed	O
by	O
quantitative	O
PCR	O
(	O
Q	O
-	O
PCR	O
)	O
on	O
an	O
ABI	O
Prism	O
7900HT	O
Sequence	O
detection	O
system	O
(	O
Applied	O
Biosystems	O
)	O
using	O
SYBR	O
Green	O
-	O
PCR	O
reaction	O
mixture	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
)	O
and	O
specific	O
primers	O
(	O
Table	O
1	O
)	O
as	O
previously	O
described	O
[	O
14	O
].	O

Furthermore	O
,	O
instead	O
of	O
measuring	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
both	O
KOALA	O
and	O
Canadian	O
studies	O
determined	O
the	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
during	O
preschool	O
or	O
school	O
age	O
.	O

Consequences	O
in	O
newborns	O
are	O
low	O
birth	O
weight	O
,	O
neonatal	O
rickets	O
,	O
a	O
risk	O
of	O
neonatal	O
hypocalcaemia	O
,	O
asthma	O
and	O
/	O
or	O
type	O
1	O
diabetes	O
.	O

Our	O
findings	O
suggest	O
that	O
an	O
adequate	O
maternal	O
vitamin	O
status	O
have	O
been	O
achieved	O
in	O
Finland	O
.	O

When	O
dealing	O
with	O
MTC	O
,	O
we	O
should	O
always	O
bear	O
in	O
mind	O
that	O
these	O
patients	O
may	O
be	O
the	O
index	O
-	O
case	O
for	O
one	O
of	O
the	O
familial	O
forms	O
of	O
the	O
disease	O
:	O
presymptomatic	O
screening	O
of	O
relatives	O
of	O
MTC	O
patients	O
enables	O
early	O
diagnosis	O
of	O
this	O
malignancy	O
.	O

Association	O
of	O
SNPs	O
With	O
Achieved	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
Weeks	O
of	O
Gestation	O
Following	O
Supplementation	O
With	O
1000	O
IU	O
/	O
d	O
Cholecalciferol	O
in	O
PregnancySNPReference	O
AlleleCommon	O
AlleleUnivariateAdjustedaCorrected	O
P	O
Valuebnβ	O
(	O
95	O
%	O
CI	O
)	O
P	O
Valuenβ	O
(	O
95	O
%	O
CI	O
)	O
P	O
Value	O
rs12785878	O
(	O
DHCR7	O
)	O
GT3282	O
.	O
6	O
(−	O
1	O
.	O
4	O
to	O
6	O
.	O
5	O
)	O
0	O
.	O
203040	O
.	O
3	O
(−	O
3	O
.	O
5	O
to	O
4	O
.	O
0	O
)	O
0	O
.	O
891	O
.	O
0rs10741657	O
(	O
CYP2R1	O
)	O
AG328	O
−	O
4	O
.	O
8	O
(−	O
8	O
.	O
0	O
to	O
−	O
1	O
.	O
6	O
)	O
0	O
.	O
004304	O
−	O
5	O
.	O
2	O
(−	O
8	O
.	O
2	O
to	O
−	O
2	O
.	O
2	O
)	O
0	O
.	O
0010	O
.	O
004rs6013897	O
(	O
CYP24A1	O
)	O
AT325	O
−	O
3	O
.	O
2	O
(−	O
7	O
.	O
1	O
to	O
0	O
.	O
8	O
)	O
0	O
.	O
11301	O
−	O
1	O
.	O
0	O
(−	O
4	O
.	O
8	O
to	O
2	O
.	O
8	O
)	O
0	O
.	O
601	O
.	O
0rs2282679	O
(	O
GC	O
)	O
CA3294	O
.	O
3	O
(	O
0	O
.	O
9	O
to	O
7	O
.	O
7	O
)	O
0	O
.	O
013054	O
.	O
2	O
(	O
0	O
.	O
9	O
to	O
7	O
.	O
5	O
)	O
0	O
.	O
010	O
.	O
04	O
The	O
homozygous	O
low	O
frequency	O
gene	O
variant	O
was	O
used	O
as	O
the	O
reference	O
group	O
.	O

All	O
the	O
mothers	O
completed	O
a	O
questionnaire	O
pertaining	O
to	O
their	O
diet	O
in	O
the	O
12	O
months	O
prior	O
to	O
pregnancy	O
.	O

Additionally	O
,	O
LINE1	O
,	O
AluYb8	O
,	O
and	O
specific	O
array	O
-	O
based	O
methylation	O
loci	O
often	O
interrogate	O
different	O
genetic	O
regions	O
;	O
therefore	O
,	O
their	O
methylation	O
may	O
have	O
a	O
differential	O
genomic	O
impact	O
.	O

This	O
raises	O
the	O
possibility	O
that	O
,	O
in	O
contrast	O
to	O
its	O
beneficial	O
effects	O
on	O
peripheral	O
metabolism	O
,	O
FGF21	O
may	O
exert	O
deleterious	O
effects	O
by	O
acting	O
centrally	O
.	O

We	O
aimed	O
to	O
study	O
the	O
relationship	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
and	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
population	O
-	O
based	O
birth	O
cohort	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
.	O

All	O
covariate	O
data	O
were	O
collected	O
from	O
a	O
structured	O
inpatient	O
medical	O
record	O
review	O
.	O

Differential	O
Expression	O
of	O
Placental	O
Glucocorticoid	O
Receptors	O
and	O
Growth	O
Arrest	O
-	O
Specific	O
Transcript	O
5	O
in	O
Term	O
and	O
Preterm	O
Pregnancies	O
:	O
Evidence	O
for	O
Involvement	O
of	O
Maternal	O
Stress	O
Abstract	O
Pregnancy	O
-	O
specific	O
stress	O
predicts	O
birth	O
outcomes	O
.	O

Correlation	O
of	O
offspring	O
'	O
s	O
height	O
with	O
those	O
of	O
the	O
mother	O
and	O
father	O
increased	O
with	O
age	O
.	O

Full	O
adherence	O
may	O
have	O
resulted	O
in	O
even	O
greater	O
changes	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Association	O
of	O
LINE	O
-	O
1	O
(	O
A	O
)	O
and	O
AluYb8	O
(	O
B	O
)	O
methylation	O
with	O
mean	O
RPMM	O
class	O
methylation	O
.	O

Due	O
to	O
the	O
high	O
prevalence	O
of	O
HIV	O
in	O
the	O
country	O
(	O
36	O
%	O
of	O
women	O
aged	O
30	O
–	O
34	O
years	O
[	O
31	O
]),	O
their	O
inclusion	O
will	O
make	O
generalisation	O
to	O
the	O
wider	O
South	O
African	O
population	O
a	O
possibility	O
.	O

Patients	O
’	O
vitamin	O
D	O
status	O
was	O
determined	O
by	O
measuring	O
serum	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
concentration	O
.	O

Compared	O
to	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
summer	O
,	O
extended	O
winter	O
was	O
associated	O
with	O
increased	O
HOMA	O
-	O
IR	O
in	O
early	O
-	O
pregnancy	O
(	O
46	O
.	O
7	O
%)	O
and	O
late	O
pregnancy	O
(	O
53	O
.	O
7	O
%),	O
independent	O
of	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
confounders	O
.	O

Differences	O
between	O
male	O
and	O
female	O
offspring	O
(	O
CC	O
)	O
were	O
also	O
observed	O
.	O

Postnatal	O
data	O
are	O
collected	O
at	O
the	O
Empilweni	O
Services	O
and	O
Research	O
Unit	O
(	O
ESRU	O
)	O
at	O
RMMCH	O
.	O

In	O
contrast	O
to	O
infants	O
born	O
vaginally	O
,	O
maternal	O
dietary	O
fish	O
and	O
seafood	O
were	O
positively	O
associated	O
with	O
OTUs	O
in	O
the	O
genus	O
Bacteroides	O
including	O
the	O
species	O
B	O
.	O
uniformis	O
and	O
negatively	O
associated	O
with	O
OTUs	O
in	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
other	O
OTUs	O
of	O
the	O
Streptococcus	O
genus	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5c	O
).	O

In	O
one	O
of	O
the	O
publications	O
,	O
it	O
was	O
also	O
found	O
that	O
vitamin	O
D	O
binding	O
protein	O
(	O
VDBP	O
)	O
has	O
a	O
molecular	O
similarity	O
to	O
anti	O
-	O
sperm	O
antibodies	O
,	O
and	O
another	O
one	O
concluded	O
that	O
both	O
low	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
high	O
(>	O
125	O
nmol	O
/	O
L	O
)	O
concentration	O
of	O
vitamin	O
D	O
are	O
associated	O
with	O
decreased	O
number	O
and	O
quality	O
of	O
spermatozoa	O
in	O
semen	O
.	O

When	O
examined	O
by	O
gender	O
,	O
girls	O
were	O
only	O
weakly	O
correlated	O
with	O
the	O
mother	O
,	O
but	O
with	O
boys	O
the	O
correlation	O
was	O
much	O
stronger	O
.	O

Moreover	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
the	O
expression	O
of	O
GAS5	O
in	O
human	O
placentas	O
.	O

Our	O
previous	O
study	O
showed	O
the	O
possible	O
involvement	O
of	O
DNA	O
methylation	O
in	O
regulating	O
tissue	O
-	O
specific	O
expression	O
of	O
PPARG	O
gene	O
in	O
IMF	O
and	O
muscle	O
of	O
beef	O
cattle	O
[	O
6	O
].	O

However	O
,	O
it	O
is	O
likely	B
that	O
by	O
three	O
months	O
of	O
age	O
,	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
in	O
calcium	O
absorption	O
,	O
especially	O
in	O
breast	O
-	O
fed	O
infants	O
with	O
a	O
relatively	O
low	O
calcium	O
intake	O
compared	O
to	O
formula	O
-	O
fed	O
infants	O
.	O

Another	O
independent	O
determinant	O
of	O
offspring	O
weight	O
status	O
is	O
gestational	O
weight	O
gain	O
(	O
GWG	O
).	O

According	O
to	O
the	O
current	O
staging	O
score	O
,	O
DTCs	O
of	O
any	O
dimension	O
,	O
even	O
with	O
nodal	O
invasion	O
,	O
for	O
patients	O
below	O
45	O
years	O
of	O
age	O
,	O
are	O
classified	O
as	B
Stage	O
I	O
tumours	O
,	O
and	O
usually	O
pregnant	O
patients	O
are	O
below	O
45	O
years	O
of	O
age	O
.	O

This	O
provided	O
a	O
broad	O
yet	O
manageable	O
sample	O
frame	O
from	O
within	O
the	O
original	O
trial	O
cohort	O
,	O
given	O
the	O
logistical	O
constraints	O
under	O
which	O
the	O
current	O
study	O
was	O
carried	O
out	O
.	O

Calcitonin	O
is	O
the	O
most	O
clinically	O
useful	O
biochemical	O
marker	O
for	O
these	O
tumours	O
,	O
and	O
C	O
cell	O
hyperplasia	O
represents	O
a	O
pre	O
-	O
cancerous	O
stage	O
.	O

Scanning	O
densitometry	O
of	O
the	O
bands	O
corresponding	O
to	O
GR	O
α	O
/	O
β	O
normalized	O
over	O
GAPDH	O
revealed	O
no	O
apparent	O
differences	O
in	O
the	O
expression	O
of	O
these	O
variants	O
between	O
the	O
term	O
and	O
the	O
preterm	O
groups	O
(	O
Figure	O
1	O
(	O
b	O
)).	O

Control	O
□	O
group	O
;	O
■	O
Intervention	O
group	O
.	O

However	O
,	O
most	O
of	O
the	O
evidence	O
is	O
from	O
observational	O
epidemiological	O
studies	O
except	O
for	O
a	O
very	O
few	O
randomised	O
controlled	O
trials	O
.	O

Maternal	O
skin	O
prick	O
tests	O
are	O
performed	O
by	O
a	O
medical	O
doctor	O
according	O
to	O
the	O
procedure	O
described	O
in	O
the	O
Allergy	O
Society	O
of	O
South	O
Africa	O
’	O
s	O
position	O
statement	O
on	O
skin	O
prick	O
testing	O
[	O
49	O
].	O

The	O
correlation	O
coefficient	O
between	O
the	O
results	O
for	O
the	O
two	O
machines	O
was	O
0	O
.	O
96	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
addition	O
,	O
for	O
certain	O
reasons	O
,	O
a	O
substantial	O
proportion	O
(	O
20	O
%	O
to	O
80	O
%)	O
of	O
pregnant	O
women	O
in	O
these	O
settings	O
make	O
their	O
first	O
antenatal	O
visit	O
in	O
their	O
third	O
trimester	O
[	O
54	O
–	O
56	O
].	O

Marbling	O
adipocytes	O
are	O
also	O
found	O
within	O
muscle	O
bundles	O
in	O
the	O
longissimus	O
dorsi	O
muscle	O
(	O
LM	O
)	O
of	O
high	O
-	O
quality	O
grade	O
Japanese	O
Black	O
cattle	O
[	O
5	O
].	O

The	O
level	O
of	O
significance	O
will	O
be	O
set	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Data	O
was	O
expressed	O
as	O
percent	O
of	O
subjects	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

Materials	O
and	O
Methods	O
Program	O
implementation	O
,	O
compliance	O
and	O
impact	O
assessment	O
In	O
May	O
2006	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
(	O
NIMPE	O
)	O
and	O
partners	O
introduced	O
a	O
pilot	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
periodic	O
de	O
-	O
worming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
province	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Tarbiat	O
Modares	O
University	O
(	O
registration	O
number	O
:	O
IR	O
.	O
TMU	O
.	O
REC	O
.	O
1394	O
.	O
120	O
).	O

p	O
Values	O
are	O
denoted	O
by	O
p	O
,	O
and	O
p	O
values	O
less	O
than	O
0	O
.	O
05	O
are	O
regarded	O
as	O
statistically	O
significant	O
.	O

Cluster	O
1	O
is	O
the	O
reference	O
group	O
.	O

In	O
an	O
attempt	O
to	O
mimic	O
moderate	O
and	O
high	O
stress	O
environment	O
in	O
vitro	O
,	O
BeWo	O
and	O
JEG	O
-	O
3	O
cytotrophoblast	O
cell	O
lines	O
were	O
treated	O
with	O
10	O
nM	O
–	O
1000	O
nM	O
cortisol	O
.	O

This	O
combination	O
of	O
interactive	O
pathways	O
helps	O
to	O
confer	O
efficiency	O
,	O
redundancy	O
,	O
robustness	O
and	O
fidelity	O
onto	O
epigenetic	O
re	O
-	O
programing	O
/	O
programing	O
during	O
development	O
,	O
and	O
thus	O
the	O
successful	O
and	O
continued	O
production	O
of	O
multiple	O
generations	O
.	O

In	O
particular	O
,	O
the	O
low	O
protein	O
diet	O
provides	O
a	O
model	O
for	O
prenatal	O
dietary	O
undersupply	O
and	O
exposure	O
to	O
famine	O
that	O
regrettably	O
still	O
burdens	O
a	O
considerable	O
proportion	O
of	O
the	O
human	O
population	O
.	O

Vitamin	O
C	O
,	O
which	O
is	O
mostly	O
found	O
in	O
seasonal	O
fruits	O
and	O
vegetables	O
,	O
can	O
react	O
with	O
and	O
then	O
inhibit	O
nitrite	O
formation	O
of	O
nitrosamines	O
[	O
163	O
].	O

Eligible	O
women	O
were	O
contacted	O
to	O
arrange	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
their	O
child	O
,	O
either	O
at	O
the	O
hospital	O
of	O
their	O
birth	O
,	O
or	O
if	O
more	O
convenient	O
,	O
for	O
a	O
research	O
assistant	O
to	O
visit	O
their	O
home	O
.	O

Most	O
(	O
63	O
.	O
1	O
%,	O
595	O
/	O
943	O
)	O
reported	O
currently	O
attending	O
school	O
or	O
working	O
outside	O
of	O
the	O
home	O
.	O

Currently	O
,	O
the	O
ICDS	O
scheme	O
symbolizes	O
one	O
of	O
the	O
most	O
extensive	O
and	O
the	O
unique	O
initiative	O
for	O
safeguarding	O
early	O
childhood	O
development	O
,	O
catering	O
to	O
more	O
than	O
100	O
million	O
under	O
-	O
six	O
year	O
children	O
under	O
the	O
different	O
provisions	O
available	O
in	O
the	O
scheme	O
(	O
2	O
).	O

On	O
the	O
other	O
hand	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
for	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

The	O
pathogenesis	O
of	O
AAOC	O
remains	O
unclear	O
.	O

Community	O
antenatal	O
and	O
paediatric	O
clinics	O
,	O
which	O
often	O
already	O
serve	O
these	O
populations	O
,	O
can	O
readily	O
be	O
used	O
to	O
identify	O
those	O
at	O
particular	O
risk	O
on	O
finger	O
-	O
prick	O
testing	O
and	O
target	O
them	O
for	O
supplementation	O
.	O

While	O
the	O
initial	O
drugs	O
,	O
now	O
referred	O
to	O
as	O
first	O
-	O
generation	O
antipsychotics	O
(	O
FGAs	O
),	O
demonstrated	O
a	O
profound	O
effect	O
on	O
treatment	O
outcomes	O
,	O
this	O
group	O
of	O
medications	O
is	O
not	O
only	O
associated	O
with	O
serious	O
extrapyramidal	O
complications	O
,	O
but	O
is	O
also	O
known	O
to	O
induce	O
hyperprolactinaemia	O
and	O
to	O
affect	O
fertility	O
.	O

On	O
the	O
other	O
hand	O
,	O
liver	O
dysfunction	O
in	O
patients	O
with	O
HELLP	O
syndrome	O
decreases	O
the	O
degradation	O
of	O
the	O
vasopressinase	O
as	O
described	O
by	O
Ellidokuz	O
et	O
al	O
.	O

The	O
patients	O
were	O
randomly	O
assigned	O
into	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
).	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
CCM	O
KW	O
SP	O
EM	O
.	O

It	O
closely	O
resembles	O
other	O
benign	O
lesions	O
such	O
as	O
PG	O
.	O

Furthermore	O
,	O
they	O
are	O
more	O
sensitive	O
to	O
airborne	O
chemicals	O
since	O
their	O
resting	O
air	O
intake	O
is	O
about	O
twice	O
that	O
of	O
an	O
adult	O
[	O
34	O
].	O

The	O
association	O
between	O
fish	O
,	O
fatty	O
acids	O
or	O
vitamin	O
D	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risk	O
ratios	O
(	O
RRRs	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
,	O
and	O
it	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
(	O
polytomous	O
logistic	O
regression	O
),	O
for	O
example	O
:	O
RRR	O
=	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
no	O
fish	O
intake	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
no	O
fish	O
intake	O
).	O

After	O
three	O
washes	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
the	O
nitrocellulose	O
membranes	O
were	O
incubated	O
with	O
primary	O
antibodies	O
against	O
GR	O
α	O
/	O
β	O
(	O
Abcam	O
,	O
ab3580	O
,	O
UK	O
)	O
and	O
GAPDH	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
).	O

The	O
present	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
with	O
the	O
ethics	O
code	O
93	O
–	O
7212	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
association	O
between	O
the	O
intake	O
of	O
different	O
fish	O
species	O
,	O
PUFA	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
population	O
-	O
based	O
study	O
among	O
Swedish	O
women	O
.	O

In	O
this	O
study	O
using	O
C57BL	O
/	O
6	O
male	O
mice	O
,	O
stress	O
induced	O
GAS5	O
RNA	O
levels	O
in	O
the	O
hippocampus	O
and	O
this	O
increase	O
was	O
accompanied	O
by	O
a	O
rise	O
of	O
corticosterone	O
levels	O
[	O
22	O
].	O

Blood	O
pressure	O
increased	O
continually	O
from	O
3	O
to	O
6	O
months	O
of	O
age	O
in	O
both	O
groups	O
.	O

An	O
important	O
limitation	O
of	O
this	O
study	O
is	O
that	O
we	O
measured	O
dietary	O
intake	O
only	O
once	O
,	O
involving	O
misclassification	O
among	O
those	O
who	O
changed	O
their	O
dietary	O
pattern	O
during	O
follow	O
-	O
up	O
.	O

The	O
prevalence	O
of	O
gestational	O
diabetes	O
diagnosed	O
on	O
1	O
-	O
h	O
OGTT	O
result	O
was	O
45	O
%	O
higher	O
in	O
November	O
(	O
summer	O
)	O
and	O
46	O
%	O
lower	O
in	O
July	O
(	O
winter	O
)	O
than	O
the	O
overall	O
prevalence	O
,	O
however	O
,	O
diagnoses	O
based	O
on	O
fasting	O
glucose	O
concentrations	O
were	O
similar	O
across	O
the	O
year	O
.	O

It	O
is	O
possible	O
that	O
this	O
change	O
of	O
relative	O
transcript	O
abundance	O
ratio	O
might	O
be	O
involved	O
in	O
the	O
correlation	O
between	O
negative	O
maternal	O
attitudes	O
(	O
hence	B
highly	O
stressed	O
)	O
and	O
fetal	O
birth	O
weight	O
.	O

None	O
of	O
the	O
pregnant	O
women	O
in	O
our	O
study	O
received	O
insulin	O
therapy	O
nor	O
other	O
regular	O
medication	O
,	O
but	O
mothers	O
with	O
GDM	O
obtained	O
dietary	O
counselling	O
at	O
community	O
prenatal	O
clinics	O
[	O
19	O
].	O

It	O
is	O
well	O
recognised	O
that	O
a	O
woman	O
’	O
s	O
nutrition	O
during	O
pregnancy	O
impacts	O
pregnancy	O
and	O
birth	O
outcomes	O
,	O
with	O
the	O
intra	O
-	O
uterine	O
environment	O
playing	O
a	O
key	O
role	O
in	O
an	O
individual	O
’	O
s	O
later	O
health	O
and	O
disease	O
[	O
3	O
].	O

[	O
3	O
]	O
A	O
fatal	O
case	O
of	O
biphasic	O
wheezing	O
in	O
an	O
infant	O
attributed	O
to	O
hypocalcemia	O
has	O
been	O
described	O
in	O
literature	O
.	O

Linear	O
models	O
suggested	O
additional	O
associations	O
between	O
maternal	O
diet	O
and	O
infant	O
intestinal	O
microbes	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

Potential	O
for	O
lives	O
saved	O
To	O
understand	O
the	O
impact	O
of	O
evidence	O
-	O
based	O
interventions	O
on	O
deaths	O
due	O
to	O
complications	O
of	O
preterm	O
birth	O
,	O
we	O
considered	O
analyses	O
including	O
historical	O
data	O
from	O
high	O
income	O
countries	O
(	O
Figure4	O
),	O
recent	O
change	O
in	O
middle	O
income	O
countries	O
(	O
Figures5and6	O
)	O
and	O
a	O
new	O
analysis	O
using	O
lives	O
saved	O
modelling	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

ES	O
:	O
Analysis	O
and	O
interpretation	O
of	O
data	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
maternal	O
and	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
r2	O
=	O
0	O
.	O
457	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
Fig	O
2	O
).	O

found	O
that	O
a	O
prolonged	O
labor	O
(	O
greater	O
than	O
18	O
–	O
24	O
hours	O
)	O
resulted	O
in	O
an	O
increased	O
risk	O
for	O
autism	O
[	O
18	O
].	O

Pregnant	O
women	O
were	O
recruited	O
at	O
antenatal	O
clinics	O
in	O
south	O
-	O
west	O
Sweden	O
at	O
latitude	O
57	O
–	O
58	O
°	O
N	O
.	O

This	O
is	O
an	O
exciting	O
area	O
of	O
study	O
;	O
especially	O
as	O
antibiotic	O
resistance	O
becomes	O
an	O
increasing	O
problem	O
.	O

tested	O
children	O
at	O
six	O
months	O
of	O
age	O
using	O
Visual	O
Recognition	O
Memory	O
(	O
VRM	O
)	O
paradigm	O
and	O
found	O
a	O
significant	O
improvement	O
of	O
2	O
.	O
8	O
points	O
for	O
each	O
additional	O
serving	O
of	O
fish	O
(	O
85	O
–	O
140	O
g	O
)	O
consumed	O
by	O
the	O
mother	O
during	O
pregnancy	O
[	O
19	O
].	O

Fatty	O
acids	O
in	O
red	O
blood	O
cell	O
total	O
phospholipids	O
are	O
determined	O
using	O
gas	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
GCMSMS	O
)	O
[	O
73	O
].	O

The	O
data	O
included	O
partially	O
missing	O
information	O
.	O

Newborn	O
babies	O
,	O
and	O
especially	O
premature	O
newborns	O
,	O
are	O
the	O
most	B
sensitive	O
test	O
of	O
health	O
systems	O
function	O
as	B
these	O
babies	O
can	O
die	O
within	O
minutes	O
without	O
the	O
right	O
care	O
.	O

For	O
any	O
patient	O
,	O
both	O
with	O
first	O
diagnosis	O
or	O
recurrent	O
disease	O
,	O
post	O
-	O
operative	O
therapy	O
for	O
DTC	O
is	O
based	O
on	O
the	O
administration	O
of	O
supraphysiologic	O
"	O
suppressive	O
"	O
oral	O
doses	O
of	O
levothyroxine	O
.	O

For	O
obese	O
women	O
,	O
a	O
30	O
%–	O
33	O
%	O
calorie	O
restriction	O
to	O
approximately	O
25	O
kcal	O
/	O
kg	O
actual	O
weight	O
per	O
day	O
is	O
recommended	O
.	O

“	O
We	O
’	O
ve	O
pretty	O
much	O
been	O
clear	O
from	O
the	O
beginning	O
that	O
if	O
we	O
see	O
something	O
that	O
’	O
s	O
wrong	O
,	O
we	O
’	O
re	O
not	O
going	O
to	O
let	O
it	O
stick	O
around	O
just	O
to	O
preserve	O
the	O
data	O
,”	O
Lewis	O
says	O
.	O

Vitamin	O
D	O
is	O
normally	B
stored	O
in	O
the	O
liver	O
and	O
adipose	O
tissue	O
,	O
and	O
after	O
six	O
weeks	O
on	O
a	O
restricted	O
diet	O
,	O
the	O
vitamin	O
D	O
levels	O
were	O
extremely	O
reduced	O
without	O
alteration	O
of	O
calcium	O
or	O
phosphate	O
levels	O
in	O
the	O
rodents	O
[	O
21	O
].	O

VD	O
serum	O
levels	O
were	O
positively	O
associated	O
with	O
sperm	O
motility	O
[	O
48	O
,	O
49	O
].	O

This	O
test	O
allows	O
us	O
to	O
measure	O
food	O
intake	O
,	O
chocolate	O
preference	O
as	O
well	O
as	O
to	O
detect	O
the	O
development	O
of	O
inflexible	O
feeding	O
behavior	O
.	O

Urinary	O
iodine	O
concentrations	O
are	O
determined	O
in	O
spot	O
urine	O
samples	O
using	O
a	O
modification	O
of	O
the	O
Sandell	O
-	O
Kolthoff	O
reaction	O
with	O
spectrophotometric	O
detection	O
[	O
70	O
].	O

Predictors	O
with	O
p	O
level	O
≤	O
0	O
.	O
1	O
were	O
further	O
includes	O
in	O
multivariate	O
logistic	O
or	O
linear	O
regression	O
analysis	O
.	O

16	O
/	O
169	O
women	O
did	O
not	O
refer	O
to	O
the	O
lab	O
.	O

Logistic	O
regression	O
for	O
S	O
-	O
ECC	O
including	O
variables	O
associated	O
at	O
the	O
bivariate	O
level	O
was	O
also	O
performed	O
.	O

Majority	B
(	O
95	O
%)	O
of	O
the	O
mothers	O
took	O
vitamin	O
D	O
supplements	O
during	O
pregnancy	O
,	O
most	B
of	O
them	O
were	O
highly	O
educated	O
(	O
75	O
%	O
had	O
at	O
least	O
a	O
bachelor	O
level	O
education	O
),	O
and	O
73	O
%	O
had	O
normal	O
weight	O
before	O
pregnancy	O
.	O

Further	O
,	O
other	O
studies	O
using	O
animal	O
models	O
show	O
that	O
preclinical	O
findings	O
in	O
rodents	O
exposed	O
to	O
SSRIs	O
during	O
development	O
point	O
to	O
an	O
increase	O
in	O
depression	O
and	O
anxiety	O
,	O
exhibiting	O
alteration	O
in	O
social	O
behaviors	O
in	O
the	O
offspring	O
.	O

Lifestyle	O
measures	O
can	O
provide	O
adequate	O
control	O
in	O
the	O
majority	O
of	O
cases	O
.	O

Guidelines	O
from	O
Australia	O
,	O
Europe	O
and	O
the	O
USA	O
encourage	O
fish	O
consumption	O
during	O
pregnancy	O
.	O

This	O
study	O
therefore	O
fills	O
a	O
major	O
gap	O
in	O
the	O
cost	O
literature	O
,	O
namely	O
estimating	O
the	O
cost	O
of	O
implementing	O
weekly	O
iron	O
supplementation	O
programs	O
.	O

PubMed	O
Central	O
:	O

What	O
are	O
the	O
real	O
short	O
-	O
and	O
/	O
or	O
long	O
-	O
term	O
consequence	O
(	O
s	O
)	O
of	O
environmentally	O
induced	O
epigenetic	O
change	O
(	O
s	O
)?	O

As	O
stated	O
by	O
the	O
authors	O
,	O
the	O
results	O
of	O
their	O
study	O
prove	B
an	O
increased	O
production	O
of	O
active	O
form	O
of	O
vitamin	O
D	O
in	O
the	O
first	O
trimester	O
decidua	O
,	O
which	O
modulates	O
reactions	O
in	O
a	O
paracrine	O
manner	O
between	O
the	O
mother	O
’	O
s	O
and	O
the	O
embryo	O
’	O
s	O
immune	O
system	O
during	O
the	O
implantation	O
.	O

Therefore	B
,	O
recommendations	O
regarding	O
the	O
optimal	O
times	O
to	O
interrupt	O
pathogen	O
transmission	O
,	O
while	O
preserving	O
the	O
transfer	O
of	O
healthy	O
microbiota	O
to	O
neonates	O
,	O
should	O
be	O
articulated	O
based	B
on	I
an	O
increased	B
understanding	I
of	O
the	O
mechanisms	O
of	O
transmission	O
of	O
pathogenic	O
and	O
commensal	O
organisms	O
from	O
mothers	O
to	O
neonates	O
.	O

old	O
.	O

However	O
,	O
the	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
on	O
PTB	O
among	O
those	O
receiving	O
vaccination	O
in	O
their	O
second	O
and	O
third	O
trimester	O
was	O
significant	O
with	O
PSM	O
(	O
aOR	O
:	O
0	O
.	O
87	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
75	O
–	O
0	O
.	O
99	O
and	O
aOR	O
:	O
0	O
.	O
66	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
45	O
–	O
0	O
.	O
96	O
,	O
respectively	O
;	O
Table	O
4	O
).	O

It	O
also	O
includes	O
a	O
medical	O
plan	O
for	O
the	O
infant	O
.	O

an	O
indicative	B
of	O
the	O
cardiac	O
vagal	O
modulation	O
were	O
positively	O
correlated	O
with	O
birth	O
weight	O
.	O

Promotion	O
accounted	O
for	O
11	O
%	O
of	O
the	O
non	O
-	O
supplement	O
costs	O
,	O
training	O
6	O
%	O
,	O
volunteer	O
time	O
24	O
%,	O
temporary	O
paid	O
workers	O
10	O
%,	O
permanent	O
,	O
salaried	O
staff	O
41	O
%,	O
and	O
other	O
11	O
%	O
for	O
vitamin	O
A	O
.	O

There	O
is	O
strong	O
evidence	O
that	O
maternal	O
iron	O
deficiency	O
anaemia	O
increases	O
the	O
risk	O
of	O
adverse	O
perinatal	O
outcomes	O
.	O

The	O
first	O
step	O
in	O
treatment	O
of	O
urticaria	O
and	O
angioedema	O
in	O
pregnancy	O
is	O
identification	O
and	O
avoidance	O
of	O
causative	O
factors	O
.	O

[	O
24	O
]	O
Vitamin	O
D	O
supplementation	O
in	O
early	O
pregnancy	O
should	O
be	O
explored	O
for	O
preventing	O
preeclampsia	O
and	O
promoting	O
neonatal	O
well	O
-	O
being	O
.	O

Ninety	O
-	O
nine	O
women	O
(	O
76	O
.	O
2	O
%),	O
25	O
women	O
(	O
19	O
.	O
2	O
%),	O
and	O
six	O
women	O
(	O
4	O
.	O
6	O
%)	O
had	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
,	O
20	O
–	O
29	O
and	O
≥	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

The	O
distribution	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
baseline	O
and	O
childbirth	O
was	O
not	O
normal	O
in	O
the	O
all	O
participants	O
.	O

Though	O
,	O
because	O
of	O
its	O
immediate	O
bioavailability	O
,	O
it	O
may	O
result	O
in	O
a	O
more	O
rapid	O
rise	O
in	O
haemoglobin	O
level	O
in	O
anaemic	O
patients	O
compared	O
with	O
oral	O
iron	O
;	O
but	O
it	O
probably	B
does	O
not	O
confer	O
an	O
advantage	O
in	O
preventing	O
anaemia	O
in	O
pregnancy	O
[	O
25	O
,	O
38	O
].	O

A	O
parallel	O
increase	O
in	O
BAT	O
activity	O
and	O
cold	O
-	O
induced	O
energy	O
expenditure	O
was	O
also	O
observed	O
in	O
response	O
to	O
acute	O
cold	O
exposure	O
in	O
subjects	O
with	O
low	O
BAT	O
activity	O
,	O
demonstrating	O
the	O
possible	O
occurrence	O
of	O
BAT	O
recruitment	O
in	O
humans	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

The	O
IMF	O
content	O
in	O
the	O
LM	O
of	O
somatic	O
-	O
cell	O
-	O
cloned	O
Japanese	O
black	O
steers	O
increased	O
with	O
age	O
at	O
slaughter	O
:	O
20	O
(	O
23	O
.	O
7	O
%),	O
25	O
(	O
38	O
.	O
7	O
%),	O
and	O
30	O
months	O
(	O
41	O
.	O
1	O
%)	O
[	O
65	O
].	O

CONCLUSION	O
Vitamin	O
D	O
has	O
emerged	O
as	O
something	O
of	O
a	O
wonder	O
supplement	O
,	O
according	O
to	O
the	O
claims	O
of	O
dozens	O
of	O
studies	O
published	O
in	O
the	O
past	O
few	O
years	O
.	O

Nutritional	O
vitamin	O
D	O
status	O
has	O
very	O
recently	O
been	O
linked	O
to	O
the	O
human	O
innate	O
immune	O
system	O
and	O
its	O
ability	O
to	O
contain	O
Mycobacterium	O
tuberculosis	O
.	O

The	O
structured	O
observation	O
was	O
conducted	O
on	O
days	O
30	O
–	O
32	O
postpartum	O
and	O
lasted	O
3	O
hours	O
.	O

We	O
enrolled	O
randomly	O
50	O
patients	O
from	O
definitive	O
MS	O
patients	O
on	O
the	O
basis	O
of	O
their	O
MRI	O
findings	O
and	O
clinical	O
presentations	O
that	O
were	O
recorded	O
in	O
MS	O
society	O
of	O
Isfahan	O
as	O
case	O
group	O
.	O

Whitaker	O
and	O
colleagues	O
[	O
13	O
]	O
specifically	O
reviewed	O
mobile	O
phone	O
-	O
based	O
cessation	O
interventions	O
and	O
found	O
them	O
to	O
be	O
effective	O
in	O
long	O
-	O
term	O
quitting	O
outcomes	O
.	O

(	O
2015	O
)	O
*	O
FormaldehydeLifetimeAdulthoodADDNA	O
methylation	O
Epigenetic	O
machineryTong	O
et	O
al	O
.	O

Nevertheless	O
,	O
the	O
findings	O
are	O
in	O
contrast	O
to	O
a	O
previously	O
published	O
study	O
which	O
found	O
that	O
in	O
utero	O
exposure	O
to	O
SGAs	O
was	O
associated	O
with	O
a	O
significantly	O
elevated	O
risk	O
of	O
small	O
for	O
gestational	O
age	O
births	O
.	O
16However	O
,	O
it	O
is	O
possible	O
that	O
this	O
difference	O
may	B
be	I
due	I
to	I
the	O
lack	O
of	O
control	O
of	O
potential	O
confounders	O
,	O
such	O
as	O
maternal	O
indication	O
for	O
smoking	O
or	O
substance	O
use	O
during	O
pregnancy	O
.	O

Other	O
studies	O
,	O
however	O
,	O
have	O
found	O
no	O
evidence	O
to	O
support	O
this	O
hypothesis	O
[	O
23	O
],[	O
24	O
],[	O
25	O
],[	O
26	O
],[	O
27	O
],[	O
28	O
],[	O
29	O
],[	O
30	O
].	O

Handwashing	O
with	O
soap	O
was	O
more	O
frequently	O
observed	O
among	O
intervention	O
mothers	O
than	O
controls	O
before	O
breastfeeding	O
(	O
RD	O
0	O
.	O
65	O
,	O
95	O
%	O
CI	O
0	O
.	O
03	O
–	O
0	O
.	O
99	O
)	O
and	O
after	O
fecal	O
contact	O
(	O
RD	O
0	O
.	O
10	O
,	O
95	O
%	O
CI	O
0	O
.	O
04	O
–	O
0	O
.	O
17	O
)	O
(	O
Table	O
3	O
).	O

Meanwhile	O
,	O
diastolic	O
BP	O
(	O
r	O
=	O
-	O
0	O
.	O
182	O
;	O
P	O
=	O
0	O
.	O
070	O
)	O
was	O
not	O
influenced	O
by	O
BW	O
in	O
these	O
children	O
(	O
Fig	O
1B	O
).	O

in	O
a	O
study	O
with	O
a	O
small	O
sample	O
size	O
(	O
97	O
participants	O
),	O
observed	O
an	O
association	O
between	O
maternal	O
low	O
serum	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
and	O
high	O
depression	O
scores	O
within	O
several	O
post	O
-	O
partum	O
visits	O
[	O
32	O
].	O

[	O
20	O
]	O
also	O
adjusted	O
for	O
maternal	O
diet	O
,	O
while	O
Mendez	O
et	O
al	O
.	O

However	O
,	O
conflicting	O
evidence	O
exists	O
[	O
27	O
,	O
28	O
].	O

Different	O
indicator	O
such	O
as	O
the	O
number	O
of	O
beneficiaries	O
enrolled	O
in	O
Anganwadicentre	O
for	O
supplementary	O
nutrition	O
or	O
for	O
preschool	O
education	O
has	O
been	O
proposed	O
to	O
monitor	O
the	O
implementation	O
of	O
the	O
scheme	O
in	O
different	O
Anganwadi	O
centres	O
of	O
the	O
country	O
(	O
1	O
,	O
5	O
).	O

It	O
indicated	O
that	O
X	O
linked	O
epigenetic	O
inheritance	O
via	O
spermatozoa	O
seemed	O
to	O
be	O
plausible	O
,	O
with	O
the	O
transmission	O
,	O
limited	O
to	O
being	O
through	O
the	O
father	O
,	O
possibly	O
explained	B
by	O
the	O
sex	O
differences	O
in	O
the	O
meiosis	O
stage	O
of	O
cell	O
reproduction	O
.	O

Also	O
,	O
increasing	O
physical	O
activity	O
during	O
pregnancy	O
has	O
been	O
related	O
to	O
lower	O
GWG	O
in	O
some	O
[	O
41	O
]	O
but	O
not	O
all	O
[	O
42	O
]	O
observational	O
studies	O
.	O

Adapted	O
from	O
Lawn	O
et	O
al	O
.,	O
2008	O
;	O
Rubens	O
et	O
al	O
.,	O
2010	O
.	O

If	O
vitamin	O
D	O
supplementation	O
does	O
not	O
occur	O
during	O
pregnancy	O
,	O
it	O
may	O
be	O
imperative	O
to	O
identify	O
and	O
offer	O
additional	O
supplementation	O
beyond	O
the	O
routinely	O
recommended	O
400	O
IU	O
per	O
day	O
for	O
all	O
infants	O
.	O
28	O
There	O
were	O
several	O
limitations	O
to	O
our	O
study	O
.	O

The	O
means	O
at	O
each	O
time	O
point	O
and	O
for	O
hypothalamic	O
gene	O
expression	O
,	O
folate	O
status	O
and	O
glucose	O
response	O
were	O
compared	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
using	O
the	O
PROC	O
GLM	O
followed	O
by	O
a	O
Tukey	O
’	O
s	O
post	O
-	O
hoc	O
test	O
.	O

Early	O
childhood	O
and	O
adolescence	O
are	O
also	O
periods	O
of	O
significant	O
growth	O
and	O
development	O
,	O
so	O
it	O
is	O
easy	O
to	O
envisage	B
how	O
environmentally	O
induced	O
epigenetic	O
changes	O
during	O
these	O
stages	O
could	O
have	O
detrimental	O
effects	O
on	O
future	O
health	O
and	O
fertility	O
.	O

Subgroup	O
analyses	O
were	O
also	O
conducted	O
.	O

In	O
our	O
patient	O
,	O
the	O
lesion	O
did	O
not	O
recur	O
after	O
the	O
second	O
surgical	O
removal	O
after	O
6	O
months	O
of	O
observation	O
.	O

Results	O
Between	O
October	O
2010	O
and	O
October	O
2011	O
,	O
we	O
identified	O
695	O
pregnant	O
women	O
reported	O
to	O
be	O
between	O
28	O
and	O
32	O
weeks	O
of	O
gestation	O
in	O
the	O
study	O
villages	O
(	O
Figure	O
2	O
).	O

The	O
greatest	O
potential	O
for	O
the	O
global	O
prevention	O
of	O
preterm	O
birth	O
,	O
therefore	B
,	O
lies	O
in	O
a	O
comprehensive	B
,	O
strategic	B
,	O
and	O
sufficiently	O
-	O
funded	O
research	O
agenda	O
of	O
the	O
causes	O
of	O
preterm	O
birth	O
and	O
novel	O
strategies	O
for	O
prevention	O
[	O
13	O
].	O

Birth	O
weight	O
was	O
abstracted	O
from	O
birth	O
records	O
and	O
analyzed	O
as	O
a	O
continuous	O
variable	O
.	O

Measurement	O
of	O
the	O
vasopressinase	O
serum	O
concentrations	O
is	O
not	O
available	O
commercially	O
,	O
and	O
the	O
diagnosis	O
is	O
usually	O
established	O
based	O
on	O
the	O
clinical	O
presentation	O
and	O
the	O
appropriate	O
laboratory	O
studies	O
.	O

Vitamin	O
D	O
supplementation	O
is	O
advised	O
in	O
infertility	O
therapy	O
in	O
both	O
partners	O
.	O

Demographic	O
details	O
,	O
pregnancy	O
history	O
and	O
maternal	O
medical	O
history	O
were	O
found	O
through	O
direct	O
interviews	O
with	O
mothers	O
in	O
their	O
first	O
pregnancy	O
visit	O
,	O
based	O
on	O
the	O
ministry	O
of	O
health	O
’	O
s	O
routine	O
prenatal	O
care	O
questionnaire	O
.	O

The	O
IMF	O
contents	O
in	O
longissimus	O
lumborum	O
and	O
semitendinosus	O
muscle	O
were	O
higher	O
in	O
high	O
-	O
concentrate	O
-	O
fed	O
than	O
in	O
low	O
-	O
concentrate	O
-	O
fed	O
Barrosã	O
bulls	O
.	O

The	O
data	O
show	O
new	O
way	O
to	O
study	O
porcine	O
hepatic	O
function	O
of	O
glucocorticoid	O
receptor	O
.	O

(	O
2016	O
)*	O
Chemicals	O
Bisphenol	O
A	O
(	O
BPA	O
)	O
In	O
utero	O
ChildhoodBehavioral	O
abnormalitiesDNA	O
methylationKundakovic	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Adjusted	O
and	O
unadjusted	O
GEE	O
models	O
comparing	O
treatment	O
(	O
text4baby	O
group	O
)	O
and	O
control	O
(	O
no	O
text4baby	O
enrollment	O
).	O
Questionnaire	O
itemsTreatment	O
vs	O
controlUnadjustedAdjustedaOR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
PKAB	O
items	O
Eating	O
5	O
or	O
more	O
fruits	O
and	O
vegetables	O
per	O
day	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
781	O
(	O
0	O
.	O
409	O
,	O
7	O
.	O
760	O
).	O
442	O
.	O
261	O
(	O
0	O
.	O
400	O
,	O
12	O
.	O
787	O
).	O
36Taking	O
a	O
prenatal	O
vitamin	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby2	O
.	O
931	O
(	O
0	O
.	O
463	O
,	O
18	O
.	O
551	O
).	O
251	O
.	O
512	O
(	O
0	O
.	O
162	O
,	O
14	O
.	O
092	O
).	O
72I	O
am	O
prepared	O
to	O
be	O
a	O
new	O
mother0	O
.	O
923	O
(	O
0	O
.	O
563	O
,	O
1	O
.	O
514	O
).	O
750	O
.	O
976	O
(	O
0	O
.	O
495	O
,	O
1	O
.	O
924	O
).	O
94If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
I	O
will	O
be	O
a	O
healthy	O
new	O
mother1	O
.	O
016	O
(	O
0	O
.	O
666	O
,	O
1	O
.	O
549	O
).	O
940	O
.	O
759	O
(	O
0	O
.	O
461	O
,	O
1	O
.	O
251	O
).	O
28If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
my	O
baby	O
will	O
be	O
healthy1	O
.	O
188	O
(	O
0	O
.	O
771	O
,	O
1	O
.	O
829	O
).	O
430	O
.	O
949	O
(	O
0	O
.	O
595	O
,	O
1	O
.	O
513	O
).	O
83Smoking	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
880	O
(	O
0	O
.	O
583	O
,	O
1	O
.	O
328	O
).	O
540	O
.	O
753	O
(	O
0	O
.	O
473	O
,	O
1	O
.	O
198	O
).	O
23Secondhand	O
smoke	O
will	O
not	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby	O
(	O
reverse	O
coded	O
)	O
1	O
.	O
189	O
(	O
0	O
.	O
944	O
,	O
1	O
.	O
497	O
).	O
140	O
.	O
978	O
(	O
0	O
.	O
715	O
,	O
1	O
.	O
336	O
).	O
89Drinking	O
alcohol	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
018	O
(	O
0	O
.	O
619	O
,	O
1	O
.	O
675	O
).	O
941	O
.	O
253	O
(	O
0	O
.	O
717	O
,	O
2	O
.	O
188	O
).	O
43Taking	O
prenatal	O
vitamins	O
will	O
improve	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
943	O
(	O
0	O
.	O
722	O
,	O
1	O
.	O
233	O
).	O
670	O
.	O
709	O
(	O
0	O
.	O
488	O
,	O
1	O
.	O
030	O
).	O
07	O
Behaviors	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?	O
0	O
.	O
699	O
(	O
0	O
.	O
293	O
,	O
1	O
.	O
665	O
).	O
432	O
.	O
310	O
(	O
0	O
.	O
491	O
,	O
10	O
.	O
874	O
).	O
29In	O
the	O
last	O
30	O
days	O
,	O
did	O
you	O
smoke	O
?	O
0	O
.	O
927	O
(	O
0	O
.	O
533	O
,	O
1	O
.	O
615	O
).	O
790	O
.	O
938	O
(	O
0	O
.	O
318	O
,	O
2	O
.	O
770	O
).	O
91Ate	O
3	O
or	O
more	O
servings	O
of	O
fruit	O
a	O
day1	O
.	O
160	O
(	O
0	O
.	O
924	O
,	O
1	O
.	O
456	O
).	O
201	O
.	O
107	O
(	O
0	O
.	O
835	O
,	O
1	O
.	O
468	O
).	O
48Ate	O
3	O
or	O
more	O
servings	O
of	O
vegetables	O
a	O
day1	O
.	O
065	O
(	O
0	O
.	O
846	O
,	O
1	O
.	O
339	O
).	O
591	O
.	O
042	O
(	O
0	O
.	O
755	O
,	O
1	O
.	O
438	O
).	O
80Have	O
you	O
ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
?	O
0	O
.	O
853	O
(	O
0	O
.	O
584	O
,	O
1	O
.	O
246	O
).	O
410	O
.	O
822	O
(	O
0	O
.	O
476	O
,	O
1	O
.	O
420	O
).	O
48	O
aAdjusted	O
for	O
age	O
,	O
parity	O
,	O
imputed	O
marital	O
status	O
,	O
and	O
race	O
.	O

The	O
UPBEAT	O
trial	O
evaluated	O
the	O
effect	O
of	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
among	O
obese	O
women	O
,	O
with	O
no	O
impact	O
on	O
infant	O
birth	O
weight	O
demonstrated	O
[	O
17	O
].	O

Multivariate	O
linear	O
regression	O
was	O
then	O
used	O
to	O
adjust	O
for	O
relevant	O
confounders	O
.	O

It	O
is	O
quite	O
possible	O
that	O
the	O
adverse	O
findings	O
in	O
this	O
study	O
are	O
due	O
to	O
more	O
women	O
in	O
the	O
metformin	O
group	O
having	O
a	O
greater	O
severity	O
of	O
hyperglycemia	O
early	O
in	O
the	O
pregnancy	O
.	O

The	O
investigators	O
will	O
have	O
information	O
on	O
the	O
women	O
’	O
s	O
environmental	O
exposures	O
and	O
their	O
body	O
burden	O
of	O
metals	O
,	O
so	O
they	O
can	O
start	O
to	O
zero	O
in	O
on	O
how	O
arsenic	O
and	O
uranium	O
exposures	O
affect	O
protein	O
function	O
and	O
whether	O
zinc	O
supplementation	O
provides	O
any	O
protection	O
.	O

All	O
dietary	O
variables	O
were	O
modeled	O
as	O
continuous	O
variables	O
.	O

Interestingly	O
,	O
the	O
amount	O
of	O
air	O
pollution	O
that	O
a	O
mother	O
and	O
child	O
were	O
exposed	O
to	O
including	O
traffic	O
related	O
air	O
pollution	O
and	O
nitrogen	O
dioxide	O
,	O
both	O
during	O
pregnancy	O
and	O
during	O
the	O
first	O
year	O
of	O
life	O
,	O
was	O
associated	O
with	O
autism	O
[	O
35	O
].	O

For	O
ease	O
of	O
administration	O
in	O
the	O
field	O
,	O
randomisation	O
was	O
to	O
one	O
of	O
four	O
colour	O
-	O
coded	O
groups	O
(	O
2	O
for	O
intervention	O
;	O
2	O
for	O
placebo	O
),	O
stratified	O
by	O
age	O
.	O

Both	O
stunting	O
and	O
poverty	O
are	O
known	O
risk	O
factors	O
for	O
poor	O
child	O
development	O
[	O
23	O
].	O

RCT	O
cohort	O
[	O
12	O
]	O
for	O
comparison	O
is	O
shown	O
inFig	O
1	O
.	O

In	O
addition	O
,	O
in	O
the	O
regression	O
model	O
for	O
analysis	O
of	O
predictors	O
,	O
the	O
power	O
still	O
can	O
achieve	O
as	O
high	O
as	O
0	O
.	O
8	O
(	O
alpha	O
risk	O
,	O
0	O
.	O
05	O
;	O
effect	O
size	O
f2	O
,	O
0	O
.	O
15	O
).	O

Fewer	O
children	O
in	O
the	O
S	O
-	O
ECC	O
group	O
were	O
reported	O
as	O
having	O
good	O
or	O
very	O
good	O
oral	O
health	O
compared	O
to	O
controls	O
(	O
19	O
.	O
4	O
%	O
vs	O
.	O
95	O
.	O
9	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	O
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	O
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
.	O

reported	O
high	O
correlations	O
(	O
r	O
=	O
0	O
.	O
7	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
EPA	O
and	O
DHA	O
and	O
serum	O
levels	O
of	O
EPA	O
and	O
DHA	O
in	O
subjects	O
with	O
schizophrenia	O
[	O
51	O
],	O
indicating	O
a	O
good	B
ability	I
to	O
report	O
dietary	O
intake	O
accurately	O
.	O

At	O
4	O
months	O
,	O
BP	O
was	O
10	O
%	O
higher	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
group	O
than	O
in	O
the	O
F1	O
-	O
SC	O
group	O
(	O
P	O
=	O
0	O
.	O
04	O
),	O
and	O
this	O
difference	O
continued	O
to	O
increase	O
:	O
at	O
5	O
months	O
,	O
it	O
was	O
15	O
%	O
higher	O
(	O
P	O
=	O
0	O
.	O
001	O
),	O
and	O
at	O
six	O
months	O
,	O
it	O
was	O
20	O
%	O
higher	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

(	O
A	O
)	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

The	O
study	O
design	O
did	O
not	O
allow	O
for	O
a	O
direct	O
measure	O
of	O
reproductive	O
performance	O
,	O
however	O
,	O
high	O
salivary	O
progesterone	O
concentrations	O
in	O
women	O
is	O
associated	O
with	O
greater	O
ovulation	O
rates	O
and	O
ovulatory	O
events	O
are	O
associated	O
with	O
childhood	O
and	O
adult	O
environmental	O
and	O
ecological	O
factors	O
[	O
58	O
].	O

Few	O
in	O
vivo	O
studies	O
have	O
been	O
performed	O
on	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
beef	O
marbling	O
.	O

Due	O
to	O
ethical	O
restrictions	O
,	O
we	O
were	O
only	O
able	O
to	O
assess	O
the	O
expression	O
of	O
GR	O
α	O
/	O
β	O
in	O
4	O
term	O
and	O
3	O
preterm	O
placentas	O
.	O

We	O
hypothesized	O
that	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
lower	O
in	O
Hispanic	O
than	O
Caucasian	O
newborns	O
but	O
that	O
these	O
differences	O
would	O
not	O
be	O
substantial	O
enough	O
to	O
be	O
related	O
closely	O
to	O
BMC	O
and	O
bone	O
mineral	O
density	O
(	O
BMD	O
)	O
or	O
their	O
changes	O
during	O
the	O
first	O
three	O
months	O
of	O
life	O
.	O

In	O
other	O
words	O
,	O
early	O
PNV	O
use	O
was	O
associated	O
with	O
vitamin	O
D	O
sufficiency	O
earlier	O
in	O
pregnancy	O
but	O
not	O
later	O
in	O
pregnancy	O
(	O
Table	O
4	O
).	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
alone	O
advanced	O
the	O
age	O
of	O
puberty	O
in	O
female	O
offspring	O
born	O
to	O
dams	O
fed	O
a	O
control	O
diet	O
during	O
pregnancy	O
and	O
lactation	O
(	O
p	O
<	O
0	O
.	O
001	O
,	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Age	O
and	O
weight	O
at	O
puberty	O
in	O
female	O
offspring	O
.	O
GroupsPubertal	O
Age	O
(	O
days	O
)	O
Pubertal	O
Weight	O
(	O
g	O
)	O
Cont	O
+	O
C	O
34	O
.	O
6	O
±	O
0	O
.	O
5121	O
.	O
5	O
±	O
3	O
.	O
7	O
Cont	O
+	O
HF	O
32	O
.	O
8	O
±	O
0	O
.	O
4116	O
.	O
7	O
±	O
6	O
.	O
3	O
UN	O
P	O
+	O
C	O
33	O
.	O
3	O
±	O
0	O
.	O
3111	O
.	O
6	O
±	O
5	O
.	O
6	O
UN	O
P	O
+	O
HF	O
31	O
.	O
8	O
±	O
0	O
.	O
2105	O
.	O
9	O
±	O
2	O
.	O
4	O
UN	O
L	O
+	O
C	O
33	O
.	O
5	O
±	O
0	O
.	O
394	O
.	O
6	O
±	O
3	O
.	O
8	O
UN	O
L	O
+	O
HF	O
31	O
.	O
8	O
±	O
0	O
.	O
392	O
.	O
1	O
±	O
2	O
.	O
8	O
UN	O
PL	O
+	O
C	O
33	O
.	O
3	O
±	O
0	O
.	O
484	O
.	O
9	O
±	O
3	O
.	O
6	O
UN	O
PL	O
+	O
HF	O
30	O
.	O
7	O
±	O
0	O
.	O
377	O
.	O
9	O
±	O
3	O
.	O
3	O
MHF	O
+	O
C	O
33	O
.	O
0	O
±	O
0	O
.	O
3114	O
.	O
4	O
±	O
2	O
.	O
4	O
MHF	O
+	O
HF	O
32	O
.	O
6	O
±	O
0	O
.	O
7122	O
.	O
5	O
±	O
5	O
.	O
0	O
PLHF	O
+	O
C	O
32	O
.	O
7	O
±	O
0	O
.	O
4108	O
.	O
6	O
±	O
2	O
.	O
7	O
PLHF	O
+	O
HF	O
31	O
.	O
4	O
±	O
0	O
.	O
5103	O
.	O
8	O
±	O
3	O
.	O
8	O
effect	O
of	O
maternal	O
diet	O
across	O
groups	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

(	O
2014b	O
)*/†	O
Vinyl	O
carbamateMouseInjection	O
(	O
ip	O
)	O
(	O
0	O
.	O
32	O
mg	O
/	O
mouse	O
)	O
Adolescence	O
/	O
early	O
adulthoodAdulthoodPulmonary	O
carcinogenesismiRNAsKassie	O
et	O
al	O
.	O

Average	O
daily	O
intake	O
of	O
dairy	O
products	O
,	O
egg	O
,	O
animal	O
organ	O
and	O
seafood	O
was	O
calculated	O
based	O
on	O
participants	O
’	O
dietary	O
record	O
.	O

The	O
majority	O
lived	O
in	O
an	O
urban	O
area	O
(	O
54	O
.	O
3	O
%).	O

Currently	O
,	O
it	O
is	O
recommended	O
to	O
use	O
multiVitamin	O
or	O
calcium	O
supplements	O
containing	O
Vitamin	O
D	O
for	O
women	O
during	O
pregnancy	O
to	O
increase	O
their	O
Vitamin	O
D	O
intake	O
.	O

The	O
association	O
between	O
GWG	O
and	O
offspring	O
overweight	O
may	O
decrease	O
as	O
children	O
grow	O
older	O
[	O
49	O
,	O
50	O
].	O

As	O
reviewed	O
previously	O
,	O
prenatal	O
maternal	O
stress	O
has	O
been	O
shown	O
to	O
have	O
long	O
-	O
term	O
effects	O
on	O
the	O
psychological	O
as	O
well	O
as	O
behavioral	O
development	O
of	O
the	O
offspring	O
[	O
15	O
,	O
16	O
].	O

The	O
acceptance	O
capacity	O
of	O
methyl	O
groups	O
in	O
the	O
whole	O
genome	O
is	O
known	O
to	O
be	O
inversely	O
related	O
to	O
the	O
exogenous3H	O
-	O
methyl	O
incorporation	O
.	O

*/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
control	O
dams	O
.	O

Also	O
women	O
are	O
encouraged	O
to	O
continue	O
to	O
take	O
vitamin	O
D	O
supplements	O
after	O
pregnancy	O
to	O
help	O
protect	O
against	O
health	O
problems	O
such	O
as	O
osteoporosis	O
.	O

However	O
,	O
this	O
was	O
significant	O
between	O
women	O
who	O
received	O
best	O
practice	O
care	O
(-	O
7	O
.	O
9	O
±	O
6	O
.	O
1	O
)	O
and	O
not	O
best	O
practice	O
care	O
(-	O
2	O
.	O
1	O
±	O
4	O
.	O
4	O
,	O
p	O
=	O
0	O
.	O
014	O
),	O
and	O
also	O
pre	O
-	O
intervention	O
women	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

At	O
the	O
postnatal	O
weeks	O
21	O
–	O
23	O
,	O
adult	O
offspring	O
were	O
finally	O
weighted	O
and	O
sacrificed	O
(	O
Figure1	O
).	O

Cost	O
of	O
the	O
supplements	O
and	O
anthelminthics	O
was	O
47	O
%	O
of	O
the	O
total	O
,	O
while	O
costs	O
of	O
training	O
,	O
monitoring	O
,	O
and	O
health	O
workers	O
'	O
time	O
accounted	O
for	O
53	O
%.	O

First	O
,	O
the	O
BHLM	O
model	O
did	O
not	O
account	O
for	O
interactions	O
between	O
classes	O
,	O
and	O
we	O
assumed	B
that	O
all	O
chemicals	O
within	O
a	O
class	O
share	O
a	O
similar	O
mode	O
of	O
action	O
and	O
arise	O
from	O
a	O
common	O
prior	O
distribution	O
.	O

Evaluating	O
Provider	O
Advice	O
and	O
Women	O
’	O
s	O
Beliefs	O
on	O
Total	O
Weight	O
Gain	O
During	O
Pregnancy	O
Abstract	O
Excessive	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
is	O
associated	O
with	O
complications	O
for	O
both	O
mother	O
and	O
child	O
.	O

The	O
2	O
OPPs	O
,	O
Pb	O
and	O
Hg	O
were	O
included	O
in	O
the	O
model	O
as	O
covariates	O
without	O
hierarchical	O
modeling	O
.	O

A	O
recent	O
case	O
control	O
study	O
done	O
in	O
New	O
South	O
Wales	O
,	O
Australia	O
,	O
focused	O
on	O
determining	O
risk	O
factors	O
for	O
autism	O
.	O

In	O
univariate	O
analyses	O
,	O
thyroxine	O
therapy	O
apparently	O
helps	O
decrease	O
cancer	O
-	O
related	O
death	O
rates	O
among	O
patients	O
with	O
PTC	O
.	O

Physical	O
activity	O
In	O
people	O
with	O
type	O
2	O
diabetes	O
,	O
there	O
is	O
ample	O
evidence	O
that	O
regular	O
physical	O
activity	O
enhances	O
insulin	O
sensitivity	O
,	O
facilitates	O
weight	O
loss	O
,	O
and	O
thereby	O
improves	O
glucose	O
control	O
.	O

Additionally	O
,	O
lifestyle	O
behaviours	O
that	O
may	O
be	O
influenced	O
by	O
seasonal	O
changes	O
(	O
dietary	O
intakes	O
,	O
physical	O
activity	O
,	O
and	O
well	O
-	O
being	O
)	O
did	O
not	O
explain	O
the	O
associations	O
between	O
exposure	O
to	O
winter	O
at	O
the	O
first	O
antenatal	O
visit	O
and	O
markers	O
of	O
glucose	O
metabolism	O
.	O

This	O
so	O
-	O
called	O
transgenerational	O
epigenetic	O
inheritance	O
is	O
a	O
hotly	O
debated	O
topic	O
.	O

Adjunctive	O
treatment	O
of	O
rhinitis	O
,	O
which	O
is	O
permitted	O
in	O
pregnancy	O
,	O
includes	O
oxymetazoline	O
drops	O
or	O
spray	O
for	O
nasal	O
congestion	O
,	O
pseudoephedrine	O
(	O
after	O
the	O
first	O
trimester	O
)	O
for	O
persistent	O
nasal	O
congestion	O
,	O
and	O
buffered	O
saline	O
sprays	O
for	O
nasal	O
dryness	O
,	O
nasal	O
bleeding	O
,	O
and	O
vascular	O
congestion	O
associated	O
with	O
pregnancy	O
.	O

For	O
the	O
microarray	O
analyses	O
,	O
8	O
sib	O
pairs	O
(	O
light	O
and	O
heavy	O
piglet	O
from	O
one	O
litter	O
)	O
which	O
were	O
balanced	O
for	O
sex	O
(	O
all	O
stages	O
)	O
and	O
discordant	O
for	O
weight	O
(	O
light	O
and	O
heavy	O
piglet	O
;	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
only	O
)	O
were	O
chosen	O
per	O
stage	O
and	O
diet	O
.	O

1	O
.	O

To	O
visualize	O
the	O
results	O
,	O
we	O
performed	O
principal	O
coordinates	O
analysis	O
(	O
PCoA	O
)	O
on	O
generalized	O
UniFrac	O
distances	O
using	O
the	O
cmdscale	O
function	O
in	O
R	O
[	O
42	O
]	O
and	O
plotted	O
the	O
samples	O
by	O
the	O
first	O
two	O
coordinates	O
,	O
colored	O
by	O
each	O
dietary	O
variable	O
tertile	O
to	O
aid	O
in	O
visualization	O
.	O

Inability	O
to	O
address	O
confounding	O
by	O
indication	O
and	O
separate	O
the	O
effects	O
of	O
maternal	O
mental	O
illness	O
and	O
its	O
severity	O
from	O
psychotropic	O
pharmacotherapy	O
on	O
pregnancy	O
outcome	O
.	O

No	O
effects	O
of	O
diet	O
and	O
sex	O
were	O
detected	O
,	O
but	O
interaction	O
between	O
time	O
and	O
diet	O
was	O
significant	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
11	O
.	O
27	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

There	O
were	O
no	O
differences	O
in	O
NAL	O
throughout	O
the	O
study	O
.	O

In	O
a	O
large	O
retrospective	O
study	O
on	O
595	O
pregnancy	O
-	O
associated	O
thyroid	O
cancers	O
,	O
Yasmeen	O
et	O
al	O
.	O

The	O
Hispanic	O
community	O
may	O
be	O
at	O
higher	O
risk	O
due	O
to	O
darker	O
skin	O
pigmentation	O
,	O
greater	O
obesity	O
,	O
lower	O
dairy	O
intake	O
and	O
less	O
supplement	O
use	O
.	O

The	O
pain	O
began	O
roughly	O
30	O
minutes	O
prior	O
to	O
her	O
presentation	O
to	O
the	O
ED	O
and	O
occurred	O
as	O
she	O
was	O
getting	O
out	O
of	O
the	O
swimming	O
pool	O
.	O

Japan	O
and	O
Korea	O
have	O
developed	O
stage	O
-	O
specific	O
feeding	O
systems	O
to	O
produce	O
highly	O
marbled	O
beef	O
.	O

Specifically	O
,	O
a	O
test	O
statistic	O
was	O
constructed	O
as	O
the	O
maximum	O
absolute	O
t	O
-	O
statistic	O
for	O
the	O
appropriate	O
coefficient	O
from	O
the	O
regression	O
model	O
,	O
where	O
the	O
maximum	O
was	O
computed	O
over	O
the	O
16	O
or	O
41	O
individual	O
regression	O
models	O
.	O

MTRL	O
,	O
JS	O
,	O
and	O
FR	O
wrote	O
the	O
first	O
draft	O
of	O
the	O
manuscript	O
that	O
was	O
revised	O
by	O
all	O
authors	O
.	O

Concerning	O
to	O
total	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
adolescence	O
(	O
Figure3C	O
),	O
we	O
detected	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
272	O
.	O
872	O
;	O
P	O
<	O
0	O
.	O
001	O
],	O
sex	O
[	O
F	O
(	O
1	O
,	O
67	O
)=	O
25	O
.	O
663	O
;	O
P	O
<	O
0	O
.	O
001	O
],	O
and	O
interaction	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
22	O
.	O
908	O
;	O
P	O
<	O
0	O
.	O
001	O
].	O

In	O
contrast	O
,	O
both	O
CC	O
and	O
RC	O
males	O
treated	O
with	O
AM251	O
showed	O
a	O
decrease	O
in	O
the	O
total	O
caloric	O
intake	O
(	O
Figure3F	O
).	O

PubMed	O
Central	O
:	O

Japanese	O
Black	O
steers	O
fed	O
a	O
16	O
%	O
CP	O
diet	O
had	O
greater	O
backfat	O
thickness	O
than	O
those	O
fed	O
a	O
12	O
%	O
CP	O
diet	O
[	O
127	O
].	O

Frequent	O
monitoring	O
and	O
adjustment	O
of	O
L	O
-	O
T4	O
dosages	O
are	O
very	O
important	O
because	B
of	O
large	O
fluctuations	O
of	O
T4	O
metabolism	O
during	O
pregnancy	O
;	O
calcium	O
and	O
D	O
vitamin	O
supplementation	O
,	O
often	B
indispensable	O
,	O
must	O
be	O
carefully	O
tailored2324	O
.	O

There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
concentration	O
(	O
ρ	O
=	O
0	O
.	O
236	O
,	O
p	O
=	O
0	O
.	O
005	O
);	O
ρ	O
value	O
represents	O
Spearman	O
correlation	O
.	O

Sources	O
of	O
vitamin	O
D	O
The	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
'	O
s	O
synthesis	O
of	O
the	O
vitamin	O
from	O
sunlight	O
.	O

Of	O
all	O
pregnant	O
women	O
included	O
,	O
640	O
were	O
in	O
the	O
first	O
,	O
666	O
were	O
in	O
the	O
third	O
and	O
2	O
were	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
.	O

¶	O
Studies	O
in	O
which	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
were	O
reported	O
in	O
separate	O
publications	O
but	O
were	O
performed	O
within	O
the	O
same	O
experimental	O
animals	O
.	O

The	O
clinical	O
relevance	O
of	O
this	O
finding	O
remains	O
unsolved	O
and	O
needs	O
to	O
be	O
considered	O
in	O
future	O
studies	O
.	O

55	O
obstetric	O
clinics	O
were	O
randomly	O
selected	O
and	O
1311	O
pregnant	O
women	O
participated	O
in	O
the	O
study	O
.	O

Among	O
other	O
findings	O
,	O
Grandjean	O
’	O
s	O
team	O
linked	O
postnatal	O
exposure	O
to	O
a	O
group	O
of	O
chemicals	O
called	O
perfluoroalkyl	O
substances	O
(	O
PFASs	O
)	O
with	O
lower	O
immune	O
response	O
to	O
tetanus	O
and	O
diphtheria	O
vaccinations	O
in	O
Faroese	O
children	O
.	O
20PFASs	O
are	O
widely	O
used	O
chemicals	O
that	O
build	O
up	O
in	O
the	O
bodies	O
of	O
humans	O
and	O
other	O
animals	O
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
with	O
no	O
PNV	O
use	O
(	O
vs	O
.	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
)	O
had	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
(	O
adjusted	O
OR	O
2	O
.	O
8	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
3	O
)	O
earlier	O
in	O
pregnancy	O
,	O
and	O
no	O
difference	O
later	O
in	O
pregnancy	O
(	O
adjusted	O
OR	O
1	O
.	O
3	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
8	O
,	O
2	O
.	O
0	O
).	O

Assessment	O
of	O
Other	O
Variables	O
For	O
the	O
infants	O
,	O
birth	O
date	O
,	O
gestational	O
age	O
,	O
and	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
were	O
recorded	O
at	O
birth	O
.	O

Macronutrient	O
(	O
i	O
.	O
e	O
.,	O
%	O
kcal	O
from	O
sweets	O
,	O
fat	O
,	O
and	O
protein	O
)	O
and	O
specific	O
dietary	O
components	O
(	O
i	O
.	O
e	O
.,	O
fast	O
food	O
or	O
soft	O
drinks	O
)	O
were	O
analyzed	O
in	O
separate	O
models	O
due	O
to	O
their	O
high	O
collinearity	O
.	O

Continuous	O
variables	O
were	O
evaluated	O
across	O
quintile	O
categories	O
of	O
dietary	O
pattern	O
scores	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
.	O

Furthermore	O
,	O
they	O
were	O
less	O
satisfied	O
with	O
the	O
comfort	O
in	O
the	O
sitting	O
area	O
and	O
the	O
way	O
the	O
staff	O
attended	O
to	O
them	O
.	O

Data	O
on	O
initial	O
costs	O
for	O
training	O
and	O
educational	O
materials	O
were	O
obtained	O
from	O
the	O
records	O
of	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
and	O
the	O
Yen	O
Bai	O
Malaria	O
Control	O
Program	O
.	O

Unadjusted	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
assess	O
the	O
association	O
between	O
T1	O
25OHD	O
(<	O
30	O
nmol	O
/	O
L	O
;	O
no	O
/	O
yes	O
)	O
and	O
IUFD	O
.	O

They	O
had	O
free	O
access	O
to	O
standard	O
diets	O
formulated	O
for	O
post	O
-	O
weaning	O
(	O
d	O
29	O
to	O
d	O
76	O
),	O
growing	O
(	O
d	O
77	O
to	O
d	O
105	O
)	O
and	O
finishing	O
periods	O
[	O
64	O
].	O

In	O
the	O
present	O
study	O
we	O
employed	O
an	O
established	O
model	O
of	O
nutritional	O
programming	O
to	O
evaluate	O
the	O
relative	O
influences	O
of	O
prenatal	O
and	O
postnatal	O
nutrition	O
on	O
growth	O
and	O
ovarian	O
function	O
in	O
female	O
offspring	O
.	O

This	O
can	O
include	O
pain	O
,	O
disturbed	O
sleep	O
and	O
behavioural	O
changes	O
[	O
6	O
-	O
8	O
].	O

3	O
.	O
4	O
.	O

Hypothalamic	O
Gene	O
Expression	O
The	O
HV	O
but	O
not	O
HFol	O
pup	O
diet	O
brought	O
POMC	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
from	O
HV	O
dams	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
(	O
Figure	O
5a	O
).	O

GDM	O
is	O
a	O
multifactorial	O
disease	O
involving	O
various	O
risk	O
factors	O
,	O
for	O
example	O
lifestyle	O
factors	O
,	O
obesity	O
,	O
rapid	O
weight	O
gain	O
and	O
predisposing	O
genetic	O
factors	O
.	O

Negative	O
maternal	O
energy	O
status	O
at	O
mid	O
-	O
gestation	O
(	O
80	O
%	O
of	O
the	O
energy	O
requirements	O
for	O
maintenance	O
of	O
body	O
weight	O
)	O
did	O
not	O
affect	O
MS	O
,	O
intramuscular	O
fat	O
percentage	O
,	O
and	O
HCW	O
,	O
but	O
increased	O
the	O
ratio	O
of	O
MS	O
to	O
12th	O
rib	O
fat	O
thickness	O
and	O
the	O
ratio	O
of	O
percent	O
intramuscular	O
fat	O
to	O
12th	O
rib	O
fat	O
thickness	O
in	O
offspring	O
compared	O
with	O
positive	O
energy	O
status	O
[	O
154	O
].	O

Dissemination	O
plan	O
The	O
research	O
team	O
will	O
share	O
the	O
lessons	O
learned	O
from	O
the	O
study	O
widely	O
throughout	O
Bangladesh	O
and	O
among	O
global	O
audiences	O
.	O

Marked	O
improvement	O
was	O
seen	O
in	O
the	O
patient	O
'	O
s	O
hypernatremia	O
,	O
in	O
which	O
her	O
serum	O
sodium	O
concentrations	O
decreased	O
from	O
158	O
mEq	O
/	O
L	O
to143	O
mEq	O
/	O
L	O
within	O
30	O
hours	O
from	O
the	O
initial	O
DDAVP	O
dose	O
(	O
Figure	O
1	O
),	O
and	O
normalization	O
of	O
her	O
serum	O
osmolality	O
(	O
Figure	O
2	O
).	O

A	O
research	O
nurse	O
or	O
a	O
gynecologist	O
conducted	O
a	O
face	O
-	O
to	O
-	O
face	O
interview	O
with	O
each	O
woman	O
lasting	O
approximately	O
20	O
–	O
30	O
minutes	O
.	O

This	O
study	O
also	O
has	O
its	O
challenges	O
.	O

We	O
used	O
an	O
algorithm	O
to	O
generate	O
randomized	O
individual	O
assignments	O
to	O
condition	O
for	O
each	O
participant	O
.	O

Disclaimer	O
The	O
findings	O
and	O
conclusions	O
in	O
this	O
publication	O
are	O
those	O
of	O
the	O
authors	O
and	O
do	O
not	O
necessarily	O
represent	O
the	O
views	O
of	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
and	O
the	O
Pan	O
American	O
Health	O
Organization	O
(	O
PAHO	O
).	O

Expression	O
values	O
of	O
genes	O
participating	O
in	O
'	O
AMPK	O
signaling	O
'	O
and	O
'	O
mTOR	O
signaling	O
'	O
were	O
increased	O
,	O
whereas	O
genes	O
associated	O
with	O
the	O
'	O
degradation	O
of	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
'	O
were	O
decreased	O
in	O
AP	O
offspring	O
.	O

In	O
the	O
absence	O
of	O
survey	O
data	O
from	O
other	O
European	O
countries	O
,	O
we	O
suspect	B
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
Belgium	O
likely	B
reflects	O
the	O
situation	O
in	O
other	O
Western	O
European	O
countries	O
.	O

High	O
VD	O
serum	O
levels	O
and	O
their	O
derivatives	O
are	O
found	O
in	O
human	O
decidua	O
from	O
the	O
1st	O
trimester	O
of	O
pregnancy	O
,	O
which	O
strongly	B
suggests	O
its	O
contribution	O
in	O
the	O
implantation	O
process	O
and	O
a	O
local	O
immunological	O
preference	O
of	O
the	O
embryo	O
.	O

Following	O
widely	B
accepted	B
practice	I
,	O
Cronbach	O
alpha	O
of	O
.	O
6	O
was	O
used	O
to	O
confirm	O
interitem	O
agreement	O
for	O
use	O
of	O
the	O
factor	O
in	O
descriptive	O
and	O
regression	O
analyses	O
[	O
39	O
].	O

They	O
were	O
impatient	O
because	O
they	O
claimed	O
they	O
had	O
other	O
preoccupations	O
.	O

We	O
included	O
the	O
50	O
%	O
CIs	O
in	O
our	O
study	O
to	O
account	O
for	O
this	O
.	O

Significant	O
differences	O
were	O
noted	O
in	O
the	O
use	O
of	O
folic	O
acid	O
and	O
multivitamin	O
supplements	O
,	O
but	O
not	O
in	O
the	O
use	O
of	O
iron	O
supplements	O
,	O
depending	O
on	O
area	O
of	O
residence	O
(	O
rural	O
versus	O
urban	O
)	O
and	O
parity	O
.	O

This	O
vitamin	O
is	O
photosynthesized	O
by	O
ultraviolet	O
-	O
B	O
radiation	O
in	O
the	O
epidermis	O
.	O

The	O
24	O
h	O
urine	O
output	O
and	O
water	O
intake	O
were	O
adjusted	O
for	O
BM	O
(	O
mL	O
/	O
g	O
BM	O
)	O
and	O
analyzed	O
for	O
urea	O
,	O
creatinine	O
,	O
uric	O
acid	O
and	O
proteinuria	O
using	O
the	O
colorimetric	O
method	O
(	O
Bioclin	O
System	O
II	O
,	O
Quibasa	O
,	O
Belo	O
Horizonte	O
,	O
MG	O
,	O
Brazil	O
).	O

Using	O
RNA	O
FISH	O
,	O
GAS5	O
localized	O
primarily	B
in	O
syncytiotrophoblasts	O
(	O
Figure	O
2	O
(	O
c	O
)).	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

The	O
on	O
-	O
site	O
study	O
coordinator	O
assisted	O
treatment	O
participants	O
in	O
enrolling	O
in	O
text4baby	O
by	O
texting	O
“	O
DODBABY	O
”	O
to	O
a	O
designated	O
SMS	O
short	O
code	O
that	O
tagged	O
them	O
as	O
participants	O
in	O
the	O
study	O
.	O

This	O
may	O
therefore	O
be	O
affecting	O
the	O
number	O
of	O
these	O
elements	O
in	O
the	O
genome	O
and	O
the	O
functional	O
relevance	O
of	O
their	O
methylation	O
,	O
particularly	O
in	O
the	O
placenta	O
.	O

Staying	O
on	O
vitamin	O
D	O
consumption	O
until	O
childbirth	O
resulted	O
in	O
higher	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
that	O
induced	O
the	O
effect	O
on	O
postnatal	O
depression	O
exceeding	O
than	O
prenatal	O
depression	O
.	O

The	O
field	O
team	O
consisted	O
of	O
three	O
women	O
and	O
two	O
men	O
trained	O
in	O
anthropology	O
or	O
social	O
sciences	O
,	O
who	O
had	O
experience	O
in	O
collecting	O
qualitative	O
data	O
.	O

We	O
will	O
provide	O
a	O
specially	O
designed	O
medicine	O
box	O
to	O
each	O
participant	O
to	O
preserve	O
the	O
medicine	O
.	O

Prokaryote	O
genomes	O
contain	O
only	O
10	O
%	O
ncDNA	O
,	O
more	O
complex	O
fungi	O
and	O
animals	O
>	O
50	O
%,	O
rising	O
to	O
>	O
98	O
%	O
in	O
complex	O
mammals	O
(	O
including	O
mice	O
and	O
humans	O
)	O
(	O
Carey2011	O
).	O

Much	O
of	O
that	O
damage	O
may	O
be	O
permanent	O
,	O
that	O
is	O
,	O
it	O
cannot	O
be	O
fully	O
reversed	O
by	O
taking	O
Vitamin	O
D	O
after	O
birth	O
.	O

BMI	O
Body	O
mass	O
index	O
.	O

Models	O
were	O
adjusted	O
for	O
age	O
,	O
physical	O
activity	O
,	O
smoking	O
status	O
,	O
educational	O
attainment	O
,	O
season	O
of	O
blood	O
sampling	O
,	O
compliance	O
,	O
and	O
pregnancy	O
weight	O
gain	O
.	O

Our	O
data	O
,	O
from	O
this	O
small	O
dataset	O
,	O
can	O
only	O
be	O
used	O
to	O
partially	O
answer	O
this	O
question	O
specifically	O
related	O
to	O
bone	O
health	O
.	O

Bacterial	O
urinary	O
tract	O
infections	O
have	O
been	O
shown	O
to	O
follow	O
a	O
well	O
defined	O
seasonal	O
pattern	O
with	O
a	O
peak	O
in	O
August	O
[	O
127	O
].	O

Recommendations	O
should	O
be	O
made	O
on	O
informing	O
women	O
of	O
the	O
importance	O
of	O
maintaining	O
adequate	O
vitamin	O
D	O
stores	O
in	O
pregnancy	O
,	O
particularly	O
for	O
those	O
at	O
greatest	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Thus	B
,	O
it	O
is	O
likely	B
that	O
the	O
full	O
spectrum	O
of	O
potential	O
effects	O
will	O
not	O
be	O
identified	O
.	O

For	O
those	O
countries	O
in	O
the	O
Southeast	O
Asia	O
region	O
(	O
SearD	O
)	O
with	O
high	O
adult	O
and	O
child	O
mortality	O
rates	O
,	O
they	O
estimate	O
the	O
cost	O
as	O
$	O
10	O
.	O
12	O
(	O
but	O
as	O
high	O
as	O
$	O
46	O
.	O
04	O
per	O
pregnancy	O
in	O
the	O
low	O
mortality	O
countries	O
in	O
the	O
Europe	O
region	O
,	O
EurA	O
).	O

Regardless	O
of	O
the	O
underlying	O
cause	O
for	O
increased	O
markers	O
of	O
glucose	O
metabolism	O
,	O
our	O
findings	O
suggest	O
that	O
during	O
early	O
pregnancy	O
,	O
exposure	O
to	O
a	O
typical	O
winter	O
in	O
the	O
northern	O
hemisphere	O
,	O
which	O
often	B
includes	O
low	O
serum	O
25OHD	O
,	O
is	O
unfavourable	O
for	O
maternal	O
glucose	O
homeostasis	O
.	O

There	O
are	O
,	O
however	O
,	O
no	O
current	O
established	O
regulatory	O
procedures	O
or	O
guidelines	O
in	O
chemical	O
safety	O
programs	O
for	O
determining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

The	O
effects	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
are	O
complex	O
and	O
may	O
extend	O
beyond	O
bone	O
health	O
effects	O
in	O
infants	O
.	O

However	O
,	O
substitution	O
of	O
equivalent	O
amount	O
of	O
energy	O
from	O
grazed	O
pasture	O
with	O
high	O
-	O
energy	O
grain	O
-	O
based	O
feed	O
has	O
not	O
increased	O
IMF	O
contents	O
.	O

In	O
addition	O
,	O
no	B
case	O-
of	O-
hypervitaminosis	O-
D	O-
from	O-
sun	O-
exposure	O-
has	O-
ever	I
been	O
reported	O
.	O

Statistical	O
significance	O
was	O
accepted	O
at	O
the	O
p	O
<	O
0	O
.	O
05	O
level	O
.	O

The	O
median	O
BMI	O
of	O
the	O
cohort	O
was	O
31	O
.	O
0	O
kg	O
/	O
m2	O
(	O
Inter	O
Quartile	O
Range	O
(	O
IQR	O
)	O
27	O
.	O
8	O
–	O
35	O
.	O
6	O
kg	O
/	O
m2	O
),	O
with	O
42	O
.	O
1	O
%	O
of	O
women	O
overweight	O
,	O
and	O
57	O
.	O
9	O
%	O
obese	O
.	O

Radiographs	O
of	O
normal	O
(	O
A	O
,	O
B	O
),	O
Skm1	O
(	O
C	O
,	O
D	O
),	O
and	O
Skm2	O
(	O
E	O
,	O
F	O
)	O
mice	O
in	O
lateral	O
and	O
supine	O
positions	O
.	O

PTB	O
rates	O
were	O
calculated	O
for	O
the	O
overall	O
population	O
as	O
well	O
as	O
among	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
,	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
,	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
and	O
≥	O
40	O
ng	O
/	O
mL	O
closest	O
to	O
delivery	O
.	O

Food	O
and	O
beverages	O
consumed	O
over	O
three	O
consecutive	O
days	O
were	O
recorded	O
by	O
participants	O
during	O
each	O
trimester	O
using	O
3	O
-	O
day	O
food	O
diaries	O
.	O

Feeding	O
behavior	O
tests	O
in	O
the	O
offspring	O
were	O
carried	O
out	O
at	O
the	O
adolescence	O
(	O
postnatal	O
weeks	O
8	O
–	O
9	O
)	O
and	O
the	O
adulthood	O
(	O
postnatal	O
weeks	O
12	O
–	O
13	O
).	O

Such	O
commonly	O
identified	O
,	O
prenatal	O
risk	O
factors	O
may	O
include	O
advanced	O
-	O
aged	O
parents	O
,	O
a	O
short	O
gestation	O
period	O
,	O
low	O
birth	O
weight	O
,	O
hyperbilirubinemia	O
,	O
and	O
breech	O
presentation	O
[	O
3	O
].	O

All	O
studies	O
were	O
found	O
to	O
be	O
either	O
positive	O
or	O
neutral	O
in	O
regards	O
to	O
quality	O
rating	O
.	O

Acryomns	O
used	O
:	O
ANC	O
=	O
Antenatal	O
care	O
;	O
CPAP	O
=	O
Continuous	O
positive	O
airway	O
pressure	O
;	O
HIV	O
=	O
Human	O
Immunodeficiency	O
Virus	O
;	O
IMCI	O
=	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
;	O
IPTp	O
=	O
Intermittent	O
presumptive	O
treatment	O
during	O
pregnancy	O
for	O
malaria	O
;	O
pPROM	O
=	O
prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
STI	O
=	O
Sexually	O
Transmitted	O
Illness	O
.	O

Severe	O
intrauterine	O
growth	O
retardation	O
occurred	O
in	O
the	O
infant	O
of	O
a	O
mother	O
who	O
applied	O
40	O
mg	O
/	O
d	O
of	O
topical	O
triamcinolone	O
cream	O
from	O
week	O
12	O
to	O
29	O
of	O
gestation	O
to	O
treat	O
her	O
atopic	O
dermatitis	O
[	O
44	O
].	O

They	O
were	O
more	O
interested	O
in	O
having	O
an	O
indebt	O
knowledge	O
on	O
how	O
complications	O
arising	O
during	O
pregnancy	O
could	O
be	O
managed	O
.	O

Since	O
then	O
,	O
numerous	O
other	O
observational	O
studies	O
have	O
shown	O
that	O
the	O
offspring	O
of	O
diabetic	O
pregnancies	O
have	O
a	O
higher	O
risk	O
of	O
developing	O
a	O
diabetes	O
phenotype	O
.	O
18	O
,	O
19There	O
is	O
also	O
concern	O
that	O
this	O
leads	O
to	O
an	O
intergenerational	O
effect	O
,	O
with	O
GDM	O
promoting	O
diabetes	O
in	O
the	O
offspring	O
,	O
with	O
perpetuation	O
of	O
the	O
vicious	O
cycle	O
when	O
the	O
offspring	O
herself	O
develops	O
GDM	O
,	O
thereby	O
predisposing	O
the	O
grandchild	O
to	O
the	O
development	O
of	O
diabetes	O
as	O
well	O
.	O
20It	O
is	O
unknown	O
however	O
,	O
what	O
degree	O
of	O
hyperglycemia	O
,	O
or	O
indeed	O
if	O
it	O
is	O
related	O
metabolic	O
disturbances	O
,	O
which	O
increases	O
the	O
risk	O
of	O
diabetes	O
to	O
the	O
offspring	O
.	O

For	O
example	O
,	O
a	O
randomized	O
controlled	O
trial	O
among	O
pregnant	O
women	O
in	O
Switzerland	O
showed	O
that	O
the	O
parenteral	O
route	O
of	O
iron	O
prophylaxis	O
of	O
anaemia	O
has	O
no	O
clinically	O
significant	O
benefit	O
over	O
oral	O
route	O
as	B
there	O
was	O
no	O
significant	O
difference	O
in	O
maternal	O
outcomes	O
and	O
serious	O
adverse	O
events	O
between	O
the	O
two	O
groups	O
[	O
25	O
].	O

The	O
PFAS	O
exhibited	O
a	O
minimum	O
GM	O
of	O
1	O
μg	O
/	O
L	O
(	O
PFNA	O
)	O
and	O
maximum	O
GM	O
of	O
13	O
.	O
6	O
μg	O
/	O
L	O
(	O
PFOS	O
).	O

In	O
supplemental	O
multivariate	O
analyses	O
,	O
we	O
adjusted	O
for	O
baseline	O
differences	O
between	O
study	O
arms	O
.	O

Blood	O
glucose	O
monitoring	O
Women	O
with	O
GDM	O
should	O
perform	O
home	O
blood	O
glucose	O
monitoring	O
.	O

A	O
BRAC	O
PO	O
area	O
approximately	O
comprises	O
of	O
40	O
to	O
50	O
villages	O
with	O
an	O
average	O
population	O
of	O
13	O
,	O
000	O
people	O
.	O

People	O
residing	O
far	O
from	O
the	O
equator	O
are	O
at	O
an	O
increased	O
risk	O
for	O
vitamin	O
D	O
deficiency	O
due	O
to	O
decreased	O
cutaneous	O
synthesis	O
of	O
vitamin	O
D	O
[	O
9	O
].	O

[	O
15	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
a	O
younger	O
group	O
of	O
premenopausal	O
women	O
found	O
the	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
to	O
be	O
77	O
.	O
8	O
%,	O
which	O
was	O
as	O
high	O
as	O
the	O
rate	O
found	O
in	O
elderly	O
Thai	O
women	O
living	O
in	O
nursing	O
homes	O
.	O

From	O
this	O
information	O
,	O
we	O
categorized	O
participants	O
as	O
snoring	O
if	O
their	O
reported	O
snoring	O
most	O
or	O
all	O
of	O
the	O
time	O
;	O
all	O
other	O
women	O
were	O
classified	O
as	O
non	O
-	O
snorers	O
.	O

An	O
analysis	O
of	O
data	O
from	O
12	O
,	O
067	O
people	O
in	O
the	O
Framingham	O
Heart	O
Study	O
revealed	O
an	O
association	O
between	O
people	O
'	O
s	O
weight	O
gain	O
and	O
weight	O
gain	O
in	O
their	O
social	O
networks	O
(	O
97	O
).	O

Interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
predominantly	O
known	O
as	O
a	O
pro	O
-	O
inflammatory	O
cytokine	O
,	O
is	O
secreted	O
by	O
skeletal	O
muscle	O
(	O
Pal	O
et	O
al	O
.,	O
2014	O
),	O
helper	O
T	O
cells	O
,	O
as	O
well	O
as	O
by	O
WAT	O
and	O
BAT	O
(	O
Mohamed	O
-	O
Ali	O
et	O
al	O
.,	O
1997	O
;	O
Cannon	O
et	O
al	O
.,	O
1998	O
).	O

Being	O
right	O
-	O
handed	O
has	O
been	O
associated	O
with	O
a	O
greater	O
risk	O
for	O
glioma	O
than	O
being	O
left	O
-	O
handed	O
or	O
ambidextrous	O
[	O
178	O
].	O

2	O
.	O
3	O
.	O

The	O
effect	O
was	O
most	O
pronounced	O
for	O
omega	O
-	O
6	O
PUFAs	O
.	O

In	O
our	O
analysis	O
,	O
MEOHP	O
was	O
associated	O
with	O
a	O
13	O
g	O
birth	O
weight	O
increase	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
).	O

Only	O
,	O
4	O
women	O
(	O
2	O
.	O
2	O
%)	O
were	O
sufficient	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
≥	O
30	O
ng	O
/	O
mL	O
).	O

The	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
relative	O
risk	O
(	O
RR	O
)	O
for	O
anaemia	O
in	O
relation	O
to	O
MMN	O
supplement	O
,	O
age	O
and	O
ESR	O
were	O
computed	O
using	O
logistic	O
regression	O
.	O

Children	O
'	O
s	O
heightened	O
preference	O
for	O
salty	O
tastes	O
(	O
29	O
)	O
attracts	O
them	O
to	O
necessary	O
minerals	O
,	O
and	O
rejecting	O
bitter	O
-	O
tasting	O
substances	O
protects	O
them	O
from	O
poisons	O
because	B
most	B
poisonous	O
compounds	O
taste	O
bitter	O
(	O
30	O
).	O

Germany	O
)	O
to	O
the	O
nearest	O
0	O
.	O
1	O
kg	O
and	O
height	O
was	O
measured	O
without	O
shoes	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
using	O
a	O
wall	O
-	O
mounted	O
stadiometer	O
.	O

Female	O
military	O
health	O
beneficiaries	O
who	O
met	O
inclusion	O
criteria	O
were	O
eligible	O
for	O
the	O
study	O
.	O

The	O
chapters	O
on	O
nutrition	O
in	O
pregnancy	O
,	O
exercise	O
,	O
food	O
allergies	O
and	O
intolerance	O
,	O
etc	O
are	O
informative	O
and	O
will	O
be	O
a	O
good	O
read	O
for	O
students	O
in	O
the	O
respective	O
field	O
.	O

It	O
was	O
confirmed	O
that	O
abnormally	O
high	O
VD	O
concentration	O
causes	O
impaired	O
elimination	O
of	O
endometrium	O
cells	O
passing	O
to	O
the	O
peritoneal	O
cavity	O
via	O
ovarian	O
reflux	O
[	O
38	O
].	O

Our	O
study	O
has	O
limitations	O
associated	O
with	O
self	O
-	O
report	O
of	O
PNV	O
use	O
which	O
could	O
differ	O
from	O
actual	O
use	O
.	O

To	O
enable	O
de	O
-	O
differentiation	O
of	O
the	O
highly	O
specialized	O
mature	O
male	O
and	O
female	O
gametes	O
and	O
subsequent	O
generation	O
of	O
multiple	O
specialized	O
cell	O
types	O
capable	O
of	O
performing	O
a	O
wide	O
range	O
of	O
diverse	O
functions	O
,	O
these	O
genomes	O
require	O
differential	O
modifications	O
so	O
that	O
functionally	O
relevant	O
genes	O
can	O
be	O
switched	O
on	O
/	O
off	O
.	O

The	O
effective	O
target	O
group	O
accessed	O
was	O
calculated	O
at	O
70	O
%	O
of	O
the	O
250	O
,	O
00	O
eligible	O
women	O
or	O
175	O
,	O
581	O
women	O
of	O
reproductive	O
age	O
.	O

All	O
that	O
changed	O
on	O
16	O
July	O
1979	O
.	O

Height	O
was	O
measured	O
to	O
the	O
nearest	O
cm	O
using	O
a	O
stadiometer	O
(	O
Seca	O
Leicester	O
,	O
UK	O
),	O
and	O
weight	O
to	O
the	O
nearest	O
100	O
g	O
using	O
an	O
electronic	O
scale	O
(	O
Tanita	O
,	O
USA	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
.	O

It	O
is	O
not	O
necessarily	O
important	O
whether	O
an	O
environmental	O
exposure	O
induces	O
adverse	O
outcomes	O
in	O
multiple	O
exposed	O
or	O
non	O
-	O
exposed	O
generations	O
.	O

Conversely	O
,	O
other	O
recent	O
studies	O
have	O
suggested	O
that	O
there	O
may	O
actually	O
not	O
be	O
a	O
strong	O
association	O
between	O
SSRI	O
intake	O
and	O
the	O
subsequent	O
development	O
of	O
autism	O
.	O

Attendance	O
at	O
the	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
,	O
compared	O
to	O
summer	O
,	O
was	O
associated	O
with	O
significantly	O
higher	O
early	O
-	O
pregnancy	O
HOMA	O
-	O
IR	O
(	O
31	O
.	O
1	O
%)	O
and	O
insulin	O
(	O
30	O
.	O
6	O
%),	O
but	O
not	O
glucose	O
(	O
Table3	O
[	O
b	O
]).	O

In	O
this	O
paper	O
,	O
we	O
describe	O
the	O
protocol	O
of	O
a	O
community	O
-	O
based	O
cluster	O
randomised	O
controlled	O
trial	O
that	O
aims	O
to	O
evaluate	O
the	O
impact	O
of	O
maternal	O
antenatal	O
IFA	O
supplements	O
on	O
perinatal	O
outcomes	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
lower	O
rate	O
of	O
psychotic	O
-	O
like	O
symptoms	O
with	O
increasing	O
vitamin	O
D	O
intake	O
.	O

Additionally	O
,	O
genome	O
-	O
wide	O
and	O
spermatic	O
methylation	O
studies	O
were	O
performed	O
.	O

Tertiary	O
prevention	O
is	O
directed	O
at	O
patients	O
with	O
a	O
chronic	O
disease	O
to	O
prevent	O
additional	O
problems	O
related	O
to	O
the	O
disease	O
.	O

Nevertheless	O
,	O
there	O
was	O
a	O
higher	O
(	O
adequate	O
level	O
)	O
mean	O
serum	O
concentration	O
of	O
calcifediol	O
at	O
the	O
end	O
of	O
first	O
supplementation	O
period	O
in	O
the	O
intervention	O
group	O
compared	O
with	O
the	O
lower	O
(	O
not	O
adequate	O
)	O
mean	O
concentrations	O
in	O
the	O
placebo	O
group	O
(	O
data	O
not	O
shown	O
).	O

Materials	O
and	O
methods	O
Study	O
population	O
and	O
data	O
collection	O
Records	O
were	O
obtained	O
from	O
an	O
ongoing	O
prospective	O
birth	O
cohort	O
study	O
called	O
the	O
Prediction	O
of	O
Allergy	O
in	O
Taiwanese	O
Children	O
(	O
PATCH	O
),	O
from	O
January	O
2013	O
to	O
December	O
2015	O
.	O

Body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
computed	O
using	O
the	O
formula	O
weight	O
(	O
kg	O
)/	O
height	O
(	O
m2	O
).	O

Follow	O
-	O
up	O
data	O
collection	O
was	O
conducted	O
remotely	O
primarily	O
through	O
a	O
secure	O
survey	O
website	O
[	O
23	O
].	O

Pregnancy	O
does	O
not	O
seem	O
to	O
be	O
compromised	O
by	O
thyroid	O
cancer	O
.	O

The	O
normality	O
of	O
the	O
data	O
was	O
evaluated	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

We	O
enrolled	O
50	O
definitive	O
MS	O
patients	O
,	O
according	O
to	O
McDonald	O
’	O
s	O
criteria	O
as	O
case	O
group	O
and	O
50	O
matched	O
controls	O
.	O

There	O
was	O
no	O
apparent	O
change	O
in	O
the	O
expression	O
of	O
any	O
of	O
the	O
genes	O
in	O
these	O
two	O
categories	O
(	O
data	O
not	O
shown	O
).	O

The	O
ASQ	O
has	O
been	O
validated	O
against	O
the	O
Bayley	O
Scales	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

They	O
collected	O
milk	O
samples	O
at	O
multiple	O
points	O
throughout	O
lactation	O
and	O
estimated	O
concentrations	O
of	O
PCBs	O
and	O
DDE	O
(	O
a	O
breakdown	O
product	O
of	O
DDT	O
)	O
in	O
milk	O
at	O
birth	O
.	O

Focusing	O
on	O
post	O
-	O
natal	O
issues	O
was	O
not	O
usually	O
appealing	O
to	O
pregnant	O
women	O
who	O
were	O
more	O
eager	O
to	O
learn	O
about	O
labor	O
.	O

Therefore	O
,	O
the	O
up	O
-	O
regulation	O
of	O
'	O
AMPK	O
signaling	O
'	O
in	O
developmental	O
periods	O
I	O
,	O
II	O
and	O
III	O
in	O
AP	O
offspring	O
accounts	O
for	O
metabolic	O
health	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
LP	O
offspring	O
.	O

S	O
-	O
ECC	O
,	O
infrequent	O
milk	O
intake	O
,	O
and	O
winter	O
season	O
were	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
but	O
not	O
household	O
income	O
or	O
vitamin	O
D	O
drop	O
use	O
.	O

However	O
,	O
certain	O
stages	O
in	O
development	O
and	O
cell	O
types	O
can	O
be	O
thought	O
of	O
as	B
particularly	O
sensitive	O
to	O
epigenetic	O
change	O
due	O
to	O
the	O
resulting	O
severity	O
of	O
the	O
outcome	O
for	O
the	O
individual	O
or	O
the	O
potential	O
for	O
affecting	O
multiple	O
generations	O
.	O

The	O
Institute	O
of	O
Medicine	O
recommends	O
a	O
daily	O
intake	O
of	O
400	O
μg	O
of	O
folic	O
acid	O
and	O
30	O
mg	O
of	O
iron	O
during	O
the	O
second	O
and	O
third	O
trimesters	O
[	O
31	O
].	O

Briefly	O
,	O
women	O
attending	O
one	O
of	O
three	O
UK	O
hospitals	O
[	O
University	O
Hospital	O
Southampton	O
National	O
Health	O
Service	O
(	O
NHS	O
)	O
Foundation	O
Trust	O
,	O
Southampton	O
,	O
UK	O
(	O
latitude	O
50	O
.	O
9	O
°	O
North	O
);	O
Oxford	O
University	O
Hospitals	O
NHS	O
Foundation	O
Trust	O
,	O
Oxford	O
,	O
UK	O
(	O
latitude	O
51	O
.	O
8	O
°	O
North	O
);	O
Sheffield	O
Hospitals	O
NHS	O
Trust	O
(	O
University	O
of	O
Sheffield	O
),	O
Sheffield	O
,	O
UK	O
(	O
latitude	O
53	O
.	O
4	O
°	O
North	O
)]	O
for	O
early	O
pregnancy	O
ultrasound	O
screening	O
(	O
11	O
to	O
14	O
weeks	O
of	O
gestation	O
)	O
between	O
6	O
October	O
2008	O
and	O
11	O
February	O
2014	O
were	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

A	O
mutation	O
in	O
this	O
domain	O
would	O
prevent	O
clearance	O
of	O
the	O
NPs	O
and	O
result	O
in	O
their	O
accumulation	O
.	O

This	O
document	O
also	O
includes	O
a	O
summary	O
of	O
evidence	O
-	O
based	O
guidelines	O
and	O
strength	O
of	O
recommendations	O
.	O

At	O
188	O
dpn	O
the	O
body	O
weight	O
was	O
slightly	O
but	O
significantly	O
reduced	O
in	O
LP	O
compared	O
to	O
AP	O
(	O
LP	O
:	O
123	O
.	O
19	O
±	O
9	O
.	O
15	O
kg	O
,	O
AP	O
:	O
131	O
.	O
55	O
±	O
15	O
.	O
11	O
kg	O
,	O
P	O
-	O
0	O
.	O
03	O
;	O
n	O
-	O
32	O
).	O

Other	O
commonly	B
used	O
guidelines	B
are	O
Rotterdam	O
and	O
Androgen	O
Access	O
Society	O
criteria	O
[	O
22	O
,	O
23	O
].	O

In	O
humans	O
,	O
low	O
protein	O
intake	O
by	O
women	O
in	O
late	O
pregnancy	O
has	O
been	O
associated	O
with	O
low	O
birth	O
weight	O
,	O
a	O
marker	O
of	O
risk	O
for	O
obesity	O
and	O
other	O
metabolic	O
disorders	O
later	O
in	O
life	O
(	O
14	O
).	O

It	O
was	O
concluded	O
that	O
although	O
autism	O
is	O
unlikely	B
to	O
be	O
caused	O
by	O
a	O
single	O
obstetric	O
factor	O
,	O
there	O
was	O
an	O
increased	O
prevalence	O
of	O
obstetric	O
complications	O
among	O
autism	O
cases	O
that	O
is	O
most	B
likely	I
due	O
to	O
underlying	O
genetic	O
factors	O
and	O
an	O
interaction	O
of	O
these	O
factors	O
with	O
the	O
environment	O
[	O
8	O
].	O

For	O
the	O
small	O
numbers	O
of	O
fathers	O
we	O
measured	O
,	O
there	O
was	O
a	O
significantly	O
lower	O
height	O
than	O
in	O
those	O
we	O
reported	O
.	O

Therefore	B
,	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
machinery	O
in	O
the	O
adipose	O
tissue	O
of	O
male	O
offspring	O
at	O
adulthood	O
may	O
result	O
in	O
a	O
putative	B
compensatory	O
effect	O
in	O
order	O
to	O
respond	O
to	O
an	O
unbalanced	O
endocannabinoid	O
tone	O
originated	O
at	O
birth	O
after	O
maternal	O
undernutrition	O
.	O

Both	O
serum	O
25	O
(	O
OH	O
)	O
D3and	O
25	O
(	O
OH	O
)	O
D2were	O
measured	O
independently	O
and	O
combined	O
to	O
provide	O
a	O
total	O
25	O
(	O
OH	O
)	O
D	O
in	O
nmol	O
/	O
L	O
[	O
27	O
].	O

It	O
is	O
an	O
unrecognized	O
epidemic	O
common	B
among	O
children	O
,	O
adults	O
and	O
pregnant	O
women	O
throughout	O
the	O
world	O
,	O
across	O
ethnicity	O
and	O
season	O
.	O

Use	O
of	O
the	O
Report	O
Card	O
grades	O
by	O
state	O
governments	O
has	O
grown	O
since	O
the	O
Report	O
Cards	O
were	O
first	O
launched	O
in	O
2008	O
,	O
and	O
coverage	O
by	O
local	O
media	O
is	O
consistently	O
strong	O
.	O

Three	O
studies	O
[	O
19	O
,	O
21	O
,	O
24	O
]	O
reported	O
on	O
the	O
frequency	O
of	O
consumption	O
without	O
specifying	O
the	O
weight	O
of	O
fish	O
servings	O
while	O
the	O
remaining	O
studies	O
made	O
assumptions	O
based	O
on	O
standard	O
serving	O
sizes	O
,	O
as	O
to	O
the	O
quantity	O
of	O
fish	O
consumed	O
at	O
each	O
occasion	O
.	O

The	O
mRNA	O
expression	O
level	O
of	O
genes	O
associated	O
with	O
cell	O
cycle	O
,	O
mitosis	O
,	O
and	O
metabolism	O
of	O
purines	O
and	O
pyrimidines	O
was	O
increased	O
in	O
LP	O
offspring	O
.	O

A	O
national	O
survey	O
in	O
2000	O
found	O
anaemia	O
rates	O
were	O
24	O
.	O
3	O
%	O
for	O
non	O
-	O
pregnant	O
women	O
nationally	O
(	O
26	O
.	O
3	O
%	O
in	O
rural	O
areas	O
),	O
and	O
32	O
.	O
2	O
%	O
in	O
pregnant	O
women	O
(	O
33	O
.	O
8	O
%	O
in	O
rural	O
areas	O
)[	O
10	O
].	O

(	O
2016	O
).	O

Another	O
Australian	O
study	O
evaluated	O
maternal	O
conditions	O
and	O
perinatal	O
characteristics	O
associated	O
with	O
ASD	O
and	O
intellectual	O
disability	O
.	O

Treatment	O
to	O
post	O
-	O
prandial	O
targets	O
results	O
in	O
superior	O
pregnancy	O
outcomes	O
compared	O
to	O
pre	O
-	O
prandial	O
targets	O
.	O
25The	O
recommended	O
treatment	O
targets	O
vary	O
from	O
country	O
to	O
country	O
(	O
Table	O
2	O
).	O

Further	O
evaluation	O
of	O
the	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
protocol	O
is	O
planned	O
.	O

(	O
2013	O
)	O
*	O
Xie	O
et	O
al	O
.	O

Also	O
we	O
exclude	O
twin	O
pregnancies	O
.	O

As	B
a	O
consequence	B
the	O
Vietnam	O
National	O
Nutrition	O
Strategy	O
2011	O
–	O
2020	O
has	O
the	O
reduction	O
of	O
iron	O
deficiency	O
anemia	O
in	O
children	O
less	O
than	O
5	O
years	O
of	O
age	O
and	O
reproductive	O
-	O
age	O
women	O
as	O
an	O
objective	O
.	O

As	B
these	O
nuclear	O
receptors	O
has	O
been	O
also	O
linked	O
to	O
the	O
activation	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
and	O
insulin	O
sensitivity	O
(	O
Auwerx	O
,	O
1999	O
;	O
Minnich	O
et	O
al	O
.,	O
2001	O
),	O
their	O
decreased	O
levels	O
in	O
RC	O
females	O
might	O
be	O
associated	O
to	O
alterations	O
in	O
lipid	O
and	O
glucose	O
metabolism	O
(	O
Liu	O
et	O
al	O
.,	O
2015	O
).	O

1998	O
;	O
Yasoda	O
et	O
al	O
.	O

Fetal	O
growth	O
may	O
have	O
later	O
health	O
implications	O
also	O
within	O
the	O
normal	O
-	O
birth	O
-	O
weight	O
range	O
[	O
14	O
].	O

Table	O
1describes	O
the	O
baseline	O
characteristics	O
of	O
the	O
subset	O
of	O
eligible	O
maternal	O
participants	O
,	O
and	O
are	O
similar	O
to	O
the	O
entire	O
randomised	O
cohort	O
(	O
data	O
not	O
shown	O
)	O
[	O
22	O
].	O

Although	O
liver	O
and	O
cod	O
liver	O
oil	O
contain	O
vitamin	O
D	O
,	O
they	O
are	O
not	O
recommended	O
in	O
pregnancy	O
as	O
they	O
also	O
contain	O
too	O
much	O
vitamin	O
A	O
.	O
Vitamin	O
D	O
is	O
a	O
unique	O
nutrient	O
because	B
its	O
requirement	O
can	O
be	O
met	O
by	O
both	O
endogenous	O
production	O
from	O
sunlight	O
as	O
well	O
as	O
exogenous	O
dietary	O
sources	O
,	O
which	O
complicates	O
determining	O
the	O
body	O
'	O
s	O
daily	O
nutritional	O
requirements	O
.	O

As	O
few	O
food	O
items	O
contain	O
or	O
are	O
fortified	O
with	O
vitamin	O
D	O
(	O
such	O
as	O
liver	O
,	O
fatty	O
fish	O
,	O
eggs	O
,	O
milk	O
and	O
dairy	O
products	O
,	O
soy	O
milk	O
,	O
butter	O
,	O
margarines	O
),	O
the	O
skin	O
synthesis	O
of	O
vitamin	O
D	O
induced	O
by	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
is	O
the	O
main	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
[	O
23	O
].	O

The	O
adequacy	O
of	O
the	O
current	O
vitamin	O
D	O
dietary	O
recommendations	O
to	O
reach	O
an	O
optimal	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
has	O
been	O
questioned	O
[	O
24	O
].	O

In	O
addition	O
,	O
brown	O
adipocytes	O
can	O
be	O
found	O
scattered	O
in	O
WAT	O
,	O
especially	O
upon	O
cold	O
exposure	O
(	O
Young	O
et	O
al	O
.,	O
1984	O
;	O
Guerra	O
et	O
al	O
.,	O
1998	O
),	O
treatment	O
with	O
β	O
-	O
adrenergic	O
(	O
Himms	O
-	O
Hagen	O
et	O
al	O
.,	O
2000	O
),	O
or	O
with	O
peroxisome	O
-	O
proliferator	O
-	O
activated	O
receptor	O
-	O
γ	O
(	O
PPAR	O
-	O
γ	O
)	O
agonists	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
).	O

After	O
the	O
filtering	O
steps	O
described	O
above	O
,	O
10	O
,	O
293	O
probe	O
-	O
sets	O
were	O
detected	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
10	O
,	O
317	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
8	O
,	O
892	O
).	O

Oral	O
antihistamines	O
should	O
be	O
avoided	O
during	O
the	O
first	O
trimester	O
,	O
unless	O
definitely	O
clinically	O
indicated	O
,	O
and	O
then	O
should	O
be	O
used	O
at	O
the	O
lowest	O
effective	O
dose	O
,	O
starting	O
with	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
.	O

As	B
the	O
level	O
of	O
insulin	O
resistance	O
varies	O
from	O
person	O
to	O
person	O
,	O
it	O
is	O
common	O
practice	O
to	O
commence	O
the	O
woman	O
on	O
small	O
doses	O
of	O
insulin	O
,	O
and	O
then	O
to	O
increase	O
the	O
doses	O
at	O
frequent	O
intervals	O
until	O
target	O
glucose	O
levels	O
are	O
attained	O
.	O

This	O
is	O
in	O
contrast	O
to	O
a	O
previous	O
study	O
involving	O
12	O
fetal	O
cord	O
blood	O
samples	O
,	O
which	O
reported	O
a	O
significant	O
correlation	O
between	O
LINE	O
-	O
1	O
methylation	O
and	O
methylation	O
of	O
specific	O
loci	O
residing	O
mostly	O
in	O
CGIs	O
(	O
Fryer	O
et	O
al	O
.	O

Vitamin	O
D	O
has	O
effects	O
on	O
the	O
immune	O
system	O
,	O
cytokines	O
,	O
and	O
antibacterial	O
peptides	O
that	O
are	O
likely	B
to	O
regulate	O
the	O
bacterial	O
flora	O
.	O

In	O
post	O
hoc	O
analysis	O
of	O
two	O
-	O
tail	O
t	O
test	O
,	O
the	O
statistical	O
power	O
could	O
reach	O
0	O
.	O
6	O
(	O
alpha	O
risk	O
,	O
0	O
.	O
05	O
;	O
effect	O
size	O
,	O
0	O
.	O
5	O
).	O

The	O
RR	O
comparing	O
the	O
highest	O
to	O
the	O
lowest	O
quartile	O
of	O
omega	O
-	O
6	O
PUFAs	O
intake	O
was	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

For	O
our	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
we	O
included	O
all	O
children	O
randomly	O
assigned	O
to	O
our	O
study	O
groups	O
.	O

The	O
supernatant	O
was	O
removed	O
to	O
a	O
new	O
tube	O
then	O
dried	O
in	O
a	O
centrifugal	O
vacuum	O
drier	O
.	O

In	O
a	O
study	O
by	O
Cekmez	O
et	O
al	O
.	O

Expression	O
of	O
hepatic	O
miRNAs	O
targeting	O
porcine	O
glucocorticoid	O
receptor	O
(	O
GR	O
)	O
3	O
′	O
UTR	O
in	O
the	O
neonatal	O
piglets	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
Abstract	O
Glucocorticoid	O
receptor	O
(	O
GR	O
)	O
has	O
been	O
previously	O
demonstrated	O
an	O
important	O
transcriptional	O
factor	O
of	O
hepatic	O
metabolic	O
genes	O
in	O
the	O
neonates	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
(“	O
Gestational	O
dietary	O
betaine	O
supplementation	O
suppresses	O
hepatic	O
expression	O
of	O
lipogenic	O
genes	O
in	O
neonatal	O
piglets	O
through	O
epigenetic	O
and	O
glucocorticoid	O
receptor	O
-	O
dependent	O
mechanisms	O
”	O
Cai	O
et	O
al	O
.,	O
2015	O
[	O
1	O
]).	O

Despite	O
differences	O
in	O
vitamin	O
D	O
status	O
,	O
there	O
were	O
no	O
significant	O
associations	O
between	O
cathelicidin	O
,	O
race	O
/	O
ethnicity	O
and	O
vitamin	O
D	O
status	O
(	O
see	O
Table	O
2	O
).	O

However	O
,	O
the	O
findings	O
in	O
our	O
study	O
appear	O
meaningful	B
in	O
that	O
the	O
provision	O
of	O
vitamin	O
D	O
at	O
a	O
dose	O
of	O
400	O
IU	O
/	O
day	O
led	O
to	O
mean	O
values	O
that	O
were	O
above	O
30	O
ng	O
/	O
mL	O
regardless	O
of	O
starting	O
value	O
or	O
ethnicity	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
develop	O
methods	O
for	O
producing	O
highly	O
marbled	O
beef	O
without	O
increasing	O
overall	O
body	O
fat	O
deposition	O
,	O
including	O
internal	O
(	O
abdominal	O
,	O
perirenal	O
,	O
mesenteric	O
)	O
and	O
external	O
(	O
subcutaneous	O
)	O
inedible	O
fat	O
.	O

Serum	O
levels	O
of	O
vitamin	O
D	O
in	O
three	O
categories	O
in	O
the	O
two	O
groups	O
are	O
shown	O
inFigure	O
2	O
.	O

They	O
showed	O
that	O
there	O
was	O
no	O
evidence	O
linking	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
in	O
pregnancy	O
with	O
an	O
increase	O
in	O
autism	O
risk	O
,	O
except	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
for	O
more	O
than	O
two	O
days	O
[	O
26	O
,	O
62	O
].	O

Overall	O
,	O
there	O
was	O
no	O
relationship	O
between	O
changes	O
in	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
(	O
Figure1	O
).	O

Lower	O
vitamin	O
D	O
status	O
has	O
also	O
been	O
associated	O
with	O
a	O
medical	O
history	O
of	O
recurrent	O
miscarriage	O
[	O
12	O
]	O
but	O
only	O
two	O
prospective	O
studies	O
have	O
investigated	O
this	O
,	O
without	O
finding	O
that	O
lower	O
25OHD	O
concentrations	O
increases	O
the	O
risk	O
of	O
pregnancy	O
loss	O
[	O
5	O
,	O
13	O
].	O

Previously	O
we	O
explored	O
the	O
genomic	O
and	O
proteomic	O
characteristics	O
of	O
frontal	O
cortex	O
and	O
the	O
hippocampus	O
in	O
the	O
adult	O
DVD	O
rat	O
[	O
18	O
],[	O
19	O
].	O

MATERIALS	O
/	O
SUBJECTS	O
AND	O
METHODS	O
Study	O
design	O
and	O
intervention	O
The	O
current	O
study	O
was	O
nested	O
within	O
the	O
Periconceptional	O
Multimicronutrient	O
Supplementation	O
Trial	O
(	O
PMMST	O
)	O
[	O
ISRCTN	O
13687662	O
],	O
based	O
in	O
31	O
rural	O
Gambian	O
villages	O
of	O
Kiang	O
West	O
under	O
demographic	O
surveillance	O
by	O
the	O
UK	O
Medical	O
Research	O
Council	O
field	O
station	O
in	O
Keneba	O
and	O
which	O
ran	O
between	O
February	O
2005	O
and	O
June	O
2008	O
.	O

The	O
mothers	O
who	O
were	O
not	O
on	O
antidepressant	O
drugs	O
were	O
selected	O
as	O
the	O
control	O
group	O
.	O

Although	O
there	O
was	O
an	O
initial	O
small	O
uncontrolled	O
report	O
which	O
suggested	O
that	O
Lispro	O
may	O
have	O
teratogenic	O
effects	O
when	O
used	O
in	O
type	O
1	O
diabetic	O
pregnancy	O
,	O
37this	O
has	O
not	O
been	O
borne	O
out	O
in	O
subsequent	O
studies	O
.	O

Allergy	O
diagnosis	O
during	O
pregnancy	O
should	O
preferentially	O
consist	O
of	O
recording	O
the	O
patient	O
'	O
s	O
history	O
for	O
precise	O
recommendation	O
of	O
allergen	O
avoidance	O
and	O
in	O
vitro	O
testing	O
only	O
.	O

In	O
our	O
study	O
,	O
normal	O
weight	O
mothers	O
were	O
more	O
likely	B
to	O
have	O
low	O
weight	O
gain	O
targets	O
,	O
whereas	O
overweight	O
and	O
obese	O
women	O
were	O
more	O
likely	B
to	O
have	O
high	O
weight	O
gain	O
targets	O
.	O

The	O
team	O
analyzed	O
96	O
confirmed	O
cancer	O
cases	O
from	O
the	O
New	O
Mexico	O
Tumor	O
Registry	O
,	O
32	O
lung	O
cancer	O
cases	O
and	O
64	O
cases	O
of	O
other	O
cancers	O
.	O

The	O
women	O
were	O
asked	O
to	O
fill	O
in	O
a	O
paper	O
questionnaire	O
,	O
including	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
),	O
and	O
levels	O
of	O
fish	O
,	O
PUFAs	O
and	O
vitamin	O
D	O
intake	O
were	O
evaluated	O
.	O

Abstract	O
In	O
the	O
last	O
decade	O
,	O
vitamin	O
D	O
was	O
in	O
the	O
spotlight	O
in	O
many	O
fields	O
of	O
research	O
.	O

These	O
,	O
in	O
turn	O
,	O
can	O
trigger	O
further	O
problems	O
ranging	O
from	O
slow	O
physical	O
growth	O
and	O
motor	O
development	O
to	O
impaired	O
emotional	O
control	O
.	O

It	O
can	O
therefore	B
be	O
concluded	O
that	O
,	O
even	O
though	O
the	O
BAT	O
depots	O
are	O
present	O
in	O
small	O
amounts	O
,	O
the	O
activated	O
tissue	O
has	O
the	O
potential	O
to	O
substantially	O
contribute	O
to	O
energy	O
expenditure	O
(	O
Nedergaard	O
et	O
al	O
.,	O
2007	O
).	O

However	O
,	O
the	O
allergen	O
dose	O
should	O
not	O
be	O
increased	O
during	O
pregnancy	O
but	O
rather	O
reduced	O
if	O
necessary	O
[	O
29	O
].	O

Data	O
analysis	O
Overall	O
,	O
data	O
processing	O
and	O
statistical	O
analysis	O
are	O
performed	O
using	O
the	O
SAS	O
statistical	O
package	O
(	O
SAS	O
,	O
Cary	O
,	O
NC	O
,	O
USA	O
).	O

This	O
group	O
of	O
participants	O
may	O
not	O
be	O
representative	O
of	O
the	O
target	O
population	O
.	O

The	O
mean	O
duration	O
of	O
fetal	O
exposure	O
to	O
an	O
SGA	O
was	O
31	O
.	O
2	O
weeks	O
and	O
ranged	O
from	O
4	O
to	O
42	O
weeks	O
.	O

Studies	O
in	O
migrants	O
implicate	O
postnatal	O
environmental	O
exposures	O
,	O
but	O
do	O
not	O
exclude	O
prenatal	O
effects	O
.	O
1529Blood	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
fluctuate	O
with	O
season	O
,	O
but	O
the	O
etiological	O
relevance	O
of	O
these	O
fluctuations	O
to	O
MS	O
risk	O
is	O
unknown	O
.	O

Compared	O
with	O
lean	O
women	O
who	O
did	O
not	O
snore	O
,	O
those	O
who	O
were	O
overweight	O
and	O
snored	O
had	O
a	O
6	O
.	O
9	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

In	O
our	O
pipeline	O
,	O
ENU	O
-	O
mutagenized	O
mice	O
were	O
bred	O
to	O
homozygosity	O
in	O
a	O
three	O
-	O
generation	O
breeding	O
scheme	O
(	O
Figure	O
1A	O
),	O
and	O
although	O
G3	O
progeny	O
were	O
to	O
be	O
screened	O
for	O
susceptibility	O
to	O
bacterial	O
infection	O
,	O
mice	O
were	O
initially	O
examined	O
for	O
gross	O
morphological	O
defects	O
.	O

The	O
hypothalamus	O
is	O
able	O
to	O
cross	O
-	O
talk	O
to	O
other	O
metabolically	O
relevant	O
tissues	O
such	O
as	O
liver	O
and	O
adipose	O
tissue	O
through	O
sympathetic	O
circuits	O
and	O
circulating	O
signals	O
(	O
leptin	O
,	O
insulin	O
,	O
CCK	O
,	O
neurotrophins	O
,	O
IL	O
-	O
6	O
)	O
by	O
the	O
homeostatic	O
regulation	O
of	O
the	O
endocannabinoid	O
signaling	O
system	O
(	O
Das	O
,	O
2010	O
;	O
Maccarrone	O
et	O
al	O
.,	O
2014	O
;	O
Seoane	O
-	O
Collazo	O
et	O
al	O
.,	O
2015	O
).	O

We	O
thought	O
we	O
were	O
very	O
fortunate	O
,	O
but	O
we	O
were	O
not	O
told	O
,	O
‘	O
Later	O
on	O
this	O
will	O
affect	O
you	O
in	O
this	O
way	O
.’”	O
7	O
Yet	O
researchers	O
had	O
noted	O
as	O
early	O
as	O
1879	O
that	O
uranium	O
miners	O
in	O
Europe	O
showed	O
significantly	O
elevated	O
levels	O
of	O
lung	O
cancer	O
.	O
8By	O
the	O
1930s	O
,	O
they	O
suspected	B
radiation	O
as	O
the	O
culprit	O
.	O
9As	O
early	O
as	O
1951	O
,	O
government	O
scientists	O
had	O
begun	O
to	O
work	O
out	O
what	O
made	O
uranium	O
so	O
deadly	O
.	O

In	O
healthy	O
women	O
,	O
the	O
final	O
effect	O
consists	O
of	O
a	O
significant	O
increase	O
in	O
the	O
total	O
thyroxine	O
pool	O
,	O
mainly	B
in	O
the	O
first	O
trimester17	O
-	O
19	O
.	O

As	O
a	O
sensitivity	O
analysis	O
,	O
we	O
repeated	O
the	O
analyses	O
including	O
all	O
women	O
who	O
self	O
-	O
reported	O
vaccination	O
,	O
regardless	O
of	O
proof	O
of	O
evidence	O
.	O

Johnson	O
et	O
al	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
combined	O
or	O
system	O
-	O
specific	O
morbidity	O
profiles	O
between	O
study	O
groups	O
(	O
data	O
not	O
shown	O
).	O

Racial	O
disparities	O
in	O
cord	O
blood	O
vitamin	O
D	O
levels	O
and	O
its	O
association	O
with	O
small	O
-	O
for	O
-	O
gestational	O
-	O
age	O
infants	O
Abstract	O
Objective	O
:	O
To	O
examine	O
the	O
relationship	O
of	O
race	O
and	O
maternal	O
characteristics	O
and	O
their	O
association	O
with	O
cord	O
blood	O
vitamin	O
D	O
levels	O
and	O
small	O
-	O
for	O
-	O
gestational	O
-	O
age	O
(	O
SGA	O
)	O
status	O
.	O

From	O
the	O
final	O
analysis	O
ten	O
questionnaires	O
were	O
excluded	O
representing	O
drop	O
-	O
outs	O
(	O
refusals	O
after	O
the	O
initial	O
moment	O
of	O
the	O
study	O
or	O
incomplete	O
questionnaires	O
).	O

This	O
simple	O
,	O
inexpensive	O
and	O
safe	O
treatment	O
may	O
prevent	O
the	O
need	O
to	O
use	O
more	O
invasive	O
therapy	O
.	O

As	O
noted	O
,	O
military	O
women	O
’	O
s	O
health	O
is	O
an	O
understudied	O
topic	O
and	O
the	O
multiple	O
stressors	O
that	O
they	O
face	O
compared	O
to	O
civilian	O
women	O
suggest	O
that	O
it	O
deserves	O
greater	O
attention	O
from	O
mHealth	O
and	O
other	O
health	O
studies	O
[	O
34	O
,	O
41	O
].	O

As	B
the	O
main	O
endogenous	O
agonists	O
(	O
anandamide	O
and	O
2	O
-	O
arachidonoyl	O
glycerol	O
)	O
of	O
the	O
cannabinoid	O
receptors	O
CB1	O
and	O
CB2	O
are	O
derivatives	O
of	O
fatty	O
acids	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
the	O
lipid	O
profile	O
of	O
the	O
diet	O
could	O
modify	O
the	O
endocannabinoid	O
levels	O
(	O
Artmann	O
et	O
al	O
.,	O
2008	O
)	O
in	O
some	O
tissues	O
,	O
including	O
the	O
early	O
developing	O
brain	O
(	O
Berger	O
et	O
al	O
.,	O
2001	O
).	O

(	O
2007	O
),	O
and	O
/	O
orSquazzo	O
et	O
al	O
.	O

The	O
non	O
-	O
linearity	O
in	O
the	O
association	O
might	O
seemingly	O
argue	O
against	O
a	O
possible	O
causal	O
relationship	O
.	O

Using	O
the	O
results	O
from	O
analyses	O
of	O
the	O
three	O
future	O
scenarios	O
(	O
Figure8	O
),	O
a	O
target	O
for	O
mortality	O
reduction	O
of	O
preterm	O
births	O
was	O
set	O
and	O
agreed	O
by	O
the	O
technical	O
experts	O
(	O
Figure7	O
).	O

By	O
getting	O
messages	O
to	O
a	O
specific	O
population	O
group	O
when	O
they	O
are	O
at	O
risk	O
of	O
engaging	O
in	O
unhealthy	O
behavior	O
(	O
eg	O
,	O
teens	O
watching	O
TV	O
,	O
being	O
exposed	O
to	O
junk	O
food	O
advertising	O
,	O
being	O
sedentary	O
and	O
snacking	O
at	O
times	O
such	O
as	O
after	O
school	O
or	O
on	O
weekends	O
),	O
interventions	O
can	O
influence	O
them	O
at	O
the	O
optimal	O
time	O
[	O
46	O
,	O
47	O
].	O

In	O
22	O
.	O
6	O
%	O
of	O
221	O
infertile	O
patients	O
,	O
the	O
VD	O
serum	O
concentration	O
was	O
lesser	O
than	O
25	O
nmol	O
/	O
L	O
,	O
in	O
70	O
.	O
1	O
%	O
it	O
was	O
within	O
the	O
range	O
of	O
25	O
–	O
72	O
.	O
3	O
nmol	O
/	O
L	O
,	O
while	O
in	O
the	O
remaining	O
7	O
.	O
2	O
%	O
it	O
was	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
.	O

Regression	O
analysis	O
confirmed	O
no	O
association	O
between	O
oral	O
glucose	O
tolerance	O
test	O
results	O
and	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
>	O
0	O
.	O
53	O
).	O

Of	O
the	O
children	O
in	O
the	O
cohort	O
,	O
20	O
.	O
3	O
%	O
were	O
found	O
to	O
be	O
vitamin	O
D	O
deficient	O
,	O
as	O
defined	O
by	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
mL	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Child	O
Sociodemographics	O
and	O
Clinical	O
Characteristics	O
.	O
CharacteristicValue	O
n	O
=	O
133Race	O
/	O
Ethnicity	O
[	O
n	O
(%)]	O
Black41	O
(	O
30	O
.	O
8	O
)	O
White38	O
(	O
28	O
.	O
6	O
)	O
Hispanic54	O
(	O
40	O
.	O
6	O
)	O
Gender	O
[	O
n	O
(%)]	O
Female62	O
(	O
46	O
.	O
6	O
)	O
Male71	O
(	O
53	O
.	O
4	O
)	O
Age1	O
(	O
years	O
)	O
4	O
.	O
7	O
±	O
1	O
.	O
2	O
(	O
2	O
–	O
7	O
)	O
BMI116	O
.	O
1	O
±	O
2	O
.	O
5	O
(	O
12	O
.	O
1	O
–	O
28	O
.	O
8	O
)%	O
Fat125	O
.	O
5	O
±	O
6	O
.	O
1	O
(	O
14	O
.	O
6	O
–	O
42	O
.	O
9	O
)	O
No	O
.	O

In	B
light	I
of	I
two	O
recent	O
meta	O
-	O
analyses	O
/	O
systematic	O
reviews	O
concluding	B
that	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
during	O
pregnancy	O
are	O
associated	O
with	O
several	O
morbidities	O
in	O
pregnancy15	O
,	O
16	O
,	O
optimizing	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
may	O
be	O
important	O
.	O

We	O
have	O
recently	O
reported	O
that	O
children	O
with	O
S	O
-	O
ECC	O
from	O
this	O
same	O
study	O
group	O
were	O
more	O
likely	B
to	O
have	O
low	O
ferritin	O
and	O
hemoglobin	O
levels	O
along	O
with	O
iron	O
deficiency	O
anaemia	O
[	O
12	O
].	O

A	O
negative	O
and	O
significant	O
correlation	O
was	O
separately	O
found	O
between	O
infant	O
’	O
s	O
weight	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
024	O
,	O
r1	O
=-	O
0	O
.	O
450	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
005	O
,	O
r2	O
=-	O
0	O
.	O
540	O
)	O
in	O
group	O
B	O
.	O

This	O
could	O
reflect	O
circannual	O
rhythm	O
or	O
seasonal	O
lifestyle	O
behaviours	O
,	O
and	O
requires	O
further	O
exploration	O
.	O

The	O
sample	O
size	O
necessary	O
to	O
define	O
a	O
twofold	O
increase	O
of	O
malformation	O
rates	O
of	O
1	O
–	O
3	O
%	O
above	O
the	O
baseline	O
was	O
insufficient	O
.	O

A	O
sample	O
of	O
150	O
for	O
each	O
trial	O
arm	O
was	O
required	O
in	O
order	O
to	O
detect	O
a	O
change	O
in	O
haemoglobin	O
of	O
0	O
.	O
5	O
g	O
/	O
dL	O
between	O
study	O
arms	O
with	O
5	O
%	O
significance	O
and	O
80	O
%	O
power	O
.	O

Results	O
We	O
report	O
that	O
in	O
the	O
female	O
rat	O
,	O
pubertal	O
timing	O
and	O
subsequent	O
ovarian	O
function	O
is	O
influenced	O
by	O
the	O
animal	O
'	O
s	O
nutritional	O
status	O
in	O
utero	O
,	O
with	O
both	O
maternal	O
caloric	O
restriction	O
and	O
maternal	O
high	O
fat	O
nutrition	O
resulting	O
in	O
early	O
pubertal	O
onset	O
.	O

She	O
recently	O
presented	O
findings	O
showing	O
an	O
association	O
between	O
increased	O
levels	O
of	O
activated	O
T	O
cells	O
in	O
DiNEH	O
Project	O
participants	O
and	O
greater	O
residential	O
proximity	O
to	O
mine	O
waste	O
sites	O
.	O
36	O
“	O
If	O
we	O
see	O
any	O
of	O
these	O
activated	O
T	O
cells	O
,	O
we	O
know	O
that	O
the	O
immune	O
system	O
is	O
highly	O
reacting	O
to	O
something	O
,”	O
Erdei	O
says	O
.	O

We	O
used	O
qPCR	O
(	O
Kapa	O
Biosystems	O
)	O
to	O
quantify	O
the	O
amplicon	O
pool	O
,	O
and	O
one	O
Illumina	O
MiSeq	O
500	O
cycle	O
paired	O
-	O
end	O
run	O
to	O
sequence	O
each	O
pool	O
of	O
96	O
libraries	O
.	O

Furthermore	O
,	O
the	O
median	O
age	O
of	O
miners	O
with	O
lung	O
cancer	O
was	O
44	O
years	O
,	O
compared	O
with	O
63	O
years	O
for	O
nonminers	O
with	O
other	O
cancers	O
.	O
18Decades	O
after	O
their	O
exposure	O
ended	O
,	O
standardized	O
mortality	O
ratios	O
and	O
relative	O
risks	O
for	O
lung	O
cancer	O
and	O
other	O
respiratory	O
problems	O
were	O
still	O
nearly	O
four	O
times	O
higher	O
in	O
Navajo	O
miners	O
than	O
in	O
nonminers	O
.	O
19	O
Community	O
Exposure	O
to	O
Uranium	O
Getting	O
the	O
ore	O
out	O
of	O
the	O
ground	O
was	O
only	O
the	O
first	O
step	O
in	O
a	O
long	O
process	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
with	O
respect	O
to	O
premature	O
birth	O
(	O
p	O
=	O
0	O
.	O
88	O
),	O
whether	O
mothers	O
took	O
vitamin	O
D	O
supplements	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
92	O
),	O
or	O
maternal	O
milk	O
intake	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
56	O
)	O
(	O
data	O
not	O
shown	O
).	O

(	O
2015	O
).	O

Regarding	O
the	O
timing	O
of	O
restriction	O
,	O
protein	O
deficiency	O
during	O
early	O
pregnancy	O
induces	O
a	O
less	O
preference	O
to	O
a	O
high	O
-	O
fat	O
diet	O
in	O
the	O
female	O
offspring	O
(	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
),	O
whereas	O
a	O
high	O
preference	O
was	O
obtained	O
when	O
restriction	O
was	O
applied	O
through	O
other	O
gestational	O
periods	O
(	O
Bellinger	O
et	O
al	O
.,	O
2004	O
;	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
).	O

Infant	O
medical	O
assessments	O
A	O
medical	O
doctor	O
performs	O
a	O
general	O
and	O
physical	O
medical	O
assessment	O
of	O
infants	O
at	O
each	O
postnatal	O
visit	O
.	O

Adjusted	O
for	O
age	O
,	O
pregnancy	O
weight	O
gain	O
,	O
smoking	O
status	O
(	O
yes	O
/	O
no	O
),	O
physical	O
activity	O
(	O
strenuous	O
activity	O
more	O
than	O
once	O
per	O
week	O
,	O
yes	O
/	O
no	O
),	O
educational	O
achievement	O
(	O
A	O
levels	O
or	O
higher	O
,	O
yes	O
/	O
no	O
),	O
season	O
of	O
blood	O
sampling	O
(	O
winter	O
,	O
spring	O
,	O
summer	O
,	O
autumn	O
),	O
compliance	O
with	O
study	O
protocol	O
,	O
and	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
.	O
Bonferroni	O
-	O
corrected	O
P	O
values	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
decreases	O
serum	O
AMH	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
which	O
are	O
often	B
elevated	O
in	O
those	O
women	O
[	O
26	O
].	O

A	O
recent	O
27	O
-	O
year	O
study	O
of	O
children	O
whose	O
mothers	O
smoked	O
during	O
pregnancy	O
found	O
larger	O
annual	O
changes	O
in	O
cholesterol	O
levels	O
;	O
high	O
-	O
density	O
lipoprotein	O
cholesterol	O
levels	O
decreased	O
and	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
levels	O
increased	O
more	O
than	O
in	O
children	O
not	O
exposed	O
to	O
tobacco	O
in	O
utero	O
.	O

Call	O
to	O
action	O
Born	O
Too	O
Soon	O
is	O
sobering	O
in	O
the	O
news	O
of	O
a	O
large	O
burden	O
and	O
in	O
the	O
personal	O
stories	O
of	O
loss	O
behind	O
that	O
burden	O
.	O

Discussion	O
The	O
etiology	O
of	O
autism	O
is	O
unknown	O
,	O
although	O
perinatal	O
and	O
neonatal	O
exposures	O
have	O
been	O
the	O
focus	O
of	O
recent	O
epidemiologic	O
research	O
[	O
57	O
].	O

CYP2R1	O
encodes	O
a	O
25	O
-	O
hydroxylase	O
,	O
a	O
key	O
enzyme	O
involved	O
in	O
the	O
conversion	O
of	O
vitamin	O
D	O
to	O
25	O
(	O
OH	O
)	O
D	O
(	O
23	O
).	O

Descriptive	O
analysis	O
will	O
be	O
performed	O
to	O
present	O
the	O
cause	O
of	O
death	O
.	O

For	O
each	O
subject	O
,	O
16	O
corresponding	O
aggregate	O
methylation	O
values	O
were	O
obtained	O
by	O
averaging	O
together	O
average	O
methylation	O
β	O
-	O
values	O
from	O
all	O
CpGs	O
within	O
each	O
class	O
.	O

Data	O
in	O
humans	O
suggest	O
the	O
possibility	O
that	O
complex	O
interactions	O
between	O
prenatal	O
and	O
postnatal	O
events	O
influence	O
the	O
timing	O
of	O
puberty	O
within	O
one	O
generation	O
[	O
2	O
],[	O
10	O
],[	O
11	O
].	O

The	O
category	O
"	O
low	O
level	O
symptoms	O
group	O
"	O
(	O
no	O
psychotic	O
-	O
like	O
symptoms	O
)	O
was	O
used	O
as	B
the	O
reference	O
group	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

All	O
analyses	O
were	O
analogously	O
performed	O
in	O
the	O
Cesarean	O
section	O
group	O
to	O
assess	O
if	O
an	O
effect	O
of	O
maternal	O
diet	O
on	O
the	O
infant	O
gut	O
microbiome	O
exists	O
in	O
the	O
case	O
of	O
surgical	O
delivery	O
.	O

2011	O
[	O
26	O
]	O
to	O
prevent	O
attenuation	O
.	O

The	O
exposed	O
women	O
weighed	O
significantly	O
more	O
than	O
the	O
controls	O
prior	O
to	O
conception	O
(	O
p	O
<	O
0	O
.	O
001	O
);	O
however	O
,	O
the	O
two	O
groups	O
did	O
not	O
differ	O
with	O
respect	O
to	O
weight	O
gain	O
during	O
pregnancy	O
.	O

However	O
,	O
circadian	O
clock	O
genes	O
that	O
respond	O
to	O
light	O
are	O
still	O
part	O
of	O
our	O
genome	O
[	O
39	O
].	O

All	O
the	O
malformations	O
reported	O
were	O
observed	O
in	O
the	O
neonates	O
exposed	O
to	O
polytherapy	O
.	O

Among	O
the	O
baseline	O
participants	O
,	O
48	O
.	O
7	O
%	O
(	O
459	O
/	O
943	O
)	O
completed	O
a	O
4	O
-	O
week	O
follow	O
-	O
up	O
survey	O
and	O
24	O
.	O
5	O
%	O
(	O
231	O
/	O
943	O
)	O
completed	O
a	O
postpartum	O
follow	O
-	O
up	O
.	O

It	O
is	O
structurally	O
similar	O
to	O
estrogen	O
,	O
testosterone	O
,	O
progesterone	O
and	O
all	O
the	O
steroid	O
hormones	O
.	O

The	O
association	O
between	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
and	O
average	O
methylation	O
within	O
the	O
RPMM	O
-	O
derived	O
classes	O
for	O
each	O
of	O
the	O
184	O
individuals	O
in	O
the	O
study	O
is	O
presented	O
inFigure	O
1	O
.	O

Testing	O
and	O
treatment	O
for	O
vitamin	O
D	O
deficiency	O
Women	O
of	O
reproductive	O
age	O
are	O
assumed	B
to	O
be	O
able	O
to	O
obtain	O
the	O
recommended	O
intake	O
for	O
almost	B
all	I
vitamins	O
without	O
the	O
use	O
of	O
supplements	O
,	O
and	O
no	O
national	O
organization	O
recommends	O
routine	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
unless	O
a	O
woman	O
is	O
at	O
nutritional	O
risk	O
.	O

For	O
each	O
selected	O
mother	O
,	O
we	O
reviewed	O
vaccination	O
records	O
of	O
the	O
Expanded	O
Program	O
on	O
Immunization	O
at	O
the	O
Health	O
Unit	O
where	O
the	O
mother	O
received	O
antenatal	O
care	O
and	O
/	O
or	O
we	O
contacted	O
the	O
mother	O
and	O
documented	O
the	O
vaccination	O
date	O
directly	O
from	O
the	O
vaccination	O
card	O
(	O
during	O
a	O
home	O
visit	O
)	O
or	O
as	O
reported	O
by	O
the	O
mother	O
reading	O
from	O
the	O
card	O
(	O
by	O
telephone	O
);	O
influenza	O
vaccination	O
was	O
considered	O
confirmed	O
if	O
an	O
exact	O
date	O
for	O
vaccination	O
could	O
be	O
provided	O
by	O
any	O
of	O
these	O
methods	O
.	O

It	O
is	O
worth	O
noting	O
,	O
however	O
,	O
that	O
establishing	O
the	O
actual	O
level	O
of	O
human	O
exposure	O
to	O
a	O
particular	O
factor	O
and	O
mimicking	O
it	O
in	O
experimental	O
models	O
is	O
not	O
always	O
easy	O
.	O

Birth	O
and	O
neonatal	O
assessments	O
Maternal	O
data	O
collected	O
at	O
birth	O
(	O
phase	O
4	O
)	O
are	O
obtained	O
from	O
maternal	O
medical	O
files	O
and	O
include	O
hospital	O
admission	O
and	O
discharge	O
dates	O
and	O
times	O
,	O
mode	O
of	O
delivery	O
,	O
induction	O
/	O
augmentation	O
of	O
delivery	O
,	O
type	O
of	O
anaesthetic	O
or	O
pain	O
relief	O
if	O
any	O
,	O
rapid	O
plasma	O
reagin	O
(	O
RPR	O
)	O
status	O
(	O
indicative	O
of	O
syphilis	O
infection	O
),	O
HIV	O
status	O
,	O
rhesus	O
negative	O
status	O
and	O
presence	O
of	O
maternal	O
diabetes	O
mellitus	O
.	O

Maternal	O
diet	O
was	O
assessed	O
by	O
self	O
-	O
report	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
it	O
is	O
possible	O
that	O
dietary	O
patterns	O
change	O
near	O
the	O
end	O
of	O
pregnancy	O
or	O
during	O
lactation	O
.	O

In	O
summary	O
,	O
evaluations	O
carried	O
out	O
in	O
the	O
present	O
study	O
indicate	O
that	O
during	O
early	O
pregnancy	O
mothers	O
of	O
low	O
birth	O
weight	O
infant	O
had	O
a	O
different	O
dietary	O
pattern	O
and	O
more	O
adhered	O
to	O
the	O
western	O
dietary	O
pattern	O
compared	O
to	O
mothers	O
of	O
normal	O
weight	O
birth	O
infant	O
.	O

Only	O
23	O
.	O
6	O
%	O
of	O
women	O
reported	O
being	O
told	O
how	O
much	O
weight	O
to	O
gain	O
during	O
pregnancy	O
;	O
although	O
58	O
.	O
6	O
%	O
received	O
advice	O
that	O
met	O
Institute	O
of	O
Medicine	O
recommendations	O
.	O

These	O
first	O
-	O
ever	O
country	O
estimates	O
of	O
preterm	O
birth	O
leave	O
us	O
without	O
the	O
excuse	O
of	O
ignorance	O
[	O
3	O
].	O

Alternatively	O
,	O
higher	O
eggs	O
and	O
poultry	O
consumption	O
may	O
also	O
explain	B
the	O
high	O
detection	O
rate	O
.	O

This	O
concept	O
of	O
phenotypic	O
plasticity	O
,	O
particularly	O
as	O
a	O
consequence	B
of	O
different	O
environments	O
in	O
early	O
life	O
,	O
implicates	B
epigenetic	O
mechanisms	O
and	O
has	O
fueled	O
research	O
into	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

The	O
PGM	O
does	O
not	O
transmit	O
her	O
X	O
chromosome	O
to	O
the	O
boys	O
and	O
the	O
PGF	O
does	O
not	O
transmit	O
his	O
Y	O
chromosome	O
to	O
the	O
girls	O
.	O

Mean	O
cost	O
per	O
beneficiary	O
were	O
calculated	O
as	O
USD1	O
.	O
95	O
(	O
vitamin	O
A	O
),	O
USD3	O
.	O
64	O
(	O
iodine	O
),	O
USD0	O
.	O
52	O
(	O
zinc	O
–	O
only	O
1	O
program	O
),	O
but	O
was	O
not	O
calculated	O
for	O
iron	O
.	O

This	O
is	O
where	O
dose	O
/	O
level	O
of	O
exposure	O
and	O
relevance	O
to	O
humans	O
is	O
crucial	O
,	O
but	O
considerations	O
of	O
alternative	O
replacements	O
are	O
also	O
important	O
.	O

Angus	O
crossbred	O
cattle	O
exposed	O
to	O
greater	O
heat	O
stress	O
tend	O
to	O
have	O
a	O
greater	O
MS	O
[	O
82	O
].	O

No	O
differences	O
were	O
seen	O
in	O
the	O
nasopharyngeal	O
bacteria	O
colonization	O
rate	O
between	O
the	O
low	O
and	O
high	O
25	O
(	O
OH	O
)	O
D	O
groups	O
of	O
the	O
maternal	O
or	O
cord	O
serum	O
.	O

This	O
suggests	O
that	O
baseline	O
DA	O
signaling	O
may	O
be	O
normal	O
in	O
this	O
model	O
and	O
abnormalities	O
only	O
become	O
unmasked	O
in	O
the	O
presence	O
of	O
drugs	O
that	O
alter	O
DA	O
/	O
glutamate	O
balance	O
in	O
the	O
brain	O
.	O

We	O
performed	O
crude	O
and	O
adjusted	O
analyses	O
for	O
each	O
dietary	O
food	O
group	O
variable	O
individually	O
,	O
normalized	O
by	O
maternal	O
calorie	O
consumption	O
,	O
and	O
maternal	O
aMED	O
score	O
and	O
MUFA	O
:	O
SFA	O
ratio	O
in	O
vaginally	O
delivered	O
infants	O
.	O

Strengths	O
of	O
this	O
analysis	O
include	O
assessing	O
the	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
in	O
the	O
general	O
obstetrical	O
population	O
using	O
medical	O
record	O
data	O
at	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
.	O

High	O
levels	O
of	O
SIRT1	O
expression	O
in	O
the	O
human	O
brain	O
have	O
been	O
revealed	O
(	O
18	O
).	O

All	O
seven	O
major	O
malformations	O
occurring	O
in	O
the	O
exposed	O
group	O
were	O
associated	O
with	O
maternal	O
polytherapy	O
,	O
which	O
reached	O
8	O
.	O
4	O
%	O
for	O
this	O
subgroup	O
,	O
and	O
no	O
major	O
malformations	O
were	O
reported	O
in	O
the	O
monotherapy	O
group	O
.	O

However	O
,	O
folate	O
had	O
fewer	O
effects	O
on	O
the	O
hypothalamus	O
of	O
offspring	O
born	O
to	O
HV	O
dams	O
.	O

The	O
fold	O
changes	O
were	O
uniformly	O
small	O
,	O
with	O
the	O
largest	O
FC	O
being	O
−	O
1	O
.	O
67	O
(	O
MEPD	O
).	O

Also	O
at	O
increased	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
are	O
young	O
Thai	O
people	O
living	O
in	O
urban	O
areas	O
in	O
Thailand	O
who	O
have	O
less	O
leisure	O
time	O
and	O
spend	O
less	O
time	O
in	O
the	O
sunlight	O
.	O

In	O
response	O
,	O
Raju	O
helped	O
to	O
initiate	O
the	O
Breastfeeding	O
and	O
Human	O
Lactation	O
Research	O
Scientific	O
Interest	O
Group	O
,	O
a	O
group	O
of	O
scientists	O
organized	O
under	O
the	O
auspices	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
to	O
identify	O
and	O
discuss	O
research	O
gaps	O
.	O
43	O
“	O
The	O
intention	O
is	O
to	O
increase	O
dialogue	O
across	O
institutions	O
and	O
various	O
funding	O
agencies	O
to	O
stimulate	O
interest	O
in	O
breastfeeding	O
research	O
,”	O
says	O
Raju	O
.	O

We	O
also	O
proposed	O
that	O
these	O
putative	B
alterations	O
could	O
increase	O
the	O
vulnerability	O
to	O
develop	O
metabolic	O
diseases	O
in	O
adulthood	O
.	O

It	O
therefore	B
seems	O
likely	B
that	O
the	O
decreased	O
mortality	O
rate	O
was	O
at	B
least	I
in	O
part	O
a	O
consequence	O
of	O
treatment	O
of	O
GDM	O
,	O
rather	O
than	O
only	O
to	O
other	O
improvements	O
in	O
obstetric	O
outcome	O
.	O

Motherisk	O
is	O
a	O
free	O
counselling	O
service	O
offering	O
evidence	O
-	O
based	O
information	O
regarding	O
the	O
reproductive	O
safety	O
of	O
medications	O
and	O
other	O
potentially	O
teratogenic	O
agents	O
to	O
pregnant	O
and	O
breastfeeding	O
women	O
across	O
Canada	O
and	O
the	O
USA	O
.	O

All	O
study	O
procedures	O
were	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
Swedish	O
Medical	O
Center	O
.	O

As	O
mentioned	O
earlier	O
,	O
there	O
are	O
a	O
number	O
of	O
loci	O
within	O
PGCs	O
that	O
escape	O
the	O
two	O
global	O
DNA	O
demethylation	O
re	O
-	O
programing	O
events	O
.	O

Follow	O
-	O
up	O
may	O
be	O
carried	O
out	O
on	O
a	O
regular	O
basis	O
with	O
ultrasound	O
techniques	O
and	O
thyroglobulin	O
assay	O
,	O
as	O
in	O
non	O
-	O
pregnant	O
women	O
.	O

These	O
both	O
provide	O
evidence	O
that	O
DNA	O
methylation	O
can	O
be	O
stably	O
inherited	O
,	O
and	O
highlight	O
specific	O
loci	O
protected	O
from	O
global	O
epigenetic	O
erasure	O
that	O
could	O
be	O
involved	O
in	O
transmitting	O
epigenetic	O
information	O
across	O
generations	O
.	O

In	O
this	O
study	O
following	O
270	O
children	O
,	O
of	O
the	O
children	O
whose	O
mothers	O
took	O
folic	O
acid	O
,	O
0	O
.	O
1	O
%	O
developed	O
autistic	O
disorder	O
[	O
32	O
].	O

For	O
example	O
,	O
studies	O
have	O
examined	O
point	O
-	O
of	O
-	O
decision	O
prompts	O
to	O
increase	O
exercise	O
and	O
nutrition	O
[	O
43	O
],	O
and	O
use	O
of	O
mobile	O
technologies	O
for	O
health	O
interventions	O
[	O
11	O
,	O
44	O
],	O
but	O
no	O
study	O
has	O
combined	O
both	O
.	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Article	O
summary	O
Article	O
focuses	O
To	O
investigate	O
the	O
reproductive	O
safety	O
of	O
the	O
second	O
-	O
generation	O
(	O
atypical	O
)	O
antipsychotic	O
(	O
SGA	O
)	O
medications	O
.	O

The	O
Korean	O
Feeding	O
Standard	O
for	O
Hanwoo	O
[	O
160	O
]	O
describes	O
how	O
to	O
feed	O
Korean	O
cattle	O
at	O
each	O
stage	O
(	O
growth	O
,	O
early	O
fattening	O
,	O
and	O
late	O
fattening	O
stages	O
).	O

The	O
mean	O
maternal	O
serum	O
visfatin	O
level	O
during	O
pregnancy	O
significantly	O
increased	O
with	O
increasing	O
gestational	O
age	O
in	O
parallel	O
to	O
weight	O
gain	O
and	O
insulin	O
resistance	O
in	O
both	O
groups	O
separately	O
.	O

Normal	O
weight	O
and	O
overweight	O
/	O
obese	O
categories	O
were	O
based	O
on	O
the	O
1990	O
IOM	O
cut	O
points	O
[	O
17	O
]:	O
normal	O
weight	O
BMI	O
=	O
19	O
.	O
8	O
to	O
26	O
.	O
0	O
or	O
overweight	O
/	O
obese	O
BMI	O
26	O
.	O
1	O
–	O
40	O
.	O
0	O
[	O
17	O
].	O

Other	O
neuro	O
-	O
oncogenic	O
viruses	O
implicated	O
in	O
gliomas	O
under	O
laboratory	O
conditions	O
include	O
human	O
adenovirus	O
type	O
12	O
and	O
Rous	O
sarcoma	O
virus	O
[	O
133	O
].	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
pregnant	O
women	O
residing	O
in	O
urban	O
South	O
Africa	O
.	O

Although	O
farm	O
children	O
are	O
exposed	O
to	O
higher	O
concentrations	O
of	O
airborne	O
allergens	O
,	O
paradoxically	O
they	O
become	O
sensitized	O
less	O
often	O
and	O
manifest	O
a	O
weaker	O
sensitization	O
response	O
than	O
non	O
-	O
farm	O
controls	O
[	O
113	O
].	O

The	O
consumptions	O
of	O
pills	O
were	O
assessed	O
in	O
later	O
prenatal	O
care	O
visits	O
and	O
over	O
the	O
phone	O
.	O

In	O
response	O
,	O
the	O
Chinese	O
government	O
invested	O
US	O
$	O
100	O
million	O
in	O
2007	O
to	O
launch	O
the	O
collection	O
of	O
data	O
from	O
industrial	O
,	O
agricultural	O
,	O
and	O
residential	O
sources	O
at	O
sites	O
throughout	O
China	O
,	O
beginning	O
in	O
February	O
2008	O
.	O

The	O
Growing	O
Up	O
Today	O
Study	O
found	O
that	O
subjective	O
social	O
status	O
in	O
the	O
school	O
environment	O
predicted	O
BMI	O
in	O
adolescent	O
girls	O
(	O
96	O
).	O

Distinct	O
species	O
and	O
model	O
systems	O
metabolize	O
xenobiotics	O
differently	O
depending	O
on	O
their	O
specific	O
enzymatic	O
profiles	O
.	O

Participants	O
with	O
an	O
energy	O
intake	O
outside	O
the	O
first	O
(	O
2261	O
kJ	O
/	O
d	O
)	O
and	O
99th	O
(	O
12	O
335	O
kJ	O
/	O
d	O
)	O
percentiles	O
were	O
excluded	O
from	O
the	O
analysis	O
(	O
n	O
=	O
687	O
).	O

The	O
same	O
applies	O
to	O
in	O
vivo	O
tests	O
such	O
as	O
food	O
challenge	O
tests	O
and	O
patch	O
tests	O
.	O

These	O
results	O
combined	O
indicate	O
that	O
IFA	O
supplements	O
in	O
populations	O
of	O
iron	O
-	O
deficient	O
pregnant	O
women	O
could	O
lead	O
to	O
a	O
decrease	O
in	O
the	O
number	O
of	O
neonatal	O
deaths	O
mediated	O
by	O
reduced	O
rates	O
of	O
preterm	O
delivery	O
.	O

Promotional	O
and	O
educational	O
material	O
costs	O
included	O
the	O
development	O
and	O
production	O
of	O
posters	O
and	O
flip	O
-	O
charts	O
,	O
which	O
were	O
then	O
disseminated	O
via	O
the	O
public	O
health	O
system	O
.	O

Due	O
to	O
the	O
gestational	O
low	O
protein	O
diet	O
NCAPG	O
was	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
LP	O
fetuses	O
compared	O
to	O
AP	O
fetuses	O
,	O
which	O
reflects	O
the	O
organismal	O
effort	O
to	O
counteract	O
the	O
growth	O
retarding	O
processes	O
in	O
LP	O
fetuses	O
.	O

Studies	O
by	O
other	O
groups	O
have	O
reported	O
abnormal	O
expression	O
of	O
1α	O
-	O
hydroxylase	O
,	O
a	O
vitamin	O
D	O
—	O
activating	O
enzyme	O
in	O
preeclamptic	O
pregnancies	O
,	O
revealing	O
a	O
potential	O
role	O
for	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
as	O
a	O
regulator	O
of	O
placentation	O
.	O

Nordin	O
et	O
al	O
.	O

There	O
are	O
concerns	O
about	O
possible	O
detrimental	O
interactions	O
between	O
micronutrients	O
combined	O
within	O
a	O
single	O
supplement	O
but	O
experimental	O
data	O
are	O
sparse	O
and	O
the	O
potential	O
synergistic	O
and	O
positive	O
effects	O
of	O
particular	O
combinations	O
should	O
not	O
be	O
ignored	O
(	O
Sandstrom	O
2001	O
).	O

However	O
,	O
a	O
clinical	O
study	O
that	O
included	O
280	O
pregnant	O
women	O
did	O
not	O
demonstrate	O
correlations	O
between	O
concentrations	O
of	O
VD	O
and	O
PE	O
[	O
59	O
],	O
probably	B
due	B
to	I
its	O
multi	O
-	O
causal	O
etiology	O
.	O

We	O
selected	O
potential	O
confounders	O
from	O
a	O
list	O
of	O
variables	O
that	O
were	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
(	O
from	O
prior	O
studies	O
conducted	O
among	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
)	O
and	O
that	O
met	O
criteria	O
for	O
confounding	O
based	O
on	O
a	O
review	O
of	O
the	O
literature	O
and	O
assessment	O
of	O
potential	O
causal	O
relationships	O
based	O
on	O
prior	O
knowledge	O
.	O

Women	O
were	O
recruited	O
at	O
the	O
time	O
of	O
their	O
first	O
prenatal	O
visit	O
from	O
one	O
of	O
six	O
obstetric	O
offices	O
serving	O
a	O
socioeconomic	O
and	O
ethnically	O
diverse	O
population	O
in	O
Providence	O
,	O
RI	O
from	O
2006	O
to	O
2008	O
.	O

The	O
remaining	O
dietary	O
intake	O
of	O
different	O
food	O
items	O
and	O
specific	O
nutrients	O
were	O
similar	O
among	O
the	O
three	O
groups	O
of	O
women	O
with	O
different	O
levels	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Table1	O
).	O

Previous	O
papers	O
in	O
this	O
supplement	O
have	O
identified	O
gaps	O
in	O
coverage	O
,	O
quality	O
,	O
equity	O
and	O
metrics	O
for	O
care	O
during	O
preconception	O
,	O
pregnancy	O
and	O
care	O
of	O
preterm	O
newborns	O
[	O
4	O
-	O
6	O
].	O

Compromised	O
calcium	O
buffering	O
in	O
the	O
nucleus	O
accumbens	O
could	O
disrupt	O
adaptive	O
and	O
goal	O
-	O
directed	O
behaviors	O
.	O

The	O
prevalence	O
of	O
vitamin	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
is	O
high	O
in	O
many	O
European	O
countries	O
[	O
36	O
]–[	O
43	O
]	O
and	O
some	O
studies	O
suggest	O
that	O
pregnant	O
women	O
in	O
Europe	O
are	O
also	O
at	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
29	O
],[	O
30	O
].	O

Surveys	O
were	O
self	O
-	O
administered	O
and	O
baseline	O
surveys	O
were	O
completed	O
usually	O
in	O
clinic	O
,	O
with	O
a	O
small	O
number	O
completed	O
remotely	O
online	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

Firstly	O
,	O
a	O
quality	O
control	O
was	O
performed	O
.	O

In	O
other	O
words	O
,	O
ICDS	O
reflects	O
the	O
country	O
’	O
s	O
obligation	O
to	O
enhance	O
the	O
pre	O
-	O
school	O
education	O
rates	O
and	O
an	O
effective	O
strategy	O
to	O
break	O
the	O
vicious	O
cycle	O
of	O
malnutrition	O
,	O
infection	O
and	O
mortality	O
(	O
3	O
).	O

Thus	B
Masanumasik	O
patya	O
is	O
the	O
need	O
of	O
the	O
hour	O
.	O

NICU	O
,	O
neonatal	O
intensive	O
care	O
unit	O
;	O
PNA	O
,	O
poor	O
neonatal	O
adaptation	O
.	O

2002	O
),	O
and	O
localization	O
within	O
each	O
of	O
the	O
following	O
classes	O
of	O
repetitive	O
element	O
as	O
defined	O
by	O
the	O
Repeatmasker	O
track	O
of	O
Genomes	O
Browser	O
:	O
Alu	O
,	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
and	O
mammalian	O
wide	O
-	O
interspersed	O
repeat	O
elements	O
(	O
MIRs	O
).	O

The	O
Remaining	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
control	O
or	O
vitamin	O
D	O
groups	O
with	O
a	O
block	O
randomization	O
design	O
,	O
and	O
they	O
were	O
referred	O
to	O
the	O
laboratory	O
to	O
provide	O
blood	O
sample	O
.	O

There	O
are	O
a	O
wealth	O
of	O
data	O
showing	O
that	O
in	O
the	O
rat	O
,	O
compromising	O
early	O
life	O
signals	O
such	O
as	O
maternal	O
undernutrition	O
or	O
glucocorticoid	O
exposure	O
lead	O
to	O
offspring	O
that	O
develop	O
a	O
deleterious	O
metabolic	O
phenotype	O
;	O
including	O
obesity	O
,	O
with	O
both	O
peripheral	O
components	O
such	O
as	O
sarcopenia	O
and	O
insulin	O
resistance	O
,	O
and	O
central	O
components	O
including	O
hyperphagia	O
,	O
a	O
preference	O
for	O
fatty	O
foods	O
and	O
altered	O
willingness	O
to	O
exercise	O
[	O
27	O
]–[	O
29	O
].	O

2010	O
;	O
Marsit	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Experimental	O
design	O
.	O

Participant	O
Characteristics	O
Excluding	O
participants	O
with	O
miscarriages	O
(	O
n	O
=	O
6	O
)	O
and	O
GDM	O
(	O
n	O
=	O
32	O
),	O
363	O
mothers	O
(	O
177	O
overweight	O
/	O
obese	O
and	O
186	O
normal	O
weight	O
)	O
completed	O
the	O
baseline	O
assessment	O
,	O
which	O
occurred	O
between	O
10	O
and	O
16	O
weeks	O
of	O
pregnancy	O
(	O
13	O
weeks	O
on	O
average	O
).	O

Pregnancy	O
loss	O
The	O
total	O
rate	O
of	O
pregnancy	O
loss	O
was	O
4	O
.	O
7	O
%	O
and	O
the	O
rate	O
of	O
late	O
pregnancy	O
loss	O
(	O
gestational	O
week	O
≥	O
14	O
+	O
0	O
)	O
was	O
1	O
.	O
5	O
%	O
(	O
Table1	O
).	O

There	O
was	O
a	O
significant	O
difference	O
in	O
the	O
frequency	O
of	O
subjects	O
suffering	O
from	O
vitamin	O
deficiency	O
before	O
and	O
after	O
the	O
intervention	O
in	O
the	O
IG	O
,	O
whereas	O
no	O
significant	O
difference	O
was	O
found	O
between	O
these	O
values	O
in	O
the	O
CG	O
.	O

Both	O
non	O
-	O
esterified	O
fatty	O
acids	O
(	O
NEFAs	O
)	O
and	O
a	O
glycerol	O
backbone	O
are	O
required	O
for	O
TG	O
synthesis	O
.	O

Moreover	O
,	O
alcohol	O
consumption	O
has	O
been	O
shown	O
to	O
induce	O
higher	O
IgE	O
levels	O
against	O
aeroallergens	O
in	O
atopic	O
patients	O
[	O
76	O
].	O

The	O
school	O
environment	O
is	O
an	O
opportunity	O
for	O
study	O
and	O
intervention	O
in	O
children	O
'	O
s	O
health	O
behaviors	O
because	B
multiple	O
factors	O
can	O
influence	O
obesity	O
in	O
this	O
context	O
.	O

of	O
expressed	O
probe	O
-	O
setsNo	O
.	O

The	O
mean	O
birth	O
weight	O
of	O
our	O
study	O
cohort	O
was	O
3119	O
g	O
and	O
12	O
.	O
8	O
%	O
of	O
our	O
study	O
population	O
was	O
SGA	O
.	O

Similarly	O
,	O
in	O
a	O
large	O
birth	O
cohort	O
study	O
,	O
infants	O
with	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
had	O
a	O
higher	O
risk	O
of	O
transient	O
wheeze	O
before	O
the	O
age	O
of	O
5	O
years	O
[	O
11	O
].	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
our	O
sample	O
was	O
adequate	O
,	O
mirroring	O
our	O
pilot	O
study	O
findings	O
[	O
14	O
]	O
and	O
those	O
of	O
the	O
Canadian	O
Health	O
Measures	O
Survey	O
[	O
32	O
].	O

Controls	O
for	O
age	O
can	O
also	O
be	O
accounted	O
for	O
,	O
and	O
adverse	O
effects	O
can	O
be	O
more	O
accurately	O
studied	O
in	O
the	O
future	O
.	O

However	O
,	O
mothers	O
with	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
had	O
newborns	O
with	O
smaller	O
head	O
circumference	O
than	O
those	O
with	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
which	O
was	O
further	O
confirmed	O
as	B
a	O
linear	O
association	O
(	O
P	O
=	O
0	O
.	O
024	O
).	O

Depression	O
scores	O
were	O
determined	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
(	O
baseline	O
),	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Finally	O
we	O
detail	O
the	O
analyses	O
for	O
a	O
mortality	O
reduction	O
target	O
for	O
preterm	O
specific	O
neonatal	O
deaths	O
and	O
outline	O
the	O
specific	O
roles	O
all	O
actors	O
must	O
play	O
in	O
this	O
global	O
effort	O
to	O
reduce	O
preterm	O
birth	O
and	O
care	O
for	O
premature	O
babies	O
,	O
which	O
is	O
a	O
marker	O
of	O
the	O
health	O
and	O
care	O
of	O
women	O
and	O
girls	O
,	O
as	O
well	O
as	O
of	O
progress	O
for	O
child	O
survival	O
and	O
development	O
.	O

Scenario	O
3	O
:	O
Countries	O
achieve	O
universal	O
coverage	O
of	O
basic	O
interventions	O
Should	O
governments	O
adopt	O
universal	O
coverage	O
of	O
interventions	O
(	O
95	O
%)	O
ensuring	O
that	O
every	O
woman	O
and	O
child	O
who	O
needs	O
an	O
intervention	O
receives	O
it	O
,	O
then	O
,	O
according	O
to	O
the	O
LiST	O
analysis	O
(	O
Table2	O
)	O
and	O
the	O
historical	O
data	O
(	O
Figure4	O
),	O
countries	O
could	O
achieve	O
an	O
84	O
%	O
reduction	O
of	O
1	O
.	O
1	O
million	O
deaths	O
due	O
to	O
preterm	O
birth	O
complications	O
.	O

In	O
the	O
longest	O
follow	O
-	O
up	O
of	O
women	O
who	O
have	O
had	O
GDM	O
36	O
%	O
of	O
women	O
had	O
developed	O
diabetes	O
within	O
22	O
–	O
28	O
years	O
(	O
by	O
WHO	O
criteria	O
).	O
21This	O
was	O
in	O
a	O
predominantly	O
white	O
population	O
in	O
Boston	O
from	O
the	O
1960s	O
.	O

2008	O
).	O

A	O
randomized	O
controlled	O
trial	O
of	O
vitamin	O
D	O
supplementation	O
on	O
perinatal	O
depression	O
:	O
in	O
Iranian	O
pregnant	O
mothers	O
Abstract	O
Background	O
Mood	O
disorders	O
in	O
pregnancy	O
and	O
post	O
-	O
partum	O
period	O
are	O
common	O
and	O
considered	O
as	O
a	O
public	O
health	O
issue	O
.	O

Impact	O
of	O
an	O
Intensive	O
Perinatal	O
Handwashing	O
Promotion	O
Intervention	O
on	O
Maternal	O
Handwashing	O
Behavior	O
in	O
the	O
Neonatal	O
Period	O
:	O
Findings	O
from	O
a	O
Randomized	O
Controlled	O
Trial	O
in	O
Rural	O
Bangladesh	O
Abstract	O
One	O
-	O
quarter	O
of	O
neonatal	O
deaths	O
are	O
attributed	O
to	O
infections	O
.	O

There	O
is	O
some	O
suggestion	O
that	O
late	O
hypocalcemic	O
tetany	O
is	O
more	B
common	I
in	O
Hispanic	O
infants	O
,	O
although	O
this	O
is	O
not	O
well	O
demonstrated	O
due	O
to	O
the	O
limited	O
published	O
data	O
[	O
14	O
].	O

The	O
study	O
is	O
part	O
of	O
the	O
longitudinal	O
Vitamin	O
D	O
Intervention	O
in	O
Infants	O
(	O
VIDI	O
)	O
study	O
.	O

The	O
intervention	O
was	O
implemented	O
in	O
two	O
districts	O
targeting	O
all	O
50	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
,	O
and	O
a	O
cost	O
analysis	O
was	O
undertaken	O
.	O

The	O
occurrence	O
of	O
MTC	O
in	O
both	O
sporadic	O
and	O
familial	O
forms	O
makes	O
the	O
clinical	O
approach	O
to	O
this	O
tumour	O
different	O
from	O
that	O
to	O
other	O
thyroid	O
tumours	O
.	O

Most	O
,	O
but	O
not	O
all	O
,	O
suggest	O
that	O
glyburide	O
is	O
as	O
safe	O
as	O
insulin	O
for	O
the	O
fetus	O
.	O

Maternal	O
characteristics	O
,	O
as	O
well	O
as	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
,	O
were	O
compared	O
between	O
groups	O
.	O

Advisory	O
committee	O
To	O
facilitate	O
the	O
overall	O
implementation	O
process	O
and	O
to	O
engage	O
policymakers	O
and	O
other	O
key	O
decision	O
makers	O
,	O
we	O
will	O
establish	O
a	O
national	O
project	O
advisory	O
committee	O
consisting	O
of	O
Ministry	O
of	O
Health	O
and	O
Family	O
Welfare	O
staff	O
,	O
staff	O
,	O
representatives	O
from	O
UNICEF	O
,	O
WHO	O
,	O
the	O
Obstetric	O
and	O
Gynaecological	O
,	O
the	O
Perinatal	O
,	O
and	O
the	O
Nutrition	O
Societies	O
of	O
Bangladesh	O
.	O

Repetitive	O
element	O
DNA	O
methylation	O
was	O
determined	O
by	O
bisulfite	O
pyrosequencing	O
of	O
the	O
LINE	O
-	O
1	O
and	O
the	O
AluYb8	O
repetitive	O
elements	O
as	O
previously	O
described	O
(	O
Bollati	O
et	O
al	O
.	O

During	O
the	O
3	O
-	O
hour	O
structured	O
observations	O
,	O
45	O
%	O
in	O
the	O
intervention	O
group	O
,	O
compared	O
to	O
17	O
%	O
in	O
the	O
control	O
group	O
,	O
were	O
observed	O
to	O
wash	O
hands	O
with	O
soap	O
and	O
water	O
at	O
least	O
once	O
.	O

She	O
initially	O
noticed	O
nail	O
discoloration	O
;	O
then	O
she	O
reported	O
progressively	O
worsening	O
discomfort	O
with	O
lifting	O
of	O
her	O
nail	O
plate	O
.	O

The	O
estimated	O
benefit	O
:	O
cost	O
ratio	O
of	O
6	O
.	O
7	O
∶	O
1	O
is	O
similar	O
to	O
the	O
median	O
benefit	O
:	O
cost	O
ratio	O
for	O
iron	O
fortification	O
estimated	O
by	O
Horton	O
and	O
Ross	O
[	O
6	O
]	O
for	O
a	O
range	O
of	O
countries	O
.	O

Several	O
risk	O
factors	O
during	O
the	O
pregnancy	O
and	O
labor	O
periods	O
have	O
been	O
associated	O
with	O
autism	O
;	O
yet	O
further	O
studies	O
with	O
large	O
populations	O
are	O
needed	O
to	O
establish	O
definitive	O
associations	O
.	O

As	O
an	O
example	O
,	O
in	O
a	O
subject	O
with	O
63	O
g	O
of	O
supraclavicular	O
BAT	O
,	O
it	O
was	O
calculated	O
that	O
if	O
the	O
depot	O
was	O
fully	O
activated	O
,	O
it	O
would	O
burn	O
an	O
amount	O
of	O
energy	O
equivalent	O
to	O
4	O
.	O
1	O
kg	O
of	O
WAT	O
(	O
Virtanen	O
et	O
al	O
.,	O
2009	O
).	O

In	O
contrast	O
,	O
in	O
the	O
Faroe	O
Islands	O
study	O
researchers	O
found	O
that	O
exposure	O
to	O
PFASs	O
was	O
associated	O
with	O
shorter	O
breastfeeding	O
duration	O
among	O
both	O
primiparous	O
and	O
multiparous	O
mothers	O
.	O

Curiously	O
,	O
it	O
has	O
been	O
shown	O
that	O
calcium	O
concentration	O
is	O
an	O
important	O
modulator	O
of	O
thimet	O
oligopeptidase	O
activity	O
[	O
41	O
],	O
thus	B
the	O
disruption	O
of	O
this	O
protein	O
may	O
also	O
be	O
down	O
-	O
stream	O
consequence	O
of	O
altered	O
calcium	O
buffering	O
.	O

We	O
need	O
more	O
frontline	O
health	O
workers	O
who	O
are	O
skilled	O
and	O
confident	O
in	O
newborn	O
care	O
.	O

The	O
Shonjibon	O
study	O
area	O
will	O
consist	O
of	O
24	O
Upazilas	O
from	O
these	O
five	O
districts	O
(	O
Fig	O
.	O

A	O
summary	O
of	O
these	O
articles	O
and	O
their	O
quality	O
rating	O
is	O
presented	O
inTable	O
2	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t002_Table	O
2	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Summary	O
and	O
quality	O
rating	O
for	O
reviewed	O
articles	O
.	O
ReferenceDaniels	O
et	O
al	O
.	O

College	O
Station	O
,	O
TX	O
:	O
Stata	O
Corp	O
LP	O
.)	O

The	O
vast	B
majority	B
of	O
published	O
studies	O
on	O
neonatal	O
care	O
relate	O
to	O
high	O
-	O
technology	O
care	O
in	O
high	O
-	O
income	O
settings	O
[	O
39	O
].	O

Introduction	O
Risk	O
of	O
obesity	O
is	O
shaped	O
,	O
in	O
large	O
part	O
,	O
by	O
early	O
life	O
events	O
starting	O
during	O
gestation	O
.	O

Notably	O
,	O
the	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
synthesized	O
by	O
the	O
placenta	O
accumulates	O
in	O
bone	O
and	O
may	O
be	O
involved	O
in	O
ossification	O
of	O
the	O
fetal	O
skeleton	O
.	O

The	O
optimal	O
method	O
of	O
vitamin	O
D	O
measurement	O
remains	O
controversial	O
,	O
but	O
our	O
laboratory	O
uses	O
U	O
.	O
S	O
.	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
level	O
1	O
and	O
this	O
method	O
is	O
commonly	B
used	O
clinically	O
and	O
in	O
the	O
literature	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
provide	O
further	O
knowledge	O
to	O
elucidate	O
this	O
contradictory	O
relationship	O
.	O

(	O
2013	O
)	O
provided	O
epidemiological	O
data	O
to	O
support	O
the	O
benefits	O
of	O
smoking	O
cessation	O
,	O
with	O
DNA	O
methylation	O
-	O
related	O
colon	O
cancer	O
risk	O
reverting	O
back	O
to	O
that	O
of	O
non	O
-	O
smokers	O
within	O
10	O
years	O
of	O
cessation	O
.	O

(	O
2014	O
)*	O
Di	O
-(	O
2	O
-	O
ethyl	O
-	O
hexyl	O
)-	O
phthalate	O
(	O
DEHP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
100	O
-	O
950	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1offspring	O
↓	O
serum	O
testosteroneDNA	O
methylationMartinez	O
-	O
Arguelles	O
et	O
al	O
.	O

Regular	O
assessments	O
of	O
TSH	O
and	O
fT4	O
levels	O
every	O
6	O
/	O
8	O
weeks	O
during	O
pregnancy	O
and	O
breast	O
-	O
feeding	O
are	O
required	O
to	O
ensure	O
an	O
adequate	O
dose	O
of	O
levothyroxine	O
.	O

According	O
to	O
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
),	O
we	O
considered	O
vitamin	O
D	O
deficiency	O
as	B
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
less	O
than	O
20	O
ng	O
/	O
ml	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Logistic	O
regression	O
for	O
S	O
-	O
ECCVariableAdjusted	O
odds	O
ratio	O
±	O
95	O
%	O
confidence	O
interval	O
for	O
odds	O
ratioP	O
value	O
Age	O
started	O
cleaning	O
teeth0	O
.	O
970	O
.	O
94	O
,	O
1	O
.	O
010	O
.	O
12Bottle	O
fed	O
(	O
Reference	O
=	O
Yes	O
)	O
0	O
.	O
730	O
.	O
37	O
,	O
1	O
.	O
460	O
.	O
37General	O
health	O
(	O
Reference	O
=	O
Very	O
Good	O
)	O
3	O
.	O
041	O
.	O
50	O
,	O
6	O
.	O
150	O
.	O
002Mean	O
vitamin	O
D1	O
.	O
011	O
.	O
00	O
,	O
1	O
.	O
020	O
.	O
04Vitamin	O
D	O
drop	O
usage	O
(	O
Reference	O
=	O
Yes	O
)	O
1	O
.	O
510	O
.	O
81	O
,	O
2	O
.	O
820	O
.	O
19Yearly	O
income	O
(	O
Reference	O
=	O
<	O
28	O
k	O
)	O
0	O
.	O
300	O
.	O
16	O
,	O
0	O
.	O
55	O
<	O
0	O
.	O
001	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

Phalanges	O
are	O
indicated	O
by	O
arrowheads	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpcWnt	O
signalingup1	O
.	O
20	O
*	O
E	O
-	O
29ACVR1	O
,	O
CSNK1G3	O
,	O
FZD4	O
,	O
FZD6	O
,	O
MAP3K7	O
,	O
MMP7	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5AMitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown5	O
.	O
15	O
*	O
E	O
-	O
811CCNB1	O
,	O
CCNB2	O
,	O
CDC23	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
FZR1	O
,	O
SP90AA1	O
,	O
KIF11	O
,	O
PLK1	O
,	O
PPP2R1B	O
,	O
PTTG1G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
76	O
*	O
E	O
-	O
58CCND2	O
,	O
CCND3	O
,	O
CCNE1	O
,	O
CDK4	O
,	O
E2F1	O
,	O
E2F4	O
,	O
RB1	O
,	O
TFDP1G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown1	O
.	O
53	O
*	O
E	O
-	O
35CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
PLK11	O
dpn	O
-----	O
28	O
dpnComplement	O
systemup2	O
.	O
07	O
*	O
E	O
-	O
55C4B	O
,	O
C5	O
,	O
C6	O
,	O
C9	O
,	O
CD55G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
49	O
*	O
E	O
-	O
23CDKN1B	O
,	O
HDAC11	O
,	O
TGFB3188	O
dpnVEGF	O
signalingup2	O
.	O
80	O
*	O
E	O
-	O
412ACTA2	O
,	O
AKT3	O
,	O
BCL2	O
,	O
EIF2B1	O
,	O
KDR	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PRKCB	O
,	O
RRAS2	O
,	O
VCL	O
,	O
VEGFCmTOR	O
signalingup6	O
.	O
29	O
*	O
E	O
-	O
313AKT3	O
,	O
EIF3B	O
,	O
EIF4B	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PPP2CB	O
,	O
PRKAB2	O
,	O
PRKCB	O
,	O
RHOJ	O
,	O
RRAS2	O
,	O
TSC1	O
,	O
VEGFCSynthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
18	O
*	O
E	O
-	O
34ACAA1	O
,	O
BDH1	O
,	O
HADHA	O
,	O
HADHBBile	O
acid	O
synthesisup3	O
.	O
33	O
*	O
E	O
-	O
37ACAA1	O
,	O
ADH5	O
,	O
ADHFE1	O
,	O
ALDH7A1	O
,	O
HADHA	O
,	O
HADHB	O
,	O
LIPAFatty	O
acid	O
elongation	O
in	O
mitochondriaup4	O
.	O
81	O
*	O
E	O
-	O
34ACAA1	O
,	O
AUH	O
,	O
HADHA	O
,	O
HADHBGlucocorticoid	O
receptor	O
signalingup3	O
.	O
99	O
*	O
E	O
-	O
217AKT3	O
,	O
BCL2	O
,	O
CCL2	O
,	O
GTF2A2	O
,	O
GTF2B	O
,	O
GTF2E2	O
,	O
HSP90AB1	O
,	O
HSPA1B	O
,	O
IL1RN	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
NCOR1	O
,	O
PBX1	O
,	O
PIK3R3	O
,	O
RRAS2	O
,	O
TAF4	O
,	O
VCAM1Val	O
,	O
Leu	O
,	O
Ile	O
degradationup8	O
.	O
32	O
*	O
E	O
-	O
38ACAA1	O
,	O
ACAD10	O
,	O
ALDH7A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
HADHA	O
,	O
HADHB	O
,	O
HIBADHBiosynthesis	O
of	O
steroidsdown7	O
.	O
65	O
*	O
E	O
-	O
35CYP24A1	O
,	O
CYP7B1	O
,	O
DHCR7	O
,	O
FDFT1	O
,	O
MVD	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Parents	O
completed	O
an	O
interviewed	O
questionnaire	O
assessing	O
the	O
child	O
’	O
s	O
nutritional	O
habits	O
,	O
oral	O
health	O
,	O
and	O
family	O
demographics	O
.	O

At	O
preterm	O
,	O
the	O
values	O
were	O
0	O
.	O
278	O
,	O
0	O
.	O
004	O
,	O
0	O
.	O
003	O
,	O
0	O
.	O
006	O
,	O
and	O
0	O
.	O
180	O
for	O
GR	O
α	O
,	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
GR	O
-	O
P	O
,	O
and	O
GAS5	O
,	O
respectively	O
(	O
seeFigure	O
1	O
(	O
a	O
)).	O

The	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
was	O
investigated	O
with	O
ANCOVA	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

The	O
generalisability	O
of	O
our	O
findings	O
may	O
be	O
limited	O
,	O
as	O
participants	O
had	O
previously	O
given	O
birth	O
to	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
and	O
half	O
the	O
women	O
received	O
advice	O
to	O
follow	O
a	O
low	O
glycaemic	O
diet	O
.	O

All	O
of	O
these	O
stages	O
took	O
place	O
in	O
Khaje	O
Nasir	O
biochemistry	O
and	O
clinical	O
diagnosis	O
laboratory	O
.	O

Due	O
to	O
the	O
seasonal	O
nature	O
of	O
25OHD	O
concentrations	O
in	O
many	O
parts	O
of	O
the	O
world	O
[	O
32	O
],	O
and	O
the	O
observed	O
associations	O
between	O
vitamin	O
D	O
and	O
insulin	O
resistance	O
,	O
it	O
would	O
seem	O
prudent	O
to	O
hypothesise	O
that	O
seasonal	O
variation	O
of	O
glucose	O
homeostasis	O
may	O
be	O
mediated	O
through	O
25OHD	O
.	O

There	O
may	O
be	O
a	O
postnatal	O
override	O
such	O
that	O
if	O
energetics	O
remain	O
poor	O
during	O
postnatal	O
life	O
,	O
reproductive	O
maturation	O
may	O
be	O
delayed	O
until	O
the	O
nutritional	O
environment	O
is	O
improved	O
sufficiently	O
to	O
support	O
a	O
first	O
pregnancy	O
.	O

Introduction	O
Anthropometric	O
measurements	O
,	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
of	O
newborn	O
infants	O
,	O
are	O
widely	O
assessed	O
as	O
determinants	O
of	O
impaired	O
fetal	O
growth	O
,	O
intrauterine	O
environment	O
,	O
and	O
maternal	O
nutrition	O
[	O
1	O
].	O

Results	O
In	O
this	O
trial	O
study	O
,	O
first	O
250	O
pregnant	O
mothers	O
were	O
interviewed	O
.	O

Concerns	O
about	O
vitamin	O
D	O
have	O
resurfaced	O
in	O
medical	O
and	O
scientific	O
literature	O
owing	B
to	I
its	O
multiple	O
effects	O
on	O
human	O
health	O
.	O

This	O
data	O
-	O
driven	O
clustering	O
allowed	O
us	O
to	O
define	O
stable	O
classes	O
of	O
CpG	O
loci	O
demonstrating	O
similar	O
patterns	O
of	O
methylation	O
,	O
which	O
we	O
used	O
to	O
examine	O
associations	O
between	O
methylation	O
of	O
these	O
classes	O
of	O
CpGs	O
and	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
.	O

Vitamin	O
D	O
status	O
trajectory	O
during	O
pregnancy	O
was	O
inversely	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Therefore	B
,	O
it	O
is	O
possible	O
that	O
vasopressinase	O
could	O
have	O
crossed	O
the	O
placenta	O
thereby	O
causing	O
infant	O
'	O
s	O
hypernatremia	O
and	O
subsequently	O
could	O
have	O
benefited	O
from	O
dDAVP	O
.	O

In	O
such	O
patients	O
,	O
IL	O
-	O
6	O
is	O
preferentially	O
secreted	O
from	O
visceral	O
rather	O
than	O
from	O
subcutaneous	O
adipocytes	O
and	O
may	O
participate	O
in	O
the	O
prevailing	O
increase	O
in	O
sympathetic	O
outflow	O
by	O
exerting	O
central	O
effects	O
(	O
Wallenius	O
et	O
al	O
.,	O
2002	O
;	O
Fain	O
et	O
al	O
.,	O
2004	O
).	O

Antiproliferative	O
and	O
proapoptotic	O
activity	O
of	O
vitamin	O
D3	O
has	O
been	O
noted	O
in	O
model	O
glioma	O
cell	O
lines	O
and	O
a	O
primary	O
culture	O
,	O
as	O
well	O
as	O
tumor	O
tissue	O
experiments	O
[	O
145	O
].	O

Description	O
of	O
covariates	O
At	O
the	O
time	O
of	O
enrollment	O
in	O
the	O
study	O
,	O
a	O
45	O
to	O
60	O
-	O
minute	O
structured	O
questionnaire	O
was	O
administered	O
by	O
a	O
trained	O
interviewer	O
.	O

3	O
.	O

The	O
U	O
.	O
S	O
.	O
guidelines	B
are	O
currently	O
under	O
review	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
the	O
origin	O
for	O
a	O
host	O
of	O
future	O
perils	O
for	O
the	O
child	O
,	O
especially	O
effect	O
on	O
neurodevelopment	O
and	O
immune	O
system	O
.	O

Discussion	O
This	O
systematic	O
review	O
of	O
observational	O
cohort	O
studies	O
demonstrates	O
an	O
association	O
between	O
consumption	O
of	O
one	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
during	O
pregnancy	O
and	O
better	O
offspring	O
neurodevelopment	O
outcomes	O
.	O

Furthermore	O
,	O
two	O
Vietnamese	O
studies	O
showed	O
similar	O
improvements	O
in	O
iron	O
stores	O
following	O
ingestion	O
of	O
ironfortified	O
fish	O
sauce	O
for	O
six	O
to	O
12	O
months	O
[	O
42	O
,	O
43	O
].	O

Briefly	O
,	O
high	O
-	O
quality	O
forage	O
is	O
fed	O
ad	O
libitum	O
to	O
develop	O
the	O
rumen	O
during	O
the	O
growing	O
stage	O
(	O
7	O
to	O
12	O
months	O
of	O
age	O
),	O
and	O
the	O
concentrate	O
(	O
CP	O
15	O
%	O
to	O
16	O
%,	O
TDN	O
69	O
%	O
to	O
70	O
%)	O
is	O
restricted	O
to	O
1	O
.	O
5	O
%	O
to	O
1	O
.	O
6	O
%	O
of	O
body	O
weight	O
at	O
this	O
time	O
.	O

Therefore	B
,	O
the	O
observed	O
mRNA	O
expression	O
patterns	O
might	O
contribute	O
to	O
an	O
impaired	O
developmental	O
growth	O
in	O
LP	O
offspring	O
.	O

Deaths	O
in	O
the	O
neonatal	O
period	O
have	O
reduced	O
more	O
slowly	O
than	O
those	O
in	O
the	O
postneonatal	O
period	O
since	O
2000	O
.	O

Study	O
Design	O
:	O
Cord	O
blood	O
vitamin	O
D	O
levels	O
were	O
measured	O
in	O
438	O
infants	O
(	O
276	O
black	O
and	O
162	O
white	O
).	O

For	O
a	O
second	O
filtering	O
step	O
standard	O
deviations	O
were	O
calculated	O
for	O
each	O
probe	O
-	O
set	O
over	O
all	O
subsets	O
of	O
arrays	O
of	O
the	O
particular	O
comparisons	O
.	O

Earlier	O
research	O
suggested	O
the	O
adverse	O
effect	O
of	O
vitamin	O
D	O
on	O
fertility	O
after	O
a	O
discovery	O
of	O
a	O
molecular	O
similarity	O
of	O
its	O
transporting	O
protein	O
,	O
the	O
vitamin	O
D	O
binding	O
protein	O
(	O
VDBP	O
),	O
to	O
anti	O
-	O
sperm	O
antibodies	O
.	O

Results	O
Altered	O
maternal	O
nutrition	O
modifies	O
offspring	O
growth	O
Birth	O
weights	O
of	O
offspring	O
born	O
to	O
rat	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
were	O
significantly	O
reduced	O
compared	O
to	O
those	O
of	O
control	O
pregnancies	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
1A	O
).	O

[	O
43	O
].	O

The	O
modelling	O
methods	O
have	O
been	O
widely	B
published	O
including	O
discussions	O
of	O
the	O
limitations	O
,	O
which	O
are	O
particularly	O
related	O
to	O
the	O
lack	O
of	O
coverage	O
data	O
for	O
many	O
of	O
the	O
specific	O
interventions	O
[	O
44	O
-	O
47	O
].	O

These	O
disparities	O
may	O
have	O
been	O
due	O
to	O
the	O
use	O
of	O
different	O
routes	O
of	O
administration	O
and	O
variations	O
in	O
rat	O
strains	O
/	O
stocks	O
.	O

This	O
review	O
indicates	O
that	O
the	O
benefits	O
of	O
diets	O
providing	O
moderate	O
amounts	O
of	O
fish	O
during	O
pregnancy	O
outweigh	O
potential	O
detrimental	O
effects	O
in	O
regards	O
to	O
offspring	O
neurodevelopment	O
.	O

The	O
objective	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
haematological	O
outcomes	O
in	O
non	O
-	O
pregnant	O
,	O
rural	O
Gambian	O
women	O
of	O
reproductive	O
age	O
,	O
receiving	O
daily	O
MMN	O
supplements	O
for	O
one	O
-	O
year	O
.	O

Previously	O
,	O
most	B
investigators	O
wanted	O
to	O
determine	O
the	O
relationship	O
between	O
concentration	O
of	O
calcidiol	O
in	O
serum	O
and	O
follicular	O
fluid	O
.	O

Furthermore	O
,	O
we	O
manually	O
examined	O
the	O
bibliography	O
of	O
the	O
papers	O
that	O
were	O
identified	O
electronically	O
.	O

We	O
also	O
defined	O
a	O
reference	O
group	O
to	O
estimate	O
the	O
sample	O
size	O
.	O

The	O
reduction	O
in	O
reticulocyte	O
count	O
was	O
marginally	O
significant	O
(	O
p	O
=	O
0	O
.	O
04	O
).	O

In	O
AP	O
fetuses	O
,	O
cell	O
cycle	O
parameters	O
were	O
found	O
to	O
be	O
decreased	O
in	O
expression	O
within	O
developmental	O
period	O
I	O
,	O
which	O
indicates	O
a	O
terminated	O
fetal	O
growth	O
.	O

The	O
erythrocyte	O
sedimentation	O
rate	O
(	O
ESR	O
)	O
(	O
Sarstedt	O
,	O
UK	O
)	O
and	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
(	O
Vitros	O
system	O
250	O
,	O
Johnson	O
&	O
Johnson	O
,	O
USA	O
)	O
were	O
measured	O
.	O

Several	O
studies	O
emphasize	O
the	O
importance	O
of	O
the	O
relationship	O
between	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
intake	O
and	O
socio	O
-	O
demographic	O
factors	O
such	O
as	O
age	O
,	O
level	O
of	O
education	O
,	O
area	O
of	O
residence	O
,	O
marital	O
status	O
,	O
parity	O
,	O
economical	O
status	O
and	O
characteristics	O
of	O
prenatal	O
care	O
(	O
including	O
gestational	O
age	O
at	O
the	O
beginning	O
of	O
prenatal	O
care	O
and	O
the	O
number	O
of	O
prenatal	O
consultations	O
)	O
[	O
15	O
-	O
19	O
].	O

The	O
integration	O
of	O
the	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplement	O
and	O
deworming	O
program	O
into	O
the	O
existing	O
health	O
infrastructure	O
in	O
Yen	O
Bai	O
province	O
has	O
been	O
described	O
elsewhere	O
[	O
14	O
].	O

Whereas	O
the	O
number	O
of	O
years	O
of	O
education	O
for	O
the	O
participant	O
herself	O
was	O
similar	O
in	O
the	O
two	O
arms	O
,	O
participants	O
in	O
the	O
control	O
arm	O
reported	O
a	O
mean	O
of	O
7	O
.	O
2	O
years	O
(	O
SD	O
3	O
.	O
3	O
)	O
of	O
education	O
for	O
the	O
husband	O
,	O
compared	O
to	O
those	O
in	O
the	O
intervention	O
arm	O
who	O
reported	O
a	O
mean	O
of	O
8	O
.	O
8	O
years	O
(	O
SD	O
12	O
.	O
0	O
).	O

At	O
6	O
months	O
,	O
children	O
of	O
normal	O
weight	O
mothers	O
exposed	O
to	O
excessive	O
GWG	O
had	O
significantly	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
higher	O
odds	O
of	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
weight	O
gain	O
(	O
OR	O
=	O
4	O
.	O
0	O
(	O
1	O
.	O
2	O
,	O
13	O
.	O
6	O
)),	O
but	O
no	O
significant	O
association	O
was	O
seen	O
on	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
(	O
0	O
.	O
27	O
±	O
0	O
.	O
83	O
versus	O
0	O
.	O
39	O
±	O
1	O
.	O
1	O
;	O
P	O
=	O
.	O
28	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Perinatal	O
outcomes	O
of	O
monotherapy	O
and	O
polytherapy	O
subgroupsVariableMonotherapyPolytherapyp	O
ValueMaternal	O
characteristics	O
(	O
N	O
=	O
37	O
)(	O
N	O
=	O
96	O
)	O
MeanSDMeanSD	O
Age	O
at	O
conception	O
(	O
months	O
)*	O
375	O
.	O
6060	O
.	O
09379	O
.	O
4062	O
.	O
720	O
.	O
752	O
Pre	O
-	O
pregnancy	O
weight	O
(	O
kg	O
)†	O
73	O
.	O
9418	O
.	O
6474	O
.	O
4121	O
.	O
790	O
.	O
750	O
Maternal	O
pregnancy	O
weight	O
gain	O
(	O
kg	O
)†	O
14	O
.	O
9810	O
.	O
8415	O
.	O
028	O
.	O
790	O
.	O
953N	O
%	O
N	O
%	O
Vitamin	O
use	O
‡	O
3391	O
.	O
78086	O
.	O
00	O
.	O
554	O
Alcohol	O
use	O
‡	O
25	O
.	O
466	O
.	O
31	O
.	O
000	O
Smoking	O
‡	O
513	O
.	O
51919	O
.	O
80	O
.	O
399	O
Breastfeeding	O
‡,§	O
2374	O
.	O
24657	O
.	O
50	O
.	O
104	O
Hypertension	O
‡	O
25	O
.	O
41212	O
.	O
50	O
.	O
348	O
Gestational	O
diabetes	O
‡	O
25	O
.	O
499	O
.	O
40	O
.	O
518	O
Hypothyroidism	O
¶	O
25	O
.	O
455	O
.	O
21	O
.	O
000Pregnancy	O
outcomes	O
for	O
live	O
births	O
(	O
N	O
=	O
32	O
)(	O
N	O
=	O
83	O
)	O
MeanSDMeanSD	O
Gestational	O
age	O
†	O
39	O
.	O
702	O
.	O
0738	O
.	O
771	O
.	O
720	O
.	O
005	O
Birth	O
weight	O
*	O
3426	O
.	O
60721	O
.	O
613396	O
.	O
83526	O
.	O
460	O
.	O
810N	O
%	O
N	O
%	O
Congenital	O
malformations	O
¶	O
00	O
.	O
078	O
.	O
40	O
.	O
187	O
Preterm	O
delivery	O
‡	O
412	O
.	O
989	O
.	O
80	O
.	O
733	O
Small	O
for	O
gestational	O
age	O
(<	O
10th	O
centile	O
)‡	O
39	O
.	O
71012	O
.	O
30	O
.	O
758	O
Large	O
for	O
gestational	O
age	O
(>	O
90th	O
centile	O
)‡	O
26	O
.	O
51113	O
.	O
60	O
.	O
349Delivery	O
and	O
neonatal	O
outcomes	O
for	O
live	O
births	O
(	O
N	O
=	O
32	O
)(	O
N	O
=	O
83	O
)	O
N	O
%	O
N	O
%	O
Method	O
of	O
delivery	O
‡	O
0	O
.	O
324	O
Vaginal2374	O
.	O
25467	O
.	O
1	O
C	O
-	O
section	O
repeat00	O
.	O
056	O
.	O
1	O
C	O
-	O
section	O
emergency619	O
.	O
41113	O
.	O
4	O
C	O
-	O
section	O
schedules26	O
.	O
51113	O
.	O
4	O
Forceps	O
/	O
vacuum	O
used	O
‡	O
00	O
.	O
01012	O
.	O
30	O
.	O
059	O
Fetal	O
distress	O
‡	O
312	O
.	O
01726	O
.	O
60	O
.	O
139	O
Admitted	O
to	O
the	O
NICU	O
‡	O
416	O
.	O
01928	O
.	O
80	O
.	O
210	O
PNA	O
signs	O
‡	O
14	O
.	O
01421	O
.	O
20	O
.	O
060	O
*	O
Independent	O
t	O
test	O
.	O

The	O
lack	O
of	O
vitamin	O
A	O
supplementation	O
also	O
increased	O
marbling	O
compared	O
with	O
vitamin	O
A	O
supplementation	O
in	O
a	O
study	O
of	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

The	O
seasonal	O
variations	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
detected	O
in	O
these	O
subjects	O
are	O
consistent	O
with	O
natural	O
environmental	O
changes	O
in	O
the	O
area	O
of	O
residence	O
.	O

Women	O
and	O
children	O
are	O
most	B
vulnerable	O
due	B
to	I
greater	O
iron	O
requirements	O
and	O
those	O
in	O
resource	O
constrained	O
countries	O
are	O
particularly	O
at	O
risk	O
[	O
1	O
].	O

For	O
example	O
,	O
epigenetic	O
changes	O
have	O
the	O
potential	O
to	O
provide	O
(	O
1	O
)	O
more	O
sensitive	O
/	O
earlier	O
end	O
points	O
of	O
toxicity	O
within	O
existing	O
regulatory	O
test	O
guidelines	O
(	O
TGs	O
),	O
(	O
2	O
)	O
novel	O
markers	O
of	O
exposure	O
/	O
predictors	O
of	O
future	O
toxicity	O
for	O
the	O
development	O
of	O
in	O
vitro	O
chemical	O
screening	O
assays	O
and	O
(	O
3	O
)	O
novel	O
end	O
points	O
of	O
toxicities	O
for	O
which	O
we	O
are	O
currently	O
rarely	O
able	O
to	O
conduct	O
definitive	O
regulatory	O
testing	O
due	O
to	O
animal	O
welfare	O
,	O
cost	O
and	O
time	O
considerations	O
(	O
such	O
as	O
non	O
-	O
genotoxic	O
carcinogens	O
,	O
multigenerational	O
toxicity	O
and	O
chronic	O
low	O
-	O
dose	O
exposures	O
that	O
impact	O
health	O
in	O
later	O
life	O
).	O

Food	O
Intake	O
,	O
Weight	O
Gain	O
and	O
Oral	O
Glucose	O
Tolerance	O
Test	O
Figure	O
1boutlines	O
the	O
study	O
protocol	O
.	O

In	O
each	O
of	O
the	O
models	O
,	O
however	O
,	O
the	O
child	O
’	O
s	O
age	O
at	O
their	O
first	O
follow	O
-	O
up	O
visit	O
was	O
significantly	O
and	O
independently	O
positively	O
correlated	O
with	O
cathelicidin	O
.	O

Altogether	O
,	O
these	O
observations	O
suggest	O
that	O
FGF21	O
may	O
be	O
a	O
key	O
factor	O
linking	O
UCP1	O
expression	O
to	O
improved	O
glucose	O
metabolism	O
.	O

Methods	O
Subjects	O
Subjects	O
were	O
recruited	O
from	O
two	O
hospitals	O
in	O
the	O
Texas	O
Medical	O
Center	O
in	O
Houston	O
,	O
Texas	O
.	O

In	O
90	O
%	O
of	O
the	O
genes	O
that	O
we	O
validated	O
by	O
qRT	O
-	O
PCR	O
,	O
significant	O
expression	O
differences	O
in	O
mRNA	O
levels	O
between	O
the	O
treatment	O
groups	O
were	O
identified	O
by	O
both	O
qRT	O
-	O
PCR	O
and	O
microarray	O
analysis	O
(	O
Table4	O
).	O

Emphasis	O
is	O
given	O
to	O
spreading	O
the	O
dietary	O
intake	O
over	O
six	O
meals	O
daily	O
,	O
with	O
three	O
main	O
meals	O
and	O
three	O
snacks	O
,	O
in	O
order	O
to	O
avoid	O
large	O
carbohydrate	O
loads	O
at	O
any	O
time	O
.	O

We	O
found	O
that	O
pregnancy	O
loss	O
was	O
associated	O
with	O
lower	O
25OHD	O
when	O
expressed	O
on	O
a	O
continuous	O
but	O
not	O
categorical	O
scale	O
.	O

There	O
may	O
also	O
be	O
a	O
role	O
for	O
hand	O
cleansing	O
options	O
that	O
are	O
waterless	O
or	O
that	O
can	O
confer	O
residual	O
bacteriostatic	O
benefit	O
to	O
improve	O
the	O
convenience	O
and	O
thereby	O
the	O
frequency	O
of	O
hand	O
cleansing	O
,	O
or	O
the	O
effects	O
of	O
even	O
infrequent	O
hand	O
cleansing	O
.	O

Maternal	O
diet	O
during	O
pregnancy	O
is	O
related	O
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
manner	O
Abstract	O
Background	O
The	O
gut	O
microbiome	O
has	O
an	O
important	O
role	O
in	O
infant	O
health	O
and	O
immune	O
development	O
and	O
may	O
be	O
affected	O
by	O
early	O
-	O
life	O
exposures	O
.	O

The	O
comparison	O
of	O
maternal	O
characteristics	O
of	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
is	O
summarised	O
in	O
Table1	O
.	O

Low	O
levels	O
of	O
physical	O
activity	O
and	O
sedentary	O
lifestyle	O
are	O
known	O
contributing	O
factors	O
to	O
obesity	O
and	O
weight	O
gain	O
in	O
the	O
general	O
population	O
[	O
40	O
].	O

However	O
,	O
the	O
existence	O
of	O
this	O
protein	O
and	O
its	O
role	O
in	O
humans	O
is	O
still	O
a	O
matter	O
of	O
debate	O
(	O
Elsen	O
et	O
al	O
.,	O
2014a	O
).	O

A	O
seasonal	O
infectious	O
etiology	O
for	O
disease	O
is	O
complicated	O
by	O
many	O
factors	O
[	O
126	O
].	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
University	O
of	O
Toronto	O
Animal	O
Care	O
Committee	O
.	O

Thyroidectomy	O
during	O
pregnancy	O
has	O
not	O
been	O
associated	O
with	O
adverse	O
maternal	O
or	O
neonatal	O
outcomes3536	O
.	O

The	O
reported	O
cost	O
structures	O
of	O
delivery	O
for	O
these	O
programs	O
were	O
however	O
somewhat	O
similar	O
.	O

Seasons	O
were	O
defined	O
according	O
to	O
the	O
UK	O
Meteorological	O
Office	O
recommendations	O
(	O
www	O
.	O
metoffice	O
.	O
gov	O
.	O
uk	O
)	O
with	O
winter	O
(	O
December	O
to	O
February	O
),	O
spring	O
(	O
March	O
to	O
May	O
),	O
summer	O
(	O
June	O
to	O
August	O
),	O
and	O
autumn	O
(	O
September	O
to	O
November	O
).	O

Venous	O
blood	O
is	O
processed	O
within	O
1	O
h	O
after	O
blood	O
draw	O
;	O
plasma	O
/	O
serum	O
separated	O
and	O
red	O
blood	O
cells	O
washed	O
twice	O
with	O
normal	O
saline	O
.	O

There	O
is	O
limited	O
research	O
in	O
this	O
area	O
,	O
though	O
evidence	O
suggests	O
that	O
children	O
with	O
S	O
-	O
ECC	O
are	O
at	O
an	O
increased	O
risk	O
of	O
malnutrition	O
.	O

Sunlight	O
exposure	O
time	O
has	O
an	O
important	O
impact	O
on	O
Vitamin	O
D3	O
level	O
.	O

Study	O
also	O
has	O
shown	O
that	O
serum	O
25	O
-	O
OH	O
VitD2	O
detection	O
rate	O
is	O
less	O
than	O
5	O
%	O
in	O
China	O
[	O
4	O
].	O

Some	O
studies	O
have	O
also	O
noticed	O
that	O
the	O
metabolic	O
profile	O
exhibited	O
by	O
offspring	O
depends	O
on	O
the	O
sex	O
(	O
Desai	O
et	O
al	O
.,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
).	O

Individual	O
humans	O
demonstrate	O
substantial	O
genetic	O
differences	O
and	O
so	O
an	O
individual	O
’	O
s	O
underlying	O
genetics	O
could	O
have	O
a	O
huge	O
effect	O
on	O
his	O
/	O
her	O
susceptibility	O
to	O
a	O
particular	O
environmental	O
exposure	O
,	O
depending	O
on	O
his	O
/	O
her	O
metabolism	O
,	O
adaptability	O
,	O
gender	O
,	O
age	O
,	O
previous	O
exposures	O
,	O
etc	O
.	O

The	O
total	O
number	O
of	O
glomeruli	O
was	O
evaluated	O
at	O
6	O
months	O
of	O
age	O
.	O

One	O
possible	O
interpretation	B
for	O
our	O
present	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	O
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Differential	O
expression	O
of	O
genes	O
related	O
to	O
lipid	O
,	O
ketone	O
body	O
,	O
and	O
amino	O
acid	O
metabolism	O
indicate	O
that	O
the	O
offspring	O
of	O
both	O
groups	O
uses	O
different	O
metabolic	O
directions	O
in	O
response	O
to	O
identical	O
nutritional	O
condition	O
during	O
postnatal	O
life	O
.	O

Fifteen	O
(	O
62	O
.	O
5	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
moderate	O
vitamin	O
D	O
deficiency	O
,	O
which	O
decreased	O
to	O
zero	O
after	O
the	O
intervention	O
(	O
table	O
3	O
).	O

The	O
importance	O
of	O
age	O
of	O
exposure	O
and	O
seasonality	O
is	O
uncertain	O
.	O

Anthropometry	O
and	O
blood	O
samples	O
were	O
collected	O
from	O
participants	O
during	O
village	O
visits	O
Sample	O
size	O
Mean	O
recruitment	O
haemoglobin	O
for	O
the	O
PMMST	O
study	O
was	O
11	O
.	O
7	O
g	O
/	O
dL	O
,	O
(	O
SD	O
1	O
.	O
5	O
g	O
/	O
dL	O
)	O
for	O
a	O
population	O
of	O
1156	O
.	O

Invest	O
Bring	O
both	O
financial	O
and	O
other	O
resources	O
to	O
address	O
maternal	O
and	O
newborn	O
health	O
and	O
the	O
burden	O
of	O
preterm	O
birth	O
.	O

Interestingly	O
,	O
some	O
of	O
these	O
molecules	O
can	O
be	O
secreted	O
by	O
BAT	O
itself	O
,	O
indicating	O
the	O
occurrence	O
of	O
autocrine	O
effects	O
.	O

Statistical	O
methods	O
Among	O
the	O
34	O
415	O
women	O
included	O
in	O
the	O
study	O
,	O
we	O
had	O
information	O
on	O
dietary	O
intake	O
(	O
parent	O
study	O
)	O
and	O
psychotic	O
-	O
like	O
symptoms	O
for	O
34	O
310	O
women	O
(	O
follow	O
-	O
up	O
study	O
).	O

A	O
test	O
of	O
the	O
hypothesis	O
that	O
vitamin	O
D	O
could	O
reduce	O
MS	O
risk	O
will	O
require	O
the	O
administration	O
of	O
relatively	O
high	O
doses	O
of	O
vitamin	O
D	O
to	O
hundreds	O
of	O
thousands	O
of	O
young	O
adults	O
for	O
several	O
years	O
,	O
and	O
careful	O
monitoring	O
for	O
unforeseen	O
adverse	O
effects	O
is	O
mandatory	O
.	O

Most	O
infants	O
were	O
born	O
vaginally	O
(	O
66	O
.	O
9	O
%)	O
and	O
were	O
exclusively	O
breastfed	O
(	O
70	O
.	O
3	O
%)	O
at	O
6	O
weeks	O
of	O
age	O
.	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

The	O
current	O
stage	O
-	O
specific	O
feeding	O
program	O
for	O
producing	O
Korean	O
cattle	O
with	O
highly	O
marbled	O
beef	O
relies	O
heavily	O
on	O
feeding	O
a	O
concentrate	O
diet	O
during	O
the	O
fattening	O
period	O
.	O

The	O
frequency	O
of	O
egg	O
consumption	O
is	O
5	O
.	O
6	O
±	O
2	O
.	O
2	O
times	O
per	O
week	O
and	O
the	O
frequency	O
of	O
seafood	O
consumption	O
is	O
1	O
.	O
8	O
±	O
1	O
.	O
2	O
times	O
per	O
week	O
,	O
five	O
of	O
the	O
participants	O
did	O
not	O
take	O
seafood	O
products	O
,	O
15	O
participants	O
had	O
seafood	O
for	O
more	O
than	O
three	O
times	O
per	O
week	O
.	O

Therefore	B
,	O
the	O
poor	O
YG	O
in	O
winter	O
may	O
be	O
due	O
,	O
in	O
part	O
,	O
to	O
high	O
backfat	O
thickness	O
.	O

Other	O
suggests	O
vitamin	O
D	O
supplementation	O
of	O
400	O
IU	O
/	O
day	O
to	O
breast	O
fed	O
infants	O
is	O
the	O
most	B
secure	O
way	O
of	O
preventing	O
rickets	O
in	O
infants	O
.	O

Dose	O
,	O
route	O
,	O
metabolism	O
,	O
timing	O
and	O
mixtures	O
of	O
exposure	O
Whether	O
,	O
or	O
not	O
,	O
an	O
environmental	O
exposure	O
elicits	O
a	O
response	O
depends	O
on	O
a	O
range	O
of	O
interacting	O
variables	O
,	O
including	O
dose	O
,	O
route	O
of	O
administration	O
,	O
metabolism	O
and	O
additional	O
/	O
pre	O
-	O
existing	O
exposures	O
(	O
mixtures	O
).	O

[	O
14	O
]	O
assessed	O
vitamin	O
D	O
status	O
in	O
healthy	O
Thai	O
elderly	O
women	O
and	O
found	O
that	O
two	O
-	O
thirds	O
had	O
vitamin	O
D	O
insufficiency	O
and	O
one	O
-	O
third	O
had	O
vitamin	O
D	O
deficiency	O
.	O

Our	O
results	O
are	O
consistent	O
with	O
other	O
data	O
showing	O
that	O
early	O
nutrition	O
alters	O
the	O
central	O
appetite	O
regulatory	O
network	O
.	O
22Effects	O
of	O
the	O
maternal	O
diet	O
on	O
the	O
hypothalamic	O
expression	O
of	O
food	O
intake	O
regulatory	O
pathways	O
were	O
found	O
in	O
lambs	O
of	O
ewes	O
fed	O
a	O
diet	O
that	O
exceeded	O
their	O
energy	O
requirement	O
.	O

Herb	O
users	O
were	O
more	O
likely	O
to	O
make	O
a	O
dietary	O
change	O
during	O
pregnancy	O
.	O

An	O
unequivocal	B
positive	O
correlation	O
was	O
stated	O
between	O
VD3level	O
and	O
the	O
development	O
of	O
functional	O
ovarian	O
follicles	O
,	O
percentage	O
of	O
pregnancies	O
,	O
as	O
well	O
as	O
proper	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
[	O
28	O
].	O

The	O
mediator	O
release	O
results	O
in	O
the	O
well	O
-	O
recognized	O
acute	O
allergic	O
inflammation	O
characterized	O
by	O
itching	O
,	O
redness	O
,	O
and	O
tissue	O
edema	O
involving	O
the	O
skin	O
,	O
respiratory	O
tract	O
,	O
circulation	O
,	O
and	O
gastrointestinal	O
tract	O
.	O

It	O
would	O
also	O
be	O
of	O
interest	O
to	O
expand	O
these	O
observations	O
in	O
human	O
myometrium	O
that	O
is	O
a	O
key	O
organ	O
responsible	O
for	O
quiescence	O
and	O
contractility	O
responses	O
and	O
also	O
assess	O
whether	O
changes	O
in	O
GR	O
transcripts	O
are	O
due	O
to	O
labor	O
or	O
nonlabor	O
.	O

It	O
is	O
also	O
needed	O
for	O
bone	O
growth	O
and	O
bone	O
remodeling	O
by	O
osteoblasts	O
.	O

Vitamin	O
D	O
therapy	O
may	O
be	O
of	O
benefit	O
in	O
wheezing	O
children	O
.	O

Although	O
uncommon	O
,	O
MTC	O
is	O
interesting	O
because	O
of	O
its	O
biochemical	O
and	O
genetic	O
features	O
and	O
clinical	O
association	O
,	O
both	O
in	O
autosomal	O
-	O
dominant	O
inherited	O
syndromes	O
with	O
incomplete	O
penetrance	O
(	O
MEN	O
IIA	O
and	O
IIB	O
),	O
and	O
in	O
the	O
non	O
-	O
MEN	O
forms	O
.	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
healthy	O
women	O
means	O
;	O
any	O
one	O
with	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
such	O
as	O
hyper	O
/	O
hypothyroidism	O
,	O
parathyroid	O
,	O
renal	O
,	O
diabetes	O
and	O
heart	O
diseases	O
,	O
no	O
addiction	O
to	O
any	O
kind	O
of	O
narcotic	O
drugs	O
,	O
living	O
with	O
a	O
husband	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
such	O
as	O
preeclampsia	O
,	O
gestational	O
diabetes	O
,	O
ruptured	O
membranes	O
and	O
suspicion	O
of	O
preterm	O
birth	O
,	O
no	O
previous	O
cesarean	O
sections	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
based	O
on	O
ultrasound	O
results	O
,	O
and	O
the	O
EPDS	O
baseline	O
scores	O
of	O
0	O
to	O
13	O
.	O

In	O
Finland	O
,	O
the	O
prevalence	O
of	O
GDM	O
has	O
increased	O
from	O
6	O
%	O
in	O
2008	O
to	O
11	O
%	O
in	O
2014	O
[	O
12	O
].	O

Each	O
strip	O
will	O
consist	O
of	O
15	O
capsules	O
.	O

WHO	O
guidelines	O
recommend	O
daily	O
iron	O
supplementation	O
for	O
pregnant	O
women	O
and	O
children	O
6	O
–	O
24	O
months	O
where	O
anaemia	O
rates	O
are	O
40	O
%	O
or	O
more	O
[	O
7	O
].	O

Results	O
We	O
report	O
descriptive	O
statistics	O
including	O
dosage	O
of	O
text	O
messages	O
delivered	O
.	O

Due	O
to	O
the	O
LP	O
diet	O
a	O
number	O
of	O
molecular	O
routes	O
related	O
to	O
cell	O
cycle	O
and	O
cellular	O
turnover	O
,	O
response	O
to	O
stimuli	O
,	O
as	O
well	O
as	O
energy	O
-,	O
lipid	O
-	O
and	O
amino	O
acid	O
metabolic	O
pathways	O
are	O
shifted	O
on	O
the	O
transcriptional	O
level	O
in	O
the	O
liver	O
at	O
prenatal	O
stages	O
under	O
the	O
direct	O
influence	O
of	O
limited	O
protein	O
and	O
/	O
or	O
amino	O
acid	O
supply	O
,	O
but	O
also	O
postnatal	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
asthma	O
,	O
wheeze	O
,	O
eczema	O
,	O
hay	O
fever	O
and	O
atopy	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAsthma	O
n	O
=	O
7677	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
14	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
41	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
23	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
56	O
)	O
1	O
.	O
37	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
81	O
)	O
1	O
.	O
07	O
(	O
1	O
.	O
00	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
04	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
18	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
29	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Wheeze	O
n	O
=	O
7762	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
21	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
52	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
54	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
85	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
25	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
42	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
08	O
Eczema	O
n	O
=	O
7748	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
19	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
44	O
)	O
1	O
.	O
13	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
70	O
–	O
1	O
.	O
17	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
33	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
17	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
41	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
33	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
74	O
–	O
1	O
.	O
26	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
05	O
)	O
0	O
.	O
70	O
Hay	O
fever	O
n	O
=	O
7728	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
07	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
88	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
13	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
03	O
(	O
0	O
.	O
79	O
–	O
1	O
.	O
33	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
21	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
10	O
Atopy	O
n	O
=	O
6117	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
21	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
34	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
06	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
98	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
20	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
20	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
49	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
09	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
006	O
#:	O
controlling	O
for	O
energy	O
intake	O
;¶:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Vitamin	O
D3	O
also	O
comes	O
from	O
endogenous	O
sources	O
where	O
it	O
can	O
be	O
synthesized	O
by	O
skin	O
when	O
exposed	O
to	O
ultraviolet	O
irradiation	O
.	O

Design	O
and	O
Population	O
Design	O
and	O
protocol	O
of	O
the	O
study	O
is	O
shown	O
infigure	O
1	O
.	O

However	O
,	O
the	O
number	O
of	O
children	O
and	O
the	O
length	O
of	O
follow	O
-	O
up	O
involved	O
in	O
these	O
studies	O
could	O
only	O
detect	O
common	O
and	O
early	O
adverse	O
effects	O
.	O

Perinatal	O
outcomes	O
of	O
monotherapy	O
and	O
polytherapy	O
subgroups	O
Maternal	O
characteristics	O
Women	O
receiving	O
SGA	O
in	O
monotherapy	O
were	O
compared	O
with	O
those	O
women	O
receiving	O
polytherapy	O
with	O
at	O
least	O
one	O
additional	O
psychotropic	O
medication	O
(	O
Otable	O
4	O
).	O

GA	O
is	O
a	O
potential	O
mediating	O
variable	O
on	O
the	O
causal	O
pathway	O
between	O
EDC	O
exposure	O
and	O
birth	O
weight	O
,	O
while	O
sex	O
is	O
a	O
potential	O
modifier	O
.	O

Adjusted	O
analysis	O
confirmed	O
no	O
difference	O
in	O
mean	O
±	O
SEM	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
81	O
.	O
7	O
±	O
2	O
.	O
3	O
vs	O
81	O
.	O
7	O
±	O
0	O
.	O
8	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
99	O
).	O

Our	O
present	O
findings	O
indicate	O
a	O
reduction	O
in	O
activity	O
of	O
the	O
parasympathetic	O
ANS	O
associated	O
with	O
low	O
birth	O
weight	O
.	O

For	O
this	O
analysis	O
,	O
we	O
employ	O
only	O
measured	O
data	O
in	O
the	O
child	O
,	O
for	O
example	O
,	O
weight	O
and	O
length	O
at	O
birth	O
,	O
weight	O
and	O
height	O
at	O
ages	O
5	O
and	O
9	O
,	O
measured	O
weight	O
and	O
height	O
of	O
mother	O
(	O
when	O
the	O
child	O
was	O
aged	O
5	O
)	O
and	O
grandparents	O
(	O
at	O
baseline	O
)	O
and	O
a	O
mixture	O
of	O
measured	O
and	O
self	O
-	O
reported	O
data	O
for	O
the	O
fathers	O
.	O

Although	O
a	O
biological	O
mechanism	O
between	O
low	O
vitamin	O
D	O
status	O
and	O
diabetes	O
is	O
plausible	O
[	O
29	O
],	O
only	O
a	O
few	O
interventions	O
have	O
been	O
conducted	O
,	O
and	O
these	O
have	O
not	O
proved	O
an	O
effect	O
of	O
vitamin	O
D	O
supplementation	O
on	O
risk	O
of	O
GDM	O
[	O
30	O
].	O

Thus	B
,	O
the	O
dietary	O
vitamin	O
C	O
requirement	O
for	O
beef	O
cattle	O
is	O
not	O
specified	O
in	O
the	O
NRC	O
[	O
146	O
].	O

C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
has	O
lower	O
affinity	O
for	O
the	O
vitamin	O
D	O
receptor	O
,	O
thus	O
it	O
own	O
lower	O
bio	O
-	O
function	O
than	O
25	O
(	O
OH	O
)	O
D	O
in	O
vivo	O
.	O

This	O
results	O
in	O
the	O
increase	O
of	O
calcium	O
absorption	O
from	O
the	O
intestine	O
.	O
27	O
Previous	O
studies	O
,	O
17	O
,	O
27of	O
intramuscular	O
injection	O
of	O
600	O
,	O
000	O
unit	O
of	O
vitamin	O
D	O
was	O
associated	O
with	O
significant	O
increases	O
of	O
serum	O
vitamin	O
D	O
at	O
1	O
.	O
5	O
,	O
3	O
,	O
and	O
6	O
months	O
,	O
but	O
not	O
significant	O
at	O
9	O
and	O
12	O
months	O
later	O
.	O

In	O
addition	O
,	O
six	O
mitochondrial	O
proteins	O
were	O
down	O
-	O
regulated	O
in	O
DVD	O
-	O
deficient	O
rats	O
(	O
NDUAA	O
,	O
UQCR1	O
,	O
ODPB	O
,	O
IDH3A	O
,	O
HKK1	O
,	O
VDAC2	O
).	O

Even	O
more	O
interesting	O
,	O
some	O
of	O
the	O
patients	O
seemed	O
to	O
improve	O
when	O
treated	O
with	O
an	O
average	O
dose	O
of	O
about	O
4000	O
IU	O
of	O
vitamin	O
D	O
/	O
day	O
.	O

Survival	O
and	O
disease	O
-	O
free	O
intervals	O
identical	O
in	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
The	O
effects	O
of	O
management	O
modalities	O
on	O
pregnancy	O
outcome	O
:	O
No	O
I	O
-	O
131	O
,	O
tailored	O
therapy	O
.	O

(	O
2014	O
)‡	O
Yang	O
et	O
al	O
.	O

In	O
this	O
state	O
and	O
many	O
others	O
,	O
media	O
events	O
featuring	O
prominent	O
public	O
officials	O
are	O
held	O
to	O
announce	O
Report	O
Card	O
grades	O
or	O
report	O
on	O
state	O
progress	O
to	O
address	O
preterm	O
birth	O
.	O

trials	O
,	O
the	O
Medical	O
University	O
of	O
South	O
Carolina	O
(	O
MUSC	O
)	O
initiated	O
a	O
new	O
standard	O
of	O
care	O
for	O
pregnant	O
women	O
that	O
included	O
routine	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
in	O
September	O
2015	O
.	O

Multivariable	O
linear	O
regression	O
[	O
5	O
,	O
13	O
,	O
24	O
]	O
with	O
selected	O
predictors	O
[	O
30	O
]	O
is	O
another	O
method	O
,	O
but	O
it	O
can	O
produce	O
unreliable	O
estimates	O
due	B
to	I
the	O
highly	O
correlated	O
nature	O
of	O
some	O
EDCs	O
[	O
31	O
].	O

The	O
size	O
of	O
the	O
glomeruli	O
was	O
determined	O
with	O
the	O
same	O
method	O
used	O
to	O
estimate	O
their	O
number	O
,	O
the	O
fractionator	O
/	O
dissector	O
method	O
.	O

9	O
).	O

We	O
performed	O
multiple	O
logistic	O
regression	O
(	O
MLR	O
)	O
and	O
propensity	O
score	O
matching	O
(	O
PSM	O
).	O

Materials	O
and	O
Methods	O
The	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
The	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
is	O
a	O
multicenter	O
,	O
double	O
-	O
blind	O
,	O
randomized	O
,	O
placebo	O
-	O
controlled	O
trial	O
of	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
.	O

Postnatal	O
data	O
collection	O
time	O
points	O
are	O
at	O
infant	O
postnatal	O
age	O
of	O
6	O
weeks	O
(	O
phase	O
5	O
);	O
24	O
weeks	O
(	O
phase	O
6	O
);	O
6	O
weeks	O
post	O
measles	O
immunisation	O
(±	O
3	O
days	O
)	O
(	O
phase	O
7	O
)	O
or	O
30	O
weeks	O
(+	O
30	O
days	O
)	O
if	O
measles	O
immunization	O
was	O
not	O
given	O
between	O
24	O
and	O
28	O
weeks	O
;	O
and	O
52	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
8	O
).	O

Chest	O
and	O
soft	O
tissue	O
neck	O
X	O
-	O
ray	O
were	O
normal	O
.	O

Sunlight	O
expo	O
-	O
sure	O
questionnaires	O
are	O
imprecise	O
and	O
are	O
not	O
currently	O
recommended	O
.	O

However	O
,	O
at	O
three	O
months	O
of	O
age	O
,	O
the	O
VitD	O
-	O
groups	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
showed	O
a	O
tendency	O
toward	O
increased	O
BM	O
,	O
although	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
.	O

Previous	O
interventions	O
to	O
promote	O
reproductive	O
health	O
care	O
utilization	O
among	O
low	O
-	O
and	O
middle	O
-	O
income	O
women	O
suggested	O
an	O
approximate	O
12	O
%	O
effect	O
(	O
intervention	O
vs	O
control	O
)	O
of	O
such	O
programs	O
after	O
a	O
12	O
-	O
month	O
time	O
period	O
[	O
38	O
].	O

We	O
asked	O
women	O
if	O
they	O
discussed	O
the	O
use	O
of	O
herbs	O
with	O
their	O
prenatal	O
care	O
provider	O
,	O
and	O
how	O
satisfied	O
they	O
were	O
with	O
these	O
discussions	O
;	O
we	O
asked	O
the	O
same	O
questions	O
about	O
prenatal	O
vitamin	O
use	O
for	O
comparison	O
.	O

Nevertheless	O
,	O
fair	O
correlations	O
between	O
mother	O
and	O
cord	O
blood	O
were	O
found	O
in	O
previous	O
and	O
this	O
study	O
as	O
well	O
[	O
9	O
].	O

Data	O
were	O
checked	O
for	O
normality	O
using	O
a	O
Shapiro	O
-	O
Wilks	O
test	O
and	O
differences	O
between	O
women	O
recruited	O
in	O
Adelaide	O
compared	O
to	O
Auckland	O
were	O
tabulated	O
and	O
compared	O
using	O
a	O
Welch	O
’	O
s	O
t	O
-	O
test	O
(	O
continuous	O
variables	O
)	O
or	O
Fisher	O
’	O
s	O
exact	O
test	O
(	O
categorical	O
variables	O
).	O

Female	O
rats	O
were	O
maintained	O
on	O
the	O
same	O
diet	O
paradigm	O
as	O
in	O
the	O
pregestational	O
period	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD	O
20	O
).	O

A	O
new	O
study	O
finds	O
that	O
women	O
who	O
develop	O
severe	O
preeclampsia	O
tend	B
to	O
have	O
lower	O
blood	O
levels	O
of	O
vitamin	O
D	O
than	O
healthy	O
pregnant	O
women	O
raising	O
the	O
possibility	O
that	O
the	O
vitamin	O
plays	O
a	O
role	O
in	O
the	O
complication	O
.	O

To	B
the	I
best	I
of	I
our	I
knowledge	I
,	O
these	O
are	O
novel	O
findings	O
.	O

Sixty	O
-	O
eight	O
cases	O
were	O
within	O
normal	O
BMI	O
(	O
BMI	O
18	O
.	O
5	O
–	O
23	O
.	O
9	O
kg	O
/	O
m2	O
),	O
eighteen	O
cases	O
were	O
overweight	O
(	O
BMI24	O
~	O
27	O
.	O
9	O
kg	O
/	O
m2	O
),	O
five	O
cases	O
were	O
obese	O
(	O
BMI	O
>/=	O
28	O
kg	O
/	O
m2	O
),	O
and	O
seven	O
cases	O
were	O
underweight	O
(	O
BMI	O
<	O
18	O
.	O
5	O
kg	O
/	O
m2	O
).	O

Progesterone	O
Measures	O
Circulating	O
progesterone	O
concentrations	O
were	O
measured	O
in	O
adult	O
female	O
offspring	O
in	O
the	O
proestrous	O
stage	O
.	O

Neither	O
extended	O
winter	O
nor	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
glucose	O
in	O
early	O
or	O
late	O
pregnancy	O
,	O
or	O
the	O
GCT	O
in	O
late	O
pregnancy	O
(	O
Model	O
1	O
,	O
Table4	O
).	O

Gestational	O
and	O
neonatal	O
data	O
were	O
retrieved	O
from	O
medical	O
records	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
an	O
accumulation	O
of	O
NPR	O
-	O
C	O
ligands	O
in	O
the	O
Skm1	O
mice	O
may	O
contribute	O
to	O
the	O
skeletal	O
phenotype	O
.	O

Blood	O
pressure	O
is	O
measured	O
at	O
each	O
prenatal	O
visit	O
(	O
phases	O
1	O
to	O
3	O
)	O
as	O
well	O
as	O
postnatally	O
(	O
phases	O
5	O
,	O
6	O
and	O
8	O
)	O
according	O
to	O
international	O
guidelines	O
[	O
46	O
]	O
using	O
calibrated	O
equipment	O
.	O

Genetic	O
analysis	O
J	O
/	O
QTL	O
software	O
(	O
http	O
://	O
churchill	O
.	O
jax	O
.	O
org	O
/	O
software	O
/	O
jqtl	O
.	O
shtml	O
)	O
was	O
used	O
to	O
calculate	O
LOD	O
scores	O
for	O
the	O
whole	O
-	O
genome	O
SNP	O
analysis	O
.	O

In	O
fact	O
,	O
newborns	O
from	O
sows	O
that	O
received	O
a	O
low	O
protein	O
supply	O
during	O
gestation	O
had	O
a	O
significantly	O
lower	O
birth	O
weight	O
,	O
a	O
lower	O
body	O
fat	O
content	O
,	O
reduced	O
size	O
and	O
number	O
of	O
adipocytes	O
and	O
muscle	O
fibres	O
than	O
newborns	O
of	O
the	O
control	O
group	O
.	O

Today	O
,	O
after	O
decades	O
of	O
inactivity	O
,	O
the	O
uranium	O
from	O
these	O
ponds	O
,	O
waste	O
and	O
tailings	O
piles	O
,	O
and	O
the	O
mines	O
themselves	O
is	O
still	O
present	O
in	O
highly	O
chemically	O
soluble	O
forms6	O
,	O
21that	O
have	O
been	O
leaching	O
into	O
the	O
area	O
’	O
s	O
drinking	O
water	O
,	O
according	O
to	O
water	O
testing	O
by	O
the	O
EPA	O
and	O
the	O
Army	O
Corps	O
of	O
Engineers	O
.	O
22	O
In	O
a	O
small	O
,	O
one	O
-	O
story	O
adobe	O
building	O
tucked	O
into	O
the	O
far	O
edge	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
campus	O
,	O
Johnnye	O
Lewis	O
,	O
a	O
professor	O
of	O
toxicology	O
,	O
has	O
spent	O
more	O
than	O
a	O
decade	O
studying	O
mining	O
-	O
related	O
health	O
effects	O
in	O
the	O
Navajo	O
people	O
.	O

Linear	O
regression	O
procedures	O
were	O
used	O
to	O
estimate	O
maternal	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
while	O
adjusting	O
for	O
confounding	O
by	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

In	O
cases	O
where	O
a	O
reduced	O
sensitization	O
to	O
food	O
was	O
found	O
,	O
this	O
protective	O
effect	O
was	O
short	O
-	O
lived	O
and	O
was	O
primarily	O
observed	O
during	O
the	O
first	O
year	O
of	O
life	O
.	O

Conclusions	O
Folic	O
acid	O
allergy	O
appears	O
to	O
be	O
rare	O
and	O
would	O
not	O
be	O
expected	O
to	O
be	O
well	O
known	O
among	O
health	O
providers	O
or	O
consumers	O
.	O

Liver	O
samples	O
and	O
the	O
brains	O
were	O
also	O
collected	O
,	O
frozen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Understanding	O
the	O
role	O
EDCs	O
may	O
play	O
in	O
affecting	O
birth	O
weight	O
will	O
inform	O
efforts	O
to	O
prevent	O
low	O
birth	O
weight	O
and	O
the	O
development	O
of	O
chronic	O
diseases	O
.	O

The	O
reproductive	O
safety	O
of	O
antipsychotic	O
medications	O
should	O
be	O
studied	O
using	O
a	O
prospective	O
design	O
and	O
a	O
powerful	O
sample	O
size	O
and	O
in	O
the	O
reality	O
of	O
polytherapy	O
,	O
associated	O
comorbidities	O
and	O
environmental	O
and	O
genetic	O
confounders	O
.	O

Interestingly	O
,	O
BAT	O
glucose	O
uptake	O
is	O
close	O
to	O
the	O
values	O
observed	O
for	O
metastasis	O
in	O
cancer	O
in	O
humans	O
(	O
Aukema	O
et	O
al	O
.,	O
2010	O
).	O

However	O
,	O
by	O
weeks	O
28	O
to	O
36	O
,	O
women	O
taking	O
the	O
daily	O
supplement	O
had	O
a	O
significantly	O
higher	O
prevalence	O
of	O
hemoconcentration	O
,	O
a	O
condition	O
defined	O
as	O
hemoglobin	O
levels	O
above	O
145	O
g	O
/	O
L	O
.	O

For	O
example	O
,	O
in	O
a	O
study	O
of	O
women	O
and	O
infants	O
living	O
in	O
a	O
cotton	O
-	O
growing	O
region	O
of	O
northern	O
Mexico	O
where	O
DDT	O
was	O
heavily	O
used	O
,	O
Gladen	O
and	O
Rogan	O
found	O
that	O
women	O
with	O
the	O
lowest	O
DDE	O
levels	O
in	O
their	O
milk	O
shortly	O
after	O
birth	O
nursed	O
for	O
a	O
median	O
of	O
7	O
.	O
5	O
months	O
,	O
while	O
mothers	O
with	O
the	O
highest	O
DDE	O
levels	O
nursed	O
for	O
a	O
median	O
of	O
only	O
3	O
months	O
.	O
15A	O
study	O
in	O
Michigan	O
estimated	O
serum	O
levels	O
of	O
DDE	O
at	O
the	O
time	O
of	O
pregnancy	O
based	B
on	I
sampling	O
conducted	O
after	O
birth	O
.	O

This	O
suggests	O
that	O
cathelicidin	O
may	O
have	O
a	O
protective	O
benefit	O
in	O
preventing	O
disease	O
,	O
which	O
is	O
consistent	O
with	O
its	O
antimicrobial	O
properties	O
.	O

reported	O
that	O
conception	O
during	O
winter	O
was	O
associated	O
with	O
a	O
significantly	O
higher	O
incidence	O
of	O
gestational	O
diabetes	O
than	O
during	O
summer	O
[	O
26	O
].	O

The	O
researchers	O
studied	O
858	O
mother	O
–	O
infant	O
pairs	O
between	O
1978	O
and	O
1982	O
.	O

The	O
most	O
common	O
causes	O
of	O
nasal	O
symptoms	O
necessitating	O
treatment	O
during	O
pregnancy	O
are	O
AR	O
,	O
rhinitis	O
medicamentosa	O
,	O
sinusitis	O
,	O
and	O
(	O
non	O
-	O
AR	O
)	O
vasomotor	O
[	O
24	O
].	O

Another	O
factor	O
that	O
should	O
be	O
considered	O
is	O
the	O
composition	O
of	O
fatty	O
acids	O
present	O
in	O
breast	O
milk	O
,	O
which	O
may	O
influence	O
the	O
immune	O
response	O
of	O
the	O
child	O
[	O
68	O
].	O

In	O
a	O
systematic	O
review	O
by	O
Halbreich	O
and	O
Karkun	O
,	O
the	O
studies	O
from	O
40	O
different	O
countries	O
were	O
reviewed	O
.	O

Information	O
includes	O
medication	O
use	O
(	O
including	O
vaccines	O
),	O
HIV	O
status	O
,	O
obstetric	O
history	O
,	O
hospital	O
admission	O
during	O
pregnancy	O
,	O
use	O
of	O
alcohol	O
,	O
and	O
exposure	O
to	O
passive	O
smoking	O
.	O

These	O
ratio	O
changes	O
will	O
ultimately	O
lead	O
to	O
an	O
augmented	O
response	O
towards	O
glucocorticoids	O
with	O
potential	O
detrimental	O
effects	O
for	O
the	O
mother	O
and	O
the	O
fetus	O
.	O

The	O
validity	O
and	O
reliability	O
of	O
FFQ	O
had	O
been	O
previously	O
evaluated	O
[	O
20	O
].	O

Accumulation	O
of	O
Vitamin	O
D2	O
in	O
food	O
chain	O
,	O
such	O
as	O
from	O
poultry	O
fed	O
with	O
Vitamin	O
D2	O
fortified	O
feeds	O
and	O
their	O
eggs	O
,	O
also	O
contribute	O
to	O
elevated	O
Vitamin	O
D2	O
levels	O
in	O
human	O
bodies	O
.	O

Both	O
diet	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
generation	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
affected	O
the	O
GD	O
,	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

This	O
is	O
particularly	O
so	O
where	O
the	O
prevalence	O
of	O
anemia	O
is	O
above	O
20	O
%	O
among	O
women	O
of	O
reproductive	O
age	O
[	O
58	O
].	O

Iron	O
deficiency	O
is	O
the	O
most	O
common	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
[	O
2	O
].	O

As	O
with	O
other	O
studies	O
,	O
dietary	O
calcium	O
deficiency	O
might	O
have	O
led	O
to	O
so	O
-	O
called	O
wastage	O
of	O
body	O
stores	O
of	O
vitamin	O
D	O
in	O
both	O
groups	O
,	O
affecting	O
the	O
maintenance	O
of	O
even	O
higher	O
vitamin	O
D	O
levels	O
in	O
the	O
intervention	O
group	O
.	O

Therefore	O
,	O
cell	O
division	O
is	O
synchronous	O
with	O
cell	O
growth	O
[	O
19	O
,	O
20	O
].	O

Infant	O
allergy	O
assessment	O
A	O
medical	O
doctor	O
assesses	O
the	O
allergy	O
phenotype	O
and	O
sensitisation	O
of	O
infants	O
with	O
the	O
Childhood	O
Allergy	O
and	O
Immunology	O
Research	O
(	O
CAIR	O
)	O
questionnaire	O
and	O
skin	O
prick	O
tests	O
at	O
phases	O
7	O
and	O
8	O
postnatally	O
.	O

The	O
mean	O
age	O
of	O
women	O
was	O
similar	O
in	O
all	O
three	O
regions	O
.	O

Subjects	O
/	O
Methods	O
:	O
The	O
study	O
in	O
293	O
women	O
aged	O
from	O
17	O
to	O
45	O
years	O
old	O
was	O
nested	O
within	O
a	O
double	O
-	O
blind	O
,	O
randomised	O
placebo	O
-	O
controlled	O
trial	O
of	O
periconceptional	O
MMN	O
supplementation	O
[	O
ISRCTN	O
13687662	O
],	O
using	O
the	O
United	O
Nations	O
International	O
Multiple	O
Micronutrient	O
Preparation	O
(	O
UNIMMAP	O
),	O
received	O
daily	O
for	O
one	O
year	O
or	O
until	O
conception	O
.	O

Determining	O
the	O
impact	O
of	O
changes	O
in	O
the	O
gut	O
microbiome	O
of	O
infants	O
due	O
to	O
maternal	O
diet	O
on	O
infant	O
health	O
and	O
development	O
is	O
an	O
opportunity	O
to	O
refine	O
dietary	O
recommendations	O
for	O
pregnant	O
and	O
lactating	O
women	O
to	O
support	O
infant	O
health	O
.	O

F1	O
-	O
VitD	O
-	O
offspring	O
displayed	O
higher	O
levels	O
of	O
expression	O
of	O
AT1r	O
than	O
F1	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
02	O
)	O
There	O
was	O
no	O
difference	O
between	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
or	O
F1	O
and	O
F2	O
SC	O
offspring	O
.	O

Anaemia	O
during	O
pregnancy	O
is	O
a	O
public	O
health	O
problem	O
that	O
affects	O
both	O
developed	O
and	O
developing	O
countries	O
and	O
has	O
an	O
impact	O
not	O
only	O
on	O
health	O
providers	O
,	O
but	O
also	O
on	O
the	O
socio	O
-	O
economic	O
environment	O
[	O
12	O
].	O

There	O
was	O
no	O
statistical	O
significance	O
observed	O
when	O
respondents	O
’	O
maritalstatus	O
and	O
age	O
were	O
compared	O
with	O
the	O
satisfaction	O
of	O
the	O
different	O
services	O
in	O
the	O
health	O
centres	O
using	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
(	O
Table	O
3	O
).	O

This	O
could	O
explain	B
why	O
our	O
findings	O
of	O
exposure	O
to	O
extended	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
increased	O
HOMA	O
and	O
fasting	O
glucose	O
at	O
28	O
weeks	O
’	O
gestation	O
,	O
although	O
research	O
is	O
needed	O
to	O
explain	B
this	O
potential	O
hypothesis	O
.	O

If	O
serum	O
concentration	O
exceeded	O
70	O
.	O
3	O
nmol	O
/	O
L	O
(	O
75	O
percentile	O
),	O
the	O
chance	O
of	O
endometriosis	O
development	O
was	O
much	O
higher	O
,	O
with	O
OR	O
=	O
4	O
.	O
8	O
(	O
1	O
.	O
7	O
–	O
13	O
.	O
5	O
)	O
[	O
39	O
].	O

For	O
example	O
,	O
adolescents	O
tend	B
to	O
be	O
prone	B
to	O
impulsivity	O
and	O
the	O
fallacy	O
of	O
invincibility	O
and	O
to	O
have	O
problems	O
considering	O
long	O
-	O
term	O
consequences	O
of	O
their	O
behavior	O
.	O

The	O
majority	O
of	O
these	O
have	O
been	O
in	O
patients	O
with	O
type	O
1	O
diabetes	O
.	O

Thyroid	O
cancer	O
and	O
pregnancy	O
Treatment	O
and	O
follow	O
-	O
up	O
of	O
thyroid	O
cancer	O
in	O
pregnant	O
women	O
are	O
the	O
same	O
as	O
in	O
non	O
-	O
pregnant	O
patients	O
except	O
for	O
the	O
use	O
of	O
radioactive	O
iodine	O
.	O

As	O
noted	O
,	O
we	O
obtained	O
data	O
on	O
the	O
number	O
and	O
timing	O
of	O
text	O
messages	O
delivered	O
to	O
the	O
text4baby	O
participants	O
.	O

The	O
fetal	O
vitamin	O
D	O
status	O
is	O
dependent	O
on	O
the	O
placental	O
-	O
fetal	O
circulation	O
.	O

At	O
birth	O
,	O
umbilical	O
cord	O
blood	O
(	O
UCB	O
)	O
for	O
25	O
(	O
OH	O
)	O
D	O
measurement	O
was	O
obtained	O
at	O
gestational	O
weeks	O
37	O
to	O
42	O
between	O
January	O
2013	O
and	O
May	O
2014	O
[	O
hereafter	O
referred	O
to	O
as	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
].	O

Previous	O
studies	O
have	O
shown	O
that	O
BDNF	O
increases	O
serotonin	O
turnover	O
in	O
the	O
hypothalamus	O
,	O
30	O
,	O
31suggesting	O
that	O
the	O
effect	O
of	O
gestational	O
and	O
post	O
-	O
weaning	O
diets	O
on	O
BDNF	O
mRNA	O
levels	O
may	O
explain	B
some	O
compensatory	O
response	O
in	O
SeroR2A	O
expression	O
.	O

For	O
the	O
remaining	O
19	O
questions	O
,	O
the	O
internal	O
fidelity	O
was	O
satisfactory	O
(	O
the	O
correlation	O
coefficient	O
between	O
the	O
two	O
halves	O
-	O
0	O
.	O
83	O
;	O
the	O
-	O
split	O
half	O
reliability	O
-	O
0	O
.	O
91	O
;	O
Guttman	O
split	O
-	O
half	O
reliability	O
coefficient	O
-	O
0	O
.	O
91	O
and	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
-	O
0	O
.	O
88	O
)	O
[	O
26	O
].	O

Results	O
We	O
performed	O
a	O
longitudinal	O
holistic	O
study	O
of	O
the	O
hepatic	O
transcriptome	O
of	O
offspring	O
of	O
dams	O
fed	O
either	O
an	O
experimental	O
low	O
protein	O
diet	O
(	O
LP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
)	O
throughout	O
gestation	O
,	O
in	O
order	O
to	O
obtain	O
a	O
comprehensive	O
picture	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
sensitive	O
to	O
fetal	O
nutritional	O
programming	O
using	O
a	O
porcine	O
model	O
.	O

In	O
contrast	O
to	O
calorie	O
restricted	O
offspring	O
,	O
these	O
pups	O
regained	O
their	O
weight	O
and	O
by	O
day	O
12	O
(	O
MHF	O
)	O
or	O
day	O
14	O
(	O
PLHF	O
)	O
surpassed	O
controls	O
in	O
both	O
weight	O
and	O
rate	O
of	O
weight	O
gain	O
,	O
reflective	O
of	O
a	O
significantly	O
altered	O
growth	O
trajectory	O
(	O
Figure	O
1D	O
).	O

Our	O
findings	O
are	O
consistent	O
with	O
some	O
studies	O
in	O
nonpregnant	O
adults	O
and	O
children	O
showing	O
a	O
connection	O
between	O
higher	O
intake	O
of	O
sweets	O
and	O
soft	O
drinks	O
and	O
increased	O
weight	O
status	O
[	O
32	O
],	O
but	O
conflicting	O
results	O
have	O
been	O
reported	O
in	O
association	O
with	O
GWG	O
[	O
33	O
].	O

It	O
was	O
concluded	O
that	O
most	O
of	O
the	O
cases	O
had	O
language	O
delays	O
and	O
difficulties	O
with	O
expressive	O
skills	O
and	O
communication	O
disorders	O
.	O

Analyses	O
of	O
miRNAs	O
targeting	O
GR	O
Glucocorticoid	O
receptor	O
(	O
GR	O
)	O
has	O
been	O
previously	O
demonstrated	O
an	O
important	O
transcriptional	O
factor	O
of	O
hepatic	O
metabolic	O
genes	O
in	O
the	O
neonates	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
[	O
1	O
].	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

Then	O
,	O
myogenic	O
progenitor	O
cells	O
further	O
develop	O
into	O
muscle	O
fibres	O
and	O
satellite	O
cells	O
,	O
while	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
develop	O
into	O
the	O
stromal	O
–	O
vascular	O
fraction	O
of	O
skeletal	O
muscle	O
,	O
where	O
adipocytes	O
,	O
fibroblasts	O
,	O
and	O
resident	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
reside	O
[	O
16	O
].	O

Other	O
trials	O
assessing	O
infections	O
of	O
the	O
upper	O
respiratory	O
tract	O
also	O
had	O
mixed	O
findings	O
:	O
one	O
trial	O
in	O
post	O
-	O
menopausal	O
women26identified	O
reduced	O
self	O
-	O
reported	O
episodes	O
of	O
infection	O
of	O
the	O
upper	O
respiratory	O
tract	O
,	O
specifically	O
in	O
winter	O
,	O
whereas	O
two	O
others	O
in	O
elderly24and	O
general	O
adults27did	O
not	O
identify	O
a	O
difference	O
between	O
the	O
groups	O
with	O
regards	O
to	O
self	O
-	O
reported	O
episodes	O
.	O

RNA	O
concentration	O
was	O
determined	O
by	O
spectrophotometric	O
analysis	O
(	O
NanoDrop	O
;	O
Thermo	O
Scientific	O
,	O
UK	O
)	O
and	O
agarose	O
gel	O
electrophoresis	O
.	O

In	O
vitro	O
oestrogens	O
have	O
been	O
shown	O
to	O
down	O
-	O
regulate	O
the	O
NIS	O
(	O
sodium	O
iodide	O
symporter	O
)	O
gene	O
and	O
promote	O
the	O
production	O
of	O
thyroglobulin	O
(	O
HTG	O
),	O
increasing	O
HTG	O
-	O
gene	O
expression	O
via	O
oestrogen	O
receptors	O
present	O
in	O
thyroid	O
tissue	O
,	O
without	O
stimulating	O
rapid	O
cell	O
proliferation145	O
.	O

Moreover	O
,	O
up	O
to	O
70	O
%	O
of	O
small	O
-	O
for	O
-	O
gestational	O
-	O
age	O
(	O
SGA	O
)	O
infants	O
are	O
constitutionally	O
small	O
(“	O
small	O
but	O
healthy	O
”),	O
which	O
make	O
SGA	O
birth	O
a	O
poor	O
surrogate	O
for	O
intrauterine	O
growth	O
restriction	O
[	O
29	O
].	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

Thus	B
,	O
the	O
World	O
Health	O
Organization	O
has	O
defined	B
anaemia	O
in	O
pregnancy	O
as	B
a	O
haemoglobin	O
value	O
below	O
11	O
g	O
/	O
dL	O
[	O
1	O
,	O
3	O
].	O

It	O
is	O
defined	O
as	O
an	O
accumulation	O
of	O
adipose	O
tissue	O
that	O
is	O
of	O
sufficient	O
magnitude	O
to	O
impair	O
health	O
(	O
WHO	O
,	O
2014	O
).	O

Several	O
other	O
studies	O
have	O
focused	O
on	O
maternal	O
changes	O
during	O
pregnancy	O
and	O
their	O
association	O
with	O
autism	O
.	O

A	O
similar	O
pattern	O
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

Furthermore	O
,	O
if	O
the	O
woman	O
is	O
of	O
reproductive	O
age	O
,	O
the	O
pre	O
-	O
pregnancy	O
recognition	O
of	O
diabetes	O
is	O
vital	O
so	O
that	O
early	O
pregnancy	O
conditions	O
can	O
be	O
optimized	O
to	O
prevent	O
diabetes	O
fetopathy	O
.	O

Background	O
Pregnancy	O
and	O
fetal	O
development	O
are	O
periods	O
of	O
rapid	O
growth	O
and	O
cell	O
differentiation	O
when	O
mother	O
and	O
offspring	O
are	O
vulnerable	O
to	O
changes	O
in	O
dietary	O
supply	O
.	O

The	O
GEE	O
models	O
to	O
estimate	O
treatment	O
effects	O
on	O
measured	O
outcomes	O
did	O
not	O
demonstrate	O
any	O
significant	O
postpartum	O
text4baby	O
participation	O
effects	O
on	O
health	O
-	O
promoting	O
behaviors	O
.	O

Using	O
PSM	O
,	O
we	O
observed	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
on	O
PTB	O
and	O
LBW	O
among	O
those	O
vaccinated	O
in	O
the	O
second	O
and	O
third	O
trimester	O
.	O

The	O
patient	O
subsequently	O
returned	O
8	O
weeks	O
postprocedure	O
reporting	O
evidence	O
of	O
recurrence	O
that	O
began	O
approximately	O
2	O
weeks	O
prior	O
.	O

The	O
general	O
principles	O
of	O
treatment	O
of	O
pregnant	O
women	O
with	O
asthma	O
[	O
21	O
,	O
22	O
,	O
28	O
]	O
and	O
AR	O
[	O
29	O
]	O
do	O
not	O
differ	O
from	O
the	O
stepwise	O
approach	O
recommended	O
for	O
treatment	O
of	O
nonpregnant	O
women	O
.	O

All	O
12	O
%	O
of	O
the	O
instrumental	O
deliveries	O
were	O
observed	O
in	O
the	O
polytherapy	O
subgroup	O
.	O

PubMed	O
Central	O
:	O

2	O
.	O
2	O
.	O
2	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
IBM	O
SPSS	O
software	O
v	O
.	O
20	O
(	O
Armonk	O
,	O
NY	O
,	O
USA	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
cord	O
serum	O
.	O
Low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
6	O
±	O
1	O
.	O
138	O
.	O
4	O
±	O
1	O
.	O
7Male	O
(%)	O
36	O
*	O
59Nature	O
delivery	O
(%)	O
6763Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
43	O
.	O
0	O
±	O
0	O
.	O
3Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
4	O
±	O
2	O
.	O
449	O
.	O
8	O
±	O
1	O
.	O
9BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
08	O
.	O
3	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
68	O
.	O
8	O
±	O
3	O
.	O
668	O
.	O
2	O
±	O
2	O
.	O
2	O
%	O
of	O
fall	O
/	O
winter	O
birth47	O
.	O
146	O
.	O
8	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
85	O
.	O
7Asthma	O
,	O
father2	O
.	O
82	O
.	O
8AR	O
mother22	O
.	O
237	O
.	O
1AR	O
,	O
father30	O
.	O
622	O
.	O
9AD	O
,	O
mother16	O
.	O
78	O
.	O
6AD	O
,	O
father05	O
.	O
7Daycare	O
attendance	O
(%)	O
13	O
.	O
911	O
.	O
4Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
2	O
.	O
85	O
.	O
7Postnatal	O
smoke	O
Exposure	O
(%)	O
44	O
.	O
442	O
.	O
9	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
762	O
.	O
0Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
40	O
.	O
0	O
**	O
11	O
.	O
1Eczema	O
at	O
6	O
months	O
(%)	O
1914Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
1118	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
21423Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
18	O
±	O
-	O
0	O
.	O
37	O
**	O
0	O
.	O
10	O
±	O
0	O
.	O
29Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
19	O
±	O
0	O
.	O
86	O
-	O
0	O
.	O
20	O
±	O
1	O
.	O
20Z	O
score	O
of	O
VmaxFRC0	O
.	O
02	O
±	O
1	O
.	O
0	O
-	O
0	O
.	O
17	O
±	O
1	O
.	O
0	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

Children	O
presenting	O
at	O
the	O
study	O
hospital	O
with	O
signs	O
of	O
pneumonia	O
had	O
their	O
diagnosis	O
confirmed	O
radiographically	O
.	O

Seasonal	O
variation	O
in	O
vitamin	O
D	O
followed	O
a	O
similar	O
pattern	O
to	O
hours	O
of	O
sunlight	O
although	O
was	O
slightly	O
shifted	O
.	O

Infant	O
anthropometric	O
measurements	O
Infant	O
growth	O
is	O
assessed	O
at	O
each	O
postnatal	O
visit	O
.	O

However	O
,	O
the	O
relationship	O
between	O
vitamin	O
D	O
levels	O
and	O
lung	O
function	O
in	O
infancy	O
has	O
not	O
been	O
investigated	O
.	O

Diet	O
The	O
“	O
developmental	O
plasticity	O
hypothesis	O
”	O
refers	O
to	O
the	O
critical	O
developmental	O
period	O
in	O
utero	O
when	O
the	O
fetus	O
is	O
plastic	O
and	O
adaptively	O
imprints	O
to	O
its	O
environment	O
.	O

Based	O
on	O
the	O
distribution	O
of	O
messages	O
,	O
investigators	O
examined	O
estimated	O
dosage	O
levels	O
,	O
dichotomized	O
on	O
whether	O
a	O
participant	O
received	O
lower	O
or	O
higher	O
than	O
median	O
message	O
exposure	O
to	O
messaging	O
.	O

[	O
37	O
–	O
41	O
].	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
study	O
groups	O
in	O
relation	O
to	O
the	O
baseline	O
depression	O
score	O
.	O

The	O
survey	O
findings	O
also	O
suggest	O
a	O
positive	O
association	O
between	O
natural	O
iron	O
content	O
in	O
groundwater	O
and	O
iron	O
status	O
of	O
women	O
[	O
6	O
].	O

Maternal	O
characteristics	O
which	O
differed	O
across	O
quintiles	O
of	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
included	O
age	O
,	O
parity	O
,	O
pregnancy	O
size	O
,	O
season	O
of	O
birth	O
,	O
breastfeeding	O
duration	O
,	O
educational	O
level	O
,	O
ethnicity	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
anxiety	O
level	O
,	O
tobacco	O
exposure	O
and	O
infection	O
during	O
pregnancy	O
.	O

The	O
immunomodulating	O
role	O
of	O
vitamin	O
D	O
was	O
also	O
confirmed	O
by	O
stimulation	O
of	O
NK	O
cells	O
(	O
Natural	O
Killer	O
CD56	O
+	O
ve	O
)	O
isolated	O
from	O
the	O
1sttrimester	O
decidua	O
.	O

Conclusions	O
Iron	O
deficiency	O
remains	O
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

[	O
19	O
]	O
described	O
a	O
syndrome	O
of	O
supravalvular	O
aortic	O
stenosis	O
,	O
peripheral	O
pulmonic	O
stenosis	O
,	O
and	O
body	O
features	O
indistinguishable	O
from	O
those	O
in	O
survivors	O
of	O
the	O
syndrome	O
of	O
idiopathic	O
hypercalcemia	O
of	O
infancy	O
.	O

While	O
genetics	O
constitute	O
a	O
key	O
determinant	O
of	O
immunologic	O
memory	O
and	O
immune	O
system	O
maturation	O
[	O
56	O
–	O
58	O
],	O
environmental	O
factors	O
also	O
are	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
development	O
of	O
allergies	O
,	O
as	O
illustrated	O
by	O
the	O
discordance	O
of	O
allergies	O
in	O
twin	O
studies	O
[	O
59	O
],	O
the	O
increasing	O
prevalence	O
of	O
atopic	O
diseases	O
over	O
time	O
[	O
15	O
,	O
60	O
],	O
and	O
the	O
different	O
incidence	O
of	O
allergies	O
in	O
immigrant	O
and	O
country	O
of	O
origin	O
populations	O
[	O
61	O
].	O

Although	O
relatively	O
rare	O
,	O
clinicians	O
must	O
maintain	O
a	O
high	O
index	O
of	O
suspicion	O
for	O
aortic	O
dissection	O
in	O
any	O
pregnant	O
female	O
who	O
presents	O
with	O
acute	O
onset	O
chest	O
pain	O
.	O

The	O
diet	O
records	O
showed	O
that	O
the	O
frequencies	O
of	O
consumption	O
of	O
dairy	O
products	O
and	O
eggs	O
among	O
patients	O
were	O
7	O
.	O
5	O
±	O
3	O
.	O
8	O
/	O
week	O
and	O
5	O
.	O
6	O
±	O
2	O
.	O
2	O
/	O
week	O
,	O
respectively	O
.	O

In	O
addition	O
to	O
clinical	O
similarity	O
,	O
AAOC	O
could	O
be	O
misdiagnosed	O
as	O
PG	O
with	O
ossification	O
because	O
of	O
the	O
vascular	O
and	O
bony	O
growth	O
on	O
histology	O
.	O

The	O
exam	O
of	O
her	O
extremities	O
showed	O
1	O
+	O
right	O
radial	O
pulse	O
and	O
2	O
+	O
left	O
radial	O
pulse	O
.	O

Transfer	O
Mechanisms	O
of	O
Allergy	O
(	O
Immunopathogenesis	O
of	O
Atopy	O
)	O
The	O
allergic	O
status	O
of	O
the	O
mother	O
can	O
potentially	O
affect	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
through	O
numerous	O
factors	O
that	O
are	O
transferable	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
.	O

We	O
used	O
Bayesian	O
Hierarchical	O
Linear	O
Models	O
(	O
BHLM	O
)	O
to	O
examine	O
the	O
associations	O
between	O
newborn	O
birth	O
weight	O
and	O
53	O
EDCs	O
,	O
2	O
organochlorine	O
pesticides	O
(	O
OPPs	O
)	O
and	O
2	O
heavy	O
metals	O
.	O

Because	O
of	O
use	O
of	O
cohort	O
and	O
control	O
groups	O
,	O
it	O
not	O
only	O
allowed	O
a	O
representative	O
sample	O
of	O
Utah	O
children	O
,	O
but	O
also	O
as	O
a	O
surveillance	O
study	O
could	O
not	O
directly	O
assess	O
cases	O
and	O
controls	O
[	O
48	O
].	O

Moreover	O
,	O
RC	O
females	O
also	O
exhibited	O
a	O
reduction	O
in	O
the	O
percentage	O
of	O
perirenal	O
fat	O
relative	O
to	O
body	O
weight	O
compared	O
to	O
RC	O
males	O
.	O

Several	O
studies	O
have	O
shown	O
a	O
high	O
prevalence	O
of	O
postnatal	O
depression	O
in	O
Iran	O
.	O

HMHB	O
and	O
Voxiva	O
,	O
joint	O
owners	O
of	O
the	O
text4baby	O
service	O
,	O
did	O
not	O
have	O
access	O
to	O
any	O
data	O
collected	O
through	O
the	O
study	O
or	O
any	O
patient	O
information	O
stored	O
at	O
Madigan	O
.	O

Body	O
mass	O
index	O
(	O
BMI	O
)	O
(	O
kg	O
/	O
m2	O
)	O
was	O
calculated	O
.	O

High	O
dose	O
(>	O
2000	O
IU	O
)	O
vitamin	O
D	O
supplementation	O
is	O
associated	O
with	O
decreasing	O
risk	O
of	O
pregnancy	O
complications	O
[	O
23	O
–	O
25	O
].	O

Other	O
measures	O
of	O
neurodevelopment	O
not	O
significant	O
in	O
either	O
direction	O
.	O
QualityNeutralPositivePositiveNeutral	O
Studies	O
were	O
heterogeneous	O
in	O
methodology	O
in	O
regard	O
to	O
the	O
covariates	O
,	O
neurological	O
assessment	O
tools	O
,	O
length	O
of	O
follow	O
up	O
statistical	O
analyses	O
.	O

The	O
use	O
of	O
GTT	O
(	O
75	O
g	O
glucose	O
load	O
),	O
rather	O
than	O
glucose	O
challenge	O
test	O
,	O
would	O
have	O
allowed	O
for	O
better	O
comparison	O
with	O
the	O
seasonal	O
gestational	O
diabetes	O
papers	O
discussed	O
,	O
however	O
universal	O
screening	O
for	O
gestational	O
diabetes	O
using	O
GTT	O
is	O
not	O
currently	O
standard	O
practice	O
in	O
Ireland	O
.	O

However	O
,	O
the	O
mechanisms	O
of	O
action	O
and	O
protective	O
abilities	O
of	O
PUFA	O
could	O
differ	O
between	O
different	O
diseases	O
.	O

Thus	O
,	O
season	O
at	O
pregnancy	O
blood	O
sampling	O
and	O
at	O
birth	O
was	O
coded	O
using	O
dummy	O
variables	O
(	O
with	O
autumn	O
as	O
a	O
reference	O
)	O
in	O
ANCOVA	O
and	O
used	O
as	O
a	O
covariate	O
.	O

Participants	O
completed	O
the	O
questionnaire	O
in	O
reference	O
to	O
intake	O
over	O
the	O
past	O
month	O
.	O

The	O
rats	O
were	O
fasted	O
overnight	O
for	O
10	O
h	O
before	O
glucose	O
gavage	O
.	O

The	O
mass	O
transitions	O
followed	O
were	O
:	O
315	O
.	O
1	O
→	O
109	O
.	O
0	O
at	O
28V	O
for	O
progesterone	O
and	O
355	O
.	O
3	O
→	O
125	O
.	O
2	O
at	O
24V	O
for	O
corticosterone	O
-	O
d8	O
.	O

Maternal	O
medical	O
and	O
obstetric	O
histories	O
and	O
type	O
and	O
duration	O
of	O
SGAs	O
and	O
other	O
psychotropic	O
medications	O
used	O
in	O
pregnancy	O
were	O
documented	O
.	O

In	O
addition	O
to	O
its	O
effect	O
on	O
BAT	O
,	O
BMP	O
-	O
7	O
was	O
also	O
reported	O
to	O
induce	O
the	O
“	O
browning	O
”	O
of	O
WAT	O
and	O
to	O
improve	O
insulin	O
sensitivity	O
(	O
Schulz	O
et	O
al	O
.,	O
2011	O
).	O

Additionally	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

In	O
a	O
cohort	O
study	O
by	O
Evans	O
et	O
al	O
.	O

Especially	O
notable	O
is	O
the	O
considerably	O
lower	O
PTB	O
rate	O
for	O
those	O
who	O
reached	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
those	O
who	O
did	O
not	O
(	O
78	O
%)	O
among	O
non	O
-	O
white	O
women	O
.	O

Participants	O
and	O
Procedures	O
Participants	O
were	O
offspring	O
of	O
women	O
recruited	O
into	O
the	O
Fit	O
for	O
Delivery	O
study	O
,	O
a	O
clinical	O
trial	O
that	O
examined	O
the	O
effects	O
of	O
a	O
lifestyle	O
intervention	O
to	O
reduce	O
excessive	O
GWG	O
in	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
women	O
(	O
Clinical	O
Trials	O
no	O
.	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	O
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	O
not	O
represent	O
true	O
,	O
and	O
potentially	O
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

Introduction	O
Obesity	O
,	O
well	O
known	O
to	O
be	O
associated	O
with	O
a	O
number	O
of	O
comorbidities	O
,	O
including	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
,	O
has	O
become	O
a	O
major	O
public	O
health	O
problem	O
in	O
recent	O
decades	O
,	O
and	O
has	O
reached	O
epidemic	O
proportions	O
,	O
not	O
only	O
in	O
high	O
-	O
income	O
countries	O
,	O
but	O
also	O
in	O
most	O
middle	O
-	O
income	O
societies	O
.	O

A	O
strategic	O
research	O
approach	O
is	O
needed	O
to	O
understand	O
why	O
babies	O
are	O
born	O
preterm	O
or	O
as	O
stillbirths	O
,	O
how	O
to	O
identify	O
women	O
at	O
risk	O
,	O
to	O
test	O
strategies	O
for	O
prevention	O
and	O
care	O
,	O
and	O
reduce	O
death	O
and	O
disability	O
rates	O
for	O
preterm	O
neonates	O
.	O

Finally	O
,	O
to	O
determine	O
the	O
combined	O
effects	O
of	O
SNPs	O
,	O
a	O
genotype	O
risk	O
score	O
(	O
GRS	O
)	O
was	O
calculated	O
as	O
the	O
sum	O
of	O
the	O
number	O
of	O
risk	O
alleles	O
at	O
rs10741657	O
(	O
G	O
)	O
and	O
rs2282679	O
(	O
C	O
),	O
as	O
identified	O
in	O
the	O
previous	O
analysis	O
.	O

Indeed	O
,	O
the	O
smaller	O
glomeruli	O
could	O
explain	B
the	O
high	O
BP	O
observed	O
among	O
F1	O
-	O
VitD	O
-	O
offspring	O
and	O
the	O
strong	O
tendency	O
toward	O
high	O
BP	O
observed	O
in	O
the	O
F2	O
generation	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Regulated	O
pathways	O
in	O
liver	O
tissue	O
between	O
ontogenetic	O
stages	O
and	O
diets	O
.	O

Pubertal	O
age	O
was	O
monitored	O
and	O
blood	O
samples	O
collected	O
in	O
adulthood	O
for	O
endocrine	O
analyses	O
.	O

Other	O
mitigating	O
factors	O
may	O
include	O
a	O
greater	O
intake	O
of	O
saturated	O
fat	O
in	O
the	O
form	O
of	O
milk	O
and	O
butter	O
,	O
as	O
well	O
as	O
a	O
greater	O
number	O
of	O
older	O
siblings	O
living	O
at	O
home	O
in	O
rural	O
/	O
farm	O
communities	O
[	O
116	O
].	O

Each	O
participant	O
is	O
requested	O
to	O
recall	O
all	O
foods	O
and	O
drinks	O
consumed	O
the	O
previous	O
day	O
from	O
when	O
she	O
woke	O
up	O
until	O
the	O
next	O
day	O
the	O
same	O
time	O
.	O

Non	O
-	O
normally	O
distributed	O
variables	O
were	O
log	O
transformed	O
prior	O
to	O
regression	O
analysis	O
.	O

The	O
remaining	O
four	O
studies	O
did	O
not	O
correct	O
for	O
either	O
paternal	O
IQ	O
or	O
home	O
environment	O
.	O

In	O
final	O
adjusted	O
model	O
,	O
women	O
with	O
a	O
higher	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
4	O
.	O
88	O
times	O
larger	O
odds	O
for	O
having	O
an	O
infant	O
with	O
low	O
birth	O
head	O
circumference	O
than	O
those	O
with	O
a	O
lower	O
adherence	O
level	O
(	O
OR	O
:	O
4	O
.	O
88	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
79	O
-	O
30	O
.	O
19	O
P	O
=	O
0	O
.	O
35	O
).	O

Unfortunately	O
,	O
we	O
do	O
not	O
have	O
any	O
information	O
about	O
the	O
use	O
of	O
such	O
supplements	O
during	O
follow	O
-	O
up	O
.	O

Significant	O
correlations	O
were	O
observed	O
in	O
both	O
groups	O
between	O
first	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
002	O
,	O
ra	O
=	O
0	O
.	O
713	O
,	O
pb	O
=	O
0	O
.	O
005	O
,	O
rb	O
=-	O
0	O
.	O
540	O
,	O
in	O
A	O
and	O
B	O
group	O
,	O
respectively	O
)	O
and	O
second	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
009	O
,	O
ra	O
=	O
0	O
.	O
628	O
and	O
pb	O
=	O
0	O
.	O
008	O
,	O
rb	O
=-	O
0	O
.	O
518	O
,	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
)	O
with	O
infant	O
’	O
s	O
height	O
.	O

Approximately	O
10	O
mL	O
of	O
blood	O
was	O
drawn	O
in	O
ethylene	O
diamine	O
tetraacetic	O
acid	O
plasma	O
tubes	O
at	O
each	O
study	O
visit	O
;	O
the	O
samples	O
were	O
kept	O
at	O
4	O
°	O
C	O
until	O
processing	O
for	O
storage	O
within	O
4	O
hours	O
of	O
venipuncture	O
.	O

Sampling	O
and	O
laboratory	O
analyses	O
have	O
been	O
described	O
previously	O
[	O
3	O
].	O

Martinez	O
et	O
al	O
.	O

Women	O
with	O
25	O
(	O
OH	O
)	O
D	O
between	O
25	O
and	O
100	O
nmol	O
/	O
L	O
and	O
serum	O
calcium	O
<	O
2	O
.	O
75	O
mmol	O
/	O
L	O
were	O
eligible	O
to	O
enroll	O
fully	O
in	O
the	O
study	O
.	O

Methods	O
This	O
randomized	O
clinical	O
trial	O
was	O
done	O
in	O
pregnant	O
women	O
who	O
were	O
under	O
prenatal	O
care	O
in	O
a	O
teaching	O
hospital	O
in	O
Shiraz	O
,	O
Iran	O
.	O

In	O
contrast	O
to	O
MHF	O
and	O
PLHF	O
offspring	O
,	O
those	O
born	O
to	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
showed	O
lower	O
adult	O
circulating	O
progesterone	O
concentrations	O
.	O

Infant	O
psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
Psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
of	O
the	O
offspring	O
is	O
being	O
assessed	O
using	O
the	O
Protocol	O
for	O
Child	O
Monitoring	O
–	O
Infant	O
version	O
(	O
PCM	O
-	O
I	O
),	O
which	O
combines	O
both	O
parental	O
report	O
and	O
direct	O
observation	O
by	O
trained	O
assessors	O
to	O
provide	O
a	O
comprehensive	O
evaluation	O
of	O
a	O
child	O
’	O
s	O
motor	O
skills	O
,	O
cognition	O
,	O
language	O
,	O
personal	O
and	O
socio	O
-	O
emotional	O
development	O
[	O
62	O
].	O

Previtamin	O
D3is	O
then	O
rapidly	O
converted	O
by	O
a	O
heat	O
dependent	O
process	O
to	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
5	O
,	O
6	O
.	O

A	O
second	O
advantage	O
of	O
reporting	O
μβis	O
that	O
it	O
prevents	O
the	O
investigator	O
from	O
only	O
reporting	O
chemicals	O
that	O
are	O
significantly	O
related	O
to	O
birth	O
weight	O
by	O
virtue	O
of	O
it	O
being	O
an	O
average	O
association	O
between	O
a	O
class	O
and	O
the	O
outcome	O
.	O

Normal	O
Weight	O
Mothers	O
In	O
initial	O
,	O
unadjusted	O
analyses	O
,	O
few	O
significant	O
correlations	O
were	O
found	O
between	O
prenatal	O
behaviors	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
.	O

However	O
,	O
recently	O
published	O
findings	O
from	O
approximately	O
46	O
%	O
of	O
eligible	O
infants	O
at	O
6	O
months	O
of	O
age	O
(	O
698	O
of	O
1522	O
eligible	O
infants	O
assessed	O
)	O
suggest	O
a	O
very	O
small	O
reduction	O
in	O
subscapular	O
skinfold	O
thickness	O
measurement	O
of	O
~	O
0	O
.	O
4	O
mm	O
following	O
provision	O
of	O
the	O
antenatal	O
intervention	O
[	O
20	O
].	O

Differences	O
in	O
ethnicity	O
[	O
21	O
],	O
solar	O
exposure	O
and	O
geographical	O
location	O
,	O
as	O
well	O
as	O
genetics	O
[	O
22	O
]	O
and	O
supplementation	O
[	O
23	O
–	O
25	O
],	O
are	O
known	O
to	O
affect	O
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
therefore	B
influence	O
study	O
outcomes	O
.	O

Skm2	O
mice	O
exhibited	O
abnormal	O
skeleton	O
morphology	O
,	O
with	O
severe	O
scoliosis	O
(	O
the	O
convexity	O
of	O
the	O
curve	O
pointing	O
to	O
the	O
left	O
)	O
and	O
lordosis	O
(	O
Figure	O
4	O
,	O
E	O
and	O
F	O
).	O

Mazaki	O
-	O
Tovi	O
analyzed	O
the	O
relationship	O
of	O
increased	O
maternal	O
serum	O
visfatin	O
with	O
gestational	O
diabetes	O
mellitus	O
infection	O
and	O
the	O
birth	O
of	O
LGA	O
infants	O
.	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

These	O
results	O
informed	O
the	O
next	O
stage	O
of	O
analyses	O
that	O
examined	O
race	O
and	O
vitamin	O
D	O
levels	O
with	O
the	O
outcome	O
of	O
SGA	O
by	O
assessing	O
potential	O
confounders	O
:	O
race	O
,	O
smoking	O
,	O
pre	O
-	O
eclampsia	O
,	O
maternal	O
age	O
,	O
Medicaid	O
status	O
and	O
BMI	O
at	O
delivery	O
.	O

To	O
calculate	O
individual	O
food	O
intake	O
when	O
animals	O
were	O
housed	O
in	O
groups	O
,	O
total	O
food	O
intake	O
from	O
each	O
cage	O
was	O
measured	O
and	O
equally	O
divided	O
according	O
to	O
the	O
number	O
of	O
pups	O
per	O
cage	O
.	O

Our	O
correlation	O
estimates	O
(	O
corresponding	O
to	O
half	O
the	O
heritability	O
)	O
of	O
0	O
.	O
25	O
between	O
the	O
mother	O
and	O
the	O
MGM	O
and	O
0	O
.	O
26	O
for	O
the	O
father	O
and	O
the	O
PGM	O
are	O
consistent	O
with	O
these	O
as	O
is	O
the	O
value	O
0	O
.	O
28	O
for	O
that	O
of	O
the	O
child	O
at	O
age	O
9	O
with	O
the	O
mother	O
.	O

In	O
fact	O
the	O
percentage	O
of	O
infants	O
of	O
normal	O
weight	O
mothers	O
with	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
doubled	O
between	O
birth	O
and	O
6	O
-	O
months	O
.	O

The	O
dams	O
were	O
housed	O
individually	O
in	O
ventilated	O
plastic	O
transparent	O
cages	O
with	O
bedding	O
in	O
a	O
12	O
:	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
0700	O
at	O
22	O
±	O
1	O
°	O
C	O
).	O

Current	O
NICE	O
guidance	O
states	O
clearly	O
that	O
pregnant	O
women	O
are	O
informed	O
,	O
at	O
their	O
first	O
antenatal	O
booking	O
,	O
of	O
the	O
importance	O
of	O
adequate	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
after	O
,	O
to	O
maintain	O
their	O
own	O
and	O
their	O
baby	O
'	O
s	O
health	O
.	O

This	O
review	O
critically	O
evaluates	O
literature	O
on	O
fish	O
intake	O
in	O
pregnant	O
women	O
,	O
with	O
a	O
focus	O
on	O
the	O
association	O
between	O
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
and	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
.	O

All	O
the	O
microarray	O
data	O
is	O
MIAME	O
compliant	O
and	O
the	O
raw	O
data	O
has	O
been	O
deposited	O
in	O
a	O
MIAME	O
compliant	O
database	O
,	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
Gene	O
Expression	O
Omnibushttp	O
://	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
geo	O
(	O
accession	O
numbers	O
:	O
GSE25482	O
and	O
GSE31191	O
).	O

Two	O
recent	O
meta	O
-	O
analyses	O
also	O
found	O
that	O
higher	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
significantly	O
decreased	O
the	O
risk	O
of	O
PTB	O
[	O
9	O
,	O
10	O
].	O

Vitamin	O
D	O
deficiency	O
and	O
insufficiency	O
is	O
also	O
common	O
in	O
Thailand	O
(	O
at	O
latitudes	O
between	O
5	O
°	O
30	O
′	O
N	O
and	O
20	O
°	O
30	O
′	O
N	O
)	O
where	O
adequate	O
UVB	O
exposure	O
is	O
available	O
all	O
year	O
round	O
as	O
shown	O
inTable	O
112	O
,	O
13	O
,	O
14	O
,	O
15	O
,	O
16	O
,	O
17	O
,	O
18	O
.	O

Discussion	O
This	O
study	O
demonstrates	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
moderate	O
(	O
20	O
%)	O
caloric	O
restriction	O
(	O
undernutrition	O
)	O
during	O
preconceptional	O
(	O
2	O
weeks	O
)	O
and	O
gestational	O
(	O
up	O
2	O
days	O
before	O
birth	O
)	O
periods	O
produced	O
long	O
-	O
term	O
effects	O
on	O
body	O
weight	O
,	O
feeding	O
behavior	O
and	O
gene	O
expression	O
of	O
key	O
components	O
of	O
the	O
ECS	O
(	O
receptors	O
and	O
enzymes	O
)	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

During	O
the	O
preparation	O
for	O
pregnancy	O
in	O
VD	O
-	O
deficient	O
females	O
(	O
with	O
serum	O
VD	O
50	O
–	O
125nmol	O
/	O
L	O
),	O
it	O
is	O
advised	O
to	O
supplement	O
vitamin	O
D	O
prior	O
to	O
the	O
first	O
visit	O
in	O
a	O
fertility	O
clinic	O
.	O

The	O
information	O
on	O
pregnancy	O
loss	O
is	O
likely	B
correct	O
,	O
albeit	O
without	O
conclusive	O
information	O
on	O
the	O
time	O
of	O
fetal	O
demise	O
.	O

The	O
heritability	O
marbling	O
phenotype	O
in	O
Japanese	O
Wagyu	O
is	O
0	O
.	O
40	O
to	O
0	O
.	O
55	O
[	O
44	O
–	O
46	O
],	O
and	O
MS	O
heritabilities	O
in	O
Angus	O
and	O
Brahman	O
are	O
0	O
.	O
48	O
[	O
47	O
]	O
and	O
0	O
.	O
37	O
to	O
0	O
.	O
44	O
[	O
48	O
,	O
49	O
],	O
respectively	O
.	O

An	O
interaction	O
term	O
(	O
early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
*	O
winter	O
)	O
was	O
subsequently	O
added	O
to	O
the	O
model	O
,	O
but	O
was	O
not	O
significant	O
in	O
any	O
model	O
(	O
data	O
not	O
shown	O
).	O

We	O
recognise	B
however	O
that	O
the	O
influence	O
of	O
central	O
gonadal	O
drivers	O
cannot	O
be	O
discounted	O
.	O

First	O
,	O
an	O
unmatched	O
RV	O
post	O
-	O
weaning	O
diet	O
fed	O
the	O
offspring	O
born	O
to	O
HV	O
dams	O
resulted	O
in	O
increased	O
food	O
intake	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
,	O
as	O
observed	O
previously	O
.	O
4Second	O
,	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
prevented	O
these	O
effects	O
.	O

In	O
overweight	O
/	O
obese	O
(	O
OW	O
/	O
OB	O
;	O
n	O
=	O
132	O
)	O
mothers	O
,	O
greater	O
%	O
kcal	O
from	O
sweets	O
early	O
in	O
pregnancy	O
was	O
the	O
strongest	O
,	O
independent	O
predictor	O
of	O
higher	O
weight	O
for	O
age	O
(	O
WFA	O
)	O
(	O
beta	O
=	O
0	O
.	O
19	O
;	O
P	O
=	O
0	O
.	O
004	O
),	O
higher	O
odds	O
of	O
macrosomia	O
(	O
OR	O
=	O
1	O
.	O
1	O
(	O
1	O
.	O
0	O
–	O
1	O
.	O
2	O
);	O
P	O
=	O
0	O
.	O
004	O
)	O
andWFA	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
–	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
higher	O
WFA	O
at	O
6	O
months	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
P	O
=	O
0	O
.	O
002	O
).	O

In	O
conclusion	O
,	O
developmental	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
subtle	O
changes	O
in	O
a	O
range	O
of	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
.	O

These	O
results	O
likely	B
indicate	O
that	O
the	O
up	O
-	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
in	O
the	O
hypothalamus	O
at	O
adulthood	O
may	O
result	O
from	O
a	O
lower	O
long	O
-	O
term	O
cannabinoid	O
activity	O
that	O
,	O
in	O
turn	O
,	O
could	O
be	O
produced	O
by	O
lower	O
levels	O
of	O
eCBs	O
and	O
N	O
-	O
acylethanolamines	O
(	O
NAEs	O
)	O
in	O
the	O
hypothalamus	O
of	O
male	O
offspring	O
as	B
was	O
previous	O
described	O
at	O
birth	O
(	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
categorised	O
based	O
on	O
standardised	O
quartiles	O
and	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
statusPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Low711	O
(	O
25	O
)	O
328	O
(	O
46	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
07	O
)	O
46	O
(	O
6	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
66	O
,	O
1	O
.	O
57	O
))	O
57	O
(	O
8	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
42	O
)	O
28	O
(	O
4	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
30	O
)	O
36	O
(	O
5	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
29	O
)	O
84	O
(	O
12	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
39	O
)	O
Low	O
-	O
Moderate755	O
(	O
27	O
)	O
318	O
(	O
42	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
12	O
)	O
42	O
(	O
6	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
64	O
)	O
65	O
(	O
9	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
74	O
,	O
1	O
.	O
52	O
)	O
25	O
(	O
3	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
39	O
,	O
1	O
.	O
16	O
)	O
33	O
(	O
4	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
3572	O
(	O
10	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
32	O
)	O
Moderate	O
-	O
High702	O
(	O
25	O
)	O
309	O
(	O
44	O
)	O
1	O
.	O
0	O
†	O
37	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
50	O
(	O
7	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
39	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
81	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
High630	O
(	O
23	O
)	O
258	O
(	O
41	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
06	O
)†	O
35	O
(	O
6	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
78	O
,	O
1	O
.	O
96	O
)	O
40	O
(	O
6	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
30	O
)	O
10	O
(	O
2	O
)	O
0	O
.	O
47	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
)	O
30	O
(	O
5	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
25	O
)	O
60	O
(	O
10	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
11	O
)	O
Vitamin	O
D	O
Status	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
51	O
(	O
52	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
)	O
8	O
(	O
8	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
03	O
))	O
6	O
(	O
6	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
32	O
,	O
1	O
.	O
52	O
)	O
5	O
(	O
5	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
38	O
,	O
2	O
.	O
52	O
)	O
7	O
(	O
7	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
04	O
)	O
13	O
(	O
13	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
66	O
,	O
2	O
.	O
01	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
301	O
(	O
45	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
03	O
)	O
45	O
(	O
7	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
75	O
)	O
59	O
(	O
9	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
34	O
)	O
26	O
(	O
4	O
)	O
0	O
.	O
89	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
47	O
)	O
29	O
(	O
4	O
)	O
0	O
.	O
75	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
16	O
)	O
74	O
(	O
11	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
24	O
)	O
>	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
428	O
(	O
46	O
)	O
1	O
.	O
0	O
†	O
48	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
80	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
52	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
107	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
435	O
(	O
40	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
04	O
)	O
60	O
(	O
5	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
87	O
,	O
1	O
.	O
87	O
)	O
67	O
(	O
6	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
12	O
)†	O
26	O
(	O
2	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
28	O
)	O
51	O
(	O
5	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
26	O
)	O
104	O
(	O
9	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
12	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
pregnancy	O
outcome	O
and	O
fetal	O
sex	O
As	O
there	O
is	O
evidence	O
to	O
suggest	O
that	O
vitamin	O
D	O
metabolism	O
within	O
the	O
placenta	O
may	O
differ	O
with	O
respect	O
to	O
fetal	O
sex	O
[	O
35	O
]	O
thus	B
,	O
we	O
assessed	O
the	O
effect	O
of	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
on	O
pregnancy	O
outcome	O
stratified	O
by	O
fetal	O
sex	O
(	O
Table	O
3	O
).	O

Unfortunately	O
,	O
to	O
date	O
,	O
few	O
studies	O
have	O
assessed	O
the	O
impact	O
of	O
these	O
interventions	O
on	O
preterm	O
birth	O
in	O
these	O
countries	O
,	O
particularly	O
with	O
accurate	O
measures	O
of	O
gestational	O
age	O
[	O
12	O
].	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
impact	O
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
respiratory	O
function	O
and	O
disease	O
outcome	O
in	O
infancy	O
.	O

We	O
examined	O
treatment	O
effects	O
and	O
the	O
effects	O
of	O
higher	O
doses	O
of	O
text4baby	O
messages	O
on	O
outcomes	O
.	O

2007	O
).	O

New	O
and	O
effective	O
methods	O
for	O
monitoring	O
and	O
management	O
of	O
maternal	O
complications	O
and	O
preterm	O
labour	O
could	O
make	O
a	O
major	O
contribution	O
.	O

In	O
a	O
few	O
countries	O
,	O
case	O
management	O
of	O
neonatal	O
sepsis	O
is	O
being	O
scaled	O
up	O
using	O
community	O
-	O
based	O
health	O
workers	O
[	O
18	O
].	O

This	O
may	O
have	O
arisen	O
as	B
a	O
consequence	O
of	O
the	O
IOMC	O
study	O
only	O
examining	O
folic	O
acid	O
use	O
during	O
the	O
last	O
trimester	O
of	O
pregnancy	O
[	O
14	O
].	O

Similarly	O
,	O
the	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
S	O
-	O
ECC	O
was	O
significant	O
after	O
logistic	O
regression	O
while	O
controlling	O
for	O
factors	O
such	O
as	O
general	O
health	O
status	O
,	O
the	O
age	O
when	O
teeth	O
cleaning	O
was	O
first	O
started	O
,	O
and	O
household	O
finances	O
.	O

At	O
middle	O
or	O
late	O
term	O
of	O
pregnancy	O
;	O
3	O
).	O

It	O
is	O
the	O
largest	O
prospective	O
cohort	O
study	O
to	O
assess	O
vitamin	O
D	O
status	O
within	O
the	O
international	O
SCOPE	O
cohort	O
,	O
comparing	O
and	O
combining	O
two	O
distinct	O
populations	O
of	O
pregnant	O
women	O
living	O
at	O
similar	O
latitude	O
and	O
provides	O
a	O
greater	O
understanding	O
of	O
vitamin	O
D	O
deficiency	O
and	O
the	O
risk	O
of	O
adverse	O
pregnancy	O
outcomes	O
.	O

©	O
Tony	O
Anderson	O
/	O
Getty	O
Images	O
There	O
is	O
much	O
about	O
lactation	O
that	O
remains	O
unknown	O
.	O

50	O
.	O
9	O
±	O
29	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
05	O
).	O

Detectable	O
differences	O
would	O
range	O
from	O
6	O
.	O
2	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
80	O
%	O
of	O
children	O
),	O
to	O
6	O
.	O
7	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
70	O
%	O
of	O
children	O
;	O
alpha	O
0	O
.	O
05	O
;	O
power	O
80	O
%).	O

UVB	O
intensity	O
is	O
a	O
positive	O
predictor	O
of	O
live	O
birth	O
following	O
fresh	O
ET	O
,	O
whereas	O
altitude	O
and	O
annualized	O
average	O
regional	O
temperature	O
have	O
an	O
inverse	O
relationship	O
with	O
live	O
birth	O
ratio	O
following	O
fresh	O
ET	O
[	O
63	O
].	O

Obesity	O
is	O
correlated	O
with	O
low	O
NAD	O
+/	O
SIRT	O
pathway	O
expression	O
in	O
adipose	O
tissue	O
of	O
BMI	O
-	O
discordant	O
monozygotic	O
twins	O
(	O
22	O
).	O

In	O
addition	O
,	O
an	O
increasing	O
number	O
of	O
studies	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
(	O
gestational	O
diabetes	O
and	O
pre	O
-	O
eclampsia	O
),	O
in	O
neonates	O
(	O
wheezing	O
)	O
and	O
children	O
(	O
low	O
bone	O
mineral	O
density	O
,	O
type	O
-	O
1	O
diabetes	O
,	O
eczema	O
)[	O
16	O
]–[	O
22	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Schedule	O
of	O
enrolment	O
,	O
interventions	O
,	O
and	O
assessments	O
Electronic	O
data	O
collection	O
tool	O
Data	O
will	O
be	O
captured	O
using	O
an	O
android	O
application	O
developed	O
using	O
Java	O
.	O

Depending	O
on	O
the	O
offspring	O
'	O
s	O
nutritional	O
history	O
during	O
the	O
prenatal	O
and	O
lactational	O
periods	O
,	O
subsequent	O
nutrition	O
and	O
body	O
weight	O
gain	O
did	O
not	O
further	O
influence	O
offspring	O
reproductive	O
tempo	O
,	O
which	O
was	O
dominated	O
by	O
the	O
effect	O
of	O
prenatal	O
nutrition	O
.	O

Pre	O
-	O
pregnancy	O
BMI	O
based	O
on	O
pre	O
-	O
pregnancy	O
weight	O
was	O
calculated	O
using	O
the	O
following	O
equation	O
as	O
defined	O
by	O
the	O
World	O
Health	O
Organization	O
:	O
weight	O
/	O
height2	O
.	O

We	O
also	O
considered	O
vitamin	O
D	O
insufficiency	O
as	B
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
21	O
–	O
29	O
ng	O
/	O
ml	O
,	O
and	O
the	O
participants	O
who	O
had	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
≥	O
30	O
ng	O
/	O
ml	O
as	B
sufficient	O
[	O
19	O
,	O
46	O
].	O

A	O
total	O
of	O
251	O
study	O
subjects	O
had	O
a	O
post	O
-	O
50	O
gram	O
1	O
-	O
hour	O
glucose	O
concentration	O
≥	O
140	O
mg	O
/	O
dl	O
and	O
thus	O
required	O
the	O
follow	O
-	O
up	O
diagnostic	O
100	O
-	O
gram	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
).	O

Additionally	O
,	O
our	O
findings	O
are	O
observational	O
in	O
nature	O
thus	O
we	O
cannot	O
determine	O
causality	O
.	O

The	O
4	O
-	O
carbon	O
ring	O
backbone	O
of	O
this	O
molecule	O
makes	O
it	O
more	O
of	O
a	O
steroid	O
hormone	O
than	O
a	O
vitamin	O
.	O

Furthermore	O
,	O
we	O
have	O
utilised	O
robust	O
methodology	O
to	O
obtain	O
anthropometric	O
measures	O
of	O
the	O
infants	O
at	O
6	O
months	O
of	O
age	O
,	O
adhering	O
to	O
a	O
standardised	O
,	O
research	O
quality	O
protocol	O
.	O

The	O
ethnic	O
homogeneity	O
of	O
our	O
study	O
population	O
reduces	O
the	O
risk	O
of	O
confounding	O
by	O
unmeasured	O
factors	O
,	O
both	O
genetic	O
and	O
environmental	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
male	O
offspring	O
were	O
born	O
normoweight	O
but	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
male	O
offspring	O
in	O
several	O
days	O
of	O
the	O
lactation	O
period	O
(	O
PND	O
1	O
–	O
2	O
and	O
PND	O
9	O
–	O
11	O
).	O

Vitamin	O
D	O
deficiency	O
was	O
not	O
significantly	O
associated	O
with	O
SGA	O
for	O
white	O
infants	O
in	O
our	O
study	O
population	O
(	O
Table	O
3	O
).	O

Short	O
Communication	O
Congenital	O
abnormalities	O
are	O
the	O
leading	O
cause	O
of	O
infant	O
mortalities	O
in	O
the	O
United	O
States	O
(	O
25	O
%)	O
and	O
across	O
the	O
world	O
[	O
1	O
].	O

With	O
the	O
possible	O
driving	O
factors	O
of	O
VEGF	O
and	O
BMP	O
,	O
this	O
lesion	O
is	O
benign	O
and	O
can	O
recur	O
after	O
excision	O
.	O

After	O
adjusting	O
for	O
socioeconomic	O
variables	O
,	O
this	O
lower	O
risk	O
remained	O
(	O
OR	O
=	O
0	O
.	O
41	O
,	O
p	O
=	O
0	O
.	O
002	O
).	O

Further	O
,	O
we	O
cannot	O
conclude	O
if	O
the	O
effects	O
of	O
maternal	O
diet	O
occur	O
only	O
in	O
breastfed	O
babies	O
,	O
or	O
also	O
in	O
those	O
mostly	B
fed	O
formula	O
,	O
or	O
a	O
combination	O
of	O
formula	O
and	O
breast	O
milk	O
.	O

Priority	O
questions	O
:	O
What	O
dose	O
(	O
s	O
)	O
via	O
what	O
route	O
(	O
s	O
)	O
of	O
administration	O
are	O
human	O
populations	O
actually	O
exposed	O
to	O
,	O
and	O
what	O
metabolite	O
(	O
s	O
)	O
are	O
formed	O
?	O

We	O
examined	O
impact	O
of	O
intensive	O
handwashing	O
promotion	O
on	O
handwashing	O
behavior	O
of	O
mothers	O
of	O
neonates	O
.	O

Results	O
Three	O
identified	O
major	O
dietary	O
patterns	O
according	O
to	O
the	O
results	O
obtained	O
from	O
the	O
factor	O
loading	O
matrix	O
were	O
(	O
i	O
)	O
“	O
western	O
dietary	O
pattern	O
”;	O
(	O
ii	O
)	O
“	O
traditional	O
dietary	O
pattern	O
”;	O
(	O
iii	O
)	O
“	O
healthy	O
dietary	O
pattern	O
”.	O

Plots	O
include	O
only	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

Indeed	O
,	O
18	O
human	O
cohort	O
and	O
20	O
rodent	O
studies	O
within	O
PubMed	O
reported	O
a	O
lack	O
of	O
epigenetically	O
related	O
toxicity	O
(	O
Supplementary	O
Table	O
4	O
).	O

In	O
addition	O
,	O
authors	O
emphasize	O
importance	O
of	O
survival	O
and	O
health	O
of	O
cows	O
and	O
calves	O
and	O
of	O
subsequent	O
reproductive	O
performance	O
of	O
cows	O
for	O
relative	O
contribution	O
of	O
fetal	O
programming	O
to	O
the	O
profitability	O
of	O
beef	O
production	O
systems	O
when	O
developmental	O
programming	O
is	O
applied	O
[	O
33	O
].	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
may	O
interfere	O
with	O
many	O
functions	O
beyond	O
calcium	O
metabolism	O
,	O
such	O
as	O
foetal	O
"	O
imprinting	O
"	O
that	O
may	O
affect	O
neurodevelopment	O
,	O
immune	O
function	O
and	O
chronic	O
disease	O
susceptibility	O
later	O
in	O
life	O
,	O
as	O
well	O
as	O
soon	O
after	O
birth2425	O
.	O

The	O
routine	O
use	O
of	O
multivitamins	O
is	O
not	O
recommended	O
[	O
34	O
].	O

A	O
systematic	O
review	O
of	O
randomised	O
control	O
trials	O
examining	O
LC	O
n	O
-	O
3PUFA	O
supplementation	O
during	O
pregnancy	O
found	O
no	O
clear	O
association	O
between	O
supplement	O
use	O
and	O
infant	O
cognitive	O
outcomes	O
[	O
33	O
].	O

Human	O
insulin	O
does	O
not	O
normally	B
cross	O
the	O
placenta	O
,	O
though	O
antibody	O
bound	O
animal	O
insulin	O
has	O
been	O
reported	O
to	O
do	O
so	O
.	O
35However	O
,	O
it	O
has	O
been	O
shown	O
by36Jovanovic	O
that	O
it	O
is	O
maternal	O
glucose	O
control	O
,	O
rather	O
than	O
maternal	O
anti	O
-	O
insulin	O
antibody	O
levels	O
which	O
influence	O
birthweight	O
.	O
36Human	O
insulin	O
is	O
considered	O
safe	O
in	O
pregnancy	O
as	B
years	O
of	O
experience	O
has	O
not	O
suggested	O
an	O
increase	O
in	O
fetal	O
complications	O
as	O
a	O
consequence	O
of	O
its	O
use	O
.	O

Some	O
effects	O
of	O
maternal	O
diet	O
were	O
more	O
apparent	O
in	O
exclusively	O
breastfed	O
infants	O
;	O
however	O
,	O
we	O
were	O
unable	O
to	O
compare	O
to	O
exclusively	O
formula	O
-	O
fed	O
infants	O
since	O
most	O
infants	O
received	O
some	O
breast	O
milk	O
.	O

observed	O
significantly	O
higher	O
HbA1cin	O
the	O
UK	O
among	O
female	O
patients	O
with	O
type	O
2	O
diabetes	O
in	O
the	O
months	O
February	O
,	O
March	O
and	O
June	O
,	O
and	O
suggested	O
that	O
poorer	O
diet	O
and	O
reduced	O
physical	O
activity	O
associated	O
with	O
Christmas	O
and	O
Easter	O
celebrations	O
may	O
be	O
involved	O
[	O
20	O
].	O

Based	O
on	O
these	O
calculations	O
,	O
the	O
minimum	O
sample	O
size	O
required	O
was	O
370	O
.	O

The	O
control	O
group	O
consumed	O
extra	O
supplements	O
such	O
as	O
calcium	O
more	O
frequently	O
,	O
nonetheless	O
this	O
group	O
had	O
significantly	O
higher	O
depression	O
scores	O
compared	O
to	O
vitamin	O
D	O
group	O
.	O

It	O
is	O
well	O
recognized	O
that	O
individuals	O
with	O
darker	O
skin	O
pigmentation	O
living	O
at	O
higher	O
latitudes	O
tend	O
to	O
have	O
lower	O
25	O
(	O
OH	O
)	O
D	O
.	O
This	O
may	O
in	O
part	O
reflect	O
clustering	O
of	O
genotypes	O
within	O
ethnic	O
groups	O
.	O

UVB	O
in	O
the	O
290	O
-	O
315	O
nm	O
range	O
photolysis	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
to	O
form	O
previtamin	O
D3	O
,	O
which	O
then	O
isomerizes	O
to	O
colecalciferol	O
.	O
6Colecalciferol	O
(	O
and	O
ergocalciferol	O
[	O
vitamin	O
D2	O
])	O
is	O
also	O
available	O
from	O
fortified	O
foods	O
(	O
e	O
.	O
g	O
.,	O
milk	O
,	O
cereal	O
,	O
and	O
some	O
orange	O
juice	O
and	O
cheeses	O
),	O
dark	O
fish	O
(	O
e	O
.	O
g	O
.,	O
salmon	O
and	O
tuna	O
),	O
and	O
vitamin	O
supplements	O
(	O
colecalciferol	O
).	O

Many	O
studies	O
have	O
shown	O
that	O
those	O
born	O
in	O
winter	O
and	O
spring	O
have	O
a	O
significantly	O
increased	O
risk	O
of	O
developing	O
schizophrenia	O
[	O
2	O
],	O
and	O
that	O
those	O
born	O
at	O
higher	O
latitudes	O
are	O
also	O
at	O
increased	O
risk	O
of	O
schizophrenia	O
[	O
3	O
].	O

We	O
report	O
here	O
the	O
cost	O
and	O
cost	O
-	O
effectiveness	O
of	O
the	O
de	O
-	O
worming	O
and	O
weekly	O
iron	O
-	O
folic	O
acid	O
intervention	O
,	O
which	O
has	O
now	O
been	O
delivered	O
to	O
women	O
in	O
Yen	O
Bai	O
province	O
since	O
May	O
2006	O
.	O

Hyposensitization	O
(	O
immunotherapy	O
),	O
which	O
may	O
be	O
selectively	O
indicated	O
in	O
certain	O
patients	O
with	O
AR	O
,	O
bee	O
venom	O
sensitivity	O
,	O
and	O
asthma	O
should	O
not	O
be	O
initiated	O
during	O
pregnancy	O
because	O
of	O
the	O
risk	O
of	O
systemic	O
reactions	O
.	O

These	O
results	O
are	O
similar	O
to	O
ours	O
:	O
we	O
found	O
that	O
women	O
aged	O
over	O
18	O
years	O
,	O
with	O
parity	O
less	O
than	O
two	O
,	O
with	O
more	O
than	O
9	O
years	O
of	O
education	O
,	O
from	O
urban	O
areas	O
with	O
a	O
wanted	O
pregnancy	O
or	O
who	O
were	O
married	O
were	O
significantly	O
more	O
likely	B
to	O
use	O
iron	O
supplements	O
.	O

It	O
is	O
evident	B
that	O
the	O
major	O
transcripts	O
in	O
the	O
human	O
placenta	O
are	O
GR	O
α	O
and	O
GAS5	O
.	O

Twelve	O
mothers	O
of	O
our	O
13	O
infants	O
with	O
IIH	O
received	O
antenatal	O
vitamin	O
D3supplementation	O
.	O

Height	O
The	O
estimated	O
height	O
correlations	O
at	O
each	O
age	O
and	O
across	O
generations	O
are	O
displayed	O
in	O
(	O
table	O
5	O
).	O

Protein	O
Expression	O
in	O
the	O
Nucleus	O
Accumbens	O
of	O
Rats	O
Exposed	O
to	O
Developmental	O
Vitamin	O
D	O
Deficiency	O
Abstract	O
Introduction	O
Developmental	O
vitamin	O
D	O
(	O
DVD	O
)	O
deficiency	O
is	O
a	O
candidate	O
risk	O
factor	O
for	O
schizophrenia	O
.	O

2008	O
).	O

Purebred	O
Japanese	O
Black	O
cattle	O
show	O
a	O
linear	O
increase	O
in	O
IMF	O
content	O
with	O
increasing	O
slaughter	O
age	O
from	O
16	O
.	O
7	O
months	O
(	O
500	O
d	O
)	O
to	O
over	O
33	O
.	O
3	O
months	O
(	O
1	O
,	O
000	O
d	O
)	O
[	O
66	O
].	O

While	O
there	O
have	O
been	O
conflicting	O
reports	O
in	O
the	O
literature	O
with	O
,	O
for	O
instance	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
3reporting	O
equivalent	O
relationships	O
between	O
the	O
child	O
’	O
s	O
BMI	O
and	O
both	O
parents	O
,	O
the	O
Generation	O
R	O
study2reports	O
that	O
the	O
maternal	O
influence	O
is	O
strongest	O
.	O

Skm2	O
mice	O
presented	O
a	O
more	O
severe	O
phenotype	O
and	O
were	O
readily	O
identified	O
after	O
birth	O
by	O
a	O
shortened	O
stature	O
,	O
abnormal	O
gait	O
,	O
and	O
severe	O
scoliosis	O
and	O
lordosis	O
(	O
Figure	O
1C	O
).	O

The	O
feedback	O
loop	O
in	O
which	O
low	O
self	O
-	O
esteem	O
increases	O
the	O
risk	O
of	O
overweight	O
and	O
overweight	O
contributes	O
to	O
low	O
self	O
-	O
esteem	O
could	O
be	O
a	O
critical	O
point	O
of	O
intervention	O
.	O

The	O
relative	O
quantification	O
was	O
calculated	O
using	O
the	O
ΔΔCt	O
method	O
and	O
normalized	O
to	O
the	O
control	O
group	O
.	O

There	O
were	O
very	O
few	O
protocol	O
violations	O
and	O
the	O
results	O
of	O
our	O
per	O
-	O
protocol	O
and	O
post	O
-	O
hoc	O
analyses	O
for	O
children	O
getting	O
four	O
and	O
five	O
consecutive	O
doses	O
were	O
not	O
different	O
from	O
that	O
of	O
our	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
(	O
table	O
2	O
,	O
3	O
;	O
appendix	O
)	O
A	O
further	O
post	O
-	O
hoc	O
analysis	O
of	O
the	O
pneumonia	O
rates	O
by	O
season	O
also	O
did	O
not	O
reveal	O
any	O
difference	O
between	O
the	O
groups	O
in	O
our	O
intention	O
-	O
to	O
-	O
treat	O
or	O
per	O
-	O
protocol	O
analyses	O
(	O
data	O
not	O
shown	O
).	O

Similar	O
to	O
the	O
present	O
study	O
,	O
Mendhekar	O
et	O
al	O
47in	O
2006	O
described	O
a	O
neonate	O
who	O
presented	O
with	O
unexplained	O
fetal	O
distress	O
following	O
prenatal	O
exposure	O
to	O
aripiprazole	O
.	O

In	O
general	O
,	O
miRNAs	O
repress	O
gene	O
expression	O
by	O
binding	O
to	O
mRNAs	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
and	O
either	O
inducing	O
their	O
degradation	O
or	O
inhibiting	O
their	O
translation	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
whereas	O
piRNAs	O
and	O
esiRNAs	O
bind	O
to	O
complementary	O
transposable	O
elements	O
(	O
TEs	O
)	O
and	O
induce	O
their	O
degradation	O
(	O
Watanabe	O
et	O
al	O
.	O
2006	O
,	O
2008	O
).	O

Participants	O
are	O
asked	O
according	O
to	O
the	O
~	O
140	O
food	O
items	O
listed	O
in	O
the	O
QFFQ	O
,	O
the	O
type	O
/	O
brand	O
,	O
cooking	O
methods	O
,	O
frequency	O
and	O
the	O
amount	O
of	O
all	O
food	O
and	O
drink	O
consumed	O
in	O
the	O
past	O
4	O
weeks	O
.	O

Prenatal	O
Vitamin	O
Use	O
and	O
Vitamin	O
D	O
Status	O
during	O
Pregnancy	O
,	O
Differences	O
by	O
Race	O
and	O
Overweight	O
Status	O
Abstract	O
Objective	O
We	O
aimed	O
to	O
study	O
whether	O
prenatal	O
vitamin	O
(	O
PNV	O
)	O
use	O
protects	O
against	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
all	O
women	O
and	O
particularly	O
in	O
obese	O
and	O
black	O
women	O
who	O
are	O
both	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
poor	O
pregnancy	O
outcomes	O
.	O

Intensive	O
care	O
may	O
be	O
necessary	O
to	O
reduce	O
deaths	O
among	O
extremely	O
premature	O
babies	O
(<	O
28	O
weeks	O
),	O
who	O
account	B
for	I
5	O
%	O
of	O
all	O
premature	O
babies	O
though	O
a	O
larger	O
proportion	O
of	O
deaths	O
.	O

All	O
mice	O
that	O
carry	O
the	O
mutation	O
display	O
the	O
skeletal	O
phenotype	O
(	O
data	O
not	O
shown	O
).	O

We	O
found	O
that	O
the	O
RMSSD	O
,	O
pNN50	O
index	O
and	O
HF	O
band	O
(	O
n	O
.	O
u	O
.)	O

Vitamin	O
D	O
status	O
is	O
a	O
key	O
modifiable	O
maternal	O
risk	O
factor	O
for	O
the	O
prevention	O
of	O
PTB	O
.	O

Obesity	O
was	O
defined	O
as	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
,	O
overweight	O
as	O
BMI	O
≥	O
25	O
and	O
<	O
30	O
kg	O
/	O
m2	O
,	O
normal	O
weight	O
as	O
BMI	O
>	O
20	O
and	O
<	O
25	O
kg	O
/	O
m2and	O
underweight	O
as	O
BMI	O
≤	O
20	O
kg	O
/	O
m2	O
.	O

However	O
,	O
initial	O
short	O
-	O
term	O
findings	O
demonstrated	O
multiple	O
KAB	O
effects	O
[	O
23	O
],	O
and	O
this	O
study	O
demonstrated	O
a	O
behavioral	O
effect	O
on	O
alcohol	O
use	O
.	O

We	O
also	O
had	O
no	O
information	O
on	O
frequency	O
of	O
use	O
which	O
could	O
have	O
varied	O
from	O
daily	O
to	O
sparse	O
use	O
.	O

Serum	O
aliquots	O
were	O
then	O
stored	O
at	O
–	O
80C	O
for	O
further	O
analysis	O
.	O

We	O
report	O
that	O
early	O
life	O
caloric	O
restriction	O
,	O
either	O
before	O
birth	O
or	O
during	O
lactation	O
,	O
consistently	B
accelerates	O
the	O
age	O
of	O
maturation	O
.	O

However	O
the	O
costs	O
of	O
potential	O
strategies	O
for	O
achieving	O
this	O
are	O
currently	O
unknown	O
.	O

Antiacids	O
During	O
Pregnancy	O
Recent	O
studies	O
have	O
indicated	O
that	O
acid	O
-	O
suppressing	O
medications	O
can	O
promote	O
sensitization	O
in	O
adults	O
[	O
86	O
,	O
87	O
].	O

To	O
investigate	O
the	O
association	O
between	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
,	O
we	O
used	O
multivariable	O
logistic	O
regression	O
models	O
controlled	O
for	O
energy	O
intake	O
,	O
age	O
,	O
and	O
BMI	O
.	O

We	O
will	O
use	O
Cox	O
proportional	O
hazards	O
mixed	O
models	O
for	O
mortality	O
outcomes	O
and	O
include	O
groundwater	O
iron	O
level	O
as	O
an	O
interaction	O
term	O
in	O
the	O
mortality	O
model	O
.	O

This	O
multi	O
-	O
colinearity	O
is	O
expected	B
,	O
as	B
these	O
variables	O
are	O
physiologically	O
interrelated	O
.	O

However	O
,	O
we	O
should	O
not	O
discard	O
a	O
predictive	O
marker	O
of	O
impaired	O
fetal	O
nutrition	O
in	O
those	O
cases	O
with	O
absence	O
of	O
low	O
birth	O
weight	O
.	O

Furthermore	O
,	O
the	O
nature	O
of	O
the	O
precise	O
catalyst	O
of	O
autism	O
has	O
not	O
been	O
revealed	O
as	O
of	O
yet	O
.	O

We	O
judged	O
an	O
episode	O
happening	O
within	O
14	O
days	O
to	O
be	O
continuation	O
of	O
the	O
previous	O
episode	O
.	O

Our	O
results	O
may	O
have	O
differed	O
for	O
several	O
reasons	B
.	O

Another	O
study	O
revealed	O
that	O
the	O
ability	O
of	O
leptin	O
to	O
increase	O
the	O
metabolic	O
rate	O
early	O
in	O
life	O
is	O
independent	O
from	O
its	O
anorectic	O
action	O
(	O
Mistry	O
et	O
al	O
.,	O
1999	O
).	O

The	O
group	O
noted	O
that	O
low	O
birth	O
weight	O
increased	O
chances	O
of	O
developing	O
ASD	O
,	O
as	O
well	O
as	O
rapid	O
head	O
growth	O
.	O

Prenatal	O
vitamin	O
D	O
deficiency	O
has	O
been	O
proposed	O
to	O
be	O
a	O
risk	O
factor	O
for	O
the	O
development	O
of	O
schizophrenia	O
[	O
12	O
].	O

“	O
But	O
what	O
we	O
will	O
end	O
up	O
with	O
is	O
that	O
we	O
now	O
will	O
be	O
able	O
to	O
study	O
three	O
successive	O
generations	O
of	O
Navajos	O
that	O
have	O
been	O
exposed	O
.”	O
Although	O
the	O
literature	O
on	O
chronic	O
low	O
-	O
level	O
uranium	O
exposure	O
is	O
still	O
quite	O
small	O
,	O
by	O
2003	O
researchers	O
knew	O
that	O
the	O
dangers	O
these	O
exposures	O
posed	O
were	O
due	O
not	O
to	O
uranium	O
’	O
s	O
radioactivity	O
but	O
to	O
its	O
chemical	O
toxicity	O
.	O
24Both	O
animal25and	O
human26studies	O
have	O
found	O
uranium	O
to	O
be	O
primarily	B
toxic	O
to	O
the	O
kidneys	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

Across	O
binding	O
sites	O
of	O
transcription	O
factors	O
overrepresented	O
within	O
1	O
kb	O
of	O
loci	O
,	O
we	O
compared	O
the	O
distribution	O
of	O
statistics	O
representing	O
the	O
association	O
between	O
CpG	O
-	O
specific	O
average	O
β	O
-	O
value	O
and	O
each	O
repetitive	O
element	O
methylation	O
markers	O
.	O

All	O
that	O
the	O
current	O
epidemic	O
of	O
maternal	O
and	O
early	O
childhood	O
vitamin	O
D	O
deficiency	O
does	O
,	O
with	O
its	O
resultant	O
neural	O
deficiency	O
in	O
the	O
pluripotent	O
neurosteroid	O
calcitriol	O
,	O
is	O
to	O
allow	O
the	O
genetic	O
tendency	O
for	O
autism	O
to	O
express	O
itself	O
.	O

In	O
addition	O
,	O
the	O
Ministry	O
is	O
planning	O
to	O
improve	O
the	O
supplementary	O
nutrition	O
services	O
;	O
creating	O
Anganwadi	O
based	O
crèches	O
centers	O
;	O
intensify	O
monitoring	O
,	O
and	O
training	O
activities	O
;	O
to	O
develop	O
linkages	O
with	O
different	O
stakeholders	O
such	O
as	O
Pan	O
-	O
chayati	O
Raj	O
Institutions	O
and	O
ministry	O
of	O
rural	O
development	O
(	O
1	O
).	O

Birth	O
Weight	O
Many	O
studies	O
have	O
evaluated	O
the	O
association	O
between	O
birth	O
weight	O
and	O
the	O
development	O
of	O
autism	O
.	O

The	O
two	O
study	O
groups	O
were	O
similar	O
regarding	O
to	O
age	O
,	O
job	O
,	O
education	O
,	O
parity	O
and	O
sun	O
exposure	O
.	O

[	O
43	O
]	O
demonstrated	O
that	O
not	O
accounting	O
for	O
biases	O
in	O
observational	O
data	O
can	O
mislead	O
the	O
results	O
.	O

Interventions	O
:	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
from	O
14	O
weeks	O
of	O
gestation	O
until	O
delivery	O
.	O

Furthermore	O
,	O
the	O
offspring	O
of	O
sensitized	O
mothers	O
are	O
prone	B
to	O
experience	O
suppression	O
and	O
a	O
later	O
onset	O
of	O
normal	O
levels	O
of	O
the	O
Th1	O
cytokine	O
IFN	O
-	O
γ	O
because	O
of	O
a	O
lower	O
frequency	O
of	O
IFN	O
-	O
γ	O
-	O
producing	O
cells	O
,	O
and	O
therefore	B
a	O
further	O
bias	O
toward	O
a	O
Th2	O
immune	O
response	O
.	O

The	O
NCCLS	O
is	O
a	O
population	O
-	O
based	O
case	O
–	O
control	O
study	O
of	O
risk	O
factors	O
for	O
child	O
leukemia	O
,	O
including	O
maternal	O
diet	O
.	O

It	O
should	O
be	O
emphasized	O
that	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
included	O
a	O
fairly	O
homogeneous	O
cohort	O
of	O
Mediterranean	O
patients	O
from	O
Crete	O
.	O

Combining	O
a	O
multilevel	O
approach	O
with	O
a	O
developmental	O
perspective	O
can	O
inform	O
more	O
effective	O
and	O
sustainable	O
strategies	O
for	O
obesity	O
prevention	O
.	O

Our	O
findings	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
impact	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
on	O
early	O
infant	O
neurodevelopment	O
.	O

The	O
small	O
number	O
of	O
taste	O
qualities	O
may	O
have	O
evolved	O
because	B
of	O
the	O
functional	O
importance	O
of	O
the	O
primary	O
stimuli	O
(	O
eg	O
,	O
sugars	O
,	O
sodium	O
chloride	O
,	O
bitter	O
toxins	O
)	O
in	O
nutrient	O
selection	O
,	O
especially	O
in	O
children	O
.	O

However	O
,	O
at	O
adult	O
stage	O
a	O
diet	O
-	O
dependent	O
up	O
-	O
regulation	O
of	O
'	O
mTOR	O
signaling	O
'	O
in	O
LP	O
offspring	O
suggests	O
a	O
transcriptional	O
priority	O
for	O
cellular	O
growth	O
and	O
proliferation	O
.	O

Positional	O
cloning	O
and	O
candidate	O
gene	O
sequencing	O
localized	O
the	O
causative	O
point	O
mutations	O
within	O
the	O
genes	O
coding	O
for	O
natriuretic	O
peptide	O
receptor	O
C	O
(	O
NPR	O
-	O
C	O
)	O
and	O
filamin	O
b	O
(	O
FLNB	O
),	O
respectively	O
.	O

Here	O
,	O
we	O
provide	B
further	O
information	O
about	O
the	O
regulation	O
of	O
this	O
transcript	O
by	O
cortisol	O
using	O
two	O
in	O
vitro	O
models	O
as	O
it	O
is	O
upregulated	O
by	O
cortisol	O
in	O
a	O
dose	O
-	O
independent	O
manner	O
.	O

The	O
authors	O
suggested	O
that	O
metabolic	O
imprinting	O
by	O
early	O
weaning	O
and	O
a	O
high	O
concentrate	O
feeding	O
before	O
grazing	O
is	O
a	O
feasible	B
method	O
to	O
improve	O
MS	O
and	O
carcass	O
weight	O
.	O

To	B
our	I
knowledge	I
,	O
this	O
is	O
the	O
first	O
chemically	O
induced	O
allele	O
of	O
Flnb	O
that	O
has	O
been	O
reported	O
.	O

In	O
our	O
study	O
,	O
we	O
have	O
shown	O
that	O
all	O
known	O
transcripts	O
of	O
GR	O
splice	O
variants	O
are	O
expressed	O
in	O
the	O
human	O
placenta	O
with	O
GR	O
α	O
being	O
the	O
predominant	B
transcript	O
in	O
all	O
categories	O
studied	O
.	O

Regarding	O
the	O
fate	O
of	O
glucose	O
in	O
brown	O
adipocytes	O
under	O
anabolic	O
conditions	O
characterized	O
by	O
high	O
insulin	O
levels	O
,	O
it	O
is	O
essentially	O
metabolized	O
to	O
provide	O
glycerol	O
-	O
3	O
-	O
phosphate	O
for	O
triglyceride	O
synthesis	O
or	O
acetyl	O
-	O
CoA	O
for	O
de	O
novo	O
fatty	O
acid	O
synthesis	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

She	O
was	O
only	O
on	O
prenatal	O
vitamins	O
,	O
and	O
her	O
prenatal	O
follow	O
-	O
up	O
was	O
unremarkable	O
.	O

The	O
average	O
number	O
of	O
visits	O
to	O
the	O
general	O
practitioner	O
was	O
4	O
.	O
8	O
±	O
2	O
.	O
54	O
.	O

As	B
reported	O
by	O
the	O
United	O
Nations	O
Foundation	O
,	O
Project	O
Masiluleke	O
in	O
South	O
Africa	O
reaches	O
1	O
million	O
people	O
each	O
day	O
via	O
mobile	O
phone	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
prevention	O
,	O
testing	O
,	O
and	O
treatment	O
information	O
[	O
21	O
].	O

However	O
,	O
the	O
main	O
strengths	O
of	O
the	O
current	O
study	O
include	O
its	O
multidisciplinary	O
scope	O
including	O
epidemiology	O
,	O
statistics	O
,	O
pediatrics	O
,	O
maternity	O
,	O
and	O
nutrition	O
.	O

One	O
infant	O
also	O
received	O
400	O
units	O
/	O
day	O
Vitamin	O
D3post	O
-	O
natally	O
.	O

It	O
is	O
relevant	O
to	O
note	O
that	O
in	O
Sweden	O
low	O
-	O
fat	O
dairy	O
products	O
and	O
margarines	O
are	O
fortified	O
with	O
vitamin	O
D	O
.	O
Otherwise	O
the	O
dietary	O
intake	O
of	O
vitamin	O
D	O
would	O
be	O
lower	O
.	O

Generalized	O
UniFrac	O
unifies	O
weighted	O
and	O
unweighted	O
UniFrac	O
to	O
detect	O
differences	O
in	O
moderately	O
abundant	O
lineages	O
instead	O
of	O
those	O
exclusively	O
in	O
highly	O
abundant	O
or	O
rare	O
lineages	O
[	O
43	O
,	O
44	O
].	O

Array	O
-	O
based	O
mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
CpG	O
loci	O
did	O
not	O
differ	O
by	O
any	O
of	O
the	O
in	O
utero	O
exposures	O
explored	O
.	O

Likewise	O
,	O
in	O
patients	O
with	O
vitamin	O
D	O
deficiency	O
,	O
a	O
higher	O
occurrence	O
of	O
uterine	O
myomas	O
is	O
observed	O
—	O
another	O
established	O
reason	B
for	O
infertility	O
.	O

EAH	O
is	O
seen	O
more	O
often	B
in	O
children	O
who	O
are	O
overweight	O
(	O
39	O
,	O
47	O
,	O
49	O
,	O
52	O
)	O
and	O
in	O
children	O
with	O
higher	O
1	O
-	O
year	O
weight	O
gains	O
(	O
53	O
).	O

Recent	O
surveys	O
in	O
Bangladesh	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
IFA	O
supplements	O
in	O
their	O
last	O
pregnancy	O
,	O
but	O
this	O
falls	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
[	O
5	O
].	O

After	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
,	O
making	O
more	O
than	O
four	O
prenatal	O
consultations	O
remained	O
associated	O
with	O
the	O
use	O
of	O
multivitamin	O
supplements	O
.	O

<	O
75	O
and	O
<	O
50	O
nmol	O
/	O
L	O
,	O
respectively	O
).	O

Anthropological	O
studies	O
also	O
suggest	O
the	O
particular	O
importance	O
of	O
the	O
MGM	O
for	O
children	O
'	O
s	O
development	O
.	O
20	O
The	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
was	O
established	O
in	O
2001	O
with	O
the	O
a	O
priori	O
purpose	O
of	O
assessing	O
associations	O
across	O
generations	O
and	O
between	O
family	O
members	O
.	O
21	O
–	O
25We	O
have	O
shown	O
in	O
several	O
previous	O
analyses	O
that	O
there	O
is	O
a	O
stronger	O
association	O
with	O
children	O
'	O
s	O
outcomes	O
along	O
the	O
maternal	O
than	O
the	O
paternal	O
line	O
.	O
23	O
–	O
25In	O
the	O
present	O
study	O
,	O
we	O
analyse	O
patterns	O
in	O
BMI	O
and	O
height	O
at	O
three	O
ages	O
of	O
the	O
index	O
child	O
,	O
employing	O
primarily	O
examination	O
rather	O
than	O
self	O
-	O
reported	O
data	O
for	O
adults	O
.	O

The	O
RV	O
diet	O
has	O
2	O
mg	O
/	O
kg	O
of	O
folate	O
.	O

We	O
speculate	O
that	O
whereas	O
pubertal	O
onset	O
was	O
accelerated	O
in	O
the	O
UNP	O
group	O
to	O
maintain	O
some	O
potential	O
for	O
reproduction	O
in	O
an	O
environment	O
predicted	O
to	O
have	O
a	O
higher	O
mortality	O
risk	O
,	O
in	O
the	O
HF	O
offspring	O
maturation	O
was	O
accelerated	O
to	O
opportunistically	O
enhance	O
fitness	O
.	O

A	O
separate	O
study	O
from	O
Western	O
Australia	O
concluded	O
that	O
autistic	O
children	O
generally	B
had	O
parents	O
who	O
were	O
older	O
and	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
anesthesia	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
.	O

The	O
ncRNA	O
superfamily	O
encompasses	O
a	O
number	O
of	O
families	O
broadly	O
classified	O
according	O
to	O
their	O
length	O
:	O
long	O
non	O
-	O
coding	O
RNAs	O
(	O
lncRNAs	O
)	O
(>	O
200	O
nt	O
)	O
and	O
short	O
non	O
coding	O
RNAs	O
(	O
sncRNAs	O
)	O
(<	O
200	O
nt	O
),	O
which	O
include	O
microRNAs	O
(	O
miRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
19	O
–	O
25	O
nt	O
),	O
piwi	O
-	O
interacting	O
RNAs	O
(	O
piRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
24	O
–	O
30	O
nt	O
)	O
and	O
endogenous	O
short	O
interfering	O
RNAs	O
(	O
esiRNAs	O
,	O
double	O
stranded	O
,	O
∼	O
21	O
–	O
22	O
nt	O
).	O

The	O
existing	O
literature	O
on	O
pregnancy	O
outcomes	O
following	O
exposure	O
to	O
FGAs	O
has	O
not	O
shown	O
a	O
significantly	O
increased	O
risk	O
for	O
malformations	O
above	O
the	O
baseline	O
incidence	O
.	O

144	O
preschool	O
children	O
with	O
S	O
-	O
ECC	O
were	O
recruited	O
from	O
a	O
local	O
health	O
centre	O
on	O
the	O
day	O
of	O
their	O
slated	O
dental	O
surgery	O
under	O
general	O
anesthetic	O
.	O

[	O
50	O
]	O
found	O
that	O
the	O
beneficial	O
effects	O
of	O
prenatal	O
zinc	O
supplementation	O
on	O
the	O
ANS	O
balance	O
persisted	O
until	O
early	O
infancy	O
,	O
suggesting	O
that	O
the	O
nutritional	O
status	O
of	O
the	O
mother	O
is	O
important	O
to	O
fetal	O
ANS	O
development	O
.	O

For	O
example	O
,	O
VDP	O
rises	O
early	O
in	O
pregnancy	O
,	O
and	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
increases	O
during	O
the	O
second	O
and	O
third	O
trimesters	O
(	O
12	O
).	O

In	O
a	O
community	O
dwelling	O
sample	O
of	O
2	O
,	O
751	O
middle	O
aged	O
men	O
and	O
women	O
,	O
Kumari	O
et	O
al	O
reported	O
that	O
short	O
sleep	O
duration	O
and	O
increased	O
sleep	O
disturbance	O
are	O
independently	O
associated	O
with	O
diurnal	O
slope	O
in	O
cortisol	O
secretion	O
[	O
45	O
].	O

However	O
,	O
the	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
with	O
the	O
highest	O
burden	O
of	O
preterm	O
births	O
also	O
carry	O
the	O
greatest	O
burden	O
of	O
higher	O
-	O
risk	O
conditions	O
for	O
preterm	O
birth	O
that	O
are	O
preventable	O
or	O
treatable	O
.	O

The	O
serum	O
and	O
follicular	O
fluid	O
VD	O
levels	O
were	O
in	O
significant	O
correlation	O
,	O
with	O
p	O
<	O
0	O
.	O
0000	O
,	O
but	O
fertilization	O
(	O
43	O
.	O
17	O
%,	O
53	O
.	O
37	O
%,	O
58	O
.	O
77	O
%,	O
respectively	O
)	O
and	O
implantation	O
percentages	O
(	O
17	O
.	O
33	O
,	O
15	O
.	O
26	O
,	O
18	O
.	O
75	O
%,	O
respectively	O
)	O
did	O
not	O
present	O
any	O
significant	O
correlation	O
(	O
p	O
>	O
0	O
.	O
5	O
)	O
[	O
60	O
].	O

Maternal	O
morbidity	O
Maternal	O
morbidity	O
symptoms	O
are	O
assessed	O
from	O
enrolment	O
to	O
birth	O
using	O
a	O
daily	O
calendar	O
.	O

According	O
to	O
the	O
inclusion	O
criteria	O
,	O
the	O
mothers	O
were	O
of	O
Caucasian	O
origin	O
without	O
regular	O
medication	O
and	O
with	O
singleton	O
pregnancy	O
.	O

Anaphylaxis	O
associated	O
with	O
folic	O
acid	O
:	O
domestic	O
case	O
review	O
Background	O
Synthetic	O
folic	O
acid	O
has	O
been	O
shown	O
to	O
cause	O
serious	O
,	O
potentially	O
life	O
-	O
threatening	O
IgE	O
mediated	O
anaphylaxis	O
[	O
1	O
-	O
3	O
].	O

Objective	O
To	O
evaluate	O
and	O
relate	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
PPBMI	O
),	O
weight	O
gain	O
and	O
energy	O
intake	O
at	O
diagnosis	O
of	O
GDM	O
.	O

There	O
was	O
no	O
association	O
between	O
alcohol	O
intake	O
and	O
psychotic	O
symptoms	O
among	O
women	O
in	O
the	O
middle	O
and	O
low	O
psychotic	O
-	O
like	O
symptoms	O
groups	O
(	O
data	O
not	O
shown	O
).	O

All	O
children	O
were	O
evaluated	O
twice	O
on	O
different	O
days	O
.	O

Our	O
finding	O
extends	O
this	O
literature	O
by	O
adding	O
preliminary	O
evidence	O
that	O
links	O
snoring	O
with	O
pregnancy	O
-	O
related	O
impaired	O
glucose	O
tolerance	O
and	O
GDM	O
.	O

The	O
content	O
of	O
prenatal	O
care	O
,	O
including	O
nutritional	O
education	O
,	O
is	O
an	O
important	O
factor	O
that	O
could	O
determine	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
but	O
women	O
may	O
also	O
receive	O
advice	O
from	O
friends	O
,	O
family	O
,	O
the	O
media	O
and	O
other	O
sources	O
.	O

While	O
not	O
all	O
women	O
who	O
participated	O
in	O
this	O
trial	O
were	O
overweight	O
or	O
obese	O
(	O
mean	O
BMI	O
26	O
.	O
8	O
kg	O
/	O
m2	O
),	O
there	O
was	O
no	O
evidence	O
of	O
an	O
effect	O
on	O
infant	O
birth	O
weight	O
[	O
16	O
].	O

Background	O
Globally	O
,	O
2	O
.	O
6	O
million	O
children	O
died	O
in	O
the	O
neonatal	O
period	O
,	O
the	O
first	O
28	O
days	O
of	O
life	O
in	O
2016	O
[	O
1	O
].	O

Lower	O
vitamin	O
D	O
levels	O
have	O
been	O
found	O
in	O
many	O
autoimmune	O
diseases	O
,	O
such	O
as	O
rheumatoid	O
arthritis	O
,	O
systemic	O
lupus	O
erythematosus	O
,	O
systemic	O
sclerosis	O
,	O
type	O
1	O
diabetes	O
mellitus	O
,	O
multiple	O
sclerosis	O
,	O
inflammatory	O
bowel	O
diseases	O
,	O
autoimmune	O
thyroid	O
diseases	O
[	O
6	O
,	O
7	O
].	O

Male	O
offspring	O
of	O
female	O
rats	O
with	O
a	O
history	O
of	O
fetal	O
exposure	O
to	O
glucocorticoids	O
also	O
exhibit	O
low	O
birth	O
weight	O
and	O
glucose	O
intolerance	O
—	O
a	O
multigenerational	O
effect	O
(	O
6	O
).	O

Maternal	O
Anthropometrics	O
Maternal	O
pregravid	O
weight	O
was	O
based	O
on	O
self	O
-	O
report	O
at	O
time	O
of	O
study	O
enrollment	O
and	O
was	O
shown	O
to	O
be	O
valid	O
compared	O
with	O
physician	O
documented	O
prepregnancy	O
weight	O
[	O
16	O
].	O

Although	O
Vitamin	O
A	O
capsules	O
were	O
less	O
costly	O
than	O
iron	O
per	O
person	O
(	O
USD0	O
.	O
12	O
/	O
person	O
/	O
year	O
compared	O
to	O
USD0	O
.	O
36	O
),	O
delivery	O
costs	O
for	O
vitamin	O
A	O
were	O
higher	O
:	O
USD1	O
.	O
83	O
compared	O
to	O
USD0	O
.	O
40	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
age	O
was	O
33	O
.	O
4	O
±	O
4	O
.	O
1	O
years	O
old	O
(	O
ranges	O
from	O
24	O
to	O
46	O
years	O
old	O
),	O
the	O
gestational	O
weeks	O
were	O
29	O
.	O
0	O
±	O
3	O
.	O
3	O
weeks	O
(	O
ranges	O
from	O
14	O
to	O
39	O
weeks	O
),	O
pre	O
-	O
pregnancy	O
BMI	O
was	O
23	O
.	O
0	O
±	O
3	O
.	O
7	O
(	O
ranges	O
from	O
15	O
.	O
6	O
to	O
37	O
.	O
2	O
)	O
kg	O
/	O
m2	O
.	O

Vitamin	O
D	O
should	O
be	O
considered	O
in	O
studies	O
of	O
pets	O
and	O
atopic	O
conditions	O
.	O

The	O
study	O
was	O
conducted	O
with	O
steer	O
of	O
three	O
genotypes	O
(	O
Angus	O
,	O
Hereford	O
and	O
Wagyu	O
×	O
Angus	O
):	O
Angus	O
was	O
targeting	O
high	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
Hereford	O
was	O
targeting	O
low	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
and	O
Wagyu	O
sires	O
Angus	O
dams	O
were	O
targeting	O
high	O
IMF	O
and	O
lower	O
subcutaneous	O
fat	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
class	O
methylation	O
.	O

The	O
50	O
%	O
CI	O
is	O
the	O
smallest	O
interval	O
that	O
contains	O
50	O
%	O
posterior	O
probability	O
of	O
containing	O
the	O
true	O
parameter	O
.	O

On	O
the	O
other	O
hand	O
,	O
increased	O
serum	O
calcium	O
causes	O
the	O
intracellular	O
calcium	O
to	O
attach	O
to	O
calcium	O
receptors	O
on	O
the	O
surface	O
of	O
parathyroid	O
cells	O
causing	O
a	O
change	O
in	O
a	O
special	O
form	O
of	O
the	O
receptors	O
.	O

Long	O
-	O
term	O
effects	O
of	O
ECS	O
activation	O
could	O
finally	O
increase	O
the	O
risk	O
from	O
suffering	O
metabolic	O
diseases	O
that	O
lead	O
to	O
obesity	O
and	O
metabolic	O
syndrome	O
(	O
Tibirica	O
,	O
2010	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

However	O
,	O
some	O
researchers	O
think	O
mammary	O
gland	O
development	O
and	O
maternal	O
metabolism	O
may	O
provide	B
some	O
clues	O
.	O

Radioiodine	O
therapy	O
,	O
when	O
needed	O
,	O
can	O
be	O
safely	O
postponed	O
until	O
after	O
breast	O
-	O
feeding	O
.	O

Results	O
The	O
basis	O
and	O
source	O
of	O
data	O
for	O
programmatic	O
and	O
health	O
system	O
costs	O
are	O
shown	O
inTable	O
1	O
.	O

The	O
risk	O
of	O
high	O
level	O
symptoms	O
was	O
53	O
%	O
(	O
95	O
%	O
CI	O
,	O
30	O
-	O
69	O
%)	O
lower	O
among	O
women	O
who	O
ate	O
fish	O
3	O
-	O
4	O
times	O
per	O
week	O
compared	O
to	O
women	O
who	O
never	O
ate	O
fish	O
.	O

None	O
of	O
the	O
women	O
in	O
this	O
study	O
reported	O
the	O
use	O
of	O
dietary	O
supplements	O
containing	O
fish	O
oil	O
or	O
PUFA	O
at	O
baseline	O
.	O

After	O
delivery	O
,	O
thyroxine	O
dose	O
can	O
be	O
gradually	O
reduced	O
to	O
pre	O
-	O
pregnancy	O
levels	O
,	O
while	O
TSH	O
levels	O
should	O
be	O
constantly	O
monitored1015	O
.	O

[	O
27	O
]	O
Weishaar	O
and	O
Simpson	O
[	O
28	O
]	O
showed	O
that	O
lengthy	O
periods	O
of	O
vitamin	O
D	O
deficiency	O
in	O
rats	O
are	O
associated	O
with	O
profound	O
changes	O
in	O
cardiovascular	O
function	O
,	O
including	O
increases	O
in	O
cardiac	O
and	O
vascular	O
muscle	O
contractile	O
function	O
.	O

Surprisingly	O
,	O
no	O
particular	O
phenotype	O
was	O
noted	O
in	O
these	O
mice	O
when	O
they	O
were	O
kept	O
at	O
23	O
°	O
C	O
,	O
except	O
for	O
their	O
increased	O
cold	O
sensitivity	O
(	O
Enerback	O
et	O
al	O
.,	O
1997	O
;	O
Kontani	O
et	O
al	O
.,	O
2005	O
).	O

She	O
was	O
blind	O
to	O
group	O
allocations	O
.	O

IMF	O
also	O
has	O
lower	O
lipogenic	O
activity	O
than	O
does	O
subcutaneous	O
fat	O
[	O
98	O
].	O

The	O
third	O
section	O
has	O
14	O
chapters	O
and	O
covers	O
various	O
diseases	O
from	O
cardiovascular	O
diseases	O
to	O
HIV	O
/	O
AIDS	O
,	O
osteoporosis	O
,	O
liver	O
diseases	O
and	O
neurological	O
disorders	O
.	O

Oken	O
et	O
al	O
.	O

Regarding	O
the	O
differences	O
between	O
male	O
and	O
female	O
offspring	O
,	O
CC	O
females	O
showed	O
an	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
in	O
liver	O
,	O
but	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
in	O
PAT	O
(	O
Figures6A	O
,	O
B	O
).	O

The	O
increased	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
in	O
neonates	O
relative	O
to	O
maternal	O
BMI	O
level	O
were	O
seen	O
in	O
both	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
population	O
and	O
supports	O
similar	O
findings	O
seen	O
in	O
a	O
study	O
done	O
by	O
Bodnar	O
et	O
al	O
.	O
38Although	O
prenatal	O
vitamin	O
use	O
was	O
not	O
significantly	O
different	O
between	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
,	O
prenatal	O
vitamin	O
use	O
was	O
significant	O
among	O
those	O
with	O
and	O
without	O
vitamin	O
D	O
deficiency	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Descriptions	O
of	O
malformations	O
reported	O
in	O
the	O
assessed	O
cohortCongenital	O
malformation	O
/	O
abnormalityExposed	O
to	O
polytherapyDaily	O
dose	O
(	O
mg	O
/	O
day	O
)	O
Timing	O
of	O
exposure	O
Quetiapine25Throughout	O
pregnancyChiari	O
malformation	O
Fluoxetine80Throughout	O
pregnancy	O
Clonazepam0	O
.	O
5From	O
week	O
18	O
Zoplicone7	O
.	O
5Throughout	O
pregnancy	O
Quetiapine25Throughout	O
pregnancyCongenital	O
heart	O
defect	O
Citalopram60Throughout	O
pregnancy	O
Quetiapine400Throughout	O
pregnancyAtrial	O
septal	O
defect	O
Citalopram20From	O
weeks	O
8	O
–	O
16	O
Quetiapine12	O
.	O
5	O
;	O
50Up	O
to	O
week	O
36	O
;	O
from	O
week	O
36Small	O
bowel	O
atresia	O
Citalopram60Throughout	O
pregnancy	O
Quetiapine400Throughout	O
pregnancyHypospadias	O
Atomextine40Throughout	O
pregnancy	O
Quetiapine25Up	O
to	O
week	O
7Ureterocele	O
with	O
hydronephrosis	O
of	O
left	O
kidney	O
Sertraline150	O
gradually	O
decreased	O
to	O
50Throughout	O
pregnancy	O
Olanzapine2	O
.	O
5Throughout	O
pregnancyAtrial	O
septal	O
defect	O
Citalopram20Throughout	O
pregnancyHealthy	O
controls	O
No	O
drugMacrocystic	O
lymphatic	O
malformation	O
No	O
drugVentricular	O
septal	O
defect	O
No	O
drugVentricular	O
septal	O
defect	O
Delivery	O
and	O
neonatal	O
outcomes	O
The	O
exposed	O
and	O
comparison	O
groups	O
differed	O
significantly	O
in	O
terms	O
of	O
the	O
method	O
of	O
delivery	O
reported	O
(	O
p	O
=	O
0	O
.	O
042	O
),	O
with	O
more	O
scheduled	O
c	O
-	O
sections	O
occurring	O
in	O
the	O
exposed	O
group	O
.	O

The	O
associated	O
decrease	O
in	O
ZnPP	O
concentration	O
and	O
increased	O
MCV	O
in	O
supplemented	O
women	O
suggests	O
that	O
the	O
iron	O
content	O
of	O
the	O
supplements	O
underpinned	O
the	O
improved	O
haematological	O
profile	O
,	O
while	O
the	O
differences	O
in	O
reticulocyte	O
count	O
suggest	O
a	O
reduction	O
in	O
red	O
cell	O
turnover	O
among	O
MMN	O
supplemented	O
women	O
.	O

Japanese	O
Black	O
cattle	O
bulls	O
are	O
normally	O
castrated	O
to	O
get	O
highly	O
marbled	O
beef	O
in	O
Japan	O
[	O
61	O
].	O

Multiple	O
regression	O
(	O
for	O
continuous	O
outcomes	O
)	O
and	O
logistic	O
regression	O
(	O
for	O
categorical	O
outcomes	O
)	O
were	O
used	O
to	O
examine	O
predictors	O
of	O
infant	O
macrosomia	O
,	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
,	O
and	O
changes	O
in	O
WFA	O
z	O
-	O
scores	O
,	O
adjusting	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

Materials	O
and	O
methods	O
Full	O
-	O
term	O
infants	O
without	O
any	O
chronic	O
diseases	O
or	O
major	O
anomalies	O
were	O
enrolled	O
in	O
the	O
Prediction	O
of	O
Allergies	O
in	O
Taiwanese	O
Children	O
cohort	O
study	O
.	O

It	O
has	O
been	O
suggested	O
that	O
adipocyte	O
formation	O
in	O
muscle	O
begins	O
approximately	O
between	O
late	O
gestation	O
and	O
250	O
d	O
after	O
birth	O
in	O
cattle	O
[	O
16	O
].	O

Results	O
for	O
the	O
38	O
infants	O
(	O
19	O
Hispanic	O
and	O
19	O
Caucasian	O
),	O
with	O
the	O
values	O
obtained	O
initially	O
,	O
are	O
shown	O
in	O
Table1	O
.	O

Multivitamins	O
were	O
used	O
by	O
68	O
%	O
of	O
the	O
women	O
in	O
our	O
study	O
,	O
comparable	O
with	O
the	O
60	O
%	O
reported	O
by	O
the	O
IOMC	O
study	O
[	O
14	O
].	O

The	O
risk	O
was	O
four	O
-	O
fold	O
higher	O
in	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
below	O
37	O
.	O
5	O
nmol	O
/	O
L	O
(	O
15ng	O
/	O
mL	O
)	O
controlling	O
for	O
multiple	O
confounding	O
factors	O
.	O

Thus	B
,	O
there	O
are	O
reasons	B
to	O
believe	O
that	O
the	O
dimension	O
of	O
positive	O
symptoms	O
is	O
an	O
independent	O
dimension	O
.	O

We	O
hypothesized	O
that	O
maternal	O
habitual	O
short	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
were	O
positively	O
associated	O
with	O
post	O
load	O
glucose	O
concentrations	O
later	O
in	O
pregnancy	O
and	O
with	O
an	O
increased	O
risk	O
of	O
clinically	O
diagnosed	O
GDM	O
.	O

Results	O
are	O
shown	O
as	O
means	O
or	O
adjusted	O
means	O
with	O
SD	O
or	O
SEM	O
.	O

Thus	B
,	O
all	O
the	O
machinery	O
involved	O
in	O
these	O
pathways	O
,	O
including	O
DNA	O
and	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
,	O
are	O
epigenetically	O
important	O
.	O

Implement	O
•	O
Define	O
norms	O
and	O
guidelines	B
to	O
support	O
efforts	O
to	O
improve	O
women	O
'	O
s	O
and	O
children	O
'	O
s	O
health	O
,	O
and	O
encourage	O
their	O
adoption	O
through	O
provision	O
of	O
technical	O
assistance	O
and	O
programmatic	O
support	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
preterm	O
births	O
.	O

The	O
reaction	O
was	O
quenched	O
by	O
adding	O
10	O
mM	O
DTT	O
followed	O
by	O
20	O
mg	O
citric	O
acid	O
to	O
adjust	O
pH	O
to	O
approximately	O
pH	O
6	O
.	O
0	O
.	O

For	O
this	O
model	O
,	O
gender	O
,	O
birth	O
weight	O
,	O
season	O
of	O
measurement	O
and	O
ethnicity	O
were	O
covariates	O
.	O

Midstream	O
spot	O
urine	O
samples	O
(	O
5	O
ml	O
)	O
are	O
collected	O
from	O
the	O
participating	O
women	O
at	O
phases	O
1	O
,	O
2	O
and	O
3	O
during	O
pregnancy	O
and	O
at	O
phase	O
6	O
postnatally	O
into	O
a	O
urine	O
collection	O
cup	O
.	O

Generally	B
,	O
the	O
relationship	O
between	O
visfatin	O
and	O
the	O
infants	O
’	O
s	O
growth	O
indicators	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Energy	O
expenditure	O
was	O
measured	O
using	O
the	O
Paffenbarger	O
Physical	O
Activity	O
Questionnaire	O
[	O
26	O
],	O
a	O
measure	O
which	O
estimates	O
weekly	O
energy	O
expenditure	O
from	O
self	O
-	O
reports	O
of	O
stairs	O
climbed	O
,	O
blocks	O
walked	O
,	O
and	O
other	O
recreational	O
activities	O
performed	O
in	O
the	O
past	O
week	O
.	O

Studies	O
of	O
protein	O
intake	O
in	O
pregnancy	O
have	O
indicated	O
that	O
higher	O
maternal	O
protein	O
intake	O
was	O
positively	O
associated	O
with	O
birth	O
weight	O
[	O
8	O
,	O
9	O
],	O
but	O
there	O
are	O
notable	O
exceptions	O
[	O
34	O
,	O
35	O
]	O
and	O
most	O
studies	O
assessed	O
diet	O
later	O
in	O
gestation	O
.	O

Among	O
the	O
four	O
seasons	O
,	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
highest	O
in	O
Summer	O
,	O
lowest	O
in	O
the	O
Winter	O
,	O
which	O
is	O
significantly	O
lower	O
than	O
summer	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
spring	O
(	O
p	O
=	O
0	O
.	O
003	O
).	O

Thus	B
,	O
the	O
continuous	O
cycling	O
of	O
triglyceride	O
hydrolysis	O
coupled	O
to	O
resynthesis	O
,	O
which	O
requires	O
large	O
amounts	O
of	O
ATP	O
,	O
could	O
be	O
another	O
important	O
mechanism	O
to	O
increase	O
thermogenesis	O
in	O
BAT	O
,	O
in	O
addition	O
to	O
the	O
role	O
of	O
UCP1	O
activation	O
in	O
this	O
process	O
(	O
Mottillo	O
et	O
al	O
.,	O
2014	O
).	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
South	O
African	O
study	O
focusing	O
on	O
the	O
assessment	O
of	O
both	O
maternal	O
dietary	O
intake	O
and	O
nutritional	O
status	O
in	O
women	O
pre	O
-	O
and	O
postnatally	O
and	O
to	O
investigate	O
associations	O
with	O
outcomes	O
of	O
maternal	O
and	O
infant	O
health	O
.	O

The	O
uncovering	O
of	O
the	O
magnitude	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
(	O
and	O
Western	O
Europe	O
)	O
should	O
be	O
translated	O
into	O
new	O
research	O
in	O
order	O
to	O
fill	O
the	O
huge	O
knowledge	O
gap	O
concerning	O
the	O
adequate	O
amount	O
of	O
vitamin	O
D	O
to	O
prevent	O
and	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

This	O
correlation	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

She	O
will	O
also	O
counsel	O
the	O
mother	O
about	O
the	O
benefits	O
of	O
IFA	O
supplements	O
in	O
pregnancy	O
.	O

In	O
calorie	O
restricted	O
offspring	O
(	O
UNP	O
,	O
UNL	O
,	O
UNPL	O
),	O
a	O
post	O
-	O
weaning	O
HF	O
diet	O
further	O
advanced	O
the	O
age	O
at	O
puberty	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Figure	O
2B	O
,	O
C	O
,	O
D	O
;	O
Table	O
1	O
)	O
compared	O
to	O
those	O
offspring	O
who	O
were	O
normally	O
nourished	O
in	O
utero	O
and	O
fed	O
a	O
HF	O
diet	O
post	O
-	O
weaning	O
(	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Percentage	O
of	O
offspring	O
entering	O
puberty	O
over	O
time	O
in	O
animals	O
whose	O
dams	O
received	O
50	O
%	O
of	O
normal	O
nutrition	O
.	O

This	O
study	O
focuses	O
on	O
the	O
F1	O
and	O
F2	O
generations	O
after	O
F0	O
maternal	O
vitamin	O
D	O
restriction	O
.	O

We	O
made	O
initial	O
comparisons	O
of	O
time	O
-	O
to	O
-	O
an	O
-	O
episode	O
between	O
the	O
two	O
groups	O
with	O
log	O
-	O
rank	O
tests	O
and	O
Kaplan	O
–	O
Meier	O
plots	O
.	O

This	O
study	O
has	O
reported	O
the	O
prevalence	O
of	O
postnatal	O
depression	O
up	O
to	O
60	O
%	O
[	O
6	O
].	O

[	O
32	O
],	O
the	O
proportion	O
of	O
women	O
taking	O
folic	O
acid	O
varies	O
between	O
0	O
.	O
9	O
%	O
and	O
49	O
%	O
before	O
conception	O
and	O
between	O
0	O
.	O
5	O
%	O
and	O
52	O
%	O
in	O
the	O
peri	O
-	O
conception	O
period	O
.	O

Preterm	O
labor	O
is	O
associated	O
with	O
high	O
mortality	O
and	O
morbidity	O
[	O
22	O
]	O
and	O
a	O
recent	O
study	O
pointed	O
towards	O
an	O
association	O
between	O
maternal	O
stress	O
and	O
complications	O
of	O
pregnancy	O
,	O
especially	O
preterm	O
birth	O
[	O
23	O
].	O

We	O
also	O
found	O
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
related	O
to	O
pregnancy	O
loss	O
.	O

In	O
order	O
to	O
achieve	O
Millennium	O
Development	O
Goals	O
,	O
new	O
strategies	O
to	O
address	O
nutritional	O
problems	O
in	O
women	O
of	O
reproductive	O
age	O
are	O
required	O
.	O

A	O
random	O
sample	O
of	O
812	O
pregnant	O
women	O
was	O
selected	O
from	O
20	O
various	O
health	O
centers	O
by	O
the	O
multistage	O
cluster	O
random	O
sampling	O
method	O
.	O

Introduction	O
Increasing	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
and	O
obesity	O
levels	O
in	O
current	O
populations	O
are	O
a	O
source	O
of	O
concern	O
for	O
public	O
health	O
policy	O
in	O
many	O
countries	O
.	O

For	O
BMD	O
,	O
changes	O
were	O
greater	O
in	O
Hispanic	O
than	O
Caucasians	O
(	O
0	O
.	O
019	O
±	O
0	O
.	O
012	O
g	O
/	O
cm2vs	O
0	O
.	O
010	O
±	O
0	O
.	O
012	O
g	O
/	O
cm2	O
,	O
p	O
=	O
0	O
.	O
017	O
).	O

Guidelines	O
emphasising	O
the	O
health	O
risks	O
of	O
methyl	O
-	O
mercury	O
,	O
with	O
little	O
mention	O
of	O
important	O
nutrients	O
found	O
in	O
fish	O
,	O
may	O
be	O
contributing	O
to	O
women	O
consuming	O
less	O
than	O
the	O
recommended	O
fish	O
servings	O
during	O
pregnancy	O
[	O
10	O
].	O

Contributing	O
factors	O
included	O
lack	O
of	O
variety	O
in	O
the	O
diet	O
associated	O
with	O
low	O
income	O
,	O
compounded	O
by	O
high	O
rates	O
of	O
infection	O
with	O
soil	O
-	O
transmitted	O
helminths	O
,	O
particularly	O
hookworm	O
.	O

Measures	O
were	O
made	O
using	O
mass	O
spectrometry	O
.	O

Bodnar	O
et	O
al	O
.	O

2	O
.	O

At	O
the	O
prenatal	O
stage	O
mRNA	O
expression	O
profiles	O
were	O
extensively	O
altered	O
between	O
the	O
dietary	O
groups	O
.	O

Vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
has	O
been	O
shown	O
to	O
positively	O
affect	O
cord	O
blood	O
vitamin	O
D	O
levels	O
at	O
birth	O
.	O
43	O
,	O
44Studies	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
thus	O
far	O
have	O
shown	O
conflicting	O
results	O
with	O
respect	O
to	O
birth	O
weight	O
and	O
reduction	O
of	O
SGA	O
.	O
43	O
,	O
45	O
,	O
46	O
,	O
47	O
,	O
48Adequately	O
powered	O
and	O
randomized	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
are	O
needed	O
to	O
assess	O
the	O
impact	O
of	O
supplementation	O
on	O
SGA	O
as	O
well	O
as	O
the	O
appropriate	O
dose	O
and	O
timing	O
of	O
supplementation	O
.	O

Improved	O
communication	O
and	O
collaboration	O
among	O
researchers	O
investigating	O
these	O
linked	O
outcomes	O
will	O
provide	O
an	O
opportunity	O
to	O
accelerate	O
the	O
discovery	O
,	O
development	O
and	O
delivery	O
of	O
innovation	O
,	O
especially	O
across	O
disciplines	O
and	O
between	O
laboratory	O
benches	O
and	O
remote	O
and	O
under	O
-	O
resourced	O
hospitals	O
.	O

The	O
fold	O
changes	O
were	O
uniformly	O
small	O
,	O
with	O
the	O
largest	O
FC	O
being	O
−	O
1	O
.	O
67	O
.	O

However	O
,	O
the	O
majority	B
of	O
family	O
studies	O
of	O
BMI	O
examine	O
relationships	O
between	O
two	O
generations	O
only	O
and	O
are	O
not	O
adjusted	O
for	O
cohort	O
effects	O
.	O

The	O
porcine	O
expression	O
patterns	O
in	O
this	O
study	O
showed	O
a	O
decreased	O
mRNA	O
expression	O
of	O
genes	O
associated	O
with	O
the	O
control	O
of	O
mitosis	O
and	O
cell	O
cycle	O
checkpoint	O
regulation	O
at	O
stage	O
94	O
dpc	O
in	O
LP	O
fetuses	O
.	O

Vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
frequent	O
in	O
many	O
populations	O
over	O
the	O
world	O
.	O

As	O
part	O
of	O
a	O
series	O
entitled	O
"	O
Born	O
Too	O
Soon	O
"	O
drawing	O
from	O
the	O
report	O
,	O
this	O
final	O
paper	O
summarises	O
the	O
problem	O
,	O
underlining	O
the	O
need	O
for	O
concerted	O
action	O
on	O
both	O
the	O
prevention	O
of	O
preterm	O
birth	O
and	O
care	O
of	O
the	O
premature	O
baby	O
,	O
to	O
ensure	O
every	O
mother	O
and	O
every	O
baby	O
survives	O
[	O
2	O
-	O
6	O
].	O

Animals	O
were	O
shown	O
to	O
exhibit	O
enhanced	O
insulin	O
sensitivity	O
,	O
while	O
they	O
become	O
obese	O
and	O
to	O
develop	O
insulin	O
resistance	O
a	O
few	O
weeks	O
later	O
,	O
during	O
hibernation	O
,	O
to	O
finally	O
recover	O
their	O
insulin	O
sensitivity	O
upon	O
awakening	O
.	O

2	O
.	O
8	O
.	O

•	O
Undertake	O
immediate	O
action	O
to	O
scale	O
up	O
KMC	O
as	O
a	O
standard	O
of	O
care	O
for	O
all	O
preterm	O
babies	O
under	O
2	O
,	O
000	O
grams	O
,	O
regardless	O
of	O
resource	O
setting	O
.	O

The	O
study	O
was	O
designed	O
as	O
an	O
observational	O
study	O
where	O
a	O
cohort	O
of	O
women	O
who	O
provided	O
informed	O
consent	O
were	O
interviewed	O
between	O
July	O
21st	O
and	O
December	O
4th	O
2014	O
,	O
within	O
48	O
h	O
after	O
delivery	O
.	O

First	O
,	O
patients	O
with	O
MTC	O
should	O
always	O
be	O
suspected	B
of	O
carrying	O
the	O
genetic	O
form	O
of	O
the	O
disease	O
.	O

New	O
alternatives	O
focusing	O
on	O
adipose	O
tissue	O
function	O
could	O
potentially	O
be	O
of	O
therapeutic	O
relevance	O
in	O
the	O
future	O
.	O

Pregnancy	O
is	O
a	O
special	O
situation	O
in	O
oncology	O
:	O
we	O
need	O
to	O
control	O
two	O
patients	O
at	O
the	O
same	O
time	O
,	O
and	O
both	O
are	O
vulnerable	O
.	O

2	O
.	O
2	O
.	O

3	O
.	O
2	O
.	O
2	O
.	O

This	O
interpretation	O
also	O
agrees	O
with	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
metabolism	O
in	O
peripheral	O
tissues	O
.	O

For	O
instance	O
,	O
different	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFAs	O
)	O
have	O
been	O
shown	O
to	O
differently	O
influence	O
the	O
outcome	O
of	O
eczema	O
in	O
the	O
child	O
.	O

The	O
lower	O
compulsive	O
feeding	O
in	O
RC	O
females	O
can	O
be	O
associated	O
with	O
the	O
hyperglycemia	O
via	O
a	O
hypothalamic	O
impairment	O
of	O
glucose	O
-	O
sensing	O
to	O
control	O
hunger	O
and	O
satiety	O
(	O
Routh	O
et	O
al	O
.,	O
2014	O
).	O

This	O
light	O
synthesized	O
steroid	O
,	O
resulting	O
from	O
the	O
absorption	O
of	O
ultraviolet	O
B	O
photons	O
by	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
[	O
148	O
],	O
has	O
been	O
suggested	O
as	O
a	O
possible	O
factor	O
underlying	O
the	O
season	O
of	O
birth	O
risk	O
for	O
adult	O
gliomas	O
observed	O
in	O
some	O
studies	O
[	O
145	O
].	O

We	O
investigated	O
the	O
long	O
-	O
term	O
effects	O
of	O
maternal	O
exposure	O
to	O
a	O
20	O
%	O
standard	O
diet	O
restriction	O
during	O
preconceptional	O
and	O
gestational	O
periods	O
on	O
the	O
metabolically	O
-	O
relevant	O
tissues	O
hypothalamus	O
,	O
liver	O
,	O
and	O
perirenal	O
fat	O
(	O
PAT	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

Study	O
setting	O
We	O
will	O
conduct	O
the	O
Shonjibon	O
trial	O
in	O
five	O
districts	O
in	O
Dhaka	O
Division	O
,	O
Bangladesh	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
starch	O
digestion	O
in	O
dairy	O
cows	O
revealed	O
that	O
the	O
ruminal	O
digestibility	O
of	O
corn	O
was	O
57	O
.	O
4	O
%	O
[	O
112	O
],	O
demonstrating	O
that	O
a	O
substantial	O
portion	O
of	O
corn	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
.	O

We	O
evaluated	O
the	O
determinants	O
for	O
the	O
intake	O
of	O
multivitamins	O
as	O
previous	O
studies	O
,	O
as	O
well	O
as	O
the	O
common	O
practice	O
in	O
Romania	O
suggested	O
a	O
high	O
incidence	O
of	O
use	O
[	O
14	O
,	O
35	O
],	O
despite	O
the	O
lack	O
of	O
recommendation	O
.	O

Gestational	O
age	O
at	O
enrollment	O
or	O
interview	O
was	O
not	O
a	O
confounder	O
in	O
this	O
study	O
.	O

CONCLUSION	O
In	O
this	O
article	O
,	O
we	O
reviewed	O
several	O
factors	O
(	O
genetic	O
,	O
management	O
,	O
and	O
nutritional	O
factors	O
)	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
(	O
Table	O
2	O
).	O

Despite	O
this	O
,	O
it	O
remains	O
important	O
to	O
continue	O
to	O
follow	O
-	O
up	O
the	O
children	O
whose	O
mothers	O
participated	O
in	O
this	O
intervention	O
trial	O
,	O
particularly	O
in	O
view	O
of	O
the	O
well	O
recognised	O
association	O
between	O
high	O
-	O
infant	O
birth	O
weight	O
and	O
subsequent	O
childhood	O
obesity	O
[	O
48	O
],	O
and	O
the	O
emerging	O
associations	O
between	O
maternal	O
obesity	O
and	O
impaired	O
childhood	O
neurodevelopmental	O
function	O
[	O
46	O
].	O

In	O
a	O
very	O
recent	O
study	O
,	O
the	O
grizzly	O
bear	O
was	O
used	O
as	O
a	O
hibernation	O
model	O
,	O
in	O
which	O
obesity	O
is	O
a	O
natural	O
adaptation	O
to	O
survive	O
months	O
of	O
fasting	O
(	O
Nelson	O
et	O
al	O
.,	O
2014	O
).	O

The	O
original	O
article	O
was	O
published	O
in	O
PDF	O
format	O
in	O
the	O
WHO	O
Report	O
"	O
Born	O
Too	O
Soon	O
:	O
the	O
global	O
action	O
report	O
on	O
preterm	O
birth	O
"	O
(	O
ISBN	O
978	O
92	O
4	O
150343	O
30	O
),	O
which	O
involved	O
collaboration	O
from	O
more	O
than	O
50	O
organizations	O
.	O

As	O
with	O
the	O
BHLM	O
,	O
Pb	O
,	O
Hg	O
and	O
OPPs	O
were	O
included	O
as	O
covariates	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
calorict	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
transcription	O
factors	O
(	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
)	O
regulating	O
the	O
expression	O
of	O
genes	O
implicated	O
in	O
lipid	O
and	O
carbohydrate	O
metabolism	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure6	O
).	O

This	O
is	O
because	O
these	O
settings	O
are	O
characterized	O
by	O
poor	O
maternal	O
health	O
service	O
indicators	O
such	O
as	O
nonutilization	O
of	O
service	O
or	O
delayed	O
antenatal	O
visit	O
.	O

Labs	O
revealed	O
an	O
unremarkable	O
BMP	O
,	O
coagulation	O
study	O
,	O
and	O
CBC	O
with	O
a	O
hemoglobin	O
of	O
10	O
.	O
8	O
and	O
hematocrit	O
of	O
32	O
.	O
2	O
.	O

Sunscreen	O
lotions	O
prevent	O
UV	O
radiation	O
from	O
reaching	O
the	O
skin	O
and	O
might	O
therefore	B
reduce	O
the	O
skin	O
’	O
s	O
vitamin	O
D	O
production	O
[	O
56	O
].	O

Physical	O
activity	O
,	O
smoking	O
and	O
educational	O
attainment	O
were	O
also	O
self	O
-	O
reported	O
.	O

These	O
include	O
DHCR7	O
encoding	O
7	O
-	O
dehydrocholesterol	O
(	O
7	O
-	O
DHC	O
)	O
reductase	O
;	O
CYP2R1	O
and	O
CYP24A1	O
encoding	O
25	O
-	O
hydroxylase	O
and	O
24	O
-	O
hydroxylase	O
,	O
respectively	O
;	O
and	O
GC	O
encoding	O
vitamin	O
D	O
binding	O
protein	O
(	O
VDP	O
).	O

When	O
appropriate	O
,	O
data	O
from	O
body	O
weight	O
,	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
test	O
over	O
time	O
were	O
analyzed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
or	O
three	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
with	O
time	O
,	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

At	O
T1	O
,	O
10	O
%	O
had	O
25OHD	O
concentrations	O
<	O
30	O
nmol	O
/	O
L	O
and	O
9	O
%	O
at	O
T3	O
(	O
Table	O
2	O
).	O

One	O
of	O
the	O
mechanisms	O
responsible	O
for	O
the	O
effect	O
of	O
fetal	O
nutritional	O
programming	O
on	O
growth	O
and	O
adiposity	O
of	O
progeny	O
is	O
epigenetic	O
modification	O
(	O
DNA	O
methylation	O
,	O
histone	O
modification	O
,	O
and	O
microRNA	O
)	O
of	O
gene	O
expression	O
during	O
early	O
development	O
and	O
permanent	O
changes	O
in	O
offspring	O
phenotypes	O
in	O
later	O
life	O
.	O

[	O
24	O
]	O
revealed	O
that	O
low	O
birth	O
weight	O
infants	O
in	O
China	O
tended	O
to	O
have	O
much	O
higher	O
meconium	O
phthalate	O
levels	O
than	O
infants	O
who	O
were	O
normal	O
weight	O
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
reported	O
that	O
a	O
high	O
level	O
of	O
diet	O
processing	O
can	O
increase	O
the	O
accessibility	O
of	O
dietary	O
starch	O
granules	O
for	O
both	O
rumen	O
and	O
small	O
intestine	O
amylases	O
,	O
resulting	O
in	O
maximum	O
glucose	O
availability	O
to	O
the	O
fattening	O
animal	O
[	O
113	O
].	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

According	O
to	O
the	O
longitudinal	O
study	O
design	O
the	O
'	O
AMPK	O
(	O
AMP	O
-	O
dependent	O
activated	O
kinase	O
)	O
signaling	O
'	O
was	O
found	O
to	O
be	O
regulated	O
throughout	O
ontogenesis	O
in	O
AP	O
offspring	O
only	O
.	O

Although	O
Skm2	O
mice	O
are	O
viable	O
,	O
the	O
occurrence	O
of	O
the	O
mutant	O
phenotype	O
(	O
eight	O
mutants	O
in	O
84	O
pups	O
)	O
suggests	O
that	O
there	O
may	O
be	O
some	O
embryonic	O
lethality	O
in	O
the	O
Skm2	O
mice	O
as	O
well	O
.	O

Whereas	O
in	O
pregnancy	O
,	O
serum	O
ferritin	O
levels	O
decline	O
even	O
in	O
women	O
ingesting	O
daily	O
supplements	O
of	O
iron	O
[	O
22	O
–	O
24	O
].	O

Recruitment	O
of	O
participants	O
started	O
on	O
7	O
March	O
2016	O
and	O
completion	O
of	O
data	O
collection	O
is	O
expected	O
in	O
June	O
2019	O
.	O

The	O
slides	O
were	O
then	O
briefly	O
rinsed	O
in	O
DEPC	O
treated	O
H2O	O
and	O
mounted	O
in	O
Vectashield	O
Mounting	O
Medium	O
containing	O
DAPI	O
prior	O
to	O
examining	O
the	O
emitted	O
fluorescent	O
signal	O
under	O
a	O
Zeiss	O
Axiovert	O
200M	O
microscope	O
viewed	O
using	O
the	O
AxioVision	O
software	O
.	O

Briefly	O
,	O
Japanese	O
Black	O
cattle	O
are	O
generally	O
fed	O
a	O
high	O
concentrate	O
diet	O
from	O
11	O
to	O
30	O
months	O
of	O
age	O
to	O
induce	O
deposition	O
of	O
IMF	O
.	O

In	O
addition	O
,	O
IMF	O
has	O
higher	O
ATP	O
-	O
citrate	O
lyase	O
activity	O
compared	O
to	O
subcutaneous	O
fat	O
[	O
90	O
].	O

While	O
such	O
studies	O
are	O
more	O
difficult	O
to	O
interpret	O
with	O
respect	O
to	O
epigenetic	O
toxicity	O
(	O
and	O
so	O
were	O
not	O
included	O
in	O
this	O
review	O
),	O
they	O
may	O
still	O
provide	O
useful	O
mechanistic	O
data	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Unadjusted	O
regression	O
analysis	O
:	O
Percentage	O
difference	O
in	O
markers	O
of	O
glucose	O
metabolism	O
associated	O
with	O
,	O
(	O
a	O
)	O
Early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
and	O
(	O
b	O
)	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
(	O
a	O
)	O
Early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
(	O
b	O
)	O
First	O
antenatal	O
visit	O
in	O
extended	O
winterDependent	O
Variable	O
%	O
∆	O
aB95	O
%	O
CI	O
P	O
%	O
∆	O
aB95	O
%	O
CI	O
P	O
HOMA	O
-	O
IR	O
early18	O
.	O
5	O
%	O
0	O
.	O
17	O
(−	O
0	O
.	O
04	O
,	O
0	O
.	O
39	O
)	O
0	O
.	O
11031	O
.	O
1	O
%	O
0	O
.	O
27	O
(	O
0	O
.	O
08	O
,	O
0	O
.	O
46	O
)	O
0	O
.	O
006HOMA	O
-	O
IR	O
28	O
weeks11	O
.	O
6	O
%	O
0	O
.	O
11	O
(−	O
0	O
.	O
13	O
,	O
0	O
.	O
39	O
)	O
0	O
.	O
37121	O
.	O
9	O
%	O
0	O
.	O
20	O
(	O
0	O
.	O
00	O
,	O
0	O
.	O
40	O
)	O
0	O
.	O
051Insulin	O
early	O
(	O
μU	O
/	O
mL	O
)	O
16	O
.	O
2	O
%	O
0	O
.	O
15	O
(−	O
0	O
.	O
06	O
,	O
0	O
.	O
35	O
)	O
0	O
.	O
17330	O
.	O
6	O
%	O
0	O
.	O
27	O
(	O
0	O
.	O
08	O
,	O
0	O
.	O
45	O
)	O
0	O
.	O
005Insulin	O
28	O
weeks	O
(	O
μU	O
/	O
mL	O
)	O
7	O
.	O
3	O
%	O
0	O
.	O
07	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
30	O
)	O
0	O
.	O
52819	O
.	O
2	O
%	O
0	O
.	O
18	O
(−	O
0	O
.	O
02	O
,	O
0	O
.	O
37	O
)	O
0	O
.	O
074Fasting	O
glucose	O
early	O
(	O
mmol	O
/	O
L	O
)	O
0	O
.	O
03	O
(−	O
0	O
.	O
06	O
,	O
0	O
.	O
12	O
)	O
0	O
.	O
541	O
−	O
0	O
.	O
02	O
(−	O
0	O
.	O
09	O
,	O
0	O
.	O
05	O
)	O
0	O
.	O
566Fasting	O
glucose	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
0	O
.	O
09	O
(−	O
0	O
.	O
02	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
1120	O
.	O
07	O
(−	O
0	O
.	O
03	O
,	O
0	O
.	O
17	O
)	O
0	O
.	O
1571	O
-	O
h	O
GCT	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
0	O
.	O
04	O
(−	O
0	O
.	O
32	O
,	O
0	O
.	O
41	O
)	O
0	O
.	O
824	O
−	O
0	O
.	O
03	O
(−	O
0	O
.	O
34	O
,	O
0	O
.	O
29	O
)	O
0	O
.	O
864	O
a	O
%	O
difference	O
in	O
metabolic	O
marker	O
Adjusted	O
analysis	O
(	O
model	O
1	O
)	O
–	O
25OHD	O
,	O
season	O
and	O
markers	O
of	O
glucose	O
metabolism	O
Multiple	O
linear	O
regression	O
models	O
(	O
Table4	O
)	O
included	O
both	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
extended	O
winter	O
as	O
predictors	O
of	O
the	O
metabolic	O
markers	O
(	O
Model	O
1	O
),	O
and	O
were	O
also	O
adjusted	O
for	O
confounders	O
(	O
Model	O
2	O
).	O

Future	O
studies	O
should	O
compare	O
placebo	O
,	O
iron	O
-	O
folate	O
and	O
UNIMMAP	O
supplementation	O
in	O
order	O
to	O
assess	O
the	O
efficacy	O
and	O
effectiveness	O
of	O
pre	O
-	O
or	O
inter	O
-	O
pregnancy	O
supplementation	O
on	O
later	O
maternal	O
anaemia	O
and	O
pregnancy	O
outcome	O
,	O
as	O
well	O
as	O
the	O
impact	O
on	O
broader	O
micronutrient	O
status	O
and	O
other	O
functional	O
outcomes	O
in	O
this	O
vulnerable	O
group	O
.	O

The	O
Skm1	O
mutation	O
occurs	O
within	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
extracellular	O
domain	O
of	O
Npr3	O
,	O
suggesting	O
that	O
ligand	O
binding	O
may	O
be	O
altered	O
in	O
these	O
mice	O
.	O

Lu	O
et	O
al	O
.	O

Melatonin	O
,	O
a	O
pineal	O
hormone	O
regulated	O
by	O
light	O
exposure	O
,	O
peaks	O
during	O
night	O
after	O
the	O
onset	O
of	O
sleep	O
,	O
with	O
little	O
production	O
during	O
daylight	O
hours	O
[	O
13	O
].	O

In	O
early	O
pregnancy	O
,	O
insulin	O
and	O
HOMA	O
-	O
IR	O
,	O
but	O
not	O
glucose	O
,	O
were	O
significantly	O
higher	O
among	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
(	O
Table2	O
).	O

Luckily	O
,	O
for	O
the	B
time	I
being	I
the	O
in	O
vitro	O
experiments	O
did	O
not	O
prove	O
cross	O
-	O
reaction	O
of	O
specific	O
immunoglobulin	O
with	O
VDBP	O
[	O
50	O
].	O

Of	O
this	O
source	O
population	O
,	O
96	O
000	O
women	O
were	O
randomly	O
selected	O
from	O
four	O
age	O
strata	O
(	O
30	O
-	O
34	O
,	O
35	O
-	O
39	O
,	O
40	O
-	O
44	O
and	O
45	O
-	O
49	O
years	O
)	O
and	O
were	O
invited	O
to	O
participate	O
in	O
the	O
Swedish	O
component	O
of	O
the	O
Scandinavian	O
Women	O
'	O
s	O
Lifestyle	O
and	O
Health	O
Cohort	O
[	O
19	O
,	O
20	O
].	O

It	O
is	O
also	O
associated	O
with	O
the	O
formation	O
of	O
new	O
thyroid	O
nodules	O
with	O
the	O
histological	O
features	O
of	O
nodular	O
hyperplasia	O
.	O

Although	O
the	O
literature	O
from	O
rigorous	O
studies	O
of	O
smoking	O
cessation	O
,	O
treatment	O
adherence	O
,	O
and	O
some	O
other	O
chronic	O
disease	O
prevention	O
and	O
management	O
studies	O
show	O
that	O
mHealth	O
programs	O
can	O
promote	O
behavior	O
change	O
,	O
more	O
randomized	O
controlled	O
trials	O
(	O
RCTs	O
)	O
are	O
needed	O
[	O
11	O
].	O

For	O
instance	O
,	O
it	O
has	O
been	O
also	O
documented	O
excessive	O
body	O
weight	O
in	O
absence	O
of	O
higher	O
food	O
intake	O
(	O
Yura	O
et	O
al	O
.,	O
2005	O
;	O
Sebert	O
et	O
al	O
.,	O
2009	O
;	O
Theys	O
et	O
al	O
.,	O
2011	O
).	O

In	O
another	O
study	O
conducted	O
in	O
rural	O
pocket	O
of	O
Varanasi	O
to	O
evaluate	O
the	O
impact	O
of	O
ICDS	O
on	O
maternal	O
nutrition	O
and	O
birth	O
weight	O
,	O
it	O
was	O
concluded	O
that	O
undernourished	O
antenatal	O
women	O
are	O
definitely	O
benefitted	O
by	O
late	O
pregnancy	O
nutrition	O
supplement	O
(	O
7	O
).	O

1	O
Comparison	O
of	O
Vitamin	O
D	O
deficiency	O
rate	O
of	O
different	O
seasons	O
between	O
the	O
two	O
groups	O
.	O

Ratings	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
follow	O
-	O
up	O
questionnaire	O
contained	O
20	O
questions	O
on	O
psychotic	O
-	O
like	O
symptoms	O
,	O
(	O
Additional	O
file1	O
),	O
constituting	O
the	O
positive	O
symptoms	O
of	O
the	O
CAPE	O
(	O
Community	O
Assessment	O
of	O
Psychic	O
Experiences	O
)	O
questionnaire	O
,	O
a	O
modified	O
version	O
of	O
the	O
Peters	O
et	O
al	O
.	O

Excess	O
weight	O
is	O
usually	O
defined	O
by	O
the	O
body	O
mass	O
index	O
or	O
BMI	O
.	O

)#	O
tp	O
valueHigh	O
cord	O
25	O
(	O
OH	O
)	O
D0	O
.	O
252	O
(	O
0	O
.	O
088	O
)	O
2	O
.	O
736	O
0	O
.	O
005	O
AR	O
,	O
father	O
-	O
0	O
.	O
232	O
(	O
0	O
.	O
103	O
)-	O
2	O
.	O
416	O
0	O
.	O
018	O
Maternal	O
smoke	O
in	O
pregnancy	O
-	O
0	O
.	O
396	O
(	O
0	O
.	O
196	O
)-	O
2	O
.	O
024	O
0	O
.	O
032	O
NP	O
colonization	O
-	O
0	O
.	O
121	O
(	O
0	O
.	O
90	O
)-	O
1	O
.	O
3530	O
.	O
182Male	O
-	O
0	O
.	O
109	O
(	O
0	O
.	O
087	O
)-	O
1	O
.	O
2550	O
.	O
215Asthma	O
,	O
mother	O
-	O
0	O
.	O
144	O
(	O
0	O
.	O
152	O
)-	O
0	O
.	O
9460	O
.	O
348	O
(	O
Constant	O
)	O
0	O
.	O
110	O
(	O
0	O
.	O
102	O
)	O
1	O
.	O
0820	O
.	O
284	O
R2	O
=	O
0	O
.	O

For	O
example	O
,	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
undernutrition	O
have	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
various	O
adult	O
-	O
onset	O
diseases	O
,	O
including	O
psychiatric	O
disorders	O
,	O
type	O
2	O
diabetes	O
and	O
obesity	O
,	O
in	O
numerous	O
famine	O
cohorts	O
such	O
as	O
the	O
Dutch	O
Hunger	O
Winter	O
,	O
the	O
Chinese	O
Great	O
Leap	O
Forward	O
and	O
the	O
Överkalix	O
cohorts	O
(	O
Lumey	O
et	O
al	O
.	O
2011	O
;	O
Pembrey	O
et	O
al	O
.	O
2014	O
).	O

[	O
66	O
],	O
it	O
was	O
shown	O
that	O
the	O
manipulation	O
of	O
serotonin	O
during	O
early	O
development	O
in	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
disturbs	O
characteristic	O
chemoarchitectural	O
and	O
electrophysiological	O
brain	O
features	O
.	O

These	O
findings	O
also	O
highlight	O
the	O
importance	O
of	O
achieving	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
substantially	O
above	O
20	O
ng	O
/	O
mL	O
,	O
the	O
concentration	O
recommended	O
by	O
the	O
IOM	O
for	O
pregnant	O
women	O
[	O
16	O
],	O
for	O
PTB	O
prevention	O
.	O

Eligibility	O
Criteria	O
Articles	O
published	O
in	O
peer	O
-	O
reviewed	O
journals	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
in	O
this	O
review	O
.	O

It	O
has	O
been	O
proven	B
that	O
the	O
synthesis	O
of	O
VD	O
is	O
higher	O
in	O
the	O
1st	O
trimester	O
(	O
41	O
±	O
11	O
.	O
8	O
fMole	O
/	O
h	O
/	O
mg	O
)	O
compared	O
to	O
the	O
3rd	O
trimester	O
(	O
8	O
±	O
4	O
.	O
4	O
fMole	O
/	O
h	O
/	O
mg	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

Dams	O
were	O
sacrificed	O
.	O

At	O
the	O
same	O
time	O
,	O
research	O
and	O
innovation	O
for	O
preterm	O
birth	O
prevention	O
is	O
urgent	O
.	O

EAH	O
in	O
children	O
is	O
associated	O
with	O
higher	O
fasting	O
insulin	O
and	O
leptin	O
levels	O
(	O
64	O
),	O
2	O
hormones	O
that	O
regulate	O
appetite	O
and	O
body	O
weight	O
(	O
68	O
).	O

Maternal	O
habitual	O
sleep	O
duration	O
and	O
snoring	O
was	O
obtained	O
from	O
self	O
-	O
report	O
,	O
and	O
thus	B
are	O
likely	B
susceptible	O
to	O
misclassification	O
.	O

CHL	O
is	O
measured	O
by	O
placing	O
the	O
newborn	O
in	O
supine	O
position	O
on	O
the	O
tape	O
measure	O
on	O
a	O
flat	O
surface	O
with	O
all	O
limbs	O
extended	O
and	O
measurement	O
taken	O
from	O
vertex	O
to	O
heel	O
of	O
foot	O
,	O
with	O
foot	O
held	O
in	O
a	O
perpendicular	O
position	O
to	O
the	O
leg	O
.	O

PubMed	O
Central	O
:	O

Interestingly	O
,	O
Flnb	O
knockout	O
is	O
associated	O
with	O
embryonic	O
lethality	O
beginning	O
at	O
E11	O
.	O
5	O
and	O
<	O
3	O
%	O
of	O
Flnb	O
−/−	O
survive	O
to	O
birth	O
,	O
with	O
all	O
mice	O
being	O
killed	O
by	O
4	O
weeks	O
of	O
age	O
because	O
of	O
impaired	O
movement	O
and	O
reduced	O
body	O
weight	O
(	O
Zhou	O
et	O
al	O
.	O

The	O
latter	O
tend	O
to	O
live	O
and	O
work	O
in	O
a	O
more	O
closed	O
indoor	O
environment	O
and	O
thus	O
suffer	O
greater	O
exposure	O
to	O
indoor	O
pollutants	O
(	O
e	O
.	O
g	O
.,	O
polychlorinated	O
biphenyls	O
,	O
phthalates	O
,	O
phenols	O
,	O
flame	O
retardants	O
)	O
[	O
29	O
].	O

(	O
a	O
).	O

Patients	O
with	O
MTC	O
whose	O
tumours	O
deriving	O
from	O
C	O
cells	O
are	O
not	O
TSH	O
-	O
dependent	O
do	O
not	O
require	O
suppressive	O
therapy	O
,	O
but	O
only	O
thyroxine	O
replacement	O
therapy	O
after	O
surgery	O
,	O
and	O
the	O
dosages	O
are	O
the	O
same	O
as	O
those	O
used	O
for	O
hypothyroidism	O
.	O

Intramuscular	O
or	O
intravenous	O
iron	O
is	O
thought	O
to	O
be	O
associated	O
with	O
allergic	O
reactions	O
and	O
anaphylactic	O
shock	O
;	O
furthermore	O
,	O
parenteral	O
iron	O
is	O
thought	O
to	O
predispose	O
to	O
venous	O
thrombosis	O
and	O
occasionally	O
cardiac	O
arrest	O
and	O
death	O
[	O
2	O
].	O

Maternal	O
vitamin	O
D	O
status	O
associated	O
with	O
birth	O
size	O
:	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
showed	O
a	O
positive	O
association	O
towards	O
birth	O
weight	O
,	O
but	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
an	O
inverse	O
association	O
with	O
head	O
circumference	O
,	O
while	O
only	O
the	O
inverse	O
association	O
with	O
head	O
circumference	O
was	O
verified	O
with	O
linear	O
model	O
.	O

The	O
approach	O
to	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
methylation	O
was	O
not	O
designed	O
to	O
assess	O
specific	O
loci	O
or	O
genes	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
but	O
rather	O
to	O
evaluate	O
whether	O
methylation	O
of	O
particular	O
groups	O
of	O
CpG	O
loci	O
with	O
like	O
methylation	O
patterns	O
or	O
similar	O
bioinformatic	O
attributes	O
were	O
coordinately	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
because	O
this	O
could	O
inform	O
on	O
the	O
process	O
responsible	O
for	O
the	O
variation	O
between	O
the	O
two	O
.	O

Of	O
the	O
104	O
women	O
reporting	O
prenatal	O
vitamin	O
use	O
,	O
82	O
%	O
discussed	O
it	O
and	O
91	O
%	O
were	O
satisfied	O
with	O
the	O
conversation	O
.	O

The	O
σβposterior	O
mean	O
was	O
10	O
g	O
,	O
which	O
indicated	O
heterogeneity	O
in	O
the	O
phthalate	O
and	O
BPA	O
effects	O
around	O
this	O
estimate	O
,	O
and	O
that	O
roughly	O
two	O
thirds	O
of	O
the	O
beta	O
coefficients	O
were	O
within	O
10	O
g	O
(	O
one	O
standard	O
deviation	O
)	O
of	O
μβ	O
.	O

The	O
group	O
cites	O
insufficient	O
evidence	O
on	O
the	O
impact	O
of	O
nanomaterials	O
on	O
the	O
environment	O
and	O
human	O
health	O
.	O

The	O
typical	O
age	O
of	O
onset	O
for	O
schizophrenia	O
is	O
early	O
adulthood	O
(	O
20	O
-	O
25	O
years	O
of	O
age	O
).	O

Infant	O
sex	O
uses	O
female	O
sex	O
as	O
the	O
referent	O
.	O

All	O
research	O
participants	O
provide	O
written	O
informed	O
consent	O
before	O
data	O
collection	O
.	O

In	O
total	O
we	O
found	O
13	O
,	O
357	O
probe	O
-	O
sets	O
expressed	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
13	O
,	O
259	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
12	O
,	O
637	O
)	O
according	O
to	O
MAS5	O
analysis	O
(	O
Table1	O
).	O

The	O
sample	O
size	O
of	O
our	O
study	O
was	O
determined	O
based	O
on	O
an	O
unknown	O
prevalence	O
of	O
supplements	O
intake	O
(	O
which	O
was	O
set	O
by	O
default	O
to	O
be	O
50	O
%),	O
but	O
may	O
have	O
been	O
too	O
small	O
to	O
accommodate	O
some	O
subgroup	O
analyses	O
;	O
we	O
must	O
therefore	B
be	O
cautious	O
about	O
the	O
conclusions	B
that	O
can	O
be	O
drawn	O
from	O
subgroup	O
analysis	O
and	O
test	O
the	O
hypotheses	O
that	O
arise	O
from	O
these	O
findings	O
in	O
future	O
studies	O
.	O

Other	O
measurements	O
Social	O
,	O
economic	O
and	O
demographic	O
characteristics	O
will	O
be	O
collected	O
in	O
a	O
questionnaire	O
collected	O
at	O
enrolment	O
and	O
will	O
use	O
standard	O
demographic	O
and	O
health	O
survey	O
methods	O
of	O
an	O
inventory	O
of	O
household	O
assets	O
to	O
construct	O
a	O
wealth	O
index	O
,	O
[	O
16	O
]	O
as	O
well	O
as	O
the	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
mother	O
.	O

The	O
remaining	O
95	O
–	O
99	O
%	O
of	O
the	O
genome	O
was	O
regarded	B
as	O
‘	O
junk	O
’	O
DNA	O
.	O

Further	O
studies	O
are	O
warranted	O
to	O
test	O
the	O
feasibility	O
of	O
early	O
nutritional	O
programming	O
for	O
regulating	O
IMF	O
deposition	O
in	O
cattle	O
.	O

Women	O
with	O
an	O
increase	O
in	O
25OHD	O
≥	O
30	O
nmol	O
/	O
L	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Flow	O
diagram	O
for	O
inclusion	O
of	O
journal	O
articles	O
[	O
17	O
].	O

When	O
both	O
rs10741657	O
(	O
CYP2R1	O
)	O
(	O
β	O
=	O
−	O
5	O
.	O
0	O
nmol	O
/	O
L	O
per	O
G	O
allele	O
;	O
95	O
%	O
CI	O
,	O
−	O
8	O
.	O
0	O
to	O
−	O
1	O
.	O
9	O
nmol	O
/	O
L	O
per	O
G	O
allele	O
;	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
(	O
β	O
=	O
3	O
.	O
8	O
nmol	O
/	O
L	O
per	O
A	O
allele	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
6	O
to	O
7	O
.	O
1	O
nmol	O
/	O
L	O
per	O
A	O
allele	O
;	O
P	O
=	O
0	O
.	O
021	O
)	O
were	O
included	O
simultaneously	O
in	O
a	O
regression	O
model	O
with	O
confounders	O
,	O
the	O
effect	O
sizes	O
were	O
maintained	O
.	O

There	O
were	O
no	O
significant	O
associations	O
between	O
the	O
SNPs	O
at	O
rs12785878	O
(	O
DHCR7	O
)	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
and	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
Table	O
3	O
).	O

Accordingly	O
,	O
we	O
conducted	O
sensitivity	O
analyses	O
without	O
controlling	O
for	O
GA	O
(	O
Table3	O
)	O
and	O
stratified	O
the	O
BHLM	O
results	O
by	O
sex	O
(	O
Additional	O
file1	O
:	O
Tables	O
S1	O
and	O
S2	O
).	O

Initiating	O
IFA	O
supplements	O
in	O
the	O
first	O
four	O
months	O
of	O
pregnancy	O
,	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
neonatal	O
mortality	O
by	O
35	O
%	O
[	O
11	O
].	O

The	O
best	O
treatment	O
for	O
nearly	B
all	I
identified	O
malignant	O
thyroid	O
neoplasm	O
is	O
surgery	O
.	O

During	O
pregnancy	O
,	O
iron	O
requirements	O
are	O
not	O
uniform	O
[	O
14	O
].	O

Mahalanobis	O
distance	O
was	O
used	O
to	O
screen	O
outliers	O
,	O
and	O
all	O
CpG	O
loci	O
on	O
X	O
and	O
Y	O
chromosomes	O
were	O
excluded	O
from	O
the	O
analysis	O
,	O
to	O
avoid	O
sex	O
-	O
specific	O
methylation	O
bias	O
,	O
leaving	O
a	O
final	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
representing	O
13	O
,	O
890	O
unique	O
genes	O
(	O
Poage	O
et	O
al	O
.	O

However	O
,	O
neither	O
study	O
was	O
designed	O
to	O
replicate	O
typical	O
human	O
exposures	O
to	O
PFOA	O
,	O
and	O
the	O
doses	O
were	O
much	O
higher	O
than	O
the	O
levels	O
people	O
are	O
typically	B
exposed	O
to	O
in	O
the	O
real	O
world	O
.	O
27	O
It	O
is	O
not	O
clear	O
whether	O
altered	O
development	O
of	O
the	O
mammary	O
gland	O
itself	O
or	O
disruptions	O
in	O
hormonal	O
status	O
are	O
responsible	B
for	O
the	O
negative	O
impacts	O
on	O
lactation	O
that	O
Fenton	O
observed	O
.	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
no	O
significant	O
effects	O
were	O
observed	O
.	O

PubMed	O
Central	O
:	O

Gestational	O
Period	O
Risk	O
for	O
obesity	O
and	O
metabolic	O
disorders	O
begins	O
during	O
gestation	O
(	O
1	O
).	O

Interestingly	O
,	O
apples	O
consumed	O
during	O
pregnancy	O
were	O
able	O
to	O
decrease	O
wheezing	O
in	O
children	O
[	O
80	O
].	O

While	O
such	O
complex	O
networks	O
exist	O
to	O
maintain	O
cellular	O
homeostasis	O
,	O
they	O
are	O
open	O
to	O
environmental	O
perturbation	O
(	O
Figure	O
1	O
).	O

The	O
proportion	O
of	O
control	O
mothers	O
who	O
took	O
vitamins	O
during	O
pregnancy	O
varied	O
tremendously	O
:	O
from	O
3	O
%	O
in	O
Israel	O
and	O
France	O
,	O
21	O
%	O
in	O
Italy	O
,	O
33	O
%	O
in	O
Canada	O
,	O
52	O
%	O
in	O
Spain	O
and	O
86	O
to	O
92	O
%	O
at	O
the	O
three	O
U	O
.	O
S	O
.	O
centers	O
.	O

Similarly	O
,	O
indoor	O
-	O
outdoor	O
pets	O
are	O
efficient	O
carriers	O
of	O
agents	O
into	O
the	O
home	O
,	O
and	O
also	O
pose	O
an	O
exposure	O
source	O
for	O
pesticides	O
from	O
anti	O
flea	O
/	O
tick	O
collars	O
,	O
sprays	O
,	O
and	O
shampoos	O
.	O

PubMed	O
Central	O
:	O

“	O
We	O
’	O
re	O
going	O
to	O
make	O
sure	O
people	O
know	O
their	O
risks	O
and	O
can	O
take	O
action	O
.”	O
PubMed	O
Central	O
:	O

A	O
screening	O
blood	O
sample	O
was	O
obtained	O
and	O
analyzed	O
on	O
the	O
local	O
NHS	O
platform	O
[	O
all	O
three	O
laboratories	O
(	O
Southampton	O
,	O
Oxford	O
,	O
and	O
Sheffield	O
)	O
participate	O
in	O
the	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
http	O
://	O
www	O
.	O
deqas	O
.	O
org	O
/)].	O

For	O
protein	O
identification	O
,	O
approximately	O
0	O
.	O
8	O
µl	O
of	O
the	O
peptide	O
mixture	O
was	O
spotted	O
onto	O
a	O
target	O
plate	O
and	O
covered	O
with	O
the	O
same	O
volume	O
of	O
matrix	O
solution	O
(	O
α	O
-	O
cyano	O
-	O
4	O
-	O
hydroxy	O
cinnamic	O
acid	O
(	O
Sigma	O
),	O
8	O
mg	O
/	O
ml	O
in	O
70	O
%	O
(	O
v	O
/	O
v	O
)	O
acetonitrile	O
/	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
formic	O
acid	O
)	O
and	O
allowed	O
to	O
air	O
dry	O
.	O

As	O
described	O
earlier	O
[	O
2	O
],	O
VD	O
has	O
a	O
potent	O
immuno	O
-	O
modulating	O
activity	O
towards	O
lymphocytes	O
T	O
and	O
the	O
antigen	O
-	O
presenting	O
cells	O
.	O

(	O
2015	O
)	O
*	O
Metals	O
:	O
Arsenic	O
(	O
As	O
)	O
LifetimeAdulthoodSkin	O
abnormalitiesDNA	O
methylationPaul	O
et	O
al	O
.	O

Specifications	O
table	O
TableSubject	O
areaBiologyMore	O
specific	O
subject	O
areaAnimal	O
nutrition	O
and	O
metabolismType	O
of	O
dataFigure	O
of	O
miRNAs	O
predicted	O
to	O
target	O
GR	O
,	O
Table	O
of	O
miRNAs	O
expressionHow	O
data	O
was	O
acquiredQuantitative	O
PCR	O
analysis	O
was	O
performed	O
using	O
SYBR	O
Premix	O
Ex	O
Taq	O
™	O
PCR	O
Master	O
Mix	O
in	O
Mastercycler	O
®	O
ep	O
realplex	O
PCR	O
detection	O
system	O
.	O
Data	O
formatFiltered	O
and	O
analyzedExperimental	O
factorsMaternal	O
gestational	O
betaine	O
supplementationExperimental	O
featuresRNA	O
isolation	O
and	O
polyadenylation	O
;	O
real	O
-	O
time	O
PCR	O
.	O
Data	O
source	O
locationDafeng	O
,	O
Jiangsu	O
,	O
ChinaData	O
accessibilityData	O
are	O
provided	O
in	O
the	O
paper	O
Value	O
of	O
the	O
data	O
miRNAs	O
participation	O
in	O
post	O
-	O
transcription	O
of	O
genes	O
could	O
be	O
included	O
in	O
other	O
studies	O
of	O
fetal	O
programming	O
.	O

Due	O
to	O
its	O
longer	O
half	O
-	O
life	O
,	O
25	O
-(	O
OH	O
)	O
D	O
is	O
considered	O
the	O
best	O
bio	O
-	O
marker	O
of	O
vitamin	O
D	O
status	O
.	O

We	O
observed	O
differential	O
expression	O
of	O
genes	O
related	O
to	O
lipid	O
metabolism	O
(	O
e	O
.	O
g	O
.	O

Data	O
are	O
mean	O
±	O
SD	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
pregnancy	O
outcome	O
Of	O
the	O
2800	O
women	O
present	O
in	O
this	O
study	O
,	O
1217	O
(	O
43	O
%)	O
women	O
went	O
on	O
to	O
develop	O
a	O
pregnancy	O
complication	O
and	O
included	O
5	O
.	O
8	O
%	O
(	O
n	O
=	O
161	O
)	O
who	O
developed	O
PE	O
,	O
7	O
.	O
6	O
%	O
(	O
n	O
=	O
213	O
)	O
who	O
developed	O
GH	O
,	O
3	O
.	O
3	O
%	O
(	O
n	O
=	O
92	O
)	O
who	O
developed	O
GDM	O
,	O
5	O
%	O
(	O
n	O
=	O
139	O
)	O
who	O
spontaneously	O
delivered	O
preterm	O
and	O
10	O
.	O
6	O
%	O
(	O
n	O
=	O
298	O
)	O
who	O
delivered	O
an	O
SGA	O
infant	O
.	O

2	O
).	O

Most	O
pregnant	O
mothers	O
tolerated	O
the	O
2000	O
IU	O
well	O
without	O
any	O
adverse	O
effects	O
and	O
just	O
a	O
few	O
of	O
them	O
temporarily	O
complained	O
about	O
nausea	O
.	O

Women	O
who	O
agreed	O
to	O
participate	O
in	O
the	O
study	O
could	O
have	O
been	O
different	O
from	O
women	O
who	O
did	O
not	O
participate	O
in	O
the	O
study	O
,	O
and	O
we	O
did	O
not	O
collect	O
characteristics	O
on	O
women	O
who	O
refused	O
to	O
participate	O
in	O
the	O
study	O
to	O
ascertain	O
this	O
bias	O
.	O

gave	O
2000	O
IU	O
of	O
vitamin	O
D	O
per	O
day	O
to	O
non	O
-	O
pregnant	O
women	O
in	O
form	O
of	O
oral	O
drops	O
for	O
105	O
days	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
13	O
Health	O
care	O
workers	O
-	O
Health	O
care	O
providers	O
as	O
champions	O
of	O
change	O
for	O
mothers	O
and	O
newborns	O
.	O

Our	O
model	O
indicates	O
that	O
gestational	O
LP	O
diets	O
affected	O
the	O
hepatic	O
expression	O
profiles	O
in	O
an	O
acute	O
,	O
short	O
-	O
term	O
as	O
well	O
as	O
in	O
a	O
delayed	O
,	O
long	O
-	O
term	O
manner	O
in	O
LP	O
offspring	O
.	O

The	O
a	B
priori	I
goal	O
was	O
the	O
achievement	O
of	O
a	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
to	O
achieve	O
maximal	O
production	O
of	O
the	O
active	O
hormone	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
[	O
13	O
].	O

Standard	O
procedures	O
are	O
used	O
for	O
a	O
2	O
-	O
h	O
75	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
between	O
24	O
and	O
28	O
weeks	O
gestation	O
to	O
determine	O
development	O
of	O
gestational	O
diabetes	O
mellitus	O
[	O
47	O
].	O

α	O
-	O
linolenic	O
acid	O
,	O
the	O
parent	O
fatty	O
acid	O
of	O
the	O
omega	O
-	O
3	O
family	O
can	O
,	O
to	O
a	O
limited	O
extent	O
,	O
be	O
converted	O
into	O
EPA	O
,	O
DPA	O
and	O
DHA	O
.	O

Statistical	O
analytical	O
methods	O
We	O
compared	O
the	O
frequency	O
distribution	O
of	O
sociodemographic	O
,	O
lifestyle	O
,	O
behavioral	O
and	O
medical	O
history	O
characteristics	O
of	O
participants	O
according	O
to	O
GDM	O
diagnosis	O
status	O
.	O

We	O
aimed	O
to	O
examine	O
associations	O
for	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
across	O
three	O
generations	O
of	O
the	O
same	O
families	O
.	O

Data	O
were	O
collected	O
before	O
the	O
2009	O
IOM	O
guidelines	O
were	O
released	O
.	O

These	O
retained	O
histones	O
are	O
not	O
randomly	O
distributed	O
throughout	O
the	O
male	O
genome	O
,	O
they	O
are	O
particularly	O
enriched	O
at	O
the	O
promoters	O
of	O
developmental	O
genes	O
.	O

In	O
fact	O
,	O
valproate	O
use	O
during	O
pregnancy	O
showed	O
an	O
11	O
.	O
3	O
%	O
increased	O
risk	O
in	O
developmental	O
malformations	O
,	O
and	O
it	O
relied	O
heavily	O
on	O
the	O
dosage	O
prescribed	O
[	O
64	O
].	O

Statistical	O
Analysis	O
Statistical	O
analyses	O
were	O
conducted	O
using	O
SPSS	O
version	O
21	O
.	O
0	O
for	O
Windows	O
(	O
IBM	O
Corporation	O
,	O
USA	O
).	O

Such	O
an	O
approach	O
would	O
also	O
respect	O
the	O
3Rs	O
.	O

We	O
also	O
collected	O
samples	O
at	O
other	O
times	O
(	O
appendix	O
)	O
from	O
a	O
different	O
set	O
of	O
randomly	O
selected	O
children	O
to	O
check	O
fluctuations	O
in	O
serum	O
concentrations	O
.	O

In	B
general	I
,	O
height	O
correlations	O
of	O
the	O
child	O
with	O
each	O
parent	O
increased	O
with	O
age	O
.	O

Eicosapentaenoic	O
acid	O
(	O
EPA	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
belong	O
to	O
the	O
omega	O
-	O
3	O
family	O
,	O
and	O
are	O
mainly	O
found	O
in	O
fatty	O
fish	O
.	O

Daycare	O
attendance	O
and	O
infant	O
antibiotic	O
exposure	O
at	O
or	O
before	O
4	O
months	O
of	O
age	O
were	O
rare	O
.	O

Participants	O
were	O
considered	O
to	O
have	O
quit	O
the	O
study	O
if	O
they	O
were	O
unreachable	O
after	O
7	O
recontact	O
attempts	O
,	O
and	O
no	O
further	O
follow	O
-	O
up	O
attempts	O
were	O
made	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Well	O
-	O
preforming	O
countries	O
for	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
reduction	O
by	O
region	O
.	O

Late	O
antenatal	O
visits	O
attendance	O
is	O
detrimental	O
because	O
it	O
prevents	O
the	O
clients	O
from	O
obtaining	O
the	O
maximum	O
benefits	O
from	O
the	O
antenatal	O
service	O
[	O
14	O
–	O
16	O
].	O

Strongly	O
associated	O
with	O
risk	O
of	O
oesophageal	O
cancer	O
were	O
low	O
socio	O
-	O
economic	O
status	O
and	O
low	O
intake	O
of	O
fresh	O
fruit	O
and	O
vegetables	O
.	O

We	O
will	O
attach	O
the	O
details	O
of	O
the	O
pregnant	O
women	O
to	O
the	O
box	O
during	O
registration	O
in	O
the	O
trial	O
.	O

Skm1	O
mice	O
were	O
thin	O
and	O
exhibited	O
a	O
marked	O
thoracolumbar	O
kyphosis	O
(	O
Figure	O
4	O
,	O
C	O
and	O
D	O
)	O
compared	O
to	O
wild	O
-	O
type	O
littermates	O
(	O
Figure	O
4	O
,	O
A	O
and	O
B	O
).	O

Discussion	O
In	O
our	O
study	O
population	O
,	O
we	O
found	O
that	O
compared	O
with	O
white	O
infants	O
,	O
black	O
infants	O
had	O
significantly	O
lower	O
cord	O
blood	O
vitamin	O
D	O
levels	O
and	O
a	O
greater	O
proportion	O
of	O
vitamin	O
D	O
deficiency	O
.	O

For	O
that	O
matter	O
,	O
the	O
requirement	O
for	O
the	O
general	O
population	O
is	O
not	O
known	O
either	O
.	O

Compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
),	O
women	O
with	O
a	O
decrease	O
in	O
25OHD	O
had	O
significantly	O
higher	O
OR	O
of	O
having	O
a	O
child	O
born	O
SGA	O
(	O
OR	O
=	O
3	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
002	O
),	O
with	O
LBW	O
(	O
OR	O
=	O
4	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
014	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
higher	O
odds	O
of	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
061	O
).	O

As	O
stated	O
in	O
the	O
previous	O
report	O
[	O
2	O
],	O
much	O
higher	O
concentrations	O
of	O
follicular	O
VD	O
were	O
found	O
in	O
Caucasians	O
(	O
76	O
.	O
1	O
±	O
32	O
.	O
3	O
nmol	O
/	O
L	O
)	O
compared	O
to	O
people	O
of	O
African	O
descent	O
(	O
47	O
.	O
1	O
±	O
21	O
.	O
2	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
001	O
).	O

Fast	O
food	O
consumption	O
was	O
assessed	O
based	O
on	O
self	O
-	O
report	O
questions	O
used	O
in	O
our	O
previous	O
research	O
[	O
25	O
].	O

Phthalate	O
metabolites	O
and	O
BPA	O
were	O
creatinine	O
-	O
normalized	O
in	O
μg	O
/	O
g	O
creatinine	O
and	O
measured	O
twice	O
.	O

The	O
tailing	O
reactions	O
including	O
2	O
µg	O
RNA	O
samples	O
(	O
500	O
ng	O
/	O
µl	O
),	O
4	O
µl	O
of	O
5	O
×	O
Escherichia	O
coli	O
poly	O
(	O
A	O
)	O
polymerase	O
(	O
E	O
-	O
PAP	O
)	O
buffer	O
,	O
2	O
µl	O
of	O
25	O
mM	O
-	O
MgCl2	O
,	O
2	O
µl	O
of	O
10	O
mM	O
-	O
ATP	O
and	O
0	O
.	O
8	O
µl	O
E	O
-	O
PAP	O
(	O
2	O
U	O
/	O
µl	O
)	O
adjusted	O
to	O
20	O
µl	O
with	O
nuclease	O
-	O
free	O
water	O
.	O

In	O
conclusion	O
,	O
our	O
study	O
revealed	O
that	O
children	O
born	O
with	O
low	O
weight	O
presents	O
detriment	O
of	O
the	O
cardiac	O
vagal	O
autonomic	O
modulation	O
.	O

Conclusions	O
In	O
conclusion	O
,	O
in	O
this	O
large	O
-	O
scale	O
cohort	O
of	O
Swedish	O
women	O
we	O
found	O
that	O
a	O
frequent	O
consumption	O
of	O
fish	O
,	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
fatty	O
acids	O
appears	O
to	O
reduce	O
the	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Studies	O
focused	O
on	O
high	O
-	O
risk	O
populations	O
,	O
for	O
example	O
,	O
veiled	O
,	O
dark	O
-	O
skinned	O
or	O
obese	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
report	O
between	O
50	O
and	O
94	O
%	O
of	O
women	O
to	O
be	O
vitamin	O
D	O
deficient	O
[	O
8	O
–	O
10	O
].	O

By	O
contrast	O
,	O
in	O
normal	O
weight	O
mothers	O
,	O
lower	O
fat	O
intake	O
(	O
and	O
higher	O
carbohydrate	O
intake	O
)	O
early	O
in	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

Research	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
reproduction	O
process	O
modulation	O
seems	O
especially	O
interesting	O
;	O
their	O
conclusions	B
presumably	B
have	O
a	O
significant	O
practical	O
meaning	O
in	O
infertility	O
treatment	O
,	O
a	O
serious	O
medical	O
problem	O
affecting	O
up	O
to	O
53	O
million	O
people	O
worldwide	O
[	O
8	O
].	O

We	O
generated	O
the	O
following	O
four	O
experimental	O
groups	O
:	O
Male	O
offspring	O
from	O
control	O
diet	O
-	O
fed	O
dams	O
(	O
CC	O
male	O
;	O
n	O
=	O
15	O
);	O
Male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
(	O
RC	O
male	O
;	O
n	O
=	O
23	O
);	O
Female	O
offspring	O
from	O
control	O
diet	O
-	O
fed	O
dams	O
(	O
CC	O
female	O
;	O
n	O
=	O
16	O
);	O
and	O
Female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
(	O
RC	O
female	O
;	O
n	O
=	O
23	O
).	O

Table	O
1provides	O
the	O
baseline	O
sample	O
characteristics	O
.	O

Furthermore	O
,	O
genes	O
participating	O
in	O
'	O
Wnt	O
signaling	O
'	O
were	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
perinatal	O
piglets	O
.	O

When	O
surgery	O
is	O
planned	O
during	O
pregnancy	O
,	O
it	O
is	O
important	O
to	O
consider	O
both	O
gestational	O
age	O
and	O
the	O
type	O
of	O
general	O
anaesthesia	O
.	O

Safety	O
of	O
Asthma	O
and	O
Allergy	O
Medication	O
in	O
Pregnancy	O
The	O
ideal	O
situation	O
during	O
pregnancy	O
is	O
"	O
no	O
pharmacological	O
therapy	O
,"	O
especially	O
during	O
the	O
first	O
trimester	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Moreover	O
,	O
it	O
fails	O
to	O
bind	O
glucocorticoids	O
and	O
activate	O
subsequent	O
transcriptional	O
events	O
[	O
24	O
].	O

Ethics	O
approval	O
was	O
obtained	O
from	O
Central	O
Northern	O
Adelaide	O
Health	O
Service	O
Ethics	O
of	O
Human	O
Research	O
Committee	O
on	O
2	O
September	O
2005	O
(	O
ethics	O
number	O
REC	O
1714	O
/	O
5	O
/	O
2008	O
)	O
and	O
Northern	O
Region	O
Ethics	O
Committee	O
,	O
in	O
Auckland	O
on	O
23	O
April	O
2003	O
(	O
ethics	O
number	O
AKX	O
/	O
02	O
/	O
00	O
/	O
364	O
).	O

Male	O
adult	O
offspring	O
(	O
n	O
=	O
8	O
)	O
were	O
compared	O
to	O
control	O
male	O
(	O
n	O
=	O
8	O
).	O

Conclusions	O
The	O
present	O
trial	O
showed	O
that	O
consuming	O
2000	O
IU	O
vitamin	O
D3daily	O
during	O
late	O
pregnancy	O
was	O
effective	O
in	O
decreasing	O
perinatal	O
depression	O
levels	O
.	O

The	O
costing	O
reported	O
here	O
includes	O
distribution	O
of	O
supplements	O
,	O
health	O
staff	O
training	O
,	O
production	O
and	O
distribution	O
of	O
educational	O
materials	O
and	O
regular	O
monitoring	O
.	O

Because	B
the	O
poor	O
vitamin	O
D	O
stores	O
of	O
the	O
mother	O
may	O
impair	O
vitamin	O
D	O
state	O
in	O
the	O
infant	O
,	O
it	O
is	O
important	O
to	O
know	O
whether	O
rickets	O
can	O
be	O
prevented	O
in	O
breast	O
fed	O
infants	O
by	O
supplementation	O
of	O
the	O
mother	O
.	O

For	O
the	O
IG	O
,	O
the	O
PTH	O
was	O
significantly	O
lower	O
and	O
Ca	O
was	O
significantly	O
higher	O
after	O
the	O
intervention	O
.	O

The	O
reason	B
why	O
low	O
birth	O
weight	O
promotes	O
alterations	O
in	O
cardiac	O
ANS	O
activity	O
among	O
health	O
individuals	O
is	O
unknown	O
.	O

Thus	O
far	O
,	O
the	O
major	O
evidence	O
in	O
support	O
of	O
a	O
seasonal	O
effect	O
involves	O
farming	O
,	O
allergies	O
/	O
immunity	O
,	O
viruses	O
,	O
and	O
vitamin	O
D	O
.	O
Other	O
possible	O
factors	O
related	O
to	O
seasonal	O
birth	O
are	O
diet	O
,	O
birth	O
weight	O
,	O
and	O
handedness	O
.	O

The	O
limited	O
number	O
and	O
effectiveness	O
of	O
available	O
interventions	O
for	O
preterm	O
prevention	O
further	O
underscores	B
this	O
critical	O
major	O
knowledge	O
gap	O
,	O
and	O
makes	B
the	I
case	I
for	O
a	O
strategic	O
and	O
coordinated	O
research	O
effort	O
to	O
advance	O
understanding	O
of	O
causes	O
and	O
mechanisms	O
of	O
preterm	O
birth	O
and	O
identification	O
of	O
innovative	O
solutions	O
.	O

Experimental	O
Section	O
2	O
.	O
1	O
.	O

In	O
male	O
patients	O
,	O
the	O
VDR	O
was	O
found	O
in	O
testicles	O
and	O
spermatozoa	O
.	O

Mothers	O
were	O
asked	O
to	O
return	O
the	O
supplements	O
bottles	O
at	O
the	O
final	O
visit	O
.	O

The	O
central	O
team	O
will	O
train	O
the	O
field	O
team	O
and	O
monitor	O
the	O
process	O
of	O
delivery	O
of	O
the	O
intervention	O
.	O

Brandenburg	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Infant	O
gut	O
microbiome	O
cluster	O
is	O
influenced	O
by	O
maternal	O
dietOR	O
(	O
95	O
%	O
confidence	O
interval	O
)	O
1	O
,	O
2Dietary	O
factorCluster	O
2Cluster	O
3aMED	O
score1	O
.	O
31	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
89	O
)	O
0	O
.	O
96	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
27	O
)	O
Dairy0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
37	O
)	O
0	O
.	O
84	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
18	O
)	O
Fruit2	O
.	O
73	O
(	O
1	O
.	O
36	O
,	O
5	O
.	O
46	O
)	O
31	O
.	O
61	O
(	O
0	O
.	O
97	O
,	O
2	O
.	O
68	O
)	O
3Vegetables0	O
.	O
88	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
28	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
11	O
)	O
Whole	O
grains0	O
.	O
94	O
(	O
0	O
.	O
36	O
,	O
2	O
.	O
41	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
57	O
,	O
2	O
.	O
13	O
)	O
Fish	O
and	O
seafood0	O
.	O
67	O
(	O
0	O
.	O
01	O
,	O
32	O
.	O
26	O
)	O
0	O
.	O
50	O
(	O
0	O
.	O
02	O
,	O
12	O
.	O
57	O
)	O
Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
49	O
(	O
0	O
.	O
20	O
,	O
1	O
.	O
20	O
)	O
0	O
.	O
48	O
(	O
0	O
.	O
24	O
,	O
0	O
.	O
96	O
)	O
Red	O
and	O
processed	O
meat4	O
.	O
39	O
(	O
0	O
.	O
82	O
,	O
23	O
.	O
47	O
)	O
2	O
.	O
35	O
(	O
0	O
.	O
62	O
,	O
8	O
.	O
95	O
)	O
Polyunsaturated	O
fat0	O
.	O
84	O
(	O
0	O
.	O
65	O
,	O
1	O
.	O
09	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
72	O
,	O
1	O
.	O
06	O
)	O
EPA0	O
.	O
24	O
(	O
0	O
.	O
00	O
,	O
72	O
.	O
57	O
)	O
4	O
.	O
13	O
(	O
0	O
.	O
08	O
,	O
217	O
.	O
72	O
)	O
DHA0	O
.	O
15	O
(	O
0	O
.	O
00	O
,	O
62	O
.	O
82	O
)	O
2	O
.	O
66	O
(	O
0	O
.	O
04	O
,	O
158	O
.	O
91	O
)	O
MUFA	O
:	O
SFA	O
ratio1	O
.	O
64	O
(	O
0	O
.	O
15	O
,	O
17	O
.	O
73	O
)	O
1	O
.	O
78	O
(	O
0	O
.	O
26	O
,	O
12	O
.	O
28	O
)	O
1Models	O
include	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
)	O
2Cluster	O
1	O
is	O
the	O
reference	O
group	O
3Corresponds	O
to	O
Fig	O
.	O

Cox	O
proportional	O
hazards	O
mixed	O
models	O
will	O
be	O
used	O
for	O
mortality	O
outcomes	O
&	O
will	O
include	O
groundwater	O
iron	O
level	O
as	O
an	O
interaction	O
term	O
in	O
the	O
mortality	O
model	O
.	O

In	O
conclusion	O
,	O
the	O
present	O
findings	O
provide	O
insight	O
into	O
the	O
relationship	O
between	O
maternal	O
vitamin	O
D	O
deficiency	O
and	O
the	O
occurrence	O
of	O
a	O
greater	O
number	O
of	O
glomeruli	O
in	O
offspring	O
.	O

Inhibitory	O
processes	O
are	O
shown	O
in	O
red	O
and	O
positive	O
in	O
green	O
.	O

Maternal	O
and	O
cord	O
blood	O
were	O
collected	O
for	O
determining	O
the	O
25	O
(	O
OH	O
)	O
D	O
level	O
.	O

Furthermore	O
,	O
the	O
common	O
practice	O
of	O
swaddling	O
infants	O
might	O
reduce	O
exposure	O
to	O
sunlight	O
.	O
2Thus	B
young	O
children	O
are	O
at	O
a	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Therefore	B
,	O
vitamin	O
D	O
status	O
may	O
be	O
important	O
in	O
populations	O
where	O
dietary	O
calcium	O
intake	O
is	O
low	O
which	O
is	O
unlikely	B
in	O
the	O
population	O
of	O
women	O
studied	O
here	O
.	O

The	O
serum	O
samples	O
were	O
used	O
to	O
measure	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
,	O
paratormone	O
(	O
PTH	O
),	O
calcium	O
and	O
phosphorus	O
.	O

Children	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
mean	O
25	O
(	O
OH	O
)	O
D	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
),	O
calcium	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
albumin	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
,	O
and	O
significantly	O
higher	O
parathyroid	O
hormone	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
than	O
those	O
caries	O
-	O
free	O
.	O

Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
file	O
PubMed	O
Central	O
:	O

Methods	O
2	O
.	O
1	O
.	O

1RRs	O
and	O
95	O
%	O
CIs	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

Dermatologists	O
should	O
be	O
aware	O
of	O
the	O
distinguishing	O
features	O
of	O
scattered	O
bone	O
formation	O
and	O
diffuse	O
capillary	O
proliferation	O
of	O
AAOC	O
rather	O
than	O
the	O
lobular	O
aggregates	O
in	O
PG	O
.	O

Data	O
Analysis	O
The	O
primary	O
outcome	O
of	O
interest	O
was	O
based	O
on	O
structured	O
observation	O
data	O
and	O
reflects	O
the	O
proportion	O
of	O
intervention	O
-	O
recommended	O
times	O
at	O
which	O
one	O
or	O
both	O
hands	O
were	O
washed	O
with	O
soap	O
.	O

These	O
results	O
suggest	O
that	O
visfatin	O
may	O
play	O
an	O
important	O
role	O
in	O
maternal	O
-	O
fetal	O
metabolic	O
interaction	O
.	O

To	O
account	O
for	O
variation	O
in	O
RNA	O
input	O
and	O
efficiency	O
of	O
reverse	O
transcription	O
the	O
calculated	O
mRNA	O
copy	O
numbers	O
were	O
normalized	O
by	O
dividing	O
with	O
a	O
normalization	O
factor	O
derived	O
from	O
the	O
expression	O
of	O
the	O
reference	O
gene	O
.	O

Ultimately	O
,	O
the	O
mature	O
gametes	O
come	O
together	O
to	O
enable	O
the	O
cycle	O
to	O
begin	O
again	O
and	O
so	O
on	O
.	O

Even	O
in	O
adulthood	O
the	O
same	O
epigenetic	O
processes	O
drive	O
cell	O
proliferation	O
,	O
differentiation	O
,	O
function	O
and	O
adaptation	O
.	O

[	O
24	O
]	O
and	O
Hibbeln	O
et	O
al	O
.	O

Due	O
to	O
the	O
guidelines	O
for	O
providing	O
vitamin	O
D	O
supplements	O
to	O
all	O
breast	O
-	O
fed	O
infants	O
,	O
it	O
is	O
not	O
ethically	O
possible	O
to	O
conduct	O
a	O
placebo	O
-	O
controlled	O
study	O
of	O
vitamin	O
D	O
supplementation	O
in	O
the	O
United	O
States	O
.	O

These	O
results	O
are	O
similar	O
to	O
ours	O
,	O
with	O
slightly	O
higher	O
25	O
(	O
OH	O
)	O
D	O
values	O
found	O
in	O
the	O
Greer	O
study	O
.	O

Finally	O
,	O
thyroid	O
cancer	O
patients	O
often	B
undergo	O
total	O
thyroidectomy	O
and	O
thus	B
need	O
adequate	O
supplementation	O
of	O
both	O
calcium	O
and	O
thyroxine	O
.	O

Acryomns	O
used	O
:	O
ANC	O
=	O
Antenatal	O
care	O
;	O
DTP3	O
=	O
Three	O
doses	O
of	O
diphtheria	O
,	O
tetanus	O
and	O
pertussis	O
vaccine	O
.	O

While	O
the	O
urban	O
/	O
rural	O
gradient	O
in	O
rickets	O
is	O
well	B
known	I
and	O
was	O
one	O
of	O
the	O
keys	O
to	O
discovering	O
that	O
sunlight	O
prevented	O
rickets	O
,	O
less	O
well	O
known	O
is	O
a	O
meta	O
-	O
analysis	O
showing	O
a	O
twofold	O
urban	O
/	O
rural	O
gradient	O
for	O
autism	O
(	O
18	O
).	O

Risk	O
factors	O
for	O
gestational	O
diabetes	O
mellitus	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
diagnosed	O
with	O
the	O
disease	O
Background	O
The	O
known	O
risk	O
factors	O
for	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
)	O
are	O
advanced	O
age	O
(≥	O
35	O
yrs	O
.	O

(	O
2016	O
),	O
found	O
an	O
association	O
between	O
PCB	O
153	O
and	O
low	O
birth	O
weight	O
[	O
21	O
]	O
whereas	O
Lenters	O
et	O
al	O
.	O

The	O
same	O
relationship	O
was	O
observed	O
for	O
women	O
with	O
9	O
–	O
12	O
years	O
of	O
formal	O
education	O
regarding	O
folic	O
acid	O
use	O
(	O
p	O
<	O
.	O
001	O
),	O
iron	O
(	O
p	O
=	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
).	O

The	O
mucosal	O
microbe	O
sample	O
is	O
taken	O
approximately	O
±	O
3	O
cm	O
into	O
the	O
anal	O
canal	O
,	O
beyond	O
the	O
anal	O
verge	O
.	O

Baseline	O
characteristics	O
of	O
recruited	O
(	O
n	O
=	O
293	O
)	O
and	O
non	O
-	O
recruited	O
(	O
n	O
=	O
128	O
)	O
women	O
are	O
summarised	O
inTable	O
2	O
.	O

Methods	O
.	O

Residual	O
placental	O
tissues	O
were	O
obtained	O
from	O
479	O
patients	O
delivering	O
at	O
the	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
),	O
from	O
September	O
2008	O
through	O
September	O
2009	O
.	O

At	O
least	O
two	O
physicians	O
will	O
independently	O
review	O
the	O
data	O
,	O
and	O
they	O
will	O
base	O
their	O
decision	O
on	O
an	O
agreement	O
.	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

The	O
methylation	O
status	O
for	O
each	O
individual	O
CpG	O
locus	O
was	O
calculated	O
as	O
the	O
ratio	O
of	O
fluorescent	O
signals	O
:	O
β	O
=	O
max	O
(	O
M	O
,	O
0	O
)/[	O
max	O
(	O
M	O
,	O
0	O
)	O
+	O
max	O
(	O
U	O
,	O
0	O
)	O
+	O
100	O
],	O
using	O
the	O
average	O
probe	O
intensity	O
for	O
the	O
methylated	O
(	O
M	O
)	O
and	O
unmethylated	O
(	O
U	O
)	O
alleles	O
.	O

The	O
"	O
high	O
level	O
symptoms	O
group	O
"	O
included	O
women	O
with	O
frequent	O
experiences	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(≥	O
3	O
"	O
almost	O
always	O
"	O
or	O
"	O
often	O
"	O
answers	O
).	O

Given	B
that	O
this	O
is	O
the	O
first	O
study	O
to	O
be	O
conducted	O
among	O
pregnant	O
women	O
,	O
and	O
that	O
pre	O
-	O
pregnancy	O
BMI	O
may	O
reasonably	B
be	O
considered	O
a	O
confounder	O
or	O
a	O
covariate	O
along	O
the	O
causal	O
pathway	O
between	O
maternal	O
habitual	O
sleep	O
behaviors	O
and	O
GDM	O
,	O
we	O
were	O
careful	O
to	O
assess	O
the	O
potential	O
independent	O
contributions	O
of	O
the	O
sleep	O
variables	O
(	O
from	O
pre	O
-	O
pregnancy	O
BMI	O
).	O

Food	O
intake	O
and	O
body	O
weight	O
of	O
the	O
dams	O
and	O
pups	O
were	O
3	O
–	O
4	O
days	O
per	O
week	O
and	O
/	O
or	O
weekly	O
measured	O
along	O
lactation	O
and	O
post	O
-	O
weaning	O
periods	O
(	O
infancy	O
,	O
adolescence	O
,	O
and	O
adulthood	O
).	O

Evidence	O
abounds	O
on	O
their	O
effectiveness	O
in	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

Objectives	O
To	O
determine	O
if	O
the	O
reported	O
inverse	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
could	O
be	O
replicated	O
at	O
MUSC	O
,	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
.	O

On	O
initial	O
presentation	O
,	O
her	O
BP	O
was	O
94	O
/	O
30	O
mmHg	O
,	O
heart	O
rate	O
71	O
beats	O
/	O
min	O
,	O
respiratory	O
rate	O
16	O
breaths	O
/	O
min	O
,	O
oxygen	O
saturation	O
99	O
%	O
on	O
room	O
air	O
,	O
and	O
temperature	O
of	O
95	O
.	O
3	O
°	O
F	O
(	O
35	O
.	O
1	O
°	O
C	O
).	O

The	O
dose	O
-	O
response	O
effects	O
observed	O
here	O
suggest	O
the	O
need	O
to	O
study	O
methods	O
to	O
evaluate	O
exposure	O
and	O
achieve	O
optimal	O
dosage	O
effects	O
in	O
future	O
research	O
.	O

Exploratory	O
analyses	O
examined	O
whether	O
treatment	O
condition	O
(	O
intervention	O
versus	O
standard	O
care	O
)	O
interacted	O
with	O
dietary	O
variables	O
and	O
physical	O
activity	O
in	O
predicting	O
offspring	O
weight	O
status	O
.	O

However	O
,	O
no	O
differences	O
in	O
body	O
weight	O
between	O
CC	O
and	O
RC	O
females	O
were	O
found	O
.	O

When	O
then	O
we	O
stratified	O
by	O
overweight	O
/	O
obesity	O
status	O
,	O
we	O
found	O
that	O
among	O
women	O
with	O
BMI	O
>	O
25	O
kg	O
/	O
m2	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
-	O
adjusted	O
OR	O
4	O
.	O
1	O
,	O
95	O
%	O
CI	O
2	O
.	O
7	O
,	O
6	O
.	O
3	O
)	O
and	O
later	O
in	O
pregnancy	O
(	O
OR	O
2	O
.	O
5	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
6	O
,	O
3	O
.	O
7	O
).	O

Fetuses	O
of	O
LP	O
-	O
fed	O
dams	O
showed	O
a	O
numerically	O
lowered	O
weight	O
compared	O
to	O
AP	O
fetuses	O
at	O
94	O
dpc	O
(	O
LP	O
:	O
661	O
±	O
115	O
g	O
,	O
and	O
AP	O
:	O
711	O
±	O
118	O
g	O
,	O
respectively	O
;	O
P	O
=	O
0	O
.	O
12	O
;	O
n	O
=	O
32	O
).	O

In	O
non	O
-	O
pregnant	O
adult	O
populations	O
,	O
conflicting	O
results	O
have	O
been	O
reported	O
regarding	O
seasonal	O
variation	O
HbA1c	O
(	O
a	O
measure	O
that	O
reflects	O
average	O
circulating	O
blood	O
glucose	O
concentrations	O
for	O
the	O
previous	O
90	O
days	O
)	O
and	O
glucose	O
concentrations	O
among	O
individuals	O
with	O
type	O
2	O
diabetes	O
[	O
19	O
,	O
43	O
].	O

The	O
functional	O
groups	O
are	O
added	O
or	O
removed	O
by	O
a	O
range	O
of	O
enzymes	O
:	O
acetylases	O
,	O
methyltransferases	O
,	O
kinases	O
,	O
ADP	O
ribosyltransferases	O
,	O
ubiquitin	O
ligases	O
,	O
sumo	O
ligases	O
;	O
and	O
deacteylases	O
,	O
demethylases	O
,	O
phosphatases	O
,	O
ADP	O
ribosyl	O
hydrolases	O
,	O
deubiquitinases	O
,	O
sumo	O
deconjugating	O
enzymes	O
,	O
respectively	O
(	O
Wang	O
&	O
Dasso2009	O
;	O
Khare	O
et	O
al	O
.	O
2012	O
).	O

Interpretation	O
of	O
the	O
effect	O
of	O
supplementation	O
on	O
ESR	O
is	O
complex	O
(	O
Breckenridge	O
and	O
Okpanachi	O
1976	O
)	O
but	O
the	O
reduction	O
in	O
ESR	O
following	O
supplementation	O
could	O
indicate	O
a	O
ameliorating	O
effect	O
of	O
MMN	O
on	O
systemic	O
inflammation	O
.	O

Scope	O
of	O
the	O
Integrated	O
Child	O
Development	O
Scheme	O
in	O
Ensuring	O
Holistic	O
Development	O
of	O
the	O
Child	O
Dear	O
Editor	O
-	O
In	O
-	O
Chief	O
The	O
Government	O
of	O
India	O
launched	O
Integrated	O
Child	O
Development	O
Services	O
Scheme	O
(	O
ICDS	O
)	O
in	O
the	O
year	O
1975	O
to	O
prevent	O
malnutrition	O
in	O
children	O
,	O
reduce	O
infant	O
mortality	O
rate	O
,	O
and	O
empower	O
the	O
mothers	O
to	O
ensure	O
holistic	O
development	O
of	O
the	O
child	O
(	O
1	O
).	O

Chailurkit	O
et	O
al	O
.	O

2002	O
;	O
Jaenisch	O
1997	O
;	O
Rougier	O
et	O
al	O
.	O

DISCUSSION	O
We	O
found	O
the	O
same	O
results	O
as	O
studies	O
in	O
Europe	O
and	O
North	O
America	O
,	O
which	O
implicates	B
lower	O
serum	O
vitamin	O
D	O
level	O
in	O
MS	O
patients	O
than	O
in	O
normal	O
population	O
,	O
in	O
spite	O
of	O
sufficient	O
sun	O
exposure	O
in	O
Isfahan	O
region	O
.	O
23815The	O
hypothesis	O
that	O
vitamin	O
D	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
MS	O
was	O
first	O
proposed	O
over	O
30	O
years	O
ago4and	O
gained	B
credibility	I
after	O
the	O
discovery	O
of	O
the	O
immunomodulatory	O
effects	O
of	O
vitamin	O
D	O
.	O
5Moreover	O
,	O
in	O
the	O
past	O
few	O
years	O
,	O
the	O
epidemiological	O
evidence	O
of	O
an	O
increased	O
MS	O
risk	O
among	O
individuals	O
with	O
low	O
vitamin	O
D	O
concentrations	O
has	O
achieved	B
substantial	I
strength	I
.	O

Therefore	B
,	O
current	O
studies	O
are	O
inconsistent	O
in	O
their	O
results	O
and	O
conclusions	O
on	O
the	O
effects	O
of	O
dietary	O
protein	O
levels	O
affect	O
IMF	O
deposition	O
.	O

The	O
effect	O
of	O
maternal	O
diet	O
on	O
child	O
leukemia	O
risk	O
has	O
not	O
been	O
rigorously	O
studied	O
;	O
the	O
few	O
studies	O
that	O
have	O
been	O
done	O
have	O
focused	O
on	O
specific	O
dietary	O
factors	O
,	O
and	O
the	O
results	O
have	O
been	O
mixed	O
.	O

However	O
,	O
we	O
detected	O
a	O
main	O
effect	O
of	O
treatment	O
on	O
chocolate	O
intake	O
[	O
F	O
(	O
3	O
,	O
30	O
)=	O
9	O
.	O
917	O
,	O
P	O
<	O
0	O
.	O
01	O
]	O
and	O
total	O
caloric	O
intake	O
[	O
F	O
(	O
3	O
,	O
30	O
)=	O
11	O
.	O
189	O
,	O
P	O
<	O
0	O
.	O
01	O
].	O

Subsequent	O
analyses	O
were	O
performed	O
using	O
R	O
version	O
3	O
.	O
2	O
.	O
2	O
[	O
42	O
].	O

This	O
instrument	O
was	O
based	O
upon	O
a	O
previously	O
piloted	O
questionnaire	O
[	O
14	O
].	O

The	O
shift	O
towards	O
an	O
earlier	O
puberty	O
may	O
represent	B
a	O
life	O
course	O
strategy	B
[	O
10	O
]	O
intended	O
to	O
preserve	O
fitness	O
[	O
36	O
],[	O
41	O
]	O
by	O
reducing	O
the	O
risk	O
of	O
death	O
before	O
reproducing	O
,	O
or	O
by	O
allowing	O
a	O
greater	O
number	O
of	O
successful	O
reproductive	O
episodes	O
before	O
death	O
.	O

Fertility	O
-	O
assisted	O
pregnancies	O
,	O
twin	O
/	O
triplet	O
pregnancies	O
or	O
pregnancies	O
with	O
known	O
outcomes	O
at	O
the	O
initial	O
time	O
of	O
contact	O
(	O
eg	O
,	O
contacted	O
Motherisk	O
following	O
the	O
birth	O
,	O
reported	O
abnormal	O
pregnancy	O
screening	O
tests	O
and	O
/	O
or	O
ultrasounds	O
)	O
were	O
excluded	O
from	O
the	O
exposed	O
and	O
comparison	O
groups	O
.	O

Out	O
of	O
which	O
,	O
79	O
women	O
(	O
42	O
.	O
9	O
%)	O
scored	O
<	O
9	O
,	O
90	O
women	O
(	O
57	O
.	O
1	O
%)	O
scored	O
9	O
–	O
13	O
and	O
15	O
women	O
(	O
8	O
.	O
2	O
%)	O
scored	O
>	O
13	O
.	O

To	O
counteract	O
the	O
growing	O
incidence	O
of	O
obesity	O
,	O
interventions	O
must	O
adopt	O
an	O
approach	O
that	O
grasps	O
the	O
interplay	O
of	O
economic	O
,	O
social	O
,	O
behavioral	O
,	O
biomedical	O
,	O
and	O
environmental	O
influences	O
.	O

Bacterial	O
culture	O
of	O
nasopharyngeal	O
swab	O
At	O
1	O
month	O
of	O
age	O
,	O
specimens	O
were	O
collected	O
through	O
the	O
nose	O
with	O
a	O
cotton	O
-	O
tipped	O
swab	O
(	O
Copan	O
Swab	O
Applicator	O
,	O
Copan	O
Diagnostics	O
,	O
Brescia	O
,	O
Italy	O
).	O

Findings	O
in	O
this	O
study	O
indicate	O
that	O
children	O
with	O
autism	O
had	O
a	O
significantly	O
higher	O
history	O
of	O
meconium	O
aspiration	O
syndrome	O
than	O
the	O
controls	O
[	O
43	O
].	O

Four	O
(	O
16	O
.	O
7	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
mild	O
vitamin	O
D	O
deficiency	O
,	O
which	O
was	O
reduced	O
to	O
one	O
(	O
4	O
.	O
2	O
%)	O
after	O
the	O
intervention	O
.	O

This	O
concept	O
is	O
supported	O
by	O
Oken	O
et	O
al	O
.	O

Follow	O
-	O
up	O
data	O
collection	O
began	O
in	O
January	O
2012	O
and	O
was	O
completed	O
by	O
September	O
2013	O
.	O

Thus	B
,	O
the	O
researchers	O
suggest	O
that	O
excess	O
iron	O
supplementation	O
can	O
cause	O
the	O
same	O
problems	O
it	O
is	O
supposed	O
to	O
correct	O
.	O

Results	O
3	O
.	O
1	O
.	O

Between	O
28	O
and	O
32	O
weeks	O
,	O
the	O
risks	O
and	O
benefits	O
of	O
early	O
delivery	O
should	O
be	O
considered	O
.	O

Results	O
HV	O
or	O
HFol	O
pup	O
diets	O
increased	O
brain	O
and	O
plasma	O
folate	O
concentrations	O
and	O
prevented	O
the	O
increase	O
in	O
food	O
intake	O
(	O
5	O
%,	O
P	O
=	O
0	O
.	O
03	O
),	O
body	O
weight	O
(	O
8	O
%,	O
P	O
=	O
0	O
.	O
0006	O
)	O
and	O
glucose	O
response	O
to	O
a	O
glucose	O
load	O
(	O
36	O
%,	O
P	O
=	O
0	O
.	O
02	O
)	O
found	O
in	O
those	O
fed	O
the	O
RV	O
diet	O
.	O

Only	O
24	O
.	O
2	O
%	O
of	O
all	O
pregnant	O
women	O
started	O
taking	O
multivitamins	O
before	O
pregnancy	O
,	O
while	O
46	O
.	O
6	O
%	O
of	O
these	O
women	O
started	O
taking	O
multivitamins	O
within	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

Environmentally	O
induced	O
epigenetic	O
toxicity	O
:	O
potential	O
public	O
health	O
concerns	O
AbstractAbstract	O
Throughout	O
our	O
lives	O
,	O
epigenetic	O
processes	O
shape	O
our	O
development	O
and	O
enable	O
us	O
to	O
adapt	O
to	O
a	O
constantly	O
changing	O
environment	O
.	O

Summary	O
Based	O
on	O
currently	O
available	O
evidence	O
,	O
guidelines	O
for	O
primary	O
and	O
secondary	O
prevention	O
of	O
allergic	O
disease	O
can	O
be	O
summarized	O
as	O
follows	O
(	O
Table3	O
).	O

Abstract	O
An	O
international	O
case	O
-	O
control	O
study	O
of	O
primary	O
pediatric	O
brain	O
tumors	O
included	O
interviews	O
with	O
mothers	O
of	O
cases	O
diagnosed	O
from	O
1976	O
to	O
1994	O
and	O
mothers	O
of	O
population	O
controls	O
.	O

All	O
are	O
assured	O
that	O
participation	O
is	O
voluntary	O
and	O
that	O
participation	O
or	O
non	O
-	O
participation	O
in	O
the	O
study	O
will	O
not	O
affect	O
their	O
clinical	O
care	O
.	O

Briefly	O
,	O
vitamin	O
D	O
concentrations	O
were	O
standardized	O
by	O
taking	O
the	O
difference	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
to	O
the	O
average	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
the	O
corresponding	O
month	O
.	O

The	O
total	O
mean	O
was	O
19	O
.	O
4	O
±	O
3	O
.	O
9	O
ng	O
/	O
mL	O
[	O
56	O
].	O

However	O
,	O
there	O
was	O
a	O
J	O
-	O
shaped	O
association	O
between	O
psychotic	O
-	O
like	O
symptoms	O
and	O
fatty	O
fish	O
(	O
herring	O
/	O
mackerel	O
and	O
salmon	O
-	O
type	O
fish	O
)	O
with	O
the	O
strongest	O
inverse	O
association	O
for	O
intermediate	O
dietary	O
intake	O
(	O
RR	O
:	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
66	O
-	O
0	O
.	O
98	O
),	O
whereas	O
a	O
high	O
intake	O
(	O
RR	O
:	O
1	O
.	O
90	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
34	O
-	O
2	O
.	O
70	O
)	O
of	O
fatty	O
fish	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
.	O

In	O
addition	O
,	O
lower	O
marginal	O
significant	O
chance	B
of	O
having	O
low	O
weight	O
infant	O
was	O
found	O
among	O
women	O
who	O
were	O
in	O
the	O
top	O
adherence	O
of	O
traditional	O
dietary	O
pattern	O
[	O
OR	O
0	O
.	O
76	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
32	O
-	O
1	O
.	O
77	O
),	O
P	O
=	O
0	O
.	O
05	O
]	O
in	O
the	O
crude	O
model	O
.	O

It	O
is	O
also	O
reasonable	B
to	O
add	O
nebulized	O
ipratropium	O
bromide	O
in	O
patients	O
who	O
do	O
not	O
respond	O
to	O
β2agonists	O
.	O

The	O
country	O
is	O
undergoing	O
a	O
rapid	O
nutrition	O
transition	O
characterised	O
by	O
changes	O
in	O
dietary	O
patterns	O
and	O
nutrient	O
intake	O
alongside	O
urbanisation	O
[	O
19	O
,	O
20	O
],	O
which	O
has	O
resulted	O
in	O
a	O
growing	O
double	O
-	O
burden	O
of	O
under	O
-	O
and	O
over	O
-	O
nutrition	O
[	O
20	O
,	O
21	O
].	O

Third	O
,	O
MS	O
risk	O
seems	O
to	O
decrease	O
with	O
migration	O
from	O
high	O
to	O
low	O
latitudes	O
.	O
15If	O
vitamin	O
D	O
had	O
any	O
effect	O
on	O
MS	O
risk	O
,	O
we	O
would	O
expect	O
MS	O
incidence	O
to	O
decrease	O
with	O
increasing	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

We	O
found	O
the	O
lowest	O
odds	O
of	O
SGA	O
among	O
women	O
with	O
the	O
highest	O
T3	O
25OHD	O
concentration	O
,	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

The	O
PFAS	O
levels	O
of	O
the	O
Faroese	O
women	O
were	O
comparable	O
to	O
levels	O
reported	O
for	O
pregnant	O
women	O
in	O
Denmark	O
and	O
lower	O
than	O
those	O
reported	O
for	O
a	O
group	O
of	O
U	O
.	O
S	O
.	O
pregnant	O
women	O
.	O
22	O
The	O
findings	O
echoed	O
a	O
2010	O
Danish	O
national	O
study	O
,	O
which	O
found	O
associations	O
between	O
higher	O
levels	O
of	O
PFASs	O
in	O
maternal	O
serum	O
samples	O
and	O
shorter	O
duration	O
of	O
breastfeeding	O
.	O
23Yet	O
the	O
Danish	O
study	O
found	O
that	O
this	O
association	O
held	O
true	B
only	O
for	O
multiparous	O
women	O
,	O
and	O
not	O
primiparous	O
mothers	O
.	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
extent	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
but	O
not	O
between	O
LINE	O
-	O
1	O
methylation	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
.	O

These	O
findings	O
show	O
that	O
higher	O
vitamin	O
D	O
status	O
is	O
significantly	O
associated	O
with	O
lower	O
PTB	O
risk	O
for	O
both	O
PTB	O
subtypes	O
and	O
that	O
vitamin	O
D	O
plays	O
an	O
important	O
role	O
in	O
the	O
underlying	O
causes	O
of	O
indicated	O
PTB	O
including	O
maternal	O
hypertension	O
,	O
pre	O
-	O
existing	O
diabetes	O
,	O
and	O
non	O
-	O
reassuring	O
fetal	O
status	O
.	O

Patients	O
with	O
medical	O
history	O
of	O
bone	O
mineral	O
metabolic	O
disease	O
,	O
liver	O
or	O
kidney	O
dysfunction	O
were	O
excluded	O
.	O

Additionally	O
,	O
RC	O
females	O
showed	O
lower	O
plasma	O
levels	O
of	O
leptin	O
,	O
total	O
cholesterol	O
,	O
LDL	O
,	O
and	O
bilirubin	O
than	O
RC	O
males	O
.	O

These	O
pregnancies	O
resulted	O
in	O
13	O
972	O
singleton	O
or	O
twin	O
children	O
who	O
were	O
alive	O
at	O
1	O
year	O
of	O
age	O
.	O

Only	O
in	O
situations	O
where	O
in	O
vitro	O
diagnosis	O
is	O
not	O
conclusive	O
and	O
the	O
mother	O
is	O
at	O
risk	O
for	O
developing	O
allergy	O
symptoms	O
should	O
in	O
vivo	O
skin	O
tests	O
be	O
used	O
.	O

Exclusion	O
criteria	O
were	O
avoiding	O
of	O
follow	O
-	O
up	O
during	O
the	O
study	O
and	O
current	O
-	O
smoker	O
women	O
.	O

This	O
corresponds	O
to	O
the	O
well	B
-	I
known	I
association	O
that	O
women	O
with	O
higher	O
BMI	O
tend	O
to	O
deliver	O
infants	O
with	O
higher	O
birth	O
weights	O
.	O
40	O
,	O
41	O
,	O
42	O
Furthermore	O
,	O
identification	O
and	O
recognition	O
of	O
women	O
and	O
infants	O
at	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
can	O
lead	B
to	I
opportunities	O
for	O
risk	O
modification	O
and	O
reduction	O
in	O
adverse	O
outcomes	O
.	O

Methylation	O
extent	O
was	O
calculated	O
as	O
the	O
mean	O
LINE	O
-	O
1	O
methylation	O
of	O
four	O
positions	O
in	O
the	O
element	O
and	O
mean	O
AluYb8	O
methylation	O
of	O
five	O
positions	O
in	O
the	O
element	O
.	O

2	O
.	O
3	O
.	O

Most	O
(~	O
90	O
%)	O
dietary	O
lipids	O
reach	O
the	O
duodenum	O
as	O
NEFAs	O
,	O
unless	O
they	O
are	O
protected	O
[	O
105	O
].	O

All	O
rights	O
reserved	O
PubMed	O
Central	O
:	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Frequency	O
of	O
distribution	O
of	O
health	O
topics	O
discussed	O
during	O
ANC	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
P	O
-	O
Value	O
of	O
the	O
different	O
service	O
satisfaction	O
rating	O
with	O
respect	O
to	O
the	O
educational	O
level	O
in	O
the	O
study	O
populationServicesFisher	O
'	O
s	O
exact	O
testp	O
-	O
valueReception0	O
.	O
091P	O
>	O
O	O
.	O
O5Sitting	O
area	O
comfort0	O
.	O
842Waiting	O
time4	O
.	O
357Staff	O
rapport1	O
.	O
838Competence	O
of	O
personnel0	O
.	O
672Health	O
talks5	O
.	O
43	O
Pregnancy	O
groups	O
There	O
was	O
a	O
statistically	O
significant	O
association	O
when	O
comparing	O
respondents	O
at	O
their	O
first	O
pregnancy	O
with	O
those	O
at	O
their	O
second	O
or	O
more	O
pregnancies	O
in	O
terms	O
of	O
their	O
satisfaction	O
ratings	O
;	O
the	O
sitting	O
area	O
comfort	O
(	O
F	O
=	O
7	O
.	O
052	O
;	O
P	O
=	O
0	O
.	O
04	O
),	O
competence	O
of	O
staff	O
(	O
F	O
=	O
8	O
.	O
92	O
,	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
health	O
talk	O
comprehensiveness	O
(	O
F	O
=	O
18	O
.	O
499	O
,	O
P	O
Number	O
of	O
Visits	O
at	O
the	O
time	O
of	O
study	O
There	O
was	O
no	O
statistically	O
significant	O
difference	O
when	O
the	O
service	O
rating	O
(	O
reception	O
,	O
sitting	O
area	O
comfort	O
,	O
waiting	O
time	O
,	O
staff	O
rapport	O
,	O
competence	O
of	O
personnel	O
and	O
health	O
talk	O
)	O
of	O
women	O
attending	O
their	O
second	O
visit	O
and	O
those	O
attending	O
subsequent	O
visits	O
was	O
compared	O
.	O

Antipsychotics	O
have	O
been	O
utilised	O
in	O
the	O
treatment	O
of	O
psychiatric	O
disorders	O
for	O
a	O
number	O
of	O
decades	O
.	O

Atopic	O
Eczema	O
(	O
Dermatitis	O
)	O
Gestational	O
itchy	O
dermatoses	O
are	O
relatively	O
common	O
,	O
with	O
eczema	O
being	O
diagnosed	O
in	O
30	O
%	O
to	O
50	O
%	O
of	O
all	O
cases	O
[	O
41	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Comparison	O
of	O
socio	O
-	O
demographic	O
characteristics	O
with	O
respondent	O
'	O
s	O
knowledge	O
about	O
when	O
to	O
start	O
ANC	O
visits	O
and	O
the	O
number	O
of	O
visitsSocio	O
-	O
demographic	O
characteristicFisher	O
'	O
s	O
exact	O
test	O
(	O
N	O
=	O
385	O
)	O
=	O
x	O
p	O
-	O
valueWhen	O
to	O
start	O
ANCMarital	O
status2	O
.	O
220	O
.	O
55Age	O
group16	O
.	O
560	O
.	O
09Pregnancy	O
number10	O
.	O
230	O
.	O
46Number	O
of	O
visit8	O
.	O
130	O
.	O
039	O
+	O
Educational	O
level7	O
.	O
690	O
.	O
27How	O
many	O
visits	O
to	O
attendMarital	O
status7	O
.	O
80	O
.	O
049	O
+	O
Age	O
group36	O
.	O
040	O
.	O
000	O
+	O
Pregnancy	O
number18	O
.	O
970	O
.	O
000	O
+	O
Number	O
of	O
visit1	O
.	O
0750	O
.	O
81Educational	O
level11	O
.	O
320	O
.	O
065	O
statistically	O
significant	O
Primigravida	O
,	O
younger	O
and	O
single	O
women	O
were	O
less	O
likely	B
to	O
know	O
how	O
many	O
ANC	O
visits	O
they	O
were	O
expected	O
to	O
attend	O
during	O
their	O
gestational	O
period	O
when	O
compared	O
to	O
older	O
and	O
multiparous	O
womenPTable	O
2	O
).	O

Briefly	O
,	O
DVD	O
-	O
deficient	O
neonates	O
had	O
larger	O
lateral	O
ventricles	O
,	O
increased	O
cellular	O
proliferation	O
and	O
reduced	O
apoptosis	O
,	O
altered	O
neurogenesis	O
,	O
reduced	O
density	O
of	O
neurotrophin	O
receptor	O
(	O
p75NTR	O
),	O
and	O
reduced	O
levels	O
of	O
nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
and	O
glial	O
cell	O
line	O
-	O
derived	O
growth	O
factor	O
(	O
GDNF	O
)	O
compared	O
to	O
controls	O
[	O
5	O
]–[	O
7	O
].	O

Strengths	O
and	O
limitations	O
A	O
potential	O
limitation	O
of	O
our	O
work	O
is	O
the	O
dichotomised	O
seasonal	O
divisions	O
.	O

After	O
this	O
incubation	O
,	O
three	O
10	O
-	O
minute	O
washes	O
were	O
followed	O
in	O
2xSSC	O
at	O
37	O
°	O
C	O
.	O

We	O
also	O
noted	O
that	O
associations	O
between	O
short	O
sleep	O
duration	O
and	O
GDM	O
risk	O
were	O
particularly	O
pronounced	O
among	O
overweight	O
women	O
(	O
far	O
right	O
column	O
of	O
Table2	O
).	O

For	O
example	O
,	O
we	O
have	O
shown	O
that	O
while	O
habituated	O
DVD	O
rats	O
have	O
normal	O
locomotion	O
activity	O
in	O
the	O
open	O
field	O
at	O
baseline	O
,	O
they	O
have	O
pronounced	O
hyperlocomotion	O
after	O
exposure	O
to	O
MK	O
-	O
801	O
[	O
10	O
],[	O
12	O
].	O

The	O
questionnaire	O
asked	O
about	O
their	O
current	O
weekly	O
frequency	O
of	O
consumption	O
of	O
43	O
food	O
groups	O
and	O
food	O
items	O
.	O

Because	O
the	O
G	O
allele	O
at	O
rs10741657	O
,	O
which	O
was	O
more	O
frequent	O
in	O
our	O
population	O
,	O
was	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
following	O
supplementation	O
,	O
it	O
could	O
be	O
postulated	O
that	O
this	O
allele	O
previously	O
conferred	O
an	O
evolutionary	O
advantage	O
to	O
prevent	O
vitamin	O
D	O
toxicity	O
.	O

Results	O
3	O
.	O
1	O
.	O

[	O
7	O
].	O

Multiple	O
regression	O
for	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
revealed	O
that	O
levels	O
were	O
significantly	O
and	O
independently	O
associated	O
with	O
S	O
-	O
ECC	O
,	O
regular	O
milk	O
consumption	O
,	O
and	O
season	O
of	O
assessment	O
but	O
not	O
household	O
income	O
and	O
or	O
the	O
use	O
of	O
vitamin	O
D	O
drops	O
(	O
Table	O
3	O
).	O

We	O
have	O
previously	O
shown	O
that	O
a	O
comprehensive	O
dietary	O
and	O
lifestyle	O
intervention	O
during	O
pregnancy	O
,	O
in	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
,	O
significantly	O
improves	O
both	O
maternal	O
diet	O
and	O
physical	O
activity	O
[	O
21	O
],	O
is	O
associated	O
with	O
an	O
18	O
and	O
41	O
%	O
relative	O
reduction	O
in	O
the	O
risk	O
of	O
high	O
infant	O
birth	O
weight	O
above	O
4	O
and	O
4	O
.	O
5	O
kg	O
[	O
22	O
,	O
23	O
],	O
and	O
was	O
a	O
cost	O
neutral	O
intervention	O
[	O
24	O
].	O

Three	O
factors	O
were	O
retained	O
,	O
based	O
on	O
the	O
screen	O
plot	O
,	O
an	O
eigenvalue	O
of	O
more	O
than	O
1	O
.	O
9	O
,	O
and	O
the	O
interpretability	O
of	O
the	O
derived	O
factors	O
and	O
of	O
the	O
earlier	O
literature	O
.	O

3	O
.	O
2	O
.	O

MM	O
:	O
Conception	O
and	O
design	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

Similarly	O
,	O
left	O
-	O
handedness	O
has	O
been	O
linked	O
to	O
congenital	O
adrenal	O
hyperplasia	O
,	O
a	O
condition	O
characterized	O
by	O
high	O
in	O
utero	O
levels	O
of	O
androgeizing	O
hormones	O
[	O
197	O
].	O

In	O
the	O
case	O
of	O
a	O
cohort	O
appearing	O
in	O
the	O
literature	O
multiple	O
times	O
only	O
the	O
most	O
recent	O
version	O
was	O
included	O
since	O
it	O
provided	O
the	O
largest	O
number	O
of	O
cases	O
and	O
the	O
longest	O
follow	O
-	O
up	O
.	O

Our	O
objectives	O
were	O
to	O
study	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
,	O
as	O
well	O
as	O
change	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
with	O
neonatal	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
no	O
competing	O
interests	O
(	O
financial	O
or	O
personal	O
)	O
exist	O
with	O
regards	O
to	O
this	O
manuscript	O
.	O

Oken	O
et	O
al	O
.	O

Between	O
March	O
and	O
July	O
2006	O
,	O
resident	O
females	O
aged	O
17	O
-	O
45y	O
were	O
identified	O
from	O
the	O
demographic	O
database	O
and	O
pre	O
-	O
randomised	O
to	O
receive	O
daily	O
supplementation	O
with	O
UNIMMAP	O
or	O
placebo	O
.	O

In	O
particular	O
,	O
stage	O
-	O
specific	O
feeding	O
programs	O
with	O
concentrate	O
-	O
based	O
diets	O
developed	O
by	O
Japan	O
and	O
Korea	O
are	O
described	O
in	O
this	O
article	O
.	O

Discussion	O
This	O
is	O
one	O
of	O
the	O
few	O
studies	O
to	O
prospectively	O
and	O
simultaneously	O
examine	O
the	O
impact	O
of	O
dietary	O
,	O
physical	O
activity	O
,	O
and	O
psychosocial	O
parameters	O
during	O
pregnancy	O
on	O
the	O
offspring	O
weight	O
status	O
of	O
overweight	O
/	O
obese	O
and	O
normal	O
weight	O
mothers	O
.	O

The	O
correlation	O
between	O
testosterone	O
and	O
VD	O
has	O
not	O
been	O
observed	O
yet	O
in	O
another	O
study	O
conducted	O
in	O
Denmark	O
on	O
307	O
fertile	O
men	O
.	O

In	O
fact	O
,	O
a	O
lower	O
than	O
expected	O
occurrence	O
of	O
skin	O
cancer	O
was	O
reported	O
among	O
individuals	O
with	O
MS	O
in	O
a	O
study	O
in	O
the	O
UK	O
.	O
38Month	O
of	O
birth	O
has	O
also	O
been	O
suggested	O
as	B
a	O
factor	O
that	O
affects	O
MS	O
risk	O
.	O

Using	O
model	O
organisms	O
and	O
using	O
a	O
phenotype	O
-	O
driven	O
approach	O
to	O
identify	O
causal	O
genes	O
underlying	O
spinal	O
deformities	O
can	O
overcome	O
some	O
of	O
the	O
limitations	O
to	O
studying	O
the	O
genetic	O
basis	O
of	O
these	O
syndromes	O
.	O

BHLM	O
,	O
because	O
it	O
is	O
a	O
shrinkage	O
method	O
,	O
is	O
also	O
prone	B
to	O
higher	O
Type	O
II	O
errors	O
.	O

Allergies	O
and	O
Immunity	O
The	O
perinatal	O
period	O
represents	O
a	O
time	O
of	O
heightened	O
sensitivity	O
to	O
environmental	O
allergens	O
[	O
51	O
,	O
52	O
].	O

In	O
the	O
few	O
women	O
in	O
our	O
sample	O
(<	O
25	O
%)	O
who	O
reported	O
receiving	O
provider	O
advice	O
on	O
appropriate	O
weight	O
gain	O
,	O
31	O
%	O
received	O
recommendations	O
in	O
excess	O
of	O
current	O
clinical	O
guidelines	O
.	O

Optimising	O
the	O
pre	O
-	O
and	O
inter	O
-	O
pregnancy	O
micronutritional	O
status	O
of	O
women	O
,	O
particularly	O
in	O
low	O
resource	O
settings	O
could	O
be	O
extremely	O
beneficial	O
(	O
Allen	O
2000	O
,	O
Bartley	O
et	O
al	O
2005	O
,	O
Huffman	O
SL	O
et	O
al	O
1998	O
,	O
Owens	O
and	O
Fall	O
2008	O
)	O
and	O
may	O
lead	O
to	O
improved	O
subsequent	O
maternal	O
and	O
pregnancy	O
outcomes	O
.	O

One	O
week	O
later	O
,	O
subjects	O
returned	O
to	O
the	O
research	O
facility	O
for	O
whole	O
body	O
dual	O
-	O
energy	O
x	O
-	O
ray	O
absorptiometry	O
(	O
DXA	O
)	O
measurements	O
and	O
to	O
receive	O
the	O
vitamin	O
D	O
supplements	O
(	O
400	O
IU	O
/	O
mL	O
)	O
with	O
instructions	O
to	O
give	O
daily	O
by	O
mouth	O
until	O
the	O
final	O
study	O
visit	O
.	O

During	O
gestation	O
,	O
fetal	O
demand	O
for	O
calcium	O
increases	O
and	O
it	O
is	O
imperative	O
that	O
maternal	O
vitamin	O
D	O
status	O
remain	O
adequate	O
to	O
support	O
increased	O
calcium	O
absorption	O
from	O
the	O
gut	O
[	O
54	O
].	O

For	O
example	O
,	O
their	O
skin	O
surface	O
area	O
is	O
comparatively	O
larger	O
and	O
more	O
permeable	O
to	O
lipophilic	O
compounds	O
,	O
which	O
serves	O
to	O
maximize	O
the	O
absorption	O
of	O
compounds	O
such	O
as	O
pesticides	O
into	O
the	O
bloodstream	O
[	O
35	O
–	O
37	O
].	O

[	O
35	O
]	O
Maternal	O
vitamin	O
D	O
deficiency	O
also	O
has	O
been	O
associated	O
with	O
craniotabes	O
,[	O
35	O
]	O
a	O
softening	O
of	O
skull	O
bones	O
that	O
is	O
one	O
of	O
the	O
earliest	O
signs	O
of	O
vitamin	O
D	O
deficiency	O
,	O
in	O
a	O
case	O
study	O
with	O
neonatal	O
seizures	O
of	O
a	O
hypocalcemic	O
infant	O
and	O
with	O
impaired	O
skeletal	O
development	O
in	O
utero	O
.	O

Similarly	O
,	O
as	O
the	O
percentage	O
of	O
calories	O
from	O
fat	O
and	O
carbohydrates	O
was	O
highly	O
correlated	O
(	O
r	O
=	O
−.	O
90	O
;	O
P	O
=	O
.	O
0001	O
),	O
only	O
the	O
percentage	O
of	O
calories	O
from	O
fat	O
was	O
used	O
in	O
initial	O
modeling	O
.	O

We	O
also	O
searched	O
for	O
unpublished	O
studies	O
,	O
PhD	O
dissertations	O
,	O
internal	O
reports	O
,	O
and	O
conference	O
proceedings	O
/	O
abstracts	O
.	O

2	O
.	O
4	O
.	O

In	O
the	O
present	O
study	O
,	O
adiposity	O
was	O
not	O
the	O
focus	O
.	O

Elevated	O
folate	O
levels	O
in	O
the	O
brain	O
and	O
plasma	O
at	O
maturity	O
confirmed	O
the	O
folate	O
content	O
of	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
,	O
and	O
importantly	O
,	O
revealed	O
that	O
the	O
brain	O
responds	O
to	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Since	O
mothers	O
with	O
depression	O
level	O
of	O
>	O
13	O
were	O
excluded	O
from	O
this	O
study	O
,	O
the	O
results	O
can	O
not	O
extend	O
to	O
mothers	O
with	O
high	O
levels	O
of	O
depression	O
.	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	O
to	O
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

Mature	O
clusters	O
are	O
vascularized	O
and	O
formed	O
by	O
an	O
increase	O
in	O
the	O
cytoplasm	O
of	O
podocytes	O
and	O
invaginations	O
into	O
the	O
center	O
of	O
mesangial	O
area	O
,	O
creating	O
a	O
sphere	O
[	O
11	O
],[	O
16	O
].	O

Because	B
expression	O
of	O
these	O
anorexigenic	O
neuropeptides	O
was	O
normalized	O
,	O
it	O
may	O
be	O
suggested	O
that	O
vitamin	O
content	O
of	O
post	O
-	O
weaning	O
diets	O
contribute	O
to	O
remodeling	O
of	O
hypothalamic	O
functioning	O
in	O
mature	O
as	O
well	O
as	O
developing	O
rats	O
.	O

Some	O
data	O
suggest	O
the	O
importance	O
of	O
growth	O
factors	O
(	O
mainly	B
TSH	O
,	O
but	O
also	O
HCG	O
)	O
in	O
growth	O
,	O
progression	O
and	O
spread	O
of	O
papillary	O
tumours	O
.	O

Discussion	O
Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
.	O

This	O
QFFQ	O
includes	O
a	O
list	O
of	O
typically	O
consumed	O
foods	O
and	O
minor	O
changes	O
were	O
made	O
to	O
the	O
questionnaire	O
according	O
to	O
vernacular	O
used	O
by	O
the	O
study	O
population	O
in	O
that	O
particular	O
area	O
.	O

The	O
dams	O
were	O
separated	O
from	O
the	O
males	O
and	O
fed	O
their	O
respective	O
experimental	O
diets	O
until	O
the	O
10th	O
day	O
of	O
suckling	O
(	O
lactation	O
),	O
when	O
the	O
VitD	O
-	O
diet	O
was	O
switched	O
to	O
SC	O
.	O

BHLM	O
assumes	O
that	O
in	O
a	O
linear	O
model	O
,	O
individual	O
regression	O
coefficients	O
arise	O
from	O
a	O
normal	O
distribution	O
,	O
called	O
the	O
prior	O
distribution	O
.	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
to	O
participate	O
.	O

Furthermore	O
,	O
male	O
gender	O
was	O
significantly	O
associated	O
with	O
increased	O
cathelicidin	O
concentrations	O
.	O

Results	O
Among	O
women	O
with	O
a	O
live	O
,	O
singleton	O
birth	O
and	O
at	O
least	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
(	O
N	O
=	O
1	O
,	O
064	O
),	O
the	O
overall	O
PTB	O
rate	O
was	O
13	O
%.	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
into	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Airborne	O
farm	O
pollutants	O
also	O
may	O
enter	O
the	O
home	O
environment	O
by	O
way	O
of	O
the	O
wind	O
,	O
after	O
spraying	O
,	O
gassing	O
,	O
or	O
open	O
-	O
air	O
application	O
.	O

Dry	O
blood	O
spots	O
are	O
collected	O
on	O
filter	O
paper	O
cards	O
(	O
Whatman	O
,	O
Inc	O
)	O
immediately	O
after	O
blood	O
collection	O
(	O
maternal	O
,	O
cord	O
and	O
infant	O
).	O

Thus	B
,	O
stressors	O
,	O
such	O
as	O
temperature	O
and	O
transportation	O
,	O
may	O
have	O
a	O
negative	O
effect	O
on	O
IMF	O
deposition	O
through	O
lipolysis	O
in	O
beef	O
cattle	O
.	O

Respondents	O
rated	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
generally	B
as	O
satisfactory	O
.	O

Already	O
widely	O
used	O
in	O
the	O
pharmaceutical	O
industry	O
for	O
developmental	O
toxicity	O
screening	O
,	O
zebrafish	O
models	O
appear	O
to	O
be	O
a	O
promising	B
alternative	O
to	O
mice	O
.	O

The	O
positive	O
association	O
remained	O
,	O
though	O
was	O
attenuated	O
somewhat	O
,	O
after	O
further	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
4	O
.	O
18	O
;	O
95	O
%	O
CI	O
0	O
.	O
94	O
-	O
18	O
.	O
60	O
).	O

Correlated	O
variables	O
are	O
aggregated	O
by	O
factor	O
analysis	O
.	O

Usually	O
the	O
dosage	O
needs	O
to	O
be	O
increased	O
as	O
early	O
as	O
during	O
the	O
fifth	O
week	O
of	O
gestation	O
,	O
and	O
fT4	O
TSH	O
monitoring	O
is	O
recommended	O
every	O
6	O
weeks	O
for	O
adequate	O
adjustment	O
of	O
dosage	O
.	O

However	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
podocin	O
expression	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
the	O
F2	O
-	O
SC	O
offspring	O
.	O

However	O
,	O
after	O
adjusting	O
for	O
factors	O
shown	O
to	O
be	O
associated	O
with	O
vitamin	O
D	O
status	O
including	O
BMI	O
and	O
recreational	O
walking	O
,	O
serum	O
25	O
(	O
OH	O
)	O
D	O
remained	O
significantly	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
suggesting	O
the	O
influence	O
of	O
other	O
factors	O
not	O
measured	O
as	O
part	O
of	O
SCOPE	O
for	O
example	O
,	O
hours	O
spent	O
outside	O
in	O
the	O
sun	O
.	O

Black	O
infants	O
with	O
vitamin	O
D	O
deficiency	O
had	O
2	O
.	O
4	O
greater	O
adjusted	O
odds	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
0	O
,	O
5	O
.	O
8	O
)	O
of	O
SGA	O
.	O

One	O
trial	O
in	O
schoolchildren28	O
(	O
measuring	O
influenza	O
A	O
antigen	O
from	O
swabs	O
)	O
found	O
a	O
statistically	O
significant	O
reduced	O
incidence	O
in	O
the	O
intervention	O
group	O
(	O
RR	O
0	O
·	O
58	O
,	O
95	O
%	O
CI	O
0	O
·	O
34	O
–	O
0	O
·	O
99	O
).	O

These	O
results	O
will	O
supply	O
context	O
to	O
intervention	O
studies	O
with	O
the	O
aim	O
to	O
improve	O
maternal	O
as	O
well	O
as	O
offspring	O
health	O
in	O
South	O
Africa	O
.	O

Based	O
on	O
the	O
1990	O
IOM	O
guidelines	O
[	O
17	O
],	O
we	O
classified	O
GWG	O
as	O
“	O
excessive	O
”	O
in	O
normal	O
weight	O
women	O
whose	O
gains	O
were	O
more	O
than	O
35	O
pounds	O
(	O
15	O
.	O
9	O
kg	O
)	O
and	O
overweight	O
(	O
BMI	O
>	O
26	O
to	O
29	O
)	O
women	O
whose	O
gains	O
were	O
above	O
25	O
pounds	O
(	O
11	O
.	O
4	O
kg	O
).	O

The	O
results	O
were	O
not	O
meaningfully	O
affected	O
by	O
additional	O
adjustment	O
for	O
tobacco	O
use	O
or	O
vitamin	O
D	O
supplementation	O
or	O
by	O
excluding	O
cases	O
of	O
preeclampsia	O
(	O
data	O
not	O
shown	O
).	O

A	O
study	O
of	O
32	O
women	O
randomized	O
to	O
circuit	O
type	O
exercise	O
three	O
times	O
a	O
week	O
or	O
control	O
,	O
found	O
that	O
resistance	O
training	O
resulted	O
in	O
lower	O
postprandial	O
glucose	O
levels	O
,	O
and	O
a	O
delay	O
in	O
the	O
requirement	O
of	O
insulin	O
.	O
33Amongst	O
women	O
with	O
a	O
prepregnancy	O
BMI	O
>	O
25	O
,	O
those	O
who	O
were	O
in	O
the	O
exercise	O
arm	O
were	O
less	O
likely	B
to	O
require	O
insulin	O
.	O

Software	O
.	O
Socio	O
-	O
demographic	O
data	O
was	O
expressed	O
using	O
descriptive	O
statistics	O
and	O
means	O
(±	O
Standard	O
Deviation	O
).	O

Recently	O
,	O
investigators	O
reported	O
that	O
mild	O
sleep	O
restriction	O
induces	O
marked	O
reduction	O
in	O
basal	O
glucagon	O
concentrations	O
[	O
19	O
].	O

In	O
what	O
follows	O
,	O
population	O
correlations	O
are	O
denoted	O
by	O
r	O
and	O
estimates	O
by	O
.	O

The	O
researchers	O
believe	O
the	O
antioxidant	O
properties	O
of	O
garlic	O
,	O
along	O
with	O
the	O
chelating	O
efficacy	O
exhibited	O
,	O
led	O
to	O
the	O
success	O
of	O
the	O
treatment	O
.	O

One	O
recent	O
study	O
suggests	O
that	O
both	O
the	O
microbial	O
and	O
fatty	O
acid	O
composition	O
of	O
breast	O
milk	O
may	O
differ	O
by	O
delivery	O
mode	O
[	O
18	O
],	O
so	O
the	O
differential	O
effect	O
of	O
maternal	O
dairy	O
intake	O
by	O
delivery	O
mode	O
on	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
attributable	O
to	O
the	O
differences	O
in	O
breast	O
milk	O
microbiota	O
or	O
lipids	O
in	O
relation	O
to	O
maternal	O
diet	O
by	O
delivery	O
mode	O
.	O

Moreover	O
,	O
due	O
to	O
the	O
similarity	O
in	O
metabolism	O
,	O
physiology	O
,	O
anatomy	O
and	O
genome	O
the	O
study	O
is	O
also	O
a	O
beneficial	O
model	O
for	O
nutritional	O
programming	O
in	O
humans	O
[	O
13	O
,	O
14	O
].	O

Amplifications	O
were	O
done	O
in	O
triplicate	O
with	O
one	O
negative	O
control	O
for	O
internal	O
quality	O
control	O
at	O
the	O
MBL	O
.	O

Quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
First	O
-	O
strand	O
cDNA	O
was	O
synthesized	O
from	O
2	O
μg	O
of	O
total	O
RNA	O
(	O
n	O
=	O
14	O
per	O
diet	O
and	O
stage	O
)	O
using	O
random	O
primers	O
and	O
oligo	O
d	O
(	O
T	O
)	O
13VN	O
in	O
the	O
presence	O
of	O
Superscript	O
III	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
,	O
Karlsruhe	O
,	O
Germany	O
).	O

Except	O
for	O
the	O
age	O
factor	O
,	O
anti	O
-	O
Müllerian	O
hormone	O
(	O
AMH	O
)	O
is	O
well	O
recognized	O
as	O
the	O
biochemical	O
marker	O
of	O
this	O
syndrome	O
[	O
41	O
].	O

Considering	O
cut	O
-	O
off	O
point	O
of	O
≥	O
9	O
,	O
data	O
analysis	O
showed	O
that	O
a	O
lot	O
of	O
participants	O
(	O
more	O
than	O
50	O
%)	O
were	O
susceptible	O
to	O
prenatal	O
depression	O
at	O
26	O
–	O
28	O
weeks	O
.	O

Two	O
mothers	O
(	O
1	O
Hispanic	O
,	O
1	O
Caucasian	O
)	O
reported	O
covering	O
their	O
face	O
and	O
body	O
due	O
to	O
their	O
religious	O
beliefs	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
the	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
as	B
greater	O
likelihood	B
of	O
having	O
depression	O
disorder	O
,	O
according	O
to	O
Mazhari	O
and	O
Nakhaee	O
’	O
s	O
study	O
in	O
Iranian	O
population	O
[	O
42	O
].	O

For	O
example	O
,	O
beef	O
with	O
higher	O
IMF	O
produces	O
higher	O
sensory	O
traits	O
,	O
including	O
tenderness	O
,	O
juiciness	O
,	O
flavor	O
,	O
and	O
overall	O
acceptability	O
in	O
Korean	O
cattle	O
[	O
2	O
]	O
and	O
in	O
USA	O
beef	O
samples	O
[	O
3	O
].	O

The	O
role	O
of	O
paternal	O
nutrition	O
on	O
epigenetically	O
linked	O
heritable	O
diseases	O
such	O
as	O
cardiovascular	O
and	O
obesity	O
have	O
been	O
suggested	O
in	O
epidemiological	O
studies	O
[	O
10	O
].	O

However	O
,	O
sensitization	O
may	O
not	O
be	O
restricted	O
to	O
the	O
organ	O
at	O
which	O
the	O
mother	O
experiences	O
allergic	O
symptoms	O
because	O
asthma	O
or	O
wheezing	O
in	O
children	O
was	O
associated	O
not	O
only	O
with	O
asthma	O
and	O
AR	O
,	O
but	O
also	O
with	O
eczema	O
or	O
any	O
allergic	O
disease	O
in	O
their	O
parents	O
and	O
siblings	O
[	O
56	O
,	O
57	O
].	O

While	O
farmers	O
and	O
their	O
families	O
have	O
greater	O
contact	O
with	O
seasonal	O
elements	O
,	O
they	O
may	O
be	O
less	O
prone	O
to	O
“	O
sick	O
building	O
syndrome	O
”	O
than	O
residents	O
of	O
urban	O
areas	O
[	O
117	O
].	O

•	O
Ensure	O
that	O
every	O
woman	O
receives	O
the	O
high	O
-	O
quality	O
care	O
she	O
needs	O
during	O
pregnancy	O
,	O
birth	O
and	O
postnatally	O
,	O
especially	O
if	O
she	O
is	O
at	O
risk	O
of	O
preterm	O
birth	O
.	O

Environmental	O
factors	O
and	O
epigenetic	O
perturbation	O
Epigenetic	O
processes	O
are	O
susceptible	O
to	O
perturbation	O
throughout	O
an	O
individual	O
’	O
s	O
life	O
(	O
Figure	O
1	O
).	O

All	O
children	O
clinically	O
diagnosed	O
with	O
pneumonia	O
were	O
offered	O
free	O
chest	O
radiographs	O
taken	O
by	O
radiographers	O
trained	O
by	O
a	O
WHO	O
trainer	O
.	O

Although	O
these	O
latter	O
findings	O
were	O
not	O
statistically	O
significant	O
,	O
they	O
may	O
be	O
of	O
clinical	O
relevance	O
.	O

Few	O
clinical	O
trial	O
intervention	O
studies	O
have	O
specifically	O
measured	O
changes	O
in	O
physical	O
activity	O
during	O
pregnancy	O
,	O
but	O
available	O
evidence	O
suggests	O
little	O
to	O
no	O
effect	O
on	O
maternal	O
GWG	O
[	O
16	O
,	O
43	O
].	O

Even	O
so	O
,	O
this	O
study	O
will	O
provide	O
a	O
comprehensive	O
and	O
unique	O
database	O
from	O
an	O
urban	O
South	O
African	O
setting	O
which	O
will	O
allow	O
for	O
cross	O
-	O
sectional	O
,	O
prospective	O
and	O
retrospective	O
analyses	O
to	O
describe	O
the	O
nutritional	O
status	O
and	O
dietary	O
intake	O
of	O
pregnant	O
women	O
,	O
and	O
to	O
determine	O
associations	O
with	O
health	O
outcome	O
measures	O
.	O

Expression	O
of	O
other	O
genes	O
was	O
unaffected	O
.	O

In	O
these	O
studies	O
,	O
17	O
,	O
27as	O
well	O
as	O
ours	O
,	O
serum	O
calcium	O
level	O
considerably	O
increased	O
,	O
but	O
contrary	O
to	O
ours	O
,	O
they	O
reported	O
abnormal	O
calcium	O
level	O
in	O
7	O
%	O
to	O
12	O
%	O
of	O
the	O
patients	O
during	O
the	O
study	O
.	O

Moderate	O
physical	O
activity	O
should	O
be	O
encouraged	O
.	O

Ethics	O
statement	O
The	O
Institutional	O
Review	O
Board	O
at	O
the	O
Nicaraguan	O
Ministry	O
of	O
Health	O
reviewed	O
and	O
approved	O
the	O
protocol	O
.	O

The	O
patient	O
had	O
no	O
known	O
risk	O
factors	O
and	O
a	O
negative	O
family	O
history	O
of	O
aortic	O
dissection	O
or	O
connective	O
tissue	O
disease	O
.	O

We	O
present	O
that	O
the	O
hepatic	O
expression	O
profiles	O
showed	O
considerable	O
modulation	O
during	O
prenatal	O
and	O
postnatal	O
stages	O
,	O
i	O
.	O
e	O
.	O

(	O
2015	O
)‡	O
Susiarjo	O
et	O
al	O
.	O

Depression	O
was	O
reported	O
in	O
8	O
.	O
6	O
%	O
of	O
European	O
mothers	O
,	O
in	O
19	O
.	O
5	O
%	O
of	O
Middle	O
Eastern	O
mothers	O
,	O
and	O
in	O
17	O
.	O
5	O
%	O
of	O
South	O
Asian	O
mothers	O
.	O

General	O
health	O
,	O
health	O
service	O
utilisation	O
,	O
and	O
quality	O
of	O
life	O
:	O
as	O
assessed	O
by	O
questionnaire	O
[	O
34	O
]	O
completed	O
by	O
the	O
infant	O
’	O
s	O
primary	O
caregiver	O
.	O

On	O
the	O
other	O
hand	O
,	O
increased	O
risk	O
for	O
childhood	O
brain	O
tumors	O
has	O
been	O
associated	O
in	O
some	O
studies	O
with	O
a	O
history	O
of	O
chicken	O
pox	O
[	O
137	O
],	O
influenza	O
[	O
138	O
,	O
139	O
],	O
measles	O
[	O
138	O
],	O
general	O
viral	O
infections	O
[	O
140	O
,	O
141	O
],	O
and	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

Comparisons	O
of	O
values	O
between	O
study	O
time	O
points	O
were	O
made	O
using	O
a	O
generalized	O
linear	O
regression	O
model	O
with	O
covariate	O
adjustment	O
based	O
on	O
the	O
specific	O
analysis	O
conducted	O
.	O

We	O
did	O
not	O
identify	O
any	O
correlations	O
between	O
baseline	O
variables	O
.	O

However	O
,	O
the	O
associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
did	O
not	O
always	O
differ	O
by	O
delivery	O
mode	O
.	O

Potential	O
confounders	O
We	O
selected	O
potential	O
confounding	O
factors	O
which	O
are	O
known	O
(	O
from	O
existing	O
literature	O
)	O
to	O
be	O
associated	O
with	O
one	O
or	O
more	O
of	O
the	O
outcomes	O
of	O
interest	O
[	O
20	O
].	O

Conversely	O
,	O
a	O
recent	O
cohort	O
study	O
conducted	O
by	O
Bay	O
et	O
al	O
.	O

Respondent	O
'	O
s	O
occupations	O
varied	O
with	O
the	O
highest	O
proportion	O
consisting	O
of	O
students	O
(	O
n	O
=	O
87	O
,	O
22	O
.	O
6	O
%)	O
(	O
Figure	O
1	O
).	O

In	O
those	O
clinical	O
trials	O
,	O
4000	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
was	O
found	O
to	O
safely	O
achieve	O
a	O
concentration	O
of	O
at	O
least	O
32	O
ng	O
/	O
mL	O
by	O
early	O
in	O
the	O
second	O
trimester	O
in	O
a	O
diverse	O
group	O
of	O
pregnant	O
women	O
[	O
13	O
–	O
15	O
].	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
Turkey	O
'	O
s	O
test	O
:	O
compared	O
to	O
SC	O
counterpart	O
;	O
compared	O
to	O
F1	O
generation	O
.	O

Several	O
other	O
studies	O
,	O
however	O
,	O
have	O
found	O
associations	O
between	O
increased	O
exposure	O
to	O
phthalates	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
whereas	O
we	O
did	O
not	O
.	O

Other	O
studies	O
reported	O
36	O
–	O
54	O
%	O
iron	O
supplementation	O
[	O
51	O
,	O
55	O
].	O

We	O
analysed	O
the	O
repeat	O
episodes	O
accounting	O
for	O
clustering	O
within	O
individuals	O
.	O

One	O
OTU	O
classified	O
to	O
the	O
genus	O
Corynebacterium	O
was	O
negatively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
(	O
p	O
=	O
0	O
.	O
0044	O
),	O
and	O
one	O
each	O
OTU	O
classified	O
to	O
the	O
species	O
Acinetobacter	O
rhizosphaerae	O
(	O
p	O
=	O
0	O
.	O
0040	O
)	O
and	O
to	O
the	O
family	O
Ruminococcaceae	O
(	O
p	O
=	O
0	O
.	O
0061	O
),	O
respectively	O
,	O
were	O
also	O
positively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
,	O
but	O
we	O
did	O
not	O
observe	O
multiple	O
related	O
OTUs	O
with	O
similar	O
associations	O
.	O

Those	O
having	O
a	O
dmft	O
score	O
of	O
0	O
were	O
considered	O
caries	O
-	O
free	O
.	O

Analyzed	O
the	O
data	O
:	O
MO	O
EM	O
SP	O
KW	O
.	O

Similar	O
inconsistent	O
associations	O
exist	O
for	O
phthalates	O
and	O
BPA	O
[	O
22	O
–	O
24	O
],	O
OCPs	O
[	O
18	O
,	O
25	O
]	O
and	O
PBDEs	O
[	O
26	O
,	O
27	O
].	O

There	O
is	O
no	O
consensus	O
about	O
the	O
optimal	O
25	O
(	O
OH	O
)	O
D	O
level	O
,	O
but	B
many	O
experts	B
accept	O
a	O
range	O
75nmol	O
/	O
L	O
(≥	O
30	O
ng	O
/	O
mL	O
)	O
as	O
optimal	O
.	O

Uterine	O
Myomas	O
Last	O
year	O
gave	O
us	O
a	O
new	O
insight	O
on	O
VD	O
-	O
related	O
gene	O
polymorphism	O
and	O
the	O
risk	O
of	O
uterine	O
myomas	O
(	O
UM	O
).	O

and	O
Camargo	O
et	O
al	O
.	O

The	O
potential	O
for	O
such	O
adaptations	O
is	O
already	O
acknowledged	B
at	O
the	O
OECD	O
,	O
but	O
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	O
validation	O
work	O
is	O
needed	O
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

The	O
sub	O
-	O
sample	O
was	O
drawn	O
from	O
12	O
of	O
the	O
original	O
31	O
villages	O
,	O
chosen	O
on	O
the	O
grounds	O
of	O
their	O
larger	O
size	O
and	O
easier	O
accessibility	O
.	O

Evidence	O
-	O
Based	O
Preventive	O
Treatment	O
Options	O
3	O
.	O
2	O
.	O
1	O
.	O

Cold	O
stress	O
during	O
winter	O
decreases	O
animal	O
performance	O
and	O
production	O
efficiency	O
[	O
76	O
,	O
77	O
].	O

A	O
female	O
must	O
reprogram	O
the	O
paternally	O
imprinted	O
genes	O
on	O
the	O
chromosomes	O
inherited	O
from	O
her	O
father	O
into	O
maternally	O
imprinted	O
genes	O
and	O
vice	O
versa	O
.	O

This	O
increase	O
in	O
C	O
-	O
reactive	O
protein	O
has	O
been	O
found	O
to	O
have	O
a	O
correlation	O
with	O
a	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
29	O
].	O

The	O
inclusion	O
criteria	O
applied	O
during	O
recruitment	O
screening	O
are	O
:	O
1	O
)	O
Confirmed	O
pregnancy	O
and	O
planning	O
to	O
deliver	O
her	O
baby	O
at	O
RMMCH	O
;	O
2	O
)	O
<	O
18	O
weeks	O
’	O
gestational	O
age	O
;	O
3	O
)	O
Born	O
in	O
South	O
Africa	O
,	O
Lesotho	O
,	O
Swaziland	O
,	O
Zimbabwe	O
,	O
Botswana	O
or	O
Namibia	O
and	O
has	O
been	O
living	O
in	O
South	O
Africa	O
for	O
at	O
least	O
12	O
months	O
;	O
4	O
)	O
Able	O
to	O
communicate	O
effectively	O
in	O
one	O
of	O
the	O
following	O
languages	O
:	O
English	O
,	O
Afrikaans	O
,	O
Sotho	O
,	O
Zulu	O
or	O
Xhosa	O
.	O

This	O
was	O
a	O
single	O
-	O
blind	O
study	O
.	O

Nonetheless	O
,	O
in	O
our	O
study	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
lower	O
depression	O
scores	O
after	O
intervention	O
.	O

Genetic	O
components	O
and	O
complex	O
environmental	O
factors	O
contribute	O
to	O
the	O
etiology	O
of	O
asthma	O
and	O
atopic	O
diseases	O
.	O

Use	O
of	O
Antiacid	O
Medications	O
The	O
changing	O
hormone	O
levels	O
during	O
pregnancy	O
lead	O
to	O
a	O
lower	O
esophageal	O
sphincter	O
pressure	O
in	O
the	O
mother	O
,	O
and	O
concomitantly	O
with	O
growing	O
volume	O
of	O
the	O
fetus	O
,	O
these	O
factors	O
often	O
result	O
in	O
heartburn	O
,	O
reflux	O
,	O
and	O
abdominal	O
pain	O
.	O

Allergy	O
is	O
a	O
hypersensitivity	O
reaction	O
initiated	O
by	O
specific	O
immunologic	O
responses	O
[	O
1	O
,	O
2	O
]	O
against	O
foreign	O
,	O
usually	O
harmless	O
,	O
substances	O
.	O

GDM	O
diagnosis	O
and	O
birth	O
size	O
were	O
obtained	O
from	O
medical	O
records	O
.	O

In	O
the	O
next	O
stage	O
,	O
two	O
neurologists	O
estimated	O
expanded	O
disability	O
status	O
scale	O
(	O
EDSS	O
)	O
in	O
MS	O
patients	O
and	O
those	O
with	O
EDSS	O
less	O
than	O
5	O
(	O
that	O
had	O
capability	O
to	O
do	O
outdoor	O
activity	O
)	O
were	O
included	O
in	O
our	O
study	O
.	O

Expanding	O
on	O
this	O
,	O
a	O
matched	O
case	O
control	O
studies	O
of	O
children	O
in	O
Stockholm	O
county	O
showed	O
a	O
correlation	O
between	O
low	O
growth	O
for	O
gestation	O
age	O
and	O
preterm	O
birth	O
with	O
ASD	O
combined	O
with	O
intellectual	O
disabilities	O
.	O

Anthropometrics	O
were	O
recorded	O
at	O
each	O
outpatient	O
visit	O
using	O
a	O
digital	O
scale	O
and	O
length	O
board	O
.	O

Women	O
living	O
in	O
a	O
nursing	O
home	O
have	O
a	O
higher	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
than	O
in	O
free	O
-	O
living	O
women	O
,	O
39	O
.	O
8	O
%	O
compared	O
to	O
30	O
%,	O
respectively	O
[	O
13	O
].	O

The	O
mean	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
case	O
and	O
control	O
groups	O
were	O
48	O
and	O
62	O
nmol	O
/	O
L	O
,	O
respec	O
-	O
tively	O
,	O
and	O
it	O
showed	O
a	O
significant	O
difference	O
between	O
them	O
(	O
P	O
=	O
0	O
.	O
036	O
).	O
There	O
was	O
not	O
any	O
significant	O
relationship	O
between	O
age	O
and	O
serum	O
level	O
of	O
vitamin	O
D	O
in	O
both	O
groups	O
(	O
P	O
=	O
0	O
.	O
83	O
).	O

Also	O
,	O
the	O
median	O
gestation	O
when	O
women	O
start	O
antenatal	O
care	O
(	O
and	O
would	O
have	O
access	O
to	O
iron	O
/	O
folic	O
acid	O
supplements	O
)	O
is	O
5	O
.	O
2	O
months	O
(	O
3	O
)	O
.	O

A	O
recent	O
study	O
on	O
gene	O
polymorphism	O
in	O
2232	O
postmenopausal	O
women	O
has	O
proven	B
that	O
two	O
single	O
nucleotide	O
polymorphisms	O
are	O
significantly	O
associated	O
with	O
UM	O
.	O

There	O
was	O
an	O
80	O
%	O
lower	O
risk	O
of	O
recurrent	O
PTB	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
among	O
women	O
with	O
a	O
prior	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
20	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
05	O
–	O
0	O
.	O
74	O
,	O
p	O
=	O
0	O
.	O
02	O
;	O
AAR	O
=	O
29	O
.	O
6	O
%;	O
NNT	O
=	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIG	O
3	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
by	O
gestational	O
age	O
(	O
weeks	O
)	O
at	O
birth	O
for	O
women	O
with	O
a	O
prior	O
preterm	O
birth	O
.	O

The	O
distinction	O
is	O
important	O
because	O
adjustment	O
for	O
covariates	O
along	O
the	O
causal	O
pathway	O
may	O
spuriously	O
attenuate	O
estimates	O
of	O
association	O
.	O

Apart	O
from	O
IL	O
-	O
6	O
,	O
another	O
circulating	O
factor	O
,	O
named	O
irisin	O
,	O
was	O
shown	O
to	O
be	O
produced	O
by	O
skeletal	O
muscles	O
during	O
physical	O
exercise	O
in	O
rodents	O
(	O
De	O
Matteis	O
et	O
al	O
.,	O
2013	O
).	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
the	O
order	O
of	O
effectiveness	O
of	O
nutritional	O
management	O
for	O
manipulating	O
IMF	O
deposition	O
is	O
fetal	O
stage	O
>	O
neonatal	O
stage	O
>	O
weaning	O
stage	O
>	O
older	O
stages	O
.	O

Lactation	O
support	O
includes	O
breastfeeding	O
-	O
related	O
counseling	O
and	O
education	O
from	O
trained	O
specialists	O
both	O
in	O
the	O
hospital	O
shortly	O
after	O
birth	O
and	O
at	O
home	O
for	O
the	O
first	O
months	O
of	O
the	O
baby	O
’	O
s	O
life	O
.	O
9	O
While	O
an	O
absolute	O
inability	O
to	O
lactate	O
is	O
rare	O
,	O
estimated	O
to	O
occur	O
in	O
less	O
than	O
2	O
%	O
of	O
mothers	O
,	O
10	O
“	O
we	O
have	O
no	O
idea	O
about	O
the	O
prevalence	O
of	O
women	O
who	O
are	O
lactating	O
less	O
than	O
optimally	O
,	O
who	O
may	O
be	O
unable	O
to	O
exclusively	O
breastfeed	O
a	O
baby	O
no	O
matter	O
how	O
frequently	O
and	O
thoroughly	O
they	O
breastfeed	O
,”	O
says	O
Nommsen	O
-	O
Rivers	O
.	O

So	O
in	O
this	O
survey	O
,	O
we	O
investigated	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
compared	O
it	O
with	O
controls	O
in	O
central	O
region	O
of	O
Iran	O
,	O
an	O
area	O
with	O
medium	O
to	O
high	O
risk	O
for	O
MS	O
disease	O
,	O
in	O
spite	O
of	O
high	O
sun	O
exposure	O
.	O

Atopy	O
For	O
newborns	O
at	O
suspected	O
risk	O
for	O
atopy	O
,	O
that	O
is	O
,	O
with	O
a	O
history	O
of	O
atopy	O
/	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
(	O
parents	O
,	O
siblings	O
),	O
exposure	O
to	O
irritating	O
air	O
pollutants	O
and	O
airborne	O
allergens	O
such	O
as	O
molds	O
should	O
be	O
minimized	O
.	O

Furthermore	O
,	O
some	O
studies	O
have	O
found	O
a	O
beneficial	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
,	O
specifically	O
a	O
decreased	O
likelihood	B
of	O
delivering	O
a	O
baby	O
preterm	O
or	O
small	O
for	O
gestational	O
age	O
[	O
16	O
],[	O
17	O
],[	O
18	O
],[	O
19	O
],[	O
20	O
],[	O
21	O
],[	O
22	O
].	O

Sows	O
were	O
anaesthetised	O
as	O
described	O
[	O
15	O
].	O

2012	O
[	O
29	O
],	O
excluding	O
alcohol	O
consumption	O
to	O
adapt	O
the	O
score	O
to	O
a	O
pregnant	O
cohort	O
.	O

Top	O
health	O
officials	O
in	O
every	O
state	O
,	O
along	O
with	O
Puerto	O
Rico	O
and	O
the	O
District	O
of	O
Columbia	O
,	O
signed	O
the	O
pledge	O
.	O

(	O
A	O
)	O
Schematic	O
representation	O
of	O
the	O
breeding	O
scheme	O
used	O
during	O
the	O
identification	O
of	O
deviant	O
pedigrees	O
.	O

The	O
effect	O
observed	O
in	O
the	O
RC	O
offspring	O
were	O
contrary	O
to	O
those	O
from	O
previous	O
studies	O
,	O
which	O
described	O
either	O
,	O
an	O
increased	O
preference	O
for	O
higher	O
caloric	O
diets	O
after	O
exposure	O
to	O
caloric	O
restriction	O
during	O
pregnancy	O
(	O
Lussana	O
et	O
al	O
.,	O
2008	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
)	O
or	O
hyperphagia	O
in	O
animals	O
fed	O
with	O
a	O
high	O
-	O
fat	O
diet	O
(	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

However	O
,	O
although	O
bitter	O
tastes	O
are	O
innately	O
disliked	O
,	O
with	O
repeated	O
exposure	O
,	O
infants	O
can	O
come	O
to	O
like	O
certain	O
foods	O
that	O
are	O
bitter	O
,	O
particularly	O
some	O
vegetables	O
(	O
31	O
-	O
34	O
).	O

In	O
Tehran	O
,	O
Taheri	O
et	O
al	O
.	O

Blood	O
Measures	O
Total	O
circulating	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
measured	O
in	O
duplicate	O
within	O
the	O
month	O
the	O
blood	O
sample	O
was	O
obtained	O
using	O
radioimmunoassay	O
(	O
RIA	O
;	O
DiaSorin	O
,	O
Stillwater	O
,	O
MN	O
).	O

One	O
important	O
factor	O
that	O
could	O
contribute	O
to	O
these	O
discrepant	O
findings	O
is	O
the	O
use	O
of	O
birth	O
weight	O
as	B
a	O
unique	O
marker	O
of	O
fetal	O
development	O
.	O

After	O
supplementation	O
with	O
MMN	O
the	O
relative	O
risk	O
of	O
anaemia	O
(<	O
12g	O
/	O
dL	O
)	O
was	O
0	O
.	O
59	O
(	O
0	O
.	O
46	O
,	O
0	O
.	O
76	O
)	O
compared	O
to	O
placebo	O
.	O

Our	O
present	O
pilot	O
study	O
has	O
several	O
important	O
strengths	O
.	O

If	O
neither	O
parent	O
is	O
allergic	O
,	O
the	O
chance	O
for	O
allergies	O
in	O
the	O
child	O
is	O
about	O
15	O
%.	O

Outcomes	O
were	O
additionally	O
adjusted	O
for	O
maternal	O
age	O
,	O
socioeconomic	O
status	O
and	O
maternal	O
smoking	O
There	O
was	O
no	O
evidence	O
to	O
suggest	O
that	O
the	O
effect	O
of	O
the	O
antenatal	O
intervention	O
was	O
modified	O
by	O
maternal	O
BMI	O
category	O
for	O
any	O
of	O
the	O
reported	O
outcomes	O
(	O
data	O
not	O
shown	O
).	O

Results	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
body	O
weight	O
and	O
caloric	O
intake	O
in	O
dams	O
and	O
their	O
offspring	O
in	O
gestation	O
,	O
lactation	O
,	O
and	O
/	O
or	O
postweaning	O
periods	O
Body	O
weight	O
gain	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
dams	O
were	O
evaluated	O
after	O
the	O
gestation	O
and	O
lactation	O
periods	O
(	O
Figure2A	O
).	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
similar	O
results	O
were	O
observed	O
.	O

There	O
was	O
no	O
difference	O
in	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
82	O
vs	O
82	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
99	O
).	O

Funding	O
from	O
Save	O
the	O
Children	O
is	O
provided	O
by	O
a	O
grant	O
from	O
Bill	O
&	O
Melinda	O
Gates	O
Foundation	O
to	O
Save	O
the	O
Children	O
'	O
s	O
Saving	O
Newborn	O
Lives	O
programme	O
.	O

In	B
general	I
,	O
life	O
history	O
concepts	O
suggest	O
that	O
poor	O
nutrition	O
or	O
threatening	O
circumstances	O
in	O
early	O
life	O
lead	O
to	O
accelerated	O
maturation	O
,	O
through	O
which	O
the	O
organism	O
trades	O
body	O
size	O
and	O
longevity	O
for	O
earlier	O
reproduction	O
in	O
a	O
threatening	O
environment	O
[	O
26	O
].	O

HendersonERJ	O
-	O
00073	O
-	O
2017_Henderson	O
PubMed	O
Central	O
:	O

Subject	O
scanning	O
does	O
not	O
take	O
place	O
unless	O
all	O
quality	O
control	O
results	O
fall	O
within	O
acceptable	O
limits	O
.	O

Soontrapa	O
et	O
al	O
.	O

The	O
mean	O
number	O
of	O
check	O
-	O
ups	O
with	O
the	O
obstetrician	O
was	O
4	O
.	O
7	O
±	O
3	O
.	O
07	O
;	O
but	O
16	O
.	O
5	O
%	O
of	O
women	O
did	O
not	O
see	O
an	O
obstetrician	O
during	O
their	O
pregnancy	O
.	O

The	O
nutrients	O
most	O
studied	O
during	O
pregnancy	O
include	O
B	O
-	O
vitamins	O
(	O
particularly	O
folic	O
acid	O
),	O
vitamin	O
D	O
,	O
iron	O
,	O
long	O
-	O
chain	O
polyunsaturated	O
fatty	O
acids	O
(	O
particularly	O
n	O
-	O
3	O
fatty	O
acids	O
)	O
and	O
iodine	O
[	O
8	O
,	O
10	O
].	O

Such	O
epigenetic	O
processes	O
can	O
be	O
perturbed	O
by	O
environmental	O
factors	O
,	O
potentially	O
leading	O
to	O
an	O
adverse	O
phenotypic	O
outcome	O
.	O

Moreover	O
,	O
reimbursement	O
for	O
multivitamin	O
supplements	O
is	O
not	O
covered	O
by	O
insurance	O
in	O
Romania	O
,	O
suggesting	O
that	O
there	O
are	O
other	O
factors	O
contributing	O
to	O
their	O
use	O
.	O

Some	O
studies	O
suggest	O
that	O
the	O
dietary	O
requirement	O
during	O
pregnancy	O
and	O
lactation	O
may	O
be	O
as	O
high	O
as	O
6000	O
IU	O
/	O
d	O
[	O
59	O
]	O
and	O
recognize	O
that	O
at	B
least	I
1500	O
–	O
2000	O
IU	O
/	O
d	O
of	O
vitamin	O
D	O
may	O
be	O
needed	O
in	O
order	O
to	O
maintain	O
a	O
blood	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
above	O
30	O
ng	O
/	O
ml	O
[	O
24	O
].	O

The	O
incidence	O
of	O
first	O
episodes	O
of	O
simple	O
,	O
severe	O
or	O
very	O
severe	O
pneumonias	O
confirmed	O
with	O
chest	O
radiography	O
also	O
did	O
not	O
differ	O
(	O
table	O
1	O
,	O
appendix	O
).	O

Our	O
data	O
also	O
suggest	O
that	O
these	O
alterations	O
may	O
reflect	O
underlying	O
functional	O
epigenetic	O
alterations	O
to	O
genes	O
important	O
in	O
placental	O
growth	O
and	O
development	O
.	O

PubMed	O
Central	O
:	O

Although	O
folate	O
has	O
been	O
shown	O
to	O
be	O
an	O
active	O
participant	O
in	O
methyltransfer	O
reactions	O
,	O
12global	O
methylation	O
was	O
not	O
affected	O
by	O
either	O
the	O
gestational	O
or	O
post	O
-	O
weaning	O
diet	O
.	O

In	O
2013	O
,	O
the	O
influenza	O
vaccination	O
recommendation	O
was	O
extended	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
Municipality	O
of	O
Managua	O
,	O
and	O
in	O
2014	O
,	O
the	O
Government	O
of	O
Nicaragua	O
extended	O
influenza	O
vaccination	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
country	O
.	O

Concurrently	O
,	O
there	O
has	O
been	O
a	O
“	O
nutrition	O
transition	O
”	O
in	O
the	O
same	O
populations	O
.	O

A	O
P	O
value	O
of	O
≤	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Multiple	O
Linear	O
Regression	O
analysis	O
and	O
associated	O
percentage	O
difference	O
in	O
markers	O
of	O
glucose	O
metabolism	O
(	O
Model	O
1	O
unadjusted	O
,	O
and	O
Model	O
2	O
adjusted	O
)	O
Model	O
1	O
–	O
Unadjusted	O
modelModel	O
2	O
–	O
Final	O
Adjusted	O
modelDependent	O
VariableIndependent	O
variable	O
(	O
early	O
pregnancy	O
)%	O
∆	O
aB95	O
%	O
CI	O
P	O
Model	O
P	O
%	O
∆	O
aB95	O
%	O
CI	O
P	O
Model	O
P	O
HOMA	O
-	O
IR	O
earlyWinter32	O
.	O
8	O
%	O
0	O
.	O
28	O
(	O
0	O
.	O
08	O
,	O
0	O
.	O
49	O
)	O
0	O
.	O
0080	O
.	O
00846	O
.	O
72	O
%	O
0	O
.	O
38	O
(	O
0	O
.	O
15	O
,	O
0	O
.	O
62	O
)	O
0	O
.	O
001	O
<	O
0	O
.	O
00125OHD	O
<	O
30	O
nmol	O
/	O
L11	O
.	O
6	O
%	O
0	O
.	O
11	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
32	O
)	O
0	O
.	O
32511	O
.	O
64	O
%	O
0	O
.	O
11	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
36	O
)	O
0	O
.	O
382HOMA	O
-	O
IR	O
28	O
weeks	O
’	O
Winter29	O
.	O
7	O
%	O
0	O
.	O
26	O
(	O
0	O
.	O
04	O
,	O
0	O
.	O
49	O
)	O
0	O
.	O
0240	O
.	O
05153	O
.	O
70	O
%	O
0	O
.	O
43	O
(	O
0	O
.	O
17	O
,	O
0	O
.	O
69	O
)	O
0	O
.	O
0020	O
.	O
00125OHD	O
<	O
30	O
nmol	O
/	O
L4	O
.	O
1	O
%	O
0	O
.	O
04	O
(−	O
0	O
.	O
20	O
,	O
0	O
.	O
28	O
)	O
0	O
.	O
7533	O
.	O
00	O
%	O
0	O
.	O
03	O
(−	O
0	O
.	O
25	O
,	O
0	O
.	O
31	O
)	O
0	O
.	O
837Insulin	O
early	O
(	O
μU	O
/	O
mL	O
)	O
Winter32	O
.	O
4	O
%	O
0	O
.	O
28	O
(	O
0	O
.	O
08	O
,	O
0	O
.	O
48	O
)	O
0	O
.	O
0070	O
.	O
01047	O
.	O
57	O
%	O
0	O
.	O
39	O
(	O
0	O
.	O
16	O
,	O
0	O
.	O
62	O
)	O
0	O
.	O
001	O
<	O
0	O
.	O
00125OHD	O
<	O
30	O
nmol	O
/	O
L8	O
.	O
3	O
%	O
0	O
.	O
08	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
29	O
)	O
0	O
.	O
4748	O
.	O
16	O
%	O
0	O
.	O
08	O
(−	O
0	O
.	O
17	O
,	O
0	O
.	O
32	O
)	O
0	O
.	O
530Insulin	O
28	O
weeks	O
(	O
μU	O
/	O
mL	O
)	O
Winter25	O
.	O
9	O
%	O
0	O
.	O
23	O
(	O
0	O
.	O
01	O
,	O
0	O
.	O
46	O
)	O
0	O
.	O
0410	O
.	O
10249	O
.	O
53	O
%	O
0	O
.	O
40	O
(	O
0	O
.	O
14	O
,	O
0	O
.	O
66	O
)	O
0	O
.	O
0030	O
.	O
00225OHD	O
<	O
30	O
nmol	O
/	O
L1	O
.	O
0	O
%	O
0	O
.	O
01	O
(−	O
0	O
.	O
22	O
,	O
0	O
.	O
24	O
)	O
0	O
.	O
927	O
−	O
0	O
.	O
17	O
%	O
0	O
.	O
00	O
(−	O
0	O
.	O
28	O
,	O
0	O
.	O
28	O
)	O
0	O
.	O
991Fasting	O
glucose	O
early	O
(	O
mmol	O
/	O
L	O
)	O
Winter	O
−	O
0	O
.	O
02	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
5830	O
.	O
713	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
13	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
4350	O
.	O
02125OHD	O
<	O
30	O
nmol	O
/	O
L0	O
.	O
03	O
(−	O
0	O
.	O
06	O
,	O
0	O
.	O
13	O
)	O
0	O
.	O
4690	O
.	O
06	O
(−	O
0	O
.	O
04	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
257Fasting	O
glucose	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
Winter0	O
.	O
07	O
(−	O
0	O
.	O
04	O
,	O
0	O
.	O
18	O
)	O
0	O
.	O
1850	O
.	O
1180	O
.	O
13	O
(	O
0	O
.	O
00	O
,	O
0	O
.	O
26	O
)	O
0	O
.	O
0450	O
.	O
01525OHD	O
<	O
30	O
nmol	O
/	O
L0	O
.	O
08	O
(−	O
0	O
.	O
04	O
,	O
0	O
.	O
19	O
)	O
0	O
.	O
2080	O
.	O
15	O
(	O
0	O
.	O
01	O
,	O
0	O
.	O
29	O
)	O
0	O
.	O
0411	O
-	O
h	O
GCT	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
Winter0	O
.	O
04	O
(−	O
0	O
.	O
31	O
,	O
0	O
.	O
39	O
)	O
0	O
.	O
8060	O
.	O
9460	O
.	O
02	O
(−	O
0	O
.	O
41	O
,	O
0	O
.	O
45	O
)	O
0	O
.	O
9300	O
.	O
68825OHD	O
<	O
30	O
nmol	O
/	O
L0	O
.	O
03	O
(−	O
0	O
.	O
35	O
,	O
0	O
.	O
41	O
)	O
0	O
.	O
8730	O
.	O
02	O
(−	O
0	O
.	O
45	O
,	O
0	O
.	O
50	O
)	O
0	O
.	O
923	O
a	O
%	O
difference	O
in	O
metabolic	O
marker	O
Model	O
1	O
:	O
model	O
not	O
controlled	O
for	O
confounders	O
.	O

The	O
challenge	O
now	O
is	O
to	O
fully	O
identify	O
and	O
investigate	O
the	O
specific	O
functional	O
epigenetic	O
mechanisms	O
and	O
biological	O
pathways	O
relevant	O
to	O
humans	O
so	O
that	O
the	O
risk	O
(	O
s	O
)	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
to	O
public	O
health	O
can	O
be	O
properly	O
assessed	O
and	O
addressed	O
.	O

In	O
order	O
to	O
assess	O
confounding	O
arising	O
from	O
other	O
dimensions	O
of	O
diet	O
,	O
we	O
additionally	O
adjusted	O
separately	O
for	O
maternal	O
intake	O
of	O
vitamin	O
E	O
,	O
zinc	O
,	O
selenium	O
,	O
n	O
-	O
3	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFAs	O
),	O
n	O
-	O
6	O
PUFAs	O
,	O
and	O
total	O
fruits	O
and	O
vegetables	O
in	O
pregnancy	O
[	O
1	O
,	O
29	O
–	O
31	O
].	O

However	O
,	O
meta	O
-	O
analysis	O
of	O
the	O
4	O
case	O
-	O
control	O
studies	O
revealed	O
a	O
significantly	O
increased	O
risk	O
of	O
oral	O
clefts	O
in	O
infants	O
of	O
corticosteroid	O
-	O
treated	O
mothers	O
(	O
odds	O
ratio	O
,	O
3	O
.	O
35	O
;	O
confidence	O
interval	O
1	O
.	O
97	O
-	O
5	O
.	O
69	O
)	O
[	O
12	O
].	O

The	O
intake	O
forms	O
of	O
women	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
or	O
declined	O
to	O
participate	O
were	O
analysed	O
.	O

We	O
also	O
present	O
data	O
indicating	O
that	O
these	O
two	O
early	O
life	O
nutritional	O
exposures	O
had	O
differential	O
effects	O
on	O
later	O
life	O
ovarian	O
function	O
,	O
suggestive	O
of	O
two	O
developmental	O
pathways	O
that	O
affect	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
in	O
the	O
rat	O
.	O

The	O
30	O
ng	O
/	O
mL	O
target	O
is	O
well	O
above	O
that	O
likely	O
to	O
be	O
needed	O
for	O
adequate	O
vitamin	O
D	O
status	O
in	O
the	O
newborn	O
based	O
upon	O
the	O
recent	O
recommendations	O
of	O
the	O
Institute	O
of	O
Medicine	O
[	O
2	O
].	O

An	O
increased	O
risk	O
for	O
a	O
respiratory	O
tract	O
infection	O
before	O
the	O
age	O
of	O
6	O
months	O
was	O
also	O
found	O
in	O
infants	O
with	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
.	O

3	O
.	O
3	O
.	O
2	O
.	O

The	O
study	O
medication	O
was	O
provided	O
in	O
a	O
blister	O
pack	O
in	O
a	O
single	O
box	O
containing	O
all	O
medication	O
for	O
the	O
whole	O
pregnancy	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g007	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
7	O
Photomicrographs	O
of	O
developing	O
kidneys	O
from	O
offspring	O
at	O
10	O
days	O
of	O
age	O
.	O

Ultrasound	O
is	O
also	O
used	O
to	O
determine	O
the	O
number	O
of	O
foetuses	O
and	O
confirm	O
foetal	O
movement	O
,	O
as	O
well	O
as	O
foetal	O
growth	O
at	O
22	O
and	O
36	O
weeks	O
’	O
gestation	O
(	O
phases	O
2	O
and	O
3	O
).	O

First	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

The	O
only	O
significant	O
predictor	O
found	O
was	O
group	O
affiliation	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Otable	O
2	O
).	O

Ratios	O
range	O
from	O
0	O
to	O
1	O
:	O
β	O
=	O
1	O
indicates	O
complete	O
methylation	O
and	O
β	O
=	O
0	O
represents	O
no	O
methylation	O
.	O

To	O
check	O
the	O
linearity	O
assumption	O
for	O
the	O
regression	O
models	O
,	O
we	O
plotted	O
residuals	O
by	O
birth	O
weight	O
percentile	O
for	O
all	O
models	O
and	O
found	O
no	O
evidence	O
for	O
systematic	O
nonlinearity	O
.	O

1998	O
).	O

Although	O
these	O
results	O
are	O
provocative	O
,	O
reported	O
handwashing	O
behavior	O
consistently	B
exaggerates	O
observed	O
handwashing	O
behavior	O
and	O
so	O
reported	O
handwashing	O
behavior	O
is	O
not	O
a	O
valid	O
measure	O
of	O
handwashing	O
[	O
4	O
–	O
6	O
].	O

Verburg	O
et	O
al	O
.	O

Results	O
from	O
a	O
large	O
Danish	O
national	O
birth	O
cohort	O
(	O
n	O
=	O
25	O
,	O
446	O
)	O
indicated	O
a	O
significant	O
improvement	O
in	O
motor	O
,	O
cognitive	O
and	O
total	O
developmental	O
scores	O
for	O
eighteen	O
month	O
old	O
children	O
who	O
were	O
born	O
to	O
women	O
within	O
the	O
highest	O
three	O
quintiles	O
of	O
fish	O
intake	O
during	O
pregnancy	O
.	O

These	O
findings	O
are	O
more	O
pronounced	O
in	O
F1	O
progeny	O
,	O
but	O
F2	O
progeny	O
are	O
also	O
affected	O
.	O

Above	O
-	O
average	O
nutritional	O
knowledge	O
was	O
independently	O
associated	O
with	O
the	O
use	O
of	O
folic	O
acid	O
(	O
aOR	O
,	O
4	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
6	O
-	O
13	O
.	O
8	O
),	O
iron	O
(	O
aOR	O
,	O
2	O
.	O
6	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
5	O
.	O
7	O
)	O
and	O
multivitamins	O
(	O
aOR	O
,	O
2	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
6	O
.	O
8	O
).	O

The	O
mean	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
case	O
and	O
control	O
groups	O
were	O
48	O
and	O
62	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
difference	O
was	O
significant	O
(	O
P	O
=	O
0	O
.	O
036	O
).	O

Some	O
clinical	O
trials	O
in	O
non	O
-	O
pregnant	O
people	O
showed	O
that	O
vitamin	O
D	O
was	O
effective	O
in	O
decreasing	O
depression	O
level	O
.	O

detected	O
no	O
difference	O
in	O
outcome	O
,	O
disease	O
-	O
free	O
survival	O
and	O
morbidity	O
when	O
compared	O
to	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women2	O
.	O

Also	O
,	O
intervention	O
exposure	O
,	O
as	B
measured	O
by	O
estimated	O
number	O
of	O
antepartum	O
messages	O
delivered	O
and	O
number	O
of	O
antepartum	O
days	O
enrolled	O
in	O
the	O
messaging	O
campaign	O
,	O
were	O
assessed	O
for	O
all	O
study	O
participants	O
in	O
the	O
intervention	O
group	O
.	O

Though	O
the	O
training	O
lays	O
emphasis	O
on	O
core	O
midwifery	O
skills	O
,	O
it	O
could	O
be	O
expanded	O
to	O
include	O
cardiopulmonary	O
resuscitation	O
of	O
mothers	O
;	O
furthermore	O
,	O
local	O
health	O
staff	O
should	O
be	O
provided	O
with	O
appropriate	O
state	O
-	O
of	O
-	O
art	O
equipment	O
to	O
work	O
with	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
use	O
BHLM	O
to	O
simultaneously	O
examine	O
the	O
association	O
between	O
exposure	O
to	O
5	O
different	O
EDC	O
classes	O
(	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
),	O
2	O
organophosphate	O
pesticides	O
(	O
OPPs	O
)	O
and	O
2	O
heavy	O
metals	O
,	O
lead	O
(	O
Pb	O
)	O
and	O
mercury	O
(	O
Hg	O
),	O
with	O
birth	O
weight	O
among	O
women	O
and	O
their	O
children	O
in	O
the	O
Health	O
Outcomes	O
and	O
Measures	O
of	O
Environment	O
(	O
HOME	O
)	O
Study	O
[	O
34	O
].	O

The	O
frequency	O
of	O
dairy	O
consumption	O
is	O
7	O
.	O
5	O
±	O
3	O
.	O
8	O
times	O
per	O
week	O
,	O
and	O
four	O
participants	O
did	O
not	O
take	O
dairy	O
products	O
at	O
all	O
.	O

Further	O
adjustment	O
for	O
BMI	O
did	O
not	O
change	O
this	O
estimate	O
.	O

Initial	O
research	O
efforts	O
,	O
which	O
were	O
embarked	O
upon	O
during	O
the	O
1950s	O
,	O
assert	B
that	O
complications	O
in	O
a	O
given	O
pregnancy	O
,	O
the	O
birthing	O
process	O
,	O
and	O
the	O
incidence	O
of	O
autism	O
are	O
linked	O
.	O

Procedures	O
Cord	O
blood	O
was	O
obtained	O
at	O
birth	O
for	O
analysis	O
of	O
25	O
(	O
OH	O
)	O
D	O
and	O
ionized	O
calcium	O
.	O

The	O
topics	O
focused	O
mainly	O
on	O
care	O
in	O
pregnancy	O
(	O
diet	O
,	O
exercise	O
and	O
importance	O
of	O
ANC	O
)	O
and	O
for	O
the	O
newborn	O
(	O
diet	O
and	O
breastfeeding	O
).	O

Lower	O
maternal	O
vitamin	O
D	O
status	O
was	O
associated	O
with	O
lower	O
bone	O
mineral	O
concentration	O
and	O
impaired	O
glucose	O
homeostasis	O
in	O
newborn	O
infants	O
.	O

Three	O
subjects	O
had	O
cathelicidin	O
concentrations	O
that	O
were	O
more	O
than	O
two	O
times	O
greater	O
than	O
the	O
next	O
lowest	O
concentration	O
.	O

A	O
possible	O
connection	O
between	O
fetal	O
sex	O
,	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
complications	O
reveals	O
further	O
questions	O
and	O
encourages	O
continual	O
research	O
and	O
discussion	O
into	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
,	O
particularly	O
in	O
vitamin	O
D	O
replete	O
populations	O
.	O

Development	O
and	O
validation	O
of	O
the	O
nutritional	O
knowledge	O
questionnaire	O
To	O
evaluate	O
nutritional	O
knowledge	O
we	O
developed	O
a	O
questionnaire	O
based	O
on	O
the	O
recommendations	O
of	O
the	O
“	O
Pregnancy	O
Notebook	O
”	O
[	O
24	O
]	O
and	O
“	O
The	O
Principles	O
of	O
the	O
Child	O
’	O
s	O
and	O
Mother	O
’	O
s	O
Diet	O
:	O
Guidelines	O
for	O
Health	O
Providers	O
at	O
Community	O
Level	O
”	O
[	O
25	O
],	O
educational	O
tools	O
developed	O
by	O
the	O
Ministry	O
of	O
Health	O
in	O
Romania	O
.	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

PubMed	O
Central	O
:	O

In	O
2011	O
the	O
U	O
.	O
S	O
.	O

No	O
subjects	O
had	O
malaria	O
parasitaemia	O
at	O
follow	O
-	O
up	O
.	O

Participants	O
in	O
the	O
study	O
received	O
3	O
text	O
messages	O
per	O
week	O
throughout	O
their	O
enrollment	O
,	O
which	O
were	O
tailored	O
to	O
the	O
date	O
of	O
enrollment	O
and	O
gestational	O
age	O
.	O

It	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
preventive	O
method	O
,	O
warranting	O
a	O
need	O
for	O
research	O
to	O
identify	O
possible	O
environmental	O
triggers	O
.	O

Each	O
data	O
collector	O
will	O
need	O
to	O
log	O
into	O
the	O
system	O
using	O
a	O
pre	O
-	O
assigned	O
unique	O
user	O
ID	O
and	O
password	O
.	O

Cont	O
–	O
control	O
pregnancies	O
;	O
UN	O
P	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
only	O
;	O
UN	O
L	O
–	O
dams	O
undernourished	O
during	O
lactation	O
only	O
;	O
UN	O
PL	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
and	O
lactation	O
.	O

Given	B
the	O
predominance	O
of	O
polytherapy	O
involving	O
these	O
two	O
classes	O
of	O
medications	O
in	O
the	O
treatment	O
of	O
various	O
psychiatric	O
disorders	O
in	O
pregnant	O
women	O
,	O
designing	O
future	O
cohort	O
studies	O
aimed	O
at	O
investigating	O
the	O
relative	O
and	O
combined	O
effects	O
of	O
prenatal	O
exposure	O
to	O
SGAs	O
and	O
antidepressants	O
is	O
of	O
considerable	O
importance	O
.	O

A	O
moderate	O
maternal	O
caloric	O
restriction	O
produces	O
sex	O
-	O
dimorphic	O
effects	O
in	O
feeding	O
and	O
body	O
weight	O
gain	O
only	O
after	O
weaning	O
The	O
dams	O
exposed	O
to	O
undernutrition	O
during	O
prenatal	O
stages	O
exhibited	O
a	O
reduction	O
in	O
their	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
during	O
gestation	O
that	O
contrasts	O
with	O
the	O
increase	O
in	O
their	O
body	O
weight	O
during	O
lactation	O
with	O
normal	O
nutrition	O
.	O

However	O
,	O
by	O
limiting	O
unmeasured	O
confounding	O
due	O
to	O
differences	O
in	O
human	O
microbiomes	O
between	O
populations	O
that	O
may	O
result	O
in	O
erroneous	O
associations	O
with	O
dietary	O
differences	O
,	O
our	O
study	O
also	O
may	O
have	O
greater	O
internal	O
validity	O
.	O

Trial	O
registration	O
The	O
project	O
protocol	O
is	O
registered	O
in	O
ClinicalTrials	O
.	O
gov	O
in	O
November	O
8	O
,	O
2012	O
(	O
NCT01723852	O
).	O

These	O
children	O
were	O
more	O
often	O
born	O
first	O
,	O
had	O
a	O
low	O
Apgar	O
score	O
,	O
and	O
tended	O
to	O
have	O
more	O
complications	O
[	O
8	O
].	O

On	O
the	O
other	O
hand	O
,	O
multiple	O
regression	O
analysis	O
revealed	O
a	O
significant	O
interaction	O
of	O
the	O
three	O
independent	O
variables	O
birth	O
weight	O
,	O
age	O
and	O
BMI	O
in	O
predicting	O
PNN50	O
(	O
Table	O
2	O
).	O

Sample	O
size	O
of	O
the	O
random	O
sample	O
,	O
per	O
group	O
,	O
was	O
calculated	O
using	O
the	O
formula	O
to	O
estimate	O
a	O
proportion	O
assuming	O
that	O
90	O
%	O
of	O
those	O
who	O
self	O
-	O
reported	O
being	O
vaccinated	O
or	O
unvaccinated	O
status	O
were	O
truly	O
vaccinated	O
or	O
unvaccinated	O
,	O
respectively	O
[	O
37	O
].	O

Then	O
nutrient	O
and	O
energy	O
intakes	O
were	O
computed	O
by	O
using	O
NUTRITIONIST	O
IV	O
software	O
(	O
version	O
7	O
.	O
0	O
;	O
N	O
-	O
Squared	O
Computing	O
,	O
Salem	O
,	O
OR	O
),	O
which	O
was	O
designed	O
for	O
Iranian	O
foods	O
.	O

In	O
addition	O
,	O
we	O
analysed	O
13	O
infants	O
treated	O
by	O
our	O
department	O
for	O
idiopathic	O
infantile	O
hypercalcaemia	O
(	O
IIH	O
)	O
from	O
2011	O
-	O
2013	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
determinants	O
of	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamins	O
supplements	O
by	O
expectant	O
mothers	O
in	O
Romania	O
,	O
in	O
terms	O
of	O
nutritional	O
knowledge	O
evaluated	O
by	O
a	O
structured	O
questionnaire	O
,	O
socio	O
-	O
demographic	O
factors	O
and	O
engagement	O
with	O
prenatal	O
care	O
.	O

Herb	O
use	O
among	O
low	O
income	O
women	O
at	O
an	O
urban	O
tertiary	O
care	O
center	O
and	O
their	O
communications	O
with	O
prenatal	O
care	O
providers	O
Purpose	O
Little	O
is	O
known	O
about	O
the	O
use	O
of	O
herbs	O
in	O
low	O
income	O
underserved	O
mothers	O
and	O
patterns	O
of	O
communication	O
about	O
herb	O
use	O
to	O
prenatal	O
providers	O
.	O

Such	O
changes	O
could	O
have	O
far	O
-	O
reaching	O
consequences	O
on	O
embryo	O
viability	O
and	O
development	O
(	O
including	O
early	O
germ	O
line	O
formation	O
),	O
and	O
thus	B
subsequent	O
future	O
health	O
and	O
fertility	O
.	O

The	O
coefficients	O
of	O
variation	O
(	O
CV	O
)	O
for	O
the	O
25OHD	O
assay	O
determined	O
at	O
assay	O
verification	O
were	O
as	O
follows	O
:	O
inter	O
-	O
assay	O
CV	O
,	O
8	O
.	O
9	O
%	O
at	O
a	O
concentration	O
of	O
49	O
.	O
5	O
nmol	O
/	O
L	O
and	O
3	O
.	O
7	O
%	O
at	O
103	O
nmol	O
/	O
L	O
(	O
intra	O
-	O
assay	O
CV	O
,	O
2	O
.	O
9	O
%	O
and	O
1	O
.	O
4	O
%	O
respectively	O
).	O

Part	O
of	O
the	O
problem	O
is	O
that	O
it	O
is	O
difficult	O
to	O
design	O
breastfeeding	O
studies	O
.	O

It	O
is	O
also	O
increasingly	O
recognized	B
that	O
genetic	O
variation	O
influences	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
status	O
.	O

(	O
2008	O
)*/†	O
Nickel	O
(	O
Ni	O
)	O
RatInjection	O
(	O
im	O
)	O
(	O
10	O
mg	O
/	O
animal	O
Ni3S2	O
)	O
Early	O
adulthoodLater	O
adulthoodMuscle	O
tumorsmiRNAsZhang	O
et	O
al	O
.	O

P	O
<	O
0	O
.	O
05	O
was	O
regarded	O
as	O
statistically	O
significant	O
.	O

Inform	O
•	O
Use	O
and	O
strengthen	O
existing	O
tracking	O
systems	O
for	O
commodities	O
and	O
devices	O
to	O
improve	O
supply	O
chain	O
logistics	O
.	O

As	O
,	O
in	O
the	O
two	O
subgroups	O
,	O
the	O
depression	O
scores	O
were	O
not	O
significantly	O
lower	O
in	O
vitamin	O
D	O
group	O
compared	O
to	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
.	O

Young	O
[	O
81	O
]	O
suggested	O
that	O
energy	O
requirements	O
increase	O
during	O
winter	O
or	O
when	O
animals	O
are	O
under	O
cold	O
stress	O
,	O
as	O
increased	O
heat	O
production	O
is	O
needed	O
to	O
maintain	O
body	O
temperature	O
by	O
shivering	O
or	O
other	O
thermogenic	O
process	O
.	O

Immature	O
glomeruli	O
begin	O
to	O
disappear	O
at	O
10	O
days	O
,	O
but	O
at	O
this	O
age	O
,	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
more	O
immature	O
and	O
mature	O
glomeruli	O
than	O
F1	O
-	O
SC	O
mice	O
.	O

MUSC	O
is	O
a	O
comprehensive	O
,	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
(~	O
3000	O
deliveries	O
/	O
year	O
).	O

Pregnant	O
and	O
lactating	O
women	O
should	O
widen	O
their	O
food	O
choices	O
to	O
include	O
as	O
many	O
flavorful	O
and	O
healthy	O
foods	O
as	O
possible	O
.	O

We	O
also	O
excluded	O
16	O
women	O
with	O
pre	O
-	O
gestational	O
diabetes	O
.	O

This	O
could	O
lead	O
to	O
activation	O
of	O
TEs	O
,	O
and	O
abnormal	O
imprinting	O
and	O
gene	O
expression	O
.	O

Prematurity	O
and	O
Low	O
Birth	O
Weight	O
As	O
shown	O
within	O
the	O
Manitoba	O
birth	O
cohort	O
study	O
,	O
prematurity	O
and	O
low	O
birth	O
weight	O
are	O
not	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
development	O
of	O
food	O
allergy	O
in	O
childhood	O
[	O
90	O
].	O

Laboratory	O
evaluation	O
of	O
the	O
infant	O
showed	O
serum	O
sodium	O
of	O
177	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
4	O
mEq	O
/	O
L	O
,	O
chloride	O
140	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
14	O
mEq	O
/	O
L	O
,	O
BUN	O
49	O
mEq	O
/	O
L	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
glucose	O
30	O
mg	O
/	O
dL	O
,	O
and	O
calcium	O
8	O
.	O
3	O
mEq	O
/	O
L	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
birth	O
weight	O
,	O
length	O
,	O
head	O
circumference	O
SD	O
-	O
scores	O
and	O
ponderal	O
index	O
z	O
-	O
score	O
between	O
(	O
a	O
)	O
maternal	O
prepregnancy	O
BMI	O
groups	O
of	O
underweight	O
,	O
normal	O
weight	O
,	O
overweight	O
and	O
obese	O
;	O
(	O
b	O
)	O
mothers	O
’	O
inadequate	O
GWG	O
,	O
adequate	O
GWG	O
and	O
excessive	O
GWG	O
;	O
(	O
c	O
)	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
;	O
(	O
d	O
)	O
suboptimal	O
and	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
;	O
and	O
(	O
e	O
)	O
suboptimal	O
and	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
.	O
Statistical	O
significance	O
is	O
denoted	O
by	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
and	O
***	O
P	O
<	O
0	O
.	O
001	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
without	O
wheezes	O
,	O
rhonchi	O
,	O
or	O
rales	O
.	O

The	O
relationship	O
between	O
non	O
-	O
dietary	O
Vitamin	O
D	O
intake	O
dose	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
was	O
analyzed	O
using	O
Pearson	O
independence	O
test	O
.	O

This	O
association	O
did	O
not	O
extend	O
to	O
neighbors	O
,	O
nor	O
was	O
it	O
associated	O
with	O
changes	O
in	O
smoking	O
behavior	O
.	O

2	O
.	O
2	O
.	O

In	O
pregnancy	O
,	O
the	O
association	O
between	O
low	O
vitamin	O
D	O
levels	O
and	O
abnormalities	O
in	O
glucose	O
tolerance	O
is	O
the	O
subject	O
of	O
scientific	O
debate	O
,	O
with	O
some	O
studies	O
reporting	O
that	O
maternal	O
insulin	O
sensitivity	O
,	O
fasting	O
glucose	O
and	O
gestational	O
diabetes	O
are	O
not	O
associated	O
with	O
25OHD	O
[	O
7	O
],	O
while	O
others	O
have	O
found	O
inverse	O
associations	O
between	O
25OHD	O
,	O
fasting	O
glucose	O
[	O
8	O
]	O
and	O
risk	O
of	O
gestational	O
diabetes	O
[	O
9	O
].	O

In	O
the	O
high	O
level	O
symptoms	O
group	O
compared	O
with	O
the	O
low	O
level	O
symptoms	O
group	O
,	O
the	O
intake	O
of	O
shellfish	O
1	O
-	O
3	O
times	O
per	O
month	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
,	O
whereas	O
the	O
intake	O
of	O
shellfish	O
more	O
than	O
three	O
times	O
per	O
week	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
.	O

Curtis	O
and	O
colleagues	O
have	O
found	O
that	O
mothers	O
and	O
other	O
caregivers	O
commonly	B
report	O
that	O
they	O
wash	O
hands	O
out	O
of	O
a	O
wish	O
to	O
nurture	O
their	O
young	O
children	O
[	O
22	O
].	O

Total	O
GWG	O
was	O
categorised	O
into	O
inadequate	O
,	O
adequate	O
and	O
excessive	O
based	B
on	I
national	O
recommendations	B
by	O
prepregnancy	O
BMI	O
:	O
recommended	O
GWG	O
for	O
underweight	O
mothers	O
was	O
12	O
.	O
5	O
–	O
18	O
.	O
0	O
kg	O
,	O
for	O
normal	O
weight	O
11	O
.	O
5	O
–	O
16	O
.	O
0	O
kg	O
,	O
for	O
overweight	O
7	O
.	O
0	O
–	O
11	O
.	O
5	O
kg	O
,	O
and	O
for	O
obese	O
5	O
.	O
0	O
–	O
9	O
.	O
0	O
kg	O
[	O
19	O
].	O

Concerning	O
the	O
number	O
of	O
ANC	O
visits	O
,	O
the	O
health	O
centres	O
follow	O
the	O
Western	O
model	O
of	O
clinic	O
visits	O
with	O
an	O
average	O
of	O
10	O
to	O
12	O
visits	O
.	O

Despite	O
these	O
limitations	O
,	O
the	O
strengths	O
of	O
our	O
study	O
include	O
having	O
access	O
to	O
birth	O
outcomes	O
from	O
medical	O
records	O
as	O
well	O
as	O
having	O
available	O
influenza	O
surveillance	O
data	O
.	O

In	O
a	O
four	O
-	O
arm	O
cluster	O
-	O
randomized	O
controlled	O
trial	O
in	O
Pakistan	O
investigating	O
the	O
neonatal	O
mortality	O
effects	O
of	O
umbilical	O
cord	O
cleansing	O
with	O
chlorhexidine	O
and	O
handwashing	O
with	O
soap	O
promotion	O
separately	O
and	O
together	O
,	O
Soofi	O
and	O
colleagues	O
found	O
no	O
benefit	O
from	O
promoting	O
handwashing	O
with	O
soap	O
[	O
9	O
].	O

Data	O
on	O
cost	O
per	O
pregnancy	O
of	O
daily	O
iron	O
supplementation	O
is	O
quite	O
weak	O
.	O

In	O
a	O
pooled	O
analysis	O
of	O
data	O
from	O
Canada	O
,	O
UK	O
,	O
Denmark	O
,	O
and	O
Sweden	O
including	O
more	O
than	O
40	O
,	O
000	O
individuals	O
with	O
MS	O
,	O
significantly	O
fewer	O
(	O
8	O
.	O
5	O
%)	O
people	O
with	O
MS	O
were	O
born	O
in	O
November	O
and	O
significantly	O
more	O
(	O
9	O
.	O
1	O
%)	O
were	O
born	O
in	O
May	O
.	O
39This	O
finding	O
suggests	O
that	O
prenatal	O
exposures	O
or	O
exposures	O
in	O
the	O
first	O
months	O
of	O
life	O
could	O
be	O
important	O
in	O
MS	O
etiology	O
,	O
but	O
the	O
link	O
to	O
vitamin	O
D	O
is	O
unclear	O
.	O

For	O
the	O
entire	O
cohort	O
,	O
inverse	O
correlations	O
were	O
observed	O
between	O
the	O
HRV	O
parameters	O
with	O
BMI	O
(	O
RMSSD	O
:	O
r	O
=	O
-	O
0	O
.	O
199	O
,	O
P	O
=	O
0	O
.	O
047	O
;	O
PNN50	O
:	O
r	O
=	O
-	O
0	O
.	O
231	O
,	O
P	O
=	O
0	O
.	O
021	O
;	O
HF	O
:	O
r	O
=	O
-	O
0	O
.	O
205	O
,	O
P	O
=	O
0	O
.	O
041	O
),	O
systolic	O
(	O
RMSSD	O
:	O
r	O
=	O
-	O
0	O
.	O
227	O
,	O
P	O
=	O
0	O
.	O
023	O
;	O
PNN50	O
:	O
r	O
=	O
-	O
0	O
.	O
214	O
,	O
P	O
=	O
0	O
.	O
032	O
)	O
and	O
diastolic	O
(	O
PNN50	O
:	O
r	O
=	O
-	O
0	O
.	O
217	O
,	O
P	O
=	O
0	O
.	O
030	O
)	O
BP	O
levels	O
.	O

Of	O
the	O
original	O
cohort	O
of	O
mothers	O
participating	O
in	O
this	O
vitamin	O
D	O
supplementation	O
trial	O
,	O
55	O
%	O
of	O
the	O
children	O
were	O
available	O
for	O
follow	O
-	O
up	O
,	O
and	O
of	O
those	O
,	O
68	O
%	O
of	O
those	O
who	O
came	O
for	O
follow	O
-	O
up	O
(	O
38	O
%	O
of	O
the	O
original	O
cohort	O
)	O
were	O
able	O
to	O
have	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
visit	O
.	O

also	O
found	O
similar	O
reductions	O
in	O
PTB	O
risk	O
for	O
spontaneous	O
and	O
medically	O
indicated	O
PTBs	O
[	O
4	O
].	O

However	O
,	O
the	O
exact	O
prevalence	O
of	O
allergic	O
forms	O
of	O
dermatitis	O
in	O
the	O
pregnant	O
population	O
is	O
not	O
known	O
.	O

These	O
spots	O
were	O
mapped	O
to	O
33	O
unique	O
proteins	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
12	O
The	O
business	O
community	O
-	O
Industry	O
partnership	O
for	O
innovative	O
technology	O
for	O
preterm	O
baby	O
care	O
in	O
Asia	O
.	O

Rodent	O
models	O
The	O
deleterious	O
effects	O
of	O
exposures	O
to	O
environmental	O
factors	O
in	O
human	O
cohorts	O
have	O
stimulated	O
investigations	O
of	O
environmentally	O
induced	O
toxicity	O
in	O
rodent	O
models	O
.	O

These	O
results	O
suggest	O
that	O
higher	O
energy	O
levels	O
are	O
required	O
for	O
IMF	O
deposition	O
than	O
for	O
general	O
body	O
fat	O
deposition	O
,	O
including	O
for	O
subcutaneous	O
fat	O
deposition	O
.	O

We	O
have	O
chosen	O
the	O
current	O
usual	O
programs	O
as	O
our	O
comparator	O
.	O

We	O
found	O
that	O
6	O
of	O
the	O
9	O
KAB	O
items	O
formed	O
a	O
single	O
factor	O
.	O

Maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
transfers	O
to	O
the	O
fetus	O
by	O
the	O
placenta	O
.	O

(%)	O
ever16	O
258	O
(	O
88	O
)	O
12	O
614	O
(	O
88	O
)	O
668	O
(	O
82	O
)	O
never2	O
153	O
(	O
12	O
)	O
1	O
781	O
(	O
12	O
)	O
149	O
(	O
18	O
)	O
Dietary	O
intake	O
,	O
g	O
/	O
day	O
,	O
median	O
(	O
5	O
-	O
95	O
%)	O
of	O
:	O
fatty	O
fish7	O
(	O
0	O
-	O
21	O
)	O
7	O
(	O
0	O
-	O
21	O
)	O
7	O
(	O
0	O
-	O
28	O
)	O
meat76	O
(	O
26	O
-	O
144	O
)	O
78	O
(	O
22	O
-	O
149	O
)	O
77	O
(	O
3	O
-	O
167	O
)	O
dairy	O
products330	O
(	O
20	O
-	O
831	O
)	O
331	O
(	O
14	O
-	O
850	O
)	O
320	O
(	O
4	O
-	O
857	O
)	O
vegetables79	O
(	O
22	O
-	O
177	O
)	O
79	O
(	O
21	O
-	O
186	O
)	O
80	O
(	O
19	O
-	O
214	O
)	O
fruit107	O
(	O
15	O
-	O
315	O
)	O
106	O
(	O
11	O
-	O
311	O
)	O
102	O
(	O
7	O
-	O
337	O
)	O
cereals125	O
(	O
47	O
-	O
280	O
)	O
129	O
(	O
47	O
-	O
288	O
)	O
129	O
(	O
41	O
-	O
299	O
)	O
saccharides	O
(	O
sugar	O
)	O
20	O
(	O
7	O
-	O
44	O
)	O
20	O
(	O
7	O
-	O
45	O
)	O
21	O
(	O
6	O
-	O
51	O
)	O
alcohol2	O
.	O
5	O
(	O
0	O
-	O
11	O
)	O
2	O
.	O
4	O
(	O
0	O
-	O
11	O
)	O
1	O
.	O
8	O
(	O
0	O
-	O
12	O
)	O
marine	O
fatty	O
acidsc0	O
.	O
27	O
(	O
0	O
.	O
07	O
-	O
0	O
.	O
6	O
)	O
0	O
.	O
27	O
(	O
0	O
.	O
06	O
-	O
0	O
.	O
6	O
)	O
0	O
.	O
26	O
(	O
0	O
.	O
05	O
-	O
0	O
.	O
7	O
)	O
omega	O
-	O
3	O
fatty	O
acidsd1	O
.	O
3	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
1	O
.	O
3	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
1	O
.	O
2	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
omega	O
-	O
6	O
fatty	O
acidse4	O
.	O
8	O
(	O
2	O
-	O
8	O
)	O
4	O
.	O
8	O
(	O
2	O
-	O
8	O
)	O
4	O
.	O
7	O
(	O
2	O
-	O
8	O
)	O
vitamin	O
D	O
(	O
μg	O
/	O
day	O
)	O
4	O
.	O
0	O
(	O
1	O
.	O
8	O
-	O
7	O
.	O
1	O
)	O
3	O
.	O
9	O
(	O
1	O
.	O
7	O
-	O
7	O
.	O
2	O
)	O
3	O
.	O
8	O
(	O
1	O
.	O
4	O
-	O
7	O
.	O
1	O
)	O
Total	O
energy	O
intake	O
,	O
kJ	O
/	O
day	O
,	O
mean	O
(	O
SD	O
)	O
6	O
509	O
(	O
1	O
801	O
)	O
6	O
626	O
(	O
1	O
886	O
)	O
6	O
637	O
(	O
1	O
986	O
)	O
Proportion	O
of	O
total	O
energy	O
intake	O
,	O
%	O
from	O
:	O
•	O
fat313131	O
•	O
protein161616	O
•	O
carbohydrate515151	O
•	O
alcohol111	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bAge	O
at	O
the	O
completeness	O
of	O
the	O
follow	O
-	O
up	O
questionnaire	O
cSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
and	O
docosapentaenoic	O
acid	O
dSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
),	O
docosapentaenoic	O
acid	O
and	O
α	O
-	O
linolenic	O
acid	O
eSum	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
Dietary	O
intake	O
of	O
fish	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fish	O
is	O
shown	O
in	O
Table2	O
.	O

We	O
will	O
train	O
the	O
BRAC	O
village	O
workers	O
and	O
volunteers	O
in	O
sub	O
-	O
district	O
health	O
centres	O
to	O
detect	O
and	O
monitor	O
pregnancies	O
,	O
to	O
maintain	O
pregnancy	O
records	O
,	O
to	O
manage	O
supply	O
and	O
distribution	O
of	O
supplements	O
,	O
communication	O
and	O
counselling	O
skills	O
for	O
behaviour	O
change	O
related	O
to	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

Sympathetic	O
hyperactivity	O
can	O
alter	O
glucose	O
homeostasis	O
and	O
induce	O
insulin	O
resistance	O
by	O
increasing	O
glycogen	O
breakdown	O
and	O
gluconeogenesis	O
.	O

Juul	O
-	O
Dam	O
et	O
al	O
.	O

Management	O
of	O
Chronic	O
Asthma	O
The	O
goals	O
of	O
management	O
during	O
pregnancy	O
are	O
the	O
same	O
as	O
those	O
for	O
asthma	O
in	O
general	O
,	O
including	O
prevention	O
of	O
severe	O
exacerbations	O
,	O
improvement	O
of	O
quality	O
of	O
life	O
(	O
no	O
interference	O
with	O
sleep	O
or	O
daily	O
activities	O
),	O
and	O
maintenance	O
of	O
normal	O
lung	O
function	O
.	O

Similar	O
magnitudes	O
of	O
decreased	O
risk	O
for	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
were	O
observed	O
among	O
PTB	O
subtypes	O
:	O
spontaneous	O
PTB	O
(	O
58	O
%)	O
and	O
indicated	O
PTB	O
(	O
61	O
%).	O

[	O
15	O
]	O
indicating	O
that	O
the	O
body	O
of	O
evidence	O
is	O
supportive	O
of	O
fish	O
intake	O
during	O
pregnancy	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t003_Table	O
3	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Evidence	O
Rating	O
Table	O
[	O
13	O
].	O
ComponentRatingCommentsEvidence	O
BaseSatisfactoryNHMRC	O
Level	O
III	O
(	O
cohort	O
studies	O
)	O
with	O
moderate	O
risk	O
of	O
bias	O
[	O
20	O
].	O
ConsistencyGoodSeven	O
out	O
of	O
eight	O
studies	O
demonstrated	O
a	O
positive	O
association	O
between	O
fish	O
intake	O
and	O
foetal	O
neurodevelopment	O
.	O
Clinical	O
impactSatisfactoryTrend	O
towards	O
improved	O
neurodevelopment	O
with	O
significant	O
results	O
in	O
several	O
domains	O
.	O
GeneralisabilityGoodAll	O
studies	O
in	O
pregnant	O
women	O
.	O
ApplicabilityPoorA	O
variety	O
of	O
populations	O
studied	O
from	O
different	O
countries	O
where	O
type	O
of	O
fish	O
and	O
the	O
level	O
of	O
contaminants	O
would	O
likely	B
vary	O
.	O

Delivering	O
high	O
doses	O
of	O
mHealth	O
interventions	O
has	O
implications	O
in	O
terms	O
of	O
cost	O
,	O
participant	O
burden	O
,	O
and	O
potential	O
“	O
wear	O
out	O
”	O
effects	O
(	O
ie	O
,	O
overexposure	O
).	O

Four	O
identically	O
trained	O
study	O
nurses	O
obtain	O
newborn	O
anthropometry	O
(	O
weight	O
,	O
midarm	O
circumference	O
(	O
MAC	O
),	O
crown	O
-	O
heel	O
length	O
(	O
CHL	O
),	O
head	O
circumference	O
(	O
HC	O
)	O
and	O
thoracic	O
circumference	O
(	O
TC	O
))	O
within	O
12	O
h	O
of	O
birth	O
[	O
57	O
].	O

RT	O
reactions	O
contained	O
2	O
µg	O
poly	O
-	O
A	O
-	O
tailed	O
miRNA	O
,	O
1	O
µl	O
oligo	O
-	O
dT	O
adapter	O
(	O
1	O
µg	O
/	O
µl	O
)	O
and	O
nuclease	O
-	O
free	O
water	O
.	O

Based	O
on	O
the	O
main	O
effects	O
on	O
adiposity	O
,	O
the	O
perirenal	O
fat	O
was	O
considered	O
the	O
most	O
suitable	O
adipose	O
tissue	O
for	O
gene	O
expression	O
analysis	O
.	O

Hod	O
et	O
al	O
.	O

The	O
overall	O
response	O
rate	O
was	O
72	O
%,	O
and	O
34	O
415	O
answered	O
the	O
follow	O
-	O
up	O
questionnaire	O
and	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
measured	O
(	O
outcome	O
under	O
study	O
).	O

Taken	O
together	O
,	O
policy	O
makers	O
should	O
implement	O
changes	O
in	O
the	O
health	O
care	O
delivery	O
system	O
taking	O
into	O
account	O
the	O
users	O
’	O
opinion	O
,	O
more	O
so	O
in	O
the	O
light	O
of	O
increasing	O
female	O
education	O
in	O
Cameroon	O
.	O

At	O
minimum	O
,	O
if	O
a	O
causal	O
relationship	O
exists	O
,	O
season	O
of	O
birth	O
meets	O
the	O
criteria	O
of	O
temporality	O
as	O
the	O
period	O
surrounding	O
birth	O
clearly	O
predates	O
disease	O
occurrence	O
.	O

Women	O
classified	O
themselves	O
as	O
Latina	O
(	O
78	O
%),	O
African	O
–	O
American	O
(	O
14	O
%),	O
Caucasian	O
(	O
4	O
%),	O
or	O
other	O
(	O
4	O
%).	O

The	O
repeated	O
measures	O
analysis	O
showed	O
that	O
the	O
control	O
group	O
had	O
gone	O
through	O
significant	O
changes	O
with	O
regards	O
to	O
depression	O
scores	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Fig	O
.	O

Increases	O
in	O
stress	O
were	O
related	O
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	O
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

During	O
pregnancy	O
vitamin	O
D	O
and	O
calcium	O
metabolism	O
undergo	O
significant	O
changes	O
to	O
provide	O
the	O
calcium	O
needed	O
for	O
maternal	O
skeletal	O
preservation	O
and	O
foetal	O
skeletal	O
formation	O
.	O

This	O
behavior	O
included	O
social	O
behavior	O
deficits	O
,	O
increased	O
repetitive	O
behaviors	O
,	O
and	O
deficits	O
in	O
communication	O
.	O

However	O
,	O
it	O
must	O
be	O
borne	O
in	O
mind	O
that	O
a	O
proportion	O
of	O
children	O
who	O
develop	O
atopic	O
manifestations	O
in	O
the	O
first	O
years	O
of	O
life	O
come	O
from	O
families	O
in	O
which	O
neither	O
parents	O
nor	O
siblings	O
are	O
atopic	O
.	O

Cognitive	O
behavioral	O
strategies	O
are	O
often	B
used	O
to	O
help	O
children	O
make	O
better	O
decisions	O
,	O
solve	O
problems	O
,	O
and	O
monitor	O
their	O
own	O
progress	O
.	O

Similarly	O
,	O
there	O
were	O
no	O
significant	O
differences	O
identified	O
with	O
regards	O
to	O
general	O
health	O
or	O
health	O
service	O
utilisation	O
(	O
Table	O
4	O
).	O

Mean	O
early	O
pregnancy	O
25OHD	O
versus	O
month	O
of	O
first	O
antenatal	O
visit	O
is	O
displayed	O
in	O
Additional	O
file1	O
:	O
Fig	O
.	O

BMC	O
was	O
highly	O
correlated	O
to	O
body	O
weight	O
(	O
r	O
=	O
0	O
.	O
86	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
as	O
was	O
BMD	O
(	O
r	O
=	O
0	O
.	O
56	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
distributions	O
of	O
alleles	O
within	O
the	O
SNPs	O
of	O
interest	O
were	O
also	O
similar	O
between	O
the	O
two	O
groups	O
(	O
Table	O
1	O
).	O

CYP24A1	O
mutations	O
have	O
been	O
identified	O
as	B
a	O
potential	O
cause	O
of	O
IIH	O
.	O

A	O
P	O
-	O
value	O
≤	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Materials	O
and	O
Methods	O
Mice	O
The	O
129S1	O
/	O
SvImJ	O
(	O
129S1	O
)	O
males	O
,	O
129X1	O
/	O
SvJ	O
(	O
129X1	O
)	O
females	O
,	O
and	O
DBA	O
/	O
2J	O
mice	O
were	O
purchased	O
from	O
the	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
ME	O
)	O
at	O
age	O
6	O
wk	O
.	O

Our	O
findings	O
could	O
be	O
affected	O
by	O
unmeasured	O
or	O
inadequately	O
measured	O
confounding	O
variables	O
such	O
as	O
socioeconomic	O
status	O
which	O
could	O
vary	O
by	O
weight	O
and	O
race	O
and	O
could	O
possibly	O
affect	O
self	O
-	O
report	O
of	O
PNV	O
use	O
.	O

In	O
vitro	O
diagnostic	O
tools	O
such	O
as	O
serological	O
testing	O
,	O
for	O
example	O
,	O
radioallergosorbent	O
test	O
for	O
type	O
I	O
allergy	O
or	O
the	O
lymphocyte	O
transformation	O
test	O
for	O
type	O
IV	O
allergy	O
[	O
49	O
]	O
are	O
preferred	B
to	O
in	O
vivo	O
testing	O
.	O

There	O
are	O
some	O
potential	O
limitations	O
to	O
our	O
findings	O
.	O

In	O
Bangladesh	O
,	O
Parveen	O
and	O
colleagues	O
found	O
that	O
mothers	O
perceived	O
handwashing	O
is	O
an	O
important	O
approach	O
to	O
nurturing	O
their	O
newborns	O
and	O
young	O
children	O
and	O
that	O
they	O
were	O
more	O
likely	O
to	O
practice	O
the	O
behavior	O
when	O
supported	O
to	O
do	O
so	O
by	O
their	O
families	O
.	O

The	O
strength	O
of	O
this	O
study	O
is	O
its	O
focus	O
on	O
minority	O
women	O
who	O
are	O
underrepresented	O
in	O
published	O
GWG	O
interventions	O
yet	O
carry	O
increased	O
burden	O
of	O
gaining	O
excessively	O
during	O
pregnancy	O
.	O

Chromosome	O
distances	O
were	O
established	O
using	O
NCBI	O
build	O
37	O
.	O
1	O
.	O

Poor	O
vitamin	O
D	O
intakes	O
have	O
been	O
reported	O
among	O
pregnant	O
women	O
living	O
in	O
Ireland	O
[	O
5	O
].	O

Reactions	O
were	O
performed	O
in	O
a	O
final	O
volume	O
of	O
10	O
μl	O
using	O
5	O
.	O
0	O
μl	O
of	O
LightCycler	O
480	O
SYBR	O
Green	O
I	O
Master	O
(	O
Roche	O
),	O
2	O
.	O
0	O
μl	O
of	O
Aqua	O
dest	O
.,	O
10	O
μM	O
(	O
0	O
.	O
5	O
μl	O
)	O
of	O
each	O
primer	O
(	O
Table5	O
)	O
and	O
40	O
ng	O
(	O
2	O
μl	O
)	O
cDNA	O
.	O

RESULTS	O
Food	O
Intake	O
,	O
Weight	O
Gain	O
and	O
Glucose	O
Response	O
There	O
was	O
no	O
difference	O
in	O
body	O
weight	O
at	O
birth	O
and	O
weaning	O
between	O
the	O
offspring	O
born	O
to	O
dams	O
on	O
the	O
HV	O
diet	O
compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
a	O
RV	O
diet	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Madigan	O
text4baby	O
CONSORT	O
flow	O
diagram	O
.	O

Peripheral	O
ossifying	O
fibroma	O
resembles	O
PG	O
clinically	O
but	O
occurs	O
exclusively	O
in	O
the	O
gingiva	O
.	O

Articles	O
that	O
investigated	O
the	O
relationship	O
between	O
the	O
maternal	O
consumption	O
of	O
fish	O
or	O
seafood	O
and	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
were	O
included	O
.	O

After	O
intervention	O
,	O
the	O
two	O
groups	O
were	O
different	O
significantly	O
.	O

It	O
is	O
important	O
that	O
the	O
type	O
of	O
fish	O
consumed	O
is	O
low	O
in	O
mercury	O
.	O

In	O
pairwise	O
comparison	O
,	O
the	O
baseline	O
depression	O
score	O
and	O
the	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
142	O
).	O

In	O
addition	O
,	O
vitamin	O
C	O
may	O
help	O
to	O
regulate	O
adipogenesis	O
.	O

There	O
are	O
differences	O
in	O
optimal	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
but	O
nowadays	O
internationally	O
accepted	O
normal	O
range	O
is	O
between	O
75	O
nmol	O
/	O
L	O
and	O
200	O
nmol	O
/	O
L	O
,	O
and	O
we	O
consider	O
serum	O
level	O
below	O
75	O
nmol	O
/	O
L	O
and	O
below	O
2	O
nmol	O
/	O
L	O
as	O
insufficiency	O
and	O
deficiency	O
,	O
respectively	O
.	O
42325Even	O
it	O
seems	O
to	O
achieve	O
the	O
prevention	O
of	O
autoimmune	O
diseases	O
,	O
the	O
serum	O
level	O
of	O
vitamin	O
D	O
must	O
be	O
higher	O
than	O
the	O
level	O
required	O
to	O
reduce	O
osteoporosis	O
(	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
).	O
4In	O
attention	O
to	O
high	O
prevalence	O
of	O
MS	O
in	O
Iran	O
and	O
especially	O
in	O
Isfahan	O
which	O
is	O
about	O
43	O
.	O
5	O
/	O
100	O
,	O
0002627and	O
given	B
that	O
Iran	O
is	O
located	O
in	O
an	O
latitude	O
of	O
32	O
°	O
50	O
’	O
and	O
longitude	O
of	O
51	O
°	O
43	O
’	O
with	O
enough	O
sun	O
exposure	O
and	O
because	B
nobody	O
investigated	O
the	O
relationship	O
between	O
vitamin	O
D	O
,	O
as	B
an	O
environmental	O
agent	O
,	O
and	O
MS	O
disease	O
in	O
Iran	O
before	O
,	O
we	O
decided	O
to	O
compare	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
healthy	O
control	O
group	O
in	O
Isfahan	O
region	O
.	O

We	O
conducted	O
stratified	O
analyses	O
by	O
parity	O
status	O
to	O
assess	O
whether	O
the	O
trend	O
of	O
effectiveness	O
is	O
different	O
among	O
the	O
two	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

A	O
recent	O
mouse	O
study	O
by	O
Lambrot	O
et	O
al	O
.	O

Cross	O
-	O
sectional	O
,	O
observational	O
,	O
and	O
randomized	O
control	O
trials	O
'	O
literature	O
on	O
the	O
subject	O
published	O
between	O
2000	O
and	O
2011	O
served	O
as	O
the	O
main	O
sources	O
of	O
information	O
.	O

In	O
addition	O
education	O
level	O
was	O
associated	O
with	O
vitamin	O
D	O
status	O
in	O
our	O
pregnant	O
women	O
population	O
.	O

To	O
conclude	O
,	O
the	O
ICDS	O
scheme	O
is	O
a	O
comprehensive	O
approach	O
for	O
delivering	O
an	O
integrated	O
package	O
of	O
services	O
to	O
bring	O
about	O
a	O
significant	O
improvement	O
in	O
the	O
child	O
related	O
health	O
,	O
care	O
,	O
and	O
nutrition	O
practices	O
of	O
the	O
community	O
.	O

Wang	O
et	O
al	O
[	O
144	O
]	O
suggested	O
that	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
competes	O
with	O
PPARG	O
for	O
binding	O
to	O
the	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
).	O

Since	B
the	O
maternal	O
attitude	O
towards	O
the	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
fetal	O
birth	O
weight	O
,	O
we	O
reexamined	O
this	O
association	O
as	O
a	O
function	O
of	O
the	O
GR	O
genepolymorphisms	O
,	O
resembling	O
a	O
gene	O
-	O
environment	O
interaction	O
and	O
statistically	O
controlling	O
for	O
mothers	O
'	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
pregnancy	O
nutritional	O
habits	O
,	O
to	O
remove	O
any	O
potential	O
sources	O
of	O
statistical	O
bias	O
that	O
could	O
skew	O
our	O
data	O
.	O

The	O
influence	O
of	O
maternal	O
sensitization	O
on	O
the	O
immune	O
response	O
of	O
newborns	O
was	O
recently	O
shown	O
in	O
a	O
human	O
observational	O
study	O
of	O
AR	O
,	O
in	O
which	O
only	O
the	O
organ	O
-	O
specific	O
symptoms	O
of	O
the	O
mother	O
but	O
not	O
the	O
father	O
were	O
demonstrated	O
to	O
be	O
relevant	O
for	O
the	O
imprinting	O
of	O
the	O
child	O
[	O
55	O
].	O

IFA	O
supplements	O
have	O
also	O
been	O
found	O
to	O
reduce	O
the	O
preterm	O
delivery	O
rate	O
and	O
neonatal	O
mortality	O
attributable	O
to	O
prematurity	O
and	O
birth	O
asphyxia	O
.	O

All	O
authors	O
interpreted	O
the	O
data	O
,	O
critically	O
revised	O
the	O
draft	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
gave	O
final	O
approval	O
of	O
the	O
manuscript	O
to	O
be	O
published	O
.	O

This	O
agenda	O
is	O
ambitious	O
,	O
yet	O
it	O
can	O
and	O
must	O
be	O
accomplished	O
if	O
the	O
actions	O
are	O
to	O
be	O
given	O
the	O
visibility	O
,	O
funding	O
and	O
attention	O
they	O
deserve	O
.	O

Although	O
we	O
did	O
not	O
measure	O
reproductive	O
performance	O
,	O
we	O
speculate	O
that	O
the	O
higher	O
progesterone	O
concentrations	O
observed	O
may	O
be	O
associated	O
with	O
better	O
functioning	O
of	O
the	O
corpora	O
lutea	O
.	O

In	O
addition	O
,	O
they	O
summarise	O
the	O
actions	O
that	O
must	O
be	O
taken	O
to	O
fund	O
prevention	O
programs	O
,	O
address	O
health	O
care	O
access	O
and	O
bring	O
about	O
needed	O
change	O
in	O
health	O
care	O
systems	O
.	O

Topical	O
corticosteroid	O
treatment	O
should	O
be	O
initiated	O
when	O
clinically	O
indicated	O
,	O
with	O
the	O
least	O
potent	O
preparations	O
such	O
as	O
hydrocortisone	O
(	O
0	O
.	O
5	O
%	O
to	O
1	O
%),	O
reserving	O
more	O
potent	O
preparations	O
for	O
more	O
recalcitrant	O
areas	O
in	O
selected	O
patients	O
.	O

Discussion	O
Iron	O
deficiency	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
maternal	O
death	O
,	O
preterm	O
delivery	O
,	O
impaired	O
foetal	O
growth	O
and	O
development	O
,	O
low	O
birth	O
weight	O
,	O
increased	O
neonatal	O
mortality	O
and	O
impaired	O
infant	O
development	O
[	O
17	O
].	O

The	O
results	O
of	O
the	O
Behavioural	O
Risk	O
Factor	O
Surveillance	O
System	O
(	O
BRFSS	O
)	O
also	O
emphasize	O
the	O
role	O
of	O
income	O
and	O
marital	O
status	O
in	O
the	O
use	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
[	O
40	O
].	O

In	O
the	O
same	O
study	O
,	O
LM	O
area	O
also	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
.	O

Inspired	O
by	O
the	O
work	O
identifying	O
adult	O
enterotypes	O
by	O
Arumugam	O
et	O
al	O
.	O

Moreover	O
,	O
the	O
exposed	O
neonates	O
were	O
admitted	O
more	O
often	O
to	O
the	O
NICU	O
,	O
and	O
a	O
greater	O
proportion	O
presented	O
with	O
PNA	O
signs	O
.	O

Although	O
the	O
VitD	O
-	O
offspring	O
in	O
the	O
present	O
study	O
did	O
not	O
show	O
a	O
reduction	O
in	O
WT1	O
expression	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
did	O
alter	O
the	O
ratio	O
of	O
immature	O
-	O
to	O
-	O
mature	O
glomeruli	O
at	O
birth	O
by	O
extending	O
the	O
period	O
of	O
glomerular	O
maturation	O
.	O

As	B
there	O
was	O
a	O
strong	O
relationship	O
between	O
education	O
and	O
income	O
,	O
education	O
was	O
not	O
included	O
in	O
the	O
model	O
to	O
avoid	O
multi	O
-	O
colinearity	O
.	O

Results	O
Dams	O
and	O
pregnancies	O
No	O
differences	O
were	O
observed	O
in	O
weight	O
gain	O
,	O
litter	O
size	O
,	O
or	O
the	O
number	O
of	O
dead	O
pups	O
in	O
either	O
generation	O
between	O
the	O
mothers	O
in	O
the	O
SC	O
and	O
VitD	O
-	O
groups	O
(	O
data	O
not	O
shown	O
).	O

The	O
restriction	O
enzyme	O
Tsp509I	O
(	O
10	O
U	O
)	O
was	O
used	O
to	O
digest	O
the	O
PCR	O
products	O
at	O
65	O
°	O
C	O
for	O
4	O
hours	O
.	O

The	O
data	O
were	O
then	O
assembled	O
using	O
BeadStudio	O
methylation	O
software	O
(	O
version	O
1	O
.	O
9	O
.	O
0	O
;	O
Illumina	O
),	O
without	O
normalization	O
,	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

To	O
complete	O
the	O
network	O
,	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
can	O
both	O
inhibit	O
or	O
promote	O
gene	O
expression	O
whilst	O
their	O
own	O
expression	O
is	O
under	O
the	O
control	O
of	O
the	O
DNA	O
modifications	O
and	O
ncRNAs	O
they	O
promote	O
and	O
/	O
or	O
interact	O
with	O
.	O

However	O
,	O
studies	O
show	O
that	O
the	O
majority	O
of	O
South	O
African	O
women	O
only	O
seek	O
or	O
get	O
access	O
to	O
public	O
antenatal	O
care	O
in	O
their	O
second	O
trimester	O
of	O
pregnancy	O
[	O
27	O
–	O
30	O
],	O
which	O
might	O
be	O
too	O
late	O
for	O
the	O
routine	O
supplementation	O
programme	O
or	O
other	O
interventions	O
to	O
be	O
effective	O
.	O

Thus	B
using	O
patient	O
views	O
to	O
evaluate	O
health	O
care	O
has	O
been	O
criticized	O
[	O
30	O
],	O
regarding	O
their	O
responses	O
as	O
a	O
mixture	O
of	O
the	O
healthcare	O
performance	O
measurement	O
and	O
the	O
respondent	O
'	O
s	O
reflection	O
.	O

wks	O
,	O
weeks	O
;	O
d	O
,	O
days	O
,	O
pp	O
,	O
postpartum	O
Maternal	O
socio	O
-	O
economics	O
and	O
-	O
demographics	O
Socio	O
-	O
economic	O
and	O
-	O
demographic	O
data	O
are	O
collected	O
at	O
phase	O
1	O
by	O
means	O
of	O
a	O
structured	O
interview	O
.	O

In	O
the	O
phthalates	O
and	O
BPA	O
class	O
,	O
there	O
was	O
a	O
9	O
g	O
birth	O
weight	O
increase	O
in	O
response	O
to	O
a	O
10	O
-	O
fold	O
increase	O
exposure	O
to	O
MEOHP	O
,	O
and	O
a	O
10	O
-	O
fold	O
increase	O
in	O
MEHP	O
exposure	O
was	O
associated	O
with	O
a	O
7	O
g	O
decrease	O
in	O
birth	O
weight	O
.	O

Statistical	O
analyses	O
We	O
compared	O
the	O
distributions	O
of	O
child	O
and	O
maternal	O
variables	O
across	O
maternal	O
free	O
sugar	O
intake	O
quintiles	O
using	O
F	O
-	O
statistics	O
for	O
differences	O
in	O
continuous	O
variables	O
and	O
Chi	O
-	O
squared	O
tests	O
for	O
differences	O
in	O
categorical	O
variables	O
.	O

Consenting	O
subjects	O
who	O
were	O
present	O
in	O
the	O
village	O
on	O
an	O
allotted	O
day	O
were	O
recruited	O
.	O

Indeed	O
,	O
PGCs	O
,	O
which	O
represent	O
an	O
interim	O
stage	O
of	O
the	O
developing	O
germ	O
line	O
that	O
requires	O
miRNA	O
-	O
mediated	O
proliferation	O
and	O
differentiation	O
with	O
some	O
pi	O
/	O
esiRNA	O
-	O
mediated	O
genome	O
protection	O
,	O
express	O
greater	O
levels	O
of	O
miRNAs	O
and	O
reduced	O
levels	O
of	O
piRNAs	O
and	O
esiRNAs	O
compared	O
with	O
the	O
mature	O
gametes	O
and	O
early	O
zygote	O
(	O
Garcia	O
-	O
Lopez	O
et	O
al	O
.	O
2015	O
).	O

As	O
a	O
result	O
the	O
calculated	O
cost	O
per	O
woman	O
treated	O
is	O
USD	O
0	O
.	O
76	O
per	O
year	O
(	O
USD133900	O
/	O
175581	O
).	O

Currently	O
,	O
researchers	O
are	O
attempting	O
to	O
reveal	O
the	O
non	O
-	O
classical	O
influence	O
of	O
cholecalciferol	O
on	O
health	O
.	O

Other	O
variables	O
abstracted	O
from	O
infant	O
medical	O
records	O
included	O
infant	O
sex	O
and	O
gestational	O
age	O
at	O
birth	O
(	O
calculated	O
from	O
last	O
menstrual	O
period	O
or	O
from	O
second	O
trimester	O
ultrasound	O
if	O
the	O
two	O
estimated	O
differed	O
by	O
>	O
10	O
days	O
).	O

It	O
is	O
possible	O
that	O
in	O
previous	O
studies	O
where	O
no	O
adjustment	O
for	O
confounding	O
factors	O
was	O
performed	O
,	O
the	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
GDM	O
reflects	O
shared	O
factors	O
such	O
as	O
an	O
unhealthy	O
lifestyle	O
or	O
adiposity	O
[	O
26	O
].	O

Maternal	O
anthropometric	O
measurements	O
Maternal	O
weight	O
and	O
mid	O
-	O
upperarm	O
circumference	O
(	O
MUAC	O
)	O
are	O
obtained	O
at	O
each	O
phase	O
(	O
1	O
to	O
8	O
),	O
and	O
height	O
only	O
at	O
phase	O
1	O
and	O
5	O
.	O

Grain	O
type	O
and	O
processing	O
affect	O
IMF	O
content	O
[	O
115	O
]:	O
maize	O
is	O
more	O
effective	O
at	O
increasing	O
IMF	O
content	O
than	O
is	O
barley	O
,	O
followed	O
by	O
sorghum	O
.	O

[	O
48	O
],	O
which	O
has	O
been	O
validated	O
against	O
weighed	O
dietary	O
records	O
and	O
modified	O
in	O
the	O
light	O
of	O
a	O
more	O
recent	O
weighed	O
dietary	O
survey	O
[	O
13	O
].	O

Her	O
only	O
medication	O
was	O
prenatal	O
vitamins	O
and	O
she	O
denied	O
any	O
alcohol	O
,	O
tobacco	O
,	O
or	O
drug	O
use	O
.	O

PubMed	O
Central	O
:	O

Conclusion	O
We	O
found	O
that	O
healthier	O
maternal	O
dietary	O
patterns	O
during	O
early	O
pregnancy	O
might	O
be	O
associated	O
with	O
lower	O
risk	O
of	O
low	O
birth	O
weight	O
.	O

National	O
Osteoporosis	O
Foundation	O
'	O
s	O
(	O
NOF	O
)	O
recommends	O
400	O
-	O
800IU	O
vitamin	O
D	O
for	O
pregnant	O
women	O
.	O

We	O
cannot	O
overlook	O
that	O
the	O
long	O
time	O
adherence	O
to	O
a	O
specific	O
diet	O
affects	O
health	O
outcomes	O
.	O

We	O
used	O
observed	O
handwashing	O
as	O
our	O
primary	O
outcome	O
of	O
interest	O
.	O

Many	O
of	O
them	O
contradict	O
each	O
other	O
,	O
or	O
are	O
at	O
least	O
incoherent	O
.	O

1	O
Map	O
of	O
study	O
area	O
,	O
Shonjibon	O
Trial	O
(	O
created	O
by	O
the	O
authors	O
)	O
Cluster	O
selection	O
We	O
will	O
define	O
a	O
cluster	O
as	O
a	O
BRAC	O
PO	O
area	O
,	O
which	O
will	O
consist	O
of	O
a	O
pair	O
of	O
BRAC	O
village	O
field	O
workers	O
(	O
called	O
Shasthya	O
Kormi	O
or	O
SK	O
)	O
and	O
their	O
20	O
BRAC	O
village	O
volunteers	O
(	O
referred	O
to	O
as	O
Shasthya	O
Shebika	O
or	O
SS	O
)	O
who	O
are	O
supervised	O
by	O
a	O
single	O
BRAC	O
PO	O
.	O

There	O
are	O
also	O
other	O
factors	O
that	O
are	O
influenced	O
by	O
season	O
:	O
diet	O
[	O
29	O
],	O
physical	O
activity	O
levels	O
[	O
30	O
],	O
and	O
even	O
body	O
mass	O
index	O
[	O
31	O
].	O

Results	O
Figure	O
1outlines	O
the	O
flow	O
of	O
participants	O
.	O

As	O
has	O
been	O
pointed	O
out	O
,	O
119the	O
relationship	O
between	O
the	O
MGM	O
in	O
particular	O
,	O
her	O
daughter	O
and	O
grandchild	O
represents	O
a	O
100	O
years	O
of	O
nutritional	O
flow	O
,	O
including	O
intrauterine	O
,	O
genetic	O
,	O
mitochondrial	O
and	O
environmental	O
nutritional	O
pathways	O
and	O
these	O
data	O
illustrate	O
this	O
effect	O
.	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	O
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

The	O
main	O
groups	O
of	O
PUFA	O
are	O
omega	O
-	O
6	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
of	O
which	O
some	O
need	O
to	O
be	O
supplied	O
through	O
the	O
diet	O
.	O

The	O
effects	O
of	O
text4baby	O
offer	O
lessons	O
for	O
future	O
scalable	O
mHealth	O
programs	O
and	O
suggest	O
the	O
need	O
to	O
study	O
dose	O
-	O
response	O
effects	O
of	O
these	O
interventions	O
.	O

The	O
content	O
of	O
this	O
article	O
has	O
not	O
been	O
previously	O
presented	O
.	O

Assuming	O
a	O
20	O
%	O
loss	O
to	O
follow	O
-	O
up	O
and	O
allowing	O
for	O
protocol	O
violations	O
we	O
intended	O
to	O
recruit	O
3050	O
children	O
for	O
18	O
months	O
follow	O
-	O
up	O
.	O

Consequently	B
,	O
the	O
cannabinoid	O
receptor	O
activity	O
may	O
be	O
modified	O
.	O

Maternal	O
diet	O
effect	O
;	O
p	O
<	O
0	O
.	O
001	O
;	O
postnatal	O
diet	O
effect	O
;	O
p	O
<	O
0	O
.	O
001	O
.	O

In	O
adipose	O
tissue	O
,	O
it	O
appears	O
that	O
PPARγ	O
transcriptionally	O
controls	O
FGF21	O
,	O
which	O
then	O
acts	O
as	O
an	O
autocrine	O
or	O
paracrine	O
way	O
to	O
increase	O
PPARγ	O
transcriptional	O
activity	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
system	O
(	O
Wang	O
et	O
al	O
.,	O
2008	O
;	O
Dutchak	O
et	O
al	O
.,	O
2012	O
).	O

[	O
18	O
]	O
showed	O
in	O
a	O
recent	O
study	O
in	O
Thai	O
children	O
that	O
vitamin	O
D	O
deficiency	O
was	O
also	O
highly	O
prevalent	O
in	O
school	O
children	O
aged	O
3	O
–	O
12	O
.	O
9	O
years	O
.	O

For	O
bivariate	O
analyses	O
,	O
we	O
classified	O
participants	O
into	O
4	O
sleep	O
duration	O
categories	O
:	O
≤	O
4	O
,	O
5	O
-	O
8	O
,	O
9	O
,	O
and	O
≥	O
10	O
hours	O
,	O
respectively	O
.	O

The	O
frequency	O
of	O
PTB	O
was	O
10	O
%	O
among	O
white	O
women	O
and	O
15	O
%	O
among	O
non	O
-	O
white	O
women	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Translation	O
of	O
a	O
gestational	O
diabetes	O
nutrition	O
model	O
of	O
care	O
into	O
practice	O
:	O
results	O
from	O
an	O
implementation	O
project	O
Background	O
Reduced	O
need	O
for	O
insulin	O
therapy	O
in	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
)	O
has	O
been	O
documented	O
in	O
a	O
study	O
validating	O
American	O
Nutrition	O
Practice	O
Guidelines	O
,	O
which	O
recommend	O
at	B
least	I
3	O
dietitian	O
visits	O
.	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

Upstream	O
signaling	O
events	O
of	O
'	O
mTOR	O
signaling	O
'	O
include	O
alterations	O
in	O
amino	O
acid	O
availability	O
,	O
abundance	O
of	O
hormones	O
,	O
AMP	O
and	O
growth	O
factors	O
[	O
32	O
].	O

Across	O
the	O
five	O
visits	O
made	O
in	O
the	O
neonatal	O
period	O
,	O
intervention	O
households	O
were	O
between	O
5	O
.	O
7	O
and	O
15	O
.	O
2	O
times	O
as	O
likely	B
as	O
control	O
households	O
to	O
have	O
soap	O
and	O
water	O
present	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
.	O

No	O
specific	O
article	O
examined	O
specific	O
aspects	O
such	O
as	O
room	O
temperature	O
,	O
lack	O
of	O
equipment	O
,	O
time	O
spent	O
with	O
the	O
mother	O
,	O
or	O
proximity	O
to	O
other	O
neonates	O
.	O

A	O
70	O
%	O
lower	O
risk	O
of	O
PTB	O
was	O
found	O
for	O
women	O
≥	O
20	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
in	O
a	O
study	O
by	O
Perez	O
-	O
Ferre	O
et	O
al	O
.	O

showing	O
“	O
hyperlocomotion	O
”)[	O
9	O
],[	O
10	O
].	O

GDM	O
increases	O
the	O
risk	O
of	O
adverse	O
pregnancy	O
and	O
neonatal	O
outcomes	O
,	O
and	O
the	O
risk	O
of	O
obesity	O
,	O
metabolic	O
syndrome	O
,	O
diabetes	O
,	O
and	O
cardiovascular	O
disease	O
in	O
later	O
life	O
both	O
of	O
the	O
mother	O
and	O
the	O
child	O
[	O
13	O
].	O

Collectively	O
,	O
the	O
findings	O
from	O
this	O
pilot	O
study	O
provides	O
evidence	O
consistent	O
with	O
the	O
notion	O
that	O
glucose	O
homeostasis	O
in	O
pregnancy	O
is	O
sensitive	O
to	O
maternal	O
habitual	O
short	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
.	O

No	O
differences	O
in	O
large	O
for	O
gestational	O
age	O
,	O
macrosomia	O
,	O
neonatal	O
hypoglycemia	O
,	O
admission	O
to	O
neonatal	O
intensive	O
care	O
,	O
or	O
fetal	O
anomalies	O
were	O
observed	O
.	O

Normal	O
embryo	O
development	O
requires	O
a	O
maternal	O
and	O
paternal	O
contribution	O
,	O
generation	O
of	O
uniparental	O
embryos	O
by	O
pronuclear	O
transplantation	O
results	O
in	O
developmental	O
failure	O
(	O
Barton	O
et	O
al	O
.	O
1984	O
;	O
McGrath	O
&	O
Solter1984	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
The	O
influence	O
of	O
vitamin	O
D	O
on	O
the	O
activity	O
and	O
the	O
morphology	O
of	O
sperm	O
(	O
after	O
:	O
Grzechocinska	O
B	O
,	O
Dabrowski	O
FA	O
,	O
Cyganek	O
A	O
,	O
Wielgos	O
M	O
.	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
impaired	O
fertility	O
treatment	O
[	O
2	O
]).	O

This	O
study	O
examined	O
the	O
relationship	O
between	O
mothers	O
'	O
stress	O
and	O
attitude	O
towards	O
their	O
pregnancies	O
,	O
placental	O
glucocorticoid	O
receptors	O
(	O
GRs	O
)	O
and	O
growth	O
arrest	O
-	O
specific	O
transcript	O
5	O
(	O
GAS5	O
)	O
expression	O
,	O
and	O
the	O
status	O
of	O
GR	O
polymorphism	O
,	O
with	O
their	O
infants	O
'	O
birth	O
weights	O
.	O

Our	O
results	O
are	O
similar	O
to	O
those	O
of	O
the	O
HAPO	O
trial	O
,	O
which	O
found	O
that	O
maternal	O
insulin	O
sensitivity	O
and	O
gestational	O
diabetes	O
were	O
not	O
associated	O
with	O
25OHD	O
[	O
7	O
].	O

Greenwood	O
et	O
al	O
[	O
30	O
]	O
conducted	O
a	O
study	O
to	O
test	O
effects	O
of	O
genotypes	O
and	O
nutrition	O
during	O
the	O
immediate	O
postweaning	O
period	O
on	O
IMF	O
contents	O
in	O
5	O
muscles	O
,	O
marbling	O
,	O
and	O
subcutaneous	O
fat	O
(	O
rib	O
fat	O
or	O
P8	O
rump	O
fat	O
)	O
in	O
Bos	O
Taurus	O
steers	O
.	O

Furthermore	O
,	O
it	O
must	O
be	O
noted	O
that	O
the	O
effect	O
of	O
depression	O
itself	O
as	O
a	O
factor	O
in	O
autism	O
separate	O
from	O
the	O
administration	O
of	O
SSRIs	O
is	O
a	O
possibility	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
8	O
Results	O
of	O
three	O
scenarios	O
of	O
preterm	O
-	O
specific	O
mortality	O
reduction	O
to	O
2025	O
.	O

The	O
relatively	O
greater	O
calcium	O
and	O
phosphorus	O
concentration	O
in	O
US	O
infant	O
formulas	O
compared	O
to	O
human	O
milk	O
may	O
also	O
be	O
protective	O
against	O
rickets	O
in	O
some	O
infants	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
between	O
serum	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
and	O
S	O
-	O
ECC	O
in	O
preschool	O
children	O
.	O

Categorical	O
variables	O
Children	O
were	O
further	O
classified	O
,	O
post	O
hoc	O
,	O
according	O
to	O
their	O
asthmatic	O
/	O
atopic	O
status	O
,	O
thus	O
defining	O
a	O
four	O
-	O
category	O
variable	O
(	O
no	O
atopy	O
or	O
asthma	O
,	O
atopy	O
only	O
,	O
nonatopic	O
asthma	O
and	O
atopic	O
asthma	O
),	O
and	O
according	O
to	O
their	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
(	O
n	O
=	O
0	O
,	O
1	O
and	O
≥	O
2	O
).	O

The	O
risk	O
of	O
belonging	O
to	O
the	O
high	O
or	O
middle	O
psychotic	O
-	O
like	O
symptom	O
group	O
compared	O
to	O
the	O
low	O
level	O
group	O
was	O
significantly	O
lower	O
among	O
women	O
with	O
a	O
high	O
intake	O
of	O
white	O
fish	O
(	O
cod	O
/	O
saithe	O
/	O
pike	O
)	O
or	O
total	O
fish	O
and	O
seafood	O
products	O
.	O

Comparisons	O
among	O
groups	O
were	O
performed	O
by	O
calculating	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
(	O
kcal	O
/	O
kg	O
)	O
at	O
each	O
time	O
point	O
.	O

However	O
,	O
the	O
present	O
study	O
has	O
some	O
limitations	O
.	O

have	O
recently	O
shown	O
that	O
infants	O
with	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
have	O
a	O
higher	O
risk	O
of	O
childhood	O
wheezing	O
[	O
7	O
,	O
11	O
].	O

However	O
,	O
the	O
present	O
study	O
is	O
the	O
first	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
in	O
Belgium	O
.	O

BMI	O
:	O
body	O
mass	O
index	O
.#:	O
n	O
=	O
8956	O
.	O

We	O
have	O
previously	O
suggested	O
the	O
U	O
-	O
shaped	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
inflammatory	O
biomarkers	O
in	O
cord	O
blood	O
[	O
5	O
].	O

After	O
28	O
hours	O
of	O
incubation	O
with	O
VD2or	O
VD3	O
,	O
the	O
cells	O
demonstrated	O
lower	O
production	O
of	O
granulocytes	O
and	O
macrophages	O
colony	O
stimulating	O
factor	O
,	O
interleukin	O
6	O
,	O
Tumor	O
Necrosis	O
Factor	O
,	O
and	O
an	O
increase	O
in	O
mRNA	O
expression	O
for	O
Cathelicidin	O
Antimicrobial	O
Peptide	O
(	O
CAP	O
),	O
which	O
has	O
a	O
direct	O
antibacterial	O
activity	O
[	O
15	O
].	O

Bonferroni	O
-	O
corrected	O
P	O
values	O
.	O

Table3details	O
actions	O
for	O
the	O
seven	O
constituencies	O
and	O
Figures9	O
,	O
10	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
14provide	O
examples	O
of	O
action	O
.	O

Cathelicidin	O
concentration	O
in	O
the	O
deficient	O
group	O
did	O
not	O
correlate	O
with	O
percent	O
fat	O
,	O
BMI	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
prior	O
to	O
delivery	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
,	O
child	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
,	O
or	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
.	O

We	O
found	O
that	O
black	O
race	O
was	O
associated	O
with	O
a	O
significantly	O
greater	O
incidence	O
of	O
SGA	O
,	O
and	O
that	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
together	O
were	O
associated	O
with	O
even	O
greater	O
odds	O
of	O
SGA	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
perinatal	O
depression	O
is	O
more	O
frequent	O
and	O
serious	O
in	O
primiparous	O
women	O
than	O
multiparous	O
women	O
[	O
75	O
,	O
76	O
].	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
a	O
)	O
and	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
nmol	O
/	O
L	O
)	O
(	O
b	O
)	O
in	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

It	O
is	O
known	O
that	O
the	O
two	O
ends	O
of	O
the	O
birth	O
weight	O
spectrum	O
,	O
low	O
and	O
high	O
birth	O
weight	O
,	O
are	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
cardiovascular	O
events	O
in	O
childhood	O
[	O
6	O
–	O
8	O
]	O
and	O
adult	O
life	O
[	O
9	O
,	O
10	O
].	O

Interestingly	O
,	O
the	O
findings	O
for	O
atopy	O
became	O
stronger	O
when	O
we	O
examined	O
the	O
association	O
with	O
multiple	O
sensitisation	O
.	O

Discussion	O
Our	O
findings	O
indicate	O
that	O
provision	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
overweight	O
or	O
obese	O
women	O
was	O
not	O
associated	O
with	O
effects	O
on	O
infant	O
growth	O
,	O
measures	O
of	O
adiposity	O
,	O
and	O
neurodevelopmental	O
outcomes	O
at	O
6	O
months	O
of	O
age	O
.	O

Personnel	O
costs	O
were	O
imputed	O
based	B
on	I
information	O
obtained	O
from	O
interviews	O
with	O
district	O
,	O
commune	O
and	O
village	O
health	O
workers	O
about	O
their	O
total	O
salary	O
and	O
the	O
proportion	O
of	O
time	O
they	O
spent	O
on	O
this	O
intervention	O
.	O

Results	O
were	O
qualitatively	O
the	O
same	O
when	O
infants	O
born	O
before	O
37	O
weeks	O
gestation	O
were	O
excluded	O
(	O
see	O
Additional	O
file	O
1	O
:	O
Supplementary	O
Information	O
).	O

Our	O
study	O
was	O
implicitly	O
limited	O
to	O
congenital	O
cryptorchidism	O
because	O
the	O
literature	O
search	O
did	O
not	O
yield	O
any	O
case	O
–	O
control	O
or	O
cohort	O
studies	O
that	O
addressed	O
the	O
question	O
of	O
prenatal	O
exposure	O
to	O
estrogenic	O
compounds	O
and	O
acquired	O
cryptorchidism	O
in	O
humans	O
.	O

summarized	O
causes	O
of	O
prolonged	O
labor	O
,	O
including	O
“	O
fetal	O
malposition	O
,	O
fetopelvic	O
disproportion	O
,	O
excess	O
sedation	O
,	O
inadequate	O
contraction	O
,	O
and	O
rupture	O
of	O
fetal	O
membranes	O
before	O
the	O
onset	O
of	O
active	O
labor	O
.”	O
However	O
,	O
these	O
complications	O
differ	O
in	O
severity	O
and	O
may	O
require	O
varied	O
quantity	O
of	O
induction	O
agent	O
used	O
at	O
distinctive	O
stages	O
of	O
labor	O
.	O

Closing	O
gaps	O
in	O
coverage	O
,	O
equity	O
and	O
quality	O
In	O
order	O
for	O
health	O
services	O
to	O
save	O
the	O
maximum	O
number	O
of	O
lives	O
,	O
coverage	O
,	O
quality	O
and	O
equity	O
need	O
to	O
be	O
high	O
;	O
thus	B
ensuring	O
high	O
coverage	O
of	O
care	O
means	O
reaching	O
every	O
woman	O
,	O
mother	O
-	O
to	O
-	O
be	O
,	O
mother	O
,	O
newborn	O
,	O
child	O
and	O
family	O
with	O
targeted	O
interventions	O
.	O

Other	O
systems	O
were	O
normal	O
.	O

Thus	B
,	O
animals	O
with	O
low	O
genetic	O
potential	O
for	O
QG	O
are	O
not	O
recommended	O
for	O
a	O
long	O
fattening	O
stage	O
,	O
which	O
would	O
result	O
in	O
low	O
feed	O
efficiency	O
.	O

Study	O
midwifes	O
and	O
/	O
or	O
fieldworkers	O
collect	O
birth	O
data	O
(	O
phase	O
4	O
)	O
within	O
a	O
window	O
of	O
12	O
h	O
.	O
Postnatal	O
data	O
are	O
collected	O
at	O
6	O
weeks	O
(+	O
14	O
days	O
)	O
(	O
phase	O
5	O
);	O
24	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
6	O
);	O
6	O
weeks	O
post	O
measles	O
immunisation	O
(±	O
3	O
days	O
)	O
(	O
phase	O
7	O
)	O
or	O
30	O
weeks	O
(+	O
30	O
days	O
)	O
if	O
measles	O
immunization	O
was	O
not	O
given	O
between	O
24	O
and	O
28	O
weeks	O
;	O
and	O
52	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
8	O
)	O
postnatal	O
age	O
.	O

For	O
care	O
of	O
preterm	O
babies	O
,	O
the	O
emphasis	O
is	O
on	O
rapidly	O
scaling	O
up	O
implementations	O
,	O
so	B
that	O
the	O
maximum	O
number	O
of	O
preterm	O
babies	O
and	O
their	O
mothers	O
benefit	O
.	O

Bone	O
morphogenic	O
proteins	O
(	O
BMPs	O
)	O
are	O
members	O
of	O
the	O
transforming	O
growth	O
factor	O
β	O
superfamily	O
(	O
TGF	O
-	O
β	O
).	O

Rhinitis	O
Significant	O
nasal	O
symptoms	O
occur	O
in	O
approximately	O
30	O
%	O
of	O
pregnant	O
women	O
[	O
23	O
].	O

Implement	O
•	O
Strengthen	O
health	O
systems	O
for	O
quality	O
maternal	O
and	O
neonatal	O
care	O
,	O
including	O
improved	O
community	O
awareness	O
and	O
demand	O
for	O
RMNCH	O
services	O
and	O
adopt	O
policies	O
to	O
promote	O
universal	O
access	O
to	O
quality	O
preconception	O
and	O
maternal	O
and	O
perinatal	O
services	O
.	O

We	O
sought	O
to	O
increase	O
the	O
convenience	O
of	O
handwashing	O
by	O
providing	O
soap	O
and	O
handwashing	O
stations	O
and	O
encouraged	O
maintenance	O
of	O
soap	O
and	O
water	O
at	O
handwashing	O
locations	O
throughout	O
the	O
newborn	O
period	O
.	O

A	O
further	O
limitation	O
is	O
the	O
possibility	O
that	O
deceased	O
grandparents	O
would	O
have	O
different	O
patterns	O
of	O
association	O
with	O
their	O
grandchildren	O
than	O
those	O
living	O
.	O

During	O
neuronal	O
development	O
,	O
SIRT1	O
has	O
a	O
important	O
role	O
in	O
promoting	O
xonal	O
elongation	O
,	O
neurite	O
outgrowth	O
,	O
and	O
dendritic	O
branching	O
via	O
several	O
targets	O
and	O
mechanisms	O
(	O
19	O
).	O

It	O
is	O
noteworthy	O
that	O
there	O
are	O
few	O
studies	O
assessing	O
the	O
birth	O
anthropometric	O
measurements	O
along	O
the	O
maternal	O
dietary	O
patterns	O
[	O
16	O
].	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

For	O
example	O
,	O
we	O
have	O
shown	O
that	O
DVD	O
-	O
deficient	O
rats	O
have	O
enhanced	O
locomotion	O
in	O
response	O
to	O
the	O
psychomimetic	O
agents	O
such	O
as	O
NMDA	O
antagonist	O
MK	O
-	O
801	O
[	O
10	O
],[	O
12	O
].	O

Considering	O
type	O
of	O
pet	O
,	O
the	O
relationship	O
for	O
no	O
pet	O
compared	O
to	O
1	O
or	O
>	O
1	O
dog	O
(	O
37	O
.	O
7	O
,	O
46	O
.	O
1	O
,	O
49	O
.	O
9	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
001	O
)	O
was	O
similar	O
to	O
that	O
for	O
no	O
pet	O
versus	O
1	O
or	O
>	O
1	O
cat	O
(	O
37	O
.	O
7	O
,	O
43	O
.	O
0	O
,	O
46	O
.	O
5	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
065	O
).	O

While	O
this	O
small	O
body	O
of	O
evidence	O
is	O
largely	O
composed	O
of	O
exploratory	O
in	O
vivo	O
high	O
-	O
dose	O
range	O
studies	O
,	O
it	O
does	O
set	O
a	O
precedent	O
for	O
the	O
existence	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

Schizophrenia	O
is	O
a	O
multifactorial	O
disorder	O
with	O
strong	O
genetic	O
vulnerability	O
and	O
the	O
vulnerability	O
might	O
include	O
metabolic	O
aberrations	O
.	O

Our	O
correlation	O
estimates	O
of	O
0	O
.	O
15	O
of	O
the	O
child	O
at	O
age	O
0	O
with	O
the	O
mother	O
rising	O
to	O
0	O
.	O
25	O
at	O
age	O
9	O
and	O
averaging	O
at	O
0	O
.	O
25	O
in	O
adulthood	O
is	O
consistent	O
with	O
this	O
with	O
the	O
caveat	O
that	O
no	O
change	O
was	O
seen	O
between	O
age	O
0	O
and	O
5	O
.	O

Discussion	O
No	O
study	O
has	O
yet	O
been	O
conducted	O
to	O
assess	O
the	O
relationship	O
between	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
anthropometric	O
indicators	O
by	O
categorizing	O
mothers	O
based	O
on	O
BMI	O
.	O

Supplementing	O
rumen	O
-	O
protected	O
vitamin	O
C	O
in	O
a	O
high	O
sulfur	O
diet	O
increased	O
the	O
MS	O
and	O
the	O
percentage	O
of	O
Choice	O
grade	O
beef	O
in	O
Angus	O
cross	O
steers	O
[	O
151	O
].	O

Differences	O
of	O
longitudinal	O
ontogenetic	O
regulation	O
among	O
LP	O
and	O
AP	O
offspring	O
Considering	O
two	O
adjacent	O
ontogenetic	O
stages	O
within	O
one	O
treatment	O
group	O
,	O
significantly	O
regulated	O
transcripts	O
were	O
determined	O
.	O

For	O
example	O
,	O
based	B
on	I
the	O
polymorphic	O
profile	O
and	O
our	O
brief	O
assessment	O
of	O
mothers	O
'	O
attitude	O
towards	O
the	O
pregnancy	O
,	O
we	O
could	O
screen	O
noninvasively	O
and	O
identify	O
mothers	O
during	O
pregnancy	O
that	O
may	O
benefit	O
from	O
stress	O
-	O
management	O
strategies	O
,	O
and	O
this	O
could	O
possibly	O
dramatically	O
improve	O
health	O
outcomes	O
for	O
the	O
mother	O
as	O
well	O
as	O
the	O
fetus	O
.	O

)	O
52	O
.	O
50	O
±	O
14	O
.	O
25HF	O
(	O
n	O
.	O
u	O
.	O

In	O
addition	O
to	O
the	O
uncertainty	O
concerning	O
the	O
optimal	O
vitamin	O
D	O
intakes	O
preventing	O
vitamin	O
D	O
deficiency	O
,	O
there	O
exists	O
also	O
a	O
lack	O
of	O
recommendations	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

Surgeon	O
General	O
issued	O
“	O
A	O
Call	O
to	O
Action	O
to	O
Support	O
Breastfeeding	O
.”	O
42This	O
document	O
urged	O
more	O
research	O
support	O
for	O
topics	O
related	O
to	O
lactation	O
.	O

The	O
primary	O
form	O
of	O
vitamin	O
D	O
,	O
colecalciferol	O
(	O
vitamin	O
D3	O
),	O
is	O
available	O
from	O
two	O
sources	O
:	O
skin	O
exposure	O
to	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
in	O
sunlight	O
and	O
diet	O
.	O

(	O
2014	O
)	O
Only	O
studies	O
that	O
measured	O
both	O
adverse	O
phenotypes	O
and	O
associated	O
epigenetic	O
changes	O
in	O
response	O
to	O
an	O
environmental	O
exposure	O
were	O
reviewed	O
.	O

However	O
this	O
recommended	O
level	O
,	O
which	O
was	O
largely	O
arbitrarily	O
set	O
,	O
seems	O
to	O
be	O
less	O
helpful	O
to	O
improve	O
the	O
nutritional	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
.	O

Conclusion	O
Low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
seen	O
in	O
Hispanic	O
infants	O
,	O
but	O
their	O
functional	O
significance	O
is	O
uncertain	O
related	O
to	O
bone	O
health	O
in	O
a	O
southern	O
US	O
setting	O
.	O

Red	O
text	O
indicates	O
q	O
<	O
0	O
.	O
10	O
.	O

BMI	O
—	O
Body	O
Mass	O
Index	O
;	O
WC	O
—	O
Waist	O
Circumference	O
;	O
HP	O
—	O
Hip	O
Circumference	O
;	O
BF	O
—	O
Body	O
Fat	O
;	O
SBP	O
—	O
Systolic	O
Blood	O
Pressure	O
;	O
DBP	O
—	O
Diastolic	O
Blood	O
;	O
HR	O
—	O
Heart	O
Rate	O
;	O
SDNN	O
—	O
Standard	O
Deviation	O
Normal	O
-	O
to	O
-	O
Normal	O
Intervals	O
;	O
RMSSD	O
—	O
Root	O
Mean	O
Square	O
of	O
Successive	O
Differences	O
;	O
pNN50	O
—	O
Percentage	O
of	O
Differences	O
Between	O
Adjacent	O
Normal	O
-	O
to	O
-	O
Normal	O
Intervals	O
that	O
is	O
Greater	O
than	O
50	O
Milliseconds	O
;	O
LF	O
(	O
n	O
.	O
u	O
.	O

Specifically	O
,	O
we	O
disconfirmed	O
our	O
first	O
hypothesis	O
that	O
there	O
was	O
no	O
direct	O
treatment	O
effect	O
of	O
text4baby	O
.	O

If	O
the	O
pregnancy	O
test	O
is	O
positive	O
and	O
the	O
pregnancy	O
is	O
within	O
the	O
first	O
trimester	O
,	O
the	O
Field	O
Implementers	O
will	O
register	O
the	O
mother	O
and	O
seek	O
written	O
consent	O
.	O

The	O
Efficacy	O
and	O
Safety	O
of	O
a	O
High	O
Dose	O
of	O
Vitamin	O
D	O
in	O
Mothers	O
with	O
Gestational	O
Diabetes	O
Mellitus	O
:	O
A	O
Randomized	O
Controlled	O
Clinical	O
Trial	O
Abstract	O
Background	O
:	O
During	O
pregnancy	O
and	O
lactation	O
outstanding	O
changes	O
occur	O
in	O
mother	O
’	O
s	O
vitamin	O
D	O
metabolism	O
.	O

Several	O
biologic	O
mechanisms	O
underlying	O
the	O
nutritional	O
programming	O
,	O
which	O
become	O
altered	O
after	O
the	O
exposure	O
to	O
a	O
maternal	O
restricted	O
diet	O
during	O
pregnancy	O
,	O
have	O
been	O
identified	O
.	O

Conclusions	O
In	O
summary	O
,	O
we	O
have	O
demonstrated	O
that	O
in	O
the	O
rat	O
,	O
pre	O
-	O
and	O
postnatal	O
nutritional	O
histories	O
together	O
influence	O
both	O
ovarian	O
function	O
and	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
in	O
female	O
offspring	O
.	O

Vitamin	O
A	O
and	O
E	O
status	O
will	O
be	O
determined	O
using	O
high	O
pressure	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
and	O
ultraviolet	O
light	O
detection	O
[	O
71	O
].	O

Vitamin	O
D	O
status	O
will	O
be	O
determined	O
by	O
measuring	O
total	O
25	O
-	O
Hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentrations	O
in	O
serum	O
using	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LCMSMS	O
)	O
[	O
72	O
].	O

Another	O
key	O
factor	O
may	O
be	O
the	O
use	O
of	O
any	O
prenatal	O
,	O
prescription	O
medication	O
[	O
4	O
–	O
6	O
].	O

Of	O
the	O
patients	O
,	O
79	O
.	O
2	O
%	O
of	O
IG	O
and	O
81	O
.	O
9	O
%	O
of	O
CG	O
suffered	O
to	O
some	O
degree	O
from	O
vitamin	O
D	O
deficiency	O
.	O

Those	O
homes	O
where	O
the	O
carer	O
or	O
infant	O
was	O
absent	O
were	O
revisited	O
again	O
within	O
4	O
weeks	O
of	O
the	O
recruitment	O
period	O
.	O

[	O
12	O
]	O
Vitamin	O
D	O
deficiency	O
can	O
result	O
in	O
lower	O
bone	O
mineral	O
density	O
and	O
an	O
increased	O
risk	O
of	O
bone	O
loss	O
(	O
osteoporosis	O
)	O
or	O
bone	O
fracture	O
because	B
a	O
lack	O
of	O
vitamin	O
D	O
alters	O
mineral	O
metabolism	O
in	O
the	O
body	O
.	O

We	O
then	O
controlled	O
for	O
potential	O
confounders	O
that	O
changed	O
multivariable	O
RRs	O
by	O
more	O
than	O
10	O
%	O
relative	O
to	O
the	O
unadjusted	O
RR	O
[	O
31	O
].	O

Another	O
study	O
demonstrated	O
that	O
,	O
in	O
obese	O
women	O
,	O
the	O
concentration	O
of	O
VD	O
was	O
considerably	O
lower	O
in	O
patients	O
with	O
PCOS	O
,	O
which	O
may	O
prove	O
its	O
role	O
in	O
PCOS	O
development	O
[	O
32	O
].	O

Two	O
-	O
way	O
ANOVA	O
showed	O
effects	O
of	O
diet	O
and	O
sex	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
in	O
liver	O
and	O
PAT	O
(	O
see	O
TableS4for	O
statistical	O
values	O
).	O

Therefore	B
,	O
it	O
is	O
justifiable	B
that	O
in	O
our	O
study	O
,	O
vitamin	O
D	O
group	O
had	O
lower	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
compared	O
to	O
those	O
were	O
in	O
the	O
study	O
by	O
Taheri	O
et	O
al	O
.	O

Therefore	B
,	O
considering	O
the	O
following	O
values	O
:	O
effect	O
size	O
=	O
0	O
.	O
5	O
,	O
α	O
=	O
0	O
.	O
05	O
,	O
β	O
=	O
0	O
.	O
20	O
,	O
to	O
the	O
power	O
of	O
80	O
%	O
and	O
using	O
the	O
formula	O
(	O
16	O
/∆	O
2	O
,	O
∆	O
=	O
0	O
.	O
05	O
),	O
the	O
sample	O
size	O
was	O
estimated	O
at	O
64	O
in	O
each	O
group	O
.	O

There	O
is	O
evidence	O
suggesting	O
that	O
negative	O
insults	O
during	O
intrauterine	O
development	O
promote	O
functional	O
disorders	O
in	O
the	O
ANS	O
,	O
which	O
may	O
persist	O
later	O
in	O
life	O
[	O
32	O
].	O

Conversely	O
,	O
if	O
a	O
woman	O
was	O
carrying	O
a	O
female	O
fetus	O
,	O
there	O
was	O
generally	B
no	O
effect	O
of	O
having	O
low	O
,	O
low	O
-	O
moderate	O
or	O
high	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
on	O
developing	O
any	O
pregnancy	O
complication	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
(	O
Table3	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
high	O
and	O
low	O
exposure	O
to	O
text4baby	O
messages	O
:	O
adjusted	O
and	O
unadjusted	O
GEE	O
models	O
.	O
Questionnaire	O
itemsHigh	O
vs	O
low	O
exposureUnadjustedAdjustedaOR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
P	O
Eating	O
5	O
or	O
more	O
fruits	O
and	O
vegetables	O
per	O
day	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
744	O
(	O
0	O
.	O
138	O
,	O
4	O
.	O
003	O
).	O
732	O
.	O
511	O
(	O
0	O
.	O
158	O
,	O
39	O
.	O
867	O
).	O
51Taking	O
a	O
prenatal	O
vitamin	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
760	O
(	O
0	O
.	O
115	O
,	O
5	O
.	O
000	O
).	O
774	O
.	O
216	O
(	O
0	O
.	O
201	O
,	O
88	O
.	O
417	O
).	O
35I	O
am	O
prepared	O
to	O
be	O
a	O
new	O
mother1	O
.	O
471	O
(	O
0	O
.	O
788	O
,	O
2	O
.	O
746	O
).	O
221	O
.	O
609	O
(	O
0	O
.	O
607	O
,	O
4	O
.	O
268	O
).	O
34If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
I	O
will	O
be	O
a	O
healthy	O
new	O
mother1	O
.	O
033	O
(	O
0	O
.	O
607	O
,	O
1	O
.	O
759	O
).	O
901	O
.	O
288	O
(	O
0	O
.	O
585	O
,	O
2	O
.	O
834	O
).	O
53If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
my	O
baby	O
will	O
be	O
healthy0	O
.	O
783	O
(	O
0	O
.	O
468	O
,	O
1	O
.	O
313	O
).	O
351	O
.	O
328	O
(	O
0	O
.	O
737	O
,	O
2	O
.	O
393	O
).	O
34Smoking	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
139	O
(	O
0	O
.	O
717	O
,	O
1	O
.	O
810	O
).	O
581	O
.	O
236	O
(	O
0	O
.	O
651	O
,	O
2	O
.	O
350	O
).	O
52Secondhand	O
smoke	O
will	O
not	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby	O
(	O
reverse	O
coded	O
*)	O
0	O
.	O
892	O
(	O
0	O
.	O
668	O
,	O
1	O
.	O
193	O
).	O
440	O
.	O
947	O
(	O
0	O
.	O
631	O
,	O
1	O
.	O
423	O
).	O
79Drinking	O
alcohol	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
088	O
(	O
0	O
.	O
655	O
,	O
1	O
.	O
808	O
).	O
740	O
.	O
803	O
(	O
0	O
.	O
451	O
,	O
1	O
.	O
431	O
).	O
45Taking	O
prenatal	O
vitamins	O
will	O
improve	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
090	O
(	O
0	O
.	O
782	O
,	O
1	O
.	O
520	O
).	O
611	O
.	O
378	O
(	O
0	O
.	O
861	O
,	O
2	O
.	O
204	O
).	O
18BehaviorsSince	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?	O
1	O
.	O
344	O
(	O
0	O
.	O
473	O
,	O
3	O
.	O
820	O
).	O
580	O
.	O
212	O
(	O
0	O
.	O
046	O
,	O
0	O
.	O
973	O
).	O
046In	O
the	O
last	O
30	O
days	O
,	O
did	O
you	O
smoke	O
?	O
0	O
.	O
938	O
(	O
0	O
.	O
490	O
,	O
1	O
.	O
794	O
).	O
851	O
.	O
271	O
(	O
0	O
.	O
406	O
,	O
3	O
.	O
980	O
).	O
68Ate	O
3	O
or	O
more	O
servings	O
of	O
fruit	O
a	O
day0	O
.	O
852	O
(	O
0	O
.	O
647	O
,	O
1	O
.	O
122	O
).	O
250	O
.	O
908	O
(	O
0	O
.	O
649	O
,	O
1	O
.	O
271	O
).	O
57Ate	O
3	O
or	O
more	O
servings	O
of	O
vegetables	O
a	O
day0	O
.	O
889	O
(	O
0	O
.	O
679	O
,	O
1	O
.	O
164	O
).	O
390	O
.	O
969	O
(	O
0	O
.	O
673	O
,	O
1	O
.	O
394	O
).	O
86Have	O
you	O
ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
?	O
0	O
.	O
992	O
(	O
0	O
.	O
661	O
,	O
1	O
.	O
488	O
).	O
970	O
.	O
893	O
(	O
0	O
.	O
519	O
,	O
1	O
.	O
536	O
).	O
68	O
aAdjusted	O
for	O
age	O
(	O
quintile	O
),	O
parity	O
,	O
imputed	O
marital	O
status	O
,	O
and	O
race	O
.	O

However	O
,	O
at	O
the	O
whole	O
-	O
body	O
level	O
adverse	O
consequences	O
of	O
restricted	O
intrauterine	O
supply	O
were	O
observed	O
[	O
15	O
].	O

Women	O
of	O
other	O
ethnic	O
origins	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
ml	O
)	O
all	O
year	O
round	O
,	O
except	O
during	O
summer	O
for	O
third	O
trimester	O
women	O
(	O
Figure	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Serum	O
25	O
-(	O
OH	O
)	O
D	O
concentrations	O
over	O
the	O
different	O
seasons	O
,	O
by	O
trimester	O
of	O
pregnancy	O
and	O
ethnicity	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
in	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O

Observational	O
findings	O
of	O
the	O
benefit	O
of	O
washing	O
hands	O
before	O
contact	O
with	O
the	O
umbilical	O
stump	O
[	O
3	O
]	O
and	O
the	O
available	O
evidence	O
that	O
a	O
number	O
of	O
Gram	O
positive	O
organisms	O
that	O
colonize	O
the	O
nasopharynx	O
and	O
Gram	O
negative	O
organisms	O
found	O
in	O
stool	O
are	O
commonly	O
associated	O
with	O
sepsis	O
in	O
neonates	O
and	O
young	O
infants	O
[	O
23	O
,	O
24	O
]	O
drove	B
the	O
decision	O
-	O
making	O
regarding	O
recommendation	O
of	O
handwashing	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
and	O
after	O
fecal	O
contact	O
.	O

However	O
,	O
the	O
tentative	O
nature	O
of	O
these	O
data	O
and	O
the	O
lack	O
of	O
equally	O
effective	O
substitutes	O
justify	O
their	O
use	O
in	O
pregnancy	O
for	O
this	O
life	O
-	O
threatening	O
emergency	O
.	O

While	O
the	O
remaining	O
studies	O
do	O
not	O
necessarily	O
demonstrate	O
causality	O
,	O
they	O
do	O
provide	O
additional	O
mechanistic	O
associations	O
between	O
exposure	O
(	O
again	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
nickel	O
,	O
phthalates	O
,	O
TCDD	O
,	O
alcohol	O
,	O
undernutrition	O
,	O
2	O
-	O
amino	O
-	O
1	O
-	O
methyl	O
-	O
6	O
-	O
phenyl	O
-	O
imidazo	O
[	O
4	O
,	O
5	O
-	O
b	O
]	O
pyridine	O
(	O
PhIP	O
),	O
peanut	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
NKK	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

Covariate	O
data	O
.	O

Although	O
these	O
more	O
detailed	O
body	O
composition	O
assessment	O
tools	O
may	O
have	O
yielded	O
more	O
accurate	O
estimates	O
of	O
the	O
relative	O
proportions	O
of	O
adipose	O
and	O
lean	O
tissue	O
mass	O
,	O
they	O
were	O
not	O
considered	O
feasible	O
for	O
use	O
in	O
the	O
large	O
scale	O
setting	O
required	O
for	O
this	O
follow	O
-	O
up	O
study	O
,	O
and	O
its	O
associated	O
practical	O
and	O
financial	O
constraints	O
.	O

The	O
results	O
indicated	O
that	O
CC	O
male	O
rats	O
showed	O
an	O
increase	O
in	O
body	O
weight	O
and	O
abdominal	O
fat	O
mass	O
that	O
contrasted	O
with	O
a	O
decrease	O
in	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
during	O
the	O
adolescence	O
and	O
adulthood	O
compared	O
to	O
CC	O
female	O
rats	O
.	O

While	O
the	O
results	O
are	O
mostly	O
unchanged	O
,	O
the	O
phthalates	O
and	O
BPA	O
exposures	O
were	O
associated	O
with	O
a	O
decrease	O
in	O
birth	O
weight	O
for	O
male	O
infants	O
compared	O
to	O
the	O
combined	O
analysis	O
(	O
3	O
g	O
decrease	O
compared	O
with	O
1	O
g	O
increase	O
).	O

Vitamin	O
D	O
is	O
likely	B
safe	O
during	O
pregnancy	O
and	O
breast	O
feeding	O
when	O
taken	O
by	O
mouth	O
in	O
recommended	O
amounts	O
,	O
that	O
is	O
10	O
mcg	O
(	O
400	O
USP	O
units	O
)	O
of	O
vitamin	O
D	O
daily	O
in	O
normal	O
pregnancy	O
.	O

The	O
results	O
,	O
in	O
terms	O
of	O
both	O
direction	O
and	O
magnitude	O
of	O
effect	O
,	O
were	O
consistent	O
across	O
all	O
of	O
these	O
analyses	O
.	O

All	O
data	O
are	O
expressed	O
as	O
means	O
±	O
standard	O
error	O
of	O
means	O
(	O
SEM	O
).	O

Waist	O
and	O
hip	O
circumferences	O
were	O
measured	O
using	O
inextensible	O
tape	O
.	O

Four	O
factors	O
were	O
shown	O
to	O
be	O
significantly	O
associated	O
with	O
autism	O
:	O
being	O
male	O
,	O
premature	O
birth	O
,	O
maternal	O
age	O
greater	O
than	O
or	O
equal	O
to	O
35	O
years	O
,	O
and	O
mothers	O
born	O
outside	O
of	O
Australia	O
,	O
with	O
highest	O
risk	O
found	O
in	O
mothers	O
from	O
North	O
-	O
East	O
or	O
South	O
-	O
East	O
Asia	O
[	O
7	O
].	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

True	O
deficiency	O
would	O
be	O
evident	B
only	O
by	O
measuring	O
25	O
(	O
OH	O
)	O
D	O
.	O
Of	O
note	O
,	O
questions	O
have	O
been	O
raised	O
regarding	O
the	O
need	O
for	O
standardization	O
of	O
assays	O
.	O

At	O
the	O
verge	O
of	O
the	O
21st	O
century	O
,	O
rickets	O
was	O
sporadically	O
observed	O
in	O
Europe	O
.	O

The	O
effect	O
of	O
each	O
gene	O
is	O
further	O
diluted	O
by	O
variable	O
penetrance	O
[	O
61	O
].	O

Overall	O
,	O
the	O
current	O
study	O
extends	O
existing	O
work	O
by	O
suggesting	O
that	O
exposure	O
to	O
foods	O
or	O
drinks	O
high	O
in	O
sugar	O
content	O
early	O
in	O
gestation	O
may	O
predispose	O
offspring	O
to	O
higher	O
weight	O
status	O
early	O
in	O
infancy	O
,	O
independent	O
of	O
maternal	O
GWG	O
.	O

Following	O
the	O
first	O
hydroxylation	O
in	O
the	O
liver	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
is	O
produced	O
.	O

During	O
the	O
late	O
fattening	O
phase	O
,	O
from	O
22	O
months	O
to	O
slaughter	O
age	O
(	O
28	O
to	O
31	O
months	O
of	O
age	O
),	O
about	O
90	O
%	O
concentrate	O
(	O
CP	O
11	O
%	O
to	O
12	O
%,	O
TDN	O
73	O
%	O
to	O
74	O
%)	O
is	O
fed	O
,	O
and	O
roughage	O
(	O
rice	O
straw	O
and	O
rye	O
grass	O
)	O
is	O
about	O
10	O
%	O
of	O
the	O
diet	O
.	O

Multicollinearity	O
was	O
evaluated	O
using	O
variance	O
inflation	O
factor	O
(	O
VIF	O
)	O
and	O
significance	O
level	O
was	O
set	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Methods	O
and	O
materials	O
A	O
descriptive	O
cohort	O
study	O
with	O
matched	O
controls	O
using	O
a	O
prospectively	O
collected	O
database	O
was	O
conducted	O
.	O

MicroRNA	O
RT	O
-	O
PCR	O
quantification	O
Total	O
RNA	O
was	O
extracted	O
from	O
liver	O
samples	O
using	O
the	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
)	O
and	O
subsequently	O
purified	O
with	O
the	O
RNase	O
-	O
Free	O
DNase	O
Kit	O
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
׳	O
s	O
instructions	O
.	O

It	O
is	O
important	O
to	O
pay	O
attention	O
to	O
Vitamin	O
D	O
nutritional	O
status	O
in	O
GDM	O
pregnancy	O
nutrition	O
management	O
.	O

Sampling	O
As	O
detailed	O
elsewhere	O
,	O
the	O
sampling	O
frame	O
consisted	O
of	O
all	O
female	O
military	O
health	O
care	O
beneficiaries	O
first	O
presenting	O
for	O
initial	O
prenatal	O
care	O
at	O
Madigan	O
.	O

A	O
recent	O
cohort	O
study	O
of	O
live	O
births	O
in	O
Denmark	O
from	O
1996	O
to	O
2005	O
involving	O
3	O
,	O
892	O
cases	O
of	O
ASD	O
found	O
no	O
significant	O
association	O
,	O
as	B
only	O
52	O
cases	O
of	O
SSRI	O
use	O
were	O
found	O
[	O
39	O
].	O

Thus	O
,	O
for	O
practical	O
purposes	O
,	O
the	O
early	O
pregnancy	O
window	O
was	O
set	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
.	O

BDNF	O
was	O
corrected	O
to	O
similar	O
levels	O
by	O
the	O
HV	O
diet	O
,	O
and	O
only	O
partially	O
by	O
the	O
HFol	O
pup	O
diet	O
.	O

Linked	O
to	O
the	O
United	O
Nation	O
'	O
s	O
Every	O
Women	O
Every	O
Child	O
strategy	O
,	O
a	O
target	O
was	O
set	O
for	O
50	O
%	O
reduction	O
in	O
preterm	O
deaths	O
by	O
2025	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
,	O
compared	O
with	O
the	O
Standard	O
Care	O
group	O
(	O
Lifestyle	O
Advice	O
233	O
(	O
21	O
.	O
71	O
%)	O
vs	O
.	O
Standard	O
Care	O
233	O
(	O
21	O
.	O
90	O
%);	O
adjusted	O
relative	O
risk	O
(	O
aRR	O
)	O
0	O
.	O
99	O
;	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
82	O
to	O
1	O
.	O
18	O
;	O
p	O
=	O
0	O
.	O
88	O
).	O

Within	O
this	O
same	O
group	O
,	O
cathelicidin	O
concentration	O
was	O
negatively	O
associated	O
with	O
the	O
number	O
of	O
documented	O
infections	O
a	O
child	O
experienced	O
in	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
205	O
,	O
p	O
=	O
0	O
.	O
047	O
).	O

Furthermore	O
,	O
seasonal	O
variation	O
in	O
immune	O
function	O
may	O
increase	O
host	O
susceptibility	O
to	O
infections	O
at	O
certain	O
times	O
of	O
the	O
year	O
[	O
143	O
,	O
144	O
].	O

However	O
,	O
this	O
sample	O
may	O
have	O
decreased	O
the	O
representativeness	O
of	O
our	O
study	O
;	O
mothers	O
with	O
a	O
newborn	O
who	O
also	O
have	O
infants	O
or	O
older	O
children	O
to	O
care	O
for	O
may	O
be	O
less	O
likely	B
to	O
change	O
handwashing	O
behavior	O
because	O
of	O
time	O
constraints	O
,	O
or	O
because	O
their	O
current	O
pregnancy	O
does	O
not	O
lead	O
to	O
a	O
dramatic	O
alteration	O
of	O
their	O
self	O
-	O
definition	O
or	O
role	O
in	O
the	O
family	O
and	O
society	O
since	O
they	O
already	O
have	O
children	O
.	O

Genes	O
participating	O
in	O
'	O
AMPK	O
signaling	O
'	O
and	O
'	O
fatty	O
acid	O
metabolism	O
'	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
while	O
genes	O
associated	O
with	O
'	O
mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinase	O
'	O
and	O
'	O
VEGF	O
signaling	O
'	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
AP	O
offspring	O
.	O

3	O
.	O
2	O
.	O

Sporadic	O
MTC	O
tumours	O
are	O
often	B
monolateral	O
with	O
a	O
single	O
localization	O
,	O
while	O
familial	O
forms	O
are	O
mostly	B
bilateral	O
and	O
often	B
multifocal	O
or	O
diffuse	O
.	O

Global	O
methylation	O
status	O
of	O
hypothalamic	O
genomic	O
DNA	O
was	O
determined	O
by	O
the	O
in	O
vitro	O
methyl	O
acceptance	O
assay	O
method	O
as	O
described	O
previously	O
.	O
18	O
,	O
19This	O
assay	O
involves3H	O
-	O
methyl	O
-	O
S	O
-	O
adenosylmethionine	O
(	O
New	O
England	O
Nuclear	O
,	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
as	O
a	O
methyl	O
donor	O
mediated	O
by	O
Sss1	O
DNA	O
methyltransferase	O
(	O
New	O
England	O
Biolabs	O
,	O
Pickering	O
,	O
ON	O
,	O
Canada	O
).	O

Priority	O
question	O
:	O
How	O
can	O
we	O
identify	O
particularly	O
susceptible	O
individuals	O
or	O
populations	O
?	O

Histopathologic	O
examination	O
found	O
an	O
inflammatory	O
crust	O
covering	O
an	O
ulceration	O
that	O
consisted	O
of	O
a	O
dense	O
proliferation	O
of	O
capillaries	O
and	O
endothelial	O
cells	O
in	O
the	O
dermis	O
(	O
Fig	O
2	O
).	O

After	O
mating	O
,	O
the	O
presence	O
of	O
a	O
vaginal	O
plug	O
was	O
used	O
to	O
diagnose	O
pregnancy	O
.	O

Results	O
3	O
.	O
1	O
.	O

More	O
or	O
less	O
4	O
%	O
of	O
the	O
women	O
within	O
the	O
sample	O
had	O
had	O
a	O
miscarriage	O
before	O
at	O
least	O
once	O
.	O

We	O
think	O
that	O
confounding	O
of	O
the	O
main	O
findings	O
by	O
lifestyle	O
or	O
other	O
aspects	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
is	O
unlikely	B
,	O
as	O
we	O
controlled	O
for	O
numerous	O
potential	O
confounders	O
in	O
the	O
analyses	O
,	O
including	O
nutrients	O
and	O
foods	O
that	O
have	O
been	O
previously	O
linked	O
to	O
childhood	O
asthma	O
and	O
atopy	O
.	O

Transparency	O
and	O
objectivity	O
of	O
the	O
data	O
and	O
analysis	O
are	O
important	O
factors	O
in	O
the	O
success	O
of	O
the	O
Report	O
Cards	O
.	O

Conclusion	O
These	O
findings	O
demonstrate	O
that	O
maternal	O
vitamin	O
D	O
deficiency	O
accompanies	O
changes	O
in	O
the	O
renal	O
expression	O
of	O
important	O
factors	O
that	O
may	O
retard	O
the	O
maturation	O
of	O
glomeruli	O
by	O
extending	O
the	O
period	O
of	O
nephrogenesis	O
.	O

The	O
range	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
was	O
0	O
–	O
24	O
.	O
71	O
nmol	O
/	O
L	O
,	O
with	O
the	O
detection	O
rate	O
of	O
19	O
.	O
4	O
%	O
(	O
19	O
/	O
98	O
).	O

Prior	O
to	O
analysis	O
,	O
collinearity	O
between	O
the	O
two	O
predictor	O
variables	O
was	O
measured	O
using	O
Spearman	O
’	O
s	O
rho	O
to	O
ensure	O
they	O
were	O
independent	O
;	O
relatively	O
low	O
correlation	O
was	O
observed	O
between	O
the	O
variables	O
(	O
r	O
=	O
0	O
.	O
24	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Information	O
obtained	O
from	O
the	O
Finnish	O
prenatal	O
study	O
of	O
autism	O
and	O
autism	O
spectrum	O
disorders	O
correlated	O
advanced	O
paternal	O
age	O
with	O
an	O
increased	O
risk	O
of	O
ASD	O
[	O
10	O
].	O

Such	O
studies	O
are	O
difficult	O
as	B
they	O
raise	O
sensitive	O
social	O
issues	O
.	O

Among	O
the	O
140	O
women	O
(	O
13	O
%	O
of	O
cohort	O
)	O
with	O
a	O
prior	O
PTB	O
,	O
29	O
%	O
experienced	O
a	O
recurrent	O
PTB	O
.	O

Performed	O
the	O
experiments	O
:	O
MO	O
EM	O
CCM	O
SP	O
KW	O
.	O

We	O
did	O
not	O
find	O
any	O
medical	O
record	O
documentation	O
of	O
a	O
discussion	O
about	O
herb	O
use	O
.	O

Thus	B
,	O
significant	O
correlation	O
between	O
lower	O
HRV	O
parameters	O
and	O
low	O
birth	O
weight	O
found	O
in	O
healthy	O
children	O
may	O
have	O
adverse	O
prognostic	O
effects	O
and	O
serve	O
as	B
an	O
early	O
sign	O
of	O
cardiometabolic	O
diseases	O
.	O

Bile	O
salts	O
are	O
amphipathic	O
compounds	O
that	O
act	O
as	O
biological	O
detergents	O
,	O
converting	O
dietary	O
fats	O
into	O
mixed	O
micelles	O
of	O
bile	O
salts	O
and	O
TGs	O
[	O
109	O
].	O

These	O
five	O
interventions	O
were	O
:	O
smoking	O
cessation	O
(	O
0	O
·	O
01	O
rate	O
reduction	O
),	O
decreasing	O
multiple	O
embryo	O
transfers	O
during	O
assisted	O
reproductive	O
technologies	O
(	O
0	O
·	O
06	O
),	O
cervical	O
cerclage	O
(	O
0	O
·	O
15	O
),	O
use	O
of	O
progesterone	O
agents	O
(	O
0	O
·	O
01	O
),	O
and	O
reduction	O
of	O
elective	O
labour	O
induction	O
or	O
caesarean	O
delivery	O
without	O
medical	O
indication	O
(	O
0	O
·	O
29	O
).	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
for	O
the	O
entire	O
sample	O
was	O
75	O
.	O
4	O
±	O
30	O
.	O
2	O
nmol	O
/	O
L	O
.	O

Formative	O
research	O
Before	O
the	O
intervention	O
started	O
,	O
we	O
conducted	O
a	O
formative	O
study	O
using	O
qualitative	O
methods	O
.	O

Additionally	O
,	O
multiple	O
other	O
immune	O
symptoms	O
and	O
demographic	O
variables	O
tested	O
were	O
also	O
not	O
predictive	O
of	O
fetal	O
weight	O
.	O

Moreover	O
,	O
dietary	O
factors	O
,	O
before	O
and	O
during	O
pregnancy	O
,	O
have	O
been	O
linked	O
to	O
increased	O
risk	O
for	O
GDM	O
.	O

Genetic	O
alterations	O
activating	O
a	O
common	O
pathway	O
of	O
the	O
RET	O
-	O
RAS	O
-	O
BRAF	O
signalling	O
cascade	O
and	O
other	O
chromosomal	O
rearrangements	O
have	O
been	O
identified	O
in	O
most	B
DTC	O
.	O

Maternal	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
The	O
level	O
of	O
the	O
participating	O
women	O
’	O
s	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
is	O
assessed	O
at	O
phase	O
1	O
in	O
pregnancy	O
and	O
again	O
at	O
phases	O
6	O
and	O
8	O
postnatally	O
.	O

White	O
children	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
35	O
.	O
1	O
ng	O
/	O
mL	O
(	O
87	O
.	O
8	O
nmol	O
/	O
L	O
)	O
at	O
the	O
follow	O
-	O
up	O
visit	O
,	O
which	O
was	O
also	O
found	O
to	O
be	O
significantly	O
higher	O
than	O
both	O
Black	O
and	O
Hispanic	O
children	O
with	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
22	O
.	O
5	O
ng	O
/	O
mL	O
(	O
56	O
.	O
3	O
nmol	O
/	O
L	O
)	O
and	O
25	O
.	O
4	O
ng	O
/	O
mL	O
(	O
63	O
.	O
5	O
nmol	O
/	O
L	O
),	O
respectively	O
(	O
p	O
≤	O
0	O
.	O
0001	O
and	O
≤	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

Our	O
sample	O
testing	O
suggest	O
that	O
the	O
vitamin	O
D	O
group	O
maintained	O
above	O
mean	O
adequate	O
vitamin	O
D	O
concetrations	O
verses	O
consistently	B
low	O
concentrations	O
in	O
the	O
placebo	O
group	O
.	O

Treatment	O
with	O
calcium	O
usually	O
reverses	O
the	O
symptoms	O
rapidly	O
.	O

Oka	O
[	O
134	O
]	O
recommended	O
that	O
vitamin	O
A	O
-	O
deficient	O
levels	O
not	O
fall	O
below	O
30	O
IU	O
/	O
dL	O
to	O
enhance	O
MS	O
and	O
maintain	O
health	O
.	O

There	O
are	O
high	O
-	O
impact	O
,	O
cost	O
-	O
effective	O
interventions	O
currently	O
at	O
low	O
coverage	O
[	O
5	O
,	O
6	O
],	O
such	O
as	O
antenatal	O
corticosteroids	O
and	O
KMC	O
,	O
that	O
could	O
significantly	O
accelerate	O
progress	O
,	O
which	O
were	O
not	O
available	O
in	O
the	O
United	O
States	O
and	O
the	O
United	O
Kingdom	O
in	O
the	O
middle	O
of	O
the	O
20th	O
century	O
when	O
the	O
neonatal	O
mortality	O
rate	O
(	O
NMR	O
)	O
was	O
significantly	O
reduced	O
.	O

Significant	O
higher	O
levels	O
of	O
DHA	O
have	O
been	O
found	O
in	O
red	O
cell	O
membranes	O
of	O
un	O
-	O
medicated	O
schizophrenic	O
patients	O
compared	O
to	O
healthy	O
control	O
subjects	O
[	O
42	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
the	O
lipid	O
flux	O
and	O
storage	O
regulators	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
the	O
liver	O
(	O
A	O
)	O
and	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
)	O
(	O
B	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

Costs	O
resulting	O
from	O
the	O
research	O
activities	O
on	O
program	O
impact	O
and	O
compliance	O
rates	O
are	O
not	O
included	O
.	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
028	O
for	O
maternal	O
fruit	O
intake	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
fruit	O
intake	O
tertiles	O
.	O

PubMed	O
Central	O
:	O

Radiographs	O
of	O
normal	O
(	O
A	O
–	O
C	O
)	O
and	O
Skm1	O
(	O
B	O
–	O
D	O
)	O
manus	O
(	O
A	O
,	O
B	O
)	O
and	O
pes	O
(	O
C	O
,	O
D	O
).	O

Based	B
on	I
the	O
demonstrated	O
reductions	O
in	O
PTB	O
in	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

[	O
59	O
]	O
have	O
reported	O
that	O
prenatal	O
undernutrition	O
,	O
in	O
contrast	O
to	O
postnatal	O
undernutrition	O
,	O
leads	O
to	O
reduced	O
longevity	O
in	O
mice	O
.	O

In	O
humans	O
,	O
BAT	O
develops	O
in	O
the	O
fetus	O
during	O
gestation	O
.	O

Although	O
we	O
accept	O
that	O
rodents	O
and	O
humans	O
may	O
differ	O
in	O
their	O
adaptive	O
responses	O
to	O
early	O
life	O
cues	O
,	O
there	O
are	O
many	O
reports	O
outlining	O
associations	O
between	O
a	O
suboptimal	O
early	O
life	O
environment	O
and	O
altered	O
phenotype	O
in	O
both	O
species	O
[	O
60	O
],[	O
61	O
].	O

Regression	O
techniques	O
were	O
employed	O
to	O
determine	O
whether	O
the	O
association	O
between	O
caries	O
and	O
vitamin	O
D	O
status	O
remained	O
after	O
controlling	O
for	O
confounders	O
.	O

The	O
up	O
-	O
expression	O
of	O
Cnr1	O
in	O
the	O
hypothalamus	O
has	O
been	O
associated	O
with	O
the	O
leptin	O
resistance	O
in	O
obesity	O
(	O
Thanos	O
et	O
al	O
.,	O
2008	O
;	O
Cardinal	O
et	O
al	O
.,	O
2012	O
).	O

In	O
a	O
recent	O
mouse	O
study	O
,	O
exposure	O
to	O
smoke	O
in	O
utero	O
induced	O
a	O
higher	O
risk	O
of	O
sensitization	O
against	O
allergens	O
in	O
adult	O
age	O
in	O
the	O
offspring	O
[	O
70	O
].	O

However	O
,	O
the	O
urinary	O
uric	O
acid	O
and	O
proteinuria	O
values	O
were	O
not	O
different	O
across	O
the	O
groups	O
.	O

The	O
IMF	O
of	O
Angus	O
steers	O
grown	O
in	O
South	O
Dakota	O
(	O
USA	O
)	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
from	O
189	O
to	O
368	O
kg	O
(	O
live	O
weight	O
from	O
340	O
to	O
591	O
kg	O
)	O
[	O
73	O
].	O

Sustainability	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
could	O
be	O
achieved	O
if	O
the	O
identified	O
threats	O
are	O
adequately	O
addressed	O
.	O

The	O
program	O
addresses	O
a	O
wide	O
range	O
of	O
health	O
topics	O
,	O
as	B
compared	O
to	O
other	O
studies	O
that	O
focused	O
on	O
1	O
or	O
a	O
few	O
closely	O
related	O
health	O
behaviors	O
.	O

2	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Percentage	O
of	O
distribution	O
of	O
respondents	O
’	O
occupations	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
the	O
study	O
populationCharacteristicFrequency	O
n	O
=	O
385Percentage	O
(%)	O
Mean	O
±	O
SDAge	O
group	O
(	O
years	O
)	O
15	O
–	O
207118	O
.	O
425	O
.	O
2	O
±	O
5	O
.	O
121	O
–	O
2515740	O
.	O
826	O
–	O
309825	O
.	O
531	O
–	O
354210	O
.	O
936	O
–	O
40174	O
.	O
4Marital	O
StatusMarried27270	O
.	O
6Single11329	O
.	O
4Number	O
of	O
Pregnancy115240	O
.	O
8210226	O
.	O
535815	O
.	O
144210	O
.	O
9	O
≥	O
5166	O
.	O
8Number	O
of	O
visits212733	O
.	O
039624	O
.	O
945815	O
.	O
155915	O
.	O
3	O
≥	O
64511	O
.	O
7Trimester	O
at	O
first	O
visitFirst	O
trimester0030	O
.	O
3	O
±	O
5	O
.	O
6Second	O
trimester30579	O
.	O
2Third	O
trimester8020	O
.	O
8Educational	O
levelPrimary10627	O
.	O
5Secondary20252	O
.	O
5Tertiary7720	O
.	O
0	O
Area	O
of	O
residence	O
and	O
reasons	O
for	O
choice	O
of	O
site	O
The	O
most	O
attended	O
health	O
centres	O
were	O
those	O
of	O
Buea	O
Road	O
,	O
PMI	O
(“	O
Prevention	O
Maternelle	O
et	O
Infantile	O
”),	O
Muea	O
and	O
Buea	O
Town	O
(	O
32	O
.	O
5	O
%,	O
26	O
.	O
2	O
%	O
and	O
19	O
.	O
2	O
%	O
respectively	O
).	O

Among	O
the	O
20	O
BMP	O
family	O
members	O
,	O
BMP	O
-	O
7	O
has	O
been	O
implicated	O
in	O
the	O
development	O
of	O
BAT	O
,	O
being	O
able	O
to	O
drive	O
the	O
complete	O
brown	O
fat	O
differentiation	O
program	O
,	O
including	O
PRDM16	O
expression	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
).	O

With	O
good	O
medical	O
and	O
obstetric	O
care	O
,	O
the	O
risks	O
to	O
the	O
pregnancy	O
should	O
be	O
minimal	O
.	O

At	O
14	O
weeks	O
gestation	O
,	O
on	O
average	O
,	O
participants	O
reported	O
sociodemographic	O
,	O
behavioral	O
,	O
and	O
health	O
characteristics	O
in	O
a	O
structured	O
interview	O
.	O

Data	O
management	O
and	O
analysis	O
Sample	O
size	O
calculation	O
The	O
number	O
of	O
participants	O
to	O
sample	O
has	O
been	O
calculated	O
using	O
the	O
G	O
*	O
Power	O
3	O
.	O
1	O
.	O
9	O
.	O
2	O
statistical	O
programme	O
[	O
78	O
].	O

The	O
size	O
of	O
the	O
correlations	O
,	O
between	O
the	O
child	O
and	O
each	O
parent	O
at	O
this	O
age	O
,	O
was	O
a	O
little	O
lower	O
than	O
those	O
between	O
the	O
mother	O
and	O
her	O
parents	O
and	O
the	O
father	O
and	O
his	O
parents	O
.	O

Animals	O
were	O
assigned	O
to	O
one	O
of	O
6	O
nutritional	O
groups	O
:	O
1	O
)	O
dams	O
fed	O
a	O
standard	O
diet	O
(	O
protein	O
18	O
%,	O
fat	O
5	O
%,	O
digestible	O
energy	O
3	O
.	O
4	O
kcal	O
/	O
gm	O
,	O
Teklad	O
Global	O
18	O
%	O
Protein	O
Diet	O
,	O
Diet	O
2018	O
)	O
ad	O
libitum	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
Cont	O
group	O
),	O
2	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
UNPL	O
group	O
),	O
3	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
pregnancy	O
only	O
(	O
UNP	O
group	O
),	O
4	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
lactation	O
only	O
(	O
UNL	O
group	O
),	O
5	O
)	O
dams	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
PLHF	O
group	O
;	O
45	O
%	O
kcal	O
as	O
fat	O
,	O
20	O
%	O
protein	O
;	O
4	O
.	O
73	O
kcal	O
/	O
gm	O
,	O
Research	O
Diets	O
Inc	O
.	O
D12451	O
)	O
and	O
6	O
)	O
dams	O
fed	O
a	O
pre	O
-	O
conceptional	O
high	O
-	O
fat	O
diet	O
,	O
from	O
the	O
time	O
of	O
their	O
weaning	O
(	O
22	O
days	O
of	O
age	O
)	O
through	O
to	O
conception	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
MHF	O
group	O
;	O
45	O
%	O
kcal	O
as	O
fat	O
,	O
20	O
%	O
protein	O
;	O
Research	O
Diets	O
Inc	O
.	O
D12451	O
).	O

Each	O
of	O
these	O
3	O
possibilities	O
are	O
observed	O
in	O
about	O
one	O
third	O
of	O
all	O
cases	O
[	O
10	O
].	O

In	O
addition	O
,	O
a	O
twofold	O
increase	O
in	O
the	O
GR	O
α	O
/	O
GAS5	O
ratio	O
was	O
also	O
noted	O
in	O
the	O
preterm	O
group	O
compared	O
to	O
the	O
term	O
group	O
(	O
seeTable	O
2	O
).	O

In	O
addition	O
,	O
a	O
systematic	O
review	O
of	O
several	O
studies	O
found	O
no	O
clear	O
negative	O
association	O
between	O
early	O
solid	O
food	O
introduction	O
and	O
the	O
development	O
of	O
asthma	O
,	O
food	O
allergy	O
,	O
AR	O
,	O
or	O
animal	O
dander	O
allergy	O
[	O
89	O
].	O

Introduction	O
Iron	O
deficiency	O
anaemia	O
is	O
defined	O
as	O
anaemia	O
accompanied	O
by	O
depleted	O
iron	O
stores	O
and	O
signs	O
of	O
a	O
compromised	O
supply	O
of	O
iron	O
to	O
the	O
tissues	O
[	O
1	O
].	O

When	O
compared	O
with	O
the	O
neonates	O
exposed	O
to	O
monotherapy	O
,	O
a	O
larger	O
proportion	O
of	O
neonates	O
in	O
the	O
polytherapy	O
group	O
were	O
admitted	O
to	O
the	O
NICU	O
(	O
28	O
.	O
8	O
%	O
vs	O
16	O
%)	O
and	O
presented	O
with	O
PNA	O
signs	O
(	O
21	O
.	O
2	O
%	O
vs	O
4	O
%).	O

Thus	B
,	O
not	O
all	O
humans	O
will	O
respond	O
to	O
an	O
environmental	O
exposure	O
in	O
the	O
same	O
way	O
.	O

Supplemental	O
Material	O
Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Some	O
earlier	O
experiments	O
,	O
in	O
which	O
the	O
serum	O
and	O
follicular	O
fluid	O
VD	O
levels	O
were	O
compared	O
with	O
the	O
pregnancy	O
rate	O
,	O
did	O
not	O
show	O
the	O
same	O
results	O
.	O

It	O
is	O
worth	O
noting	O
that	O
some	O
genomic	O
regions	O
escape	O
this	O
first	O
global	O
‘	O
reset	O
’,	O
including	O
imprinted	O
control	O
regions	O
(	O
ICRs	O
)	O
and	O
the	O
most	O
active	O
TEs	O
.	O

We	O
acknowledge	O
the	O
limitation	O
that	O
the	O
scale	O
have	O
not	O
been	O
used	O
earlier	O
in	O
Sweden	O
and	O
validated	O
in	O
the	O
Swedish	O
population	O
.	O

Results	O
Analyses	O
of	O
the	O
hepatic	O
gene	O
expression	O
of	O
the	O
offspring	O
at	O
prenatal	O
(	O
94	O
dies	O
post	O
conceptionem	O
,	O
dpc	O
)	O
and	O
postnatal	O
stages	O
(	O
1	O
,	O
28	O
,	O
188	O
dies	O
post	O
natum	O
,	O
dpn	O
)	O
included	O
comparisons	O
between	O
dietary	O
groups	O
within	O
stages	O
as	O
well	O
as	O
comparisons	O
between	O
ontogenetic	O
stages	O
within	O
diets	O
to	O
separate	O
diet	O
-	O
specific	O
transcriptional	O
changes	O
and	O
maturation	O
processes	O
.	O

Considering	O
the	O
HRV	O
analysis	O
,	O
there	O
was	O
no	O
significant	O
gender	O
effects	O
with	O
respect	O
to	O
the	O
time	O
-	O
domain	O
(	O
HR	O
:	O
P	O
=	O
0	O
.	O
098	O
;	O
MNN	O
:	O
P	O
=	O
0	O
.	O
271	O
;	O
SDNN	O
:	O
P	O
=	O
0	O
.	O
208	O
;	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
624	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
882	O
)	O
or	O
frequency	O
-	O
domain	O
(	O
LF	O
:	O
P	O
=	O
0	O
.	O
294	O
;	O
HF	O
:	O
P	O
=	O
0	O
.	O
844	O
;	O
ratio	O
LF	O
/	O
HF	O
:	O
P	O
=	O
0	O
.	O
546	O
)	O
indices	O
;	O
therefore	B
,	O
analyses	O
were	O
performed	O
considering	O
boys	O
and	O
girls	O
together	O
.	O

Exposed	O
neonates	O
were	O
approximately	O
two	O
and	O
a	O
half	O
times	O
more	O
likely	B
to	O
be	O
premature	O
(	O
gestational	O
age	O
<	O
37	O
weeks	O
)	O
compared	O
with	O
controls	O
(	O
10	O
.	O
6	O
%	O
vs	O
4	O
.	O
3	O
%).	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
only	O
found	O
in	O
the	O
perirenal	O
fat	O
weight	O
.	O

Hepatic	O
hydroxylation	O
of	O
previtamin	O
D	O
to	O
25	O
(	O
OH	O
)	O
D	O
is	O
thought	O
not	O
to	O
be	O
regulated	O
and	O
is	O
therefore	B
primarily	B
dependent	O
on	O
availability	O
of	O
the	O
substrate	O
.	O

Glucose	O
/	O
starch	O
availability	O
and	O
roughage	O
vs	O
concentrate	O
ratios	O
Consuming	O
surplus	O
net	O
energy	O
is	O
an	O
important	O
factor	O
for	O
deposition	O
of	O
IMF	O
.	O

The	O
extensive	O
training	O
and	O
community	O
education	O
program	O
was	O
another	O
positive	O
factor	O
which	O
increased	O
acceptance	O
of	O
the	O
supplements	O
as	O
a	O
valuable	O
contribution	O
to	O
women	O
'	O
s	O
health	O
.	O

The	O
mothers	O
with	O
depression	O
score	O
of	O
0	O
–	O
13	O
were	O
entered	O
in	O
the	O
study	O
.	O

Besides	O
the	O
role	O
of	O
genetic	O
predisposition	O
,	O
some	O
factors	O
have	O
been	O
identified	O
that	O
may	O
either	O
contribute	O
to	O
sensitization	O
of	O
the	O
mother	O
and	O
to	O
the	O
subsequent	O
transfer	O
of	O
a	O
predisposition	O
for	O
allergy	O
to	O
the	O
offspring	O
,	O
or	O
that	O
directly	O
induce	O
sensitization	O
in	O
offspring	O
that	O
manifests	O
shortly	O
after	O
birth	O
or	O
at	O
a	O
young	O
age	O
.	O

In	O
a	O
meta	O
-	O
analysis	O
undertaken	O
by	O
Pena	O
-	O
Rosas	O
et	O
al	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
synergistic	O
effects	O
of	O
food	O
[	O
34	O
]	O
and	O
associated	O
with	O
fish	O
being	O
a	O
source	O
of	O
other	O
nutrients	O
which	O
are	O
important	O
for	O
infant	O
development	O
such	O
as	O
iodine	O
and	O
vitamin	O
D	O
.	O
Presently	O
,	O
there	O
have	O
been	O
no	O
randomised	O
control	O
trials	O
examining	O
neurocognitive	O
outcomes	O
associated	O
with	O
prenatal	O
multivitamin	O
use	O
and	O
infant	O
neurodevelopment	O
,	O
and	O
these	O
are	O
unlikely	B
to	O
occur	O
given	O
ethical	O
implications	O
of	O
such	O
[	O
35	O
].	O

The	O
ICDS	O
scheme	O
was	O
introduced	O
on	O
a	O
nationwide	O
scale	O
to	O
upgrade	O
the	O
nutritional	O
and	O
health	O
status	O
of	O
children	O
(	O
0	O
-	O
6	O
years	O
);	O
to	O
develop	O
a	O
framework	O
for	O
ensuring	O
adequate	O
physical	O
,	O
psychological	O
and	O
social	O
development	O
of	O
the	O
child	O
;	O
to	O
minimize	O
the	O
incidence	O
of	O
morbidity	O
,	O
malnutrition	O
,	O
school	O
dropout	O
and	O
mortality	O
;	O
to	O
establish	O
effective	O
collaboration	O
between	O
different	O
departments	O
working	O
for	O
promoting	O
child	O
development	O
;	O
and	O
finally	O
to	O
enable	O
mothers	O
to	O
participate	O
actively	O
for	O
meeting	O
the	O
health	O
and	O
nutritional	O
needs	O
of	O
the	O
child	O
through	O
proper	O
nutrition	O
and	O
health	O
education	O
(	O
1	O
,	O
4	O
).	O

1	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

While	O
one	O
study	O
showed	O
that	O
children	O
whose	O
mothers	O
received	O
augmented	O
and	O
/	O
or	O
induced	O
childbirth	O
showed	O
a	O
greater	O
risk	O
for	O
autism	O
compared	O
with	O
controls	O
,	O
further	O
research	O
is	O
needed	O
to	O
prove	O
an	O
association	O
.	O

Conclusion	O
The	O
findings	O
of	O
the	O
study	O
indicate	O
that	O
intramuscular	O
administration	O
of	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
is	O
effective	O
and	O
safe	O
to	O
improve	O
vitamin	O
D	O
status	O
,	O
and	O
to	O
ameliorate	O
the	O
factors	O
related	O
to	O
the	O
health	O
of	O
mothers	O
and	O
infants	O
,	O
particularly	O
in	O
the	O
regions	O
with	O
severe	O
vitamin	O
D	O
deficiency	O
.	O

Development	O
research	O
Equipment	O
and	O
commodities	O
are	O
considered	O
essential	O
for	O
neonatal	O
care	O
units	O
in	O
high	O
-	O
income	O
countries	O
,	O
yet	O
for	O
many	O
such	O
units	O
in	O
low	O
-	O
income	O
settings	O
,	O
basic	O
equipment	O
and	O
essential	O
medicines	O
are	O
not	O
available	O
or	O
functional	O
.	O

Vitamin	O
D	O
induces	O
insulin	O
receptor	O
expression	O
through	O
Vitamin	O
D	O
receptor	O
(	O
VDR	O
),	O
enhancing	O
insulin	O
-	O
dependent	O
glucose	O
transport	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Maternal	O
25OHD	O
and	O
markers	O
of	O
glucose	O
metabolism	O
in	O
early	O
and	O
late	O
pregnancy	O
among	O
the	O
total	O
group	O
and	O
categorised	O
by	O
season	O
of	O
first	O
antenatal	O
visitSeason	O
at	O
first	O
antenatal	O
visitTotal	O
Group	O
(	O
n	O
=	O
334	O
)	O
Winter	O
(	O
n	O
=	O
166	O
)	O
Summer	O
(	O
n	O
=	O
168	O
)	O
Pd25OHD	O
early	O
<	O
30	O
nmol	O
/	O
La90	O
(	O
26	O
.	O
9	O
)	O
64	O
(	O
38	O
.	O
6	O
)	O
26	O
(	O
15	O
.	O
5	O
)<	O
0	O
.	O
00125OHD	O
early	O
<	O
50	O
nmol	O
/	O
La205	O
(	O
61	O
.	O
4	O
)	O
121	O
(	O
72	O
.	O
9	O
)	O
84	O
(	O
50	O
.	O
0	O
)	O
0	O
.	O
00225OHD	O
28	O
weeks	O
<	O
30	O
nmol	O
/	O
La111	O
(	O
33	O
.	O
2	O
)	O
56	O
(	O
33	O
.	O
7	O
)	O
55	O
(	O
32	O
.	O
7	O
)	O
0	O
.	O
66225OHD	O
28	O
weeks	O
<	O
50	O
nmol	O
/	O
La211	O
(	O
63	O
.	O
2	O
)	O
103	O
(	O
62	O
.	O
0	O
)	O
107	O
(	O
63	O
.	O
7	O
)	O
0	O
.	O
999HOMA	O
-	O
IR	O
earlyb2	O
.	O
1	O
(	O
2	O
.	O
6	O
)	O
2	O
.	O
4	O
(	O
2	O
.	O
8	O
)	O
1	O
.	O
7	O
(	O
2	O
.	O
0	O
)	O
0	O
.	O
004HOMA	O
-	O
IR	O
28	O
weeksb2	O
.	O
8	O
(	O
3	O
.	O
15	O
)	O
2	O
.	O
9	O
(	O
3	O
.	O
4	O
)	O
2	O
.	O
6	O
(	O
2	O
.	O
6	O
)	O
0	O
.	O
064Insulin	O
early	O
(	O
μU	O
/	O
mL	O
)	O
b11	O
.	O
3	O
(	O
12	O
.	O
3	O
)	O
12	O
.	O
8	O
(	O
13	O
.	O
1	O
)	O
9	O
.	O
3	O
(	O
11	O
.	O
1	O
)	O
0	O
.	O
002Insulin	O
28	O
weeks	O
(	O
μU	O
/	O
mL	O
)	O
b14	O
.	O
4	O
(	O
15	O
.	O
6	O
)	O
14	O
.	O
6	O
(	O
16	O
.	O
8	O
)	O
14	O
.	O
1	O
(	O
11	O
.	O
8	O
)	O
0	O
.	O
108Fasting	O
glucose	O
early	O
(	O
mmol	O
/	O
L	O
)	O
c4	O
.	O
48	O
(	O
0	O
.	O
35	O
)	O
4	O
.	O
47	O
(	O
0	O
.	O
33	O
)	O
4	O
.	O
49	O
(	O
0	O
.	O
37	O
)	O
0	O
.	O
566Fasting	O
glucose	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
c4	O
.	O
46	O
(	O
0	O
.	O
46	O
)	O
4	O
.	O
49	O
(	O
0	O
.	O
45	O
)	O
4	O
.	O
42	O
(	O
0	O
.	O
46	O
)	O
0	O
.	O
1571	O
-	O
h	O
GCT	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
c6	O
.	O
48	O
(	O
1	O
.	O
44	O
)	O
6	O
.	O
47	O
(	O
1	O
.	O
39	O
)	O
6	O
.	O
50	O
(	O
1	O
.	O
48	O
)	O
0	O
.	O
864	O
Data	O
presented	O
asan	O
(%),	O
bmedian	O
(	O
interquartile	O
range	O
),	O
cmean	O
(	O
SD	O
)	O
dComparison	O
between	O
winter	O
and	O
summer	O
Unadjusted	O
analysis	O
–	O
25OHD	O
,	O
season	O
and	O
markers	O
of	O
glucose	O
metabolism	O
On	O
unadjusted	O
,	O
simple	O
linear	O
regression	O
,	O
early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
was	O
not	O
associated	O
with	O
any	O
marker	O
of	O
glucose	O
metabolism	O
in	O
early	O
or	O
late	O
pregnancy	O
(	O
Table3	O
[	O
a	O
]).	O

Prevalence	O
of	O
postpartum	O
depression	O
varies	O
throughout	O
the	O
world	O
;	O
however	O
researchers	O
have	O
used	O
different	O
scales	O
and	O
cut	O
off	O
points	O
to	O
describe	O
this	O
psychological	O
disorder	O
.	O

Moreover	O
,	O
it	O
should	O
be	O
noted	O
that	O
alterations	O
in	O
autonomic	O
nervous	O
function	O
are	O
associated	O
with	O
low	O
birth	O
weight	O
and	O
cardiometabolic	O
abnormalities	O
[	O
17	O
,	O
19	O
,	O
20	O
,	O
33	O
].	O

The	O
purpose	O
of	O
the	O
phase	O
7	O
data	O
collection	O
point	O
specifically	O
is	O
to	O
assess	O
measles	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
as	O
marker	O
of	O
response	O
to	O
immunisation	O
at	O
6	O
months	O
and	O
immune	O
function	O
.	O

The	O
SS	O
will	O
notify	O
the	O
Field	O
Implementers	O
of	O
any	O
births	O
in	O
their	O
area	O
,	O
and	O
both	O
will	O
visit	O
the	O
mother	O
and	O
her	O
infant	O
within	O
24	O
h	O
,	O
although	O
measurements	O
will	O
be	O
accepted	O
up	O
to	O
72	O
h	O
after	O
birth	O
.	O

This	O
leaves	O
the	O
intrauterine	O
environment	O
or	O
genetic	O
transmission	O
on	O
the	O
sex	O
chromosome	O
with	O
evidence	O
suggesting	O
the	O
latter	O
,	O
since	B
there	O
are	O
no	O
correlations	O
with	O
the	O
grandfathers	O
or	O
of	O
boys	O
with	O
the	O
PGM	O
.	O

The	O
main	O
problems	O
are	O
:	O
i	O
)	O
to	O
reach	O
an	O
adequate	O
balance	O
of	O
maternal	O
thyroid	O
hormones	O
that	O
is	O
absolutely	O
required	O
by	O
the	O
foetal	O
central	O
nervous	O
system	O
for	O
normal	O
maturation7	O
,	O
ii	O
)	O
to	O
maintain	O
maternal	O
levels	O
of	O
l	O
-	O
thyroxin	O
to	O
avoid	O
possible	O
recurrence	O
or	O
spread	O
of	O
disease	O
,	O
and	O
iii	O
)	O
to	O
perform	O
safe	O
follow	O
-	O
up	O
controls	O
for	O
the	O
mother	O
and	O
to	O
plan	O
further	O
therapy	O
when	O
needed	O
.	O

The	O
initial	O
weight	O
of	O
the	O
child	O
was	O
also	O
included	O
in	O
the	O
regression	O
to	O
adjust	O
for	O
regression	O
towards	O
the	O
mean	O
.	O

No	O
monetary	O
value	O
was	O
assigned	O
to	O
the	O
women	O
'	O
s	O
time	O
since	O
the	O
time	O
required	O
per	O
person	O
was	O
very	O
modest	O
and	O
respondents	O
stated	O
that	O
this	O
did	O
not	O
involve	O
loss	O
of	O
work	O
time	O
or	O
incur	O
a	O
financial	O
cost	O
.	O

Tobacco	O
smoke	O
exposure	O
also	O
predicted	O
lower	O
birth	O
weight	O
with	O
a	O
210	O
g	O
reduction	O
among	O
smoking	O
mothers	O
(>	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
)	O
compared	O
with	O
non	O
-	O
smoking	O
mothers	O
(<	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
).	O

Methods	O
We	O
measured	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
bone	O
mineral	O
content	O
(	O
BMC	O
),	O
bone	O
mineral	O
density	O
(	O
BMD	O
)	O
and	O
their	O
changes	O
over	O
3	O
months	O
of	O
life	O
with	O
400	O
IU	O
/	O
day	O
of	O
vitamin	O
D3	O
supplementation	O
.	O

Performance	O
in	O
assessments	O
can	O
be	O
significantly	O
altered	O
if	O
the	O
participant	O
is	O
hungry	O
,	O
tired	O
or	O
fearful	O
of	O
being	O
in	O
a	O
strange	O
place	O
or	O
being	O
tested	O
[	O
27	O
].	O

Severe	O
or	O
poorly	O
controlled	O
asthma	O
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
fetal	O
death	O
,	O
low	O
birth	O
weight	O
,	O
congenital	O
malformations	O
,[	O
18	O
]	O
and	O
parental	O
complications	O
[	O
14	O
].	O

These	O
brown	O
-	O
like	O
adipocytes	O
have	O
interchangeably	O
been	O
called	O
“	O
recruitable	O
”	O
(	O
Tseng	O
et	O
al	O
.,	O
2008	O
;	O
Schulz	O
et	O
al	O
.,	O
2013	O
),	O
“	O
beige	O
”	O
(	O
Ishibashi	O
and	O
Seale	O
,	O
2010	O
;	O
Auffret	O
et	O
al	O
.,	O
2012	O
;	O
Wu	O
et	O
al	O
.,	O
2012	O
),	O
or	O
“	O
brite	O
”	O
(	O
for	O
brown	O
to	O
white	O
)	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
;	O
Gburcik	O
et	O
al	O
.,	O
2012	O
)	O
cells	O
.	O

A	O
meta	O
-	O
analysis	O
which	O
included	O
the	O
above	O
studies	O
as	O
well	O
as	O
others	O
examining	O
women	O
with	O
pre	O
-	O
existing	O
diabetes	O
,	O
with	O
745	O
glyburide	O
exposed	O
pregnancies	O
and	O
637	O
treated	O
with	O
insulin	O
,	O
has	O
been	O
performed	O
.	O
65This	O
study	O
found	O
that	O
glyburide	O
did	O
not	O
increase	O
the	O
risk	O
of	O
macrosomia	O
,	O
large	O
for	O
gestational	O
age	O
,	O
or	O
neonatal	O
hypoglycemia	O
,	O
but	O
did	O
not	O
examine	O
more	O
serious	O
consequences	O
such	O
as	O
perinatal	O
mortality	O
or	O
congenital	O
anomalies	O
.	O

However	O
,	O
familial	O
occurrences	O
(	O
Miller	O
et	O
al	O
.	O

Gels	O
were	O
scanned	O
using	O
a	O
transmissive	O
,	O
flatbed	O
scanner	O
(	O
UMAX	O
)	O
and	O
analyzed	O
using	O
Phoretix	O
2D	O
Expression	O
software	O
(	O
Nonlinear	O
Dynamics	O
,	O
Newcastle	O
-	O
upon	O
-	O
Tyne	O
,	O
UK	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
depression	O
scores	O
in	O
nulliparous	O
and	O
multiparous	O
subgroupsVariables	O
Mean	O
(	O
sd	O
)	O
NulliparousMultiparousVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
valueVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
13	O
.	O
13	O
(	O
6	O
.	O
91	O
)	O
13	O
.	O
25	O
(	O
6	O
.	O
55	O
)	O
41	O
/	O
510	O
.	O
9312	O
.	O
49	O
(	O
9	O
.	O
08	O
)	O
9	O
.	O
31	O
(	O
5	O
.	O
34	O
)	O
34	O
/	O
270	O
.	O
1525	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
18	O
.	O
40	O
(	O
11	O
.	O
38	O
)	O
12	O
.	O
49	O
(	O
6	O
.	O
29	O
)	O
33	O
/	O
430	O
.	O
0116	O
.	O
58	O
(	O
8	O
.	O
54	O
)	O
11	O
.	O
36	O
(	O
5	O
.	O
47	O
)	O
28	O
/	O
250	O
.	O
02Depression	O
score	O
at	O
baseline8	O
.	O
41	O
(	O
3	O
.	O
52	O
)	O
8	O
.	O
73	O
(	O
3	O
.	O
57	O
)	O
41	O
/	O
510	O
.	O
678	O
.	O
47	O
(	O
4	O
.	O
35	O
)	O
8	O
.	O
48	O
(	O
4	O
.	O
30	O
)	O
34	O
/	O
270	O
.	O
99Depression	O
score	O
at	O
38	O
-	O
40w	O
gestation6	O
.	O
47	O
(	O
3	O
.	O
43	O
)	O
7	O
.	O
98	O
(	O
3	O
.	O
74	O
)	O
38	O
/	O
460	O
.	O
065	O
.	O
80	O
(	O
3	O
.	O
62	O
)	O
7	O
.	O
44	O
(	O
4	O
.	O
28	O
)	O
30	O
/	O
270	O
.	O
12Depression	O
score	O
at	O
postpartum	O
(	O
4w	O
)	O
4	O
.	O
59	O
(	O
3	O
.	O
24	O
)	O
7	O
.	O
27	O
(	O
4	O
.	O
04	O
)	O
34	O
/	O
450	O
.	O
0024	O
.	O
60	O
(	O
3	O
.	O
40	O
)	O
7	O
.	O
52	O
(	O
4	O
.	O
70	O
)	O
30	O
/	O
270	O
.	O
01Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
18	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
24	O
(	O
3	O
.	O
79	O
)	O
34	O
/	O
450	O
.	O
0014	O
.	O
20	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
07	O
(	O
4	O
.	O
37	O
)	O
30	O
/	O
270	O
.	O
01	O
*	O
Mann	O
–	O
Whitney	O
U	O
test	O
We	O
examined	O
the	O
correlation	O
between	O
change	O
in	O
vitamin	O
D	O
concentrations	O
and	O
change	O
in	O
depression	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Comparison	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
based	O
on	O
month	O
of	O
sampling	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
black	O
line	O
&	O
left	O
axis	O
)	O
and	O
average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
(	O
grey	O
line	O
&	O
right	O
axis	O
).	O

found	O
a	O
56	O
%	O
lower	O
risk	O
of	O
PTB	O
among	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
30	O
ng	O
/	O
mL	O
compared	O
to	O
<	O
20	O
ng	O
/	O
mL	O
(	O
95	O
%	O
CI	O
=	O
23	O
–	O
62	O
%)	O
[	O
4	O
].	O

[	O
6	O
]	O
in	O
resource	O
limited	O
settings	O
like	O
the	O
study	O
area	O
.	O

There	O
is	O
a	O
well	O
-	O
established	O
relation	O
of	O
the	O
infant	O
gut	O
microbiome	O
with	O
delivery	O
mode	O
(	O
Cesarean	O
section	O
versus	O
vaginally	O
born	O
infants	O
)	O
[	O
7	O
,	O
8	O
]	O
which	O
may	O
persist	O
through	O
adulthood	O
[	O
9	O
].	O

Women	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
participated	O
in	O
follow	O
-	O
up	O
telephone	O
interviews	O
between	O
2009	O
and	O
2012	O
,	O
which	O
gathered	O
information	O
regarding	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
in	O
order	O
to	O
define	O
the	O
variables	O
of	O
interest	O
.	O

Whether	O
environmentally	O
or	O
biologically	O
driven	O
,	O
we	O
found	O
novel	O
evidence	O
of	O
seasonal	O
rhythms	O
in	O
insulin	O
resistance	O
.	O

While	O
the	O
study	O
is	O
strong	O
in	O
that	O
it	O
uses	O
a	O
large	O
national	O
sample	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
both	O
diagnoses	O
and	O
fertility	O
treatments	O
were	O
self	O
-	O
reported	O
[	O
40	O
].	O

Such	O
changes	O
may	O
still	O
prove	O
useful	O
for	O
regulatory	O
purposes	O
and	O
also	O
do	O
not	O
rule	O
out	O
the	O
possibility	O
of	O
later	O
onset	O
effects	O
.	O

All	O
the	O
aforementioned	O
neonatal	O
outcomes	O
were	O
found	O
mainly	B
in	O
the	O
polytherapy	O
subgroup	O
.	O

Darwin	O
’	O
s	O
‘	O
On	O
the	O
Origin	O
of	O
the	O
Species	O
’	O
highlighted	O
the	O
role	O
of	O
the	O
environment	O
in	O
the	O
process	O
of	O
evolution	O
,	O
the	O
natural	O
selection	O
of	O
advantageous	O
genetic	O
mutations	O
through	O
environmental	O
pressures	O
(	O
Darwin1859	O
).	O

During	O
the	O
first	O
trimester	O
,	O
which	O
is	O
the	O
organogenesis	O
period	O
,	O
general	O
anaesthetic	O
agents	O
may	O
have	O
some	O
teratogenic	O
potential	O
or	O
may	O
increase	O
the	O
risk	O
of	O
miscarriage	O
.	O

Miscarriages	O
or	O
premature	O
birth	O
have	O
raised	O
concern	O
about	O
the	O
use	O
of	O
radioactive	O
iodine	O
in	O
a	O
childbearing	O
age	O
due	O
to	O
the	O
known	O
mutagenic	O
effect	O
of	O
radiation	O
and	O
the	O
theoretical	O
possibility	O
that	O
it	O
may	O
affect	O
germ	O
cells	O
,	O
thereby	O
causing	O
genetic	O
damage	O
,	O
congenital	O
abnormalities	O
and	O
malignancy	O
in	O
offspring	O
.	O

Each	O
year	O
,	O
great	O
care	O
is	O
taken	O
to	O
explain	O
the	O
methodology	O
for	O
grade	O
determination	O
and	O
the	O
basis	O
of	O
comparison	O
to	O
other	O
states	O
.	O

Thus	B
,	O
increasing	O
vitamin	O
D	O
intake	O
from	O
vitamin	O
D	O
fortified	O
foods	O
,	O
and	O
vitamin	O
D	O
supplements	O
,	O
in	O
combination	O
with	O
sensible	O
sun	O
exposure	O
,	O
maximize	O
a	O
person	O
'	O
s	O
vitamin	O
D	O
status	O
to	O
promote	O
good	O
health	O
.	O

In	O
summer	O
,	O
light	O
-	O
skinned	O
people	O
who	O
spend	O
at	O
least	O
15	O
minutes	O
outside	O
during	O
the	O
day	O
with	O
their	O
hands	O
and	O
face	O
exposed	O
will	O
have	O
adequate	O
vitamin	O
D	O
levels	O
.	O

For	O
binary	O
outcomes	O
,	O
relative	O
risks	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
log	O
binomial	O
regression	O
.	O

Methods	O
Study	O
design	O
This	O
study	O
is	O
a	O
cluster	O
randomised	O
controlled	O
trial	O
,	O
with	O
2	O
-	O
arm	O
parallel	O
groups	O
,	O
superiority	O
design	O
and	O
1	O
:	O
1	O
allocation	O
ratio	O
.	O

Apart	O
from	O
the	O
development	O
of	O
diabetes	O
,	O
women	O
who	O
have	O
had	O
GDM	O
have	O
an	O
adverse	O
cardiac	O
risk	O
profile	O
,	O
including	O
the	O
metabolic	O
syndrome	O
.	O
83	O
,	O
84A	O
higher	O
prevalence	O
of	O
cardiovascular	O
disease	O
that	O
occurs	O
at	O
a	O
younger	O
age	O
,	O
independent	O
of	O
the	O
metabolic	O
syndrome	O
and	O
type	O
2	O
diabetes	O
has	O
also	O
been	O
demonstrated	O
.	O
83	O
In	O
view	O
of	O
the	O
above	O
,	O
it	O
is	O
important	O
that	O
the	O
woman	O
who	O
has	O
had	O
GDM	O
receive	O
counseling	O
and	O
support	O
to	O
reduce	O
her	O
long	O
-	O
term	O
risk	O
of	O
diabetes	O
.	O

While	O
fruit	O
is	O
considered	O
healthful	O
and	O
red	O
and	O
processed	O
meat	O
consumption	O
is	O
recommended	O
to	O
be	O
limited	O
,	O
OTUs	O
in	O
the	O
genus	O
Bifidobacterium	O
,	O
generally	O
recognized	O
as	O
a	O
beneficial	O
microbe	O
,	O
were	O
decreased	O
with	O
increasing	O
maternal	O
fruit	O
consumption	O
in	O
vaginally	O
born	O
infants	O
yet	O
increased	O
with	O
higher	O
maternal	O
red	O
and	O
processed	O
meat	O
consumption	O
in	O
those	O
born	O
by	O
Cesarean	O
section	O
.	O

They	O
include	O
hormones	O
,	O
such	O
as	O
insulin	O
,	O
leptin	O
and	O
glucocorticoids	O
,	O
proinflammatory	O
cytokines	O
,	O
as	O
well	O
as	O
complex	O
epigenetic	O
modifications	O
(	O
Tamashiro	O
and	O
Moran	O
,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2013	O
).	O

However	O
,	O
due	O
to	O
the	O
lack	O
of	O
sufficient	O
information	O
about	O
the	O
physiologic	O
role	O
of	O
visfatin	O
in	O
adults	O
,	O
its	O
source	O
and	O
regulation	O
mechanism	O
in	O
fetal	O
and	O
neonatal	O
stages	O
cannot	O
be	O
argued	O
absolutely	O
.	O

In	O
our	O
study	O
,	O
the	O
definition	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
based	O
on	O
self	O
-	O
reported	O
frequency	O
of	O
psychosis	O
-	O
like	O
experiences	O
.	O

All	O
these	O
costs	O
could	O
be	O
identified	O
from	O
financial	O
records	O
.	O

Considering	O
the	O
possible	O
connection	O
between	O
low	O
serum	O
vitamin	O
D	O
and	O
depression	O
,	O
researchers	O
studied	O
the	O
relationship	O
between	O
low	O
vitamin	O
D	O
and	O
perinatal	O
depression	O
.	O

The	O
fattening	O
period	O
can	O
be	O
divided	O
into	O
early	O
and	O
late	O
periods	O
,	O
during	O
which	O
the	O
concentrate	O
is	O
mainly	O
fed	O
with	O
a	O
small	O
portion	O
of	O
roughage	O
.	O

Many	O
questions	O
remain	O
and	O
future	O
research	O
will	O
benefit	O
from	O
focused	O
studies	O
aimed	O
at	O
specific	O
exposures	O
and	O
subpopulations	O
,	O
allowing	O
for	O
more	O
detailed	O
analyses	O
by	O
histologic	O
subtypes	O
.	O

Thus	B
,	O
once	O
individual	O
exposures	O
have	O
been	O
characterized	O
,	O
it	O
may	O
also	O
be	O
relevant	O
to	O
assess	O
the	O
effect	O
of	O
(	O
1	O
)	O
mixtures	O
of	O
environmental	O
exposures	O
,	O
(	O
2	O
)	O
multiple	O
lifetime	O
exposures	O
of	O
single	O
environmental	O
exposures	O
,	O
and	O
(	O
3	O
)	O
multiple	O
lifetime	O
exposures	O
of	O
mixtures	O
of	O
environmental	O
exposures	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
6	O
month	O
infant	O
neurodevelopmental	O
outcomes	O
by	O
treatment	O
group	O
,	O
assessed	O
by	O
the	O
Ages	O
and	O
Stages	O
QuestionnaireOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueCommunication	O
domain51	O
.	O
30	O
(	O
9	O
.	O
03	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
63	O
)	O
0	O
.	O
35	O
(−	O
0	O
.	O
68	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
5010	O
.	O
36	O
(−	O
0	O
.	O
67	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
493Gross	O
motor	O
domain53	O
.	O
35	O
(	O
10	O
.	O
05	O
)	O
52	O
.	O
74	O
(	O
10	O
.	O
84	O
)	O
0	O
.	O
61	O
(−	O
0	O
.	O
54	O
,	O
1	O
.	O
75	O
)	O
0	O
.	O
2970	O
.	O
55	O
(−	O
0	O
.	O
59	O
,	O
1	O
.	O
69	O
)	O
0	O
.	O
344Fine	O
motor	O
domain52	O
.	O
25	O
(	O
10	O
.	O
52	O
)	O
51	O
.	O
20	O
(	O
10	O
.	O
74	O
)	O
1	O
.	O
05	O
(−	O
0	O
.	O
11	O
,	O
2	O
.	O
21	O
)	O
0	O
.	O
0751	O
.	O
00	O
(−	O
0	O
.	O
13	O
,	O
2	O
.	O
14	O
)	O
0	O
.	O
082Problem	O
solving	O
domain53	O
.	O
60	O
(	O
9	O
.	O
55	O
)	O
52	O
.	O
86	O
(	O
9	O
.	O
15	O
)	O
0	O
.	O
74	O
(−	O
0	O
.	O
29	O
,	O
1	O
.	O
76	O
)	O
0	O
.	O
1580	O
.	O
72	O
(−	O
0	O
.	O
31	O
,	O
1	O
.	O
74	O
)	O
0	O
.	O
170Social	O
domain51	O
.	O
71	O
(	O
9	O
.	O
52	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
74	O
)	O
0	O
.	O
77	O
(−	O
0	O
.	O
34	O
,	O
1	O
.	O
87	O
)	O
0	O
.	O
1730	O
.	O
69	O
(−	O
0	O
.	O
41	O
,	O
1	O
.	O
79	O
)	O
0	O
.	O
218Total	O
score262	O
.	O
47	O
(	O
34	O
.	O
92	O
)	O
258	O
.	O
72	O
(	O
36	O
.	O
54	O
)	O
3	O
.	O
75	O
(−	O
0	O
.	O
13	O
,	O
7	O
.	O
63	O
)	O
0	O
.	O
0583	O
.	O
53	O
(−	O
0	O
.	O
33	O
,	O
7	O
.	O
40	O
)	O
0	O
.	O
073More	O
than	O
1	O
score	O
below	O
cut	O
-	O
off	O
*	O
49	O
(	O
4	O
.	O
58	O
)	O
69	O
(	O
6	O
.	O
51	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
44	O
,	O
1	O
.	O
12	O
)	O
0	O
.	O
1370	O
.	O
69	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
126	O
Values	O
are	O
mean	O
and	O
standard	O
deviation	O
(	O
or	O
number	O
and	O
percentage	O
),	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
(	O
or	O
relative	O
risks	O
)	O
and	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

Data	O
include	O
date	O
and	O
country	O
of	O
birth	O
,	O
marital	O
status	O
,	O
educational	O
level	O
,	O
home	O
language	O
,	O
employment	O
status	O
,	O
household	O
income	O
,	O
number	O
of	O
members	O
in	O
the	O
household	O
,	O
and	O
beneficiaries	O
of	O
social	O
grants	O
.	O

Furthermore	O
,	O
the	O
protective	O
effect	O
against	O
vitamin	O
D	O
deficiency	O
was	O
seen	O
in	O
both	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
,	O
in	O
contrast	O
to	O
a	O
recently	O
published	O
study	O
by	O
Burris	O
et	O
al	O
.	O

Health	O
care	O
workers	O
and	O
their	O
professional	O
organisations	O
:	O
Invest	O
•	O
Advocate	O
for	O
and	O
participate	O
in	O
evidence	O
-	O
based	O
training	O
,	O
deployment	O
and	O
retention	O
of	O
workers	O
with	O
the	O
necessary	O
skills	O
to	O
address	O
the	O
burden	O
of	O
preterm	O
birth	O
.	O

After	O
adjustment	O
for	O
potential	O
confounders	O
,	O
there	O
was	O
weak	O
evidence	O
for	O
positive	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
doctor	O
-	O
diagnosed	O
asthma	O
and	O
childhood	O
wheeze	O
(	O
OR	O
comparing	O
highest	O
versus	O
lowest	O
quintile	O
1	O
.	O
31	O
,	O
95	O
%	O
CI	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
09	O
and	O
1	O
.	O
42	O
,	O
95	O
%	O
CI	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
08	O
,	O
respectively	O
),	O
and	O
stronger	O
evidence	O
for	O
a	O
positive	O
association	O
with	O
atopy	O
at	O
age	O
7	O
years	O
(	O
OR	O
1	O
.	O
38	O
,	O
95	O
%	O
CI	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
006	O
)	O
(	O
table	O
2	O
).	O

This	O
result	O
is	O
consistent	O
with	O
the	O
findings	O
of	O
Jeng	O
et	O
al	O
.,	O
who	O
also	O
showed	O
no	O
correlation	O
with	O
BMI	O
and	O
cathelicidin	O
in	O
adults	O
with	O
sepsis	O
[	O
9	O
].	O

At	O
weaning	O
,	O
all	O
offspring	O
were	O
weight	O
matched	O
within	O
maternal	O
dietary	O
groups	O
and	O
placed	O
on	O
either	O
standard	O
rat	O
chow	O
or	O
a	O
high	O
-	O
fat	O
diet	O
(	O
HF	O
;	O
Research	O
Diets	O
Inc	O
.	O
D12451	O
,	O
45	O
%	O
kcal	O
as	O
fat	O
),	O
resulting	O
in	O
a	O
total	O
of	O
12	O
groups	O
(	O
Table	O
2	O
).	O

3	O
.	O
5	O
.	O

However	O
,	O
in	O
this	O
study	O
no	O
regulation	O
of	O
both	O
'	O
insulin	O
signaling	O
'	O
and	O
'	O
IGF1	O
signaling	O
'	O
was	O
observed	O
in	O
liver	O
tissue	O
of	O
LP	O
porcine	O
offspring	O
,	O
possibly	O
due	O
to	O
maturation	O
-,	O
species	O
-,	O
tissue	O
-,	O
sex	O
-	O
and	O
time	O
-	O
dependent	O
regulations	O
.	O

In	O
our	O
cohort	O
,	O
women	O
with	O
negative	O
attitudes	O
exhibited	O
higher	O
levels	O
of	O
stress	O
during	O
pregnancy	O
compared	O
to	O
women	O
with	O
neutral	O
/	O
positive	O
attitudes	O
and	O
gave	O
birth	O
to	O
infants	O
with	O
lower	O
birth	O
weights	O
than	O
those	O
with	O
positive	O
/	O
neutral	O
attitudes	O
towards	O
their	O
pregnancy	O
(	O
500	O
gr	O
difference	O
[	O
13	O
]).	O

Epigenetic	O
changes	O
that	O
act	O
as	B
markers	O
of	O
exposure	O
and	O
/	O
or	O
predictors	O
of	O
future	O
toxicity	O
,	O
but	O
do	O
not	O
in	O
themselves	O
directly	O
induce	O
an	O
adverse	O
effect	O
,	O
may	O
also	O
be	O
useful	O
in	O
risk	O
assessment	O
and	O
intervention	O
.	O

Race	O
,	O
Medicaid	O
status	O
,	O
higher	O
BMI	O
at	O
delivery	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
were	O
all	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
25	O
(	O
OH	O
)	O
D	O
<	O
50	O
nmol	O
l	O
−	O
1	O
;	O
P	O
<	O
0	O
.	O
01	O
).	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

We	O
identified	O
clusters	O
in	O
all	O
infants	O
(	O
n	O
=	O
145	O
)	O
and	O
within	O
infants	O
delivered	O
vaginally	O
(	O
n	O
=	O
97	O
)	O
or	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
)	O
for	O
within	O
delivery	O
group	O
analyses	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

The	O
mean	O
GD	O
was	O
7	O
%	O
smaller	O
(	O
81	O
.	O
0	O
±	O
0	O
.	O
6	O
µm	O
)	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
87	O
.	O
2	O
±	O
0	O
.	O
6	O
µm	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
regression	O
for	O
mean	O
vitamin	O
D	O
levelVariableUnstandardized	O
regression	O
coefficient	O
(	O
b	O
)±	O
95	O
%	O
confidence	O
intervalP	O
value	O
Intercept71	O
.	O
01	O
//	O
S	O
-	O
ECC	O
(	O
Reference	O
=	O
Yes	O
)	O
5	O
.	O
331	O
.	O
24	O
,	O
9	O
.	O
420	O
.	O
01Regular	O
milk	O
drinker	O
(	O
Reference	O
=	O
Yes	O
)-	O
6	O
.	O
60	O
-	O
13	O
.	O
16	O
,	O
-	O
0	O
.	O
030	O
.	O
05Season	O
(	O
Reference	O
=	O
Winter	O
)	O
5	O
.	O
221	O
.	O
37	O
,	O
9	O
.	O
060	O
.	O
008Vitamin	O
D	O
drop	O
user	O
(	O
Reference	O
=	O
Yes	O
)-	O
2	O
.	O
172	O
.	O
01	O
,	O
-	O
6	O
.	O
130	O
.	O
28Yearly	O
income	O
(	O
Reference	O
=	O
<	O
28	O
k	O
)	O
2	O
.	O
732	O
.	O
06	O
,	O
-	O
1	O
.	O
320	O
.	O
19	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

It	O
has	O
been	O
shown	O
that	O
fetal	O
growth	O
retardation	O
is	O
accompanied	O
by	O
alterations	O
in	O
cell	O
cycle	O
regulating	O
molecules	O
at	O
both	O
transcriptome	O
[	O
25	O
]	O
and	O
proteome	O
level	O
[	O
26	O
].	O

A	O
relatively	O
low	O
proportion	O
of	O
women	O
in	O
our	O
study	O
used	O
iron	O
supplements	O
(	O
45	O
.	O
3	O
%),	O
although	O
these	O
are	O
provided	O
free	O
of	O
charge	O
to	O
women	O
after	O
the	O
16thweek	O
of	O
pregnancy	O
.	O

In	O
a	O
Nigerian	O
study	O
by	O
Fawoleet	O
al	O
[	O
7	O
]	O
and	O
in	O
Entebe	O
,	O
a	O
semi	O
-	O
urban	O
district	O
in	O
Uganda	O
[	O
28	O
]	O
a	O
proportionately	O
similar	O
profile	O
of	O
ANC	O
services	O
were	O
offered	O
as	O
in	O
our	O
area	O
of	O
study	O
.	O

For	O
all	O
genes	O
exemplarily	O
analysed	O
,	O
qRT	O
-	O
PCR	O
confirmed	O
the	O
direction	O
of	O
differential	O
regulation	O
as	O
obtained	O
by	O
microarray	O
analysis	O
.	O

In	O
Model	O
2	O
we	O
adjusted	O
additionally	O
for	O
all	O
potential	O
confounders	O
listed	O
above	O
.	O

Results	O
Population	O
characteristics	O
Of	O
3229	O
women	O
recruited	O
as	O
part	O
of	O
SCOPE	O
at	O
the	O
Adelaide	O
and	O
Auckland	O
centres	O
,	O
serum	O
samples	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
to	O
measure	O
25	O
(	O
OH	O
)	O
D	O
were	O
available	O
for	O
2800	O
(	O
87	O
%)	O
women	O
of	O
whom	O
,	O
1156	O
(	O
41	O
%)	O
were	O
recruited	O
in	O
Adelaide	O
and	O
1644	O
(	O
59	O
%)	O
were	O
recruited	O
in	O
Auckland	O
.	O

Excessive	O
GWG	O
was	O
related	O
to	O
offspring	O
weight	O
but	O
more	O
strongly	O
at	O
birth	O
than	O
at	O
6	O
months	O
and	O
was	O
not	O
significantly	O
related	O
to	O
changes	O
in	O
WFA	O
z	O
-	O
scores	O
.	O

Environmental	O
insults	O
in	O
utero	O
may	O
lead	O
to	O
changes	O
in	O
epigenetic	O
mechanisms	O
potentially	O
affecting	O
fetal	O
development	O
.	O

A	O
study	O
of	O
15	O
,	O
390	O
Brazilian	O
students	O
was	O
unable	O
to	O
detect	O
a	O
difference	O
in	O
the	O
season	O
of	O
birth	O
between	O
right	O
-	O
and	O
left	O
-	O
handers	O
.	O

Birth	O
weight	O
and	O
gestational	O
age	O
were	O
recorded	O
for	O
each	O
infant	O
.	O

When	O
looking	O
at	O
the	O
change	O
in	O
BMC	O
during	O
the	O
study	O
period	O
,	O
the	O
change	O
was	O
significantly	O
greater	O
in	O
Hispanic	O
infants	O
than	O
Caucasians	O
(	O
51	O
.	O
0	O
±	O
11	O
.	O
3	O
g	O
vs	O
41	O
.	O
2	O
±	O
10	O
.	O
1	O
g	O
,	O
p	O
=	O
0	O
.	O
006	O
).	O

At	O
present	O
,	O
there	O
remains	O
a	O
lack	O
of	O
consensus	O
regarding	O
recommendations	O
for	O
UVB	O
exposure	O
for	O
the	O
production	O
of	O
vitamin	O
D	O
for	O
pregnant	O
women	O
[	O
46	O
].	O

Children	O
who	O
live	O
in	O
polluted	O
,	O
inner	O
city	O
environments	O
and	O
who	O
are	O
deprived	O
of	O
regular	O
sunlight	O
exposure	O
have	O
been	O
shown	O
to	O
suffer	O
a	O
higher	O
prevalence	O
of	O
rickets	O
(	O
due	O
to	O
vitamin	O
D	O
deficiency	O
)	O
than	O
children	O
in	O
rural	O
areas	O
[	O
148	O
].	O

Lastly	O
,	O
since	O
the	O
clinical	O
behaviour	O
of	O
MTC	O
is	O
extremely	O
variable	O
,	O
this	O
tumour	O
represents	O
a	O
true	B
therapeutic	O
challenge	O
.	O

Hypercalciuria	O
due	O
to	O
excessive	O
vitamin	O
D	O
intakes	O
is	O
always	O
accompanied	O
by	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
>	O
250nmol	O
/	O
L	O
(	O
100	O
ng	O
/	O
mL	O
).	O

This	O
variable	O
was	O
calculated	O
in	O
stages	O
,	O
first	O
by	O
dividing	O
the	O
number	O
of	O
positive	O
influenza	O
samples	O
by	O
the	O
total	O
number	O
of	O
samples	O
tested	O
per	O
week	O
from	O
the	O
surveillance	O
data	O
and	O
then	O
assigning	O
the	O
cumulative	O
sum	O
of	O
the	O
influenza	O
positive	O
proportions	O
per	O
week	O
to	O
the	O
weeks	O
that	O
women	O
were	O
pregnant	O
;	O
we	O
dichotomized	O
this	O
variable	O
by	O
high	O
or	O
low	O
exposure	O
using	O
the	O
median	O
cumulative	O
influenza	O
exposure	O
as	O
a	O
cutoff	O
.	O

N	O
—	O
sample	O
size7421	O
mother	O
-	O
child	O
pairs	O
.	O
135	O
mother	O
-	O
child	O
pairs5449	O
children	O
assessed	O
.	O
217	O
mother	O
-	O
child	O
pairs	O
.	O
MethodMeasured	O
fish	O
intake	O
during	O
at	O
32	O
weeks	O
gestation	O
by	O
Food	O
Frequency	O
Questionnaire	O
(	O
FFQ	O
)	O
during	O
.	O

The	O
duration	O
of	O
natural	O
sunlight	O
in	O
our	O
environment	O
varies	O
depending	O
on	O
season	O
,	O
and	O
although	O
it	O
is	O
known	O
that	O
many	O
animals	O
adapt	O
physiologically	O
and	O
behaviourally	O
in	O
order	O
to	O
survive	O
the	O
changing	O
seasons	O
,	O
there	O
is	O
also	O
evidence	O
of	O
circannual	O
biological	O
clocks	O
among	O
humans	O
[	O
15	O
,	O
17	O
].	O

With	O
the	O
aim	O
of	O
evaluating	O
the	O
hypothesis	O
that	O
influenza	O
vaccination	O
has	O
a	O
beneficial	O
effect	O
on	O
birth	O
outcomes	O
,	O
we	O
collected	O
birth	O
outcome	O
data	O
,	O
current	O
influenza	O
vaccination	O
status	O
,	O
and	O
risk	O
factors	O
for	O
adverse	O
pregnancy	O
outcomes	O
by	O
interviewing	O
post	O
-	O
partum	O
women	O
at	O
two	O
large	O
hospitals	O
in	O
Managua	O
.	O

This	O
is	O
a	O
first	O
time	O
that	O
GAS5	O
localization	O
has	O
been	O
studied	O
in	O
human	O
placentas	O
.	O

Stata	O
V	O
.	O
14	O
(	O
StataCorp	O
.	O

Bacterial	O
vaginosis	O
is	O
more	O
prevalent	O
in	O
black	O
women	O
,	O
who	O
typically	B
have	O
lower	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
have	O
a	O
six	O
-	O
fold	O
higher	O
chance	B
of	O
vitamin	O
D	O
deficiency	O
,	O
compared	O
with	O
white	O
women	O
.	O

Skm2	O
mice	O
in	O
the	O
supine	O
(	O
E	O
)	O
and	O
lateral	O
(	O
F	O
)	O
positions	O
.	O

Therefore	B
,	O
our	O
data	O
are	O
consistent	O
and	O
complements	O
the	O
results	O
of	O
previous	O
studies	O
reporting	O
the	O
presence	O
of	O
impairment	O
in	O
the	O
vagal	O
cardiac	O
autonomic	O
modulation	O
in	O
children	O
born	O
with	O
low	O
weight	O
[	O
15	O
,	O
34	O
,	O
39	O
].	O

Control	O
animals	O
were	O
kept	O
under	O
similar	O
conditions	O
except	O
they	O
received	O
a	O
vitamin	O
D	O
replete	O
diet	O
(	O
Dyets	O
,	O
PA	O
,	O
USA	O
and	O
Specialty	O
Foods	O
,	O
WA	O
,	O
Australia	O
)	O
and	O
were	O
housed	O
under	O
standard	O
lighting	O
conditions	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
The	O
effects	O
and	O
causes	O
of	O
vitamin	O
D	O
deficiency	O
in	O
women	O
with	O
PCOS	O
(	O
after	O
:	O
Grzechocinska	O
B	O
,	O
Dabrowski	O
FA	O
,	O
Cyganek	O
A	O
,	O
Wielgos	O
M	O
.	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
impaired	O
fertility	O
treatment	O
.	O

(	O
2010	O
)	O
*	O
Ostrow	O
et	O
al	O
.	O

Nevertheless	O
,	O
patient	O
views	O
provide	O
an	O
insight	O
to	O
the	O
care	O
provided	O
and	O
the	O
system	O
as	O
a	O
whole	O
.	O

The	O
mean	O
KM	O
(	O
mean	O
±	O
SEM	O
,	O
n	O
=	O
6	O
animals	O
each	O
group	O
)	O
varied	O
from	O
47	O
.	O
4	O
±	O
2	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
60	O
.	O
2	O
±	O
1	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
more	O
than	O
27	O
%	O
variation	O
;	O
P	O
=	O
0	O
.	O
009	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
53	O
.	O
0	O
±	O
2	O
.	O
9	O
mg	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
56	O
.	O
3	O
±	O
3	O
.	O
0	O
mg	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

These	O
were	O
not	O
evaluated	O
in	O
this	O
study	O
but	B
there	O
are	O
no	O
clear	O
cultural	O
reasons	B
to	O
expect	O
a	O
substantial	O
difference	O
in	O
Houston	O
.	O

The	O
mean	O
total	O
number	O
of	O
combined	O
visits	O
was	O
9	O
.	O
58	O
±	O
4	O
.	O
88	O
:	O
18	O
%	O
of	O
participants	O
made	O
≤	O
4	O
visits	O
,	O
28	O
.	O
5	O
%	O
made	O
between	O
5	O
–	O
9	O
visits	O
and	O
53	O
.	O
3	O
%	O
had	O
≥	O
10	O
visits	O
.	O

[	O
15	O
]	O
Thus	B
,	O
Daily	O
vitamin	O
requirement	O
varies	O
with	O
ethnicity	O
,	O
and	O
this	O
is	O
relevant	O
in	O
case	O
of	O
Indian	O
population	O
.	O

Generally	B
,	O
these	O
results	O
show	O
that	O
visfatin	O
has	O
a	O
major	O
role	O
in	O
maternal	O
-	O
fetal	O
metabolic	O
interaction	O
.	O

Potentially	O
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

Hip	O
circumference	O
(	O
HP	O
)	O
was	O
measured	O
at	O
the	O
maximum	O
circumference	O
of	O
the	O
buttocks	O
.	O

Anthropometry	O
Body	O
weight	O
and	O
height	O
were	O
measured	O
in	O
light	O
clothing	O
without	O
shoes	O
using	O
a	O
standard	O
balance	O
beam	O
scale	O
.	O

Both	O
models	O
were	O
adjusted	O
for	O
infant	O
sex	O
and	O
maternal	O
age	O
,	O
BMI	O
,	O
ethnicity	O
,	O
and	O
tobacco	O
,	O
alcohol	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
.	O

Lewis	O
and	O
colleagues	O
surveyed	O
1	O
,	O
304	O
residents	O
,	O
obtaining	O
basic	O
demographic	O
information	O
,	O
mapping	O
the	O
locations	O
of	O
their	O
homes	O
,	O
and	O
taking	O
samples	O
from	O
the	O
wells	O
where	O
they	O
obtained	O
their	O
drinking	O
water	O
.	O

Exposure	O
to	O
psychotropic	O
polytherapy	O
was	O
reported	O
in	O
72	O
.	O
2	O
%	O
of	O
the	O
assessed	O
cohort	O
.	O

such	O
values	O
for	O
the	O
control	O
group	O
were	O
33	O
.	O
3	O
%	O
and	O
14	O
.	O
3	O
%,	O
respectively	O
.	O

Our	O
trial	O
had	O
a	O
large	O
sample	O
size	O
with	O
a	O
low	O
loss	O
to	O
follow	O
-	O
up	O
that	O
remained	O
within	O
our	O
sample	O
size	O
estimates	O
.	O

Since	O
socioeconomic	O
status	O
plays	O
a	O
significant	O
role	O
in	O
PTB	O
risk	O
,	O
multivariate	O
logistic	O
regression	O
was	O
used	O
to	O
adjust	O
for	O
socioeconomic	O
status	O
(	O
SES	O
)	O
proxy	O
variables	O
(	O
insurance	O
status	O
and	O
education	O
).	O

For	O
each	O
animal	O
,	O
two	O
gels	O
were	O
averaged	O
.	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	O
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	O
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
[	O
1	O
-	O
6	O
].	O

In	O
Model	O
1	O
we	O
adjusted	O
for	O
total	O
energy	O
intake	O
only	O
.	O

There	O
was	O
no	O
evidence	O
to	O
suggest	O
that	O
the	O
effects	O
of	O
the	O
intervention	O
were	O
modified	O
by	O
maternal	O
BMI	O
category	O
.	O

However	O
,	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
participants	O
born	O
from	O
late	O
fall	O
through	O
early	O
spring	O
,	O
glioma	O
risk	O
also	O
has	O
been	O
shown	O
to	O
be	O
higher	O
than	O
for	O
those	O
born	O
at	O
other	O
times	O
of	O
the	O
year	O
[	O
16	O
].	O

Some	O
studies	O
investigated	O
the	O
effect	O
of	O
reduced	O
exposure	O
of	O
infants	O
to	O
allergen	O
-	O
provoking	O
food	O
.	O

Genetic	O
constitution	O
is	O
important	O
[	O
4	O
],	O
but	O
environmental	O
factors	O
like	O
an	O
unhealthy	O
lifestyle	O
with	O
a	O
poor	O
diet	O
may	O
be	O
involved	O
[	O
5	O
,	O
6	O
].	O

Cord	O
25	O
(	O
OH	O
)	O
D	O
was	O
not	O
significantly	O
related	O
to	O
BMC	O
(	O
p	O
=	O
0	O
.	O
39	O
)	O
or	O
BMD	O
(	O
also	O
,	O
p	O
=	O
0	O
.	O
39	O
).	O

It	O
is	O
,	O
therefore	B
,	O
important	O
to	O
assess	O
if	O
the	O
model	O
system	O
being	O
used	O
accurately	O
replicates	O
the	O
in	O
vivo	O
human	O
metabolic	O
environment	O
,	O
and	O
if	O
not	O
to	O
conduct	O
further	O
studies	O
using	O
any	O
additional	O
appropriate	O
metabolites	O
.	O

studied	O
the	O
relationship	O
between	O
the	O
maternal	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
measured	O
in	O
the	O
18thweek	O
of	O
gestation	O
and	O
postnatal	O
depression	O
in	O
796	O
people	O
.	O

Non	O
-	O
normally	O
distributed	O
variables	O
were	O
log	O
-	O
transformed	O
to	O
normalize	O
the	O
distribution	O
.	O

Measurement	O
of	O
infant	O
skinfold	O
thickness	O
[	O
36	O
,	O
37	O
]	O
and	O
bio	O
-	O
impedance	O
are	O
considered	O
reliable	O
and	O
relatively	O
non	O
-	O
invasive	O
methods	O
of	O
assessing	O
fat	O
distribution	O
,	O
both	O
of	O
which	O
have	O
been	O
correlated	O
with	O
more	O
invasive	O
measures	O
[	O
36	O
,	O
38	O
–	O
40	O
].	O

Although	O
the	O
women	O
were	O
recruited	O
prospectively	O
,	O
there	O
are	O
potential	O
limitations	O
in	O
the	O
retrospectivity	O
of	O
a	O
database	O
.	O

This	O
is	O
a	O
direct	O
competitive	O
chemiluminescence	O
immunoassay	O
used	O
to	O
quantitatively	O
determine	O
total	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

Cord	O
25	O
(	O
OH	O
)	O
D	O
averaged	O
14	O
.	O
9	O
ng	O
/	O
mL	O
and	O
BMC	O
at	O
one	O
week	O
of	O
life	O
averaged	O
70	O
.	O
3	O
g	O
for	O
the	O
2	O
Caucasian	O
infants	O
who	O
did	O
not	O
return	O
at	O
3	O
months	O
.	O

The	O
overall	O
client	O
satisfaction	O
was	O
compared	O
with	O
the	O
different	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
respondents	O
(	O
Table	O
4	O
).	O

found	O
vitamin	O
D	O
deficiency	O
in	O
52	O
.	O
9	O
%	O
of	O
women	O
aged	O
20	O
–	O
74	O
years	O
in	O
Shiraz	O
,	O
Iran	O
[	O
54	O
].	O

This	O
variable	O
had	O
a	O
median	O
value	O
of	O
11	O
.	O
20	O
and	O
mode	O
value	O
of	O
4	O
.	O

Circulating	O
progesterone	O
concentrations	O
in	O
adult	O
female	O
offspring	O
born	O
to	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
(	O
UNP	O
)	O
were	O
significantly	O
lower	O
than	O
concentrations	O
in	O
Cont	O
,	O
UNL	O
or	O
UNPL	O
offspring	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
4A	O
).	O

On	O
the	O
other	O
hand	O
,	O
it	O
might	O
be	O
associated	O
to	O
the	O
transcriptional	O
excursions	O
within	O
the	O
lipid	O
metabolism	O
in	O
LP	O
offspring	O
.	O

Any	O
unscheduled	O
visits	O
to	O
a	O
medical	O
facility	O
and	O
medicine	O
given	O
to	O
the	O
infant	O
are	O
also	O
recorded	O
.	O

Introduction	O
Obesity	O
results	O
from	O
a	O
combination	O
of	O
factors	O
that	O
occur	O
at	O
different	O
stages	O
during	O
a	O
person	O
'	O
s	O
lifetime	O
.	O

Maternal	O
Diet	O
During	O
Pregnancy	O
A	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
of	O
4	O
clinical	O
studies	O
concluded	O
that	O
antigen	O
avoidance	O
during	O
pregnancy	O
is	O
unlikely	B
to	O
reduce	O
the	O
child	O
'	O
s	O
risk	O
of	O
developing	O
atopic	O
disease	O
,	O
and	O
dietary	O
restrictions	O
could	O
adversely	O
affect	O
maternal	O
or	O
fetal	O
nutrition	O
[	O
99	O
].	O

However	O
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
BM	O
in	O
both	O
generations	O
of	O
VitD	O
-	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
but	O
the	O
BM	O
was	O
higher	O
only	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
group	O
at	O
weaning	O
.	O

Though	O
this	O
implies	O
a	O
certain	O
etiological	O
premise	O
of	O
difference	O
in	O
gender	O
,	O
it	O
is	O
also	O
important	O
to	O
note	O
that	O
while	O
the	O
population	O
cohort	O
design	O
is	O
strong	O
,	O
there	O
was	O
not	O
a	O
large	O
number	O
overall	O
of	O
the	O
lower	O
birth	O
weight	O
categories	O
in	O
females	O
[	O
44	O
].	O

We	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
a	O
small	O
number	O
of	O
infants	O
will	O
be	O
hypocalcemic	O
in	O
the	O
first	O
weeks	O
of	O
life	O
with	O
this	O
approach	O
,	O
but	O
,	O
this	O
appears	O
to	O
be	O
uncommon	O
and	O
may	O
be	O
more	O
related	O
to	O
PTH	O
function	O
than	O
vitamin	O
D	O
.	O
Further	O
research	O
is	O
needed	O
relative	O
to	O
the	O
etiology	O
of	O
symptomatic	O
hypocalcemia	O
in	O
the	O
first	O
weeks	O
of	O
life	O
.	O

Others	O
have	O
also	O
reported	O
that	O
rampant	O
caries	O
can	O
negatively	O
impact	O
nutritional	O
health	O
status	O
and	O
well	O
-	O
being	O
[	O
3	O
,	O
10	O
,	O
13	O
,	O
35	O
].	O

In	O
the	O
Projahnmo	O
trial	O
conducted	O
in	O
rural	O
Bangladesh	O
,	O
only	O
40	O
%	O
of	O
women	O
in	O
the	O
baseline	O
surveys	O
reported	O
any	O
use	O
of	O
IFA	O
supplements	O
in	O
pregnancy	O
[	O
18	O
].	O

Two	O
separate	O
cohort	O
studies	O
recently	O
reported	O
the	O
prevalence	O
of	O
gestational	O
diabetes	O
diagnosis	O
to	O
be	O
significantly	O
higher	O
in	O
summer	O
compared	O
to	O
winter	O
[	O
24	O
,	O
25	O
].	O

Data	O
collection	O
We	O
created	O
a	O
pro	O
forma	O
for	O
data	O
collection	O
that	O
was	O
completed	O
during	O
an	O
interview	O
conducted	O
48	O
to	O
72	O
hours	O
after	O
delivery	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
:	O
The	O
baseline	O
characteristics	O
of	O
subjects	O
from	O
the	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
)	O
VariablesIG	O
(	O
N	O
=	O
24	O
)	O
CG	O
(	O
N	O
=	O
21	O
)	O
P	O
valueAge	O
(	O
year	O
)	O
30	O
.	O
7	O
±	O
6	O
.	O
229	O
.	O
5	O
±	O
40	O
.	O
4Pregnancy	O
month	O
for	O
diagnosing	O
GDM5	O
.	O
1	O
±	O
2	O
.	O
34	O
.	O
7	O
±	O
2	O
.	O
20	O
.	O
6Weight	O
(	O
kg	O
)	O
70	O
.	O
2	O
±	O
12	O
.	O
569	O
.	O
9	O
±	O
110	O
.	O
9Height	O
(	O
cm	O
)	O
155	O
.	O
6	O
±	O
5157	O
.	O
9	O
±	O
4	O
.	O
40	O
.	O
4BMI	O
(	O
kg	O
/	O
m2	O
)	O
28	O
.	O
9	O
±	O
4	O
.	O
827	O
.	O
9	O
±	O
3	O
.	O
60	O
.	O
4HA1C	O
(%)	O
5	O
.	O
48	O
±	O
0	O
.	O
695	O
.	O
20	O
±	O
0	O
.	O
730	O
.	O
1Literacy	O
LevelNumber	O
(%)	O
Number	O
(%)	O
0	O
.	O
3	O
Illiterate2	O
(	O
8	O
.	O
3	O
)	O
3	O
(	O
14	O
.	O
4	O
)	O
Guidance	O
school	O
graduate10	O
(	O
41	O
.	O
7	O
)	O
11	O
(	O
52	O
.	O
4	O
)	O
High	O
school	O
graduate7	O
(	O
29	O
.	O
2	O
)	O
3	O
(	O
14	O
.	O
3	O
)	O
University	O
graduate5	O
(	O
20	O
.	O
8	O
)	O
4	O
(	O
19	O
)	O
Type	O
of	O
treatment0	O
.	O
9	O
Insulin11	O
(	O
45	O
.	O
8	O
)	O
9	O
(	O
42	O
.	O
9	O
)	O
Food	O
therapy10	O
(	O
41	O
.	O
7	O
)	O
10	O
(	O
47	O
.	O
6	O
)	O
Insulin	O
and	O
diet	O
therapy2	O
(	O
9	O
.	O
5	O
)	O
3	O
(	O
12	O
.	O
5	O
)	O
Type	O
of	O
delivery0	O
.	O
2	O
Natural12	O
(	O
50	O
)	O
14	O
(	O
66	O
.	O
7	O
)	O
Cesarean	O
section12	O
(	O
50	O
)	O
7	O
(	O
33	O
.	O
3	O
)	O
There	O
was	O
a	O
significant	O
increase	O
in	O
serum	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
in	O
the	O
IG	O
group	O
,	O
but	O
there	O
was	O
no	O
significant	O
change	O
in	O
that	O
of	O
CG	O
during	O
the	O
study	O
(	O
table	O
2	O
).	O

Antihistamines	O
should	O
be	O
avoided	O
if	O
possible	O
,	O
but	O
if	O
required	O
,	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
may	O
be	O
used	O
.	O

Indeed	O
,	O
over	O
the	O
last	O
decade	O
,	O
the	O
previous	O
gene	O
-	O
centric	O
dogma	O
,	O
central	O
to	O
molecular	O
biology	O
,	O
has	O
been	O
shown	O
to	O
be	O
incorrect	O
.	O

Similarly	O
,	O
the	O
use	O
of	O
the	O
Ages	O
and	O
Stages	O
questionnaire	O
is	O
considered	O
a	O
screening	O
tool	O
to	O
identify	O
infants	O
at	O
risk	O
of	O
neurodevelopmental	O
delay	O
[	O
31	O
].	O

Fat	O
supplementation	O
for	O
extra	O
energy	O
supply	O
has	O
been	O
recommended	O
during	O
cold	O
or	O
heat	O
stress	O
to	O
prevent	O
fat	O
degradation	O
.	O

Low	O
adherence	O
with	O
advice	O
about	O
supplements	O
was	O
associated	O
with	O
unwanted	O
pregnancy	O
,	O
low	O
maternal	O
age	O
and	O
low	O
economic	O
status	O
in	O
the	O
United	O
Kingdom	O
[	O
36	O
],	O
unplanned	O
pregnancy	O
and	O
lack	O
of	O
education	O
regarding	O
the	O
role	O
of	O
folic	O
acid	O
in	O
South	O
Korea	O
[	O
37	O
].	O

RESULTS	O
Of	O
1156	O
women	O
recruited	O
for	O
the	O
original	O
trial	O
421	O
were	O
considered	O
to	O
be	O
eligible	O
for	O
the	O
current	O
study	O
according	O
to	O
the	O
criteria	O
above	O
.	O

Furthermore	O
,	O
recent	O
studies	O
have	O
shown	O
that	O
this	O
restriction	O
can	O
generate	O
“	O
genomic	O
imprinting	O
”	O
in	O
the	O
fetus	O
,	O
which	O
is	O
related	O
to	O
the	O
genesis	O
of	O
chronic	O
diseases	O
in	O
adulthood	O
[	O
9	O
].	O

Another	O
limitation	O
is	O
the	O
inability	O
to	O
address	O
confounding	O
by	O
indication	O
and	O
separate	O
the	O
relative	O
effects	O
of	O
maternal	O
mental	O
illness	O
from	O
psychotropic	O
pharmacotherapy	O
on	O
pregnancy	O
outcome	O
.	O

Conclusion	O
Black	O
obese	O
mothers	O
on	O
Medicaid	O
without	O
prenatal	O
vitamin	O
use	O
were	O
at	O
the	O
highest	O
risk	O
of	O
delivering	O
neonates	O
with	O
vitamin	O
D	O
deficiency	O
.	O

Data	O
were	O
entered	O
into	O
a	O
Microsoft	O
Access	O
database	O
(	O
version	O
2007	O
)	O
and	O
data	O
processing	O
and	O
analysis	O
was	O
done	O
in	O
STATA	O
(	O
version	O
11	O
.	O
0	O
).	O

The	O
baseline	O
BMI	O
at	O
the	O
younger	O
age	O
is	O
included	O
as	O
a	O
covariate	O
to	O
adjust	O
for	O
regression	O
towards	O
the	O
mean	O
.	O
28In	O
this	O
analysis	O
,	O
it	O
can	O
be	O
argued	O
that	O
effects	O
on	O
BMI	O
common	O
to	O
both	O
ages	O
are	O
cancelled	O
and	O
what	O
remains	O
are	O
differential	O
genetic	O
effects	O
,	O
intrauterine	O
effects	O
and	O
possibly	O
environmental	O
effects	O
.	O

When	O
a	O
woman	O
struggles	O
,	O
Stuebe	O
says	O
,	O
“	O
she	O
is	O
often	B
told	O
to	O
try	O
harder	O
.”	O
Early	O
Environmental	O
Clues	O
In	O
1949	O
Morton	O
Biskind	O
,	O
a	O
Connecticut	O
physician	O
,	O
treated	O
a	O
pregnant	O
patient	O
with	O
acute	O
DDT	O
poisoning	O
.	O

We	O
performed	O
multivariable	O
logistic	O
regression	O
(	O
MLR	O
)	O
analyses	O
per	O
birth	O
outcome	O
(	O
SGA	O
,	O
PTB	O
and	O
LBW	O
)	O
as	O
the	O
variable	O
of	O
interest	O
and	O
influenza	O
vaccination	O
as	O
the	O
exposure	O
variable	O
.	O

However	O
,	O
some	O
studies	O
have	O
revealed	O
that	O
mild	O
temperature	O
stress	O
can	O
increase	O
body	O
fat	O
deposition	O
and	O
marbling	O
for	O
insulation	O
and	O
other	O
purposes	O
[	O
74	O
,	O
82	O
],	O
as	O
described	O
above	O
.	O

However	O
,	O
we	O
did	O
not	O
identify	O
any	O
specific	O
physiological	O
consequences	O
of	O
these	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
for	O
bone	O
mineralization	O
at	O
birth	O
as	O
evidenced	O
by	O
initial	O
DXA	O
measurements	O
.	O

A	O
P	O
value	O
of	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Many	O
interventions	O
have	O
been	O
evaluated	B
,	O
and	O
some	O
have	O
been	O
identified	O
as	O
beneficial	O
though	O
limited	O
in	O
public	O
health	O
impact	O
,	O
such	O
as	O
therapy	O
with	O
progestational	O
agents	O
,	O
which	O
have	O
only	O
been	O
studied	O
in	O
certain	O
high	O
-	O
risk	O
populations	O
.	O

BHLM	O
also	O
has	O
the	O
advantage	O
that	O
it	O
yields	O
estimates	O
of	O
the	O
hyperparameters	O
that	O
aid	O
in	O
interpreting	B
the	O
effects	O
of	O
multiple	O
correlated	O
exposures	O
.	O

Diagnosis	O
of	O
allergy	O
during	O
pregnancy	O
should	O
mainly	B
consist	O
of	O
the	O
patient	O
'	O
s	O
history	O
and	O
in	O
vitro	O
testing	O
.	O

First	O
,	O
in	O
cause	O
of	O
the	O
difficulties	O
in	O
performing	O
infant	O
lung	O
function	O
testing	O
,	O
relatively	O
small	O
number	O
of	O
mother	O
-	O
infant	O
pairs	O
was	O
enrolled	O
in	O
this	O
study	O
.	O

Therefore	B
,	O
the	O
high	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
in	O
infants	O
may	O
explain	B
that	O
low	O
cord	O
—	O
but	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
poor	O
lung	O
function	O
and	O
increased	O
risk	O
of	O
respiratory	O
infection	O
in	O
this	O
study	O
.	O

After	O
adjusting	O
for	O
obstetrical	O
factors	O
(	O
model	O
3	O
),	O
there	O
was	O
a	O
positive	O
significant	O
relationship	O
between	O
adherence	O
to	O
western	O
dietary	O
pattern	O
[	O
OR	O
5	O
.	O
51	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
1	O
.	O
82	O
-	O
16	O
.	O
66	O
),	O
P	O
=	O
0	O
.	O
001	O
]	O
with	O
having	O
low	O
birth	O
weight	O
infant	O
.	O

Sample	O
Preparation	O
Tissue	O
was	O
sampled	O
from	O
8	O
control	O
and	O
8	O
DVD	O
deficient	O
male	O
adult	O
offspring	O
.	O

The	O
median	O
was	O
used	O
as	O
the	O
measure	O
of	O
central	O
tendency	O
.	O

Established	O
risk	O
factors	O
include	O
ionizing	O
radiation	O
and	O
a	O
few	O
genetic	O
syndromes	O
[	O
2	O
].	O

The	O
dissection	O
started	O
at	O
the	O
aortic	O
root	O
and	O
extended	O
inferiorly	O
into	O
the	O
descending	O
aorta	O
and	O
upper	O
abdomen	O
.	O

There	O
was	O
a	O
further	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
birth	O
weight	O
of	O
female	O
offspring	O
born	O
to	O
PLHF	O
dams	O
compared	O
to	O
MHF	O
and	O
Cont	O
offspring	O
.	O

Supplementation	O
was	O
associated	O
with	O
increased	O
haemoglobin	O
concentration	O
and	O
MCV	O
and	O
reduced	O
ZnPP	O
concentration	O
(	O
all	O
p	O
<	O
0	O
.	O
001	O
).	O

1	O
.	O

Conclusions	O
Studies	O
of	O
text4baby	O
have	O
helped	O
to	O
build	O
the	O
mHealth	O
evidence	O
base	O
.	O

As	O
can	O
be	O
seen	O
from	O
the	O
bottom	O
panel	O
of	O
Table2	O
,	O
maternal	O
snoring	O
was	O
associated	O
with	O
a	O
statistically	O
non	O
-	O
significant	O
1	O
.	O
86	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
1	O
.	O
86	O
;	O
95	O
%	O
CI	O
0	O
.	O
88	O
-	O
3	O
.	O
94	O
).	O

Finally	O
,	O
Monteagudo	O
et	O
al	O
.	O

Nonetheless	O
the	O
woman	O
should	O
be	O
advised	O
regarding	O
appropriate	O
hypoglycemia	O
prevention	O
and	O
management	O
measures	O
.	O

Pregnancy	O
outcomes	O
following	O
maternal	O
exposure	O
to	O
second	O
-	O
generation	O
antipsychotics	O
given	O
with	O
other	O
psychotropic	O
drugs	O
:	O
a	O
cohort	O
study	O
Abstract	O
Objectives	O
Second	O
-	O
generation	O
antipsychotics	O
(	O
SGAs	O
),	O
in	O
conjunction	O
with	O
other	O
psychotropic	O
medications	O
,	O
are	O
increasingly	O
used	O
to	O
treat	O
psychiatric	O
disorders	O
in	O
pregnancy	O
.	O

Endocrine	O
factors	O
,	O
such	O
as	O
fibroblast	O
growth	O
factor	O
21	O
(	O
FGF21	O
)	O
and	O
bone	O
morphogenic	O
protein	O
factor	O
-	O
9	O
(	O
BMP	O
-	O
9	O
),	O
predominantly	O
produced	O
in	O
the	O
liver	O
,	O
were	O
shown	O
to	O
lead	O
to	O
activation	O
of	O
BAT	O
thermogenesis	O
,	O
as	O
well	O
as	O
to	O
“	O
browning	O
”	O
of	O
WAT	O
.	O

A	O
sample	O
size	O
of	O
1350	O
infants	O
(	O
75	O
%	O
follow	O
-	O
up	O
)	O
would	O
provide	O
80	O
%	O
power	O
to	O
detect	O
at	O
least	O
a	O
difference	O
in	O
the	O
incidence	O
of	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
of	O
6	O
.	O
4	O
%	O
(	O
from	O
25	O
to	O
18	O
.	O
6	O
%;	O
alpha	O
0	O
.	O
05	O
).	O

Hence	B
efforts	O
should	O
be	O
geared	O
towards	O
improving	O
on	O
health	O
centre	O
variables	O
(	O
cleanliness	O
,	O
comfort	O
in	O
sitting	O
area	O
and	O
quality	O
of	O
care	O
amongst	O
others	O
)	O
to	O
improve	O
on	O
their	O
utilization	O
by	O
the	O
women	O
who	O
live	O
nearby	O
especially	O
for	O
those	O
health	O
centres	O
which	O
are	O
relatively	O
new	O
and	O
by	O
so	O
doing	O
increasing	O
their	O
attendance	O
rate	O
.	O

Moreover	O
,	O
descriptive	O
analysis	O
showed	O
that	O
the	O
quantity	O
of	O
drinking	O
was	O
lower	O
among	O
text4baby	O
participants	O
postpartum	O
.	O

Another	O
positive	O
point	O
is	O
that	O
few	O
studies	O
have	O
collected	O
data	O
on	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

This	O
study	O
finds	O
that	O
85	O
.	O
7	O
%	O
of	O
pregnant	O
women	O
received	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
Their	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
those	O
without	O
supplement	O
use	O
.	O

A	O
questionnaire	O
assessing	O
marital	O
status	O
and	O
socioeconomic	O
status	O
was	O
carried	O
out	O
.	O

Increasing	O
awareness	O
amongst	O
health	O
providers	O
regarding	O
folic	O
acid	O
allergy	O
may	O
improve	O
the	O
identification	O
and	O
counselling	O
of	O
patients	O
with	O
this	O
allergy	O
.	O

The	O
main	O
limitation	O
of	O
the	O
impact	O
evaluation	O
was	O
the	O
lack	O
of	O
a	O
control	O
arm	O
where	O
no	O
intervention	O
was	O
given	O
.	O

None	O
of	O
the	O
participants	O
in	O
the	O
control	O
arm	O
and	O
only	O
2	O
(	O
2	O
%)	O
in	O
the	O
intervention	O
arm	O
were	O
observed	O
to	O
have	O
their	O
main	O
handwashing	O
station	O
inside	O
the	O
house	O
.	O

Nine	O
hundred	O
seventy	O
-	O
six	O
subjects	O
were	O
enrolled	O
and	O
361	O
provided	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
,	O
187	O
of	O
which	O
had	O
16S	O
rRNA	O
gene	O
sequencing	O
data	O
available	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S2	O
).	O

The	O
study	O
was	O
approved	O
by	O
Ethics	O
Committee	O
,	O
Shahid	O
Sadoughi	O
University	O
of	O
Medical	O
Sciences	O
.	O

Maternal	O
caloric	O
restriction	O
induces	O
sex	O
-	O
dimorphic	O
alterations	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
lipid	O
metabolism	O
Sexual	O
dimorphism	O
in	O
offspring	O
after	O
maternal	O
caloric	O
restriction	O
was	O
also	O
observed	O
in	O
the	O
gene	O
expression	O
of	O
key	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
that	O
include	O
elements	O
of	O
the	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
.	O

A	O
previous	O
expert	O
review	O
that	O
was	O
not	O
a	O
structured	O
meta	O
-	O
analysis	O
and	O
did	O
not	O
exclude	O
as	O
many	O
studies	O
as	O
the	O
Cochrane	O
review	O
concluded	O
that	O
special	O
maternal	O
lactation	O
avoidance	O
diets	O
were	O
unnecessary	O
[	O
114	O
].	O

In	O
2002	O
/	O
2003	O
a	O
follow	O
-	O
up	O
study	O
was	O
initiated	O
,	O
and	O
women	O
who	O
had	O
responded	O
to	O
the	O
1991	O
/	O
1992	O
questionnaire	O
and	O
who	O
were	O
alive	O
and	O
living	O
in	O
Sweden	O
in	O
October	O
2002	O
were	O
contacted	O
.	O

According	O
to	O
the	O
characteristics	O
of	O
the	O
weather	O
in	O
Beijing	O
,	O
the	O
season	O
was	O
divided	O
to	O
winter	O
(	O
November	O
–	O
February	O
),	O
spring	O
and	O
fall	O
(	O
March	O
–	O
May	O
,	O
September	O
–	O
October	O
)	O
and	O
summer	O
(	O
June	O
–	O
August	O
),	O
the	O
seasonal	O
distribution	O
of	O
the	O
data	O
was	O
also	O
analyzed	O
.	O

The	O
optimum	O
concentrations	O
of	O
vitamin	O
D	O
for	O
adults	O
and	O
children6are	O
based	O
on	O
non	O
-	O
immunological	O
and	O
,	O
mostly	B
,	O
bone	O
outcomes	O
.	O

At	O
10	O
-	O
12	O
weeks	O
of	O
embryo	O
development	O
,	O
follicles	O
containing	O
colloid	O
become	O
visible	O
,	O
and	O
the	O
thyroid	O
is	O
able	O
to	O
incorporate	O
iodine	O
into	O
thyroid	O
hormones	O
.	O

Further	O
questions	O
arise	O
with	O
respect	O
to	O
the	O
previous	O
treatment	O
trial	O
in	O
the	O
same	O
region	O
of	O
Kabul	O
,	O
which	O
showed	O
that	O
a	O
single	O
high	O
-	O
dose	O
supplementation	O
with	O
100	O
000	O
IU	O
vitamin	O
D3given	O
orally	O
to	O
young	O
children	O
,	O
along	O
with	O
antibiotic	O
treatment	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
reduced	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
.	O
3The	O
inconsistent	O
results	O
could	O
be	O
related	O
to	O
the	O
evidence	O
that	O
stimulation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
macrophages	O
and	O
monocytes	O
by	O
bacterial	O
antigens	O
is	O
important	O
in	O
up	O
-	O
regulation	O
of	O
CYP27B1	O
and	O
the	O
vitamin	O
D	O
receptor	O
,	O
5which	O
are	O
crucial	O
in	O
production	O
of	O
cathelicidins	O
in	O
vitamin	O
-	O
D	O
-	O
depleted	O
individuals	O
.	O

The	O
most	O
popular	O
vitamin	O
and	O
mineral	O
supplements	O
contain	O
iron	O
,	O
folic	O
acid	O
and	O
vitamin	O
D	O
[	O
12	O
,	O
28	O
].	O

Additionally	O
,	O
Bayesian	O
modeling	O
produces	O
the	O
σβvalue	O
that	O
measures	O
the	O
heterogeneity	O
of	O
EDC	O
class	O
effects	O
.	O

Conversely	O
,	O
Janghorbani	O
et	O
al	O
.	O

PubMed	O
Central	O
:	O

Guidelines	B
for	O
evaluation	O
and	O
treatment	O
of	O
thyroid	O
cancer	O
must	O
consider	O
the	O
gestational	O
age	O
but	O
also	O
the	O
patients	O
'	O
desires	O
.	O

Methods	O
This	O
cross	O
-	O
sectional	O
study	O
included	O
723	O
mother	O
-	O
child	O
pairs	O
.	O

These	O
Results	O
emphasize	O
the	O
need	O
for	O
pregnant	O
women	O
to	O
be	O
professionally	O
monitored	O
so	O
that	O
modifiable	O
risk	O
factors	O
can	O
be	O
managed	O
.	O

(	O
2010	O
)	O
described	O
a	O
higher	O
preference	O
for	O
a	O
fat	O
-	O
rich	O
liquid	O
diet	O
than	O
a	O
carbohydrate	O
-	O
rich	O
liquid	O
diet	O
in	O
male	O
offspring	O
fed	O
for	O
1	O
h	O
after	O
an	O
adaptation	O
period	O
of	O
8	O
days	O
(	O
habituation	O
to	O
diet	O
).	O

Making	O
more	O
than	O
four	O
prenatal	O
visits	O
was	O
also	O
associated	O
with	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
intake	O
,	O
a	O
positive	O
association	O
that	O
persisted	O
after	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
(	O
Table	O
5	O
).	O

For	O
each	O
pathway	O
,	O
scores	O
are	O
calculated	O
as	O
the	O
negative	O
base	O
-	O
10	O
logarithm	O
of	O
the	O
P	O
value	O
,	O
indicating	O
the	O
likelihood	O
that	O
the	O
dysregulated	O
proteins	O
would	O
be	O
found	O
in	O
a	O
given	O
network	O
by	O
chance	O
.	O

The	O
observed	O
rate	O
of	O
PNA	O
signs	O
in	O
the	O
monotherapy	O
group	O
was	O
similar	O
to	O
that	O
reported	O
in	O
the	O
healthy	O
comparison	O
group	O
(	O
4	O
%	O
vs	O
5	O
.	O
2	O
%).	O

Discussion	O
This	O
paper	O
aims	O
to	O
describe	O
the	O
study	O
protocol	O
of	O
a	O
community	O
based	O
randomised	O
controlled	O
trial	O
evaluating	O
the	O
impact	O
of	O
the	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
early	O
in	O
pregnancy	O
on	O
the	O
risk	O
of	O
neonatal	O
mortality	O
.	O

Weight	O
,	O
blood	O
pressure	O
,	O
and	O
heart	O
rate	O
of	O
the	O
fetus	O
were	O
measured	O
by	O
the	O
same	O
person	O
using	O
a	O
digital	O
scale	O
,	O
digital	O
barometer	O
,	O
and	O
fetal	O
heart	O
detector	O
(	O
sonicaid	O
).	O

As	O
observed	O
at	O
birth	O
(	O
Fig	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

•	O
Ensure	O
that	O
every	O
family	O
has	O
the	O
support	O
they	O
need	O
,	O
immediately	O
after	O
birth	O
of	O
a	O
premature	O
baby	O
,	O
following	O
its	O
loss	O
,	O
or	O
living	O
with	O
a	O
child	O
with	O
prematurity	O
-	O
associated	O
disability	O
.	O

Due	O
to	O
the	O
high	O
iron	O
requirements	O
for	O
pregnancy	O
,	O
it	O
is	O
highly	O
prevalent	O
and	O
severe	O
in	O
pregnant	O
women	O
.	O

Compared	O
to	O
women	O
who	O
were	O
recruited	O
at	O
the	O
Adelaide	O
site	O
,	O
women	O
recruited	O
in	O
Auckland	O
were	O
older	O
,	O
had	O
a	O
lower	O
BMI	O
,	O
less	O
likely	B
to	O
smoke	O
or	O
drink	O
alcohol	O
during	O
pregnancy	O
and	O
more	O
likely	B
to	O
eat	O
fruit	O
and	O
undertake	O
recreational	O
walks	O
.	O

Vitamin	O
D	O
status	O
could	O
also	O
facilitate	O
fetal	O
development	O
by	O
regulating	O
placental	O
inflammation	O
[	O
23	O
].	O

2	O
.	O
6	O
.	O

'	O
AMPK	O
signaling	O
'	O
is	O
a	O
metabolic	O
pathway	O
which	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
lipid	O
and	O
energy	O
metabolism	O
in	O
mammalian	O
cells	O
[	O
51	O
-	O
56	O
].	O

Mice	O
that	O
lack	O
functional	O
Flnb	O
have	O
been	O
generated	O
that	O
exhibit	O
impaired	O
development	O
of	O
the	O
microvascular	O
and	O
skeletal	O
systems	O
,	O
including	O
lack	O
of	O
invertebral	O
discs	O
and	O
kyphotic	O
and	O
scoliotic	O
spines	O
(	O
Farrington	O
-	O
Rock	O
et	O
al	O
.	O

In	O
order	O
to	O
make	O
the	O
MAR	O
assumption	O
more	O
plausible	O
,	O
a	O
range	O
of	O
auxiliary	O
variables	O
,	O
including	O
stratification	O
(	O
centre	O
,	O
parity	O
,	O
BMI	O
category	O
)	O
and	O
adjustment	O
variables	O
(	O
socioeconomic	O
status	O
,	O
smoking	O
,	O
maternal	O
age	O
at	O
consent	O
,	O
infant	O
gender	O
),	O
along	O
with	O
infant	O
birth	O
measures	O
(	O
weight	O
,	O
length	O
,	O
circumferences	O
and	O
skinfold	O
thickness	O
measures	O
),	O
were	O
included	O
in	O
the	O
imputation	O
model	O
.	O

Methods	O
Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
)	O
was	O
sampled	O
in	O
gestational	O
week	O
≤	O
16	O
(	O
trimester	O
1	O
(	O
T1	O
),	O
N	O
=	O
2046	O
)	O
and	O
>	O
31	O
(	O
trimester	O
3	O
(	O
T3	O
),	O
N	O
=	O
1816	O
)	O
and	O
analysed	O
using	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
.	O

Similar	O
observations	O
were	O
obtained	O
by	O
adipose	O
tissue	O
-	O
specific	O
overexpression	O
of	O
PR	O
-	O
domain	O
-	O
containing	O
16	O
(	O
PRDM16	O
)	O
in	O
mice	O
.	O

Corresponding	O
maternal	O
vitamin	O
D	O
status	O
at	O
different	O
gestations	O
during	O
pregnancy	O
was	O
unknown	O
.	O

Multiple	O
linear	O
regression	O
was	O
then	O
used	O
to	O
evaluate	O
the	O
association	O
between	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
levels	O
and	O
continuous	O
birth	O
weight	O
percentile	O
.	O

A	O
recently	O
published	O
randomized	O
study	O
found	O
no	O
difference	O
in	O
most	O
pregnancy	O
outcomes	O
between	O
daily	O
and	O
twice	O
weekly	O
iron	O
supplementation	O
regimens	O
,	O
though	O
the	O
daily	O
regimen	O
was	O
found	O
to	O
be	O
more	O
effective	O
than	O
twice	O
weekly	O
regimen	O
in	O
preventing	O
Hb	O
decrement	O
at	O
near	O
term	O
[	O
8	O
].	O

The	O
tests	O
adhered	O
to	O
American	O
Thoracic	O
Society	O
(	O
ATS	O
)	O
criteria	O
for	O
standardisation	O
and	O
reproducibility	O
of	O
flow	O
–	O
volume	O
measurement	O
[	O
18	O
],	O
with	O
the	O
exception	O
of	O
ATS	O
recommendations	O
for	O
duration	O
of	O
expiration	O
[	O
19	O
];	O
as	O
many	O
children	O
did	O
not	O
fulfil	O
forced	O
expiratory	O
time	O
>	O
6	O
s	O
end	O
-	O
of	O
-	O
test	O
criteria	O
,	O
a	O
minimal	O
volume	O
change	O
over	O
the	O
final	O
1	O
s	O
was	O
used	O
.	O

Mothers	O
were	O
randomized	O
to	O
receive	O
400	O
,	O
2000	O
,	O
or	O
4000	O
IU	O
vitamin	O
D3	O
/	O
day	O
beginning	O
at	O
12	O
to	O
16	O
weeks	O
of	O
gestation	O
and	O
continuing	O
through	O
delivery	O
[	O
22	O
,	O
23	O
].	O

Thus	O
,	O
the	O
rate	O
of	O
refusal	O
was	O
relatively	O
low	O
,	O
of	O
only	O
2	O
.	O
5	O
%	O
of	O
all	O
the	O
women	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

Further	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
study	O
if	O
dietary	O
aspects	O
are	O
associated	O
with	O
separable	O
latent	O
dimensions	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
and	O
if	O
the	O
associations	O
are	O
valid	O
for	O
men	O
and	O
for	O
other	O
age	O
groups	O
.	O

The	O
failing	O
grade	O
mobilised	O
state	O
health	O
officials	O
in	O
early	O
2012	O
to	O
launch	O
a	O
statewide	O
initiative	O
with	O
the	O
goal	O
of	O
reducing	O
rates	O
.	O

[	O
5	O
].	O

More	O
investigation	O
is	O
required	O
to	O
further	O
understand	O
the	O
role	O
of	O
vitamin	O
D	O
for	O
the	O
prevention	O
of	O
respiratory	O
tract	O
infection	O
in	O
infancy	O
.	O

(%)	O
northern	O
countries18	O
060	O
(	O
98	O
)	O
13	O
942	O
(	O
97	O
)	O
744	O
(	O
91	O
)	O
other	O
countries318	O
(	O
2	O
)	O
427	O
(	O
3	O
)	O
68	O
(	O
8	O
)	O
missing33	O
(	O
0	O
.	O
2	O
)	O
26	O
(	O
0	O
.	O
2	O
)	O
5	O
(	O
0	O
.	O
6	O
)	O
Smokers	O
,	O
No	O
.	O

Asibey	O
-	O
Berko	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	O
be	O
implemented	O
.	O

The	O
mixed	O
model	O
includes	O
group	O
,	O
age	O
and	O
group	O
Χ	O
age	O
of	O
the	O
family	O
member	O
as	O
fixed	O
effects	O
and	O
a	O
random	O
family	O
effect	O
with	O
an	O
unstructured	O
correlation	O
matrix	O
.	O

Our	O
exclusion	O
criteria	O
were	O
families	O
expecting	O
to	O
move	O
to	O
another	O
town	O
within	O
18	O
months	O
,	O
diagnosis	O
of	O
rickets	O
or	O
treatment	O
with	O
vitamin	O
D	O
in	O
the	O
previous	O
3	O
months	O
,	O
and	O
clinical	O
diagnosis	O
of	O
Kwashiorkor	O
or	O
Marasmus	O
.	O

1a	O
;	O
black	O
line	O
/	O
left	O
axis	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
grey	O
line	O
/	O
right	O
axis	O
average	O
hours	O
of	O
sunlight	O
).	O

This	O
study	O
was	O
carried	O
out	O
to	O
evaluate	O
the	O
efficacy	O
of	O
300	O
,	O
000	O
IU	O
vitamin	O
D	O
given	O
intramuscularly	O
on	O
body	O
status	O
in	O
new	O
cases	O
of	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

Whilst	O
there	O
are	O
studies	O
demonstrating	O
short	O
-	O
term	O
safety	O
of	O
glyburide	O
and	O
metformin	O
during	O
pregnancy	O
,	O
I	O
suggest	O
that	O
they	O
be	O
reserved	O
for	O
situations	O
where	O
implementation	O
of	O
insulin	O
therapy	O
is	O
impractical	O
or	O
not	O
possible	O
.	O

Several	O
studies	O
have	O
suggested	O
the	O
association	O
between	O
perinatal	O
factors	O
and	O
the	O
onset	O
of	O
autism	O
.	O

Other	O
hypotheses	O
postulate	O
mechanisms	O
such	O
as	O
poor	O
placental	O
blood	O
supply	O
because	B
of	O
nicotine	O
-	O
induced	O
vasoconstriction	O
,	O
poor	O
maternal	O
nutrition	O
,	O
and	O
fetal	O
exposure	O
to	O
carbon	O
monoxide	O
.	O

Mean	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
differed	O
significantly	O
by	O
birth	O
weight	O
status	O
[	O
see	O
Supplemental	O
Material	O
,	O
Table	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
);	O
p	O
<	O
0	O
.	O
0001	O
].	O

The	O
cut	O
-	O
points	O
were	O
based	O
on	O
categorizations	O
used	O
in	O
prior	O
research	O
[	O
4	O
,	O
11	O
].	O

Once	O
there	O
,	O
existing	O
distribution	O
channels	O
of	O
the	O
public	O
health	O
care	O
system	O
were	O
utilized	O
.	O

We	O
defined	B
vitamin	O
D	O
deficiency	O
as	B
25	O
(	O
OH	O
)	O
D	O
<	O
50	O
nmol	O
/	O
L	O
,	O
and	O
vitamin	O
D	O
sufficiency	O
as	B
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
,	O
since	B
a	O
concentration	O
of	O
≥	O
50	O
nmol	O
/	O
L	O
is	O
considered	O
sufficient	O
for	O
bone	O
health	O
[	O
17	O
].	O

After	O
DNase	O
treatment	O
a	O
column	O
-	O
based	O
purification	O
using	O
the	O
RNeasy	O
Mini	O
Kit	O
(	O
Qiagen	O
,	O
Hilden	O
,	O
Germany	O
)	O
was	O
done	O
.	O

GDM	O
is	O
the	O
most	O
common	O
pregnancy	O
complication	O
in	O
Europe	O
[	O
11	O
].	O

Railroad	O
jobs	O
were	O
available	O
only	O
far	O
off	O
like	O
Denver	O
.	O

Results	O
showed	O
that	O
at	O
baseline	O
,	O
in	O
72	O
.	O
8	O
%	O
of	O
the	O
participants	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
lower	O
than20	O
ng	O
/	O
mL	O
.	O

Some	O
of	O
the	O
respondents	O
(	O
25	O
.	O
6	O
%)	O
were	O
recommended	O
an	O
ANC	O
site	O
.	O

considered	O
maternal	O
diet	O
by	O
classifying	O
women	O
as	O
following	O
a	O
“	O
prudent	O
”	O
or	O
“	O
western	O
”	O
dietary	O
pattern	O
[	O
23	O
].	O

The	O
children	O
of	O
mothers	O
participating	O
in	O
the	O
NICHD	O
trial	O
were	O
then	O
seen	O
at	O
yearly	O
follow	O
-	O
up	O
visits	O
for	O
three	O
years	O
between	O
the	O
ages	O
of	O
2	O
and	O
7	O
as	O
part	O
of	O
an	O
IRB	O
-	O
approved	O
follow	O
-	O
up	O
study	O
funded	O
by	O
the	O
Thrasher	O
Research	O
Fund	O
(	O
HR	O
#	O
19641	O
,	O
CTRC	O
protocol	O
870	O
).	O

I	O
think	O
it	O
is	O
cause	O
for	O
concern	O
,”	O
says	O
Romano	O
,	O
now	O
an	O
assistant	O
professor	O
at	O
the	O
Geisel	O
School	O
of	O
Medicine	O
at	O
Dartmouth	O
.	O

Therefore	O
,	O
the	O
infants	O
were	O
then	O
sedated	O
with	O
oral	O
chloral	O
hydrate	O
(	O
50	O
–	O
75	O
mg	O
/	O
kg	O
)	O
and	O
placed	O
in	O
the	O
supine	O
position	O
,	O
with	O
the	O
neck	O
mildly	O
extended	O
.	O

AD	O
:	O
Alzheimer	O
’	O
s	O
disease	O
;	O
COPD	O
:	O
chronic	O
obstructive	O
pulmonary	O
disease	O
;	O
ECAT	O
:	O
elemental	O
carbon	O
attributable	O
to	O
traffic	O
;	O
NSCLC	O
:	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
;	O
PBL	O
:	O
peripheral	O
blood	O
lymphocyte	O
.	O

It	O
locally	O
extends	O
into	O
lymph	O
nodes	O
and	O
into	O
the	O
surrounding	O
muscles	O
and	O
trachea	O
,	O
and	O
may	O
invade	O
lymphatic	O
and	O
blood	O
vessels	O
and	O
metastasize	O
in	O
lungs	O
,	O
bones	O
and	O
liver	O
.	O

Results	O
Between	O
September	O
2015	O
and	O
December	O
2016	O
,	O
delivery	O
information	O
was	O
available	O
for	O
1	O
,	O
064	O
women	O
with	O
at	O
least	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
result	O
during	O
pregnancy	O
.	O

Many	O
of	O
the	O
dopaminergic	O
cells	O
in	O
this	O
region	O
also	O
express	O
neuropeptides	O
such	O
as	O
bradykinan	O
,	O
neurotensin	O
and	O
substance	O
P	O
.	O
The	O
protein	O
with	O
the	O
greatest	O
fold	O
change	O
in	O
this	O
study	O
was	O
thimet	O
oligopeptidase	O
(	O
down	O
-	O
regulated	O
1	O
.	O
67	O
),	O
which	O
is	O
involved	O
in	O
the	O
degradation	O
of	O
these	O
small	O
proteins	O
[	O
37	O
].	O

She	O
denied	O
any	O
other	O
medical	O
problems	O
,	O
denied	O
any	O
medications	O
other	O
than	O
prenatal	O
vitamins	O
,	O
and	O
reported	O
no	O
complications	O
with	O
her	O
pregnancy	O
.	O

For	O
all	O
animals	O
of	O
the	O
experiment	O
no	O
significant	O
differences	O
in	O
body	O
weight	O
were	O
observed	O
at	O
28	O
and	O
188	O
dpn	O
[	O
15	O
,	O
16	O
].	O

The	O
nutritional	O
and	O
physiological	O
condition	O
of	O
the	O
fetus	O
and	O
the	O
early	O
postnatal	O
stage	O
affects	O
the	O
number	O
of	O
adipocytes	O
in	O
adipose	O
tissues	O
of	O
animals	O
[	O
16	O
].	O

The	O
recall	O
is	O
done	O
chronologically	O
unless	O
the	O
participant	O
wishes	O
to	O
recall	O
randomly	O
.	O

In	O
LP	O
offspring	O
1	O
,	O
959	O
probe	O
-	O
sets	O
were	O
differently	O
expressed	O
(	O
834	O
188	O
dpn	O
≻	O
28	O
dpn	O
).	O

#:	O
adjusted	O
OR	O
for	O
total	O
number	O
of	O
prenatal	O
medical	O
visits	O
.	O

Individual	O
chemicals	O
within	O
a	O
class	O
tended	O
to	O
be	O
positively	O
correlated	O
with	O
each	O
other	O
,	O
particularly	O
for	O
persistent	O
compounds	O
like	O
PCBs	O
and	O
PBDEs	O
(	O
Additional	O
file1	O
:	O
Figure	O
S2	O
[	O
43	O
]).	O

Results	O
We	O
found	O
that	O
48	O
.	O
0	O
%	O
of	O
participants	O
used	O
folic	O
acid	O
,	O
45	O
.	O
3	O
%	O
used	O
iron	O
supplements	O
and	O
68	O
.	O
0	O
%	O
used	O
multivitamins	O
during	O
pregnancy	O
(	O
Table	O
1	O
).	O

Methylation	O
at	O
CGIs	O
is	O
generally	B
associated	O
with	O
transcriptional	O
repression	O
,	O
although	O
the	O
local	O
CpG	O
density	O
within	O
a	O
specific	O
promoter	O
can	O
contribute	O
to	O
the	O
actual	O
transcriptional	O
effect	O
(	O
Hackett	O
&	O
Surani2013	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
).	O

2	O
.	O
3	O
.	O

After	O
research	O
assistants	O
explained	O
the	O
study	O
protocols	O
,	O
women	O
provided	O
consent	O
for	O
themselves	O
and	O
their	O
children	O
.	O

The	O
line	O
between	O
the	O
posterior	O
hypothalamus	O
and	O
the	O
mammillary	O
bodies	O
was	O
considered	O
a	O
caudal	O
section	O
.	O

The	O
sensitivity	O
of	O
the	O
test	O
was	O
2	O
nmol	O
/	O
ml	O
.	O

Hibbeln	O
et	O
al	O
.	O

Adjusted	O
for	O
age	O
,	O
BMI	O
,	O
smoking	O
status	O
(	O
yes	O
/	O
no	O
),	O
physical	O
activity	O
(	O
strenuous	O
activity	O
more	O
than	O
once	O
per	O
week	O
,	O
yes	O
/	O
no	O
),	O
educational	O
achievement	O
(	O
A	O
levels	O
or	O
higher	O
,	O
yes	O
/	O
no	O
),	O
and	O
season	O
of	O
blood	O
sampling	O
(	O
winter	O
,	O
spring	O
,	O
summer	O
,	O
autumn	O
).	O

Additionally	O
,	O
it	O
was	O
assessed	O
the	O
spontaneous	O
and	O
compulsive	O
feeding	O
behavior	O
,	O
growing	O
parameters	O
,	O
leptin	O
,	O
plasma	O
metabolites	O
,	O
and	O
adiposity	O
after	O
weaning	O
(	O
adolescence	O
and	O
adulthood	O
).	O

There	O
was	O
a	O
65	O
%	O
lower	O
risk	O
of	O
PTB	O
among	O
white	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
35	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
13	O
–	O
0	O
.	O
92	O
,	O
p	O
=	O
0	O
.	O
03	O
;	O
AAR	O
=	O
13	O
.	O
8	O
%;	O
NNT	O
=	O
7	O
)	O
and	O
a	O
68	O
%	O
lower	O
risk	O
among	O
non	O
-	O
white	O
women	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
14	O
–	O
0	O
.	O
74	O
,	O
p	O
=	O
0	O
.	O
008	O
;	O
AAR	O
=	O
11	O
.	O
7	O
%;	O
NNT	O
=	O
9	O
).	O

General	O
Practice	O
Physical	O
Activity	O
Questionnaire	O
(	O
GPPAQ	O
)	O
was	O
used	O
to	O
assess	O
the	O
physical	O
activity	O
of	O
participants	O
[	O
22	O
].	O

Prepregnancy	O
weight	O
and	O
weight	O
recorded	O
in	O
prenatal	O
clinics	O
were	O
utilised	O
to	O
calculate	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
(	O
kg	O
).	O

will	O
be	O
used	O
for	O
all	O
analyses	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sexPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Males	O
Low367	O
(	O
26	O
)	O
173	O
(	O
47	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
18	O
)	O
24	O
(	O
7	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
65	O
,	O
2	O
.	O
34	O
)	O
31	O
(	O
8	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
64	O
,	O
1	O
.	O
94	O
)	O
18	O
(	O
5	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
58	O
,	O
2	O
.	O
68	O
)	O
22	O
(	O
6	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
98	O
)	O
43	O
(	O
12	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
79	O
)	O
Low	O
-	O
Moderate364	O
(	O
26	O
)	O
163	O
(	O
45	O
)	O
1	O
.	O
01	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
19	O
))	O
20	O
(	O
5	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
58	O
,	O
2	O
.	O
12	O
)	O
32	O
(	O
9	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
73	O
,	O
2	O
.	O
13	O
)	O
13	O
(	O
4	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
48	O
,	O
2	O
.	O
38	O
)	O
18	O
(	O
5	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
49	O
,	O
1	O
.	O
76	O
)	O
45	O
(	O
12	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
88	O
)	O
Moderate	O
-	O
High359	O
(	O
25	O
)	O
152	O
(	O
42	O
)	O
1	O
.	O
0	O
†	O
16	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
23	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
11	O
(	O
3	O
)	O
1	O
.	O
0	O
†	O
18	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
10	O
)	O
1	O
.	O
0	O
†	O
High325	O
(	O
23	O
)	O
111	O
(	O
34	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
04	O
)	O
15	O
(	O
5	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
59	O
,	O
2	O
.	O
36	O
)	O
17	O
(	O
5	O
)	O
0	O
.	O
90	O
(	O
0	O
.	O
50	O
,	O
1	O
.	O
62	O
)	O
4	O
(	O
1	O
)	O
0	O
.	O
45	O
(	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
)	O
15	O
(	O
5	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
50	O
,	O
1	O
.	O
88	O
)	O
26	O
(	O
8	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
26	O
)	O
Females	O
Low380	O
(	O
28	O
)	O
169	O
(	O
44	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
77	O
,	O
1	O
.	O
06	O
)	O
23	O
(	O
6	O
)	O
0	O
.	O
85	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
55	O
)	O
30	O
(	O
8	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
52	O
,	O
1	O
.	O
45	O
)	O
13	O
(	O
3	O
)	O
0	O
.	O
51	O
(	O
0	O
.	O
25	O
,	O
1	O
.	O
04	O
)	O
14	O
(	O
4	O
)	O
0	O
.	O
61	O
(	O
0	O
.	O
31	O
,	O
1	O
.	O
18	O
)	O
45	O
(	O
12	O
)	O
0	O
.	O
88	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
35	O
)	O
Low	O
-	O
Moderate353	O
(	O
26	O
)	O
168	O
(	O
48	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
15	O
)	O
24	O
(	O
7	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
85	O
)	O
31	O
(	O
9	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
50	O
)	O
9	O
(	O
3	O
)	O
0	O
.	O
44	O
(	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
)	O
18	O
(	O
5	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
45	O
)	O
33	O
(	O
9	O
)	O
0	O
.	O
74	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
13	O
)	O
Moderate	O
-	O
High334	O
(	O
24	O
)	O
149	O
(	O
45	O
)	O
1	O
.	O
0	O
†	O
19	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
8	O
)	O
1	O
.	O
0	O
†	O
17	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
21	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
31	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
High314	O
(	O
23	O
)	O
128	O
(	O
41	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
19	O
)	O
19	O
(	O
6	O
)	O
1	O
.	O
29	O
(	O
0	O
.	O
70	O
,	O
2	O
.	O
35	O
)	O
20	O
(	O
6	O
)	O
0	O
.	O
85	O
(	O
0	O
.	O
49	O
,	O
1	O
.	O
46	O
)	O
6	O
(	O
2	O
)	O
0	O
.	O
48	O
(	O
0	O
.	O
19	O
,	O
1	O
.	O
23	O
)	O
12	O
(	O
4	O
)	O
0	O
.	O
60	O
(	O
0	O
.	O
30	O
,	O
1	O
.	O
21	O
)	O
29	O
(	O
9	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
53	O
,	O
1	O
.	O
28	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Discussion	O
This	O
study	O
adds	O
to	O
the	O
current	O
body	O
of	O
literature	O
on	O
vitamin	O
D	O
status	O
in	O
a	O
population	O
of	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
and	O
provides	O
insight	O
into	O
normal	O
circulating	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
in	O
early	O
pregnancy	O
.	O

Statistical	O
analysis	O
Results	O
were	O
expressed	O
as	O
a	O
mean	O
±	O
standard	O
error	O
.	O

In	O
our	O
study	O
,	O
while	O
puberty	O
was	O
accelerated	O
in	O
maternal	O
high	O
fat	O
exposed	O
offspring	O
,	O
ovarian	O
function	O
was	O
maintained	O
or	O
enhanced	O
into	O
adult	O
life	O
.	O

However	O
,	O
there	O
are	O
few	O
studies	O
investigating	O
whether	O
common	O
genetic	O
variants	O
modify	O
the	O
response	O
to	O
supplementation	O
and	O
,	O
to	B
our	I
knowledge	I
,	O
no	O
previous	O
studies	O
in	O
pregnant	O
women	O
.	O

Measures	O
and	O
distributions	O
of	O
maternal	O
prenatal	O
diet	O
are	O
shown	O
in	O
Table	O
1	O
.	O

Sex	O
and	O
age	O
was	O
matched	O
between	O
the	O
two	O
groups	O
.	O

Findings	O
from	O
the	O
present	O
study	O
demonstrated	O
that	O
children	O
with	O
low	O
birth	O
weight	O
have	O
abnormal	O
autonomic	O
modulation	O
,	O
suggesting	O
that	O
variation	O
in	O
birth	O
weight	O
seems	O
associated	O
with	O
the	O
differences	O
in	O
autonomic	O
function	O
observed	O
in	O
later	O
childhood	O
.	O

Both	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
corrected	O
by	O
applying	O
a	O
linear	O
regression	O
equation	O
(	O
Oct	O
2014	O
value	O
(	O
nmol	O
/	O
L	O
)	O
=	O
[(	O
early	O
2014	O
value	O
)	O
–	O
8	O
.	O
2	O
]	O
/	O
0	O
.	O
99	O
)	O
provided	O
by	O
the	O
manufacturer	O
because	O
of	O
methodological	O
changes	O
in	O
the	O
IDS	O
-	O
iSYS	O
system	O
between	O
2014	O
and	O
2016	O
(	O
see	O
Additional	O
file	O
1	O
).	O

Several	O
recent	O
studies	O
have	O
reported	O
an	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
.	O

Average	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
coefficient	O
of	O
variation	O
(	O
CV	O
)	O
were	O
5	O
.	O
4	O
and	O
8	O
.	O
8	O
%,	O
respectively	O
.	O

The	O
other	O
newborn	O
was	O
a	O
female	O
with	O
a	O
birthweight	O
of	O
2180	O
grams	O
.	O

Only	O
biological	O
(	O
grand	O
)	O
parents	O
were	O
included	O
in	O
the	O
sample	O
.	O

Data	O
was	O
collected	O
using	O
a	O
pretested	O
interviewer	O
-	O
administered	O
semi	O
-	O
structured	O
questionnaire	O
modeled	O
according	O
to	O
that	O
devised	O
by	O
the	O
WHO	O
in	O
assessing	O
women	O
'	O
s	O
perceptions	O
about	O
quality	O
of	O
care	O
[	O
11	O
]	O
and	O
after	O
due	O
consultation	O
on	O
questionnaire	O
design	O
[	O
12	O
].	O

Ozanne	O
et	O
al	O
.	O

Our	O
results	O
lie	O
within	O
these	O
ranges	O
,	O
but	O
it	O
is	O
difficult	O
to	O
make	O
a	O
comparison	O
,	O
as	B
the	O
variations	O
are	O
very	O
wide	O
and	O
we	O
recorded	O
the	O
use	O
of	O
folic	O
acid	O
throughout	O
pregnancy	O
without	O
focusing	O
on	O
the	O
first	O
trimester	O
.	O

However	O
,	O
there	O
were	O
no	O
petechial	O
lesions	O
,	O
lower	O
limb	O
edema	O
,	O
or	O
focal	O
neurological	O
deficit	O
.	O

(	O
A	O
)	O
female	O
offspring	O
in	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

This	O
suggests	O
that	O
the	O
type	O
of	O
fish	O
and	O
timing	O
of	O
consumption	O
during	O
pregnancy	O
may	O
impact	O
on	O
neurodevelopmental	O
outcomes	O
of	O
offspring	O
.	O

Second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O

This	O
tissue	O
also	O
responds	O
to	O
insulin	O
with	O
a	O
5	O
-	O
fold	O
increase	O
in	O
glucose	O
uptake	O
,	O
without	O
any	O
change	O
in	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
),	O
while	O
under	O
cold	O
exposure	O
,	O
glucose	O
uptake	O
increases	O
by	O
12	O
-	O
folds	O
,	O
dissipating	O
energy	O
as	O
a	O
function	O
of	O
increased	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
).	O

Introduction	O
WHO	O
estimates	O
suggest	O
that	O
globally	O
up	O
to	O
500	O
million	O
women	O
of	O
reproductive	O
age	O
suffer	O
from	O
anaemia	O
.	O

The	O
country	O
was	O
divided	O
into	O
two	O
regions	O
.	O

The	O
cohort	O
,	O
consisting	O
of	O
46	O
.	O
6	O
%	O
females	O
and	O
53	O
.	O
4	O
%	O
males	O
,	O
included	O
41	O
Blacks	O
,	O
38	O
Whites	O
,	O
and	O
54	O
Hispanics	O
.	O

Background	O
Vitamin	O
D	O
deficiency	O
,	O
defined	B
as	B
a	O
circulating	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
concentration	O
below	O
50	O
nmol	O
/	O
L	O
,	O
has	O
been	O
common	B
among	O
Finnish	O
pregnant	O
women	O
[	O
1	O
].	O

However	O
,	O
as	O
they	O
reached	O
adolescence	O
(	O
age	O
11	O
years	O
for	O
girls	O
,	O
16	O
for	O
boys	O
),	O
children	O
exposed	O
to	O
tobacco	O
in	O
utero	O
had	O
a	O
significantly	O
greater	O
risk	O
of	O
being	O
in	O
the	O
highest	O
10	O
%	O
of	O
BMI	O
for	O
their	O
age	O
group	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
associations	O
between	O
the	O
SNPs	O
at	O
rs10741657	O
(	O
CYP2R1	O
),	O
rs6013897	O
(	O
CYP24A1	O
),	O
and	O
rs2282679	O
(	O
GC	O
)	O
and	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
fully	O
adjusted	O
model	O
(	O
Table	O
2	O
).	O

Most	O
importantly	O
,	O
they	O
can	O
help	O
prevent	O
stillbirths	O
,	O
improve	O
prevention	O
and	O
care	O
of	O
premature	O
babies	O
and	O
avert	O
death	O
and	O
disability	O
in	O
women	O
,	O
newborns	O
and	O
children	O
[	O
25	O
-	O
27	O
].	O

In	O
the	O
mission	O
to	O
enhance	O
and	O
compound	O
the	O
benefit	O
of	O
services	O
delivered	O
under	O
ICDS	O
,	O
Government	O
of	O
India	O
has	O
developed	O
partnerships	O
with	O
the	O
international	O
agencies	O
like	O
United	O
Nations	O
International	O
Children	O
’	O
Emergency	O
Fund	O
(	O
for	O
providing	O
technical	O
guidance	O
in	O
developing	O
need	O
-	O
based	O
training	O
plans	O
;	O
assist	O
in	O
organizing	O
scientific	O
workshops	O
;	O
and	O
in	O
impact	O
assessment	O
on	O
early	O
childhood	O
nutrition	O
and	O
development	O
),	O
Cooperative	O
for	O
Assistance	O
and	O
Relief	O
Everywhere	O
(	O
contribution	O
in	O
the	O
areas	O
of	O
maternal	O
and	O
child	O
health	O
,	O
girl	O
primary	O
education	O
,	O
etc	O
.	O

In	O
normal	O
weight	O
(	O
n	O
=	O
153	O
)	O
mothers	O
,	O
higher	O
intake	O
of	O
soft	O
drinks	O
was	O
the	O
strongest	O
predictor	O
of	O
higher	O
offspring	O
WFA	O
at	O
birth	O
(	O
beta	O
=	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
04	O
)	O
but	O
not	O
at	O
6	O
months	O
.	O

Consequently	O
,	O
the	O
Nutrition	O
during	O
Pregnancy	O
and	O
Early	O
Development	O
(	O
NuPED	O
)	O
cohort	O
study	O
was	O
initiated	O
to	O
investigate	O
nutritional	O
status	O
during	O
pregnancy	O
and	O
assess	O
early	O
nutrition	O
-	O
related	O
exposures	O
predictive	O
of	O
early	O
childhood	O
development	O
in	O
urban	O
South	O
Africa	O
.	O

To	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
preterm	O
delivery	O
from	O
15	O
%	O
in	O
control	O
compared	O
to	O
10	O
.	O
5	O
%	O
in	O
the	O
intervention	O
arm	O
,	O
assuming	O
80	O
%	O
power	O
,	O
5	O
%	O
level	O
of	O
significance	O
,	O
intracluster	O
correlation	O
of	O
0	O
.	O
012	O
for	O
small	O
birth	O
size	O
(	O
Bangladesh	O
DHS	O
data	O
),	O
would	O
require	O
a	O
sample	O
size	O
of	O
1300	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
64	O
clusters	O
.	O

Most	B
experts	O
agree	O
that	O
vitamin	O
D	O
supplementation	O
is	O
a	O
necessity	O
,	O
particularly	O
in	O
women	O
suffering	O
from	O
obesity	O
,	O
insulin	O
resistance	O
or	O
small	O
ovarian	O
reserve	O
,	O
as	O
well	O
as	O
in	O
men	O
with	O
oligo	O
-	O
and	O
asthenozoospermia	O
if	O
serum	O
concentration	O
should	O
fall	O
below	O
50	O
nmol	O
/	O
L	O
(	O
normal	O
range	O
up	O
to	O
125	O
nmol	O
/	O
L	O
).	O

Therefore	B
,	O
an	O
alteration	O
in	O
the	O
hypothalamic	O
levels	O
of	O
endocannabinoids	O
in	O
newborn	O
animals	O
,	O
as	B
was	O
previously	O
described	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.	O

This	O
creates	O
a	O
hat	O
trick	O
of	O
DNA	O
damage	O
:	O
Uranium	O
’	O
s	O
radioactive42and	O
chemical43properties	O
both	O
can	O
harm	O
DNA	O
,	O
and	O
the	O
presence	O
of	O
arsenic	O
may	O
prevent	O
cells	O
from	O
repairing	O
the	O
damage	O
.	O

The	O
effect	O
of	O
maternal	O
dairy	O
intake	O
on	O
infant	O
gut	O
microbiota	O
was	O
primarily	O
observed	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
.	O

Potential	O
confounders	O
for	O
vitamin	O
D	O
status	O
were	O
assessed	O
using	O
linear	O
modelling	O
.	O

Furthermore	O
,	O
understanding	O
the	O
associations	O
of	O
maternal	O
diet	O
and	O
nutritional	O
status	O
during	O
pregnancy	O
with	O
birth	O
outcomes	O
,	O
as	O
well	O
as	O
offspring	O
health	O
and	O
development	O
in	O
the	O
South	O
African	O
population	O
will	O
form	O
the	O
basis	O
for	O
the	O
development	O
of	O
context	O
-	O
specific	O
nutrition	O
interventions	O
that	O
may	O
improve	O
birth	O
outcomes	O
and	O
long	O
-	O
term	O
quality	O
of	O
life	O
of	O
the	O
mother	O
and	O
her	O
offspring	O
.	O

Therefore	B
all	O
women	O
with	O
GDM	O
should	O
receive	O
counseling	O
from	O
a	O
specialist	O
dietitian	O
.	O

Infections	O
in	O
the	O
newborn	O
period	O
typically	O
include	O
pneumonia	O
,	O
sepsis	O
,	O
and	O
those	O
of	O
the	O
umbilical	O
cord	O
[	O
1	O
].	O

Economic	O
situation	O
was	O
assessed	O
by	O
ownership	O
of	O
radio	O
and	O
/	O
or	O
bicycle	O
and	O
information	O
on	O
perceived	O
economic	O
status	O
.	O

Also	O
,	O
dietary	O
surveys	O
during	O
pregnancy	O
have	O
suggested	O
the	O
poor	O
diet	O
quality	O
and	O
quantity	O
of	O
low	O
socioeconomic	O
groups	O
[	O
27	O
].	O

Study	O
Design	O
and	O
Participants	O
The	O
current	O
prospective	O
observational	O
study	O
was	O
conducted	O
among	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
,	O
who	O
were	O
being	O
attended	O
at	O
health	O
centers	O
across	O
Isfahan	O
city	O
in	O
the	O
central	O
part	O
of	O
Iran	O
during	O
2015	O
-	O
2016	O
.	O

Of	O
the	O
10	O
term	O
placentas	O
4	O
were	O
nonlabor	O
and	O
all	O
CS	O
,	O
and	O
6	O
were	O
from	O
laboring	O
tissues	O
(	O
mode	O
of	O
delivery	O
:	O
3	O
CS	O
,	O
3	O
vaginal	O
deliveries	O
).	O

Further	O
,	O
we	O
aimed	O
to	O
explore	O
whether	O
alterations	O
to	O
the	O
methylation	O
of	O
these	O
regions	O
are	O
associated	O
with	O
methylation	O
of	O
gene	O
-	O
associated	O
loci	O
using	O
a	O
genomewide	O
bioinformatic	O
approach	O
,	O
in	O
order	O
to	O
provide	O
clues	O
about	O
the	O
potential	O
importance	O
of	O
these	O
alterations	O
.	O

Biological	O
sample	O
collection	O
Venous	O
blood	O
(	O
42	O
ml	O
)	O
is	O
drawn	O
from	O
the	O
participating	O
women	O
into	O
labelled	O
EDTA	O
-	O
coated	O
,	O
serum	O
and	O
trace	O
element	O
free	O
evacuated	O
tubes	O
at	O
phases	O
1	O
–	O
4	O
during	O
pregnancy	O
and	O
at	O
phase	O
6	O
postnatally	O
.	O

Our	O
longitudinal	O
findings	O
linking	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
to	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
extend	O
the	O
ecological	O
results	O
and	O
allow	O
stronger	O
causal	O
inference	O
.	O

The	O
mean	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
level	O
for	O
our	O
study	O
population	O
(	O
n	O
=	O
438	O
)	O
was	O
46	O
.	O
9	O
nmol	O
l	O
−	O
1	O
,	O
with	O
a	O
range	O
of	O
5	O
.	O
0	O
to	O
135	O
.	O
8	O
nmol	O
l	O
−	O
1	O
.	O

Diagnostic	O
Services	O
of	O
Manitoba	O
laboratory	O
reference	O
ranges	O
were	O
adopted	O
for	O
calcium	O
(	O
2	O
.	O
1	O
-	O
2	O
.	O
6	O
mmol	O
/	O
L	O
),	O
albumin	O
(	O
35	O
–	O
47	O
g	O
/	O
L	O
for	O
those	O
<	O
48	O
months	O
and	O
33	O
–	O
39	O
g	O
/	O
L	O
for	O
those	O
≥	O
48	O
months	O
),	O
and	O
PTH	O
(	O
7	O
–	O
50	O
ng	O
/	O
L	O
).	O

Overweight	O
/	O
Obese	O
Mothers	O
In	O
initial	O
unadjusted	O
analyses	O
,	O
several	O
significant	O
associations	O
between	O
overweight	O
/	O
obese	O
mothers	O
'	O
prenatal	O
behaviors	O
and	O
offspring	O
WFA	O
z	O
-	O
scores	O
were	O
observed	O
(	O
Table	O
2	O
).	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

The	O
requirement	O
for	O
vitamin	O
D	O
in	O
maintaining	O
normal	O
calcium	O
metabolism	O
throughout	O
pregnancy	O
and	O
lactation	O
in	O
mothers	O
,	O
fetuses	O
and	O
newborn	O
infants	O
is	O
still	O
controversial	O
.	O

Moreover	O
,	O
it	O
was	O
found	O
that	O
a	O
high	O
concentration	O
of	O
calcidiol	O
is	O
related	O
to	O
greater	O
endometriosis	O
incidence	O
,	O
which	O
was	O
explained	B
by	O
diminishing	O
elimination	O
of	O
endometrial	O
cells	O
that	O
pass	O
to	O
the	O
peritoneal	O
cavity	O
via	O
ovarian	O
reflux	O
.	O

Implement	O
•	O
Scale	O
up	O
best	O
practices	O
and	O
partner	O
with	O
the	O
public	O
sector	O
to	O
improve	O
service	O
delivery	O
and	O
infrastructure	O
for	O
prevention	O
and	O
management	O
of	O
preterm	O
birth	O
.	O

It	O
has	O
been	O
suggested	O
that	O
intrauterine	O
growth	O
patterns	O
improved	O
prediction	O
of	O
childhood	O
anthropometry	O
,	O
above	O
and	O
beyond	O
birth	O
weight	O
alone	O
.	O

The	O
internal	O
standard	O
(	O
IS	O
)	O
was	O
corticosterone	O
-	O
d8	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
difference	O
between	O
the	O
serum	O
concentration	O
of	O
Ca	O
of	O
the	O
IG	O
and	O
CG	O
prior	O
or	O
after	O
the	O
intervention	O
.	O

In	O
contrast	O
,	O
backfat	O
thickness	O
,	O
which	O
is	O
a	O
negative	O
YG	O
factor	O
,	O
was	O
highest	O
in	O
winter	O
.	O

Thus	B
,	O
the	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
relationship	O
between	O
race	O
,	O
maternal	O
characteristics	O
,	O
cord	O
blood	O
vitamin	O
D	O
levels	O
and	O
SGA	O
status	O
among	O
infants	O
during	O
one	O
winter	O
season	O
in	O
a	O
Midwestern	O
US	O
population	O
.	O

Clear	O
diagnosis	O
of	O
GDM	O
after	O
OGTT	O
test	O
;	O
2	O
).	O

The	O
vitamin	O
D	O
measurements	O
were	O
all	O
done	O
in	O
one	O
laboratory	O
in	O
Shiraz	O
.	O

Apart	O
from	O
the	O
long	O
-	O
term	O
health	O
consequences	O
,	O
severe	O
growth	O
-	O
restricted	O
foetuses	O
are	O
at	O
increased	O
risk	O
of	O
stillbirth	O
,	O
and	O
the	O
live	O
births	O
have	O
an	O
increased	O
risk	O
of	O
neonatal	O
death	O
,	O
morbidity	O
and	O
permanent	O
deficits	O
in	O
growth	O
and	O
neurocognitive	O
development	O
[	O
5	O
,	O
6	O
].	O

This	O
study	O
also	O
analyzed	O
the	O
use	O
of	O
fish	O
oil	O
supplements	O
,	O
which	O
showed	O
no	O
association	O
with	O
autistic	O
disorder	O
[	O
32	O
].	O

Heat	O
stress	O
can	O
also	O
negatively	O
affect	O
animal	O
performance	O
,	O
including	O
growth	O
,	O
milk	O
production	O
,	O
reproduction	O
,	O
feed	O
intake	O
,	O
overall	O
health	O
,	O
and	O
well	O
-	O
being	O
in	O
cattle	O
[	O
79	O
,	O
80	O
].	O

Among	O
the	O
essential	O
regulators	O
of	O
kidney	O
development	O
are	O
components	O
of	O
the	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
),	O
podocin	O
(	O
a	O
critical	O
component	O
of	O
the	O
glomerular	O
slit	O
diaphragm	O
)	O
and	O
the	O
Wilms	O
'	O
tumor	O
suppressor	O
gene	O
WT1	O
[	O
12	O
].	O

Discussion	O
Intensive	O
handwashing	O
promotion	O
employing	O
emotional	O
drivers	O
,	O
improving	O
convenience	O
,	O
and	O
providing	O
visual	O
cues	O
led	O
to	O
only	O
a	O
modest	O
increase	O
in	O
the	O
frequency	O
of	O
handwashing	O
with	O
soap	O
among	O
new	O
mothers	O
in	O
rural	O
Bangladesh	O
during	O
the	O
first	O
30	O
days	O
after	O
the	O
birth	O
of	O
their	O
child	O
.	O

Experimental	O
models	O
have	O
demonstrated	O
that	O
blocking	O
the	O
RAS	O
during	O
development	O
causes	O
changes	O
in	O
the	O
glomerular	O
vasculature	O
that	O
affects	O
the	O
normal	O
maturity	O
of	O
the	O
kidney	O
,	O
although	O
the	O
RAS	O
cascade	O
during	O
kidney	O
development	O
is	O
not	O
fully	O
understood	O
[	O
28	O
],[	O
29	O
].	O

Rapid	O
progress	O
is	O
possible	O
.	O

Outcome	O
assessors	O
were	O
blinded	O
to	O
the	O
allocated	O
treatment	O
group	O
.	O

As	O
soon	O
as	O
the	O
data	O
is	O
uploaded	O
to	O
the	O
server	O
,	O
information	O
will	O
be	O
passed	O
to	O
the	O
separate	O
evaluation	O
team	O
for	O
first	O
follow	O
up	O
visit	O
.	O

Furthermore	O
,	O
the	O
measurement	O
of	O
respiratory	O
mechanics	O
relies	B
on	I
both	O
the	O
absence	O
of	O
airflow	O
and	O
the	O
invocation	O
of	O
the	O
Hering	O
—	O
Breuer	O
reflex	O
while	O
occluding	O
the	O
air	O
outflow	O
[	O
53	O
].	O

WT1	O
expression	O
(	O
Figure	O
11	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g011	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
11	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
birth	O
for	O
WT1	O
expression	O
.	O

The	O
mother	O
is	O
the	O
only	O
source	O
of	O
foetal	O
thyroid	O
hormones	O
from	O
conception	O
to	O
approximately	O
13	O
weeks	O
of	O
gestation	O
,	O
when	O
foetal	O
thyroid	O
function	O
has	O
developed14	O
-	O
16	O
.	O

Our	O
study	O
did	O
not	O
have	O
the	O
ability	O
to	O
identify	O
the	O
effects	O
of	O
small	O
amounts	O
of	O
formula	O
or	O
other	O
nutritional	O
differences	O
between	O
groups	O
.	O

Since	O
1991	O
/	O
1992	O
,	O
688	O
women	O
were	O
deceased	O
,	O
and	O
491	O
women	O
had	O
emigrated	O
.	O

According	O
to	B
our	I
knowledge	I
,	O
this	O
study	O
was	O
the	O
first	O
trial	O
held	O
on	O
vitamin	O
D	O
and	O
perinatal	O
depression	O
.	O

According	O
to	O
the	O
extent	O
of	O
the	O
disease	O
,	O
hemithyroidectomy	O
or	O
radical	O
thyroidectomy	O
is	O
performed	O
.	O

2009	O
).	O

Recurrent	O
PTB	O
rates	O
for	O
this	O
subgroup	O
were	O
42	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
57	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
34	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
25	O
)	O
and	O
13	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
24	O
).	O

The	O
mean	O
time	O
of	O
follow	O
up	O
was	O
similar	O
in	O
both	O
groups	O
(	O
MMN	O
:	O
14	O
.	O
1	O
±	O
1	O
.	O
2	O
months	O
,	O
placebo	O
14	O
.	O
0	O
±	O
1	O
.	O
2	O
months	O
).	O

In	O
pooled	O
data	O
of	O
different	O
sexes	O
(	O
cows	O
,	O
bulls	O
,	O
and	O
steers	O
)	O
of	O
Korean	O
cattle	O
,	O
MS	O
and	O
LM	O
area	O
increased	O
with	O
increasing	O
carcass	O
weight	O
from	O
143	O
to	O
536	O
kg	O
[	O
39	O
].	O

All	O
of	O
these	O
complications	O
could	O
lead	O
to	O
permanent	O
damages	O
in	O
the	O
neonates	O
'	O
developing	O
brain	O
[	O
52	O
].	O

The	O
WHO	O
technical	O
working	O
group	O
on	O
the	O
prevention	O
and	O
the	O
treatment	O
of	O
severe	O
anaemia	O
has	O
documented	O
that	O
parenteral	O
iron	O
therapy	O
produces	O
a	O
rapid	O
and	O
complete	O
correction	O
of	O
iron	O
deficiency	O
,	O
including	O
replacement	O
of	O
iron	O
stores	O
;	O
thereby	O
producing	O
a	O
more	O
rapid	O
erythropoietic	O
response	O
than	O
oral	O
iron	O
replacement	O
[	O
39	O
].	O

Measurements	O
of	O
vitamin	O
D	O
serum	O
level	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
have	O
yielded	O
conflicting	O
results	O
regarding	O
the	O
relationship	O
between	O
maternal	O
-	O
or	O
cord	O
-	O
blood	O
levels	O
and	O
subsequent	O
asthma	O
development	O
[	O
6	O
–	O
15	O
].	O

Some	O
of	O
the	O
results	O
presented	O
above	O
suggest	O
restricted	O
nutrition	O
at	O
certain	O
stages	O
of	O
pregnancy	O
has	O
more	O
favourable	O
outcomes	O
.	O

Fourth	O
,	O
our	O
study	O
includes	O
both	O
persistent	O
and	O
non	O
-	O
persistent	O
EDCs	O
when	O
examining	O
EDC	O
exposure	O
.	O

This	O
positive	O
correlation	O
between	O
cathelicidin	O
and	O
age	O
was	O
also	O
shown	O
in	O
the	O
oral	O
environment	O
when	O
examining	O
cathelicidin	O
concentrations	O
in	O
saliva	O
in	O
healthy	O
children	O
aged	O
2	O
to	O
18	O
years	O
[	O
30	O
].	O

Interestingly	O
however	O
,	O
white	O
race	O
with	O
vitamin	O
D	O
deficiency	O
was	O
not	O
significantly	O
associated	O
with	O
increased	O
odds	O
of	O
SGA	O
.	O

The	O
primer	O
sequences	O
used	O
for	O
miRNAs	O
analysis	O
are	O
listed	O
inTable	O
1	O
.	O
The	O
fold	O
change	O
was	O
calculated	O
using	O
the	O
2	O
-△△	O
Ct	O
method	O
.	O

However	O
,	O
the	O
24	O
h	O
urine	O
output	O
,	O
adjusted	O
for	O
BM	O
,	O
was	O
significant	O
lower	O
(−	O
60	O
%;	O
P	O
=	O
0	O
.	O
004	O
)	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
the	O
F1	O
-	O
SC	O
mice	O
,	O
even	O
without	O
differences	O
in	O
water	O
intake	O
between	O
these	O
groups	O
.	O

Donors	O
and	O
philanthropic	O
institutions	O
:	O
Invest	O
•	O
Provide	O
sustained	O
long	O
-	O
term	O
support	O
in	O
line	O
with	O
national	O
health	O
policies	O
and	O
RMNCH	O
plans	O
that	O
incorporate	O
preterm	O
births	O
and	O
are	O
harmonised	O
with	O
other	O
related	O
global	O
health	O
initiatives	O
.	O

The	O
MGM	O
could	O
arguably	O
have	O
influenced	O
her	O
daughter	O
'	O
s	O
culinary	O
and	O
dietary	O
habits	O
and	O
hence	B
her	O
grandchild	O
'	O
s	O
BMI	O
,	O
25but	O
the	O
PGM	O
is	O
associated	O
with	O
the	O
paternal	O
granddaughter	O
and	O
not	O
her	O
paternal	O
grandson	O
.	O

Following	O
fertilization	O
epigenetic	O
marks	O
are	O
removed	O
to	O
generate	O
a	O
totipotent	O
zygote	O
,	O
capable	O
of	O
producing	O
all	O
the	O
different	O
cell	O
types	O
required	O
to	O
form	O
a	O
new	O
individual	O
.	O

While	O
several	O
observational	O
studies	O
point	O
to	O
correlations	O
between	O
vitamin	O
D	O
insufficiency	O
and	O
maternal	O
and	O
neonatal	O
ill	O
health	O
,	O
experimental	O
evidence	O
from	O
supplementation	O
clinical	O
trials	O
is	O
needed	O
to	O
inform	O
health	O
policy	O
.	O

Moreover	O
,	O
the	O
outcomes	O
of	O
the	O
present	O
study	O
enhance	O
the	O
importance	O
of	O
the	O
periconceptional	O
period	O
as	O
well	O
as	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
the	O
early	O
life	O
programming	O
,	O
due	O
to	O
the	O
fact	O
that	O
the	O
maternal	O
undernutrition	O
was	O
implemented	O
before	O
mating	O
and	O
offspring	O
were	O
raised	O
in	O
an	O
ad	O
libitum	O
standard	O
feeding	O
.	O

Interestingly	O
fetal	O
death	O
and	O
malformations	O
were	O
not	O
a	O
component	O
of	O
the	O
primary	O
outcome	O
;	O
however	O
,	O
19	O
events	O
in	O
the	O
metformin	O
group	O
were	O
classified	O
as	O
serious	O
fetal	O
or	O
neonatal	O
adverse	O
events	O
(	O
including	O
11	O
congenital	O
anomalies	O
)	O
compared	O
to	O
23	O
events	O
in	O
the	O
insulin	O
arm	O
(	O
including	O
18	O
congenital	O
anomalies	O
and	O
one	O
fetal	O
death	O
).	O

ACHOIS	O
has	O
shown	O
that	O
it	O
is	O
acceptable	O
to	O
the	O
majority	O
of	O
women	O
.	O

Furthermore	O
,	O
Camargo	O
et	O
al	O
.	O

While	O
this	O
approach	O
is	O
being	O
pursued	O
,	O
we	O
recommend	O
that	O
appropriate	O
measures	O
be	O
taken	O
to	O
strengthen	O
the	O
existing	O
health	O
systems	O
in	O
dealing	O
with	O
gastro	O
-	O
intestinal	O
and	O
life	O
-	O
threatening	O
side	O
effects	O
of	O
iron	O
supplements	O
.	O

The	O
effect	O
was	O
stronger	O
between	O
same	O
-	O
sex	O
friends	O
and	O
siblings	O
.	O

For	O
boys	O
,	O
change	O
in	O
height	O
was	O
correlated	O
with	O
the	O
height	O
of	O
the	O
mother	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
and	O
father	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
borderline	O
significance	O
with	O
MGM	O
p	O
=	O
0	O
.	O
080	O
,	O
and	O
with	O
PGF	O
p	O
=	O
0	O
.	O
009	O
.	O

This	O
association	O
was	O
only	O
significant	O
in	O
children	O
breastfed	O
for	O
up	O
to	O
6	O
months	O
.	O
Greater	O
than	O
3	O
serves	O
per	O
week	O
was	O
not	O
associated	O
with	O
improved	O
outcomes	O
.	O
Seafood	O
intake	O
weakly	O
(	O
p	O
=	O
0	O
.	O
1	O
)	O
correlated	O
with	O
motor	O
development	O
.	O

The	O
newborn	O
in	O
this	O
case	O
also	O
had	O
hypernatremia	O
thereby	O
raising	O
possibilities	O
of	O
vasopressinase	O
crossing	O
the	O
placenta	O
.	O

Follow	O
-	O
up	O
participants	O
answered	O
additional	O
questions	O
on	O
recall	O
,	O
reactions	O
,	O
and	O
receptivity	O
to	O
the	O
texts	O
.	O

The	O
impact	O
of	O
short	O
sleep	O
duration	O
on	O
the	O
risk	O
of	O
diabetes	O
has	O
been	O
shown	O
in	O
several	O
epidemiological	O
studies	O
,	O
with	O
significant	O
increases	O
in	O
the	O
incidence	O
of	O
diabetes	O
among	O
individuals	O
who	O
report	O
habitual	O
short	O
sleep	O
duration	O
and	O
those	O
who	O
report	O
having	O
difficulty	O
maintaining	O
sleep	O
[	O
4	O
,	O
9	O
-	O
11	O
].	O

[	O
20	O
]	O
Based	O
on	O
these	O
accumulated	O
observations	O
,	O
the	O
uncertain	O
teratogenic	O
potential	O
of	O
high	O
doses	O
of	O
calciferol	O
analogs	O
or	O
of	O
the	O
associated	O
disturbances	O
in	O
mineral	O
homeostasis	O
continues	O
to	O
cause	O
concern	O
.	O

Ponderal	O
index	O
was	O
calculated	O
(	O
birth	O
weight	O
(	O
kg	O
)	O
/	O
birth	O
length	O
(	O
m	O
)	O
3	O
)	O
and	O
standardised	O
into	O
sex	O
-	O
specific	O
z	O
-	O
score	O
.	O

Discussion	O
Micronutrient	O
deficiency	O
during	O
development	O
,	O
such	O
as	O
maternal	O
vitamin	O
D	O
deficiency	O
,	O
is	O
a	O
subject	O
of	O
increasing	O
importance	O
because	B
of	O
the	O
nutritional	O
deficiencies	O
caused	O
by	O
excessive	O
consumption	O
of	O
junk	O
food	O
during	O
pregnancy	O
.	O

The	O
supernatant	O
was	O
reduced	O
and	O
alkylated	O
in	O
5	O
mM	O
tributylphosphine	O
(	O
TBP	O
)	O
and	O
1M	O
acrylamide	O
monomer	O
at	O
room	O
temperature	O
for	O
2	O
hr	O
.	O

Abdomen	O
was	O
gravid	O
,	O
consistent	O
with	O
gestational	O
age	O
.	O

However	O
,	O
the	O
attributable	O
risk	O
for	O
these	O
factors	O
is	O
small	O
and	O
can	O
only	O
explain	O
a	O
fraction	O
of	O
cases	O
.	O

To	O
arrive	O
at	O
a	O
final	O
regression	O
model	O
,	O
stepwise	O
analyses	O
were	O
first	O
conducted	O
within	O
predefined	O
categories	O
(	O
i	O
.	O
e	O
.,	O
demographic	O
(	O
age	O
,	O
parity	O
,	O
race	O
,	O
marital	O
status	O
,	O
education	O
,	O
prepregnancy	O
BMI	O
),	O
physical	O
activity	O
(	O
calories	O
expended	O
per	O
week	O
in	O
moderate	O
physical	O
activity	O
TV	O
hours	O
per	O
day	O
),	O
macronutrient	O
(%	O
of	O
calories	O
from	O
fat	O
,	O
carbohydrates	O
,	O
protein	O
,	O
sweets	O
,	O
and	O
total	O
calories	O
),	O
dietary	O
components	O
(	O
fast	O
food	O
and	O
sugar	O
-	O
sweetened	O
soft	O
drinks	O
)	O
psychosocial	O
variables	O
(	O
mood	O
,	O
restraint	O
,	O
disinhibition	O
,	O
and	O
stress	O
),	O
and	O
sleep	O
.	O

We	O
used	O
several	O
methods	O
to	O
address	O
noncontact	O
and	O
noncooperation	O
,	O
including	O
(	O
1	O
)	O
text	O
messages	O
,	O
(	O
2	O
)	O
a	O
local	O
phone	O
number	O
for	O
participants	O
to	O
call	O
the	O
investigators	O
or	O
a	O
clinic	O
nurse	O
with	O
questions	O
,	O
and	O
(	O
3	O
)	O
assurances	O
of	O
confidentiality	O
.	O

Associations	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
We	O
separately	O
assessed	O
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
infant	O
gut	O
microbiome	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

5	O
).	O

A	O
recent	O
study	O
on	O
children	O
with	O
low	O
birth	O
weight	O
found	O
a	O
reduction	O
in	O
the	O
overall	O
activity	O
of	O
the	O
ANS	O
[	O
15	O
].	O

The	O
dosage	O
is	O
based	O
on	O
dietary	O
intake	O
recommendations	O
[	O
10	O
,	O
11	O
].	O

The	O
Center	O
for	O
the	O
Protection	O
of	O
Human	O
Subjects	O
at	O
Dartmouth	O
provided	O
institutional	O
review	O
board	O
approval	O
.	O

The	O
focus	O
of	O
this	O
review	O
is	O
set	O
on	O
asthma	O
and	O
type	O
I	O
allergy	O
associated	O
with	O
pregnancy	O
.	O

A	O
limitation	O
is	O
the	O
relatively	O
small	O
numbers	O
of	O
respondents	O
with	O
differential	O
response	O
rates	O
at	O
each	O
sweep	O
,	O
particularly	O
when	O
children	O
averaged	O
9	O
years	O
of	O
age	O
.	O

A	O
second	O
person	O
checks	O
20	O
%	O
of	O
all	O
the	O
captured	O
data	O
randomly	O
and	O
notes	O
and	O
corrects	O
any	O
errors	O
.	O

Furthermore	O
,	O
it	O
has	O
previously	O
been	O
shown	O
that	O
rs2282679	O
(	O
GC	O
)	O
was	O
only	O
significantly	O
associated	O
with	O
25	O
(	O
OH	O
)	O
D	O
in	O
European	O
Americans	O
and	O
not	O
African	O
Americans	O
(	O
30	O
),	O
suggesting	O
further	O
ethnicity	O
-	O
specific	O
associations	O
,	O
which	O
might	O
form	O
the	O
basis	O
of	O
future	O
study	O
,	O
and	O
consideration	O
in	O
clinical	O
approaches	O
to	O
supplementation	O
.	O

Also	O
,	O
using	O
a	O
questionnaire	O
,	O
data	O
were	O
collected	O
on	O
age	O
,	O
literacy	O
level	O
,	O
occupation	O
,	O
type	O
of	O
therapy	O
for	O
diabetes	O
,	O
and	O
type	O
of	O
delivery	O
using	O
medical	O
history	O
and	O
interview	O
with	O
the	O
patients	O
.	O

Not	O
having	O
necessary	O
materials	O
for	O
washing	O
hands	O
in	O
close	O
proximity	O
was	O
an	O
important	O
barrier	O
to	O
maternal	O
handwashing	O
in	O
the	O
neonatal	O
period	O
,	O
particularly	O
given	B
prevalent	O
social	O
expectations	O
regarding	O
mothers	O
and	O
newborns	O
staying	O
almost	O
exclusively	O
in	O
just	O
1	O
-	O
2	O
rooms	O
or	O
immediately	O
outside	O
the	O
home	O
[	O
11	O
,	O
12	O
].	O

Key	O
components	O
in	O
terms	O
of	O
cell	O
cycle	O
regulation	O
are	O
cyclins	O
.	O

Discussion	O
We	O
found	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
20	O
ng	O
/	O
mL	O
to	O
be	O
common	O
in	O
the	O
cord	O
blood	O
of	O
infants	O
in	O
a	O
southern	O
climate	O
in	O
the	O
United	O
States	O
representing	B
about	O
60	O
%	O
of	O
the	O
infants	O
in	O
our	O
study	O
,	O
with	O
about	O
20	O
%	O
of	O
the	O
infants	O
having	O
values	O
≤	O
10	O
ng	O
/	O
mL	O
.	O

Abbreviations	O
:	O
25	O
(	O
OH	O
)	O
D	O
,	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
;	O
UCB	O
,	O
umbilical	O
cord	O
blood	O
;	O
GDM	O
,	O
gestational	O
diabetes	O
mellitus	O
We	O
further	O
tested	O
for	O
possible	O
associations	O
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
OGTT	O
results	O
with	O
a	O
univariate	O
regression	O
model	O
.	O

Verbal	O
autopsy	O
Trained	O
Field	O
Research	O
Officers	O
will	O
interview	O
caretakers	O
of	O
infants	O
who	O
die	O
in	O
the	O
neonatal	O
period	O
using	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
Standard	O
Verbal	O
Autopsy	O
Questionnaire	O
[	O
15	O
]	O
within	O
one	O
month	O
of	O
the	O
death	O
.	O

In	O
our	O
study	O
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
the	O
maternal	O
serum	O
was	O
low	O
,	O
at	O
15	O
ng	O
/	O
ml	O
,	O
which	O
might	O
hinder	O
our	O
investigation	O
.	O

While	O
less	O
than	O
a	O
quarter	O
of	O
women	O
in	O
our	O
study	O
reported	O
receiving	O
any	O
information	O
on	O
weight	O
gain	O
,	O
those	O
who	O
did	O
were	O
more	O
likely	B
to	O
have	O
target	O
weights	O
within	O
clinical	O
recommendations	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Clinical	O
recommendations	O
for	O
cumulative	O
gestational	O
weight	O
gain	O
by	O
pre	O
-	O
pregnancy	O
BMI	O
for	O
mothers	O
of	O
singletons	O
and	O
twins	O
at	O
gestational	O
ages	O
37	O
–	O
42	O
weeks	O
(	O
IOM	O
,	O
2009	O
)	O
Prepregnancy	O
BMIRecommended	O
range	O
ofCumulative	O
weight	O
gain	O
(	O
lbs	O
)	O
SingletonTwinsUnderweight	O
(<	O
18	O
.	O
5	O
kg	O
/	O
m2	O
)	O
28	O
–	O
40	O
–	O
Normal	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
kg	O
/	O
m2	O
)	O
25	O
–	O
3537	O
–	O
54Overweight	O
(	O
25	O
.	O
0	O
–	O
29	O
.	O
9	O
kg	O
/	O
m2	O
)	O
15	O
–	O
2531	O
–	O
50Obese	O
(≥	O
30	O
.	O
0	O
kg	O
/	O
m2	O
)	O
11	O
–	O
2024	O
–	O
42	O
Actual	O
weight	O
gain	O
during	O
pregnancy	O
is	O
strongly	O
influenced	O
by	O
provider	O
recommendation	O
[	O
6	O
,	O
7	O
].	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

We	O
developed	O
an	O
intensive	O
intervention	O
to	O
improve	O
maternal	O
handwashing	O
behavior	O
during	O
the	O
neonatal	O
period	O
,	O
addressing	O
several	O
of	O
the	O
key	O
barriers	O
and	O
motivators	O
identified	O
by	O
Parveen	O
and	O
colleagues	O
,	O
described	O
above	O
.	O

Although	O
studies	O
have	O
shown	O
that	O
supplementation	O
increases	O
maternal	O
and	O
cord	O
blood	O
vitamin	O
D	O
levels	O
,	O
changes	O
in	O
clinical	O
outcomes	O
have	O
not	O
yet	O
been	O
well	O
proven	O
.	O

Vitamin	O
D	O
is	O
associated	O
with	O
the	O
two	O
main	O
oral	O
diseases	O
,	O
caries	O
and	O
periodontal	O
disease	O
[	O
14	O
,	O
18	O
-	O
23	O
].	O

Handedness	O
Handedness	O
is	O
believed	O
to	O
be	O
determined	O
in	O
utero	O
[	O
179	O
],	O
possibly	O
through	O
hormonal	O
influences	O
[	O
180	O
–	O
183	O
],	O
and	O
has	O
been	O
linked	O
with	O
immune	O
disease	O
[	O
184	O
,	O
185	O
],	O
various	O
developmental	O
learning	O
disorders	O
[	O
184	O
],	O
epilepsy	O
[	O
186	O
],	O
and	O
breast	O
cancer	O
risk	O
in	O
both	O
pre	O
-	O
and	O
post	O
-	O
menopausal	O
women	O
[	O
187	O
–	O
190	O
].	O

The	O
Field	O
Implementers	O
will	O
then	O
visit	O
the	O
pregnant	O
mother	O
along	O
with	O
the	O
SS	O
within	O
the	O
next	O
48	O
h	O
to	O
conduct	O
a	O
pregnancy	O
test	O
and	O
enquire	O
about	O
the	O
last	O
menstrual	O
period	O
.	O

Moreover	O
,	O
control	O
women	O
who	O
reported	O
a	O
history	O
of	O
psychiatric	O
disorders	O
or	O
who	O
were	O
exposed	O
in	O
their	O
current	O
pregnancy	O
to	O
a	O
known	O
teratogen	O
were	O
excluded	O
.	O

Nutrient	O
density	O
was	O
calculated	O
by	O
dividing	O
the	O
estimated	O
intake	O
of	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
other	O
nutrients	O
by	O
the	O
total	O
energy	O
intake	O
(	O
i	O
.	O
e	O
.,	O
the	O
multivariate	O
nutrient	O
density	O
model	O
)	O
[	O
28	O
].	O

We	O
will	O
ask	O
the	O
participants	O
to	O
record	O
use	O
of	O
health	O
services	O
at	O
each	O
follow	O
-	O
up	O
interview	O
,	O
which	O
will	O
enable	O
assessment	O
of	O
potential	O
cost	O
offsets	O
particularly	O
associated	O
with	O
differences	O
in	O
rates	O
of	O
birth	O
complications	O
and	O
neonatal	O
morbidity	O
.	O

There	O
are	O
no	O
studies	O
using	O
glitazones	O
in	O
pregnancy	O
.	O

Nutritional	O
manipulation	O
of	O
the	O
fetus	O
during	O
gestation	O
may	O
affect	O
animal	O
performance	O
and	O
modify	O
the	O
quality	O
and	O
quantity	O
of	O
livestock	O
products	O
.	O

Notably	O
,	O
in	O
the	O
aforementioned	O
study	O
examining	O
localized	O
cathelicidin	O
concentrations	O
in	O
saliva	O
,	O
the	O
female	O
gender	O
was	O
found	O
to	O
positively	O
correlate	O
with	O
cathelicidin	O
[	O
30	O
].	O

At	O
birth	O
,	O
children	O
are	O
less	O
able	O
to	O
detoxify	O
chemicals	O
and	O
other	O
inorganic	O
substances	O
commonly	O
used	O
on	O
farms	O
[	O
33	O
,	O
34	O
],	O
and	O
they	O
tend	O
to	O
have	O
higher	O
concentrations	O
in	O
their	O
blood	O
due	O
to	O
a	O
decreased	O
capacity	O
to	O
bind	O
plasma	O
protein	O
[	O
35	O
].	O

This	O
is	O
worrisome	O
as	O
suboptimal	O
childhood	O
development	O
is	O
associated	O
with	O
poorer	O
adult	O
health	O
,	O
well	O
-	O
being	O
and	O
productivity	O
–	O
leading	O
to	O
an	O
intergenerational	O
cycle	O
of	O
poverty	O
.	O

Based	O
on	O
the	O
sum	O
population	O
prevalence	O
of	O
schizophrenia	O
and	O
other	O
psychoses	O
in	O
middle	O
-	O
aged	O
women	O
[	O
54	O
],	O
we	O
might	O
expect	O
that	O
2	O
-	O
3	O
%	O
of	O
the	O
study	O
participants	O
would	O
cross	O
the	O
boundaries	O
to	O
clinically	O
valid	O
syndromes	O
.	O

TG	O
hydrolysis	O
by	O
lipolysis	O
generates	O
NEFAs	O
and	O
glycerol	O
,	O
and	O
it	O
decreases	O
IMF	O
deposition	O
,	O
as	O
lipolysis	O
is	O
a	O
fat	O
mobilisation	O
pathway	O
.	O

Upon	O
the	O
glucose	O
gavage	O
,	O
blood	O
glucose	O
concentrations	O
were	O
determined	O
15	O
and	O
60	O
min	O
later	O
and	O
the	O
incremental	O
area	O
under	O
the	O
curve	O
(	O
iAUC	O
)	O
was	O
calculated	O
.	O

An	O
increased	O
calcidiol	O
level	O
increases	O
the	O
risk	O
of	O
endometriosis	O
occurrence	O
,	O
but	O
in	O
already	O
existing	O
cysts	O
,	O
it	O
is	O
a	O
powerful	O
inhibitor	O
of	O
neovascularization	O
.	O

To	B
our	I
knowledge	I
,	O
ours	O
is	O
one	O
of	O
the	O
first	O
studies	O
to	O
find	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
.	O

Recruitment	O
took	O
place	O
over	O
this	O
time	O
period	O
until	O
the	O
targeted	O
sample	O
was	O
reached	O
.	O

Prenatal	O
physical	O
activity	O
,	O
depressive	O
symptoms	O
,	O
and	O
sleep	O
-	O
related	O
variables	O
did	O
not	O
significantly	O
predict	O
offspring	O
weight	O
outcomes	O
.	O

If	O
exposure	O
to	O
such	O
toxins	O
were	O
the	O
main	O
contributors	O
to	O
autism	O
incidence	O
,	O
then	O
we	O
should	O
have	O
seen	O
an	O
autism	O
incidence	O
pattern	O
in	O
the	O
US	O
that	O
mirrored	O
air	O
and	O
water	O
pollution	O
with	O
a	O
dramatic	O
increase	O
in	O
the	O
1950s	O
,	O
a	O
peak	O
in	O
the	O
1960s	O
and	O
then	O
a	O
progressive	O
decline	O
by	O
the	O
early	O
1980s	O
,	O
coincident	O
with	O
enactment	O
and	O
enforcement	O
of	O
the	O
US	O
clean	O
air	O
and	O
clean	O
water	O
acts	O
of	O
the	O
1960s	O
.	O

Reverse	O
transcription	O
was	O
carried	O
out	O
from	O
1	O
μg	O
of	O
RNA	O
using	O
the	O
Transcriptor	O
Reverse	O
Transcriptase	O
kit	O
and	O
random	O
hexamer	O
primers	O
(	O
Transcriptor	O
RT	O
,	O
Roche	O
).	O

However	O
,	O
the	O
number	O
of	O
differentially	O
expressed	O
probe	O
-	O
sets	O
increased	O
extensively	O
at	O
adult	O
stage	O
.	O

PubMed	O
Central	O
:	O

Yet	O
,	O
our	O
main	O
results	O
were	O
repeated	O
in	O
a	O
subgroup	O
analysis	O
of	O
only	O
those	O
women	O
to	O
whom	O
an	O
OGTT	O
was	O
performed	O
.	O

Thus	B
the	O
risks	O
and	O
benefits	O
resulting	O
from	O
fish	O
consumption	O
need	O
to	O
be	O
considered	O
and	O
scientific	O
evidence	O
should	O
direct	O
advice	O
given	O
to	O
pregnant	O
women	O
to	O
help	O
them	O
make	O
the	O
safest	O
choice	O
.	O

This	O
study	O
showed	O
a	O
significant	O
relationship	O
between	O
serum	O
levels	O
of	O
vitamin	O
D	O
between	O
the	O
two	O
groups	O
(	O
P	O
=	O
0	O
.	O
021	O
).	O

Concerning	O
hyperphagia	O
,	O
several	O
studies	O
have	O
reported	O
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	O
been	O
proposed	O
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Most	O
sleep	O
studies	O
,	O
however	O
,	O
have	O
excluded	O
pregnant	O
women	O
;	O
hence	B
very	O
little	O
is	O
known	O
about	O
how	O
insufficient	O
sleep	O
and	O
sleep	O
disordered	O
breathing	O
during	O
gestation	O
contribute	O
to	O
increased	O
risks	O
of	O
medical	O
complications	O
of	O
pregnancy	O
including	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

Intense	O
maternal	O
protein	O
restriction	O
,	O
for	O
example	O
,	O
leads	O
to	O
chronic	O
diseases	O
in	O
adult	O
life	O
,	O
affecting	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
[	O
37	O
],[	O
38	O
],	O
and	O
reaching	O
even	O
the	O
F3	O
generation	O
[	O
39	O
].	O

The	O
proteins	O
with	O
calcium	O
-	O
related	O
functions	O
are	O
annotated	O
(	O
Fx	O
).	O

As	O
long	O
as	O
the	O
proposed	O
values	O
are	O
not	O
validated	O
in	O
clinical	O
trials	O
the	O
controversy	O
will	O
remain	O
[	O
28	O
].	O

We	O
considered	O
infants	O
with	O
cord	O
25	O
(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
above	O
20	O
ng	O
/	O
mL	O
regardless	O
of	O
ethnicity	O
.	O

The	O
TSH	O
concentration	O
generally	B
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

Of	O
these	O
,	O
78	O
.	O
5	O
%	O
(	O
n	O
=	O
285	O
/	O
363	O
;	O
132	O
overweight	O
/	O
obese	O
and	O
153	O
normal	O
weight	O
)	O
had	O
pediatrician	O
records	O
at	O
birth	O
and	O
68	O
.	O
6	O
%	O
(	O
n	O
=	O
249	O
/	O
363	O
;	O
121	O
overweight	O
/	O
obese	O
and	O
128	O
normal	O
weight	O
)	O
had	O
pediatrician	O
information	O
at	O
6	O
months	O
.	O

This	O
limits	O
the	O
accuracy	O
of	O
a	O
quantifiable	O
conclusion	O
as	O
due	O
to	O
individual	O
variability	O
in	O
the	O
perception	O
of	O
a	O
‘	O
serving	O
size	O
’.	O

Many	O
pre	O
-	O
existing	O
chronic	O
conditions	O
and	O
medical	O
complications	O
of	O
pregnancy	O
may	O
result	O
in	O
increased	O
risk	O
of	O
preterm	O
delivery	O
,	O
such	O
as	O
pre	O
-	O
eclampsia	O
,	O
hypertension	O
,	O
aberrations	O
in	O
placentation	O
and	O
placental	O
growth	O
,	O
diabetes	O
and	O
infectious	O
diseases	O
.	O

While	O
this	O
may	O
reflect	O
evidence	O
of	O
a	O
true	O
lack	O
of	O
persisting	O
effect	O
of	O
maternal	O
dietary	O
modification	O
and	O
birth	O
weight	O
on	O
weight	O
at	O
6	O
-	O
months	O
of	O
age	O
,	O
it	O
may	O
also	O
be	O
indicative	O
that	O
other	O
factors	O
are	O
of	O
relatively	O
greater	O
importance	O
in	O
driving	O
early	O
,	O
ex	O
-	O
utero	O
,	O
infant	O
growth	O
and	O
development	O
.	O

For	O
the	O
preterm	O
prevention	O
research	O
agenda	O
,	O
the	O
greatest	O
emphasis	O
is	O
on	O
discovery	O
and	O
descriptive	O
research	O
,	O
which	O
is	O
a	O
longer	O
-	O
term	O
investment	O
.	O

Associated	O
symptoms	O
include	O
nausea	O
,	O
vomiting	O
,	O
diaphoresis	O
,	O
and	O
light	O
-	O
headedness	O
.	O

In	O
2016	O
the	O
Scientific	O
Advisory	O
Committee	O
on	O
Nutrition	O
stated	O
that	O
the	O
metabolic	O
implications	O
of	O
seasonal	O
variation	O
in	O
serum	O
25OHD	O
remain	O
unknown	O
,	O
highlighting	O
the	O
necessity	O
for	O
research	O
on	O
this	O
topic	O
[	O
33	O
].	O

With	O
respect	O
to	O
partial	O
implementation	O
of	O
preventive	O
treatment	O
,	O
local	O
health	O
staff	O
should	O
be	O
encouraged	O
on	O
adherence	O
to	O
the	O
guidelines	O
on	O
antenatal	O
care	O
package	O
at	O
any	O
given	O
antenatal	O
visit	O
so	O
that	O
partial	O
implementation	O
of	O
preventive	O
treatments	O
is	O
minimized	O
.	O

Specifically	O
,	O
this	O
study	O
supports	O
a	O
need	O
to	O
target	O
supplementation	O
strategies	O
to	O
mitigate	O
the	O
impact	O
of	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

Alcohol	O
Alcohol	O
intake	O
should	O
be	O
avoided	O
by	O
the	O
pregnant	O
mother	O
because	O
of	O
well	B
-	I
known	I
toxic	O
effects	O
on	O
both	O
mother	O
and	O
fetus	O
.	O

The	O
brains	O
were	O
thawed	O
on	O
ice	O
and	O
the	O
right	O
and	O
left	O
sides	O
of	O
the	O
hypothalamus	O
were	O
dissected	O
separately	O
using	O
the	O
method	O
described	O
previously	O
.	O
14The	O
optic	O
chiasma	O
was	O
used	O
as	O
demarcation	O
for	O
the	O
anterior	O
part	O
of	O
the	O
hypothalamus	O
.	O

The	O
current	O
body	O
of	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
predominantly	B
a	O
collection	O
of	O
human	O
epidemiological	O
data	O
and	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	B
single	O
)	O
dose	O
range	O
studies	O
,	O
performed	O
,	O
not	O
for	O
regulatory	O
purposes	O
,	O
but	O
to	O
investigate	O
the	O
theoretical	O
potential	O
and	O
putative	B
mechanisms	O
of	O
epigenetic	O
toxicity	O
in	O
biological	O
systems	O
.	O

In	O
this	O
study	O
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
the	O
cord	O
serum	O
(	O
13	O
.	O
8	O
ng	O
/	O
mL	O
)	O
was	O
comparable	O
with	O
other	O
reports	O
,	O
but	O
a	O
lower	O
mean	O
level	O
in	O
the	O
maternal	O
serum	O
(	O
15	O
.	O
0	O
ng	O
/	O
mL	O
)	O
was	O
observed	O
.	O

Allergic	O
rhinitis	O
commonly	O
coexists	O
with	O
asthma	O
;	O
80	O
%	O
of	O
asthmatic	O
adults	O
also	O
have	O
AR	O
,	O
and	O
20	O
%	O
to	O
50	O
%	O
of	O
patients	O
with	O
AR	O
also	O
have	O
asthma	O
[	O
25	O
].	O

The	O
diagnosis	O
of	O
a	O
tumour	O
during	O
pregnancy	O
obviously	O
causes	O
anxiety	O
about	O
the	O
optimal	O
timing	O
of	O
recommended	O
treatments	O
and	O
about	O
both	O
maternal	O
and	O
neonatal	O
morbidity	O
.	O

Cortisol	O
is	O
also	O
an	O
important	O
regulator	O
of	O
energy	O
metabolism	O
,	O
including	O
the	O
regulation	O
of	O
lipolysis	O
and	O
lipogenesis	O
,	O
and	O
increases	O
plasma	O
NEFA	O
concentrations	O
[	O
100	O
].	O

One	O
hundred	O
children	O
aged	O
5	O
and	O
14	O
years	O
had	O
anthropometric	O
parameters	O
,	O
body	O
composition	O
and	O
blood	O
pressure	O
levels	O
determined	O
.	O

There	O
are	O
few	O
data	O
from	O
India	O
about	O
the	O
prevalence	O
of	O
hypovitaminosis	O
D	O
in	O
pregnancy	O
and	O
in	O
the	O
newborn	O
.	O

We	O
consider	O
this	O
risk	O
,	O
and	O
the	O
impact	O
on	O
the	O
validity	O
of	O
our	O
findings	O
to	O
be	O
low	O
.	O

Examining	O
GWG	O
as	O
a	O
potential	O
mediator	O
,	O
the	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
were	O
generally	O
attenuated	O
(	O
i	O
.	O
e	O
.,	O
P	O
value	O
increases	O
between	O
0	O
.	O
01	O
and	O
0	O
.	O
06	O
across	O
analyses	O
)	O
but	O
not	O
entirely	O
removed	O
when	O
GWG	O
was	O
included	O
in	O
the	O
models	O
(	O
Table	O
3	O
).	O

Thus	B
the	O
lack	O
of	O
a	O
protective	O
effect	O
of	O
vitamin	O
D	O
against	O
pneumonia	O
is	O
probably	B
not	O
due	O
to	O
misclassification	O
of	O
outcomes	O
or	O
inadequate	O
supplementation	O
.	O

Our	O
findings	O
indicate	O
no	O
evidence	O
of	O
an	O
effect	O
of	O
a	O
comprehensive	O
dietary	O
and	O
lifestyle	O
intervention	O
provided	O
during	O
pregnancy	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
,	O
on	O
measures	O
of	O
infant	O
growth	O
,	O
adiposity	O
,	O
and	O
neurodevelopment	O
at	O
6	O
-	O
months	O
of	O
age	O
.	O

Second	O
,	O
although	O
we	O
observed	O
dosage	O
effects	O
,	O
we	O
are	O
only	O
able	O
to	O
conclude	O
that	O
higher	O
levels	O
of	O
text	O
messages	O
had	O
an	O
effect	O
on	O
alcohol	O
use	O
.	O

The	O
risks	O
were	O
particularly	O
elevated	O
among	O
overweight	O
women	O
with	O
these	O
sleep	O
disorders	O
.	O

PNV	O
use	O
among	O
black	O
women	O
was	O
not	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
adjusted	O
OR	O
1	O
.	O
0	O
,	O
95	O
%	O
CI	O
0	O
.	O
4	O
,	O
2	O
.	O
3	O
)	O
but	O
was	O
among	O
white	O
women	O
(	O
3	O
.	O
5	O
,	O
95	O
%	O
CI	O
2	O
.	O
1	O
,	O
5	O
.	O
8	O
)(	O
Interaction	O
P	O
<	O
0	O
.	O
01	O
).	O

However	O
,	O
there	O
is	O
no	O
data	O
on	O
cost	O
and	O
cost	O
-	O
effectiveness	O
of	O
population	O
-	O
based	O
weekly	O
supplementation	O
programs	O
,	O
and	O
limited	O
data	O
on	O
other	O
nutritional	O
supplementation	O
programs	O
.	O

The	O
25	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
42	O
°	O
Cand	O
then	O
at	O
95	O
°	O
C	O
for	O
5	O
min	O
.	O

3	O
.	O

Furthermore	O
,	O
percentage	O
fat	O
,	O
as	O
determined	O
by	O
skinfold	O
thickness	O
measurements	O
has	O
been	O
validated	O
against	O
DXA	O
calculations	O
of	O
fat	O
mass	O
in	O
both	O
infants	O
and	O
children	O
[	O
36	O
,	O
41	O
].	O

The	O
following	O
were	O
found	O
not	O
to	O
be	O
associated	O
with	O
oesophageal	O
cancer	O
:	O
consumption	O
of	O
sheep	O
'	O
s	O
milk	O
and	O
yoghurt	O
,	O
sesame	O
oil	O
,	O
chewing	O
of	O
nass	O
,	O
making	O
of	O
carpets	O
,	O
use	O
of	O
pregnancy	O
diets	O
,	O
salting	O
and	O
sun	O
-	O
drying	O
of	O
meat	O
and	O
use	O
of	O
wild	O
spinach	O
.	O

Calcium	O
binding	O
proteins	O
are	O
central	O
to	O
a	O
wide	O
range	O
of	O
cellular	O
functions	O
,	O
of	O
which	O
calcium	O
sequestration	O
and	O
buffering	O
are	O
particularly	O
important	O
for	O
neurons	O
.	O

The	O
researchers	O
found	O
that	O
the	O
more	O
vegetables	O
,	O
fruits	O
,	O
and	O
proteins	O
a	O
woman	O
ate	O
,	O
the	O
lower	O
the	O
risk	O
of	O
her	O
child	O
having	O
leukemia	O
.	O

Ward	O
et	O
al	O
.	O

The	O
analysis	O
will	O
follow	O
the	O
intention	O
to	O
treat	O
principle	O
.	O

Dean	O
et	O
al	O
.	O

Iron	O
supplements	O
can	O
be	O
given	O
by	O
mouth	O
and	O
parenteral	O
route	O
as	O
intramuscular	O
and	O
intravenous	O
injections	O
;	O
in	O
addition	O
,	O
it	O
can	O
be	O
administered	O
as	O
blood	O
transfusion	O
and	O
recombinant	O
erythropoietin	O
with	O
iron	O
.	O

Thus	B
,	O
the	O
common	O
estimate	O
of	O
heritability	O
assuming	O
additive	O
genetic	O
effects	O
may	O
not	O
work	O
for	O
height	O
.	O
36However	O
,	O
at	O
ages	O
0	O
and	O
9	O
,	O
height	O
was	O
primarily	B
correlated	O
in	O
the	O
nuclear	O
family	O
and	O
similar	O
correlations	O
were	O
observed	O
for	O
the	O
parents	O
with	O
the	O
grandparents	O
.	O

Elastic	O
Net	O
selected	O
the	O
same	O
variables	O
as	O
LASSO	O
,	O
as	O
well	O
as	O
an	O
additional	O
5	O
PCBs	O
and	O
1	O
PBDE	O
.	O

Both	O
hyperplasia	O
and	O
hypertrophy	O
are	O
involved	O
in	O
IMF	O
deposition	O
(	O
Figure	O
1	O
).	O

Seasonal	O
variation	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
based	O
on	O
month	O
of	O
sampling	O
between	O
women	O
recruited	O
in	O
Adelaide	O
compared	O
to	O
Auckland	O
.	O

Yet	O
,	O
importantly	O
,	O
these	O
factors	O
may	O
work	O
separately	O
or	O
may	O
work	O
together	O
with	O
other	O
stimuli	O
.	O
Table	O
1provides	O
a	O
summary	O
of	O
the	O
findings	O
in	O
the	O
studies	O
explored	O
in	O
this	O
article	O
.	O

Targeted	O
epigenetic	O
marks	O
,	O
specifically	O
DNA	O
methylation	O
signatures	O
,	O
will	O
also	O
be	O
assessed	O
in	O
the	O
context	O
of	O
the	O
primary	O
and	O
secondary	O
outcomes	O
of	O
this	O
study	O
.	O

Generalized	O
linear	O
models	O
were	O
fitted	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
of	O
GDM	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
,	O
respectively	O
.	O

Similarly	O
,	O
maternal	O
prenatal	O
behaviors	O
may	O
differentially	O
impact	O
birth	O
and	O
6	O
months	O
offspring	O
weights	O
(	O
e	O
.	O
g	O
.,	O
protein	O
impacting	O
6	O
month	O
but	O
not	O
birth	O
weight	O
in	O
the	O
current	O
study	O
).	O

Anaemia	O
was	O
defined	O
as	O
hemoglobin	O
concentration	O
less	O
than	O
12	O
g	O
/	O
dL	O
(	O
UNICEF	O
/	O
WHO	O
/	O
UNU	O
2001	O
).	O

Thus	B
,	O
focal	O
cortical	O
dysplasias	O
may	O
be	O
a	O
risk	O
factor	O
for	O
ASD	O
patients	O
.	O

Lack	O
of	O
engagement	O
may	O
be	O
a	O
consequence	O
of	O
insufficient	O
involvement	O
of	O
policy	O
makers	O
,	O
issues	O
regarding	O
distribution	O
and	O
costs	O
and	O
difficulties	O
in	O
training	O
the	O
educators	O
,	O
or	O
the	O
beliefs	O
and	O
cultural	O
practices	O
of	O
the	O
target	O
population	O
and	O
the	O
characteristics	O
and	O
side	O
effects	O
of	O
supplements	O
[	O
11	O
,	O
14	O
].	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

Strengths	O
of	O
this	O
study	O
are	O
that	O
the	O
GraviD	O
cohort	O
is	O
representative	O
of	O
the	O
general	O
pregnant	O
population	O
in	O
terms	O
of	O
origin	O
,	O
education	O
,	O
parity	O
,	O
BMI	O
and	O
tobacco	O
use	O
[	O
25	O
],	O
which	O
increases	O
the	O
external	O
validity	O
of	O
the	O
findings	O
.	O

A	O
thumbprint	O
was	O
requested	O
from	O
women	O
who	O
were	O
unable	O
to	O
write	O
.	O

Peptides	O
were	O
eluted	O
in	O
0	O
.	O
8	O
µl	O
of	O
matrix	O
solution	O
directly	O
onto	O
a	O
MALDI	O
-	O
TOF	O
target	O
plate	O
.	O

Setting	O
The	O
study	O
is	O
situated	O
in	O
Johannesburg	O
,	O
the	O
largest	O
city	O
in	O
South	O
Africa	O
.	O

It	O
is	O
probably	B
regulated	O
by	O
glucose	O
and	O
insulin	O
(	O
6	O
),	O
and	O
increases	O
with	O
gradual	O
degradation	O
of	O
B	O
-	O
cell	O
and	O
progress	O
of	O
insulin	O
-	O
resistance	O
and	O
maternal	O
weight	O
(	O
7	O
).	O

Epidemiological	O
data	O
suggest	O
that	O
seasonality	O
in	O
sunlight	O
and	O
vitamin	O
D	O
are	O
related	O
to	O
mortality	O
and	O
infection	O
rates	O
[	O
18	O
].	O

The	O
early	O
expansion	O
of	O
neurons	O
initiates	O
with	O
neurite	O
process	O
elongation	O
pursued	O
by	O
axon	O
differentiation	O
,	O
dendritic	O
arborization	O
,	O
and	O
synapse	O
formation	O
.	O

Our	O
knowledge	O
is	O
growing	O
of	O
how	O
,	O
beginning	O
very	O
early	O
in	O
life	O
,	O
early	O
sensory	O
experience	O
can	O
shape	O
and	O
modify	O
flavor	O
and	O
food	O
preferences	O
.	O

The	O
Vitamin	O
D	O
deficiency	O
level	O
identified	O
in	O
this	O
study	O
was	O
20	O
.	O
4	O
%,	O
which	O
is	O
lower	O
than	O
those	O
identified	O
in	O
the	O
studies	O
discussed	O
previously	O
.	O

Some	O
epidemiological	O
evidence	O
suggests	O
that	O
children	O
who	O
are	O
breastfed	O
exclusively	O
during	O
the	O
first	O
several	O
months	O
tend	O
to	O
have	O
higher	O
IQs	O
than	O
those	O
fed	O
formula	O
or	O
a	O
combination	O
of	O
formula	O
and	O
breast	O
milk	O
.	O
39However	O
,	O
there	O
is	O
some	O
debate	O
as	O
to	O
whether	O
breastfeeding	O
actually	O
makes	O
children	O
more	O
intelligent	O
or	O
whether	O
associations	O
between	O
breastfeeding	O
and	O
IQ	O
could	O
be	O
due	B
largely	O-
to	I
parents	O
’	O
intelligence	O
.	O
40Some	O
studies	O
also	O
suggest	O
that	O
breastfed	O
babies	O
have	O
a	O
lower	O
risk	O
of	O
obesity	O
,	O
asthma	O
,	O
and	O
other	O
allergies	O
.	O
41	O
But	O
despite	O
the	O
body	O
of	O
evidence	O
in	O
humans	O
and	O
animals	O
suggesting	O
that	O
ubiquitous	O
environmental	O
exposures	O
may	O
interfere	O
with	O
this	O
highly	O
beneficial	O
process	O
,	O
opportunities	O
to	O
further	O
probe	O
these	O
associations	O
remain	O
spotty	O
at	O
best	O
,	O
say	O
many	O
of	O
the	O
researchers	O
interviewed	O
for	O
this	O
article	O
.	O

The	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
is	O
then	O
metabolized	O
in	O
the	O
kidneys	O
to	O
its	O
biologically	O
more	O
active	O
form	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
].	O

(	O
2016	O
)	O
stated	O
that	O
maternal	O
fasting	O
glucose	O
or	O
GDM	O
status	O
was	O
not	O
associated	O
with	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
,	O
which	O
in	O
their	O
study	O
was	O
on	O
average	O
93	O
nmol	O
/	O
L	O
[	O
23	O
].	O

This	O
belief	B
among	O
public	O
health	O
and	O
medical	O
professional	O
is	O
justifiable	B
,	O
says	O
Nommsen	O
-	O
Rivers	O
,	O
because	B
formula	O
companies	O
have	O
a	O
long	O
history	O
of	O
dubious	O
marketing	O
practices	O
that	O
can	O
undermine	O
a	O
woman	O
’	O
s	O
confidence	O
in	O
her	O
ability	O
to	O
nourish	O
her	O
baby	O
without	O
the	O
use	O
of	O
their	O
products	O
.	O
4	O
,	O
5Breastfeeding	O
rates	O
began	O
to	O
dwindle	O
worldwide	O
with	O
the	O
advent	O
of	O
infant	O
formula	O
in	O
the	O
1860s	O
.	O
4They	O
reached	O
an	O
all	O
-	O
time	O
low	O
in	O
the	O
United	O
States	O
in	O
1971	O
,	O
when	O
fewer	O
than	O
25	O
%	O
of	O
new	O
mothers	O
initiated	O
breastfeeding	O
at	O
all	O
,	O
and	O
only	O
5	O
%	O
of	O
mothers	O
were	O
still	O
breastfeeding	O
at	O
6	O
months	O
.	O
6Today	O
,	O
largely	O
due	B
to	I
parent	O
education	O
efforts	O
and	O
improved	O
support	O
for	O
lactating	O
mothers	O
,	O
more	O
than	O
75	O
%	O
of	O
U	O
.	O
S	O
.	O
mothers	O
initiate	O
breastfeeding	O
,	O
and	O
about	O
20	O
%	O
of	O
U	O
.	O
S	O
.	O
babies	O
are	O
breastfed	O
exclusively	O
through	O
6	O
months	O
.	O
7	O
Robust	O
milk	O
production	O
depends	O
on	O
frequent	O
and	O
thorough	O
draining	O
of	O
the	O
breast	O
through	O
suckling	O
or	O
pumping	O
.	O

Specific	O
pharmacological	O
agents	O
for	O
treatment	O
of	O
asthma	O
or	O
allergic	O
diseases	O
must	O
be	O
cautiously	O
selected	O
.	O

Exposed	O
women	O
weighed	O
significantly	O
more	O
prior	O
to	O
becoming	O
pregnant	O
,	O
although	O
body	O
mass	O
index	O
could	O
not	O
be	O
calculated	O
due	O
to	O
the	O
lack	O
of	O
available	O
data	O
on	O
maternal	O
height	O
.	O

Mothers	O
are	O
instructed	O
on	O
how	O
to	O
complete	O
the	O
calendar	O
and	O
to	O
return	O
completed	O
calendars	O
at	O
each	O
visit	O
.	O

This	O
information	O
is	O
critical	O
for	O
the	O
design	O
of	O
future	O
intervention	O
trials	O
targeting	O
obesity	O
prevention	O
in	O
children	O
.	O

However	O
,	O
factors	O
including	O
ethnicity	O
,	O
paternal	O
intelligence	O
,	O
the	O
home	O
environment	O
,	O
drug	O
use	O
,	O
dietary	O
patterns	O
,	O
supplement	O
use	O
and	O
maternal	O
responsiveness	O
were	O
not	O
always	O
measured	O
.	O

While	O
in	O
a	O
study	O
by	O
Cassidy	O
-	O
Bushrow	O
et	O
al	O
.,	O
in	O
African	O
-	O
American	O
women	O
,	O
an	O
inverse	O
relationship	O
was	O
observed	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
the	O
early	O
stages	O
of	O
pregnancy	O
and	O
antenatal	O
depression	O
.	O

Their	O
offspring	O
were	O
more	O
likely	B
to	O
have	O
weighed	O
less	O
at	O
birth	O
and	O
to	O
have	O
had	O
a	O
lower	O
BMI	O
at	O
age	O
7	O
years	O
(	O
table	O
1	O
).	O

Pregnant	O
women	O
'	O
s	O
knowledge	O
about	O
the	O
timing	O
,	O
goals	O
of	O
ANC	O
visits	O
,	O
and	O
the	O
number	O
of	O
antenatal	O
visits	O
was	O
very	O
high	O
among	O
the	O
study	O
participants	O
contrary	O
to	O
what	O
was	O
shown	O
in	O
studies	O
carried	O
out	O
in	O
Tanzania	O
[	O
14	O
]	O
and	O
South	O
Africa	O
[	O
15	O
].	O

When	O
relative	O
mRNA	O
abundance	O
was	O
calculated	O
,	O
an	O
approximate	O
4	O
-	O
fold	O
change	O
in	O
the	O
GR	O
α	O
/	O
GR	O
-	O
P	O
in	O
the	O
preterm	O
labor	O
group	O
was	O
noted	O
compared	O
with	O
the	O
term	O
group	O
.	O

Interventions	O
to	O
prevent	O
child	O
and	O
adolescent	O
obesity	O
should	O
focus	O
on	O
multiple	O
settings	O
,	O
including	O
the	O
home	O
and	O
school	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
.	O

The	O
final	O
study	O
visit	O
was	O
conducted	O
at	O
three	O
months	O
of	O
age	O
.	O

Statistical	O
analysis	O
indicated	O
a	O
significant	O
decrease	O
in	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
in	O
the	O
calorie	O
-	O
restricted	O
dams	O
after	O
gestation	O
.	O

Although	O
DNMT2	O
has	O
demonstrated	O
some	O
weak	O
DNMT	O
activity	O
,	O
it	O
is	O
predominantly	O
associated	O
with	O
RNA	O
,	O
particularly	O
tRNA	O
,	O
methylation	O
,	O
potentially	O
contributing	O
to	O
the	O
regulation	O
of	O
RNA	O
stability	O
and	O
translation	O
(	O
Motorin	O
et	O
al	O
.	O
2010	O
).	O

To	B
the	I
best	I
of	I
our	I
knowledge	I
no	O
one	O
has	O
evaluated	O
the	O
impact	O
of	O
sleep	O
duration	O
and	O
snoring	O
on	O
maternal	O
glucose	O
metabolism	O
in	O
pregnancy	O
.	O

Maternal	O
depression	O
and	O
fatigue	O
Perinatal	O
depression	O
is	O
assessed	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
and	O
at	O
phases	O
5	O
,	O
6	O
and	O
8	O
postnatally	O
using	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
Scale	O
(	O
EPDS	O
).	O

Dose	O
and	O
Follow	O
-	O
Up	O
The	O
administered	O
vitamin	O
D	O
was	O
vitamin	O
D3	O
,	O
which	O
were	O
kept	O
from	O
light	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
15	O
to	O
30oC	O
during	O
the	O
study	O
.	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Chocolate	O
and	O
total	O
caloric	O
intakes	O
relative	O
to	O
body	O
weight	O
(	O
kcal	O
/	O
kg	O
)	O
were	O
calculated	O
for	O
4	O
h	O
.	O
We	O
generated	O
the	O
following	O
eight	O
experimental	O
offspring	O
groups	O
:	O
Vehicle	O
in	O
CC	O
male	O
(	O
n	O
=	O
7	O
);	O
AM251	O
in	O
CC	O
male	O
(	O
n	O
=	O
8	O
);	O
Vehicle	O
in	O
RC	O
male	O
(	O
n	O
=	O
9	O
);	O
AM251	O
in	O
RC	O
male	O
(	O
n	O
=	O
10	O
);	O
Vehicle	O
in	O
CC	O
female	O
(	O
n	O
=	O
6	O
);	O
AM251	O
in	O
CC	O
female	O
(	O
n	O
=	O
7	O
);	O
Vehicle	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
);	O
and	O
AM251	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
).	O

Bonferroni	O
analysis	O
indicated	O
that	O
the	O
RC	O
males	O
showed	O
a	O
significant	O
increase	O
in	O
the	O
plasma	O
levels	O
of	O
leptin	O
,	O
triglycerides	O
,	O
VLDL	O
,	O
and	O
bilirubin	O
compared	O
to	O
the	O
plasma	O
of	O
CC	O
males	O
.	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
found	O
in	O
the	O
plasma	O
levels	O
of	O
bilirubin	O
and	O
ALT	O
(	O
Table1	O
),	O
and	O
an	O
almost	O
significant	O
interaction	O
in	O
leptin	O
levels	O
[	O
F	O
(	O
1	O
,	O
18	O
)=	O
3	O
.	O
349	O
,	O
P	O
=	O
0	O
.	O
084	O
].	O

The	O
FFQ	O
was	O
used	O
to	O
estimate	O
total	O
energy	O
intake	O
and	O
daily	O
nutrient	O
intake	O
,	O
by	O
multiplying	O
the	O
daily	O
frequency	O
of	O
consumption	O
of	O
a	O
food	O
by	O
the	O
nutrient	O
content	O
[	O
14	O
]	O
of	O
a	O
standard	O
portion	O
[	O
15	O
]	O
of	O
that	O
food	O
,	O
and	O
summing	O
this	O
for	O
all	O
the	O
foods	O
consumed	O
.	O

However	O
,	O
a	O
randomized	O
trial	O
revealed	O
quite	O
contrary	O
that	O
promoted	O
and	O
prolonged	O
(	O
exclusive	O
)	O
breast	O
-	O
feeding	O
is	O
not	O
able	O
to	O
prevent	O
development	O
of	O
allergy	O
or	O
asthma	O
in	O
children	O
at	O
the	O
age	O
of	O
about	O
6	O
years	O
[	O
88	O
].	O

Carbohydrate	O
should	O
be	O
restricted	O
to	O
35	O
%–	O
40	O
%	O
of	O
calories	O
.	O

In	O
this	O
respect	O
,	O
government	O
recommendations	O
must	O
be	O
carefully	O
worded	O
,	O
as	O
1	O
study	O
found	O
that	O
avoidance	O
of	O
peanuts	O
was	O
overdone	O
among	O
pregnant	O
women	O
:	O
although	O
such	O
avoidance	O
was	O
recommended	O
only	O
for	O
women	O
with	O
atopy	O
risk	O
,	O
65	O
%	O
of	O
all	O
pregnant	O
women	O
had	O
avoided	O
peanuts	O
during	O
pregnancy	O
(	O
42	O
%	O
of	O
all	O
women	O
who	O
responded	O
had	O
heard	O
about	O
the	O
advice	O
,	O
eg	O
,	O
from	O
their	O
midwives	O
,	O
and	O
50	O
%	O
subsequently	O
changed	O
their	O
diet	O
)	O
[	O
101	O
].	O

Follow	O
up	O
ended	O
in	O
May	O
,	O
2009	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
determinants	O
of	O
season	O
-	O
corrected	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
include	O
origin	O
,	O
sun	O
-	O
exposure	O
and	O
dietary	O
as	O
well	O
as	O
supplementary	O
vitamin	O
D	O
intake	O
[	O
18	O
].	O

Second	O
,	O
the	O
high	O
follow	O
-	O
up	O
rate	O
(>	O
95	O
%)	O
minimized	O
possible	O
selection	O
bias	O
.	O

There	O
are	O
some	O
potentially	O
interesting	O
differences	O
in	O
the	O
impact	O
of	O
DEP	O
and	O
DMP	O
on	O
birth	O
weight	O
when	O
the	O
study	O
sample	O
is	O
stratified	O
by	O
infant	O
sex	O
.	O

Similarly	O
as	O
in	O
our	O
pregnant	O
women	O
population	O
,	O
in	O
the	O
adult	O
population	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
higher	O
in	O
winter	O
than	O
in	O
summer	O
and	O
increased	O
with	O
BMI	O
[	O
36	O
],[	O
37	O
],[	O
44	O
],[	O
45	O
],[	O
46	O
].	O

However	O
,	O
there	O
is	O
a	O
limitation	O
to	O
the	O
use	O
of	O
some	O
of	O
these	O
biochemical	O
indicators	O
of	O
iron	O
status	O
in	O
certain	O
settings	O
and	O
conditions	O
;	O
thus	B
,	O
necessitating	O
caution	O
in	O
their	O
interpretations	O
.	O

A	O
number	O
of	O
studies	O
have	O
shown	O
a	O
significant	O
rise	O
in	O
the	O
incidence	O
of	O
polytherapy	O
with	O
two	O
or	O
more	O
antidepressants	O
,	O
antipsychotics	O
and	O
sedative	O
-	O
hypnotics	O
,	O
as	O
well	O
as	O
an	O
increase	O
in	O
the	O
concomitant	O
prescription	O
of	O
an	O
antidepressant	O
and	O
antipsychotic	O
.	O
151619	O
–	O
24Although	O
polytherapy	O
involving	O
SGAs	O
and	O
other	O
psychotropic	O
medications	O
appears	O
to	O
be	O
increasingly	O
common	O
,	O
no	O
study	O
until	O
now	O
has	O
directly	O
compared	O
the	O
reproductive	O
safety	O
of	O
SGA	O
monotherapy	O
versus	O
polytherapy	O
with	O
other	O
medications	O
.	O

If	O
these	O
measures	O
are	O
unsuccessful	O
,	O
then	O
prescription	O
of	O
antiacid	O
drugs	O
should	O
be	O
considered	O
,	O
for	O
example	O
,	O
in	O
the	O
form	O
of	O
a	O
step	O
-	O
up	O
program	O
beginning	O
with	O
antacids	O
,	O
and	O
in	O
case	O
of	O
failure	O
with	O
histamine	O
-	O
2	O
receptor	O
antagonists	O
,	O
whereas	O
proton	O
pump	O
inhibitors	O
should	O
only	O
be	O
used	O
in	O
women	O
with	O
intractable	O
symptoms	O
or	O
complicated	O
reflux	O
disease	O
[	O
111	O
,	O
112	O
].	O

This	O
could	O
support	O
the	O
hypothesis	O
that	O
sex	O
hormones	O
and	O
,	O
therefore	B
,	O
menstrual	O
and	O
reproductive	O
events	O
,	O
may	O
modify	O
thyroid	O
cancer	O
risk	O
in	O
women6	O
,	O
although	O
these	O
associations	O
–	O
which	O
could	O
indicate	O
either	O
a	O
causal	O
link	O
or	O
a	O
surveillance	O
bias	O
–	O
may	O
reflect	O
an	O
aetiology	O
shared	O
by	O
both	O
the	O
above	O
-	O
mentioned	O
factors	O
and	O
by	O
thyroid	O
cancer	O
.	O

Inverse	O
associations	O
between	O
fat	O
intake	O
early	O
in	O
pregnancy	O
and	O
offspring	O
weight	O
have	O
been	O
reported	O
previously	O
[	O
36	O
],	O
but	O
not	O
consistently	O
[	O
37	O
].	O

Statistical	O
analysis	O
Serum	O
25OHD	O
concentrations	O
in	O
early	O
pregnancy	O
were	O
categorised	O
according	O
to	O
the	O
Institute	O
of	O
Medicine	O
;	O
<	O
30	O
nmol	O
/	O
L	O
and	O
<	O
50	O
nmol	O
/	O
L	O
[	O
37	O
].	O

Hence	B
,	O
thyroid	O
cancer	O
ranks	O
among	O
the	O
most	O
common	O
cancers	O
during	O
pregnancy	O
,	O
with	O
a	O
prevalence	O
of	O
3	O
.	O
6	O
-	O
14	O
per	O
100	O
,	O
000	O
live	O
births	O
,	O
mirroring	O
the	O
its	O
incidence1	O
-	O
4	O
.	O

In	O
contrast	O
,	O
LP	O
fetuses	O
showed	O
an	O
increased	O
expression	O
of	O
transcripts	O
associated	O
with	O
cell	O
division	O
within	O
the	O
corresponding	O
developmental	O
period	O
.	O

Acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
is	O
the	O
most	O
common	O
childhood	O
cancer	O
(	O
with	O
2	O
,	O
400	O
cases	O
diagnosed	O
each	O
year	O
in	O
those	O
under	O
age	O
20	O
)	O
and	O
the	O
second	O
most	O
common	O
cause	O
of	O
mortality	O
in	O
children	O
aged	O
1	O
–	O
14	O
.	O

A	O
study	O
by	O
Oken	O
et	O
al	O
.	O

Data	O
,	O
experimental	O
design	O
,	O
materials	O
and	O
methods	O
Liver	O
samples	O
Sows	O
were	O
divided	O
randomly	O
into	O
control	O
and	O
betaine	O
groups	O
(	O
8	O
per	O
group	O
)	O
while	O
sows	O
were	O
fed	O
basal	O
diet	O
and	O
received	O
betaine	O
-	O
supplemented	O
(	O
3	O
g	O
/	O
kg	O
)	O
diet	O
respectively	O
throughout	O
the	O
pregnancy	O
.	O

Using	O
a	O
robust	O
,	O
validated	O
chemiluminescent	O
-	O
based	O
assay	O
to	O
measure	O
serum	O
25	O
(	O
OH	O
)	O
D	O
[	O
27	O
],	O
we	O
aimed	O
to	O
investigate	O
the	O
differences	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
in	O
two	O
distinct	O
populations	O
of	O
nulliparous	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
.	O

Investigators	O
estimated	O
the	O
odds	O
of	O
change	O
over	O
time	O
in	O
response	O
to	O
each	O
of	O
the	O
behavioral	O
outcome	O
variables	O
as	O
a	O
function	O
of	O
text4baby	O
text	O
message	O
exposure	O
through	O
use	O
of	O
an	O
interaction	O
term	O
including	O
program	O
exposure	O
and	O
progression	O
to	O
follow	O
-	O
up	O
measurement	O
.	O

Abbreviations	O
AA	O
:	O
arachidonic	O
acid	O
;	O
BMI	O
:	O
body	O
mass	O
index	O
;	O
CAPE	O
:	O
community	O
assessment	O
of	O
psychic	O
experiences	O
;	O
CI	O
:	O
confidence	O
intervals	O
;	O
DHA	O
:	O
docosahexaenoic	O
acid	O
;	O
DPA	O
:	O
docosapentaenoic	O
acid	O
;	O
EPA	O
:	O
eicosapentaenoic	O
acid	O
;	O
FFQ	O
:	O
food	O
-	O
frequency	O
questionnaire	O
;	O
PCB	O
:	O
polychlorinated	O
biphenyls	O
;	O
PUFA	O
:	O
polyunsaturated	O
fatty	O
acids	O
;	O
RR	O
:	O
relative	O
risk	O
;	O
SD	O
:	O
standard	O
deviation	O
.	O

One	O
child	O
in	O
the	O
first	O
sample	O
(	O
1	O
week	O
after	O
the	O
first	O
dose	O
in	O
November	O
,	O
2008	O
)	O
and	O
one	O
in	O
the	O
spring	O
sample	O
(	O
a	O
month	O
after	O
the	O
second	O
dose	O
)	O
of	O
the	O
intervention	O
group	O
had	O
results	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
—	O
a	O
toxic	O
level	O
.	O
6	O
Discussion	O
Our	O
trial	O
in	O
a	O
population	O
known	O
to	O
be	O
vitamin	O
D	O
deficient	O
shows	O
that	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
of	O
vitamin	O
D3supplementation	O
once	O
every	O
3	O
months	O
did	O
not	O
affect	O
the	O
incidence	O
or	O
severity	O
of	O
childhood	O
pneumonia	O
,	O
in	O
this	O
population	O
.	O

As	B
compared	O
to	O
mothers	O
with	O
suboptimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
,	O
mothers	O
with	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
had	O
heavier	O
newborns	O
(	O
P	O
=	O
0	O
.	O
010	O
),	O
but	O
this	O
positive	O
association	O
was	O
not	O
verified	O
in	O
linear	O
regression	O
(	O
B	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
00	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
16	O
).	O

Outcome	O
Measures	O
We	O
used	O
two	O
principal	O
methods	O
to	O
measure	O
handwashing	O
behavior	O
:	O
rapid	O
assessments	O
of	O
the	O
presence	O
of	O
handwashing	O
materials	O
and	O
direct	O
(	O
structured	O
)	O
observations	O
.	O

Low	O
25OHD	O
at	O
the	O
first	O
antenatal	O
visit	O
was	O
not	O
associated	O
with	O
insulin	O
resistance	O
in	O
early	O
or	O
late	O
pregnancy	O
when	O
controlling	O
for	O
season	O
and	O
confounders	O
.	O

For	O
PCB	O
exposure	O
,	O
the	O
μβposterior	O
mean	O
was	O
0	O
.	O
2	O
g	O
,	O
95	O
%	O
CI	O
(-	O
9	O
,	O
10	O
).	O

In	O
the	O
entire	O
country	O
,	O
by	O
the	O
end	O
of	O
June	O
2013	O
,	O
1373349	O
AWCs	O
/	O
mini	O
-	O
AWCs	O
have	O
been	O
sanctioned	O
,	O
of	O
which	O
around	O
1339410	O
(	O
97	O
.	O
5	O
%)	O
are	O
operational	O
.	O

Handedness	O
has	O
been	O
shown	O
to	O
follow	O
a	O
gender	O
-	O
invariant	O
seasonal	O
pattern	O
,	O
with	O
more	O
left	O
-	O
handers	O
than	O
right	O
-	O
handers	O
born	O
between	O
March	O
and	O
July	O
[	O
177	O
,	O
178	O
].	O

First	O
,	O
we	O
did	O
not	O
have	O
information	O
regarding	O
exact	O
amounts	O
of	O
dietary	O
maternal	O
vitamin	O
D	O
intake	O
and	O
sun	O
exposure	O
that	O
may	O
affect	O
maternal	O
and	O
cord	O
blood	O
vitamin	O
D	O
levels	O
.	O

Antiepileptic	O
drugs	O
and	O
oral	O
supplements	O
may	O
play	O
a	O
role	O
in	O
later	O
onset	O
.	O

This	O
study	O
was	O
conducted	O
according	O
to	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
all	O
procedures	O
were	O
approved	O
by	O
the	O
Regional	O
Ethics	O
Committee	O
in	O
Gothenburg	O
,	O
Sweden	O
.	O

demonstrated	O
that	O
in	O
utero	O
exposure	O
to	O
the	O
environmental	O
chemical	O
vinclozolin	O
(	O
a	O
fungicide	O
used	O
in	O
the	O
wine	O
industry	O
)	O
reduced	O
sperm	O
quantity	O
,	O
quality	O
and	O
thus	B
male	O
fertility	O
with	O
a	O
>	O
90	O
%	O
penetrance	O
through	O
multiple	O
generations	O
(	O
to	O
at	B
least	I
the	O
F4generation	O
).	O

However	O
,	O
according	O
to	O
literature	O
data	O
and	O
our	O
own	O
experience	O
pregnancy	O
after	O
thyroid	O
cancer	O
has	O
been	O
shown	O
to	O
have	O
no	O
significant	O
effect	O
on	O
morbidity	O
,	O
disease	O
-	O
free	O
period	O
or	O
survival	O
time	O
.	O

An	O
earlier	O
study	O
by	O
Wilkerson	O
supports	O
this	O
finding	O
as	B
it	O
determined	O
that	O
birth	O
weight	O
was	O
a	O
factor	O
for	O
the	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
,	O
with	O
significant	O
associations	O
between	O
autism	O
and	O
gestational	O
age	O
,	O
maternal	O
morphology	O
and	O
intrauterine	O
stress	O
.	O

The	O
PBDE	O
μβestimate	O
was	O
-	O
4	O
g	O
,	O
95	O
%	O
CI	O
(-	O
31	O
,	O
22	O
).	O

The	O
data	O
show	O
adverse	O
effects	O
of	O
maternal	O
mental	O
illness	O
on	O
pregnancy	O
outcomes	O
and	O
infant	O
neurodevelopment	O
but	O
are	O
not	O
robust	O
enough	O
to	O
discourage	O
the	O
use	O
of	O
SSRIs	O
during	O
human	O
pregnancy	O
[	O
66	O
].	O

Primary	O
analyses	O
were	O
of	O
vaginally	O
delivered	O
infants	O
.	O

Thyroid	O
nodules	O
in	O
pregnancy	O
are	O
often	B
misdiagnosed	O
because	O
of	O
physiological	O
thyroid	O
increases	O
during	O
pregnancy	O
,	O
but	O
clinical	O
and	O
ultrasound	O
findings	O
are	O
sufficient	O
to	O
suspect	B
malignancy	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Adequacy	O
of	O
energy	O
intake	O
in	O
total	O
sample	O
and	O
stratified	O
by	O
the	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
PPBMI	O
)	O
classification	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
gestational	O
diabetes	O
mellitus	O
.	O

The	O
respective	O
biological	O
effects	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
and	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
the	O
etiology	O
of	O
psychiatric	O
symptoms	O
could	O
very	O
well	O
differ	O
and	O
the	O
balance	O
between	O
the	O
intakes	O
of	O
these	O
fatty	O
acids	O
might	O
be	O
of	O
importance	O
.	O

Thus	B
,	O
the	O
impact	O
of	O
early	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
needs	O
confirmation	O
in	O
a	O
larger	O
scale	O
trial	O
.	O

We	O
identified	O
the	O
week	O
of	O
pregnancy	O
in	O
which	O
participants	O
enrolled	O
using	O
the	O
assumption	O
of	O
a	O
40	O
-	O
week	O
gestation	O
period	O
and	O
subtracting	O
the	O
total	O
number	O
of	O
days	O
between	O
the	O
participant	O
’	O
s	O
date	O
of	O
enrollment	O
and	O
due	O
date	O
recorded	O
by	O
the	O
study	O
site	O
.	O

The	O
HFol	O
pup	O
diet	O
partially	O
brought	O
BDNF	O
to	O
the	O
control	O
level	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
lowered	O
SeroR2A	O
(	O
P	O
=	O
0	O
.	O
008	O
).	O

Although	O
cord	O
vitamin	O
D	O
levels	O
are	O
strongly	B
correlated	O
with	O
maternal	O
vitamin	O
D	O
levels	O
,	O
the	O
extent	O
of	O
the	O
impact	O
on	O
later	O
respiratory	O
function	O
is	O
distinctive	O
.	O

Methodology	O
2	O
.	O
1	O
.	O

Since	B
GR	O
is	O
present	O
as	O
different	O
isoforms	O
,	O
multiple	O
bands	O
were	O
observed	O
and	O
there	O
was	O
an	O
expected	O
interpatient	O
variation	O
in	O
the	O
protein	O
expression	O
.	O

The	O
secondary	O
objective	O
was	O
to	O
further	O
clarify	O
the	O
effect	O
on	O
the	O
risk	O
of	O
eczema	O
,	O
wheezing	O
,	O
and	O
respiratory	O
tract	O
infections	O
in	O
early	O
life	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

Adjusted	O
analyses	O
included	O
both	O
variables	O
known	O
to	O
be	O
related	O
to	O
the	O
infant	O
gut	O
microbiome	O
by	O
previous	O
studies	O
and	O
variables	O
significantly	O
related	O
to	O
infant	O
gut	O
microbiota	O
in	O
our	O
population	O
to	O
control	O
confounding	O
.	O

This	O
fact	O
agrees	O
with	O
the	O
increased	O
body	O
weight	O
and	O
the	O
higher	O
plasma	O
levels	O
of	O
leptin	O
in	O
RC	O
male	O
offspring	O
despite	O
of	O
the	O
absence	O
of	O
hyperphagia	O
or	O
alterations	O
in	O
hypothalamic	O
endocannabinoid	O
machinery	O
.	O

On	O
the	O
first	O
day	O
,	O
the	O
Baecke	O
questionnaire	O
was	O
administered	O
and	O
body	O
composition	O
was	O
assessed	O
.	O

Findings	O
from	O
other	O
studies	O
on	O
routine	O
daily	O
or	O
weekly	O
antenatal	O
iron	O
or	O
iron	O
plus	O
folic	O
acid	O
supplementation	O
showed	O
that	O
it	O
may	O
be	O
of	O
benefit	O
,	O
especially	O
where	O
pregestational	O
iron	O
deficiency	O
and	O
anaemia	O
are	O
prevalent	O
[	O
7	O
].	O

Nearly	O
half	O
of	O
the	O
participants	O
(	O
47	O
.	O
8	O
%,	O
451	O
/	O
943	O
)	O
reported	O
having	O
had	O
a	O
prior	O
live	O
birth	O
.	O

If	O
the	O
proportion	O
of	O
non	O
-	O
urbanized	O
participants	O
was	O
high	O
in	O
the	O
study	O
population	O
this	O
could	O
have	O
confounded	O
our	O
results	O
,	O
nevertheless	O
this	O
is	O
not	O
the	O
case	O
in	O
the	O
Swedish	O
population	O
.	O

Indeed	O
,	O
murine	O
spermatozoal	O
miRNAs	O
and	O
/	O
or	O
esiRNAs	O
have	O
been	O
shown	O
to	O
function	O
in	O
fertilization	O
and	O
early	O
embryo	O
development	O
(	O
Liu	O
et	O
al	O
.	O
2012	O
,	O
2016	O
;	O
Yuan	O
et	O
al	O
.	O
2016	O
),	O
and	O
to	O
influence	O
phenotypic	O
outcomes	O
in	O
subsequent	O
progeny	O
(	O
Rassoulzadegan	O
et	O
al	O
.	O
2006	O
;	O
Wagner	O
et	O
al	O
.	O
2008	O
;	O
Grandjean	O
et	O
al	O
.	O
2009	O
).	O

Most	O
marbling	O
fat	O
is	O
deposited	O
between	O
muscle	O
fibre	O
bundles	O
in	O
the	O
perimysial	O
connective	O
tissue	O
in	O
beef	O
cattle	O
[	O
4	O
].	O

They	O
were	O
also	O
asked	O
to	O
attend	O
weekly	O
supplementation	O
clinics	O
held	O
in	O
their	O
own	O
villages	O
when	O
they	O
were	O
re	O
-	O
supplied	O
with	O
supplements	O
.	O

The	O
physiological	O
response	O
to	O
sunlight	O
exposure	O
,	O
beyond	O
that	O
of	O
vitamin	O
D	O
production	O
,	O
includes	O
regulation	O
of	O
biological	O
circadian	O
and	O
circannual	O
rhythms	O
,	O
control	O
of	O
circulating	O
melatonin	O
,	O
as	O
well	O
as	O
production	O
of	O
nitric	O
oxide	O
,	O
a	O
vasodilator	O
,	O
and	O
beta	O
-	O
endorphins	O
which	O
promote	O
a	O
feeling	O
of	O
well	O
-	O
being	O
[	O
11	O
–	O
13	O
].	O

Packages	O
usually	O
are	O
initially	O
comprised	O
of	O
the	O
essential	O
interventions	O
and	O
then	O
increase	O
in	O
complexity	O
over	O
time	O
according	O
to	O
local	O
needs	O
and	O
capacity	O
.	O

The	O
standard	O
text4baby	O
message	O
libraries	O
are	O
summarized	O
on	O
the	O
text4baby	O
website	O
[	O
37	O
].	O

Subjects	O
The	O
study	O
population	O
consisted	O
of	O
pregnant	O
women	O
attending	O
the	O
Department	O
of	O
Obstetrics	O
and	O
Gynaecology	O
,	O
University	O
Hospital	O
,	O
University	O
of	O
Crete	O
.	O

We	O
will	O
identify	O
and	O
confirm	O
pregnant	O
women	O
in	O
the	O
control	O
clusters	O
using	O
methods	O
similar	O
to	O
those	O
described	O
for	O
the	O
intervention	O
arm	O
.	O

GR	O
β	O
differs	O
from	O
GR	O
α	O
on	O
the	O
C	O
-	O
terminus	O
of	O
the	O
receptor	O
protein	O
.	O

All	O
statistical	O
analyses	O
were	O
performed	O
using	O
the	O
R	O
statistical	O
package	O
(	O
version	O
2	O
.	O
10	O
;	O
http	O
://	O
www	O
.	O
r	O
-	O
project	O
.	O
org	O
),	O
and	O
the	O
R	O
function	O
was	O
made	O
available	O
on	O
the	O
GSEA	O
website	O
,	O
using	O
permutation	O
tests	O
as	O
described	O
bySubramanian	O
et	O
al	O
.	O

Treat	O
women	O
,	O
newborns	O
and	O
children	O
with	O
respect	O
and	O
sensitivity	O
.	O

However	O
,	O
it	O
is	O
argued	O
that	O
cost	O
benefit	O
of	O
intravenous	O
iron	O
prophylaxis	O
may	O
be	O
large	O
taking	O
into	O
consideration	O
the	O
opportunity	O
costs	O
of	O
erythropoiesis	O
-	O
stimulating	O
agents	O
,	O
blood	O
transfusions	O
,	O
and	O
hospitalization	O
[	O
25	O
].	O

The	O
comparison	O
of	O
neonatal	O
height	O
in	O
different	O
categories	O
of	O
maternal	O
dietary	O
patterns	O
showed	O
maternal	O
dietary	O
patterns	O
were	O
not	O
related	O
to	O
neonatal	O
height	O
in	O
all	O
crude	O
and	O
adjusted	O
models	O
.	O

β	O
:	O
Parameter	O
estimate	O
indicating	O
the	O
alteration	O
in	O
HRV	O
components	O
caused	O
by	O
one	O
unit	O
of	O
change	O
in	O
the	O
independent	O
variable	O
;	O
SE	O
:	O
Standard	O
error	O
;	O
CI	O
:	O
Confidence	O
interval	O
;	O
BMI	O
—	O
Body	O
Mass	O
Index	O
;	O
RMSSD	O
—	O
Root	O
Mean	O
Square	O
of	O
Successive	O
Differences	O
;	O
pNN50	O
—	O
Percentage	O
of	O
Differences	O
Between	O
Adjacent	O
Normal	O
-	O
to	O
-	O
Normal	O
Intervals	O
that	O
is	O
Greater	O
than	O
50	O
Milliseconds	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

More	O
detailed	O
data	O
about	O
issues	O
during	O
pregnancy	O
should	O
be	O
obtained	O
in	O
an	O
attempt	O
to	O
identify	O
specific	O
periods	O
during	O
gestation	O
that	O
are	O
important	O
for	O
the	O
programming	O
of	O
the	O
fetal	O
autonomic	O
system	O
.	O

A	O
2016	O
report	O
of	O
nationwide	O
pooled	O
data	O
in	O
Korean	O
cattle	O
revealed	O
that	O
the	O
majority	O
(	O
76	O
%)	O
of	O
bulls	O
had	O
a	O
QG	O
3	O
,	O
whereas	O
85	O
.	O
5	O
%	O
of	O
castrated	O
cattle	O
showed	O
grades	O
of	O
QG	O
1	O
or	O
higher	O
(	O
QG1	O
,	O
QG1	O
+,	O
and	O
QG1	O
++)	O
([	O
59	O
];	O
Figure	O
2	O
).	O

Children	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
mean	O
calcium	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
mean	O
albumin	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
as	O
well	O
as	O
higher	O
mean	O
PTH	O
concentrations	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
than	O
controls	O
.	O

This	O
very	O
recent	O
report	O
correlates	O
well	O
with	O
a	O
2007	O
CDC	O
report	O
(	O
13	O
),	O
which	O
found	O
a	O
similar	O
increased	O
risk	O
for	O
the	O
wealthy	O
and	O
well	O
-	O
educated	O
,	O
findings	O
the	O
authors	O
tried	O
but	O
could	O
not	O
dismiss	O
as	O
being	O
because	B
of	O
ascertainment	O
bias	O
.	O

Intravenous	O
epinephrine	O
may	O
be	O
required	O
despite	O
its	O
potential	O
to	O
cause	O
decreased	O
uteroplacental	O
blood	O
flow	O
.	O

Infant	O
skin	O
prick	O
tests	O
are	O
performed	O
at	O
phases	O
7	O
and	O
8	O
by	O
a	O
medical	O
doctor	O
according	O
to	O
the	O
procedure	O
described	O
in	O
the	O
Allergy	O
Society	O
of	O
South	O
Africa	O
’	O
s	O
position	O
statement	O
on	O
skin	O
prick	O
testing	O
[	O
49	O
].	O

The	O
benefits	O
of	O
such	O
inheritance	O
are	O
obvious	O
and	O
even	O
Darwin	O
himself	O
proposed	O
a	O
hypothetical	O
mechanism	O
for	O
the	O
transmission	O
of	O
somatic	O
tissue	O
characteristics	O
via	O
the	O
germ	O
cells	O
to	O
subsequent	O
generations	O
,	O
which	O
he	O
termed	O
pangenesis	O
(	O
Darwin1868	O
).	O

The	O
high	O
frequency	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
developing	O
countries	O
has	O
substantial	O
health	O
and	O
economic	O
cost	O
implications	O
.	O

Methods	O
The	O
current	O
prospective	O
observational	O
study	O
is	O
based	O
on	O
the	O
data	O
collected	O
from	O
812	O
pregnant	O
women	O
.	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

A	O
seasonal	O
peak	O
evident	O
in	O
the	O
general	O
population	O
may	O
not	O
behave	O
uniformly	O
within	O
certain	O
subpopulations	O
.	O

None	O
of	O
the	O
remaining	O
GR	O
polymorphism	O
subgroups	O
demonstrated	O
any	O
differential	O
correlations	O
between	O
maternal	O
attitudes	O
and	O
fetal	O
weight	O
(	O
data	O
not	O
shown	O
).	O

In	O
the	O
analyses	O
stratified	O
to	O
infants	O
born	O
vaginally	O
and	O
adjusted	O
for	O
other	O
potential	O
confounders	O
,	O
maternal	O
fruit	O
intake	O
was	O
associated	O
with	O
infant	O
gut	O
microbial	O
community	O
structure	O
(	O
PERMANOVA	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

Evaluation	O
of	O
the	O
reasons	O
why	O
55	O
.	O
2	O
%	O
of	O
respondents	O
changed	O
their	O
ANC	O
site	O
,	O
revealed	O
that	O
the	O
change	O
of	O
residence	O
,	O
closeness	O
to	O
the	O
health	O
facility	O
and	O
the	O
quality	O
of	O
care	O
offered	O
at	O
the	O
previous	O
site	O
were	O
the	O
predominant	O
reasons	O
.	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	O
might	O
also	O
increase	O
the	O
likelihood	B
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

When	O
compared	O
to	O
normal	O
weight	O
women	O
,	O
the	O
chance	O
of	O
developing	O
the	O
disease	O
steadily	O
increases	O
in	O
those	O
who	O
are	O
overweight	O
,	O
obese	O
and	O
severely	O
obese	O
.	O

More	O
detailed	O
questions	O
were	O
asked	O
about	O
daily	O
consumption	O
of	O
a	O
further	O
eight	O
basic	O
foods	O
(	O
including	O
sugar	O
,	O
coffee	O
and	O
tea	O
).	O

Consistent	O
with	O
these	O
observations	O
,	O
genes	O
associated	O
with	O
lipid	O
metabolism	O
were	O
found	O
to	O
be	O
altered	O
at	O
pre	O
-	O
and	O
postnatal	O
stages	O
in	O
rodents	O
,	O
where	O
the	O
LP	O
model	O
was	O
studied	O
intensively	O
[	O
44	O
-	O
49	O
].	O

Three	O
factors	O
were	O
considered	O
major	O
dietary	O
patterns	O
.	O

Nucleotide	O
polymorphism	O
of	O
the	O
β	O
2	O
adrenergic	O
receptor	O
gene	O
has	O
also	O
been	O
implicated	O
as	O
risk	O
factors	O
for	O
autism	O
,	O
namely	O
,	O
Gly	O
16	O
and	O
Glu	O
27	O
[	O
24	O
,	O
25	O
].	O

The	O
composition	O
(	O
in	O
g	O
/	O
kg	O
)	O
of	O
the	O
RV	O
AIN	O
-	O
93G	O
diet	O
is	O
529	O
.	O
5	O
cornstarch	O
,	O
200	O
casein	O
,	O
100	O
sucrose	O
,	O
70	O
soybean	O
oil	O
,	O
50	O
cellulose	O
,	O
10	O
vitamin	O
mixture	O
,	O
35	O
mineral	O
mixture	O
,	O
3	O
L	O
-	O
cystine	O
,	O
2	O
.	O
5	O
choline	O
bitartarate	O
and	O
0	O
.	O
014	O
tert	O
-	O
butyl	O
hydroquinone	O
.	O

Changes	O
in	O
height	O
with	O
age	O
This	O
was	O
carried	O
out	O
separately	O
for	O
boys	O
and	O
girls	O
.	O

All	O
analyses	O
were	O
performed	O
in	O
Stata	O
v14	O
.	O
2	O
(	O
StataCorp	O
,	O
College	O
Station	O
,	O
TX	O
).	O

Inter	O
-	O
and	O
intra	O
-	O
assay	O
coefficients	O
of	O
variation	O
for	O
the	O
hip	O
and	O
spine	O
phantoms	O
were	O
1	O
%	O
or	O
less	O
.	O

Thus	B
,	O
both	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
gestational	O
vitamin	O
D	O
status	O
trajectory	O
can	O
be	O
suspected	B
to	O
play	O
a	O
role	O
in	O
healthy	O
pregnancy	O
.	O

At	O
the	O
first	O
postnatal	O
visit	O
(	O
phase	O
6	O
)	O
a	O
follow	O
-	O
up	O
is	O
made	O
on	O
the	O
maternal	O
medical	O
history	O
at	O
birth	O
.	O

Maternal	O
aMED	O
score	O
was	O
positively	O
associated	O
with	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
,	O
the	O
genus	O
Streptococcus	O
,	O
and	O
the	O
family	O
Clostridiaceae	O
,	O
and	O
negatively	O
with	O
OTUs	O
classified	O
to	O
the	O
species	O
Bacteroides	O
uniformis	O
,	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
the	O
species	O
Escherichia	O
coli	O
and	O
[	O
Ruminococcus	O
]	O
gnavus	O
(	O
Fig	O
.	O

Geneticists	O
have	O
found	O
genes	O
for	O
height	O
on	O
the	O
7th	O
,	O
8th	O
and	O
20th	O
chromosomes	O
,	O
as	O
well	O
as	O
on	O
the	O
X	O
chromosome	O
.	O

Standard	O
questionnaires	O
on	O
atopic	O
heredity	O
,	O
smoke	O
exposure	O
,	O
and	O
atopic	O
symptoms	O
were	O
answered	O
by	O
parents	O
or	O
legal	O
guardians	O
at	O
birth	O
and	O
6	O
months	O
.	O

Synthetic	O
folic	O
acid	O
does	O
not	O
occur	O
naturally	O
and	O
is	O
distinct	O
from	O
naturally	O
occurring	O
folic	O
acid	O
[	O
1	O
,	O
4	O
,	O
5	O
].	O

All	O
procedures	O
were	O
approved	O
by	O
the	O
appropriate	O
institutional	O
review	O
boards	O
at	O
Women	O
and	O
Infants	O
Hospital	O
and	O
at	O
Brown	O
University	O
,	O
and	O
participants	O
were	O
exempted	O
from	O
informed	O
consent	O
requirements	O
.	O

As	O
part	O
of	O
the	O
FFQ	O
,	O
the	O
participants	O
reported	O
how	O
often	O
,	O
on	O
average	O
,	O
they	O
ate	O
salmon	O
-	O
type	O
fish	O
(	O
Baltic	O
herring	O
,	O
herring	O
,	O
or	O
mackerel	O
),	O
white	O
fish	O
(	O
cod	O
,	O
saithe	O
,	O
or	O
pike	O
),	O
caviar	O
,	O
or	O
shellfish	O
(	O
e	O
.	O
g	O
.,	O
shrimp	O
):	O
never	O
-	O
seldom	O
,	O
1	O
-	O
3	O
times	O
/	O
month	O
,	O
1	O
time	O
/	O
week	O
,	O
2	O
times	O
/	O
week	O
,	O
3	O
-	O
4	O
times	O
/	O
week	O
,	O
5	O
-	O
6	O
times	O
/	O
week	O
,	O
1	O
time	O
/	O
day	O
,	O
2	O
times	O
/	O
day	O
or	O
3	O
times	O
/	O
day	O
.	O

In	O
addition	O
,	O
we	O
found	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
on	O
LBW	O
among	O
those	O
vaccinated	O
in	O
the	O
second	O
trimester	O
(	O
aOR	O
:	O
0	O
.	O
80	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
64	O
–	O
0	O
.	O
97	O
)	O
using	O
PSM	O
.	O

Obesogenic	O
phenotype	O
of	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
multivitamin	O
diet	O
is	O
prevented	O
by	O
a	O
post	O
-	O
weaning	O
high	O
multivitamin	O
or	O
high	O
folate	O
diet	O
Abstract	O
Background	O
High	O
multivitamin	O
(	O
10	O
-	O
fold	O
AIN	O
-	O
93G	O
,	O
HV	O
)	O
diets	O
fed	O
during	O
pregnancy	O
to	O
Wistar	O
rats	O
increase	O
characteristics	O
of	O
metabolic	O
syndrome	O
in	O
offspring	O
when	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

To	O
assess	O
the	O
potential	O
problem	O
of	O
multicollinearity	O
we	O
used	O
Pearsons	O
correlation	O
coefficient	O
or	O
Cramers	O
V	O
(	O
for	O
paired	O
categorical	O
variables	O
).	O

Results	O
A	O
total	O
of	O
1055	O
newborns	O
were	O
included	O
in	O
the	O
study	O
:	O
62	O
.	O
4	O
%	O
were	O
African	O
Americans	O
and	O
49	O
.	O
4	O
%	O
were	O
female	O
.	O

Methods	O
Animals	O
and	O
sample	O
collection	O
Animal	O
care	O
and	O
tissue	O
collection	O
processes	O
followed	O
the	O
guidelines	O
of	O
the	O
German	O
Law	O
of	O
Animal	O
Protection	O
and	O
the	O
experimental	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Care	O
Committee	O
of	O
the	O
State	O
Mecklenburg	O
-	O
Vorpommern	O
(	O
Landesamt	O
für	O
Landwirtschaft	O
,	O
Lebensmittelsicherheit	O
und	O
Fischerei	O
,	O
Mecklenburg	O
-	O
Vorpommern	O
,	O
Germany	O
;	O
LVL	O
MV	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
1	O
-	O
006	O
/	O
04	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
05	O
/	O
06	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
013	O
/	O
06	O
).	O

Additionally	O
,	O
maternal	O
red	O
and	O
processed	O
meat	O
was	O
positively	O
associated	O
with	O
OTUs	O
in	O
the	O
genus	O
Bifidobacterium	O
among	O
others	O
including	O
the	O
species	O
Escherichia	O
coli	O
and	O
the	O
genus	O
Enterococcus	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5e	O
).	O

Statistical	O
analyses	O
compared	O
cathelicidin	O
concentrations	O
with	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
various	O
time	O
points	O
(	O
maternal	O
levels	O
throughout	O
pregnancy	O
,	O
at	O
birth	O
,	O
and	O
child	O
’	O
s	O
current	O
level	O
);	O
and	O
with	O
race	O
/	O
ethnicity	O
,	O
age	O
,	O
gender	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
and	O
frequency	O
of	O
infections	O
using	O
Student	O
’	O
s	O
t	O
-	O
test	O
,	O
χ2	O
,	O
Wilcoxon	O
ranked	O
-	O
sum	O
analysis	O
,	O
and	O
multivariate	O
regression	O
.	O

There	O
is	O
variation	O
in	O
haemoglobin	O
levels	O
during	O
pregnancy	O
;	O
at	O
the	O
beginning	O
of	O
a	O
pregnancy	O
,	O
there	O
is	O
a	O
normal	O
reduction	O
in	O
haemoglobin	O
level	O
followed	O
by	O
a	O
slight	O
rise	O
towards	O
the	O
end	O
of	O
pregnancy	O
[	O
2	O
].	O

No	O
child	O
had	O
any	O
clinical	O
signs	O
of	O
endocrine	O
,	O
renal	O
or	O
cardiovascular	O
disease	O
.	O

As	O
it	O
is	O
not	O
expressed	O
in	O
mature	O
brown	O
adipocytes	O
,	O
BMP7	O
appears	O
to	O
exert	O
its	O
action	O
on	O
BAT	O
as	O
an	O
endocrine	O
factor	O
.	O

Considering	B
that	O
exposure	O
to	O
SGA	O
monotherapy	O
was	O
not	O
associated	O
with	O
birth	O
defects	O
in	O
our	O
cohort	O
and	O
that	O
the	O
majority	O
of	O
pregnant	O
women	O
with	O
psychiatric	O
disorders	O
are	O
on	O
psychotropic	O
drug	O
polytherapy	O
,	O
research	O
on	O
the	O
reproductive	O
safety	O
of	O
these	O
medications	O
should	O
reflect	O
this	O
reality	O
.	O

Our	O
novel	O
finding	O
of	O
the	O
association	O
between	O
season	O
and	O
insulin	O
resistance	O
,	O
independent	O
of	O
25OHD	O
,	O
could	O
reflect	O
circannual	O
rhythm	O
or	O
seasonal	O
lifestyle	O
behaviours	O
and	O
requires	O
further	O
exploration	O
.	O

The	O
AxinFu	O
mouse	O
may	O
,	O
therefore	B
,	O
represent	O
a	O
more	O
promising	B
reporter	O
model	O
in	O
the	O
development	O
of	O
regulatory	O
toxicological	O
assays	O
for	O
potential	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

However	O
,	O
these	O
prospects	O
are	O
threatened	O
by	O
side	O
effects	O
of	O
iron	O
supplements	O
,	O
low	O
utilization	O
of	O
maternal	O
health	O
service	O
in	O
developing	O
countries	O
,	O
partial	O
implementation	O
of	O
preventive	O
treatments	O
,	O
and	O
weak	O
infrastructure	O
and	O
political	O
commitment	O
to	O
implement	O
mass	O
fortification	O
of	O
local	O
staple	O
foods	O
by	O
national	O
governments	O
.	O

Introduction	O
Afghanistan	O
has	O
the	O
third	O
highest	O
mortality	O
of	O
children	O
younger	O
than	O
5	O
years	O
in	O
the	O
world	O
(	O
257	O
per	O
1000	O
livebirths	O
);	O
a	O
leading	O
cause	O
of	O
this	O
is	O
pneumonia	O
.	O

Data	O
Collection	O
Blood	O
samples	O
were	O
collected	O
from	O
the	O
antecubital	O
vein	O
and	O
a	O
general	O
questionnaire	O
about	O
socio	O
-	O
demographic	O
and	O
socio	O
-	O
economic	O
characteristics	O
,	O
smoking	O
and	O
alcohol	O
consumption	O
during	O
pregnancy	O
and	O
during	O
the	O
4	O
weeks	O
prior	O
to	O
the	O
interview	O
,	O
diseases	O
and	O
medication	O
and	O
use	O
of	O
food	O
supplements	O
was	O
completed	O
in	O
a	O
face	O
-	O
to	O
-	O
face	O
interview	O
conducted	O
by	O
the	O
study	O
nurse	O
.	O

In	O
the	O
first	O
dimension	O
,	O
rehydrated	O
strips	O
were	O
focused	O
using	O
an	O
ElectrophoretIQ3	O
isoelectric	O
focusing	O
system	O
(	O
Proteome	O
Systems	O
)	O
for	O
a	O
total	O
of	O
120	O
kVh	O
.	O

The	O
impact	O
of	O
nutritional	O
knowledge	O
on	O
the	O
use	O
of	O
folic	O
acid	O
was	O
emphasised	O
in	O
a	O
study	O
conducted	O
in	O
Turkey	O
,	O
where	O
factors	O
negatively	O
associated	O
with	O
pre	O
-	O
conception	O
supplementation	O
were	O
low	O
socio	O
-	O
economic	O
status	O
,	O
age	O
below	O
30	O
years	O
,	O
low	O
levels	O
of	O
education	O
and	O
unplanned	O
pregnancy	O
.	O

As	O
noted	O
,	O
we	O
received	O
information	O
on	O
enrollment	O
and	O
service	O
end	O
dates	O
,	O
and	O
from	O
those	O
data	O
determined	O
the	O
number	O
of	O
texts	O
delivered	O
to	O
participants	O
as	O
part	O
of	O
the	O
Madigan	O
study	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Interestingly	O
,	O
vitamin	O
D	O
status	O
at	O
T1	O
-	O
around	O
the	O
time	O
the	O
maternal	O
blood	O
flow	O
of	O
the	O
placenta	O
is	O
fully	O
developed	O
-	O
is	O
only	O
related	O
to	O
pregnancy	O
loss	O
.	O

4	O
.	O

However	O
,	O
the	O
sample	O
size	O
for	O
this	O
study	O
is	O
small	O
.	O

In	O
Tht111	O
I	O
CT	O
,	O
no	O
significant	O
correlations	O
were	O
noted	O
,	O
controlling	O
for	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
consumption	O
of	O
fast	O
food	O
during	O
pregnancy	O
.	O

BHLM	O
uses	O
shrinkage	O
estimation	O
to	O
bias	O
the	O
regression	O
coefficient	O
estimates	O
towards	O
the	O
group	O
mean	O
parameter	O
.	O

A	O
challenge	O
in	O
previous	O
studies	O
on	O
vitamin	O
D	O
status	O
and	O
GDM	O
has	O
been	O
the	O
lack	O
of	O
relevant	O
adjustments	O
,	O
for	O
example	O
adjustments	O
for	O
BMI	O
and	O
smoking	O
status	O
[	O
6	O
].	O

b	O
.	O

In	O
addition	O
,	O
the	O
attending	O
physician	O
should	O
bear	O
in	O
mind	O
that	O
some	O
symptoms	O
may	O
be	O
a	O
direct	O
result	O
of	O
pregnancy	O
and	O
not	O
allergy	O
related	O
,	O
for	O
example	O
,	O
vasomotor	O
rhinitis	O
in	O
the	O
last	O
trimester	O
[	O
51	O
]	O
and	O
gestational	O
urticaria	O
(	O
pruritic	O
urticarial	O
papules	O
and	O
plaques	O
in	O
pregnancy	O
)	O
[	O
52	O
].	O

Kidney	O
structure	O
Kidney	O
mass	O
(	O
KM	O
)	O
and	O
glomerular	O
diameter	O
(	O
GD	O
)	O
differed	O
between	O
the	O
VitD	O
-	O
and	O
SC	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

Additionally	O
,	O
those	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
are	O
more	O
likely	B
to	O
have	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
season	O
.	O

These	O
data	O
therefore	B
may	O
be	O
consistent	O
with	O
clinical	O
observations	O
that	O
that	O
lower	O
but	O
normal	O
birth	O
weight	O
followed	O
by	O
accelerated	O
weight	O
gain	O
up	O
to	O
age	O
8	O
is	O
associated	O
with	O
earlier	O
menarche	O
[	O
12	O
],[	O
13	O
].	O

Consistent	O
with	O
the	O
findings	O
from	O
the	O
qualitative	O
work	O
,	O
behavior	O
change	O
communicators	O
used	O
an	O
interactive	O
approach	O
to	O
validate	O
the	O
prevalent	O
perceived	O
susceptibility	O
of	O
the	O
neonatal	O
period	O
.	O

They	O
also	O
suggested	O
that	O
animals	O
deposit	O
fat	O
in	O
the	O
winter	O
to	O
provide	O
insulation	O
for	O
the	O
body	O
under	O
cold	O
stress	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
is	O
accepted	O
as	O
the	O
best	O
marker	O
of	O
vitamin	O
D	O
status	O
although	O
it	O
may	O
serve	O
primarily	B
as	O
a	O
marker	O
of	O
exposure	O
rather	O
than	O
clinical	O
outcomes	O
[	O
2	O
].	O
There	O
are	O
few	O
data	O
that	O
correlate	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
with	O
functional	O
outcomes	O
in	O
newborns	O
and	O
small	O
infants	O
.	O

However	O
,	O
several	O
limitations	O
merit	O
discussion	O
and	O
consideration	O
.	O

They	O
also	O
demonstrated	O
that	O
intake	O
of	O
prenatal	O
vitamins	O
at	O
the	O
vitamin	O
D	O
dose	O
of	O
400	O
IU	O
/	O
day	O
was	O
sufficient	O
to	O
prevent	O
vitamin	O
D	O
deficiency	O
but	O
was	O
not	O
high	O
enough	O
to	O
prevent	O
vitamin	O
D	O
insufficiency	O
.	O

Human	O
studies	O
examining	O
the	O
role	O
of	O
paternal	O
micronutrient	O
supplementation	O
are	O
scant	O
.	O

Finally	O
,	O
any	O
possible	O
reduction	O
in	O
the	O
incidence	O
of	O
pneumonia	O
in	O
our	O
trial	O
might	O
be	O
restricted	O
to	O
only	O
certain	O
genotypes	O
as	O
recorded	O
in	O
a	O
single	O
tt	O
genotype	O
after	O
the	O
start	O
of	O
our	O
trial	O
in	O
a	O
study	O
of	O
tuberculosis	O
.	O
20Both	O
the	O
pneumonia	O
treatment	O
and	O
the	O
population	O
supplementation	O
trials	O
need	O
to	O
be	O
repeated	O
in	O
other	O
settings	O
for	O
confirmation	O
,	O
and	O
frequent	O
determination	O
of	O
serum	O
calcifediol	O
concentrations	O
might	O
guide	O
the	O
interpretation	O
of	O
the	O
findings	O
.	O

The	O
study	O
protocol	O
has	O
been	O
described	O
previously	O
[	O
11	O
,	O
12	O
]	O
and	O
further	O
information	O
can	O
be	O
found	O
atwww	O
.	O
alspac	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
,	O
which	O
contains	O
details	O
of	O
all	O
the	O
data	O
that	O
are	O
available	O
(	O
www	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
/	O
alspac	O
/	O
researchers	O
/	O
data	O
-	O
access	O
/	O
data	O
-	O
dictionary	O
/).	O

These	O
metabolites	O
were	O
not	O
,	O
however	O
,	O
included	O
in	O
the	O
regression	O
models	O
as	B
they	O
were	O
strongly	B
correlated	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

This	O
review	O
concludes	O
with	O
a	O
discussion	O
highlighting	O
some	O
of	O
the	O
methodological	O
issues	O
in	O
researching	O
associations	O
between	O
diet	O
and	O
infant	O
neurodevelopment	O
.	O

Table2shows	O
the	O
interventions	O
included	O
in	O
the	O
LiST	O
analysis	O
that	O
prevent	O
preterm	O
births	O
and	O
improve	O
survival	O
of	O
premature	O
babies	O
.	O

For	O
girls	O
,	O
change	O
in	O
height	O
at	O
age	O
9	O
–	O
5	O
was	O
correlated	O
with	O
the	O
height	O
of	O
the	O
mother	O
,	O
p	O
=	O
0	O
.	O
008	O
,	O
and	O
height	O
of	O
the	O
father	O
,	O
p	O
=	O
0	O
.	O
031	O
.	O

Partial	O
adherence	O
to	O
the	O
model	O
of	O
care	O
may	O
have	O
attenuated	O
changes	O
in	O
medication	O
requirements	O
and	O
dietary	O
patterns	O
.	O

Women	O
who	O
had	O
participated	O
in	O
the	O
NICHD	O
trial	O
provided	O
their	O
written	O
informed	O
consent	O
.	O

The	O
goal	O
is	O
to	O
achieve	O
universal	O
,	O
equitable	O
coverage	O
and	O
high	O
quality	O
in	O
all	O
these	O
RMNCH	O
interventions	O
.	O

Larger	O
studies	O
are	O
needed	O
in	O
diverse	O
populations	O
at	O
various	O
latitudes	O
to	O
further	O
characterize	O
the	O
relationship	O
between	O
vitamin	O
D	O
supplementation	O
and	O
bone	O
mineral	O
content	O
.	O

In	O
addition	O
,	O
in	O
women	O
randomized	O
to	O
cholecalciferol	O
,	O
we	O
assessed	O
the	O
relationship	O
between	O
the	O
SNPs	O
and	O
the	O
change	O
in	O
vitamin	O
D	O
using	O
the	O
residuals	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
regressed	O
on	O
25	O
(	O
OH	O
)	O
D	O
at	O
14	O
weeks	O
of	O
gestation	O
as	O
the	O
outcome	O
.	O

Many	O
studies	O
have	O
indicated	O
a	O
link	O
between	O
smoking	O
during	O
pregnancy	O
and	O
the	O
offspring	O
'	O
s	O
subsequent	O
obesity	O
,	O
but	O
the	O
underlying	O
mechanism	O
has	O
not	O
been	O
established	O
.	O

The	O
effects	O
of	O
roughage	O
/	O
concentrate	O
ratio	O
on	O
body	O
fat	O
deposition	O
and	O
the	O
expression	O
of	O
angiogenic	O
and	O
adipogenic	O
factors	O
in	O
adipose	O
tissue	O
have	O
been	O
examined	O
in	O
fattening	O
Wagyu	O
steers	O
[	O
122	O
].	O

The	O
factors	O
were	O
rotated	O
by	O
varimax	O
rotation	O
function	O
.	O

Error	O
bars	O
are	O
standard	O
errors	O
.	O

Pre	O
-	O
and	O
Postnatal	O
Nutritional	O
Histories	O
Influence	O
Reproductive	O
Maturation	O
and	O
Ovarian	O
Function	O
in	O
the	O
Rat	O
Abstract	O
Background	O
While	O
prepubertal	O
nutritional	O
influences	O
appear	O
to	O
play	O
a	O
role	O
in	O
sexual	O
maturation	O
,	O
there	O
is	O
a	O
need	O
to	O
clarify	O
the	O
potential	O
contributions	O
of	O
maternal	O
and	O
childhood	O
influences	O
in	O
setting	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
.	O

Over	O
the	O
last	O
two	O
decades	O
,	O
there	O
has	O
been	O
a	O
substantial	O
global	O
reduction	O
in	O
under	O
-	O
5	O
child	O
mortality	O
rates	O
.	O

Moreover	O
,	O
we	O
used	O
international	O
standards	O
to	O
define	O
the	O
variable	O
small	O
for	O
gestational	O
age	O
[	O
36	O
]	O
and	O
validated	O
it	O
with	O
a	O
World	O
Health	O
Organization	O
calculator	O
to	O
estimate	O
SGA	O
[	O
56	O
];	O
results	O
were	O
consistent	O
for	O
both	O
(	O
data	O
not	O
shown	O
).	O

Of	O
current	O
concern	O
in	O
developed	O
countries	O
are	O
the	O
rising	O
rates	O
of	O
obesity	O
[	O
30	O
]	O
and	O
gestational	O
diabetes	O
,	O
both	O
of	O
which	O
produce	O
offspring	O
who	O
develop	O
obesity	O
[	O
31	O
]–[	O
35	O
].	O

Associations	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
the	O
SNPs	O
were	O
assessed	O
by	O
linear	O
regression	O
using	O
an	O
additive	O
model	O
[	O
β	O
represents	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
per	O
additional	O
common	O
allele	O
].	O

After	O
the	O
six	O
-	O
week	O
period	O
,	O
the	O
mice	O
were	O
mated	O
overnight	O
.	O

However	O
,	O
a	O
limitation	O
of	O
50	O
%	O
CIs	O
when	O
used	O
for	O
multiple	O
frequentist	O
hypothesis	O
tests	O
is	O
that	O
they	O
have	O
a	O
higher	O
Type	O
I	O
error	O
rate	O
than	O
using	O
alpha	O
level	O
=	O
0	O
.	O
05	O
.	O

During	O
the	O
subsequent	O
visits	O
,	O
the	O
app	O
will	O
provide	O
each	O
data	O
collector	O
with	O
a	O
list	O
of	O
women	O
,	O
for	O
whom	O
a	O
follow	O
-	O
up	O
visit	O
is	O
scheduled	O
within	O
seven	O
days	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
I	O
.	O
Physiological	O
changes	O
in	O
thyroid	O
function	O
during	O
pregnancy	O
.	O
IncreaseDecreaseHCG	O
(	O
TSH	O
–	O
like	O
effect	O
)	O
TSHTBG	O
,	O
serum	O
total	O
T	O
4	O
and	O
T3	O
,	O
T3	O
and	O
T4	O
pool	O
sizeHTGType	O
III	O
5	O
-	O
deiodinase	O
,	O
iodine	O
clearance	O
,	O
T3	O
and	O
T4	O
degradationThyroid	O
volume	O
Besides	O
the	O
well	B
-	I
known	I
association	O
between	O
gestational	O
hypothyroidism	O
and	O
impaired	O
intellectual	O
and	O
cognitive	O
development	O
in	O
offspring	O
,	O
untreated	O
or	O
inadequately	O
treated	O
and	O
subclinical	O
hypothyroidism	O
is	O
associated	O
with	O
foetal	O
loss	O
,	O
anaemia	O
,	O
gestational	O
hypertension	O
and	O
preeclampsia	O
,	O
abruption	O
placentae	O
,	O
increased	O
risk	O
of	O
miscarriage	O
,	O
foetal	O
growth	O
retardation	O
,	O
perinatal	O
mortality	O
and	O
neonatal	O
morbidity91315	O
-	O
172122	O
.	O

In	O
our	O
model	O
,	O
early	O
life	O
signals	O
of	O
high	O
fat	O
nutritional	O
conditions	O
led	O
to	O
accelerated	O
maturation	O
.	O

Questionnaire	O
The	O
questionnaire	O
included	O
demographic	O
information	O
(	O
age	O
,	O
race	O
,	O
living	O
environment	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
persons	O
in	O
the	O
household	O
,	O
delivery	O
hospital	O
),	O
antenatal	O
care	O
(	O
number	O
of	O
antenatal	O
visits	O
,	O
vaccinations	O
received	O
during	O
pregnancy	O
,	O
consumption	O
of	O
antenatal	O
supplements	O
),	O
presence	O
of	O
medical	O
conditions	O
prior	O
to	O
pregnancy	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
any	O
complications	O
during	O
pregnancy	O
(	O
hospitalization	O
for	O
any	O
specific	O
complication	O
such	O
as	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
,	O
or	O
influenza	O
-	O
like	O
illness	O
),	O
other	O
risk	O
factors	O
for	O
adverse	O
pregnancy	O
outcomes	O
(	O
alcohol	O
consumption	O
and	O
smoking	O
before	O
and	O
during	O
pregnancy	O
),	O
obstetric	O
characteristics	O
of	O
the	O
mother	O
(	O
number	O
of	O
parturitions	O
,	O
number	O
of	O
abortions	O
,	O
number	O
of	O
livebirths	O
and	O
stillbirths	O
,	O
type	O
of	O
delivery	O
),	O
and	O
characteristics	O
of	O
the	O
offspring	O
(	O
sex	O
,	O
weight	O
,	O
gestational	O
age	O
at	O
delivery	O
).	O

It	O
should	O
be	O
added	O
at	O
that	O
point	O
that	O
,	O
although	O
β3	O
adrenoceptors	O
are	O
expressed	O
in	O
humans	O
(	O
for	O
rev	O
.,	O
see	O
Mund	O
and	O
Frishman	O
,	O
2013	O
)	O
and	O
β3	O
agonists	O
are	O
potent	O
UCP1	O
activators	O
in	O
rodents	O
,	O
the	O
molecules	O
which	O
are	O
active	O
in	O
rodents	O
cannot	O
be	O
used	O
in	O
humans	O
due	O
to	O
inter	O
-	O
species	O
differences	O
.	O

Information	O
on	O
the	O
child	O
'	O
s	O
free	O
sugar	O
consumption	O
at	O
age	O
3	O
years	O
,	O
as	O
well	O
as	O
maternal	O
and	O
paternal	O
sugar	O
consumption	O
at	O
4	O
years	O
post	O
-	O
partum	O
,	O
was	O
collected	O
by	O
a	O
similar	O
FFQ	O
.	O

There	O
were	O
no	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
in	O
handwashing	O
with	O
water	O
alone	O
at	O
either	O
of	O
these	O
times	O
.	O

The	O
interventions	O
within	O
each	O
package	O
are	O
based	B
on	I
multiple	O
systematic	O
reviews	O
and	O
are	O
consistent	O
with	O
the	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
Essential	O
Interventions	O
report	O
[	O
23	O
].	O

The	O
3	O
′	O
UTR	O
of	O
GR	O
gene	O
(	O
NR3C1	O
)	O
were	O
acquired	O
from	O
NCBI	O
database	O
(	O
NM_001008481	O
.	O
1	O
).	O

Analysis	O
conducted	O
by	O
Mortality	O
Reduction	O
Goal	O
Group	O
and	O
Boston	O
Consulting	O
Group	O
using	O
multiple	O
data	O
sources	O
(	O
Liu	O
et	O
al	O
.,	O
2012	O
;	O
EIU	O
GDP	O
projections	O
2010	O
to	O
2030	O
;	O
World	O
Population	O
Prospects	O
,	O
2010	O
;	O
UN	O
Department	O
of	O
Economic	O
and	O
Social	O
Affairs	O
;	O
LiST	O
analysis	O
)	O
[	O
50	O
,	O
52	O
,	O
53	O
].	O

The	O
2005	O
autism	O
prevalence	O
rate	O
among	O
school	O
-	O
aged	O
children	O
,	O
after	O
controlling	O
for	O
differences	O
in	O
population	O
size	O
,	O
demographic	O
characteristics	O
,	O
per	O
capita	O
income	O
and	O
state	O
,	O
was	O
higher	O
in	O
cloudy	O
areas	O
.	O

Regular	O
milk	O
drinkers	O
had	O
better	O
vitamin	O
D	O
concentrations	O
,	O
a	O
finding	O
supported	O
by	O
a	O
large	O
-	O
scale	O
clinical	O
study	O
observing	O
an	O
association	O
between	O
frequent	O
milk	O
consumption	O
and	O
increased	O
25	O
(	O
OH	O
)	O
D	O
[	O
33	O
].	O

A	O
detailed	O
description	O
of	O
the	O
study	O
methods	O
(	O
14	O
)	O
and	O
primary	O
findings	O
have	O
been	O
published	O
previously	O
(	O
7	O
).	O

Advantage	O
of	O
this	O
questionnaire	O
is	O
that	O
it	O
focuses	O
on	O
psychological	O
signs	O
of	O
depression	O
rather	O
than	O
physical	O
signs	O
[	O
36	O
].	O

Interaction	O
between	O
time	O
and	O
diet	O
,	O
time	O
and	O
sex	O
,	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
were	O
also	O
significant	O
[	O
F	O
(	O
16	O
,	O
58	O
)=	O
1	O
.	O
83	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
72	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
2	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
].	O

Over	O
three	O
-	O
quarters	O
of	O
premature	O
babies	O
who	O
die	O
could	O
be	O
saved	O
if	O
basic	O
care	O
reached	O
them	O
and	O
their	O
mothers	O
.	O

For	O
mapping	O
,	O
a	O
total	O
of	O
six	O
mice	O
for	O
each	O
of	O
the	O
visible	O
phenotypes	O
were	O
used	O
in	O
a	O
SNP	O
panel	O
with	O
708	O
markers	O
polymorphic	O
between	O
129	O
and	O
DBA	O
/	O
2J	O
strains	O
across	O
the	O
entire	O
genome	O
.	O

Maternal	O
characteristics	O
in	O
Table	O
1are	O
described	O
only	O
as	O
un	O
-	O
imputed	O
values	O
.	O

Furthermore	O
,	O
inverse	O
relationships	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
both	O
fasting	O
glucose	O
and	O
fasting	O
insulin	O
have	O
been	O
shown	O
during	O
pregnancy	O
indicating	O
poorer	O
glycaemic	O
control	O
[	O
19	O
,	O
43	O
].	O

The	O
NAD	O
+	O
dependent	O
deacetylase	O
SIRT1	O
is	O
implicated	O
in	O
energy	O
balance	O
regulation	O
by	O
its	O
effect	O
on	O
pro	O
-	O
opiomelanocortin	O
and	O
agouti	O
-	O
related	O
peptide	O
(	O
AgRP	O
)	O
neurons	O
in	O
the	O
arcuate	O
nucleus	O
of	O
the	O
hypothalamusthis	O
(	O
20	O
).	O

This	O
treatment	O
has	O
been	O
widely	O
used	O
for	O
more	O
than	O
40	O
years	O
,	O
with	O
the	O
assumption	O
that	O
suppression	O
of	O
endogenous	O
TSH	O
deprives	O
TSH	O
-	O
dependent	O
DTC	O
cells	O
of	O
the	O
most	O
important	O
growth	O
factor	O
.	O

The	O
effect	O
of	O
high	O
vitamin	O
maternal	O
diets	O
on	O
chronic	O
disease	O
in	O
the	O
offspring	O
can	O
be	O
attributed	O
primarily	B
to	O
epigenetic	O
modulation	O
of	O
gene	O
expression	O
leading	O
to	O
programming	O
of	O
regulatory	O
systems	O
.	O
11Because	B
methyl	O
group	O
vitamins	O
,	O
and	O
specifically	O
folate	O
,	O
have	O
been	O
shown	O
to	O
participate	O
in	O
epigenetic	O
changes	O
through	O
its	O
functions	O
in	O
DNA	O
methylation	O
,	O
12we	O
also	O
fed	O
offspring	O
a	O
high	O
folate	O
(	O
HFol	O
)	O
diet	O
.	O

Confirmatory	O
allergy	O
tests	O
for	O
folic	O
acid	O
were	O
not	O
available	O
for	O
any	O
of	O
the	O
cases	O
.	O

MTC	O
is	O
somewhat	O
more	O
aggressive	O
than	O
papillary	O
or	O
follicular	O
carcinoma	O
.	O

For	O
the	O
microarray	O
experiments	O
individual	O
biotin	O
-	O
labeled	O
cRNA	O
was	O
synthesised	O
by	O
the	O
Gene	O
Chip	O
3	O
'	O
Express	O
Kit	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

However	O
,	O
children	O
with	O
S	O
-	O
ECC	O
may	O
experience	O
ongoing	O
pain	O
which	O
may	O
alter	O
their	O
eating	O
habits	O
.	O

However	O
,	O
it	O
could	O
be	O
argued	O
that	O
,	O
for	O
our	O
results	O
to	O
be	O
totally	O
spurious	O
in	O
those	O
included	O
in	O
our	O
analysis	O
(	O
and	O
for	O
the	O
associations	O
to	O
be	O
truly	O
null	O
in	O
the	O
population	O
as	O
a	O
whole	O
),	O
associations	O
in	O
the	O
excluded	O
mother	O
–	O
child	O
pairs	O
would	O
have	O
to	O
be	O
in	O
the	O
opposite	O
direction	O
and	O
much	O
stronger	O
,	O
compared	O
with	O
the	O
positive	O
associations	O
we	O
reported	O
in	O
the	O
included	O
mother	O
–	O
child	O
pairs	O
,	O
which	O
seems	O
extremely	O
unlikely	B
.	O

Antenatal	O
supplements	O
for	O
pregnant	O
women	O
have	O
to	O
be	O
accessed	O
at	O
the	O
Commune	O
Health	O
Station	O
,	O
which	O
is	O
generally	O
further	O
for	O
women	O
to	O
travel	O
.	O

Late	O
-	O
phase	O
reactions	O
are	O
observed	O
several	O
hours	O
to	O
days	O
after	O
allergen	O
contact	O
.	O

As	B
vitamin	O
D	O
levels	O
also	O
differed	O
by	O
race	O
,	O
we	O
stratified	O
the	O
models	O
predicting	O
SGA	O
by	O
race	O
and	O
examined	O
vitamin	O
D	O
deficiency	O
,	O
smoking	O
,	O
pre	O
-	O
eclampsia	O
,	O
maternal	O
age	O
,	O
Medicaid	O
status	O
and	O
BMI	O
at	O
delivery	O
as	O
covariates	O
(	O
Table	O
3	O
).	O

Infants	O
were	O
not	O
statistically	O
significantly	O
different	O
between	O
the	O
two	O
treatment	O
groups	O
with	O
regards	O
their	O
weight	O
(	O
Lifestyle	O
Advice	O
8	O
.	O
26	O
kg	O
(±	O
1	O
.	O
33	O
)	O
vs	O
.	O
Standard	O
Care	O
8	O
.	O
29	O
kg	O
(±	O
1	O
.	O
33	O
);	O
adjusted	O
mean	O
difference	O
(	O
aMD	O
)	O
−	O
0	O
.	O
05	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
16	O
to	O
0	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
38	O
),	O
weight	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
30	O
(±	O
1	O
.	O
13	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
34	O
(±	O
1	O
.	O
11	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
14	O
to	O
0	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
43	O
),	O
length	O
(	O
Lifestyle	O
Advice	O
68	O
.	O
24	O
cm	O
(±	O
3	O
.	O
76	O
)	O
vs	O
.	O
Standard	O
Care	O
68	O
.	O
28	O
cm	O
(±	O
4	O
.	O
13	O
);	O
aMD	O
−	O
0	O
.	O
12	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
41	O
to	O
0	O
.	O
16	O
;	O
p	O
=	O
0	O
.	O
41	O
),	O
length	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
06	O
(±	O
1	O
.	O
22	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
11	O
(±	O
1	O
.	O
28	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
16	O
to	O
0	O
.	O
07	O
;	O
p	O
=	O
0	O
.	O
46	O
),	O
weight	O
for	O
length	O
ratio	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
12	O
(±	O
0	O
.	O
01	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
12	O
(±	O
0	O
.	O
01	O
);	O
aMD	O
−	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
00	O
to	O
0	O
.	O
00	O
;	O
p	O
=	O
0	O
.	O
72	O
),	O
or	O
weight	O
for	O
length	O
ratio	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
44	O
(±	O
1	O
.	O
18	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
48	O
(±	O
1	O
.	O
14	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
15	O
to	O
0	O
.	O
07	O
;	O
p	O
=	O
0	O
.	O
47	O
).	O

Support	O
provided	O
by	O
NIMPE	O
:	O
source	O
NIMPE	O
financial	O
records	O
Health	O
care	O
system	O
costsNational	O
InstituteDistrict	O
Health	O
ServiceCommune	O
Health	O
ServiceVillage	O
Health	O
Workers	O
Source	O
:	O
NIMPE	O
financial	O
recordsAverage	O
DHW	O
income	O
(	O
USD260	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
11	O
%)	O
X	O
3	O
workers	O
/	O
district	O
X	O
7	O
districtsAverage	O
CHW	O
income	O
(	O
USD157	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
10	O
%)	O
X	O
175	O
communesAverage	O
VHW	O
income	O
(	O
USD13	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
30	O
%)	O
X	O
2000	O
individualsNon	O
-	O
salary	O
costs	O
are	O
also	O
incurred	O
at	O
each	O
level	O
(	O
obtained	O
from	O
worker	O
surveys	O
)	O
CHW	O
=	O
commune	O
health	O
worker	O
,	O
DHW	O
=	O
district	O
health	O
worker	O
,	O
VHW	O
=	O
village	O
health	O
worker	O
.	O

1	O
.	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

Once	O
Upon	O
a	O
Mine	O
:	O
The	O
Legacy	O
of	O
Uranium	O
on	O
the	O
Navajo	O
Nation	O
On	O
a	O
low	O
,	O
windswept	O
rise	O
at	O
the	O
southeastern	O
edge	O
of	O
the	O
Navajo	O
Nation	O
,	O
Jackie	O
Bell	O
-	O
Jefferson	O
prepares	O
to	O
move	O
her	O
family	O
from	O
their	O
home	O
for	O
a	O
temporary	O
stay	O
that	O
could	O
last	O
up	O
to	O
seven	O
years	O
.	O

In	O
asthmatic	O
children	O
,	O
episodes	O
of	O
acute	O
exacerbation	O
relating	O
to	O
respiratory	O
infection	O
were	O
also	O
inversely	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
[	O
49	O
].	O

In	O
sheep	O
,	O
the	O
mother	O
'	O
s	O
diet	O
during	O
pregnancy	O
determines	O
the	O
size	O
of	O
the	O
placenta	O
and	O
can	O
affect	O
both	O
the	O
BAT	O
and	O
WAT	O
mass	O
,	O
depending	O
on	O
the	O
timing	O
and	O
the	O
nature	O
of	O
the	O
diet	O
perturbation	O
.	O

Nutritional	O
knowledge	O
as	O
a	O
determinant	O
of	O
vitamin	O
and	O
mineral	O
supplementation	O
during	O
pregnancy	O
Abstract	O
Background	O
Pregnancy	O
is	O
a	O
critical	O
period	O
for	O
both	O
woman	O
and	O
baby	O
from	O
a	O
nutritional	O
perspective	O
.	O

The	O
amplification	O
was	O
conducted	O
in	O
duplicate	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
using	O
10	O
μM	O
of	O
each	O
primer	O
.	O

The	O
infectious	O
morbidity	O
symptoms	O
assessed	O
are	O
fever	O
,	O
headache	O
,	O
diarrhoea	O
,	O
nasal	O
discharge	O
and	O
coughing	O
.	O

3	O
.	O
4	O
.	O

Vitamin	O
D	O
requirement	O
during	O
pregnancy	O
Thyroidectomised	O
patients	O
often	B
need	O
calcium	O
and	O
D	O
vitamin	O
supplementation	O
,	O
and	O
the	O
treatment	O
needs	O
frequent	O
adjustment	O
during	O
the	O
pregnancy	O
to	O
prevent	O
maternal	O
and	O
neonatal	O
hypocalcemia	O
.	O

Vitamin	O
D	O
Effect	O
on	O
In	O
Vitro	O
Fertilization	O
VD	O
insufficiency	O
has	O
been	O
in	O
the	O
spotlight	O
of	O
in	O
vitro	O
fertilization	O
(	O
IVF	O
)	O
researchers	O
for	O
many	O
years	O
.	O

Virtually	O
any	O
person	O
treated	O
with	O
any	O
dosage	O
of	O
I	O
-	O
131	O
is	O
at	O
potential	O
risk	O
,	O
but	O
experimental	O
evidence	O
in	O
animals	O
and	O
follow	O
-	O
up	O
studies	O
in	O
humans	O
has	O
failed	O
to	O
reveal	O
any	O
statistically	O
significant	O
effects	O
of	O
I	O
-	O
131	O
on	O
chromosomal	O
abnormalities	O
,	O
congenital	O
malformation	O
or	O
childhood	O
cancers	O
.	O

Our	O
data	O
do	O
have	O
limitations	O
,	O
as	B
they	O
are	O
based	B
on	I
a	O
relatively	O
small	O
-	O
scale	O
cohort	O
with	O
differential	O
response	O
rates	O
at	O
each	O
sweep	O
and	O
the	O
numbers	O
of	O
measured	O
children	O
at	O
age	O
9	O
was	O
considerably	O
lower	O
than	O
in	O
the	O
previous	O
sweeps	O
.	O

Conclusions	O
Overall	O
,	O
we	O
have	O
demonstrated	O
that	O
altered	O
methylation	O
of	O
repetitive	O
elements	O
in	O
the	O
placenta	O
is	O
associated	O
with	O
birth	O
outcome	O
and	O
with	O
specific	O
environmental	O
exposures	O
encountered	O
by	O
the	O
fetus	O
.	O

More	O
than	O
half	O
of	O
the	O
surveyed	O
women	O
(	O
57	O
%)	O
reported	O
having	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
);	O
conditions	O
were	O
more	B
common	I
among	O
vaccinated	O
(	O
60	O
%)	O
than	O
unvaccinated	O
women	O
(	O
53	O
%)	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
).	O

LASSO	O
and	O
Elastic	O
Net	O
regression	O
coefficients	O
were	O
larger	O
in	O
size	O
but	O
with	O
less	O
precise	O
95	O
%	O
intervals	O
compared	O
to	O
BHLM	O
.	O

Ward	O
et	O
al	O
[	O
140	O
]	O
examined	O
nutrigenetic	O
interactions	O
between	O
the	O
alcohol	O
dehydrogenase	O
1C	O
(	O
ADH1C	O
)	O
single	O
nucleotide	O
polymorphism	O
(	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
)	O
and	O
vitamin	O
A	O
levels	O
and	O
the	O
impact	O
on	O
IMF	O
deposition	O
in	O
Angus	O
-	O
cross	O
steers	O
.	O

Such	O
reactivity	O
may	O
be	O
exacerbated	O
by	O
the	O
provision	O
of	O
handwashing	O
materials	O
and	O
promotion	O
of	O
handwashing	O
behavior	O
in	O
the	O
intervention	O
arm	O
.	O

PubMed	O
Central	O
:	O

Perceptions	O
about	O
the	O
knowledge	O
of	O
ANC	O
and	O
the	O
service	O
ratings	O
for	O
quality	O
were	O
compared	O
among	O
these	O
different	O
groups	O
using	O
the	O
Chi	O
-	O
squared	O
test	O
to	O
determine	O
associations	O
and	O
where	O
it	O
was	O
not	O
valid	O
,	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
was	O
used	O
.	O

2	O
.	O

Data	O
analysis	O
The	O
bioinformatic	O
analysis	O
was	O
done	O
in	O
R	O
[	O
65	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Summary	O
of	O
pregnancy	O
text4baby	O
text	O
messages	O
delivered	O
(	O
n	O
=	O
192	O
).	O
Text	O
message	O
delivery	O
variablesMean	O
(	O
SD	O
)	O
RangeTotal	O
number	O
of	O
messages	O
sent61	O
.	O
3	O
(	O
43	O
.	O
2	O
)	O
10	O
-	O
151Week	O
of	O
pregnancy	O
when	O
enrolled8	O
.	O
1	O
(	O
1	O
.	O
9	O
)	O
4	O
-	O
14Weeks	O
in	O
pregnancy	O
protocol12	O
.	O
6	O
(	O
10	O
.	O
9	O
)	O
0	O
-	O
33	O
.	O
7	O
Table	O
3presents	O
results	O
of	O
unadjusted	O
and	O
adjusted	O
versions	O
of	O
the	O
first	O
set	O
of	O
GEE	O
models	O
.	O

Moreover	O
,	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
caloric	O
intake	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
day	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3D	O
).	O

This	O
study	O
indicates	O
little	O
or	O
no	O
effect	O
of	O
reduced	O
maternal	O
energy	O
status	O
during	O
midgestation	O
on	O
offspring	O
IMF	O
deposition	O
and	O
muscle	O
mass	O
.	O

In	O
2012	O
,	O
similar	O
results	O
were	O
obtained	O
from	O
a	O
group	O
of	O
188	O
IVF	O
-	O
treated	O
females	O
in	O
a	O
tertiary	O
academic	O
center	O
.	O

Trial	O
registration	O
This	O
trial	O
has	O
been	O
registered	O
with	O
the	O
Australian	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ANZCTR	O
)	O
on	O
31	O
May	O
2012	O
.	O

Fish	O
Intake	O
during	O
Pregnancy	O
and	O
Foetal	O
Neurodevelopment	O
—	O
A	O
Systematic	O
Review	O
of	O
the	O
Evidence	O
Abstract	O
Fish	O
is	O
a	O
source	O
of	O
several	O
nutrients	O
that	O
are	O
important	O
for	O
healthy	O
foetal	O
development	O
.	O

In	O
the	O
literature	O
,	O
2	O
out	O
of	O
23	O
children	O
fathered	O
by	O
men	O
on	O
methotrexate	O
were	O
found	O
to	O
have	O
congenital	O
abnormalities	O
.	O

Season	O
of	O
Birth	O
and	O
Risk	O
for	O
Adult	O
Onset	O
Glioma	O
Abstract	O
Adult	O
onset	O
glioma	O
is	O
a	O
rare	O
cancer	O
which	O
occurs	O
more	O
frequently	O
in	O
Caucasians	O
than	O
African	O
Americans	O
,	O
and	O
in	O
men	O
than	O
women	O
.	O

There	O
is	O
limited	O
evidence	O
about	O
the	O
optimal	O
timing	O
of	O
IFA	O
supplementation	O
in	O
pregnancy	O
.	O

Groups	O
denoted	O
by	O
different	O
letters	O
are	O
significantly	O
different	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

The	O
published	O
GWAS	O
(	O
8	O
,	O
22	O
)	O
did	O
not	O
stratify	O
individuals	O
by	O
vitamin	O
D	O
supplement	O
usage	O
,	O
which	O
could	O
account	B
for	I
differing	O
associations	O
before	O
and	O
after	O
supplementation	O
in	O
our	O
cohort	O
,	O
or	O
the	O
differing	O
findings	O
might	O
reflect	O
the	O
lower	O
power	O
in	O
our	O
study	O
.	O

In	O
addition	O
,	O
many	O
of	O
these	O
interventions	O
,	O
such	O
as	O
obstetric	O
care	O
and	O
antibiotics	O
for	O
prelabour	O
premature	O
rupture	O
of	O
membranes	O
(	O
pPROM	O
),	O
also	O
benefit	O
maternal	O
health	O
and	O
prevent	O
stillbirths	O
[	O
8	O
].	O

Moreover	O
,	O
we	O
observed	O
a	O
sex	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perigonadal	O
fat	O
relative	O
to	O
body	O
weight	O
.	O

Steroids	O
were	O
immediately	O
extracted	O
into	O
ethyl	O
acetate	O
(	O
1	O
mL	O
).	O

Furthermore	O
,	O
the	O
literature	O
shows	O
some	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
adipose	O
tissue	O
development	O
,	O
and	O
other	O
studies	O
should	O
evaluate	O
such	O
effects	O
,	O
and	O
the	O
transgenerational	O
effects	O
.	O

Hence	B
,	O
pre	O
-	O
pregnancy	O
BMI	O
appears	O
to	O
be	O
a	O
determining	O
factor	O
in	O
creating	O
the	O
difference	O
and	O
the	O
amount	O
of	O
maternal	O
plasma	O
visfatin	O
during	O
pregnancy	O
,	O
which	O
can	O
predict	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
and	O
maternal	O
outcomes	O
.	O

Iron	O
deficiency	O
in	O
nonpregnant	O
populations	O
can	O
be	O
measured	O
quite	O
precisely	O
using	O
laboratory	O
tests	O
such	O
as	O
serum	O
ferritin	O
,	O
serum	O
iron	O
,	O
transferrin	O
,	O
transferrin	O
saturation	O
,	O
and	O
transferrin	O
receptors	O
[	O
7	O
].	O

The	O
MS	O
standard	O
ranges	O
from	O
1	O
to	O
9	O
in	O
Korea	O
[	O
59	O
].	O

Hypothalamic	O
Gene	O
Expression	O
Each	O
dissected	O
hypothalamus	O
was	O
homogenized	O
using	O
a	O
tissue	O
ruptor	O
homogenizer	O
(	O
Qiagen	O
Tech	O
.,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
).	O

This	O
study	O
reported	O
an	O
improved	O
verbal	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
in	O
offspring	O
aged	O
nine	O
years	O
in	O
children	O
born	O
to	O
mothers	O
who	O
consumed	O
up	O
to	O
two	O
servings	O
of	O
fish	O
per	O
week	O
compared	O
with	O
children	O
born	O
to	O
mothers	O
who	O
had	O
not	O
consumed	O
any	O
fish	O
during	O
late	O
pregnancy	O
(	O
32	O
weeks	O
gestation	O
).	O

A	O
population	O
-	O
based	O
study	O
in	O
Utah	O
(	O
US	O
)	O
looked	O
at	O
prenatal	O
variables	O
of	O
autistic	O
children	O
and	O
focused	O
on	O
gestational	O
weight	O
.	O

The	O
observation	O
that	O
early	O
registration	O
with	O
a	O
physician	O
in	O
pregnancy	O
was	O
associated	O
with	O
folic	O
acid	O
intake	O
could	O
indicate	O
the	O
recognised	B
importance	O
of	O
early	O
prenatal	O
care	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
expression	O
of	O
WT1	O
at	O
birth	O
in	O
either	O
the	O
F1	O
or	O
F2	O
generations	O
between	O
the	O
SC	O
and	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
two	O
-	O
way	O
ANOVA	O
).	O

As	O
expected	O
,	O
a	O
greater	O
proportion	O
of	O
CpGs	O
in	O
the	O
relatively	O
methylated	O
(	O
rightmost	O
)	O
classes	O
9	O
–	O
12	O
are	O
localized	O
in	O
repetitive	O
elements	O
(	O
Figure	O
2A	O
–	O
D	O
).	O

At	O
weaning	O
,	O
HF	O
offspring	O
weights	O
were	O
significantly	O
increased	O
compared	O
to	O
controls	O
(	O
Cont	O
59	O
.	O
1	O
±	O
0	O
.	O
7	O
g	O
,	O
MHF	O
66	O
.	O
3	O
±	O
0	O
.	O
9	O
g	O
,	O
PLHF	O
63	O
.	O
8	O
±	O
0	O
.	O
7	O
g	O
,	O
p	O
<	O
0	O
.	O
0001	O
and	O
p	O
<	O
0	O
.	O
05	O
versus	O
controls	O
respectively	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Offspring	O
birth	O
weights	O
and	O
neonatal	O
growth	O
curves	O
in	O
all	O
groups	O
.	O

The	O
research	O
done	O
by	O
Glasson	O
et	O
al	O
.	O

It	O
is	O
noted	O
that	O
the	O
detection	O
rate	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
study	O
is	O
19	O
.	O
4	O
%,	O
higher	O
than	O
the	O
usual	O
5	O
%	O
in	O
the	O
general	O
population	O
[	O
3	O
].	O

Program	O
dosage	O
and	O
optimization	O
research	O
should	O
be	O
included	O
to	O
address	O
other	O
features	O
of	O
the	O
mobile	O
phone	O
,	O
such	O
as	O
ubiquity	O
,	O
constant	O
use	O
,	O
and	O
potential	O
to	O
act	O
as	O
a	O
point	O
of	O
decision	O
prompt	O
.	O

At	O
follow	O
-	O
up	O
,	O
28	O
%	O
of	O
control	O
arm	O
(	O
30	O
/	O
106	O
)	O
and	O
36	O
%	O
(	O
40	O
/	O
110	O
)	O
of	O
intervention	O
said	O
that	O
someone	O
reminded	O
them	O
.	O

Although	O
the	O
measurement	O
scales	O
specific	O
for	O
the	O
PNA	O
syndrome	O
are	O
not	O
available	O
,	O
numerous	O
studies	O
have	O
found	O
that	O
use	O
of	O
SSRI	O
late	O
in	O
pregnancy	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
infants	O
developing	O
this	O
clinical	O
presentation	O
,	O
4445which	O
is	O
also	O
labelled	O
as	O
Prenatal	O
Antidepressant	O
Exposure	O
Syndrome	O
.	O
46The	O
three	O
remaining	O
neonates	O
in	O
our	O
cohort	O
who	O
displayed	O
PNA	O
symptoms	O
were	O
prenatally	O
exposed	O
to	O
an	O
SGA	O
but	O
not	O
to	O
an	O
SSRI	O
.	O

The	O
few	O
available	O
studies	O
investigating	O
the	O
reproductive	O
safety	O
of	O
SGAs	O
did	O
not	O
reach	O
conclusive	O
results	O
,	O
and	O
none	O
have	O
compared	O
monotherapy	O
with	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

Current	O
OECD	O
human	O
health	O
related	O
TGs	O
that	O
have	O
the	O
potential	O
for	O
adaptation	O
to	O
include	O
epigenetic	O
endpoints	O
.	O
Type	O
of	O
studyTGsDescriptionGeneral	O
exposure	O
studiesTG	O
451Carcinogenicity	O
studies	O
TG	O
452Chronic	O
toxicity	O
studies	O
TG	O
453Combined	O
chronic	O
toxicity	O
/	O
carcinogenicity	O
studiesPost	O
-	O
mitotic	O
cell	O
studiesTG	O
424Neurotoxicity	O
study	O
in	O
rodentsPrenatal	O
effectsTG	O
414Prenatal	O
development	O
toxicity	O
study	O
TG	O
426Developmental	O
neurotoxicity	O
studyReproductive	O
effectsTGs	O
415	O
,	O
416One	O
-	O
and	O
two	O
-	O
generation	O
reproduction	O
toxicity	O
TG	O
421	O
(	O
Revised	O
)	O
Reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
422	O
(	O
Revised	O
)	O
Combined	O
repeated	O
dose	O
toxicity	O
study	O
with	O
the	O
reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
443Extended	O
one	O
-	O
generation	O
reproductive	O
toxicity	O
studyGenotoxicity	O
testsTG	O
483	O
(	O
Revised	O
2015	O
)	O
Mammalian	O
spermatogonial	O
chromosome	O
aberration	O
testAlternative	O
models	O
integrating	O
multiple	O
mechanisms	O
of	O
toxicityTG	O
236	O
-	O
Zebrafish	O
embryo	O
epigenetic	O
toxicity	O
assay	O
Xenopus	O
Embryo	O
Thyroid	O
Assay	O
(	O
XETA	O
Assay	O
)	O
(	O
in	O
validation	O
)	O
Updated	O
from	O
Greally	O
and	O
Jacobs	O
(	O
2013	O
).	O

Moreover	O
,	O
another	O
study	O
,	O
18showed	O
that	O
a	O
single	O
dose	O
of	O
200	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
in	O
the	O
healthy	O
youths	O
was	O
associated	O
with	O
a	O
peak	O
in	O
vitamin	O
D	O
concentration	O
after	O
two	O
weeks	O
of	O
treatment	O
,	O
but	O
lower	O
than	O
that	O
of	O
our	O
study	O
at	O
three	O
months	O
after	O
treatment	O
.	O

In	O
their	O
cross	O
sectional	O
study	O
of	O
740	O
Canadians	O
(	O
323	O
men	O
and	O
417	O
women	O
),	O
Chaput	O
et	O
al	O
noted	O
that	O
short	O
sleep	O
duration	O
(<	O
7	O
hours	O
)	O
was	O
associated	O
with	O
prevalent	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
58	O
;	O
95	O
%	O
CI	O
1	O
.	O
13	O
-	O
2	O
.	O
31	O
)	O
[	O
33	O
].	O

Source	O
:	O
adapted	O
from	O
Born	O
Too	O
Soon	O
report	O
,	O
chapter	O
6	O
[	O
48	O
]	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
9	O
Government	O
-	O
national	O
integrated	O
campaign	O
for	O
preterm	O
births	O
.	O

High	O
educational	O
level	O
(	O
high	O
school	O
and	O
university	O
)	O
(	O
X2	O
=	O
8	O
.	O
714	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
first	O
time	O
pregnancy	O
(	O
X2	O
=	O
4	O
.	O
217	O
;	O
p	O
=	O
0	O
.	O
04	O
)	O
were	O
significantly	O
associated	O
with	O
poor	O
satisfaction	O
.	O

A	O
research	O
pipeline	O
to	O
address	O
preterm	O
birth	O
Greater	O
investment	O
in	O
research	O
and	O
,	O
in	O
particular	O
,	O
into	O
discovery	O
of	O
the	O
many	O
complex	O
and	O
interrelated	O
factors	O
causing	O
preterm	O
birth	O
is	O
needed	O
to	O
strengthen	O
prevention	O
and	O
offers	O
a	O
potential	O
over	O
the	O
longer	O
term	O
for	O
significant	O
reductions	O
in	O
mortality	O
,	O
childhood	O
disability	O
and	O
healthcare	O
expenditure	O
.	O

The	O
corresponding	O
correlation	O
between	O
the	O
child	O
and	O
the	O
father	O
was	O
also	O
significant	O
overall	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
a	O
wide	O
range	O
of	O
disorders	O
,	O
including	O
neuropsychiatric	O
disorders	O
and	O
autism	O
,	O
are	O
associated	O
with	O
increased	O
homocysteine	O
levels	O
in	O
biological	O
fluids	O
.	O

Autism	O
spectrum	O
disorders	O
in	O
childhood	O
have	O
also	O
been	O
observed	O
and	O
diagnosed	O
more	O
frequently	O
among	O
children	O
born	O
to	O
women	O
with	O
metabolic	O
conditions	O
identified	O
during	O
pregnancy	O
,	O
including	O
diabetes	O
and	O
obesity	O
[	O
47	O
].	O

The	O
interaction	O
between	O
low	O
birth	O
weight	O
and	O
reduction	O
in	O
parasympathetic	O
regulation	O
observed	O
in	O
the	O
present	O
study	O
occurs	O
independently	O
of	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

Nine	O
integrated	O
public	O
health	O
centres	O
which	O
accounted	O
for	O
about	O
two	O
thirds	O
of	O
the	O
total	O
study	O
population	O
were	O
selected	O
as	O
study	O
sites	O
.	O

Previous	O
studies	O
have	O
focused	O
on	O
cathelicidin	O
and	O
vitamin	O
D	O
concentrations	O
in	O
patient	O
populations	O
affected	O
by	O
various	O
illnesses	O
or	O
diseases	O
[	O
6	O
],	O
such	O
as	O
tuberculosis	O
[	O
7	O
],	O
pneumonia	O
[	O
8	O
],	O
sepsis	O
[	O
9	O
],	O
HIV	O
[	O
10	O
–	O
12	O
],	O
and	O
end	O
-	O
stage	O
renal	O
disease	O
hemodialysis	O
[	O
13	O
],	O
as	O
well	O
as	O
healthy	O
adult	O
populations	O
[	O
14	O
–	O
19	O
].	O

Some	O
validation	O
rules	O
will	O
be	O
set	O
in	O
the	O
application	O
to	O
prevent	O
errors	O
during	O
data	O
collection	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
for	O
the	O
subjects	O
in	O
the	O
IG	O
(	O
28	O
.	O
9	O
±	O
4	O
.	O
8	O
kg	O
/	O
m2	O
)	O
and	O
CG	O
(	O
27	O
.	O
9	O
±	O
3	O
.	O
6	O
kg	O
/	O
m2	O
)	O
(	O
table	O
1	O
).	O

The	O
hyperparameters	O
for	O
the	O
different	O
chemical	O
classes	O
were	O
assigned	O
uninformative	O
prior	O
distributions	O
:	O
μβnormal	O
with	O
mean	O
0	O
and	O
variance	O
105	O
,	O
and	O
σβnormal	O
with	O
mean	O
0	O
with	O
variance	O
105such	O
that	O
σβ	O
>	O
0	O
.	O

Statistical	O
analyses	O
Statistical	O
analyses	O
were	O
performed	O
in	O
R	O
(	O
v3	O
.	O
1	O
.	O
1	O
)	O
[	O
33	O
].	O

The	O
α	O
isoform	O
was	O
shown	O
to	O
regulate	O
adaptive	O
thermogenesis	O
,	O
whereas	O
the	O
β	O
isoform	O
appears	O
to	O
modulate	O
UCP1	O
expression	O
,	O
without	O
increasing	O
thermogenesis	O
(	O
Ribeiro	O
et	O
al	O
.,	O
2001	O
).	O

This	O
suggests	O
the	O
possibility	O
that	O
some	O
infants	O
who	O
would	O
never	O
have	O
developed	O
atopy	O
would	O
undergo	O
preventive	O
regimens	O
,	O
whereas	O
others	O
who	O
become	O
symptomatic	O
in	O
early	O
life	O
would	O
not	O
have	O
received	O
adequate	O
advice	O
.	O

We	O
defined	O
as	O
a	O
new	O
episode	O
of	O
pneumonia	O
an	O
episode	O
happening	O
15	O
days	O
or	O
longer	O
after	O
the	O
first	O
.	O

Model	O
adjusted	O
for	O
delivery	O
hospital	O
,	O
number	O
of	O
parturitions	O
,	O
education	O
level	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
number	O
of	O
antenatal	O
visits	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

A	O
cross	O
-	O
sectional	O
survey	O
during	O
the	O
high	O
-	O
risk	O
winter	O
months	O
in	O
2005	O
showed	O
that	O
greater	O
than	O
95	O
%	O
of	O
children	O
younger	O
than	O
5	O
years	O
in	O
a	O
socioeconomically	O
deprived	O
part	O
of	O
Kabul	O
had	O
serum	O
calcifediol	O
levels	O
of	O
less	O
than	O
37	O
·	O
5	O
nmol	O
/	O
L	O
.	O
12	O
On	O
the	O
basis	O
of	O
findings	O
that	O
vitamin	O
D	O
is	O
an	O
immunomodulator	O
,	O
that	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
pneumonia	O
,	O
and	O
that	O
quarterly	O
supplementation	O
had	O
better	O
compliance	O
than	O
daily	O
or	O
weekly	O
supplementation	O
,	O
13	O
,	O
14we	O
aimed	O
to	O
test	O
the	O
hypothesis	O
that	O
quarterly	O
100	O
000	O
IU	O
vitamin	O
D	O
supplementation	O
would	O
reduce	O
the	O
incidence	O
of	O
radiologically	O
confirmed	O
pneumonia	O
by	O
35	O
%	O
in	O
our	O
study	O
population	O
.	O

GSEA	O
analysis	O
.	O

Rodents	O
are	O
commonly	O
used	O
to	O
investigate	O
the	O
mechanisms	O
underlying	O
long	O
-	O
term	O
programming	O
of	O
energy	O
balance	O
in	O
the	O
offspring	O
.	O

Finally	O
,	O
supplementation	O
of	O
PUFA	O
,	O
especially	O
EPA	O
,	O
has	O
been	O
reported	O
to	O
be	O
of	O
possible	O
benefit	O
for	O
patients	O
with	O
schizophrenia	O
[	O
17	O
].	O

This	O
is	O
an	O
open	O
-	O
access	O
article	O
distributed	O
under	O
the	O
terms	O
of	O
the	O
Creative	O
Commons	O
Attribution	O
License	O
,	O
which	O
permits	O
unrestricted	O
use	O
,	O
distribution	O
,	O
and	O
reproduction	O
in	O
any	O
medium	O
,	O
provided	O
the	O
original	O
author	O
and	O
source	O
are	O
credited	O
.	O

Due	O
to	O
the	O
lack	O
of	O
conclusive	O
evidence	O
,	O
we	O
cannot	O
recommend	O
the	O
ubiquitous	O
use	O
of	O
prenatal	O
vitamins	O
,	O
in	O
particular	O
folate	O
,	O
in	O
men	O
attempting	O
to	O
plan	O
a	O
pregnancy	O
with	O
their	O
female	O
partner	O
at	O
this	O
time	O
.	O

An	O
OGTT	O
was	O
performed	O
at	O
gestational	O
weeks	O
10	O
to	O
40	O
between	O
October	O
2012	O
and	O
March	O
2014	O
,	O
and	O
the	O
results	O
were	O
collected	O
from	O
prenatal	O
maternity	O
cards	O
or	O
the	O
hospital	O
laboratory	O
database	O
.	O

An	O
above	O
average	O
level	O
of	O
nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
use	O
of	O
supplements	O
,	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
age	O
,	O
area	O
of	O
residence	O
or	O
formal	O
education	O
(	O
Table	O
5	O
),	O
but	O
also	O
when	O
the	O
interaction	O
effect	O
of	O
prenatal	O
care	O
and	O
formal	O
education	O
together	O
was	O
taken	O
into	O
consideration	O
(	O
Table	O
4	O
).	O

Between	O
birth	O
and	O
6	O
months	O
,	O
the	O
percentage	O
of	O
children	O
with	O
WFA	O
>	O
90th	O
percentile	O
declined	O
slightly	O
in	O
overweight	O
/	O
obese	O
mothers	O
(	O
from	O
19	O
.	O
6	O
%	O
to	O
17	O
.	O
6	O
%)	O
but	O
increased	O
from	O
7	O
%	O
to	O
15	O
%	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
(	O
Table	O
1	O
).	O

Infant	O
Neurodevelopment	O
:	O
The	O
infant	O
’	O
s	O
primary	O
caregiver	O
was	O
asked	O
to	O
complete	O
a	O
structured	O
Ages	O
and	O
Stages	O
Questionnaire	O
(	O
ASQ	O
)	O
[	O
31	O
],	O
reporting	O
five	O
domains	O
of	O
development	O
(	O
communication	O
,	O
gross	O
motor	O
,	O
fine	O
motor	O
,	O
problem	O
solving	O
,	O
and	O
personal	O
-	O
social	O
skills	O
).	O

Du	O
et	O
al	O
[	O
16	O
]	O
proposed	O
that	O
myogenic	O
,	O
adipogenic	O
,	O
and	O
fibrogenic	O
cells	O
are	O
derived	O
from	O
common	O
mesenchymal	O
progenitor	O
cells	O
.	O

Multianalyte	O
profiling	O
was	O
performed	O
on	O
the	O
Luminex	O
Magpix	O
system	O
(	O
Luminex	O
Corporation	O
Austin	O
,	O
USA	O
).	O

Interestingly	O
,	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
(	O
Table	O
5	O
).	O

The	O
BHLM	O
approach	O
has	O
advantages	O
compared	O
with	O
other	O
analytic	O
techniques	O
including	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

The	O
plasma	O
levels	O
of	O
leptin	O
were	O
measured	O
using	O
a	O
commercial	O
rat	O
leptin	O
ELISA	O
kit	O
(	O
Cat	O
.	O

We	O
have	O
shown	O
recently	O
that	O
feeding	O
a	O
diet	O
containing	O
10	O
-	O
fold	O
the	O
recommended	O
multivitamin	O
content	O
(	O
HV	O
)	O
to	O
Wistar	O
rats	O
during	O
pregnancy	O
results	O
in	O
increased	O
food	O
intake	O
,	O
obesity	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
in	O
both	O
adult	O
male4and	O
female5offspring	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

Efforts	O
to	O
reduce	O
allergen	O
exposure	O
immediately	O
after	O
birth	O
often	O
only	O
delay	O
the	O
onset	O
of	O
allergic	O
conditions	O
,	O
rather	O
than	O
preventing	O
it	O
,	O
suggesting	O
that	O
immunologic	O
memory	O
may	O
predate	O
birth	O
[	O
15	O
].	O

Women	O
in	O
the	O
highest	O
quartile	O
of	O
adherence	O
to	O
traditional	O
dietary	O
pattern	O
were	O
20	O
%	O
less	O
likely	B
to	O
have	O
short	O
height	O
infant	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
[	O
OR	O
0	O
.	O
80	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
34	O
-	O
1	O
.	O
85	O
),	O
P	O
<	O
0	O
.	O
93	O
]	O
in	O
the	O
final	O
adjusted	O
model	O
.	O

We	O
speculate	O
that	O
our	O
findings	O
may	O
imply	O
adaptive	O
responses	O
to	O
early	O
life	O
cues	O
predicted	O
by	O
a	O
life	O
-	O
history	O
approach	O
,	O
although	O
confirmation	O
of	O
these	O
predictions	O
requires	O
further	O
studies	O
to	O
assess	O
reproductive	O
fitness	O
.	O

did	O
not	O
find	O
an	O
association	O
between	O
season	O
and	O
gestational	O
diabetes	O
incidence	O
among	O
4942	O
British	O
women	O
between	O
1996	O
and	O
1997	O
[	O
28	O
].	O

All	O
data	O
are	O
collected	O
either	O
by	O
health	O
professionals	O
on	O
site	O
or	O
by	O
trained	O
fieldworkers	O
.	O

Interestingly	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
Ppar	O
γ	O
has	O
been	O
linked	O
to	O
inflammatory	O
processes	O
associated	O
with	O
obesity	O
and	O
insulin	O
resistance	O
(	O
Odegaard	O
et	O
al	O
.,	O
2007	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
),	O
an	O
issue	O
that	O
enhances	O
the	O
importance	O
of	O
the	O
inflammatory	O
responses	O
in	O
the	O
developmental	O
programming	O
.	O

Assuming	O
a	O
crude	O
birth	O
rate	O
of	O
23	O
per	O
1000	O
people	O
,	O
10	O
%	O
loss	O
of	O
pregnancies	O
before	O
birth	O
and	O
15	O
%	O
loss	O
to	O
follow	O
up	O
each	O
cluster	O
will	O
yield	O
300	O
births	O
over	O
15	O
months	O
,	O
and	O
this	O
will	O
be	O
sufficient	O
to	O
reach	O
the	O
desired	O
sample	O
size	O
.	O

Birth	O
Weight	O
and	O
Its	O
Relationship	O
with	O
the	O
Cardiac	O
Autonomic	O
Balance	O
in	O
Healthy	O
Children	O
Abstract	O
Several	O
studies	O
indicate	O
that	O
the	O
fetal	O
environment	O
plays	O
a	O
significant	O
role	O
in	O
the	O
development	O
of	O
cardiometabolic	O
disease	O
later	O
in	O
life	O
.	O

To	O
examine	O
similarities	O
in	O
the	O
genomic	O
context	O
of	O
the	O
CpGs	O
making	O
up	O
these	O
data	O
-	O
driven	O
RPMM	O
classes	O
,	O
we	O
examined	O
the	O
proportion	O
of	O
CpG	O
loci	O
associated	O
with	O
specific	O
DNA	O
sequence	O
features	O
within	O
each	O
class	O
,	O
including	O
location	O
within	O
a	O
repetitive	O
element	O
(	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
Alu	O
,	O
or	O
MIR	O
),	O
within	O
a	O
CGI	O
,	O
or	O
having	O
the	O
associated	O
gene	O
considered	O
a	O
PcG	O
protein	O
target	O
gene	O
(	O
Figure	O
2	O
).	O

These	O
were	O
then	O
further	O
evaluated	O
and	O
collated	O
to	O
provide	O
a	O
critical	O
review	O
that	O
summarizes	O
the	O
main	O
epigenetic	O
mechanisms	O
important	O
during	O
the	O
mammalian	O
life	O
cycle	O
,	O
evaluates	O
the	O
current	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodents	O
models	O
,	O
and	O
highlights	O
the	O
research	O
considerations	O
and	O
implications	O
of	O
this	O
emerging	O
knowledge	O
for	O
public	O
health	O
and	O
regulatory	O
toxicology	O
.	O

To	O
examine	O
gene	O
-	O
related	O
CpG	O
methylation	O
on	O
a	O
subset	O
of	O
the	O
samples	O
(	O
n	O
=	O
184	O
),	O
methylation	O
was	O
measured	O
at	O
27	O
,	O
578	O
CpG	O
loci	O
using	O
the	O
Infinium	O
HumanMethylation27	O
BeadArray	O
(	O
Illumina	O
,	O
San	O
Diego	O
,	O
CA	O
).	O

Considering	O
that	O
reports	O
that	O
polytherapy	O
do	O
not	O
commonly	O
alter	O
the	O
course	O
and	O
outcome	O
of	O
the	O
baseline	O
disorder	O
,	O
2224indications	O
for	O
polytherapy	O
in	O
pregnant	O
women	O
should	O
be	O
seriously	O
considered	O
and	O
made	O
on	O
an	O
individual	O
basis	O
following	O
a	O
thorough	O
risk	O
/	O
benefit	O
analysis	O
.	O

2005	O
).	O

Participants	O
Members	O
of	O
556	O
families	O
in	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
2001	O
–	O
2014	O
.	O

Recent	O
work	O
emphasizes	O
the	O
importance	O
of	O
non	O
-	O
classical	O
roles	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
and	O
the	O
placenta	O
.	O

Castrating	O
bulls	O
gener	B
ally	I
increases	O
IMF	O
content	O
in	O
several	O
breeds	O
,	O
including	O
Korean	O
cattle	O
and	O
Holstein	O
[	O
9	O
,	O
38	O
–	O
40	O
].	O

In	O
our	O
setting	O
,	O
family	O
planning	O
and	O
care	O
of	O
the	O
newborn	O
are	O
usually	O
discussed	O
in	O
Infant	O
Welfare	O
Clinic	O
.	O

Central	O
administration	O
of	O
BMP8B	O
induced	O
thermogenesis	O
and	O
increased	O
core	O
temperature	O
,	O
leading	O
to	O
weight	O
loss	O
(	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

The	O
few	O
identified	O
studies	O
abound	O
with	O
conflicting	O
evidence	O
.	O

We	O
have	O
collected	O
a	O
homogenous	O
cohort	O
of	O
Caucasian	O
mothers	O
from	O
the	O
capital	O
region	O
of	O
Finland	O
representing	B
mothers	O
without	O
regular	O
medication	O
and	O
their	O
newborns	O
who	O
were	O
born	O
at	O
term	O
with	O
normal	O
birth	O
weight	O
.	O

A	O
study	O
team	O
member	O
not	O
involved	O
in	O
day	O
-	O
to	O
-	O
day	O
field	O
operations	O
constructed	O
the	O
assignment	O
table	O
.	O

All	O
samples	O
were	O
analyzed	O
in	O
a	O
single	O
batch	O
at	O
the	O
end	O
of	O
the	O
study	O
at	O
Medical	O
Research	O
Council	O
Human	O
Nutrition	O
Research	O
(	O
Cambridge	O
,	O
United	O
Kingdom	O
).	O

During	O
hunter	O
-	O
gatherer	O
times	O
,	O
summer	O
was	O
a	O
season	O
of	O
increased	O
daylight	O
and	O
nutritional	O
abundance	O
that	O
prepared	O
our	O
ancestors	O
for	O
harsher	O
winter	O
conditions	O
by	O
depositing	O
fat	O
reserves	O
during	O
autumn	O
[	O
17	O
].	O

With	O
respect	O
to	O
the	O
nucleus	O
accumbens	O
,	O
calcium	O
-	O
binding	O
proteins	O
such	O
as	O
calbindin	O
are	O
often	O
used	O
to	O
demarcate	O
discrete	O
neuroanatomical	O
boundaries	O
,	O
inferring	O
that	O
these	O
proteins	O
confer	O
selective	O
functional	O
properties	O
to	O
these	O
cells	O
[	O
35	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
:	O
The	O
number	O
and	O
(	O
percentage	O
)	O
frequency	O
distribution	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
)	O
before	O
and	O
after	O
interventionGroupsVitamin	O
D	O
status	O
(	O
nmol	O
/	O
l	O
)	O
IGCGBeforeAfterBeforeAfterSevere	O
deficient	O
(<	O
12	O
.	O
5	O
)	O
0000Moderate	O
deficient	O
(	O
12	O
.	O
5	O
-	O
24	O
.	O
9	O
)	O
15	O
(	O
62	O
.	O
5	O
%)	O
09	O
(	O
42	O
.	O
9	O
%)	O
10	O
(	O
47	O
.	O
6	O
%)	O
Mild	O
deficient	O
(	O
25	O
-	O
34	O
.	O
9	O
)	O
4	O
(	O
16	O
.	O
7	O
%)	O
1	O
(	O
4	O
.	O
2	O
%)	O
7	O
(	O
33	O
.	O
3	O
%)	O
3	O
(	O
14	O
.	O
3	O
%)	O
Optimal	O
(>	O
35	O
)	O
5	O
(	O
20	O
.	O
8	O
%)	O
23	O
(	O
95	O
.	O
8	O
%)	O
4	O
(	O
19	O
%)	O
6	O
(	O
28	O
.	O
6	O
%)	O
Discussion	O
If	O
vitamin	O
D	O
deficiency	O
is	O
defined	B
as	O
serum	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
lower	O
than	O
35	O
nmol	O
/	O
l	O
,	O
12about	O
80	O
%	O
of	O
the	O
mothers	O
with	O
GDM	O
in	O
the	O
present	O
study	O
were	O
suffering	O
to	O
some	O
degrees	O
from	O
vitamin	O
D	O
deficiency	O
.	O

Vitamin	O
D	O
once	O
synthesized	O
in	O
the	O
skin	O
is	O
metabolized	O
into	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
25	O
-(	O
OH	O
)	O
D	O
]	O
in	O
the	O
liver	O
.	O

Importantly	O
,	O
as	B
Alvarez	O
–	O
Rodriguez	O
and	O
colleagues	O
have	O
found	O
a	O
negative	O
correlation	O
between	O
age	O
and	O
immune	O
function	O
in	O
healthy	O
adult	O
subjects	O
,	O
especially	O
those	O
over	O
the	O
age	O
of	O
60	O
[	O
15	O
],	O
perhaps	O
innate	O
immune	O
function	O
,	O
in	O
particular	O
cytokine	O
function	O
,	O
increases	O
with	O
age	O
for	O
a	O
period	O
of	O
time	O
,	O
reaches	O
a	O
threshold	O
and	O
then	O
decreases	O
later	O
in	O
life	O
.	O

Furthermore	O
,	O
while	O
human	O
epidemiological	O
cohort	O
studies	O
can	O
demonstrate	O
association	O
,	O
they	O
do	O
not	O
prove	O
causality	O
.	O

A	O
high	O
index	O
of	O
suspicion	O
of	O
gestational	O
diabetes	O
insipidus	O
is	O
required	O
in	O
a	O
correct	O
clinical	O
setting	O
especially	O
in	O
the	O
presence	O
of	O
other	O
risk	O
factors	O
such	O
as	O
preeclampsia	O
,	O
HELLP	O
syndrome	O
,	O
and	O
twin	O
pregnancies	O
.	O

The	O
continued	O
transcriptional	O
silencing	O
of	O
such	O
regions	O
is	O
essential	O
for	O
early	O
embryogenesis	O
and	O
genome	O
stability	O
,	O
respectively	O
.	O

2007	O
).	O

Additional	O
recent	O
studies	O
about	O
pregnancy	O
diets	O
reveal	O
that	O
components	O
other	O
than	O
specific	O
allergens	O
,	O
such	O
as	O
fat	O
,	O
may	O
influence	O
atopy	O
outcomes	O
[	O
103	O
,	O
104	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Independent	O
effect	O
of	O
maternal	O
factors	O
on	O
birth	O
sizeaBirth	O
weight	O
(	O
SDS	O
)	O
Birth	O
length	O
(	O
SDS	O
)	O
Head	O
circumference	O
(	O
SDS	O
)	O
bPonderal	O
index	O
(	O
z	O
-	O
score	O
)	O
cMaternal	O
factors	O
np	O
value	O
p	O
value	O
p	O
value	O
p	O
valuePrepregnancy	O
BMI	O
0	O
.	O
020	O
0	O
.	O
2010	O
.	O
3640	O
.	O
719	O
Underweight19	O
−	O
0	O
.	O
49	O
±	O
0	O
.	O
17	O
−	O
0	O
.	O
36	O
±	O
0	O
.	O
19	O
−	O
0	O
.	O
34	O
±	O
0	O
.	O
22	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
23	O
Normal	O
weight494	O
−	O
0	O
.	O
30	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
14	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
01	O
±	O
0	O
.	O
05	O
Overweight117	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
08	O
−	O
0	O
.	O
04	O
±	O
0	O
.	O
090	O
.	O
08	O
±	O
0	O
.	O
09	O
Obese44	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
12	O
−	O
0	O
.	O
01	O
±	O
0	O
.	O
130	O
.	O
03	O
±	O
0	O
.	O
140	O
.	O
08	O
±	O
0	O
.	O
16Gestational	O
weight	O
gain	O
<	O
0	O
.	O
0010	O
.	O
006	O
0	O
.	O
1860	O
.	O
505	O
Inadequate164	O
−	O
0	O
.	O
43	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
37	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
08	O
Adequate261	O
−	O
0	O
.	O
28	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
20	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
11	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
06	O
Excessive242	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
060	O
.	O
07	O
±	O
0	O
.	O
07Prepregnancy	O
smoking	O
0	O
.	O
021	O
0	O
.	O
2270	O
.	O
0930	O
.	O
173	O
Yes101	O
−	O
0	O
.	O
43	O
±	O
0	O
.	O
08	O
−	O
0	O
.	O
30	O
±	O
0	O
.	O
09	O
−	O
0	O
.	O
27	O
±	O
0	O
.	O
10	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
11	O
No573	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
18	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
040	O
.	O
03	O
±	O
0	O
.	O
04Maternal	O
education0	O
.	O
9720	O
.	O
6700	O
.	O
7210	O
.	O
634	O
Higher513	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
19	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
11	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
00	O
±	O
0	O
.	O
05	O
Lower161	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
14	O
±	O
0	O
.	O
080	O
.	O
04	O
±	O
0	O
.	O
08Parity	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0070	O
.	O
027	O
Nullipara431	O
−	O
0	O
.	O
40	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
32	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
20	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
05	O
Secundipara185	O
−	O
0	O
.	O
03	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
03	O
±	O
0	O
.	O
070	O
.	O
18	O
±	O
0	O
.	O
07	O
Multipara580	O
.	O
04	O
±	O
0	O
.	O
100	O
.	O
22	O
±	O
0	O
.	O
110	O
.	O
17	O
±	O
0	O
.	O
12	O
−	O
0	O
.	O
07	O
±	O
0	O
.	O
13Gestational	O
diabetes	O
mellitus0	O
.	O
0630	O
.	O
5590	O
.	O
3510	O
.	O
075	O
Yes76	O
−	O
0	O
.	O
10	O
±	O
0	O
.	O
09	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
10	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
110	O
.	O
21	O
±	O
0	O
.	O
12	O
No598	O
−	O
0	O
.	O
28	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
21	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
04Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
0	O
.	O
010	O
0	O
.	O
0950	O
.	O
3980	O
.	O
236	O
Suboptimal	O
(<	O
80	O
nmol	O
/	O
L	O
)	O
333	O
−	O
0	O
.	O
34	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
04	O
±	O
0	O
.	O
06	O
Optimal	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
341	O
−	O
0	O
.	O
19	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
050	O
.	O
05	O
±	O
0	O
.	O
06UCB	O
25	O
(	O
OH	O
)	O
D	O
concentration0	O
.	O
1490	O
.	O
486	O
0	O
.	O
003	O
0	O
.	O
234	O
Suboptimal	O
(<	O
80	O
nmol	O
/	O
L	O
)	O
369	O
−	O
0	O
.	O
22	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
18	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
050	O
.	O
05	O
±	O
0	O
.	O
05	O
Optimal	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
305	O
−	O
0	O
.	O
31	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
24	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
06	O
25	O
(	O
OH	O
)	O
D	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
,	O
UCB	O
umbilical	O
cord	O
blood	O
Values	O
are	O
adjusted	O
mean	O
±	O
SEM	O
.	O

While	O
there	O
are	O
no	O
firmly	O
established	O
practice	O
guidelines	O
,	O
it	O
has	O
been	O
suggested	O
that	O
before	O
28	O
weeks	O
of	O
gestation	O
,	O
aortic	O
repair	O
should	O
proceed	O
without	O
cesarean	O
section	O
and	O
after	O
32	O
weeks	O
gestation	O
,	O
emergency	O
cesarean	O
section	O
precede	O
aortic	O
repair	O
[	O
6	O
].	O

Therefore	B
,	O
in	O
considering	O
early	O
vitamin	O
D	O
supplementation	O
,	O
the	O
question	O
becomes	O
whether	O
there	O
is	O
physiological	O
benefit	O
to	O
rapid	O
replenishment	O
with	O
vitamin	O
D	O
(	O
e	O
.	O
g	O
.	O

This	O
is	O
probably	B
because	O
their	O
contact	O
with	O
the	O
health	O
system	O
had	O
tailored	O
their	O
expectations	O
and	O
they	O
expressed	O
satisfaction	O
with	O
the	O
existing	O
services	O
.	O

By	O
the	O
end	O
of	O
our	O
trial	O
2616	O
of	O
the	O
3046	O
recruited	O
children	O
were	O
present	O
in	O
our	O
study	O
and	O
17	O
had	O
died	O
.	O

Vitamin	O
D	O
and	O
calcium	O
disturbances	O
during	O
tooth	O
development	O
may	O
result	O
in	O
dentin	O
and	O
enamel	O
defects	O
,	O
which	O
can	O
increase	O
the	O
risk	O
for	O
caries	O
.	O

Of	O
the	O
256	O
(	O
37	O
%)	O
women	O
who	O
met	O
eligibility	O
criteria	O
,	O
253	O
(	O
99	O
%)	O
consented	O
to	O
take	O
part	O
.	O

Additionally	O
,	O
more	O
women	O
using	O
metformin	O
indicated	O
that	O
their	O
treatment	O
was	O
acceptable	O
compared	O
to	O
those	O
on	O
insulin	O
.	O

All	O
participants	O
have	O
normal	O
liver	O
and	O
kidney	O
function	O
.	O

Because	B
the	O
hypothalamus	O
is	O
an	O
important	O
regulator	O
of	O
food	O
intake	O
and	O
appetite	O
control	O
,	O
6it	O
can	O
be	O
hypothesized	O
that	O
the	O
HV	O
diet	O
alters	O
development	O
of	O
feeding	O
neurocircuitry	O
in	O
the	O
offspring	O
resulting	O
in	O
an	O
obesogenic	O
phenotype	O
.	O

This	O
may	O
decrease	O
digestibility	O
of	O
feed	O
,	O
increase	O
animal	O
feed	O
waste	O
,	O
and	O
eventually	O
raise	O
issues	O
of	O
animal	O
industry	O
sustainability	O
.	O

In	O
addition	O
,	O
not	O
all	O
of	O
the	O
spermatozoal	O
histones	O
are	O
replaced	O
with	O
protamines	O
during	O
spermiogenesis	O
,	O
up	O
to	O
15	O
%	O
of	O
histones	O
within	O
human	O
spermatozoa	O
and	O
1	O
%	O
in	O
mouse	O
spermatozoa	O
are	O
retained	O
(	O
Miller	O
et	O
al	O
.	O
2010	O
;	O
Carrell2012	O
).	O

Ancient	O
Chinese	O
Cancer	O
Secret	O
?	O

Although	O
the	O
developmental	O
stage	O
of	O
formal	O
operational	O
thought	O
enables	O
skills	O
such	O
as	O
enhanced	O
problem	O
solving	O
,	O
decision	O
making	O
,	O
and	O
abstract	O
reasoning	O
(	O
90	O
),	O
the	O
underdeveloped	O
prefrontal	O
cortex	O
(	O
99	O
)	O
still	O
leaves	O
adolescents	O
at	O
risk	O
for	O
behaviors	O
that	O
may	O
increase	O
the	O
risk	O
of	O
obesity	O
.	O

Some	O
have	O
speculated	O
that	O
the	O
excess	O
of	O
winter	O
births	O
in	O
autism	O
is	O
explained	B
by	O
wintertime	O
maternal	O
viral	O
infections	O
.	O

For	O
the	O
Yen	O
Bai	O
iron	O
-	O
folic	O
acid	O
supplementation	O
program	O
,	O
promotion	O
accounted	O
for	O
1	O
%	O
of	O
the	O
non	O
-	O
supplement	O
costs	O
,	O
training	O
6	O
%,	O
monitoring	O
36	O
%,	O
village	O
health	O
worker	O
time	O
39	O
%,	O
and	O
permanent	O
,	O
salaried	O
staff	O
18	O
%.	O

After	O
adjusting	O
for	O
the	O
total	O
number	O
of	O
prenatal	O
visits	O
,	O
we	O
noted	O
independent	O
effects	O
of	O
area	O
of	O
residence	O
and	O
level	O
of	O
education	O
on	O
the	O
use	O
of	O
supplements	O
:	O
women	O
from	O
urban	O
areas	O
and	O
those	O
with	O
more	O
than	O
9	O
years	O
of	O
formal	O
education	O
were	O
more	O
likely	B
to	O
have	O
used	O
folic	O
acid	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
1	O
.	O
5	O
;	O
9	O
–	O
12	O
years	O
of	O
education	O
:	O
aOR	O
,	O
4	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
3	O
-	O
10	O
.	O
0	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
8	O
.	O
1	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
7	O
-	O
18	O
.	O
0	O
)	O
and	O
multivitamin	O
supplements	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
2	O
.	O
7	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
3	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
7	O
-	O
7	O
.	O
4	O
)	O
(	O
Table	O
5	O
).	O

Slaughter	O
age	O
needs	O
to	O
be	O
optimised	O
to	O
get	O
maximum	O
profits	O
for	O
farmers	O
by	O
monitoring	O
the	O
QG	O
and	O
quantity	O
grade	O
of	O
carcasses	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
(	O
auction	O
prices	O
).	O

These	O
clinics	O
fall	O
in	O
the	O
catchment	O
area	O
of	O
Rahima	O
Moosa	O
Mother	O
and	O
Child	O
Hospital	O
(	O
RMMCH	O
).	O

Altogether	O
,	O
the	O
existing	O
literature	O
suggests	O
that	O
BAT	O
activation	O
is	O
not	O
only	O
involved	O
in	O
non	O
-	O
shivering	O
thermogenesis	O
,	O
but	O
also	O
in	O
the	O
regulation	O
of	O
insulin	O
-	O
mediated	O
glucose	O
disposal	O
.	O

For	O
example	O
,	O
active	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
)	O
is	O
the	O
principal	O
hormone	O
that	O
regulates	O
calcium	O
absorption	O
within	O
the	O
intestine	O
[	O
53	O
]	O
and	O
is	O
integral	O
to	O
maintaining	O
calcium	O
homeostasis	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
depression	O
in	O
non	O
-	O
pregnant	O
people	O
are	O
not	O
entirely	O
clear	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
resulted	O
in	O
adult	O
offspring	O
progesterone	O
concentrations	O
that	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
offspring	O
born	O
to	O
Cont	O
dams	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
4B	O
),	O
although	O
in	O
MHF	O
offspring	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

Here	O
,	O
we	O
review	O
results	O
of	O
research	O
on	O
genetic	O
factors	O
(	O
breed	O
and	O
sex	O
differences	O
and	O
heritability	O
)	O
that	O
affect	O
IMF	O
deposition	O
.	O

Other	O
methods	O
to	O
adjust	O
for	O
gestational	O
age	O
include	O
birth	O
weight	O
z	O
-	O
scores	O
[	O
49	O
]	O
and	O
semi	O
-	O
parametric	O
modeling	O
[	O
50	O
].	O

1	O
).	O
Fig	O
.	O

Furthermore	O
,	O
it	O
is	O
perhaps	O
unsurprising	B
that	O
women	O
with	O
higher	O
educational	O
achievement	O
and	O
also	O
those	O
with	O
greater	O
engagement	O
with	O
prenatal	O
care	O
had	O
better	O
nutritional	O
knowledge	O
and	O
used	O
supplements	O
more	O
.	O

Feeding	O
practices	O
have	O
also	O
been	O
looked	O
at	O
,	O
as	O
well	O
as	O
maternal	O
states	O
such	O
as	O
high	O
temperature	O
or	O
an	O
unhappy	O
maternal	O
emotional	O
state	O
[	O
17	O
–	O
19	O
,	O
58	O
].	O

Future	O
research	O
should	O
include	O
more	O
discrete	O
and	O
refined	O
dosage	O
and	O
other	O
optimization	O
studies	O
.	O

There	O
are	O
data	O
that	O
suggest	O
that	O
at	B
least	I
in	O
mice	O
,	O
aging	O
per	O
se	O
may	O
be	O
accelerated	O
in	O
offspring	O
of	O
poorly	O
nourished	O
dams	O
.	O

Then	O
,	O
preadipocytes	O
can	O
differentiate	O
during	O
the	O
finishing	O
stage	O
when	O
they	O
fill	O
with	O
lipid	O
to	O
grow	O
into	O
visible	O
marbling	O
by	O
hypertrophy	O
.	O

in	O
taxonomy	O
labels	O
indicate	O
that	O
the	O
level	O
of	O
taxonomy	O
is	O
family	O
,	O
genus	O
,	O
or	O
species	O
,	O
respectively	O
Infant	O
gut	O
microbiome	O
clusters	O
We	O
identified	O
three	O
distinct	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
in	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
),	O
with	O
cluster	O
1	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
the	O
genus	O
Bifidobacterium	O
,	O
cluster	O
2	O
by	O
the	O
genera	O
Streptococcus	O
and	O
Clostridium	O
,	O
and	O
cluster	O
3	O
by	O
the	O
genus	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S1	O
,	O
Table	O
S1	O
).	O

Nutritional	O
effects	O
on	O
the	O
fetus	O
and	O
mother	O
may	O
vary	O
with	O
prepregnancy	O
body	O
weight	O
,	O
trimester	O
of	O
exposure	O
during	O
pregnancy	O
,	O
and	O
overall	O
balance	O
of	O
macronutrients	O
[	O
8	O
,	O
38	O
].	O

Authors	O
'	O
contributions	O
CQ	O
and	O
MAW	O
had	O
full	O
access	O
to	O
all	O
the	O
data	O
in	O
the	O
study	O
and	O
take	O
responsibility	O
for	O
the	O
integrity	O
of	O
the	O
data	O
,	O
the	O
accuracy	O
of	O
the	O
data	O
analysis	O
,	O
and	O
the	O
decision	O
to	O
submit	O
for	O
publication	O
.	O

The	O
services	O
offered	O
were	O
acceptable	O
in	O
contrast	O
with	O
observations	O
from	O
other	O
studies	O
in	O
Sub	O
-	O
Saharan	O
countries	O
such	O
as	O
in	O
Uganda	O
by	O
Cham	O
et	O
al	O
[	O
27	O
]	O
and	O
that	O
by	O
van	O
Eijket	O
al	O
[	O
4	O
]	O
in	O
Kenya	O
where	O
for	O
example	O
,	O
urine	O
and	O
serological	O
tests	O
are	O
not	O
routinely	O
done	O
.	O

Of	O
all	O
women	O
included	O
,	O
15	O
%	O
smoked	O
during	O
pregnancy	O
and	O
12	O
%	O
reported	O
having	O
drunk	O
alcohol	O
during	O
pregnancy	O
(	O
Table	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
CharacteristicNMean	O
age28	O
.	O
5	O
±	O
5	O
.	O
11305Mean	O
BMI	O
*(	O
kg	O
/	O
m2	O
)	O
24	O
.	O
4	O
±	O
5	O
.	O
11290	O
%	O
Underweight5	O
.	O
6673	O
%	O
Healthy	O
weight59	O
.	O
20763	O
%	O
Overweight22	O
.	O
09285	O
%	O
Obese13	O
.	O
10169	O
Ethnicity	O
%	O
White	O
/	O
Caucasian73	O
.	O
61965	O
%	O
Asiatic2	O
.	O
5233	O
%	O
African	O
(	O
Black	O
)	O
4	O
.	O
8864	O
%	O
North	O
African13	O
.	O
42176	O
%	O
Hispanic0	O
.	O
9212	O
%	O
Not	O
known4	O
.	O
6561	O
Education	O
level	O
%	O
Secondary	O
education	O
or	O
lower54	O
.	O
54715	O
%	O
Higher	O
education27	O
.	O
23357	O
%	O
University	O
or	O
higher14	O
.	O
87195	O
%	O
Other	O
education0	O
.	O
233	O
%	O
No	O
diploma0	O
.	O
699	O
%	O
Not	O
known2	O
.	O
4432	O
Smoking	O
%	O
Yes16	O
.	O
78220	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks15	O
.	O
41202	O
%	O
No82	O
.	O
911087	O
%	O
Not	O
known0	O
.	O
314	O
Drinking	O
alcohol	O
%	O
Yes20	O
.	O
37267	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks11	O
.	O
51151	O
%	O
No78	O
.	O
491029	O
%	O
Not	O
known1	O
.	O
1415	O
First	O
trimester	O
BMI	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
.	O

Pregnancy	O
termination	O
was	O
mostly	O
due	O
to	O
fetal	O
malformations	O
.	O

However	O
,	O
diets	O
are	O
often	O
stable	O
,	O
and	O
a	O
mid	O
-	O
pregnancy	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)-	O
assessment	O
is	O
likely	B
to	O
be	O
sufficiently	O
representative	O
of	O
late	O
pregnancy	O
and	O
lactation	O
diet	O
in	O
a	O
high	O
proportion	O
of	O
individuals	O
[	O
25	O
,	O
26	O
].	O

The	O
lowest	O
possible	O
effective	O
dose	O
(	O
alternate	O
-	O
day	O
dose	O
or	O
single	O
daily	O
dose	O
)	O
should	O
be	O
used	O
.	O

Detailed	O
methods	O
and	O
results	O
of	O
this	O
study	O
have	O
been	O
previously	O
published	O
[	O
34	O
,	O
35	O
].	O

The	O
masked	O
radiographs	O
were	O
read	O
by	O
two	O
independent	O
paediatric	O
radiologists	O
(	O
based	O
at	O
the	O
Acute	O
Respiratory	O
Infections	O
Unit	O
of	O
the	O
Pakistan	O
Institute	O
of	O
Medical	O
Sciences	O
),	O
experienced	O
in	O
reading	O
paediatric	O
chest	O
radiographs	O
from	O
WHO	O
vaccine	O
trials	O
,	O
with	O
WHO	O
proformas	O
for	O
standardised	O
interpretation	O
of	O
paediatric	O
chest	O
radiographs	O
for	O
the	O
diagnosis	O
of	O
pneumonia	O
.	O
17In	O
case	O
of	O
disagreement	O
,	O
radiographs	O
were	O
read	O
by	O
a	O
third	O
independent	O
radiologist	O
and	O
most	O
decisions	O
were	O
accepted	O
.	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

However	O
,	O
this	O
information	O
is	O
limited	O
to	O
a	O
single	O
study	O
,	O
which	O
was	O
conducted	O
in	O
a	O
relatively	O
small	O
sample	O
(	O
n	O
=	O
217	O
).	O

The	O
level	O
of	O
significance	O
was	O
designated	O
at	O
P	O
Results	O
Characteristics	O
of	O
respondents	O
A	O
total	O
of	O
385	O
participants	O
were	O
recruited	O
into	O
the	O
study	O
out	O
of	O
399	O
women	O
who	O
were	O
approached	O
for	O
informed	O
consent	O
.	O

CC	O
females	O
showed	O
an	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
and	O
Insig1	O
in	O
liver	O
,	O
and	O
Scd1	O
in	O
PAT	O
,	O
compared	O
to	O
CC	O
males	O
(	O
Figures5A	O
–	O
C	O
).	O

2004	O
).	O

Methods	O
A	O
cross	O
-	O
sectional	O
case	O
–	O
control	O
study	O
was	O
undertaken	O
to	O
test	O
the	O
hypothesis	O
that	O
children	O
with	O
S	O
-	O
ECC	O
have	O
lower	O
serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
calcium	O
,	O
albumin	O
,	O
and	O
higher	O
parathyroid	O
hormone	O
(	O
PTH	O
)	O
levels	O
than	O
caries	O
-	O
free	O
controls	O
.	O

While	O
a	O
previous	O
ecological	O
study	O
reported	O
a	O
positive	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
the	O
limitations	O
of	O
ecological	O
studies	O
for	O
inferring	O
causality	O
are	O
well	O
known	O
(	O
not	O
least	O
because	O
of	O
the	O
high	O
likelihood	B
of	O
confounding	O
)	O
[	O
36	O
].	O

For	O
PSM	O
,	O
we	O
used	O
the	O
nearest	O
neighbor	O
approach	O
that	O
requires	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
[	O
39	O
].	O

The	O
study	O
exclusion	O
criteria	O
were	O
pregnancy	O
complications	O
(	O
e	O
.	O
g	O
.,	O
diabetes	O
,	O
preeclampsia	O
),	O
psychological	O
problems	O
,	O
tobacco	O
or	O
alcohol	O
use	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
medications	O
other	O
than	O
pregnancy	O
supplements	O
,	O
abnormal	O
stresses	O
such	O
as	O
family	O
bereavement	O
and	O
accidents	O
,	O
migration	O
,	O
living	O
outside	O
of	O
the	O
study	O
area	O
,	O
failure	O
to	O
cooperate	O
,	O
follow	O
-	O
up	O
exitus	O
,	O
and	O
becoming	O
pregnant	O
again	O
within	O
a	O
year	O
.	O

At	O
present	O
,	O
vitamin	O
D	O
supplementation	O
is	O
not	O
a	O
part	O
of	O
antenatal	O
care	O
programs	O
in	O
India	O
.	O

Today	O
we	O
know	O
that	O
,	O
in	O
a	O
healthy	O
woman	O
,	O
vitamin	O
D	O
serum	O
concentration	O
is	O
higher	O
than	O
in	O
patients	O
suffering	O
from	O
polycystic	O
ovaries	O
syndrome	O
(	O
PCOS	O
).	O

Our	O
analysis	O
of	O
the	O
relationship	O
between	O
the	O
extent	O
of	O
methylation	O
at	O
these	O
elements	O
and	O
genomewide	O
gene	O
-	O
associated	O
methylation	O
was	O
aimed	O
to	O
better	O
characterize	O
the	O
similarities	O
and	O
differences	O
in	O
the	O
potential	O
functional	O
importance	O
of	O
these	O
markers	O
.	O

Tyagi	O
et	O
al	O
.	O

We	O
do	O
not	O
yet	O
understand	O
how	O
much	O
handwashing	O
of	O
mothers	O
and	O
others	O
needs	O
to	O
be	O
increased	O
,	O
and	O
at	O
which	O
times	O
of	O
potential	O
pathogen	O
transmission	O
,	O
in	O
order	O
to	O
reduce	O
the	O
risk	O
of	O
infection	O
in	O
newborns	O
.	O

This	O
was	O
further	O
substantiated	O
in	O
our	O
bioinformatically	O
informed	O
classification	O
analysis	O
,	O
because	O
we	O
identified	O
a	O
significant	O
association	O
between	O
AluYb8	O
methylation	O
and	O
methylation	O
of	O
a	O
group	O
of	O
loci	O
defined	O
by	O
their	O
position	O
in	O
a	O
CGI	O
,	O
PcG	O
target	O
gene	O
,	O
and	O
a	O
TFBS	O
,	O
as	O
well	O
CpGs	O
defined	O
by	O
association	O
with	O
a	O
PcG	O
target	O
gene	O
and	O
LINE	O
-	O
2	O
element	O
and	O
proximal	O
to	O
a	O
TFBS	O
.	O

The	O
dietary	O
source	O
of	O
Vitamin	O
D2	O
can	O
be	O
plants	O
and	O
/	O
or	O
fortified	O
food	O
products	O
.	O

Results	O
We	O
identified	O
three	O
infant	O
gut	O
microbiome	O
clusters	O
,	O
characterized	O
by	O
increased	O
abundance	O
of	O
Bifidobacterium	O
,	O
Streptococcus	O
and	O
Clostridium	O
,	O
and	O
Bacteroides	O
,	O
respectively	O
,	O
overall	O
and	O
in	O
the	O
vaginally	O
delivered	O
infant	O
stratum	O
.	O

The	O
blood	O
pressure	O
value	O
was	O
the	O
average	O
of	O
three	O
measurements	O
made	O
at	O
2	O
-	O
min	O
intervals	O
[	O
26	O
].	O

We	O
then	O
highlight	O
evidence	O
-	O
based	O
interventions	O
for	O
preterm	O
birth	O
in	O
the	O
context	O
of	O
the	O
wider	O
health	O
system	O
drawing	O
on	O
the	O
other	O
papers	O
in	O
this	O
supplement	O
,	O
and	O
here	O
we	O
focus	O
on	O
the	O
implications	O
for	O
integrating	O
and	O
scaling	O
up	O
those	O
available	O
interventions	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
the	O
coverage	O
of	O
care	O
is	O
lowest	O
and	O
the	O
potential	O
lives	O
saved	O
as	O
a	O
result	O
.	O

2006	O
)	O
of	O
the	O
intrauterine	O
and	O
extrauterine	O
environment	O
(	O
Nelissen	O
et	O
al	O
.	O

A	O
household	O
was	O
categorised	O
as	O
in	O
‘	O
economic	O
deficit	O
’	O
if	O
the	O
subject	O
answered	O
either	O
always	O
deficit	O
or	O
occasionally	O
deficit	O
(	O
Hyder	O
et	O
al	O
2004	O
).	O

Mean	O
birth	O
weights	O
of	O
LP	O
newborn	O
piglets	O
used	O
for	O
microarray	O
analyses	O
were	O
numerically	O
lower	O
than	O
birth	O
weights	O
of	O
AP	O
offspring	O
(	O
LP	O
:	O
1	O
.	O
21	O
±	O
0	O
.	O
30	O
kg	O
,	O
AP	O
:	O
1	O
.	O
36	O
±	O
0	O
.	O
31	O
kg	O
,	O
P	O
=	O
0	O
.	O
08	O
,	O
n	O
=	O
32	O
).	O

All	O
procedures	O
were	O
conducted	O
in	O
a	O
quiet	O
room	O
with	O
minimum	O
disturbance	O
between	O
9	O
:	O
00	O
and	O
11	O
:	O
00	O
am	O
.	O

To	O
inform	O
future	O
interventions	O
,	O
we	O
examined	O
the	O
prevalence	O
and	O
accuracy	O
of	O
provider	O
advice	O
and	O
its	O
association	O
with	O
personal	O
beliefs	O
about	O
necessary	O
maternal	O
weight	O
gain	O
among	O
predominantly	O
Latina	O
pregnant	O
women	O
.	O

Key	O
messages	O
The	O
use	O
of	O
SGAs	O
in	O
polytherapy	O
in	O
pregnant	O
women	O
with	O
mental	O
health	O
disorders	O
is	O
presently	O
a	O
common	O
practice	O
and	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
for	O
both	O
the	O
mother	O
and	O
the	O
child	O
.	O

Because	O
of	O
notable	O
differences	O
in	O
vitamin	O
D	O
concentrations	O
between	O
African	O
Americans	O
and	O
Whites	O
,	O
analyses	O
were	O
stratified	O
by	O
race	O
.	O

A	O
recent	O
trial	O
in	O
northern	O
China	O
identified	O
an	O
annual	O
cost	O
of	O
USD40	O
.	O
00	O
to	O
improve	O
antenatal	O
,	O
delivery	O
and	O
postnatal	O
care	O
of	O
which	O
22	O
%	O
(	O
USD8	O
.	O
80	O
)	O
was	O
to	O
supply	O
and	O
distribute	O
daily	O
supplements	O
to	O
pregnant	O
women	O
[	O
24	O
].	O

Season	O
with	O
four	O
categories	O
affected	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

Similar	O
or	O
greater	O
magnitudes	O
of	O
decreased	O
risk	O
were	O
observed	O
for	O
PTB	O
subtypes	O
,	O
race	O
/	O
ethnic	O
groups	O
,	O
and	O
among	O
women	O
with	O
a	O
prior	O
PTB	O
.	O

Patients	O
whose	O
asthma	O
is	O
not	O
controlled	O
with	O
maximal	O
doses	O
of	O
bronchodilators	O
and	O
anti	O
-	O
inflammatory	O
agents	O
may	O
need	O
systemic	O
corticosteroids	O
.	O

Gestational	O
age	O
was	O
calculated	O
based	O
on	O
the	O
first	O
day	O
of	O
the	O
last	O
menstruation	O
(	O
LMP	O
),	O
or	O
the	O
first	O
trimester	O
ultrasound	O
(	O
if	O
uncertain	O
about	O
LMP	O
).	O

All	O
study	O
procedures	O
were	O
approved	O
by	O
The	O
Hospital	O
for	O
Sick	O
Children	O
Research	O
Ethics	O
Board	O
.	O

Observational	O
studies	O
like	O
ours	O
are	O
subject	O
to	O
potential	O
residual	O
confounding	O
,	O
and	O
Vazquez	O
-	O
Benitez	O
et	O
al	O
.	O

Our	O
pilot	O
study	O
was	O
also	O
limited	O
by	O
the	O
relatively	O
small	O
sample	O
of	O
GDM	O
cases	O
(	O
n	O
=	O
68	O
)	O
and	O
the	O
imprecision	O
of	O
relative	O
risk	O
estimates	O
which	O
were	O
reflected	O
by	O
their	O
wide	O
95	O
%	O
confidence	O
intervals	O
.	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

In	O
addition	O
,	O
specific	O
deletion	O
of	O
Pten	O
in	O
the	O
liver	O
in	O
LPTENKO	O
mice	O
induces	O
a	O
strong	O
hepatic	O
steatosis	O
(	O
Stiles	O
et	O
al	O
.,	O
2004	O
;	O
Peyrou	O
et	O
al	O
.,	O
2015	O
),	O
but	O
improves	O
the	O
overall	O
insulin	O
sensitivity	O
,	O
and	O
decreases	O
the	O
fat	O
mass	O
.	O

In	O
addition	O
,	O
each	O
situation	O
must	O
be	O
considered	O
in	O
development	O
,	O
nothing	O
is	O
static	O
,	O
mainly	B
in	O
the	O
first	O
trimester	O
.	O

Image	O
acquisition	O
and	O
analysis	O
Gels	O
were	O
fixed	O
in	O
solution	O
containing	O
25	O
%	O
(	O
v	O
/	O
v	O
)	O
methanol	O
and	O
10	O
%	O
(	O
v	O
/	O
v	O
)	O
acetic	O
acid	O
for	O
1	O
hr	O
and	O
stained	O
using	O
colloidal	O
Coomassie	O
Blue	O
for	O
spot	O
visualization	O
.	O

Evaluations	O
of	O
these	O
programs	O
using	O
maternal	O
anaemia	O
as	O
the	O
outcome	O
report	O
little	O
or	O
no	O
impact	O
because	O
of	O
the	O
multiple	O
causes	O
of	O
maternal	O
anaemia	O
,	O
low	O
compliance	O
,	O
and	O
inadequate	O
distribution	O
programs	O
.	O

Assessment	O
of	O
Dietary	O
Intake	O
Pregnant	O
women	O
in	O
these	O
analyses	O
completed	O
validated	O
117	O
-	O
item	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
in	O
the	O
first	O
visit	O
,	O
at	O
8	O
–	O
16	O
weeks	O
.	O

Modest	O
limitations	O
of	O
this	O
study	O
include	O
the	O
use	O
of	O
data	O
from	O
medical	O
records	O
,	O
which	O
may	O
have	O
reduced	O
the	O
quality	O
of	O
covariate	O
data	O
used	O
in	O
this	O
study	O
.	O

Women	O
who	O
were	O
exposed	O
to	O
teratogenic	O
medications	O
unrelated	O
to	O
their	O
psychiatric	O
disorder	O
treatment	O
,	O
such	O
as	O
acutane	O
,	O
or	O
who	O
abused	O
substances	O
(	O
eg	O
,	O
alcohol	O
,	O
marijuana	O
,	O
cocaine	O
,	O
heroin	O
,	O
etc	O
)	O
were	O
excluded	O
from	O
the	O
study	O
cohort	O
.	O

We	O
hypothesised	O
that	O
gestating	O
through	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
both	O
reduced	O
serum	O
25OHD	O
and	O
increased	O
markers	O
of	O
glucose	O
metabolism	O
(	O
fasting	O
glucose	O
and	O
insulin	O
resistance	O
);	O
that	O
reduced	O
serum	O
25OHD	O
is	O
associated	O
with	O
increased	O
markers	O
of	O
glucose	O
metabolism	O
;	O
and	O
that	O
seasonal	O
differences	O
in	O
these	O
markers	O
are	O
associated	O
with	O
seasonal	O
variation	O
in	O
serum	O
25OHD	O
.	O

We	O
will	O
present	O
the	O
intermediate	O
and	O
immediate	O
results	O
,	O
which	O
support	O
the	O
hypotheses	O
generated	O
from	O
the	O
trial	O
,	O
at	O
national	O
and	O
international	O
conferences	O
and	O
publish	O
them	O
in	O
conference	O
proceedings	O
.	O

Conclusions	O
Level	O
of	O
nutritional	O
knowledge	O
has	O
a	O
strong	O
independent	O
association	O
with	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
.	O

The	O
majority	B
of	O
S	O
-	O
ECC	O
children	O
came	O
from	O
lower	O
-	O
income	O
households	O
.	O

Towards	O
the	O
end	O
of	O
the	O
pregnancy	O
,	O
insulin	O
requirements	O
can	O
drop	O
.	O

First	O
,	O
due	O
to	O
stipulations	O
made	O
during	O
the	O
ethics	O
approval	O
process	O
,	O
we	O
were	O
unable	O
to	O
include	O
participants	O
with	O
a	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
less	O
than	O
25	O
nmol	O
/	O
L	O
or	O
greater	O
than	O
100	O
nmol	O
/	O
L	O
.	O

The	O
study	O
participants	O
were	O
mostly	O
white	O
(	O
61	O
%),	O
married	O
(	O
64	O
%),	O
and	O
university	O
educated	O
(	O
50	O
%)	O
(	O
Table1	O
).	O

Vitamin	O
D	O
status	O
of	O
children	O
with	O
severe	O
early	O
childhood	O
caries	O
:	O
a	O
case	O
–	O
control	O
study	O
Abstract	O
Background	O
Severe	O
Early	O
Childhood	O
Caries	O
(	O
S	O
-	O
ECC	O
)	O
affects	O
the	O
health	O
and	O
well	O
-	O
being	O
of	O
young	O
children	O
.	O

2010	O
).	O

All	O
procedures	O
were	O
performed	O
with	O
approval	O
from	O
the	O
Queensland	O
University	O
Animal	O
Ethics	O
Committee	O
,	O
under	O
the	O
guidelines	O
of	O
the	O
National	O
Health	O
and	O
Medical	O
Research	O
Council	O
of	O
Australia	O
.	O

This	O
is	O
despite	O
our	O
previously	O
published	O
findings	O
of	O
significant	O
but	O
modest	O
improvements	O
in	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
[	O
21	O
],	O
and	O
an	O
18	O
and	O
41	O
%	O
relative	O
reduction	O
in	O
risk	O
of	O
infant	O
birth	O
weight	O
above	O
4	O
[	O
22	O
]	O
and	O
4	O
.	O
5	O
kg	O
,	O
respectively	O
[	O
23	O
].	O

Euglycemia	O
is	O
maintained	O
through	O
a	O
compensatory	O
increase	O
in	O
insulin	O
secretion	O
.	O

We	O
have	O
previously	O
shown	O
that	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
throughout	O
life	O
(	O
including	O
during	O
pregnancy	O
and	O
lactation	O
)	O
show	O
accelerated	O
weight	O
gain	O
in	O
postnatal	O
life	O
,	O
independent	O
of	O
postnatal	O
diet	O
[	O
58	O
].	O

However	O
,	O
keeping	O
the	O
prevalence	O
figures	O
for	O
psychotic	O
disorders	O
in	O
mind	O
,	O
rather	O
few	O
participants	O
in	O
our	O
population	O
sample	O
are	O
likely	B
to	O
have	O
a	O
disorder	O
,	O
which	O
may	O
diminish	O
the	O
problem	O
of	O
reversed	O
causality	O
related	O
to	O
psychotic	O
diagnosis	O
or	O
medication	O
.	O

Priority	O
was	O
given	O
to	O
papers	O
that	O
presented	O
original	O
data	O
rather	O
than	O
reviews	O
or	O
meta	O
-	O
analyses	O
.	O

Among	O
the	O
71	O
infants	O
,	O
36	O
were	O
boys	O
.	O

Higher	O
glucose	O
levels	O
,	O
either	O
in	O
the	O
glucose	O
tolerance	O
test	O
upon	O
which	O
GDM	O
was	O
diagnosed	O
,	O
or	O
on	O
self	O
-	O
monitoring	O
,	O
and	O
early	O
dietary	O
failure	O
have	O
been	O
found	O
to	O
be	O
associated	O
with	O
glyburide	O
failure	O
.	O
60	O
,	O
58These	O
findings	O
lead	O
to	O
the	O
logical	O
conclusion	O
that	O
subjects	O
with	O
more	O
severe	O
GDM	O
are	O
more	O
likely	B
to	O
require	O
insulin	O
.	O

Labor	O
Time	O
A	O
review	O
of	O
literature	O
found	O
limited	O
number	O
of	O
researches	O
on	O
the	O
topic	O
of	O
labor	O
time	O
and	O
autism	O
.	O

Serum	O
visfatin	O
level	O
appears	O
to	O
be	O
related	O
to	O
the	O
fetus	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
(	O
infant	O
’	O
s	O
weight	O
,	O
height	O
and	O
birth	O
height	O
.	O

Winter	O
-	O
time	O
supplementation	O
of	O
1000	O
IU	O
/	O
day	O
vitamin	O
D	O
is	O
an	O
effective	B
strategy	I
to	O
improve	O
25OHD	O
in	O
pregnancy	O
[	O
45	O
].	O

A	O
recent	O
study	O
provides	O
evidence	O
with	O
reference	O
to	O
the	O
consequences	O
of	O
vitamin	O
D	O
deficiency	O
on	O
the	O
neurodevelopment	O
of	O
the	O
fetus	O
during	O
pregnancy	O
in	O
a	O
rat	O
model	O
.	O

We	O
considered	O
p	O
<	O
0	O
.	O
05	O
to	O
be	O
significant	O
.	O

Differences	O
between	O
groups	O
were	O
determined	O
by	O
ANOVA	O
with	O
maternal	O
background	O
,	O
gender	O
and	O
diet	O
as	O
factors	O
;	O
where	O
appropriate	O
differences	O
were	O
observed	O
at	O
p	O
<	O
0	O
.	O
05	O
level	O
,	O
post	O
-	O
hoc	O
analyses	O
were	O
performed	O
(	O
Fishers	O
PLSD	O
(	O
Protected	O
Least	O
Significant	O
Difference	O
)).	O

PubMed	O
Central	O
:	O

At	O
child	O
birth	O
,	O
blood	O
sample	O
was	O
collected	O
for	O
130	O
mothers	O
.	O

Our	O
finding	O
that	O
18	O
.	O
6	O
%	O
in	O
the	O
S	O
-	O
ECC	O
group	O
had	O
low	O
albumin	O
is	O
comparable	O
to	O
the	O
15	O
%	O
reported	O
in	O
another	O
Canadian	O
sample	O
.	O

Study	O
staff	O
also	O
improved	O
access	O
to	O
handwashing	O
materials	O
in	O
the	O
physical	O
environment	O
to	O
facilitate	O
handwashing	O
[	O
18	O
,	O
19	O
].	O

Then	O
,	O
the	O
sample	O
was	O
purified	O
to	O
remove	O
any	O
residual	O
tailing	O
reagents	O
.	O

Except	O
for	O
a	O
small	O
percentage	O
of	O
cases	O
,	O
the	O
tumors	O
continue	O
to	O
show	O
high	O
morbidity	O
and	O
mortality	O
.	O

Other	O
tumours	O
(	O
lung	O
,	O
stomach	O
,	O
breast	O
,	O
large	O
bowel	O
,	O
larynx	O
and	O
pharynx	O
)	O
were	O
included	O
to	O
distinguish	O
findings	O
specific	O
for	O
oesophageal	O
cancer	O
from	O
general	O
characteristics	O
of	O
cancer	O
patients	O
,	O
due	O
for	O
example	O
to	O
ascertainment	O
bias	O
,	O
and	O
to	O
verify	O
that	O
expected	O
associations	O
,	O
such	O
as	O
between	O
lung	O
cancer	O
and	O
cigarette	O
smoking	O
,	O
would	O
emerge	O
under	O
the	O
prevailing	O
field	O
conditions	O
.	O

Because	O
AAOC	O
might	O
be	O
misdiagnosed	O
as	O
PG	O
or	O
other	O
benign	O
cutaneous	O
neoplasm	O
,	O
it	O
may	O
not	O
be	O
rare	O
but	O
rather	O
underreported	O
.	O

Processing	O
of	O
the	O
HRV	O
Data	O
The	O
HRV	O
indices	O
were	O
calculated	O
as	O
previously	O
described	O
[	O
27	O
,	O
28	O
].	O

Women	O
who	O
stated	O
that	O
they	O
had	O
received	O
dietary	O
or	O
breastfeeding	O
advice	O
had	O
a	O
higher	O
probability	B
of	O
using	O
folic	O
acid	O
or	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

Thus	B
,	O
although	O
the	O
current	O
literature	O
remains	O
incomplete	O
regarding	O
specific	O
mechanisms	O
of	O
epigenetically	O
mediated	O
environmentally	O
induced	O
toxicity	O
in	O
humans	O
at	O
doses	O
relevant	O
to	O
human	O
exposures	O
,	O
there	O
is	O
sufficient	O
information	O
to	O
perform	O
retrospective	O
epigenetic	O
analysis	O
of	O
existing	O
regulatory	O
studies	O
and	O
identify	O
future	O
research	O
needs	O
.	O

Hence	B
the	O
benefit	O
:	O
cost	O
ratio	O
is	O
approximately	O
6	O
.	O
7	O
∶	O
1	O
,	O
just	O
based	O
on	O
improvements	O
in	O
productivity	O
of	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
workforce	O
.	O

Early	O
weaned	O
-	O
animals	O
showed	O
lighter	O
final	O
body	O
weight	O
,	O
and	O
tended	O
to	O
eat	O
less	O
than	O
conventionally	O
weaned	O
-	O
animals	O
.	O

This	O
period	O
is	O
roughly	B
comparable	O
to	O
the	O
third	O
gestational	O
trimester	O
of	O
humans	O
[	O
27	O
].	O

Feed	O
efficiency	O
decreases	O
as	O
animal	O
age	O
and	O
slaughter	O
weight	O
exceed	O
a	O
certain	O
level	O
.	O

Gut	O
microbiome	O
profiling	O
will	O
be	O
done	O
by	O
isolating	O
microbial	O
DNA	O
from	O
the	O
collected	O
rectal	O
swabs	O
using	O
Qiagen	O
Stool	O
minikit	O
and	O
analysing	O
the	O
16S	O
rRNA	O
genes	O
DNA	O
sequences	O
on	O
the	O
Ion	O
Torrent	O
16S	O
metagenomics	O
solution	O
offered	O
by	O
ThermoFisher	O
Scientific	O
.	O

Third	O
,	O
the	O
study	O
demonstrates	O
a	O
behavioral	O
effect	O
of	O
text4baby	O
among	O
high	O
-	O
exposure	O
users	O
.	O

We	O
cannot	O
easily	O
change	O
the	O
basic	O
ingrained	O
biology	O
of	O
liking	O
sweets	O
and	O
avoiding	O
bitterness	O
—	O
preferring	O
candy	O
to	O
spinach	O
.	O

Additionally	O
,	O
since	O
women	O
with	O
a	O
history	O
of	O
PTB	O
have	O
a	O
known	O
2	O
to	O
3	O
-	O
fold	O
increased	O
risk	O
of	O
a	O
recurrent	O
premature	O
delivery	O
compared	O
to	O
women	O
without	O
a	O
history	O
of	O
PTB	O
[	O
18	O
],	O
logistic	O
regression	O
was	O
conducted	O
for	O
this	O
subgroup	O
as	O
well	O
.	O

According	O
to	O
recent	O
studies	O
NCAPG	O
is	O
important	O
during	O
mitotic	O
cell	O
division	O
.	O

47	O
859	O
women	O
were	O
invited	O
to	O
complete	O
a	O
web	O
-	O
based	O
questionnaire	O
,	O
and	O
non	O
-	O
responders	O
received	O
a	O
paper	O
questionnaire	O
.	O

Van	O
Eijk	O
et	O
al	O
.	O

At	O
94	O
dpc	O
15	O
AP	O
-	O
samples	O
met	O
the	O
appropriate	O
quality	O
control	O
criteria	O
(	O
94	O
dpc	O
-	O
LP	O
:	O
16	O
;	O
1	O
dpn	O
-	O
AP	O
:	O
15	O
;	O
1	O
dpn	O
-	O
LP	O
:	O
14	O
;	O
28	O
dpn	O
-	O
AP	O
:	O
14	O
;	O
28	O
dpn	O
-	O
LP	O
:	O
15	O
;	O
188	O
dpn	O
-	O
AP	O
:	O
16	O
;	O
188	O
dpn	O
-	O
LP	O
:	O
16	O
samples	O
).	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
alterations	O
to	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
may	O
act	O
as	O
a	O
marker	O
for	O
key	O
changes	O
to	O
the	O
extent	O
of	O
methylation	O
at	O
loci	O
targeted	O
by	O
important	O
transcription	O
factors	O
for	O
normal	O
development	O
and	O
placenta	O
processes	O
necessary	O
for	O
appropriate	O
growth	O
.	O

PubMed	O
Central	O
:	O

A	O
follow	O
-	O
up	O
survey	O
was	O
repeated	O
at	O
30	O
months	O
post	O
-	O
implementation	O
.	O

While	O
the	O
GraviD	O
study	O
indicates	O
an	O
association	O
between	O
T3	O
25OHD	O
and	O
consequences	O
of	O
placental	O
insufficiency	O
,	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
might	O
be	O
a	O
stronger	O
predictor	O
of	O
placental	O
dysfunction	O
,	O
as	B
it	O
is	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Participants	O
’	O
dietary	O
intake	O
and	O
nutrient	O
status	O
(	O
focus	O
on	O
micronutrients	O
and	O
fatty	O
acids	O
)	O
are	O
assessed	O
at	O
<	O
18	O
,	O
22	O
and	O
36	O
weeks	O
’	O
gestation	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
using	O
SPSS	O
20	O
.	O
0	O
for	O
windows	O
(	O
SPSS	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
and	O
GraphPad	O
Prism	O
version	O
6	O
.	O
0	O
(	O
GraphPad	O
Software	O
Inc	O
.,	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
).	O

The	O
most	O
abundant	O
taxonomic	O
group	O
was	O
Enterobacteriaceae	O
comprising	O
20	O
.	O
0	O
%	O
of	O
the	O
6	O
-	O
week	O
infant	O
stool	O
microbiome	O
,	O
followed	O
by	O
Bifidobacterium	O
(	O
18	O
.	O
4	O
%),	O
Bacteroides	O
(	O
10	O
.	O
4	O
%),	O
and	O
Streptococcus	O
(	O
8	O
.	O
10	O
%)	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

The	O
sum	O
of	O
the	O
total	O
deposits	O
of	O
perirenal	O
and	O
perigonadal	O
fat	O
determines	O
the	O
amount	O
of	O
abdominal	O
fat	O
.	O

The	O
inclusion	O
criteria	O
were	O
:	O
1	O
).	O

The	O
primary	O
objective	O
of	O
a	O
quantitative	O
meta	O
-	O
analysis	O
is	O
to	O
combine	O
the	O
results	O
of	O
previous	O
studies	O
examining	O
a	O
specific	O
research	O
question	O
to	O
arrive	O
at	O
a	O
summary	O
conclusion	O
about	O
a	O
body	O
of	O
research	O
.	O

Almost	B
all	I
mother	O
-	O
child	O
pairs	O
(	O
97	O
%)	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
],	O
and	O
about	O
half	O
of	O
the	O
mother	O
-	O
child	O
pairs	O
had	O
optimal	O
vitamin	O
D	O
status	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
80	O
nmol	O
/	O
L	O
].	O

Indeed	O
,	O
transfer	O
of	O
many	O
commensal	O
organisms	O
from	O
mother	O
to	O
neonate	O
represents	B
an	O
important	O
element	O
of	O
developing	O
healthy	O
microbiota	O
and	O
immune	O
systems	O
[	O
25	O
–	O
28	O
].	O

Improvement	O
occurred	O
with	O
vitamin	O
D	O
supplementation	O
and	O
was	O
not	O
related	O
to	O
changes	O
in	O
bone	O
mineral	O
content	O
.	O

As	O
the	O
age	O
of	O
the	O
child	O
increased	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
also	O
increased	O
(	O
Fig	O
1	O
).	O

The	O
characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
are	O
shown	O
inTable	O
2	O
.	O

(	O
2016	O
)*	O
2	O
-	O
amino	O
-	O
1	O
-	O
methyl	O
-	O
6	O
-	O
phenylimidazo	O
[	O
4	O
,	O
5	O
-	O
b	O
]	O
pyridine	O
(	O
PhIP	O
)	O
Mouse	O
(	O
Human	O
CYP1A2	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
200	O
mg	O
/	O
kg	O
)	O
Adolescence	O
/	O
early	O
adulthoodLater	O
adulthoodProstate	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryLi	O
et	O
al	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
quality	O
and	O
apnea	O
are	O
needed	O
to	O
obtain	O
more	O
precise	O
estimates	O
of	O
observed	O
associations	O
.	O

Pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
,	O
weight	O
gain	O
and	O
energy	O
intake	O
in	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
Background	O
Studies	O
have	O
shown	O
that	O
maternal	O
obesity	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
).	O

A	O
developmental	O
perspective	O
recognizes	O
the	O
cumulative	O
effects	O
of	O
factors	O
that	O
contribute	O
to	O
eating	O
behavior	O
and	O
obesity	O
,	O
including	O
biological	O
and	O
socioenvironmental	O
factors	O
that	O
are	O
relevant	O
at	O
different	O
stages	O
of	O
development	O
.	O

The	O
level	O
of	O
25	O
-	O
hydroxy	O
Vitamin	O
D	O
(	O
25	O
-	O
OH	O
Vit	O
D	O
)	O
and	O
the	O
sources	O
of	O
Vitamin	O
D	O
intake	O
and	O
the	O
frequency	O
of	O
food	O
consumption	O
rich	O
in	O
Vitamin	O
D	O
were	O
investigated	O
.	O

Thus	B
,	O
the	O
incorporation	O
of	O
epigenetics	O
within	O
chemical	O
regulation	O
could	O
ultimately	O
reduce	O
animal	O
usage	O
and	O
the	O
time	O
and	O
cost	O
of	O
chemical	O
research	O
and	O
development	O
,	O
while	O
simultaneously	O
improving	O
the	O
protection	O
of	O
public	O
health	O
worldwide	O
.	O

The	O
latter	O
result	O
did	O
not	O
remain	O
significant	O
after	O
multivariate	O
adjustment	O
(	O
Table2	O
).	O

Differences	O
in	O
physical	O
activity	O
levels	O
were	O
clinically	O
,	O
but	O
not	O
significantly	O
different	O
(	O
15	O
.	O
5	O
mins	O
vs	O
9l	O
.	O
8mins	O
/	O
week	O
).	O

It	O
should	O
be	O
noted	O
here	O
that	O
the	O
interactions	O
presented	O
in	O
the	O
networks	O
are	O
not	O
specific	O
for	O
porcine	O
liver	O
tissue	O
,	O
as	O
the	O
database	O
contains	O
literature	O
from	O
many	O
different	O
research	O
areas	O
.	O

The	O
reactions	O
occurred	O
within	O
1	O
to	O
3	O
days	O
postpartum	O
and	O
resolved	O
within	O
1	O
to	O
2	O
days	O
.	O

Phase	O
1	O
data	O
are	O
collected	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
as	O
confirmed	O
by	O
obstetric	O
ultrasound	O
).	O

A	O
comparison	O
of	O
the	O
maternal	O
characteristics	O
between	O
those	O
included	O
(	O
n	O
=	O
334	O
)	O
and	O
excluded	O
from	O
the	O
original	O
ROLO	O
study	O
is	O
included	O
in	O
Additional	O
file1	O
:	O
Table	O
S1	O
.	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

Both	O
chemically	O
induced	O
DNA	O
adducts	O
and	O
those	O
generated	O
as	O
a	O
consequence	O
of	O
reactive	O
oxygen	O
species	O
damage	O
resulting	O
from	O
chemical	O
exposure	O
can	O
interfere	O
with	O
the	O
ability	O
of	O
epigenetic	O
machinery	O
to	O
interact	O
with	O
DNA	O
(	O
Baccarelli	O
&	O
Bollati2009	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Castration	O
is	O
also	O
known	O
to	O
increase	O
tenderness	O
in	O
several	O
cattle	O
breeds	O
,	O
including	O
Korean	O
cattle	O
[	O
62	O
],	O
Angus	O
and	O
Angus	O
–	O
Hereford	O
cross	O
breeds	O
[	O
63	O
],	O
and	O
Brahman	O
and	O
Charolais	O
cross	O
breeds	O
[	O
64	O
].	O

Sampling	O
frame	O
and	O
sample	O
size	O
To	O
detect	O
a	O
25	O
%	O
reduction	O
in	O
neonatal	O
mortality	O
(	O
33	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
control	O
to	O
24	O
.	O
8	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
the	O
intervention	O
group	O
),	O
with	O
90	O
%	O
power	O
,	O
5	O
%	O
two	O
-	O
sided	O
alpha	O
,	O
1	O
:	O
1	O
ratio	O
of	O
treatment	O
allocation	O
and	O
intra	O
-	O
cluster	O
correlation	O
coefficient	O
(	O
ICC	O
)	O
of	O
0	O
.	O
0245	O
,	O
we	O
require	O
100	O
clusters	O
(	O
each	O
covering	O
an	O
average	O
of	O
4000	O
households	O
),	O
or	O
50	O
clusters	O
per	O
treatment	O
group	O
,	O
with	O
a	O
total	O
of	O
30	O
,	O
000	O
live	O
births	O
over	O
one	O
year	O
.	O

However	O
,	O
placental	O
GAS5	O
levels	O
were	O
inversely	O
correlated	O
with	O
maternal	O
stress	O
.	O

Data	O
collection	O
for	O
the	O
current	O
study	O
took	O
place	O
between	O
July	O
and	O
August	O
2007	O
.	O

Their	O
liver	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
,	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
,	O
the	O
de	O
novo	O
lipogenic	O
enzymes	O
Acaca	O
and	O
Fasn	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

Plasma	O
cathelicidin	O
was	O
measured	O
from	O
the	O
children	O
’	O
s	O
samples	O
by	O
ELISA	O
(	O
Hycult	O
Biotech	O
,	O
the	O
Netherlands	O
),	O
in	O
which	O
each	O
sample	O
was	O
diluted	O
24	O
times	O
and	O
analyzed	O
in	O
duplicate	O
.	O

Two	O
lines	O
of	O
evidence	O
support	O
the	O
PAR	O
hypothesis	O
.	O

Baltussen	O
et	O
al	O
(	O
2004	O
)[	O
22	O
]	O
use	O
the	O
WHO	O
“	O
ingredients	O
”	O
approach	O
to	O
estimate	O
costs	O
(	O
at	O
95	O
%	O
coverage	O
)	O
for	O
various	O
regions	O
.	O

Prospective	O
studies	O
are	O
needed	O
to	O
minimize	O
these	O
biases	O
.	O

Not	O
alone	O
is	O
this	O
now	O
more	O
robust	O
,	O
but	O
also	O
it	O
is	O
a	O
substantial	O
scientific	O
addition	O
using	O
novel	O
data	O
to	O
build	O
on	O
our	O
previous	O
observation	O
.	O

We	O
present	O
the	O
case	O
of	O
the	O
successful	O
diagnosis	O
and	O
surgical	O
repair	O
of	O
a	O
41	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
an	O
acute	O
type	O
A	O
aortic	O
dissection	O
at	O
36	O
weeks	O
of	O
gestation	O
.	O

Factors	O
known	O
to	O
influence	O
the	O
development	O
of	O
asthma	O
include	O
race	O
[	O
80	O
,	O
81	O
],	O
low	O
yearly	O
family	O
income	O
[	O
81	O
],	O
less	O
than	O
a	O
high	O
school	O
education	O
[	O
81	O
],	O
residence	O
in	O
high	O
poverty	O
areas	O
[	O
81	O
],	O
exposure	O
to	O
urban	O
air	O
pollution	O
[	O
64	O
]	O
and	O
childhood	O
viral	O
infections	O
[	O
64	O
,	O
82	O
].	O

These	O
genes	O
display	O
diet	O
-	O
dependent	O
longitudinal	O
transcriptomic	O
regulation	O
(	O
Figure1	O
).	O

This	O
observation	O
could	O
be	O
a	O
consequence	O
of	O
social	O
inequity	O
or	O
particular	O
health	O
beliefs	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
regulates	O
insulin	O
secretion	O
by	O
pancreatic	O
β	O
-	O
cells	O
and	O
thereby	O
affects	O
circulating	O
glucose	O
levels	O
.	O

There	O
were	O
no	O
differences	O
in	O
maternal	O
weight	O
gain	O
in	O
pregnancy	O
between	O
the	O
exposed	O
and	O
comparison	O
groups	O
and	O
between	O
the	O
monotherapy	O
-	O
exposed	O
and	O
polytherapy	O
-	O
exposed	O
subgroups	O
.	O

In	O
an	O
attempt	O
to	O
assess	O
a	O
stress	O
versus	O
gene	O
interaction	O
,	O
we	O
studied	O
four	O
GR	O
polymorphisms	O
.	O

Behaviors	O
such	O
as	O
EAH	O
may	O
also	O
be	O
heritable	O
(	O
64	O
),	O
although	O
evidence	O
is	O
limited	O
.	O

While	O
these	O
packages	O
may	O
exist	O
in	O
nearly	B
all	I
health	O
systems	O
,	O
lower	O
-	O
income	O
countries	O
cannot	O
scale	O
up	O
and	O
implement	O
all	O
the	O
individual	O
RMNCH	O
interventions	O
within	O
all	O
the	O
packages	O
at	O
once	O
[	O
25	O
].	O

Median	O
initial	O
calcium	O
was	O
3	O
.	O
00mmol	O
/	O
L	O
(	O
range	O
2	O
.	O
84	O
-	O
4	O
.	O
03	O
)	O
and	O
phosphate	O
2	O
.	O
04mmol	O
/	O
L	O
(	O
1	O
.	O
1	O
-	O
3	O
.	O
33	O
).	O

Indeed	O
many	O
of	O
the	O
studies	O
that	O
have	O
assessed	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
adverse	O
pregnancy	O
outcome	O
that	O
have	O
reported	O
statistically	O
significant	O
differences	O
have	O
been	O
in	O
populations	O
with	O
higher	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
[	O
2	O
,	O
4	O
].	O

Therefore	B
,	O
a	O
decreased	O
perinatal	O
depression	O
level	O
is	O
justifiable	B
.	O

A	O
number	O
of	O
lessons	O
can	O
be	O
drawn	O
from	O
this	O
historical	O
data	O
:	O
Basic	O
care	O
and	O
infection	O
case	O
management	O
interventions	O
have	O
an	O
effect	O
on	O
neonatal	O
deaths	O
and	O
on	O
deaths	O
amongst	O
moderate	O
and	O
late	O
preterm	O
births	O
,	O
which	O
account	B
for	I
over	O
80	O
%	O
of	O
preterm	O
births	O
.	O

Introduction	O
Vitamin	O
D	O
status	O
is	O
a	O
well	B
-	I
known	I
determinant	O
of	O
bone	O
health	O
[	O
1	O
],[	O
2	O
].	O

The	O
HV	O
pup	O
diet	O
brought	O
BDNF	O
expression	O
to	O
control	O
levels	O
but	O
the	O
HFol	O
pup	O
diet	O
only	O
attenuated	O
the	O
decrease	O
in	O
expression	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
(	O
Figure	O
5a	O
).	O

Six	O
per	O
cent	O
of	O
exposed	O
infants	O
presented	O
with	O
major	O
malformations	O
compared	O
with	O
2	O
.	O
6	O
%	O
in	O
the	O
comparison	O
group	O
.	O

Serum	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
reflects	O
the	O
body	O
’	O
s	O
vitamin	O
D	O
reserves	O
and	O
this	O
is	O
a	O
well	B
-	I
known	I
indicator	O
for	O
examining	O
vitamin	O
D	O
status	O
[	O
15	O
].	O

Bonferrroni	O
analysis	O
indicated	O
that	O
RC	O
male	O
exhibited	O
an	O
increase	O
in	O
the	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perirenal	O
fat	O
compared	O
to	O
those	O
of	O
the	O
CC	O
males	O
.	O

Materials	O
and	O
Methods	O
This	O
study	O
was	O
conducted	O
in	O
Matlab	O
,	O
a	O
rural	O
area	O
55	O
km	O
southeast	O
of	O
Dhaka	O
,	O
Bangladesh	O
.	O

Of	O
the	O
139	O
PTBs	O
,	O
approximately	O
half	O
were	O
spontaneous	O
(	O
47	O
%)	O
and	O
half	O
were	O
indicated	O
(	O
53	O
%),	O
of	O
the	O
latter	O
,	O
66	O
%	O
were	O
indicated	O
for	O
maternal	O
hypertensive	O
disorders	O
.	O

We	O
defined	O
clinical	O
pneumonia	O
as	O
a	O
history	O
of	O
cough	O
plus	O
increased	O
respiratory	O
rate	O
for	O
age	O
,	O
chest	O
in	O
-	O
drawing	O
,	O
or	O
any	O
danger	O
sign	O
(	O
ie	O
,	O
not	O
drinking	O
or	O
breastfeeding	O
,	O
convulsion	O
,	O
vomiting	O
,	O
lethargic	O
or	O
unconscious	O
,	O
stridor	O
in	O
a	O
calm	O
child	O
).	O

Conclusions	O
:	O
Our	O
results	O
suggest	O
that	O
repetitive	O
element	O
methylation	O
markers	O
,	O
most	O
notably	O
AluYb8	O
methylation	O
,	O
may	O
be	O
susceptible	O
to	O
epigenetic	O
alterations	O
resulting	O
from	O
the	O
intrauterine	O
environment	O
and	O
play	O
a	O
critical	O
role	O
in	O
mediating	O
placenta	O
function	O
,	O
and	O
may	O
ultimately	O
inform	O
on	O
the	O
developmental	O
basis	O
of	O
health	O
and	O
disease	O
.	O

Lignell	O
et	O
al	O
.	O

This	O
study	O
evaluates	O
final	O
outcomes	O
of	O
text4baby	O
(	O
a	O
text	O
message	O
service	O
for	O
pregnant	O
and	O
postpartum	O
women	O
)	O
from	O
a	O
randomized	O
trial	O
performed	O
in	O
a	O
population	O
of	O
pregnant	O
female	O
soldiers	O
and	O
family	O
members	O
.	O

Changing	O
covariates	O
appearing	O
in	O
the	O
ANCOVA	O
models	O
were	O
:	O
prepregnancy	O
BMI	O
,	O
GWG	O
at	O
last	O
measurement	O
,	O
smoking	O
,	O
education	O
,	O
parity	O
,	O
GDM	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

This	O
increased	O
rate	O
of	O
overweight	O
and	O
obesity	O
puts	O
Latinas	O
at	O
increased	O
risk	O
for	O
excessive	O
GWG	O
.	O

The	O
Born	O
Too	O
Soon	O
report	O
was	O
funded	O
by	O
March	O
of	O
Dimes	O
,	O
the	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
and	O
Save	O
the	O
Children	O
.	O

Both	O
cutaneous	O
production	O
and	O
dietary	O
consumption	O
of	O
vitamin	O
D	O
must	O
undergo	O
two	O
hydroxylations	O
in	O
the	O
body	O
for	O
activation	O
.	O

F	O
.,	O
G	O
.,	O
and	O
S	O
.	O

In	O
LP	O
offspring	O
,	O
genes	O
involved	O
in	O
'	O
mTOR	O
signaling	O
',	O
'	O
fatty	O
acid	O
elongation	O
in	O
mitochondria	O
'	O
as	O
well	O
as	O
the	O
'	O
degradation	O
of	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
'	O
were	O
up	O
regulated	O
.	O

Conversely	O
,	O
a	O
high	O
proportion	O
of	O
CpGs	O
in	O
the	O
relatively	O
unmethylated	O
classes	O
1	O
–	O
6	O
and	O
8	O
are	O
in	O
CGIs	O
(	O
Figure	O
2E	O
).	O

Low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
correlated	O
with	O
increased	O
bacterial	O
vaginosis	O
in	O
the	O
first	O
trimester	O
.	O

However	O
,	O
we	O
could	O
not	O
do	O
it	O
,	O
which	O
is	O
a	O
limitation	O
of	O
our	O
study	O
.	O

This	O
prevents	O
the	O
conclusion	O
of	O
a	O
definitive	O
relationship	O
without	O
further	O
research	O
,	O
preferably	B
clinical	O
randomised	O
controlled	O
trials	O
,	O
and	O
a	O
proper	O
meta	O
-	O
analysis	O
.	O

Rates	O
of	O
severe	O
anemia	O
in	O
women	O
of	O
reproductive	O
age	O
fell	O
from	O
1	O
.	O
1	O
%	O
to	O
0	O
%	O
after	O
3	O
months	O
of	O
the	O
intervention	O
[	O
15	O
].	O

Generally	B
,	O
a	O
peptide	O
match	O
with	O
at	B
least	I
30	O
%	O
total	O
sequence	O
coverage	O
was	O
required	O
for	O
confidence	O
in	O
identification	O
,	O
but	O
very	O
low	O
and	O
high	O
mass	O
protein	O
,	O
and	O
those	O
resulting	O
from	O
protein	O
fragmentation	O
may	O
not	O
always	O
meet	O
the	O
criterion	O
.	O

Common	O
risk	O
factors	O
for	O
developing	O
aortic	O
dissection	O
include	O
hypertension	O
,	O
collagen	O
disorders	O
including	O
Marfan	O
/	O
Ehlers	O
-	O
Danlos	O
syndromes	O
,	O
bicuspid	O
aortic	O
valve	O
,	O
positive	O
family	O
history	O
,	O
trauma	O
,	O
and	O
cocaine	O
use	O
[	O
3	O
–	O
7	O
].	O

We	O
evaluated	O
the	O
relationship	O
between	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
and	O
BMD	O
at	O
one	O
week	O
of	O
age	O
.	O

Maternal	O
attitudes	O
were	O
related	O
to	O
self	O
-	O
reported	O
stress	O
status	O
ranging	O
from	O
low	O
and	O
medium	O
(	O
low	O
stress	O
response	O
)	O
to	O
high	O
and	O
very	O
high	O
(	O
high	O
stress	O
response	O
).	O

Because	O
it	O
is	O
possible	O
to	O
consume	O
fish	O
and	O
seafood	O
safely	O
during	O
pregnancy	O
,	O
through	O
following	O
recommendations	O
to	O
limit	O
high	O
mercury	O
species	O
,	O
it	O
is	O
prudent	O
to	O
recommend	O
that	O
pregnant	O
women	O
consume	O
these	O
foods	O
,	O
rather	O
than	O
rely	O
on	O
supplementation	O
,	O
in	O
order	O
to	O
maximise	O
infant	O
neurodevelopment	O
outcomes	O
.	O

Respond	O
In	O
response	O
to	O
Prasad	O
’	O
s	O
constructive	O
comments	O
on	O
our	O
quantitative	O
meta	O
-	O
analysis	O
of	O
the	O
estrogen	O
hypothesis	O
and	O
testicular	O
dysgenesis	O
syndrome	O
(	O
Martin	O
et	O
al	O
.	O

Vitamin	O
D	O
does	O
not	O
occur	O
naturally	O
in	O
foods	O
.	O

However	O
,	O
differences	O
in	O
vitamin	O
D	O
status	O
between	O
the	O
women	O
recruited	O
in	O
Adelaide	O
and	O
those	O
recruited	O
in	O
Auckland	O
reflect	O
obvious	O
difficulties	O
in	O
studying	O
how	O
vitamin	O
D	O
may	O
support	O
healthy	O
pregnancies	O
.	O

The	O
threshold	O
for	O
defining	O
vitamin	O
D	O
deficiency	O
and	O
the	O
diagnostic	O
criteria	O
for	O
GDM	O
vary	O
between	O
studies	O
,	O
which	O
might	O
affect	O
the	O
results	O
and	O
complicate	O
the	O
comparison	O
of	O
studies	O
.	O

During	O
summer	O
,	O
early	O
pregnancy	O
energy	O
(	O
kcal	O
)	O
was	O
associated	O
with	O
a	O
negligible	O
reduction	O
in	O
late	O
pregnancy	O
insulin	O
resistance	O
(−	O
0	O
.	O
1	O
%),	O
while	O
fat	O
(	O
g	O
)	O
was	O
associated	O
with	O
a	O
small	O
increase	O
in	O
late	O
pregnancy	O
insulin	O
resistance	O
(	O
1	O
.	O
4	O
%).	O

Discussion	O
Exposure	O
to	O
extended	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
increased	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

There	O
were	O
no	O
correlations	O
between	O
BMI	O
of	O
the	O
child	O
of	O
either	O
sex	O
at	O
ages	O
0	O
and	O
5	O
with	O
maternal	O
or	O
PGFs	O
,	O
so	O
this	O
evidence	O
suggests	O
that	O
transmission	O
of	O
BMI	O
is	O
not	O
primarily	B
genetic	O
.	O

Ex	O
vivo	O
or	O
in	O
vitro	O
experiments	O
on	O
human	O
embryonic	O
tissue	O
and	O
cells	O
are	O
quite	O
rightly	O
restricted	O
by	O
ethics	O
,	O
and	O
can	O
only	O
model	O
a	O
small	O
part	O
of	O
the	O
in	O
vivo	O
situation	O
.	O

Results	O
Cohort	O
While	O
194	O
children	O
had	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
(	O
55	O
%	O
of	O
the	O
original	O
cohort	O
participating	O
in	O
the	O
vitamin	O
D	O
pregnancy	O
study	O
),	O
133	O
(	O
38	O
%)	O
had	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
study	O
visit	O
and	O
thus	O
,	O
were	O
able	O
to	O
have	O
cathelicidin	O
measured	O
.	O

[	O
37	O
]	O
expanded	O
on	O
this	O
and	O
illustrated	O
a	O
case	O
control	O
study	O
of	O
4429	O
children	O
with	O
autism	O
.	O

PubMed	O
Central	O
:	O

Provider	O
advice	O
is	O
key	O
in	O
helping	O
women	O
meet	O
appropriate	O
GWG	O
targets	O
[	O
6	O
].	O

We	O
suggest	O
different	O
adaptive	O
explanations	B
for	O
these	O
pathways	O
and	O
for	O
their	O
relationship	O
to	O
altered	O
metabolic	O
homeostasis	O
.	O

Type	O
2	O
iodothyronine	O
deiodinase	O
(	O
D2	O
),	O
responsible	O
for	O
the	O
transformation	O
of	O
thyroxine	O
(	O
T4	O
)	O
to	O
triiodothyronine	O
(	O
T3	O
),	O
is	O
also	O
inducing	O
UCP1	O
expression	O
locally	O
,	O
in	O
BAT	O
(	O
de	O
Jesus	O
et	O
al	O
.,	O
2001	O
).	O

Eukaryotic	O
cells	O
evolved	O
elaborate	O
mechanisms	O
to	O
verify	O
the	O
fidelity	O
of	O
cell	O
division	O
.	O

The	O
primary	O
analysis	O
was	O
powered	O
to	O
assess	O
changes	O
in	O
haemoglobin	O
concentration	O
,	O
which	O
limited	O
the	O
scope	O
of	O
this	O
study	O
to	O
the	O
functional	O
effect	O
of	O
MMN	O
supplementation	O
on	O
nutritional	O
anaemia	O
.	O

The	O
induction	O
of	O
adverse	O
DNA	O
mutations	O
by	O
environmental	O
factors	O
that	O
lead	O
to	O
disease	O
,	O
particularly	O
cancer	O
,	O
is	O
well	B
established	I
and	O
recognized	B
by	O
regulatory	O
bodies	O
worldwide	O
.	O

These	O
women	O
had	O
significantly	O
higher	O
pre	O
-	O
pregnancy	O
weight	O
,	O
experienced	O
more	O
associated	O
comorbidities	O
and	O
instrumental	O
deliveries	O
,	O
and	O
delivered	O
a	O
greater	O
proportion	O
of	O
large	O
for	O
gestational	O
age	O
neonates	O
.	O

Hypocalcemia	O
is	O
common	O
in	O
preterm	O
infants	O
,	O
infants	O
born	O
to	O
gestational	O
diabetic	O
mothers	O
and	O
infants	O
on	O
cow	O
'	O
s	O
milk	O
.	O

Logistic	O
regression	O
,	O
multinomial	O
logistic	O
regression	O
and	O
linear	O
regression	O
were	O
used	O
to	O
analyse	O
relations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
binary	O
,	O
categorical	O
and	O
continuous	O
outcomes	O
,	O
respectively	O
.	O

Cardiovascular	O
exam	O
revealed	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	O
,	O
rubs	O
,	O
or	O
gallops	O
.	O

In	O
view	O
of	O
the	O
multiple	O
analyses	O
carried	O
out	O
and	O
the	O
post	O
hoc	O
nature	O
of	O
the	O
findings	O
for	O
atopic	O
asthma	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
the	O
main	O
findings	O
occurred	O
by	O
chance	O
;	O
hence	B
,	O
they	O
should	O
be	O
interpreted	O
with	O
caution	O
.	O

Given	B
the	O
small	O
sample	O
size	O
,	O
unadjusted	O
models	O
were	O
used	O
in	O
most	O
of	O
the	O
analyses	O
.	O

The	O
aim	O
of	O
the	O
primary	O
treatment	O
is	O
an	O
adequate	O
excision	O
of	O
the	O
primary	O
tumour	O
and	O
any	O
loco	O
-	O
regional	O
extension	O
.	O

We	O
collected	O
the	O
data	O
from	O
July	O
to	O
October	O
2012	O
,	O
in	O
two	O
villages	O
,	O
one	O
in	O
Mymensingh	O
and	O
one	O
in	O
Netrokona	O
–	O
two	O
of	O
the	O
five	O
districts	O
included	O
in	O
the	O
Shonjibon	O
Trial	O
.	O

We	O
will	O
base	O
the	O
data	O
for	O
the	O
cost	O
-	O
effectiveness	O
analysis	O
on	O
the	O
costs	O
and	O
outcomes	O
observed	O
in	O
the	O
trial	O
.	O

Persistent	O
or	O
recurrent	O
disease	O
Pregnant	O
patients	O
with	O
the	O
evidence	O
of	O
persistent	O
disease	O
despite	O
therapy	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

A	O
study	O
of	O
postpartum	O
women	O
employed	O
a	O
team	O
approach	O
to	O
encourage	O
women	O
to	O
use	O
a	O
Facebook	O
app	O
to	O
promote	O
PA	O
[	O
19	O
].	O

We	O
and	O
others	O
have	O
previously	O
demonstrated	O
that	O
methylation	O
of	O
CpG	O
loci	O
detected	O
through	O
BeadArray	O
platforms	O
can	O
be	O
reliably	O
replicated	O
using	O
alternative	O
detection	O
techniques	O
including	O
pyrosequencing	O
,	O
MassARRAY	O
analysis	O
,	O
and	O
quantitative	O
methylation	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
(	O
Ang	O
et	O
al	O
.	O

In	O
Romania	O
,	O
almost	O
all	O
women	O
are	O
hospitalised	O
for	O
at	O
least	O
3	O
days	O
post	O
-	O
partum	O
during	O
which	O
time	O
the	O
newborn	O
is	O
immunised	O
against	O
tuberculosis	O
and	O
hepatitis	O
B	O
;	O
it	O
is	O
very	O
uncommon	O
to	O
leave	O
the	O
hospital	O
earlier	O
.	O

It	O
is	O
important	O
to	O
recognize	O
that	O
many	O
individuals	O
who	O
use	O
text	O
messages	O
receive	O
large	O
numbers	O
of	O
texts	O
per	O
day	O
.	O

With	O
respect	O
to	O
the	O
reasons	O
that	O
influenced	O
the	O
respondents	O
’	O
choice	O
of	O
health	O
centre	O
,	O
the	O
main	O
factor	O
affecting	O
the	O
choice	O
of	O
ANC	O
site	O
was	O
geographical	O
accessibility	O
.	O

To	O
our	O
knowledge	O
,	O
only	O
three	O
randomised	O
trials	O
involving	O
the	O
provision	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
[	O
15	O
–	O
17	O
]	O
have	O
conducted	O
and	O
reported	O
findings	O
of	O
follow	O
-	O
up	O
to	O
6	O
months	O
after	O
birth	O
[	O
18	O
–	O
20	O
].	O

Pre	O
-	O
pregnancy	O
obesity	O
is	O
also	O
associated	O
with	O
significant	O
increases	O
in	O
the	O
odds	O
of	O
maternal	O
and	O
neonatal	O
vitamin	O
D	O
deficiency	O
,	O
independent	O
of	O
other	O
factors	O
such	O
as	O
ethnicity	O
.	O

This	O
accounts	O
for	O
the	O
low	O
rate	O
of	O
these	O
health	O
talks	O
in	O
this	O
study	O
as	O
opposed	O
to	O
other	O
studies	O
[	O
26	O
].	O

2	O
.	O
7	O
.	O

After	O
that	O
,	O
several	O
studies	O
have	O
validated	O
its	O
use	O
throughout	O
the	O
antenatal	O
period	O
[	O
37	O
–	O
39	O
].	O

In	O
the	O
40	O
children	O
in	O
whom	O
repeat	O
yearly	O
cathelicidin	O
concentrations	O
were	O
available	O
,	O
a	O
Wilcoxon	O
signed	O
rank	O
test	O
of	O
paired	O
samples	O
was	O
performed	O
.	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Furthermore	O
,	O
loss	O
to	O
follow	O
-	O
up	O
bias	O
has	O
been	O
shown	O
to	O
only	O
slightly	O
modify	O
associations	O
in	O
longitudinal	O
studies	O
,	O
including	O
in	O
ALSPAC	O
[	O
49	O
],	O
and	O
the	O
results	O
of	O
our	O
inverse	O
probability	O
weighting	O
analysis	O
[	O
35	O
]	O
confirmed	O
that	O
loss	O
to	O
follow	O
-	O
up	O
is	O
unlikely	B
to	O
have	O
biased	O
our	O
results	O
.	O

Studies	O
in	O
which	O
participants	O
were	O
chosen	O
at	O
convenience	O
were	O
not	O
considered	O
in	O
this	O
review	O
.	O

Therefore	B
,	O
rampant	O
caries	O
can	O
influence	O
nutritional	O
health	O
.	O

Our	O
systematic	O
review	O
identified	O
one	O
randomised	O
placebo	O
controlled	O
trial3relating	O
pneumonia	O
or	O
lower	O
respiratory	O
infections	O
to	O
vitamin	O
D	O
deficiency	O
supplementation	O
in	O
young	O
children	O
.	O

No	O
studies	O
adjusted	O
for	O
maternal	O
responsiveness	O
which	O
has	O
been	O
shown	O
to	O
be	O
related	O
to	O
developmental	O
outcomes	O
independent	O
of	O
sociodemographic	O
factors	O
[	O
28	O
].	O

Research	O
considerations	O
for	O
public	O
health	O
There	O
is	O
no	O
doubt	O
that	O
humans	O
are	O
exposed	O
to	O
a	O
range	O
of	O
environmental	O
factors	O
during	O
everyday	O
life	O
.	O

2	O
.	O
5	O
.	O

Smoking	O
Maternal	O
smoking	O
and	O
passive	O
exposure	O
to	O
smoke	O
should	O
both	O
be	O
avoided	O
.	O

Delivery	O
research	O
Delivery	O
or	O
implementation	O
research	O
addresses	O
how	O
interventions	O
can	O
be	O
best	O
implemented	O
,	O
especially	O
in	O
resource	O
-	O
constrained	O
settings	O
where	O
coverage	O
inequalities	O
are	O
more	O
pronounced	O
so	O
that	O
all	O
families	O
are	O
reached	O
with	O
effective	O
care	O
.	O

Significance	O
was	O
assumed	O
at	O
a	O
p	O
<	O
0	O
.	O
05	O
.	O

Owing	O
to	O
the	O
lack	O
of	O
other	O
available	O
data	O
,	O
we	O
used	O
the	O
annual	O
number	O
of	O
live	O
births	O
in	O
Iaşi	O
county	O
reported	O
on	O
01	O
July	O
2009	O
(	O
n	O
=	O
9	O
,	O
499	O
)	O
to	O
define	O
the	O
size	O
of	O
the	O
reference	O
group	O
[	O
23	O
].	O

The	O
results	O
from	O
this	O
study	O
may	O
serve	O
as	O
a	O
basis	O
for	O
the	O
development	O
of	O
context	O
-	O
specific	O
nutritional	O
interventions	O
which	O
can	O
improve	O
birth	O
outcomes	O
and	O
long	O
-	O
term	O
quality	O
of	O
life	O
of	O
the	O
mother	O
and	O
her	O
offspring	O
.	O

2	O
Trial	O
flow	O
chart	O
and	O
intervention	O
schedule	O
Types	O
of	O
information	O
collected	O
Over	O
the	O
pregnancy	O
and	O
neonatal	O
period	O
,	O
data	O
collectors	O
will	O
collect	O
information	O
regarding	O
household	O
characteristics	O
,	O
reproductive	O
history	O
,	O
pregnancy	O
information	O
,	O
medication	O
history	O
,	O
details	O
about	O
consumption	O
of	O
IFA	O
supplements	O
,	O
current	O
health	O
status	O
,	O
any	O
side	O
effects	O
from	O
the	O
supplements	O
,	O
antenatal	O
care	O
,	O
birth	O
outcome	O
,	O
birth	O
weight	O
,	O
immediate	O
newborn	O
care	O
and	O
neonatal	O
deaths	O
.	O

Secondary	O
prevention	O
addresses	O
individuals	O
with	O
early	O
indicators	O
of	O
atopic	O
disease	O
.	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

None	O
of	O
the	O
top	O
5	O
vegetables	O
eaten	O
by	O
toddlers	O
was	O
a	O
dark	O
green	O
vegetable	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
feeding	O
response	O
to	O
AM251	O
in	O
adult	O
offspring	O
The	O
feeding	O
behavior	O
to	O
AM251	O
(	O
chocolate	O
and	O
total	O
caloric	O
intake	O
)	O
was	O
evaluated	O
for	O
4	O
h	O
in	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
13	O
–	O
14	O
(	O
Figures3E	O
–	O
H	O
).	O

Findings	O
of	O
a	O
study	O
revealed	O
the	O
positive	O
impact	O
on	O
reducing	O
the	O
levels	O
of	O
anemia	O
in	O
children	O
between	O
6	O
-	O
60	O
months	O
in	O
India	O
(	O
6	O
).	O

Social	O
context	O
can	O
range	O
from	O
family	O
,	O
to	O
school	O
,	O
to	O
the	O
broader	O
community	O
.	O

Hogans	O
and	O
corrals	O
were	O
built	O
with	O
mine	O
wastes	O
,	O
as	O
were	O
roads	O
.	O

Alarmingly	O
,	O
in	O
the	O
birth	O
cohort	O
study	O
from	O
the	O
Isle	O
of	O
Wight	O
,	O
about	O
43	O
%	O
of	O
children	O
had	O
been	O
exposed	O
to	O
environmental	O
tobacco	O
smoke	O
during	O
their	O
first	O
year	O
of	O
life	O
[	O
38	O
].	O

The	O
unit	O
in	O
the	O
model	O
is	O
the	O
family	O
member	O
.	O

We	O
suggest	O
the	O
long	O
-	O
term	O
fallow	O
up	O
of	O
mothers	O
and	O
infants	O
with	O
more	O
abundant	O
sample	O
.	O

Women	O
who	O
were	O
prescribed	O
increased	O
doses	O
of	O
valproic	O
acid	O
showed	O
a	O
twofold	O
increase	O
in	O
risk	O
of	O
developmental	O
malformations	O
and	O
significantly	O
reduced	O
intelligence	O
[	O
30	O
].	O

Conversely	O
,	O
several	O
studies	O
in	O
both	O
rodents	O
and	O
humans	O
have	O
shown	O
that	O
BAT	O
activation	O
(	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
treatment	O
,	O
transplantation	O
and	O
others	O
)	O
improves	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
.	O

There	O
are	O
also	O
data	O
from	O
a	O
total	O
of	O
48	O
women	O
with	O
GDM	O
.	O
46	O
,	O
47To	O
date	O
no	O
randomized	O
controlled	O
studies	O
have	O
been	O
published	O
.	O

Guidelines	O
from	O
Australia	O
[	O
2	O
],	O
Europe	O
[	O
3	O
]	O
and	O
the	O
USA	O
[	O
4	O
]	O
encourage	O
the	O
consumption	O
of	O
fish	O
during	O
pregnancy	O
.	O

Cole	O
et	O
al	O
,	O
30for	O
instance	O
,	O
concluded	O
that	O
ponderal	O
index	O
was	O
not	O
appropriate	O
for	O
measuring	O
intrauterine	O
malnutrition	O
.	O

There	O
was	O
a	O
systematic	O
and	O
statistically	O
significant	O
difference	O
in	O
the	O
height	O
of	O
the	O
two	O
groups	O
of	O
fathers	O
—	O
those	O
reported	O
were	O
significantly	O
taller	O
than	O
those	O
measured	O
.	O

The	O
frequencies	O
of	O
subjects	O
suffering	O
from	O
moderate	O
vitamin	O
deficiency	O
in	O
the	O
CG	O
group	O
were	O
42	O
.	O
9	O
%	O
and	O
47	O
.	O
6	O
%	O
before	O
and	O
after	O
the	O
intervention	O
,	O
respectively	O
.	O

Twice	O
this	O
correlation	O
is	O
then	O
defined	O
to	O
be	O
the	O
heritability	O
.	O

Strong	O
homogeneous	O
staining	O
mainly	B
in	O
the	O
cytoplasm	O
is	O
detected	O
in	O
the	O
syncytiotrophoblast	O
cells	O
on	O
the	O
outermost	O
layer	O
of	O
the	O
placental	O
villi	O
,	O
with	O
some	O
scattered	O
expression	O
in	O
cytotrophoblast	O
cells	O
(	O
Figure	O
2	O
(	O
a	O
)).	O

There	O
is	O
an	O
increased	O
risk	O
of	O
Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
[	O
9	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Distribution	O
of	O
birth	O
weight	O
in	O
relation	O
to	O
participant	O
characteristics	O
among	O
women	O
in	O
the	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
Cincinnati	O
,	O
OHn	O
(%)	O
Birth	O
weight	O
(	O
g	O
)	O
mean	O
(	O
SD	O
)	O
All	O
participants384	O
(	O
100	O
%)	O
3371	O
(	O
618	O
)	O
Age	O
at	O
delivery	O
<	O
2593	O
(	O
24	O
.	O
2	O
%)	O
3079	O
(	O
597	O
)	O
25	O
-<	O
30107	O
(	O
27	O
.	O
8	O
%)	O
3489	O
(	O
876	O
)	O
30	O
-<	O
35121	O
(	O
31	O
.	O
5	O
%)	O
3469	O
(	O
906	O
)	O
>	O
3563	O
(	O
16	O
.	O
5	O
%)	O
3409	O
(	O
773	O
)	O
Race	O
White273	O
(	O
61	O
.	O
7	O
%)	O
3514	O
(	O
592	O
)	O
Black	O
or	O
Other147	O
(	O
38	O
.	O
3	O
%)	O
3141	O
(	O
753	O
)	O
Marital	O
Status	O
Living	O
with	O
spouse	O
/	O
partner248	O
(	O
64	O
.	O
5	O
%)	O
3484	O
(	O
600	O
)	O
Not	O
living	O
with	O
spouse	O
/	O
partner136	O
(	O
35	O
.	O
5	O
%)	O
3165	O
(	O
746	O
)	O
Employment	O
Status	O
Unemployed74	O
(	O
19	O
.	O
3	O
%)	O
3278	O
(	O
617	O
)	O
Employed310	O
(	O
80	O
.	O
7	O
%)	O
3392	O
(	O
1263	O
)	O
Income	O
<	O
25	O
,	O
000124	O
(	O
32	O
.	O
3	O
%)	O
3154	O
(	O
729	O
)	O
≥	O
25	O
,	O
000260	O
(	O
67	O
.	O
7	O
%)	O
3475	O
(	O
600	O
)	O
Insurance	O
Private272	O
(	O
70	O
.	O
8	O
%)	O
3466	O
(	O
601	O
)	O
Public	O
/	O
None112	O
(	O
29	O
.	O
2	O
%)	O
3141	O
(	O
714	O
)	O
Education	O
Level	O
≥	O
High	O
school343	O
(	O
89	O
.	O
3	O
%)	O
3409	O
(	O
608	O
)	O
<	O
High	O
school41	O
(	O
10	O
.	O
7	O
%)	O
3050	O
(	O
644	O
)	O
Tobacco	O
Use	O
(	O
Mean	O
Cotinine	O
Levels	O
)	O
Non	O
smoker	O
(≤	O
3	O
ng	O
/	O
ml	O
)	O
341	O
(	O
88	O
.	O
8	O
%)	O
3387	O
(	O
617	O
)	O
Active	O
Smoker	O
(>	O
3	O
ng	O
/	O
ml	O
)	O
43	O
(	O
12	O
.	O
1	O
%)	O
3241	O
(	O
655	O
)	O
Gender	O
of	O
Baby	O
Male178	O
(	O
46	O
.	O
3	O
%)	O
3477	O
(	O
610	O
)	O
Female206	O
(	O
53	O
.	O
7	O
%)	O
3279	O
(	O
897	O
)	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Underweight4	O
(	O
0	O
.	O
1	O
%)	O
2940	O
(	O
625	O
)	O
Normal159	O
(	O
41	O
.	O
4	O
%)	O
3328	O
(	O
618	O
)	O
Overweight127	O
(	O
33	O
.	O
1	O
%)	O
3412	O
(	O
828	O
)	O
Obese94	O
(	O
24	O
.	O
4	O
%)	O
3406	O
(	O
779	O
)	O
Abbreviations	O
:	O
SD	O
standard	O
deviation	O
,	O
BMI	O
body	O
mass	O
index	O
Outcome	O
variables	O
The	O
outcome	O
variable	O
was	O
birth	O
weight	O
,	O
measured	O
in	O
grams	O
(	O
g	O
).	O

Procedures	O
We	O
chose	O
a	O
quarterly	O
supplementation	O
regimen	O
because	O
in	O
routine	O
programme	O
conditions	O
a	O
quarterly	O
regimen	O
is	O
likely	B
to	O
have	O
better	O
adherence	O
than	O
a	O
daily	O
regimen	O
,	O
13	O
,	O
14and	O
has	O
been	O
shown	O
to	O
be	O
effective	O
at	O
maintaining	O
the	O
serum	O
vitamin	O
D	O
concentration	O
within	O
normal	O
ranges	O
for	O
2	O
–	O
3	O
months	O
in	O
a	O
French	O
high	O
-	O
risk	O
infant	O
population	O
.	O
16The	O
syringes	O
containing	O
vitamin	O
D	O
or	O
placebo	O
were	O
stored	O
in	O
conditions	O
recommended	O
by	O
the	O
manufacturer	O
—	O
a	O
dry	O
cool	O
environment	O
—	O
between	O
2	O
and	O
24	O
weeks	O
before	O
administration	O
.	O

Research	O
has	O
found	O
direct	O
connections	O
between	O
vitamin	O
D	O
and	O
the	O
genes	O
known	O
to	O
be	O
involved	O
in	O
MS	O
,	O
but	O
exact	O
pathology	O
and	O
whether	O
vitamin	O
D	O
supplements	O
during	O
pregnancy	O
or	O
childhood	O
can	O
lessen	O
the	O
likelihood	O
of	O
the	O
child	O
developing	O
MS	O
later	O
in	O
life	O
is	O
not	O
known	O
.	O

Therefore	B
,	O
understanding	O
the	O
differences	O
between	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
dietary	O
patterns	O
and	O
usual	O
Iranian	O
dietary	O
pattern	O
might	O
help	O
interpreting	O
the	O
importance	O
of	O
the	O
findings	O
we	O
reached	O
.	O

Uncomplicated	O
pregnancies	O
were	O
defined	O
as	O
those	O
without	O
any	O
pregnancy	O
disorder	O
who	O
delivered	O
an	O
appropriate	O
weight	O
for	O
gestational	O
age	O
infant	O
at	O
term	O
(≥	O
37	O
weeks	O
gestation	O
)	O
[	O
31	O
].	O

As	O
shown	O
in	O
a	O
companion	O
qualitative	O
investigation	O
,	O
this	O
model	O
was	O
used	O
to	O
understand	O
drivers	O
of	O
maternal	O
handwashing	O
in	O
the	O
neonatal	O
period	O
[	O
11	O
].	O

Differences	O
between	O
the	O
SC	O
group	O
(	O
c	O
)	O
and	O
the	O
VitD	O
-	O
group	O
(	O
d	O
)	O
are	O
less	O
marked	O
in	O
the	O
F2	O
generation	O
.	O

This	O
was	O
an	O
important	O
focus	O
of	O
text4baby	O
messages	O
,	O
including	O
both	O
recommendations	O
not	O
to	O
drink	O
and	O
also	O
warnings	O
about	O
the	O
health	O
risks	O
of	O
fetal	O
alcohol	O
syndrome	O
for	O
unborn	O
babies	O
.	O

But	O
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

A	O
deficiency	O
in	O
this	O
protein	O
in	O
conjunction	O
with	O
undesirable	O
vitamin	O
D	O
,	O
PTH	O
,	O
and	O
calcium	O
levels	O
may	O
suggest	O
that	O
children	O
with	O
S	O
-	O
ECC	O
have	O
nutritional	O
deficiencies	O
.	O

Their	O
median	O
increase	O
in	O
cathelicidin	O
from	O
the	O
first	O
visit	O
to	O
the	O
second	O
visit	O
was	O
24	O
.	O
0	O
ng	O
/	O
mL	O
(	O
ranging	O
from	O
-	O
1	O
.	O
9	O
ng	O
/	O
mL	O
to	O
+	O
223	O
.	O
4	O
ng	O
/	O
mL	O
,	O
p	O
≤	O
0	O
.	O
0001	O
)	O
(	O
Fig	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Change	O
of	O
Cathelicidin	O
Concentration	O
over	O
Time	O
.	O

Despite	O
numerous	O
publications	O
,	O
its	O
influence	O
on	O
reproductive	O
health	O
remains	O
ambiguous	O
.	O

liver	O
,	O
eggs	O
,	O
fish	O
,	O
fortified	O
orange	O
juice	O
)	O
were	O
not	O
significantly	O
associated	O
with	O
higher	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
data	O
not	O
shown	O
).	O

To	O
clarify	O
the	O
TFBSs	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	O
with	O
either	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
gene	O
set	O
enrichment	O
analysis	O
(	O
GSEA	O
)	O
(	O
Subramanian	O
et	O
al	O
.	O

The	O
purpose	O
of	O
the	O
single	O
24	O
-	O
HR	O
is	O
to	O
describe	O
the	O
average	O
intake	O
of	O
the	O
group	O
[	O
38	O
].	O

U51GH001191	O
)	O
and	O
thePan	O
American	O
Health	O
Organization	O
(	O
PAHO	O
)	O
(	O
NIC	O
15010973	O
).	O

Wagner	O
et	O
al	O
.	O

Attributes	O
of	O
the	O
delivery	O
room	O
and	O
birthing	O
experience	O
also	O
may	O
have	O
a	O
role	O
in	O
autism	O
.	O

The	O
experiment	O
comprises	O
a	O
valuable	O
model	O
especially	O
for	O
'	O
fetal	O
'	O
programming	O
,	O
because	O
cross	O
-	O
fostering	O
enabled	O
assessment	O
of	O
solely	O
the	O
nutritional	O
effects	O
during	O
gestation	O
.	O

Particularly	O
,	O
we	O
evaluated	O
the	O
gene	O
expression	O
of	O
relevant	O
components	O
of	O
the	O
endocannabinoid	O
system	O
,	O
and	O
key	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
metabolically	O
relevant	O
tissues	O
,	O
such	O
as	O
the	O
hypothalamus	O
,	O
the	O
liver	O
,	O
and	O
the	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
),	O
of	O
male	O
and	O
female	O
adult	O
offspring	O
.	O

Therefore	O
,	O
a	O
nonparametric	O
test	O
was	O
used	O
for	O
25	O
-	O
hydroxyvitamin	O
D	O
data	O
.	O

Our	O
age	O
limits	O
were	O
15	O
to	O
55	O
years	O
and	O
those	O
patients	O
with	O
estimated	O
expanded	O
disability	O
status	O
scale	O
less	O
than	O
5	O
were	O
introduced	O
to	O
the	O
study	O
.	O

The	O
accuracy	O
of	O
the	O
tests	O
for	O
the	O
population	O
depends	O
on	O
when	O
the	O
test	O
was	O
standardised	O
and	O
within	O
what	O
population	O
.	O

However	O
,	O
maternal	O
adherence	O
to	O
healthy	O
dietary	O
pattern	O
was	O
not	O
related	O
to	O
birth	O
weight	O
of	O
infants	O
in	O
all	O
crude	O
and	O
adjusted	O
models	O
.	O

In	O
contrast	O
,	O
in	O
the	O
previous	O
studies	O
2000	O
IU	O
vitamin	O
D	O
supplementation	O
was	O
more	O
sufficient	O
to	O
increase	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
up	O
to	O
the	O
adequate	O
amount	O
(≥	O
32	O
ng	O
/	O
mL	O
)	O
[	O
18	O
,	O
57	O
,	O
58	O
].	O

Surveys	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
iron	O
/	O
folic	O
acid	O
in	O
their	O
last	O
pregnancy	O
but	O
this	O
dropped	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
(	O
3	O
).	O

The	O
numbers	O
at	O
vertical	O
arrows	O
are	O
the	O
number	O
of	O
probe	O
-	O
sets	O
differentially	O
expressed	O
between	O
AP	O
and	O
LP	O
offspring	O
at	O
the	O
same	O
ontogenetic	O
stage	O
.	O

If	O
a	O
fetal	O
loss	O
occurred	O
at	O
any	O
time	O
during	O
the	O
pregnancy	O
,	O
patients	O
were	O
disenrolled	O
from	O
text4baby	O
and	O
appropriate	O
perinatal	O
grief	O
counseling	O
was	O
offered	O
to	O
the	O
patient	O
and	O
her	O
partner	O
.	O

FLNB	O
comprises	O
an	O
actin	O
-	O
binding	O
domain	O
(	O
ABD	O
)	O
containing	O
two	O
calponin	O
homology	O
(	O
CH	O
)	O
domains	O
at	O
the	O
amino	O
terminus	O
,	O
followed	O
by	O
24	O
filamin	O
repeat	O
domains	O
that	O
are	O
separated	O
by	O
two	O
hinge	O
(	O
1H	O
-	O
2	O
)	O
regions	O
.	O

Conclusion	O
We	O
found	O
that	O
a	O
handwashing	O
promotion	O
strategy	O
that	O
consisted	O
of	O
both	O
providing	O
the	O
necessary	O
materials	O
for	O
handwashing	O
and	O
intensive	O
behavior	O
change	O
communication	O
resulted	O
in	O
anemic	O
improvements	O
in	O
handwashing	O
behavior	O
among	O
mothers	O
of	O
newborns	O
.	O

Therefore	O
it	O
is	O
commonplace	O
for	O
the	O
diabetes	O
care	O
team	O
to	O
provide	O
the	O
women	O
with	O
information	O
and	O
education	O
to	O
facilitate	O
self	O
-	O
care	O
.	O

The	O
lower	O
SEI	O
of	O
the	O
Adelaide	O
women	O
could	O
therefore	B
make	O
them	O
more	O
susceptible	O
to	O
lower	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
because	O
of	O
factors	O
relating	O
to	O
disadvantage	O
.	O

In	O
contrast	O
to	O
a	O
previous	O
study	O
which	O
reported	O
a	O
link	O
between	O
gestational	O
diabetes	O
and	O
risk	O
of	O
atopic	O
eczema	O
and	O
atopy	O
in	O
early	O
childhood	O
[	O
43	O
],	O
we	O
found	O
no	O
association	O
between	O
maternal	O
diabetes	O
during	O
pregnancy	O
and	O
any	O
outcome	O
in	O
the	O
offspring	O
,	O
although	O
,	O
as	O
expected	O
[	O
44	O
],	O
maternal	O
diabetes	O
was	O
associated	O
with	O
higher	O
birthweight	O
.	O

1997	O
)	O
and	O
therefore	O
may	O
play	O
a	O
distinct	O
role	O
in	O
both	O
repetitive	O
element	O
and	O
gene	O
-	O
directed	O
methylation	O
.	O

We	O
investigated	O
whether	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
differed	O
between	O
mothers	O
with	O
(	O
n	O
=	O
81	O
)	O
and	O
without	O
GDM	O
(	O
n	O
=	O
639	O
)	O
(	O
Fig	O
.	O

The	O
albendazole	O
for	O
helminth	O
control	O
was	O
kindly	O
donated	O
by	O
WHO	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

The	O
deleterious	O
effects	O
on	O
development	O
often	B
vary	O
in	O
accordance	O
to	O
nature	O
of	O
the	O
cause	O
and	O
period	O
of	O
exposure	O
to	O
adverse	O
factors	O
which	O
have	O
led	O
to	O
low	O
birth	O
weight	O
.	O

that	O
late	O
but	O
not	O
early	O
pregnancy	O
25OHD	O
was	O
related	O
to	O
gestational	O
length	O
and	O
neonatal	O
birth	O
size	O
[	O
8	O
].	O

Preeclampsia	O
rates	O
are	O
elevated	O
during	O
winter	O
months	O
,	O
when	O
sunlight	O
-	O
dependent	O
25	O
(	O
OH	O
)	O
D	O
productions	O
are	O
reduced	O
.	O

The	O
characteristics	O
of	O
this	O
cohort	O
are	O
found	O
inTable	O
1	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Maternal	O
sociodemographic	O
and	O
clinical	O
characteristics	O
of	O
cohort	O
.	O
CharacteristicMUSC	O
Cohort	O
(	O
N	O
=	O
1	O
,	O
064	O
)	O
Race	O
/	O
ethnicity	O
(	O
N	O
,	O
%)	O
*	O
White488	O
(	O
46	O
%)	O
African	O
American395	O
(	O
37	O
%)	O
Hispanic117	O
(	O
11	O
%)	O
Asian	O
/	O
PI19	O
(	O
2	O
%)	O
Multiple	O
/	O
Other39	O
(	O
4	O
%)	O
Maternal	O
age	O
,	O
years	O
(	O
median	O
and	O
range	O
)	O
29	O
(	O
18	O
–	O
45	O
)	O
Parity	O
(	O
median	O
and	O
range	O
)	O
1	O
(	O
0	O
–	O
9	O
)	O
Gravidity	O
(	O
median	O
and	O
range	O
)	O
2	O
(	O
1	O
–	O
11	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
(	O
median	O
and	O
range	O
)	O
*	O
25	O
(	O
12	O
–	O
66	O
)	O
Marital	O
status	O
(	O
N	O
,%)	O
Married530	O
(	O
50	O
%)	O
Insurance	O
status	O
(	O
N	O
,%)	O
None	O
/	O
Medicaid519	O
(	O
49	O
%)	O
Education	O
,	O
years	O
(	O
median	O
and	O
range	O
)	O
*	O
13	O
(	O
4	O
–	O
20	O
)	O
History	O
of	O
Preterm	O
Birth	O
(	O
N	O
,%)	O
Yes140	O
(	O
13	O
%)	O
Birth	O
Outcome	O
(	O
N	O
,%)	O
Preterm	O
(<	O
37	O
weeks	O
)	O
139	O
(	O
13	O
%)	O
*	O
6	O
women	O
missing	O
race	O
/	O
ethnicity	O
data	O
,	O
31	O
missing	O
BMI	O
data	O
,	O
and	O
91	O
missing	O
education	O
data	O
.	O

Obviously	O
,	O
this	O
initiates	O
an	O
immediate	O
recovery	O
of	O
the	O
activity	O
of	O
genes	O
to	O
'	O
normal	O
level	O
'	O
reflected	O
by	O
similar	O
expression	O
pattern	O
in	O
LP	O
and	O
AP	O
piglets	O
.	O

Many	O
of	O
the	O
findings	O
regarding	O
the	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
GDM	O
are	O
based	O
on	O
case	O
-	O
control	O
studies	O
,	O
which	O
may	O
include	O
a	O
potential	O
selection	O
bias	O
.	O

2008	O
).	O

Papillary	O
thyroid	O
cancer	O
is	O
the	O
most	O
common	O
histological	O
type	O
detected	O
in	O
pregnant	O
women	O
,	O
and	O
in	O
most	O
series	O
90	O
%	O
to	O
95	O
%	O
of	O
thyroid	O
carcinoma	O
diagnosed	O
are	O
Stage	O
I	O
disease	O
,	O
with	O
the	O
majority	B
found	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
during	O
the	O
first	O
antenatal	O
visit	O
.	O

In	O
multivariable	O
modeling	O
,	O
each	O
EDC	O
exposure	O
was	O
standardized	O
(	O
mean	O
=	O
0	O
,	O
standard	O
deviation	O
=	O
1	O
)	O
and	O
BHLM	O
was	O
fitted	O
using	O
Bayesian	O
software	O
Stan	O
and	O
the	O
'	O
rstan	O
'	O
package	O
in	O
R	O
[	O
40	O
,	O
41	O
].	O

It	O
has	O
been	O
reported	O
that	O
low	O
birth	O
weight	O
is	O
related	O
to	O
modulation	O
of	O
both	O
the	O
sympathetic	O
and	O
parasympathetic	O
function	O
from	O
the	O
prenatal	O
period	O
through	O
childhood	O
and	O
adult	O
life	O
[	O
17	O
,	O
19	O
,	O
20	O
,	O
34	O
–	O
38	O
].	O

In	O
addition	O
,	O
it	O
was	O
recently	O
proposed	O
that	O
FGF21	O
could	O
act	O
within	O
the	O
central	O
nervous	O
system	O
,	O
both	O
at	O
the	O
level	O
of	O
the	O
hypothalamus	O
and	O
the	O
hindbrain	O
to	O
promote	O
a	O
set	O
of	O
responses	O
that	O
occur	O
during	O
starvation	O
(	O
i	O
.	O
e	O
.	O

Medical	O
history	O
of	O
liver	O
disease	O
;	O
3	O
).	O

The	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
[	O
25	O
(	O
OH	O
)	O
D	O
<	O
50	O
nmol	O
/	O
L	O
]	O
during	O
pregnancy	O
was	O
similar	O
between	O
mothers	O
with	O
or	O
without	O
GDM	O
[	O
4	O
.	O
9	O
%	O
(	O
4	O
/	O
81	O
)	O
vs	O
3	O
.	O
3	O
%	O
(	O
21	O
/	O
642	O
),	O
P	O
=	O
0	O
.	O
51	O
].	O

In	O
the	O
current	O
study	O
the	O
birth	O
weight	O
explained	O
15	O
%	O
of	O
the	O
variance	O
in	O
RMSSD	O
index	O
(	O
R2	O
=	O
0	O
.	O
15	O
)	O
(	O
Table	O
2	O
).	O

Introduction	O
Pregnancy	O
is	O
associated	O
with	O
major	O
physiological	O
and	O
future	O
psychosocial	O
changes	O
and	O
adaptation	O
to	O
these	O
changes	O
is	O
crucial	O
for	O
normal	O
fetal	O
development	O
and	O
for	O
healthy	O
infant	O
-	O
mother	O
relationships	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Height	O
correlations	O
from	O
a	O
mixed	O
model	O
between	O
the	O
child	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
membersHeight	O
correlations	O
between	O
girls	O
and	O
boys	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
membersGroupChildMotherFatherMGMMGFPGMPGFChild	O
'	O
s	O
age	O
01	O
.	O
0000	O
.	O
1330	O
.	O
1960	O
.	O
0610	O
.	O
0360	O
.	O
1050	O
.	O
079p	O
Value0	O
.	O
002	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
2770	O
.	O
6240	O
.	O
1570	O
.	O
309Child	O
'	O
s	O
age	O
5	O
0	O
.	O
3860	O
.	O
3630	O
.	O
1820	O
.	O
1910	O
.	O
2470	O
.	O
424p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
003	O
*	O
0	O
.	O
014	O
*	O
0	O
.	O
001	O
*<	O
0	O
.	O
0001	O
*	O
Child	O
'	O
s	O
age	O
9	O
0	O
.	O
4120	O
.	O
3880	O
.	O
1330	O
.	O
1320	O
.	O
2250	O
.	O
425p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
0810	O
.	O
1290	O
.	O
022	O
*	O
0	O
.	O
0003	O
*	O
Mother	O
1	O
.	O
0000	O
.	O
1460	O
.	O
4200	O
.	O
4410	O
.	O
0770	O
.	O
001p	O
Value0	O
.	O
004	O
*<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
3470	O
.	O
993Father	O
1	O
.	O
0000	O
.	O
1480	O
.	O
0110	O
.	O
5670	O
.	O
506p	O
Value0	O
.	O
027	O
*	O
0	O
.	O
893	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
001	O
*	O
MGM	O
1	O
.	O
0000	O
.	O
3700	O
.	O
093	O
−	O
0	O
.	O
101p	O
Value	O
<	O
0	O
.	O
0001	O
*	O
0	O
.	O
2440	O
.	O
272MGF	O
1	O
.	O
0000	O
.	O
0760	O
.	O
040p	O
Value0	O
.	O
4850	O
.	O
733PGM	O
1	O
.	O
0000	O
.	O
351p	O
Value	O
<	O
0	O
.	O
0001	O
*	O
PGF1	O
.	O
000Girl	O
'	O
s	O
age	O
0	O
–	O
0	O
.	O
1750	O
.	O
2530	O
.	O
1280	O
.	O
1150	O
.	O
0470	O
.	O
257p	O
Value0	O
.	O
003	O
*	O
0	O
.	O
0001	O
*	O
0	O
.	O
1080	O
.	O
2430	O
.	O
6520	O
.	O
034Boy	O
'	O
s	O
age	O
0	O
–	O
0	O
.	O
0900	O
.	O
155	O
−	O
0	O
.	O
018	O
−	O
0	O
.	O
0370	O
.	O
1330	O
.	O
003p	O
Value0	O
.	O
1250	O
.	O
027	O
*	O
0	O
.	O
8160	O
.	O
7350	O
.	O
2060	O
.	O
974Girl	O
'	O
s	O
age	O
5	O
–	O
0	O
.	O
4010	O
.	O
3340	O
.	O
1700	O
.	O
1480	O
.	O
2230	O
.	O
394p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
031	O
*	O
0	O
.	O
1220	O
.	O
020	O
*	O
0	O
.	O
0005	O
*	O
Boy	O
'	O
s	O
age	O
5	O
–	O
0	O
.	O
3780	O
.	O
4040	O
.	O
1790	O
.	O
2800	O
.	O
2550	O
.	O
423p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
036	O
*	O
0	O
.	O
011	O
*	O
0	O
.	O
015	O
*	O
0	O
.	O
005	O
*	O
Girl	O
'	O
s	O
age	O
9	O
–	O
0	O
.	O
4450	O
.	O
3400	O
.	O
1110	O
.	O
1980	O
.	O
1360	O
.	O
472p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
2360	O
.	O
0580	O
.	O
3350	O
.	O
002	O
*	O
Boy	O
'	O
s	O
age	O
9	O
–	O
0	O
.	O
3820	O
.	O
4450	O
.	O
0960	O
.	O
0480	O
.	O
3030	O
.	O
482p	O
Value	O
<	O
0	O
.	O
0001	O
*<	O
0	O
.	O
0001	O
*	O
0	O
.	O
4090	O
.	O
7400	O
.	O
016	O
*	O
0	O
.	O
003	O
*	O
*	O
Significant	O
findings	O
.	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
significantly	O
increased	O
progesterone	O
concentrations	O
in	O
Cont	O
and	O
UN	O
animals	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
4C	O
),	O
although	O
in	O
UNL	O
offspring	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

The	O
authors	O
did	O
not	O
say	O
if	O
the	O
improvement	O
occurred	O
in	O
the	O
autism	O
group	O
.	O

Pregnancy	O
outcomes	O
The	O
average	O
rates	O
of	O
miscarriage	O
(<	O
20	O
weeks	O
)	O
and	O
fetal	O
death	O
(≥	O
20	O
weeks	O
),	O
13	O
.	O
2	O
%	O
and	O
1	O
.	O
5	O
%,	O
respectively	O
,	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
two	O
groups	O
.	O

Estimates	O
of	O
this	O
correlation	O
matrix	O
are	O
obtained	O
providing	O
estimates	O
of	O
correlations	O
between	O
the	O
different	O
groups	O
,	O
that	O
is	O
,	O
child	O
with	O
mother	O
,	O
child	O
with	O
father	O
and	O
so	O
on	O
,	O
together	O
with	O
p	O
values	O
.	O

A	O
possible	O
explanation	B
for	O
this	O
might	O
be	O
a	O
U	O
-	O
shaped	O
association	O
between	O
maternal	O
vitamin	O
D	O
concentration	O
and	O
fetal	O
outcomes	O
in	O
a	O
population	O
with	O
sufficient	O
vitamin	O
D	O
status	O
.	O

;	O
P	O
=	O
.	O
002	O
).	O

In	O
addition	O
,	O
our	O
recent	O
research	O
has	O
shown	O
that	O
transport	O
stress	O
causes	O
temporal	O
increases	O
in	O
circulating	O
cortisol	O
and	O
NEFA	O
concentrations	O
,	O
along	O
with	O
a	O
decrease	O
in	O
circulating	O
TG	O
concentration	O
in	O
pregnant	O
Holstein	O
heifers	O
[	O
103	O
],	O
consistent	O
with	O
transport	O
stress	O
also	O
causing	O
lipolysis	O
.	O

They	O
found	O
that	O
vitamin	O
D	O
status	O
was	O
associated	O
with	O
risk	O
of	O
SGA	O
in	O
white	O
and	O
nonobese	O
women	O
,	O
but	O
that	O
there	O
was	O
no	O
association	O
between	O
vitamin	O
D	O
and	O
SGA	O
in	O
black	O
or	O
obese	O
mothers	O
.	O

The	O
OR	O
was	O
2	O
.	O
2	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
88	O
,	O
5	O
.	O
4	O
)	O
for	O
black	O
neonates	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
25	O
to	O
50	O
nmol	O
l	O
−	O
1compared	O
with	O
⩾	O
50	O
nmol	O
l	O
−	O
1	O
.	O

Albumin	O
is	O
a	O
serum	O
protein	O
that	O
can	O
be	O
used	O
as	B
an	O
additional	O
indicator	O
of	O
overall	O
nutritional	O
status	O
and	O
malnutrition	O
[	O
34	O
].	O

PubMed	O
Central	O
:	O

The	O
major	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
glomerular	O
development	O
and	O
renal	O
structure	O
at	O
birth	O
,	O
10	O
days	O
and	O
adulthood	O
in	O
mice	O
born	O
to	O
mothers	O
fed	O
a	O
diet	O
restricted	O
in	O
vitamin	O
D	O
.	O
Although	O
,	O
we	O
examined	O
other	O
variables	O
,	O
such	O
as	O
body	O
mass	O
and	O
24	O
h	O
urine	O
,	O
the	O
present	O
study	O
was	O
not	O
designed	O
to	O
investigate	O
renal	O
functional	O
and	O
metabolic	O
consequences	O
but	O
rather	O
was	O
designed	O
to	O
answer	O
the	O
question	O
of	O
whether	O
there	O
were	O
structural	O
,	O
glomerular	O
alterations	O
or	O
transgenerational	O
effects	O
.	O

The	O
inter	O
-	O
and	O
intra	O
-	O
assay	O
coefficients	O
of	O
variation	O
in	O
that	O
laboratory	O
are	O
9	O
.	O
6	O
%	O
and	O
6	O
.	O
6	O
%,	O
respectively	O
.	O

No	O
earlier	O
studies	O
that	O
we	O
are	B
aware	I
of	I
have	O
evaluated	O
the	O
relationship	O
between	O
adult	O
vitamin	O
D	O
levels	O
and	O
psychotic	O
symptoms	O
.	O

trial	O
cohort	O
[	O
12	O
].	O

Such	O
effects	O
should	O
be	O
evaluated	O
because	B
podocin	O
serves	O
in	O
the	O
structural	O
organization	O
of	O
the	O
slit	O
diaphragm	O
and	O
the	O
regulation	O
of	O
its	O
filtration	O
function	O
[	O
35	O
].	O

Neonates	O
exposed	O
to	O
polytherapy	O
were	O
five	O
times	O
more	O
likely	B
to	O
present	O
with	O
PNA	O
signs	O
compared	O
with	O
those	O
exposed	O
to	O
monotherapy	O
.	O

These	O
effects	O
extended	O
to	O
lipid	O
and	O
cholesterol	O
metabolic	O
pathways	O
,	O
suggesting	O
the	O
existence	O
of	O
a	O
complex	O
pattern	O
alterations	O
derived	O
of	O
adaptation	O
to	O
maternal	O
malnutrition	O
.	O

The	O
restriction	O
endonuclease	O
Tth111	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
was	O
used	O
to	O
digest	O
the	O
PCR	O
products	O
at	O
65	O
°	O
C	O
for	O
4	O
hours	O
.	O

Another	O
possibility	O
is	O
that	O
air	O
pollution	O
from	O
Eastern	O
Europe	O
,	O
India	O
and	O
China	O
,	O
which	O
has	O
been	O
increasing	O
in	O
the	O
last	O
20	O
years	O
,	O
has	O
engendered	O
the	O
current	O
crop	O
of	O
autism	O
.	O

Smoking	O
has	O
not	O
been	O
found	O
to	O
have	O
a	O
direct	O
association	O
.	O

In	O
this	O
issue	O
of	O
Journal	O
of	O
Clinical	O
and	O
Translational	O
Endocrinology	O
,	O
Alissa	O
et	O
al	O
.	O

Since	O
inception	O
,	O
it	O
has	O
enrolled	O
more	O
than	O
700	O
,	O
000	O
participants	O
and	O
is	O
one	O
of	O
the	O
largest	O
public	O
health	O
text	O
messaging	O
programs	O
in	O
the	O
United	O
States	O
.	O

Analysis	O
of	O
data	O
from	O
the	O
Massachusetts	O
Male	O
Aging	O
Study	O
revealed	O
that	O
short	O
sleep	O
duration	O
at	O
baseline	O
(≤	O
5	O
or	O
6	O
hours	O
per	O
night	O
)	O
was	O
associated	O
with	O
elevated	O
risk	O
of	O
developing	O
incident	O
type	O
2	O
diabetes	O
after	O
adjustment	O
for	O
covariates	O
,	O
including	O
age	O
,	O
hypertension	O
,	O
smoking	O
,	O
self	O
-	O
rated	O
health	O
,	O
waist	O
circumference	O
,	O
education	O
,	O
total	O
testosterone	O
and	O
cortisol	O
[	O
11	O
].	O

In	O
particular	O
,	O
exposing	O
feedlot	O
animals	O
to	O
hot	O
or	O
cold	O
stress	O
reduces	O
growth	O
and	O
feed	O
efficiency	O
[	O
75	O
].	O

At	O
baseline	O
,	O
anaemia	O
prevalence	O
was	O
50	O
.	O
7	O
%	O
(	O
MMN	O
group	O
)	O
and	O
54	O
.	O
1	O
%	O
(	O
placebo	O
group	O
).	O

The	O
participants	O
were	O
in	O
the	O
third	O
trimester	O
of	O
their	O
pregnancy	O
.	O

Similar	O
decreases	O
in	O
PTB	O
risk	O
were	O
observed	O
for	O
PTB	O
subtypes	O
(	O
spontaneous	O
:	O
58	O
%,	O
p	O
=	O
0	O
.	O
02	O
;	O
indicated	O
:	O
61	O
%,	O
p	O
=	O
0	O
.	O
006	O
),	O
by	O
race	O
/	O
ethnicity	O
(	O
white	O
:	O
65	O
%,	O
p	O
=	O
0	O
.	O
03	O
;	O
non	O
-	O
white	O
:	O
68	O
%,	O
p	O
=	O
0	O
.	O
008	O
),	O
and	O
among	O
women	O
with	O
a	O
prior	O
PTB	O
(	O
80	O
%,	O
p	O
=	O
0	O
.	O
02	O
).	O

The	O
majority	O
of	O
women	O
(	O
80	O
.	O
8	O
%)	O
were	O
married	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

3	O
.	O
2	O
.	O

In	O
addition	O
,	O
more	O
recent	O
studies	O
indicated	O
that	O
,	O
compared	O
to	O
individuals	O
without	O
BAT	O
,	O
the	O
BAT	O
-	O
positive	O
subjects	O
were	O
younger	O
,	O
had	O
lower	O
body	O
mass	O
index	O
,	O
fasting	O
insulin	O
,	O
insulin	O
resistance	O
,	O
but	O
a	O
greater	O
level	O
of	O
high	O
-	O
density	O
lipoprotein	O
cholesterol	O
(	O
Zhang	O
et	O
al	O
.,	O
2013	O
).	O

The	O
membranes	O
were	O
washed	O
thoroughly	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
,	O
before	O
incubation	O
with	O
the	O
secondary	O
HRP	O
-	O
conjugated	O
immunoglobulin	O
(	O
1	O
:	O
2000	O
)	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
and	O
further	O
washing	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
.	O

Obviously	O
,	O
hepatic	O
ontogenetic	O
growth	O
is	O
not	O
finished	O
at	O
adult	O
stage	O
in	O
LP	O
offspring	O
in	O
contrast	O
to	O
AP	O
offspring	O
.	O

Moreover	O
,	O
further	O
research	O
is	O
required	O
in	O
order	O
to	O
separate	O
the	O
effects	O
of	O
polytherapy	O
from	O
the	O
baseline	O
mental	O
illness	O
,	O
as	O
well	O
as	O
the	O
genetic	O
and	O
environmental	O
confounders	O
on	O
pregnancy	O
outcome	O
,	O
particularly	O
as	B
those	O
receiving	O
psychotropic	O
polytherapy	O
may	O
suffer	O
from	O
more	O
severe	O
and	O
persistent	O
psychiatric	O
disorders	O
.	O

The	O
measles	O
immunisation	O
in	O
South	O
Africa	O
forms	O
part	O
of	O
the	O
National	O
Expanded	O
Programme	O
for	O
Immunisation	O
and	O
permission	O
to	O
administer	O
it	O
at	O
the	O
study	O
site	O
has	O
been	O
granted	O
by	O
the	O
Department	O
of	O
Health	O
of	O
Gauteng	O
Province	O
and	O
the	O
City	O
of	O
Johannesburg	O
.	O

Endometriosis	O
A	O
paper	O
published	O
last	O
year	O
,	O
entitled	O
:	O
“	O
1	O
-	O
alpha	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
regresses	O
endometriotic	O
implants	O
in	O
rats	O
by	O
inhibiting	O
neovascularization	O
and	O
altering	O
regulation	O
of	O
matrix	O
metalloproteinase	O
”	O
sets	O
a	O
new	O
direction	O
in	O
VD	O
research	O
[	O
37	O
].	O

Health	O
care	O
system	O
costs	O
made	O
up	O
31	O
%	O
of	O
the	O
total	O
,	O
the	O
largest	O
component	O
of	O
which	O
was	O
support	O
for	O
nearly	O
2000	O
village	O
health	O
workers	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0023723	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Annual	O
cost	O
of	O
weekly	O
iron	O
supplementation	O
,	O
Yen	O
Bai	O
province	O
,	O
Vietnam	O
.	O
Project	O
costs	O
(	O
USD	O
)	O
Iron	O
-	O
folic	O
acid	O
supplements	O
(	O
purchase	O
,	O
transport	O
and	O
storage	O
)	O
PromotionTrainingMonitoring	O
62	O
,	O
7348144	O
,	O
08625	O
,	O
330	O
Subtotal	O
92	O
,	O
878	O
Health	O
care	O
system	O
costs	O
(	O
USD	O
)	O
National	O
InstituteDistrict	O
Health	O
ServiceCommune	O
Health	O
ServiceVillage	O
Health	O
Workers	O
6084	O
,	O
4967	O
,	O
81228	O
,	O
020	O
Total	O
133	O
,	O
900Number	O
of	O
women	O
targetedNumber	O
of	O
women	O
treated1250	O
,	O
000175	O
,	O
581Cost	O
per	O
woman	O
treated0	O
.	O
76	O
81	O
%	O
of	O
target	O
population	O
accessed	O
;	O
compliance	O
(	O
taking	O
>	O
=	O
75	O
%	O
of	O
recommended	O
intake	O
)	O
was	O
87	O
%[	O
13	O
].	O

Although	O
this	O
technique	O
is	O
relatively	O
noninvasive	O
and	O
easy	O
to	O
perform	O
,	O
there	O
is	O
limited	O
evidence	O
showing	O
that	O
the	O
Rrs	O
is	O
sensitive	O
enough	O
to	O
distinguish	O
between	O
different	O
groups	O
of	O
infants	O
with	O
various	O
clinical	O
conditions	O
[	O
54	O
].	O

This	O
hospital	O
performs	O
approximately	O
85	O
%	O
of	O
all	O
obstetrical	O
deliveries	O
in	O
Providence	O
County	O
(	O
the	O
largest	O
population	O
center	O
in	O
Rhode	O
Island	O
)	O
and	O
approximately	O
74	O
%	O
of	O
all	O
deliveries	O
in	O
Rhode	O
Island	O
.	O

Vitamin	O
D	O
Vitamin	O
D	O
is	O
a	O
fat	O
-	O
soluble	O
prohormone	O
which	O
operates	O
via	O
a	O
nuclear	O
receptor	O
[	O
145	O
].	O

(	O
2013	O
)	O
Shenker	O
et	O
al	O
.	O

Several	O
studies	O
have	O
implicated	O
SSRIs	O
in	O
autism	O
,	O
but	O
a	O
larger	O
recent	O
cohort	O
study	O
showed	O
no	O
association	O
.	O

Podocin	O
provides	O
the	O
structural	O
organization	O
of	O
the	O
slit	O
diaphragm	O
and	O
the	O
regulation	O
of	O
filtration	O
function	O
and	O
seems	O
to	O
be	O
involved	O
in	O
the	O
alteration	O
of	O
the	O
glomerular	O
basement	O
membrane	O
[	O
35	O
].	O

[	O
13	O
]	O
Kruavit	O
et	O
al	O
.	O

Substantial	O
progress	O
is	O
still	O
needed	O
for	O
the	O
reduction	O
of	O
maternal	O
and	O
newborn	O
deaths	O
,	O
especially	O
for	O
effective	O
,	O
high	O
quality	O
at	O
the	O
vital	O
contact	O
times	O
(	O
e	O
.	O
g	O
.,	O
skilled	O
attendant	O
at	O
birth	O
and	O
postnatal	O
care	O
)	O
[	O
29	O
].	O

There	O
may	O
be	O
additional	O
financial	O
benefits	O
associated	O
with	O
reductions	O
in	O
other	O
health	O
care	O
costs	O
such	O
as	O
those	O
associated	O
with	O
reduced	O
maternal	O
and	O
infant	O
mortality	O
,	O
and	O
a	O
reduction	O
in	O
neural	O
tube	O
defects	O
which	O
cannot	O
readily	O
be	O
quantified	O
.	O

However	O
,	O
there	O
was	O
no	O
gestational	O
HV	O
diet	O
effect	O
on	O
expression	O
of	O
leptin	O
and	O
insulin	O
receptors	O
,	O
which	O
are	O
known	O
to	O
modulate	O
expression	O
of	O
orexigenic	O
and	O
anorexigenic	O
neurons	O
regulating	O
energy	O
intake	O
.	O
24	O
–	O
26Despite	O
this	O
lack	O
of	O
difference	O
,	O
other	O
neurons	O
downstream	O
regulating	O
food	O
intake	O
such	O
as	O
POMC	O
and	O
BDNF	O
may	O
be	O
affected	O
by	O
the	O
high	O
vitamin	O
diets	O
.	O

Hands	O
get	O
recontaminated	O
after	O
handwashing	O
quickly	O
in	O
heavily	O
contaminated	O
household	O
environments	O
such	O
as	O
rural	O
Bangladesh	O
[	O
29	O
]	O
and	O
,	O
thus	B
,	O
infrequent	O
handwashing	O
may	O
contribute	O
to	O
pathogen	O
transmission	O
to	O
neonates	O
.	O

Importantly	O
,	O
the	O
main	O
findings	O
were	O
not	O
confounded	O
by	O
the	O
offspring	O
'	O
s	O
free	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

Higher	O
percentage	O
of	O
calories	O
from	O
protein	O
early	O
in	O
pregnancy	O
(	O
OR	O
=	O
0	O
.	O
38	O
(	O
0	O
.	O
19	O
,	O
0	O
.	O
78	O
);	O
P	O
=	O
0	O
.	O
04	O
)	O
was	O
also	O
a	O
significant	O
predictor	O
of	O
reduced	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
at	O
6	O
months	O
.	O

Hyperplasia	O
of	O
fat	O
cells	O
mainly	O
occurs	O
from	O
conception	O
until	O
birth	O
,	O
and	O
hypertrophy	O
is	O
a	O
greater	O
contributor	O
to	O
IMF	O
deposition	O
than	O
is	O
hyperplasia	O
from	O
250	O
d	O
of	O
age	O
to	O
slaughter	O
[	O
16	O
,	O
17	O
].	O

Furthermore	O
,	O
there	O
was	O
a	O
trend	O
for	O
lower	O
expression	O
of	O
DopaR1	O
in	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
HV	O
diet	O
compared	O
to	O
the	O
control	O
offspring	O
.	O

Therefore	B
,	O
defining	O
the	O
causal	O
relationship	O
between	O
Rrs	O
and	O
clinical	O
outcomes	O
in	O
infants	O
with	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
is	O
difficult	O
.	O

The	O
exact	O
biologic	O
mechanisms	O
underlying	O
a	O
protective	O
effect	O
are	O
not	O
clearly	O
understood	O
.	O

This	O
estimate	O
includes	O
financial	O
costs	O
(	O
for	O
supplies	O
,	O
training	O
),	O
and	O
costs	O
of	O
health	O
care	O
workers	O
'	O
time	O
.	O

PubMed	O
Central	O
:	O

Mild	O
laxatives	O
and	O
basti	O
,	O
which	O
will	O
smoothen	O
genital	O
tract	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
6	O
month	O
infant	O
weight	O
and	O
anthropometric	O
outcomes	O
by	O
treatment	O
groupOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
Care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueBMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
*	O
233	O
(	O
21	O
.	O
71	O
)	O
233	O
(	O
21	O
.	O
90	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
19	O
)	O
0	O
.	O
9270	O
.	O
99	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
18	O
)	O
0	O
.	O
882BMI	O
z	O
-	O
score	O
≥	O
85th	O
centile	O
*	O
299	O
(	O
27	O
.	O
88	O
)	O
303	O
(	O
28	O
.	O
48	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
14	O
)	O
0	O
.	O
7830	O
.	O
97	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
13	O
)	O
0	O
.	O
713BMI17	O
.	O
68	O
(	O
1	O
.	O
82	O
)	O
17	O
.	O
70	O
(	O
1	O
.	O
79	O
)−	O
0	O
.	O
01	O
(−	O
0	O
.	O
18	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
873	O
−	O
0	O
.	O
02	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
15	O
)	O
0	O
.	O
824BMI	O
z	O
-	O
score0	O
.	O
37	O
(	O
1	O
.	O
17	O
)	O
0	O
.	O
38	O
(	O
1	O
.	O
16	O
)−	O
0	O
.	O
01	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
10	O
)	O
0	O
.	O
860	O
−	O
0	O
.	O
01	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
09	O
)	O
0	O
.	O
792Weight	O
(	O
kg	O
)	O
8	O
.	O
26	O
(	O
1	O
.	O
33	O
)	O
8	O
.	O
29	O
(	O
1	O
.	O
33	O
)−	O
0	O
.	O
03	O
(−	O
0	O
.	O
15	O
,	O
0	O
.	O
09	O
)	O
0	O
.	O
619	O
−	O
0	O
.	O
05	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
376Weight	O
z	O
-	O
score0	O
.	O
30	O
(	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
(	O
1	O
.	O
11	O
)−	O
0	O
.	O
04	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
453	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
426Length	O
(	O
cm	O
)	O
68	O
.	O
24	O
(	O
3	O
.	O
76	O
)	O
68	O
.	O
28	O
(	O
4	O
.	O
13	O
)−	O
0	O
.	O
05	O
(−	O
0	O
.	O
41	O
,	O
0	O
.	O
31	O
)	O
0	O
.	O
793	O
−	O
0	O
.	O
12	O
(−	O
0	O
.	O
41	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
407Length	O
z	O
-	O
score0	O
.	O
06	O
(	O
1	O
.	O
22	O
)	O
0	O
.	O
11	O
(	O
1	O
.	O
28	O
)−	O
0	O
.	O
05	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
444	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
16	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
463Weight	O
-	O
Length	O
Ratio0	O
.	O
12	O
(	O
0	O
.	O
01	O
)	O
0	O
.	O
12	O
(	O
0	O
.	O
01	O
)−	O
0	O
.	O
00	O
(−	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
)	O
0	O
.	O
881	O
−	O
0	O
.	O
00	O
(−	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
)	O
0	O
.	O
718Weight	O
-	O
Length	O
Ratio	O
z	O
-	O
score0	O
.	O
44	O
(	O
1	O
.	O
18	O
)	O
0	O
.	O
48	O
(	O
1	O
.	O
14	O
)−	O
0	O
.	O
03	O
(−	O
0	O
.	O
14	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
525	O
−	O
0	O
.	O
04	O
(−	O
0	O
.	O
15	O
,	O
0	O
.	O
07	O
)	O
0	O
.	O
466Head	O
circumference	O
(	O
cm	O
)	O
43	O
.	O
83	O
(	O
1	O
.	O
77	O
)	O
43	O
.	O
79	O
(	O
1	O
.	O
88	O
)	O
0	O
.	O
04	O
(−	O
0	O
.	O
13	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
6550	O
.	O
03	O
(−	O
0	O
.	O
12	O
,	O
0	O
.	O
18	O
)	O
0	O
.	O
698Head	O
circumference	O
z	O
-	O
score0	O
.	O
45	O
(	O
1	O
.	O
08	O
)	O
0	O
.	O
43	O
(	O
1	O
.	O
13	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
08	O
,	O
0	O
.	O
12	O
)	O
0	O
.	O
6840	O
.	O
03	O
(−	O
0	O
.	O
08	O
,	O
0	O
.	O
13	O
)	O
0	O
.	O
602Chest	O
circumference	O
(	O
cm	O
)	O
44	O
.	O
45	O
(	O
2	O
.	O
77	O
)	O
44	O
.	O
51	O
(	O
2	O
.	O
75	O
)−	O
0	O
.	O
06	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
677	O
−	O
0	O
.	O
09	O
(−	O
0	O
.	O
35	O
,	O
0	O
.	O
17	O
)	O
0	O
.	O
485Abdominal	O
circumference	O
(	O
cm	O
)	O
44	O
.	O
53	O
(	O
3	O
.	O
79	O
)	O
44	O
.	O
35	O
(	O
3	O
.	O
76	O
)	O
0	O
.	O
18	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
55	O
)	O
0	O
.	O
3460	O
.	O
16	O
(−	O
0	O
.	O
20	O
,	O
0	O
.	O
52	O
)	O
0	O
.	O
392Arm	O
circumference	O
(	O
cm	O
)	O
14	O
.	O
97	O
(	O
1	O
.	O
31	O
)	O
14	O
.	O
95	O
(	O
1	O
.	O
34	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
15	O
)	O
0	O
.	O
7760	O
.	O
01	O
(−	O
0	O
.	O
11	O
,	O
0	O
.	O
14	O
)	O
0	O
.	O
841Biceps	O
SFTM	O
(	O
mm	O
)	O
6	O
.	O
47	O
(	O
2	O
.	O
00	O
)	O
6	O
.	O
34	O
(	O
2	O
.	O
00	O
)	O
0	O
.	O
13	O
(−	O
0	O
.	O
09	O
,	O
0	O
.	O
35	O
)	O
0	O
.	O
2570	O
.	O
12	O
(−	O
0	O
.	O
10	O
,	O
0	O
.	O
34	O
)	O
0	O
.	O
275Triceps	O
SFTM	O
(	O
mm	O
)	O
10	O
.	O
03	O
(	O
2	O
.	O
53	O
)	O
10	O
.	O
24	O
(	O
2	O
.	O
52	O
)−	O
0	O
.	O
21	O
(−	O
0	O
.	O
49	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
129	O
−	O
0	O
.	O
22	O
(−	O
0	O
.	O
50	O
,	O
0	O
.	O
06	O
)	O
0	O
.	O
120Subscapular	O
SFTM	O
(	O
mm	O
)	O
6	O
.	O
94	O
(	O
1	O
.	O
81	O
)	O
6	O
.	O
93	O
(	O
1	O
.	O
87	O
)	O
0	O
.	O
02	O
(−	O
0	O
.	O
18	O
,	O
0	O
.	O
22	O
)	O
0	O
.	O
8810	O
.	O
01	O
(−	O
0	O
.	O
19	O
,	O
0	O
.	O
21	O
)	O
0	O
.	O
936Supra	O
-	O
iliac	O
SFTM	O
(	O
mm	O
)	O
11	O
.	O
50	O
(	O
4	O
.	O
91	O
)	O
11	O
.	O
34	O
(	O
5	O
.	O
13	O
)	O
0	O
.	O
16	O
(−	O
0	O
.	O
37	O
,	O
0	O
.	O
69	O
)	O
0	O
.	O
5470	O
.	O
14	O
(−	O
0	O
.	O
38	O
,	O
0	O
.	O
66	O
)	O
0	O
.	O
600Abdominal	O
SFTM	O
(	O
mm	O
)	O
7	O
.	O
81	O
(	O
2	O
.	O
39	O
)	O
7	O
.	O
89	O
(	O
2	O
.	O
39	O
)−	O
0	O
.	O
08	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
17	O
)	O
0	O
.	O
543	O
−	O
0	O
.	O
09	O
(−	O
0	O
.	O
33	O
,	O
0	O
.	O
16	O
)	O
0	O
.	O
492Thigh	O
SFTM	O
(	O
mm	O
)	O
18	O
.	O
43	O
(	O
4	O
.	O
58	O
)	O
18	O
.	O
32	O
(	O
4	O
.	O
17	O
)	O
0	O
.	O
11	O
(−	O
0	O
.	O
37	O
,	O
0	O
.	O
59	O
)	O
0	O
.	O
6420	O
.	O
08	O
(−	O
0	O
.	O
39	O
,	O
0	O
.	O
56	O
)	O
0	O
.	O
725Sum	O
of	O
SFTM	O
(	O
mm	O
)	O
60	O
.	O
79	O
(	O
12	O
.	O
61	O
)	O
60	O
.	O
50	O
(	O
12	O
.	O
68	O
)	O
0	O
.	O
30	O
(−	O
0	O
.	O
96	O
,	O
1	O
.	O
56	O
)	O
0	O
.	O
6440	O
.	O
25	O
(−	O
1	O
.	O
01	O
,	O
1	O
.	O
50	O
)	O
0	O
.	O
703	O
Values	O
for	O
continuous	O
outcomes	O
are	O
mean	O
and	O
standard	O
deviation	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
.	O

Specific	O
pharmacological	O
agents	O
for	O
treatment	O
of	O
asthma	O
or	O
allergic	O
diseases	O
must	O
be	O
cautiously	O
selected	O
and	O
are	O
discussed	O
here	O
with	O
respect	O
to	O
safety	O
considerations	O
in	O
pregnancy	O
.	O

Obesity	O
has	O
profound	O
effects	O
on	O
tissue	O
insulin	O
sensitivity	O
,	O
and	O
therefore	O
on	O
systemic	O
glucose	O
homeostasis	O
.	O

(	O
2013	O
)¶/*/†	O
Vucetic	O
et	O
al	O
.	O

Although	O
essential	O
amino	O
acids	O
are	O
needed	O
for	O
growth	O
,	O
anabolic	O
and	O
developmental	O
processes	O
,	O
transcriptional	O
levels	O
of	O
genes	O
leading	O
to	O
degradation	O
of	O
those	O
dietary	O
valuable	O
compounds	O
is	O
forced	O
during	O
postnatal	O
development	O
in	O
LP	O
offspring	O
.	O

Intervention	O
mothers	O
washed	O
hands	O
with	O
soap	O
4	O
.	O
1	O
times	O
as	O
frequently	O
as	O
controls	O
(	O
95	O
%	O
CI	O
2	O
.	O
55	O
–	O
6	O
.	O
59	O
);	O
handwashing	O
with	O
soap	O
at	O
recommended	O
times	O
was	O
infrequent	O
in	O
both	O
intervention	O
(	O
9	O
%)	O
and	O
control	O
(	O
2	O
%)	O
groups	O
.	O

Many	O
studies	O
have	O
shown	O
that	O
increased	O
visfatin	O
levels	O
in	O
maternal	O
plasma	O
are	O
associated	O
with	O
small	O
-	O
for	O
-	O
gestantional	O
-	O
age	O
births	O
(	O
8	O
)	O
and	O
intrauterine	O
growth	O
restriction	O
(	O
9	O
).	O

Animal	O
studies	O
suggest	O
that	O
excess	O
iron	O
can	O
also	O
trigger	O
formation	O
of	O
free	O
radicals	O
in	O
the	O
intestinal	O
mucosa	O
and	O
other	O
tissues	O
,	O
and	O
that	O
both	O
iron	O
deficiency	O
and	O
iron	O
overload	O
can	O
damage	O
nuclear	O
DNA	O
and	O
mitochondrial	O
DNA	O
.	O

Ionized	O
calcium	O
was	O
measured	O
from	O
cord	O
blood	O
using	O
standard	O
clinical	O
measurement	O
techniques	O
in	O
the	O
blood	O
gas	O
laboratories	O
of	O
the	O
respective	O
hospitals	O
.	O

Pregnancy	O
complications	O
studied	O
included	O
PE	O
,	O
gestational	O
hypertension	O
(	O
GH	O
),	O
GDM	O
,	O
sPTB	O
and	O
SGA	O
and	O
have	O
been	O
previously	O
defined	O
[	O
28	O
,	O
29	O
,	O
31	O
,	O
32	O
].	O

Any	O
explanation	B
for	O
these	O
dimorphisms	O
should	O
be	O
supported	O
by	O
the	O
elevated	O
gene	O
expression	O
of	O
Cnr2	O
in	O
the	O
liver	O
and	O
PAT	O
of	O
the	O
RC	O
female	O
offspring	O
compared	O
to	O
those	O
of	O
the	O
RC	O
males	O
.	O

The	O
means	O
and	O
medians	O
were	O
similar	O
in	O
both	O
vitamin	O
D	O
concentrations	O
.	O

Such	O
overviews	O
are	O
,	O
however	O
,	O
rarely	O
included	O
in	O
the	O
relevant	O
literature	O
associated	O
with	O
extended	O
lifetime	O
studies	O
.	O

Dosage	O
in	O
excess	O
of	O
50	O
mcg	O
(	O
2000	O
units	O
)	O
per	O
day	O
are	O
not	O
recommended	O
,	O
thus	B
the	O
treatment	O
of	O
postsurgical	O
hypoparatithyroid	O
patient	O
calcium	O
supplementation	O
may	O
be	O
required	O
at	O
dosage	O
as	O
high	O
as	O
4	O
g	O
/	O
day	O
together	O
with	O
D	O
vitamin	O
.	O

Concurrently	O
,	O
we	O
also	O
examined	O
maternal	O
variables	O
known	O
to	O
potentially	O
affect	O
vitamin	O
D	O
levels	O
and	O
SGA	O
in	O
an	O
effort	O
to	O
better	O
understand	O
the	O
role	O
of	O
these	O
risk	O
factors	O
in	O
vitamin	O
D	O
levels	O
and	O
risk	O
of	O
SGA	O
.	O

Preliminary	O
studies	O
of	O
interventions	O
to	O
reduce	O
rates	O
of	O
elective	O
caesarean	O
births	O
or	O
inductions	O
without	O
medical	O
indication	O
before	O
the	O
recommended	O
39	O
completed	O
weeks	O
of	O
gestation	O
suggest	O
an	O
impact	O
on	O
prevention	O
of	O
early	O
term	O
deliveries	O
in	O
some	O
high	O
-	O
and	O
middle	O
-	O
income	O
countries	O
[	O
9	O
,	O
10	O
].	O

Respiratory	O
rate	O
and	O
anthropomorphic	O
data	O
were	O
collected	O
twice	O
and	O
we	O
used	O
the	O
mean	O
values	O
in	O
our	O
analysis	O
.	O

The	O
currently	O
recommended	O
supplementation	O
amount	O
of	O
vitamin	O
D	O
is	O
not	O
sufficient	O
to	O
maintain	O
a	O
value	O
of	O
25	O
hydroxy	O
vitamin	O
D	O
above	O
30	O
ng	O
/	O
ml	O
,	O
during	O
pregnancy	O
.	O

The	O
following	O
time	O
-	O
domain	O
indices	O
were	O
analyzed	O
:	O
heart	O
rate	O
(	O
HR	O
),	O
MNN	O
(	O
average	O
of	O
all	O
normal	O
RR	O
interval	O
),	O
SDNN	O
(	O
standard	O
deviation	O
of	O
RR	O
intervals	O
),	O
RMSSD	O
(	O
root	O
mean	O
square	O
of	O
successive	O
differences	O
RR	O
intervals	O
),	O
and	O
pNN50	O
(	O
percent	O
RR	O
intervals	O
with	O
a	O
difference	O
in	O
duration	O
higher	O
than	O
50	O
ms	O
).	O

Secondary	O
outcomes	O
included	O
the	O
total	O
number	O
of	O
times	O
mothers	O
were	O
observed	O
washing	O
hands	O
with	O
soap	O
during	O
3	O
-	O
hour	O
observations	O
;	O
the	O
maintenance	O
of	O
soap	O
and	O
water	O
for	O
handwashing	O
anywhere	O
in	O
the	O
home	O
and	O
specifically	O
where	O
newborns	O
rest	O
for	O
most	O
of	O
the	O
day	O
;	O
handwashing	O
with	O
soap	O
by	O
other	O
household	O
members	O
at	O
times	O
of	O
possible	O
pathogen	O
transmission	O
;	O
and	O
the	O
number	O
of	O
events	O
observed	O
among	O
household	O
members	O
other	O
than	O
the	O
mother	O
washing	O
hands	O
with	O
soap	O
during	O
the	O
3	O
-	O
hour	O
observations	O
.	O

Results	O
18	O
411	O
women	O
were	O
classified	O
as	O
having	O
a	O
low	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
14	O
395	O
as	O
middle	O
and	O
817	O
as	O
having	O
a	O
high	O
level	O
.	O

Studies	O
suggest	O
that	O
children	O
who	O
are	O
exposed	O
to	O
food	O
advertisements	O
eat	O
more	O
.	O

Simple	O
and	O
multiple	O
regression	O
analysis	O
were	O
used	O
as	O
appropriate	O
.	O

To	O
assess	O
the	O
relationship	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
infant	O
gut	O
microbiome	O
cluster	O
membership	O
,	O
we	O
used	O
multinomial	O
logistic	O
regression	O
in	O
the	O
R	O
package	O
nnet	O
adjusting	O
all	O
models	O
for	O
the	O
same	O
covariates	O
as	O
in	O
previous	O
analyses	O
.	O

The	O
placebo	O
control	O
group	O
allowed	O
for	O
an	O
absolute	O
evaluation	O
of	O
the	O
effects	O
of	O
micronutrients	O
on	O
haematological	O
parameters	O
.	O

In	O
contrast	O
,	O
a	O
lower	O
weight	O
at	O
birth	O
has	O
been	O
described	O
in	O
several	O
studies	O
when	O
the	O
calorie	O
-	O
restricted	O
diet	O
was	O
prolonged	O
to	O
birth	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

For	O
patients	O
who	O
were	O
already	O
on	O
immunotherapy	O
before	O
the	O
pregnancy	O
,	O
maintenance	O
treatment	O
may	O
be	O
continued	O
safely	O
during	O
pregnancy	O
.	O

The	O
training	O
consisted	O
of	O
didactic	O
sessions	O
,	O
role	O
plays	O
,	O
and	O
field	O
pilots	O
and	O
was	O
delivered	O
over	O
16	O
days	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Mean	O
serum	O
levels	O
of	O
vitamin	O
D	O
based	O
on	O
sex	O
in	O
the	O
two	O
groups	O
.	O

The	O
findings	O
were	O
similar	O
to	O
the	O
overall	O
population	O
except	O
one	O
thing	O
.	O

In	O
term	O
labor	O
,	O
GR	O
α	O
'	O
s	O
ΔCt	O
was	O
0	O
.	O
244	O
compared	O
with	O
0	O
.	O
006	O
for	O
GR	O
β	O
,	O
0	O
.	O
006	O
for	O
GR	O
γ	O
,	O
0	O
.	O
023	O
for	O
GR	O
-	O
P	O
,	O
and	O
0	O
.	O
26	O
for	O
GAS5	O
.	O

The	O
down	O
-	O
expression	O
of	O
these	O
elements	O
suggests	O
a	O
reduction	O
of	O
fatty	O
-	O
acid	O
and	O
cholesterol	O
biosynthesis	O
in	O
the	O
liver	O
of	O
RC	O
females	O
,	O
which	O
could	O
partially	O
explain	O
the	O
altered	O
levels	O
of	O
the	O
lipid	O
carriers	O
high	O
-	O
density	O
,	O
low	O
-	O
density	O
and	O
very	O
low	O
-	O
density	O
lipoproteins	O
(	O
HDL	O
,	O
LDL	O
,	O
and	O
HLDL	O
)	O
in	O
plasma	O
.	O

In	O
addition	O
,	O
because	B
the	O
prevalence	O
of	O
obesity	O
increases	O
among	O
children	O
after	O
puberty	O
,	O
as	B
the	O
age	O
of	O
sexual	O
maturity	O
decreases	O
in	O
the	O
population	O
(	O
86	O
)	O
obesity	O
will	O
probably	B
become	O
more	O
prevalent	O
among	O
elementary	O
school	O
students	O
.	O

Implementation	O
research	O
and	O
program	O
evaluation	O
evaluates	O
how	O
best	O
to	O
achieve	O
wide	O
scale	O
coverage	O
of	O
interventions	O
,	O
including	O
prevention	O
particularly	O
family	O
planning	O
and	O
such	O
as	O
care	O
of	O
women	O
with	O
infectious	O
diseases	O
such	O
as	O
malaria	O
,	O
HIV	O
and	O
STIs	O
;	O
improved	O
nutrition	O
;	O
smoking	O
cessation	O
;	O
and	O
reducing	O
maternal	O
workload	O
.	O

Furthermore	O
,	O
the	O
gene	O
expression	O
of	O
the	O
ECS	O
components	O
could	O
be	O
modified	O
after	O
the	O
exposure	O
to	O
different	O
dietary	O
conditions	O
(	O
Bello	O
et	O
al	O
.,	O
2012	O
).	O

Examples	O
include	O
the	O
occurrence	O
of	O
generalized	O
eczema	O
requiring	O
identification	O
of	O
the	O
cause	O
before	O
treatment	O
or	O
a	O
suspected	O
allergy	O
to	O
a	O
drug	O
needed	O
for	O
therapy	O
of	O
the	O
mother	O
(	O
eg	O
,	O
penicillin	O
for	O
treating	O
syphilis	O
)	O
[	O
50	O
].	O

Humans	O
have	O
seven	O
SIRT	O
isoforms	O
.	O

Statistical	O
Analysis	O
Q	O
-	O
PCR	O
data	O
are	O
reported	O
as	O
the	O
mean	O
±	O
SEM	O
.	O

The	O
molecular	O
mechanisms	O
that	O
underlie	O
these	O
observations	O
remain	O
unclear	O
,	O
although	O
recent	O
work	O
suggests	O
that	O
alterations	O
to	O
placental	O
function	O
may	O
lead	O
to	O
altered	O
fetal	O
development	O
and	O
programming	O
,	O
likely	B
playing	O
a	O
critical	O
role	O
in	O
mediating	O
these	O
associations	O
(	O
Higgins	O
et	O
al	O
.	O

Just	O
about	O
a	O
mile	O
and	O
a	O
half	O
from	O
Bell	O
-	O
Jefferson	O
’	O
s	O
home	O
,	O
a	O
dam	O
broke	O
at	O
the	O
United	O
Nuclear	O
Corporation	O
mill	O
,	O
where	O
workers	O
processed	O
ore	O
from	O
the	O
nearby	O
Northeast	O
Church	O
Rock	O
uranium	O
mine	O
.	O

PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
and	O
OPPs	O
were	O
lipid	O
-	O
normalized	O
in	O
units	O
of	O
ng	O
/	O
g	O
serum	O
lipid	O
.	O

In	O
our	O
analysis	O
,	O
it	O
was	O
found	O
that	O
the	O
child	O
’	O
s	O
height	O
was	O
correlated	O
with	O
that	O
of	O
all	O
family	O
members	O
at	O
age	O
5	O
,	O
suggesting	O
perhaps	O
many	O
genetic	O
effects	O
.	O

The	O
rationale	O
to	O
deliver	O
a	O
bunch	O
of	O
services	O
is	O
to	O
mutually	O
enhance	O
the	O
impact	O
of	O
a	O
specific	O
service	O
with	O
the	O
aid	O
of	O
other	O
services	O
in	O
the	O
long	O
-	O
run	O
(	O
2	O
).	O

Participants	O
also	O
completed	O
a	O
questionnaire	O
about	O
use	O
of	O
dietary	O
supplements	O
.	O

Post	O
-	O
intervention	O
,	O
significantly	O
more	O
women	O
(	O
50	O
.	O
6	O
%)	O
received	O
best	O
-	O
practice	O
care	O
(	O
2	O
+	O
reviews	O
)	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

These	O
disorders	O
are	O
characterized	O
by	O
vertebral	O
fusions	O
,	O
abnormal	O
spinal	O
segmentation	O
,	O
and	O
skeletogenesis	O
(	O
Krakow	O
et	O
al	O
.	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
14	O
.	O

The	O
effect	O
of	O
vitamin	O
D	O
on	O
ovarian	O
granulosa	O
cells	O
responsible	B
for	O
steroidogenesis	O
,	O
as	O
well	O
as	O
on	O
immune	O
system	O
regulation	O
,	O
was	O
established	O
after	O
finding	O
1	O
-	O
α	O
-	O
hydroxylase	O
and	O
VDR	O
receptors	O
in	O
deciduae	O
,	O
placentas	O
,	O
ovaries	O
,	O
endometriums	O
and	O
pituitary	O
glands	O
,	O
and	O
was	O
confirmed	O
in	O
vitro	O
by	O
demonstrating	O
active	O
metabolites	O
of	O
vitamin	O
D	O
such	O
as	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D	O
and	O
24	O
,	O
25	O
[	O
OH	O
]	O
2D	O
in	O
mentioned	O
tissues	O
[	O
14	O
,	O
15	O
,	O
16	O
,	O
17	O
,	O
18	O
].	O

Children	O
born	O
to	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
are	O
more	O
likely	B
to	O
be	O
identified	O
with	O
moderate	O
to	O
severe	O
cognitive	O
,	O
motor	O
and	O
global	O
developmental	O
delay	O
at	O
3	O
years	O
of	O
age	O
[	O
46	O
],	O
as	O
well	O
as	O
poorer	O
academic	O
achievement	O
extending	O
to	O
14	O
years	O
of	O
age	O
[	O
44	O
,	O
45	O
].	O

Neonatal	O
oxygen	O
deprivation	O
can	O
be	O
quantified	O
by	O
several	O
measurements	O
,	O
including	O
low	O
Apgar	O
score	O
,	O
fetal	O
distress	O
,	O
caesarian	O
delivery	O
,	O
threatened	O
abortion	O
,	O
and	O
hemorrhage	O
during	O
pregnancy	O
[	O
68	O
].	O

The	O
serum	O
Phosphorus	O
before	O
and	O
after	O
the	O
intervention	O
in	O
each	O
group	O
or	O
between	O
the	O
two	O
groups	O
was	O
not	O
significant	O
.	O

Our	O
study	O
was	O
advantageous	O
for	O
the	O
presence	O
of	O
a	O
control	O
group	O
in	O
which	O
all	O
measurements	O
were	O
made	O
similar	O
to	O
those	O
of	O
the	O
IG	O
.	O

PubMed	O
Central	O
:	O

Recent	O
studies	O
indicate	O
that	O
pregnant	O
women	O
lack	O
sufficient	O
knowledge	O
regarding	O
the	O
importance	O
of	O
iodine	O
and	O
LC	O
n	O
-	O
3	O
PUFAs	O
[	O
5	O
,	O
6	O
],	O
nutrients	O
that	O
are	O
present	O
in	O
fish	O
and	O
seafood	O
.	O

Characteristics	O
of	O
the	O
8956	O
mother	O
–	O
child	O
pairs	O
who	O
were	O
included	O
in	O
the	O
analyses	O
and	O
those	O
of	O
the	O
3122	O
mother	O
–	O
child	O
pairs	O
with	O
information	O
on	O
maternal	O
diet	O
who	O
were	O
excluded	O
because	O
of	O
incomplete	O
outcome	O
data	O
are	O
compared	O
in	O
supplementary	O
table	O
E1	O
.	O

Her	O
neck	O
was	O
supple	O
without	O
jugular	O
venous	O
distension	O
.	O

In	O
addition	O
,	O
maternal	O
25D	O
(	O
OH	O
)	O
level	O
≥	O
15	O
.	O
0	O
ng	O
/	O
ml	O
was	O
described	B
as	B
“	O
high	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
”	O
and	O
<	O
15	O
.	O
0	O
ng	O
/	O
ml	O
as	B
“	O
low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
.”	O
A	O
significant	O
difference	O
in	O
the	O
Rrs	O
was	O
found	O
between	O
the	O
high	O
and	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
groups	O
(	O
3	O
.	O
8	O
±	O
0	O
.	O
8	O
vs	O
.	O
4	O
.	O
4	O
±	O
1	O
.	O
0	O
kPa	O
*	O
s	O
/	O
L	O
,	O
p	O
<	O
0	O
.	O
01	O
).	O

No	O
significant	O
effects	O
of	O
text4baby	O
were	O
observed	O
in	O
these	O
models	O
.	O

The	O
answer	O
was	O
finally	O
found	O
in	O
an	O
experiment	O
that	O
involved	O
99	O
oocyte	O
donor	O
-	O
recipient	O
couples	O
.	O

In	O
inherited	O
forms	O
,	O
the	O
initial	O
germline	O
mutation	O
produces	O
multiple	O
foci	O
of	O
cells	O
–	O
the	O
so	O
-	O
called	O
C	O
-	O
cell	O
hyperplasia	O
–	O
that	O
are	O
susceptible	O
to	O
tumour	O
formation	O
,	O
and	O
each	O
MTC	O
is	O
the	O
result	O
of	O
a	O
second	O
cell	O
transformation	O
in	O
one	O
of	O
these	O
susceptible	O
clones	O
.	O

Blood	O
sugar	O
checked	O
at	O
that	O
time	O
was	O
normal	O
.	O

There	O
is	O
probably	B
no	O
specific	O
etiologic	O
agent	O
acting	O
in	O
isolation	O
that	O
completely	O
explains	O
a	O
season	O
of	O
birth	O
association	O
with	O
adult	O
glioma	O
risk	O
.	O

The	O
Cochrane	O
Library	O
issued	O
a	O
review	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
and	O
identified	O
7	O
relevant	O
studies	O
.	O

Stress	O
was	O
assessed	O
using	O
the	O
short	O
form	O
of	O
the	O
Perceived	O
Stress	O
Scale	O
[	O
29	O
].	O

The	O
findings	O
of	O
this	O
study	O
provide	O
evidence	O
of	O
the	O
efficacy	O
of	O
MMN	O
supplementation	O
and	O
support	O
its	O
promotion	O
in	O
non	O
-	O
pregnant	O
women	O
as	B
a	O
means	O
of	O
optimising	O
haematological	O
and	O
micronutrient	O
status	O
in	O
between	O
pregnancies	O
,	O
especially	O
in	O
relation	O
to	O
iron	O
status	O
.	O

In	O
both	O
rodents	O
and	O
humans	O
,	O
this	O
BA	O
-	O
D2	O
-	O
UCP1	O
pathway	O
appears	O
to	O
be	O
crucial	O
for	O
the	O
fine	O
-	O
tuning	O
of	O
energy	O
homeostasis	O
,	O
improving	O
the	O
metabolic	O
control	O
(	O
Watanabe	O
et	O
al	O
.,	O
2006	O
).	O

This	O
study	O
'	O
s	O
focus	O
was	O
on	O
predictors	O
of	O
large	O
for	O
gestational	O
age	O
at	O
birth	O
and	O
6	O
months	O
,	O
but	O
future	O
research	O
is	O
needed	O
to	O
examine	O
predictors	O
of	O
small	O
for	O
gestational	O
age	O
,	O
which	O
may	O
also	O
predispose	O
offspring	O
to	O
increased	O
fat	O
mass	O
and	O
incidence	O
of	O
metabolic	O
syndrome	O
as	O
children	O
and	O
adults	O
[	O
53	O
].	O

There	O
are	O
many	O
documented	O
health	O
benefits	O
from	O
fish	O
consumption	O
with	O
regard	O
to	O
foetal	O
health	O
,	O
including	O
improved	O
neurodevelopment	O
,	O
increased	O
birth	O
weight	O
and	O
a	O
reduced	O
risk	O
of	O
spontaneous	O
abortion	O
[	O
11	O
,	O
12	O
].	O

P04	O
.	O
49	O
.	O

Whether	O
brown	O
and	O
brite	O
adipocytes	O
display	O
some	O
degree	O
of	O
specialization	O
with	O
regard	O
to	O
these	O
different	O
functions	O
has	O
to	O
be	O
established	O
.	O

Also	O
,	O
there	O
were	O
positive	O
nonsignificant	O
relationships	O
between	O
adherence	O
to	O
western	O
[	O
OR	O
1	O
.	O
31	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
51	O
),	O
P	O
=	O
0	O
.	O
28	O
]	O
and	O
healthy	O
[	O
OR	O
1	O
.	O
02	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
39	O
-	O
2	O
.	O
63	O
),	O
P	O
=	O
0	O
.	O
40	O
]	O
dietary	O
pattern	O
of	O
mothers	O
with	O
having	O
short	O
height	O
infant	O
in	O
the	O
final	O
adjusted	O
model	O
.	O

In	O
subsets	O
of	O
the	O
cohort	O
with	O
complete	O
data	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
no	O
association	O
was	O
found	O
between	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
and	O
childhood	O
atopy	O
or	O
atopic	O
asthma	O
.	O

Multiple	O
exposures	O
at	O
multiple	O
life	O
stages	O
could	O
be	O
additive	O
and	O
/	O
or	O
cumulative	O
.	O

Additionally	O
,	O
a	O
post	O
-	O
hoc	O
analysis	O
of	O
two	O
pregnancy	O
supplementation	O
trials	O
by	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Interestingly	O
,	O
increased	O
risk	O
for	O
glioma	O
has	O
been	O
observed	O
in	O
patients	O
with	O
AIDS	O
-	O
related	O
immuno	O
-	O
suppression	O
[	O
122	O
–	O
124	O
],	O
but	O
not	O
in	O
those	O
with	O
iatrogenic	O
immuno	O
-	O
suppression	O
[	O
125	O
].	O

Although	O
calcium	O
and	O
phosphorus	O
are	O
transported	O
transplacentally	O
without	O
vitamin	O
D	O
,	O
the	O
effects	O
of	O
low	O
vitamin	O
D	O
in	O
utero	O
or	O
shortly	O
after	O
birth	O
are	O
uncertain	O
[	O
7	O
].	O

It	O
is	O
related	O
to	O
excess	O
vasopressinase	O
enzyme	O
activity	O
which	O
is	O
metabolized	O
in	O
the	O
liver	O
.	O

In	O
general	O
,	O
Stanford	O
type	O
A	O
dissections	O
involve	O
the	O
ascending	O
aorta	O
and	O
are	O
managed	O
surgically	O
while	O
type	O
B	O
dissections	O
involved	O
the	O
descending	O
aorta	O
and	O
are	O
managed	O
medically	O
.	O

Responses	O
were	O
as	O
follows	O
:	O
(	O
i	O
)	O
all	O
of	O
the	O
time	O
,	O
(	O
ii	O
)	O
most	O
of	O
the	O
time	O
,	O
(	O
iii	O
)	O
some	O
of	O
the	O
time	O
,	O
(	O
iv	O
)	O
a	O
little	O
of	O
the	O
time	O
,	O
and	O
(	O
v	O
)	O
none	O
of	O
the	O
time	O
.	O

The	O
overall	O
quality	O
rating	O
score	O
for	O
the	O
reviewed	O
studies	O
are	O
presented	O
inTable	O
2	O
.	O

Thus	B
,	O
it	B
is	I
clear	I
that	O
a	O
southern	O
US	O
location	O
is	O
not	O
protective	O
against	O
seasonal	O
deficiency	O
of	O
vitamin	O
D	O
or	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

GENETIC	O
FACTORS	O
Breed	O
and	O
sex	O
differences	O
Intramuscular	O
fat	O
content	O
in	O
the	O
LM	O
varies	O
significantly	O
depending	O
on	O
the	O
cattle	O
breed	O
.	O

When	O
Grandjean	O
and	O
his	O
team	O
dug	O
a	O
little	O
deeper	O
,	O
they	O
saw	O
that	O
women	O
with	O
the	O
highest	O
PFAS	O
levels	O
in	O
their	O
blood	O
tended	O
to	O
spend	O
less	O
time	O
breastfeeding	O
their	O
babies	O
.	O
22	O
In	O
the	O
study	O
,	O
led	O
by	O
Timmermann	O
—	O
who	O
at	O
the	O
time	O
was	O
pursuing	O
her	O
PhD	O
under	O
Grandjean	O
’	O
s	O
supervision	O
—	O
the	O
researchers	O
estimated	O
the	O
average	O
duration	O
of	O
total	O
breastfeeding	O
(	O
i	O
.	O
e	O
.,	O
with	O
or	O
without	O
any	O
other	O
sources	O
of	O
nutrition	O
)	O
in	O
association	O
with	O
serum	O
levels	O
of	O
two	O
PFASs	O
,	O
perfluorooctane	O
sulfonic	O
acid	O
(	O
PFOS	O
)	O
and	O
perfluorooctanoic	O
acid	O
(	O
PFOA	O
).	O

Note	O
:	O
in	O
the	O
case	O
of	O
the	O
child	O
,	O
age	O
represents	O
the	O
exact	O
age	O
when	O
measurements	O
were	O
made	O
.	O

Evidence	O
from	O
more	O
contemporary	O
populations	O
is	O
that	O
the	O
likelihood	B
of	O
subsequent	O
diabetes	O
may	O
be	O
substantially	O
higher	O
.	O
22Women	O
who	O
have	O
had	O
GDM	O
account	O
for	O
a	O
significant	O
burden	O
of	O
the	O
population	O
prevalence	O
of	O
diabetes	O
.	O

Demand	O
for	O
family	O
planning	O
satisfied	O
and	O
antenatal	O
care	O
coverage	O
,	O
even	O
though	O
feasible	B
through	O
primary	O
care	O
services	O
,	O
still	O
leave	O
out	O
many	O
women	O
,	O
especially	O
the	O
poorest	O
.	O

China	O
’	O
s	O
use	O
of	O
the	O
venom	O
in	O
the	O
treatment	O
of	O
a	O
number	O
of	O
illnesses	O
can	O
be	O
traced	O
back	O
to	O
the	O
tenth	O
century	O
.	O

However	O
there	O
is	O
so	O
far	O
no	O
conclusive	O
evidence	O
about	O
the	O
causality	O
of	O
these	O
relationships	O
,	O
as	O
no	O
randomised	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
with	O
an	O
appropriate	O
assessment	O
of	O
a	O
variety	O
of	O
health	O
outcomes	O
have	O
been	O
carried	O
out	O
to	O
date	O
[	O
21	O
].	O

Similarly	O
to	O
human	O
cohort	O
studies	O
,	O
our	O
results	O
emphasize	O
the	O
importance	O
of	O
early	O
life	O
programming	O
as	B
the	O
exposure	O
to	O
undernutrition	O
during	O
early	O
development	O
increases	O
the	O
risk	O
from	O
suffering	O
features	O
of	O
metabolic	O
syndrome	O
and	O
cardiovascular	O
disease	O
later	O
in	O
life	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
,	O
2007b	O
;	O
Jimenez	O
-	O
Chillaron	O
et	O
al	O
.,	O
2005	O
;	O
Yura	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Theys	O
et	O
al	O
.,	O
2011	O
).	O

The	O
existence	O
of	O
common	O
genomic	O
changes	O
between	O
DTC	O
and	O
anaplastic	O
carcinoma	O
may	O
provide	O
convincing	O
proof	B
of	O
the	O
multi	O
-	O
step	O
carcinogenesis	O
hypothesis	O
in	O
which	O
cancer	O
cells	O
are	O
produced	O
from	O
well	O
-	O
differentiated	O
benign	O
cells	O
by	O
transformation	O
caused	O
by	O
accumulating	O
damage	O
to	O
their	O
genome	O
Although	O
gene	O
expression	O
in	O
thyroid	O
cancer	O
reveals	O
highly	O
consistent	O
profiles	O
,	O
a	O
second	O
hypothesis	O
has	O
been	O
proposed	O
,	O
which	O
can	O
possibly	O
explain	B
other	O
"	O
non	O
-	O
RET	O
"	O
tumours	O
:	O
namely	O
foetal	O
cell	O
carcinogenesis	O
,	O
according	O
to	O
which	O
cancer	O
cells	O
are	O
derived	O
from	O
the	O
remnants	O
of	O
foetal	O
thyroid	O
cells	O
,	O
or	O
from	O
stem	O
cells	O
instead	O
of	O
differentiated	O
follicular	O
cells	O
.	O

The	O
concentrate	O
constitutes	O
36	O
.	O
8	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
from	O
11	O
to	O
18	O
months	O
of	O
age	O
.	O

prospectively	O
evaluated	O
7369	O
oral	O
glucose	O
tolerance	O
tests	O
(	O
OGTT	O
)	O
over	O
a	O
3	O
-	O
year	O
period	O
in	O
Australia	O
[	O
24	O
].	O

At	O
present	O
,	O
consensus	B
has	O
been	O
reached	O
on	O
the	O
fact	O
that	O
radioiodine	O
treatment	O
of	O
DTC	O
does	O
not	O
affect	O
pregnancy	O
outcome	O
and	O
does	O
not	O
appear	O
to	O
be	O
associated	O
with	O
any	O
genetic	O
risk	O
,	O
with	O
the	O
usual	O
recommendation	O
to	O
delay	O
pregnancy	O
for	O
6	O
-	O
12	O
months	O
after	O
radioiodine	O
exposure	O
,	O
even	O
if	O
there	O
is	O
no	O
evidence	O
that	O
pregnancy	O
before	O
this	O
period	O
could	O
lead	O
to	O
a	O
less	O
favourable	O
outcome2238	O
.	O

The	O
LC	O
-	O
MS	O
/	O
MS	O
method	O
has	O
a	O
measuring	O
range	O
of	O
6	O
–	O
450	O
nmol	O
/	O
L	O
for	O
25OHD3and	O
of	O
6	O
–	O
225	O
nmol	O
/	O
L	O
for	O
25OHD2	O
.	O

Long	O
-	O
term	O
concerns	O
regarding	O
glyburide	O
and	O
metformin	O
therapy	O
for	O
GDM	O
Although	O
the	O
above	O
randomized	O
trials	O
have	O
demonstrated	O
non	O
-	O
inferiority	O
of	O
glyburide	O
and	O
metformin	O
in	O
achieving	O
glycemic	O
control	O
,	O
and	O
satisfactory	O
birth	O
outcomes	O
compared	O
to	O
insulin	O
therapy	O
,	O
concerns	O
must	O
remain	O
as	B
long	O
-	O
term	O
issues	O
have	O
not	O
yet	O
been	O
addressed	O
.	O

[	O
15	O
]	O
Nimitphong	O
et	O
al	O
.	O

Data	O
on	O
child	O
'	O
s	O
asthma	O
status	O
at	O
age	O
7	O
and	O
14	O
years	O
were	O
used	O
to	O
derive	O
asthma	O
status	O
phenotypes	O
between	O
age	O
7	O
and	O
14	O
years	O
(	O
none	O
,	O
remitting	O
,	O
incident	O
and	O
persisting	O
)	O
[	O
16	O
].	O

This	O
study	O
is	O
critical	O
because	O
it	O
will	O
determine	O
if	O
antenatal	O
IFA	O
supplements	O
commenced	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
rather	O
than	O
later	O
,	O
will	O
significantly	O
reduce	O
neonatal	O
deaths	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
if	O
this	O
approach	O
is	O
cost	O
-	O
effective	O
.	O

Reports	O
from	O
lower	O
-	O
risk	O
groups	O
have	O
indicated	O
that	O
vitamin	O
D	O
deficiency	O
occurs	O
in	O
25	O
–	O
55	O
%	O
of	O
pregnant	O
women	O
[	O
11	O
–	O
13	O
].	O

The	O
answer	O
,	O
as	O
it	O
turned	O
out	O
,	O
wasn	O
’	O
t	O
uranium	O
itself	O
but	O
its	O
decay	O
products	O
,	O
including	O
radium	O
,	O
10thorium	O
,	O
11and	O
radon	O
.	O
12	O
Radon	O
is	O
a	O
gas	O
,	O
but	O
with	O
a	O
half	O
-	O
life	O
of	O
four	O
days	O
,	O
it	O
rapidly	O
decays	O
into	O
solid	O
products	O
,	O
explains	O
Doug	O
Brugge	O
,	O
a	O
professor	O
of	O
public	O
health	O
at	O
Tufts	O
University	O
.	O
13	O
“	O
Being	O
solids	O
,	O
these	O
are	O
going	O
to	O
want	O
to	O
stick	O
to	O
things	O
like	O
your	O
lungs	O
,”	O
Brugge	O
says	O
.	O

Supplementation	O
can	O
therefore	B
only	O
partly	O
explain	B
the	O
large	O
proportion	O
with	O
high	O
vitamin	O
D	O
status	O
,	O
and	O
other	O
likely	B
contributors	O
are	O
pregnancy	O
associated	O
endocrine	O
changes	O
and	O
possibly	O
lifestyle	O
factors	O
.	O

Once	O
in	O
the	O
circulatory	O
system	O
,	O
compounds	O
enter	O
the	O
brain	O
of	O
the	O
infant	O
relatively	O
quickly	O
as	O
the	O
blood	O
-	O
brain	O
barrier	O
is	O
not	O
fully	O
operational	O
until	O
at	O
least	O
6	O
months	O
of	O
age	O
[	O
10	O
].	O

2shows	O
timing	O
of	O
influenza	O
vaccination	O
(	O
Trivalent	O
inactivated	O
influenza	O
vaccine	O
,	O
southern	O
hemisphere	O
formulation	O
)	O
with	O
respect	O
to	O
influenza	O
circulation	O
in	O
the	O
country	O
;	O
most	O
participants	O
(	O
96	O
%)	O
received	O
influenza	O
vaccination	O
before	O
the	O
peak	O
of	O
influenza	O
circulation	O
in	O
August	O
through	O
November	O
2014	O
.	O

Each	O
point	O
represents	O
an	O
individual	O
,	O
and	O
lines	O
indicate	O
the	O
distance	O
from	O
tertile	O
centroid	O
.	O

Results	O
In	O
the	O
study	O
population	O
97	O
%	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
>	O
50	O
nmol	O
/	O
L	O
]	O
in	O
both	O
mothers	O
and	O
newborns	O
,	O
while	O
optimal	O
vitamin	O
D	O
status	O
[	O
25	O
(	O
OH	O
)	O
D	O
above	O
80	O
nmol	O
/	O
L	O
]	O
was	O
seen	O
in	O
52	O
%	O
of	O
the	O
mothers	O
and	O
45	O
%	O
of	O
the	O
newborns	O
.	O

Of	O
the	O
13	O
term	O
placentas	O
12	O
were	O
in	O
labor	O
(	O
mode	O
of	O
delivery	O
:	O
10	O
caesarean	O
sections	O
[	O
CS	O
],	O
2	O
vaginal	O
deliveries	O
)	O
and	O
1	O
nonlabor	O
/	O
CS	O
tissue	O
.	O

We	O
used	O
the	O
same	O
test	O
frame	O
size	O
over	O
the	O
photomicrographs	O
of	O
the	O
two	O
groups	O
to	O
emphasize	O
that	O
the	O
number	O
of	O
glomeruli	O
was	O
greater	O
in	O
the	O
VitD	O
-	O
group	O
than	O
in	O
the	O
SC	O
group	O
.	O

Subsequent	O
analyses	O
separately	O
examined	O
predictors	O
of	O
offspring	O
weight	O
in	O
normal	O
weight	O
versus	O
overweight	O
/	O
obese	O
mothers	O
.	O

In	O
contrast	O
,	O
rs10741657	O
(	O
CYP2R1	O
)	O
(	O
β	O
=	O
−	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
−	O
8	O
.	O
2	O
to	O
−	O
2	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
(	O
β	O
=	O
4	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
9	O
to	O
7	O
.	O
5	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
were	O
associated	O
with	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
status	O
following	O
supplementation	O
,	O
whereas	O
rs12785878	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
were	O
not	O
.	O

A	O
recent	O
study	O
conducted	O
in	O
Sweden	O
by	O
Rai	O
et	O
al	O
.	O

We	O
used	O
influenza	O
surveillance	O
data	O
to	O
adjust	O
for	O
timing	O
of	O
influenza	O
circulation	O
.	O

The	O
study	O
is	O
registered	O
in	O
the	O
Iranian	O
Research	O
Institute	O
for	O
Information	O
Sciences	O
and	O
Technology	O
.	O

We	O
obtained	O
a	O
CT	O
angiography	O
of	O
the	O
chest	O
due	O
to	O
our	O
high	O
index	O
of	O
suspicion	O
for	O
an	O
acute	O
aortic	O
dissection	O
.	O

Given	B
that	O
the	O
association	O
between	O
early	O
gestation	O
through	O
extended	O
winter	O
and	O
insulin	O
resistance	O
is	O
independent	O
of	O
serum	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
our	O
novel	O
findings	O
imply	B
that	O
seasonal	O
variation	O
in	O
insulin	O
resistance	O
may	O
not	O
be	O
fully	O
explained	B
by	O
differences	O
in	O
vitamin	O
D	O
status	O
.	O

Because	O
of	O
changes	O
in	O
the	O
diagnostic	O
criteria	O
for	O
GDM	O
over	O
the	O
years	O
,	O
Beischer	O
(	O
1996	O
)	O
was	O
able	O
to	O
examine	O
perinatal	O
mortality	O
amongst	O
women	O
who	O
would	O
have	O
been	O
diagnosed	O
as	O
having	O
GDM	O
by	O
contemporary	O
criteria	O
,	O
but	O
were	O
not	O
considered	O
to	O
have	O
GDM	O
at	O
the	O
time	O
,	O
and	O
were	O
therefore	O
untreated	O
.	O

PTB	O
rates	O
(<	O
37	O
weeks	O
)	O
were	O
calculated	O
,	O
and	O
logistic	O
regression	O
and	O
locally	O
weighted	O
regression	O
(	O
LOESS	O
)	O
were	O
used	O
to	O
explore	O
the	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
.	O

2011	O
;	O
Sood	O
et	O
al	O
.	O

The	O
involvement	O
of	O
a	O
dietician	O
and	O
diabetes	O
educator	O
experienced	O
in	O
the	O
care	O
of	O
women	O
with	O
GDM	O
will	O
facilitate	O
these	O
areas	O
of	O
management	O
.	O

BPA	O
is	O
added	O
to	O
many	O
plastics	O
and	O
consumer	O
products	O
[	O
9	O
,	O
10	O
].	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

The	O
multivitamin	O
supplementations	O
contained	O
200	O
–	O
400	O
IU	O
of	O
vitamin	O
D	O
.	O
Sample	O
size	O
and	O
statistical	O
analysis	O
We	O
could	O
not	O
find	O
a	O
similar	O
study	O
to	O
use	O
its	O
means	O
for	O
determining	O
the	O
sample	O
size	O
.	O

Vitamin	O
D	O
levels	O
in	O
an	O
Australian	O
and	O
New	O
Zealand	O
cohort	O
and	O
the	O
association	O
with	O
pregnancy	O
outcome	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
at	O
increased	O
susceptibility	O
to	O
vitamin	O
D	O
deficiency	O
.	O

Rectal	O
swabs	O
(	O
FLOQSwab	O
,	O
COPAN	O
)	O
are	O
collected	O
from	O
both	O
the	O
mother	O
and	O
the	O
baby	O
at	O
phases	O
4	O
and	O
6	O
of	O
data	O
collection	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
30	O
ng	O
/	O
ml	O
)	O
and	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
of	O
the	O
pregnant	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
of	O
the	O
women	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
10	O
ng	O
/	O
ml	O
).	O

In	O
an	O
uncontrolled	O
trial	O
,	O
supplementation	O
with	O
a	O
multivitamin	O
/	O
mineral	O
supplement	O
and	O
halibut	O
liver	O
oil	O
(	O
containing	O
900	O
IU	O
/	O
d	O
vitamin	O
D	O
)	O
provided	O
at	O
20	O
wk	O
gestation	O
reduced	O
the	O
odds	O
of	O
preeclampsia	O
by	O
32	O
%	O
(	O
95	O
%	O
CI	O
,	O
11	O
-	O
47	O
%).	O

Nimitphong	O
et	O
al	O
.	O

In	O
multinomial	O
logistic	O
regression	O
analyses	O
,	O
increased	O
fruit	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
belonging	O
to	O
the	O
high	O
Streptococcus	O
/	O
Clostridium	O
group	O
among	O
infants	O
born	O
vaginally	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
73	O
(	O
1	O
.	O
36	O
,	O
5	O
.	O
46	O
)).	O

Thus	O
,	O
in	O
this	O
study	O
we	O
examined	O
how	O
the	O
intrauterine	O
environment	O
is	O
related	O
to	O
the	O
methylation	O
status	O
of	O
LINE	O
-	O
1	O
and	O
Alu	O
regions	O
(	O
specifically	O
LINE	O
-	O
1	O
and	O
AluYb8	O
,	O
respectively	O
)	O
in	O
a	O
functionally	O
relevant	O
fetal	O
tissue	O
,	O
the	O
placenta	O
.	O

Even	O
breast	O
-	O
feeding	O
has	O
been	O
associated	O
with	O
anaphylaxis	O
in	O
2	O
postpartum	O
women	O
.	O

Women	O
who	O
initially	O
called	O
the	O
service	O
to	O
inquire	O
about	O
the	O
safety	O
of	O
an	O
SGA	O
and	O
who	O
confirmed	O
the	O
use	O
of	O
this	O
medication	O
for	O
a	O
minimum	O
of	O
4	O
weeks	O
of	O
pregnancy	O
were	O
invited	O
to	O
participate	O
.	O

Multiple	O
linear	O
and	O
logistic	O
regression	O
models	O
were	O
constructed	O
to	O
investigate	O
significant	O
predictors	O
of	O
the	O
outcomes	O
of	O
interest	O
.	O

The	O
quotient	O
omega	O
-	O
6	O
PUFA	O
/	O
omega	O
-	O
3	O
PUFA	O
was	O
4	O
:	O
1	O
in	O
this	O
study	O
,	O
and	O
this	O
value	O
is	O
comparable	O
to	O
other	O
European	O
cohorts	O
[	O
56	O
,	O
57	O
],	O
but	O
lower	O
than	O
that	O
has	O
been	O
reported	O
for	O
US	O
populations	O
(	O
Food	O
and	O
Nutrition	O
Board	O
.	O

Information	O
on	O
usage	O
of	O
over	O
-	O
the	O
-	O
counter	O
and	O
prescription	O
medications	O
,	O
substance	O
use	O
and	O
breastfeeding	O
was	O
collected	O
as	O
well	O
.	O

Pre	O
-	O
pregnancy	O
weight	O
and	O
height	O
were	O
also	O
based	O
on	O
self	O
-	O
reports	O
made	O
during	O
the	O
interview	O
.	O

For	O
every	O
10	O
-	O
fold	O
increase	O
in	O
DEP	O
exposure	O
,	O
there	O
was	O
a	O
14	O
g	O
increase	O
in	O
birth	O
weight	O
95	O
%	O
CI	O
(-	O
51	O
,	O
79	O
).	O

For	O
categorical	O
analysis	O
of	O
vitamin	O
D	O
levels	O
,	O
we	O
used	O
cutoff	O
values	O
of	O
:	O
sufficient	O
(⩾	O
50	O
nmol	O
l	O
−	O
1	O
)	O
and	O
deficient	O
(<	O
50	O
nmol	O
l	O
−	O
1	O
).	O
28	O
,	O
29	O
,	O
30	O
,	O
31	O
Statistical	O
analysis	O
Distributions	O
of	O
continuous	O
variables	O
were	O
evaluated	O
for	O
normality	O
graphically	O
using	O
histogram	O
and	O
box	O
plots	O
and	O
are	O
described	O
using	O
means	O
and	O
s	O
.	O
d	O
.	O

The	O
Avy	O
model	O
in	O
particular	O
has	O
been	O
put	O
forward	O
as	B
a	O
potential	O
epigenetic	O
toxicological	O
tool	O
(	O
Dolinoy2008	O
;	O
Rosenfeld2010	O
;	O
Faulk	O
et	O
al	O
.	O
2013	O
).	O

Increased	O
adiposity	O
,	O
lipid	O
profile	O
,	O
glycemia	O
,	O
and	O
leptinemia	O
in	O
male	O
offspring	O
have	O
been	O
reported	O
after	O
the	O
exposure	O
to	O
a	O
moderate	O
undernutrition	O
at	O
different	O
pregnancy	O
periods	O
(	O
Desai	O
et	O
al	O
.,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
).	O

Studies	O
have	O
been	O
done	O
determining	O
the	O
effects	O
of	O
smoking	O
in	O
a	O
pregnant	O
patient	O
and	O
the	O
risk	O
of	O
autism	O
in	O
the	O
mother	O
'	O
s	O
offspring	O
.	O

Detailed	O
data	O
on	O
micronutrient	O
supplement	O
use	O
were	O
not	O
available	O
,	O
however	O
,	O
use	O
of	O
dietary	O
supplements	O
(	O
yes	O
/	O
no	O
)	O
was	O
included	O
as	O
a	O
confounder	O
in	O
multiple	O
regression	O
models	O
.	O

In	O
their	O
study	O
,	O
early	O
weaning	O
calves	O
(	O
123	O
d	O
of	O
age	O
;	O
145	O
kg	O
of	O
body	O
weight	O
)	O
were	O
compared	O
with	O
conventional	O
weaning	O
animals	O
(	O
259	O
d	O
of	O
age	O
;	O
273	O
kg	O
of	O
body	O
weight	O
)	O
in	O
contemporary	O
feeding	O
management	O
.	O

In	O
the	O
core	O
region	O
of	O
the	O
nucleus	O
accumbens	O
,	O
neurons	O
have	O
dense	O
spines	O
,	O
which	O
may	O
reflect	O
the	O
degree	O
of	O
synaptic	O
plasticity	O
required	O
for	O
the	O
integrative	O
function	O
of	O
cells	O
in	O
this	O
region	O
[	O
36	O
].	O

However	O
,	O
one	O
study	O
,	O
a	O
randomised	O
controlled	O
trial	O
,	O
was	O
underpowered	O
to	O
realistically	O
address	O
the	O
effectiveness	O
and	O
safety	O
of	O
metformin	O
in	O
GDM	O
.	O
73In	O
another	O
study	O
,	O
a	O
retrospective	O
case	O
control	O
study	O
,	O
subjects	O
treated	O
with	O
insulin	O
had	O
a	O
greater	O
degree	O
of	O
initial	O
glucose	O
intolerance	O
,	O
so	O
the	O
comparison	O
was	O
of	O
limited	O
validity	O
.	O
74A	O
third	O
study	O
comprised	O
a	O
retrospective	O
cohort	O
which	O
included	O
a	O
mixture	O
of	O
both	O
GDM	O
and	O
women	O
with	O
Type	O
2	O
diabetes	O
seen	O
from	O
1966	O
–	O
1991	O
.	O

Early	O
diagnosis	O
rather	O
than	O
more	O
extensive	O
surgery	O
may	O
improve	O
survival	O
and	O
reduce	O
recurrences	O
,	O
mostly	B
in	O
the	O
MEN	O
IIB	O
form	O
of	O
MTC	O
,	O
which	O
is	O
highly	O
aggressive	O
.	O

While	O
no	O
interaction	O
effect	O
was	O
observed	O
between	O
season	O
and	O
vitamin	O
D	O
with	O
regards	O
to	O
glucose	O
homeostasis	O
,	O
it	O
is	O
well	O
recognised	B
that	O
25OHD	O
declines	O
in	O
winter	O
,	O
and	O
is	O
a	O
modifiable	O
factor	O
.	O

VDR	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
normally	B
increase	O
skeletal	O
muscle	O
function	O
.	O

The	O
low	O
risk	O
women	O
for	O
depression	O
(	O
a	O
depression	O
score	O
of	O
<	O
9	O
)	O
were	O
compared	O
to	O
the	O
high	O
risk	O
women	O
(	O
a	O
depression	O
score	O
of	O
>	O
13	O
)	O
concerning	O
age	O
(	O
26	O
.	O
91	O
±	O
4	O
.	O
36	O
vs	O
.	O
25	O
.	O
80	O
±	O
4	O
.	O
74	O
)	O
and	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
(	O
11	O
.	O
26	O
±	O
6	O
vs	O
.	O
13	O
.	O
25	O
±	O
7	O
.	O
96	O
).	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
-(	O
OH	O
)	O
D	O
)	O
concentrations	O
were	O
measured	O
by	O
radioimmunoassay	O
(	O
Diasorin	O
,	O
Stillwater	O
,	O
MN	O
,	O
USA	O
).	O

Polyomaviruses	O
have	O
been	O
shown	O
to	O
induce	O
brain	O
tumors	O
in	O
animals	O
[	O
128	O
–	O
131	O
]	O
and	O
have	O
been	O
detected	O
in	O
human	O
gliomas	O
[	O
132	O
].	O

Rapid	O
assessments	O
were	O
unannounced	O
.	O

Data	O
from	O
gene	O
expression	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

The	O
exception	O
were	O
regular	O
milk	O
drinkers	O
(≥	O
5	O
servings	O
weekly	O
),	O
who	O
had	O
significantly	O
higher	O
mean	O
vitamin	O
D	O
levels	O
than	O
non	O
-	O
regular	O
milk	O
drinkers	O
(	O
76	O
.	O
6	O
±	O
30	O
.	O
3	O
nmol	O
/	O
L	O
vs	O
.	O
63	O
.	O
2	O
±	O
27	O
.	O
0	O
,	O
p	O
=	O
0	O
.	O
042	O
).	O

Differences	O
in	O
mean	O
calcium	O
,	O
albumin	O
,	O
and	O
PTH	O
concentrations	O
between	O
the	O
groups	O
are	O
also	O
reported	O
in	O
Table	O
2	O
.	O

For	O
the	O
present	O
cross	O
-	O
sectional	O
study	O
,	O
we	O
included	O
mothers	O
who	O
had	O
a	O
record	O
from	O
a	O
community	O
prenatal	O
clinic	O
or	O
baseline	O
questionnaire	O
and	O
both	O
two	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
.	O

PubMed	O
Central	O
:	O

Dietary	O
information	O
was	O
consistent	O
with	O
current	O
Australian	O
standards	O
[	O
25	O
],	O
while	O
physical	O
activity	O
advice	O
focussed	O
on	O
the	O
benefits	O
of	O
exercise	O
in	O
pregnancy	O
[	O
26	O
].	O

Alternatively	O
,	O
maternal	O
diet	O
may	O
affect	O
fetal	O
development	O
and	O
subsequent	O
host	O
response	O
to	O
microbial	O
populations	O
at	O
and	O
after	O
birth	O
.	O

Therefore	B
,	O
intrauterine	O
growth	O
conditions	O
might	O
be	O
improved	O
through	O
the	O
adoption	O
of	O
certain	O
dietary	O
patterns	O
during	O
pregnancy	O
.	O

The	O
Cochrane	O
review	O
concluded	O
that	O
there	O
is	O
not	O
enough	O
evidence	O
to	O
evaluate	O
the	O
requirements	O
and	O
effects	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
.	O

Constraints	O
to	O
Successful	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
4	O
.	O
1	O
.	O

The	O
overall	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
impact	O
of	O
differing	O
nutritional	O
exposures	O
(	O
standard	O
rat	O
chow	O
,	O
high	O
fat	O
or	O
caloric	O
restriction	O
)	O
during	O
intrauterine	O
and	O
early	O
postnatal	O
life	O
on	O
pubertal	O
onset	O
and	O
ovarian	O
function	O
in	O
female	O
rat	O
offspring	O
.	O

There	O
were	O
no	O
differences	O
in	O
anthropometric	O
indices	O
(	O
BMI	O
,	O
weight	O
,	O
and	O
MUAC	O
)	O
between	O
the	O
two	O
groups	O
(	O
Table	O
3	O
).	O

Eligibility	O
criteria	O
for	O
inclusion	O
of	O
cluster	O
We	O
will	O
exclude	O
any	O
potential	O
BRAC	O
PO	O
area	O
(	O
cluster	O
)	O
if	O
there	O
are	O
any	O
other	O
maternal	O
and	O
or	O
neonatal	O
interventions	O
either	O
by	O
the	O
government	O
or	O
non	O
-	O
government	O
organisations	O
in	O
the	O
area	O
.	O

BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Historical	O
phasing	O
of	O
reductions	O
in	O
neonatal	O
mortality	O
rates	O
in	O
the	O
United	O
Kingdom	O
and	O
United	O
States	O
during	O
the	O
20th	O
century	O
.	O

For	O
girls	O
,	O
there	O
was	O
a	O
significant	O
change	O
with	O
the	O
BMI	O
of	O
the	O
father	O
,	O
p	O
=	O
0	O
.	O
010	O
,	O
and	O
a	O
borderline	O
significant	O
change	O
associated	O
with	O
the	O
BMI	O
of	O
the	O
PGM	O
,	O
p	O
=	O
0	O
.	O
066	O
,	O
but	O
no	O
association	O
with	O
other	O
family	O
members	O
.	O

Mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
birth	O
weight	O
groups	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
1	O
).	O

The	O
metals	O
were	O
also	O
measured	O
twice	O
while	O
remaining	O
biomarkers	O
were	O
only	O
measured	O
once	O
.	O

The	O
Health	O
and	O
Demographic	O
Surveillance	O
System	O
(	O
HDSS	O
)	O
in	O
Matlab	O
identifies	O
pregnant	O
women	O
within	O
two	O
months	O
of	O
conception	O
through	O
bimonthly	O
home	O
visits	O
.	O

According	O
to	O
Du	O
et	O
al	O
[	O
16	O
],	O
this	O
adipogenesic	O
phase	O
extends	O
to	O
the	O
neonatal	O
period	O
for	O
abdominal	O
adipocytes	O
,	O
to	O
the	O
early	O
weaning	O
stage	O
for	O
subcutaneous	O
and	O
intermuscular	O
adipocytes	O
,	O
and	O
to	O
around	O
250	O
d	O
of	O
age	O
for	O
IMF	O
.	O

The	O
associations	O
for	O
fatty	O
fish	O
or	O
shellfish	O
were	O
J	O
-	O
shaped	O
,	O
with	O
the	O
strongest	O
inverse	O
association	O
for	O
an	O
intermediate	O
dietary	O
intake	O
,	O
whereas	O
a	O
high	O
intake	O
was	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Furthermore	O
,	O
no	O
interaction	O
effect	O
was	O
observed	O
between	O
season	O
and	O
vitamin	O
D	O
with	O
regards	O
to	O
glucose	O
homeostasis	O
.	O

We	O
found	O
that	O
the	O
rs10741657	O
SNP	O
was	O
not	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
but	O
was	O
associated	O
with	O
the	O
response	O
to	O
gestational	O
vitamin	O
D	O
supplementation	O
,	O
therefore	B
suggesting	O
that	O
this	O
SNP	O
only	O
modifies	O
25	O
(	O
OH	O
)	O
D	O
status	O
when	O
the	O
substrate	O
is	O
more	O
readily	O
available	O
and	O
that	O
at	O
the	O
baseline	O
measurement	O
,	O
saturation	O
of	O
the	O
enzyme	O
had	O
not	O
been	O
reached	O
.	O

These	O
data	O
suggest	O
that	O
prenatal	O
care	O
providers	O
of	O
low	O
-	O
income	O
,	O
minority	O
women	O
in	O
particular	O
should	O
make	O
healthy	O
maternal	O
weight	O
gain	O
targets	O
a	O
priority	O
in	O
their	O
care	O
to	O
prevent	O
excessive	O
weight	O
gain	O
during	O
pregnancy	O
and	O
the	O
associated	O
complications	O
.	O

The	O
vulnerability	O
of	O
the	O
developing	O
fetus	O
[	O
15	O
]	O
coupled	O
with	O
the	O
pervasive	O
nature	O
of	O
EDCs	O
has	O
raised	O
concerns	O
about	O
reproductive	O
health	O
effects	O
arising	O
from	O
gestational	O
EDC	O
exposure	O
,	O
such	O
as	O
low	O
birth	O
weight	O
[	O
15	O
].	O

However	O
,	O
in	O
a	O
recent	O
study	O
,	O
the	O
role	O
of	O
diabetes	O
during	O
gestation	O
on	O
such	O
adverse	O
long	O
-	O
term	O
metabolic	O
consequences	O
has	O
been	O
seriously	O
questioned	O
,	O
as	O
they	O
seem	O
to	O
relate	O
more	O
on	O
known	O
confounders	O
,	O
such	O
as	O
the	O
BMI	O
of	O
either	O
one	O
of	O
the	O
parents	O
(	O
Donovan	O
and	O
Cundy	O
,	O
2014	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

The	O
authors	O
reported	O
that	O
the	O
link	O
was	O
particularly	O
significant	O
in	O
males	O
.	O

Background	O
Endocrine	O
disrupting	O
chemicals	O
(	O
EDC	O
)	O
are	O
synthetic	O
compounds	O
found	O
in	O
many	O
consumer	O
products	O
[	O
1	O
–	O
3	O
]	O
that	O
alter	O
the	O
endocrine	O
system	O
[	O
4	O
,	O
5	O
].	O

This	O
may	O
reflect	B
lower	O
coverage	O
with	O
volunteer	O
health	O
workers	O
and	O
lower	O
population	O
densities	O
in	O
Africa	O
,	O
where	O
most	O
costing	O
studies	O
of	O
vitamin	O
A	O
were	O
done	O
.	O

Both	O
hypotheses	O
can	O
be	O
valid	O
and	O
coexist	O
,	O
and	O
the	O
second	O
(	O
foetal	O
-	O
cell	O
carcinogenesis	O
)	O
could	O
explain	B
some	O
cases	O
of	O
unusual	O
,	O
rapidly	O
growing	O
DTC	O
.	O

After	O
physiological	O
fluctuations	O
in	O
childhood	O
,	O
AMH	O
is	O
stabilized	O
at	O
the	O
age	O
of	O
eight	O
and	O
later	O
begins	O
to	O
decrease	O
from	O
about	O
the	O
25th	O
year	O
of	O
life	O
up	O
to	O
the	O
beginning	O
of	O
menopause	O
[	O
42	O
].	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

2	O
)	O
.	O

The	O
system	O
will	O
also	O
generate	O
daily	O
reports	O
of	O
the	O
completed	O
interviews	O
and	O
enrolment	O
and	O
make	O
them	O
available	O
on	O
the	O
online	O
monitoring	O
interface	O
(	O
in	O
real	O
time	O
).	O

Intercellular	O
Nampt	O
is	O
substantially	O
released	O
by	O
embryonic	O
,	O
amniotic	O
,	O
and	O
placental	O
membrane	O
and	O
adipose	O
tissue	O
.	O

Moreover	O
,	O
we	O
tested	O
the	O
effect	O
of	O
cortisol	O
on	O
GR	O
splicing	O
and	O
GAS5	O
expression	O
of	O
BeWo	O
and	O
JEG	O
-	O
3	O
placental	O
cells	O
,	O
in	O
an	O
attempt	O
to	O
resemble	O
a	O
low	O
,	O
moderate	O
,	O
and	O
high	O
stress	O
milieu	O
in	O
vitro	O
.	O

(	O
2005	O
).	O

These	O
conditions	O
were	O
maintained	O
for	O
six	O
weeks	O
prior	O
to	O
mating	O
and	O
throughout	O
gestation	O
.	O

It	O
is	O
conceivable	B
that	O
a	O
slight	O
reduction	O
in	O
calcium	O
buffering	O
proteins	O
may	O
affect	O
the	O
ability	O
of	O
neurons	O
within	O
the	O
nucleus	O
accumbens	O
to	O
repolarise	O
in	O
response	O
to	O
psychomimetic	O
agents	O
.	O

Moreover	O
,	O
vitamin	O
D	O
is	O
associated	O
with	O
premature	O
births	O
,	O
obesity	O
and	O
renal	O
dysfunction	O
in	O
adulthood	O
,	O
making	O
it	O
more	O
than	O
an	O
essential	O
fat	O
-	O
soluble	O
vitamin	O
responsible	B
for	O
calcium	O
metabolism	O
[	O
9	O
],[	O
10	O
].	O

Further	O
analyses	O
including	O
those	O
who	O
self	O
-	O
reported	O
vaccination	O
showed	O
similar	O
trends	O
(	O
seeSupplementary	O
materials	O
A3	O
-	O
A5	O
).	O

The	O
small	O
proportion	O
of	O
neonates	O
who	O
were	O
SGA	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
>	O
75	O
nmol	O
l	O
−	O
1precluded	O
evaluation	O
at	O
higher	O
cutpoints	O
.	O

Sample	O
size	O
The	O
available	O
sample	O
size	O
for	O
follow	O
-	O
up	O
assessment	O
at	O
6	O
-	O
months	O
of	O
age	O
was	O
predetermined	O
by	O
the	O
LIMIT	O
trial	O
,	O
which	O
was	O
powered	O
on	O
the	O
primary	O
outcome	O
of	O
large	O
for	O
gestational	O
age	O
,	O
with	O
2212	O
women	O
randomised	O
[	O
22	O
].	O

Motivated	O
by	O
the	O
variation	O
in	O
sequence	O
features	O
(	O
bioinformatic	O
attributes	O
)	O
observed	O
between	O
RPMM	O
-	O
based	O
classes	O
,	O
we	O
next	O
performed	O
a	O
bioinformatically	O
informed	O
clustering	O
of	O
CpG	O
loci	O
into	O
classes	O
,	O
grouping	O
CpGs	O
according	O
to	O
their	O
sequence	O
context	O
:	O
presence	O
within	O
a	O
CGI	O
,	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
Alu	O
,	O
or	O
MIR	O
element	O
,	O
or	O
PcG	O
target	O
gene	O
and	O
proximity	O
(≤	O
1	O
,	O
000	O
bases	O
)	O
to	O
any	O
TFBS	O
.	O

Further	O
studies	O
are	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

The	O
problem	O
is	O
increasing	O
-	O
for	O
the	O
countries	O
with	O
20	O
-	O
year	O
trend	O
data	O
,	O
the	O
majority	B
show	O
an	O
increase	O
in	O
preterm	O
birth	O
rates	O
[	O
3	O
].	O

Body	O
weight	O
was	O
measured	O
at	O
birth	O
and	O
weaning	O
,	O
and	O
weight	O
gain	O
was	O
calculated	O
weekly	O
from	O
0	O
–	O
29	O
weeks	O
post	O
-	O
weaning	O
.	O

[	O
46	O
]	O
and	O
Wu	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Participant	O
CharacteristicsSeason	O
at	O
first	O
antenatal	O
visitCharacteristicTotal	O
Group	O
(	O
n	O
=	O
334	O
)	O
Winter	O
(	O
n	O
=	O
166	O
)	O
Summer	O
(	O
n	O
=	O
168	O
)	O
PaAge	O
(	O
years	O
)	O
33	O
.	O
0	O
(	O
3	O
.	O
9	O
)	O
32	O
.	O
8	O
(	O
3	O
.	O
7	O
)	O
33	O
.	O
2	O
(	O
4	O
.	O
0	O
)	O
0	O
.	O
409Gestation	O
at	O
first	O
antenatal	O
visit	O
(	O
weeks	O
)	O
12	O
.	O
8	O
(	O
2	O
.	O
3	O
)	O
12	O
.	O
7	O
(	O
2	O
.	O
3	O
)	O
12	O
.	O
9	O
(	O
2	O
.	O
2	O
)	O
0	O
.	O
556BMI	O
at	O
first	O
antenatal	O
visit	O
Mean	O
(	O
SD	O
),	O
(	O
kg	O
/	O
m2	O
)	O
26	O
.	O
3	O
(	O
4	O
.	O
5	O
)	O
26	O
.	O
3	O
(	O
4	O
.	O
4	O
)	O
26	O
.	O
2	O
(	O
4	O
.	O
7	O
)	O
0	O
.	O
948	O
Underweight	O
(	O
BMI	O
<	O
18	O
.	O
5	O
kg	O
/	O
m2	O
)	O
[	O
n	O
(%)]	O
2	O
(	O
0	O
.	O
6	O
)	O
1	O
(	O
0	O
.	O
6	O
)	O
1	O
(	O
0	O
.	O
6	O
)	O
0	O
.	O
953	O
Normal	O
(	O
BMI	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
kg	O
/	O
m2	O
)	O
[	O
n	O
(%)]	O
153	O
(	O
45	O
.	O
8	O
)	O
78	O
(	O
46	O
.	O
4	O
)	O
75	O
(	O
45	O
.	O
2	O
)	O
Overweight	O
(	O
BMI	O
25	O
.	O
0	O
–	O
29	O
.	O
9	O
kg	O
/	O
m2	O
)	O
[	O
n	O
(%)]	O
125	O
(	O
37	O
.	O
4	O
)	O
60	O
(	O
35	O
.	O
7	O
)	O
65	O
(	O
39	O
.	O
2	O
)	O
Obese	O
(	O
BMI	O
>	O
30	O
.	O
0	O
kg	O
/	O
m2	O
)	O
[	O
n	O
(%)]	O
52	O
(	O
15	O
.	O
6	O
)	O
27	O
(	O
16	O
.	O
1	O
)	O
25	O
(	O
15	O
.	O
1	O
)	O
Smoking	O
at	O
baseline	O
[	O
n	O
(%)]	O
7	O
(	O
2	O
.	O
1	O
)	O
4	O
(	O
2	O
.	O
4	O
)	O
3	O
(	O
1	O
.	O
8	O
)	O
0	O
.	O
697Intervention	O
group	O
[	O
n	O
(%)]	O
171	O
(	O
51	O
.	O
2	O
)	O
84	O
(	O
50	O
.	O
6	O
)	O
87	O
(	O
50	O
.	O
9	O
)	O
0	O
.	O
829Ethnicity	O
:	O
Caucasian	O
[	O
n	O
(%)]	O
331	O
(	O
99	O
.	O
1	O
)	O
166	O
(	O
100	O
.	O
0	O
)	O
165	O
(	O
98	O
.	O
2	O
)	O
0	O
.	O
250Achieved	O
3rd	O
level	O
education	O
[	O
n	O
(%)]	O
177	O
(	O
53	O
.	O
0	O
)	O
87	O
(	O
52	O
.	O
6	O
)	O
90	O
(	O
53	O
.	O
6	O
)	O
0	O
.	O
940Birth	O
weight	O
(	O
g	O
)	O
4065	O
.	O
9	O
(	O
470	O
.	O
0	O
)	O
4043	O
.	O
1	O
(	O
434	O
.	O
4	O
)	O
4088	O
.	O
4	O
(	O
503	O
.	O
0	O
)	O
0	O
.	O
382	O
Data	O
are	O
presented	O
as	O
mean	O
(	O
SD	O
)	O
unless	O
otherwise	O
stated	O
aComparison	O
between	O
winter	O
and	O
summer	O
Participant	O
characteristics	O
-	O
25OHD	O
,	O
season	O
and	O
markers	O
of	O
glucose	O
metabolism	O
Median	O
(	O
IQR	O
)	O
25OHD	O
concentrations	O
were	O
39	O
.	O
2	O
nmol	O
/	O
L	O
(	O
27	O
.	O
2	O
nmol	O
/	O
L	O
)	O
and	O
35	O
.	O
8	O
nmol	O
/	O
L	O
(	O
27	O
.	O
3	O
nmol	O
/	O
L	O
)	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
respectively	O
.	O

As	O
was	O
mentioned	O
,	O
we	O
did	O
not	O
see	O
any	O
associations	O
of	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
with	O
consumption	O
of	O
red	O
meats	O
in	O
the	O
healthy	O
dietary	O
pattern	O
and	O
refined	O
grain	O
,	O
salt	O
,	O
and	O
sugar	O
in	O
the	O
traditional	O
dietary	O
pattern	O
.	O

Repeated	O
episodes	O
of	O
GDM	O
are	O
associated	O
with	O
the	O
earlier	O
development	O
of	O
diabetes	O
,	O
and	O
this	O
has	O
been	O
postulated	O
to	O
be	O
due	O
to	O
the	O
increased	O
stress	O
that	O
the	O
β	O
-	O
cells	O
are	O
exposed	O
to	O
with	O
each	O
pregnancy	O
.	O
75By	O
treating	O
the	O
mother	O
with	O
glyburide	O
,	O
it	O
is	O
possible	O
that	O
this	O
accentuates	O
β	O
-	O
cell	O
stress	O
and	O
accelerates	O
their	O
decline	O
,	O
whereas	O
insulin	O
therapy	O
would	O
conversely	O
provide	O
a	O
degree	O
of	O
relief	O
to	O
the	O
β	O
-	O
cells	O
.	O

After	O
2	O
weeks	O
of	O
feeding	O
(	O
pregestational	O
period	O
),	O
adult	O
females	O
(	O
4	O
month	O
old	O
)	O
were	O
allowed	O
to	O
mate	O
with	O
male	O
rats	O
of	O
the	O
same	O
strain	O
weighting	O
484	O
.	O
5	O
±	O
7	O
.	O
96	O
(	O
Figure1	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
vitamin	O
DDietary	O
intake	O
g	O
/	O
day	O
·	O
MJPositive	O
psychotic	O
-	O
like	O
symptomsaMedianInterquintile	O
rangeLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
group	O
Energy	O
adjustedMultivariatebEnergy	O
adjustedMultivariatebVitamin	O
DNo	O
.	O
No	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CINo	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CI	O
0	O
.	O
4	O
(	O
0	O
.	O
01	O
-	O
0	O
.	O
5	O
)	O
4132Ref	O
.	O
36682400	O
.	O
6	O
(	O
0	O
.	O
5	O
-	O
0	O
.	O
6	O
)	O
447634620	O
.	O
870	O
.	O
82	O
-	O
0	O
.	O
930	O
.	O
88a0	O
.	O
82	O
-	O
0	O
.	O
931850	O
.	O
710	O
.	O
58	O
-	O
0	O
.	O
860	O
.	O
72a0	O
.	O
59	O
-	O
0	O
.	O
880	O
.	O
7	O
(	O
0	O
.	O
6	O
-	O
0	O
.	O
8	O
)	O
459033930	O
.	O
840	O
.	O
79	O
-	O
0	O
.	O
890	O
.	O
84a0	O
.	O
79	O
-	O
0	O
.	O
901710	O
.	O
640	O
.	O
53	O
-	O
0	O
.	O
790	O
.	O
65a0	O
.	O
52	O
-	O
0	O
.	O
800	O
.	O
9	O
(	O
0	O
.	O
8	O
-	O
4	O
.	O
0	O
)	O
462033430	O
.	O
830	O
.	O
78	O
-	O
0	O
.	O
880	O
.	O
82a0	O
.	O
77	O
-	O
0	O
.	O
881750	O
.	O
660	O
.	O
54	O
-	O
0	O
.	O
810	O
.	O
63a0	O
.	O
50	O
-	O
0	O
.	O
78	O
aAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
,	O
country	O
of	O
birth	O
,	O
BMI	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
Discussion	O
We	O
report	O
here	O
results	O
from	O
the	O
first	O
study	O
that	O
has	O
evaluated	O
the	O
dietary	O
intake	O
of	O
fish	O
,	O
PUFA	O
and	O
vitamin	O
D	O
in	O
relation	O
to	O
the	O
experience	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
large	O
cohort	O
of	O
over	O
30	O
000	O
Swedish	O
women	O
.	O

of	O
expressed	O
probe	O
-	O
sets	O
,	O
filtered	O
probe	O
-	O
sets	O
,	O
and	O
regulated	O
probe	O
-	O
sets	O
of	O
LP	O
and	O
AP	O
offspring	O
at	O
distinct	O
developmental	O
stages	O
and	O
periodsNo	O
.	O

Only	O
text4baby	O
participants	O
who	O
were	O
enrolled	O
in	O
the	O
Madigan	O
study	O
were	O
counted	O
in	O
our	O
treatment	O
group	O
.	O

Concordance	O
of	O
mothers	O
’	O
personal	O
weight	O
gain	O
target	O
with	O
clinical	O
recommendations	O
varied	O
by	O
mothers	O
’	O
pre	O
-	O
pregnancy	O
weight	O
status	O
[	O
χ	O
(	O
4	O
)	O
2	O
=	O
9	O
.	O
781	O
,	O
p	O
=	O
0	O
.	O
044	O
].	O

Also	O
,	O
58	O
(	O
2	O
.	O
8	O
%)	O
infants	O
had	O
LBW	O
,	O
while	O
78	O
(	O
3	O
.	O
8	O
%)	O
infants	O
were	O
delivered	O
preterm	O
(	O
Table1	O
).	O

Women	O
were	O
not	O
from	O
household	O
compounds	O
that	O
had	O
participated	O
in	O
the	O
qualitative	O
research	O
on	O
motivators	O
and	O
barriers	O
to	O
handwashing	O
in	O
the	O
neonatal	O
period	O
.	O

High	O
meat	O
consumption	O
during	O
pregnancy	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
wheeze	O
in	O
the	O
first	O
year	O
of	O
life	O
,	O
while	O
maternal	O
dairy	O
intake	O
is	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
infantile	O
wheeze	O
[	O
2	O
].	O

However	O
,	O
such	O
drugs	O
are	O
not	O
environmental	O
factors	O
and	O
so	O
were	O
not	O
considered	O
any	O
further	O
.	O

Recently	O
,	O
LC	O
-	O
MS	O
/	O
MS	O
became	O
the	O
gold	O
standard	O
of	O
measuring	O
Vitamin	O
D	O
level	O
due	B
to	I
its	O
ability	O
to	O
differentiate	O
and	O
accurately	O
quantify	O
the	O
two	O
subgroups	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
(	O
25	O
-	O
OH	O
Vitamin	O
D2	O
and	O
25	O
-	O
OH	O
Vitamin	O
D3	O
);	O
(	O
2	O
)	O
high	O
specificity	O
,	O
which	O
allows	O
differentiation	O
of	O
the	O
target	O
molecule	O
from	O
other	O
metabolic	O
intermediates	O
,	O
as	O
well	O
as	O
avoiding	O
interference	O
as	O
seen	O
in	O
immunological	O
methods	O
;	O
(	O
3	O
)	O
high	O
sensitivity	O
,	O
which	O
allows	O
detection	O
at	O
ng	O
/	O
mL	O
level	O
.	O

We	O
computed	O
birth	O
weight	O
for	O
gestational	O
age	O
z	O
-	O
scores	O
using	O
US	O
Natality	O
reference	O
data	O
from	O
Oken	O
et	O
al	O
.	O

The	O
primary	O
follow	O
-	O
up	O
study	O
endpoint	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
sex	O
and	O
age	O
.	O

Analyses	O
used	O
intention	O
to	O
treat	O
principles	O
according	O
to	O
the	O
treatment	O
group	O
allocated	O
in	O
pregnancy	O
.	O

?	O

Temporal	O
patterns	O
in	O
birth	O
weight	O
may	O
result	O
from	O
seasonal	O
variations	O
in	O
food	O
availability	O
.	O

The	O
membranes	O
were	O
washed	O
and	O
incubated	O
with	O
anti	O
-	O
mouse	O
(	O
1	O
∶	O
5000	O
for	O
renin	O
)	O
or	O
anti	O
-	O
rabbit	O
(	O
1	O
∶	O
8000	O
for	O
podocin	O
and	O
AT1r	O
;	O
1	O
∶	O
5000	O
for	O
WT1	O
)	O
secondary	O
antibodies	O
.	O

Gale	O
et	O
al	O
.	O

After	O
blocking	O
,	O
the	O
membranes	O
were	O
incubated	O
with	O
the	O
follow	O
antibodies	O
:	O
a	O
)	O
polyclonal	O
antibody	O
against	O
rabbit	O
anti	O
-	O
human	O
AT1	O
receptor	O
(	O
AT1r	O
306	O
;	O
43	O
kDa	O
;	O
sc	O
-	O
579	O
;	O
1	O
∶	O
1000	O
;	O
Santa	O
Cruz	O
Biotechnology	O
);	O
b	O
)	O
monoclonal	O
antibody	O
against	O
mouse	O
renin	O
(	O
A	O
-	O
1	O
;	O
38	O
–	O
46	O
kDa	O
;	O
sc	O
-	O
137252	O
;	O
1	O
∶	O
1000	O
;	O
Santa	O
Cruz	O
Biotechnology	O
);	O
c	O
)	O
polyclonal	O
antibody	O
against	O
rabbit	O
anti	O
-	O
human	O
podocin	O
(	O
H	O
-	O
130	O
;	O
42	O
kDa	O
;	O
sc	O
-	O
21009	O
;	O
1	O
∶	O
1000	O
;	O
Santa	O
Cruz	O
Biotechnology	O
);	O
and	O
d	O
)	O
polyclonal	O
antibody	O
against	O
rabbit	O
anti	O
-	O
human	O
WT1	O
(	O
C	O
-	O
19	O
;	O
52	O
kDa	O
;	O
sc	O
-	O
192	O
;	O
1	O
∶	O
500	O
;	O
Santa	O
Cruz	O
Biotechnology	O
).	O

Pregnancy	O
weight	O
gain	O
was	O
calculated	O
as	O
the	O
difference	O
between	O
the	O
weights	O
at	O
commencing	O
the	O
study	O
medication	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
.	O

This	O
is	O
concomitant	O
with	O
observational	O
data	O
showing	O
that	O
mean	O
25	O
[	O
OH	O
]	O
D	O
concentrations	O
in	O
African	O
Americans	O
are	O
near	O
40	O
nmol	O
/	O
L	O
compared	O
to	O
about	O
65	O
nmol	O
/	O
L	O
for	O
white	O
Americans	O
[	O
34	O
].	O

Therefore	B
,	O
health	O
professionals	O
should	O
be	O
aware	O
of	O
the	O
potential	O
nutritional	O
deficiencies	O
in	O
children	O
suffering	O
from	O
extensive	O
dental	O
caries	O
.	O

Mothers	O
in	O
the	O
intervention	O
arm	O
were	O
3	O
.	O
9	O
times	O
as	O
likely	B
as	O
those	O
in	O
the	O
control	O
arm	O
to	O
be	O
observed	O
washing	O
their	O
hands	O
at	O
the	O
times	O
recommended	O
as	O
part	O
of	O
the	O
handwashing	O
intervention	O
(	O
95	O
%	O
CI	O
1	O
.	O
23	O
–	O
2	O
.	O
02	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Identification	O
of	O
mutations	O
underlying	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
)	O
and	O
skeletal	O
morphology	O
mutant	O
2	O
(	O
Skm2	O
).	O

Association	O
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
and	O
OGTT	O
results	O
/	O
birth	O
weight	O
,	O
and	O
between	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
and	O
head	O
circumference	O
at	O
birth	O
were	O
tested	O
with	O
univariate	O
linear	O
regression	O
.	O

In	O
addition	O
,	O
the	O
prevalence	O
of	O
GDM	O
was	O
in	O
accordance	O
with	O
the	O
national	O
statistics	O
[	O
12	O
].	O

A	O
recent	O
meta	O
-	O
analysis	O
found	O
a	O
latitude	O
related	O
increase	O
in	O
schizophrenia	O
prevalence	O
that	O
was	O
greater	O
for	O
groups	O
with	O
low	O
fish	O
consumption	O
[	O
12	O
].	O

Unlike	O
the	O
previously	O
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Categorical	O
variables	O
were	O
expressed	O
as	O
percentage	O
.	O

Children	O
ranging	O
in	O
age	O
from	O
3	O
(	O
50	O
)	O
to	O
19	O
years	O
(	O
51	O
)	O
have	O
been	O
observed	O
in	O
laboratory	O
settings	O
to	O
eat	O
large	O
amounts	O
of	O
palatable	O
food	O
in	O
the	O
absence	O
of	O
hunger	O
,	O
after	O
a	O
meal	O
.	O

1	O
.	O

To	O
identify	O
differences	O
by	O
race	O
/	O
ethnic	O
group	O
,	O
PTB	O
rates	O
were	O
calculated	O
and	O
logistic	O
regression	O
was	O
conducted	O
for	O
white	O
and	O
non	O
-	O
white	O
women	O
.	O

Nevertheless	O
,	O
over	O
the	O
ensuing	O
decade	O
the	O
hundreds	O
of	O
subsequent	O
studies	O
have	O
provided	O
more	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

It	O
has	O
been	O
estimated	O
that	O
up	O
to	O
one	O
third	O
of	O
women	O
with	O
diabetes	O
,	O
had	O
a	O
GDM	O
pregnancy	O
earlier	O
in	O
their	O
life	O
,	O
2though	O
this	O
was	O
not	O
evident	O
in	O
a	O
recent	O
survey	O
of	O
women	O
with	O
type	O
2	O
diabetes	O
.	O
23	O
This	O
review	O
will	O
focus	O
on	O
the	O
medical	O
management	O
of	O
GDM	O
,	O
in	O
particular	O
self	O
monitoring	O
of	O
blood	O
glucose	O
and	O
diabetes	O
education	O
,	O
dietary	O
therapy	O
and	O
physical	O
activity	O
,	O
pharmacotherapy	O
,	O
and	O
post	O
-	O
partum	O
management	O
.	O

For	O
descriptive	O
purposes	O
,	O
the	O
race	O
variable	O
was	O
defined	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
,	O
Latina	O
/	O
Hispanic	O
,	O
African	O
-	O
American	O
,	O
and	O
“	O
other	O
.”	O
In	O
other	O
analyses	O
,	O
race	O
was	O
categorized	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
versus	O
all	O
other	O
groups	O
combined	O
.	O

Briefly	O
,	O
normal	O
beat	O
to	O
beat	O
intervals	O
(	O
RR	O
)	O
were	O
transferred	O
from	O
Polar	O
S810i	O
to	O
Precision	O
Performance	O
Software	O
by	O
an	O
infrared	O
interface	O
device	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
IBM	O
SPSS	O
Statistics	O
for	O
Windows	O
,	O
Version	O
20	O
.	O
0	O
(	O
IBM	O
,	O
Armonk	O
,	O
NY	O
).	O

Indeed	O
those	O
offspring	O
,	O
for	O
which	O
maternal	O
calorie	O
restriction	O
was	O
extended	O
into	O
lactation	O
,	O
did	O
not	O
show	O
obesity	O
as	O
adults	O
,	O
but	O
still	O
displayed	O
accelerated	O
reproductive	O
maturation	O
.	O

Cases	O
were	O
less	O
likely	B
to	O
be	O
of	O
non	O
-	O
Hispanic	O
White	O
race	O
/	O
ethnicity	O
than	O
non	O
-	O
cases	O
.	O

The	O
cut	O
-	O
off	O
points	O
of	O
<	O
9	O
and	O
9	O
–	O
13	O
were	O
used	O
as	B
low	O
and	O
moderate	O
risk	O
for	O
depression	O
.	O

The	O
SNPs	O
included	O
in	O
this	O
analysis	O
were	O
chosen	O
based	O
on	O
findings	O
in	O
the	O
previous	O
GWAS	O
,	O
which	O
included	O
only	O
individuals	O
of	O
European	O
ancestry	O
(	O
8	O
).	O

Our	O
study	O
implementing	O
partner	O
BRAC	O
,	O
a	O
non	O
-	O
government	O
organisation	O
co	O
-	O
ordinates	O
a	O
community	O
-	O
based	O
maternal	O
,	O
neonatal	O
and	O
child	O
health	O
program	O
in	O
the	O
area	O
which	O
includes	O
a	O
prospective	O
pregnancy	O
surveillance	O
and	O
home	O
-	O
based	O
antenatal	O
care	O
program	O
.	O

Gross	O
anatomical	O
abnormalities	O
were	O
greater	O
in	O
mice	O
fathered	O
by	O
FD	O
mice	O
(	O
27	O
%	O
vs	O
.	O
3	O
%)	O
which	O
included	O
craniofacial	O
,	O
hydrocephalus	O
,	O
limb	O
,	O
and	O
muscle	O
/	O
skeletal	O
defects	O
.	O

Pregnant	O
women	O
who	O
fulfilled	O
the	O
inclusion	O
criteria	O
(	O
pregnant	O
women	O
presenting	O
for	O
the	O
second	O
or	O
subsequent	O
visit	O
)	O
and	O
consented	O
to	O
participate	O
in	O
the	O
study	O
were	O
enrolled	O
into	O
the	O
study	O
.	O

Also	O
,	O
impaired	O
fetal	O
growth	O
,	O
in	O
particular	O
in	O
head	O
circumference	O
,	O
is	O
associated	O
with	O
nonoptimal	O
neurodevelopmental	O
outcome	O
[	O
4	O
].	O

The	O
timing	O
of	O
an	O
environmental	O
exposure	O
can	O
also	O
be	O
a	O
major	O
contributing	O
factor	O
to	O
the	O
significance	O
of	O
the	O
overall	O
outcome	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
adipose	O
tissue	O
is	O
very	O
insulin	O
sensitive	O
in	O
the	O
fed	O
state	O
,	O
while	O
being	O
able	O
to	O
drive	O
insulin	O
resistance	O
in	O
the	O
fasting	O
state	O
,	O
independently	O
from	O
insulin	O
levels	O
(	O
Nelson	O
et	O
al	O
.,	O
2014	O
).	O

Conversely	O
,	O
a	O
multigenerational	O
change	O
represents	O
an	O
epigenetic	O
effect	O
that	O
affects	O
multiple	O
generations	O
,	O
all	O
of	O
which	O
were	O
exposed	O
to	O
the	O
original	O
stimulus	O
,	O
either	O
directly	O
as	O
the	O
exposed	O
mother	O
or	O
child	O
/	O
adult	O
or	O
indirectly	O
as	O
an	O
embryo	O
or	O
PGC	O
within	O
the	O
exposed	O
generation	O
.	O

The	O
control	O
group	O
was	O
offspring	O
fed	O
the	O
RV	O
diet	O
and	O
born	O
to	O
dams	O
fed	O
the	O
RV	O
diet	O
.	O

No	O
matter	O
which	O
angle	O
we	O
choose	O
to	O
look	O
at	O
for	O
endometriosis	O
,	O
it	O
is	O
a	O
disease	O
caused	O
by	O
metabolic	O
and	O
biochemical	O
imbalance	O
.	O

Overall	O
,	O
AluYb8	O
had	O
higher	O
DNA	O
methylation	O
levels	O
than	O
did	O
LINE	O
-	O
1	O
,	O
which	O
may	O
be	O
due	O
to	O
the	O
lower	O
degree	O
of	O
C	O
-	O
to	O
-	O
T	O
transition	O
mutations	O
owing	O
to	O
the	O
younger	O
age	O
of	O
AluYb8	O
elements	O
(	O
Choi	O
et	O
al	O
.	O

Our	O
cluster	O
is	O
one	O
BRAC	O
PO	O
area	O
that	O
consists	O
of	O
~	O
13	O
,	O
000	O
people	O
.	O

This	O
is	O
due	B
to	I
follow	O
-	O
up	O
testing	O
being	O
on	O
the	O
recommended	O
test	O
order	O
set	O
but	O
still	O
needing	O
provider	O
selection	O
compared	O
to	O
the	O
initial	O
test	O
which	O
is	O
automated	O
as	O
part	O
of	O
the	O
initial	O
prenatal	O
screening	O
.	O

INTRODUCTION	O
Vitamin	O
D	O
has	O
been	O
a	O
hot	O
topic	O
in	O
the	O
medical	O
world	O
for	O
the	O
past	O
10	O
years	O
.	O

With	O
the	O
current	O
complement	O
and	O
pace	O
of	O
public	O
health	O
efforts	O
,	O
neonatal	O
sepsis	O
is	O
projected	O
to	O
continue	O
to	O
cause	O
roughly	B
123	O
,	O
000	O
preventable	O
deaths	O
per	O
1000	O
live	O
births	O
in	O
2030	O
[	O
1	O
].	O

There	O
was	O
an	O
inverse	O
relationship	O
between	O
the	O
vitamin	O
D	O
logarithm	O
and	O
depression	O
scores	O
,	O
as	B
by	O
adding	O
one	O
unit	O
to	O
the	O
vitamin	O
D	O
concentration	O
logarithm	O
,	O
equal	O
to	O
2	O
.	O
72	O
ng	O
/	O
mL	O
,	O
a	O
46	O
%	O
reduction	O
in	O
the	O
depression	O
scores	O
occurred	O
[	O
63	O
].	O

Vitamin	O
D2	O
was	O
not	O
detected	O
among	O
participants	O
without	O
Vitamin	O
D	O
supplement	O
use	O
in	O
this	O
study	O
.	O

In	O
mouse	O
studies	O
,	O
the	O
compound	O
was	O
better	O
at	O
shrinking	O
pancreatic	O
tumors	O
than	O
gemcitabine	O
,	O
a	O
standard	O
chemotherapy	O
drug	O
.	O

One	O
study	O
conducted	O
in	O
Poland	O
concluded	O
that	O
the	O
level	O
of	O
nutritional	O
knowledge	O
of	O
pregnant	O
women	O
regarding	O
mineral	O
and	O
vitamins	O
was	O
insufficient	O
,	O
without	O
focusing	O
on	O
the	O
relationship	O
with	O
their	O
intake	O
[	O
20	O
].	O

Summary	O
Many	O
women	O
experience	O
type	O
I	O
allergies	O
during	O
pregnancy	O
.	O

The	O
delivery	O
mode	O
was	O
drawn	O
from	O
maternal	O
delivery	O
records	O
,	O
and	O
maternal	O
pre	O
-	O
pregnancy	O
height	O
,	O
weight	O
,	O
and	O
parity	O
were	O
determined	O
via	O
a	O
self	O
-	O
administered	O
questionnaire	O
upon	O
study	O
entry	O
and	O
used	O
to	O
compute	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

Follow	O
-	O
up	O
of	O
MTC	O
patients	O
suspected	O
for	O
recurrence	O
can	O
therefore	O
be	O
performed	O
by	O
using	O
the	O
somatostatin	O
analogue	O
octreotide	O
(	O
octreoscan	O
).	O

Similarly	O
,	O
animal	O
studies	O
documented	O
normoweight	O
at	O
birth	O
when	O
the	O
early	O
pregnancy	O
was	O
conducted	O
under	O
caloric	O
restriction	O
(	O
Cleal	O
et	O
al	O
.,	O
2007	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Poore	O
et	O
al	O
.,	O
2010	O
).	O

[	O
10	O
]	O
In	O
rats	O
,	O
the	O
placenta	O
transports	O
25	O
(	O
OH	O
)	O
2D	O
and	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
but	O
not	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

Ninety	O
-	O
nine	O
percent	O
(	O
99	O
%)	O
of	O
the	O
respondents	O
affirmed	O
that	O
ANC	O
was	O
important	O
not	O
only	O
for	O
the	O
mother	O
but	O
for	O
the	O
foetus	O
as	O
well	O
.	O

However	O
,	O
such	O
associations	O
were	O
not	O
seen	O
with	O
healthy	O
and	O
traditional	O
dietary	O
pattern	O
.	O

Thus	B
,	O
we	O
do	O
not	O
know	O
the	O
stage	O
of	O
maturation	O
when	O
the	O
post	O
-	O
weaning	O
diets	O
altered	O
the	O
hypothalamus	O
.	O

This	O
may	O
reflect	O
the	O
lower	O
power	O
of	O
this	O
study	O
,	O
although	O
our	O
findings	O
are	O
similar	O
to	O
other	O
small	O
studies	O
(	O
10	O
,	O
11	O
).	O

No	O
studies	O
reported	O
adjusting	O
results	O
from	O
the	O
FFQ	O
for	O
energy	O
intake	O
,	O
a	O
recommendation	O
made	O
by	O
Freedman	O
et	O
al	O
.	O

Reproductive	O
Toxicity	O
:	O
Too	O
Much	O
of	O
a	O
Good	O
Thing	O
?	O

The	O
RR	O
comparing	O
ever	O
smokers	O
to	O
never	O
smokers	O
,	O
for	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
compared	O
with	O
the	O
low	O
level	O
group	O
was	O
1	O
.	O
2	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
1	O
.	O
3	O
)	O
and	O
1	O
.	O
5	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
3	O
-	O
1	O
.	O
7	O
),	O
respectively	O
.	O

Furthermore	O
,	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
were	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
SGA	O
.	O

Totally	O
45	O
participants	O
were	O
randomly	O
divided	O
into	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
).	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
,	O
Fasn	O
,	O
Acox1	O
,	O
and	O
Insig1	O
in	O
liver	O
,	O
and	O
Scd1	O
and	O
Cpt1b	O
in	O
PAT	O
(	O
TableS3	O
).	O

The	O
current	O
recommendation	O
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

The	O
reported	O
results	O
should	O
be	O
considered	O
with	O
caution	O
,	O
given	O
the	O
small	O
sample	O
size	O
of	O
our	O
cohort	O
and	O
that	O
previously	O
published	O
case	O
reports	O
have	O
observed	O
healthy	O
outcomes	O
in	O
neonates	O
/	O
infants	O
prenatally	O
exposed	O
to	O
SGA	O
polytherapy	O
.	O
30	O
–	O
34	O
Maternal	O
pre	O
-	O
pregnancy	O
characteristics	O
and	O
behavioural	O
risk	O
factors	O
may	O
be	O
considered	O
when	O
interpreting	B
the	O
findings	O
of	O
the	O
present	O
study	O
.	O

Patients	O
were	O
also	O
provided	O
the	O
option	O
to	O
disenroll	O
from	O
text4baby	O
by	O
texting	O
“	O
STOP	O
”	O
from	O
their	O
mobile	O
phones	O
if	O
they	O
no	O
longer	O
wanted	O
to	O
participate	O
in	O
the	O
program	O
.	O

Conclusions	O
The	O
transcriptomic	O
modulations	O
point	O
to	O
persistent	O
functional	O
demand	O
on	O
the	O
liver	O
towards	O
cell	O
proliferation	O
in	O
the	O
LP	O
group	O
but	O
not	O
in	O
the	O
AP	O
group	O
at	O
identical	O
nutritional	O
conditions	O
during	O
postnatal	O
life	O
due	O
to	O
divergent	O
'	O
programming	O
'	O
of	O
the	O
genome	O
.	O

Recent	O
estimates	O
of	O
the	O
prevalence	O
of	O
psychiatric	O
disorders	O
in	O
pregnancy	O
range	O
from	O
14	O
%	O
to	O
30	O
.	O
5	O
%	O
1	O
–	O
3and	O
include	O
mood	O
,	O
anxiety	O
and	O
psychotic	O
disorders	O
.	O
1	O
–	O
4Untreated	O
mental	O
illness	O
during	O
pregnancy	O
is	O
associated	O
with	O
risks	O
to	O
both	O
the	O
mother	O
and	O
the	O
child	O
.	O
5Uncontrolled	O
schizophrenia	O
,	O
depression	O
and	O
bipolar	O
disorder	O
have	O
all	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
.	O
6	O
–	O
8The	O
risks	O
associated	O
with	O
uncontrolled	O
mental	O
illness	O
often	O
lead	O
physicians	O
to	O
recommend	O
maintenance	O
of	O
treatment	O
with	O
psychotropic	O
medications	O
throughout	O
gestation	O
.	O

During	O
this	O
time	O
,	O
a	O
protocol	O
that	O
included	O
25	O
(	O
OH	O
)	O
D	O
testing	O
at	O
first	O
prenatal	O
visit	O
with	O
recommended	O
follow	O
-	O
up	O
testing	O
was	O
initiated	O
.	O

Fetuses	O
originated	O
from	O
litters	O
of	O
at	O
least	O
11	O
viable	O
piglets	O
.	O

Furthermore	O
,	O
that	O
study	O
was	O
unable	O
to	O
specifically	O
investigate	O
the	O
potential	O
role	O
of	O
maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
nor	O
the	O
specific	O
role	O
of	O
free	O
sugar	O
.	O

The	O
CAPE	O
measures	O
of	O
psychosis	O
are	O
strongly	O
correlated	O
with	O
measures	O
of	O
general	O
psychopathology	O
,	O
including	O
depression	O
.	O

Regardless	O
of	O
vitamin	O
D	O
status	O
,	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
cathelicidin	O
concentrations	O
between	O
subjects	O
,	O
consistent	O
with	O
the	O
findings	O
of	O
other	O
recent	O
studies	O
[	O
6	O
,	O
7	O
,	O
12	O
,	O
14	O
,	O
17	O
,	O
20	O
].	O

Although	O
vitamin	O
D	O
overload	O
is	O
a	O
theoretical	O
possibility	O
,	O
100	O
000	O
IU	O
of	O
vitamin	O
D3has	O
been	O
shown	O
to	O
provide	O
the	O
best	O
protection	O
against	O
vitamin	O
D	O
deficiency	O
without	O
overload	O
or	O
side	O
-	O
effects	O
in	O
high	O
-	O
risk	O
infants	O
aged	O
0	O
–	O
9	O
months	O
with	O
normal	O
baseline	O
ranges	O
of	O
vitamin	O
D	O
.	O
16Furthermore	O
,	O
single	O
intramuscular	O
injection	O
of	O
three	O
times	O
this	O
dose	O
(	O
300	O
000	O
IU	O
)	O
was	O
safe	O
in	O
treating	O
nutritional	O
rickets	O
in	O
6	O
–	O
30	O
-	O
month	O
-	O
old	O
children	O
residing	O
in	O
lower	O
socioeconomic	O
regions	O
of	O
sunny	O
Istanbul	O
.	O
35Higher	O
than	O
recommended	O
doses	O
of	O
daily	O
supplementation	O
of	O
vitamin	O
D	O
(	O
500	O
–	O
1000	O
IU	O
per	O
day	O
,	O
adding	O
up	O
to	O
120	O
000	O
IU	O
over	O
3	O
months	O
)	O
plus	O
additional	O
milk	O
fortified	O
with	O
vitamin	O
D	O
,	O
has	O
been	O
shown	O
not	O
to	O
induce	O
an	O
overload	O
,	O
13including	O
in	O
infants	O
starting	O
with	O
normal	O
ranges	O
of	O
vitamin	O
D	O
,	O
even	O
when	O
supplementation	O
continued	O
during	O
the	O
summer	O
(	O
in	O
France	O
)	O
and	O
when	O
mothers	O
had	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O
36It	O
is	O
important	O
to	O
note	O
that	O
in	O
our	O
study	O
,	O
where	O
community	O
supplementation	O
was	O
in	O
a	O
population	O
with	O
known	O
high	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
,	O
1	O
%	O
of	O
children	O
tested	O
had	O
a	O
calcifediol	O
concentration	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
—	O
thought	O
undesirably	O
high	O
.	O
6Although	O
these	O
did	O
not	O
produce	O
any	O
clinical	O
signs	O
and	O
symptoms	O
,	O
these	O
measurements	O
raise	O
a	O
need	O
for	O
caution	O
with	O
doses	O
for	O
population	O
supplementation	O
.	O

We	O
have	O
rather	O
shown	O
that	O
older	O
,	O
anaemic	O
multiparae	O
who	O
are	O
experiencing	O
recurrent	O
demands	O
of	O
pregnancy	O
and	O
lactation	O
under	O
seasonally	O
adverse	O
conditions	O
(	O
Anya	O
2004	O
,	O
Billewicz	O
and	O
McGregor	O
1981	O
)	O
clearly	O
benefit	O
from	O
MMN	O
supplementation	O
.	O

A	O
blood	O
sample	O
was	O
withdrawn	O
from	O
the	O
tail	O
vein	O
and	O
baseline	O
glucose	O
was	O
immediately	O
assayed	O
using	O
a	O
commercial	O
glucometer	O
(	O
MediSense	O
Precision	O
Xtra	O
,	O
Abbott	O
Laboratories	O
,	O
Abbott	O
Park	O
,	O
IL	O
,	O
USA	O
).	O

Should	O
its	O
supplementation	O
become	O
a	O
golden	O
standard	O
in	O
fertility	O
treatment	O
,	O
or	O
do	O
we	O
still	O
need	O
more	O
evidence	O
on	O
its	O
effect	O
?	O

Conclusions	O
In	O
summary	O
,	O
20	O
.	O
4	O
%	O
pregnant	O
women	O
with	O
GDM	O
in	O
their	O
middle	O
and	O
late	O
pregnancy	O
are	O
deficient	O
in	O
Vitamin	O
D	O
,	O
though	O
their	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
the	O
general	O
population	O
.	O

NUTRITIONAL	O
FACTORS	O
Several	O
nutritional	O
factors	O
including	O
fat	O
metabolism	O
,	O
fat	O
digestion	O
and	O
absorption	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
roughage	O
vs	O
.	O
concentrate	O
ratio	O
,	O
dietary	O
energy	O
and	O
protein	O
levels	O
,	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
,	O
fetal	O
nutritional	O
programming	O
,	O
and	O
stage	O
-	O
specific	O
feeding	O
systems	O
can	O
affect	O
IMF	O
deposition	O
.	O

Therefore	O
,	O
we	O
constructed	O
additional	O
models	O
that	O
simultaneously	O
adjusted	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

It	O
is	O
a	O
well	O
-	O
known	O
hormone	O
increasing	O
BAT	O
activity	O
and	O
inducing	O
“	O
browning	O
”	O
of	O
WAT	O
via	O
activation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
and	O
resulting	O
increased	O
β3	O
adrenoceptor	O
signaling	O
(	O
Haynes	O
et	O
al	O
.,	O
1997	O
;	O
Commins	O
et	O
al	O
.,	O
2000	O
).	O

Furthermore	O
,	O
it	O
is	O
worth	O
noticing	O
that	O
the	O
increased	O
airway	O
resistance	O
may	O
result	O
in	O
a	O
higher	O
risk	O
of	O
wheezing	O
in	O
early	O
childhood	O
.	O

In	O
addition	O
to	O
this	O
,	O
a	O
special	O
call	O
centre	O
will	O
be	O
set	O
up	O
centrally	O
where	O
trained	O
nutrition	O
counsellors	O
will	O
systematically	O
make	O
bi	O
-	O
weekly	O
calls	O
to	O
monitor	O
compliance	O
with	O
the	O
supplementation	O
regime	O
.	O

At	O
baseline	O
and	O
during	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
10	O
–	O
12	O
,	O
13	O
–	O
15	O
,	O
and	O
20	O
–	O
22	O
,	O
the	O
data	O
collector	O
identified	O
the	O
presence	O
and	O
location	O
of	O
a	O
designated	O
handwashing	O
station	O
(	O
s	O
),	O
and	O
the	O
presence	O
of	O
water	O
and	O
soap	O
at	O
the	O
handwashing	O
station	O
(	O
s	O
)	O
(	O
Figure	O
1	O
).	O

We	O
employed	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
to	O
reflect	B
both	O
the	O
maternal	O
vitamin	O
D	O
status	O
at	O
the	O
end	O
of	O
pregnancy	O
and	O
the	O
newborn	O
’	O
s	O
vitamin	O
D	O
status	O
at	O
birth	O
[	O
1	O
].	O

found	O
that	O
early	O
pregnancy	O
25OHD	O
concentrations	O
<	O
75	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
higher	O
risk	O
of	O
both	O
medically	O
indicated	O
and	O
spontaneous	O
preterm	O
delivery	O
[	O
11	O
].	O

Treatment	O
of	O
atopic	O
dermatitis	O
during	O
pregnancy	O
should	O
emphasize	O
avoidance	O
of	O
triggering	O
factors	O
and	O
reliance	O
on	O
topical	O
treatment	O
in	O
an	O
attempt	O
to	O
reduce	O
dryness	O
and	O
pruritus	O
,	O
modulate	O
inflammation	O
,	O
and	O
treat	O
secondary	O
infections	O
.	O

According	O
to	O
a	O
directive	O
of	O
the	O
Commission	O
of	O
European	O
Communities	O
from	O
2005	O
,	O
the	O
most	O
allergenic	O
foods	O
have	O
to	O
be	O
labeled	O
because	O
of	O
their	O
potency	O
of	O
eliciting	O
severe	O
allergic	O
reactions	O
:	O
these	O
are	O
crustacean	O
,	O
fish	O
,	O
nuts	O
,	O
milk	O
,	O
egg	O
,	O
wheat	O
/	O
gluten	O
,	O
peanuts	O
,	O
soy	O
,	O
sesame	O
,	O
mustard	O
,	O
and	O
celery	O
.	O

Animals	O
,	O
housing	O
,	O
mating	O
,	O
and	O
feeding	O
Adolescent	O
female	O
Wistar	O
rats	O
(	O
Harlan	O
,	O
Barcelona	O
,	O
Spain	O
)	O
weighing	O
191	O
.	O
7	O
±	O
2	O
.	O
6	O
g	O
were	O
individually	O
housed	O
in	O
standard	O
cages	O
and	O
maintained	O
in	O
controlled	O
room	O
conditions	O
at	O
21	O
±	O
1	O
°	O
C	O
room	O
temperature	O
,	O
40	O
±	O
5	O
%	O
relative	O
humidity	O
and	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
off	O
8	O
:	O
00	O
p	O
.	O
m	O
.).	O

A	O
more	O
subtly	O
calibrated	O
iron	O
supplementation	O
during	O
pregnancy	O
may	O
be	O
as	O
effective	O
as	O
current	O
public	O
health	O
recommendations	O
,	O
and	O
perhaps	O
safer	O
.	O

None	O
of	O
the	O
reports	O
noted	O
a	O
known	O
diagnosis	O
of	O
folic	O
acid	O
allergy	O
.	O

(	O
2013	O
)*/†	O
FormaldehydeRatAge	O
-	O
related	O
accumulation	O
(	O
0	O
.	O
07	O
–	O
0	O
.	O
5	O
mM	O
)	O
Injection	O
(	O
ih	O
)	O
(	O
1	O
µl	O
of	O
0	O
.	O
5	O
mM	O
)	O
Adulthood	O
LifetimeAdulthoodBehavioral	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryTong	O
et	O
al	O
.	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

Vitamin	O
D	O
deficiency	O
has	O
previously	O
been	O
associated	O
with	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
given	O
its	O
role	O
in	O
supporting	O
insulin	O
secretion	O
and	O
pancreatic	O
β	O
-	O
cell	O
function	O
[	O
42	O
].	O

Targeted	O
16S	O
rRNA	O
gene	O
sequencing	O
The	O
V4	O
-	O
V5	O
hypervariable	O
region	O
of	O
the	O
bacterial	O
16S	O
rRNA	O
gene	O
was	O
sequenced	O
at	O
the	O
Marine	O
Biological	O
Laboratory	O
(	O
MBL	O
)	O
in	O
Woods	O
Hole	O
,	O
MA	O
,	O
using	O
established	O
methods	O
[	O
31	O
,	O
32	O
].	O

In	O
addition	O
to	O
a	O
lower	O
birth	O
weight	O
population	O
,	O
a	O
secondary	O
analysis	O
longitudinal	O
design	O
study	O
using	O
cranial	O
ultrasound	O
evidence	O
of	O
14	O
study	O
participants	O
diagnosed	O
with	O
ASD	O
identified	O
that	O
children	O
with	O
ventricular	O
enlargement	O
were	O
strong	O
indicators	O
of	O
the	O
potential	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
50	O
].	O

Secondly	O
,	O
the	O
possible	O
presence	O
of	O
associated	O
conditions	O
,	O
such	O
as	O
pheochromocytoma	O
,	O
should	O
be	O
recognized	B
before	O
submitting	O
patients	O
to	O
thyroidectomy	O
.	O

There	O
were	O
nine	O
cases	O
of	O
IUFD	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

This	O
suggested	O
that	O
FGF21	O
could	O
play	O
a	O
similar	O
role	O
in	O
humans	O
as	O
in	O
rodents	O
in	O
promoting	O
cold	O
-	O
induced	O
metabolic	O
changes	O
(	O
i	O
.	O
e	O
.,	O
lipolysis	O
and	O
cold	O
-	O
induced	O
thermogenesis	O
).	O

This	O
questionnaire	O
is	O
comprised	O
of	O
ten	O
multiple	O
choice	O
questions	O
,	O
the	O
minimum	O
score	O
is	O
0	O
and	O
the	O
maximum	O
is	O
30	O
.	O

To	O
be	O
successful	O
in	O
our	O
goals	O
,	O
the	O
constituencies	O
identified	O
must	O
work	O
together	O
collaboratively	O
and	O
in	O
partnership	O
in	O
ways	O
that	O
are	O
transparent	O
to	O
all	O
,	O
vigorous	O
and	O
accountable	O
.	O

Female	O
service	O
members	O
and	O
spouses	O
of	O
active	O
duty	O
soldiers	O
are	O
a	O
group	O
exposed	O
to	O
multiple	O
stressors	O
that	O
may	O
increase	O
health	O
risks	O
during	O
pregnancy	O
[	O
33	O
-	O
35	O
].	O

Urine	O
was	O
collected	O
and	O
centrifuged	O
(	O
120	O
g	O
for	O
15	O
min	O
)	O
to	O
remove	O
the	O
solid	O
waste	O
.	O

F	O
.,	O
G	O
.,	O
and	O
S	O
.	O

Importantly	O
,	O
this	O
hypothesis	O
supports	O
that	O
fetal	O
undernutrition	O
can	O
represent	O
the	O
origin	O
of	O
cardiovascular	O
disease	O
,	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
,	O
hypertension	O
and	O
hyperlipidaemia	O
at	O
adulthood	O
(	O
Barker	O
and	O
Osmond	O
,	O
1988	O
;	O
Barker	O
et	O
al	O
.,	O
1989	O
,	O
1993	O
).	O

Introduction	O
Aortic	O
dissection	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
with	O
significant	O
morbidity	O
and	O
mortality	O
for	O
both	O
the	O
mother	O
and	O
infant	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
increased	O
significantly	O
with	O
BMI	O
and	O
was	O
significantly	O
higher	O
for	O
women	O
who	O
reported	O
not	O
taking	O
vitamin	O
D	O
-	O
containing	O
multivitamins	O
(	O
Table	O
4	O
).	O

However	O
,	O
they	O
write	O
,	O
it	O
remains	O
prudent	O
for	O
women	O
who	O
are	O
pregnant	O
or	O
think	O
they	O
may	O
become	O
pregnant	O
to	O
eat	O
a	O
diet	O
rich	O
in	O
fruits	O
and	O
vegetables	O
.	O

We	O
found	O
that	O
birth	O
weight	O
percentile	O
levels	O
increased	O
by	O
about	O
10	O
and	O
15	O
points	O
,	O
respectively	O
,	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
levels	O
,	O
suggesting	O
a	O
strong	O
association	O
of	O
repetitive	O
element	O
methylation	O
markers	O
with	O
fetal	O
growth	O
.	O

Rather	O
,	O
it	O
is	O
a	O
surrogate	O
marker	O
for	O
underlying	O
risk	O
factors	O
that	O
may	O
offer	O
subtle	O
clues	O
about	O
the	O
possible	O
perinatal	O
etiology	O
of	O
adult	O
gliomas	O
.	O

Feeding	O
high	O
-	O
oil	O
corn	O
(	O
1	O
.	O
3	O
%	O
more	O
total	O
lipid	O
than	O
typical	O
corn	O
)	O
enhanced	O
IMF	O
deposition	O
in	O
predominantly	O
Angus	O
finishing	O
crossbred	O
steers	O
[	O
94	O
].	O

Multiple	O
gestations	O
and	O
terminated	O
pregnancies	O
were	O
excluded	O
from	O
the	O
analyses	O
.	O

The	O
dynamics	O
of	O
this	O
first	O
re	O
-	O
programing	O
and	O
programing	O
event	O
are	O
particularly	O
well	O
highlighted	O
by	O
the	O
functional	O
switching	O
of	O
sncRNAs	O
from	O
a	O
focus	O
on	O
guarding	O
the	O
genome	O
to	O
guiding	O
development	O
.	O

Results	O
The	O
first	O
two	O
generations	O
of	O
the	O
VitD	O
-	O
group	O
had	O
higher	O
blood	O
pressure	O
at	O
6	O
months	O
of	O
age	O
than	O
the	O
offspring	O
of	O
the	O
SC	O
group	O
as	O
well	O
as	O
an	O
increase	O
in	O
renin	O
and	O
AT1r	O
expression	O
.	O

Concurrent	O
changes	O
in	O
rates	O
of	O
hyper	O
and	O
hypo	O
-	O
calcaemia	O
suggest	O
antenatal	O
vitamin	O
D3supplementation	O
as	B
an	O
aetiological	O
factor	O
.	O

Much	O
like	O
anticonvulsants	O
and	O
other	O
drug	O
exposures	O
,	O
the	O
use	O
of	O
SSRIs	O
in	O
pregnant	O
women	O
and	O
its	O
association	O
to	O
autism	O
have	O
been	O
explored	O
.	O

§	O
N	O
(%)	O
of	O
live	O
births	O
.	O

Although	O
we	O
found	O
that	O
these	O
repetitive	O
element	O
indicators	O
are	O
weakly	O
to	O
moderately	O
correlated	O
,	O
they	O
have	O
their	O
own	O
unique	O
distributions	O
of	O
methylation	O
values	O
,	O
consistent	O
with	O
previous	O
comparisons	O
between	O
LINE	O
-	O
1	O
and	O
Alu	O
methylation	O
in	O
normal	O
blood	O
(	O
Jintaridth	O
and	O
Mutirangura	O
2010	O
).	O

Thus	O
,	O
the	O
cost	O
-	O
effectiveness	O
of	O
the	O
project	O
is	O
assessed	O
at	O
USD	O
4	O
.	O
24	O
per	O
anaemia	O
case	O
prevented	O
per	O
year	O
.	O

Prenatal	O
Predictors	O
of	O
Offspring	O
Weight	O
3	O
.	O
3	O
.	O
1	O
.	O

Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
file	O
PubMed	O
Central	O
:	O

Among	O
those	O
children	O
born	O
from	O
I	O
-	O
131	O
treated	O
women	O
,	O
the	O
authors	O
found	O
only	O
one	O
case	O
of	O
ventricular	O
septal	O
defect	O
and	O
patent	O
ductus	O
arteriosus223940	O
.	O

In	O
addition	O
,	O
researchers	O
find	O
dairy	O
products	O
in	O
China	O
are	O
mainly	B
fortified	O
with	O
Vitamin	O
D3	O
,	O
which	O
will	O
not	O
translate	O
into	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
participants	O
.	O

Since	O
there	O
were	O
few	O
cases	O
of	O
SGA	O
based	O
on	O
birth	O
weight	O
alone	O
,	O
the	O
definition	O
of	O
SGA	O
used	O
in	O
this	O
study	O
was	O
based	O
on	O
birth	O
weight	O
and	O
/	O
or	O
length	O
.	O

In	O
fact	O
,	O
the	O
rates	O
of	O
recurrence	O
or	O
the	O
disease	O
-	O
free	O
period	O
do	O
not	O
differ	O
between	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
affected	O
by	O
the	O
same	O
disease22729	O
-	O
32	O
.	O

Telephone	O
interviews	O
conducted	O
every	O
4	O
months	O
ascertained	O
the	O
infant	O
’	O
s	O
feeding	O
method	O
,	O
including	O
the	O
timing	O
of	O
breastfeeding	O
cessation	O
and	O
the	O
start	O
date	O
of	O
each	O
new	O
formula	O
,	O
as	O
applicable	O
,	O
as	O
well	O
as	O
medication	O
use	O
such	O
as	O
antibiotics	O
.	O

Exposure	O
to	O
a	O
high	O
level	O
of	O
testosterone	O
during	O
the	O
earlier	O
part	O
of	O
pregnancy	O
is	O
thought	O
to	O
promote	O
right	O
brain	O
development	O
and	O
influence	O
hand	O
preference	O
,	O
although	O
the	O
evidence	O
in	O
support	O
of	O
a	O
relationship	O
is	O
not	O
conclusive	O
[	O
191	O
].	O

2009	O
),	O
including	O
the	O
examination	O
of	O
repetitive	O
elements	O
as	O
surrogate	O
markers	O
of	O
global	O
methylation	O
(	O
Choi	O
et	O
al	O
.	O

Materials	O
and	O
Methods	O
This	O
study	O
was	O
a	O
cross	O
-	O
sectional	O
survey	O
conducted	O
in	O
a	O
representative	O
group	O
of	O
children	O
identified	O
in	O
the	O
Youth	O
Healthcare	O
Centre	O
located	O
near	O
the	O
Federal	O
University	O
of	O
São	O
Paulo	O
(	O
UNIFESP	O
,	O
São	O
Paulo	O
,	O
SP	O
,	O
Brazil	O
).	O

RNA	O
was	O
polyadenylated	O
by	O
poly	O
(	O
A	O
)	O
polymerase	O
and	O
then	O
dissolved	O
and	O
reverse	O
transcribed	O
using	O
poly	O
(	O
T	O
)	O
adapter	O
.	O

However	O
,	O
Baiz	O
et	O
al	O
.	O

A	O
possible	O
explanation	O
of	O
this	O
discrepancy	O
could	O
be	O
related	O
to	O
the	O
critical	O
consequences	O
of	O
the	O
maternal	O
undernutrition	O
at	O
preconceptional	O
periods	O
.	O

There	O
were	O
50	O
%	O
more	O
immature	O
glomeruli	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
offspring	O
than	O
in	O
the	O
F1	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
20	O
%	O
more	O
immature	O
glomeruli	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
offspring	O
than	O
in	O
the	O
F2	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
t	O
-	O
test	O
).	O

Following	O
medical	O
consultation	O
,	O
the	O
health	O
care	O
provider	O
asked	O
if	O
the	O
patient	O
would	O
be	O
willing	O
to	O
participate	O
in	O
the	O
research	O
study	O
and	O
those	O
who	O
agreed	O
underwent	O
informed	O
consent	O
and	O
then	O
were	O
offered	O
the	O
opportunity	O
to	O
complete	O
a	O
baseline	O
survey	O
on	O
a	O
secure	O
computer	O
in	O
a	O
private	O
setting	O
in	O
the	O
clinic	O
.	O

The	O
PGM	O
transmits	O
an	O
X	O
chromosome	O
,	O
which	O
is	O
the	O
female	O
sex	O
chromosome	O
,	O
exclusively	O
to	O
her	O
granddaughter	O
,	O
while	O
girls	O
on	O
the	O
maternal	O
side	O
may	O
receive	O
their	O
X	O
chromosome	O
from	O
either	O
grandparent	O
through	O
their	O
mother	O
.	O

At	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
,	O
women	O
were	O
interviewed	O
by	O
a	O
research	O
midwife	O
and	O
asked	O
questions	O
on	O
maternal	O
demographics	O
and	O
lifestyle	O
and	O
had	O
physical	O
measurements	O
taken	O
,	O
including	O
height	O
and	O
weight	O
.	O

These	O
compounds	O
may	O
be	O
present	O
in	O
foods	O
through	O
their	O
use	O
as	O
preservatives	O
or	O
in	O
fertilizers	O
[	O
166	O
].	O

Then	O
,	O
the	O
tissue	O
samples	O
were	O
dehydrated	O
by	O
placing	O
them	O
in	O
ethanol	O
solutions	O
(	O
70	O
%,	O
90	O
%,	O
and	O
100	O
%)	O
for	O
5	O
minutes	O
.	O

Among	O
EDCs	O
,	O
broad	O
classes	O
include	O
phthalates	O
and	O
phenols	O
(	O
e	O
.	O
g	O
.,	O
bisphenol	O
A	O
[	O
BPA	O
]),	O
perfluoroalkyl	O
substances	O
(	O
PFAS	O
),	O
polychlorinated	O
biphenyls	O
(	O
PCBs	O
),	O
polybrominated	O
diphenyl	O
ethers	O
(	O
PBDEs	O
),	O
and	O
organochlorine	O
pesticides	O
(	O
OCPs	O
).	O

Educational	O
level	O
There	O
was	O
insignificant	O
difference	O
using	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
,	O
with	O
regards	O
to	O
all	O
the	O
service	O
ratings	O
when	O
different	O
educational	O
levels	O
were	O
compared	O
(	O
Table	O
3	O
).	O

In	O
addition	O
,	O
large	O
human	O
cohorts	O
that	O
have	O
recruited	O
participants	O
at	O
birth	O
for	O
long	O
-	O
term	O
follow	O
up	O
with	O
comprehensive	O
data	O
and	O
sample	O
collection	O
,	O
such	O
as	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
cohort	O
(	O
Boyd	O
et	O
al	O
.	O
2013	O
),	O
provide	O
a	O
wealth	O
of	O
information	O
to	O
investigate	O
epidemiological	O
links	O
between	O
specific	O
environmental	O
exposures	O
and	O
public	O
health	O
outcomes	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

Using	O
data	O
from	O
a	O
U	O
.	O
S	O
.	O
national	O
study	O
on	O
the	O
health	O
effects	O
of	O
prenatal	O
diethylstilbestrol	O
exposure	O
,	O
a	O
team	O
of	O
researchers	O
reported	O
in	O
the	O
11	O
January	O
2008	O
advance	O
access	O
edition	O
of	O
the	O
American	O
Journal	O
of	O
Epidemiology	O
that	O
study	O
participants	O
who	O
had	O
never	O
smoked	O
cigarettes	O
but	O
had	O
been	O
prenatally	O
exposed	O
to	O
maternal	O
cigarette	O
smoke	O
experienced	O
earlier	O
-	O
onset	O
menopause	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
was	O
significantly	O
associated	O
with	O
a	O
decreased	O
relative	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

To	O
some	O
degree	O
,	O
effect	O
modification	O
or	O
publication	O
bias	O
may	O
explain	O
the	O
inconsistencies	O
.	O

To	B
our	I
knowledge	I
,	O
the	O
present	O
study	O
is	O
the	O
first	O
to	O
show	O
a	O
significant	O
association	O
between	O
maternal	O
SGA	O
use	O
in	O
pregnancy	O
and	O
an	O
elevated	O
risk	O
of	O
NICU	O
admission	O
.	O

Future	O
analyses	O
of	O
health	O
effects	O
of	O
vitamin	O
D	O
status	O
in	O
this	O
population	O
are	O
planned	O
but	O
beyond	O
the	O
scope	O
of	O
this	O
analysis	O
.	O

Differences	O
extend	O
not	O
only	O
to	O
metabolic	O
parameters	O
and	O
gene	O
expression	O
but	O
also	O
to	O
behavioral	O
responses	O
.	O

Among	O
pregnant	O
women	O
,	O
IDA	O
has	O
been	O
associated	O
with	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
[	O
11	O
].	O

Camargo	O
et	O
al	O
.	O

Food	O
fortification	O
with	O
iron	O
has	O
thus	B
become	O
a	O
promising	B
approach	O
for	O
preventing	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

Significantly	O
dysregulated	O
proteins	O
were	O
examined	O
in	O
bioinformatic	O
pathways	O
analysis	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
[	O
IPA	O
];	O
Ingenuity	O
Systems	O
,	O
Mountain	O
View	O
,	O
CA	O
).	O

The	O
authors	O
stress	O
that	O
dietary	O
factors	O
work	O
together	O
,	O
and	O
no	O
one	O
food	O
should	O
be	O
singled	O
out	O
in	O
attributing	O
risk	O
or	O
benefit	O
.	O

In	O
addition	O
to	O
genetic	O
factors	O
[	O
9	O
],	O
placenta	O
structural	O
[	O
10	O
]	O
and	O
environmental	O
factors	O
affect	O
fetal	O
growth	O
in	O
utero	O
[	O
9	O
],	O
and	O
maternal	O
nutritional	O
status	O
could	O
impact	O
on	O
fetal	O
growth	O
and	O
development	O
[	O
11	O
].	O

The	O
study	O
controlled	O
for	O
environmental	O
factors	O
such	O
as	O
socioeconomic	O
status	O
,	O
maternal	O
health	O
,	O
pregnancy	O
-	O
related	O
events	O
and	O
conditions	O
,	O
and	O
birth	O
year	O
.	O

Methods	O
:	O
We	O
conducted	O
a	O
retrospective	O
cohort	O
study	O
to	O
evaluate	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
.	O

While	O
diet	O
can	O
impact	O
health	O
at	O
any	O
life	O
stage	O
,	O
it	O
is	O
likely	B
to	O
be	O
most	O
important	O
during	O
the	O
fetal	O
and	O
infancy	O
periods	O
,	O
when	O
the	O
immune	O
system	O
is	O
immature	O
.	O

The	O
benefit	O
:	O
cost	O
ratio	O
was	O
estimated	O
using	O
the	O
methods	O
described	O
by	O
Horton	O
and	O
Ross	O
(	O
2003	O
)[	O
6	O
]	O
based	O
on	O
improved	O
labour	O
market	O
productivity	O
for	O
women	O
of	O
reproductive	O
age	O
after	O
removal	O
from	O
anaemia	O
.	O

The	O
primary	O
analyses	O
will	O
compare	O
the	O
neonatal	O
mortality	O
rates	O
and	O
their	O
95	O
%	O
confidence	O
intervals	O
adjusted	O
for	O
clustering	O
and	O
groundwater	O
iron	O
level	O
in	O
each	O
group	O
.	O

[	O
45	O
]	O
The	O
NICE	O
guidelines	O
for	O
antenatal	O
care	O
were	O
therefore	O
updated	O
in	O
2008	O
.	O

In	O
same	O
study	O
,	O
neither	O
MS	O
nor	O
QG	O
was	O
associated	O
with	O
air	O
temperature	O
.	O

[	O
22	O
]	O
used	O
developmental	O
testing	O
carried	O
out	O
by	O
the	O
mother	O
and	O
thus	B
results	O
may	O
not	O
be	O
as	O
reliable	O
as	O
those	O
reported	O
by	O
other	O
studies	O
,	O
which	O
used	O
trained	O
professionals	O
.	O

Distribution	O
/	O
storage	O
costs	O
were	O
for	O
receiving	O
the	O
supplements	O
at	O
NIMPE	O
and	O
then	O
periodically	O
transporting	O
them	O
to	O
Yen	O
Bai	O
city	O
.	O

So	B
a	O
perceived	B
problem	O
with	O
supply	O
can	O
quickly	O
become	O
a	O
real	O
problem	O
once	O
a	O
mother	O
introduces	O
formula	O
and	O
the	O
frequency	O
of	O
breastfeeding	O
declines	O
,	O
especially	O
if	O
formula	O
is	O
offered	O
while	O
a	O
mother	O
is	O
still	O
trying	O
to	O
establish	O
her	O
milk	O
supply	O
.	O
8	O
To	O
complicate	O
matters	O
,	O
a	O
number	O
of	O
key	O
socioeconomic	O
,	O
cultural	O
,	O
and	O
clinical	O
factors	O
also	O
can	O
prevent	O
some	O
women	O
from	O
breastfeeding	O
as	O
long	O
as	O
they	O
would	O
like	O
.	O

Whole	O
body	O
DXA	O
measurements	O
,	O
BMC	O
,	O
and	O
BMD	O
were	O
conducted	O
using	O
Hologic	O
Delphi	O
Model	O
(	O
Hologic	O
Inc	O
.,	O
Waltham	O
MA	O
).	O

In	O
many	O
previous	O
studies	O
,	O
participants	O
had	O
various	O
ethnic	O
backgrounds	O
which	O
could	O
affect	O
both	O
vitamin	O
D	O
status	O
and	O
their	O
risk	O
of	O
GDM	O
[	O
7	O
,	O
38	O
].	O

We	O
speculate	O
that	O
the	O
well	O
reported	O
phenomenon	O
of	O
metabolic	O
programming	O
as	B
a	O
result	O
of	O
poor	O
prenatal	O
nutrition	O
might	O
be	O
a	O
secondary	O
outcome	O
of	O
a	O
life	O
history	O
strategy	B
to	O
accelerate	O
maturation	O
.	O

Moreover	O
,	O
males	O
were	O
housed	O
in	O
a	O
separate	O
room	O
.	O

Reduction	O
of	O
energy	O
intake	O
induced	O
SIRT1	O
in	O
brain	O
(	O
21	O
).	O

Researchers	O
have	O
persistently	B
reported	O
noncompliance	O
with	O
this	O
recommendation	O
at	O
a	O
given	O
antenatal	O
visit	O
.	O

Construction	O
validity	O
was	O
also	O
found	O
to	O
be	O
satisfactory	O
(	O
ANOVA	O
F	O
statistic	O
=	O
39	O
.	O
9	O
,	O
p	O
<	O
.	O
001	O
),	O
and	O
post	O
hoc	O
testing	O
revealed	O
statistically	O
significant	O
differences	O
between	O
the	O
mean	O
score	O
of	O
the	O
questionnaire	O
according	O
to	O
each	O
category	O
of	O
formal	O
education	O
(	O
4	O
.	O
9	O
for	O
1	O
–	O
4	O
years	O
of	O
formal	O
education	O
;	O
8	O
.	O
35	O
for	O
5	O
–	O
8	O
years	O
of	O
education	O
;	O
10	O
.	O
8	O
for	O
9	O
–	O
12	O
years	O
of	O
education	O
;	O
and	O
13	O
.	O
7	O
for	O
more	O
than	O
12	O
years	O
;	O
p	O
<	O
.	O
001	O
).	O

Researchers	O
can	O
determine	O
which	O
women	O
are	O
taking	O
their	O
vitamins	O
by	O
who	O
refills	O
their	O
prescription	O
.	O

Animals	O
were	O
housed	O
at	O
a	O
controlled	O
temperature	O
(	O
21	O
±	O
1	O
°	O
C	O
)	O
and	O
humidity	O
(	O
60	O
±	O
10	O
%),	O
with	O
a	O
12	O
h	O
light	O
/	O
dark	O
cycle	O
and	O
free	O
access	O
to	O
food	O
and	O
water	O
.	O

I	O
will	O
not	O
repeat	O
the	O
evidence	O
from	O
my	O
original	O
2007	O
paper	O
and	O
I	O
am	O
well	O
aware	O
that	O
evidence	O
consistent	O
with	O
a	O
theory	O
is	O
not	O
proof	O
of	O
that	O
theory	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
rate	O
of	O
cesarean	O
section	O
.	O

Thereafter	O
,	O
frozen	O
samples	O
are	O
transported	O
to	O
the	O
North	O
-	O
West	O
University	O
for	O
storage	O
at	O
−	O
80	O
°	O
C	O
until	O
analysis	O
.	O

An	O
optimal	O
level	O
of	O
vitamin	O
D	O
concentration	O
in	O
blood	O
serum	O
should	O
range	O
between	O
50	O
and	O
125	O
nmol	O
/	O
L	O
[	O
10	O
],	O
even	O
though	O
some	O
environmental	O
studies	O
imply	B
that	O
the	O
target	O
level	O
should	O
be	O
set	O
much	O
higher	O
—	O
up	O
to	O
250	O
,	O
or	O
even	O
at	O
300	O
nmol	O
/	O
L	O
[	O
11	O
,	O
12	O
].	O

Moreover	O
,	O
these	O
metabolic	O
alterations	O
after	O
a	O
maternal	O
calorie	O
restricted	O
diet	O
have	O
been	O
found	O
associated	O
to	O
abnormalities	O
in	O
feeding	O
behavior	O
such	O
as	O
hyperphagia	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
)	O
or	O
high	O
preference	O
for	O
high	O
-	O
fat	O
diet	O
(	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

Serum	O
paratormone	O
was	O
also	O
measured	O
by	O
ELISA	O
and	O
immunodiagnostic	O
systems	O
Ltd	O
(	O
IDS	O
Ltd	O
),	O
which	O
had	O
a	O
sensitivity	O
of	O
0	O
.	O
6	O
picomol	O
/	O
l	O
.	O

In	O
a	O
study	O
by	O
Kazemi	O
et	O
al	O
.,	O
in	O
67	O
mothers	O
with	O
term	O
birth	O
in	O
Zanjan	O
,	O
86	O
%	O
in	O
the	O
winter	O
and	O
46	O
%	O
in	O
the	O
summer	O
had	O
vitamin	O
D	O
levels	O
lower	O
than	O
25	O
ng	O
/.	O

They	O
examined	O
milk	O
and	O
venous	O
blood	O
samples	O
of	O
24	O
healthy	O
breastfeeding	O
women	O
with	O
complication	O
-	O
free	O
physiologic	O
pregnancies	O
and	O
neonates	O
with	O
appropriate	O
weight	O
for	O
gestational	O
age	O
at	O
birth	O
and	O
180	O
days	O
after	O
birth	O
.	O

Such	O
tolerance	O
could	O
conceivably	O
develop	O
early	O
in	O
life	O
,	O
following	O
repeated	O
exposure	O
to	O
high	O
levels	O
of	O
allergens	O
such	O
as	O
organic	O
dusts	O
,	O
fungi	O
,	O
and	O
endotoxins	O
;	O
this	O
is	O
perhaps	O
the	O
result	O
of	O
component	O
lipopolysaccharides	O
that	O
excite	O
Th1	O
responses	O
and	O
suppress	O
the	O
development	O
of	O
immunoglobulin	O
-	O
E	O
(	O
IgE	O
)-	O
antibodies	O
[	O
109	O
,	O
116	O
].	O

As	O
such	O
,	O
testing	O
procedures	O
and	O
safety	O
guidelines	O
are	O
in	O
place	O
to	O
protect	O
human	O
health	O
against	O
the	O
adverse	O
effects	O
of	O
environmentally	O
induced	O
genetic	O
mutations	O
.	O

For	O
the	O
GRs	O
,	O
significantly	O
higher	O
expression	O
levels	O
were	O
detected	O
only	O
for	O
GR	O
γ	O
and	O
GR	O
-	O
P	O
in	O
the	O
JEG	O
-	O
3	O
cells	O
compared	O
to	O
the	O
BeWo	O
cells	O
(	O
Figure	O
3	O
(	O
b	O
)).	O

Diet	O
significantly	O
affected	O
KM	O
(	O
P	O
=	O
0	O
.	O
006	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

The	O
results	O
of	O
this	O
study	O
are	O
novel	O
,	O
suggesting	O
that	O
body	O
mass	O
index	O
is	O
predominantly	B
associated	O
with	O
maternal	O
pathways	O
,	O
whether	O
through	O
intrauterine	O
development	O
or	O
inherited	O
through	O
the	O
X	O
chromosome	O
or	O
both	O
.	O

Introduction	O
The	O
past	O
century	O
has	O
seen	O
a	O
dramatic	O
decline	O
in	O
the	O
age	O
of	O
menarche	O
:	O
in	O
Europe	O
the	O
age	O
of	O
menarche	O
has	O
fallen	O
from	O
17	O
to	O
∼	O
12	O
.	O
5	O
years	O
of	O
age	O
[	O
1	O
]–[	O
5	O
],	O
although	O
the	O
rate	O
of	O
decline	O
is	O
slowing	O
[	O
6	O
],[	O
7	O
].	O

Furthermore	O
,	O
the	O
effectiveness	O
of	O
this	O
intervention	O
has	O
been	O
evaluated	O
mostly	B
in	O
terms	O
of	O
improvement	O
in	O
haemoglobin	O
concentration	O
,	O
rather	O
than	O
maternal	O
or	O
infant	O
health	O
[	O
35	O
].	O

Ursodeoxycholic	O
acid	O
,	O
which	O
is	O
a	O
bile	O
acid	O
,	O
is	O
synthesized	O
chemically	O
from	O
cholic	O
acid	O
.	O

showed	O
that	O
sun	O
exposure	O
in	O
childhood	O
period	O
prevents	O
from	O
MS	O
.	O
16Third	O
,	O
it	O
seems	O
low	O
risk	O
of	O
MS	O
in	O
white	O
population	O
is	O
associated	O
with	O
high	O
serum	O
level	O
of	O
vitamin	O
D	O
or	O
high	O
oral	O
intake	O
via	O
supplements	O
or	O
oily	O
fish	O
in	O
some	O
studies	O
.	O
217	O
–	O
19Fourth	O
,	O
it	O
have	O
been	O
shown	O
that	O
vitamin	O
D	O
can	O
be	O
a	O
protective	O
agent	O
against	O
experimental	O
autoimmune	O
encephalitis	O
in	O
mice	O
(	O
like	O
MS	O
in	O
humans	O
).	O
48Finally	O
,	O
some	O
scientists	O
administered	O
100	O
-	O
1700	O
IU	O
/	O
day	O
vitamin	O
D	O
supplements	O
in	O
MS	O
patients	O
and	O
observed	O
the	O
reduction	O
of	O
relapses	O
.	O
20	O
–	O
22The	O
candidate	O
for	O
estimating	O
serum	O
level	O
of	O
vitamin	O
D	O
is	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
,	O
because	B
of	O
its	O
prolonged	O
half	O
-	O
life	O
.	O
823	O
–	O
25It	O
is	O
used	O
to	O
assess	O
an	O
individual	O
’	O
s	O
overall	O
vitamin	O
D	O
nutritional	O
status	O
,	O
because	B
its	O
formation	O
,	O
unlike	O
that	O
of	O
1	O
,	O
25	O
-	O
dihydroxy	O
vitamin	O
D	O
,	O
is	O
not	O
tightly	O
regulated	O
and	O
it	O
has	O
a	O
relatively	O
long	O
half	O
-	O
life	O
(	O
20	O
-	O
60	O
days	O
).	O

Body	O
circumference	O
and	O
skin	O
-	O
fold	O
thickness	O
measures	O
also	O
did	O
not	O
differ	O
significantly	O
between	O
infants	O
born	O
to	O
women	O
who	O
received	O
the	O
antenatal	O
intervention	O
,	O
and	O
those	O
who	O
received	O
standard	O
care	O
.	O

A	O
significant	O
fourfold	O
increased	O
risk	O
was	O
observed	O
in	O
low	O
birth	O
weight	O
females	O
for	O
autism	O
accompanied	O
by	O
mental	O
retardation	O
.	O

Phase	O
2	O
data	O
are	O
collected	O
at	O
22	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
)	O
when	O
anomaly	O
ultrasounds	O
are	O
typically	O
scheduled	O
.	O

effect	O
of	O
postnatal	O
diet	O
in	O
undernourished	O
and	O
control	O
animals	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

For	O
participants	O
in	O
their	O
second	O
trimester	O
,	O
a	O
combination	O
of	O
multiple	O
biometric	O
parameters	O
(	O
biparietal	O
diameter	O
,	O
head	O
circumference	O
,	O
abdominal	O
circumference	O
,	O
and	O
femur	O
length	O
)	O
are	O
used	O
to	O
determine	O
gestational	O
age	O
[	O
55	O
].	O

A	O
zoom	O
of	O
the	O
fitted	O
LOESS	O
curve	O
for	O
the	O
MUSC	O
cohort	O
with	O
confidence	O
bounds	O
superimposed	O
shows	O
gestational	O
age	O
at	O
birth	O
initially	O
rising	O
steadily	O
with	O
increasing	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
then	O
reaching	O
a	O
plateau	O
at	O
approximately	O
30	O
–	O
50	O
ng	O
/	O
mL	O
(	O
Fig	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
by	O
gestational	O
age	O
(	O
weeks	O
)	O
at	O
birth	O
.	O

After	O
many	O
years	O
of	O
living	O
next	O
to	O
the	O
contamination	O
and	O
a	O
litany	O
of	O
health	O
problems	O
she	O
believes	O
it	O
caused	O
,	O
Bell	O
-	O
Jefferson	O
and	O
several	O
other	O
local	O
families	O
will	O
have	O
to	O
vacate	O
their	O
homes	O
for	O
a	O
third	O
round	O
of	O
cleanup	O
efforts	O
by	O
the	O
U	O
.	O
S	O
.	O
Environmental	O
Protection	O
Agency	O
(	O
EPA	O
).	O

Furthermore	O
,	O
farmers	O
usually	O
are	O
non	O
-	O
smokers	O
and	O
healthier	O
than	O
the	O
population	O
-	O
at	O
-	O
large	O
[	O
43	O
,	O
116	O
,	O
118	O
–	O
120	O
].	O

Also	O
,	O
postpregnancy	O
dietary	O
habits	O
and	O
choices	O
may	O
be	O
different	O
compared	O
with	O
prepregnancy	O
.	O

Roughly	O
two	O
-	O
thirds	O
of	O
the	O
participants	O
were	O
white	O
,	O
and	O
half	O
had	O
attained	O
a	O
college	O
degree	O
or	O
higher	O
.	O

Iron	O
deficiency	O
is	O
an	O
important	O
risk	O
factor	O
for	O
increased	O
maternal	O
mortality	O
,	O
low	O
birth	O
weight	O
and	O
preterm	O
delivery	O
(	O
Brabin	O
et	O
al	O
2001	O
)	O
and	O
the	O
availability	O
of	O
calcium	O
,	O
iodine	O
,	O
folate	O
and	O
vitamins	O
A	O
and	O
D	O
may	O
modulate	O
fetal	O
development	O
(	O
Bartley	O
et	O
al	O
2005	O
).	O

The	O
presence	O
of	O
vitamin	O
D	O
receptors	O
and	O
expression	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
enzyme	O
in	O
pancreatic	O
beta	O
cells	O
suggest	O
that	O
vitamin	O
D	O
may	O
be	O
a	O
modulator	O
of	O
insulin	O
secretion	O
and	O
thus	B
,	O
influence	O
glucose	O
homeostasis	O
[	O
6	O
].	O

Essentially	O
,	O
women	O
at	O
risk	O
of	O
type	O
2	O
diabetes	O
are	O
at	O
risk	O
of	O
GDM	O
.	O

There	O
is	O
no	O
universal	O
standard	O
for	O
which	O
neurodevelopmental	O
tests	O
are	O
most	O
appropriate	O
for	O
use	O
in	O
children	O
of	O
varying	O
ages	O
and	O
at	O
what	O
age	O
meaningful	O
differences	O
in	O
neurocognitive	O
development	O
can	O
be	O
detected	O
[	O
29	O
].	O

To	O
minimize	O
the	O
effect	O
of	O
stress	O
during	O
HRV	O
assessment	O
,	O
we	O
conducted	O
a	O
pilot	O
project	O
two	O
months	O
prior	O
to	O
begin	O
the	O
current	O
study	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

2010	O
;	O
Christensen	O
et	O
al	O
.	O

First	O
,	O
the	O
majority	O
of	O
populations	O
in	O
the	O
studies	O
of	O
Bodnar	O
et	O
al	O
.	O
8and	O
Burris	O
et	O
al	O
.	O
14were	O
white	O
,	O
whereas	O
the	O
majority	O
of	O
our	O
study	O
population	O
was	O
black	O
.	O

3	O
.	O

The	O
discount	O
rate	O
assumed	O
was	O
zero	O
:	O
using	O
a	O
higher	O
discount	O
rate	O
would	O
increase	O
costs	O
by	O
a	O
trivial	O
amount	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

Although	O
we	O
report	O
that	O
the	O
combination	O
of	O
prenatal	O
caloric	O
restriction	O
and	O
postnatal	O
high	O
fat	O
nutrition	O
also	O
advanced	O
the	O
age	O
at	O
puberty	O
,	O
this	O
was	O
not	O
directly	O
linked	O
to	O
body	O
weight	O
at	O
puberty	O
.	O

From	O
three	O
to	O
six	O
months	O
,	O
all	O
animals	O
had	O
systolic	O
blood	O
pressure	O
(	O
BP	O
)	O
measured	O
weekly	O
with	O
a	O
non	O
-	O
invasive	O
tail	O
-	O
cuff	O
plethysmography	O
(	O
Letica	O
LE	O
5100	O
,	O
Panlab	O
,	O
Barcelona	O
,	O
Spain	O
).	O

Following	O
the	O
approach	O
of	O
Lenters	O
et	O
al	O
.	O

1	O
.	O

Handwashing	O
with	O
soap	O
was	O
significantly	O
more	O
frequently	O
observed	O
in	O
intervention	O
arm	O
household	O
members	O
overall	O
and	O
at	O
the	O
recommended	O
times	O
;	O
however	O
,	O
handwashing	O
with	O
soap	O
was	O
infrequent	O
in	O
household	O
members	O
in	O
both	O
arms	O
(	O
handwashing	O
at	O
6	O
%	O
of	O
recommended	O
times	O
in	O
intervention	O
arm	O
and	O
1	O
%	O
of	O
recommended	O
times	O
in	O
the	O
control	O
arm	O
).	O

Secondary	O
study	O
outcomes	O
included	O
a	O
range	O
of	O
infant	O
anthropometric	O
measures	O
,	O
neurodevelopment	O
,	O
general	O
health	O
,	O
and	O
infant	O
feeding	O
.	O

The	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
Belgium	O
stems	O
from	O
the	O
fact	O
that	O
the	O
contribution	O
of	O
dietary	O
sources	O
to	O
the	O
vitamin	O
D	O
status	O
is	O
negligible	O
as	O
was	O
shown	O
by	O
the	O
Flemish	O
food	O
consumption	O
survey	O
among	O
preschoolers	O
which	O
estimated	O
the	O
mean	O
vitamin	O
D	O
intake	O
at	O
only	O
2	O
µg	O
/	O
day	O
[	O
35	O
].	O

Descriptive	O
research	O
Improved	O
and	O
consistently	B
applied	O
epidemiologic	O
definitions	O
and	O
methods	O
,	O
with	O
clearly	O
defined	B
preterm	O
phenotypes	O
,	O
are	O
the	O
foundation	O
for	O
improved	O
understanding	O
of	O
the	O
burden	O
of	O
preterm	O
birth	O
[	O
31	O
,	O
32	O
]	O
and	O
addressing	O
the	O
multiple	O
and	O
often	B
interrelated	O
causes	O
of	O
preterm	O
birth	O
.	O

Biomarkers	O
of	O
gestational	O
EDC	O
exposure	O
Blood	O
and	O
urine	O
samples	O
were	O
collected	O
from	O
participants	O
at	O
approximately	O
16	O
weeks	O
and	O
26	O
weeks	O
gestation	O
.	O

Thus	O
,	O
49	O
261	O
returned	O
the	O
questionnaires	O
and	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Further	O
well	O
designed	O
studies	O
are	O
required	O
to	O
strengthen	O
the	O
evidence	O
base	O
regarding	O
the	O
type	O
and	O
quantity	O
of	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
and	O
associated	O
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
,	O
while	O
considering	O
the	O
contribution	O
of	O
mercury	O
from	O
fish	O
-	O
containing	O
diets	O
.	O

And	O
in	O
order	O
to	O
determine	O
changes	O
over	O
time	O
,	O
the	O
repeated	O
measures	O
analysis	O
was	O
used	O
.	O

These	O
characteristics	O
are	O
often	B
seen	O
in	O
patients	O
with	O
psychotic	O
disorders	O
[	O
51	O
-	O
53	O
].	O

Finally	O
,	O
the	O
Tth111	O
I	O
polymorphism	O
was	O
assessed	O
using	O
the	O
PCR	O
primers	O
:	O
5	O
′-	O
GGCCACAACAATAACCCAGT	O
-	O
3	O
′	O
and	O
5	O
′-	O
CCTATGACACGTATTTTGTGAAAGT	O
-	O
3	O
′.	O

Although	O
prepregnancy	O
weight	O
was	O
self	O
-	O
reported	O
,	O
our	O
research	O
has	O
found	O
that	O
women	O
in	O
this	O
study	O
were	O
quite	O
accurate	O
in	O
recalling	O
prepregnancy	O
weight	O
[	O
16	O
].	O

As	O
we	O
will	O
discuss	O
below	O
,	O
these	O
sex	O
-	O
differences	O
extend	O
to	O
metabolic	O
pathways	O
under	O
the	O
control	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
,	O
as	B
previously	O
suggested	O
(	O
Wagner	O
,	O
2016	O
).	O

A	O
patient	O
’	O
s	O
innate	O
and	O
adaptive	O
immune	O
response	O
and	O
a	O
host	O
of	O
hormonal	O
and	O
metabolic	O
factors	O
,	O
likely	B
play	O
important	O
and	O
closely	O
interrelated	O
roles	O
in	O
understanding	O
the	O
complex	O
biologic	O
and	O
etiologic	O
mechanisms	O
in	O
the	O
season	O
of	O
birth	O
effect	O
for	O
adult	O
gliomas	O
.	O

It	O
was	O
earlier	O
observed	O
that	O
lower	O
concentration	O
of	O
VD	O
is	O
typical	O
for	O
women	O
with	O
fibroids	O
(	O
44	O
.	O
9	O
±	O
19	O
.	O
2	O
vs	O
.	O

We	O
found	O
similar	O
ionized	O
calcium	O
levels	O
in	O
Hispanic	O
and	O
Caucasians	O
at	O
birth	O
.	O

By	O
the	O
F2	O
generation	O
,	O
no	O
urinary	O
parameter	O
differed	O
between	O
the	O
VitD	O
-	O
and	O
SC	O
mice	O
.	O

found	O
neuroinflammatory	O
and	O
behavioral	O
changes	O
,	O
similar	O
to	O
that	O
in	O
autism	O
,	O
after	O
administering	O
terbutaline	O
to	O
subjects	O
.	O

Neonates	O
born	O
prematurely	O
(	O
gestational	O
age	O
<	O
37	O
weeks	O
),	O
those	O
with	O
major	O
birth	O
defects	O
or	O
congenital	O
structural	O
anomalies	O
of	O
the	O
upper	O
airway	O
,	O
those	O
who	O
were	O
hemodynamically	O
unstable	O
,	O
and	O
those	O
with	O
a	O
history	O
of	O
severe	O
lower	O
airway	O
infection	O
with	O
intensive	O
care	O
admission	O
,	O
were	O
excluded	O
from	O
the	O
study	O
.	O

Real	O
-	O
time	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
the	O
ABI	O
PRISM	O
7000	O
Sequence	O
Detection	O
System	O
(	O
SDS	O
)	O
using	O
Taqman	O
assays	O
for	O
the	O
following	O
genes	O
purchased	O
from	O
ABI	O
(	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
):	O
neuropeptide	O
Y	O
(	O
NPY	O
;	O
Cat	O
#	O
Rn01410146_m1	O
);	O
pro	O
-	O
opiomelanocortin	O
(	O
POMC	O
;	O
Cat	O
#	O
Rn00595020_m1	O
);	O
insulin	O
receptor	O
(	O
InsR	O
;	O
Cat	O
#	O
Rn00567070_m1	O
);	O
leptin	O
receptor	O
(	O
LepR	O
;	O
Cat	O
#	O
Rn01433205_m1	O
);	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
;	O
Cat	O
#	O
Rn02531967_s1	O
);	O
dopamine	O
receptor	O
1	O
(	O
DopaR1	O
;	O
Cat	O
#	O
Rn03062203_s1	O
);	O
dopamine	O
receptor	O
2	O
(	O
DopaR2	O
;	O
Cat	O
#	O
Rn00561126_m1	O
);	O
dopamine	O
receptor	O
5	O
(	O
DopaR5	O
;	O
Cat	O
#	O
Rn00562768_s1	O
);	O
serotonin	O
receptor	O
1A	O
(	O
SeroR1A	O
;	O
Cat	O
#	O
Rn00561409_s1	O
);	O
serotonin	O
receptor	O
2A	O
(	O
SeroR2A	O
;	O
Cat	O
#	O
Rn01468302_m1	O
);	O
serotonin	O
receptor	O
2C	O
(	O
SeroR2C	O
;	O
Cat	O
#	O
Rn00562748_m1	O
).	O

The	O
“	O
fraction	O
”	O
of	O
the	O
kidney	O
that	O
we	O
used	O
to	O
count	O
glomeruli	O
considered	O
the	O
size	O
of	O
the	O
glomeruli	O
.	O

Nonetheless	O
,	O
although	O
the	O
functional	O
consequences	O
of	O
these	O
genetic	O
markers	O
remain	O
the	O
subject	O
of	O
research	O
,	O
these	O
differences	O
are	O
biologically	O
plausible	O
.	O

Serum	O
was	O
stored	O
at	O
−	O
70	O
°	O
C	O
until	O
analysis	O
of	O
25OHD	O
.	O

Additionally	O
,	O
the	O
lack	O
of	O
correlation	O
may	O
suggest	O
that	O
circulating	O
cathelicidin	O
concentration	O
is	O
not	O
reflective	O
of	O
what	O
is	O
happening	O
at	O
the	O
cellular	O
level	O
,	O
and	O
in	O
this	O
regard	O
,	O
cathelicidin	O
mRNA	O
expression	O
by	O
immune	O
cells	O
or	O
target	O
tissue	O
may	O
be	O
a	O
better	O
indicator	O
of	O
vitamin	O
D	O
’	O
s	O
long	O
-	O
term	O
effect	O
on	O
the	O
cathelicidin	O
system	O
.	O

The	O
women	O
were	O
selected	O
according	O
to	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
stratified	O
sampling	O
design	O
as	O
recommended	O
for	O
studies	O
assessing	O
iodine	O
deficiency	O
[	O
31	O
].	O

There	O
is	O
,	O
thus	B
,	O
a	O
need	O
for	O
delivery	O
research	O
that	O
can	O
help	O
understand	O
context	O
-	O
specific	O
reasons	O
for	O
the	O
continued	O
low	O
coverage	O
in	O
these	O
countries	O
and	O
identify	O
ways	O
to	O
adapt	O
known	O
effective	O
strategies	O
for	O
use	O
in	O
low	O
-	O
resource	O
settings	O
[	O
14	O
].	O

Maternal	O
characteristics	O
were	O
explored	O
using	O
independent	O
t	O
tests	O
,	O
Mann	O
-	O
Whitney	O
U	O
tests	O
and	O
Chi	O
-	O
square	O
tests	O
.	O

In	O
accordance	O
with	O
other	O
studies	O
,	O
our	O
results	O
imply	B
that	O
in	O
a	O
vitamin	O
D	O
sufficient	O
population	O
,	O
the	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
GDM	O
may	O
not	O
exist	O
[	O
8	O
,	O
21	O
,	O
22	O
].	O

Very	O
low	O
-	O
density	O
lipoprotein	O
(	O
VLDL	O
)	O
were	O
estimated	O
following	O
the	O
Friedewald	O
equation	O
(	O
Warnick	O
et	O
al	O
.,	O
1990	O
)	O
and	O
low	O
-	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
was	O
determined	O
by	O
the	O
modification	O
of	O
Friedewal	O
equation	O
proposed	O
by	O
Ahmadi	O
et	O
al	O
.	O

The	O
question	O
of	O
how	O
developmental	O
programming	O
passes	O
to	O
subsequent	O
generations	O
deserves	O
further	O
attention	O
.	O

The	O
degree	O
of	O
risk	O
seems	O
to	O
be	O
directly	O
related	O
to	O
the	O
family	O
history	O
of	O
allergy	O
and	O
especially	O
to	O
maternal	O
atopy	O
,[	O
53	O
]	O
particularly	O
when	O
the	O
mother	O
has	O
diagnosed	O
atopic	O
eczema	O
and	O
has	O
elevated	O
IgE	O
levels	O
.	O

Maternal	O
dietary	O
data	O
and	O
Mediterranean	O
diet	O
score	O
Maternal	O
diet	O
during	O
pregnancy	O
was	O
assessed	O
during	O
gestational	O
weeks	O
24	O
–	O
28	O
with	O
a	O
validated	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
[	O
25	O
].	O

In	O
Indian	O
women	O
calcium	O
intakes	O
are	O
low	O
and	O
the	O
demands	O
on	O
calcium	O
economy	O
are	O
high	O
because	B
of	O
repeated	O
cycles	O
of	O
pregnancy	O
and	O
lactation	O
.	O

The	O
true	O
lumen	O
was	O
found	O
to	O
be	O
on	O
the	O
left	O
side	O
near	O
the	O
aortic	O
root	O
and	O
included	O
the	O
origins	O
of	O
the	O
great	O
vessels	O
and	O
extended	O
inferiorly	O
along	O
the	O
anterior	O
and	O
left	O
sides	O
of	O
the	O
descending	O
aorta	O
(	O
Figures1	O
,	O
2	O
,	O
and3	O
).	O

Whereas	O
maternal	O
calorie	O
restriction	O
leads	O
to	O
early	O
pubertal	O
onset	O
,	O
it	O
also	O
leads	O
to	O
a	O
reduction	O
in	O
adult	O
progesterone	O
levels	O
later	O
in	O
life	O
.	O

'	O
s	O
analysis	O
showed	O
induction	O
increase	O
in	O
the	O
risk	O
of	O
autism	O
by	O
72	O
%	O
in	O
three	O
clinic	O
based	O
studies	O
,	O
while	O
the	O
selected	O
population	O
-	O
based	O
studies	O
reported	O
no	O
association	O
[	O
57	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Estimated	O
lives	O
saved	O
of	O
premature	O
babies	O
in	O
settings	O
with	O
universal	O
coverage	O
of	O
interventionsIntervention	O
reaching	O
95	O
%	O
coverageAlso	O
saves	O
mothers	O
or	O
other	O
babiesBy	O
2015By	O
2025	O
%	O
Deaths	O
avertedLives	O
saved	O
%	O
Deaths	O
avertedLives	O
savedFamily	O
planning	O
*	O
M	O
,	O
SB	O
,	O
N24228	O
,	O
00032345	O
,	O
000Antenatal	O
corticosteroidsN40373	O
,	O
00041444	O
,	O
000Antibiotics	O
for	O
pPRoMN985	O
,	O
0009101	O
,	O
000Immediate	O
assessment	O
and	O
simple	O
care	O
of	O
all	O
babiesN544	O
,	O
000553	O
,	O
000Neonatal	O
resuscitationN765	O
,	O
000777	O
,	O
000Thermal	O
careN15142	O
,	O
00016171	O
,	O
000Kangaroo	O
mother	O
careN48452	O
,	O
00048531	O
,	O
000Interventions	O
implemented	O
togetherM	O
,	O
SB	O
,	O
N81757	O
,	O
00084921	O
,	O
000	O
Note	O
:	O
interventions	O
marked	O
with	O
M	O
will	O
also	O
save	O
maternal	O
lives	O
,	O
SB	O
would	O
avert	O
stillbirth	O
,	O
and	O
N	O
will	O
save	O
newborns	O
dying	O
from	O
causes	O
other	O
than	O
preterm	O
birth	O
.	O

Pregnant	O
women	O
with	O
thyroid	O
cancer	O
have	O
been	O
shown	O
to	O
have	O
favourable	O
outcomes	O
regardless	O
of	O
the	O
timing	O
of	O
diagnosis13233	O
.	O

In	O
general	O
,	O
treatment	O
of	O
asthma	O
and	O
allergic	O
diseases	O
does	O
not	O
differ	O
from	O
that	O
in	O
nonpregnant	O
women	O
.	O

Study	O
has	O
found	O
that	O
the	O
prevalence	O
of	O
Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
66	O
–	O
96	O
%	O
[	O
7	O
].	O

The	O
study	O
lacked	O
a	O
valid	O
measurement	O
of	O
infant	O
height	O
.	O

Statistical	O
estimates	O
show	O
that	O
one	O
out	O
of	O
every	O
88	O
individuals	O
in	O
the	O
United	O
States	O
is	O
diagnosed	O
with	O
autism	O
.	O

Accordingly	O
,	O
another	O
study	O
showed	O
that	O
fish	O
consumption	O
decreased	O
eczema	O
[	O
80	O
].	O

Second	O
,	O
it	O
provides	O
one	B
of	I
the	I
most	I
comprehensive	B
studies	O
to	O
date	O
evaluating	O
the	O
effect	O
of	O
mHealth	O
on	O
the	O
health	O
of	O
pregnant	O
military	O
female	O
soldiers	O
and	O
family	O
members	O
.	O

It	O
should	O
be	O
added	O
that	O
the	O
understanding	O
of	O
the	O
role	O
of	O
IL	O
-	O
6	O
is	O
more	O
complex	O
,	O
as	O
this	O
cytokine	O
is	O
known	O
to	O
be	O
secreted	O
by	O
skeletal	O
muscle	O
in	O
response	O
to	O
exercise	O
,	O
exerting	O
insulin	O
sensitizing	O
effects	O
(	O
Kelly	O
et	O
al	O
.,	O
2004	O
;	O
Petersen	O
and	O
Pedersen	O
,	O
2005	O
).	O

Much	O
of	O
the	O
attrition	O
was	O
attributable	B
to	O
redeployments	O
and	O
,	O
thus	O
,	O
lack	O
of	O
access	O
to	O
participants	O
at	O
the	O
Madigan	O
clinic	O
.	O

Expression	O
of	O
Placental	O
GAS5	O
and	O
GRs	O
Quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
GAS5	O
and	O
all	O
GRs	O
were	O
expressed	O
in	O
human	O
placentas	O
(	O
n	O
=	O
23	O
);	O
13	O
were	O
preterm	O
labor	O
(<	O
37	O
gestational	O
weeks	O
)	O
and	O
10	O
were	O
term	O
(>	O
37	O
gestational	O
weeks	O
)	O
labor	O
,	O
with	O
GAS5	O
and	O
GR	O
α	O
being	O
the	O
predominant	B
transcripts	O
.	O

Analyses	O
were	O
conducted	O
from	O
March	O
24	O
to	O
June	O
13	O
,	O
2014	O
.	O

Women	O
under	O
the	O
age	O
of	O
35	O
using	O
fertility	O
therapies	O
such	O
as	O
ovulation	O
inducing	O
drugs	O
and	O
artificial	O
insemination	O
did	O
not	O
increase	O
the	O
risk	O
for	O
having	O
a	O
child	O
with	O
autism	O
,	O
while	O
researchers	O
suggest	O
that	O
the	O
rise	O
in	O
fertility	O
treatments	O
in	O
older	O
women	O
above	O
35	O
may	O
increase	O
the	O
risk	O
of	O
having	O
a	O
child	O
with	O
autism	O
for	O
those	O
using	O
artificial	O
insemination	O
and	O
/	O
or	O
ovulation	O
inducing	O
drugs	O
.	O

Both	O
papers	O
describe	O
‘	O
weak	O
mindedness	O
,’‘	O
feeble	O
minds	O
,’‘	O
mental	O
dullness	O
,’	O
unresponsiveness	O
and	O
developmental	O
delays	O
.	O

in	O
2007	O
recorded	O
19	O
.	O
5	O
%	O
significant	O
increase	O
in	O
the	O
prevalence	O
of	O
anaemia	O
among	O
rural	O
Ghanaian	O
women	O
,	O
who	O
were	O
not	O
exposed	O
to	O
iron	O
-	O
fortified	O
salt	O
[	O
29	O
].	O

In	O
summary	O
,	O
some	O
investigations	O
have	O
shown	O
an	O
association	O
between	O
length	O
of	O
labor	O
and	O
autism	O
,	O
but	O
findings	O
have	O
been	O
inconsistent	O
owing	O
to	O
differences	O
in	O
sampling	O
and	O
methods	O
.	O

Alternately	O
,	O
it	O
might	O
be	O
that	O
immunological	O
effectiveness	O
of	O
supplementation	O
is	O
highly	O
dependent	O
upon	O
other	O
factors	O
as	O
yet	O
unidentified	O
,	O
or	O
other	O
prevalent	O
factors	O
in	O
this	O
high	O
-	O
risk	O
population	O
(	O
for	O
example	O
,	O
other	O
malnutrition	O
factors	O
and	O
that	O
5	O
·	O
5	O
%	O
of	O
the	O
children	O
in	O
our	O
study	O
had	O
a	O
Z	O
score	O
of	O
weight	O
for	O
age	O
below	O
−	O
3	O
).	O

More	O
frequent	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
higher	O
socio	O
-	O
economic	O
status	O
,	O
higher	O
level	O
of	O
education	O
and	O
use	O
of	O
prenatal	O
medical	O
services	O
in	O
studies	O
conducted	O
in	O
Finland	O
[	O
15	O
],	O
the	O
United	O
Kingdom	O
[	O
16	O
],	O
the	O
United	O
States	O
of	O
America	O
[	O
17	O
],	O
Denmark	O
[	O
18	O
]	O
and	O
Tanzania	O
[	O
19	O
].	O

These	O
results	O
combined	O
indicate	O
that	O
IFA	O
supplements	O
in	O
populations	O
of	O
iron	O
-	O
deficient	O
pregnant	O
women	O
could	O
lead	O
to	O
a	O
decrease	O
in	O
the	O
number	O
of	O
neonatal	O
deaths	O
mediated	O
by	O
reduced	O
rates	O
of	O
preterm	O
delivery	O
.	O

Present	O
study	O
showed	O
that	O
the	O
women	O
with	O
prior	O
problematic	O
pregnancies	O
or	O
higher	O
socioeconomic	O
status	O
or	O
education	O
level	O
were	O
more	O
prone	B
to	O
have	O
a	O
healthy	O
dietary	O
pattern	O
.	O

The	O
symptoms	O
of	O
autism	O
become	O
notable	O
in	O
patient	O
in	O
the	O
first	O
three	O
years	O
of	O
life	O
and	O
may	O
necessitate	O
lifelong	O
care	O
that	O
must	O
be	O
provided	O
by	O
family	O
members	O
,	O
guardians	O
,	O
or	O
healthcare	O
professionals	O
.	O

Overall	O
,	O
the	O
sample	O
was	O
predominantly	O
white	O
(	O
69	O
.	O
6	O
%,	O
656	O
/	O
943	O
),	O
with	O
a	O
mean	O
age	O
of	O
26	O
.	O
5	O
(	O
SD	O
74	O
.	O
4	O
)	O
years	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

In	O
utero	O
exposure	O
to	O
SGA	O
monotherapy	O
appears	O
to	O
be	O
associated	O
with	O
less	O
risk	O
to	O
the	O
fetus	O
.	O

There	O
is	O
debate	O
between	O
investigators	O
regarding	O
concentrations	O
that	O
relate	O
to	O
optimum	O
stores	O
of	O
vitamin	O
D	O
in	O
the	O
body	O
.	O

Researchers	O
at	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
initiated	O
the	O
North	O
Carolina	O
Breast	O
Milk	O
and	O
Formula	O
Project	O
.	O

Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
,	O
adjusted	O
for	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
were	O
highest	O
for	O
women	O
who	O
reported	O
habitual	O
sleep	O
duration	O
≤	O
4	O
hours	O
per	O
night	O
during	O
early	O
pregnancy	O
and	O
lowest	O
for	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
on	O
average	O
.	O

Results	O
We	O
evaluated	O
pregnant	O
women	O
aged	O
20	O
to	O
46	O
yrs	O
.	O

We	O
show	O
that	O
Skm1	O
and	O
Skm2	O
mice	O
carry	O
a	O
missense	O
mutation	O
in	O
the	O
Npr3	O
and	O
Flnb	O
genes	O
,	O
respectively	O
.	O

Provision	O
of	O
all	O
pregnant	O
and	O
lactating	O
women	O
with	O
the	O
Recommended	O
Daily	O
Allowance	O
of	O
600	O
IU	O
/	O
day	O
is	O
an	O
important	O
public	O
health	O
strategy	O
.	O

Beside	O
pathways	O
related	O
to	O
the	O
control	O
of	O
growth	O
and	O
cell	O
deviation	O
,	O
the	O
diet	O
-	O
dependent	O
expression	O
patterns	O
showed	O
regulation	O
in	O
genes	O
associated	O
with	O
biosynthesis	O
,	O
degradation	O
and	O
salvage	O
of	O
nucleotides	O
('	O
purine	O
and	O
pyrimidine	O
metabolism	O
')	O
as	O
well	O
as	O
cell	O
motility	O
and	O
cytokinesis	O
('	O
actin	O
cytoskeleton	O
signaling	O
',	O
'	O
Rac	O
signaling	O
',	O
'	O
RhoA	O
signaling	O
').	O

On	O
the	O
other	O
hand	O
,	O
there	O
were	O
consistent	O
positive	O
correlations	O
between	O
the	O
HRV	O
parameters	O
and	O
birth	O
weight	O
(	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
001	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
001	O
;	O
HF	O
:	O
P	O
=	O
0	O
.	O
002	O
).	O

However	O
,	O
the	O
suitability	O
of	O
the	O
Avy	O
mouse	O
as	B
a	O
true	B
reporter	O
model	O
has	O
since	O
been	O
questioned	O
following	O
both	O
lack	O
of	O
reproducibility	O
(	O
Rosenfeld	O
et	O
al	O
.	O
2013	O
),	O
and	O
the	O
suggestion	O
that	O
it	O
may	O
possess	O
a	O
“	O
thrifty	O
”	O
genotype	O
,	O
naturally	O
predisposing	O
offspring	O
to	O
a	O
metabolic	O
syndrome	O
when	O
food	O
is	O
plentiful	O
,	O
thus	B
confounding	O
results	O
following	O
environmental	O
exposures	O
(	O
Greally	O
&	O
Jacobs2013	O
).	O

These	O
features	O
were	O
also	O
linked	O
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

Other	O
oral	O
antidiabetic	O
agents	O
for	O
gestational	O
diabetes	O
There	O
is	O
one	O
study	O
which	O
randomized	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
,	O
glyburide	O
,	O
or	O
acarbose	O
.	O
61Forty	O
two	O
percent	O
of	O
the	O
acarbose	O
subjects	O
failed	O
to	O
achieve	O
adequate	O
glycemic	O
control	O
and	O
ultimately	O
required	O
insulin	O
therapy	O
.	O

NICU	O
,	O
neonatal	O
intensive	O
care	O
unit	O
;	O
PNA	O
,	O
poor	O
neonatal	O
adaptation	O
.	O

This	O
enzyme	O
counteracts	O
the	O
action	O
of	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
bisphosphate	O
3	O
-	O
kinase	O
(	O
PI3K	O
),	O
resulting	O
in	O
inhibition	O
of	O
the	O
AKT	O
signaling	O
pathway	O
involved	O
in	O
multiple	O
biological	O
processes	O
,	O
including	O
insulin	O
action	O
.	O

The	O
association	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
repetitive	O
element	O
methylation	O
and	O
aggregate	O
methylation	O
values	O
of	O
the	O
autosomal	O
CpG	O
loci	O
within	O
each	O
of	O
the	O
41	O
bioinformatic	O
classes	O
is	O
depicted	O
inFigure	O
3	O
.	O

Bivariate	O
analysis	O
was	O
performed	O
using	O
χ2	O
;	O
mean	O
continuous	O
variables	O
were	O
analyzed	O
using	O
Student	O
’	O
s	O
t	O
-	O
test	O
;	O
median	O
values	O
were	O
analyzed	O
using	O
Wilcoxon	O
ranked	O
-	O
sum	O
analysis	O
;	O
and	O
multivariate	O
analyses	O
were	O
analyzed	O
using	O
linear	O
regression	O
.	O

Another	O
potential	O
drawback	O
should	O
be	O
also	O
considered	O
.	O

Note	O
:	O
more	O
information	O
on	O
history	O
of	O
neonatal	O
mortality	O
reduction	O
in	O
UK	O
and	O
USA	O
available	O
(	O
Lawn	O
et	O
al	O
,	O
2013	O
)	O
[	O
6	O
].	O

The	O
daily	O
dietary	O
calcium	O
intake	O
of	O
both	O
the	O
urban	O
and	O
rural	O
populations	O
was	O
low	O
compared	O
with	O
the	O
recommended	O
dietary	O
allowances	O
issued	O
by	O
the	O
Indian	O
Council	O
of	O
Medical	O
Research	O
.	O

Intriguingly	O
,	O
maternal	O
high	O
fat	O
consumption	O
also	O
accelerated	O
reproductive	O
maturation	O
in	O
female	O
offspring	O
,	O
but	O
here	O
a	O
post	O
-	O
weaning	O
high	O
fat	O
diet	O
had	O
limited	O
additional	O
effect	O
.	O

In	O
this	O
study	O
,	O
data	O
collection	O
lasted	O
from	O
November	O
2014	O
until	O
early	O
October	O
2015	O
.	O

[	O
12	O
]	O
conducted	O
the	O
largest	O
-	O
scale	O
examination	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
population	O
and	O
reported	O
a	O
45	O
.	O
2	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
insufficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
30	O
ng	O
/	O
mL	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
a	O
5	O
.	O
7	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

Another	O
reason	B
for	O
high	O
compliance	O
with	O
the	O
weekly	O
program	O
was	O
the	O
maintenance	O
of	O
a	O
reliable	O
supply	O
.	O

Power	O
analysis	O
estimated	O
the	O
required	O
sample	O
to	O
be	O
996	O
participants	O
in	O
total	O
assuming	O
a	O
10	O
%	O
attrition	O
rate	O
at	O
postpartum	O
follow	O
-	O
up	O
.	O

Therefore	B
,	O
programs	O
that	O
target	O
peer	O
norms	O
may	O
be	O
effective	O
in	O
preventing	O
overweight	O
in	O
adolescents	O
.	O

Statistical	O
analysis	O
The	O
normality	O
of	O
the	O
variables	O
was	O
visually	O
inspected	O
.	O

Several	O
maternal	O
nutritional	O
factors	O
have	O
been	O
investigated	O
in	O
relation	O
to	O
adverse	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
offspring	O
health	O
and	O
development	O
[	O
7	O
–	O
9	O
].	O

Women	O
in	O
the	O
highest	O
quartile	O
of	O
healthy	O
dietary	O
pattern	O
were	O
more	O
likely	B
to	O
be	O
employed	O
and	O
graduated	O
and	O
have	O
employed	O
husband	O
,	O
history	O
of	O
IUGR	O
,	O
and	O
less	O
history	O
of	O
early	O
delivery	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
.	O

These	O
findings	O
are	O
largely	O
driven	O
by	O
data	O
from	O
the	O
United	O
States	O
,	O
where	O
most	O
mothers	O
took	O
vitamins	O
.	O

Several	O
studies	O
of	O
advertising	O
on	O
children	O
'	O
s	O
television	O
programs	O
found	O
that	O
the	O
foods	O
promoted	O
increased	O
the	O
risk	O
of	O
becoming	O
obese	O
.	O

Normal	O
distribution	O
of	O
variables	O
in	O
each	O
group	O
was	O
assessed	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

Before	O
measurements	O
are	O
taken	O
,	O
the	O
infant	O
is	O
assessed	O
for	O
presence	O
of	O
oedema	O
.	O

In	O
2006	O
,	O
following	O
a	O
baseline	O
study	O
of	O
the	O
prevalence	O
of	O
anaemia	O
,	O
iron	O
deficiency	O
and	O
soil	O
transmitted	O
helminth	O
infection	O
prevalences	O
[	O
12	O
],	O
we	O
introduced	O
an	O
anaemia	O
and	O
helminth	O
control	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
regular	O
deworming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
,	O
a	O
rural	O
province	O
in	O
the	O
northern	O
mountainous	O
region	O
of	O
Vietnam	O
.	O

These	O
offspring	O
also	O
had	O
higher	O
rates	O
of	O
physiological	O
changes	O
,	O
including	O
atypical	O
sperm	O
formation	O
.	O
38And	O
a	O
mouse	O
study	O
produced	O
evidence	O
that	O
uranium	O
in	O
drinking	O
water	O
caused	O
estrogenic	O
activity	O
even	O
at	O
levels	O
below	O
the	O
EPA	O
safe	O
drinking	O
water	O
level	O
of	O
30	O
µg	O
/	O
L	O
.	O
39	O
To	O
look	O
more	O
closely	O
at	O
the	O
effects	O
of	O
uranium	O
exposure	O
on	O
human	O
reproduction	O
and	O
development	O
,	O
Lewis	O
has	O
recently	O
begun	O
recruiting	O
up	O
to	O
1	O
,	O
500	O
pregnant	O
women	O
to	O
participate	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
.	O
40Besides	O
tracking	O
birth	O
outcomes	O
and	O
infant	O
development	O
,	O
pharmacologist	O
Laurie	O
Hudson	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
is	O
looking	O
at	O
molecular	O
changes	O
that	O
may	O
be	O
induced	O
by	O
exposure	O
to	O
uranium	O
waste	O
.	O

Data	O
are	O
expressed	O
as	O
group	O
means	O
±	O
SEM	O
.	O

Harvey	O
et	O
al	O
.	O

Associations	O
were	O
considered	O
significant	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

At	O
six	O
months	O
,	O
this	O
improvement	O
was	O
only	O
significant	O
for	O
children	O
of	O
women	O
in	O
the	O
highest	O
quintile	O
of	O
fish	O
consumption	O
,	O
suggesting	O
that	O
age	O
of	O
testing	O
may	O
be	O
relevant	O
[	O
22	O
].	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
23	O
.	O
6	O
times	O
more	O
likely	B
to	O
have	O
elevated	O
PTH	O
levels	O
compared	O
to	O
controls	O
and	O
3	O
.	O
6	O
times	O
more	O
likely	B
to	O
have	O
abnormally	O
low	O
albumin	O
concentrations	O
(	O
Table	O
2	O
).	O

A	O
range	O
of	O
studies	O
(	O
proteomics	O
,	O
genomics	O
,	O
gene	O
association	O
studies	O
)	O
have	O
linked	O
schizophrenia	O
with	O
alterations	O
in	O
malate	O
dehydrogenase	O
cytoplasmic	O
(	O
MDHC	O
,	O
now	O
known	O
as	O
malic	O
enzyme	O
2	O
)[	O
42	O
]–[	O
47	O
].	O

Lastly	O
,	O
living	O
standards	O
data	O
are	O
obtained	O
to	O
allow	O
classification	O
according	O
to	O
the	O
Living	O
Standards	O
Measure	O
(	O
LSM	O
)	O
developed	O
by	O
the	O
South	O
African	O
Audience	O
Reference	O
Foundation	O
(	O
SAARF	O
)	O
[	O
32	O
].	O

1	O
Flow	O
of	O
participants	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Baseline	O
characteristics	O
for	O
6	O
month	O
participantsCharacteristicLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Total	O
(	O
N	O
=	O
2136e	O
)	O
Maternal	O
Age	O
(	O
Years	O
)	O
a29	O
.	O
6	O
(	O
5	O
.	O
4	O
)	O
29	O
.	O
8	O
(	O
5	O
.	O
3	O
)	O
29	O
.	O
7	O
(	O
5	O
.	O
4	O
)	O
Gestational	O
Age	O
at	O
Entry	O
(	O
Weeks	O
)	O
b14	O
.	O
3	O
(	O
12	O
.	O
0	O
–	O
17	O
.	O
0	O
)	O
14	O
.	O
3	O
(	O
12	O
.	O
1	O
–	O
17	O
.	O
1	O
)	O
14	O
.	O
3	O
(	O
12	O
.	O
0	O
–	O
17	O
.	O
4	O
)	O
Body	O
Mass	O
Index	O
(	O
kg	O
/	O
m2	O
)	O
b31	O
.	O
2	O
(	O
28	O
.	O
0	O
–	O
35	O
.	O
8	O
)	O
31	O
.	O
0	O
(	O
27	O
.	O
7	O
–	O
35	O
.	O
4	O
)	O
31	O
.	O
0	O
(	O
27	O
.	O
8	O
–	O
35	O
.	O
6	O
)	O
Body	O
Mass	O
Index	O
Categoryc	O
BMI	O
25	O
.	O
0	O
–	O
29	O
.	O
9358	O
(	O
41	O
.	O
2	O
)	O
381	O
(	O
43	O
.	O
1	O
)	O
739	O
(	O
42	O
.	O
1	O
)	O
BMI	O
30	O
.	O
0	O
–	O
34	O
.	O
9226	O
(	O
30	O
.	O
2	O
)	O
256	O
(	O
28	O
.	O
9	O
)	O
518	O
(	O
29	O
.	O
5	O
)	O
BMI	O
35	O
.	O
0	O
–	O
39	O
.	O
9159	O
(	O
18	O
.	O
3	O
)	O
148	O
(	O
16	O
.	O
7	O
)	O
307	O
(	O
17	O
.	O
5	O
)	O
BMI	O
>	O
=	O
40	O
.	O
090	O
(	O
10	O
.	O
4	O
)	O
100	O
(	O
11	O
.	O
3	O
)	O
190	O
(	O
10	O
.	O
8	O
)	O
Weight	O
(	O
kg	O
)	O
a88	O
.	O
3	O
(	O
16	O
.	O
6	O
)	O
88	O
·	O
0	O
(	O
17	O
.	O
6	O
)	O
88	O
.	O
1	O
(	O
17	O
.	O
1	O
)	O
Height	O
(	O
cm	O
)	O
a164	O
.	O
9	O
(	O
6	O
.	O
4	O
)	O
164	O
·	O
7	O
(	O
6	O
.	O
5	O
)	O
164	O
.	O
8	O
(	O
6	O
.	O
5	O
)	O
Racec	O
Caucasian790	O
(	O
90	O
.	O
9	O
)	O
802	O
(	O
90	O
.	O
6	O
)	O
1592	O
(	O
90	O
.	O
8	O
)	O
Asian19	O
(	O
2	O
.	O
2	O
)	O
31	O
(	O
3	O
.	O
5	O
)	O
50	O
(	O
2	O
.	O
9	O
)	O
Indian35	O
(	O
4	O
.	O
0	O
)	O
30	O
(	O
3	O
.	O
4	O
)	O
65	O
(	O
3	O
.	O
7	O
)	O
Other25	O
(	O
2	O
.	O
9	O
)	O
22	O
(	O
2	O
.	O
5	O
)	O
47	O
(	O
2	O
.	O
7	O
)	O
Smokerc98	O
(	O
11	O
.	O
3	O
)	O
91	O
(	O
10	O
.	O
3	O
)	O
189	O
(	O
10	O
.	O
8	O
)	O
Nulliparousc359	O
(	O
41	O
.	O
3	O
)	O
353	O
(	O
39	O
.	O
9	O
)	O
712	O
(	O
40	O
.	O
6	O
)	O
Index	O
of	O
Socio	O
-	O
economic	O
Disadvantaged	O
Unknown1	O
(	O
0	O
.	O
1	O
)	O
1	O
(	O
0	O
.	O
1	O
)	O
2	O
(	O
0	O
.	O
1	O
)	O
Quintile	O
1	O
(	O
Most	O
Disadvantaged	O
)	O
256	O
(	O
29	O
.	O
5	O
)	O
251	O
(	O
28	O
.	O
4	O
)	O
507	O
(	O
28	O
.	O
9	O
)	O
Quintile	O
2214	O
(	O
24	O
.	O
6	O
)	O
222	O
(	O
25	O
.	O
1	O
)	O
436	O
(	O
24	O
.	O
9	O
)	O
Quintile	O
3139	O
(	O
16	O
.	O
0	O
)	O
134	O
(	O
15	O
.	O
1	O
)	O
273	O
(	O
15	O
.	O
6	O
)	O
Quintile	O
4122	O
(	O
14	O
.	O
0	O
)	O
141	O
(	O
15	O
.	O
9	O
)	O
263	O
(	O
15	O
.	O
0	O
)	O
Quintile	O
5	O
(	O
Least	O
Disadvantaged	O
)	O
137	O
(	O
15	O
.	O
7	O
)	O
136	O
(	O
15	O
.	O
4	O
)	O
273	O
(	O
15	O
.	O
6	O
)	O
amean	O
and	O
standard	O
deviation	O
bmedian	O
and	O
interquartile	O
range	O
cnumber	O
and	O
%	O
dSocioeconomic	O
index	O
as	O
measured	O
by	O
SEIFA	O
IRSD	O
eIncludes	O
all	O
women	O
whose	O
infants	O
were	O
eligible	O
for	O
the	O
6	O
month	O
follow	O
-	O
up	O
study	O
There	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
,	O
as	O
compared	O
with	O
those	O
born	O
to	O
women	O
in	O
the	O
Standard	O
Care	O
group	O
(	O
Lifestyle	O
Advice	O
233	O
(	O
21	O
.	O
71	O
%)	O
vs	O
.	O
Standard	O
Care	O
233	O
(	O
21	O
.	O
90	O
%);	O
adjusted	O
relative	O
risk	O
aRR	O
0	O
.	O
99	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
82	O
to	O
1	O
.	O
18	O
;	O
p	O
=	O
0	O
.	O
88	O
),	O
or	O
in	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
85th	O
centile	O
(	O
Lifestyle	O
Advice	O
299	O
(	O
27	O
.	O
88	O
%)	O
vs	O
.	O
Standard	O
Care	O
303	O
(	O
28	O
.	O
48	O
%);	O
aRR	O
0	O
.	O
97	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
84	O
to	O
1	O
.	O
13	O
;	O
p	O
=	O
0	O
.	O
71	O
)	O
(	O
Table	O
2	O
).	O

Only	O
three	O
TFBS	O
genes	O
were	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	O
with	O
LINE	O
-	O
1	O
methylation	O
:	O
MEF2	O
,	O
TBX1	O
,	O
and	O
POU2F1	O
.	O

SAS	O
version	O
9	O
.	O
3	O
(	O
SAS	O
Institute	O
Inc	O
.,	O
Cary	O
,	O
NC	O
,	O
USA	O
)	O
was	O
used	O
to	O
conduct	O
all	O
analyses	O
.	O

Tested	O
at	O
42	O
months	O
,	O
7	O
and	O
8	O
years	O
.	O
Two	O
FFQs	O
during	O
pregnancy	O
(	O
at	O
15	O
weeks	O
and	O
32	O
weeks	O
)	O
were	O
used	O
to	O
estimate	O
fish	O
intake	O
in	O
early	O
and	O
late	O
pregnancy	O
.	O
Cognitive	O
&	O
behavioural	O
outcomes	O
in	O
offspring	O
at	O
9	O
years	O
using	O
the	O
Wechsler	O
Abbreviated	O
Scale	O
of	O
Intelligence	O
.	O

Following	O
sex	O
determination	O
,	O
epigenetic	O
programing	O
via	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
redirect	O
and	O
drive	O
differentiation	O
of	O
the	O
PGCs	O
along	O
the	O
distinct	O
spermatozoal	O
or	O
oocyte	O
lineage	O
.	O

This	O
issue	O
was	O
also	O
revealed	O
in	O
Fawole	O
and	O
colleagues	O
’	O
study	O
[	O
7	O
]	O
where	O
they	O
hypothesized	O
that	O
as	O
the	O
level	O
of	O
education	O
in	O
the	O
community	O
steadily	O
increases	O
,	O
pregnant	O
women	O
may	O
become	O
more	O
and	O
more	O
critical	O
of	O
health	O
care	O
.	O

Groups	O
The	O
exogenous	O
Vitamin	O
D	O
came	O
from	O
Vitamin	O
D	O
supplement	O
or	O
Vitamin	O
D	O
rich	O
food	O
.	O

SNPs	O
selected	O
for	O
analysis	O
were	O
based	O
on	O
the	O
findings	O
of	O
a	O
previous	O
GWAS	O
(	O
8	O
).	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
linked	O
to	O
rickets	O
in	O
children	O
and	O
osteomalacia	O
in	O
adults	O
[	O
1	O
].	O

Vitamin	O
D	O
is	O
critical	O
for	O
the	O
development	O
of	O
the	O
nervous	O
system	O
[	O
5	O
],[	O
6	O
]	O
and	O
immunological	O
functions	O
[	O
7	O
]	O
during	O
fetal	O
development	O
.	O

This	O
experiment	O
was	O
performed	O
over	O
5	O
replicates	O
.	O

PTH	O
was	O
not	O
elevated	O
(	O
median	O
1	O
.	O
0pmol	O
/	O
L	O
[<	O
0	O
.	O
3	O
-	O
3	O
.	O
1	O
]),	O
urinary	O
calcium	O
:	O
creatinine	O
ratio	O
not	O
suppressed	O
(	O
median	O
2	O
.	O
3	O
,	O
[	O
0	O
.	O
4	O
-	O
9	O
]),	O
25OHVitD	O
low	O
-	O
normal	O
(	O
median	O
44nmol	O
/	O
L	O
[	O
17	O
-	O
218	O
])	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2VitD	O
elevated	O
(	O
median	O
232pmol	O
/	O
L	O
[	O
64	O
-	O
720	O
]),	O
in	O
keeping	O
with	O
an	O
abnormality	O
in	O
CYP24A1	O
.	O

The	O
height	O
of	O
the	O
child	O
was	O
correlated	O
with	O
the	O
height	O
of	O
all	O
family	O
members	O
including	O
all	O
four	O
grandparents	O
,	O
with	O
the	O
strongest	O
correlations	O
being	O
with	O
the	O
parents	O
and	O
the	O
PGF	O
.	O

Because	O
the	O
risk	O
of	O
developing	O
GDM	O
gradually	O
increases	O
in	O
overweight	O
and	O
obese	O
women	O
,	O
the	O
total	O
sample	O
was	O
divided	O
into	O
three	O
pre	O
-	O
pregnancy	O
BMI	O
groups	O
for	O
comparison	O
:	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
BMI	O
≥	O
25	O
kg	O
/	O
m2and	O
<	O
30	O
kg	O
/	O
m2and	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
.	O

Foods	O
high	O
in	O
N	O
-	O
nitroso	O
compounds	O
have	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
brain	O
tumors	O
in	O
some	O
studies	O
[	O
162	O
–	O
165	O
].	O

To	O
date	O
,	O
there	O
are	O
no	O
biomarkers	O
that	O
can	O
reliably	O
predict	O
which	O
newborn	O
will	O
develop	O
atopy	O
.	O

The	O
MAS5	O
algorithm	O
was	O
used	O
to	O
skip	O
those	O
transcripts	O
which	O
were	O
expressed	O
in	O
less	O
than	O
50	O
%	O
of	O
the	O
animals	O
within	O
one	O
dietary	O
group	O
per	O
stage	O
.	O

Objective	O
:	O
To	O
determine	O
whether	O
SNPs	O
in	O
DHCR7	O
,	O
CYP2R1	O
,	O
CYP24A1	O
,	O
and	O
GC	O
are	O
associated	O
with	O
the	O
response	O
to	O
gestational	O
cholecalciferol	O
supplementation	O
.	O

We	O
invited	O
women	O
aged	O
between	O
15	O
and	O
49	O
years	O
,	O
resident	O
in	O
Iaşi	O
county	O
,	O
with	O
singleton	O
pregnancies	O
to	O
participate	O
in	O
the	O
study	O
within	O
48	O
–	O
72	O
hours	O
of	O
giving	O
birth	O
.	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

The	O
most	O
common	O
indications	O
for	O
psychotropic	O
medication	O
use	O
were	O
bipolar	O
disorder	O
(	O
36	O
.	O
8	O
%),	O
depression	O
(	O
27	O
.	O
1	O
%),	O
anxiety	O
and	O
depression	O
(	O
9	O
.	O
8	O
%)	O
and	O
sleep	O
disorders	O
(	O
9	O
.	O
8	O
%).	O

(	O
2008	O
)*	O
NicotineRatInjection	O
(	O
sc	O
)	O
(	O
1	O
mg	O
/	O
kg	O
twice	O
/	O
d	O
)	O
Implant	O
(	O
sc	O
)	O
(	O
4	O
µg	O
/	O
kg	O
/	O
min	O
)	O
Combinations	O
of	O
:	O
In	O
utero	O
Neonatal	O
In	O
utero	O
Neonatal	O
F0	O
-	O
F1generationsGrowth	O
retardation	O
Neurological	O
and	O
adrenal	O
abnormalitiesHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machineryLi	O
et	O
al	O
.	O

We	O
calculated	O
person	O
-	O
time	O
at	O
risk	O
for	O
each	O
child	O
up	O
to	O
the	O
date	O
a	O
child	O
reached	O
our	O
primary	O
endpoint	O
,	O
was	O
last	O
seen	O
at	O
the	O
end	O
of	O
our	O
study	O
,	O
or	O
when	O
censored	O
because	O
they	O
were	O
lost	O
to	O
follow	O
-	O
up	O
.	O

This	O
includes	O
information	O
regarding	O
GDM	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
counseling	O
,	O
and	O
advice	O
regarding	O
healthy	O
lifestyle	O
measures	O
post	O
-	O
partum	O
.	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

Furthermore	O
,	O
studies	O
have	O
focussed	O
predominantly	O
on	O
measures	O
of	O
adiposity	O
,	O
and	O
have	O
not	O
reported	O
other	O
clinically	O
relevant	O
infant	O
outcomes	O
[	O
18	O
,	O
20	O
],	O
or	O
specifically	O
reported	O
infant	O
outcomes	O
among	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
[	O
19	O
].	O

injection	O
of	O
T61	O
in	O
the	O
V	O
.	O
cava	O
cranialis	O
and	O
liver	O
samples	O
were	O
immediately	O
collected	O
(	O
approximately	O
500	O
mg	O
),	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

Objective	O
To	O
identify	O
the	O
presence	O
of	O
GDM	O
risk	O
factors	O
during	O
pregnancy	O
at	O
the	O
time	O
of	O
diagnosis	O
of	O
this	O
pathology	O
.	O

We	O
also	O
tested	O
the	O
relationships	O
between	O
continuous	O
predictors	O
(	O
women	O
'	O
s	O
age	O
,	O
stress	O
)	O
and	O
infant	O
weight	O
,	O
using	O
Pearson	O
correlations	O
and	O
partial	O
correlations	O
(	O
when	O
adjusting	O
for	O
age	O
and	O
BMI	O
)	O
and	O
using	O
t	O
-	O
tests	O
for	O
dichotomous	O
predictors	O
(	O
e	O
.	O
g	O
.,	O
planned	O
pregnancy	O
)	O
and	O
ANOVA	O
for	O
testing	O
the	O
relationship	O
between	O
attitude	O
type	O
and	O
infant	O
birth	O
weight	O
,	O
while	O
controlling	O
statistically	O
for	O
relevant	O
confounders	O
such	O
as	O
mothers	O
'	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
pregnancy	O
nutritional	O
habits	O
.	O

‡	O
Pearson	O
'	O
s	O
χ²	O
test	O
.	O

The	O
direct	O
transfer	O
of	O
food	O
or	O
inhalant	O
allergens	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
has	O
long	B
been	O-
recognized	I
[	O
58	O
-	O
60	O
].	O

Mass	O
Spectrometry	O
Excised	O
spots	O
were	O
washed	O
in	O
50	O
mM	O
ammonium	O
bicarbonate	O
/	O
acetonitrile	O
(	O
60	O
∶	O
40	O
solution	O
)	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
.	O

A	O
reduction	O
in	O
simple	O
carbohydrates	O
and	O
fat	O
intake	O
is	O
advisable	O
.	O

BHLM	O
is	O
a	O
statistical	O
method	O
belonging	O
to	O
a	O
class	O
of	O
methods	O
known	O
as	O
shrinkage	O
methods	O
that	O
,	O
by	O
placing	O
constraints	O
on	O
the	O
distribution	O
of	O
the	O
variables	O
in	O
the	O
model	O
,	O
compress	O
the	O
beta	O
coefficients	O
toward	O
a	O
common	O
mean	O
,	O
resulting	O
in	O
more	O
stable	O
estimates	O
and	O
avoiding	O
the	O
collinearity	O
problem	O
.	O

Studies	O
have	O
focused	O
particularly	O
on	O
the	O
potentially	O
beneficial	O
effects	O
of	O
antioxidants	O
,	O
following	O
the	O
hypothesis	O
that	O
a	O
declining	O
intake	O
of	O
antioxidants	O
in	O
Westernised	O
countries	O
has	O
led	O
to	O
a	O
reduction	O
in	O
pulmonary	O
antioxidant	O
defences	O
,	O
and	O
hence	B
to	O
an	O
increase	O
in	O
prevalence	O
of	O
asthma	O
and	O
atopy	O
in	O
recent	O
decades	O
[	O
2	O
].	O

These	O
findings	O
were	O
preserved	O
even	O
after	O
adjusting	O
for	O
these	O
confounders	O
.	O

An	O
unquantified	O
food	O
frequency	O
questionnaire	O
for	O
the	O
infant	O
is	O
administered	O
at	O
phases	O
6	O
and	O
8	O
for	O
qualitative	O
assessment	O
(	O
types	O
and	O
frequency	O
)	O
of	O
milk	O
and	O
complementary	O
feeding	O
at	O
6	O
and	O
12	O
months	O
postnatally	O
.	O

(	O
2010	O
)¶/†	O
Melkamu	O
et	O
al	O
.	O

In	O
addition	O
,	O
elevation	O
of	O
“	O
free	O
iron	O
”	O
in	O
the	O
plasma	O
and	O
hence	B
lipid	O
peroxidation	O
which	O
is	O
indicative	O
of	O
oxidative	O
stress	O
has	O
been	O
reported	O
[	O
44	O
–	O
46	O
].	O

Studies	O
on	O
ANC	O
in	O
low	O
income	O
countries	O
have	O
mainly	B
focused	O
on	O
monitoring	O
quantifiable	O
data	O
such	O
as	O
the	O
number	O
of	O
antennal	O
visits	O
during	O
ANC	O
[	O
3	O
,	O
4	O
]	O
and	O
its	O
effects	O
on	O
pregnancy	O
outcome	O
[	O
5	O
].	O

Greer	O
et	O
al	O
[	O
16	O
]	O
found	O
an	O
increase	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
24	O
to	O
39	O
ng	O
/	O
mL	O
at	O
three	O
months	O
of	O
age	O
with	O
the	O
provision	O
of	O
400	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
to	O
breast	O
-	O
fed	O
infants	O
.	O

There	O
is	O
no	O
significant	O
association	O
between	O
dose	O
of	O
Vitamin	O
D	O
supplement	O
intake	O
,	O
time	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
.	O

All	O
pregnant	O
women	O
in	O
the	O
waiting	O
areas	O
of	O
the	O
ANC	O
clinics	O
are	O
informed	O
about	O
the	O
study	O
.	O

A	O
group	O
in	O
Norway	O
assessed	O
the	O
association	O
between	O
interpregnancy	O
lengths	O
and	O
ASD	O
and	O
found	O
that	O
interpregnancy	O
intervals	O
for	O
less	O
than	O
9	O
months	O
and	O
interpregnancy	O
between	O
9	O
and	O
11	O
months	O
carried	O
an	O
increased	O
risk	O
for	O
ASD	O
[	O
11	O
].	O

Substantially	O
more	O
information	O
is	O
available	O
regarding	O
the	O
frequency	O
of	O
hand	O
cleansing	O
after	O
defecation	O
.	O

Because	O
they	O
are	O
widely	O
distributed	O
in	O
the	O
environment	O
,	O
the	O
majority	O
of	O
pregnant	O
women	O
in	O
the	O
United	O
States	O
have	O
detectable	O
levels	O
of	O
multiple	O
EDCs	O
in	O
their	O
blood	O
or	O
urine	O
[	O
6	O
,	O
7	O
].	O

Moreover	O
,	O
the	O
ratio	O
of	O
LF	O
/	O
HF	O
was	O
also	O
calculated	O
.	O

The	O
DHCR7	O
gene	O
encodes	O
7	O
-	O
DHC	O
reductase	O
,	O
which	O
converts	O
7	O
-	O
DHC	O
back	O
to	O
cholesterol	O
,	O
thereby	O
reducing	O
the	O
availability	O
of	O
7	O
-	O
DHC	O
for	O
conversion	O
to	O
previtamin	O
D	O
.	O
The	O
association	O
of	O
this	O
SNP	O
with	O
only	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
is	O
biologically	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
relative	O
proportion	O
of	O
25	O
(	O
OH	O
)	O
D	O
obtained	O
from	O
vitamin	O
D	O
biosynthesis	O
in	O
the	O
skin	O
as	O
opposed	O
to	O
dietary	O
intake	O
is	O
lower	O
following	O
supplementation	O
.	O

Significant	O
neurodevelopmental	O
abnormalities	O
were	O
observed	O
and	O
a	O
high	O
frequency	O
of	O
autism	O
was	O
found	O
in	O
children	O
exposed	O
to	O
cocaine	O
,	O
especially	O
in	O
comparison	O
to	O
those	O
exposed	O
to	O
alcohol	O
or	O
opiates	O
alone	O
[	O
33	O
].	O

In	O
the	O
USA	O
excessive	O
GWG	O
remains	O
of	O
predominant	O
concern	O
,	O
as	O
60	O
%	O
of	O
obese	O
women	O
gain	O
more	O
than	O
recommended	O
.	O

Variables	O
BMI	O
,	O
season	O
of	O
conception	O
,	O
education	O
level	O
and	O
origin	O
were	O
identified	O
and	O
included	O
in	O
the	O
final	O
models	O
.	O

As	B
the	O
results	O
between	O
change	O
in	O
25OHD	O
and	O
neonatal	O
birth	O
size	O
and	O
preterm	O
delivery	O
remained	O
after	O
adjustment	O
for	O
season	O
of	O
conception	O
,	O
origin	O
and	O
vitamin	O
D	O
supplementation	O
,	O
vitamin	O
D	O
status	O
trajectory	O
can	O
be	O
suspected	B
to	O
play	O
a	O
role	O
in	O
healthy	O
pregnancy	O
.	O

effect	O
of	O
postnatal	O
diet	O
in	O
undernourished	O
and	O
control	O
animals	O
,	O
NS	O
.	O

Those	O
identified	O
as	O
at	O
-	O
risk	O
include	O
:	O
Women	O
from	O
black	O
and	O
ethnic	O
minorities	O
who	O
are	O
socially	O
-	O
excluded	O
,	O
women	O
with	O
limited	O
exposure	O
to	O
sunlight	O
,	O
especially	O
those	O
who	O
are	O
housebound	O
and	O
obese	O
women	O
with	O
prepregnancy	O
BMI	O
>	O
30	O
.	O

Thus	B
,	O
if	O
vitamin	O
D	O
was	O
protective	O
,	O
these	O
cancers	O
would	O
be	O
expected	O
to	O
be	O
rare	O
among	O
individuals	O
with	O
MS	O
.	O

(	O
2013	O
)*/†	O
Tong	O
et	O
al	O
.	O

China	O
Begins	O
National	O
Survey	O
of	O
Pollution	O
Sources	O
Although	O
China	O
has	O
set	O
goals	O
to	O
cut	O
emissions	O
of	O
major	O
pollutants	O
,	O
emissions	O
of	O
sulfur	O
dioxide	O
and	O
some	O
indicators	O
of	O
poor	O
water	O
quality	O
increased	O
in	O
2006	O
.	O

Headliners	O
:	O
Maternal	O
Nutrition	O
and	O
Child	O
Cancer	O
:	O
Mother	O
’	O
s	O
Pre	O
-	O
pregnancy	O
Diet	O
May	O
Influence	O
Child	O
Cancer	O
Risk	O
Jensen	O
CD	O
,	O
Block	O
G	O
,	O
Buffler	O
P	O
,	O
Ma	O
X	O
,	O
Selvin	O
S	O
,	O
Month	O
S	O
.	O
2004	O
.	O

RNA	O
(	O
200	O
ng	O
from	O
placental	O
tissue	O
and	O
500	O
ng	O
from	O
cell	O
lysates	O
)	O
was	O
reverse	O
-	O
transcribed	O
into	O
cDNA	O
using	O
5	O
IU	O
/	O
μ	O
L	O
RNase	O
H	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
,	O
Paisley	O
,	O
UK	O
).	O

N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
is	O
a	O
chemical	O
mutagen	O
that	O
introduces	O
random	O
point	O
mutations	O
into	O
the	O
mouse	O
genome	O
that	O
,	O
together	O
with	O
positional	O
cloning	O
or	O
exome	O
sequencing	O
,	O
permits	B
the	O
identification	O
of	O
phenotype	O
–	O
genotype	O
relationships	O
in	O
an	O
unbiased	O
manner	O
(	O
Probst	O
and	O
Justice	O
2010	O
).	O

Instead	O
,	O
I	O
concentrate	O
on	O
papers	O
either	O
published	O
since	O
my	O
paper	O
,	O
or	O
on	O
evidence	O
I	O
overlooked	O
when	O
researching	O
the	O
original	O
paper	O
.	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	O
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

Many	O
factors	O
influence	O
how	O
long	O
a	O
mother	O
nurses	O
,	O
but	O
new	O
mothers	O
often	B
state	O
a	O
common	B
problem	O
when	O
asked	O
why	O
they	O
quit	O
breastfeeding	O
earlier	O
than	O
they	O
wanted	O
:	O
They	O
can	O
’	O
t	O
produce	O
enough	O
milk	O
.	O
2	O
Caption	O
(	O
FIG	O
)	O
New	O
mothers	O
who	O
quit	O
breastfeeding	O
earlier	O
than	O
they	O
had	O
wanted	O
often	B
chalk	O
it	O
up	O
to	O
not	O
being	O
able	O
to	O
produce	O
enough	O
milk	O
.	O

Up	O
to	O
this	O
moment	O
,	O
researchers	O
were	O
focused	O
on	O
immunomodulating	O
effect	O
of	O
vitamin	O
D	O
on	O
endometriosis	O
.	O

IMF	O
deposition	O
can	O
positively	O
affect	O
beef	O
taste	O
including	O
tenderness	O
and	O
flavor	O
,	O
favoring	O
highly	O
marbled	O
beef	O
.	O

In	O
particular	O
,	O
we	O
wanted	O
to	O
evaluate	O
the	O
additive	O
effects	O
of	O
race	O
and	O
maternal	O
characteristics	O
such	O
as	O
obesity	O
on	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O

The	O
most	O
commonly	O
used	O
herbs	O
were	O
ginger	O
and	O
peppermint	O
.	O

The	O
authors	O
suggested	O
that	O
mild	O
heat	O
stress	O
in	O
summer	O
and	O
mild	O
cold	O
stress	O
in	O
winter	O
may	O
be	O
beneficial	O
to	O
fat	O
deposition	O
under	O
ad	O
libitum	O
feeding	O
conditions	O
for	O
cattle	O
fed	O
in	O
an	O
unprotected	O
,	O
unsheltered	O
area	O
.	O

Grandjean	O
and	O
others	O
have	O
begun	O
to	O
investigate	O
the	O
potential	O
impacts	O
of	O
chemical	O
exposures	O
on	O
the	O
process	O
of	O
lactation	O
itself	O
.	O

Questionnaires	O
were	O
recorded	O
at	O
birth	O
and	O
6	O
months	O
of	O
age	O
.	O

Influenza	O
vaccination	O
was	O
self	O
-	O
reported	O
;	O
however	O
,	O
interviewers	O
validated	O
this	O
information	O
using	O
vaccination	O
cards	O
and	O
/	O
or	O
antenatal	O
medical	O
records	O
if	O
available	O
.	O

This	O
was	O
similar	O
for	O
boys	O
and	O
girls	O
(	O
table	O
5	O
).	O

Our	O
laboratory	O
has	O
studied	O
IMF	O
deposition	O
for	O
more	O
than	O
a	O
decade	O
to	O
understand	O
the	O
mechanisms	O
responsible	O
for	O
IMF	O
deposition	O
in	O
beef	O
cattle	O
[	O
6	O
–	O
12	O
],	O
and	O
we	O
have	O
reviewed	O
molecular	O
mechanisms	O
responsible	O
for	O
IMF	O
deposition	O
in	O
cattle	O
[	O
13	O
].	O

Portion	O
sizes	O
of	O
consumed	O
foods	O
were	O
converted	O
to	O
grams	O
from	O
household	O
measures	O
.	O

In	O
Bangladesh	O
,	O
42	O
%	O
of	O
all	O
women	O
of	O
reproductive	O
age	O
and	O
nearly	O
50	O
%	O
of	O
pregnant	O
women	O
had	O
anaemia	O
in	O
2011	O
[	O
5	O
].	O

On	O
the	O
present	O
evidence	O
,	O
it	O
is	O
not	O
possible	O
to	O
definitively	O
answer	O
the	O
question	O
of	O
how	O
season	O
of	O
birth	O
influences	O
glioma	O
risk	O
,	O
or	O
to	O
favor	O
any	O
specific	O
hypothesis	O
.	O

Actually	O
,	O
this	O
is	O
not	O
a	O
new	O
finding	O
.	O

There	O
were	O
139	O
(	O
13	O
%)	O
PTBs	O
(<	O
37	O
weeks	O
),	O
of	O
which	O
20	O
were	O
very	O
preterm	O
(<	O
32	O
weeks	O
),	O
21	O
were	O
moderately	O
preterm	O
(	O
32	O
to	O
<	O
34	O
weeks	O
),	O
and	O
98	O
were	O
late	O
preterm	O
(	O
34	O
to	O
<	O
37	O
weeks	O
).	O

A	O
53	O
%	O
decreased	O
risk	O
for	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
observed	O
with	O
high	O
(>	O
81	O
nmol	O
/	O
L	O
)	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
(	O
63	O
–	O
81	O
nmol	O
/	O
L	O
,	O
aRR	O
,	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
).	O

[	O
18	O
]	O
This	O
recommendation	O
may	O
be	O
controversial	O
because	B
very	O
high	O
doses	O
of	O
vitamin	O
D	O
have	O
long	O
been	O
believed	O
to	O
cause	O
birth	O
defects	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
components	O
of	O
the	O
endocannabinoid	O
system	O
(	O
Cnr1	O
,	O
Cnr2	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
in	O
the	O
hypothalamus	O
(	O
A	O
)	O
,	O
liver	O
(	O
B	O
)	O
,	O
and	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
,	O
C	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

The	O
main	O
epigenetic	O
pathways	O
,	O
including	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
and	O
sncRNAs	O
,	O
are	O
also	O
conserved	O
in	O
zebrafish	O
(	O
Mishima2012	O
;	O
Kamstra	O
et	O
al	O
.	O
2015	O
;	O
Williams	O
et	O
al	O
.	O
2014	O
).	O

Dams	O
(	O
and	O
corresponding	O
litters	O
)	O
were	O
placed	O
under	O
control	O
conditions	O
for	O
the	O
remainder	O
of	O
the	O
experiment	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
are	O
consistent	O
with	O
the	O
“	O
overload	O
hypothesis	O
”.	O

Global	O
DNA	O
methylation	O
was	O
similar	O
among	O
the	O
diet	O
groups	O
.	O

The	O
Report	O
Card	O
,	O
a	O
familiar	O
means	O
of	O
assessing	O
progress	O
for	O
school	O
-	O
age	O
children	O
,	O
has	O
been	O
a	O
powerful	O
tool	O
used	O
in	O
the	O
United	O
States	O
to	O
prevent	O
preterm	O
birth	O
and	O
its	O
serious	O
health	O
consequences	O
.	O

Since	O
in	O
the	O
present	O
study	O
neonatal	O
growth	O
trajectories	O
in	O
pups	O
that	O
were	O
exposed	O
to	O
maternal	O
undernutrition	O
began	O
to	O
deviate	O
from	O
those	O
of	O
control	O
pups	O
at	O
a	O
time	O
that	O
coincides	O
with	O
a	O
neonatal	O
surge	O
in	O
circulating	O
leptin	O
concentrations	O
,	O
which	O
itself	O
is	O
nutritionally	O
influenced	O
[	O
49	O
],[	O
50	O
],	O
leptin	O
may	O
be	O
a	O
central	O
driver	O
in	O
initiating	O
maturational	O
changes	O
.	O

The	O
RV	O
,	O
HV	O
and	O
HFol	O
diets	O
were	O
all	O
of	O
the	O
same	O
energy	O
density	O
(	O
3	O
.	O
8	O
kcal	O
/	O
g	O
).	O

In	O
conclusion	O
,	O
there	O
are	O
several	O
ways	O
to	O
expedite	O
the	O
diagnosis	O
of	O
MTC	O
and	O
to	O
follow	O
-	O
up	O
patients	O
after	O
surgery	O
:	O
biochemical	O
markers	O
(	O
e	O
.	O
g	O
.	O

Thus	B
,	O
a	O
similar	O
sncRNA	O
switch	O
,	O
this	O
time	O
back	O
to	O
increased	O
genome	O
protection	O
makes	B
functional	O-
sense	I
.	O

To	O
combat	O
this	O
,	O
it	O
has	O
been	O
suggested	O
that	O
testing	O
occurs	O
at	O
more	O
than	O
one	O
time	O
point	O
[	O
27	O
]	O
and	O
that	O
testing	O
should	O
extend	O
beyond	O
the	O
first	O
two	O
years	O
,	O
preferable	O
to	O
school	O
aged	O
children	O
in	O
order	O
to	O
detect	O
more	O
subtle	O
differences	O
[	O
28	O
].	O

In	O
terms	O
of	O
seasonal	O
difference	O
,	O
during	O
autumn	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
group	O
who	O
took	O
Vitamin	O
D	O
supplements	O
was	O
significantly	O
higher	O
than	O
control	O
group	O
(	O
78	O
.	O
59	O
±	O
27	O
.	O
54	O
vs	O
46	O
.	O
18	O
±	O
18	O
.	O
77	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
045	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
General	O
characteristics	O
of	O
study	O
subjectsGroupsNAge	O
(	O
Year	O
)	O
Gestational	O
weeks	O
(	O
Week	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Control1434	O
.	O
3	O
±	O
4	O
.	O
928	O
.	O
9	O
±	O
4	O
.	O
124	O
.	O
7	O
±	O
4	O
.	O
5Intervention8433	O
.	O
3	O
±	O
3	O
.	O
828	O
.	O
9	O
±	O
3	O
.	O
322	O
.	O
8	O
±	O
3	O
.	O
5	O
Comparison	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
women	O
of	O
the	O
two	O
groups	O
As	O
shown	O
in	O
Table	O
2	O
,	O
the	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
the	O
intervention	O
and	O
control	O
group	O
were	O
74	O
.	O

Interventions	O
in	O
the	O
LiST	O
analysis	O
included	O
KMC	O
,	O
antenatal	O
corticosteroids	O
,	O
antibiotics	O
for	O
pPRoM	O
,	O
skilled	O
birth	O
attendance	O
,	O
and	O
others	O
.	O

Of	O
the	O
3268	O
women	O
included	O
in	O
the	O
analysis	O
,	O
55	O
%	O
(	O
1789	O
)	O
had	O
documented	O
influenza	O
vaccination	O
in	O
2014	O
.	O

Furthermore	O
,	O
mean	O
LINE	O
-	O
1	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
;	O
however	O
,	O
limited	O
numbers	O
may	O
affect	O
our	O
precision	O
,	O
so	O
this	O
result	O
should	O
be	O
confirmed	O
in	O
further	O
analyses	O
.	O

LiST	O
is	O
a	O
free	O
and	O
widely	O
used	O
module	O
in	O
a	O
demographic	O
software	O
package	O
called	O
Spectrum	O
,	O
which	O
allows	O
the	O
user	O
to	O
compare	O
the	O
effects	O
of	O
different	O
interventions	O
on	O
the	O
numbers	O
of	O
maternal	O
,	O
neonatal	O
and	O
child	O
deaths	O
and	O
stillbirths	O
,	O
as	O
well	O
as	O
stunting	O
and	O
wasting	O
[	O
43	O
].	O

To	O
investigate	O
the	O
role	O
of	O
BAT	O
,	O
of	O
UCP1	O
in	O
particular	O
,	O
studies	O
were	O
carried	O
out	O
in	O
UCP1	O
knockout	O
mice	O
.	O

(	O
2011	O
)*/†	O
Peng	O
et	O
al	O
.	O

Another	O
study	O
showed	O
that	O
a	O
higher	O
level	O
of	O
nutritional	O
knowledge	O
was	O
associated	O
with	O
vitamin	O
/	O
mineral	O
supplementation	O
use	O
[	O
21	O
].	O

Low	O
birth	O
weight	O
is	O
a	O
predictor	O
for	O
coronary	O
heart	O
disease	O
[	O
16	O
],	O
diabetes	O
mellitus	O
[	O
17	O
]	O
and	O
infant	O
mortality	O
[	O
17	O
].	O

Between	O
-	O
group	O
and	O
within	O
-	O
group	O
comparisons	O
of	O
qualitative	O
data	O
were	O
performed	O
Chi	O
-	O
Square	O
or	O
McNemar	O
tests	O
.	O

However	O
microcephaly	O
can	O
also	O
be	O
caused	O
by	O
other	O
factors	O
such	O
as	O
low	O
intelligence	O
and	O
heredity	O
,	O
which	O
could	O
not	O
be	O
controlled	O
for	O
,	O
and	O
also	O
only	O
focused	O
on	O
measurements	O
obtained	O
at	O
birth	O
[	O
46	O
].	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Supplementary_Material_CRT_Revisions	O
.	O
docx	O
Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Where	O
possible	O
,	O
estimation	O
of	O
serum	O
ferritin	O
level	O
is	O
desirable	O
to	O
adjust	O
the	O
dose	O
of	O
iron	O
supplements	O
[	O
62	O
].	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

The	O
book	O
covers	O
a	O
variety	O
of	O
topics	O
in	O
a	O
lucid	O
manner	O
under	O
four	O
distinct	O
sections	O
namely	O
'	O
Nutrition	O
for	O
Health	O
',	O
'	O
Nutrition	O
for	O
Special	O
Circumstances	O
',	O
'	O
Nutrition	O
for	O
Disease	O
States	O
',	O
and	O
'	O
Food	O
Policy	O
'.	O

Four	O
weeks	O
later	O
,	O
once	O
she	O
was	O
well	O
into	O
the	O
second	O
trimester	O
of	O
her	O
pregnancy	O
,	O
a	O
shave	O
removal	O
with	O
electrodessication	O
of	O
the	O
base	O
was	O
performed	O
after	O
reflecting	O
the	O
nail	O
plate	O
proximally	O
to	O
expose	O
the	O
lesion	O
.	O

Researchers	O
have	O
studied	O
the	O
relationship	O
between	O
low	O
serum	O
vitamin	O
D	O
concentration	O
and	O
perinatal	O
depression	O
,	O
although	O
no	O
clinical	O
trial	O
has	O
been	O
conducted	O
on	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
depression	O
related	O
to	O
childbirth	O
.	O

We	O
carried	O
out	O
glucose	O
challenge	O
tests	O
(	O
1	O
-	O
h	O
post	O
50	O
g	O
glucose	O
load	O
)	O
for	O
all	O
women	O
in	O
our	O
population	O
,	O
not	O
OGTT	O
as	O
in	O
the	O
above	O
studies	O
.	O

With	O
few	O
exceptions	O
(	O
e	O
.	O
g	O
.,	O
PFOA	O
),	O
median	O
concentrations	O
among	O
HOME	O
Study	O
participants	O
tended	O
to	O
be	O
similar	O
to	O
concentrations	O
observed	O
in	O
US	O
women	O
(	O
Table2	O
).	O

Estimated	O
BMI	O
correlations	O
,	O
employing	O
the	O
mixed	O
models	O
,	O
and	O
adjusting	O
for	O
age	O
,	O
are	O
shown	O
at	O
each	O
time	O
point	O
for	O
the	O
children	O
and	O
across	O
generations	O
are	O
then	O
displayed	O
intable	O
4	O
.	O

However	O
and	O
despite	O
these	O
limitations	O
,	O
there	O
is	O
a	O
wealth	O
of	O
literature	O
using	O
those	O
two	O
cell	O
lines	O
as	O
experimental	O
models	O
to	O
study	O
placental	O
function	O
.	O

This	O
may	O
be	O
explained	O
,	O
in	O
part	O
,	O
by	O
inadequate	O
control	O
of	O
related	O
risk	O
factors	O
and	O
confounders	O
in	O
statistical	O
analyses	O
,	O
variations	O
between	O
assays	O
that	O
measure	O
vitamin	O
D	O
and	O
significant	O
heterogeneity	O
between	O
studied	O
populations	O
[	O
6	O
].	O

Of	O
the	O
infants	O
,	O
367	O
were	O
girls	O
and	O
356	O
boys	O
.	O

Additionally	O
,	O
a	O
main	O
effect	O
of	O
sex	O
was	O
also	O
detected	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
in	O
liver	O
.	O

Sample	O
suspensions	O
were	O
sonicated	O
3	O
×	O
10	O
sec	O
at	O
40	O
%	O
intensity	O
and	O
centrifuged	O
at	O
14	O
,	O
000	O
×	O
g	O
for	O
20	O
min	O
at	O
15	O
°	O
C	O
.	O

Although	O
the	O
explanation	B
for	O
this	O
association	O
is	O
still	O
unknown	O
,	O
studies	O
in	O
the	O
past	O
several	O
years	O
have	O
hinted	O
that	O
insulin	O
resistance	O
may	O
be	O
involved	O
in	O
reduced	O
lactation	O
.	O

The	O
outcome	O
variables	O
include	O
birth	O
outcomes	O
such	O
as	O
birth	O
weight	O
and	O
gestational	O
age	O
as	O
well	O
as	O
postnatal	O
growth	O
and	O
psychomotor	O
development	O
Methods	O
/	O
design	O
Study	O
design	O
This	O
prospective	O
cohort	O
study	O
follows	O
250	O
women	O
throughout	O
pregnancy	O
to	O
birth	O
,	O
and	O
their	O
infants	O
up	O
to	O
12	O
months	O
of	O
age	O
.	O

For	O
patients	O
with	O
local	O
recurrent	O
disease	O
,	O
ultrasound	O
controls	O
by	O
skilled	O
hands	O
is	O
of	O
outmost	O
importance	O
,	O
both	O
to	O
help	O
surgeons	O
in	O
selecting	O
tissues	O
for	O
excision	O
and	O
to	O
perform	O
local	O
therapy	O
,	O
such	O
as	O
alcoholization	O
of	O
small	O
lesions	O
.	O

Discussion	O
In	O
this	O
study	O
,	O
we	O
have	O
identified	O
significant	O
associations	O
between	O
infant	O
growth	O
,	O
in	O
utero	O
exposures	O
,	O
and	O
repetitive	O
element	O
methylation	O
in	O
placental	O
tissue	O
.	O

A	O
similar	O
question	O
was	O
asked	O
for	O
sleep	O
duration	O
before	O
pregnancy	O
.	O

Generally	B
,	O
there	O
is	O
a	O
lack	O
of	O
evidence	O
for	O
maternal	O
pregnancy	O
restriction	O
diets	O
.	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
found	O
to	O
have	O
significantly	O
lower	O
albumin	O
levels	O
than	O
caries	O
-	O
free	O
controls	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
high	O
renin	O
and	O
AT1r	O
expressions	O
observed	O
in	O
the	O
present	O
study	O
.	O

Since	O
having	O
had	O
a	O
previous	O
PTB	O
is	O
a	O
significant	O
risk	O
factor	O
for	O
a	O
recurrent	O
PTB	O
,	O
we	O
also	O
assessed	O
the	O
relationship	O
between	O
PTB	O
and	O
25	O
(	O
OH	O
)	O
D	O
for	O
these	O
women	O
separately	O
.	O

However	O
,	O
the	O
majority	B
of	O
vitamin	O
D	O
supplementation	O
intervention	O
trials	O
in	O
pregnancy	O
have	O
not	O
had	O
a	O
significant	O
impact	O
on	O
maternal	O
and	O
offspring	O
health	O
[	O
10	O
].	O

Conclusions	O
:	O
We	O
found	O
evidence	O
to	O
support	O
an	O
association	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
by	O
trimester	O
of	O
receipt	O
with	O
data	O
from	O
an	O
urban	O
population	O
in	O
Nicaragua	O
.	O

A	O
total	O
of	O
25	O
%	O
of	O
the	O
women	O
had	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
at	O
T3	O
.	O

Four	O
qualitative	O
methods	O
–	O
in	O
-	O
depth	O
interviews	O
(	O
35	O
pregnant	O
women	O
,	O
20	O
older	O
women	O
and	O
11	O
husbands	O
),	O
key	O
informant	O
interviews	O
(	O
20	O
with	O
CHWs	O
,	O
program	O
managers	O
,	O
informal	O
care	O
providers	O
,	O
gynaecologists	O
and	O
traditional	O
birth	O
attendants	O
),	O
focus	O
group	O
discussions	O
(	O
2	O
with	O
Shasthya	O
Shebika	O
and	O
1	O
with	O
female	O
college	O
students	O
)	O
and	O
observations	O
of	O
the	O
lowest	O
level	O
of	O
health	O
facility	O
(	O
community	O
clinics	O
)	O
(	O
2	O
)	O
were	O
conducted	O
.	O

Additionally	O
,	O
there	O
are	O
some	O
data	O
that	O
suggest	O
an	O
increase	O
in	O
fetal	O
malformation	O
and	O
perinatal	O
mortality	O
.	O
7	O
,	O
12	O
–	O
15The	O
above	O
risks	O
can	O
be	O
minimized	O
with	O
good	O
glycemic	O
control	O
and	O
judicious	O
obstetric	O
care	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
study	O
groups	O
in	O
relation	O
to	O
the	O
baseline	O
depression	O
scores	O
(	O
0	O
.	O
74	O
).	O

One	O
key	O
reason	B
we	O
conclude	O
that	O
intrauterine	O
or	O
X	O
-	O
mediated	O
influences	O
are	O
important	O
is	O
because	B
the	O
grandmothers	O
of	O
both	O
lineages	O
,	O
who	O
do	O
not	O
share	O
their	O
grandchildren	O
'	O
s	O
direct	O
daily	O
environment	O
,	O
are	O
each	O
exerting	O
an	O
association	O
.	O

In	O
a	O
nonrandomized	O
study	O
,	O
women	O
with	O
GDM	O
on	O
a	O
diet	O
comprising	O
less	O
than	O
42	O
%	O
carbohydrate	O
,	O
had	O
lower	O
post	O
-	O
prandial	O
glucose	O
levels	O
,	O
were	O
less	O
likely	B
to	O
require	O
insulin	O
,	O
and	O
had	O
a	O
lower	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
.	O
28A	O
small	O
study	O
which	O
randomized	O
pregnant	O
women	O
to	O
low	O
glycemic	O
index	O
(	O
GI	O
)	O
or	O
high	O
GI	O
diets	O
found	O
that	O
the	O
former	O
resulted	O
in	O
lower	O
glucose	O
levels	O
,	O
a	O
blunting	O
of	O
the	O
pregnancy	O
associated	O
rise	O
in	O
insulin	O
resistance	O
,	O
and	O
lower	O
birthweight	O
.	O
29In	O
another	O
study	O
of	O
GI	O
,	O
women	O
assigned	O
to	O
a	O
low	O
GI	O
diet	O
during	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
who	O
were	O
lighter	O
(	O
3408	O
±	O
78	O
g	O
vs	O
3644	O
±	O
90	O
g	O
)	O
and	O
had	O
a	O
lower	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
,	O
compared	O
to	O
women	O
given	O
a	O
high	O
GI	O
diet	O
.	O
30Both	O
diets	O
comprised	O
55	O
%	O
carbohydrate	O
.	O

Intervention	O
Participants	O
assigned	O
to	O
the	O
control	O
condition	O
were	O
excused	O
immediately	O
after	O
completing	O
the	O
baseline	O
survey	O
.	O

Autism	O
,	O
to	O
reiterate	O
,	O
impairs	O
an	O
individual	O
'	O
s	O
ability	O
to	O
use	O
language	O
to	O
effectively	O
communicate	O
and	O
navigate	O
social	O
situations	O
.	O

)—	O
High	O
Frequency	O
in	O
Normalized	O
Units	O
.	O

Such	O
findings	O
,	O
both	O
positive	O
and	O
negative	O
,	O
have	O
been	O
incorporated	O
into	O
UK	O
governmental	O
advice	O
and	O
recommendations	O
(	O
Boyd	O
et	O
al	O
.	O
2013	O
).	O

We	O
adjusted	O
p	O
values	O
for	O
multiple	O
comparisons	O
using	O
the	O
Benjamini	O
and	O
Hochberg	O
method	O
to	O
control	O
the	O
false	O
discovery	O
rate	O
[	O
49	O
].	O

PubMed	O
Central	O
:	O

Associations	O
with	O
25	O
(	O
OH	O
)	O
D	O
following	O
supplementation	O
In	O
women	O
who	O
were	O
randomized	O
to	O
cholecalciferol	O
supplements	O
,	O
the	O
common	O
G	O
allele	O
of	O
rs10741657	O
(	O
CYP2R1	O
)	O
was	O
associated	O
with	O
lower	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
whereas	O
the	O
common	O
A	O
allele	O
of	O
rs2282679	O
(	O
GC	O
)	O
was	O
associated	O
with	O
greater	O
34	O
-	O
week	O
serum	O
25	O
(	O
OH	O
)	O
D	O
(	O
Table	O
3	O
).	O

We	O
also	O
examined	O
pair	O
wise	O
EDC	O
correlation	O
in	O
a	O
heat	O
map	O
(	O
Additional	O
file1	O
:	O
Figure	O
S2	O
).	O

If	O
a	O
woman	O
provided	O
multiple	O
urine	O
or	O
blood	O
samples	O
at	O
both	O
16	O
and	O
26	O
weeks	O
gestation	O
,	O
then	O
the	O
sample	O
concentrations	O
were	O
averaged	O
following	O
log10transformation	O
and	O
treated	O
as	O
continuous	O
variables	O
[	O
34	O
,	O
37	O
].	O

When	O
activated	O
,	O
this	O
protein	O
uncouples	O
mitochondrial	O
respiration	O
from	O
ATP	O
synthesis	O
,	O
resulting	O
in	O
heat	O
production	O
,	O
a	O
process	O
that	O
consumes	O
substantial	O
amounts	O
of	O
fuels	O
.	O

In	O
conclusion	O
,	O
despite	O
that	O
more	O
than	O
60	O
%	O
of	O
the	O
pregnant	O
women	O
reported	O
taking	O
multivitamins	O
containing	O
vitamin	O
D	O
,	O
vitamin	O
D	O
deficiency	O
is	O
highly	O
prevalent	O
among	O
pregnant	O
women	O
in	O
Belgium	O
and	O
up	O
to	O
12	O
%	O
of	O
pregnant	O
women	O
are	O
severely	O
vitamin	O
D	O
deficient	O
.	O

The	O
primary	O
outcome	O
was	O
neonatal	O
bone	O
mass	O
.	O

The	O
mothers	O
of	O
autistic	O
children	O
were	O
studied	O
,	O
and	O
it	O
was	O
demonstrated	O
that	O
the	O
cases	O
with	O
autism	O
had	O
more	O
pregnancy	O
complications	O
.	O

Early	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
extended	O
winter	O
were	O
independently	O
associated	O
with	O
significantly	O
higher	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
(	O
B	O
=	O
0	O
.	O
15	O
and	O
0	O
.	O
13	O
,	O
respectively	O
).	O

Are	O
Attributes	O
of	O
Pregnancy	O
and	O
the	O
Delivery	O
Room	O
Experience	O
Related	O
to	O
Development	O
of	O
Autism	O
?	O

All	O
statistical	O
analyses	O
were	O
carried	O
out	O
using	O
Stata	O
version	O
12	O
.	O
1	O
(	O
StataCorp	O
,	O
College	O
Station	O
,	O
TX	O
,	O
USA	O
).	O

Women	O
who	O
terminated	O
the	O
pregnancy	O
(	O
N	O
=	O
31	O
),	O
were	O
lost	O
to	O
follow	O
-	O
up	O
(	O
N	O
=	O
13	O
)	O
or	O
carried	O
more	O
than	O
one	O
foetus	O
(	O
N	O
=	O
26	O
)	O
were	O
excluded	O
from	O
the	O
present	O
analyses	O
.	O

There	O
were	O
194	O
children	O
who	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
(	O
55	O
%	O
of	O
the	O
original	O
cohort	O
),	O
but	O
blood	O
samples	O
were	O
obtained	O
from	O
133	O
of	O
those	O
children	O
.	O

The	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
this	O
cohort	O
is	O
comparable	O
to	O
several	O
other	O
European	O
populations	O
[	O
58	O
].	O

The	O
Role	O
of	O
Vitamin	O
D	O
in	O
Reproductive	O
Health	O
—	O
A	O
Trojan	O
Horse	O
or	O
the	O
Golden	O
Fleece	O
?	O

The	O
nature	O
of	O
the	O
intervention	O
precludes	O
the	O
masking	O
of	O
the	O
treatments	O
.	O

Outcomes	O
were	O
additionally	O
adjusted	O
for	O
maternal	O
age	O
,	O
socioeconomic	O
status	O
and	O
maternal	O
smoking	O
There	O
were	O
no	O
significant	O
differences	O
between	O
the	O
two	O
treatment	O
groups	O
with	O
regards	O
to	O
infant	O
feeding	O
patterns	O
,	O
with	O
59	O
.	O
80	O
%	O
of	O
infants	O
still	O
being	O
breast	O
fed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
324	O
(	O
59	O
.	O
12	O
%)	O
vs	O
.	O
Standard	O
Care	O
347	O
(	O
60	O
.	O
45	O
%);	O
aRR	O
1	O
.	O
01	O
;	O
95	O
%	O
CI	O
0	O
.	O
97	O
to	O
1	O
.	O
05	O
;	O
p	O
=	O
0	O
.	O
60	O
).	O

The	O
fetus	O
seems	O
to	O
be	O
relatively	O
protected	O
from	O
anaphylaxis	O
perhaps	O
because	O
the	O
placenta	O
does	O
not	O
transmit	O
specific	O
IgE	O
antibodies	O
to	O
the	O
fetus	O
[	O
31	O
].	O

Some	O
investigators	O
,	O
documenting	O
similar	O
positive	O
association	O
between	O
long	O
sleep	O
duration	O
and	O
type	O
2	O
diabetes	O
mellitus	O
speculate	O
that	O
the	O
association	O
may	O
be	O
due	O
in	O
part	O
to	O
residual	O
confounding	O
by	O
undiagnosed	O
health	O
conditions	O
,	O
co	O
-	O
morbid	O
depression	O
,	O
unemployment	O
,	O
or	O
poor	O
general	O
health	O
[	O
1	O
,	O
4	O
].	O

Significant	O
differences	O
were	O
reported	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Data	O
will	O
also	O
be	O
analysed	O
retrospectively	O
in	O
matched	O
-	O
control	O
sub	O
-	O
studies	O
by	O
determining	O
associations	O
between	O
observed	O
outcomes	O
and	O
variables	O
collected	O
at	O
previous	O
time	O
points	O
.	O

Another	O
important	O
need	O
is	O
for	O
standardised	O
methods	O
for	O
diagnosing	O
and	O
treating	O
prematurity	O
-	O
related	O
impairment	O
in	O
childhood	O
and	O
more	O
consistent	O
measures	O
and	O
timing	O
for	O
assessing	O
multi	O
-	O
domain	O
impairments	O
[	O
33	O
,	O
34	O
].	O

However	O
,	O
such	O
management	O
may	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
adverse	O
pregnancy	O
outcomes	O
.	O

The	O
present	O
report	O
is	O
one	O
of	O
the	O
first	O
to	O
compare	O
the	O
pregnancy	O
outcomes	O
of	O
women	O
receiving	O
SGA	O
monotherapy	O
with	O
those	O
receiving	O
SGAs	O
in	O
polytherapy	O
.	O

In	O
this	O
sample	O
there	O
was	O
a	O
high	O
prevalence	O
of	O
:	O
unfavorable	O
pre	O
-	O
pregnancy	O
nutritional	O
status	O
(	O
overweight	O
or	O
obesity	O
),	O
gestational	O
weight	O
gain	O
above	O
recommendations	O
(	O
PPBMI	O
<	O
25	O
kg	O
/	O
m2is	O
associated	O
with	O
greater	O
weight	O
gain	O
compared	O
to	O
obese	O
),	O
family	O
history	O
of	O
diabetes	O
,	O
advanced	O
age	O
(	O
38	O
.	O
2	O
%)	O
and	O
low	O
levels	O
of	O
physical	O
activity	O
(	O
data	O
shown	O
in	O
Figure1	O
).	O

Thus	B
it	O
is	O
possible	O
that	O
longer	O
follow	O
up	O
may	O
be	O
needed	O
to	O
determine	O
significant	O
associations	O
.	O

First	O
,	O
pregnant	O
women	O
were	O
briefed	O
on	O
the	O
study	O
objectives	O
and	O
the	O
confidentiality	O
of	O
maternal	O
and	O
neonatal	O
information	O
,	O
and	O
they	O
then	O
signed	O
informed	O
consents	O
.	O

The	O
pregnant	O
hypotensive	O
patient	O
should	O
be	O
placed	O
on	O
her	O
left	O
side	O
to	O
prevent	O
added	O
positional	O
hypotension	O
resulting	O
from	O
compression	O
of	O
the	O
inferior	O
vena	O
cava	O
by	O
the	O
gravid	O
uterus	O
[	O
37	O
].	O

However	O
,	O
T3	O
25OHD	O
was	O
not	O
significantly	O
associated	O
with	O
preterm	O
delivery	O
.	O

In	O
case	O
venous	O
blood	O
cannot	O
be	O
obtained	O
from	O
the	O
infants	O
,	O
capillary	O
blood	O
is	O
being	O
collected	O
by	O
foot	O
venepuncture	O
.	O

In	O
the	O
nucleus	O
accumbens	O
,	O
dopamine	O
influences	O
the	O
integration	O
of	O
inputs	O
from	O
the	O
ventral	O
hippocampus	O
,	O
the	O
amygdala	O
,	O
and	O
the	O
prefrontal	O
cortex	O
.	O

Along	O
this	O
line	O
,	O
it	O
was	O
recently	O
shown	O
that	O
BAT	O
transplantation	O
into	O
the	O
abdominal	O
cavity	O
of	O
high	O
fat	O
diet	O
-	O
induced	O
obese	O
mice	O
was	O
able	O
to	O
improve	O
their	O
glucose	O
tolerance	O
,	O
increase	O
their	O
insulin	O
sensitivity	O
,	O
lower	O
their	O
body	O
weight	O
,	O
decrease	O
their	O
fat	O
mass	O
and	O
completely	O
reverse	O
their	O
insulin	O
resistance	O
(	O
Stanford	O
et	O
al	O
.,	O
2013	O
).	O

However	O
,	O
cytokines	O
and	O
other	O
soluble	O
inflammation	O
markers	O
are	O
found	O
in	O
breast	O
milk	O
from	O
atopic	O
as	O
well	O
as	O
in	O
nonatopic	O
women	O
.	O

However	O
,	O
the	O
highest	O
impact	O
interventions	O
,	O
notably	O
access	O
to	O
quality	O
intrapartum	O
care	O
and	O
emergency	O
obstetric	O
and	O
newborn	O
care	O
[	O
19	O
],	O
require	O
facility	O
-	O
based	O
services	O
.	O

Methods	O
The	O
cross	O
sectional	O
study	O
was	O
carried	O
out	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
one	O
of	O
the	O
18	O
health	O
districts	O
in	O
the	O
South	O
West	O
Region	O
of	O
Cameroon	O
with	O
an	O
estimated	O
population	O
of	O
86	O
,	O
272	O
inhabitants	O
[	O
9	O
].	O

Previous	O
studies	O
on	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
have	O
reported	O
that	O
while	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
was	O
significantly	O
lower	O
in	O
women	O
with	O
PE	O
,	O
sPTB	O
,	O
GDM	O
and	O
those	O
who	O
delivered	O
a	O
small	O
-	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
infant	O
,	O
no	O
association	O
between	O
vitamin	O
D	O
deficiency	O
and	O
these	O
pregnancy	O
complications	O
was	O
found	O
after	O
adjusting	O
for	O
covariates	O
[	O
18	O
–	O
20	O
].	O

Measurement	O
of	O
caloric	O
intake	O
Food	O
intake	O
was	O
determined	O
by	O
subtracting	O
the	O
amount	O
of	O
food	O
left	O
in	O
the	O
cage	O
from	O
the	O
total	O
amount	O
of	O
food	O
provided	O
.	O

This	O
was	O
also	O
observed	O
in	O
response	O
to	O
irisin	O
,	O
a	O
hormone	O
secreted	O
by	O
skeletal	O
muscles	O
.	O

We	O
are	O
therefore	O
grateful	O
for	O
Prasad	O
’	O
s	O
insights	O
.	O

Written	O
informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

The	O
presence	O
of	O
plug	O
or	O
spermatozoa	O
in	O
the	O
vaginal	O
smear	O
confirmed	O
the	O
successful	O
mating	O
,	O
and	O
this	O
was	O
designated	O
as	O
gestational	O
day	O
0	O
(	O
GD	O
0	O
).	O

Finally	O
,	O
visfatin	O
levels	O
were	O
compared	O
using	O
data	O
from	O
maternal	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Friedman	O
and	O
colleagues	O
developed	O
a	O
model	O
for	O
this	O
disorder	O
in	O
rabbits	O
by	O
administering	O
near	O
-	O
fatal	O
amounts	O
of	O
ergocalciferol	O
during	O
pregnancy	O
.	O

These	O
data	O
point	O
towards	O
an	O
interaction	O
between	O
stress	O
and	O
genetics	O
,	O
since	B
only	O
in	O
the	O
CC	O
polymorphic	O
GR	O
group	O
did	O
negative	O
maternal	O
attitude	O
predict	O
fetal	O
weight	O
reduction	O
,	O
but	O
not	O
in	O
the	O
CT	O
group	O
,	O
independent	O
of	O
confounders	O
.	O

Consequently	B
,	O
the	O
recommendations	O
for	O
primary	O
and	O
secondary	O
preventive	O
measures	O
are	O
also	O
very	O
limited	O
in	O
number	O
and	O
verification	O
.	O

Results	O
Population	O
characteristics	O
.	O

The	O
International	O
Nutritional	O
Anaemia	O
Consultative	O
Group	O
had	O
recommended	O
a	O
daily	O
dose	O
of	O
60	O
mg	O
of	O
iron	O
for	O
pregnant	O
nonanaemic	O
women	O
,	O
if	O
supplementation	O
for	O
more	O
than	O
six	O
months	O
is	O
possible	O
before	O
delivery	O
[	O
27	O
].	O

The	O
ratio	O
of	O
muscle	O
to	O
fat	O
cells	O
varies	O
depending	O
on	O
the	O
amount	O
of	O
IMF	O
deposited	O
.	O

Similarly	O
,	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
1	O
,	O
significantly	O
down	O
-	O
regulated	O
in	O
this	O
study	O
,	O
has	O
been	O
found	O
to	O
be	O
down	O
-	O
regulated	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
in	O
post	O
-	O
mortem	O
schizophrenia	O
brain	O
tissue	O
(	O
thalamus	O
)[	O
48	O
]	O
Like	O
the	O
previous	O
proteomic	O
study	O
[	O
18	O
],	O
we	O
found	O
no	O
alterations	O
in	O
proteins	O
directly	O
associated	O
with	O
DA	O
signaling	O
.	O

We	O
have	O
utilised	O
robust	O
methodology	O
in	O
terms	O
of	O
obtaining	O
accurate	O
measurement	O
of	O
early	O
pregnancy	O
weight	O
,	O
height	O
,	O
and	O
BMI	O
;	O
detailed	O
maternal	O
dietary	O
and	O
physical	O
activity	O
history	O
;	O
and	O
have	O
delivered	O
the	O
antenatal	O
intervention	O
in	O
a	O
consistent	O
manner	O
to	O
participants	O
.	O

Women	O
whose	O
personal	O
weight	O
gain	O
targets	O
are	O
below	O
IOM	O
recommendations	O
are	O
five	O
times	O
more	O
likely	B
to	O
gain	O
less	O
than	O
recommended	O
,	O
and	O
women	O
with	O
targets	O
above	O
the	O
recommendations	O
are	O
six	O
times	O
more	O
likely	B
to	O
gain	O
more	O
than	O
recommended	O
[	O
7	O
].	O

of	O
regulated	O
probe	O
-	O
sets	O
private	O
to	O
AP	O
offspringNo	O
.	O

Circulating	O
Cathelicidin	O
Concentrations	O
in	O
a	O
Cohort	O
of	O
Healthy	O
Children	O
:	O
Influence	O
of	O
Age	O
,	O
Body	O
Composition	O
,	O
Gender	O
and	O
Vitamin	O
D	O
Status	O
Abstract	O
Cathelicidin	O
is	O
an	O
antimicrobial	O
peptide	O
whose	O
circulating	O
levels	O
are	O
related	O
to	O
vitamin	O
D	O
status	O
in	O
adults	O
.	O

Overdose	O
Hypervitaminosis	O
D	O
is	O
a	O
serious	O
,	O
albeit	O
very	O
rare	O
,	O
condition	O
.	O

We	O
compared	O
baseline	O
characteristics	O
and	O
the	O
distribution	O
of	O
our	O
prestated	O
confounders	O
for	O
intervention	O
and	O
placebo	O
groups	O
.	O

Additionally	O
,	O
we	O
identified	O
clusters	O
of	O
infant	O
gut	O
microbiota	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
that	O
differed	O
slightly	O
from	O
those	O
identified	O
in	O
vaginally	O
delivered	O
infants	O
;	O
cluster	O
1	O
was	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
the	O
genus	O
Bifidobacterium	O
,	O
cluster	O
2	O
by	O
high	O
Clostridium	O
and	O
low	O
Streptococcus	O
and	O
Ruminococcus	O
genera	O
,	O
and	O
cluster	O
3	O
by	O
high	O
abundances	O
of	O
the	O
family	O
Enterobacteriaceae	O
,	O
the	O
genus	O
Ruminococcus	O
,	O
and	O
the	O
family	O
Lachnospiraceae	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
,	O
Figure	O
S1	O
).	O

Vitamin	O
D	O
activity	O
pathways	O
in	O
patients	O
with	O
PCOS	O
remain	O
unknown	O
,	O
but	O
cholecalciferol	O
supplementation	O
improves	O
their	O
insulin	O
resistance	O
and	O
the	O
effects	O
of	O
infertility	O
treatment	O
.	O

This	O
results	O
in	O
possible	O
aMED	O
score	O
values	O
from	O
0	O
to	O
7	O
,	O
with	O
a	O
higher	O
score	O
indicating	O
greater	O
adherence	O
to	O
a	O
Mediterranean	O
dietary	O
pattern	O
.	O

The	O
mean	O
age	O
in	O
case	O
and	O
control	O
group	O
was	O
36	O
.	O
62	O
and	O
34	O
.	O
96	O
years	O
,	O
respectively	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Relationship	O
between	O
changes	O
in	O
25	O
(	O
OH	O
)	O
D	O
level	O
during	O
3	O
months	O
of	O
supplementation	O
and	O
change	O
in	O
total	O
body	O
bone	O
mineral	O
content	O
,	O
r	O
=	O
0	O
.	O
17	O
,	O
p	O
=	O
0	O
.	O
30	O
,	O
effect	O
size	O
=	O
0	O
.	O
18	O
.	O

Proteins	O
were	O
extracted	O
in	O
homogenizing	O
buffer	O
with	O
protease	O
inhibitors	O
.	O

More	O
recently	O
,	O
using	O
a	O
genome	O
-	O
wide	O
analysis	O
,	O
NPR3	O
was	O
shown	O
to	O
be	O
associated	O
with	O
overall	O
body	O
height	O
and	O
trunk	O
length	O
in	O
humans	O
(	O
Soranzo	O
et	O
al	O
.	O

Blood	O
Pressure	O
(	O
Figure	O
3	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Systolic	O
blood	O
pressure	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

Among	O
them	O
,	O
107	O
women	O
could	O
not	O
be	O
reached	O
at	O
their	O
last	O
reported	O
contact	O
details	O
,	O
20	O
refused	O
participation	O
and	O
110	O
did	O
not	O
meet	O
the	O
inclusion	O
criteria	O
.	O

In	O
addition	O
to	O
the	O
previously	O
mentioned	O
soluble	O
factors	O
,	O
also	O
cells	O
are	O
transferred	O
in	O
utero	O
,	O
for	O
instance	O
,	O
leukocytes	O
pass	O
from	O
mother	O
to	O
fetus	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
African	O
Americans	O
are	O
two	O
to	O
three	O
times	O
more	O
prone	B
to	O
myomas	O
than	O
European	O
Americans	O
.	O

The	O
associations	O
were	O
J	O
-	O
shaped	O
with	O
the	O
strongest	O
reduced	O
risk	O
for	O
an	O
intermediate	O
intake	O
of	O
fish	O
or	O
PUFA	O
.	O

Funding	O
The	O
time	O
of	O
JEL	O
and	O
MVK	O
was	O
funded	O
by	O
a	O
grant	O
from	O
Bill	O
&	O
Melinda	O
Gates	O
Foundation	O
to	O
Save	O
the	O
Children	O
'	O
s	O
Saving	O
Newborn	O
Lives	O
programme	O
.	O

The	O
second	O
re	O
-	O
programing	O
and	O
programing	O
event	O
involves	O
PGCs	O
only	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
closely	O
associated	O
with	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
).	O

Further	O
study	O
is	O
needed	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
D	O
on	O
MS	O
and	O
QG	O
in	O
beef	O
cattle	O
.	O

In	O
the	O
original	O
paper	O
,	O
we	O
used	O
only	O
self	O
-	O
reported	O
height	O
and	O
weight	O
data	O
for	O
all	O
adults	O
,	O
whereas	O
this	O
time	O
we	O
are	O
reporting	O
examination	O
data	O
for	O
mothers	O
and	O
grandparents	O
.	O

C	O
-	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

This	O
is	O
comparable	O
with	O
the	O
prevalence	O
of	O
Vitamin	O
D	O
deficiency	O
among	O
the	O
general	O
population	O
in	O
Beijing	O
area	O
(	O
LC	O
-	O
MS	O
method	O
,	O
11	O
%	O
if	O
diagnosed	O
with	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
<	O
25	O
nmol	O
/	O
L	O
,	O
or	O
55	O
%	O
if	O
diagnosed	O
with	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
between	O
25	O
and	O
50	O
nmol	O
/	O
L	O
method	O
)	O
[	O
5	O
].	O

Twenty	O
participants	O
(	O
28	O
%)	O
consumed	O
animal	O
organ	O
,	O
four	O
of	O
them	O
consumed	O
animal	O
organ	O
for	O
more	O
twice	O
per	O
week	O
,	O
with	O
an	O
average	O
consumption	O
frequency	O
0	O
.	O
2	O
±	O
0	O
.	O
6	O
times	O
per	O
week	O
.	O

The	O
additive	O
model	O
thus	O
expresses	O
the	O
change	O
in	O
outcome	O
per	O
additional	O
common	O
allele	O
.	O

This	O
was	O
to	O
ascertain	O
calcifediol	O
serum	O
concentrations	O
1	O
week	O
after	O
giving	O
the	O
first	O
dose	O
in	O
the	O
placebo	O
group	O
(	O
a	O
baseline	O
value	O
for	O
the	O
whole	O
population	O
)	O
as	O
well	O
as	O
early	O
concentrations	O
after	O
the	O
first	O
vitamin	O
D	O
supplementation	O
in	O
the	O
intervention	O
group	O
(	O
70	O
in	O
placebo	O
and	O
69	O
in	O
intervention	O
groups	O
).	O

Finally	O
,	O
humans	O
are	O
continuously	O
exposed	O
to	O
a	O
mixture	O
of	O
different	O
environmental	O
factors	O
.	O

country16	O
(	O
13	O
.	O
0	O
)	O
African	O
country3	O
(	O
2	O
.	O
4	O
)	O
Other	O
country2	O
(	O
1	O
.	O
6	O
)	O
Highest	O
education	O
level	O
Eighth	O
grade	O
or	O
below26	O
(	O
21	O
.	O
1	O
)	O
Some	O
HS	O
,	O
no	O
diploma51	O
(	O
41	O
.	O
5	O
)	O
HS	O
diploma	O
/	O
GED28	O
(	O
22	O
.	O
7	O
)	O
Some	O
college	O
,	O
vocational	O
/	O
technical	O
degree13	O
(	O
10	O
.	O
6	O
)	O
Bachelor	O
’	O
s	O
degree	O
or	O
higher5	O
(	O
4	O
.	O
1	O
)	O
Language	O
of	O
preference	O
English29	O
(	O
23	O
.	O
6	O
)	O
Spanish85	O
(	O
69	O
.	O
1	O
)	O
English	O
and	O
Spanish9	O
(	O
7	O
.	O
3	O
)	O
WIC	O
No48	O
(	O
39	O
.	O
3	O
)	O
Yes74	O
(	O
60	O
.	O
7	O
)	O
Expecting	O
Twins	O
No121	O
(	O
98	O
.	O
4	O
)	O
Yes2	O
(	O
1	O
.	O
6	O
)	O
Previous	O
pregnancies	O
042	O
(	O
34	O
.	O
1	O
)	O
134	O
(	O
27	O
.	O
6	O
)	O
224	O
(	O
19	O
.	O
5	O
)	O
316	O
(	O
13	O
.	O
0	O
)	O
44	O
(	O
3	O
.	O
3	O
)	O
52	O
(	O
1	O
.	O
6	O
)	O
60	O
(	O
0	O
)	O
71	O
(	O
0	O
.	O
8	O
)	O
Smoked	O
after	O
pregnancy	O
was	O
confirmed	O
No110	O
(	O
90	O
.	O
2	O
)	O
Yes12	O
(	O
9	O
.	O
8	O
)	O
Consumed	O
alcohol	O
after	O
pregnancy	O
was	O
confirmed	O
No111	O
(	O
91	O
.	O
0	O
)	O
Yes11	O
(	O
9	O
)	O
Taking	O
prenatal	O
vitamins	O
No9	O
(	O
7	O
.	O
3	O
)	O
Yes114	O
(	O
92	O
.	O
7	O
)	O
Currently	O
employed	O
No	O
,	O
by	O
choice17	O
(	O
13	O
.	O
9	O
)	O
No	O
,	O
not	O
by	O
choice56	O
(	O
45	O
.	O
9	O
)	O
Yes	O
,	O
but	O
with	O
an	O
irregular	O
schedule10	O
(	O
8	O
.	O
2	O
)	O
Yes	O
,	O
part	O
time18	O
(	O
14	O
.	O
8	O
)	O
Yes	O
,	O
full	O
time21	O
(	O
17	O
.	O
2	O
)	O
Provider	O
Advice	O
on	O
Gestational	O
Weight	O
Gain	O
Although	O
all	O
of	O
the	O
women	O
had	O
at	O
least	O
one	O
prenatal	O
appointment	O
before	O
completing	O
the	O
baseline	O
survey	O
,	O
only	O
24	O
%	O
reported	O
that	O
their	O
healthcare	O
provider	O
told	O
them	O
how	O
much	O
weight	O
to	O
gain	O
during	O
their	O
pregnancy	O
.	O

Class	O
9	O
,	O
which	O
was	O
associated	O
with	O
AluYb8	O
methylation	O
extent	O
,	O
contained	O
a	O
high	O
proportion	O
of	O
CpG	O
loci	O
located	O
within	O
CGIs	O
(	O
81	O
%)	O
and	O
whose	O
genes	O
are	O
considered	O
PcG	O
target	O
genes	O
(	O
32	O
%).	O

Lindberg	O
et	O
al	O
[	O
37	O
],	O
in	O
their	O
cross	O
sectional	O
study	O
of	O
6	O
,	O
799	O
Swedish	O
women	O
,	O
for	O
instance	O
,	O
reported	O
that	O
self	O
-	O
reported	O
snoring	O
and	O
excessive	O
daytime	O
sleepiness	O
was	O
an	O
independent	O
risk	O
factor	O
for	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
82	O
;	O
95	O
%	O
CI	O
0	O
.	O
97	O
-	O
3	O
.	O
43	O
).	O

For	O
example	O
,	O
after	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
was	O
53	O
%	O
(	O
95	O
%	O
CI	O
,	O
30	O
-	O
69	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
all	O
types	O
of	O
fish	O
and	O
seafood	O
3	O
-	O
4	O
times	O
per	O
week	O
,	O
and	O
55	O
%	O
(	O
95	O
%	O
CI	O
,	O
46	O
-	O
68	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
white	O
fish	O
two	O
times	O
per	O
week	O
,	O
compared	O
to	O
women	O
who	O
never	O
ate	O
fish	O
and	O
seafood	O
or	O
white	O
fish	O
(	O
Figure1	O
).	O

(	O
10	O
)	O
and	O
Didriksen	O
et	O
al	O
.	O

The	O
two	O
hospitals	O
consisted	O
of	O
a	O
private	O
hospital	O
from	O
which	O
most	O
of	O
the	O
Caucasian	O
subjects	O
were	O
recruited	O
(	O
St	O
.	O
Luke	O
'	O
s	O
Episcopal	O
Hospital	O
)	O
and	O
a	O
nearby	O
public	O
hospital	O
(	O
Ben	O
Taub	O
General	O
Hospital	O
)	O
from	O
which	O
nearly	O
all	O
of	O
the	O
Hispanic	O
patients	O
were	O
recruited	O
.	O

Differences	O
between	O
these	O
markers	O
can	O
most	B
likely	B
be	I
explained	O
by	O
the	O
unequal	O
distributions	O
of	O
these	O
sequences	O
throughout	O
the	O
genome	O
,	O
owing	O
in	O
some	O
part	O
to	O
the	O
evolutionary	O
age	O
of	O
these	O
two	O
retrotransposable	O
elements	O
(	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

The	O
extent	O
of	O
absorption	O
is	O
increased	O
in	O
fasting	O
status	O
and	O
decreased	O
if	O
there	O
is	O
inadequate	O
intestinal	O
absorption	O
,	O
often	B
caused	O
by	O
other	O
drugs	O
,	O
such	O
as	O
ferrous	O
sulphate	O
.	O

Commodities	O
,	O
such	O
as	O
antenatal	O
corticosteroids	O
,	O
could	O
reach	O
more	O
women	O
and	O
babies	O
though	O
innovation	O
for	O
example	O
in	O
single	O
-	O
dose	O
syringes	O
or	O
,	O
ideally	O
,	O
needle	O
-	O
free	O
devices	O
[	O
37	O
].	O

Several	O
of	O
these	O
SNPs	O
have	O
been	O
associated	O
with	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
increase	O
in	O
response	O
to	O
vitamin	O
D	O
supplementation	O
in	O
small	O
studies	O
(	O
9	O
–	O
11	O
).	O

For	O
instance	O
,	O
women	O
with	O
asthma	O
or	O
allergic	O
diseases	O
require	O
drug	O
therapy	O
during	O
pregnancy	O
to	O
prevent	O
symptoms	O
severe	O
enough	O
to	O
be	O
life	O
threatening	O
to	O
the	O
mother	O
or	O
the	O
fetus	O
(	O
eg	O
,	O
severe	O
acute	O
asthma	O
that	O
can	O
result	O
in	O
hypoxia	O
).	O

PRECIS	O
:	O
We	O
measured	O
the	O
serum	O
visfatin	O
level	O
in	O
pregnancy	O
,	O
and	O
assess	O
its	O
relationship	O
with	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
,	O
to	O
determine	O
if	O
it	O
can	O
be	O
used	O
as	O
biomarker	O
.	O

The	O
field	O
supervision	O
team	O
will	O
comprise	O
of	O
five	O
Field	O
Research	O
Officers	O
and	O
five	O
District	O
Managers	O
.	O

A	O
high	O
intake	O
ratio	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
favor	O
omega	O
-	O
3	O
fatty	O
acid	O
metabolism	O
.	O

Mid	O
-	O
upper	O
arm	O
circumference	O
(	O
MUAC	O
)	O
was	O
measured	O
at	O
the	O
mid	O
-	O
point	O
of	O
the	O
left	O
arm	O
using	O
standard	O
tapes	O
(	O
TALC	O
,	O
UK	O
).	O

The	O
obtained	O
factors	O
are	O
linear	O
combinations	O
of	O
the	O
included	O
variables	O
,	O
explaining	O
as	O
much	O
variation	O
in	O
the	O
original	O
variables	O
as	O
possible	O
.	O

Also	O
,	O
other	O
study	O
protocol	O
measures	O
for	O
this	O
group	O
were	O
similar	O
to	O
the	O
vitamin	O
D	O
group	O
.	O

For	O
these	O
reasons	B
,	O
total	O
thyroidectomy	O
appears	O
to	O
be	O
the	O
appropriate	O
approach	O
to	O
MTC	O
.	O

The	O
majority	O
of	O
pregnant	O
women	O
are	O
encouraged	O
to	O
healthier	O
dietary	O
changes	O
.	O

The	O
Vitamin	O
D	O
dietary	O
supplements	O
they	O
took	O
included	O
Vitamin	O
D3	O
calcium	O
,	O
multi	O
-	O
Vitamin	O
supplement	O
,	O
most	O
are	O
in	O
the	O
form	O
of	O
Vitamin	O
D3	O
,	O
only	O
4	O
participants	O
took	O
supplements	O
in	O
the	O
form	O
of	O
D2	O
(	O
Forceval	O
,	O
Vitamin	O
D2	O
200	O
IU	O
/	O
pill	O
,	O
once	O
daily	O
).	O

Suboptimal	O
vitamin	O
D	O
status	O
was	O
defined	B
as	B
25	O
(	O
OH	O
)	O
D	O
<	O
80	O
nmol	O
/	O
L	O
,	O
and	O
optimal	O
vitamin	O
D	O
status	O
as	B
25	O
(	O
OH	O
)	O
D	O
≥	O
80	O
nmol	O
/	O
L	O
,	O
as	B
has	O
been	O
suggested	O
based	O
on	O
calcium	O
absorption	O
studies	O
[	O
18	O
].	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
similar	O
in	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

Conclusions	O
The	O
use	O
of	O
SGAs	O
in	O
polytherapy	O
was	O
prevalent	O
in	O
the	O
assessed	O
cohort	O
and	O
was	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
for	O
both	O
the	O
mother	O
and	O
the	O
child	O
.	O

Likewise	O
,	O
metabolic	O
syndromes	O
,	O
hormonal	O
perturbation	O
,	O
reduced	O
sperm	O
quality	O
and	O
increased	O
cancer	O
risks	O
have	O
been	O
associated	O
with	O
chemical	O
and	O
radiation	O
exposures	O
in	O
the	O
survivors	O
of	O
human	O
disasters	O
,	O
including	O
the	O
Seveso	O
dioxin	O
release	O
,	O
the	O
Hiroshima	O
and	O
Nagasaki	O
atomic	O
bombs	O
and	O
the	O
Chernobyl	O
nuclear	O
accident	O
(	O
Warner	O
et	O
al	O
.	O
2011	O
,	O
2013	O
;	O
Foley	O
et	O
al	O
.	O
2015	O
;	O
Kamiya	O
et	O
al	O
.	O
2015	O
).	O

Note	O
:	O
Eight	O
selected	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
indicators	O
,	O
showing	O
median	O
for	O
Countdown	O
priority	O
countries	O
.	O

Conclusions	O
In	O
conclusion	O
,	O
the	O
longitudinal	O
survey	O
of	O
the	O
hepatic	O
transcriptomic	O
response	O
in	O
offspring	O
of	O
dams	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
)	O
at	O
prenatal	O
(	O
94	O
dpc	O
),	O
perinatal	O
(	O
1	O
dpn	O
),	O
juvenile	O
(	O
28	O
dpn	O
),	O
and	O
adult	O
(	O
188	O
dpn	O
)	O
ontogenetic	O
stages	O
revealed	O
acute	O
short	O
-	O
term	O
and	O
delayed	O
long	O
-	O
term	O
modulations	O
.	O

Thus	O
far	O
,	O
studies	O
on	O
delayed	O
introduction	O
of	O
solids	O
led	O
to	O
conflicting	O
results	O
.	O

[	O
5	O
]	O
The	O
above	O
observations	O
highlight	O
the	O
fact	O
that	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
to	O
play	O
in	O
the	O
pathogenesis	O
of	O
wheezing	O
/	O
asthma	O
.	O

1	O
.	O

The	O
mutation	O
in	O
Skm2	O
(	O
S96P	O
)	O
recapitulates	O
the	O
phenotype	O
observed	O
in	O
the	O
knockout	O
mice	O
,	O
suggesting	O
that	O
this	O
residue	O
is	O
critical	O
for	O
the	O
function	O
of	O
FLNB	O
.	O

1	O
Associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
in	O
infants	O
delivered	O
vaginally	O
.	O

A	O
recent	O
study	O
showed	O
that	O
for	O
each	O
hour	O
of	O
television	O
watched	O
,	O
children	O
consumed	O
an	O
extra	O
167	O
kcal	O
/	O
d	O
(	O
89	O
).	O

Pollutants	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
,	O
artificial	O
insemination	O
,	O
and	O
fertility	O
medications	O
may	O
have	O
a	O
link	O
,	O
but	O
results	O
are	O
often	O
conflicted	O
.	O

Taken	O
together	O
,	O
our	O
observations	O
could	O
suggest	O
that	O
the	O
prenatal	O
undernutrition	O
-	O
induced	O
acceleration	O
in	O
pubertal	O
onset	O
observed	O
in	O
the	O
present	O
study	O
may	O
contribute	O
to	O
a	O
significant	O
drive	O
to	O
alter	O
metabolic	O
capacity	O
.	O

GWAS	O
has	O
been	O
used	O
to	O
identify	O
SNPs	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
(	O
8	O
,	O
22	O
).	O

Regarding	O
the	O
birth	O
size	O
,	O
mothers	O
with	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
had	O
heavier	O
newborns	O
than	O
those	O
with	O
suboptimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
010	O
).	O

Mean	O
glucose	O
concentrations	O
1	O
-	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
were	O
16	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
in	O
women	O
who	O
reported	O
sleeping	O
≤	O
4	O
hours	O
(	O
95	O
%	O
CI	O
1	O
.	O
1	O
-	O
31	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
04	O
),	O
2	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
5	O
-	O
8	O
hours	O
(	O
95	O
%	O
CI	O
-	O
1	O
.	O
8	O
-	O
6	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
27	O
),	O
and	O
6	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
≥	O
10	O
hours	O
(	O
95	O
%	O
CI	O
-	O
0	O
.	O
5	O
-	O
13	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
07	O
)	O
compared	O
with	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
.	O

Correlations	O
in	O
the	O
nuclear	O
family	O
were	O
stronger	O
for	O
the	O
girls	O
and	O
there	O
was	O
a	O
borderline	O
significant	O
association	O
of	O
girls	O
with	O
MGM	O
.	O

SIRT	O
Nampt	O
expression	O
increased	O
in	O
both	O
cell	O
models	O
in	O
the	O
course	O
of	O
bone	O
tissue	O
differentiation	O
from	O
multipotent	O
fibroblast	O
and	O
monopotent	O
pre	O
-	O
osteoblast	O
in	O
rats	O
.	O

Early	O
life	O
Early	O
embryo	O
and	O
germ	O
line	O
development	O
can	O
be	O
affected	O
by	O
in	O
utero	O
exposures	O
.	O

Information	O
regarding	O
neonatal	O
intensive	O
care	O
unit	O
(	O
NICU	O
)	O
admissions	O
and	O
neonatal	O
signs	O
after	O
delivery	O
was	O
available	O
for	O
91	O
exposed	O
neonates	O
and	O
116	O
controls	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
11	O
Donors	O
and	O
philanthropic	O
institutions	O
-	O
Helping	O
Babies	O
Breathe	O
as	O
an	O
example	O
of	O
a	O
public	O
-	O
private	O
alliance	O
to	O
save	O
newborns	O
.	O

The	O
mother	O
was	O
correlated	O
with	O
the	O
MGM	O
and	O
with	O
the	O
MGF	O
,	O
while	O
the	O
father	O
was	O
also	O
correlated	O
with	O
his	O
mother	O
and	O
father	O
.	O

Therefore	B
,	O
we	O
hypothesized	O
that	O
the	O
effects	O
of	O
HV	O
gestational	O
diets	O
on	O
obesogenic	O
phenotype	O
in	O
the	O
offspring	O
arise	O
as	B
a	O
consequence	B
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
and	O
these	O
effects	O
could	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
diets	O
.	O

Furthermore	O
,	O
15	O
women	O
(	O
9	O
.	O
8	O
%)	O
had	O
insufficiency	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
20	O
–	O
29	O
ng	O
/	O
mL	O
).	O

Any	O
medication	O
and	O
supplementation	O
use	O
is	O
also	O
recorded	O
daily	O
.	O

Pre	O
-	O
intervention	O
,	O
only	O
one	O
of	O
the	O
91	O
women	O
with	O
GDM	O
seen	O
received	O
≥	O
1	O
dietetic	O
follow	O
-	O
up	O
appointment	O
.	O

Indeed	O
,	O
the	O
higher	O
leptin	O
levels	O
in	O
plasma	O
without	O
reduction	O
in	O
food	O
intake	O
suggest	O
leptin	O
resistance	O
and	O
,	O
therefore	B
,	O
an	O
altered	O
leptin	O
signaling	O
(	O
Friedman	O
and	O
Halaas	O
,	O
1998	O
).	O

In	O
addition	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
increased	O
for	O
women	O
who	O
reported	O
not	O
taking	O
vitamin	O
D	O
containing	O
multivitamins	O
,	O
who	O
were	O
of	O
non	O
Caucasian	O
origin	O
and	O
who	O
reported	O
smoking	O
during	O
pregnancy	O
.	O

This	O
study	O
found	O
an	O
effect	O
of	O
social	O
networks	O
on	O
obesity	O
in	O
adolescents	O
,	O
and	O
the	O
effect	O
was	O
more	O
pronounced	O
among	O
girls	O
and	O
heavier	O
adolescents	O
.	O

1b	O
Operational	O
taxonomic	O
units	O
in	O
the	O
infant	O
gut	O
and	O
maternal	O
dietary	O
factors	O
To	O
investigate	O
the	O
microbial	O
taxa	O
that	O
may	O
drive	O
differences	O
observed	O
above	O
,	O
we	O
measured	O
associations	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
the	O
relative	O
abundance	O
of	O
individual	O
infant	O
stool	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
with	O
linear	O
models	O
adjusted	O
for	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

In	O
recent	O
times	O
,	O
when	O
food	O
has	O
become	O
cheaper	O
and	O
more	O
widely	O
available	O
,	O
excessive	O
WAT	O
storage	O
contributed	O
to	O
the	O
worldwide	O
alarming	O
development	O
of	O
obesity	O
mentioned	O
above	O
(	O
World	O
Health	O
Organization	O
,	O
2009	O
).	O

Patients	O
who	O
took	O
Vitamin	O
D	O
supplements	O
had	O
higher	O
serum	O
level	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
than	O
who	O
did	O
not	O
(	O
74	O
.	O
35	O
±	O
26	O
.	O
13	O
vs	O
60	O
.	O
45	O
±	O
23	O
.	O
63	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
031	O
),	O
and	O
the	O
rates	O
of	O
deficiency	O
were	O
17	O
.	O
9	O
%	O
and	O
35	O
.	O
7	O
%,	O
respectively	O
.	O

Megan	O
Romano	O
,	O
then	O
a	O
postdoctoral	O
research	O
associate	O
at	O
Brown	O
University	O
,	O
looked	O
at	O
336	O
women	O
who	O
gave	O
birth	O
at	O
Cincinnati	O
hospitals	O
.	O

For	O
all	O
women	O
included	O
in	O
the	O
study	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
obtained	O
from	O
weight	O
and	O
height	O
recorded	O
by	O
the	O
gynaecologist	O
during	O
the	O
first	O
prenatal	O
consultation	O
in	O
the	O
beginning	O
of	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

A	O
flow	O
chart	O
of	O
the	O
study	O
is	O
presented	O
inFigure	O
1	O
.	O

This	O
paper	O
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
of	O
current	O
knowledge	O
concerning	O
the	O
role	O
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
.	O

He	O
believes	O
there	O
is	O
far	O
more	O
research	O
that	O
needs	O
to	O
be	O
done	O
to	O
understand	O
the	O
barriers	O
to	O
breastfeeding	O
and	O
why	O
some	O
women	O
have	O
difficulties	O
with	O
lactation	O
.	O

In	O
addition	O
to	O
the	O
increased	O
costs	O
and	O
animal	O
welfare	O
issues	O
associated	O
with	O
housing	O
and	O
monitoring	O
up	O
to	O
the	O
natural	O
death	O
of	O
the	O
animals	O
,	O
there	O
is	O
also	O
the	O
confounding	O
factor	O
of	O
increased	O
background	O
pathology	O
with	O
age	O
.	O

According	O
to	O
Ayurvedic	O
diets	O
,	O
the	O
junk	O
&	O
fast	O
food	O
which	O
is	O
prevalent	O
now	O
is	O
not	O
benificial	O
for	O
mother	O
&	O
fetus	O
is	O
also	O
described	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
case	O
is	O
the	O
first	O
report	O
of	O
AAOC	O
in	O
pregnancy	O
.	O

We	O
observed	O
additional	O
associations	O
between	O
these	O
and	O
other	O
maternal	O
dietary	O
factors	O
and	O
infant	O
stool	O
OTUs	O
,	O
which	O
are	O
presented	O
in	O
the	O
supplementary	O
tables	O
.	O

While	O
a	O
post	O
-	O
weaning	O
high	O
fat	O
diet	O
had	O
the	O
effect	O
of	O
accelerating	O
puberty	O
,	O
this	O
was	O
restricted	O
to	O
only	O
those	O
offspring	O
of	O
control	O
dams	O
or	O
those	O
born	O
to	O
dams	O
that	O
were	O
calorie	O
restricted	O
,	O
and	O
in	O
calorie	O
restricted	O
offspring	O
this	O
effect	O
was	O
relatively	O
small	O
compared	O
to	O
that	O
of	O
early	O
life	O
nutrition	O
.	O

However	O
,	O
a	O
recent	O
multi	O
-	O
centered	O
international	O
case	O
-	O
control	O
study	O
of	O
adult	O
diet	O
and	O
brain	O
tumor	O
risk	O
found	O
no	O
evidence	O
of	O
confounding	O
or	O
effect	O
modification	O
by	O
vitamin	O
supplementation	O
,	O
especially	O
in	O
the	O
association	O
between	O
consumption	O
of	O
cured	O
meats	O
(	O
containing	O
high	O
levels	O
of	O
nitrates	O
)	O
and	O
gliomas	O
[	O
167	O
].	O

This	O
process	O
is	O
active	O
and	O
specific	O
,	O
much	O
like	O
the	O
process	O
of	O
sensitization	O
[	O
119	O
].	O

However	O
,	O
longitudinal	O
studies	O
focussed	O
on	O
diet	O
-	O
dependent	O
alterations	O
of	O
cell	O
cycle	O
regulators	O
are	O
scarce	O
.	O

Dietary	O
habits	O
during	O
the	O
6	O
months	O
preceding	O
the	O
woman	O
'	O
s	O
enrolment	O
in	O
the	O
study	O
were	O
ascertained	O
through	O
a	O
validated	O
FFQ	O
that	O
covered	O
the	O
frequency	O
of	O
consumption	O
and	O
quantity	O
of	O
about	O
eighty	O
food	O
items	O
and	O
beverages	O
[	O
26	O
].	O

There	O
is	O
controversy	O
concerning	O
levels	O
of	O
nutrient	O
intake	O
,	O
and	O
at	O
times	O
the	O
concept	O
that	O
“	O
more	O
is	O
better	O
”	O
emerges	O
.	O

The	O
sample	O
was	O
diverse	O
but	O
self	O
-	O
selected	O
and	O
free	O
of	O
diseases	O
that	O
might	O
contraindicate	O
participation	O
in	O
a	O
lifestyle	O
intervention	O
study	O
;	O
thus	O
,	O
findings	O
may	O
not	O
generalize	O
to	O
the	O
population	O
at	O
large	O
.	O

Search	O
Strategy	O
Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
terms	O
outlined	O
inTable	O
1	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t001_Table	O
1	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Database	O
search	O
strategy	O
.	O
Search	O
termsKeywords	O
searchedBOOLEAN	O
operatorTerm	O
1Pregnant	O
or	O
pregnancyPregnan	O
*	O
ANDTerm	O
2Fish	O
or	O
seafoodFishseafoodORANDTerm	O
3Neurodevelopment	O
or	O
neurodevelopmental	O
or	O
cognition	O
or	O
cognitiveNeurodevelopment	O
*	O
cogniti	O
*	O
OR	O
The	O
Dietitians	O
Association	O
of	O
Australia	O
Process	O
Manual	O
for	O
review	O
of	O
the	O
Australian	O
Dietary	O
Guidelines	O
[	O
15	O
]	O
was	O
the	O
basis	O
for	O
reviewing	O
the	O
articles	O
and	O
guided	O
the	O
concluding	O
evidence	O
statement	O
.	O

However	O
,	O
we	O
chose	O
these	O
for	O
multiple	O
reasons	B
;	O
the	O
HAPO	O
study	O
used	O
similar	O
divisions	O
in	O
countries	O
with	O
a	O
latitude	O
of	O
41	O
.	O
9	O
–	O
43	O
.	O
7	O
°	O
North	O
[	O
7	O
],	O
mean	O
daily	O
temperatures	O
in	O
Ireland	O
are	O
highest	O
during	O
the	O
months	O
May	O
to	O
October	O
[	O
47	O
],	O
and	O
we	O
based	O
these	O
seasons	O
on	O
25OHD	O
concentrations	O
for	O
the	O
month	O
of	O
the	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Fig	O
.	O

To	O
investigate	O
the	O
relationship	O
between	O
repeat	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
methylation	O
,	O
we	O
clustered	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
interrogated	O
on	O
the	O
Infinium	O
HumanMethylation27	O
BeadArray	O
into	O
16	O
methylation	O
classes	O
based	O
on	O
their	O
methylation	O
pattern	O
using	O
an	O
RPMM	O
[	O
for	O
the	O
heat	O
map	O
of	O
the	O
16	O
classes	O
,	O
see	O
Supplemental	O
Material	O
,	O
Figure	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

(	O
2015	O
)*/†	O
Carlin	O
et	O
al	O
.	O

This	O
finding	O
provides	B
further	O
evidence	O
of	O
regulation	O
of	O
GAS5	O
by	O
stress	O
and	O
corroborates	O
initial	O
in	O
vivo	O
data	O
in	O
mice	O
[	O
21	O
].	O

Missing	O
data	O
were	O
imputed	O
and	O
analyses	O
adjusted	O
for	O
maternal	O
early	O
pregnancy	O
BMI	O
,	O
parity	O
,	O
study	O
centre	O
,	O
socioeconomic	O
status	O
,	O
age	O
,	O
and	O
smoking	O
status	O
.	O

DMP	O
exposure	O
was	O
associated	O
with	O
a	O
57	O
g	O
reduction	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
123	O
,	O
10	O
),	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
)).	O

[	O
6	O
]	O
Low	O
dietary	O
calcium	O
intake	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
associated	O
with	O
deleterious	O
effects	O
on	O
bone	O
mineral	O
homeostasis	O
.	O

Pregnant	O
women	O
are	O
famously	O
exhorted	O
to	O
faithfully	O
take	O
their	O
daily	O
prenatal	O
vitamins	O
,	O
which	O
often	O
contain	O
iron	O
and	O
other	O
minerals	O
.	O

Satiety	O
responsiveness	O
,	O
a	O
separate	O
dimension	O
of	O
child	O
intake	O
regulation	O
,	O
has	O
recently	O
been	O
linked	O
to	O
variations	O
in	O
the	O
FTO	O
gene	O
(	O
69	O
),	O
which	O
confers	O
obesity	O
risk	O
and	O
is	O
highly	O
expressed	O
in	O
the	O
hypothalamus	O
,	O
a	O
center	O
of	O
appetite	O
regulation	O
in	O
the	O
brain	O
.	O

Implement	O
•	O
Build	O
capacity	O
at	O
research	O
institutions	O
,	O
especially	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
and	O
train	O
professionals	O
.	O

The	O
latter	O
has	O
been	O
found	O
also	O
among	O
Korean	O
men	O
[	O
51	O
].	O

Accordingly	O
,	O
in	O
human	O
blood	O
samples	O
,	O
Th2	O
cytokines	O
responsible	O
for	O
a	O
predisposition	O
toward	O
allergy	O
were	O
elevated	O
in	O
the	O
neonates	O
only	O
of	O
mothers	O
who	O
had	O
smoked	O
during	O
pregnancy	O
[	O
71	O
].	O

Skin	O
color	O
and	O
modern	O
practices	O
of	O
cosmetic	O
dermatology	O
(	O
sun	O
tan	O
lotions	O
and	O
creams	O
,	O
etc	O
.)	O

In	O
a	O
study	O
in	O
a	O
private	O
center	O
in	O
Brazil	O
,	O
the	O
prevalence	O
of	O
antenatal	O
depression	O
was	O
19	O
.	O
6	O
%	O
with	O
the	O
Beck	O
tool	O
[	O
61	O
].	O

Whether	O
the	O
I384N	O
mutation	O
observed	O
in	O
the	O
Skm1	O
mice	O
correlates	O
to	O
a	O
SNP	O
in	O
human	O
patients	O
with	O
kyphosis	O
or	O
in	O
a	O
subset	O
of	O
individuals	O
with	O
increased	O
torso	O
length	O
remains	O
to	O
be	O
determined	O
.	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
adult	O
females	O
exhibited	O
a	O
reduction	O
in	O
caloric	O
intake	O
compared	O
to	O
CC	O
adult	O
females	O
at	O
days	O
1	O
and	O
2	O
of	O
the	O
test	O
.	O

The	O
activity	O
of	O
glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
,	O
a	O
biomarker	O
for	O
adipogenesis	O
,	O
decreases	O
in	O
bovine	O
preadipocytes	O
cultured	O
with	O
retinol	O
[	O
129	O
].	O

Social	O
networks	O
seem	O
to	O
play	O
a	O
role	O
in	O
the	O
spread	O
of	O
obesity	O
in	O
both	O
adults	O
and	O
adolescents	O
.	O

However	O
,	O
the	O
adult	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
and	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
in	O
liver	O
as	O
well	O
as	O
the	O
NAEs	O
-	O
synthesizing	O
enzyme	O
Napepld	O
in	O
PAT	O
.	O

It	O
cannot	B
be	I
assumed	I
that	O
in	O
a	O
growing	O
child	O
these	O
relationships	O
with	O
family	O
members	O
would	O
remain	O
consistently	O
the	O
same	O
,	O
in	O
that	O
environmental	O
factors	O
would	O
come	O
more	O
into	O
play	O
as	O
the	O
child	O
grows	O
up	O
.	O
29As	O
children	O
grow	O
older	O
in	O
this	O
study	O
,	O
the	O
BMI	O
relationship	O
strengthens	O
,	O
presumably	B
because	B
of	O
shared	O
dietary	O
environments	O
,	O
and	O
to	O
reinforce	O
this	O
,	O
both	O
grandparent	O
couples	O
also	O
have	O
significantly	O
correlated	O
BMI	O
relationships	O
.	O

Interestingly	O
,	O
similar	O
results	O
were	O
obtained	O
by	O
adipose	O
tissue	O
-	O
specific	O
overexpression	O
of	O
PR	O
-	O
domain	O
-	O
containing	O
16	O
(	O
PRDM16	O
)	O
or	O
BMP4	O
in	O
mice	O
.	O

When	O
using	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
,	O
susceptibility	O
to	O
prenatal	O
depression	O
decreases	O
to	O
8	O
.	O
2	O
%.	O

In	O
our	O
study	O
we	O
found	O
that	O
the	O
adjusted	O
relative	O
risk	O
of	O
GDM	O
was	O
highest	O
among	O
overweight	O
mothers	O
who	O
snored	O
during	O
pregnancy	O
(	O
OR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
3	O
)	O
when	O
compared	O
with	O
lean	O
mothers	O
who	O
did	O
not	O
snore	O
.	O

The	O
researchers	O
chose	O
this	O
period	O
as	O
a	O
more	O
accurate	O
reflection	O
of	O
each	O
woman	O
’	O
s	O
typical	O
diet	O
,	O
compared	O
to	O
pregnancy	O
,	O
when	O
diet	O
can	O
vary	O
with	O
the	O
degree	O
of	O
nausea	O
experienced	O
.	O

(	O
2009	O
).	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
guidelines	O
by	O
the	O
Institute	O
of	O
Medicine	O
.	O

Data	O
safety	O
and	O
monitoring	O
board	O
The	O
research	O
team	O
will	O
establish	O
an	O
independent	O
data	O
safety	O
and	O
monitoring	O
board	O
(	O
DSMB	O
)	O
consisting	O
of	O
an	O
independent	O
paediatrician	O
,	O
a	O
clinical	O
trial	O
specialist	O
and	O
a	O
biostatistician	O
.	O

Results	O
were	O
expressed	O
as	O
fold	O
-	O
change	O
by	O
the	O
2	O
−	O
ΔΔCTmethod15and	O
analyzed	O
using	O
ABI	O
DataAssist	O
software	O
version	O
3	O
.	O
0	O
(	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
).	O

Furthermore	O
,	O
there	O
are	O
data	O
supporting	O
that	O
breast	O
-	O
feeding	O
should	O
not	O
be	O
continued	O
beyond	O
9	O
months	O
of	O
age	O
because	O
doing	O
so	O
seems	O
to	O
increase	O
the	O
child	O
'	O
s	O
risk	O
for	O
atopic	O
diseases	O
,	O
such	O
as	O
atopic	O
dermatitis	O
and	O
food	O
hypersensitivity	O
[	O
116	O
].	O

We	O
collected	O
venous	O
blood	O
samples	O
from	O
randomly	O
selected	O
blocks	O
of	O
children	O
on	O
the	O
basis	O
of	O
the	O
assumption	O
that	O
each	O
block	O
had	O
an	O
equal	O
number	O
of	O
children	O
from	O
the	O
vitamin	O
D3and	O
placebo	O
groups	O
.	O

The	O
exclusion	O
of	O
17	O
women	O
with	O
implausible	O
energy	O
intake	O
estimates	O
did	O
not	O
alter	O
the	O
main	O
results	O
nor	O
did	O
exclusion	O
of	O
mothers	O
with	O
diabetes	O
.	O

The	O
frequency	O
-	O
domain	O
components	O
were	O
also	O
evaluated	O
by	O
a	O
2	O
power	O
spectrum	O
.	O

The	O
serum	O
level	O
of	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
intervention	O
group	O
was	O
11	O
.	O
61	O
±	O
6	O
.	O
71	O
(	O
6	O
.	O
06	O
–	O
24	O
.	O
71	O
)	O
nmol	O
/	O
L	O
,	O
however	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
fourteen	O
cases	O
in	O
the	O
control	O
group	O
was	O
too	O
low	O
to	O
be	O
detected	O
with	O
the	O
current	O
technology	O
(	O
Table	O
2	O
).	O

Perinatal	O
risk	O
factors	O
that	O
have	O
a	O
suggested	O
association	O
include	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
,	O
labor	O
induction	O
and	O
augmentation	O
,	O
maternal	O
infection	O
and	O
disease	O
(	O
i	O
.	O
e	O
.,	O
antiphospholipid	O
syndrome	O
),	O
antiepileptic	O
drugs	O
,	O
cocaine	O
use	O
,	O
and	O
oral	O
supplements	O
.	O

Artificial	O
insemination	O
and	O
fertility	O
medications	O
,	O
meconium	O
aspiration	O
syndrome	O
,	O
and	O
birth	O
weight	O
have	O
also	O
all	O
been	O
subjects	O
of	O
focus	O
and	O
the	O
respective	O
association	O
with	O
pregnancy	O
and	O
neurodevelopmental	O
complications	O
such	O
as	O
autism	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
when	O
caloric	O
intake	O
is	O
adjusted	O
to	O
body	O
weight	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
appetite	O
seems	O
more	O
discrete	O
(	O
Lagisz	O
et	O
al	O
.,	O
2014	O
).	O

Of	O
these	O
,	O
423	O
probe	O
-	O
sets	O
showed	O
an	O
increased	O
mRNA	O
expression	O
.	O

[	O
20	O
]	O
and	O
Oken	O
et	O
al	O
.	O

Offspring	O
biometry	O
Body	O
mass	O
(	O
Figures	O
1and2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Body	O
mass	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
at	O
earlier	O
stages	O
of	O
development	O
.	O

Most	O
government	O
drug	O
agencies	O
have	O
not	O
approved	O
their	O
use	O
in	O
pregnancy	O
,	O
and	O
major	O
specialty	O
diabetes	O
organizations	O
recommend	O
that	O
oral	O
agents	O
be	O
ceased	O
if	O
the	O
woman	O
had	O
been	O
taking	O
them	O
pre	O
-	O
pregnancy53	O
–	O
55There	O
have	O
now	O
however	O
,	O
been	O
randomized	O
trials	O
conducted	O
with	O
both	O
glyburide	O
and	O
metformin	O
which	O
have	O
not	O
demonstrated	O
short	O
term	O
harm	O
to	O
the	O
pregnancy	O
.	O

Yearling	O
Brangus	O
×	O
Hereford	O
×	O
Angus	O
steers	O
fed	O
a	O
high	O
grain	O
diet	O
(	O
79	O
%	O
corn	O
)	O
had	O
more	O
growth	O
performance	O
,	O
greater	O
MS	O
,	O
and	O
higher	O
grade	O
meat	O
than	O
did	O
steers	O
fed	O
a	O
forage	O
diet	O
(	O
winter	O
wheat	O
pasture	O
with	O
sorghum	O
-	O
Sudan	O
and	O
Bermuda	O
grass	O
pasture	O
)	O
[	O
117	O
].	O

Women	O
who	O
have	O
a	O
weight	O
gain	O
target	O
that	O
is	O
concordant	O
with	O
IOM	O
recommendation	O
are	O
less	O
likely	B
to	O
have	O
excessive	O
weight	O
gain	O
[	O
4	O
].	O

These	O
CpG	O
rich	O
CGIs	O
are	O
non	O
-	O
randomly	O
distributed	O
throughout	O
the	O
mammalian	O
genome	O
,	O
being	O
predominantly	O
associated	O
with	O
regulatory	O
elements	O
such	O
as	O
promoters	O
(	O
Deaton	O
&	O
Bird2011	O
).	O

2	O
.	O

These	O
analyses	O
used	O
data	O
from	O
UN	O
demographic	O
projections	O
of	O
births	O
[	O
49	O
]	O
and	O
the	O
Child	O
Health	O
Epidemiology	O
Reference	O
Group	O
/	O
World	O
Health	O
Organization	O
neonatal	O
cause	O
of	O
death	O
time	O
series	O
,	O
2000	O
to	O
2010	O
[	O
50	O
].	O

Participants	O
between	O
18	O
and	O
45	O
years	O
old	O
were	O
recruited	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
.	O

2	O
.	O

Statistical	O
analysis	O
of	O
the	O
maternal	O
Tht111	O
I	O
polymorphism	O
has	O
shown	O
an	O
inverse	O
correlation	O
between	O
negative	O
maternal	O
attitude	O
and	O
infant	O
birth	O
weight	O
(	O
r	O
=	O
−	O
0	O
.	O
41	O
,	O
P	O
=	O
0	O
.	O
030	O
),	O
only	O
in	O
Tht111	O
I	O
CC	O
polymorphism	O
subgroup	O
.	O

However	O
,	O
intravenous	O
iron	O
sucrose	O
in	O
particular	O
has	O
been	O
used	O
in	O
several	O
recent	O
studies	O
and	O
might	O
be	O
highly	O
beneficial	O
in	O
refractory	O
patients	O
or	O
those	O
intolerant	O
of	O
oral	O
iron	O
formulations	O
[	O
4	O
].	O

Main	O
outcome	O
measures	O
Maternal	O
,	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
.	O

Additionally	O
,	O
we	O
observed	O
an	O
inverse	O
correlation	O
between	O
BW	O
and	O
systolic	O
BP	O
levels	O
(	O
r	O
=	O
-	O
0	O
.	O
261	O
,	O
P	O
=	O
0	O
.	O
009	O
)	O
(	O
Fig	O
1A	O
).	O

The	O
OGTTs	O
were	O
carried	O
out	O
at	O
24	O
–	O
28	O
weeks	O
’	O
gestation	O
;	O
thus	O
,	O
summer	O
at	O
the	O
time	O
of	O
OGTT	O
would	O
correspond	O
approximately	O
with	O
winter	O
in	O
early	O
pregnancy	O
in	O
our	O
population	O
.	O

These	O
findings	O
suggest	O
that	O
pathways	O
involved	O
in	O
calcium	O
binding	O
and	O
mitochondrial	O
function	O
may	O
underpin	O
the	O
behavioural	O
features	O
associated	O
with	O
this	O
particular	O
animal	O
model	O
of	O
schizophrenia	O
.	O

[	O
6	O
]	O
While	O
treating	O
young	O
infants	O
with	O
acute	O
stridor	O
and	O
or	O
wheeze	O
,	O
it	O
would	O
be	O
prudent	O
to	O
consider	O
hypocalcemia	O
especially	O
when	O
one	O
or	O
several	O
risk	O
factors	O
are	O
present	O
.	O

The	O
worst	O
results	O
were	O
obtained	O
in	O
patients	O
with	O
bioavailable	O
testosterone	O
level	O
below	O
11	O
.	O
6	O
nmol	O
/	O
l	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
these	O
age	O
groups	O
,	O
immature	O
glomeruli	O
were	O
identified	O
as	O
those	O
with	O
a	O
comma	O
-	O
shaped	O
body	O
(	O
when	O
the	O
cells	O
of	O
the	O
proximal	O
pole	O
of	O
the	O
vesicles	O
change	O
their	O
shape	O
and	O
develop	O
a	O
crack	O
)	O
or	O
S	O
-	O
shaped	O
body	O
(	O
when	O
there	O
is	O
a	O
second	O
crack	O
in	O
the	O
distal	O
pole	O
of	O
the	O
comma	O
-	O
shaped	O
body	O
).	O

Stuebe	O
’	O
s	O
research	O
suggests	O
that	O
as	B
many	I
1	O
in	O
8	O
women	O
wean	O
earlier	O
than	O
they	O
want	O
to	O
,	O
despite	O
receiving	O
lactation	O
care	O
.	O
11Yet	O
there	O
are	O
no	O
real	O
tests	O
to	O
measure	O
optimal	O
breast	O
function	O
,	O
she	O
says	O
.	O

Indeed	O
,	O
beta	O
actin	O
did	O
not	O
differ	O
between	O
the	O
SC	O
and	O
VitD	O
-	O
mice	O
(	O
data	O
not	O
shown	O
).	O

Our	O
study	O
compared	O
women	O
who	O
had	O
been	O
in	O
the	O
US	O
for	O
fewer	O
or	O
more	O
than	O
5	O
years	O
.	O

Additional	O
studies	O
are	O
warranted	O
to	O
produce	O
beef	O
with	O
appropriate	O
levels	O
of	O
IMF	O
deposition	O
to	O
satisfy	O
beef	O
quality	O
and	O
taste	O
,	O
support	O
human	O
health	O
,	O
and	O
sustain	O
the	O
animal	O
industry	O
,	O
depending	O
on	O
the	O
situation	O
of	O
each	O
country	O
.	O

A	O
proxy	O
variable	O
was	O
calculated	O
for	O
cumulative	O
influenza	O
exposure	O
using	O
influenza	O
surveillance	O
data	O
from	O
Nicaragua	O
[	O
38	O
].	O

Results	O
Descriptive	O
analysis	O
From	O
July	O
21st	O
through	O
December	O
4th	O
2014	O
,	O
we	O
interviewed	O
and	O
collected	O
surveys	O
on	O
4808	O
post	O
-	O
partum	O
women	O
.	O

Mother	O
’	O
s	O
Milk	O
and	O
the	O
Environment	O
:	O
Might	O
Chemical	O
Exposures	O
Impair	O
Lactation	O
?	O

Marginal	O
sex	O
-	O
specific	O
differences	O
occurred	O
between	O
vitamin	O
D	O
status	O
and	O
GDM	O
:	O
women	O
carrying	O
a	O
female	O
fetus	O
had	O
a	O
56	O
%	O
decreased	O
risk	O
for	O
GDM	O
in	O
those	O
with	O
low	O
-	O
moderate	O
levels	O
of	O
standardised	O
vitamin	O
D	O
(	O
44	O
–	O
63	O
nmol	O
/	O
L	O
)	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
(	O
aRR	O
:	O
0	O
.	O
44	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
),	O
whilst	O
in	O
women	O
carrying	O
a	O
male	O
fetus	O
,	O
a	O
55	O
%	O
decreased	O
risk	O
of	O
GDM	O
was	O
found	O
with	O
high	O
standardised	O
vitamin	O
D	O
when	O
compared	O
to	O
moderately	O
-	O
high	O
vitamin	O
D	O
,	O
but	O
this	O
was	O
not	O
statistically	O
significant	O
(	O
aRR	O
:	O
0	O
.	O
45	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
).	O

Fructose	O
consumption	O
,	O
in	O
the	O
form	O
of	O
high	O
fructose	O
corn	O
syrup	O
(	O
ratio	O
of	O
fructose	O
/	O
glucose	O
60	O
/	O
40	O
%),	O
increased	O
from	O
near	O
0	O
%	O
to	O
near	O
30	O
%	O
of	O
per	O
capita	O
consumption	O
of	O
refined	O
sugars	O
in	O
the	O
USA	O
between	O
1970	O
and	O
2000	O
,	O
whereas	O
the	O
consumption	O
of	O
sucrose	O
and	O
glucose	O
declined	O
or	O
remained	O
constant	O
[	O
3	O
].	O

Measurements	O
of	O
resistance	O
and	O
forced	O
expiration	O
are	O
the	O
most	O
commonly	O
used	O
maneuvers	O
to	O
assess	O
airway	O
function	O
.	O

Conclusion	O
Based	B
on	I
the	O
findings	O
of	O
this	O
study	O
,	O
we	O
conclude	B
that	O
:	O
•	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
be	O
at	O
significantly	O
greater	O
odds	O
of	O
having	O
low	O
vitamin	O
D	O
status	O
compared	O
to	O
their	O
caries	O
-	O
free	O
controls	O
.	O

2011	O
)	O
and	O
found	O
at	O
times	O
good	O
correlation	O
between	O
the	O
two	O
,	O
our	O
results	O
indicate	O
that	O
array	O
-	O
based	O
methylation	O
level	O
may	O
not	O
be	O
a	O
good	O
predictive	O
marker	O
of	O
repetitive	O
element	O
methylation	O
level	O
in	O
human	O
placenta	O
tissue	O
.	O

There	O
were	O
significant	O
decreases	O
in	O
PTB	O
risk	O
for	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
for	O
both	O
white	O
(	O
65	O
%)	O
and	O
non	O
-	O
white	O
women	O
(	O
68	O
%).	O

When	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
were	O
treated	O
with	O
cortisol	O
10	O
nM	O
,	O
100	O
nM	O
,	O
or	O
1000	O
nM	O
,	O
the	O
expression	O
of	O
GAS5	O
was	O
significantly	O
upregulated	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
)	O
compared	O
with	O
their	O
corresponding	O
basal	O
levels	O
(	O
Figure	O
4	O
(	O
a	O
)).	O

Differentiation	O
of	O
adipogenic	O
cells	O
occurs	O
during	O
fetal	O
and	O
postnatal	O
stages	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Baseline	O
and	O
final	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
in	O
38	O
subjects	O
based	O
on	O
initial	O
values	O
above	O
or	O
below	O
20	O
ng	O
/	O
mL	O
.	O

They	O
were	O
followed	O
in	O
the	O
antenatal	O
study	O
clinic	O
at	O
regular	O
intervals	O
until	O
delivery	O
.	O

New	O
findings	O
from	O
the	O
NIEHS	O
-	O
funded	O
Northern	O
California	O
Childhood	O
Leukemia	O
Study	O
(	O
NCCLS	O
)	O
show	O
that	O
the	O
disease	O
may	O
originate	O
even	O
earlier	O
—	O
in	O
the	O
foods	O
a	O
woman	O
eats	O
before	O
she	O
even	O
becomes	O
pregnant	O
.	O

Investigators	O
separately	O
obtained	O
available	O
demographic	O
information	O
from	O
each	O
participant	O
’	O
s	O
medical	O
record	O
.	O

As	B
most	O
women	O
with	O
high	O
vitamin	O
D	O
status	O
were	O
born	O
in	O
Sweden	O
and	O
thus	B
more	O
likely	B
to	O
be	O
familiar	O
with	O
the	O
Swedish	O
health	O
-	O
care	O
system	O
,	O
it	O
is	O
possible	O
that	O
they	O
registered	O
earlier	O
for	O
antenatal	O
care	O
and	O
were	O
more	O
likely	B
to	O
report	O
pregnancy	O
loss	O
.	O

The	O
RNA	O
from	O
the	O
homogenized	O
samples	O
was	O
isolated	O
using	O
Trizol	O
reagent	O
and	O
chloroform	O
extraction	O
by	O
the	O
manufacturer	O
’	O
s	O
protocol	O
(	O
Invitrogen	O
,	O
Grand	O
Island	O
,	O
NY	O
,	O
USA	O
)	O
and	O
quantified	O
by	O
Nanodrop	O
1000	O
.	O

Conclusion	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
have	O
relatively	O
poor	O
nutritional	O
health	O
compared	O
to	O
caries	O
-	O
free	O
controls	O
,	O
and	O
were	O
significantly	O
more	O
likely	B
to	O
have	O
low	O
vitamin	O
D	O
,	O
calcium	O
,	O
and	O
albumin	O
concentrations	O
and	O
elevated	O
PTH	O
levels	O
.	O

In	O
Vietnam	O
,	O
there	O
has	O
been	O
an	O
increasing	O
awareness	O
of	O
nutritional	O
deficiencies	O
and	O
anaemia	O
,	O
particularly	O
in	O
rural	O
populations	O
.	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

We	O
agree	O
that	O
caution	O
is	O
appropriate	O
accordingly	O
in	O
data	O
interpretation	O
as	B
the	O
numbers	O
at	O
age	O
9	O
are	O
smaller	O
.	O

Thus	O
,	O
PPV	O
was	O
61	O
%	O
(	O
75	O
/	O
123	O
)	O
for	O
self	O
-	O
reporting	O
receiving	O
influenza	O
vaccination	O
,	O
and	O
NPV	O
was	O
98	O
%	O
(	O
126	O
/	O
128	O
)	O
for	O
self	O
-	O
reports	O
of	O
being	O
unvaccinated	O
.	O

Similarly	O
,	O
infants	O
on	O
Medicaid	O
,	O
a	O
marker	O
of	O
socioeconomic	O
status	O
,	O
had	O
higher	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
(	O
odds	O
ratio	O
(	O
OR	O
)	O
2	O
.	O
3	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
4	O
,	O
3	O
.	O
8	O
),	O
whereas	O
prenatal	O
vitamin	O
use	O
showed	O
a	O
protective	O
effect	O
(	O
OR	O
0	O
.	O
24	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
09	O
,	O
0	O
.	O
62	O
).	O

In	O
this	O
study	O
,	O
BMI	O
and	O
percent	O
fat	O
were	O
analyzed	O
with	O
cathelicidin	O
concentrations	O
.	O

Infants	O
delivered	O
by	O
Cesarean	O
section	O
are	O
at	O
increased	O
risk	O
of	O
dairy	O
allergies	O
compared	O
to	O
those	O
born	O
vaginally	O
[	O
15	O
,	O
16	O
]	O
and	O
show	O
decreased	O
colonization	O
of	O
milk	O
-	O
digesting	O
bacteria	O
[	O
7	O
,	O
17	O
]	O
including	O
the	O
genus	O
Lactobacillus	O
.	O

Although	O
this	O
study	O
does	O
not	O
indicate	O
an	O
optimal	O
dose	O
,	O
it	O
suggests	O
the	O
need	O
to	O
understand	O
dosage	O
thresholds	O
and	O
delivery	O
methods	O
.	O

The	O
GRS	O
was	O
also	O
negatively	O
associated	O
with	O
the	O
change	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
β	O
=	O
−	O
4	O
.	O
4	O
nmol	O
/	O
L	O
per	O
risk	O
allele	O
;	O
95	O
%	O
CI	O
,	O
−	O
6	O
.	O
6	O
to	O
−	O
2	O
.	O
3	O
nmol	O
/	O
L	O
per	O
risk	O
allele	O
;	O
P	O
<	O
0	O
.	O
001	O
),	O
such	O
that	O
women	O
who	O
had	O
more	O
risk	O
alleles	O
had	O
a	O
smaller	O
increment	O
in	O
25	O
(	O
OH	O
)	O
D	O
.	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
.	O

We	O
will	O
employ	O
a	O
community	O
-	O
based	O
,	O
cluster	O
randomized	O
controlled	O
trial	O
design	O
,	O
in	O
which	O
pregnant	O
women	O
will	O
be	O
randomly	O
allocated	O
to	O
the	O
enhanced	O
iron	O
/	O
folic	O
acid	O
distribution	O
program	O
,	O
or	O
to	O
the	O
current	O
usual	O
programs	O
.	O

[	O
2	O
]	O
Hypocalcemic	O
laryngospasm	O
causing	O
stridor	O
and	O
tetany	O
in	O
a	O
child	O
with	O
renal	O
dysplasia	O
has	O
also	O
been	O
described	O
.	O

So	O
the	O
proteins	O
become	O
incapacitated	O
,”	O
Hudson	O
says	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
family	O
members	O
with	O
recorded	O
height	O
and	O
weight	O
at	O
each	O
of	O
three	O
time	O
points	O
—	O
baseline	O
,	O
years	O
5	O
and	O
9	O
of	O
the	O
index	O
childChildMotherFatherMGMMGFPGMPGFBaseline	O
(	O
N	O
)	O
Self	O
-	O
reported	O
–	O
92329723713813588	O
Measured925	O
––	O
369225223142Year	O
5	O
(	O
N	O
)	O
Self	O
-	O
reported	O
––	O
420	O
––––	O
Measured56854777	O
––––	O
Year	O
9	O
(	O
N	O
)	O
Self	O
-	O
reported	O
–––––––	O
Measured298268553342925	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

This	O
group	O
has	O
a	O
lower	O
rate	O
of	O
Vitamin	O
D	O
deficiency	O
(	O
17	O
.	O
9	O
%),	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
35	O
.	O
7	O
%).	O

Effects	O
of	O
Cortisol	O
on	O
GRs	O
and	O
GAS5	O
In	O
Vitro	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
were	O
treated	O
overnight	O
with	O
cortisol	O
,	O
to	O
mimic	O
moderate	O
and	O
high	O
stress	O
environments	O
in	O
vitro	O
.	O

The	O
formative	O
study	O
also	O
suggested	O
to	O
include	O
culturally	O
sensitive	O
reasons	O
for	O
the	O
use	O
of	O
IFA	O
supplements	O
during	O
pregnancy	O
,	O
improvement	O
of	O
the	O
community	O
health	O
-	O
worker	O
training	O
modules	O
and	O
to	O
standardise	O
messages	O
across	O
all	O
health	O
workers	O
.	O

However	O
,	O
the	O
EPDS	O
has	O
been	O
widely	O
used	O
in	O
screening	O
,	O
not	O
providing	O
a	O
diagnosis	O
,	O
for	O
perinatal	O
depression	O
,	O
it	O
has	O
been	O
reported	O
that	O
its	O
score	O
is	O
highly	O
correlated	O
with	O
physician	O
diagnostic	O
opinion	O
.	O

Conclusions	O
The	O
results	O
suggest	O
that	O
BMI	O
is	O
predominantly	B
associated	O
with	O
the	O
maternal	O
line	O
,	O
possibly	O
either	O
with	O
intrauterine	O
development	O
,	O
or	O
inherited	O
through	O
the	O
X	O
chromosome	O
,	O
or	O
both	O
,	O
while	O
height	O
is	O
a	O
more	O
complex	O
trait	O
with	O
genetic	O
influences	O
of	O
the	O
parents	O
and	O
that	O
of	O
the	O
paternal	O
grandfather	O
predominating	O
.	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

Therefore	B
,	O
there	O
is	O
a	O
need	O
to	O
establish	O
effective	O
and	O
safe	O
doses	O
of	O
supplemental	O
iron	O
with	O
folic	O
acid	O
either	O
as	O
daily	O
or	O
weekly	O
supplementation	O
;	O
this	O
should	O
take	O
into	O
consideration	O
nutritional	O
and	O
haematological	O
status	O
of	O
women	O
in	O
developing	O
countries	O
.	O

These	O
changes	O
include	O
increased	O
total	O
circulatory	O
volume	O
,	O
increased	O
systemic	O
blood	O
pressure	O
,	O
and	O
structural	O
changes	O
in	O
the	O
aortic	O
wall	O
secondary	O
to	O
the	O
hormonal	O
effects	O
of	O
estrogen	O
and	O
progesterone	O
[	O
4	O
].	O

In	O
particular	O
,	O
studies	O
examining	O
the	O
parental	O
and	O
grandparental	O
smoking	O
status	O
have	O
demonstrated	O
an	O
interesting	O
gender	O
-	O
specific	O
association	O
between	O
paternal	O
pre	O
-	O
conception	O
or	O
grandmaternal	O
in	O
utero	O
exposure	O
to	O
cigarette	O
smoke	O
and	O
increased	O
weight	O
-	O
related	O
issues	O
in	O
the	O
subsequent	O
sons	O
and	O
grandsons	O
,	O
but	O
not	O
daughters	O
or	O
granddaughters	O
(	O
Pembrey	O
et	O
al	O
.	O
2014	O
).	O

Bioinformatics	O
was	O
employed	O
as	O
secondary	O
analyses	O
.	O

This	O
further	O
emphasizes	O
the	O
importance	O
of	O
distance	O
as	O
a	O
dominant	O
factor	O
in	O
determining	O
women	O
'	O
s	O
choice	O
of	O
site	O
[	O
19	O
].	O

Methods	O
Male	O
offspring	O
of	O
dams	O
fed	O
HV	O
diet	O
during	O
pregnancy	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
were	O
compared	O
to	O
those	O
born	O
to	O
RV	O
dams	O
and	O
weaned	O
to	O
RV	O
diet	O
for	O
29	O
weeks	O
.	O

At	O
PND	O
22	O
–	O
23	O
,	O
offspring	O
were	O
weaned	O
,	O
housed	O
in	O
groups	O
(	O
2	O
–	O
3	O
rats	O
/	O
cage	O
)	O
according	O
to	O
the	O
litter	O
and	O
fed	O
ad	O
libitum	O
with	O
the	O
same	O
standard	O
chow	O
.	O

Outcome	O
assessment	O
Binary	O
variables	O
Current	O
doctor	O
-	O
diagnosed	O
asthma	O
was	O
defined	O
in	O
children	O
at	O
age	O
7	O
.	O
5	O
years	O
(	O
primary	O
outcome	O
)	O
if	O
mothers	O
responded	O
positively	O
to	O
the	O
question	O
“	O
Has	O
a	O
doctor	O
ever	O
actually	O
said	O
that	O
your	O
study	O
child	O
has	O
asthma	O
?”	O
and	O
to	O
one	O
or	O
both	O
of	O
the	O
questions	O
“	O
Has	O
your	O
child	O
had	O
any	O
of	O
the	O
following	O
in	O
the	O
past	O
12	O
months	O
:	O
wheezing	O
with	O
whistling	O
;	O
asthma	O
?”	O
Current	O
wheezing	O
,	O
eczema	O
and	O
hay	O
fever	O
in	O
children	O
at	O
age	O
7	O
.	O
5	O
years	O
were	O
defined	O
by	O
a	O
positive	O
answer	O
to	O
the	O
question	O
:	O
“	O
Has	O
your	O
child	O
had	O
any	O
of	O
the	O
following	O
in	O
the	O
past	O
12	O
months	O
:	O
wheezing	O
with	O
whistling	O
;	O
eczema	O
;	O
hay	O
fever	O
?”	O
Atopy	O
at	O
age	O
7	O
years	O
was	O
defined	O
as	O
a	O
positive	O
reaction	O
(	O
maximum	O
diameter	O
of	O
any	O
detectable	O
weal	O
)	O
to	O
Dermatophagoidespteronyssinus	O
,	O
cat	O
or	O
grass	O
(	O
after	O
subtracting	O
positive	O
saline	O
reactions	O
from	O
histamine	O
and	O
allergen	O
weals	O
,	O
and	O
excluding	O
children	O
unreactive	O
to	O
1	O
%	O
histamine	O
).	O

More	O
than	O
20	O
%	O
of	O
the	O
women	O
in	O
the	O
sample	O
were	O
from	O
non	O
-	O
Caucasian	O
origin	O
.	O

Discussion	O
We	O
found	O
that	O
higher	O
vitamin	O
D	O
status	O
among	O
women	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
was	O
associated	O
with	O
lower	O
probability	O
of	O
SGA	O
and	O
LBW	O
.	O

2004	O
;	O
Simon	O
and	O
Kingston	O
2009	O
).	O

(	O
Arrows	O
between	O
boxes	O
show	O
direction	O
of	O
the	O
comparison	O
;	O
small	O
arrows	O
indicate	O
up	O
and	O
down	O
regulation	O
,	O
respectively	O
).	O

Second	O
,	O
the	O
distribution	O
of	O
Bcl	O
I	O
polymorphism	O
seen	O
in	O
this	O
sample	O
may	O
be	O
unique	O
,	O
since	B
there	O
are	O
important	O
geographical	O
/	O
ethnic	O
differences	O
in	O
the	O
prevalence	O
of	O
these	O
polymorphisms	O
.	O

In	O
contrast	O
to	O
BMI	O
,	O
height	O
correlation	O
estimates	O
between	O
the	O
offspring	O
and	O
the	O
mother	O
are	O
quite	O
similar	O
to	O
those	O
between	O
the	O
offspring	O
and	O
the	O
father	O
for	O
each	O
of	O
the	O
three	O
child	O
ages	O
and	O
each	O
generation	O
.	O

Prophylaxis	O
Iron	O
Supplements	O
The	O
high	O
physiological	O
requirement	O
for	O
iron	O
in	O
pregnancy	O
is	O
difficult	O
to	O
meet	O
with	O
most	O
diets	O
;	O
this	O
is	O
so	O
especially	O
in	O
developing	O
countries	O
where	O
food	O
requirement	O
is	O
a	O
problem	O
.	O

However	O
,	O
there	O
may	O
have	O
been	O
some	O
recall	O
bias	O
and	O
head	O
circumference	O
could	O
only	O
be	O
measured	O
on	O
the	O
first	O
year	O
of	O
life	O
all	O
within	O
a	O
modest	O
sample	O
size	O
,	O
indicating	O
a	O
need	O
for	O
replicating	O
the	O
study	O
in	O
a	O
larger	O
cohort	O
[	O
45	O
].	O

A	O
limitation	O
of	O
this	O
study	O
is	O
that	O
information	O
on	O
pregnancy	O
loss	O
,	O
except	O
IUFD	O
,	O
was	O
self	O
-	O
reported	O
.	O

[	O
17	O
]	O
demonstrated	O
that	O
83	O
.	O
3	O
%	O
of	O
pregnant	O
Thai	O
women	O
,	O
especially	O
in	O
the	O
1st	O
trimester	O
of	O
pregnancy	O
,	O
had	O
vitamin	O
D	O
insufficiency	O
but	O
without	O
association	O
with	O
adverse	O
pregnancy	O
outcomes	O
such	O
as	O
spontaneous	O
abortion	O
,	O
gestational	O
diabetes	O
,	O
cesarean	O
section	O
rate	O
and	O
preterm	O
labor	O
.	O

Food	O
intake	O
over	O
72	O
hours	O
and	O
body	O
weight	O
were	O
measured	O
bi	O
-	O
weekly	O
and	O
weekly	O
,	O
respectively	O
.	O

Based	B
on	I
maternal	O
colostrum	O
visfatin	O
levels	O
,	O
the	O
aurors	O
were	O
able	O
to	O
predict	O
neonatal	O
weight	O
loss	O
in	O
the	O
first	O
three	O
days	O
of	O
birth	O
(	O
25	O
,	O
26	O
).	O

These	O
data	O
also	O
further	O
the	O
hypothesis	O
that	O
the	O
intrauterine	O
environment	O
acting	O
through	O
epigenetic	O
alteration	O
of	O
the	O
placenta	O
is	O
a	O
key	O
mechanism	O
to	O
explain	O
the	O
developmental	O
origins	O
of	O
health	O
and	O
disease	O
and	O
suggest	O
that	O
enhanced	O
examinations	O
of	O
the	O
importance	O
of	O
placental	O
epigenetic	O
variation	O
in	O
health	O
outcomes	O
should	O
be	O
undertaken	O
.	O

After	O
delivery	O
,	O
study	O
personnel	O
abstracted	O
data	O
from	O
participants	O
'	O
hospital	O
labor	O
and	O
delivery	O
medical	O
records	O
and	O
clinic	O
records	O
.	O

Increased	O
age	O
and	O
male	O
gender	O
were	O
correlated	O
with	O
increased	O
cathelicidin	O
when	O
controlling	O
for	O
race	O
/	O
ethnicity	O
,	O
percent	O
fat	O
,	O
and	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
p	O
=	O
0	O
.	O
028	O
&	O
p	O
=	O
0	O
.	O
047	O
,	O
respectively	O
).	O

Children	O
were	O
assessed	O
using	O
the	O
dmft	O
index	O
(	O
a	O
cumulative	O
score	O
of	O
decayed	O
,	O
missing	O
,	O
filled	O
primary	O
teeth	O
).	O

Different	O
factors	O
can	O
partially	O
explain	B
the	O
discrepancies	O
found	O
in	O
food	O
preferences	O
.	O

For	O
those	O
with	O
≥	O
2	O
measurements	O
and	O
initial	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
40	O
ng	O
/	O
mL	O
at	O
20	O
weeks	O
or	O
earlier	O
(	O
N	O
=	O
344	O
),	O
the	O
PTB	O
rate	O
was	O
60	O
%	O
(	O
95	O
%	O
CI	O
=	O
20	O
–	O
80	O
%,	O
p	O
=	O
0	O
.	O
006	O
)	O
lower	O
for	O
those	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
compared	O
to	O
those	O
who	O
did	O
not	O
raise	O
their	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
to	O
the	O
target	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
(	O
6	O
%	O
and	O
16	O
%	O
respectively	O
,	O
AAR	O
=	O
9	O
.	O
6	O
%;	O
NNT	O
=	O
10	O
)	O
(	O
Fig	O
4	O
).	O

Of	O
these	O
,	O
267	O
provided	O
blood	O
and	O
urine	O
samples	O
so	O
the	O
researchers	O
could	O
look	O
for	O
markers	O
of	O
biological	O
damage	O
.	O
23The	O
average	O
age	O
of	O
study	O
participants	O
was	O
51	O
.	O
5	O
years	O
.	O

Linear	O
models	O
indicated	O
a	O
positive	O
association	O
of	O
maternal	O
dairy	O
intake	O
with	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
and	O
the	O
species	O
Escherichia	O
coli	O
and	O
negative	O
association	O
with	O
the	O
OTUs	O
that	O
belong	O
to	O
the	O
genera	O
Bifidobacterium	O
,	O
Pseudomonas	O
,	O
and	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5b	O
).	O

These	O
results	O
are	O
similar	O
to	O
other	O
studies	O
of	O
patient	O
satisfaction	O
;	O
(	O
96	O
.	O
5	O
%)	O
in	O
Ibadan	O
,	O
Nigeria	O
[	O
7	O
]	O
and	O
86	O
.	O
4	O
%	O
in	O
Ogun	O
State	O
,	O
Nigeria	O
[	O
25	O
].	O

Furthermore	O
,	O
in	O
the	O
year	O
2013	O
,	O
around	O
8	O
.	O
48	O
crore	O
children	O
and	O
1	O
.	O
9	O
crore	O
mothers	O
have	O
utilized	O
the	O
benefit	O
of	O
supplemental	O
nutrition	O
services	O
(	O
2	O
).	O

Data	O
were	O
double	O
entered	O
into	O
the	O
MRC	O
Keneba	O
database	O
(	O
MS	O
Access	O
,	O
Microsoft	O
,	O
USA	O
).	O

These	O
associations	O
were	O
not	O
confounded	O
by	O
intake	O
of	O
sugar	O
in	O
early	O
childhood	O
,	O
which	O
was	O
unrelated	O
to	O
these	O
outcomes	O
.	O

The	O
intersection	O
of	O
commonly	O
regulated	O
genes	O
between	O
those	O
comparisons	O
was	O
discarded	O
because	O
regulation	O
of	O
these	O
genes	O
was	O
likely	B
due	O
to	O
physiologically	O
developmental	O
processes	O
.	O

'	O
s	O
meta	O
-	O
analysis	O
of	O
nine	O
studies	O
on	O
this	O
subject	O
,	O
five	O
have	O
neutral	O
results	O
,	O
only	O
three	O
have	O
positive	O
association	O
,	O
and	O
one	O
has	O
negative	O
association	O
[	O
57	O
].	O

Term	O
birth	O
is	O
≥	O
37	O
weeks	O
of	O
gestation	O
,	O
late	O
preterm	O
birth	O
is	O
34	O
to	O
<	O
37	O
weeks	O
,	O
moderately	O
preterm	O
is	O
32	O
to	O
<	O
34	O
weeks	O
,	O
and	O
very	O
preterm	O
is	O
<	O
32	O
weeks	O
.	O

A	O
total	O
of	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
two	O
groups	O
of	O
placebo	O
and	O
vitamin	O
D	O
through	O
block	O
randomization	O
design	O
.	O

Iron	O
-	O
deficiency	O
anaemia	O
,	O
the	O
late	O
manifestation	O
of	O
chronic	O
iron	O
deficiency	O
,	O
is	O
thought	O
to	O
be	O
the	O
most	O
common	O
nutrient	O
deficiency	O
among	O
pregnant	O
women	O
[	O
10	O
].	O

Forty	O
patients	O
evaluated	O
at	O
two	O
visits	O
showed	O
an	O
increase	O
of	O
24	O
.	O
0	O
ng	O
/	O
mL	O
in	O
cathelicidin	O
from	O
the	O
first	O
visit	O
to	O
the	O
next	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

Evidence	O
that	O
treatment	O
of	O
gestational	O
diabetes	O
improves	O
pregnancy	O
outcomes	O
The	O
strongest	O
evidence	O
that	O
treatment	O
of	O
GDM	O
is	O
of	O
benefit	O
comes	O
from	O
the	O
Australian	O
Carbohydrate	O
Intolerance	O
Study	O
(	O
ACHOIS	O
)	O
in	O
Pregnant	O
Women	O
.	O
82In	O
this	O
randomized	O
controlled	O
trial	O
,	O
1000	O
women	O
fulfilling	O
the	O
1985	O
WHO	O
criteria	O
for	O
“	O
gestational	O
glucose	O
intolerance	O
”	O
were	O
recruited	O
.	O

For	O
sustainable	O
effect	O
,	O
interventions	O
to	O
prevent	O
preterm	O
birth	O
in	O
the	O
preconception	O
and	O
antenatal	O
periods	O
and	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
must	O
be	O
integrated	O
within	O
the	O
existing	O
health	O
system	O
.	O

Of	O
4	O
reports	O
of	O
PG	O
with	O
ossification	O
,	O
only	O
one	O
commented	O
on	O
the	O
lobular	O
vascularity	O
.	O
5	O
,	O
6	O
,	O
7	O
,	O
8Kim	O
et	O
al5describes	O
PG	O
with	O
ossification	O
as	O
lobular	O
proliferation	O
of	O
capillaries	O
with	O
spicules	O
of	O
spongy	O
bone	O
with	O
osteocytelike	O
and	O
osteoblastlike	O
cells	O
.	O

A	O
maternal	O
diet	O
high	O
in	O
fat	O
also	O
causes	O
long	O
-	O
term	O
harm	O
to	O
the	O
offspring	O
.	O

On	O
average	O
,	O
Australian	O
women	O
are	O
consuming	O
33	O
g	O
of	O
fish	O
per	O
day	O
and	O
pregnant	O
women	O
an	O
average	O
of	O
28	O
g	O
of	O
fish	O
per	O
day	O
,	O
below	O
Food	O
Standards	O
Australia	O
New	O
Zealand	O
(	O
FSANZ	O
)	O
recommended	O
intakes	O
[	O
8	O
].	O

Environmentally	O
induced	O
epigenetic	O
changes	O
during	O
the	O
vital	O
first	O
developmental	O
re	O
-	O
programing	O
and	O
programing	O
event	O
could	O
result	O
in	O
incorrect	O
erasure	O
and	O
/	O
or	O
re	O
-	O
establishment	O
of	O
the	O
embryo	O
epigenome	O
.	O

Discussion	O
Normal	O
Vitamin	O
D	O
level	O
is	O
one	O
of	O
the	O
nutritional	O
management	O
goals	O
for	O
women	O
with	O
GDM	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
ECS	O
gene	O
expression	O
in	O
hypothalamus	O
,	O
liver	O
,	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
ECS	O
components	O
(	O
Cnr1	O
,	O
Cnr2	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
was	O
evaluated	O
in	O
the	O
hypothalamus	O
,	O
the	O
liver	O
and	O
the	O
PAT	O
of	O
male	O
and	O
female	O
offspring	O
from	O
rat	O
dams	O
which	O
were	O
exposed	O
to	O
an	O
ad	O
libitum	O
access	O
of	O
a	O
standard	O
chow	O
(	O
CC	O
)	O
or	O
a	O
20	O
%-	O
restricted	O
access	O
of	O
the	O
same	O
standard	O
chow	O
(	O
RC	O
)	O
during	O
pregestational	O
(	O
2	O
weeks	O
)	O
and	O
gestational	O
periods	O
(	O
Figure4	O
).	O

Male	O
Infertility	O
Factor	O
Should	O
males	O
visiting	O
infertility	O
clinics	O
be	O
treated	O
with	O
VD	O
preparations	O
?	O

The	O
mRNA	O
expression	O
levels	O
of	O
genes	O
associated	O
with	O
metabolic	O
processing	O
of	O
ketones	O
,	O
fatty	O
acids	O
,	O
bile	O
acids	O
,	O
and	O
hydrophobic	O
amino	O
acids	O
(	O
Val	O
,	O
Ile	O
,	O
Leu	O
)	O
as	O
well	O
as	O
'	O
mTOR	O
signaling	O
',	O
'	O
VEGF	O
signaling	O
',	O
and	O
'	O
glucocorticoid	O
receptor	O
signaling	O
',	O
were	O
increased	O
in	O
LP	O
offspring	O
at	O
stage	O
188	O
dpn	O
,	O
whereas	O
'	O
biosynthesis	O
of	O
steroids	O
'	O
was	O
found	O
to	O
be	O
diminished	O
.	O

Sample	O
Size	O
Estimation	O
When	O
this	O
study	O
was	O
being	O
planned	O
,	O
we	O
were	O
not	O
aware	O
of	O
data	O
describing	O
the	O
observed	O
frequency	O
of	O
hand	O
cleansing	O
before	O
cord	O
cleansing	O
.	O

In	O
children	O
,	O
serum	O
calcifediol	O
concentrations	O
should	O
be	O
maintained	O
at	O
50	O
nmol	O
/	O
L	O
(	O
20	O
ng	O
/	O
mL	O
)	O
or	O
greater	O
for	O
skeletal	O
benefits	O
.	O
6Vitamin	O
D	O
deficiency	O
rickets	O
in	O
children	O
younger	O
than	O
5	O
years	O
is	O
an	O
endemic	O
problem	O
in	O
developing	O
countries	O
,	O
ranging	O
from	O
5	O
–	O
45	O
%,	O
even	O
where	O
sunlight	O
is	O
abundant	O
,	O
1	O
,	O
2	O
,	O
7	O
,	O
8and	O
has	O
also	O
re	O
-	O
emerged	O
in	O
some	O
developed	O
countries	O
.	O
7	O
,	O
9	O
In	O
people	O
,	O
the	O
main	O
source	O
of	O
vitamin	O
D	O
is	O
through	O
the	O
action	O
of	O
ultraviolet	O
B	O
radiation	O
on	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
,	O
with	O
small	O
amounts	O
derived	O
from	O
dietary	O
sources	O
.	O

Only	O
AluYb8	O
methylation	O
levels	O
differed	O
by	O
infant	O
sex	O
(	O
p	O
=	O
0	O
.	O
04	O
),	O
with	O
male	O
infants	O
having	O
slightly	O
higher	O
mean	O
AluYb8	O
methylation	O
(	O
mean	O
±	O
SD	O
=	O
65	O
.	O
3	O
±	O
3	O
.	O
3	O
)	O
than	O
did	O
female	O
infants	O
(	O
64	O
.	O
6	O
±	O
3	O
.	O
3	O
).	O

The	O
study	O
nurses	O
obtain	O
maternal	O
weight	O
before	O
birth	O
with	O
a	O
calibrated	O
digital	O
scale	O
.	O

Acetate	O
or	O
glucose	O
is	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
[	O
85	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Percentage	O
of	O
respondents	O
attending	O
a	O
particular	O
health	O
centre	O
with	O
respect	O
to	O
their	O
health	O
area	O
of	O
origin	O
The	O
respondents	O
’	O
reasons	O
for	O
attending	O
ANC	O
at	O
their	O
respective	O
health	O
centreswere	O
accessibility	O
,	O
recommendation	O
from	O
colleague	O
or	O
friend	O
,	O
cleanliness	O
of	O
centre	O
and	O
presence	O
of	O
a	O
doctor	O
amongst	O
others	O
(	O
Figure	O
2	O
).	O
Out	O
of	O
the	O
228	O
respondents	O
attending	O
subsequent	O
ANC	O
visits	O
(	O
2	O
or	O
more	O
),	O
127	O
,	O
(	O
55	O
.	O
2	O
%)	O
of	O
them	O
changed	O
their	O
initial	O
site	O
of	O
ANC	O
visit	O
.	O

Their	O
work	O
turned	O
up	O
mixed	O
results	O
,	O
which	O
are	O
hard	O
to	O
compare	O
due	O
to	O
differences	O
in	O
study	O
design	O
,	O
such	O
as	O
the	O
timing	O
of	O
sample	O
collection	O
.	O

However	O
,	O
because	O
of	O
the	O
low	O
numbers	O
of	O
an	O
allergic	O
outcome	O
associated	O
to	O
cesarean	O
delivery	O
(	O
only	O
1	O
%-	O
4	O
%),	O
the	O
authors	O
concluded	O
that	O
the	O
epidemic	O
increase	O
of	O
allergic	O
diseases	O
might	O
not	O
be	O
attributable	O
to	O
the	O
increased	O
numbers	O
of	O
cesarean	O
delivery	O
.	O

When	O
looking	O
at	O
each	O
repetitive	O
element	O
methylation	O
marker	O
grouped	O
by	O
various	O
in	O
utero	O
exposures	O
,	O
we	O
found	O
that	O
mean	O
AluYb8	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
tobacco	O
use	O
during	O
pregnancy	O
,	O
similar	O
to	O
results	O
from	O
another	O
group	O
that	O
found	O
significantly	O
different	O
levels	O
of	O
cytosine	O
methylation	O
by	O
smoking	O
status	O
(	O
Moore	O
et	O
al	O
.	O

Therefore	B
,	O
the	O
participants	O
’	O
honesty	O
was	O
one	O
of	O
this	O
research	O
limits	O
.	O

Several	O
small	O
studies	O
have	O
examined	O
whether	O
regular	O
exercise	O
is	O
also	O
beneficial	O
in	O
the	O
management	O
of	O
GDM	O
Jovanavic	O
-	O
Petersen	O
randomized	O
19	O
women	O
with	O
GDM	O
to	O
a	O
regime	O
of	O
diet	O
alone	O
,	O
or	O
diet	O
with	O
20	O
minutes	O
of	O
supervised	O
aerobic	O
training	O
three	O
days	O
per	O
week	O
for	O
six	O
weeks	O
.	O
31This	O
modest	O
amount	O
of	O
physical	O
activity	O
resulted	O
in	O
lower	O
fasting	O
glucose	O
levels	O
,	O
lower	O
glucose	O
responses	O
to	O
a	O
glucose	O
challenge	O
,	O
and	O
a	O
lower	O
HbA1c	O
.	O

Birth	O
weight	O
is	O
an	O
independent	O
predictor	O
of	O
the	O
development	O
of	O
obesity	O
;	O
however	O
,	O
increases	O
in	O
weight	O
during	O
the	O
first	O
3	O
–	O
6	O
months	O
of	O
life	O
are	O
also	O
influential	O
on	O
long	O
-	O
term	O
increased	O
risk	O
of	O
obesity	O
[	O
47	O
,	O
48	O
].	O

Among	O
253	O
women	O
enrolled	O
,	O
intervention	O
households	O
were	O
between	O
5	O
.	O
7	O
and	O
15	O
.	O
2	O
times	O
as	O
likely	B
as	O
control	O
households	O
to	O
have	O
soap	O
and	O
water	O
present	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
.	O

We	O
also	O
hypothesised	O
that	O
the	O
early	O
start	O
to	O
IFA	O
supplements	O
would	O
not	O
increase	O
iron	O
-	O
related	O
side	O
effects	O
,	O
e	O
.	O
g	O
.	O

Iron	O
deficiency	O
is	O
not	O
only	O
the	O
most	O
prevalent	O
but	O
also	O
the	O
most	O
neglected	O
nutrient	O
deficiency	O
in	O
the	O
world	O
,	O
particularly	O
among	O
pregnant	O
women	O
and	O
children	O
in	O
developing	O
countries	O
[	O
7	O
].	O

Epigenetics	O
and	O
the	O
mammalian	O
life	O
cycle	O
.	O

Conclusion	O
About	O
one	O
third	O
of	O
pregnant	O
women	O
in	O
our	O
study	O
population	O
attended	O
an	O
ANC	O
site	O
different	O
from	O
their	O
local	O
catchment	O
area	O
despite	O
the	O
availability	O
of	O
ANC	O
in	O
their	O
residential	O
area	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Background	O
characteristics	O
of	O
the	O
participantsBackground	O
characteristics	O
Age	O
,	O
years	O
(	O
mean	O
±	O
SD	O
)	O
27	O
.	O
5	O
±	O
5	O
.	O
59Urban	O
environment	O
,	O
N	O
(%)	O
218	O
(	O
54	O
.	O
3	O
)	O
Formal	O
education	O
,	O
number	O
of	O
years	O
≤	O
8	O
(%)	O
25	O
.	O
5	O
9	O
-	O
12	O
(%)	O
40	O
.	O
5	O
>	O
12	O
(%)	O
34Married	O
,	O
N	O
(%)	O
323	O
(	O
80	O
.	O
8	O
)	O
Number	O
of	O
births	O
,	O
N	O
(%)	O
Primiparous198	O
(	O
49	O
.	O
5	O
)	O
Secundiparous129	O
(	O
32	O
.	O
3	O
)	O
Multiparous73	O
(	O
18	O
.	O
2	O
)	O
Wanted	O
pregnancy	O
,	O
N	O
(%)	O
360	O
(	O
90	O
)	O
Gestational	O
age	O
at	O
first	O
prenatal	O
visit	O
,	O
mean	O
±	O
SD2	O
.	O
59	O
±	O
1	O
.	O
23First	O
prenatal	O
visit	O
at	O
≤	O
4	O
months	O
of	O
pregnancy	O
,	O
N	O
(%)	O
364	O
(	O
91	O
)	O
Number	O
of	O
prenatal	O
visits	O
at	O
general	O
practitioner	O
,	O
mean	O
±	O
SD4	O
.	O
82	O
±	O
2	O
.	O
54Number	O
of	O
prenatal	O
visits	O
at	O
obstetrician	O
,	O
mean	O
±	O
SD4	O
.	O
76	O
±	O
3	O
.	O
07Total	O
number	O
of	O
prenatal	O
visits	O
,	O
mean	O
±	O
SD9	O
.	O
58	O
±	O
4	O
.	O
88Nutritional	O
knowledge	O
score	O
,	O
mean	O
±	O
SD11	O
±	O
4	O
.	O
8Advice	O
on	O
diet	O
,	O
YES	O
(	O
N	O
,%)	O
168	O
(	O
42	O
)	O
Advice	O
on	O
breastfeeding	O
,	O
YES	O
(	O
N	O
,%)	O
334	O
(	O
83	O
.	O
5	O
)	O
Use	O
of	O
folic	O
acid	O
(	O
N	O
,%)	O
192	O
(	O
48	O
)	O
Use	O
of	O
iron	O
(	O
N	O
,%)	O
181	O
(	O
45	O
.	O
3	O
)	O
Use	O
of	O
multivitamins	O
(	O
N	O
,%)	O
272	O
(	O
68	O
)	O
Statistical	O
analysis	O
Associations	O
between	O
socio	O
-	O
demographic	O
factors	O
,	O
prenatal	O
care	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
intake	O
of	O
nutritional	O
supplements	O
were	O
evaluated	O
using	O
the	O
Chi	O
-	O
square	O
test	O
(	O
χ2	O
)	O
and	O
binomial	O
logistical	O
regression	O
[	O
24	O
].	O

This	O
data	O
does	O
not	O
apply	O
to	O
PCOS	O
patients	O
with	O
abnormally	O
elevated	O
AMH	O
levels	O
—	O
as	O
mentioned	O
earlier	O
,	O
in	O
this	O
group	O
,	O
VD	O
supplementation	O
results	O
with	O
AMH	O
level	O
normalization	O
[	O
26	O
].	O

Exclusion	O
criteria	O
were	O
delivering	O
a	O
stillborn	O
or	O
newborn	O
with	O
congenital	O
or	O
neonatal	O
anomalies	O
,	O
receiving	O
influenza	O
vaccination	O
before	O
May	O
1st	O
,	O
2014	O
-	O
the	O
start	O
date	O
for	O
the	O
national	O
influenza	O
vaccination	O
campaign	O
[	O
32	O
]-	O
or	O
less	O
than	O
14	O
days	O
before	O
delivery	O
,	O
and	O
having	O
a	O
gestational	O
age	O
<	O
28	O
or	O
>	O
42	O
weeks	O
at	O
delivery	O
which	O
are	O
the	O
viability	O
and	O
post	O
-	O
term	O
cut	O
-	O
offs	O
,	O
respectively	O
[	O
35	O
],[	O
36	O
].	O

An	O
elevated	O
risk	O
remained	O
after	O
adjustment	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
1	O
.	O
54	O
;	O
95	O
%	O
CI	O
0	O
.	O
71	O
-	O
3	O
.	O
35	O
).	O

Similar	O
results	O
were	O
observed	O
when	O
vitamin	O
D	O
status	O
was	O
based	O
on	O
clinical	O
definitions	O
of	O
deficiency	O
(	O
Additional	O
file1	O
:	O
Table	O
S1	O
).	O

Studies	O
of	O
text4baby	O
have	O
helped	O
establish	O
and	O
expand	O
the	O
mHealth	O
evidence	O
base	O
.	O

For	O
this	O
analysis	O
,	O
women	O
pregnant	O
with	O
multiples	O
and	O
those	O
participating	O
in	O
vitamin	O
D	O
clinical	O
trials	O
at	O
MUSC	O
were	O
excluded	O
.	O

These	O
spots	O
were	O
matched	O
,	O
normalized	O
and	O
quantified	O
.	O

The	O
IMF	O
content	O
in	O
the	O
LM	O
of	O
the	O
high	O
-	O
concentrate	O
group	O
(	O
31	O
.	O
7	O
%	O
±	O
5	O
.	O
4	O
%)	O
was	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
(	O
22	O
.	O
9	O
%±	O
5	O
.	O
3	O
%).	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

Maternal	O
anaphylaxis	O
has	O
been	O
associated	O
with	O
fetal	O
distress	O
,	O
brain	O
injury	O
,	O
and	O
fetal	O
loss	O
(	O
presumably	B
because	O
of	O
diminished	O
uteroplacental	O
perfusion	O
),	O
as	O
well	O
as	O
neonatal	O
death	O
[	O
32	O
-	O
35	O
].	O

British	O
and	O
British	O
×	O
Continental	O
crossbred	O
cattle	O
grown	O
with	O
no	O
shelter	O
or	O
windbreak	O
had	O
greater	O
fat	O
thickness	O
and	O
MS	O
in	O
winter	O
than	O
did	O
animals	O
fed	O
in	O
a	O
protected	O
area	O
[	O
74	O
].	O

Fetal	O
distress	O
and	O
admission	O
to	O
the	O
NICU	O
were	O
reported	O
approximately	O
twice	O
as	O
often	O
in	O
the	O
polytherapy	O
subgroup	O
.	O

This	O
might	O
well	O
be	O
expected	O
since	O
the	O
fundamental	O
idea	O
that	O
environmental	O
factors	O
can	O
induce	O
phenotypic	O
changes	O
across	O
multiple	O
generations	O
challenges	O
the	O
central	O
dogma	O
of	O
genetic	O
inheritance	O
,	O
moving	O
into	O
what	O
was	O
a	O
controversial	O
area	O
of	O
genetics	O
,	O
but	O
is	O
now	O
better	O
accepted	O
and	O
established	O
,	O
Lamarckism	O
.	O

What	O
is	O
the	O
role	O
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
?	O

In	B
general	I
,	O
BMI	O
correlations	O
of	O
the	O
child	O
with	O
the	O
mother	O
and	O
MGM	O
increased	O
with	O
age	O
.	O

Conclusion	O
To	O
conclude	O
,	O
UCP1	O
is	O
an	O
excellent	O
target	O
to	O
struggle	O
diabetes	O
and	O
decrease	O
body	O
fat	O
mass	O
,	O
improving	O
whole	O
metabolism	O
.	O

Bager	O
and	O
colleagues	O
[	O
93	O
,	O
94	O
]	O
also	O
showed	O
an	O
increased	O
risk	O
for	O
asthma	O
,	O
allergic	O
rhinitis	O
,	O
and	O
possibly	O
for	O
food	O
allergies	O
in	O
their	O
meta	O
-	O
analysis	O
.	O

As	O
a	O
result	O
,	O
adjusted	O
clinical	O
pregnancy	O
rates	O
were	O
lower	O
among	O
VD	O
-	O
deficient	O
recipients	O
than	O
among	O
VD	O
-	O
replete	O
recipients	O
(	O
37	O
%	O
vs	O
.	O

Similarly	O
,	O
greater	O
consumption	O
of	O
sweets	O
early	O
in	O
pregnancy	O
was	O
significantly	O
related	O
to	O
higher	O
odds	O
of	O
macrosomia	O
(	O
OR	O
=	O
1	O
.	O
1	O
(	O
1	O
.	O
0	O
,	O
1	O
.	O
2	O
);	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
WFA	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
002	O
).	O

Two	O
different	O
types	O
of	O
adipose	O
tissue	O
have	O
been	O
described	O
:	O
brown	O
adipose	O
tissue	O
(	O
BAT	O
),	O
composed	O
mainly	O
of	O
brown	O
adipocytes	O
,	O
and	O
white	O
adipose	O
tissue	O
(	O
WAT	O
),	O
defined	O
by	O
a	O
majority	O
of	O
white	O
adipocytes	O
,	O
both	O
tissues	O
being	O
able	O
to	O
accumulate	O
lipids	O
in	O
intracellular	O
droplets	O
.	O

Multivariate	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
association	O
of	O
GRS	O
with	O
25	O
(	O
OH	O
)	O
D	O
,	O
using	O
the	O
same	O
confounding	O
factors	O
as	O
before	O
.	O

Infectious	O
pathologies	O
and	O
increased	O
incidences	O
of	O
certain	O
tumor	O
types	O
,	O
such	O
as	O
pituitary	O
tumors	O
or	O
lymphomas	O
/	O
leukaemias	O
,	O
are	O
known	O
to	O
occur	O
with	O
increasing	O
age	O
,	O
and	O
the	O
high	O
spontaneous	O
incidences	O
of	O
leukemias	O
/	O
lymphomas	O
and	O
mammary	O
gland	O
tumors	O
in	O
laboratory	O
animals	O
from	O
inbred	O
colonies	O
are	O
known	O
to	O
vary	O
considerably	O
between	O
studies	O
(	O
Innes	O
et	O
al	O
.	O
1967	O
;	O
Greaves2000	O
).	O

The	O
research	O
team	O
took	O
written	O
approval	O
for	O
the	O
study	O
from	O
Directorate	O
General	O
of	O
Health	O
Service	O
(	O
DGHS	O
)	O
under	O
Ministry	O
of	O
Health	O
&	O
Family	O
Welfare	O
before	O
allocating	O
the	O
clusters	O
to	O
a	O
treatment	O
group	O
or	O
the	O
trial	O
interventions	O
begin	O
.	O

Recent	O
studies	O
,	O
however	O
,	O
have	O
shown	O
that	O
exposure	O
to	O
valproate	O
during	O
pregnancy	O
indicates	O
a	O
significantly	O
increased	O
risk	O
of	O
autism	O
spectrum	O
disorder	O
,	O
even	O
after	O
adjusting	O
for	O
maternal	O
epilepsy	O
.	O

Dietary	O
patterns	O
are	O
different	O
based	O
on	O
cultural	O
,	O
geographical	O
,	O
and	O
regional	O
influence	O
in	O
each	O
area	O
and	O
can	O
have	O
effects	O
on	O
health	O
outcomes	O
[	O
17	O
,	O
18	O
].	O

SSRIs	O
Selective	O
serotonin	O
reuptake	O
inhibitors	O
(	O
SSRIs	O
)	O
are	O
a	O
class	O
of	O
drugs	O
currently	O
and	O
increasingly	O
prescribed	O
for	O
anxiety	O
disorders	O
and	O
depression	O
.	O

Conclusion	O
This	O
paper	O
introduces	O
BHLM	O
as	O
a	O
method	O
for	O
tackling	O
multiple	O
correlated	O
exposures	O
in	O
relation	O
to	O
health	O
outcomes	O
and	O
compared	O
this	O
method	O
with	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

The	O
questionnaire	O
is	O
designed	O
to	O
assess	O
rhinitis	O
,	O
asthma	O
and	O
eczema	O
in	O
children	O
and	O
has	O
been	O
used	O
successfully	O
in	O
an	O
older	O
black	O
population	O
in	O
South	O
Africa	O
[	O
50	O
].	O

This	O
would	O
have	O
allowed	O
for	O
a	O
more	O
expansive	O
definition	O
of	O
the	O
relationship	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
perinatal	O
outcomes	O
.	O

Stress	O
increases	O
circulating	O
concentrations	O
of	O
cortisol	O
,	O
a	O
typical	O
stress	O
marker	O
[	O
99	O
].	O

Our	O
results	O
of	O
the	O
protective	O
effect	O
of	O
fatty	O
fish	O
could	O
in	O
part	O
be	O
due	O
to	O
the	O
content	O
of	O
vitamin	O
D	O
.	O
While	O
the	O
epidemiological	O
evidence	O
linking	O
low	O
prenatal	O
vitamin	O
D	O
and	O
schizophrenia	O
remains	O
inconclusive	O
,	O
rodent	O
models	O
have	O
provided	O
compelling	O
evidence	O
about	O
the	O
role	O
of	O
vitamin	O
D	O
deficiency	O
for	O
brain	O
development	O
like	O
larger	O
lateral	O
volumes	O
[	O
36	O
],	O
subtle	O
memory	O
dysfunction	O
and	O
altered	O
attention	O
processing	O
[	O
37	O
]	O
which	O
have	O
implications	O
for	O
neuropsychiatric	O
disorders	O
.	O

The	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
coefficients	O
of	O
variation	O
were	O
4	O
.	O
2	O
%,	O
and	O
9	O
%	O
respectively	O
.	O

Conclusion	O
In	O
this	O
study	O
39	O
%	O
of	O
women	O
reported	O
using	O
herbs	O
during	O
pregnancy	O
,	O
a	O
higher	O
frequency	O
than	O
reported	O
in	O
other	O
studies	O
.	O

We	O
will	O
compare	O
the	O
causes	O
of	O
death	O
by	O
sex	O
of	O
newborn	O
,	O
the	O
time	O
-	O
period	O
of	O
death	O
,	O
and	O
treatment	O
arms	O
(	O
intervention	O
Vs	O
control	O
).	O

Of	O
279	O
papers	O
sourced	O
,	O
eight	O
were	O
included	O
in	O
the	O
final	O
review	O
.	O

Still	O
,	O
the	O
finding	O
that	O
only	O
39	O
%	O
of	O
households	O
in	O
the	O
intervention	O
were	O
found	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
at	O
all	O
five	O
of	O
the	O
rapid	O
observations	O
suggests	O
that	O
maintaining	O
handwashing	O
materials	O
at	O
fixed	O
locations	O
at	O
all	O
times	O
was	O
difficult	O
in	O
the	O
newborn	O
period	O
,	O
that	O
such	O
maintenance	O
had	O
not	O
become	O
habitual	O
,	O
or	O
that	O
this	O
approach	O
to	O
handwashing	O
was	O
not	O
acceptable	O
to	O
our	O
study	O
population	O
.	O

We	O
used	O
FGDs	O
to	O
understand	O
both	O
perceptions	O
regarding	O
the	O
need	O
for	O
IFA	O
tablets	O
during	O
pregnancy	O
and	O
the	O
state	O
of	O
IFA	O
supplementation	O
programmes	O
.	O

The	O
relationship	O
of	O
vitamin	O
D	O
level	O
with	O
other	O
factors	O
was	O
compared	O
by	O
chi	O
-	O
square	O
test	O
.	O

The	O
assured	O
and	O
well	O
-	O
evaluated	O
risk	O
factors	O
revealed	O
for	O
sensitization	O
in	O
mother	O
and	O
child	O
are	O
very	O
limited	O
,	O
to	O
date	O
,	O
and	O
include	O
alcohol	O
consumption	O
,	O
exposure	O
to	O
tobacco	O
smoke	O
,	O
maternal	O
diet	O
and	O
diet	O
of	O
the	O
newborn	O
,	O
drug	O
usage	O
,	O
and	O
insufficient	O
exposure	O
to	O
environmental	O
bacteria	O
.	O

This	O
effect	O
,	O
exerted	O
within	O
the	O
ventromedial	O
hypothalamus	O
(	O
VMH	O
),	O
was	O
described	O
as	O
being	O
AMPK	O
-	O
dependent	O
,	O
resulting	O
in	O
the	O
activation	O
of	O
the	O
sympathetic	O
outlflow	O
to	O
BAT	O
,	O
without	O
any	O
change	O
in	O
the	O
feeding	O
behavior	O
(	O
Whittle	O
et	O
al	O
.,	O
2012	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Among	O
the	O
animals	O
used	O
for	O
the	O
microarray	O
expression	O
analysis	O
,	O
weaners	O
of	O
the	O
LP	O
group	O
showed	O
numerically	O
but	O
not	O
significantly	O
lower	O
body	O
weight	O
than	O
the	O
AP	O
group	O
,	O
(	O
LP	O
:	O
7	O
.	O
24	O
±	O
1	O
.	O
56	O
kg	O
,	O
AP	O
:	O
7	O
.	O
59	O
±	O
2	O
.	O
14	O
kg	O
,	O
P	O
=	O
0	O
.	O
30	O
,	O
n	O
=	O
32	O
).	O

Maternal	O
dairy	O
intake	O
was	O
positively	O
associated	O
with	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
C	O
.	O
butyricum	O
and	O
the	O
genus	O
Staphylococcus	O
,	O
and	O
negatively	O
related	O
to	O
OTUs	O
classified	O
to	O
the	O
Lachnospiraceae	O
family	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2b	O
).	O

Between	O
15thNovember	O
2011	O
and	O
15thJuly	O
2012	O
,	O
a	O
total	O
of	O
385	O
women	O
were	O
recruited	O
into	O
the	O
study	O
based	O
on	O
the	O
calculated	O
sample	O
size	O
using	O
the	O
Eng	O
'	O
s	O
formula	O
[	O
10	O
]	O
assuming	O
that	O
50	O
%	O
of	O
the	O
women	O
were	O
satisfied	O
with	O
ANC	O
offered	O
them	O
.	O

Importantly	O
,	O
among	O
the	O
exposed	O
group	O
,	O
all	O
seven	O
major	O
malformations	O
occurred	O
among	O
the	O
96	O
women	O
receiving	O
polytherapy	O
;	O
however	O
,	O
no	O
specific	O
pattern	O
of	O
malformation	O
was	O
found	O
.	O

RD291001200R	O
;	O
BioVendor	O
,	O
Brno	O
,	O
Czech	O
Republic	O
).	O

[	O
2	O
]	O
Also	O
the	O
media	O
has	O
been	O
taking	O
increasing	O
interest	O
,	O
and	O
public	O
expectations	O
have	O
been	O
raised	O
regarding	O
the	O
enhanced	O
roles	O
for	O
vitamin	O
D	O
in	O
pregnancy	O
.	O

Although	O
,	O
a	O
56	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
in	O
those	O
with	O
low	O
-	O
moderate	O
levels	O
of	O
standardised	O
vitamin	O
D	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
for	O
women	O
carrying	O
a	O
female	O
fetus	O
(	O
aRR	O
:	O
0	O
.	O
44	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
).	O

To	O
ensure	O
a	O
high	O
standard	O
of	O
analysis	O
for	O
serum	O
25OHD	O
concentrations	O
,	O
the	O
laboratory	O
participates	O
in	O
an	O
external	O
quality	O
assurance	O
scheme	O
;	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
DEQAS	O
).	O

Three	O
-	O
quarters	O
of	O
participants	O
reported	O
not	O
receiving	O
advice	O
on	O
appropriate	O
weight	O
gain	O
during	O
early	O
prenatal	O
care	O
visits	O
.	O

The	O
lab	O
technicians	O
were	O
blind	O
to	O
group	O
allocations	O
.	O

On	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
,	O
the	O
incidence	O
of	O
the	O
first	O
episode	O
of	O
pneumonia	O
was	O
greater	O
in	O
the	O
vitamin	O
D	O
rather	O
than	O
the	O
placebo	O
group	O
,	O
although	O
this	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
table	O
2	O
).	O

Characteristics	O
of	O
Women	O
Included	O
in	O
the	O
AnalysisCharacteristic	O
Placebo	O
(	O
n	O
=	O
351	O
)	O
Cholecalciferol	O
1000	O
IU	O
/	O
d	O
(	O
n	O
=	O
331	O
)	O
Age	O
(	O
years	O
),	O
mean	O
(	O
SD	O
)	O
30	O
.	O
8	O
(	O
5	O
.	O
4	O
)	O
30	O
.	O
8	O
(	O
5	O
.	O
0	O
)	O
Current	O
smoking	O
,	O
n	O
(%)	O
29	O
(	O
8	O
.	O
3	O
)	O
24	O
(	O
7	O
.	O
3	O
)	O
Educational	O
attainment	O
≥	O
A	O
level	O
(	O
high	O
school	O
),	O
n	O
(%)	O
258	O
(	O
74	O
.	O
4	O
)	O
264	O
(	O
80	O
.	O
0	O
)	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
median	O
(	O
IQR	O
)	O
25	O
.	O
5	O
(	O
23	O
.	O
0	O
to	O
29	O
.	O
7	O
)	O
24	O
.	O
7	O
(	O
22	O
.	O
3	O
to	O
29	O
.	O
3	O
)	O
Pregnancy	O
weight	O
gain	O
(	O
kg	O
),	O
mean	O
(	O
SD	O
)	O
9	O
.	O
5	O
(	O
3	O
.	O
6	O
)	O
9	O
.	O
5	O
(	O
3	O
.	O
4	O
)	O
Strenuous	O
exercise	O
≥	O
once	O
per	O
week	O
,	O
n	O
(%)	O
45	O
(	O
13	O
.	O
8	O
)	O
50	O
(	O
16	O
.	O
2	O
)	O
25	O
(	O
OH	O
)	O
D	O
at	O
14	O
weeks	O
(	O
nmol	O
/	O
L	O
),	O
mean	O
(	O
SD	O
)	O
45	O
.	O
4	O
(	O
16	O
.	O
5	O
)	O
46	O
.	O
1	O
(	O
17	O
.	O
0	O
)	O
rs12785878	O
(	O
DHCR7	O
),	O
n	O
(%)	O
G	O
:	O
G17	O
(	O
4	O
.	O
8	O
)	O
14	O
(	O
4	O
.	O
3	O
)	O
T	O
:	O
G114	O
(	O
32	O
.	O
5	O
)	O
120	O
(	O
36	O
.	O
6	O
)	O
T	O
:	O
T220	O
(	O
62	O
.	O
7	O
)	O
194	O
(	O
59	O
.	O
1	O
)	O
rs10741657	O
(	O
CYP2R1	O
),	O
n	O
(%)	O
A	O
:	O
A57	O
(	O
16	O
.	O
6	O
)	O
51	O
(	O
15	O
.	O
5	O
)	O
G	O
:	O
A156	O
(	O
45	O
.	O
3	O
)	O
148	O
(	O
45	O
.	O
1	O
)	O
G	O
:	O
G131	O
(	O
38	O
.	O
1	O
)	O
129	O
(	O
39	O
.	O
3	O
)	O
rs6013897	O
(	O
CYP24A1	O
),	O
n	O
(%)	O
A	O
:	O
A10	O
(	O
2	O
.	O
9	O
)	O
15	O
(	O
4	O
.	O
6	O
)	O
T	O
:	O
A126	O
(	O
36	O
.	O
5	O
)	O
102	O
(	O
31	O
.	O
4	O
)	O
T	O
:	O
T209	O
(	O
60	O
.	O
6	O
)	O
208	O
(	O
64	O
.	O
0	O
)	O
rs2282679	O
(	O
GC	O
),	O
n	O
(%)	O
C	O
:	O
C37	O
(	O
10	O
.	O
6	O
)	O
34	O
(	O
10	O
.	O
3	O
)	O
C	O
:	O
A149	O
(	O
42	O
.	O
6	O
)	O
136	O
(	O
41	O
.	O
3	O
)	O
A	O
:	O
A164	O
(	O
46	O
.	O
9	O
)	O
159	O
(	O
48	O
.	O
3	O
)	O
Abbreviation	O
:	O
IQR	O
,	O
interquartile	O
range	O
.	O

There	O
are	O
no	O
representative	O
country	O
data	O
available	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
Europe	O
.	O

The	O
liver	O
of	O
RC	O
females	O
also	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
de	O
novo	O
lipogenic	O
enzyme	O
Acaca	O
and	O
Fasn	O
,	O
which	O
constitute	O
rate	O
-	O
limit	O
steps	O
in	O
the	O
fatty	O
-	O
acid	O
synthesis	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

The	O
change	O
in	O
25OHD	O
from	O
early	O
pregnancy	O
to	O
late	O
pregnancy	O
was	O
calculated	O
.	O

Possible	O
responses	O
included	O
Yes	O
,	O
Sometimes	O
,	O
or	O
No	O
,	O
with	O
a	O
score	O
in	O
any	O
one	O
domain	O
>	O
2SD	O
below	O
the	O
mean	O
considered	O
indicative	O
of	O
the	O
need	O
for	O
further	O
assessment	O
and	O
when	O
identified	O
,	O
the	O
primary	O
caregiver	O
was	O
advised	O
to	O
seek	O
additional	O
medical	O
advice	O
.	O

Further	O
studies	O
are	O
necessary	O
to	O
clarify	O
the	O
impact	O
of	O
maternal	O
vitamin	O
D	O
restriction	O
on	O
the	O
renal	O
function	O
of	O
offspring	O
.	O

Kitsantas	O
and	O
colleagues	O
[	O
9	O
]	O
report	O
that	O
maternal	O
pre	O
-	O
gravid	O
obesity	O
increases	O
the	O
odds	O
of	O
pre	O
-	O
school	O
obesity	O
by	O
a	O
factor	O
of	O
1	O
.	O
6	O
(	O
OR	O
1	O
.	O
60	O
;	O
95	O
%	O
CI	O
1	O
.	O
26	O
–	O
2	O
.	O
03	O
),	O
while	O
Rooney	O
and	O
colleagues	O
[	O
10	O
]	O
report	O
a	O
substantially	O
greater	O
increase	O
in	O
risk	O
(	O
RR	O
6	O
.	O
35	O
;	O
95	O
%	O
CI	O
3	O
.	O
28	O
–	O
12	O
.	O
30	O
).	O

The	O
importance	O
of	O
environmental	O
exposures	O
during	O
intrauterine	O
development	O
on	O
health	O
throughout	O
the	O
life	O
course	O
is	O
now	O
well	O
recognized	O
in	O
the	O
epidemiologic	O
literature	O
(	O
Barker	O
2004	O
).	O

Relatively	O
few	O
women	O
worldwide	O
meet	O
the	O
World	O
Health	O
Organization	O
’	O
s	O
recommendation	O
that	O
infants	O
breastfeed	O
exclusively	O
for	O
the	O
first	O
6	O
months	O
of	O
life	O
,	O
with	O
continued	O
breastfeeding	O
combined	O
with	O
appropriate	O
foods	O
thereafter	O
for	O
2	O
years	O
or	O
more1	O
—	O
even	O
those	O
who	O
intend	O
to	O
do	O
so	O
at	O
the	O
outset	O
.	O

The	O
maximal	O
stimulation	O
for	O
GAS5	O
was	O
at	O
10	O
nM	O
of	O
cortisol	O
in	O
JEG	O
-	O
3	O
cells	O
and	O
at	O
1000	O
nM	O
in	O
BeWo	O
.	O

Conclusion	O
In	O
summary	O
,	O
maternal	O
vitamin	O
D	O
concentration	O
was	O
similar	O
in	O
mothers	O
with	O
and	O
without	O
GDM	O
in	O
a	O
vitamin	O
D	O
sufficient	O
population	O
.	O

In	O
serum	O
,	O
vitamin	O
D	O
is	O
transported	O
by	O
vitamin	O
D	O
-	O
binding	O
protein	O
(	O
VDBP	O
)	O
to	O
the	O
liver	O
and	O
metabolized	O
to	O
an	O
active	O
form	O
of	O
25	O
-	O
hydroxycalciferol	O
(	O
25	O
[	O
OH	O
]	O
D	O
)	O
[	O
9	O
].	O

The	O
numbers	O
at	O
the	O
horizontal	O
arrows	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
significantly	O
regulated	O
between	O
the	O
adjacent	O
ontogenetic	O
stages	O
in	O
either	O
AP	O
or	O
LP	O
offspring	O
,	O
whereas	O
the	O
numbers	O
in	O
the	O
intersections	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
commonly	O
regulated	O
between	O
stages	O
in	O
AP	O
and	O
LP	O
offspring	O
.	O

These	O
probe	O
-	O
sets	O
represent	O
7	O
,	O
697	O
genes	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
7	O
,	O
758	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
6	O
,	O
879	O
).	O

Some	O
researchers	O
have	O
hypothesized	O
that	O
the	O
protective	O
effect	O
may	O
be	O
attributed	O
to	O
a	O
form	O
of	O
“	O
tolerance	O
”.	O

Initial	O
mean	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
was	O
9	O
.	O
35	O
±	O
6	O
.	O
33	O
ng	O
/	O
mL	O
in	O
the	O
control	O
group	O
and	O
was	O
10	O
.	O
05	O
±	O
7	O
.	O
38	O
ng	O
/	O
mL	O
in	O
the	O
intervention	O
group	O
.	O

PubMed	O
Central	O
:	O

As	O
far	O
as	O
the	O
vacancy	O
status	O
is	O
concerned	O
,	O
almost	O
33	O
.	O
9	O
%,	O
35	O
%,	O
7	O
.	O
1	O
%,	O
and	O
7	O
.	O
2	O
%	O
of	O
CDPOs	O
,	O
Supervisors	O
,	O
Anganwadi	O
workers	O
and	O
Anganwadi	O
helpers	O
posts	O
are	O
still	O
vacant	O
in	O
the	O
country	O
.	O

Surgical	O
removal	O
of	O
AAOC	O
is	O
the	O
treatment	O
of	O
choice	O
.	O

All	O
cost	O
data	O
were	O
collected	O
in	O
Viet	O
Nam	O
dong	O
and	O
converted	O
to	O
US	O
dollars	O
using	O
the	O
exchange	O
rate	O
on	O
March	O
10	O
2010	O
(	O
USD1	O
.	O
00	O
=	O
VND18	O
,	O
685	O
).	O

Infant	O
lung	O
function	O
,	O
including	O
tidal	O
breathing	O
analysis	O
,	O
respiratory	O
mechanics	O
,	O
and	O
forced	O
tidal	O
expiration	O
,	O
was	O
tested	O
at	O
6	O
months	O
of	O
age	O
.	O

*	O
denotes	O
p	O
<	O
0	O
.	O
05	O
.	O

It	O
assists	O
in	O
identifying	O
the	O
normal	O
ranges	O
of	O
circulating	O
cathelicidin	O
concentrations	O
found	O
in	O
healthy	O
children	O
.	O

Caption	O
(	O
FIG	O
)	O
Many	O
studies	O
on	O
DDT	O
exposures	O
and	O
lactation	O
have	O
been	O
conducted	O
with	O
populations	O
of	O
Hispanic	O
women	O
who	O
work	O
on	O
farms	O
or	O
live	O
in	O
agricultural	O
areas	O
.	O

This	O
puzzling	O
finding	O
may	O
be	O
due	O
to	O
unknown	O
or	O
known	O
unhealthy	O
constituents	O
of	O
fatty	O
fish	O
.	O

Primary	O
prevention	O
addresses	O
symptom	O
-	O
free	O
children	O
at	O
risk	O
(	O
ie	O
,	O
without	O
the	O
established	O
disease	O
).	O

Outcomes	O
of	O
mother	O
–	O
child	O
pairs	O
exposed	O
to	O
SGAs	O
in	O
monotherapy	O
(	O
N	O
=	O
37	O
)	O
were	O
compared	O
with	O
those	O
exposed	O
to	O
SGAs	O
with	O
other	O
psychotropic	O
medications	O
(	O
in	O
polytherapy	O
;	O
N	O
=	O
96	O
).	O

There	O
were	O
no	O
significant	O
differences	O
in	O
retention	O
or	O
availability	O
of	O
pediatrician	O
records	O
in	O
normal	O
weight	O
versus	O
overweight	O
/	O
obese	O
mothers	O
at	O
all	O
time	O
points	O
.	O

Feeding	O
low	O
-	O
protein	O
diets	O
to	O
pregnant	O
rats	O
produces	O
a	O
broad	O
spectrum	O
of	O
disorders	O
in	O
their	O
offspring	O
(	O
7	O
):	O
hypertension	O
and	O
vascular	O
defects	O
(	O
8	O
,	O
9	O
),	O
altered	O
fetal	O
pancreatic	O
development	O
and	O
structure	O
(	O
10	O
),	O
altered	O
glucose	O
tolerance	O
(	O
11	O
),	O
altered	O
liver	O
structure	O
and	O
function	O
(	O
12	O
),	O
altered	O
gene	O
expression	O
(	O
13	O
),	O
and	O
possibly	O
type	O
2	O
diabetes	O
mellitus	O
(	O
10	O
).	O

Conclusions	O
Findings	O
from	O
the	O
current	O
study	O
indicate	O
that	O
excessive	O
GWG	O
and	O
mothers	O
'	O
eating	O
behaviors	O
during	O
pregnancy	O
,	O
especially	O
intake	O
of	O
sweets	O
in	O
overweight	O
/	O
obese	O
mothers	O
,	O
may	O
influence	O
offspring	O
weight	O
status	O
early	O
in	O
infancy	O
.	O

[	O
16	O
]	O
This	O
deficiency	O
is	O
because	B
body	O
fat	O
stores	O
much	O
of	O
the	O
vitamin	O
D	O
made	O
in	O
the	O
skin	O
,	O
making	O
it	O
less	O
available	O
to	O
the	O
body	O
.	O

However	O
,	O
weaning	O
treatment	O
did	O
not	O
affect	O
feed	O
efficiency	O
,	O
post	O
weaning	O
growth	O
,	O
MS	O
,	O
and	O
other	O
carcass	O
traits	O
.	O

Sexual	O
dimorphisms	O
:	O
an	O
open	O
question	O
A	O
major	O
finding	O
of	O
this	O
study	O
is	O
the	O
appearance	O
of	O
sexual	O
dimorphisms	O
on	O
the	O
effects	O
of	O
maternal	O
caloric	O
restriction	O
in	O
the	O
adult	O
offspring	O
.	O

Vitamin	O
D	O
status	O
and	O
GDM	O
In	O
our	O
cohort	O
GDM	O
was	O
present	O
in	O
81	O
of	O
the	O
723	O
women	O
(	O
11	O
%).	O

This	O
would	O
begin	O
to	O
address	O
regulatory	O
concerns	O
and	O
help	O
to	O
develop	O
formal	O
epigenetically	O
relevant	O
toxicity	O
TGs	O
.	O

A	O
continuous	O
supply	O
of	O
normal	O
levels	O
of	O
dietary	O
vitamin	O
A	O
during	O
the	O
entire	O
growth	O
period	O
may	O
also	O
result	O
in	O
poor	O
marbling	O
and	O
QG	O
,	O
even	O
if	O
the	O
growth	O
rate	O
were	O
normal	O
and	O
no	O
health	O
problems	O
occurred	O
.	O

After	O
all	O
,	O
we	O
know	O
that	O
insulin	O
therapy	O
is	O
safe	O
and	O
usually	O
effective	O
.	O

2004	O
).	O

Introduction	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
fertility	O
treatment	O
has	O
been	O
recently	O
described	O
in	O
some	O
comprehensive	B
reports	O
[	O
1	O
,	O
2	O
].	O

This	O
adjunctive	O
therapy	O
is	O
supposed	B
to	I
destroy	O
occult	O
microscopic	O
carcinoma	O
within	O
the	O
thyroid	O
remnant	O
by	O
being	O
actively	O
trapped	O
both	O
by	O
normal	O
and	O
pathological	O
thyroid	O
cells	O
,	O
and	O
to	O
facilitate	O
follow	O
-	O
up	O
because	B
serum	O
thyroglobulin	O
(	O
HTG	O
)	O
measurements	O
are	O
more	O
reliable	O
after	O
the	O
destruction	O
of	O
residual	O
normal	O
thyroid	O
tissue	O
.	O

Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
:	O
A	O
Review	O
of	O
Their	O
Effectiveness	O
and	O
Implications	O
for	O
Health	O
System	O
Strengthening	O
Abstract	O
Objectives	O
.	O

The	O
LASSO	O
results	O
are	O
given	O
in	O
Additional	O
file1	O
:	O
Figure	O
S3	O
.	O

Also	O
chemokines	O
,	O
for	O
example	O
,	O
IL	O
-	O
8	O
,	O
a	O
cytokine	O
that	O
is	O
regulated	O
on	O
activation	O
with	O
normal	O
T	O
cell	O
expressed	O
and	O
secreted	O
(	O
RANTES	O
),	O
IFN	O
-	O
γ	O
-	O
inducible	O
protein	O
10	O
,	O
and	O
monokine	O
induced	O
by	O
IFN	O
-	O
γ	O
have	O
been	O
detected	O
in	O
breast	O
milk	O
[	O
66	O
,	O
67	O
].	O

At	O
the	O
earlier	O
time	O
point	O
,	O
34	O
.	O
5	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
;	O
at	O
the	O
later	O
time	O
point	O
,	O
29	O
.	O
1	O
%	O
did	O
.	O

Variables	O
included	O
in	O
the	O
PSM	O
model	O
that	O
could	O
explain	O
probability	O
of	O
receiving	O
vaccination	O
were	O
selected	O
a	O
priori	O
(	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
)	O
and	O
because	O
of	O
a	O
crude	O
association	O
with	O
vaccination	O
and	O
/	O
or	O
birth	O
outcomes	O
(	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
iron	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazole	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
calculated	O
from	O
height	O
and	O
weight	O
measurements	O
taken	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
).	O

The	O
results	O
of	O
the	O
LiST	O
analysis	O
found	O
that	O
84	O
%	O
of	O
premature	O
babies	O
(	O
more	O
than	O
921	O
,	O
000	O
lives	O
)	O
could	O
be	O
saved	O
in	O
2025	O
if	O
these	O
interventions	O
were	O
made	O
universally	O
available	O
(	O
95	O
%).	O

Therefore	O
,	O
the	O
adverse	O
effects	O
of	O
vitamin	O
D	O
restriction	O
during	O
kidney	O
development	O
need	O
further	O
exploration	O
.	O

Obesity	O
prevention	O
efforts	O
at	O
this	O
stage	O
of	O
development	O
have	O
typically	B
focused	O
on	O
encouraging	O
healthy	O
prenatal	O
nutrition	O
and	O
breast	O
-	O
feeding	O
;	O
however	O
,	O
interventions	O
to	O
reduce	O
maternal	O
obesity	O
during	O
pregnancy	O
have	O
been	O
limited	O
.	O

In	O
addition	O
,	O
3	O
-	O
month	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
not	O
closely	O
related	O
to	O
BMC	O
at	O
3	O
months	O
,	O
r	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
18	O
.	O

This	O
study	O
is	O
therefore	B
designed	O
to	O
investigate	O
pregnant	O
women	O
'	O
s	O
perception	O
of	O
quality	O
of	O
ANC	O
services	O
rendered	O
in	O
health	O
facilities	O
within	O
the	O
Buea	O
Health	O
District	O
area	O
.	O

Sunshine	O
in	O
not	O
adequate	O
in	O
many	O
parts	O
of	O
world	O
.	O

We	O
collected	O
baseline	O
demographics	O
using	O
a	O
questionnaire	O
including	O
race	O
/	O
ethnicity	O
and	O
education	O
obtained	O
data	O
from	O
the	O
medical	O
record	O
.	O

Additionally	O
,	O
16	O
(	O
6	O
.	O
1	O
%)	O
had	O
deficient	O
vitamin	O
D	O
concentrations	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

INTRODUCTION	O
Diets	O
consumed	O
during	O
pregnancy	O
and	O
early	O
postnatal	O
life	O
shape	O
the	O
developmental	O
trajectory	O
of	O
the	O
offspring	O
.	O
1	O
,	O
2Although	O
vitamins	O
contribute	O
to	O
all	O
phases	O
of	O
development	O
,	O
3the	O
effects	O
of	O
multivitamin	O
consumption	O
above	O
requirements	O
(	O
but	O
at	O
non	O
-	O
toxic	O
levels	O
)	O
during	O
pregnancy	O
as	B
determinants	O
of	O
physiologic	O
phenotypes	O
of	O
the	O
offspring	O
have	O
received	O
little	O
attention	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
prospective	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
sleep	O
quality	O
,	O
and	O
sleep	O
apnea	O
during	O
pregnancy	O
are	O
needed	O
to	O
confirm	O
our	O
findings	O
.	O

We	O
showed	O
that	O
gestational	O
exposure	O
to	O
phthalates	O
and	O
BPA	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
had	O
small	O
or	O
null	O
associations	O
with	O
differences	O
in	O
birth	O
weight	O
.	O

Other	O
potential	O
mechanism	O
that	O
would	O
explain	B
the	O
impairment	O
of	O
the	O
vagal	O
modulation	O
observed	O
in	O
children	O
with	O
low	O
birth	O
weight	O
could	O
be	O
mediated	O
by	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
).	O

Thus	B
,	O
while	O
it	O
is	O
important	O
to	O
fully	O
characterize	O
the	O
hazard	O
,	O
further	O
studies	O
at	O
doses	O
and	O
routes	O
of	O
administration	O
similar	O
to	O
those	O
found	O
in	O
humans	O
are	O
necessary	O
for	O
determining	O
relevance	O
to	O
public	O
health	O
.	O

While	O
we	O
did	O
not	O
identify	O
statistically	O
or	O
clinically	O
significant	O
differences	O
in	O
neurodevelopment	O
at	O
6	O
-	O
months	O
of	O
age	O
using	O
a	O
reliable	O
screening	O
tool	O
,	O
ongoing	O
follow	O
-	O
up	O
of	O
participants	O
further	O
into	O
childhood	O
will	O
again	O
be	O
important	O
to	O
determine	O
whether	O
there	O
are	O
any	O
potential	O
benefits	O
of	O
improving	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
on	O
childhood	O
neurodevelopment	O
.	O

The	O
human	O
endometrial	O
decidua	O
makes	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
the	O
placenta	O
synthesizes	O
only	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

Information	O
on	O
psychotic	O
-	O
like	O
symptoms	O
was	O
derived	O
from	O
a	O
follow	O
-	O
up	O
questionnaire	O
in	O
the	O
years	O
2002	O
/	O
03	O
.	O

PubMed	O
Central	O
:	O

A	O
number	O
of	O
techniques	O
have	O
been	O
described	O
in	O
the	O
assessment	O
of	O
early	O
infant	O
body	O
composition	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

However	O
,	O
long	O
-	O
term	O
studies	O
should	O
be	O
performed	O
to	O
investigate	O
this	O
possibility	O
.	O

All	O
samples	O
were	O
run	O
in	O
duplicates	O
and	O
the	O
entire	O
assay	O
was	O
performed	O
twice	O
.	O

Oral	O
iron	O
,	O
either	O
as	O
iron	O
sulphate	O
or	O
fumarate	O
,	O
is	O
the	O
most	O
commonly	O
used	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
and	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

Thus	B
,	O
it	O
is	O
very	O
necessary	O
to	O
promote	O
the	O
pregnant	O
women	O
to	O
take	O
proper	O
diet	O
i	O
.	O
e	O
.	O

The	O
greatest	O
risk	O
reduction	O
was	O
among	O
children	O
diagnosed	O
under	O
5	O
years	O
of	O
age	O
whose	O
mothers	O
used	O
supplements	O
during	O
all	O
three	O
trimesters	O
(	O
OR	O
0	O
.	O
5	O
,	O
CI	O
0	O
.	O
3	O
-	O
0	O
.	O
8	O
).	O

We	O
will	O
only	O
share	O
datasets	O
with	O
all	O
personally	O
identifiable	O
information	O
removed	O
,	O
and	O
every	O
reasonable	O
effort	O
to	O
keep	O
the	O
identification	O
of	O
study	O
subjects	O
in	O
the	O
strictest	O
confidence	O
.	O

Computer	O
software	O
IBM	O
SPSS	O
Statistics	O
version	O
22	O
.	O
0	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

In	O
addition	O
,	O
a	O
significant	O
percentage	O
of	O
infants	O
from	O
families	O
with	O
an	O
atopic	O
background	O
do	O
not	O
develop	O
atopy	O
during	O
childhood	O
.	O

These	O
figures	O
were	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
after	O
the	O
intervention	O
.	O

Maternal	O
pre	O
-	O
pregnancy	O
weight	O
was	O
the	O
only	O
significant	O
predictor	O
identified	O
(	O
p	O
=	O
0	O
.	O
015	O
).	O

This	O
study	O
points	O
towards	O
a	O
potential	O
gene	O
-	O
environment	O
interaction	O
that	O
could	O
be	O
of	O
predictive	O
value	O
for	O
fetal	O
weight	O
.	O

Radioactive	O
iodine	O
is	O
ineffective	O
because	O
I	O
-	O
131	O
uptake	O
by	O
MTC	O
cells	O
is	O
negligible	O
.	O

Although	O
a	O
person	O
is	O
at	O
risk	O
for	O
obesity	O
throughout	O
his	O
life	O
,	O
we	O
focus	O
on	O
specific	O
developmental	O
susceptibilities	O
for	O
obesity	O
from	O
gestation	O
through	O
adolescence	O
(	O
Table	O
).	O

MANAGEMENT	O
FACTORS	O
Several	O
management	O
factors	O
,	O
including	O
weaning	O
age	O
,	O
castration	O
,	O
slaughter	O
age	O
and	O
weight	O
,	O
nutrition	O
and	O
other	O
environmental	O
conditions	O
can	O
affect	O
IMF	O
deposition	O
.	O

Separate	O
analyses	O
were	O
carried	O
out	O
for	O
the	O
three	O
end	O
points	O
but	O
the	O
methodology	O
applied	O
did	O
not	O
allow	O
us	O
to	O
explore	O
the	O
specific	O
nature	O
of	O
causal	O
relationships	O
between	O
congenital	O
cryptorchidism	O
,	O
hypospadias	O
,	O
and	O
testicular	O
cancer	O
.	O

While	O
vitamin	O
A	O
restriction	O
improves	O
marbling	O
,	O
but	O
vitamin	O
D	O
restriction	O
did	O
not	O
significantly	O
affect	O
marbling	O
in	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Lesions	O
of	O
testis	O
and	O
epididymis	O
associated	O
with	O
prenatal	O
diethylstilbestrol	O
exposure	O
.	O

Among	O
all	O
the	O
predicted	O
miRNAs	O
,	O
4	O
miRNAs	O
targeting	O
GR	O
were	O
quantitated	O
by	O
real	O
-	O
time	O
PCR	O
.	O

[	O
43	O
]	O
If	O
electing	O
to	O
test	O
vitamin	O
D	O
status	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
is	O
the	O
accepted	O
biomarker	O
to	O
be	O
offered	O
early	O
in	O
pregnancy	O
.	O

Harper	O
and	O
Pethick	O
[	O
23	O
]	O
recommended	O
that	O
producers	O
focus	O
on	O
individuals	O
with	O
high	O
genetic	O
capacity	O
to	O
create	O
more	O
preadipocytes	O
within	O
animal	O
muscle	O
.	O

Given	O
that	O
all	O
these	O
factors	O
significantly	O
influenced	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
linear	O
regression	O
model	O
,	O
it	O
was	O
unsurprising	O
that	O
vitamin	O
D	O
status	O
of	O
the	O
women	O
was	O
significantly	O
different	O
between	O
the	O
two	O
recruitment	O
sites	O
.	O

This	O
may	O
have	O
been	O
especially	O
relevant	O
in	O
our	O
measurement	O
of	O
maternal	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
and	O
could	O
have	O
potentially	O
introduced	O
a	O
bias	O
toward	O
the	O
null	O
.	O

In	O
such	O
instances	O
,	O
the	O
avoidance	O
of	O
peanuts	O
,	O
nuts	O
,	O
fish	O
,	O
eggs	O
,	O
and	O
sesame	O
during	O
the	O
last	O
3	O
months	O
of	O
pregnancy	O
may	O
have	O
a	O
protective	O
effect	O
[	O
106	O
].	O

Exposure	O
to	O
such	O
an	O
intra	O
-	O
uterine	O
environment	O
potentially	O
creates	O
a	O
vicious	O
cycle	O
in	O
which	O
the	O
propensity	O
to	O
obesity	O
is	O
perpetuated	O
,	O
with	O
major	O
adverse	O
public	O
health	O
implications	O
[	O
11	O
,	O
12	O
],	O
and	O
implications	O
for	O
the	O
health	O
of	O
successive	O
generations	O
[	O
13	O
].	O

Solid	O
gray	O
circles	O
and	O
solid	O
black	O
line	O
represent	O
MUSC	O
cohort	O
(	O
N	O
=	O
1064	O
)	O
and	O
open	O
circles	O
and	O
dashed	O
line	O
represent	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Based	O
on	O
these	O
scores	O
,	O
we	O
created	O
the	O
following	O
categories	O
of	O
nutritional	O
knowledge	O
:	O
low	O
level	O
(<	O
mean	O
–	O
standard	O
deviation	O
),	O
medium	O
level	O
(	O
mean	O
±	O
standard	O
deviation	O
)	O
and	O
high	O
level	O
(>	O
mean	O
+	O
standard	O
deviation	O
).	O

Among	O
primiparous	O
(	O
first	O
-	O
time	O
)	O
mothers	O
,	O
women	O
with	O
the	O
highest	O
estimated	O
serum	O
levels	O
of	O
DDE	O
at	O
delivery	O
breastfed	O
for	O
a	O
median	O
of	O
13	O
.	O
0	O
weeks	O
,	O
compared	O
with	O
a	O
median	O
of	O
30	O
.	O
3	O
weeks	O
for	O
women	O
with	O
the	O
lowest	O
levels	O
;	O
among	O
multiparous	O
mothers	O
—	O
women	O
who	O
had	O
given	O
birth	O
previously	O
—	O
these	O
numbers	O
were	O
13	O
.	O
0	O
and	O
21	O
.	O
7	O
weeks	O
,	O
respectively	O
.	O

Long	O
-	O
acting	O
insulin	O
analogs	O
,	O
particularly	O
glargine	O
,	O
are	O
increasingly	O
being	O
used	O
in	O
women	O
with	O
type	O
1	O
diabetes	O
,	O
and	O
they	O
are	O
often	O
continued	O
through	O
the	O
pregnancy	O
.	O

Hence	O
,	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
influences	O
pregnancy	O
health	O
.	O

Introduction	O
Perinatal	O
health	O
outcomes	O
vary	O
dramatically	O
by	O
race	O
in	O
the	O
United	O
States	O
.	O
1African	O
American	O
women	O
develop	O
preeclampsia	O
more	O
often	B
than	O
their	O
white	O
counterparts2and	O
are	O
more	O
likely	B
to	O
develop	O
preterm	O
labor	O
.	O
3The	O
result	O
is	O
that	O
black	O
infants	O
are	O
60	O
%	O
more	O
likely	B
be	I
preterm	O
and	O
four	O
times	O
more	O
likely	B
to	O
die	O
due	O
to	O
prematurity	O
than	O
white	O
infants	O
.	O
1Because	B
of	O
less	O
efficient	O
vitamin	O
D	O
synthesis	O
in	O
the	O
skin	O
of	O
darker	O
pigmented	O
individuals	O
,	O
African	O
Americans	O
are	O
at	O
higher	O
risk	O
than	O
white	O
Americans	O
of	O
vitamin	O
D	O
deficiency	O
.	O
4	O
,	O
5Black	O
women	O
are	O
also	O
more	O
likely	B
than	O
white	O
women	O
to	O
be	O
overweight	O
or	O
obese6which	O
is	O
of	O
concern	O
because	B
obesity	O
is	O
another	O
risk	O
factor	O
for	O
vitamin	O
D	O
deficiency5	O
,	O
7and	O
poor	O
perinatal	O
outcomes	O
.	O
8In	O
observational	O
studies	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
[	O
OH	O
]	O
D	O
)	O
levels	O
have	O
been	O
shown	O
to	O
be	O
associated	O
with	O
higher	O
risk	O
of	O
several	O
adverse	O
perinatal	O
outcomes	O
including	O
gestational	O
diabetes9	O
,	O
10	O
,	O
preeclampsia	O
,	O
11preterm	O
birth12and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
status	O
.	O
13	O
,	O
14	O
,	O
15	O
,	O
16	O
,	O
17Because	B
of	O
the	O
paucity	O
of	O
vitamin	O
D	O
trial	O
data	O
with	O
respect	O
to	O
perinatal	O
outcomes	O
,	O
whether	O
differences	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
explains	O
or	O
partially	O
explains	O
perinatal	O
disparities	O
is	O
plausible18but	O
remains	O
unknown	O
.	O

[	O
21	O
]	O
and	O
validated	O
in	O
a	O
young	O
adolescent	O
population	O
[	O
22	O
].	O

2006	O
;	O
Wynne	O
-	O
Davies	O
1975	O
)	O
and	O
twin	O
studies	O
(	O
Kesling	O
and	O
Reinker	O
1997	O
)	O
have	O
shown	O
that	O
the	O
cause	O
of	O
spinal	O
deformities	O
,	O
including	O
scoliosis	O
and	O
kyphosis	O
,	O
can	O
have	O
a	O
genetic	O
component	O
.	O

The	O
perinatal	O
mortality	O
rate	O
was	O
2	O
.	O
6	O
%	O
in	O
these	O
women	O
with	O
‘	O
mild	O
GDM	O
’	O
in	O
the	O
1970s	O
,	O
compared	O
to	O
0	O
.	O
7	O
%,	O
in	O
the	O
1980s	O
after	O
routine	O
treatment	O
had	O
been	O
introduced	O
for	O
this	O
group	O
.	O

In	O
vivo	O
testing	O
should	O
generally	B
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	O
needed	O
.	O

demonstrated	O
no	O
adverse	O
effects	O
on	O
offspring	O
neurodevelopment	O
with	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
equal	O
to	O
or	O
greater	O
than	O
once	O
per	O
week	O
.	O

The	O
lower	O
acceptance	O
to	O
novel	O
foods	O
has	O
been	O
found	O
in	O
animals	O
with	O
protein	O
deficiency	O
from	O
early	O
gestational	O
stages	O
(	O
Peregoy	O
et	O
al	O
.,	O
1972	O
;	O
Pettus	O
et	O
al	O
.,	O
1974	O
)	O
and	O
could	O
be	O
associated	O
with	O
abnormal	O
behaviors	O
in	O
adulthood	O
related	O
to	O
anxiety	O
(	O
Peleg	O
-	O
Raibstein	O
et	O
al	O
.,	O
2012	O
).	O

Although	O
no	O
causality	O
was	O
found	O
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

2	O
.	O
9	O
.	O

Frequency	O
of	O
the	O
type	O
of	O
food	O
eaten	O
during	O
the	O
past	O
month	O
can	O
be	O
reported	O
by	O
the	O
mother	O
as	O
every	O
day	O
;	O
most	O
days	O
(	O
not	O
every	O
day	O
,	O
but	O
at	O
least	O
4	O
times	O
per	O
week	O
);	O
once	O
a	O
week	O
(	O
less	O
than	O
4	O
times	O
per	O
week	O
,	O
but	O
at	O
least	O
once	O
per	O
week	O
)	O
or	O
never	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
018	O
-	O
1887	O
-	O
x	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
premise	O
that	O
modification	O
in	O
the	O
fetal	O
environment	O
could	O
alter	O
ANS	O
development	O
.	O

Using	O
image	O
analysis	O
with	O
an	O
LC	O
Evolution	O
camera	O
on	O
an	O
Olympus	O
BX51	O
microscope	O
running	O
Image	O
-	O
Pro	O
Plus	O
software	O
version	O
7	O
.	O
01	O
for	O
Windows	O
(	O
Media	O
Cybernetics	O
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
),	O
glomerular	O
size	O
(	O
mean	O
diameter	O
)	O
was	O
estimated	O
as	O
described	O
elsewhere	O
using	O
a	O
minimum	O
of	O
100	O
glomeruli	O
per	O
group	O
among	O
those	O
cut	O
equatorially	O
[	O
19	O
].	O

Analyses	O
were	O
performed	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
Mass	O
spectrometer	O
API	O
4000	O
)	O
by	O
the	O
clinical	O
chemistry	O
laboratory	O
in	O
Region	O
Skåne	O
,	O
Sweden	O
,	O
certified	O
by	O
the	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
[	O
15	O
].	O

In	O
the	O
study	O
,	O
steers	O
from	O
dams	O
fed	O
a	O
corn	O
-	O
based	O
diet	O
during	O
late	O
gestation	O
had	O
a	O
lower	O
MS	O
compared	O
with	O
progeny	O
from	O
dams	O
fed	O
diets	O
low	O
in	O
starch	O
(	O
grass	O
hay	O
or	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
).	O

Timmermann	O
and	O
colleagues	O
estimated	O
that	O
breastfeeding	O
was	O
1	O
.	O
4	O
months	O
shorter	O
when	O
women	O
’	O
s	O
serum	O
levels	O
of	O
PFOS	O
were	O
doubled	O
and	O
1	O
.	O
3	O
months	O
shorter	O
when	O
their	O
levels	O
of	O
PFOA	O
were	O
doubled	O
.	O

The	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
decreased	O
for	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
,	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
smokers	O
and	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
.	O

Whatever	O
their	O
developmental	O
origin	O
,	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
seem	O
to	O
greatly	O
differ	O
in	O
their	O
function	O
.	O

Investigating	O
ways	O
to	O
improve	O
natural	O
immune	O
function	O
and	O
limit	O
the	O
number	O
of	O
infections	O
people	O
experience	O
is	O
of	O
great	O
importance	O
…	O
In	O
this	O
study	O
,	O
a	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
was	O
shown	O
.	O

All	O
five	O
assessments	O
were	O
successfully	O
completed	O
in	O
104	O
intervention	O
households	O
and	O
97	O
control	O
households	O
.	O

Training	O
of	O
trainers	O
involved	O
national	O
staff	O
training	O
staff	O
from	O
the	O
provincial	O
level	O
,	O
who	O
then	O
trained	O
district	O
,	O
commune	O
and	O
village	O
level	O
health	O
workers	O
.	O

Each	O
mouse	O
was	O
decapitated	O
,	O
and	O
the	O
kidneys	O
were	O
rapidly	O
removed	O
and	O
weighed	O
.	O

In	O
total	O
,	O
there	O
were	O
6	O
messages	O
related	O
to	O
risks	O
of	O
alcohol	O
consumption	O
,	O
spread	O
over	O
the	O
intervention	O
period	O
,	O
among	O
the	O
pregnancy	O
messages	O
delivered	O
.	O

110	O
Is	O
Pet	O
Ownership	O
Associated	O
with	O
Higher	O
Vitamin	O
D	O
?	O

However	O
,	O
due	B
to	I
recent	O
changes	O
in	O
national	O
health	O
policies	O
,	O
intake	O
of	O
vitamin	O
D	O
has	O
increased	O
resulting	O
in	O
decreasing	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
[	O
2	O
–	O
5	O
].	O

Symptoms	O
assessed	O
are	O
fever	O
,	O
diarrhoea	O
,	O
vomiting	O
,	O
nasal	O
discharge	O
,	O
coughing	O
,	O
diaper	O
and	O
other	O
rash	O
.	O

Results	O
from	O
several	O
studies	O
hint	O
that	O
non	O
-	O
genetic	O
factors	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
determination	O
of	O
handedness	O
.	O

Vitamin	O
D	O
may	O
act	O
as	B
an	O
anti	O
-	O
inflammatory	O
agent	O
in	O
the	O
brain	O
by	O
keeping	O
harmful	O
pro	O
-	O
inflammatory	O
cytokines	O
in	O
check	O
.	O

PubMed	O
Central	O
:	O

Effects	O
of	O
ethnicity	O
and	O
vitamin	O
D	O
supplementation	O
on	O
vitamin	O
D	O
status	O
and	O
changes	O
in	O
bone	O
mineral	O
content	O
in	O
infants	O
Abstract	O
Abstract	O
Background	O
To	O
evaluate	O
the	O
effects	O
on	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
bone	O
mineralization	O
of	O
supplementation	O
of	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
infants	O
with	O
vitamin	O
D	O
in	O
infants	O
in	O
Houston	O
,	O
Texas	O
.	O

However	O
,	O
if	O
the	O
mother	O
is	O
already	O
allergic	O
or	O
if	O
there	O
is	O
a	O
family	O
history	O
of	O
atopy	O
or	O
allergy	O
,	O
food	O
comprising	O
potential	O
allergens	O
should	O
be	O
avoided	O
.	O

These	O
processes	O
are	O
complex	O
and	O
normal	O
development	O
is	O
dependent	O
on	O
several	O
factors	O
.	O

All	O
the	O
investigators	O
will	O
have	O
the	O
right	O
to	O
analyse	O
and	O
publish	O
data	O
.	O

Women	O
at	O
their	O
first	O
pregnancy	O
and	O
those	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
more	O
likely	B
to	O
be	O
unsatisfied	O
with	O
the	O
ANC	O
services	O
they	O
received	O
at	O
their	O
attending	O
health	O
centres	O
.	O

With	O
thanks	O
to	O
Boston	O
Consulting	O
Group	O
.	O

In	O
conclusion	O
,	O
common	O
genetic	O
variation	O
is	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
in	O
pregnancy	O
and	O
the	O
response	O
to	O
antenatal	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
,	O
but	O
with	O
differing	O
SNPs	O
appearing	O
to	O
be	O
important	O
before	O
and	O
after	O
supplementation	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

In	O
addition	O
the	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
10	O
ng	O
/	O
ml	O
(	O
severe	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
severe	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
same	O
predictors	O
in	O
the	O
model	O
.	O

Intravenous	O
aminophylline	O
is	O
not	O
generally	B
recommended	O
in	O
the	O
emergency	O
management	O
of	O
acute	O
asthma	O
(	O
because	O
of	O
its	O
potentially	O
harmful	O
effects	O
)	O
but	O
may	O
be	O
used	O
in	O
pregnant	O
patients	O
hospitalized	O
for	O
acute	O
asthma	O
(	O
theophylline	O
levels	O
should	O
be	O
monitored	O
).	O

Women	O
with	O
missing	O
covariates	O
were	O
not	O
included	O
in	O
final	O
multivariable	O
models	O
.	O

After	O
controlling	O
for	O
potential	O
confounders	O
,	O
maternal	O
intake	O
of	O
free	O
sugar	O
was	O
positively	O
associated	O
with	O
atopy	O
(	O
OR	O
for	O
highest	O
versus	O
lowest	O
quintile	O
of	O
sugar	O
intake	O
1	O
.	O
38	O
,	O
95	O
%	O
CI	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
006	O
)	O
and	O
atopic	O
asthma	O
(	O
OR	O
2	O
.	O
01	O
,	O
95	O
%	O
CI	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
004	O
).	O

Data	O
from	O
the	O
feeding	O
response	O
to	O
AM251	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
treatment	O
and	O
diet	O
as	O
factors	O
.	O

Lipid	O
-	O
derived	O
immune	O
modulators	O
will	O
be	O
determined	O
with	O
LCMSMS	O
[	O
75	O
].	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

Authors	O
’	O
contributions	O
RS	O
:	O
Conception	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

BMI	O
,	O
defined	O
as	O
weight	O
in	O
kilograms	O
divided	O
by	O
height	O
in	O
meters	O
squared	O
,	O
was	O
calculated	O
.	O

Background	O
:	O
Since	O
classical	O
development	O
of	O
medicine	O
in	O
1920	O
,	O
Vitamin	O
D	O
(	O
cholecalciferol	O
,	O
VD	O
)	O
was	O
strongly	B
associated	O
with	O
rickets	O
,	O
after	O
observation	O
that	O
cod	O
liver	O
consumption	O
leads	B
to	O
a	O
regression	O
in	O
rickets	O
symptoms	O
[	O
3	O
].	O

Meanwhile	O
,	O
paternal	O
history	O
with	O
allergic	O
rhinitis	O
and	O
maternal	O
smoke	O
in	O
pregnancy	O
also	O
had	O
adverse	O
effect	O
on	O
lung	O
function	O
.	O

prematurity	O
[	O
21	O
,	O
22	O
],	O
impaired	O
fetal	O
growth	O
[	O
21	O
,	O
23	O
],	O
maternal	O
obesity	O
and	O
weight	O
gain	O
[	O
24	O
–	O
26	O
],	O
and	O
offspring	O
obesity	O
[	O
27	O
,	O
28	O
].	O

We	O
performed	O
secondary	O
analyses	O
restricting	O
to	O
women	O
who	O
initiated	O
PNV	O
use	O
before	O
pregnancy	O
only	O
and	O
after	O
pregnancy	O
only	O
and	O
compared	O
each	O
group	O
to	O
women	O
with	O
no	O
reported	O
PNV	O
use	O
.	O

Results	O
3	O
.	O
1	O
.	O

Volunteering	O
women	O
reporting	O
for	O
ANC	O
planned	O
visits	O
at	O
the	O
study	O
sites	O
were	O
sensitized	O
on	O
the	O
purpose	O
and	O
the	O
procedure	O
of	O
the	O
study	O
.	O

Our	O
findings	O
support	O
current	O
guidelines	B
to	O
begin	O
vitamin	O
D	O
supplementation	O
of	O
400	O
IU	O
/	O
day	O
to	O
all	O
breast	O
-	O
fed	O
infants	O
in	O
the	O
first	O
week	O
of	O
life	O
and	O
to	O
further	O
encourage	O
the	O
provision	O
of	O
adequate	O
vitamin	O
D	O
to	O
pregnant	O
women	O
.	O

The	O
visfatin	O
regulation	O
mechanism	O
in	O
human	O
fetal	O
blood	O
circulation	O
is	O
unknown	O
(	O
12	O
).	O

2	O
.	O
1	O
.	O

To	O
this	O
end	O
,	O
one	O
of	O
the	O
very	O
useful	O
tools	O
is	O
the	O
use	O
of	O
rodent	O
strains	O
with	O
different	O
sensitivities	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	O
resistance	O
.	O

Table	O
2presents	O
the	O
results	O
of	O
our	O
exploration	O
of	O
the	O
differences	O
in	O
the	O
measures	O
of	O
DNA	O
methylation	O
by	O
various	O
in	O
utero	O
exposures	O
.	O

Central	O
neck	O
and	O
upper	O
mediastinum	O
clearance	O
and	O
,	O
in	O
addition	O
,	O
mono	O
or	O
bilateral	O
node	O
dissection	O
(	O
depending	O
on	O
the	O
extent	O
of	O
nodal	O
involvement	O
)	O
is	O
also	O
advisable	O
.	O

This	O
study	O
reports	O
on	O
analysis	O
of	O
the	O
full	O
dataset	O
from	O
baseline	O
to	O
postpartum	O
follow	O
-	O
up	O
.	O

Materials	O
and	O
Methods	O
The	O
present	O
cohort	O
study	O
was	O
conducted	O
between	O
2013	O
and	O
2015	O
after	O
obtaining	O
approval	O
of	O
the	O
Research	O
Council	O
of	O
Tarbiat	O
Modares	O
University	O
,	O
Tehran	O
,	O
Iran	O
,	O
and	O
permission	O
from	O
the	O
Medical	O
Ethics	O
Committee	O
of	O
the	O
Faculty	O
of	O
Medical	O
Sciences	O
,	O
and	O
presenting	O
a	O
letter	O
of	O
introduction	O
from	O
the	O
university	O
to	O
selected	O
and	O
densely	O
populated	O
medical	O
centers	O
covered	O
by	O
Shahid	O
Beheshti	O
University	O
of	O
Medical	O
Sciences	O
in	O
the	O
north	O
,	O
east	O
,	O
and	O
Shemiranat	O
districts	O
of	O
Tehran	O
,	O
Iran	O
.	O

The	O
normal	O
BMI	O
range	O
is	O
18	O
.	O
5	O
–	O
25	O
kg	O
/	O
m2	O
,	O
although	O
the	O
range	O
may	O
vary	O
for	O
different	O
countries	O
.	O

The	O
model	O
allows	O
all	O
data	O
from	O
incomplete	O
families	O
to	O
be	O
used	O
.	O

There	O
were	O
1754	O
infants	O
who	O
were	O
assessed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
.	O

Four	O
large	O
cohort	O
studies	O
conducted	O
across	O
Sweden	O
,	O
Australia	O
,	O
and	O
Denmark	O
found	O
that	O
an	O
Apgar	O
score	O
of	O
7	O
has	O
a	O
strong	O
predictive	O
value	O
of	O
autism	O
[	O
18	O
,	O
54	O
–	O
56	O
];	O
similar	O
findings	O
were	O
reported	O
by	O
Garderner	O
et	O
al	O
.	O

Primary	O
outcome	O
The	O
primary	O
outcome	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
age	O
and	O
sex	O
at	O
follow	O
-	O
up	O
[	O
27	O
].	O

Model	O
2	O
:	O
model	O
controlled	O
for	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
education	O
>	O
secondary	O
school	O
,	O
being	O
part	O
of	O
the	O
ROLO	O
study	O
intervention	O
group	O
,	O
early	O
-	O
pregnancy	O
energy	O
(	O
kcal	O
),	O
early	O
-	O
pregnancy	O
protein	O
(	O
g	O
),	O
early	O
-	O
pregnancy	O
fat	O
(	O
g	O
),	O
moderate	O
-	O
vigorous	O
activity	O
,	O
well	O
-	O
being	O
score	O
and	O
dietary	O
supplements	O
Post	O
-	O
hoc	O
analysis	O
-	O
exploring	O
potential	O
confounders	O
Dietary	O
intakes	O
,	O
lifestyle	O
behaviours	O
,	O
and	O
emotional	O
well	O
-	O
being	O
were	O
analysed	O
by	O
season	O
of	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Table	O
S2	O
).	O

IMF	O
contents	O
in	O
the	O
5	O
muscles	O
(	O
biceps	O
femoris	O
,	O
supraspinatus	O
,	O
semitendinosus	O
,	O
longissimus	O
lumborum	O
,	O
and	O
infraspinatus	O
)	O
also	O
increased	O
along	O
with	O
the	O
increase	O
of	O
HCW	O
at	O
5	O
slaughter	O
stages	O
in	O
Angus	O
(	O
from	O
114	O
.	O
8	O
to	O
459	O
.	O
1	O
kg	O
),	O
Hereford	O
(	O
from	O
114	O
.	O
0	O
to	O
452	O
.	O
2	O
kg	O
),	O
and	O
Wagyu	O
×	O
Angus	O
(	O
from	O
116	O
.	O
8	O
to	O
459	O
.	O
2	O
kg	O
)	O
[	O
30	O
].	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

We	O
also	O
found	O
a	O
sex	O
effect	O
on	O
the	O
gene	O
expression	O
of	O
Chrebp	O
,	O
Acaca	O
,	O
Acox1	O
,	O
Srebf1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
,	O
Cpt1b	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
.	O

In	O
the	O
first	O
trimester	O
,	O
daily	O
needs	O
decrease	O
due	O
to	O
the	O
absence	O
of	O
menstruation	O
;	O
thereby	O
saving	O
about	O
0	O
.	O
56	O
mg	O
of	O
iron	O
per	O
day	O
,	O
or	O
160	O
mg	O
for	O
the	O
pregnancy	O
[	O
15	O
].	O

Furthermore	O
,	O
not	O
only	O
the	O
F1	O
generation	O
but	O
also	O
the	O
F2	O
generation	O
was	O
affected	O
by	O
the	O
gestational	O
vitamin	O
D	O
deficiency	O
of	O
the	O
F0	O
generation	O
mice	O
.	O

BMI	O
—	O
child	O
age	O
5	O
There	O
was	O
a	O
strong	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
,	O
similar	O
to	O
that	O
at	O
age	O
0	O
(	O
table	O
4	O
).	O

A	O
Danish	O
study	O
reported	O
that	O
adherence	O
with	O
an	O
iron	O
supplementation	O
regime	O
was	O
associated	O
with	O
maternal	O
age	O
(	O
over	O
20	O
years	O
),	O
primiparity	O
and	O
educational	O
level	O
[	O
18	O
].	O

Few	O
herb	O
users	O
discussed	O
use	O
with	O
their	O
providers	O
,	O
and	O
there	O
was	O
no	O
documentation	O
in	O
the	O
medical	O
record	O
.	O

A	O
further	O
limitation	O
is	O
that	O
the	O
OGTT	O
was	O
not	O
performed	O
on	O
all	O
mothers	O
,	O
and	O
a	O
slight	O
possibility	O
exists	O
that	O
the	O
actual	O
prevalence	O
of	O
GDM	O
might	O
be	O
underestimated	O
.	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

The	O
Muslim	O
community	O
in	O
Houston	O
represents	O
about	O
3	O
%	O
of	O
the	O
population	O
,	O
and	O
therefore	O
,	O
mothers	O
were	O
asked	O
if	O
they	O
had	O
any	O
religious	O
or	O
cultural	O
practices	O
that	O
included	O
covering	O
their	O
head	O
and	O
bodies	O
with	O
clothing	O
in	O
the	O
context	O
that	O
this	O
may	O
affect	O
sunlight	O
exposure	O
and	O
therefore	O
cord	O
25	O
(	O
OHD	O
)	O
values	O
.	O

Additionally	O
,	O
there	O
is	O
a	O
high	O
correlation	O
between	O
vitamin	O
D	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
(	O
correlation	O
=	O
0	O
.	O
77	O
).	O

Critics	O
of	O
these	O
genetic	O
predisposition	O
argued	O
that	O
since	O
many	O
genes	O
are	O
involved	O
in	O
the	O
etiology	O
of	O
autism	O
,	O
the	O
role	O
of	O
any	O
single	O
gene	O
polymorphism	O
in	O
causing	O
autism	O
is	O
small	O
.	O

First	O
trimester	O
BMI	O
was	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
for	O
both	O
first	O
and	O
third	O
trimester	O
pregnant	O
women	O
.	O

The	O
calculation	O
was	O
based	O
on	O
a	O
small	O
effect	O
size	O
F2of	O
0	O
.	O
05	O
;	O
probability	O
of	O
error	O
(	O
alpha	O
)	O
of	O
5	O
%;	O
a	O
power	O
of	O
80	O
%	O
and	O
ten	O
predictors	O
on	O
the	O
birth	O
outcome	O
“	O
low	O
birth	O
weight	O
”.	O

A	O
Pearson	O
correlation	O
was	O
used	O
to	O
examine	O
the	O
correlation	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extents	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
show	O
that	O
low	O
cord	O
—	O
and	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
relatively	O
poor	O
lung	O
performance	O
at	O
6	O
months	O
of	O
age	O
.	O

The	O
increase	O
in	O
haemoglobin	O
concentration	O
in	O
the	O
intervention	O
group	O
relative	O
to	O
placebo	O
was	O
more	O
marked	O
in	O
women	O
who	O
were	O
anaemic	O
at	O
the	O
start	O
of	O
the	O
study	O
(	O
Figure	O
2	O
).	O

The	O
mean	O
kidney	O
mass	O
(	O
KM	O
;	O
mean	O
±	O
SEM	O
,	O
n	O
=	O
6	O
animals	O
each	O
group	O
)	O
varied	O
from	O
8	O
.	O
2	O
±	O
0	O
.	O
2	O
mg	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
10	O
.	O
3	O
±	O
0	O
.	O
4	O
mg	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
),	O
with	O
more	O
than	O
25	O
%	O
variation	O
between	O
the	O
groups	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

Schools	O
'	O
food	O
policies	O
affect	O
student	O
BMI	O
;	O
in	O
1	O
study	O
,	O
as	B
the	O
number	O
of	O
school	O
food	O
policies	O
increased	O
,	O
students	O
'	O
mean	O
BMI	O
decreased	O
(	O
93	O
).	O

There	O
are	O
other	O
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	O
be	O
assessed	O
,	O
for	O
example	O
using	O
zebrafish	O
models	O
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	B
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

The	O
association	O
of	O
later	O
life	O
health	O
with	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
environmental	O
factors	O
has	O
led	O
to	O
the	O
“	O
Developmental	O
Origins	O
of	O
Health	O
and	O
Disease	O
”	O
(	O
DOHaD	O
)	O
hypothesis	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

1999	O
).	O

The	O
differential	O
response	O
to	O
the	O
maternal	O
undernutrition	O
in	O
energy	O
balance	O
is	O
sexual	O
dimorphism	O
dependent	O
during	O
the	O
post	O
-	O
weaning	O
periods	O
.	O

Consequently	O
,	O
only	O
genes	O
whose	O
regulation	O
between	O
two	O
consecutive	O
ontogenetic	O
stages	O
(	O
period	O
I	O
:	O
94dpc	O
-	O
1dpn	O
;	O
period	O
II	O
:	O
1dpn	O
-	O
28dpn	O
;	O
period	O
III	O
:	O
28dpn	O
-	O
188dpn	O
)	O
was	O
private	O
to	O
either	O
the	O
LP	O
or	O
the	O
AP	O
group	O
were	O
analysed	O
(	O
Table1	O
).	O

We	O
considered	O
the	O
period	O
from	O
2010	O
to	O
2015	O
and	O
then	O
through	O
2025	O
to	O
allow	O
for	O
a	O
more	O
feasible	O
time	O
frame	O
to	O
scale	O
up	O
care	O
and	O
progress	O
on	O
the	O
prevention	O
agenda	O
.	O

Such	O
findings	O
will	O
be	O
used	O
to	O
implement	O
informative	O
interventional	O
programs	O
to	O
control	O
impaired	O
fetal	O
growth	O
and	O
develop	O
practical	O
policies	O
to	O
improve	O
the	O
diet	O
quality	O
among	O
pregnant	O
women	O
.	O

Lower	O
25OHD	O
in	O
early	O
pregnancy	O
was	O
only	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Gluckman	O
et	O
al	O
.	O

The	O
clinic	O
’	O
s	O
geographical	O
location	O
(	O
region	O
)	O
should	O
also	O
be	O
analyzed	O
,	O
because	B
the	O
midyear	O
UVB	O
intensity	O
and	O
VD	O
intake	O
in	O
diet	O
are	O
different	O
between	O
populations	O
.	O

Slaughter	O
weight	O
IMF	O
content	O
or	O
MS	O
generally	B
increases	O
with	O
slaughter	O
weight	O
in	O
several	O
cattle	O
breeds	O
.	O

There	O
is	O
also	O
evidence	O
that	O
decreased	O
parasympathetic	O
activity	O
is	O
correlated	O
with	O
high	O
blood	O
pressure	O
and	O
obesity	O
in	O
childhood	O
[	O
41	O
].	O

Because	B
of	O
its	O
steroid	O
structure	O
and	O
function	O
,	O
vitamin	O
D	O
plays	O
an	O
important	O
role	O
in	O
priming	O
cells	O
for	O
other	O
hormones	O
to	O
do	O
their	O
action	O
.	O

(	O
A	O
)	O
female	O
offspring	O
of	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

Further	O
,	O
a	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
can	O
not	O
be	O
concluded	O
from	O
this	O
study	O
.	O

The	O
fact	O
that	O
several	O
risk	O
factors	O
during	O
the	O
prenatal	O
and	O
labor	O
periods	O
are	O
implicated	O
in	O
autism	O
should	O
prompt	O
the	O
medical	O
community	O
to	O
focus	O
on	O
the	O
pregnancy	O
and	O
labor	O
periods	O
as	O
preventive	O
measures	O
to	O
curb	O
the	O
incidence	O
of	O
autism	O
.	O

The	O
ubiquitous	O
presence	O
of	O
vitamin	O
D	O
receptors	O
in	O
most	O
tissues	O
,	O
including	O
the	O
placenta	O
,	O
suggests	O
that	O
vitamin	O
D	O
may	O
have	O
other	O
roles	O
as	O
well	O
.	O

Should	O
Men	O
Take	O
Prenatal	O
Vitamins	O
?	O

Our	O
purpose	O
was	O
to	O
assess	O
if	O
there	O
are	O
any	O
similarities	O
in	O
BMI	O
patterns	O
within	O
families	O
and	O
whether	O
similarities	O
are	O
constant	O
over	O
the	O
three	O
time	O
points	O
and	O
across	O
generations	O
.	O

“	O
This	O
gives	O
us	O
more	O
confidence	O
that	O
the	O
association	O
is	O
not	B
due	I
to	O
reverse	O
causation	O
and	O
is	O
real	O
,”	O
says	O
Timmermann	O
.	O

However	O
,	O
adequate	O
maternal	O
intakes	O
of	O
zinc	O
and	O
vitamin	O
A	O
may	O
also	O
be	O
important	O
for	O
optimal	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
for	O
maternal	O
and	O
offspring	O
health	O
[	O
11	O
–	O
13	O
].	O

A	O
number	O
of	O
specific	O
actions	O
,	O
pursued	O
by	O
all	O
partners	O
and	O
applied	O
across	O
the	O
RMNCH	O
continuum	O
of	O
care	O
,	O
will	O
help	O
prevent	O
preterm	O
birth	O
and	O
associated	O
mortality	O
,	O
and	O
have	O
an	O
immediate	O
,	O
profound	O
and	O
sustained	O
impact	O
on	O
human	O
capital	O
.	O

Should	O
these	O
data	O
be	O
replicated	O
in	O
a	O
much	O
wider	O
cohort	O
,	O
given	B
the	O
simplicity	O
in	O
assessing	O
such	O
attitudes	O
and	O
the	O
feasibility	O
to	O
identify	O
the	O
homozygous	O
group	O
of	O
women	O
early	O
on	O
in	O
pregnancy	O
,	O
these	O
findings	O
may	O
have	O
significant	O
implications	O
for	O
public	O
health	O
and	O
prevention	O
.	O

However	O
this	O
current	O
practice	O
is	O
based	B
on	I
the	O
skeletal	O
actions	O
of	O
the	O
vitamin	O
and	O
may	O
not	O
be	O
applicable	O
for	O
its	O
non	O
-	O
classic	O
actions	O
.	O

If	O
the	O
delivery	O
is	O
induced	O
or	O
caesarean	O
section	O
conducted	O
,	O
the	O
reason	O
for	O
this	O
intervention	O
is	O
obtained	O
.	O

Measurement	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
Blood	O
was	O
collected	O
after	O
overnight	O
fasting	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
(	O
Molecular	O
weight	O
412	O
.	O
66	O
)	O
and	O
D3	O
(	O
Molecular	O
weight	O
400	O
.	O
63	O
)	O
levels	O
were	O
measured	O
by	O
using	O
LC	O
-	O
MS	O
/	O
MS	O
(	O
Waters	O
UPLC	O
,	O
AB	O
Sciex	O
4000QTRP	O
),	O
and	O
then	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
was	O
calculated	O
.	O

adjusted	O
for	O
paternal	O
IQ	O
but	O
not	O
the	O
home	O
environment	O
[	O
22	O
,	O
23	O
].	O

The	O
use	O
of	O
self	O
-	O
reported	O
snoring	O
as	O
a	O
tool	O
to	O
detect	O
sleep	O
disordered	O
breathing	O
is	O
well	B
established	I
.	O

Further	O
evidence	O
supporting	O
the	O
safety	O
of	O
glyburide	O
for	O
the	O
fetus	O
comes	O
from	O
a	O
study	O
using	O
an	O
in	O
vitro	O
perfusion	O
,	O
where	O
it	O
was	O
not	O
found	O
to	O
cross	O
the	O
placenta	O
in	O
significant	O
amounts	O
.	O
66However	O
,	O
another	O
in	O
vitro	O
study	O
has	O
found	O
transplacental	O
transfer	O
of	O
glyburide	O
.	O
67In	O
the	O
Langer	O
randomized	O
controlled	O
trial	O
,	O
glyburide	O
was	O
not	O
detected	O
in	O
the	O
cord	O
blood	O
of	O
the	O
neonates	O
and	O
cord	O
insulin	O
levels	O
were	O
similar	O
between	O
the	O
two	O
groups	O
.	O
57	O
Metformin	O
A	O
number	O
of	O
studies	O
have	O
provided	O
conflicting	O
information	O
regarding	O
the	O
safety	O
of	O
metformin	O
use	O
in	O
type	O
2	O
diabetic	O
pregnancy	O
.	O
68	O
–	O
70There	O
are	O
studies	O
which	O
have	O
used	O
metformin	O
during	O
pregnancy	O
in	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
,	O
without	O
any	O
noticeable	O
adverse	O
effects	O
on	O
the	O
fetus	O
.	O
71There	O
are	O
few	O
publications	O
of	O
its	O
use	O
in	O
GDM	O
,	O
and	O
these	O
are	O
dominated	O
by	O
the	O
Metformin	O
in	O
Gestational	O
Diabetes	O
(	O
MiG	O
)	O
Study	O
.	O

The	O
above	O
studies	O
provide	O
reassurance	B
that	O
moderate	O
intensity	O
activities	O
such	O
as	O
walking	O
for	O
20	O
–	O
30	O
minutes	O
each	O
day	O
,	O
and	O
attendance	O
at	O
antenatal	O
exercise	O
classes	O
can	O
be	O
safely	O
encouraged	O
,	O
and	O
that	O
modest	O
improvements	O
in	O
glycemic	O
control	O
might	O
be	O
achieved	O
.	O

In	O
contrast	O
,	O
the	O
RC	O
males	O
presented	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
whereas	O
RC	O
females	O
showed	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Faah	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Napepld	O
in	O
PAT	O
,	O
compared	O
to	O
those	O
of	O
their	O
respective	O
CC	O
offspring	O
(	O
Figures4B	O
,	O
C	O
).	O

PubMed	O
Central	O
:	O

Dietary	O
Reference	O
Intakes	O
for	O
macronutrients	O
Institute	O
of	O
Medicine	O
,	O
National	O
Academic	O
Press	O
,	O
Washington	O
:	O
2005	O
).	O

However	O
,	O
this	O
review	O
did	O
not	O
include	O
antenatal	O
iron	O
and	O
folic	O
acid	O
(	O
IFA	O
)	O
supplementation	O
for	O
pregnant	O
women	O
.	O

In	O
group	O
A	O
,	O
there	O
was	O
a	O
strong	O
positive	O
relationship	O
between	O
birth	O
head	O
circumference	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
054	O
,	O
r1	O
=	O
0	O
.	O
580	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
051	O
,	O
r2	O
=	O
0	O
.	O
530	O
).	O

When	O
analyses	O
were	O
restricted	O
to	O
overweight	O
women	O
,	O
we	O
noted	O
that	O
the	O
GDM	O
risk	O
was	O
reduced	O
by	O
24	O
%	O
for	O
each	O
sleep	O
hour	O
increment	O
(	O
RR	O
=	O
0	O
.	O
76	O
;	O
95	O
%	O
CI	O
0	O
.	O
57	O
-	O
1	O
.	O
00	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
),	O
but	O
again	O
the	O
association	O
was	O
not	O
statistically	O
significant	O
.	O

Other	O
disadvantages	O
of	O
intravenous	O
iron	O
supplementation	O
include	O
cost	O
and	O
invasiveness	O
of	O
the	O
procedure	O
.	O

It	O
would	O
not	O
be	O
possible	O
however	O
to	O
relate	O
such	O
levels	O
to	O
prenatal	O
exposure	O
.	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

In	O
humans	O
,	O
a	O
unique	O
patient	O
suffering	O
from	O
extreme	O
diabetes	O
due	O
to	O
a	O
mutation	O
in	O
the	O
insulin	O
receptor	O
gene	O
had	O
to	O
undergo	O
total	O
thyroidectomy	O
because	O
of	O
the	O
presence	O
of	O
a	O
papillary	O
carcinoma	O
.	O

Serum	O
25OHD	O
,	O
fasting	O
glucose	O
,	O
insulin	O
and	O
insulin	O
resistance	O
(	O
HOMA	O
-	O
IR	O
)	O
were	O
measured	O
in	O
early	O
(	O
12	O
weeks	O
’	O
gestation	O
)	O
and	O
late	O
pregnancy	O
(	O
28	O
weeks	O
’	O
gestation	O
).	O

Another	O
possible	O
explanation	B
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

Information	O
on	O
IUFD	O
was	O
collected	O
from	O
medical	O
records	O
from	O
the	O
obstetrics	O
care	O
.	O

Early	O
identification	O
of	O
pregnancy	O
In	O
the	O
intervention	O
clusters	O
,	O
trained	O
SS	O
will	O
identify	O
pregnant	O
women	O
through	O
systematic	O
door	O
-	O
to	O
-	O
door	O
visits	O
of	O
the	O
households	O
in	O
her	O
catchment	O
area	O
and	O
follow	O
-	O
up	O
with	O
all	O
women	O
of	O
reproductive	O
age	O
about	O
their	O
recent	O
history	O
of	O
missed	O
menstrual	O
periods	O
.	O

The	O
latter	O
goal	O
was	O
set	O
through	O
consultation	O
by	O
a	O
group	O
of	O
technical	O
experts	O
,	O
and	O
several	O
analyses	O
were	O
undertaken	O
to	O
inform	O
this	O
target	O
,	O
notably	O
(	O
1	O
)	O
projections	O
by	O
country	O
of	O
the	O
deaths	O
due	O
to	O
preterm	O
birth	O
from	O
now	O
until	O
2025	O
,	O
assuming	O
no	O
change	O
in	O
trends	O
and	O
assuming	O
expected	O
changes	O
in	O
Gross	O
National	O
Income	O
(	O
GNI	O
);	O
(	O
2	O
)	O
reduction	O
in	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
if	O
the	O
historical	O
trends	O
from	O
the	O
United	O
Kingdom	O
or	O
the	O
United	O
States	O
(	O
Figure4	O
)	O
were	O
applied	O
or	O
if	O
more	O
rapid	O
recent	O
reductions	O
in	O
middle	O
-	O
income	O
countries	O
were	O
applied	O
(	O
Figures5and6	O
);	O
(	O
3	O
)	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
reductions	O
predicted	O
based	O
on	O
coverage	O
changes	O
according	O
to	O
the	O
Lives	O
Saved	O
Tool	O
Modelling	O
(	O
Table2	O
).	O

We	O
found	O
a	O
significant	O
correlation	O
(	O
at	O
the	O
0	O
.	O
01	O
level	O
,	O
two	O
-	O
tailed	O
)	O
between	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
and	O
neonatal	O
birth	O
weight	O
.	O

Using	O
moderate	O
-	O
high	O
as	O
a	O
reference	O
(	O
standardised	O
vitamin	O
D	O
63	O
–	O
81	O
nmol	O
/	O
L	O
),	O
there	O
was	O
no	O
appreciable	O
effect	O
of	O
having	O
a	O
low	O
,	O
low	O
-	O
moderate	O
or	O
high	O
vitamin	O
D	O
with	O
the	O
risk	O
of	O
developing	O
any	O
pregnancy	O
complication	O
after	O
adjusting	O
for	O
confounders	O
.	O

The	O
20	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
and	O
held	O
at	O
4	O
°	O
C	O
.	O

Similarly	O
,	O
rs10741657	O
(	O
CYP2R1	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
were	O
associated	O
with	O
the	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
in	O
women	O
who	O
received	O
the	O
cholecalciferol	O
supplement	O
,	O
whereas	O
rs12785878	O
(	O
DHCR7	O
)	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
were	O
not	O
(	O
Fig	O
.	O

Conclusion	O
.	O

A	O
large	O
literature	O
primarily	O
focused	O
on	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
suggest	O
that	O
sleep	O
loss	O
adversely	O
affects	O
glucose	O
metabolism	O
and	O
increases	O
the	O
risk	O
of	O
type	O
2	O
diabetes	O
[	O
4	O
,	O
11	O
,	O
16	O
,	O
32	O
-	O
35	O
].	O

In	O
the	O
presence	O
of	O
adequate	O
concentrations	O
of	O
calcifediol	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
),	O
CYP27B1	O
leads	O
to	O
an	O
increase	O
synthesis	O
of	O
intracellular	O
calcitriol	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
).	O

Results	O
T1	O
25OHD	O
was	O
negatively	O
associated	O
with	O
pregnancy	O
loss	O
and	O
1	O
nmol	O
/	O
L	O
increase	O
in	O
25OHD	O
was	O
associated	O
with	O
1	O
%	O
lower	O
odds	O
of	O
pregnancy	O
loss	O
(	O
OR	O
0	O
.	O
99	O
,	O
p	O
=	O
0	O
.	O
046	O
).	O

Written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
/	O
guardians	O
on	O
behalf	O
of	O
the	O
children	O
enrolled	O
in	O
this	O
study	O
.	O

However	O
,	O
we	O
were	O
not	O
able	O
take	O
environmental	O
factors	O
and	O
geographic	O
area	O
into	O
account	O
,	O
because	O
the	O
study	O
questionnaire	O
did	O
not	O
assess	O
the	O
origin	O
of	O
fish	O
,	O
such	O
as	O
the	O
Baltic	O
Sea	O
or	O
the	O
Atlantic	O
Ocean	O
.	O

They	O
concluded	O
that	O
the	O
TT	O
genotype	O
of	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
is	O
related	O
to	O
greater	O
IMF	O
than	O
the	O
CC	O
genotype	O
when	O
vitamin	O
A	O
is	O
restricted	O
,	O
and	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
could	O
be	O
a	O
genetic	O
marker	O
for	O
enhancing	O
marbling	O
in	O
feedlot	O
steers	O
.	O

Fourth	O
,	O
we	O
based	B
our	O
calculation	O
of	O
gestational	O
age	O
at	O
delivery	O
on	O
LMP	O
which	O
is	O
known	O
to	O
be	O
subject	O
to	O
recall	O
bias	O
and	O
could	O
have	O
introduced	O
errors	O
in	O
our	O
calculations	O
[	O
53	O
].	O

The	O
models	O
will	O
evaluate	O
the	O
impact	O
of	O
the	O
interventions	O
over	O
time	O
by	O
testing	O
for	O
an	O
interaction	O
between	O
time	O
and	O
intervention	O
group	O
.	O

We	O
will	O
conduct	O
analyses	O
to	O
identify	O
the	O
subgroups	O
(	O
based	O
on	O
household	O
wealth	O
,	O
sex	O
of	O
infant	O
and	O
maternal	O
education	O
)	O
that	O
modify	O
the	O
response	O
to	O
the	O
intervention	O
.	O

In	O
early	O
childhood	O
,	O
feeding	O
practices	O
,	O
taste	O
acquisition	O
,	O
and	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
must	O
be	O
considered	O
.	O

Morton	O
et	O
al	O
16indicate	O
that	O
population	O
strategies	O
aimed	O
at	O
optimising	O
size	O
at	O
birth	O
require	O
intergenerational	O
considerations	O
for	O
social	O
as	O
well	O
as	O
biological	O
reasons	O
.	O

We	O
will	O
use	O
sensitivity	O
analyses	O
of	O
the	O
findings	O
to	O
assess	O
uncertainty	O
in	O
key	O
parameters	O
.	O

Additionally	O
,	O
glucose	O
concentrations	O
were	O
statistically	O
significantly	O
elevated	O
among	O
women	O
who	O
snored	O
during	O
pregnancy	O
;	O
and	O
the	O
relative	O
risk	O
of	O
GDM	O
among	O
overweight	O
women	O
who	O
snored	O
,	O
compared	O
to	O
their	O
non	O
-	O
snoring	O
and	O
lean	O
counterparts	O
was	O
6	O
.	O
91	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

One	O
mechanism	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
affected	O
by	O
maternal	O
diet	O
is	O
via	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
at	O
delivery	O
.	O

This	O
was	O
done	O
using	O
a	O
sequential	O
list	O
prepared	O
based	O
on	O
tables	O
of	O
random	O
numbers	O
.	O

Vitamin	O
and	O
mineral	O
supplements	O
are	O
recommended	O
for	O
women	O
with	O
multiple	O
pregnancy	O
,	O
those	O
who	O
misuse	O
alcohol	O
or	O
drugs	O
,	O
or	O
have	O
an	O
unbalanced	O
diet	O
[	O
32	O
].	O

Same	O
result	O
was	O
obtained	O
about	O
healthy	O
dietary	O
pattern	O
[	O
OR	O
3	O
.	O
70	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
72	O
-	O
17	O
.	O
86	O
),	O
P	O
=	O
0	O
.	O
52	O
].	O

It	O
will	O
be	O
valuable	O
to	O
utilise	O
our	O
clinical	O
and	O
biological	O
databases	O
to	O
explore	O
potential	O
pathways	O
whereby	O
maternal	O
obesity	O
contributes	O
to	O
childhood	O
outcomes	O
,	O
including	O
obesity	O
and	O
impaired	O
neurodevelopment	O
.	O

While	O
statistically	O
significant	O
,	O
the	O
clinical	O
significance	O
of	O
such	O
a	O
small	O
difference	O
is	O
questionable	O
,	O
the	O
findings	O
also	O
consistent	O
with	O
a	O
chance	O
occurrence	O
,	O
particularly	O
as	O
this	O
was	O
a	O
secondary	O
outcome	O
,	O
and	O
no	O
other	O
statistically	O
significant	O
differences	O
were	O
identified	O
between	O
the	O
treatment	O
groups	O
in	O
infant	O
BMI	O
,	O
abdominal	O
circumference	O
,	O
or	O
the	O
remainder	O
of	O
infant	O
anthropometric	O
measures	O
obtained	O
.	O

In	O
perinatal	O
piglets	O
(	O
stage	O
1	O
dpn	O
)	O
1	O
probe	O
-	O
set	O
differed	O
between	O
LP	O
offspring	O
and	O
AP	O
offspring	O
(	O
0	O
increased	O
).	O

2	O
.	O
4	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

Given	O
the	O
very	O
high	O
levels	O
of	O
sugar	O
consumption	O
currently	O
in	O
the	O
West	O
,	O
where	O
childhood	O
allergy	O
and	O
asthma	O
are	O
so	O
prevalent	O
,	O
confirmation	O
of	O
a	O
causal	O
link	O
would	O
raise	O
exciting	O
prospects	O
for	O
the	O
primary	O
prevention	O
of	O
these	O
disorders	O
.	O

We	O
demultiplexed	O
and	O
divided	O
datasets	O
using	O
Illumina	O
MiSeq	O
Reporter	O
and	O
a	O
custom	O
Python	O
script	O
.	O

The	O
relative	O
quantification	O
method	O
was	O
performed	O
using	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
;	O
Cat	O
#	O
Rn99999916_s1	O
)	O
as	O
an	O
endogenous	O
control	O
,	O
which	O
was	O
selected	O
based	O
on	O
a	O
preliminary	O
screen	O
for	O
its	O
lowest	O
variation	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
,	O
independently	O
of	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

(	O
2015	O
)*	O
Kundakovic	O
et	O
al	O
.	O

Paradoxically	O
,	O
central	O
IL	O
-	O
6	O
delivery	O
was	O
shown	O
to	O
suppress	O
weight	O
gain	O
and	O
visceral	O
obesity	O
,	O
without	O
affecting	O
food	O
intake	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Our	O
results	O
further	O
show	O
different	O
metabolic	O
regulations	O
in	O
groups	O
A	O
and	O
B	O
,	O
which	O
may	O
be	O
due	B
to	I
differences	O
in	O
expression	O
of	O
SIRT1	O
,	O
glucose	O
transfer	O
or	O
insulin	O
resistance	O
as	O
a	O
result	O
of	O
resistance	O
to	O
glucose	O
entry	O
to	O
fetal	O
tissues	O
for	O
unknown	O
reasons	O
,	O
which	O
require	O
further	O
studies	O
.	O

Food	O
intake	O
was	O
recorded	O
daily	O
until	O
the	O
end	O
of	O
pregnancy	O
.	O

Materials	O
and	O
Methods	O
Ethics	O
Statement	O
All	O
animal	O
work	O
was	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
University	O
of	O
Auckland	O
.	O

All	O
calves	O
were	O
then	O
fed	O
the	O
same	O
diet	O
for	O
22	O
months	O
,	O
and	O
muscle	O
tissues	O
were	O
collected	O
by	O
biopsy	O
.	O

After	O
expert	O
review	O
,	O
the	O
final	O
questionnaire	O
used	O
had	O
29	O
items	O
(	O
see	O
Additional	O
file1	O
).	O

SGA	O
was	O
defined	O
as	O
weight	O
and	O
/	O
or	O
length	O
at	O
birth	O
<	O
2	O
SD	O
of	O
the	O
population	O
mean	O
and	O
LBW	O
as	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
<	O
37	O
+	O
0	O
gestational	O
weeks	O
and	O
pregnancy	O
loss	O
as	O
spontaneous	O
abortion	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Part	O
of	O
an	O
adaptive	O
response	O
to	O
early	O
life	O
nutritional	O
challenge	O
might	O
therefore	B
be	O
expected	O
to	O
be	O
an	O
acceleration	O
in	O
the	O
age	O
of	O
reproductive	O
maturation	O
,	O
provided	O
that	O
the	O
organism	O
can	O
metabolically	O
sustain	O
earlier	O
reproduction	O
without	O
further	O
compromising	O
its	O
own	O
viability	O
.	O

Further	O
,	O
Gangwisch	O
et	O
al	O
,	O
in	O
their	O
analysis	O
of	O
data	O
from	O
the	O
first	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
(	O
NHANES	O
I	O
)	O
noted	O
that	O
individuals	O
reporting	O
≤	O
5	O
hours	O
of	O
sleep	O
(	O
OR	O
=	O
1	O
.	O
47	O
;	O
95	O
%	O
CI	O
1	O
.	O
03	O
-	O
2	O
.	O
09	O
)	O
and	O
those	O
reporting	O
sleeping	O
≥	O
9	O
hours	O
(	O
OR	O
=	O
1	O
.	O
52	O
;	O
95	O
%	O
CI	O
1	O
.	O
06	O
-	O
2	O
.	O
18	O
)	O
had	O
increased	O
risks	O
of	O
developing	O
diabetes	O
as	O
compared	O
to	O
those	O
reporting	O
7	O
hours	O
of	O
sleep	O
[	O
34	O
].	O

Of	O
these	O
,	O
952	O
probe	O
-	O
sets	O
showed	O
higher	O
expression	O
and	O
1	O
,	O
132	O
probe	O
-	O
sets	O
showed	O
lower	O
expression	O
in	O
LP	O
than	O
in	O
AP	O
offspring	O
.	O

This	O
DSMB	O
is	O
responsible	O
for	O
assessing	O
the	O
interim	O
data	O
,	O
data	O
quality	O
,	O
data	O
completeness	O
,	O
adequacy	O
of	O
compliance	O
with	O
goals	O
for	O
recruitment	O
and	O
retention	O
,	O
and	O
factors	O
that	O
might	O
affect	O
the	O
study	O
outcome	O
or	O
compromise	O
the	O
confidentiality	O
of	O
the	O
trial	O
data	O
.	O

Due	O
to	O
the	O
normal	O
dietary	O
conditions	O
at	O
juvenile	O
and	O
adult	O
stages	O
the	O
alterations	O
found	O
here	O
can	O
be	O
regarded	O
as	O
fetal	O
nutritional	O
programming	O
.	O

We	O
recruited	O
385	O
consenting	O
pregnant	O
women	O
for	O
the	O
study	O
.	O

It	O
demonstrated	O
an	O
association	O
between	O
in	O
utero	O
exposure	O
to	O
both	O
SSRIs	O
and	O
nonselective	O
monoamine	O
reuptake	O
inhibitors	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
,	O
particularly	O
without	O
intellectual	O
disability	O
.	O

Mean	O
haemoglobin	O
concentration	O
change	O
(	O
baseline	O
to	O
follow	O
-	O
up	O
)	O
was	O
compared	O
between	O
treatment	O
groups	O
with	O
analysis	O
of	O
covariance	O
.	O

Short	O
-	O
term	O
diets	O
comprised	O
solely	O
of	O
either	O
plant	O
or	O
animal	O
foods	O
have	O
been	O
shown	O
to	O
alter	O
the	O
human	O
gut	O
microbiome	O
[	O
3	O
].	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

Therefore	B
glyburide	O
has	O
the	O
potential	O
to	O
result	O
in	O
earlier	O
development	O
of	O
maternal	O
diabetes	O
,	O
and	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
mothers	O
are	O
needed	O
to	O
alleviate	O
this	O
concern	O
.	O

Limitations	O
Vitamin	O
D	O
consumption	O
by	O
mothers	O
was	O
merely	O
controlled	O
through	O
reminders	O
during	O
prenatal	O
care	O
visits	O
or	O
over	O
the	O
phone	O
.	O

Although	O
self	O
-	O
reported	O
alcohol	O
consumption	O
would	O
be	O
expected	O
to	O
be	O
lower	O
after	O
pregnancy	O
given	B
social	O
cues	O
and	O
available	O
information	O
about	O
health	O
risks	O
for	O
all	O
participants	O
,	O
the	O
dose	O
-	O
response	O
effect	O
among	O
text4baby	O
participants	O
was	O
pronounced	O
,	O
as	B
high	O
-	O
dose	O
participants	O
were	O
more	O
than	O
twice	O
as	O
likely	B
to	O
abstain	O
from	O
drinking	O
compared	O
to	O
low	O
-	O
dose	O
participants	O
.	O

W	O
Epidemiological	O
analyses	O
implicated	O
high	O
dietary	O
vitamin	O
D	O
intake	O
during	O
pregnancy	O
results	O
in	O
birth	O
of	O
syndromic	O
babies	O
.	O

Mice	O
fed	O
with	O
a	O
folate	O
deficient	O
diet	O
were	O
less	O
fertile	O
(	O
52	O
%	O
vs	O
.	O
85	O
%)	O
and	O
experienced	O
a	O
greater	O
post	O
-	O
implantation	O
loss	O
than	O
mice	O
fathered	O
by	O
mice	O
with	O
a	O
folate	O
sufficient	O
diet	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
with	O
propensity	O
score	O
matching	O
(	O
PSM	O
)	O
analysis	O
*,	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonVaccinated	O
in	O
first	O
trimester	O
(	O
n	O
=	O
280	O
)	O
Vaccinated	O
in	O
second	O
trimester	O
(	O
n	O
=	O
1600	O
)	O
Vaccinated	O
in	O
third	O
trimester	O
(	O
n	O
=	O
1162	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
×	O
1000sim	O
***	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
0	O
.	O
90	O
(	O
0	O
.	O
40	O
;	O
2	O
.	O
03	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
86	O
;	O
1	O
.	O
17	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
25	O
)	O
Preterm	O
birth	O
**(	O
PTB	O
)	O
1	O
.	O
67	O
(	O
0	O
.	O
73	O
;	O
3	O
.	O
83	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
75	O
;	O
0	O
.	O
99	O
)	O
0	O
.	O
66	O
(	O
0	O
.	O
45	O
;	O
0	O
.	O
96	O
)	O
Low	O
birth	O
weight	O
(	O
LBW	O
)**	O
1	O
.	O
71	O
(	O
0	O
.	O
55	O
;	O
5	O
.	O
26	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
64	O
;	O
0	O
.	O
97	O
)	O
0	O
.	O
64	O
(	O
0	O
.	O
38	O
;	O
1	O
.	O
09	O
)	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

Those	O
that	O
may	O
be	O
of	O
particular	O
interest	O
for	O
development	O
into	O
regulatory	O
strategies	O
/	O
procedures	O
are	O
presented	O
inTables	O
1and2	O
.	O

Further	O
research	O
should	O
investigate	O
variables	O
in	O
family	O
relationships	O
,	O
the	O
home	O
,	O
and	O
the	O
extended	O
environment	O
that	O
influence	O
eating	O
.	O

Genetics	O
and	O
breed	O
,	O
management	O
,	O
and	O
nutrition	O
affect	O
IMF	O
deposition	O
.	O

Only	O
one	O
stool	O
sample	O
showed	O
hookworm	O
infection	O
.	O

Amongst	O
them	O
,	O
15	O
mothers	O
leaved	O
the	O
study	O
,	O
because	O
their	O
depression	O
scores	O
were	O
higher	O
than	O
13	O
.	O

Vitamin	O
D	O
deficiency	O
was	O
not	O
significantly	O
associated	O
with	O
SGA	O
in	O
white	O
infants	O
.	O

Application	O
of	O
fetal	O
nutritional	O
programming	O
to	O
increase	O
IMF	O
deposition	O
of	O
progeny	O
in	O
later	O
life	O
is	O
reviewed	O
.	O

Otherwise	O
,	O
we	O
found	O
no	O
clear	O
published	O
evidence	O
for	O
times	O
at	O
which	O
maternal	O
or	O
other	O
caregiver	O
handwashing	O
may	O
prevent	O
pathogen	O
transfer	O
to	O
/	O
from	O
hands	O
in	O
low	O
-	O
income	O
settings	O
.	O

All	O
the	O
studies	O
shown	O
here	O
demonstrated	O
associations	O
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

Results	O
from	O
a	O
review	O
of	O
several	O
randomized	O
clinical	O
trials	O
of	O
PUFA	O
treatment	O
of	O
schizophrenia	O
were	O
inconclusive	O
,	O
although	O
,	O
it	O
seems	O
that	O
supplementation	O
of	O
especially	O
EPA	O
to	O
these	O
patients	O
may	O
have	O
a	O
positive	O
effect	O
on	O
their	O
schizophrenic	O
symptoms	O
[	O
17	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Selected	O
characteristics	O
of	O
participant	O
pregnant	O
women	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
AllVaccinatedUnvaccinatedp	O
-	O
value	O
†	O
n	O
=	O
3268n	O
=	O
1789n	O
=	O
1479n	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Age	O
<	O
18	O
years415	O
(	O
13	O
)	O
232	O
(	O
13	O
)	O
183	O
(	O
12	O
)	O
0	O
.	O
80	O
18	O
–	O
34	O
years2620	O
(	O
80	O
)	O
1433	O
(	O
80	O
)	O
1187	O
(	O
80	O
)	O
≥	O
35	O
years233	O
(	O
7	O
)	O
124	O
(	O
7	O
)	O
109	O
(	O
7	O
)	O
Number	O
of	O
persons	O
in	O
household	O
2	O
–	O
4898	O
(	O
27	O
)	O
528	O
(	O
30	O
)	O
370	O
(	O
25	O
)	O
0	O
.	O
02	O
5	O
–	O
61070	O
(	O
33	O
)	O
580	O
(	O
32	O
)	O
490	O
(	O
33	O
)	O
7	O
–	O
8707	O
(	O
22	O
)	O
381	O
(	O
21	O
)	O
326	O
(	O
22	O
)	O
>	O
8593	O
(	O
18	O
)	O
300	O
(	O
17	O
)	O
293	O
(	O
20	O
)	O
Delivered	O
at	O
reference	O
*	O
obstetric	O
hospital1722	O
(	O
53	O
)	O
1083	O
(	O
61	O
)	O
639	O
(	O
43	O
)<	O
0	O
.	O
01Education	O
level	O
No	O
education	O
/	O
primary	O
school	O
incomplete421	O
(	O
13	O
)	O
231	O
(	O
13	O
)	O
190	O
(	O
13	O
)	O
0	O
.	O
01	O
Primary	O
school	O
complete337	O
(	O
10	O
)	O
195	O
(	O
11	O
)	O
142	O
(	O
10	O
)	O
Secondary	O
school	O
incomplete1372	O
(	O
42	O
)	O
771	O
(	O
43	O
)	O
601	O
(	O
41	O
)	O
Secondary	O
school	O
complete637	O
(	O
19	O
)	O
353	O
(	O
20	O
)	O
284	O
(	O
19	O
)	O
Technical	O
/	O
university	O
studies501	O
(	O
15	O
)	O
239	O
(	O
13	O
)	O
262	O
(	O
18	O
)	O
Received	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine2984	O
(	O
91	O
)	O
1759	O
(	O
98	O
)	O
1225	O
(	O
83	O
)<	O
0	O
.	O
01At	O
least	O
one	O
antenatal	O
visits3172	O
(	O
97	O
)	O
1786	O
(	O
100	O
)	O
1386	O
(	O
94	O
)<	O
0	O
.	O
01Four	O
or	O
more	O
antenatal	O
visits2549	O
(	O
78	O
)	O
1542	O
(	O
86	O
)	O
1007	O
(	O
68	O
)<	O
0	O
.	O
01Gestational	O
age	O
at	O
first	O
antenatal	O
visit	O
(	O
median	O
,	O
quantiles	O
in	O
weeks	O
)	O
12	O
(	O
9	O
,	O
19	O
)	O
12	O
(	O
9	O
,	O
17	O
)	O
13	O
(	O
9	O
,	O
22	O
)<	O
0	O
.	O
01	O
‡	O
Consumption	O
of	O
iron	O
and	O
folic	O
acid1485	O
(	O
45	O
)	O
805	O
(	O
45	O
)	O
680	O
(	O
46	O
)	O
0	O
.	O
59Consumption	O
of	O
albendazol703	O
(	O
22	O
)	O
482	O
(	O
27	O
)	O
221	O
(	O
15	O
)<	O
0	O
.	O
01Consumption	O
of	O
calcium1243	O
(	O
38	O
)	O
722	O
(	O
40	O
)	O
521	O
(	O
35	O
)<	O
0	O
.	O
01Consumption	O
of	O
aspirin938	O
(	O
29	O
)	O
600	O
(	O
34	O
)	O
338	O
(	O
23	O
)<	O
0	O
.	O
01	O
BMI	O
(	O
height	O
and	O
weight	O
measured	O
at	O
1st	O
antenatal	O
visit	O
)	O
Underweight	O
(<	O
18	O
.	O
5	O
)	O
315	O
(	O
10	O
)	O
116	O
(	O
6	O
)	O
199	O
(	O
13	O
)<	O
0	O
.	O
01	O
Normal	O
weight	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
)	O
1338	O
(	O
41	O
)	O
808	O
(	O
45	O
)	O
530	O
(	O
36	O
)	O
Overweight	O
(	O
25	O
–	O
29	O
.	O
9	O
)	O
928	O
(	O
28	O
)	O
510	O
(	O
29	O
)	O
418	O
(	O
28	O
)	O
Obesity	O
I	O
(	O
30	O
–	O
34	O
.	O
9	O
)	O
408	O
(	O
12	O
)	O
224	O
(	O
13	O
)	O
184	O
(	O
12	O
)	O
Obesity	O
II	O
(	O
35	O
–	O
39	O
.	O
9	O
)	O
163	O
(	O
5	O
)	O
87	O
(	O
5	O
)	O
76	O
(	O
5	O
)	O
Extreme	O
obesity	O
(>	O
40	O
)	O
88	O
(	O
3	O
)	O
41	O
(	O
2	O
)	O
47	O
(	O
3	O
)	O
Alcohol	O
consumption	O
before	O
pregnancy441	O
(	O
13	O
)	O
220	O
(	O
12	O
)	O
221	O
(	O
15	O
)	O
0	O
.	O
05Renal	O
Disease1266	O
(	O
39	O
)	O
734	O
(	O
41	O
)	O
532	O
(	O
36	O
)<	O
0	O
.	O
01Blood	O
Disease743	O
(	O
23	O
)	O
445	O
(	O
25	O
)	O
298	O
(	O
20	O
)<	O
0	O
.	O
01At	O
least	O
one	O
chronic	O
condition	O
**	O
1855	O
(	O
57	O
)	O
1069	O
(	O
60	O
)	O
786	O
(	O
53	O
)<	O
0	O
.	O
01	O
Number	O
of	O
parturitions	O
11519	O
(	O
46	O
)	O
879	O
(	O
49	O
)	O
640	O
(	O
43	O
)<	O
0	O
.	O
01	O
2	O
–	O
31447	O
(	O
44	O
)	O
768	O
(	O
43	O
)	O
679	O
(	O
46	O
)	O
>	O
3302	O
(	O
9	O
)	O
142	O
(	O
8	O
)	O
160	O
(	O
11	O
)	O
Female1585	O
(	O
49	O
)	O
804	O
(	O
45	O
)	O
781	O
(	O
53	O
)<	O
0	O
.	O
01Preterm	O
birth175	O
(	O
5	O
)	O
95	O
(	O
5	O
)	O
80	O
(	O
5	O
)	O
0	O
.	O
96Small	O
for	O
gestational	O
age343	O
(	O
10	O
)	O
198	O
(	O
11	O
)	O
145	O
(	O
10	O
)	O
0	O
.	O
26Low	O
birth	O
weight195	O
(	O
6	O
)	O
99	O
(	O
6	O
)	O
96	O
(	O
6	O
)	O
0	O
.	O
28	O
X2test	O
.	O

Harmon	O
and	O
McLeod	O
[	O
111	O
]	O
reported	O
that	O
starch	O
digestion	O
is	O
more	O
efficient	O
in	O
the	O
small	O
intestine	O
than	O
during	O
fermentation	O
in	O
the	O
rumen	O
:	O
the	O
total	O
energetic	O
efficiency	O
of	O
rumen	O
-	O
fermented	O
starch	O
was	O
about	O
73	O
%	O
that	O
of	O
small	O
intestine	O
-	O
digested	O
starch	O
.	O

Illicit	O
Drug	O
Exposure	O
,	O
Smoking	O
,	O
and	O
Pollutants	O
Drug	O
exposure	O
may	O
have	O
very	O
serious	O
complications	O
during	O
pregnancy	O
.	O

All	O
the	O
different	O
cell	O
types	O
that	O
comprise	O
the	O
new	O
individual	O
develop	O
from	O
this	O
zygote	O
and	O
so	O
contain	O
the	O
same	O
unique	O
genome	O
.	O

Follow	O
-	O
up	O
testing	O
was	O
recommended	O
between	O
24	O
–	O
28	O
weeks	O
and	O
prior	O
to	O
delivery	O
by	O
provider	O
request	O
.	O

This	O
assumption	O
is	O
based	O
on	O
the	O
fact	O
that	O
the	O
main	O
risk	O
factors	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
sun	O
exposure	O
and	O
/	O
or	O
ethnicity	O
)	O
are	O
common	O
to	O
many	O
European	O
countries	O
.	O

Results	O
The	O
prevalence	O
of	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
48	O
%	O
for	O
folic	O
acid	O
,	O
45	O
.	O
3	O
%	O
for	O
iron	O
and	O
68	O
%	O
for	O
multivitamins	O
.	O

Of	O
note	O
,	O
brain	O
tumors	O
are	O
known	O
to	O
contain	O
sex	O
steroid	O
receptors	O
(	O
e	O
.	O
g	O
.,	O
estrogen	O
,	O
androgen	O
,	O
progestin	O
)	O
[	O
198	O
],	O
and	O
sex	O
hormones	O
have	O
been	O
shown	O
to	O
promote	O
brain	O
tumors	O
in	O
animal	O
studies	O
[	O
199	O
,	O
200	O
].	O

Previous	O
studies	O
reported	O
that	O
unplanned	O
pregnancy	O
is	O
a	O
risk	O
factor	O
for	O
perinatal	O
depression	O
.	O

While	O
much	O
of	O
the	O
work	O
to	O
date	O
has	O
focused	O
on	O
rodent	O
models	O
,	O
there	O
is	O
also	O
some	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
other	O
mammalian	O
species	O
,	O
including	O
sheep	O
and	O
monkeys	O
(	O
Wu	O
et	O
al	O
.	O
2008	O
;	O
Begum	O
et	O
al	O
.	O
2013	O
;	O
Lie	O
et	O
al	O
.	O
2014a	O
,	O
2014b	O
).	O

The	O
strengths	O
of	O
this	O
study	O
include	O
the	O
large	O
sample	O
size	O
,	O
population	O
-	O
based	O
ascertainment	O
of	O
placenta	O
samples	O
,	O
quantitative	O
assessment	O
of	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
,	O
and	O
the	O
use	O
of	O
a	O
well	O
-	O
established	O
,	O
high	O
-	O
density	O
methylation	O
array	O
for	O
methylation	O
profiling	O
.	O

While	O
the	O
exact	O
mechanism	O
by	O
which	O
PFAS	O
impact	O
birth	O
weight	O
is	O
unknown	O
,	O
several	O
theories	O
have	O
been	O
proposed	O
.	O

Current	O
understanding	O
suggests	O
that	O
hypoxia	O
is	O
one	O
of	O
the	O
complications	O
of	O
prolonged	O
labor	O
,	O
along	O
with	O
infection	O
,	O
or	O
head	O
trauma	O
from	O
extended	O
pressure	O
.	O

In	O
our	O
study	O
,	O
maternal	O
vitamin	O
D	O
concentrations	O
were	O
similar	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
,	O
and	O
there	O
was	O
no	O
linear	O
association	O
between	O
vitamin	O
D	O
concentrations	O
and	O
OGTT	O
results	O
.	O

In	O
the	O
clinical	O
trials	O
,	O
compounds	O
from	O
the	O
venom	O
have	O
proven	O
beneficial	O
and	O
caused	O
no	O
apparent	O
side	O
effects	O
in	O
patients	O
with	O
advanced	O
liver	O
,	O
pancreatic	O
,	O
or	O
lung	O
cancer	O
.	O

MTRL	O
has	O
been	O
funded	O
by	O
a	O
FPU	O
predoctoral	O
fellowship	O
of	O
the	O
Spanish	O
Ministerio	O
de	O
Educación	O
,	O
Cultura	O
y	O
Deporte	O
(	O
AP	O
-	O
2009	O
-	O
0225	O
);	O
JS	O
holds	O
a	O
“	O
Miguel	O
Servet	O
”	O
research	O
contract	O
from	O
the	O
National	O
System	O
of	O
Health	O
,	O
ISCIII	O
(	O
grant	O
number	O
CP12	O
/	O
03109	O
).	O

Statistical	O
Analysis	O
Sample	O
size	O
determination	O
(	O
at	O
least	O
16	O
each	O
Hispanic	O
and	O
Caucasian	O
)	O
was	O
done	O
to	O
identify	O
a	O
one	O
standard	O
deviation	O
difference	O
in	O
the	O
change	O
in	O
bone	O
mineralization	O
between	O
one	O
week	O
of	O
age	O
and	O
three	O
months	O
of	O
age	O
by	O
ethnicity	O
.	O

[	O
20	O
]	O
and	O
defined	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
at	O
birth	O
as	O
WFA	O
z	O
-	O
scores	O
<	O
10th	O
percentile	O
and	O
large	O
for	O
gestational	O
age	O
as	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
.	O

Whatever	O
the	O
mechanism	O
,	O
the	O
relationship	O
between	O
smoking	O
during	O
pregnancy	O
and	O
children	O
'	O
s	O
overweight	O
is	O
well	O
documented	O
(	O
16	O
,	O
17	O
)	O
In	O
1	O
study	O
,	O
for	O
example	O
,	O
babies	O
born	O
to	O
mothers	O
who	O
smoked	O
during	O
pregnancy	O
weighed	O
less	O
than	O
did	O
babies	O
born	O
to	O
nonsmokers	O
(	O
18	O
).	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
and	O
RPMM	O
class	O
methylation	O
(	O
p	O
=	O
0	O
.	O
01	O
);	O
no	O
association	O
was	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
RPMM	O
class	O
methylation	O
.	O

Mean	O
(	O
SD	O
)	O
maternal	O
25OHD	O
at	O
T1	O
was	O
64	O
(	O
24	O
.	O
4	O
)	O
nmol	O
/	O
L	O
and	O
75	O
(	O
34	O
.	O
4	O
)	O
nmol	O
/	O
L	O
at	O
T3	O
.	O

For	O
Whites	O
,	O
but	O
not	O
African	O
Americans	O
,	O
having	O
no	O
pet	O
compared	O
to	O
1	O
or	O
>	O
1	O
pet	O
during	O
pregnancy	O
was	O
associated	O
with	O
lower	O
cord	O
blood	O
vitamin	O
D	O
concentrations	O
(	O
37	O
.	O
7	O
,	O
45	O
.	O
2	O
,	O
47	O
.	O
0	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

Lung	O
function	O
was	O
measured	O
by	O
spirometry	O
(	O
Vitalograph	O
2120	O
;	O
Vitalograph	O
,	O
Maids	O
Moreton	O
,	O
UK	O
)	O
at	O
age	O
8	O
.	O
5	O
years	O
after	O
withholding	O
short	O
-	O
acting	O
bronchodilators	O
for	O
at	O
least	O
6	O
h	O
and	O
long	O
-	O
acting	O
bronchodilators	O
and	O
theophyllines	O
for	O
at	O
least	O
24	O
h	O
.	O
The	O
best	O
of	O
three	O
reproducible	O
flow	O
–	O
volume	O
curves	O
was	O
used	O
to	O
measure	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
(	O
FEV1	O
),	O
forced	O
vital	O
capacity	O
(	O
FVC	O
)	O
and	O
maximal	O
mid	O
-	O
expiratory	O
flow	O
(	O
forced	O
expiratory	O
flow	O
at	O
25	O
–	O
75	O
%	O
of	O
FVC	O
(	O
FEF25	O
–	O
75	O
)),	O
which	O
were	O
further	O
transformed	O
to	O
age	O
-,	O
height	O
-	O
and	O
sex	O
-	O
adjusted	O
standard	O
deviation	O
units	O
[	O
17	O
].	O

The	O
final	O
version	O
of	O
the	O
database	O
will	O
be	O
stored	O
under	O
protected	O
zipped	O
files	O
.	O

Over	O
the	O
past	O
several	O
decades	O
,	O
continuing	O
research	O
has	O
been	O
conducted	O
,	O
and	O
much	O
literature	O
has	O
been	O
published	O
that	O
has	O
supported	O
the	O
existence	O
of	O
the	O
links	O
between	O
autism	O
and	O
factors	O
that	O
relate	O
to	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
.	O

This	O
would	O
be	O
expected	O
as	B
subjects	O
who	O
are	O
iron	O
-	O
depleted	O
use	O
iron	O
more	O
effectively	O
than	O
those	O
who	O
are	O
iron	O
-	O
replete	O
(	O
Moriarty	O
-	O
Craige	O
et	O
al	O
2004	O
).	O

‡	O
Pearson	O
'	O
s	O
χ²	O
test	O
.	O

The	O
mechanism	O
of	O
PTH	O
reduction	O
is	O
that	O
an	O
increased	O
serum	O
vitamin	O
D	O
leads	O
to	O
a	O
decrease	O
in	O
PTH	O
gene	O
translation	O
,	O
and	O
thus	B
PTH	O
secretion	O
.	O

To	O
ensure	O
the	O
absence	O
of	O
a	O
DNA	O
contamination	O
within	O
the	O
isolated	O
RNA	O
a	O
PCR	O
amplification	O
with	O
the	O
porcine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
gene	O
was	O
done	O
(	O
Forward	O
primer	O
:	O
aagcagggatgatgttctgg	O
;	O
Reverse	O
primer	O
:	O
atgcctcctgtaccaccaac	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Risk	O
factors	O
related	O
to	O
the	O
development	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
stratified	O
by	O
pre	O
-	O
pregnancy	O
Body	O
Mass	O
Index	O
(	O
PPBMI	O
)	O
classification	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
the	O
disease	O
,	O
Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

S1	O
.	O

For	O
example	O
,	O
rather	O
than	O
sorting	O
through	O
23	O
PCBs	O
to	O
identify	O
those	O
that	O
are	O
significant	O
,	O
we	O
simply	O
reported	O
the	O
average	O
association	O
of	O
all	O
23	O
PCBs	O
and	O
birth	O
weight	O
.	O

Thus	B
,	O
sufficient	O
evidence	O
is	O
lacking	O
at	O
this	O
time	O
to	O
recommend	O
routine	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
.	O
12However	O
,	O
identification	O
of	O
specific	O
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
and	O
the	O
additive	O
effects	O
of	O
these	O
risk	O
factors	O
may	O
lead	O
to	O
opportunities	O
for	O
targeted	O
supplementation	O
with	O
improved	O
outcomes	O
.	O

As	B
insulin	O
therapy	O
is	O
effective	O
and	O
safe	O
,	O
it	O
is	O
considered	O
the	O
gold	O
standard	O
of	O
pharmacotherapy	O
for	O
gestational	O
diabetes	O
,	O
against	O
which	O
other	O
treatments	O
have	O
been	O
compared	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIG	O
3	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
HF	O
,	O
parameter	O
of	O
the	O
frequency	O
domain	O
.	O

Nevertheless	O
,	O
the	O
statistically	O
significant	O
effect	O
and	O
the	O
size	O
of	O
differences	O
observed	O
between	O
mothers	O
with	O
negative	O
versus	O
positive	O
and	O
neutral	O
attitudes	O
in	O
the	O
Tht111	O
I	O
CC	O
polymorphism	O
group	O
suggest	O
that	O
this	O
effect	O
may	O
be	O
robust	O
.	O

Further	O
,	O
the	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
of	O
the	O
hormone	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
,	O
was	O
optimized	O
at	O
40	O
ng	O
/	O
mL	O
among	O
pregnant	O
women	O
[	O
13	O
].	O

Seventeen	O
vitamin	O
D	O
experts	B
recently	O
stated	O
,	O
‘	O
In	O
our	O
opinion	O
,	O
children	O
with	O
chronic	O
illnesses	O
such	O
as	O
autism	O
,	O
diabetes	O
and	O
/	O
or	O
frequent	O
infections	O
should	O
be	O
supplemented	O
with	O
higher	O
doses	O
of	O
sunshine	O
or	O
vitamin	O
D3	O
,	O
doses	O
adequate	O
to	O
maintain	O
their	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
the	O
mid	O
-	O
normal	O
of	O
the	O
reference	O
range	O
[	O
65	O
ng	O
/	O
mL	O
(	O
162	O
nmol	O
/	O
L	O
)]	O
–	O
and	O
should	O
be	O
so	O
supplemented	O
year	O
round	O
.’	O
(	O
22	O
)	O
Finally	O
,	O
if	O
true	B
,	O
a	O
darker	O
side	O
of	O
the	O
theory	O
emerges	O
.	O

Background	O
With	O
an	O
increasing	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
and	O
insufficiency	O
reported	O
both	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
as	O
well	O
as	O
worldwide	O
[	O
1	O
],	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
deficiency	O
may	O
influence	O
health	O
in	O
pregnancy	O
.	O

Lower	O
expression	O
of	O
the	O
anorexigenic	O
genes	O
in	O
the	O
offspring	O
of	O
dams	O
fed	O
the	O
multivamins	O
during	O
pregnancy	O
is	O
consistent	O
with	O
the	O
observed	O
increased	O
food	O
intake	O
.	O

Statistical	O
Analysis	O
Analysis	O
was	O
completed	O
using	O
the	O
cathelicidin	O
concentration	O
values	O
obtained	O
from	O
each	O
child	O
’	O
s	O
yearly	O
follow	O
-	O
up	O
visit	O
.	O

Then	O
they	O
compared	O
concentrations	O
of	O
these	O
compounds	O
in	O
mother	O
’	O
s	O
milk	O
to	O
outcomes	O
of	O
child	O
health	O
,	O
growth	O
,	O
and	O
development	O
.	O

The	O
questions	O
are	O
styled	O
in	O
a	O
'	O
Do	O
you	O
ever	O
feel	O
/	O
think	O
'	O
fashion	O
in	O
order	O
to	O
study	O
continuous	O
experiences	O
during	O
life	O
-	O
time	O
.	O

Objectives	O
:	O
We	O
examined	O
associations	O
between	O
in	O
utero	O
exposures	O
,	O
infant	O
growth	O
,	O
and	O
methylation	O
of	O
repetitive	O
elements	O
and	O
gene	O
-	O
associated	O
DNA	O
in	O
human	O
term	O
placenta	O
tissue	O
samples	O
.	O

The	O
Madigan	O
study	O
was	O
ambitious	O
in	O
that	O
it	O
followed	O
a	O
baseline	O
sample	O
of	O
nearly	O
1000	O
women	O
for	O
a	O
total	O
study	O
period	O
of	O
nearly	O
2	O
years	O
.	O

Less	O
than	O
half	O
the	O
participants	O
(	O
42	O
.	O
0	O
%)	O
declared	O
they	O
received	O
advice	O
on	O
diet	O
during	O
pregnancy	O
and	O
83	O
.	O
5	O
%	O
stated	O
they	O
were	O
advised	O
to	O
breastfeed	O
(	O
Table	O
1	O
).	O

Additionally	O
,	O
we	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
2	O
.	O
19	O
,	O
P	O
<	O
0	O
.	O
05	O
],	O
time	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
13	O
.	O
28	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

In	O
this	O
context	O
,	O
the	O
sheep	O
appears	O
to	O
be	O
a	O
very	O
good	O
model	O
,	O
because	O
as	O
for	O
humans	O
,	O
the	O
major	O
source	O
of	O
BAT	O
in	O
the	O
fetus	O
is	O
around	O
central	O
organs	O
and	O
is	O
replaced	O
by	O
WAT	O
after	O
birth	O
,	O
whereas	O
in	O
rodents	O
,	O
the	O
primary	O
BAT	O
depot	O
is	O
interscapular	O
and	O
it	O
remains	O
throughout	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
infants	O
belonging	O
to	O
the	O
high	O
Clostridium	O
cluster	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
36	O
(	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
)).	O

PubMed	O
Central	O
:	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
use	O
of	O
supplements	O
and	O
socio	O
-	O
demographic	O
factors	O
,	O
pre	O
-	O
natal	O
care	O
and	O
nutritional	O
knowledge	O
Folic	O
acidIronVitamins	O
YES	O
YES	O
YES	O
N	O
%	O
pn	O
%	O
pn	O
%	O
p	O
Urban	O
environment13863	O
.	O
6	O
<	O
0	O
.	O
001	O
17178	O
.	O
80	O
.	O
1417178	O
.	O
8	O
<	O
0	O
.	O
001	O
Rural	O
environment5436	O
.	O
410155	O
.	O
210155	O
.	O
2Education	O
(	O
number	O
of	O
years	O
)	O
≤	O
8115	O
.	O
7	O
<	O
0	O
.	O
001	O
4524	O
.	O
9	O
<	O
0	O
.	O
001	O
4315	O
.	O
8	O
<	O
0	O
.	O
001	O
9	O
-	O
128242	O
.	O
77541	O
.	O
411040	O
.	O
4	O
>	O
129951	O
.	O
6	O
6133	O
.	O
7	O
11943	O
.	O
8	O
Age	O
(	O
years	O
old	O
)	O
<	O
1800	O
<	O
0	O
.	O
001	O
942	O
.	O
9	O
0	O
.	O
043	O
942	O
.	O
9	O
0	O
.	O
011	O
≥	O
1819250	O
.	O
726369	O
.	O
426369	O
.	O
4Number	O
of	O
births	O
≤	O
217352	O
.	O
624273	O
.	O
624273	O
.	O
6	O
>	O
21926	O
.	O
83042	O
.	O
33042	O
.	O
3Wanted	O
pregnancy17949	O
.	O
9	O
0	O
.	O
017	O
25470	O
.	O
8	O
0	O
.	O
009	O
25470	O
.	O
8	O
<	O
0	O
.	O
001	O
Unwanted	O
pregnancy1230	O
.	O
01742	O
.	O
51742	O
.	O
5	O
Married17654	O
.	O
5	O
<	O
0	O
.	O
001	O
23572	O
.	O
8	O
0	O
.	O
01	O
23572	O
.	O
8	O
<	O
0	O
.	O
001	O
Single1620	O
.	O
83748	O
.	O
13748	O
.	O
1Pregnancy	O
registration	O
General	O
practitioner	O
Yes18949	O
.	O
1	O
0	O
.	O
027	O
26769	O
.	O
40	O
.	O

However	O
,	O
dietary	O
protein	O
levels	O
do	O
not	O
affect	O
IMF	O
deposition	O
in	O
Angus	O
or	O
Shorthorn	O
steers	O
(	O
reviewed	O
in	O
Bindon	O
[	O
115	O
]).	O

One	O
of	O
the	O
studies	O
looked	O
at	O
serum	O
levels	O
in	O
samples	O
collected	O
from	O
Mexican	O
mothers	O
within	O
a	O
day	O
of	O
birth	O
,	O
17while	O
the	O
other	O
used	O
maternal	O
serum	O
samples	O
collected	O
during	O
the	O
second	O
trimester	O
from	O
Mexican	O
-	O
American	O
women	O
who	O
lived	O
in	O
California	O
’	O
s	O
Salinas	O
Valley	O
,	O
a	O
major	O
agricultural	O
region	O
.	O
18	O
Reverse	O
causality	O
is	O
a	O
major	O
concern	O
in	O
environmental	O
health	O
research	O
,	O
and	O
Amalie	O
Timmermann	O
,	O
a	O
research	O
assistant	O
in	O
the	O
Department	O
of	O
Environmental	O
Medicine	O
at	O
the	O
University	O
of	O
Southern	O
Denmark	O
,	O
points	O
it	O
out	O
as	B
a	O
potential	O
explanation	B
for	O
findings	O
in	O
studies	O
such	O
as	O
these	O
.	O

Correlations	O
between	O
continuous	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
insufficiency	O
was	O
significantly	O
lower	O
for	O
more	O
educated	O
women	O
and	O
for	O
persons	O
reporting	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

Also	O
no	O
association	O
was	O
also	O
found	O
between	O
a	O
children	O
’	O
s	O
vitamin	O
D	O
levels	O
and	O
their	O
lung	O
function	O
at	O
6	O
–	O
7	O
years	O
of	O
age	O
in	O
the	O
KOALA	O
birth	O
cohort	O
study	O
[	O
34	O
].	O

It	O
is	O
expressed	O
in	O
BAT	O
and	O
WAT	O
,	O
although	O
its	O
main	O
production	O
site	O
is	O
the	O
liver	O
(	O
Nishimura	O
et	O
al	O
.,	O
2000	O
;	O
Muise	O
et	O
al	O
.,	O
2008	O
;	O
Schulz	O
et	O
al	O
.,	O
2013	O
;	O
Zafrir	O
,	O
2013	O
).	O

The	O
close	O
relationships	O
between	O
weight	O
and	O
length	O
and	O
initial	O
BMC	O
imply	B
that	O
calcium	O
transfer	O
across	O
the	O
placenta	O
is	O
closely	O
related	O
to	O
overall	O
nutrient	O
transfer	O
and	O
not	O
to	O
vitamin	O
D	O
status	O
(	O
7	O
).	O

This	O
rule	O
,	O
the	O
first	O
of	O
its	O
kind	O
in	O
the	O
world	O
,	O
will	O
apply	O
mainly	O
to	O
personal	O
care	O
products	O
but	O
also	O
could	O
apply	O
to	O
other	O
categories	O
such	O
as	O
food	O
and	O
textiles	O
.	O

The	O
doses	O
for	O
adults	O
and	O
elderly	O
people	O
of	O
proper	O
body	O
weight	O
,	O
and	O
pregnant	O
and	O
lactating	O
women	O
should	O
not	O
exceed	O
4000	O
IU	O
daily	O
,	O
and	O
the	O
supplementation	O
dosage	O
recommended	O
for	O
pregnant	O
women	O
in	O
winter	O
and	O
less	O
sunny	O
countries	O
is	O
1500	O
–	O
4000	O
IU	O
per	O
day	O
(	O
37	O
.	O
5	O
–	O
50	O
.	O
0	O
μg	O
/	O
day	O
)	O
[	O
10	O
,	O
66	O
,	O
70	O
].	O

C	O
-	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

LASSO	O
(	O
Least	O
Absolute	O
Shrinkage	O
and	O
Selection	O
Operator	O
)	O
[	O
30	O
]	O
and	O
Elastic	O
Net	O
are	O
more	O
sophisticated	O
multivariable	O
linear	O
modeling	O
methods	O
that	O
have	O
been	O
used	O
for	O
analyzing	O
multiple	O
correlated	O
exposure	O
variables	O
.	O

In	O
the	O
case	O
of	O
asthma	O
,	O
the	O
risk	O
of	O
uncontrolled	O
severe	O
asthma	O
(	O
which	O
may	O
include	O
maternal	O
or	O
fetal	O
mortality	O
)	O
would	O
usually	O
be	O
the	O
greater	O
risk	O
,	O
suggesting	O
that	O
oral	O
corticosteroids	O
must	O
still	O
be	O
used	O
when	O
indicated	O
for	O
the	O
management	O
of	O
severe	O
gestational	O
asthma	O
.	O

Discussion	O
The	O
provision	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
a	O
weekly	O
basis	O
for	O
women	O
of	O
reproductive	O
age	O
is	O
aimed	B
at	O
improving	O
iron	O
stores	O
,	O
particularly	O
prior	O
to	O
pregnancy	O
and	O
during	O
the	O
first	O
trimester	O
before	O
women	O
access	O
ante	O
-	O
natal	O
care	O
.	O

However	O
,	O
as	O
the	O
effect	O
doesn	O
'	O
t	O
vary	O
by	O
cats	O
versus	O
dogs	O
,	O
differences	O
by	O
race	O
in	O
factors	O
correlated	O
with	O
pet	O
ownership	O
or	O
variations	O
in	O
pet	O
keeping	O
styles	O
may	O
be	O
more	O
important	O
.	O

On	O
the	O
other	O
hand	O
,	O
cytokines	O
are	O
messengers	O
produced	O
by	O
immune	O
cells	O
which	O
affect	O
all	O
tissues	O
,	O
including	O
brain	O
.	O

Manipulating	O
IMF	O
deposition	O
through	O
developmental	O
programming	O
via	O
metabolic	O
imprinting	O
is	O
a	O
recently	O
proposed	O
nutritional	O
method	O
to	O
change	O
potential	O
IMF	O
deposition	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
in	O
rodents	O
and	O
domestic	O
animals	O
.	O

Vitamin	O
D	O
during	O
the	O
pregnancy	O
is	O
important	O
to	O
both	O
maternal	O
skeletal	O
preservation	O
and	O
fetal	O
skeletal	O
formation	O
.	O

We	O
further	O
increased	O
the	O
desired	O
sample	O
to	O
200	O
per	O
arm	O
to	O
account	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
,	O
and	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
maternal	O
or	O
neonatal	O
death	O
,	O
since	O
structured	O
observations	O
would	O
not	O
be	O
feasible	O
or	O
appropriate	O
in	O
such	O
cases	O
.	O

There	O
was	O
a	O
trend	O
for	O
lower	O
DopaR1	O
expression	O
in	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
HV	O
pup	O
diet	O
compared	O
to	O
the	O
RV	O
offspring	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
(	O
Figure	O
5b	O
).	O

These	O
data	O
have	O
a	O
few	O
girls	O
whose	O
mothers	O
have	O
a	O
very	O
high	O
BMI	O
and	O
these	O
values	O
appear	O
to	O
dilute	O
the	O
correlation	O
between	O
girls	O
and	O
mother	O
.	O

[	O
2	O
]	O
There	O
are	O
increasing	O
studies	O
worldwide	O
reporting	O
poor	O
vitamin	O
D	O
status	O
,	O
including	O
those	O
in	O
tropical	O
countries	O
.	O

The	O
researchers	O
checked	O
the	O
women	O
’	O
s	O
levels	O
of	O
hemoglobin	O
(	O
which	O
transports	O
oxygen	O
)	O
and	O
ferritin	O
every	O
four	O
weeks	O
through	O
the	O
end	O
of	O
pregnancy	O
.	O

However	O
,	O
the	O
girl	O
’	O
s	O
height	O
was	O
more	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
mother	O
than	O
father	O
.	O

Results	O
:	O
Forty	O
five	O
patients	O
including	O
24	O
with	O
the	O
mean	O
age	O
of	O
30	O
.	O
7	O
±	O
6	O
.	O
2	O
years	O
in	O
the	O
IG	O
and	O
21	O
with	O
the	O
mean	O
age	O
of	O
29	O
.	O
5	O
±	O
4	O
.	O
0	O
years	O
in	O
the	O
CG	O
participated	O
in	O
the	O
study	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
for	O
intake	O
of	O
omega	O
-	O
3	O
or	O
marine	O
fatty	O
acids	O
was	O
24	O
%	O
lower	O
in	O
the	O
third	O
quartile	O
compared	O
to	O
the	O
lowest	O
.	O

GR	O
alternative	O
splicing	O
might	O
also	O
influence	O
the	O
subsequent	O
activation	O
of	O
signalling	O
pathways	O
by	O
glucocorticoids	O
[	O
20	O
].	O

2	O
).	O

The	O
first	O
sign	O
is	O
a	O
rise	O
in	O
the	O
ratio	O
of	O
calcium	O
to	O
creatinine	O
in	O
the	O
urine	O
,	O
which	O
precedes	O
hypercalcemia	O
.	O

PubMed	O
Central	O
:	O

As	O
can	O
be	O
seen	O
in	O
Figure2b	O
,	O
the	O
frequency	O
distribution	O
of	O
women	O
with	O
post	O
-	O
50	O
gram	O
1	O
-	O
hour	O
glucose	O
concentration	O
≥	O
140	O
mg	O
/	O
dl	O
(	O
i	O
.	O
e	O
.,	O
the	O
threshold	O
for	O
screen	O
positive	O
for	O
glucose	O
intolerance	O
)	O
also	O
had	O
a	O
curvilinear	O
pattern	O
.	O

However	O
,	O
excluding	O
preeclampsia	O
cases	O
from	O
the	O
analysis	O
did	O
not	O
change	O
the	O
results	O
.	O

In	O
this	O
cohort	O
,	O
we	O
have	O
collected	O
detailed	O
information	O
on	O
social	O
and	O
environmental	O
influences	O
on	O
the	O
child	O
'	O
s	O
development	O
and	O
in	O
a	O
number	O
of	O
other	O
publications	O
address	O
this	O
question	O
,	O
including	O
cultural	O
and	O
familial	O
influences	O
.	O

Although	O
previous	O
small	O
surveys	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
common	O
in	O
Europe	O
[	O
29	O
],[	O
30	O
],	O
there	O
are	O
no	O
reliable	O
country	O
-	O
wide	O
estimates	O
of	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
European	O
countries	O
.	O

In	O
order	O
to	O
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

There	O
was	O
no	O
association	O
with	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
,	O
FEV1	O
,	O
FVC	O
or	O
FEF25	O
–	O
75	O
(	O
table	O
2and	O
supplementary	O
table	O
E2	O
).	O

Although	O
there	O
was	O
no	O
difference	O
in	O
the	O
rate	O
of	O
clinical	O
infection	O
diagnosis	O
between	O
the	O
two	O
arms	O
of	O
the	O
parent	O
trial	O
,	O
longitudinal	O
malaria	O
exposure	O
may	O
have	O
been	O
an	O
effect	O
modifier	O
or	O
confounding	O
variable	O
in	O
this	O
study	O
and	O
ought	O
to	O
be	O
assessed	O
formally	O
in	O
future	O
work	O
.	O

For	O
the	O
quantitative	O
PCR	O
,	O
the	O
following	O
equations	O
were	O
used	O
:	O
ΔCt	O
=	O
Ct	O
(	O
gene	O
of	O
interest	O
)−	O
Ct	O
(	O
house	O
keeping	O
gene	O
),	O
ΔΔCt	O
=	O
ΔCt	O
(	O
sample	O
)−	O
ΔCt	O
(	O
calibrator	O
),	O
and	O
Relative	O
Quantity	O
(	O
RQ	O
)	O
=	O
2	O
−	O
ΔΔCtas	O
previously	O
described	O
[	O
12	O
].	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#/##/###	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;$	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
RC	O
males	O
.	O

For	O
example	O
,	O
research	O
has	O
suggested	O
that	O
Alu	O
sequences	O
often	O
flank	O
CGIs	O
(	O
Graff	O
et	O
al	O
.	O

There	O
was	O
insufficient	O
case	O
information	O
available	O
to	O
assess	O
any	O
causal	O
association	O
between	O
the	O
allergic	O
reaction	O
and	O
the	O
fetal	O
loss	O
.	O

Participants	O
were	O
classified	O
into	O
three	O
predefined	O
levels	O
:	O
low	O
,	O
middle	O
and	O
high	O
frequency	O
of	O
symptoms	O
.	O

;	O
P	O
=	O
0	O
.	O
0001	O
)	O
and	O
at	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
19	O
.	O
6	O
%	O
versus	O
7	O
.	O
1	O
%;	O
P	O
=	O
.	O
001	O
;	O
Table	O
1	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Mapping	O
of	O
the	O
mutant	O
pedigrees	O
.	O

Low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
more	O
prevalent	O
in	O
individuals	O
with	O
female	O
gender	O
,	O
younger	O
age	O
and	O
urban	O
versus	O
rural	O
residence	O
in	O
Thailand	O
.	O

While	O
a	O
link	O
between	O
smoking	O
and	O
autism	O
could	O
not	O
be	O
established	O
,	O
air	O
pollution	O
may	O
have	O
a	O
role	O
.	O

Of	O
these	O
293	O
subjects	O
were	O
identified	O
and	O
recruited	O
(	O
Figure	O
1	O
).	O

The	O
serum	O
osmolality	O
was	O
356	O
mOsm	O
/	O
kg	O
;	O
urine	O
sodium	O
21	O
mEq	O
/	O
L	O
and	O
urine	O
osmolality	O
was	O
inappropriately	O
low	O
(	O
225	O
mOsm	O
/	O
kg	O
).	O

Thyroxin	O
therapy	O
should	O
be	O
started	O
immediately	O
after	O
surgery	O
because	O
untreated	O
hypothyroidism	O
may	O
expose	O
the	O
mother	O
to	O
a	O
higher	O
risk	O
of	O
disease	O
recurrence	O
and	O
may	O
have	O
an	O
adverse	O
effect	O
on	O
cognitive	O
function	O
and	O
regular	O
growth	O
of	O
the	O
offspring	O
.	O

In	O
this	O
case	O
,	O
the	O
optimum	O
slaughter	O
age	O
for	O
the	O
highest	O
profit	O
was	O
28	O
months	O
.	O

More	O
than	O
50	O
%	O
of	O
the	O
women	O
included	O
had	O
a	O
lower	O
education	O
level	O
,	O
which	O
means	O
only	O
completion	O
of	O
secondary	O
school	O
or	O
even	O
lower	O
education	O
.	O

Preventive	O
pharmacotherapy	O
and	O
immunotherapy	O
will	O
not	O
be	O
discussed	O
.	O

Insufficient	O
Exposure	O
to	O
Environmental	O
Bacteria	O
The	O
hygiene	O
hypothesis	O
states	O
that	O
low	O
exposure	O
of	O
the	O
mother	O
during	O
pregnancy	O
and	O
of	O
the	O
newborn	O
in	O
early	O
life	O
to	O
environmental	O
bacteria	O
contributes	O
to	O
a	O
Th2	O
-	O
biased	O
immune	O
response	O
.	O

Following	O
in	O
utero	O
exposure	O
to	O
a	O
gestational	O
low	O
protein	O
diet	O
at	O
1	O
dpn	O
we	O
could	O
not	O
find	O
significant	O
regulatory	O
changes	O
of	O
genes	O
of	O
any	O
molecular	O
route	O
in	O
porcine	O
perinatal	O
liver	O
.	O

The	O
ADA	O
states	O
that	O
all	O
women	O
should	O
receive	O
individualized	O
counseling	O
to	O
provide	O
adequate	O
calories	O
and	O
nutrients	O
to	O
meet	O
the	O
needs	O
of	O
pregnancy	O
and	O
consistent	O
with	O
the	O
blood	O
glucose	O
goals	O
(	O
fasting	O
≤	O
105	O
mg	O
/	O
dl	O
[	O
5	O
.	O
8	O
mmol	O
/	O
L	O
],	O
1	O
hr	O
≤	O
155	O
mg	O
/	O
dl	O
[	O
8	O
.	O
6	O
mmol	O
/	O
L	O
],	O
and	O
2	O
hrs	O
≤	O
130	O
mg	O
/	O
dl	O
[	O
7	O
.	O
2	O
mmol	O
/	O
L	O
]).	O

Eight	O
viable	O
fetuses	O
per	O
sow	O
were	O
collected	O
starting	O
at	O
the	O
tip	O
of	O
the	O
left	O
uterus	O
horn	O
and	O
alternating	O
between	O
left	O
and	O
right	O
horn	O
.	O

In	O
this	O
article	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
mutations	O
affecting	O
skeletal	O
morphology	O
,	O
skeletal	O
morphology	O
1	O
(	O
skm1	O
)	O
and	O
skeletal	O
morphology	O
2	O
(	O
Skm2	O
),	O
in	O
a	O
recessive	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
.	O

These	O
data	O
will	O
supply	O
information	O
on	O
the	O
nutritional	O
status	O
of	O
women	O
early	O
in	O
their	O
pregnancy	O
.	O

1	O
)	O
in	O
a	O
crude	O
model	O
and	O
in	O
a	O
model	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

Bonferrroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
).	O

Cont	O
–	O
control	O
pregnancies	O
;	O
UN	O
P	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
only	O
;	O
UN	O
L	O
–	O
dams	O
undernourished	O
during	O
lactation	O
only	O
;	O
UN	O
PL	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
and	O
lactation	O
.	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	O
that	O
there	O
would	O
be	O
at	B
least	I
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Taken	O
together	O
,	O
the	O
observed	O
regulations	O
were	O
seen	O
as	O
a	O
clue	O
for	O
impairments	O
in	O
energy	O
metabolism	O
in	O
LP	O
offspring	O
during	O
ontogenesis	O
.	O

Women	O
of	O
Indian	O
origin	O
,	O
especially	O
pregnant	O
women	O
,	O
are	O
known	O
to	O
have	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
not	O
contraindicated	O
,	O
skin	O
prick	O
testing	O
should	O
be	O
postponed	O
until	O
after	O
birth	O
because	O
of	O
possible	O
,	O
although	O
rare	O
,	O
anaphylactic	O
reactions	O
to	O
skin	O
prick	O
testing	O
.	O

Subsequently	O
,	O
the	O
title	O
of	O
an	O
article	O
in	O
Scientific	O
American	O
recently	O
asked	O
,	O
‘	O
What	O
if	O
vitamin	O
D	O
deficiency	O
is	O
a	O
cause	O
of	O
autism	O
?’	O
(	O
3	O
)	O
Since	O
then	O
,	O
an	O
article	O
on	O
vitamin	O
D	O
and	O
autism	O
in	O
Acta	O
Paediatrica	O
(	O
4	O
)	O
and	O
the	O
accompanying	O
commentary	O
(	O
5	O
)	O
have	O
added	O
to	O
the	O
accelerating	O
suspicion	O
that	O
vitamin	O
D	O
deficiency	O
–	O
either	O
during	O
pregnancy	O
or	O
early	O
childhood	O
–	O
may	O
be	O
an	O
environmental	O
trigger	O
for	O
the	O
genetic	O
disease	O
of	O
autism	O
.	O

(	O
2011	O
)*	O
UrethaneMouseInjection	O
(	O
ip	O
)	O
(	O
1	O
mg	O
/	O
g	O
/	O
wk	O
)	O
Late	O
childhood	O
/	O
adolescence	O
+	O
early	O
adulthoodAdulthoodHepatic	O
tumorsHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPandey	O
et	O
al	O
.	O

While	O
we	O
did	O
not	O
assess	O
caries	O
rates	O
,	O
all	O
children	O
with	O
S	O
-	O
ECC	O
had	O
multiple	O
cavitated	O
caries	O
lesions	O
necessitating	O
surgery	O
.	O

(	O
2015	O
)*/‡	O
Metals	O
:	O
Cadmium	O
(	O
Cd	O
)	O
Mouse	O
RatInjection	O
(	O
ip	O
)	O
(	O
20	O
nmol	O
/	O
kg	O
/	O
2	O
d	O
CdCl2	O
)	O
Adolescence	O
/	O
early	O
adulthoodLater	O
adulthoodHepatic	O
abnormalitiesDNA	O
methylationWang	O
et	O
al	O
.	O

Women	O
attending	O
ANC	O
for	O
their	O
subsequent	O
pregnancies	O
probably	B
had	O
a	O
notion	O
of	O
what	O
health	O
topics	O
were	O
discussed	O
during	O
clinic	O
sessions	O
and	O
so	O
their	O
objectives	O
at	O
ANC	O
were	O
not	O
only	O
aimed	O
at	O
acquiring	O
knowledge	O
about	O
diet	O
,	O
danger	O
signs	O
and	O
other	O
topics	O
but	O
also	O
in	O
the	O
state	O
of	O
their	O
babies	O
.	O

PcG	O
targets	O
are	O
a	O
family	O
of	O
developmentally	O
related	O
genes	O
that	O
can	O
remodel	O
chromatin	O
and	O
are	O
responsible	O
for	O
silencing	O
HOX	O
genes	O
,	O
which	O
are	O
critical	O
in	O
embryonic	O
development	O
as	O
well	O
as	O
potentially	O
hundreds	O
of	O
other	O
genes	O
involved	O
in	O
cellular	O
differentiation	O
(	O
Kirmizis	O
et	O
al	O
.	O

The	O
pills	O
were	O
produced	O
by	O
the	O
Jalinous	O
pharmaceutical	O
company	O
in	O
Iran	O
.	O

Comparisons	O
between	O
groups	O
were	O
performed	O
using	O
student	O
t	O
-	O
test	O
for	O
continuous	O
variables	O
,	O
and	O
Fisher	O
exact	O
test	O
for	O
categorical	O
variables	O
.	O

Dietary	O
therapy	O
It	O
is	O
generally	B
accepted	O
that	O
dietary	O
therapy	O
is	O
the	O
cornerstone	B
of	O
treatment	O
of	O
GDM	O
.	O

This	O
is	O
true	O
both	O
in	O
the	O
fetus	O
itself	O
and	O
in	O
the	O
placenta	O
,	O
where	O
changes	O
to	O
the	O
appropriate	O
methylation	O
patterning	O
have	O
been	O
linked	O
to	O
adverse	O
placental	O
morphology	O
and	O
birth	O
outcomes	O
(	O
Serman	O
et	O
al	O
.	O

Six	O
children	O
in	O
the	O
vitamin	O
D	O
and	O
four	O
in	O
the	O
placebo	O
group	O
died	O
of	O
septicaemia	O
or	O
pneumonia	O
.	O

Data	O
on	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
collected	O
from	O
obstetrics	O
charts	O
based	O
on	O
standardized	O
measures	O
.	O

Rules	O
will	O
include	O
logical	O
and	O
range	O
checks	O
,	O
uniqueness	O
check	O
and	O
skipping	O
rules	O
as	O
appropriate	O
.	O

Overall	O
,	O
lower	O
T1	O
25OHD	O
(	O
as	O
a	O
continuous	O
but	O
not	O
categorical	O
variable	O
)	O
was	O
associated	O
with	O
pregnancy	O
loss	O
(	O
Table3	O
).	O

To	O
exercise	O
the	O
delivery	O
of	O
services	O
Anganwadi	O
centres	O
(	O
AWCs	O
)	O
has	O
been	O
created	O
in	O
all	O
regions	O
of	O
the	O
country	O
.	O

)•	O
Create	O
and	O
implement	O
effective	O
community	O
-	O
based	O
approaches	O
(	O
e	O
.	O
g	O
.,	O
community	O
health	O
workers	O
home	O
visit	O
packages	O
,	O
women	O
'	O
s	O
'	O
groups	O
)	O
Typical	O
timeline	O
to	O
impactNear	O
-	O
term	O
to	O
Long	O
-	O
term	O
(	O
2	O
to	O
15	O
years	O
)	O
Long	O
-	O
term	O
(	O
5	O
to	O
15	O
years	O
)	O
Medium	O
-	O
term	O
(	O
5	O
to	O
10	O
years	O
)	O
Near	O
-	O
term	O
(	O
2	O
to	O
5	O
years	O
)	O
Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Therefore	O
,	O
no	O
significant	O
regulated	O
metabolic	O
pathway	O
was	O
determined	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
do	O
not	O
have	O
an	O
association	O
that	O
might	O
pose	O
a	O
conflict	O
of	O
interest	O
.	O

Undernourishment	O
in	O
utero	O
can	O
stress	O
the	O
foetus	O
in	O
ways	O
that	O
permanently	O
affect	O
physiological	O
growth	O
and	O
development	O
,	O
and	O
can	O
be	O
described	O
as	O
a	O
reprogramming	O
of	O
the	O
foetus	O
’	O
s	O
developing	O
phenotype	O
[	O
4	O
].	O

Cytokines	O
and	O
hepcidin	O
will	O
be	O
determined	O
using	O
ELISA	O
.	O

S1	O
).	O

Slight	O
modifications	O
to	O
the	O
standard	O
text4baby	O
messages	O
were	O
made	O
due	O
to	O
specific	O
health	O
care	O
resources	O
(	O
eg	O
,	O
toll	O
-	O
free	O
numbers	O
for	O
prenatal	O
health	O
information	O
)	O
available	O
to	O
military	O
women	O
[	O
23	O
,	O
25	O
].	O

Such	O
findings	O
have	O
been	O
echoed	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
in	O
recently	O
issued	O
warnings	O
suggesting	O
that	O
,	O
similar	O
to	O
SSRIs	O
,	O
antipsychotics	O
may	O
cause	O
PNA	O
syndrome	O
.	O
48In	O
the	O
present	O
study	O
,	O
82	O
.	O
6	O
%	O
of	O
neonates	O
admitted	O
to	O
the	O
NICU	O
were	O
exposed	O
to	O
polytherapy	O
,	O
mostly	O
with	O
SSRIs	O
.	O

Allergies	O
or	O
hyperreactivities	O
have	O
been	O
classified	O
by	O
Gells	O
and	O
Coombs	O
into	O
types	O
I	O
through	O
IV	O
,	O
with	O
types	O
I	O
,	O
II	O
,	O
and	O
III	O
being	O
mediated	O
by	O
antibodies	O
or	O
immune	O
complexes	O
and	O
type	O
IV	O
reactions	O
as	O
well	O
as	O
chronic	O
stages	O
of	O
allergic	O
diseases	O
being	O
mediated	O
by	O
T	O
cells	O
[	O
1	O
].	O

This	O
seems	O
to	O
be	O
important	O
because	O
allergen	O
-	O
specific	O
T	O
cells	O
transferred	O
from	O
1	O
mouse	O
mother	O
to	O
another	O
can	O
transmit	O
asthma	O
risk	O
to	O
the	O
offspring	O
of	O
the	O
recipient	O
mouse	O
mother	O
[	O
69	O
].	O

One	O
child	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
above	O
four	O
SD	O
from	O
the	O
mean	O
and	O
was	O
excluded	O
from	O
subsequent	O
analyses	O
.	O

We	O
used	O
the	O
R	O
package	O
‘	O
glmnet	O
’	O
[	O
42	O
],	O
and	O
included	O
the	O
BHLM	O
confounders	O
(	O
Table3	O
)	O
in	O
the	O
regression	O
as	O
unpenalized	O
variables	O
.	O

BMC	O
was	O
significantly	O
related	O
to	O
length	O
at	O
one	O
week	O
(	O
r	O
=	O
0	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
however	O
,	O
in	O
multivariate	O
analysis	O
including	O
weight	O
and	O
length	O
,	O
only	O
weight	O
was	O
significant	O
,	O
p	O
<	O
0	O
.	O
001	O
and	O
length	O
was	O
not	O
significant	O
,	O
p	O
=	O
0	O
.	O
87	O
.	O

We	O
are	O
describing	O
a	O
unique	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

Not	O
really	O
a	O
vitamin	O
,	O
D3is	O
a	O
pro	O
-	O
prehormone	O
made	O
in	O
the	O
skin	O
in	O
response	O
to	O
ultraviolet	O
-	O
B	O
light	O
exposure	O
.	O

PFAS	O
levels	O
were	O
similar	O
across	O
women	O
’	O
s	O
reported	O
reasons	O
for	O
ending	O
breastfeeding	O
,	O
and	O
the	O
researchers	O
saw	O
no	O
clear	O
differences	O
between	O
primiparous	O
and	O
multiparous	O
mothers	O
.	O
24	O
“	O
You	O
have	O
three	O
studies	O
telling	O
a	O
similar	O
story	O
from	O
different	O
parts	O
of	O
the	O
world	O
.	O

Adjusted	O
odd	O
ratios	O
(	O
aORs	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
were	O
first	O
determined	O
after	O
adjusting	O
for	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
then	O
after	O
adjusting	O
for	O
number	O
of	O
prenatal	O
visits	O
and	O
socio	O
-	O
demographic	O
factors	O
(	O
age	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
).	O

Supplements	O
containing	O
vitamin	O
D	O
were	O
used	O
by	O
43	O
%	O
in	O
T1	O
and	O
39	O
%	O
in	O
T3	O
-	O
mainly	O
multivitamins	O
[	O
19	O
].	O

A	O
plot	O
of	O
gestational	O
age	O
at	O
birth	O
as	O
a	O
function	O
of	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
with	O
the	O
fitted	O
LOESS	O
curve	O
for	O
women	O
with	O
a	O
history	O
of	O
PTB	O
is	O
shown	O
inFig	O
3	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
and	O
RC	O
females	O
did	O
not	O
displayed	O
higher	O
caloric	O
intake	O
compared	O
to	O
the	O
respective	O
CC	O
males	O
and	O
CC	O
females	O
.	O

Genomewide	O
DNA	O
methylation	O
profiles	O
were	O
obtained	O
in	O
a	O
subset	O
of	O
184	O
samples	O
using	O
the	O
Illumina	O
Infinium	O
HumanMethylation27	O
BeadArray	O
.	O

BAT	O
consists	O
in	O
brown	O
adipocytes	O
,	O
characterized	O
by	O
multiple	O
,	O
small	O
,	O
multilocular	O
lipid	O
droplets	O
with	O
a	O
central	O
nucleus	O
and	O
a	O
high	O
number	O
of	O
mitochondria	O
.	O

The	O
management	O
of	O
gestational	O
diabetes	O
Abstract	O
The	O
incidence	O
of	O
gestational	O
diabetes	O
is	O
increasing	O
.	O

Thus	B
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

A	O
sufficient	O
maternal	O
vitamin	O
D	O
status	O
,	O
specified	O
as	B
25	O
(	O
OH	O
)	O
D	O
above	O
50	O
nmol	O
/	O
L	O
,	O
may	O
be	O
a	O
threshold	O
above	O
which	O
the	O
physiological	O
requirements	O
of	O
pregnancy	O
are	O
achieved	O
.	O

High	O
vitamin	O
D	O
status	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
and	O
LBW	O
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

Some	O
examples	O
include	O
technologies	O
for	O
ventilatory	O
support	O
,	O
novel	O
surfactant	O
formulations	O
,	O
safe	O
and	O
effective	O
intravenous	O
fluid	O
and	O
drug	O
administration	O
,	O
devices	O
for	O
testing	O
bilirubin	O
levels	O
for	O
jaundice	O
and	O
innovative	O
phototherapy	O
equipment	O
[	O
6	O
].	O

Most	O
pregnant	O
women	O
were	O
satisfied	O
with	O
the	O
level	O
of	O
care	O
received	O
during	O
ANC	O
in	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

We	O
drew	O
a	O
random	O
sample	O
of	O
all	O
women	O
meeting	O
criteria	O
at	O
the	O
Madigan	O
Obstetrics	O
and	O
Gynecology	O
Clinic	O
between	O
December	O
2011	O
and	O
January	O
2013	O
.	O

Indeed	O
,	O
without	O
the	O
genetic	O
tendency	O
for	O
autism	O
,	O
I	O
suspect	B
that	O
severe	O
maternal	O
or	O
early	O
childhood	O
vitamin	O
D	O
deficiency	O
may	O
cause	O
bone	O
abnormalities	O
,	O
as	O
referenced	O
above	O
,	O
with	O
no	O
evidence	O
autism	O
.	O

This	O
was	O
mediated	O
by	O
phosphorylation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
(	O
pSTAT3	O
).	O

This	O
increment	O
may	O
be	O
brought	O
about	O
largely	O
by	O
thyroid	O
stimulation	O
induced	O
by	O
human	O
chorionic	O
gonadotropin	O
(	O
HCG	O
)	O
through	O
its	O
structural	O
affinity	O
with	O
thyrotropin	O
(	O
TSH	O
).	O

Mothers	O
were	O
paid	O
$	O
25	O
for	O
attending	O
the	O
30	O
-	O
week	O
gestation	O
and	O
6	O
-	O
month	O
postpartum	O
assessments	O
.	O

Apart	O
from	O
the	O
inconvenience	O
of	O
taking	O
time	O
to	O
answer	O
the	O
research	O
questionnaire	O
,	O
participants	O
were	O
not	O
exposed	O
to	O
undue	O
risk	O
.	O

Our	O
findings	O
of	O
elevated	O
risks	O
of	O
incident	O
GDM	O
among	O
women	O
reporting	O
both	O
long	O
and	O
short	O
sleep	O
durations	O
in	O
early	O
pregnancy	O
are	O
consistent	O
with	O
these	O
earlier	O
reports	O
from	O
men	O
and	O
non	O
pregnant	O
women	O
.	O

Unplanned	O
pregnancy	O
was	O
more	O
frequent	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
group	O
.	O

Effect	O
of	O
weaning	O
age	O
has	O
been	O
studied	O
in	O
Shorthorn	O
calves	O
[	O
52	O
].	O

Premature	O
Ovarian	O
Failure	O
Premature	O
ovarian	O
failure	O
,	O
defined	O
as	O
starting	O
the	O
menopausal	O
period	O
before	O
the	O
40th	O
year	O
of	O
life	O
,	O
can	O
also	O
be	O
influenced	O
by	O
VD	O
level	O
.	O

These	O
sensory	O
and	O
biological	O
considerations	O
shed	O
light	O
on	O
why	O
lifestyle	O
changes	O
are	O
difficult	O
for	O
young	O
children	O
to	O
make	O
.	O

The	O
number	O
of	O
mature	O
glomeruli	O
was	O
20	O
%	O
lower	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1VitD	O
-	O
mice	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
number	O
of	O
mature	O
glomeruli	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
F2	O
-	O
SC	O
mice	O
at	O
this	O
age	O
.	O

Epigenetics	O
thus	B
offers	O
an	O
opportunity	O
for	O
improved	O
chemical	O
regulation	O
and	O
public	O
health	O
protection	O
.	O

Frequent	O
regular	O
follow	O
-	O
up	O
visits	O
to	O
or	O
by	O
health	O
professionals	O
skilled	O
in	O
managing	O
asthma	O
are	O
essential	O
to	O
ensure	O
optimal	O
success	O
and	O
safety	O
of	O
asthma	O
management	O
during	O
pregnancy	O
.	O

The	O
differing	O
outcomes	O
between	O
each	O
of	O
the	O
perinatal	O
undernutrition	O
approaches	O
reported	O
here	O
are	O
likely	B
to	O
reflect	O
these	O
confounders	O
of	O
severity	O
and	O
timing	O
.	O

The	O
day	O
before	O
the	O
test	O
,	O
all	O
animals	O
were	O
food	O
-	O
deprived	O
for	O
20	O
h	O
.	O
Then	O
AM251	O
or	O
vehicle	O
was	O
intraperitoneally	O
administered	O
(	O
3	O
mg	O
/	O
mL	O
).	O

Vitamin	O
D	O
is	O
linked	O
with	O
other	O
non	O
-	O
bone	O
health	O
outcomes	O
,	O
but	O
the	O
few	O
completed	O
and	O
adequately	O
powered	O
trials	O
assessing	O
the	O
effect	O
of	O
supplementation	O
have	O
mixed	O
findings	O
in	O
improving	O
outcomes	O
—	O
ie	O
,	O
cancers	O
,	O
vascular	O
disease	O
,	O
and	O
diabetes	O
.	O

In	O
contrast	O
for	O
white	O
women	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
significantly	O
higher	O
seasonally	O
-	O
adjusted	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
early	O
(	O
OR	O
3	O
.	O
5	O
,	O
95	O
%	O
CI	O
2	O
.	O
1	O
,	O
5	O
.	O
8	O
)	O
(	O
Interaction	O
P	O
value	O
0	O
.	O
01	O
).	O

Environmentally	O
induced	O
epigenetic	O
changes	O
in	O
the	O
sperm	O
or	O
egg	O
prior	O
to	O
conception	O
could	O
,	O
therefore	B
,	O
affect	O
embryo	O
viability	O
and	O
development	O
and	O
the	O
subsequent	O
future	O
health	O
and	O
fertility	O
of	O
the	O
next	O
generation	O
.	O

One	O
study	O
reported	O
that	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3inhibited	O
lipid	O
accumulation	O
by	O
inhibiting	O
key	O
adipogenic	O
factors	O
such	O
as	O
PPARG	O
[	O
143	O
].	O

Design	O
:	O
Within	O
-	O
randomization	O
group	O
analysis	O
of	O
the	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
trial	O
of	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Studies	O
in	O
which	O
BMI	O
of	O
children	O
is	O
documented	O
at	O
repeated	O
times	O
show	O
strong	O
tracking	O
patterns	O
with	O
age	O
,	O
6	O
–	O
9but	O
this	O
has	O
not	O
been	O
reported	O
in	O
relation	O
to	O
family	O
lineages	O
including	O
grandparents	O
.	O

While	O
this	O
large	O
body	O
of	O
work	O
also	O
provides	O
some	O
comprehensive	B
evidence	O
for	O
,	O
and	O
specific	O
mechanisms	O
of	O
,	O
epigenetic	O
toxicity	O
,	O
it	O
was	O
considered	O
outside	O
the	O
scope	O
of	O
this	O
review	O
.	O

We	O
further	O
the	O
study	O
for	O
analyses	O
of	O
miRNAs	O
targeting	O
porcine	O
GR	O
.	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Box	O
2	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

Promotion	O
of	O
handwashing	O
with	O
soap	O
before	O
umbilical	O
cord	O
care	O
should	O
be	O
emphasized	O
in	O
antenatal	O
and	O
neonatal	O
care	O
messaging	O
,	O
given	B
existing	O
evidence	O
supporting	O
prevention	O
of	O
umbilical	O
cord	O
infections	O
by	O
caregiver	O
handwashing	O
.	O

Factors	O
affecting	O
BAT	O
function	O
and	O
energy	O
metabolism	O
improve	O
overall	O
metabolism	O
In	O
rodents	O
,	O
brown	O
adipocytes	O
are	O
found	O
in	O
discrete	O
areas	O
,	O
such	O
as	O
interscapular	O
,	O
cervical	O
,	O
peri	O
-	O
aortic	O
,	O
peri	O
-	O
renal	O
,	O
intercostal	O
and	O
mediastinal	O
depots	O
(	O
Cinti	O
,	O
2001	O
),	O
which	O
are	O
referred	O
to	O
as	O
“	O
classical	O
”	O
BAT	O
depots	O
.	O

Also	O
,	O
future	O
adequately	O
powered	O
randomized	O
clinical	O
trials	O
are	O
needed	O
to	O
determine	O
whether	O
modifying	O
maternal	O
prenatal	O
behaviors	O
and	O
GWG	O
can	O
prevent	O
offspring	O
obesity	O
.	O

The	O
resulting	O
gene	O
lists	O
were	O
compared	O
between	O
LP	O
and	O
AP	O
offspring	O
at	O
the	O
corresponding	O
ontogenetic	O
periods	O
.	O

A	O
subgroup	O
of	O
infants	O
from	O
the	O
MIG	O
Study	O
are	O
currently	O
being	O
followed	O
up	O
.	O
72It	O
may	O
be	O
circumspect	O
to	O
await	O
the	O
findings	O
from	O
this	O
follow	O
-	O
up	O
study	O
before	O
metformin	O
can	O
be	O
considered	O
safe	O
for	O
the	O
routine	O
treatment	O
of	O
GDM	O
.	O

While	O
some	O
tests	O
in	O
the	O
OECD	O
Conceptual	O
Framework	O
do	O
cover	O
exposure	O
during	O
critical	O
periods	O
of	O
development	O
in	O
utero	O
,	O
to	O
date	O
,	O
they	O
may	O
not	O
address	O
effects	O
that	O
might	O
be	O
induced	O
by	O
exposure	O
during	O
neonatal	O
or	O
pubertal	O
development	O
,	O
and	O
/	O
or	O
emerge	O
during	O
later	O
life	O
stages	O
.	O

There	O
was	O
also	O
no	O
significant	O
difference	O
in	O
multivitamin	O
usage	O
between	O
the	O
groups	O
(	O
76	O
with	O
S	O
-	O
ECC	O
vs	O
.	O
67	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
73	O
).	O

Lab	O
and	O
questionnaire	O
data	O
were	O
entered	O
into	O
an	O
Excel	O
(	O
Microsoft	O
Office	O
)	O
spreadsheet	O
and	O
analyzed	O
using	O
Number	O
Cruncher	O
Statistical	O
Software	O
(	O
NCSS	O
)	O
version	O
7	O
.	O
0	O
(	O
Kaysville	O
,	O
Utah	O
).	O

There	O
was	O
an	O
association	O
also	O
with	O
each	O
parent	O
and	O
their	O
own	O
mother	O
.	O

The	O
commonly	O
used	O
organophospate	O
pesticide	O
chlorpyrifos	O
(	O
CPF	O
)	O
is	O
known	O
to	O
specifically	O
target	O
the	O
immature	O
brain	O
,	O
from	O
the	O
early	O
embryonic	O
stage	O
to	O
the	O
postweaning	O
period	O
,	O
and	O
it	O
causes	O
a	O
host	O
of	O
irreversible	O
changes	O
to	O
developing	O
brain	O
cells	O
[	O
39	O
].	O

Severe	O
maternal	O
anaemia	O
increases	O
the	O
risk	O
of	O
maternal	O
and	O
neonatal	O
mortality	O
and	O
morbidity	O
while	O
less	O
severe	O
anaemia	O
and	O
iron	O
deficiency	O
have	O
been	O
linked	O
to	O
sub	O
-	O
optimal	O
fetal	O
growth	O
,	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
,	O
as	O
well	O
as	O
iron	O
deficiency	O
in	O
infants	O
[	O
2	O
]–[	O
4	O
]	O
which	O
may	O
impair	O
cognitive	O
development	O
[	O
5	O
].	O

We	O
will	O
also	O
collect	O
information	O
on	O
exposure	O
to	O
household	O
air	O
pollution	O
and	O
out	O
of	O
pocket	O
expenses	O
for	O
any	O
antenatal	O
and	O
postnatal	O
care	O
seeking	O
(	O
Table1	O
).	O

Gestational	O
exposure	O
to	O
endocrine	O
disrupting	O
chemicals	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
:	O
a	O
Bayesian	O
analysis	O
of	O
the	O
HOME	O
Study	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
exposed	O
to	O
a	O
mixture	O
of	O
endocrine	O
disrupting	O
chemicals	O
(	O
EDCs	O
).	O

Shea	O
et	O
al	O
studied	O
2500	O
elderly	O
adults	O
and	O
found	O
that	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
vitamin	O
D	O
insufficiency	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
in	O
both	O
black	O
(	O
5	O
.	O
2	O
(	O
95	O
%	O
CI	O
:	O
3	O
.	O
5	O
,	O
7	O
.	O
7	O
))	O
and	O
white	O
participants	O
(	O
OR	O
2	O
.	O
6	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
0	O
,	O
3	O
.	O
2	O
),	O
however	O
these	O
subjects	O
were	O
much	O
older	O
and	O
not	O
pregnant	O
.	O
26A	O
small	O
Turkish	O
study	O
of	O
79	O
pregnant	O
women	O
showed	O
significantly	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
among	O
women	O
reporting	O
PNV	O
use	O
in	O
the	O
third	O
trimester	O
,	O
27but	O
this	O
study	O
did	O
not	O
include	O
women	O
of	O
African	O
descent	O
and	O
did	O
not	O
have	O
the	O
power	O
to	O
address	O
potential	O
interaction	O
by	O
BMI	O
.	O

Q	O
:	O
quintile	O
.#:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

As	B
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

Our	O
findings	O
represent	O
an	O
important	O
key	O
point	O
to	O
understand	O
the	O
complexity	O
of	O
the	O
fetal	O
programming	O
process	O
and	O
might	O
be	O
particularly	O
useful	O
in	O
the	O
searching	O
of	O
efficient	O
therapies	O
against	O
a	O
malprogramming	O
.	O

Whereas	O
the	O
frequency	O
of	O
handwashing	O
with	O
water	O
alone	O
was	O
similar	O
in	O
the	O
two	O
groups	O
(	O
mean	O
1	O
.	O
6	O
events	O
in	O
intervention	O
arm	O
,	O
1	O
.	O
5	O
events	O
in	O
control	O
arm	O
),	O
mothers	O
in	O
the	O
intervention	O
arm	O
washed	O
their	O
hands	O
with	O
soap	O
with	O
a	O
mean	O
of	O
0	O
.	O
82	O
times	O
(	O
SD	O
1	O
.	O
2	O
)	O
during	O
the	O
3	O
-	O
hour	O
observation	O
period	O
,	O
compared	O
to	O
0	O
.	O
20	O
times	O
by	O
mothers	O
in	O
the	O
control	O
arm	O
(	O
RD	O
0	O
.	O
61	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
37	O
–	O
0	O
.	O
86	O
)	O
(	O
Table	O
2	O
).	O

However	O
,	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
bone	O
-	O
related	O
outcomes	O
in	O
supplemented	O
infants	O
provides	O
information	O
about	O
the	O
effects	O
of	O
these	O
cord	O
levels	O
and	O
vitamin	O
D	O
supplementation	O
in	O
early	O
infancy	O
.	O

Any	O
unexpected	O
test	O
result	O
and	O
any	O
symptoms	O
that	O
change	O
over	O
time	O
should	O
be	O
reevaluated	O
after	O
pregnancy	O
.	O

2	O
.	O
2	O
.	O

It	O
is	O
unknown	O
whether	O
this	O
reflects	O
differences	O
in	O
brain	O
size	O
or	O
in	O
skull	O
bones	O
’	O
structure	O
,	O
and	O
needs	O
to	O
be	O
explored	O
in	O
future	O
studies	O
.	O

For	O
more	O
information	O
on	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
prevention	O
of	O
allergy	O
,	O
readers	O
are	O
referred	O
to	O
the	O
document	O
,	O
"	O
Prevention	O
of	O
Allergy	O
and	O
Allergic	O
Asthma	O
,"	O
an	O
article	O
based	O
on	O
findings	O
presented	O
at	O
the	O
World	O
Health	O
Organization	O
/	O
World	O
Allergy	O
Organization	O
meeting	O
in	O
January	O
2002	O
[	O
120	O
].	O

On	O
evaluation	O
of	O
this	O
recurrence	O
,	O
a	O
0	O
.	O
8	O
-	O
×	O
0	O
.	O
9	O
-	O
cm	O
friable	O
erythematous	O
papule	O
was	O
noted	O
under	O
the	O
onycholytic	O
distal	O
right	O
great	O
toenail	O
and	O
extended	O
distal	O
to	O
the	O
onychodermal	O
band	O
(	O
Fig	O
1	O
).	O

With	O
respect	O
to	O
public	O
health	O
,	O
however	O
,	O
this	O
is	O
mere	O
semantics	O
;	O
both	O
could	O
have	O
far	O
-	O
reaching	O
consequences	O
for	O
the	O
present	O
and	O
future	O
health	O
of	O
human	O
populations	O
.	O

The	O
same	O
researcher	O
blinded	O
to	O
the	O
clinical	O
data	O
conducted	O
the	O
assessment	O
of	O
all	O
children	O
.	O

Mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
significantly	O
lower	O
among	O
children	O
with	O
S	O
-	O
ECC	O
than	O
caries	O
-	O
free	O
controls	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Table	O
2	O
).	O

This	O
was	O
followed	O
by	O
incubation	O
for	O
1	O
hr	O
with	O
antibodies	O
against	O
GR	O
α	O
at	O
a	O
1	O
:	O
200	O
dilution	O
in	O
1	O
%	O
BSA	O
/	O
PBS	O
.	O

Therefore	B
,	O
these	O
potential	O
limitations	O
should	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
our	O
results	O
.	O

Various	O
human	O
studies	O
are	O
done	O
so	O
far	O
involving	O
pharmacological	O
doses	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
.	O

A	O
detailed	O
description	O
of	O
the	O
follow	O
-	O
up	O
study	O
and	O
exposure	O
assessment	O
has	O
been	O
described	O
elsewhere	O
[	O
21	O
].	O

Also	O
,	O
few	O
maternal	O
psychosocial	O
predictors	O
of	O
offspring	O
weight	O
status	O
were	O
observed	O
within	O
both	O
overweight	O
/	O
obese	O
and	O
normal	O
weight	O
mothers	O
.	O

Despite	O
small	O
cell	O
sizes	O
,	O
it	O
should	O
be	O
noted	O
that	O
all	O
of	O
the	O
children	O
with	O
low	O
calcium	O
concentrations	O
belonged	O
to	O
the	O
S	O
-	O
ECC	O
group	O
.	O

Data	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
,	O
including	O
effects	O
of	O
diet	O
,	O
sex	O
,	O
mother	O
,	O
birth	O
weight	O
and	O
interaction	O
between	O
diet	O
and	O
sex	O
(	O
SAS	O
version	O
9	O
.	O
1	O
;	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
).	O

Infections	O
were	O
defined	O
as	O
discrete	O
events	O
that	O
were	O
documented	O
in	O
the	O
medical	O
record	O
and	O
/	O
or	O
the	O
primary	O
health	O
care	O
record	O
.	O

The	O
plasma	O
levels	O
of	O
LDL	O
were	O
significantly	O
increased	O
in	O
RC	O
males	O
and	O
females	O
.	O

However	O
,	O
the	O
previous	O
study	O
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	O
the	O
current	O
study	O
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

As	B
15	O
%	O
of	O
the	O
women	O
in	O
the	O
Diabetes	O
Prevention	O
Program	O
and	O
Diabetes	O
Prevention	O
Study	O
had	O
GDM	O
,	O
similar	O
measures	O
should	O
be	O
recommended	O
to	O
women	O
after	O
they	O
have	O
had	O
GDM	O
.	O

Ethical	O
approval	O
was	O
granted	O
from	O
the	O
local	O
ethics	O
authority	O
.	O

The	O
highest	O
profit	O
in	O
this	O
steer	O
group	O
was	O
for	O
a	O
slaughter	O
age	O
of	O
31	O
months	O
.	O

Only	O
a	O
small	O
proportion	O
of	O
white	O
infants	O
were	O
SGA	O
,	O
and	O
this	O
may	O
have	O
limited	O
our	O
ability	O
to	O
detect	O
significant	O
associations	O
between	O
vitamin	O
D	O
and	O
SGA	O
among	O
white	O
infants	O
.	O

Maternal	O
Diet	O
The	O
maternal	O
dietary	O
component	O
consumed	O
during	O
gestation	O
could	O
influence	O
the	O
immune	O
status	O
of	O
the	O
child	O
.	O

could	O
be	O
replicated	O
in	O
the	O
general	O
obstetrical	O
population	O
at	O
MUSC	O
.	O

Reactive	O
oxygen	O
species	O
are	O
also	O
proposed	O
to	O
stimulate	O
the	O
production	O
of	O
alpha	O
-	O
ketoglutarate	O
,	O
a	O
co	O
-	O
substrate	O
for	O
TETs	O
and	O
one	O
of	O
the	O
two	O
main	O
classes	O
of	O
histone	O
demethylases	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

The	O
corresponding	O
null	O
distribution	O
,	O
signifying	O
a	O
lack	O
of	O
association	O
between	O
repetitive	O
element	O
methylation	O
and	O
autosomal	O
CpG	O
methylation	O
,	O
was	O
obtained	O
by	O
randomly	O
permuting	O
each	O
repetitive	O
element	O
methylation	O
marker	O
with	O
respect	O
to	O
aggregate	O
methylation	O
values	O
of	O
the	O
RPMM	O
and	O
bioinformatic	O
classes	O
.	O

We	O
acknowledge	O
that	O
measurement	O
of	O
GR	O
polymorphisms	O
posed	O
certain	O
limitations	O
,	O
for	O
example	O
,	O
the	O
use	O
of	O
cell	O
lines	O
as	O
in	O
vitro	O
experimental	O
models	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
as	O
the	O
main	O
precursor	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
has	O
a	O
circulating	O
half	O
-	O
life	O
of	O
2	O
–	O
3	O
weeks	O
.	O

At	O
baseline	O
,	O
using	O
Pearson	O
’	O
s	O
correlation	O
coefficient	O
,	O
no	O
relations	O
were	O
observed	O
between	O
the	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
and	O
depression	O
scores	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

Kolmogro	O
-	O
Smirnov	O
test	O
was	O
used	O
to	O
determine	O
the	O
distribution	O
of	O
quantitative	O
data	O
.	O

Doses	O
of	O
L	O
-	O
thyroxine	O
greater	O
than	O
150	O
/	O
200	O
μg	O
(	O
at	B
least	I
2	O
μg	O
/	O
kg	O
/	O
day	O
)	O
are	O
usually	O
needed	O
to	O
maintain	O
maternal	O
serum	O
-	O
free	O
thyroxin	O
concentrations	O
within	O
the	O
upper	O
third	O
of	O
the	O
reference	O
range	O
and	O
to	O
suppress	O
TSH	O
levels	O
.	O

A	O
more	O
recent	O
study	O
examined	O
the	O
peer	O
effects	O
on	O
adolescent	O
BMI	O
by	O
using	O
the	O
National	O
Longitudinal	O
Study	O
of	O
Adolescent	O
Health	O
(	O
98	O
).	O

Black	O
line	O
represents	O
fitted	O
LOESS	O
curve	O
.	O

[	O
18	O
]	O
both	O
found	O
changes	O
in	O
birth	O
weight	O
associated	O
with	O
increased	O
OCP	O
exposure	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2458	O
/	O
13	O
/	O
1105	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Nutritional	O
knowledge	O
questionnaire	O
.	O

The	O
quality	O
and	O
accuracy	O
of	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
analysis	O
is	O
validated	O
on	O
an	O
ongoing	O
basis	O
by	O
participation	O
in	O
the	O
vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
DEQAS	O
,	O
Charing	O
Cross	O
Hospital	O
,	O
London	O
,	O
UK	O
).	O

©	O
2009	O
Dove	O
Medical	O
Press	O
Limited	O
.	O

Chart	O
reviews	O
were	O
conducted	O
to	O
determine	O
whether	O
the	O
PTBs	O
were	O
spontaneous	O
(	O
occurring	O
after	O
preterm	O
labor	O
with	O
intact	O
membranes	O
or	O
preterm	O
pre	O
-	O
labor	O
rupture	O
of	O
the	O
fetal	O
membranes	O
)	O
or	O
indicated	O
.	O

Providing	O
quality	O
care	O
involves	O
doing	O
the	O
right	O
thing	O
at	O
the	O
right	O
time	O
.	O

In	O
this	O
way	O
free	O
sugar	O
intake	O
was	O
estimated	O
.	O

Weight	O
at	O
the	O
last	O
clinic	O
visit	O
was	O
objectively	O
measured	O
using	O
a	O
calibrated	O
digital	O
or	O
balance	O
beam	O
scale	O
by	O
research	O
assistant	O
or	O
clinic	O
staff	O
.	O

The	O
evaluation	O
team	O
will	O
consist	O
of	O
135	O
data	O
collectors	O
,	O
five	O
field	O
supervisors	O
and	O
five	O
field	O
research	O
officers	O
.	O

The	O
following	O
narrative	O
review	O
aims	O
to	O
better	O
understand	O
the	O
existing	O
evidence	O
for	O
perinatal	O
and	O
labor	O
-	O
related	O
associations	O
with	O
autism	O
.	O

Postoperatively	O
,	O
the	O
mother	O
continued	O
to	O
be	O
hypernatremic	O
despite	O
IV	O
infusion	O
of	O
hypotonic	O
fluids	O
.	O

Maternal	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
closest	O
to	O
delivery	O
were	O
plotted	O
against	O
gestational	O
age	O
at	O
birth	O
and	O
locally	O
weighted	O
regression	O
(	O
LOESS	O
)	O
was	O
used	O
to	O
explore	O
the	O
relationship	O
in	O
more	O
detail	O
and	O
compare	O
to	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

However	O
,	O
a	O
few	O
studies	O
present	O
conflicting	O
data	O
about	O
the	O
correlation	O
between	O
birth	O
weight	O
and	O
the	O
impairment	O
of	O
cardiac	O
autonomic	O
modulation	O
.	O

Years	O
of	O
life	O
saved	O
will	O
be	O
based	O
on	O
any	O
difference	O
in	O
survival	O
of	O
mothers	O
and	O
infants	O
observed	O
during	O
the	O
trial	O
and	O
estimated	O
using	O
current	O
life	O
expectancy	O
in	O
Bangladesh	O
.	O

Malaria	O
blood	O
films	O
were	O
prepared	O
and	O
stained	O
with	O
giemsa	O
stain	O
and	O
100	O
microscopic	O
fields	O
examined	O
to	O
determine	O
parasite	O
count	O
.	O

While	O
dental	O
surgery	O
targets	O
the	O
visible	O
signs	O
of	O
the	O
disease	O
,	O
our	O
understanding	O
of	O
the	O
systemic	O
influence	O
of	O
S	O
-	O
ECC	O
on	O
overall	O
health	O
is	O
limited	O
.	O

(	O
a	O
)	O
SC	O
offspring	O
and	O
(	O
b	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F1	O
generation	O
;	O
(	O
c	O
)	O
SC	O
offspring	O
and	O
(	O
d	O
)	O
VitD	O
-	O
offspring	O
in	O
the	O
F2	O
generation	O
;	O
(	O
arrows	O
)	O
clusters	O
with	O
comma	O
-	O
shaped	O
and	O
S	O
-	O
shaped	O
glomerular	O
structures	O
at	O
the	O
cortex	O
;	O
(	O
open	O
arrows	O
)	O
vascularized	O
glomerular	O
structures	O
in	O
the	O
inner	O
region	O
.	O

They	O
are	O
also	O
complicated	O
by	O
the	O
fact	O
that	O
the	O
biological	O
material	O
under	O
study	O
,	O
often	B
blood	O
cells	O
,	O
is	O
not	O
from	O
the	O
target	O
organ	O
/	O
tissue	O
.	O

2	O
.	O

The	O
rapid	O
acting	O
analogs	O
lispro	O
and	O
aspart	O
are	O
considered	O
safe	O
,	O
but	O
the	O
safety	O
of	O
the	O
long	O
-	O
acting	O
analogs	O
are	O
yet	O
to	O
be	O
determined	O
.	O

Those	O
who	O
participated	O
gave	O
written	O
informed	O
consent	O
.	O

Regarding	O
the	O
potential	O
relation	O
between	O
ECS	O
and	O
fetal	O
undernutrition	O
,	O
a	O
few	O
studies	O
have	O
demonstrated	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
calorie	O
-	O
restricted	O
diet	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
could	O
decrease	O
the	O
hypothalamic	O
endocannabinoids	O
and	O
/	O
or	O
acylethanolamines	O
in	O
offspring	O
(	O
Matias	O
et	O
al	O
.,	O
2003	O
;	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

None	O
of	O
the	O
other	O
variables	O
listed	O
in	O
Table1were	O
found	O
to	O
be	O
confounders	O
.	O

Overall	O
,	O
snoring	O
was	O
associated	O
with	O
a	O
1	O
.	O
86	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
1	O
.	O
86	O
;	O
95	O
%	O
CI	O
0	O
.	O
88	O
-	O
3	O
.	O
94	O
).	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Blood	O
samples	O
were	O
collected	O
and	O
a	O
questionnaire	O
was	O
completed	O
face	O
-	O
to	O
-	O
face	O
.	O

The	O
cost	O
per	O
woman	O
treated	O
(	O
defined	O
as	O
consuming	O
at	O
least	O
75	O
%	O
of	O
the	O
recommended	O
intake	O
)	O
was	O
USD0	O
.	O
76	O
per	O
annum	O
.	O

It	O
is	O
possible	O
that	O
the	O
increased	O
energy	O
,	O
protein	O
and	O
fat	O
observed	O
in	O
our	O
study	O
during	O
extended	O
summer	O
could	O
be	O
due	O
to	O
changes	O
in	O
dietary	O
habits	O
during	O
the	O
summer	O
holidays	O
.	O

The	O
decision	O
whether	O
to	O
use	O
a	O
first	O
-	O
generation	O
or	O
second	O
-	O
generation	O
antihistamine	O
for	O
a	O
particular	O
patient	O
must	O
be	O
individualized	O
.	O

Methods	O
Study	O
design	O
and	O
subjects	O
This	O
retrospective	O
study	O
was	O
conducted	O
at	O
University	O
of	O
Cincinnati	O
Medical	O
Center	O
in	O
Cincinnati	O
,	O
OH	O
,	O
USA	O
.	O

Results	O
Figure	O
1shows	O
the	O
trial	O
profile	O
.	O

Follow	O
-	O
up	O
schedule	O
Each	O
infant	O
was	O
assessed	O
by	O
a	O
research	O
assistant	O
,	O
blinded	O
to	O
the	O
allocated	O
treatment	O
group	O
.	O

By	O
identifying	O
and	O
contributing	O
to	O
the	O
knowledge	O
gaps	O
PHE	O
,	O
and	O
similar	O
organizations	O
worldwide	O
,	O
can	O
ensure	O
that	O
they	O
stay	O
fully	O
aware	O
of	O
the	O
current	O
situation	O
and	O
are	O
in	O
the	O
best	O
position	O
to	O
give	O
advice	O
and	O
put	O
forward	O
any	O
necessary	O
recommendations	O
and	O
policies	O
to	O
protect	O
public	O
health	O
against	O
such	O
toxicity	O
.	O

Such	O
barriers	O
may	O
include	O
lack	O
of	O
prenatal	O
education	O
about	O
breastfeeding	O
,	O
inadequate	O
lactation	O
support	O
from	O
healthcare	O
providers	O
after	O
delivery	O
,	O
disapproval	O
from	O
spouses	O
or	O
family	O
members	O
,	O
short	O
maternity	O
leave	O
,	O
and	O
few	O
opportunities	O
to	O
pump	O
at	O
work	O
.	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
also	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
males	O
in	O
several	O
weeks	O
of	O
the	O
post	O
-	O
weaning	O
period	O
that	O
comprise	O
the	O
adulthood	O
(	O
postnatal	O
weeks	O
15	O
–	O
18	O
and	O
postnatal	O
week	O
19	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Approximately	O
three	O
-	O
quarters	O
of	O
the	O
women	O
were	O
immigrants	O
(	O
75	O
%),	O
primarily	O
from	O
Mexico	O
and	O
Honduras	O
.	O

Programmatic	O
costs	O
included	O
cost	O
of	O
supplements	O
,	O
which	O
were	O
originally	O
distributed	O
in	O
tamper	O
-	O
proof	O
bottles	O
(	O
UNICEF	O
,	O
Copenhagen	O
),	O
and	O
after	O
12	O
months	O
sourced	O
domestically	O
in	O
blister	O
packs	O
consisting	O
of	O
6	O
tear	O
-	O
off	O
strips	O
of	O
5	O
tablets	O
,	O
each	O
strip	O
enough	O
for	O
one	O
month	O
(	O
Nam	O
Ha	O
Pharmaceutical	O
Company	O
,	O
Nam	O
Dinh	O
,	O
Vietnam	O
).	O

Therefore	B
,	O
vitamin	O
D	O
supplementation	O
in	O
high	O
doses	O
has	O
been	O
recommended	O
,	O
and	O
oral	O
doses	O
of	O
20000	O
or	O
40000	O
IU	O
were	O
associated	O
with	O
positive	O
outcomes	O
.	O
6	O
,	O
14Moreover	O
,	O
higher	O
oral	O
dose	O
of	O
(	O
6400	O
IU	O
per	O
day	O
)	O
to	O
lactating	O
mothers	O
significantly	O
increased	O
vitamin	O
D	O
status	O
in	O
mothers	O
as	O
well	O
as	O
the	O
vitamin	O
D	O
content	O
and	O
antirachitic	O
activity	O
of	O
their	O
milk	O
.	O
14Therefore	B
,	O
high	O
doses	O
of	O
vitamin	O
D	O
,	O
either	O
orally	O
or	O
through	O
injection	O
,	O
has	O
recently	O
been	O
recommended	O
.	O
15	O
-	O
24	O
A	O
single	O
dose	O
of	O
vitamin	O
D	O
,	O
administered	O
parenterally	O
,	O
would	O
be	O
more	O
effective	O
,	O
because	O
it	O
is	O
not	O
associated	O
with	O
the	O
noncompliance	O
associated	O
with	O
an	O
oral	O
dose	O
.	O

The	O
mean	O
number	O
of	O
glomeruli	O
varied	O
from	O
10897	O
±	O
614	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
14064	O
±	O
308	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
30	O
%	O
difference	O
;	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
10466	O
±	O
867	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
12015	O
±	O
785	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

PubMed	O
Central	O
:	O

Briefly	O
,	O
maternal	O
stress	O
/	O
maternal	O
attitudes	O
towards	O
their	O
pregnancy	O
were	O
assessed	O
in	O
the	O
3rd	O
trimester	O
,	O
using	O
a	O
questionnaire	O
approach	O
.	O

The	O
thermogenic	O
activity	O
of	O
BAT	O
is	O
mainly	O
controlled	O
by	O
the	O
sympathetic	O
nervous	O
system	O
.	O

Influenza	O
vaccination	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
risk	O
of	O
influenza	O
virus	O
disease	O
and	O
its	O
complications	O
among	O
pregnant	O
women	O
and	O
their	O
infants	O
[	O
5	O
],[	O
6	O
],[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],[	O
12	O
],[	O
13	O
],[	O
14	O
],[	O
15	O
].	O

Women	O
with	O
known	O
metabolic	O
bone	O
disease	O
,	O
renal	O
stones	O
,	O
hyperparathyroidism	O
or	O
hypercalciuria	O
,	O
those	O
taking	O
medication	O
known	O
to	O
interfere	O
with	O
fetal	O
growth	O
,	O
fetal	O
anomalies	O
on	O
ultrasonography	O
,	O
and	O
women	O
already	O
using	O
>	O
400	O
IU	O
/	O
d	O
vitamin	O
D	O
supplementation	O
were	O
excluded	O
.	O

Insulin	O
therapy	O
for	O
gestational	O
diabetes	O
When	O
treatment	O
targets	O
are	O
not	O
achieved	O
by	O
dietary	O
means	O
,	O
then	O
insulin	O
is	O
required	O
.	O

The	O
duration	O
of	O
supplementation	O
in	O
these	O
studies	O
was	O
short	O
,	O
different	O
MMN	O
formulations	O
were	O
used	O
and	O
sample	O
sizes	O
were	O
smaller	O
than	O
in	O
the	O
present	O
study	O
.	O

However	O
,	O
as	B
there	O
was	O
no	O
evaluation	O
of	O
glycemic	O
control	O
early	O
in	O
pregnancy	O
,	O
and	O
more	O
women	O
on	O
metformin	O
had	O
pre	O
-	O
existing	O
type	O
2	O
diabetes	O
,	O
the	O
groups	O
do	O
not	O
appear	O
to	O
be	O
well	O
matched	O
.	O

Differences	O
in	O
ferritin	O
and	O
haemoglobin	O
between	O
these	O
groups	O
has	O
previously	O
been	O
reported	O
in	O
this	O
sample	O
[	O
12	O
].	O

Neuronal	O
membranes	O
are	O
largely	O
made	O
up	O
of	O
phospholipids	O
,	O
and	O
the	O
brain	O
phospholipids	O
are	O
rich	O
in	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
).	O

In	O
rodents	O
,	O
many	O
studies	O
reported	O
an	O
impact	O
of	O
maternal	O
low	O
protein	O
diets	O
on	O
expression	O
and	O
affinity	O
of	O
the	O
glucocorticoid	O
receptor	O
and	O
its	O
signaling	O
molecules	O
[	O
8	O
,	O
48	O
,	O
59	O
-	O
61	O
].	O

Overall	O
the	O
data	O
support	O
the	O
hypothesis	O
that	O
the	O
cause	O
of	O
the	O
phenotype	O
of	O
HV	O
offspring	O
fed	O
RV	O
diets	O
may	O
be	O
accounted	B
for	I
by	O
its	O
effects	O
in	O
utero	O
on	O
development	O
of	O
hypothalamic	O
pathways	O
of	O
intake	O
regulation	O
,	O
leading	O
to	O
excess	O
food	O
intake	O
,	O
and	O
consequently	B
increased	O
body	O
weight	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
.	O
4Offspring	O
born	O
to	O
dams	O
fed	O
the	O
HV	O
diet	O
during	O
pregnancy	O
had	O
lower	O
expression	O
of	O
POMC	O
and	O
BDNF	O
,	O
which	O
are	O
anorexigenic	O
(	O
appetite	O
-	O
suppressing	O
)	O
genes	O
,	O
20	O
,	O
21compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
the	O
RV	O
diet	O
.	O

Antenatal	O
vitamin	O
D	O
supplementation	O
is	O
now	O
recommended	O
for	O
all	O
pregnant	O
women	O
in	O
many	O
national	O
guidelines	B
(	O
1	O
–	O
3	O
)	O
as	B
severe	O
maternal	O
vitamin	O
D	O
deficiency	O
can	O
result	O
in	O
symptomatic	O
neonatal	O
hypocalcemia	O
(	O
4	O
).	O

As	O
early	O
development	O
progresses	O
and	O
the	O
embryonic	O
genome	O
is	O
activated	O
,	O
miRNA	O
expression	O
increases	O
and	O
piRNA	O
and	O
esiRNA	O
expression	O
decreases	O
,	O
so	O
that	O
the	O
pattern	O
of	O
sncRNA	O
expression	O
is	O
reversed	O
(	O
Ohnishi	O
et	O
al	O
.	O
2010	O
;	O
Suh	O
&	O
Blelloch2011	O
).	O

In	O
these	O
sessions	O
,	O
71	O
maneuvers	O
of	O
tidal	O
breathing	O
analysis	O
,	O
65	O
maneuvers	O
of	O
respiratory	O
mechanics	O
,	O
and	O
59	O
maneuvers	O
of	O
tidal	O
forced	O
expiration	O
were	O
eligible	O
for	O
the	O
final	O
analysis	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Study	O
flow	O
chart	O
.	O

Although	O
some	O
studies	O
have	O
found	O
evidence	O
of	O
a	O
correlation	O
between	O
low	O
birth	O
weight	O
and	O
autonomic	O
dysfunction	O
,	O
the	O
results	O
remain	O
inconclusive	O
.	O

Previous	O
studies	O
have	O
shown	O
a	O
positive	O
association	O
between	O
socioeconomic	O
status	O
and	O
vitamin	O
D	O
in	O
both	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
[	O
36	O
,	O
37	O
].	O

From	O
birth	O
to	O
PND	O
22	O
(	O
lactation	O
),	O
three	O
-	O
way	O
repeated	O
measures	O
ANOVA	O
showed	O
a	O
main	O
and	O
significant	O
effect	O
of	O
time	O
on	O
body	O
weight	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
675	O
.	O
53	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
Figure2B	O
].	O

Development	O
of	O
robust	O
,	O
fit	O
-	O
for	O
-	O
purpose	O
equipment	O
,	O
is	O
a	O
critical	O
next	O
frontier	O
for	O
referral	O
care	O
for	O
premature	O
babies	O
in	O
the	O
settings	O
where	O
most	O
die	O
,	O
especially	O
for	O
care	O
in	O
hospitals	O
[	O
6	O
].	O

[	O
20	O
]	O
report	O
autonomic	O
dysfunction	O
in	O
adults	O
with	O
low	O
birth	O
weight	O
,	O
characterized	O
by	O
increased	O
sympathetic	O
activity	O
and	O
reduced	O
parasympathetic	O
activity	O
and	O
baroreflex	O
sensitivity	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
clarify	O
and	O
strengthen	O
the	O
role	O
of	O
BMP	O
proteins	O
in	O
the	O
regulation	O
of	O
BAT	O
or	O
“	O
brite	O
”	O
cells	O
and	O
their	O
consequences	O
on	O
metabolic	O
homeostasis	O
.	O

We	O
will	O
use	O
population	O
average	O
Poisson	O
model	O
for	O
other	O
outcomes	O
including	O
preterm	O
,	O
small	O
for	O
gestation	O
and	O
low	O
birth	O
weights	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
vitamin	O
D	O
status	O
in	O
pregnancy	O
with	O
birth	O
size	O
and	O
pregnancy	O
loss	O
(	O
adjusted	O
logistic	O
regression	O
analysis	O
)	O
Small	O
for	O
gestational	O
ageaPreterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
bLow	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
cPregnancy	O
lossdORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
T1	O
25OHDe	O
Continuous	O
nmol	O
/	O
L1	O
.	O
0030	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9960	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9990	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
989	O
*	O
0	O
.	O
98	O
–	O
1	O
.	O
00	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
91	O
.	O
0780	O
.	O
44	O
–	O
2	O
.	O
661	O
.	O
6470	O
.	O
63	O
–	O
4	O
.	O
332	O
.	O
5490	O
.	O
88	O
–	O
7	O
.	O
381	O
.	O
0300	O
.	O
44	O
–	O
2	O
.	O
41	O
50	O
–	O
74	O
.	O
91	O
.	O
6320	O
.	O
69	O
–	O
3	O
.	O
851	O
.	O
2600	O
.	O
47	O
–	O
3	O
.	O
362	O
.	O
2870	O
.	O
77	O
–	O
6	O
.	O
830	O
.	O
6880	O
.	O
29	O
–	O
1	O
.	O
62	O
75	O
–	O
99	O
-	O
91	O
.	O
2920	O
.	O
51	O
–	O
3	O
.	O
271	O
.	O
3320	O
.	O
48	O
–	O
3	O
.	O
731	O
.	O
6650	O
.	O
51	O
–	O
5	O
.	O
490	O
.	O
8090	O
.	O
33	O
–	O
1	O
.	O
96	O
≥	O
1001	O
.	O
2940	O
.	O
38	O
–	O
4	O
.	O
420	O
.	O
5020	O
.	O
09	O
–	O
2	O
.	O
721	O
.	O
2550	O
.	O
22	O
–	O
7	O
.	O
270	O
.	O
000fT3	O
25OHDe	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
90	O
.	O
7710	O
.	O
34	O
–	O
1	O
.	O
750	O
.	O
3020	O
.	O
08	O
–	O
1	O
.	O
140	O
.	O
071	O
*	O
0	O
.	O
01	O
–	O
0	O
.	O
63	O
50	O
–	O
74	O
.	O
90	O
.	O
6230	O
.	O
27	O
–	O
1	O
.	O
450	O
.	O
9330	O
.	O
31	O
–	O
2	O
.	O
790	O
.	O
5840	O
.	O
17	O
–	O
1	O
.	O
98	O
75	O
–	O
99	O
-	O
90	O
.	O
6570	O
.	O
27	O
–	O
1	O
.	O
610	O
.	O
6140	O
.	O
18	O
–	O
2	O
.	O
140	O
.	O
2370	O
.	O
06	O
–	O
1	O
.	O
01	O
≥	O
1000	O
.	O
318	O
*	O
0	O
.	O
11	O
–	O
0	O
.	O
900	O
.	O
4460	O
.	O
11	O
–	O
1	O
.	O
760	O
.	O
215	O
*	O
0	O
.	O
05	O
–	O
0	O
.	O
97Δ25OHDg	O
Large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
Small	O
increase	O
(	O
0	O
–	O
30	O
nmol	O
/	O
L	O
)	O
2	O
.	O
564	O
*	O
1	O
.	O
16	O
–	O
5	O
.	O
672	O
.	O
905	O
*	O
1	O
.	O
01	O
–	O
8	O
.	O
343	O
.	O
1220	O
.	O
97	O
–	O
10	O
.	O
09	O
Decrease	O
(<	O
0	O
nmol	O
/	O
L	O
)	O
3	O
.	O
679	O
**	O
1	O
.	O
60	O
–	O
8	O
.	O
442	O
.	O
8940	O
.	O
95	O
–	O
8	O
.	O
854	O
.	O
722	O
*	O
1	O
.	O
37	O
–	O
16	O
.	O
28	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
*	O
p	O
<	O
0	O
.	O
05	O
**	O
p	O
<	O
0	O
.	O
01	O
aModels	O
include	O
92	O
(	O
T1	O
)	O
and	O
80	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
small	O
for	O
gestational	O
age	O
bModels	O
include	O
77	O
(	O
T1	O
)	O
and	O
43	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
preterm	O
delivery	O
cModels	O
include	O
57	O
(	O
T1	O
)	O
and	O
31	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
low	O
birth	O
weight	O
dModels	O
include	O
96	O
cases	O
of	O
pregnancy	O
loss	O
eAdjusted	O
for	O
education	O
,	O
origin	O
,	O
season	O
of	O
conception	O
and	O
BMI	O
at	O
T1	O
.	O

Similarly	O
,	O
seasonal	O
occurrence	O
has	O
been	O
observed	O
for	O
chicken	O
pox	O
,	O
measles	O
,	O
influenza	O
and	O
many	O
other	O
common	O
childhood	O
infectious	O
diseases	O
[	O
7	O
,	O
142	O
].	O

It	O
should	O
be	O
noted	O
,	O
however	O
,	O
that	O
,	O
from	O
a	O
stand	O
-	O
alone	O
perspective	O
,	O
each	O
of	O
the	O
factors	O
(	O
as	O
listed	O
above	O
)	O
that	O
link	O
autism	O
with	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
does	O
not	O
correlate	O
consistently	O
as	B
the	O
incidence	O
of	O
autism	O
is	O
reviewed	O
in	O
terms	O
of	O
its	O
cross	O
-	O
reference	O
amongst	O
various	O
research	O
studies	O
.	O

First	O
,	O
it	O
provides	B
a	O
randomized	O
trial	O
of	O
text4baby	O
with	O
a	O
large	O
sample	O
over	O
the	O
full	O
course	O
of	O
the	O
prenatal	O
texting	O
module	O
.	O

Randomisation	O
was	O
by	O
use	O
of	O
a	O
computer	O
-	O
generated	O
list	O
.	O

It	O
was	O
hypothesized	O
that	O
(	O
1	O
)	O
total	O
current	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
positively	O
correlated	O
with	O
cathelicidin	O
in	O
children	O
;	O
(	O
2	O
)	O
children	O
with	O
higher	O
plasma	O
cathelicidin	O
concentrations	O
would	O
have	O
had	O
fewer	O
infections	O
than	O
children	O
with	O
lower	O
cathelicidin	O
concentrations	O
;	O
and	O
(	O
3	O
)	O
cathelicidin	O
concentration	O
would	O
increase	O
with	O
advancing	O
age	O
.	O

Results	O
Participant	O
characteristics	O
-	O
demographics	O
Half	O
of	O
the	O
participants	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
(	O
November	O
–	O
April	O
)	O
(	O
n	O
=	O
166	O
[	O
49	O
.	O
7	O
%]).	O

From	O
murine	O
studies	O
,	O
it	O
may	O
be	O
expected	O
that	O
the	O
sensitization	O
of	O
a	O
mother	O
to	O
a	O
(	O
food	O
)	O
allergen	O
will	O
also	O
bias	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
toward	O
Th2	O
[	O
39	O
,	O
40	O
].	O

The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
is	O
still	O
evolving	O
,	O
and	O
recent	O
randomized	O
controlled	O
trials	O
have	O
added	O
considerably	O
to	O
our	O
knowledge	O
in	O
this	O
area	O
.	O

For	O
41	O
.	O
7	O
%	O
of	O
the	O
women	O
this	O
was	O
their	O
first	O
pregnancy	O
(	O
unknown	O
for	O
0	O
.	O
4	O
%	O
of	O
the	O
women	O
),	O
while	O
for	O
45	O
.	O
6	O
%	O
of	O
the	O
women	O
this	O
would	O
be	O
their	O
first	O
child	O
(	O
status	O
not	O
known	O
for	O
1	O
.	O
4	O
%	O
of	O
the	O
women	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Skeletal	O
abnormalities	O
in	O
skeletal	O
morphology	O
mutant	O
(	O
Skm	O
)	O
mice	O
.	O

At	O
weaning	O
(	O
28	O
dpn	O
)	O
offspring	O
of	O
the	O
LP	O
group	O
showed	O
slight	O
but	O
significant	O
higher	O
fat	O
content	O
and	O
adipocyte	O
size	O
,	O
and	O
still	O
lower	O
muscle	O
fibre	O
numbers	O
.	O

These	O
districts	O
are	O
Netrokona	O
,	O
Kishoreganj	O
,	O
Mymensingh	O
,	O
Sherpur	O
,	O
and	O
Gazipur	O
,	O
with	O
a	O
total	O
number	O
of	O
47	O
Upazila	O
(	O
subdistricts	O
)	O
and	O
a	O
combined	O
population	O
of	O
20	O
million	O
.	O

Preeclampsia	O
occurred	O
less	O
frequently	O
in	O
the	O
intervention	O
group	O
(	O
12	O
%	O
vs	O
18	O
%,	O
adjusted	O
risk	O
reduction	O
0	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

In	O
terms	O
of	O
the	O
polymorphic	O
study	O
,	O
our	O
study	O
provides	B
a	O
novel	O
insight	O
into	O
the	O
involvement	O
of	O
GR	O
polymorphisms	O
in	O
pregnancy	O
outcome	O
.	O

Other	O
allergic	O
diseases	O
that	O
may	O
complicate	O
pregnancy	O
include	O
conjunctivitis	O
,	O
acute	O
urticaria	O
,	O
anaphylaxis	O
,	O
food	O
allergy	O
,	O
and	O
drug	O
allergy	O
.	O

There	O
are	O
also	O
high	O
preterm	O
birth	O
rates	O
in	O
many	O
high	O
-	O
income	O
countries	O
,	O
including	O
the	O
United	O
States	O
.	O

In	O
either	O
design	O
,	O
contamination	O
of	O
the	O
control	O
group	O
would	O
be	O
a	O
potential	O
concern	O
.	O

Furthermore	O
,	O
women	O
were	O
asked	O
a	O
validated	O
,	O
single	O
-	O
item	O
question	O
on	O
food	O
insufficiency	O
–“	O
How	O
many	O
days	O
in	O
the	O
past	O
week	O
have	O
you	O
gone	O
hungry	O
?	O

Those	O
receiving	O
standard	O
care	O
were	O
unaware	O
that	O
they	O
had	O
GDM	O
.	O

These	O
in	O
vitro	O
and	O
in	O
vivo	O
observations	O
together	O
are	O
highly	B
suggestive	O
of	O
a	O
functional	O
link	O
between	O
stress	O
and	O
this	O
ncRNA	O
.	O

Second	O
,	O
the	O
fallow	O
up	O
of	O
mothers	O
and	O
infants	O
was	O
short	O
-	O
term	O
.	O

Independent	O
t	O
-	O
tests	O
were	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
continuous	O
variables	O
and	O
each	O
outcome	O
.	O

injection	O
of	O
1	O
.	O
25	O
mg	O
propionyl	O
-	O
promazine	O
(	O
0	O
.	O
2	O
ml	O
Combelen	O
,	O
Bayer	O
AG	O
,	O
Leverkusen	O
,	O
Germany	O
)	O
and	O
50	O
mg	O
ketamine	O
(	O
Ursotamin	O
,	O
Serumwerk	O
Bernburg	O
AG	O
,	O
Germany	O
).	O

Associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
and	O
pregnancy	O
loss	O
were	O
also	O
studied	O
.	O

Methods	O
The	O
GraviD	O
study	O
is	O
a	O
prospective	O
cohort	O
study	O
,	O
conducted	O
in	O
parts	O
of	O
the	O
Västra	O
Götaland	O
region	O
in	O
the	O
southwest	O
of	O
Sweden	O
,	O
at	O
latitude	O
57	O
–	O
58	O
°	O
N	O
[	O
3	O
].	O

Chailurkit	O
et	O
al	O
.	O

Asthma	O
and	O
allergic	O
disorders	O
can	O
affect	O
the	O
course	O
and	O
outcome	O
of	O
the	O
pregnancy	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
25	O
(	O
OH	O
)	O
D	O
,	O
Calcium	O
,	O
Albumin	O
,	O
and	O
PTH	O
status	O
by	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groupVariableOverall	O
valueCaries	O
statusP	O
valueS	O
-	O
ECCCaries	O
-	O
FreeN	O
(%)	O
95	O
%	O
CIN	O
(%)	O
95	O
%	O
CI25	O
(	O
OH	O
)	O
D	O
status	O
Mean	O
(	O
nmol	O
/	O
L	O
)†	O
75	O
.	O
4	O
±	O
30	O
.	O
268	O
.	O
9	O
±	O
27	O
.	O
9	O
/	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
/	O
<	O
0	O
.	O
001Optimal	O
*	O
(≥	O
75	O
nmol	O
/	O
L	O
)	O
Yes12556	O
(	O
44	O
.	O
8	O
)	O
36	O
.	O
1	O
,	O
53	O
.	O
569	O
(	O
55	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
64	O
.	O
00	O
.	O
006No13684	O
(	O
61	O
.	O
8	O
)	O
53	O
.	O
6	O
,	O
69	O
.	O
952	O
(	O
38	O
.	O
2	O
)	O
30	O
.	O
1	O
,	O
46	O
.	O
4	O
Adequate	O
*	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
Yes218111	O
(	O
50	O
.	O
9	O
)	O
44	O
.	O
3	O
,	O
57	O
.	O
6107	O
(	O
49	O
.	O
1	O
)	O
42	O
.	O
4	O
,	O
55	O
.	O
70	O
.	O
05No4329	O
(	O
67	O
.	O
4	O
)	O
53	O
.	O
4	O
,	O
81	O
.	O
414	O
(	O
32	O
.	O
6	O
)	O
18	O
.	O
6	O
,	O
46	O
.	O
6	O
Deficient	O
*	O
(<	O
35	O
nmol	O
/	O
L	O
)	O
Yes1612	O
(	O
75	O
.	O
0	O
)	O
53	O
.	O
8	O
,	O
96	O
.	O
24	O
(	O
25	O
.	O
0	O
)	O
3	O
.	O
8	O
,	O
46	O
.	O
20	O
.	O
12aNo245128	O
(	O
52	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
58	O
.	O
5117	O
(	O
47	O
.	O
8	O
)	O
41	O
.	O
5	O
,	O
54	O
.	O
0	O
Calcium	O
status	O
Mean	O
(	O
mmol	O
/	O
L	O
)†	O
2	O
.	O
3	O
±	O
0	O
.	O
12	O
.	O
2	O
±	O
0	O
.	O
1	O
/	O
2	O
.	O
4	O
±	O
0	O
.	O
1	O
/<	O
0	O
.	O
001Low	O
calcium	O
*	O
Yes1010	O
(	O
100	O
.	O
0	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
00	O
.	O
002aNo248130	O
(	O
52	O
.	O
4	O
)	O
46	O
.	O
2	O
,	O
58	O
.	O
6118	O
(	O
47	O
.	O
6	O
)	O
41	O
.	O
4	O
,	O
53	O
.	O
8	O
Low	O
calcium	O
(	O
Corrected	O
)*	O
Yes66	O
(	O
100	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
0	O
No252134	O
(	O
53	O
.	O
2	O
)	O
47	O
.	O
0	O
,	O
59	O
.	O
3118	O
(	O
46	O
.	O
8	O
)	O
41	O
.	O
0	O
,	O
53	O
.	O
00	O
.	O
03aPTH	O
status	O
Mean	O
(	O
ng	O
/	O
L	O
)†	O
47	O
.	O
3	O
±	O
22	O
.	O
059	O
.	O
1	O
±	O
21	O
.	O
8	O
/	O
32	O
.	O
9	O
±	O
10	O
.	O
8	O
/<	O
0	O
.	O
001Elevated	O
PTH	O
*	O
Yes9285	O
(	O
92	O
.	O
4	O
)	O
87	O
.	O
0	O
,	O
97	O
.	O
87	O
(	O
7	O
.	O
6	O
)	O
2	O
.	O
2	O
,	O
13	O
.	O
0	O
<	O
0	O
.	O
001No16255	O
(	O
34	O
.	O
0	O
)	O
26	O
.	O
7	O
,	O
41	O
.	O
2107	O
(	O
66	O
.	O
0	O
)	O
58	O
.	O
7	O
,	O
73	O
.	O
3	O
Albumin	O
status	O
Mean	O
(	O
g	O
/	O
L	O
)†	O
38	O
.	O
4	O
±	O
3	O
.	O
736	O
.	O
8	O
±	O
3	O
.	O
1	O
/	O
40	O
.	O
3	O
±	O
3	O
.	O
5	O
/<	O
0	O
.	O
001Low	O
albumin	O
*	O
Yes3326	O
(	O
78	O
.	O
8	O
)	O
64	O
.	O
8	O
,	O
92	O
.	O
77	O
(	O
21	O
.	O
2	O
)	O
7	O
.	O
3	O
,	O
35	O
.	O
20	O
.	O
002No225114	O
(	O
50	O
.	O
7	O
)	O
44	O
.	O
1	O
,	O
57	O
.	O
2111	O
(	O
49	O
.	O
3	O
)	O
43	O
.	O
0	O
,	O
56	O
.	O
0	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

As	O
sensitivity	O
analyses	O
,	O
we	O
repeated	O
analyses	O
after	O
exclusion	O
of	O
mothers	O
with	O
implausible	O
energy	O
intakes	O
(<	O
2500	O
or	O
>	O
25	O
000	O
kJ	O
·	O
day	O
−	O
1	O
[	O
34	O
])	O
and	O
after	O
exclusion	O
of	O
mothers	O
with	O
diabetes	O
(	O
whose	O
offspring	O
will	O
have	O
experienced	O
high	O
fetal	O
exposure	O
to	O
glucose	O
).	O

The	O
research	O
that	O
ensued	O
found	O
significantly	O
different	O
results	O
between	O
population	O
-	O
based	O
studies	O
and	O
clinic	O
based	O
studies	O
.	O

A	O
step	O
in	O
this	O
direction	O
will	O
go	O
a	O
long	O
way	O
to	O
consolidate	O
the	O
improvement	O
in	O
health	O
care	O
delivery	O
sought	O
by	O
Cameroon	O
in	O
the	O
framework	O
of	O
the	O
MDGs	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Determinants	O
of	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
vitamins	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
Urban	O
environment	O
1	O
.	O
47	O
(	O
1	O
.	O
18	O
;	O
1	O
.	O
48	O
)	O
1	O
.	O
46	O
(	O
0	O
.	O
83	O
;	O
2	O
.	O
54	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
34	O
)	O
0	O
.	O
72	O
(	O
0	O
.	O
44	O
;	O
1	O
.	O
19	O
)	O
1	O
.	O
66	O
(	O
1	O
.	O
01	O
;	O
2	O
.	O
73	O
)	O
1	O
.	O
58	O
(	O
0	O
.	O
90	O
;	O
2	O
.	O
78	O
)	O
Age	O
(	O
yrs	O
)	O
≤	O
1911111119	O
-	O
342	O
.	O
061	O
.	O
271	O
.	O
050	O
.	O
931	O
.	O
551	O
.	O
18	O
(	O
0	O
.	O
66	O
;	O
6	O
.	O
47	O
)(	O
0	O
.	O
39	O
;	O
4	O
.	O
19	O
)(	O
0	O
.	O
47	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
41	O
;	O
2	O
.	O
14	O
)	O
0	O
.	O
67	O
;	O
3	O
.	O
580	O
.	O
50	O
;	O
2	O
.	O
78	O
≥	O
353	O
.	O
111	O
.	O
590	O
.	O
760	O
.	O
640	O
.	O
790	O
.	O
50	O
(	O
0	O
.	O
84	O
;	O
11	O
.	O
46	O
)(	O
0	O
.	O
41	O
;	O
6	O
.	O
17	O
)(	O
0	O
.	O
28	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
23	O
;	O
1	O
.	O
79	O
)	O
0	O
.	O
28	O
;	O
2	O
.	O
250	O
.	O
17	O
;	O
1	O
.	O
47Schooling	O
(	O
grades	O
)	O
≤	O
8	O
9	O
-	O
12	O
11	O
1111	O
4	O
.	O
764	O
.	O
01	O
1	O
.	O
141	O
.	O
341	O
.	O
631	O
.	O
640	O
>	O
12	O
(	O
2	O
.	O
28	O
;	O
9	O
.	O
97	O
)(	O
1	O
.	O
88	O
;	O
8	O
.	O
56	O
)	O
(	O
0	O
.	O
66	O
;	O
1	O
.	O
98	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
93	O
;	O
2	O
.	O
88	O
)(	O
0	O
.	O
908	O
;	O
2	O
.	O
964	O
)	O
8	O
.	O
125	O
.	O
21	O
1	O
.	O
54	O
2	O
.	O
303	O
.	O
543	O
.	O
372	O
(	O
3	O
.	O
67	O
;	O
17	O
.	O
96	O
)(	O
2	O
.	O
12	O
;	O
12	O
.	O
82	O
)	O
(	O
0	O
.	O
82	O
;	O
2	O
.	O
90	O
)	O
(	O
1	O
.	O
08	O
;	O
4	O
.	O
86	O
)(	O
1	O
.	O
68	O
;	O
7	O
.	O
43	O
)(	O
1	O
.	O
432	O
;	O
7	O
.	O
940	O
)	O
Married	O
2	O
.	O
68	O
1	O
.	O
931	O
.	O
300	O
.	O
741	O
.	O
491	O
.	O
330	O
(	O
1	O
.	O
34	O
;	O
5	O
.	O
36	O
)	O
(	O
0	O
.	O
93	O
;	O
4	O
.	O
01	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
25	O
)(	O
0	O
.	O
45	O
;	O
1	O
.	O
22	O
)(	O
0	O
.	O
83	O
;	O
2	O
.	O
68	O
)(	O
0	O
.	O
712	O
;	O
2	O
.	O
487	O
)	O
Wanted	O
pregnancy0	O
.	O
960	O
.	O
821	O
.	O
611	O
.	O
480	O
.	O
961	O
.	O
49	O
(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
32	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
78	O
;	O
3	O
.	O
33	O
)(	O
0	O
.	O
71	O
;	O
3	O
.	O
09	O
)(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
68	O
;	O
3	O
.	O
26First	O
birth1	O
.	O
3540	O
.	O
9470	O
.	O
9130	O
.	O
8982	O
.	O
0361	O
.	O
79	O
(	O
0	O
.	O
706	O
;	O
2	O
.	O
599	O
)(	O
0	O
.	O
474	O
;	O
1	O
.	O
891	O
)(	O
0	O
.	O
519	O
;	O
1	O
.	O
604	O
)(	O
0	O
.	O
506	O
;	O
1	O
.	O
593	O
)(	O
1	O
.	O
128	O
;	O
3	O
.	O
673	O
)(	O
0	O
.	O
98	O
;	O
3	O
.	O
26	O
)≤	O
4	O
pregnancy	O
registration	O
3	O
.	O
763	O
.	O
41	O
1	O
.	O
070	O
.	O
920	O
.	O
482	O
.	O
02	O
(	O
1	O
.	O
19	O
;	O
11	O
.	O
89	O
)(	O
1	O
.	O
05	O
;	O
11	O
.	O
14	O
)	O
(	O
0	O
.	O
52	O
;	O
2	O
.	O
24	O
)(	O
0	O
.	O
48	O
;	O
1	O
.	O
93	O
)(	O
0	O
.	O
22	O
;	O
1	O
.	O
05	O
)(	O
0	O
.	O
91	O
;	O
4	O
.	O
46	O
)	O
No	O
.	O

Whenever	O
possible	O
,	O
surgery	O
should	O
be	O
carried	O
out	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery	O
,	O
as	O
for	O
newly	O
diagnosed	O
thyroid	O
cancer	O
.	O

RA	O
,	O
JD	O
,	O
PR	O
,	O
and	O
JS	O
did	O
both	O
,	O
the	O
biochemical	O
and	O
statistical	O
analysis	O
.	O

The	O
lack	O
of	O
differentiation	O
of	O
underlying	O
complications	O
in	O
pregnancy	O
,	O
which	O
lead	O
to	O
eventual	O
use	O
of	O
induction	O
,	O
could	O
be	O
the	O
cause	O
of	O
these	O
conflicting	O
findings	O
[	O
51	O
].	O

The	O
eight	O
eligible	O
studies	O
were	O
graded	O
as	O
negative	O
,	O
neutral	O
or	O
positive	O
overall	O
based	O
on	O
NHMRC	O
guidelines	O
for	O
scientific	O
literature	O
reviews	O
[	O
16	O
].	O

At	O
present	O
,	O
it	O
is	O
impossible	O
to	O
conclusively	O
state	O
that	O
a	O
particular	O
dietary	O
pattern	O
or	O
food	O
will	O
alter	O
AM	O
risk	O
in	O
infants	O
.	O

Celery	O
and	O
citrus	O
fruits	O
seem	O
to	O
increase	O
the	O
risk	O
of	O
food	O
sensitization	O
,	O
whereas	O
vegetable	O
oils	O
,	O
raw	O
sweet	O
pepper	O
,	O
and	O
again	O
citrus	O
fruit	O
increase	O
sensitization	O
to	O
respiratory	O
antigens	O
[	O
79	O
].	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

Infant	O
outcomes	O
other	O
than	O
z	O
-	O
scores	O
were	O
additionally	O
adjusted	O
for	O
gender	O
and	O
actual	O
age	O
at	O
assessment	O
.	O

The	O
central	O
team	O
will	O
comprise	O
of	O
three	O
research	O
fellows	O
,	O
one	O
medical	O
officer	O
and	O
one	O
research	O
investigator	O
and	O
one	O
BRAC	O
national	O
manager	O
.	O

Critical	O
monthly	O
adjustment	O
of	O
levothyroxine	O
therapy	O
:	O
maintain	O
fT4	O
in	O
the	O
upper	O
third	O
of	O
reference	O
range	O
.	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

The	O
researchers	O
of	O
independent	O
subjects	O
and	O
dizygotic	O
twins	O
found	O
that	O
activation	O
of	O
receptors	O
with	O
either	O
polymorphism	O
has	O
been	O
link	O
with	O
increased	O
signaling	O
,	O
secondary	O
to	O
decreased	O
downregulation	O
of	O
the	O
β	O
2	O
adrenergic	O
receptor	O
gene	O
.	O

The	O
recommended	O
dose	O
of	O
400	O
IU	O
(	O
10	O
micrograms	O
)	O
daily	O
for	O
infants	O
was	O
established	O
based	B
on	I
typical	O
amounts	O
in	O
a	O
teaspoon	O
of	O
cod	O
liver	O
oil	O
[	O
1	O
].	O

Further	O
study	O
is	O
needed	O
to	O
confirm	O
this	O
.	O

General	O
Characteristics	O
and	O
Dietary	O
Intakes	O
of	O
Study	O
Participants	O
According	O
to	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
812	O
subjects	O
with	O
mean	O
(	O
SD	O
)	O
maternal	O
age	O
of	O
29	O
.	O
4	O
(	O
4	O
.	O
85	O
)	O
remained	O
for	O
the	O
current	O
analysis	O
.	O

The	O
expression	O
of	O
the	O
RAS	O
and	O
podocin	O
proteins	O
was	O
also	O
altered	O
.	O

Maternal	O
diet	O
may	O
influence	O
the	O
infant	O
gut	O
microbiome	O
through	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
during	O
vaginal	O
delivery	O
and	O
breastfeeding	O
.	O

The	O
GM	O
of	O
phthalate	O
and	O
BPA	O
concentrations	O
ranged	O
from	O
2	O
.	O
4	O
ng	O
/	O
ml	O
(	O
MCPP	O
)	O
to	O
41	O
.	O
3	O
ng	O
/	O
ml	O
(	O
MECPP	O
).	O

Most	O
studies	O
on	O
breastfeeding	O
over	O
the	O
past	O
few	O
decades	O
have	O
focused	O
on	O
the	O
advantages	O
of	O
breastfeeding	O
and	O
how	O
to	O
get	O
more	O
women	O
to	O
breastfeed	O
their	O
babies	O
.	O

PubMed	O
Central	O
:	O

Another	O
study	O
was	O
organized	O
to	O
determine	O
ASD	O
in	O
children	O
born	O
preterm	O
and	O
the	O
role	O
of	O
exposure	O
to	O
perinatal	O
inflammation	O
.	O

All	O
offspring	O
was	O
nursed	O
by	O
foster	O
sows	O
receiving	O
standard	O
diets	O
.	O

Epigenetic	O
programing	O
via	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNAs	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

Recurrent	O
acral	O
angioosteoma	O
cutis	O
in	O
a	O
pregnant	O
patient	O
Introduction	O
Googe	O
et	O
al	O
in	O
2006	O
first	O
described	O
11	O
cases	O
of	O
acral	O
angioosteoma	O
cutis	O
(	O
AAOC	O
),	O
characterized	O
by	O
benign	O
vascular	O
and	O
osseous	O
lesions	O
on	O
acral	O
skin	O
.	O
1Since	O
then	O
,	O
there	O
have	O
been	O
only	O
3	O
additional	O
cases	O
reported	O
.	O
2	O
,	O
3	O
,	O
4This	O
friable	O
erythematous	O
exophytic	O
papule	O
has	O
clinical	O
resemblance	O
to	O
pyogenic	O
granuloma	O
(	O
PG	O
)	O
but	O
has	O
distinct	O
histologic	O
features	O
.	O

We	O
have	O
previously	O
shown	O
that	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
larger	O
increase	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
preeclampsia	O
[	O
3	O
].	O

This	O
association	O
was	O
not	O
significant	O
for	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
(	O
15	O
weeks	O
gestation	O
)	O
suggesting	O
that	O
fish	O
consumption	O
may	O
be	O
of	O
more	O
benefit	O
during	O
the	O
third	O
trimester	O
[	O
21	O
].	O

Results	O
Of	O
the	O
506	O
non	O
-	O
Hispanic	O
white	O
and	O
black	O
infants	O
,	O
438	O
with	O
available	O
data	O
on	O
vitamin	O
D	O
status	O
,	O
BMI	O
at	O
delivery	O
,	O
prenatal	O
vitamin	O
use	O
and	O
pre	O
-	O
eclampsia	O
/	O
pregnancy	O
-	O
induced	O
hypertension	O
(	O
PIH	O
)	O
history	O
were	O
included	O
in	O
final	O
analyses	O
.	O

AMH	O
is	O
produced	O
by	O
ovary	O
granulosa	O
cells	O
irrespective	O
of	O
stimulation	O
with	O
gonadotropins	O
,	O
but	O
,	O
as	O
stated	O
above	O
,	O
it	O
may	O
be	O
triggered	O
by	O
VD	O
supplementation	O
.	O

We	O
excluded	O
stillbirths	O
,	O
those	O
who	O
declined	O
to	O
participate	O
,	O
those	O
with	O
obstetric	O
pathology	O
,	O
or	O
psychiatric	O
,	O
cognitive	O
or	O
other	O
disease	O
that	O
might	O
adversely	O
affect	O
understanding	O
of	O
the	O
study	O
objectives	O
or	O
the	O
ability	O
to	O
provide	O
accurate	O
information	O
.	O

Study	O
design	O
We	O
conducted	O
follow	O
-	O
up	O
of	O
infants	O
born	O
to	O
women	O
who	O
participated	O
in	O
the	O
LIMIT	O
randomised	O
trial	O
6	O
-	O
months	O
after	O
birth	O
.	O

Meticulous	O
observation	O
should	O
include	O
seasonal	O
and	O
regional	O
patterns	O
.	O

The	O
metabolism	O
of	O
choline	O
and	O
other	O
methyl	O
group	O
vitamins	O
(	O
ie	O
.	O

Low	O
birth	O
weight	O
infants	O
are	O
susceptible	O
to	O
higher	O
risk	O
of	O
developing	O
iron	O
deficiency	O
anemia	O
leading	O
to	O
impaired	O
development	O
and	O
altered	O
longer	O
term	O
neurodevelopment	O
[	O
3	O
].	O

Soon	O
after	O
,	O
the	O
Association	O
of	O
State	O
and	O
Territorial	O
Health	O
Officials	O
(	O
ASTHO	O
)	O
joined	O
with	O
the	O
March	O
of	O
Dimes	O
to	O
ask	O
state	O
health	O
officials	O
to	O
pledge	O
to	O
reduce	O
preterm	O
birth	O
rates	O
in	O
their	O
states	O
,	O
and	O
the	O
pledge	O
was	O
incorporated	O
into	O
Report	O
Cards	O
.	O

When	O
analysing	O
separately	O
the	O
interaction	O
effect	O
between	O
education	O
and	O
prenatal	O
care	O
,	O
the	O
probability	B
of	O
using	O
folic	O
acid	O
,	O
iron	O
and	O
vitamins	O
supplements	O
was	O
increasing	O
with	O
the	O
level	O
of	O
formal	O
education	O
and	O
number	O
of	O
prenatal	O
visits	O
(	O
Table	O
4	O
).	O

A	O
possible	O
association	O
between	O
fetal	O
sex	O
,	O
vitamin	O
D	O
status	O
and	O
GDM	O
provides	O
further	O
questions	O
and	O
encourages	O
continual	O
research	O
and	O
discussion	O
into	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
,	O
particularly	O
in	O
vitamin	O
D	O
replete	O
populations	O
.	O

Interestingly	O
the	O
risk	O
for	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
lower	O
among	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

Much	O
less	O
is	O
known	O
about	O
the	O
mechanisms	O
of	O
DNA	O
demethylation	O
.	O

They	O
suggest	O
that	O
VD	O
changes	O
AMH	O
production	O
patterns	O
in	O
ovarian	O
granulose	O
cells	O
and	O
alters	O
follicle	O
stimulating	O
hormone	O
(	O
FHS	O
)	O
sensitivity	O
,	O
possibly	O
playing	O
a	O
role	O
in	O
ovarian	O
follicle	O
development	O
.	O

Three	O
analyses	O
informed	O
this	O
target	O
:	O
historical	O
change	O
in	O
high	O
income	O
countries	O
,	O
recent	O
progress	O
in	O
best	O
performing	O
countries	O
,	O
and	O
modelling	O
of	O
mortality	O
reduction	O
with	O
high	O
coverage	O
of	O
existing	O
interventions	O
.	O

For	O
62	O
.	O
0	O
%	O
of	O
them	O
the	O
multivitamin	O
contained	O
vitamin	O
D	O
.	O
In	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
the	O
percentage	O
of	O
women	O
taking	O
a	O
multivitamin	O
containing	O
vitamin	O
D	O
was	O
52	O
.	O
6	O
%	O
and	O
72	O
.	O
3	O
%	O
respectively	O
.	O

Those	O
receiving	O
advice	O
were	O
more	O
likely	B
to	O
have	O
accurate	O
personal	O
weight	O
gain	O
targets	O
,	O
whereas	O
those	O
women	O
who	O
did	O
not	O
receive	O
professional	O
advice	O
were	O
more	O
likely	B
to	O
have	O
low	O
or	O
high	O
personal	O
weight	O
gain	O
targets	O
(	O
Table	O
4	O
).	O
The	O
concordance	O
of	O
mothers	O
’	O
weight	O
gain	O
targets	O
with	O
IOM	O
recommendations	O
did	O
not	O
vary	O
by	O
language	O
preference	O
,	O
years	O
in	O
the	O
US	O
,	O
maternal	O
education	O
,	O
or	O
WIC	O
status	O
.	O

1	O
.	O

5	O
.	O

Three	O
independent	O
reports	O
have	O
observed	O
a	O
peak	O
risk	O
for	O
winter	O
births	O
[	O
16	O
–	O
18	O
],	O
while	O
no	O
seasonal	O
variation	O
for	O
risk	O
was	O
noted	O
in	O
two	O
other	O
epidemiologic	O
studies	O
[	O
19	O
,	O
20	O
].	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	O
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	O
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	B
practices	O
in	O
February	O
2012	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Potential	O
side	O
effects	O
of	O
any	O
drug	O
taken	O
during	O
pregnancy	O
by	O
the	O
mother	O
must	O
be	O
balanced	O
againts	O
the	O
risk	O
of	O
the	O
mother	O
of	O
the	O
infant	O
suffering	O
from	O
inadequately	O
treated	O
symptoms	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Scenario	O
1	O
:	O
"	O
Business	O
as	O
usual	O
"	O
Should	O
governments	O
and	O
the	O
global	O
community	O
take	O
no	O
further	O
direct	O
action	O
to	O
address	O
deaths	O
due	O
to	O
preterm	O
birth	O
,	O
mortality	O
will	O
decline	O
by	O
24	O
%	O
by	O
2025	O
according	O
to	O
an	O
analysis	O
of	O
regional	O
trends	O
over	O
the	O
past	O
decade	O
and	O
forward	O
projection	O
(	O
or	O
16	O
%,	O
if	O
the	O
projection	O
is	O
based	O
on	O
forecasted	O
GNI	O
change	O
)	O
(	O
Figure4	O
).	O

We	O
computed	O
the	O
relative	O
abundance	O
for	O
each	O
OTU	O
by	O
dividing	O
the	O
read	O
count	O
in	O
each	O
cell	O
by	O
the	O
total	O
number	O
of	O
reads	O
in	O
the	O
sample	O
and	O
filtered	O
out	O
OTUs	O
with	O
zero	O
or	O
near	O
-	O
zero	O
variance	O
using	O
the	O
caret	O
package	O
in	O
R	O
.	O
This	O
results	O
in	O
624	O
OTUs	O
.	O

With	O
bold	O
significant	O
OR	O
for	O
p	O
<	O
0	O
.	O
005	O
.	O

Methods	O
Study	O
population	O
.	O

increase	O
in	O
corticosterone	O
levels	O
,	O
suppression	O
of	O
physical	O
activity	O
,	O
alteration	O
in	O
circadian	O
behavior	O
)	O
(	O
Bookout	O
et	O
al	O
.,	O
2013	O
).	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	O
that	O
feed	O
that	O
has	O
a	O
high	O
glycemic	O
index	O
to	O
allow	O
rapid	O
glucose	O
absorption	O
and	O
concomitant	O
high	O
insulin	O
levels	O
through	O
either	O
grain	O
feeding	O
instead	O
of	O
grass	O
finishing	O
or	O
grain	O
processing	O
provides	O
increased	O
net	O
energy	O
levels	O
for	O
FA	O
synthesis	O
.	O

The	O
timing	O
and	O
dosage	O
of	O
oral	O
iron	O
are	O
also	O
controversial	O
as	B
most	O
studies	O
have	O
focused	O
on	O
preventive	O
treatment	O
from	O
midpregnancy	O
,	O
at	O
or	O
before	O
20	O
weeks	O
gestation	O
[	O
4	O
].	O

We	O
need	O
facilities	O
equipped	O
with	O
life	O
-	O
saving	O
commodities	O
,	O
and	O
girls	O
,	O
and	O
women	O
who	O
are	O
educated	O
,	O
and	O
enabled	O
,	O
can	O
protect	O
their	O
own	O
health	O
,	O
and	O
that	O
of	O
their	O
babies	O
.	O

has	O
described	O
that	O
pregnancy	O
is	O
a	O
transformative	O
moment	O
in	O
a	O
woman	O
'	O
s	O
life	O
,	O
at	O
which	O
time	O
she	O
is	O
reenvisioning	O
her	O
role	O
of	O
herself	O
as	O
well	O
as	O
creating	O
and	O
reacting	O
to	O
the	O
expectancies	O
of	O
her	O
pregnancy	O
outcome	O
(	O
i	O
.	O
e	O
.,	O
the	O
new	O
baby	O
she	O
will	O
care	O
for	O
)	O
[	O
15	O
].	O

Seasonal	O
variations	O
in	O
the	O
number	O
of	O
pregnancies	O
have	O
already	O
been	O
noted	O
both	O
in	O
spontaneous	O
reproduction	O
and	O
in	O
IVF	O
.	O

Differences	O
in	O
the	O
distributions	O
of	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
by	O
race	O
were	O
evident	O
(	O
Figure	O
1	O
),	O
with	O
a	O
higher	O
proportion	O
of	O
vitamin	O
D	O
-	O
deficient	O
samples	O
found	O
in	O
the	O
black	O
population	O
.	O

Though	O
compliance	O
with	O
weekly	O
dosage	O
may	O
be	O
better	O
than	O
daily	O
regimen	O
because	O
of	O
reduced	O
side	O
effects	O
,	O
it	O
is	O
desirable	O
to	O
conduct	O
further	O
field	O
randomized	O
controlled	O
trials	O
in	O
order	O
to	O
establish	O
the	O
efficacy	O
of	O
weekly	O
supplementation	O
compared	O
to	O
daily	O
regimen	O
.	O

We	O
recruited	O
from	O
49	O
villages	O
in	O
the	O
study	O
area	O
,	O
which	O
were	O
not	O
receiving	O
any	O
active	O
maternal	O
and	O
child	O
health	O
or	O
nutrition	O
interventions	O
.	O

A	O
strong	O
negative	O
correlation	O
was	O
separately	O
found	O
between	O
the	O
second	O
trimester	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
head	O
circumference	O
(	O
p2	O
=	O
0	O
.	O
05	O
,	O
r2	O
=-	O
0	O
.	O
392	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

Their	O
mean	O
depression	O
score	O
changed	O
to	O
8	O
.	O
54	O
±	O
3	O
.	O
84	O
.	O

When	O
comparing	O
cathelicidin	O
concentrations	O
of	O
children	O
who	O
were	O
deficient	O
with	O
those	O
who	O
were	O
sufficient	O
,	O
(	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
20	O
ng	O
/	O
mL	O
),	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
.	O

Numerous	O
studies	O
have	O
also	O
reported	O
the	O
expression	O
of	O
different	O
GR	O
splice	O
variants	O
in	O
different	O
cell	O
and	O
tissue	O
types	O
[	O
3	O
–	O
6	O
].	O

Symptoms	O
usually	O
develop	O
over	O
a	O
few	O
days	O
and	O
include	O
polyuria	O
,	O
polydipsia	O
,	O
fatigue	O
,	O
nausea	O
,	O
weight	O
loss	O
,	O
and	O
decreased	O
skin	O
turgor	O
.	O

The	O
smallest	O
and	O
the	O
heaviest	O
fetus	O
within	O
one	O
litter	O
were	O
selected	O
for	O
transcriptome	O
analysis	O
.	O

However	O
,	O
among	O
Gardener	O
et	O
al	O
.	O

American	O
Wagyu	O
steers	O
fed	O
a	O
high	O
-	O
corn	O
diet	O
had	O
greater	O
fat	O
accumulation	O
than	O
did	O
animals	O
fed	O
a	O
hay	O
-	O
based	O
diet	O
[	O
120	O
].	O

Inflammatory	O
responses	O
also	O
may	O
favor	O
tumor	O
development	O
[	O
93	O
].	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

The	O
mean	O
visfatin	O
and	O
adiponectin	O
levels	O
were	O
significantly	O
higher	O
in	O
the	O
macrosomia	O
group	O
compared	O
with	O
the	O
AGA	O
group	O
.	O

Extending	O
the	O
time	O
between	O
two	O
consecutive	O
episodes	O
of	O
pneumonia	O
to	O
30	O
days	O
to	O
define	O
a	O
new	O
repeat	O
episode	O
of	O
pneumonia	O
(	O
used	O
by	O
the	O
WHO	O
Vaccine	O
Trials	O
group	O
),	O
19gave	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

At	O
3	O
months	O
,	O
they	O
were	O
mated	O
with	O
males	O
to	O
give	O
birth	O
to	O
the	O
F2	O
generation	O
.	O

1	O
.	O

Therefore	B
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
carry	O
out	O
the	O
first	O
national	O
representative	O
random	O
sample	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
in	O
a	O
European	O
country	O
and	O
to	O
assess	O
the	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Mothers	O
were	O
of	O
Caucasian	O
origin	O
,	O
and	O
infants	O
were	O
born	O
at	O
term	O
with	O
normal	O
birth	O
weight	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
first	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
(	O
Table	O
3	O
).	O

Renin	O
expression	O
was	O
significantly	O
higher	O
at	O
6	O
months	O
of	O
age	O
than	O
at	O
weaning	O
in	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
(	O
P	O
=	O
0	O
.	O
0003	O
,	O
Fig	O
.	O

The	O
infants	O
were	O
born	O
between	O
37	O
+	O
0	O
and	O
42	O
+	O
0	O
weeks	O
of	O
gestation	O
,	O
and	O
newborn	O
’	O
s	O
birth	O
weight	O
was	O
appropriate	O
for	O
gestational	O
age	O
(	O
SD	O
-	O
score	O
[	O
SDS	O
]	O
between	O
−	O
2	O
.	O
0	O
and	O
+	O
2	O
.	O
0	O
).	O

Gestational	O
OPP	O
,	O
Pb	O
,	O
and	O
PFAS	O
exposures	O
were	O
most	O
strongly	O
associated	O
with	O
lower	O
birth	O
weight	O
.	O

Results	O
A	O
total	O
of	O
1754	O
infants	O
were	O
assessed	O
at	O
age	O
6	O
months	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
(	O
n	O
=	O
2136	O
).	O

This	O
study	O
examined	O
the	O
relationship	O
between	O
mothers	O
'	O
stress	O
levels	O
and	O
attitude	O
towards	O
their	O
pregnancies	O
,	O
placental	O
GR	O
and	O
GAS5	O
expression	O
,	O
and	O
the	O
status	O
of	O
GR	O
polymorphism	O
,	O
with	O
their	O
infants	O
'	O
birth	O
weights	O
.	O

Response	O
to	O
Antenatal	O
Cholecalciferol	O
Supplementation	O
Is	O
Associated	O
With	O
Common	O
Vitamin	O
D	O
–	O
Related	O
Genetic	O
Variants	O
Abstract	O
Context	O
:	O
Single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
genes	O
related	O
to	O
vitamin	O
D	O
metabolism	O
have	O
been	O
associated	O
with	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentration	O
,	O
but	O
these	O
relationships	O
have	O
not	O
been	O
examined	O
following	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Vitamin	O
D	O
supplementation	O
reduces	O
preeclampsia	O
risk	O
,	O
compared	O
to	O
unsupplemented	O
controls	O
.	O

Eligible	O
studies	O
were	O
those	O
with	O
healthy	O
pregnant	O
women	O
,	O
full	O
term	O
births	O
and	O
offspring	O
with	O
no	O
anomalies	O
or	O
diseases	O
.	O

We	O
acknowledge	O
the	O
following	O
limitations	O
.	O

List	O
of	O
abbreviations	O
used	O
KMC	O
:	O
Kangaroo	O
Mother	O
Care	O
;	O
PMNCH	O
:	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
pPROM	O
:	O
Prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
RMNCH	O
:	O
Reproductive	O
,	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
STI	O
:	O
Sexually	O
Transmitted	O
Infection	O
;	O
WHO	O
:	O
World	O
Health	O
Organization	O
.	O

Although	O
some	O
of	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
(	O
table	O
4	O
),	O
it	O
appears	O
that	O
polytherapy	O
with	O
SGAs	O
and	O
other	O
psychotropic	O
medications	O
may	O
be	O
associated	O
with	O
a	O
higher	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
,	O
compared	O
with	O
SGA	O
monotherapy	O
.	O

They	O
do	O
,	O
however	O
,	O
agree	O
with	O
previously	O
published	O
studies	O
[	O
14	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

Maternal	O
vitamin	O
D	O
deficiency	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
renal	O
expression	O
of	O
podocin	O
,	O
renin	O
and	O
AT1	O
receptors	O
,	O
and	O
it	O
delays	O
the	O
maturity	O
of	O
the	O
glomeruli	O
,	O
by	O
extending	O
nephrogenesis	O
.	O

In	O
juvenile	O
piglets	O
(	O
stage	O
28	O
dpn	O
)	O
483	O
probe	O
-	O
sets	O
differed	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

Gardener	O
et	O
al	O
.	O

Oka	O
et	O
al	O
[	O
134	O
]	O
recommended	O
selective	O
restriction	O
of	O
dietary	O
vitamin	O
A	O
from	O
14	O
to	O
22	O
or	O
25	O
months	O
of	O
age	O
to	O
improve	O
MS	O
and	O
QG	O
without	O
adverse	O
health	O
effects	O
(	O
blindness	O
,	O
arthritis	O
,	O
and	O
muscular	O
edema	O
),	O
given	O
the	O
effect	O
of	O
vitamin	O
A	O
restriction	O
from	O
23	O
months	O
of	O
age	O
in	O
improving	O
MS	O
is	O
minimal	O
.	O

For	O
instance	O
,	O
greater	O
fish	O
consumption	O
is	O
associated	O
with	O
child	O
development	O
outcomes	O
including	O
decreased	O
risk	O
of	O
asthma	O
and	O
improved	O
cognition	O
[	O
13	O
,	O
14	O
].	O

People	O
residing	O
near	O
the	O
equator	O
should	O
have	O
lower	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
people	O
living	O
at	O
high	O
latitudes	O
.	O

This	O
measure	O
is	O
widely	O
used	O
in	O
South	O
Africa	O
to	O
describe	O
the	O
socio	O
-	O
economic	O
status	O
of	O
the	O
population	O
[	O
33	O
].	O

We	O
also	O
lacked	O
data	O
on	O
vitamin	O
D	O
binding	O
protein	O
which	O
may	O
differ	O
by	O
race	O
/	O
ethnicity	O
and	O
could	O
affect	O
the	O
association	O
between	O
PNV	O
use	O
and	O
25	O
(	O
OH	O
)	O
D	O
measured	O
in	O
the	O
plasma	O
.	O

The	O
fixed	O
effects	O
are	O
chosen	O
to	O
account	O
for	O
different	O
mean	O
levels	O
of	O
BMI	O
for	O
the	O
sexes	O
and	O
for	O
different	O
generations	O
.	O

3	O
.	O

Abbreviations	O
:	O
SC	O
,	O
standard	O
chow	O
;	O
VitD	O
−,	O
vitamin	O
D	O
restricted	O
diet	O
.	O

It	O
is	O
also	O
relevant	O
to	O
note	O
that	O
Hibbeln	O
et	O
al	O
.	O

Although	O
the	O
importance	O
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	O
.	O

A	O
secondary	O
aim	O
is	O
to	O
prevent	O
excessive	O
maternal	O
weight	O
gain	O
,	O
particularly	O
in	O
women	O
who	O
are	O
overweight	O
or	O
have	O
gained	O
excess	O
weight	O
in	O
pregnancy	O
.	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

However	O
,	O
none	O
of	O
these	O
covariates	O
change	O
the	O
estimates	O
substantially	O
,	O
and	O
was	O
therefore	B
not	O
included	O
in	O
the	O
final	O
multivariate	O
model	O
cAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
cod	O
-	O
type	O
fish	O
and	O
shellfish	O
dAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
shellfish	O
eAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
cod	O
-	O
type	O
fish	O
fAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
all	O
fish	O
and	O
seafood4	O
.	O
1Relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
evaluated	O
by	O
multinomial	O
logistic	O
regression	O
,	O
adjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
.	O
2The	O
group	O
with	O
no	O
or	O
low	O
level	O
of	O
psychotic	O
symptoms	O
was	O
used	O
as	O
reference	O
group	O
.	O
3Participants	O
categorized	O
into	O
levels	O
;	O
no	O
/	O
low	O
,	O
middle	O
,	O
high	O
frequency	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O
4Total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
were	O
grouped	O
into	O
six	O
categories	O
;	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
.	O

293	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
.	O

There	O
was	O
the	O
assumption	O
that	O
in	O
utero	O
exposure	O
represents	O
the	O
most	O
vulnerable	O
period	O
in	O
an	O
individual	O
’	O
s	O
life	O
with	O
respect	O
to	O
their	O
future	O
development	O
.	O

During	O
pregnancy	O
,	O
the	O
mother	O
'	O
s	O
thyroid	O
physiology	O
undergoes	O
many	O
well	O
-	O
defined	O
changes	O
,	O
leading	O
to	O
an	O
increase	O
in	O
thyroid	O
volume	O
which	O
is	O
often	B
associated	O
with	O
higher	O
urinary	O
iodine	O
excretion	O
.	O

Data	O
suggest	O
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
aids	O
implantation	O
and	O
maintains	O
normal	O
pregnancy	O
,	O
supports	O
fetal	O
growth	O
through	O
delivery	O
of	O
calcium	O
,	O
controls	O
secretion	O
of	O
multiple	O
placental	O
hormones	O
,	O
and	O
limits	O
production	O
of	O
proinflammatory	O
cytokines	O
.	O

However	O
,	O
few	O
obesity	O
interventions	O
show	O
clinically	O
or	O
statistically	O
significant	O
weight	O
loss	O
beyond	O
the	O
intervention	O
period	O
(	O
100	O
),	O
which	O
suggests	O
that	O
new	O
and	O
more	O
comprehensive	O
interventions	O
are	O
needed	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
incidence	O
of	O
first	O
or	O
only	O
pneumonia	O
between	O
the	O
vitamin	O
D	O
(	O
0	O
·	O
145	O
per	O
child	O
per	O
year	O
,	O
95	O
%	O
CI	O
0	O
·	O
129	O
–	O
0	O
·	O
164	O
)	O
and	O
the	O
placebo	O
group	O
(	O
0	O
.	O
137	O
,	O
0	O
·	O
121	O
–	O
0	O
·	O
155	O
);	O
the	O
incidence	O
rate	O
ratio	O
was	O
1	O
·	O
06	O
(	O
95	O
%	O
CI	O
0	O
·	O
89	O
–	O
1	O
·	O
27	O
).	O

Third	O
,	O
we	O
did	O
not	O
power	O
the	O
sample	O
size	O
to	O
analyze	O
effects	O
by	O
trimester	O
of	O
vaccination	O
and	O
so	B
may	O
have	O
missed	O
important	O
effects	O
.	O

In	O
a	O
sensitivity	O
analysis	O
,	O
the	O
effect	O
of	O
maternal	O
fruit	O
consumption	O
on	O
the	O
infant	O
gut	O
microbiome	O
in	O
babies	O
born	O
vaginally	O
persisted	O
when	O
restricted	O
to	O
infants	O
who	O
were	O
exclusively	O
breastfed	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
022	O
;	O
Table	O
2	O
)	O
.	O

Data	O
sources	O
for	O
Afghanistan	O
,	O
India	O
,	O
Brazil	O
,	O
and	O
Russia	O
from	O
Child	O
Health	O
Epidemiology	O
Reference	O
Group	O
/	O
World	O
Health	O
Organization	O
cause	O
of	O
death	O
estimates	O
for	O
2010	O
from	O
Liu	O
et	O
al	O
.,	O
2012	O
[	O
50	O
].	O

Primordial	O
germ	O
cells	O
(	O
PGCs	O
)	O
undergo	O
a	O
second	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
to	O
ensure	O
correct	O
imprinting	O
and	O
development	O
of	O
mature	O
germ	O
cells	O
according	O
to	O
the	O
gender	O
of	O
the	O
embryo	O
,	O
and	O
enable	O
the	O
successful	O
production	O
of	O
subsequent	O
generations	O
in	O
a	O
continuous	O
cycle	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Integrated	O
service	O
delivery	O
packages	O
for	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
.	O

Drug	O
Allergy	O
There	O
is	O
a	O
lack	O
of	O
data	O
on	O
the	O
prevalence	O
of	O
adverse	O
drug	O
reactions	O
during	O
pregnancy	O
.	O

Four	O
major	O
adipose	O
tissue	O
depots	O
exist	O
in	O
animals	O
:	O
ab	O
dominal	O
,	O
subcutaneous	O
,	O
intermuscular	O
,	O
and	O
intramuscular	O
.	O

To	O
examine	O
how	O
repetitive	O
element	O
methylation	O
was	O
related	O
to	O
gene	O
-	O
associated	O
methylation	O
,	O
we	O
restricted	O
our	O
analysis	O
to	O
placentas	O
for	O
which	O
we	O
had	O
both	O
repetitive	O
element	O
and	O
gene	O
-	O
associated	O
(	O
array	O
)	O
methylation	O
data	O
for	O
the	O
26	O
,	O
486	O
CpG	O
autosomal	O
loci	O
(	O
n	O
=	O
184	O
).	O

This	O
was	O
independent	O
of	O
diet	O
and	O
lifestyles	O
factors	O
including	O
BMI	O
and	O
SEI	O
and	O
highlights	O
the	O
difficulty	O
in	O
understanding	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
in	O
human	O
cohort	O
studies	O
.	O

Exclusion	O
criteria	O
for	O
the	O
newborns	O
were	O
:	O
nasal	O
continuous	O
positive	O
airway	O
pressure	O
treatment	O
>	O
one	O
day	O
,	O
intravenous	O
glucose	O
infusion	O
,	O
seizures	O
,	O
duration	O
of	O
phototherapy	O
>	O
three	O
days	O
and	O
need	O
for	O
nasogastric	O
tube	O
>	O
one	O
day	O
.	O

Mothers	O
were	O
instructed	O
to	O
continue	O
the	O
supplements	O
as	O
long	O
as	O
they	O
were	O
breastfeeding	O
.	O

After	O
baseline	O
survey	O
completion	O
,	O
participants	O
were	O
assigned	O
to	O
the	O
text4baby	O
(	O
plus	O
usual	O
care	O
)	O
or	O
to	O
control	O
(	O
usual	O
care	O
only	O
)	O
groups	O
.	O

analysed	O
11	O
,	O
538	O
pregnancies	O
,	O
and	O
found	O
a	O
51	O
%	O
increase	O
in	O
gestational	O
diabetes	O
diagnosed	O
by	O
OGTT	O
in	O
the	O
months	O
of	O
June	O
to	O
July	O
(	O
summer	O
),	O
compared	O
to	O
other	O
months	O
[	O
25	O
].	O

Based	O
on	O
estimated	O
productivity	O
gains	O
for	O
adult	O
women	O
,	O
the	O
benefit	O
:	O
cost	O
ratio	O
is	O
6	O
.	O
7	O
∶	O
1	O
.	O

purports	O
that	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
carries	O
an	O
increased	O
risk	O
of	O
developing	O
ASD	O
[	O
8	O
].	O

We	O
ascertained	O
causes	O
of	O
death	O
through	O
scrutiny	O
of	O
hospital	O
notes	O
,	O
and	O
verbal	O
autopsy	O
interviews	O
with	O
the	O
WHO	O
standard	O
questionnaire	O
and	O
review	O
of	O
the	O
interview	O
data	O
by	O
two	O
physicians	O
independently	O
.	O

She	O
described	O
the	O
pain	O
as	O
continuous	O
,	O
10	O
/	O
10	O
in	O
severity	O
,	O
worsened	O
with	O
movement	O
and	O
breathing	O
,	O
and	O
relieved	O
by	O
nothing	O
.	O

Distribution	O
and	O
storage	O
USD3	O
,	O
597	O
:	O
source	O
Yen	O
Bai	O
People	O
'	O
s	O
Committee	O
financial	O
recordsPromotional	O
material	O
development	O
and	O
production	O
:	O
amortized	O
over	O
5	O
years	O
.	O

Relationships	O
between	O
repetitive	O
element	O
and	O
gene	O
associated	O
methylation	O
.	O

While	O
the	O
possibility	O
of	O
residual	O
confounding	O
cannot	O
be	O
ruled	O
out	O
,	O
the	O
null	O
findings	O
for	O
maternal	O
and	O
paternal	O
free	O
sugar	O
intakes	O
after	O
pregnancy	O
make	O
confounding	O
by	O
unmeasured	O
familial	O
behaviours	O
linked	O
to	O
sugar	O
intake	O
and	O
asthma	O
risk	O
a	O
less	O
likely	B
explanation	O
.	O

New	O
OB	O
patients	O
were	O
offered	O
a	O
free	O
bottle	O
of	O
Bio	O
-	O
Tech	O
Pharmacal	O
,	O
Inc	O
.	O
(	O
Fayetteville	O
,	O
AR	O
)	O
vitamin	O
D	O
supplements	O
(	O
5000	O
IU	O
per	O
capsule	O
)	O
at	O
their	O
first	O
visit	O
and	O
personalized	O
dosing	O
recommendations	O
were	O
provided	O
based	O
on	O
the	O
result	O
of	O
their	O
initial	O
25	O
(	O
OH	O
)	O
D	O
test	O
using	O
an	O
algorithm	O
of	O
existing	O
dose	O
-	O
response	O
data	O
[	O
11	O
].	O

Substantial	O
racial	O
disparities	O
in	O
PTB	O
rates	O
have	O
also	O
been	O
found	O
in	O
the	O
United	O
States	O
:	O
18	O
%	O
among	O
African	O
Americans	O
,	O
12	O
%	O
among	O
Hispanics	O
,	O
and	O
11	O
%	O
among	O
whites	O
in	O
2009	O
[	O
2	O
].	O

We	O
will	O
obtain	O
written	O
,	O
witnessed	O
informed	O
consent	O
from	O
all	O
participants	O
.	O

The	O
mean	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
levels	O
in	O
case	O
and	O
control	O
groups	O
were	O
compared	O
with	O
independent	O
t	O
test	O
.	O

Data	O
Analysis	O
Stata	O
version	O
12	O
(	O
StataCorp	O
LP	O
,	O
College	O
Station	O
,	O
TX	O
,	O
USA	O
)	O
was	O
used	O
in	O
all	O
analyses	O
.	O

Being	O
synthesized	O
from	O
the	O
placenta	O
,	O
higher	O
enzyme	O
concentrations	O
were	O
observed	O
in	O
twin	O
and	O
triple	O
pregnancies	O
.	O

This	O
slurry	O
was	O
frequently	O
stored	O
in	O
large	O
,	O
unlined	O
ponds	O
,	O
says	O
Chris	O
Shuey	O
,	O
an	O
environmental	O
health	O
specialist	O
with	O
the	O
Southwest	O
Research	O
and	O
Information	O
Center	O
in	O
Albuquerque	O
,	O
who	O
has	O
spent	O
the	O
last	O
three	O
decades	O
working	O
with	O
Navajo	O
communities	O
affected	O
by	O
uranium	O
mining	O
and	O
milling	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O
of	O
the	O
outcome	O
pregnancy	O
loss	O
was	O
also	O
performed	O
with	O
25OHD	O
at	O
T1	O
(	O
continuous	O
and	O
categorical	O
)	O
as	O
independent	O
variable	O
.	O

In	O
addition	O
,	O
nutritional	O
restriction	O
during	O
early	O
and	O
mid	O
gestation	O
reduced	O
ovarian	O
characteristics	O
(	O
wet	O
ovary	O
weight	O
,	O
luteal	O
tissue	O
weight	O
)	O
of	O
heifers	O
,	O
indicating	O
negative	O
effects	O
of	O
fetal	O
programming	O
on	O
productive	O
efficiency	O
of	O
replacement	O
heifers	O
.	O

Model	O
2	O
of	O
the	O
multiple	O
linear	O
regression	O
analysis	O
was	O
additionally	O
controlled	O
for	O
change	O
in	O
25OHD	O
from	O
early	O
to	O
late	O
pregnancy	O
(	O
Additional	O
file1	O
:	O
Table	O
S3	O
).	O

An	O
adapted	O
questionnaire	O
previously	O
used	O
in	O
the	O
South	O
African	O
context	O
is	O
used	O
[	O
58	O
].	O

Of	O
total	O
,	O
89	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
20	O
ng	O
/	O
mL	O
and	O
56	O
%	O
achieved	O
vitamin	O
D	O
concentration	O
of	O
higher	O
than	O
32	O
ng	O
/	O
mL	O
[	O
57	O
].	O

The	O
composition	O
of	O
UNIMMAP	O
is	O
shown	O
inTable	O
1	O
(	O
UNICEF	O
/	O
WHO	O
/	O
UNU	O
1999	O
).	O

The	O
aim	O
of	O
this	O
review	O
was	O
to	O
critically	O
appraise	O
literature	O
investigating	O
fish	O
intake	O
in	O
pregnant	O
women	O
to	O
assess	O
the	O
hypothesis	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
positively	O
influences	O
foetal	O
neurodevelopment	O
.	O

An	O
increase	O
in	O
25OHD	O
from	O
early	O
to	O
late	O
pregnancy	O
was	O
not	O
associated	O
with	O
markers	O
of	O
glucose	O
metabolism	O
.	O

The	O
2009	O
survey	O
identified	O
that	O
it	O
took	O
women	O
an	O
average	O
of	O
17	O
minutes	O
to	O
access	O
the	O
distribution	O
point	O
for	O
weekly	O
supplements	O
.	O

Each	O
data	O
collector	O
will	O
be	O
responsible	O
for	O
one	O
cluster	O
.	O

Implementation	O
research	O
from	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
is	O
critical	O
to	O
inform	O
and	O
accelerate	O
the	O
scale	O
up	O
of	O
high	O
-	O
impact	O
care	O
,	O
such	O
as	O
KMC	O
and	O
neonatal	O
resuscitation	O
[	O
19	O
,	O
21	O
,	O
40	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Subject	O
characteristics	O
by	O
delivery	O
mode	O
(	O
n	O
=	O
145	O
)	O
n	O
(%)	O
or	O
mean	O
[	O
range	O
]	O
p	O
value1All	O
(	O
n	O
=	O
145	O
)	O
Vaginal	O
(	O
n	O
=	O
97	O
)	O
Cesarean	O
(	O
n	O
=	O
48	O
)	O
Maternal	O
characteristics	O
Maternal	O
age31	O
.	O
9	O
[	O
22	O
–	O
44	O
]	O
31	O
.	O
8	O
[	O
22	O
–	O
44	O
]	O
32	O
.	O
2	O
[	O
23	O
–	O
42	O
]	O
0	O
.	O
65	O
Education	O
level0	O
.	O
14	O
Less	O
than	O
11th	O
grade1	O
(	O
0	O
.	O
7	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
0	O
(	O
0	O
.	O
0	O
)	O
High	O
school	O
graduate	O
or	O
equivalent15	O
(	O
10	O
.	O
3	O
)	O
7	O
(	O
7	O
.	O
2	O
)	O
8	O
(	O
16	O
.	O
7	O
)	O
Junior	O
college	O
graduate	O
or	O
some	O
college25	O
(	O
17	O
.	O
2	O
)	O
16	O
(	O
16	O
.	O
5	O
)	O
9	O
(	O
18	O
.	O
8	O
)	O
College	O
graduate54	O
(	O
37	O
.	O
2	O
)	O
34	O
(	O
35	O
.	O
1	O
)	O
20	O
(	O
41	O
.	O
7	O
)	O
Any	O
post	O
-	O
graduate	O
schooling50	O
(	O
34	O
.	O
5	O
)	O
39	O
(	O
40	O
.	O
2	O
)	O
11	O
(	O
22	O
.	O
9	O
)	O
Relationship	O
status0	O
.	O
29	O
Married133	O
(	O
91	O
.	O
7	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
42	O
(	O
87	O
.	O
5	O
)	O
Separated	O
or	O
divorced3	O
(	O
2	O
.	O
1	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
Single	O
and	O
never	O
married9	O
(	O
6	O
.	O
2	O
)	O
5	O
(	O
5	O
.	O
2	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Smoking0	O
.	O
43	O
No138	O
(	O
95	O
.	O
2	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
47	O
(	O
97	O
.	O
9	O
)	O
Yes7	O
(	O
4	O
.	O
8	O
)	O
6	O
(	O
6	O
.	O
2	O
)	O
1	O
(	O
2	O
.	O
1	O
)	O
Parity0	O
.	O
8	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
9	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
7	O
[	O
0	O
–	O
2	O
]	O
0	O
.	O
07	O
Maternal	O
BMI25	O
.	O
6	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
26	O
.	O
0	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
24	O
.	O
7	O
[	O
18	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
0	O
.	O
22	O
Gestational	O
diabetes20	O
.	O
58	O
No121	O
(	O
83	O
.	O
4	O
)	O
84	O
(	O
86	O
.	O
6	O
)	O
37	O
(	O
77	O
.	O
1	O
)	O
Yes16	O
(	O
11	O
.	O
0	O
)	O
10	O
(	O
10	O
.	O
3	O
)	O
6	O
(	O
12	O
.	O
5	O
)	O
Dietary	O
factors	O
(	O
servings	O
/	O
day	O
)	O
3	O
aMED	O
score3	O
.	O
67	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
8	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
5	O
[	O
0	O
–	O
7	O
]	O
0	O
.	O
32	O
Dairy3	O
.	O
6	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
5	O
[	O
0	O
.	O
8	O
–	O
6	O
.	O
8	O
]	O
0	O
.	O
40	O
Fruit2	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
3	O
[	O
0	O
.	O
2	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
6	O
]	O
0	O
.	O
52	O
Vegetables3	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
3	O
[	O
0	O
.	O
5	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
7	O
.	O
6	O
]	O
0	O
.	O
78	O
Whole	O
grains1	O
.	O
0	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
1	O
–	O
4	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
03	O
Fish	O
and	O
seafood0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
56	O
Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
1	O
.	O
00	O
Red	O
and	O
processed	O
meat0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
0	O
]	O
0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
21	O
Polyunsaturated	O
fat	O
(	O
g	O
/	O
day	O
)	O
13	O
.	O
9	O
[	O
8	O
.	O
67	O
–	O
23	O
.	O
7	O
]	O
13	O
.	O
6	O
[	O
8	O
.	O
7	O
–	O
21	O
.	O
0	O
]	O
14	O
.	O
5	O
[	O
9	O
.	O
2	O
–	O
23	O
.	O
7	O
]	O
0	O
.	O
12	O
EPA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
28	O
DHA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
79	O
Monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
35Infant	O
characteristics	O
Sex0	O
.	O
38	O
Female62	O
(	O
42	O
.	O
8	O
)	O
44	O
(	O
45	O
.	O
4	O
)	O
18	O
(	O
37	O
.	O
5	O
)	O
Male83	O
(	O
57	O
.	O
2	O
)	O
53	O
(	O
54	O
.	O
6	O
)	O
30	O
(	O
62	O
.	O
5	O
)	O
Birth	O
weight	O
(	O
g	O
)	O
43427	O
.	O
4	O
[	O
1960	O
–	O
4710	O
]	O
3466	O
.	O
3	O
[	O
2030	O
–	O
4565	O
]	O
3348	O
.	O
9	O
[	O
1960	O
–	O
4710	O
]	O
0	O
.	O
18	O
Gestational	O
age	O
(	O
weeks	O
)	O
39	O
.	O
3	O
[	O
30	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
39	O
.	O
5	O
[	O
30	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
39	O
.	O
1	O
[	O
33	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
0	O
.	O
21	O
Feeding	O
method0	O
.	O
04	O
Exclusively	O
breastfed102	O
(	O
70	O
.	O
3	O
)	O
74	O
(	O
76	O
.	O
3	O
)	O
28	O
(	O
58	O
.	O
3	O
)	O
Combination37	O
(	O
25	O
.	O
5	O
)	O
21	O
(	O
21	O
.	O
7	O
)	O
16	O
(	O
33	O
.	O
3	O
)	O
Exclusively	O
formula	O
fed6	O
(	O
4	O
.	O
1	O
)	O
2	O
(	O
2	O
.	O
1	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Antibiotics	O
by	O
4	O
months	O
old50	O
.	O
66	O
No135	O
(	O
93	O
.	O
1	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
44	O
(	O
91	O
.	O
7	O
)	O
Yes5	O
(	O
3	O
.	O
5	O
)	O
3	O
(	O
3	O
.	O
1	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
1p	O
value	O
determined	O
by	O
two	O
-	O
sided	O
Welch	O
’	O
s	O
t	O
test	O
or	O
Fisher	O
’	O
s	O
exact	O
test	O
2Missing	O
data	O
on	O
eight	O
subjects	O
3All	O
dietary	O
factors	O
are	O
standardized	O
to	O
a	O
2000	O
cal	O
/	O
day	O
diet	O
,	O
excluding	O
aMED	O
score	O
and	O
monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio	O
4Missing	O
data	O
on	O
three	O
subjects	O
5Missing	O
data	O
on	O
five	O
subjects	O
Microbial	O
community	O
composition	O
and	O
maternal	O
dietary	O
factors	O
We	O
identified	O
11	O
,	O
029	O
,	O
093	O
bacterial	O
sequences	O
in	O
145	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
passing	O
quality	O
control	O
.	O

The	O
obvious	O
explanations	B
to	O
the	O
higher	O
body	O
weight	O
found	O
in	O
RC	O
males	O
after	O
weaning	O
could	O
be	O
as	O
a	O
consequence	O
of	O
an	O
increased	O
food	O
intake	O
,	O
decreased	O
energy	O
expenditure	O
or	O
higher	O
metabolic	O
efficiency	O
.	O

Height	O
—	O
child	O
age	O
5	O
This	O
correlation	O
in	O
the	O
nuclear	O
family	O
became	O
stronger	O
at	O
age	O
5	O
.	O

Current	O
Thinking	O
on	O
Low	O
Milk	O
Production	O
Standard	O
lactation	O
support	O
guidelines3are	B
based	B
on	I
the	O
assumption	O
that	O
virtually	B
any	O
woman	O
can	O
breastfeed	O
normally	B
.	O

In	O
addition	O
the	O
current	O
vitamin	O
D	O
content	O
of	O
multivitamins	O
for	O
pregnancy	O
,	O
400	O
IU	O
,	O
do	O
not	O
even	O
comply	O
with	O
the	O
current	O
Belgian	O
recommendations	O
of	O
800	O
IU	O
per	O
day	O
,	O
therefore	B
a	O
prudent	O
step	O
should	O
at	B
least	I
be	O
to	O
increase	O
the	O
vitamin	O
D	O
content	O
in	O
multivitamins	O
for	O
pregnant	O
women	O
to	O
800	O
IU	O
.	O

However	O
,	O
a	O
multi	O
-	O
centre	O
study	O
might	O
have	O
resulted	O
in	O
a	O
wider	O
variety	O
of	O
socio	O
-	O
economic	O
backgrounds	O
.	O

Moreover	O
,	O
the	O
majority	O
of	O
these	O
47	O
studies	O
represent	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	B
single	O
)	O
dose	O
range	O
experiments	O
,	O
many	O
orders	O
of	O
magnitude	O
above	O
likely	B
human	O
exposures	O
.	O

There	O
were	O
no	O
apparent	O
differences	O
in	O
the	O
intake	O
of	O
foods	O
containing	O
vitamin	O
D	O
between	O
the	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groups	O
,	O
including	O
the	O
frequency	O
of	O
milk	O
consumption	O
(	O
data	O
not	O
shown	O
).	O

At	O
the	O
time	O
of	O
the	O
lung	O
function	O
testing	O
,	O
the	O
mean	O
body	O
weight	O
was	O
8	O
.	O
3	O
±	O
1	O
.	O
0	O
kg	O
,	O
and	O
the	O
mean	O
body	O
length	O
was	O
68	O
.	O
6	O
±	O
3	O
.	O
0	O
cm	O
.	O

In	O
order	O
to	O
minimize	O
the	O
estrous	O
cycle	O
-	O
related	O
variability	O
,	O
the	O
female	O
rats	O
were	O
closely	O
housed	O
in	O
adjacent	O
cages	O
and	O
randomly	O
distributed	O
among	O
the	O
different	O
experimental	O
groups	O
(	O
McClintock	O
,	O
1978	O
,	O
1984	O
).	O

The	O
infant	O
is	O
weighed	O
on	O
a	O
calibrated	O
scale	O
with	O
minimum	O
of	O
clothing	O
,	O
namely	O
only	O
a	O
vest	O
,	O
and	O
without	O
a	O
nappy	O
;	O
and	O
recorded	O
to	O
the	O
nearest	O
5	O
g	O
.	O
Recumbent	O
length	O
of	O
the	O
infants	O
is	O
taken	O
by	O
means	O
of	O
an	O
infantometer	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
.	O

Only	O
POU2F1	O
was	O
found	O
to	O
be	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
.	O

A	O
developmental	O
perspective	O
considers	B
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

However	O
,	O
research	O
in	O
recent	O
years	O
has	O
been	O
challenging	O
those	O
ideas	O
on	O
what	O
is	O
enough	O
,	O
and	O
what	O
is	O
too	O
much	O
.	O

Data	O
from	O
a	O
review	O
of	O
the	O
literature	O
and	O
the	O
authors	O
'	O
own	O
experience	O
show	O
that	O
in	O
patients	O
undergoing	O
either	O
suppressive	O
or	O
substitutive	O
thyroxine	O
therapy	O
foetal	O
thyroid	O
growth	O
is	O
normal	O
at	O
ultrasound	O
study	O
,	O
newborn	O
thyroid	O
status	O
is	O
normal	O
,	O
and	O
the	O
incidence	O
of	O
maternal	O
morbidity	O
is	O
not	O
influenced	O
by	O
the	O
pregnancy	O
.	O

Both	O
higher	O
late	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
gestational	O
vitamin	O
D	O
status	O
trajectory	O
can	O
be	O
suspected	B
to	O
play	O
a	O
role	O
in	O
healthy	O
pregnancy	O
.	O

Women	O
with	O
a	O
higher	O
level	O
of	O
nutritional	O
knowledge	O
used	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
more	O
frequently	O
(	O
Table	O
2	O
).	O

The	O
nucleus	O
accumbens	O
(	O
NAc	O
)	O
were	O
sampled	O
from	O
all	O
animals	O
according	O
to	O
boundaries	O
determined	O
from	O
a	O
standard	O
rat	O
brain	O
atlas	O
[	O
22	O
].	O

Animal	O
models	O
of	O
vitamin	O
D	O
deficiency	O
have	O
shown	O
just	O
how	O
important	O
adequate	O
nutritional	O
intakes	O
of	O
vitamin	O
D	O
are	O
to	O
skeletal	O
,	O
cardiovascular	O
,	O
and	O
neurologic	O
development	O
in	O
experimental	O
animals	O
.	O

There	O
are	O
few	O
large	O
intervention	O
trials	O
of	O
multiple	O
micronutrient	O
supplementation	O
in	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
and	O
none	O
have	O
been	O
conducted	O
in	O
Africa	O
.	O

Primers	O
used	O
were	O
obtained	O
based	O
on	O
TaqMan	O
®	O
Gene	O
Expression	O
Assays	O
and	O
the	O
FAM	O
™	O
dye	O
label	O
format	O
(	O
ThermoFisher	O
;	O
TableS1	O
).	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Cincinnati	O
and	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
Institutional	O
Review	O
Boards	O
.	O

2008	O
),	O
we	O
offer	O
the	O
following	O
observations	O
regarding	O
the	O
scope	O
of	O
our	O
study	O
and	O
limitations	O
of	O
the	O
methodology	O
applied	O
.	O

Under	O
the	O
key	O
words	O
“	O
vitamin	O
D	O
,	O
fertility	O
”,	O
129	O
articles	O
were	O
found	O
in	O
the	O
PubMed	O
database	O
,	O
for	O
“	O
vitamin	O
D	O
,	O
infertility	O
”,	O
another	O
106	O
were	O
located	O
(	O
March	O
15th	O
,	O
2015	O
).	O

However	O
,	O
the	O
reality	O
is	O
that	O
medications	O
must	O
be	O
considered	O
for	O
pregnant	O
patients	O
with	O
medical	O
disorders	O
,	O
based	O
on	O
a	O
thorough	O
appreciation	O
of	O
the	O
potential	O
deleterious	O
effects	O
of	O
untreated	O
disease	O
.	O

IFA	O
supplements	O
have	O
also	O
been	O
found	O
to	O
reduce	O
the	O
preterm	O
delivery	O
rate	O
and	O
neonatal	O
mortality	O
attributable	O
to	O
prematurity	O
and	O
birth	O
asphyxia	O
[	O
7	O
].	O

In	O
contrast	O
,	O
when	O
bred	O
under	O
thermoneutral	O
conditions	O
(	O
29	O
°	O
C	O
),	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
enhanced	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
(	O
Feldmann	O
et	O
al	O
.,	O
2009	O
).	O

Subjects	O
who	O
attended	O
this	O
visit	O
were	O
considered	O
enrolled	O
.	O

Bonferroni	O
analysis	O
indicated	O
a	O
significant	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypoyhalamus	O
of	O
RC	O
male	O
offspring	O
compared	O
to	O
CC	O
ones	O
(	O
Figure4A	O
).	O

The	O
main	O
food	O
sources	O
of	O
Vitamin	O
D3	O
are	O
dairy	O
,	O
egg	O
,	O
fish	O
and	O
meat	O
.	O

There	O
was	O
no	O
correlation	O
between	O
BMI	O
at	O
the	O
time	O
of	O
the	O
visit	O
and	O
cathelicidin	O
in	O
this	O
population	O
,	O
nor	O
was	O
there	O
a	O
correlation	O
between	O
percent	O
fat	O
and	O
cathelicidin	O
concentration	O
.	O

Candidate	O
genes	O
were	O
prioritized	O
based	B
on	I
reported	O
phenotypes	O
and	O
natriuretic	O
peptide	O
receptor	O
C	O
(	O
Npr3	O
)	O
was	O
selected	O
for	O
sequencing	O
based	B
on	I
the	O
existence	O
of	O
seven	O
known	B
alleles	O
(	O
spontaneous	O
and	O
generated	O
)	O
with	O
phenotypes	O
similar	O
to	O
those	O
of	O
the	O
Skm1	O
mice	O
.	O

A	O
similar	O
analysis	O
was	O
undertaken	O
for	O
BMI	O
difference	O
in	O
the	O
child	O
.	O

Thus	B
,	O
preventive	O
treatment	O
with	O
iron	O
supplements	O
has	O
always	O
been	O
given	O
in	O
combination	O
with	O
folic	O
acid	O
and	O
this	O
has	O
been	O
included	O
as	O
part	O
of	O
routine	O
antenatal	O
care	O
provided	O
to	O
pregnant	O
women	O
at	O
every	O
visit	O
in	O
developing	O
countries	O
[	O
26	O
].	O

The	O
role	O
of	O
radiotherapy	O
is	O
controversial	O
as	B
MTC	O
is	O
generally	B
not	O
believed	O
to	O
be	O
radio	O
-	O
sensitive	O
.	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	O
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

BMI	O
Table	O
3displays	O
raw	O
BMI	O
correlations	O
for	O
the	O
index	O
child	O
with	O
family	O
members	O
together	O
with	O
the	O
sample	O
size	O
.	O

A	O
further	O
limitation	O
of	O
our	O
study	O
is	O
that	O
it	O
was	O
not	O
feasible	O
to	O
undertake	O
biochemical	O
assessment	O
of	O
the	O
supplements	O
or	O
assess	O
serum	O
concentrations	O
in	O
all	O
participants	O
after	O
each	O
and	O
between	O
supplementation	O
.	O

found	O
a	O
59	O
%	O
lower	O
risk	O
of	O
PTB	O
for	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
concentrations	O
≤	O
20	O
ng	O
/	O
mL	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
[	O
12	O
].	O

Our	O
findings	O
represent	O
the	O
largest	O
,	O
most	O
extensive	O
,	O
and	O
most	O
complete	O
follow	O
-	O
up	O
of	O
infants	O
to	O
6	O
months	O
of	O
age	O
who	O
were	O
born	O
to	O
overweight	O
and	O
obese	O
women	O
following	O
the	O
conduct	O
of	O
the	O
largest	O
randomised	O
trial	O
to	O
date	O
evaluating	O
the	O
provision	O
of	O
a	O
comprehensive	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
.	O

Our	O
goal	O
was	O
to	O
identify	O
specific	O
high	O
-	O
risk	O
subsets	O
of	O
pregnant	O
women	O
who	O
may	O
benefit	O
from	O
vitamin	O
D	O
supplementation	O
in	O
order	O
to	O
mitigate	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

This	O
leaves	O
the	O
important	O
question	O
of	O
exact	O
dosage	O
and	O
timing	O
of	O
delivery	O
requirements	O
for	O
future	O
studies	O
.	O

These	O
numbers	O
for	O
control	O
group	O
were	O
9	O
(	O
18	O
%),	O
22	O
(	O
44	O
%),	O
19	O
(	O
38	O
%),	O
respectively	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
the	O
STATA	O
version	O
10	O
.	O
0	O
Results	O
Characteristics	O
of	O
study	O
participants	O
Baseline	O
characteristics	O
of	O
the	O
study	O
participants	O
are	O
presented	O
in	O
Table1	O
.	O

Of	O
course	O
,	O
any	O
strategies	O
to	O
prolong	O
labour	O
,	O
including	O
delaying	O
caesarean	O
birth	O
,	O
must	O
be	O
evaluated	O
against	O
the	O
potential	O
risk	O
of	O
continued	O
exposure	O
of	O
woman	O
and	O
foetus	O
to	O
sub	O
-	O
optimal	O
conditions	O
that	O
may	O
result	O
in	O
harmful	O
effects	O
.	O

For	O
boys	O
,	O
there	O
was	O
a	O
positive	O
change	O
associated	O
with	O
the	O
BMI	O
of	O
the	O
mother	O
,	O
p	O
=	O
0	O
.	O
002	O
,	O
but	O
no	O
association	O
with	O
other	O
family	O
members	O
.	O

Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
[	O
25	O
].	O

The	O
actions	O
identified	O
aim	O
to	O
support	O
the	O
goals	O
of	O
the	O
Global	O
Strategy	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
launched	O
by	O
the	O
United	O
Nations	O
(	O
UN	O
)	O
Secretary	O
-	O
General	O
Ban	O
Ki	O
-	O
moon	O
in	O
September	O
2010	O
to	O
further	O
advance	O
progress	O
for	O
the	O
Millennium	O
Development	O
Goal	O
4	O
for	O
child	O
survival	O
and	O
the	O
Every	O
Woman	O
Every	O
Child	O
movement	O
to	O
mobilise	O
action	O
and	O
resources	O
for	O
these	O
goals	O
[	O
7	O
].	O

Primiparous	O
women	O
were	O
eligible	O
if	O
the	O
following	O
criteria	O
were	O
met	O
:	O
Woman	O
planned	O
to	O
remain	O
in	O
the	O
study	O
area	O
for	O
at	O
least	O
one	O
month	O
before	O
and	O
one	O
month	O
after	O
delivery	O
.	O

This	O
can	O
improve	O
after	O
dental	O
surgery	O
under	O
GA	O
[	O
3	O
,	O
9	O
].	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
inversely	O
related	O
to	O
primary	O
cesarean	O
section	O
in	O
nulliparous	O
women	O
,	O
an	O
unexpected	O
and	O
unexplained	O
maternal	O
outcome	O
recently	O
identified	O
.	O

In	O
a	O
previous	O
genome	O
-	O
wide	O
association	O
study	O
(	O
GWAS	O
),	O
we	O
demonstrated	O
that	O
a	O
number	O
of	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
or	O
near	O
to	O
genes	O
encoding	O
key	O
components	O
of	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
are	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
8	O
).	O

The	O
following	O
search	O
terms	O
were	O
used	O
:	O
prevalence	O
,	O
burden	O
,	O
iron	O
deficiency	O
,	O
anaemia	O
in	O
pregnancy	O
,	O
preventive	O
treatments	O
,	O
and	O
developing	O
countries	O
.	O

However	O
,	O
in	O
countries	O
at	O
northern	O
latitudes	O
,	O
such	O
as	O
Ireland	O
(	O
51	O
–	O
55	O
°	O
N	O
),	O
production	O
reduces	O
substantially	O
from	O
October	O
to	O
March	O
[	O
1	O
,	O
2	O
]	O
with	O
striking	O
seasonal	O
variation	O
observed	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
)	O
in	O
pregnant	O
and	O
non	O
-	O
pregnant	O
populations	O
[	O
3	O
–	O
5	O
].	O

Ninety	O
-	O
three	O
per	O
cent	O
of	O
the	O
exposed	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
born	O
to	O
mothers	O
receiving	O
psychotropic	O
polytherapy	O
,	O
and	O
53	O
%	O
of	O
these	O
neonates	O
were	O
prenatally	O
exposed	O
to	O
a	O
selective	O
serotonin	O
reuptake	O
inhibitor	O
(	O
SSRI	O
).	O

Although	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
do	O
correlate	O
to	O
maternal	O
levels	O
,	O
factors	O
that	O
affect	O
fetal	O
growth	O
may	O
not	O
be	O
uniform	O
throughout	O
pregnancy	O
and	O
this	O
difference	O
in	O
timing	O
could	O
affect	O
study	O
findings	O
.	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6In	O
addition	O
,	O
maternal	O
characteristics	O
such	O
as	O
obesity	O
or	O
pre	O
-	O
eclampsia	O
could	O
also	O
affect	O
results	O
that	O
may	O
not	O
have	O
been	O
seen	O
if	O
vitamin	O
D	O
samples	O
were	O
obtained	O
during	O
early	O
pregnancy	O
.	O

Methods	O
This	O
case	O
–	O
control	O
study	O
was	O
conducted	O
from	O
2009	O
to	O
2011	O
in	O
the	O
city	O
of	O
Winnipeg	O
,	O
Manitoba	O
,	O
Canada	O
.	O

In	O
the	O
ventromedial	O
hypothalamic	O
nucleus	O
,	O
dopamine	O
release	O
is	O
required	O
to	O
initiate	O
a	O
meal	O
,	O
and	O
is	O
positively	O
associated	O
with	O
meal	O
number	O
and	O
duration	O
.	O
27	O
,	O
28By	O
possibly	O
reducing	O
dopamine	O
signaling	O
,	O
the	O
HV	O
pup	O
diet	O
may	O
have	O
provided	O
some	O
protection	O
against	O
excess	O
food	O
intake	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
.	O

Funding	O
This	O
study	O
was	O
supported	O
by	O
theCenters	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
United	O
States	O
(	O
CDC	O
)	O
(	O
Grant	O
No	O
.	O

Therapy	O
with	O
long	O
-	O
acting	O
somatostatin	O
analogues	O
has	O
been	O
tested	O
in	O
metastatic	O
disease	O
,	O
with	O
some	O
positive	O
benefots	O
in	O
most	O
patients	O
.	O

The	O
women	O
who	O
contacted	O
Motherisk	O
tended	O
to	O
be	O
middle	O
to	O
upper	O
middle	O
class	O
,	O
whereas	O
a	O
smaller	O
proportion	O
of	O
callers	O
came	O
from	O
the	O
lower	O
socioeconomic	O
and	O
/	O
or	O
immigrant	O
population	O
;	O
however	O
,	O
this	O
may	O
not	O
affect	O
the	O
generalisability	O
of	O
the	O
results	O
,	O
as	B
their	O
outcomes	O
may	O
be	O
confounded	O
by	O
other	O
factors	O
unrelated	O
to	O
the	O
drug	O
effect	O
.	O

To	O
this	O
end	O
,	O
we	O
recommend	O
a	O
cue	O
to	O
be	O
taken	O
from	O
new	O
approaches	O
to	O
iron	O
fortification	O
technology	O
development	O
whereby	O
iron	O
-	O
mediated	O
undesirable	O
taste	O
and	O
appearance	O
are	O
prevented	O
while	O
its	O
stability	O
and	O
bioavailability	O
are	O
preserved	O
[	O
60	O
].	O

[	O
44	O
]	O
Controversy	O
exists	O
regarding	O
the	O
optimum	O
concentration	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
for	O
defining	O
vitamin	O
D	O
deficiency	O
,	O
especially	O
in	O
pregnancy	O
.	O

Due	O
to	O
the	O
high	O
iron	O
requirements	O
for	O
pregnancy	O
,	O
it	O
is	O
highly	O
prevalent	O
and	O
severe	O
in	O
pregnant	O
women	O
[	O
4	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Means	O
age	O
and	O
depression	O
score	O
,	O
sun	O
exposure	O
and	O
seasons	O
in	O
the	O
participants	O
with	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
and	O
≥	O
20	O
ng	O
/	O
mLVariablesSerum	O
25	O
(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
ml	O
)	O
p	O
-	O
value	O
<	O
20	O
≥	O
20Age	O
(	O
years	O
),	O
mean	O
±	O
sd28	O
.	O
45	O
±	O
4	O
.	O
6225	O
.	O
32	O
±	O
4	O
.	O
390	O
.	O
31Depression	O
score	O
at	O
baseline	O
,	O
mean	O
±	O
sd8	O
.	O
34	O
±	O
3	O
.	O
829	O
.	O
37	O
±	O
3	O
.	O
940	O
.	O
31Sun	O
exposure	O
,	O
N	O
(%)<	O
0	O
.	O
001	O
<	O
60	O
m105	O
(	O
89	O
.	O
7	O
%)	O
8	O
(	O
44	O
.	O
4	O
%)	O
≥	O
60	O
m12	O
(	O
10	O
.	O
3	O
%)	O
10	O
(	O
55	O
.	O
6	O
%)	O
Season	O
,	O
N	O
(%)	O
0	O
.	O
05	O
Spring24	O
(	O
75	O
%)	O
8	O
(	O
25	O
%)	O
Summer16	O
(	O
88	O
.	O
9	O
%)	O
2	O
(	O
11	O
.	O
1	O
%)	O
Winter94	O
(	O
91	O
.	O
3	O
%)	O
9	O
(	O
8	O
.	O
7	O
%)	O
At	O
childbirth	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
14	O
.	O
64	O
±	O
8	O
.	O
60	O
,	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
4	O
and	O
51	O
.	O
10	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

This	O
illustrates	O
the	O
importance	O
of	O
previous	O
contact	O
with	O
a	O
facility	O
to	O
determine	O
further	O
use	O
.	O

Fine	O
needle	O
aspiration	O
shows	O
a	O
mixture	O
of	O
round	O
,	O
polyhedral	O
and	O
spindle	O
-	O
shaped	O
cells	O
that	O
may	O
seem	O
undifferentiated	O
,	O
and	O
look	O
like	O
a	O
variable	O
amount	O
of	O
extra	O
-	O
cellular	O
amyloid	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
marginal	O
sex	O
-	O
specific	O
differences	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
where	O
by	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
male	O
fetus	O
was	O
moderately	O
associated	O
with	O
decreasing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

Courtesy	O
U	O
.	O
S	O
.	O
National	O
Archives	O
There	O
are	O
other	O
reasons	B
why	O
reported	O
associations	O
may	O
not	O
actually	O
reveal	O
much	O
about	O
environmental	O
impacts	O
on	O
lactation	O
.	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

Delivery	O
and	O
neonatal	O
outcomes	O
All	O
instrumental	O
deliveries	O
were	O
performed	O
in	O
the	O
polytherapy	O
-	O
exposed	O
group	O
(	O
12	O
.	O
3	O
%	O
vs	O
0	O
%).	O

However	O
,	O
our	O
data	O
indicated	O
a	O
lower	O
preference	O
for	O
a	O
novel	O
highly	O
-	O
palatable	O
food	O
(	O
chocolate	O
mixture	O
)	O
than	O
the	O
familiar	O
standard	O
diet	O
in	O
RC	O
females	O
when	O
they	O
were	O
exposed	O
for	O
4	O
days	O
.	O

Positional	O
cloning	O
of	O
the	O
Skm	O
mutants	O
The	O
Skm	O
mutations	O
originally	O
generated	O
on	O
a	O
129S1	O
background	O
were	O
segregated	O
on	O
a	O
mixed	O
genetic	O
background	O
of	O
129S1	O
,	O
129X1	O
,	O
and	O
DBA	O
/	O
2J	O
.	O

Growth	O
arrest	O
-	O
specific	O
transcript	O
5	O
(	O
GAS5	O
)	O
encodes	O
a	O
single	O
strand	O
noncoding	O
RNA	O
(	O
ncRNA	O
)	O
and	O
,	O
as	O
its	O
name	O
suggests	O
,	O
can	O
accumulate	O
in	O
growth	O
-	O
arrested	O
cells	O
[	O
7	O
].	O

However	O
,	O
recent	O
studies	O
suggest	O
that	O
allergen	O
exposure	O
may	O
be	O
necessary	O
to	O
induce	O
tolerance	O
,	O
and	O
moreover	O
,	O
a	O
balanced	O
diet	O
prevents	O
malnutrition	O
of	O
both	O
mother	O
and	O
child	O
[	O
82	O
].	O

Sustained	O
advocacy	O
in	O
tackling	O
micronutrient	O
deficiencies	O
at	O
national	O
and	O
international	O
policy	O
levels	O
is	O
also	O
a	O
prerequisite	O
to	O
the	O
attainment	O
of	O
Millennium	O
Development	O
Goals	O
4	O
and	O
5	O
.	O

Mouse	O
models	O
have	O
contributed	O
greatly	O
to	O
our	O
understanding	O
of	O
molecular	O
embryonic	O
development	O
,	O
including	O
vertebral	O
formation	O
and	O
segmentation	O
(	O
Sparrow	O
et	O
al	O
.	O

To	O
examine	O
predictors	O
within	O
the	O
polytherapy	O
subgroup	O
only	O
,	O
unadjusted	O
logistic	O
regression	O
models	O
(	O
due	O
to	O
the	O
small	O
sample	O
size	O
)	O
were	O
subsequently	O
tested	O
.	O

Note	O
:	O
Analysis	O
is	O
for	O
countries	O
with	O
NMR	O
of	O
more	O
than	O
5	O
per	O
1	O
,	O
000	O
live	O
births	O
;	O
other	O
countries	O
are	O
excluded	O
.	O

To	O
determine	O
the	O
effect	O
of	O
birth	O
weight	O
on	O
HRV	O
parameters	O
,	O
we	O
perform	O
multivariate	O
linear	O
regression	O
analysis	O
adjusted	O
for	O
potentially	O
confounding	O
factors	O
(	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
).	O

examined	O
the	O
relationships	O
between	O
16	O
chemicals	O
(	O
6	O
phthalates	O
,	O
8	O
PFAS	O
,	O
2	O
PCBs	O
and	O
1	O
OCP	O
)	O
and	O
birth	O
weight	O
using	O
Elastic	O
Net	O
Regression	O
analyses	O
;	O
2	O
phthalates	O
,	O
1	O
PFAS	O
,	O
and	O
1	O
OCP	O
were	O
associated	O
with	O
lower	O
birth	O
weight	O
[	O
18	O
].	O

Education	O
about	O
asthma	O
and	O
its	O
interaction	O
with	O
pregnancy	O
reduces	O
anxiety	O
and	O
improves	O
compliance	O
.	O

The	O
mechanisms	O
protecting	O
specific	O
genomic	O
regions	O
from	O
epigenetic	O
re	O
-	O
programing	O
are	O
not	O
yet	O
well	O
-	O
understood	O
.	O

In	O
the	O
second	O
experiment	O
(	O
EXP2	O
)	O
offspring	O
selected	O
for	O
the	O
postnatal	O
time	O
points	O
was	O
born	O
to	O
primiparous	O
sows	O
after	O
prostaglandin	O
induction	O
of	O
parturition	O
as	O
described	O
[	O
15	O
]	O
and	O
farrowed	O
after	O
mean	O
pregnancy	O
duration	O
of	O
115	O
days	O
.	O

Geographical	O
accessibility	O
was	O
the	O
main	O
reason	O
for	O
choosing	O
an	O
ANC	O
site	O
,	O
followed	O
by	O
perceived	O
quality	O
of	O
care	O
provided	O
.	O

Results	O
The	O
initial	O
search	O
identified	O
279	O
articles	O
after	O
duplicates	O
were	O
removed	O
,	O
eight	O
of	O
which	O
were	O
suitable	O
for	O
inclusion	O
.	O

Twice	O
as	O
many	O
women	O
exposed	O
to	O
polytherapy	O
experienced	O
hypertension	O
and	O
gestational	O
diabetes	O
comorbidities	O
.	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
we	O
combined	O
the	O
intake	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
.	O

The	O
findings	O
of	O
the	O
formative	O
study	O
suggested	O
that	O
introduction	O
of	O
IFA	O
supplements	O
early	O
in	O
pregnancy	O
is	O
feasible	B
with	O
support	O
from	O
BRAC	O
or	O
government	O
community	O
health	O
workers	O
.	O

Initiating	O
these	O
changes	O
can	O
start	O
to	O
move	O
countries	O
toward	O
their	O
goal	O
of	O
preterm	O
mortality	O
reduction	O
while	O
also	O
preventing	O
death	O
due	O
to	O
other	O
causes	O
of	O
newborn	O
death	O
,	O
as	O
well	O
as	O
maternal	O
deaths	O
and	O
stillbirths	O
,	O
through	O
shared	O
interventions	O
such	O
as	O
skilled	O
care	O
at	O
birth	O
.	O

The	O
use	O
of	O
opium	O
,	O
bread	O
and	O
tea	O
could	O
not	O
be	O
assessed	O
in	O
the	O
retrospective	O
framework	O
.	O

Methods	O
Study	O
population	O
This	O
study	O
utilised	O
data	O
collected	O
from	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
Screening	O
for	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
[	O
28	O
].	O

There	O
are	O
randomized	O
controlled	O
trials	O
which	O
have	O
demonstrated	O
efficacy	O
of	O
the	O
oral	O
agents	O
glyburide	O
and	O
metformin	O
.	O

Effects	O
of	O
dietary	O
energy	O
(	O
TDN	O
:	O
70	O
%,	O
80	O
%;	O
DM	O
basis	O
)	O
and	O
protein	O
levels	O
(	O
crude	O
protein	O
[	O
CP	O
]:	O
11	O
.	O
9	O
%,	O
14	O
.	O
3	O
%;	O
DM	O
basis	O
)	O
on	O
growth	O
performance	O
,	O
carcass	O
characteristics	O
and	O
meat	O
quality	O
were	O
examined	O
in	O
F1	O
Angus	O
×	O
Chinese	O
Xiangxi	O
yellow	O
cattle	O
[	O
125	O
].	O

Of	O
the	O
routine	O
antianaphylaxis	O
medications	O
,	O
epinephrine	O
and	O
diphenhydramine	O
have	O
been	O
implicated	O
in	O
causing	O
fetal	O
malformations	O
.	O

Innovate	O
•	O
Promote	O
the	O
discovery	O
,	O
development	O
and	O
delivery	O
of	O
affordable	O
and	O
essential	O
medicines	O
,	O
new	O
technologies	O
and	O
novel	O
models	O
for	O
training	O
and	O
services	O
to	O
prevent	O
preterm	O
birth	O
and	O
improve	O
care	O
of	O
premature	O
babies	O
.	O

However	O
,	O
in	O
that	O
study	O
neurodevelopment	O
was	O
assessed	O
when	O
the	O
infant	O
was	O
only	O
three	O
days	O
old	O
.	O

Thus	O
,	O
the	O
caloric	O
restriction	O
finished	O
at	O
GD	O
20	O
(	O
2	O
days	O
before	O
birth	O
),	O
and	O
all	O
dams	O
and	O
their	O
offspring	O
were	O
fed	O
ad	O
libitum	O
with	O
the	O
standard	O
chow	O
along	O
the	O
remaining	O
experimental	O
periods	O
(	O
lactation	O
and	O
postweaning	O
periods	O
).	O

Innovate	O
•	O
Advance	O
policy	O
development	O
by	O
improving	O
the	O
metrics	O
for	O
impairment	O
outcomes	O
as	O
well	O
as	O
preterm	O
birth	O
rates	O
,	O
and	O
link	O
to	O
other	O
pregnancy	O
outcomes	O
,	O
reporting	O
on	O
trends	O
and	O
emerging	O
issues	O
relating	O
to	O
preterm	O
births	O
.	O

Furthermore	O
,	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
were	O
studied	O
.	O

Results	O
For	O
a	O
10	O
-	O
fold	O
increase	O
in	O
chemical	O
concentration	O
,	O
the	O
mean	O
differences	O
in	O
birth	O
weights	O
(	O
95	O
%	O
credible	O
intervals	O
(	O
CI	O
))	O
were	O
1	O
g	O
(-	O
20	O
,	O
23	O
)	O
for	O
phthalates	O
,	O
-	O
11	O
g	O
(-	O
52	O
,	O
34	O
)	O
for	O
PFAS	O
,	O
0	O
.	O
2	O
g	O
(-	O
9	O
,	O
10	O
)	O
for	O
PCBs	O
,	O
-	O
4	O
g	O
(-	O
30	O
,	O
22	O
)	O
for	O
PBDEs	O
,	O
and	O
7	O
g	O
(-	O
25	O
,	O
40	O
)	O
for	O
OCPs	O
.	O

Questionnaires	O
regarding	O
maternal	O
stress	O
/	O
maternal	O
attitudes	O
as	O
well	O
as	O
anthropometric	O
data	O
were	O
collected	O
as	O
previously	O
described	O
[	O
12	O
,	O
13	O
].	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

All	O
these	O
mechanisms	O
play	O
critical	O
roles	O
throughout	O
normal	O
mammalian	O
development	O
,	O
particularly	O
during	O
early	O
embryo	O
and	O
germ	O
cell	O
development	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Beaujean2014	O
;	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Luk	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Mukherjee	O
et	O
al	O
.	O
2014	O
;	O
O	O
'	O
Doherty	O
&	O
McGettigan2014	O
;	O
Grote	O
&	O
Herrmann2015	O
;	O
Hogg	O
&	O
Western2015	O
;	O
Marcho	O
et	O
al	O
.	O
2015	O
).	O

Omnibus	O
tests	O
for	O
the	O
overall	O
association	O
between	O
each	O
repetitive	O
methylation	O
and	O
class	O
methylation	O
were	O
obtained	O
by	O
permutation	O
test	O
,	O
using	O
a	O
test	O
analogous	O
to	O
a	O
Kolmogorov	O
–	O
Smirnov	O
test	O
.	O

Methods	O
are	O
currently	O
available	O
to	O
quantify	O
the	O
contribution	O
of	O
endogenous	O
vitamin	O
D	O
synthesis	O
resulting	O
from	O
sun	O
exposure	O
,	O
but	O
serious	O
limitations	O
remain	O
in	O
accurately	O
estimating	O
dietary	O
vitamin	O
D	O
intake	O
because	O
of	O
the	O
incompleteness	O
of	O
nutrient	O
databases	O
for	O
both	O
vitamin	O
D	O
-	O
fortified	O
food	O
and	O
vitamin	O
D	O
supplements	O
.	O

There	O
were	O
no	O
associations	O
between	O
the	O
predictor	O
T1	O
25OHD	O
and	O
the	O
outcomes	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
(	O
Table	O
3	O
).	O

More	O
research	O
with	O
larger	O
sample	O
sizes	O
and	O
frequent	O
assessments	O
of	O
diet	O
is	O
needed	O
to	O
inform	O
the	O
impact	O
of	O
timing	O
of	O
nutrient	O
exposures	O
on	O
offspring	O
weight	O
status	O
.	O

This	O
study	O
concluded	O
that	O
abnormal	O
maternal	O
gestational	O
weight	O
indirectly	O
caused	O
an	O
increased	O
chance	O
of	O
developing	O
ASD	O
[	O
49	O
].	O

The	O
concordance	O
of	O
mothers	O
’	O
personal	O
weight	O
gain	O
target	O
with	O
IOM	O
recommendations	O
varied	O
by	O
their	O
pre	O
-	O
pregnancy	O
weight	O
status	O
:	O
Normal	O
weight	O
mothers	O
were	O
more	O
likely	B
to	O
have	O
low	O
weight	O
gain	O
targets	O
,	O
whereas	O
overweight	O
and	O
obese	O
women	O
were	O
more	O
likely	B
to	O
have	O
high	O
weight	O
gain	O
targets	O
(	O
Table	O
3	O
).	O

Pepsin	O
(	O
0	O
.	O
01	O
%	O
in	O
0	O
.	O
01	O
M	O
HCl	O
)	O
was	O
used	O
to	O
treat	O
the	O
tissue	O
for	O
5	O
minutes	O
at	O
37	O
°	O
C	O
,	O
and	O
a	O
brief	O
rinse	O
in	O
DEPC	O
treated	O
H2O	O
followed	O
.	O

Participants	O
took	O
an	O
average	O
of	O
12	O
minutes	O
to	O
complete	O
the	O
questionnaire	O
.	O

As	O
reported	O
previously	O
[	O
16	O
],	O
the	O
intervention	O
reduced	O
excessive	O
GWG	O
in	O
normal	O
weight	O
but	O
not	O
overweight	O
/	O
obese	O
women	O
.	O

[	O
37	O
–	O
39	O
]	O
The	O
concept	O
that	O
maternal	O
nutritional	O
status	O
influences	O
the	O
risk	O
of	O
chronic	O
disorders	O
in	O
the	O
offspring	O
has	O
attracted	O
interest	O
over	O
the	O
past	O
2	O
decades	O
.	O

One	O
participant	O
assigned	O
to	O
the	O
intervention	O
arm	O
and	O
two	O
in	O
the	O
control	O
arm	O
were	O
later	O
found	O
to	O
be	O
ineligible	O
because	O
another	O
woman	O
residing	O
in	O
the	O
same	O
household	O
compound	O
had	O
previously	O
been	O
enrolled	O
in	O
the	O
study	O
;	O
data	O
collection	O
was	O
discontinued	O
upon	O
identification	O
of	O
the	O
ineligibility	O
criteria	O
.	O

When	O
juvenile	O
and	O
young	O
adult	O
pigs	O
(	O
period	O
III	O
)	O
are	O
compared	O
,	O
1	O
,	O
549	O
probe	O
-	O
sets	O
differed	O
significantly	O
(	O
697	O
188	O
dpn	O
≻	O
28	O
dpn	O
)	O
in	O
AP	O
offspring	O
.	O

GDM	O
cases	O
were	O
older	O
,	O
and	O
heavier	O
than	O
women	O
who	O
did	O
not	O
develop	O
the	O
disorder	O
.	O

Girls	O
who	O
ranked	O
themselves	O
at	O
the	O
low	O
end	O
of	O
school	O
social	O
status	O
were	O
69	O
%	O
more	O
likely	B
to	O
have	O
a	O
BMI	O
2	O
kg	O
/	O
m2higher	O
than	O
that	O
of	O
girls	O
of	O
higher	O
subjective	O
social	O
status	O
.	O

The	O
results	O
of	O
several	O
meta	O
-	O
analyses	O
reinforce	O
the	O
beneficial	O
role	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
during	O
pregnancy	O
in	O
reducing	O
the	O
prevalence	O
of	O
neural	O
tube	O
defects	O
,	O
low	O
-	O
birth	O
weight	O
babies	O
,	O
small	O
for	O
gestational	O
age	O
newborns	O
and	O
maternal	O
anaemia	O
[	O
7	O
-	O
9	O
].	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
between	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
levels	O
and	O
S	O
-	O
ECC	O
.	O

Interactions	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
34	O
.	O
005	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
diet	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
4	O
.	O
58	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
were	O
found	O
.	O

DNA	O
sequence	O
analysis	O
of	O
Flnb	O
revealed	O
a	O
T	O
-	O
to	O
-	O
C	O
transition	O
at	O
nucleotide	O
position	O
481	O
converting	O
a	O
serine	O
residue	O
to	O
a	O
proline	O
residue	O
(	O
S96P	O
),	O
resulting	O
in	O
a	O
missense	O
mutation	O
(	O
Figure	O
3A	O
,	O
right	O
panel	O
)	O
within	O
the	O
actin	O
-	O
binding	O
domain	O
of	O
FLNB	O
(	O
Figure	O
3C	O
,	O
bottom	O
panel	O
).	O

Although	O
not	O
prespecified	O
,	O
we	O
also	O
generated	O
rate	O
ratios	O
to	O
compare	O
the	O
proportion	O
of	O
intervention	O
-	O
recommended	O
times	O
at	O
which	O
hands	O
were	O
washed	O
in	O
the	O
two	O
study	O
arms	O
;	O
we	O
used	O
log	O
binomial	O
regression	O
,	O
accounting	O
for	O
repeated	O
measures	O
at	O
the	O
caregiver	O
level	O
to	O
adjust	O
standard	O
errors	O
.	O

Since	O
we	O
completed	O
structured	O
observations	O
at	O
the	O
end	O
of	O
the	O
neonatal	O
period	O
during	O
postnatal	O
days	O
30	O
–	O
32	O
,	O
we	O
cannot	O
know	O
whether	O
handwashing	O
was	O
more	O
common	O
or	O
less	O
common	O
during	O
the	O
early	O
days	O
of	O
the	O
newborn	O
period	O
,	O
when	O
babies	O
may	O
have	O
been	O
perceived	O
to	O
be	O
particularly	O
vulnerable	O
but	O
mothers	O
may	O
have	O
been	O
particularly	O
fatigued	O
or	O
getting	O
adjusted	O
to	O
the	O
new	O
household	O
routine	O
following	O
the	O
birth	O
.	O

Additionally	O
,	O
the	O
discordance	O
of	O
handedness	O
in	O
twin	O
studies	O
illustrates	O
that	O
genetics	O
alone	O
cannot	O
explain	O
the	O
development	O
of	O
handedness	O
[	O
202	O
–	O
207	O
].	O

Is	O
any	O
part	O
of	O
the	O
life	O
cycle	O
particularly	O
more	O
sensitive	O
to	O
an	O
exposure	O
than	O
others	O
?	O

Also	O
,	O
weekly	O
supplements	O
may	O
be	O
better	O
tolerated	O
,	O
with	O
less	O
frequent	O
side	O
-	O
effects	O
thereby	B
increasing	O
acceptance	O
and	O
compliance	O
.	O

A	O
10	O
-	O
fold	O
increase	O
in	O
Pb	O
exposure	O
was	O
associated	O
with	O
a	O
45	O
g	O
birth	O
weight	O
reduction	O
(	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
),	O
while	O
increased	O
exposure	O
to	O
DMP	O
was	O
associated	O
with	O
a	O
-	O
57	O
g	O
(	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
))	O
change	O
in	O
birth	O
weight	O
.	O

On	O
the	O
basis	O
of	O
these	O
criteria	O
,	O
we	O
controlled	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

In	O
addition	O
,	O
smoking	O
is	O
a	O
cause	O
of	O
reflux	O
and	O
should	O
be	O
avoided	O
.	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

Exposure	O
to	O
the	O
sun	O
during	O
week	O
and	O
weekend	O
days	O
,	O
and	O
consumption	O
of	O
milk	O
and	O
dairy	O
products	O
were	O
not	O
associated	O
with	O
either	O
severe	O
or	O
normal	O
vitamin	O
D	O
deficiency	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t005	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
in	O
Belgium	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
(	O
n	O
=	O
1121	O
),	O
results	O
of	O
multiple	O
logistic	O
regressions	O
.	O
N	O
of	O
subjectsN	O
of	O
severe	O
deficient	O
casesOR	O
[	O
95	O
%	O
Conf	O
Interval	O
]	O
p	O
Trimester	O
of	O
pregnancy	O
first	O
trimester633741	O
.	O
000third	O
trimester665841	O
.	O
7511	O
.	O
1282	O
.	O
7190	O
.	O
013	O
Season	O
Winter470891	O
.	O
000Spring384350	O
.	O
2830	O
.	O
1680	O
.	O
477	O
<	O
0	O
.	O
001Summer930Autumn351340	O
.	O
3240	O
.	O
1910	O
.	O
551	O
<	O
0	O
.	O
001	O
Smoking	O
Yes219331	O
.	O
000No10781250	O
.	O
4630	O
.	O
2680	O
.	O
8010	O
.	O
006	O
Alcohol	O
consumption	O
Yes264131	O
.	O
000No10221432	O
.	O
3701	O
.	O
1624	O
.	O
8340	O
.	O
018	O
Use	O
of	O
multivitamins	O
containing	O
vitamin	O
D	O
No4891151	O
.	O
000Yes809430	O
.	O
1210	O
.	O
0750	O
.	O
193	O
<	O
0	O
.	O
001	O
Ethnicity	O
Caucasian	O
,	O
white955691	O
.	O
000Asiatic3396	O
.	O
6562	O
.	O
41318	O
.	O
359	O
<	O
0	O
.	O
001African	O
,	O
black64132	O
.	O
6051	O
.	O
1515	O
.	O
8960	O
.	O
022African	O
,	O
north174638	O
.	O
1744	O
.	O
71214	O
.	O
177	O
<	O
0	O
.	O
001	O
Frequency	O
fatty	O
fish	O
consumption	O
Never192181	O
.	O
000Less	O
than	O
once	O
a	O
month188242	O
.	O
2051	O
.	O
0104	O
.	O
8160	O
.	O
0471	O
–	O
3	O
days	O
a	O
month498591	O
.	O
4810	O
.	O
7552	O
.	O
9040	O
.	O
2541	O
day	O
per	O
week291351	O
.	O
3910	O
.	O
6712	O
.	O
8850	O
.	O
3752	O
–	O
4	O
days	O
a	O
week	O
or	O
more	O
frequent128221	O
.	O
5130	O
.	O
6593	O
.	O
4720	O
.	O
328	O
Use	O
of	O
sunscreen	O
lotion	O
Yes	O
,	O
much	O
of	O
the	O
time644361	O
.	O
000Yes	O
,	O
sometimes281342	O
.	O
0871	O
.	O
1713	O
.	O
7220	O
.	O
013No368883	O
.	O
2631	O
.	O
9355	O
.	O
504	O
<	O
0	O
.	O
001	O
Preference	O
sun	O
/	O
shadow	O
Sun476531	O
.	O
000Shadow497701	O
.	O
9831	O
.	O
2253	O
.	O
2100	O
.	O
005Does	O
not	O
matter321351	O
.	O
2060	O
.	O
6912	O
.	O
1040	O
.	O
510	O
OR	O
Odds	O
ratio	O
.	O

Women	O
presenting	O
for	O
other	O
services	O
than	O
ANC	O
visits	O
were	O
excluded	O
on	O
the	O
grounds	O
that	O
they	O
did	O
not	O
have	O
any	O
experience	O
of	O
a	O
particular	O
health	O
centre	O
and	O
so	O
could	O
not	O
give	O
an	O
opinion	O
on	O
the	O
ANC	O
services	O
.	O

Tobacco	O
use	O
and	O
vitamin	O
D	O
supplement	O
use	O
were	O
also	O
investigated	O
as	O
potential	O
confounders	O
but	O
did	O
not	O
show	O
any	O
confounding	O
effect	O
and	O
were	O
thus	B
not	O
included	O
in	O
the	O
final	O
models	O
.	O

The	O
findings	O
will	O
provide	O
a	O
concrete	O
way	O
for	O
the	O
researchers	O
to	O
give	O
back	O
to	O
the	O
community	O
.	O

Biomarkers	O
with	O
<	O
90	O
%	O
detection	O
level	O
or	O
that	O
were	O
only	O
examined	O
in	O
a	O
subset	O
of	O
the	O
participants	O
were	O
excluded	O
from	O
analysis	O
to	O
preserve	O
sample	O
size	O
(	O
Table2	O
).	O

This	O
is	O
the	O
next	O
step	O
to	O
find	O
out	O
how	O
it	O
’	O
s	O
really	O
happening	O
on	O
the	O
molecular	O
level	O
.”	O
Uranium	O
’	O
s	O
Toxic	O
Legacy	O
Human	O
and	O
animal	O
studies	O
elsewhere	O
have	O
indicated	O
the	O
health	O
legacy	O
of	O
uranium	O
exposure	O
may	O
extend	O
to	O
the	O
children	O
of	O
exposed	O
parents	O
.	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	O
a	O
relationship	O
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	O
effects	O
in	O
the	O
two	O
groups	O
,	O
suggesting	O
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

Additionally	O
,	O
the	O
initial	O
test	O
was	O
not	O
automated	O
until	O
May	O
2016	O
so	B
many	O
women	O
who	O
delivered	O
during	O
the	O
early	O
study	O
time	O
period	O
did	O
not	O
have	O
a	O
25	O
(	O
OH	O
)	O
D	O
measurement	O
and	O
therefore	B
could	O
not	O
be	O
included	O
in	O
this	O
analysis	O
.	O

Prior	O
to	O
ACHOIS	O
,	O
a	O
large	O
number	O
of	O
other	O
studies	O
had	O
been	O
performed	O
to	O
ascertain	O
if	O
treatment	O
of	O
GDM	O
is	O
of	O
benefit	O
.	O

If	O
this	O
approach	O
is	O
vulgarized	O
,	O
it	O
might	O
increase	O
the	O
uptake	O
of	O
ANC	O
services	O
and	O
improve	O
on	O
the	O
quality	O
of	O
health	O
care	O
.	O

Also	O
,	O
vitamin	O
D	O
supplements	O
were	O
used	O
by	O
almost	O
half	O
of	O
the	O
women	O
but	O
most	O
(	O
88	O
%)	O
used	O
multivitamins	O
containing	O
5	O
–	O
10	O
μg	O
of	O
vitamin	O
D3	O
.	O

N	O
-	O
nitroso	O
compounds	O
are	O
a	O
potent	O
inducer	O
of	O
cancer	O
and	O
brain	O
tumors	O
in	O
various	O
animal	O
species	O
[	O
159	O
,	O
160	O
],	O
and	O
fetal	O
exposure	O
produces	O
more	O
tumors	O
than	O
postnatal	O
exposure	O
[	O
161	O
].	O

Inform	O
•	O
Improve	O
systems	O
for	O
collecting	O
,	O
evaluating	O
and	O
disseminating	O
data	O
on	O
preterm	O
birth	O
rates	O
,	O
mortality	O
,	O
disability	O
,	O
quality	O
of	O
life	O
and	O
equitable	O
coverage	O
of	O
evidence	O
-	O
based	O
interventions	O
to	O
track	O
progress	O
towards	O
MDGs	O
4	O
and	O
5	O
for	O
maternal	O
and	O
child	O
survival	O
.	O

Nutritional	O
education	O
is	O
considered	O
an	O
important	O
tool	O
for	O
promoting	O
a	O
healthy	O
lifestyle	O
,	O
but	O
has	O
not	O
been	O
studied	O
as	O
a	O
determinant	O
for	O
maternal	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
especially	O
in	O
Romania	O
,	O
where	O
evidence	O
about	O
pregnancy	O
and	O
nutrition	O
is	O
scarce	O
.	O

Glucose	O
intolerance	O
and	O
gestational	O
diabetes	O
risk	O
in	O
relation	O
to	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
:	O
a	O
pilot	O
study	O
Abstract	O
Background	O
Insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
,	O
considered	O
endemic	O
in	O
modern	O
society	O
,	O
are	O
associated	O
with	O
obesity	O
,	O
impaired	O
glucose	O
tolerance	O
and	O
diabetes	O
.	O

We	O
observed	O
consistent	O
associations	O
between	O
maternal	O
DHA	O
and	O
EPA	O
intake	O
and	O
infant	O
gut	O
microbiota	O
.	O

Familial	O
cases	O
account	B
for	I
about	O
30	O
%	O
of	O
MTCs	O
.	O

Given	B
that	O
pregnant	O
women	O
,	O
particularly	O
those	O
in	O
the	O
first	O
trimester	O
,	O
are	O
known	O
to	O
require	O
30	O
-	O
45	O
more	O
minutes	O
of	O
sleep	O
per	O
night	O
than	O
their	O
non	O
-	O
pregnant	O
counterparts	O
[	O
25	O
-	O
27	O
],	O
we	O
a	O
priori	O
defined	O
those	O
women	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
as	O
the	O
reference	O
group	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1472	O
-	O
6874	O
/	O
10	O
/	O
17	O
/	O
prepub	O
PubMed	O
Central	O
:	O

These	O
alterations	O
are	O
primarily	B
the	O
result	O
of	O
hormonal	O
effects	O
.	O

In	O
accordance	O
to	O
a	O
guideline	B
by	O
Holick	O
et	O
al	O
.,	O
6	O
–	O
8	O
weeks	O
consumption	O
of	O
a	O
high	O
dose	O
vitamin	O
D	O
supplement	O
are	O
essential	O
to	O
obtain	O
an	O
adequate	O
blood	O
reserves	O
of	O
vitamin	O
D	O
[	O
19	O
].	O

Therefore	B
,	O
nutritionally	O
-	O
induced	O
accelerated	O
reproductive	O
maturation	O
following	O
high	O
fat	O
exposure	O
may	O
not	O
be	O
limited	O
to	O
one	O
distinct	O
critical	O
developmental	O
window	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
vs	O
.	O
respective	O
vehicle	O
males	O
;#/##	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
(	O
vehicle	O
)	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
;§	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
AM251	O
-	O
treated	O
CC	O
females	O
.	O

Such	O
a	O
relation	O
has	O
been	O
attributed	O
to	O
special	O
receptors	O
for	O
vitamin	O
D	O
in	O
pancreatic	O
betacells	O
.	O
9Moreover	O
,	O
vitamin	O
D	O
was	O
shown	O
to	O
have	O
positive	O
effects	O
on	O
insulin	O
sensitivity	O
,	O
and	O
its	O
deficiency	O
to	O
have	O
negative	O
effects	O
on	O
the	O
function	O
of	O
betacells	O
.	O
11In	O
agreement	O
with	O
this	O
,	O
cohort	O
studies	O
revealed	O
that	O
vitamin	O
D	O
had	O
a	O
protective	O
effect	O
against	O
diabetes	O
type	O
II	O
.	O
8	O
,	O
11Also	O
,	O
serum	O
concentration	O
of	O
vitamin	O
D	O
during	O
24	O
-	O
29thweek	O
of	O
pregnancy	O
in	O
women	O
suffering	O
from	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
the	O
disease	O
.	O
12	O
The	O
study	O
of	O
vitamin	O
D	O
status	O
and	O
improving	O
it	O
in	O
the	O
lactating	O
mothers	O
with	O
previous	O
GDM	O
is	O
of	O
conspicuous	O
value	O
.	O
4	O
,	O
13	O
Due	O
to	O
the	O
limited	O
exposure	O
to	O
sunshine	O
and	O
inadequate	O
intake	O
,	O
the	O
level	O
of	O
vitamin	O
D	O
is	O
reduced	O
in	O
the	O
milk	O
of	O
lactating	O
mothers	O
.	O

Authorship	O
eligibility	O
will	O
be	O
based	O
on	O
recommendation	O
from	O
International	O
committee	O
for	O
medical	O
journals	O
editors	O
(	O
ICMJE	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

,	O
2008	O
[	O
21	O
]	O
Type	O
of	O
studyObservational	O
cohort	O
(	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
-	O
ALSPAC	O
)	O
Prospective	O
cohort	O
(	O
Project	O
Viva	O
)	O
Observational	O
cohort	O
(	O
ALSPAC	O
)	O
Observational	O
cohortNHMRC	O
Level	O
of	O
evidence	O
[	O
20	O
]	O
Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3Level	O
III	O
-	O
3PopulationPregnant	O
women	O
living	O
in	O
Bristol	O
&	O
surrounds	O
,	O
United	O
Kingdom	O
(	O
UK	O
).	O
Pregnant	O
women	O
recruited	O
in	O
Massachusetts	O
,	O
United	O
States	O
of	O
America	O
(	O
USA	O
)	O
Pregnant	O
women	O
in	O
Bristol	O
&	O
surrounds	O
,	O
UK	O
.	O
Pregnant	O
women	O
recruited	O
in	O
Southampton	O
,	O
UK	O
.	O

Mothers	O
in	O
several	O
low	O
-	O
income	O
countries	O
have	O
indicated	O
that	O
their	O
responsibilities	O
increase	O
in	O
the	O
postnatal	O
period	O
,	O
often	O
without	O
increased	O
support	O
for	O
household	O
or	O
child	O
care	O
activities	O
from	O
others	O
[	O
12	O
].	O

On	O
the	O
one	O
hand	O
,	O
this	O
matter	O
may	O
be	O
related	O
to	O
mitochondrial	O
impairments	O
which	O
may	O
happen	O
due	O
to	O
the	O
LP	O
diet	O
,	O
as	O
has	O
been	O
suggested	O
previously	O
[	O
57	O
,	O
58	O
].	O

Detailed	O
data	O
collection	O
procedures	O
have	O
been	O
published	O
elsewhere	O
[	O
23	O
].	O

Pregnancy	O
loss	O
was	O
defined	O
as	O
both	O
spontaneous	O
abortions	O
from	O
gestational	O
week	O
4	O
and	O
intrauterine	O
fetal	O
death	O
(	O
IUFD	O
).	O

Therefore	B
,	O
examining	O
childhood	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
is	O
warranted	O
.	O

These	O
findings	O
are	O
compatible	O
with	O
a	O
previous	O
report	O
of	O
early	O
puberty	O
following	O
high	O
fat	O
nutrition	O
during	O
pregnancy	O
[	O
57	O
].	O

Innovate	O
Conduct	O
multi	O
-	O
country	O
collaborative	O
research	O
on	O
the	O
:	O
•	O
Etiology	O
of	O
preterm	O
birth	O
,	O
advancing	O
the	O
understanding	O
of	O
strategies	O
to	O
prevent	O
and	O
treat	O
maternal	O
health	O
conditions	O
associated	O
with	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
pre	O
-	O
eclampsia	O
and	O
gestational	O
diabetes	O
)	O
and	O
improving	O
identification	O
of	O
diagnostic	O
markers	O
and	O
related	O
screening	O
tools	O
.	O

Currently	O
,	O
the	O
venom	O
-	O
based	O
treatment	O
is	O
administered	O
by	O
injection	O
,	O
but	O
the	O
Texas	O
researchers	O
hope	O
to	O
develop	O
a	O
pill	O
form	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
in	O
intervention	O
and	O
control	O
groups25	O
-	O
OH	O
VitD2	O
(	O
nmol	O
/	O
L	O
)	O
25	O
-	O
OH	O
VitD2	O
detection	O
rate25	O
-	O
OH	O
VitD3	O
(	O
nmol	O
/	O
L	O
)	O
Total25	O
-	O
OH	O
VitD	O
(	O
nmol	O
/	O
L	O
)	O
Deficiency	O
rate	O
(%)	O
Intervention	O
(	O
n	O
=	O
84	O
)	O
11	O
.	O
61	O
±	O
6	O
.	O
7122	O
.	O
6	O
%	O
71	O
.	O
77	O
±	O
26	O
.	O
7874	O
.	O
35	O
±	O
26	O
.	O
13	O
*	O
17	O
.	O
9	O
%	O
Control	O
(	O
n	O
=	O
14	O
)	O
00060	O
.	O
45	O
±	O
23	O
.	O
6335	O
.	O
7	O
%	O
Note	O
:	O
*	O
Compared	O
with	O
control	O
group	O
,	O
p	O
<	O
0	O
.	O
05	O
Seasonal	O
changes	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
pregnant	O
women	O
with	O
GDM	O
Blood	O
samples	O
were	O
taken	O
between	O
October	O
2013	O
and	O
July	O
2015	O
,	O
twenty	O
-	O
one	O
cases	O
were	O
collected	O
in	O
winter	O
,	O
forty	O
-	O
three	O
cases	O
in	O
Spring	O
,	O
twenty	O
two	O
cases	O
in	O
Summer	O
,	O
and	O
twelve	O
cases	O
in	O
Autumn	O
.	O

Our	O
study	O
revealed	O
that	O
a	O
single	O
high	O
dose	O
injection	O
of	O
vitamin	O
D	O
is	O
more	O
economic	O
and	O
effective	O
particularly	O
in	O
lactating	O
mothers	O
who	O
refrain	O
from	O
consuming	O
oral	O
daily	O
doses	O
due	O
to	O
postpartum	O
care	O
,	O
unwillingness	O
or	O
depression	O
.	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

Albrecht	O
et	O
al	O
[	O
24	O
]	O
reported	O
that	O
hyperplasia	O
of	O
preadipocytes	O
also	O
plays	O
an	O
important	O
role	O
in	O
marbling	O
formation	O
during	O
postnatal	O
growth	O
of	O
IMF	O
because	O
new	O
marbling	O
flecks	O
appear	O
after	O
recruitment	O
and	O
filling	O
with	O
preadipocytes	O
.	O

We	O
have	O
,	O
for	O
instance	O
,	O
established	O
dietary	O
associations	O
between	O
nuclear	O
family	O
members	O
and	O
have	O
shown	O
that	O
maternal	O
pregnancy	O
diet	O
is	O
associated	O
with	O
a	O
number	O
of	O
outcomes	O
,	O
including	O
child	O
'	O
s	O
risk	O
of	O
asthma	O
,	O
overweight	O
and	O
obesity	O
.	O
22	O
There	O
are	O
powerful	O
environmental	O
influences	O
at	O
play	O
in	O
familial	O
studies	O
.	O

Vitamin	O
D	O
receptors	O
are	O
present	O
in	O
most	O
cells	O
and	O
tissues	O
in	O
the	O
body	O
[	O
152	O
],	O
including	O
the	O
brain	O
[	O
148	O
],	O
so	O
this	O
hormone	O
is	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
disease	O
management	O
and	O
cancer	O
prevention	O
as	O
a	O
modulator	O
of	O
immune	O
system	O
activity	O
[	O
148	O
,	O
153	O
–	O
155	O
].	O

We	O
examined	O
the	O
relationship	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
6	O
-	O
week	O
-	O
old	O
infants	O
and	O
identified	O
associations	O
within	O
delivery	O
mode	O
groups	O
.	O

They	O
found	O
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
levels	O
in	O
the	O
second	O
trimester	O
were	O
a	O
risk	O
factor	O
for	O
postnatal	O
depression	O
.	O

Liver	O
samples	O
were	O
obtained	O
and	O
RNA	O
was	O
isolated	O
.	O

The	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
was	O
10	O
.	O
5	O
%,	O
compared	O
to	O
3	O
.	O
7	O
%	O
for	O
insulin	O
and	O
25	O
%	O
for	O
glyburide	O
(	O
p	O
=	O
0	O
.	O
07	O
).	O

Measures	O
The	O
study	O
questionnaire	O
was	O
administered	O
by	O
trained	O
study	O
personnel	O
in	O
Spanish	O
or	O
English	O
in	O
participants	O
’	O
homes	O
.	O

Most	O
of	O
them	O
recommended	O
an	O
improvement	O
in	O
the	O
nurses	O
’	O
skills	O
.	O

This	O
project	O
will	O
determine	O
if	O
antenatal	O
IFA	O
supplements	O
commenced	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
rather	O
than	O
later	O
,	O
will	O
significantly	O
reduce	O
neonatal	O
deaths	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
if	O
this	O
approach	O
is	O
cost	O
-	O
effective	O
.	O

However	O
,	O
very	O
few	O
studies	O
have	O
been	O
in	O
position	O
to	O
examine	O
this	O
association	O
directly	O
in	O
animals	O
.	O

In	O
the	O
second	O
piece	O
of	O
research	O
,	O
VD	O
supplementation	O
was	O
proven	O
to	O
increase	O
serum	O
levels	O
of	O
pro	O
-	O
inflammatory	O
advanced	O
glycation	O
end	O
products	O
receptor	O
(	O
sRAGE	O
),	O
a	O
particle	O
binding	O
those	O
glycation	O
end	O
products	O
(	O
AGEs	O
),	O
which	O
are	O
known	O
to	O
be	O
one	O
of	O
PCOS	O
triggers	O
(	O
p	O
=	O
0	O
.	O
03	O
).	O

Differences	O
between	O
regions	O
,	O
trimesters	O
and	O
age	O
groups	O
were	O
explored	O
using	O
two	O
-	O
sample	O
Wilcoxon	O
rank	O
-	O
sum	O
test	O
or	O
Kruskal	O
-	O
Wallis	O
equality	O
-	O
of	O
-	O
populations	O
rank	O
test	O
.	O

We	O
didn	O
’	O
t	O
consider	O
placebo	O
because	O
WHO	O
and	O
Government	O
of	O
Bangladesh	O
have	O
a	O
recommendation	O
that	O
pregnant	O
women	O
should	O
receive	O
60	O
mg	O
of	O
iron	O
supplementation	O
.	O

Improving	O
the	O
vitamin	O
D	O
status	O
of	O
women	O
with	O
underlying	O
conditions	O
may	O
avert	O
the	O
need	O
for	O
a	O
medically	O
indicated	O
preterm	O
delivery	O
.	O

When	O
studied	O
under	O
thermoneutral	O
conditions	O
,	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
increased	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
.	O

All	O
categorical	O
outcomes	O
were	O
analysed	O
using	O
Pearson	O
'	O
s	O
χ²	O
or	O
Fisher	O
'	O
s	O
exact	O
tests	O
.	O

Black	O
infants	O
with	O
vitamin	O
D	O
deficiency	O
had	O
2	O
.	O
4	O
greater	O
odds	O
of	O
SGA	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
0	O
,	O
5	O
.	O
8	O
)	O
after	O
adjusting	O
for	O
maternal	O
history	O
of	O
PIH	O
and	O
maternal	O
BMI	O
,	O
two	O
significant	O
confounding	O
variables	O
in	O
our	O
model	O
(	O
Table	O
3	O
).	O

Therefore	B
meconium	O
aspiration	O
syndrome	O
cannot	O
be	O
the	O
cause	O
of	O
autistic	O
disorder	O
in	O
children	O
,	O
but	O
it	O
can	O
be	O
a	O
contributing	O
factor	O
[	O
57	O
].	O

In	O
this	O
way	O
,	O
hundreds	O
of	O
thousands	O
of	O
lives	O
could	O
be	O
saved	O
with	O
the	O
application	O
of	O
current	O
knowledge	O
.	O

In	O
other	O
words	O
,	O
this	O
system	O
might	O
not	O
be	O
effective	O
unless	O
there	O
is	O
existing	O
infection	O
with	O
pathogens	O
when	O
vitamin	O
D	O
supplementation	O
is	O
given	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
frequency	O
of	O
daily	O
“	O
between	O
-	O
meal	O
”	O
snacking	O
between	O
the	O
groups	O
(	O
93	O
.	O
8	O
%	O
S	O
-	O
ECC	O
vs	O
.	O
96	O
.	O
7	O
%	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
39	O
,	O
Fisher	O
’	O
s	O
Exact	O
Test	O
).	O

Iron	O
fortification	O
of	O
foods	O
might	O
be	O
particularly	O
useful	O
and	O
cost	O
effective	O
in	O
settings	O
where	O
the	O
logistics	O
of	O
oral	O
iron	O
supplementation	O
among	O
pregnant	O
women	O
are	O
highly	O
challenging	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Experimental	O
design	O
.	O

The	O
importance	O
of	O
effective	O
3	O
-	O
way	O
communication	O
among	O
the	O
patient	O
,	O
asthma	O
specialist	O
,	O
and	O
obstetrician	O
cannot	O
be	O
overemphasized	O
.	O

The	O
influence	O
of	O
the	O
educational	O
level	O
of	O
respondents	O
is	O
predominant	O
here	O
as	O
it	O
is	O
noticed	O
that	O
those	O
at	O
a	O
high	O
educational	O
level	O
are	O
more	O
likely	B
to	O
be	O
critical	O
about	O
care	O
received	O
and	O
defer	O
a	O
positive	O
satisfaction	O
.	O

A	O
strength	O
of	O
the	O
present	O
study	O
lies	O
in	O
the	O
recruitment	O
of	O
subjects	O
,	O
which	O
took	O
place	O
in	O
a	O
single	O
hospital	O
,	O
enabled	O
standardised	O
data	O
collection	O
and	O
covered	O
all	O
seasons	O
.	O

Microbiome	O
profiling	O
To	O
identify	O
microbial	O
population	O
structure	O
profiles	O
,	O
we	O
used	O
full	O
-	O
length	O
amplicon	O
sequences	O
for	O
the	O
rRNA	O
gene	O
V4	O
-	O
V5	O
hypervariable	O
regions	O
.	O

On	O
admission	O
,	O
her	O
blood	O
pressure	O
was	O
108	O
/	O
60	O
mmHg	O
,	O
pulse	O
95	O
beats	O
/	O
minute	O
,	O
temperature	O
97	O
°	O
F	O
,	O
respiratory	O
rate	O
of	O
17	O
breaths	O
/	O
min	O
,	O
and	O
saturating	O
98	O
%	O
on	O
ambient	O
air	O
.	O

These	O
authors	O
estimate	O
that	O
the	O
productivity	O
gains	O
for	O
an	O
individual	O
removed	O
from	O
anaemia	O
are	O
5	O
%	O
in	O
manual	O
occupations	O
(	O
70	O
%	O
of	O
employment	O
in	O
a	O
country	O
such	O
as	O
Viet	O
Nam	O
),	O
and	O
17	O
%	O
in	O
heavy	O
manual	O
occupations	O
(	O
which	O
form	O
12	O
.	O
7	O
%	O
of	O
employment	O
in	O
manual	O
occupations	O
in	O
Viet	O
Nam	O
:	O
the	O
share	O
of	O
agriculture	O
in	O
GDP	O
is	O
22	O
.	O
1	O
%)[	O
16	O
].	O

For	O
this	O
purpose	O
,	O
we	O
searched	O
the	O
current	O
literature	O
on	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
and	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
rodent	O
models	O
in	O
PubMed	O
using	O
the	O
terms	O
in	O
Supplementary	O
Table	O
1	O
;	O
defining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
as	O
environmental	O
factors	O
(	O
chemicals	O
,	O
radiation	O
and	O
lifestyle	O
factors	O
(	O
including	O
alcohol	O
,	O
nutrition	O
and	O
smoking	O
))	O
that	O
induce	O
adverse	O
effects	O
(	O
growth	O
retardation	O
,	O
fertility	O
problems	O
,	O
hormonal	O
changes	O
,	O
reproductive	O
and	O
/	O
or	O
other	O
organ	O
-	O
and	O
system	O
-	O
specific	O
abnormalities	O
(	O
including	O
immune	O
disorders	O
,	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
))	O
and	O
are	O
associated	O
with	O
epigenetic	O
mechanisms	O
(	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
,	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
and	O
other	O
epigenetic	O
machinery	O
(	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
)).	O

Thus	O
,	O
to	O
estimate	O
the	O
required	O
sample	O
size	O
for	O
measuring	O
the	O
impact	O
of	O
handwashing	O
promotion	O
on	O
maternal	O
handwashing	O
behavior	O
,	O
we	O
assumed	B
that	O
the	O
probability	O
of	O
observed	O
handwashing	O
with	O
soap	O
after	O
a	O
fecal	O
contact	O
event	O
would	O
be	O
0	O
.	O
20	O
in	O
the	O
control	O
arm	O
[	O
20	O
]	O
and	O
that	O
the	O
probability	O
would	O
increase	O
to	O
0	O
.	O
40	O
in	O
the	O
intervention	O
arm	O
.	O

All	O
patients	O
should	O
undergo	O
neck	O
ultrasound	O
and	O
serum	O
assay	O
for	O
HTG	O
,	O
HTG	O
antibodies	O
,	O
fT4	O
and	O
TSH	O
.	O

In	O
the	O
United	O
States	O
,	O
median	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
in	O
a	O
northern	O
setting	O
in	O
the	O
first	O
days	O
of	O
life	O
were	O
17	O
ng	O
/	O
mL	O
with	O
58	O
%	O
of	O
infants	O
<	O
20	O
ng	O
/	O
mL	O
,	O
results	O
very	O
similar	O
to	O
those	O
seen	O
in	O
our	O
study	O
[	O
13	O
].	O

Regular	O
supply	O
of	O
IFA	O
supplements	O
and	O
counselling	O
Upon	O
receiving	O
the	O
consent	O
icddr	O
,	O
b	O
study	O
staff	O
(	O
Field	O
Implementers	O
or	O
FI	O
)	O
will	O
hand	O
over	O
the	O
first	O
two	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
capsules	O
,	O
each	O
containing	O
60	O
mg	O
of	O
elemental	O
iron	O
and	O
400μg	O
of	O
folic	O
acid	O
.	O

Women	O
who	O
had	O
attended	O
antenatal	O
visits	O
in	O
their	O
previous	O
pregnancy	O
thought	O
that	O
it	O
was	O
beneficial	O
to	O
start	O
ANC	O
early	O
in	O
pregnancy	O
unlike	O
those	O
who	O
did	O
not	O
have	O
this	O
experience	O
and	O
who	O
opted	O
for	O
third	O
trimester	O
enrollment	O
.	O

A	O
follow	O
-	O
up	O
study	O
among	O
overweight	O
men	O
also	O
found	O
higher	O
weight	O
loss	O
using	O
Internet	O
and	O
mobile	O
phone	O
[	O
15	O
].	O

However	O
,	O
these	O
studies	O
have	O
been	O
limited	O
by	O
the	O
relatively	O
low	O
rates	O
of	O
assessment	O
[	O
18	O
–	O
20	O
].	O

Although	O
potentially	O
complex	O
,	O
the	O
use	O
of	O
a	O
systems	O
biology	O
approach	O
,	O
incorporating	O
genome	O
-	O
wide	O
analysis	O
at	O
multiple	O
levels	O
(	O
histone	O
code	O
,	O
methylome	O
,	O
non	O
-	O
coding	O
RNA	O
expression	O
,	O
transcriptome	O
,	O
proteome	O
and	O
metabolome	O
)	O
would	O
provide	O
comprehensive	B
analysis	O
of	O
epigenetic	O
changes	O
and	O
associated	O
phenotypic	O
outcomes	O
.	O

In	O
another	O
study	O
,	O
20	O
,	O
000	O
and	O
40	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
week	O
were	O
given	O
to	O
the	O
obese	O
and	O
overweight	O
people	O
for	O
one	O
year	O
.	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
a	O
shift	O
in	O
development	O
of	O
mesenchymal	O
stem	O
cells	O
from	O
myogenesis	O
to	O
adipogenesis	O
may	O
increase	O
IMF	O
deposition	O
later	O
in	O
life	O
.	O

Intensively	O
promoting	O
handwashing	O
with	O
soap	O
resulted	O
in	O
increased	O
availability	O
of	O
soap	O
and	O
water	O
at	O
handwashing	O
places	O
,	O
but	O
only	O
a	O
modest	O
increase	O
in	O
maternal	O
handwashing	O
with	O
soap	O
.	O

(	O
2014	O
)*/†	O
Nutrition	O
:	O
High	O
fat	O
dietMouse	O
RatOral	O
(	O
diet	O
)	O
(	O
60	O
%	O
fat	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
to	O
lactation	O
Early	O
adulthoodAdulthood	O
F0	O
-	O
F1generationsWeight	O
-,	O
glucose	O
-	O
and	O
lipid	O
-	O
related	O
metabolic	O
and	O
food	O
preference	O
abnormalitiesDNA	O
methylation	O
miRNAsBaselga	O
-	O
Escudero	O
et	O
al	O
.	O

Season	O
and	O
vitamin	O
D	O
status	O
are	O
independently	O
associated	O
with	O
glucose	O
homeostasis	O
in	O
pregnancy	O
Abstract	O
Background	O
Vitamin	O
D	O
status	O
and	O
season	O
are	O
intrinsically	O
linked	O
,	O
and	O
both	O
have	O
been	O
proposed	O
to	O
be	O
associated	O
with	O
glucose	O
homeostasis	O
in	O
pregnancy	O
,	O
with	O
conflicting	O
results	O
.	O

Glyburide	O
(	O
Glibenclamide	O
)	O
American	O
authors	O
have	O
stated	O
that	O
glyburide	O
has	O
replaced	O
insulin	O
as	O
first	B
line	I
pharmacological	O
treatment	O
of	O
GDM	O
in	O
many	O
practices	O
.	O
56This	O
has	O
largely	O
occurred	O
on	O
the	O
basis	O
of	O
a	O
randomized	O
controlled	O
trial	O
where	O
404	O
women	O
with	O
GDM	O
were	O
treated	O
with	O
glyburide	O
(	O
up	O
to	O
20	O
mg	O
/	O
day	O
)	O
or	O
insulin57In	O
this	O
study	O
,	O
the	O
level	O
of	O
glycemic	O
control	O
achieved	O
was	O
the	O
same	O
in	O
both	O
groups	O
(	O
mean	O
glucose	O
concentration	O
during	O
treatment	O
with	O
glyburide	O
5	O
.	O
9	O
±	O
0	O
.	O
9	O
mmol	O
/	O
L	O
compared	O
to	O
5	O
.	O
9	O
±	O
1	O
.	O
0	O
mmol	O
/	O
L	O
in	O
insulin	O
group	O
).	O

Methods	O
:	O
Placental	O
tissues	O
and	O
associated	O
demographic	O
and	O
clinical	O
data	O
were	O
obtained	O
from	O
subjects	O
delivering	O
at	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
).	O

The	O
intervention	O
resulted	O
in	O
greater	O
maintenance	O
of	O
handwashing	O
materials	O
in	O
locations	O
where	O
mothers	O
are	O
cocooned	O
with	O
neonate	O
.	O

Providers	O
may	O
need	O
to	O
re	O
-	O
emphasize	O
their	O
recommendations	O
with	O
overweight	O
and	O
obese	O
patients	O
to	O
help	O
align	O
their	O
personal	O
weight	O
gain	O
targets	O
with	O
current	O
clinical	O
recommendations	O
.	O

Indeed	O
,	O
resistance	O
to	O
the	O
development	O
of	O
obesity	O
has	O
at	B
least	I
partly	O
been	O
attributed	O
to	O
elevated	O
recruitment	O
of	O
brown	O
adipocytes	O
in	O
skeletal	O
muscle	O
or	O
WAT	O
(	O
Guerra	O
et	O
al	O
.,	O
1998	O
;	O
Almind	O
et	O
al	O
.,	O
2007	O
;	O
Veyrat	O
-	O
Durebex	O
et	O
al	O
.,	O
2009	O
;	O
Harms	O
and	O
Seale	O
,	O
2013	O
).	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
and	O
Kruskal	O
-	O
Wallis	O
were	O
employed	O
.	O

F1	O
females	O
were	O
separated	O
at	O
21	O
days	O
from	O
the	O
SC	O
and	O
VitD	O
-	O
groups	O
to	O
produce	O
the	O
F2	O
generation	O
(	O
n	O
=	O
10	O
females	O
per	O
group	O
).	O

To	O
stay	O
consistent	O
with	O
typical	O
handwashing	O
promotion	O
messages	O
,	O
we	O
also	O
recommended	O
handwashing	O
with	O
soap	O
before	O
food	O
preparation	O
.	O

Vitamins	O
Several	O
vitamins	O
,	O
including	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
,	O
are	O
implicated	O
in	O
regulating	O
IMF	O
deposition	O
.	O

This	O
might	O
be	O
a	O
reason	B
why	O
we	O
failed	O
to	O
report	O
a	O
significant	O
positive	O
association	O
between	O
high	O
adherence	O
to	O
healthy	O
dietary	O
pattern	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

While	O
the	O
risk	O
factors	O
outlined	O
in	O
this	O
review	O
do	O
not	O
conflict	O
with	O
our	O
current	O
understanding	O
of	O
the	O
natural	O
history	O
of	O
cancer	O
or	O
glioma	O
specifically	O
,	O
the	O
evidence	O
in	O
support	O
of	O
a	O
causal	O
relationship	O
has	O
not	O
been	O
consistent	O
.	O

Women	O
who	O
suffered	O
a	O
stillbirth	O
or	O
neonatal	O
death	O
,	O
or	O
who	O
withdrew	O
from	O
participation	O
in	O
ongoing	O
follow	O
-	O
up	O
were	O
excluded	O
.	O

Additionally	O
,	O
to	O
better	O
understand	O
the	O
impact	O
of	O
the	O
BHLM	O
shrinkage	O
on	O
the	O
regression	O
coefficients	O
,	O
we	O
re	O
-	O
analyzed	O
the	O
data	O
using	O
both	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

Birth	O
by	O
Cesarean	O
Delivery	O
The	O
delivery	O
of	O
a	O
baby	O
by	O
cesarean	O
delivery	O
has	O
been	O
suggested	O
to	O
be	O
associated	O
with	O
increased	O
risk	O
of	O
allergies	O
and	O
atopic	O
diseases	O
in	O
the	O
child	O
,	O
most	O
probably	B
because	O
of	O
a	O
lower	O
bacterial	O
exposure	O
for	O
the	O
child	O
.	O

Maternal	O
pregnancy	O
-	O
specific	O
stress	O
may	O
be	O
a	O
more	O
powerful	O
contributor	O
to	O
birth	O
outcomes	O
than	O
general	O
stress	O
[	O
1	O
].	O

Interestingly	O
,	O
maternal	O
prenatal	O
stress	O
could	O
have	O
negative	O
effects	O
on	O
fetal	O
ANS	O
[	O
46	O
].	O

In	O
addition	O
,	O
participating	O
women	O
were	O
surveyed	O
to	O
assess	O
their	O
estimate	O
of	O
costs	O
involved	O
in	O
accessing	O
the	O
supplements	O
.	O

In	O
order	O
to	O
further	O
investigate	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
we	O
performed	O
a	O
compulsive	O
feeding	O
test	O
in	O
the	O
adult	O
offspring	O
.	O

These	O
include	O
not	O
only	O
the	O
in	O
vitro	O
endocrine	O
TGs	O
and	O
in	O
vivo	O
reproductive	O
and	O
developmental	O
TGs	O
(	O
Greally	O
&	O
Jacobs2013	O
)	O
but	O
also	O
a	O
newly	O
revised	O
genotoxicity	O
TG	O
(	O
TG	O
483	O
)	O
where	O
spermatogonal	O
samples	O
could	O
be	O
further	O
utilized	O
for	O
RNA	O
analyzes	O
(	O
Linschooten	O
et	O
al	O
.	O
2009	O
;	O
Marczylo	O
et	O
al	O
.	O
2012	O
;	O
Metzler	O
-	O
Guillemain	O
et	O
al	O
.	O
2015	O
).	O

All	O
women	O
received	O
prenatal	O
care	O
in	O
their	O
dominant	O
language	O
(	O
Spanish	O
/	O
English	O
)	O
(	O
Table	O
2	O
).	O

Exposure	O
to	O
winter	O
in	O
early	O
pregnancy	O
was	O
not	O
associated	O
with	O
glucose	O
challenge	O
test	O
results	O
,	O
however	O
it	O
was	O
associated	O
with	O
increased	O
fasting	O
glucose	O
and	O
insulin	O
resistance	O
at	O
28	O
weeks	O
.	O

Correlations	O
between	O
expression	O
values	O
of	O
microarray	O
and	O
qRT	O
-	O
PCR	O
of	O
positive	O
validated	O
transcripts	O
ranged	O
between	O
0	O
.	O
47	O
and	O
0	O
.	O
86	O
and	O
were	O
highly	O
significant	O
.	O

According	O
to	O
these	O
results	O
,	O
visfatin	O
can	O
have	O
a	O
major	O
role	O
in	O
regulating	O
neonatal	O
obesity	O
after	O
birth	O
.	O

All	O
participants	O
gave	O
informed	O
consent	O
to	O
participate	O
in	O
the	O
study	O
and	O
ethical	O
approval	O
was	O
granted	O
by	O
the	O
local	O
ethics	O
committee	O
of	O
the	O
hospital	O
.	O

Furthermore	O
,	O
genetic	O
variations	O
in	O
vitamin	O
-	O
D	O
-	O
related	O
and	O
other	O
genes	O
might	O
influence	O
the	O
effects	O
of	O
vitamin	O
D	O
on	O
the	O
immune	O
system	O
.	O

(	O
2012	O
)¶/†	O
Leu	O
et	O
al	O
.	O

If	O
the	O
vitamin	O
D	O
theory	O
is	O
true	B
,	O
autism	O
should	O
be	O
more	B
common	I
in	O
richer	O
well	O
-	O
educated	O
mothers	O
,	O
who	O
are	O
more	O
likely	B
than	O
other	O
mothers	O
to	O
practice	O
sun	O
avoidance	O
and	O
use	O
sunblock	O
(	O
1	O
,	O
2	O
).	O

Unexpectedly	O
,	O
the	O
intake	O
of	O
fatty	O
fish	O
(	O
salmon	O
,	O
herring	O
and	O
mackerel	O
)	O
or	O
shellfish	O
more	O
than	O
twice	O
a	O
week	O
increased	O
the	O
risk	O
of	O
being	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Neither	O
of	O
these	O
results	O
changed	O
after	O
adjustment	O
for	O
tobacco	O
use	O
and	O
vitamin	O
D	O
supplementation	O
at	O
T3	O
or	O
after	O
excluding	O
cases	O
of	O
preeclampsia	O
.	O

Peptide	O
mass	O
maps	O
of	O
tryptic	O
peptides	O
were	O
generated	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
using	O
an	O
Applied	O
Biosystems	O
Q	O
-	O
STAR	O
Pulsar	O
with	O
MALDI	O
source	O
(	O
APAF	O
,	O
University	O
of	O
Sydney	O
).	O

A	O
growing	O
body	O
of	O
evidence	O
links	O
hypertension	O
,	O
32heart	O
disease	O
,	O
33and	O
autoimmune	O
diseases34to	O
markers	O
of	O
inflammation	O
such	O
as	O
C	O
-	O
reactive	O
protein	O
and	O
assorted	O
chemokines	O
.	O
35Erdei	O
hypothesizes	O
that	O
uranium	O
exposure	O
might	O
contribute	O
to	O
these	O
diseases	O
through	O
effects	O
on	O
inflammation	O
.	O

Wells	O
,	O
in	O
a	O
recent	O
commentary	O
,	O
indicates	O
the	O
need	O
for	O
such	O
cross	O
-	O
generational	O
grandparental	O
data	O
to	O
understand	O
more	O
fully	O
the	O
influence	O
of	O
maternal	O
and	O
paternal	O
lineages	O
on	O
growth	O
and	O
development	O
.	O
19	O
In	O
a	O
previous	O
study	O
employing	O
primarily	O
self	O
-	O
reported	O
data	O
,	O
we	O
showed	O
that	O
BMI	O
appeared	O
to	O
be	O
strongly	O
familial	O
in	O
the	O
maternal	O
line	O
,	O
23and	O
we	O
have	O
shown	O
that	O
familial	O
dietary	O
patterns	O
are	O
also	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O
2425The	O
present	O
analysis	O
of	O
BMI	O
has	O
extended	O
this	O
to	O
include	O
both	O
birth	O
weight	O
and	O
data	O
when	O
the	O
children	O
were	O
aged	O
9	O
years	O
and	O
shows	O
this	O
strong	O
maternal	O
pattern	O
consistently	B
for	O
children	O
while	O
height	O
,	O
by	O
comparison	O
,	O
is	O
heritable	O
across	O
lineages	O
.	O

the	O
same	O
association	O
(	O
s	O
)	O
reported	O
in	O
multiple	O
independent	O
cohorts	O
or	O
multiple	O
association	O
(	O
s	O
)	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
are	O
,	O
therefore	B
,	O
included	O
in	O
Supplementary	O
Table	O
2	O
.	O

Pairwise	O
comparisons	O
showed	O
that	O
the	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
,	O
4	O
and	O
8	O
weeks	O
postpartum	O
were	O
significantly	O
lower	O
than	O
the	O
baseline	O
depression	O
scores	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
brief	O
,	O
text	O
-	O
based	O
intervention	O
format	O
of	O
text4baby	O
is	O
consistent	O
with	O
other	O
brief	O
prenatal	O
alcohol	O
interventions	O
found	O
to	O
be	O
effective	O
in	O
recent	O
studies	O
[	O
42	O
].	O

For	O
simplicity	O
of	O
language	O
we	O
abbreviated	O
'	O
relative	O
risk	O
ratio	O
'	O
to	O
'	O
relative	O
risk	O
'	O
(	O
RR	O
).	O

Anaemia	O
prevalence	O
was	O
almost	O
halved	O
in	O
supplemented	O
women	O
and	O
anaemic	O
women	O
showed	O
the	O
greatest	O
increase	O
in	O
haemoglobin	O
concentration	O
following	O
supplementation	O
(+	O
1	O
.	O
2g	O
/	O
dL	O
).	O

Calbindin	O
is	O
strongly	O
induced	O
by	O
vitamin	O
D	O
[	O
29	O
],	O
and	O
thus	B
it	O
is	O
feasible	B
that	O
the	O
reduction	O
in	O
this	O
protein	O
may	O
be	O
a	O
consequence	O
of	O
the	O
early	O
life	O
reduction	O
in	O
vitamin	O
D	O
.	O
The	O
potential	O
links	O
between	O
vitamin	O
D	O
and	O
neuronal	O
calcium	O
binding	O
proteins	O
has	O
been	O
noted	O
in	O
a	O
recent	O
review	O
article	O
[	O
30	O
]	O
Two	O
members	O
of	O
the	O
dynamin	O
family	O
(	O
dynamin	O
1	O
and	O
dynamin	O
1	O
-	O
like	O
proteins	O
)	O
were	O
also	O
significantly	O
down	O
-	O
regulated	O
.	O

Results	O
In	O
total	O
,	O
2052	O
women	O
were	O
included	O
in	O
this	O
study	O
,	O
2046	O
with	O
a	O
blood	O
sample	O
at	O
T1	O
and	O
1816	O
at	O
T3	O
(	O
Fig	O
.	O
1	O
).	O

At	O
6	O
months	O
of	O
age	O
The	O
mean	O
KM	O
(	O
mean	O
±	O
SEM	O
,	O
n	O
=	O
6	O
animals	O
each	O
group	O
)	O
varied	O
from	O
390	O
.	O
2	O
±	O
27	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
421	O
.	O
3	O
±	O
21	O
.	O
0	O
mg	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
403	O
.	O
9	O
±	O
29	O
.	O
0	O
mg	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
414	O
.	O
8	O
±	O
29	O
.	O
0	O
mg	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

This	O
indicates	O
the	O
efficacy	O
of	O
this	O
procedure	O
in	O
dramatic	O
improvement	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
mothers	O
,	O
especially	O
in	O
the	O
region	O
with	O
high	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
a	O
weak	O
correlation	O
was	O
found	O
between	O
poor	O
intrauterine	O
environments	O
and	O
ASD	O
with	O
intellectual	O
disabilities	O
,	O
there	O
was	O
no	O
relationship	O
found	O
between	O
ASD	O
without	O
intellectual	O
disabilities	O
and	O
perinatal	O
factors	O
[	O
12	O
].	O

One	O
study	O
observed	O
that	O
maternal	O
high	O
-	O
fat	O
diet	O
during	O
pregnancy	O
was	O
associated	O
with	O
meconium	O
microbial	O
composition	O
but	O
had	O
limited	O
maternal	O
diet	O
data	O
[	O
6	O
].	O

Results	O
From	O
2005	O
to	O
2009	O
,	O
370	O
women	O
called	O
Motherisk	O
regarding	O
SGA	O
counselling	O
.	O

Raised	O
ESR	O
values	O
(>	O
20mm	O
/	O
hr	O
)	O
were	O
less	O
frequent	O
in	O
supplemented	O
women	O
OR	O
0	O
.	O
71	O
(	O
0	O
.	O
55	O
,	O
0	O
.	O
91	O
).	O

Barker	O
and	O
Osmond	O
[	O
2	O
]	O
proposed	O
that	O
the	O
cardiovascular	O
disease	O
they	O
observed	O
in	O
an	O
adult	O
population	O
from	O
England	O
and	O
Wales	O
was	O
at	B
least	I
partly	O
associated	O
with	O
poor	O
early	O
nutrition	O
,	O
and	O
specifically	O
undernutrition	O
in	O
utero	O
[	O
3	O
].	O

With	O
regards	O
to	O
pharmacokinetics	O
,	O
oral	O
dosing	O
produces	O
therapeutic	O
effects	O
within	O
3	O
-	O
5	O
days	O
.	O

However	O
,	O
genes	O
related	O
to	O
cell	O
cycle	O
and	O
cellular	O
turnover	O
were	O
differentially	O
expressed	O
at	O
all	O
stages	O
except	O
stage	O
1	O
dpn	O
.	O

With	O
respect	O
to	O
health	O
education	O
,	O
the	O
most	O
mentioned	O
topic	O
was	O
“	O
hygiene	O
and	O
nutrition	O
”	O
followed	O
by	O
“	O
malaria	O
prevention	O
”	O
(	O
Figure	O
3	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
of	O
mother	O
’	O
s	O
personal	O
gestational	O
weight	O
gain	O
targets	O
and	O
their	O
pre	O
-	O
pregnancy	O
weight	O
categoryPre	O
-	O
pregnancy	O
BMINormalOverweightObeseTotalAccuracy	O
of	O
mother	O
’	O
s	O
weight	O
gain	O
targetUnder	O
IOM	O
rec18	O
(	O
40	O
.	O
9	O
%)	O
6	O
(	O
16	O
.	O
7	O
%)	O
7	O
(	O
23	O
.	O
26	O
%)	O
31	O
(	O
28	O
.	O
2	O
%)	O
Within	O
IOM	O
rec23	O
(	O
52	O
.	O
3	O
%)	O
23	O
(	O
63	O
.	O
9	O
%)	O
15	O
(	O
50	O
%)	O
61	O
(	O
55	O
.	O
5	O
%)	O
Above	O
IOM	O
rec3	O
(	O
6	O
.	O
8	O
%)	O
7	O
(	O
19	O
.	O
4	O
%)	O
8	O
(	O
26	O
.	O
7	O
%)	O
18	O
(	O
16	O
.	O
4	O
%)	O
44	O
(	O
100	O
%)	O
36	O
(	O
100	O
%)	O
30	O
(	O
100	O
%)	O
110	O
(	O
100	O
%)	O
Only	O
110	O
of	O
the	O
123	O
women	O
in	O
the	O
sample	O
responded	O
to	O
the	O
survey	O
question	O
about	O
personal	O
weight	O
gain	O
target	O
χ2	O
(	O
4	O
)	O
=	O
9	O
.	O
781	O
,	O
p	O
=	O
0	O
.	O
044	O
The	O
concordance	O
of	O
mothers	O
’	O
weight	O
gain	O
targets	O
with	O
IOM	O
recommendations	O
also	O
varied	O
by	O
receipt	O
of	O
professional	O
advice	O
.	O

Another	O
signaling	O
pathway	O
identified	O
to	O
be	O
regulated	O
in	O
a	O
diet	O
-	O
dependent	O
manner	O
is	O
the	O
'	O
VEGF	O
(	O
vascular	O
endothelial	O
growth	O
factor	O
)	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
known	O
from	O
gene	O
deletion	O
studies	O
to	O
be	O
essential	O
in	O
developmental	O
processes	O
[	O
36	O
,	O
37	O
].	O

PubMed	O
Central	O
:	O

A	O
novel	O
observation	O
of	O
our	O
study	O
is	O
that	O
the	O
hypothalamic	O
feeding	O
pathways	O
respond	O
to	O
the	O
vitamin	O
content	O
of	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Finally	O
,	O
proteomic	O
analyses	O
are	O
prone	B
to	O
Type	O
I	O
errors	O
.	O

Any	O
relationship	O
with	O
glioma	O
risk	O
is	O
probably	B
complex	O
and	O
must	O
be	O
interpreted	O
in	O
light	O
of	O
differences	O
in	O
farming	O
practices	O
and	O
the	O
protective	O
ability	O
of	O
farming	O
environments	O
,	O
especially	O
with	O
respect	O
to	O
microbial	O
exposures	O
[	O
102	O
,	O
103	O
,	O
114	O
].	O

Therefore	B
,	O
during	O
pregnancy	O
,	O
thyroxin	O
and	O
ferrous	O
sulphate	O
doses	O
should	O
be	O
spaced	O
by	O
at	B
least	I
4	O
hours	O
.	O

The	O
serum	O
calcium	O
and	O
phosphorus	O
were	O
respectively	O
measured	O
by	O
calorimetric	O
method	O
by	O
AutoAnalyzer	O
(	O
Echoplus	O
Corporation	O
,	O
Italy	O
),	O
Biosystems	O
kit	O
(	O
Spain	O
),	O
and	O
ELISA	O
method	O
.	O

Multiple	O
linear	O
regression	O
models	O
were	O
created	O
using	O
a	O
forced	O
-	O
enter	O
approach	O
and	O
were	O
adjusted	O
for	O
confounders	O
.	O

Importantly	O
,	O
our	O
study	O
illustrates	O
the	O
additive	O
effect	O
of	O
maternal	O
risk	O
factors	O
and	O
their	O
predictive	O
probabilities	O
for	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O

The	O
objective	O
of	O
this	O
analysis	O
was	O
to	O
determine	O
if	O
the	O
inverse	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
rate	O
of	O
PTB	O
found	O
in	O
the	O
earlier	O
randomized	O
controlled	O
trials	O
by	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Treatment	O
of	O
reflux	O
during	O
pregnancy	O
should	O
focus	O
on	O
nonpharmacological	O
measures	O
,	O
such	O
as	O
avoiding	O
large	O
meals	O
shortly	O
before	O
bedtime	O
,	O
sleeping	O
with	O
the	O
upper	O
body	O
elevated	O
,	O
and	O
avoiding	O
extensive	O
consumption	O
of	O
coffee	O
,	O
sweets	O
,	O
and	O
fatty	O
foods	O
.	O

Storage	O
temperature	O
is	O
monitored	O
and	O
logged	O
for	O
the	O
entire	O
duration	O
of	O
the	O
study	O
.	O

Newborn	O
weight	O
is	O
measured	O
with	O
a	O
calibrated	O
digital	O
infant	O
scale	O
to	O
the	O
nearest	O
10	O
g	O
.	O
In	O
order	O
to	O
minimize	O
intra	O
-	O
observer	O
variability	O
all	O
circumferences	O
and	O
CHL	O
are	O
measured	O
with	O
an	O
inelastic	O
tape	O
to	O
the	O
nearest	O
0	O
.	O
5	O
cm	O
(	O
metal	O
measuring	O
tape	O
not	O
used	O
to	O
prevent	O
possible	O
lacerations	O
).	O

Feed	O
comprising	O
about	O
80	O
%	O
concentrate	O
(	O
1	O
.	O
6	O
%	O
to	O
1	O
.	O
9	O
%	O
of	O
body	O
weight	O
;	O
CP	O
12	O
%	O
to	O
13	O
%,	O
TDN	O
72	O
%	O
to	O
73	O
%)	O
is	O
provided	O
during	O
the	O
early	O
fattening	O
stage	O
(	O
13	O
to	O
21	O
months	O
of	O
age	O
).	O

Vitamin	O
D	O
deficiency	O
in	O
Thailand	O
☆	O
Vitamin	O
D	O
deficiency	O
has	O
received	O
increased	O
attention	O
over	O
the	O
past	O
several	O
years	O
since	O
vitamin	O
D	O
may	O
play	O
an	O
important	O
role	O
not	O
only	O
in	O
bone	O
metabolism	O
but	O
also	O
in	O
a	O
variety	O
of	O
non	O
-	O
skeletal	O
diseases	O
such	O
as	O
diabetes	O
mellitus	O
,	O
autoimmune	O
diseases	O
,	O
infectious	O
diseases	O
,	O
cardiovascular	O
diseases	O
and	O
cancer1	O
,	O
2	O
,	O
3	O
.	O

A	O
draft	O
list	O
of	O
40	O
questions	O
was	O
revised	O
by	O
a	O
group	O
of	O
experts	O
.	O

In	O
vivo	O
studies	O
showed	O
increased	O
marbling	O
in	O
response	O
to	O
dietary	O
vitamin	O
C	O
supplementation	O
in	O
beef	O
cattle	O
;	O
dietary	O
supplementation	O
of	O
rumen	O
-	O
protected	O
l	O
-	O
ascorbic	O
acid	O
-	O
2	O
-	O
phosphate	O
during	O
the	O
final	O
fattening	O
period	O
increased	O
both	O
MS	O
and	O
fat	O
content	O
in	O
carcasses	O
of	O
Japanese	O
Black	O
cattle	O
[	O
150	O
].	O

Conclusions	O
Women	O
who	O
attend	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	B
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

Antidepressants	O
were	O
most	O
frequently	O
used	O
in	O
conjunction	O
with	O
an	O
SGA	O
(	O
54	O
.	O
1	O
%),	O
followed	O
by	O
benzodiazepines	O
(	O
15	O
.	O
8	O
%)	O
and	O
anticonvulsants	O
(	O
14	O
.	O
3	O
%),	O
primarily	O
lamotrigine	O
(	O
table	O
1	O
).	O

Finally	O
,	O
I	O
explain	B
my	O
reasons	B
why	O
this	O
theory	O
deserves	O
immediate	O
attempts	O
to	O
disprove	O
it	O
.	O

Additionally	O
,	O
some	O
previously	O
published	O
studies	O
[	O
14	O
,	O
15	O
]	O
found	O
associations	O
between	O
gestational	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Southampton	O
and	O
South	O
West	O
Hampshire	O
Research	O
Ethics	O
Committee	O
.	O

In	O
conclusion	O
,	O
it	O
appears	O
that	O
psychotropic	O
polytherapy	O
in	O
pregnant	O
women	O
with	O
mental	O
health	O
disorders	O
is	O
presently	O
a	O
common	O
practice	O
.	O

This	O
index	O
is	O
not	O
recorded	O
in	O
Romania	O
;	O
instead	O
,	O
we	O
evaluated	O
engagement	O
in	O
prenatal	O
care	O
according	O
to	O
Ministry	O
of	O
Health	O
recommendations	O
,	O
which	O
refer	O
to	O
the	O
total	O
number	O
of	O
prenatal	O
consultations	O
and	O
time	O
of	O
initiation	O
of	O
care	O
.	O

2010	O
;	O
Lin	O
et	O
al	O
.	O

Unfortunately	O
,	O
analysis	O
of	O
VDP	O
was	O
not	O
available	O
in	O
this	O
cohort	O
of	O
women	O
.	O

Post	O
-	O
hoc	O
analysis	O
of	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

In	O
a	O
separate	O
study	O
on	O
group	O
B	O
,	O
visfatin	O
levels	O
in	O
the	O
first	O
and	O
second	O
trimesters	O
showed	O
a	O
significant	O
negative	O
correlation	O
with	O
infant	O
’	O
s	O
weight	O
.	O

The	O
key	O
factor	O
which	O
results	O
in	O
the	O
development	O
of	O
gestational	O
diabetes	O
appears	O
to	O
be	O
a	O
failure	O
to	O
compensate	O
with	O
increased	O
insulin	O
secretion	O
.	O
3As	O
the	O
increase	O
in	O
insulin	O
resistance	O
is	O
greatest	O
in	O
the	O
third	O
trimester	O
,	O
GDM	O
usually	O
develops	O
going	O
into	O
this	O
period	O
.	O

A	O
nested	O
case	O
control	O
study	O
done	O
by	O
Lyall	O
et	O
al	O
.	O

This	O
is	O
the	O
first	O
time	O
that	O
a	O
gene	O
-	O
environment	O
interaction	O
between	O
a	O
GR	O
polymorphism	O
and	O
maternal	O
attitudes	O
towards	O
pregnancy	O
was	O
found	O
,	O
in	O
relation	O
to	O
fetal	O
weight	O
.	O

The	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
was	O
able	O
to	O
decrease	O
the	O
motivation	O
to	O
obtain	O
highly	O
palatable	O
food	O
in	O
a	O
free	O
choice	O
test	O
(	O
Mathes	O
et	O
al	O
.,	O
2008	O
;	O
Droste	O
et	O
al	O
.,	O
2010	O
;	O
Deshmukh	O
and	O
Sharma	O
,	O
2012	O
).	O

Cross	O
-	O
linking	O
is	O
more	O
likely	B
if	O
the	O
allergen	O
occurs	O
in	O
dimerized	O
or	O
multimerized	O
form	O
[	O
3	O
].	O

The	O
predominant	O
substrate	O
for	O
FA	O
synthesis	O
in	O
ruminants	O
is	O
acetate	O
,	O
which	O
is	O
mainly	O
derived	O
from	O
ruminal	O
fermentation	O
.	O

Where	O
dietary	O
measures	O
are	O
inadequate	O
to	O
achieve	O
glycemic	O
targets	O
,	O
insulin	O
should	O
be	O
introduced	O
.	O

We	O
dropped	O
three	O
samples	O
of	O
low	O
quality	O
,	O
with	O
read	O
counts	O
<	O
5000	O
,	O
yielding	O
a	O
final	O
sample	O
size	O
of	O
145	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S2	O
),	O
with	O
97	O
vaginally	O
delivered	O
infants	O
and	O
48	O
delivered	O
by	O
Cesarean	O
section	O
.	O

The	O
statistical	O
analysis	O
is	O
novel	O
,	O
using	O
mixed	O
-	O
model	O
techniques	O
that	O
enable	O
all	O
the	O
data	O
to	O
be	O
utilised	O
including	O
incomplete	O
families	O
.	O

Approximately	O
two	O
to	O
three	O
times	O
as	O
many	O
women	O
in	O
the	O
exposed	O
group	O
suffered	O
from	O
hypertension	O
,	O
gestational	O
diabetes	O
and	O
hypothyroidism	O
.	O

However	O
,	O
environmental	O
exposures	O
during	O
critical	O
windows	O
of	O
human	O
development	O
and	O
subsequent	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
changes	O
that	O
may	O
lead	O
to	O
later	O
life	O
adverse	O
health	O
outcomes	O
(	O
such	O
as	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
)	O
across	O
multiple	O
generations	O
continues	O
to	O
be	O
of	O
high	O
concern	O
for	O
all	O
the	O
Organization	O
for	O
Economic	O
Co	O
-	O
operation	O
and	O
Development	O
(	O
OECD	O
)	O
member	O
countries	O
,	O
the	O
International	O
Agency	O
on	O
Research	O
for	O
Cancer	O
(	O
IARC	O
)	O
and	O
the	O
European	O
Commission	O
(	O
EFSA2013	O
;	O
Greally	O
&	O
Jacobs2013	O
;	O
Herceg	O
et	O
al	O
.	O
2013	O
;	O
OECD2014	O
).	O

However	O
,	O
in	O
developed	O
countries	O
,	O
seasonal	O
availablity	O
of	O
food	O
has	O
a	O
limited	O
impact	O
on	O
diet	O
,	O
although	O
seasonal	O
differences	O
in	O
dietary	O
intakes	O
among	O
pregnant	O
women	O
have	O
been	O
observed	O
[	O
29	O
].	O

However	O
,	O
in	O
primary	O
human	O
adipose	O
stem	O
cells	O
,	O
both	O
BMP4	O
and	O
BMP7	O
induced	O
a	O
white	O
-	O
to	O
-	O
brown	O
adipocyte	O
transdifferentiation	O
(	O
Elsen	O
et	O
al	O
.,	O
2014b	O
),	O
pointing	O
to	O
the	O
occurrence	O
of	O
different	O
effects	O
,	O
depending	O
on	O
the	O
model	O
used	O
for	O
investigation	O
.	O

In	O
LP	O
offspring	O
1	O
,	O
042	O
probe	O
-	O
sets	O
showed	O
ontogenetic	O
regulation	O
(	O
384	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
during	O
the	O
corresponding	O
time	O
period	O
that	O
was	O
group	O
-	O
specific	O
.	O

Similarly	O
,	O
vitamin	O
D3supplementation	O
did	O
not	O
affect	O
hospital	O
admissions	O
and	O
all	O
-	O
cause	O
mortality	O
.	O

Salmeterol	O
is	O
the	O
preferred	B
agent	O
when	O
long	O
-	O
acting	O
β2	O
agonists	O
are	O
indicated	O
in	O
pregnant	O
women	O
as	O
add	O
-	O
on	O
treatment	O
of	O
persistent	O
asthma	O
.	O

To	O
date	O
,	O
however	O
,	O
South	O
African	O
public	O
health	O
nutrition	O
interventions	O
for	O
pregnant	O
women	O
are	O
limited	O
to	O
folic	O
-	O
iron	O
and	O
calcium	O
supplementation	O
,	O
while	O
it	O
is	O
highly	O
likely	B
that	O
the	O
diet	O
of	O
pregnant	O
women	O
living	O
in	O
South	O
Africa	O
is	O
lacking	O
vital	O
micronutrients	O
and	O
essential	O
fatty	O
acids	O
beyond	O
those	O
supplied	O
,	O
or	O
is	O
even	O
containing	O
excessive	O
amounts	O
of	O
specific	O
micro	O
-	O
and	O
macro	O
-	O
nutrients	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
the	O
rate	O
of	O
major	O
malformations	O
reported	O
in	O
the	O
exposed	O
group	O
was	O
approximately	O
two	O
and	O
a	O
half	O
times	O
higher	O
than	O
in	O
the	O
comparison	O
group	O
(	O
6	O
.	O
2	O
%	O
vs	O
2	O
.	O
6	O
%).	O

They	O
did	O
not	O
differ	O
concerning	O
the	O
two	O
above	O
-	O
mentioned	O
variables	O
,	O
P	O
=	O
0	O
.	O
09	O
and	O
p	O
=	O
0	O
.	O
13	O
,	O
respectively	O
.	O

Using	O
a	O
life	O
-	O
history	O
interpretation	O
,	O
adaptive	O
developmental	O
responses	O
to	O
environmental	O
cues	O
may	O
be	O
graded	O
;	O
according	O
to	O
the	O
severity	O
of	O
the	O
stress	O
experienced	O
[	O
22	O
],[	O
54	O
]–[	O
56	O
].	O

Thus	B
,	O
migrating	O
women	O
or	O
those	O
unable	O
to	O
speak	O
local	O
languages	O
could	O
not	O
be	O
included	O
in	O
the	O
study	O
.	O

None	O
of	O
the	O
cell	O
lines	O
exhibited	O
dose	O
dependency	O
.	O

However	O
,	O
according	O
to	O
the	O
recent	O
studies	O
,	O
vitamin	O
D	O
deficiency	O
is	O
also	O
common	O
in	O
these	O
countries10	O
,	O
11	O
.	O

DISCUSSION	O
Our	O
findings	O
support	O
the	O
hypothesis	O
that	O
HV	O
or	O
HFol	O
pup	O
diet	O
prevents	O
the	O
increase	O
in	O
food	O
intake	O
,	O
body	O
weight	O
and	O
glucose	O
response	O
to	O
a	O
glucose	O
load	O
in	O
offspring	O
of	O
the	O
HV	O
dams	O
,	O
possibly	O
by	O
post	O
-	O
weaning	O
changes	O
in	O
food	O
intake	O
regulatory	O
systems	O
.	O

Little	O
is	O
known	O
about	O
the	O
actual	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
affects	O
children	O
’	O
s	O
health	O
;	O
we	O
hypothesize	O
that	O
maternal	O
diet	O
impacts	O
the	O
development	O
of	O
the	O
gut	O
microbiome	O
in	O
infancy	O
and	O
subsequently	O
influences	O
child	O
health	O
outcomes	O
.	O

Abstract	O
The	O
results	O
are	O
presented	O
of	O
a	O
case	O
-	O
control	O
study	O
conducted	O
in	O
the	O
north	O
of	O
Iran	O
.	O

Historic	O
influenza	O
surveillance	O
data	O
from	O
Nicaragua	O
shows	O
that	O
influenza	O
circulates	O
between	O
June	O
and	O
November	O
[	O
32	O
].	O

Further	O
adjustment	O
for	O
maternal	O
age	O
,	O
education	O
,	O
smoking	O
status	O
,	O
BMI	O
and	O
race	O
/	O
ethnicity	O
race	O
/	O
ethnicity	O
attenuated	O
these	O
estimates	O
but	O
women	O
reporting	O
no	O
PNV	O
use	O
still	O
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
5	O
,	O
3	O
.	O
0	O
).	O

Importantly	O
,	O
this	O
evidence	O
supports	O
the	O
idea	O
that	O
the	O
contribution	O
of	O
the	O
endocannabinoid	O
system	O
in	O
the	O
early	O
life	O
programming	O
could	O
be	O
critical	O
.	O

However	O
,	O
those	O
who	O
did	O
receive	O
advice	O
were	O
more	O
likely	B
to	O
have	O
personal	O
weight	O
gain	O
targets	O
in	O
line	O
with	O
current	O
clinical	O
recommendations	O
.	O

Additionally	O
,	O
the	O
burden	O
is	O
not	O
shared	O
equally	O
,	O
with	O
the	O
impact	O
of	O
preterm	O
birth	O
falling	O
most	O
severely	O
on	O
the	O
poorest	O
families	O
and	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
health	O
systems	O
are	O
less	O
prepared	O
to	O
respond	O
.	O

Some	O
studies	O
have	O
attributed	O
seasonal	O
differences	O
in	O
gestational	O
diabetes	O
to	O
temperature	O
changes	O
.	O

[	O
10	O
]	O
The	O
synthesis	O
,	O
metabolism	O
and	O
function	O
of	O
vitamin	O
D	O
compounds	O
during	O
pregnancy	O
are	O
complex	O
.	O

PSM	O
matched	O
one	O
vaccinated	O
case	O
to	O
one	O
unvaccinated	O
case	O
for	O
the	O
probability	O
of	O
vaccination	O
.	O

Increasing	O
propionate	O
production	O
for	O
glucose	O
synthesis	O
is	O
also	O
important	O
for	O
IMF	O
deposition	O
,	O
especially	O
during	O
the	O
fattening	O
period	O
.	O

Genes	O
involved	O
in	O
'	O
fatty	O
acid	O
metabolism	O
',	O
'	O
biosynthesis	O
of	O
steroids	O
',	O
'	O
synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
',	O
'	O
glucocorticoid	O
receptor	O
signaling	O
'	O
as	O
well	O
as	O
the	O
'	O
degradation	O
of	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
'	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
LP	O
offspring	O
,	O
while	O
genes	O
associated	O
with	O
'	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
'	O
were	O
down	O
-	O
regulated	O
.	O

We	O
carried	O
out	O
interviews	O
and	O
reviewed	O
medical	O
records	O
post	O
-	O
partum	O
to	O
collect	O
data	O
on	O
demographics	O
,	O
influenza	O
vaccination	O
during	O
pregnancy	O
,	O
birth	O
outcomes	O
and	O
other	O
risk	O
factors	O
associated	O
with	O
adverse	O
neonatal	O
outcomes	O
.	O

It	O
was	O
also	O
used	O
previously	O
to	O
assess	O
individual	O
and	O
total	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
fatty	O
acid	O
intake	O
in	O
a	O
rural	O
and	O
urban	O
South	O
-	O
African	O
population	O
[	O
42	O
].	O

1	O
).	O

high	O
doses	O
of	O
vitamin	O
D	O
in	O
early	O
life	O
)	O
with	O
or	O
without	O
monitoring	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
or	O
whether	O
the	O
400	O
IU	O
/	O
day	O
dose	O
is	O
adequate	O
.	O

The	O
children	O
we	O
enrolled	O
into	O
our	O
study	O
largely	O
came	O
from	O
five	O
of	O
the	O
18	O
socioeconomically	O
deprived	O
inner	O
-	O
city	O
districts	O
.	O

Obesity	O
,	O
VD	O
accumulation	O
in	O
adipose	O
tissue	O
,	O
and	O
sunbathing	O
avoidance	O
due	O
to	O
hirsutism	O
results	O
in	O
65	O
%–	O
87	O
%	O
rate	O
of	O
VD	O
deficiency	O
in	O
PCOS	O
patients	O
[	O
27	O
].	O

Methods	O
Dietary	O
intake	O
was	O
estimated	O
using	O
a	O
food	O
frequency	O
questionnaire	O
among	O
33	O
623	O
women	O
aged	O
30	O
-	O
49	O
years	O
at	O
enrolment	O
(	O
1991	O
/	O
92	O
).	O

With	O
the	O
approval	O
from	O
the	O
IRB	O
,	O
pregnant	O
women	O
aged	O
less	O
than	O
the	O
legal	O
age	O
of	O
consent	O
in	O
Cameroon	O
(	O
21	O
years	O
)	O
and	O
attending	O
antenatal	O
care	O
services	O
were	O
considered	O
emancipated	O
minors	O
and	O
thus	O
allowed	O
to	O
provide	O
consent	O
for	O
themselves	O
.	O

investigated	O
the	O
role	O
of	O
supplemental	O
folate	O
,	O
zinc	O
and	O
antioxidants	O
(	O
vitamins	O
C	O
,	O
E	O
,	O
and	O
β	O
-	O
carotene	O
)	O
on	O
spermatocyte	O
aneuploidy	O
.	O

As	O
yet	O
there	O
have	O
been	O
no	O
reports	O
of	O
the	O
use	O
of	O
glulisine	O
in	O
pregnancy	O
.	O

This	O
study	O
found	O
that	O
four	O
calcium	O
binding	O
proteins	O
were	O
significantly	O
altered	O
in	O
the	O
nucleus	O
accumbens	O
of	O
the	O
adult	O
DVD	O
-	O
deficient	O
rat	O
(	O
calbindin	O
,	O
calbindin2	O
,	O
hippocalcin	O
and	O
calreticulin	O
).	O

Results	O
We	O
identified	O
637	O
spots	O
in	O
DVD	O
deplete	O
samples	O
and	O
655	O
spots	O
in	O
Control	O
samples	O
(	O
seeFigure	O
1for	O
a	O
representative	O
gel	O
).	O

Nonetheless	O
,	O
there	O
are	O
undisputed	B
benefits	O
to	O
healthy	O
eating	O
and	O
regular	O
physical	O
activity	O
so	O
these	O
activities	O
should	O
be	O
encouraged	O
.	O

Furthermore	O
,	O
regarding	O
the	O
role	O
of	O
allergies	O
and	O
immunity	O
,	O
there	O
is	O
no	O
clear	O
trend	O
toward	O
a	O
decreasing	O
risk	O
for	O
glioma	O
with	O
younger	O
ages	O
at	O
onset	O
of	O
the	O
allergic	O
condition	O
[	O
121	O
].	O

Sample	O
collection	O
At	O
21	O
–	O
23	O
postnatal	O
weeks	O
,	O
adult	O
offspring	O
were	O
sacrificed	O
by	O
decapitation	O
after	O
the	O
administration	O
of	O
Equitesin	O
®	O
(	O
3	O
mg	O
/	O
kg	O
).	O

At	O
adult	O
age	O
(	O
stage	O
188	O
dpn	O
)	O
2	O
,	O
084	O
probe	O
-	O
sets	O
were	O
significantly	O
different	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
and	O
**	O
p	O
<	O
0	O
.	O
01	O
comparing	O
“	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
maternal	O
serum	O
.	O
Low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
4	O
±	O
1	O
.	O
238	O
.	O
8	O
±	O
1	O
.	O
3Male	O
(%)	O
5049Nature	O
delivery	O
(%)	O
6662Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
33	O
.	O
2	O
±	O
0	O
.	O
4Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
6	O
±	O
2	O
.	O
150	O
.	O
4	O
±	O
2	O
.	O
5BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
18	O
.	O
1	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
69	O
.	O
0	O
±	O
2	O
.	O
868	O
.	O
6	O
±	O
3	O
.	O
3	O
%	O
of	O
fall	O
/	O
winter	O
birth38	O
.	O
951	O
.	O
4	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
88	O
.	O
6Asthma	O
,	O
father2	O
.	O
80AR	O
mother22	O
.	O
231	O
.	O
4AR	O
,	O
father30	O
.	O
631	O
.	O
4AD	O
,	O
mother13	O
.	O
98	O
.	O
6AD	O
,	O
father02	O
.	O
8Daycare	O
attendance	O
(%)	O
11	O
.	O
114	O
.	O
3Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
8	O
.	O
32	O
.	O
8Postnatal	O
smoke	O
Exposure	O
(%)	O
41	O
.	O
637	O
.	O
1	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
766	O
.	O
7Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
25	O
.	O
022	O
.	O
8Eczema	O
at	O
6	O
months	O
(%)	O
1720Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
2523	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2259Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
33	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
39Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
03	O
±	O
1	O
.	O
13	O
-	O
0	O
.	O
39	O
±	O
1	O
.	O
08Z	O
score	O
of	O
VmaxFRC0	O
.	O
07	O
±	O
1	O
.	O
01	O
-	O
0	O
.	O
24	O
±	O
1	O
.	O
09	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

Researchers	O
compared	O
138	O
mothers	O
of	O
children	O
diagnosed	O
with	O
ALL	O
with	O
a	O
control	O
group	O
of	O
138	O
mothers	O
whose	O
children	O
did	O
not	O
have	O
cancer	O
.	O

Further	O
adjustment	O
for	O
race	O
did	O
not	O
substantially	O
change	O
these	O
estimates	O
(	O
Table	O
3	O
).	O

Our	O
findings	O
suggest	O
that	O
analysis	O
of	O
SNPs	O
may	O
have	O
an	O
important	O
role	O
in	O
identifying	O
high	O
-	O
risk	O
categories	O
of	O
individuals	O
who	O
are	O
likely	B
to	O
require	O
higher	O
doses	O
of	O
vitamin	O
D	O
to	O
achieve	O
repletion	O
,	O
and	O
studies	O
are	O
needed	O
to	O
establish	O
clinical	O
approaches	O
to	O
vitamin	O
D	O
supplementation	O
that	O
are	O
centered	O
on	O
individual	O
characteristics	O
.	O

Two	O
key	O
global	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
events	O
occur	O
,	O
one	O
after	O
fertilization	O
in	O
the	O
early	O
embryo	O
in	O
all	O
cells	O
,	O
and	O
the	O
second	O
in	O
germ	O
cells	O
only	O
during	O
primordial	O
germ	O
cell	O
(	O
PGC	O
)	O
development	O
(	O
Figure	O
1	O
).	O

The	O
results	O
of	O
original	O
articles	O
up	O
to	O
2015	O
have	O
been	O
summarized	O
and	O
discussed	O
in	O
a	O
critical	O
manner	O
to	O
provide	O
a	O
consistent	O
review	O
.	O

The	O
secondary	O
trial	O
outcomes	O
will	O
include	O
:	O
(	O
1	O
)	O
percentage	O
of	O
women	O
using	O
IFA	O
supplements	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
percentage	O
of	O
live	O
births	O
with	O
low	O
birth	O
weight	O
and	O
with	O
preterm	O
delivery	O
;	O
(	O
3	O
)	O
percentage	O
of	O
neonatal	O
deaths	O
attributable	O
to	O
preterm	O
delivery	O
,	O
and	O
to	O
birth	O
asphyxia	O
;	O
(	O
4	O
)	O
mean	O
marginal	O
additional	O
expenditure	O
associated	O
with	O
early	O
IFA	O
supplements	O
,	O
and	O
the	O
mean	O
cost	O
per	O
neonatal	O
death	O
prevented	O
;	O
(	O
5	O
)	O
the	O
percentage	O
of	O
pregnant	O
women	O
reporting	O
side	O
effects	O
including	O
nausea	O
and	O
vomiting	O
.	O

Future	O
mHealth	O
interventions	O
may	O
build	O
on	O
these	O
lessons	O
to	O
engage	O
audiences	O
in	O
health	O
programs	O
through	O
multiple	O
digital	O
channels	O
[	O
31	O
,	O
32	O
].	O

4	O
.	O

Genes	O
also	O
can	O
affect	O
vitamin	O
D	O
metabolism	O
,	O
skin	O
color	O
,	O
and	O
behavior	O
,	O
all	O
of	O
which	O
can	O
influence	O
circulating	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Relative	O
to	O
sun	O
exposure	O
,	O
diet	O
is	O
a	O
poor	O
source	O
of	O
colecalciferol	O
,	O
providing	O
only	O
40	O
-	O
400	O
IU	O
per	O
food	O
serving	O
,	O
12whereas	O
whole	O
-	O
body	O
UVB	O
exposure	O
for	O
20	O
min	O
for	O
a	O
light	O
-	O
skinned	O
person	O
during	O
the	O
summer	O
months	O
will	O
produce	O
at	B
least	I
10	O
,	O
000	O
IU	O
.	O
713However	O
,	O
increased	O
skin	O
pigmentation	O
,	O
age	O
,	O
use	O
of	O
sunscreen	O
,	O
built	O
environment	O
,	O
and	O
environmental	O
factors	O
that	O
reduce	O
the	O
strength	O
of	O
UVB	O
reaching	O
the	O
earth	O
’	O
s	O
surface	O
(	O
e	O
.	O
g	O
.,	O
winter	O
season	O
,	O
high	O
latitude	O
,	O
pollution	O
,	O
cloud	O
cover	O
,	O
and	O
ozone	O
levels	O
)	O
all	O
contribute	O
to	O
reduce	O
skin	O
colecalciferol	O
production	O
to	O
the	O
point	O
at	O
which	O
diet	O
might	O
become	O
the	O
primary	O
source	O
.	O
7	O
–	O
14Because	B
melanin	O
pigment	O
in	O
human	O
skin	O
absorbs	O
UVB	O
,	O
28black	O
people	O
have	O
lower	O
25	O
hydroxyvitamin	O
D	O
concentrations	O
than	O
white	O
people	O
,	O
and	O
are	O
often	B
vitamin	O
D	O
deficient	O
.	O
21However	O
,	O
the	O
risk	O
of	O
MS	O
in	O
black	O
people	O
is	O
lower	O
than	O
in	O
white	O
people	O
(	O
because	B
of	O
genetic	O
differences	O
).	O
28Analyses	O
of	O
the	O
relation	O
between	O
vitamin	O
D	O
status	O
and	O
MS	O
risk	O
are	O
therefore	B
better	O
done	O
separately	O
within	O
each	O
race	O
/	O
ethnic	O
group	O
.	O

Dean	O
et	O
al	O
.,	O
2013	O
[	O
4	O
];	O
Requejo	O
et	O
al	O
.,	O
2013	O
[	O
5	O
];	O
Lawn	O
et	O
al	O
.,	O
2013	O
[	O
6	O
].	O

In	O
the	O
present	O
study	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
in	O
mice	O
led	O
to	O
significant	O
changes	O
in	O
kidney	O
development	O
in	O
the	O
offspring	O
,	O
such	O
as	O
retardation	O
of	O
glomerular	O
maturation	O
and	O
an	O
increase	O
in	O
the	O
number	O
of	O
glomeruli	O
.	O

In	O
Models	O
1	O
and	O
4	O
,	O
there	O
was	O
also	O
a	O
trend	O
noted	O
with	O
the	O
child	O
’	O
s	O
percent	O
fat	O
being	O
positively	O
associated	O
with	O
cathelicidin	O
(	O
beta	O
=	O
0	O
.	O
028	O
,	O
p	O
=	O
0	O
.	O
052	O
and	O
beta	O
=	O
0	O
.	O
025	O
,	O
p	O
=	O
0	O
.	O
087	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multivariable	O
Linear	O
Regression	O
Models	O
Assessing	O
Factors	O
Associated	O
with	O
Natural	O
Logarithm	O
for	O
Cathelicidin	O
.	O
Model	O
1	O
Independent	O
VariablesBetaSE1p	O
valueRace	O
/	O
Ethnicity	O
Black	O
-	O
0	O
.	O
0390	O
.	O
230	O
.	O
864White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1490	O
.	O
2000	O
.	O
459GenderFemale	O
---------	O
Male0	O
.	O
3180	O
.	O
16	O
0	O
.	O
047	O
Age0	O
.	O
1450	O
.	O
065	O
0	O
.	O
028	O
Percent	O
Fat0	O
.	O
0280	O
.	O
0140	O
.	O
052Child	O
'	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
-	O
0	O
.	O
0050	O
.	O
010	O
.	O
598	O
Model	O
2	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
EthnicityBlack0	O
.	O
0350	O
.	O
210	O
.	O
868White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1490	O
.	O
210	O
.	O
470GenderFemale	O
---------	O
Male0	O
.	O
2750	O
.	O
170	O
.	O
104Age0	O
.	O
2120	O
.	O
07	O
0	O
.	O
004	O
Percent	O
Fat0	O
.	O
0250	O
.	O
020	O
.	O
087Child	O
'	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
birth	O
-	O
0	O
.	O
0030	O
.	O
010	O
.	O
748	O
Model	O
3	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
Ethnicity	O
Black0	O
.	O
0410	O
.	O
180	O
.	O
821White	O
---------	O
Hispanic	O
-	O
0	O
.	O
1220	O
.	O
160	O
.	O
458GenderFemale	O
---------	O
Male0	O
.	O
0910	O
.	O
140	O
.	O
507Age0	O
.	O
1550	O
.	O
07	O
0	O
.	O
023	O
Percent	O
Fat0	O
.	O
0120	O
.	O
010	O
.	O
359Maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
<-	O
0	O
.	O
000100	O
.	O
999	O
Model	O
4	O
Independent	O
VariablesBetaSEp	O
valueRace	O
/	O
Ethnicity	O
Black0	O
.	O
0460	O
.	O
1990	O
.	O
816White	O
---------	O
Hispanic	O
-	O
0	O
.	O
0800	O
.	O
1850	O
.	O
669GenderFemale	O
---------	O
Male0	O
.	O
3180	O
.	O
158	O
0	O
.	O
047	O
Age0	O
.	O
1510	O
.	O
064	O
0	O
.	O
021	O
Percent	O
Fat0	O
.	O
0260	O
.	O
010	O
.	O
069Maternal	O
25	O
(	O
OH	O
)	O
D	O
1	O
-	O
month	O
before	O
delivery0	O
.	O
0030	O
.	O
010	O
.	O
606	O
1SE	O
represents	O
Standard	O
Error	O
Discussion	O
In	O
this	O
study	O
of	O
healthy	O
children	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
during	O
pregnancy	O
,	O
despite	O
differences	O
in	O
both	O
maternal	O
and	O
childhood	O
vitamin	O
D	O
status	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
cathelicidin	O
concentration	O
between	O
the	O
three	O
racial	O
/	O
ethnic	O
groups	O
studied	O
.	O

In	O
humans	O
,	O
the	O
only	O
physiological	O
recovery	O
of	O
insulin	O
sensitivity	O
after	O
a	O
period	O
of	O
insulin	O
resistance	O
,	O
partially	O
due	O
to	O
an	O
increase	O
in	O
food	O
intake	O
and	O
lipogenesis	O
,	O
is	O
observed	O
in	O
women	O
after	O
pregnancy	O
(	O
Barbour	O
et	O
al	O
.,	O
2007	O
).	O

This	O
review	O
,	O
therefore	B
,	O
examines	O
the	O
present	O
understanding	O
of	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
,	O
evaluates	O
the	O
current	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
and	O
highlights	O
the	O
research	O
considerations	O
and	O
implications	O
of	O
this	O
emerging	O
knowledge	O
for	O
public	O
health	O
and	O
regulatory	O
toxicology	O
.	O

P	O
-	O
values	O
(	O
significance	O
set	O
at	O
P	O
≤	O
0	O
.	O
05	O
)	O
for	O
each	O
stage	O
were	O
converted	O
to	O
a	O
set	O
of	O
q	O
-	O
values	O
(	O
q	O
≤	O
0	O
.	O
25	O
)	O
using	O
the	O
algorithm	O
proposed	O
by	O
Storey	O
and	O
Tibshirani	O
[	O
66	O
].	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

This	O
very	O
clever	O
approach	O
gave	O
the	O
authors	O
of	O
these	O
,	O
and	O
of	O
other	O
similar	O
studies	O
from	O
both	O
Europe	O
and	O
the	O
USA	O
,	O
reasons	B
to	O
state	O
that	O
their	O
data	O
strongly	B
suggest	O
that	O
the	O
effects	O
of	O
vitamin	O
D	O
may	O
be	O
mediated	O
through	O
the	O
endometrium	O
,	O
not	O
the	O
follicle	O
or	O
oocyte	O
[	O
56	O
,	O
57	O
].	O

African	O
American	O
women	O
accounted	O
for	O
a	O
majority	O
(	O
69	O
%)	O
of	O
the	O
non	O
-	O
white	O
births	O
and	O
had	O
a	O
19	O
%	O
PTB	O
rate	O
.	O

Thus	B
,	O
the	O
correlation	O
between	O
vitamin	O
D	O
intake	O
and	O
serum	O
levels	O
may	O
vary	O
.	O

We	O
provided	O
each	O
child	O
with	O
an	O
identification	O
card	O
,	O
which	O
included	O
a	O
photograph	O
of	O
the	O
child	O
,	O
to	O
enable	O
easy	O
access	O
to	O
outpatient	O
and	O
out	O
-	O
of	O
-	O
hours	O
paediatric	O
services	O
at	O
the	O
study	O
hospital	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
was	O
lower	O
.	O

It	O
also	O
secretes	O
several	O
batokines	O
,	O
allowing	O
for	O
inter	O
-	O
organ	O
communication	O
.	O

Maternal	O
nutrient	O
restriction	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
significantly	O
advanced	O
pubertal	O
age	O
in	O
female	O
offspring	O
to	O
a	O
similar	O
degree	O
(	O
p	O
<	O
0	O
.	O
01	O
,	O
figure	O
2A	O
;	O
Table	O
1	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Clouds	O
and	O
rain	O
retard	O
vitamin	O
D	O
-	O
producing	O
ultraviolet	O
B	O
light	O
from	O
penetrating	O
the	O
atmosphere	O
.	O

In	O
view	O
of	O
hypocalcemia	O
,	O
the	O
child	O
was	O
treated	O
with	O
2	O
ml	O
/	O
kg	O
of	O
10	O
%	O
calcium	O
gluconate	O
followed	O
by	O
maintenance	O
calcium	O
,	O
following	O
which	O
the	O
stridor	O
disappeared	O
and	O
there	O
were	O
no	O
further	O
seizures	O
.	O

Further	O
,	O
linear	O
regression	O
confirmed	O
the	O
inverse	O
association	O
between	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
and	O
head	O
circumference	O
(	O
B	O
-	O
1	O
.	O
74	O
;	O
95	O
%	O
CI	O
-	O
3	O
.	O
25	O
,	O
−	O
0	O
.	O
23	O
;	O
P	O
=	O
0	O
.	O
024	O
).	O

Their	O
medical	O
and	O
psychiatric	O
histories	O
,	O
medications	O
,	O
concomitant	O
disorders	O
and	O
demographic	O
characteristics	O
did	O
not	O
differ	O
from	O
those	O
of	O
the	O
included	O
cohort	O
.	O

These	O
recommendations	O
were	O
pooled	O
into	O
themes	O
of	O
which	O
the	O
most	O
prevalent	O
theme	O
concerned	O
health	O
centre	O
amenities	O
(	O
20	O
.	O
2	O
%)	O
such	O
as	O
good	O
toilet	O
facilities	O
,	O
cleanliness	O
,	O
reduced	O
congestion	O
and	O
preferential	O
care	O
towards	O
the	O
women	O
in	O
aspects	O
such	O
as	O
rapid	O
delivery	O
of	O
laboratory	O
results	O
.	O

evaluated	O
fertility	O
and	O
the	O
long	O
-	O
term	O
effects	O
of	O
I	O
-	O
131	O
therapy	O
in	O
815	O
women	O
.	O

006	O
26769	O
.	O
4	O
0	O
.	O
003	O
No320533	O
.	O
3533	O
.	O
3	O
Obstetrician	O
Yes18555	O
.	O
425576	O
.	O
325576	O
.	O
3	O
No710	O
.	O
61725	O
.	O
81725	O
.	O
8Total	O
number	O
or	O
prenatal	O
visits	O
≤	O
422	O
.	O
8	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
>	O
419057	O
.	O
925477	O
.	O
425477	O
.	O
4Gestational	O
age	O
at	O
registration	O
(	O
months	O
)	O
<	O
418053	O
.	O
7	O
<	O
0	O
.	O
001	O
19257	O
.	O
3	O
0	O
.	O
019	O
24472	O
.	O
8	O
<	O
0	O
.	O
001	O
≥	O
41218	O
.	O
52741	O
.	O
52843	O
.	O
1Nutritional	O
questionnaire	O
score	O
Low710	O
.	O
1	O
<	O
0	O
.	O
001	O
2333	O
.	O
3	O
<	O
0	O
.	O
001	O
2231	O
.	O
9	O
<	O
0	O
.	O
001	O
Medium13747	O
.	O
114756	O
.	O
819274	O
.	O
3	O
High4865	O
.	O
84967	O
.	O
65879	O
.	O
7	O
The	O
proportion	O
of	O
less	O
well	O
-	O
educated	O
women	O
(	O
less	O
than	O
8	O
years	O
of	O
school	O
completed	O
)	O
using	O
folic	O
acid	O
(	O
p	O
=	O
.	O
007	O
),	O
iron	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
)	O
increased	O
with	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

Japanese	O
Black	O
cattle	O
breed	O
has	O
the	O
highest	O
IMF	O
content	O
in	O
the	O
world	O
,	O
and	O
Korean	O
cattle	O
(	O
also	O
called	O
Hanwoo	O
)	O
the	O
second	O
highest	O
.	O

Patients	O
with	O
high	O
initial	O
VD	O
levels	O
(	O
267	O
.	O
8	O
±	O
66	O
.	O
4	O
nmol	O
/	O
L	O
)	O
had	O
a	O
four	O
time	O
better	O
chance	B
(	O
p	O
=	O
0	O
.	O
02	O
)	O
for	O
successful	O
IVF	O
procedure	O
compared	O
to	O
the	O
group	O
with	O
low	O
VD	O
levels	O
(	O
104	O
.	O
3	O
±	O
21	O
nmol	O
/	O
L	O
)	O
[	O
54	O
].	O

Moreover	O
,	O
by	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
DNA	O
methylation	O
and	O
genomewide	O
(	O
array	O
)	O
gene	O
-	O
associated	O
methylation	O
,	O
this	O
work	O
suggests	O
potential	O
epigenetic	O
mechanisms	O
underlying	O
changes	O
to	O
placental	O
function	O
that	O
may	O
lead	O
to	O
altered	O
fetal	O
development	O
and	O
programming	O
.	O

[	O
4142	O
]	O
Endocrine	O
Society	O
Issues	O
Practice	O
Guideline	O
on	O
Vitamin	O
D	O
and	O
the	O
guideline	B
recommend	O
that	O
clinicians	O
screen	O
for	O
vitamin	O
D	O
deficiency	O
in	O
people	O
at	O
risk	O
for	O
deficiency	O
,	O
including	O
obese	O
individuals	O
,	O
blacks	O
,	O
pregnant	O
and	O
lactating	O
women	O
,	O
and	O
patients	O
with	O
malabsorption	O
syndromes	O
.	O

The	O
study	O
population	O
were	O
pregnant	O
women	O
attending	O
ANC	O
facilities	O
in	O
any	O
of	O
the	O
selected	O
sites	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

This	O
overview	O
of	O
the	O
developmental	O
influences	O
on	O
childhood	O
overweight	O
and	O
obesity	O
suggests	O
opportunities	O
for	O
intervention	O
.	O

Toxins	O
delivered	O
by	O
water	O
or	O
air	O
pollution	O
appear	O
to	O
damage	O
the	O
genome	O
of	O
the	O
vitamin	O
D	O
deficient	O
(	O
14	O
).	O

no	O
.	O

Both	O
overweight	O
/	O
obesity	O
as	O
well	O
as	O
darker	O
skin	O
pigmentation	O
are	O
both	O
well	B
-	I
established	I
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
the	O
dose	O
of	O
400	O
IU	O
daily	O
is	O
used	O
for	O
both	O
breast	O
-	O
fed	O
and	O
formula	O
-	O
fed	O
babies	O
,	O
vitamin	O
D	O
-	O
deficient	O
rickets	O
is	O
extremely	O
rare	O
in	O
formula	O
-	O
fed	O
infants	O
primarily	O
due	O
to	O
the	O
mandatory	O
addition	O
of	O
vitamin	O
D	O
to	O
infant	O
formulas	O
in	O
the	O
United	O
States	O
.	O

Summary	O
and	O
conclusions	O
Gestational	O
diabetes	O
is	O
a	O
common	O
disorder	O
which	O
in	O
the	O
majority	O
of	O
cases	O
,	O
should	O
initially	O
be	O
managed	O
by	O
dietary	O
measures	O
.	O

Of	O
the	O
total	O
(	O
n	O
=	O
128	O
)	O
of	O
participants	O
who	O
self	O
-	O
reported	O
not	O
receiving	O
influenza	O
vaccination	O
,	O
only	O
2	O
(	O
2	O
%),	O
had	O
evidence	O
of	O
influenza	O
vaccination	O
.	O

Conclusion	O
:	O
It	O
is	O
therefore	B
clear	O
that	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
Ayurveda	O
will	O
prevent	O
many	O
complications	O
of	O
pregnancy	O
,	O
which	O
will	O
lead	O
to	O
healthy	O
pregnancy	O
&	O
healthy	O
fetus	O
&	O
finally	O
good	O
outcome	O
.	O

Increasing	O
the	O
percentage	O
of	O
concentrate	O
(	O
60	O
%,	O
75	O
%,	O
and	O
90	O
%	O
concentrate	O
)	O
in	O
growing	O
diets	O
increased	O
MS	O
in	O
steers	O
[	O
118	O
].	O

Alternately	O
,	O
any	O
reduction	O
in	O
cellular	O
energetics	O
within	O
this	O
region	O
may	O
delay	O
the	O
integration	O
of	O
cortical	O
and	O
/	O
or	O
sub	O
-	O
cortical	O
inputs	O
.	O

However	O
,	O
the	O
potential	O
side	O
effects	O
of	O
any	O
drug	O
must	O
be	O
balanced	O
against	O
the	O
risks	O
of	O
the	O
mother	O
or	O
the	O
infant	O
having	O
inadequately	O
treated	O
disease	O
.	O

An	O
active	O
form	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
in	O
sperm	O
proves	O
the	O
existence	O
of	O
local	O
synthesis	O
of	O
cholecalciferol	O
and	O
strongly	B
suggests	O
its	O
paracrine	O
effect	O
on	O
spermatogenesis	O
as	O
described	O
inFigure	O
1	O
[	O
19	O
,	O
20	O
].	O

Certain	O
foods	O
and	O
the	O
chemicals	O
contained	O
in	O
these	O
foods	O
may	O
be	O
more	O
or	O
less	O
available	O
at	O
particular	O
times	O
of	O
the	O
year	O
due	O
to	O
crop	O
cycles	O
,	O
storage	O
capability	O
,	O
transportation	O
access	O
,	O
and	O
cost	O
;	O
and	O
the	O
use	O
of	O
preservatives	O
in	O
foods	O
also	O
may	O
vary	O
accordingly	O
.	O

Two	O
hundred	O
and	O
seventy	O
(	O
69	O
.	O
9	O
%)	O
respondents	O
attended	O
ANC	O
at	O
the	O
health	O
centre	O
corresponding	O
to	O
their	O
catchment	O
health	O
area	O
while	O
30	O
.	O
1	O
%	O
attended	O
at	O
a	O
different	O
health	O
centre	O
out	O
of	O
their	O
catchment	O
health	O
area	O
(	O
Figure	O
2	O
).	O

All	O
reported	O
p	O
-	O
values	O
are	O
two	O
-	O
tailed	O
.	O

Lack	O
of	O
funding	O
to	O
obtain	O
fetal	O
weights	O
estimated	O
via	O
serial	O
ultrasound	O
is	O
an	O
issue	O
in	O
the	O
analyses	O
.	O

Management	O
of	O
these	O
patients	O
and	O
providing	O
evidencebased	O
advice	O
are	O
obviously	O
extremely	O
difficult	O
tasks	O
.	O

A	O
GR	O
Bcl	O
I	O
polymorphism	O
has	O
been	O
associated	O
with	O
increased	O
glucocorticoid	O
sensitivity	O
and	O
was	O
overrepresented	O
in	O
pregnant	O
women	O
with	O
pathological	O
,	O
fetomaternal	O
immune	O
adaptation	O
.	O

In	O
Mozambique	O
,	O
mobile	O
phones	O
are	O
used	O
to	O
link	O
inventory	O
,	O
distributors	O
,	O
and	O
marketers	O
of	O
socially	O
marketed	O
products	O
,	O
such	O
as	O
condoms	O
and	O
mosquito	O
bed	O
nets	O
,	O
to	O
reach	O
low	O
income	O
consumers	O
[	O
22	O
].	O

Interestingly	O
,	O
chronic	O
central	O
IL	O
-	O
6	O
stimulation	O
desensitized	O
IL	O
-	O
6	O
signal	O
transduction	O
characterized	O
by	O
reversal	O
of	O
elevated	O
pSTAT3	O
levels	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Mendez	O
et	O
al	O
.	O

We	O
fitted	O
generalized	O
linear	O
models	O
,	O
using	O
a	O
log	O
-	O
link	O
function	O
,	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
[	O
29	O
,	O
30	O
]	O
of	O
the	O
associations	O
between	O
sleep	O
duration	O
and	O
snoring	O
variables	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
risk	O
.	O

The	O
criteria	O
described	O
by	O
Vickers	O
were	O
adopted	O
to	O
refer	O
to	O
different	O
stages	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
).	O

Data	O
from	O
three	O
trials	O
involving	O
463	O
women	O
show	O
a	O
trend	O
for	O
women	O
who	O
receive	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
to	O
more	O
frequently	O
have	O
a	O
baby	O
with	O
a	O
birth	O
weight	O
below	O
2500	O
grams	O
than	O
those	O
women	O
receiving	O
no	O
treatment	O
or	O
placebo	O
,	O
although	O
the	O
statistical	O
significance	O
was	O
borderline	O
.	O

The	O
mean	O
difference	O
in	O
head	O
circumference	O
was	O
0	O
.	O
22	O
SD	O
units	O
between	O
the	O
groups	O
with	O
optimal	O
and	O
suboptimal	O
UCB	O
25OHD	O
.	O

Alcohol	O
dehydrogenase	O
1	O
(	O
ADH	O
)	O
is	O
the	O
primary	O
enzyme	O
that	O
oxidizes	O
retinol	O
to	O
retinaldehyde	O
[	O
138	O
],	O
and	O
retinaldehyde	O
inhibits	O
adipocyte	O
differentiation	O
[	O
139	O
].	O

When	O
a	O
woman	O
lactates	O
,	O
she	O
reduces	O
her	O
own	O
body	O
burden	O
of	O
certain	O
chemicals	O
by	O
transferring	O
them	O
to	O
her	O
nursing	O
child	O
via	O
milk	O
.	O

Even	O
after	O
controlling	O
for	O
seasonal	O
influence	O
on	O
endogenous	O
synthesis	O
,	O
low	O
household	O
income	O
,	O
and	O
infrequent	O
consumption	O
of	O
vitamin	O
D	O
drops	O
and	O
milk	O
,	O
the	O
significant	O
association	O
remained	O
.	O

“	O
Browning	O
”	O
of	O
WAT	O
could	O
be	O
one	O
of	O
the	O
mechanisms	O
underlying	O
the	O
increased	O
insulin	O
sensitivity	O
of	O
LPTENKO	O
mice	O
,	O
in	O
keeping	O
with	O
the	O
observation	O
of	O
increased	O
WAT	O
glucose	O
uptake	O
(	O
Peyrou	O
et	O
al	O
.,	O
2015	O
).	O

Although	O
many	O
proteins	O
were	O
found	O
to	O
be	O
significantly	O
altered	O
in	O
DVD	O
-	O
deficient	O
adults	O
,	O
the	O
fold	O
-	O
change	O
level	O
was	O
insufficient	O
for	O
confirmation	O
analysis	O
by	O
western	O
blot	O
.	O

OR	O
Odds	O
ratio	O
.	O

We	O
mitigated	O
against	O
this	O
possible	O
source	O
of	O
error	O
by	O
asking	O
additional	O
questions	O
about	O
the	O
type	O
of	O
supplement	O
and	O
its	O
commercial	O
name	O
.	O

Maternal	O
use	O
of	O
supplements	O
,	O
specific	O
brand	O
names	O
,	O
dosing	O
,	O
and	O
date	O
of	O
commencement	O
were	O
recorded	O
.	O

Decreases	O
in	O
the	O
HRV	O
parameters	O
were	O
noted	O
in	O
newborns	O
at	O
term	O
with	O
low	O
weight	O
[	O
34	O
],	O
while	O
other	O
studies	O
observed	O
a	O
normal	O
cardiac	O
autonomic	O
balance	O
in	O
these	O
neonates	O
[	O
17	O
,	O
35	O
].	O

Decreases	O
in	O
perceived	O
stress	O
during	O
pregnancy	O
were	O
also	O
independently	O
related	O
to	O
higher	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
OR	O
=	O
1	O
.	O
5	O
(	O
1	O
.	O
1	O
,	O
2	O
.	O
0	O
);	O
P	O
=	O
.	O
01	O
)	O
but	O
did	O
not	O
independently	O
predict	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

Among	O
the	O
factors	O
evaluated	O
in	O
our	O
study	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
and	O
marital	O
status	O
were	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
during	O
pregnancy	O
,	O
independently	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

[	O
27	O
]	O
found	O
a	O
statistically	O
significant	O
inverse	O
association	O
between	O
PBDE	O
exposure	O
and	O
birth	O
weight	O
.	O

Vitamin	O
D	O
metabolism	O
in	O
the	O
placenta	O
has	O
been	O
shown	O
to	O
be	O
influenced	O
by	O
testosterone	O
production	O
and	O
thus	B
varies	O
by	O
fetal	O
sex	O
[	O
35	O
].	O

In	O
addition	O
,	O
fruits	O
,	O
vegetables	O
,	O
and	O
low	O
-	O
fat	O
dairy	O
intake	O
among	O
them	O
is	O
low	O
;	O
however	O
,	O
legumes	O
intake	O
is	O
good	O
in	O
the	O
mentioned	O
population	O
[	O
28	O
].	O

Insulin	O
is	O
still	O
the	O
mainstay	O
of	O
pharmacological	O
treatment	O
of	O
GDM	O
,	O
and	O
this	O
is	O
ideally	O
administered	O
in	O
a	O
basal	O
bolus	O
regimen	O
.	O

Visfatin	O
,	O
a	O
new	O
52KDa	O
adipokine	O
(	O
2	O
),	O
was	O
renamed	O
to	O
nicotinamide	O
phosphoribosyl	O
transferase	O
(	O
Nampt	O
)	O
in	O
2002	O
after	O
it	O
was	O
shown	O
that	O
it	O
encodes	O
an	O
enzyme	O
called	O
Nampt	O
,	O
which	O
is	O
involved	O
in	O
the	O
conversion	O
of	O
nicotinamide	O
into	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NAD	O
)(	O
3	O
).	O

A	O
brief	O
questionnaire	O
on	O
prenatal	O
vitamins	O
,	O
including	O
name	O
and	O
frequency	O
,	O
and	O
intake	O
of	O
vitamin	O
D	O
rich	O
foods	O
was	O
completed	O
.	O

However	O
,	O
only	O
among	O
participants	O
vaccinated	O
in	O
the	O
first	O
trimester	O
,	O
the	O
percentage	O
with	O
preterm	O
birth	O
was	O
12	O
%,	O
significantly	O
higher	O
than	O
the	O
unvaccinated	O
group	O
(	O
6	O
%;	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
;	O
Supplementary	O
material	O
A2	O
).	O

Briefly	O
,	O
the	O
left	O
kidneys	O
were	O
fixed	O
in	O
freshly	O
prepared	O
fixative	O
(	O
1	O
.	O
27	O
M	O
formaldehyde	O
in	O
0	O
.	O
1	O
M	O
phosphate	O
buffer	O
,	O
pH	O
7	O
.	O
2	O
)	O
for	O
48	O
h	O
at	O
room	O
temperature	O
,	O
longitudinally	O
divided	O
into	O
two	O
halves	O
,	O
embedded	O
face	O
down	O
in	O
Paraplast	O
plus	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
Louis	O
,	O
MO	O
,	O
USA	O
),	O
serially	O
sectioned	O
at	O
a	O
nominal	O
thickness	O
of	O
5	O
µm	O
and	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

Additionally	O
,	O
differences	O
in	O
breast	O
milk	O
composition	O
due	O
to	O
maternal	O
diet	O
may	O
contribute	O
to	O
the	O
infant	O
gut	O
microbiome	O
in	O
breastfed	O
infants	O
.	O

Newborn	O
piglets	O
were	O
individually	O
weighed	O
immediately	O
after	O
birth	O
and	O
one	O
male	O
piglets	O
of	O
the	O
mean	O
body	O
weight	O
were	O
selected	O
per	O
litter	O
and	O
sacrificed	O
before	O
suckling	O
.	O

Lenters	O
et	O
al	O
.	O

has	O
shown	O
that	O
infants	O
with	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
have	O
a	O
higher	O
risk	O
of	O
respiratory	O
tract	O
infection	O
before	O
the	O
age	O
of	O
3	O
months	O
[	O
7	O
].	O

We	O
aimed	O
to	O
examine	O
the	O
association	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
with	O
the	O
infant	O
gut	O
microbiome	O
6	O
weeks	O
post	O
-	O
delivery	O
in	O
mother	O
-	O
infant	O
dyads	O
enrolled	O
in	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
.	O

A	O
strong	O
,	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
VD	O
and	O
sperm	O
motility	O
and	O
morphology	O
was	O
also	O
found	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

This	B
means	I
that	I
for	O
each	O
dollar	O
invested	O
in	O
a	O
weekly	O
iron	O
supplementation	O
and	O
de	O
-	O
worming	O
program	O
the	O
monetary	O
value	O
in	O
terms	O
of	O
productivity	O
was	O
USD6	O
.	O
70	O
.	O

Furthermore	O
,	O
men	O
were	O
not	O
included	O
in	O
the	O
study	O
and	O
there	O
is	O
gender	O
difference	O
in	O
the	O
prevalence	O
of	O
psychosis	O
[	O
59	O
].	O

The	O
25OHD	O
concentration	O
has	O
been	O
shown	O
to	O
have	O
immunological	O
effects	O
in	O
women	O
with	O
a	O
history	O
of	O
recurrent	O
pregnancy	O
loss	O
[	O
12	O
].	O

In	O
other	O
words	O
,	O
the	O
respective	O
growth	O
of	O
the	O
BAT	O
and	O
WAT	O
depots	O
depends	O
on	O
the	O
maternal	O
diet	O
during	O
gestation	O
and	O
it	O
may	O
be	O
responsible	O
for	O
the	O
development	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
the	O
offspring	O
,	O
later	O
in	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Overall	O
,	O
findings	O
from	O
the	O
current	O
study	O
support	O
a	O
stronger	O
role	O
for	O
maternal	O
intake	O
than	O
expenditure	O
in	O
predicting	O
offspring	O
weight	O
outcomes	O
,	O
but	O
additional	O
studies	O
with	O
objective	O
measures	O
of	O
physical	O
activity	O
(	O
e	O
.	O
g	O
.,	O
accelerometry	O
)	O
are	O
clearly	O
needed	O
.	O

Furthermore	O
,	O
individuals	O
with	O
sleep	O
disorders	O
may	O
be	O
predisposed	O
to	O
insulin	O
resistance	O
and	O
glucose	O
intolerance	O
due	O
to	O
sleep	O
-	O
related	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
with	O
consequent	O
elevations	O
in	O
serum	O
cortisol	O
[	O
16	O
,	O
45	O
].	O

Knowledge	O
of	O
ANC	O
activities	O
done	O
at	O
the	O
ANC	O
The	O
responses	O
by	O
participants	O
concerning	O
routine	O
activities	O
at	O
antenatal	O
clinics	O
revealed	O
that	O
physical	O
examination	O
was	O
the	O
most	O
frequent	O
activity	O
and	O
the	O
least	O
was	O
vaccination	O
.	O

TG	O
synthesis	O
is	O
a	O
key	O
factor	O
for	O
IMF	O
deposition	O
[	O
69	O
].	O

Interventions	O
such	O
as	O
family	O
planning	O
;	O
prevention	O
and	O
management	O
of	O
sexually	O
transmitted	O
infections	O
(	O
STIs	O
);	O
use	O
of	O
insecticide	O
-	O
treated	O
bednets	O
and	O
intermittent	O
preventive	O
treatment	O
for	O
malaria	O
;	O
identification	O
and	O
treatment	O
of	O
pre	O
-	O
eclampsia	O
,	O
and	O
reduction	O
of	O
physical	O
workload	O
are	O
examples	O
of	O
strategies	O
that	O
could	O
improve	O
birth	O
outcomes	O
in	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
.	O

By	O
comparison	O
,	O
forced	O
expiration	O
maneuvers	O
more	O
closely	O
reflect	O
the	O
function	O
of	O
the	O
intrathoracic	O
airway	O
.	O

There	O
is	O
evidence	O
that	O
lifestyle	O
modification	O
,	O
aiming	O
for	O
a	O
5	O
%–	O
7	O
%	O
reduction	O
in	O
body	O
weight	O
,	O
is	O
effective	O
in	O
preventing	O
or	O
delaying	O
the	O
development	O
of	O
diabetes	O
in	O
people	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Improving	O
the	O
nutritional	O
condition	O
of	O
cows	O
during	O
pregnancy	O
affects	O
growth	O
,	O
fat	O
deposition	O
,	O
and	O
beef	O
quality	O
in	O
steers	O
;	O
steers	O
from	O
cows	O
grazing	O
with	O
better	O
pasture	O
(	O
Thinopyrum	O
–	O
Elymus	O
–	O
Psathrystachus	O
,	O
CP	O
11	O
.	O
1	O
%	O
to	O
6	O
.	O
0	O
%)	O
during	O
mid	O
-	O
to	O
late	O
gestation	O
had	O
greater	O
live	O
body	O
weight	O
at	O
slaughter	O
,	O
HCW	O
,	O
and	O
tenderness	O
,	O
and	O
had	O
an	O
increased	O
tendency	O
for	O
IMF	O
deposition	O
compared	O
with	O
offspring	O
of	O
cows	O
grazing	O
on	O
native	O
range	O
(	O
Bouteloua	O
–	O
Hesperostipa	O
–	O
Pascopyron	O
,	O
CP	O
6	O
.	O
5	O
%	O
to	O
5	O
.	O
4	O
%)	O
[	O
155	O
].	O

Furthermore	O
,	O
the	O
propensity	O
score	O
analyses	O
minimized	O
biases	O
introduced	O
by	O
differences	O
in	O
baseline	O
characteristics	O
between	O
unvaccinated	O
and	O
vaccinated	O
pregnant	O
women	O
by	O
accounting	O
for	O
the	O
probability	O
of	O
vaccination	O
based	B
on	I
these	O
characteristics	O
[	O
43	O
].	O

Ethnicity	O
was	O
also	O
a	O
major	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
present	O
study	O
,	O
as	O
previously	O
reported	O
in	O
the	O
adult	O
population	O
[	O
32	O
]	O
and	O
in	O
pregnant	O
women	O
[	O
29	O
],[	O
48	O
],[	O
49	O
].	O

Irisin	O
,	O
obtained	O
by	O
cleavage	O
from	O
the	O
precursor	O
protein	O
,	O
fibronectin	O
type	O
III	O
domain	O
containing	O
5	O
(	O
FNDC5	O
),	O
was	O
described	O
as	O
promoting	O
the	O
appearance	O
/	O
recruitment	O
of	O
“	O
brite	O
”	O
cells	O
in	O
white	O
adipose	O
depots	O
(	O
Bostrom	O
et	O
al	O
.,	O
2012	O
;	O
Lee	O
et	O
al	O
.,	O
2014a	O
).	O

Finding	O
about	O
neonatal	O
weight	O
showed	O
that	O
those	O
in	O
the	O
top	O
quartile	O
of	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
marginally	O
significant	O
chance	B
of	O
having	O
low	O
weight	O
infant	O
compared	O
with	O
those	O
in	O
the	O
bottom	O
quartile	O
in	O
the	O
crude	O
model	O
[	O
OR	O
1	O
.	O
84	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
94	O
-	O
3	O
.	O
60	O
),	O
P	O
=	O
0	O
.	O
05	O
].	O

EPA	O
and	O
DHA	O
are	O
mainly	O
found	O
in	O
fatty	O
fish	O
,	O
with	O
levels	O
that	O
vary	O
by	O
the	O
species	O
of	O
the	O
fish	O
,	O
environmental	O
factors	O
and	O
geographic	O
area	O
[	O
27	O
].	O

Furthermore	O
,	O
a	O
GRS	O
including	O
rs10741657	O
and	O
rs2282679	O
showed	O
that	O
for	O
each	O
additional	O
risk	O
allele	O
,	O
late	O
pregnancy	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
after	O
supplementation	O
with	O
cholecalciferol	O
was	O
lower	O
by	O
4	O
.	O
4	O
nmol	O
/	O
L	O
(	O
95	O
%	O
CI	O
,	O
2	O
.	O
3	O
to	O
6	O
.	O
6	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Another	O
study	O
found	O
that	O
smoking	O
during	O
the	O
12	O
months	O
before	O
birth	O
of	O
a	O
child	O
was	O
associated	O
with	O
adolescent	O
overweight	O
(	O
21	O
).	O

The	O
service	O
launched	O
in	O
February	O
2010	O
and	O
delivers	O
text	O
messages	O
to	O
pregnant	O
women	O
and	O
new	O
mothers	O
.	O

Background	O
Early	O
Childhood	O
Caries	O
(	O
ECC	O
)	O
is	O
the	O
most	O
common	O
chronic	O
disease	O
of	O
childhood	O
and	O
is	O
defined	B
as	B
any	O
decay	O
in	O
the	O
primary	O
dentition	O
of	O
children	O
<	O
72	O
months	O
of	O
age	O
[	O
1	O
,	O
2	O
].	O

The	O
latitude	O
of	O
Houston	O
,	O
TX	O
is	O
29	O
degrees	O
,	O
more	O
southern	O
than	O
the	O
typically	O
used	O
latitude	O
cutoff	O
of	O
Atlanta	O
,	O
Georgia	O
of	O
33	O
degrees	O
for	O
sunlight	O
exposure	O
to	O
lead	O
to	O
vitamin	O
D	O
formation	O
in	O
the	O
dermis	O
to	O
occur	O
throughout	O
the	O
year	O
.	O

Not	B
surprisingly	I
,	O
they	O
found	O
that	O
children	O
who	O
breastfed	O
longer	O
had	O
higher	O
levels	O
of	O
PFASs	O
in	O
their	O
blood	O
.	O

The	O
microarrays	O
were	O
processed	O
at	O
the	O
University	O
of	O
California	O
–	O
San	O
Francisco	O
Institute	O
for	O
Human	O
Genetics	O
and	O
Genomics	O
Core	O
Facility	O
,	O
following	O
standard	O
protocols	O
.	O

These	O
mutant	O
mice	O
will	O
serve	O
as	O
useful	O
models	O
for	O
the	O
study	O
of	O
vertebral	O
malformations	O
.	O

For	B
this	I
reason	I
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	O
biochemical	O
markers	O
that	O
reflect	O
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	O
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

FGF21	O
deficiency	O
in	O
mice	O
was	O
shown	O
to	O
result	O
in	O
impaired	O
ability	O
to	O
adapt	O
to	O
long	O
-	O
term	O
cold	O
exposure	O
with	O
diminished	O
“	O
browning	O
”	O
of	O
WAT	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

This	O
limitation	O
has	O
to	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
the	O
data	O
and	O
further	O
research	O
will	O
be	O
addressed	O
to	O
evaluate	O
the	O
reasons	O
for	O
the	O
sex	O
-	O
dimorphic	O
alterations	O
.	O

In	O
Finland	O
,	O
Baum	O
et	O
al	O
.	O

Conclusions	O
Developmental	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
subtle	O
changes	O
in	O
protein	O
expression	O
in	O
the	O
nucleus	O
accumbens	O
.	O

A	O
limitation	O
of	O
this	O
study	O
was	O
that	O
nearly	O
two	O
-	O
thirds	O
of	O
the	O
women	O
(	O
63	O
%)	O
had	O
only	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
,	O
which	O
prohibited	O
assessment	O
by	O
trimester	O
and	O
a	O
more	O
thorough	O
analysis	O
of	O
vitamin	O
D	O
benefit	O
among	O
those	O
with	O
low	O
initial	O
levels	O
.	O

When	O
a	O
simple	O
increase	O
in	O
serum	O
Htg	O
levels	O
is	O
observed	O
,	O
further	O
therapy	O
is	O
not	O
necessary	O
.	O

Food	O
restriction	O
in	O
dams	O
produced	O
a	O
decrease	O
in	O
caloric	O
intake	O
of	O
female	O
offspring	O
treated	O
with	O
AM251	O
(	O
Figure3H	O
).	O

It	O
is	O
important	O
that	O
providers	O
be	O
given	O
the	O
tools	O
to	O
empower	O
them	O
to	O
discuss	O
herbal	O
medicine	O
use	O
with	O
patients	O
,	O
and	O
are	O
encouraged	O
to	O
do	O
so	O
.	O

Methods	O
A	O
search	O
of	O
the	O
Canada	O
Vigilance	O
Database	O
from	O
April	O
1	O
,	O
2008	O
to	O
August	O
31	O
,	O
2013	O
identified	O
15	O
cases	O
of	O
anaphylaxis	O
and	O
16	O
reports	O
of	O
serious	O
non	O
-	O
anaphylactic	O
allergic	O
reactions	O
.	O

The	O
cohort	O
has	O
been	O
followed	O
since	O
birth	O
with	O
annual	O
questionnaires	O
and	O
,	O
since	O
age	O
7	O
years	O
,	O
with	O
objective	O
measures	O
in	O
annual	O
research	O
clinics	O
.	O

Approximately	O
40	O
-	O
80	O
%	O
of	O
the	O
oral	O
dose	O
is	O
absorbed	O
,	O
with	O
peak	O
serum	O
levels	O
measured	O
within	O
2	O
-	O
4	O
hour	O
,	O
and	O
the	O
half	O
-	O
life	O
of	O
the	O
administered	O
dose	O
is	O
approximately	O
1	O
week	O
.	O

3	O
.	O
7	O
.	O

The	O
mediators	O
of	O
such	O
beneficial	O
effects	O
seem	O
to	O
include	O
FGF21	O
,	O
interleukin	O
-	O
6	O
,	O
BMP8B	O
and	O
prostaglandin	O
D2	O
synthase	O
.	O

Body	O
weight	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
offspring	O
were	O
evaluated	O
during	O
the	O
lactation	O
and	O
/	O
or	O
post	O
-	O
weaning	O
periods	O
(	O
Figures2B	O
,	O
C	O
).	O

We	O
conducted	O
a	O
literature	O
review	O
to	O
assess	O
evidence	O
suggested	O
in	O
the	O
worldwide	O
literature	O
.	O

